APPROVED

                         DRUG

                       PRODUCTS

                                           WITH


                                THERAPEUTIC

                                EQUIVALENCE

                                EVALUATIONS

                     35th EDITION


THE PRODUCTS IN THIS LIST HAVE BEEN APPROVED UNDER
SECTION 505 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.


          U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

                   FOOD AND DRUG ADMINISTRATION

             CENTER FOR DRUG EVALUATION AND RESEARCH

              OFFICE OF MEDICAL PRODUCTS AND TOBACCO
                      OFFICE OF GENERIC DRUGS



                              2015

        APPROVED DRUG PRODUCTS

                  with

  THERAPEUTIC EQUIVALENCE EVALUATIONS





The products in this list have been approved under section 505 of the
Federal Food, Drug, and Cosmetic Act. This volume is current through
December 31, 2014.




                      35th EDITION




      U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

                   FOOD AND DRUG ADMINISTRATION

             CENTER FOR DRUG EVALUATION AND RESEARCH

              OFFICE OF MEDICAL PRODUCTS AND TOBACCO

                      OFFICE OF GENERIC DRUGS





                                2015

                           FOOD AND DRUG ADMINISTRATION
                   CENTER FOR DRUG EVALUATION AND RESEARCH
                             APPROVED DRUG PRODUCTS
                                          with
                           Therapeutic Equivalence Evaluations

                                                          CONTENTS
                                                                                                                         PAGE

PREFACE TO THIRTY FIFTH EDITION……….………………………………..…................iv


 1 INTRODUCTION................................................................................................................ vi

1.1  Content and Exclusion ................................................................................................... vi

1.2  Therapeutic Equivalence-Related Terms ....................................................................... vi

1.3  Statistical Criteria for Bioequivalence ............................................................................viii

1.4  Reference Listed Drug .................................................................................................... x

1.5  General Policies and Legal Status ................................................................................. xi

1.6  Practitioner/User Responsibilities .................................................................................. xi

1.7  Therapeutic Equivalence Evaluations Codes ................................................................xiii

1.8  Description of Special Situations...................................................................................xxi

1.9  Therapeutic Equivalence Code Change for a Drug Entity ........................................... xxiii

1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product .................... xxiv

1.11 Discontinued Section ..................................................................................................xxiv

1.12 Changes to the Orange Book......................................................................................xxiv

1.13 Availability of the Edition ..............................................................................................xxv


  2      HOW TO USE THE DRUG PRODUCTS LISTS ..............................................................2-1

2.1       Key Sections for Using the Drug Product Lists …………………….….………………......2-1

2.2       Drug Product Illustration ……………………………………………..….…………….……..2-3

2.3       Therapeutic Equivalence Evaluations Illustration ………………….….…………..………2-4

DRUG PRODUCT LISTS

 Prescription Drug Product List ……………………………………….…………….………………...3-1

 OTC Drug Product List ……………………………………………….…………….…………………4-1

 Drug Products with Approval under Section 505 of the Act Administered

      by the Center for Biologics Evaluation and Research List ...……….…….………………...5-1

 Discontinued Drug Product List .…………………………………………….…….………………....6-1

 Orphan Products Designations and Approvals List …………….………….…….………………..7-1

 Drug Products Which Must Demonstrate in vivo Bioavailability

 Only if Product Fails to Achieve Adequate Dissolution …………………..………………………..8-1


APPENDICES
      A. Product Name Index ……….…...………………………….………..……………………A-1
      B. Product Name Index Listed by Applicant ………………….……..……………………..B-1

      C. Uniform Terms …………………………………………….………..…………...………...C-1


PATENT AND EXCLUSIVITY INFORMATION ADDENDUM ……….……..………………..........AD1

       A. Patent and Exclusivity Lists …………………………….…..……..……………..……ADA1
       B. Patent and Exclusivity Terms ...……………………….….………...…………………ADB1
                 FOOD AND DRUG ADMINISTRATION

            CENTER FOR DRUG EVALUATION AND RESEARCH

                    APPROVED DRUG PRODUCTS

                                with

                 Therapeutic Equivalence Evaluations


                  PREFACE TO THIRTY FIFTH EDITION
    The publication, Approved Drug Products with Therapeutic Equivalence
Evaluations (the List, commonly known as the Orange Book), identifies drug
products approved on the basis of safety and effectiveness by the Food and
Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the
Act). Drugs on the market approved only on the basis of safety (covered by
the ongoing Drug Efficacy Study Implementation [DESI] review [e.g., Donnatal®
Tablets and Librax® Capsules] or pre-1938 drugs [e.g., Phenobarbital
Tablets]) are not included in this publication. The main criterion for the
inclusion of any product is that the product is the subject of an application
with an effective approval that has not been withdrawn for safety or efficacy
reasons. Inclusion of products on the List is independent of any current
regulatory action through administrative or judicial means against a drug
product. In addition, the List contains therapeutic equivalence evaluations
for approved multisource prescription drug products. These evaluations have
been prepared to serve as public information and advice to state health
agencies, prescribers, and pharmacists to promote public education in the
area of drug product selection and to foster containment of health care
costs. Therapeutic equivalence evaluations in this publication are not
official FDA actions affecting the legal status of products under the Act.

    Background of the Publication. To contain drug costs, virtually every
state has adopted laws and/or regulations that encourage the substitution of
drug products. These state laws generally require either that substitution
be limited to drugs on a specific list (the positive formulary approach) or
that it be permitted for all drugs except those prohibited by a particular
list (the negative formulary approach). Because of the number of requests in
the late 1970s for FDA assistance in preparing both positive and negative
formularies, it became apparent that FDA could not serve the needs of each
state on an individual basis. The Agency also recognized that providing a
single list based on common criteria would be preferable to evaluating drug
products on the basis of differing definitions and criteria in various state
laws. As a result, on May 31, 1978, the Commissioner of the Food and Drug
Administration sent a letter to officials of each state stating FDA's intent
to provide a list of all prescription drug products that are approved by FDA
for safety and effectiveness, along with therapeutic equivalence
determinations for multisource prescription products.

    The List was distributed as a proposal in January l979. It included only
currently marketed prescription drug products approved by FDA through new
drug applications (NDAs) and abbreviated new drug applications (ANDAs) under
the provisions of Section 505 of the Act.

    The therapeutic equivalence evaluations in the List reflect FDA's
application of specific criteria to the multisource prescription drug
products on the List approved under Section 505 of the Act. These
evaluations are presented in the form of code letters that indicate the basis
for the evaluation made. An explanation of the code appears in the
Introduction.

                                      iv
    A complete discussion of the background and basis of FDA's therapeutic
equivalence evaluation policy was published in the Federal Register on
January 12, 1979 (44 FR 2932). The final rule, which includes FDA's
responses to the public comments on the proposal, was published in the
Federal Register on October 31, 1980 (45 FR 72582). The first publication,
October 1980, of the final version of the List incorporated appropriate
corrections and additions. Each subsequent edition has included the new
approvals and made appropriate changes in data.

    On September 24, 1984, the President signed into law the Drug Price
Competition and Patent Term Restoration Act (1984 Amendments). The 1984
Amendments require that FDA, among other things, make publicly available a
list of approved drug products with monthly supplements. The Approved Drug
Products with Therapeutic Equivalence Evaluations publication and its monthly
Cumulative Supplements satisfy this requirement. The Addendum to this
publication identifies drugs that qualify under the 1984 Amendments for
periods of exclusivity (during which ANDAs or applications described in
Section 505(b)(2) of the Act for those drugs may not be submitted for a
specified period of time and, if allowed to be submitted, would be
tentatively approved) and provides patent information concerning the listed
drugs which also may delay the approval of ANDAs or Section 505(b)(2)
applications. The Addendum also provides additional information that may be
helpful to those submitting a new drug application to the Agency.

    The Agency intends to use this publication to further its objective of
obtaining input and comment on the publication itself and related Agency
procedures. Therefore, if you have comments on how the publication can be
improved, please send them to the Director, Division of Legal & Regulatory
Support, Office of Generic Drugs, Center for Drug and Evaluation and
Research, 7620 Standish Place, Rockville, MD 20855-2773. Comments received
are publicly available to the extent allowable under the Freedom of
Information regulations.




                                      v
                                   1. INTRODUCTION


1.1 Content and Exclusion

    The List is composed of four parts: (1) approved prescription drug
products with therapeutic equivalence evaluations; (2) approved
over-the-counter (OTC) drug products for those drugs that may not be marketed
without NDAs or ANDAs because they are not covered under existing OTC
monographs; (3) drug products with approval under Section 505 of the Act
administered by the Center for Biologics Evaluation and Research; and (4) a
cumulative list of approved products that have never been marketed, are for
exportation, are for military use, have been discontinued from marketing, or
have had their approvals withdrawn for other than safety or efficacy reasons
subsequent to being discontinued from marketing. 1 This publication also
includes indices of prescription and OTC drug products by trade or
established name (if no trade name exists) and by applicant name (holder of
the approved application). All established names for active ingredients
generally conform to official compendial names or United States Adopted Names
(USAN) as prescribed in (21 CFR 299.4(e)). The latter list includes
applicants’ names as abbreviated in this publication; in addition, a list of
uniform terms is provided.

    An Addendum contains drug patent and exclusivity information for the
Prescription, OTC, Discontinued Drug Product Lists, and for the Drug Products
with Approval under Section 505 of the Act Administered by the Center for
Biologics Evaluation and Research. The publication may include additional
information that the Agency deems appropriate to disseminate.

    Prior to the 6th Edition, the publication had excluded OTC drug products
and drug products with approval under Section 505 of the Act administered by
the Center for Biologics Evaluation and Research because the main purpose of
the publication was to provide information to states regarding FDA's
recommendation as to which generic prescription drug products were acceptable
candidates for drug product selection. The 1984 Amendments required the
Agency to begin publishing an up-to-date list of all marketed drug products,
OTC as well as prescription, that have been approved for safety and efficacy
and for which new drug applications are required.

    Under the 1984 Amendments, some drug products are given tentative
approvals. The Agency will not include drug products with tentative approval
in the List. Tentative approval lists are available at ANDA (Generic) Drug
Approvals. When the tentative approval becomes a full approval through a
subsequent action letter to the application holder, the Agency will list the
drug product and the final approval date in the appropriate approved drug
product list.

    Distributors or repackagers of products on the List are not identified.
Because distributors or repackagers are not required to notify FDA when they
shift their sources of supply from one approved manufacturer to another, it
is not possible to maintain complete information linking product approval
with the distributor or repackager handling the products.


1.2 Therapeutic Equivalence-Related Terms

1
  Newly approved products are added to parts 1, 2, or 3, of the List, depending on the dispensing
requirements (prescription or OTC) or approval authority, unless the Orange Book staff is
otherwise notified before publication.


                                                vi
    Pharmaceutical Equivalents. Drug products are considered pharmaceutical
equivalents if they contain the same active ingredient(s), are of the same
dosage form, route of administration and are identical in strength or
concentration (e.g., chlordiazepoxide hydrochloride, 5mg capsules).
Pharmaceutically equivalent drug products are formulated to contain the same
amount of active ingredient in the same dosage form and to meet the same or
compendial or other applicable standards (i.e., strength, quality, purity,
and identity), but they may differ in characteristics such as shape, scoring
configuration, release mechanisms, packaging, excipients (including colors,
flavors, preservatives), expiration time, and, within certain limits,
labeling.

    Pharmaceutical Alternatives. Drug products are considered pharmaceutical
alternatives if they contain the same therapeutic moiety, but are different
salts, esters, or complexes of that moiety, or are different dosage forms or
strengths (e.g., tetracycline hydrochloride, 250mg capsules vs. tetracycline
phosphate complex, 250mg capsules; quinidine sulfate, 200mg tablets vs.
quinidine sulfate, 200mg capsules). Data are generally not available for FDA
to make the determination of tablet to capsule bioequivalence. Different
dosage forms and strengths within a product line by a single manufacturer are
thus pharmaceutical alternatives, as are extended-release products when
compared with immediate-release or standard-release formulations of the same
active ingredient.

    Therapeutic Equivalents. Drug products are considered to be therapeutic
equivalents only if they are pharmaceutical equivalents and if they can be
expected to have the same clinical effect and safety profile when
administered to patients under the conditions specified in the labeling.

    FDA classifies as therapeutically equivalent those products that meet the
following general criteria: (1) they are approved as safe and effective;
(2) they are pharmaceutical equivalents in that they (a) contain identical
amounts of the same active drug ingredient in the same dosage form and route
of administration, and (b) meet compendial or other applicable standards of
strength, quality, purity, and identity; (3) they are bioequivalent in that
(a) they do not present a known or potential bioequivalence problem, and they
meet an acceptable in vitro standard, or (b) if they do present such a known
or potential problem, they are shown to meet an appropriate bioequivalence
standard; (4) they are adequately labeled; (5) they are manufactured in
compliance with Current Good Manufacturing Practice regulations. The concept
of therapeutic equivalence, as used to develop the List, applies only to drug
products containing the same active ingredient(s) and does not encompass a
comparison of different therapeutic agents used for the same condition (e.g.,
propoxyphene hydrochloride vs. pentazocine hydrochloride for the treatment of
pain). Any drug product in the List repackaged and/or distributed by other
than the application holder is considered to be therapeutically equivalent to
the application holder's drug product even if the application holder's drug
product is single source or coded as non-equivalent (e.g., BN). Also,
distributors or repackagers of an application holder's drug product are
considered to have the same code as the application holder. Therapeutic
equivalence determinations are not made for unapproved, off-label
indications.

    FDA considers drug products to be therapeutically equivalent if they meet
the criteria outlined above, even though they may differ in certain other
characteristics such as shape, scoring configuration, release mechanisms,
packaging, excipients (including colors, flavors, preservatives), expiration
date/time and minor aspects of labeling (e.g., the presence of specific
pharmacokinetic information) and storage conditions. When such differences
are important in the care of a particular patient, it may be appropriate for
                                      vii
the prescribing physician to require that a particular brand be dispensed as
a medical necessity. With this limitation, however, FDA believes that
products classified as therapeutically equivalent can be substituted with the
full expectation that the substituted product will produce the same clinical
effect and safety profile as the prescribed product.

    Bioavailability. This term means the rate and extent to which the active
ingredient or active moiety is absorbed from a drug product and becomes
available at the site of action. For drug products that are not intended to
be absorbed into the bloodstream, bioavailability may be assessed by
measurements intended to reflect the rate and extent to which the active
ingredient or active moiety becomes available at the site of action.

    Bioequivalent Drug Products. This term describes pharmaceutical equivalent
or pharmaceutical alternative products that display comparable
bioavailability when studied under similar experimental conditions. Section
505 (j)(8)(B) of the Act describes one set of conditions under which a test
and reference listed drug (see Section 1.4) shall be considered
bioequivalent:

        the rate and extent of absorption of the test drug do not show a
        significant difference from the rate and extent of absorption of the
        reference drug when administered at the same molar dose of the
        therapeutic ingredient under similar experimental conditions in either
        a single dose or multiple doses; or

        the extent of absorption of the test drug does not show a significant
        difference from the extent of absorption of the reference drug when
        administered at the same molar dose of the therapeutic ingredient under
        similar experimental conditions in either a single dose or multiple
        doses and the difference from the reference drug in the rate of
        absorption of the drug is intentional, is reflected in its proposed
        labeling, is not essential to the attainment of effective body drug
        concentrations on chronic use, and is considered medically
        insignificant for the drug.

    Where these above methods are not applicable (e.g., for drug products that
are not intended to be absorbed into the bloodstream), other in vivo or in
vitro test methods to demonstrate bioequivalence may be appropriate.

    Bioequivalence may sometimes be demonstrated using an in vitro
bioequivalence standard, especially when such an in vitro test has been
correlated with human in vivo bioavailability data. In other situations,
bioequivalence may sometimes be demonstrated through comparative clinical
trials or pharmacodynamic studies.


1.3 Statistical Criteria for Bioequivalence

    Under the Drug Price Competition and Patent Term Restoration Act of 1984,
manufacturers seeking approval to market a generic drug product must submit
data demonstrating that the drug product is bioequivalent to the pioneer
(innovator) drug product. A major premise underlying the 1984 law is that
bioequivalent drug products are therapeutically equivalent, and therefore,
interchangeable.

    Bioavailability refers to the rate and extent to which the active
ingredient or therapeutic ingredient is absorbed from a drug product and
becomes available at the site of drug action (Federal Food, Drug and Cosmetic
Act, section 505(j)(8)). Bioequivalence refers to equivalent release of the
same drug substance from two or more drug products or formulations. This
                                              viii
leads to an equivalent rate and extent of absorption from these formulations.
Underlying the concept of bioequivalence is the thesis that, if a drug
product contains a drug substance that is chemically identical and is
delivered to the site of action at the same rate and extent as another drug
product, then it is equivalent and can be substituted for that drug product.
Methods used to define bioequivalence can be found in 21 CFR 320.24, and
include (1) pharmacokinetic (PK) studies, (2) pharmacodynamic (PD) studies,
(3) comparative clinical trials, and (4) in-vitro studies. The choice of
study used is based on the site of action of the drug and the ability of the
study design to compare drug delivered to that site by the two products.

    The standard bioequivalence (PK) study is conducted using a two-treatment
crossover study design in a limited number of volunteers, usually 24 to 36
adults. Alternately, a four-period, replicate design crossover study may
also be used.   Single doses of the test and reference drug products are
administered and blood or plasma levels of the drug are measured over time.
Pharmacokinetic parameters characterizing rate and extent of drug absorption
are evaluated statistically. The PK parameters of interest are the resulting
area under the plasma concentration-time curve (AUC), calculated to the last
measured concentration (AUC(0-t)) and extrapolated to infinity (AUC(0-inf)), for
extent of absorption; and the maximum or peak drug concentrations (Cmax), for
rate of absorption. Crossover studies may not be practical in drugs with a
long half-life in the body, and a parallel study design may be used instead.
Alternate study methods, such as in-vitro studies or equivalence studies with
clinical or pharmacodynamic endpoints, are used for drug products where
plasma concentrations are not useful to determine delivery of the drug
substance to the site of activity (such as inhalers, nasal sprays and topical
products applied to the skin).

    The statistical methodology for analyzing these bioequivalence studies is
called the two one-sided test procedure. Two situations are tested with this
statistical methodology. The first of the two one-sided tests determines
whether a generic product (test), when substituted for a brand-name product
(reference) is significantly less bioavailable. The second of the two one-
sided tests determines whether a brand-name product when substituted for a
generic product is significantly less bioavailable. Based on the opinions of
FDA medical experts, a difference of greater than 20% for each of the above
tests was determined to be significant, and therefore, undesirable for all
drug products. Numerically, this is expressed as a limit of test-product
average/reference-product average of 80% for the first statistical test and a
limit of reference-product average/test-product average of 80% for the second
statistical test. By convention, all data is expressed as a ratio of the
average response (AUC and Cmax) for test/reference, so the limit expressed in
the second statistical test is 125% (reciprocal of 80%).

    For statistical reasons, all data is log-transformed prior to conducting
statistical testing. In practice, these statistical tests are carried out
using an analysis of variance procedure (ANOVA) and calculating a 90%
confidence interval for each pharmacokinetic parameter (Cmax and AUC). The
confidence interval for both pharmacokinetic parameters, AUC and Cmax, must
be entirely within the 80% to 125% boundaries cited above. Because the mean
of the study data lies in the center of the 90% confidence interval, the mean
of the data is usually close to 100% (a test/reference ratio of 1). Different
statistical criteria are sometimes used when bioequivalence is demonstrated
through comparative clinical trials pharmacodynamic studies, or comparative
in-vitro methodology.

    The bioequivalence methodology and criteria described above simultaneously
control for both differences in the average response between test and
reference, as well as the precision with which the average response in the
population is estimated. This precision depends on the within-subject
                                       ix
(normal volunteer or patient) variability in the pharmacokinetic parameters
(AUC and Cmax) of the two products and on the number of subjects in the
study. The width of the 90% confidence interval is a reflection in part of
the within-subject variability of the test and reference products in the
bioequivalence study. A test product with no differences in the average
response when compared to the reference might still fail to pass the
bioequivalence criteria if the variability of one or both products is high
and the bioequivalence study has insufficient statistical power (i.e.,
insufficient number of subjects). Likewise, a test product with low
variability may pass the bioequivalence criteria, when there are somewhat
larger differences in the average response.

    This system of assessing bioequivalence of generic products assures that
these substitutable products do not deviate substantially in in-vivo
performance from the reference product. The Office of Generic Drugs has
conducted two surveys to quantify the differences between generic and brand
name products. The first survey included 224 bioequivalence studies
submitted in approved applications during 1985 and 1986. The observed
average differences between reference and generic products for AUC was 3.5%
(JAMA, Sept. 4, 1987, Vol. 258, No. 9). The second survey included 127
bioequivalence studies submitted to the agency in 273 ANDAs approved in 1997.
The three measures reviewed include AUC(0-t), AUC(0-inf), and Cmax. The observed
average differences between the reference and generic products were + 3.47%
(SD 2.84) for AUC(0-t), + 3.25% (SD 2.97) for AUC(0-inf), and + 4.29% (SD 3.72)
for Cmax (JAMA, Dec. 1, 1999, Vol. 282, No. 21).

    The primary concern from the regulatory point of view is the protection of
the patient against approval of products that are not bioequivalent. The
current practice of carrying out two one-sided tests at the 0.05 level of
significance ensures that there is no more than a 5% chance that a generic
product that is not truly equivalent to the reference will be approved.


1.4 Reference Listed Drug

    A reference listed drug (21 CFR 314.94(a)(3)) means the listed drug
identified by FDA as the drug product upon which an applicant relies in
seeking approval of its ANDA.

    FDA has identified in the Prescription Drug Product and OTC Drug Product
Lists those reference listed drugs to which the in vivo bioequivalence
(reference standard) and, in some instances, the in vitro bioequivalence of
the applicant's product is compared. By designating a single reference
listed drug as the standard to which all generic versions must be shown to be
bioequivalent, FDA hopes to avoid possible significant variations among
generic drugs and their brand name counterpart. Such variations could result
if generic drugs were compared to different reference listed drugs. However,
in some instances when listed drugs are approved for a single drug product, a
product not designated as the reference listed drug and not shown to be
bioequivalent to the reference listed drug may be shielded from generic
competition. A firm wishing to market a generic version of a listed drug
that is not designated as the reference listed drug may petition the Agency
through the Citizen Petition procedure (see 21 CFR 10.25(a) and CFR 10.30).
When the Citizen Petition is approved, the second listed drug will be
designated as an additional reference listed drug and the petitioner may
submit an Abbreviated New Drug Application citing the designated reference
listed drug. Section 1.7, Therapeutic Equivalence Evaluations Codes products
meeting necessary bioequivalence requirements explains the (AB, AB1, AB2,
AB3... coding system for multisource drug products listed under the same
heading with two reference listed drugs.

                                        x
    In addition, there are two situations in which two listed drugs that have
been shown to be bioequivalent to each other may both be designated as
reference listed drugs. The first situation occurs when the in vivo
determination of bioequivalence is self-evident and a waiver of the in vivo
bioequivalence may be granted. The second situation occurs when the
bioequivalence of two listed products may be determined through in vitro
methodology. The reference listed drug is identified by the symbol "+" in
the Prescription and Over-the-Counter (OTC) Drug Product Lists. These
identified reference listed drugs represent the best judgment of the Division
of Bioequivalence at this time. The Prescription and OTC Drug Product Lists
identify reference drugs for oral dosage forms, Injectables, ophthalmics,
otics, and topical products. It is recommended that a firm planning to
conduct an in vivo bioequivalence study, or planning to manufacture a batch
of a drug product for which an in vivo waiver of bioequivalence will be
requested, contact the Division of Bioequivalence, Office of Generic Drugs,
to confirm the appropriate reference listed drug.




1.5 General Policies and Legal Status

    The List contains public information and advice. It does not mandate the
drug products which is purchased, prescribed, dispensed, or substituted for
one another, nor does it, conversely, mandate the products that should be
avoided. To the extent that the List sets forth FDA's evaluations of the
therapeutic equivalence of drug products that have been approved, it contains
FDA's advice to the public, to practitioners and to the states regarding drug
product selection. These evaluations do not constitute determinations that
any product is in violation of the Act or that any product is preferable to
any other. Therapeutic equivalence evaluations are a scientific judgment
based upon evidence, while generic substitution may involve social and
economic policy administered by the states, intended to reduce the cost of
drugs to consumers. To the extent that the List identifies drug products
approved under Section 505 of the Act, it sets forth information that the
Agency is required to publish and that the public is entitled to under the
Freedom of Information Act. Exclusion of a drug product from the List does
not necessarily mean that the drug product is either in violation of Section
505 of the Act, or that such a product is not safe or effective, or that such
a product is not therapeutically equivalent to other drug products. Rather,
the exclusion is based on the fact that FDA has not evaluated the safety,
effectiveness, and quality of the drug product.


1.6   Practitioner/User Responsibilities

    Professional care and judgment should be exercised in using the List.
Evaluations of therapeutic equivalence for prescription drugs are based on
scientific and medical evaluations by FDA. Products evaluated as
therapeutically equivalent can be expected, in the judgment of FDA, to have
equivalent clinical effect and no difference in their potential for adverse
effects when used under the conditions of their labeling. However, these
products may differ in other characteristics such as shape, scoring
configuration, release mechanisms, packaging, excipients (including colors,
flavors, preservatives), expiration date/time, and, in some instances,
labeling. If products with such differences are substituted for each other,
there is a potential for patient confusion due to differences in color or
shape of tablets, inability to provide a given dose using a partial tablet if
the proper scoring configuration is not available, or decreased patient
acceptance of certain products because of flavor. There may also be better
                                           xi
stability of one product over another under adverse storage conditions, or
allergic reactions in rare cases due to a coloring or a preservative
ingredient, as well as differences in cost to the patient.

    FDA evaluation of therapeutic equivalence in no way relieves practitioners
of their professional responsibilities in prescribing and dispensing such
products with due care and with appropriate information to individual
patients. In those circumstances where the characteristics of a specific
product, other than its active ingredient, are important in the therapy of a
particular patient, the physician's specification of that product is
appropriate. Pharmacists must also be familiar with the expiration
dates/times and labeling directions for storage of the different products,
particularly for reconstituted products, to assure that patients are properly
advised when one product is substituted for another.

    Multisource and single-source drug products. FDA has evaluated for
therapeutic equivalence only multisource prescription drug products approved
under Section 505 of the Act, which in most instances means those
pharmaceutical equivalents available from more than one manufacturer. For
such products, a therapeutic equivalence code is included and, in addition,
product information is highlighted in bold face and underlined. Those
products with approved applications that are single-source (i.e., there is
only one approved product available for that active ingredient, dosage form,
route of administration, and strength) are also included on the List, but no
therapeutic equivalence code is included with such products. Any drug
product in the List repackaged and/or distributed by other than the
application holder is considered to be therapeutically equivalent to the
application holder's drug product even if the application holder's drug
product is single source or coded as non-equivalent (e.g., BN). Also,
although not identified in the List, distributors or repackagers of an
application holder's drug product are considered to have the same code as the
application holder. The details of these codes and the policies underlying
them are discussed in Section 1.7, Therapeutic Equivalence Evaluations Codes.

    Products on the List are identified by the names of the holders of
approved applications (applicants) who may not necessarily be the
manufacturer of the product. The applicant may have had its product
manufactured by a contract manufacturer and may simply be distributing the
product for which it has obtained approval. In most instances, however, the
manufacturer of the product is also the applicant. The name of the
manufacturer is permitted by regulation to appear on the label, even when the
manufacturer is not the marketer.

    Although the products on the List are identified by the names of the
applicants, circumstances, such as changing corporate ownership, have
sometimes made identification of the applicant difficult. The Agency
believes, based on continuing document review and communication with firms,
that the applicant designations on the List are, in most cases, correct.

    To relate firm name information on a product label to that on the List,
the following should be noted: the applicant's name always appears on the
List. This applies whether the applicant (firm name on the Form FDA 356h in
the application) is the marketer (firm name in largest letters on the label)
or not. However, the applicant's name may not always appear on the label of
the product.

    If the applicant is the marketer, its name appears on the List and on the
label; if the applicant is not the marketer, and the Agency is aware of a
corporate relationship (e.g., parent and subsidiary) between the applicant
and the marketer, the name of the applicant appears on the List and both firm
names may appear on the label. Firms with known corporate relationships are
                                      xii
displayed in Appendix B. If there is no known corporate relationship between
the applicant and the marketer, the applicant's name appears on the List;
however, unless the applicant is the manufacturer, packager, or distributor,
the applicant's name may not appear on the label. In this case, the
practitioner, from labeling alone, will not be able to relate the marketed
product to an applicant cited in the List, and hence to a specific approved
drug product. In such cases, to assure that the product in question is the
subject of an approved application, the firm named on the label should be
contacted.

    To relate trade name (proprietary name) information on a product label to
that on the List, the following should be noted: if the applicant is the
marketer, its name appears on the List and on the label; if the Agency is
aware of a corporate relationship between the applicant and the marketer, the
trade name (proprietary name) of the drug product (established drug name if
no trade name exists) appears on the List. If a corporate relationship
exists between an application holder and a marketer and both firms are
distributing the drug product, the FDA reserves the right to select the trade
name of either the marketer or the application holder to appear on the List.
If there is no known corporate relationship between the applicant and the
marketer, the established drug name appears on the List.

    Every product on the List is subject at all times to regulatory action.
From time to time, approved products may be found in violation of one or more
provisions of the Act. In such circumstances, the Agency will commence
appropriate enforcement action to correct the violation, if necessary, by
securing removal of the product from the market by voluntary recall, seizure,
or other enforcement actions. Such regulatory actions are, however,
independent of the inclusion of a product on the List. The main criterion
for inclusion of a product is that it has an application with an effective
approval that has not been withdrawn for safety or efficacy reasons. FDA
believes that retention of a violative product on the List will not have any
significant adverse health consequences, because other legal mechanisms are
available to the Agency to prevent the product's actual marketing. FDA may
however, change a product's therapeutic equivalence rating if the
circumstances giving rise to the violation change or otherwise call into
question the data upon which the Agency's assessment of whether a product
meets the criteria for therapeutic equivalence was made.


1.7 Therapeutic Equivalence Evaluations Codes

    The coding system for therapeutic equivalence evaluations is constructed
to allow users to determine quickly whether the Agency has evaluated a
particular approved product as therapeutically equivalent to other
pharmaceutically equivalent products (first letter) and to provide additional
information on the basis of FDA's evaluations (second letter). With few
exceptions, the therapeutic equivalence evaluation date is the same as the
approval date.

    The two basic categories into which multisource drugs have been placed are
indicated by the first letter as follows:

    A Drug products that FDA considers to be therapeutically equivalent to
    other pharmaceutically equivalent products, i.e., drug products for which:

       (1) there are no known or suspected bioequivalence problems. 	 These are
           designated AA, AN, AO, AP, or AT, depending on the dosage form; or

       (2) actual or potential bioequivalence problems have been resolved with
           adequate in vivo and/or in vitro evidence supporting
                                            xiii
              bioequivalence.      These are designated AB.

      B Drug products that FDA at this time, considers not to be
      therapeutically equivalent to other pharmaceutically equivalent products,
      i.e.,

          drug products for which actual or potential bioequivalence problems
          have not been resolved by adequate evidence of bioequivalence. Often
          the problem is with specific dosage forms rather than with the active
          ingredients. These are designated BC, BD, BE, BN, BP, BR, BS, BT, BX,
          or B*.

    Individual drug products have been evaluated as therapeutically equivalent
to the reference product in accordance with the definitions and policies
outlined below:


                                               "A" CODES

      Drug products that are considered to be therapeutically equivalent to other pharmaceutically
      equivalent products.

    "A" products are those for which actual or potential bioequivalence
problems have been resolved with adequate in vivo and/or in vitro evidence
supporting bio-equivalence. Drug products designated with an "A" code fall
under one of two main policies:

(1)    for those active ingredients or dosage forms for which no in vivo
       bioequivalence issue is known or suspected, the information necessary to
       show bioequivalence between pharmaceutically equivalent products is
       presumed and considered self-evident based on other data in the
       application for some dosage forms (e.g., solutions) or satisfied for
       solid oral dosage forms by a showing that an acceptable in vitro
       dissolution standard is met. A therapeutically equivalent rating is
       assigned such products so long as they are manufactured in accordance
       with Current Good Manufacturing Practice regulations and meet the other
       requirements of their approved applications (these are designated AA, AN,
       AO, AP, or AT, depending on the dosage form, as described below); or

(2) for those DESI drug products containing active ingredients or dosage

     forms that have been identified by FDA as having actual or potential

     bioequivalence problems, and for post-1962 drug products in a dosage 

     form presenting a potential bioequivalence problem, an evaluation of 

     therapeutic equivalence is assigned to pharmaceutical equivalents only

     if the approved application contains adequate scientific evidence

     establishing through in vivo and/or in vitro studies the bioequivalence

     of the product to a selected reference product (these products are 

     designated as AB).


    There are some general principles that may affect the substitution of
pharmaceutically equivalent products in specific cases. Prescribers and
dispensers of drugs should be alert to these principles so as to deal
appropriately with situations that require professional judgment and
discretion.

    There may be labeling differences among pharmaceutically equivalent
products that require attention on the part of the health professional. For
example, pharmaceutically equivalent powders to be reconstituted for
administration as oral or injectable liquids may vary with respect to their
expiration time or storage conditions after reconstitution. An FDA
evaluation that such products are therapeutically equivalent is applicable
                                                xiv
only when each product is reconstituted, stored, and used under the
conditions specified in the labeling of that product.

    The Agency will use notes in this publication to point out special
situations such as potential differences between two drug products that have
been evaluated as bioequivalent and otherwise therapeutically equivalent,
when they should be brought to the attention of health professionals. These
notes are contained in Section 1.8, Description of Special Situations.

    For example, in rare instances, there may be variations among
therapeutically equivalent products in their use or in conditions of
administration. Such differences may be due to patent or exclusivity rights
associated with such use. When such variations may, in the Agency's opinion,
affect prescribing or substitution decisions by health professionals, a note
will be added to Section 1.8.

    Also, occasionally a situation may arise in which changes in a listed drug
product after its approval (for example, a change in dosing interval) may
have an impact on the substitutability of already approved generic versions
of that product that were rated by the Agency as therapeutically equivalent
to the listed product. When such changes in the listed drug product are
considered by the Agency to have a significant impact on therapeutic
equivalence, the Agency will change the therapeutic equivalence ratings for
other versions of the drug product unless the manufacturers of those other
versions of the product provide additional information to assure equivalence
under the changed conditions. Pending receipt of the additional data, the
Agency may add a note to Section 1.8, or, in rare cases, may even change the
therapeutic equivalence rating.

    In some cases (e.g., Isolyte® S w/ Dextrose 5% in Plastic Container and
Plasma-Lyte® 148 and Dextrose 5% in Plastic Container), closely related
products are listed as containing the same active ingredients, but in
somewhat different amounts. In determining which of these products are
pharmaceutically equivalent, the Agency has considered products to be
pharmaceutically equivalent with labeled strengths of an ingredient that do
not vary by more than 1%.

    Different salts and esters of the same therapeutic moiety are regarded as
pharmaceutical alternatives. For the purpose of this publication, such
products are not considered to be therapeutically equivalent. There are no
instances in this List where pharmaceutical alternatives are evaluated or
coded with regard to therapeutic equivalence. Anhydrous and hydrated
entities, as well as different polymorphs, are considered pharmaceutical
equivalents and must meet the same standards and, where necessary, as in the
case of ampicillin/ampicillin trihydrate, their equivalence is supported by
appropriate bioavailability/bioequivalence studies.

    The codes in this book are not intended to preclude health care
professionals from converting pharmaceutically different concentrations into
pharmaceutical equivalents using accepted professional practice.

    Where package size variations have therapeutic implications, products so
packaged have not been considered pharmaceutically equivalent. For example,
some oral contraceptives are supplied in 21-tablet and 28-tablet packets; the
28-tablet packets contain 7 placebo or iron tablets. These two packaging
configurations are not regarded as pharmaceutically equivalent; thus, they
are not designated as therapeutically equivalent.

    Preservatives may differ among some therapeutically equivalent drug
products. Differences in preservatives and other inactive ingredients do not

                                      xv
affect FDA's evaluation of therapeutic equivalence except in cases where
these components may influence bioequivalence or routes of administration.

    The specific sub-codes for those drugs evaluated as therapeutically
equivalent and the policies underlying these sub-codes follow:


   AA Products in conventional dosage forms not presenting bioequivalence problems

   Products coded as AA contain active ingredients and dosage forms that are
   not regarded as presenting either actual or potential bioequivalence
   problems or drug quality or standards issues. However, all oral dosage
   forms must, nonetheless, meet an appropriate in vitro bioequivalence
   standard that is acceptable to the Agency in order to be approved.

   AB, AB1, AB2, AB3... Products meeting necessary bioequivalence requirements

   Multisource drug products listed under the same heading (i.e., identical
   active ingredients(s), dosage form, and route(s) of administration) and
   having the same strength (see Section 1.2, Therapeutic Equivalence-Related
   Terms, Pharmaceutical Equivalents) generally will be coded AB if a study
   is submitted demonstrating bioequivalence.

   In certain instances, a number is added to the end of the AB code to make
   a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes
   are assigned only in situations when more than one reference listed drug
   of the same strength has been designated under the same heading. Two or
   more reference listed drugs are generally selected only when there are at
   least two potential reference drug products which are not bioequivalent to
   each other. If a study is submitted that demonstrates bioequivalence to a
   specific listed drug product, the generic product will be given the same
   three-character code as the reference listed drug it was compared against.
   For example, Adalat® CC (Miles) and Procardia XL® (Pfizer), extended-
   release tablets, are listed under the active ingredient nifedipine. These
   drug products, listed under the same heading, are not bioequivalent to
   each other. Generic drug products deemed by FDA to be bioequivalent to
   Adalat® CC and Procardia XL® have been approved, Adalat® CC and Procardia
   XL® have been assigned ratings of AB1 and AB2, respectively. The generic
   drug products bioequivalent to Adalat® CC would be assigned a rating of
   AB1 and those bioequivalent to Procardia XL® would be assigned a rating of
   AB2. (The assignment of an AB1 or AB2 rating to a specific product does
   not imply product preference.) Even though drug products of distributors
   and/or repackagers are not included in the List, they are considered
   therapeutically equivalent to the application holder's drug product if the
   application holder's drug product is rated either with an AB or three-
   character code or is single source in the List. Drugs coded as AB under a
   heading are considered therapeutically equivalent only to other drugs
   coded as AB under that heading. Drugs coded with a three-character code
   under a heading are considered therapeutically equivalent only to other
   drugs coded with the same three-character code under that heading.


   AN Solutions and powders for aerosolization

   Uncertainty regarding the therapeutic equivalence of aerosolized products
   arises primarily because of differences in the drug delivery system.
   Solutions and powders intended for aerosolization that are marketed for
   use in any of several delivery systems are considered to be
   pharmaceutically and therapeutically equivalent and are coded AN. Those
   products that are compatible only with a specific delivery system or those
   products that are packaged in and with a specific delivery system are
                                           xvi
coded BN, unless they have met an appropriate bioequivalence standard.
Solutions or suspensions in a specific delivery system will be coded AN if
the bioequivalence standard is based upon in vitro methodology, if
bioequivalence needs to be demonstrated by in vivo methodology then the
drug products will be coded AB.


AO Injectable oil solutions

The absorption of drugs in injectable (parenteral) oil solutions may vary
substantially with the type of oil employed as a vehicle and the
concentration of the active ingredient. Injectable oil solutions are
therefore considered to be pharmaceutically and therapeutically equivalent
only when the active ingredient, its concentration, and the type of oil
used as a vehicle are all identical.


AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous
   solutions

It should be noted that even though injectable (parenteral) products under
a specific listing may be evaluated as therapeutically equivalent, there
may be important differences among the products in the general category,
Injectable; Injection. For example, some injectable products that are
rated therapeutically equivalent are labeled for different routes of
administration. In addition, some products evaluated as therapeutically
equivalent may have different preservatives or no preservatives at all.
Injectable products available as dry powders for reconstitution,
concentrated sterile solutions for dilution, or sterile solutions ready
for injection are pharmaceutical alternative drug products. They are not
rated as therapeutically equivalent (AP) to each other even if these
pharmaceutical alternative drug products are designed to produce the same
concentration prior to injection and are similarly labeled.   Consistent
with accepted professional practice, it is the responsibility of the
prescriber, dispenser, or individual administering the product to be
familiar with a product's labeling to assure that it is given only by the
route(s) of administration stated in the labeling.

Certain commonly used large volume intravenous products in glass
containers are not included on the List (e.g., dextrose injection 5%,
dextrose injection 10%, sodium chloride injection 0.9%) since these
products are on the market without FDA approval and the FDA has not
published conditions for marketing such parenteral products under approved
NDAs. When packaged in plastic containers, however, FDA regulations
require approved applications prior to marketing. Approval then depends
on, among other things, the extent of the available safety data involving
the specific plastic component of the product. All large volume
parenteral products are manufactured under similar standards, regardless
of whether they are packaged in glass or plastic. Thus, FDA has no reason
to believe that the packaging container of large volume parenteral drug
products that are pharmaceutically equivalent would have any effect on
their therapeutic equivalence.


The strength of parenteral drugs products is defined as the total drug
content of the container. Until recently the strength of liquid
parenteral drug products in the Orange Book have not been displayed. The
concentration of the liquid parenteral drug product in the Orange Book has
been shown as xmg/ml. The amount of dry powder or freeze dried powder in
a container has always been identified as the strength.

                                         xvii
   With the finalization of the Waxman-Hatch amendments that characterized
   each strength of a drug product as a listed drug, it became evident that
   the format of the Orange Book should be changed to reflect each strength
   of a parenteral solution. To this end the OGD has started to display the
   strength of all new approvals of parenteral solutions. Previously we
   would have displayed only the concentration of an approved parenteral
   solution, e.g. 50mg/ml. If this drug product had a 20 ml and 60 ml
   container approved the two products would be shown as 1Gm / 20ml (50mg/ml)
   and 3Gm / 60ml (50mg/ml).


   AT Topical products

   There are a variety of topical dosage forms available for dermatologic,
   ophthalmic, otic, rectal, and vaginal administration, including creams,
   gels, lotions, oils, ointments, pastes, solutions, sprays and
   suppositories. Even though different topical dosage forms may contain the
   same active ingredient and potency, these dosage forms are not considered
   pharmaceutically equivalent. Therefore, they are not considered
   therapeutically equivalent. All solutions and DESI drug products
   containing the same active ingredient in the same topical dosage form for
   which a waiver of in vivo bioequivalence has been granted and for which
   chemistry and manufacturing processes are adequate to demonstrate
   bioequivalence, are considered therapeutically equivalent and coded AT.
   Pharmaceutically equivalent topical products that raise questions of
   bioequivalence, including all post-1962 non-solution topical drug
   products, are coded AB when supported by adequate bioequivalence data, and
   BT in the absence of such data.


                                             "B" CODES

   Drug products that FDA, at this time, considers not to be therapeutically equivalent to other
   pharmaceutically equivalent products.

    "B" products, for which actual or potential bioequivalence problems have
not been resolved by adequate evidence of bioequivalence, often have a
problem with specific dosage forms rather than with the active ingredients.
Drug products designated with a "B" code fall under one of three main
policies:

   (1)   the drug products contain active ingredients or are manufactured in
         dosage forms that have been identified by the Agency as having
         documented bio-equivalence problems or a significant potential for
         such problems and for which no adequate studies demonstrating
         bioequivalence have been submitted to FDA; or

   (2)   the quality standards are inadequate or FDA has an insufficient basis
         to determine therapeutic equivalence; or

   (3)   the drug products are under regulatory review.

    The specific coding definitions and policies for the "B" sub-codes are as
follows:




                                              xviii
B* Drug products requiring further FDA investigation and review to determine therapeutic
equivalence

The code B* is assigned to products previously assigned an A or B code
when FDA receives new information that raises a significant question
regarding therapeutic equivalence that can be resolved only through
further Agency investigation and/or review of data and information
submitted by the applicant. The B* code signifies that the Agency will
take no position regarding the therapeutic equivalence of the product
until the Agency completes its investigation and review.


BC Extended-release dosage forms (capsules, injectables and tablets)

Extended-release tablets are formulated in such a manner as to make the
contained medicament available over an extended period of time following
ingestion.

Although bioavailability studies have been conducted on these dosage
forms, they may be subject to bioavailability differences, primarily
because firms developing extended-release products for the same active
ingredient rarely employ the same formulation approach. FDA, therefore,
does not consider different extended-release dosage forms containing the
same active ingredient in equal strength to be therapeutically equivalent
unless equivalence between individual products in both rate and extent has
been specifically demonstrated through appropriate bioequivalence studies.
Extended-release products for which such bioequivalence data have not been
submitted are coded BC, while those for which such data are available have
been coded AB.


BD Active ingredients and dosage forms with documented bioequivalence problems

The BD code denotes products containing active ingredients with known
bioequivalence problems and for which adequate studies have not been
submitted to FDA demonstrating bioequivalence. Where studies showing
bioequivalence have been submitted, the product has been coded AB.


BE Delayed-release oral dosage forms

Where the drug may be destroyed or inactivated by the gastric juice or
where it may irritate the gastric mucosa, the use of “enteric” coatings is
indicated. Such coatings are intended to delay the release of the
medication until the tablet has passed through the stomach. Drug products
in delayed-release dosage forms containing the same active ingredients are
subject to significant differences in absorption. Unless otherwise
specifically noted, the Agency considers different delayed-release
products containing the same active ingredients as presenting a potential
bioequivalence problem and codes these products BE in the absence of
in vivo studies showing bioequivalence. If adequate in vivo studies have
demonstrated the bioequivalence of specific delayed-release products, such
products are coded AB.


BN Products in aerosol-nebulizer drug delivery systems

This code applies to drug solutions or powders that are marketed only as a
component of, or as compatible with, a specific drug delivery system.
There may, for example, be significant differences in the dose of drug and
particle size delivered by different products of this type. Therefore,
                                         xix
the Agency does not consider different metered aerosol dosage forms
containing the same active ingredient(s) in equal strengths to be
therapeutically equivalent unless the drug products meet an appropriate
bioequivalence standard, such products are coded AB.


BP Active ingredients and dosage forms with potential bioequivalence problems

FDA's bioequivalence regulations (21 CFR 320.33) contain criteria and
procedures for determining whether a specific active ingredient in a
specific dosage form has a potential for causing a bioequivalence problem.
It is FDA's policy to consider an ingredient meeting these criteria as
having a potential bioequivalence problem even in the absence of positive
data demonstrating inequivalence. Pharmaceutically equivalent products
containing these ingredients in oral dosage forms are coded BP until
adequate in vivo bioequivalence data are submitted, such products are
coded AB. Injectable suspensions containing an active ingredient
suspended in an aqueous or oleaginous vehicle have also been coded BP.
Injectable suspensions are subject to bioequivalence problems because
differences in particle size, polymorphic structure of the suspended
active ingredient, or the suspension formulation can significantly affect
the rate of release and absorption. FDA does not consider pharmaceutical
equivalents of these products bioequivalent without adequate evidence of
bioequivalence, such products would be coded AB.


BR Suppositories or enemas that deliver drugs for systemic absorption

The absorption of active ingredients from suppositories or enemas that are
intended to have a systemic effect (as distinct from suppositories
administered for local effect) can vary significantly from product to
product. Therefore, FDA considers pharmaceutically equivalent systemic
suppositories or enemas bio-equivalent only if in vivo evidence of
bioequivalence is available. In those cases where in vivo evidence is
available, the product is coded AB. If such evidence is not available,
the products are coded BR.


BS Products having drug standard deficiencies

If the drug standards for an active ingredient in a particular dosage form
are found by FDA to be deficient so as to prevent an FDA evaluation of
either pharmaceutical or therapeutic equivalence, all drug products
containing that active ingredient in that dosage form are coded BS. For
example, if the standards permit a wide variation in pharmacologically
active components of the active ingredient such that pharmaceutical
equivalence is in question, all products containing that active ingredient
in that dosage form are coded BS.



BT Topical products with bioequivalence issues

This code applies mainly to post-1962 dermatologic, ophthalmic, otic,
rectal, and vaginal products for topical administration, including creams,
ointments, gels, lotions, pastes, and sprays, as well as suppositories not
intended for systemic drug absorption. Topical products evaluated as
having acceptable clinical performance, but that are not bioequivalent to
other pharmaceutically equivalent products or that lack sufficient
evidence of bioequivalence, will be coded BT.

                                         xx
    BX Drug products for which the data are insufficient to determine therapeutic equivalence

    The code BX is assigned to specific drug products for which the data that
    have been reviewed by the Agency are insufficient to determine therapeutic
    equivalence under the policies stated in this document. In these
    situations, the drug products are presumed to be therapeutically
    inequivalent until the Agency has determined that there is adequate
    information to make a full evaluation of therapeutic equivalence.


1.8 Description of Special Situations

    Certain drugs listed in the Orange Book present special situations that
merit further discussion. Following is a description of those special
situations:

    Amino Acid and Protein Hydrolysate Injections. These products differ in
the amount and kinds of amino acids they contain and, therefore, are not
considered pharmaceutical equivalents. For this reason, these products are
not considered therapeutically equivalent. At the same time, the Agency
believes that it is appropriate to point out that where nitrogen balance is
the sole therapeutic objective and individual amino acid content is not a
consideration, pharmaceutical alternatives with the same total amount of
nitrogen content may be considered therapeutically equivalent.

    Follitropin Alfa and Beta. Based on available data derived from physico­
chemical tests and bioassay, follitropin alfa and follitropin beta are
indistinguishable.

    Gaviscon®.   Gaviscon® is an OTC product which has been marketed since
September 1970. The active ingredients in this product, aluminum hydroxide
and magnesium trisilicate, were reviewed by the Agency's OTC Antacid Panel
and were considered to be safe and effective ingredients (Category I) by that
Panel. However, the tablet failed to pass the antacid test which is required
of all antacid products. The Agency, therefore, placed the tablet in
Category III for lack of effectiveness. A full NDA with clinical studies was
submitted by Marion Laboratories, Inc., and approved by FDA on December 9,
1983. Gaviscon®’s activity in treating reflux acidity is made possible by
the physical-chemical properties of the inactive ingredients, sodium
bicarbonate and alginic acid. Therefore, all ANDAs which cite Gaviscon®
tablets as the listed drug must contain the inactive ingredients sodium
bicarbonate and alginic acid. A full NDA will be required to support the
effectiveness of the drug product if different inactive ingredients are to be
substituted for sodium bicarbonate or alginic acid or if different
proportions of these ingredients are to be used.

      Levothyroxine Sodium. Because there are multiple reference listed drugs
of levothyroxine sodium tablets and some reference listed drugs' sponsors
have conducted studies to establish their drugs' therapeutic equivalence to
other reference listed drugs, FDA has determined that its usual practice of
assigning two or three character TE codes may be potentially confusing and
inadequate for these drug products. Accordingly, FDA provides the following
explanation and chart of therapeutic equivalence evaluations for
levothyroxine sodium drug products.

Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to be
therapeutically equivalent to corresponding strengths of Unithroid (Jerome
Stevens NDA 021210) tablets.

Levo-T (Alara NDA 021342), Levothyroxine Sodium (Mylan ANDA 76187), Unithroid
                                              xxi
(Jerome Stevens NDA 021210), and Levothyroxine Sodium (Merck KGAA ANDA
76752)tablets have been determined to be therapeutically equivalent to
corresponding strengths of Synthroid (Abbott NDA 021402) tablets.

Levo-T (Alara NDA 021342), Unithroid (Jerome Stevens NDA 021210),
Levothyroxine Sodium (Mylan ANDA 076187), and Levothyroxine Sodium (Merck
KGAA ANDA 76752) tablets have been determined to be therapeutically
equivalent to corresponding strengths of Levoxyl (King Pharms NDA 021301)
tablets.

Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to be
therapeutically equivalent to corresponding strengths of Levothroid (Lloyd
NDA 021116) tablets.

The chart outlines TE codes for all 0.025mg products. Other product
strengths may be similar. Therapeutic equivalence has been established
between products that have the same AB+number TE code. More than one TE code
may apply to some products. One common TE code indicates therapeutic
equivalence between products.

                                                           TE    Appl     Product
         Trade Name          Applicant          Potency
                                                          Code    No         No
    UNITHROID              STEVENS J            0.025MG   AB1    021210     001
    LEVOTHYROXINE SODIUM   MYLAN                0.025MG   AB1    076187     001
    LEVOXYL                KING PHARMS          0.025MG   AB1    021301     001
    SYNTHROID              ABBOTT               0.025MG   AB1    021402     001
    LEVO-T                 ALARA PHARM          0.025MG   AB1    021342     001


    SYNTHROID              ABBOTT               0.025MG   AB2    021402     001
    LEVOTHYROXINE SODIUM   MYLAN                0.025MG   AB2    076187     001
    LEVO-T                 ALARA PHARM          0.025MG   AB2    021342     001
    UNITHROID              STEVENS J            0.025MG   AB2    021210     001


    LEVOXYL                KING PHARMS          0.025MG   AB3    021301     001
    LEVO-T                 ALARA PHARM          0.025MG   AB3    021342     001
    UNITHROID              STEVENS J            0.025MG   AB3    021210     001
    LEVOTHYROXINE SODIUM   MYLAN                0.025MG   AB3    076187     001


    LEVOTHROID             LLOYD                0.025MG   AB4    021116     001
    LEVOTHYROXINE SODIUM   MYLAN                0.025MG   AB4    076187     001



Patent Certification(s) Reference Listed Drug based upon a suitability
petition. An abbreviated new drug application that refers to a Reference
Listed Drug (RLD) approved pursuant to a suitability petition must
demonstrate that the proposed product is bioequivalent to the RLD, and it
must include appropriate patent certification(s) and an exclusivity statement
with respect to the listed drug which served as the basis for the approved
suitability petition. This concept also applies to an ANDA applicant that
cites a RLD that was based upon an NDA that is still covered by patent (s)
and/or exclusivity, e.g. a second RLD that was selected when the in vivo
determination of bioequivalence of the original RLD is self evident and the
waiver of the in vivo determination of bioequivalence may be granted.


   Waived exclusivity.     If a new drug application (NDA) submitted under
                                         xxii
section 505(b) of the Federal Food, Drug, and Cosmetic Act (Act) qualifies
for exclusivity under sections 505(c)(3)(D) and 505(j)(5)(D), the exclusivity
is listed in the Patent and Exclusivity Section of the Orange Book. If a
drug product has received this exclusivity, the FDA will delay the approval
of a 505(b)(2) application or an abbreviated new drug application (ANDA)
under section 505(j) of the Act until the expiration of the exclusivity. If
the listed drug is also protected by one or more patents, the approval date
for the 505(b)(2) application or ANDA will be determined by the latest
expiring patent or exclusivity listed in the Orange Book. However, the
holder of the NDA may waiver its exclusivity as to any or all 505(b)(2) and
ANDA applications referencing the protected drug product. If an NDA sponsor
waivers its right to the exclusivity protection, qualified 505(b)(2) or ANDA
applications may be approved without regard to the NDA holder's exclusivity.
An NDA for which the holder has waived its exclusivity as to all 505(b)(2)
and ANDA applications will be coded with a W in the Patent and Exclusivity
Section of the Orange Book and be referred to this section. The applicant
referencing this listed drug should indicate in the exclusivity statement
that the holder of the listed drug has waived its exclusivity.


1.9 Therapeutic Equivalence Code Change for a Drug Entity

    The Agency will use the following procedures when, in response to a
petition or on its own initiative, it is considering a change in the
therapeutic equivalence code for approved multi-source drug products. Such
changes will generally occur when the Agency becomes aware of new scientific
information affecting the therapeutic equivalence of an entire category of
drug products in the List (e.g., information concerning the active ingredient
or the dosage form), rather than information concerning a single drug product
within the category. These procedures will be used when a change in
therapeutic equivalence code is under consideration for all drug products
found in the Prescription Drug Product List under a specific drug entity and
dosage form. The change may be from the code signifying that the drug does
not present a bioequivalence problem (e.g., AA) to a code signifying a
bioequivalence problem (e.g., BP), or vice versa. This procedure does not
apply to a change of a particular product code (e.g., a change from BP to AB
or from AB to BX).




    Before making a change in a therapeutic equivalence code for an entire
category of drugs, the Agency will announce in the Introduction to the
Cumulative Supplement that it is considering the change and will invite
comment. Comments, along with scientific data, may be sent to the Director,
Division of Bioequivalence, Office of Generic Drugs, Center for Drug
Evaluation and Research, HFD-650, 7620 Standish Place, Rockville, MD 20855.


   The comment period will generally be 60 days in length, and the closing
date for comments will be listed in the description of the proposed change
for each drug entity.

    The most useful type of scientific data submission is an in vivo
bioavailability/bioequivalence study conducted on batches of the subject drug
products. These submissions should present a full description of the
analytical procedures and equipment used, a validation of the analytical
methodology, including the standard curve, a description of the method of
calculating results, and a description of the pharmacokinetic and statistical
models used in analyzing the data. Anecdotal or testimonial information is
the least useful to the Agency, and such submissions are discouraged. Copies
                                            xxiii
of supporting reports published in the scientific literature or unpublished
material, however, are welcome.


1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product

    The aforementioned procedure does not apply to a change in a single drug
product code. For example, a change in a single drug product's code from BP
to AB as a result of the submission of an acceptable bioequivalence study
ordinarily will not be the subject of notice and comment. Likewise, a change
in a single drug product's code from AB to BX (e.g., as a result of new
information raising a significant question as to bioequivalence) does not
require notice and comment. The Agency's responsibility to provide the
public with the Agency's most current information related to therapeutic
equivalence may require a change in a drug product's code prior to any formal
notice and opportunity for the applicant to be heard. The publication in the
Federal Register of a proposal to withdraw approval of a drug product will
ordinarily result in a change in a product's code from AB to BX if this
action has not already been taken.


1.11 Discontinued Section

    Those drug products in the Discontinued Section of the Orange Book in
which a determination has already been made that the products were not
withdrawn for safety or efficacy reasons have “**Federal Register
determination that product was not discontinued or withdrawn for safety or
efficacy reasons**” following the product strength. Those drug products are
only reflective of citizen petitions determinations made since 1995. The
identification of these drug products in the Discontinued Section of the
Orange Book should avoid the submission of multiple citizen petitions for the
same drug product. FR notices no longer applicable are removed from the
Annual Edition (i.e., there is a currently marketed Reference Listed Drug and
no applicable patent or exclusivity). FR Safety or Effectiveness
Determinations List lists products that have current and removed notices.
The list is updated quarterly. Notices issued during the year are added to
the Electronic Orange Book Query in the month they become effective.

    Generally, approved products are added to the Discontinued Section of the
Orange Book when the applicant holder notifies the Orange Book staff of the
products’ not marketed status. Products may also be added if annual reports
indicate the product is no longer marketed or other Agency administrative
action (e.g., Withdrawal of an Application). Changes to the Orange Book are
not affected by the drug registration and listing requirements of Section 510
of the Act.

1.12 Changes to the Orange Book

     Every effort is made to ensure the Annual Edition is current and
accurate. Applicant holders are requested to inform the FDA Orange Book
Staff (OBS) of any changes or corrections. Please inform the OBS when
products are no longer marketed. Notification of the Orange Book staff to
include the newly approved product in the Discontinued Drug Product List
rather than parts 1, 2 or 3 of the List (as discussed in Section 1.1) must
occur by the end of the month in which the product is approved to ensure that
the product is not included in the “active” portions of the next published
Orange Book update




                                             xxiv
    We can be contacted by email at drugproducts@fda.hhs.gov.   Send Changes by
FAX: 301-595-1446; mail to:

                                   FDA/CDER Orange Book Staff
                                   Office of Generic Drugs,
                                   7620 Standish Place
                                   Rockville, MD 20855-2773




1.13 Availability of the Edition

     Commencing with the 25th edition, the Annual Edition and current monthly
Cumulative Supplement are available in a Portable Document Format (PDF) at
the EOB home page, Electronic Orange Book Query, by clicking on Publications.
The PDF annual format duplicates previous paper versions except for the
Orphan Products Designations and Approvals List. An annual subscription of
the PDF format may be obtained from the U.S. Government Printing Office, 866­
512-1800.




                                                xxv
              2. HOW TO USE THE DRUG PRODUCT LISTS


2.1   Key Sections for Using the Drug Product Lists

     This publication contains illustrations, along with Drug Product Lists,
indices, and lists of abbreviations and terms which facilitate their use.

     Illustrations. The annotated Drug Product Illustration, see Section
2.2, and the Therapeutic Equivalence Evaluations Illustration, see
Section 2.3, are offered to provide further clarification. These depict the
format found in the Prescription Drug Product List (the only list in which
therapeutic equivalence evaluation codes are displayed).

     Drug Product Lists. The Prescription and OTC Drug Product Lists,
arranged alphabetically by active ingredient(s), contain product
identification information (active ingredients, dosage forms, routes of
administration, product names, application holders, strengths) for single and
multiple ingredient drug products. Also shown are the application number and
drug product number (FDA internal computer data use only) and approval dates
for those drug products approved on or after January 1, 1982. The application
number preceded by “N” is a New Drug Application (NDA or commonly the
innovator). The application number preceded by an “A” is an Abbreviated New
Drug Application (ANDA or commonly the generic).

     The Discontinued Product List, arranged alphabetically by active
ingredient(s), contains product identification information (dosage form,
product name, strength, and application number).

     If a prescription drug product is available from more than one source
(multisource), a therapeutic equivalence code will appear in front of the
applicant's name. If a product is therapeutically equivalent to one or more
products or to an appropriate reference, it will be designated with a code
beginning with "A" and the entry will be underlined and printed in bold font
for emphasis.

     Active ingredient headings for multiple ingredient (combination) drug
products are arranged alphabetically. For purposes of this publication, this
alphabetical sort takes precedence over United States Pharmacopeia official
monograph order (i.e., Reserpine, Hydralazine Hydrochloride,
Hydrochlorothiazide). For example, product information labeled as Reserpine,
Hydrochlorothiazide and Hydralazine Hydrochloride appears under the active
ingredient heading Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine.
A cross-reference to the product information (for prescription and OTC
products) appears for each additional active ingredient in the product. For
combination drug products, the ingredient strengths are separated by
semicolons and appear in the same relative sequence as the ingredients in the
heading. Available strengths of the dosage form from an applicant appear on
separate lines.

     To use the Drug Product Lists, determine by alphabetical order the
ingredient under which the product information is listed, using the Product
Name Index, if necessary. Then, find the ingredient in the applicable Drug
Product List. Proceed to the dosage form and route of administration and
compare products within that ingredient heading only. Therapeutic equivalence
or inequivalence for prescription products is determined on the basis of the
therapeutic equivalence codes provided within that specific dosage form and
route heading. The OTC Drug Product List, Discontinued Drug Product List, and



                                     2-1

Drug Products with Approval under Section 505 of the Act Administered by the
Center for Biologics Evaluation and Research List have their data arranged
similarly.
     The Discontinued Drug Product List contains approved products that have
never been marketed, have been discontinued from marketing, are for military
use, or have had their approvals withdrawn for other than safety or efficacy
reasons subsequent to being discontinued from marketing. All products having
a "@" in the December Cumulative Supplement of the previous Edition List have
been added to the Discontinued Drug Product List appearing in this Edition.
In addition, approved drug products that are not in the commercial
distribution channel e.g., approved drug products in applications for export
only are also listed in the Discontinued Section of the Orange Book.


     Product Name Index (Prescription and OTC Drug Product Lists). This is an
index of drug products by established or trade name. The second term of each
entry indicates the active ingredient name under which product information can
be found in the appropriate Drug Product List. For those drug products with
multiple active ingredients, only the first active ingredient (in alphabetical
order) will appear. OTC products are so designated.

     Product Name Index Listed by Applicant (Prescription and OTC Drug
Product Lists). This is an index that cross-references applicants to drug
products. The bolded and underlined entry represents the applicant name
abbreviation used in this publication. Each complete applicant name that is
represented by the abbreviated name is marked with an asterisk (*). Listed
under each complete applicant name is the first alphabetically arranged
ingredient under which product information can be found in the appropriate
Drug Product List. OTC products are so designated. To use the Drug Product
Lists, determine by alphabetical order the ingredient under which the product
information is listed, using the Product Name Index, if appropriate.

     Uniform Terms. To improve readability, uniform terms are used to
designate dosage forms, routes of administration, and abbreviations used to
express strengths. These terms are listed in Appendix C. In some cases, the
terms used may differ from those used in product labels and other labeling.




                                     2-2

2.2    DRUG PRODUCT ILLUSTRATION


                                        SINGLE INGREDIENT

ACTIVE INGREDIENT                          MEPERIDINE HYDROCHLORIDE

DOSAGE FORM; ROUTE OF ADMINISTRATION       INJECTABLE;INJECTION
                                             HEXANON
TRADE OR GENERIC NAMES
                                           AP   + PAGE PHARMA      25MG/ML    N013111   001   AUG   22,   1983
                                           AP   +                  50MG/ML    N013111   002   AUG   22,   1983
REFERENCE LISTED DRUG                      AP   +                  75MG/ML    N013111   003   AUG   22,   1983
                                           AP   +                  100MG/ML   N013111   004   JAN   04,   1989

                                                MEPERIDINE HCL
                                           AP      GREENBERG PHARM 25MG/ML    A064890   001   FEB   29,   1987
THERAPEUTIC EQUIVALENCE (TE)               AP                      50MG/ML    A064890   002   FEB   29,   1987
  CODE FOR MULTISOURCE PRODUCT             AP                      75MG/ML    A064890   003   FEB   29,   1987
                                           AP                      100MG/ML   A064890   004   MAR   08,   1992

SINGLE SOURCE PRODUCT (NO TE CODE)                TIMOKIM LLC      10MG/ML A099225 001 DEC 12, 1995
                                           AP     JOHNSON MED      25MG/ML A099226 001 NOV 27, 1993
                                                  KENDRA PHARM     150MG/ML A079444 001 OCT 31, 1999


APPLICANT

AVAILABLE STRENGTH(S) OF A PRODUCT

APPLICATION NUMBER AND PRODUCT NUMBER
PRODUCT NUMBER IS FOR FDA INTERNAL COMPUTER DATA USE ONLY

APPROVAL DATE




                           MULTIPLE INGREDIENTS WITH PRODUCT INFORMATION

ALPHABETICALLY SORTED BY
ACTIVE INGREDIENT            HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE

                             TABLET;ORAL
PRODUCT INFORMATION            HYDROCHLOROTHIAZIDE, RESERPINE AND HYDRALAZINE HCL
                                  REINWALD INC    25MG;15MG;0.1MG A069808 001 JAN 18, 1982




THIS EXAMPLE IS FOR PURPOSE OF ILLUSTRATION ONLY.     IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE
PRESCRIPTION DRUG PRODUCT LIST.
2.3 THERAPEUTIC EQUIVALENCE EVALUATIONS ILLUSTRATION
DRUG PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN "A") UNDER AN INGREDIENT AND DOSAGE FORM HEADING
ARE CONSIDERED THERAPEUTICALLY EQUIVALENT ONLY TO OTHER PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN
A") AND NOT TO THOSE CODED BP (OR ANY CODE BEGINNING WITH "B") AND ANY PRODUCTS NOT LISTED. DRUG
PRODUCTS CODED BP (OR ANY CODE BEGINNING WITH A "B") ARE NOT CONSIDERED THERAPEUTICALLY EQUIVALENT TO ANY
OTHER PRODUCT. FOR A COMPLETE EXPLANATION OF THE TE CODES REFER TO SECTION 1.7 OF THE INTRODUCTION.



                                                                 SULFASALAZINE

                                                                      TABLET; ORAL

                                                                        FAZINE

                                                                 AB        PARKLAND             500MG   A042999 001

PRODUCTS CONSIDERED THERAPEUTICALLY                                    SULAZINE

EQUIVALENT TO EACH OTHER                                         AB        URSA                 500MG   A042222 001



                                                                 SULFASALAZINE


PRODUCTS CONSIDERED NOT THERAPEUTICALLY                          BP       BROWN                 500MG   A041297 001

EQUIVALENT TO ANY OTHER PRODUCTS LISTED



                                                                 SULFASALAZINE

                                                                   TABLET; ORAL
                                                                     FAZINE
                                                                 AB    PARKLAND                 500MG   A042999 001


PRODUCTS CONSIDERED NOT THERAPEUTICALLY                                SULFASALAZINE

EQUIVALENT TO EACH OTHER                                         BP       BROWN                 500MG   A041297 001

                                                                          SOUTH                 500MG   A067627 001




NOTE: BOLD    FONT   AND   UNDERLINING   DENOTES   MULTISOURCE    PRODUCTS        WHICH   ARE    CONSIDERED   THERAPEUTICALLY
EQUIVALENT.


THIS EXAMPLE IS FOR PURPOSES OF ILLUSTRATION ONLY.               IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE
PRESCRIPTION DRUG PRODUCT LIST.
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                        3-1(of 371)


ABACAVIR SULFATE
	
  SOLUTION;ORAL
	
    ZIAGEN
	
      + VIIV HLTHCARE             EQ 20MG BASE/ML                  N020978 001 Dec 17, 1998
	
  TABLET;ORAL

    ABACAVIR SULFATE
	
AB       APOTEX INC               EQ   300MG   BASE                A201570   001   Dec   17,   2012

AB       AUROBINDO PHARMA LTD     EQ   300MG   BASE                A077844   001   Dec   17,   2012

AB       HETERO LABS LTD III      EQ   300MG   BASE                A091560   001   Sep   13,   2013

AB       MYLAN PHARMS INC         EQ   300MG   BASE                A091294   001   Jun   18,   2012

    ZIAGEN
	
AB    + VIIV HLTHCARE             EQ 300MG BASE                    N020977 001 Dec 17, 1998
	
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
	
  TABLET;ORAL
	
    TRIUMEQ
	
      + VIIV HLTHCARE           EQ 600MG BASE;EQ 50MG BASE;300MG   N205551 001 Aug 22, 2014
	
ABACAVIR SULFATE; LAMIVUDINE
	
  TABLET;ORAL
	
    EPZICOM
	
      + VIIV HLTHCARE             EQ 600MG BASE;300MG              N021652 001 Aug 02, 2004
	
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
	
  TABLET;ORAL

    ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE

AB       LUPIN LTD              EQ 300MG BASE;150MG;300MG          A202912 001 Dec 05, 2013

    TRIZIVIR
	
AB    + VIIV HLTHCARE           EQ 300MG BASE;150MG;300MG          N021205 001 Nov 14, 2000
	
ABIRATERONE ACETATE
	
  TABLET;ORAL
	
    ZYTIGA
	
      + JANSSEN BIOTECH           250MG                            N202379 001 Apr 28, 2011
	
ACAMPROSATE CALCIUM
	
  TABLET, DELAYED RELEASE;ORAL

    ACAMPROSATE CALCIUM
	
AB       BARR LABS DIV TEVA       333MG                            A200143 001 Nov 18, 2013

AB       GLENMARK GENERICS        333MG                            A202229 001 Jul 16, 2013

AB       MYLAN PHARMS INC         333MG                            A200142 001 Mar 11, 2014

    CAMPRAL
	
AB    + FOREST LABS               333MG                            N021431 001 Jul 29, 2004
	
ACARBOSE
	
  TABLET;ORAL

    ACARBOSE
	
AB        EMCURE PHARMS LTD       25MG                             A202271   001   Feb   07,   2012

AB                                50MG                             A202271   002   Feb   07,   2012

AB                                100MG                            A202271   003   Feb   07,   2012

AB        IMPAX LABS              25MG                             A078441   001   May   14,   2009

AB                                50MG                             A078441   002   May   14,   2009

AB                                100MG                            A078441   003   May   14,   2009

AB        MYLAN                   25MG                             A091053   001   Jan   06,   2011

AB                                50MG                             A091053   002   Jan   06,   2011

AB                                100MG                            A091053   003   Jan   06,   2011

AB        ROXANE                  25MG                             A078470   001   May   07,   2008

AB                                50MG                             A078470   002   May   07,   2008

AB                                100MG                            A078470   003   May   07,   2008

AB        STRIDES PHARMA          25MG                             A090912   001   Jul   27,   2011

AB                                50MG                             A090912   002   Jul   27,   2011

AB                                100MG                            A090912   003   Jul   27,   2011

AB        VIRTUS PHARM            25MG                             A091343   001   Oct   17,   2013

AB                                50MG                             A091343   002   Oct   17,   2013

AB                                100MG                            A091343   003   Oct   17,   2013

AB        WATSON LABS             25MG                             A077532   001   May   07,   2008

AB                                50MG                             A077532   002   May   07,   2008

AB                                100MG                            A077532   003   May   07,   2008

    PRECOSE
	
AB    + BAYER HLTHCARE            25MG                             N020482 004 May 29, 1997

AB                                50MG                             N020482 001 Sep 06, 1995

AB                                100MG                            N020482 002 Sep 06, 1995
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                         3-2(of 371)


ACEBUTOLOL HYDROCHLORIDE
	
  CAPSULE;ORAL

    ACEBUTOLOL HYDROCHLORIDE
	
AB       AMNEAL PHARM            EQ   200MG   BASE                A075047   001   Dec   30,   1999

AB                               EQ   400MG   BASE                A075047   002   Dec   30,   1999

AB       MYLAN                   EQ   200MG   BASE                A074288   001   Apr   24,   1995

AB                               EQ   400MG   BASE                A074288   002   Apr   24,   1995

    SECTRAL
	
AB       PROMIUS PHARMA          EQ 200MG BASE                    N018917 001 Dec 28, 1984

AB    +                          EQ 400MG BASE                    N018917 003 Dec 28, 1984
	
ACETAMINOPHEN
	
  SOLUTION;IV (INFUSION)

    OFIRMEV
	
      + CADENCE PHARMS           1000MG/100ML (10MG/ML)           N022450 001 Nov 02, 2010
	
ACETAMINOPHEN; BUTALBITAL
	
  TABLET;ORAL
	
    BUTALBITAL AND ACETAMINOPHEN
	
      + NEXGEN PHARMA           300MG;50MG                        A090956 001 Aug 23, 2011

    BUTAPAP
	
      + MIKART                  325MG;50MG                        A089987 001 Oct 26, 1992
	
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
	
  CAPSULE;ORAL
	
    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
	
      + MIKART                  325MG;50MG;40MG                   A089007 001 Mar 17, 1986
	
      + NEXGEN PHARMA           300MG;50MG;40MG                   A040885 001 Nov 16, 2009
	
  SOLUTION;ORAL
	
    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
	
      + MIKART                  325MG/15ML;50MG/15ML;40MG/15ML    A040387 001 Jan 31, 2003
	
  TABLET;ORAL

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

AA       HIKMA PHARMS LLC       325MG;50MG;40MG                   A089718   001   Jun   12,   1995

AA       LANNETT HOLDINGS INC   325MG;50MG;40MG                   A200243   001   Sep   13,   2012

AA       MALLINCKRODT           325MG;50MG;40MG                   A087804   001   Jan   24,   1985

AA       MIKART                 325MG;50MG;40MG                   A089175   001   Jan   21,   1987

AA    + VINTAGE PHARMS          325MG;50MG;40MG                   A040511   001   Aug   27,   2003
	
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
	
  CAPSULE;ORAL

    BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE

AB       HIKMA INTL PHARMS      325MG;50MG;40MG;30MG              A075618 001 Mar 23, 2001

AB       NEXGEN PHARMA INC      325MG;50MG;40MG;30MG              A076560 001 Jun 10, 2004

AB       VINTAGE PHARMS         325MG;50MG;40MG;30MG              A075929 001 Apr 22, 2002

    FIORICET W/ CODEINE

AB    + WATSON LABS INC         325MG;50MG;40MG;30MG              N020232 001 Jul 30, 1992
	
    BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
	
         NEXGEN PHARMA INC      300MG;50MG;40MG;30MG              A076560 002 Jul 19, 2012
	
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
	
  CAPSULE;ORAL
	
    TREZIX
	
         WRASER PHARMS LLC      320.5MG;30MG;16MG                 A204785 001 Nov 26, 2014
	
ACETAMINOPHEN; CODEINE PHOSPHATE
	
  SOLUTION;ORAL

    ACETAMINOPHEN AND CODEINE PHOSPHATE
	
AA       HI TECH PHARMA         120MG/5ML;12MG/5ML                A040119   001 Apr 26, 1996

AA       MIKART                 120MG/5ML;12MG/5ML                A089450   001 Oct 27, 1992

AA    + PHARM ASSOC             120MG/5ML;12MG/5ML                A087508   001
	
AA       VINTAGE PHARMS         120MG/5ML;12MG/5ML                A091238   001 Nov 10, 2011

AA       WOCKHARDT              120MG/5ML;12MG/5ML                A087006   001
	
  SUSPENSION;ORAL
	
    CAPITAL AND CODEINE
	
      + VALEANT PHARMS LLC      120MG/5ML;12MG/5ML                A086024 001
	
  TABLET;ORAL

    ACETAMINOPHEN AND CODEINE PHOSPHATE
	
AA       AMNEAL PHARMS NY       300MG;30MG                        A040779   001   May   29,   2008

AA       AUROLIFE PHARMA LLC    300MG;15MG                        A202800   001   Apr   15,   2013

AA                              300MG;30MG                        A202800   002   Apr   15,   2013

AA                              300MG;60MG                        A202800   003   Apr   15,   2013

AA    + MALLINCKRODT INC        300MG;15MG                        A040419   001   May   31,   2001

AA                              300MG;30MG                        A040419   002   May   31,   2001

AA                              300MG;60MG                        A040419   003   May   31,   2001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                         3-3(of 371)


ACETAMINOPHEN; CODEINE PHOSPHATE
	
  TABLET;ORAL

    ACETAMINOPHEN AND CODEINE PHOSPHATE
	
AA       RANBAXY                300MG;30MG                     A085868   001
	
AA                              300MG;60MG                     A087083   001
	
AA       TEVA                   300MG;15MG                     A088627   001     Mar   06,   1985

AA                              300MG;30MG                     A088628   001     Mar   06,   1985

AA    +                         300MG;60MG                     A088629   001     Mar   06,   1985

AA       VINTAGE                300MG;15MG                     A089990   001     Sep   30,   1988

AA                              300MG;30MG                     A089805   001     Sep   30,   1988
	
AA       VINTAGE PHARMS         300MG;60MG                     A089828   001     Sep   30,   1988

    TYLENOL W/ CODEINE NO. 3

AA    + JANSSEN PHARMS          300MG;30MG                     A085055 003
	
    TYLENOL W/ CODEINE NO. 4

AA       JANSSEN PHARMS         300MG;60MG                     A085055 004
	
ACETAMINOPHEN; HYDROCODONE BITARTRATE
	
  SOLUTION;ORAL

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
	
AA    + MIKART                  325MG/15ML;7.5MG/15ML          A040482   001     Sep   25,   2003

AA       PHARM ASSOC            325MG/15ML;7.5MG/15ML          A040838   001     May   10,   2013

AA       VINTAGE PHARMS         325MG/15ML;7.5MG/15ML          A040894   001     Jul   19,   2011

AA       VISTAPHARM             325MG/15ML;7.5MG/15ML          A200343   001     Jan   25,   2012
	
      + MIKART                  300MG/15ML;10MG/15ML           A040881   001     Feb   25,   2010
	
      + PHARM ASSOC             325MG/15ML;10MG/15ML           A040834   001     Apr   18,   2008

  TABLET;ORAL

    ANEXSIA 5/325

AA       MALLINCKRODT           325MG;5MG                      A040409 001 Oct 20, 2000

    ANEXSIA 7.5/325

AA       MALLINCKRODT           325MG;7.5MG                    A040405 001 Sep 08, 2000

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
	
AA       AMNEAL PHARMS NY       325MG;5MG                      A040736   001     Aug   25,   2006

AA                              325MG;10MG                     A040746   001     Aug   25,   2006

AA       AUROLIFE PHARMA LLC    325MG;5MG                      A201013   001     Apr   11,   2012

AA                              325MG;7.5MG                    A201013   002     Apr   11,   2012

AA                              325MG;10MG                     A201013   003     Apr   11,   2012

AA       MALLINCKRODT           325MG;10MG                     A040400   001     Jul   26,   2000

AA    + MIKART                  300MG;5MG                      A040658   001     Jan   19,   2006

AA    +                         300MG;7.5MG                    A040556   002     Mar   24,   2006

AA    +                         300MG;10MG                     A040556   001     Jun   23,   2004

AA                              325MG;7.5MG                    A040432   001     Jan   22,   2003

AA       SUN PHARM INDS INC     325MG;5MG                      A090118   001     Dec   23,   2008

AA                              325MG;7.5MG                    A090118   002     Dec   23,   2008

AA                              325MG;10MG                     A090118   003     Dec   23,   2008

AA       TRIS PHARMA INC        325MG;5MG                      A202214   001     Mar   27,   2013

AA                              325MG;7.5MG                    A202214   002     Mar   27,   2013

AA                              325MG;10MG                     A202214   003     Mar   27,   2013

AA       VINTAGE PHARMS         300MG;5MG                      A090415   001     Jan   24,   2011

AA                              300MG;7.5MG                    A090415   002     Jan   24,   2011

AA                              300MG;10MG                     A090415   003     Jan   24,   2011

AA                              325MG;5MG                      A040655   001     Jan   19,   2006

AA                              325MG;7.5MG                    A040656   001     Jan   19,   2006

AA                              325MG;10MG                     A040355   001     May   31,   2000

    NORCO
	
AA    + ACTAVIS LABS FL INC     325MG;7.5MG                    A040148 003 Sep 12, 2000

AA    +                         325MG;10MG                     A040148 001 Feb 14, 1997

AA    + WATSON LABS             325MG;5MG                      A040099 001 Jun 25, 1997
	
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
	
      + MIKART                  325MG;2.5MG                    A040846 001 Jun 09, 2010
	
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
	
  SOLUTION;ORAL

    OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN
	
AA       VINTAGE PHARMS           325MG/5ML;5MG/5ML            A203573 001 Dec 18, 2014

    ROXICET
	
AA    + ROXANE                    325MG/5ML;5MG/5ML            A089351 001 Dec 03, 1986
	
  TABLET;ORAL

    OXYCET
	
AA       MALLINCKRODT             325MG;5MG                    A087463 001 Dec 07, 1983

    OXYCODONE AND ACETAMINOPHEN
	
AA       ACTAVIS ELIZABETH        325MG;2.5MG                  A201447 001 Apr 12, 2013

AA                                325MG;5MG                    A201447 002 Apr 12, 2013

AA                                325MG;7.5MG                  A201447 003 Apr 12, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                       3-4(of 371)


ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
	
  TABLET;ORAL

    OXYCODONE AND ACETAMINOPHEN
	
AA                                325MG;10MG                    A201447   004   Apr   12,   2013

AA       ALVOGEN INC              325MG;7.5MG                   A202677   001   Jul   26,   2012

AA                                325MG;10MG                    A202677   002   Jul   26,   2012

AA       AMNEAL PHARMS NY         325MG;5MG                     A040777   001   Nov   27,   2007

AA                                325MG;10MG                    A040778   001   Nov   27,   2007

AA       AUROLIFE PHARMA LLC      325MG;2.5MG                   A201972   001   Jul   15,   2013

AA                                325MG;5MG                     A201972   002   Jul   15,   2013

AA                                325MG;7.5MG                   A201972   003   Jul   15,   2013

AA                                325MG;10MG                    A201972   004   Jul   15,   2013

AA       COASTAL PHARMS           325MG;2.5MG                   A090177   001   Oct   20,   2008

AA                                325MG;5MG                     A090177   002   Oct   20,   2008

AA                                325MG;7.5MG                   A090177   003   Oct   20,   2008

AA                                325MG;10MG                    A090177   004   Oct   20,   2008

AA       MALLINCKRODT             325MG;7.5MG                   A040545   001   Jun   30,   2004

AA                                325MG;10MG                    A040545   002   Jun   30,   2004

AA       RHODES PHARMS            325MG;5MG                     A201278   001   Aug   28,   2014

AA                                325MG;7.5MG                   A201278   002   Aug   28,   2014

AA                                325MG;10MG                    A201278   003   Aug   28,   2014

AA       SUN PHARM INDS INC       325MG;2.5MG                   A090535   001   Dec   26,   2013

AA                                325MG;5MG                     A090535   002   Dec   26,   2013

AA                                325MG;7.5MG                   A090535   003   Dec   26,   2013

AA                                325MG;10MG                    A090535   004   Dec   26,   2013

AA       VINTAGE PHARMS           325MG;2.5MG                   A090733   001   Jul   11,   2013

AA                                325MG;5MG                     A040105   001   Jul   30,   1996

AA                                325MG;7.5MG                   A090734   001   Jul   11,   2013

AA                                325MG;10MG                    A090734   002   Jul   11,   2013

AA       WATSON LABS              325MG;5MG                     A040171   001   Oct   30,   1997

AA                                325MG;7.5MG                   A040535   001   Sep   05,   2003

AA                                325MG;10MG                    A040535   002   Sep   05,   2003

    PERCOCET
	
AA    + VINTAGE PHARMS LLC        325MG;2.5MG                   A040330   001   Jun   25,   1999

AA    +                           325MG;5MG                     A040330   002   Jun   25,   1999

AA    +                           325MG;7.5MG                   A040434   001   Nov   23,   2001

AA    +                           325MG;10MG                    A040434   002   Nov   23,   2001

    ROXICET
	
AA       ROXANE                   325MG;5MG                     A087003 001
	
    OXYCODONE AND ACETAMINOPHEN
	
      + MIKART                    300MG;2.5MG                   A040608   001   Dec   30,   2005
	
      +                           300MG;5MG                     A040608   002   Dec   30,   2005
	
      +                           300MG;7.5MG                   A040608   003   Dec   30,   2005
	
      +                           300MG;10MG                    A040608   004   Dec   30,   2005
	
  TABLET, EXTENDED RELEASE;ORAL
	
    XARTEMIS XR
	
      + MALLINCKRODT INC          325MG;7.5MG                   N204031 001 Mar 11, 2014
	
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN
	
         MYLAN                  325MG;32MG                      A083689 001
	
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
	
  TABLET;ORAL

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN
	
AB       ALLIED PHARMA INC      325MG;37.5MG                    A202076   001   Mar   30,   2012

AB       AMNEAL PHARMS          325MG;37.5MG                    A090485   001   Dec   09,   2009

AB       APOTEX INC             325MG;37.5MG                    A078778   001   Apr   07,   2014

AB       MICRO LABS LTD INDIA   325MG;37.5MG                    A201952   001   Dec   14,   2012

AB       MYLAN                  325MG;37.5MG                    A077858   001   Sep   26,   2008

AB       PAR PHARM              325MG;37.5MG                    A076475   001   Apr   21,   2005

AB       SUN PHARM INDS INC     325MG;37.5MG                    A077184   001   Dec   16,   2005

AB       ZYDUS PHARMS USA INC   325MG;37.5MG                    A090460   001   Sep   06,   2012

    ULTRACET
	
AB    + JANSSEN PHARMS          325MG;37.5MG                    N021123 001 Aug 15, 2001
	
ACETAZOLAMIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    ACETAZOLAMIDE
	
AB       HERITAGE PHARMS INC    500MG                           A090779 001 Jul 14, 2011

AB       ZYDUS PHARMS USA INC   500MG                           A040904 001 Dec 10, 2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                     3-5(of 371)


ACETAZOLAMIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    DIAMOX
	
AB    + DURAMED PHARMS BARR     500MG                           N012945 001
	
  TABLET;ORAL

    ACETAZOLAMIDE
	
AB       LANNETT                250MG                           A084840   001
	
AB       MUTUAL PHARM           125MG                           A089752   001 Jun 22, 1988

AB       TARO                   125MG                           A040195   001 May 28, 1997

AB    +                         250MG                           A040195   002 May 28, 1997
	
ACETAZOLAMIDE SODIUM
	
  INJECTABLE;INJECTION

    ACETAZOLAMIDE SODIUM
	
AP       EUROHLTH INTL           EQ 500MG BASE/VIAL             A040089 001 Feb 28, 1995

AP       SAGENT AGILA            EQ 500MG BASE/VIAL             A200880 001 May 09, 2012

AP    + X GEN PHARMS             EQ 500MG BASE/VIAL             A040784 001 Dec 10, 2008

    ACETAZOLAMIDE SODIUM
	
AP       EMCURE PHARMS LTD       EQ 500MG BASE/VIAL             A202693 001 Dec 19, 2014
	
ACETIC ACID, GLACIAL
	
  SOLUTION;IRRIGATION, URETHRAL

    ACETIC ACID 0.25% IN PLASTIC CONTAINER
	
AT       B BRAUN                 250MG/100ML                    N018161 001
	
AT       BAXTER HLTHCARE         250MG/100ML                    N018523 001 Feb 19, 1982

AT       HOSPIRA                 250MG/100ML                    N017656 001
	
  SOLUTION/DROPS;OTIC

    ACETIC ACID
	
AT       TARO                    2%                             A088638 001 Sep 06, 1984

AT       VINTAGE                 2%                             A040607 001 Feb 24, 2005

AT    + WOCKHARDT                2%                             A040166 001 Jul 26, 1996

    VOSOL
	
AT       HI TECH PHARMA          2%                             N012179 001
	
ACETIC ACID, GLACIAL; ALUMINUM ACETATE
	
  SOLUTION/DROPS;OTIC

    ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE
	
      + BAUSCH AND LOMB         2%;0.79%                        A040063 001 Feb 25, 1994
	
ACETIC ACID, GLACIAL; HYDROCORTISONE
	
  SOLUTION/DROPS;OTIC

    ACETASOL HC
	
AT       ACTAVIS MID ATLANTIC   2%;1%                           A087143 001 Jan 13, 1982

    HYDROCORTISONE AND ACETIC ACID
	
AT       TARO                   2%;1%                           A088759 001 Mar 04, 1985

AT       VINTAGE                2%;1%                           A040609 001 Feb 06, 2006

    VOSOL HC
	
AT    + HI TECH PHARMA          2%;1%                           N012770 001
	
ACETOHYDROXAMIC ACID
	
  TABLET;ORAL
	
    LITHOSTAT
	
      + MISSION PHARMA           250MG                          N018749 001 May 31, 1983
	
ACETYLCHOLINE CHLORIDE
	
  FOR SOLUTION;OPHTHALMIC
	
    MIOCHOL-E
	
      + BAUSCH AND LOMB          20MG/VIAL                      N020213 001 Sep 22, 1993
	
ACETYLCYSTEINE
	
  INJECTABLE;INTRAVENOUS

    ACETADOTE
	
AP    + CUMBERLAND PHARMS        6GM/30ML (200MG/ML)            N021539 001 Jan 23, 2004

    ACETYLCYSTEINE
	
AP       INNOPHARMA LICENSING    6GM/30ML (200MG/ML)            A200644 001 Nov 07, 2012
	
  SOLUTION;INHALATION, ORAL

    ACETYLCYSTEINE
	
AN       HOSPIRA                 10%                            A073664   001   Aug   30,   1994

AN                               20%                            A074037   001   Aug   30,   1994

AN       INNOPHARMA LICENSING    10%                            A204674   001   Feb   11,   2014

AN                               20%                            A203853   001   Jun   21,   2012

AN    + LUITPOLD                 10%                            A072489   001   Jul   28,   1995

AN    +                          20%                            A072547   001   Jul   28,   1995
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-6(of 371)


ACITRETIN
	
  CAPSULE;ORAL

    ACITRETIN
	
AB       BARR LABS INC           10MG                          A091455   001   Apr   04,   2013

AB                               25MG                          A091455   002   Apr   04,   2013

AB       TEVA PHARMS USA         17.5MG                        A202897   001   Apr   04,   2013

AB                               22.5MG                        A202897   002   Apr   04,   2013

    SORIATANE
	
AB       STIEFEL LABS INC        10MG                          N019821   001   Oct   28,   1996

AB                               17.5MG                        N019821   003   Aug   06,   2009

AB                               22.5MG                        N019821   004   Aug   06,   2009

AB    +                          25MG                          N019821   002   Oct   28,   1996
	
ACLIDINIUM BROMIDE
	
  POWDER, METERED;INHALATION
	
    TUDORZA PRESSAIR
	
      + FOREST LABS INC          0.375MG/INH                   N202450 001 Jul 23, 2012
	
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    SEMPREX-D
	
      + AUXILIUM PHARMS LLC     8MG;60MG                       N019806 001 Mar 25, 1994
	
ACYCLOVIR
	
  CAPSULE;ORAL

    ACYCLOVIR
	
AB       APOTEX INC              200MG                         A075677   001   Sep   28,   2005

AB       CADILA PHARMS LTD       200MG                         A201445   001   Mar   06,   2014

AB       DAVA PHARMS INC         200MG                         A074833   001   Apr   22,   1997

AB       MYLAN                   200MG                         A074727   001   Apr   22,   1997

AB       RANBAXY                 200MG                         A074975   001   Sep   30,   1998

AB       STASON                  200MG                         A075090   001   Jan   26,   1999

AB       TEVA                    200MG                         A074578   001   Apr   22,   1997

    ZOVIRAX
	
AB    + DELCOR ASSET             200MG                         N018828 001 Jan 25, 1985
	
  CREAM;TOPICAL
	
    ZOVIRAX
	
      + VALEANT BERMUDA          5%                            N021478 001 Dec 30, 2002
	
  OINTMENT;TOPICAL

    ACYCLOVIR
	
AB       AMNEAL PHARMS           5%                            A204605 001 Jun 18, 2014

AB       MYLAN PHARMS INC        5%                            A202459 001 Apr 03, 2013

    ZOVIRAX
	
AB    + VALEANT BERMUDA          5%                            N018604 001 Mar 29, 1982
	
  SUSPENSION;ORAL

    ACYCLOVIR
	
AB       ACTAVIS MID ATLANTIC    200MG/5ML                     A074738 001 Apr 28, 1997

AB       HI TECH PHARMA          200MG/5ML                     A077026 001 Jun 07, 2005

    ZOVIRAX
	
AB    + DELCOR ASSET             200MG/5ML                     N019909 001 Dec 22, 1989
	
  TABLET;BUCCAL
	
    SITAVIG
	
      + INNOCUTIS HOLDINGS       50MG                          N203791 001 Apr 12, 2013

  TABLET;ORAL

    ACYCLOVIR
	
AB       APOTEX INC              400MG                         A077309   001   Sep   29,   2005

AB                               800MG                         A077309   002   Sep   29,   2005

AB       CADILA PHARMS LTD       400MG                         A202168   001   Nov   15,   2013

AB                               800MG                         A202168   002   Nov   15,   2013

AB       CARLSBAD                400MG                         A075382   001   Apr   30,   1999

AB                               800MG                         A075382   002   Apr   30,   1999

AB       DAVA PHARMS INC         400MG                         A074946   001   Nov   19,   1997

AB                               800MG                         A074946   002   Nov   19,   1997

AB       HETERO LABS LTD V       400MG                         A203834   001   Oct   29,   2013

AB                               800MG                         A203834   002   Oct   29,   2013

AB       MYLAN                   400MG                         A075211   001   Sep   28,   1998

AB                               800MG                         A075211   002   Sep   28,   1998

AB       RANBAXY                 400MG                         A074980   001   Sep   30,   1998

AB                               800MG                         A074980   002   Sep   30,   1998

AB       TEVA                    400MG                         A074556   002   Apr   22,   1997

AB                               800MG                         A074556   003   Apr   22,   1997

AB       ZYDUS PHARMS USA INC    400MG                         A204314   001   Aug   19,   2014

AB                               800MG                         A204314   002   Aug   19,   2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-7(of 371)


ACYCLOVIR
	
  TABLET;ORAL

    ZOVIRAX
	
AB       DELCOR ASSET            400MG                         N020089 001 Apr 30, 1991

AB    +                          800MG                         N020089 002 Apr 30, 1991
	
ACYCLOVIR SODIUM
	
  INJECTABLE;INJECTION

    ACYCLOVIR SODIUM
	
AP       AUROBINDO PHARMA LTD   EQ 50MG BASE/ML                A203701   001   Oct   11,   2013

AP       BEDFORD                EQ 500MG BASE/VIAL             A074596   002   Apr   22,   1997

AP    + FRESENIUS KABI USA      EQ 50MG BASE/ML                A074930   001   May   13,   1998

AP    +                         EQ 500MG BASE/VIAL             A075015   001   Apr   30,   1998

    ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
	
         HIKMA MAPLE            EQ 1GM BASE/VIAL               A074885 002 Dec 19, 1997
	
      +                         EQ 500MG BASE/VIAL             A074885 001 Dec 19, 1997
	
    ACYCLOVIR SODIUM
	
      + BEDFORD                 EQ 1GM BASE/VIAL               A074596 001 Apr 22, 1997
	
ACYCLOVIR; HYDROCORTISONE
	
  CREAM;TOPICAL
	
    XERESE
	
      + VALEANT BERMUDA          5%;1%                         N022436 001 Jul 31, 2009
	
ADAPALENE
	
  CREAM;TOPICAL

    ADAPALENE
	
AB       FOUGERA PHARMS          0.1%                          A090824 001 Jun 30, 2010

    DIFFERIN
	
AB    + GALDERMA LABS LP         0.1%                          N020748 001 May 26, 2000

  GEL;TOPICAL

    ADAPALENE
	
AB       ACTAVIS MID ATLANTIC    0.3%                          A201000   001   Oct   27,   2014

AB       GLENMARK GENERICS       0.1%                          A091314   001   Jul   01,   2010

AB       PLIVA HRVATSKA DOO      0.1%                          A090962   001   Jun   02,   2010

AB       TOLMAR                  0.3%                          A200298   001   Jun   14,   2012

    DIFFERIN
	
AB    + GALDERMA LABS LP         0.1%                          N020380 001 May 31, 1996

AB    +                          0.3%                          N021753 001 Jun 19, 2007
	
  LOTION;TOPICAL
	
    DIFFERIN
	
      + GALDERMA LABS LP         0.1%                          N022502 001 Mar 17, 2010
	
ADAPALENE; BENZOYL PEROXIDE
	
  GEL;TOPICAL
	
    EPIDUO
	
      + GALDERMA LABS LP         0.1%;2.5%                     N022320 001 Dec 08, 2008
	
ADEFOVIR DIPIVOXIL
	
  TABLET;ORAL

    ADEFOVIR DIPIVOXIL
	
AB       SIGMAPHARM LABS LLC     10MG                          A202051 001 Aug 29, 2013

    HEPSERA
	
AB    + GILEAD                   10MG                          N021449 001 Sep 20, 2002
	
ADENOSINE
	
  INJECTABLE;INJECTION

    ADENOCARD
	
AP    + ASTELLAS                 3MG/ML                        N019937 002 Oct 30, 1989

    ADENOSINE
	
AP       AGILA SPECLTS           3MG/ML                        A078640   001   Mar   21,   2014

AP                               3MG/ML                        A078686   001   May   13,   2009

AP       AKORN                   3MG/ML                        A078076   001   Oct   31,   2008

AP       BEDFORD                 3MG/ML                        A076404   001   Jun   16,   2004

AP       FRESENIUS KABI USA      3MG/ML                        A077133   001   Apr   27,   2005

AP       GLAND PHARMA LTD        3MG/ML                        A077283   001   Jun   14,   2007

AP       HIKMA MAPLE             3MG/ML                        A076500   001   Jun   16,   2004

AP       LUITPOLD                3MG/ML                        A090010   001   Apr   28,   2009

AP       WOCKHARDT               3MG/ML                        A090220   001   Jul   20,   2009
	
  SOLUTION;IV (INFUSION)

    ADENOSCAN
	
AP    + ASTELLAS                 60MG/20ML (3MG/ML)            N020059 001 May 18, 1995

AP    +                          90MG/30ML (3MG/ML)            N020059 002 May 18, 1995

    ADENOSINE
	
AP       AKORN                   60MG/20ML (3MG/ML)            A090450 001 Oct 02, 2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                      3-8(of 371)


ADENOSINE
	
  SOLUTION;IV (INFUSION)

    ADENOSINE
	
AP                                90MG/30ML   (3MG/ML)          A090450   002   Oct   02,   2014

AP       EMCURE PHARMS LTD        60MG/20ML   (3MG/ML)          A202313   001   Sep   15,   2014

AP                                90MG/30ML   (3MG/ML)          A202313   002   Sep   15,   2014

AP       HOSPIRA INC              60MG/20ML   (3MG/ML)          A203883   001   Mar   24,   2014

AP                                90MG/30ML   (3MG/ML)          A203883   002   Mar   24,   2014

AP       SAGENT STRIDES           60MG/20ML   (3MG/ML)          A090212   001   Mar   28,   2014

AP                                90MG/30ML   (3MG/ML)          A090212   002   Mar   28,   2014

AP       TEVA PHARMS USA          60MG/20ML   (3MG/ML)          A077425   001   Aug   29,   2013

AP                                90MG/30ML   (3MG/ML)          A077425   002   Aug   29,   2013
	
AFATINIB DIMALEATE
	
  TABLET;ORAL
	
    GILOTRIF
	
         BOEHRINGER INGELHEIM     EQ 20MG BASE                  N201292 001 Jul 12, 2013
	
                                  EQ 30MG BASE                  N201292 002 Jul 12, 2013
	
     +                            EQ 40MG BASE                  N201292 003 Jul 12, 2013
	
ALBENDAZOLE
	
  TABLET;ORAL
	
    ALBENZA
	
      + AMEDRA PHARMS             200MG                         N020666 001 Jun 11, 1996
	
ALBUMIN HUMAN
	
  INJECTABLE;INJECTION
	
    OPTISON
	
      + GE HEALTHCARE             10MG/ML                       N020899 001 Dec 31, 1997
	
ALBUMIN IODINATED I-125 SERUM
	
  INJECTABLE;INJECTION
	
    JEANATOPE
	
         ISO TEX                  100uCi/10ML (10uCi/ML)        N017836 003 Jun 08, 2004
	
                                  500uCi/0.5ML                  N017836 001
	
     +                            1,000uCi/ML                   N017836 002
	
ALBUMIN IODINATED I-131 SERUM
	
  INJECTABLE;INJECTION
	
    MEGATOPE
	
      + ISO TEX                   0.5mCi/VIAL                   N017837 001
	
      +                           1mCi/VIAL                     N017837 002
	
ALBUTEROL SULFATE
	
  AEROSOL, METERED;INHALATION
	
    PROAIR HFA
	
BX    + TEVA BRANDED PHARM        EQ 0.09MG BASE/INH            N021457 001 Oct 29, 2004
	
    PROVENTIL-HFA
	
BX    + 3M                        EQ 0.09MG BASE/INH            N020503 001 Aug 15, 1996

    VENTOLIN HFA
	
BX    + GLAXOSMITHKLINE           EQ 0.09MG BASE/INH            N020983 001 Apr 19, 2001

  SOLUTION;INHALATION

    ACCUNEB
	
AN    + MYLAN SPECLT              EQ 0.021% BASE                N020949 002 Apr 30, 2001

AN    +                           EQ 0.042% BASE                N020949 001 Apr 30, 2001

    ALBUTEROL SULFATE
	
AN    + BAUSCH AND LOMB           EQ   0.5% BASE                A075050   001   Jun   18,   1998

AN       HI TECH PHARMA           EQ   0.083% BASE              A075063   001   Feb   09,   1999

AN                                EQ   0.5% BASE                A074543   001   Jan   15,   1998

AN       LANDELA PHARM            EQ   0.083% BASE              A077569   001   Apr   04,   2006

AN    + MYLAN SPECLT              EQ   0.083% BASE              A072652   001   Feb   21,   1992

AN       NEPHRON                  EQ   0.021% BASE              A076355   002   Mar   31,   2010

AN                                EQ   0.042% BASE              A076355   001   Jun   28,   2004

AN                                EQ   0.083% BASE              A074880   001   Sep   17,   1997

AN                                EQ   0.5% BASE                A075664   001   Jun   26,   2001

AN       RITEDOSE CORP            EQ   0.083% BASE              A077839   001   Dec   16,   2008

AN       TEVA PHARMS              EQ   0.083% BASE              A075343   001   Nov   09,   1999

AN       WATSON LABS              EQ   0.021% BASE              A077772   001   Sep   25,   2007

AN                                EQ   0.042% BASE              A077772   002   Sep   25,   2007

AN       WATSON LABS INC          EQ   0.083% BASE              A076370   001   Nov   24,   2003
	
  SYRUP;ORAL

    ALBUTEROL SULFATE
	
AA       ACTAVIS MID ATLANTIC     EQ 2MG BASE/5ML               A074454 001 Sep 25, 1995

AA       AMNEAL PHARMS            EQ 2MG BASE/5ML               A079241 001 May 12, 2010

AA       HI TECH PHARMA           EQ 2MG BASE/5ML               A074749 001 Jan 30, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                        3-9(of 371)


ALBUTEROL SULFATE
	
  SYRUP;ORAL

    ALBUTEROL SULFATE
	
AA    + TEVA                     EQ     2MG BASE/5ML             A073419 001 Mar 30, 1992

AA       VINTAGE                 EQ     2MG BASE/5ML             A078105 001 Dec 27, 2006

AA       VISTAPHARM              EQ     2MG BASE/5ML             A077788 001 Jun 26, 2007
	
  TABLET;ORAL

    ALBUTEROL SULFATE
	
AB       MUTUAL PHARM            EQ     2MG   BASE               A072637   002   Dec   05,   1989

AB                               EQ     4MG   BASE               A072637   001   Dec   05,   1989

AB       MYLAN                   EQ     2MG   BASE               A072894   002   Jan   17,   1991

AB    +                          EQ     4MG   BASE               A072894   001   Jan   17,   1991
	
  TABLET, EXTENDED RELEASE;ORAL

    ALBUTEROL SULFATE
	
AB       MYLAN                   EQ     4MG BASE                 A078092 002 Jan 29, 2007

AB                               EQ     8MG BASE                 A078092 001 Jan 29, 2007

    VOSPIRE ER
	
AB       DAVA PHARMS INC         EQ     4MG BASE                 A076130 002 Sep 26, 2002

AB    +                          EQ     8MG BASE                 A076130 003 Sep 26, 2002
	
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
	
  AEROSOL, METERED;INHALATION
	
    COMBIVENT
	
      + BOEHRINGER INGELHEIM    EQ 0.09MG BASE/INH;0.018MG/INH   N020291 001 Oct 24, 1996
	
  SOLUTION;INHALATION

    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
	
AN       CIPLA LTD              EQ 0.083% BASE;0.017%            A077559   001   Dec   31,   2007

AN       NEPHRON                EQ 0.083% BASE;0.017%            A076749   001   Dec   31,   2007

AN       RITEDOSE CORP          EQ 0.083% BASE;0.017%            A202496   001   Oct   01,   2012

AN       TEVA PHARMS            EQ 0.083% BASE;0.017%            A076724   001   Dec   31,   2007

AN       WATSON LABS            EQ 0.083% BASE;0.017%            A077063   001   Dec   31,   2007

    DUONEB
	
AN    + MYLAN SPECLT            EQ 0.083% BASE;0.017%            N020950 001 Mar 21, 2001
	
  SPRAY, METERED;INHALATION
	
    COMBIVENT RESPIMAT
	
      + BOEHRINGER INGELHEIM    EQ 0.1MG BASE/INH;0.02MG/INH     N021747 001 Oct 07, 2011
	
ALCAFTADINE
	
  SOLUTION/DROPS;OPHTHALMIC

    LASTACAFT
	
      + ALLERGAN                   0.25%                         N022134 001 Jul 28, 2010
	
ALCLOMETASONE DIPROPIONATE
	
  CREAM;TOPICAL

    ALCLOMETASONE DIPROPIONATE
	
AB    + FOUGERA PHARMS             0.05%                         A076973 001 Jul 12, 2005

AB       GLENMARK GENERICS         0.05%                         A079061 001 Jun 23, 2009

AB       TARO                      0.05%                         A076587 001 Sep 15, 2005

  OINTMENT;TOPICAL

    ALCLOMETASONE DIPROPIONATE
	
AB    + FOUGERA PHARMS             0.05%                         A076884 001 Jul 18, 2005

AB       GLENMARK GENERICS         0.05%                         A079227 001 Jul 30, 2009

AB       TARO                      0.05%                         A076730 001 Jul 29, 2004
	
ALCOHOL; DEXTROSE
	
  INJECTABLE;INJECTION

    ALCOHOL 5% AND DEXTROSE 5%
	
AP    + B BRAUN                   5ML/100ML;5GM/100ML            N004589 004
	
    ALCOHOL 10% AND DEXTROSE 5%
	
      + B BRAUN                   10ML/100ML;5GM/100ML           N004589 006
	
ALENDRONATE SODIUM
	
  SOLUTION;ORAL

    ALENDRONATE SODIUM
	
AA       ROXANE                    EQ 70MG BASE/75ML             A090520 001 Feb 25, 2013

    FOSAMAX
	
AA    + MERCK                      EQ 70MG BASE/75ML             N021575 001 Sep 17, 2003

  TABLET;ORAL

    ALENDRONATE SODIUM
	
AB       APOTEX                    EQ   5MG BASE                 A077982   001   Aug   04,   2008

AB                                 EQ   10MG BASE                A077982   002   Aug   04,   2008

AB                                 EQ   35MG BASE                A077982   003   Aug   04,   2008

AB                                 EQ   70MG BASE                A077982   004   Aug   04,   2008

AB       AUROBINDO PHARMA          EQ   10MG BASE                A090124   001   Aug   04,   2008

AB                                 EQ   35MG BASE                A090124   002   Aug   04,   2008
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-10(of 371)


ALENDRONATE SODIUM
	
  TABLET;ORAL

    ALENDRONATE SODIUM
	
AB                              EQ   70MG BASE                 A090124   003   Aug   04,   2008

AB       AUSTARPHARMA LLC       EQ   5MG BASE                  A090258   001   Sep   24,   2009

AB                              EQ   10MG BASE                 A090258   002   Sep   24,   2009

AB                              EQ   35MG BASE                 A090258   003   Sep   24,   2009

AB                              EQ   70MG BASE                 A090258   004   Sep   24,   2009

AB       CADISTA PHARMS         EQ   5MG BASE                  A090557   001   Feb   18,   2010

AB                              EQ   10MG BASE                 A090557   002   Feb   18,   2010

AB                              EQ   35MG BASE                 A090557   003   Feb   18,   2010

AB                              EQ   70MG BASE                 A090557   004   Feb   18,   2010

AB       CIPLA LTD              EQ   5MG BASE                  A076768   001   Aug   04,   2008

AB                              EQ   10MG BASE                 A076768   002   Aug   04,   2008

AB                              EQ   35MG BASE                 A076768   003   Aug   04,   2008

AB                              EQ   40MG BASE                 A076768   004   Aug   04,   2008

AB                              EQ   70MG BASE                 A076768   005   Aug   04,   2008

AB       DR REDDYS LABS LTD     EQ   5MG BASE                  A079109   001   Aug   04,   2008

AB                              EQ   10MG BASE                 A079109   002   Aug   04,   2008

AB                              EQ   35MG BASE                 A079049   001   Aug   04,   2008

AB                              EQ   70MG BASE                 A079049   002   Aug   04,   2008

AB       MYLAN                  EQ   5MG BASE                  A076584   001   Aug   04,   2008

AB                              EQ   10MG BASE                 A076584   002   Aug   04,   2008

AB                              EQ   35MG BASE                 A076584   003   Aug   04,   2008

AB                              EQ   70MG BASE                 A076584   004   Aug   04,   2008

AB       SUN PHARMA GLOBAL      EQ   5MG BASE                  A090022   001   Sep   10,   2008

AB                              EQ   10MG BASE                 A090022   002   Sep   10,   2008

AB                              EQ   35MG BASE                 A090022   003   Sep   10,   2008

AB                              EQ   70MG BASE                 A090022   004   Sep   10,   2008

AB       TEVA PHARMS            EQ   5MG BASE                  A075710   001   Feb   06,   2008

AB                              EQ   10MG BASE                 A075710   002   Feb   06,   2008

AB                              EQ   35MG BASE                 A075710   003   Feb   06,   2008

AB                              EQ   40MG BASE                 A075710   004   Feb   06,   2008

AB                              EQ   70MG BASE                 A075710   005   Feb   06,   2008

AB       WATSON LABS            EQ   35MG BASE                 A076984   001   Aug   04,   2008

AB                              EQ   40MG BASE                 A076984   002   Aug   04,   2008

AB                              EQ   70MG BASE                 A076984   003   Aug   04,   2008

    FOSAMAX
	
AB    + MERCK AND CO INC        EQ 70MG BASE                   N020560 005 Oct 20, 2000
	
  TABLET, EFFERVESCENT;ORAL
	
    BINOSTO
	
      + MISSION PHARMA          EQ 70MG BASE                   N202344 001 Mar 12, 2012
	
ALENDRONATE SODIUM; CHOLECALCIFEROL
	
  TABLET;ORAL
	
    FOSAMAX PLUS D
	
         MERCK                  EQ 70MG BASE;2,800 IU          N021762 001 Apr 07, 2005

      +                         EQ 70MG BASE;5,600 IU          N021762 002 Apr 26, 2007
	
ALFENTANIL HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    ALFENTA
	
AP    + AKORN                   EQ 0.5MG BASE/ML               N019353 001 Dec 29, 1986

    ALFENTANIL
	
AP       HOSPIRA                EQ 0.5MG BASE/ML               A075221 001 Oct 28, 1999
	
ALFUZOSIN HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    ALFUZOSIN HYDROCHLORIDE
	
AB       APOTEX INC              10MG                          A079013   001   Jul   18,   2011

AB       AUROBINDO PHARMA LTD    10MG                          A079060   001   Aug   30,   2012

AB       INVAGEN PHARMS          10MG                          A090284   001   Jan   17,   2012

AB       MYLAN                   10MG                          A079014   001   Jul   18,   2011

AB       SUN PHARMA GLOBAL       10MG                          A079057   001   Jul   18,   2011

AB       TEVA PHARMS             10MG                          A079056   001   Jul   18,   2011

AB       TORRENT PHARMS          10MG                          A079054   001   Jul   18,   2011

AB       WOCKHARDT LTD           10MG                          A090221   001   Aug   10,   2012

    UROXATRAL
	
AB    + COVIS PHARMA SARL        10MG                          N021287 001 Jun 12, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                            3-11(of 371)


ALISKIREN HEMIFUMARATE
	
  TABLET;ORAL
	
    TEKTURNA
	
         NOVARTIS               EQ 150MG BASE                        N021985 001 Mar 05, 2007
	
      +                         EQ 300MG BASE		                      N021985 002 Mar 05, 2007
	
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
	
  TABLET;ORAL
	
    TEKAMLO
	
          NOVARTIS		            EQ 150MG BASE;EQ   5MG BASE          N022545   001   Aug   26,   2010

                                EQ 150MG BASE;EQ   10MG BASE         N022545   002   Aug   26,   2010

                                EQ 300MG BASE;EQ   5MG BASE          N022545   003   Aug   26,   2010

      +		                       EQ 300MG BASE;EQ   10MG BASE         N022545   004   Aug   26,   2010
	
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    AMTURNIDE
	
          NOVARTIS		            EQ 150MG BASE;EQ 5MG BASE;12.5MG     N200045   001   Dec   21,   2010
	
                                EQ 300MG BASE;EQ 5MG BASE;12.5MG     N200045   002   Dec   21,   2010
	
                                EQ 300MG BASE;EQ 5MG BASE;25MG       N200045   003   Dec   21,   2010
	
                                EQ 300MG BASE;EQ 10MG BASE;12.5MG    N200045   004   Dec   21,   2010
	
      +		                       EQ 300MG BASE;EQ 10MG BASE;25MG      N200045   005   Dec   21,   2010
	
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    TEKTURNA HCT
	
          NOVARTIS              EQ 150MG BASE;12.5MG                 N022107   001   Jan   18,   2008
	
                                EQ 150MG BASE;25MG                   N022107   002   Jan   18,   2008
	
      +		                       EQ 300MG BASE;12.5MG                 N022107   003   Jan   18,   2008
	
      +                         EQ 300MG BASE;25MG                   N022107   004   Jan   18,   2008
	
ALITRETINOIN
	
  GEL;TOPICAL
	
    PANRETIN
	
      + EISAI INC               EQ 0.1% BASE		                       N020886 001 Feb 02, 1999
	
ALLOPURINOL
	
  TABLET;ORAL

    ALLOPURINOL
	
AB       ACCORD HLTHCARE        100MG                                A203154   001   May   06,   2013

AB                              300MG                                A203154   002   May   06,   2013

AB       APOTEX INC             100MG                                A077353   001   Sep   08,   2005

AB                              300MG                                A077353   002   Sep   08,   2005

AB       IPCA LABS LTD          100MG                                A090637   001   Mar   16,   2011

AB                              300MG                                A090637   002   Mar   16,   2011

AB       MUTUAL PHARM           100MG                                A071449   001   Jan   09,   1987

AB                              300MG                                A071450   001   Jan   09,   1987

AB       MYLAN                  100MG                                A018659   001   Oct   24,   1986

AB                              300MG                                A018659   002   Oct   24,   1986

AB       NORTHSTAR HLTHCARE     100MG                                A078253   001   Sep   11,   2007

AB                              300MG                                A078253   002   Sep   11,   2007

AB       SUN PHARM INDS INC     100MG                                A078390   001   Aug   30,   2007

AB                              300MG                                A078390   002   Aug   30,   2007

AB       VINTAGE PHARMS         100MG                                A075798   001   Jun   27,   2003

AB                              300MG                                A075798   002   Jun   27,   2003

AB       WATSON LABS            100MG                                N018832   002   Sep   28,   1984

AB                              300MG                                N018877   001   Sep   28,   1984

    LOPURIN
	
AB       DR REDDYS LA           100MG                                A071586 001 Apr 02, 1987

AB                              300MG                                A071587 001 Apr 02, 1987

    ZYLOPRIM
	
AB       PROMETHEUS LABS        100MG                                N016084 001
	
AB    +                         300MG                                N016084 002
	
ALLOPURINOL SODIUM
	
  INJECTABLE;INJECTION

    ALLOPURINOL SODIUM
	
AP       EUROHLTH INTL          EQ 500MG BASE/VIAL                   A076870 001 Aug 26, 2004

    ALOPRIM
	
AP    + MYLAN INSTITUTIONAL     EQ 500MG BASE/VIAL                   N020298 001 May 17, 1996
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                              3-12(of 371)


ALMOTRIPTAN MALATE
	
  TABLET;ORAL
	
    AXERT
	
         JANSSEN PHARMS         EQ 6.25MG BASE                           N021001 001 May 07, 2001

      +                         EQ 12.5MG BASE                           N021001 002 May 07, 2001
	
ALOGLIPTIN BENZOATE
	
  TABLET;ORAL
	
    NESINA
	
         TAKEDA PHARMS USA      EQ 6.25MG BASE                           N022271 001 Jan 25, 2013
                                EQ 12.5MG BASE                           N022271 002 Jan 25, 2013
     +                          EQ 25MG BASE                             N022271 003 Jan 25, 2013
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    KAZANO
	
      +		 TAKEDA PHARMS USA     EQ 12.5MG BASE;1GM                       N203414 002 Jan 25, 2013
	
                                EQ 12.5MG BASE;500MG                     N203414 001 Jan 25, 2013
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    OSENI
	
          TAKEDA PHARMS USA     EQ 12.5MG BASE;EQ 15MG BASE              N022426   004   Jan   25,   2013
	
                                EQ 12.5MG BASE;EQ 30MG BASE		            N022426   005   Jan   25,   2013
	
                                EQ 12.5MG BASE;EQ 45MG BASE		            N022426   006   Jan   25,   2013
	
                                EQ 25MG BASE;EQ 15MG BASE		              N022426   001   Jan   25,   2013
	
                                EQ 25MG BASE;EQ 30MG BASE		              N022426   002   Jan   25,   2013
	
      +		                       EQ 25MG BASE;EQ 45MG BASE                N022426   003   Jan   25,   2013
	
ALOSETRON HYDROCHLORIDE
	
  TABLET;ORAL
	
    LOTRONEX
	
          PROMETHEUS LABS       EQ 0.5MG BASE                            N021107 002 Dec 23, 2003
	
      +		                       EQ 1MG BASE                              N021107 001 Feb 09, 2000
	
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL;

FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE

HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
	
  INJECTABLE;INJECTION
	
    INFUVITE ADULT
	
      +		 SANDOZ                2 IU/ML;40MG/ML;12MCG/ML;40               N021163 001 May 18, 2000

                                IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1

                                .2MG/ML;0.72MG/ML;1.2MG/ML;660

                                IU/ML;0.03MG/ML

  INJECTABLE;IV (INFUSION)

    INFUVITE ADULT
	
      +		 SANDOZ                2 IU/ML;40MG/ML;12MCG/ML;40               N021559 001 Jun 16, 2003

                                IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1

                                .2MG/ML;0.72MG/ML;1.2MG/ML;660

                                IU/ML;30MCG/ML
	
ALPRAZOLAM
	
  CONCENTRATE;ORAL
	
    ALPRAZOLAM
	
      + ROXANE                  1MG/ML                                   A074312 001 Oct 31, 1993
	
  TABLET;ORAL

    ALPRAZOLAM
	
AB       ACTAVIS ELIZABETH      0.25MG                                   A074342   001   Oct   31,   1993

AB                              0.5MG                                    A074342   002   Oct   31,   1993

AB                              1MG                                      A074342   003   Oct   31,   1993

AB                              2MG                                      A074342   004   Oct   31,   1993

AB       APOTEX INC             0.25MG                                   A077741   001   Jan   19,   2007

AB                              0.5MG                                    A077741   002   Jan   19,   2007

AB                              1MG                                      A077741   003   Jan   19,   2007

AB                              2MG                                      A077741   004   Jan   19,   2007

AB       DAVA INTL INC          0.25MG                                   A074174   001   Oct   19,   1993

AB                              0.5MG                                    A074174   002   Oct   19,   1993

AB                              1MG                                      A074174   003   Oct   19,   1993

AB                              2MG                                      A074174   004   Oct   19,   1993

AB       MYLAN                  0.25MG                                   A074215   001   Jan   27,   1994

AB                              0.5MG                                    A074215   002   Jan   27,   1994

AB                              1MG                                      A074215   003   Jan   27,   1994

AB                              2MG                                      A074215   004   Jan   27,   1994

AB       MYLAN PHARMS INC       0.25MG                                   A074046   001   Oct   19,   1993

AB                              0.5MG                                    A074046   002   Oct   19,   1993

AB                              1MG                                      A074046   003   Oct   19,   1993
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-13(of 371)


ALPRAZOLAM
	
  TABLET;ORAL

    ALPRAZOLAM
	
AB                               2MG                           A074046   004   May   07,   1997

AB       SANDOZ                  0.25MG                        A074112   001   Dec   29,   1995

AB                               0.5MG                         A074112   002   Dec   29,   1995

AB                               1MG                           A074112   003   Dec   29,   1995

AB                               2MG                           A074909   001   Mar   25,   1998

AB       SUN PHARMA GLOBAL       0.25MG                        A090082   001   Jun   17,   2010

AB                               0.5MG                         A090082   002   Jun   17,   2010

AB                               1MG                           A090082   003   Jun   17,   2010

AB                               2MG                           A090082   004   Jun   17,   2010

AB       VINTAGE                 0.25MG                        A078491   001   Sep   25,   2008

AB                               0.5MG                         A078491   002   Sep   25,   2008

AB                               1MG                           A078491   003   Sep   25,   2008

AB                               2MG                           A078491   004   Dec   12,   2008

AB       VINTAGE PHARMS          0.25MG                        A090248   001   Sep   17,   2010

AB                               0.5MG                         A090248   002   Sep   17,   2010

AB                               1MG                           A090248   003   Sep   17,   2010

AB                               2MG                           A090248   004   Sep   17,   2010

    XANAX
	
AB       PHARMACIA AND UPJOHN    0.25MG                        N018276   001
	
AB                               0.5MG                         N018276   002
	
AB    +                          1MG                           N018276   003
	
AB                               2MG                           N018276   004 Nov 27, 1985
	
  TABLET, EXTENDED RELEASE;ORAL

    ALPRAZOLAM
	
AB       ACTAVIS ELIZABETH       0.5MG                         A078056   001   Feb   13,   2007

AB                               1MG                           A078056   002   Feb   13,   2007

AB                               2MG                           A078056   003   Feb   13,   2007

AB                               3MG                           A078056   004   Feb   13,   2007

AB       ACTAVIS LABS FL INC     0.5MG                         A077198   001   May   13,   2010

AB                               1MG                           A077198   002   May   13,   2010

AB                               2MG                           A077198   003   May   13,   2010

AB                               3MG                           A077198   004   May   13,   2010

AB       AMNEAL PHARMS NY        0.5MG                         A078387   001   May   30,   2008

AB                               1MG                           A078387   002   May   30,   2008

AB                               2MG                           A078387   003   May   30,   2008

AB                               3MG                           A078387   004   May   30,   2008

AB       ANCHEN PHARMS           0.5MG                         A078469   001   Sep   29,   2011

AB                               1MG                           A078469   002   Sep   29,   2011

AB                               2MG                           A078469   003   Sep   29,   2011

AB                               3MG                           A078469   004   Sep   29,   2011

AB       ANI PHARMS INC          0.5MG                         A077725   001   Jul   31,   2006

AB                               1MG                           A077725   002   Jul   31,   2006

AB                               2MG                           A077725   004   Jul   31,   2006

AB                               3MG                           A077725   003   Jul   31,   2006

AB       APOTEX INC              0.5MG                         A078449   001   Nov   12,   2008

AB                               2MG                           A078449   002   Nov   12,   2008

AB                               3MG                           A078449   003   Nov   12,   2008

AB       AUROBINDO PHARMA USA    0.5MG                         A090871   001   Jun   07,   2011

AB                               1MG                           A090871   002   Jun   07,   2011

AB                               2MG                           A090871   003   Jun   07,   2011

AB                               3MG                           A090871   004   Jun   07,   2011

AB       COREPHARMA              0.5MG                         A077996   001   Jan   31,   2007

AB                               1MG                           A077996   002   Jan   31,   2007

AB                               2MG                           A077996   003   Jan   31,   2007

AB                               3MG                           A077996   004   Jan   31,   2007

AB       IMPAX LABS              0.5MG                         A077968   004   May   24,   2007

AB                               1MG                           A077968   003   May   24,   2007

AB                               2MG                           A077968   002   May   24,   2007

AB                               3MG                           A077968   001   May   24,   2007

AB       MYLAN                   0.5MG                         A077391   002   Jan   26,   2006

AB                               1MG                           A077391   003   Jan   26,   2006

AB                               2MG                           A077391   004   Jan   26,   2006

AB                               3MG                           A077391   001   Jan   26,   2006

AB       ZYDUS PHARMS USA INC    0.5MG                         A078489   001   Oct   17,   2008

AB                               1MG                           A078489   002   Oct   17,   2008

AB                               2MG                           A078489   003   Oct   17,   2008

AB                               3MG                           A078489   004   Oct   17,   2008

    XANAX XR
	
AB       PHARMACIA AND UPJOHN    0.5MG                         N021434 001 Jan 17, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-14(of 371)


ALPRAZOLAM
	
  TABLET, EXTENDED RELEASE;ORAL

    XANAX XR
	
AB                               1MG                            N021434 002 Jan 17, 2003

AB                               2MG                            N021434 003 Jan 17, 2003

AB    +                          3MG                            N021434 004 Jan 17, 2003
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    ALPRAZOLAM
	
AB       ACTAVIS ELIZABETH       0.25MG                         A078561   001   Mar   16,   2010

AB                               0.5MG                          A078561   002   Mar   16,   2010

AB                               1MG                            A078561   003   Mar   16,   2010

AB                               2MG                            A078561   004   Mar   16,   2010

AB       PAR PHARM               0.25MG                         A078088   001   Jan   09,   2009

AB                               0.5MG                          A078088   002   Jan   09,   2009

AB    +                          1MG                            A078088   003   Jan   09,   2009

AB                               2MG                            A078088   004   Jan   09,   2009
	
ALPROSTADIL
	
  INJECTABLE;INJECTION

    ALPROSTADIL
	
AP         EUROHLTH INTL          0.5MG/ML                      A074815 001 Jan 20, 1998

AP         TEVA PHARMS USA        0.5MG/ML                      A075196 001 Apr 30, 1999

    CAVERJECT
	
AP         PHARMACIA AND UPJOHN   0.01MG/VIAL                   N020379 001 Jul 06, 1995

AP    +                           0.02MG/VIAL                   N020379 002 Jul 06, 1995

AP    +                           0.04MG/VIAL                   N020379 004 May 19, 1997

    EDEX
	
AP         AUXILIUM PHARMS LLC    0.01MG/VIAL                   N020649 002 Jun 12, 1997

AP                                0.02MG/VIAL                   N020649 003 Jun 12, 1997

AP    +                           0.04MG/VIAL                   N020649 004 Jun 12, 1997

    PROSTIN VR PEDIATRIC
	
AP    + PHARMACIA AND UPJOHN      0.5MG/ML                      N018484 001
	
    CAVERJECT
	
           PHARMACIA AND UPJOHN   0.005MG/VIAL                  N020379 003 Jun 27, 1996
	
    CAVERJECT IMPULSE
	
           PHARMACIA AND UPJOHN   0.01MG/VIAL                   N021212 001 Jun 11, 2002
	
                                  0.02MG/VIAL                   N021212 002 Jun 11, 2002
	
    EDEX
	
      + AUXILIUM PHARMS LLC       0.01MG/VIAL		                 N020649 005 Jul 30, 1998
	
      +                           0.02MG/VIAL		                 N020649 006 Jul 30, 1998
	
      +                           0.04MG/VIAL                   N020649 007 Jul 30, 1998
	
  SUPPOSITORY;URETHRAL
	
    MUSE
	
           MEDA PHARMS		          0.125MG                       N020700   001   Nov   19,   1996
	
                                  0.25MG                        N020700   002   Nov   19,   1996
	
                                  0.5MG                         N020700   003   Nov   19,   1996
	
     +                            1MG                           N020700   004   Nov   19,   1996
	
ALTRETAMINE
	
  CAPSULE;ORAL
	
    HEXALEN
	
      + EISAI INC                 50MG                          N019926 001 Dec 26, 1990
	
ALVIMOPAN
	
  CAPSULE;ORAL
	
    ENTEREG
	
      + CUBIST PHARMS             12MG		                        N021775 001 May 20, 2008
	
AMANTADINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    AMANTADINE HYDROCHLORIDE
	
AB       BANNER PHARMACAPS        100MG                         A078720 001 May 29, 2008

AB    + SANDOZ                    100MG                         A071293 001 Feb 18, 1987

AB       USL PHARMA               100MG                         A070589 001 Aug 05, 1986

  SYRUP;ORAL

    AMANTADINE HYDROCHLORIDE
	
AA    + CAROLINA MEDCL            50MG/5ML                      A075819   001   Sep   11,   2002

AA    + HI TECH PHARMA            50MG/5ML                      A074170   001   Oct   28,   1994

AA    + MIKART                    50MG/5ML                      A074028   001   Jun   28,   1993

AA    + PHARM ASSOC               50MG/5ML                      A074509   001   Jul   17,   1995

AA    + SILARX                    50MG/5ML                      A076352   001   Sep   10,   2004

AA    + VINTAGE                   50MG/5ML                      A077992   001   Dec   12,   2006

AA    + WOCKHARDT                 50MG/5ML                      A075060   001   Dec   24,   1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-15(of 371)


AMANTADINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    AMANTADINE HYDROCHLORIDE
	
      + USL PHARMA               100MG                          A076186 001 Dec 16, 2002
	
AMBRISENTAN
	
  TABLET;ORAL
	
    LETAIRIS
	
         GILEAD                  5MG                            N022081 001 Jun 15, 2007
	
      +                          10MG                           N022081 002 Jun 15, 2007
	
AMCINONIDE
	
  CREAM;TOPICAL

    AMCINONIDE
	
AB    + FOUGERA PHARMS           0.1%                           A076065 001 May 15, 2003

AB       TARO PHARM INDS         0.1%                           A076229 001 May 31, 2002

  LOTION;TOPICAL
	
    AMCINONIDE
	
      + FOUGERA PHARMS           0.1%                           A076329 001 Nov 06, 2002
	
  OINTMENT;TOPICAL

    AMCINONIDE
	
AB    + FOUGERA PHARMS           0.1%                           A076096 001 Nov 19, 2002

AB       TARO PHARM INDS         0.1%                           A076367 001 Mar 19, 2003
	
AMIFOSTINE
	
  INJECTABLE;INJECTION

    AMIFOSTINE
	
AP       SUN PHARMA GLOBAL       500MG/VIAL                     A077126 001 Mar 14, 2008

    ETHYOL
	
AP    + CLINIGEN HLTHCARE        500MG/VIAL                     N020221 001 Dec 08, 1995
	
AMIKACIN SULFATE
	
  INJECTABLE;INJECTION

    AMIKACIN SULFATE
	
AP       EMCURE PHARMS LTD       EQ    250MG BASE/ML            A204040   001   Dec   12,   2013

AP    + EUROHLTH INTL            EQ    50MG BASE/ML             A063313   001   Apr   11,   1994

AP    +                          EQ    250MG BASE/ML            A063315   001   Apr   11,   1994

AP       TEVA PHARMS USA         EQ    250MG BASE/ML            A064045   002   Sep   28,   1993
	
AMILORIDE HYDROCHLORIDE
	
  TABLET;ORAL

    AMILORIDE HYDROCHLORIDE
	
AB    + PAR PHARM                5MG                            A070346 001 Jan 22, 1986

AB       SIGMAPHARM LABS LLC     5MG                            A079133 001 Jan 30, 2009

    MIDAMOR
	
AB       PADDOCK LLC             5MG                            N018200 001
	
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
AB       BARR                   EQ 5MG ANHYDROUS;50MG           A071111 001 May 10, 1988

AB    + MYLAN                   EQ 5MG ANHYDROUS;50MG           A073209 001 Oct 31, 1991
	
AMINO ACIDS
	
  INJECTABLE;INJECTION
	
    AMINO ACIDS
	
         B BRAUN                 15%(150GM/1000ML)              A091112 001 Apr 13, 2012

                                 15%(300GM/2000ML)              A091112 002 Apr 13, 2012

   AMINOSYN 10%
	
        HOSPIRA                  10% (10GM/100ML)               N017673 003
	
   AMINOSYN 10% (PH6)

        HOSPIRA                  10% (10GM/100ML)               N017673 008 Nov 18, 1985
	
   AMINOSYN 3.5%
	
        HOSPIRA                  3.5% (3.5GM/100ML)             N017789 004
	
   AMINOSYN 5%
	
        HOSPIRA                  5% (5GM/100ML)                 N017673 001
	
   AMINOSYN 7%
	
        HOSPIRA                  7% (7GM/100ML)                 N017673 002
	
   AMINOSYN 7% (PH6)

        HOSPIRA                  7% (7GM/100ML)                 N017673 006 Nov 18, 1985
	
   AMINOSYN 8.5%
	
        HOSPIRA                  8.5% (8.5GM/100ML)             N017673 004
	
   AMINOSYN 8.5% (PH6)

        HOSPIRA                  8.5% (8.5GM/100ML)             N017673 007 Nov 18, 1985
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                            3-16(of 371)


AMINO ACIDS
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 10%
	
         HOSPIRA                10% (10GM/100ML)
                        N019438 005 Apr 03, 1986
    AMINOSYN II 10% IN PLASTIC CONTAINER
	
         HOSPIRA                10% (10GM/100ML)
                        N020015 001 Dec 19, 1991
    AMINOSYN II 15% IN PLASTIC CONTAINER
	
         HOSPIRA
	              15% (15GM/100ML)
	                       N020041 001 Dec 19, 1991
    AMINOSYN II 7%
	
         HOSPIRA
	              7% (7GM/100ML)
	                         N019438 003 Apr 03, 1986
    AMINOSYN II 8.5%
	
         HOSPIRA
	              8.5% (8.5GM/100ML)
	                     N019438 004 Apr 03, 1986
    AMINOSYN-HBC 7%
	
         HOSPIRA
	              7% (7GM/100ML)
	                         N019374 001 Jul 12, 1985
    AMINOSYN-HF 8%
	
         HOSPIRA
	              8% (8GM/100ML)
	                         A020345 001 Apr 04, 1996
    AMINOSYN-PF 10%
	
         HOSPIRA
	              10% (10GM/100ML)
	                       N019492 002 Oct 17, 1986
    AMINOSYN-PF 7%
	
         HOSPIRA
	              7% (7GM/100ML)
	                         N019398 001 Sep 06, 1985
    AMINOSYN-RF 5.2%
	
         HOSPIRA
	              5.2% (5.2GM/100ML)
	                     N018429 001
    BRANCHAMIN 4% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4% (4GM/100ML)
                          N018684 001 Sep 28, 1984
    CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE
	      15% (15GM/100ML)
	                       A020512 001 Aug 30, 1996
    FREAMINE HBC 6.9%
	
         B BRAUN
	              6.9% (6.9GM/100ML)
	                     N016822 006 May 17, 1983
    FREAMINE III 10%
	
         B BRAUN
	              10% (10GM/100ML)
	                       N016822 005
    FREAMINE III 8.5%
	
         B BRAUN
	              8.5% (8.5GM/100ML)
	                     N016822 004
    HEPATAMINE 8%
	
         B BRAUN
	              8% (8GM/100ML)
	                         N018676 001 Aug 03, 1982
    NEPHRAMINE 5.4%
	
         B BRAUN
	              5.4% (5.4GM/100ML)
	                     N017766 001
    PREMASOL 10% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        10% (10GM/100ML)
                        A075880 002 Jun 19, 2003
    PREMASOL 6% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        6% (6GM/100ML)
                          A075880 001 Jun 19, 2003
    PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         20% (20GM/100ML)
                        N020849 001 Aug 26, 1998
    TRAVASOL 10% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        10% (10MG/100ML)
                        N018931 003 Aug 23, 1984
    TRAVASOL 5.5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5.5% (5.5GM/100ML)
                      N018931 001 Aug 23, 1984
    TRAVASOL 8.5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        8.5% (8.5GM/100ML)
                      N018931 002 Aug 23, 1984
    TROPHAMINE
	
      + B BRAUN                 6% (6GM/100ML)
                          N019018 001 Jul 20, 1984
    TROPHAMINE 10%
	
      + B BRAUN		               10% (10GM/100ML)
	                       N019018 003 Sep 07, 1988
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE;

SODIUM ACETATE; SODIUM CHLORIDE
  INJECTABLE;INJECTION
    PROCALAMINE
         B BRAUN                3%;26MG/100ML;3GM/100ML;54MG/100ML;41MG   N018582 001 May 08, 1982
                                /100ML;150MG/100ML;200MG/100ML;120MG/10
                                0ML
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM

ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE		       2.75%;33MG/100ML;10GM/100ML;51MG/100ML;   N020678 002 Mar 26, 1997

                                261MG/100ML;217MG/100ML;112MG/100ML

    CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE		       2.75%;33MG/100ML;25GM/100ML;51MG/100ML;   N020678 005 Mar 26, 1997

                                261MG/100ML;217MG/100ML;112MG/100ML

    CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER

      +		 BAXTER HLTHCARE       2.75%;33MG/100ML;5GM/100ML;51MG/100ML;2   N020678 001 Mar 26, 1997

                                61MG/100ML;217MG/100ML;112MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                              3-17(of 371)


AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM

ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         4.25%;33MG/100ML;10GM/100ML;51MG/100ML;   N020678 009 Mar 26, 1997

                                261MG/100ML;297MG/100ML;77MG/100ML

    CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         4.25%;33MG/100ML;20GM/100ML;51MG/100ML;   N020678 011 Mar 26, 1997

                                261MG/100ML;297MG/100ML;77MG/100ML

    CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         4.25%;33MG/100ML;25GM/100ML;51MG/100ML;   N020678 012 Mar 26, 1997

                                261MG/100ML;297MG/100ML;77MG/100ML

    CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         4.25%;33MG/100ML;5GM/100ML;51MG/100ML;2   N020678 008 Mar 26, 1997

                                61MG/100ML;297MG/100ML;77MG/100ML

    CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         5%;33MG/100ML;10GM/100ML;51MG/100ML;261   N020678 016 Mar 26, 1997

                                MG/100ML;340MG/100ML;59MG/100ML

    CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         5%;33MG/100ML;15GM/100ML;51MG/100ML;261   N020678 017 Mar 26, 1997

                                MG/100ML;340MG/100ML;59MG/100ML

    CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         5%;33MG/100ML;20GM/100ML;51MG/100ML;261   N020678 018 Mar 26, 1997

                                MG/100ML;340MG/100ML;59MG/100ML

    CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

      + BAXTER HLTHCARE         5%;33MG/100ML;25GM/100ML;51MG/100ML;261   N020678 019 Mar 26, 1997

                                MG/100ML;340MG/100ML;59MG/100ML

    CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER

      +		 BAXTER HLTHCARE       5%;33MG/100ML;35GM/100ML;51MG/100ML;261   N020678 021 Mar 26, 1997

                                MG/100ML;340MG/100ML;59MG/100ML
	
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE;

SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
	
  EMULSION;IV (INFUSION)

    KABIVEN IN PLASTIC CONTAINER
	
          FRESENIUS KABI USA		  3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;   N200656 004 Aug 25, 2014

                                174MG/100ML;239MG/100ML

                                ;147MG/100ML;3.9GM/100ML (1026ML)

                                3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;   N200656 005 Aug 25, 2014

                                174MG/100ML;239MG/100ML;147MG/100ML;3.9

                                GM/100ML (1540ML)

                                3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;   N200656 006 Aug 25, 2014

                                174MG/100ML;239MG/100ML;147MG/100ML;3.9

                                GM/100ML (2053ML)

      +		                       3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;   N200656 007 Aug 25, 2014

                                174MG/100ML;239MG/100ML;147MG/100ML;3.9

                                GM/100ML (2566ML)

    PERIKABIVEN IN PLASTIC CONTAINER
	
          FRESENIUS KABI USA		  2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;   N200656 001 Aug 25, 2014

                                124MG/100ML;170MG/100ML;105MG/100ML;3.5

                                GM/100ML (1440ML)

                                2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;   N200656 002 Aug 25, 2014

                                124MG/100ML;170MG/100ML;105MG/100ML;3.5

                                GM/100ML (1920ML)

                                2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;   N200656 003 Aug 25, 2014

                                124MG/100ML;170MG/100ML

                                ;105MG/100ML;3.5GM/100ML (2400ML)
	
AMINO ACIDS; DEXTROSE
	
  INJECTABLE;INJECTION
	
    CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        2.75%;10GM/100ML                          N020734 002 Sep 29, 1997

    CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        2.75%;25GM/100ML                          N020734 005 Sep 29, 1997

    CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        2.75%;5GM/100ML                           N020734 001 Sep 29, 1997

    CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        4.25%;10GM/100ML                          N020734 008 Sep 29, 1997

    CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        4.25%;20GM/100ML                          N020734 010 Sep 29, 1997

    CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        4.25%;25GM/100ML                          N020734 011 Sep 29, 1997

    CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        4.25%;5GM/100ML                           N020734 007 Sep 29, 1997

    CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        5%;10GM/100ML                             N020734 014 Sep 29, 1997
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                  3-18(of 371)


AMINO ACIDS; DEXTROSE
	
  INJECTABLE;INJECTION
	
    CLINIMIX 5/15 SULFITE   FREE IN DEXTROSE 15%    IN PLASTIC CONTAINER

         BAXTER HLTHCARE          5%;15GM/100ML
                            N020734 015 Sep 29, 1997
	
    CLINIMIX 5/20 SULFITE   FREE IN DEXTROSE 20%    IN PLASTIC CONTAINER

         BAXTER HLTHCARE          5%;20GM/100ML
                            N020734 016 Sep 29, 1997
	
    CLINIMIX 5/25 SULFITE   FREE IN DEXTROSE 25%    IN PLASTIC CONTAINER

         BAXTER HLTHCARE          5%;25GM/100ML
                            N020734 017 Sep 29, 1997
	
    CLINIMIX 5/35 SULFITE   FREE IN DEXTROSE 35%    IN PLASTIC CONTAINER

         BAXTER HLTHCARE          5%;35GM/100ML
	                           N020734 018 Sep 29, 1997
	
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM

ACETATE
	
  INJECTABLE;INJECTION
	
    FREAMINE III 8.5% W/ ELECTROLYTES

          B BRAUN               8.5%;110MG/100ML;230MG/100ML;10MG/100ML   N016822 007 Jul 01, 1988

                                ;440MG/100ML;690MG/100ML
	
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN 3.5% M
	
         HOSPIRA                3.5%;21MG/100ML;40MG/100ML;128MG/100ML;   N017789 003
	
                                234MG/100ML
	
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM

CHLORIDE
	
  INJECTABLE;INJECTION
	
    FREAMINE III 3% W/ ELECTROLYTES

          B BRAUN               3%;54MG/100ML;40MG/100ML;150MG/100ML;20   N016822 003
	
                                0MG/100ML;120MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 10% W/ ELECTROLYTES

         HOSPIRA                10%;102MG/100ML;45MG/100ML;522MG/100ML;   N019437 004 Apr 03, 1986

                                410MG/100ML

    AMINOSYN II 8.5% W/ ELECTROLYTES

         HOSPIRA                8.5%;102MG/100ML;45MG/100ML;522MG/100ML   N019437 005 Apr 03, 1986

                                ;410MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM       CHLORIDE
	
  INJECTABLE;INJECTION
	
    TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER

         BAXTER HLTHCARE        3.5%;51MG/100ML;131MG/100ML;218MG/100ML
  N020177 001       Oct 23, 1995
	
                                ;35MG/100ML

    TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER

         BAXTER HLTHCARE        5.5%;102MG/100ML;522MG/100ML;431MG/100M
  N020173 001       Oct 27, 1995
	
                                L;224MG/100ML

    TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER

         BAXTER HLTHCARE        8.5%;102MG/100ML;522MG/100ML;594MG/100M
  N020173 002       Oct 27, 1995
	
                                L;154MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN 7% W/ ELECTROLYTES

         HOSPIRA                 7%;102MG/100ML;522MG/100ML;410MG/100ML
  N017789 002
	
    AMINOSYN 8.5% W/ ELECTROLYTES

         HOSPIRA                 8.5%;102MG/100ML;522MG/100ML;410MG/100M  N017673 005
	
                                 L
AMINOCAPROIC ACID
  INJECTABLE;INJECTION
    AMINOCAPROIC ACID
AP       LUITPOLD               250MG/ML                                    A071192 001 Dec 01, 1987
	
    AMINOCAPROIC ACID IN PLASTIC CONTAINER
	
AP    + HOSPIRA
	               250MG/ML
	                                  A070010 001 Mar 09, 1987
	
  SYRUP;ORAL

    AMICAR
AA    + CLOVER PHARMS           1.25GM/5ML
	                                N015230 002
	
    AMINOCAPROIC ACID
AA       MIKART                 1.25GM/5ML
	                                A074759 001 Sep 02, 1998
	
  TABLET;ORAL

    AMICAR
	
AB       CLOVER PHARMS
	        500MG
	                                     N015197 001
	
    AMINOCAPROIC
	
AB       MIKART
	               500MG
	                                     A075602 001 May 24, 2001
	
    AMICAR
	
      + CLOVER PHARMS
	         1GM
	                                       N015197 002 Jun 24, 2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                        3-19(of 371)


AMINOLEVULINIC ACID HYDROCHLORIDE
	
  SOLUTION;TOPICAL
	
    LEVULAN
	
      + DUSA                    20%                             N020965 001 Dec 03, 1999
	
AMINOPHYLLINE
	
  INJECTABLE;INJECTION

    AMINOPHYLLINE
	
AP    + HOSPIRA                  25MG/ML                        A087242 001 Oct 26, 1983

AP       LUITPOLD                25MG/ML                        A087600 001
	
AMINOSALICYLIC ACID
	
  GRANULE, DELAYED RELEASE;ORAL
	
    PASER
	
      + JACOBUS                  4GM/PACKET                     A074346 001 Jun 30, 1994
	
AMIODARONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    AMIODARONE HYDROCHLORIDE
	
AP    + AKORN                    50MG/ML                        A076232   001     Jul   05,   2006

AP    + FRESENIUS KABI USA       50MG/ML                        A075761   001     Oct   15,   2002

AP    + GLAND PHARMA LTD         50MG/ML                        A077161   001     Apr   20,   2005

AP       HIKMA FARMACEUTICA      50MG/ML                        A077234   001     Feb   25,   2008

AP    + HOSPIRA                  50MG/ML                        A075955   001     Oct   18,   2002

AP       HOSPIRA INC             50MG/ML                        A203884   001     Nov   25,   2013

AP                               50MG/ML                        A203885   001     Nov   25,   2013

AP    + MYLAN INSTITUTIONAL      50MG/ML                        A076217   001     Oct   15,   2002

AP       WOCKHARDT               50MG/ML                        A077610   001     Oct   30,   2008

AP                               50MG/ML                        A077834   001     Oct   30,   2008

    NEXTERONE
	
AP       BAXTER HLTHCARE         50MG/ML                        N022325 001 Dec 24, 2008
	
      +                          150MG/100ML (1.5MG/ML)         N022325 002 Nov 16, 2010
	
      +                          360MG/200ML (1.8MG/ML)         N022325 003 Nov 16, 2010
	
  TABLET;ORAL

    AMIODARONE HYDROCHLORIDE
	
AB       APOTEX CORP             200MG                          A078578   001     Nov   06,   2008

AB       BARR                    200MG                          A075389   001     Jan   25,   2001

AB       MURTY PHARMS            200MG                          A077069   001     Apr   08,   2005

AB                               400MG                          A077069   002     Apr   08,   2005

AB       MYLAN                   200MG                          A075188   001     Feb   24,   1999

AB       SANDOZ                  200MG                          A075315   001     Dec   23,   1998

AB                               400MG                          A075315   002     Jun   30,   2000

AB       TARO                    100MG                          A075424   002     Dec   18,   2002

AB                               200MG                          A075424   001     Mar   30,   2001

AB                               400MG                          A076362   001     Nov   29,   2002

AB       TEVA PHARMS             200MG                          A074739   001     Nov   30,   1998

AB       ZYDUS PHARMS USA INC    200MG                          A079029   001     Sep   16,   2008

    CORDARONE
	
AB    + WYETH PHARMS INC         200MG                          N018972 001 Dec 24, 1985

    PACERONE
	
AB       UPSHER SMITH            100MG                          A075135 002 Apr 12, 2005

AB                               200MG                          A075135 001 Apr 30, 1998

    AMIODARONE HYDROCHLORIDE
	
         TARO                    300MG                          A076362 002 Dec 02, 2003
	
AMITRIPTYLINE HYDROCHLORIDE
	
  TABLET;ORAL

    AMITRIPTYLINE HYDROCHLORIDE
	
AB       ACCORD HLTHCARE          10MG                          A202446   001     Jun   04,   2014

AB                                25MG                          A202446   002     Jun   04,   2014

AB                                50MG                          A202446   003     Jun   04,   2014

AB                                75MG                          A202446   004     Jun   04,   2014

AB                                100MG                         A202446   005     Jun   04,   2014

AB                                150MG                         A202446   006     Jun   04,   2014

AB       MUTUAL PHARM             10MG                          A089399   002     Jul   14,   1987

AB                                25MG                          A089399   001     Jul   14,   1987

AB                                50MG                          A089399   003     Jul   14,   1987

AB                                75MG                          A089399   004     Jul   14,   1987

AB                                100MG                         A089399   005     Jul   14,   1987

AB                                150MG                         A089399   006     Jul   14,   1987

AB       MYLAN                    10MG                          A086009   002
	
AB                                25MG                          A086009   003
	
AB                                50MG                          A086009   001
	
AB                                75MG                          A086009   004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                     3-20(of 371)


AMITRIPTYLINE HYDROCHLORIDE
	
  TABLET;ORAL

    AMITRIPTYLINE HYDROCHLORIDE
	
AB                                100MG
	                       A086009   005
	
AB                                150MG
	                       A086009   006
	
AB       SANDOZ                   10MG
	                        A085969   001
	
AB    +                           25MG
	                        A085966   001
	
AB                                50MG
	                        A085968   001
	
AB                                75MG
	                        A085971   001
	
AB                                100MG
	                       A085967   001
	
AB                                150MG
	                       A085970   001
	
AB       SUN PHARM INDS INC       10MG
	                        A040816   002     Jun   27,   2008

AB                                25MG
	                        A040816   001     Jun   27,   2008

AB                                50MG
	                        A040816   003     Jun   27,   2008

AB                                75MG
	                        A040816   004     Jun   27,   2008

AB                                100MG
	                       A040816   005     Jun   27,   2008

AB                                150MG
	                       A040816   006     Jun   27,   2008

AB       VINTAGE PHARMS           10MG
	                        A040218   001     Sep   11,   1997

AB                                25MG
	                        A040218   002     Sep   11,   1997

AB                                50MG
	                        A040218   003     Sep   11,   1997

AB                                75MG
	                        A040218   004     Sep   11,   1997

AB                                100MG
	                       A040218   005     Sep   11,   1997

AB                                150MG
	                       A040218   006     Sep   11,   1997
	
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE
	
  TABLET;ORAL
	
    CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE
	
         MYLAN PHARMS INC       EQ 12.5MG BASE;5MG
	            A071297 002 Dec 10, 1986
	
      +                         EQ 25MG BASE;10MG
	             A071297 001 Dec 10, 1986
	
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
	
  TABLET;ORAL
	
    PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
	
          MYLAN
	               10MG;2MG
	                      A071443   002     Nov   10,   1988
	
                                10MG;4MG
	                      A071443   003     Nov   10,   1988
	
      +
	                       25MG;2MG
	                      A071443   004     Nov   10,   1988
	
      +
	                       25MG;4MG
	                      A071443   005     Nov   10,   1988
	
      +
	                       50MG;4MG
	                      A071443   001     Nov   10,   1988
	
AMLODIPINE BESYLATE
	
  TABLET;ORAL

    AMLODIPINE BESYLATE
AB       ACCORD HLTHCARE          EQ   2.5MG BASE
              A202553   001     Apr   29,   2013

AB                                EQ   5MG BASE
                A202553   002     Apr   29,   2013

AB                                EQ   10MG BASE
               A202553   003     Apr   29,   2013

AB       ALKEM                    EQ   2.5MG BASE
              A078925   001     May   04,   2009

AB                                EQ   5MG BASE
                A078925   002     May   04,   2009

AB                                EQ   10MG BASE
               A078925   003     May   04,   2009

AB       AMNEAL PHARMS NY         EQ   2.5MG BASE
              A078477   001     Jan   16,   2008

AB                                EQ   5MG BASE
                A078477   002     Jan   16,   2008

AB                                EQ   10MG BASE
               A078477   003     Jan   16,   2008

AB       APOTEX                   EQ   2.5MG BASE
              A076719   001     May   23,   2007

AB                                EQ   5MG BASE
                A076719   002     May   23,   2007

AB                                EQ   10MG BASE
               A076719   003     May   23,   2007

AB       AUROBINDO PHARMA         EQ   2.5MG BASE
              A078021   001     Jul   17,   2007

AB                                EQ   5MG BASE
                A078021   002     Jul   17,   2007

AB                                EQ   10MG BASE
               A078021   003     Jul   17,   2007

AB       CIPLA LTD                EQ   2.5MG BASE
              A077073   001     Sep   26,   2007

AB                                EQ   5MG BASE
                A077073   002     Sep   26,   2007

AB                                EQ   10MG BASE
               A077073   003     Sep   26,   2007

AB       DR REDDYS LABS LTD       EQ   2.5MG BASE
              A076692   001     Jul   20,   2007

AB                                EQ   5MG BASE
                A076692   002     Jul   20,   2007

AB                                EQ   10MG BASE
               A076692   003     Jul   20,   2007

AB       EPIC PHARMA LLC          EQ   2.5MG BASE
              A078552   001     Apr   08,   2009

AB                                EQ   5MG BASE
                A078552   002     Apr   08,   2009

AB                                EQ   10MG BASE
               A078552   003     Apr   08,   2009

AB       HIKMA PHARMS             EQ   2.5MG BASE
              A077771   001     Apr   12,   2011

AB                                EQ   5MG BASE
                A077771   002     Apr   12,   2011

AB                                EQ   10MG BASE
               A077771   003     Apr   12,   2011

AB       INVAGEN PHARMS           EQ   2.5MG BASE
              A077955   001     Aug   28,   2007

AB                                EQ   5MG BASE
                A077955   002     Aug   28,   2007

AB                                EQ   10MG BASE
               A077955   003     Aug   28,   2007

AB       LUPIN                    EQ   2.5MG BASE
              A078043   001     Jul   12,   2007

AB                                EQ   5MG BASE
	               A078043   002     Jul   12,   2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-21(of 371)


AMLODIPINE BESYLATE
	
  TABLET;ORAL

    AMLODIPINE BESYLATE
	
AB                             EQ   10MG BASE                  A078043   003   Jul   12,   2007

AB       MACLEODS PHARMS LTD   EQ   5MG BASE                   A201380   001   Apr   13,   2012

AB                             EQ   10MG BASE                  A201380   002   Apr   13,   2012

AB       MATRIX LABS LTD       EQ   2.5MG BASE                 A078224   001   Feb   27,   2008

AB                             EQ   5MG BASE                   A078224   002   Feb   27,   2008

AB                             EQ   10MG BASE                  A078224   003   Feb   27,   2008

AB       MYLAN                 EQ   2.5MG BASE                 A076418   001   Oct   03,   2005

AB                             EQ   5MG BASE                   A076418   002   Oct   03,   2005

AB                             EQ   10MG BASE                  A076418   003   Oct   03,   2005

AB       ORCHID HLTHCARE       EQ   2.5MG BASE                 A078453   001   Jul   02,   2009

AB                             EQ   5MG BASE                   A078453   002   Jul   02,   2009

AB                             EQ   10MG BASE                  A078453   003   Jul   02,   2009

AB       RANBAXY               EQ   2.5MG BASE                 A077974   001   Jul   09,   2007

AB                             EQ   5MG BASE                   A077974   002   Jul   09,   2007

AB                             EQ   10MG BASE                  A077974   003   Jul   09,   2007

AB       ROXANE                EQ   2.5MG BASE                 A077262   001   Jul   09,   2007

AB                             EQ   5MG BASE                   A077262   002   Jul   09,   2007

AB                             EQ   10MG BASE                  A077262   003   Jul   09,   2007

AB       SECAN PHARMS          EQ   5MG BASE                   A090752   001   Apr   15,   2011

AB                             EQ   10MG BASE                  A090752   002   Apr   15,   2011

AB       SUN PHARM INDS INC    EQ   2.5MG BASE                 A078231   001   Nov   30,   2007

AB                             EQ   5MG BASE                   A078231   002   Nov   30,   2007

AB                             EQ   10MG BASE                  A078231   003   Nov   30,   2007

AB       TEVA                  EQ   2.5MG BASE                 A076846   001   Jun   28,   2007

AB                             EQ   5MG BASE                   A076846   002   Jun   28,   2007

AB                             EQ   10MG BASE                  A076846   003   Jun   28,   2007

AB       TORRENT PHARMS        EQ   2.5MG BASE                 A078573   001   Sep   22,   2008

AB                             EQ   5MG BASE                   A078573   002   Sep   22,   2008

AB                             EQ   10MG BASE                  A078573   003   Sep   22,   2008

AB       UNICHEM LABS LTD      EQ   2.5MG BASE                 A203245   001   Oct   21,   2013

AB                             EQ   5MG BASE                   A203245   002   Oct   21,   2013

AB                             EQ   10MG BASE                  A203245   003   Oct   21,   2013

AB       UPSHER SMITH          EQ   2.5MG BASE                 A077759   001   Jul   09,   2007

AB                             EQ   5MG BASE                   A077759   002   Jul   09,   2007

AB                             EQ   10MG BASE                  A077759   003   Jul   09,   2007

AB       VINTAGE               EQ   2.5MG BASE                 A078414   001   Apr   07,   2010

AB                             EQ   5MG BASE                   A078414   002   Apr   07,   2010

AB                             EQ   10MG BASE                  A078414   003   Apr   07,   2010

AB       VIVIMED LABS          EQ   2.5MG BASE                 A077516   001   Jul   11,   2007

AB                             EQ   5MG BASE                   A077516   002   Jul   11,   2007

AB                             EQ   10MG BASE                  A077516   003   Jul   11,   2007

AB       WATSON LABS           EQ   2.5MG BASE                 A077671   001   Jul   19,   2007

AB                             EQ   5MG BASE                   A077671   002   Jul   19,   2007

AB                             EQ   10MG BASE                  A077671   003   Jul   19,   2007

AB       WOCKHARDT             EQ   2.5MG BASE                 A078500   001   Sep   06,   2007

AB                             EQ   5MG BASE                   A078500   002   Sep   06,   2007

AB                             EQ   10MG BASE                  A078500   003   Sep   06,   2007

AB       ZYDUS PHARMS USA      EQ   2.5MG BASE                 A078226   001   Jul   09,   2007

AB                             EQ   5MG BASE                   A078226   002   Jul   09,   2007

AB                             EQ   10MG BASE                  A078226   003   Jul   09,   2007

    NORVASC
	
AB       PFIZER                EQ 2.5MG BASE                   N019787 001 Jul 31, 1992

AB                             EQ 5MG BASE                     N019787 002 Jul 31, 1992

AB    +                        EQ 10MG BASE                    N019787 003 Jul 31, 1992
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
	
  TABLET;ORAL

    AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
	
AB       DR REDDYS LABS LTD     EQ 2.5MG BASE;EQ 10MG BASE     A203874   001   Mar   07,   2014

AB                              EQ 2.5MG BASE;EQ 20MG BASE     A203874   002   Mar   07,   2014

AB                              EQ 2.5MG BASE;EQ 40MG BASE     A203874   003   Mar   07,   2014

AB                              EQ 5MG BASE;EQ 10MG BASE       A203874   004   Mar   07,   2014

AB                              EQ 5MG BASE;EQ 20MG BASE       A203874   005   Mar   07,   2014

AB                              EQ 5MG BASE;EQ 40MG BASE       A203874   006   Mar   07,   2014

AB                              EQ 5MG BASE;EQ 80MG BASE       A203874   007   Mar   07,   2014

AB                              EQ 10MG BASE;EQ 10MG BASE      A203874   008   Mar   07,   2014

AB                              EQ 10MG BASE;EQ 20MG BASE      A203874   009   Mar   07,   2014

AB                              EQ 10MG BASE;EQ 40MG BASE      A203874   010   Mar   07,   2014

AB                              EQ 10MG BASE;EQ 80MG BASE      A203874   011   Mar   07,   2014

AB       MYLAN PHARMS INC       EQ 2.5MG BASE;EQ 10MG BASE     A200465   001   Nov   29,   2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                    3-22(of 371)


AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM
	
  TABLET;ORAL

    AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
	
AB                              EQ 2.5MG BASE;EQ 20MG BASE
    A200465   002   Nov   29,   2013

AB                              EQ 2.5MG BASE;EQ 40MG BASE
    A200465   003   Nov   29,   2013

AB                              EQ 5MG BASE;EQ 10MG BASE
      A200465   004   Nov   29,   2013

AB                              EQ 5MG BASE;EQ 20MG BASE
      A200465   005   Nov   29,   2013

AB                              EQ 5MG BASE;EQ 40MG BASE
      A200465   006   Nov   29,   2013

AB                              EQ 5MG BASE;EQ 80MG BASE
      A200465   007   Nov   29,   2013

AB                              EQ 10MG BASE;EQ 10MG BASE
     A200465   008   Nov   29,   2013

AB                              EQ 10MG BASE;EQ 20MG BASE
     A200465   009   Nov   29,   2013

AB                              EQ 10MG BASE;EQ 40MG BASE
     A200465   010   Nov   29,   2013

AB                              EQ 10MG BASE;EQ 80MG BASE
     A200465   011   Nov   29,   2013
	
    CADUET
	
AB       PFIZER                 EQ 2.5MG BASE;EQ 10MG BASE
    N021540   009   Jul   29,   2004

AB                              EQ 2.5MG BASE;EQ 20MG BASE
    N021540   010   Jul   29,   2004

AB                              EQ 2.5MG BASE;EQ 40MG BASE
    N021540   011   Jul   29,   2004

AB                              EQ 5MG BASE;EQ 10MG BASE
      N021540   001   Jan   30,   2004

AB                              EQ 5MG BASE;EQ 20MG BASE
      N021540   002   Jan   30,   2004

AB                              EQ 5MG BASE;EQ 40MG BASE
      N021540   003   Jan   30,   2004

AB                              EQ 5MG BASE;EQ 80MG BASE
      N021540   004   Jan   30,   2004

AB                              EQ 10MG BASE;EQ 10MG BASE
     N021540   005   Jan   30,   2004

AB                              EQ 10MG BASE;EQ 20MG BASE
     N021540   006   Jan   30,   2004

AB                              EQ 10MG BASE;EQ 40MG BASE
     N021540   007   Jan   30,   2004

AB    +                         EQ 10MG BASE;EQ 80MG BASE
	    N021540   008   Jan   30,   2004
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
	
  CAPSULE;ORAL

     AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
	
AB        APOTEX INC
	           EQ 2.5MG BASE;10MG
           A091431   001   Dec   30,   2013

AB
	                             EQ 5MG BASE;10MG
             A091431   002   Dec   30,   2013

AB
	                             EQ 5MG BASE;20MG
             A091431   003   Dec   30,   2013

AB
	                             EQ 5MG BASE;40MG
             A091431   004   Dec   30,   2013

AB
	                             EQ 10MG BASE;20MG
            A091431   005   Dec   30,   2013

AB
	                             EQ 10MG BASE;40MG
            A091431   006   Dec   30,   2013

AB        AUROBINDO PHARMA LTD
	 EQ 2.5MG BASE;10MG
           A202239   001   Sep   05,   2012

AB
	                             EQ 5MG BASE;10MG
             A202239   002   Sep   05,   2012

AB
	                             EQ 5MG BASE;20MG
             A202239   003   Sep   05,   2012

AB
	                             EQ 5MG BASE;40MG
             A202239   004   Sep   05,   2012

AB
	                             EQ 10MG BASE;20MG
            A202239   005   Sep   05,   2012

AB
	                             EQ 10MG BASE;40MG
            A202239   006   Sep   05,   2012

AB        DR REDDYS LABS INC
	   EQ 2.5MG BASE;10MG
           A077183   001   Apr   15,   2010

AB
	                             EQ 5MG BASE;10MG
             A077183   002   Apr   15,   2010

AB
	                             EQ 5MG BASE;20MG
             A077183   003   Apr   15,   2010

AB
	                             EQ 5MG BASE;40MG
             A090149   001   Jul   05,   2011

AB
	                             EQ 10MG BASE;20MG
            A077183   004   Apr   15,   2010

AB
	                             EQ 10MG BASE;40MG
            A090149   002   Jul   05,   2011

AB        LUPIN PHARMS
	         EQ 2.5MG BASE;10MG
           A078466   001   Feb   05,   2010

AB
	                             EQ 5MG BASE;10MG
             A078466   002   Feb   05,   2010

AB
	                             EQ 5MG BASE;20MG
             A078466   003   Feb   05,   2010

AB
	                             EQ 5MG BASE;40MG
             A078466   005   Jul   05,   2011

AB
	                             EQ 10MG BASE;20MG
            A078466   004   Feb   05,   2010

AB
	                             EQ 10MG BASE;40MG
            A078466   006   Jul   05,   2011

AB        MYLAN
	                EQ 2.5MG BASE;10MG
           A077375   001   May   21,   2010

AB
	                             EQ 5MG BASE;10MG
             A077375   002   May   21,   2010

AB
	                             EQ 5MG BASE;20MG
             A077375   003   May   21,   2010

AB
	                             EQ 5MG BASE;40MG
             A079047   001   Jul   05,   2011

AB
	                             EQ 10MG BASE;20MG
            A077375   004   May   21,   2010

AB
	                             EQ 10MG BASE;40MG
            A079047   002   Jul   05,   2011

AB        PAR PHARM
	            EQ 2.5MG BASE;10MG
           A078381   001   Jul   29,   2010

AB
	                             EQ 5MG BASE;10MG
             A078381   002   Jul   29,   2010

AB
	                             EQ 5MG BASE;20MG
             A078381   003   Jul   29,   2010

AB
	                             EQ 5MG BASE;40MG
             A078381   005   Jul   29,   2010

AB
	                             EQ 10MG BASE;20MG
            A078381   004   Jul   29,   2010

AB
	                             EQ 10MG BASE;40MG
            A078381   006   Jul   29,   2010

AB        TEVA PHARMS
	          EQ 2.5MG BASE;10MG
           A077179   001   May   18,   2007

AB
	                             EQ 5MG BASE;10MG
             A077179   002   May   18,   2007

AB
	                             EQ 5MG BASE;20MG
             A077179   003   May   18,   2007

AB
	                             EQ 5MG BASE;40MG
             A077179   005   Jul   05,   2011

AB
	                             EQ 10MG BASE;20MG
            A077179   004   May   18,   2007

AB
	                             EQ 10MG BASE;40MG
            A077179   006   Jul   05,   2011

AB        WATSON LABS
	          EQ 2.5MG BASE;10MG
           A077890   001   Oct   14,   2010

AB
	                             EQ 5MG BASE;10MG
	            A077890   002   Oct   14,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                          3-23(of 371)


AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
	
  CAPSULE;ORAL

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
	
AB                              EQ 5MG BASE;20MG                   A077890   003   Oct   14,   2010

AB                              EQ 10MG BASE;20MG                  A077890   004   Oct   14,   2010

AB       WATSON LABS INC        EQ 5MG BASE;40MG                   A090364   001   Jul   05,   2011

AB                              EQ 10MG BASE;40MG                  A090364   002   Jul   05,   2011

    LOTREL
	
AB       NOVARTIS               EQ 2.5MG BASE;10MG                 N020364   002   Mar   03,   1995

AB                              EQ 5MG BASE;10MG                   N020364   003   Mar   03,   1995

AB                              EQ 5MG BASE;20MG                   N020364   004   Mar   03,   1995

AB                              EQ 5MG BASE;40MG                   N020364   007   Apr   11,   2006

AB                              EQ 10MG BASE;20MG                  N020364   005   Jun   20,   2002

AB    +                         EQ 10MG BASE;40MG                  N020364   006   Apr   11,   2006
	
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
	
  TABLET;ORAL
	
    TRIBENZOR
	
          DAIICHI SANKYO		      EQ 5MG BASE;12.5MG;20MG            N200175   001   Jul   23,   2010
	
                                EQ 5MG BASE;12.5MG;40MG            N200175   002   Jul   23,   2010
	
                                EQ 5MG BASE;25MG;40MG              N200175   003   Jul   23,   2010
	
                                EQ 10MG BASE;12.5MG;40MG           N200175   004   Jul   23,   2010
	
      +		                       EQ 10MG BASE;25MG;40MG             N200175   005   Jul   23,   2010
	
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
	
  TABLET;ORAL

    EXFORGE HCT
	
AB       NOVARTIS               5MG;12.5MG;160MG                   N022314   001   Apr   30,   2009

AB                              5MG;25MG;160MG                     N022314   002   Apr   30,   2009

AB                              10MG;12.5MG;160MG                  N022314   003   Apr   30,   2009

AB                              10MG;25MG;160MG                    N022314   004   Apr   30,   2009

AB    +                         10MG;25MG;320MG                    N022314   005   Apr   30,   2009
	
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
	
  TABLET;ORAL
	
    AZOR
	
           DAIICHI SANKYO		     EQ 5MG BASE;20MG                   N022100   001   Sep   26,   2007

                                EQ 5MG BASE;40MG                   N022100   002   Sep   26,   2007

                                EQ 10MG BASE;20MG                  N022100   003   Sep   26,   2007

      +		                       EQ 10MG BASE;40MG                  N022100   004   Sep   26,   2007
	
AMLODIPINE BESYLATE; TELMISARTAN
	
  TABLET;ORAL

    TELMISARTAN AND AMLODIPINE
	
AB       LUPIN LTD               EQ   5MG BASE;40MG                A201586   001   Jan   08,   2014

AB                               EQ   5MG BASE;80MG                A201586   003   Jan   08,   2014

AB                               EQ   10MG BASE;40MG               A201586   002   Jan   08,   2014

AB                               EQ   10MG BASE;80MG               A201586   004   Jan   08,   2014

AB       MYLAN PHARMS INC        EQ   5MG BASE;40MG                A202516   001   Aug   26,   2014

AB                               EQ   5MG BASE;80MG                A202516   003   Aug   26,   2014

AB                               EQ   10MG BASE;40MG               A202516   002   Aug   26,   2014

AB                               EQ   10MG BASE;80MG               A202516   004   Aug   26,   2014

AB       TORRENT PHARMS LTD      EQ   5MG BASE;40MG                A202517   001   Jan   08,   2014

AB                               EQ   5MG BASE;80MG                A202517   003   Jan   08,   2014

AB                               EQ   10MG BASE;40MG               A202517   002   Jan   08,   2014

AB                               EQ   10MG BASE;80MG               A202517   004   Jan   08,   2014

    TWYNSTA
	
AB       BOEHRINGER INGELHEIM    EQ   5MG BASE;40MG                N022401   001   Oct   16,   2009

AB                               EQ   5MG BASE;80MG                N022401   003   Oct   16,   2009

AB                               EQ   10MG BASE;40MG               N022401   002   Oct   16,   2009

AB    +                          EQ   10MG BASE;80MG               N022401   004   Oct   16,   2009
	
AMLODIPINE BESYLATE; VALSARTAN
	
  TABLET;ORAL

    AMLODIPINE BESYLATE AND VALSARTAN
	
AB       PAR PHARM INC           EQ 5MG BASE;160MG                 A090011   001   Mar   28,   2013

AB                               EQ 5MG BASE;320MG                 A090144   001   Mar   28,   2013

AB                               EQ 10MG BASE;160MG                A090011   002   Mar   28,   2013

AB                               EQ 10MG BASE;320MG                A090011   004   Mar   28,   2013

    EXFORGE
	
AB       NOVARTIS                EQ 5MG BASE;160MG                 N021990   002   Jun   20,   2007

AB                               EQ 5MG BASE;320MG                 N021990   004   Jun   20,   2007

AB    +                          EQ 10MG BASE;160MG                N021990   003   Jun   20,   2007

AB    +                          EQ 10MG BASE;320MG                N021990   005   Jun   20,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                               3-24(of 371)


AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN
	
  TABLET;ORAL

    AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE

AB       TEVA PHARMS            5MG;12.5MG;160MG                       A200435   001     Sep   25,   2012

AB                              5MG;25MG;160MG                         A200435   002     Sep   25,   2012

AB                              10MG;12.5MG;160MG                      A200435   005     Sep   25,   2012

AB                              10MG;25MG;160MG                        A200435   003     Sep   25,   2012

AB                              10MG;25MG;320MG                        A200435   004     Sep   25,   2012
	
AMMONIA N-13
	
  INJECTABLE;INTRAVENOUS

    AMMONIA N 13
	
AP       BRIGHAM WOMENS HOSP    30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A203783   001     Oct   30,   2014

AP       CARDINAL HEALTH 414    30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A203700   001     Feb   25,   2013

AP    + FEINSTEIN               30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   N022119   001     Aug   23,   2007

AP       GLOBAL ISOTOPES LLC    30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A204465   001     Oct   23,   2014

AP       JOHNS HOPKINS UNIV     30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A204514   001     Aug   19,   2014

AP       KREITCHMAN PET CTR     30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A203938   001     Dec   09,   2013

AP       MCPRF                  30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A203321   001     Feb   25,   2013

AP       MIPS CRF               30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A204535   001     Nov   20,   2014

AP       UCLA BIOMEDICAL        30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A203812   001     Jun   27,   2013

AP       UCSF RODIOPHARM        30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A204496   001     Mar   28,   2014

AP       UNIV TX MD ANDERSON    30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A203933   001     Jun   27,   2014

AP       WA UNIV SCH MED        30mCi-300mCi/8ML   (3.75-37.5mCi/ML)   A204506   001     Feb   07,   2014
	
         HOUSTON CYCLOTRON      3.75-260mCi/ML                         A203543   001     Dec   14,   2012
	
         SHERTECH LABS LLC      3.75-260mCi/ML                         A204366   001     Sep   19,   2014

         WI MEDCL CYCLOTRON     3.75-260mCi/ML                         A204356   001     Dec   18,   2014
	
AMMONIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMMONIUM CHLORIDE IN PLASTIC CONTAINER
	
      + HOSPIRA                 5MEQ/ML		                              A088366 001 Jun 13, 1984
	
AMMONIUM LACTATE
	
  CREAM;TOPICAL

    AMMONIUM LACTATE
	
AB       PERRIGO NEW YORK       EQ 12% BASE                            A075774 001 May 01, 2002

AB       TARO                   EQ 12% BASE                            A075883 001 Apr 10, 2003

AB       WATSON LABS INC        EQ 12% BASE                            A076829 001 Feb 07, 2006

    LAC-HYDRIN
	
AB    + RANBAXY                 EQ 12% BASE                            N020508 001 Aug 29, 1996

  LOTION;TOPICAL

    AMMONIUM LACTATE
	
AB       PERRIGO NEW YORK       EQ 12% BASE                            A075570 001 Jun 23, 2004

AB       TARO                   EQ 12% BASE                            A076216 001 May 28, 2004

AB       WATSON LABS INC        EQ 12% BASE                            A075575 001 Jun 11, 2002

    LAC-HYDRIN
	
AB    + RANBAXY                 EQ 12% BASE                            N019155 001 Apr 24, 1985
	
AMOXAPINE
	
  TABLET;ORAL
	
    AMOXAPINE
	
         WATSON LABS		          25MG                                   A072688   001     Aug   28,   1992

                                50MG                                   A072689   001     Aug   28,   1992

                                100MG                                  A072690   001     Aug   28,   1992

     +                          150MG		                                A072691   001     Aug   28,   1992
	
AMOXICILLIN
	
  CAPSULE;ORAL

    AMOXICILLIN
	
AB       AM ANTIBIOTICS         250MG                                  A062058   001
	
AB                              500MG                                  A062058   002
	
AB       AUROBINDO              250MG                                  A065271   001     Nov   09,   2005

AB                              500MG                                  A065271   002     Nov   09,   2005

AB       DAVA PHARMS INC        250MG                                  A062884   001     Feb   25,   1988

AB                              500MG                                  A062881   001     Feb   25,   1988

AB       HIKMA PHARMS           250MG                                  A065291   001     Feb   05,   2007

AB                              500MG                                  A065291   002     Feb   05,   2007

AB       RANBAXY                250MG                                  A065016   001     Apr   08,   1999

AB                              500MG                                  A065016   002     Apr   08,   1999

AB       SANDOZ                 250MG                                  A064076   001     Sep   30,   1994

AB                              500MG                                  A064076   002     Sep   30,   1994

AB       TEVA                   250MG                                  A061926   001
	
AB    +                         500MG                                  A061926   003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                   3-25(of 371)


AMOXICILLIN
	
  CAPSULE;ORAL

    AMOXIL
	
AB       DR REDDYS LABS INC      250MG                                    A062216 001
	
AB                               500MG                                    A062216 004
	
  FOR SUSPENSION;ORAL

    AMOXICILLIN
	
AB       AUROBINDO               200MG/5ML                                A065334   001     Dec   28,   2006

AB                               400MG/5ML                                A065334   002     Dec   28,   2006

AB       AUROBINDO PHARMA LTD    125MG/5ML                                A204030   001     Sep   15,   2014

AB                               250MG/5ML                                A204030   002     Sep   15,   2014

AB       DAVA PHARMS INC         125MG/5ML                                A062927   001     Nov   25,   1988

AB                               250MG/5ML                                A062927   002     Nov   25,   1988

AB       HIKMA                   125MG/5ML                                A065322   002     Jun   19,   2006

AB                               200MG/5ML                                A065325   002     Jun   19,   2006

AB                               250MG/5ML                                A065322   001     Jun   19,   2006

AB                               400MG/5ML                                A065325   001     Jun   19,   2006

AB       SANDOZ                  125MG/5ML                                A065387   001     Mar   26,   2007

AB                               200MG/5ML                                A065378   001     Mar   26,   2007

AB                               250MG/5ML                                A065387   002     Mar   26,   2007

AB                               400MG/5ML                                A065378   002     Mar   26,   2007

AB       TEVA                    125MG/5ML                                A061931   001
	
AB                               200MG/5ML                                A065119   001     Dec 04, 2002

AB    +                          250MG/5ML                                A061931   002
	
AB    +                          400MG/5ML                                A065119   002     Dec 04, 2002

AB       WOCKHARDT               400MG/5ML                                A065319   002     Jun 18, 2007

    AMOXICILLIN PEDIATRIC
	
AB       TEVA                    50MG/ML                                  A061931 003 Dec 01, 1982

    AMOXIL
	
AB       DR REDDYS LABS INC      50MG/ML                                  A062226   005
	
AB                               125MG/5ML                                A062226   001
	
AB                               200MG/5ML                                N050760   001 Apr 15, 1999

AB                               250MG/5ML                                A062226   002
	
AB                               400MG/5ML                                N050760   002 Apr 15, 1999

    LAROTID
	
AB       DR REDDYS LABS INC      125MG/5ML                                A062226 003
	
AB                               250MG/5ML                                A062226 004
	
  TABLET;ORAL

    AMOXICILLIN
	
AB       AUROBINDO               500MG                                    A065256   001     Nov   09,   2005

AB                               875MG                                    A065256   002     Nov   09,   2005

AB       HIKMA                   875MG                                    A065255   001     Mar   29,   2006

AB       RANBAXY                 500MG                                    A065059   001     Nov   24,   2000

AB                               875MG                                    A065059   002     Nov   24,   2000

AB       SANDOZ                  500MG                                    A065228   001     Jul   13,   2005

AB                               875MG                                    A065228   002     Jul   13,   2005

AB       TEVA                    500MG                                    A065056   001     Sep   18,   2000

AB    +                          875MG                                    A065056   002     Sep   18,   2000

    AMOXIL
	
AB       DR REDDYS LABS INC      500MG                                    N050754 002 Jul 10, 1998

AB                               875MG                                    N050754 001 Jul 10, 1998
	
  TABLET, CHEWABLE;ORAL

    AMOXICILLIN
	
AB       RANBAXY                 125MG                                    A065021   001     Dec   23,   1999

AB                               250MG                                    A065021   002     Dec   23,   1999

AB       TEVA                    125MG                                    A064013   002     Sep   11,   1995

AB    +                          250MG                                    A064013   001     Dec   22,   1992

    AMOXIL
	
AB       DR REDDYS LABS INC      125MG                                    N050542 002
	
AB                               250MG                                    N050542 001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    MOXATAG
	
      + PRAGMA PHARMS LLC        775MG                                    N050813 001 Jan 23, 2008
	
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
	
  CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL

    LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN

AB       SANDOZ                 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30M   A202588 001 Mar 04, 2014

                                G
	
AB       TEVA PHARMS USA        500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,30M   A200218 001 Aug 30, 2013

                                G
	
    PREVPAC
	
AB    + TAKEDA PHARMS USA       500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,      N050757 001 Dec 02, 1997
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                                  3-26(of 371)


AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE
	
  CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL

    PREVPAC
	
                                30MG
	
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE
	
  CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL
	
    OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN
	
      +		 GASTROENTERO          500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20M   N050824 001 Feb 08, 2011

                                G
	
AMOXICILLIN; CLAVULANATE POTASSIUM
	
  FOR SUSPENSION;ORAL

    AMOXICILLIN AND CLAVULANATE POTASSIUM
	
AB       HIKMA PHARMS           200MG/5ML;EQ 28.5MG BASE/5ML              A065191   002   Jan   25,   2005

AB                              400MG/5ML;EQ 57MG BASE/5ML                A065191   001   Jan   25,   2005

AB                              600MG/5ML;EQ 42.9MG BASE/5ML              A065373   001   Nov   09,   2007

AB       RANBAXY                200MG/5ML;EQ 28.5MG BASE/5ML              A065132   001   Mar   19,   2003

AB                              400MG/5ML;EQ 57MG BASE/5ML                A065132   002   Mar   19,   2003

AB                              600MG/5ML;EQ 42.9MG BASE/5ML              A065207   002   Jan   30,   2007

AB       SANDOZ                 200MG/5ML;EQ 28.5MG BASE/5ML              A065066   001   Jun   05,   2002

AB                              400MG/5ML;EQ 57MG BASE/5ML                A065066   002   Jun   05,   2002

AB       SANDOZ INC             200MG/5ML;EQ 28.5MG BASE/5ML              A065098   001   Dec   16,   2002

AB                              400MG/5ML;EQ 57MG BASE/5ML                A065098   002   Dec   16,   2002

AB                              600MG/5ML;EQ 42.9MG BASE/5ML              A065358   001   Aug   13,   2007

AB       TEVA                   200MG/5ML;EQ 28.5MG BASE/5ML              A065089   001   May   25,   2004

AB    +                         400MG/5ML;EQ 57MG BASE/5ML                A065089   002   May   25,   2004

AB    +                         600MG/5ML;EQ 42.9MG BASE/5ML              A065162   001   Mar   12,   2004

AB       WOCKHARDT              250MG/5ML;EQ 62.5MG BASE/5ML              A065431   001   Nov   25,   2008

AB       WOCKHARDT EU OPERATN   600MG/5ML;EQ 42.9MG BASE/5ML              A065420   001   Dec   02,   2013

    AUGMENTIN '125'
	
AB       DR REDDYS LABS INC     125MG/5ML;EQ 31.25MG BASE/5ML             N050575 001 Aug 06, 1984

    AUGMENTIN '200'
	
AB       DR REDDYS LABS INC     200MG/5ML;EQ 28.5MG BASE/5ML              N050725 001 May 31, 1996

    AUGMENTIN '250'
	
AB    + DR REDDYS LABS INC      250MG/5ML;EQ 62.5MG BASE/5ML              N050575 002 Aug 06, 1984

    AUGMENTIN '400'
	
AB       DR REDDYS LABS INC     400MG/5ML;EQ 57MG BASE/5ML                N050725 002 May 31, 1996

    AUGMENTIN ES-600
	
AB       DR REDDYS LABS INC     600MG/5ML;EQ 42.9MG BASE/5ML              N050755 001 Jun 22, 2001
	
  SUSPENSION;ORAL

    AMOXICILLIN AND CLAVULANATE POTASSIUM
	
AB       AUROBINDO PHARMA LTD   200MG/5ML;EQ 28.5MG BASE/5ML              A201090 001 Dec 20, 2011

AB                              400MG/5ML;EQ 57MG BASE/5ML                A201090 002 Dec 20, 2011

AB                              600MG/5ML;EQ 42.9MG BASE/5ML              A201091 001 Dec 20, 2011
	
  TABLET;ORAL

    AMOXICILLIN AND CLAVULANATE POTASSIUM
	
AB       AUROBINDO PHARMA LTD   250MG;EQ 125MG BASE                       A091569   001   Jan   20,   2012

AB                              500MG;EQ 125MG BASE                       A091569   002   Jan   20,   2012

AB                              875MG;EQ 125MG BASE                       A091568   001   Jan   20,   2012

AB       RANBAXY                875MG;EQ 125MG BASE                       A065102   001   Sep   17,   2002

AB       SANDOZ                 250MG;EQ 125MG BASE                       A065189   001   Aug   23,   2005

AB                              500MG;EQ 125MG BASE                       A065064   001   Mar   15,   2002

AB                              875MG;EQ 125MG BASE                       A065063   001   Mar   14,   2002

AB       SANDOZ INC             500MG;EQ 125MG BASE                       A065117   001   Nov   27,   2002

AB                              875MG;EQ 125MG BASE                       A065093   001   Nov   21,   2002

AB       TEVA                   500MG;EQ 125MG BASE                       A065101   001   Oct   30,   2002

AB       TEVA PHARMS USA        875MG;EQ 125MG BASE                       A065096   001   Oct   29,   2002

    AUGMENTIN '250'
	
AB    + DR REDDYS LABS INC      250MG;EQ 125MG BASE                       N050564 001 Aug 06, 1984

    AUGMENTIN '500'
	
AB    + DR REDDYS LABS INC      500MG;EQ 125MG BASE                       N050564 002 Aug 06, 1984

    AUGMENTIN '875'
	
AB    + DR REDDYS LABS INC      875MG;EQ 125MG BASE                       N050720 001 Feb 13, 1996
	
  TABLET, CHEWABLE;ORAL

    AMOXICILLIN AND CLAVULANATE POTASSIUM
	
AB       RANBAXY                200MG;EQ 28.5MG BASE                      A065161   001   Dec   03,   2003

AB                              400MG;EQ 57MG BASE                        A065161   002   Dec   03,   2003

AB       SANDOZ                 200MG;EQ 28.5MG BASE                      A065065   001   Apr   18,   2002

AB                              400MG;EQ 57MG BASE                        A065065   002   Apr   18,   2002

AB       TEVA                   200MG;EQ 28.5MG BASE                      A065205   001   Feb   09,   2005

AB    +                         400MG;EQ 57MG BASE                        A065205   002   Feb   09,   2005
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-27(of 371)


AMOXICILLIN; CLAVULANATE POTASSIUM
	
  TABLET, CHEWABLE;ORAL

    AUGMENTIN '125'
	
AB       DR REDDYS LABS INC      125MG;EQ 31.25MG BASE                    N050597 001 Jul 22, 1985

    AUGMENTIN '200'
	
AB       DR REDDYS LABS INC      200MG;EQ 28.5MG BASE                     N050726 001 May 31, 1996

    AUGMENTIN '250'
	
AB       DR REDDYS LABS INC      250MG;EQ 62.5MG BASE                     N050597 002 Jul 22, 1985

    AUGMENTIN '400'
	
AB       DR REDDYS LABS INC      400MG;EQ 57MG BASE                       N050726 002 May 31, 1996

  TABLET, EXTENDED RELEASE;ORAL

    AMOXICILLIN AND CLAVULANATE POTASSIUM
	
AB       SANDOZ                  1GM;EQ 62.5MG BASE                       A090227 001 Apr 21, 2010

    AUGMENTIN XR
	
AB    + DR REDDYS LABS INC       1GM;EQ 62.5MG BASE                       N050785 001 Sep 25, 2002
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE

SULFATE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    ADDERALL XR 10
	
AB        SHIRE                 2.5MG;2.5MG;2.5MG;2.5MG                     N021303 001 Oct 11,   2001

    ADDERALL XR 15
	
AB        SHIRE                 3.75MG;3.75MG;3.75MG;3.75MG                 N021303 006 May 22,   2002

    ADDERALL XR 20
	
AB        SHIRE                 5MG;5MG;5MG;5MG                             N021303 002 Oct 11,   2001

    ADDERALL XR 25
	
AB        SHIRE                 6.25MG;6.25MG;6.25MG;6.25MG                 N021303 004 May 22,   2002

    ADDERALL XR 30
	
AB    + SHIRE                   7.5MG;7.5MG;7.5MG;7.5MG                     N021303 003 Oct 11,   2001

    ADDERALL XR 5
	
AB        SHIRE                 1.25MG;1.25MG;1.25MG;1.25MG                 N021303 005 May 22,   2002

    AMPHETAMINE ASP AMPHETAMINE SULF DEXTROAMPHET SACCHARATE & DEXTR SULF
	
AB        TEVA                  1.25MG;1.25MG;1.25MG;1.25MG                 A077488 001 Apr 29,   2013

AB                              2.5MG;2.5MG;2.5MG;2.5MG                     A077488 002 Apr 29,   2013

AB                              3.75MG;3.75MG;3.75MG;3.75MG                 A077488 003 Apr 29,   2013

AB                              5MG;5MG;5MG;5MG                             A077488 004 Apr 29,   2013

AB                              6.25MG;6.25MG;6.25MG;6.25MG                 A077488 005 Apr 29,   2013

AB                              7.5MG;7.5MG;7.5MG;7.5MG                     A077488 006 Apr 29,   2013

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

AB        ACTAVIS ELIZABETH     1.25MG;1.25MG;1.25MG;1.25MG                 A077302 001 Jun 22,   2012

AB                              2.5MG;2.5MG;2.5MG;2.5MG                     A077302 002 Jun 22,   2012

AB                              3.75MG;3.75MG;3.75MG;3.75MG                 A077302 003 Jun 22,   2012

AB                              5MG;5MG;5MG;5MG                             A077302 004 Jun 22,   2012

AB                              6.25MG;6.25MG;6.25MG;6.25MG                 A077302 005 Jun 22,   2012

AB                              7.5MG;7.5MG;7.5MG;7.5MG                     A077302 006 Jun 22,   2012

    DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE

AB        BARR LABS INC         1.25MG;1.25MG;1.25MG;1.25MG                 A076536 001 Feb 12,   2013

AB                              2.5MG;2.5MG;2.5MG;2.5MG                     A076536 002 Feb 12,   2013

AB                              3.75MG;3.75MG;3.75MG;3.75MG                 A076536 003 Feb 12,   2013

AB                              5MG;5MG;5MG;5MG                             A076536 004 Feb 12,   2013

AB                              6.25MG;6.25MG;6.25MG;6.25MG                 A076536 005 Feb 12,   2013

AB                              7.5MG;7.5MG;7.5MG;7.5MG                     A076536 006 Feb 12,   2013
	
  TABLET;ORAL

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

AB        ACTAVIS ELIZABETH     1.25MG;1.25MG;1.25MG;1.25MG                 A040456 001 May 06,   2003

AB                              2.5MG;2.5MG;2.5MG;2.5MG                     A040456 002 May 06,   2003

AB                              5MG;5MG;5MG;5MG                             A040456 003 May 06,   2003

AB                              7.5MG;7.5MG;7.5MG;7.5MG                     A040456 004 May 06,   2003

AB        AUROLIFE PHARMA LLC   1.25MG;1.25MG;1.25MG;1.25MG                 A202424 001 Nov 27,   2013

AB                              1.875MG;1.875MG;1.875MG;1.875MG             A202424 002 Nov 27,   2013

AB                              2.5MG;2.5MG;2.5MG;2.5MG                     A202424 003 Nov 27,   2013

AB                              3.125MG;3.125MG;3.125MG;3.125MG             A202424 004 Nov 27,   2013

AB                              3.75MG;3.75MG;3.75MG;3.75MG                 A202424 005 Nov 27,   2013

AB                              5MG;5MG;5MG;5MG                             A202424 006 Nov 27,   2013

AB                              7.5MG;7.5MG;7.5MG;7.5MG                     A202424 007 Nov 27,   2013

AB        BARR                  1.25MG;1.25MG;1.25MG;1.25MG                 A040422 001 Feb 11,   2002

AB                              1.875MG;1.875MG;1.875MG;1.875MG             A040422 005 Mar 19,   2003

AB                              2.5MG;2.5MG;2.5MG;2.5MG                     A040422 002 Feb 11,   2002

AB                              3.125MG;3.125MG;3.125MG;3.125MG             A040422 006 Mar 19,   2003

AB                              3.75MG;3.75MG;3.75MG;3.75MG                 A040422 007 Mar 19,   2003

AB                              5MG;5MG;5MG;5MG                             A040422 003 Feb 11,   2002

AB    +                         7.5MG;7.5MG;7.5MG;7.5MG                     A040422 004 Feb 11,   2002

AB        COREPHARMA            1.25MG;1.25MG;1.25MG;1.25MG                 A040444 001 Jun 19,   2002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                               3-28(of 371)


AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE

SULFATE
	
  TABLET;ORAL

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

AB                              2.5MG;2.5MG;2.5MG;2.5MG                   A040444 002 Jun 19,        2002

AB                              5MG;5MG;5MG;5MG                           A040444 003 Jun 19,        2002

AB                              7.5MG;7.5MG;7.5MG;7.5MG                   A040444 004 Jun 19,        2002

AB        MALLINCKRODT INC      1.25MG;1.25MG;1.25MG;1.25MG               A040440 001 Oct 07,        2003

AB                              1.875MG;1.875MG;1.875MG;1.875MG           A040440 002 Oct 07,        2003

AB                              2.5MG;2.5MG;2.5MG;2.5MG                   A040440 003 Oct 07,        2003

AB                              3.125MG;3.125MG;3.125MG;3.125MG           A040440 004 Oct 07,        2003

AB                              3.75MG;3.75MG;3.75MG;3.75MG               A040440 005 Oct 07,        2003

AB                              5MG;5MG;5MG;5MG                           A040440 006 Oct 07,        2003

AB                              7.5MG;7.5MG;7.5MG;7.5MG                   A040440 007 Oct 07,        2003

AB        MUTUAL PHARM          1.25MG;1.25MG;1.25MG;1.25MG               A040480 001 Sep 09,        2003

AB                              1.875MG;1.875MG;1.875MG;1.875MG           A040480 002 Sep 09,        2003

AB                              2.5MG;2.5MG;2.5MG;2.5MG                   A040480 003 Sep 09,        2003

AB                              3.125MG;3.125MG;3.125MG;3.125MG           A040480 004 Sep 09,        2003

AB                              3.75MG;3.75MG;3.75MG;3.75MG               A040480 005 Sep 09,        2003

AB                              5MG;5MG;5MG;5MG                           A040480 006 Sep 09,        2003

AB                              7.5MG;7.5MG;7.5MG;7.5MG                   A040480 007 Sep 09,        2003

AB        SANDOZ                1.25MG;1.25MG;1.25MG;1.25MG               A040439 004 Sep 27,        2002

AB                              2.5MG;2.5MG;2.5MG;2.5MG                   A040439 001 Jun 14,        2002

AB                              5MG;5MG;5MG;5MG                           A040439 002 Jun 14,        2002

AB                              7.5MG;7.5MG;7.5MG;7.5MG                   A040439 003 Jun 14,        2002
	
AMPHETAMINE SULFATE
	
  TABLET;ORAL
	
    AMPHETAMINE SULFATE
	
         ARBOR PHARMS LLC       5MG                                      A200166 001 Aug 09, 2012

      +                         10MG                                     A200166 002 Aug 09, 2012
	
AMPHOTERICIN B
	
  INJECTABLE;INJECTION
	
    AMPHOTERICIN B
	
      + X GEN PHARMS            50MG/VIAL                                A063206 001 Apr 29, 1992

  INJECTABLE, LIPID COMPLEX;INJECTION
	
    ABELCET
	
      + SIGMA TAU               5MG/ML                                   N050724 001 Nov 20, 1995
	
    AMPHOTEC
	
      + ALKOPHARMA USA          50MG/VIAL                                N050729 001 Nov 22, 1996
	
      +                         100MG/VIAL                               N050729 002 Nov 22, 1996
	
  INJECTABLE, LIPOSOMAL;INJECTION
	
    AMBISOME
	
      + ASTELLAS                50MG/VIAL                                N050740 001 Aug 11, 1997
	
AMPICILLIN SODIUM
	
  INJECTABLE;INJECTION

    AMPICILLIN SODIUM
	
AP       ACS DOBFAR SPA         EQ   1GM BASE/VIAL                       A090884   002   Apr   03,   2013

AP                              EQ   2GM BASE/VIAL                       A090884   003   Apr   03,   2013

AP                              EQ   10GM BASE/VIAL                      A090889   001   Apr   03,   2013

AP                              EQ   500MG BASE/VIAL                     A090884   001   Apr   03,   2013

AP       AGILA SPECLTS          EQ   10GM BASE/VIAL                      A202198   001   Apr   07,   2014

AP       ANTIBIOTICE            EQ   1GM BASE/VIAL                       A090354   003   Dec   28,   2009

AP                              EQ   2GM BASE/VIAL                       A090354   004   Dec   28,   2009

AP                              EQ   250MG BASE/VIAL                     A090354   001   Dec   28,   2009

AP                              EQ   500MG BASE/VIAL                     A090354   002   Dec   28,   2009

AP       AUROBINDO PHARMA       EQ   1GM BASE/VIAL                       A065499   004   Aug   17,   2010

AP                              EQ   2GM BASE/VIAL                       A065499   005   Aug   17,   2010

AP                              EQ   10GM BASE/VIAL                      A065493   001   Aug   17,   2010

AP                              EQ   125MG BASE/VIAL                     A065499   001   Aug   17,   2010

AP                              EQ   250MG BASE/VIAL                     A065499   002   Aug   17,   2010

AP                              EQ   500MG BASE/VIAL                     A065499   003   Aug   17,   2010

AP       HANFORD GC             EQ   1GM BASE/VIAL                       A062772   001   Apr   15,   1993

AP                              EQ   2GM BASE/VIAL                       A063140   001   Apr   15,   1993

AP                              EQ   10GM BASE/VIAL                      A063142   001   Apr   15,   1993

AP                              EQ   250MG BASE/VIAL                     A063145   001   Apr   15,   1993

AP                              EQ   500MG BASE/VIAL                     A063146   001   Apr   15,   1993

AP       ISTITUTO BIO ITA SPA   EQ   1GM BASE/VIAL                       A062719   002   May   12,   1987

AP                              EQ   2GM BASE/VIAL                       A062797   002   Jul   12,   1993

AP                              EQ   10GM BASE/VIAL                      A201404   001   Dec   20,   2013

AP                              EQ   125MG BASE/VIAL                     A062797   001   Jul   12,   1993

AP                              EQ   250MG BASE/VIAL                     A062719   001   May   12,   1987
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                                3-29(of 371)


AMPICILLIN SODIUM
	
  INJECTABLE;INJECTION

    AMPICILLIN SODIUM
	
AP                             EQ    500MG BASE/VIAL                  A062719   003     May 12, 1987

AP    + SANDOZ                 EQ    1GM BASE/VIAL                    A061395   004
	
AP    +                        EQ    2GM BASE/VIAL                    A061395   005
	
AP    +                        EQ    10GM BASE/VIAL                   A061395   006
	
AP    +                        EQ    125MG BASE/VIAL                  A061395   001
	
AP    +                        EQ    250MG BASE/VIAL                  A061395   002
	
AP    +                        EQ    500MG BASE/VIAL                  A061395   003
	
AP       STRIDES ARCOLAB LTD   EQ    1GM BASE/VIAL                    A201025   003     Apr   09,   2014

AP                             EQ    2GM BASE/VIAL                    A201025   004     Apr   09,   2014

AP                             EQ    250MG BASE/VIAL                  A201025   001     Apr   09,   2014

AP                             EQ    500MG BASE/VIAL                  A201025   002     Apr   09,   2014

  POWDER;INTRAVENOUS

    AMPICILLIN SODIUM
	
AP    + SANDOZ                 EQ 1GM BASE/VIAL                       A062738 001 Feb 19, 1987

AP    +                        EQ 2GM BASE/VIAL                       A062738 002 Feb 19, 1987
	
AMPICILLIN SODIUM; SULBACTAM SODIUM
	
  INJECTABLE;INJECTION

    AMPICILLIN AND SULBACTAM
	
AP       ACS DOBFAR             EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065406   001     Dec   22,   2009

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065406   002     Dec   22,   2009

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A065403   001     Dec   23,   2009

AP       AGILA SPECLTS          EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A201024   001     Apr   07,   2014

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A201024   002     Apr   07,   2014

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A202197   001     Apr   07,   2014

AP       AUROBINDO PHARMA       EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A090340   001     Sep   20,   2010

AP                              EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A090349   001     Sep   20,   2010

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A090340   002     Sep   20,   2010

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A090349   002     Sep   20,   2010

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A090339   001     Sep   20,   2010

AP       HANFORD GC             EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065176   001     Nov   30,   2005

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065176   002     Nov   30,   2005

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A065188   001     Nov   25,   2005

AP       HIKMA MAPLE            EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065074   001     Mar   19,   2002

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065074   002     Mar   19,   2002

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A065076   001     Mar   19,   2002

AP       HOSPIRA INC            EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A090375   001     Dec   21,   2011

AP                              EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A090653   001     Dec   21,   2011

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A090375   002     Dec   21,   2011

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A090653   002     Dec   21,   2011

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A090646   001     Dec   21,   2011

AP       ISTITUTO BIO ITA SPA   EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065222   001     Nov   29,   2005

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065222   002     Nov   29,   2005

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A065314   001     Nov   27,   2006

AP       MUSTAFA NEVZAT ILAC    EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065316   001     Jun   29,   2007

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065316   002     Jun   29,   2007

AP       SANDOZ                 EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065241   001     Jul   25,   2006

AP                              EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A065310   001     Jul   25,   2006

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065241   002     Jul   25,   2006

AP                              EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A065310   002     Jul   25,   2006

AP                              EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    A065240   001     Jul   25,   2006

    UNASYN
	
AP    + PFIZER                  EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     A062901   002     Feb   27,   1992

AP    +                         EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   A062901   001     Nov   23,   1988

AP    +                         EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL   N050608   002     Dec   31,   1986

AP    +                         EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL     N050608   001     Dec   31,   1986

AP    +                         EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL    N050608   005     Dec   10,   1993
	
AMPICILLIN/AMPICILLIN TRIHYDRATE

  CAPSULE;ORAL

    AMPICILLIN TRIHYDRATE
	
AB       DAVA PHARMS INC        EQ   250MG   BASE                     A062883   001     Feb   25,   1988

AB    +                         EQ   500MG   BASE                     A062882   001     Feb   25,   1988

AB       SANDOZ                 EQ   250MG   BASE                     A064082   001     Aug   29,   1995

AB                              EQ   500MG   BASE                     A064082   002     Aug   29,   1995

  FOR SUSPENSION;ORAL
	
    AMPICILLIN TRIHYDRATE
	
         DAVA PHARMS INC        EQ   125MG BASE/5ML                   A062982 001 Feb 10, 1989
	
      +                         EQ   250MG BASE/5ML                   A062982 002 Feb 10, 1989
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-30(of 371)


ANAGRELIDE HYDROCHLORIDE
	
  CAPSULE;ORAL

    AGRYLIN
	
AB       SHIRE LLC               EQ 0.5MG BASE                  N020333 001 Mar 14, 1997

    ANAGRELIDE HYDROCHLORIDE
	
AB       BARR                    EQ    0.5MG BASE               A076530   001   Apr   18,   2005

AB                               EQ    1MG BASE                 A076530   002   Apr   18,   2005

AB       IMPAX LABS              EQ    0.5MG BASE               A076910   001   Apr   18,   2005

AB                               EQ    1MG BASE                 A076910   002   Apr   18,   2005

AB       IVAX SUB TEVA PHARMS    EQ    0.5MG BASE               A076468   001   Apr   18,   2005

AB    +                          EQ    1MG BASE                 A076468   002   Apr   18,   2005

AB       MYLAN                   EQ    0.5MG BASE               A076811   001   Apr   18,   2005

AB                               EQ    1MG BASE                 A076811   002   Apr   18,   2005

AB       MYLAN PHARMS INC        EQ    0.5MG BASE               A077613   001   Jun   27,   2006

AB                               EQ    1MG BASE                 A077613   002   Jun   27,   2006
	
ANASTROZOLE
	
  TABLET;ORAL

    ANASTROZOLE
	
AB       ACCORD HLTHCARE         1MG                            A090568   001   Jun   28,   2010

AB       APOTEX INC              1MG                            A200654   001   May   11,   2012

AB       CIPLA LTD               1MG                            A091164   001   Jun   28,   2010

AB       DR REDDYS LABS LTD      1MG                            A090732   001   Jun   28,   2010

AB       FRESENIUS KABI ONCOL    1MG                            A090088   001   Jun   28,   2010

AB       MYLAN                   1MG                            A091051   001   Jun   28,   2010

AB       NATCO PHARMA LTD        1MG                            A079220   001   Jun   28,   2010

AB       ROXANE                  1MG                            A078485   001   Jun   28,   2010

AB       SANDOZ                  1MG                            A079007   001   Jun   28,   2010

AB       SANTOS BIOTECH          1MG                            A078944   001   Jun   28,   2010

AB       SUN PHARM INDS LTD      1MG                            A091177   001   Jul   15,   2011

AB       TEVA PHARMS             1MG                            A078058   001   Jun   28,   2010

AB       ZYDUS PHARMS USA INC    1MG                            A078921   001   Jun   28,   2010

    ARIMIDEX
	
AB    + ASTRAZENECA              1MG                            N020541 001 Dec 27, 1995
	
ANIDULAFUNGIN
	
  INJECTABLE;IV (INFUSION)

    ERAXIS
	
      + VICURON                  50MG/VIAL                      N021632 001 Feb 17, 2006
	
      +                          100MG/VIAL                     N021632 002 Nov 14, 2006
	
APIXABAN
	
  TABLET;ORAL
	
    ELIQUIS
	
          BRISTOL MYERS SQUIBB   2.5MG                          N202155 001 Dec 28, 2012
	
      +                          5MG                            N202155 002 Dec 28, 2012
	
APOMORPHINE HYDROCHLORIDE
	
  INJECTABLE;SUBCUTANEOUS
	
    APOKYN
	
      + US WORLDMEDS             30MG/3ML (10MG/ML)             N021264 002 Apr 20, 2004
	
APRACLONIDINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    APRACLONIDINE HYDROCHLORIDE
	
AT       AKORN INC                EQ 0.5% BASE                  A077764 001 Mar 12, 2009

    IOPIDINE
	
AT    + ALCON                     EQ 0.5% BASE                  N020258 001 Jul 30, 1993
	
      +                           EQ 1% BASE                    N019779 001 Dec 31, 1987
	
APREMILAST
	
  TABLET;ORAL
	
    OTEZLA
	
         CELGENE CORP            10MG                           N205437 001 Mar 21, 2014
	
                                 20MG                           N205437 002 Mar 21, 2014
	
     +                           30MG                           N205437 003 Mar 21, 2014
	
APREPITANT
	
  CAPSULE;ORAL

    APREPITANT
	
AB       SANDOZ                  40MG                           A090999 001 Sep 24, 2012

AB                               80MG                           A090999 002 Sep 24, 2012

AB                               125MG                          A090999 003 Sep 24, 2012

    EMEND
	
AB       MERCK                   40MG                           N021549 003 Jun 30, 2006

AB                               80MG                           N021549 001 Mar 26, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-31(of 371)


APREPITANT
	
  CAPSULE;ORAL

    EMEND
	
AB    +                        125MG                            N021549 002 Mar 26, 2003
	
ARFORMOTEROL TARTRATE
	
  SOLUTION;INHALATION
	
    BROVANA
	
      + SUNOVION               EQ 0.015MG BASE/2ML              N021912 001 Oct 06, 2006
	
ARGATROBAN
	
  INJECTABLE;INJECTION

    ACOVA
	
AP    + PFIZER                  250MG/2.5ML (100MG/ML)          N020883 001 Jun 30, 2000

    ARGATROBAN
	
AP       HIKMA PHARM CO LTD     250MG/2.5ML (100MG/ML)          N203049 001 Jan 05, 2012

AP       MYLAN INSTITUTIONAL    250MG/2.5ML (100MG/ML)          A202626 001 Jun 30, 2014

AP       PAR STERILE PRODUCTS   250MG/2.5ML (100MG/ML)          A091665 001 Jun 30, 2014
	
  INJECTABLE;IV (INFUSION)

    ARGATROBAN IN 0.9% SODIUM CHLORIDE
	
         TEVA PHARMS USA        250MG/250ML (1MG/ML)            N206769 001 Dec 15, 2014
	
    ARGATROBAN IN SODIUM CHLORIDE
	
      + EAGLE PHARMS            50MG/50ML (1MG/ML)              N022434 001 Jun 29, 2011
	
      + SANDOZ                  125MG/125ML (1MG/ML)            N022485 001 May 09, 2011
	
ARGININE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    R-GENE 10
	
      + PHARMACIA AND UPJOHN   10GM/100ML                       N016931 001
	
ARIPIPRAZOLE
	
  FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
	
    ABILIFY MAINTENA KIT
	
         OTSUKA PHARM CO LTD    300MG/VIAL                      N202971   001   Feb   28,   2013
                                300MG                           N202971   003   Sep   29,   2014
      +                         400MG/VIAL                      N202971   002   Feb   28,   2013
                                400MG                           N202971   004   Sep   29,   2014
  INJECTABLE;INTRAMUSCULAR
    ABILIFY
      + OTSUKA                  9.75MG/1.3ML (7.5MG/ML)         N021866 001 Sep 20, 2006
  SOLUTION;ORAL
    ABILIFY
      + OTSUKA                  1MG/ML                          N021713 001 Dec 10, 2004
  TABLET;ORAL
    ABILIFY
         OTSUKA                 2MG                             N021436   006   Nov   15,   2002
      +                         5MG                             N021436   005   Nov   15,   2002
      +                         10MG                            N021436   001   Nov   15,   2002
                                15MG                            N021436   002   Nov   15,   2002
                                20MG                            N021436   003   Nov   15,   2002
                                30MG                            N021436   004   Nov   15,   2002
  TABLET, ORALLY DISINTEGRATING;ORAL
    ABILIFY
      + OTSUKA                  10MG                            N021729 002 Jun 07, 2006
                                15MG                            N021729 003 Jun 07, 2006
ARMODAFINIL
  TABLET;ORAL
    NUVIGIL
         CEPHALON              50MG                             N021875   001   Jun   15,   2007
                               150MG                            N021875   003   Jun   15,   2007
                               200MG                            N021875   005   Mar   26,   2009
     +                         250MG                            N021875   004   Jun   15,   2007
ARSENIC TRIOXIDE
  INJECTABLE;INJECTION
    TRISENOX
      + CEPHALON               1MG/ML                           N021248 001 Sep 25, 2000
ARTEMETHER; LUMEFANTRINE
  TABLET;ORAL
    COARTEM
      + NOVARTIS               20MG;120MG                       N022268 001 Apr 07, 2009
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-32(of 371)


ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
	
  INJECTABLE;INJECTION

    ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE
	
AP        HOSPIRA               4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG    A079138 001 Jun 18, 2010

                                BASE/ML)

    SEPTOCAINE
	
AP    + DEPROCO                 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG    N020971 001 Apr 03, 2000

                                BASE/ML)

    ORABLOC
	
          PIERREL               4%;EQ 0.009MG BASE/1.8ML (EQ 0.005MG      N022466 001 Feb 26, 2010

                                BASE/ML)

      +		                       4%;EQ 0.018MG BASE/1.8ML (EQ 0.01MG       N022466 002 Feb 26, 2010

                                BASE/ML)

    SEPTOCAINE
	
      +		 DEPROCO               4%;EQ 0.0085MG BASE/1.7ML (4%;EQ          N022010 001 Mar 30, 2006

                                0.005MG BASE/ML)
	
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
	
  INJECTABLE;IV (INFUSION)

    INFUVITE PEDIATRIC
	
      +		 SANDOZ                80MG/VIAL;0.02MG/VIAL;400                 N021265 001 Feb 21, 2001

                                IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI

                                AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/

                                VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

    INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)

      +		 SANDOZ                80MG/VIAL;0.02MG/VIAL;400                 N021646 001 Jan 29, 2004

                                IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI

                                AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/

                                VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL
	
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE;

VITAMIN A; VITAMIN E
	
  FOR SOLUTION;IV (INFUSION)

    M.V.I. PEDIATRIC
	
      +		 HOSPIRA               80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/   N018920 001 Sep 21, 2000

                                VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;

                                0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG

                                BASE/VIAL;0.7MG/VIAL;7MG/VIAL
	

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A;

VITAMIN E
	
  INJECTABLE;INJECTION
	
    M.V.I.-12 (WITHOUT VITAMIN K)

      +		 HOSPIRA               20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;   N008809 006 Sep 09, 2004

                                0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0

                                .36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
	
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A;

VITAMIN E; VITAMIN K
	
  INJECTABLE;IV (INFUSION)

    M.V.I. ADULT
	
      +		 HOSPIRA               200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M   N021625 001 Jan 30, 2004

                                G/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIA

                                L;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL

                                ;10MG/VIAL;0.15MG/VIAL

    M.V.I. ADULT (PHARMACY BULK PACKAGE)

      +		 HOSPIRA               200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5   N021643 001 Feb 18, 2004

                                ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5

                                ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0

                                .15MG/5ML
	
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE;

SODIUM SULFATE
	
  FOR SOLUTION;ORAL
	
    MOVIPREP
	
      + SALIX PHARMS            4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM   N021881 001 Aug 02, 2006
	
ASENAPINE MALEATE
	
  TABLET;SUBLINGUAL
	
    SAPHRIS
	
         FOREST LABS INC       EQ 5MG BASE                                N022117 001 Aug 13, 2009

      +                        EQ 10MG BASE		                             N022117 002 Aug 13, 2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-33(of 371)


ASPIRIN; BUTALBITAL; CAFFEINE
	
  CAPSULE;ORAL

    FIORINAL
AA    + WATSON LABS INC         325MG;50MG;40MG                  N017534 005 Apr 16, 1986
	
    LANORINAL
AA       LANNETT                325MG;50MG;40MG                  A086996 002 Oct 11, 1985
	
  TABLET;ORAL
    BUTALBITAL, ASPIRIN AND CAFFEINE

AA    + HIKMA INTL PHARMS       325MG;50MG;40MG
	                A086162 002 Feb 16, 1984
	
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
	
  CAPSULE;ORAL

    BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

AB       NEXGEN PHARMA INC      325MG;50MG;40MG;30MG
            A075231 001 Nov 30, 2001

AB       STEVENS J              325MG;50MG;40MG;30MG
            A074951 001 Aug 31, 1998
	
    FIORINAL W/CODEINE

AB    + WATSON LABS INC         325MG;50MG;40MG;30MG
	           N019429 003 Oct 26, 1990
	
ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE
	
  CAPSULE;ORAL
	
    SYNALGOS-DC
	
      + CARACO                  356.4MG;30MG;16MG
	              N011483 004 Sep 06, 1983
	
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
	
  TABLET;ORAL

     NORGESIC
	
AB        MEDICIS                385MG;30MG;25MG
                N013416 003 Oct 27, 1982
	
     NORGESIC FORTE
	
AB     + MEDICIS                 770MG;60MG;50MG
                N013416 004 Oct 27, 1982
	
     ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

AB        SANDOZ
	               385MG;30MG;25MG
                A074654 001 Dec 31, 1996

AB
	                             770MG;60MG;50MG
	               A074654 002 Dec 31, 1996
	
ASPIRIN; CARISOPRODOL
	
  TABLET;ORAL

    CARISOPRODOL AND ASPIRIN
AB       HERITAGE PHARMS INC      325MG;200MG
                   A089594   001   Mar   31,   1989

AB       MIRROR PHARMS            325MG;200MG
                   A040832   001   Jan   07,   2010

AB       PROSAM LABS              325MG;200MG
                   A040252   001   Dec   10,   1997

AB       SANDOZ                   325MG;200MG
	                  A040116   001   Apr   25,   1996
	
    SOMA COMPOUND
AB    + MEDA PHARMS               325MG;200MG
	                  N012365 005 Jul 11, 1983
	
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
	
  TABLET;ORAL

    CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE

AB       SANDOZ                 325MG;200MG;16MG
                A040118 001 Apr 16, 1996
	
    SOMA COMPOUND W/ CODEINE

AB    + MEDA PHARMS             325MG;200MG;16MG
	               N012366 002 Jul 11, 1983
	
ASPIRIN; DIPYRIDAMOLE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    AGGRENOX
	
AB    + BOEHRINGER INGELHEIM    25MG;200MG
                      N020884 001 Nov 22, 1999
	
    ASPIRIN AND DIPYRIDAMOLE
	
AB       BARR                   25MG;200MG
	                     A078804 001 Aug 14, 2009
	
ASPIRIN; METHOCARBAMOL
	
  TABLET;ORAL
	
    METHOCARBAMOL AND ASPIRIN
	
      + STEVENS J                 325MG;400MG
	                  A081145 001 Jan 31, 1995
	
ASPIRIN; OXYCODONE HYDROCHLORIDE
	
  TABLET;ORAL

    OXYCODONE AND ASPIRIN
AA       COASTAL PHARMS         325MG;4.8355MG
                  A091670 001 Mar 16, 2011

AA       WATSON LABS            325MG;4.8355MG
	                 A090084 001 Mar 22, 2011
	
    PERCODAN
AA    + ENDO PHARMS             325MG;4.8355MG
	                 N007337 007 Aug 05, 2005
	
ATAZANAVIR SULFATE
	
  CAPSULE;ORAL

     ATAZANAVIR SULFATE
	
AB        TEVA PHARMS USA
	       EQ 150MG BASE
                 A091673 002 Apr 22, 2014

AB
	                              EQ 200MG BASE
                 A091673 003 Apr 22, 2014

AB
	                              EQ 300MG BASE
	                A091673 004 Apr 22, 2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-34(of 371)


ATAZANAVIR SULFATE
	
  CAPSULE;ORAL

    REYATAZ
	
AB       BRISTOL MYERS SQUIBB    EQ 150MG BASE                  N021567 002 Jun 20, 2003

AB                               EQ 200MG BASE                  N021567 003 Jun 20, 2003

AB    +                          EQ 300MG BASE                  N021567 004 Oct 16, 2006
	
    ATAZANAVIR SULFATE
	
         TEVA PHARMS USA         EQ 100MG BASE                  A091673 001 Apr 22, 2014

  POWDER;ORAL
	
    REYATAZ
	
      + BRISTOL MYERS SQUIBB     EQ 50MG BASE/PACKET            N206352 001 Jun 02, 2014
	
ATENOLOL
	
  TABLET;ORAL

    ATENOLOL
	
AB        AUROBINDO PHARMA       25MG                           A078512   001   Oct   31,   2007

AB                               50MG                           A078512   002   Oct   31,   2007

AB                               100MG                          A078512   003   Oct   31,   2007

AB        DAVA PHARMS INC        25MG                           A074099   001   Apr   28,   1992

AB                               50MG                           A073542   001   Dec   19,   1991

AB                               100MG                          A073543   001   Dec   19,   1991

AB        IPCA LABS LTD          25MG                           A077877   001   Dec   27,   2006

AB                               50MG                           A077877   002   Dec   27,   2006

AB                               100MG                          A077877   003   Dec   27,   2006

AB        IPR                    25MG                           A073646   001   Jul   31,   1992

AB                               50MG                           A072303   001   Jul   15,   1988

AB                               100MG                          A072304   001   Jul   15,   1988

AB        MUTUAL PHARM           25MG                           A074499   001   Jul   30,   1997

AB                               50MG                           A073475   001   Mar   30,   1993

AB                               100MG                          A073476   001   Mar   30,   1993

AB        MYLAN                  25MG                           A073457   002   Apr   26,   1999

AB                               50MG                           A073457   003   Jan   24,   1992

AB                               100MG                          A073457   001   Jan   24,   1992

AB        NORTHSTAR HLTHCARE     25MG                           A078254   001   Sep   25,   2009

AB                               50MG                           A078254   002   Sep   25,   2009

AB                               100MG                          A078254   003   Sep   25,   2009

AB        SANDOZ                 25MG                           A074052   001   May   01,   1992

AB                               50MG                           A073025   001   Sep   17,   1991

AB                               100MG                          A073026   001   Sep   17,   1991

AB        SUN PHARM INDS INC     25MG                           A078210   001   Jul   10,   2007

AB                               50MG                           A078210   002   Jul   10,   2007

AB                               100MG                          A078210   003   Jul   10,   2007

AB        TEVA                   25MG                           A074056   003   Jul   19,   2004

AB                               50MG                           A074056   001   Jan   18,   1995

AB                               100MG                          A074056   002   Jan   18,   1995

AB        UNIQUE PHARM LABS      25MG                           A077443   001   Sep   13,   2006

AB                               50MG                           A077443   002   Sep   13,   2006

AB                               100MG                          A077443   003   Sep   13,   2006

AB        ZYDUS PHARMS USA       25MG                           A076900   001   Jan   28,   2005

AB                               50MG                           A076900   002   Jan   28,   2005

AB                               100MG                          A076900   003   Jan   28,   2005

    TENORMIN
	
AB        ASTRAZENECA            25MG                           N018240 004 Apr 09, 1990

AB                               50MG                           N018240 001
	
AB    +                          100MG                          N018240 002
	
ATENOLOL; CHLORTHALIDONE
	
  TABLET;ORAL

    ATENOLOL AND CHLORTHALIDONE
	
AB       IPR                      50MG;25MG                     A072301   001   May   31,   1990

AB                                100MG;25MG                    A072302   001   May   31,   1990

AB       MUTUAL PHARM             50MG;25MG                     A073581   001   Apr   29,   1993

AB                                100MG;25MG                    A073582   001   Apr   29,   1993

AB       MYLAN                    50MG;25MG                     A074203   001   Oct   31,   1993

AB                                100MG;25MG                    A074203   002   Oct   31,   1993

AB       WATSON LABS              50MG;25MG                     A073665   001   Jul   02,   1992

AB                                100MG;25MG                    A073665   002   Jul   02,   1992

    TENORETIC 100
	
AB    + ASTRAZENECA               100MG;25MG                    N018760 001 Jun 08, 1984

    TENORETIC 50
	
AB       ASTRAZENECA              50MG;25MG                     N018760 002 Jun 08, 1984
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-35(of 371)


ATOMOXETINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    STRATTERA
	
         LILLY
	                 10MG
	                          N021411   002   Nov   26,   2002
	
                                 18MG
	                          N021411   003   Nov   26,   2002
	
                                 25MG
	                          N021411   004   Nov   26,   2002
	
                                 40MG
	                          N021411   005   Nov   26,   2002
	
     +
	                         60MG
	                          N021411   006   Nov   26,   2002
	
                                 80MG
	                          N021411   007   Feb   14,   2005
	
                                 100MG
	                         N021411   008   Feb   14,   2005
	
ATORVASTATIN CALCIUM
	
  TABLET;ORAL

    ATORVASTATIN CALCIUM
AB       APOTEX INC              EQ   10MG   BASE
               A090548   001   May   29,   2012

AB                               EQ   20MG   BASE
               A090548   002   May   29,   2012

AB                               EQ   40MG   BASE
               A090548   003   May   29,   2012

AB                               EQ   80MG   BASE
               A090548   004   May   29,   2012

AB       DR REDDYS LABS LTD      EQ   10MG   BASE
               A091650   001   Jul   17,   2012

AB                               EQ   20MG   BASE
               A091650   002   Jul   17,   2012

AB                               EQ   40MG   BASE
               A091650   003   Jul   17,   2012

AB                               EQ   80MG   BASE
               A202357   001   Jul   17,   2012

AB       KUDCO IRELAND           EQ   10MG   BASE
               A091624   001   Apr   05,   2013

AB                               EQ   20MG   BASE
               A091624   002   Apr   05,   2013

AB                               EQ   40MG   BASE
               A091624   003   Apr   05,   2013

AB                               EQ   80MG   BASE
               A091624   004   Apr   05,   2013

AB       MYLAN PHARMS INC        EQ   10MG   BASE
               A091226   001   May   29,   2012

AB                               EQ   20MG   BASE
               A091226   002   May   29,   2012

AB                               EQ   40MG   BASE
               A091226   003   May   29,   2012

AB                               EQ   80MG   BASE
               A091226   004   May   29,   2012

AB       RANBAXY LABS LTD        EQ   10MG   BASE
               A076477   001   Nov   30,   2011

AB                               EQ   20MG   BASE
               A076477   002   Nov   30,   2011

AB                               EQ   40MG   BASE
               A076477   003   Nov   30,   2011

AB                               EQ   80MG   BASE
               A076477   004   Nov   30,   2011

AB       SANDOZ INC              EQ   10MG   BASE
               A077575   001   May   29,   2012

AB                               EQ   20MG   BASE
               A077575   002   May   29,   2012

AB                               EQ   40MG   BASE
               A077575   003   May   29,   2012

AB                               EQ   80MG   BASE
	              A077575   004   May   29,   2012
	
    LIPITOR
AB       PFIZER                  EQ   10MG   BASE
               N020702   001   Dec   17,   1996

AB                               EQ   20MG   BASE
               N020702   002   Dec   17,   1996

AB                               EQ   40MG   BASE
               N020702   003   Dec   17,   1996

AB    +                          EQ   80MG   BASE
	              N020702   004   Apr   07,   2000
	
ATORVASTATIN CALCIUM; EZETIMIBE
	
  TABLET;ORAL
	
    LIPTRUZET
	
          MERCK SHARP DOHME
	    EQ   10MG   BASE;10MG
	         N200153   001   May   03,   2013

                                 EQ   20MG   BASE;10MG
	         N200153   002   May   03,   2013

                                 EQ   40MG   BASE;10MG
	         N200153   003   May   03,   2013

      +
	                        EQ   80MG   BASE;10MG
	         N200153   004   May   03,   2013
	
ATOVAQUONE
	
  SUSPENSION;ORAL

    ATOVAQUONE

AB       AMNEAL PHARMS
	         750MG/5ML
	                     A202960 001 Mar 18, 2014
	
    MEPRON
	
AB    + GLAXOSMITHKLINE LLC
	    750MG/5ML
	                     N020500 001 Feb 08, 1995
	
ATOVAQUONE; PROGUANIL HYDROCHLORIDE
	
  TABLET;ORAL

     ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

AB        GLENMARK GENERICS
	    250MG;100MG
                    A091211 001 Jan 12, 2011

AB        MYLAN PHARMS INC
	     62.5MG;25MG
                    A202362 001 May 27, 2014

AB
	                             250MG;100MG
	                   A202362 002 May 27, 2014
	
     MALARONE
	
AB     + GLAXOSMITHKLINE
	       250MG;100MG
	                   N021078 001 Jul 14, 2000
	
     MALARONE PEDIATRIC
	
AB        GLAXOSMITHKLINE
	      62.5MG;25MG
	                   N021078 002 Jul 14, 2000
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-36(of 371)


ATRACURIUM BESYLATE
	
  INJECTABLE;INJECTION

    ATRACURIUM BESYLATE
	
AP    + EUROHLTH INTL           10MG/ML                        A074901 001 Jul 18, 1997

AP       HOSPIRA INC            10MG/ML                        A090761 001 Oct 18, 2012

AP       SAGENT PHARMS          10MG/ML                        A091489 001 Feb 17, 2012

    ATRACURIUM BESYLATE PRESERVATIVE FREE
	
AP    + EUROHLTH INTL           10MG/ML                        A074900 001 Jul 18, 1997

AP       HOSPIRA INC            10MG/ML                        A090782 001 Oct 18, 2012

AP       SAGENT PHARMS          10MG/ML                        A091488 001 Feb 17, 2012
	
ATROPINE
	
  INJECTABLE;INJECTION
	
    ATROPEN
	
      + MERIDIAN MEDCL TECHN      EQ    0.25MG SULFATE/0.3ML   N017106   004 Sep 17, 2004

      +                           EQ    0.5MG SULFATE/0.7ML    N017106   003 Jun 19, 2003
	
      +                           EQ    1MG SULFATE/0.7ML      N017106   002 Jun 19, 2003
	
      +                           EQ    2MG SULFATE/0.7ML      N017106   001
	
ATROPINE SULFATE
	
  INJECTABLE;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
	
    ATROPINE SULFATE ANSYR PLASTIC SYRINGE
	
      + HOSPIRA                 0.05MG/ML                      N021146 002 Jul 09, 2001
	
      +                         0.1MG/ML                       N021146 001 Jul 09, 2001
	
  SOLUTION/DROPS;OPHTHALMIC

    ATROPINE SULFATE
	
         AKORN                  1%                             N206289 001 Jul 18, 2014
	
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    MOTOFEN
	
      + VALEANT                 0.025MG;1MG                    N017744 002
	
ATROPINE SULFATE; DIPHENOXYLATE   HYDROCHLORIDE
	
  SOLUTION;ORAL

    DIPHENOXYLATE HYDROCHLORIDE   AND ATROPINE SULFATE
	
AA    + ROXANE                    0.025MG/5ML;2.5MG/5ML        A087708 001 May 03, 1982

  TABLET;ORAL

    DIPHENOXYLATE HYDROCHLORIDE   AND ATROPINE SULFATE
	
AA       LANNETT                  0.025MG;2.5MG                A085372 001
	
AA       MYLAN                    0.025MG;2.5MG                A085762 001
	
AA       PAR PHARM                0.025MG;2.5MG                A040357 001 May 02, 2000

    LOMOTIL
	
AA    + GD SEARLE LLC             0.025MG;2.5MG                N012462 001
	
    LONOX
	
AA       SANDOZ                   0.025MG;2.5MG                A085311 002
	
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ENLON-PLUS
	
      + MYLAN INSTITUTIONAL     0.14MG/ML;10MG/ML              N019678 001 Nov 06, 1991
	
ATROPINE; PRALIDOXIME CHLORIDE
	
  INJECTABLE;INTRAMUSCULAR
	
    DUODOTE
	
      + MERIDIAN MEDCL           2.1MG/0.7ML;600MG/2ML         N021983 001 Sep 28, 2006
	
AURANOFIN
	
  CAPSULE;ORAL
	
    RIDAURA
	
      + PROMETHEUS LABS           3MG                          N018689 001 May 24, 1985
	
AVANAFIL
	
  TABLET;ORAL
	
    STENDRA
	
          VIVUS                   50MG                         N202276 001 Apr 27, 2012

                                  100MG                        N202276 002 Apr 27, 2012

     +                            200MG                        N202276 003 Apr 27, 2012
	
AXITINIB
	
  TABLET;ORAL
	
    INLYTA
	
          PFIZER                  1MG                          N202324 001 Jan 27, 2012
	
      +                           5MG                          N202324 002 Jan 27, 2012
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                          3-37(of 371)


AZACITIDINE
	
  INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

    AZACITIDINE
	
AP       DR REDDYS LABS LTD     100MG/VIAL                           A201537 001 Sep 16, 2013

    VIDAZA
	
AP    + CELGENE                 100MG/VIAL                           N050794 001 May 19, 2004
	
AZATHIOPRINE
	
  TABLET;ORAL

    AZASAN
	
AB       AAIPHARMA LLC           25MG                                A075252   002   Feb   03,   2003

AB                               50MG                                A075252   001   Jun   07,   1999

AB                               75MG                                A075252   003   Feb   03,   2003

AB                               100MG                               A075252   004   Feb   03,   2003

    AZATHIOPRINE
	
AB       AMNEAL PHARMS LLC       50MG                                A074069   001   Feb   16,   1996

AB       MYLAN                   50MG                                A075568   001   Dec   13,   1999

AB       ZYDUS PHARMS USA        25MG                                A077621   002   Sep   05,   2008

AB                               50MG                                A077621   001   Mar   15,   2007

AB                               75MG                                A077621   003   Sep   05,   2008

AB                               100MG                               A077621   004   Sep   05,   2008

    IMURAN
	
AB    + PROMETHEUS LABS          50MG                                N016324 001
	
AZATHIOPRINE SODIUM
	
  INJECTABLE;INJECTION
	
    AZATHIOPRINE SODIUM
	
      + EUROHLTH INTL            EQ 100MG BASE/VIAL                  A074419 001 Mar 31, 1995
	
AZELAIC ACID
	
  CREAM;TOPICAL
	
    AZELEX
	
      + ALLERGAN                 20%                                 N020428 001 Sep 13, 1995

  GEL;TOPICAL
	
    FINACEA
	
      + BAYER HLTHCARE           15%                                 N021470 001 Dec 24, 2002
	
AZELASTINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    AZELASTINE HYDROCHLORIDE
	
AT       ALCON PHARMA            0.05%                               A202305 001 May 31, 2012

AT       APOTEX INC              0.05%                               A078621 001 Aug 03, 2009

AT       SUN PHARMA GLOBAL       0.05%                               A078738 001 Jun 21, 2010

    OPTIVAR
	
AT    + MEDA PHARMS              0.05%                               N021127 001 May 22, 2000

  SPRAY, METERED;NASAL

    ASTELIN
	
AB    + MEDA PHARMS              EQ 0.125MG BASE/SPRAY               N020114 001 Nov 01, 1996

    ASTEPRO
	
AB    + MEDA PHARMS              EQ 0.1876MG BASE/SPRAY              N022371 001 Aug 31, 2009

    AZELASTINE HYDROCHLORIDE
	
AB       APOTEX INC              EQ   0.125MG BASE/SPRAY             A077954   001   Apr   30,   2009

AB                               EQ   0.1876MG BASE/SPRAY            A201846   001   Aug   31,   2012

AB       PERRIGO ISRAEL          EQ   0.1876MG BASE/SPRAY            A202743   001   May   08,   2014

AB       ROXANE                  EQ   0.125MG BASE/SPRAY             A091444   001   Oct   24,   2014

AB       SUN PHARMA GLOBAL       EQ   0.125MG BASE/SPRAY             A090423   001   May   23,   2012
	
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
	
  SPRAY, METERED;NASAL
	
    DYMISTA
	
      + MEDA PHARMS             EQ 0.125MG BASE/SPRAY;0.05MG/SPRAY   N202236 001 May 01, 2012
	
AZILSARTAN KAMEDOXOMIL
	
  TABLET;ORAL
	
    EDARBI
	
         ARBOR PHARMS IRELAND    EQ 40MG MEDOXOMIL                   N200796 001 Feb 25, 2011
	
      +                          EQ 80MG MEDOXOMIL                   N200796 002 Feb 25, 2011
	
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
	
  TABLET;ORAL
	
    EDARBYCLOR
	
         ARBOR PHARMS IRELAND   EQ 40MG MEDOXOMIL;12.5MG             N202331 001 Dec 20, 2011
	
      +                         EQ 40MG MEDOXOMIL;25MG               N202331 002 Dec 20, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-38(of 371)


AZITHROMYCIN
	
  FOR SUSPENSION;ORAL

    AZITHROMYCIN
	
AB         PLIVA                EQ 100MG BASE/5ML              A065246   002   Jul   05,   2006

AB                              EQ 200MG BASE/5ML              A065246   001   Jul   05,   2006

AB         TEVA PHARMS          EQ 100MG BASE/5ML              A065419   001   Jun   24,   2008

AB                              EQ 200MG BASE/5ML              A065419   002   Jun   24,   2008

    ZITHROMAX
	
AB         PFIZER               EQ 100MG BASE/5ML              N050710 001 Oct 19, 1995

AB    +                         EQ 200MG BASE/5ML              N050710 002 Oct 19, 1995
	
      +                         EQ 1GM BASE/PACKET             N050693 001 Sep 28, 1994

  FOR SUSPENSION, EXTENDED RELEASE;ORAL
	
    ZMAX
	
      + PF PRISM CV             EQ 2GM BASE/BOT                N050797 001 Jun 10, 2005
	
  INJECTABLE;INJECTION

    AZITHROMYCIN
	
AP         FRESENIUS KABI USA   EQ 500MG BASE/VIAL             A065179   001   Dec   13,   2005

AP         GLAND PHARMA LTD     EQ 500MG BASE/VIAL             A065501   001   Nov   09,   2009

AP         HOSPIRA              EQ 500MG BASE/VIAL             A065500   001   Jun   26,   2009

AP                              EQ 500MG BASE/VIAL             A065511   001   Jun   26,   2009

AP         SAGENT STRIDES       EQ 500MG BASE/VIAL             A065506   001   Mar   24,   2009

AP         SUN PHARM INDS LTD   EQ 500MG BASE/VIAL             A090923   001   Apr   02,   2013

    ZITHROMAX
	
AP    + PFIZER                  EQ 500MG BASE/VIAL             N050733 001 Jan 30, 1997
	
  SOLUTION/DROPS;OPHTHALMIC

    AZASITE
	
      + OAK PHARMS INC          1%                             N050810 001 Apr 27, 2007

  TABLET;ORAL

    AZITHROMYCIN
	
AB         APOTEX CORP          EQ 250MG BASE                  A065507   001   Jul   13,   2011

AB                              EQ 500MG BASE                  A065509   001   Jul   13,   2011

AB                              EQ 600MG BASE                  A065508   001   Jul   13,   2011

AB         MYLAN                EQ 250MG BASE                  A065365   001   May   30,   2007

AB                              EQ 500MG BASE                  A065366   001   May   30,   2007

AB                              EQ 600MG BASE                  A065360   001   Jan   08,   2007

AB         PLIVA                EQ 250MG BASE                  A065225   001   Nov   14,   2005

AB                              EQ 500MG BASE                  A065223   001   Nov   14,   2005

AB                              EQ 600MG BASE                  A065218   001   Nov   14,   2005

AB         SANDOZ               EQ 250MG BASE                  A065211   001   Nov   14,   2005

AB                              EQ 500MG BASE                  A065212   001   Nov   14,   2005

AB                              EQ 600MG BASE                  A065209   001   Nov   14,   2005

AB         TEVA                 EQ 250MG BASE                  A065153   001   Nov   14,   2005

AB                              EQ 500MG BASE                  A065193   001   Nov   14,   2005

AB                              EQ 600MG BASE                  A065150   001   Nov   14,   2005

AB         WOCKHARDT            EQ 250MG BASE                  A065404   001   Feb   11,   2008

AB                              EQ 500MG BASE                  A065405   001   Feb   11,   2008

AB                              EQ 600MG BASE                  A065302   003   Feb   11,   2008

    ZITHROMAX
	
AB         PFIZER               EQ 250MG BASE                  N050711 001 Jul 18, 1996

AB                              EQ 500MG BASE                  N050784 001 May 24, 2002

AB    +                         EQ 600MG BASE                  N050730 001 Jun 12, 1996
	
AZTREONAM
	
  FOR SOLUTION;INHALATION
	
    CAYSTON
	
      + GILEAD                  75MG/VIAL                      N050814 001 Feb 22, 2010
	
  INJECTABLE;INJECTION

    AZACTAM
	
AP    + BRISTOL MYERS SQUIBB    1GM/VIAL                       N050580 002 Dec 31, 1986

AP    +                         2GM/VIAL                       N050580 003 Dec 31, 1986

    AZTREONAM
	
AP       EUROHLTH INTL          1GM/VIAL                       A065286   001   Mar   23,   2011

AP                              2GM/VIAL                       A065286   002   Mar   23,   2011

AP       FRESENIUS KABI USA     1GM/VIAL                       A065439   002   Jun   18,   2010

AP                              2GM/VIAL                       A065439   003   Jun   18,   2010
	
    AZACTAM IN PLASTIC CONTAINER
	
      + BRISTOL MYERS SQUIBB    20MG/ML                        N050632 002 May 24, 1989

      +                         40MG/ML                        N050632 001 May 24, 1989

    AZTREONAM
	
         FRESENIUS KABI USA     500MG/VIAL                     A065439 001 Jun 18, 2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                  3-39(of 371)


BACITRACIN
	
  INJECTABLE;INJECTION

    BACIIM
	
AP       X GEN PHARMS            50,000 UNITS/VIAL                         A064153 001 May 09, 1997

    BACITRACIN
	
AP       FRESENIUS KABI USA      50,000   UNITS/VIAL                       A065116   001 Dec 03, 2002

AP    + PHARMACIA AND UPJOHN     50,000   UNITS/VIAL                       A060733   002
	
AP       SAGENT STRIDES          50,000   UNITS/VIAL                       A090211   001 May 11, 2010

AP       XELLIA PHARMS APS       50,000   UNITS/VIAL                       A203177   001 Aug 25, 2014

         PHARMACIA AND UPJOHN    10,000   UNITS/VIAL                       A060733   001
	
  OINTMENT;OPHTHALMIC
	
    BACITRACIN
	
      + PERRIGO CO TENNESSEE		   500 UNITS/GM                              A061212 001
	
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC

    NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE

AT        AKORN                 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000    A065213 001 Jul 25, 2012

                                UNITS/GM

AT    + BAUSCH AND LOMB         400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000    A064068 001 Oct 30, 1995

                                UNITS/GM

  OINTMENT;TOPICAL
	
    CORTISPORIN
	
      +		 MONARCH PHARMS        400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000     N050168 002 May 04, 1984

                                UNITS/GM
	
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC

    NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
	
AT       AKORN                  400 UNITS/GM;EQ 3.5MG BASE/GM;10,000       A065088 001 Feb 06, 2004

                                UNITS/GM

AT    + BAUSCH AND LOMB         400 UNITS/GM;EQ 3.5MG BASE/GM;10,000       A064064 001 Oct 30, 1995

                                UNITS/GM

AT       PERRIGO CO TENNESSEE   400 UNITS/GM;EQ 3.5MG BASE;10,000          A060764 002
	
                                UNITS/GM
	
BACITRACIN ZINC; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC

    BACITRACIN ZINC AND POLYMYXIN B SULFATE
	
AT       AKORN                  500 UNITS/GM;10,000 UNITS/GM               A064028 001 Jan 30, 1995

AT    + BAUSCH AND LOMB         500 UNITS/GM;10,000 UNITS/GM               A064046 001 Jan 26, 1995

AT       PERRIGO CO TENNESSEE   500 UNITS/GM;10,000 UNITS/GM               A065022 001 Feb 27, 2002
	
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE

      +		 PERRIGO CO TENNESSEE  400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000    A062166 002
	
                                UNITS/GM
	
BACLOFEN
	
  INJECTABLE;INTRATHECAL

    GABLOFEN
	
AP        MALLINCKRODT INC       0.05MG/ML                                 N022462 001 Nov 19, 2010

AP                               0.5MG/ML                                  N022462 002 Nov 19, 2010

AP                               2MG/ML                                    N022462 003 Nov 19, 2010

    LIORESAL
	
AP    + MEDTRONIC NEURO          0.05MG/ML                                 N020075 003 Nov 07, 1996

AP    +                          0.5MG/ML                                  N020075 001 Jun 17, 1992

AP    +                          2MG/ML                                    N020075 002 Jun 17, 1992
	
    GABLOFEN
	
          MALLINCKRODT INC       1MG/ML                                    N022462 004 Jun 22, 2012
	
  TABLET;ORAL

    BACLOFEN
	
AB        CARACO                 10MG                                      A077984   001   Aug   14,   2006

AB        IMPAX LABS             10MG                                      A078146   001   Oct   26,   2007

AB                               20MG                                      A077971   002   Oct   26,   2007

AB        IVAX SUB TEVA PHARMS   10MG                                      A072234   001   Jul   21,   1988

AB    +                          20MG                                      A072235   001   Jul   21,   1988

AB        LANNETT                10MG                                      A078220   001   Jul   06,   2007

AB                               20MG                                      A077241   001   Dec   20,   2005

AB        MYLAN                  10MG                                      A077181   001   Jul   29,   2005

AB                               20MG                                      A077121   002   Jul   29,   2005

AB        MYLAN PHARMS INC       10MG                                      A090334   001   Feb   18,   2010

AB                               20MG                                      A090334   002   Feb   18,   2010

AB        NORTHSTAR HLTHCARE     10MG                                      A078504   001   Sep   18,   2009

AB                               20MG                                      A078401   001   Sep   18,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-40(of 371)


BACLOFEN
	
  TABLET;ORAL

     BACLOFEN
	
AB        PROSAM LABS
	           10MG
	                        A077089   001   Oct   31,   2007

AB
	                              20MG
	                        A077088   001   Oct   31,   2007

AB        SUN PHARM INDS INC
	    20MG
	                        A077862   002   Aug   14,   2006

AB        USL PHARMA
	            10MG
	                        A074584   001   Aug   19,   1996

AB
	                              20MG
	                        A074584   002   Aug   19,   1996

AB        VINTAGE PHARMS
	        10MG
	                        A077156   001   Aug   30,   2005

AB
	                              20MG
	                        A077068   001   Aug   30,   2005

AB        WATSON LABS
	           10MG
	                        A072824   001   Sep   18,   1991

AB
	                              20MG
	                        A072825   001   Sep   18,   1991
	
BALSALAZIDE DISODIUM
	
  CAPSULE;ORAL

    BALSALAZIDE DISODIUM
	
AB       APOTEX INC
	             750MG
	                       A077883 001 Dec 28, 2007

AB       MYLAN
	                  750MG
	                       A077807 001 Dec 28, 2007

AB       ROXANE
	                 750MG
	                       A077806 001 Dec 28, 2007
	
    COLAZAL
	
AB    + SALIX PHARMS
	            750MG
	                       N020610 001 Jul 18, 2000
	
  TABLET;ORAL
	
    GIAZO
	
      + SALIX PHARMS
	            1.1GM
	                       N022205 001 Feb 03, 2012
	
BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED
	
  TABLET;ORAL
	
    DUAVEE
	
      + WYETH PHARMS PFIZER
	   EQ 20MG BASE;0.45MG
	           N022247 001 Oct 03, 2013
	
BECLOMETHASONE DIPROPIONATE
	
  AEROSOL, METERED;INHALATION
	
    QVAR 40
	
      + TEVA BRANDED PHARM
	      0.04MG/INH
	                  N020911 002 Sep 15, 2000
	
    QVAR 80
	
      + TEVA BRANDED PHARM
	      0.08MG/INH
	                  N020911 001 Sep 15, 2000
	
  AEROSOL, METERED;NASAL
	
    QNASL
	
          TEVA BRANDED PHARM
	    0.04MG/ACTUATION
             N202813 002 Dec 17, 2014
	
      +
	                         0.08MG/ACTUATION
	            N202813 001 Mar 23, 2012
	
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
	
  SPRAY, METERED;NASAL
	
    BECONASE AQ
	
      + GLAXOSMITHKLINE
	       EQ 0.042MG DIPROP/SPRAY
	       N019389 001 Jul 27, 1987
	
BEDAQUILINE FUMARATE
	
  TABLET;ORAL
	
    SIRTURO
	
      + JANSSEN THERAP
	          EQ 100MG BASE
	               N204384 001 Dec 28, 2012
	
BELINOSTAT
	
  POWDER;IV (INFUSION)

    BELEODAQ
	
      + SPECTRUM PHARMS
	         500MG/VIAL
	                  N206256 001 Jul 03, 2014
	
BENAZEPRIL HYDROCHLORIDE
	
  TABLET;ORAL

    BENAZEPRIL HYDROCHLORIDE
AB       ACTAVIS LABS FL INC      5MG
	                         A076267   001   Feb   11,   2004

AB                                10MG
	                        A076267   002   Feb   11,   2004

AB                                20MG
	                        A076267   003   Feb   11,   2004

AB                                40MG
	                        A076267   004   Feb   11,   2004

AB       APOTEX INC               5MG
	                         A077128   001   Mar   08,   2006

AB                                10MG
	                        A077128   002   Mar   08,   2006

AB                                20MG
	                        A077128   003   Mar   08,   2006

AB                                40MG
	                        A077128   004   Mar   08,   2006

AB       AUROBINDO PHARMA         10MG
	                        A078212   001   May   22,   2008

AB                                20MG
	                        A078212   002   May   22,   2008

AB                                40MG
	                        A078212   003   May   22,   2008

AB       BIOKEY                   5MG
	                         A076820   001   Feb   03,   2006

AB                                10MG
	                        A076820   002   Feb   03,   2006

AB                                20MG
	                        A076820   003   Feb   03,   2006

AB                                40MG
	                        A076820   004   Feb   03,   2006

AB       IVAX SUB TEVA PHARMS     5MG
	                         A076333   001   Feb   11,   2004

AB                                10MG
	                        A076333   002   Feb   11,   2004
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-41(of 371)


BENAZEPRIL HYDROCHLORIDE
	
  TABLET;ORAL

     BENAZEPRIL HYDROCHLORIDE
	
AB
	                                20MG
	                       A076333   003   Feb   11,   2004

AB
	                                40MG
	                       A076333   004   Feb   11,   2004

AB         MYLAN
	                  5MG
	                        A076430   001   Feb   11,   2004

AB
	                                10MG
	                       A076430   002   Feb   11,   2004

AB
	                                20MG
	                       A076430   003   Feb   11,   2004

AB
	                                40MG
	                       A076430   004   Feb   11,   2004

AB         PRINSTON INC
	           5MG
	                        A076118   001   Feb   11,   2004

AB
	                                10MG
	                       A076118   002   Feb   11,   2004

AB
	                                20MG
	                       A076118   003   Feb   11,   2004

AB
	                                40MG
	                       A076118   004   Feb   11,   2004

AB         RANBAXY
	                5MG
	                        A076344   001   Feb   11,   2004

AB
	                                10MG
	                       A076344   002   Feb   11,   2004

AB
	                                20MG
	                       A076344   003   Feb   11,   2004

AB
	                                40MG
	                       A076344   004   Feb   11,   2004

AB         SANDOZ
	                 5MG
	                        A076402   001   Feb   11,   2004

AB
	                                10MG
	                       A076402   002   Feb   11,   2004

AB
	                                20MG
	                       A076402   003   Feb   11,   2004

AB
	                                40MG
	                       A076402   004   Feb   11,   2004

AB         TEVA
	                   5MG
	                        A076211   001   Feb   11,   2004

AB
	                                10MG
	                       A076211   002   Feb   11,   2004

AB
	                                20MG
	                       A076211   003   Feb   11,   2004

AB
	                                40MG
	                       A076211   004   Feb   11,   2004

AB         ZYDUS PHARMS USA
	       5MG
	                        A078848   001   May   23,   2008

AB
	                                10MG
	                       A078848   002   May   23,   2008

AB
	                                20MG
	                       A078848   003   May   23,   2008

AB
	                                40MG
	                       A078848   004   May   23,   2008
	
     LOTENSIN
	
AB         US PHARMS HOLDINGS I
	   5MG
	                        N019851   001   Jun   25,   1991

AB
	                                10MG
	                       N019851   002   Jun   25,   1991

AB
	                                20MG
	                       N019851   003   Jun   25,   1991

AB     +
	                          40MG
	                       N019851   004   Jun   25,   1991
	
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

     BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
AB         ACTAVIS LABS FL INC
	  5MG;6.25MG
                    A076342   001   Feb   11,   2004

AB
	                              10MG;12.5MG
                   A076342   002   Feb   11,   2004

AB
	                              20MG;12.5MG
                   A076342   003   Feb   11,   2004

AB
	                              20MG;25MG
                     A076342   004   Feb   11,   2004

AB         APOTEX INC
	           5MG;6.25MG
                    A078794   001   Aug   21,   2014

AB
	                              10MG;12.5MG
                   A078794   002   Aug   21,   2014

AB
	                              20MG;12.5MG
                   A078794   003   Aug   21,   2014

AB
	                              20MG;25MG
                     A078794   004   Aug   21,   2014

AB         IVAX SUB TEVA PHARMS
	 5MG;6.25MG
                    A076348   001   Feb   11,   2004

AB
	                              10MG;12.5MG
                   A076348   002   Feb   11,   2004

AB
	                              20MG;12.5MG
                   A076348   003   Feb   11,   2004

AB
	                              20MG;25MG
                     A076348   004   Feb   11,   2004

AB         MYLAN
	                5MG;6.25MG
                    A076688   001   Feb   11,   2004

AB
	                              10MG;12.5MG
                   A076688   002   Feb   11,   2004

AB
	                              20MG;12.5MG
                   A076688   003   Feb   11,   2004

AB
	                              20MG;25MG
                     A076688   004   Feb   11,   2004

AB         RANBAXY
	              5MG;6.25MG
                    A077483   001   Sep   08,   2005

AB
	                              10MG;12.5MG
                   A077483   002   Sep   08,   2005

AB
	                              20MG;12.5MG
                   A077483   003   Sep   08,   2005

AB
	                              20MG;25MG
                     A077483   004   Sep   08,   2005

AB         SANDOZ
	               5MG;6.25MG
                    A076631   001   Feb   11,   2004

AB
	                              10MG;12.5MG
                   A076631   002   Feb   11,   2004

AB
	                              20MG;12.5MG
                   A076631   003   Feb   11,   2004

AB
	                              20MG;25MG
	                    A076631   004   Feb   11,   2004
	
     LOTENSIN HCT
	
AB         US PHARMS HOLDINGS I
	 5MG;6.25MG
                    N020033   001   May   19,   1992

AB
	                              10MG;12.5MG
                   N020033   002   May   19,   1992

AB
	                              20MG;12.5MG
                   N020033   004   May   19,   1992

AB     +
	                        20MG;25MG
	                    N020033   003   May   19,   1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-42(of 371)


BENDAMUSTINE HYDROCHLORIDE
	
  POWDER;IV (INFUSION)

    TREANDA
	
      + CEPHALON                 25MG/VIAL                      N022249 002 May 01, 2009

      +                          100MG/VIAL                     N022249 001 Mar 20, 2008
	
  SOLUTION;IV (INFUSION)

    TREANDA
	
      + CEPHALON                 45MG/0.5ML (90MG/ML)           N022249 003 Sep 13, 2013

      +                          180MG/2ML (90MG/ML)            N022249 004 Sep 13, 2013
	
BENDROFLUMETHIAZIDE; NADOLOL
	
  TABLET;ORAL

    CORZIDE
	
AB       KING PHARMS            5MG;40MG                        N018647 001 May 25, 1983

AB    +                         5MG;80MG                        N018647 002 May 25, 1983

    NADOLOL AND BENDROFLUMETHIAZIDE
	
AB       IMPAX LABS             5MG;40MG                        A077833   001   Mar   30,   2007

AB                              5MG;80MG                        A077833   002   Mar   30,   2007

AB       MYLAN                  5MG;40MG                        A078688   001   Feb   15,   2008

AB                              5MG;80MG                        A078688   002   Feb   15,   2008
	
BENZONATATE
	
  CAPSULE;ORAL

    BENZONATATE
	
AA       BANNER PHARMACAPS       100MG                          A081297   001   Jan   29,   1993

AA                               200MG                          A081297   002   Oct   30,   2007

AA       MIKART                  100MG                          A040851   001   Nov   09,   2009

AA                               150MG                          A040851   002   Nov   09,   2009

AA                               200MG                          A040851   003   Nov   09,   2009

AA       ORIT LABS LLC           100MG                          A040682   001   Jul   30,   2007

AA                               200MG                          A040682   002   Jul   30,   2007

AA       SUN PHARM INDS INC      100MG                          A040587   001   Mar   19,   2008

AA                               200MG                          A040587   002   Mar   19,   2008

AA    + THE PHARMA NETWORK       100MG                          A040627   001   Mar   30,   2007

AA    +                          200MG                          A040749   001   Jul   25,   2007

AA    + THEPHARMANETWORK LLC     150MG                          A201209   001   Sep   24,   2014

AA       ZYDUS PHARMS USA        100MG                          A040597   001   Jun   08,   2007

AA                               200MG                          A040597   002   Jun   08,   2007

    TESSALON
	
AA       PFIZER                  100MG                          N011210 001
	
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
	
  GEL;TOPICAL

    BENZACLIN
	
AB    + VALEANT BERMUDA         5%;EQ 1% BASE                   N050756 001 Dec 21, 2000

    CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
	
AB         MYLAN PHARMS INC     5%;EQ 1% BASE                   A065443 001 Aug 11, 2009

AB         PERRIGO ISRAEL       5%;1.2%                         A090979 001 Jun 26, 2012

    DUAC
	
AB    + STIEFEL                 5%;1.2%                         N050741 001 Aug 26, 2002

    ACANYA
	
      + DOW PHARM               2.5%;EQ 1.2% BASE               N050819 001 Oct 23, 2008
	
    ONEXTON
	
           DOW PHARM            3.75%;EQ 1.2% BASE              N050819 002 Nov 24, 2014
	
BENZOYL PEROXIDE; ERYTHROMYCIN
	
  GEL;TOPICAL

    BENZAMYCIN
	
AB    + VALEANT INTL             5%;3%                          N050557 001 Oct 26, 1984

    ERYTHROMYCIN AND BENZOYL PEROXIDE
	
AB       TOLMAR                  5%;3%                          A065112 001 Mar 29, 2004
	
    BENZAMYCIN PAK
	
      + VALEANT LUXEMBOURG       5%;3%                          N050769 001 Nov 27, 2000
	
BENZPHETAMINE HYDROCHLORIDE
	
  TABLET;ORAL

    BENZPHETAMINE HYDROCHLORIDE
	
AA       EMCURE PHARMS LTD        50MG                          A202061   001   Jan   27,   2012

AA       IMPAX LABS               50MG                          A040845   001   Nov   18,   2008

AA       KVK TECH                 50MG                          A090968   001   Jul   20,   2010

AA       MALLINCKRODT INC         50MG                          A040773   001   Apr   25,   2007

AA       MIKART                   25MG                          A090473   001   Sep   15,   2010

AA                                50MG                          A090473   002   Sep   15,   2010

AA       PADDOCK                  50MG                          A040578   001   Apr   17,   2006

AA       TEDOR PHARM              50MG                          A040747   001   Mar   30,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                     3-43(of 371)


BENZPHETAMINE HYDROCHLORIDE
	
  TABLET;ORAL

    DIDREX
	
AA    + PHARMACIA AND UPJOHN
	   50MG
	                          N012427 002
	
BENZTROPINE MESYLATE
	
  INJECTABLE;INJECTION

    BENZTROPINE MESYLATE
	
AP       FRESENIUS KABI USA
	    1MG/ML
                         A090233   001   Jul   28,   2009

AP       HIKMA FARMACEUTICA
	    1MG/ML
                         A090287   001   Aug   31,   2009

AP       LUITPOLD
	              1MG/ML
                         A091152   001   Mar   29,   2010

AP       NAVINTA LLC
	           1MG/ML
	                        A091525   001   Feb   05,   2013
	
    COGENTIN
	
AP    + OAK PHARMS AKORN
	       1MG/ML
	                        N012015 001
	
  TABLET;ORAL

    BENZTROPINE MESYLATE
	
AA       COREPHARMA              0.5MG
	                         A072264   001   Feb   27,   1989

AA                               1MG
	                           A072265   001   Feb   27,   1989

AA                               2MG
	                           A072266   001   Feb   27,   1989

AA       EXCELLIUM               0.5MG
	                         A090168   001   Nov   28,   2012

AA                               1MG
	                           A090168   002   Nov   28,   2012

AA                               2MG
	                           A090168   003   Nov   28,   2012

AA       INVAGEN PHARMS          0.5MG
	                         A090294   001   Mar   29,   2010

AA                               1MG
	                           A090294   002   Mar   29,   2010

AA                               2MG
	                           A090294   003   Mar   29,   2010

AA       PLIVA                   0.5MG
	                         A089058   001   Aug   10,   1988

AA                               1MG
	                           A089059   001   Aug   10,   1988

AA                               2MG
	                           A089060   001   Aug   10,   1988

AA    + USL PHARMA               0.5MG
	                         A040103   001   Dec   12,   1996

AA    +                          1MG
	                           A040103   002   Dec   12,   1996

AA    +                          2MG
	                           A040103   003   Dec   12,   1996

AA       VINTAGE                 0.5MG
	                         A040738   001   Aug   27,   2007

AA                               1MG
	                           A040742   001   Aug   27,   2007

AA                               2MG
	                           A040715   003   Aug   27,   2007
	
BENZYL ALCOHOL
	
  LOTION;TOPICAL
	
    ULESFIA
	
      + SHIONOGI INC
	           5%
	                            N022129 001 Apr 09, 2009
	
BENZYLPENICILLOYL POLYLYSINE
	
  INJECTABLE;INJECTION
	
    PRE-PEN
	
      + ALLERQUEST
	             60UMOLAR
	                      N050114 001
	
BEPOTASTINE BESILATE
	
  SOLUTION/DROPS;OPHTHALMIC

    BEPREVE
	
      + BAUSCH AND LOMB INC
	    1.5%
	                          N022288 001 Sep 08, 2009
	
BERACTANT
	
  SUSPENSION;INTRATRACHEAL
	
    SURVANTA
	
      + ABBVIE
	                 25MG/ML
	                       N020032 001 Jul 01, 1991
	
BESIFLOXACIN HYDROCHLORIDE
	
  SUSPENSION/DROPS;OPHTHALMIC

    BESIVANCE
	
      + BAUSCH AND LOMB
	        EQ 0.6% BASE
	                  N022308 001 May 28, 2009
	
BETAINE HYDROCHLORIDE
	
  FOR SOLUTION;ORAL
	
    CYSTADANE
	
      + RARE DIS THERAP
	        1GM/SCOOPFUL
	                  N020576 001 Oct 25, 1996
	
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
	
  INJECTABLE;INJECTION

    BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
	
AB       LUITPOLD               3MG/ML;EQ 3MG BASE/ML            A090747 001 Jul 31, 2009

    CELESTONE SOLUSPAN
	
AB    + MERCK SHARP DOHME       3MG/ML;EQ 3MG BASE/ML            N014602 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-44(of 371)


BETAMETHASONE DIPROPIONATE
	
  CREAM;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB       ACTAVIS MID ATLANTIC      EQ 0.05% BASE               A070885 001 Feb 03, 1987

AB    + FOUGERA PHARMS             EQ 0.05% BASE               N019137 001 Jun 26, 1984

AB       TARO                      EQ 0.05% BASE               A073552 001 Apr 30, 1992

  CREAM, AUGMENTED;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB       FOUGERA PHARMS            EQ   0.05%   BASE           A076215   001   Dec   09,   2003

AB       GLENMARK GENERICS         EQ   0.05%   BASE           A078930   001   Sep   23,   2008

AB       PERRIGO NEW YORK          EQ   0.05%   BASE           A076592   001   Dec   09,   2003

AB       TARO                      EQ   0.05%   BASE           A076543   001   Dec   09,   2003

AB       TOLMAR                    EQ   0.05%   BASE           A076603   001   Jan   23,   2004

    DIPROLENE AF
	
AB    + MERCK SHARP DOHME          EQ 0.05% BASE               N019555 001 Apr 27, 1987

  GEL, AUGMENTED;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB    + FOUGERA PHARMS             EQ 0.05% BASE               A075276 001 May 13, 2003

AB       TARO                      EQ 0.05% BASE               A076508 001 Dec 02, 2003
	
  LOTION;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB       ACTAVIS MID ATLANTIC      EQ   0.05%   BASE           A070281   001   Jul   31,   1985

AB    + FOUGERA                    EQ   0.05%   BASE           A070275   001   Aug   12,   1985

AB       PERRIGO NEW YORK          EQ   0.05%   BASE           A072538   001   Jan   31,   1990

AB       TEVA                      EQ   0.05%   BASE           A071467   001   Aug   10,   1987

  LOTION, AUGMENTED;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB       FOUGERA PHARMS            EQ 0.05% BASE               A077111 001 May 21, 2007

AB       TARO                      EQ 0.05% BASE               A077477 001 May 21, 2007

    DIPROLENE
	
AB    + MERCK SHARP DOHME          EQ 0.05% BASE               N019716 001 Aug 01, 1988

  OINTMENT;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB       ACTAVIS MID ATLANTIC      EQ 0.05% BASE               A071012 001 Feb 03, 1987

AB    + FOUGERA                    EQ 0.05% BASE               N019141 001 Sep 04, 1984

AB       TARO                      EQ 0.05% BASE               A074271 001 Sep 15, 1994

  OINTMENT, AUGMENTED;TOPICAL

    BETAMETHASONE DIPROPIONATE
	
AB       ACTAVIS MID ATLANTIC      EQ 0.05% BASE               A074304 001 Aug 31, 1995

AB       FOUGERA PHARMS            EQ 0.05% BASE               A075373 001 Jun 22, 1999

AB       TARO                      EQ 0.05% BASE               A076753 001 Oct 12, 2004

    DIPROLENE
	
AB    + MERCK SHARP DOHME          EQ 0.05% BASE               N018741 001 Jul 27, 1983
	
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
	
  OINTMENT;TOPICAL

    CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
	
AB       PERRIGO ISRAEL         0.064%;0.005%                  A200174 001 Dec 12, 2014

AB       TOLMAR                 0.064%;0.005%                  A201615 001 Jan 14, 2013

    TACLONEX
	
AB    + LEO PHARMA AS           0.064%;0.005%                  N021852 001 Jan 09, 2006
	
  SUSPENSION;TOPICAL
	
    TACLONEX
	
      + LEO PHARMA AS           0.064%;0.005%                  N022185 001 May 09, 2008
	
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
	
  CREAM;TOPICAL

    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
	
AB       ACTAVIS MID ATLANTIC   EQ 0.05% BASE;1%               A076002 001 Aug 02, 2002

AB       FOUGERA PHARMS         EQ 0.05% BASE;1%               A075502 001 Jun 05, 2001

AB       TARO                   EQ 0.05% BASE;1%               A075673 001 May 29, 2001

    LOTRISONE
	
AB    + MERCK SHARP DOHME       EQ 0.05% BASE;1%               N018827 001 Jul 10, 1984
	
  LOTION;TOPICAL

    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
	
AB       FOUGERA PHARMS         EQ 0.05% BASE;1%               A076516 001 Jun 16, 2005

AB       TARO                   EQ 0.05% BASE;1%               A076493 001 Jul 28, 2004

    LOTRISONE
	
AB    + MERCK SHARP DOHME       EQ 0.05% BASE;1%               N020010 001 Dec 08, 2000
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-45(of 371)


BETAMETHASONE VALERATE
	
  AEROSOL, FOAM;TOPICAL

    BETAMETHASONE VALERATE
	
AB       PERRIGO                 0.12%                         A078337 001 Nov 26, 2012

    LUXIQ

AB    + DELCOR ASSET             0.12%                         N020934 001 Feb 28, 1999
	
  CREAM;TOPICAL

    BETA-VAL
	
AB       TEVA                    EQ 0.1% BASE                  N018642 001 Mar 24, 1983

    BETAMETHASONE VALERATE
	
AB    + FOUGERA                  EQ 0.1% BASE                  N018861 001 Aug 31, 1983

    DERMABET
	
AB       TARO                    EQ 0.1% BASE                  A072041 001 Jan 06, 1988

    VALNAC
	
AB       ACTAVIS MID ATLANTIC    EQ 0.1% BASE                  A070050 001 Oct 10, 1984
	
  LOTION;TOPICAL

    BETA-VAL
	
AB       TEVA                    EQ 0.1% BASE                  A070072 001 Jun 27, 1985

    BETAMETHASONE VALERATE
	
AB    + FOUGERA                  EQ 0.1% BASE                  N018866 001 Aug 31, 1983

AB       STI PHARMA LLC          EQ 0.1% BASE                  A070052 001 Jul 31, 1985
	
  OINTMENT;TOPICAL

    BETAMETHASONE VALERATE
	
AB       ACTAVIS MID ATLANTIC    EQ 0.1% BASE                  A070051 001 Oct 10, 1984

AB    + FOUGERA                  EQ 0.1% BASE                  N018865 001 Aug 31, 1983
	
BETAXOLOL HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    BETAXOLOL HYDROCHLORIDE
	
AT       AKORN                   EQ 0.5% BASE                  A075386 001 Jun 30, 2000

AT       IGI LABS INC            EQ 0.5% BASE                  A075630 001 Apr 12, 2001

AT       WOCKHARDT               EQ 0.5% BASE                  A078694 001 Nov 16, 2009

    BETOPTIC
	
AT    + ALCON                    EQ 0.5% BASE                  N019270 001 Aug 30, 1985

  SUSPENSION/DROPS;OPHTHALMIC

    BETOPTIC S
	
      + ALCON                    EQ 0.25% BASE                 N019845 001 Dec 29, 1989
	
  TABLET;ORAL

    BETAXOLOL HYDROCHLORIDE
	
AB       EPIC PHARMA             10MG                          A075541   001   Oct   22,   1999

AB    +                          20MG                          A075541   002   Oct   22,   1999

AB       KVK TECH                10MG                          A078962   001   Jun   27,   2008

AB                               20MG                          A078962   002   Jun   27,   2008
	
BETHANECHOL CHLORIDE
	
  TABLET;ORAL

    BETHANECHOL CHLORIDE
	
AA       AMNEAL PHARM            5MG                           A040855   001   Nov   21,   2007

AA                               10MG                          A040855   002   Nov   21,   2007

AA                               25MG                          A040855   003   Nov   21,   2007

AA                               50MG                          A040855   004   Nov   21,   2007

AA       EMCURE USA              5MG                           A091256   001   May   04,   2010

AA                               10MG                          A091256   002   May   04,   2010

AA                               25MG                          A091256   003   May   04,   2010

AA                               50MG                          A091256   004   May   04,   2010

AA       IMPAX LABS              5MG                           A040739   001   Nov   01,   2006

AA                               10MG                          A040741   001   Nov   01,   2006

AA                               25MG                          A040740   001   Nov   01,   2006

AA                               50MG                          A040721   004   Nov   01,   2006

AA       LANNETT                 10MG                          A040704   001   Mar   27,   2008

AA                               25MG                          A040678   003   Mar   27,   2008

AA       PHARMAX                 5MG                           A040725   001   Oct   26,   2007

AA                               10MG                          A040726   001   Oct   26,   2007

AA                               25MG                          A040727   001   Oct   26,   2007

AA                               50MG                          A040728   001   Oct   26,   2007

AA       SUN PHARM INDS INC      5MG                           A040897   001   Apr   22,   2009

AA                               10MG                          A040897   002   Apr   22,   2009

AA                               25MG                          A040897   003   Apr   22,   2009

AA                               50MG                          A040897   004   Apr   22,   2009

AA       UPSHER SMITH            5MG                           A040633   001   Jun   01,   2005

AA                               10MG                          A040634   001   Jun   01,   2005

AA                               25MG                          A040635   001   Jun   01,   2005

AA                               50MG                          A040636   001   Jun   01,   2005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                              3-46(of 371)


BETHANECHOL CHLORIDE
	
  TABLET;ORAL

    BETHANECHOL CHLORIDE
	
AA       WOCKHARDT              5MG                                      A040532   001   Sep   29,   2003

AA                              10MG                                     A040533   001   Sep   29,   2003

AA                              25MG                                     A040534   001   Sep   29,   2003

AA                              50MG                                     A040518   001   Sep   29,   2003

    URECHOLINE
	
AA    + ODYSSEY PHARMS          5MG                                      A089095   001   Dec   19,   1985

AA    +                         10MG                                     A088440   001   May   29,   1984

AA    +                         25MG                                     A088441   001   May   29,   1984

AA    +                         50MG                                     A089096   001   Dec   19,   1985
	
BEXAROTENE
	
  CAPSULE;ORAL
	
    TARGRETIN
	
      + VALEANT LUXEMBOURG		    75MG                                     N021055 001 Dec 29, 1999
	
  GEL;TOPICAL
	
    TARGRETIN
	
      + VALEANT LUXEMBOURG		    1%                                       N021056 001 Jun 28, 2000
	
BICALUTAMIDE
	
  TABLET;ORAL

    BICALUTAMIDE
	
AB       ACCORD HLTHCARE        50MG                                     A078917   001   Jul   06,   2009

AB       ACTAVIS TOTOWA         50MG                                     A078634   001   Aug   28,   2009

AB       FRESENIUS KABI ONCOL   50MG                                     A079045   001   May   13,   2010

AB       MYLAN                  50MG                                     A079185   001   Jul   06,   2009

AB       SANDOZ                 50MG                                     A078575   001   Jul   06,   2009

AB       SUN PHARMA GLOBAL      50MG                                     A079110   001   Jul   06,   2009

AB       TEVA                   50MG                                     A076932   001   Jul   06,   2009

AB       ZYDUS PHARMS USA INC   50MG                                     A079089   001   Jul   06,   2009

    CASODEX
	
AB    + ASTRAZENECA             50MG                                     N020498 001 Oct 04, 1995
	
BIMATOPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    LUMIGAN
	
      + ALLERGAN                0.01%                                    N022184 001 Aug 31, 2010

  SOLUTION/DROPS;TOPICAL

    BIMATOPROST
	
AT       APOTEX INC             0.03%                                    A201894 001 Dec 01, 2014

    LATISSE
	
AT    + ALLERGAN                0.03%                                    N022369 001 Dec 24, 2008
	
BIPERIDEN HYDROCHLORIDE
	
  TABLET;ORAL
	
    AKINETON
	
      + ABBVIE		                2MG                                      N012003 001
	
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
	
  FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL
	
    PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
	
      +		 NOVEL LABS INC        5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM   A202217 001 Aug 20, 2014

                                ;N/A,5.6GM
	
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
	
  CAPSULE;ORAL
	
    PYLERA
	
      + FOREST LABS INC		       140MG;125MG;125MG                        N050786 001 Sep 28, 2006
	
BISOPROLOL FUMARATE
	
  TABLET;ORAL

    BISOPROLOL FUMARATE
	
AB       AUROBINDO PHARMA       5MG                                      A077910   001   Dec   27,   2006

AB                              10MG                                     A077910   002   Dec   27,   2006

AB       MYLAN                  5MG                                      A075831   001   Dec   14,   2005

AB                              10MG                                     A075831   002   Dec   14,   2005

AB       SANDOZ                 5MG                                      A075643   001   Nov   16,   2000

AB                              10MG                                     A075643   002   Nov   16,   2000

AB       TEVA PHARMS            5MG                                      A075644   001   Jun   26,   2001

AB                              10MG                                     A075644   002   Jun   26,   2001

AB       UNICHEM PHARMS (USA)   5MG                                      A078635   001   Aug   18,   2009

AB                              10MG                                     A078635   002   Aug   18,   2009

    ZEBETA
	
AB       TEVA WOMENS            5MG                                      N019982 002 Jul 31, 1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-47(of 371)


BISOPROLOL FUMARATE
	
  TABLET;ORAL

    ZEBETA
	
AB    +                         10MG                            N019982 001 Jul 31, 1992
	
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
	
AB         MYLAN                2.5MG;6.25MG                    A075768   001   Sep   25,   2000

AB                              5MG;6.25MG                      A075768   002   Sep   25,   2000

AB                              10MG;6.25MG                     A075768   003   Sep   25,   2000

AB         SANDOZ               2.5MG;6.25MG                    A075579   001   Sep   25,   2000

AB                              5MG;6.25MG                      A075579   002   Sep   25,   2000

AB                              10MG;6.25MG                     A075579   003   Sep   25,   2000

AB         UNICHEM              2.5MG;6.25MG                    A079106   001   Jul   28,   2010

AB                              5MG;6.25MG                      A079106   002   Jul   28,   2010

AB                              10MG;6.25MG                     A079106   003   Jul   28,   2010

    ZIAC
	
AB         TEVA WOMENS          2.5MG;6.25MG                    N020186 003 Mar 26, 1993

AB                              5MG;6.25MG                      N020186 001 Mar 26, 1993

AB    +                         10MG;6.25MG                     N020186 002 Mar 26, 1993
	
BIVALIRUDIN
	
  INJECTABLE;INTRAVENOUS
	
    ANGIOMAX
	
      + MEDICINES CO            250MG/VIAL                      N020873 001 Dec 15, 2000
	
BLEOMYCIN SULFATE
	
  INJECTABLE;INJECTION

    BLEOMYCIN SULFATE
	
AP       EUROHLTH INTL          EQ   15   UNITS   BASE/VIAL     A065042   002   Oct   17,   2001

AP                              EQ   30   UNITS   BASE/VIAL     A065042   001   Oct   17,   2001

AP    + FRESENIUS KABI USA      EQ   15   UNITS   BASE/VIAL     A065185   001   Jan   28,   2008

AP    +                         EQ   30   UNITS   BASE/VIAL     A065185   002   Jan   28,   2008

AP       HOSPIRA                EQ   15   UNITS   BASE/VIAL     A065031   001   Mar   10,   2000

AP                              EQ   30   UNITS   BASE/VIAL     A065031   002   Mar   10,   2000

AP       TEVA PHARMS USA        EQ   15   UNITS   BASE/VIAL     A065033   001   Jun   27,   2000

AP                              EQ   30   UNITS   BASE/VIAL     A065033   002   Jun   27,   2000
	
BOCEPREVIR
	
  CAPSULE;ORAL
	
    VICTRELIS
	
      + MERCK SHARP DOHME       200MG                           N202258 001 May 13, 2011
	
BORTEZOMIB
	
  INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
	
    VELCADE
	
      + MILLENNIUM PHARMS       3.5MG/VIAL                      N021602 001 May 13, 2003
	
BOSENTAN
	
  TABLET;ORAL
	
    TRACLEER
	
          ACTELION PHARMS LTD   62.5MG                          N021290 001 Nov 20, 2001
	
      +                         125MG                           N021290 002 Nov 20, 2001
	
BOSUTINIB MONOHYDRATE
	
  TABLET;ORAL
	
    BOSULIF
	
         WYETH PHARMS INC       EQ 100MG BASE                   N203341 001 Sep 04, 2012

      +                         EQ 500MG BASE                   N203341 002 Sep 04, 2012
	
BRETYLIUM TOSYLATE
	
  INJECTABLE;INJECTION
	
    BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
      + B BRAUN                 100MG/100ML                     N019121 001 Apr 29, 1986

      +                         200MG/100ML                     N019121 002 Apr 29, 1986

      +                         400MG/100ML                     N019121 003 Apr 29, 1986
	
BRIMONIDINE TARTRATE
	
  GEL;TOPICAL
	
    MIRVASO
	
      + GALDERMA LABS LP        EQ 0.33% BASE                   N204708 001 Aug 23, 2013

  SOLUTION/DROPS;OPHTHALMIC

    ALPHAGAN P
	
AT    + ALLERGAN                0.15%                           N021262 001 Mar 16, 2001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-48(of 371)


BRIMONIDINE TARTRATE
	
  SOLUTION/DROPS;OPHTHALMIC

    BRIMONIDINE TARTRATE
	
AT       AKORN                   0.2%                                     A076439   001   Mar   14,   2006
AT       ALCON PHARMS LTD        0.2%                                     A076254   001   Sep   16,   2003
AT    + BAUSCH AND LOMB          0.2%                                     A076260   001   May   28,   2003
AT       INDOCO REMEDIES         0.2%                                     A091691   001   Nov   18,   2014
AT       SANDOZ                  0.2%                                     A078075   001   Jan   30,   2008
    QOLIANA
AT       ALCON PHARMS LTD        0.15%                                    N021764 001 May 22, 2006
    ALPHAGAN P
      + ALLERGAN                 0.1%                                     N021770 001 Aug 19, 2005
BRIMONIDINE TARTRATE; BRINZOLAMIDE
	
  SUSPENSION/DROPS;OPHTHALMIC

    SIMBRINZA
	
      + ALCON RES LTD           0.2%;1%                                   N204251 001 Apr 19, 2013
	
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
	
  SOLUTION/DROPS;OPHTHALMIC

    COMBIGAN
	
      + ALLERGAN                0.2%;EQ 0.5% BASE                         N021398 001 Oct 30, 2007
	
BRINZOLAMIDE
	
  SUSPENSION/DROPS;OPHTHALMIC

    AZOPT
	
      + ALCON PHARMS LTD         1%                                       N020816 001 Apr 01, 1998
	
BROMFENAC SODIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    BROMDAY
	
AT    + BAUSCH AND LOMB INC      EQ 0.09% ACID                            N021664 002 Oct 16, 2010

    BROMFENAC SODIUM
	
AT       APOTEX INC              EQ    0.09%   ACID                       A202620   001   Jun   23,   2014

AT       HI-TECH PHARMACAL       EQ    0.09%   ACID                       A203395   001   Jan   22,   2014

AT1      APOTEX INC              EQ    0.09%   ACID                       A202435   001   Jun   19,   2014

AT1      COASTAL PHARMS          EQ    0.09%   ACID                       A201211   001   May   11,   2011

AT1      LUITPOLD                EQ    0.09%   ACID                       A202030   001   Jan   09,   2013
	
    PROLENSA
	
      + BAUSCH AND LOMB          EQ 0.07% ACID                            N203168 001 Apr 05, 2013
	
BROMOCRIPTINE MESYLATE
	
  CAPSULE;ORAL

    BROMOCRIPTINE MESYLATE
	
AB       MYLAN                   EQ 5MG BASE                              A077226 001 Apr 04, 2005

AB       ZYDUS PHARMS USA INC    EQ 5MG BASE                              A078899 001 Jul 30, 2008

    PARLODEL
	
AB    + US PHARMS HOLDINGS I     EQ 5MG BASE                              N017962 002 Mar 01, 1982
	
  TABLET;ORAL

    BROMOCRIPTINE MESYLATE
	
AB       LEK PHARMS              EQ 2.5MG BASE                            A074631 001 Jan 13, 1998

AB       MYLAN                   EQ 2.5MG BASE                            A076962 001 Sep 24, 2004

AB       PADDOCK LLC             EQ 2.5MG BASE                            A077646 001 Oct 01, 2008

    PARLODEL
	
AB    + US PHARMS HOLDINGS I     EQ 2.5MG BASE                            N017962 001
	
    CYCLOSET
	
      + VEROSCIENCE              EQ 0.8MG BASE                            N020866 001 May 05, 2009
	
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  SYRUP;ORAL

    BROMFED-DM
	
AA    + WOCKHARDT               2MG/5ML;10MG/5ML;30MG/5ML                 A088811 001 Jun 07, 1985

    BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE

AA       PADDOCK LLC            2MG/5ML;10MG/5ML;30MG/5ML                 A205292 001 Jul 15, 2014

AA       VINTAGE PHARMS         2MG/5ML;10MG/5ML;30MG/5ML                 A202940 001 Jul 21, 2014
	
BUDESONIDE
	
  AEROSOL, FOAM;RECTAL
	
    UCERIS
	
      + SALIX PHARMS INC         2MG/ACTUATION                            N205613 001 Oct 07, 2014
	
  CAPSULE;ORAL

    BUDESONIDE
	
AB       BARR LABS DIV TEVA      3MG                                      A090379 001 Apr 02, 2014

AB       MYLAN                   3MG                                      A090410 001 May 16, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                        3-49(of 371)


BUDESONIDE
	
  CAPSULE;ORAL

    ENTOCORT EC
	
AB    + ASTRAZENECA              3MG                           N021324 001 Oct 02, 2001
	
  POWDER, METERED;INHALATION
	
    PULMICORT FLEXHALER
	
         ASTRAZENECA             0.08MG/INH                    N021949 001 Jul 12, 2006
	
      +                          0.16MG/INH                    N021949 002 Jul 12, 2006
	
  SPRAY, METERED;NASAL

    BUDESONIDE
	
AB       APOTEX INC              0.032MG/INH                   A078949 001 May 12, 2014

    RHINOCORT
	
AB    + ASTRAZENECA PHARMS       0.032MG/INH                   N020746 001 Oct 01, 1999
	
  SUSPENSION;INHALATION

    BUDESONIDE
	
AN       SANDOZ                  0.25MG/2ML                    A201966   003     Sep   27,   2013

AN                               0.5MG/2ML                     A201966   002     Sep   27,   2013

AN                               1MG/2ML                       A201966   001     Sep   27,   2013

AN       TEVA PHARMS             0.25MG/2ML                    A077519   001     Nov   18,   2008

AN                               0.5MG/2ML                     A077519   002     Nov   18,   2008

AN       WATSON LABS INC         0.25MG/2ML                    A078404   001     Jul   31,   2012

AN                               0.5MG/2ML                     A078404   002     Jul   31,   2012

    PULMICORT RESPULES
	
AN       ASTRAZENECA PHARMS      0.25MG/2ML                    N020929 001 Aug 08, 2000

AN                               0.5MG/2ML                     N020929 002 Aug 08, 2000

AN    +                          1MG/2ML                       N020929 003 Aug 08, 2000

  TABLET, EXTENDED RELEASE;ORAL
	
    UCERIS
	
      + SANTARUS INC             9MG                           N203634 001 Jan 14, 2013
	
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
	
  AEROSOL, METERED;INHALATION
	
    SYMBICORT
	
      + ASTRAZENECA             0.08MG/INH;0.0045MG/INH        N021929 001 Jul 21, 2006
	
      +                         0.16MG/INH;0.0045MG/INH        N021929 002 Jul 21, 2006
	
BUMETANIDE
	
  INJECTABLE;INJECTION

    BUMETANIDE
	
AP    + BEDFORD                 0.25MG/ML                      A074441 001 Jan 27, 1995

AP       HIKMA MAPLE            0.25MG/ML                      A079196 001 Apr 30, 2008

AP       HOSPIRA                0.25MG/ML                      A074332 001 Oct 31, 1994
	
  TABLET;ORAL

    BUMETANIDE
	
AB       IVAX SUB TEVA PHARMS   0.5MG                          A074225   001     Apr   24,   1995

AB                              1MG                            A074225   002     Apr   24,   1995

AB                              2MG                            A074225   003     Apr   24,   1995

AB       SANDOZ                 0.5MG                          A074700   001     Nov   21,   1996

AB                              1MG                            A074700   002     Nov   21,   1996

AB    +                         2MG                            A074700   003     Nov   21,   1996
	
BUPIVACAINE
	
  INJECTABLE, LIPOSOMAL;INJECTION
	
    EXPAREL
	
      + PACIRA PHARMS INC       266MG/20ML (13.3MG/ML)         N022496 002 Oct 28, 2011
	
BUPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    BUPIVACAINE HYDROCHLORIDE
	
AP       HOSPIRA                0.25%                          A070583   001     Feb 17, 1987

AP                              0.25%                          A070586   001     Mar 03, 1987

AP                              0.25%                          A070590   001     Feb 17, 1987

AP                              0.25%                          N018053   002
	
AP                              0.5%                           A070584   001     Feb 17, 1986

AP                              0.5%                           A070597   001     Mar 03, 1987

AP                              0.5%                           A070609   001     Mar 03, 1987

AP                              0.5%                           N018053   001
	
AP                              0.75%                          A070585   001     Mar 03, 1987

AP                              0.75%                          N018053   003
	
AP       SAGENT AGILA           0.25%                          A091503   001     Oct 18, 2011

AP                              0.5%                           A091503   002     Oct 18, 2011

    BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
	
AP       AUROBINDO PHARMA LTD   0.25%                          A203895 001 Nov 05, 2013

AP                              0.5%                           A203895 002 Nov 05, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-50(of 371)


BUPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
	
AP                              0.75%                           A203895   003   Nov   05,   2013

AP       SAGENT AGILA           0.25%                           A091487   002   Oct   18,   2011

AP                              0.5%                            A091487   001   Oct   18,   2011

AP                              0.75%                           A091487   003   Oct   18,   2011

    MARCAINE HYDROCHLORIDE
	
AP    + HOSPIRA                 0.25%                           N016964 001
	
AP    +                         0.5%                            N016964 006
	
    MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
	
AP    + HOSPIRA                 0.25%                           N016964 012
AP    +                         0.5%                            N016964 005
AP    +                         0.75%                           N016964 009
    SENSORCAINE
AP       FRESENIUS KABI USA     0.25%                           A070552   001 May 21, 1986
AP                              0.25%                           N018304   001
AP                              0.5%                            A070553   001 May 21, 1986
AP                              0.5%                            N018304   002
AP                              0.75%                           A070554   001 May 21, 1986
AP                              0.75%                           N018304   003
  INJECTABLE;SPINAL
    BUPIVACAINE HYDROCHLORIDE
AP       HOSPIRA                0.75%                           A071810 001 Dec 11, 1987
    MARCAINE
AP    + HOSPIRA                 0.75%                           N018692 001 May 04, 1984
    SENSORCAINE
AP       FRESENIUS KABI USA     0.75%                           A071202 001 Apr 15, 1987
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
	
  INJECTABLE;INJECTION

    BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
	
AP    + HOSPIRA                 0.5%;0.005MG/ML                 A071168   001   Jun   16,   1988

AP                              0.5%;0.005MG/ML                 A071170   001   Jun   16,   1988
	
      +		                       0.25%;0.005MG/ML                A071165   001   Jun   16,   1988
	
                                0.25%;0.005MG/ML                A071167   001   Jun   16,   1988
	
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
	
  INJECTABLE;INJECTION

    BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
	
AP       SEPTODONT              0.5%;0.0091MG/ML                A077250 001 Sep 27, 2006

    BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE

AP    + HOSPIRA                 0.5%;0.0091MG/ML                N022046 001 Jul 13, 1983

    MARCAINE HYDROCHLORIDE W/ EPINEPHRINE

AP    + HOSPIRA                 0.25%;0.0091MG/ML               N016964 004
	
AP    +                         0.5%;0.0091MG/ML                N016964 008
	
    MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE

AP    + HOSPIRA                 0.25%;0.0091MG/ML               N016964 013
	
AP    +                         0.5%;0.0091MG/ML                N016964 007
	
AP    +                         0.75%;0.0091MG/ML               N016964 010
	
    SENSORCAINE
	
AP       FRESENIUS KABI USA     0.25%;0.0091MG/ML               A070966   001   Oct   13,   1987

AP                              0.25%;0.0091MG/ML               A070967   001   Oct   13,   1987

AP                              0.5%;0.0091MG/ML                A070968   001   Oct   13,   1987

AP                              0.5%;0.0091MG/ML                N018304   004   Sep   02,   1983

AP                              0.75%;0.0091MG/ML               N018304   005   Sep   02,   1983
	
BUPRENORPHINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    BUTRANS
	
          PURDUE PHARMA LP		    5MCG/HR                         N021306   001   Jun   30,   2010
	
                                7.5MCG/HR                       N021306   005   Jun   30,   2014
	
                                10MCG/HR                        N021306   002   Jun   30,   2010
	
                                15MCG/HR                        N021306   004   Jul   25,   2013
	
      +		                       20MCG/HR                        N021306   003   Jun   30,   2010
	
BUPRENORPHINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    BUPRENEX
	
AP    + RECKITT BENCKISER         EQ   0.3MG BASE/ML            N018401 001
	
    BUPRENORPHINE HYDROCHLORIDE
	
AP       EUROHLTH INTL            EQ   0.3MG BASE/ML            A076931 001 Mar 02, 2005

AP       HOSPIRA                  EQ   0.3MG BASE/ML            A074137 001 Jun 03, 1996

AP       LUITPOLD                 EQ   0.3MG BASE/ML            A078331 001 Mar 27, 2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-51(of 371)


BUPRENORPHINE HYDROCHLORIDE
	
  TABLET;SUBLINGUAL

    BUPRENORPHINE HYDROCHLORIDE
	
AB       BARR                     EQ   2MG   BASE               A090360   001   May   07,   2010

AB                                EQ   8MG   BASE               A090360   002   May   07,   2010

AB       ETHYPHARM                EQ   2MG   BASE               A090622   001   Sep   24,   2010

AB                                EQ   8MG   BASE               A090622   002   Sep   24,   2010

AB       ROXANE                   EQ   2MG   BASE               A078633   001   Oct   08,   2009

AB    +                           EQ   8MG   BASE               A078633   002   Oct   08,   2009
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
	
  FILM;BUCCAL
	
    BUNAVAIL
	
          BIODELIVERY SCI INTL  EQ 2.1MG BASE;EQ 0.3MG BASE     N205637 001 Jun 06, 2014
	
                                EQ 4.2MG BASE;EQ 0.7MG BASE     N205637 002 Jun 06, 2014
	
      +                         EQ 6.3MG BASE;EQ 1MG BASE       N205637 003 Jun 06, 2014
	
  FILM;SUBLINGUAL
	
    SUBOXONE
	
          RECKITT BENCKISER		   EQ 2MG BASE;EQ 0.5MG BASE       N022410   001   Aug   30,   2010

                                EQ 4MG BASE;EQ 1MG BASE         N022410   003   Aug   10,   2012

                                EQ 8MG BASE;EQ 2MG BASE         N022410   002   Aug   30,   2010

      +                         EQ 12MG BASE;EQ 3MG BASE        N022410   004   Aug   10,   2012

  TABLET;SUBLINGUAL

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
	
AB        ACTAVIS ELIZABETH     EQ 2MG BASE;EQ 0.5MG BASE       A091422   001   Feb   22,   2013

AB    +                         EQ 8MG BASE;EQ 2MG BASE         A091422   002   Feb   22,   2013

AB        AMNEAL PHARMS         EQ 8MG BASE;EQ 2MG BASE         A203136   002   Feb   22,   2013

AB        ROXANE                EQ 2MG BASE;EQ 0.5MG BASE       A203326   001   Jun   27,   2014

AB                              EQ 8MG BASE;EQ 2MG BASE         A203326   002   Jun   27,   2014

AB        TEVA PHARMS USA       EQ 2MG BASE;EQ 0.5MG BASE       A091149   001   Sep   08,   2014

AB                              EQ 8MG BASE;EQ 2MG BASE         A091149   002   Sep   08,   2014

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
	
AB        AMNEAL PHARMS         EQ 2MG BASE;EQ 0.5MG BASE       A203136 001 Feb 22, 2013
	
    ZUBSOLV
	
          OREXO AB              EQ 1.4MG BASE;EQ 0.36MG BASE    N204242   001   Jul   03,   2013
	
      +		                       EQ 5.7MG BASE;EQ 1.4MG BASE     N204242   002   Jul   03,   2013
	
                                EQ 8.6MG BASE;EQ 2.1MG BASE     N204242   003   Dec   11,   2014
	
                                EQ 11.4MG BASE;EQ 2.9MG BASE    N204242   004   Dec   11,   2014
	
BUPROPION HYDROBROMIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    APLENZIN
	
         VALEANT BERMUDA         174MG                          N022108 001 Apr 23, 2008

                                 348MG                          N022108 002 Apr 23, 2008

      +                          522MG		                        N022108 003 Apr 23, 2008
	
BUPROPION HYDROCHLORIDE
	
  TABLET;ORAL

    BUPROPION HYDROCHLORIDE
	
AB       APOTEX INC              75MG                           A076143   001   Jan   17,   2006

AB                               100MG                          A076143   002   Jan   17,   2006

AB       MYLAN                   75MG                           A075491   001   Apr   17,   2000

AB                               100MG                          A075491   002   Apr   17,   2000

AB       SANDOZ                  75MG                           A075584   001   Feb   07,   2000

AB                               100MG                          A075584   002   Feb   07,   2000

    WELLBUTRIN
	
AB       GLAXOSMITHKLINE         75MG                           N018644 002 Dec 30, 1985

AB    +                          100MG                          N018644 003 Dec 30, 1985
	
  TABLET, EXTENDED RELEASE;ORAL

    BUPROPION HYDROCHLORIDE
	
AB1      ACTAVIS LABS FL INC     100MG                          A079095   001   Mar   24,   2009

AB1                              150MG                          A079095   002   Mar   24,   2009

AB1                              200MG                          A079095   003   Mar   24,   2009

AB1      ANCHEN PHARMS           100MG                          A091459   001   Jun   09,   2011

AB1                              150MG                          A091459   002   Jun   09,   2011

AB1                              200MG                          A091459   003   Jun   09,   2011

AB1      IMPAX LABS              100MG                          A075913   001   Jan   28,   2004

AB1                              150MG                          A075913   002   Mar   22,   2004

AB1                              200MG                          A076711   001   Dec   03,   2004

AB1      JUBILANT GENERICS       100MG                          A202774   001   Oct   11,   2013

AB1                              150MG                          A202774   002   Oct   11,   2013

AB1                              200MG                          A202774   003   Oct   11,   2013

AB1      MYLAN                   100MG                          A090325   001   Apr   08,   2010

AB1                              150MG                          A090325   002   Apr   08,   2010
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-52(of 371)


BUPROPION HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

     BUPROPION HYDROCHLORIDE
	
AB1
	                            200MG
	                        A090325   003   Apr   08,   2010

AB1        SANDOZ
	              100MG
	                        A075932   001   Nov   25,   2003

AB1
	                            150MG
	                        A075932   002   Mar   22,   2004

AB1
	                            200MG
	                        A075932   003   Jun   22,   2005

AB1        SUN PHARMA GLOBAL
	   100MG
	                        A078866   001   Apr   06,   2010

AB1
	                            150MG
	                        A078866   002   Apr   06,   2010

AB1
	                            200MG
	                        A078866   003   Apr   06,   2010

AB1        TORRENT PHARMS LTD
	  100MG
	                        A203969   001   Oct   31,   2014

AB1
	                            150MG
	                        A203969   002   Oct   31,   2014

AB1
	                            200MG
	                        A203969   003   Oct   31,   2014

AB1        WATSON LABS INC
	     100MG
	                        A077455   001   Jul   19,   2010

AB1
	                            150MG
	                        A077455   002   Mar   12,   2008

AB1
	                            200MG
	                        A077455   003   Jul   19,   2010

AB1        WOCKHARDT LTD
	       100MG
	                        A201331   001   Aug   30,   2012

AB1
	                            150MG
	                        A201331   002   Aug   30,   2012

AB1
	                            200MG
	                        A201331   003   Aug   30,   2012
	
     WELLBUTRIN SR
	
AB1        GLAXOSMITHKLINE       100MG
	                        N020358 002 Oct 04, 1996

AB1                              150MG
	                        N020358 003 Oct 04, 1996

AB1 +                            200MG
	                        N020358 004 Jun 14, 2002
	
     BUPROPION HYDROCHLORIDE
AB2        ACTAVIS               150MG
	                        A077475   001   Mar   12,   2008

AB2        ACTAVIS LABS FL INC   150MG
	                        A079094   001   Mar   24,   2009

AB2        ANCHEN PHARMS         150MG
	                        A091520   001   Jun   09,   2011

AB2        IMPAX LABS            150MG
	                        A075914   001   May   27,   2004

AB2        JUBILANT GENERICS     150MG
	                        A202775   001   Oct   11,   2013

AB2        MYLAN                 150MG
	                        A090941   001   May   03,   2010
	
     ZYBAN
AB2 + GLAXOSMITHKLINE            150MG
	                        N020711 003 May 14, 1997
	
     BUPROPION HYDROCHLORIDE
AB3        ACTAVIS LABS FL INC   150MG
	                        A077715   001   Nov   26,   2008

AB3        ANCHEN PHARMS         150MG
	                        A077284   001   Dec   14,   2006

AB3                              300MG
	                        A077284   002   Dec   14,   2006

AB3        IMPAX LABS            150MG
	                        A077415   001   Nov   26,   2008

AB3        MYLAN                 150MG
	                        A090942   001   Jul   14,   2010

AB3                              300MG
	                        A090942   002   Jul   14,   2010

AB3        SUN PHARMA GLOBAL     150MG
	                        A200695   001   Dec   18,   2014

AB3        WATSON LABS INC       150MG
	                        A077285   001   Nov   26,   2008

AB3                              300MG
	                        A077285   002   Aug   15,   2008

AB3        WOCKHARDT LTD         150MG
	                        A202189   001   Nov   21,   2012

AB3        ZYDUS PHARMS USA INC  300MG
	                        A201567   001   Jan   17,   2014
	
     WELLBUTRIN XL
AB3        VALEANT INTL          150MG
	                        N021515 001 Aug 28, 2003

AB3 +                            300MG
	                        N021515 002 Aug 28, 2003
	
     FORFIVO XL
       + EDGEMONT PHARMS LLC     450MG
	                        N022497 001 Nov 10, 2011
	
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    CONTRAVE
      + TAKEDA PHARMS USA        90MG;8MG                       N200063 001 Sep 10, 2014
	
BUSPIRONE HYDROCHLORIDE
  TABLET;ORAL
    BUSPIRONE HYDROCHLORIDE
AB       ACCORD HLTHCARE         5MG                            A202557   001   Dec   30,   2014

AB                               7.5MG                          A202557   002   Dec   30,   2014

AB                               10MG                           A202557   003   Dec   30,   2014

AB                               15MG                           A202557   004   Dec   30,   2014

AB                               30MG                           A202557   005   Dec   30,   2014

AB       DR REDDYS LABS LTD      5MG                            A078246   001   Feb   27,   2009

AB                               10MG                           A078246   002   Feb   27,   2009

AB                               15MG                           A078246   003   Feb   27,   2009

AB                               30MG                           A078246   004   Feb   27,   2009

AB       MYLAN                   5MG                            A075272   001   Mar   01,   2002

AB                               5MG                            A075467   001   Feb   28,   2002

AB                               7.5MG                          A075467   002   Mar   28,   2001

AB                               10MG                           A075272   002   Mar   01,   2002

AB                               10MG                           A075467   003   Feb   28,   2002

AB                               15MG                           A075272   003   Mar   28,   2001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-53(of 371)


BUSPIRONE HYDROCHLORIDE
	
  TABLET;ORAL

    BUSPIRONE HYDROCHLORIDE
	
AB                               15MG
	                         A075467   004   Feb   28,   2002

AB                               30MG
	                         A076008   001   Jun   28,   2001

AB       PROSAM LABS             30MG
	                         A078302   001   Dec   17,   2007

AB       STRIDES ARCOLAB LTD     5MG
	                          A202330   001   Aug   25,   2014

AB                               10MG
	                         A202330   002   Aug   25,   2014

AB                               15MG
	                         A202330   003   Aug   25,   2014

AB                               30MG
	                         A202330   004   Aug   25,   2014

AB       TEVA                    5MG
	                          A075022   001   Feb   28,   2002

AB                               10MG
	                         A075022   002   Feb   28,   2002

AB    +                          15MG
	                         A075022   003   Feb   28,   2002

AB                               30MG
	                         A075022   004   Mar   25,   2004

AB       WATSON LABS             5MG
	                          A074253   001   Mar   28,   2001

AB                               10MG
	                         A074253   002   Mar   28,   2001

AB                               15MG
	                         A074253   003   Mar   13,   2002

AB       ZYDUS PHARMS USA INC    5MG
	                          A078888   001   Feb   07,   2014

AB                               10MG
	                         A078888   002   Feb   07,   2014

AB                               15MG
	                         A078888   003   Feb   07,   2014

AB                               30MG
	                         A078888   004   Feb   07,   2014
	
BUSULFAN
	
  INJECTABLE;INJECTION
	
    BUSULFEX
	
      + OTSUKA PHARM
	           6MG/ML
	                       N020954 001 Feb 04, 1999
	
  TABLET;ORAL
	
    MYLERAN
	
      + ASPEN GLOBAL
	           2MG
	                          N009386 001
	
BUTABARBITAL SODIUM
	
  ELIXIR;ORAL
	
    BUTISOL SODIUM
	
      + MEDA PHARMS
	            30MG/5ML
	                     A085380 001
	
  TABLET;ORAL
	
    BUTISOL SODIUM
	
      + MEDA PHARMS
	            30MG
	                         N000793 004
	
      +
	                        50MG
	                         N000793 003
	
BUTENAFINE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    MENTAX
	
      + MYLAN
	                  1%
	                           N020524 001 Oct 18, 1996
	
BUTOCONAZOLE NITRATE
	
  CREAM;VAGINAL
	
    BUTOCONAZOLE NITRATE
	
      + PERRIGO ISRAEL
	         2%
	                           A200923 001 May 18, 2012
	
BUTORPHANOL TARTRATE
	
  INJECTABLE;INJECTION

     BUTORPHANOL TARTRATE
	
AP        BEDFORD
	              2MG/ML
                        A075046 001 Aug 12, 1998

AP        HIKMA FARMACEUTICA
	   1MG/ML
                        A078400 001 May 01, 2009

AP
	                             2MG/ML
	                       A078400 002 May 01, 2009
	
     BUTORPHANOL TARTRATE PRESERVATIVE FREE
	
AP        BEDFORD
	              1MG/ML
                        A075045   001   Aug   12,   1998

AP
	                             2MG/ML
                        A075045   002   Aug   12,   1998

AP        HOSPIRA
	              1MG/ML
                        A074626   001   Jan   23,   1997

AP
	                             2MG/ML
	                       A074626   002   Jan   23,   1997
	
  SPRAY, METERED;NASAL

     BUTORPHANOL TARTRATE
	
AB     + MYLAN                   1MG/SPRAY
                     A075759 001 Aug 08, 2001

AB        NOVEX                  1MG/SPRAY
                     A075499 001 Dec 04, 2002

AB        ROXANE                 1MG/SPRAY
	                    A075824 001 Mar 12, 2002
	
CABAZITAXEL
	
  SOLUTION;IV (INFUSION)

    JEVTANA KIT
	
      + SANOFI AVENTIS US
	      60MG/1.5ML (40MG/ML)
	         N201023 001 Jun 17, 2010
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                     3-54(of 371)


CABERGOLINE
	
  TABLET;ORAL

    CABERGOLINE
	
AB       ACTAVIS LABS FL INC    0.5MG                                          A078035   001   Apr   21,   2008

AB       APOTEX CORP            0.5MG                                          A201503   001   Mar   08,   2013

AB       IMPAX LABS INC         0.5MG                                          A077843   001   Jul   03,   2007

AB       IVAX SUB TEVA PHARMS   0.5MG                                          A077750   001   Mar   07,   2007

AB       MYLAN PHARMS INC       0.5MG                                          A202947   001   Dec   02,   2013

AB    + PAR PHARM               0.5MG                                          A076310   001   Dec   29,   2005
	
CABOZANTINIB S-MALATE
	
  CAPSULE;ORAL
	
    COMETRIQ
	
         EXELIXIS               EQ 20MG BASE                                   N203756 001 Nov 29, 2012
	
      +                         EQ 80MG BASE                                   N203756 002 Nov 29, 2012
	
CAFFEINE CITRATE
	
  SOLUTION;INTRAVENOUS

    CAFCIT
	
AP    + EUROHLTH INTL           EQ 30MG BASE/3ML (EQ 10MG BASE/ML)             N020793 001 Sep 21, 1999

    CAFFEINE CITRATE
	
AP       EXELA PHARMA SCIENCE   EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A077233   001   Sep   21,   2006

AP       FRESENIUS KABI USA     EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A077997   001   Jul   20,   2007

AP       LUITPOLD               EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A077906   001   May   15,   2007

AP       SAGENT PHARMS          EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A090827   001   Aug   29,   2012

AP       SUN PHARMA GLOBAL      EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A090077   001   Sep   30,   2009

  SOLUTION;ORAL

    CAFCIT
	
AA    + EUROHLTH INTL           EQ 30MG BASE/3ML (EQ 10MG BASE/ML)             N020793 002 Apr 12, 2000

    CAFFEINE CITRATE
	
AA       EXELA PHARMA SCS LLC   EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A077304   001   Sep   21,   2006

AA       FRESENIUS KABI USA     EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A078002   001   Jan   31,   2008

AA       LUITPOLD               EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A090064   001   Nov   20,   2009

AA       SAGENT PHARMS          EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A091102   001   Aug   29,   2012

AA       SUN PHARMA GLOBAL      EQ   30MG   BASE/3ML   (EQ   10MG   BASE/ML)   A090357   001   Sep   30,   2009
	
CAFFEINE; ERGOTAMINE TARTRATE
	
  SUPPOSITORY;RECTAL
	
    MIGERGOT
	
      + CREALTA PHARMS LLC      100MG;2MG                                      A086557 001 Oct 04, 1983
	
  TABLET;ORAL

    CAFERGOT
	
AA    + SANDOZ                  100MG;1MG                                      A084294 001
	
    ERGOTAMINE TARTRATE AND CAFFEINE
	
AA       HIKMA INTL PHARMS      100MG;1MG                                      A040510 001 Sep 17, 2004

AA       MIKART                 100MG;1MG                                      A040590 001 Sep 16, 2005
	
CALCIPOTRIENE
	
  AEROSOL, FOAM;TOPICAL
	
    SORILUX
	
      + STIEFEL LABS INC        0.005%                                         N022563 001 Oct 06, 2010
	
  CREAM;TOPICAL

    CALCIPOTRIENE
	
AB       TOLMAR                 0.005%                                         A200935 001 May 30, 2012

    DOVONEX
	
AB    + LEO PHARMA AS           0.005%                                         N020554 001 Jul 22, 1996
	
  OINTMENT;TOPICAL
	
    CALCIPOTRIENE
	
      + GLENMARK GENERICS       0.005%                                         A090633 001 Mar 24, 2010
	
  SOLUTION;TOPICAL

    CALCIPOTRIENE
	
AT       FOUGERA PHARMS         0.005%                                         A078305   001   May   06,   2008

AT       G AND W LABS INC       0.005%                                         A078468   001   Mar   24,   2011

AT       HI TECH PHARMA         0.005%                                         A077579   001   Nov   19,   2009

AT    + TOLMAR                  0.005%                                         A077029   001   Nov   20,   2009
	
CALCITONIN SALMON
	
  INJECTABLE;INJECTION
	
    MIACALCIN
	
      + SEBELA IRELAND LTD      200 IU/ML                                      N017808 002 Mar 29, 1991
	
  SPRAY, METERED;NASAL

    CALCITONIN-SALMON
	
AB       APOTEX INC             200 IU/SPRAY                                   A076396 001 Nov 17, 2008

AB       PAR PHARM              200 IU/SPRAY                                   A076979 001 Jun 08, 2009
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-55(of 371)


CALCITONIN SALMON
	
  SPRAY, METERED;NASAL

    MIACALCIN
	
AB    + SEBELA IRELAND LTD        200 IU/SPRAY                 N020313 002 Aug 17, 1995
	
CALCITONIN SALMON RECOMBINANT
	
  SPRAY, METERED;NASAL
	
    FORTICAL
	
      + UPSHER SMITH              200 IU/SPRAY                 N021406 001 Aug 12, 2005
	
CALCITRIOL
	
  CAPSULE;ORAL

    CALCITRIOL
	
AB       BANNER PHARMACAPS        0.25MCG                      A091174   001   May   24,   2013

AB                                0.5MCG                       A091174   002   May   24,   2013

AB       ROXANE                   0.25MCG                      A076917   001   Mar   27,   2006

AB       STRIDES ARCOLAB LTD      0.25MCG                      A091356   001   Dec   12,   2014

AB                                0.5MCG                       A091356   002   Dec   12,   2014

AB       TEVA                     0.25MCG                      A075765   001   Oct   12,   2001

AB                                0.5MCG                       A075765   002   Oct   12,   2001

    ROCALTROL
	
AB       VALIDUS PHARMS           0.25MCG                      N018044 001
	
AB    +                           0.5MCG                       N018044 002
	
  INJECTABLE;INJECTION

    CALCIJEX
	
AP    + ABBVIE                    0.001MG/ML                   N018874 001 Sep 25, 1986

AP    +                           0.002MG/ML                   N018874 002 Sep 25, 1986

    CALCITRIOL
	
AP       AKORN                    0.001MG/ML                   A078066   001   Jan   29,   2008

AP                                0.002MG/ML                   A078066   002   Jan   29,   2008

AP       FRESENIUS KABI USA       0.001MG/ML                   A075836   001   Dec   31,   2002

AP                                0.002MG/ML                   A075836   002   Dec   31,   2002

AP       FRESENIUS MEDCL          0.001MG/ML                   A075766   001   Feb   20,   2003

AP                                0.002MG/ML                   A075766   002   Feb   20,   2003

AP       LUITPOLD                 0.001MG/ML                   A075746   001   Sep   26,   2003

AP                                0.002MG/ML                   A075746   002   Sep   26,   2003

AP       ROCKWELL MEDCL           0.001MG/ML                   A076206   001   Sep   17,   2003

AP       SAGENT PHARMS            0.001MG/ML                   A077102   001   Feb   08,   2006
	
  OINTMENT;TOPICAL
	
    VECTICAL
	
      + GALDERMA LABS LP          3MCG/GM                      N022087 001 Jan 23, 2009
	
  SOLUTION;ORAL

    CALCITRIOL
	
AA       ROXANE                   1MCG/ML                      A076242 001 Jul 18, 2003

    ROCALTROL
	
AA    + VALIDUS PHARMS            1MCG/ML                      N021068 001 Nov 20, 1998
	
CALCIUM ACETATE
	
  CAPSULE;ORAL

    CALCIUM ACETATE
	
AB       AMNEAL PHARMS            EQ   169MG   CALCIUM         A201658   001   Oct   06,   2014

AB       INVAGEN PHARMS           EQ   169MG   CALCIUM         A203135   001   Feb   07,   2013

AB       PADDOCK LLC              EQ   169MG   CALCIUM         A091312   001   Jun   01,   2012

AB       ROXANE                   EQ   169MG   CALCIUM         A077728   001   Feb   26,   2008

    PHOSLO GELCAPS
	
AB    + FRESENIUS MEDCL           EQ 169MG CALCIUM             N021160 003 Apr 02, 2001

  SOLUTION;ORAL
	
    PHOSLYRA
	
      + FRESENIUS MEDCL           EQ 169MG CALCIUM/5ML         N022581 001 Apr 18, 2011

  TABLET;ORAL

    CALCIUM ACETATE
	
AB       INVAGEN PHARMS           EQ 169MG CALCIUM             A202420 001 Feb 05, 2013

AB       PADDOCK LLC              EQ 169MG CALCIUM             A091561 001 Apr 13, 2011

    ELIPHOS
	
AB    + CYPRESS PHARM             EQ 169MG CALCIUM             A078502 001 Nov 25, 2008
	
CALCIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
	
      + HOSPIRA                 100MG/ML                       N021117 001 Jan 28, 2000
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                               3-56(of 371)


CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM

BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
	
  SOLUTION;IRRIGATION

    BSS PLUS
	
AT    + ALCON		                 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/M   N018469 001
	
                                L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M

                                L
	
    ENDOSOL EXTRA
	
AT    + AKORN		                 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/M   N020079 001 Nov 27, 1991

                                L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M

                                L
	
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM

BICARBONATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0
  N021703 010 Oct     10, 2008
	
                                5GM/1000ML;0.157GM/1000ML;2.21GM/1000ML

                                ;7.07GM/1000ML

    PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0
  N021703 011 Oct     10, 2008
	
                                5GM/1000ML;0.314GM/1000ML;2.21GM/1000ML

                                ;7.07GM/1000ML

    PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;
  N021703 013 Oct     10, 2008
	
                                3.05GM/1000ML;0.314GM/1000ML;2.21GM/100

                                0ML;7.07GM/1000ML

    PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;
  N021703 006 Oct     25, 2006
	
                                3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;

                                6.46GM/1000ML

    PRISMASOL BGK 2/0 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.0
  N021703 002 Oct     25, 2006
	
                                3GM/1000ML;0.157GM/1000ML;3.09GM/1000ML

                                ;6.46GM/1000ML

    PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;
  N021703 003 Oct     25, 2006
	
                                2.03GM/1000ML;0.157GM/1000ML;3.09GM/100

                                0ML;6.46GM/1000ML

    PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.4
  N021703 015 Oct     10, 2008
	
                                4GM/1000ML;0.314GM/1000ML;3.09GM/1000ML

                                ;6.46GM/1000ML

    PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;
  N021703 004 Oct     25, 2006
	
                                3.05GM/1000ML;0.314GM/1000ML;3.09GM/100

                                0ML;6.46GM/1000ML

    PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44
  N021703 014 Oct     10, 2008
	
                                GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46

                                GM/1000ML

    PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER

      +		 GAMBRO RENAL PRODS    5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2
  N021703 001 Oct     25, 2006
	
                                .03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6

                                .46GM/1000ML
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM

BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
	
  SOLUTION;IRRIGATION
	
    NAVSTEL
	
      +		 ALCON PHARMS LTD      0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/M   N022193 001 Jul 24, 2008

                                L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M

                                L
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM

CHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER
	
      +		 B BRAUN               37MG/100ML;5GM/100ML;31MG/100ML;120MG/1   N019864 001 Jun 10, 1993

                                00ML;330MG/100ML;88MG/100ML
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM

CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER
	
      +		 BAXTER HLTHCARE       37MG/100ML;5GM/100ML;30MG/100ML;119MG/1   N017390 001
	
                                00ML;161MG/100ML;94MG/100ML;138MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                                    3-57(of 371)


CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  SOLUTION;INTRAPERITONEAL
	
    DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER

      +		 B BRAUN               510MG/100ML;30GM/100ML;200MG/100ML;9.2G   N018807   001 Aug 26, 1983

                                M/100ML;9.6GM/100ML

      +		                       510MG/100ML;30GM/100ML;200MG/100ML;9.4G   N018807   003 Aug 26, 1983

                                M/100ML;11GM/100ML

    DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER

      +		 B BRAUN               510MG/100ML;50GM/100ML;200MG/100ML;9.2G   N018807   002 Aug 26, 1983

                                M/100ML;9.6GM/100ML

      +		                       510MG/100ML;50GM/100ML;200MG/100ML;9.4G   N018807   004 Aug 26, 1983

                                M/100ML;11GM/100ML
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  SOLUTION;INTRAPERITONEAL

    DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5
  N018379   002
	
                                67MG/100ML;392MG/100ML

AT                              25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5
  N018883   001 Nov 30, 1984
	
                                67MG/100ML;392MG/100ML

    DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  N018883   004 Nov 30, 1984
	
                                38MG/100ML;448MG/100ML

    DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  N020171   001 Aug 19, 1992
	
                                38MG/100ML;448MG/100ML

    DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5
  N018379   003
	
                                67MG/100ML;392MG/100ML

AT                              25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5
  N018883   002 Nov 30, 1984
	
                                67MG/100ML;392MG/100ML

    DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  N018883   005 Nov 30, 1984
	
                                38MG/100ML;448MG/100ML

    DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  N020171   002 Aug 19, 1992
	
                                38MG/100ML;448MG/100ML

    DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;5
  N018379   007 Jun 24, 1988
	
                                67MG/100ML;392MG/100ML

    DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;
  N018379   001
	
                                567MG/100ML;392MG/100ML

AT                              25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;
  N018883   003 Nov 30, 1984
	
                                567MG/100ML;392MG/100ML

    DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;
  N018883   006 Nov 30, 1984
	
                                538MG/100ML;448MG/100ML

    DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;
  N020171   003 Aug 19, 1992
	
                                538MG/100ML;448MG/100ML

    DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  N018379   004 Jul 07, 1982
	
                                38MG/100ML;448MG/100ML

    DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  N018379   005 Jul 07, 1982
	
                                38MG/100ML;448MG/100ML

    DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;5
  N018379   008 Jun 24, 1988
	
                                38MG/100ML;448MG/100ML

    DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

AT       FRESENIUS MEDCL        25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;
  N018379   006 Jul 07, 1982
	
                                538MG/100ML;448MG/100ML

    DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5
  N017512   001
	
                                67MG/100ML;392MG/100ML

    DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5
  N017512   003
	
                                67MG/100ML;392MG/100ML

    DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;
  N017512   002
	
                                567MG/100ML;392MG/100ML

    DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  N020183   001 Dec 04, 1992
	
                                38MG/100ML;448MG/100ML

    DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;5
  N017512   007 Jul 09, 1984
	
                                67MG/100ML;392MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                                    3-58(of 371)


CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  SOLUTION;INTRAPERITONEAL

    DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;5
  N017512   008 Jul 09, 1984
	
                                67MG/100ML;392MG/100ML

    DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;5
  N017512   010 Nov 18, 1985
	
                                67MG/100ML;392MG/100ML

    DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;
  N017512   009 Jul 09, 1984
	
                                567MG/100ML;392MG/100ML

    DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  N017512   004
	
                                38MG/100ML;448MG/100ML

AT                              25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  N020163   001 Dec 04, 1992
	
                                38MG/100ML;448MG/100ML

    DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  N017512   005
	
                                38MG/100ML;448MG/100ML

AT                              25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  N020163   002 Dec 04, 1992
	
                                38MG/100ML;448MG/100ML

    DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;5
  N017512   011 Nov 18, 1985
	
                                38MG/100ML;448MG/100ML

    DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

AT       BAXTER HLTHCARE        25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;
  N017512   006
	
                                538MG/100ML;448MG/100ML

AT                              25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;
  N020163   003 Dec 04, 1992
	
                                538MG/100ML;448MG/100ML

    DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER

         B BRAUN                26MG/100ML;1.5GM/100ML;5MG/100ML;530MG/
  N018460   007 Jan 29, 1986
                                100ML;450MG/100ML

    DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER

         B BRAUN                26MG/100ML;2.5GM/100ML;5MG/100ML;530MG/
  N018460   005 Nov 02, 1983
                                100ML;450MG/100ML

    DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER

         B BRAUN                26MG/100ML;4.25GM/100ML;5MG/100ML;530MG
  N018460   009 Jan 29, 1986
                                /100ML;450MG/100ML

    DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  N020183   002 Dec 04, 1992
                                38MG/100ML;448MG/100ML

    DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;5
  N020183   003 Dec 04, 1992
                                38MG/100ML;448MG/100ML

    DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

         BAXTER HLTHCARE        18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;
  N020183   004 Dec 04, 1992
                                538MG/100ML;448MG/100ML
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM

CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
	
  INJECTABLE;INTRATHECAL
	
    ELLIOTTS B SOLUTION
	
      +		 LUKARE MEDICAL LLC    0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9   N020577 001 Sep 27, 1996

                                MG/ML;7.3MG/ML;0.2MG/ML
	
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
	
      +		 B BRAUN               20MG/100ML;5GM/100ML;30MG/100ML;380MG/1
  N018258 001
	
                                00ML;600MG/100ML
	
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION

    DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER
AP       HOSPIRA                33MG/100ML;5GM/100ML;30MG/100ML;860MG/1   N018254 001
	
                                00ML
    DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER
AP       B BRAUN                33MG/100ML;5GM/100ML;30MG/100ML;860MG/1   N020000 001 Apr 17, 1992
	
                                00ML
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION

    DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
AP       HOSPIRA                20MG/100ML;5GM/100ML;30MG/100ML;600MG/1   N017608 001
	
                                00ML;310MG/100ML

    DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER
	
AP       B BRAUN                20MG/100ML;5GM/100ML;30MG/100ML;600MG/1   N019634 003 Feb 24, 1988

                                00ML;310MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                               3-59(of 371)


CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION

    LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        20MG/100ML;5GM/100ML;30MG/100ML;600MG/1     N016679 001
	
                                00ML;310MG/100ML

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        20MG/100ML;5GM/100ML;254MG/100ML;600MG/     N019367 006 Apr   05, 1985

                                100ML;310MG/100ML

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        20MG/100ML;5GM/100ML;179MG/100ML;600MG/     N019367 004 Apr   05, 1985

                                100ML;310MG/100ML

AP                              20MG/100ML;5GM/100ML;328MG/100ML;600MG/     N019367 005 Apr   05, 1985

                                100ML;310MG/100ML

AP       HOSPIRA                20MG/100ML;5GM/100ML;179MG/100ML;600MG/     N019685 002 Oct   17, 1988

                                100ML;310MG/100ML

AP                              20MG/100ML;5GM/100ML;328MG/100ML;600MG/     N019685 008 Oct   17, 1988

                                100ML;310MG/100ML

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        20MG/100ML;5GM/100ML;254MG/100ML;600MG/     N019367 007 Apr   05, 1985

                                100ML;310MG/100ML

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        20MG/100ML;5GM/100ML;328MG/100ML;600MG/     N019367 008 Apr   05, 1985

                                100ML;310MG/100ML

AP       HOSPIRA                20MG/100ML;5GM/100ML;328MG/100ML;600MG/     N019685 004 Oct   17, 1988

                                100ML;310MG/100ML

    DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER
	
         B BRAUN                10MG/100ML;2.5GM/100ML;15MG/100ML;300MG     N019634 001 Feb   24, 1988

                                /100ML;160MG/100ML

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        20MG/100ML;5GM/100ML;105MG/100ML;600MG/     N019367 002 Apr   05, 1985

                                100ML;310MG/100ML

                                20MG/100ML;5GM/100ML;179MG/100ML;600MG/     N019367 003 Apr   05, 1985

                                100ML;310MG/100ML

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        20MG/100ML;5GM/100ML;105MG/100ML;600MG/     N019367 001 Apr   05, 1985

                                100ML;310MG/100ML
	
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    TPN ELECTROLYTES IN PLASTIC CONTAINER
	
      +		 HOSPIRA               16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;   N018895 001 Jul 20, 1984

                                16.1MG/ML
	
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE;   SODIUM CHLORIDE; SODIUM

CITRATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE E IN PLASTIC CONTAINER
	
      + B BRAUN		               35MG/100ML;30MG/100ML;74MG/100ML;640MG/     N019718 001 Sep 29, 1989

                                100ML;500MG/100ML;74MG/100ML

  SOLUTION;IRRIGATION

    BALANCED SALT
	
AT        AKORN                 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6     A075503 001 Sep 27, 2006

                                .4MG/ML;1.7MG/ML

AT        B BRAUN               0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6     A091387 001 Feb 03, 2010

                                .4MG/ML;1.7MG/ML

    BSS
	
AT    + ALCON                   0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6     N020742 001 Dec 10, 1997

                                .4MG/ML;1.7MG/ML
	
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM

LACTATE
	
  INJECTABLE;INJECTION
	
    PLASMA-LYTE R IN PLASTIC CONTAINER
	
      +		 BAXTER HLTHCARE       36.8MG/100ML;30.5MG/100ML;74.6MG/100ML;   N017438 001
	
                                640MG/100ML;496MG/100ML;89.6MG/100ML
	
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  SOLUTION;PERFUSION, CARDIAC

    CARDIOPLEGIC IN PLASTIC CONTAINER
	
AT       BAXTER HLTHCARE        17.6MG/100ML;325.3MG/100ML;119.3MG/100M    A075323 001 Apr 21, 2000

                                L;643MG/100ML

    PLEGISOL IN PLASTIC CONTAINER
	
AT    + HOSPIRA                 17.6MG/100ML;325.3MG/100ML;119.3MG/100M    N018608 001 Feb 26, 1982

                                L;643MG/100ML
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                              3-60(of 371)


CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION

    RINGER'S IN PLASTIC CONTAINER
	
AP       B BRAUN                33MG/100ML;30MG/100ML;860MG/100ML         N020002 001 Apr 17, 1992

AP       BAXTER HLTHCARE        33MG/100ML;30MG/100ML;860MG/100ML         N016693 001
	
AP       HOSPIRA                33MG/100ML;30MG/100ML;860MG/100ML         N018251 001
	
  SOLUTION;IRRIGATION

    RINGER'S IN PLASTIC CONTAINER
	
AT       B BRAUN                33MG/100ML;30MG/100ML;860MG/100ML         N018156 001
	
AT       BAXTER HLTHCARE        33MG/100ML;30MG/100ML;860MG/100ML         N018495 001 Feb 19, 1982

AT       HOSPIRA                33MG/100ML;30MG/100ML;860MG/100ML         N017635 001
	
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION

    LACTATED RINGER'S IN PLASTIC CONTAINER
	
AP       B BRAUN                20MG/100ML;30MG/100ML;600MG/100ML;310MG   N019632 001 Feb 29, 1988

                                /100ML

AP       BAXTER HLTHCARE        20MG/100ML;30MG/100ML;600MG/100ML;310MG   N016682 001
	
                                /100ML

AP       HOSPIRA                20MG/100ML;30MG/100ML;600MG/100ML;310MG   N017641 001
	
                                /100ML

  SOLUTION;IRRIGATION

    LACTATED RINGER'S IN PLASTIC CONTAINER
	
AT    + B BRAUN                 20MG/100ML;30MG/100ML;600MG/100ML;310MG   N018681 001 Dec 27, 1982

                                /100ML

AT       BAXTER HLTHCARE        20MG/100ML;30MG/100ML;600MG/100ML;310MG   N018494 001 Feb 19, 1982

                                /100ML

AT    +                         20MG/100ML;30MG/100ML;600MG/100ML;310MG   N018921 001 Apr 03, 1984

                                /100ML

AT    +                         20MG/100ML;30MG/100ML;600MG/100ML;310MG   N019933 001 Aug 29, 1989

                                /100ML

AT    + HOSPIRA                 20MG/100ML;30MG/100ML;600MG/100ML;310MG   N019416 001 Jan 17, 1986

                                /100ML
	
CALFACTANT
	
  SUSPENSION;INTRATRACHEAL
	
    INFASURF PRESERVATIVE FREE
	
      + ONY                      35MG/ML		                                N020521 001 Jul 01, 1998
	
CANAGLIFLOZIN
	
  TABLET;ORAL
	
    INVOKANA
	
         JANSSEN PHARMS          100MG                                    N204042 001 Mar 29, 2013
	
      +                          300MG		                                  N204042 002 Mar 29, 2013
	
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    INVOKAMET
	
         JANSSEN PHARMS		       50MG;500MG                                N204353   001   Aug   08,   2014

                                50MG;1GM                                  N204353   002   Aug   08,   2014

                                150MG;500MG                               N204353   003   Aug   08,   2014

      +                         150MG;1GM		                               N204353   004   Aug   08,   2014
	
CANDESARTAN CILEXETIL
	
  TABLET;ORAL

    ATACAND
	
AB       ASTRAZENECA             4MG                                      N020838   001   Jun   04,   1998

AB                               8MG                                      N020838   002   Jun   04,   1998

AB                               16MG                                     N020838   003   Jun   04,   1998

AB    +                          32MG                                     N020838   004   Jun   04,   1998

    CANDESARTAN CILEXETIL
	
AB       APOTEX INC              4MG                                      A202079   001   Jan   10,   2014

AB                               8MG                                      A202079   002   Jan   10,   2014

AB                               16MG                                     A202079   003   Jan   10,   2014

AB                               32MG                                     A202079   004   Jan   10,   2014

AB       SANDOZ                  4MG                                      A078702   001   May   03,   2013

AB                               8MG                                      A078702   002   May   03,   2013

AB                               16MG                                     A078702   003   May   03,   2013

AB                               32MG                                     A078702   004   May   03,   2013
	
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    ATACAND HCT
	
AB       ASTRAZENECA            16MG;12.5MG                               N021093 001 Sep 05, 2000

AB                              32MG;12.5MG                               N021093 002 Sep 05, 2000

AB    +                         32MG;25MG                                 N021093 003 May 16, 2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-61(of 371)


CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE
	
AB       APOTEX INC             16MG;12.5MG
                    A202884   001   Dec   04,   2012

AB                              32MG;12.5MG
                    A202884   002   Dec   04,   2012

AB                              32MG;25MG
                      A202884   003   Jun   03,   2013

AB       DR REDDYS LABS LTD     16MG;12.5MG
                    A202965   001   Jun   03,   2013

AB                              32MG;12.5MG
                    A202965   002   Jun   03,   2013

AB                              32MG;25MG
                      A202965   003   Jun   03,   2013

AB       MYLAN LABS             16MG;12.5MG
                    A090704   001   Dec   04,   2012

AB                              32MG;12.5MG
                    A090704   002   Dec   04,   2012

AB                              32MG;25MG
	                     A090704   003   Dec   04,   2012
	
CAPECITABINE
	
  TABLET;ORAL

    CAPECITABINE
	
AB       MYLAN PHARMS INC       150MG
	                         A090943   001   Aug   08,   2014

AB                              500MG
	                         A090943   002   Aug   08,   2014

AB       TEVA PHARMS USA        150MG
	                         A091649   001   Sep   16,   2013

AB                              500MG
	                         A091649   002   Sep   16,   2013
	
    XELODA
	
AB       HOFFMANN LA ROCHE      150MG
	                         N020896 001 Apr 30, 1998

AB    +                         500MG
	                         N020896 002 Apr 30, 1998
	
CAPREOMYCIN SULFATE
	
  INJECTABLE;INJECTION
	
    CAPASTAT SULFATE
	
      + AKORN                   EQ 1GM BASE/VIAL
	              N050095 001
	
CAPSAICIN
	
  PATCH;TOPICAL
	
    QUTENZA
	
      + ACORDA                  8%
	                            N022395 001 Nov 16, 2009
	
CAPTOPRIL
	
  TABLET;ORAL

    CAPOTEN
	
AB       PAR PHARM              12.5MG
	                        N018343   005 Jan 17, 1985

AB                              25MG
	                          N018343   002
	
AB                              50MG
	                          N018343   001
	
AB    +                         100MG
	                         N018343   003
	
    CAPTOPRIL
	
AB       APOTEX                 12.5MG
	                        A074737   001   Oct   28,   1998

AB                              25MG
	                          A074737   002   Oct   28,   1998

AB                              50MG
	                          A074737   003   Oct   28,   1998

AB                              100MG
	                         A074737   004   Oct   28,   1998

AB       HIKMA PHARMS LLC       12.5MG
	                        A074505   001   Feb   13,   1996

AB                              25MG
	                          A074505   002   Feb   13,   1996

AB                              50MG
	                          A074505   003   Feb   13,   1996

AB                              100MG
	                         A074505   004   Feb   13,   1996

AB       MYLAN                  12.5MG
	                        A074434   001   Feb   13,   1996

AB                              25MG
	                          A074434   002   Feb   13,   1996

AB                              50MG
	                          A074434   003   Feb   13,   1996

AB                              100MG
	                         A074434   004   Feb   13,   1996

AB       SANDOZ                 12.5MG
	                        A074363   001   Nov   09,   1995

AB                              25MG
	                          A074363   002   Nov   09,   1995

AB                              50MG
	                          A074363   003   Nov   09,   1995

AB                              100MG
	                         A074363   004   Nov   09,   1995

AB       STASON                 12.5MG
	                        A074677   004   May   30,   1997

AB                              25MG
	                          A074677   002   May   30,   1997

AB                              50MG
	                          A074677   001   May   30,   1997

AB                              100MG
	                         A074677   003   May   30,   1997

AB       TEVA                   12.5MG
	                        A074322   001   Feb   13,   1996

AB                              25MG
	                          A074322   002   Feb   13,   1996

AB                              50MG
	                          A074322   003   Feb   13,   1996

AB                              100MG
	                         A074322   004   Feb   13,   1996

AB       WATSON LABS            12.5MG
	                        A074386   001   May   23,   1996

AB                              25MG
	                          A074386   002   May   23,   1996

AB                              50MG
	                          A074386   003   May   23,   1996

AB                              100MG
	                         A074386   004   May   23,   1996

AB       WOCKHARDT              12.5MG
	                        A074532   001   Mar   28,   1997

AB                              25MG
	                          A074532   002   Mar   28,   1997

AB                              50MG
	                          A074532   003   Mar   28,   1997

AB                              100MG
	                         A074532   004   Mar   28,   1997
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-62(of 371)


CAPTOPRIL; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    CAPTOPRIL AND HYDROCHLOROTHIAZIDE
	
AB       MYLAN                   25MG;15MG                      A074896   001   Dec   29,   1997

AB    +                          25MG;25MG                      A074896   002   Dec   29,   1997

AB    +                          50MG;15MG                      A074896   004   Dec   29,   1997

AB                               50MG;25MG                      A074896   003   Dec   29,   1997

AB       TEVA                    25MG;15MG                      A074827   001   Dec   29,   1997

AB                               25MG;25MG                      A074827   002   Dec   29,   1997

AB                               50MG;15MG                      A074827   004   Dec   29,   1997

AB                               50MG;25MG                      A074827   003   Dec   29,   1997
	
CARBACHOL
	
  SOLUTION;INTRAOCULAR
	
    MIOSTAT
	
      + ALCON                   0.01%		                         N016968 001
	
CARBAMAZEPINE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    CARBAMAZEPINE
	
AB       APOTEX INC              100MG                          A078986   001   Nov   25,   2011

AB                               200MG                          A078986   002   Nov   25,   2011

AB                               300MG                          A078986   003   Nov   25,   2011

AB       NOSTRUM                 100MG                          A076697   001   May   20,   2011

AB                               200MG                          A076697   002   May   20,   2011

AB                               300MG                          A076697   003   May   20,   2011

AB       TARO                    100MG                          A201106   001   Jun   21,   2013

AB                               200MG                          A201106   002   Jun   21,   2013

AB                               300MG                          A201106   003   Jun   21,   2013

AB       TEVA PHARMS             100MG                          A078592   001   Sep   20,   2012

AB                               200MG                          A078592   002   Sep   20,   2012

AB                               300MG                          A078592   003   Sep   20,   2012

    CARBATROL
	
AB       SHIRE                   100MG                          N020712 003 Sep 30, 1997

AB                               200MG                          N020712 001 Sep 30, 1997

AB    +                          300MG                          N020712 002 Sep 30, 1997

    EQUETRO
	
         VALIDUS PHARMS INC      100MG                          N021710 001 Dec 10, 2004
	
                                 200MG                          N021710 002 Dec 10, 2004
	
      +                          300MG                          N021710 003 Dec 10, 2004
	
  SUSPENSION;ORAL

    CARBAMAZEPINE
	
AB       WOCKHARDT               100MG/5ML                      A075714 001 Jun 05, 2002

    TEGRETOL
	
AB    + NOVARTIS                 100MG/5ML                      N018927 001 Dec 18, 1987

    TERIL
	
AB       TARO                    100MG/5ML                      A076729 001 Sep 20, 2004

  TABLET;ORAL

    CARBAMAZEPINE
	
AB       APOTEX INC              200MG                          A075948 001 Feb 27, 2002

AB       TARO                    200MG                          A074649 001 Oct 03, 1996

AB       TORRENT PHARMS          200MG                          A077272 002 Dec 07, 2005

    EPITOL
	
AB       TEVA                    200MG                          A070541 001 Sep 17, 1986

    TEGRETOL
	
AB    + NOVARTIS                 200MG                          N016608 001
	
    CARBAMAZEPINE
	
         TORRENT PHARMS		        100MG                          A077272 001 Dec 07, 2005
	
                                 300MG                          A077272 003 Dec 07, 2005
	
                                 400MG                          A077272 004 Dec 07, 2005
	
  TABLET, CHEWABLE;ORAL

    CARBAMAZEPINE
	
AB       TARO PHARM INDS         100MG                          A075687 001 Oct 24, 2000

AB       TORRENT PHARMS          100MG                          A075712 001 Jul 05, 2001

    EPITOL
	
AB       TEVA                    100MG                          A073524 001 Jul 29, 1992

    TEGRETOL
	
AB    + NOVARTIS                 100MG                          N018281 001
	
    CARBAMAZEPINE
	
      + TARO PHARM INDS          200MG                          A075687 002 Jul 29, 2002
	
  TABLET, EXTENDED RELEASE;ORAL

    CARBAMAZEPINE
	
AB       TARO                    100MG                          A078115 001 Mar 31, 2009
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-63(of 371)


CARBAMAZEPINE
	
  TABLET, EXTENDED RELEASE;ORAL

    CARBAMAZEPINE
	
AB                               200MG                         A078115 002 Mar 31, 2009

AB                               400MG                         A078115 003 Mar 31, 2009

    TEGRETOL-XR
	
AB       NOVARTIS                100MG                         N020234 001 Mar 25, 1996

AB                               200MG                         N020234 002 Mar 25, 1996

AB    +                          400MG                         N020234 003 Mar 25, 1996
	
CARBIDOPA
	
  TABLET;ORAL

    CARBIDOPA
	
AB       AMERIGEN PHARMS LTD    25MG                           A203261 001 Mar 10, 2014

    LODOSYN
	
AB    + ATON                    25MG                           N017830 001
	
CARBIDOPA; ENTACAPONE; LEVODOPA
	
  TABLET;ORAL

    CARBIDOPA, LEVODOPA AND ENTACAPONE

AB       SUN PHARMA GLOBAL       25MG;200MG;100MG              A079085   001   May   10,   2012

AB                               37.5MG;200MG;150MG            A079085   002   May   10,   2012

AB       WOCKHARDT LTD           12.5MG;200MG;50MG             A090786   001   Nov   20,   2012

AB                               18.75MG;200MG;75MG            A090833   001   Nov   20,   2012

AB                               25MG;200MG;100MG              A090833   002   Nov   20,   2012

AB                               31.25MG;200MG;125MG           A090833   003   Nov   20,   2012

AB                               37.5MG;200MG;150MG            A090833   004   Nov   20,   2012

AB                               50MG;200MG;200MG              A090833   005   Nov   20,   2012

    STALEVO 100
	
AB       ORION PHARMA            25MG;200MG;100MG              N021485 002 Jun 11, 2003

    STALEVO 125
	
AB       ORION PHARMA            31.25MG;200MG;125MG           N021485 006 Aug 29, 2008

    STALEVO 150
	
AB       ORION PHARMA            37.5MG;200MG;150MG            N021485 003 Jun 11, 2003

    STALEVO 200
	
AB    + ORION PHARMA             50MG;200MG;200MG              N021485 004 Aug 02, 2007

    STALEVO 50
	
AB    + ORION PHARMA             12.5MG;200MG;50MG             N021485 001 Jun 11, 2003

    STALEVO 75
	
AB       ORION PHARMA            18.75MG;200MG;75MG            N021485 005 Aug 29, 2008
	
CARBIDOPA; LEVODOPA
	
  TABLET;ORAL

    CARBIDOPA AND LEVODOPA
	
AB       ACTAVIS ELIZABETH       10MG;100MG                    A074260   001   Sep   03,   1993

AB                               25MG;100MG                    A074260   002   Sep   03,   1993

AB                               25MG;250MG                    A074260   003   Sep   03,   1993

AB       APOTEX INC              10MG;100MG                    A077120   001   Jun   02,   2008

AB                               25MG;100MG                    A077120   002   Jun   02,   2008

AB                               25MG;250MG                    A077120   003   Jun   02,   2008

AB       MYLAN                   10MG;100MG                    A090324   001   Sep   28,   2009

AB                               25MG;100MG                    A090324   002   Sep   28,   2009

AB                               25MG;250MG                    A090324   003   Sep   28,   2009

AB       SUN PHARM INDS          10MG;100MG                    A078536   001   Oct   28,   2008

AB                               25MG;100MG                    A078536   002   Oct   28,   2008

AB                               25MG;250MG                    A078536   003   Oct   28,   2008

AB       TEVA                    10MG;100MG                    A073618   001   Aug   28,   1992

AB                               25MG;100MG                    A073589   001   Aug   28,   1992

AB                               25MG;250MG                    A073607   001   Aug   28,   1992

    SINEMET
	
AB       MERCK SHARP DOHME       10MG;100MG                    N017555 001
	
AB                               25MG;100MG                    N017555 003
	
AB    +                          25MG;250MG                    N017555 002
	
  TABLET, EXTENDED RELEASE;ORAL

    CARBIDOPA AND LEVODOPA
	
AB       ACCORD HLTHCARE         25MG;100MG                    A202323   001   Feb   08,   2013

AB                               50MG;200MG                    A202323   002   Feb   08,   2013

AB       APOTEX                  25MG;100MG                    A076212   001   Jun   16,   2004

AB                               50MG;200MG                    A076212   002   Jun   16,   2004

AB       IMPAX LABS              25MG;100MG                    A076521   001   May   14,   2004

AB                               50MG;200MG                    A076521   002   May   14,   2004

AB       MYLAN                   25MG;100MG                    A075091   002   Apr   21,   2000

AB                               50MG;200MG                    A075091   001   Sep   30,   1999

AB       SUN PHARM INDS          25MG;100MG                    A077828   001   Aug   23,   2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-64(of 371)


CARBIDOPA; LEVODOPA
	
  TABLET, EXTENDED RELEASE;ORAL

    CARBIDOPA AND LEVODOPA
	
AB                               50MG;200MG                    A077828 002 Aug 23, 2007

    SINEMET CR
	
AB       MERCK SHARP DOHME       25MG;100MG                    N019856 002 Dec 24, 1992

AB    +                          50MG;200MG                    N019856 001 May 30, 1991

  TABLET, ORALLY DISINTEGRATING;ORAL

    CARBIDOPA AND LEVODOPA
	
AB       MYLAN                   10MG;100MG                    A078893   001   Sep   18,   2008

AB                               25MG;100MG                    A078893   002   Sep   18,   2008

AB    +                          25MG;250MG                    A078893   003   Sep   18,   2008

AB       SUN PHARMA GLOBAL       10MG;100MG                    A078690   001   Jul   31,   2009

AB                               25MG;100MG                    A078690   002   Jul   31,   2009

AB                               25MG;250MG                    A078690   003   Jul   31,   2009
	
CARBINOXAMINE MALEATE
	
  SOLUTION;ORAL

    CARBINOXAMINE MALEATE
	
AA       CYPRESS PHARM          4MG/5ML                        A090418 001 May 04, 2010

AA    + MIKART                  4MG/5ML                        A040458 001 Apr 25, 2003

AA       VINTAGE PHARMS         4MG/5ML                        A040814 001 Feb 26, 2008
	
  SUSPENSION, EXTENDED RELEASE;ORAL
	
    KARBINAL ER
	
      + TRIS PHARMA INC         4MG/5ML                        N022556 001 Mar 28, 2013
	
  TABLET;ORAL

    CARBINOXAMINE MALEATE
	
AA       CYPRESS PHARM          4MG                            A090417   001   Aug   23,   2010

AA       INVAGEN PHARMS         4MG                            A090435   001   Apr   15,   2010

AA    + MIKART                  4MG                            A040442   001   Mar   19,   2003

AA       MISSION PHARMACAL CO   4MG                            A090756   001   May   27,   2011

AA       VINTAGE PHARMS         4MG                            A040639   002   May   30,   2008
	
CARBOPLATIN
	
  INJECTABLE;IV (INFUSION)

    CARBOPLATIN
	
AP       ACTAVIS TOTOWA         50MG/5ML (10MG/ML)             A078732   001   Feb   06,   2012

AP                              150MG/15ML (10MG/ML)           A078732   002   Feb   06,   2012

AP                              450MG/45ML (10MG/ML)           A078732   003   Feb   06,   2012

AP                              600MG/60ML (10MG/ML)           A078732   004   Feb   06,   2012

AP       AKORN                  50MG/5ML (10MG/ML)             A090475   001   Jul   29,   2009

AP                              150MG/15ML (10MG/ML)           A090475   002   Jul   29,   2009

AP                              450MG/45ML (10MG/ML)           A090475   003   Jul   29,   2009

AP                              600MG/60ML (10MG/ML)           A091268   002   Jul   28,   2010

AP       CIPLA LTD              50MG/5ML (10MG/ML)             A077861   001   Jan   18,   2007

AP                              150MG/15ML (10MG/ML)           A077861   002   Jan   18,   2007

AP                              450MG/45ML (10MG/ML)           A077861   003   Jan   18,   2007

AP                              600MG/60ML (10MG/ML)           A077861   004   Jan   18,   2007

AP       EBEWE PHARMA           50MG/5ML (10MG/ML)             A078280   001   May   08,   2008

AP                              150MG/15ML (10MG/ML)           A078280   002   May   08,   2008

AP                              450MG/45ML (10MG/ML)           A078280   003   May   08,   2008

AP       EUROHLTH INTL          50MG/5ML (10MG/ML)             A077244   001   Oct   15,   2004

AP                              150MG/15ML (10MG/ML)           A077244   002   Oct   15,   2004

AP                              450MG/45ML (10MG/ML)           A077244   003   Oct   15,   2004

AP                              600MG/60ML (10MG/ML)           A077244   004   Jan   20,   2006

AP       FRESENIUS KABI ONCOL   50MG/5ML (10MG/ML)             A077432   001   Sep   29,   2006

AP                              150MG/15ML (10MG/ML)           A077432   002   Sep   29,   2006

AP                              450MG/45ML (10MG/ML)           A077432   003   Sep   29,   2006

AP       FRESENIUS KABI USA     450MG/45ML (10MG/ML)           A077247   003   Oct   21,   2004

AP                              450MG/45ML (10MG/ML)           A077266   003   Feb   15,   2006

AP                              600MG/60ML (10MG/ML)           A077266   004   Feb   15,   2006

AP       HOSPIRA                50MG/5ML (10MG/ML)             A076517   001   Oct   14,   2004

AP                              150MG/15ML (10MG/ML)           A076517   002   Oct   14,   2004

AP                              450MG/45ML (10MG/ML)           A076517   003   Oct   14,   2004

AP                              600MG/60ML (10MG/ML)           A077059   001   Nov   23,   2004

AP       MYLAN INSTITUTIONAL    50MG/5ML (10MG/ML)             A077998   001   Apr   24,   2007

AP                              150MG/15ML (10MG/ML)           A077998   002   Apr   24,   2007

AP                              450MG/45ML (10MG/ML)           A077998   003   Apr   24,   2007

AP       ONCO THERAPIES LTD     50MG/5ML (10MG/ML)             A091063   001   Nov   09,   2011

AP                              150MG/15ML (10MG/ML)           A091063   002   Nov   09,   2011

AP                              450MG/45ML (10MG/ML)           A091063   003   Nov   09,   2011

AP                              600MG/60ML (10MG/ML)           A091063   004   Nov   09,   2011

AP    + PHARMACHEMIE BV         50MG/5ML (10MG/ML)             A077269   001   Oct   14,   2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-65(of 371)


CARBOPLATIN
	
  INJECTABLE;IV (INFUSION)

    CARBOPLATIN
	
AP    +                           150MG/15ML (10MG/ML)          A077269   002   Oct   14,   2004

AP    +                           450MG/45ML (10MG/ML)          A077269   003   Oct   14,   2004

AP    +                           600MG/60ML (10MG/ML)          A077269   004   Dec   28,   2007

AP       PLIVA LACHEMA            50MG/5ML (10MG/ML)            A078631   001   Dec   02,   2008

AP                                150MG/15ML (10MG/ML)          A078631   002   Dec   02,   2008

AP                                450MG/45ML (10MG/ML)          A078631   003   Dec   02,   2008

AP                                600MG/60ML (10MG/ML)          A078631   004   Dec   02,   2008

AP       SAGENT PHARMS            50MG/5ML (10MG/ML)            A077096   001   Jun   14,   2005

AP                                150MG/15ML (10MG/ML)          A077096   002   Jun   14,   2005

AP                                450MG/45ML (10MG/ML)          A077096   003   Jun   14,   2005

AP                                600MG/60ML (10MG/ML)          A077096   004   Jun   03,   2013

AP       SUN PHARMA GLOBAL        50MG/5ML (10MG/ML)            A077926   001   Sep   19,   2008

AP                                150MG/15ML (10MG/ML)          A077926   002   Sep   19,   2008

AP                                450MG/45ML (10MG/ML)          A077926   003   Sep   19,   2008

AP    + TEVA PHARMS USA           50MG/5ML (10MG/ML)            A077139   001   Sep   21,   2005

AP    +                           150MG/15ML (10MG/ML)          A077139   002   Sep   21,   2005

AP    +                           450MG/45ML (10MG/ML)          A077139   003   Sep   21,   2005

AP    +                           600MG/60ML (10MG/ML)          A077139   004   Sep   21,   2005

      + ONCO THERAPIES LTD        1GM/100ML (10MG/ML)           A091478   001   Nov   23,   2011
	
CARBOPROST TROMETHAMINE
	
  INJECTABLE;INJECTION
	
    HEMABATE
	
      + PHARMACIA AND UPJOHN      EQ 0.25MG BASE/ML             N017989 001
	
CARFILZOMIB
	
  POWDER;INTRAVENOUS
	
    KYPROLIS
	
      + ONYX PHARMS               60MG/VIAL                     N202714 001 Jul 20, 2012
	
CARGLUMIC ACID
	
  TABLET;ORAL
	
    CARBAGLU
	
      + ORPHAN EUROPE             200MG                         N022562 001 Mar 18, 2010
	
CARISOPRODOL
	
  TABLET;ORAL

    CARISOPRODOL
	
AA         ACCELRX LABS           350MG                         A040576   001   Jun   07,   2005

AA         AUROBINDO PHARMA       350MG                         A040792   001   Aug   06,   2009

AA         MIRROR PHARMS          350MG                         A040823   001   Oct   22,   2008

AA         MUTUAL PHARM           350MG                         A089346   001   Oct   17,   1991

AA         NATCO PHARMA LTD       350MG                         A090988   001   Oct   28,   2014

AA         ORIENT PHARMA CO LTD   350MG                         A205085   001   Oct   28,   2014

AA         SCIEGEN PHARMS INC     350MG                         A203374   001   Jan   27,   2014

AA         SUN PHARM INDS LTD     350MG                         A040755   001   Feb   27,   2007

AA         VINTAGE PHARMS         350MG                         A040245   001   Sep   08,   1997

AA         WATSON LABS            350MG                         A087499   001   Apr   20,   1982

    SOMA
	
AA         MEDA PHARMS            350MG                         N011792 001
	
      +                           250MG                         N011792 004 Sep 13, 2007
	
CARMUSTINE
	
  IMPLANT;INTRACRANIAL
	
    GLIADEL
	
      + ARBOR PHARMS LLC          7.7MG                         N020637 001 Sep 23, 1996

  INJECTABLE;INJECTION
	
    BICNU
	
      + EMCURE PHARMS LTD         100MG/VIAL                    N017422 001
	
CARTEOLOL HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    CARTEOLOL HYDROCHLORIDE
	
AT       ALCON                    1%                            A075476 001 Jan 03, 2000

AT       BAUSCH AND LOMB          1%                            A075546 001 Jan 20, 2000

    OCUPRESS
	
AT    + NOVARTIS                  1%                            N019972 001 May 23, 1990
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-66(of 371)


CARVEDILOL
	
  TABLET;ORAL

    CARVEDILOL
	
AB       APOTEX INC             3.125MG                        A078165   001   Sep   05,   2007

AB                              6.25MG                         A078165   002   Sep   05,   2007

AB                              12.5MG                         A078165   003   Sep   05,   2007

AB                              25MG                           A078165   004   Sep   05,   2007

AB       AUROBINDO PHARMA       3.125MG                        A078332   001   Sep   05,   2007

AB                              6.25MG                         A078332   002   Sep   05,   2007

AB                              12.5MG                         A078332   003   Sep   05,   2007

AB                              25MG                           A078332   004   Sep   05,   2007

AB       BEXIMCO USA            3.125MG                        A078384   001   Sep   05,   2007

AB                              6.25MG                         A078384   002   Sep   05,   2007

AB                              12.5MG                         A078384   003   Sep   05,   2007

AB                              25MG                           A078384   004   Sep   05,   2007

AB       CIPLA LTD              3.125MG                        A077474   001   Sep   05,   2007

AB                              6.25MG                         A077474   002   Sep   05,   2007

AB                              12.5MG                         A077474   003   Sep   05,   2007

AB                              25MG                           A077474   004   Sep   05,   2007

AB       DR REDDYS LABS LTD     3.125MG                        A076649   001   Sep   05,   2007

AB                              6.25MG                         A076649   002   Sep   05,   2007

AB                              12.5MG                         A076649   003   Sep   05,   2007

AB                              25MG                           A076649   004   Sep   05,   2007

AB       GLENMARK GENERICS      3.125MG                        A078251   001   Sep   05,   2007

AB                              6.25MG                         A078251   002   Sep   05,   2007

AB                              12.5MG                         A078251   003   Sep   05,   2007

AB                              25MG                           A078251   004   Sep   05,   2007

AB       HIKMA                  3.125MG                        A077887   001   Sep   07,   2007

AB                              6.25MG                         A077887   002   Sep   07,   2007

AB                              12.5MG                         A077887   003   Sep   07,   2007

AB                              25MG                           A077887   004   Sep   07,   2007

AB       LUPIN                  3.125MG                        A078217   001   Sep   05,   2007

AB                              6.25MG                         A078217   002   Sep   05,   2007

AB                              12.5MG                         A078217   003   Sep   05,   2007

AB                              25MG                           A078217   004   Sep   05,   2007

AB       MYLAN                  3.125MG                        A077316   001   Sep   05,   2007

AB                              6.25MG                         A077316   002   Sep   05,   2007

AB                              12.5MG                         A077316   003   Sep   05,   2007

AB                              25MG                           A077316   004   Sep   05,   2007

AB       PLIVA HRVATSKA DOO     3.125MG                        A078240   001   Oct   30,   2007

AB                              6.25MG                         A078240   002   Oct   30,   2007

AB                              12.5MG                         A078240   003   Oct   30,   2007

AB                              25MG                           A078240   004   Oct   30,   2007

AB       RANBAXY                3.125MG                        A076989   001   Sep   05,   2007

AB                              6.25MG                         A076989   002   Sep   05,   2007

AB                              12.5MG                         A076989   003   Sep   05,   2007

AB                              25MG                           A076989   004   Sep   05,   2007

AB       SANDOZ                 3.125MG                        A078227   001   Sep   05,   2007

AB                              6.25MG                         A078227   002   Sep   05,   2007

AB                              12.5MG                         A078227   003   Sep   05,   2007

AB                              25MG                           A078227   004   Sep   05,   2007

AB       SUN PHARM INDS INC     3.125MG                        A077346   004   Sep   05,   2007

AB                              6.25MG                         A077346   001   Sep   05,   2007

AB                              12.5MG                         A077346   002   Sep   05,   2007

AB                              25MG                           A077346   003   Sep   05,   2007

AB       TARO                   3.125MG                        A077780   001   Sep   05,   2007

AB                              6.25MG                         A077780   002   Sep   05,   2007

AB                              12.5MG                         A077780   003   Sep   05,   2007

AB                              25MG                           A077780   004   Sep   05,   2007

AB       TEVA                   3.125MG                        A076373   001   Sep   05,   2007

AB                              6.25MG                         A076373   002   Sep   05,   2007

AB                              12.5MG                         A076373   003   Sep   05,   2007

AB                              25MG                           A076373   004   Sep   05,   2007

AB       ZYDUS PHARMS USA INC   3.125MG                        A077614   004   Sep   05,   2007

AB                              6.25MG                         A077614   001   Sep   05,   2007

AB                              12.5MG                         A077614   002   Sep   05,   2007

AB                              25MG                           A077614   003   Sep   05,   2007

    COREG
	
AB       SMITHKLINE BEECHAM     3.125MG                        N020297   004   May   29,   1997

AB                              6.25MG                         N020297   003   Sep   14,   1995

AB    +                         12.5MG                         N020297   002   Sep   14,   1995

AB                              25MG                           N020297   001   Sep   14,   1995
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                     3-67(of 371)


CARVEDILOL PHOSPHATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    COREG CR
	
          SB PHARMCO            10MG                           N022012   001     Oct   20,   2006
	
                                20MG                           N022012   002     Oct   20,   2006
	
      +		                       40MG                           N022012   003     Oct   20,   2006
	
                                80MG                           N022012   004     Oct   20,   2006
	
CASPOFUNGIN ACETATE
	
  INJECTABLE;IV (INFUSION)

    CANCIDAS
	
      + MERCK                    50MG/VIAL		                   N021227 001 Jan 26, 2001
	
      +                          70MG/VIAL		                   N021227 002 Jan 26, 2001
	
CEFACLOR
	
  CAPSULE;ORAL

    CEFACLOR
	
AB        HIKMA                  EQ   250MG   BASE             A065350   001     Apr   03,   2007

AB    +                          EQ   500MG   BASE             A065350   002     Apr   03,   2007

AB        YUNG SHIN PHARM        EQ   250MG   BASE             A065146   001     Jan   22,   2004

AB                               EQ   500MG   BASE             A065146   002     Jan   22,   2004
	
  FOR SUSPENSION;ORAL

    CEFACLOR
	
AB        YUNG SHIN PHARM        EQ   125MG   BASE/5ML         A065412   001     Feb   17,   2012

AB                               EQ   187MG   BASE/5ML         A065412   002     Feb   17,   2012

AB                               EQ   250MG   BASE/5ML         A065412   003     Feb   17,   2012

AB    +                          EQ   375MG   BASE/5ML         A065412   004     Feb   17,   2012
	
  TABLET, EXTENDED RELEASE;ORAL
	
    CEFACLOR
	
          TEVA                   EQ   375MG BASE               A065058 001 Sep 04, 2002

      +                          EQ   500MG BASE		             A065058 002 Sep 04, 2002
	
CEFADROXIL/CEFADROXIL HEMIHYDRATE

  CAPSULE;ORAL

    CEFADROXIL
	
AB       AUROBINDO PHARMA       EQ    500MG   BASE             A065352   001     Jan   25,   2007

AB       HIKMA                  EQ    500MG   BASE             A065311   001     Feb   07,   2006

AB       LUPIN                  EQ    500MG   BASE             A065392   001     May   29,   2007

AB       ORCHID HLTHCARE        EQ    500MG   BASE             A065309   001     Sep   18,   2006

AB       SANDOZ                 EQ    500MG   BASE             A062291   001
	
AB    + TEVA PHARMS             EQ    500MG   BASE             A065282   001     Jan 20, 2006
	
  FOR SUSPENSION;ORAL

    CEFADROXIL
	
AB       AUROBINDO              EQ    250MG   BASE/5ML         A065349   001     Apr   25,   2013

AB                              EQ    500MG   BASE/5ML         A065349   002     Apr   25,   2013

AB       HIKMA PHARMS           EQ    250MG   BASE/5ML         A091036   001     Nov   28,   2012

AB                              EQ    500MG   BASE/5ML         A091036   002     Nov   28,   2012

AB       LUPIN                  EQ    250MG   BASE/5ML         A065396   001     Feb   21,   2008

AB    +                         EQ    500MG   BASE/5ML         A065396   002     Feb   21,   2008

AB       ORCHID HLTHCARE        EQ    250MG   BASE/5ML         A065307   002     Oct   16,   2006

AB                              EQ    500MG   BASE/5ML         A065307   003     Oct   16,   2006

AB       RANBAXY                EQ    250MG   BASE/5ML         A065115   002     Mar   26,   2003

AB                              EQ    500MG   BASE/5ML         A065115   003     Mar   26,   2003
	
                                EQ    125MG   BASE/5ML         A065115   001     Mar   26,   2003
	
  TABLET;ORAL

    CEFADROXIL
	
AB       HIKMA                  EQ    1GM BASE                 A065260 001 Mar 30, 2006

AB       ORCHID HLTHCARE        EQ    1GM BASE                 A065301 001 Sep 18, 2006

      + TEVA PHARMS             EQ    1GM BASE		               A062774 001 Apr 08, 1987
	
CEFAZOLIN SODIUM
	
  INJECTABLE;INJECTION

    CEFAZOLIN SODIUM
	
AP       ACS DOBFAR              EQ   1GM BASE/VIAL            A065303   002     Oct   22,   2008

AP                               EQ   10GM BASE/VIAL           A065306   001     Oct   22,   2008

AP                               EQ   20GM BASE/VIAL           A065306   002     Aug   18,   2014

AP                               EQ   500MG BASE/VIAL          A065303   001     Oct   22,   2008

AP       HIKMA FARMACEUTICA      EQ   1GM BASE/VIAL            A065047   002     Sep   18,   2001

AP                               EQ   10GM BASE/VIAL           A065143   001     Oct   18,   2004

AP                               EQ   500MG BASE/VIAL          A065047   001     Sep   18,   2001

AP    + HOSPIRA INC              EQ   1GM BASE/VIAL            A065226   002     Apr   21,   2005

AP    +                          EQ   1GM BASE/VIAL            A065244   001     Aug   12,   2005

AP    +                          EQ   10GM BASE/VIAL           A065247   001     Aug   12,   2005

AP    +                          EQ   500MG BASE/VIAL          A065226   001     Apr   21,   2005
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                PRESCRIPTION DRUG PRODUCT LIST
	                       3-68(of 371)


CEFAZOLIN SODIUM
	
  INJECTABLE;INJECTION

     CEFAZOLIN SODIUM
	
AP         SANDOZ                   EQ   1GM BASE/VIAL
                A062831   002   Dec   09,   1988

AP                                  EQ   1GM BASE/VIAL
                A065345   001   May   09,   2007

AP                                  EQ   10GM BASE/VIAL
               A062831   003   Sep   25,   1992

AP                                  EQ   500MG BASE/VIAL
              A062831   001   Dec   09,   1988

AP         STERI PHARMA             EQ   1GM BASE/VIAL
                A063207   001   Dec   27,   1991

AP                                  EQ   10GM BASE/VIAL
               A063209   001   Dec   27,   1991

AP     +                            EQ   20GM BASE/VIAL
               A063209   002   Apr   30,   1999

AP                                  EQ   500MG BASE/VIAL
	             A063214   001   Dec   27,   1991
	
     KEFZOL
	
AP         ACS DOBFAR
	             EQ 1GM BASE/VIAL
                  A061773 003
	
AP
	                                EQ 10GM BASE/VIAL
                 A061773 004
	
AP
	                                EQ 500MG BASE/VIAL
	               A061773 002
	
     ANCEF IN PLASTIC CONTAINER
	
       + BAXTER HLTHCARE
	          EQ 10MG BASE/ML
                   A063002 001 Mar 28, 1991
	
       +
	                          EQ 20MG BASE/ML
	                  A063002 002 Mar 28, 1991
	
     CEFAZOLIN AND DEXTROSE
	
       + B BRAUN
	                  EQ 1GM BASE/VIAL
                  N050779 002 Jul 27, 2000
	
                                    EQ 2GM BASE/VIAL
	                 N050779 003 Jan 13, 2012
	
    CEFAZOLIN SODIUM
	
      + SAMSON MEDCL
	              EQ 100GM BASE/VIAL
                A065141 001 Nov 29, 2006
	
      +
	                           EQ 300GM BASE/VIAL
	               A065141 002 Nov 29, 2006
	
CEFDINIR
	
  CAPSULE;ORAL

     CEFDINIR
	
AB         AUROBINDO PHARMA
	       300MG
	                            A065434   001   Jan   07,   2008

AB         LUPIN
	                  300MG
	                            A065264   001   May   19,   2006

AB         ORCHID HLTHCARE
	        300MG
	                            A065418   001   Jul   18,   2007

AB     + SANDOZ
	                   300MG
	                            A065330   001   Apr   06,   2007

AB         TEVA PHARMS
	            300MG
	                            A065368   001   May   09,   2007
	
  FOR SUSPENSION;ORAL

     CEFDINIR
	
AB         AUROBINDO PHARMA
	       125MG/5ML
                         A065473   001   Dec   14,   2007

AB
	                                250MG/5ML
                         A065473   002   Dec   14,   2007

AB         LUPIN
	                  125MG/5ML
                         A065259   001   May   31,   2006

AB
	                                250MG/5ML
                         A065259   002   May   07,   2007

AB         ORCHID HLTHCARE
	        125MG/5ML
                         A065429   001   Jul   18,   2007

AB
	                                250MG/5ML
                         A065429   002   Jul   18,   2007

AB         SANDOZ
	                 125MG/5ML
                         A065337   001   Apr   06,   2007

AB     +
	                          250MG/5ML
                         A065337   002   Apr   06,   2007

AB         TEVA PHARMS
	            125MG/5ML
                         A065332   001   May   04,   2007

AB
	                                250MG/5ML
	                        A065332   002   May   04,   2007
	
CEFDITOREN PIVOXIL
	
  TABLET;ORAL
	
    SPECTRACEF
	
          VANSEN PHARMA
	           200MG
	                            N021222 001 Aug 29, 2001

      +
	                           400MG
	                            N021222 002 Jul 21, 2008
	
CEFEPIME HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     CEFEPIME HYDROCHLORIDE
	
AP         ACS DOBFAR
	          EQ 1GM BASE/VIAL
                     A065441   001   Mar   20,   2008

AP
	                             EQ 2GM BASE/VIAL
                     A065441   002   Mar   20,   2008

AP         HOSPIRA INC
	         EQ 1GM BASE/VIAL
                     A065369   002   Jun   18,   2007

AP
	                             EQ 1GM BASE/VIAL
                     A202268   001   Jul   30,   2012

AP
	                             EQ 2GM BASE/VIAL
                     A065369   003   Jun   18,   2007

AP
	                             EQ 2GM BASE/VIAL
                     A202268   002   Jul   30,   2012

AP
	                             EQ 500MG BASE/VIAL
	                  A065369   001   Jun   18,   2007
	
     MAXIPIME
	
AP     + HOSPIRA INC
	           EQ 1GM BASE/VIAL
                     N050679 002 Jan 18, 1996

AP     +
	                       EQ 2GM BASE/VIAL
                     N050679 003 Jan 18, 1996

AP     +
	                       EQ 500MG BASE/VIAL
	                  N050679 001 Jan 18, 1996
	
     CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
	
           B BRAUN               EQ 1GM BASE/VIAL                      N050821 001 May 06, 2010

                                 EQ 2GM BASE/VIAL                      N050821 002 May 06, 2010

     CEFEPIME IN PLASTIC CONTAINER
	
       + BAXTER HLTHCARE         EQ 1GM BASE/50ML (EQ 20MG BASE/ML)    N050817 001 Aug 05, 2008

       +                         EQ 2GM BASE/100ML (EQ 20MG BASE/ML)   N050817 002 Aug 05, 2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-69(of 371)


CEFIXIME
	
  CAPSULE;ORAL
	
    SUPRAX
	
      + LUPIN LTD               400MG		                         N203195 001 Jun 01, 2012
	
  FOR SUSPENSION;ORAL
	
    SUPRAX
	
      + LUPIN LTD               500MG/5ML                       N202091 001 Feb 20, 2013
	
          LUPIN PHARMS          100MG/5ML                       A065129 001 Feb 23, 2004
	
                                200MG/5ML                       A065355 001 Apr 10, 2007

 TABLET;ORAL
	
   SUPRAX
	
     + LUPIN PHARMS             400MG                           A065130 001 Feb 12, 2004
	
 TABLET, CHEWABLE;ORAL
	
   SUPRAX
	
        LUPIN LTD		             100MG                           A065380 001 Oct 25, 2010
	
                                150MG                           A065380 002 Oct 25, 2010
	
     +                          200MG		                         A065380 003 Oct 25, 2010
	
CEFOTAXIME SODIUM
	
  INJECTABLE;INJECTION

    CEFOTAXIME
	
AP       HIKMA                  EQ 1GM BASE/VIAL                A065072   002   Nov   20,   2002

AP                              EQ 2GM BASE/VIAL                A065072   003   Nov   20,   2002

AP                              EQ 10GM BASE/VIAL               A065071   001   Nov   20,   2002

AP                              EQ 500MG BASE/VIAL              A065072   001   Nov   20,   2002

AP       WOCKHARDT              EQ 1GM BASE/VIAL                A065197   001   Aug   29,   2006

    CEFOTAXIME SODIUM
	
AP       HOSPIRA INC            EQ 1GM BASE/VIAL                A065290   002   Aug   11,   2006

AP                              EQ 1GM BASE/VIAL                A065293   001   Aug   10,   2006

AP                              EQ 2GM BASE/VIAL                A065290   003   Aug   11,   2006

AP                              EQ 2GM BASE/VIAL                A065293   002   Aug   10,   2006

AP                              EQ 10GM BASE/VIAL               A065292   001   Aug   10,   2006

AP                              EQ 500MG BASE/VIAL              A065290   001   Aug   11,   2006

AP       LUPIN                  EQ 1GM BASE/VIAL                A065124   002   Sep   24,   2003

AP                              EQ 2GM BASE/VIAL                A065124   003   Sep   24,   2003

AP                              EQ 500MG BASE/VIAL              A065124   001   Sep   24,   2003

AP       WOCKHARDT              EQ 2GM BASE/VIAL                A065197   003   Jun   20,   2008

AP                              EQ 500MG BASE/VIAL              A065197   002   Jun   20,   2008

    CLAFORAN
	
AP    + SANOFI AVENTIS US       EQ 1GM BASE/VIAL                A062659   001 Jan 13, 1987

AP    +                         EQ 1GM BASE/VIAL                N050547   002
	
AP    +                         EQ 2GM BASE/VIAL                A062659   002 Jan 13, 1987

AP    +                         EQ 2GM BASE/VIAL                N050547   003
	
AP    +                         EQ 10GM BASE/VIAL               N050547   004 Dec 29, 1983

AP    +                         EQ 500MG BASE/VIAL              N050547   001
	
    CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
	
      + SANOFI AVENTIS US       EQ 20MG BASE/ML		               N050596 002 May 20, 1985

      +                         EQ 40MG BASE/ML		               N050596 004 May 20, 1985
	
CEFOTETAN DISODIUM
	
  INJECTABLE;INJECTION

    CEFOTETAN
	
AP    + FRESENIUS KABI USA      EQ 1GM BASE/VIAL                A065374   001   Aug   09,   2007

AP    +                         EQ 2GM BASE/VIAL                A065374   002   Aug   09,   2007

AP    +                         EQ 10GM BASE/VIAL               A065375   001   Aug   09,   2007

AP       WEST-WARD PHARM CORP   EQ 1GM BASE/VIAL                A091031   001   Oct   26,   2011

AP                              EQ 2GM BASE/VIAL                A091031   002   Oct   26,   2011

AP                              EQ 10GM BASE/VIAL               A091030   001   Oct   26,   2011
	
    CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
	
      + B BRAUN                 EQ 1GM BASE/VIAL		              A065430 001 Aug 09, 2007

      +                         EQ 2GM BASE/VIAL		              A065430 002 Aug 09, 2007
	
CEFOXITIN SODIUM
	
  INJECTABLE;INJECTION

    CEFOXITIN
	
AP    + ACS DOBFAR              EQ   1GM BASE/VIAL              A065414   001   Jun   12,   2009

AP    +                         EQ   2GM BASE/VIAL              A065414   002   Jun   12,   2009

AP    +                         EQ   10GM BASE/VIAL             A065415   001   May   19,   2010

AP       ANTIBIOTICOS BRASIL    EQ   1GM BASE/VIAL              A065467   001   Aug   31,   2011

AP                              EQ   2GM BASE/VIAL              A065467   002   Aug   31,   2011

AP                              EQ   10GM BASE/VIAL             A065464   001   Aug   31,   2011

AP       HIKMA FARMACEUTICA     EQ   1GM BASE/VIAL              A065238   001   Mar   12,   2010

AP                              EQ   2GM BASE/VIAL              A065238   002   Mar   12,   2010

AP                              EQ   10GM BASE/VIAL             A065239   001   Mar   02,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-70(of 371)


CEFOXITIN SODIUM
	
  INJECTABLE;INJECTION

    CEFOXITIN
	
AP       HIKMA MAPLE            EQ 1GM BASE/VIAL               A065051   001   Sep   11,   2000

AP                              EQ 2GM BASE/VIAL               A065051   002   Sep   11,   2000

AP                              EQ 10GM BASE/VIAL              A065050   001   Sep   11,   2000

AP       HOSPIRA INC            EQ 1GM BASE/VIAL               A065313   001   Jan   23,   2006

AP                              EQ 2GM BASE/VIAL               A065313   002   Jan   23,   2006

AP                              EQ 10GM BASE/VIAL              A065312   001   Feb   13,   2006

    CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
	
AP       B BRAUN                EQ 1GM BASE/VIAL               A065214 001 Mar 10, 2006

AP                              EQ 2GM BASE/VIAL               A065214 002 Mar 10, 2006
	
    MEFOXIN IN PLASTIC CONTAINER
	
      + MYLAN INSTITUTIONAL     EQ 20MG BASE/ML                A063182 001 Jan 25, 1993
	
      +                         EQ 40MG BASE/ML                A063182 002 Jan 25, 1993
	
CEFPODOXIME PROXETIL
	
  FOR SUSPENSION;ORAL

    CEFPODOXIME PROXETIL
	
AB       AUROBINDO PHARMA LTD   EQ   50MG BASE/5ML             A065409   001   Jun   08,   2007

AB                              EQ   100MG BASE/5ML            A065409   002   Jun   08,   2007

AB       RANBAXY                EQ   50MG BASE/5ML             A065082   001   May   31,   2002

AB                              EQ   100MG BASE/5ML            A065082   002   May   31,   2002

AB       SANDOZ                 EQ   50MG BASE/5ML             A090031   001   Jan   14,   2009

AB    +                         EQ   100MG BASE/5ML            A090031   002   Jan   14,   2009
	
  TABLET;ORAL

    CEFPODOXIME PROXETIL
	
AB       AUROBINDO PHARMA       EQ   100MG   BASE              A065370   001   Jun   11,   2007

AB                              EQ   200MG   BASE              A065370   002   Jun   11,   2007

AB       ORCHID HLTHCARE        EQ   100MG   BASE              A065388   001   Nov   14,   2007

AB                              EQ   200MG   BASE              A065388   002   Nov   14,   2007

AB       RANBAXY                EQ   100MG   BASE              A065083   001   Aug   20,   2003

AB                              EQ   200MG   BASE              A065083   002   Aug   20,   2003

AB       SANDOZ                 EQ   100MG   BASE              A065462   001   May   28,   2008

AB    +                         EQ   200MG   BASE              A065462   002   May   28,   2008
	
CEFPROZIL
	
  FOR SUSPENSION;ORAL

    CEFPROZIL
	
AB       APOTEX INC             125MG/5ML                      A065351   001   Feb   29,   2012

AB                              250MG/5ML                      A065351   002   Feb   29,   2012

AB       AUROBINDO PHARMA       125MG/5ML                      A065381   001   Jan   30,   2007

AB                              250MG/5ML                      A065381   002   Jan   30,   2007

AB       LUPIN                  125MG/5ML                      A065261   001   Dec   19,   2005

AB    +                         250MG/5ML                      A065261   002   Dec   19,   2005

AB       ORCHID HLTHCARE        125MG/5ML                      A065284   002   Dec   30,   2005

AB                              250MG/5ML                      A065284   001   Dec   30,   2005

AB       SANDOZ                 125MG/5ML                      A065257   001   Dec   08,   2005

AB                              250MG/5ML                      A065257   002   Dec   08,   2005

AB       TEVA PHARMS            125MG/5ML                      A065236   001   Dec   08,   2005

AB                              250MG/5ML                      A065236   002   Dec   08,   2005
	
  TABLET;ORAL

    CEFPROZIL
	
AB       APOTEX INC             250MG                          A065327   001   Mar   26,   2008

AB                              500MG                          A065327   002   Mar   26,   2008

AB       AUROBINDO PHARMA LTD   250MG                          A065340   001   May   24,   2007

AB                              500MG                          A065340   002   May   24,   2007

AB       LUPIN                  250MG                          A065276   001   Dec   08,   2005

AB    +                         500MG                          A065276   002   Dec   08,   2005

AB       ORCHID HLTHCARE        250MG                          A065267   001   Dec   19,   2005

AB                              500MG                          A065267   002   Dec   19,   2005

AB       SANDOZ                 250MG                          A065235   001   Nov   14,   2005

AB                              500MG                          A065235   002   Nov   14,   2005

AB       TEVA                   250MG                          A065208   001   Dec   06,   2005

AB                              500MG                          A065208   002   Dec   06,   2005

AB       WOCKHARDT              250MG                          A065428   001   Jun   14,   2007

AB                              500MG                          A065428   002   Jun   14,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                             3-71(of 371)


CEFTAROLINE FOSAMIL
	
  POWDER;IV (INFUSION)

    TEFLARO
	
         CEREXA                  400MG/VIAL                           N200327 001 Oct 29, 2010
	
      +                          600MG/VIAL                           N200327 002 Oct 29, 2010
	
CEFTAZIDIME
	
  INJECTABLE;INJECTION

    CEFTAZIDIME
	
AP       ACS DOBFAR             1GM/VIAL                              A062640   002   Nov   20,   1985

AP                              2GM/VIAL                              A062640   003   Nov   20,   1985

AP                              6GM/VIAL                              A062640   004   Feb   03,   1992

AP                              500MG/VIAL                            A062640   001   Nov   20,   1985

AP       WOCKHARDT              1GM/VIAL                              A065196   001   Oct   15,   2008

    FORTAZ
	
AP    + COVIS INJECTABLES       1GM/VIAL                              N050578   002   Jul   19,   1985

AP    +                         2GM/VIAL                              N050578   003   Jul   19,   1985

AP    +                         6GM/VIAL                              N050578   004   Jul   19,   1985

AP    +                         500MG/VIAL                            N050578   001   Jul   19,   1985

    TAZICEF
	
AP       HOSPIRA                1GM/VIAL                              A062662   002   Mar   06,   1986

AP                              1GM/VIAL                              A064032   001   Oct   31,   1993

AP                              2GM/VIAL                              A062662   003   Mar   06,   1986

AP                              2GM/VIAL                              A064032   002   Oct   31,   1993

AP                              6GM/VIAL                              A062662   004   Mar   06,   1986

AP                              500MG/VIAL                            A062662   001   Mar   06,   1986
	
    CEFTAZIDIME IN DEXTROSE CONTAINER
	
         B BRAUN                EQ 1GM BASE                           N050823 001 Jun 13, 2011
	
      +                         EQ 2GM BASE                           N050823 002 Jun 13, 2011
	
CEFTAZIDIME SODIUM
	
  INJECTABLE;INJECTION
	
    FORTAZ IN PLASTIC CONTAINER
	
      + COVIS INJECTABLES         EQ 20MG BASE/ML                     N050634 002 Apr 28, 1989

      +                           EQ 40MG BASE/ML                     N050634 003 Apr 28, 1989
	
CEFTIBUTEN DIHYDRATE
	
  CAPSULE;ORAL
	
    CEDAX
	
      + PERNIX THERAP            EQ 400MG BASE                        N050685 002 Dec 20, 1995
	
  FOR SUSPENSION;ORAL
	
    CEDAX
	
      + PERNIX THERAP            EQ 90MG BASE/5ML                     N050686 001 Dec 20, 1995
	
      +                          EQ 180MG BASE/5ML                    N050686 002 Dec 20, 1995
	
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
	
  POWDER;IV (INFUSION)

    ZERBAXA
	
      + CUBIST PHARMS           EQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL   N206829 001 Dec 19, 2014
	
CEFTRIAXONE SODIUM
	
  INJECTABLE;INJECTION

    CEFTRIAXONE
	
AP       ACS DOBFAR             EQ 1GM BASE/VIAL                      A065329   002   Jul   24,   2008

AP                              EQ 2GM BASE/VIAL                      A065329   003   Jul   24,   2008

AP                              EQ 10GM BASE/VIAL                     A065328   001   Jul   24,   2008

AP                              EQ 500MG BASE/VIAL                    A065329   001   Jul   24,   2008

AP       BEDFORD                EQ 10GM BASE/VIAL                     A065475   001   Aug   18,   2008

AP       HOSPIRA INC            EQ 1GM BASE/VIAL                      A065231   001   Aug   02,   2005

AP                              EQ 1GM BASE/VIAL                      A202563   001   Aug   20,   2012

AP                              EQ 2GM BASE/VIAL                      A065231   002   Aug   02,   2005

AP                              EQ 2GM BASE/VIAL                      A202563   002   Aug   20,   2012

AP                              EQ 10GM BASE/VIAL                     A065232   001   Aug   02,   2005

AP       LUPIN                  EQ 10GM BASE/VIAL                     A065263   001   Sep   12,   2006

AP    + SANDOZ                  EQ 10GM BASE/VIAL                     A065168   001   May   17,   2005

AP    + SANDOZ INC              EQ 1GM BASE/VIAL                      A065204   001   May   03,   2005

AP    +                         EQ 2GM BASE/VIAL                      A065204   002   May   03,   2005

AP       STERI PHARMA           EQ 10GM BASE/VIAL                     A065269   001   Feb   28,   2007

AP       WOCKHARDT              EQ 1GM BASE/VIAL                      A065180   001   May   12,   2006

    CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
	
AP    + B BRAUN                 EQ 1GM BASE/VIAL                      N050796 001 Apr 20, 2005

AP    +                         EQ 2GM BASE/VIAL                      N050796 002 Apr 20, 2005

    ROCEPHIN
	
AP    + HOFFMANN LA ROCHE       EQ 1GM BASE/VIAL                      A063239 003 Aug 13, 1993

AP    +                         EQ 500MG BASE/VIAL                    A063239 002 Aug 13, 1993
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-72(of 371)


CEFTRIAXONE SODIUM
	
  INJECTABLE;INJECTION
	
    CEFTRIAXONE
	
         SAMSON MEDCL           EQ 100GM BASE/VIAL             A090057 001 Apr 25, 2014

    CEFTRIAXONE IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         EQ 20MG BASE/ML                A065224 001 Aug 23, 2005

      +                         EQ 40MG BASE/ML                A065224 002 Aug 23, 2005

  INJECTABLE;INTRAMUSCULAR, INTRAVENOUS

    CEFTRIAXONE
	
AP       AKORN INC              EQ 1GM BASE/VIAL               A065305   003   Jan   11,   2008

AP                              EQ 2GM BASE/VIAL               A065305   004   Jan   11,   2008

AP                              EQ 250MG BASE/VIAL             A065305   001   Jan   11,   2008

AP                              EQ 500MG BASE/VIAL             A065305   002   Jan   11,   2008

AP       BEDFORD                EQ 1GM BASE/VIAL               A065465   003   Aug   18,   2008

AP                              EQ 2GM BASE/VIAL               A065465   004   Aug   18,   2008

AP                              EQ 250MG BASE/VIAL             A065465   001   Aug   18,   2008

AP                              EQ 500MG BASE/VIAL             A065465   002   Aug   18,   2008

AP       FRESENIUS KABI USA     EQ 250MG BASE/VIAL             A065245   001   Feb   15,   2006

AP       HIKMA FARMACEUTICA     EQ 1GM BASE/VIAL               A065342   003   Jan   10,   2008

AP                              EQ 2GM BASE/VIAL               A065342   004   Jan   10,   2008

AP                              EQ 250MG BASE/VIAL             A065342   001   Jan   10,   2008

AP                              EQ 500MG BASE/VIAL             A065342   002   Jan   10,   2008

AP       HOSPIRA INC            EQ 1GM BASE/VIAL               A065230   003   Aug   02,   2005

AP                              EQ 2GM BASE/VIAL               A065230   004   Aug   02,   2005

AP                              EQ 250MG BASE/VIAL             A065230   001   Aug   02,   2005

AP                              EQ 500MG BASE/VIAL             A065230   002   Aug   02,   2005

AP       LUPIN                  EQ 1GM BASE/VIAL               A065125   003   Sep   30,   2003

AP                              EQ 2GM BASE/VIAL               A065125   004   Sep   30,   2003

AP                              EQ 250MG BASE/VIAL             A065125   001   Sep   30,   2003

AP                              EQ 500MG BASE/VIAL             A065125   002   Sep   30,   2003

AP    + SANDOZ                  EQ 1GM BASE/VIAL               A065169   003   May   09,   2005

AP    +                         EQ 2GM BASE/VIAL               A065169   004   May   09,   2005

AP    +                         EQ 250MG BASE/VIAL             A065169   001   May   09,   2005

AP    +                         EQ 500MG BASE/VIAL             A065169   002   May   09,   2005

AP       WOCKHARDT              EQ 2GM BASE/VIAL               A065391   003   Apr   12,   2007

AP                              EQ 250MG BASE/VIAL             A065391   001   Apr   12,   2007

AP                              EQ 500MG BASE/VIAL             A065391   002   Apr   12,   2007
	
CEFUROXIME AXETIL
	
  FOR SUSPENSION;ORAL

    CEFTIN
	
AB       GLAXOSMITHKLINE        EQ 125MG BASE/5ML              N050672 001 Jun 30, 1994

AB    +                         EQ 250MG BASE/5ML              N050672 002 Apr 29, 1997

    CEFUROXIME AXETIL
	
AB       RANBAXY                EQ 125MG BASE/5ML              A065323 001 Feb 05, 2008

AB                              EQ 250MG BASE/5ML              A065323 002 Feb 05, 2008
	
  TABLET;ORAL

    CEFTIN
	
AB       GLAXOSMITHKLINE        EQ 125MG BASE                  N050605 001 Dec 28, 1987

AB                              EQ 250MG BASE                  N050605 002 Dec 28, 1987

AB    +                         EQ 500MG BASE                  N050605 003 Dec 28, 1987

    CEFUROXIME AXETIL
	
AB       ALKEM LABS LTD         EQ   250MG   BASE              A065496   001   Jun   07,   2010

AB                              EQ   500MG   BASE              A065496   002   Jun   07,   2010

AB       APOTEX                 EQ   250MG   BASE              A065069   001   Oct   02,   2002

AB                              EQ   500MG   BASE              A065069   002   Oct   02,   2002

AB       AUROBINDO PHARMA LTD   EQ   125MG   BASE              A065308   001   Mar   29,   2006

AB                              EQ   250MG   BASE              A065308   002   Mar   29,   2006

AB                              EQ   500MG   BASE              A065308   003   Mar   29,   2006

AB       LUPIN                  EQ   250MG   BASE              A065135   001   Jul   25,   2003

AB                              EQ   500MG   BASE              A065135   002   Jul   25,   2003

AB       ORCHID HLTHCARE        EQ   125MG   BASE              A065359   001   Feb   15,   2008

AB                              EQ   250MG   BASE              A065359   002   Feb   15,   2008

AB                              EQ   500MG   BASE              A065359   003   Feb   15,   2008

AB       RANBAXY                EQ   125MG   BASE              A065118   001   Apr   25,   2003

AB                              EQ   250MG   BASE              A065118   002   Apr   25,   2003

AB                              EQ   500MG   BASE              A065118   003   Apr   25,   2003

AB       TEVA                   EQ   250MG   BASE              A065190   001   Oct   18,   2004

AB                              EQ   500MG   BASE              A065190   002   Oct   18,   2004

AB       WOCKHARDT              EQ   125MG   BASE              A065166   001   Jul   29,   2005

AB                              EQ   250MG   BASE              A065166   002   Jul   29,   2005

AB                              EQ   500MG   BASE              A065166   003   Jul   29,   2005
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-73(of 371)


CEFUROXIME SODIUM
	
  INJECTABLE;INJECTION

    CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
	
AP    + B BRAUN                 EQ 1.5GM BASE/VIAL             N050780 002 Feb 21, 2001

AP    +                         EQ 750MG BASE/VIAL             N050780 001 Feb 21, 2001

    CEFUROXIME SODIUM
	
AP       HIKMA FARMACEUTICA     EQ 1.5GM BASE/VIAL             A065048   002   Jan   09,   2004

AP                              EQ 7.5GM BASE/VIAL             A065046   001   Jan   09,   2004

AP       HOSPIRA INC            EQ 1.5GM BASE/VIAL             A065483   002   Oct   15,   2008

AP                              EQ 1.5GM BASE/VIAL             A065503   001   Oct   15,   2008

AP                              EQ 7.5GM BASE/VIAL             A065484   001   Oct   15,   2008

AP       STERI PHARMA           EQ 1.5GM BASE/VIAL             A064125   002   May   30,   1997

AP                              EQ 7.5GM BASE/VIAL             A064124   001   May   30,   1997

    ZINACEF
	
AP    + COVIS INJECTABLES       EQ 1.5GM BASE/VIAL             N050558 003 Oct 19, 1983

AP    +                         EQ 7.5GM BASE/VIAL             N050558 004 Oct 23, 1986
	
    ZINACEF IN PLASTIC CONTAINER
	
      + COVIS INJECTABLES       EQ 30MG BASE/ML                N050643 002 Apr 28, 1989

  INJECTABLE;INTRAMUSCULAR, INTRAVENOUS

    CEFUROXIME SODIUM
	
AB       HIKMA FARMACEUTICA     EQ 750MG BASE/VIAL             A065048 001 Jan 09, 2004

AB       STERI PHARMA           EQ 750MG BASE/VIAL             A064125 001 May 30, 1997

    ZINACEF
	
AB    + COVIS INJECTABLES       EQ 750MG BASE/VIAL             N050558 002 Oct 19, 1983

    CEFUROXIME SODIUM
	
AP       HOSPIRA INC            EQ 750MG BASE/VIAL             A065483 001 Oct 15, 2008
	
CELECOXIB
	
  CAPSULE;ORAL

    CELEBREX
	
AB       GD SEARLE              50MG                           N020998   004   Dec   15,   2006

AB                              100MG                          N020998   001   Dec   31,   1998

AB                              200MG                          N020998   002   Dec   31,   1998

AB    +                         400MG                          N020998   003   Aug   29,   2002

    CELECOXIB
	
AB       LUPIN LTD              50MG                           A202240   001   Oct   29,   2014

AB       MYLAN PHARMS INC       50MG                           A078857   001   May   30,   2014

AB       TEVA                   50MG                           A076898   001   May   30,   2014

AB                              100MG                          A076898   002   May   30,   2014

AB                              200MG                          A076898   003   May   30,   2014

AB                              400MG                          A076898   004   May   30,   2014
	
CEPHALEXIN
	
  CAPSULE;ORAL

    CEPHALEXIN
	
AB       ALKEM LABS LTD         EQ   250MG   BASE              A090836   001   Dec   20,   2010

AB                              EQ   500MG   BASE              A090836   002   Dec   20,   2010

AB                              EQ   750MG   BASE              A090836   004   Mar   29,   2013

AB       AUROBINDO PHARMA LTD   EQ   250MG   BASE              A065253   001   Nov   16,   2005

AB                              EQ   500MG   BASE              A065253   002   Nov   16,   2005

AB       BELCHER PHARMS         EQ   250MG   BASE              A062713   001   Jul   15,   1988

AB                              EQ   500MG   BASE              A062713   002   Jul   15,   1988

AB       HIKMA                  EQ   250MG   BASE              A065215   001   Jan   24,   2006

AB                              EQ   500MG   BASE              A065215   002   Jan   24,   2006

AB       LUPIN                  EQ   250MG   BASE              A065229   001   Nov   25,   2005

AB                              EQ   500MG   BASE              A065229   002   Nov   25,   2005

AB       ORCHID HLTHCARE        EQ   250MG   BASE              A065248   001   Jun   28,   2005

AB                              EQ   500MG   BASE              A065248   002   Jun   28,   2005

AB       RANBAXY                EQ   250MG   BASE              A065007   001   Sep   16,   1999

AB                              EQ   500MG   BASE              A065007   002   Sep   16,   1999

AB       SUN PHARM INDS (IN)    EQ   250MG   BASE              A062791   001   Jun   11,   1987

AB                              EQ   500MG   BASE              A062791   002   Jun   11,   1987

AB       TEVA                   EQ   250MG   BASE              A062702   001   Feb   13,   1987

AB                              EQ   500MG   BASE              A062702   002   Feb   13,   1987

AB       YUNG SHIN PHARM        EQ   250MG   BASE              A065152   001   Feb   24,   2005

AB                              EQ   500MG   BASE              A065152   002   Feb   24,   2005

    KEFLEX
	
AB       SHIONOGI INC           EQ 250MG BASE                  N050405 002
	
AB                              EQ 500MG BASE                  N050405 003
	
AB    +                         EQ 750MG BASE                  N050405 005 May 12, 2006

    CEPHALEXIN
	
         ALKEM LABS LTD         EQ 333MG BASE                  A090836 003 Mar 29, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                         3-74(of 371)


CEPHALEXIN
	
  FOR SUSPENSION;ORAL

    CEPHALEXIN
	
AB       LUPIN                   EQ    125MG   BASE/5ML         A065234   001     Aug   17,   2005

AB                               EQ    250MG   BASE/5ML         A065234   002     Aug   17,   2005

AB       ORCHID HLTHCARE         EQ    125MG   BASE/5ML         A065326   001     Jul   10,   2006

AB                               EQ    250MG   BASE/5ML         A065326   002     Jul   10,   2006

AB       TEVA                    EQ    125MG   BASE/5ML         A062703   001     Feb   13,   1987

AB    +                          EQ    250MG   BASE/5ML         A062703   002     Feb   13,   1987
	
  TABLET;ORAL
	
    CEPHALEXIN
	
         TEVA                    EQ 250MG BASE                  A063023 001 Jan 12, 1989
	
      +                          EQ 500MG BASE                  A063024 001 Jan 12, 1989
	
CERITINIB
	
  CAPSULE;ORAL
	
    ZYKADIA
	
      + NOVARTIS PHARMS CORP     150MG                          N205755 001 Apr 29, 2014
	
CETIRIZINE HYDROCHLORIDE
	
  SYRUP;ORAL

    CETIRIZINE HYDROCHLORIDE
	
AA       AMNEAL PHARMS           5MG/5ML                        A090766   001     Oct   07,   2009

AA       BIO PHARM INC           5MG/5ML                        A078870   001     Apr   27,   2009

AA       BRECKENRIDGE PHARM      5MG/5ML                        A078488   001     Oct   06,   2008

AA       PERRIGO R AND D         5MG/5ML                        A078398   001     Jun   17,   2008

AA       SILARX                  5MG/5ML                        A078876   001     May   11,   2012

AA       SUN PHARM INDS INC      5MG/5ML                        A090191   001     Nov   12,   2009

AA       TARO                    5MG/5ML                        A076601   001     Jun   20,   2008

AA       TEVA PHARMS             5MG/5ML                        A077279   001     May   27,   2008

AA       VINTAGE                 5MG/5ML                        A078496   001     Sep   25,   2009

AA       WOCKHARDT               5MG/5ML                        A078757   001     Aug   28,   2009

    ZYRTEC
	
AA    + MCNEIL CONSUMER          5MG/5ML                        N020346 001 Sep 27, 1996
	
CETRORELIX
	
  INJECTABLE;INJECTION
	
    CETROTIDE
	
      + EMD SERONO INC           EQ 0.25MG BASE/ML              N021197 001 Aug 11, 2000
	
CEVIMELINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    CEVIMELINE
	
AB       APOTEX INC              30MG                           A091260 001 Aug 25, 2011

    CEVIMELINE HYDROCHLORIDE
	
AB       PACK PHARMS LLC         30MG                           A203775 001 Jun 04, 2014

AB       ROXANE                  30MG                           A091591 001 Jul 08, 2013

    EVOXAC
	
AB    + DAIICHI SANKYO           30MG                           N020989 002 Jan 11, 2000
	
CHENODIOL
	
  TABLET;ORAL
	
    CHENODIOL
	
      + NEXGEN PHARMA            250MG                          A091019 001 Oct 22, 2009
	
CHLORAMBUCIL
	
  TABLET;ORAL
	
    LEUKERAN
	
      + ASPEN GLOBAL INC         2MG                            N010669 002
	
CHLORAMPHENICOL SODIUM SUCCINATE
	
  INJECTABLE;INJECTION
	
    CHLORAMPHENICOL SODIUM SUCCINATE
	
      + FRESENIUS KABI USA      EQ 1GM BASE/VIAL                A062365 001 Aug 25, 1982
	
CHLORDIAZEPOXIDE HYDROCHLORIDE
	
  CAPSULE;ORAL

    CHLORDIAZEPOXIDE HYDROCHLORIDE
	
AB       BARR                    5MG                            A084768   001
	
AB                               10MG                           A083116   001
	
AB                               25MG                           A084769   001
	
AB       USL PHARMA              10MG                           A084623   001
	
    LIBRIUM
	
AB       VALEANT PHARM INTL      5MG                            A085461 001
	
AB                               10MG                           A085472 001
	
AB    +                          25MG                           A085475 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                       3-75(of 371)


CHLORHEXIDINE GLUCONATE
	
  SOLUTION;DENTAL

    CHLORHEXIDINE GLUCONATE
	
AT       HI TECH PHARMA         0.12%                           A074356   001     May   07,   1996

AT       LYNE                   0.12%                           A074291   001     Dec   28,   1995

AT       TEVA                   0.12%                           A074522   001     Dec   15,   1995

AT       WOCKHARDT              0.12%                           A075006   001     Mar   03,   2004

AT       XTTRIUM                0.12%                           A077789   001     Jun   18,   2009

    PAROEX
	
AT       SUNSTAR AMERICAS       0.12%                           A076434 001 Nov 29, 2005

    PERIDEX
	
AT    + 3M                      0.12%                           N019028 001 Aug 13, 1986

    PERIOGARD
	
AT       COLGATE                0.12%                           A073695 001 Jan 14, 1994
	
  TABLET;DENTAL
	
    PERIOCHIP
	
      + DEXCEL PHARMA           2.5MG		                         N020774 001 May 15, 1998
	
CHLOROPROCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    CHLOROPROCAINE HYDROCHLORIDE
	
AP       EUROHLTH INTL          2%                              A040273   001     Sep   09,   1998

AP                              3%                              A040273   002     Sep   09,   1998

AP       HOSPIRA                2%                              A087447   001     Apr   16,   1982

AP                              3%                              A087446   001     Apr   16,   1982

    NESACAINE
	
AP       FRESENIUS KABI USA     2%                              N009435 002
	
    NESACAINE-MPF
	
AP    + FRESENIUS KABI USA      2%                              N009435 006 May 02, 1996

AP    +                         3%                              N009435 007 May 02, 1996

    NESACAINE
	
      + FRESENIUS KABI USA		    1%                              N009435 001
	
CHLOROQUINE PHOSPHATE
	
  TABLET;ORAL

    ARALEN
	
AA    + SANOFI AVENTIS US       EQ 300MG BASE                   N006002 001
	
    CHLOROQUINE PHOSPHATE

AA    + HIKMA PHARMS LLC        EQ   150MG   BASE               A083082   001
	
AA                              EQ   300MG   BASE               A083082   002     Sep 17, 1999

AA       IMPAX LABS             EQ   150MG   BASE               A080880   001
	
AA                              EQ   300MG   BASE               A040516   001     Aug   29,   2003

AA       IPCA LABS LTD          EQ   150MG   BASE               A090610   001     Dec   03,   2009

AA                              EQ   300MG   BASE               A090249   001     Dec   03,   2009

AA       NATCO PHARMA LTD       EQ   150MG   BASE               A091621   001     Jan   21,   2011

AA                              EQ   300MG   BASE               A090612   001     Jan   21,   2011
	
CHLOROTHIAZIDE
	
  SUSPENSION;ORAL
	
    DIURIL
	
      + SALIX PHARMS		          250MG/5ML                       N011870 001
	
  TABLET;ORAL
	
    CHLOROTHIAZIDE
	
      +		 MYLAN                 250MG                           A084388 001
	
                                500MG                           A084217 001
	
CHLOROTHIAZIDE SODIUM
	
  INJECTABLE;INJECTION

    CHLOROTHIAZIDE SODIUM
	
AP       FRESENIUS KABI USA     EQ   500MG   BASE/VIAL          A090896   001     Oct   16,   2009

AP       LUITPOLD               EQ   500MG   BASE/VIAL          A202561   001     Apr   22,   2013

AP       MYLAN INSTITUTIONAL    EQ   500MG   BASE/VIAL          A202493   001     Jun   18,   2014

AP       SUN PHARMA GLOBAL      EQ   500MG   BASE/VIAL          A091546   001     Jul   26,   2011

    DIURIL
	
AP    + OAK PHARMS AKORN        EQ 500MG BASE/VIAL              N011145 005
	
CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
	
  SOLUTION;ORAL
	
    VITUZ
	
      + CYPRESS PHARM		         4MG/5ML;5MG/5ML                 N204307 001 Feb 20, 2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                  3-76(of 371)


CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  SOLUTION;ORAL

    HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE

AA       TRIS PHARMA INC        4MG/5ML;5MG/5ML;60MG/5ML                  A203838 001 Nov 26, 2014

    HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE

AA       PADDOCK LLC            4MG/5ML;5MG/5ML;60MG/5ML                  A204627 001 Apr 29, 2014

    ZUTRIPRO
	
AA    + CYPRESS PHARM           4MG/5ML;5MG/5ML;60MG/5ML                  N022439 001 Jun 08, 2011
	
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    TUSSICAPS
	
         ECR PHARMA             EQ 4MG MALEATE;EQ 5MG BITARTRATE          A077273 002 Sep 24, 2007

      +                         EQ 8MG MALEATE;EQ 10MG BITARTRATE         A077273 001 Sep 24, 2007

  SUSPENSION, EXTENDED RELEASE;ORAL

    HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
	
AB       TRIS PHARMA INC        EQ 8MG MALEATE/5ML;EQ 10MG                A091632 001 Oct 01, 2010

                                BITARTRATE/5ML

    HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX
	
AB       NEOS THERAP INC        EQ 8MG MALEATE/5ML;EQ 10MG                A091671 001 Jun 29, 2012

                                BITARTRATE/5ML

    TUSSIONEX PENNKINETIC
	
AB    + UCB INC                 EQ 8MG MALEATE/5ML;EQ 10MG                N019111 001 Dec 31, 1987

                                BITARTRATE/5ML
	
CHLORPROMAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CHLORPROMAZINE HYDROCHLORIDE
	
      + HIKMA MAPLE             25MG/ML                                   A083329 001
	
  TABLET;ORAL
	
    CHLORPROMAZINE HYDROCHLORIDE
	
BP       SANDOZ                 10MG                                      A080439   001
	
BP                              25MG                                      A080439   002
	
BP                              50MG                                      A080439   003
	
BP    +                         100MG                                     A080439   004
	
BP                              200MG                                     A080439   005
	
BP       USL PHARMA             10MG                                      A083386   001
	
BP                              25MG                                      A084112   001
	
BP                              50MG                                      A084113   001
	
BP                              100MG                                     A084114   001
	
BP                              200MG                                     A084115   001
	
CHLORPROPAMIDE
	
  TABLET;ORAL

    CHLORPROPAMIDE
	
AB       ANI PHARMS INC        100MG                                      A088921   001     Apr   12,   1985

AB                             250MG                                      A088922   001     Apr   12,   1985

AB       MYLAN                 100MG                                      A088549   002     Jun   01,   1984

AB                             250MG                                      A088549   001     Jun   01,   1984

    DIABINESE
	
AB       PFIZER                100MG                                      N011641 003
	
AB    +                        250MG                                      N011641 006
	
CHLORTHALIDONE
	
  TABLET;ORAL
	
    CHLORTHALIDONE
	
         MYLAN                 25MG                                       A086831 002
	
      +                        50MG                                       A086831 001
	
    THALITONE
	
      + CITRON PHARMA LLC      15MG                                       N019574 001 Dec 20, 1988
	
CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    CLORPRES
	
         MYLAN                  15MG;0.1MG                                A071325 003 Feb 09, 1987
	
                                15MG;0.2MG                                A071325 002 Feb 09, 1987
	
      +                         15MG;0.3MG                                A071325 001 Feb 09, 1987
	
CHLORZOXAZONE
	
  TABLET;ORAL

    CHLORZOXAZONE
	
AA       BARR                  500MG                                      A089895 001 May 04, 1988

AA       WATSON LABS           500MG                                      A089859 001 May 04, 1988

    PARAFON FORTE DSC
	
AA    + JANSSEN R AND D        500MG                                      N011529 002 Jun 15, 1987
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                      3-77(of 371)


CHLORZOXAZONE
	
  TABLET;ORAL
	
    CHLORZOXAZONE
	
         MIKART                   375MG                           A040861 001 Jun 01, 2010
	
                                  750MG                           A040861 002 Jun 01, 2010
	
CHOLESTYRAMINE
	
  POWDER;ORAL

    CHOLESTYRAMINE
	
AB       PAR PHARM                EQ   4GM   RESIN/PACKET         A077204   001   Aug   26,   2005

AB                                EQ   4GM   RESIN/SCOOPFUL       A077204   002   Aug   26,   2005

AB    + SANDOZ                    EQ   4GM   RESIN/PACKET         A074557   001   Aug   15,   1996

AB                                EQ   4GM   RESIN/SCOOPFUL       A074557   002   Aug   15,   1996

    CHOLESTYRAMINE LIGHT
	
AB       PAR PHARM                EQ   4GM   RESIN/PACKET         A077203   001   Aug   26,   2005

AB                                EQ   4GM   RESIN/SCOOPFUL       A077203   002   Aug   26,   2005

AB    + SANDOZ                    EQ   4GM   RESIN/PACKET         A074558   001   Aug   15,   1996

AB                                EQ   4GM   RESIN/SCOOPFUL       A074558   002   Aug   15,   1996

    PREVALITE
	
AB       UPSHER SMITH             EQ 4GM RESIN/PACKET             A073263 001 Feb 22, 1996

AB                                EQ 4GM RESIN/SCOOPFUL           A073263 002 Oct 30, 1997
	
CHOLINE C-11
	
  INJECTABLE;INTRAVENOUS
	
    CHOLINE C-11
	
      + MCPRF                     4-33.1mCi/ML                    N203155 001 Sep 12, 2012
	
CHOLINE FENOFIBRATE
	
  CAPSULE, DELAYED RELEASE;ORAL

    FENOFIBRIC ACID
	
AB       ANCHEN PHARMS           EQ    45MG FENOFIBRIC ACID       A201573   002   Jul   18,   2013

AB                               EQ    135MG FENOFIBRIC ACID      A201573   001   Jul   18,   2013

AB       LUPIN LTD               EQ    45MG FENOFIBRIC ACID       A200750   001   Dec   04,   2013

AB                               EQ    135MG FENOFIBRIC ACID      A200750   002   Dec   04,   2013

AB       MYLAN PHARMS INC        EQ    45MG FENOFIBRIC ACID       A200913   001   Mar   25,   2013

AB                               EQ    135MG FENOFIBRIC ACID      A200913   002   Mar   25,   2013

    TRILIPIX
	
AB       ABBVIE                  EQ    45MG FENOFIBRIC ACID       N022224 001 Dec 15, 2008

AB    +                          EQ    135MG FENOFIBRIC ACID      N022224 002 Dec 15, 2008
	
CHORIOGONADOTROPIN ALFA
	
  INJECTABLE;SUBCUTANEOUS
	
    OVIDREL
	
      + EMD SERONO                EQ 0.25MG /0.5ML                N021149 002 Oct 06, 2003
	
CHROMIC CHLORIDE
	
  INJECTABLE;INJECTION
	
    CHROMIC CHLORIDE IN PLASTIC CONTAINER
	
      + HOSPIRA                 EQ 0.004MG CHROMIUM/ML            N018961 001 Jun 26, 1986
	
CICLESONIDE
	
  AEROSOL, METERED;INHALATION
	
    ALVESCO
	
         TAKEDA GMBH              0.08MG/INH                      N021658 002 Jan 10, 2008
	
      +                           0.16MG/INH                      N021658 003 Jan 10, 2008
	
  AEROSOL, METERED;NASAL
	
    ZETONNA
	
      + TAKEDA GMBH               0.037MG/INH                     N202129 001 Jan 20, 2012
	
  SPRAY, METERED;NASAL
	
    OMNARIS
	
      + TAKEDA GMBH               0.05MG/INH                      N022004 001 Oct 20, 2006
	
CICLOPIROX
	
  CREAM;TOPICAL

    CICLOPIROX
	
AB       FOUGERA PHARMS           0.77%                           A076435   001   Dec   29,   2004

AB       G AND W LABS INC         0.77%                           A078463   001   Dec   20,   2010

AB       GLENMARK PHARMS          0.77%                           A090273   001   Nov   10,   2009

AB       PERRIGO                  0.77%                           A077364   001   Mar   03,   2006

AB       TARO                     0.77%                           A076790   001   Apr   12,   2005

    LOPROX
	
AB    + MEDIMETRIKS PHARMS        0.77%                           N018748 001 Dec 30, 1982
	
  GEL;TOPICAL

    CICLOPIROX
	
AB       FOUGERA PHARMS           0.77%                           A077896 001 Jun 10, 2008

AB       GLENMARK GENERICS        0.77%                           A091595 001 Feb 29, 2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                           3-78(of 371)


CICLOPIROX
	
  GEL;TOPICAL

    CICLOPIROX
	
AB       PADDOCK LLC            0.77%                               A078266 001 Jan 07, 2009

    LOPROX
	
AB    + CNTY LINE PHARMS        0.77%                               N020519 001 Jul 21, 1997
	
  SHAMPOO;TOPICAL

    CICLOPIROX
	
AT       ACTAVIS MID ATLANTIC   1%                                  A090490   001   Nov   24,   2009

AT       FOUGERA PHARMS         1%                                  A090146   001   May   25,   2010

AT       PERRIGO                1%                                  A078594   001   Feb   16,   2010

AT       TARO                   1%                                  A090269   001   Feb   23,   2011

    LOPROX
	
AT    + MEDICIS                 1%                                  N021159 001 Feb 28, 2003
	
  SOLUTION;TOPICAL

    CICLOPIROX
	
AT       ACTAVIS MID ATLANTIC   8%                                  A078046   001   Sep   18,   2007

AT       CIPLA LTD              8%                                  A078124   001   Sep   18,   2007

AT       G AND W LABS           8%                                  A078233   001   Sep   18,   2007

AT       HI TECH PHARMA         8%                                  A078270   001   Sep   18,   2007

AT       PERRIGO NEW YORK       8%                                  A077623   001   Sep   18,   2007

AT       TARO PHARM INDS        8%                                  A078144   001   Sep   18,   2007

AT       TOLMAR                 8%                                  A077687   001   Sep   18,   2007

AT       VERSAPHARM             8%                                  A078975   001   Feb   17,   2010

    PENLAC
	
AT    + VALEANT BERMUDA         8%                                  N021022 001 Dec 17, 1999
	
  SUSPENSION;TOPICAL

    CICLOPIROX
	
AB       FOUGERA PHARMS         0.77%                               A076422 001 Aug 06, 2004

AB       PERRIGO NEW YORK       0.77%                               A077676 001 Dec 15, 2006

AB       TARO                   0.77%                               A077092 001 Aug 10, 2005

    LOPROX
	
AB    + MEDIMETRIKS PHARMS      0.77%                               N019824 001 Dec 30, 1988
	
CIDOFOVIR
	
  INJECTABLE;INJECTION

    CIDOFOVIR
	
AP       EMCURE PHARMS LTD      EQ 75MG BASE/ML                     A202501 001 Jul 26, 2012

AP       MYLAN INSTITUTIONAL    EQ 75MG BASE/ML                     A201276 001 Jun 27, 2012

    VISTIDE
	
AP    + GILEAD SCIENCES INC     EQ 75MG BASE/ML                     N020638 001 Jun 26, 1996
	
CILASTATIN SODIUM; IMIPENEM
	
  POWDER;INTRAMUSCULAR
	
    PRIMAXIN
	
         MERCK                  EQ 500MG BASE/VIAL;500MG/VIAL       N050630 001 Dec 14, 1990
	
  POWDER;INTRAVENOUS

    IMIPENEM AND CILASTATIN
	
AP       ACS DOBFAR             EQ   250MG   BASE/VIAL;250MG/VIAL   A090577   001   Dec   21,   2011

AP                              EQ   500MG   BASE/VIAL;500MG/VIAL   A090577   002   Dec   21,   2011

AP       HOSPIRA INC            EQ   250MG   BASE/VIAL;250MG/VIAL   A090825   001   Nov   16,   2011

AP                              EQ   500MG   BASE/VIAL;500MG/VIAL   A090825   002   Nov   16,   2011

AP                              EQ   500MG   BASE/VIAL;500MG/VIAL   A091007   001   Nov   16,   2011

    PRIMAXIN
	
AP    + MERCK                   EQ 250MG BASE/VIAL;250MG/VIAL       N050587 001 Nov 26, 1985

AP    +                         EQ 500MG BASE/VIAL;500MG/VIAL       N050587 002 Nov 26, 1985
	
CILOSTAZOL
	
  TABLET;ORAL

    CILOSTAZOL
	
AB       APOTEX INC             50MG                                A077030   001   Dec   10,   2004

AB                              100MG                               A077030   002   Dec   10,   2004

AB       BIOKEY                 50MG                                A077722   001   Sep   24,   2012

AB                              100MG                               A077831   001   Sep   24,   2012

AB       BRECKENRIDGE PHARM     50MG                                A077708   001   Sep   28,   2009

AB                              100MG                               A077708   002   Sep   28,   2009

AB       MYLAN                  50MG                                A077323   002   Apr   20,   2006

AB                              100MG                               A077323   001   Apr   20,   2006

AB       MYLAN PHARMS INC       50MG                                A077019   001   Nov   23,   2004

AB                              100MG                               A077019   002   Nov   23,   2004

AB       PLIVA HRVATSKA DOO     50MG                                A077898   001   Oct   29,   2007

AB                              100MG                               A077898   002   Oct   29,   2007

AB       ROXANE                 50MG                                A077024   001   May   17,   2005

AB                              100MG                               A077024   002   May   17,   2005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-79(of 371)


CILOSTAZOL
	
  TABLET;ORAL

    CILOSTAZOL
	
AB       SANDOZ                  50MG                           A077310   001   Nov   08,   2005

AB                               100MG                          A077021   001   Nov   23,   2004

AB       TEVA                    50MG                           A077027   001   Nov   24,   2004

AB                               100MG                          A077027   002   Nov   24,   2004

    PLETAL
	
AB    + OTSUKA                   50MG                           N020863 001 Jan 15, 1999

AB    +                          100MG                          N020863 002 Jan 15, 1999
	
CIMETIDINE
	
  TABLET;ORAL

    CIMETIDINE
	
AB       APOTEX                  200MG                          A074890   001   Dec   18,   1998

AB                               300MG                          A074890   002   Dec   18,   1998

AB                               400MG                          A074890   003   Dec   18,   1998

AB                               800MG                          A074890   004   Dec   18,   1998

AB       MYLAN                   200MG                          A074246   001   May   17,   1994

AB                               300MG                          A074246   002   May   17,   1994

AB                               400MG                          A074246   003   May   17,   1994

AB    +                          800MG                          A074246   004   May   17,   1994

AB       PLIVA                   800MG                          A074566   001   Feb   27,   1997

AB       TEVA                    200MG                          A074151   001   May   17,   1994

AB                               300MG                          A074151   002   May   17,   1994

AB                               400MG                          A074151   003   May   17,   1994

AB                               800MG                          A074463   001   May   17,   1994
	
CIMETIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    CIMETIDINE HYDROCHLORIDE
	
AP       DAVA PHARMS INC         EQ 300MG BASE/2ML              A074428 001 Apr 25, 1996

  SOLUTION;ORAL

    CIMETIDINE HYDROCHLORIDE
	
AA       ANI PHARMS INC          EQ   300MG   BASE/5ML          A074610   001   Sep   26,   1996

AA    + HI TECH PHARMA           EQ   300MG   BASE/5ML          A074664   001   Oct   28,   1997

AA       PHARM ASSOC             EQ   300MG   BASE/5ML          A074553   001   Jan   27,   1997

AA       WOCKHARDT               EQ   300MG   BASE/5ML          A074757   001   Oct   17,   1997
	
CINACALCET HYDROCHLORIDE
	
  TABLET;ORAL
	
    SENSIPAR
	
         AMGEN                   EQ 30MG BASE                   N021688 001 Mar 08, 2004
	
                                 EQ 60MG BASE                   N021688 002 Mar 08, 2004
	
     +                           EQ 90MG BASE                   N021688 003 Mar 08, 2004
	
CIPROFLOXACIN
	
  FOR SUSPENSION;ORAL

    CIPRO
	
AB       BAYER HLTHCARE         250MG/5ML                       N020780 001 Sep 26, 1997

AB    +                         500MG/5ML                       N020780 002 Sep 26, 1997

    CIPROFLOXACIN
	
AB       LUPIN LTD              250MG/5ML                       A200563 001 Mar 05, 2014

AB                              500MG/5ML                       A200563 002 Mar 05, 2014
	
  INJECTABLE;INJECTION

    CIPRO
	
AP    + BAYER HLTHCARE          400MG/40ML (10MG/ML)            N019847 001 Dec 26, 1990

AP    +                         200MG/20ML (10MG/ML)            N019847 002 Dec 26, 1990

    CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + BAYER HLTHCARE          200MG/100ML                     N019857 001 Dec 26, 1990

AP    +                         400MG/200ML                     N019857 002 Dec 26, 1990

    CIPROFLOXACIN
	
AP       CLARIS LIFESCIENCES    200MG/20ML (10MG/ML)            A078062   001   Apr   29,   2008

AP                              400MG/40ML (10MG/ML)            A078062   002   Apr   29,   2008

AP       HIKMA FARMACEUTICA     200MG/20ML (10MG/ML)            A076717   001   Dec   22,   2009

AP                              400MG/40ML (10MG/ML)            A076717   002   Dec   22,   2009

AP       HOSPIRA                200MG/20ML (10MG/ML)            A077245   001   Aug   28,   2006

AP                              400MG/40ML (10MG/ML)            A077245   002   Aug   28,   2006

    CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       ACS DOBFAR INFO SA     200MG/100ML                     A078252   001   Mar   18,   2008

AP                              400MG/200ML                     A078252   002   Mar   18,   2008

AP       CLARIS LIFESCIENCES    200MG/100ML                     A078024   001   Mar   18,   2008

AP                              400MG/200ML                     A078024   002   Mar   18,   2008

AP       HIKMA FARMACEUTICA     400MG/200ML                     A078431   001   Nov   18,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-80(of 371)


CIPROFLOXACIN
	
  INJECTABLE;INJECTION

     CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP        HOSPIRA
	              200MG/100ML
                   A077753 001 Mar 18, 2008

AP
	                             400MG/200ML
	                  A077753 002 Mar 18, 2008
	
CIPROFLOXACIN HYDROCHLORIDE
	
  OINTMENT;OPHTHALMIC
	
     CILOXAN
	
       + ALCON PHARMS LTD
	        EQ   0.3% BASE
	             N020369 001 Mar 30, 1998
	
  SOLUTION/DROPS;OPHTHALMIC

     CILOXAN
	
AT     + ALCON PHARMS LTD
	        EQ   0.3% BASE
	             N019992 001 Dec 31, 1990
	
     CIPROFLOXACIN HYDROCHLORIDE
	
AT         AKORN INC
	             EQ   0.3%   BASE
            A076555   001   Dec   11,   2008

AT         FDC LTD
	               EQ   0.3%   BASE
            A077568   001   Jun   30,   2008

AT         IGI LABS INC
	          EQ   0.3%   BASE
            A076754   001   Jun   09,   2004

AT         NEXUS PHARMS
	          EQ   0.3%   BASE
            A077689   001   Dec   13,   2006

AT         PHARMAFORCE
	           EQ   0.3%   BASE
            A078598   001   Jan   16,   2008

AT         WATSON LABS INC
	       EQ   0.3%   BASE
	           A076673   001   Jan   21,   2005
	
  SOLUTION/DROPS;OTIC

     CETRAXAL
	
       + WRASER PHARMS
	           EQ   0.2% BASE
	             N021918 001 May 01, 2009
	
  TABLET;ORAL

     CIPRO
	
AB         BAYER HLTHCARE
	        EQ   100MG   BASE
           N019537   001   Apr   08,   1996

AB
	                               EQ   250MG   BASE
           N019537   002   Oct   22,   1987

AB     +
	                         EQ   500MG   BASE
           N019537   003   Oct   22,   1987

AB
	                               EQ   750MG   BASE
	          N019537   004   Oct   22,   1987
	
     CIPROFLOXACIN HYDROCHLORIDE
	
AB         APOTEX
	                EQ   250MG   BASE
           A076896   001   Nov   04,   2004

AB
	                               EQ   500MG   BASE
           A076896   002   Nov   04,   2004

AB
	                               EQ   750MG   BASE
           A076896   003   Nov   04,   2004

AB         AUROBINDO PHARMA
	      EQ   250MG   BASE
           A077859   001   Apr   26,   2007

AB
	                               EQ   500MG   BASE
           A077859   002   Apr   26,   2007

AB
	                               EQ   750MG   BASE
           A077859   003   Apr   26,   2007

AB         CARLSBAD
	              EQ   250MG   BASE
           A076126   002   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A076126   003   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A076126   004   Jun   09,   2004

AB         DR REDDYS LABS LTD
	    EQ   100MG   BASE
           A075593   002   Jun   09,   2004

AB
	                               EQ   250MG   BASE
           A075593   003   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A075593   004   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A075593   001   Jun   09,   2004

AB         HIKMA
	                 EQ   250MG   BASE
           A076558   002   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A076558   003   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A076558   004   Jun   09,   2004

AB         IVAX SUB TEVA PHARMS
	 EQ    250MG   BASE
           A076089   002   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A076089   003   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A076089   004   Jun   09,   2004

AB         MYLAN
	                 EQ   100MG   BASE
           A075817   001   Jun   25,   2007

AB
	                               EQ   250MG   BASE
           A075685   002   Jun   09,   2004

AB
	                               EQ   250MG   BASE
           A075817   002   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A075685   003   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A075817   003   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A075685   001   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A075817   004   Jun   09,   2004

AB         RANBAXY
	               EQ   250MG   BASE
           A075747   001   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A075747   002   Jun   09,   2004

AB
	                               EQ   750MG   BASE
           A075747   003   Jun   09,   2004

AB         TARO
	                  EQ   100MG   BASE
           A076912   001   Feb   18,   2005

AB
	                               EQ   250MG   BASE
           A076912   002   Oct   06,   2004

AB
	                               EQ   500MG   BASE
           A076912   003   Oct   06,   2004

AB
	                               EQ   750MG   BASE
           A076912   004   Oct   06,   2004

AB         UNIQUE PHARM LABS
      EQ   250MG   BASE
           A076639   001   Sep   10,   2004

AB
	                               EQ   500MG   BASE
           A076639   002   Sep   10,   2004

AB
	                               EQ   750MG   BASE
           A076639   003   Sep   10,   2004

AB         WATSON LABS
	           EQ   100MG   BASE
           A076794   001   Feb   10,   2005

AB
	                               EQ   250MG   BASE
           A076794   002   Jun   09,   2004

AB
	                               EQ   500MG   BASE
           A076794   003   Jun   09,   2004

AB
	                               EQ   750MG   BASE
	          A076794   004   Jun   09,   2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-81(of 371)


CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
	
  SUSPENSION/DROPS;OTIC

    CIPRO HC
	
      + ALCON PHARMS LTD        EQ 0.2% BASE;1%                 N020805 001 Feb 10, 1998
	
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    CIPROFLOXACIN EXTENDED RELEASE
	
AB       ACTAVIS LABS FL INC     212.6MG;EQ 287.5MG   BASE      A077417   001   Nov   30,   2010

AB                               425.2MG;EQ 574.9MG   BASE      A077809   001   Nov   30,   2010

AB       ANCHEN PHARMS           212.6MG;EQ 287.5MG   BASE      A078166   002   Nov   27,   2007

AB                               425.2MG;EQ 574.9MG   BASE      A078166   001   Nov   27,   2007

AB       DR REDDYS LABS LTD      425.2MG;EQ 574.9MG   BASE      A077701   001   Mar   26,   2007

AB    + MYLAN PHARMS INC         212.6MG;EQ 287.5MG   BASE      A078183   001   Mar   22,   2007

AB    +                          425.2MG;EQ 574.9MG   BASE      A078183   002   Mar   22,   2007
	
CIPROFLOXACIN; DEXAMETHASONE
	
  SUSPENSION/DROPS;OTIC

    CIPRODEX
	
      + ALCON PHARMS LTD         0.3%;0.1%                      N021537 001 Jul 18, 2003
	
CISATRACURIUM BESYLATE
	
  INJECTABLE;INJECTION

    CISATRACURIUM BESYLATE
	
AP       SANDOZ INC             EQ 2MG BASE/ML                  A200159 001 Feb 03, 2012

    CISATRACURIUM BESYLATE PRESERVATIVE FREE
	
AP       SANDOZ INC             EQ 2MG BASE/ML                  A200154 001 Feb 03, 2012

AP                              EQ 10MG BASE/ML                 A200154 002 Feb 03, 2012

    NIMBEX
	
AP    + ABBVIE                  EQ 2MG BASE/ML                  N020551 001 Dec 15, 1995

    NIMBEX PRESERVATIVE FREE
	
AP    + ABBVIE                  EQ 2MG BASE/ML                  N020551 003 Dec 15, 1995

AP    +                         EQ 10MG BASE/ML                 N020551 002 Dec 15, 1995
	
CISPLATIN
	
  INJECTABLE;INJECTION

    CISPLATIN
	
AP       EUROHLTH INTL           1MG/ML                         A075036   001   Nov   07,   2000

AP    + FRESENIUS KABI USA       1MG/ML                         A074735   001   Jul   16,   1999

AP       HQ SPCLT PHARMA         1MG/ML                         N018057   004   Nov   08,   1988

AP       ONCO THERAPIES LTD      1MG/ML                         A091062   001   Apr   18,   2012

AP       PHARMACHEMIE BV         1MG/ML                         A074656   001   May   16,   2000
	
CITALOPRAM HYDROBROMIDE
	
  CAPSULE;ORAL
	
    CITALOPRAM HYDROBROMIDE
	
         MYLAN PHARMS INC        EQ 10MG BASE                   A077668 001 Feb 28, 2007
	
                                 EQ 20MG BASE                   A077668 002 Feb 28, 2007
	
      +                          EQ 40MG BASE                   A077668 003 Feb 28, 2007
	
  SOLUTION;ORAL

    CITALOPRAM HYDROBROMIDE
	
AA       AUROBINDO PHARMA LTD    EQ 10MG BASE/5ML               A077812 001 Aug 28, 2006

AA    + ROXANE                   EQ 10MG BASE/5ML               A077043 001 Dec 13, 2004

AA       SILARX                  EQ 10MG BASE/5ML               A077629 001 Jun 15, 2006
	
  TABLET;ORAL

    CELEXA
	
AB       FOREST LABS             EQ 10MG BASE                   N020822 001 Apr 27, 2000

AB                               EQ 20MG BASE                   N020822 002 Jul 17, 1998

AB    +                          EQ 40MG BASE                   N020822 003 Jul 17, 1998

    CITALOPRAM HYDROBROMIDE
	
AB       AMNEAL PHARMS NY        EQ   10MG   BASE               A077289   001   Nov   30,   2006

AB                               EQ   20MG   BASE               A077289   002   Nov   30,   2006

AB                               EQ   40MG   BASE               A077289   003   Nov   30,   2006

AB       APOTEX INC              EQ   10MG   BASE               A077046   001   Nov   24,   2004

AB                               EQ   20MG   BASE               A077046   002   Nov   24,   2004

AB                               EQ   40MG   BASE               A077046   003   Nov   24,   2004

AB       AUROBINDO               EQ   10MG   BASE               A077031   001   Oct   28,   2004

AB                               EQ   20MG   BASE               A077031   002   Oct   28,   2004

AB                               EQ   40MG   BASE               A077031   003   Oct   28,   2004

AB       CIPLA LTD               EQ   10MG   BASE               A077044   001   Nov   05,   2004

AB                               EQ   20MG   BASE               A077044   002   Nov   05,   2004

AB                               EQ   40MG   BASE               A077044   003   Nov   05,   2004

AB       DR REDDYS LABS LTD      EQ   10MG   BASE               A077038   001   Oct   28,   2004

AB                               EQ   20MG   BASE               A077038   002   Oct   28,   2004

AB                               EQ   40MG   BASE               A077038   003   Oct   28,   2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                               3-82(of 371)


CITALOPRAM HYDROBROMIDE
	
  TABLET;ORAL

    CITALOPRAM HYDROBROMIDE
	
AB       EPIC PHARMA            EQ   10MG   BASE                          A077045   003   Apr   29,   2005

AB                              EQ   20MG   BASE                          A077045   002   Apr   29,   2005

AB                              EQ   40MG   BASE                          A077045   001   Apr   29,   2005

AB       GLENMARK GENERICS      EQ   10MG   BASE                          A077654   001   Feb   27,   2009

AB                              EQ   20MG   BASE                          A077654   002   Feb   27,   2009

AB                              EQ   40MG   BASE                          A077654   003   Feb   27,   2009

AB       INVAGEN PHARMS         EQ   10MG   BASE                          A077534   001   Oct   03,   2006

AB                              EQ   20MG   BASE                          A077534   002   Oct   03,   2006

AB                              EQ   40MG   BASE                          A077534   003   Oct   03,   2006

AB       MYLAN                  EQ   10MG   BASE                          A077039   001   Feb   03,   2005

AB                              EQ   10MG   BASE                          A077042   001   Nov   05,   2004

AB                              EQ   20MG   BASE                          A077039   002   Feb   03,   2005

AB                              EQ   20MG   BASE                          A077042   002   Nov   05,   2004

AB                              EQ   40MG   BASE                          A077039   003   Feb   03,   2005

AB                              EQ   40MG   BASE                          A077042   003   Nov   05,   2004

AB       MYLAN PHARMS INC       EQ   10MG   BASE                          A077037   001   Nov   05,   2004

AB                              EQ   20MG   BASE                          A077037   002   Nov   05,   2004

AB                              EQ   40MG   BASE                          A077037   003   Nov   05,   2004

AB       PLIVA                  EQ   10MG   BASE                          A077232   001   Oct   31,   2005

AB                              EQ   20MG   BASE                          A077232   002   Oct   31,   2005

AB                              EQ   40MG   BASE                          A077232   003   Oct   31,   2005

AB       SUN PHARM INDS INC     EQ   10MG   BASE                          A077032   001   Nov   12,   2004

AB                              EQ   20MG   BASE                          A077032   002   Nov   12,   2004

AB                              EQ   40MG   BASE                          A077032   003   Nov   12,   2004

AB       TEVA PHARMS            EQ   10MG   BASE                          A077048   001   Nov   16,   2004

AB                              EQ   20MG   BASE                          A077048   002   Nov   16,   2004

AB                              EQ   40MG   BASE                          A077048   003   Nov   16,   2004

AB       TORRENT PHARMS         EQ   10MG   BASE                          A078216   001   Mar   27,   2007

AB                              EQ   20MG   BASE                          A078216   002   Mar   27,   2007

AB                              EQ   40MG   BASE                          A078216   003   Mar   27,   2007
	
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
	
  SOLUTION;IRRIGATION
	
    RENACIDIN
	
      + UNITED GUARDIAN         6.602GM/100ML;198MG/100ML;3.177GM/100ML   N019481 001 Oct 02, 1990
	
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
	
  FOR SOLUTION;ORAL
	
    PREPOPIK
	
      + FERRING PHARMS AS       12GM/PACKET;3.5GM/PACKET;10MG/PACKET      N202535 001 Jul 16, 2012
	
CITRIC ACID; UREA C-13
	
  FOR SOLUTION, TABLET, FOR SOLUTION;ORAL
	
    IDKIT:HP
	
      + EXALENZ BIOSCIENCE      N/A,4GM;75MG,N/A                          N021314 001 Dec 17, 2002
	
CLADRIBINE
	
  INJECTABLE;INJECTION

    CLADRIBINE
	
AP       EUROHLTH INTL          1MG/ML                                    A075405 001 Feb 28, 2000

AP    + FRESENIUS KABI USA      1MG/ML                                    A076571 001 Apr 22, 2004

AP       ONCO THERAPIES LTD     1MG/ML                                    A200510 001 Oct 06, 2011
	
CLARITHROMYCIN
	
  FOR SUSPENSION;ORAL

    BIAXIN
	
AB       ABBVIE                 125MG/5ML                                 N050698 001 Dec 23, 1993

AB    +                         250MG/5ML                                 N050698 002 Dec 23, 1993

    CLARITHROMYCIN
	
AB       RANBAXY                125MG/5ML                                 A065382   001   Aug   30,   2007

AB                              250MG/5ML                                 A065382   002   Aug   30,   2007

AB       SANDOZ                 125MG/5ML                                 A065283   002   Sep   04,   2007

AB                              250MG/5ML                                 A065283   003   Sep   04,   2007

  TABLET;ORAL

    BIAXIN
	
AB    + ABBVIE                  250MG                                     N050662 001 Oct 31, 1991

AB    +                         500MG                                     N050662 002 Oct 31, 1991

    CLARITHROMYCIN
	
AB       ALLIED PHARMA INC      250MG                                     A202710   001   Jun   10,   2013

AB                              500MG                                     A202710   002   Jun   10,   2013

AB       APOTEX CORP            250MG                                     A065384   001   Aug   20,   2007

AB                              500MG                                     A065384   002   Aug   20,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                  3-83(of 371)


CLARITHROMYCIN
	
  TABLET;ORAL

    CLARITHROMYCIN
	
AB       AUROBINDO               250MG                                      A065489   001   Jul   25,   2012

AB                               500MG                                      A065489   002   Jul   25,   2012

AB       MYLAN                   250MG                                      A065195   001   Mar   11,   2005

AB                               500MG                                      A065195   002   Mar   11,   2005

AB       RANBAXY                 250MG                                      A065174   001   Sep   24,   2004

AB                               500MG                                      A065174   002   Sep   24,   2004

AB       ROXANE                  250MG                                      A065178   002   May   25,   2004

AB                               500MG                                      A065178   001   May   25,   2004

AB       SANDOZ                  250MG                                      A065144   001   Oct   18,   2005

AB                               500MG                                      A065136   001   Aug   25,   2005

AB       TEVA                    250MG                                      A065155   001   May   31,   2005

AB                               500MG                                      A065155   002   May   31,   2005

AB       WOCKHARDT               250MG                                      A065266   001   May   31,   2006

AB                               500MG                                      A065266   002   May   31,   2006

  TABLET, EXTENDED RELEASE;ORAL

    BIAXIN XL
	
AB    + ABBVIE                   500MG                                      N050775 001 Mar 03, 2000

    CLARITHROMYCIN
	
AB       ACTAVIS LABS FL INC     500MG                                      A065145 001 Jun 24, 2004

AB       TEVA                    500MG                                      A065154 001 May 18, 2005
	
CLAVULANATE POTASSIUM; TICARCILLIN     DISODIUM
	
  INJECTABLE;INJECTION
	
    TIMENTIN
	
      +		 GLAXOSMITHKLINE       EQ     1GM BASE/VIAL;EQ 30GM BASE/VIAL      N050590   003   Aug   18,   1987

                                EQ     100MG BASE/VIAL;EQ 3GM BASE/VIAL     A062691   001   Dec   19,   1986
	
      +		                       EQ     100MG BASE/VIAL;EQ 3GM BASE/VIAL     N050590   001   Apr   01,   1985

      +                         EQ     200MG BASE/VIAL;EQ 3GM BASE/VIAL     N050590   002   Apr   01,   1985

    TIMENTIN IN PLASTIC CONTAINER
	
      + GLAXOSMITHKLINE         EQ     100MG BASE/100ML;EQ 3GM BASE/100ML   N050658 001 Dec 15, 1989
	
CLEMASTINE FUMARATE
	
  SYRUP;ORAL

    CLEMASTINE FUMARATE
	
AA    + TEVA                      EQ 0.5MG BASE/5ML                         A073399 001 Jun 30, 1994

AA       WOCKHARDT                EQ 0.5MG BASE/5ML                         A074863 001 Mar 13, 1998
	
  TABLET;ORAL

    CLEMASTINE FUMARATE
	
AB       SANDOZ                   2.68MG                                    A073459 001 Oct 31, 1993

AB    + TEVA                      2.68MG                                    A073283 001 Jan 31, 1992
	
CLEVIDIPINE
	
  EMULSION;INTRAVENOUS
	
    CLEVIPREX
	
      + MEDICINES CO              25MG/50ML (0.5MG/ML)		                    N022156 001 Aug 01, 2008

      +		                         50MG/100ML (0.5MG/ML)                     N022156 002 Aug 01, 2008

      +		                         125MG/250ML (0.5MG/ML)                    N022156 003 Nov 08, 2013
	
CLINDAMYCIN HYDROCHLORIDE
	
  CAPSULE;ORAL

    CLEOCIN HYDROCHLORIDE
	
AB       PHARMACIA AND UPJOHN     EQ 75MG BASE                              N050162 001
	
AB                                EQ 150MG BASE                             N050162 002
	
AB    +                           EQ 300MG BASE                             N050162 003 Apr 14, 1988

    CLINDAMYCIN HYDROCHLORIDE
	
AB       AUROBINDO PHARMA         EQ   150MG BASE                           A065442   001   Aug   26,   2009

AB                                EQ   300MG BASE                           A065442   002   Aug   26,   2009

AB       COREPHARMA               EQ   150MG BASE                           A065194   001   Mar   22,   2004

AB                                EQ   300MG BASE                           A065194   002   Mar   22,   2004

AB       LANNETT                  EQ   75MG BASE                            A065242   001   Aug   12,   2005

AB                                EQ   150MG BASE                           A065242   002   Aug   12,   2005

AB                                EQ   300MG BASE                           A065243   001   Aug   12,   2005

AB       MYLAN PHARMS INC         EQ   75MG BASE                            A091225   001   May   31,   2011

AB                                EQ   150MG BASE                           A091225   002   May   31,   2011

AB                                EQ   300MG BASE                           A091225   003   May   31,   2011

AB       RANBAXY                  EQ   150MG BASE                           A065061   001   Feb   02,   2001

AB                                EQ   300MG BASE                           A065061   002   Feb   02,   2001

AB       TEVA                     EQ   150MG BASE                           A063029   001   Sep   20,   1989

AB                                EQ   300MG BASE                           A063029   002   Aug   05,   2005

AB       WATSON LABS              EQ   150MG BASE                           A063083   001   Jul   31,   1991

AB                                EQ   300MG BASE                           A063083   002   Mar   18,   2003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                         3-84(of 371)


CLINDAMYCIN HYDROCHLORIDE
	
  CAPSULE;ORAL

    CLINDAMYCIN HYDROCHLORIDE
	
AB       ZYDUS PHARMS USA         EQ 75MG BASE                    A065217 001 Jan 31, 2005

AB                                EQ 150MG BASE                   A065217 002 Jan 31, 2005

AB                                EQ 300MG BASE                   A065217 003 Jan 31, 2005
	
CLINDAMYCIN PALMITATE HYDROCHLORIDE
	
  FOR SOLUTION;ORAL

    CLEOCIN
	
AA    + PHARMACIA AND UPJOHN    EQ 75MG BASE/5ML                  A062644 001 Apr 07, 1986

    CLINDAMYCIN PALMITATE HYDROCHLORIDE
	
AA       AMNEAL PHARMS          EQ 75MG BASE/5ML                  A203513   001   Mar   13,   2014

AA       AUROBINDO PHARMA LTD   EQ 75MG BASE/5ML                  A202409   001   Apr   30,   2013

AA       LYNE                   EQ 75MG BASE/5ML                  A201821   001   Aug   28,   2012

AA       PADDOCK LABS           EQ 75MG BASE/5ML                  A090902   001   Jul   07,   2010
	
CLINDAMYCIN PHOSPHATE
	
  AEROSOL, FOAM;TOPICAL

    CLINDAMYCIN PHOSPHATE
	
AT       PERRIGO UK FINCO       1%                                A090785 001 Mar 31, 2010

    EVOCLIN
	
AT    + DELCOR ASSET            1%                                N050801 001 Oct 22, 2004
	
  CREAM;VAGINAL

    CLEOCIN
	
AB    + PHARMACIA AND UPJOHN    EQ 2% BASE                        N050680 002 Mar 02, 1998

    CLINDAMYCIN PHOSPHATE
	
AB       FOUGERA PHARMS         EQ 2% BASE                        A065139 001 Dec 27, 2004
	
    CLINDESSE
	
      + ELAN PHARMA INTL LTD    EQ 2% BASE                        N050793 001 Nov 30, 2004
	
  GEL;TOPICAL

    CLEOCIN T
	
AB    + PHARMACIA AND UPJOHN    EQ 1% BASE                        N050615 001 Jan 07, 1987

    CLINDAMYCIN PHOSPHATE
	
AB       FOUGERA PHARMS         EQ 1% BASE                        A064160 001 Jan 28, 2000
	
    CLINDAGEL
	
BT    + PRECISION DERMAT        EQ 1% BASE                        N050782 001 Nov 27, 2000
	
  INJECTABLE;INJECTION

    CLEOCIN PHOSPHATE
	
AP       PHARMACIA AND UPJOHN   EQ 150MG BASE/ML                  A062803 001 Oct 16, 1987

AP    +                         EQ 150MG BASE/ML                  N050441 001
	
    CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + PHARMACIA AND UPJOHN    EQ 6MG BASE/ML                    N050639 001 Aug 30, 1989

AP    +                         EQ 12MG BASE/ML                   N050639 002 Aug 30, 1989

AP    +                         EQ 18MG BASE/ML                   N050639 003 Apr 10, 1991

    CLINDAMYCIN PHOSPHATE
	
AP       BEDFORD                EQ 150MG BASE/ML                  A065206   001   Sep   24,   2004

AP       FRESENIUS KABI USA     EQ 150MG BASE/ML                  A065346   001   Mar   29,   2007

AP                              EQ 150MG BASE/ML                  A065347   001   May   09,   2007

AP       HIKMA MAPLE            EQ 150MG BASE/ML                  A062889   001   Apr   25,   1988

AP       HOSPIRA                EQ 150MG BASE/ML                  A062800   001   Jul   24,   1987

AP                              EQ 150MG BASE/ML                  A062801   001   Jul   24,   1987

AP                              EQ 150MG BASE/ML                  A062943   001   Sep   29,   1988

AP       SAGENT PHARMS          EQ 150MG BASE/ML                  A090108   001   Sep   30,   2011

AP       SAGENT STRIDES         EQ 150MG BASE/ML                  A090109   001   Sep   30,   2011

    CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER
	
AP       AKORN INC              EQ 6MG BASE/ML                    A203048   001   Apr   04,   2013

AP                              EQ 12MG BASE/ML                   A203048   002   Apr   04,   2013

AP                              EQ 18MG BASE/ML                   A203048   003   Apr   04,   2013

AP       SANDOZ INC             EQ 6MG BASE/ML                    A201692   001   May   31,   2012

AP                              EQ 12MG BASE/ML                   A201692   002   May   31,   2012

AP                              EQ 18MG BASE/ML                   A201692   003   May   31,   2012

    CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
	
      + ABRAXIS PHARM           EQ 900MG BASE/100ML               N050635 001 Dec 22, 1989
	
  LOTION;TOPICAL

    CLEOCIN T
	
AB    + PHARMACIA AND UPJOHN    EQ 1% BASE                        N050600 001 May 31, 1989

    CLINDAMYCIN PHOSPHATE
	
AB       FOUGERA PHARMS         EQ 1% BASE                        A065067 001 Jan 31, 2002
	
  SOLUTION;TOPICAL

    CLEOCIN T
	
AT    + PHARMACIA AND UPJOHN    EQ 1% BASE                        N050537 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                        3-85(of 371)


CLINDAMYCIN PHOSPHATE
	
  SOLUTION;TOPICAL

    CLINDA-DERM
	
AT       PADDOCK LLC            EQ 1% BASE                       A063329 001 Sep 30, 1992

    CLINDAMYCIN PHOSPHATE
	
AT       FOUGERA                EQ   1%   BASE                   A064159   001   Jun   05,   1997

AT       FOUGERA PHARMS         EQ   1%   BASE                   A065254   001   Feb   14,   2006

AT       G AND W LABS INC       EQ   1%   BASE                   A062811   001   Sep   01,   1988

AT       PERRIGO NEW YORK       EQ   1%   BASE                   A064050   001   Nov   30,   1995

AT       TARO PHARM INDS        EQ   1%   BASE                   A065184   001   Mar   31,   2004

AT       WOCKHARDT              EQ   1%   BASE                   A063304   001   Jul   15,   1997
	
  SUPPOSITORY;VAGINAL
	
    CLEOCIN
	
      + PHARMACIA AND UPJOHN    100MG                            N050767 001 Aug 13, 1999

  SWAB;TOPICAL

    CLEOCIN
	
AT       PHARMACIA AND UPJOHN   EQ 1% BASE                       N050537 002 Feb 22, 1994

    CLINDAMYCIN PHOSPHATE
	
AT       PERRIGO NEW YORK       EQ 1% BASE                       A065049 001 May 25, 2000

AT       VERSAPHARM             EQ 1% BASE                       A065513 001 Jun 17, 2010

    CLINDETS
	
AT       PERRIGO                EQ 1% BASE                       A064136 001 Sep 30, 1996
	
CLINDAMYCIN PHOSPHATE; TRETINOIN
	
  GEL;TOPICAL
	
    VELTIN
	
BX    + STIEFEL GSK             1.2%;0.025%                      N050803 001 Jul 16, 2010
	
    ZIANA
	
BX    + MEDICIS                 1.2%;0.025%                      N050802 001 Nov 07, 2006
	
CLOBAZAM
	
  SUSPENSION;ORAL
	
    ONFI
	
      + LUNDBECK LLC            2.5MG/ML                         N203993 001 Dec 14, 2012
	
  TABLET;ORAL
	
    ONFI
	
           LUNDBECK LLC         10MG                             N202067 002 Oct 21, 2011
	
      +                         20MG                             N202067 003 Oct 21, 2011
	
CLOBETASOL PROPIONATE
	
  AEROSOL, FOAM;TOPICAL

    CLOBETASOL PROPIONATE
	
AB1        PERRIGO ISRAEL       0.05%                            A077763 001 Mar 10, 2008

    OLUX
	
AB1 + DELCOR ASSET              0.05%                            N021142 001 May 26, 2000

    CLOBETASOL PROPIONATE
	
AB2        PERRIGO ISRAEL       0.05%                            A201402 001 Aug 14, 2012

    OLUX E
	
AB2 + DELCOR ASSET              0.05%                            N022013 001 Jan 12, 2007
	
  CREAM;TOPICAL

    CLOBETASOL PROPIONATE
	
AB1        FOUGERA              0.05%                            A074392 001 Sep 30, 1996

AB1        G AND W LABS INC     0.05%                            A074139 001 Aug 03, 1994

AB1        TARO                 0.05%                            A074249 001 Jul 08, 1996

    CORMAX
	
AB1        HI TECH PHARMA       0.05%                            A074220 001 May 16, 1997

    TEMOVATE
	
AB1 + FOUGERA PHARMS            0.05%                            N019322 001 Dec 27, 1985

    CLOBETASOL PROPIONATE (EMOLLIENT)

AB2        FOUGERA PHARMS       0.05%                            A075430 001 May 26, 1999

AB2        TARO                 0.05%                            A075633 001 May 17, 2000

    EMBELINE E
	
AB2        HI TECH PHARMA       0.05%                            A075325 001 Dec 24, 1998

    TEMOVATE E
	
AB2 + FOUGERA PHARMS            0.05%                            N020340 001 Jun 17, 1994
	
  GEL;TOPICAL
    CLOBETASOL PROPIONATE
AB         FOUGERA PHARMS       0.05%                            A075368 001 Feb 15, 2000
AB         PERRIGO              0.05%                            A075027 001 Oct 31, 1997
AB         TARO                 0.05%                            A075279 001 May 28, 1999
    EMBELINE
AB         HI TECH PHARMA       0.05%                            A076141 001 Apr 12, 2002
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                   3-86(of 371)


CLOBETASOL PROPIONATE
	
  GEL;TOPICAL

    TEMOVATE
	
AB    + FOUGERA PHARMS             0.05%                       N020337 001 Apr 29, 1994

  LOTION;TOPICAL

    CLOBETASOL PROPIONATE
	
AB       ACTAVIS MID ATLANTIC      0.05%                       A078223 001 Dec 04, 2008

AB       TARO                      0.05%                       A200302 001 Jul 02, 2012

    CLOBEX
	
AB    + GALDERMA LABS LP           0.05%                       N021535 001 Jul 24, 2003
	
  OINTMENT;TOPICAL

    CLOBETASOL PROPIONATE
	
AB       FOUGERA PHARMS            0.05%                       A074407 001 Feb 23, 1996

AB       TARO                      0.05%                       A074248 001 Jul 12, 1996

AB       TEVA PHARMS               0.05%                       A074089 001 Feb 16, 1994

    EMBELINE
	
AB       HI TECH PHARMA            0.05%                       A074221 001 Mar 31, 1995

    TEMOVATE
	
AB    + FOUGERA PHARMS             0.05%                       N019323 001 Dec 27, 1985
	
  SHAMPOO;TOPICAL

    CLOBETASOL PROPIONATE
	
AB       ACTAVIS MID ATLANTIC      0.05%                       A078854 001 Jun 07, 2011

AB       PERRIGO ISRAEL            0.05%                       A090974 001 Aug 09, 2012

    CLOBEX
	
AB    + GALDERMA LABS              0.05%                       N021644 001 Feb 05, 2004
	
  SOLUTION;TOPICAL

    CLOBETASOL PROPIONATE
	
AT       FOUGERA PHARMS            0.05%                       A075391   001   Feb   08,   1999

AT       TARO                      0.05%                       A075224   001   Nov   16,   1998

AT                                 0.05%                       A075363   001   Dec   29,   2000

AT       TOLMAR                    0.05%                       A076977   001   Aug   05,   2005

AT       WOCKHARDT                 0.05%                       A075205   001   Nov   13,   1998

    EMBELINE
	
AT    + HI TECH PHARMA             0.05%                       A074222 001 Dec 06, 1995
	
  SPRAY;TOPICAL

    CLOBETASOL PROPIONATE
	
AT       PADDOCK LLC               0.05%                       A090898 001 Jun 16, 2011

    CLOBEX
	
AT    + GALDERMA LABS LP           0.05%                       N021835 001 Oct 27, 2005
	
CLOCORTOLONE PIVALATE
	
  CREAM;TOPICAL
	
    CLODERM
	
      + PROMIUS PHARMA LLC         0.1%                        N017765 001
	
CLOFARABINE
	
  INJECTABLE;IV (INFUSION)

    CLOLAR
	
      + GENZYME                    20MG/20ML (1MG/ML)          N021673 001 Dec 28, 2004
	
CLOFAZIMINE
	
  CAPSULE;ORAL
	
    LAMPRENE
	
      + NOVARTIS                   50MG                        N019500 002 Dec 15, 1986
	
CLOMIPHENE CITRATE
	
  TABLET;ORAL

    CLOMID
	
AB    + SANOFI AVENTIS US          50MG                        N016131 002
	
    CLOMIPHENE CITRATE
	
AB       PAR PHARM                 50MG                        A075528 001 Aug 30, 1999

    SEROPHENE
	
AB       EMD SERONO                50MG                        N018361 001 Mar 22, 1982
	
CLOMIPRAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    ANAFRANIL
	
AB       MALLINCKRODT LLC          25MG                        N019906 001 Dec 29, 1989

AB    +                            50MG                        N019906 002 Dec 29, 1989

AB                                 75MG                        N019906 003 Dec 29, 1989

    CLOMIPRAMINE HYDROCHLORIDE
	
AB       MYLAN                     25MG                        A074947   001   Apr   30,   1998

AB                                 50MG                        A074947   002   Apr   30,   1998

AB                                 75MG                        A074947   003   Apr   30,   1998

AB       SANDOZ                    25MG                        A074364   001   Mar   29,   1996
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-87(of 371)


CLOMIPRAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    CLOMIPRAMINE HYDROCHLORIDE
	
AB                                 50MG                        A074364   002   Mar   29,   1996

AB                                 75MG                        A074364   003   Mar   29,   1996

AB       TARO                      25MG                        A074694   001   Dec   31,   1996

AB                                 50MG                        A074694   002   Dec   31,   1996

AB                                 75MG                        A074694   003   Dec   31,   1996

AB       TEVA                      25MG                        A074958   001   Aug   26,   1997

AB                                 50MG                        A074958   002   Aug   26,   1997

AB                                 75MG                        A074958   003   Aug   26,   1997
	
CLONAZEPAM
	
  TABLET;ORAL

    CLONAZEPAM
	
AB       ACCORD HLTHCARE        0.5MG                          A077147   001   May   02,   2005

AB                              1MG                            A077147   002   May   02,   2005

AB                              2MG                            A077147   003   May   02,   2005

AB       ACTAVIS ELIZABETH      0.5MG                          A074869   001   Oct   31,   1996

AB                              1MG                            A074869   002   Oct   31,   1996

AB                              2MG                            A074869   003   Oct   31,   1996

AB       MYLAN                  0.5MG                          A075150   001   Oct   05,   1998

AB                              1MG                            A075150   002   Oct   05,   1998

AB                              2MG                            A075150   003   Oct   05,   1998

AB       MYLAN PHARMS INC       0.5MG                          A074940   001   Oct   30,   1997

AB                              1MG                            A074940   002   Oct   30,   1997

AB                              2MG                            A074940   003   Oct   30,   1997

AB       SANDOZ                 0.5MG                          A074979   001   Aug   29,   1997

AB                              1MG                            A074979   002   Aug   29,   1997

AB                              2MG                            A074979   003   Aug   29,   1997

AB       SUN PHARM INDS INC     0.5MG                          A075423   001   Apr   27,   2001

AB                              1MG                            A075423   002   Apr   27,   2001

AB                              2MG                            A075423   003   Apr   27,   2001

AB       TEVA                   0.5MG                          A074569   001   Sep   10,   1996

AB                              1MG                            A074569   002   Sep   10,   1996

AB                              2MG                            A074569   003   Sep   10,   1996

AB       VINTAGE PHARMS         0.5MG                          A077856   001   Jun   28,   2006

AB                              1MG                            A077856   002   Jun   28,   2006

AB                              2MG                            A077856   003   Jun   28,   2006

AB       WATSON LABS            0.5MG                          A074964   001   Dec   30,   1997

AB                              1MG                            A074964   002   Dec   30,   1997

AB                              2MG                            A074964   003   Dec   30,   1997

    KLONOPIN
	
AB       ROCHE                  0.5MG                          N017533 001
	
AB    +                         1MG                            N017533 002
	
AB                              2MG                            N017533 003
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    CLONAZEPAM
	
AB       BARR                   0.125MG                        A077194   001   Aug   10,   2005

AB                              0.25MG                         A077194   002   Aug   10,   2005

AB                              0.5MG                          A077194   003   Aug   10,   2005

AB                              1MG                            A077194   004   Aug   10,   2005

AB                              2MG                            A077194   005   Aug   10,   2005

AB       PAR PHARM              0.125MG                        A077171   001   Aug   03,   2005

AB                              0.25MG                         A077171   002   Aug   03,   2005

AB                              0.5MG                          A077171   003   Aug   03,   2005

AB    +                         1MG                            A077171   004   Aug   03,   2005

AB                              2MG                            A077171   005   Aug   03,   2005

AB       SUN PHARM INDS INC     0.125MG                        A078654   001   Aug   27,   2014

AB                              0.25MG                         A078654   002   Aug   27,   2014

AB                              0.5MG                          A078654   003   Aug   27,   2014

AB                              1MG                            A078654   004   Aug   27,   2014

AB                              2MG                            A078654   005   Aug   27,   2014
	
CLONIDINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    CATAPRES-TTS-1
	
AB       BOEHRINGER INGELHEIM   0.1MG/24HR                     N018891 001 Oct 10, 1984

    CATAPRES-TTS-2
	
AB       BOEHRINGER INGELHEIM   0.2MG/24HR                     N018891 002 Oct 10, 1984

    CATAPRES-TTS-3
	
AB    + BOEHRINGER INGELHEIM    0.3MG/24HR                     N018891 003 Oct 10, 1984
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-88(of 371)


CLONIDINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

     CLONIDINE
	
AB        AVEVA
	               0.1MG/24HR
                     A076157   001   Aug   18,   2009

AB
	                            0.2MG/24HR
                     A076157   002   Aug   18,   2009

AB
	                            0.3MG/24HR
                     A076157   003   Aug   18,   2009

AB        BARR
	                0.1MG/24HR
                     A079090   001   Aug   20,   2010

AB
	                            0.2MG/24HR
                     A079090   002   Aug   20,   2010

AB
	                            0.3MG/24HR
                     A079090   003   Aug   20,   2010

AB        MYLAN TECHNOLOGIES
	  0.1MG/24HR
                     A076166   001   Jul   16,   2010

AB
	                            0.2MG/24HR
                     A076166   002   Jul   16,   2010

AB
	                            0.3MG/24HR
                     A076166   003   Jul   16,   2010

AB        WATSON LABS INC
	     0.1MG/24HR
                     A090873   001   May   06,   2014

AB
	                            0.2MG/24HR
                     A090873   002   May   06,   2014

AB
	                            0.3MG/24HR
	                    A090873   003   May   06,   2014
	
CLONIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     CLONIDINE HYDROCHLORIDE
	
AP         EXELA PHARMA SCS LLC
	 1MG/10ML   (0.1MG/ML)
        A203167   001   Oct   29,   2013

AP
	                              5MG/10ML   (0.5MG/ML)
        A203167   002   Oct   29,   2013

AP         FRESENIUS KABI USA
	   1MG/10ML   (0.1MG/ML)
        A200673   001   Jul   08,   2011

AP
	                              5MG/10ML   (0.5MG/ML)
        A200673   002   Jul   08,   2011

AP         HIKMA FARMACEUTICA
	   1MG/10ML   (0.1MG/ML)
        A200300   001   Jan   26,   2011

AP
	                              5MG/10ML   (0.5MG/ML)
        A200300   002   Jan   26,   2011

AP         LUITPOLD
	             1MG/10ML   (0.1MG/ML)
        A091104   001   Oct   08,   2009

AP
	                              5MG/10ML   (0.5MG/ML)
        A091104   002   Oct   08,   2009

AP         ZYDUS PHARMS USA INC
	 1MG/10ML   (0.1MG/ML)
        A202601   001   Feb   20,   2014

AP
	                              5MG/10ML   (0.5MG/ML)
	       A202601   002   Feb   20,   2014
	
     DURACLON
	
AP         MYLAN INSTITUTIONAL
	  1MG/10ML   (0.1MG/ML)
        N020615 001 Oct 02, 1996

AP     +
	                        5MG/10ML   (0.5MG/ML)
	       N020615 002 Apr 27, 1999
	
  TABLET;ORAL

     CATAPRES
	
AB         BOEHRINGER INGELHEIM
	 0.1MG
	                       N017407 001
	
AB
	                              0.2MG
	                       N017407 002
	
AB     +
	                        0.3MG
	                       N017407 003
	
     CLONIDINE HYDROCHLORIDE
	
AB         ACTAVIS ELIZABETH
	    0.1MG
	                       A070974   001   Dec   16,   1986

AB
	                              0.2MG
	                       A070975   001   Dec   16,   1986

AB
	                              0.3MG
	                       A070976   001   Dec   16,   1986

AB         ALEMBIC PHARMS LTD
	   0.1MG
	                       A091368   001   Dec   06,   2011

AB
	                              0.2MG
	                       A091368   002   Dec   06,   2011

AB
	                              0.3MG
	                       A091368   003   Dec   06,   2011

AB         CARLSBAD
	             0.1MG
	                       A202297   001   Jun   13,   2013

AB
	                              0.2MG
	                       A202297   002   Jun   13,   2013

AB
	                              0.3MG
	                       A202297   003   Jun   13,   2013

AB         DAVA PHARMS INC
	      0.1MG
	                       A071783   001   Apr   05,   1988

AB
	                              0.2MG
	                       A071784   001   Apr   05,   1988

AB
	                              0.3MG
	                       A071785   001   Apr   05,   1988

AB         IMPAX LABS
	           0.1MG
	                       A078099   001   Aug   27,   2009

AB
	                              0.2MG
	                       A078099   002   Aug   27,   2009

AB
	                              0.3MG
	                       A078099   003   Aug   27,   2009

AB         MUTUAL PHARM
	         0.1MG
	                       A070925   001   Sep   04,   1987

AB
	                              0.2MG
	                       A070924   001   Sep   04,   1987

AB
	                              0.3MG
	                       A070923   001   Sep   04,   1987

AB         MYLAN
	                0.1MG
	                       A070317   002   Jul   09,   1987

AB
	                              0.2MG
	                       A070317   003   Jun   09,   1987

AB
	                              0.3MG
	                       A070317   001   Jun   09,   1987

AB         SUN PHARM INDS INC
	   0.1MG
	                       A090329   001   Jul   03,   2014

AB
	                              0.2MG
	                       A090329   002   Jul   03,   2014

AB
	                              0.3MG
	                       A090329   003   Jul   03,   2014

AB         UNICHEM
	              0.1MG
	                       A078895   001   Aug   26,   2009

AB
	                              0.2MG
	                       A078895   002   Aug   26,   2009

AB
	                              0.3MG
	                       A078895   003   Aug   26,   2009

AB         VINTAGE
	              0.1MG
	                       A077901   001   Mar   09,   2007

AB
	                              0.2MG
	                       A077901   002   Mar   09,   2007

AB
	                              0.3MG
	                       A077901   003   Mar   09,   2007
	
  TABLET, EXTENDED RELEASE;ORAL

     CLONIDINE HYDROCHLORIDE
	
AB         ANCHEN PHARMS
	        0.1MG
	                       A202983 001 Apr 02, 2014

AB
	                              0.2MG
	                       A202983 002 Apr 02, 2014
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-89(of 371)


CLONIDINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

     CLONIDINE HYDROCHLORIDE
	
AB        ANCHEN PHARMS
	        0.1MG
	                         A202984 001 Sep 30, 2013

AB
	                             0.2MG
	                         A202984 002 Sep 30, 2013
	
     KAPVAY
	
AB     + CONCORDIA PHARMS INC
	 0.1MG
	                          N022331 003 Sep 28, 2010

AB
	                             0.2MG
	                         N022331 004 Sep 28, 2010
	
CLOPIDOGREL
	
  TABLET;ORAL

    CLOPIDOGREL
	
AB       AMNEAL PHARMS
	            75MG
	                       A203751 001 Apr 11, 2014
	
CLOPIDOGREL BISULFATE
	
  TABLET;ORAL

     CLOPIDOGREL BISULFATE
	
AB         ACCORD HLTHCARE
	        EQ     75MG BASE
            A202925   001   Mar   27,   2013

AB
	                                EQ     300MG BASE
           A202925   002   Mar   27,   2013

AB         ACTAVIS TOTOWA
	         EQ     75MG BASE
            A090307   001   May   28,   2013

AB         APOTEX INC
	             EQ     75MG BASE
            A076274   001   May   17,   2012

AB
	                                EQ     300MG BASE
           A076274   002   Mar   04,   2014

AB         AUROBINDO PHARMA LTD
	   EQ     75MG BASE
            A090540   001   May   17,   2012

AB         DR REDDYS LABS INC
	     EQ     75MG BASE
            A076273   001   Jan   14,   2008

AB         DR REDDYS LABS LTD
	     EQ     300MG BASE
           A091023   001   May   17,   2012

AB         GATE PHARMS
	            EQ     300MG BASE
           A091216   001   May   17,   2012

AB         MACLEODS PHARMS LTD
	    EQ     75MG BASE
            A202928   001   Feb   10,   2014

AB         MUTUAL PHARM
	           EQ     75MG BASE
            A078133   001   Jun   10,   2013

AB         MYLAN PHARMS INC
	       EQ     75MG BASE
            A077665   001   May   17,   2012

AB
	                                EQ     300MG BASE
           A077665   002   May   17,   2012

AB         ROXANE
	                 EQ     75MG BASE
            A078004   001   May   17,   2012

AB         SCIEGEN PHARMS INC
	     EQ     75MG BASE
            A204165   001   Sep   15,   2014

AB
	                                EQ     300MG BASE
           A204165   002   Sep   15,   2014

AB         SUN PHARMA GLOBAL
	      EQ     75MG BASE
            A090494   001   May   17,   2012

AB         TEVA
	                   EQ     75MG BASE
            A076999   001   May   17,   2012

AB         TEVA PHARMS
	            EQ     300MG BASE
           A090625   001   May   17,   2012

AB         TORRENT PHARMS LTD
	     EQ     75MG BASE
            A090844   001   May   17,   2012

AB         WOCKHARDT LTD
	          EQ     75MG BASE
            A202266   001   Aug   14,   2012

AB
	                                EQ     300MG BASE
           A202266   002   Nov   20,   2012

AB         ZYDUS PHARMS USA INC
	   EQ     75MG BASE
	           A201686   001   Oct   10,   2012
	
     PLAVIX
	
AB         SANOFI AVENTIS US
	      EQ 75MG BASE
                N020839 001 Nov 17, 1997

AB     +
	                          EQ 300MG BASE
	              N020839 002 Sep 20, 2007
	
CLORAZEPATE DIPOTASSIUM
	
  TABLET;ORAL

     CLORAZEPATE DIPOTASSIUM
	
AB         MYLAN
	                  3.75MG
	                     A071858   002   Jul   17,   1987

AB
	                                7.5MG
	                      A071858   003   Jul   17,   1987

AB
	                                15MG
	                       A071858   001   Jul   17,   1987

AB         RANBAXY
	                3.75MG
	                     A076911   001   Sep   29,   2004

AB
	                                7.5MG
	                      A076911   002   Sep   29,   2004

AB
	                                15MG
	                       A076911   003   Sep   29,   2004

AB         TARO
	                   3.75MG
	                     A075731   003   Apr   27,   2000

AB
	                                7.5MG
	                      A075731   002   Apr   27,   2000

AB
	                                15MG
	                       A075731   001   Apr   27,   2000
	
     GEN-XENE
	
AB         ALRA
	                   3.75MG
	                     A071787 001 Apr 26, 1988

AB
	                                7.5MG
	                      A071788 001 Apr 26, 1988

AB
	                                15MG
	                       A071789 001 Apr 26, 1988
	
     TRANXENE
	
AB         RECORDATI RARE
	         3.75MG
	                     N017105 006
	
AB
	                                7.5MG
	                      N017105 007
	
AB     +
	                          15MG
	                       N017105 008
	
CLOTRIMAZOLE
	
  CREAM;TOPICAL

    CLOTRIMAZOLE
	
AB       FOUGERA PHARMS
	           1%
	                         A078338 001 Sep 02, 2008

AB       GLENMARK PHARMS
	          1%
	                         A090219 001 Aug 03, 2010

AB    + TARO
	                      1%
	                         A072640 001 Aug 31, 1993
	
  SOLUTION;TOPICAL

    CLOTRIMAZOLE
	
AT    + TARO
	                      1%
	                         A074580 001 Jul 29, 1996
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                                3-90(of 371)


CLOTRIMAZOLE
	
  SOLUTION;TOPICAL

    CLOTRIMAZOLE
	
AT       TEVA
	                 1%
	                                       A073306 001 Feb 28, 1995
	
  TROCHE/LOZENGE;ORAL

    CLOTRIMAZOLE
	
AB       PADDOCK LLC
	          10MG
	                                     A076763 001 Oct 28, 2005

AB    + ROXANE
	                10MG
	                                     A076387 001 Jul 29, 2004
	
CLOZAPINE
	
  SUSPENSION;ORAL
	
    VERSACLOZ
	
      + JAZZ PHARMS III
	       50MG/ML
	                                  N203479 001 Feb 06, 2013
	
  TABLET;ORAL

    CLOZAPINE
AB        IVAX SUB TEVA PHARMS  12.5MG
	                                   A074949   003   Jul   31,   2003

AB                              25MG
	                                     A074949   001   Nov   26,   1997

AB                              50MG
	                                     A074949   004   Apr   25,   2005

AB                              50MG
	                                     A076809   003   Dec   16,   2005

AB                              100MG
	                                    A074949   002   Nov   26,   1997

AB                              100MG
	                                    A076809   002   Dec   16,   2005

AB                              200MG
	                                    A076809   001   Dec   16,   2005

AB        MYLAN                 12.5MG
	                                   A075417   003   Apr   15,   2010

AB                              25MG
	                                     A075417   001   May   27,   1999

AB                              50MG
	                                     A075417   004   Apr   15,   2010

AB                              100MG
	                                    A075417   002   May   27,   1999

AB                              200MG
	                                    A075417   005   Apr   15,   2010

AB        SUN PHARM INDS INC    25MG
	                                     A075713   001   Nov   15,   2002

AB                              50MG
	                                     A075713   003   Aug   19,   2005

AB                              100MG
	                                    A075713   002   Nov   15,   2002
	
    CLOZARIL
AB        NOVARTIS              25MG
	                                     N019758 001 Sep 26, 1989

AB    +                         100MG
	                                    N019758 002 Sep 26, 1989
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    FAZACLO ODT
	
          JAZZ PHARMS III       12.5MG
	                                   N021590   004   May   30,   2007

                                25MG
	                                     N021590   001   Feb   10,   2004
	
      +		                       100MG
	                                    N021590   002   Feb   10,   2004
	
                                150MG
	                                    N021590   005   Jul   09,   2010
	
                                200MG
	                                    N021590   006   Jul   09,   2010
	
COBICISTAT
	
  TABLET;ORAL
	
    TYBOST
	
      + GILEAD SCIENCES INC     150MG
	                                    N203094 001 Sep 24, 2014
	
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
	
  TABLET;ORAL
	
    STRIBILD
	
      + GILEAD SCIENCES INC		   150MG;150MG;200MG;300MG
	                  N203100 001 Aug 27, 2012
	
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL

    PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

AA       VINTAGE                10MG/5ML;5MG/5ML;6.25MG/5ML                A040660 001 Dec 07, 2006

    PROMETH VC W/ CODEINE

AA    + ACTAVIS MID ATLANTIC    10MG/5ML;5MG/5ML;6.25MG/5ML                A088764 001 Oct 31, 1984

    PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

AA       HI-TECH PHARMA CO      10MG/5ML;5MG/5ML;6.25MG/5ML		              A040674 001 Dec 23, 2014
	
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
	
AA    + ACTAVIS MID ATLANTIC    10MG/5ML;6.25MG/5ML                        A088763   001   Oct   31,   1984
AA       AMNEAL PHARMS          10MG/5ML;6.25MG/5ML                        A200894   001   Apr   24,   2013
AA       HI TECH PHARMA         10MG/5ML;6.25MG/5ML                        A040151   001   Aug   26,   1997
AA       SUN PHARM INDS INC     10MG/5ML;6.25MG/5ML                        A090180   001   Mar   17,   2010
AA       TRIS PHARMA INC        10MG/5ML;6.25MG/5ML                        A200386   001   Jun   29,   2012
AA       WOCKHARDT              10MG/5ML;6.25MG/5ML                        A088875   001   Dec   17,   1984
    PROMETHAZINE WITH CODEINE
AA       VINTAGE                10MG/5ML;6.25MG/5ML                        A040650 001 Jan 31, 2006
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                              3-91(of 371)


CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    TRIACIN-C
	
      + STI PHARMA LLC
	        10MG/5ML;30MG/5ML;1.25MG/5ML
	            A088704 001 Mar 22, 1985
	
CODEINE SULFATE
	
  SOLUTION;ORAL
	
    CODEINE SULFATE
	
      + ROXANE
	                    30MG/5ML
	                            N202245 001 Jun 30, 2011
	
  TABLET;ORAL

    CODEINE SULFATE
	
AB       LANNETT HOLDINGS INC       15MG
	                                A203046   001   Jun   13,   2014

AB                                  30MG
	                                A203046   002   Jun   13,   2014

AB                                  60MG
	                                A203046   003   Jun   13,   2014

AB       ROXANE                     15MG
	                                N022402   001   Jul   16,   2009

AB                                  30MG
	                                N022402   002   Jul   16,   2009

AB    +                             60MG
	                                N022402   003   Jul   16,   2009
	
COLCHICINE
	
  CAPSULE;ORAL
	
    MITIGARE
	
         HIKMA PHARMS LLC
	         0.6MG
	                               N204820 001 Sep 26, 2014
	
  TABLET;ORAL
	
    COLCRYS
	
      + TAKEDA PHARMS USA
	         0.6MG
	                               N022352 001 Jul 29, 2009
	
COLCHICINE; PROBENECID
	
  TABLET;ORAL

    COL-PROBENECID
	
AB    + WATSON LABS
	               0.5MG;500MG
	                         A084279 001
	
    PROBENECID AND COLCHICINE
	
AB       MIRROR PHARMS
	            0.5MG;500MG
	                         A040618 001 May 13, 2008
	
COLESEVELAM HYDROCHLORIDE
	
  FOR SUSPENSION;ORAL
	
    WELCHOL
	
          DAIICHI SANKYO
	          1.875GM/PACKET
                       N022362 001 Oct 02, 2009
	
      +
	                           3.75GM/PACKET
	                       N022362 002 Oct 02, 2009
	
  TABLET;ORAL
	
    WELCHOL
	
      + DAIICHI SANKYO
	            625MG
	                               N021176 001 May 26, 2000
	
COLESTIPOL HYDROCHLORIDE
	
  GRANULE;ORAL

     COLESTID
	
AB         PHARMACIA AND UPJOHN
	   5GM/SCOOPFUL
                         N017563 003 Sep 22, 1995

AB     +
	                          5GM/PACKET
	                          N017563 004 Sep 22, 1995
	
     COLESTIPOL HYDROCHLORIDE
	
AB         IMPAX LABS
	             5GM/SCOOPFUL
                         A077277 001 May 02, 2006

AB
	                                5GM/PACKET
	                          A077277 002 May 02, 2006
	
     FLAVORED COLESTID
	
           PHARMACIA AND UPJOHN
	   5GM/PACKET
                           N017563 001
	
                                    5GM/SCOOPFUL
	                        N017563 002
	
  TABLET;ORAL

    COLESTID
	
AB    + PHARMACIA AND UPJOHN
	      1GM
	                                 N020222 001 Jul 19, 1994
	
    COLESTIPOL HYDROCHLORIDE
	
AB       IMPAX LABS
	               1GM
	                                 A077510 001 Oct 24, 2006
	
COLISTIMETHATE SODIUM
	
  INJECTABLE;INJECTION

    COLISTIMETHATE SODIUM
	
AP       EMCURE PHARMS LTD
	        EQ   150MG   BASE/VIAL
               A202359   001   Sep   28,   2012

AP       FRESENIUS KABI USA
	       EQ   150MG   BASE/VIAL
               A065364   001   Apr   17,   2008

AP       PADDOCK LLC
	              EQ   150MG   BASE/VIAL
               A065177   001   Mar   19,   2004

AP       SAGENT PHARMS
	            EQ   150MG   BASE/VIAL
               A201365   001   Feb   19,   2014

AP       X GEN PHARMS
	             EQ   150MG   BASE/VIAL
	              A064216   001   Feb   26,   1999
	
    COLY-MYCIN M
	
AP    + PAR STERILE PRODUCTS
	      EQ 150MG BASE/VIAL
	                  N050108 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                3-92(of 371)


COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
	
  SUSPENSION/DROPS;OTIC

    COLY-MYCIN S
	
      +		 PAR STERILE PRODUCTS  EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG           N050356 001
	
                                BASE/ML;0.5MG/ML
	
CONIVAPTAN HYDROCHLORIDE
	
  INJECTABLE;IV (INFUSION)

    VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
	
      + CUMBERLAND PHARMS		     20MG/100ML (0.2MG/ML)                     N021697 002 Oct 08, 2008
	
COPPER
	
  INTRAUTERINE DEVICE;INTRAUTERINE
	
    PARAGARD T 380A
	
      + TEVA WOMENS		           309MG/COPPER                              N018680 001 Nov 15, 1984
	
CORTICORELIN OVINE TRIFLUTATE
	
  INJECTABLE;INJECTION
	
    ACTHREL
	
      + FERRING		                 EQ 0.1MG BASE/VIAL                      N020162 001 May 23, 1996
	
CORTICOTROPIN
	
  INJECTABLE;INJECTION
	
    H.P. ACTHAR GEL
	
      + QUESTCOR PHARMS		         80 UNITS/ML                             N008372 008
	
CORTISONE ACETATE
	
  TABLET;ORAL
	
    CORTISONE ACETATE
	
      + HIKMA INTL PHARMS		       25MG                                    A080776 002
	
COSYNTROPIN
	
  INJECTABLE;INJECTION

    CORTROSYN
	
AP    + AMPHASTAR PHARMS INC      0.25MG/VIAL                             N016750 001
	
    COSYNTROPIN
	
AP       MYLAN INSTITUTIONAL      0.25MG/VIAL                             A090574 001 Dec 17, 2009

AP       SANDOZ                   0.25MG/VIAL                             A202147 001 Jun 29, 2012
	
CRIZOTINIB
	
  CAPSULE;ORAL
	
    XALKORI
	
          PF PRISM CV             200MG                                   N202570 001 Aug 26, 2011

      +		                         250MG                                   N202570 002 Aug 26, 2011
	
CROFELEMER
	
  TABLET, DELAYED RELEASE;ORAL
	
    FULYZAQ
	
      + SALIX PHARMS		           125MG                                    N202292 001 Dec 31, 2012
	
CROMOLYN SODIUM
	
  CONCENTRATE;ORAL

    CROMOLYN SODIUM
	
AA       MICRO LABS LTD INDIA     100MG/5ML                               A202745 001 Apr 04, 2013

AA       PACK PHARMS LLC          100MG/5ML                               A202583 001 Oct 27, 2011

    GASTROCROM
	
AA    + MEDA PHARMS               100MG/5ML                               N020479 001 Feb 29, 1996
	
  SOLUTION;INHALATION

    CROMOLYN SODIUM
	
AN       BAUSCH AND LOMB          10MG/ML                                 A075585   001   Dec   21,   2000
AN       MYLAN SPECLT             10MG/ML                                 A074209   001   Apr   26,   1994
AN    + TEVA PHARMS               10MG/ML                                 A075271   001   Jan   18,   2000
AN       WOCKHARDT                10MG/ML                                 A075346   001   Oct   25,   1999
  SOLUTION/DROPS;OPHTHALMIC
    CROLOM
AT       BAUSCH AND LOMB          4%                                      A074443 001 Jan 30, 1995
    CROMOLYN SODIUM
AT    + AKORN                     4%                                      A074706 001 Apr 29, 1998
AT       ALCON                    4%                                      A075282 001 Jun 16, 1999
CROTAMITON
  CREAM;TOPICAL
    EURAX
      + RANBAXY                   10%                                     N006927 001
  LOTION;TOPICAL
    CROTAN
AT       SUMMERS                  10%                                     A087204 001
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-93(of 371)


CROTAMITON
	
  LOTION;TOPICAL

    EURAX
	
AT    + RANBAXY                  10%                            N009112 003
	
CUPRIC CHLORIDE
	
  INJECTABLE;INJECTION
	
    CUPRIC CHLORIDE IN PLASTIC CONTAINER
	
      + HOSPIRA                 EQ 0.4MG COPPER/ML              N018960 001 Jun 26, 1986
	
CYANOCOBALAMIN
	
  INJECTABLE;INJECTION

    CYANOCOBALAMIN
	
AP    + LUITPOLD                 1MG/ML                         A080737 001
	
    VIBISONE
	
AP    + FRESENIUS KABI USA       1MG/ML                         A080557 003
	
  SPRAY, METERED;NASAL
	
    NASCOBAL
	
      + PAR PHARM                0.5MG/SPRAY                    N021642 001 Jan 31, 2005
	
CYCLOBENZAPRINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    AMRIX
	
AB       IVAX INTL              15MG                            N021777 001 Feb 01, 2007

AB    +                         30MG                            N021777 002 Feb 01, 2007

    CYCLOBENZAPRINE HYDROCHLORIDE
	
AB       TWI PHARMS INC         15MG                            A091281 001 Jan 31, 2013

AB                              30MG                            A091281 002 Jan 31, 2013
	
  TABLET;ORAL

    CYCLOBENZAPRINE HYDROCHLORIDE
	
AB       ACTAVIS LABS FL INC    5MG                             A071611   002   Feb   03,   2006

AB                              7.5MG                           A071611   003   Feb   03,   2006

AB                              10MG                            A071611   001   May   03,   1989

AB       AUROBINDO PHARMA       5MG                             A078643   001   Sep   26,   2008

AB                              10MG                            A078643   002   Sep   26,   2008

AB       INVAGEN PHARMS         5MG                             A090478   001   Jul   23,   2010

AB                              10MG                            A090478   002   Jul   23,   2010

AB       JUBILANT CADISTA       5MG                             A077563   001   Apr   19,   2006

AB                              10MG                            A077563   002   Apr   19,   2006

AB       KVK TECH               5MG                             A078048   001   Feb   28,   2011

AB                              10MG                            A078048   002   Feb   28,   2011

AB       MUTUAL PHARM           5MG                             A073541   002   Apr   06,   2006

AB                              10MG                            A073541   001   May   23,   1995

AB       MYLAN PHARMS INC       5MG                             A073144   002   Feb   03,   2006

AB                              7.5MG                           A073144   003   Mar   25,   2013

AB    +                         10MG                            A073144   001   May   30,   1991

AB       ORIT LABS LLC          10MG                            A078218   001   Apr   18,   2008

AB       PLIVA                  10MG                            A074421   001   Sep   29,   1995

AB       PROSAM LABS            10MG                            A077209   001   Oct   04,   2005

AB       RANBAXY                5MG                             A078722   001   May   12,   2008

AB                              7.5MG                           A078722   002   May   12,   2008

AB                              10MG                            A078722   003   May   12,   2008

AB       VINTAGE PHARMS         5MG                             A077797   001   Feb   28,   2007

AB                              10MG                            A077797   002   Feb   28,   2007
	
CYCLOPENTOLATE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    AKPENTOLATE
	
AT       AKORN                   1%                             A040164 001 Jan 13, 1997

    CYCLOGYL
	
AT    + ALCON                    1%                             A084110 001
	
    PENTOLAIR
	
AT       BAUSCH AND LOMB         1%                             A040075 001 Apr 29, 1994

    CYCLOGYL
	
      + ALCON                    0.5%                           A084109 001
	
      + ALCON LABS INC           2%                             A084108 001
	
CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    CYCLOMYDRIL
	
      + ALCON                   0.2%;1%                         A084300 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                        3-94(of 371)


CYCLOPHOSPHAMIDE
	
  CAPSULE;ORAL
	
    CYCLOPHOSPHAMIDE
	
         ROXANE                 25MG                             N203856 001 Sep 16, 2013

      +                         50MG                             N203856 002 Sep 16, 2013

  INJECTABLE;INJECTION

    CYCLOPHOSPHAMIDE
	
AP    + BAXTER HLTHCARE         1GM/VIAL                         A040745   002   May   21,   2008

AP    +                         2GM/VIAL                         A040745   003   May   21,   2008

AP    +                         500MG/VIAL                       A040745   001   May   21,   2008

AP       JIANGSU HENGRUI MED    1GM/VIAL                         A204555   002   Oct   31,   2014

AP                              2GM/VIAL                         A204555   003   Oct   31,   2014

AP                              500MG/VIAL                       A204555   001   Oct   31,   2014

    CYTOXAN (LYOPHILIZED)

AP    + BAXTER HLTHCARE         1GM/VIAL                         N012142 004 Aug 30, 1982

AP    +                         2GM/VIAL                         N012142 005 Aug 30, 1982

AP    +                         500MG/VIAL                       N012142 003
	
  TABLET;ORAL
	
    CYCLOPHOSPHAMIDE
	
         ROXANE                 25MG                             A040032 001 Aug 17, 1999

      +                         50MG                             A040032 002 Aug 17, 1999
	
CYCLOSERINE
	
  CAPSULE;ORAL
	
    SEROMYCIN
	
      + PURDUE GMP              250MG                            A060593 001
	
CYCLOSPORINE
	
  CAPSULE;ORAL

    CYCLOSPORINE
	
AB1      IVAX SUB TEVA PHARMS   25MG                             A065110   003   Mar   29,   2005

AB1                             50MG                             A065110   001   Mar   29,   2005

AB1                             100MG                            A065110   002   Mar   29,   2005

AB1      SANDOZ                 25MG                             A065017   002   Jan   13,   2000

AB1                             100MG                            A065017   001   Jan   13,   2000

AB1      WATSON LABS INC        25MG                             A065044   002   Dec   20,   2000

AB1                             100MG                            A065044   001   Dec   20,   2000

    GENGRAF
	
AB1      ABBVIE                 25MG                             A065003 001 May 12, 2000

AB1                             50MG                             A065003 002 May 12, 2000

AB1                             100MG                            A065003 003 May 12, 2000

    NEORAL
	
AB1      NOVARTIS               25MG                             N050715 001 Jul 14, 1995

AB1 +                           100MG                            N050715 002 Jul 14, 1995

    CYCLOSPORINE
	
AB2      APOTEX                 25MG                             A065040 001 May 09, 2002

AB2                             100MG                            A065040 002 May 09, 2002

    SANDIMMUNE
	
AB2      NOVARTIS               25MG                             N050625 001 Mar 02, 1990

AB2 +                           100MG                            N050625 002 Mar 02, 1990
	
BX                              50MG                             N050625 003 Nov 23, 1992
	
  EMULSION;OPHTHALMIC
	
    RESTASIS
	
      + ALLERGAN                0.05%                            N050790 001 Dec 23, 2002
	
  INJECTABLE;INJECTION

    CYCLOSPORINE
	
AP       EUROHLTH INTL          50MG/ML                          A065004 001 Oct 29, 1999

AP       LUITPOLD               50MG/ML                          A065151 001 Oct 07, 2003

    SANDIMMUNE
	
AP    + NOVARTIS                50MG/ML                          N050573 001 Nov 14, 1983
	
  SOLUTION;ORAL

    CYCLOSPORINE
	
AB1      ABBVIE                 100MG/ML                         A065025 001 Mar 03, 2000

AB1      IVAX SUB TEVA PHARMS   100MG/ML                         A065078 001 Mar 25, 2005

AB1      WATSON LABS            100MG/ML                         A065054 001 Dec 18, 2001

    NEORAL
	
AB1 + NOVARTIS                  100MG/ML                         N050716 001 Jul 14, 1995

    CYCLOSPORINE
	
AB2      WOCKHARDT              100MG/ML                         A065133 001 Sep 17, 2004

    SANDIMMUNE
	
AB2 + NOVARTIS                  100MG/ML                         N050574 001 Nov 14, 1983
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-95(of 371)


CYPROHEPTADINE HYDROCHLORIDE
	
  SYRUP;ORAL

    CYPROHEPTADINE HYDROCHLORIDE
	
AA    + LYNE                    2MG/5ML                        A040668 001 Jun 28, 2006

AA       PHARM ASSOC            2MG/5ML                        A091295 001 Mar 28, 2013
	
  TABLET;ORAL

    CYPROHEPTADINE HYDROCHLORIDE
	
AA       COREPHARMA             4MG                            A040537   001 Sep 30, 2003

AA    + IVAX SUB TEVA PHARMS    4MG                            A087056   001
	
AA       PAR PHARM              4MG                            A087129   001
	
AA       STASON PHARMS          4MG                            A040644   001 May 30, 2006
	
CYSTEAMINE BITARTRATE
	
  CAPSULE;ORAL
	
    CYSTAGON
	
         MYLAN                   EQ   50MG BASE                N020392 001 Aug 15, 1994

      +                          EQ   150MG BASE               N020392 002 Aug 15, 1994

  CAPSULE, DELAYED RELEASE;ORAL
	
    PROCYSBI
	
         RAPTOR INC              EQ   25MG BASE                N203389 001 Apr 30, 2013

      +                          EQ   75MG BASE                N203389 002 Apr 30, 2013
	
CYSTEAMINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    CYSTARAN
	
      + SIGMA TAU                 EQ 0.44% BASE                N200740 001 Oct 02, 2012
	
CYTARABINE
	
  INJECTABLE;INJECTION

    CYTARABINE
	
AP       EUROHLTH INTL          1GM/VIAL                       A074245   001   Aug   31,   1994

AP                              2GM/VIAL                       A074245   002   Aug   31,   1994

AP                              100MG/VIAL                     A071471   001   Aug   02,   1989

AP                              500MG/VIAL                     A071472   001   Aug   02,   1989

AP    + FRESENIUS KABI USA      100MG/ML                       A076512   001   Jan   15,   2004

AP    + HOSPIRA                 20MG/ML                        A071868   001   Jun   04,   1990

AP    +                         20MG/ML                        A072168   001   Aug   31,   1990

AP    +                         20MG/ML                        A072945   001   Feb   28,   1994

AP                              100MG/ML                       A075383   001   Nov   22,   1999

AP       ONCO THERAPIES LTD     20MG/ML                        A200914   001   Dec   13,   2011

AP                              20MG/ML                        A200915   001   Dec   13,   2011

AP                              20MG/ML                        A200916   001   Dec   13,   2011

AP                              100MG/ML                       A201784   001   Jan   30,   2012

    CYTOSAR-U
	
AP    + TEVA PHARMS USA         1GM/VIAL                       A075206   004   Dec   30,   1998

AP    +                         2GM/VIAL                       A075206   003   Dec   30,   1998

AP                              100MG/VIAL                     A075206   001   Dec   30,   1998

AP    +                         500MG/VIAL                     A075206   002   Dec   30,   1998
	
  INJECTABLE, LIPOSOMAL;INJECTION
	
    DEPOCYT
	
      + PACIRA PHARMS INC       10MG/ML                        N021041 001 Apr 01, 1999
	
DABIGATRAN ETEXILATE MESYLATE
	
  CAPSULE;ORAL
	
    PRADAXA
	
         BOEHRINGER INGELHEIM     EQ 75MG BASE                 N022512 001 Oct 19, 2010
	
      +                           EQ 150MG BASE                N022512 002 Oct 19, 2010
	
DABRAFENIB MESYLATE
	
  CAPSULE;ORAL
	
    TAFINLAR
	
         GLAXOSMITHKLINE          EQ 50MG BASE                 N202806 001 May 29, 2013

      +                           EQ 75MG BASE                 N202806 002 May 29, 2013
	
DACARBAZINE
	
  INJECTABLE;INJECTION

    DACARBAZINE
	
AP       EUROHLTH INTL            200MG/VIAL                   A075812   001   Jun   15,   2001

AP                                500MG/VIAL                   A075812   002   Oct   31,   2002

AP       FRESENIUS KABI USA       100MG/VIAL                   A075371   001   Aug   27,   1999

AP                                200MG/VIAL                   A075371   002   Aug   27,   1999

AP       HOSPIRA                  200MG/VIAL                   A075940   001   Oct   18,   2001

AP       TEVA PHARMS USA          200MG/VIAL                   A075259   002   Aug   27,   1998

AP    +                           500MG/VIAL                   A075259   001   Sep   22,   2000
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                     3-96(of 371)


DACARBAZINE
	
  INJECTABLE;INJECTION

    DTIC-DOME
	
AP    + BAYER HLTHCARE           100MG/VIAL                      N017575 001
	
AP    +                          200MG/VIAL                      N017575 002
	
DACTINOMYCIN
	
  INJECTABLE;INJECTION

    COSMEGEN
	
AP    + RECORDATI RARE           0.5MG/VIAL                      N050682 001
	
    DACTINOMYCIN
	
AP       EUROHLTH INTL           0.5MG/VIAL                      A090304 001 Mar 16, 2010

AP       LUITPOLD                0.5MG/VIAL                      A202562 001 Aug 23, 2013
	
DALBAVANCIN HYDROCHLORIDE
	
  INJECTABLE;IV (INFUSION)

    DALVANCE
	
      + DURATA THERAPS INTL      EQ 500MG BASE/VIAL              N021883 001 May 23, 2014
	
DALFAMPRIDINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    AMPYRA
	
      + ACORDA                   10MG                            N022250 001 Jan 22, 2010
	
DALFOPRISTIN; QUINUPRISTIN
	
  INJECTABLE;IV (INFUSION)

    SYNERCID
	
      + KING PHARMS              350MG/VIAL;150MG/VIAL		         N050748 001 Sep 21, 1999
	
DALTEPARIN SODIUM
	
  INJECTABLE;SUBCUTANEOUS
	
    FRAGMIN
	
         EISAI INC		             2,500IU/0.2ML (12,500IU/ML)     N020287   001   Dec   22,   1994
	
                                 5,000IU/0.2ML (25,000IU/ML)     N020287   003   Mar   18,   1996
	
                                 7,500IU/0.3ML (25,000IU/ML)     N020287   005   Apr   04,   2002

                                 10,000IU/ML (10,000IU/ML)       N020287   004   Jan   30,   1998
	
                                 12,500IU/0.5ML (25,000IU/ML)    N020287   009   May   01,   2007

                                 15,000IU/0.6ML (25,000IU/ML)    N020287   010   May   01,   2007

                                 18,000IU/0.72ML (25,000IU/ML)   N020287   011   May   01,   2007

     +		                         95,000IU/3.8ML (25,000IU/ML)    N020287   006   Apr   04,   2002
	
DANAZOL
	
  CAPSULE;ORAL

    DANAZOL
	
AB        BARR                   50MG                            A074582   003   May   29,   1998

AB                               100MG                           A074582   002   May   29,   1998

AB    +                          200MG                           A074582   001   Aug   09,   1996

AB        LANNETT                50MG                            A078214   001   Apr   19,   2007

AB                               100MG                           A078214   002   Apr   19,   2007

AB                               200MG                           A077246   001   Sep   28,   2005
	
DANTROLENE SODIUM
	
  CAPSULE;ORAL

    DANTRIUM
	
AB       PAR STERILE PRODUCTS    25MG                            N017443 001
	
AB                               50MG                            N017443 003
	
AB    +                          100MG                           N017443 002
	
    DANTROLENE SODIUM
	
AB       IMPAX LABS              25MG                            A076856   001   Mar   01,   2005

AB                               50MG                            A076856   002   Mar   01,   2005

AB                               100MG                           A076856   003   Mar   01,   2005

AB       MIKAH PHARMA            25MG                            A076686   001   Oct   24,   2005

AB                               50MG                            A076686   002   Oct   24,   2005

AB                               100MG                           A076686   003   Oct   24,   2005
	
  FOR SUSPENSION;INTRAVENOUS
	
    RYANODEX
	
         EAGLE PHARMS            250MG/VIAL                      N205579 001 Jul 22, 2014
	
  INJECTABLE;INJECTION

    DANTRIUM
	
AP    + PAR STERILE PRODUCTS     20MG/VIAL                       N018264 001
	
    REVONTO
	
AP       US WORLDMEDS            20MG/VIAL                       A078378 001 Jul 24, 2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-97(of 371)


DAPAGLIFLOZIN
	
  TABLET;ORAL
	
    FARXIGA
	
         ASTRAZENECA AB            5MG                         N202293 001 Jan 08, 2014
	
      +                            10MG                        N202293 002 Jan 08, 2014
	
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    XIGDUO XR
	
         ASTRAZENECA AB          5MG;1GM                       N205649   002   Oct   29,   2014
                                 5MG;500MG                     N205649   001   Oct   29,   2014
      +                          10MG;1GM                      N205649   004   Oct   29,   2014
                                 10MG;500MG                    N205649   003   Oct   29,   2014
DAPSONE
  GEL;TOPICAL
    ACZONE
      + ALLERGAN                   5%                          N021794 001 Jul 07, 2005
  TABLET;ORAL
    DAPSONE
         JACOBUS                   25MG                        A086841 001
      +                            100MG                       A086842 001
DAPTOMYCIN
  INJECTABLE;IV (INFUSION)
    CUBICIN
AP    + CUBIST                     500MG/VIAL                  N021572 002 Sep 12, 2003
    DAPTOMYCIN
AP       HOSPIRA INC               500MG/VIAL                  A202857 001 Sep 12, 2014
DARIFENACIN HYDROBROMIDE
  TABLET, EXTENDED RELEASE;ORAL
    ENABLEX
         WARNER CHILCOTT LLC    EQ 7.5MG BASE                  N021513 001 Dec 22, 2004
      +                         EQ 15MG BASE                   N021513 002 Dec 22, 2004
DARUNAVIR ETHANOLATE
  SUSPENSION;ORAL
    PREZISTA
      + JANSSEN PRODS              EQ 100MG BASE/ML            N202895 001 Dec 16, 2011
  TABLET;ORAL
    PREZISTA
         JANSSEN PRODS             EQ   75MG BASE              N021976   004   Dec   18,   2008
                                   EQ   150MG BASE             N021976   005   Dec   18,   2008
                                   EQ   600MG BASE             N021976   002   Feb   25,   2008
     +                             EQ   800MG BASE             N021976   006   Nov   09,   2012
DASABUVIR SODIUM ; OMBITASVIR; PARITAPREVIR; RITONAVIR
	
  TABLET, TABLET;ORAL
	
    VIEKIRA PAK (COPACKAGED)

      +		 ABBVIE INC            EQ 250MG BASE,N/A,N/A,N/A;     N206619 001 Dec 19, 2014

                                N/A,12.5MG,75MG,50MG
	
DASATINIB
	
  TABLET;ORAL
	
    SPRYCEL
	
         BRISTOL MYERS SQUIBB		    20MG                        N021986   001   Jun   28,   2006
	
                                   50MG                        N021986   002   Jun   28,   2006
	
                                   70MG                        N021986   003   Jun   28,   2006
	
                                   80MG                        N021986   005   Oct   28,   2010
	
                                   100MG                       N021986   004   May   30,   2008

     +		                           140MG                       N021986   006   Oct   28,   2010
	
DAUNORUBICIN CITRATE
	
  INJECTABLE, LIPOSOMAL;INJECTION
	
    DAUNOXOME
	
      + GALEN (UK)		            EQ 2MG BASE/ML                 N050704 002 Apr 08, 1996
	
DAUNORUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    CERUBIDINE
	
AP    + EUROHLTH INTL              EQ 20MG BASE/VIAL		         A064103 001 Feb 03, 1995

    DAUNORUBICIN HYDROCHLORIDE
	
AP    + EUROHLTH INTL              EQ   5MG BASE/ML            N050731   001   Jan   30,   1998

AP       FRESENIUS KABI USA        EQ   20MG BASE/VIAL         A065000   001   May   25,   1999

AP       TEVA PHARMS USA           EQ   5MG BASE/ML            A065035   001   Jan   24,   2000
	
         FRESENIUS KABI USA		      EQ   5MG BASE/VIAL          A065034   001   Nov   20,   2001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-98(of 371)


DECITABINE
	
  INJECTABLE;INTRAVENOUS

    DACOGEN
	
AP    + EISAI INC                 50MG/VIAL                     N021790 001 May 02, 2006

    DECITABINE
	
AP       DR REDDYS LABS LTD       50MG/VIAL                     A203131 001 Jul 11, 2013

AP       SANDOZ                   50MG/VIAL                     A202969 001 Aug 28, 2014

  POWDER;INTRAVENOUS
	
    DECITABINE
	
      + SUN PHARMA GLOBAL         50MG/VIAL                     N205582 001 Jan 28, 2014
	
DEFERASIROX
	
  TABLET, FOR SUSPENSION;ORAL
	
    EXJADE
	
         NOVARTIS                 125MG                         N021882 001 Nov 02, 2005
	
                                  250MG                         N021882 002 Nov 02, 2005
	
     +                            500MG                         N021882 003 Nov 02, 2005
	
DEFERIPRONE
	
  TABLET;ORAL
	
    FERRIPROX
	
      + APOPHARMA INC             500MG                         N021825 001 Oct 14, 2011
	
DEFEROXAMINE MESYLATE
	
  INJECTABLE;INJECTION

    DEFEROXAMINE MESYLATE
	
AP       EUROHLTH INTL            2GM/VIAL                      A078086   002   May   30,   2007

AP                                500MG/VIAL                    A078086   001   May   30,   2007

AP       FRESENIUS KABI USA       2GM/VIAL                      A078718   002   Sep   15,   2009

AP                                500MG/VIAL                    A078718   001   Sep   15,   2009

AP       HOSPIRA                  2GM/VIAL                      A076019   002   Mar   17,   2004

AP                                500MG/VIAL                    A076019   001   Mar   17,   2004

    DESFERAL
	
AP    + NOVARTIS                  2GM/VIAL                      N016267 002 May 25, 2000

AP    +                           500MG/VIAL                    N016267 001
	
DEGARELIX ACETATE
	
  POWDER;SUBCUTANEOUS
	
    FIRMAGON
	
         FERRING                  EQ 80MG BASE/VIAL             N022201 001 Dec 24, 2008
	
      +                           EQ 120MG BASE/VIAL            N022201 002 Dec 24, 2008
	
DELAVIRDINE MESYLATE
	
  TABLET;ORAL
	
    RESCRIPTOR
	
         VIIV HLTHCARE            100MG                         N020705 001 Apr 04, 1997

      +                           200MG                         N020705 002 Jul 14, 1999
	
DEMECLOCYCLINE HYDROCHLORIDE
	
  TABLET;ORAL

    DEMECLOCYCLINE HYDROCHLORIDE
	
AB       AMNEAL PHARM           150MG                           A065425   001   Feb   27,   2008

AB    +                         300MG                           A065425   002   Feb   27,   2008

AB       BARR                   150MG                           A065171   001   Dec   13,   2004

AB                              300MG                           A065171   002   Dec   13,   2004

AB       IMPAX LABS             150MG                           A065094   001   Mar   22,   2004

AB                              300MG                           A065094   002   Mar   22,   2004

AB       VERSAPHARM             150MG                           A065389   001   Dec   01,   2008

AB                              300MG                           A065389   002   Dec   01,   2008
	
DESFLURANE
	
  LIQUID;INHALATION
	
    SUPRANE
	
      + BAXTER HLTHCARE           99.9%                         N020118 001 Sep 18, 1992
	
DESIPRAMINE HYDROCHLORIDE
	
  TABLET;ORAL

    DESIPRAMINE HYDROCHLORIDE
	
AB       ACTAVIS TOTOWA           10MG                          A074430   001   Feb   09,   1996

AB                                25MG                          A071601   001   Jun   05,   1987

AB                                50MG                          A071588   001   Jun   05,   1987

AB                                75MG                          A071602   001   Oct   05,   1987

AB                                100MG                         A071766   001   Oct   05,   1987

AB                                150MG                         A074430   002   Feb   09,   1996

AB       SANDOZ                   10MG                          A072099   001   May   24,   1988

AB                                25MG                          A072100   001   May   24,   1988
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-99(of 371)


DESIPRAMINE HYDROCHLORIDE
	
  TABLET;ORAL

    DESIPRAMINE HYDROCHLORIDE
	
AB                                50MG                         A072101   001   May   24,   1988

AB                                75MG                         A072102   001   Jun   20,   1988

AB                                100MG                        A072103   001   Jun   20,   1988

AB                                150MG                        A072104   001   Jun   20,   1988

    NORPRAMIN
	
AB       SANOFI AVENTIS US        10MG                         N014399   007 Feb 11, 1982

AB                                25MG                         N014399   001
	
AB                                50MG                         N014399   003
	
AB                                75MG                         N014399   004
	
AB    +                           100MG                        N014399   005
	
AB                                150MG                        N014399   006
	
DESIRUDIN RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    IPRIVASK
	
      + MARATHON PHARMS LLC       15MG/VIAL                    N021271 001 Apr 04, 2003
	
DESLORATADINE
	
  SOLUTION;ORAL
	
    CLARINEX
	
      + MERCK SHARP DOHME       0.5MG/ML                       N021300 001 Sep 01, 2004

  TABLET;ORAL

    CLARINEX
	
AB    + MERCK SHARP DOHME       5MG                            N021165 001 Dec 21, 2001

    DESLORATADINE
	
AB       BELCHER PHARMS         5MG                            A078355   001   Apr   19,   2012

AB       DR REDDYS LABS LTD     5MG                            A078365   001   Mar   08,   2011

AB       LUPIN PHARMS           5MG                            A078352   001   Oct   25,   2010

AB       MYLAN PHARMS INC       5MG                            A078351   001   Feb   10,   2012

AB       ORCHID HLTHCARE        5MG                            A078357   001   Feb   19,   2010

AB       PERRIGO R AND D        5MG                            A078361   001   Dec   22,   2011

AB       SANDOZ                 5MG                            A078364   001   Dec   03,   2010

AB       SUN PHARM INDS         5MG                            A078359   001   Nov   16,   2010
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    CLARINEX
	
AB       MERCK SHARP DOHME      2.5MG                          N021312 002 Jul 14, 2005

AB    +                         5MG                            N021312 001 Jun 26, 2002

    DESLORATADINE
	
AB       REDDYS                 2.5MG                          A078367 001 Jul 12, 2010

AB                              5MG                            A078367 002 Jul 12, 2010
	
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL

    CLARINEX D 24 HOUR
	
AB    + MERCK SHARP DOHME        5MG;240MG                     N021605 001 Mar 03, 2005

    DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR
	
AB       DR REDDYS LABS LTD      5MG;240MG                     A078366 001 Apr 26, 2011

    CLARINEX-D 12 HOUR
	
      + MERCK SHARP DOHME        2.5MG;120MG                   N021313 001 Feb 01, 2006
	
DESMOPRESSIN ACETATE
	
  INJECTABLE;INJECTION

    DDAVP
	
AP    + FERRING PHARMS INC      0.004MG/ML                     N018938 001 Mar 30, 1984

    DESMOPRESSIN ACETATE
	
AP       HOSPIRA                0.004MG/ML                     A075220 001 Aug 28, 2000

AP       SUN PHARM INDS LTD     0.004MG/ML                     A091280 001 Jan 25, 2013

AP       TEVA PHARMS USA        0.004MG/ML                     A074888 001 Oct 15, 1997
	
  SOLUTION;NASAL

    DDAVP
	
AB    + FERRING PHARMS INC      0.01%                          N017922 001
	
    DESMOPRESSIN ACETATE
	
AB       SUN PHARM INDS         0.01%                          A077212 001 Apr 12, 2012

  SPRAY, METERED;NASAL

    DDAVP (NEEDS NO REFRIGERATION)

AB    + FERRING PHARMS INC      0.01MG/SPRAY                   N017922 003 Aug 07, 1996

    DESMOPRESSIN ACETATE
	
AB    + BAUSCH AND LOMB         0.01MG/SPRAY                   A074830 001 Jan 25, 1999

    DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)

AB       APOTEX INC             0.01MG/SPRAY                   A076703 001 Jan 27, 2005

AB       SUN PHARMA GLOBAL      0.01MG/SPRAY                   A078271 001 Dec 23, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                                3-100(of 371)


DESMOPRESSIN ACETATE
	
  SPRAY, METERED;NASAL

    MINIRIN
	
AB    + FERRING                 0.01MG/SPRAY                               N021333 001 Sep 16, 2002

    STIMATE (NEEDS NO REFRIGERATION)

      + CSL BEHRING             1.5MG/SPRAY                                N020355 002 Oct 24, 2007
	
  TABLET;ORAL

    DDAVP
	
AB       SANOFI AVENTIS US      0.1MG                                      N019955 001 Sep 06, 1995

AB    +                         0.2MG                                      N019955 002 Sep 06, 1995

    DESMOPRESSIN ACETATE
	
AB       ACTAVIS LABS FL INC    0.1MG                                      A076470   001    Jul   01,   2005

AB                              0.2MG                                      A076470   002    Jul   01,   2005

AB       APOTEX INC             0.1MG                                      A077414   001    Mar   07,   2006

AB                              0.2MG                                      A077414   002    Mar   07,   2006

AB       MYLAN PHARMS INC       0.1MG                                      A200653   001    Jun   27,   2014

AB                              0.2MG                                      A200653   002    Jun   27,   2014

AB       TEVA PHARMS            0.1MG                                      A077122   001    Jan   25,   2006

AB                              0.2MG                                      A077122   002    Jan   25,   2006
	
         FERRING                0.1MG                                      N021795   001    May   08,   2008

      +                         0.2MG                                      N021795   002    May   08,   2008
	
DESOGESTREL; ETHINYL ESTRADIOL
	
  TABLET;ORAL-28

    CYCLESSA
	
AB    + ORGANON USA INC          0.125MG;0.15MG;0.1MG;0.025MG;0.025MG;0.   N021090 001 Dec 20, 2000

                                 025MG
	
    DESOGEN
	
AB       ORGANON USA INC         0.15MG;0.03MG                             N020071 002 Dec 10, 1992

    DESOGESTREL AND ETHINYL ESTRADIOL
	
AB       DURAMED PHARMS BARR     0.15MG;0.03MG                             A075256   002    Aug   12,   1999

AB       FAMY CARE LTD           0.15MG,N/A;0.02MG,0.01MG                  A202296   001    Aug   30,   2013

AB       NOVAST LABS LTD         0.15MG;0.03MG                             A091234   001    Jul   12,   2013

AB       WATSON LABS             0.15MG,N/A;0.02MG,0.01MG;0.02MG,0.01MG    A076916   001    Dec   29,   2008

AB                               0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.   A077182   001    Jan   24,   2006

                                 025MG
	
AB                               0.15MG;0.03MG                             A076915 001 Jul 29, 2005

    EMOQUETTE

AB       VINTAGE PHARMS LLC      0.15MG;0.03MG                             A076675 001 Feb 25, 2011

    ENSKYCE
	
AB       LUPIN LTD               0.15MG;0.03MG                             A201887 001 Mar 07, 2013

    ORTHO-CEPT
	
AB    + JANSSEN PHARMS           0.15MG;0.03MG                             N020301 002 Dec 14, 1992

    PIMTREA
	
AB       NOVAST LABS LTD         0.15MG,N/A;0.02MG,0.01MG                  A091247 001 Aug 01, 2013

    VELIVET
	
AB       DURAMED PHARMS BARR     0.125MG;0.15MG;0.1MG;0.025MG;0.025MG;0.   A076455 001 Feb 24, 2004

                                 025MG
	
    VIORELE
	
AB       GLENMARK GENERICS       0.15MG,N/A;0.02MG,0.01MG                  A091346 001 Apr 02, 2012

    KARIVA
	
      + BARR                     0.15MG,N/A;0.02MG,0.01MG;0.02MG,0.01MG    A075863 001 Apr 05, 2002
	
DESONIDE
	
  AEROSOL, FOAM;TOPICAL
	
    VERDESO
	
      + AQUA PHARMS             0.05%                                      N021978 001 Sep 19, 2006

  CREAM;TOPICAL

    DESONIDE
	
AB    + PERRIGO NEW YORK        0.05%                                      N017010 001
	
AB        TARO                  0.05%                                      A073548 001 Jun 30, 1992

    DESOWEN
	
AB        GALDERMA LABS LP      0.05%                                      N019048 001 Dec 14, 1984
	
  GEL;TOPICAL
	
    DESONATE
	
      + BAYER HLTHCARE          0.05%                                      N021844 001 Oct 20, 2006
	
  LOTION;TOPICAL

    DESONIDE
	
AB        FOUGERA PHARMS        0.05%                                      A075860 001 Mar 19, 2002

AB        TARO                  0.05%                                      A202161 001 Oct 31, 2014

    DESOWEN
	
AB    + GALDERMA LABS LP        0.05%                                      A072354 001 Jan 24, 1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                  3-101(of 371)


DESONIDE
	
  OINTMENT;TOPICAL

    DESONIDE
	
AB        FOUGERA PHARMS        0.05%                           A075751 001 Mar 12, 2001

AB    + PERRIGO NEW YORK        0.05%                           N017426 001
	
AB        TARO                  0.05%                           A074254 001 Aug 03, 1994

    DESOWEN
	
AB        GALDERMA LABS LP      0.05%                           A071425 001 Jun 15, 1988
	
DESOXIMETASONE
	
  CREAM;TOPICAL

    DESOXIMETASONE
	
AB       FOUGERA PHARMS         0.25%                           A078369 001 Jun 29, 2010

AB       PERRIGO NEW YORK       0.25%                           A076510 001 Jul 01, 2003

    TOPICORT
	
AB    + TARO                    0.25%                           A073193 001 Nov 30, 1990
	
      +                         0.05%                           A073210 001 Nov 30, 1990
	
  GEL;TOPICAL

    DESOXIMETASONE
	
AB       PERRIGO NEW YORK       0.05%                           A077552 001 Jan 09, 2006

AB       VERSAPHARM             0.05%                           A090727 001 Mar 10, 2011

    TOPICORT
	
AB    + TARO                    0.05%                           A074904 001 Jul 14, 1998
	
  OINTMENT;TOPICAL

    DESOXIMETASONE
	
AB       FOUGERA PHARMS         0.25%                           A078657 001 Sep 28, 2012

AB       GLENMARK GENERICS      0.25%                           A202838 001 Sep 20, 2013

AB       VERSAPHARM INC         0.25%                           A201005 001 Apr 24, 2014

    TOPICORT
	
AB    + TARO                    0.25%                           A074286 001 Jun 07, 1996
	
      + TARO PHARMS NORTH       0.05%                           N018594 001 Jan 17, 1985
	
  SPRAY;TOPICAL
	
    TOPICORT
	
      + TARO                    0.25%                           N204141 001 Apr 11, 2013
	
DESVENLAFAXINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DESVENLAFAXINE
	
BC    + ALEMBIC PHARMS LTD       50MG                           N204150 001 Mar 04, 2013
	
BC    +                          100MG                          N204150 002 Mar 04, 2013
	
    KHEDEZLA
	
BC       OSMOTICA PHARM CORP     50MG                           N204683 001 Jul 10, 2013
	
BC                               100MG                          N204683 002 Jul 10, 2013
	
DESVENLAFAXINE FUMARATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DESVENLAFAXINE
	
      + SUN PHARMA GLOBAL        EQ 50MG BASE                   N205583 001 Jan 28, 2014
	
      +                          EQ 100MG BASE                  N205583 002 Jan 28, 2014
	
DESVENLAFAXINE SUCCINATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    PRISTIQ
	
         WYETH PHARMS INC        EQ 25MG BASE                   N021992 003 Aug 20, 2014

      +                          EQ 50MG BASE                   N021992 001 Feb 29, 2008
	
      +                          EQ 100MG BASE                  N021992 002 Feb 29, 2008
	
DEXAMETHASONE
	
  CONCENTRATE;ORAL
	
    DEXAMETHASONE INTENSOL
	
      + ROXANE                  1MG/ML                          A088252 001 Sep 01, 1983

  ELIXIR;ORAL

    DEXAMETHASONE
	
AA       LYNE                   0.5MG/5ML                       A090891   001 Jul 12, 2011

AA    + STI PHARMA LLC          0.5MG/5ML                       A084754   001
	
AA       VINTAGE PHARMS         0.5MG/5ML                       A091188   001 May 11, 2011

AA       WOCKHARDT EU OPERATN   0.5MG/5ML                       A088254   001 Jul 27, 1983
	
  IMPLANT;INTRAVITREAL
	
    OZURDEX
	
      + ALLERGAN                0.7MG                           N022315 001 Jun 17, 2009
	
  SOLUTION;ORAL
	
    DEXAMETHASONE
	
      + ROXANE                  0.5MG/5ML                       A088248 001 Sep 01, 1983
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                              3-102(of 371)


DEXAMETHASONE
	
  SUSPENSION/DROPS;OPHTHALMIC

    MAXIDEX
	
      + ALCON                    0.1%                                     N013422 001
	
  TABLET;ORAL

    DEXAMETHASONE
	
AB       ECR                     1.5MG                                    A040700   001     Aug 15, 2008

AB       ROXANE                  1.5MG                                    A084610   001
	
BP       PAR PHARM               0.5MG                                    A088148   001     Apr   28,   1983

BP                               0.75MG                                   A088160   001     Apr   28,   1983

BP                               1.5MG                                    A088237   001     Apr   28,   1983

BP                               4MG                                      A088238   001     Apr   28,   1983

BP    +                          6MG                                      A088481   001     Nov   28,   1983
	
BP       ROXANE                  0.5MG                                    A084611   001
	
BP                               0.75MG                                   A084613   001
	
BP                               1MG                                      A088306   001     Sep 15, 1983

BP                               2MG                                      A087916   001     Aug 26, 1982

BP                               4MG                                      A084612   001
	
BP    +                          6MG                                      A088316   001     Sep 15, 1983
	
DEXAMETHASONE SODIUM PHOSPHATE
	
  INJECTABLE;INJECTION

    DEXAMETHASONE SODIUM PHOSPHATE
	
AP       AGILA SPECLTS           EQ 4MG PHOSPHATE/ML                      A040803   001     Aug 29, 2008

AP                               EQ 10MG PHOSPHATE/ML                     A040802   001     Aug 29, 2008

AP       FRESENIUS KABI USA      EQ 4MG PHOSPHATE/ML                      A084916   001
	
AP    +                          EQ 10MG PHOSPHATE/ML                     A040491   001     Apr   11,   2003

AP    +                          EQ 10MG PHOSPHATE/ML                     A040572   001     Apr   22,   2005

AP    + HIKMA MAPLE              EQ 10MG PHOSPHATE/ML                     A087702   001     Sep   07,   1982

AP    + LUITPOLD                 EQ 4MG PHOSPHATE/ML                      A087440   001     Jul   21,   1982
	
  SOLUTION/DROPS;OPHTHALMIC, OTIC

    DEXAMETHASONE SODIUM PHOSPHATE
	
AT    + ALCON PHARMS LTD         EQ 0.1% PHOSPHATE                        A088771 001 Jan 16, 1985

AT       BAUSCH AND LOMB         EQ 0.1% PHOSPHATE                        A040069 001 Jul 26, 1996
	
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC

    MAXITROL
	
AT    + FALCON PHARMS           0.1%;EQ 3.5MG BASE/GM;10,000   UNITS/GM   N050065 002
	
    NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
	
AT       BAUSCH AND LOMB        0.1%;EQ 3.5MG BASE/GM;10,000   UNITS/GM   A064063 001 Jul 25, 1994

AT       PERRIGO CO TENNESSEE   0.1%;EQ 3.5MG BASE/GM;10,000   UNITS/GM   A062938 001 Jul 31, 1989
	
  SUSPENSION/DROPS;OPHTHALMIC

    DEXASPORIN
	
AT       BAUSCH AND LOMB        0.1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A064135 001 Sep 13, 1995

    MAXITROL
	
AT       ALCON                  0.1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A062341 001 May 22, 1984

AT    + FALCON PHARMS           0.1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   N050023 002
	
DEXAMETHASONE; TOBRAMYCIN
	
  OINTMENT;OPHTHALMIC
	
    TOBRADEX
	
      + ALCON                   0.1%;0.3%                                 N050616 001 Sep 28, 1988

  SUSPENSION/DROPS;OPHTHALMIC

    TOBRADEX
	
AB    + ALCON                   0.1%;0.3%                                 N050592 001 Aug 18, 1988

    TOBRAMYCIN AND DEXAMETHASONE
	
AB       BAUSCH AND LOMB        0.1%;0.3%                                 A064134 001 Oct 27, 1999
	
    TOBRADEX ST
	
      + ALCON PHARMS LTD        0.05%;0.3%                                N050818 001 Feb 13, 2009
	
DEXCHLORPHENIRAMINE MALEATE
	
  SYRUP;ORAL
	
    DEXCHLORPHENIRAMINE MALEATE
	
      + WOCKHARDT                 2MG/5ML                                 A088251 001 Mar 23, 1984
	
DEXLANSOPRAZOLE
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    DEXILANT
	
         TAKEDA PHARMS USA       30MG                                     N022287 001 Jan 30, 2009
	
      +                          60MG                                     N022287 002 Jan 30, 2009
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                    3-103(of 371)


DEXMEDETOMIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DEXMEDETOMIDINE HYDROCHLORIDE
	
AP       AKORN INC              EQ     200MCG BASE/2ML (EQ 100MCG BASE/ML)   A202585 001 Nov 24, 2014

AP       MYLAN INSTITUTIONAL    EQ     200MCG BASE/2ML (EQ 100MCG BASE/ML)   A202881 001 Aug 18, 2014

AP       PAR STERILE PRODUCTS   EQ     200MCG BASE/2ML (EQ 100MCG BASE/ML)   A203972 001 Aug 18, 2014

    PRECEDEX
	
AP    + HOSPIRA                 EQ     200MCG BASE/2ML (EQ 100MCG BASE/ML)   N021038 001 Dec 17, 1999
	
      +                         EQ     200MCG BASE/50ML (EQ 4MCG BASE/ML)    N021038 002 Mar 13, 2013
	
      +                         EQ     400MCG BASE/100ML (EQ 4MCG BASE/ML)   N021038 003 Mar 13, 2013
	
DEXMETHYLPHENIDATE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    DEXMETHYLPHENIDATE HYDROCHLORIDE
	
AB       INTELLIPHARMACEUTICS   15MG                                         A078992   003    Nov   18,   2013

AB                              30MG                                         A078992   004    Nov   18,   2013

AB       MYLAN PHARMS INC       30MG                                         A202580   001    Aug   28,   2013

AB       TEVA PHARMS USA        5MG                                          A078908   001    Nov   19,   2013

AB                              10MG                                         A078908   002    Nov   19,   2013

AB                              15MG                                         A078908   004    May   19,   2014

AB                              20MG                                         A078908   003    Nov   19,   2013

AB                              30MG                                         A202731   003    May   19,   2014

AB                              40MG                                         A202731   002    Nov   19,   2013

AB       WATSON LABS INC        15MG                                         A079108   003    May   19,   2014

AB                              30MG                                         A079108   005    Nov   21,   2013

    FOCALIN XR
	
AB       NOVARTIS               5MG                                          N021802   001    May   26,   2005

AB                              10MG                                         N021802   002    May   26,   2005

AB                              15MG                                         N021802   004    Aug   01,   2006

AB                              20MG                                         N021802   003    May   26,   2005

AB                              30MG                                         N021802   005    Oct   23,   2009

AB    +                         40MG                                         N021802   006    Aug   11,   2010

                                25MG                                         N021802   008    Apr   21,   2011

                                35MG                                         N021802   007    Apr   21,   2011

  TABLET;ORAL

    DEXMETHYLPHENIDATE HYDROCHLORIDE
	
AB       TEVA PHARMS            2.5MG                                        A077107 003 Jan 29, 2007

AB                              5MG                                          A077107 001 Jan 29, 2007

AB                              10MG                                         A077107 002 Jan 29, 2007

    FOCALIN
	
AB       NOVARTIS               2.5MG                                        N021278 001 Nov 13, 2001

AB                              5MG                                          N021278 002 Nov 13, 2001

AB    +                         10MG                                         N021278 003 Nov 13, 2001
	
DEXRAZOXANE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DEXRAZOXANE HYDROCHLORIDE
	
AP       EUROHLTH INTL            EQ   250MG   BASE/VIAL                     A076068   001    Sep   28,   2004

AP                                EQ   500MG   BASE/VIAL                     A076068   002    Sep   28,   2004

AP       MYLAN INSTITUTIONAL      EQ   250MG   BASE/VIAL                     A200752   001    Oct   19,   2011

AP                                EQ   500MG   BASE/VIAL                     A200752   002    Oct   19,   2011

    ZINECARD
	
AP    + PHARMACIA AND UPJOHN      EQ 250MG BASE/VIAL                         N020212 001 May 26, 1995

AP    +                           EQ 500MG BASE/VIAL                         N020212 002 May 26, 1995

    TOTECT
	
      + BIOCODEX INC              EQ 500MG BASE/VIAL                         N022025 001 Sep 06, 2007
	
DEXTROAMPHETAMINE SULFATE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    DEXEDRINE
	
AB       AMEDRA PHARMS          5MG                                          N017078 001
	
AB                              10MG                                         N017078 002
	
AB    +                         15MG                                         N017078 003
	
    DEXTROAMPHETAMINE SULFATE
	
AB       ACTAVIS ELIZABETH      5MG                                          A203901   001    Nov   30,   2012

AB                              10MG                                         A203901   002    Nov   30,   2012

AB                              15MG                                         A203901   003    Nov   30,   2012

AB       BARR                   5MG                                          A076137   001    Jan   18,   2002

AB                              10MG                                         A076137   002    Jan   18,   2002

AB                              15MG                                         A076137   003    Jan   18,   2002

AB       MALLINCKRODT           5MG                                          A076353   001    May   06,   2003

AB                              10MG                                         A076353   002    May   06,   2003

AB                              15MG                                         A076353   003    May   06,   2003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                            3-104(of 371)


DEXTROAMPHETAMINE SULFATE
	
  SOLUTION;ORAL

    DEXTROAMPHETAMINE SULFATE
	
AA    + OUTLOOK PHARMS            5MG/5ML                            A040776 001 Jan 29, 2008

AA       TRIS PHARMA INC          5MG/5ML                            A203644 001 May 29, 2013

  TABLET;ORAL

    DEXTROAMPHETAMINE SULFATE
	
AA       AUROLIFE PHARMA LLC      5MG                                A202893   001     Jul   31,   2013

AA                                10MG                               A202893   002     Jul   31,   2013

AA       BARR                     5MG                                A040361   001     Jan   31,   2001

AA    +                           10MG                               A040361   002     Jan   31,   2001

AA       COREPHARMA               5MG                                A090652   001     Mar   07,   2014

AA                                10MG                               A090652   002     Mar   07,   2014

AA       MALLINCKRODT             5MG                                A040436   001     Jan   29,   2002

AA                                10MG                               A040436   002     Jan   29,   2002

AA       MIKART                   5MG                                A090533   002     Oct   25,   2011

AA                                10MG                               A090533   004     Oct   25,   2011
	
                                  2.5MG                              A090533   001     Oct   25,   2011
	
                                  7.5MG                              A090533   003     Oct   25,   2011
	
                                  15MG                               A090533   005     Oct   25,   2011
	
                                  20MG                               A090533   006     Oct   25,   2011
	
                                  30MG                               A090533   007     Oct   25,   2011
	
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL

    PROMETHAZINE DM
	
AA    + VINTAGE                 15MG/5ML;6.25MG/5ML                  A040649 001 Feb 14, 2006

    PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
	
AA       HI TECH PHARMA         15MG/5ML;6.25MG/5ML                  A040027 001 Jul 31, 1996

    PROMETHAZINE W/ DEXTROMETHORPHAN

AA       WOCKHARDT              15MG/5ML;6.25MG/5ML                  A088864 001 Jan 04, 1985
	
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
	
  CAPSULE;ORAL
	
    NUEDEXTA
	
      + AVANIR PHARMS           20MG;10MG                            N021879 001 Oct 29, 2010
	
DEXTROSE
	
  INJECTABLE;INJECTION

    DEXTROSE 10% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 10GM/100ML                           N019626 004 Feb 02, 1988

AP    + BAXTER HLTHCARE         10GM/100ML                           N016694 001
	
AP    + HOSPIRA                 10GM/100ML                           N018080 001
	
    DEXTROSE 20% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         20GM/100ML                           N017521 004
	
AP    + HOSPIRA                 20GM/100ML                           N018564 001 Mar 23, 1982

    DEXTROSE 30% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         30GM/100ML                           N017521 003
	
AP    + HOSPIRA                 30GM/100ML                           N019345 001 Jan 26, 1985

    DEXTROSE 40% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         40GM/100ML                           N017521 002
	
AP    + HOSPIRA                 40GM/100ML                           N018562 001 Mar 23, 1982

    DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 5GM/100ML                            N016730   001
	
AP    +                         5GM/100ML                            N019626   002     Feb 02, 1988

AP    +                         50MG/ML                              N016730   002
	
AP    + BAXTER HLTHCARE         5GM/100ML                            N016673   001
	
AP    +                         5GM/100ML                            N020179   001     Dec   07,   1992

AP    +                         50MG/ML                              N016673   003     Oct   30,   1985

AP    +                         50MG/ML                              N020179   002     Dec   07,   1992

AP    + HOSPIRA                 5GM/100ML                            N019466   001     Jul   15,   1985

AP    +                         5GM/100ML                            N019479   001     Sep   17,   1985

AP    +                         50MG/ML                              N016367   002
	
AP    +                         50MG/ML                              N019222   001     Jul 13, 1984

    DEXTROSE 50% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         50GM/100ML                           N017521   001
	
AP    +                         50GM/100ML                           N020047   001     Jul   02,   1991

AP    + HOSPIRA                 50GM/100ML                           N018563   001     Mar   23,   1982

AP    +                         50GM/100ML                           N019894   001     Dec   26,   1989

AP                              500MG/ML                             N019445   001     Jun   03,   1986

    DEXTROSE 60% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         60GM/100ML                           N017521 005 Mar 26, 1982
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-105(of 371)


DEXTROSE
	
  INJECTABLE;INJECTION

    DEXTROSE 70% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         70GM/100ML
                               N017521   006    Mar   26,   1982

AP    +                         70GM/100ML
                               N020047   003    Jul   02,   1991

AP    + HOSPIRA                 70GM/100ML
                               N018561   001    Mar   23,   1982

AP    +                         70GM/100ML
                               N019893   001    Dec   26,   1989
	
    DEXTROSE 25%
	
      + HOSPIRA		               250MG/ML
	                                N019445 002 Nov 23, 1998
	
DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5GM/100ML;32MG/100ML;128MG/100ML;234MG/   N017385 001
	
                                100ML
	
DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;21MG/100ML;128MG/100ML;234MG/   N017610 001
	
                                100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;31MG/100ML;130MG/100ML;26MG/1   N019873 001 Jun 10, 1993

                                00ML;320MG/100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE;

SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
	
  INJECTABLE;INJECTION
	
    IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA		              5GM/100ML;53MG/100ML;100MG/100ML;100MG/   N019515 001 May 08, 1986

                                100ML;180MG/100ML;280MG/100ML;16MG/100M

                                L
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE;

SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5GM/100ML;31MG/100ML;141MG/100ML;20MG/1   N017484 001
	
                                00ML;12MG/100ML;260MG/100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE;

SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
	
  INJECTABLE;INJECTION
	
    IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;30MG/100ML;141MG/100ML;15MG/1   N019513 001 May 08, 1986

                                00ML;260MG/100ML;25MG/100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;30MG/100ML;97MG/100ML;220MG/1   N019844 001 Jun 10, 1993

                                00ML;140MG/100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM

GLUCONATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;30MG/100ML;37MG/100ML;370MG/1
  N019843 001 Aug 09, 1993
	
                                00ML;530MG/100ML;500MG/100ML

    NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;30MG/100ML;37MG/100ML;222MG/1
  N017609 001
	
                                00ML;526MG/100ML;502MG/100ML

    PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5GM/100ML;30MG/100ML;37MG/100ML;368MG/1   N017451 001
	
                                00ML;526MG/100ML;502MG/100ML
DEXTROSE; POTASSIUM CHLORIDE
  INJECTABLE;INJECTION
    DEXTROSE 5% AND POTASSIUM   CHLORIDE 0.075% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE          5GM/100ML;75MG/100ML
                   N017634 004
	
    DEXTROSE 5% AND POTASSIUM   CHLORIDE 0.15% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE          5GM/100ML;150MG/100ML
                  N017634 001
	
    DEXTROSE 5% AND POTASSIUM   CHLORIDE 0.224% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE          5GM/100ML;224MG/100ML
                  N017634 003
	
    DEXTROSE 5% AND POTASSIUM   CHLORIDE 0.3% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE          5GM/100ML;300MG/100ML
	                 N017634 002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-106(of 371)


DEXTROSE; POTASSIUM CHLORIDE
	
  INJECTABLE;INJECTION

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;75MG/100ML                     N018744 001 Nov 09, 1982

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;150MG/100ML                    N018744 002 Nov 09, 1982

AP                              5GM/100ML;150MG/100ML                    N019699 004 Sep 29, 1989

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;300MG/100ML                    N018744 004 Nov 09, 1982
AP                              5GM/100ML;300MG/100ML                    N019699 006 Sep 29, 1989
    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
AP       HOSPIRA                5GM/100ML;224MG/100ML                    N018371 003
    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
         HOSPIRA                5GM/100ML;149MG/100ML                    N018371 001
    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
         HOSPIRA                5GM/100ML;298MG/100ML                    N018371 002
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;150MG/100ML;130MG/100ML;280MG   N019870 001 Jun 10, 1993

                                /100ML;91MG/100ML
	
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5GM/100ML;205MG/100ML;100MG/100ML;120MG   N018840 001 Jun 29, 1983

                                /100ML;220MG/100ML
	
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ

AP       BAXTER HLTHCARE        5GM/100ML;75MG/100ML;200MG/100ML          N018037 006 Apr 13,   1982

AP                              5GM/100ML;150MG/100ML;200MG/100ML         N018037 007 Apr 13,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K)

AP       BAXTER HLTHCARE        5GM/100ML;224MG/100ML;200MG/100ML         N018037 004
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;200MG/100ML         N018037 008 Apr 13,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)

AP       BAXTER HLTHCARE        5GM/100ML;300MG/100ML;200MG/100ML         N018037 001
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ

AP       BAXTER HLTHCARE        5GM/100ML;224MG/100ML;200MG/100ML         N018037 005 Apr 13,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ

AP       BAXTER HLTHCARE        5GM/100ML;300MG/100ML;200MG/100ML         N018037 009 Apr 13,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ

AP       BAXTER HLTHCARE        5GM/100ML;75MG/100ML;200MG/100ML          N018037 002
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K)

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;200MG/100ML         N018037 003
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;75MG/100ML;330MG/100ML          N018629 005 Mar 23,   1982

AP                              5GM/100ML;150MG/100ML;330MG/100ML         N018629 002 Mar 23,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;224MG/100ML;330MG/100ML         N018629 003 Mar 23,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;330MG/100ML         N018629 004 Mar 23,   1982

AP                              5GM/100ML;300MG/100ML;330MG/100ML         N018629 006 Mar 23,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;224MG/100ML;330MG/100ML         N018629 007 Mar 23,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;300MG/100ML;330MG/100ML         N018629 008 Mar 23,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;75MG/100ML;330MG/100ML          N018629 001 Mar 23,   1982

    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;300MG/100ML;450MG/100ML         N018008 010
	
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;75MG/100ML;200MG/100ML          N019630 008 Feb 17,   1988
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;75MG/100ML;330MG/100ML          N019630 014 Feb 17,   1988
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;75MG/100ML;450MG/100ML          N019630 020 Feb 17,   1988
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;75MG/100ML;900MG/100ML          N019630 026 Feb 17,   1988
    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;150MG/100ML;200MG/100ML         N019630 010 Feb 17,   1988
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                             3-107(of 371)


DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;150MG/100ML;330MG/100ML         N019630 016 Feb 17,    1988

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;150MG/100ML;450MG/100ML         N019630 022 Feb 17,    1988

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;150MG/100ML;900MG/100ML         N019630 028 Feb 17,    1988

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;300MG/100ML;200MG/100ML         N019630 012 Feb 17,    1988

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;300MG/100ML;330MG/100ML         N019630 018 Feb 17,    1988

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;300MG/100ML;450MG/100ML         N019630 024 Feb 17,    1988

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP       B BRAUN                5GM/100ML;300MG/100ML;900MG/100ML         N019630 030 Feb 17,    1988

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;75MG/100ML;450MG/100ML          N018008 005 Apr 28,    1982

AP                              5GM/100ML;150MG/100ML;450MG/100ML         N018008 006 Apr 28,    1982

AP       HOSPIRA                5GM/100ML;74.5MG/100ML;450MG/100ML        N018362 005 Mar 28,    1988

AP                              5GM/100ML;74.5MG/100ML;450MG/100ML        N018362 009 Jul 05,    1983

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;75MG/100ML;900MG/100ML          N019308 004 Apr 05,    1985

AP                              5GM/100ML;150MG/100ML;900MG/100ML         N019308 002 Apr 05,    1985

AP       HOSPIRA                5GM/100ML;74.5MG/100ML;900MG/100ML        N019691 002 Mar 24,    1988

AP                              5GM/100ML;149MG/100ML;900MG/100ML         N019691 004 Mar 24,    1988

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

AP       HOSPIRA                5GM/100ML;224MG/100ML;450MG/100ML         N018362 006 Mar 28,    1988

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       HOSPIRA                5GM/100ML;224MG/100ML;900MG/100ML         N019691 006 Mar 24,    1988

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;450MG/100ML         N018008 007 Apr 28,    1982

AP       HOSPIRA                5GM/100ML;149MG/100ML;450MG/100ML         N018362 010 Jul 05,    1983

AP                              5GM/100ML;298MG/100ML;450MG/100ML         N018362 007 Mar 28,    1988

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;900MG/100ML         N019308 005 Apr 05,    1985

AP                              5GM/100ML;300MG/100ML;900MG/100ML         N019308 003 Apr 05,    1985

AP       HOSPIRA                5GM/100ML;149MG/100ML;900MG/100ML         N019691 005 Mar 24,    1988

AP                              5GM/100ML;298MG/100ML;900MG/100ML         N019691 008 Mar 24,    1988

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;224MG/100ML;450MG/100ML         N018008 008 Apr 28,    1982

AP       HOSPIRA                5GM/100ML;224MG/100ML;450MG/100ML         N018362 002
	
    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;224MG/100ML;900MG/100ML         N019308 006 Apr 05,    1985

AP       HOSPIRA                5GM/100ML;224MG/100ML;900MG/100ML         N019691 007 Mar 24,    1988

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;300MG/100ML;450MG/100ML         N018008 009 Apr 28,    1982

AP       HOSPIRA                5GM/100ML;298MG/100ML;450MG/100ML         N018362 003
	
    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;300MG/100ML;900MG/100ML         N019308 007 Apr 05,    1985

AP       HOSPIRA                5GM/100ML;298MG/100ML;900MG/100ML         N019691 009 Mar 24,    1988

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;450MG/100ML         N018008 004
	
AP       HOSPIRA                5GM/100ML;74.5MG/100ML;450MG/100ML        N018362 008 Mar 28,    1988

AP                              5GM/100ML;149MG/100ML;450MG/100ML         N018362 004 Mar 28,    1988

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        5GM/100ML;150MG/100ML;900MG/100ML         N019308 001 Apr 05,    1985

AP       HOSPIRA                5GM/100ML;74.5MG/100ML;900MG/100ML        N019691 001 Mar 24,    1988

AP                              5GM/100ML;149MG/100ML;900MG/100ML         N019691 003 Mar 24,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;37MG/100ML;200MG/100ML         N019630 031 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;37MG/100ML;450MG/100ML         N019630 037 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;37MG/100ML;900MG/100ML         N019630 043 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;37MG/100ML;110MG/100ML          N019630 001 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;37MG/100ML;200MG/100ML          N019630 007 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;37MG/100ML;330MG/100ML          N019630 013 Feb 17,    1988
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                             3-108(of 371)


DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;37MG/100ML;450MG/100ML          N019630 019 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;37MG/100ML;900MG/100ML          N019630 025 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;75MG/100ML;200MG/100ML         N019630 032 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;75MG/100ML;450MG/100ML         N019630 038 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;75MG/100ML;900MG/100ML         N019630 044 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                3.3GM/100ML;75MG/100ML;300MG/100ML        N019630 049 May 07,    1992

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;75MG/100ML;110MG/100ML          N019630 002 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;110MG/100ML;200MG/100ML        N019630 033 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;110MG/100ML;450MG/100ML        N019630 039 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;110MG/100ML;900MG/100ML        N019630 045 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                3.3GM/100ML;110MG/100ML;300MG/100ML       N019630 050 May 07,    1992

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML;110MG/100ML         N019630 003 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML;200MG/100ML         N019630 009 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML;330MG/100ML         N019630 015 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML;450MG/100ML         N019630 021 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML;900MG/100ML         N019630 027 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;150MG/100ML;200MG/100ML        N019630 034 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;150MG/100ML;450MG/100ML        N019630 040 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;150MG/100ML;900MG/100ML        N019630 046 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                3.3GM/100ML;150MG/100ML;300MG/100ML       N019630 051 May 07,    1992

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;150MG/100ML;110MG/100ML         N019630 004 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;220MG/100ML;200MG/100ML        N019630 035 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;220MG/100ML;450MG/100ML        N019630 041 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;220MG/100ML;900MG/100ML        N019630 047 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                3.3GM/100ML;220MG/100ML;300MG/100ML       N019630 052 May 07,    1992

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;110MG/100ML         N019630 005 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;200MG/100ML         N019630 011 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;330MG/100ML         N019630 017 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;450MG/100ML         N019630 023 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;900MG/100ML         N019630 029 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;300MG/100ML;200MG/100ML        N019630 036 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;300MG/100ML;450MG/100ML        N019630 042 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                10GM/100ML;300MG/100ML;900MG/100ML        N019630 048 Feb 17,    1988
	
    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                3.3GM/100ML;300MG/100ML;300MG/100ML       N019630 053 May 07,    1992

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;300MG/100ML;110MG/100ML         N019630 006 Feb 17,    1988
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                               3-109(of 371)


DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;74.5MG/100ML;225MG/100ML        N018365 002 Jul 05,   1983
	
                                5GM/100ML;149MG/100ML;225MG/100ML         N018365 006 Mar 28,   1988
	
    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;74.5MG/100ML;300MG/100ML        N018876 001 Jan 17,   1986
	
                                5GM/100ML;149MG/100ML;300MG/100ML         N018876 006 Mar 28,   1988
	
    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;224MG/100ML;225MG/100ML         N018365 008 Mar 28,   1988
	
    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;224MG/100ML;300MG/100ML         N018876 007 Mar 28,   1988
	
    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;149MG/100ML;225MG/100ML         N018365 001
	
                                5GM/100ML;298MG/100ML;225MG/100ML         N018365 009 Mar 28,   1988
	
    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;298MG/100ML;300MG/100ML         N018876 008 Mar 28,   1988
	
    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;149MG/100ML;300MG/100ML         N018876 002 Jan 17,   1986
	
    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;224MG/100ML;225MG/100ML         N018365 003 Jul 05,   1983
	
    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;224MG/100ML;300MG/100ML         N018876 003 Jan 17,   1986
	
    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;298MG/100ML;225MG/100ML         N018365 004 Jul 05,   1983
	
    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;298MG/100ML;300MG/100ML         N018876 004 Mar 28,   1988
	
    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;74.5MG/100ML;225MG/100ML        N018365 005 Mar 28,   1988
	
                                5GM/100ML;149MG/100ML;225MG/100ML         N018365 007 Mar 28,   1988
	
    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;74.5MG/100ML;300MG/100ML        N018876 005 Mar 28,   1988
                                5GM/100ML;149MG/100ML;300MG/100ML         N018876 009 Mar 28,   1988
DEXTROSE; SODIUM CHLORIDE
  INJECTABLE;INJECTION
    DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP       B BRAUN                10GM/100ML;900MG/100ML                   N019631 015 Feb 24, 1988
AP       BAXTER HLTHCARE        10GM/100ML;900MG/100ML                   N016696 001
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP       B BRAUN                2.5GM/100ML;450MG/100ML                  N019631 004 Feb 24, 1988
AP       BAXTER HLTHCARE        2.5GM/100ML;450MG/100ML                  N016697 001
    DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;200MG/100ML                    N019631 007 Feb 24, 1988
    DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;330MG/100ML                    N019631 008 Feb 24, 1988
    DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;450MG/100ML                    N019631 009 Feb 24, 1988
AP       HOSPIRA                5GM/100ML;450MG/100ML                    N017607 001
    DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP       B BRAUN                5GM/100ML;900MG/100ML                    N019631 010 Feb 24, 1988
AP       HOSPIRA                5GM/100ML;900MG/100ML                    N017585 001
    DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
AP       BAXTER HLTHCARE        5GM/100ML;200MG/100ML                    N016689 001
    DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
AP       BAXTER HLTHCARE        5GM/100ML;330MG/100ML                    N016687 001
    DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
AP       BAXTER HLTHCARE        5GM/100ML;450MG/100ML                    N016683 001
    DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AP       BAXTER HLTHCARE        5GM/100ML;900MG/100ML                    N016678 001
    DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;110MG/100ML                   N019631 011 Feb 24, 1988
    DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;200MG/100ML                   N019631 012 Feb 24, 1988
    DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;330MG/100ML                   N019631 013 Feb 24, 1988
    DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;450MG/100ML                   N019631 014 Feb 24, 1988
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
         B BRAUN                2.5GM/100ML;110MG/100ML                  N019631 001 Feb 24, 1988
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
         B BRAUN                2.5GM/100ML;200MG/100ML                  N019631 002 Feb 24, 1988
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                        3-110(of 371)


DEXTROSE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
	
         B BRAUN                2.5GM/100ML;330MG/100ML
             N019631 003 Feb 24, 1988
	
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                2.5GM/100ML;900MG/100ML
             N019631 005 Feb 24, 1988
	
    DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                3.3GM/100ML;300MG/100ML
             N019631 016 Jan 19, 1990
	
    DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML
               N019631 006 Feb 24, 1988
	
    DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;225MG/100ML
               N017606 001
	
    DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         HOSPIRA
	              5GM/100ML;300MG/100ML
	              N017799 001
	
DIATRIZOATE MEGLUMINE
	
  SOLUTION;URETHRAL
	
    CYSTOGRAFIN
	
         BRACCO
	                   30%
	                            N010040 018
	
    CYSTOGRAFIN DILUTE
	
         BRACCO
	                   18%
	                            N010040 022 Nov 09, 1982
	
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
	
  INJECTABLE;INJECTION

    MD-76R
	
AP    + MALLINCKRODT
	          66%;10%
	                            N019292 001 Sep 29, 1989
	
    RENOGRAFIN-76
	
AP    + BRACCO
	                66%;10%
	                            N010040 001
	
  SOLUTION;ORAL, RECTAL

    GASTROGRAFIN
	
AA    + BRACCO
	                66%;10%
	                            N011245 003
	
    MD-GASTROVIEW
	
AA       MALLINCKRODT
	         66%;10%
	                            A087388 001
	
DIATRIZOATE MEGLUMINE; IODIPAMIDE MEGLUMINE
	
  SOLUTION;INTRAUTERINE
	
    SINOGRAFIN
	
      + BRACCO
	                52.7%;26.8%
	                        N011324 002
	
DIAZEPAM
	
  CONCENTRATE;ORAL

     DIAZEPAM
	
AA         LANNETT HOLDINGS INC
	   5MG/ML
	                         A204433 001 Apr 14, 2014
	
     DIAZEPAM INTENSOL
	
AA     + ROXANE
	                   5MG/ML
	                         A071415 001 Apr 03, 1987
	
  GEL;RECTAL
	
     DIASTAT
	
           VALEANT PHARMS NORTH
	   2.5MG/0.5ML (5MG/ML)
	           N020648 001 Jul 29, 1997
	
     DIASTAT ACUDIAL
	
           VALEANT PHARMS NORTH
	   10MG/2ML (5MG/ML)
               N020648 007 Sep 15, 2005

       +
	                          20MG/4ML (5MG/ML)
	              N020648 006 Sep 15, 2005
	
  INJECTABLE;INJECTION

     DIAZEPAM
	
AP     + HOSPIRA
	                  5MG/ML
                          A071583 001 Oct 13, 1987

AP
	                                5MG/ML
	                         A072079 001 Dec 20, 1988
	
  SOLUTION;ORAL
	
     DIAZEPAM
	
       + ROXANE
	                   5MG/5ML
	                        A070928 001 Apr 03, 1987
	
  TABLET;ORAL

     DIAZEPAM
	
AB         BARR
	                   2MG
	                            A070152   001    Nov   01,   1985

AB
	                                10MG
	                           A070154   001    Nov   01,   1985

AB         IVAX SUB TEVA PHARMS
	   2MG
	                            A071307   001    Dec   10,   1986

AB
	                                5MG
	                            A071321   001    Dec   10,   1986

AB
	                                10MG
	                           A071322   001    Dec   10,   1986

AB         MYLAN
	                  2MG
	                            A070325   002    Sep   04,   1985

AB
	                                5MG
	                            A070325   003    Sep   04,   1985

AB
	                                10MG
	                           A070325   001    Sep   04,   1985

AB         VINTAGE PHARMS
	         2MG
	                            A077749   001    Mar   31,   2006

AB
	                                5MG
	                            A077749   002    Mar   31,   2006

AB
	                                10MG
	                           A077749   003    Mar   31,   2006

AB         WATSON LABS
	            2MG
	                            A071134   001    Feb   03,   1987

AB
	                                5MG
	                            A071135   001    Feb   03,   1987

AB
	                                10MG
	                           A071136   001    Feb   03,   1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-111(of 371)


DIAZEPAM
	
  TABLET;ORAL

    VALIUM
	
AB        ROCHE                   2MG                           N013263 002
	
AB                                5MG                           N013263 004
	
AB    +                           10MG                          N013263 006
	
DIAZOXIDE
	
  SUSPENSION;ORAL
	
    PROGLYCEM
	
      + TEVA BRANDED PHARM        50MG/ML                       N017453 001
	
DICLOFENAC
	
  CAPSULE;ORAL
	
    ZORVOLEX
	
         IROKO PHARMS LLC         18MG                          N204592 001 Oct 18, 2013
	
      +                           35MG                          N204592 002 Oct 18, 2013
	
DICLOFENAC EPOLAMINE
	
  PATCH;TOPICAL
	
    FLECTOR
	
      + INST BIOCHEM              1.3%                          N021234 001 Jan 31, 2007
	
DICLOFENAC POTASSIUM
	
  CAPSULE;ORAL
	
    ZIPSOR
	
      + DEPOMED INC               25MG                          N022202 001 Jun 16, 2009
	
  FOR SOLUTION;ORAL
	
    CAMBIA
	
      + DEPOMED INC               50MG                          N022165 001 Jun 17, 2009
	
  TABLET;ORAL

    CATAFLAM
	
AB    + NOVARTIS                  50MG                          N020142 002 Nov 24, 1993

    DICLOFENAC POTASSIUM
	
AB       APOTEX                   50MG                          A076561   001    Mar   18,   2004

AB       MYLAN                    50MG                          A075463   001    Jul   26,   1999

AB       SANDOZ                   50MG                          A075229   001    Nov   20,   1998

AB       TEVA                     50MG                          A075219   001    Aug   06,   1998
	
DICLOFENAC SODIUM
	
  GEL;TOPICAL

    DICLOFENAC SODIUM
	
AB       TOLMAR                   3%                            A200936 001 Oct 28, 2013

    SOLARAZE
	
AB    + FOUGERA PHARMS            3%                            N021005 001 Oct 16, 2000
	
    VOLTAREN
	
      + NOVARTIS                  1%                            N022122 001 Oct 17, 2007
	
  SOLUTION;INTRAVENOUS
	
    DYLOJECT
	
      + JAVELIN PHARMS INC        37.5MG/ML (37.5MG/ML)         N022396 001 Dec 23, 2014
	
  SOLUTION;TOPICAL

    DICLOFENAC SODIUM
	
AT       APOTEX INC               1.5%                          A202027   001    May   27,   2014

AT       PADDOCK LLC              1.5%                          A202393   001    Nov   24,   2014

AT       TARO                     1.5%                          A203818   001    Nov   26,   2014

AT       WATSON LABS INC          1.5%                          A202852   001    Nov   24,   2014

    PENNSAID
	
AT    + NUVO RES INC              1.5%                          N020947 001 Nov 04, 2009
	
      + HORIZON PHARMA            2%                            N204623 001 Jan 16, 2014
	
  SOLUTION/DROPS;OPHTHALMIC

    DICLOFENAC SODIUM
	
AT       AKORN                    0.1%                          A077845   001    Apr   17,   2008

AT       ALCON PHARMS LTD         0.1%                          A078031   001    Feb   06,   2008

AT       BAUSCH AND LOMB          0.1%                          A078792   001    Dec   28,   2007

AT       NEXUS PHARMS             0.1%                          A078553   001    Dec   28,   2007

    VOLTAREN
	
AT    + NOVARTIS                  0.1%                          N020037 001 Mar 28, 1991
	
  TABLET, DELAYED RELEASE;ORAL

    DICLOFENAC SODIUM
	
AB       ACTAVIS ELIZABETH        50MG                          A074514   001    Mar   26,   1996

AB                                75MG                          A074514   002    Mar   26,   1996

AB       CARLSBAD                 25MG                          A075185   002    Nov   13,   1998

AB                                50MG                          A075185   003    Nov   13,   1998

AB                                75MG                          A075185   001    Nov   13,   1998

AB       MYLAN PHARMS INC         50MG                          A075281   002    Feb   12,   2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-112(of 371)


DICLOFENAC SODIUM
	
  TABLET, DELAYED RELEASE;ORAL

    DICLOFENAC SODIUM
	
AB                               75MG                           A075281   003    Feb   12,   2002

AB    + SANDOZ                   25MG                           A074376   001    Sep   28,   1995

AB    +                          50MG                           A074376   002    Sep   28,   1995

AB    +                          75MG                           A074394   001    Nov   30,   1995

AB       UNIQUE PHARM LABS       25MG                           A090066   001    Dec   01,   2010

AB                               50MG                           A090066   002    Dec   01,   2010

AB                               75MG                           A077863   003    Jun   08,   2007
	
  TABLET, EXTENDED RELEASE;ORAL

    DICLOFENAC SODIUM
	
AB       ACTAVIS ELIZABETH       100MG                          A075910   001    Jan   07,   2002

AB       DEXCEL LTD              100MG                          A076201   001    Nov   06,   2002

AB       MYLAN                   100MG                          A076152   001    Dec   13,   2001

AB       VALEANT INTL            100MG                          A075492   001    Feb   11,   2000

    VOLTAREN-XR
	
AB    + NOVARTIS                 100MG                          N020254 001 Mar 08, 1996
	
DICLOFENAC SODIUM; MISOPROSTOL
	
  TABLET, DELAYED RELEASE;ORAL

    ARTHROTEC
	
AB       GD SEARLE LLC           50MG;0.2MG                     N020607 001 Dec 24, 1997

AB    +                          75MG;0.2MG                     N020607 002 Dec 24, 1997

    DICLOFENAC SODIUM AND MISOPROSTOL
	
AB       ACTAVIS LABS FL INC     50MG;0.2MG                     A201089   001    Jul   09,   2012

AB                               75MG;0.2MG                     A201089   002    Jul   09,   2012

AB       EAGLE PHARMS            50MG;0.2MG                     A200540   001    Mar   14,   2014

AB                               75MG;0.2MG                     A200540   002    Mar   14,   2014

AB       SANDOZ                  50MG;0.2MG                     A200158   001    May   09,   2013

AB                               75MG;0.2MG                     A200158   002    May   09,   2013
	
DICLOXACILLIN SODIUM
	
  CAPSULE;ORAL

    DICLOXACILLIN SODIUM
	
AB       SANDOZ                 EQ   250MG   BASE               A061454   001
	
AB    +                         EQ   500MG   BASE               A061454   003
	
AB       TEVA                   EQ   250MG   BASE               A062286   001 Jun 03, 1982

AB                              EQ   500MG   BASE               A062286   002 Jun 03, 1982
	
         SANDOZ                 EQ   125MG   BASE               A061454   002
	
DICYCLOMINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    BENTYL
	
AB    + FOREST LABS INC         10MG                            N007409 003 Oct 15, 1984

    DICYCLOMINE HYDROCHLORIDE
	
AB       LANNETT                10MG                            A084285 001
	
AB       MYLAN                  10MG                            A040319 001 Sep 07, 1999

AB       WATSON LABS            10MG                            A085082 001 Jun 19, 1986
	
  INJECTABLE;INJECTION

    BENTYL
	
AP    + FOREST LABS INC         10MG/ML                         N008370 001 Oct 15, 1984

    BENTYL PRESERVATIVE FREE
	
AP    + FOREST LABS INC         10MG/ML                         N008370 002 Oct 15, 1984

    DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE)

AP       EUROHLTH INTL          10MG/ML                         A040465 001 Jun 30, 2003
	
  SYRUP;ORAL

    BENTYL
	
AA    + APTALIS PHARMA US       10MG/5ML                        N007961 002 Oct 15, 1984

    DICYCLOMINE HYDROCHLORIDE
	
AA       MIKART                 10MG/5ML                        A040169 001 Mar 24, 2005
	
  TABLET;ORAL

    BENTYL
	
AB    + FOREST LABS INC         20MG                            N007409 001 Oct 15, 1984

    DICYCLOMINE HYDROCHLORIDE
	
AB       LANNETT                20MG                            A040230 001 Feb 26, 1999

AB       MYLAN                  20MG                            A040317 001 Sep 07, 1999

AB       WATSON LABS            20MG                            A085223 001 Jul 30, 1986
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                        3-113(of 371)


DIDANOSINE
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    DIDANOSINE
	
AB       AUROBINDO PHARMA       125MG                               A090094   001    Sep   24,   2008

AB                              200MG                               A090094   002    Sep   24,   2008

AB                              250MG                               A090094   003    Sep   24,   2008

AB                              400MG                               A090094   004    Sep   24,   2008

AB       BARR                   200MG                               A077167   001    Dec   03,   2004

AB                              250MG                               A077167   002    Dec   03,   2004

AB                              400MG                               A077167   003    Dec   03,   2004

AB       MYLAN PHARMS INC       125MG                               A090788   001    Apr   08,   2010

AB                              200MG                               A090788   002    Apr   08,   2010

AB                              250MG                               A090788   003    Apr   08,   2010

AB                              400MG                               A090788   004    Apr   08,   2010

    VIDEX EC
	
AB       BRISTOL MYERS SQUIBB   125MG                               N021183   001    Oct   31,   2000

AB                              200MG                               N021183   002    Oct   31,   2000

AB                              250MG                               N021183   003    Oct   31,   2000

AB    +                         400MG                               N021183   004    Oct   31,   2000
	
  FOR SOLUTION;ORAL

    DIDANOSINE
	
AA       AUROBINDO PHARMA       10MG/ML                             A078112 001 Mar 08, 2007

    VIDEX
	
AA    + BRISTOL MYERS SQUIBB    10MG/ML                             N020156 001 Oct 09, 1991
	
  TABLET, FOR SUSPENSION;ORAL
	
    DIDANOSINE
	
         AUROBINDO              100MG                               A077275 001 Aug 14, 2012

                                150MG                               A077275 002 Aug 14, 2012

      +                         200MG                               A077275 003 Aug 14, 2012
	
DIENOGEST; ESTRADIOL VALERATE
	
  TABLET;ORAL
	
    NATAZIA
	
      + BAYER HLTHCARE            2MG;3MG;N/A;1MG;2MG;2MG;3MG;N/A   N022252 001 May 06, 2010
	
DIETHYLPROPION HYDROCHLORIDE
	
  TABLET;ORAL

    DIETHYLPROPION HYDROCHLORIDE
	
AA       AVANTHI INC             25MG                               A201212 001 Dec 22, 2010

AA       COREPHARMA              25MG                               A040828 001 Nov 05, 2008

AA       LANNETT HOLDINGS INC    25MG                               A200177 001 Jul 18, 2011

    TENUATE
	
AA    + WATSON PHARMS            25MG                               N011722 002
	
  TABLET, EXTENDED RELEASE;ORAL

    DIETHYLPROPION HYDROCHLORIDE
	
AB       LANNETT HOLDINGS INC    75MG                               A091680 001 Oct 24, 2011

    TENUATE DOSPAN
	
AB    + WATSON PHARMS            75MG                               N012546 001
	
DIFLORASONE DIACETATE
	
  CREAM;TOPICAL
	
    DIFLORASONE DIACETATE
	
BX    + FOUGERA PHARMS            0.05%                             A076263 001 Dec 20, 2002
	
BX    + TARO                      0.05%                             A075508 001 Apr 24, 2000

  OINTMENT;TOPICAL

    DIFLORASONE DIACETATE
	
AB       FOUGERA PHARMS           0.05%                             A075374 001 Apr 27, 1999

AB    + TARO                      0.05%                             A075331 001 May 14, 1999
	
DIFLUNISAL
	
  TABLET;ORAL

    DIFLUNISAL
	
AB       EMCURE PHARMS USA        500MG                             A202845 001 Mar 08, 2012

AB    + TEVA                      500MG                             A073673 001 Jul 31, 1992
	
DIFLUPREDNATE
	
  EMULSION;OPHTHALMIC
	
    DUREZOL
	
      + ALCON PHARMS LTD          0.05%                             N022212 001 Jun 23, 2008
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                   3-114(of 371)


DIGOXIN
	
  ELIXIR;ORAL
	
    DIGOXIN
	
      + ROXANE                     0.05MG/ML                   N021648 001 Aug 26, 2004

  INJECTABLE;INJECTION

    DIGOXIN
	
AP        HIKMA MAPLE              0.25MG/ML                   A083391 001
	
AP        SANDOZ                   0.25MG/ML                   A040481 001 Aug 21, 2003

    LANOXIN
	
AP    + COVIS INJECTABLES          0.25MG/ML                   N009330 002
	
    LANOXIN PEDIATRIC
	
      + COVIS INJECTABLES          0.1MG/ML                    N009330 004
	
  TABLET;ORAL

    DIGOXIN
	
AB        HIKMA INTL PHARMS        0.125MG                     A077002   002    Oct   30,   2007

AB                                 0.25MG                      A077002   001    Oct   30,   2007

AB        IMPAX LABS               0.125MG                     A078556   001    Jul   20,   2009

AB                                 0.25MG                      A078556   002    Jul   20,   2009

AB        STEVENS J                0.125MG                     A076268   001    Jul   26,   2002

AB                                 0.25MG                      A076268   002    Jul   26,   2002

    LANOXIN
	
AB        COVIS PHARMA             0.125MG                     N020405 002 Sep 30, 1997

AB    +                            0.25MG                      N020405 004 Sep 30, 1997

    DIGOXIN
	
          MYLAN PHARMS INC         0.125MG                     A040282 001 Dec 23, 1999
	
                                   0.25MG                      A040282 002 Dec 23, 1999
	
   LANOXIN
	
        COVIS PHARMA               0.0625MG                    N020405 001 Sep 30, 1997

                                   0.1875MG                    N020405 003 Sep 30, 1997
	
DIHYDROERGOTAMINE MESYLATE
	
  INJECTABLE;INJECTION

    D.H.E. 45
	
AP    + VALEANT                    1MG/ML                      N005929 001
	
    DIHYDROERGOTAMINE MESYLATE
	
AP       BEDFORD LABS              1MG/ML                      A040453 001 Jun 09, 2003

AP       PADDOCK LLC               1MG/ML                      A040475 001 Apr 28, 2003

  SPRAY, METERED;NASAL
	
    MIGRANAL
	
      + VALEANT                    0.5MG/INH                   N020148 001 Dec 08, 1997
	
DILTIAZEM HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    DILACOR XR
	
AB2      WATSON LABS            120MG                          N020092 001 May 29, 1992

AB2                             180MG                          N020092 002 May 29, 1992

AB2 +                           240MG                          N020092 003 May 29, 1992

    DILTIAZEM HYDROCHLORIDE
	
AB2      ACTAVIS LABS FL INC    120MG                          A074852   001    Oct   10,   1997

AB2                             180MG                          A074852   002    Oct   10,   1997

AB2                             240MG                          A074852   003    Oct   10,   1997

AB2      APOTEX                 120MG                          A074943   003    Dec   19,   2000

AB2                             180MG                          A074943   002    Dec   19,   2000

AB2                             240MG                          A074943   001    Aug   06,   1998

AB2      MYLAN                  120MG                          A075124   002    Mar   18,   1998

AB2                             180MG                          A075124   003    Mar   18,   1998

AB2                             240MG                          A075124   001    Mar   18,   1998

    CARDIZEM CD
	
AB3      VALEANT INTL           120MG                          N020062   001    Aug   10,   1992

AB3                             180MG                          N020062   002    Dec   27,   1991

AB3                             240MG                          N020062   003    Dec   27,   1991

AB3                             300MG                          N020062   004    Dec   27,   1991

AB3 +                           360MG                          N020062   005    Aug   24,   1999

    CARTIA XT
	
AB3      ACTAVIS LABS FL INC    120MG                          A074752   002    Jul   09,   1998

AB3                             180MG                          A074752   001    Jul   09,   1998

AB3                             240MG                          A074752   003    Jul   09,   1998

AB3                             300MG                          A074752   004    Jul   09,   1998

    DILT-CD
	
AB3      APOTEX                 120MG                          A076151   001    May   20,   2004

AB3                             180MG                          A076151   002    May   20,   2004

AB3                             240MG                          A076151   003    May   20,   2004

AB3                             300MG                          A076151   004    May   20,   2004
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-115(of 371)


DILTIAZEM HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    DILTIAZEM HYDROCHLORIDE
	
AB3      ACTAVIS ELIZABETH      360MG                          A202463   001    Dec   07,   2012

AB3      PAR PHARM              120MG                          A074984   001    Dec   20,   1999

AB3                             180MG                          A074984   002    Dec   20,   1999

AB3                             240MG                          A074984   003    Dec   20,   1999

AB3                             300MG                          A074984   004    Dec   20,   1999

AB3      SUN PHARMA GLOBAL      120MG                          A090492   001    Oct   28,   2011

AB3                             180MG                          A090492   002    Oct   28,   2011

AB3                             240MG                          A090492   003    Oct   28,   2011

AB3                             300MG                          A090492   004    Oct   28,   2011

AB3                             360MG                          A090492   005    Oct   28,   2011

AB3      VALEANT INTL           120MG                          A075116   001    Dec   23,   1999

AB3                             180MG                          A075116   002    Dec   23,   1999

AB3                             240MG                          A075116   003    Dec   23,   1999

AB3                             300MG                          A075116   004    Dec   23,   1999

AB4      SANDOZ                 120MG                          A091022   001    Sep   28,   2012

AB4                             180MG                          A091022   002    Sep   28,   2012

AB4                             240MG                          A091022   003    Sep   28,   2012

AB4                             300MG                          A091022   004    Sep   28,   2012

AB4                             360MG                          A091022   005    Sep   28,   2012

AB4                             420MG                          A091022   006    Sep   28,   2012

AB4      SUN PHARMA GLOBAL      120MG                          A090421   001    Nov   15,   2010

AB4                             180MG                          A090421   002    Nov   15,   2010

AB4                             240MG                          A090421   003    Nov   15,   2010

AB4                             300MG                          A090421   004    Nov   15,   2010

AB4                             360MG                          A090421   005    Nov   15,   2010

    DILTZAC
	
AB4      APOTEX INC             120MG                          A076395   001    Feb   01,   2006

AB4                             180MG                          A076395   002    Feb   01,   2006

AB4                             240MG                          A076395   003    Feb   01,   2006

AB4                             300MG                          A076395   004    Feb   01,   2006

AB4                             360MG                          A076395   005    Feb   01,   2006

    TAZTIA XT
	
AB4      ACTAVIS LABS FL INC    120MG                          A075401   001    Apr   10,   2003

AB4                             180MG                          A075401   002    Apr   10,   2003

AB4                             240MG                          A075401   003    Apr   10,   2003

AB4                             300MG                          A075401   004    Apr   10,   2003

AB4                             360MG                          A075401   005    Apr   10,   2003

    TIAZAC
	
AB4      VALEANT INTL           120MG                          N020401   001    Sep   11,   1995

AB4                             180MG                          N020401   002    Sep   11,   1995

AB4                             240MG                          N020401   003    Sep   11,   1995

AB4                             300MG                          N020401   004    Sep   11,   1995

AB4                             360MG                          N020401   005    Sep   11,   1995

AB4 +                           420MG                          N020401   006    Oct   16,   1998
	
    DILTIAZEM HYDROCHLORIDE
	
BC    + MYLAN                   120MG                          A074910 003 May 02, 1997

                                60MG                           A074910 001 May 02, 1997

                                90MG                           A074910 002 May 02, 1997

  INJECTABLE;INJECTION

    DILTIAZEM HYDROCHLORIDE
	
AP       AKORN INC              5MG/ML                         A075086   001    Apr   09,   1998

AP    + BEDFORD                 5MG/ML                         A074617   001    Feb   28,   1996

AP       HIKMA FARMACEUTICA     5MG/ML                         A202651   001    Aug   09,   2012

AP       HIKMA MAPLE            5MG/ML                         A078538   001    Dec   17,   2008

AP       HOSPIRA                5MG/ML                         A074941   001    Apr   15,   1998

AP       INTL MEDICATION        5MG/ML                         A075749   001    Nov   21,   2001
	
      + HOSPIRA                 100MG/VIAL                     A075853   001    Dec   17,   2002
	
      + TEVA PHARMS USA         10MG/ML                        A074894   002    Apr   19,   2002

  TABLET;ORAL

    CARDIZEM
	
AB       VALEANT INTL           30MG                           N018602   001    Nov   05,   1982

AB                              60MG                           N018602   002    Nov   05,   1982

AB                              90MG                           N018602   003    Dec   08,   1986

AB    +                         120MG                          N018602   004    Dec   08,   1986

    DILTIAZEM HYDROCHLORIDE
	
AB       MYLAN                  30MG                           A072838   004    Nov   05,   1992

AB                              60MG                           A072838   003    Nov   05,   1992

AB                              90MG                           A072838   002    Nov   05,   1992

AB                              120MG                          A072838   001    Nov   05,   1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-116(of 371)


DILTIAZEM HYDROCHLORIDE
	
  TABLET;ORAL

     DILTIAZEM HYDROCHLORIDE
AB         TEVA                  30MG
	                         A074185   001    May   31,   1995

AB                               60MG
	                         A074185   002    May   31,   1995

AB                               90MG
	                         A074185   003    May   31,   1995

AB                               120MG
	                        A074185   004    May   31,   1995
	
  TABLET, EXTENDED RELEASE;ORAL

     CARDIZEM LA
	
AB         VALEANT INTL
	        120MG
	                        N021392   001    Feb   06,   2003

AB
	                             180MG
	                        N021392   002    Feb   06,   2003

AB
	                             240MG
	                        N021392   003    Feb   06,   2003

AB
	                             300MG
	                        N021392   004    Feb   06,   2003

AB
	                             360MG
	                        N021392   005    Feb   06,   2003

AB     +
	                       420MG
	                        N021392   006    Feb   06,   2003
	
     DILTIAZEM HYDROCHLORIDE
	
AB         ACTAVIS LABS FL INC
	 120MG
	                        A077686   006    Mar   15,   2010

AB
	                             180MG
	                        A077686   005    Mar   15,   2010

AB
	                             240MG
	                        A077686   004    Mar   15,   2010

AB
	                             300MG
	                        A077686   003    Mar   15,   2010

AB
	                             360MG
	                        A077686   002    Mar   15,   2010

AB
	                             420MG
	                        A077686   001    Mar   15,   2010
	
DIMENHYDRINATE
	
  INJECTABLE;INJECTION
	
    DIMENHYDRINATE
	
      + FRESENIUS KABI USA
	     50MG/ML
	                      A040519 001 Jun 23, 2004
	
DIMERCAPROL
	
  INJECTABLE;INJECTION
	
    BAL
	
      + AKORN
	                  10%
	                          N005939 001
	
DIMETHYL FUMARATE
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    TECFIDERA
	
          BIOGEN IDEC INC
	      120MG
	                        N204063 001 Mar 27, 2013
	
      +
	                        240MG
	                        N204063 002 Mar 27, 2013
	
DIMETHYL SULFOXIDE
	
  SOLUTION;INTRAVESICAL

    DIMETHYL SULFOXIDE
	
AT       MYLAN INSTITUTIONAL
	   50%
	                          A076185 001 Nov 29, 2002
	
    RIMSO-50
	
AT    + MYLAN INSTITUTIONAL
	    50%
	                          N017788 001
	
DINOPROSTONE
	
  GEL;ENDOCERVICAL
	
    PREPIDIL
	
      + PHARMACIA AND UPJOHN
	 0.5MG/3GM
	                      N019617 001 Dec 09, 1992
	
  INSERT, EXTENDED RELEASE;VAGINAL
	
    CERVIDIL
	
      + FERRING CONTROLLED      10MG
	                          N020411 001 Mar 30, 1995
	
  SUPPOSITORY;VAGINAL
	
    PROSTIN E2
	
      + PHARMACIA AND UPJOHN    20MG
	                          N017810 001
	
DIPHENHYDRAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    DIPHENHYDRAMINE HYDROCHLORIDE
	
      + BARR                    50MG
	                          A080738 001
	
  ELIXIR;ORAL
	
    DIPHENHYDRAMINE HYDROCHLORIDE
	
      + PHARM ASSOC             12.5MG/5ML
                     A087513 001 Feb 10, 1982
	
  INJECTABLE;INJECTION

    DIPHENHYDRAMINE HYDROCHLORIDE
	
AP       APP PHARMS             50MG/ML
                        A040466   001 May 28, 2002

AP    + HIKMA MAPLE             50MG/ML
                        A080817   002
	
AP       HOSPIRA                50MG/ML
                        A040140   001 Nov 20, 1998

AP       MYLAN INSTITUTIONAL    50MG/ML
                        A040498   001 Jul 12, 2005
	
    DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
	
AP       BD RX                  50MG/ML
	                       A091526 001 Mar 26, 2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-117(of 371)


DIPYRIDAMOLE
	
  INJECTABLE;INJECTION

    DIPYRIDAMOLE
	
AP    + BEDFORD                 5MG/ML                         A074939 001 Apr 13, 1998

AP       FRESENIUS KABI USA     5MG/ML                         A074956 001 Sep 30, 1998

AP       HIKMA MAPLE            5MG/ML                         A074521 001 Oct 18, 1996
	
  TABLET;ORAL

    DIPYRIDAMOLE
	
AB       BARR                   25MG                           A087184   001    Oct   03,   1990

AB                              50MG                           A087716   001    Oct   03,   1990

AB                              75MG                           A087717   001    Oct   03,   1990

AB       IMPAX LABS             25MG                           A040782   001    Jul   18,   2007

AB                              50MG                           A040782   002    Jul   18,   2007

AB                              75MG                           A040782   003    Jul   18,   2007

AB       LANNETT                25MG                           A040898   001    Apr   23,   2008

AB                              50MG                           A040898   002    Apr   23,   2008

AB                              75MG                           A040898   003    Apr   23,   2008

AB       MURTY PHARMS           25MG                           A040733   001    Feb   13,   2007

AB                              50MG                           A040733   002    Feb   13,   2007

AB                              75MG                           A040733   003    Feb   13,   2007

AB       PUREPAC PHARM          25MG                           A089425   001    Jul   12,   1990

AB       ZYDUS PHARMS USA INC   25MG                           A040874   001    Jan   28,   2008

AB                              50MG                           A040874   002    Jan   28,   2008

AB                              75MG                           A040874   003    Jan   28,   2008

    PERSANTINE
	
AB       BOEHRINGER INGELHEIM   25MG                           N012836 003 Dec 22, 1986

AB                              50MG                           N012836 004 Feb 06, 1987

AB    +                         75MG                           N012836 005 Feb 06, 1987
	
DISOPYRAMIDE PHOSPHATE
	
  CAPSULE;ORAL

    DISOPYRAMIDE PHOSPHATE
	
AB       TEVA                   EQ   100MG   BASE              A070101   001    Feb   22,   1985

AB                              EQ   150MG   BASE              A070102   001    Feb   22,   1985

AB       WATSON LABS            EQ   100MG   BASE              A070173   001    May   31,   1985

AB                              EQ   150MG   BASE              A070174   001    May   31,   1985

    NORPACE
	
AB       GD SEARLE LLC          EQ   100MG BASE                N017447 001
	
AB    +                         EQ   150MG BASE                N017447 002
	
  CAPSULE, EXTENDED RELEASE;ORAL

    NORPACE CR
	
AB    + GD SEARLE LLC           EQ   150MG BASE                N018655 002 Jul 20, 1982
	
                                EQ   100MG BASE                N018655 001 Jul 20, 1982
	
DISULFIRAM
	
  TABLET;ORAL

    ANTABUSE
	
AB       ODYSSEY PHARMS         250MG                          A088482 001 Dec 08, 1983

AB    +                         500MG                          A088483 001 Dec 08, 1983

    DISULFIRAM
	
AB       ROXANE                 250MG                          A202652   001    Feb   05,   2014

AB                              500MG                          A202652   002    Feb   05,   2014

AB       SIGMAPHARM LABS LLC    250MG                          A091619   001    Mar   28,   2011

AB                              500MG                          A091619   002    Mar   28,   2011

AB       VINTAGE PHARMS         250MG                          A091563   001    Dec   31,   2012

AB                              500MG                          A091563   002    Dec   31,   2012

    DISULFIRAM
	
AB       ALVOGEN PINE BROOK     250MG                          A091681 001 Aug 08, 2013
	
DIVALPROEX SODIUM
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    DEPAKOTE
	
AB    + ABBVIE                  EQ 125MG     VALPROIC ACID     N019680 001 Sep 12, 1989

    DIVALPROEX SODIUM
	
AB       DR REDDYS LABS LTD     EQ 125MG     VALPROIC ACID     A078979 001 Jan 23, 2009

AB       MYLAN                  EQ 125MG     VALPROIC ACID     A090407 001 Mar 28, 2011

AB       ZYDUS PHARMS USA INC   EQ 125MG     VALPROIC ACID     A078919 001 Jan 27, 2009
	
  TABLET, DELAYED RELEASE;ORAL

    DEPAKOTE
	
AB       ABBVIE                 EQ 125MG     VALPROIC ACID     N018723 003 Oct 26, 1984

AB                              EQ 250MG     VALPROIC ACID     N018723 001 Mar 10, 1983

AB    +                         EQ 500MG     VALPROIC ACID     N018723 002 Mar 10, 1983
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-118(of 371)


DIVALPROEX SODIUM
	
  TABLET, DELAYED RELEASE;ORAL

    DIVALPROEX SODIUM
	
AB       ACTAVIS LABS FL INC     EQ   500MG   VALPROIC   ACID   A079080   001    Feb   25,   2011

AB       ANCHEN PHARMS           EQ   500MG   VALPROIC   ACID   A078411   001    Nov   03,   2008

AB       AUROBINDO PHARMA LTD    EQ   125MG   VALPROIC   ACID   A090554   001    Apr   21,   2011

AB                               EQ   250MG   VALPROIC   ACID   A090554   002    Apr   21,   2011

AB                               EQ   500MG   VALPROIC   ACID   A090554   003    Apr   21,   2011

AB       DR REDDYS LABS LTD      EQ   125MG   VALPROIC   ACID   A078755   001    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A078755   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A078755   003    Jul   29,   2008

AB       LUPIN                   EQ   125MG   VALPROIC   ACID   A078790   001    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A078790   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A078790   003    Jul   29,   2008

AB       MYLAN                   EQ   125MG   VALPROIC   ACID   A090062   001    Mar   17,   2009

AB                               EQ   250MG   VALPROIC   ACID   A090062   002    Mar   17,   2009

AB                               EQ   500MG   VALPROIC   ACID   A090062   003    Mar   17,   2009

AB       NU PHARM                EQ   125MG   VALPROIC   ACID   A077615   003    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A077615   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A077615   001    Jul   29,   2008

AB       ORCHID HLTHCARE         EQ   125MG   VALPROIC   ACID   A078853   001    Nov   25,   2008

AB                               EQ   250MG   VALPROIC   ACID   A078853   002    Nov   25,   2008

AB                               EQ   500MG   VALPROIC   ACID   A078853   003    Nov   25,   2008

AB       SANDOZ                  EQ   125MG   VALPROIC   ACID   A078290   003    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A078290   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A078290   001    Jul   29,   2008

AB       SUN PHARM INDS          EQ   125MG   VALPROIC   ACID   A078597   001    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A078597   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A078597   003    Jul   29,   2008

AB       TEVA                    EQ   125MG   VALPROIC   ACID   A076941   001    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A076941   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A076941   003    Jul   29,   2008

AB       UNICHEM LABS LTD        EQ   125MG   VALPROIC   ACID   A079163   001    Apr   05,   2011

AB                               EQ   250MG   VALPROIC   ACID   A079163   002    Apr   05,   2011

AB                               EQ   500MG   VALPROIC   ACID   A079163   003    Apr   05,   2011

AB       UPSHER SMITH            EQ   125MG   VALPROIC   ACID   A078182   001    Jul   29,   2008

AB                               EQ   250MG   VALPROIC   ACID   A078182   002    Jul   29,   2008

AB                               EQ   500MG   VALPROIC   ACID   A078182   003    Jul   29,   2008

AB       VINTAGE                 EQ   125MG   VALPROIC   ACID   A090210   001    Nov   30,   2009

AB                               EQ   250MG   VALPROIC   ACID   A090210   002    Nov   30,   2009

AB                               EQ   500MG   VALPROIC   ACID   A090210   003    Nov   30,   2009

AB       WOCKHARDT               EQ   125MG   VALPROIC   ACID   A077296   001    Jul   31,   2008

AB                               EQ   250MG   VALPROIC   ACID   A077296   002    Jul   31,   2008

AB                               EQ   500MG   VALPROIC   ACID   A077296   003    Jul   31,   2008

AB       ZYDUS PHARMS USA INC    EQ   125MG   VALPROIC   ACID   A077100   001    Mar   05,   2009

AB                               EQ   250MG   VALPROIC   ACID   A077100   002    Mar   05,   2009

AB                               EQ   500MG   VALPROIC   ACID   A077100   003    Mar   05,   2009
	
  TABLET, EXTENDED RELEASE;ORAL

    DEPAKOTE ER
	
AB       ABBVIE                  EQ   250MG VALPROIC ACID       N021168 002 May 31, 2002

AB    +                          EQ   500MG VALPROIC ACID       N021168 001 Aug 04, 2000

    DIVALPROEX SODIUM
	
AB       ANCHEN PHARMS           EQ   250MG   VALPROIC   ACID   A078445   001    Feb   26,   2009

AB                               EQ   500MG   VALPROIC   ACID   A078445   002    Aug   04,   2009

AB       AUROBINDO PHARMA LTD    EQ   250MG   VALPROIC   ACID   A202419   001    Jun   02,   2014

AB                               EQ   500MG   VALPROIC   ACID   A202419   002    Jun   02,   2014

AB       DR REDDYS LABS LTD      EQ   250MG   VALPROIC   ACID   A090161   001    Mar   15,   2012

AB       IMPAX LABS              EQ   250MG   VALPROIC   ACID   A078791   001    May   06,   2009

AB                               EQ   500MG   VALPROIC   ACID   A078791   002    Aug   04,   2009

AB       MYLAN                   EQ   250MG   VALPROIC   ACID   A077567   001    Jan   29,   2009

AB                               EQ   500MG   VALPROIC   ACID   A077567   002    Jan   29,   2009

AB       REDDYS                  EQ   500MG   VALPROIC   ACID   A090070   001    Mar   12,   2012

AB       WOCKHARDT               EQ   250MG   VALPROIC   ACID   A078705   002    Feb   10,   2009

AB                               EQ   500MG   VALPROIC   ACID   A078705   001    Aug   04,   2009

AB       ZYDUS PHARMS USA INC    EQ   250MG   VALPROIC   ACID   A078239   001    Feb   27,   2009

AB                               EQ   500MG   VALPROIC   ACID   A078239   002    Aug   04,   2009
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                            3-119(of 371)


DOBUTAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DOBUTAMINE HYDROCHLORIDE
	
AP       EUROHLTH INTL            EQ 12.5MG BASE/ML                    A074277 001 Oct 31, 1994

AP       HOSPIRA                  EQ 12.5MG BASE/ML                    A074086 001 Nov 29, 1993

AP    +                           EQ 12.5MG BASE/ML                    A074292 001 Feb 16, 1995

    DOBUTAMINE HYDROCHLORIDE IN   DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE           EQ 50MG BASE/100ML                   N020255   001    Oct   19,   1993
AP    +                           EQ 100MG BASE/100ML                  N020255   003    Oct   19,   1993
AP    +                           EQ 200MG BASE/100ML                  N020255   004    Oct   19,   1993
AP    +                           EQ 400MG BASE/100ML                  N020255   005    Oct   19,   1993
AP    + HOSPIRA                   EQ 50MG BASE/100ML                   N020201   003    Oct   19,   1993
AP    +                           EQ 100MG BASE/100ML                  N020201   002    Oct   19,   1993
AP    +                           EQ 200MG BASE/100ML                  N020201   001    Oct   19,   1993
AP    +                           EQ 400MG BASE/100ML                  N020201   006    Jul   07,   1994
DOCETAXEL
  INJECTABLE;INJECTION
    DOCETAXEL
AP       ACCORD HLTHCARE          20MG/ML (20MG/ML)                    N201195   003    Apr   20,   2012
AP                                80MG/4ML (20MG/ML)                   N201195   004    Apr   20,   2012
AP    +                           160MG/8ML (20MG/ML)                  N201195   005    Apr   20,   2012
AP       ACTAVIS INC              20MG/ML (20MG/ML)                    N203551   001    Apr   12,   2013
AP                                80MG/4ML (20MG/ML)                   N203551   002    Apr   12,   2013
AP       DR REDDYS LABS LTD       20MG/ML (20MG/ML)                    A204193   001    Nov   05,   2014
AP                                80MG/4ML (20MG/ML)                   A204193   002    Nov   05,   2014
AP    + HOSPIRA INC               20MG/2ML (10MG/ML)                   N022234   001    Mar   08,   2011
AP    +                           80MG/8ML (10MG/ML)                   N022234   002    Mar   08,   2011
AP    +                           160MG/16ML (10MG/ML)                 N022234   003    Mar   08,   2011
AP       SANDOZ                   20MG/2ML (10MG/ML)                   N201525   001    Jun   29,   2011
AP                                80MG/8ML (10MG/ML)                   N201525   002    Jun   29,   2011
AP                                160MG/16ML (10MG/ML)                 N201525   003    Jun   29,   2011
    TAXOTERE
AP    + SANOFI AVENTIS US         20MG/ML (20MG/ML)                    N020449 003 Aug 03, 2010
AP    +                           80MG/4ML (20MG/ML)                   N020449 004 Aug 02, 2010
AP    +                           160MG/8ML (20MG/ML)                  N020449 005 Apr 13, 2012
    DOCEFREZ
      + SUN PHARMA GLOBAL         20MG/VIAL                            N022534 001 May 03, 2011
      +                           80MG/VIAL                            N022534 002 May 03, 2011
    DOCETAXEL
         ACCORD HLTHCARE          20MG/0.5ML (40MG/ML)                 N201195   001    Jun   08,   2011
                                  80MG/2ML (40MG/ML)                   N201195   002    Jun   08,   2011
         ACTAVIS INC              140MG/7ML (20MG/ML)                  N203551   003    Apr   12,   2013
         PFIZER LABS              20MG/2ML (10MG/ML)                   N202356   001    Mar   13,   2014
                                  80MG/8ML (10MG/ML)                   N202356   002    Mar   13,   2014
                                  130MG/13ML (10MG/ML)                 N202356   003    Mar   13,   2014
                                  200MG/20ML (10MG/ML)                 N202356   004    Mar   13,   2014
DOFETILIDE
  CAPSULE;ORAL
    TIKOSYN
         PFIZER                   0.125MG                              N020931 001 Oct 01, 1999
                                  0.25MG                               N020931 002 Oct 01, 1999
     +                            0.5MG                                N020931 003 Oct 01, 1999
DOLASETRON MESYLATE
  INJECTABLE;INJECTION
    ANZEMET
      + SANOFI AVENTIS US         12.5MG/0.625ML (20MG/ML)             N020624 002 Sep 11, 1997
      +                           100MG/5ML (20MG/ML)                  N020624 001 Sep 11, 1997
      +                           500MG/25ML (20MG/ML)                 N020624 003 Dec 11, 2001
  TABLET;ORAL
    ANZEMET
         SANOFI AVENTIS US        50MG                                 N020623 001 Sep 11, 1997
      +                           100MG                                N020623 002 Sep 11, 1997
DOLUTEGRAVIR SODIUM
  TABLET;ORAL
    TIVICAY
      + VIIV HLTHCARE             EQ 50MG BASE                         N204790 001 Aug 12, 2013
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                    3-120(of 371)


DONEPEZIL HYDROCHLORIDE
  TABLET;ORAL
    ARICEPT
AB       EISAI INC              5MG                            N020690 002 Nov 25, 1996

AB    +                         10MG                           N020690 001 Nov 25, 1996

AB    +                         23MG                           N022568 001 Jul 23, 2010
	
    DONEPEZIL HYDROCHLORIDE
AB       ALEMBIC PHARMS LTD     5MG                            A201724   001    Feb   25,   2013

AB                              10MG                           A201724   002    Feb   25,   2013

AB       APOTEX                 5MG                            A078841   001    Jun   02,   2011

AB                              10MG                           A078841   002    Jun   02,   2011

AB       AUROBINDO              5MG                            A090056   001    May   31,   2011

AB                              10MG                           A090056   002    May   31,   2011

AB       CIPLA LTD              5MG                            A077518   001    May   31,   2011

AB                              10MG                           A077518   002    May   31,   2011

AB       CSPC OUYI PHARM CO     5MG                            A202114   001    Jul   05,   2013

AB                              10MG                           A202114   002    Jul   05,   2013

AB       DR REDDYS LABS LTD     5MG                            A201001   001    May   31,   2011

AB                              10MG                           A201001   002    May   31,   2011

AB                              23MG                           A202723   001    Jul   24,   2013

AB       HIKMA PHARMS           5MG                            A090247   001    May   31,   2011

AB                              10MG                           A090247   002    May   31,   2011

AB       INDICUS PHARMA         5MG                            A201634   001    Jun   13,   2012

AB                              10MG                           A201634   002    Jun   13,   2012

AB       JUBILANT GENERICS      5MG                            A090768   001    May   31,   2011

AB                              10MG                           A090768   002    May   31,   2011

AB       MACLEODS PHARMS LTD    5MG                            A201146   001    Aug   17,   2012

AB                              10MG                           A201146   002    Aug   17,   2012

AB                              23MG                           A202631   001    Jan   22,   2014

AB       MYLAN PHARMS INC       5MG                            A090521   001    May   31,   2011

AB                              10MG                           A090521   002    May   31,   2011

AB       PAR PHARM              23MG                           A202542   001    Jul   24,   2013

AB       PLIVA HRVATSKA DOO     5MG                            A090425   001    May   31,   2011

AB                              10MG                           A090425   002    May   31,   2011

AB       PRINSTON INC           5MG                            A200292   001    May   31,   2011

AB                              10MG                           A200292   002    May   31,   2011

AB       RANBAXY                5MG                            A076786   001    Nov   26,   2010

AB                              10MG                           A076786   002    Nov   26,   2010

AB       ROXANE                 5MG                            A078662   001    May   31,   2011

AB                              10MG                           A078662   002    May   31,   2011

AB       SANDOZ                 5MG                            A090290   001    May   31,   2011

AB                              10MG                           A090290   002    May   31,   2011

AB       SCIEGEN PHARMS INC     5MG                            A203907   001    Oct   29,   2014

AB                              10MG                           A203907   002    Oct   29,   2014

AB       SUN PHARM INDS         5MG                            A090493   001    May   31,   2011

AB                              10MG                           A090493   002    May   31,   2011

AB       TEVA                   5MG                            A077344   001    May   31,   2011

AB                              10MG                           A077344   002    May   31,   2011

AB       TORRENT PHARMS         5MG                            A090686   001    May   31,   2011

AB                              10MG                           A090686   002    May   31,   2011

AB       TWI PHARMS INC         23MG                           A203104   001    Oct   29,   2014

AB       VIVIMED LABS           5MG                            A090551   001    May   31,   2011

AB                              10MG                           A090551   002    May   31,   2011

AB       WOCKHARDT              5MG                            A091267   001    May   31,   2011

AB                              10MG                           A091267   002    May   31,   2011

AB       ZYDUS PHARMS USA INC   5MG                            A090100   001    Oct   24,   2012

AB                              10MG                           A090100   002    Oct   24,   2012
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    ARICEPT ODT
AB       EISAI INC              5MG                            N021720 001 Oct 18, 2004

AB    +                         10MG                           N021720 002 Oct 18, 2004
	
    DONEPEZIL HYDROCHLORIDE
AB       BARR                   5MG                            A078388   002    Nov   26,   2010

AB                              10MG                           A078388   001    Nov   26,   2010

AB       MACLEODS PHARMS LTD    5MG                            A201787   001    Dec   14,   2012

AB                              10MG                           A201787   002    Dec   14,   2012

AB       SANDOZ                 5MG                            A091198   001    May   10,   2011

AB                              10MG                           A091198   002    May   10,   2011

AB       ZYDUS PHARMS USA INC   5MG                            A090175   001    May   10,   2011

AB                              10MG                           A090175   002    May   10,   2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                        3-121(of 371)


DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    NAMZARIC
	
         FOREST LABS INC        10MG;14MG                           N206439 001 Dec 23, 2014
	
      +                         10MG;28MG                           N206439 002 Dec 23, 2014
	
DOPAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DOPAMINE HYDROCHLORIDE
	
AP    + HOSPIRA                 40MG/ML                             N018132   001
	
AP    +                         80MG/100ML                          N018132   002     Feb   04,   1982

AP    +                         80MG/ML                             N018132   004     Jul   09,   1982

AP    +                         160MG/100ML                         N018132   003     Feb   04,   1982

AP    + LUITPOLD                40MG/ML                             A070799   001     Feb   11,   1987

AP    +                         80MG/ML                             A070820   001     Feb   11,   1987

AP    +                         160MG/ML                            A070826   001     Feb   11,   1987

    DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%
	
AP    + B BRAUN                 80MG/100ML                          N019099 002 Oct 15, 1986

AP    +                         320MG/100ML                         N019099 004 Oct 15, 1986

    DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 160MG/100ML                         N019099 003 Oct 15, 1986

    DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         80MG/100ML                          N019615   001     Mar   27,   1987

AP    +                         160MG/100ML                         N019615   002     Mar   27,   1987

AP    +                         320MG/100ML                         N019615   003     Mar   27,   1987

AP    + HOSPIRA                 80MG/100ML                          N018826   001     Sep   30,   1983

AP    +                         160MG/100ML                         N018826   002     Sep   30,   1983

AP    +                         320MG/100ML                         N018826   003     Sep   30,   1983

    DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
	
      + B BRAUN                 40MG/100ML                          N019099 001 Oct 15, 1986
	
    DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         640MG/100ML                         N019615 004 Mar 27, 1987
	
DORIPENEM
	
  INJECTABLE;IV (INFUSION)

    DORIBAX
	
         SHIONOGI INC             250MG/VIAL                        N022106 002 Oct 05, 2010
	
      +                           500MG/VIAL                        N022106 001 Oct 12, 2007
	
DORZOLAMIDE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    DORZOLAMIDE HYDROCHLORIDE
	
AT       ALCON PHARMS LTD         EQ   2%   BASE                    A078981   001     Apr   13,   2009

AT       BAUSCH AND LOMB          EQ   2%   BASE                    A090143   001     Jun   25,   2009

AT       HI TECH PHARMA           EQ   2%   BASE                    A077846   001     Oct   28,   2008

AT       LUITPOLD                 EQ   2%   BASE                    A079186   001     Nov   18,   2009

AT       SANDOZ                   EQ   2%   BASE                    A078748   001     Nov   06,   2008

AT       TEVA PHARMS              EQ   2%   BASE                    A078756   001     Dec   04,   2008

AT       WATSON LABS INC          EQ   2%   BASE                    A202053   001     Sep   11,   2014

AT       ZACH SYSTEMS             EQ   2%   BASE                    A091034   001     Dec   04,   2013

    TRUSOPT
	
AT    + MERCK                     EQ 2% BASE                        N020408 001 Dec 09, 1994
	
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
	
  SOLUTION/DROPS;OPHTHALMIC

    COSOPT
	
AT    + OAK PHARMS INC          EQ 2% BASE;EQ 0.5%    BASE          N020869 001 Apr 07, 1998

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
	
AT       AKORN INC              EQ 2% BASE;EQ 0.5%    BASE          A203058   001     Sep   22,   2014

AT       ALCON RES              EQ 2% BASE;EQ 0.5%    BASE          A090604   001     Nov   18,   2009

AT       BAUSCH AND LOMB        EQ 2% BASE;EQ 0.5%    BASE          A090037   001     Jul   14,   2009

AT       HI TECH PHARMA         EQ 2% BASE;EQ 0.5%    BASE          A077847   001     Oct   28,   2008

AT       LANNETT HOLDINGS INC   EQ 2% BASE;EQ 0.5%    BASE          A201998   001     Dec   17,   2014

AT       SANDOZ                 EQ 2% BASE;EQ 0.5%    BASE          A078749   001     Nov   06,   2008

AT       TEVA PHARMS            EQ 2% BASE;EQ 0.5%    BASE          A078704   001     Sep   28,   2009

AT       WATSON LABS INC        EQ 2% BASE;EQ 0.5%    BASE          A202054   001     Sep   03,   2014

AT       ZACH SYSTEMS           EQ 2% BASE;EQ 0.5%    BASE          A091180   001     Dec   04,   2013
	
    COSOPT PF
	
      + OAK PHARMS INC          EQ 2% BASE;EQ 0.5%    BASE          N202667 001 Feb 01, 2012
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-122(of 371)


DOXAPRAM HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DOPRAM
	
AP    + HIKMA MAPLE
	             20MG/ML
	                      N014879 001
	
    DOXAPRAM HYDROCHLORIDE
	
AP       BEDFORD
	                20MG/ML
	                      A076266 001 Jan 10, 2003
	
DOXAZOSIN MESYLATE
	
  TABLET;ORAL

     CARDURA
	
AB     + PFIZER
	                EQ      1MG   BASE
             N019668   001    Nov   02,   1990

AB
	                             EQ      2MG   BASE
             N019668   002    Nov   02,   1990

AB
	                             EQ      4MG   BASE
             N019668   003    Nov   02,   1990

AB
	                             EQ      8MG   BASE
	            N019668   004    Nov   02,   1990
	
     DOXAZOSIN MESYLATE
	
AB         ACCORD HLTHCARE
	     EQ      1MG   BASE
             A202824   001    Jun   11,   2014

AB
	                             EQ      2MG   BASE
             A202824   002    Jun   11,   2014

AB
	                             EQ      4MG   BASE
             A202824   003    Jun   11,   2014

AB
	                             EQ      8MG   BASE
             A202824   004    Jun   11,   2014

AB         APOTEX
	              EQ      1MG   BASE
             A075580   001    Oct   18,   2000

AB
	                             EQ      2MG   BASE
             A075580   002    Oct   18,   2000

AB
	                             EQ      4MG   BASE
             A075580   003    Oct   18,   2000

AB
	                             EQ      8MG   BASE
             A075580   004    Oct   18,   2000

AB         DAVA PHARMS INC
	     EQ      1MG   BASE
             A076161   001    Jun   10,   2004

AB
	                             EQ      2MG   BASE
             A076161   002    Jun   10,   2004

AB
	                             EQ      4MG   BASE
             A076161   003    Jun   10,   2004

AB
	                             EQ      8MG   BASE
             A076161   004    Jun   10,   2004

AB         MYLAN
	               EQ      1MG   BASE
             A075509   001    Oct   19,   2000

AB
	                             EQ      2MG   BASE
             A075509   002    Oct   19,   2000

AB
	                             EQ      4MG   BASE
             A075509   003    Oct   19,   2000

AB
	                             EQ      8MG   BASE
             A075509   004    Oct   19,   2000

AB         PLIVA
	               EQ      1MG   BASE
             A075750   001    Jun   08,   2001

AB
	                             EQ      2MG   BASE
             A075750   002    Jun   08,   2001

AB
	                             EQ      4MG   BASE
             A075750   003    Jun   08,   2001

AB
	                             EQ      8MG   BASE
             A075750   004    Jun   08,   2001

AB         TEVA
	                EQ      1MG   BASE
             A075536   001    Oct   18,   2000

AB
	                             EQ      2MG   BASE
             A075536   002    Oct   18,   2000

AB
	                             EQ      4MG   BASE
             A075536   003    Oct   18,   2000

AB
	                             EQ      8MG   BASE
	            A075536   004    Oct   18,   2000
	
  TABLET, EXTENDED RELEASE;ORAL
	
     CARDURA XL
	
           PFIZER
	              EQ      4MG BASE
	              N021269 001 Feb 22, 2005
	
       +
	                       EQ      8MG BASE
	              N021269 002 Feb 22, 2005
	
DOXEPIN HYDROCHLORIDE
	
  CAPSULE;ORAL

     DOXEPIN HYDROCHLORIDE
	
AB         MYLAN PHARMS INC
	     EQ     10MG BASE
              A070791   002    May   13,   1986

AB     +
	                        EQ     25MG BASE
              A070791   003    May   13,   1986

AB
	                              EQ     50MG BASE
              A070791   001    May   13,   1986

AB
	                              EQ     75MG BASE
              A070791   004    May   13,   1986

AB
	                              EQ     100MG BASE
             A070791   005    May   13,   1986

           PAR PHARM
	            EQ     150MG BASE
	            A071669   001    Nov   09,   1987
	
  CONCENTRATE;ORAL

     DOXEPIN HYDROCHLORIDE
	
AA         SILARX
	               EQ 10MG BASE/ML
               A074721 001 Dec 29, 1998

AA     + TEVA PHARMS
	            EQ 10MG BASE/ML
               A071609 001 Nov 09, 1987

AA         WOCKHARDT
	            EQ 10MG BASE/ML
	              A071918 001 Jul 20, 1988
	
  CREAM;TOPICAL
	
     ZONALON
	
       + FOUGERA PHARMS
	         5%
	                           N020126 001 Apr 01, 1994
	
  TABLET;ORAL

     DOXEPIN HYDROCHLORIDE
	
AB         ACTAVIS ELIZABETH
	    EQ 3MG BASE
                   A201951 001 Jul 26, 2013

AB
	                              EQ 6MG BASE
	                  A201951 002 Jul 26, 2013
	
     SILENOR
	
AB         PERNIX THERAPS LLC
	   EQ 3MG BASE
                   N022036 001 Mar 17, 2010

AB     +
	                        EQ 6MG BASE
	                  N022036 002 Mar 17, 2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-123(of 371)


DOXERCALCIFEROL
	
  CAPSULE;ORAL

    DOXERCALCIFEROL
	
AB       ROXANE                0.5MCG                          A091433 001 Sep 23, 2011

AB                             1MCG                            A091433 002 Jan 14, 2014

AB                             2.5MCG                          A091433 003 Jan 14, 2014

    HECTOROL
	
AB       GENZYME CORP          0.5MCG                          N020862 002 Apr 23, 2004

AB                             1MCG                            N020862 003 Jul 13, 2009

AB    +                        2.5MCG                          N020862 001 Jun 09, 1999
	
  INJECTABLE;INJECTION

    DOXERCALCIFEROL
	
AP       HIKMA PHARMS LLC      4MCG/2ML (2MCG/ML)              A091101 001 Aug 30, 2013

AP       SANDOZ                4MCG/2ML (2MCG/ML)              A091333 001 May 05, 2014

AP                             4MCG/2ML (2MCG/ML)              A200926 001 Feb 04, 2014

    HECTOROL
	
AP    + GENZYME CORP           4MCG/2ML (2MCG/ML)              N021027 001 Apr 06, 2000

                               2MCG/ML (2MCG/ML)               N021027 002 Apr 06, 2000
	
DOXORUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DOXORUBICIN HYDROCHLORIDE
	
AP       ACTAVIS INC            2MG/ML                         A203622   001    Jun   27,   2014

AP       ALVOGEN INC            2MG/ML                         A065515   001    Nov   08,   2012

AP    + EUROHLTH INTL           2MG/ML                         A062975   001    Mar   17,   1989

AP    +                         10MG/VIAL                      A062921   001    Mar   17,   1989

AP    +                         20MG/VIAL                      A062921   002    Mar   17,   1989

AP    +                         50MG/VIAL                      A062921   003    Mar   17,   1989

AP    +                         200MG/100ML                    A064097   001    Sep   13,   1994

AP       FRESENIUS KABI USA     2MG/ML                         A063277   001    Oct   26,   1995

AP       ONCO THERAPIES LTD     2MG/ML                         A200901   001    Feb   14,   2012

AP                              10MG/VIAL                      A200170   001    Oct   28,   2011

AP                              50MG/VIAL                      A200170   002    Oct   28,   2011

AP       PHARMACHEMIE BV        2MG/ML                         A063336   001    Feb   28,   1995

AP                              10MG/VIAL                      A063097   001    May   21,   1990

AP                              20MG/VIAL                      A063097   002    May   21,   1990

AP                              50MG/VIAL                      A063097   003    May   21,   1990

AP                              200MG/100ML                    A063336   004    Feb   28,   1995

AP       SAGENT PHARMS          2MG/ML                         A091495   001    Mar   18,   2013

AP       SANDOZ INC             2MG/ML                         A200146   001    Jul   18,   2012

AP       SUN PHARM INDS         2MG/ML                         A091418   001    Feb   15,   2012

AP       TEVA PHARMS USA        2MG/ML                         A064140   001    Jul   28,   1995

AP                              200MG/100ML                    A064140   002    Jul   28,   1995
	
  INJECTABLE, LIPOSOMAL;INJECTION

    DOXIL (LIPOSOMAL)

AB       JANSSEN RES AND DEV    20MG/10ML (2MG/ML)             N050718 001 Nov 17, 1995

AB                              50MG/25ML (2MG/ML)             N050718 002 Jun 13, 2000

    DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)

AB    + SUN PHARMA GLOBAL       20MG/10ML (2MG/ML)             A203263 001 Feb 04, 2013

AB    +                         50MG/25ML (2MG/ML)             A203263 002 Feb 04, 2013
	
DOXYCYCLINE
	
  CAPSULE;ORAL

    DOXYCYCLINE
	
AB       IMPAX LABS INC        EQ   150MG BASE                 A200065   001    Feb   17,   2011

AB       LUPIN LTD             EQ   50MG BASE                  A204234   001    Mar   05,   2014

AB                             EQ   75MG BASE                  A204234   002    Mar   05,   2014

AB                             EQ   100MG BASE                 A204234   003    Mar   05,   2014

AB       MYLAN PHARMS INC      EQ   150MG BASE                 A202778   001    Jun   08,   2012

AB       PAR PHARM             EQ   50MG BASE                  A065055   001    Dec   01,   2000

AB                             EQ   100MG BASE                 A065055   002    Dec   01,   2000

AB    +                        EQ   150MG BASE                 A065055   003    Jul   15,   2005

AB       RANBAXY               EQ   50MG BASE                  A065053   001    Nov   22,   2000

AB                             EQ   75MG BASE                  A065053   003    Sep   10,   2003

AB                             EQ   100MG BASE                 A065053   002    Nov   22,   2000

    MONODOX
	
AB       AQUA PHARMS           EQ 50MG BASE                    N050641 002 Feb 10, 1992

AB                             EQ 75MG BASE                    N050641 003 Oct 18, 2006

AB    +                        EQ 100MG BASE                   N050641 001 Dec 29, 1989
	
    ORACEA
	
      + GALDERMA LABS LP       40MG                            N050805 001 May 26, 2006
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-124(of 371)


DOXYCYCLINE
	
  FOR SUSPENSION;ORAL

    DOXYCYCLINE
	
AB       CHARTWELL LIFE SCI     EQ 25MG BASE/5ML                A065454 001 Jul 16, 2008

AB       LUPIN LTD              EQ 25MG BASE/5ML                A201678 001 Mar 18, 2013

    VIBRAMYCIN
	
AB    + PFIZER                  EQ 25MG BASE/5ML                N050006 001
	
  TABLET;ORAL

    DOXYCYCLINE
	
AB       HERITAGE PHARMS INC    EQ   50MG BASE                  A091605   001     Dec   20,   2011

AB                              EQ   75MG BASE                  A091605   002     Dec   20,   2011

AB                              EQ   100MG BASE                 A091605   003     Dec   20,   2011

AB                              EQ   150MG BASE                 A091605   004     Dec   20,   2011

AB       LANNETT                EQ   50MG BASE                  A065285   001     Dec   08,   2005

AB                              EQ   75MG BASE                  A065285   003     Jul   30,   2008

AB                              EQ   100MG BASE                 A065285   002     Dec   08,   2005

AB                              EQ   150MG BASE                 A065285   004     Jul   30,   2008

AB       MYLAN                  EQ   50MG BASE                  A065377   001     Nov   07,   2006

AB                              EQ   75MG BASE                  A065377   002     Nov   07,   2006

AB                              EQ   100MG BASE                 A065377   003     Nov   07,   2006

AB                              EQ   150MG BASE                 A065427   001     Jun   07,   2007

AB       PAR PHARM              EQ   50MG BASE                  A065070   001     Dec   15,   2000

AB                              EQ   75MG BASE                  A065070   003     Dec   30,   2002

AB                              EQ   100MG BASE                 A065070   002     Dec   15,   2000

AB    +                         EQ   150MG BASE                 A065070   004     Jul   14,   2005

AB       RANBAXY                EQ   50MG BASE                  A065356   001     May   31,   2006

AB                              EQ   75MG BASE                  A065356   002     May   31,   2006

AB                              EQ   100MG BASE                 A065356   003     May   31,   2006
	
DOXYCYCLINE CALCIUM
	
  SUSPENSION;ORAL
	
    VIBRAMYCIN
	
      + PFIZER                  EQ 50MG BASE/5ML                N050480 001
	
DOXYCYCLINE HYCLATE
	
  CAPSULE;ORAL

    DOXYCYCLINE HYCLATE
	
AB       ACTAVIS LABS FL INC     EQ 50MG BASE                   A062031   002     Oct 13, 1982

AB                               EQ 100MG BASE                  A062031   001
	
AB       CHARTWELL LIFE SCI      EQ 50MG BASE                   A062500   001     Sep   11,   1984

AB                               EQ 100MG BASE                  A062500   002     Sep   11,   1984

AB       HIKMA INTL PHARMS       EQ 50MG BASE                   A062396   002     Nov   07,   1984

AB                               EQ 100MG BASE                  A062396   001     May   07,   1984

AB       MUTUAL PHARM            EQ 50MG BASE                   A062675   001     Jul   10,   1986

AB                               EQ 100MG BASE                  A062676   001     Jul   10,   1986

AB       MYLAN                   EQ 50MG BASE                   A062337   001     Mar   29,   1982

AB                               EQ 100MG BASE                  A062337   002     Mar   29,   1982

    VIBRAMYCIN
	
AB       PFIZER                  EQ 50MG BASE                   N050007 001
	
AB    +                          EQ 100MG BASE                  N050007 002
	
    DOXYCYCLINE HYCLATE
	
      + HIKMA INTL PHARMS        EQ 20MG BASE                   A065103 001 May 13, 2005

  CAPSULE, DELAYED RELEASE;ORAL
	
    DOXYCYCLINE HYCLATE
	
         MEDICIS                 EQ 75MG BASE                   A065281 001 Dec 21, 2005
	
      +                          EQ 100MG BASE                  A065281 002 Dec 21, 2005
	
  INJECTABLE;INJECTION

    DOXY 100
	
AP    + FRESENIUS KABI USA       EQ 100MG BASE/VIAL             A062475 001 Dec 09, 1983

    DOXYCYCLINE
	
AP       AGILA SPECLTS           EQ 100MG BASE/VIAL             A091406 001 Aug 21, 2012

AP    + EUROHLTH INTL            EQ 100MG BASE/VIAL             A062569 001 Mar 09, 1988
	
    DOXY 200
	
      + FRESENIUS KABI USA       EQ 200MG BASE/VIAL             A062475 002 Dec 09, 1983
	
  SYSTEM, EXTENDED RELEASE;PERIODONTAL
	
    ATRIDOX
	
      + TOLMAR                   50MG                           N050751 001 Sep 03, 1998

  TABLET;ORAL

    DOXYCYCLINE HYCLATE
	
AB       ACTAVIS LABS FL INC     EQ 100MG BASE                  A062421   001     Feb   02,   1983

AB       BLU CARIBE INC          EQ 100MG BASE                  A062269   002     Nov   08,   1982

AB       CHARTWELL LIFE SCI      EQ 100MG BASE                  A062505   001     Sep   11,   1984

AB       COREPHARMA              EQ 20MG BASE                   A065182   001     May   13,   2005
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                   3-125(of 371)


DOXYCYCLINE HYCLATE
	
  TABLET;ORAL

    DOXYCYCLINE HYCLATE
	
AB    + HIKMA INTL PHARMS         EQ   100MG BASE              A065095   001    Jul   02,   2003

AB       IVAX SUB TEVA PHARMS     EQ   20MG BASE               A065163   001    May   13,   2005

AB    + LANNETT                   EQ   20MG BASE               A065277   001    Nov   10,   2005

AB       LARKEN LABS              EQ   20MG BASE               A065287   001    Feb   28,   2006

AB       MUTUAL PHARM             EQ   100MG BASE              A062677   001    Jul   10,   1986

AB       MUTUAL PHARMA            EQ   20MG BASE               A065134   001    May   13,   2005

AB       MYLAN                    EQ   100MG BASE              A062432   001    Feb   15,   1983

AB       VINTAGE PHARMS           EQ   100MG BASE              A062538   001    Apr   07,   1986

    ACTICLATE
	
         AQUA PHARMS LLC          EQ 75MG BASE                 N205931 001 Jul 25, 2014
	
      +                           EQ 150MG BASE                N205931 002 Jul 25, 2014
	
  TABLET, DELAYED RELEASE;ORAL

    DORYX
	
AB       MAYNE PHARMA             EQ 75MG BASE                 N050795 001 May 06, 2005

AB                                EQ 100MG BASE                N050795 002 May 06, 2005

AB                                EQ 150MG BASE                N050795 003 Jun 20, 2008

    DOXYCYCLINE HYCLATE
	
AB       ACTAVIS ELIZABETH        EQ   75MG BASE               A090134   001    Dec   14,   2011

AB                                EQ   100MG BASE              A090134   002    Dec   14,   2011

AB       HERITAGE PHARMS INC      EQ   75MG BASE               A200856   001    Apr   30,   2013

AB                                EQ   100MG BASE              A200856   002    Apr   30,   2013

AB                                EQ   150MG BASE              A200856   003    Apr   30,   2013

AB       IMPAX LABS INC           EQ   75MG BASE               A090505   001    Dec   28,   2010

AB                                EQ   100MG BASE              A090505   002    Dec   28,   2010

AB       MYLAN                    EQ   75MG BASE               A090431   001    Dec   28,   2010

AB                                EQ   100MG BASE              A090431   002    Dec   28,   2010

AB       MYLAN PHARMS INC         EQ   150MG BASE              A091052   001    Feb   08,   2012
	
    DORYX
	
         MAYNE PHARMA             EQ 80MG BASE                 N050795 004 Apr 11, 2013

      +                           EQ 200MG BASE                N050795 005 Apr 11, 2013

    DOXTERIC
	
         MAYNE PHARMA             EQ 50MG BASE                 N050795 006 Dec 19, 2014
	
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
	
  TABLET, DELAYED RELEASE;ORAL
	
    DICLEGIS
	
      + DUCHESNAY                10MG;10MG                     N021876 001 Apr 08, 2013
	
DRONABINOL
	
  CAPSULE;ORAL

    DRONABINOL
	
AB       AKORN INC                2.5MG                        A079217   001    Jun   20,   2014

AB                                5MG                          A079217   002    Jun   20,   2014

AB                                10MG                         A079217   003    Jun   20,   2014

AB       INSYS THERAP             2.5MG                        A078501   001    Aug   19,   2011

AB                                5MG                          A078501   002    Aug   19,   2011

AB                                10MG                         A078501   003    Aug   19,   2011

AB       SVC PHARMA               2.5MG                        A078292   001    Jun   27,   2008

AB                                5MG                          A078292   002    Jun   27,   2008

AB                                10MG                         A078292   003    Jun   27,   2008

    MARINOL
	
AB       ABBVIE                   2.5MG                        N018651 001 May 31, 1985

AB    +                           5MG                          N018651 002 May 31, 1985

AB                                10MG                         N018651 003 May 31, 1985
	
DRONEDARONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    MULTAQ
	
      + SANOFI AVENTIS US         EQ 400MG BASE                N022425 001 Jul 01, 2009
	
DROPERIDOL
	
  INJECTABLE;INJECTION

    DROPERIDOL
	
AP       HOSPIRA                  2.5MG/ML                     A071981 001 Feb 29, 1988

AP       LUITPOLD                 2.5MG/ML                     A072123 001 Oct 24, 1988

    INAPSINE
	
AP    + AKORN INC                 2.5MG/ML                     N016796 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                           3-126(of 371)


DROSPIRENONE; ESTRADIOL
	
  TABLET;ORAL
	
    ANGELIQ
	
         BAYER HLTHCARE         0.25MG;0.5MG                         N021355 001 Feb 29, 2012
	
      +                         0.5MG;1MG                            N021355 002 Sep 28, 2005
	
DROSPIRENONE; ETHINYL ESTRADIOL
	
  TABLET;ORAL

    DROSPIRENONE AND ETHINYL ESTRADIOL
	
AB        BARR                   3MG;0.02MG                          A078515 001 Mar 30, 2009

AB        WATSON LABS            3MG;0.02MG                          A078833 001 Nov 28, 2011

    LORYNA
	
AB        SANDOZ                 3MG;0.02MG                          A079221 001 Mar 28, 2011

    NIKKI
	
AB        LUPIN LTD              3MG;0.02MG                          A201661 001 May 27, 2014

    YAZ
	
AB    + BAYER HLTHCARE           3MG;0.02MG                          N021676 001 Mar 16, 2006
	
  TABLET;ORAL-28

    DROSPIRENONE AND ETHINYL ESTRADIOL
	
AB        BARR                   3MG;0.03MG                          A077527 001 May 09, 2008

AB        LUPIN LTD              3MG;0.03MG                          A201663 001 Dec 18, 2012

AB        WATSON LABS            3MG;0.03MG                          A090081 001 Sep 07, 2010

    SYEDA
	
AB        SANDOZ                 3MG;0.03MG                          A090114 001 Mar 28, 2011

    YAELA
	
AB        NOVAST LABS LTD        3MG;0.03MG                          A202015 001 Nov 19, 2014

    YASMIN
	
AB    + BAYER HLTHCARE           3MG;0.03MG                          N021098 001 May 11, 2001
	
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
	
  TABLET;ORAL
	
    BEYAZ
	
         BAYER HLTHCARE         3MG,N/A;0.02MG,N/A;0.451MG,0.451MG   N022532 001 Sep 24, 2010

    SAFYRAL
	
      + BAYER HLTHCARE          3MG,N/A;0.03MG,N/A;0.451MG,0.451MG   N022574 001 Dec 16, 2010
	
DROXIDOPA
	
  CAPSULE;ORAL
	
    NORTHERA
	
         LUNDBECK NA LTD        100MG                                N203202 001 Feb 18, 2014
	
                                200MG                                N203202 002 Feb 18, 2014
	
     +                          300MG                                N203202 003 Feb 18, 2014
	
DULOXETINE HYDROCHLORIDE
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    CYMBALTA
	
AB       LILLY                  EQ 20MG   BASE                       N021427 001 Aug 03, 2004

AB                              EQ 30MG   BASE                       N021427 002 Aug 03, 2004

AB    +                         EQ 60MG   BASE                       N021427 004 Aug 03, 2004

    DULOXETINE HYDROCHLORIDE
	
AB       ACTAVIS ELIZABETH      EQ 20MG   BASE                       A090776   001    Dec   17,   2013

AB                              EQ 30MG   BASE                       A090776   002    Dec   17,   2013

AB                              EQ 60MG   BASE                       A090776   003    Dec   17,   2013

AB       ALEMBIC PHARMS LTD     EQ 20MG   BASE                       A202949   001    Jun   09,   2014

AB                              EQ 30MG   BASE                       A202949   002    Jun   09,   2014

AB                              EQ 60MG   BASE                       A202949   003    Jun   09,   2014

AB       APOTEX INC             EQ 20MG   BASE                       A202045   001    Jun   11,   2014

AB                              EQ 30MG   BASE                       A202045   002    Jun   11,   2014

AB                              EQ 60MG   BASE                       A202045   003    Jun   11,   2014

AB       AUROBINDO PHARMA LTD   EQ 20MG   BASE                       A090778   001    Dec   11,   2013

AB                              EQ 30MG   BASE                       A090778   002    Dec   11,   2013

AB                              EQ 60MG   BASE                       A090778   003    Dec   11,   2013

AB       BRECKENRIDGE PHARM     EQ 20MG   BASE                       A203088   001    Jun   11,   2014

AB                              EQ 30MG   BASE                       A203088   002    Jun   11,   2014

AB                              EQ 60MG   BASE                       A203088   003    Jun   11,   2014

AB       DR REDDYS LABS LTD     EQ 20MG   BASE                       A090723   001    Dec   11,   2013

AB                              EQ 30MG   BASE                       A090723   002    Dec   11,   2013

AB                              EQ 60MG   BASE                       A090723   003    Dec   11,   2013

AB       LUPIN LTD              EQ 20MG   BASE                       A090694   001    Dec   11,   2013

AB                              EQ 30MG   BASE                       A090694   002    Dec   11,   2013

AB                              EQ 60MG   BASE                       A090694   004    Dec   11,   2013

AB       SUN PHARMA GLOBAL      EQ 20MG   BASE                       A090745   001    Dec   11,   2013

AB                              EQ 30MG   BASE                       A090745   002    Dec   11,   2013

AB                              EQ 60MG   BASE                       A090745   003    Dec   11,   2013
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-127(of 371)


DULOXETINE HYDROCHLORIDE
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    DULOXETINE HYDROCHLORIDE
AB       TEVA PHARMS USA        EQ 20MG       BASE
              A090783   001    Dec   11,   2013

AB                              EQ 30MG       BASE
              A090783   002    Dec   11,   2013

AB                              EQ 60MG       BASE
              A090783   003    Dec   11,   2013

AB       TORRENT PHARMS LTD     EQ 20MG       BASE
              A090774   001    Dec   11,   2013

AB                              EQ 30MG       BASE
              A090774   002    Dec   11,   2013

AB                              EQ 60MG       BASE
              A090774   003    Dec   11,   2013

AB       ZYDUS PHARMS USA INC   EQ 20MG       BASE
              A090728   001    Jan   08,   2014

AB                              EQ 20MG       BASE
              A090739   001    Jan   08,   2014

AB                              EQ 30MG       BASE
              A090728   002    Jan   08,   2014

AB                              EQ 30MG       BASE
              A090739   002    Jan   08,   2014

AB                              EQ 60MG       BASE
              A090728   003    Jan   08,   2014

AB                              EQ 60MG       BASE
              A090739   003    Jan   08,   2014
	
         LUPIN LTD              EQ 40MG       BASE
	             A090694   003    Dec   11,   2013
	
DUTASTERIDE
	
  CAPSULE;ORAL

    AVODART
	
AB    + GLAXOSMITHKLINE
	          0.5MG
	                       N021319 001 Nov 20, 2001
	
    DUTASTERIDE
	
AB       BARR
	                    0.5MG
	                       A090095 001 Dec 21, 2010
	
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL

    DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
	
AB       ANCHEN PHARMS
	        0.5MG;0.4MG
	                    A202509 001 Feb 26, 2014
	
    JALYN
	
AB    + GLAXOSMITHKLINE
	       0.5MG;0.4MG
	                    N022460 001 Jun 14, 2010
	
DYPHYLLINE
	
  TABLET;ORAL
	
    LUFYLLIN
	
          MEDA PHARMS
	            200MG
	                       A084566 001
	
      +
	                          400MG
	                       A084566 002
	
ECHOTHIOPHATE IODIDE
	
  FOR SOLUTION;OPHTHALMIC
	
    PHOSPHOLINE IODIDE
	
      + WYETH PHARMS INC
	         0.125%
	                      N011963 001
	
ECONAZOLE NITRATE
	
  AEROSOL, FOAM;TOPICAL
	
    ECOZA
	
      + VELDANA MEDICAL SA
	       1%
	                          N205175 001 Oct 24, 2013
	
  CREAM;TOPICAL

    ECONAZOLE NITRATE
	
AB    + FOUGERA PHARMS             1%
	                          A076075   001    Nov   26,   2002

AB       IGI LABS INC              1%
	                          A076574   001    Dec   17,   2004

AB       PERRIGO NEW YORK          1%
	                          A076479   001    Jun   23,   2004

AB       TARO                      1%
	                          A076005   001    Nov   26,   2002
	
EDETATE CALCIUM DISODIUM
	
  INJECTABLE;INJECTION
	
    CALCIUM DISODIUM VERSENATE
	
      + MEDICIS
	                200MG/ML
	                      N008922 001
	
EDROPHONIUM CHLORIDE
	
  INJECTABLE;INJECTION

    ENLON
	
AP       MYLAN INSTITUTIONAL
	   10MG/ML
	                       A088873 001 Aug 06, 1985
	
    TENSILON
	
AP    + VALEANT PHARMS
	         10MG/ML
	                       N007959 001
	
    TENSILON PRESERVATIVE FREE
	
AP    + VALEANT PHARMS
	         10MG/ML
	                       N007959 002
	
EFAVIRENZ
	
  CAPSULE;ORAL
	
    SUSTIVA
	
          BRISTOL MYERS SQUIBB
	   50MG
	                        N020972 001 Sep 17, 1998

      +
	                          200MG
	                       N020972 003 Sep 17, 1998
	
  TABLET;ORAL
	
    SUSTIVA
	
      + BRISTOL MYERS SQUIBB
	     600MG
	                       N021360 002 Feb 01, 2002
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                               3-128(of 371)


EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
	
  TABLET;ORAL
	
    ATRIPLA
	
      + GILEAD
	                600MG;200MG;300MG
	                         N021937 001 Jul 12, 2006
	
EFINACONAZOLE
	
  SOLUTION;TOPICAL
	
    JUBLIA
	
      + DOW PHARM
	                10%
	                                    N203567 001 Jun 06, 2014
	
EFLORNITHINE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    VANIQA
	
      + SKINMEDICA
	               13.9%
	                                  N021145 001 Jul 27, 2000
	
ELETRIPTAN HYDROBROMIDE
	
  TABLET;ORAL
	
    RELPAX
	
          PFIZER IRELAND
	         EQ 20MG BASE
	                           N021016 001 Dec 26, 2002
	
      +
	                          EQ 40MG BASE
	                           N021016 002 Dec 26, 2002
	
ELIGLUSTAT TARTRATE
	
  CAPSULE;ORAL
	
    CERDELGA
	
      + GENZYME CORP
	             EQ 84MG BASE
	                           N205494 001 Aug 19, 2014
	
ELTROMBOPAG OLAMINE
	
  TABLET;ORAL
	
    PROMACTA
	
         GLAXOSMITHKLINE
	         EQ   12.5MG ACID
	                       N022291   004    Oct   20,   2011
	
                                   EQ   25MG ACID
	                         N022291   001    Nov   20,   2008
	
     +
	                           EQ   50MG ACID
	                         N022291   002    Nov   20,   2008
	
                                   EQ   75MG ACID
	                         N022291   003    Sep   08,   2009

                                   EQ   100MG ACID
	                        N022291   005    Nov   16,   2012
	
ELVITEGRAVIR
	
  TABLET;ORAL
	
    VITEKTA
	
          GILEAD SCIENCES INC
	    85MG
	                                   N203093 001 Sep 24, 2014

      +
	                          150MG
	                                  N203093 002 Sep 24, 2014
	
EMEDASTINE DIFUMARATE
	
  SOLUTION/DROPS;OPHTHALMIC

    EMADINE
	
      + ALCON
	                    0.05%
	                                  N020706 001 Dec 29, 1997
	
EMPAGLIFLOZIN
	
  TABLET;ORAL
	
    JARDIANCE
	
          BOEHRINGER INGELHEIM
	   10MG
	                                   N204629 001 Aug 01, 2014

      +
	                          25MG
	                                   N204629 002 Aug 01, 2014
	
EMTRICITABINE
	
  CAPSULE;ORAL
	
    EMTRIVA
	
      + GILEAD
	                   200MG
	                                  N021500 001 Jul 02, 2003
	
  SOLUTION;ORAL
	
    EMTRIVA
	
      + GILEAD
	                   10MG/ML
	                                N021896 001 Sep 28, 2005
	
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
	
  TABLET;ORAL
	
    COMPLERA
	
      + GILEAD SCIENCES INC     200MG;EQ 25MG BASE;300MG
	                  N202123 001 Aug 10, 2011
	
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
	
  TABLET;ORAL
	
    TRUVADA
	
      + GILEAD
	                200MG;300MG
	                               N021752 001 Aug 02, 2004
	
ENALAPRIL MALEATE
	
  FOR SOLUTION;ORAL
	
     EPANED KIT
	
       + SILVERGATE PHARMS
	       1MG/ML
	                                 N204308 001 Aug 13, 2013
	
  TABLET;ORAL

     ENALAPRIL MALEATE
	
AB        APOTEX
	                 2.5MG
	                                  A075178 002 Mar 23, 2001

AB
	                               5MG
	                                    A075178 001 Mar 23, 2001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-129(of 371)


ENALAPRIL MALEATE
	
  TABLET;ORAL

    ENALAPRIL MALEATE
AB                               10MG
	                          A075178   003    Mar   23,   2001

AB                               20MG
	                          A075178   004    Mar   23,   2001

AB       MYLAN                   2.5MG
	                         A075480   001    Aug   22,   2000

AB                               5MG
	                           A075480   002    Aug   22,   2000

AB                               10MG
	                          A075480   003    Aug   22,   2000

AB                               20MG
	                          A075480   004    Aug   22,   2000

AB       TARO                    2.5MG
	                         A075657   001    Jan   23,   2001

AB                               5MG
	                           A075657   002    Jan   23,   2001

AB                               10MG
	                          A075657   003    Jan   23,   2001

AB                               20MG
	                          A075657   004    Jan   23,   2001

AB       TEVA                    2.5MG
	                         A075479   001    Aug   22,   2000

AB                               5MG
	                           A075479   002    Aug   22,   2000

AB                               10MG
	                          A075479   003    Aug   22,   2000

AB                               20MG
	                          A075479   004    Aug   22,   2000

AB       WOCKHARDT USA           2.5MG
	                         A075483   001    Aug   22,   2000

AB                               5MG
	                           A075483   002    Aug   22,   2000

AB                               10MG
	                          A075483   003    Aug   22,   2000

AB                               20MG
	                          A075483   004    Aug   22,   2000
	
    VASOTEC
AB       VALEANT INTL            2.5MG
	                         N018998   005    Jul   26,   1988

AB                               5MG
	                           N018998   001    Dec   24,   1985

AB                               10MG
	                          N018998   002    Dec   24,   1985

AB    +                          20MG
	                          N018998   003    Dec   24,   1985
	
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

     ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
	
AB         APOTEX INC
	          5MG;12.5MG
                     A076486   001    Oct   27,   2004

AB
	                             10MG;25MG
                      A076486   002    Oct   27,   2004

AB         DR REDDYS LABS LTD
	  5MG;12.5MG
                     A075909   001    Oct   15,   2001

AB
	                             10MG;25MG
                      A075909   002    Oct   15,   2001

AB         MYLAN
	               5MG;12.5MG
                     A075624   001    Sep   18,   2001

AB
	                             10MG;25MG
                      A075624   002    Sep   18,   2001

AB         TARO PHARM INDS
	     5MG;12.5MG
                     A075788   001    Sep   18,   2001

AB
	                             10MG;25MG
                      A075788   002    Sep   18,   2001

AB         TEVA
	                5MG;12.5MG
                     A075727   001    Sep   18,   2001

AB
	                             10MG;25MG
	                     A075727   002    Sep   18,   2001
	
     VASERETIC
	
AB         VALEANT INTL
	        5MG;12.5MG
                     N019221 003 Jul 12, 1995

AB     +
	                       10MG;25MG
	                     N019221 001 Oct 31, 1986
	
ENALAPRILAT
	
  INJECTABLE;INJECTION

    ENALAPRILAT
	
AP    + BEDFORD                  1.25MG/ML
                      A075634   001    Aug   22,   2000

AP       HIKMA FARMACEUTICA      1.25MG/ML
                      A078687   001    Dec   23,   2008

AP    + HOSPIRA                  1.25MG/ML
                      A075458   001    Aug   22,   2000

AP       TEVA PHARMS USA         1.25MG/ML
	                     A075578   001    Aug   22,   2000
	
ENFLURANE
	
  LIQUID;INHALATION

    ENFLURANE
	
AN       PIRAMAL CRITICAL
	      99.9%
	                         A074396 001 Jul 29, 1994
	
    ETHRANE
	
AN    + BAXTER HLTHCARE
	        99.9%
	                         N017087 001
	
ENFUVIRTIDE
	
  INJECTABLE;SUBCUTANEOUS
	
    FUZEON
	
      + ROCHE
	                  90MG/VIAL
	                     N021481 001 Mar 13, 2003
	
ENOXAPARIN SODIUM
	
  INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

    ENOXAPARIN SODIUM
	
AB       SANDOZ INC             300MG/3ML (100MG/ML)
            A078660 001 Nov 28, 2011
	
    LOVENOX
	
AB       SANOFI AVENTIS US      300MG/3ML (100MG/ML)
            N020164 009 Jan 23, 2003
	
  INJECTABLE;SUBCUTANEOUS

    ENOXAPARIN SODIUM (PRESERVATIVE FREE)

AP       AMPHASTAR PHARM        30MG/0.3ML (100MG/ML)
           A076684 001 Sep 19, 2011

AP                              40MG/0.4ML (100MG/ML)
           A076684 002 Sep 19, 2011

AP                              60MG/0.6ML (100MG/ML)
	          A076684 003 Sep 19, 2011
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                     3-130(of 371)


ENOXAPARIN SODIUM
	
  INJECTABLE;SUBCUTANEOUS

    ENOXAPARIN SODIUM (PRESERVATIVE FREE)

AP                              80MG/0.8ML (100MG/ML)
           A076684   004    Sep   19,   2011

AP                              100MG/ML (100MG/ML)
             A076684   005    Sep   19,   2011

AP                              120MG/0.8ML (150MG/ML)
          A076684   006    Sep   19,   2011

AP                              150MG/ML (150MG/ML)
             A076684   007    Sep   19,   2011

AP       SANDOZ                 30MG/0.3ML (100MG/ML)
           A077857   002    Jul   23,   2010

AP                              40MG/0.4ML (100MG/ML)
           A077857   003    Jul   23,   2010

AP                              60MG/0.6ML (100MG/ML)
           A077857   004    Jul   23,   2010

AP                              80MG/0.8ML (100MG/ML)
           A077857   005    Jul   23,   2010

AP                              100MG/ML (100MG/ML)
             A077857   001    Jul   23,   2010

AP                              120MG/0.8ML (150MG/ML)
          A077857   006    Jul   23,   2010

AP                              150MG/ML (150MG/ML)
             A077857   007    Jul   23,   2010

AP       TEVA                   30MG/0.3ML (100MG/ML)
           A076726   001    Jun   23,   2014

AP                              40MG/0.4ML (100MG/ML)
           A076726   002    Jun   23,   2014

AP                              60MG/0.6ML (100MG/ML)
           A076726   003    Jun   23,   2014

AP                              80MG/0.8ML (100MG/ML)
           A076726   004    Jun   23,   2014

AP                              100MG/ML (100MG/ML)
             A076726   005    Jun   23,   2014

AP                              120MG/0.8ML (150MG/ML)
          A076726   006    Jun   23,   2014

AP                              150MG/ML (150MG/ML)
	            A076726   007    Jun   23,   2014
	
    LOVENOX (PRESERVATIVE FREE)
AP       SANOFI AVENTIS US      30MG/0.3ML (100MG/ML)
           N020164   001    Mar   29,   1993

AP                              40MG/0.4ML (100MG/ML)
           N020164   002    Jan   30,   1998

AP                              60MG/0.6ML (100MG/ML)
           N020164   003    Mar   27,   1998

AP                              80MG/0.8ML (100MG/ML)
           N020164   004    Mar   27,   1998

AP    +                         100MG/ML (100MG/ML)
             N020164   005    Mar   27,   1998

AP                              120MG/0.8ML (150MG/ML)
          N020164   007    Jun   02,   2000

AP                              150MG/ML (150MG/ML)
	            N020164   008    Jun   02,   2000
	
ENTACAPONE
	
  TABLET;ORAL

    COMTAN
	
AB    + ORION PHARMA
	             200MG
	                       N020796 001 Oct 19, 1999
	
    ENTACAPONE
	
AB       MYLAN PHARMS INC
	        200MG
	                       A202394 001 May 13, 2013

AB       SUN PHARMA GLOBAL
	       200MG
	                       A090690 001 Jul 16, 2012

AB       WOCKHARDT LTD
	           200MG
	                       A078941 001 Aug 16, 2012
	
ENTECAVIR
	
  SOLUTION;ORAL
	
     BARACLUDE
	
       + BRISTOL MYERS SQUIBB
	    0.05MG/ML
	                   N021798 001 Mar 29, 2005
	
  TABLET;ORAL

     BARACLUDE
	
AB         BRISTOL MYERS SQUIBB
   0.5MG
	                       N021797 001 Mar 29, 2005

AB     +
	                         1MG
	                         N021797 002 Mar 29, 2005
	
     ENTECAVIR
	
AB         TEVA PHARMS USA
	       0.5MG
	                       A202122 001 Aug 26, 2014

AB
	                               1MG
	                         A202122 002 Aug 26, 2014
	
ENZALUTAMIDE
	
  CAPSULE;ORAL
	
    XTANDI
	
      + ASTELLAS
	                 40MG
	                        N203415 001 Aug 31, 2012
	
EPINASTINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    ELESTAT
	
AT    + ALLERGAN
	                 0.05%
	                       N021565 001 Oct 16, 2003
	
    EPINASTINE HYDROCHLORIDE
	
AT       APOTEX
	                  0.05%
	                       A090919   001    Oct   31,   2011

AT       BRECKENRIDGE PHARM
	      0.05%
	                       A090870   001    Mar   14,   2011

AT       GAVIS PHARMS LLC
	        0.05%
	                       A090951   001    Oct   31,   2011

AT       SUN PHARM INDS
	          0.05%
	                       A091626   001    Oct   31,   2011
	
EPINEPHRINE
	
  INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
    ADRENACLICK
BX    + AMEDRA PHARMS           EQ 0.15MG/DELIVERY               N020800 003 Nov 25, 2009
BX    +                         EQ 0.3MG/DELIVERY                N020800 004 Nov 25, 2009
    AUVI-Q
BX    + SANOFI AVENTIS US       EQ 0.15MG/DELIVERY               N201739 002 Aug 10, 2012
BX                              EQ 0.3MG/DELIVERY                N201739 001 Aug 10, 2012
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                            3-131(of 371)


EPINEPHRINE
	
  INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
	
    EPIPEN
	
BX    + MYLAN SPECLT            0.3MG/DELIVERY                       N019430 001 Dec 22, 1987
	
    EPIPEN JR.
	
BX    + MYLAN SPECLT            0.15MG/DELIVERY                      N019430 002 Dec 22, 1987
	
    TWINJECT 0.15
	
BX    + AMEDRA PHARMS           EQ 0.15MG/DELIVERY                   N020800 002 May 28, 2004

    TWINJECT 0.3
	
BX    + AMEDRA PHARMS           EQ 0.3MG/DELIVERY                    N020800 001 May 30, 2003
	
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    LIGNOSPAN FORTE
	
      + DEPROCO                 EQ 0.02MG BASE/ML;2%                 A088389 001 Jan 22, 1985
	
    LIGNOSPAN STANDARD
	
      + DEPROCO                 EQ 0.01MG BASE/ML;2%                 A088390 001 Jan 22, 1985
	
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    CITANEST FORTE DENTAL
	
AP    + DENTSPLY PHARM          0.005MG/ML;4%                        N021383 001
	
    PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE
	
AP       SEPTODONT INC          0.005MG/ML;4%                        A078959 001 Aug 30, 2011
	
EPINEPHRINE HYDROCHLORIDE
	
  INJECTABLE;INTRAMUSCULAR, INTRAOCULAR, SUBCUTANEOUS
	
    ADRENALIN
	
      + PAR STERILE PRODUCTS    EQ 1MG BASE/ML (EQ 1MG BASE/ML)      N204200 001 Dec 07, 2012
	
  INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
	
    ADRENALIN
	
      + PAR STERILE PRODUCTS    EQ 30MG BASE/30ML (EQ 1MG BASE/ML)   N204640 001 Dec 18, 2013
	
  SOLUTION;IV (INFUSION)

    EPINEPHRINE
	
         BELCHER PHARMS LLC     EQ 1MG BASE/ML (EQ 1MG BASE/ML)      N205029 001 Jul 29, 2014
	
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
	
AP       EASTMAN KODAK          0.01MG/ML;2%                         A040057   002    Feb   26,   1993

AP                              0.02MG/ML;2%                         A040057   001    Feb   26,   1993

AP       HOSPIRA                0.005MG/ML;0.5%                      A089635   001    Jun   21,   1988

AP                              0.005MG/ML;1.5%                      A088571   001    Sep   13,   1985

AP                              0.005MG/ML;1.5%                      A089645   001    Jun   21,   1988

AP                              0.005MG/ML;2%                        A089651   001    Jun   21,   1988

AP                              0.01MG/ML;1%                         A089644   001    Jun   21,   1988

AP                              0.01MG/ML;2%                         A078772   001    May   12,   2008

AP                              0.01MG/ML;2%                         A089646   001    Jun   21,   1988

AP                              0.02MG/ML;2%                         A078772   002    May   12,   2008

    OCTOCAINE
	
AP    + SEPTODONT               0.01MG/ML;2%                         A084048 001
	
AP    +                         0.02MG/ML;2%                         A084048 002
	
    XYLOCAINE W/ EPINEPHRINE

AP    + FRESENIUS KABI USA      0.005MG/ML;0.5%                      N006488   012
	
AP    +                         0.005MG/ML;1%                        N006488   018 Nov 13, 1986

AP    +                         0.005MG/ML;1.5%                      N006488   017
	
AP    +                         0.005MG/ML;2%                        N006488   019 Nov 13, 1986

AP    +                         0.01MG/ML;1%                         N006488   004
	
AP    +                         0.02MG/ML;2%                         N006488   005
	
EPIRUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    ELLENCE
	
AP    + PFIZER INC               200MG/100ML (2MG/ML)                N050778 001 Sep 15, 1999

AP                               50MG/25ML (2MG/ML)                  N050778 002 Sep 15, 1999

    EPIRUBICIN HYDROCHLORIDE
	
AP       ACTAVIS TOTOWA          10MG/5ML (2MG/ML)                   A065445   001    Sep   18,   2008

AP                               50MG/25ML (2MG/ML)                  A065445   002    Sep   18,   2008

AP                               200MG/100ML (2MG/ML)                A065445   003    Sep   18,   2008

AP       AKORN INC               50MG/25ML (2MG/ML)                  A090163   001    Jun   24,   2009

AP       CIPLA LTD               50MG/25ML (2MG/ML)                  A065361   001    Oct   22,   2007

AP                               200MG/100ML (2MG/ML)                A065361   002    Oct   22,   2007

AP       EUROHLTH INTL           50MG/25ML (2MG/ML)                  A065289   001    Jun   27,   2007

AP                               200MG/100ML (2MG/ML)                A065289   002    Jun   27,   2007

AP       FRESENIUS KABI ONCOL    200MG/100ML (2MG/ML)                A065411   001    Aug   20,   2007
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                PRESCRIPTION DRUG PRODUCT LIST
	                   3-132(of 371)


EPIRUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    EPIRUBICIN HYDROCHLORIDE
AP                                 50MG/25ML (2MG/ML)
             A065411   002    Aug   20,   2007

AP       FRESENIUS KABI USA        10MG/5ML (2MG/ML)
              A065408   001    Oct   15,   2007

AP                                 50MG/25ML (2MG/ML)
             A065408   002    Oct   15,   2007

AP                                 150MG/75ML (2MG/ML)
            A065408   003    Oct   15,   2007

AP                                 200MG/100ML (2MG/ML)
           A065408   004    Oct   15,   2007

AP       HISUN PHARM HANGZHOU      50MG/25ML (2MG/ML)
             A090075   001    Mar   25,   2010

AP                                 200MG/100ML (2MG/ML)
           A090075   002    Mar   25,   2010

AP       HOSPIRA                   10MG/5ML (2MG/ML)
              A065343   001    Apr   19,   2007

AP                                 150MG/75ML (2MG/ML)
            A065343   003    Apr   19,   2007

AP                                 200MG/100ML (2MG/ML)
           A065343   004    Apr   19,   2007

AP       ONCO THERAPIES LTD        50MG/25ML (2MG/ML)
             A091599   001    Mar   12,   2012

AP                                 200MG/100ML (2MG/ML)
           A091599   002    Mar   12,   2012

AP       TEVA PHARMS USA           50MG/25ML (2MG/ML)
             A065331   001    Aug   09,   2007

AP                                 200MG/100ML (2MG/ML)
	          A065331   002    Aug   09,   2007
	
EPLERENONE
	
  TABLET;ORAL

     EPLERENONE
	
AB         APOTEX
	                25MG
	                          A078482   001    Jul   30,   2008

AB
	                               50MG
	                          A078482   002    Jul   30,   2008

AB         SANDOZ
	                25MG
	                          A078510   001    Aug   01,   2008

AB
	                               50MG
	                          A078510   002    Aug   01,   2008
	
     INSPRA
	
AB         GD SEARLE LLC
	         25MG
	                          N021437 001 Sep 27, 2002

AB     +
	                         50MG
	                          N021437 002 Sep 27, 2002
	
EPOPROSTENOL SODIUM
	
  INJECTABLE;INJECTION

     EPOPROSTENOL SODIUM
	
AP         TEVA PHARMS USA
	       EQ 0.5MG BASE/VIAL
             A078396 001 Apr 23, 2008

AP
	                               EQ 1.5MG BASE/VIAL
	            A078396 002 Apr 23, 2008
	
     FLOLAN
	
AP     + GLAXOSMITHKLINE LLC
	     EQ 0.5MG BASE/VIAL
             N020444 001 Sep 20, 1995

AP     +
	                         EQ 1.5MG BASE/VIAL
	            N020444 002 Sep 20, 1995
	
     VELETRI
	
           ACTELION PHARMS LTD
	   EQ 0.5MG BASE/VIAL
             N022260 002 Jun 28, 2012
	
       +
	                         EQ 1.5MG BASE/VIAL
	            N022260 001 Jun 27, 2008
	
EPROSARTAN MESYLATE
	
  TABLET;ORAL

     EPROSARTAN MESYLATE
	
AB         MYLAN PHARMS INC
	      EQ 400MG BASE
                  A202012 001 Nov 16, 2011

AB
	                               EQ 600MG BASE
	                 A202012 002 Nov 16, 2011
	
     TEVETEN
	
AB         ABBVIE
	                EQ 400MG BASE
                  N020738 005 Dec 22, 1997

AB     +
	                         EQ 600MG BASE
	                 N020738 006 May 27, 1999
	
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    TEVETEN HCT
	
          ABBVIE
	              600MG;12.5MG
	                     N021268 001 Nov 01, 2001
	
      +
	                       600MG;25MG
	                       N021268 002 Nov 01, 2001
	
EPTIFIBATIDE
	
  INJECTABLE;INJECTION
	
    INTEGRILIN
	
      + SCHERING
	                 2MG/ML
                         N020718 001 May 18, 1998

      +
	                          75MG/100ML
	                    N020718 002 May 18, 1998
	
ERGOCALCIFEROL
	
  CAPSULE;ORAL

    DRISDOL
AA    + SANOFI AVENTIS US          50,000 IU
	                     N003444 001
	
    ERGOCALCIFEROL
AA       ORIT LABS LLC             50,000   IU
                    A040833   001    May   20,   2009

AA       SIGMAPHARM LABS LLC       50,000   IU
                    A091004   001    Jul   14,   2010

AA       STRIDES PHARMA            50,000   IU
                    A090455   001    Aug   03,   2010

AA       SUN PHARM INDS INC        50,000   IU
	                   A040865   001    Dec   29,   2009
	
    VITAMIN D
AA       BANNER PHARMACAPS         50,000 IU
	                     A080704 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                   3-133(of 371)


ERGOLOID MESYLATES
	
  TABLET;ORAL

    ERGOLOID MESYLATES
	
AB       MUTUAL PHARM           1MG                             A081113 001 Oct 31, 1991

    HYDERGINE
	
AB    + NOVARTIS                1MG                             N017993 001
	
ERGOTAMINE TARTRATE
	
  TABLET;SUBLINGUAL
	
    ERGOMAR
	
      + ROSEDALE THERAPEUTIC    2MG                             A087693 001 Feb 24, 1983
	
ERIBULIN MESYLATE
	
  SOLUTION;INTRAVENOUS
	
    HALAVEN
	
      + EISAI INC               1MG/2ML (0.5MG/ML)              N201532 001 Nov 15, 2010
	
ERLOTINIB HYDROCHLORIDE
	
  TABLET;ORAL

    ERLOTINIB HYDROCHLORIDE
	
AB       MYLAN PHARMS INC       EQ 25MG BASE                    A091002 001 Jun 11, 2014

AB                              EQ 100MG BASE                   A091002 002 Jun 11, 2014

AB                              EQ 150MG BASE                   A091002 003 Jun 11, 2014

    TARCEVA
	
AB       OSI PHARMS             EQ 25MG BASE                    N021743 001 Nov 18, 2004

AB                              EQ 100MG BASE                   N021743 002 Nov 18, 2004

AB    +                         EQ 150MG BASE                   N021743 003 Nov 18, 2004
	
ERTAPENEM SODIUM
	
  INJECTABLE;INTRAMUSCULAR, IV (INFUSION)

    INVANZ
	
      + MERCK SHARP DOHME       EQ 1GM BASE/VIAL                N021337 001 Nov 21, 2001
	
ERYTHROMYCIN
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    ERYC
	
AB    + MAYNE PHARMA            250MG                           N050536 001
	
    ERYTHROMYCIN
	
AB         ARBOR PHARMS LLC     250MG                           A062746 001 Dec 22, 1986
	
  GEL;TOPICAL

    ERYGEL
	
AT    + DELCOR ASSET CORP       2%                              N050617 001 Oct 21, 1987

    ERYTHROMYCIN
	
AT         FOUGERA PHARMS       2%                              A064184 001 Sep 30, 1997

AT         PERRIGO              2%                              A063211 001 Jan 29, 1993
	
  OINTMENT;OPHTHALMIC

    ERYTHROMYCIN
	
AT         AKORN                0.5%                            A064030 001 Jul 18, 1996

AT         BAUSCH AND LOMB      0.5%                            A064067 001 Jul 29, 1994

AT    + PERRIGO CO TENNESSEE    0.5%                            A062447 001 Sep 26, 1983

  OINTMENT;TOPICAL
	
    AKNE-MYCIN
	
      + DOW PHARM               2%                              N050584 001 Jan 10, 1985
	
  SOLUTION;TOPICAL

    C-SOLVE-2
	
AT         FOUGERA PHARMS       2%                              A062468 001 Jul 03, 1985

    ERYTHRA-DERM
	
AT         PADDOCK LLC          2%                              A062687 001 Feb 05, 1988

    ERYTHRO-STATIN
	
AT         HI TECH PHARMA       2%                              A064101 001 Oct 22, 1996

    ERYTHROMYCIN
	
AT    + FOUGERA PHARMS          2%                              A064187 001 Sep 30, 1997

AT         PERRIGO NEW YORK     2%                              A063038 001 Jan 11, 1991

AT         WOCKHARDT            2%                              A062825 001 Oct 23, 1987
	
  SWAB;TOPICAL

    ERYTHROMYCIN
	
AT    + PERRIGO                 2%                              A064126 001 Jul 03, 1996

AT         VERSAPHARM           2%                              A090215 001 May 12, 2010

  TABLET;ORAL
	
    ERYTHROMYCIN
	
           ARBOR PHARMS LLC     250MG                           A061621 001
	
      +                         500MG                           A061621 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                          3-134(of 371)


ERYTHROMYCIN
	
  TABLET, COATED PARTICLES;ORAL
	
    PCE
	
          ARBOR PHARMS LLC       333MG                                N050611 001 Sep 09, 1986

      +                          500MG                                N050611 002 Aug 22, 1990

  TABLET, DELAYED RELEASE;ORAL
	
    ERY-TAB
	
          ARBOR PHARMS LLC		     250MG                                A062298 001
	
                                 333MG                                A062298 003 Mar 29, 1982
	
      +                          500MG		                              A062298 002
	
ERYTHROMYCIN ETHYLSUCCINATE
	
  GRANULE;ORAL

     E.E.S.
	
AB        ARBOR PHARMS LLC         EQ   200MG BASE/5ML                N050207 001
	
     ERYPED
	
AB        ARBOR PHARMS LLC         EQ   200MG BASE/5ML                N050207 003 Mar 30, 1987
	
       +                           EQ   400MG BASE/5ML                N050207 002
	
  SUSPENSION;ORAL

     E.E.S. 200
	
AB        ARBOR PHARMS LLC         EQ   200MG BASE/5ML                A061639 001
	
     E.E.S. 400
	
AB     + ARBOR PHARMS LLC          EQ   400MG BASE/5ML                A061639 002
	
     PEDIAMYCIN
	
AB        ARBOR PHARMS LLC         EQ   200MG BASE/5ML                A062304 001
	
     PEDIAMYCIN 400
	
AB		      ARBOR PHARMS LLC         EQ   400MG BASE/5ML                A062304 002
	
  TABLET;ORAL
	
     E.E.S. 400
	
BX     + ARBOR PHARMS LLC          EQ   400MG BASE                    A061905 002 Aug 12, 1982

     ERYTHROMYCIN ETHYLSUCCINATE
	
BX     + ARBOR PHARMS LLC          EQ   400MG BASE                    A061904 001
	
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
	
  GRANULE;ORAL
	
    ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
	
      + BARR		                  EQ 200MG BASE/5ML;EQ 600MG BASE/5ML   A062759 001 May 20, 1988
	
ERYTHROMYCIN LACTOBIONATE
	
  INJECTABLE;INJECTION

    ERYTHROCIN
	
AP       HOSPIRA                  EQ 500MG BASE/VIAL                  A062638 001 Oct 31, 1986

AP    +                           EQ 500MG BASE/VIAL                  N050609 001 Sep 24, 1986

      +                           EQ 1GM BASE/VIAL                    A062638 002 Oct 31, 1986
	
ERYTHROMYCIN STEARATE
	
  TABLET;ORAL
	
    ERYTHROCIN STEARATE
	
      + ARBOR PHARMS LLC          EQ 250MG BASE		                     A060359 001
	
ESCITALOPRAM OXALATE
	
  SOLUTION;ORAL

    ESCITALOPRAM OXALATE
	
AA       AMNEAL PHARMS            EQ    5MG   BASE/5ML                A202227   001    Mar   14,   2012

AA       AUROBINDO PHARMA LTD     EQ    5MG   BASE/5ML                A079062   001    Apr   02,   2012

AA       HETERO LABS LTD III      EQ    5MG   BASE/5ML                A202221   001    Jun   12,   2012

AA       SILARX PHARMS INC        EQ    5MG   BASE/5ML                A090477   001    Jun   12,   2013

AA       TARO                     EQ    5MG   BASE/5ML                A079121   001    May   03,   2012

    LEXAPRO
	
AA    + FOREST LABS               EQ 5MG BASE/5ML                     N021365 001 Nov 27, 2002
	
  TABLET;ORAL

    ESCITALOPRAM OXALATE
	
AB       ACCORD HLTHCARE          EQ    5MG BASE                      A202389   001    Sep   11,   2012

AB                                EQ    10MG BASE                     A202389   002    Sep   11,   2012

AB                                EQ    20MG BASE                     A202389   003    Sep   11,   2012

AB       APOTEX INC               EQ    5MG BASE                      A078777   001    Sep   11,   2012

AB                                EQ    10MG BASE                     A078777   002    Sep   11,   2012

AB                                EQ    20MG BASE                     A078777   003    Sep   11,   2012

AB       AUROBINDO PHARMA LTD     EQ    5MG BASE                      A090432   001    Sep   11,   2012

AB                                EQ    10MG BASE                     A090432   002    Sep   11,   2012

AB                                EQ    20MG BASE                     A090432   003    Sep   11,   2012

AB       HIKMA PHARMS             EQ    5MG BASE                      A078766   001    Sep   11,   2012

AB                                EQ    10MG BASE                     A078766   002    Sep   11,   2012

AB                                EQ    20MG BASE                     A078766   003    Sep   11,   2012

AB       INVAGEN PHARMS           EQ    5MG BASE                      A078604   001    Sep   11,   2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-135(of 371)


ESCITALOPRAM OXALATE
	
  TABLET;ORAL

    ESCITALOPRAM OXALATE
	
AB                              EQ   10MG BASE                 A078604   002    Sep   11,   2012

AB                              EQ   20MG BASE                 A078604   003    Sep   11,   2012

AB       JUBILANT GENERICS      EQ   5MG BASE                  A202280   001    Sep   12,   2012

AB                              EQ   10MG BASE                 A202280   002    Sep   12,   2012

AB                              EQ   20MG BASE                 A202280   003    Sep   12,   2012

AB       LUPIN LTD              EQ   5MG BASE                  A078169   001    Sep   11,   2012

AB                              EQ   10MG BASE                 A078169   002    Sep   11,   2012

AB                              EQ   20MG BASE                 A078169   003    Sep   11,   2012

AB       MACLEODS PHARMS LTD    EQ   5MG BASE                  A202210   001    Sep   11,   2012

AB                              EQ   10MG BASE                 A202210   002    Sep   11,   2012

AB                              EQ   20MG BASE                 A202210   003    Sep   11,   2012

AB       STI PHARMA LLC         EQ   5MG BASE                  A077512   001    Sep   12,   2012

AB                              EQ   10MG BASE                 A077512   002    Sep   12,   2012

AB                              EQ   20MG BASE                 A077512   003    Sep   12,   2012

AB       TEVA PHARMS USA        EQ   5MG BASE                  A076765   001    Mar   14,   2012

AB                              EQ   10MG BASE                 A076765   002    Mar   14,   2012

AB                              EQ   20MG BASE                 A076765   003    Mar   14,   2012

AB       TORRENT PHARMS LTD     EQ   5MG BASE                  A090939   001    Sep   11,   2012

AB                              EQ   10MG BASE                 A090939   002    Sep   11,   2012

AB                              EQ   20MG BASE                 A090939   003    Sep   11,   2012

AB       ZYDUS PHARMS USA INC   EQ   5MG BASE                  A077734   001    Sep   11,   2012

AB                              EQ   10MG BASE                 A077734   002    Sep   11,   2012

AB                              EQ   20MG BASE                 A077734   003    Sep   11,   2012

    LEXAPRO
	
AB       FOREST LABS            EQ 5MG BASE                    N021323 001 Aug 14, 2002

AB                              EQ 10MG BASE                   N021323 002 Aug 14, 2002

AB    +                         EQ 20MG BASE                   N021323 003 Aug 14, 2002
	
ESLICARBAZEPINE ACETATE
	
  TABLET;ORAL
	
    APTIOM
	
         SUNOVION PHARMS INC    200MG		                        N022416   001    Nov   08,   2013
	
                                400MG		                        N022416   002    Nov   08,   2013
	
                                600MG		                        N022416   003    Nov   08,   2013
	
     +                          800MG		                        N022416   004    Nov   08,   2013
	
ESMOLOL HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    BREVIBLOC
	
AP    + BAXTER HLTHCARE         10MG/ML                        N019386 006 Feb 25, 2003

    ESMOLOL HYDROCHLORIDE
	
AP       EUROHLTH INTL          10MG/ML                        A076323 001 Aug 10, 2004

AP       FRESENIUS KABI USA     10MG/ML                        A076573 001 May 02, 2005

AP       MYLAN INSTITUTIONAL    10MG/ML                        A076474 001 May 02, 2005

    BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         2GM/100ML                      N019386 005 Jan 27, 2003
	
    BREVIBLOC IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         1GM/100ML		                    N019386 004 Feb 16, 2001
	
ESOMEPRAZOLE MAGNESIUM
	
  CAPSULE, DELAYED REL PELLETS;ORAL
	
    NEXIUM
	
          ASTRAZENECA PHARMS    EQ 20MG BASE                   N021153 001 Feb 20, 2001
	
      +                         EQ 40MG BASE                   N021153 002 Feb 20, 2001
	
  FOR SUSPENSION, DELAYED RELEASE;ORAL
	
    NEXIUM
	
          ASTRAZENECA PHARMS		  EQ 2.5MG BASE/PACKET           N021957   003    Dec   15,   2011
	
                                EQ 5MG BASE/PACKET             N021957   004    Dec   15,   2011
	
                                EQ 10MG BASE/PACKET            N022101   001    Feb   27,   2008
	
                                EQ 20MG BASE/PACKET            N021957   001    Oct   20,   2006
	
      +		                       EQ 40MG BASE/PACKET            N021957   002    Oct   20,   2006
	
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
	
  TABLET, DELAYED RELEASE;ORAL

    NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
	
AB       DR REDDYS LABS LTD     EQ 20MG BASE;375MG             A202461 001 Sep 27, 2013

AB                              EQ 20MG BASE;500MG             A202461 002 Sep 27, 2013

    VIMOVO
	
AB       HORIZON PHARMA         EQ 20MG BASE;375MG             N022511 002 Apr 30, 2010

AB    +                         EQ 20MG BASE;500MG             N022511 001 Apr 30, 2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-136(of 371)


ESOMEPRAZOLE SODIUM
	
  INJECTABLE;INTRAVENOUS

    ESOMEPRAZOLE SODIUM
	
AP       SUN PHARMA GLOBAL      EQ 20MG BASE/VIAL              A200882 001 Mar 18, 2013

AP                              EQ 40MG BASE/VIAL              A200882 002 Mar 18, 2013

    NEXIUM IV
	
AP    + ASTRAZENECA PHARMS      EQ 20MG BASE/VIAL              N021689 001 Mar 31, 2005

AP    +                         EQ 40MG BASE/VIAL              N021689 002 Mar 31, 2005
	
ESOMEPRAZOLE STRONTIUM
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    ESOMEPRAZOLE STRONTIUM
	
         HANMI PHARM CO LTD      EQ 20MG BASE                  N202342 001 Aug 06, 2013

      +                          EQ 40MG BASE                  N202342 002 Aug 06, 2013
	
ESTAZOLAM
	
  TABLET;ORAL

    ESTAZOLAM
	
AB       PAR PHARM              1MG                            A074826   001    Jul   03,   1997

AB                              2MG                            A074826   002    Jul   03,   1997

AB       TEVA                   1MG                            A074921   001    Jul   10,   1997

AB    +                         2MG                            A074921   002    Jul   10,   1997

AB       WATSON LABS            1MG                            A074818   001    Aug   19,   1997

AB                              2MG                            A074818   002    Aug   19,   1997
	
ESTRADIOL
	
  CREAM;VAGINAL
	
    ESTRACE
	
      + WARNER CHILCOTT US      0.01%                          A086069 001 Jan 31, 1984
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    CLIMARA
	
AB       BAYER HLTHCARE         0.0375MG/24HR                  N020375 005 May 27, 2003

AB                              0.06MG/24HR                    N020375 006 May 27, 2003

    ESTRADIOL
	
AB       MYLAN TECHNOLOGIES     0.0375MG/24HR                  A075182   004    Jul   20,   2006

AB                              0.06MG/24HR                    A075182   005    Jul   20,   2006

AB1                             0.025MG/24HR                   A201675   001    Dec   19,   2014

AB1                             0.0375MG/24HR                  A201675   002    Dec   19,   2014

AB1                             0.05MG/24HR                    A201675   003    Dec   19,   2014

AB1                             0.075MG/24HR                   A201675   004    Dec   19,   2014

AB1                             0.1MG/24HR                     A201675   005    Dec   19,   2014

    VIVELLE
	
AB1      NOVARTIS               0.05MG/24HR                    N020323 002 Oct 28, 1994

AB1                             0.1MG/24HR                     N020323 004 Oct 28, 1994

    VIVELLE-DOT
	
AB1      NOVARTIS               0.025MG/24HR                   N020538   009    May   03,   2002

AB1                             0.0375MG/24HR                  N020538   005    Jan   08,   1999

AB1                             0.05MG/24HR                    N020538   006    Jan   08,   1999

AB1                             0.075MG/24HR                   N020538   007    Jan   08,   1999

AB1 +                           0.1MG/24HR                     N020538   008    Jan   08,   1999

    CLIMARA
	
AB2      BAYER HLTHCARE         0.025MG/24HR                   N020375   004    Mar   05,   1999

AB2                             0.05MG/24HR                    N020375   001    Dec   22,   1994

AB2                             0.075MG/24HR                   N020375   003    Mar   23,   1998

AB2 +                           0.1MG/24HR                     N020375   002    Dec   22,   1994

    ESTRADIOL
	
AB2      MYLAN TECHNOLOGIES     0.025MG/24HR                   A075182   003    Jan   26,   2005

AB2                             0.05MG/24HR                    A075182   006    Feb   24,   2000

AB2                             0.075MG/24HR                   A075182   002    Jan   26,   2005

AB2                             0.1MG/24HR                     A075182   001    Feb   24,   2000
	
    ALORA
	
BX       WATSON LABS            0.025MG/24HR                   N020655   004    Apr   05,   2002

BX                              0.05MG/24HR                    N020655   001    Dec   20,   1996
	
BX                              0.075MG/24HR                   N020655   002    Dec   20,   1996
	
BX                              0.1MG/24HR                     N020655   003    Dec   20,   1996
	
    ESTRADERM
	
BX       NOVARTIS               0.05MG/24HR                    N019081 002 Sep 10, 1986

BX    +                         0.1MG/24HR                     N019081 003 Sep 10, 1986

    MENOSTAR
	
      + BAYER HLTHCARE          0.014MG/24HR                   N021674 001 Jun 08, 2004
	
    MINIVELLE
	
         NOVEN                  0.0375MG/24HR                  N203752 001 Oct 29, 2012
	
                                0.05MG/24HR                    N203752 003 Oct 29, 2012
	
                                0.075MG/24HR                   N203752 002 Oct 29, 2012
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-137(of 371)


ESTRADIOL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    MINIVELLE
	
      +                         0.1MG/24HR                      N203752 004 Oct 29, 2012
	
  GEL;TRANSDERMAL
	
    DIVIGEL
	
          VERTICAL PHARMS LLC		 0.1% (0.25GM/PACKET)            N022038 001 Jun 04, 2007
	
                                0.1% (0.5GM/PACKET)             N022038 002 Jun 04, 2007
	
      +		                       0.1% (1GM/PACKET)               N022038 003 Jun 04, 2007
	
  GEL, METERED;TRANSDERMAL
	
    ELESTRIN
	
      + MEDA PHARMS             0.06% (0.87GM/ACTIVATION)       N021813 001 Dec 15, 2006
	
    ESTROGEL
	
      + ASCEND THERAPS US       0.06% (1.25GM/ACTIVATION)		     N021166 002 Feb 09, 2004
	
  INSERT, EXTENDED RELEASE;VAGINAL
	
    ESTRING
	
      + PHARMACIA AND UPJOHN    0.0075MG/24HR		                 N020472 001 Apr 26, 1996

  SPRAY;TRANSDERMAL
	
    EVAMIST
	
      + ELAN PHARMA INTL LTD    1.53MG/SPRAY                    N022014 001 Jul 27, 2007
	
  TABLET;ORAL

    ESTRADIOL
	
AB        BARR LABS INC         0.5MG                           A040197   001    Oct   22,   1997

AB                              1MG                             A040197   002    Oct   22,   1997

AB    +                         2MG                             A040197   003    Oct   22,   1997

AB        MYLAN                 0.5MG                           A040326   001    Apr   21,   1999

AB                              1MG                             A040326   002    Apr   21,   1999

AB                              2MG                             A040326   003    Apr   21,   1999

AB        USL PHARMA            0.5MG                           A040297   001    Apr   17,   2002

AB                              1MG                             A040297   002    Apr   17,   2002

AB                              2MG                             A040297   003    Apr   17,   2002

AB        WATSON LABS           0.5MG                           A040114   003    Mar   14,   1996

AB                              1MG                             A040114   001    Mar   14,   1996

AB                              2MG                             A040114   002    Mar   14,   1996
	
  TABLET;VAGINAL
	
    VAGIFEM
	
      + NOVO NORDISK INC        10MCG		                         N020908 002 Nov 25, 2009
	
ESTRADIOL ACETATE
	
  INSERT, EXTENDED RELEASE;VAGINAL
	
    FEMRING
	
         WARNER IRELAND         EQ 0.05MG BASE/24HR             N021367 001 Mar 20, 2003
	
      +                         EQ 0.1MG BASE/24HR              N021367 002 Mar 20, 2003
	
  TABLET;ORAL
	
    FEMTRACE
	
         WARNER CHILCOTT LLC		  0.45MG                          N021633 001 Aug 20, 2004

                                0.9MG                           N021633 002 Aug 20, 2004

      +                         1.8MG                           N021633 003 Aug 20, 2004
	
ESTRADIOL CYPIONATE
	
  INJECTABLE;INJECTION
	
    DEPO-ESTRADIOL
	
      + PHARMACIA AND UPJOHN    5MG/ML                          A085470 003
	
ESTRADIOL HEMIHYDRATE
	
  EMULSION;TOPICAL
	
    ESTRASORB
	
      + MEDICIS                 0.25%		                         N021371 001 Oct 09, 2003
	
ESTRADIOL VALERATE
	
  INJECTABLE;INJECTION

    DELESTROGEN
	
AO    + PAR STERILE PRODUCTS    20MG/ML                         N009402 004
	
AO    +                         40MG/ML                         N009402 003
	
    ESTRADIOL VALERATE
	
AO       LUITPOLD               20MG/ML                         A090920 001 Jan 19, 2010

AO                              40MG/ML                         A090920 002 Jan 19, 2010
	
    DELESTROGEN
	
      + PAR STERILE PRODUCTS    10MG/ML		                       N009402 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                               3-138(of 371)


ESTRADIOL; LEVONORGESTREL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    CLIMARA PRO
	
      + BAYER HLTHCARE          0.045MG/24HR;0.015MG/24HR		               N021258 001 Nov 21, 2003
	
ESTRADIOL; NORETHINDRONE ACETATE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    COMBIPATCH
	
         NOVEN PHARMS INC       0.05MG/24HR;0.14MG/24HR                   N020870 001 Aug 07, 1998

      +                         0.05MG/24HR;0.25MG/24HR                   N020870 002 Aug 07, 1998

  TABLET;ORAL

    ACTIVELLA
	
AB       AMNEAL PHARMS LLC      0.5MG;0.1MG                               N020907 002 Dec 28, 2006

AB    +                         1MG;0.5MG                                 N020907 001 Nov 18, 1998

    ESTRADIOL AND NORETHINDRONE ACETATE
	
AB       BARR                   1MG;0.5MG                                 A079193   001    May   11,   2010

AB       BRECKENRIDGE PHARM     0.5MG;0.1MG                               A078324   002    Jun   09,   2011

AB                              1MG;0.5MG                                 A078324   001    Apr   17,   2008

AB       TEVA PHARMS USA        0.5MG;0.1MG                               A200747   001    Mar   08,   2012
	
ESTRADIOL; NORGESTIMATE
	
  TABLET;ORAL
	
    ESTRADIOL AND NORGESTIMATE
	
      + BARR                     1MG,1MG;1MG,1MG;N/A,0.09MG               A076812 001 Apr 29, 2005
	
ESTRAMUSTINE PHOSPHATE SODIUM
	
  CAPSULE;ORAL
	
    EMCYT
	
      + PHARMACIA AND UPJOHN      EQ 140MG PHOSPHATE                      N018045 001
	
ESTROGENS, CONJUGATED
	
  CREAM;TOPICAL, VAGINAL
	
    PREMARIN
	
      + WYETH PHARMS INC          0.625MG/GM		                            N020216 001
	
  INJECTABLE;INJECTION
	
    PREMARIN
	
      + WYETH PHARMS INC          25MG/VIAL		                             N010402 001
	
  TABLET;ORAL
	
    PREMARIN
	
         WYETH PHARMS INC         0.3MG                                   N004782   003
                                  0.45MG                                  N004782   006 Jul 16, 2003
     +                            0.625MG                                 N004782   004
     +                            0.9MG                                   N004782   005 Jan 26, 1984
     +                            1.25MG                                  N004782   001
ESTROGENS, CONJUGATED SYNTHETIC A
	
  TABLET;ORAL
	
    CENESTIN
	
         TEVA BRANDED PHARM		   0.3MG                                     N020992   001    Jun   21,   2002
	
                                0.45MG                                    N020992   005    Feb   05,   2004
	
                                0.625MG                                   N020992   002    Mar   24,   1999
	
                                0.9MG                                     N020992   003    Mar   24,   1999
	
      +                         1.25MG		                                  N020992   004    Mar   13,   2000
	
ESTROGENS, CONJUGATED SYNTHETIC B
	
  TABLET;ORAL
	
    ENJUVIA
	
         TEVA WOMENS		          0.3MG                                     N021443   001    Dec   20,   2004
	
                                0.45MG                                    N021443   002    Dec   20,   2004
	
                                0.625MG                                   N021443   003    May   10,   2004

                                0.9MG                                     N021443   005    Apr   27,   2007

      +                         1.25MG                                    N021443   004    May   10,   2004
	
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
	
  TABLET;ORAL-28
	
    PREMPHASE 14/14

      + WYETH PHARMS INC        0.625MG,0.625MG;0.625MG,0.625MG;N/A,5MG   N020527 002 Nov 17, 1995
	
    PREMPRO
	
      + WYETH PHARMS INC        0.3MG;1.5MG		                             N020527   005    Jun   04,   2003
	
      +                         0.45MG;1.5MG		                            N020527   004    Mar   12,   2003
	
      +		                       0.625MG;0.625MG;2.5MG;2.5MG               N020527   001    Nov   17,   1995
	
      +		                       0.625MG;0.625MG;5MG;5MG                   N020527   003    Jan   09,   1998
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST
	                   3-139(of 371)


ESTROGENS, ESTERIFIED
	
  TABLET;ORAL
	
    MENEST
	
         MONARCH PHARMS
	             0.3MG
	                     A084951   001
	
                                      0.625MG
	                   A084948   001
	
                                      1.25MG
	                    A084950   001
	
      +
	                             2.5MG
	                     A084949   001
	
ESTROPIPATE
	
  TABLET;ORAL

     ESTROPIPATE
	
AB        BARR
	                      0.75MG
	                    A040135   001     Nov   27,   1996

AB
	                                  1.5MG
	                     A040135   002     Nov   27,   1996

AB
	                                  3MG
	                       A040135   003     Nov   27,   1996

AB        MYLAN
	                     0.75MG
	                    A040359   001     Aug   26,   1999

AB
	                                  1.5MG
	                     A040359   002     Aug   26,   1999

AB        WATSON LABS
	               0.75MG
	                    A081213   001     Sep   23,   1993

AB
	                                  1.5MG
	                     A081214   001     Sep   23,   1993

AB
	                                  3MG
	                       A081215   001     Sep   23,   1993
	
     OGEN .625
	
AB        PHARMACIA AND    UPJOHN
	   0.75MG
	                    A083220 001
	
     OGEN 1.25
	
AB        PHARMACIA AND    UPJOHN
	   1.5MG
	                     A083220 002
	
     OGEN 2.5
	
AB     + PHARMACIA AND     UPJOHN
	   3MG
	                       A083220 003
	
     OGEN 5
	
          PHARMACIA AND    UPJOHN
	   6MG
	                       A083220 004
	
ESZOPICLONE
	
  TABLET;ORAL

     ESZOPICLONE
	
AB         DR REDDYS LABS LTD
	       1MG
	                       A091024   001     Apr   15,   2014

AB
	                                  2MG
	                       A091024   002     Apr   15,   2014

AB
	                                  3MG
	                       A091024   003     Apr   15,   2014

AB         GLENMARK GENERICS
	        1MG
	                       A091166   001     Apr   15,   2014

AB
	                                  2MG
	                       A091166   002     Apr   15,   2014

AB
	                                  3MG
	                       A091166   003     Apr   15,   2014

AB         LUPIN LTD
	                1MG
	                       A091124   001     Sep   13,   2011

AB
	                                  2MG
	                       A091124   002     Sep   13,   2011

AB
	                                  3MG
	                       A091124   003     Sep   13,   2011

AB         MYLAN PHARMS INC
	         1MG
	                       A091151   001     Mar   26,   2013

AB
	                                  2MG
	                       A091151   002     Mar   26,   2013

AB
	                                  3MG
	                       A091151   003     Mar   26,   2013

AB         ORCHID HLTHCARE
	          1MG
	                       A091113   001     Jun   10,   2014

AB
	                                  2MG
	                       A091113   002     Jun   10,   2014

AB
	                                  3MG
	                       A091113   003     Jun   10,   2014

AB         ROXANE
	                   1MG
	                       A091153   001     Apr   15,   2014

AB
	                                  2MG
	                       A091153   002     Apr   15,   2014

AB
	                                  3MG
	                       A091153   003     Apr   15,   2014

AB         SUN PHARMA GLOBAL
	        1MG
	                       A091103   001     Apr   03,   2013

AB
	                                  2MG
	                       A091103   002     Apr   03,   2013

AB
	                                  3MG
	                       A091103   003     Apr   03,   2013

AB         TEVA
	                     1MG
	                       A091169   001     May   23,   2011

AB
	                                  2MG
	                       A091169   002     May   23,   2011

AB
	                                  3MG
	                       A091169   003     May   23,   2011
	
     LUNESTA
	
AB         SUNOVION PHARMS INC
	      1MG
	                       N021476 001 Dec 15, 2004

AB
	                                  2MG
	                       N021476 002 Dec 15, 2004

AB     +
	                            3MG
	                       N021476 003 Dec 15, 2004
	
ETHACRYNATE SODIUM
	
  INJECTABLE;INJECTION
	
    EDECRIN
	
      + ATON
	                        EQ 50MG BASE/VIAL
	         N016093 001
	
ETHACRYNIC ACID
	
  TABLET;ORAL
	
    EDECRIN
	
      + ATON
	                        25MG
	                      N016092 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                             3-140(of 371)


ETHAMBUTOL HYDROCHLORIDE
	
  TABLET;ORAL

    ETHAMBUTOL HYDROCHLORIDE
	
AB       BARR                    400MG                                    A076057 001 Nov 26, 2001

AB       LUPIN                   100MG                                    A078939 001 Jun 17, 2009

AB                               400MG                                    A078939 002 Jun 17, 2009

    MYAMBUTOL
	
AB       STI PHARMA LLC          100MG                                    N016320 001
	
AB    +                          400MG                                    N016320 003
	
ETHANOLAMINE OLEATE
	
  INJECTABLE;INJECTION
	
    ETHAMOLIN
	
      + QOL MEDCL                50MG/ML                                  N019357 001 Dec 22, 1988
	
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
	
  TABLET;ORAL-28

    KELNOR
	
AB       BARR                   0.035MG;1MG                               A076785 001 May 23, 2005

    ZOVIA 1/35E-28

AB       WATSON LABS            0.035MG;1MG                               A072721 001 Dec 30, 1991
	
    ZOVIA 1/50E-28

      + WATSON LABS             0.05MG;1MG                                A072723 001 Dec 30, 1991
	
ETHINYL ESTRADIOL; ETONOGESTREL
	
  RING;VAGINAL
	
    NUVARING
	
      + ORGANON USA INC          0.015MG/24HR;0.12MG/24HR                 N021187 001 Oct 03, 2001
	
ETHINYL ESTRADIOL; LEVONORGESTREL
	
  TABLET;ORAL

    DAYSEE
	
AB       LUPIN LTD              0.03MG,0.01MG;0.15MG,N/A                  A091467 001 Apr 10, 2013

    INTROVALE
	
AB       SANDOZ                 0.03MG;0.15MG                             A079064 001 Sep 27, 2010

    LEVONORGESTREL AND ETHINYL ESTRADIOL
	
AB       LUPIN LTD              0.02MG,0.01MG;0.1MG,N/A                   A091674 001 Oct 26, 2011

AB                              0.03MG;0.15MG                             A091440 001 Oct 23, 2012

AB       WATSON LABS            0.02MG,0.01MG;0.1MG,N/A                   A200407 001 Oct 25, 2011

    LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
	
AB       WATSON LABS            0.03MG,0.01MG;0.15MG,N/A                  A078834 001 May 31, 2011

    LOSEASONIQUE

AB       TEVA BRANDED PHARM     0.01MG;0.02MG;0.1MG                       N022262 001 Oct 24, 2008

    QUASENSE

AB       WATSON LABS            0.03MG;0.15MG                             A077101 001 Sep 06, 2006

    SEASONALE
	
AB    + TEVA BRANDED PHARM      0.03MG;0.15MG                             N021544 001 Sep 05, 2003

    SEASONIQUE

AB    + TEVA BRANDED PHARM      0.03MG,0.01MG;0.03MG,0.01MG;0.15MG,N/A    N021840 001 May 25, 2006

    SETLAKIN
	
AB       NOVAST LABS LTD        0.03MG;0.15MG                             A090716 001 Sep 15, 2014

    LEVONORGESTREL AND ETHINYL ESTRADIOL
	
      + WATSON LABS             0.02MG;0.09MG                             A079218 001 Jun 06, 2011
	
    QUARTETTE
	
      + TEVA BRANDED PHARM      0.02MG;0.15MG                             N204061 001 Mar 28, 2013
	
  TABLET;ORAL-28

    ALTAVERA
	
AB       SANDOZ                 0.03MG;0.15MG                             A079102 001 Aug 03, 2010

    ENPRESSE-28
	
AB       DURAMED PHARMS BARR    0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1   A075809 002 Jul 16, 2001

                                25MG
	
    KURVELO
	
AB       LUPIN LTD              0.03MG;0.15MG                             A091408 001 Oct 17, 2012

    LEVONEST
	
AB       NOVAST LABS LTD        0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1   A090719 001 Dec 29, 2010

                                25MG
	
    LEVONORGESTREL AND ETHINYL ESTRADIOL
	
AB       FAMY CARE LTD          0.03MG;0.15MG                             A091663 001 Dec 21, 2012

AB       HAUPT PHARMA           0.03MG;0.15MG                             A201095 001 Dec 08, 2014

    LEVORA 0.15/30-28

AB       WATSON LABS            0.03MG;0.15MG                             A073594 001 Dec 13, 1993

    MARLISSA
	
AB       GLENMARK GENERICS      0.03MG;0.15MG                             A091452 001 Feb 29, 2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                                  3-141(of 371)


ETHINYL ESTRADIOL; LEVONORGESTREL
	
  TABLET;ORAL-28

    MYZILRA
	
AB       VINTAGE PHARMS LLC     0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1   A077502 001 Nov 23, 2011

                                25MG
	
    NORDETTE-28
	
AB    + TEVA BRANDED PHARM      0.03MG;0.15MG                             N018782 001 Jul 21, 1982

    PORTIA-28
	
AB       BARR                   0.03MG;0.15MG                             A075866 002 May 23, 2002

    TRIVORA-28
	
AB    + WATSON LABS             0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1   A074538 002 Dec 18, 1997

                                25MG
	
    AVIANE-28
	
AB1      DURAMED PHARMS BARR    0.02MG;0.1MG                              A075796 001 Apr 30, 2001

    FALMINA
	
AB1      NOVAST LABS LTD        0.02MG;0.1MG                              A090721 001 Mar 28, 2012

    LEVONORGESTREL AND ETHINYL ESTRADIOL
	
AB1      FAMY CARE LTD          0.02MG;0.1MG                              A200245   001    Oct   09,   2013

AB1      HAUPT PHARMA           0.02MG;0.1MG                              A201108   001    Feb   05,   2014

AB1      LUPIN LTD              0.02MG;0.1MG                              A091425   001    Jan   18,   2013

AB1 + WATSON LABS               0.02MG;0.1MG                              A076625   001    Nov   18,   2004

    ORSYTHIA
	
AB1      VINTAGE PHARMS LLC     0.02MG;0.1MG                              A077099 001 May 11, 2011

    LESSINA-28
	
AB2      BARR                   0.02MG;0.1MG                              A075803 002 Mar 20, 2002

    LEVONORGESTREL AND ETHINYL ESTRADIOL
	
AB2      FAMY CARE LTD          0.02MG;0.1MG                              A202247 001 Dec 08, 2014

AB2 + WATSON LABS               0.02MG;0.1MG                              A077681 001 May 31, 2006
	
ETHINYL ESTRADIOL; NORELGESTROMIN
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    ORTHO EVRA
	
AB    + JANSSEN PHARMS          0.035MG/24HR;0.15MG/24HR                  N021180 001 Nov 20, 2001

    XULANE
	
AB       MYLAN TECHNOLOGIES     0.035MG/24HR;0.15MG/24HR                  A200910 001 Apr 16, 2014
	
ETHINYL ESTRADIOL; NORETHINDRONE
	
  TABLET;ORAL-21

    NORINYL 1+35 21-DAY
	
AB       WATSON LABS            0.035MG;1MG                               N017565 001
	
    NORTREL 1/35-21

AB       BARR                   0.035MG;1MG                               A072693 001 Feb 28, 1992
	
    NORTREL 7/7/7

         BARR                   0.035MG;0.035MG;0.035MG;0.5MG;0.75MG;1M   A075478 001 Aug 30, 2002

                                G
	
  TABLET;ORAL-28

    ALYACEN 1/35

AB       GLENMARK GENERICS      0.035MG;1MG                               A091634 001 Jan 19, 2012

    ALYACEN 7/7/7

AB       GLENMARK GENERICS      0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M   A091636 001 Jan 19, 2012

                                G
	
    ARANELLE
	
AB       BARR                   0.035MG;0.035MG;0.035MG;0.5MG;0.5MG;1MG   A076783 001 Sep 29, 2004

    BALZIVA-28
	
AB       BARR                   0.035MG;0.4MG                             A076238 001 Apr 22, 2004

    BREVICON 28-DAY
	
AB       WATSON LABS            0.035MG;0.5MG                             N017743 001
	
    BRIELLYN
	
AB       GLENMARK GENERICS      0.035MG;0.4MG                             A090538 001 Mar 22, 2011

    CYCLAFEM 1/35

AB       VINTAGE PHARMS LLC     0.035MG;1MG                               A076337 001 Nov 12, 2010

    CYCLAFEM 7/7/7

AB       VINTAGE PHARMS LLC     0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M   A076338 001 Nov 16, 2010

                                G
	
    DASETTA 1/35

AB       NOVAST LABS LTD        0.035MG;1MG                               A090948 001 Dec 22, 2011

    DASETTA 7/7/7

AB       NOVAST LABS LTD        0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M   A090946 001 Dec 22, 2011

                                G
	
    GILDAGIA
	
AB       VINTAGE PHARMS         0.035MG;0.4MG                             A078376 001 Nov 06, 2012

    MODICON 28
	
AB    + JANSSEN PHARMS          0.035MG;0.5MG                             N017735 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-142(of 371)


ETHINYL ESTRADIOL; NORETHINDRONE
	
  TABLET;ORAL-28

    NORETHINDRONE AND ETHINYL ESTRADIOL
	
AB    + FAMY CARE LTD           0.05MG;1MG                                A203006   001    Aug   05,   2013

AB         WATSON LABS          0.035MG;0.4MG                             A078323   001    Feb   04,   2010

AB                              0.035MG;0.5MG                             A070686   001    Jan   29,   1987

AB                              0.035MG;1MG                               A070687   001    Jan   29,   1987

    NORINYL 1+35 28-DAY
	
AB         WATSON LABS          0.035MG;1MG                               N017565 002
	
    NORTREL 0.5/35-28

AB         BARR                 0.035MG;0.5MG                             A072695 001 Feb 28, 1992

    NORTREL 1/35-28

AB         BARR                 0.035MG;1MG                               A072696 001 Feb 28, 1992

    NORTREL 7/7/7

AB         BARR                 0.035MG;0.035MG;0.035MG;0.5MG;0.75MG;1M   A075478 002 Aug 30, 2002

                                G
	
    ORTHO-NOVUM 1/35-28

AB    + JANSSEN PHARMS          0.035MG;1MG                               N017919 002
	
    ORTHO-NOVUM 7/7/7-28

AB    + JANSSEN PHARMS          0.035MG;0.035MG;0.035MG;0.5MG;0.75MG;1M   N018985 002 Apr 04, 1984

                                G
	
    OVCON-35
	
AB    + WARNER CHILCOTT LLC     0.035MG;0.4MG                             N017716 001
	
    PHILITH
	
AB         NOVAST LABS LTD      0.035MG;0.4MG                             A090947 001 Dec 22, 2011

    PIRMELLA 1/35

AB         LUPIN LTD            0.035MG;1MG                               A201512 001 Apr 24, 2013

    PIRMELLA 7/7/7

AB         LUPIN LTD            0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M   A201510 001 Apr 24, 2013

                                G
	
    TRI-NORINYL 28-DAY
	
AB    + WATSON LABS             0.035MG;0.035MG;0.035MG;0.5MG;0.5MG;1MG   N018977 002 Apr 13, 1984

    VYFEMLA
	
AB         LUPIN LTD            0.035MG;0.4MG                             A201886 001 Sep 26, 2013

    WERA
	
AB         NOVAST LABS LTD      0.035MG;0.5MG                             A091204 001 Mar 27, 2012
	
    NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)

           WATSON LABS          0.035MG;0.035MG;0.5MG;1MG                 A071044 001 Apr 01, 1988

  TABLET, CHEWABLE;ORAL

    FEMCON FE
	
AB    + WARNER CHILCOTT LLC     0.035MG;0.4MG                             N021490 001 Nov 14, 2003

    NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
	
AB         AMNEAL PHARMS        0.035MG;0.4MG                             A078892   001    Sep   26,   2011

AB         BARR                 0.035MG;0.4MG                             A078965   001    Aug   05,   2010

AB         FAMY CARE LTD        0.025MG;0.8MG                             A203371   001    Apr   23,   2014

AB    + WARNER CHILCOTT         0.025MG;0.8MG                             N022573   001    Dec   22,   2010
	
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
	
  TABLET;ORAL

    GILDESS 24 FE
	
AB       VINTAGE PHARMS         0.02MG;1MG                                A090293 001 Dec 01, 2014

    LOESTRIN 24 FE
	
AB    + WARNER CHILCOTT         0.02MG;1MG                                N021871 001 Feb 17, 2006

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
	
AB       AMNEAL PHARMS          0.02MG;1MG                                A078267 001 Sep 01, 2009

AB       BARR LABS INC          0.02MG;1MG                                A090938 001 Dec 01, 2014

AB       FAMY CARE LTD          0.02MG;1MG                                A202742 001 Oct 30, 2014
	
    FEMHRT
	
         WARNER CHILCOTT LLC    0.0025MG;0.5MG                            N021065 001 Jan 14, 2005
	
    LO LOESTRIN FE
	
      + WARNER CHILCOTT LLC     0.01MG,0.01MG;1MG,N/A                     N022501 001 Oct 21, 2010
	
    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
	
      + BARR LABS INC           0.005MG;1MG                               A076221 001 Nov 06, 2009
	
  TABLET;ORAL-21

    GILDESS 1.5/30

AB       VINTAGE PHARMS LLC     0.03MG;1.5MG                              A077075 002 Jul 24, 2012

    GILDESS 1/20

AB       VINTAGE PHARMS LLC     0.02MG;1MG                                A077077 002 Jul 24, 2012

    JUNEL 1.5/30

AB       BARR                   0.03MG;1.5MG                              A076381 001 May 30, 2003

    JUNEL 1/20

AB       BARR                   0.02MG;1MG                                A076380 001 May 30, 2003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-143(of 371)


ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
	
  TABLET;ORAL-21

    LARIN 1.5/30

AB       NOVAST LABS LTD         0.03MG;1.5MG                              A202996 001 Mar 20, 2014

    LARIN 1/20

AB       NOVAST LABS LTD         0.02MG;1MG                                A202995 001 Dec 04, 2013

    LOESTRIN 21 1.5/30

AB       WARNER CHILCOTT LLC     0.03MG;1.5MG                              N017875 001
	
    LOESTRIN 21 1/20

AB       WARNER CHILCOTT LLC     0.02MG;1MG                                N017876 001
	
    MICROGESTIN 1.5/30

AB       WATSON LABS             0.03MG;1.5MG                              A075548 002 Jul 30, 2003

    MICROGESTIN 1/20

AB       WATSON LABS             0.02MG;1MG                                A075647 002 Jul 30, 2003

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
	
AB       FAMY CARE LTD           0.02MG;1MG                                A202771 001 Nov 06, 2013
	
    TRI-LEGEST 21
	
         BARR                    0.02MG;0.035MG;0.03MG;1MG;1MG;1MG         A076405 001 Oct 26, 2007
	
  TABLET;ORAL-28

    ESTROSTEP FE
	
AB    + WARNER CHILCOTT LLC      0.02MG;0.035MG;0.03MG;1MG;1MG;1MG         N020130 002 Oct 09, 1996

    GILDESS FE 1.5/30

AB       VINTAGE PHARMS LLC      0.03MG;1.5MG                              A077075 001 Apr 28, 2005

    GILDESS FE 1/20

AB       VINTAGE PHARMS LLC      0.02MG;1MG                                A077077 001 May 20, 2005

    JUNEL FE 1.5/30

AB       BARR                    0.03MG;1.5MG                              A076064 001 Sep 18, 2003

    JUNEL FE 1/20

AB       BARR                    0.02MG;1MG                                A076081 001 Sep 18, 2003

    LARIN FE 1.5/30

AB       NOVAST LABS LTD         0.03MG;1.5MG                              A091453 001 Aug 23, 2013

    LARIN FE 1/20

AB       NOVAST LABS LTD         0.02MG;1MG                                A091454 001 Aug 26, 2013

    LOESTRIN FE 1.5/30

AB    + WARNER CHILCOTT LLC      0.03MG;1.5MG                              N017355 001
	
    LOESTRIN FE 1/20

AB       WARNER CHILCOTT         0.02MG;1MG                                N017354 001
	
    MICROGESTIN FE 1.5/30

AB       WATSON LABS             0.03MG;1.5MG                              A075548 001 Feb 05, 2001

    MICROGESTIN FE 1/20

AB       WATSON LABS             0.02MG;1MG                                A075647 001 Feb 05, 2001

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
	
AB       FAMY CARE LTD           0.02MG;1MG                                A202772 001 Nov 14, 2013

AB       WATSON LABS             0.02MG,0.03MG,0.035MG;1MG,1MG,1MG         A076629 001 Mar 18, 2010

    TRI-LEGEST FE
	
AB       BARR                    0.02MG;0.035MG;0.03MG;1MG;1MG;1MG         A076105 001 Oct 26, 2007
	
  TABLET, CHEWABLE;ORAL
	
    MINASTRIN 24 FE
	
      + WARNER CHILCOTT LLC      0.02MG;1MG                                N203667 001 May 08, 2013

  TABLET, CHEWABLE, TABLET;ORAL
	
    LO MINASTRIN FE
	
      + WARNER CHILCOTT          0.01MG,0.01MG,N/A;1MG,N/A,N/A             N204654 001 Jul 24, 2013
	
ETHINYL ESTRADIOL; NORGESTIMATE
	
  TABLET;ORAL

    NORGESTIMATE AND ETHINYL ESTRADIOL
	
AB       GLENMARK GENERICS       0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,   A200494 001 Jun 17, 2011

                                 0.25MG
	
  TABLET;ORAL-28

    ESTARYLLA
	
AB       SANDOZ                  0.035MG;0.25MG                            A090794 001 Jan 30, 2013

    MONO-LINYAH
	
AB       NOVAST LABS LTD         0.035MG;0.25MG                            A090523 001 May 23, 2012

    NORGESTIMATE AND ETHINYL ESTRADIOL
	
AB       GLENMARK GENERICS       0.035MG;0.25MG                            A200538 001 Apr 05, 2012

AB       LUPIN PHARMS            0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,   A200541 001 Jun 25, 2012

                                 0.25MG
	
    ORTHO CYCLEN-28
	
AB    + JANSSEN PHARMS           0.035MG;0.25MG                            N019653 002 Dec 29, 1989

    ORTHO TRI-CYCLEN
	
AB    + JANSSEN PHARMS           0.035MG;0.035MG;0.035MG;0.18MG;0.215MG;   N019697 001 Jul 03, 1992

                                 0.25MG
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                           3-144(of 371)


ETHINYL ESTRADIOL; NORGESTIMATE
	
  TABLET;ORAL-28

    ORTHO TRI-CYCLEN LO
AB    + JANSSEN PHARMS           0.025MG;0.025MG;0.025MG;0.18MG;0.215MG;
   N021241 001 Aug 22, 2002
	
                                 0.25MG
	
    PREVIFEM
AB       VINTAGE PHARMS LLC      0.035MG;0.25MG
	                           A076334 001 Jan 09, 2004
	
    SPRINTEC
AB       BARR                    0.035MG;0.25MG
	                           A075804 001 Sep 25, 2002
	
    TRI-ESTARYLLA
AB       SANDOZ                  0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,
   A090793 001 Jan 30, 2013
	
                                 0.25MG
	
    TRI-LINYAH
AB       NOVAST LABS LTD         0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,
   A090524 001 May 30, 2012
	
                                 0.25MG
	
    TRI-PREVIFEM
AB       VINTAGE PHARMS LLC      0.035MG;0.035MG;0.035MG;0.18MG;0.215MG;
   A076335 001 Mar 26, 2004
	
                                 0.25MG
	
    TRI-SPRINTEC
AB       BARR                    0.035MG;0.035MG;0.035MG;0.18MG;0.215MG;
   A075808 001 Dec 29, 2003
	
                                 0.25MG
	
ETHINYL ESTRADIOL; NORGESTREL
	
  TABLET;ORAL-21

    CRYSELLE
	
AB       DURAMED PHARMS BARR
	    0.03MG;0.3MG
	                            A075840 001 Nov 30, 2001
	
  TABLET;ORAL-28

    CRYSELLE
	
AB       DURAMED PHARMS BARR
	    0.03MG;0.3MG
	                            A075840 002 Nov 30, 2001
	
    ELINEST
	
AB       NOVAST LABS LTD
	        0.03MG;0.3MG
	                            A091105 001 Mar 28, 2012
	
    LO/OVRAL-28

AB       WYETH PHARMS
	           0.03MG;0.3MG
	                            N017802 001
	
    OGESTREL 0.5/50-28

      + WATSON LABS
	             0.05MG;0.5MG
	                            A075406 002 Dec 15, 1999
	
ETHIODIZED OIL
	
  OIL;INTRALYMPHATIC, INTRAUTERINE
	
    LIPIODOL
	
      + GUERBET
	               99%
	                                       N009190 001
	
ETHIONAMIDE
	
  TABLET;ORAL
	
    TRECATOR
	
      + WYETH PHARMS INC
	        250MG
	                                   N013026 002
	
ETHOSUXIMIDE
	
  CAPSULE;ORAL

    ETHOSUXIMIDE
AB       BANNER PHARMACAPS        250MG
	                                   A040430 001 Oct 28, 2002

AB       VERSAPHARM               250MG
	                                   A040686 001 May 28, 2008

AB       ZYDUS PHARMS USA INC     250MG
	                                   A200892 001 Sep 25, 2012
	
    ZARONTIN
AB    + PARKE DAVIS               250MG
	                                   N012380 001
	
  SYRUP;ORAL

    ETHOSUXIMIDE
	
AA       MIKART
	                 250MG/5ML
                                A040506 001 Dec 22, 2003

AA       PHARM ASSOC
	            250MG/5ML
                                A040253 001 Nov 22, 2000

AA       TEVA PHARMS
	            250MG/5ML
	                               A081306 001 Jul 30, 1993
	
    ZARONTIN
	
AA    + PARKE DAVIS
	             250MG/5ML
	                               A080258 001
	
ETHOTOIN
	
  TABLET;ORAL
	
    PEGANONE
	
      + RECORDATI RARE
	          250MG
	                                   N010841 001
	
ETIDRONATE DISODIUM
	
  TABLET;ORAL

     DIDRONEL
	
AB         PROCTER AND GAMBLE
	   200MG
	                                   N017831 001
	
AB     +
	                        400MG
	                                   N017831 002
	
     ETIDRONATE DISODIUM
	
AB         MYLAN
	                200MG
	                                   A075800 001 Jan 24, 2003

AB
	                              400MG
	                                   A075800 002 Jan 24, 2003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-145(of 371)


ETODOLAC
	
  CAPSULE;ORAL

    ETODOLAC
	
AB        ANI PHARMS INC         200MG                         A075126   001    Sep   16,   1999

AB                               300MG                         A075126   002    Sep   16,   1999

AB        APOTEX                 200MG                         A075419   001    Jul   28,   2000

AB                               300MG                         A075419   002    Jul   28,   2000

AB        TARO                   200MG                         A075078   001    Apr   30,   1998

AB    +                          300MG                         A075078   002    Apr   30,   1998

  TABLET;ORAL

    ETODOLAC
	
AB        APOTEX INC             400MG                         A076004   001    Dec   03,   2002

AB                               500MG                         A076004   002    Dec   03,   2002

AB        MYLAN                  400MG                         A075104   001    Feb   06,   1998

AB                               500MG                         A075104   002    Nov   20,   1998

AB        SANDOZ                 400MG                         A074903   001    Apr   11,   1997

AB                               500MG                         A074903   002    Apr   19,   1999

AB        TARO PHARM INDS        400MG                         A075074   001    Mar   11,   1998

AB    +                          500MG                         A075074   002    Apr   25,   2000

AB        TEVA                   400MG                         A075009   001    Nov   26,   1997

AB                               500MG                         A075009   002    Dec   28,   1999
	
  TABLET, EXTENDED RELEASE;ORAL

    ETODOLAC
	
AB        TARO                   400MG                         A076174   001    Mar   13,   2003

AB                               500MG                         A076174   002    Mar   13,   2003

AB                               600MG                         A076174   003    Mar   13,   2003

AB        TEVA                   400MG                         A075665   003    Feb   05,   2001

AB                               500MG                         A075665   002    Jul   31,   2000

AB    +                          600MG                         A075665   001    Jul   31,   2000

AB        ZYDUS PHARMS USA INC   400MG                         A091134   001    Jan   23,   2014

AB                               500MG                         A091134   002    Jan   23,   2014

AB                               600MG                         A091134   003    Jan   23,   2014
	
ETOMIDATE
	
  INJECTABLE;INJECTION

    AMIDATE
	
AP    + HOSPIRA                  2MG/ML                        N018227 001 Sep 07, 1982

    ETOMIDATE
	
AP       AGILA SPECLTS           2MG/ML                        A078289   001    Jan   02,   2009

AP       BEDFORD                 2MG/ML                        A074593   001    Nov   04,   1996

AP       EMCURE PHARMS LTD       2MG/ML                        A204618   001    Aug   13,   2014

AP       LUITPOLD                2MG/ML                        A078867   001    Dec   22,   2009

AP       PAR STERILE PRODUCTS    2MG/ML                        A091297   001    Jun   20,   2012

AP       ZYDUS PHARMS USA INC    2MG/ML                        A202360   001    Jul   18,   2014
	
ETONOGESTREL
	
  IMPLANT;IMPLANTATION
	
    IMPLANON
	
      + ORGANON USA INC          68MG/IMPLANT                  N021529 001 Jul 17, 2006
	
    NEXPLANON
	
      + ORGANON USA INC          68MG/IMPLANT                  N021529 002 May 31, 2011
	
ETOPOSIDE
	
  CAPSULE;ORAL
	
    ETOPOSIDE
	
      + MYLAN                    50MG                          A075635 001 Sep 19, 2001

  INJECTABLE;INJECTION

    ETOPOSIDE
	
AP       ACCORD HLTHCARE         20MG/ML                       A074513   001    Mar   14,   1996

AP       EUROHLTH INTL           20MG/ML                       A074290   001    Jul   17,   1995

AP    + FRESENIUS KABI USA       20MG/ML                       A074983   001    Sep   30,   1998

AP       TEVA PHARMS USA         20MG/ML                       A074529   001    Jul   24,   1996
	
ETOPOSIDE PHOSPHATE
	
  INJECTABLE;INJECTION
	
    ETOPOPHOS PRESERVATIVE FREE
	
      + BRISTOL MYERS SQUIBB      EQ 100MG BASE/VIAL           N020457 001 May 17, 1996
	
ETRAVIRINE
	
  TABLET;ORAL
	
    INTELENCE
	
         JANSSEN R AND D         25MG                          N022187 003 Mar 26, 2012
	
                                 100MG                         N022187 001 Jan 18, 2008
	
     +                           200MG                         N022187 002 Dec 22, 2010
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                       3-146(of 371)


EVEROLIMUS
	
  TABLET;ORAL
	
    AFINITOR
	
         NOVARTIS		               2.5MG                           N022334   003    Jul   09,   2010
	
                                  5MG                             N022334   001    Mar   30,   2009
	
                                  7.5MG                           N022334   004    Mar   30,   2012
	
      +                           10MG                            N022334   002    Mar   30,   2009
	
    ZORTRESS
	
         NOVARTIS		               0.25MG                          N021560 001 Apr 20, 2010

                                  0.5MG                           N021560 002 Apr 20, 2010

      +                           0.75MG                          N021560 003 Apr 20, 2010

  TABLET, FOR SUSPENSION;ORAL
	
    AFINITOR DISPERZ
	
         NOVARTIS PHARM		         2MG                             N203985 001 Aug 29, 2012

                                  3MG                             N203985 002 Aug 29, 2012

     +                            5MG		                           N203985 003 Aug 29, 2012
	
EXEMESTANE
	
  TABLET;ORAL

    AROMASIN
	
AB    + PHARMACIA AND UPJOHN      25MG                            N020753 001 Oct 21, 1999

    EXEMESTANE
	
AB       ALVOGEN INC              25MG                            A200898 001 Jul 28, 2014

AB       ROXANE                   25MG                            A077431 001 Apr 01, 2011
	
EXENATIDE SYNTHETIC
	
  FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
	
    BYDUREON
	
      + ASTRAZENECA AB          2MG/VIAL		                        N022200 001 Jan 27, 2012
	
  INJECTABLE;SUBCUTANEOUS
	
    BYETTA
	
      + ASTRAZENECA AB          300MCG/1.2ML (250MCG/ML)		        N021773 001 Apr 28, 2005

      +                         600MCG/2.4ML (250MCG/ML)          N021773 002 Apr 28, 2005
	
EZETIMIBE
	
  TABLET;ORAL
	
    ZETIA
	
      + MSD INTL GMBH             10MG		                          N021445 001 Oct 25, 2002
	
EZETIMIBE; SIMVASTATIN
	
  TABLET;ORAL
	
    VYTORIN
	
         MSD INTL		               10MG;10MG                       N021687   001    Jul   23,   2004
	
                                  10MG;20MG                       N021687   002    Jul   23,   2004
	
                                  10MG;40MG                       N021687   003    Jul   23,   2004
	
     +                            10MG;80MG		                     N021687   004    Jul   23,   2004
	
EZOGABINE
	
  TABLET;ORAL
	
    POTIGA
	
         GLAXOSMITHKLINE		        50MG                            N022345   001    Jun   10,   2011
	
                                  200MG                           N022345   002    Jun   10,   2011
	
                                  300MG                           N022345   003    Jun   10,   2011
	
     +                            400MG		                         N022345   004    Jun   10,   2011
	
FAMCICLOVIR
	
  TABLET;ORAL

    FAMCICLOVIR
	
AB       APOTEX                   125MG                           A091480   001    Jul   22,   2011

AB                                250MG                           A091480   002    Jul   22,   2011

AB                                500MG                           A091480   003    Jul   22,   2011

AB       AUROBINDO PHARMA LTD     125MG                           A091114   001    Mar   21,   2011

AB                                250MG                           A091114   002    Mar   21,   2011

AB                                500MG                           A091114   003    Mar   21,   2011

AB       CIPLA LTD                125MG                           A078278   001    Mar   21,   2011

AB                                250MG                           A078278   002    Mar   21,   2011

AB                                500MG                           A078278   003    Mar   21,   2011

AB       HETERO LABS LTD V        125MG                           A202438   001    Sep   10,   2014

AB                                250MG                           A202438   002    Sep   10,   2014

AB                                500MG                           A202438   003    Sep   10,   2014

AB       MACLEODS PHARMS LTD      125MG                           A201022   001    Jan   12,   2012

AB                                250MG                           A201022   002    Jan   12,   2012

AB                                500MG                           A201022   003    Jan   12,   2012

AB       MYLAN                    125MG                           A201333   001    Mar   24,   2011

AB                                250MG                           A201333   002    Mar   24,   2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-147(of 371)


FAMCICLOVIR
	
  TABLET;ORAL

    FAMCICLOVIR
	
AB                              500MG                          A201333   003    Mar   24,   2011

AB       ROXANE                 125MG                          A090128   001    Mar   21,   2011

AB                              250MG                          A090128   002    Mar   21,   2011

AB                              500MG                          A090128   003    Mar   21,   2011

AB       TEVA PHARMS            125MG                          A077487   001    Aug   24,   2007

AB                              250MG                          A077487   002    Aug   24,   2007

AB                              500MG                          A077487   003    Aug   24,   2007

    FAMVIR
	
AB       NOVARTIS               125MG                          N020363 003 Dec 11, 1995

AB                              250MG                          N020363 001 Apr 26, 1996

AB    +                         500MG                          N020363 002 Jun 29, 1994
	
FAMOTIDINE
	
  FOR SUSPENSION;ORAL

    FAMOTIDINE
	
AB       HI-TECH PHARMA CO      40MG/5ML                       A201995 001 May 30, 2014

AB       LUPIN LTD              40MG/5ML                       A090440 001 Jun 29, 2010

AB       NAVINTA LLC            40MG/5ML                       A091020 001 May 27, 2010

    PEPCID
	
AB    + SALIX PHARMS            40MG/5ML                       N019527 001 Feb 02, 1987
	
  INJECTABLE;INJECTION

    FAMOTIDINE
	
AP       AGILA SPECLTS          10MG/ML                        A078641   001    Jun   25,   2008

AP       BEDFORD                10MG/ML                        A075651   001    Apr   16,   2001

AP                              10MG/ML                        A075684   001    Apr   16,   2001

AP       FRESENIUS KABI USA     10MG/ML                        A075709   001    Apr   16,   2001

AP    + HIKMA MAPLE             10MG/ML                        A075488   001    Apr   16,   2001

    FAMOTIDINE PRESERVATIVE FREE
	
AP       AGILA SPECLTS          10MG/ML                        A078642   001    Jun   25,   2008

AP       BEDFORD                10MG/ML                        A075622   001    Apr   16,   2001

AP       BEDFORD LABS           10MG/ML                        A075825   001    Apr   17,   2001

AP       FRESENIUS KABI USA     10MG/ML                        A075813   001    Apr   16,   2001

AP    + HIKMA MAPLE             10MG/ML                        A075486   001    Apr   16,   2001

    FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         0.4MG/ML                       A075591 001 May 10, 2001

  SUSPENSION;ORAL

    FAMOTIDINE
	
AB       NOVEL LABS INC         40MG/5ML                       A201695 001 Dec 17, 2012
	
  TABLET;ORAL

    FAMOTIDINE
	
AB       ALEMBIC PHARMS LTD     20MG                           A078916   001    May   22,   2009

AB                              40MG                           A078916   002    May   22,   2009

AB       APOTEX                 20MG                           A075611   001    Jul   23,   2001

AB                              40MG                           A075611   002    Jul   23,   2001

AB       CARLSBAD               20MG                           A075805   001    Apr   16,   2001

AB                              40MG                           A075805   002    Apr   16,   2001

AB       DR REDDYS LABS LTD     20MG                           A075718   001    Apr   16,   2001

AB                              40MG                           A075718   002    Apr   16,   2001

AB       IVAX SUB TEVA PHARMS   20MG                           A075511   001    Apr   16,   2001

AB                              40MG                           A075511   002    Apr   16,   2001

AB       MYLAN                  20MG                           A075704   001    Apr   16,   2001

AB                              40MG                           A075704   002    Apr   16,   2001

AB       PERRIGO                20MG                           A077352   002    Jul   27,   2005

AB                              40MG                           A077352   001    Jul   27,   2005

AB       TEVA                   20MG                           A075311   001    Apr   16,   2001

AB                              40MG                           A075311   002    Apr   16,   2001

AB       WOCKHARDT              20MG                           A075786   001    Apr   16,   2001

AB                              40MG                           A075786   002    Apr   16,   2001

    PEPCID
	
AB       MARATHON PHARMS        20MG                           N019462 001 Oct 15, 1986

AB    +                         40MG                           N019462 002 Oct 15, 1986
	
FAMOTIDINE; IBUPROFEN
	
  TABLET;ORAL
	
    DUEXIS
	
      + HORIZON PHARMA          26.6MG;800MG                   N022519 001 Apr 23, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-148(of 371)


FEBUXOSTAT
	
  TABLET;ORAL
	
    ULORIC
	
         TAKEDA PHARMS USA      40MG                           N021856 001 Feb 13, 2009
	
      +                         80MG                           N021856 002 Feb 13, 2009
	
FELBAMATE
	
  SUSPENSION;ORAL

    FELBAMATE
	
AB       AMNEAL PHARMS          600MG/5ML                      A202385 001 Dec 16, 2011

    FELBATOL
	
AB    + MEDA PHARMS             600MG/5ML                      N020189 003 Jul 29, 1993
	
  TABLET;ORAL

    FELBAMATE
	
AB       AMNEAL PHARMS          400MG                          A201680 001 Sep 13, 2011

AB                              600MG                          A201680 002 Sep 13, 2011

    FELBATOL
	
AB       MEDA PHARMS            400MG                          N020189 001 Jul 29, 1993

AB    +                         600MG                          N020189 002 Jul 29, 1993
	
FELODIPINE
	
  TABLET, EXTENDED RELEASE;ORAL

    FELODIPINE
	
AB       AUROBINDO PHARMA LTD    2.5MG                         A203417   001    Jan   17,   2013

AB                               5MG                           A203417   002    Jan   17,   2013

AB                               10MG                          A203417   003    Jan   17,   2013

AB       GLENMARK GENERICS       2.5MG                         A090365   001    Dec   17,   2010

AB                               5MG                           A090365   002    Dec   17,   2010

AB                               10MG                          A090365   003    Dec   17,   2010

AB       HERITAGE PHARMS INC     2.5MG                         A201964   001    Nov   08,   2013

AB                               5MG                           A201964   002    Nov   08,   2013

AB                               10MG                          A201964   003    Nov   08,   2013

AB       MUTUAL PHARM            2.5MG                         A075896   001    Nov   02,   2004

AB                               5MG                           A075896   002    Nov   02,   2004

AB                               10MG                          A075896   003    Nov   02,   2004

AB       MYLAN                   2.5MG                         A078855   001    Apr   17,   2008

AB                               5MG                           A078855   002    Apr   17,   2008

AB    +                          10MG                          A078855   003    Apr   17,   2008

AB       RANBAXY LABS LTD        2.5MG                         A091200   001    Dec   13,   2013

AB                               5MG                           A091200   002    Dec   13,   2013

AB                               10MG                          A091200   003    Dec   13,   2013

AB       TORRENT PHARMS LTD      2.5MG                         A202170   001    Nov   28,   2011

AB                               5MG                           A202170   002    Nov   28,   2011

AB                               10MG                          A202170   003    Nov   28,   2011

AB       VINTAGE PHARMS LLC      2.5MG                         A200815   001    Oct   28,   2011

AB                               5MG                           A200815   002    Oct   28,   2011

AB                               10MG                          A200815   003    Oct   28,   2011

    PLENDIL
	
AB       ASTRAZENECA             2.5MG                         N019834 004 Sep 22, 1994

AB                               5MG                           N019834 001 Jul 25, 1991

AB                               10MG                          N019834 002 Jul 25, 1991
	
FENOFIBRATE
	
  CAPSULE;ORAL

    ANTARA (MICRONIZED)

AB       LUPIN ATLANTIS         43MG                           N021695 001 Nov 30, 2004

AB    +                         130MG                          N021695 003 Nov 30, 2004

    FENOFIBRATE
	
AB       RANBAXY LABS LTD       43MG                           A201748 001 Oct 31, 2014

AB                              130MG                          A201748 002 Oct 31, 2014

    FENOFIBRATE (MICRONIZED)

AB       APOTEX INC             43MG                           A202252   001    Jul   26,   2013

AB                              130MG                          A202252   002    Jul   26,   2013

AB       DR REDDYS LABS SA      43MG                           A090859   001    Mar   01,   2012

AB                              130MG                          A090859   002    Mar   01,   2012

AB       IMPAX LABS             67MG                           A075868   001    Oct   27,   2003

AB                              134MG                          A075868   002    Oct   27,   2003

AB                              200MG                          A075868   003    Oct   27,   2003

AB       MYLAN PHARMS INC       43MG                           A202579   001    Jan   10,   2013

AB                              67MG                           A202676   001    Oct   23,   2012

AB                              130MG                          A202579   002    Jan   10,   2013

AB                              134MG                          A202676   002    Oct   23,   2012

AB                              200MG                          A202676   003    Oct   23,   2012

AB       TEVA                   67MG                           A075753   001    Sep   03,   2002
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                       3-149(of 371)


FENOFIBRATE
	
  CAPSULE;ORAL

    FENOFIBRATE (MICRONIZED)

AB                               134MG                             A075753 002 Apr 09, 2002

AB    +                          200MG                             A075753 003 Apr 09, 2002

    ANTARA (MICRONIZED)

         LUPIN ATLANTIS          30MG                              N021695 004 Oct 18, 2013
	
                                 90MG                              N021695 005 Oct 18, 2013
	
    LIPOFEN
	
          CIPHER PHARMS INC      50MG                              N021612 001 Jan 11, 2006
	
      +                          150MG                             N021612 003 Jan 11, 2006
	
  TABLET;ORAL

    FENOFIBRATE
	
AB        IMPAX LABS             54MG                              A076509   001    Mar   26,   2008

AB                               160MG                             A076509   002    Mar   26,   2008

AB        LUPIN LTD              48MG                              A090856   001    Dec   23,   2011

AB                               145MG                             A090856   002    Dec   23,   2011

AB        MYLAN                  54MG                              A076520   001    Oct   25,   2007

AB                               160MG                             A076520   003    Oct   25,   2007

AB        MYLAN PHARMS INC       48MG                              A202856   001    Dec   07,   2012

AB                               145MG                             A202856   002    Dec   07,   2012

AB        RANBAXY                54MG                              A076635   001    Oct   31,   2005

AB                               160MG                             A076635   003    Oct   31,   2005

AB        TEVA                   54MG                              A076433   001    May   13,   2005

AB    +                          160MG                             A076433   002    May   13,   2005

AB        VALEANT INTL           48MG                              A090715   001    Apr   05,   2012

AB                               145MG                             A090715   002    Apr   05,   2012

    TRICOR
	
AB        ABBVIE                 48MG                              N021656 001 Nov 05, 2004

AB    +                          145MG                             N021656 002 Nov 05, 2004
	
    TRIGLIDE
	
BX    + SKYEPHARMA AG            160MG                             N021350 002 May 07, 2005

    FENOFIBRATE
	
          RANBAXY                107MG                             A076635 002 Oct 31, 2005
	
    FENOGLIDE
	
          SANTARUS INC           40MG                              N022118 001 Aug 10, 2007

      +		                        120MG                             N022118 002 Aug 10, 2007
	
FENOFIBRIC ACID
	
  TABLET;ORAL
	
    FIBRICOR
	
          MUTUAL PHARM CO INC    35MG		                            N022418 001 Aug 14, 2009

      +		                        105MG                             N022418 002 Aug 14, 2009
	
FENOLDOPAM MESYLATE
	
  INJECTABLE;INJECTION

    CORLOPAM
	
AP    + HOSPIRA                  EQ 10MG BASE/ML                   N019922 001 Sep 23, 1997

    FENOLDOPAM MESYLATE
	
AP       EUROHLTH INTL           EQ 10MG BASE/ML                   A076582 001 Oct 12, 2004

AP       SANDOZ                  EQ 10MG BASE/ML                   A077155 001 Feb 15, 2005
	
FENOPROFEN CALCIUM
	
  CAPSULE;ORAL
	
    NALFON
	
      +		 XSPIRE                 EQ 200MG BASE                     N017604 003
	
                                 EQ 400MG BASE                     N017604 004 Jul 21, 2009
	
 TABLET;ORAL
	
   FENOPROFEN CALCIUM
	
     + MYLAN PHARMS INC		        EQ 600MG BASE                     A072267 001 Aug 17, 1988
	
FENTANYL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    DURAGESIC-100
	
AB        JANSSEN PHARMS        100MCG/HR                          N019813 001 Aug 07, 1990

    DURAGESIC-12
	
AB        JANSSEN PHARMS        12.5MCG/HR                         N019813 005 Feb 04, 2005

    DURAGESIC-25
	
AB    + JANSSEN PHARMS          25MCG/HR                           N019813 004 Aug 07, 1990

    DURAGESIC-50
	
AB        JANSSEN PHARMS        50MCG/HR                           N019813 003 Aug 07, 1990

    DURAGESIC-75
	
AB        JANSSEN PHARMS        75MCG/HR                           N019813 002 Aug 07, 1990
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-150(of 371)


FENTANYL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    FENTANYL-100
AB        AVEVA                 100MCG/HR
                      A077449   004    Oct   20,   2008

AB        LAVIPHARM LABS        100MCG/HR
                      A077051   004    Aug   04,   2006

AB        MALLINCKRODT INC      100MCG/HR
                      A077154   004    Feb   09,   2011

AB        MYLAN TECHNOLOGIES    100MCG/HR
                      A076258   004    Jan   28,   2005

AB        PAR PHARM INC         100MCG/HR
                      A077062   004    Aug   20,   2007

AB        WATSON LABS           100MCG/HR
	                     A076709   004    Aug   20,   2007
	
    FENTANYL-12
AB        MYLAN TECHNOLOGIES    12.5MCG/HR
	                    A076258 005 Jan 23, 2007
	
    FENTANYL-25
AB        AVEVA                 25MCG/HR
                       A077449   001    Oct   20,   2008

AB        LAVIPHARM LABS        25MCG/HR
                       A077051   001    Aug   04,   2006

AB        MALLINCKRODT INC      25MCG/HR
                       A077154   001    Feb   09,   2011

AB        MYLAN TECHNOLOGIES    25MCG/HR
                       A076258   001    Jan   28,   2005

AB        PAR PHARM INC         25MCG/HR
                       A077062   001    Aug   20,   2007

AB        WATSON LABS           25MCG/HR
	                      A076709   001    Aug   20,   2007
	
    FENTANYL-50
AB        AVEVA                 50MCG/HR
                       A077449   002    Oct   20,   2008

AB        LAVIPHARM LABS        50MCG/HR
                       A077051   002    Aug   04,   2006

AB        MALLINCKRODT INC      50MCG/HR
                       A077154   002    Feb   09,   2011

AB        MYLAN TECHNOLOGIES    50MCG/HR
                       A076258   002    Jan   28,   2005

AB        PAR PHARM INC         50MCG/HR
                       A077062   002    Aug   20,   2007

AB        WATSON LABS           50MCG/HR
	                      A076709   002    Aug   20,   2007
	
    FENTANYL-75
AB        AVEVA                 75MCG/HR
                       A077449   003    Oct   20,   2008

AB        LAVIPHARM LABS        75MCG/HR
                       A077051   003    Aug   04,   2006

AB        MALLINCKRODT INC      75MCG/HR
                       A077154   003    Feb   09,   2011

AB        MYLAN TECHNOLOGIES    75MCG/HR
                       A076258   003    Jan   28,   2005

AB        PAR PHARM INC         75MCG/HR
                       A077062   003    Aug   20,   2007

AB        WATSON LABS           75MCG/HR
	                      A076709   003    Aug   20,   2007
	
    FENTANYL-37
          MYLAN TECHNOLOGIES    37.5MCG/HR
	                    A076258 006 Dec 29, 2014
	
    FENTANYL-62
          MYLAN TECHNOLOGIES    62.5MCG/HR
	                    A076258 007 Dec 29, 2014
	
    FENTANYL-87
          MYLAN TECHNOLOGIES    87.5MCG/HR
	                    A076258 008 Dec 29, 2014
	
  SPRAY;SUBLINGUAL
	
    SUBSYS
	
          INSYS THERAP
	        0.1MG
	                         N202788   001    Jan   04,   2012
	
                                0.2MG
	                         N202788   002    Jan   04,   2012
	
      +
	                       0.4MG
	                         N202788   003    Jan   04,   2012
	
                                0.6MG
	                         N202788   004    Jan   04,   2012
	
                                0.8MG
	                         N202788   005    Jan   04,   2012
	
                                1.2MG
	                         N202788   006    Aug   30,   2012

                                1.6MG
	                         N202788   007    Aug   30,   2012
	
FENTANYL CITRATE
	
  INJECTABLE;INJECTION

    FENTANYL CITRATE
	
AP        HOSPIRA
	               EQ 0.05MG BASE/ML
	           N019115 001 Jan 12, 1985
	
    FENTANYL CITRATE PRESERVATIVE FREE
	
AP    + HIKMA MAPLE
	             EQ 0.05MG BASE/ML
            N019101 001 Jul 11, 1984

AP        HOSPIRA
	               EQ 0.05MG BASE/ML
	           A072786 001 Sep 24, 1991
	
    SUBLIMAZE PRESERVATIVE FREE
	
AP    + AKORN
	                   EQ 0.05MG BASE/ML
	           N016619 001
	
  SPRAY, METERED;NASAL
	
    LAZANDA
	
          DEPOMED INC
	           EQ 0.1MG BASE
	               N022569 001 Jun 30, 2011
	
      +
	                         EQ 0.4MG BASE
	               N022569 002 Jun 30, 2011
	
  TABLET;BUCCAL, SUBLINGUAL
	
    FENTORA
	
          CEPHALON
	              EQ 0.1MG BASE
	               N021947   001    Sep   25,   2006

                                  EQ 0.2MG BASE
	               N021947   002    Sep   25,   2006

      +
	                         EQ 0.4MG BASE
	               N021947   003    Sep   25,   2006

                                  EQ 0.6MG BASE
	               N021947   004    Sep   25,   2006

                                  EQ 0.8MG BASE
	               N021947   005    Sep   25,   2006
	
  TABLET;SUBLINGUAL
	
    ABSTRAL
	
          GALENA BIOPHARMA
	      EQ 0.1MG BASE
	               N022510 001 Jan 07, 2011
	
                                  EQ 0.2MG BASE
	               N022510 002 Jan 07, 2011
	
                                  EQ 0.3MG BASE
	               N022510 003 Jan 07, 2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                                3-151(of 371)


FENTANYL CITRATE
	
  TABLET;SUBLINGUAL
	
    ABSTRAL
	
      +
	                           EQ 0.4MG BASE
	                          N022510 004 Jan 07, 2011
	
                                    EQ 0.6MG BASE
	                          N022510 005 Jan 07, 2011
	
                                    EQ 0.8MG BASE
	                          N022510 006 Jan 07, 2011
	
  TROCHE/LOZENGE;TRANSMUCOSAL

     ACTIQ

AB         CEPHALON
	               EQ   0.2MG   BASE
                       N020747   001    Nov   04,   1998

AB     +
	                          EQ   0.4MG   BASE
                       N020747   002    Nov   04,   1998

AB
	                                EQ   0.6MG   BASE
                       N020747   003    Nov   04,   1998

AB
	                                EQ   0.8MG   BASE
                       N020747   004    Nov   04,   1998

AB
	                                EQ   1.2MG   BASE
                       N020747   005    Nov   04,   1998

AB
	                                EQ   1.6MG   BASE
	                      N020747   006    Nov   04,   1998
	
     FENTANYL CITRATE
	
AB         MALLINCKRODT
	           EQ   0.2MG   BASE
                       A078907   001    Oct   30,   2009

AB
	                                EQ   0.4MG   BASE
                       A078907   002    Oct   30,   2009

AB
	                                EQ   0.6MG   BASE
                       A078907   003    Oct   30,   2009

AB
	                                EQ   0.8MG   BASE
                       A078907   004    Oct   30,   2009

AB
	                                EQ   1.2MG   BASE
                       A078907   005    Oct   30,   2009

AB
	                                EQ   1.6MG   BASE
                       A078907   006    Oct   30,   2009

AB         PAR PHARM
	              EQ   0.2MG   BASE
                       A077312   001    Oct   30,   2009

AB
	                                EQ   0.4MG   BASE
                       A077312   002    Oct   30,   2009

AB
	                                EQ   0.6MG   BASE
                       A077312   003    Oct   30,   2009

AB
	                                EQ   0.8MG   BASE
                       A077312   004    Oct   30,   2009

AB
	                                EQ   1.2MG   BASE
                       A077312   005    Oct   30,   2009

AB
	                                EQ   1.6MG   BASE
	                      A077312   006    Oct   30,   2009
	
FERRIC CARBOXYMALTOSE
	
  INJECTABLE;INTRAVENOUS
	
    INJECTAFER
	
      + LUITPOLD
	                  750MG IRON/15ML (50MG IRON/ML)
	         N203565 001 Jul 25, 2013
	
FERRIC CITRATE
	
  TABLET;ORAL
	
    FERRIC CITRATE
	
      + KERYX BIOPHARMS
	           EQ 210MG IRON
	                          N205874 001 Sep 05, 2014
	
FERRIC HEXACYANOFERRATE(II)

  CAPSULE;ORAL
	
    RADIOGARDASE (PRUSSIAN BLUE)

      + HEYL CHEMISCH
	         500MG
	                                      N021626 001 Oct 02, 2003
	
FERUMOXYTOL
	
  SOLUTION;INTRAVENOUS
	
    FERAHEME
	
      + AMAG PHARMS INC
	           EQ 510MG IRON/17ML (EQ 30MG IRON/ML)
	   N022180 001 Jun 30, 2009
	
FESOTERODINE FUMARATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TOVIAZ
	
          PFIZER
	               4MG
	                                       N022030 001 Oct 31, 2008
	
      +
	                        8MG
	                                       N022030 002 Oct 31, 2008
	
FEXOFENADINE HYDROCHLORIDE
	
  SUSPENSION;ORAL

     ALLEGRA
AB     + SANOFI AVENTIS US          30MG/5ML
	                               N021963 001 Oct 16, 2006
	
     FEXOFENADINE HYDROCHLORIDE
AB        ACTAVIS MID ATLANTIC      30MG/5ML
	                               A201311 001 Jul 25, 2012
	
  TABLET;ORAL

     FEXOFENADINE HYDROCHLORIDE
	
AB        BARR
	                    30MG
	                                   A076191   001    Aug   31,   2005

AB
	                                60MG
	                                   A076191   002    Aug   31,   2005

AB
	                                180MG
	                                  A076191   003    Aug   31,   2005

AB        DR REDDYS LABS LTD
	      30MG
	                                   A076502   001    Apr   11,   2006

AB
	                                60MG
	                                   A076502   002    Apr   11,   2006

AB
	                                180MG
	                                  A076502   003    Apr   11,   2006

AB        MYLAN
	                   30MG
	                                   A077081   002    Apr   11,   2008

AB
	                                60MG
	                                   A077081   003    Apr   11,   2008

AB
	                                180MG
	                                  A077081   001    Apr   16,   2007

AB        TEVA
	                    30MG
	                                   A076447   001    Sep   01,   2005

AB
	                                60MG
	                                   A076447   002    Sep   01,   2005

AB
	                                180MG
	                                  A076447   003    Sep   01,   2005
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                         3-152(of 371)


FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
AB       BARR
	                  60MG;120MG
                         A076236 001 Apr 14, 2005

AB       IMPAX PHARMS
	          60MG;120MG
	                        A076298 001 Nov 12, 2010
	
FIDAXOMICIN
	
  TABLET;ORAL
	
    DIFICID
	
      + CUBIST PHARMS
	            200MG
	                           N201699 001 May 27, 2011
	
FINAFLOXACIN
	
  SUSPENSION/DROPS;OTIC

    XTORO
	
      + ALCON RES LTD
	            0.3%
	                            N206307 001 Dec 17, 2014
	
FINASTERIDE
	
  TABLET;ORAL

     FINASTERIDE
	
AB        ACCORD HLTHCARE
	        5MG
	                             A090121   001    Feb   23,   2010

AB        ACCORD HLTHCARE INC
	    1MG
	                             A091643   001    Nov   05,   2013

AB        ACTAVIS TOTOWA
	         1MG
	                             A078371   001    Nov   05,   2013

AB
	                               5MG
	                             A077914   001    Mar   28,   2007

AB        AUROBINDO PHARMA
	       5MG
	                             A078341   001    Oct   30,   2007

AB        AUROBINDO PHARMA LTD
	   1MG
	                             A203687   001    Nov   05,   2013

AB        CIPLA LTD
	              1MG
	                             A077335   001    Nov   20,   2014

AB        DR REDDYS LABS INC
	     1MG
	                             A076436   001    Jul   28,   2006

AB        DR REDDYS LABS LTD
	     5MG
	                             A076437   001    Feb   28,   2007

AB        GEDEON RICHTER USA
	     5MG
	                             A077251   001    Dec   22,   2006

AB        HETERO LABS LTD III
	    1MG
	                             A090060   001    Jul   01,   2013

AB
	                               5MG
	                             A090061   001    Jun   07,   2010

AB        MYLAN
	                  5MG
	                             A077578   001    Dec   18,   2006

AB        MYLAN PHARMS INC
	       1MG
	                             A078161   001    Nov   05,   2013

AB        SUN PHARMA GLOBAL
	      1MG
	                             A090508   001    Jul   01,   2013

AB
	                               5MG
	                             A090507   001    Aug   16,   2011

AB        TEVA
	                   1MG
	                             A076905   001    Nov   05,   2013

AB
	                               5MG
	                             A076511   001    Dec   15,   2006

AB        ZYDUS PHARMS USA INC
	   5MG
	                             A078900   001    Dec   28,   2009
	
     PROPECIA
	
AB     + MERCK
	                   1MG
	                             N020788 001 Dec 19, 1997
	
     PROSCAR
	
AB     + MERCK
	                   5MG
	                             N020180 001 Jun 19, 1992
	
FINGOLIMOD
	
  CAPSULE;ORAL
	
    GILENYA
	
      + NOVARTIS
	                 0.5MG
	                           N022527 001 Sep 21, 2010
	
FLAVOXATE HYDROCHLORIDE
	
  TABLET;ORAL

    FLAVOXATE HYDROCHLORIDE
	
AB       EPIC PHARMA               100MG
	                           A076835 001 Nov 30, 2005

AB       IMPAX PHARMS              100MG
	                           A076234 001 Aug 28, 2003

AB    + PADDOCK LLC                100MG
	                           A076831 001 Dec 16, 2004
	
FLECAINIDE ACETATE
	
  TABLET;ORAL

     FLECAINIDE ACETATE
	
AB         AMNEAL PHARM
	          50MG
	                            A075442   001    Jul   31,   2001

AB
	                               100MG
	                           A075442   002    Jul   31,   2001

AB
	                               150MG
	                           A075442   003    Jul   31,   2001

AB         BARR
	                  50MG
	                            A075882   001    Oct   28,   2002

AB
	                               100MG
	                           A075882   002    Oct   28,   2002

AB
	                               150MG
	                           A075882   003    Oct   28,   2002

AB         RANBAXY
	               50MG
	                            A076421   001    Mar   28,   2003

AB
	                               100MG
	                           A076421   002    Mar   28,   2003

AB
	                               150MG
	                           A076421   003    Mar   28,   2003

AB         ROXANE
	                50MG
	                            A076278   001    Jan   14,   2003

AB
	                               100MG
	                           A076278   002    Jan   14,   2003

AB     +
	                         150MG
	                           A076278   003    Jan   14,   2003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                        3-153(of 371)


FLORBETABEN F-18
	
  SOLUTION;INTRAVENOUS
	
    NEURACEQ
	
      + PIRAMAL IMAGING         30ML (1.4-135mCi/ML)             N204677 001 Mar 19, 2014
	
FLORBETAPIR F-18
	
  SOLUTION;INTRAVENOUS
	
    AMYVID
	
      + AVID RADIOPHARMS INC    10ML (13.5-51mCi/ML)             N202008 001 Apr 06, 2012

      +                         10-30ML (13.5-51mCi/ML)          N202008 002 Apr 06, 2012

      +                         10-50ML (13.5-51mCi/ML)          N202008 003 Apr 06, 2012
	
FLOXURIDINE
	
  INJECTABLE;INJECTION

    FLOXURIDINE
	
AP    + EUROHLTH INTL           500MG/VIAL                       A075387 001 Apr 16, 2000

AP       FRESENIUS KABI USA     500MG/VIAL                       A075837 001 Feb 22, 2001
	
FLUCONAZOLE
	
  FOR SUSPENSION;ORAL

    DIFLUCAN
	
AB       PFIZER                 50MG/5ML                         N020090 001 Dec 23, 1993

AB    +                         200MG/5ML                        N020090 002 Dec 23, 1993

    FLUCONAZOLE
	
AB       AUROBINDO PHARM        50MG/5ML                         A079150   001    Sep   18,   2009

AB                              200MG/5ML                        A079150   002    Sep   18,   2009

AB       IVAX SUB TEVA PHARMS   50MG/5ML                         A077523   001    Sep   12,   2007

AB                              200MG/5ML                        A077523   002    Sep   12,   2007

AB       RANBAXY                50MG/5ML                         A076332   001    Jul   29,   2004

AB                              200MG/5ML                        A076332   002    Jul   29,   2004

AB       ROXANE                 50MG/5ML                         A076246   001    Jul   29,   2004

AB                              200MG/5ML                        A076246   002    Jul   29,   2004
	
  INJECTABLE;INJECTION

    DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + PFIZER                  200MG/100ML (2MG/ML)             N019950 003 Sep 29, 1992

AP    +                         400MG/200ML (2MG/ML)             N019950 005 Jul 08, 1994

    DIFLUCAN IN SODIUM CHLORIDE 0.9%
	
AP    + PFIZER                  200MG/100ML (2MG/ML)             N019950 001 Jan 29, 1990

AP    +                         400MG/200ML (2MG/ML)             N019950 006 Jan 29, 1990

    DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP    + PFIZER                  200MG/100ML (2MG/ML)             N019950 002 Jan 29, 1990

AP    +                         400MG/200ML (2MG/ML)             N019950 004 Jan 29, 1990

    FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP       ACS DOBFAR INFO SA     200MG/100ML (2MG/ML)             A079104 001 Jul 30, 2009

AP                              400MG/200ML (2MG/ML)             A079104 002 Jul 30, 2009

    FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       CLARIS LIFESCIENCES    200MG/100ML (2MG/ML)             A077988   001    May   26,   2010

AP                              400MG/200ML (2MG/ML)             A077988   002    May   26,   2010

AP       HIKMA FARMACEUTICA     200MG/100ML (2MG/ML)             A078764   001    Jan   30,   2012

AP                              400MG/200ML (2MG/ML)             A078764   002    Jan   30,   2012

AP       HOSPIRA                200MG/100ML (2MG/ML)             A076304   001    Jul   29,   2004

AP                              400MG/200ML (2MG/ML)             A076304   002    Jul   29,   2004

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
	
AP       BEDFORD                200MG/100ML (2MG/ML)             A076087   001    Jul   29,   2004

AP                              400MG/200ML (2MG/ML)             A076087   003    Jul   29,   2004

AP       CLARIS LIFESCIENCES    200MG/100ML (2MG/ML)             A077947   001    May   26,   2010

AP                              400MG/200ML (2MG/ML)             A077947   002    May   26,   2010

AP       FRESENIUS KABI USA     200MG/100ML (2MG/ML)             A076145   001    Jul   29,   2004

AP                              400MG/200ML (2MG/ML)             A076145   002    Jul   29,   2004

AP       HIKMA FARMACEUTICA     200MG/100ML (2MG/ML)             A076736   001    Aug   23,   2005

AP       TEVA PHARMS USA        200MG/100ML (2MG/ML)             A076653   001    Jul   29,   2004

AP                              400MG/200ML (2MG/ML)             A076653   002    Jul   29,   2004

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        200MG/100ML (2MG/ML)             A076766   001    Jul   29,   2004

AP                              400MG/200ML (2MG/ML)             A076766   002    Jul   29,   2004

AP       BEDFORD LABS           200MG/100ML (2MG/ML)             A078107   001    Jul   30,   2008

AP                              400MG/200ML (2MG/ML)             A078107   002    Jul   30,   2008

AP       CLARIS LIFESCIENCES    200MG/100ML (2MG/ML)             A077909   001    May   26,   2010

AP                              400MG/200ML (2MG/ML)             A077909   002    May   26,   2010

AP       HIKMA FARMACEUTICA     200MG/100ML (2MG/ML)             A078698   001    Jan   30,   2012

AP                              400MG/200ML (2MG/ML)             A078698   002    Jan   30,   2012

AP       HOSPIRA                200MG/100ML (2MG/ML)             A076303   001    Jul   29,   2004

AP                              400MG/200ML (2MG/ML)             A076303   002    Jul   29,   2004
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-154(of 371)


FLUCONAZOLE
	
  INJECTABLE;INJECTION
	
    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%
	
         BEDFORD                100MG/50ML (2MG/ML)            A076087 002 Sep 26, 2008

  TABLET;ORAL

    DIFLUCAN
	
AB       PFIZER                 50MG                           N019949   001    Jan   29,   1990

AB                              100MG                          N019949   002    Jan   29,   1990

AB                              150MG                          N019949   004    Jun   30,   1994

AB    +                         200MG                          N019949   003    Jan   29,   1990

    FLUCONAZOLE
	
AB       APOTEX                 50MG                           A076665   001    Jul   29,   2004

AB                              100MG                          A076665   002    Jul   29,   2004

AB                              150MG                          A076665   003    Jul   29,   2004

AB                              200MG                          A076665   004    Jul   29,   2004

AB       AUROBINDO PHARMA       50MG                           A077731   001    Oct   07,   2008

AB                              100MG                          A077731   002    Oct   07,   2008

AB                              150MG                          A077731   003    Oct   07,   2008

AB                              200MG                          A077731   004    Oct   07,   2008

AB       DR REDDYS LABS INC     50MG                           A076658   001    Jul   29,   2004

AB                              100MG                          A076658   002    Jul   29,   2004

AB                              150MG                          A076658   003    Jul   29,   2004

AB                              200MG                          A076658   004    Jul   29,   2004

AB       GLENMARK GENERICS      50MG                           A077253   001    Jan   25,   2006

AB                              100MG                          A077253   002    Jan   25,   2006

AB                              150MG                          A077253   003    Jan   25,   2006

AB                              200MG                          A077253   004    Jan   25,   2006

AB       IVAX SUB TEVA PHARMS   50MG                           A076077   001    Jul   29,   2004

AB                              100MG                          A076077   002    Jul   29,   2004

AB                              150MG                          A076077   003    Jul   29,   2004

AB                              200MG                          A076077   004    Jul   29,   2004

AB       MYLAN                  50MG                           A076351   001    Jul   29,   2004

AB                              100MG                          A076351   002    Jul   29,   2004

AB                              150MG                          A076351   003    Jul   29,   2004

AB                              200MG                          A076351   004    Jul   29,   2004

AB       TARO                   50MG                           A076507   001    Jul   29,   2004

AB                              100MG                          A076507   002    Jul   29,   2004

AB                              150MG                          A076507   003    Jul   29,   2004

AB                              200MG                          A076507   004    Jul   29,   2004

AB       TEVA                   50MG                           A074681   001    Jul   29,   2004

AB                              100MG                          A074681   002    Jul   29,   2004

AB                              150MG                          A074681   003    Jul   29,   2004

AB                              200MG                          A074681   004    Jul   29,   2004

AB       UNIQUE PHARM LABS      50MG                           A076957   001    Sep   28,   2005

AB                              100MG                          A076957   002    Sep   28,   2005

AB                              200MG                          A076957   003    Sep   28,   2005
	
FLUCYTOSINE
	
  CAPSULE;ORAL

    ANCOBON
	
AB       VALEANT               250MG                           N017001 001
	
AB    +                        500MG                           N017001 002
	
    FLUCYTOSINE
	
AB       SIGMAPHARM LABS LLC   250MG                           A201566 001 Jun 28, 2011

AB                             500MG                           A201566 002 Jun 28, 2011
	
FLUDARABINE PHOSPHATE
	
  INJECTABLE;INJECTION

    FLUDARABINE PHOSPHATE
	
AP       ACTAVIS TOTOWA        50MG/VIAL                       A078610   001    Feb   11,   2009

AP    + FRESENIUS KABI USA     50MG/2ML (25MG/ML)              A078393   001    Oct   15,   2007

AP                             50MG/VIAL                       A078544   001    Oct   15,   2007

AP    + HOSPIRA                50MG/VIAL                       A077790   001    Apr   06,   2007

AP       MUSTAFA NEVZAT ILAC   50MG/2ML (25MG/ML)              A090724   001    Sep   27,   2010

AP       ONCO THERAPIES LTD    50MG/2ML (25MG/ML)              A200647   001    Dec   21,   2011

AP                             50MG/VIAL                       A200648   001    Oct   16,   2012

AP    + SANDOZ                 50MG/2ML (25MG/ML)              N022137   001    Sep   21,   2007

AP       TEVA PHARMS USA       50MG/VIAL                       A076349   001    Aug   28,   2003

AP                             50MG/2ML (25MG/ML)              A076661   001    Apr   28,   2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-155(of 371)


FLUDEOXYGLUCOSE F-18
	
  INJECTABLE;INTRAVENOUS

    FLUDEOXYGLUCOSE F18
	
AP        BRIGHAM WOMENS          20-300mCi/ML                  A203816   001    Oct   30,   2014

AP        CHILDRENS HOSP MI       20-300mCi/ML                  A204385   001    Oct   29,   2014

AP        CPDC                    20-300mCi/ML                  A204525   001    Oct   29,   2014

AP        ESSENTIAL ISOTOPES      20-300mCi/ML                  A203946   001    Feb   05,   2014

AP    + FEINSTEIN                 20-200mCi/ML                  N021870   001    Aug   19,   2005

AP    +                           20-400mCi/ML                  N021870   002    Nov   21,   2008

AP        GLOBAL ISOTOPES LLC     20-300mCi/ML                  A204463   001    Oct   21,   2014

AP    + HOUSTON CYCLOTRON         20-500mCi/ML                  A203665   001    Feb   14,   2013

AP        LANTHEUS MEDICAL        20-200mCi/ML                  A203664   001    Feb   04,   2014

AP        MA GENERAL HOSP         20-300mCi/ML                  A204333   001    Sep   25,   2014

AP        MCPRF                   20-240mCi/ML                  A203612   001    Aug   05,   2013

AP        NCM USA BRONX LLC       20-300mCi/ML                  A204512   001    Jan   07,   2015

AP        PETNET                  20-200mCi/ML                  A079086   001    Feb   25,   2011

AP        SHERTECH LABS LLC       20-300mCi/ML                  A204264   001    Dec   18,   2014

AP        TRUSTEES UNIV PA        20-200mCi/ML                  A203801   001    Oct   29,   2014

AP        UCSF RODIOPHARM         20-300mCi/ML                  A203902   001    May   09,   2014

AP        UIHC PET IMAGING        20-300mCi/ML                  A203990   001    Aug   06,   2014

AP        UNIV TX MD ANDERSON     20-300mCi/ML                  A203246   002    Jan   13,   2014

AP        WI MEDCL CYCLOTRON      20-500mCi/ML                  A203709   001    Oct   23,   2013

AP        WUSM CYCLOTRON          20-300mCi/ML                  A203935   001    Feb   05,   2014
	
          HOT SHOTS NM LLC        4-500mCi/ML                   A203937   001    Oct   30,   2014
	
      +		 UCLA BIOMEDICAL         4-40mCi/ML                    A203811   001    Jun   27,   2013
	
          UNIV TX MD ANDERSON     20-150mCi/ML                  A203246   001    Jan   13,   2014
	
FLUDROCORTISONE ACETATE
	
  TABLET;ORAL

    FLUDROCORTISONE ACETATE
	
AB       BARR                     0.1MG                         A040425 001 Jan 21, 2003

AB       HIKMA PHARMS             0.1MG                         A091302 001 Jul 22, 2011

AB    + IMPAX LABS                0.1MG                         A040431 001 Mar 18, 2002
	
FLUMAZENIL
	
  INJECTABLE;INJECTION

    FLUMAZENIL
	
AP       AGILA SPECLTS            0.5MG/5ML (0.1MG/ML)          A078595   001    May   13,   2008

AP    +                           1MG/10ML (0.1MG/ML)           A078595   002    May   13,   2008

AP       BEDFORD LABS             0.5MG/5ML (0.1MG/ML)          A076256   002    Oct   12,   2004

AP                                1MG/10ML (0.1MG/ML)           A076256   001    Oct   12,   2004

AP       FRESENIUS KABI USA       0.5MG/5ML (0.1MG/ML)          A076955   002    Oct   12,   2004

AP                                1MG/10ML (0.1MG/ML)           A076955   001    Oct   12,   2004

AP       HIKMA FARMACEUTICA       0.5MG/5ML (0.1MG/ML)          A078527   001    Mar   23,   2009

AP                                1MG/10ML (0.1MG/ML)           A078527   002    Mar   23,   2009

AP       HIKMA MAPLE              0.5MG/5ML (0.1MG/ML)          A076787   002    Oct   12,   2004

AP                                1MG/10ML (0.1MG/ML)           A076787   001    Oct   12,   2004

AP       SAGENT PHARMS            0.5MG/5ML (0.1MG/ML)          A090584   001    Aug   28,   2012

AP                                1MG/10ML (0.1MG/ML)           A090584   002    Aug   28,   2012

AP       SANDOZ                   0.5MG/5ML (0.1MG/ML)          A077071   001    May   03,   2005

AP                                1MG/10ML (0.1MG/ML)           A077071   002    May   03,   2005
	
FLUNISOLIDE
	
  AEROSOL, METERED;INHALATION
	
    AEROSPAN HFA
	
      + MEDA PHARMS INC           0.078MG/INH                   N021247 001 Jan 27, 2006
	
  SPRAY, METERED;NASAL

    FLUNISOLIDE
	
AB    + BAUSCH AND LOMB           0.025MG/SPRAY                 A074805 001 Feb 20, 2002

AB       HI TECH PHARMA CO        0.025MG/SPRAY                 A077704 001 Aug 03, 2006

      + APOTEX INC                0.029MG/SPRAY                 A077436 001 Aug 09, 2007
	
FLUOCINOLONE ACETONIDE
	
  CREAM;TOPICAL

    FLUOCINOLONE ACETONIDE
	
AT       FOUGERA                  0.01%                         A088170   001    Dec   16,   1982

AT                                0.025%                        A088169   001    Dec   16,   1982

AT       G AND W LABS             0.01%                         A089526   001    Jul   26,   1988

AT                                0.025%                        A089525   001    Jul   26,   1988

AT       TARO                     0.025%                        A087104   001    Apr   27,   1982

    SYNALAR
	
AT    + MEDIMETRIKS PHARMS        0.01%                         N012787 004
	
AT    +                           0.025%                        N012787 002
	
AT    +                           0.025%                        N012787 005
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-156(of 371)


FLUOCINOLONE ACETONIDE
	
  IMPLANT;INTRAVITREAL
	
    ILUVIEN
	
      + ALIMERA SCIENCES INC    0.19MG                         N201923 001 Sep 26, 2014

    RETISERT
	
      + BAUSCH AND LOMB         0.59MG                         N021737 001 Apr 08, 2005

  OIL;TOPICAL

    DERMA-SMOOTHE/FS

AT    + HILL DERMAC             0.01%                          N019452 001 Feb 03, 1988

AT    +                         0.01%                          N019452 002 Nov 09, 2005

    FLUOCINOLONE ACETONIDE
	
AT       IDENTI PHARMS INC      0.01%                          A201759   001    Oct   17,   2011

AT                              0.01%                          A201764   001    Oct   17,   2011

AT       PERRIGO ISRAEL         0.01%                          A202847   001    Aug   09,   2013

AT                              0.01%                          A202848   001    Aug   09,   2013

  OIL/DROPS;OTIC

    DERMOTIC
	
AT    + HILL DERMAC             0.01%                          N019452 003 Nov 09, 2005

    FLUOCINOLONE ACETONIDE
	
AT       IDENTI PHARMS INC      0.01%                          A091306 001 Oct 17, 2011
	
  OINTMENT;TOPICAL

    FLUOCINOLONE ACETONIDE
	
AT       FOUGERA                0.025%                         A088168 001 Dec 16, 1982

AT       G AND W LABS           0.025%                         A089524 001 Jul 26, 1988

AT       TARO                   0.025%                         A040041 001 Sep 15, 1994

    SYNALAR
	
AT    + MEDIMETRIKS PHARMS      0.025%                         N013960 001
	
  SHAMPOO;TOPICAL
	
    CAPEX
	
      + GALDERMA LABS LP        0.01%                          N020001 001 Aug 27, 1990

  SOLUTION;TOPICAL

    FLUOCINOLONE ACETONIDE
	
AT       FOUGERA                0.01%                          A088167 001 Dec 16, 1982

AT       TARO                   0.01%                          A089124 001 Sep 11, 1985

    SYNALAR
	
AT    + MEDIMETRIKS PHARMS      0.01%                          N015296 001
	
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN
	
  CREAM;TOPICAL
	
    TRI-LUMA
	
      + GALDERMA LABS LP        0.01%;4%;0.05%                 N021112 001 Jan 18, 2002
	
FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE
	
  CREAM;TOPICAL
	
    NEO-SYNALAR
	
      + MEDIMETRIKS PHARMS      0.025%;EQ 3.5MG BASE/GM        A060700 001
	
FLUOCINONIDE
	
  CREAM;TOPICAL

    FLUOCINONIDE
	
AB       FOUGERA PHARMS INC     0.1%                           A200735   001    Jul   14,   2014

AB       GLENMARK GENERICS      0.1%                           A091282   001    Jul   14,   2014

AB       PERRIGO ISRAEL         0.1%                           A090256   001    Jan   14,   2014

AB       TARO                   0.1%                           A200734   001    Jul   14,   2014

    VANOS
	
AB    + MEDICIS                 0.1%                           N021758 001 Feb 11, 2005

    FLUOCINONIDE
	
AB1      FOUGERA                0.05%                          A073030   001    Oct   17,   1994

AB1      G AND W LABS INC       0.05%                          A073085   001    Feb   14,   1992

AB1 + TARO                      0.05%                          N019117   001    Jun   26,   1984

AB1      TEVA                   0.05%                          A072488   001    Feb   06,   1989

    FLUOCINONIDE EMULSIFIED BASE
	
AB2      FOUGERA PHARMS         0.05%                          A076586 001 Jun 23, 2004

AB2 + TARO                      0.05%                          A072494 001 Jan 19, 1989

AB2      TEVA                   0.05%                          A072490 001 Feb 07, 1989
	
  GEL;TOPICAL
    FLUOCINONIDE
AB       FOUGERA                0.05%                          A072933 001 Dec 30, 1994
AB    + TARO                    0.05%                          A074935 001 Jul 29, 1997
AB       TEVA                   0.05%                          A072537 001 Feb 07, 1989
  OINTMENT;TOPICAL
    FLUOCINONIDE
AB       FOUGERA PHARMS         0.05%                          A074905 001 Aug 26, 1997
AB    + TARO                    0.05%                          A075008 001 Jun 30, 1999
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                              3-157(of 371)


FLUOCINONIDE
	
  OINTMENT;TOPICAL

    FLUOCINONIDE
	
AB       TEVA                    0.05%                                  A073481 001 Dec 27, 1991
	
  SOLUTION;TOPICAL

    FLUOCINONIDE
	
AT       FOUGERA                 0.05%                                  A072934   001    Feb   27,   1995

AT       G AND W LABS INC        0.05%                                  A071535   001    Dec   02,   1988

AT    + TARO                     0.05%                                  A074799   001    Dec   31,   1996

AT       TEVA                    0.05%                                  A072511   001    Feb   07,   1989

    LIDEX
	
AT       CNTY LINE PHARMS        0.05%                                  N018849 001 Apr 06, 1984
	
FLUORESCEIN SODIUM
	
  INJECTABLE;INTRAVENOUS

    AK-FLUOR 10%
	
AP       AKORN                   EQ 500MG BASE/5ML (EQ 100MG BASE/ML)   N022186 001 Aug 08, 2008

    FLUORESCITE
	
AP    + ALCON PHARMS LTD         EQ 500MG BASE/5ML (EQ 100MG BASE/ML)   N021980 001 Mar 28, 2006
	
    AK-FLUOR 25%
	
      + AKORN                    EQ 500MG BASE/2ML (EQ 250MG BASE/ML)   N022186 002 Aug 08, 2008
	
FLUOROMETHOLONE
	
  OINTMENT;OPHTHALMIC
	
    FML
	
      + ALLERGAN                 0.1%                                   N017760 001 Sep 04, 1985

  SUSPENSION/DROPS;OPHTHALMIC

    FML
	
      + ALLERGAN                 0.1%                                   N016851 002 Jul 28, 1982
	
    FML FORTE
	
          ALLERGAN               0.25%                                  N019216 001 Apr 23, 1986
	
FLUOROMETHOLONE ACETATE
	
  SUSPENSION/DROPS;OPHTHALMIC

    FLAREX
	
      + ALCON                    0.1%                                   N019079 001 Feb 11, 1986
	
FLUOROURACIL
	
  CREAM;TOPICAL

    EFUDEX
	
AB    + VALEANT PHARM INTL       5%                                     N016831 003
	
    FLUOROURACIL
	
AB       SPEAR PHARMS            5%                                     A077524 001 Apr 11, 2008

AB       TARO                    5%                                     A090368 001 Mar 05, 2010
	
    CARAC
	
      + VALEANT BERMUDA          0.5%                                   N020985 001 Oct 27, 2000
	
    FLUOROPLEX
	
      + AQUA PHARMS              1%                                     N016988 001
	
  INJECTABLE;INJECTION

    FLUOROURACIL
	
AP    + ACCORD HLTHCARE          1GM/20ML (50MG/ML)                     A040743   001    Apr   26,   2007

AP    +                          2.5GM/50ML (50MG/ML)                   A040798   002    Apr   26,   2007

AP    +                          5GM/100ML (50MG/ML)                    A040798   001    Apr   26,   2007

AP    +                          500MG/10ML (50MG/ML)                   A040743   002    Apr   26,   2007

AP    + FRESENIUS KABI USA       1GM/20ML (50MG/ML)                     A040279   001    Sep   30,   1998

AP    +                          2.5GM/50ML (50MG/ML)                   A040278   001    Sep   30,   1998

AP    +                          5GM/100ML (50MG/ML)                    A040278   002    Sep   30,   1998

AP    +                          500MG/10ML (50MG/ML)                   A040279   002    Sep   30,   1998

AP       ONCO THERAPIES LTD      1GM/20ML (50MG/ML)                     A202668   002    Jul   17,   2012

AP                               2.5GM/50ML (50MG/ML)                   A202669   001    Jul   17,   2012

AP                               5GM/100ML (50MG/ML)                    A202669   002    Jul   17,   2012

AP                               500MG/10ML (50MG/ML)                   A202668   001    Jul   17,   2012

AP       SANDOZ                  2.5GM/50ML (50MG/ML)                   A091299   001    May   02,   2011

AP                               5GM/100ML (50MG/ML)                    A091299   002    May   02,   2011

AP    + TEVA PHARMS USA          2.5GM/50ML (50MG/ML)                   A040334   001    Feb   25,   2000

AP    +                          5GM/100ML (50MG/ML)                    A040334   002    Feb   25,   2000

AP    +                          500MG/10ML (50MG/ML)                   A040333   001    Jan   27,   2000
	
  SOLUTION;TOPICAL

    EFUDEX
	
AT    + VALEANT PHARM INTL       2%                                     N016831 001
	
AT    +                          5%                                     N016831 002
	
    FLUOROURACIL
	
AT       TARO                    2%                                     A076526 001 Nov 05, 2003

AT                               5%                                     A076526 002 Nov 05, 2003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST
	                     3-158(of 371)


FLUOXETINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    FLUOXETINE HYDROCHLORIDE
AB       ALEMBIC PHARMS LTD     EQ 40MG   BASE
                A090223   003    Mar   19,   2009

AB       AUROBINDO PHARMA       EQ 40MG   BASE
                A078619   003    Jan   31,   2008

AB       DR REDDYS LABS LTD     EQ 40MG   BASE
                A075465   003    Aug   02,   2001

AB       HERITAGE PHARMS INC    EQ 40MG   BASE
                A201336   003    Oct   01,   2012

AB       IVAX SUB TEVA PHARMS   EQ 40MG   BASE
                A075245   003    Sep   28,   2004

AB       MYLAN                  EQ 40MG   BASE
                A075207   003    May   25,   2007

AB       PAR PHARM              EQ 40MG   BASE
                A076922   003    Dec   16,   2004

AB       RANBAXY                EQ 40MG   BASE
                A076990   001    Dec   13,   2004

AB       SANDOZ                 EQ 40MG   BASE
                A075049   003    Jan   29,   2002

AB       TEVA                   EQ 40MG   BASE
	               A075452   003    Jan   29,   2002
	
    PROZAC
AB    + ELI LILLY AND CO        EQ 40MG   BASE
	               N018936 003 Jun 15, 1999
	
    FLUOXETINE HYDROCHLORIDE
AB1      ALEMBIC PHARMS LTD     EQ 10MG   BASE
                A090223   001    Mar   19,   2009

AB1                             EQ 20MG   BASE
                A090223   002    Mar   19,   2009

AB1      AUROBINDO PHARMA       EQ 10MG   BASE
                A078619   001    Jan   31,   2008

AB1                             EQ 20MG   BASE
                A078619   002    Jan   31,   2008

AB1      BARR                   EQ 10MG   BASE
                A074803   002    Jan   30,   2002

AB1                             EQ 20MG   BASE
                A074803   001    Aug   02,   2001

AB1      DR REDDYS LABS LTD     EQ 10MG   BASE
                A075465   001    Jan   29,   2002

AB1                             EQ 20MG   BASE
                A075465   002    Jan   29,   2002

AB1      HERITAGE PHARMS INC    EQ 10MG   BASE
                A201336   001    Oct   01,   2012

AB1                             EQ 20MG   BASE
                A201336   002    Oct   01,   2012

AB1      IVAX SUB TEVA PHARMS   EQ 10MG   BASE
                A075245   002    Jan   31,   2002

AB1                             EQ 20MG   BASE
                A075245   001    Jan   31,   2002

AB1      LANDELA PHARM          EQ 10MG   BASE
                A075464   001    Jan   30,   2002

AB1                             EQ 20MG   BASE
                A075464   002    Jan   30,   2002

AB1      MALLINCKRODT           EQ 10MG   BASE
                A075658   001    Jan   29,   2002

AB1                             EQ 20MG   BASE
                A075658   002    Jan   29,   2002

AB1      MYLAN                  EQ 10MG   BASE
                A075207   001    Jan   30,   2002

AB1                             EQ 20MG   BASE
                A075207   002    Jan   30,   2002

AB1      MYLAN PHARMS INC       EQ 10MG   BASE
                A075577   001    Jan   29,   2002

AB1                             EQ 20MG   BASE
                A075577   002    Jan   29,   2002

AB1      SANDOZ                 EQ 10MG   BASE
                A075049   001    Aug   02,   2001

AB1                             EQ 20MG   BASE
                A075049   002    Jan   29,   2002

AB1      TEVA                   EQ 10MG   BASE
                A075452   001    Jan   29,   2002

AB1                             EQ 20MG   BASE
                A075452   002    Jan   29,   2002

AB1      TEVA PHARMS USA        EQ 10MG   BASE
                A076001   001    Jan   29,   2002

AB1                             EQ 20MG   BASE
	               A076001   002    Jan   29,   2002
	
    PROZAC
AB1      ELI LILLY AND CO       EQ 10MG   BASE
                N018936 006 Dec 23, 1992

AB1                             EQ 20MG   BASE
	               N018936 001 Dec 29, 1987
	
    FLUOXETINE HYDROCHLORIDE
AB2      ANI PHARMS INC         EQ 10MG   BASE
                A076287   001    May   20,   2008

AB2                             EQ 20MG   BASE
                A076287   002    May   20,   2008

AB2      MYLAN                  EQ 10MG   BASE
                A078045   001    Nov   17,   2008

AB2                             EQ 20MG   BASE
                A078045   002    Nov   17,   2008

AB2      SANDOZ                 EQ 10MG   BASE
                A077469   001    Nov   17,   2008

AB2                             EQ 20MG   BASE
	               A077469   002    Nov   17,   2008
	
    SARAFEM
AB2      ELI LILLY AND CO       EQ 10MG   BASE
                N018936 007 Jul 06, 2000

AB2 +                           EQ 20MG   BASE
	               N018936 008 Jul 06, 2000
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    FLUOXETINE HYDROCHLORIDE
	
AB       BARR
	                 EQ 90MG   BASE
                A076237 001 Mar 24, 2010

AB       DR REDDYS LABS LTD
	   EQ 90MG   BASE
	               A078572 001 Mar 22, 2010
	
    PROZAC WEEKLY
	
AB    + LILLY
	                 EQ 90MG   BASE
	               N021235 001 Feb 26, 2001
	
  SOLUTION;ORAL

    FLUOXETINE HYDROCHLORIDE
	
AA       AUROBINDO PHARM        EQ 20MG   BASE/5ML
            A079209   001    Mar   20,   2009

AA       LANNETT                EQ 20MG   BASE/5ML
            A076458   001    May   14,   2004

AA       MALLINCKRODT           EQ 20MG   BASE/5ML
            A075920   001    Jan   29,   2002

AA    + PHARM ASSOC             EQ 20MG   BASE/5ML
            A076015   001    Jan   30,   2002

AA       SILARX                 EQ 20MG   BASE/5ML
            A077849   001    Feb   09,   2007

AA       TEVA                   EQ 20MG   BASE/5ML
            A075506   001    Aug   02,   2001

AA       WOCKHARDT              EQ 20MG   BASE/5ML
	           A075514   001    Aug   29,   2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                       3-159(of 371)


FLUOXETINE HYDROCHLORIDE
	
  TABLET;ORAL

     FLUOXETINE HYDROCHLORIDE
	
AB        DR REDDYS LABS INC
	      EQ 10MG BASE
                  A076006 001 Jan 30, 2002

AB        MYLAN
	                   EQ 10MG BASE
                  A075755 001 Aug 02, 2001

AB        TEVA
	                    EQ 10MG BASE
	                 A075872 001 Jan 29, 2002
	
     SARAFEM
	
AB1       WARNER CHILCOTT LLC
	     EQ 10MG BASE
                  N021860 001 May 19, 2006

AB1
	                               EQ 15MG BASE
                  N021860 002 May 19, 2006

AB1 +
	                             EQ 20MG BASE
	                 N021860 003 May 19, 2006
	
     SELFEMRA
	
AB1       TEVA PHARMS USA
	         EQ 10MG BASE
                  A200151 001 Feb 03, 2014

AB1
	                               EQ 15MG BASE
                  A200151 002 Feb 03, 2014

AB1
	                               EQ 20MG BASE
	                 A200151 003 Feb 03, 2014
	
     FLUOXETINE HYDROCHLORIDE
	
          EDGEMONT PHARMS LLC
	     EQ 60MG BASE
	                 N202133 001 Oct 06, 2011
	
       + MYLAN
	                    EQ 20MG BASE
	                 A075755 002 Aug 02, 2001
	
FLUOXETINE HYDROCHLORIDE; OLANZAPINE
	
  CAPSULE;ORAL

     OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
	
AB         PAR PHARM
	           EQ 25MG BASE;EQ     3MG BASE
     A077742   001    Nov   02,   2012

AB
	                             EQ 25MG BASE;EQ     6MG BASE
     A077742   002    Nov   02,   2012

AB
	                             EQ 25MG BASE;EQ     12MG BASE
    A077742   003    Nov   02,   2012

AB
	                             EQ 50MG BASE;EQ     6MG BASE
     A077742   004    Nov   02,   2012

AB
	                             EQ 50MG BASE;EQ     12MG BASE
    A077742   005    Nov   02,   2012

AB         SANDOZ
	              EQ 25MG BASE;EQ     3MG BASE
     A078901   005    Nov   16,   2012

AB
	                             EQ 25MG BASE;EQ     6MG BASE
     A078901   001    Nov   16,   2012

AB
	                             EQ 25MG BASE;EQ     12MG BASE
    A078901   003    Nov   16,   2012

AB
	                             EQ 50MG BASE;EQ     6MG BASE
     A078901   002    Nov   16,   2012

AB
	                             EQ 50MG BASE;EQ     12MG BASE
    A078901   004    Nov   16,   2012

AB         TEVA PHARMS
	         EQ 25MG BASE;EQ     3MG BASE
     A202074   001    Mar   25,   2013

AB
	                             EQ 25MG BASE;EQ     6MG BASE
     A077528   001    Jun   19,   2012

AB
	                             EQ 25MG BASE;EQ     12MG BASE
    A077528   002    Jun   19,   2012

AB
	                             EQ 50MG BASE;EQ     6MG BASE
     A077528   003    Jun   19,   2012

AB
	                             EQ 50MG BASE;EQ     12MG BASE
	   A077528   004    Jun   19,   2012
	
     SYMBYAX
	
AB         LILLY
	               EQ 25MG BASE;EQ     3MG BASE
     N021520   001    Apr   09,   2007

AB
	                             EQ 25MG BASE;EQ     6MG BASE
     N021520   002    Dec   24,   2003

AB
	                             EQ 25MG BASE;EQ     12MG BASE
    N021520   004    Dec   24,   2003

AB     +
	                       EQ 50MG BASE;EQ     6MG BASE
     N021520   003    Dec   24,   2003

AB
	                             EQ 50MG BASE;EQ     12MG BASE
	   N021520   005    Dec   24,   2003
	
FLUOXYMESTERONE
	
  TABLET;ORAL
	
    FLUOXYMESTERONE
	
      + USL PHARMA
	                10MG
	                         A088342 001 Oct 21, 1983
	
FLUPHENAZINE DECANOATE
	
  INJECTABLE;INJECTION

    FLUPHENAZINE DECANOATE
	
AO       EUROHLTH INTL              25MG/ML
                       A074531 001 Aug 30, 1996

AO    + FRESENIUS KABI USA          25MG/ML
                       A071413 001 Jul 14, 1987

AO       PAR STERILE PRODUCTS       25MG/ML
	                      A203732 001 Jul 03, 2014
	
FLUPHENAZINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
     FLUPHENAZINE HYDROCHLORIDE
	
       + PHARM ASSOC
	              5MG/ML
	                       A074725 001 Sep 16, 1996
	
  ELIXIR;ORAL
	
     FLUPHENAZINE HYDROCHLORIDE
	
       + PHARM ASSOC
	              2.5MG/5ML
	                    A040146 001 Aug 21, 1996
	
  INJECTABLE;INJECTION
	
     FLUPHENAZINE HYDROCHLORIDE
	
       + FRESENIUS KABI USA
	       2.5MG/ML
	                     A089556 001 Apr 16, 1987
	
  TABLET;ORAL

     FLUPHENAZINE HYDROCHLORIDE
	
AB        LANNETT
	                 1MG
	                          A089740   001    Aug   25,   1988

AB
	                                2.5MG
	                        A089741   001    Aug   25,   1988

AB
	                                5MG
	                          A089742   001    Aug   25,   1988

AB
	                                10MG
	                         A089743   001    Aug   25,   1988

AB        MYLAN
	                   1MG
	                          A089804   002    Aug   12,   1988

AB
	                                2.5MG
	                        A089804   003    Aug   12,   1988

AB
	                                5MG
	                          A089804   004    Aug   12,   1988
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                     3-160(of 371)


FLUPHENAZINE HYDROCHLORIDE
	
  TABLET;ORAL

     FLUPHENAZINE HYDROCHLORIDE
	
AB     +
	                          10MG
	                         A089804   001    Aug   12,   1988

AB         SANDOZ
	                 1MG
	                          A089583   001    Oct   16,   1987

AB
	                                2.5MG
	                        A089584   001    Oct   16,   1987

AB
	                                5MG
	                          A089585   001    Oct   16,   1987

AB
	                                10MG
	                         A089586   001    Oct   16,   1987
	
FLURANDRENOLIDE
	
  CREAM;TOPICAL
	
    CORDRAN SP
	
      + AQUA PHARMS
	               0.025%
	                       N012806 003
	
      +
	                           0.05%
	                        N012806 002
	
  LOTION;TOPICAL
	
    CORDRAN
	
      + AQUA PHARMS
	               0.05%
	                        N013790 001
	
  TAPE;TOPICAL
	
    CORDRAN
	
      + WATSON LABS INC
	           0.004MG/SQ CM
	                N016455 001
	
FLURAZEPAM HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    FLURAZEPAM HYDROCHLORIDE
	
          MYLAN PHARMS INC
	        15MG
	                         A070345 002 Nov 27, 1985
	
      +
	                           30MG
	                         A070345 001 Nov 27, 1985
	
FLURBIPROFEN
	
  TABLET;ORAL

     ANSAID
	
AB         PHARMACIA AND UPJOHN
	   50MG
	                         N018766 002 Oct 31, 1988

AB     +
	                          100MG
	                        N018766 003 Oct 31, 1988
	
     FLURBIPROFEN
	
AB         MYLAN
	                  50MG
	                         A074358   001    Jun   20,   1994

AB
	                                100MG
	                        A074358   002    Jun   20,   1994

AB         SUN PHARM INDS INC
	     50MG
	                         A075058   001    Apr   27,   2001

AB
	                                100MG
	                        A075058   002    Apr   27,   2001

AB         TEVA
	                   100MG
	                        A074431   001    May   31,   1995
	
FLURBIPROFEN SODIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    FLURBIPROFEN SODIUM
	
AT       BAUSCH AND LOMB
	          0.03%
	                        A074447 001 Jan 04, 1995
	
    OCUFEN
	
AT    + ALLERGAN
	                  0.03%
	                        N019404 001 Dec 31, 1986
	
FLUTAMIDE
	
  CAPSULE;ORAL

    FLUTAMIDE
	
AB       ACTAVIS LABS FL INC        125MG
	                        A075820   001    Sep   18,   2001

AB    + IVAX SUB TEVA PHARMS        125MG
	                        A075780   001    Sep   19,   2001

AB       MYLAN                      125MG
	                        A076224   001    May   09,   2003

AB       PAR PHARM                  125MG
	                        A075298   001    Sep   18,   2001
	
FLUTEMETAMOL F-18
	
  INJECTABLE;INTRAVENOUS
	
    VIZAMYL
	
      + GE HEALTHCARE
	             40.5mCi/10ML (4.05mCi/ML)
     N203137 001 Oct 25, 2013
	
      +
	                           121.5mCi/30ML (4.05mCi/ML)
	   N203137 002 Oct 25, 2013
	
FLUTICASONE FUROATE
	
  POWDER;INHALATION
	
    ARNUITY ELLIPTA
	
          GLAXOSMITHKLINE
	         0.1MG/INH
                     N205625 001 Aug 20, 2014

      +
	                           0.2MG/INH
	                    N205625 002 Aug 20, 2014
	
  SPRAY, METERED;NASAL
	
    VERAMYST
	
      + GLAXOSMITHKLINE
	           0.0275MG/INH
	                 N022051 001 Apr 27, 2007
	
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
	
  POWDER;INHALATION
	
    BREO ELLIPTA
	
      + GLAXO GRP LTD           0.1MG/INH;EQ 0.025MG BASE/INH      N204275 001 May 10, 2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                         3-161(of 371)


FLUTICASONE PROPIONATE
	
  AEROSOL, METERED;INHALATION
	
    FLOVENT HFA
	
      + GLAXO GRP LTD             0.044MG/INH                     N021433 003 May 14, 2004

      +                           0.11MG/INH                      N021433 002 May 14, 2004

      +                           0.22MG/INH                      N021433 001 May 14, 2004

  CREAM;TOPICAL

    FLUTICASONE PROPIONATE
	
AB       FOUGERA PHARMS           0.05%                           A076451   001    May   14,   2004

AB       G AND W LABS             0.05%                           A077055   001    Jun   30,   2006

AB       PERRIGO NEW YORK         0.05%                           A076793   001    May   14,   2004

AB       TOLMAR                   0.05%                           A076633   001    May   14,   2004

  LOTION;TOPICAL

    CUTIVATE
	
AB    + FOUGERA PHARMS            0.05%                           N021152 001 Mar 31, 2005

    FLUTICASONE PROPIONATE
	
AB       GLENMARK GENERICS        0.05%                           A090759 001 May 02, 2011

AB       PERRIGO ISRAEL           0.05%                           A091553 001 Jul 30, 2013
	
  OINTMENT;TOPICAL

    CUTIVATE
	
AB    + FOUGERA PHARMS            0.005%                          N019957 001 Dec 14, 1990

    FLUTICASONE PROPIONATE
	
AB       FOUGERA PHARMS           0.005%                          A076300 001 May 14, 2004

AB       G AND W LABS             0.005%                          A077168 001 Mar 03, 2006

AB       PERRIGO NEW YORK         0.005%                          A076668 001 May 14, 2004

  POWDER;INHALATION
	
    FLOVENT DISKUS 100
	
      + GLAXO GRP LTD             0.1MG/INH                       N020833 002 Sep 29, 2000

    FLOVENT DISKUS 250
	
      + GLAXO GRP LTD             0.25MG/INH                      N020833 003 Sep 29, 2000

    FLOVENT DISKUS 50
	
      + GLAXO GRP LTD             0.05MG/INH                      N020833 001 Sep 29, 2000

  SPRAY, METERED;NASAL

    FLONASE
	
AB    + GLAXOSMITHKLINE           0.05MG/SPRAY                    N020121 001 Oct 19, 1994

    FLUTICASONE PROPIONATE
	
AB       APOTEX INC               0.05MG/SPRAY                    A077538   001    Sep   12,   2007

AB       HI TECH PHARMA           0.05MG/SPRAY                    A077570   001    Jan   16,   2008

AB       ROXANE                   0.05MG/SPRAY                    A076504   001    Feb   22,   2006

AB       WOCKHARDT                0.05MG/SPRAY                    A078492   001    Jan   09,   2012
	
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
	
  AEROSOL, METERED;INHALATION
	
    ADVAIR HFA
	
      + GLAXO GRP LTD           0.045MG/INH;EQ 0.021MG BASE/INH   N021254 001 Jun 08, 2006
	
      +                         0.115MG/INH;EQ 0.021MG BASE/INH   N021254 002 Jun 08, 2006
	
      +                         0.23MG/INH;EQ 0.021MG BASE/INH    N021254 003 Jun 08, 2006
	
  POWDER;INHALATION
	
    ADVAIR DISKUS 100/50

      + GLAXO GRP LTD           0.1MG/INH;EQ 0.05MG BASE/INH      N021077 001 Aug 24, 2000

    ADVAIR DISKUS 250/50

      + GLAXO GRP LTD           0.25MG/INH;EQ 0.05MG BASE/INH     N021077 002 Aug 24, 2000

    ADVAIR DISKUS 500/50

      + GLAXO GRP LTD           0.5MG/INH;EQ 0.05MG BASE/INH      N021077 003 Aug 24, 2000
	
FLUVASTATIN SODIUM
	
  CAPSULE;ORAL

    FLUVASTATIN SODIUM
	
AB       MYLAN PHARMS INC        EQ 20MG   BASE                   A090595   001    Apr   11,   2012

AB                               EQ 40MG   BASE                   A090595   002    Apr   11,   2012

AB       TEVA PHARMS             EQ 20MG   BASE                   A078407   001    Jun   12,   2012

AB                               EQ 40MG   BASE                   A078407   002    Jun   12,   2012

    LESCOL
	
AB       NOVARTIS                EQ 20MG   BASE                   N020261 001 Dec 31, 1993

AB    +                          EQ 40MG   BASE                   N020261 002 Dec 31, 1993
	
  TABLET, EXTENDED RELEASE;ORAL
	
    LESCOL XL
	
      + NOVARTIS                 80MG                             N021192 001 Oct 06, 2000
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-162(of 371)


FLUVOXAMINE MALEATE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    FLUVOXAMINE MALEATE
	
AB       ACTAVIS ELIZABETH      100MG                           A091482   001     Apr   23,   2013

AB                              150MG                           A091482   002     Nov   18,   2013

AB       ANCHEN PHARMS          100MG                           A091476   001     Mar   13,   2013

AB                              150MG                           A091476   002     Mar   13,   2013

AB       TORRENT PHARMS LTD     100MG                           A203240   001     Oct   31,   2014

AB                              150MG                           A203240   002     Oct   31,   2014

    LUVOX CR
	
AB       JAZZ PHARMS            100MG                           N022033 001 Feb 28, 2008

AB    +                         150MG                           N022033 002 Feb 28, 2008
	
  TABLET;ORAL

    FLUVOXAMINE MALEATE
	
AB       APOTEX                 25MG                            A075902   001     May   07,   2001

AB                              50MG                            A075902   002     May   07,   2001

AB                              100MG                           A075902   003     May   07,   2001

AB       BARR                   25MG                            A075897   001     Jan   25,   2001

AB                              50MG                            A075897   002     Jan   25,   2001

AB                              100MG                           A075897   003     Jan   25,   2001

AB       MYLAN                  25MG                            A075889   001     Nov   29,   2000

AB                              50MG                            A075889   002     Nov   29,   2000

AB                              100MG                           A075889   003     Nov   29,   2000

AB       SANDOZ                 25MG                            A075888   001     Nov   29,   2000

AB                              50MG                            A075888   002     Nov   29,   2000

AB    +                         100MG                           A075888   003     Nov   29,   2000

AB       TEVA                   25MG                            A075893   001     Sep   10,   2002

AB                              50MG                            A075893   002     Sep   10,   2002

AB                              100MG                           A075893   003     Sep   10,   2002

    LUVOX
	
AB       ANI PHARMS             25MG                            N021519 001 Dec 20, 2007

AB                              50MG                            N021519 002 Dec 20, 2007

AB                              100MG                           N021519 003 Dec 20, 2007
	
FOLIC ACID
	
  INJECTABLE;INJECTION
	
    FOLIC ACID
	
      + FRESENIUS KABI USA       5MG/ML                         A089202 001 Feb 18, 1986
	
  TABLET;ORAL

    FOLIC ACID
	
AA    + AMNEAL PHARM             1MG                            A040625   001     Jul 21, 2005

AA       BICON PHARM             1MG                            A091145   001     Jul 12, 2013

AA       CADILA PHARMS LTD       1 MG                           A202437   001     Jan 27, 2014

AA       CONTRACT PHARMACAL      1MG                            A085061   001
	
AA       EXCELLIUM               1MG                            A040796   001     Jan 12, 2009

AA       HIKMA PHARMS LLC        1MG                            A080600   001
	
AA       INVAGEN PHARMS          1MG                            A090035   001     Jun 09, 2009

AA       VINTAGE                 1MG                            A040756   001     Jun 04, 2010

AA    + WATSON LABS              1MG                            A080680   001
	
FOLLITROPIN ALFA/BETA

  INJECTABLE;SUBCUTANEOUS
	
    FOLLISTIM AQ
	
      + ORGANON USA INC          75 IU/0.5ML		                  N021273   001     Aug   26,   2005

      +                          150 IU/0.5ML		                 N021273   002     Aug   26,   2005

      +                          300 IU/0.36ML		                N021211   001     Mar   23,   2004
	
      +                          600 IU/0.72ML		                N021211   002     Mar   23,   2004
	
      +                          900 IU/1.08ML                  N021211   004     Feb   11,   2005
	
    GONAL-F
	
      +		 EMD SERONO             450 IU/VIAL                    N020378 005 Mar 26, 2004
	
                                 1,050 IU/VIAL                  N020378 004 Feb 28, 2001
	
   GONAL-F RFF
	
     + EMD SERONO                75 IU/VIAL                     N021765 002 Mar 25, 2004
	
   GONAL-F RFF REDI-JECT
	
     + EMD SERONO                300 IU/0.5ML		                 N021684 001 May 25, 2004

     +                           450 IU/0.75ML		                N021684 002 May 25, 2004

     +                           900 IU/1.5ML		                 N021684 003 May 25, 2004
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-163(of 371)


FOMEPIZOLE
	
  INJECTABLE;INJECTION

    ANTIZOL
	
AP    + PALADIN LABS
	             1.5GM/1.5ML (1GM/ML)
	        N020696 001 Dec 04, 1997
	
    FOMEPIZOLE
	
AP       LUITPOLD
	                1.5GM/1.5ML (1GM/ML)
         A078368 001 Dec 14, 2007

AP       MYLAN INSTITUTIONAL
	     1.5GM/1.5ML (1GM/ML)
         A078639 001 Mar 03, 2008

AP       NAVINTA LLC
	             1.5GM/1.5ML (1GM/ML)
	        A078537 001 Mar 06, 2008
	
FONDAPARINUX SODIUM
	
  INJECTABLE;SUBCUTANEOUS

     ARIXTRA
	
AP     + MYLAN IRELAND LTD
	       2.5MG/0.5ML
                  N021345   001    Dec   07,   2001

AP     +
	                         5MG/0.4ML
                    N021345   002    May   28,   2004

AP     +
	                         7.5MG/0.6ML
                  N021345   003    May   28,   2004

AP     +
	                         10MG/0.8ML
	                  N021345   004    May   28,   2004
	
     FONDAPARINUX SODIUM
	
AP         DR REDDYS LABS LTD
	    2.5MG/0.5ML
                  A091316   001    Jul   11,   2011

AP
	                               5MG/0.4ML
                    A091316   002    Jul   11,   2011

AP
	                               7.5MG/0.6ML
                  A091316   003    Jul   11,   2011

AP
	                               10MG/0.8ML
	                  A091316   004    Jul   11,   2011
	
FORMOTEROL FUMARATE
	
  POWDER;INHALATION
	
    FORADIL
	
      + NOVARTIS
	                 0.012MG/INH
	                 N020831 001 Feb 16, 2001
	
  SOLUTION;INHALATION
	
    PERFOROMIST
	
      + MYLAN SPECLT
	             0.02MG/2ML
	                  N022007 001 May 11, 2007
	
FORMOTEROL FUMARATE; MOMETASONE FUROATE
	
  AEROSOL, METERED;INHALATION
	
    DULERA
	
      + MERCK SHARP DOHME
	     0.005MG/INH;0.1MG/INH
           N022518 001 Jun 22, 2010
	
      +
	                       0.005MG/INH;0.2MG/INH
	          N022518 002 Jun 22, 2010
	
FOSAMPRENAVIR CALCIUM
	
  SUSPENSION;ORAL
	
    LEXIVA
	
      + VIIV HLTHCARE
	            EQ 50MG BASE/ML
	             N022116 001 Jun 14, 2007
	
  TABLET;ORAL
	
    LEXIVA
	
      + VIIV HLTHCARE
	            EQ 700MG BASE
	               N021548 001 Oct 20, 2003
	
FOSAPREPITANT DIMEGLUMINE
	
  POWDER;INTRAVENOUS
	
    EMEND
	
      + MERCK AND CO INC
	         EQ 150MG BASE/VIAL
	          N022023 002 Nov 12, 2010
	
FOSCARNET SODIUM
	
  INJECTABLE;INJECTION

    FOSCARNET SODIUM
AP       HOSPIRA                   2.4GM/100ML
	                 A077174 001 May 31, 2005
	
    FOSCAVIR
AP    + CLINIGEN HLTHCARE          2.4GM/100ML
	                 N020068 001 Sep 27, 1991
	
FOSFOMYCIN TROMETHAMINE
	
  FOR SUSPENSION;ORAL
	
    MONUROL
	
      + ZAMBON SPA
	               EQ 3GM BASE/PACKET
	          N050717 001 Dec 19, 1996
	
FOSINOPRIL SODIUM
	
  TABLET;ORAL

     FOSINOPRIL SODIUM
	
AB        ACTAVIS LABS FL INC
	    10MG
	                        A076620   001    Oct   15,   2004

AB
	                               20MG
	                        A076620   002    Oct   15,   2004

AB
	                               40MG
	                        A076620   003    Oct   15,   2004

AB        APOTEX INC
	             10MG
	                        A076906   001    May   17,   2005

AB
	                               20MG
	                        A076906   002    May   17,   2005

AB
	                               40MG
	                        A076906   003    May   17,   2005

AB        AUROBINDO PHARMA LTD
	   10MG
	                        A091163   001    Mar   30,   2011

AB
	                               20MG
	                        A091163   002    Mar   30,   2011

AB
	                               40MG
	                        A091163   003    Mar   30,   2011

AB        INVAGEN PHARMS
	         10MG
	                        A077222   001    Apr   20,   2005

AB
	                               20MG
	                        A077222   002    Apr   20,   2005

AB
	                               40MG
	                        A077222   003    Apr   20,   2005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                          3-164(of 371)


FOSINOPRIL SODIUM
  TABLET;ORAL
    FOSINOPRIL SODIUM
AB       SANDOZ                   10MG                              A076483   001    Apr   23,   2004

AB                                20MG                              A076483   002    Apr   23,   2004

AB                                40MG                              A076483   003    Apr   23,   2004

AB       TEVA                     10MG                              A076139   001    Nov   25,   2003

AB                                20MG                              A076139   002    Nov   25,   2003

AB    +                           40MG                              A076139   003    Nov   25,   2003
	
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
	
AB       ACTAVIS LABS FL INC    10MG;12.5MG
                        A076608   001    Dec   03,   2004

AB                              20MG;12.5MG
                        A076608   002    Dec   03,   2004

AB       AUROBINDO PHARMA       10MG;12.5MG
                        A079245   001    Jul   09,   2009

AB                              20MG;12.5MG
                        A079245   002    Jul   09,   2009

AB       EMCURE PHARMS INDIA    10MG;12.5MG
                        A079025   001    Sep   17,   2010

AB    +                         20MG;12.5MG
                        A079025   002    Sep   17,   2010

AB       INVAGEN PHARMS         10MG;12.5MG
                        A090228   001    Jul   09,   2009

AB                              20MG;12.5MG
                        A090228   002    Jul   09,   2009

AB       RANBAXY                10MG;12.5MG
                        A076739   001    Dec   17,   2004

AB                              20MG;12.5MG
                        A076739   002    Dec   17,   2004

AB       SANDOZ                 10MG;12.5MG
                        A076961   001    Sep   28,   2005

AB                              20MG;12.5MG
	                       A076961   002    Sep   28,   2005
	
FOSPHENYTOIN SODIUM
	
  INJECTABLE;INJECTION

     CEREBYX
	
AP        PARKE DAVIS
	           EQ 50MG PHENYTOIN NA/ML
	         N020450 001 Aug 05, 1996
	
     FOSPHENYTOIN SODIUM
	
AP        AGILA SPECLTS
	         EQ   50MG   PHENYTOIN   NA/ML
    A078736   001    Jun   08,   2010

AP        AMNEAL PHARMS CO
	      EQ   50MG   PHENYTOIN   NA/ML
    A078476   001    Mar   18,   2008

AP        BEDFORD
	               EQ   50MG   PHENYTOIN   NA/ML
    A077481   001    Aug   06,   2007

AP     + FRESENIUS KABI USA
	     EQ   50MG   PHENYTOIN   NA/ML
    A078052   001    Aug   06,   2007

AP        HIKMA FARMACEUTICA
	    EQ   50MG   PHENYTOIN   NA/ML
    A078765   001    Dec   02,   2009

AP        HIKMA MAPLE
	           EQ   50MG   PHENYTOIN   NA/ML
    A077989   001    Aug   06,   2007

AP        HOSPIRA
	               EQ   50MG   PHENYTOIN   NA/ML
    A078158   001    Aug   06,   2007

AP        LUITPOLD
	              EQ   50MG   PHENYTOIN   NA/ML
    A078277   001    Aug   06,   2007

AP
	                              EQ   50MG   PHENYTOIN   NA/ML
    A090099   001    May   13,   2010

AP        SUN PHARMA GLOBAL
	     EQ   50MG   PHENYTOIN   NA/ML
    A078417   001    Mar   18,   2008

AP        WOCKHARDT
	             EQ   50MG   PHENYTOIN   NA/ML
	   A078137   001    Aug   06,   2007
	
FROVATRIPTAN SUCCINATE
	
  TABLET;ORAL

    FROVA
	
AB    + ENDO PHARMS
	             EQ 2.5MG BASE
	                   N021006 001 Nov 08, 2001
	
    FROVATRIPTAN SUCCINATE
	
AB       MYLAN PHARMS INC
	       EQ 2.5MG BASE
	                   A202931 001 Aug 28, 2014
	
FULVESTRANT
	
  INJECTABLE;INTRAMUSCULAR
	
    FASLODEX
	
      + ASTRAZENECA
	             50MG/ML
	                         N021344 001 Apr 25, 2002
	
FUROSEMIDE
	
  INJECTABLE;INJECTION

     FUROSEMIDE
	
AP        CLARIS LIFESCIENCES
	   10MG/ML
                          A202747   001    Jan   27,   2014

AP        EMCURE PHARMS LTD
	     10MG/ML
                          A203428   001    Aug   26,   2014

AP        FRESENIUS KABI USA
	    10MG/ML
                          N018902   001    May   22,   1984

AP        HOSPIRA
	               10MG/ML
                          A075241   001    May   28,   1999

AP
	                              10MG/ML
                          N018667   001    May   28,   1982

AP     + LUITPOLD
	               10MG/ML
                          N018579   001    Nov   30,   1983

AP        WOCKHARDT
	             10MG/ML
	                         A077941   001    Mar   22,   2007
	
  SOLUTION;ORAL

     FUROSEMIDE
	
AA     + ROXANE
	                 10MG/ML
                          A070434 001 Apr 22, 1987

AA        WOCKHARDT
	             10MG/ML
                          A070655 001 Oct 02, 1987
	
          ROXANE
	                40MG/5ML
	                        A070433 001 Apr 22, 1987
	
  TABLET;ORAL

     FUROSEMIDE
	
AB        EXCELLIUM
	             20MG
	                            A077293 001 Nov 09, 2005

AB
	                              40MG
	                            A077293 002 Nov 09, 2005

AB
	                              80MG
	                            A077293 003 Nov 09, 2005
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-165(of 371)


FUROSEMIDE
	
  TABLET;ORAL

    FUROSEMIDE
	
AB       IPCA LABS LTD          20MG                           A078010   001     Sep   18,   2006

AB                              40MG                           A078010   002     Sep   18,   2006

AB                              80MG                           A078010   003     Sep   18,   2006

AB       IVAX SUB TEVA PHARMS   20MG                           N018413   001     Nov   30,   1983

AB                              40MG                           N018413   002     Nov   30,   1983

AB       MYLAN                  20MG                           N018487   001
	
AB                              40MG                           N018487   002
	
AB                              80MG                           A070082   001     Oct   29,   1986

AB       ROXANE                 20MG                           N018823   001     Nov   10,   1983

AB                              40MG                           N018823   002     Nov   10,   1983

AB                              80MG                           A070086   001     Jan   24,   1986

AB       SANDOZ                 20MG                           N018569   002
	
AB                              40MG                           N018569   001
	
AB                              80MG                           N018569   005     Aug   14,   1984

AB       SUN PHARM INDS INC     20MG                           A091258   001     Apr   01,   2014

AB                              40MG                           A091258   002     Apr   01,   2014

AB                              80MG                           A091258   003     Apr   01,   2014

AB       VINTAGE PHARMS         20MG                           A076796   001     Mar   26,   2004

AB                              40MG                           A076796   002     Mar   26,   2004

AB                              80MG                           A076796   003     Mar   26,   2004

    LASIX
	
AB       SANOFI AVENTIS US      20MG                           N016273 002
	
AB                              40MG                           N016273 001
	
AB    +                         80MG                           N016273 003
	
GABAPENTIN
	
  CAPSULE;ORAL

    GABAPENTIN
	
AB       ACTAVIS ELIZABETH      100MG                          A075350   001     Sep   12,   2003

AB                              300MG                          A075350   002     Sep   12,   2003

AB                              400MG                          A075350   003     Sep   12,   2003

AB       ALKEM                  100MG                          A090858   001     Dec   17,   2010

AB                              300MG                          A090858   002     Dec   17,   2010

AB                              400MG                          A090858   003     Dec   17,   2010

AB       AMNEAL PHARMS NY       100MG                          A078428   001     Jul   25,   2007

AB                              300MG                          A078428   002     Jul   25,   2007

AB                              400MG                          A078428   003     Jul   25,   2007

AB       APOTEX INC             100MG                          A075360   001     Apr   06,   2005

AB                              300MG                          A075360   002     Apr   06,   2005

AB                              400MG                          A075360   003     Apr   06,   2005

AB       AUROBINDO PHARM        100MG                          A078787   001     Jan   31,   2008

AB                              300MG                          A078787   002     Jan   31,   2008

AB                              400MG                          A078787   003     Jan   31,   2008

AB       HIKMA                  100MG                          A078150   001     Sep   25,   2007

AB                              300MG                          A078150   002     Sep   25,   2007

AB                              400MG                          A078150   003     Sep   25,   2007

AB       INVAGEN PHARMS         100MG                          A090705   001     Dec   30,   2009

AB                              300MG                          A090705   002     Dec   30,   2009

AB                              400MG                          A090705   003     Dec   30,   2009

AB       MARKSANS PHARMA        100MG                          A090007   001     Jul   21,   2011

AB                              300MG                          A090007   002     Jul   21,   2011

AB                              400MG                          A090007   003     Jul   21,   2011

AB       MYLAN                  100MG                          A090158   001     Feb   14,   2011

AB                              300MG                          A090158   002     Feb   14,   2011

AB                              400MG                          A090158   003     Feb   14,   2011

AB       RANBAXY                100MG                          A076606   001     Oct   07,   2005

AB                              300MG                          A076606   002     Oct   07,   2005

AB                              400MG                          A076606   003     Oct   07,   2005

AB       SUN PHARM INDS LTD     100MG                          A077242   001     Aug   24,   2006

AB                              300MG                          A077242   002     Aug   24,   2006

AB                              400MG                          A077242   003     Aug   24,   2006

AB       TARO                   100MG                          A077261   001     Aug   02,   2013

AB                              300MG                          A077261   002     Aug   02,   2013

AB                              400MG                          A077261   003     Aug   02,   2013

AB       TEVA PHARMS            100MG                          A075435   001     Oct   08,   2004

AB                              300MG                          A075435   002     Oct   08,   2004

AB                              400MG                          A075435   003     Oct   08,   2004

    NEURONTIN
	
AB       PFIZER PHARMS          100MG                          N020235 001 Dec 30, 1993

AB                              300MG                          N020235 002 Dec 30, 1993
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-166(of 371)


GABAPENTIN
	
  CAPSULE;ORAL

    NEURONTIN
	
AB    +                         400MG                           N020235 003 Dec 30, 1993
	
  SOLUTION;ORAL

    GABAPENTIN
	
AA       ACELLA PHARMS LLC      250MG/5ML                       A076403   001    May   01,   2012

AA       AMNEAL PHARMS          250MG/5ML                       A202024   001    Mar   23,   2012

AA       HI TECH PHARMA         250MG/5ML                       A078974   001    Feb   18,   2011

AA       TARO                   250MG/5ML                       A076672   001    Jul   03,   2013

    NEURONTIN
	
AA    + PARKE DAVIS             250MG/5ML                       N021129 001 Mar 02, 2000
	
  TABLET;ORAL

    GABAPENTIN
	
AB       ACI HEALTHCARE LTD     600MG                           A203244   002    Jul   12,   2013

AB                              800MG                           A203244   001    Jul   12,   2013

AB       ACTAVIS ELIZABETH      600MG                           A075694   001    Oct   21,   2004

AB                              800MG                           A075694   002    Oct   21,   2004

AB       APOTEX INC             100MG                           A077894   001    Oct   10,   2006

AB                              300MG                           A077894   002    Oct   10,   2006

AB                              400MG                           A077894   003    Oct   10,   2006

AB                              600MG                           A077661   004    Sep   13,   2006

AB                              800MG                           A077661   005    Sep   13,   2006

AB       AUROBINDO PHARMA LTD   600MG                           A200651   001    Oct   06,   2011

AB                              800MG                           A200651   002    Oct   06,   2011

AB       GLENMARK GENERICS      600MG                           A077662   001    Aug   18,   2006

AB                              800MG                           A077662   002    Aug   18,   2006

AB       HIKMA PHARMS           600MG                           A078782   001    Jul   21,   2011

AB                              800MG                           A078782   002    Jul   21,   2011

AB       INVAGEN PHARMS         600MG                           A202764   001    Oct   16,   2012

AB                              800MG                           A202764   002    Oct   16,   2012

AB       IVAX SUB TEVA PHARMS   100MG                           A076017   001    Apr   28,   2004

AB                              300MG                           A076017   002    Apr   28,   2004

AB                              400MG                           A076017   003    Apr   28,   2004

AB                              600MG                           A076017   004    Apr   29,   2005

AB                              800MG                           A076017   005    Apr   29,   2005

AB       MYLAN PHARMS INC       600MG                           A090335   001    Jun   01,   2010

AB                              800MG                           A090335   002    Jun   01,   2010

AB       SUN PHARM INDS LTD     600MG                           A077525   001    Aug   24,   2006

AB                              800MG                           A077525   002    Aug   24,   2006

AB       ZYDUS PHARMS USA INC   600MG                           A078926   001    Feb   11,   2011

AB                              800MG                           A078926   002    Feb   11,   2011

    NEURONTIN
	
AB       PFIZER PHARMS          600MG                           N020882 001 Oct 09, 1998

AB    +                         800MG                           N020882 002 Oct 09, 1998
	
    GRALISE
	
BX    + DEPOMED INC             300MG                           N022544 001 Jan 28, 2011
	
BX    +                         600MG                           N022544 002 Jan 28, 2011
	
GABAPENTIN ENACARBIL
	
  TABLET, EXTENDED RELEASE;ORAL
	
    HORIZANT
	
         XENOPORT INC            300MG                          N022399 002 Dec 13, 2011
	
      +                          600MG                          N022399 001 Apr 06, 2011
	
GADOBENATE DIMEGLUMINE
	
  INJECTABLE;INTRAVENOUS
	
    MULTIHANCE
	
      + BRACCO                  2.645GM/5ML (529MG/ML)          N021357   001    Nov   23,   2004
	
      +                         5.29GM/10ML (529MG/ML)          N021357   002    Nov   23,   2004
	
      +                         7.935GM/15ML (529MG/ML)         N021357   003    Nov   23,   2004
	
      +                         10.58GM/20ML (529MG/ML)         N021357   004    Nov   23,   2004
	
    MULTIHANCE MULTIPACK
	
      + BRACCO                  26.45GM/50ML (529MG/ML)         N021358 001 Nov 23, 2004
	
      +                         52.9GM/100ML (529MG/ML)         N021358 002 Nov 23, 2004
	
GADOBUTROL
	
  SOLUTION;INTRAVENOUS
	
    GADAVIST
	
      + BAYER HLTHCARE          1.20944GM/2ML (604.72MG/ML)     N201277   006    Dec   18,   2013
	
      +                         4.5354GM/7.5ML (604.72MG/ML)    N201277   001    Mar   14,   2011
	
      +                         6.0472GM/10ML (604.72MG/ML)     N201277   002    Mar   14,   2011
	
      +                         9.0708GM/15ML (604.72MG/ML)     N201277   003    Mar   14,   2011
	
      +                         18.1416GM/30ML (604.72MG/ML)    N201277   004    Mar   14,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-167(of 371)


GADOBUTROL
	
  SOLUTION;INTRAVENOUS
	
    GADAVIST
	
      +                          39.3068GM/65ML (604.72MG/ML)   N201277 005 Mar 14, 2011
	
GADODIAMIDE
	
  INJECTABLE;INJECTION
	
    OMNISCAN
	
      + GE HEALTHCARE            28.7GM/100ML (287MG/ML)		      N022066 002 Sep 05, 2007

      +                          287MG/ML		                     N020123 001 Jan 08, 1993
	
GADOFOSVESET TRISODIUM
	
  SOLUTION;INTRAVENOUS
	
    ABLAVAR
	
         LANTHEUS MEDCL          2440MG/10ML (244MG/ML)         N021711 001 Dec 22, 2008
	
      +                          3660MG/15ML (244MG/ML)         N021711 002 Dec 22, 2008
	
GADOPENTETATE DIMEGLUMINE
	
  INJECTABLE;INJECTION
	
    MAGNEVIST
	
      + BAYER HLTHCARE		         469.01MG/ML                    N019596 001 Jun 02, 1988
	
      +                          469.01MG/ML                    N021037 001 Mar 10, 2000
	
GADOTERATE MEGLUMINE
	
  SOLUTION;INTRAVENOUS
	
    DOTAREM
	
      + GUERBET                  3.769GM/10ML (376.9MG/ML)		    N204781   002    Mar   20,   2013
	
      +		                        5.6535GM/15ML (376.9MG/ML)     N204781   003    Mar   20,   2013
	
      +		                        7.538GM/20ML (376.9MG/ML)      N204781   004    Mar   20,   2013
	
      +                          37.69GM/100ML (376.9MG/ML)     N204781   001    Mar   20,   2013
	
GADOTERIDOL
	
  INJECTABLE;INJECTION
	
    PROHANCE
	
      + BRACCO                   279.3MG/ML                     N020131 001 Nov 16, 1992
	
    PROHANCE MULTIPACK
	
      + BRACCO                   279.3MG/ML                     N021489 001 Oct 09, 2003
	
GADOVERSETAMIDE
	
  INJECTABLE;INJECTION
	
    OPTIMARK
	
      + MALLINCKRODT            16.545GM/50ML (330.9MG/ML)		    N020975   001    Dec   08,   1999
	
      +		                       1654.5MG/5ML (330.9MG/ML)       N020937   001    Dec   08,   1999
	
      +		                       3309MG/10ML (330.9MG/ML)        N020937   002    Dec   08,   1999
	
      +		                       4963.5MG/15ML (330.9MG/ML)      N020937   003    Dec   08,   1999
	
      +                         6618MG/20ML (330.9MG/ML)        N020937   004    Dec   08,   1999
	
    OPTIMARK IN PLASTIC CONTAINER
	
      + MALLINCKRODT            3309MG/10ML (330.9MG/ML)		      N020976   002    Dec   08,   1999
	
      +		                       4963.5MG/15ML (330.9MG/ML)      N020976   003    Dec   08,   1999
	
      +		                       6618MG/20ML (330.9MG/ML)        N020976   004    Dec   08,   1999
	
      +                         9927MG/30ML (330.9MG/ML)        N020976   001    Dec   08,   1999
	
GADOXETATE DISODIUM
	
  SOLUTION;INTRAVENOUS
	
    EOVIST
	
      +		 BAYER HLTHCARE         1.8143GM/10ML (181.43MG/ML)    N022090 001 Jul 03, 2008
	
                                 2.72145GM/15ML (181.43MG/ML)   N022090 002 Feb 04, 2013
	
GALANTAMINE HYDROBROMIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    GALANTAMINE HYDROBROMIDE
	
AB       BARR                   EQ   8MG BASE                   A078189   001    Sep   15,   2008

AB                              EQ   16MG BASE                  A078189   002    Sep   15,   2008

AB                              EQ   24MG BASE                  A078189   003    Sep   15,   2008

AB       IMPAX LABS             EQ   8MG BASE                   A078484   001    May   27,   2009

AB                              EQ   16MG BASE                  A078484   002    May   27,   2009

AB                              EQ   24MG BASE                  A078484   003    May   27,   2009

AB       MYLAN                  EQ   8MG BASE                   A090900   001    Jan   24,   2011

AB                              EQ   16MG BASE                  A090900   002    Jan   24,   2011

AB                              EQ   24MG BASE                  A090900   003    Jan   24,   2011

AB       SUN PHARMA GLOBAL      EQ   8MG BASE                   A090178   001    Feb   02,   2011

AB                              EQ   16MG BASE                  A090178   002    Feb   02,   2011

AB                              EQ   24MG BASE                  A090178   003    Feb   02,   2011

AB       WATSON LABS            EQ   8MG BASE                   A079028   001    Dec   15,   2008

AB                              EQ   16MG BASE                  A079028   002    Dec   15,   2008

AB                              EQ   24MG BASE                  A079028   003    Dec   15,   2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-168(of 371)


GALANTAMINE HYDROBROMIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    RAZADYNE ER
	
AB    + JANSSEN PHARMS          EQ 8MG BASE                     N021615 001 Apr 01, 2005

AB                              EQ 16MG BASE                    N021615 002 Apr 01, 2005

AB                              EQ 24MG BASE                    N021615 003 Apr 01, 2005

  SOLUTION;ORAL

    GALANTAMINE HYDROBROMIDE
	
AA       ROXANE                 4MG/ML                          A078185 001 Jan 30, 2009

    RAZADYNE
	
AA    + JANSSEN PHARMS          4MG/ML                          N021224 001 Jun 22, 2001
	
  TABLET;ORAL

    GALANTAMINE HYDROBROMIDE
	
AB       APOTEX INC             EQ 4MG BASE                     A077781   001    Sep   27,   2011

AB                              EQ 8MG BASE                     A077781   002    Sep   27,   2011

AB                              EQ 12MG BASE                    A077781   003    Sep   27,   2011

AB       AUROBINDO PHARMA LTD   EQ 4MG BASE                     A090957   001    Mar   29,   2011

AB                              EQ 8MG BASE                     A090957   002    Mar   29,   2011

AB                              EQ 12MG BASE                    A090957   003    Mar   29,   2011

AB       BARR                   EQ 4MG BASE                     A077605   001    Aug   28,   2008

AB                              EQ 8MG BASE                     A077605   002    Aug   28,   2008

AB                              EQ 12MG BASE                    A077605   003    Aug   28,   2008

AB       DR REDDYS LABS LTD     EQ 4MG BASE                     A077593   001    Sep   11,   2008

AB                              EQ 8MG BASE                     A077593   002    Sep   11,   2008

AB                              EQ 12MG BASE                    A077593   003    Sep   11,   2008

AB       MYLAN                  EQ 4MG BASE                     A077590   001    May   29,   2009

AB                              EQ 4MG BASE                     A077603   001    Aug   28,   2008

AB                              EQ 8MG BASE                     A077590   002    May   29,   2009

AB                              EQ 8MG BASE                     A077603   002    Aug   28,   2008

AB                              EQ 12MG BASE                    A077590   003    May   29,   2009

AB                              EQ 12MG BASE                    A077603   003    Aug   28,   2008

AB       ROXANE                 EQ 4MG BASE                     A077608   001    Feb   11,   2009

AB                              EQ 8MG BASE                     A077608   002    Feb   11,   2009

AB                              EQ 12MG BASE                    A077608   003    Feb   11,   2009

AB       SANDOZ                 EQ 4MG BASE                     A077589   001    Jun   22,   2009

AB                              EQ 8MG BASE                     A077589   002    Jun   22,   2009

AB                              EQ 12MG BASE                    A077589   003    Jun   22,   2009

AB       TEVA PHARMS            EQ 4MG BASE                     A077587   001    Jul   09,   2009

AB                              EQ 8MG BASE                     A077587   002    Jul   09,   2009

AB                              EQ 12MG BASE                    A077587   003    Jul   09,   2009

AB       ZYDUS PHARMS USA INC   EQ 4MG BASE                     A078898   001    Feb   17,   2011

AB                              EQ 8MG BASE                     A078898   002    Feb   17,   2011

AB                              EQ 12MG BASE                    A078898   003    Feb   17,   2011

    RAZADYNE
	
AB    + JANSSEN PHARMS          EQ 4MG BASE                     N021169 001 Feb 28, 2001

AB                              EQ 8MG BASE                     N021169 002 Feb 28, 2001

AB                              EQ 12MG BASE                    N021169 003 Feb 28, 2001
	
GALLIUM CITRATE GA-67
	
  INJECTABLE;INJECTION
	
    GALLIUM CITRATE GA 67
	
BS       LANTHEUS MEDCL          2mCi/ML                        N017478 001
	
BS       MALLINCKRODT            2mCi/ML                        N018058 001
	
GANCICLOVIR
	
  GEL;OPHTHALMIC
	
    ZIRGAN
	
      + BAUSCH AND LOMB          0.15%                          N022211 001 Sep 15, 2009
	
GANCICLOVIR SODIUM
	
  INJECTABLE;INJECTION

    CYTOVENE
	
AP    + ROCHE PALO               EQ 500MG BASE/VIAL             N019661 001 Jun 23, 1989

    GANCICLOVIR
	
AP       FRESENIUS KABI USA      EQ 500MG BASE/VIAL             A090658 001 Jun 21, 2010

AP       LUITPOLD                EQ 500MG BASE/VIAL             A202624 001 Sep 18, 2013
	
GANIRELIX ACETATE
	
  INJECTABLE;INJECTION
	
    GANIRELIX ACETATE
	
      + ORGANON USA INC          EQ 250MCG BASE/0.5ML           N021057 001 Jul 29, 1999
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-169(of 371)


GATIFLOXACIN
	
  SOLUTION/DROPS;OPHTHALMIC

    GATIFLOXACIN
	
AT       HI-TECH PHARMA CO        0.5%                         A203189 001 Sep 03, 2014

AT       LUPIN LTD                0.5%                         A202653 001 Aug 28, 2013

    ZYMAXID
	
AT    + ALLERGAN                  0.5%                         N022548 001 May 18, 2010

    ZYMAR
	
      + ALLERGAN                  0.3%                         N021493 001 Mar 28, 2003
	
GEMCITABINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    GEMCITABINE HYDROCHLORIDE
	
AP       ACCORD HLTHCARE          EQ   1GM BASE/VIAL           A091594   002    Jul   25,   2011

AP                                EQ   2GM BASE/VIAL           A091594   003    Jul   25,   2011

AP                                EQ   200MG BASE/VIAL         A091594   001    Jul   25,   2011

AP       ACTAVIS TOTOWA           EQ   1GM BASE/VIAL           A079160   002    Jul   25,   2011

AP                                EQ   200MG BASE/VIAL         A079160   001    Jul   25,   2011

AP       CIPLA LTD                EQ   1GM BASE/VIAL           A078759   002    Jul   25,   2011

AP                                EQ   200MG BASE/VIAL         A078759   001    Jul   25,   2011

AP       DR REDDYS LABS LTD       EQ   1GM BASE/VIAL           A091365   002    Jul   25,   2011

AP                                EQ   2GM BASE/VIAL           A202997   001    May   07,   2013

AP                                EQ   200MG BASE/VIAL         A091365   001    Jul   25,   2011

AP       EMCURE PHARMS LTD        EQ   1GM BASE/VIAL           A202063   002    Sep   11,   2012

AP                                EQ   200MG BASE/VIAL         A202063   001    Sep   11,   2012

AP       FRESENIUS KABI ONCOL     EQ   1GM BASE/VIAL           A090799   002    Jul   25,   2011

AP                                EQ   2GM BASE/VIAL           A090799   003    May   16,   2011

AP                                EQ   200MG BASE/VIAL         A090799   001    Jul   25,   2011

AP       FRESENIUS KABI USA       EQ   2GM BASE/VIAL           A090242   003    May   16,   2011

AP       HAMELN RDS GMBH          EQ   1GM BASE/VIAL           A090663   002    Sep   10,   2012

AP                                EQ   200MG BASE/VIAL         A090663   001    Sep   10,   2012

AP       HOSPIRA                  EQ   1GM BASE/VIAL           A078339   002    Jul   25,   2011

AP                                EQ   200MG BASE/VIAL         A078339   001    Jul   25,   2011

AP    + HOSPIRA INC               EQ   2GM BASE/VIAL           A079183   001    Nov   15,   2010

AP       JIANGSU HANSOH PHARM     EQ   1GM BASE/VIAL           A202485   002    May   07,   2013

AP                                EQ   200MG BASE/VIAL         A202485   001    May   07,   2013

AP       LUITPOLD                 EQ   1GM BASE/VIAL           A202031   002    May   07,   2013

AP                                EQ   200MG BASE/VIAL         A202031   001    May   07,   2013

AP       ONCO THERAPIES LTD       EQ   1GM BASE/VIAL           A200145   002    Jul   25,   2011

AP                                EQ   2GM BASE/VIAL           A200145   003    Jul   25,   2011

AP                                EQ   200MG BASE/VIAL         A200145   001    Jul   25,   2011

AP       SAGENT PHARMS            EQ   1GM BASE/VIAL           A091597   002    May   07,   2013

AP                                EQ   200MG BASE/VIAL         A091597   001    May   07,   2013

AP       SUN PHARMA GLOBAL        EQ   1GM BASE/VIAL           A078433   002    Jul   25,   2011

AP                                EQ   200MG BASE/VIAL         A078433   001    Jul   25,   2011

AP       TEVA PHARMS              EQ   1GM BASE/VIAL           A077983   001    Jan   25,   2011

AP                                EQ   200MG BASE/VIAL         A077983   002    Jan   25,   2011

    GEMZAR
	
AP    + LILLY                     EQ 1GM BASE/VIAL             N020509 002 May 15, 1996

AP    +                           EQ 200MG BASE/VIAL           N020509 001 May 15, 1996

    GEMCITABINE HYDROCHLORIDE
	
      + HOSPIRA INC               1GM/26.3ML (38MG/ML)         N200795 002 Aug 04, 2011

      +                           2GM/52.6ML (38MG/ML)         N200795 003 Aug 04, 2011

      +                           200MG/5.26ML (38MG/ML)       N200795 001 Aug 04, 2011
	
GEMFIBROZIL
	
  TABLET;ORAL

    GEMFIBROZIL
	
AB       APOTEX                   600MG                        A075034   001    Jul   20,   1998

AB       BLU CARIBE               600MG                        A078012   001    Mar   26,   2007

AB       DAVA PHARMS INC          600MG                        A074270   001    Sep   27,   1993

AB       HIKMA PHARMS             600MG                        A078599   001    Aug   16,   2010

AB       IMPAX PHARMS             600MG                        A078207   001    Jun   01,   2007

AB       INVAGEN PHARMS           600MG                        A077836   001    Jul   27,   2006

AB       NORTHSTAR HLTHCARE       600MG                        A079072   001    Sep   13,   2010

AB       SUN PHARM INDS INC       600MG                        A079239   001    Dec   29,   2008

AB       TEVA                     600MG                        A074256   001    Oct   31,   1993

    LOPID
	
AB    + PFIZER PHARMS             600MG                        N018422 003 Nov 20, 1986
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                               3-170(of 371)


GEMIFLOXACIN MESYLATE
	
  TABLET;ORAL
	
    FACTIVE
	
      + LG LIFE SCIENCES        EQ 320MG BASE                           N021158 001 Apr 04, 2003
	
GENTAMICIN SULFATE
	
  CREAM;TOPICAL

    GENTAMICIN SULFATE
	
AT    + FOUGERA                 EQ 0.1% BASE                            A062531 001 Jul 05, 1984

AT       PERRIGO NEW YORK       EQ 0.1% BASE                            A062307 001
	
AT       TARO                   EQ 0.1% BASE                            A062427 001 May 26, 1983

  INJECTABLE;INJECTION

    GENTAMICIN SULFATE
	
AP       FRESENIUS KABI USA     EQ 10MG BASE/ML                         A062366   002    Feb   06,   1986

AP    +                         EQ 40MG BASE/ML                         A062366   001    Aug   04,   1983

AP       HOSPIRA                EQ 10MG BASE/ML                         A062420   001    Aug   15,   1983

AP                              EQ 10MG BASE/ML                         A062612   004    Feb   20,   1986

AP                              EQ 40MG BASE/ML                         A062420   002    Aug   15,   1983

    GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 EQ 0.8MG BASE/ML                        A062814   001    Aug   28,   1987

AP    +                         EQ 1.2MG BASE/ML                        A062814   002    Aug   28,   1987

AP    +                         EQ 1.4MG BASE/ML                        A062814   003    Aug   28,   1987

AP    +                         EQ 1.6MG BASE/ML                        A062814   004    Aug   28,   1987

AP    +                         EQ 1.8MG BASE/ML                        A062814   005    Aug   28,   1987

AP    +                         EQ 2MG BASE/ML                          A062814   006    Aug   28,   1987

AP    +                         EQ 2.4MG BASE/ML                        A062814   007    Aug   28,   1987

AP    +                         EQ 40MG BASE/100ML                      A062814   008    Aug   28,   1987

AP    +                         EQ 60MG BASE/100ML                      A062814   009    Aug   28,   1987

AP    +                         EQ 70MG BASE/100ML                      A062814   010    Aug   28,   1987

AP    +                         EQ 80MG BASE/100ML                      A062814   011    Aug   28,   1987

AP    +                         EQ 90MG BASE/100ML                      A062814   012    Aug   28,   1987

AP    +                         EQ 100MG BASE/100ML                     A062814   013    Aug   28,   1987

AP    +                         EQ 120MG BASE/100ML                     A062814   014    Aug   28,   1987

AP       HOSPIRA                EQ 1.2MG BASE/ML                        A062414   001    Aug   15,   1983

AP                              EQ 1.4MG BASE/ML                        A062414   002    Aug   15,   1983

AP                              EQ 1.6MG BASE/ML                        A062414   003    Aug   15,   1983

AP                              EQ 1.8MG BASE/ML                        A062414   004    Aug   15,   1983

AP                              EQ 2MG BASE/ML                          A062414   005    Aug   15,   1983

AP                              EQ 60MG BASE/100ML                      A062414   006    Aug   15,   1983

AP                              EQ 70MG BASE/100ML                      A062414   007    Aug   15,   1983

AP                              EQ 80MG BASE/100ML                      A062414   008    Aug   15,   1983

AP                              EQ 90MG BASE/100ML                      A062414   009    Aug   15,   1983

AP                              EQ 100MG BASE/100ML                     A062414   010    Aug   15,   1983

    ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        EQ 0.8MG BASE/ML                        A062373   001    Sep   07,   1982

AP                              EQ 1.2MG BASE/ML                        A062373   007    Sep   07,   1982

AP                              EQ 1.6MG BASE/ML                        A062373   008    Sep   07,   1982

AP                              EQ 2MG BASE/ML                          A062373   009    Sep   07,   1982

AP                              EQ 2.4MG BASE/ML                        A062373   010    Sep   07,   1982

AP                              EQ 40MG BASE/100ML                      A062373   003    Sep   07,   1982

AP                              EQ 60MG BASE/100ML                      A062373   004    Sep   07,   1982

AP                              EQ 80MG BASE/100ML                      A062373   002    Sep   07,   1982

AP                              EQ 100MG BASE/100ML                     A062373   005    Sep   07,   1982

AP                              EQ 120MG BASE/100ML                     A062373   006    Sep   07,   1982

  OINTMENT;OPHTHALMIC

    GENTAMICIN SULFATE
	
AT    + AKORN                   EQ 0.3% BASE                            A064093 001 Aug 31, 1995

AT       PERRIGO CO TENNESSEE   EQ 0.3% BASE                            A065024 001 Jul 30, 2004
	
  OINTMENT;TOPICAL

    GENTAMICIN SULFATE
	
AT       FOUGERA                EQ 0.1% BASE                            A062533 001 Oct 05, 1984

AT    + PERRIGO NEW YORK        EQ 0.1% BASE                            A062351 001 Feb 18, 1982

AT       TARO                   EQ 0.1% BASE                            A062477 001 Dec 23, 1983
	
  SOLUTION/DROPS;OPHTHALMIC

    GENOPTIC
	
AT       ALLERGAN               EQ 0.3% BASE                            A062452 001 Oct 10, 1984

    GENTAK
	
AT       AKORN                  EQ 0.3% BASE                            A064163 001 Oct 12, 2001

    GENTAMICIN SULFATE
	
AT       AKORN                  EQ 0.3% BASE                            A062635   001 Jan 08, 1987

AT       ALCON RES LTD          EQ 0.3% BASE                            A062196   001
	
AT    + BAUSCH AND LOMB         EQ 0.3% BASE                            A064048   001 May 11, 1994

AT       PERRIGO CO TENNESSEE   EQ 0.3% BASE                            A065121   001 Jan 30, 2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-171(of 371)


GENTAMICIN SULFATE; PREDNISOLONE ACETATE
	
  OINTMENT;OPHTHALMIC
	
    PRED-G
	
      + ALLERGAN                EQ 0.3% BASE;0.6%               N050612 001 Dec 01, 1989
	
  SUSPENSION/DROPS;OPHTHALMIC

    PRED-G
	
      + ALLERGAN                EQ 0.3% BASE;1%                 N050586 001 Jun 10, 1988
	
GLATIRAMER ACETATE
	
  INJECTABLE;SUBCUTANEOUS
	
    COPAXONE
	
      + TEVA PHARMS USA          20MG/ML                        N020622 002 Feb 12, 2002
	
      +                          40MG/ML                        N020622 003 Jan 28, 2014
	
GLIMEPIRIDE
	
  TABLET;ORAL

    AMARYL
	
AB    + SANOFI AVENTIS US        1MG                            N020496 001 Nov 30, 1995

AB                               2MG                            N020496 002 Nov 30, 1995

AB                               4MG                            N020496 003 Nov 30, 1995

    GLIMEPIRIDE
	
AB       ACCORD HLTHCARE         1MG                            A078181   001    Aug   23,   2007

AB                               2MG                            A078181   002    Aug   23,   2007

AB                               4MG                            A078181   003    Aug   23,   2007

AB       ACTAVIS LABS FL INC     1MG                            A076995   001    Apr   27,   2010

AB                               2MG                            A076995   002    Apr   27,   2010

AB                               4MG                            A076995   003    Apr   27,   2010

AB       AUROBINDO PHARMA LTD    1MG                            A202759   001    Jun   29,   2012

AB                               2MG                            A202759   002    Jun   29,   2012

AB                               4MG                            A202759   003    Jun   29,   2012

AB       CARLSBAD                1MG                            A077911   001    Sep   22,   2009

AB                               2MG                            A077911   002    Sep   22,   2009

AB                               4MG                            A077911   003    Sep   22,   2009

AB       DR REDDYS LABS LTD      1MG                            A077091   001    Oct   06,   2005

AB                               2MG                            A077091   002    Oct   06,   2005

AB                               4MG                            A077091   003    Oct   06,   2005

AB       HIKMA PHARMS            1MG                            A078952   001    Aug   01,   2013

AB                               2MG                            A078952   002    Aug   01,   2013

AB                               4MG                            A078952   003    Aug   01,   2013

AB       INDOCO REMEDIES         1MG                            A202112   001    Apr   17,   2013

AB                               2MG                            A202112   002    Apr   17,   2013

AB                               4MG                            A202112   003    Apr   17,   2013

AB       INVAGEN PHARMS          1MG                            A077295   001    Oct   06,   2005

AB                               2MG                            A077295   002    Oct   06,   2005

AB                               4MG                            A077295   003    Oct   06,   2005

AB       MICRO LABS LTD INDIA    1MG                            A091220   001    Jun   29,   2012

AB                               2MG                            A091220   002    Jun   29,   2012

AB                               4MG                            A091220   004    Jun   29,   2012

AB                               8MG                            A091220   006    Jun   29,   2012

AB       MYLAN                   1MG                            A077624   001    Nov   28,   2005

AB                               2MG                            A077624   002    Nov   28,   2005

AB                               4MG                            A077624   003    Nov   28,   2005

AB       TEVA                    1MG                            A076802   001    Oct   06,   2005

AB                               2MG                            A076802   002    Oct   06,   2005

AB                               4MG                            A076802   003    Oct   06,   2005

AB       VINTAGE                 1MG                            A077370   001    Dec   23,   2005

AB                               2MG                            A077370   002    Dec   23,   2005

AB                               4MG                            A077370   003    Dec   23,   2005

AB                               8MG                            A077370   004    Dec   23,   2005
	
         MICRO LABS LTD INDIA    3MG                            A091220   003    Jun   29,   2012
	
                                 6MG                            A091220   005    Jun   29,   2012
	
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
	
  TABLET;ORAL

    DUETACT
	
AB    + TAKEDA PHARMS USA       2MG;30MG                        N021925 001 Jul 28, 2006

AB                              4MG;30MG                        N021925 002 Jul 28, 2006

    PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
	
AB       SANDOZ                 2MG;30MG                        A201049 001 Jan 04, 2013

AB                              4MG;30MG                        A201049 002 Jan 04, 2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-172(of 371)


GLIMEPIRIDE; ROSIGLITAZONE MALEATE
	
  TABLET;ORAL
	
    AVANDARYL
	
      + SB PHARMCO              1MG;4MG                        N021700   001    Nov   23,   2005
	
                                2MG;4MG                        N021700   002    Nov   23,   2005
	
                                2MG;8MG                        N021700   004    Mar   30,   2007
	
                                4MG;4MG                        N021700   003    Nov   23,   2005
	
                                4MG;8MG                        N021700   005    Mar   30,   2007
	
GLIPIZIDE
	
  TABLET;ORAL

    GLIPIZIDE
	
AB       ACCORD HLTHCARE         5MG                           A074550   001    Sep   11,   1997

AB                               10MG                          A074550   002    Sep   11,   1997

AB       APOTEX                  5MG                           A075795   001    Jun   13,   2001

AB                               10MG                          A075795   002    Jun   13,   2001

AB       IVAX SUB TEVA PHARMS    5MG                           A074497   001    Aug   31,   1995

AB                               10MG                          A074497   002    Aug   31,   1995

AB       MYLAN                   5MG                           A074226   001    May   10,   1994

AB                               5MG                           A074438   001    Jun   20,   1995

AB                               10MG                          A074226   002    May   10,   1994

AB                               10MG                          A074438   002    Jun   20,   1995

AB       SANDOZ                  5MG                           A074305   001    Apr   07,   1995

AB                               10MG                          A074305   002    Apr   07,   1995

AB       SUN PHARM INDS INC      5MG                           A077820   001    Jul   11,   2006

AB                               10MG                          A077820   002    Jul   11,   2006

AB       WATSON LABS             5MG                           A074223   001    Feb   27,   1995

AB                               10MG                          A074223   002    Feb   27,   1995

    GLUCOTROL
	
AB       PFIZER                  5MG                           N017783 001 May 08, 1984

AB    +                          10MG                          N017783 002 May 08, 1984

  TABLET, EXTENDED RELEASE;ORAL

    GLIPIZIDE
	
AB       PAR PHARM               5MG                           A076159   002    Sep   20,   2013

AB                               10MG                          A076159   001    Sep   20,   2013

AB       WATSON LABS             2.5MG                         A076467   003    Mar   27,   2006

AB                               5MG                           A076467   001    Sep   08,   2003

AB                               10MG                          A076467   002    Nov   07,   2003

    GLUCOTROL XL
	
AB       PFIZER                  2.5MG                         N020329 003 Aug 10, 1999

AB                               5MG                           N020329 001 Apr 26, 1994

AB    +                          10MG                          N020329 002 Apr 26, 1994
	
GLIPIZIDE; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE
	
AB       COREPHARMA             2.5MG;250MG                    A077507   001    Oct   27,   2005

AB                              2.5MG;500MG                    A077507   002    Oct   27,   2005

AB                              5MG;500MG                      A077507   003    Oct   27,   2005

AB       HERITAGE PHARMS INC    2.5MG;250MG                    A078728   001    Jun   23,   2010

AB                              2.5MG;500MG                    A078728   002    Jun   23,   2010

AB                              5MG;500MG                      A078728   003    Jun   23,   2010

AB       MYLAN                  2.5MG;250MG                    A078083   001    Apr   12,   2007

AB                              2.5MG;500MG                    A078083   002    Apr   12,   2007

AB                              5MG;500MG                      A078083   003    Apr   12,   2007

AB       SUN PHARM INDS INC     2.5MG;250MG                    A077620   001    Jan   11,   2008

AB                              2.5MG;500MG                    A077620   002    Jan   11,   2008

AB                              5MG;500MG                      A077620   003    Jan   11,   2008

AB       TEVA PHARMS            2.5MG;250MG                    A077270   001    Oct   28,   2005

AB                              2.5MG;500MG                    A077270   002    Oct   28,   2005

AB    +                         5MG;500MG                      A077270   003    Oct   28,   2005

AB       ZYDUS PHARMS USA INC   2.5MG;250MG                    A078905   001    Jan   31,   2011

AB                              2.5MG;500MG                    A078905   002    Jan   31,   2011

AB                              5MG;500MG                      A078905   003    Jan   31,   2011
	
GLUCAGON HYDROCHLORIDE RECOMBINANT
	
  INJECTABLE;INJECTION
	
    GLUCAGEN
	
      + NOVO NORDISK            EQ 1MG BASE/VIAL               N020918 001 Jun 22, 1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-173(of 371)


GLUCAGON RECOMBINANT
	
  INJECTABLE;INJECTION
	
    GLUCAGON
	
      + LILLY                   1MG/VIAL                        N020928 001 Sep 11, 1998
	
GLUTAMINE
	
  FOR SOLUTION;ORAL
	
    NUTRESTORE
	
      + EMMAUS MEDCL            5GM/PACKET                      N021667 001 Jun 10, 2004
	
GLYBURIDE
	
  TABLET;ORAL

    GLYBURIDE
	
AB       AUROBINDO PHARMA       1.25MG                          A077537   001    Oct   18,   2007

AB                              2.5MG                           A077537   002    Oct   18,   2007

AB                              5MG                             A077537   003    Oct   18,   2007

AB       COREPHARMA             1.25MG                          A076257   001    Jun   27,   2002

AB                              2.5MG                           A076257   002    Jun   27,   2002

AB                              5MG                             A076257   003    Jun   27,   2002

AB       HERITAGE PHARMS INC    1.25MG                          A090937   001    Feb   28,   2011

AB                              2.5MG                           A090937   002    Feb   28,   2011

AB                              5MG                             A090937   003    Feb   28,   2011

AB       TEVA                   1.25MG                          A074388   001    Aug   29,   1995

AB                              2.5MG                           A074388   002    Aug   29,   1995

AB    +                         5MG                             A074388   003    Aug   29,   1995

    GLYBURIDE (MICRONIZED)

AB       DAVA PHARMS INC        1.5MG                           A074591   001    Dec   22,   1997

AB                              3MG                             A074591   002    Dec   22,   1997

AB                              4.5MG                           A074591   003    Dec   22,   1997

AB                              6MG                             A074591   004    Dec   22,   1997

AB       HIKMA                  1.5MG                           A075890   001    Jul   31,   2003

AB                              3MG                             A075890   002    Jul   31,   2003

AB                              6MG                             A075890   003    Jul   31,   2003

AB       MYLAN                  1.5MG                           A074792   001    Jun   26,   1998

AB                              3MG                             A074792   002    Jun   26,   1998

AB                              6MG                             A074792   003    Aug   17,   1999

AB       TEVA                   1.5MG                           A074686   001    Apr   20,   1999

AB                              3MG                             A074686   002    Apr   20,   1999

AB                              4.5MG                           A074686   003    Apr   20,   1999

AB                              6MG                             A074686   004    Apr   20,   1999

    GLYNASE
	
AB       PHARMACIA AND UPJOHN   1.5MG                           N020051 001 Mar 04, 1992

AB                              3MG                             N020051 002 Mar 04, 1992

AB    +                         6MG                             N020051 004 Sep 24, 1993

    DIABETA
	
BX       SANOFI AVENTIS US      1.25MG                          N017532 001 May 01, 1984

BX                              2.5MG                           N017532 002 May 01, 1984

BX    +                         5MG                             N017532 003 May 01, 1984
	
GLYBURIDE; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL

    GLUCOVANCE
	
AB       BRISTOL MYERS SQUIBB   1.25MG;250MG                    N021178 001 Jul 31, 2000

AB    +                         2.5MG;500MG                     N021178 002 Jul 31, 2000

AB                              5MG;500MG                       N021178 003 Jul 31, 2000

    GLYBURIDE AND METFORMIN HYDROCHLORIDE
	
AB       ACTAVIS ELIZABETH      1.25MG;250MG                    A076716   001    Jun   28,   2005

AB                              2.5MG;500MG                     A076716   002    Jun   28,   2005

AB                              5MG;500MG                       A076716   003    Jun   28,   2005

AB       AUROBINDO PHARMA       1.25MG;250MG                    A077870   001    Nov   14,   2007

AB                              2.5MG;500MG                     A077870   002    Nov   14,   2007

AB                              5MG;500MG                       A077870   003    Nov   14,   2007

AB       COREPHARMA             1.25MG;250MG                    A076731   001    Nov   19,   2004

AB                              2.5MG;500MG                     A076731   002    Nov   19,   2004

AB                              5MG;500MG                       A076731   003    Nov   19,   2004

AB       HERITAGE PHARMS INC    1.25MG;250MG                    A079009   001    Jun   03,   2009

AB                              2.5MG;500MG                     A079009   002    Jun   03,   2009

AB                              5MG;500MG                       A079009   003    Jun   03,   2009

AB       IVAX SUB TEVA PHARMS   1.25MG;250MG                    A076345   001    Feb   18,   2004

AB                              2.5MG;500MG                     A076345   002    Feb   18,   2004

AB                              5MG;500MG                       A076345   003    Feb   18,   2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                             3-174(of 371)


GLYCEROL PHENYLBUTYRATE
	
  LIQUID;ORAL
	
    RAVICTI
	
      + HYPERION THERAP INC     1.1GM/ML                              N203284 001 Feb 01, 2013
	
GLYCINE
	
  SOLUTION;IRRIGATION

    AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
	
AT        BAXTER HLTHCARE       1.5GM/100ML                           N017865 001
	
    GLYCINE 1.5% IN PLASTIC CONTAINER
	
AT        B BRAUN               1.5GM/100ML                           N016784 001
	
AT        HOSPIRA               1.5GM/100ML                           N018315 001
	
GLYCOPYRROLATE
	
  INJECTABLE;INJECTION

    GLYCOPYRROLATE
	
AP       HIKMA FARMACEUTICA     0.2MG/ML                              A090963 001 Sep 21, 2011

AP       LUITPOLD               0.2MG/ML                              A089335 001 Jul 23, 1986

    ROBINUL
	
AP    + HIKMA MAPLE             0.2MG/ML                              N017558 001
	
  SOLUTION;ORAL
	
    CUVPOSA
	
      + MERZ PHARMS             1MG/5ML                               N022571 001 Jul 28, 2010
	
  TABLET;ORAL

    GLYCOPYRROLATE
	
AA       AUROLIFE PHARMA LLC    1MG                                   A202675   001    Apr   15,   2013

AA       DR REDDYS LABS LTD     1MG                                   A040847   001    Mar   21,   2008

AA                              2MG                                   A040847   002    Mar   21,   2008

AA       EXCELLIUM              1MG                                   A090195   001    Sep   21,   2012

AA                              2MG                                   A090195   002    Sep   21,   2012

AA       NEXGEN PHARMA          1.5MG                                 A091522   001    Mar   12,   2012

AA       PAR PHARM              1MG                                   A040653   001    Aug   31,   2006

AA                              2MG                                   A040653   002    Aug   31,   2006

AA       RANBAXY                1MG                                   A040844   001    Aug   18,   2009

AA                              2MG                                   A040844   002    Aug   18,   2009

AA       STASON PHARMS          1MG                                   A091182   001    Feb   03,   2014

AA                              2MG                                   A091182   002    Feb   03,   2014

AA       VINTAGE                1MG                                   A040821   001    Dec   29,   2008

AA                              2MG                                   A040821   002    Dec   29,   2008

AA       VINTAGE PHARMS         1MG                                   A090020   001    Oct   19,   2011

AA                              2MG                                   A090020   002    Oct   19,   2011

    ROBINUL
	
AA    + SHIONOGI INC            1MG                                   N012827 001
	
    ROBINUL FORTE
	
AA    + SHIONOGI INC            2MG                                   N012827 002
	
GONADOTROPIN, CHORIONIC
	
  INJECTABLE;INJECTION

    CHORIONIC GONADOTROPIN
	
AP    + FERRING                 10,000 UNITS/VIAL                     N017016 007
	
AP    + FRESENIUS KABI USA      10,000 UNITS/VIAL                     N017067 002
	
    PREGNYL
	
AP    + ORGANON USA INC         10,000 UNITS/VIAL                     N017692 001
	
GOSERELIN ACETATE
	
  IMPLANT;IMPLANTATION
	
    ZOLADEX
	
      + ASTRAZENECA             EQ 3.6MG BASE                         N019726 001 Dec 29, 1989
	
      +                         EQ 10.8MG BASE                        N020578 001 Jan 11, 1996
	
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  SOLUTION/DROPS;OPHTHALMIC

    NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
	
AT    + BAUSCH AND LOMB         0.025MG/ML;EQ 1.75MG BASE/ML;10,000   A064047 001 Jan 31, 1996

                                UNITS/ML

AT       LUITPOLD               0.025MG/ML;EQ 1.75MG BASE/ML;10,000   A065187 001 Oct 28, 2005

                                UNITS/ML

    NEOSPORIN
	
AT    + MONARCH PHARMS          0.025MG/ML;EQ 1.75MG BASE/ML;10,000   A060582 001
	
                                UNITS/ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                             3-175(of 371)


GRANISETRON
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    SANCUSO
	
      + PROSTRAKAN INC
	        3.1MG/24HR
	                            N022198 001 Sep 12, 2008
	
GRANISETRON HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     GRANISETRON HYDROCHLORIDE
	
AP         AKORN INC
	           EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A079119   001    Sep   10,   2009

AP
	                             EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A079078   001    Sep   14,   2009

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A079078   002    Sep   14,   2009

AP         BANNER PHARMACAPS
	   EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A078863   001    Jun   30,   2008

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A078880   001    Jun   30,   2008

AP         BEDFORD LABS
	        EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A077913   001    Jun   26,   2008

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A077186   001    Jun   30,   2008

AP
	                             EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A077187   001    Jun   30,   2008

AP         CIPLA LTD
	           EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A078262   001    Dec   31,   2007

AP
	                             EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A078258   001    Jun   30,   2008

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A078258   002    Jun   30,   2008

AP         FRESENIUS KABI USA
	  EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A078522   001    Dec   31,   2007

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A078090   001    Jun   30,   2008

AP         HIKMA MAPLE
	         EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A077177   001    Dec   31,   2007

AP         LUITPOLD
	            EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A091274   001    Sep   22,   2010

AP         SAGENT AGILA
	        EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A091137   002    Apr   09,   2010

AP         SAGENT STRIDES
	      EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A091136   001    Apr   09,   2010

AP
	                             EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A091136   002    Apr   09,   2010

AP         SANDOZ
	              EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A078534   001    Apr   30,   2009

AP
	                             EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A078531   001    Apr   30,   2009

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A078531   002    Apr   30,   2009

AP         SANDOZ INC
	          EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A078835   001    Jun   30,   2008

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A078835   002    Jun   30,   2008

AP     + TEVA PHARMS USA
	       EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A078392   001    Dec   31,   2007

AP     +
	                       EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A077963   001    Jan   03,   2008

AP     +
	                       EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
      A077297   001    Jun   30,   2008

AP         WOCKHARDT USA
	       EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
   A078566   001    Feb   29,   2008

AP
	                             EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A078564   001    Jun   30,   2008

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
	     A078565   001    Jun   30,   2008
	
     GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
	
AP         BANNER PHARMACAPS
	   EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A078863 002 Jun 30, 2008

AP     + FRESENIUS KABI USA
	    EQ 1MG BASE/ML (EQ 1MG BASE/ML)
	      A078096 001 Jun 30, 2008
	
     GRANISTERON HYDROCHLORIDE
	
AP         HIKMA FARMACEUTICA
	  EQ 1MG BASE/ML (EQ 1MG BASE/ML)
       A078629 001 Dec 23, 2009

AP
	                             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
	     A078629 002 Dec 23, 2009
	
  TABLET;ORAL

     GRANISETRON HYDROCHLORIDE
	
AB         APOTEX INC
	          EQ 1MG BASE
                           A078843   001    Feb   27,   2008

AB         CIPLA LTD
	           EQ 1MG BASE
                           A078037   001    Feb   27,   2008

AB         COREPHARMA
	          EQ 1MG BASE
                           A078260   001    Dec   31,   2007

AB         DR REDDYS LABS LTD
	  EQ 1MG BASE
                           A078846   001    Feb   27,   2009

AB         MYLAN
	               EQ 1MG BASE
                           A078725   001    Jan   30,   2008

AB         NATCO PHARMA
	        EQ 1MG BASE
                           A078969   001    Jun   22,   2009

AB         ORCHID HLTHCARE
	     EQ 1MG BASE
                           A078678   001    Feb   13,   2008

AB         ROXANE
	              EQ 1MG BASE
                           A077842   001    Dec   31,   2007

AB         TARO
	                EQ 1MG BASE
                           A090817   001    May   28,   2010

AB     + TEVA PHARMS
	           EQ 1MG BASE
	                          A078080   001    Dec   31,   2007
	
GRISEOFULVIN, MICROSIZE
	
  SUSPENSION;ORAL

    GRISEOFULVIN
	
AB    + ACTAVIS MID ATLANTIC
	    125MG/5ML
                            A065394   001    Jul   06,   2007

AB       IVAX SUB TEVA PHARMS
	   125MG/5ML
                            A065354   001    Sep   10,   2007

AB       PERRIGO CO TENNESSEE
	   125MG/5ML
                            A065200   001    Mar   02,   2005

AB       VINTAGE PHARMS
	         125MG/5ML
	                           A065438   001    Oct   08,   2010
	
  TABLET;ORAL

    GRIFULVIN V
	
AB    + VALEANT LUXEMBOURG
	      500MG
	                               A062279 003
	
    GRISEOFULVIN
	
AB       SANDOZ
	                 500MG
	                               A091592 002 Aug 07, 2013

AB       SIGMAPHARM LABS LLC
	    500MG
	                               A202482 001 Oct 22, 2012
	
         SANDOZ
	                 250MG
	                               A091592 001 Aug 07, 2013
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                      3-176(of 371)


GRISEOFULVIN, ULTRAMICROSIZE
	
  TABLET;ORAL

    GRIS-PEG
AB       VALEANT PHARMS INC     125MG                              N050475 001
	
AB    +                         250MG                              N050475 002
	
    GRISEOFULVIN, ULTRAMICROSIZE
AB       RICONPHARMA LLC        125MG                              A204371 001 Jan 09, 2014

AB                              250MG                              A204371 002 Jan 09, 2014
	
    GRISEOFULVIN,ULTRAMICROSIZE
AB       SIGMAPHARM LABS LLC    125MG                              A202545 001 Oct 22, 2012

AB                              250MG                              A202545 002 Oct 22, 2012
	
GUAIFENESIN; HYDROCODONE BITARTRATE
	
  SOLUTION;ORAL
	
    OBREDON
	
      + SOVEREIGN PHARMS
	      200MG/5ML;2.5MG/5ML
	              N205474 001 Nov 14, 2014
	
GUANABENZ ACETATE
	
  TABLET;ORAL
	
    GUANABENZ ACETATE
	
          ANI PHARMS INC
	       EQ 4MG BASE
	                     A074149 001 Apr 07, 1995

      +
	                        EQ 8MG BASE
	                     A074149 002 Apr 07, 1995
	
GUANFACINE HYDROCHLORIDE
	
  TABLET;ORAL

     GUANFACINE HYDROCHLORIDE
AB         AMNEAL PHARM          EQ   1MG   BASE
                  A075109   001    Nov   25,   1998

AB                               EQ   2MG   BASE
                  A075109   002    Nov   25,   1998

AB         EPIC PHARMA LLC       EQ   1MG   BASE
                  A074673   001    Feb   28,   1997

AB                               EQ   2MG   BASE
                  A074673   002    Feb   28,   1997

AB         MYLAN                 EQ   1MG   BASE
                  A074796   001    Jan   27,   1997

AB                               EQ   2MG   BASE
                  A074796   002    Jan   27,   1997

AB         WATSON LABS           EQ   1MG   BASE
                  A074145   001    Oct   17,   1995

AB                               EQ   2MG   BASE
	                 A074145   002    Oct   17,   1995
	
     TENEX
AB         PROMIUS PHARMA        EQ   1MG BASE
                    N019032 001 Oct 27, 1986

AB     +                         EQ   2MG BASE
	                   N019032 002 Nov 07, 1988
	
  TABLET, EXTENDED RELEASE;ORAL

     GUANFACINE HYDROCHLORIDE
	
AB         ACTAVIS ELIZABETH
	   EQ   1MG   BASE
                  A200881   001    Oct   05,   2012

AB
	                             EQ   2MG   BASE
                  A200881   002    Oct   05,   2012

AB
	                             EQ   3MG   BASE
                  A200881   003    Oct   05,   2012

AB
	                             EQ   4MG   BASE
	                 A200881   004    Oct   05,   2012
	
     INTUNIV
	
AB         SHIRE
	               EQ   1MG   BASE
                  N022037   001    Sep   02,   2009

AB
	                             EQ   2MG   BASE
                  N022037   002    Sep   02,   2009

AB
	                             EQ   3MG   BASE
                  N022037   003    Sep   02,   2009

AB     +
	                       EQ   4MG   BASE
	                 N022037   004    Sep   02,   2009
	
GUANIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    GUANIDINE HYDROCHLORIDE
	
         MERCK SHARP DOHME
	     125MG
	                           N001546 001
	
HALCINONIDE
	
  CREAM;TOPICAL
	
    HALOG
	
      + RANBAXY
	                0.1%
	                            N017556 001
	
  OINTMENT;TOPICAL
	
    HALOG
	
      + RANBAXY
	                0.1%
	                            N017824 001
	
HALOBETASOL PROPIONATE
	
  CREAM;TOPICAL

    HALOBETASOL PROPIONATE
	
AB       FOUGERA PHARMS
	        0.05%
	                           A077001   001    Dec   16,   2004

AB       G AND W LABS
	          0.05%
	                           A078162   001    Apr   24,   2007

AB       PERRIGO ISRAEL
	        0.05%
	                           A077123   001    Dec   16,   2004

AB       TARO
	                  0.05%
	                           A077227   001    Aug   04,   2005
	
    ULTRAVATE
	
AB    + RANBAXY
	                0.05%
	                           N019967 001 Dec 27, 1990
	
  OINTMENT;TOPICAL

    HALOBETASOL PROPIONATE
	
AB       G AND W LABS
	          0.05%
	                           A077721 001 Sep 07, 2006

AB       PERRIGO
	               0.05%
	                           A076872 001 Dec 16, 2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-177(of 371)


HALOBETASOL PROPIONATE
	
  OINTMENT;TOPICAL

    HALOBETASOL PROPIONATE
	
AB       TARO                  0.05%                            A076994 001 Dec 16, 2004

    ULTRAVATE
	
AB    + RANBAXY                0.05%                            N019968 001 Dec 17, 1990
	
HALOPERIDOL
	
  TABLET;ORAL

    HALOPERIDOL
	
AB       MYLAN                 0.5MG                            A070278   006     Jun   10,   1986

AB                             1MG                              A070278   004     Jun   10,   1986

AB                             2MG                              A070278   001     Jun   10,   1986

AB                             5MG                              A070278   005     Jun   10,   1986

AB                             10MG                             A070278   002     Jul   16,   2009

AB                             20MG                             A070278   003     Jul   16,   2009

AB       SANDOZ                0.5MG                            A071206   001     Nov   17,   1986

AB                             1MG                              A071207   001     Nov   17,   1986

AB    +                        2MG                              A071208   001     Nov   17,   1986

AB                             5MG                              A071209   001     Nov   17,   1986

AB                             10MG                             A071210   001     Mar   11,   1988

AB                             20MG                             A071211   001     Mar   11,   1988

AB       ZYDUS PHARMS USA      5MG                              A077580   003     Nov   29,   2007

AB                             10MG                             A077580   004     Nov   29,   2007

AB                             20MG                             A077580   005     Nov   29,   2007
	
HALOPERIDOL DECANOATE
	
  INJECTABLE;INJECTION

    HALDOL
	
AO    + JANSSEN PHARMS         EQ 50MG BASE/ML                  N018701 001 Jan 14, 1986

AO    +                        EQ 100MG BASE/ML                 N018701 002 Jan 31, 1997

    HALOPERIDOL DECANOATE
	
AO       AGILA SPECLTS         EQ   50MG BASE/ML                A075440   001     Feb   28,   2000

AO                             EQ   100MG BASE/ML               A075440   002     Feb   28,   2000

AO       EUROHLTH INTL         EQ   50MG BASE/ML                A074811   001     Jan   30,   1998

AO                             EQ   100MG BASE/ML               A075305   001     Sep   28,   1998

AO       FRESENIUS KABI USA    EQ   50MG BASE/ML                A074893   001     Dec   19,   1997

AO                             EQ   100MG BASE/ML               A074893   002     Dec   19,   1997

AO       TEVA PHARMS USA       EQ   50MG BASE/ML                A075393   001     May   11,   1999

AO                             EQ   100MG BASE/ML               A075393   002     May   11,   1999
	
HALOPERIDOL LACTATE
	
  CONCENTRATE;ORAL

    HALOPERIDOL
	
AA       PHARM ASSOC           EQ 2MG BASE/ML                   A073037 001 Feb 26, 1993

AA       SILARX                EQ 2MG BASE/ML                   A073364 001 Sep 28, 1993

AA    + TEVA PHARMS            EQ 2MG BASE/ML                   A071617 001 Dec 01, 1988
	
  INJECTABLE;INJECTION

    HALDOL
	
AP    + JANSSEN PHARMS         EQ 5MG BASE/ML                   N015923 001
	
    HALOPERIDOL
	
AP       AGILA SPECLTS         EQ   5MG   BASE/ML               A078347   001     Sep   14,   2009

AP       EUROHLTH INTL         EQ   5MG   BASE/ML               A075858   001     Jun   18,   2001

AP       FRESENIUS KABI USA    EQ   5MG   BASE/ML               A075689   001     Mar   09,   2001

AP       GLAND PHARMA LTD      EQ   5MG   BASE/ML               A076774   001     Aug   25,   2004

AP       SAGENT PHARMS         EQ   5MG   BASE/ML               A091637   001     Sep   02,   2011

AP                             EQ   5MG   BASE/ML               A200742   001     Sep   02,   2011

AP       TEVA PHARMS USA       EQ   5MG   BASE/ML               A076035   001     Aug   29,   2001
	
HEPARIN SODIUM
	
  INJECTABLE;INJECTION

    HEPARIN SODIUM
	
AP    + FRESENIUS KABI USA     1,000 UNITS/ML                   N017029   001
	
AP    +                        5,000 UNITS/ML                   N017651   006
	
AP    +                        10,000 UNITS/ML                  N017029   003
	
AP    +                        20,000 UNITS/ML                  N017029   004
	
AP    + HIKMA MAPLE            1,000 UNITS/ML                   N017037   001
	
AP    +                        5,000 UNITS/ML                   N017037   002
	
AP    +                        10,000 UNITS/ML                  N017037   003
	
AP       HOSPIRA INC           1,000 UNITS/ML                   A090571   001     Aug   31,   2009

AP                             5,000 UNITS/ML                   A090571   002     Aug   31,   2009

AP                             10,000 UNITS/ML                  A090571   003     Aug   31,   2009

AP       SAGENT PHARMS         1,000 UNITS/ML                   A090808   001     Jun   30,   2010

AP                             5,000 UNITS/ML                   A090808   002     Jun   30,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                3-178(of 371)


HEPARIN SODIUM
	
  INJECTABLE;INJECTION

    HEPARIN SODIUM
	
AP                              10,000 UNITS/ML                           A090808   003    Jun   30,   2010

AP                              20,000 UNITS/ML                           A090809   001    Jun   30,   2010

AP       SANDOZ                 1,000 UNITS/ML                            A091682   001    Jun   08,   2011

AP                              5,000 UNITS/ML                            A091659   001    Jun   08,   2011

AP                              5,000 UNITS/ML                            A091682   002    Jun   08,   2011

AP                              10,000 UNITS/ML                           A201002   001    Jun   08,   2011

AP       SHENZHEN TECHDOW       1,000 UNITS/ML                            A202957   001    Jun   12,   2014

AP                              5,000 UNITS/ML                            A202733   001    Jun   12,   2014

AP                              5,000 UNITS/ML                            A202957   002    Jun   12,   2014

AP                              10,000 UNITS/ML                           A203198   001    Jun   12,   2014

AP                              20,000 UNITS/ML                           A203198   002    Jun   12,   2014

    HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        200 UNITS/100ML                           N018609   001 Apr 28, 1982

    HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP    + B BRAUN                 200 UNITS/100ML                           N019953   001 Jul 20, 1992

AP       HOSPIRA                200 UNITS/100ML                           N018916   010 Jun 23, 1989

    HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER

AP       HOSPIRA                10,000 UNITS/100ML                        N019339   003 Mar 27, 1985

    HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       BAXTER HLTHCARE        200 UNITS/100ML                           N018609   002 Apr 28, 1982

    HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       HOSPIRA                200 UNITS/100ML                           N018916   011 Jun 23, 1989

    HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER

AP    + B BRAUN                 4,000 UNITS/100ML                         N019952   001 Jul 20, 1992

AP       HOSPIRA                4,000 UNITS/100ML                         N019805   001 Jan 25, 1989

    HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER

AP    + B BRAUN                 5,000 UNITS/100ML                         N019952   004    Jul   20,   1992

AP    +                         10,000 UNITS/100ML                        N019952   005    Jul   20,   1992

AP       HOSPIRA                5,000 UNITS/100ML                         N019339   004    Mar   27,   1985

AP                              5,000 UNITS/100ML                         N019805   002    Jan   25,   1989

AP                              10,000 UNITS/100ML                        N019339   002    Mar   27,   1985

    HEPARIN SODIUM IN PLASTIC CONTAINER
	
AP    + FRESENIUS KABI USA      1,000 UNITS/ML                            N017029   013    Dec   05,   1985

AP    +                         5,000 UNITS/ML                            N017029   014    Dec   05,   1985

AP    +                         10,000 UNITS/ML                           N017029   015    Dec   05,   1985

AP    +                         20,000 UNITS/ML                           N017029   016    Dec   05,   1985

    HEPARIN SODIUM PRESERVATIVE FREE
	
AP    + FRESENIUS KABI USA      1,000 UNITS/ML                            N017029   010 Apr 28, 1986

AP       SAGENT PHARMS          1,000 UNITS/ML                            A090810   001 Jun 30, 2010

AP       SHENZHEN TECHDOW       1,000 UNITS/ML                            A202732   001 Jun 12, 2014
	
    HEPARIN SODIUM
	
      + FRESENIUS KABI USA      10,000 UNITS/ML                           N017029   020    Mar   31,   2011
	
      + HOSPIRA                 5,000 UNITS/ML                            A088100   001    Apr   28,   1983

      + PFIZER                  1,000 UNITS/ML                            N201370   001    Jul   21,   2011
	
      +                         5,000 UNITS/ML                            N201370   002    Jul   21,   2011
	
      +                         10,000 UNITS/ML                           N201370   003    Jul   21,   2011
	
    HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA                5,000 UNITS/100ML                         N019339   001 Mar 27, 1985
	
    HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         HOSPIRA                5,000 UNITS/100ML                         N018916   006 Jan 31, 1984
	
    HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         HOSPIRA                5,000 UNITS/100ML                         N018916   007 Jan 31, 1984
	
                                10,000 UNITS/100ML                        N018916   008 Jan 31, 1984
	
    HEPARIN SODIUM PRESERVATIVE FREE
	
      + FRESENIUS KABI USA      10,000 UNITS/ML                           N017029   019 Nov 22, 2010
	
      + HOSPIRA                 10,000 UNITS/ML                           A089522   001 May 04, 1987

      + PFIZER                  1,000 UNITS/ML                            N201370   004 Jul 21, 2011
	
HEXACHLOROPHENE
	
  EMULSION;TOPICAL
	
    PHISOHEX
	
      + SANOFI AVENTIS US      3%                                        N006882 001
	
  SPONGE;TOPICAL

    PRE-OP
	
AT    + DAVIS AND GECK         480MG                                     N017433 001
	
    PRE-OP II
	
AT       DAVIS AND GECK        480MG                                     N017433 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-179(of 371)


HEXAMINOLEVULINATE HYDROCHLORIDE
	
  FOR SOLUTION;INTRAVESICAL
	
    CYSVIEW KIT
	
      + PHOTOCURE ASA
	         100MG/VIAL
	                    N022555 001 May 28, 2010
	
HISTRELIN ACETATE
	
  IMPLANT;SUBCUTANEOUS
	
    SUPPRELIN LA
	
      + ENDO PHARM
	               50MG
	                       N022058 001 May 03, 2007
	
    VANTAS
	
      + ENDO PHARM
	               50MG
	                       N021732 001 Oct 12, 2004
	
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
	
  SYRUP;ORAL

    HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
	
AA       ACTAVIS MID ATLANTIC   1.5MG/5ML;5MG/5ML
              A088017 001 Jul 05, 1983

AA    + HI TECH PHARMA          1.5MG/5ML;5MG/5ML
              A040613 001 Feb 08, 2008

AA       WOCKHARDT              1.5MG/5ML;5MG/5ML
              A088008 001 Mar 03, 1983
	
  TABLET;ORAL

    HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
	
AA       NOVEL LABS INC
	       1.5MG;5MG
	                     A091528 001 Apr 20, 2011
	
    TUSSIGON
	
AA    + KING PHARMS
	           1.5MG;5MG
	                     A088508 001 Jul 30, 1985
	
HYALURONIDASE
	
  INJECTABLE;INJECTION
	
    AMPHADASE
	
      + AMPHASTAR PHARM
	          150 UNITS/ML
	               N021665 001 Oct 26, 2004
	
    VITRASE
	
      + BAUSCH AND LOMB
	          200 UNITS/VIAL
	             N021640 002 Dec 02, 2004
	
HYALURONIDASE RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HYLENEX RECOMBINANT
	
      + HALOZYME THERAP
	        150 UNITS/ML
	                 N021859 001 Dec 02, 2005
	
HYDRALAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     HYDRALAZINE HYDROCHLORIDE
	
AP        AKORN                    20MG/ML
                     A040730   001     Apr   21,   2009

AP        FRESENIUS KABI USA       20MG/ML
                     A040388   001     Mar   13,   2001

AP     + LUITPOLD                  20MG/ML
                     A040136   001     Jun   30,   1997

AP        NAVINTA LLC              20MG/ML
	                    A202938   001     Mar   28,   2013
	
  TABLET;ORAL

     HYDRALAZINE HYDROCHLORIDE
	
AA        ACTAVIS GRP PTC
	        10MG
	                       A091679   001     Mar   04,   2013

AA
	                               25MG
	                       A091679   002     Mar   04,   2013

AA
	                               50MG
	                       A091679   003     Mar   04,   2013

AA
	                               100MG
	                      A091679   004     Mar   04,   2013

AA        ALKEM LABS LTD
	         10MG
	                       A200737   001     Dec   07,   2012

AA
	                               25MG
	                       A200737   002     Dec   07,   2012

AA
	                               50MG
	                       A200737   003     Dec   07,   2012

AA
	                               100MG
	                      A200737   004     Dec   07,   2012

AA        CADILA PHARMS LTD
	      25MG
	                       A203845   001     Sep   18,   2014

AA
	                               50MG
	                       A203845   002     Sep   18,   2014

AA
	                               100MG
	                      A203845   003     Sep   18,   2014

AA        GLENMARK PHARMS LTD
	    10MG
	                       A090527   001     May   27,   2009

AA
	                               25MG
	                       A090527   002     May   27,   2009

AA
	                               50MG
	                       A090527   003     May   27,   2009

AA
	                               100MG
	                      A090527   004     May   27,   2009

AA        HERITAGE PHARMS INC
	    10MG
	                       A086242   001     Feb   04,   2010

AA
	                               25MG
	                       A086242   003
	
AA
	                               50MG
	                       A086242   002
	
AA
	                               100MG
	                      A086242   004     Feb   04,   2010

AA        HETERO LABS LTD III
	    10MG
	                       A040901   001     Sep   12,   2008

AA
	                               25MG
	                       A040901   002     Sep   12,   2008

AA
	                               50MG
	                       A040901   003     Sep   12,   2008

AA
	                               100MG
	                      A040901   004     Sep   12,   2008

AA        INVAGEN PHARMS
	         10MG
	                       A090255   001     Dec   15,   2008

AA
	                               25MG
	                       A090255   002     Dec   15,   2008

AA
	                               50MG
	                       A090255   003     Dec   15,   2008

AA
	                               100MG
	                      A090255   004     Dec   15,   2008

AA        MYLAN
	                  10MG
	                       A090413   001     Dec   08,   2010

AA
	                               25MG
	                       A090413   002     Dec   08,   2010

AA
	                               50MG
	                       A090413   003     Dec   08,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-180(of 371)


HYDRALAZINE HYDROCHLORIDE
	
  TABLET;ORAL

    HYDRALAZINE HYDROCHLORIDE
	
AA                                100MG                        A090413   004     Dec 08, 2010

AA       PAR PHARM                10MG                         A087836   001     Oct 05, 1982

AA                                25MG                         A086961   002
	
AA                                50MG                         A086962   001
	
AA                                100MG                        A088391   001     Sep   27,   1983

AA    + PLIVA                     10MG                         A089097   001     Dec   18,   1985

AA    +                           25MG                         A088467   001     May   01,   1984

AA    +                           50MG                         A088468   001     May   01,   1984

AA    +                           100MG                        A089098   001     Dec   18,   1985

AA       STRIDES PHARMA           25MG                         A200770   001     May   03,   2013

AA                                50MG                         A200770   002     May   03,   2013

AA                                100MG                        A200770   003     May   03,   2013
	
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
	
  CAPSULE;ORAL
	
    HYDRA-ZIDE
	
         PAR PHARM              25MG;25MG                      A088957 001 Oct 21, 1985
	
      +                         50MG;50MG                      A088946 001 Oct 21, 1985
	
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE
	
  TABLET;ORAL
	
    BIDIL
	
      + ARBOR PHARMS LLC        37.5MG;20MG                    N020727 001 Jun 23, 2005
	
HYDROCHLOROTHIAZIDE
	
  CAPSULE;ORAL

    HYDROCHLOROTHIAZIDE
	
AB       ALEMBIC PHARMS LTD       12.5MG                       A200645   001     Nov   30,   2010

AB       APOTEX                   12.5MG                       A078389   001     May   16,   2008

AB       AUROBINDO PHARMA         12.5MG                       A078164   001     Sep   18,   2007

AB       IPCA LABS LTD            12.5MG                       A079237   001     Apr   02,   2009

AB       IVAX SUB TEVA PHARMS     12.5MG                       A077005   001     Jul   13,   2005

AB       JUBILANT CADISTA         12.5MG                       A078391   001     Feb   11,   2008

AB       LANNETT HOLDINGS INC     12.5MG                       A091662   001     Jan   27,   2012

AB       MYLAN                    12.5MG                       A075640   001     Jan   28,   2000

AB       SUN PHARM INDS INC       12.5MG                       A090651   001     Apr   07,   2014

AB       UNICHEM                  12.5MG                       A090510   001     Jan   19,   2010

AB       VINTAGE PHARMS           12.5MG                       A075907   001     Sep   17,   2002

    MICROZIDE
	
AB    + WATSON LABS               12.5MG                       N020504 001 Dec 27, 1996
	
  TABLET;ORAL

    HYDROCHLOROTHIAZIDE
	
AB       ACCORD HLTHCARE          12.5MG                       A202556   001     Sep   24,   2012

AB                                25MG                         A202556   002     Sep   24,   2012

AB                                50MG                         A202556   003     Sep   24,   2012

AB       ACTAVIS ELIZABETH        12.5MG                       A040707   001     Feb   27,   2007

AB       APOTEX                   25MG                         A040774   001     Oct   03,   2007

AB                                50MG                         A040774   002     Oct   03,   2007

AB       AUROBINDO PHARMA         25MG                         A040780   001     Jul   20,   2007

AB                                50MG                         A040780   002     Jul   20,   2007

AB       DAVA PHARMS INC          25MG                         A087059   001
	
AB                                50MG                         A087068   001
	
AB       EXCELLIUM                25MG                         A040702   001     Mar 16, 2007

AB                                50MG                         A040702   002     Mar 16, 2007

AB       HERITAGE PHARMS INC      25MG                         A085182   002
	
AB                                50MG                         A085182   001
	
AB       HIKMA PHARMS LLC         50MG                         A084878   001
	
AB       IPCA LABS LTD            12.5MG                       A040807   001     Jul 20, 2007

AB                                25MG                         A040807   002     Jul 20, 2007

AB                                50MG                         A040807   003     Jul 20, 2007

AB       IVAX SUB TEVA PHARMS     25MG                         A083177   001
	
AB    +                           50MG                         A083177   002
	
AB       JUBILANT CADISTA         25MG                         A040809   001     Sep 04, 2007

AB                                50MG                         A040809   002     Sep 04, 2007

AB       LANNETT                  25MG                         A084325   001
	
AB                                50MG                         A084324   001
	
AB       MYLAN PHARMS INC         12.5MG                       A040770   001     Jan   23,   2007

AB                                25MG                         A040735   002     Jan   23,   2007

AB                                50MG                         A040735   003     Jan   23,   2007

AB       SCIEGEN PHARMS INC       25MG                         A203018   001     Jul   23,   2014

AB                                50MG                         A203018   002     Jul   23,   2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-181(of 371)


HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL

    HYDROCHLOROTHIAZIDE
AB       SUN PHARM INDS INC      12.5MG
	                       A040857   001    May   30,   2008

AB                               25MG
	                         A040810   001    Mar   27,   2007

AB                               50MG
	                         A040810   002    Mar   27,   2007

AB       UNICHEM                 25MG
	                         A040907   001    Aug   15,   2008

AB                               50MG
	                         A040907   002    Aug   15,   2008

AB       VINTAGE PHARMS          25MG
	                         A040412   001    Mar   29,   2002

AB                               50MG
	                         A040412   002    Mar   29,   2002
	
    ORETIC
AB       ABBVIE                  50MG
	                         N011971 002
	
HYDROCHLOROTHIAZIDE; IRBESARTAN
	
  TABLET;ORAL

     AVALIDE
AB     + SANOFI AVENTIS US       12.5MG;150MG                   N020758 002 Sep 30, 1997

AB     +                         12.5MG;300MG                   N020758 003 Aug 31, 1998
	
     IRBESARTAN AND HYDROCHLOROTHIAZIDE
AB        ALEMBIC LTD            12.5MG;150MG
                  A091370   001    Oct   15,   2012

AB                               12.5MG;300MG
                  A091370   002    Oct   15,   2012

AB        APOTEX INC             12.5MG;150MG
                  A201505   001    Oct   15,   2012

AB                               12.5MG;300MG
                  A201505   002    Oct   15,   2012

AB        AUROBINDO PHARMA LTD   12.5MG;150MG
                  A203630   001    Feb   22,   2013

AB                               12.5MG;300MG
                  A203630   002    Feb   22,   2013

AB        DR REDDYS LABS LTD     12.5MG;150MG
                  A203500   001    Sep   27,   2012

AB                               12.5MG;300MG
                  A203500   002    Sep   27,   2012

AB        LUPIN LTD              12.5MG;150MG
                  A201524   001    Feb   27,   2013

AB                               12.5MG;300MG
                  A201524   002    Feb   27,   2013

AB        MACLEODS PHARMS LTD    12.5MG;150MG
                  A202414   001    Sep   27,   2012

AB                               12.5MG;300MG
                  A202414   002    Sep   27,   2012

AB        MYLAN PHARMS INC       12.5MG;150MG
                  A077969   001    Sep   27,   2012

AB                               12.5MG;300MG
                  A077969   002    Sep   27,   2012

AB        PRINSTON INC           12.5MG;150MG
                  A203072   001    May   09,   2014

AB                               12.5MG;300MG
                  A203072   002    May   09,   2014

AB        ROXANE                 12.5MG;150MG
                  A090351   001    Oct   15,   2012

AB                               12.5MG;300MG
                  A090351   002    Oct   15,   2012

AB        SANDOZ                 12.5MG;150MG
                  A077446   001    Sep   27,   2012

AB                               12.5MG;300MG
                  A077446   002    Sep   27,   2012

AB        TEVA                   12.5MG;150MG
                  A077369   001    Mar   30,   2012

AB                               12.5MG;300MG
                  A077369   002    Mar   30,   2012

AB        WATSON LABS INC        12.5MG;150MG
                  A091539   001    Oct   22,   2012

AB
	                             12.5MG;300MG
	                 A091539   002    Oct   22,   2012
	
HYDROCHLOROTHIAZIDE; LISINOPRIL
	
  TABLET;ORAL

    LISINOPRIL AND HYDROCHLOROTHIAZIDE
	
AB       APOTEX INC              12.5MG;10MG
                   A076674   001    Oct   05,   2004

AB                               12.5MG;20MG
                   A076674   002    Oct   05,   2004

AB                               25MG;20MG
                     A076674   003    Oct   05,   2004

AB       AUROBINDO               12.5MG;10MG
                   A077606   001    Mar   14,   2006

AB                               12.5MG;20MG
                   A077606   002    Mar   14,   2006

AB                               25MG;20MG
                     A077606   003    Mar   14,   2006

AB       HIKMA INTL PHARMS       12.5MG;10MG
                   A076265   001    Jul   08,   2002

AB                               12.5MG;20MG
                   A076265   002    Jul   08,   2002

AB                               25MG;20MG
                     A076265   003    Jul   08,   2002

AB       IVAX SUB TEVA PHARMS    12.5MG;10MG
                   A075776   001    Jul   01,   2002

AB                               12.5MG;20MG
                   A075776   002    Jul   01,   2002

AB                               25MG;20MG
                     A075776   003    Jul   01,   2002

AB       LUPIN                   12.5MG;10MG
                   A077912   001    Sep   27,   2006

AB                               12.5MG;20MG
                   A077912   002    Sep   27,   2006

AB                               25MG;20MG
                     A077912   003    Sep   27,   2006

AB       MYLAN                   12.5MG;10MG
                   A076113   001    Jul   01,   2002

AB                               12.5MG;20MG
                   A076113   002    Jul   01,   2002

AB                               25MG;20MG
                     A076113   003    Jul   01,   2002

AB       PRINSTON INC            12.5MG;10MG
                   A076230   001    Jul   01,   2002

AB                               12.5MG;20MG
                   A076230   002    Jul   01,   2002

AB                               25MG;20MG
                     A076230   003    Jul   01,   2002

AB       RANBAXY                 12.5MG;10MG
                   A076007   001    Jul   01,   2002

AB                               12.5MG;20MG
                   A076007   002    Jul   01,   2002

AB                               25MG;20MG
                     A076007   003    Jul   01,   2002

AB       SANDOZ                  12.5MG;10MG
                   A076262   001    Jul   01,   2002

AB                               12.5MG;20MG
	                  A076262   002    Jul   01,   2002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-182(of 371)


HYDROCHLOROTHIAZIDE; LISINOPRIL
	
  TABLET;ORAL

    LISINOPRIL AND HYDROCHLOROTHIAZIDE
	
AB                               25MG;20MG                     A076262   003    Jul   01,   2002

AB       WATSON LABS             12.5MG;10MG                   A076194   003    Jul   01,   2002

AB                               12.5MG;20MG                   A076194   001    Jul   01,   2002

AB                               25MG;20MG                     A076194   002    Jul   01,   2002

    PRINZIDE
	
AB       MERCK                   12.5MG;10MG                   N019778 003 Nov 18, 1993

AB                               12.5MG;20MG                   N019778 001 Feb 16, 1989

    ZESTORETIC
	
AB       ASTRAZENECA             12.5MG;10MG                   N019888 003 Nov 18, 1993

AB    +                          12.5MG;20MG                   N019888 001 Sep 20, 1990

AB    +                          25MG;20MG                     N019888 002 Jul 20, 1989
	
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
	
  TABLET;ORAL

    HYZAAR
	
AB       MERCK SHARP DOHME      12.5MG;50MG                    N020387 001 Apr 28, 1995

AB                              12.5MG;100MG                   N020387 003 Oct 20, 2005

AB    +                         25MG;100MG                     N020387 002 Nov 10, 1998

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
	
AB       ALEMBIC PHARMS LTD     12.5MG;50MG                    A091617   001    Feb   17,   2012

AB                              12.5MG;100MG                   A091617   002    Feb   17,   2012

AB                              25MG;100MG                     A091617   003    Feb   17,   2012

AB       APOTEX                 12.5MG;50MG                    A090150   001    Oct   06,   2010

AB                              12.5MG;100MG                   A090150   002    Aug   11,   2010

AB                              25MG;100MG                     A090150   003    Oct   06,   2010

AB       AUROBINDO PHARMA       12.5MG;50MG                    A091629   001    Oct   06,   2010

AB                              12.5MG;100MG                   A091629   002    Oct   06,   2010

AB                              25MG;100MG                     A091629   003    Jan   06,   2010

AB       CADISTA PHARMS         12.5MG;50MG                    A201845   001    Sep   18,   2012

AB                              12.5MG;100MG                   A201845   002    Sep   18,   2012

AB                              25MG;100MG                     A201845   003    Sep   18,   2012

AB       IPCA LABS LTD          12.5MG;50MG                    A201682   001    Mar   01,   2013

AB                              12.5MG;100MG                   A201682   002    Mar   01,   2013

AB                              25MG;100MG                     A201682   003    Mar   01,   2013

AB       LUPIN LTD              12.5MG;50MG                    A078245   001    Oct   06,   2010

AB                              12.5MG;100MG                   A078245   002    May   21,   2010

AB                              25MG;100MG                     A078245   003    Oct   06,   2010

AB       MACLEODS PHARMS LTD    12.5MG;50MG                    A202289   001    Aug   09,   2012

AB                              12.5MG;100MG                   A202289   002    Aug   09,   2012

AB                              25MG;100MG                     A202289   003    Aug   09,   2012

AB       MYLAN                  12.5MG;50MG                    A091652   001    Oct   06,   2010

AB                              12.5MG;100MG                   A091652   002    Apr   06,   2010

AB                              25MG;100MG                     A091652   003    Oct   06,   2010

AB       ROXANE                 12.5MG;50MG                    A077732   002    Oct   06,   2010

AB                              12.5MG;100MG                   A077732   001    Apr   06,   2010

AB                              25MG;100MG                     A077732   003    Oct   06,   2010

AB       SANDOZ                 12.5MG;50MG                    A077948   001    Oct   06,   2010

AB                              12.5MG;100MG                   A077948   003    Aug   19,   2010

AB                              25MG;100MG                     A077948   002    Oct   06,   2010

AB       TEVA PHARMS            12.5MG;50MG                    A077157   001    Apr   06,   2010

AB                              12.5MG;100MG                   A077157   002    Apr   06,   2010

AB                              25MG;100MG                     A077157   003    Apr   06,   2010

AB       TORRENT PHARMS         12.5MG;50MG                    A090528   001    Oct   06,   2010

AB                              12.5MG;100MG                   A090528   003    Apr   06,   2010

AB                              25MG;100MG                     A090528   002    Oct   06,   2010

AB       ZYDUS PHARMS USA INC   12.5MG;50MG                    A078385   001    Oct   06,   2010

AB                              25MG;100MG                     A078385   002    Oct   06,   2010
	
HYDROCHLOROTHIAZIDE; METHYLDOPA
	
  TABLET;ORAL
	
    METHYLDOPA AND HYDROCHLOROTHIAZIDE
	
         MYLAN                   15MG;250MG                    A070265 002 Jan 23, 1986
	
      +                          25MG;250MG                    A070265 001 Jan 23, 1986
	
HYDROCHLOROTHIAZIDE; METOPROLOL SUCCINATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DUTOPROL
	
         COVIS PHARMA SARL       12.5MG;EQ 25MG TARTRATE       N021956 001 Aug 28, 2006

                                 12.5MG;EQ 50MG TARTRATE       N021956 002 Aug 28, 2006

      +                          12.5MG;EQ 100MG TARTRATE      N021956 003 Aug 28, 2006
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-183(of 371)


HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
	
  TABLET;ORAL

    LOPRESSOR HCT
	
AB       US PHARMS HOLDINGS I   25MG;50MG                      N018303 001 Dec 31, 1984

AB    +                         25MG;100MG                     N018303 002 Dec 31, 1984

    METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
	
AB       ALEMBIC PHARMS LTD     25MG;50MG                      A202870   001    Nov   06,   2013

AB                              25MG;100MG                     A202870   002    Nov   06,   2013

AB                              50MG;100MG                     A202870   003    Nov   06,   2013

AB       MYLAN                  25MG;50MG                      A076792   001    Aug   20,   2004

AB                              25MG;100MG                     A076792   002    Aug   20,   2004

AB                              50MG;100MG                     A076792   003    Aug   20,   2004

AB       SUN PHARM INDS         25MG;50MG                      A090654   001    Jan   19,   2012

AB                              25MG;100MG                     A090654   002    Jan   19,   2012

AB                              50MG;100MG                     A090654   003    Jan   19,   2012
	
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
	
  TABLET;ORAL

    MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
AB       GLENMARK PHARMS        12.5MG;7.5MG                   A090718   001    Mar   17,   2010

AB                              12.5MG;15MG                    A090718   002    Mar   17,   2010

AB                              25MG;15MG                      A090718   003    Mar   17,   2010

AB       TEVA                   12.5MG;7.5MG                   A076980   001    Mar   07,   2007

AB                              12.5MG;15MG                    A076980   003    Mar   07,   2007

AB                              25MG;15MG                      A076980   002    Mar   07,   2007

    MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE
	
AB       HERITAGE PHARMS INC    12.5MG;7.5MG                   A202150 001 Mar 07, 2014

AB                              12.5MG;15MG                    A202150 002 Mar 07, 2014

AB                              25MG;15MG                      A202150 003 Mar 07, 2014

    UNIRETIC
	
AB       UCB INC                12.5MG;7.5MG                   N020729 001 Jun 27, 1997

AB                              12.5MG;15MG                    N020729 003 Feb 14, 2002

AB    +                         25MG;15MG                      N020729 002 Jun 27, 1997
	
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
	
  TABLET;ORAL
	
    BENICAR HCT
	
         DAIICHI SANKYO         12.5MG;20MG                    N021532 002 Jun 05, 2003
	
                                12.5MG;40MG                    N021532 003 Jun 05, 2003
	
      +                         25MG;40MG                      N021532 005 Jun 05, 2003
	
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
	
  TABLET;ORAL

    INDERIDE-40/25

AB    + WYETH PHARMS INC        25MG;40MG                      N018031 001
	
    PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
AB       MYLAN                  25MG;40MG                      A070947   002    Mar   04,   1987

AB    +                         25MG;80MG                      A070947   001    Apr   01,   1987

AB       PLIVA                  25MG;40MG                      A072042   001    Mar   14,   1988

AB                              25MG;80MG                      A072043   001    Mar   14,   1988
	
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
	
  TABLET;ORAL

    ACCURETIC
	
AB       PFIZER PHARMS          12.5MG;EQ 10MG BASE            N020125 001 Dec 28, 1999

AB                              12.5MG;EQ 20MG BASE            N020125 002 Dec 28, 1999

AB    +                         25MG;EQ 20MG BASE              N020125 003 Dec 28, 1999

    QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

AB       APOTEX CORP            12.5MG;EQ 10MG BASE            A091524   001    Mar   12,   2013

AB                              12.5MG;EQ 20MG BASE            A091524   002    Mar   12,   2013

AB                              25MG;EQ 20MG BASE              A091524   003    Mar   12,   2013

AB       AUROBINDO PHARMA       12.5MG;EQ 10MG BASE            A078450   001    Aug   24,   2007

AB                              12.5MG;EQ 20MG BASE            A078450   002    Aug   24,   2007

AB                              25MG;EQ 20MG BASE              A078450   003    Aug   24,   2007

AB       INVAGEN PHARMS         12.5MG;10MG                    A201356   001    Apr   20,   2011

AB                              12.5MG;20MG                    A201356   002    Apr   20,   2011

AB                              25MG;20MG                      A201356   003    Apr   20,   2011

AB       MYLAN                  12.5MG;EQ 10MG BASE            A077093   001    Mar   28,   2005

AB                              12.5MG;EQ 20MG BASE            A077093   002    Mar   28,   2005

AB                              25MG;EQ 20MG BASE              A077093   003    Mar   28,   2005

AB       RANBAXY                12.5MG;EQ 10MG BASE            A078211   001    Mar   04,   2009

AB                              12.5MG;EQ 20MG BASE            A078211   002    Mar   04,   2009

AB                              25MG;EQ 20MG BASE              A078211   003    Mar   04,   2009
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-184(of 371)


HYDROCHLOROTHIAZIDE; QUINAPRIL   HYDROCHLORIDE
	
  TABLET;ORAL

    QUINARETIC

AB       GAVIS PHARMS            12.5MG;EQ 10MG BASE           A076374 001 Mar 31, 2004

AB                               12.5MG;EQ 20MG BASE           A076374 002 Mar 31, 2004

AB                               25MG;EQ 20MG BASE             A076374 003 Mar 31, 2004
	
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
	
  TABLET;ORAL

    ALDACTAZIDE
	
AB       GD SEARLE LLC          25MG;25MG                      N012616 004 Dec 30, 1982

    SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
	
AB       MUTUAL PHARM           25MG;25MG                      A089534 001 Jul 02, 1987

AB       MYLAN                  25MG;25MG                      A086513 001
	
    ALDACTAZIDE
	
      + GD SEARLE LLC           50MG;50MG                      N012616 005 Dec 30, 1982
	
HYDROCHLOROTHIAZIDE; TELMISARTAN
	
  TABLET;ORAL

    MICARDIS HCT
	
AB       BOEHRINGER INGELHEIM   12.5MG;40MG                    N021162 001 Nov 17, 2000

AB                              12.5MG;80MG                    N021162 002 Nov 17, 2000

AB    +                         25MG;80MG                      N021162 003 Apr 19, 2004

    TELMISARTAN AND HYDROCHLOROTHIAZIDE
	
AB       ALEMBIC PHARMS LTD     12.5MG;40MG                    A203010   001    Feb   25,   2014

AB                              12.5MG;80MG                    A203010   002    Feb   25,   2014

AB                              25MG;80MG                      A203010   003    Feb   25,   2014

AB       LUPIN LTD              12.5MG;40MG                    A091351   001    Aug   07,   2014

AB                              12.5MG;80MG                    A091351   002    Aug   07,   2014

AB                              25MG;80MG                      A091351   003    Aug   07,   2014

AB       MYLAN PHARMS INC       12.5MG;40MG                    A091648   001    Feb   25,   2014

AB                              12.5MG;80MG                    A091648   002    Feb   25,   2014

AB                              25MG;80MG                      A091648   003    Feb   25,   2014

AB       TORRENT PHARMS LTD     12.5MG;40MG                    A201192   001    Feb   25,   2014

AB                              12.5MG;80MG                    A201192   002    Feb   25,   2014

AB                              25MG;80MG                      A201192   003    Feb   25,   2014
	
HYDROCHLOROTHIAZIDE; TRIAMTERENE
	
  CAPSULE;ORAL

    DYAZIDE
	
AB    + GLAXOSMITHKLINE LLC     25MG;37.5MG                    N016042 003 Mar 03, 1994

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE
	
AB       DURAMED PHARMS BARR    25MG;37.5MG                    A075052   001    Jun   18,   1999

AB       IVAX SUB TEVA PHARMS   25MG;50MG                      A074259   001    Mar   30,   1995

AB       LANNETT HOLDINGS INC   25MG;37.5MG                    A201407   001    Dec   09,   2011

AB       MYLAN                  25MG;37.5MG                    A074701   001    Jun   07,   1996

AB       SANDOZ                 25MG;37.5MG                    A074821   001    Jun   05,   1997

AB    +                         25MG;50MG                      A073191   001    Jul   31,   1991
	
  TABLET;ORAL

    MAXZIDE
	
AB    + MYLAN PHARMS INC        50MG;75MG                      N019129 001 Oct 22, 1984

    MAXZIDE-25
	
AB       MYLAN PHARMS INC       25MG;37.5MG                    N019129 003 May 13, 1988

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE
	
AB       APOTEX INC             25MG;37.5MG                    A071251   002    May   05,   1998

AB                              50MG;75MG                      A071251   001    Apr   17,   1988

AB       PLIVA                  25MG;37.5MG                    A074026   001    Apr   26,   1996

AB                              50MG;75MG                      A073467   001    Jan   31,   1996

AB       SANDOZ                 25MG;37.5MG                    A073281   001    Apr   30,   1992

AB                              50MG;75MG                      A072011   001    Jun   17,   1988

AB       WATSON LABS            25MG;37.5MG                    A073449   001    Sep   23,   1993

AB                              50MG;75MG                      A071851   001    Nov   30,   1988
	
HYDROCHLOROTHIAZIDE; VALSARTAN
	
  TABLET;ORAL

    DIOVAN HCT
	
AB       NOVARTIS                12.5MG;80MG                   N020818   001    Mar   06,   1998

AB                               12.5MG;160MG                  N020818   002    Mar   06,   1998

AB                               12.5MG;320MG                  N020818   004    Apr   28,   2006

AB                               25MG;160MG                    N020818   003    Jan   17,   2002

AB    +                          25MG;320MG                    N020818   005    Apr   28,   2006

    VALSARTAN AND HYDROCHLOROTHIAZIDE
	
AB       ALEMBIC LTD             12.5MG;80MG                   A201662 001 Mar 21, 2013

AB                               12.5MG;160MG                  A201662 002 Mar 21, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-185(of 371)


HYDROCHLOROTHIAZIDE; VALSARTAN
	
  TABLET;ORAL

    VALSARTAN AND HYDROCHLOROTHIAZIDE
	
AB                               12.5MG;320MG                   A201662   003    Mar   21,   2013

AB                               25MG;160MG                     A201662   004    Mar   21,   2013

AB                               25MG;320MG                     A201662   005    Mar   21,   2013

AB       APOTEX INC              12.5MG;80MG                    A203026   001    Mar   21,   2013

AB                               12.5MG;160MG                   A203026   002    Mar   21,   2013

AB                               12.5MG;320MG                   A203026   003    Mar   21,   2013

AB                               25MG;160MG                     A203026   004    Mar   21,   2013

AB                               25MG;320MG                     A203026   005    Mar   21,   2013

AB       AUROBINDO PHARMA LTD    12.5MG;80MG                    A202519   001    Mar   21,   2013

AB                               12.5MG;160MG                   A202519   002    Mar   21,   2013

AB                               12.5MG;320MG                   A202519   003    Mar   21,   2013

AB                               25MG;160MG                     A202519   004    Mar   21,   2013

AB                               25MG;320MG                     A202519   005    Mar   21,   2013

AB       LUPIN LTD               12.5MG;80MG                    A078946   003    Mar   21,   2013

AB                               12.5MG;160MG                   A078946   004    Mar   21,   2013

AB                               12.5MG;320MG                   A078946   001    Mar   21,   2013

AB                               25MG;160MG                     A078946   005    Mar   21,   2013

AB                               25MG;320MG                     A078946   002    Mar   21,   2013

AB       MACLEODS PHARMS LTD     12.5MG;80MG                    A203145   001    Apr   19,   2013

AB                               12.5MG;160MG                   A203145   002    Apr   19,   2013

AB                               12.5MG;320MG                   A203145   003    Apr   19,   2013

AB                               25MG;160MG                     A203145   004    Apr   19,   2013

AB                               25MG;320MG                     A203145   005    Apr   19,   2013

AB       MYLAN PHARMS INC        12.5MG;80MG                    A078020   001    Sep   21,   2012

AB                               12.5MG;160MG                   A078020   002    Sep   21,   2012

AB                               12.5MG;320MG                   A078020   004    Sep   21,   2012

AB                               25MG;160MG                     A078020   003    Sep   21,   2012

AB                               25MG;320MG                     A078020   005    Sep   21,   2012

AB       WATSON LABS INC         12.5MG;80MG                    A091519   001    Mar   21,   2013

AB                               12.5MG;160MG                   A091519   002    Mar   21,   2013

AB                               12.5MG;320MG                   A091519   003    Mar   21,   2013

AB                               25MG;160MG                     A091519   004    Mar   21,   2013

AB                               25MG;320MG                     A091519   005    Mar   21,   2013
	
HYDROCODONE BITARTRATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    ZOHYDRO ER
	
      +		 ZOGENIX INC            10MG                           N202880   001    Oct   25,   2013
	
                                 15MG                           N202880   002    Oct   25,   2013
	
                                 20MG                           N202880   003    Oct   25,   2013
	
                                 30MG                           N202880   004    Oct   25,   2013
	
                                 40MG                           N202880   005    Oct   25,   2013
	
                                 50MG                           N202880   006    Oct   25,   2013
	
  TABLET, EXTENDED RELEASE;ORAL
	
    HYSINGLA
	
          PURDUE PHARMA LP       20MG		                         N206627   001    Nov   20,   2014
	
                                 30MG		                         N206627   002    Nov   20,   2014
	
                                 40MG		                         N206627   003    Nov   20,   2014
	
                                 60MG		                         N206627   004    Nov   20,   2014
	
                                 80MG		                         N206627   005    Nov   20,   2014
	
                                 100MG		                        N206627   006    Nov   20,   2014
	
                                 120MG		                        N206627   007    Nov   20,   2014
	
HYDROCODONE BITARTRATE; IBUPROFEN
	
  TABLET;ORAL

    HYDROCODONE BITARTRATE AND IBUPROFEN
	
AB       ACTAVIS LABS FL INC    5MG;200MG                       A077454   001    Jun   23,   2010

AB                              7.5MG;200MG                     A076604   001    Dec   31,   2003

AB       AMNEAL PHARMS NY       5MG;200MG                       A076642   002    Mar   18,   2004

AB                              7.5MG;200MG                     A076642   001    Oct   12,   2004

AB       SUN PHARM INDS INC     2.5MG;200MG                     A091633   001    May   28,   2013

AB                              5MG;200MG                       A091633   002    May   28,   2013

AB                              7.5MG;200MG                     A091633   003    May   28,   2013

AB                              10MG;200MG                      A091633   004    May   28,   2013

AB       TEVA                   7.5MG;200MG                     A076023   001    Apr   11,   2003

AB       VINTAGE PHARMS         5MG;200MG                       A077727   001    Nov   06,   2006

AB                              7.5MG;200MG                     A077723   001    Nov   06,   2006

AB                              10MG;200MG                      A077723   002    Nov   06,   2006

    REPREXAIN
	
AB       AMNEAL PHARMS NY       2.5MG;200MG                     A076642 003 Oct 19, 2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-186(of 371)


HYDROCODONE BITARTRATE; IBUPROFEN
	
  TABLET;ORAL

    REPREXAIN
	
AB                              10MG;200MG                       A076642 004 Oct 19, 2007

    VICOPROFEN
	
AB    + ABBVIE                  7.5MG;200MG                      N020716 001 Sep 23, 1997
	
HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  SOLUTION;ORAL

    HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
AA       PADDOCK LLC            5MG/5ML;60MG/5ML                 A204658 001 Apr 29, 2014

AA       TRIS PHARMA INC        5MG/5ML;60MG/5ML                 A203839 001 Oct 28, 2014

    REZIRA
	
AA    + CYPRESS PHARM           5MG/5ML;60MG/5ML                 N022442 001 Jun 08, 2011
	
HYDROCORTISONE
	
  CREAM;TOPICAL

    ALA-CORT
	
AT       CROWN LABS               1%                             A080706 006
	
    ANUSOL HC
	
AT       SALIX PHARMS             2.5%                           A088250 001 Jun 06, 1984

    HYDROCORTISONE
	
AT       ACTAVIS MID ATLANTIC     1%                             A087795   001     May 03, 1983

AT                                2.5%                           A089682   001     Mar 10, 1988

AT    + FOUGERA                   1%                             A080693   003
	
AT    +                           2.5%                           A089414   001     Dec 16, 1986

AT       LYNE                     2.5%                           A040879   001     Aug 20, 2010

AT       PERRIGO NEW YORK         2.5%                           A085025   001
	
AT       TARO                     2.5%                           A088799   001     Nov 09, 1984

AT       VINTAGE PHARMS           2.5%                           A040503   001     Mar 12, 2004

    SYNACORT
	
AT       MEDICIS                  1%                             A087458 001
	
AT                                2.5%                           A087457 001
	
  ENEMA;RECTAL

    COLOCORT
	
AB       PADDOCK LLC              100MG/60ML                     A075172 001 Dec 03, 1999

    CORTENEMA
	
AB    + ANI PHARMS                100MG/60ML                     N016199 001
	
    HYDROCORTISONE
	
AB       TEVA PHARMS              100MG/60ML                     A074171 001 May 27, 1994

  LOTION;TOPICAL

    HYDROCORTISONE
	
AT    + FOUGERA PHARMS            2.5%                           A040351 001 Jul 25, 2000

AT       TARO                     2.5%                           A040247 001 Jul 23, 1999

AT       VINTAGE PHARMS           2.5%                           A040417 001 Jul 30, 2003

    NUTRACORT
	
AT       DOW PHARM                2.5%                           A087644 001 Aug 24, 1982

    STIE-CORT
	
AT       PERRIGO                  2.5%                           A089074 001 Nov 26, 1985
	
    ALA-SCALP
	
         CROWN LABS               2%                             A083231 001
	
  OINTMENT;TOPICAL

    HYDROCORTISONE
	
AT       ACTAVIS MID ATLANTIC     1%                             A087796   001 Oct 13, 1982

AT    + FOUGERA                   2.5%                           A081203   001 May 28, 1993

AT    + FOUGERA PHARMS            1%                             A080692   001
	
AT       PERRIGO NEW YORK         2.5%                           A085027   001
	
AT       TARO                     1%                             A086257   001
	
    HYDROCORTISONE IN ABSORBASE
	
AT       CAROLINA MEDCL           1%                             A088138 001 Sep 06, 1985

  POWDER;FOR RX COMPOUNDING
	
    HYDRO-RX
	
      + X GEN PHARMS              100%                           A085982 001
	
  SOLUTION;TOPICAL
	
    TEXACORT
	
      + MISSION PHARMA            2.5%                           A081271 001 Apr 17, 1992

  TABLET;ORAL

    CORTEF
	
AB       PHARMACIA AND UPJOHN     5MG                            N008697 003
	
AB                                10MG                           N008697 001
	
AB    +                           20MG                           N008697 002
	
    HYDROCORTISONE
	
AB       AMEDRA PHARMS            5MG                            A040646 001 Mar 30, 2007
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                               3-187(of 371)


HYDROCORTISONE
	
  TABLET;ORAL

    HYDROCORTISONE
AB                               10MG
	                                   A040646   002    Mar   30,   2007

AB                               20MG
	                                   A040646   003    Mar   30,   2007

AB       VINTAGE                 5MG
	                                    A040761   001    Jul   16,   2007

AB                               10MG
	                                   A040761   002    Jul   16,   2007

AB                               20MG
	                                   A040761   003    Jul   16,   2007
	
HYDROCORTISONE ACETATE
	
  AEROSOL, METERED;RECTAL
	
    CORTIFOAM
	
      + MEDA PHARMS
	            10%
	                                    N017351 001 Feb 10, 1982
	
  CREAM;TOPICAL
	
    HYDROCORTISONE ACETATE
	
      + FERNDALE LABS
	          2.5%
	                                   A040259 001 Jul 29, 1999
	
    MICORT-HC
	
      + SEBELA IRELAND LTD
	     2%
	                                     A040398 001 Mar 29, 2002
	
                                 2.5%
	                                   A040396 001 Feb 27, 2001
	
 POWDER;FOR RX COMPOUNDING
	
   HYDROCORTISONE ACETATE
	
        X GEN PHARMS
	           100%
	                                   A085981 001
	
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  CREAM;TOPICAL
	
    CORTISPORIN
	
      + MONARCH PHARMS          0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
	   N050218 001 Aug 09, 1985
	
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
	
  AEROSOL, METERED;TOPICAL
	
    EPIFOAM
	
BX       MEDA PHARMS
	          1%;1%
	                                   A086457 001
	
    PROCTOFOAM HC
	
BX       MEDA PHARMS
	          1%;1%
	                                   A086195 001
	
  CREAM;TOPICAL
	
    PRAMOSONE
	
         SEBELA IRELAND LTD
	   0.5%;1%
	                                 A083778 001
	
                                1%;1%
	                                   A085368 001
	
  LOTION;TOPICAL
	
    PRAMOSONE
	
         SEBELA IRELAND LTD
	   1%;1%
	                                   A085980 001
	
                                2.5%;1%
	                                 A085979 001
	
HYDROCORTISONE ACETATE; UREA
	
  CREAM;TOPICAL
	
    U-CORT
	
         TARO
	                  1%;10%
	                                 A089472 001 Jun 13, 1988
	
HYDROCORTISONE BUTYRATE
	
  CREAM;TOPICAL

    HYDROCORTISONE BUTYRATE
	
AB1      TARO PHARM INDS
	       0.1%
	                                   A076654 001 Aug 03, 2005
	
    LOCOID
	
AB1 + PRECISION DERMAT
	         0.1%
	                                   N018514 001 Mar 31, 1982
	
    HYDROCORTISONE BUTYRATE
	
AB2      GLENMARK GENERICS
	     0.1%
	                                   A202145 001 Sep 27, 2013
	
    LOCOID LIPOCREAM
	
AB2 + PRECISION DERMAT
	         0.1%
	                                   N020769 001 Sep 08, 1997
	
  LOTION;TOPICAL
	
    LOCOID
	
      + PRECISION DERMAT
	       0.1%
	                                   N022076 001 May 18, 2007
	
  OINTMENT;TOPICAL

    HYDROCORTISONE BUTYRATE
	
AB       TARO
	                  0.1%
	                                   A076842 001 Dec 27, 2004
	
    LOCOID
	
AB    + PRECISION DERMAT
	       0.1%
	                                   N018652 001 Oct 29, 1982
	
  SOLUTION;TOPICAL

    HYDROCORTISONE BUTYRATE
	
AT       TARO PHARM INDS
	       0.1%
	                                   A076364 001 Jan 14, 2004
	
    LOCOID
	
AT    + PRECISION DERMAT
	       0.1%
	                                   N019116 001 Feb 25, 1987
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                             3-188(of 371)


HYDROCORTISONE PROBUTATE
	
  CREAM;TOPICAL
	
    PANDEL
	
      + FOUGERA PHARMS            0.1%                                  N020453 001 Feb 28, 1997
	
HYDROCORTISONE SODIUM SUCCINATE
	
  INJECTABLE;INJECTION

    A-HYDROCORT
	
AP       HOSPIRA                 EQ   100MG BASE/VIAL                   A040666 001 Apr 06, 2006

    SOLU-CORTEF
	
AP    + PHARMACIA AND UPJOHN     EQ   1GM BASE/VIAL                     N009866   004
	
AP    +                          EQ   100MG BASE/VIAL                   N009866   001
	
AP    +                          EQ   250MG BASE/VIAL                   N009866   002
	
AP    +                          EQ   500MG BASE/VIAL                   N009866   003
	
HYDROCORTISONE VALERATE
	
  CREAM;TOPICAL

    HYDROCORTISONE VALERATE
	
AB       PERRIGO NEW YORK         0.2%                                  A075666 001 May 24, 2000

AB    + TARO                      0.2%                                  A075042 001 Aug 25, 1998

  OINTMENT;TOPICAL
	
    HYDROCORTISONE VALERATE
	
      + TARO                      0.2%                                  A075043 001 Aug 25, 1998
	
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  SOLUTION/DROPS;OTIC

    CORTISPORIN
	
AT    + MONARCH PHARMS          1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   N050479 001
	
    NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
	
AT       ALCON PHARMS LTD       1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A062423 001 Aug 25, 1983
AT       BAUSCH AND LOMB        1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A064053 001 Dec 29, 1995
AT       LUITPOLD               1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A065216 001 Oct 31, 2005
  SUSPENSION/DROPS;OPHTHALMIC
    NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
      + ALCON PHARMS LTD        1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A062874 001 May 11, 1988
  SUSPENSION/DROPS;OTIC
    CORTISPORIN
AT    + CITRON PHARMA LLC       1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A060613 001
    NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
AT       ALCON PHARMS LTD       1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A062488 001 Nov 06, 1985
AT       LUITPOLD               1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A065219 001 May 01, 2006
    OTICAIR
AT       BAUSCH AND LOMB        1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A064065 001 Aug 28, 1996
    PEDIOTIC
AT       MONARCH PHARMS         1%;EQ 3.5MG BASE/ML;10,000   UNITS/ML   A062822 001 Sep 29, 1987
HYDROFLUMETHIAZIDE
  TABLET;ORAL
    SALURON
AB    + SHIRE LLC                 50MG                                  N011949 001
HYDROMORPHONE HYDROCHLORIDE
  INJECTABLE;INJECTION
    DILAUDID
AP    + PURDUE PHARM PRODS        1MG/ML                                N019034 003 Apr 30, 2009
AP    +                           2MG/ML                                N019034 004 Apr 30, 2009
AP    +                           4MG/ML                                N019034 005 Apr 30, 2009
    DILAUDID-HP
AP    + PURDUE PHARM PRODS        10MG/ML                               N019034 001 Jan 11, 1984
    HYDROMORPHONE HYDROCHLORIDE
AP       AKORN                    10MG/ML                               A078228   001     Apr   14,   2010
AP                                10MG/ML                               A078261   001     Apr   14,   2010
AP       BARR                     10MG/ML                               A076444   001     Apr   25,   2003
AP       HOSPIRA                  10MG/ML                               A074598   001     Jun   19,   1997
AP       HOSPIRA INC              1MG/ML                                N200403   001     Dec   01,   2011
AP                                2MG/ML                                N200403   002     Dec   01,   2011
AP                                4MG/ML                                N200403   003     Dec   01,   2011
AP                                10MG/ML                               A078591   001     Jun   17,   2008
    DILAUDID-HP
      + PURDUE PHARM PRODS        250MG/VIAL                            N019034 002 Aug 04, 1994
  SOLUTION;ORAL
    DILAUDID
AA    + PURDUE PHARM PRODS        5MG/5ML                               N019891 001 Dec 07, 1992
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-189(of 371)


HYDROMORPHONE HYDROCHLORIDE
	
  SOLUTION;ORAL

    HYDROMORPHONE HYDROCHLORIDE
	
AA       ROXANE                   5MG/5ML                       A074653 001 Jul 29, 1998
	
  TABLET;ORAL

    DILAUDID
	
AB       PURDUE PHARM PRODS       2MG                           N019892 003 Nov 09, 2007

AB                                4MG                           N019892 002 Nov 09, 2007

AB    +                           8MG                           N019892 001 Dec 07, 1992

    HYDROMORPHONE HYDROCHLORIDE
	
AB       ELITE LABS               8MG                           A076723   001    Oct   18,   2005

AB       LANNETT                  2MG                           A078439   001    Dec   09,   2009

AB                                4MG                           A078439   002    Dec   09,   2009

AB                                8MG                           A077471   001    Dec   09,   2009

AB       MALLINCKRODT             8MG                           A076855   001    Dec   23,   2004

AB       MALLINCKRODT INC         2MG                           A078273   001    Sep   19,   2007

AB                                4MG                           A078273   002    Sep   19,   2007

AB       ROXANE                   4MG                           A074597   003    May   29,   2009

AB                                8MG                           A074597   001    Jul   29,   1998
	
  TABLET, EXTENDED RELEASE;ORAL

    EXALGO
	
AB       MALLINCKRODT INC         8MG                           N021217 001 Mar 01, 2010

AB                                12MG                          N021217 002 Mar 01, 2010

AB                                16MG                          N021217 003 Mar 01, 2010

    HYDROMORPHONE HYDROCHLORIDE
	
AB       ACTAVIS LABS FL INC      8MG                           A202144 001 May 12, 2014

AB                                12MG                          A202144 002 May 12, 2014

AB                                16MG                          A202144 003 May 12, 2014

    EXALGO
	
      + MALLINCKRODT INC          32MG                          N021217 004 Aug 24, 2012
	
HYDROXOCOBALAMIN
	
  INJECTABLE;INJECTION
	
    CYANOKIT
	
      + MERCK SANTE SAS           5GM/VIAL (5GM/KIT)            N022041 001 Apr 08, 2011

    HYDROXOCOBALAMIN
	
      + WATSON LABS               1MG/ML                        A085998 001
	
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    PAREMYD
	
      + AKORN                   1%;0.25%                        N019261 001 Jan 30, 1992
	
HYDROXYCHLOROQUINE SULFATE
	
  TABLET;ORAL

    HYDROXYCHLOROQUINE SULFATE

AB       HIKMA PHARMS LLC         200MG                         A040760   001    Aug   15,   2007

AB       IPCA LABS LTD            200MG                         A040766   001    Jun   14,   2007

AB       MYLAN                    200MG                         A040274   001    May   29,   1998

AB       SANDOZ                   200MG                         A040104   001    Nov   30,   1995

AB       TEVA PHARMS              200MG                         A040081   001    Sep   30,   1994

AB       ZYDUS PHARMS USA INC     200MG                         A040657   001    Sep   21,   2007

    PLAQUENIL

AB    + SANOFI AVENTIS US         200MG                         N009768 001
	
HYDROXYPROGESTERONE CAPROATE
	
  SOLUTION;INTRAMUSCULAR
	
    MAKENA
	
      + LUMARA HEALTH INC         1250MG/5ML (250MG/ML)         N021945 001 Feb 03, 2011
	
HYDROXYPROPYL CELLULOSE
	
  INSERT;OPHTHALMIC
	
    LACRISERT
	
      + ATON                      5MG                           N018771 001
	
HYDROXYUREA
	
  CAPSULE;ORAL

    HYDREA
	
AB    + BRISTOL MYERS SQUIBB      500MG                         N016295 001
	
    HYDROXYUREA
	
AB       BARR                     500MG                         A075143 001 Oct 16, 1998

AB       PAR PHARM                500MG                         A075340 001 Feb 24, 1999
	
    DROXIA
	
         BRISTOL MYERS SQUIBB     200MG                         N016295 002 Feb 25, 1998
	
                                  300MG                         N016295 003 Feb 25, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-190(of 371)


HYDROXYUREA
	
  CAPSULE;ORAL
	
    DROXIA
	
                                  400MG                        N016295 004 Feb 25, 1998
	
HYDROXYZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    HYDROXYZINE HYDROCHLORIDE
	
AP    + FRESENIUS KABI USA        25MG/ML                      A087329   001
	
AP    +                           50MG/ML                      A087329   002
	
AP       LUITPOLD                 25MG/ML                      A087408   001
	
AP                                50MG/ML                      A087408   002
	
  SYRUP;ORAL

    HYDROXYZINE HYDROCHLORIDE
	
AA    + HI TECH PHARMA            10MG/5ML                     A040010   001     Oct   28,   1994

AA       SILARX PHARMS INC        10MG/5ML                     A201674   001     Aug   21,   2013

AA    + VINTAGE PHARMS            10MG/5ML                     A040391   001     Apr   10,   2002

AA    + WOCKHARDT                 10MG/5ML                     A087294   001     Apr   12,   1982

  TABLET;ORAL

    HYDROXYZINE HYDROCHLORIDE
	
AB       AMNEAL PHARM             10MG                         A040808   001     Sep   24,   2008

AB                                25MG                         A040808   002     Sep   24,   2008

AB                                50MG                         A040808   003     Sep   24,   2008

AB       EMCURE PHARMS USA        10MG                         A204279   001     Aug   20,   2014

AB                                25MG                         A204279   002     Aug   20,   2014

AB                                50MG                         A204279   003     Aug   20,   2014

AB       HERITAGE PHARMS INC      10MG                         A040804   001     Jun   30,   2008

AB                                25MG                         A040804   002     Jun   30,   2008

AB                                50MG                         A040804   003     Jun   30,   2008

AB       HETERO LABS LTD III      10MG                         A040805   001     May   29,   2008

AB                                25MG                         A040805   002     May   29,   2008

AB                                50MG                         A040805   003     May   29,   2008

AB       INVAGEN PHARMS           10MG                         A040812   001     Mar   12,   2008

AB                                25MG                         A040812   002     Mar   12,   2008

AB                                50MG                         A040812   003     Mar   12,   2008

AB       KVK TECH                 10MG                         A040786   001     Mar   20,   2007

AB                                25MG                         A040787   001     Mar   20,   2007

AB                                50MG                         A040788   001     Mar   20,   2007

AB       MUTUAL PHARM             10MG                         A089381   001     May   19,   1986

AB                                25MG                         A089382   001     May   19,   1986

AB                                50MG                         A089383   001     May   19,   1986

AB       MYLAN                    10MG                         A091176   001     Jun   07,   2010

AB                                25MG                         A091176   002     Jun   07,   2010

AB                                50MG                         A091176   003     Jun   07,   2010

AB       NORTHSTAR HLTHCARE       10MG                         A040841   001     Mar   31,   2008

AB                                25MG                         A040842   001     Mar   31,   2008

AB                                50MG                         A040840   001     Mar   31,   2008

AB    + PLIVA                     10MG                         A088617   001     Jan   10,   1986

AB    +                           25MG                         A088618   001     Jan   10,   1986

AB    +                           50MG                         A088619   001     Jan   10,   1986

AB       SUN PHARM INDS INC       10MG                         A040899   001     Jun   10,   2008

AB                                25MG                         A040899   002     Jun   10,   2008

AB                                50MG                         A040899   003     Jun   10,   2008

AB       VINTAGE PHARMS           10MG                         A040579   001     May   27,   2005

AB                                25MG                         A040574   001     May   27,   2005

AB                                50MG                         A040580   001     May   27,   2005

AB       WATSON LABS              10MG                         A088348   001     Sep   15,   1983

AB                                25MG                         A088349   001     Sep   15,   1983

AB                                50MG                         A088350   001     Sep   15,   1983
	
HYDROXYZINE PAMOATE
	
  CAPSULE;ORAL

    HYDROXYZINE PAMOATE
	
AB       BARR                     EQ   25MG   HCL              A088496   001     Jun   15,   1984

AB                                EQ   50MG   HCL              A088487   001     Jun   15,   1984

AB       EMCURE PHARMS USA        EQ   25MG   HYDROCHLORIDE    A201507   001     Jun   03,   2013

AB                                EQ   50MG   HYDROCHLORIDE    A201507   002     Jun   03,   2013

AB       SANDOZ                   EQ   25MG   HCL              A087479   001
	
AB                                EQ   50MG   HCL              A086183   001
	
AB       WATSON LABS              EQ   25MG   HCL              A040156   001     Jul 15, 1996

AB                                EQ   50MG   HCL              A040156   002     Jul 15, 1996

    VISTARIL
	
AB       PFIZER                   EQ 25MG HCL                  N011459 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-191(of 371)


HYDROXYZINE PAMOATE
	
  CAPSULE;ORAL

    VISTARIL
	
AB    +                        EQ 50MG HCL                      N011459 004
	
    HYDROXYZINE PAMOATE
	
         BARR                  EQ 100MG HCL                     A088488 001 Jun 15, 1984
	
IBANDRONATE SODIUM
	
  INJECTABLE;INTRAVENOUS

    BONIVA
	
AP    + ROCHE                  EQ 3MG BASE/3ML                  N021858 001 Jan 06, 2006

    IBANDRONATE SODIUM
	
AP       AGILA SPECLTS         EQ   3MG   BASE/3ML              A202671   001    Sep   02,   2014

AP       EMCURE PHARMS LTD     EQ   3MG   BASE/3ML              A203987   001    Sep   02,   2014

AP       SAGENT PHARMS         EQ   3MG   BASE/3ML              A202235   001    Sep   02,   2014

AP       SUN PHARM INDS LTD    EQ   3MG   BASE/3ML              A090853   001    Feb   14,   2014
	
  TABLET;ORAL

    BONIVA
	
AB    + HOFFMANN LA ROCHE      EQ 150MG BASE                    N021455 002 Mar 24, 2005

    IBANDRONATE SODIUM
	
AB       APOTEX INC            EQ   150MG   BASE                A078948   001    Mar   19,   2012

AB       DR REDDYS LABS LTD    EQ   150MG   BASE                A078997   001    Apr   30,   2012

AB       MUTUAL PHARM CO INC   EQ   150MG   BASE                A078996   001    Aug   15,   2012

AB       MYLAN PHARMS INC      EQ   150MG   BASE                A078995   001    Mar   19,   2012

AB       ORCHID HLTHCARE       EQ   150MG   BASE                A078998   001    Mar   19,   2012

AB       WATSON LABS INC       EQ   150MG   BASE                A079003   001    Mar   20,   2012
	
IBRUTINIB
	
  CAPSULE;ORAL
	
    IMBRUVICA
	
      + PHARMACYCLICS INC      140MG                            N205552 001 Nov 13, 2013
	
IBUPROFEN
	
  SOLUTION;INTRAVENOUS
	
    CALDOLOR
	
      + CUMBERLAND PHARMS      800MG/8ML (100MG/ML)             N022348 002 Jun 11, 2009
	
  SUSPENSION;ORAL

    IBUPROFEN
	
AB    + ACTAVIS MID ATLANTIC   100MG/5ML                        A074978 001 Mar 25, 1998

AB       PERRIGO R AND D       100MG/5ML                        A076925 001 Sep 23, 2004

  TABLET;ORAL

    IBU-TAB
	
AB       ALRA                  400MG                            A071058 001 Aug 11, 1988

AB                             600MG                            A071059 001 Aug 11, 1988

    IBUPROFEN
	
AB       AMNEAL PHARMS NY      400MG                            A071334   001    Nov   25,   1986

AB                             400MG                            A078558   001    Jun   18,   2007

AB                             600MG                            A071335   001    Nov   25,   1986

AB                             600MG                            A078558   002    Jun   18,   2007

AB                             800MG                            A071935   001    Oct   13,   1987

AB                             800MG                            A078558   003    Jun   18,   2007

AB       CONTRACT PHARMACAL    400MG                            A071267   001    Oct   15,   1986

AB                             600MG                            A071268   001    Oct   15,   1986

AB                             800MG                            A072300   001    Jul   01,   1988

AB       DR REDDYS LA          400MG                            A075682   001    Nov   14,   2001

AB                             600MG                            A075682   002    Nov   14,   2001

AB    +                        800MG                            A075682   003    Nov   14,   2001

AB       DR REDDYS LABS INC    400MG                            A076112   001    Oct   31,   2001

AB                             600MG                            A076112   002    Oct   31,   2001

AB                             800MG                            A076112   003    Oct   31,   2001

AB       MARKSANS PHARMA       400MG                            A090796   001    Dec   21,   2010

AB                             600MG                            A090796   002    Dec   21,   2010

AB                             800MG                            A090796   003    Dec   21,   2010

AB       PERRIGO R AND D       400MG                            A077114   001    Jul   18,   2005

AB                             600MG                            A077114   002    Jul   18,   2005

AB                             800MG                            A077114   003    Jul   18,   2005

AB       SHASUN USA            400MG                            A078329   001    Feb   05,   2009

AB                             600MG                            A078329   002    Feb   05,   2009

AB                             800MG                            A078329   003    Feb   05,   2009

AB       VINTAGE PHARMS        300MG                            A071230   001    Oct   22,   1986

AB                             400MG                            A071231   001    Oct   22,   1986

AB                             400MG                            A071644   001    Feb   01,   1988

AB                             600MG                            A071232   001    Oct   22,   1986

AB                             800MG                            A072004   001    Nov   18,   1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                          3-192(of 371)


IBUPROFEN LYSINE
	
  INJECTABLE;INTRAVENOUS
	
    NEOPROFEN
	
      + RECORDATI RARE          EQ 20MG BASE/2ML (EQ 10MG BASE/ML)   N021903 001 Apr 13, 2006
	
IBUPROFEN; OXYCODONE HYDROCHLORIDE
	
  TABLET;ORAL

    OXYCODONE HYDROCHLORIDE AND IBUPROFEN
	
AB       ACTAVIS ELIZABETH      400MG;5MG                            A078769 001 Jan 04, 2008

AB    + BARR LABS INC           400MG;5MG                            A078316 001 Nov 29, 2007

AB       WATSON LABS            400MG;5MG                            A078394 001 Nov 26, 2007
	
IBUTILIDE FUMARATE
	
  INJECTABLE;INJECTION

    CORVERT
	
AP    + PHARMACIA AND UPJOHN    0.1MG/ML                             N020491 001 Dec 28, 1995

    IBUTILIDE FUMARATE
	
AP       LUITPOLD               0.1MG/ML                             A090240 001 Jan 11, 2010

AP       MYLAN INSTITUTIONAL    0.1MG/ML                             A090643 001 Jan 11, 2010

AP                              0.1MG/ML                             A090924 001 Jan 11, 2010
	
ICATIBANT ACETATE
	
  INJECTABLE;SUBCUTANEOUS
	
    FIRAZYR
	
      + SHIRE ORPHAN THERAP     EQ 30MG BASE/3ML (EQ 10MG BASE/ML)   N022150 001 Aug 25, 2011
	
ICODEXTRIN
	
  SOLUTION;INTRAPERITONEAL
	
    EXTRANEAL
	
      + BAXTER HLTHCARE         7.5GM/100ML                          N021321 001 Dec 20, 2002
	
ICOSAPENT ETHYL
	
  CAPSULE;ORAL
	
    VASCEPA
	
      + AMARIN PHARMS           1GM                                  N202057 001 Jul 26, 2012
	
IDARUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    IDAMYCIN PFS
	
AP    + PHARMACIA AND UPJOHN    1MG/ML                               N050734 001 Feb 17, 1997

    IDARUBICIN HYDROCHLORIDE
	
AP       EUROHLTH INTL          1MG/ML                               A065275   001    Dec   14,   2006

AP                              1MG/ML                               A065288   001    May   15,   2007

AP       FRESENIUS KABI USA     1MG/ML                               A065440   001    Aug   04,   2009

AP       ONCO THERAPIES LTD     1MG/ML                               A200144   001    Oct   11,   2012

    IDARUBICIN HYDROCHLORIDE PFS
	
AP       TEVA PHARMS USA        1MG/ML                               A065036 001 May 01, 2002
	
IDELALISIB
	
  TABLET;ORAL
	
    ZYDELIG
	
         GILEAD SCIENCES INC    100MG                                N205858 001 Jul 23, 2014
	
      +                         150MG                                N205858 002 Jul 23, 2014
	
IDOXURIDINE
	
  SOLUTION/DROPS;OPHTHALMIC

    DENDRID
	
AT    + ALCON                   0.1%                                 N014169 001
	
    HERPLEX
	
AT    + ALLERGAN                0.1%                                 N013935 002
	
IFOSFAMIDE
	
  INJECTABLE;INJECTION

    IFEX
	
AP         BAXTER HLTHCARE      1GM/VIAL                             N019763 001 Dec 30, 1988

AP                              3GM/VIAL                             N019763 002 Dec 30, 1988

    IFOSFAMIDE
	
AP         EUROHLTH INTL        1GM/20ML(50MG/ML)                    A076619   001    Jun   29,   2011

AP                              3GM/60ML(50MG/ML)                    A076619   002    Jun   29,   2011

AP    + FRESENIUS KABI USA      1GM/VIAL                             A076078   001    May   28,   2002

AP                              1GM/20ML (50MG/ML)                   A090181   001    Sep   22,   2009

AP    +                         3GM/VIAL                             A076078   002    May   28,   2002

AP                              3GM/60ML (50MG/ML)                   A090181   002    Sep   22,   2009

AP         ONCO THERAPIES LTD   1GM/20ML (50MG/ML)                   A201689   001    Nov   26,   2012

AP                              3GM/60ML (50MG/ML)                   A201689   002    Nov   26,   2012

AP    + TEVA PHARMS USA         1GM/20ML (50MG/ML)                   A076657   001    Apr   04,   2007

AP    +                         3GM/60ML (50MG/ML)                   A076657   002    Apr   04,   2007
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                             3-193(of 371)


IFOSFAMIDE; MESNA
	
  INJECTABLE;INTRAVENOUS
	
    IFOSFAMIDE/MESNA KIT

      + TEVA PHARMS USA		        1GM/20ML;1GM/10ML (50MG/ML;100MG/ML)
    A075874 001 Feb 26, 2002
	
      +                          3GM/60ML;1GM/10ML (50MG/ML;100MG/ML)
	   A075874 002 Feb 26, 2002
	
ILOPERIDONE
	
  TABLET;ORAL
	
    FANAPT
	
      +		 NOVARTIS               1MG
	                                    N022192   001     May   06,   2009

                                 2MG
	                                    N022192   002     May   06,   2009

                                 4MG
	                                    N022192   003     May   06,   2009

                                 6MG
	                                    N022192   004     May   06,   2009

                                 8MG
	                                    N022192   005     May   06,   2009

                                 10MG
	                                   N022192   006     May   06,   2009

                                 12MG
	                                   N022192   007     May   06,   2009
	
ILOPROST
	
  SOLUTION;INHALATION
	
    VENTAVIS
	
      + ACTELION PHARMS LTD		    10MCG/ML (10MCG/ML)
                     N021779 002 Dec 08, 2005
	
      +		                        20MCG/ML (20MCG/ML)
	                    N021779 003 Aug 07, 2009
	
IMATINIB MESYLATE
	
  TABLET;ORAL
	
    GLEEVEC
	
          NOVARTIS               EQ 100MG BASE
	                          N021588 001 Apr 18, 2003

      +		                        EQ 400MG BASE
	                          N021588 002 Apr 18, 2003
	
IMIGLUCERASE
	
  INJECTABLE;INJECTION
	
    CEREZYME
	
          GENZYME                200 UNITS/VIAL
                          N020367 001 May 23, 1994

      +		                        400 UNITS/VIAL
	                         N020367 002 Sep 22, 1999
	
IMIPRAMINE HYDROCHLORIDE
	
  TABLET;ORAL

    IMIPRAMINE HYDROCHLORIDE
	
AB       EXCELLIUM               10MG
	                                   A040903   001     Oct   24,   2012

AB                               25MG
	                                   A040903   002     Oct   24,   2012

AB                               50MG
	                                   A040903   003     Oct   24,   2012

AB       LUPIN LTD               10MG
	                                   A090443   001     Mar   11,   2010

AB                               25MG
	                                   A090442   001     Mar   11,   2010

AB                               50MG
	                                   A090441   001     Mar   11,   2010

AB       MUTUAL PHARM            10MG
	                                   A081048   001     Jun   05,   1990

AB                               25MG
	                                   A081049   001     Jun   05,   1990

AB                               50MG
	                                   A081050   001     Jun   05,   1990

AB       PAR PHARM               10MG
	                                   A088292   001     Oct   21,   1983

AB                               10MG
	                                   A089422   001     Jul   14,   1987

AB                               25MG
	                                   A088262   001     Oct   21,   1983

AB                               50MG
	                                   A088276   001     Oct   21,   1983

AB       SANDOZ                  10MG
	                                   A084936   002
	
AB                               25MG
	                                   A083745   001
	
AB                               50MG
	                                   A084937   001
	
    TOFRANIL
	
AB       MALLINCKRODT INC        10MG                                     A087844 001 May 22, 1984

AB                               25MG                                     A087845 001 May 22, 1984

AB    +                          50MG                                     A087846 001 May 22, 1984
	
IMIPRAMINE PAMOATE
	
  CAPSULE;ORAL

    IMIPRAMINE PAMOATE
	
AB       LUPIN LTD               EQ   75MG HCL
                           A090444   001     Apr   16,   2010

AB                               EQ   100MG HCL
                          A090444   002     Apr   16,   2010

AB                               EQ   125MG HCL
                          A090444   003     Apr   16,   2010

AB                               EQ   150MG HCL
                          A090444   004     Apr   16,   2010

AB       MYLAN PHARMS INC        EQ   75MG HCL
                           A202338   001     Jun   28,   2013

AB                               EQ   100MG HCL
                          A202338   002     Jun   28,   2013

AB                               EQ   125MG HCL
                          A202338   003     Jun   28,   2013

AB                               EQ   150MG HCL
                          A202338   004     Jun   28,   2013

AB       ROXANE                  EQ   75MG HCL
                           A091099   001     Apr   16,   2010

AB                               EQ   100MG HCL
                          A091099   002     Apr   16,   2010

AB                               EQ   125MG HCL
                          A091099   003     Apr   16,   2010

AB                               EQ   150MG HCL
	                         A091099   004     Apr   16,   2010
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-194(of 371)


IMIPRAMINE PAMOATE
	
  CAPSULE;ORAL

    TOFRANIL-PM
	
AB    + MALLINCKRODT INC        EQ   75MG HCL                   N017090   001
	
AB                              EQ   100MG HCL                  N017090   004
	
AB                              EQ   125MG HCL                  N017090   003
	
AB                              EQ   150MG HCL                  N017090   002
	
IMIQUIMOD
	
  CREAM;TOPICAL

    ALDARA
	
AB    + MEDICIS                 5%                              N020723 001 Feb 27, 1997

    IMIQUIMOD

AB       APOTEX INC             5%                              A091308   001     Apr   06,   2012

AB       FOUGERA PHARMS         5%                              A078548   001     Feb   25,   2010

AB       GLENMARK GENERICS      5%                              A201994   001     Mar   06,   2012

AB       PERRIGO ISRAEL         5%                              A078837   001     Sep   07,   2010

AB       STRIDES PHARMA         5%                              A202002   001     Jun   24,   2014

AB       TARO                   5%                              A200173   001     Apr   15,   2011

AB       TEVA PHARMS USA        5%                              A200481   001     Apr   18,   2011

AB       TOLMAR                 5%                              A091044   001     Feb   28,   2011
	
    ZYCLARA
	
      + MEDICIS                 2.5%                            N022483 002 Jul 15, 2011
	
      +                         3.75%                           N022483 001 Mar 25, 2010
	
INAMRINONE LACTATE
	
  INJECTABLE;INJECTION
	
    AMRINONE LACTATE
	
      + EUROHLTH INTL           EQ 5MG BASE/ML                  A075513 001 May 09, 2000
	
INDACATEROL MALEATE
	
  POWDER;INHALATION
	
    ARCAPTA NEOHALER
	
      + NOVARTIS                EQ 75MCG BASE                   N022383 001 Jul 01, 2011
	
INDAPAMIDE
	
  TABLET;ORAL

    INDAPAMIDE
	
AB       ACTAVIS ELIZABETH      1.25MG                          A074722   001     Jun   17,   1996

AB                              2.5MG                           A074722   002     Jun   17,   1996

AB       IVAX SUB TEVA PHARMS   1.25MG                          A074299   002     Apr   29,   1996

AB                              2.5MG                           A074299   001     Jul   27,   1995

AB       MYLAN                  1.25MG                          A074461   002     Mar   26,   1997

AB    +                         2.5MG                           A074461   001     Mar   27,   1996

AB       MYLAN PHARMS INC       1.25MG                          A075105   001     Jul   23,   1998

AB                              2.5MG                           A075105   002     Jul   23,   1998
	
INDINAVIR SULFATE
	
  CAPSULE;ORAL
	
    CRIXIVAN
	
         MERCK SHARP DOHME      EQ 200MG BASE                   N020685 003 Mar 13, 1996
	
      +                         EQ 400MG BASE                   N020685 001 Mar 13, 1996
	
INDIUM IN-111 CHLORIDE
	
  INJECTABLE;INJECTION
	
    INDICLOR
	
      + GE HEALTHCARE           2mCi/0.2ML                      N019862 001 Dec 29, 1992
	
    INDIUM IN 111 CHLORIDE
	
      + MALLINCKRODT            5mCi/0.5ML                      N019841 001 Sep 27, 1994
	
INDIUM IN-111 OXYQUINOLINE
	
  INJECTABLE;INJECTION
	
    INDIUM IN-111 OXYQUINOLINE
	
      + GE HEALTHCARE            1mCi/ML                        N019044 001 Dec 24, 1985
	
INDIUM IN-111 PENTETATE DISODIUM
	
  INJECTABLE;INTRATHECAL
	
    MPI INDIUM DTPA IN 111
	
      + GE HEALTHCARE           1mCi/ML                         N017707 001 Feb 18, 1982
	
INDIUM IN-111 PENTETREOTIDE KIT
	
  INJECTABLE;INJECTION
	
    OCTREOSCAN
	
      + MALLINCKRODT             3mCi/ML                        N020314 001 Jun 02, 1994
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                           3-195(of 371)


INDOCYANINE GREEN
	
  INJECTABLE;INJECTION

    IC-GREEN
	
AP    + AKORN                   25MG/VIAL                            N011525 001
	
    INDOCYANINE GREEN
	
AP       PULSION MEDCL          25MG/VIAL                            A040811 001 Nov 21, 2007
	
INDOMETHACIN
	
  CAPSULE;ORAL

    INDOMETHACIN
	
AB       GLENMARK GENERICS      25MG                                 A091276   001    Dec   22,   2010

AB                              50MG                                 A091276   002    Dec   22,   2010

AB       HERITAGE PHARMS INC    25MG                                 N018851   001    May   18,   1984

AB                              50MG                                 N018851   002    May   18,   1984

AB       HETERO LABS LTD III    25MG                                 A091240   001    Apr   12,   2011

AB                              50MG                                 A091240   002    Apr   12,   2011

AB       IVAX SUB TEVA PHARMS   25MG                                 A070719   001    Feb   12,   1986

AB                              50MG                                 A070756   001    Feb   12,   1986

AB       MYLAN                  25MG                                 N018858   001    Apr   20,   1984

AB    +                         50MG                                 A070624   001    Sep   04,   1985

AB       SANDOZ                 25MG                                 A070673   001    Apr   29,   1987

AB                              50MG                                 A070674   001    Apr   29,   1987

AB       SUN PHARM INDS INC     25MG                                 A091401   001    Mar   28,   2013

AB                              50MG                                 A091401   002    Mar   28,   2013

AB       ZYDUS PHARMS USA INC   25MG                                 A090403   001    Nov   15,   2010

AB                              50MG                                 A090403   002    Nov   15,   2010
	
    TIVORBEX
	
         IROKO PHARMS LLC       20MG		                               N204768 001 Feb 24, 2014
	
      +                         40MG                                 N204768 002 Feb 24, 2014
	
  CAPSULE, EXTENDED RELEASE;ORAL

    INDOMETHACIN
	
AB       AMNEAL PHARMS          75MG                                 A091549   001    Dec   01,   2010

AB       AVANTHI INC            75MG                                 A079175   001    Mar   06,   2009

AB       HETERO LABS LTD III    75MG                                 A201807   001    Sep   28,   2012

AB       MYLAN PHARMS INC       75MG                                 A202139   001    Mar   20,   2014

AB       PADDOCK LLC            75MG                                 A200529   001    Nov   30,   2010

AB    + SANDOZ                  75MG                                 A074464   001    May   28,   1998

AB       WATSON LABS INC        75MG                                 A202572   001    Dec   09,   2013
	
  INJECTABLE;INJECTION
	
    INDOMETHACIN
	
      + FRESENIUS KABI USA      EQ 1MG BASE/VIAL		                   N022536 001 Mar 17, 2010
	
  SUPPOSITORY;RECTAL
	
    INDOMETHACIN
	
      + G AND W LABS            50MG		                               A073314 001 Aug 31, 1992

  SUSPENSION;ORAL
	
    INDOCIN
	
      + IROKO PHARMS            25MG/5ML		                           N018332 001 Oct 10, 1985
	
INDOMETHACIN SODIUM
	
  INJECTABLE;INJECTION

    INDOCIN
	
AP    + RECORDATI RARE          EQ 1MG BASE/VIAL                     N018878 001 Jan 30, 1985

    INDOMETHACIN SODIUM
	
AP       EUROHLTH INTL          EQ 1MG BASE/VIAL                     A078713 001 Jul 16, 2008
	
INGENOL MEBUTATE
	
  GEL;TOPICAL
	
    PICATO
	
         LEO PHARMA AS          0.015%                               N202833 001 Jan 23, 2012
	
      +                         0.05%		                              N202833 002 Jan 23, 2012
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    NOVOLOG MIX 70/30

      + NOVO NORDISK INC        700 UNITS/10ML;300 UNITS/10ML (70    N021172 001 Nov 01, 2001

                                UNITS/ML; 30 UNITS/ML)

    NOVOLOG MIX 70/30 FLEXPEN

      +		 NOVO NORDISK INC      210 UNITS/3ML;90 UNITS/3ML (70       N021172 004 May 03, 2002

                                UNITS/ML; 30 UNITS/ML)
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-196(of 371)


INSULIN ASPART RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    NOVOLOG
	
      + NOVO NORDISK INC
	       1000 UNITS/10ML (100 UNITS/ML)
	    N020986 001 Jun 07, 2000
	
    NOVOLOG FLEXPEN
	
      + NOVO NORDISK INC
	       300 UNITS/3ML (100 UNITS/ML)
	      N020986 003 Jan 19, 2001
	
    NOVOLOG FLEXTOUCH
	
      + NOVO NORDISK INC
	       300 UNITS/3ML (100 UNITS/ML)
	      N020986 005 Oct 31, 2013
	
    NOVOLOG PENFILL
	
      + NOVO NORDISK INC
	       300 UNITS/3ML (100 UNITS/ML)
	      N020986 002 Jun 07, 2000
	
INSULIN DETEMIR RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    LEVEMIR
	
      + NOVO NORDISK INC
	       1000 UNITS/10ML (100 UNITS/ML)
	    N021536 001 Jun 16, 2005
	
    LEVEMIR FLEXPEN
	
      + NOVO NORDISK INC
	       300 UNITS/3ML (100 UNITS/ML)
	      N021536 002 Jun 16, 2005
	
    LEVEMIR FLEXTOUCH
	
      + NOVO NORDISK INC
	       300 UNITS/3ML (100 UNITS/ML)
	      N021536 005 Oct 31, 2013
	
INSULIN GLARGINE RECOMBINANT
	
  INJECTABLE;INJECTION
	
    LANTUS
	
      + SANOFI AVENTIS US
	      100 UNITS/ML
	                      N021081 001 Apr 20, 2000
	
    LANTUS SOLOSTAR
	
      + SANOFI AVENTIS US
	      300 UNITS/3ML (100 UNITS/ML)
	      N021081 002 Apr 27, 2007
	
INSULIN GLULISINE RECOMBINANT
	
  INJECTABLE;IV (INFUSION), SUBCUTANEOUS

    APIDRA
	
      + SANOFI AVENTIS US       1000 UNITS/10ML (100 UNITS/ML)
      N021629 001 Apr 16, 2004

      +                         300 UNITS/3ML (100 UNITS/ML)
        N021629 002 Dec 20, 2005
	
  INJECTABLE;SUBCUTANEOUS
	
    APIDRA SOLOSTAR
	
         SANOFI AVENTIS US      300 UNITS/3ML
	                      N021629 003 Feb 24, 2009
	
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
	
  INJECTABLE;INJECTION
	
    HUMALOG MIX 50/50

      + LILLY
	                 50 UNITS/ML;50 UNITS/ML
	            N021018 001 Dec 22, 1999
	
    HUMALOG MIX 50/50 KWIKPEN

      + LILLY
	                 50 UNITS/ML;50 UNITS/ML
	            N021018 002 Sep 06, 2007
	
    HUMALOG MIX 75/25

      + LILLY
	                 75 UNITS/ML;25 UNITS/ML
	            N021017 001 Dec 22, 1999
	
    HUMALOG MIX 75/25 KWIKPEN

      + LILLY
	                 75 UNITS/ML;25 UNITS/ML
	            N021017 002 Sep 06, 2007
	
INSULIN LISPRO RECOMBINANT
	
  INJECTABLE;INJECTION
	
    HUMALOG
	
      + LILLY
	                  100 UNITS/ML
	                      N020563 001 Jun 14, 1996
	
    HUMALOG KWIKPEN
	
      + LILLY
	                  100 UNITS/ML
	                      N020563 003 Sep 06, 2007
	
INSULIN RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN R
	
      + LILLY
	                  500 UNITS/ML
	                      N018780 004 Mar 31, 1994
	
  POWDER;INHALATION
	
    AFREZZA
	
          SANOFI AVENTIS
	       4 UNITS/INH
                        N022472 001 Jun 27, 2014
	
      +
	                        8 UNITS/INH
	                       N022472 002 Jun 27, 2014
	
IOBENGUANE SULFATE I-123
	
  SOLUTION;INTRAVENOUS
	
    ADREVIEW
	
      + GE HEALTHCARE
	          10mCi/5ML (2mCi/ML)
	               N022290 001 Sep 19, 2008
	
IODIPAMIDE MEGLUMINE
	
  INJECTABLE;INJECTION
	
    CHOLOGRAFIN MEGLUMINE
	
      + BRACCO
	                 52%
	                               N009321 003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                  3-197(of 371)


IODIXANOL
	
  INJECTABLE;INJECTION
	
    VISIPAQUE 270
	
      + GE HEALTHCARE           55%		                           N020351 001 Mar 22, 1996
	
                                55%                             N020808 001 Aug 29, 1997

   VISIPAQUE 320
	
     +		 GE HEALTHCARE          65.2%                           N020351 002 Mar 22, 1996
	
                                65.2%                           N020808 002 Aug 29, 1997
	
IOFLUPANE I-123
	
  SOLUTION;INTRAVENOUS
	
    DATSCAN
	
      + GE HLTHCARE INC         5mCi/2.5ML (2mCi/ML)            N022454 001 Jan 14, 2011
	
IOHEXOL
	
  INJECTABLE;INJECTION
	
    OMNIPAQUE 140
	
      + GE HEALTHCARE           30.2%		                         N018956 005 Nov 30, 1988
	
  SOLUTION;INJECTION, ORAL
	
    OMNIPAQUE 350
	
      +		 GE HEALTHCARE        75.5%                            N018956 004 Dec 26, 1985
	
                               75.5%                            N020608 003 Oct 24, 1995
	
 SOLUTION;INJECTION, ORAL, RECTAL
	
   OMNIPAQUE 180
	
     + GE HEALTHCARE           38.8%                            N018956 001 Dec 26, 1985
	
   OMNIPAQUE 240
	
     + GE HEALTHCARE           51.8%		                          N018956 002 Dec 26, 1985
	
                               51.8%                            N020608 001 Oct 24, 1995
	
   OMNIPAQUE 300
	
     +		 GE HEALTHCARE         64.7%                            N018956 003 Dec 26, 1985
	
                               64.7%                            N020608 002 Oct 24, 1995
	
IOPAMIDOL
	
  INJECTABLE;INJECTION

    IOPAMIDOL-250
	
AP       FRESENIUS KABI USA     51%                             A074679 001 Apr 02, 1997

    IOPAMIDOL-300
	
AP       FRESENIUS KABI USA     61%                             A074679 002 Apr 02, 1997

    IOPAMIDOL-370
	
AP       FRESENIUS KABI USA     76%                             A074679 003 Apr 02, 1997

    ISOVUE-200
	
AP    + BRACCO                  41%                             N018735 006 Jul 07, 1987

    ISOVUE-250
	
AP    + BRACCO                  51%		                           N018735 007 Jul 06, 1992

AP    +                         51%                             N020327 002 Oct 12, 1994

    ISOVUE-300
	
AP    + BRACCO                  61%		                           N018735 002 Dec 31, 1985

AP    +                         61%                             N020327 003 Oct 12, 1994

    ISOVUE-370
	
AP    + BRACCO                  76%		                           N018735 003 Dec 31, 1985

AP    +                         76%                             N020327 004 Oct 12, 1994

    SCANLUX-300
	
AP       SANOCHEMIA CORP USA    61%                             A090394 001 Jun 18, 2010

    SCANLUX-370
	
AP       SANOCHEMIA CORP USA    76%                             A090394 002 Jun 18, 2010
	
    ISOVUE-M 200
	
      + BRACCO                  41%                             N018735 001 Dec 31, 1985
	
    ISOVUE-M 300
	
      + BRACCO                  61%                             N018735 004 Dec 31, 1985
	
IOPROMIDE
	
  INJECTABLE;INJECTION
	
    ULTRAVIST (PHARMACY BULK)

      + BAYER HLTHCARE          49.9%		                         N021425 003 Mar 12, 2004
	
      +                         62.3%		                         N021425 001 Sep 20, 2002

      +                         76.9%                           N021425 002 Sep 20, 2002

    ULTRAVIST 150
	
      + BAYER HLTHCARE          31.2%                           N020220 004 May 10, 1995

    ULTRAVIST 240
	
      + BAYER HLTHCARE          49.9%                           N020220 003 May 10, 1995

    ULTRAVIST 300
	
      + BAYER HLTHCARE          62.3%                           N020220 002 May 10, 1995

    ULTRAVIST 300 IN PLASTIC CONTAINER
	
      + BAYER HLTHCARE          62.3%		                         N020220 005 Nov 18, 2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-198(of 371)


IOPROMIDE
	
  INJECTABLE;INJECTION
	
    ULTRAVIST 370
	
      + BAYER HLTHCARE            76.9%                         N020220 001 May 10, 1995
	
IOTHALAMATE MEGLUMINE
	
  INJECTABLE;INJECTION
	
    CONRAY
	
      + MALLINCKRODT              60%                           N013295 001
	
    CONRAY 30
	
      + MALLINCKRODT              30%                           N016983 001
	
    CONRAY 43
	
      + MALLINCKRODT              43%                           N013295 002
	
  SOLUTION;INTRAVESICAL
	
    CYSTO-CONRAY II
	
         MALLINCKRODT             17.2%                         N017057 002
	
IOTHALAMATE SODIUM I-125
	
  INJECTABLE;INJECTION
	
    GLOFIL-125
	
         ISOTEX                   250-300uCi/ML                 N017279 001
	
IOVERSOL
	
  INJECTABLE;INJECTION
	
    OPTIRAY 240
	
      + MALLINCKRODT              51%                           N019710 002 Dec 30, 1988
	
    OPTIRAY 300
	
      + MALLINCKRODT              64%                           N019710 004 Jan 22, 1992
	
      +                           64%                           N020923 004 May 13, 1999

    OPTIRAY 320
	
      + MALLINCKRODT              68%                           N019710 001 Dec 30, 1988
	
    OPTIRAY 350
	
      + MALLINCKRODT              74%                           N019710 005 Jan 22, 1992
	
      +                           74%                           N020923 003 May 28, 1998
	
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
	
  INJECTABLE;INJECTION
	
    HEXABRIX
	
      + GUERBET                 39.3%;19.6%                     N018905 002 Jul 26, 1985
	
IOXILAN
	
  INJECTABLE;INJECTION
	
    OXILAN-300
	
          GUERBET                 62%                           N020316 001 Dec 21, 1995
	
    OXILAN-350
	
          GUERBET                 73%                           N020316 002 Dec 21, 1995
	
IPRATROPIUM BROMIDE
	
  AEROSOL, METERED;INHALATION
	
    ATROVENT HFA
	
      + BOEHRINGER INGELHEIM      0.021MG/INH                   N021527 001 Nov 27, 2004
	
  SOLUTION;INHALATION

    IPRATROPIUM BROMIDE
	
AN       BAUSCH AND LOMB          0.02%                         A075835   001    Oct   15,   2001

AN       LANDELA PHARM            0.02%                         A077072   001    Jul   19,   2005

AN    + MYLAN SPECLT              0.02%                         A074755   001    Jan   10,   1997

AN       NEPHRON                  0.02%                         A075562   001    Sep   27,   2001

AN       RITEDOSE CORP            0.02%                         A075693   001    Jan   26,   2001

AN       WATSON LABS              0.02%                         A076291   001    May   09,   2005

  SPRAY, METERED;NASAL

    ATROVENT
	
AB    + BOEHRINGER INGELHEIM      0.021MG/SPRAY                 N020393 001 Oct 20, 1995

AB    +                           0.042MG/SPRAY                 N020394 001 Oct 20, 1995

    IPRATROPIUM BROMIDE
	
AB       BAUSCH AND LOMB          0.021MG/SPRAY                 A076025   001    Mar   31,   2003

AB                                0.042MG/SPRAY                 A076103   001    Mar   31,   2003

AB       MYLAN SPECLT             0.021MG/SPRAY                 A075552   001    Mar   31,   2003

AB                                0.042MG/SPRAY                 A075553   001    Mar   31,   2003

AB       ROXANE                   0.021MG/SPRAY                 A076664   001    Nov   05,   2003

AB                                0.042MG/SPRAY                 A076598   001    Nov   05,   2003
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-199(of 371)


IRBESARTAN
	
  TABLET;ORAL

     AVAPRO
	
AB         SANOFI AVENTIS US
	      75MG
	                       N020757 001 Sep 30, 1997

AB
	                                150MG
	                      N020757 002 Sep 30, 1997

AB     +
	                          300MG
	                      N020757 003 Sep 30, 1997
	
     IRBESARTAN
	
AB         ALEMBIC PHARMS LTD
	     75MG
	                       A091236   001    Oct   15,   2012

AB
	                                150MG
	                      A091236   002    Oct   15,   2012

AB
	                                300MG
	                      A091236   003    Oct   15,   2012

AB         APOTEX INC
	             75MG
	                       A200832   001    Oct   15,   2012

AB
	                                150MG
	                      A200832   002    Oct   15,   2012

AB
	                                300MG
	                      A200832   003    Oct   15,   2012

AB         AUROBINDO PHARMA LTD
	   75MG
	                       A203081   001    Sep   27,   2012

AB
	                                150MG
	                      A203081   002    Sep   27,   2012

AB
	                                300MG
	                      A203081   003    Sep   27,   2012

AB         CIPLA LTD
	              75MG
	                       A077205   001    Nov   14,   2012

AB
	                                150MG
	                      A077205   002    Nov   14,   2012

AB
	                                300MG
	                      A077205   003    Nov   14,   2012

AB         DR REDDYS LABS LTD
	     75MG
	                       A203161   001    Sep   27,   2012

AB
	                                150MG
	                      A203161   002    Sep   27,   2012

AB
	                                300MG
	                      A203161   003    Sep   27,   2012

AB         HETERO LABS LTD V
	      75MG
	                       A202910   001    Sep   27,   2012

AB
	                                150MG
	                      A202910   002    Sep   27,   2012

AB
	                                300MG
	                      A202910   003    Sep   27,   2012

AB         LUPIN LTD
	              75MG
	                       A201531   001    Oct   15,   2012

AB
	                                150MG
	                      A201531   002    Oct   15,   2012

AB
	                                300MG
	                      A201531   003    Oct   15,   2012

AB         MACLEODS PHARMS LTD
	    75MG
	                       A202254   001    Oct   03,   2012

AB
	                                150MG
	                      A202254   002    Oct   03,   2012

AB
	                                300MG
	                      A202254   003    Oct   03,   2012

AB         MYLAN PHARMS INC
	       75MG
	                       A200461   001    Sep   27,   2012

AB
	                                150MG
	                      A200461   002    Sep   27,   2012

AB
	                                300MG
	                      A200461   003    Sep   27,   2012

AB         PRINSTON INC
	           75MG
	                       A203071   001    Sep   27,   2012

AB
	                                150MG
	                      A203071   002    Sep   27,   2012

AB
	                                300MG
	                      A203071   003    Sep   27,   2012

AB         ROXANE
	                 75MG
	                       A090201   001    Oct   15,   2012

AB
	                                150MG
	                      A090201   002    Oct   15,   2012

AB
	                                300MG
	                      A090201   003    Oct   15,   2012

AB         SANDOZ
	                 75MG
	                       A077466   001    Sep   27,   2012

AB
	                                150MG
	                      A077466   002    Sep   27,   2012

AB
	                                300MG
	                      A077466   003    Sep   27,   2012

AB         TEVA PHARMS
	            75MG
	                       A077159   001    Mar   30,   2012

AB
	                                150MG
	                      A077159   002    Mar   30,   2012

AB
	                                300MG
	                      A077159   003    Mar   30,   2012

AB         WATSON LABS INC
	        75MG
	                       A090720   001    Oct   12,   2012

AB
	                                150MG
	                      A090720   002    Oct   12,   2012

AB
	                                300MG
	                      A090720   003    Oct   12,   2012

AB         ZYDUS PHARMS USA INC
	   75MG
	                       A079213   001    Sep   27,   2012

AB
	                                150MG
	                      A079213   002    Sep   27,   2012

AB
	                                300MG
	                      A079213   003    Sep   27,   2012
	
IRINOTECAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     CAMPTOSAR
	
AP     + PFIZER INC
	               40MG/2ML (20MG/ML)
          N020571 001 Jun 14, 1996

AP     +
	                          100MG/5ML (20MG/ML)
	        N020571 002 Jun 14, 1996
	
     IRINOTECAN HYDROCHLORIDE
	
AP         ACCORD HLTHCARE
	        40MG/2ML (20MG/ML)
          A079068   001    Nov   21,   2008

AP
	                                100MG/5ML (20MG/ML)
         A079068   002    Nov   21,   2008

AP         ACTAVIS TOTOWA
	         40MG/2ML (20MG/ML)
          A078589   001    Feb   27,   2008

AP
	                                100MG/5ML (20MG/ML)
         A078589   002    Feb   27,   2008

AP         AKORN
	                  40MG/2ML (20MG/ML)
          A090726   001    Sep   16,   2009

AP
	                                100MG/5ML (20MG/ML)
         A090726   002    Sep   16,   2009

AP         BEDFORD LABS
	           40MG/2ML (20MG/ML)
          A078753   001    Dec   24,   2008

AP
	                                100MG/5ML (20MG/ML)
         A078753   002    Dec   24,   2008

AP         CIPLA LTD
	              40MG/2ML (20MG/ML)
          A077219   001    Feb   20,   2008

AP
	                                100MG/5ML (20MG/ML)
         A077219   002    Feb   20,   2008

AP         DR REDDYS LABS LTD
	     40MG/2ML (20MG/ML)
          A078953   001    Apr   15,   2010

AP
	                                100MG/5ML (20MG/ML)
         A078953   002    Apr   15,   2010

AP         EBEWE PHARMA
	           40MG/2ML (20MG/ML)
          A090137   001    Nov   12,   2009

AP
	                                100MG/5ML (20MG/ML)
	        A090137   002    Nov   12,   2009
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                               3-200(of 371)


IRINOTECAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    IRINOTECAN HYDROCHLORIDE
	
AP       EMCURE PHARMS LTD          40MG/2ML (20MG/ML)
                      A200771   001    Feb   14,   2012

AP                                  100MG/5ML (20MG/ML)
                     A200771   002    Feb   14,   2012

AP       FRESENIUS KABI ONCOL       40MG/2ML (20MG/ML)
                      A078188   001    Feb   27,   2008

AP                                  100MG/5ML (20MG/ML)
                     A078188   002    Feb   27,   2008

AP       FRESENIUS KABI USA         40MG/2ML (20MG/ML)
                      A077776   001    Feb   27,   2008

AP                                  100MG/5ML (20MG/ML)
                     A077776   002    Feb   27,   2008

AP       HIKMA FARMACEUTICA         40MG/2ML (20MG/ML)
                      A091032   001    Dec   20,   2010

AP                                  100MG/5ML (20MG/ML)
                     A091032   002    Dec   20,   2010

AP       HISUN PHARM HANGZHOU       40MG/2ML (20MG/ML)
                      A090016   001    Jan   28,   2009

AP                                  100MG/5ML (20MG/ML)
                     A090016   002    Jan   28,   2009

AP       HOSPIRA                    40MG/2ML (20MG/ML)
                      A077915   001    Feb   27,   2008

AP                                  100MG/5ML (20MG/ML)
                     A077915   002    Feb   27,   2008

AP    +                             500MG/25ML (20MG/ML)
                    A078796   001    Feb   27,   2008

AP       JIANGSU HENGRUI MED        40MG/2ML (20MG/ML)
                      A090675   002    Dec   16,   2011

AP                                  100MG/5ML (20MG/ML)
                     A090675   001    Dec   16,   2011

AP       MUSTAFA NEVZAT ILAC        40MG/2ML (20MG/ML)
                      A090393   002    May   13,   2011

AP                                  100MG/5ML (20MG/ML)
                     A090393   003    May   13,   2011

AP       PLIVA LACHEMA              40MG/2ML (20MG/ML)
                      A078122   001    Oct   31,   2008

AP                                  100MG/5ML (20MG/ML)
                     A078122   002    Oct   31,   2008

AP       SUN PHARMA GLOBAL          40MG/2ML (20MG/ML)
                      A078805   001    Apr   21,   2008

AP                                  100MG/5ML (20MG/ML)
                     A078805   002    Apr   21,   2008

AP       TEVA PHARMS USA            40MG/2ML (20MG/ML)
                      A090101   002    Feb   27,   2008

AP                                  100MG/5ML (20MG/ML)
                     A090101   003    Feb   27,   2008

AP                                  500MG/25ML (20MG/ML)
	                   A090101   001    Nov   26,   2008
	
    CAMPTOSAR
	
      + PFIZER INC
	                300MG/15ML (20MG/ML)
	                   N020571 003 Aug 05, 2010
	
IRON DEXTRAN
	
  INJECTABLE;INJECTION
	
    DEXFERRUM
	
BP       LUITPOLD
	                 EQ 50MG IRON/ML
	                        N040024 001 Feb 23, 1996
	
    INFED
	
BP    + WATSON LABS (UTAH)
         EQ 50MG IRON/ML
	                        N017441 001
	
    PROFERDEX
	
BP       NEW RIVER
	                EQ 50MG IRON/ML
	                        N017807 001
	
IRON SUCROSE
	
  INJECTABLE;INTRAVENOUS
	
    VENOFER
	
          LUITPOLD
	                EQ 50MG BASE/2.5ML (EQ 20MG BASE/ML)
    N021135 002 Mar 20, 2005
	
      +
	                           EQ 100MG BASE/5ML (EQ 20MG BASE/ML)
     N021135 001 Nov 06, 2000
	
                                    EQ 200MG BASE/10ML (EQ 20MG BASE/ML)
	   N021135 004 Feb 09, 2007
	
ISOCARBOXAZID
	
  TABLET;ORAL
	
    MARPLAN
	
      + VALIDUS PHARMS INC
	        10MG
	                                   N011961 001
	
ISOFLURANE
	
  LIQUID;INHALATION

    FORANE
	
AN    + BAXTER HLTHCARE
	           99.9%
	                                  N017624 001
	
    ISOFLURANE
	
AN       HALOCARBON PRODS
	         99.9%
	                                  A075225   001    Oct   20,   1999

AN       HOSPIRA
	                  99.9%
	                                  A074097   001    Jan   25,   1993

AN       PIRAMAL CRITICAL
	         99.9%
	                                  A074416   001    Sep   30,   1994

AN       PIRAMAL ENT
	              99.9%
	                                  A074502   001    Jun   27,   1995
	
ISONIAZID
	
  INJECTABLE;INJECTION
	
     ISONIAZID
	
       + SANDOZ
	                   100MG/ML
	                               A040648 001 Jul 05, 2005
	
  SYRUP;ORAL
	
     ISONIAZID
	
       + CAROLINA MEDCL
	           50MG/5ML
	                               A088235 001 Nov 10, 1983
	
  TABLET;ORAL

     ISONIAZID
	
AA         BARR
	                   100MG
	                                  A080936   001
	
AA
	                                300MG
	                                  A080937   002
	
AA     + SANDOZ
	                   100MG
	                                  N008678   002
	
AA     +
	                          300MG
	                                  N008678   003
	
AA         THEPHARMANETWORK LLC
	   100MG
	                                  A202610   001 Oct 29, 2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-201(of 371)


ISONIAZID
	
  TABLET;ORAL

    ISONIAZID
AA                                300MG                         A202610 002 Oct 29, 2014
	
    LANIAZID
AA       LANNETT                  300MG                         A089776 001 Jun 13, 1988
	
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
	
  TABLET;ORAL
	
    RIFATER
	
      + SANOFI AVENTIS US
	     50MG;300MG;120MG
	              N050705 001 May 31, 1994
	
ISONIAZID; RIFAMPIN
	
  CAPSULE;ORAL
	
    RIFAMATE
	
      + SANOFI AVENTIS US
	       150MG;300MG
	                 A061884 001
	
ISOPROTERENOL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ISUPREL
	
      + HOSPIRA
	                 0.2MG/ML
	                    N010515 001
	
ISOSORBIDE DINITRATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    DILATRATE-SR
	
      + AUXILIUM PHARMS LLC
	    40MG
	                         N019790 001 Sep 02, 1988
	
  TABLET;ORAL

    ISORDIL
	
AB       VALEANT BERMUDA
	       5MG
	                          N012093 007 Jul 29, 1988
	
    ISOSORBIDE DINITRATE
	
AB       HIKMA INTL PHARMS       5MG
	                          A086067   001    Oct   29,   1987

AB                               10MG
	                         A086066   001    Oct   29,   1987

AB                               20MG
	                         A088088   001    Nov   02,   1987

AB                               30MG
	                         A040591   001    Jan   10,   2007

AB       PAR PHARM               5MG
	                          A086923   001    Mar   12,   1987

AB                               10MG
	                         A086925   001    Mar   12,   1987

AB                               20MG
	                         A087537   001    Oct   02,   1987

AB    +                          30MG
	                         A087946   001    Jan   12,   1988

AB       SANDOZ                  5MG
	                          A086221   001    Jan   07,   1988

AB                               10MG
	                         A086223   001    Jan   07,   1988

AB                               20MG
	                         A089367   001    Apr   07,   1988
	
    ISORDIL
	
      + VALEANT BERMUDA
	        40MG
	                         N012093 001 Jul 29, 1988
	
  TABLET, EXTENDED RELEASE;ORAL

    ISOSORBIDE DINITRATE
	
AB       COREPHARMA
	            40MG
	                         A040723 001 Mar 17, 2008

AB    + SUN PHARM INDS INC
	     40MG
	                         A040009 001 Dec 30, 1998
	
ISOSORBIDE MONONITRATE
	
  TABLET;ORAL

     ISOSORBIDE MONONITRATE
	
AB         ACTAVIS ELIZABETH
	    10MG
	                        A075037   002    Oct   30,   1998

AB
	                              20MG
	                        A075037   001    Oct   30,   1998

AB         ANI PHARMS INC
	       20MG
	                        A075147   001    Nov   27,   1998

AB         HIKMA PHARMS LLC
	     20MG
	                        A075361   001    Oct   05,   2000
	
     MONOKET
	
AB         KREMERS URBAN PHARMS
	 10MG
	                        N020215 002 Jun 30, 1993

AB     +
	                        20MG
	                        N020215 001 Jun 30, 1993
	
  TABLET, EXTENDED RELEASE;ORAL

     ISOSORBIDE MONONITRATE
	
AB         DEXCEL LTD
	           60MG
	                        A075522   001    Apr   17,   2000

AB         HIKMA PHARMS
	         30MG
	                        A076813   002    Mar   30,   2006

AB
	                              60MG
	                        A076813   001    Jan   07,   2005

AB         KREMERS URBAN PHARMS
	 30MG
	                        A075155   002    Jan   13,   2000

AB
	                              60MG
	                        A075155   001    Oct   30,   1998

AB     +
	                        120MG
	                       A075155   003    Aug   04,   2000

AB         NESHER PHARMS
	        30MG
	                        A075395   001    Mar   16,   2000

AB
	                              60MG
	                        A075395   002    Mar   16,   2000

AB
	                              120MG
	                       A075395   003    Mar   16,   2000

AB         TORRENT PHARMS
	       30MG
	                        A200270   001    Jun   03,   2011

AB
	                              60MG
	                        A200495   001    Jun   03,   2011

AB
	                              120MG
	                       A200495   002    Jun   03,   2011

AB         VINTAGE PHARMS
	       30MG
	                        A090598   001    Aug   11,   2010

AB
	                              60MG
	                        A090598   002    Aug   11,   2010

AB
	                              120MG
	                       A090598   003    Aug   11,   2010
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                    3-202(of 371)


ISOSULFAN BLUE
	
  INJECTABLE;INJECTION
	
    ISOSULFAN BLUE
	
      + MYLAN INSTITUTIONAL
	     1%
	                            A090874 001 Jul 20, 2010
	
ISOTRETINOIN
	
  CAPSULE;ORAL

     AMNESTEEM
	
AB         MYLAN PHARMS INC
	     10MG
	                          A075945 001 Nov 08, 2002

AB
	                              20MG
	                          A075945 002 Nov 08, 2002

AB
	                              40MG
	                          A075945 003 Nov 08, 2002
	
     CLARAVIS
	
AB         TEVA PHARMS USA
	      10MG
	                          A076356   001    Apr   11,   2003

AB
	                              20MG
	                          A076135   002    Apr   11,   2003

AB
	                              30MG
	                          A076135   003    May   11,   2006

AB     +
	                        40MG
	                          A076135   001    Apr   11,   2003
	
     MYORISAN
	
AB         DOUGLAS PHARMS
	       10MG
	                          A076485 001 Jan 19, 2012

AB
	                              20MG
	                          A076485 002 Jan 19, 2012

AB
	                              40MG
	                          A076485 003 Jan 19, 2012
	
     SOTRET
	
AB         RANBAXY
	              10MG
	                          A076041   001    Dec   24,   2002

AB
	                              20MG
	                          A076041   002    Dec   24,   2002

AB
	                              30MG
	                          A076503   001    Jun   20,   2003

AB
	                              40MG
	                          A076041   003    Dec   24,   2002
	
     ZENATANE
	
AB         DR REDDYS LABS LTD
	   10MG
	                          A202099 001 Mar 25, 2013

AB
	                              20MG
	                          A202099 002 Mar 25, 2013

AB
	                              40MG
	                          A202099 003 Mar 25, 2013
	
     ABSORICA
	
BX         RANBAXY
	              10MG
	                          N021951   001    May   25,   2012

BX
	                              20MG
	                          N021951   002    May   25,   2012

BX
	                              30MG
	                          N021951   003    May   25,   2012

BX     +
	                        40MG
	                          N021951   004    May   25,   2012
	
ISRADIPINE
	
  CAPSULE;ORAL

     ISRADIPINE
	
AB         MIKAH PHARMA
	         2.5MG
	                         A077169   001    Apr   24,   2006

AB
	                              5MG
	                           A077169   002    Apr   24,   2006

AB         WATSON LABS
	          2.5MG
	                         A077317   001    Jan   05,   2006

AB     +
	                        5MG
	                           A077317   002    Jan   05,   2006
	
ITRACONAZOLE
	
  CAPSULE;ORAL

    ITRACONAZOLE
	
AB       MYLAN PHARMS INC
	       100MG
	                         A200463 001 Jul 20, 2012

AB       SANDOZ
	                 100MG
	                         A076104 001 May 28, 2004
	
    SPORANOX
	
AB    + JANSSEN PHARMS
	          100MG
	                         N020083 001 Sep 11, 1992
	
  SOLUTION;ORAL
	
    SPORANOX
	
      + JANSSEN PHARMS
	          10MG/ML
	                       N020657 001 Feb 21, 1997
	
  TABLET;ORAL
	
    ONMEL
	
      + MERZ PHARMS
	             200MG
	                         N022484 001 Apr 29, 2010
	
IVACAFTOR
	
  TABLET;ORAL
	
    KALYDECO
	
      + VERTEX PHARMS
	           150MG
	                         N203188 001 Jan 31, 2012
	
IVERMECTIN
	
  CREAM;TOPICAL
	
    SOOLANTRA
	
      + GALDERMA LABS LP
	        1%
	                            N206255 001 Dec 19, 2014
	
  LOTION;TOPICAL
	
    SKLICE
	
      + SANOFI PASTEUR INC
	      0.5%
	                          N202736 001 Feb 07, 2012
	
  TABLET;ORAL

    IVERMECTIN
	
AB       EDENBRIDGE PHARMS
	      3MG
	                           A204154 001 Oct 24, 2014
	
    STROMECTOL
	
AB    + MERCK SHARP DOHME
	       3MG
	                           N050742 002 Oct 08, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-203(of 371)


IXABEPILONE
	
  INJECTABLE;IV (INFUSION)

    IXEMPRA KIT
	
      + BRISTOL MYERS SQUIBB		   15MG/VIAL                     N022065 001 Oct 16, 2007
	
      +                          45MG/VIAL                     N022065 002 Oct 16, 2007
	
KANAMYCIN SULFATE
	
  INJECTABLE;INJECTION
	
    KANAMYCIN SULFATE
	
      +		 FRESENIUS KABI USA     EQ 1GM BASE/3ML               A065111 002 Dec 17, 2002
	
                                 EQ 500MG BASE/2ML             A065111 001 Dec 17, 2002
	
KETAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    KETALAR
	
AP    + PAR STERILE PRODUCTS     EQ 10MG BASE/ML               N016812 001
	
AP    +                          EQ 50MG BASE/ML               N016812 002
	
AP    +                          EQ 100MG BASE/ML              N016812 003
	
    KETAMINE HYDROCHLORIDE
	
AP       EUROHLTH INTL           EQ   50MG BASE/ML             A074524   001    Mar   22,   1996

AP                               EQ   100MG BASE/ML            A074524   002    Mar   22,   1996

AP       HOSPIRA                 EQ   50MG BASE/ML             A074549   001    Jun   27,   1996

AP                               EQ   100MG BASE/ML            A074549   002    Jun   27,   1996

AP       MYLAN INSTITUTIONAL     EQ   10MG BASE/ML             A076092   001    Sep   30,   2008

AP                               EQ   50MG BASE/ML             A076092   002    Dec   28,   2001

AP                               EQ   100MG BASE/ML            A076092   003    Oct   25,   2002
	
KETOCONAZOLE
	
  AEROSOL, FOAM;TOPICAL

    EXTINA
	
AT    + DELCOR ASSET CORP        2%                            N021738 001 Jun 12, 2007

    KETOCONAZOLE
	
AT       PERRIGO ISRAEL          2%                            A091550 001 Aug 25, 2011

  CREAM;TOPICAL

    KETOCONAZOLE
	
AB       FOUGERA PHARMS          2%                            A076294 001 Apr 28, 2004

AB    + TEVA                     2%                            A075581 001 Apr 25, 2000

    KETOZOLE
	
AB       TARO                    2%                            A075638 001 Dec 18, 2002
	
  GEL;TOPICAL
	
    XOLEGEL
	
      + AQUA PHARMS              2%                            N021946 001 Jul 28, 2006
	
  SHAMPOO;TOPICAL

    KETOCONAZOLE
	
AB       PERRIGO NEW YORK        2%                            A076419 001 Jan 07, 2004

AB       TOLMAR                  2%                            A076942 001 Apr 11, 2005

    NIZORAL
	
AB    + JANSSEN PHARMS           2%                            N019927 001 Aug 31, 1990

  TABLET;ORAL

    KETOCONAZOLE
	
AB       MYLAN                   200MG                         A075597 001 Dec 23, 1999

AB       TARO                    200MG                         A075319 001 Jun 15, 1999

AB    + TEVA                     200MG                         A075273 001 Jun 15, 1999
	
KETOPROFEN
	
  CAPSULE;ORAL

    KETOPROFEN
	
AB       DORADO PHARMA          50MG                           A074014   002    Jan   29,   1993

AB                              75MG                           A074014   003    Jan   29,   1993

AB       MYLAN                  50MG                           A074035   002    Dec   31,   1996

AB                              75MG                           A074035   003    Dec   31,   1996

AB       TEVA                   50MG                           A073516   001    Dec   22,   1992

AB    +                         75MG                           A073517   001    Dec   22,   1992
	
         DORADO PHARMA          25MG                           A074014   001    Jan   29,   1993
	
  CAPSULE, EXTENDED RELEASE;ORAL

    KETOPROFEN
	
AB       ACTAVIS LABS FL INC    100MG                          A075270   002    Mar   24,   1999

AB                              150MG                          A075270   003    Mar   24,   1999

AB                              200MG                          A075270   001    Mar   24,   1999

AB       MYLAN                  100MG                          A075679   003    Feb   20,   2002

AB                              150MG                          A075679   002    Feb   20,   2002

AB    +                         200MG                          A075679   001    Feb   20,   2002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-204(of 371)


KETOROLAC TROMETHAMINE
	
  INJECTABLE;INJECTION

    KETOROLAC TROMETHAMINE
	
AP       AGILA SPECLTS          15MG/ML                                A078299   001    Jul   16,   2007

AP                              15MG/ML                                A201155   001    Aug   04,   2014

AP                              30MG/ML                                A078299   002    Jul   16,   2007

AP                              30MG/ML                                A201155   002    Aug   04,   2014

AP       FRESENIUS KABI USA     15MG/ML                                A075784   001    Jan   11,   2002

AP                              30MG/ML                                A075784   002    Jan   11,   2002

AP    + HOSPIRA                 15MG/ML                                A074802   001    Jun   05,   1997

AP                              15MG/ML                                A074993   001    Jan   27,   1999

AP    +                         30MG/ML                                A074802   002    Jun   05,   1997

AP                              30MG/ML                                A074993   002    Jan   27,   1999

AP       SAGENT PHARMS          15MG/ML                                A091065   001    Nov   27,   2013

AP                              30MG/ML                                A091065   002    Nov   27,   2013

AP       SANDOZ                 30MG/ML                                A076271   002    Oct   06,   2004

AP       WOCKHARDT              15MG/ML                                A077942   001    Mar   27,   2007

AP                              30MG/ML                                A077942   002    Mar   27,   2007
	
  SOLUTION/DROPS;OPHTHALMIC

    ACULAR
	
AT    + ALLERGAN                0.5%                                   N019700 001 Nov 09, 1992

    ACULAR LS
	
AT    + ALLERGAN                0.4%                                   N021528 001 May 30, 2003

    ACUVAIL
	
AT    + ALLERGAN                0.45%                                  N022427 001 Jul 22, 2009

    KETOROLAC TROMETHAMINE
	
AT       AKORN                  0.4%                                   A078399   001    Nov   05,   2009

AT                              0.5%                                   A078434   001    Nov   05,   2009

AT       ALCON PHARMS LTD       0.4%                                   A078721   001    Nov   05,   2009

AT                              0.5%                                   A076583   001    Nov   05,   2009

AT       APOTEX INC             0.4%                                   A077308   001    Nov   05,   2009

AT                              0.5%                                   A076109   001    Nov   05,   2009

AT       SUN PHARMA GLOBAL      0.5%                                   A090017   001    Nov   05,   2009
	
  SPRAY, METERED;NASAL
	
    SPRIX
	
      + LUITPOLD                15.75MG/SPRAY                          N022382 001 May 14, 2010

  TABLET;ORAL

    KETOROLAC TROMETHAMINE
	
AB    + MYLAN                   10MG                                   A074761 001 May 16, 1997

AB       PLIVA                  10MG                                   A075284 001 Jun 23, 1999

AB       TEVA                   10MG                                   A074754 001 May 16, 1997
	
KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE
	
  SOLUTION;IRRIGATION
	
    OMIDRIA
	
      + OMEROS                  EQ 2.88MG BASE/ML;EQ 10.16MG BASE/ML   N205388 001 May 30, 2014
	
LABETALOL HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    LABETALOL HYDROCHLORIDE
	
AP       AKORN INC              5MG/ML                                 A075431   001    Nov   29,   1999

AP                              5MG/ML                                 A075524   001    Nov   29,   1999

AP       EUROHLTH INTL          5MG/ML                                 A075303   001    May   28,   1999

AP       GLAND PHARMA LTD       5MG/ML                                 A090699   001    Apr   03,   2012

AP    + HOSPIRA                 5MG/ML                                 A075239   001    Nov   29,   1999

AP    +                         5MG/ML                                 A075240   001    Nov   29,   1999

    LABETALOL HYDROCLORIDE
	
AP       SAGENT STRIDES         5MG/ML                                 A079134 001 Feb 03, 2010
	
  TABLET;ORAL

    LABETALOL HYDROCHLORIDE
	
AB       IVAX SUB TEVA PHARMS   100MG                                  A074787   001    Aug   03,   1998

AB                              200MG                                  A074787   002    Aug   03,   1998

AB                              300MG                                  A074787   003    Aug   03,   1998

AB       PAR FORM               100MG                                  A200908   001    Jul   10,   2012

AB                              200MG                                  A200908   002    Jul   10,   2012

AB                              300MG                                  A200908   003    Jul   10,   2012

AB       SANDOZ                 100MG                                  A075113   001    Aug   04,   1998

AB    +                         200MG                                  A075113   002    Aug   04,   1998

AB                              300MG                                  A075113   003    Aug   04,   1998

AB       WATSON LABS            100MG                                  A075133   001    Aug   03,   1998

AB                              200MG                                  A075133   002    Aug   03,   1998

AB                              300MG                                  A075133   003    Aug   03,   1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-205(of 371)


LABETALOL HYDROCHLORIDE
	
  TABLET;ORAL

    TRANDATE
	
AB       CNTY LINE PHARMS       100MG                           N018716 001 May 24, 1985

AB                              200MG                           N018716 002 Aug 01, 1984

AB                              300MG                           N018716 003 Aug 01, 1984
	
LACOSAMIDE
	
  SOLUTION;INTRAVENOUS
	
    VIMPAT
	
      + UCB INC                 200MG/20ML (10MG/ML)		          N022254 001 Oct 28, 2008
	
  SOLUTION;ORAL
	
    VIMPAT
	
      + UCB INC                 10MG/ML                         N022255 001 Apr 20, 2010

  TABLET;ORAL
	
    VIMPAT
	
         UCB INC		              50MG                            N022253   001    Oct   28,   2008
	
                                100MG                           N022253   002    Oct   28,   2008
	
                                150MG                           N022253   003    Oct   28,   2008
	
     +                          200MG                           N022253   004    Oct   28,   2008
	
LACTULOSE
	
  FOR SOLUTION;ORAL
	
    LACTULOSE
	
      + CUMBERLAND PHARMS       10GM/PACKET		                   A074712 001 Dec 10, 1997
	
      +                         20GM/PACKET                     A074712 002 Dec 10, 1997
	
  SOLUTION;ORAL

    CONSTILAC
	
AA       ALRA                   10GM/15ML                       A071054 001 Jul 26, 1988

    CONSTULOSE
	
AA    + ACTAVIS MID ATLANTIC    10GM/15ML                       A070288 001 Aug 15, 1988

    LACTULOSE
	
AA       ANI PHARMS             10GM/15ML                       A078430   001    Nov   28,   2007

AA       FRESENIUS KABI         10GM/15ML                       A090503   001    Jan   25,   2012

AA       HI TECH PHARMA         10GM/15ML                       A074076   001    Jul   03,   1995

AA       MORTON GROVE           10GM/15ML                       A074602   001    Nov   14,   1996

AA       PHARM ASSOC            10GM/15ML                       A074623   001    Jul   30,   1996

AA       ROXANE                 10GM/15ML                       A073591   001    May   29,   1992

AA       VINTAGE PHARMS         10GM/15ML                       A075993   001    Jul   26,   2001

AA       VISTAPHARM             10GM/15ML                       A074138   001    Sep   30,   1992

  SOLUTION;ORAL, RECTAL

    CHOLAC
	
AA       ALRA                   10GM/15ML                       A071331 001 Jul 26, 1988

    ENULOSE
	
AA    + ACTAVIS MID ATLANTIC    10GM/15ML                       A071548 001 Aug 15, 1988

    GENERLAC
	
AA       MORTON GROVE PHARMS    10GM/15ML                       A074603 001 Oct 31, 1996

    LACTULOSE
	
AA       ANI PHARMS             10GM/15ML                       A090426 001 Nov 21, 2008

AA       FRESENIUS KABI         10GM/15ML                       A090502 001 Jan 25, 2012

AA       HI TECH PHARMA         10GM/15ML                       A074077 001 Jul 03, 1995
	
LAMIVUDINE
	
  SOLUTION;ORAL

    EPIVIR
	
AA    + VIIV HLTHCARE           10MG/ML                         N020596 001 Nov 17, 1995

    LAMIVUDINE
	
AA       SILARX PHARMS INC      10MG/ML                         A203564 001 Oct 31, 2014
	
    EPIVIR-HBV
	
      + GLAXOSMITHKLINE         5MG/ML                          N021004 001 Dec 08, 1998
	
  TABLET;ORAL

    EPIVIR
	
AB       VIIV HLTHCARE          150MG                           N020564 001 Nov 17, 1995

AB    +                         300MG                           N020564 003 Jun 24, 2002

    EPIVIR-HBV
	
AB    + GLAXOSMITHKLINE         100MG                           N021003 001 Dec 08, 1998

    LAMIVUDINE
	
AB       APOTEX                 150MG                           A091606   001    Dec   02,   2011

AB                              300MG                           A091606   002    Dec   02,   2011

AB       APOTEX INC             100MG                           A202941   001    Jan   02,   2014

AB       AUROBINDO PHARMA LTD   150MG                           A202032   001    Nov   17,   2011

AB                              300MG                           A202032   002    Nov   17,   2011

AB       HETERO LABS LTD V      100MG                           A203260   001    Jan   02,   2014

AB                              150MG                           A203277   001    Jan   06,   2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST
	                   3-206(of 371)


LAMIVUDINE
	
  TABLET;ORAL

     LAMIVUDINE
	
AB
	                              300MG
	                         A203277   002    Jan   06,   2014

AB        LUPIN LTD
	             150MG
	                         A205217   001    Dec   18,   2014

AB
	                              300MG
	                         A205217   002    Dec   18,   2014

AB        MYLAN PHARMS INC
	      100MG
	                         A204002   001    Dec   31,   2014
	
LAMIVUDINE; ZIDOVUDINE
	
  TABLET;ORAL

    COMBIVIR
	
AB    + VIIV HLTHCARE
	           150MG;300MG
	                   N020857 001 Sep 26, 1997
	
    LAMIVUDINE AND ZIDOVUDINE
	
AB       AUROBINDO PHARMA LTD
	   150MG;300MG
                    A202418   001    May   15,   2012

AB       HETERO LABS LTD V
	      150MG;300MG
                    A203259   001    Feb   03,   2014

AB       LUPIN LTD
	              150MG;300MG
                    A090246   001    May   15,   2012

AB       MYLAN PHARMS INC
	       150MG;300MG
                    A204005   001    Aug   28,   2014

AB       TEVA PHARMS
	            150MG;300MG
	                   A079081   001    May   25,   2011
	
LAMOTRIGINE
	
  TABLET;ORAL

     LAMICTAL
	
AB     + GLAXOSMITHKLINE LLC
	    25MG
	                          N020241   005    Dec   27,   1994

AB
	                              100MG
	                         N020241   001    Dec   27,   1994

AB
	                              150MG
	                         N020241   002    Dec   27,   1994

AB
	                              200MG
	                         N020241   003    Dec   27,   1994
	
     LAMOTRIGINE
	
AB        ALEMBIC PHARMS LTD
	    25MG
	                          A090607   001    Jan   13,   2011

AB
	                              100MG
	                         A090607   002    Jan   13,   2011

AB
	                              150MG
	                         A090607   003    Jan   13,   2011

AB
	                              200MG
	                         A090607   004    Jan   13,   2011

AB        ALKEM LABS LTD
	        25MG
	                          A200694   001    Jun   14,   2013

AB
	                              100MG
	                         A200694   002    Jun   14,   2013

AB
	                              150MG
	                         A200694   003    Jun   14,   2013

AB
	                              200MG
	                         A200694   004    Jun   14,   2013

AB        APOTEX INC
	            25MG
	                          A078625   001    Jan   27,   2009

AB
	                              100MG
	                         A078625   002    Jan   27,   2009

AB
	                              150MG
	                         A078625   003    Jan   27,   2009

AB
	                              200MG
	                         A078625   004    Jan   27,   2009

AB        AUROBINDO PHARMA
	      25MG
	                          A078956   001    Jan   27,   2009

AB
	                              100MG
	                         A078956   002    Jan   27,   2009

AB
	                              150MG
	                         A078956   003    Jan   27,   2009

AB
	                              200MG
	                         A078956   004    Jan   27,   2009

AB        CADISTA PHARMS
	        25MG
	                          A079132   001    Jan   27,   2009

AB
	                              100MG
	                         A079132   002    Jan   27,   2009

AB
	                              150MG
	                         A079132   003    Jan   27,   2009

AB
	                              200MG
	                         A079132   004    Jan   27,   2009

AB        CIPLA LTD
	             25MG
	                          A077783   001    Nov   01,   2010

AB
	                              100MG
	                         A077783   002    Nov   01,   2010

AB
	                              150MG
	                         A077783   003    Nov   01,   2010

AB
	                              200MG
	                         A077783   004    Nov   01,   2010

AB        DR REDDYS LABS LTD
	    25MG
	                          A076708   001    Jan   27,   2009

AB
	                              100MG
	                         A076708   002    Jan   27,   2009

AB
	                              150MG
	                         A076708   003    Jan   27,   2009

AB
	                              200MG
	                         A076708   004    Jan   27,   2009

AB        GLENMARK GENERICS
	     25MG
	                          A090169   001    May   12,   2012

AB
	                              100MG
	                         A090169   002    May   12,   2012

AB
	                              150MG
	                         A090169   003    May   12,   2012

AB
	                              200MG
	                         A090169   004    May   12,   2012

AB        HIKMA PHARMS
	          25MG
	                          A078134   001    Apr   19,   2011

AB
	                              100MG
	                         A078134   002    Apr   19,   2011

AB
	                              150MG
	                         A078134   003    Apr   19,   2011

AB
	                              200MG
	                         A078134   004    Apr   19,   2011

AB        LUPIN LTD
	             25MG
	                          A078691   001    Jun   01,   2010

AB
	                              100MG
	                         A078691   002    Jun   01,   2010

AB
	                              150MG
	                         A078691   003    Jun   01,   2010

AB
	                              200MG
	                         A078691   004    Jun   01,   2010

AB        MYLAN
	                 25MG
	                          A077420   001    Jan   27,   2009

AB
	                              100MG
	                         A077420   002    Jan   27,   2009

AB
	                              150MG
	                         A077420   003    Jan   27,   2009

AB
	                              200MG
	                         A077420   004    Jan   27,   2009

AB        TARO PHARM INDS
	       25MG
	                          A078525   001    Jan   27,   2009

AB
	                              100MG
	                         A078525   002    Jan   27,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-207(of 371)


LAMOTRIGINE
	
  TABLET;ORAL

     LAMOTRIGINE
AB                                150MG
	                       A078525   003    Jan   27,   2009

AB                                200MG
	                       A078525   004    Jan   27,   2009

AB        TEVA                    25MG
	                        A076388   001    Aug   30,   2006

AB                                100MG
	                       A076388   002    Aug   30,   2006

AB                                150MG
	                       A076388   003    Aug   30,   2006

AB                                200MG
	                       A076388   004    Aug   30,   2006

AB        TORRENT PHARMS          25MG
	                        A078947   001    Jan   27,   2009

AB                                100MG
	                       A078947   002    Jan   27,   2009

AB                                150MG
	                       A078947   003    Jan   27,   2009

AB                                200MG
	                       A078947   004    Jan   27,   2009

AB        UNICHEM LABS LTD        25MG
	                        A090170   001    Oct   06,   2011

AB                                100MG
	                       A090170   002    Oct   06,   2011

AB                                150MG
	                       A090170   003    Oct   06,   2011

AB                                200MG
	                       A090170   004    Oct   06,   2011

AB        ZYDUS PHARMS USA        25MG
	                        A077633   001    Jan   27,   2009

AB                                100MG
	                       A077633   003    Jan   27,   2009

AB                                150MG
	                       A077633   004    Jan   27,   2009

AB
	                              200MG
	                       A077633   005    Jan   27,   2009
	
                                  50MG
	                        A077633   002    Jan   27,   2009
	
                                  250MG
	                       A077633   006    Jan   27,   2009
	
  TABLET, CHEWABLE;ORAL

     LAMICTAL CD
	
AB         GLAXOSMITHKLINE LLC
	  2MG
	                         N020764 004 Sep 08, 2000

AB
	                              5MG
	                         N020764 001 Aug 24, 1998

AB     +
	                        25MG
	                        N020764 002 Aug 24, 1998
	
     LAMOTRIGINE
	
AB         ALEMBIC PHARMS LTD
	   5MG
	                         A201168   001    Jun   12,   2014

AB
	                              25MG
	                        A201168   002    Jun   12,   2014

AB         AUROBINDO PHARMA
	     5MG
	                         A090401   002    Nov   04,   2009

AB
	                              25MG
	                        A090401   003    Nov   04,   2009

AB         DR REDDYS LABS LTD
	   5MG
	                         A076701   001    Jan   22,   2009

AB
	                              25MG
	                        A076701   002    Jan   22,   2009

AB         GLENMARK GENERICS
	    5MG
	                         A079099   001    Feb   19,   2009

AB
	                              25MG
	                        A079099   002    Feb   19,   2009

AB         JUBILANT GENERICS
	    5MG
	                         A200220   001    Feb   28,   2011

AB
	                              25MG
	                        A200220   002    Feb   28,   2011

AB         MYLAN
	                5MG
	                         A076630   001    Jan   22,   2009

AB
	                              25MG
	                        A076630   002    Jan   22,   2009

AB         TARO
	                 5MG
	                         A079204   001    Feb   04,   2009

AB
	                              25MG
	                        A079204   002    Feb   04,   2009

AB         TEVA
	                 5MG
	                         A076420   001    Jun   21,   2006

AB
	                              25MG
	                        A076420   002    Jun   21,   2006

AB         WATSON LABS
	          2MG
	                         A076928   001    Jan   22,   2009

AB
	                              5MG
	                         A076928   002    Jan   22,   2009

AB
	                              25MG
	                        A076928   003    Jan   22,   2009

AB         ZYDUS PHARMS USA INC
	 5MG
	                         A078009   002    Jan   22,   2009

AB
	                              25MG
	                        A078009   003    Jan   22,   2009
	
  TABLET, EXTENDED RELEASE;ORAL

     LAMICTAL XR
	
AB         GLAXOSMITHKLINE LLC
	  25MG
	                        N022115   001    May   29,   2009

AB     +
	                        50MG
	                        N022115   002    May   29,   2009

AB
	                              100MG
	                       N022115   003    May   29,   2009

AB
	                              200MG
	                       N022115   004    May   29,   2009

AB
	                              250MG
	                       N022115   006    Jun   21,   2011

AB
	                              300MG
	                       N022115   005    Apr   14,   2010
	
     LAMOTRIGINE
	
AB         ACTAVIS ELIZABETH
	    100MG
	                       A200672   003    Oct   17,   2013

AB
	                              200MG
	                       A200672   004    Oct   17,   2013

AB
	                              25MG
	                        A200672   001    Oct   17,   2013

AB
	                              50MG
	                        A200672   002    Oct   17,   2013

AB
	                              250MG
	                       A203733   001    Nov   13,   2013

AB
	                              300MG
	                       A200672   005    Oct   17,   2013

AB         ANCHEN PHARMS
	        25MG
	                        A201374   001    Dec   26,   2012

AB
	                              50MG
	                        A201374   002    Dec   26,   2012

AB
	                              100MG
	                       A201374   003    Dec   26,   2012

AB
	                              200MG
	                       A201374   004    Dec   26,   2012

AB
	                              250MG
	                       A201374   005    Dec   26,   2012

AB
	                              300MG
	                       A201374   006    Dec   26,   2012

AB         DR REDDYS LABS LTD
	   25MG
	                        A202383   001    Jun   19,   2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                3-208(of 371)


LAMOTRIGINE
	
  TABLET, EXTENDED RELEASE;ORAL

    LAMOTRIGINE
	
AB                               50MG                                     A202383   002    Jun   19,   2013

AB                               100MG                                    A202383   003    Jun   19,   2013

AB                               200MG                                    A202383   004    Jun   19,   2013

AB                               300MG                                    A202383   005    Jun   19,   2013

AB       PAR PHARM               25MG                                     A201791   001    Jan   18,   2013

AB                               50MG                                     A201791   002    Jan   18,   2013

AB                               100MG                                    A201791   003    Jan   18,   2013

AB                               200MG                                    A201791   004    Jan   18,   2013

AB                               250MG                                    A201791   005    Jan   18,   2013

AB                               300MG                                    A201791   006    Jan   18,   2013

AB       TORRENT PHARMS LTD      25MG                                     A203370   001    Dec   23,   2013

AB                               50MG                                     A203370   002    Dec   23,   2013

AB                               100MG                                    A203370   003    Dec   23,   2013

AB                               200MG                                    A203370   004    Dec   23,   2013

AB       WILSHIRE PHARMS INC     25MG                                     A202887   001    Jun   17,   2013

AB                               50MG                                     A202887   002    Jun   17,   2013

AB                               100MG                                    A202887   003    Jun   17,   2013

AB                               200MG                                    A202887   004    Jun   17,   2013

AB       WOCKHARDT LTD           25MG                                     A202498   001    Jan   04,   2013

AB                               50MG                                     A202498   002    Jan   04,   2013

AB                               100MG                                    A202498   003    Jan   04,   2013

AB                               200MG                                    A202498   004    Jan   04,   2013

AB                               300MG                                    A202498   005    Jan   04,   2013
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    LAMICTAL ODT
	
AB       GLAXOSMITHKLINE LLC     25MG                                     N022251   001    May   08,   2009

AB    +                          50MG                                     N022251   002    May   08,   2009

AB                               100MG                                    N022251   003    May   08,   2009

AB                               200MG                                    N022251   004    May   08,   2009

    LAMOTRIGINE
	
AB       IMPAX LABS INC          25MG                                     A200828   001    Jul   15,   2013

AB                               50MG                                     A200828   002    Jul   15,   2013

AB                               100MG                                    A200828   003    Jul   15,   2013

AB                               200MG                                    A200828   004    Jul   15,   2013
	
LANREOTIDE ACETATE
	
  SOLUTION;SUBCUTANEOUS
	
    SOMATULINE DEPOT
	
      + IPSEN PHARMA		          EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)   N022074 001 Aug 30, 2007

      +		                       EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)   N022074 002 Aug 30, 2007

      +		                       EQ 120MG BASE/0.5ML (EQ 120MG             N022074 003 Aug 30, 2007

                                BASE/0.5ML)
	
LANSOPRAZOLE
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    LANSOPRAZOLE
	
AB       DR REDDYS LABS LTD     15MG                                      A091269   001    Oct   15,   2010

AB                              30MG                                      A091269   002    Oct   15,   2010

AB       MYLAN PHARMS INC       15MG                                      A090763   001    Nov   10,   2009

AB                              30MG                                      A090763   002    Nov   10,   2009

AB       NATCO PHARMA LTD       15MG                                      A201921   001    Dec   18,   2012

AB                              30MG                                      A201921   002    Dec   18,   2012

AB       SANDOZ                 15MG                                      A090331   001    Apr   23,   2010

AB                              30MG                                      A090331   002    Apr   23,   2010

AB       SUN PHARMA GLOBAL      15MG                                      A202637   001    Sep   13,   2013

AB                              30MG                                      A091509   001    Sep   13,   2013

AB       TEVA PHARMS            15MG                                      A077255   001    Nov   10,   2009

AB                              30MG                                      A077255   002    Nov   10,   2009

AB       WOCKHARDT USA          15MG                                      A202176   001    Sep   14,   2012

AB                              30MG                                      A202176   002    Sep   14,   2012

AB       ZYDUS HLTHCARE         15MG                                      A202366   001    Aug   19,   2013

AB                              30MG                                      A202366   002    Aug   19,   2013

    LANSOPRAZOLE
	
AB       KRKA TOVARNA ZDRAVIL   15MG                                      A091212 001 Sep 16, 2013

AB                              30MG                                      A091212 002 Sep 16, 2013

    PREVACID
	
AB       TAKEDA PHARMS USA      15MG                                      N020406 001 May 10, 1995

AB    +                         30MG                                      N020406 002 May 10, 1995
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                       3-209(of 371)


LANSOPRAZOLE
	
  TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING;ORAL
	
    PREVACID
	
         TAKEDA PHARMS USA      15MG                             N021428 001 Aug 30, 2002

      +                         30MG                             N021428 002 Aug 30, 2002
	
LANTHANUM CARBONATE
	
  POWDER;ORAL
	
    FOSRENOL
	
      +		 SHIRE DEV LLC         EQ 1GM BASE                      N204734 002 Sep 24, 2014

                                EQ 750MG BASE                    N204734 001 Sep 24, 2014

  TABLET, CHEWABLE;ORAL
	
    FOSRENOL
	
      +		 SHIRE LLC             EQ 1GM BASE                      N021468 004 Nov 23, 2005
	
                                EQ 500MG BASE                    N021468 002 Oct 26, 2004
	
                                EQ 750MG BASE                    N021468 003 Nov 23, 2005
	
LAPATINIB DITOSYLATE
	
  TABLET;ORAL
	
    TYKERB
	
      + SMITHKLINE BEECHAM      EQ 250MG BASE		                  N022059 001 Mar 13, 2007
	
LATANOPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    LATANOPROST
	
AT       AKORN                  0.005%                           A090887   001    Jul   19,   2011

AT       ALCON RES              0.005%                           A091449   001    Mar   22,   2011

AT       BAUSCH AND LOMB        0.005%                           A201006   001    Mar   22,   2011

AT       DR REDDYS LABS LTD     0.005%                           A202077   001    Feb   11,   2013

AT       LUITPOLD               0.005%                           A200925   001    Mar   22,   2011

AT       MYLAN                  0.005%                           A201786   001    Mar   22,   2011

    XALATAN
	
AT    + PHARMACIA AND UPJOHN    0.005%                           N020597 001 Jun 05, 1996
	
LEDIPASVIR; SOFOSBUVIR
	
  TABLET;ORAL
	
    HARVONI
	
      + GILEAD SCIENCES INC     90MG;400MG		                     N205834 001 Oct 10, 2014
	
LEFLUNOMIDE
	
  TABLET;ORAL

    ARAVA
	
AB       SANOFI AVENTIS US      10MG                             N020905 001 Sep 10, 1998

AB    +                         20MG                             N020905 002 Sep 10, 1998

    LEFLUNOMIDE
	
AB       ALEMBIC PHARMS LTD     10MG                             A091369   001    Nov   21,   2011

AB                              20MG                             A091369   002    Nov   21,   2011

AB       APOTEX INC             10MG                             A077090   001    Sep   13,   2005

AB                              20MG                             A077090   002    Sep   13,   2005

AB       BARR                   10MG                             A077083   001    Sep   13,   2005

AB                              20MG                             A077083   002    Sep   13,   2005

AB       HERITAGE PHARMS INC    10MG                             A077086   001    Sep   13,   2005

AB                              20MG                             A077086   002    Sep   13,   2005

AB       TEVA PHARMS            10MG                             A077084   001    Sep   13,   2005

AB                              20MG                             A077084   002    Sep   13,   2005

    ARAVA
	
      + SANOFI AVENTIS US       100MG		                          N020905 003 Sep 10, 1998
	
LENALIDOMIDE
	
  CAPSULE;ORAL
	
    REVLIMID
	
         CELGENE		              2.5MG                            N021880   005    Dec   21,   2011
	
                                5MG                              N021880   001    Dec   27,   2005
	
                                10MG                             N021880   002    Dec   27,   2005
	
                                15MG                             N021880   003    Jun   29,   2006
	
                                20MG                             N021880   006    Jun   05,   2013
	
     +                          25MG		                           N021880   004    Jun   29,   2006
	
LETROZOLE
	
  TABLET;ORAL

    FEMARA
	
AB    + NOVARTIS PHARMS         2.5MG                            N020726 001 Jul 25, 1997

    LETROZOLE
	
AB       ACCORD HLTHCARE        2.5MG                            A090934 001 Jun 03, 2011

AB       APOTEX INC             2.5MG                            A091303 001 Apr 19, 2012

AB       DR REDDYS LABS LTD     2.5MG                            A091191 001 Jun 03, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-210(of 371)


LETROZOLE
	
  TABLET;ORAL

    LETROZOLE
	
AB       FRESENIUS KABI ONCOL   2.5MG                          A090491   001    Jun   03,   2011

AB       INDICUS PHARMA         2.5MG                          A201804   001    Jun   03,   2011

AB       JIANGSU HENGRUI MED    2.5MG                          A202716   001    May   16,   2013

AB       KUDCO IRELAND          2.5MG                          A091098   001    Jun   03,   2011

AB       LANNETT HOLDINGS INC   2.5MG                          A202048   001    Oct   29,   2014

AB       MYLAN                  2.5MG                          A078190   001    Dec   24,   2008

AB       NATCO PHARMA LTD       2.5MG                          A200161   001    Jun   03,   2011

AB       ROXANE                 2.5MG                          A090838   001    Jun   03,   2011

AB       SUN PHARM INDS LTD     2.5MG                          A091466   001    Jun   03,   2011

AB       TEVA PHARMS            2.5MG                          A090289   001    Jun   03,   2011

AB       VINTAGE PHARMS LLC     2.5MG                          A090789   001    Jun   03,   2011
	
LEUCOVORIN CALCIUM
	
  INJECTABLE;INJECTION

    LEUCOVORIN CALCIUM
	
AP    + EUROHLTH INTL           EQ 50MG BASE/VIAL              A089384   001    Sep   14,   1987

AP    +                         EQ 100MG BASE/VIAL             A089717   001    Mar   28,   1988

AP       TEVA PHARMS USA        EQ 100MG BASE/VIAL             A081277   001    Sep   28,   1993

AP                              EQ 350MG BASE/VIAL             A040174   001    Jun   12,   1997

    LEUCOVORIN CALCIUM PRESERVATIVE FREE
	
AP    + EUROHLTH INTL           EQ 200MG BASE/VIAL             A040056   001    May   23,   1995

AP    +                         EQ 350MG BASE/VIAL             A040335   001    Apr   20,   2000

AP       FRESENIUS KABI USA     EQ 200MG BASE/VIAL             A040258   001    Feb   26,   1999

AP       SAGENT PHARMS          EQ 50MG BASE/VIAL              A200753   001    Sep   06,   2012

AP                              EQ 100MG BASE/VIAL             A200753   002    Sep   06,   2012

AP                              EQ 200MG BASE/VIAL             A200753   003    Sep   06,   2012

AP                              EQ 350MG BASE/VIAL             A200855   001    Sep   06,   2012

      + EUROHLTH INTL           EQ 10MG BASE/ML                A040347   001    Apr   25,   2000

      + FRESENIUS KABI USA      EQ 500MG BASE/VIAL             A040286   001    Feb   26,   1999
	
  TABLET;ORAL

    LEUCOVORIN CALCIUM
	
AB       BARR                   EQ 5MG BASE                    A071198   001    Sep   24,   1987

AB                              EQ 25MG BASE                   A071199   001    Sep   24,   1987

AB       ROXANE                 EQ 5MG BASE                    A072733   001    Feb   22,   1993

AB                              EQ 15MG BASE                   A072735   001    Feb   22,   1993

AB    +                         EQ 25MG BASE                   A072736   001    Feb   22,   1993
	
                                EQ 10MG BASE                   A072734   001    Feb   22,   1993
	
LEUPROLIDE ACETATE
	
  INJECTABLE;INJECTION

    LEUPROLIDE ACETATE
	
AP    + SANDOZ                  1MG/0.2ML                      A074728 001 Aug 04, 1998

AP       SUN PHARMA GLOBAL      1MG/0.2ML                      A078885 001 Mar 09, 2009

AP       TEVA PHARMS USA        1MG/0.2ML                      A075471 001 Oct 25, 2000
	
    LUPRON DEPOT
	
      + ABBVIE ENDOCRINE INC    3.75MG                         N020011   002    Oct   26,   1995
	
      +                         7.5MG/VIAL                     N019732   001    Jan   26,   1989
	
      +                         11.25MG/VIAL                   N020708   001    Mar   07,   1997
	
      +                         22.5MG/VIAL                    N020517   001    Dec   22,   1995
	
      +                         30MG/VIAL                      N020517   002    May   30,   1997

                                45MG/VIAL                      N020517   003    Jun   17,   2011
	
   LUPRON DEPOT-PED
	
     + ABBVIE ENDOCRINE INC     7.5MG/VIAL                     N020263   002    Apr   16,   1993

     +                          11.25MG/VIAL                   N020263   005    Jan   21,   1994
	
     +                          11.25MG/VIAL                   N020263   007    Aug   15,   2011

     +                          15MG/VIAL                      N020263   006    Jan   21,   1994
	
     +                          30MG/VIAL                      N020263   008    Aug   15,   2011

 INJECTABLE;SUBCUTANEOUS
	
   ELIGARD
	
     + TOLMAR THERAP            7.5MG/VIAL                     N021343   001    Jan   23,   2002
	
     +                          22.5MG/VIAL                    N021379   001    Jul   24,   2002
	
     +                          30MG/VIAL                      N021488   001    Feb   13,   2003
	
     +                          45MG/VIAL                      N021731   001    Dec   14,   2004
	
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE
  INJECTABLE, TABLET;INTRAMUSCULAR, ORAL
    LUPANETA PACK
         ABBVIE ENDOCRINE       3.75MG/VIAL,N/A;N/A,5MG        N203696 001 Dec 14, 2012
      +                         11.25MG/VIAL,N/A;N/A,5MG       N203696 002 Dec 14, 2012
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-211(of 371)


LEVALBUTEROL HYDROCHLORIDE
	
  SOLUTION;INHALATION

    LEVALBUTEROL HYDROCHLORIDE
	
AN       CIPLA LTD                 EQ   0.021% BASE            A078171   002    Dec   13,   2013

AN                                 EQ   0.042% BASE            A078171   003    Dec   13,   2013

AN                                 EQ   0.0103% BASE           A078171   001    Dec   13,   2013

AN       MYLAN SPECLT              EQ   0.0103% BASE           A077800   001    Mar   15,   2013

AN                                 EQ   0.021% BASE            A077800   002    Mar   15,   2013

AN                                 EQ   0.042% BASE            A077800   003    Mar   15,   2013

AN                                 EQ   0.25% BASE             A078309   001    Mar   20,   2009

AN       TEVA PARENTERAL           EQ   0.25% BASE             A200875   001    Sep   11,   2014

AN       TEVA PHARMS USA           EQ   0.0103% BASE           A090297   001    Apr   26,   2013

AN                                 EQ   0.021% BASE            A090297   002    Apr   26,   2013

AN                                 EQ   0.042% BASE            A090297   003    Apr   26,   2013

AN       WATSON LABS INC           EQ   0.0103% BASE           A077756   003    Apr   09,   2008

AN                                 EQ   0.021% BASE            A077756   001    Apr   09,   2008

AN                                 EQ   0.042% BASE            A077756   002    Apr   09,   2008

    XOPENEX
	
AN    + OAK PHARMS INC             EQ   0.0103% BASE           N020837   003    Jan   30,   2002

AN    +                            EQ   0.021% BASE            N020837   001    Mar   25,   1999

AN    +                            EQ   0.042% BASE            N020837   002    Mar   25,   1999

AN    +                            EQ   0.25% BASE             N020837   004    Jul   18,   2003
	
LEVALBUTEROL TARTRATE
	
  AEROSOL, METERED;INHALATION
	
    XOPENEX HFA
	
      + SUNOVION                   EQ 0.045MG BASE/INH         N021730 001 Mar 11, 2005
	
LEVETIRACETAM
	
  INJECTABLE;IV (INFUSION)

    KEPPRA
	
AP    + UCB INC                 500MG/5ML (100MG/ML)           N021872 001 Jul 31, 2006

    LEVETIRACETAM
	
AP       FRESENIUS KABI USA     500MG/5ML (100MG/ML)           A090813   001    May   26,   2010

AP       HIKMA FARMACEUTICA     500MG/5ML(100MG/ML)            A090981   001    Oct   13,   2011

AP       HOSPIRA INC            500MG/ML (100MG/ML)            A202869   001    Apr   06,   2012

AP       LUITPOLD               500MG/5ML (100MG/ML)           A202143   001    Jan   31,   2012

AP       SAGENT PHARMS          500MG/5ML (100MG/ML)           A091627   001    Jun   26,   2013

AP       SUN PHARM INDS LTD     500MG/5ML (100MG/ML)           A090754   001    Jun   16,   2010

AP       X GEN PHARMS           500MG/5ML (100MG/ML)           A091485   001    Aug   05,   2011

    LEVETIRACETAM IN SODIUM CHLORIDE
	
      + HQ SPECIALITY PHARMA    500MG/100ML (5MG/ML)           N202543 001 Nov 09, 2011
	
      +                         1000MG/100ML (10MG/ML)         N202543 002 Nov 09, 2011
	
      +                         1500MG/100ML (15MG/ML)         N202543 003 Nov 09, 2011
	
  SOLUTION;ORAL

    KEPPRA
	
AA    + UCB INC                 100MG/ML                       N021505 001 Jul 15, 2003

    LEVETIRACETAM
	
AA       ACTAVIS MID ATLANTIC   100MG/ML                       A078976   001    Jan   15,   2009

AA       AMNEAL PHARMS          100MG/ML                       A090992   001    Oct   27,   2009

AA       AUROBINDO PHARM        100MG/ML                       A079063   001    Jan   15,   2009

AA       BRECKENRIDGE PHARM     100MG/ML                       A079120   001    Jan   16,   2009

AA       HETERO LABS LTD III    100MG/ML                       A203052   001    Feb   28,   2013

AA       HI-TECH PHARMACAL      100MG/ML                       A090601   001    Feb   28,   2012

AA       LUPIN LTD              100MG/ML                       A090893   001    Oct   17,   2011

AA       ORIT LABS LLC          100MG/ML                       A203067   001    May   09,   2013

AA       ROXANE                 100MG/ML                       A078582   001    Jan   15,   2009

AA       SILARX                 100MG/ML                       A090263   001    Apr   03,   2009

AA       TARO                   100MG/ML                       A078774   001    Feb   10,   2009

AA       TOLMAR                 100MG/ML                       A079107   001    Jan   15,   2009

AA       TRIS PHARMA INC        100MG/ML                       A090461   001    Sep   30,   2010

AA       VINTAGE PHARMS         100MG/ML                       A090079   001    Apr   11,   2012

AA       WOCKHARDT              100MG/ML                       A090028   001    Mar   03,   2010
	
  TABLET;ORAL

    KEPPRA
	
AB    + UCB INC                 1GM                            N021035   004    Jan   06,   2006

AB                              250MG                          N021035   001    Nov   30,   1999

AB                              500MG                          N021035   002    Nov   30,   1999

AB                              750MG                          N021035   003    Nov   30,   1999

    LEVETIRACETAM
	
AB       ACCORD HLTHCARE        1GM                            A090843 004 Feb 14, 2011

AB                              250MG                          A090843 001 Feb 14, 2011

AB                              500MG                          A090843 002 Feb 14, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-212(of 371)


LEVETIRACETAM
	
  TABLET;ORAL

    LEVETIRACETAM
	
AB                             750MG                           A090843   003    Feb   14,   2011

AB       AJANTA PHARMA         1GM                             A201293   004    Jun   14,   2011

AB                             250MG                           A201293   001    Jun   14,   2011

AB                             500MG                           A201293   002    Jun   14,   2011

AB                             750MG                           A201293   003    Jun   14,   2011

AB       APOTEX INC            1GM                             A078869   004    Mar   13,   2009

AB                             250MG                           A078869   001    Mar   13,   2009

AB                             500MG                           A078869   002    Mar   13,   2009

AB                             750MG                           A078869   003    Mar   13,   2009

AB       AUROBINDO PHARMA      1GM                             A078993   004    Jan   15,   2009

AB                             250MG                           A078993   001    Jan   15,   2009

AB                             500MG                           A078993   002    Jan   15,   2009

AB                             750MG                           A078993   003    Jan   15,   2009

AB       BRECKENRIDGE PHARM    1GM                             A090511   004    Aug   18,   2011

AB                             250MG                           A090511   001    Aug   18,   2011

AB                             500MG                           A090511   002    Aug   18,   2011

AB                             750MG                           A090511   003    Aug   18,   2011

AB       DR REDDYS LABS LTD    1GM                             A078904   001    Jan   15,   2009

AB                             250MG                           A076920   001    Jan   15,   2009

AB                             500MG                           A076920   002    Jan   15,   2009

AB                             750MG                           A076920   003    Jan   15,   2009

AB       HETERO LABS LTD III   1GM                             A090515   004    Oct   08,   2010

AB                             250MG                           A090515   001    Oct   08,   2010

AB                             500MG                           A090515   002    Oct   08,   2010

AB                             750MG                           A090515   003    Oct   08,   2010

AB       INVAGEN PHARMS        250MG                           A078234   001    Jan   15,   2009

AB                             500MG                           A078234   002    Jan   15,   2009

AB                             750MG                           A078234   003    Jan   15,   2009

AB       LOTUS PHARM CO LTD    500MG                           A090906   001    Nov   05,   2010

AB       LUPIN                 1GM                             A090025   001    Jan   15,   2009

AB                             250MG                           A078154   001    Jan   15,   2009

AB                             500MG                           A078154   002    Jan   15,   2009

AB                             750MG                           A078154   003    Jan   15,   2009

AB       METHAPHARM            1GM                             A090767   004    Jul   28,   2010

AB                             250MG                           A090767   001    Jul   28,   2010

AB                             500MG                           A090767   002    Jul   28,   2010

AB                             750MG                           A090767   003    Jul   28,   2010

AB       MYLAN                 1GM                             A090261   001    Dec   08,   2009

AB                             250MG                           A076919   001    Nov   04,   2008

AB                             500MG                           A076919   002    Nov   04,   2008

AB                             750MG                           A076919   003    Nov   04,   2008

AB       ORCHID HLTHCARE       1GM                             A090484   001    Aug   05,   2010

AB                             250MG                           A078526   001    Jan   15,   2009

AB                             500MG                           A078526   002    Jan   15,   2009

AB                             750MG                           A078526   003    Jan   15,   2009

AB       PRINSTON INC          1GM                             A078106   004    Feb   10,   2009

AB                             250MG                           A078106   001    Feb   10,   2009

AB                             500MG                           A078106   002    Feb   10,   2009

AB                             750MG                           A078106   003    Feb   10,   2009

AB       ROXANE                1GM                             A078042   004    Jan   15,   2009

AB                             250MG                           A078042   001    Jan   15,   2009

AB                             500MG                           A078042   002    Jan   15,   2009

AB                             750MG                           A078042   003    Jan   15,   2009

AB       TARO                  1GM                             A078960   001    Feb   01,   2010

AB                             250MG                           A078960   004    Feb   01,   2010

AB                             500MG                           A078960   003    Feb   01,   2010

AB                             750MG                           A078960   002    Feb   01,   2010

AB       TEVA PHARMS           1GM                             A078101   004    Jan   15,   2009

AB                             250MG                           A078101   001    Jan   15,   2009

AB                             500MG                           A078101   002    Jan   15,   2009

AB                             750MG                           A078101   003    Jan   15,   2009

AB       TORRENT PHARMS        1GM                             A078858   004    Jan   15,   2009

AB                             250MG                           A078858   001    Jan   15,   2009

AB                             500MG                           A078858   002    Jan   15,   2009

AB                             750MG                           A078858   003    Jan   15,   2009

AB       VINTAGE PHARMS        1GM                             A091491   004    Dec   14,   2010

AB                             250MG                           A077319   001    Mar   20,   2009

AB                             250MG                           A091491   001    Dec   14,   2010

AB                             500MG                           A077319   002    Mar   20,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-213(of 371)


LEVETIRACETAM
	
  TABLET;ORAL

     LEVETIRACETAM
AB                               500MG
	                        A091491   002    Dec   14,   2010

AB                               750MG
	                        A077319   003    Mar   20,   2009

AB                               750MG
	                        A091491   003    Dec   14,   2010

AB         WOCKHARDT             1GM
	                          A079042   004    Jan   15,   2009

AB                               250MG
	                        A079042   001    Jan   15,   2009

AB                               500MG
	                        A079042   002    Jan   15,   2009

AB                               750MG
	                        A079042   003    Jan   15,   2009

AB         ZYDUS PHARMS USA INC  1GM
	                          A078918   002    Apr   29,   2009

AB                               250MG
	                        A078918   001    Apr   29,   2009
	
  TABLET, EXTENDED RELEASE;ORAL

     KEPPRA XR
	
AB         UCB INC
	             500MG
	                        N022285 001 Sep 12, 2008

AB     +
	                       750MG
	                        N022285 002 Feb 12, 2009
	
     LEVETIRACETAM
	
AB         ACTAVIS ELIZABETH
	   500MG
	                        A091557   001    Sep   12,   2011

AB
	                             750MG
	                        A091557   002    Sep   12,   2011

AB         ACTAVIS LABS FL INC
	 500MG
	                        A091093   001    Sep   12,   2011

AB
	                             750MG
	                        A091093   002    Sep   12,   2011

AB         ANCHEN PHARMS
	       500MG
	                        A091360   001    Oct   04,   2011

AB
	                             750MG
	                        A091360   002    Oct   04,   2011

AB         APOTEX INC
	          500MG
	                        A091261   001    Sep   12,   2011

AB
	                             750MG
	                        A091261   002    Sep   12,   2011

AB         LUPIN LTD
	           500MG
	                        A091399   001    Sep   12,   2011

AB
	                             750MG
	                        A091399   002    Sep   12,   2011

AB         MUTUAL PHARM CO INC
	 500MG
	                        A091285   001    Sep   12,   2011

AB
	                             750MG
	                        A091285   002    Sep   12,   2011

AB         MYLAN PHARMS INC
	    500MG
	                        A200475   001    Dec   19,   2011

AB
	                             750MG
	                        A200475   002    Dec   19,   2011

AB         PAR PHARM
	           500MG
	                        A091291   001    Sep   12,   2011

AB
	                             750MG
	                        A091291   002    Sep   12,   2011

AB         ROUSES POINT PHARMS
	 500MG
	                        A202524   001    Aug   27,   2012

AB
	                             750MG
	                        A202524   002    Aug   27,   2012

AB         SUN PHARMA GLOBAL
	   500MG
	                        A203059   001    Sep   09,   2013

AB
	                             750MG
	                        A203059   002    Sep   09,   2013

AB         TEVA PHARMS
	         500MG
	                        A091430   001    Sep   12,   2011

AB
	                             750MG
	                        A091430   002    Sep   12,   2011

AB         TORRENT PHARMS LTD
	  500MG
	                        A091338   001    May   29,   2012

AB
	                             750MG
	                        A091338   002    May   29,   2012

AB         VINTAGE PHARMS
	      500MG
	                        A201464   001    May   25,   2012

AB
	                             750MG
	                        A201464   002    May   25,   2012

AB         VINTAGE PHARMS LLC
	  500MG
	                        A202533   001    Jul   20,   2012

AB
	                             750MG
	                        A202533   002    Jul   20,   2012
	
LEVOBUNOLOL HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

     AKBETA
	
AT         AKORN
	                 0.25%
	                      A074779 001 Oct 29, 1996

AT
	                               0.5%
	                       A074780 001 Oct 29, 1996
	
     BETAGAN
	
AT     + ALLERGAN
	                0.25%
	                      N019814 001 Jun 28, 1989

AT     +
	                         0.5%
	                       N019219 002 Dec 19, 1985
	
     LEVOBUNOLOL HYDROCHLORIDE
	
AT         ALCON RES LTD
	         0.5%
	                       A074850   001    Oct   28,   1996

AT         BAUSCH AND LOMB
	       0.25%
	                      A074307   001    Mar   04,   1994

AT
	                               0.5%
	                       A074326   001    Mar   04,   1994

AT         FALCON PHARMS
	         0.25%
	                      A074851   001    Oct   28,   1996
	
LEVOCARNITINE
	
  INJECTABLE;INJECTION

    CARNITOR
	
AP    + SIGMA TAU
	                200MG/ML
	                   N020182 001 Dec 16, 1992
	
    LEVOCARNITINE
	
AP       EUROHLTH INTL
	           200MG/ML
                    A075567 001 Mar 29, 2001

AP       LUITPOLD
	                200MG/ML
                    A075861 001 Jun 22, 2001

AP       TEVA PHARMS USA
	         200MG/ML
	                   A075881 001 Mar 29, 2001
	
  SOLUTION;ORAL

    CARNITOR
	
AA    + SIGMA TAU
	                1GM/10ML
	                   N019257 001 Apr 10, 1986
	
    CARNITOR SF
	
AA       SIGMA TAU
	               1GM/10ML
	                   N019257 002 Mar 28, 2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-214(of 371)


LEVOCARNITINE
	
  SOLUTION;ORAL

    LEVOCARNITINE
	
AA       HI TECH PHARMA         1GM/10ML                       A077399 001 Oct 25, 2007

AA       LYNE                   1GM/10ML                       A076851 001 Aug 10, 2004

  TABLET;ORAL

    CARNITOR
	
AB    + SIGMA TAU               330MG                          N018948 001 Dec 27, 1985

    LEVOCARNITINE
	
AB       COREPHARMA             330MG                          A076858 001 Sep 20, 2004
	
LEVOCETIRIZINE DIHYDROCHLORIDE
	
  SOLUTION;ORAL

    LEVOCETIRIZINE DIHYDROCHLORIDE
	
AA       APOTEX INC              2.5MG/5ML                     A202915 001 Aug 21, 2014

AA       L PERRIGO CO            2.5MG/5ML                     A091263 001 Nov 07, 2011

AA       TARO PHARM INDS         2.5MG/5ML                     A202673 001 Jul 26, 2013

    XYZAL
	
AA    + UCB INC                  2.5MG/5ML                     N022157 001 Jan 28, 2008
	
  TABLET;ORAL

    LEVOCETIRIZINE DIHYDROCHLORIDE
	
AB       DR REDDYS LABS LTD      5MG                           A090392   001    Feb   24,   2011

AB       GLENMARK GENERICS       5MG                           A090385   001    Feb   24,   2011

AB       HETERO LABS LTD III     5MG                           A091264   001    Jun   29,   2012

AB       MICRO LABS LTD INDIA    5MG                           A202046   001    Sep   17,   2013

AB       SCIEGEN PHARMS INC      5MG                           A203646   001    Sep   09,   2014

AB       SUN PHARMA GLOBAL       5MG                           A090362   001    Jan   31,   2013

AB       SYNTHON PHARMS          5MG                           A090229   001    Nov   26,   2010

AB       TEVA PHARMS             5MG                           A090199   001    Aug   22,   2011

    XYZAL
	
AB    + UCB INC                  5MG                           N022064 001 May 25, 2007
	
LEVOFLOXACIN
	
  INJECTABLE;INJECTION

    LEVAQUIN

AP    + JANSSEN PHARMS          EQ 500MG/20ML (EQ 25MG/ML)     N020635 001 Dec 20, 1996

AP    +                         EQ 750MG/30ML (EQ 25MG/ML)     N020635 004 Dec 20, 1996

    LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER

AP    + JANSSEN PHARMS          EQ 250MG/50ML (EQ 5MG/ML)      N020635 002 Dec 20, 1996

AP    +                         EQ 500MG/100ML (EQ 5MG/ML)     N020635 003 Dec 20, 1996

AP    +                         EQ 750MG/150ML (EQ 5MG/ML)     N020635 005 Dec 20, 1996

    LEVOFLOXACIN
	
AP       AUROBINDO PHARMA LTD   EQ 500MG/20ML (EQ 25MG/ML)     A202328   001    Jan   24,   2013

AP                              EQ 750MG/30ML (EQ 25MG/ML)     A202328   002    Jan   24,   2013

AP       CLARIS LIFESCIENCES    EQ 500MG/20ML (EQ 25MG/ML)     A091436   001    Jun   05,   2013

AP       EMCURE PHARMS LTD      EQ 500MG/20ML (EQ 25MG/ML)     A202590   001    Jan   24,   2013

AP                              EQ 750MG/30ML (EQ 25MG/ML)     A202590   002    Jan   24,   2013

AP       SAGENT PHARMS          EQ 500MG/20ML (EQ 25MG/ML)     A200560   001    Jun   20,   2011

AP                              EQ 750MG/30ML (EQ 25MG/ML)     A200560   002    Jun   20,   2011

    LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       ACS DOBFAR INFO SA     EQ 250MG/50ML (EQ 5MG/ML)      A090343   001    Jul   07,   2011

AP                              EQ 500MG/100ML (EQ 5MG/ML)     A090343   002    Jul   07,   2011

AP                              EQ 750MG/150ML (EQ 5MG/ML)     A090343   003    Jul   07,   2011

AP       CLARIS LIFESCIENCES    EQ 250MG/50ML (EQ 5MG/ML)      A091397   001    Aug   08,   2013

AP                              EQ 500MG/100ML (EQ 5MG/ML)     A091397   002    Aug   08,   2013

AP                              EQ 750MG/150ML (EQ 5MG/ML)     A091397   003    Aug   08,   2013

AP       FRESENIUS KABI USA     EQ 250MG/50ML (EQ 5MG/ML)      A200674   001    Jun   19,   2013

AP                              EQ 500MG/100ML (EQ 5MG/ML)     A200674   002    Jun   19,   2013

AP                              EQ 750MG/150ML (EQ 5MG/ML)     A200674   003    Jun   19,   2013

AP       HIKMA FARMACEUTICA     EQ 250MG/50ML (EQ 5MG/ML)      A091375   001    Sep   16,   2011

AP                              EQ 500MG/100ML (EQ5MG/ML)      A091375   002    Sep   16,   2011

AP                              EQ 750MG/150ML (EQ 5MG/ML)     A091375   003    Sep   16,   2011

  SOLUTION;ORAL

    LEVAQUIN

AA    + JANSSEN PHARMS          250MG/10ML                     N021721 001 Oct 21, 2004

    LEVOFLOXACIN
	
AA       HI TECH PHARMA         250MG/10ML                     A091678 001 Jun 20, 2011
	
  SOLUTION/DROPS;OPHTHALMIC

    LEVOFLOXACIN
	
AT       AKORN                  0.5%                           A090268 001 Dec 20, 2010

AT       NEXUS PHARMS           0.5%                           A077700 001 Dec 20, 2010

AT       WATSON LABS INC        0.5%                           A076826 001 Feb 10, 2011
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-215(of 371)


LEVOFLOXACIN
	
  SOLUTION/DROPS;OPHTHALMIC

     QUIXIN

AT     + SANTEN
	                   0.5%
	                       N021199 001 Aug 18, 2000
	
  TABLET;ORAL

     LEVAQUIN

AB         JANSSEN PHARMS
	         250MG
	                      N020634 001 Dec 20, 1996

AB
	                                500MG
	                      N020634 002 Dec 20, 1996

AB     +
	                          750MG
	                      N020634 003 Sep 08, 2000
	
     LEVOFLOXACIN
	
AB         APOTEX INC
	             250MG
	                      A090787   001    Sep   29,   2011

AB
	                                500MG
	                      A090787   002    Sep   29,   2011

AB
	                                750MG
	                      A090787   003    Sep   29,   2011

AB         AUROBINDO PHARMA LTD
	   250MG
	                      A201043   001    Jun   20,   2011

AB
	                                500MG
	                      A201043   002    Jun   20,   2011

AB
	                                750MG
	                      A201043   003    Jun   20,   2011

AB         CIPLA LTD
	              250MG
	                      A076890   001    Mar   30,   2012

AB
	                                500MG
	                      A076890   002    Mar   30,   2012

AB
	                                750MG
	                      A076890   003    Mar   30,   2012

AB         DR REDDYS LABS INC
	     250MG
	                      A076710   001    Jun   20,   2011

AB
	                                500MG
	                      A076710   002    Jun   20,   2011

AB
	                                750MG
	                      A076710   003    Jun   20,   2011

AB         GLENMARK GENERICS
	      250MG
	                      A200250   001    Jun   20,   2011

AB
	                                500MG
	                      A200250   002    Jun   20,   2011

AB
	                                750MG
	                      A200250   003    Jun   20,   2011

AB         HETERO LABS LTD V
	      250MG
	                      A202801   001    Jan   08,   2015

AB
	                                500MG
	                      A202801   002    Jan   08,   2015

AB
	                                750MG
	                      A202801   003    Jan   08,   2015

AB         LUPIN
	                  250MG
	                      A078424   001    Jun   20,   2011

AB
	                                500MG
	                      A078424   002    Jun   20,   2011

AB
	                                750MG
	                      A078424   003    Jun   20,   2011

AB         MACLEODS PHARMS LTD
	    250MG
	                      A200839   001    Mar   22,   2012

AB
	                                500MG
	                      A200839   002    Mar   22,   2012

AB
	                                750MG
	                      A200839   003    Mar   22,   2012

AB         MYLAN
	                  250MG
	                      A076276   001    Jun   20,   2011

AB
	                                500MG
	                      A076276   002    Jun   20,   2011

AB
	                                750MG
	                      A077097   001    Jun   20,   2011

AB         ORCHID HLTHCARE
	        250MG
	                      A202200   001    Jan   30,   2012

AB
	                                500MG
	                      A202200   002    Jan   30,   2012

AB
	                                750MG
	                      A202200   003    Jan   30,   2012

AB         SANDOZ
	                 250MG
	                      A077438   001    Jun   20,   2011

AB
	                                500MG
	                      A077438   002    Jun   20,   2011

AB
	                                750MG
	                      A077438   003    Jun   20,   2011

AB         TEVA
	                   250MG
	                      A076361   001    Jun   20,   2011

AB
	                                500MG
	                      A076361   002    Jun   20,   2011

AB
	                                750MG
	                      A076361   003    Jun   20,   2011

AB         TORRENT PHARMS
	         250MG
	                      A090722   001    Jun   20,   2011

AB
	                                500MG
	                      A090722   002    Jun   20,   2011

AB
	                                750MG
	                      A090722   003    Jun   20,   2011

AB         WOCKHARDT
	              250MG
	                      A090367   001    Jun   20,   2011

AB
	                                500MG
	                      A090367   002    Jun   20,   2011

AB
	                                750MG
	                      A090367   003    Jun   20,   2011

AB         ZYDUS PHARMS USA INC
	   250MG
	                      A077652   001    Sep   07,   2012

AB
	                                500MG
	                      A077652   002    Sep   07,   2012

AB
	                                750MG
	                      A077652   003    Sep   07,   2012
	
LEVOLEUCOVORIN CALCIUM
	
  POWDER;IV (INFUSION)

    FUSILEV
	
      + SPECTRUM PHARMS
	           EQ 50MG BASE/VIAL
	          N020140 001 Mar 07, 2008
	
LEVOMILNACIPRAN HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    FETZIMA
	
          FOREST LABS INC		     EQ     20MG BASE
	               N204168   001    Jul   25,   2013
	
                                EQ     40MG BASE
	               N204168   002    Jul   25,   2013
	
                                EQ     80MG BASE
	               N204168   003    Jul   25,   2013
	
      +		                       EQ     120MG BASE
	              N204168   004    Jul   25,   2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                                 3-216(of 371)


LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    SCANDONEST L
	
      + DEPROCO                 0.05MG/ML;2%                                A088388 001 Oct 10, 1984
	
LEVONORGESTREL
	
  INTRAUTERINE DEVICE;INTRAUTERINE
	
    MIRENA
	
      + BAYER HLTHCARE          52MG                                        N021225 001 Dec 06, 2000
	
    SKYLA
	
      + BAYER HLTHCARE          13.5MG                                      N203159 001 Jan 09, 2013
	
  TABLET;ORAL

    LEVONORGESTREL
	
AB       NOVEL LABS INC         1.5MG                                       A202508   001    Feb   22,   2013

AB       PERRIGO R AND D        0.75MG                                      A090740   001    Dec   30,   2010

AB    + WATSON LABS             0.75MG                                      A078665   001    Aug   28,   2009

AB       WATSON LABS INC        1.5MG                                       A200670   001    Jul   12,   2012

    PLAN B
	
AB    + TEVA BRANDED PHARM      0.75MG                                      N021045 002 Aug 24, 2006
	
LEVORPHANOL TARTRATE
	
  TABLET;ORAL
	
    LEVORPHANOL TARTRATE
	
      + ROXANE                  2MG                                         A074278 001 Mar 31, 2000
	
LEVOTHYROXINE SODIUM
	
  CAPSULE;ORAL
	
    TIROSINT
	
         INST BIOCHIMIQUE       0.013MG                                     N022121   001    Aug   01,   2007

         INSTITUT BIOCHIMIQUE   0.025MG                                     N021924   002    Oct   13,   2006
	
                                0.05MG                                      N021924   003    Oct   13,   2006
	
                                0.075MG                                     N021924   004    Oct   13,   2006
	
                                0.088MG                                     N021924   010    Oct   02,   2009
	
                                0.1MG                                       N021924   005    Oct   13,   2006
	
                                0.112MG                                     N021924   008    Oct   02,   2009
	
                                0.125MG                                     N021924   006    Oct   13,   2006
	
                                0.137MG                                     N021924   009    Oct   02,   2009
	
     +                          0.15MG                                      N021924   007    Oct   13,   2006
	
 POWDER;INTRAVENOUS
	
   LEVOTHYROXINE SODIUM
	
     + FRESENIUS KABI USA       100MCG/VIAL                                 N202231 001 Jun 24, 2011
	
     +                          200MCG/VIAL                                 N202231 002 Jun 24, 2011
	
     +                          500MCG/VIAL                                 N202231 003 Jun 24, 2011
	
LEVOTHYROXINE SODIUM **
	
**See current Annual Edition, 1.8 Description of   Special Situations, Levothyroxine Sodium

  TABLET;ORAL

    SYNTHROID
	
-->      ABBVIE                 --> AB1,AB2        0.025MG                  N021402   001    Jul   24,   2002
	
-->                             --> AB1,AB2        0.05MG                   N021402   002    Jul   24,   2002
	
-->                             --> AB1,AB2        0.075MG                  N021402   003    Jul   24,   2002
	
-->                             --> AB1,AB2        0.088MG                  N021402   004    Jul   24,   2002
	
-->                             --> AB1,AB2        0.1MG                    N021402   005    Jul   24,   2002
	
-->                             --> AB1,AB2        0.112MG                  N021402   006    Jul   24,   2002
	
-->                             --> AB1,AB2        0.125MG                  N021402   007    Jul   24,   2002
	
-->                             --> AB1,AB2        0.137MG                  N021402   008    Jul   24,   2002
	
-->                             --> AB1,AB2        0.15MG                   N021402   009    Jul   24,   2002
	
-->                             --> AB1,AB2        0.175MG                  N021402   010    Jul   24,   2002
	
-->                             --> AB1,AB2        0.2MG                    N021402   012    Jul   24,   2002
	
--> +                           --> AB1,AB2        0.3MG                    N021402   011    Jul   24,   2002

    LEVO-T
	
-->      ALARA PHARM            --> AB1,AB2,AB3    0.025MG                  N021342 001 Mar 01, 2002
	

-->                             --> AB1,AB2,AB3    0.05MG                   N021342 002 Mar 01, 2002
	

-->                             --> AB1,AB2,AB3    0.075MG                  N021342 003 Mar 01, 2002
	

-->                             --> AB1,AB2,AB3    0.088MG                  N021342 004 Mar 01, 2002
	

-->                             --> AB1,AB2,AB3    0.1MG                    N021342 005 Mar 01, 2002
	

-->                             --> AB1,AB2,AB3    0.112MG                  N021342 006 Mar 01, 2002
	

-->                             --> AB1,AB2,AB3    0.125MG                  N021342 007 Mar 01, 2002
	

-->                             --> AB1,AB2,       0.137MG                  N021342 012 Dec 08, 2003
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST                             3-217(of 371)


LEVOTHYROXINE SODIUM **
	
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

  TABLET;ORAL

    LEVO-T
	
                                AB3              0.137MG
	
-->                             --> AB1,AB2,AB3 0.15MG                    N021342 008 Mar 01, 2002
	

-->                               --> AB1,AB2,AB3    0.175MG              N021342 009 Mar 01, 2002
	

-->                               --> AB1,AB2,AB3    0.2MG                N021342 010 Mar 01, 2002
	

-->    +                          --> AB1,AB2,AB3    0.3MG                N021342 011 Mar 01, 2002
	

      UNITHROID
	
-->        STEVENS J              --> AB1,AB2,AB3    0.025MG              N021210 001 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.05MG               N021210 002 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.075MG              N021210 003 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.088MG              N021210 004 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.1MG                N021210 005 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.112MG              N021210 006 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.125MG              N021210 007 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.137MG              N021210 012 Feb 08, 2008
	

-->                               --> AB1,AB2,AB3    0.15MG               N021210 008 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.175MG              N021210 009 Aug 21, 2000
	

-->                               --> AB1,AB2,AB3    0.2MG                N021210 010 Aug 21, 2000
	

-->    +                          --> AB1,AB2,AB3    0.3MG                N021210 011 Aug 21, 2000
	

      LEVOTHYROXINE SODIUM
	
-->        MYLAN                  -->                0.025MG              A076187 001 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.05MG               A076187 002 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.075MG              A076187 003 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.088MG              A076187 004 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.1MG                A076187 005 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.112MG              A076187 006 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.125MG              A076187 007 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.137MG              A076187 012 Dec 13, 2006

                                  AB1,AB2,AB3,AB4

-->                               -->                0.15MG               A076187 008 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.175MG              A076187 009 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.2MG                A076187 010 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

-->                               -->                0.3MG                A076187 011 Jun 05, 2002

                                  AB1,AB2,AB3,AB4

      LEVOXYL
	
-->        KING PHARMS R AND D    -->   AB1,AB3      0.025MG              N021301   001    May   25,   2001

-->                               -->   AB1,AB3      0.05MG               N021301   002    May   25,   2001

-->                               -->   AB1,AB3      0.075MG              N021301   003    May   25,   2001

-->                               -->   AB1,AB3      0.088MG              N021301   004    May   25,   2001

-->                               -->   AB1,AB3      0.1MG                N021301   005    May   25,   2001

-->                               -->   AB1,AB3      0.112MG              N021301   006    May   25,   2001

-->                               -->   AB1,AB3      0.125MG              N021301   007    May   25,   2001

-->                               -->   AB1,AB3      0.137MG              N021301   008    May   25,   2001

-->                               -->   AB1,AB3      0.15MG               N021301   009    May   25,   2001

-->                               -->   AB1,AB3      0.175MG              N021301   010    May   25,   2001

-->   +                           -->   AB1,AB3      0.2MG                N021301   011    May   25,   2001

    LEVOTHROID
	
AB4      LLOYD                    0.025MG                                 N021116 001 Oct 24, 2002

AB4                               0.05MG                                  N021116 002 Oct 24, 2002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-218(of 371)


LEVOTHYROXINE SODIUM **
	
**See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

  TABLET;ORAL

    LEVOTHROID
	
AB4                             0.075MG                                   N021116 003 Oct         24,   2002

AB4                             0.088MG                                   N021116 010 Oct         24,   2002

AB4                             0.1MG                                     N021116 004 Oct         24,   2002

AB4                             0.112MG                                   N021116 011 Oct         24,   2002

AB4                             0.125MG                                   N021116 005 Oct         24,   2002

AB4                             0.137MG                                   N021116 012 Dec         07,   2004

AB4                             0.15MG                                    N021116 006 Oct         24,   2002

AB4                             0.175MG                                   N021116 007 Oct         24,   2002

AB4                             0.2MG                                     N021116 008 Oct         24,   2002

AB4 +                           0.3MG                                     N021116 009 Oct         24,   2002
	
LIDOCAINE
	
  OINTMENT;TOPICAL

    LIDOCAINE
	
AT    + FOUGERA                 5%                                        A080198 001
	
AT       NOVOCOL INC            5%                                        A040911 001 May 23, 2011

AT       TARO                   5%                                        A086724 001
	
  PATCH;TOPICAL

    LIDOCAINE
	
AB       WATSON LABS INC        5%                                        A200675 001 Aug 23, 2012

    LIDODERM
	
AB    + TEIKOKU PHARMA USA      5%                                        N020612 001 Mar 19, 1999
	
LIDOCAINE HYDROCHLORIDE
	
  GEL;OPHTHALMIC
	
    AKTEN
	
      + AKORN                   3.5%                                      N022221 001 Oct 07, 2008
	
  INJECTABLE;INJECTION

    LIDOCAINE HYDROCHLORIDE
	
AP       AGILA SPECLTS          0.5%                                      A091056   001     Dec   08,   2010

AP                              0.5%                                      A091058   001     Sep   30,   2010

AP                              1%                                        A091056   002     Dec   08,   2010

AP                              1%                                        A091058   002     Sep   30,   2010

AP                              2%                                        A202242   001     Apr   11,   2014

AP       HOSPIRA                0.5%                                      A088328   001     May   17,   1984

AP                              1%                                        A083158   001
	
AP                              1%                                        A088329   001     May 17, 1984

AP                              2%                                        A040078   001     Jun 23, 1995

AP                              2%                                        A083158   002
	
AP                              2%                                        A088294   001     May 17, 1984

AP                              20%                                       A083158   003
	
AP       INTL MEDICATION        1%                                        A083173   001
	
AP                              2%                                        A083173   002
	
AP       LUITPOLD               1%                                        A080850   001
	
    LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       B BRAUN                200MG/100ML                               N019830 002 Apr 08, 1992

AP       BAXTER HLTHCARE        200MG/100ML                               N018461 002
	
    LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       B BRAUN                400MG/100ML                               N019830 003 Apr 08, 1992
AP       BAXTER HLTHCARE        400MG/100ML                               N018461 003
    LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER
AP       HOSPIRA                400MG/100ML                               N018388 002
    LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
AP       B BRAUN                800MG/100ML                               N019830 004 Apr 08, 1992
AP       BAXTER HLTHCARE        800MG/100ML                               N018461 004 Feb 22, 1982
    LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER
AP       HOSPIRA                800MG/100ML                               N018388 003 Nov 05, 1982
    LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
AP       FRESENIUS KABI USA     1%                                        A088586   001     Jul   24,   1985
AP       HOSPIRA                0.5%                                      A088325   001     Jul   31,   1984
AP                              1%                                        A088299   001     Jul   31,   1984
AP                              2%                                        A088327   001     Jul   31,   1984
    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
AP       AGILA SPECLTS          2%                                        A090665   001     Sep   27,   2010
AP       AUROBINDO PHARMA LTD   1%                                        A203040   001     Mar   14,   2013
AP                              1%                                        A203082   001     Mar   14,   2013
AP                              2%                                        A203040   002     Mar   14,   2013
AP                              2%                                        A203082   002     Mar   14,   2013
AP       FRESENIUS KABI USA     1%                                        A080404   002
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-219(of 371)


LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
	
AP                                2%                                   A080404   003
	
AP                                2%                                   N017584   001
	
AP                                4%                                   N017584   002
	
AP       HOSPIRA                  1%                                   A080408   001
	
AP                                1.5%                                 A080408   002
	
AP                                4%                                   A088295   001 May 17, 1984

AP       INTL MEDICATION          20%                                  N017702   001
	
    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER
	
AP       HOSPIRA                  1%                                   A040302 001 Sep 28, 1998

AP                                2%                                   A040302 002 Sep 28, 1998

    XYLOCAINE
	
AP    + FRESENIUS KABI USA        0.5%                                 N006488   008
	
AP    +                           1%                                   N006488   007
	
AP    +                           1.5%                                 N006488   010
	
AP    +                           2%                                   N006488   002
	
    XYLOCAINE 4% PRESERVATIVE FREE
	
AP    + FRESENIUS KABI USA        4%                                   N010417 001
	
    XYLOCAINE PRESERVATIVE FREE
	
AP    + FRESENIUS KABI USA        1%                                   N016801   005 Jan 19, 1988

AP    +                           2%                                   N016801   001
	
AP    +                           4%                                   N016801   002
	
AP    +                           20%                                  N016801   004
	
  INJECTABLE;SPINAL
	
    LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
	
      + HOSPIRA                   5%                                   A083914 001
	
  JELLY;TOPICAL

    GLYDO
	
AT       SAGENT PHARMS            2%                                   A201094 001 Apr 28, 2014

    LIDOCAINE HYDROCHLORIDE
	
AT       AKORN                    2%                                   A040433 001 Feb 12, 2003

AT       INTL MEDICATION          2%                                   A086283 001
	
AT       WATSON LABS INC          2%                                   A040837 001 Mar 23, 2011

    XYLOCAINE
	
AT    + OAK PHARMS                2%                                   N008816 001
	
  SOLUTION;ORAL

    LIDOCAINE HYDROCHLORIDE
	
AT       HI TECH PHARMA           2%                                   A040014 001 Jul 10, 1995

AT       WOCKHARDT                2%                                   A087872 001 Nov 18, 1982

    LIDOCAINE HYDROCHLORIDE VISCOUS
	
AT       VINTAGE                  2%                                   A040708 001 Feb 27, 2007

    LIDOCAINE VISCOUS
	
AT       ROXANE                   2%                                   A088802 001 Apr 26, 1985

    XYLOCAINE VISCOUS
	
AT    + FRESENIUS KABI USA        2%                                   N009470 001
	
  SOLUTION;TOPICAL

    LARYNG-O-JET KIT
	
AT       INTL MEDICATION          4%                                   A086364 001
	
    LIDOCAINE HYDROCHLORIDE
	
AT       IGI LABS INC             4%                                   A204494   001     Mar   12,   2014

AT       ROXANE                   4%                                   A088803   001     Apr   03,   1985

AT       VINTAGE                  4%                                   A040710   001     Feb   27,   2007

AT       WOCKHARDT                4%                                   A087881   001     Nov   18,   1982

    LTA II KIT
	
AT       HOSPIRA                  4%                                   A080409 001
	
    XYLOCAINE 4% PRESERVATIVE FREE
	
AT    + FRESENIUS KABI USA        4%                                   N010417 002
	
  SYSTEM;INTRADERMAL
	
    ZINGO
	
         POWDER PHARMS            0.5MG                                N022114 001 Aug 16, 2007
	
LIDOCAINE; PRILOCAINE
	
  CREAM;TOPICAL

    EMLA
	
AB    + WATSON LABS INC          2.5%;2.5%                             N019941 001 Dec 30, 1992

    LIDOCAINE AND PRILOCAINE
	
AB         FOUGERA PHARMS        2.5%;2.5%                             A076453 001 Aug 18, 2003

AB         HI TECH PHARMA        2.5%;2.5%                             A076290 001 Sep 25, 2003

AB         TOLMAR                2.5%;2.5%                             A076320 001 Aug 27, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-220(of 371)


LIDOCAINE; PRILOCAINE
	
  GEL;PERIODONTAL
	
    ORAQIX
	
      + DENTSPLY PHARM         2.5%;2.5%                        N021451 001 Dec 19, 2003
	
LIDOCAINE; TETRACAINE
	
  CREAM;TOPICAL
	
    PLIAGLIS
	
      + GALDERMA LABS LP       7%;7%                            N021717 001 Jun 29, 2006
	
  PATCH;TOPICAL
	
    SYNERA
	
      + GALEN SPECIALTY        70MG;70MG                        N021623 001 Jun 23, 2005
	
LINACLOTIDE
	
  CAPSULE;ORAL
	
    LINZESS
	
         FOREST LABS INC       145MCG                           N202811 001 Aug 30, 2012

      +                        290MCG                           N202811 002 Aug 30, 2012
	
LINAGLIPTIN
	
  TABLET;ORAL
	
    TRADJENTA
	
      + BOEHRINGER INGELHEIM   5MG                              N201280 001 May 02, 2011
	
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    JENTADUETO
	
      + BOEHRINGER INGELHEIM    2.5MG;1GM                       N201281 003 Jan 30, 2012
                                2.5MG;500MG                     N201281 001 Jan 30, 2012
                                2.5MG;850MG                     N201281 002 Jan 30, 2012
LINCOMYCIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    LINCOCIN
	
      + PHARMACIA AND UPJOHN   EQ 300MG BASE/ML                 N050317 001
	
LINDANE
	
  LOTION;TOPICAL

    LINDANE
	
AT        OLTA PHARMS          1%                               A087313 001
	
AT    + WOCKHARDT              1%                               A088190 001 Aug 16, 1984

  SHAMPOO;TOPICAL

    LINDANE
	
AT        OLTA PHARMS          1%                               A087266 001
	
AT    + WOCKHARDT              1%                               A088191 001 Sep 18, 1984
	
LINEZOLID
	
  FOR SUSPENSION;ORAL
	
    ZYVOX
	
      + PHARMACIA AND UPJOHN   100MG/5ML                        N021132 001 Apr 18, 2000

  INJECTABLE;INJECTION

    LINEZOLID
	
AP       TEVA PHARMS           200MG/100ML                      A200222 001 Jun 27, 2012

    ZYVOX
	
AP    + PHARMACIA AND UPJOHN   200MG/100ML                      N021131 001 Apr 18, 2000

  TABLET;ORAL
	
    ZYVOX
	
      + PHARMACIA AND UPJOHN   600MG                            N021130 002 Apr 18, 2000
	
LIOTHYRONINE SODIUM
	
  INJECTABLE;INJECTION

    LIOTHYRONINE SODIUM
	
AP       X GEN PHARMS          EQ 0.01MG BASE/ML                A076923 001 Aug 17, 2005

    TRIOSTAT
	
AP    + PAR STERILE PRODUCTS   EQ 0.01MG BASE/ML                N020105 001 Dec 31, 1991
	
  TABLET;ORAL

    CYTOMEL
	
AB       KING PHARMS R AND D   EQ 0.005MG BASE                  N010379 001
	
AB                             EQ 0.025MG BASE                  N010379 002
	
AB    +                        EQ 0.05MG BASE                   N010379 003
	
    LIOTHYRONINE SODIUM
	
AB       COASTAL PHARMS        EQ   0.005MG BASE                A090097   001    Mar   20,   2009

AB                             EQ   0.025MG BASE                A090097   002    Mar   20,   2009

AB                             EQ   0.05MG BASE                 A090097   003    Mar   20,   2009

AB       MYLAN                 EQ   0.005MG BASE                A090326   001    Jul   14,   2009

AB                             EQ   0.025MG BASE                A090326   002    Jul   14,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-221(of 371)


LIOTHYRONINE SODIUM
	
  TABLET;ORAL

    LIOTHYRONINE SODIUM
AB                                 EQ   0.05MG BASE
            A090326   003    Jul   14,   2009

AB       SIGMAPHARM LABS LLC       EQ   0.005MG BASE
           A200295   001    Nov   29,   2012

AB                                 EQ   0.025MG BASE
           A200295   002    Nov   29,   2012

AB                                 EQ   0.05MG BASE
	           A200295   003    Nov   29,   2012
	
LIOTRIX (T4;T3)

  TABLET;ORAL
	
    THYROLAR-0.25
	
         FOREST LABS
	             0.0031MG;0.0125MG
	          N016807 001
	
    THYROLAR-0.5
	
         FOREST LABS
	             0.0063MG;0.025MG
	           N016807 005
	
    THYROLAR-1
	
         FOREST LABS
	             0.0125MG;0.05MG
	            N016807 004
	
    THYROLAR-2
	
         FOREST LABS
	             0.025MG;0.1MG
	              N016807 002
	
    THYROLAR-3
	
      + FOREST LABS
	              0.0375MG;0.15MG
	            N016807 003
	
LIRAGLUTIDE RECOMBINANT
	
  SOLUTION;SUBCUTANEOUS
	
    SAXENDA
	
      + NOVO NORDISK INC
	         18MG/3ML (6MG/ML)
	          N206321 001 Dec 23, 2014
	
    VICTOZA
	
      + NOVO NORDISK INC
	         18MG/3ML (6MG/ML)
	          N022341 001 Jan 25, 2010
	
LISDEXAMFETAMINE DIMESYLATE
	
  CAPSULE;ORAL
	
    VYVANSE
	
         SHIRE DEVELOPMENT
	       10MG
	                       N021977   007    Oct   30,   2014
	
                                   20MG
	                       N021977   004    Dec   10,   2007
	
                                   30MG
	                       N021977   001    Feb   23,   2007
	
                                   40MG
	                       N021977   005    Dec   10,   2007
	
                                   50MG
	                       N021977   002    Feb   23,   2007
	
                                   60MG
	                       N021977   006    Dec   10,   2007
	
     +
	                           70MG
	                       N021977   003    Feb   23,   2007
	
LISINOPRIL
	
  TABLET;ORAL

     LISINOPRIL
	
AB        ACCORD HLTHCARE
	        2.5MG
	                      A202554   001    Jul   30,   2013

AB
	                               5MG
	                        A202554   002    Jul   30,   2013

AB
	                               10MG
	                       A202554   003    Jul   30,   2013

AB
	                               20MG
	                       A202554   004    Jul   30,   2013

AB
	                               30MG
	                       A202554   005    Jul   30,   2013

AB
	                               40MG
	                       A202554   006    Jul   30,   2013

AB        APOTEX INC
	             2.5MG
	                      A076102   001    Sep   30,   2002

AB
	                               5MG
	                        A076102   002    Sep   30,   2002

AB
	                               10MG
	                       A076102   003    Sep   30,   2002

AB
	                               20MG
	                       A076102   004    Sep   30,   2002

AB
	                               30MG
	                       A076102   005    Sep   30,   2002

AB
	                               40MG
	                       A076102   006    Sep   30,   2002

AB        AUROBINDO
	              2.5MG
	                      A077622   001    Feb   22,   2006

AB
	                               5MG
	                        A077622   002    Feb   22,   2006

AB
	                               10MG
	                       A077622   003    Feb   22,   2006

AB
	                               20MG
	                       A077622   004    Feb   22,   2006

AB
	                               30MG
	                       A077622   005    Feb   22,   2006

AB
	                               40MG
	                       A077622   006    Feb   22,   2006

AB        HIKMA INTL PHARMS
	      2.5MG
	                      A076063   001    Jul   01,   2002

AB
	                               5MG
	                        A076063   002    Jul   01,   2002

AB
	                               10MG
	                       A076063   003    Jul   01,   2002

AB
	                               20MG
	                       A076063   004    Jul   01,   2002

AB
	                               30MG
	                       A076063   006    Jun   27,   2003

AB
	                               40MG
	                       A076063   005    Jul   01,   2002

AB        INVAGEN PHARMS
	         2.5MG
	                      A203508   001    Oct   29,   2013

AB
	                               5MG
	                        A203508   002    Oct   29,   2013

AB
	                               10MG
	                       A203508   003    Oct   29,   2013

AB
	                               20MG
	                       A203508   004    Oct   29,   2013

AB
	                               30MG
	                       A203508   005    Oct   29,   2013

AB
	                               40MG
	                       A203508   006    Oct   29,   2013

AB        IVAX SUB TEVA PHARMS
	   2.5MG
	                      A075752   001    Jul   01,   2002

AB
	                               5MG
	                        A075752   002    Jul   01,   2002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                         PRESCRIPTION DRUG PRODUCT LIST                        3-222(of 371)


LISINOPRIL
	
  TABLET;ORAL

    LISINOPRIL
	
AB                           10MG                              A075752   003    Jul   01,   2002

AB                           20MG                              A075752   004    Jul   01,   2002

AB                           30MG                              A075752   005    Jul   01,   2002

AB                           40MG                              A075752   006    Jul   01,   2002

AB       LUPIN               2.5MG                             A077321   001    Sep   09,   2005

AB                           5MG                               A077321   002    Sep   09,   2005

AB                           10MG                              A077321   003    Sep   09,   2005

AB                           20MG                              A077321   004    Sep   09,   2005

AB                           30MG                              A077321   005    Sep   09,   2005

AB                           40MG                              A077321   006    Sep   09,   2005

AB       MYLAN               2.5MG                             A076071   001    Jul   01,   2002

AB                           5MG                               A076071   002    Jul   01,   2002

AB                           10MG                              A076071   003    Jul   01,   2002

AB                           20MG                              A076071   004    Jul   01,   2002

AB                           30MG                              A076071   005    Jul   01,   2002

AB                           40MG                              A076071   006    Jul   01,   2002

AB       PRINSTON INC        2.5MG                             A076180   001    Jul   01,   2002

AB                           5MG                               A076180   002    Jul   01,   2002

AB                           10MG                              A076180   003    Jul   01,   2002

AB                           20MG                              A076164   001    Jul   01,   2002

AB                           30MG                              A076164   002    Jul   01,   2002

AB                           40MG                              A076164   003    Jul   01,   2002

AB       RANBAXY             2.5MG                             A075944   001    Jul   01,   2002

AB                           5MG                               A075944   002    Jul   01,   2002

AB                           10MG                              A075944   003    Jul   01,   2002

AB                           20MG                              A075944   004    Jul   01,   2002

AB                           30MG                              A075944   006    Feb   11,   2003

AB                           40MG                              A075944   005    Jul   01,   2002

AB       SANDOZ              2.5MG                             A075994   001    Jul   01,   2002

AB                           5MG                               A075994   002    Jul   01,   2002

AB                           10MG                              A075994   003    Jul   01,   2002

AB                           20MG                              A075994   004    Jul   01,   2002

AB                           30MG                              A075994   005    Jul   01,   2002

AB                           40MG                              A075994   006    Jul   01,   2002

AB       VINTAGE             2.5MG                             A075743   001    Jul   01,   2002

AB                           5MG                               A075743   002    Jul   01,   2002

AB                           10MG                              A075743   003    Jul   01,   2002

AB                           20MG                              A075743   004    Jul   01,   2002

AB                           30MG                              A075743   005    Jul   01,   2002

AB                           40MG                              A075743   006    Jul   01,   2002

AB       WATSON LABS         2.5MG                             A076059   001    Jul   01,   2002

AB                           5MG                               A076059   002    Jul   01,   2002

AB                           10MG                              A076059   003    Jul   01,   2002

AB                           20MG                              A076059   004    Jul   01,   2002

AB                           30MG                              A076059   005    Jul   01,   2002

AB                           40MG                              A076059   006    Jul   01,   2002

AB       WOCKHARDT           2.5MG                             A078402   001    Apr   19,   2007

AB                           5MG                               A078402   002    Apr   19,   2007

AB                           10MG                              A078402   003    Apr   19,   2007

AB                           20MG                              A078402   004    Apr   19,   2007

AB                           30MG                              A078402   005    Apr   19,   2007

AB                           40MG                              A078402   006    Apr   19,   2007

    PRINIVIL
	
AB       MERCK               5MG                               N019558   001    Dec   29,   1987

AB                           10MG                              N019558   002    Dec   29,   1987

AB                           20MG                              N019558   003    Dec   29,   1987

AB                           40MG                              N019558   004    Oct   25,   1988

    ZESTRIL
	
AB       ASTRAZENECA         2.5MG                             N019777   005    Apr   29,   1993

AB                           5MG                               N019777   001    May   19,   1988

AB                           10MG                              N019777   002    May   19,   1988

AB                           20MG                              N019777   003    May   19,   1988

AB                           30MG                              N019777   006    Jan   20,   1999

AB    +                      40MG                              N019777   004    May   19,   1988
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-223(of 371)


LITHIUM CARBONATE
	
  CAPSULE;ORAL

    LITHIUM CARBONATE
	
AB       ALEMBIC LTD             150MG                          A079159   001     Jan   12,   2009

AB                               300MG                          A079159   002     Jan   12,   2009

AB                               600MG                          A079159   003     Jan   12,   2009

AB       GLENMARK GENERICS       150MG                          A079139   001     Feb   03,   2009

AB                               300MG                          A079139   002     Feb   03,   2009

AB                               600MG                          A079139   003     Feb   03,   2009

AB       HETERO LABS LTD III     150MG                          A090702   001     Sep   25,   2009

AB                               300MG                          A090702   002     Sep   25,   2009

AB                               600MG                          A090702   003     Sep   25,   2009

AB       HIKMA INTL PHARMS       150MG                          A076243   002     Feb   24,   2003

AB                               300MG                          A076243   001     Jun   27,   2002

AB       ROXANE                  150MG                          N017812   002     Jan   28,   1987

AB                               300MG                          N017812   001
	
AB    +                          600MG                          N017812   003     Jan 28, 1987
	
  TABLET;ORAL

    LITHIUM CARBONATE
	
AB    + ROXANE                   300MG                          N018558 001 Jan 29, 1982

AB       SUN PHARM INDS INC      300MG                          A091027 001 Jun 24, 2010
	
  TABLET, EXTENDED RELEASE;ORAL

    LITHIUM CARBONATE
	
AB       GLENMARK GENERICS       300MG                          A091544   001     Dec   27,   2010

AB                               450MG                          A091616   001     Feb   14,   2011

AB       HIKMA INTL PHARMS       450MG                          A076490   001     Jun   17,   2003

AB       MYLAN PHARMS INC        300MG                          A202288   001     Jun   29,   2012

AB                               450MG                          A202219   001     Aug   08,   2012

AB       ROXANE                  300MG                          A076832   001     Oct   28,   2004

AB    +                          450MG                          A076691   001     Jan   05,   2004

    LITHOBID
	
AB    + ANI PHARMS INC           300MG                          N018027 001
	
LITHIUM CITRATE
	
  SYRUP;ORAL

    LITHIUM CITRATE
	
AA    + ROXANE                   EQ 300MG CARBONATE/5ML         N018421 001
	
AA       WOCKHARDT               EQ 300MG CARBONATE/5ML         A070755 001 May 21, 1986
	
LODOXAMIDE TROMETHAMINE
	
  SOLUTION/DROPS;OPHTHALMIC

    ALOMIDE
	
      + ALCON                    EQ 0.1% BASE                   N020191 001 Sep 23, 1993
	
LOMITAPIDE MESYLATE
	
  CAPSULE;ORAL
	
    JUXTAPID
	
         AEGERION                EQ 5MG BASE                    N203858 001 Dec 21, 2012
	
                                 EQ 10MG BASE                   N203858 002 Dec 21, 2012
	
     +                           EQ 20MG BASE                   N203858 003 Dec 21, 2012
	
LOMUSTINE
	
  CAPSULE;ORAL
	
    GLEOSTINE
	
         CORDEN PHARMA           10MG                           N017588 001
	
                                 40MG                           N017588 002
	
     +                           100MG                          N017588 003
	
LOPERAMIDE HYDROCHLORIDE
	
  CAPSULE;ORAL

    IMODIUM
	
AB    + MCNEIL CONS              2MG                            N017694 001
	
    LOPERAMIDE HYDROCHLORIDE
	
AB       MYLAN                   2MG                            A072741 001 Sep 18, 1991

AB       TEVA                    2MG                            A073192 001 Apr 30, 1992
	
LOPINAVIR; RITONAVIR
	
  CAPSULE;ORAL
	
    KALETRA
	
      + ABBVIE                   133.3MG;33.3MG                 N021226 001 Sep 15, 2000

  SOLUTION;ORAL
	
    KALETRA
	
      + ABBVIE                   80MG/ML;20MG/ML                N021251 001 Sep 15, 2000
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-224(of 371)


LOPINAVIR; RITONAVIR
	
  TABLET;ORAL
	
    KALETRA
	
         ABBVIE                  100MG;25MG                     N021906 002 Nov 09, 2007
	
      +                          200MG;50MG                     N021906 001 Oct 28, 2005
	
LORAZEPAM
	
  CONCENTRATE;ORAL

    LORAZEPAM
	
AA       AMNEAL PHARMS            2MG/ML                        A091383   001    Dec   23,   2009

AA       HI-TECH PHARMA CO        2MG/ML                        A200169   001    Jan   30,   2012

AA       LUPIN LTD                2MG/ML                        A091407   001    Feb   19,   2013

AA       PADDOCK LLC              2MG/ML                        A079244   001    Apr   28,   2009

AA       PHARM ASSOC              2MG/ML                        A090260   001    Jun   15,   2010

    LORAZEPAM INTENSOL
	
AA    + ROXANE                    2MG/ML                        A072755 001 Jun 28, 1991
	
  INJECTABLE;INJECTION

    ATIVAN
	
AP    + HIKMA MAPLE               2MG/ML                        N018140 001
	
AP    +                           4MG/ML                        N018140 002
	
    LORAZEPAM
	
AP       AKORN                    2MG/ML                        A075025   001    Jul   23,   1998

AP       HOSPIRA                  2MG/ML                        A074243   001    Apr   12,   1994

AP                                2MG/ML                        A074282   001    May   27,   1994

AP                                4MG/ML                        A074243   002    Apr   12,   1994

AP                                4MG/ML                        A074282   002    May   27,   1994

AP       INTL MEDICATION SYS      2MG/ML                        A076150   001    Nov   15,   2004

    LORAZEPAM PRESERVATIVE FREE
	
AP       BEDFORD LABS             2MG/ML                        A077074 001 Jul 13, 2005

AP                                4MG/ML                        A077074 002 Jul 13, 2005
	
  TABLET;ORAL

    ATIVAN
	
AB       VALEANT INTL             0.5MG                         N017794 001
	
AB                                1MG                           N017794 002
	
AB    +                           2MG                           N017794 003
	
    LORAZEPAM
	
AB       AMNEAL PHARMS            0.5MG                         A078826   001    Jun   23,   2010

AB                                1MG                           A078826   002    Jun   23,   2010

AB                                2MG                           A078826   003    Jun   23,   2010

AB       EXCELLIUM                0.5MG                         A078203   001    Jul   30,   2007

AB                                1MG                           A078203   002    Jul   30,   2007

AB                                2MG                           A078203   003    Jul   30,   2007

AB       IVAX SUB TEVA PHARMS     0.5MG                         A077396   001    Dec   13,   2006

AB                                1MG                           A077396   002    Dec   13,   2006

AB                                2MG                           A077396   003    Dec   13,   2006

AB       MYLAN                    0.5MG                         A071589   001    Oct   13,   1987

AB                                0.5MG                         A077657   001    Mar   16,   2006

AB                                1MG                           A071590   001    Oct   13,   1987

AB                                1MG                           A077657   002    Mar   16,   2006

AB                                2MG                           A071591   001    Oct   13,   1987

AB                                2MG                           A077657   003    Mar   16,   2006

AB       RANBAXY                  0.5MG                         A076045   001    Aug   29,   2001

AB                                1MG                           A076045   002    Aug   29,   2001

AB                                2MG                           A076045   003    Aug   29,   2001

AB       SANDOZ                   0.5MG                         A071403   001    Apr   21,   1987

AB                                1MG                           A071404   001    Apr   21,   1987

AB                                2MG                           A071141   001    Apr   21,   1987

AB       VINTAGE PHARMS           0.5MG                         A077754   001    May   10,   2006

AB                                1MG                           A077754   002    May   10,   2006

AB                                2MG                           A077754   003    May   10,   2006

AB       WATSON LABS              0.5MG                         A072926   001    Oct   31,   1991

AB                                1MG                           A072927   001    Oct   31,   1991

AB                                2MG                           A072928   001    Oct   31,   1991
	
LORCASERIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    BELVIQ
	
      + EISAI INC                10MG                           N022529 001 Jun 27, 2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-225(of 371)


LOSARTAN POTASSIUM
	
  TABLET;ORAL

    COZAAR
	
AB       MERCK SHARP DOHME       25MG                          N020386 001 Apr 14, 1995

AB                               50MG                          N020386 002 Apr 14, 1995

AB    +                          100MG                         N020386 003 Oct 13, 1998

    LOSARTAN POTASSIUM
	
AB       ALEMBIC PHARMS LTD      25MG                          A090428   001    Oct   06,   2010

AB                               50MG                          A090428   002    Oct   06,   2010

AB                               100MG                         A090428   003    Oct   06,   2010

AB       APOTEX CORP             25MG                          A090790   001    Oct   06,   2010

AB                               50MG                          A090790   002    Oct   06,   2010

AB                               100MG                         A090790   003    Oct   06,   2010

AB       AUROBINDO PHARMA        25MG                          A090083   001    Oct   06,   2010

AB                               50MG                          A090083   002    Oct   06,   2010

AB                               100MG                         A090083   003    Oct   06,   2010

AB       CADISTA PHARMS          25MG                          A201170   001    Sep   18,   2012

AB                               50MG                          A201170   002    Sep   18,   2012

AB                               100MG                         A201170   003    Sep   18,   2012

AB       IPCA LABS LTD           25MG                          A200290   001    Aug   30,   2013

AB                               50MG                          A200290   002    Aug   30,   2013

AB                               100MG                         A200290   003    Aug   30,   2013

AB       LUPIN LTD               25MG                          A078232   001    Oct   06,   2010

AB                               50MG                          A078232   002    Oct   06,   2010

AB                               100MG                         A078232   003    Oct   06,   2010

AB       MACLEODS PHARMS LTD     25MG                          A202230   001    May   30,   2012

AB                               50MG                          A202230   002    May   30,   2012

AB                               100MG                         A202230   003    May   30,   2012

AB       MICRO LABS LTD INDIA    25MG                          A091541   001    Sep   24,   2012

AB                               50MG                          A091541   002    Sep   24,   2012

AB                               100MG                         A091541   003    Sep   24,   2012

AB       MYLAN                   25MG                          A091590   001    Oct   06,   2010

AB                               50MG                          A091590   002    Oct   06,   2010

AB                               100MG                         A091590   003    Oct   06,   2010

AB       PRINSTON INC            25MG                          A091497   001    Jun   06,   2011

AB                               50MG                          A091497   002    Jun   06,   2011

AB                               100MG                         A091497   003    Jun   06,   2011

AB       ROXANE                  25MG                          A077459   001    Oct   06,   2010

AB                               50MG                          A077459   002    Oct   06,   2010

AB                               100MG                         A077459   003    Oct   06,   2010

AB       SANDOZ                  25MG                          A077424   001    Oct   06,   2010

AB                               50MG                          A077424   002    Oct   06,   2010

AB                               100MG                         A077424   003    Oct   06,   2010

AB       TEVA                    25MG                          A076958   001    Apr   06,   2010

AB                               50MG                          A076958   002    Apr   06,   2010

AB                               100MG                         A076958   003    Apr   06,   2010

AB       TORRENT PHARMS          25MG                          A090467   001    Oct   06,   2010

AB                               50MG                          A090467   002    Oct   06,   2010

AB                               100MG                         A090467   003    Oct   06,   2010

AB       UPSHER SMITH            25MG                          A090544   001    Oct   06,   2010

AB                               50MG                          A090544   002    Oct   06,   2010

AB                               100MG                         A090544   003    Oct   06,   2010

AB       VIVIMED LABS            25MG                          A090382   001    Oct   06,   2010

AB                               50MG                          A090382   002    Oct   06,   2010

AB                               100MG                         A090382   003    Oct   06,   2010

AB       ZYDUS PHARMS USA INC    25MG                          A078243   001    Oct   06,   2010

AB                               50MG                          A078243   002    Oct   06,   2010

AB                               100MG                         A078243   003    Oct   06,   2010
	
LOTEPREDNOL ETABONATE
	
  GEL;OPHTHALMIC
	
    LOTEMAX
	
      + BAUSCH AND LOMB INC      0.5%                          N202872 001 Sep 28, 2012

  OINTMENT;OPHTHALMIC
	
    LOTEMAX
	
      + BAUSCH AND LOMB          0.5%                          N200738 001 Apr 15, 2011

  SUSPENSION/DROPS;OPHTHALMIC

    ALREX
	
      + BAUSCH AND LOMB          0.2%                          N020803 001 Mar 09, 1998
	
    LOTEMAX
	
      + BAUSCH AND LOMB          0.5%                          N020583 001 Mar 09, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-226(of 371)


LOTEPREDNOL ETABONATE; TOBRAMYCIN
	
  SUSPENSION/DROPS;OPHTHALMIC

    ZYLET
	
      + BAUSCH AND LOMB         0.5%;0.3%                      N050804 001 Dec 14, 2004
	
LOVASTATIN
	
  TABLET;ORAL

    LOVASTATIN
	
AB       ACTAVIS ELIZABETH       10MG                          A075828   001    Dec   17,   2001

AB                               20MG                          A075828   002    Dec   17,   2001

AB                               40MG                          A075828   003    Dec   17,   2001

AB       APOTEX INC              10MG                          A077748   001    Feb   28,   2007

AB                               20MG                          A077748   002    Feb   28,   2007

AB                               40MG                          A077748   003    Feb   28,   2007

AB       CARLSBAD                10MG                          A075991   001    Jun   05,   2002

AB                               20MG                          A075991   002    Jun   05,   2002

AB    +                          40MG                          A075991   003    Jun   05,   2002

AB       LUPIN                   10MG                          A078296   001    Mar   14,   2008

AB                               20MG                          A078296   002    Nov   01,   2007

AB                               40MG                          A078296   003    Nov   01,   2007

AB       MUTUAL PHARM            10MG                          A077520   001    Apr   14,   2006

AB                               20MG                          A077520   002    Apr   14,   2006

AB                               40MG                          A077520   003    Apr   14,   2006

AB       MYLAN                   10MG                          A075451   001    Dec   17,   2001

AB                               10MG                          A075935   001    Dec   17,   2001

AB                               20MG                          A075451   002    Dec   17,   2001

AB                               20MG                          A075935   002    Dec   17,   2001

AB                               40MG                          A075451   003    Dec   17,   2001

AB                               40MG                          A075935   003    Dec   17,   2001

AB       SANDOZ                  10MG                          A075300   001    Dec   17,   2001

AB                               10MG                          A075636   001    Dec   17,   2001

AB                               20MG                          A075300   002    Dec   17,   2001

AB                               20MG                          A075636   002    Dec   17,   2001

AB                               40MG                          A075300   003    Dec   17,   2001

AB                               40MG                          A075636   003    Dec   17,   2001

AB       TEVA                    10MG                          A075551   003    Dec   17,   2001

AB                               20MG                          A075551   002    Dec   17,   2001

AB                               40MG                          A075551   001    Dec   17,   2001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ALTOPREV
	
         ANDRX LABS LLC          20MG                          N021316 002 Jun 26, 2002
	
                                 40MG                          N021316 003 Jun 26, 2002
	
      +                          60MG                          N021316 004 Jun 26, 2002
	
LOVASTATIN; NIACIN
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ADVICOR
	
      + ABBVIE                   20MG;1GM                      N021249   003    Dec   17,   2001
	
      +                          20MG;500MG                    N021249   001    Dec   17,   2001
	
      +                          20MG;750MG                    N021249   002    Dec   17,   2001
	
      +                          40MG;1GM                      N021249   004    Apr   27,   2006
	
LOXAPINE
	
  POWDER;INHALATION
	
    ADASUVE
	
      + TEVA PHARMS USA INC     10MG                           N022549 001 Dec 21, 2012
	
LOXAPINE SUCCINATE
	
  CAPSULE;ORAL

    LOXAPINE SUCCINATE
	
AB       LANNETT HOLDINGS INC   EQ   5MG BASE                  A090695   001    Sep   26,   2011

AB                              EQ   10MG BASE                 A090695   002    Sep   26,   2011

AB                              EQ   25MG BASE                 A090695   003    Sep   26,   2011

AB                              EQ   50MG BASE                 A090695   004    Sep   26,   2011

AB       MIKAH PHARMA           EQ   5MG BASE                  A076868   001    Aug   04,   2005

AB                              EQ   10MG BASE                 A076868   002    Aug   04,   2005

AB                              EQ   25MG BASE                 A076868   003    Aug   04,   2005

AB                              EQ   50MG BASE                 A076868   004    Aug   04,   2005

AB       MYLAN                  EQ   5MG BASE                  A076762   001    Nov   01,   2004

AB                              EQ   10MG BASE                 A076762   002    Nov   01,   2004

AB                              EQ   25MG BASE                 A076762   003    Nov   01,   2004

AB                              EQ   50MG BASE                 A076762   004    Nov   01,   2004

AB       WATSON LABS            EQ   5MG BASE                  A072204   001    Jun   15,   1988

AB                              EQ   10MG BASE                 A072205   001    Jun   15,   1988
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                3-227(of 371)


LOXAPINE SUCCINATE
	
  CAPSULE;ORAL

    LOXAPINE SUCCINATE
	
AB    +                         EQ 25MG BASE                             A072206 001 Jun 15, 1988

AB                              EQ 50MG BASE                             A072062 001 Jun 15, 1988
	
LUBIPROSTONE
	
  CAPSULE;ORAL
	
    AMITIZA
	
         SUCAMPO PHARMA LLC     8MCG                                     N021908 002 Apr 29, 2008

      +                         24MCG                                    N021908 001 Jan 31, 2006
	
LUCINACTANT
	
  SUSPENSION;INTRATRACHEAL
	
    SURFAXIN
	
      + DISCOVERY LABS          8.5ML                                    N021746 001 Mar 06, 2012
	
LULICONAZOLE
	
  CREAM;TOPICAL
	
    LUZU
	
      + MEDICIS                 1%                                       N204153 001 Nov 14, 2013
	
LURASIDONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    LATUDA
	
         SUNOVION PHARMS INC    20MG                                     N200603   003    Dec   07,   2011
      +                         40MG                                     N200603   001    Oct   28,   2010
                                60MG                                     N200603   005    Jul   12,   2013
                                80MG                                     N200603   002    Oct   28,   2010
                                120MG                                    N200603   004    Apr   26,   2012
MACITENTAN
	
  TABLET;ORAL
	
    OPSUMIT
	
      + ACTELION PHARMS LTD		   10MG                                     N204410 001 Oct 18, 2013
	
MAFENIDE ACETATE
	
  CREAM;TOPICAL
	
    SULFAMYLON
	
      + MYLAN INSTITUTIONAL     EQ 85MG BASE/GM                          N016763 001
	
  FOR SOLUTION;TOPICAL

    MAFENIDE ACETATE
	
AT       PAR FORM               5%                                       A201511 001 Feb 12, 2013

    SULFAMYLON
	
AT    + MYLAN INSTITUTIONAL     5%                                       N019832 003 Jun 05, 1998
	
MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    PLASMA-LYTE 56 IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        32MG/100ML;128MG/100ML;234MG/100ML       N019047 001 Jun 15, 1984
	
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM

CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
	
      +		 B BRAUN               30MG/100ML;37MG/100ML;0.82MG/100ML;370M   N019696 001 Sep 29, 1989

                                G/100ML;530MG/100ML;500MG/100ML;12MG/10

                                0ML
	
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
	
  INJECTABLE;INJECTION

    PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        30MG/100ML;37MG/100ML;368MG/100ML;526MG   N017378 001
	
                                /100ML;502MG/100ML

    PLASMA-LYTE A IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        30MG/100ML;37MG/100ML;368MG/100ML;526MG   N017378 002 Nov 22, 1982

                                /100ML;502MG/100ML

    ISOLYTE S IN PLASTIC CONTAINER
	
         B BRAUN                30MG/100ML;37MG/100ML;370MG/100ML;530MG   N019711 001 Sep 29, 1989

                                /100ML;500MG/100ML

    NORMOSOL-R IN PLASTIC CONTAINER
	
         HOSPIRA                30MG/100ML;37MG/100ML;222MG/100ML;526MG   N017586 001
	
                                /100ML;502MG/100ML

  SOLUTION;IRRIGATION
	
    PHYSIOLYTE IN PLASTIC CONTAINER
	
         B BRAUN                30MG/100ML;37MG/100ML;370MG/100ML;530MG   N019024 001 Jun 08, 1984

                                /100ML;500MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                               3-228(of 371)


MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
	
  SOLUTION;IRRIGATION
	
    PHYSIOSOL IN PLASTIC CONTAINER
	
         HOSPIRA                30MG/100ML;37MG/100ML;222MG/100ML;526MG   N017637 002 Jul 08, 1982

                                /100ML;502MG/100ML
	
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
	
  SOLUTION;INJECTION
	
    NORMOCARB HF 25
	
      + DIALYSIS SUPS           0.21GM/100ML;2.8GM/100ML;9.07GM/100ML    N021910 001 Jul 26, 2006
	
    NORMOCARB HF 35
	
      + DIALYSIS SUPS           0.21GM/100ML;3.97GM/100ML;8.3GM/100ML    N021910 002 Jul 26, 2006
	
MAGNESIUM SULFATE
	
  INJECTABLE;INJECTION

    MAGNESIUM SULFATE
	
AP        EXELA PHARMA SCS LLC  500MG/ML                                 A206039 001 Dec 18, 2014

AP    + FRESENIUS KABI USA      500MG/ML                                 N019316 001 Sep 08, 1986

AP    + HOSPIRA                 500MG/ML                                 A075151 001 Apr 25, 2000

    MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
      + HOSPIRA                 1GM/100ML		                              N020488 001 Jul 11, 1995
	
      +                         2GM/100ML		                              N020488 002 Jul 11, 1995
	
    MAGNESIUM SULFATE IN PLASTIC CONTAINER
	
          HOSPIRA               2GM/50ML (40MG/ML)                       N020309   003    Jan   26,   2007
	
      +		                       4GM/100ML (40MG/ML)                      N020309   001    Jun   24,   1994
	
      +		                       4GM/50ML (80MG/ML)                       N020309   002    Jun   24,   1994
	
                                20GM/500ML (40MG/ML)                     N020309   004    Jan   18,   1995
	
                                40GM/1000ML(40MG/ML)                     N020309   005    Jan   18,   1995
	
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE
	
  SOLUTION;ORAL
	
    SUPREP BOWEL PREP KIT
	
      + BRAINTREE LABS          1.6GM/BOT;3.13GM/BOT;17.5GM/BOT          N022372 001 Aug 05, 2010
	
MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM

BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
	
  SOLUTION;ORAL
	
    SUCLEAR
	
      +		 BRAINTREE LABS        1.6GM;210GM;0.74GM;3.13GM;2.86GM;5.6GM;   N203595 001 Jan 18, 2013

                                17.5GM
	
MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM

PHOSPHATE
	
  SOLUTION;IRRIGATION

    TIS-U-SOL
	
AT       BAXTER HLTHCARE        20MG/100ML;40MG/100ML;6.25MG/100ML;800M   N018508 001 Feb 19, 1982

                                G/100ML;8.75MG/100ML

    TIS-U-SOL IN PLASTIC CONTAINER
	
AT       BAXTER HLTHCARE        20MG/100ML;40MG/100ML;6.25MG/100ML;800M   N018336 001
	
                                G/100ML;8.75MG/100ML
	
MALATHION
	
  LOTION;TOPICAL

    MALATHION
	
AT       SUVEN LIFE             0.5%                                     A091559 001 May 23, 2012

    OVIDE
	
AT    + TARO PHARMS NORTH       0.5%                                     N018613 001 Aug 02, 1982
	
MANGANESE CHLORIDE
	
  INJECTABLE;INJECTION
	
    MANGANESE CHLORIDE IN PLASTIC CONTAINER
	
         HOSPIRA                EQ 0.1MG MANGANESE/ML                    N018962 001 Jun 26, 1986
	
MANNITOL
	
  INJECTABLE;INJECTION

    MANNITOL 10%
	
AP        B BRAUN               10GM/100ML                               N016080 002
	
    MANNITOL 10% IN PLASTIC CONTAINER
	
AP        B BRAUN               10GM/100ML                               N020006 002 Jul 26, 1993

AP        HOSPIRA               10GM/100ML                               N019603 002 Jan 08, 1987

    MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER

AP        B BRAUN               10GM/100ML                               N016080 006
	
    MANNITOL 15%
	
AP        B BRAUN               15GM/100ML                               N016080 003
	
    MANNITOL 15% IN PLASTIC CONTAINER
	
AP        B BRAUN               15GM/100ML                               N020006 003 Jul 26, 1993

AP        HOSPIRA               15GM/100ML                               N019603 003 Jan 08, 1990
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                  3-229(of 371)


MANNITOL
	
  INJECTABLE;INJECTION

    MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%

AP        B BRAUN               15GM/100ML                     N016080 005
	
    MANNITOL 20%
	
AP        B BRAUN               20GM/100ML                     N016080 004
	
    MANNITOL 20% IN PLASTIC CONTAINER
	
AP        B BRAUN               20GM/100ML                     N020006 004 Jul 26, 1993

AP        HOSPIRA               20GM/100ML                     N019603 004 Jan 08, 1990

    MANNITOL 25%
	
AP        FRESENIUS KABI USA    12.5GM/50ML                    A080677   001
	
AP        HOSPIRA               12.5GM/50ML                    N016269   006 Aug 25, 1994

AP        INTL MEDICATION       12.5GM/50ML                    A083051   001
	
AP        LUITPOLD              12.5GM/50ML                    A087409   001 Jan 21, 1982

    MANNITOL 5%
	
AP        B BRAUN               5GM/100ML                      N016080 001
	
    MANNITOL 5% IN PLASTIC CONTAINER
	
AP        B BRAUN               5GM/100ML                      N020006 001 Jul 26, 1993

AP        HOSPIRA               5GM/100ML                      N019603 001 Jan 08, 1987

    MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%

AP        B BRAUN               5GM/100ML                      N016080 007
	
    OSMITROL 10% IN WATER
	
AP        BAXTER HLTHCARE       10GM/100ML                     N013684 002
	
    OSMITROL 10% IN WATER IN PLASTIC CONTAINER
	
AP        BAXTER HLTHCARE       10GM/100ML                     N013684 006
	
    OSMITROL 15% IN WATER
	
AP        BAXTER HLTHCARE       15GM/100ML                     N013684 004
	
    OSMITROL 15% IN WATER IN PLASTIC CONTAINER
	
AP        BAXTER HLTHCARE       15GM/100ML                     N013684 008
	
    OSMITROL 20% IN WATER
	
AP        BAXTER HLTHCARE       20GM/100ML                     N013684 003
	
    OSMITROL 20% IN WATER IN PLASTIC CONTAINER
	
AP        BAXTER HLTHCARE       20GM/100ML                     N013684 007
	
    OSMITROL 5% IN WATER
	
AP        BAXTER HLTHCARE       5GM/100ML                      N013684 001
	
    OSMITROL 5% IN WATER IN PLASTIC CONTAINER
	
AP        BAXTER HLTHCARE       5GM/100ML                      N013684 005
	
  SOLUTION;IRRIGATION
	
    RESECTISOL IN PLASTIC CONTAINER
	
          B BRAUN               5GM/100ML                      N016772 002
	
MANNITOL; SORBITOL
	
  SOLUTION;IRRIGATION
	
    SORBITOL-MANNITOL IN PLASTIC CONTAINER
	
         HOSPIRA                540MG/100ML;2.7GM/100ML        N018316 001
	
MAPROTILINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    MAPROTILINE HYDROCHLORIDE
	
         MYLAN                    25MG                         A072285 002 Oct 03, 1988
      +                           50MG                         A072285 001 Oct 03, 1988
                                  75MG                         A072285 003 Oct 03, 1988
MARAVIROC
	
  TABLET;ORAL
	
    SELZENTRY
	
         VIIV HLTHCARE            150MG                        N022128 001 Aug 06, 2007

      +                           300MG                        N022128 002 Aug 06, 2007
	
MEBENDAZOLE
	
  TABLET, CHEWABLE;ORAL
	
    MEBENDAZOLE
	
      + AMEDRA PHARMS LLC         100MG                        A073580 001 Jan 04, 1995
	
MECAMYLAMINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    MECAMYLAMINE HYDROCHLORIDE
	
         NEXGEN PHARMA           2.5MG                         A204054 001 Mar 19, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-230(of 371)


MECASERMIN RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    INCRELEX
	
      + IPSEN INC                 40MG/4ML (10MG/ML)            N021839 001 Aug 30, 2005
	
MECHLORETHAMINE HYDROCHLORIDE
	
  GEL;TOPICAL
	
    VALCHLOR
	
      + ACTELION PHARMS LTD       EQ 0.016% BASE                N202317 001 Aug 23, 2013

  INJECTABLE;INJECTION
	
    MUSTARGEN
	
      + RECORDATI RARE            10MG/VIAL                     N006695 001
	
MECLIZINE HYDROCHLORIDE
	
  TABLET;ORAL

    MECLIZINE HYDROCHLORIDE
	
AA       AMNEAL PHARMS            12.5MG                        A201451   001     Feb   23,   2011

AA                                25MG                          A201451   002     Feb   23,   2011

AA       EPIC PHARMA LLC          12.5MG                        A200294   001     Apr   13,   2012

AA                                25MG                          A200294   002     Apr   13,   2012

AA       JUBILANT CADISTA         12.5MG                        A040659   001     Jun   04,   2010

AA                                25MG                          A040659   002     Jun   04,   2010

AA       MYLAN PHARMS INC         12.5MG                        A202640   001     Sep   17,   2012

AA                                25MG                          A202640   002     Sep   17,   2012

AA       PAR PHARM                12.5MG                        A087127   001
	
AA                                25MG                          A087128   001
	
AA       SANDOZ                   12.5MG                        A084843   002     May   22,   1989

AA                                25MG                          A084092   003     May   22,   1989

AA       VINTAGE PHARMS           12.5MG                        A040179   001     Jan   30,   1997

AA                                25MG                          A040179   002     Jan   30,   1997
	
MECLOFENAMATE SODIUM
	
  CAPSULE;ORAL
	
    MECLOFENAMATE SODIUM
	
         MYLAN                    EQ 50MG BASE                  A071081 002 Sep 03, 1986

      +                           EQ 100MG BASE                 A071081 001 Sep 03, 1986
	
MEDROXYPROGESTERONE ACETATE
	
  INJECTABLE;INJECTION

    DEPO-PROVERA
	
AB    + PHARMACIA AND UPJOHN      150MG/ML                      N020246 001 Oct 29, 1992

    MEDROXYPROGESTERONE ACETATE
	
AB       SANDOZ                   150MG/ML                      A078711 001 May 20, 2009

AB       TEVA PHARMS USA          150MG/ML                      A076553 001 Jul 28, 2004
	
    DEPO-PROVERA
	
      + PHARMACIA AND UPJOHN      400MG/ML                      N012541 003
	
  INJECTABLE;SUBCUTANEOUS
	
    DEPO-SUBQ PROVERA 104
	
      + PHARMACIA AND UPJOHN      104MG/0.65ML                  N021583 001 Dec 17, 2004
	
  TABLET;ORAL

    MEDROXYPROGESTERONE ACETATE
	
AB       BARR                     2.5MG                         A040159 001 Aug 09, 1996

AB                                5MG                           A040159 002 Aug 09, 1996

AB                                10MG                          A040159 003 Aug 09, 1996

    PROVERA
	
AB       PHARMACIA AND UPJOHN     2.5MG                         N011839 001
	
AB                                5MG                           N011839 003
	
AB    +                           10MG                          N011839 004
	
MEFENAMIC ACID
	
  CAPSULE;ORAL

    MEFENAMIC ACID
	
AB       BRECKENRIDGE PHARM       250MG                         A090359   001     Feb   05,   2013

AB       LUPIN LTD                250MG                         A091322   001     Jul   22,   2011

AB       MICRO LABS LTD           250MG                         A090562   001     Nov   19,   2010

AB       VINTAGE PHARMS LLC       250MG                         A091608   001     Jun   02,   2014

    PONSTEL
	
AB    + SHIONOGI INC              250MG                         N015034 003
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-231(of 371)


MEFLOQUINE HYDROCHLORIDE
	
  TABLET;ORAL

    MEFLOQUINE HYDROCHLORIDE

AB       BARR                       250MG
	                      A076392 001 Dec 29, 2003

AB       ROXANE                     250MG
	                      A076523 001 Oct 01, 2004

AB    + SANDOZ                      250MG
	                      A076175 001 Feb 20, 2002
	
MEGESTROL ACETATE
	
  SUSPENSION;ORAL

     MEGACE
	
AB     + BRISTOL MYERS SQUIBB
      40MG/ML
	                    N020264 001 Sep 10, 1993
	
     MEGACE ES
	
AB     + PAR PHARM
	                125MG/ML
	                   N021778 001 Jul 05, 2005
	
     MEGESTROL ACETATE
	
AB         PAR PHARM
	              40MG/ML
                     A075671   001    Jul   25,   2001

AB         ROXANE
	                 40MG/ML
                     A075997   001    Feb   15,   2002

AB         TEVA PHARMS
	            40MG/ML
                     A075681   001    May   05,   2003

AB         TWI PHARMS INC
	         125MG/ML
                    A203139   001    Aug   27,   2014

AB         WOCKHARDT
	              40MG/ML
	                    A076721   001    Nov   01,   2004
	
  TABLET;ORAL

     MEGESTROL ACETATE
	
AB         BARR
	                   20MG
	                       A074621   002    Aug   16,   1996

AB
	                                40MG
	                       A074621   001    Nov   30,   1995

AB         PAR PHARM
	              20MG
	                       A072422   001    Aug   08,   1988

AB     +
	                          40MG
	                       A072423   001    Aug   08,   1988

AB         ROXANE
	                 20MG
	                       A074458   001    Sep   29,   1995

AB
	                                40MG
	                       A074458   002    Sep   29,   1995
	
MELOXICAM
	
  SUSPENSION;ORAL
	
     MOBIC
	
       + BOEHRINGER INGELHEIM
	     7.5MG/5ML
	                  N021530 001 Jun 01, 2004
	
  TABLET;ORAL

     MELOXICAM
	
AB         APOTEX INC
	             7.5MG
	                      A077882   001    Jul   20,   2006

AB
	                                15MG
	                       A077882   002    Jul   20,   2006

AB         AUROBINDO PHARMA
	       7.5MG
	                      A078008   001    Oct   02,   2006

AB
	                                15MG
	                       A078008   002    Oct   02,   2006

AB         BRECKENRIDGE PHARM
	     7.5MG
	                      A077920   001    Jul   19,   2006

AB
	                                15MG
	                       A077920   002    Jul   19,   2006

AB         CARLSBAD
	               7.5MG
	                      A077918   001    Dec   07,   2006

AB
	                                15MG
	                       A077918   002    Dec   07,   2006

AB         CIPLA LTD
	              7.5MG
	                      A077929   001    Jul   19,   2006

AB
	                                15MG
	                       A077929   002    Jul   19,   2006

AB         DR REDDYS LABS INC
	     7.5MG
	                      A077931   001    Jul   25,   2006

AB
	                                15MG
	                       A077931   002    Jul   25,   2006

AB         GLENMARK GENERICS
	      7.5MG
	                      A077932   001    Jul   19,   2006

AB
	                                15MG
	                       A077932   002    Jul   19,   2006

AB         LUPIN PHARMS
	           7.5MG
	                      A077944   001    Jul   19,   2006

AB
	                                15MG
	                       A077944   002    Jul   19,   2006

AB         MYLAN
	                  7.5MG
	                      A077923   001    Jul   19,   2006

AB
	                                15MG
	                       A077923   002    Jul   19,   2006

AB         PURACAP PHARM
	          7.5MG
	                      A077938   001    Jul   19,   2006

AB
	                                15MG
	                       A077938   002    Jul   19,   2006

AB         STRIDES PHARMA
	         7.5MG
	                      A077928   001    May   13,   2009

AB
	                                15MG
	                       A077928   002    May   13,   2009

AB         SUN PHARM INDS INC
	     7.5MG
	                      A077937   001    Jul   19,   2006

AB
	                                15MG
	                       A077937   002    Jul   19,   2006

AB         TARO
	                   7.5MG
	                      A078102   001    Nov   07,   2006

AB
	                                15MG
	                       A078102   002    Nov   07,   2006

AB         TEVA PHARMS
	            7.5MG
	                      A077936   001    Jul   19,   2006

AB
	                                15MG
	                       A077936   002    Jul   19,   2006

AB         UNICHEM
	                7.5MG
	                      A077927   001    Dec   20,   2006

AB
	                                15MG
	                       A077927   002    Dec   20,   2006

AB         ZYDUS PHARMS USA
	       7.5MG
	                      A077921   001    Jul   19,   2006

AB
	                                15MG
	                       A077921   002    Jul   19,   2006
	
     MOBIC
	
AB         BOEHRINGER INGELHEIM
	   7.5MG
	                      N020938 001 Apr 13, 2000

AB     +
	                          15MG
	                       N020938 002 Aug 23, 2000
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-232(of 371)


MELPHALAN
	
  TABLET;ORAL
	
    ALKERAN
	
      + GLAXOSMITHKLINE         2MG		                          N014691 002
	
MELPHALAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    ALKERAN
	
AP    + GLAXOSMITHKLINE         EQ 50MG BASE/VIAL              N020207 001 Nov 18, 1992

    MELPHALAN HYDROCHLORIDE
	
AP       EUROHLTH INTL          EQ 50MG BASE/VIAL              A090303 001 Oct 28, 2010

AP       MYLAN INSTITUTIONAL    EQ 50MG BASE/VIAL              A090270 001 Jun 09, 2009
	
MEMANTINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    NAMENDA XR
	
         FOREST LABS		          7MG                            N022525   001     Jun   21,   2010
	
                                14MG                           N022525   002     Jun   21,   2010
	
                                21MG                           N022525   003     Jun   21,   2010
	
      +                         28MG		                         N022525   004     Jun   21,   2010
	
  SOLUTION;ORAL
	
    NAMENDA
	
      + FOREST LABS             2MG/ML                         N021627 001 Apr 18, 2005

  TABLET;ORAL

    NAMENDA
	
AB       FOREST LABS            5MG                            N021487 001 Oct 16, 2003

AB    +                         10MG                           N021487 002 Oct 16, 2003
	
MENOTROPINS (FSH;LH)

  INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
	
    REPRONEX
	
      + FERRING                 75 IU/VIAL;75 IU/VIAL		        N021047 001 Aug 27, 1999

  INJECTABLE;SUBCUTANEOUS
	
    MENOPUR
	
      + FERRING                 75 IU/VIAL;75 IU/VIAL          N021663 001 Oct 29, 2004
	
MEPENZOLATE BROMIDE
	
  TABLET;ORAL
	
    CANTIL
	
      + SANOFI AVENTIS US       25MG		                         N010679 003
	
MEPERIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    DEMEROL
	
AP    + HOSPIRA                 25MG/ML                        N021171   001
	
AP    +                         50MG/ML                        N021171   002
	
AP    +                         75MG/ML                        N021171   003
	
AP    +                         100MG/ML                       N021171   004
	
    MEPERIDINE HYDROCHLORIDE
	
AP       HIKMA MAPLE            25MG/ML                        A080445   001
	
AP                              25MG/ML                        A080455   007
	
AP                              50MG/ML                        A080445   002
	
AP                              50MG/ML                        A080455   008
	
AP                              75MG/ML                        A080445   003
	
AP                              75MG/ML                        A080455   009
	
AP                              100MG/ML                       A080445   004
	
AP                              100MG/ML                       A080455   010
	
    MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
	
AP       HIKMA MAPLE            10MG/ML                        A081002 001 Jul 30, 1993

AP    + HOSPIRA                 10MG/ML                        A088432 001 Aug 16, 1984

  SYRUP;ORAL
	
    MEPERIDINE HYDROCHLORIDE
	
      + ROXANE                  50MG/5ML                       A088744 001 Jan 30, 1985
	
  TABLET;ORAL

    DEMEROL
	
AA    + SANOFI AVENTIS US       50MG                           N005010 001
	
AA    +                         100MG                          N005010 004
	
    MEPERIDINE HYDROCHLORIDE
	
AA       BARR                   50MG                           A088639   001     Jul   02,   1984

AA                              100MG                          A088640   001     Sep   19,   1984

AA       EPIC PHARMA            50MG                           A040331   001     May   28,   1999

AA                              100MG                          A040331   002     May   28,   1999

AA       MALLINCKRODT           50MG                           A040352   001     Jun   13,   2000

AA                              100MG                          A040352   002     Jun   13,   2000

AA       MIKART                 50MG                           A040893   001     Jun   24,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-233(of 371)


MEPERIDINE HYDROCHLORIDE
	
  TABLET;ORAL

    MEPERIDINE HYDROCHLORIDE
	
AA                                100MG                         A040893   003     Jun   24,   2009

AA       ROXANE                   50MG                          A040110   001     Mar   12,   1997

AA                                100MG                         A040110   002     Mar   12,   1997

AA       SUN PHARM INDS INC       50MG                          A040446   001     Aug   08,   2002

AA                                100MG                         A040446   002     Aug   08,   2002

AA       VINTAGE PHARMS           50MG                          A040191   001     Dec   17,   1998

AA                                100MG                         A040191   002     Dec   17,   1998
	
         MIKART		                 75MG                          A040893   002     Jun   24,   2009
	
                                  150MG                         A040893   004     Jun   24,   2009
	
MEPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    CARBOCAINE
	
AP    + HOSPIRA                   1%                            N012250 001
	
AP    +                           1.5%                          N012250 005
	
AP    +                           2%                            N012250 002
	
    ISOCAINE HYDROCHLORIDE
	
AP    + NOVOCOL                   3%                            A080925 001
	
    MEPIVACAINE HYDROCHLORIDE
	
AP       HOSPIRA INC              3%                            A040806 001 Apr 28, 2008

    POLOCAINE
	
AP       FRESENIUS KABI USA       1%                            A089407 001 Dec 01, 1986

AP                                2%                            A089410 001 Dec 01, 1986

    POLOCAINE-MPF
	
AP       FRESENIUS KABI USA       1%                            A089406 001 Dec 01, 1986

AP                                1.5%                          A089408 001 Dec 01, 1986

AP                                2%                            A089409 001 Dec 01, 1986

    SCANDONEST PLAIN
	
AP    + DEPROCO                   3%                            A088387 001 Oct 10, 1984
	
MEPROBAMATE
	
  TABLET;ORAL

    MEPROBAMATE
	
AA       ALEMBIC PHARMS LTD       200MG                         A090122   001     Feb   18,   2009

AA                                400MG                         A090122   002     Feb   18,   2009

AA       INVAGEN PHARMS           200MG                         A040797   001     Feb   27,   2008

AA                                400MG                         A040797   002     Feb   27,   2008

AA    + WATSON LABS               200MG                         A083304   001
	
AA    +                           400MG                         A083308   001
	
MERCAPTOPURINE
	
  SUSPENSION;ORAL
	
    PURIXAN
	
      + NOVA LABS LTD             20MG/ML                       N205919 001 Apr 28, 2014

  TABLET;ORAL

    MERCAPTOPURINE
	
AB       MYLAN                    50MG                          A040594 001 Jul 01, 2005

AB       PROMETHEUS LABS          50MG                          A040461 001 Feb 11, 2004

AB    + ROXANE                    50MG                          A040528 001 Feb 13, 2004
	
MEROPENEM
	
  INJECTABLE;INJECTION

    MEROPENEM
	
AP       ACS DOBFAR               1GM/VIAL                      A091404   002     Oct   26,   2011

AP                                500MG/VIAL                    A091404   001     Oct   26,   2011

AP       HOSPIRA INC              1GM/VIAL                      A090940   002     Jun   22,   2010

AP                                500MG/VIAL                    A090940   001     Jun   22,   2010

AP       SANDOZ                   1GM/VIAL                      A091201   002     Mar   29,   2011

AP                                500MG/VIAL                    A091201   001     Mar   29,   2011

    MERREM
	
AP    + ASTRAZENECA               1GM/VIAL                      N050706 001 Jun 21, 1996

AP    +                           500MG/VIAL                    N050706 003 Jun 21, 1996
	
MESALAMINE
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    DELZICOL
	
      + WARNER CHILCOTT LLC      400MG		                        N204412 001 Feb 01, 2013
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    APRISO
	
      + SALIX PHARMS             375MG		                        N022301 001 Oct 31, 2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-234(of 371)


MESALAMINE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    PENTASA
	
         SHIRE                   250MG                          N020049 001 May 10, 1993

      +                          500MG                          N020049 002 Jul 08, 2004
	
  ENEMA;RECTAL

    MESALAMINE
	
AB       PERRIGO ISRAEL          4GM/60ML                       A076751 001 Sep 17, 2004

AB       TEVA                    4GM/60ML                       A076841 001 Sep 30, 2004

    ROWASA
	
AB    + MEDA PHARMS              4GM/60ML                       N019618 001 Dec 24, 1987

    SFROWASA
	
AB       MEDA PHARMS             4GM/60ML                       N019618 002 Jun 20, 2008
	
  SUPPOSITORY;RECTAL
	
    CANASA
	
      + FOREST LABS INC          1GM                            N021252 002 Nov 05, 2004
	
  TABLET, DELAYED RELEASE;ORAL
	
    ASACOL
	
      + WARNER CHILCOTT LLC      400MG                          N019651 001 Jan 31, 1992
	
    ASACOL HD
	
      + WARNER CHILCOTT LLC      800MG                          N021830 001 May 29, 2008

    LIALDA
	
      + SHIRE                    1.2GM                          N022000 001 Jan 16, 2007
	
MESNA
	
  INJECTABLE;INTRAVENOUS

    MESNA
	
AP       AGILA SPECLTS          100MG/ML                        A203364   001    Jul   18,   2014

AP       EUROHLTH INTL          100MG/ML                        A075739   001    Jan   09,   2004

AP       FRESENIUS KABI USA     100MG/ML                        A075811   001    Apr   26,   2001

AP       MYLAN INSTITUTIONAL    100MG/ML                        A076488   001    Mar   08,   2012

AP       SAGENT PHARMS          100MG/ML                        A090913   001    Apr   13,   2010

AP       TEVA PHARMS USA        100MG/ML                        A075764   001    Apr   27,   2001

    MESNEX
	
AP    + BAXTER HLTHCARE         100MG/ML                        N019884 001 Dec 30, 1988
	
  TABLET;ORAL
	
    MESNEX
	
      + BAXTER HLTHCARE         400MG                           N020855 001 Mar 21, 2002
	
MESTRANOL; NORETHINDRONE
	
  TABLET;ORAL-28
	
    NORINYL 1+50 28-DAY
	
      + WATSON LABS             0.05MG;1MG                      N016659 001
	
METAPROTERENOL SULFATE
	
  SOLUTION;INHALATION

    METAPROTERENOL SULFATE
	
AN    + MYLAN SPECLT            0.4%                            A071786   001    Aug   05,   1988

AN    +                         0.6%                            A070804   001    Aug   17,   1987

AN       WOCKHARDT              0.4%                            A075586   001    May   30,   2002

AN                              0.6%                            A075586   002    May   30,   2002

  SYRUP;ORAL
	
    METAPROTERENOL SULFATE
	
      + SILARX                  10MG/5ML                        A073632 001 Jul 22, 1992
	
  TABLET;ORAL
	
    METAPROTERENOL SULFATE
	
         PAR PHARM              10MG                            A072024 001 Jun 28, 1988
	
      +                         20MG                            A072025 001 Jun 28, 1988
	
METARAMINOL BITARTRATE
	
  INJECTABLE;INJECTION
	
    METARAMINOL BITARTRATE
	
      + FRESENIUS KABI USA      EQ 10MG BASE/ML                 A080722 001
	
METAXALONE
	
  TABLET;ORAL

    METAXALONE
	
AB       AMNEAL PHARMS          800MG                           A203399 001 Jun 21, 2013

AB       SANDOZ                 800MG                           A040445 001 Mar 31, 2010

    SKELAXIN
	
AB    + KING PHARMS             800MG                           N013217 003 Aug 30, 2002
	
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                         PRESCRIPTION DRUG PRODUCT LIST
	                     3-235(of 371)


METFORMIN HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    RIOMET
	
      + RANBAXY
	              500MG/5ML
	                    N021591 001 Sep 11, 2003
	
  TABLET;ORAL

    GLUCOPHAGE
AB    + BRISTOL MYERS SQUIBB   1GM
	                          N020357 005 Nov 05, 1998

AB                             500MG
	                        N020357 001 Mar 03, 1995

AB                             850MG
	                        N020357 002 Mar 03, 1995
	
    METFORMIN HYDROCHLORIDE
AB       ALKEM                 1GM
	                          A091184   003    Nov   01,   2010

AB                             500MG
	                        A091184   001    Nov   01,   2010

AB                             850MG
	                        A091184   002    Nov   01,   2010

AB       AMNEAL PHARMS NY      1GM
	                          A077880   003    Jun   05,   2006

AB                             500MG
	                        A077880   001    Jun   05,   2006

AB                             850MG
	                        A077880   002    Jun   05,   2006

AB       APOTEX                1GM
	                          A075984   003    Apr   23,   2002

AB                             1GM
	                          A090666   003    Dec   07,   2011

AB                             500MG
	                        A075984   001    Apr   23,   2002

AB                             500MG
	                        A090666   001    Dec   07,   2011

AB                             850MG
	                        A075984   002    Apr   23,   2002

AB                             850MG
	                        A090666   002    Dec   07,   2011

AB       ATLAS PHARMS LLC      1GM
	                          A076033   003    Jan   24,   2002

AB                             500MG
	                        A076033   001    Jan   24,   2002

AB                             850MG
	                        A076033   002    Jan   24,   2002

AB       AUROBINDO             1GM
	                          A077095   003    Jan   14,   2005

AB                             500MG
	                        A077095   001    Jan   14,   2005

AB                             850MG
	                        A077095   002    Jan   14,   2005

AB       CHARTWELL LIFE SCI    1GM
	                          A075972   003    Jan   24,   2002

AB                             500MG
	                        A075972   001    Jan   24,   2002

AB                             850MG
	                        A075972   002    Jan   24,   2002

AB       DR REDDYS LABS INC    1GM
	                          A077787   003    Aug   23,   2006

AB                             500MG
	                        A077787   001    Aug   23,   2006

AB                             850MG
	                        A077787   002    Aug   23,   2006

AB       GLENMARK GENERICS     1GM
	                          A078170   003    May   23,   2008

AB                             500MG
	                        A078170   001    May   23,   2008

AB                             850MG
	                        A078170   002    May   23,   2008

AB       GRANULES INDIA        1GM
	                          A090564   003    Apr   22,   2010

AB                             500MG
	                        A090564   001    Apr   22,   2010

AB                             850MG
	                        A090564   002    Apr   22,   2010

AB       INDICUS PHARMA        1GM
	                          A079148   003    Nov   25,   2008

AB                             500MG
	                        A079148   001    Nov   25,   2008

AB                             850MG
	                        A079148   002    Nov   25,   2008

AB       MARKSANS PHARMA       1GM
	                          A090888   003    Mar   12,   2012

AB                             500MG
	                        A090888   001    Mar   12,   2012

AB                             850MG
	                        A090888   002    Mar   12,   2012

AB       MUTUAL PHARMA         1GM
	                          A076038   003    Feb   21,   2002

AB                             500MG
	                        A076038   001    Feb   21,   2002

AB                             850MG
	                        A076038   002    Feb   21,   2002

AB       MYLAN                 1GM
	                          A075973   003    Jan   25,   2002

AB                             1GM
	                          A075976   003    Jan   24,   2002

AB                             500MG
	                        A075973   001    Jan   25,   2002

AB                             500MG
	                        A075976   001    Jan   24,   2002

AB                             850MG
	                        A075973   002    Jan   25,   2002

AB                             850MG
	                        A075976   002    Jan   24,   2002

AB       MYLAN PHARMS INC      1GM
	                          A075969   003    Jan   29,   2002

AB                             500MG
	                        A075969   001    Jan   29,   2002

AB                             850MG
	                        A075969   002    Jan   29,   2002

AB       PROVIDENT PHARM       1GM
	                          A077853   003    Jul   28,   2006

AB                             500MG
	                        A077853   001    Jul   28,   2006

AB                             850MG
	                        A077853   002    Jul   28,   2006

AB       SANDOZ                1GM
	                          A075965   003    Jan   25,   2002

AB                             1GM
	                          A075985   003    Jan   25,   2002

AB                             500MG
	                        A075965   001    Jan   25,   2002

AB                             500MG
	                        A075985   001    Jan   25,   2002

AB                             850MG
	                        A075965   002    Jan   25,   2002

AB                             850MG
	                        A075985   002    Jan   25,   2002

AB       SCIEGEN PHARMS INC    500MG
	                        A203769   001    Sep   11,   2013

AB                             850MG
	                        A203769   002    Sep   11,   2013

AB                             1GM
	                          A203769   003    Sep   11,   2013

AB       SUN PHARM INDS INC    1GM
	                          A075967   003    Jan   29,   2002

AB                             500MG
	                        A075967   001    Jan   29,   2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-236(of 371)


METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL

    METFORMIN HYDROCHLORIDE
AB                               850MG
	                        A075967   002    Jan   29,   2002

AB       TEVA                    1GM
	                          A075978   003    Nov   05,   2002

AB                               500MG
	                        A075978   001    Jan   25,   2002

AB                               850MG
	                        A075978   002    Jan   25,   2002

AB       TORRENT PHARMS          1GM
	                          A077711   003    Jan   24,   2007

AB                               500MG
	                        A077711   001    Jan   24,   2007

AB                               850MG
	                        A077711   002    Jan   24,   2007

AB       WATSON LABS FLORIDA     1GM
	                          A075961   003    Jan   25,   2002

AB                               500MG
	                        A075961   001    Jan   25,   2002

AB                               850MG
	                        A075961   002    Jan   25,   2002

AB       ZYDUS HLTHCARE          1GM
	                          A203686   003    Aug   28,   2014

AB                               500MG
	                        A203686   001    Aug   28,   2014

AB                               850MG
	                        A203686   002    Aug   28,   2014

AB       ZYDUS PHARMS USA        1GM
	                          A077064   003    Apr   18,   2005

AB                               500MG
	                        A077064   001    Apr   18,   2005

AB                               850MG
	                        A077064   002    Apr   18,   2005

         CHARTWELL LIFE SCI      625MG
	                        A075972   005    Jan   24,   2002
	
                                 750MG
	                        A075972   004    Jan   24,   2002
	
  TABLET, EXTENDED RELEASE;ORAL

     GLUCOPHAGE XR
	
AB     + BRISTOL MYERS SQUIBB
 750MG
	                          N021202 004 Apr 11, 2003
	
     METFORMIN HYDROCHLORIDE
	
AB        ACTAVIS LABS FL INC
	  750MG
	                        A076869   001    Apr   12,   2005

AB        AMNEAL PHARMS NY
	     750MG
	                        A078596   002    Jan   03,   2008

AB        APOTEX
	               750MG
	                        A076706   002    Dec   29,   2005

AB        AUROBINDO PHARMA LTD
	 750MG
	                        A079118   002    Jul   20,   2012

AB        BARR
	                 750MG
	                        A076863   001    Oct   14,   2004

AB        CSPC OUYI PHARM CO
	   750MG
	                        A078321   002    Apr   17,   2008

AB        IMPAX LABS
	           750MG
	                        A076985   001    Sep   13,   2005

AB        MYLAN
	                750MG
	                        A077113   001    Sep   08,   2005

AB        NOSTRUM PHARMS LLC
	   750MG
	                        A076756   002    Dec   12,   2011

AB        SUN PHARM INDS (IN)
   750MG
	                        A077336   002    Feb   09,   2006

AB        TEVA
	                 750MG
	                        A076864   001    Apr   12,   2005

AB        ZYDUS PHARMS USA
	     750MG
	                        A077078   001    Apr   21,   2005
	
     GLUCOPHAGE XR
	
AB1       BRISTOL MYERS SQUIBB
 500MG
	                         N021202 001 Oct 13, 2000
	
     METFORMIN HYDROCHLORIDE
	
AB1       ACTAVIS LABS FL INC
	  500MG
	                        A076172   001    Jun   16,   2004

AB1       AMNEAL PHARMS NY
	     500MG
	                        A078596   001    Jan   03,   2008

AB1       APOTEX
	               500MG
	                        A076706   001    Dec   14,   2004

AB1       AUROBINDO PHARMA LTD
	 500MG
	                        A079118   001    Jul   20,   2012

AB1       CSPC OUYI PHARM CO
	   500MG
	                        A078321   001    Apr   17,   2008

AB1       IMPAX LABS
	           500MG
	                        A076249   001    Jul   30,   2004

AB1       INVENTIA HLTHCARE
	    500MG
	                        A201991   001    Jan   18,   2012

AB1       MYLAN
	                500MG
	                        A076650   001    Sep   13,   2005

AB1       NOSTRUM PHARMS LLC
	   500MG
	                        A076756   001    Jul   26,   2006

AB1       SANDOZ
	               500MG
	                        A076873   001    Dec   14,   2004

AB1       SUN PHARM INDS (IN)
   500MG
	                        A077336   001    Feb   09,   2006

AB1       TEVA
	                 500MG
	                        A076269   001    Jun   18,   2004

AB1       TORRENT PHARM
	        500MG
	                        A090014   001    Dec   30,   2009

AB1       ZYDUS PHARMS USA
	     500MG
	                        A077060   001    Apr   20,   2005
	
     FORTAMET
	
AB2 + ANDRX LABS LLC
	           1GM
	                          N021574 002 Apr 27, 2004

AB2
	                            500MG
	                        N021574 001 Apr 27, 2004
	
     METFORMIN HYDROCHLORIDE
	
AB2       LUPIN LTD
	            1GM
	                          A090692   002    Jun   29,   2011

AB2
	                            500MG
	                        A090692   001    Jun   29,   2011

AB2       MYLAN PHARMS INC
	     1GM
	                          A200690   002    Aug   01,   2012

AB2
	                            500MG
	                        A200690   001    Aug   01,   2012

AB3       LUPIN LTD
	            1GM
	                          A091664   002    Jul   19,   2013

AB3
	                            500MG
	                        A091664   001    Jul   19,   2013
	
     GLUMETZA
	
       + SANTARUS INC
	          1GM
	                          N021748 002 Jun 03, 2005
	
                                 500MG
	                        N021748 001 Jun 03, 2005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-237(of 371)


METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
	
  TABLET;ORAL

    ACTOPLUS MET
AB        TAKEDA PHARMS USA      500MG;EQ 15MG BASE              N021842 001 Aug 29, 2005

AB    +                          850MG;EQ 15MG BASE              N021842 002 Aug 29, 2005
	
    PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
AB        AUROBINDO PHARMA LTD   500MG;EQ 15MG BASE
             A200823   001    Feb   13,   2013

AB                               850MG;EQ 15MG BASE
             A200823   002    Feb   13,   2013

AB        MYLAN                  500MG;EQ 15MG BASE
             A090406   001    Feb   25,   2011

AB                               850MG;EQ 15MG BASE
             A090406   002    Feb   25,   2011

AB        SANDOZ                 500MG;EQ 15MG BASE
             A091273   001    Apr   16,   2013

AB                               850MG;EQ 15MG BASE
             A091273   002    Apr   16,   2013

AB        TEVA PHARMS USA        500MG;EQ 15MG BASE
             A091155   001    Mar   10,   2014

AB                               850MG;EQ 15MG BASE
             A091155   002    Mar   10,   2014

AB        TORRENT PHARMS LTD     500MG;EQ 15MG BASE
             A202001   001    Feb   13,   2013

AB                               850MG;EQ 15MG BASE
	            A202001   002    Feb   13,   2013
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ACTOPLUS MET XR
	
          TAKEDA PHARMS USA
	    1GM;EQ 15MG BASE
	              N022024 001 May 12, 2009

      +
	                        1GM;EQ 30MG BASE
	              N022024 002 May 12, 2009
	
METFORMIN HYDROCHLORIDE; REPAGLINIDE
	
  TABLET;ORAL
	
    PRANDIMET
	
          NOVO NORDISK INC      500MG;1MG
	                      N022386 001 Jun 23, 2008
	
      +		                       500MG;2MG
	                      N022386 002 Jun 23, 2008
	
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
	
  TABLET;ORAL

    AVANDAMET
	
AB       SB PHARMCO             1GM;EQ 2MG BASE
                 N021410   004    Aug   25,   2003

AB    +                         1GM;EQ 4MG BASE
                 N021410   005    Aug   25,   2003

AB                              500MG;EQ 2MG BASE
               N021410   002    Oct   10,   2002

AB                              500MG;EQ 4MG BASE
               N021410   003    Oct   10,   2002
	
    ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
	
AB       TEVA                   1GM;EQ 4MG BASE
                 A077337   004    May   07,   2014

AB                              1GM;EQ 2MG BASE
                 A077337   003    May   07,   2014

AB                              500MG;EQ 2MG BASE
               A077337   001    May   07,   2014

AB                              500MG;EQ 4MG BASE
	              A077337   002    May   07,   2014
	
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    KOMBIGLYZE XR
	
          ASTRAZENECA AB         1GM;EQ 2.5MG BASE
	             N200678 003 Nov 05, 2010
	
      +		                        1GM;EQ 5MG BASE
	               N200678 002 Nov 05, 2010
	
                                 500MG;EQ 5MG BASE
	             N200678 001 Nov 05, 2010
	
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
	
  TABLET;ORAL
	
    JANUMET
	
      + MERCK SHARP DOHME
	      1GM;EQ 50MG BASE
	              N022044 002 Mar 30, 2007
	
                                 500MG;EQ 50MG BASE
	            N022044 001 Mar 30, 2007
	
  TABLET, EXTENDED RELEASE;ORAL
	
    JANUMET XR
	
          MERCK SHARP DOHME
	    1GM;EQ 50MG BASE
	              N202270 002 Feb 02, 2012
	
      +
	                        1GM;EQ 100MG BASE
	             N202270 003 Feb 02, 2012
	
                                 500MG;EQ 50MG BASE
	            N202270 001 Feb 02, 2012
	
METHACHOLINE CHLORIDE
	
  FOR SOLUTION;INHALATION
	
    PROVOCHOLINE
	
      + METHAPHARM
	             100MG/VIAL
	                    N019193 001 Oct 31, 1986
	
METHADONE HYDROCHLORIDE
	
  CONCENTRATE;ORAL

    METHADONE HYDROCHLORIDE
	
AA       ROXANE
	               10MG/ML
                         A040180 001 Apr 30, 1998

AA       VISTAPHARM
	           10MG/ML
	                        A040088 001 Nov 30, 1994
	
    METHADONE HYDROCHLORIDE INTENSOL
	
AA       ROXANE                 10MG/ML
                         A089897 001 Sep 06, 1988
	
    METHADOSE
	
AA    + MALLINCKRODT            10MG/ML
                         N017116 002
	
  INJECTABLE;INJECTION
	
    DOLOPHINE HYDROCHLORIDE
	
      + MYLAN INSTITUTIONAL		   10MG/ML
	                        N021624 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                   3-238(of 371)


METHADONE HYDROCHLORIDE
	
  POWDER;FOR RX COMPOUNDING
	
    METHADONE HYDROCHLORIDE
	
         MALLINCKRODT		          50GM/BOT                      N006383 002
	
                                 100GM/BOT                     N006383 003
	
                                 500GM/BOT                     N006383 004
	
  SOLUTION;ORAL

    METHADONE HYDROCHLORIDE
	
AA    + ROXANE                   5MG/5ML                       A087393   001
	
AA    +                          10MG/5ML                      A087997   001 Aug 30, 1982

AA       VISTAPHARM              5MG/5ML                       A090707   001 Jun 30, 2010

AA                               10MG/5ML                      A090707   002 Jun 30, 2010
	
  TABLET;ORAL

    DOLOPHINE HYDROCHLORIDE
	
AA    + ROXANE                   5MG                           N006134 002
	
AA    +                          10MG                          N006134 010
	
    METHADONE HYDROCHLORIDE
	
AA       MALLINCKRODT            5MG                           A040517   001    Apr   27,   2004

AA                               10MG                          A040517   002    Apr   27,   2004

AA       SANDOZ                  10MG                          A040241   002    May   29,   1998

AA       THE PHARMANETWORK       10MG                          A090635   001    Nov   25,   2009

    METHADOSE
	
AA       MALLINCKRODT            5MG                           A040050 001 Apr 15, 1993

AA                               10MG                          A040050 002 Apr 15, 1993

  TABLET, FOR SUSPENSION;ORAL

    METHADONE HYDROCHLORIDE
	
AA       MALLINCKRODT INC        40MG                          A077142 001 Jul 12, 2005

AA    + ROXANE                   40MG                          N017058 001
	
AA       SANDOZ                  40MG                          A075082 001 Mar 25, 1998

    METHADOSE
	
AA       MALLINCKRODT            40MG                          A074184 001 Apr 29, 1993
	
METHAMPHETAMINE HYDROCHLORIDE
	
  TABLET;ORAL

    DESOXYN
	
AA    + RECORDATI RARE          5MG                            N005378 002
	
    METHAMPHETAMINE HYDROCHLORIDE
	
AA       COASTAL PHARMS         5MG                            A091189 001 Apr 21, 2010
	
METHAZOLAMIDE
	
  TABLET;ORAL

    METHAZOLAMIDE
	
AB       ANI PHARMS INC          25MG                          A040001   001    Jun   30,   1993

AB                               50MG                          A040001   002    Jun   30,   1993

AB       MIKART                  25MG                          A040062   001    Jan   27,   1994

AB    +                          50MG                          A040062   002    Jan   27,   1994

AB       SANDOZ                  25MG                          A040036   001    Jun   30,   1993

AB                               50MG                          A040036   002    Jun   30,   1993
	
METHENAMINE HIPPURATE
	
  TABLET;ORAL

    HIPREX
	
AB    + SANOFI AVENTIS US        1GM                           N017681 001
	
    METHENAMINE HIPPURATE
	
AB         COREPHARMA            1GM                           A076411 001 Jun 20, 2003

    UREX
	
AB         CNTY LINE PHARMS      1GM                           N016151 001
	
METHIMAZOLE
	
  TABLET;ORAL

    METHIMAZOLE
	
AB       CEDAR PHARMS            5MG                           A040547   001    Feb   18,   2005

AB                               10MG                          A040547   002    Feb   18,   2005

AB       EMCURE PHARMS USA       5MG                           A040734   001    Dec   14,   2007

AB                               10MG                          A040734   002    Dec   14,   2007

AB       MYLAN                   5MG                           A040350   001    Mar   29,   2000

AB    +                          10MG                          A040350   002    Mar   29,   2000

AB       SANDOZ                  5MG                           A040411   001    Mar   27,   2001

AB                               10MG                          A040411   002    Mar   27,   2001

AB       SUN PHARM INDS INC      5MG                           A040870   001    Sep   25,   2007

AB                               10MG                          A040870   002    Sep   25,   2007

AB       VINTAGE PHARMS          5MG                           A202068   001    Mar   07,   2012

AB                               10MG                          A202068   002    Mar   07,   2012
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                            3-239(of 371)


METHIMAZOLE
	
  TABLET;ORAL

    TAPAZOLE
	
AB       KING PHARMS            5MG                                    A040320 001 Mar 31, 2000

AB                              10MG                                   A040320 002 Mar 31, 2000
	
METHOCARBAMOL
	
  SOLUTION;IM-IV

    METHOCARBAMOL
	
AP       MYLAN INSTITUTIONAL    1GM/10ML (100MG/ML)                    A204404 001 Dec 05, 2014

    ROBAXIN
	
AP    + HIKMA MAPLE             1GM/10ML (100MG/ML)                    N011790 001
	
  TABLET;ORAL

    METHOCARBAMOL
	
AA       AUSTARPHARMA LLC       500MG                                  A200958   001     Oct   21,   2011

AA                              750MG                                  A200958   002     Oct   21,   2011

AA       HETERO LABS LTD III    500MG                                  A090200   001     Nov   06,   2009

AA                              750MG                                  A090200   002     Nov   06,   2009

AA       HIKMA INTL PHARMS      500MG                                  A085159   001
	
AA                              750MG                                  A085123   001
	
AA       LANNETT HOLDINGS INC   500MG                                  A084756   002     Mar 31, 2003

AA                              750MG                                  A084756   001
	
AA       PRINSTON INC           500MG                                  A086989   001
	
AA                              750MG                                  A086988   001
	
AA       SANDOZ                 500MG                                  A084616   001
	
AA                              750MG                                  A084615   001
	
AA       VINTAGE PHARMS         500MG                                  A040489   001     Jan 29, 2003

AA                              750MG                                  A040489   002     Jan 29, 2003

AA       WATSON LABS            500MG                                  A084277   001
	
AA                              750MG                                  A084276   002
	
    ROBAXIN
	
AA    + AUXILIUM PHARMS LLC     500MG                                  N011011 004
	
    ROBAXIN-750
	
AA    + AUXILIUM PHARMS LLC     750MG                                  N011011 006
	
METHOHEXITAL SODIUM
	
  INJECTABLE;INJECTION
	
    BREVITAL SODIUM
	
      + PAR STERILE PRODUCTS    2.5GM/VIAL		                           N011559 002
	
      +                         200MG/VIAL		                           N011559 004 Dec 21, 2012
	
      +                         500MG/VIAL		                           N011559 001
	
METHOTREXATE
	
  SOLUTION;SUBCUTANEOUS
	
    OTREXUP
	
         ANTARES PHARMA INC		   7.5MG/0.4ML (7.5MG/0.4ML)              N204824   005     Nov   07,   2014
	
                                10MG/0.4ML (10MG/0.4ML)                N204824   001     Oct   11,   2013
	
                                15MG/0.4ML (15MG/0.4ML)                N204824   002     Oct   11,   2013
	
                                20MG/0.4ML (20MG/0.4ML)                N204824   003     Oct   11,   2013
	
     +                          25MG/0.4ML (25MG/0.4ML)                N204824   004     Oct   11,   2013
	
   RASUVO
	
        MEDAC PHARMA INC		      7.5MG/0.15ML (7.5MG/0.15ML)            N205776   001     Jul   10,   2014
	
                                10MG/0.20ML (10MG/0.20ML)              N205776   002     Jul   10,   2014
	
                                12.5MG/0.25ML (12.5MG/0.25ML)          N205776   003     Jul   10,   2014
	
                                15MG/0.30ML (15MG/0.30ML)              N205776   004     Jul   10,   2014
	
                                17.5MG/0.35ML (17.5MG/0.35ML)          N205776   005     Jul   10,   2014
	
                                20MG/0.4ML (20MG/0.4ML)                N205776   006     Jul   10,   2014
	
                                22.5MG/0.45ML (22.5MG/0.45ML)          N205776   007     Jul   10,   2014
	
                                25MG/0.5ML (25MG/0.5ML)                N205776   008     Jul   10,   2014
	
                                27.5MG/0.55ML (27.5MG/0.55ML)          N205776   009     Jul   10,   2014
	
                                30MG/0.6ML (30MG/0.6ML)                N205776   010     Jul   10,   2014
	
METHOTREXATE SODIUM
	
  INJECTABLE;INJECTION

    METHOTREXATE PRESERVATIVE FREE
	
AP       FRESENIUS KABI USA     EQ 1GM BASE/VIAL                       A040266 001 Feb 26, 1999

AP       PHARMACHEMIE BV        EQ 100MG BASE/4ML (EQ 25MG BASE/ML)    A200171 001 Feb 27, 2012

    METHOTREXATE SODIUM
	
AP    + EUROHLTH INTL           EQ 100MG BASE/4ML (EQ 25MG BASE/ML)    A089341   001     Sep   16,   1986

AP    + FRESENIUS KABI USA      EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     A040263   001     Feb   26,   1999

AP    +                         EQ 250MG BASE/10ML (EQ 25MG BASE/ML)   A040263   002     Feb   26,   1999

AP    + HOSPIRA                 EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     N011719   010     Dec   15,   2004

    METHOTREXATE SODIUM PRESERVATIVE FREE
	
AP    + ACCORD HLTHCARE         EQ 1GM BASE/40ML (EQ 25MG BASE/ML)     A040716 001 Apr 30, 2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-240(of 371)


METHOTREXATE SODIUM
	
  INJECTABLE;INJECTION

    METHOTREXATE SODIUM PRESERVATIVE FREE
	
AP    +                         EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     A040767   001    Apr   30,   2007

AP    +                         EQ 250MG BASE/10ML (EQ 25MG BASE/ML)   A040768   001    Apr   30,   2007

AP       EBEWE PHARMA           EQ 1GM BASE/40ML (EQ 25MG BASE/ML)     A090029   001    Mar   31,   2009

AP                              EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     A090039   001    Mar   31,   2009

AP                              EQ 250MG BASE/10ML (EQ 25MG BASE/ML)   A090039   002    Mar   31,   2009

AP    + EUROHLTH INTL           EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     A089340   001    Sep   16,   1986

AP    +                         EQ 250MG BASE/10ML (EQ 25MG BASE/ML)   A089343   001    Sep   16,   1986

AP    + HOSPIRA                 EQ 1GM BASE/40ML (EQ 25MG BASE/ML)     N011719   012    Apr   13,   2005

AP       ONCO THERAPIES LTD     EQ 1GM BASE/40ML (EQ 25MG BASE/ML)     A201530   001    Mar   29,   2012

AP                              EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     A201529   001    Mar   29,   2012

AP                              EQ 100MG BASE/4ML (EQ 25MG BASE/ML)    A201529   002    Mar   29,   2012

AP                              EQ 200MG BASE/8ML (EQ 25MG BASE/ML)    A201529   003    Mar   29,   2012

AP                              EQ 250MG BASE/10ML (EQ 25MG BASE/ML)   A201529   004    Mar   29,   2012

AP       PHARMACHEMIE BV        EQ 1GM BASE/40ML (EQ 25MG BASE/ML)     A040843   001    Jan   11,   2010

AP                              EQ 50MG BASE/2ML (EQ 25MG BASE/ML)     A040850   001    Jan   11,   2010

AP                              EQ 250MG/10ML (EQ 25MG BASE/ML)        A040853   001    Jan   11,   2010
	
    METHOTREXATE SODIUM
	
      + EUROHLTH INTL           EQ 200MG BASE/8ML (EQ 25MG BASE/ML)    A089342 001 Sep 16, 1986

    METHOTREXATE SODIUM PRESERVATIVE FREE
	
      + EUROHLTH INTL           EQ 1GM BASE/VIAL                       A040632 001 Aug 12, 2005

  TABLET;ORAL

    METHOTREXATE SODIUM
	
AB       BARR                   EQ 2.5MG BASE                          A081099   001 Oct 15, 1990

AB    + DAVA PHARMS INC         EQ 2.5MG BASE                          N008085   002
	
AB       MYLAN                  EQ 2.5MG BASE                          A081235   001 May 15, 1992

AB       ROXANE                 EQ 2.5MG BASE                          A040054   001 Aug 01, 1994

    TREXALL
	
         BARR		                 EQ 5MG BASE                            A040385   001    Mar   21,   2001
	
                                EQ 7.5MG BASE                          A040385   002    Mar   21,   2001
	
                                EQ 10MG BASE                           A040385   003    Mar   21,   2001
	
      +                         EQ 15MG BASE		                         A040385   004    Mar   21,   2001
	
METHOXSALEN
	
  CAPSULE;ORAL

    METHOXSALEN
	
AB       STRIDES PHARMA         10MG                                   A202687 001 Jun 05, 2014

    OXSORALEN-ULTRA
	
AB    + DOW PHARM               10MG                                   N019600 001 Oct 30, 1986
	
    8-MOP
	
      + VALEANT PHARM INTL      10MG		                                 N009048 001
	
  INJECTABLE;INJECTION
	
    UVADEX
	
      + THERAKOS                0.02MG/ML		                            N020969 001 Feb 25, 1999
	
  LOTION;TOPICAL
	
    OXSORALEN
	
      + VALEANT PHARM INTL      1%		                                   N009048 002
	
METHSCOPOLAMINE BROMIDE
	
  TABLET;ORAL

    METHSCOPOLAMINE BROMIDE
	
AA       BAYSHORE PHARMS LLC    2.5MG                                  A200602   001    Sep   24,   2012

AA                              5MG                                    A200602   002    Sep   24,   2012

AA       BRECKENRIDGE PHARM     2.5MG                                  A040642   001    Dec   06,   2011

AA                              5MG                                    A040642   002    Dec   06,   2011

AA       VINTAGE PHARMS         2.5MG                                  A040624   001    Dec   28,   2006

AA                              5MG                                    A040624   002    Dec   28,   2006

    PAMINE
	
AA    + FOUGERA PHARMS          2.5MG                                  N008848 001
	
    PAMINE FORTE
	
AA    + FOUGERA PHARMS          5MG                                    N008848 002 Mar 25, 2003
	
METHSUXIMIDE
	
  CAPSULE;ORAL
	
    CELONTIN
	
         PARKE DAVIS            150MG                                  N010596 007
	
      +                         300MG		                                N010596 008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-241(of 371)


METHYCLOTHIAZIDE
	
  TABLET;ORAL
	
    METHYCLOTHIAZIDE
	
      + MYLAN PHARMS INC
	       5MG
	                           A087672 001 Aug 17, 1982
	
METHYLDOPA
	
  TABLET;ORAL

    METHYLDOPA
	
AB       ACCORD HLTHCARE         250MG
	                         A070084   001    Oct   15,   1985

AB                               500MG
	                         A070085   001    Oct   15,   1985

AB       IVAX SUB TEVA PHARMS    250MG
	                         A070098   001    Feb   20,   1986

AB                               500MG
	                         A070343   001    Feb   20,   1986

AB       MYLAN                   250MG
	                         A070076   002    Apr   18,   1985

AB    +                          500MG
	                         A070076   001    Apr   18,   1985

AB       WATSON LABS             500MG
	                         A070625   001    Jun   06,   1986
	
METHYLDOPATE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    METHYLDOPATE HYDROCHLORIDE
	
AP    + LUITPOLD
	               50MG/ML
	                       A071279 001 Oct 02, 1987
	
METHYLERGONOVINE MALEATE
	
  INJECTABLE;INJECTION

    METHERGINE
	
AP    + EDISON THERAPS LLC
	     0.2MG/ML
	                      N006035 004
	
    METHYLERGONOVINE MALEATE
	
AP       ERGOJECT
	              0.2MG/ML
                       A040889 001 Sep 13, 2010

AP       LUITPOLD
	              0.2MG/ML
	                      A090193 001 Nov 24, 2008
	
  TABLET;ORAL

    METHERGINE
	
AB    + EDISON THERAPS LLC
	     0.2MG
	                         N006035 003
	
    METHYLERGONOVINE MALEATE
	
AB       NOVEL LABS INC
	        0.2MG
	                         A091577 001 May 02, 2011
	
METHYLNALTREXONE BROMIDE
	
  INJECTABLE;SUBCUTANEOUS
	
    RELISTOR
	
          SALIX PHARMS
	         8MG/0.4ML (8MG/0.4ML)
          N021964 002 Sep 27, 2010

      +
	                        12MG/0.6ML (12MG/0.6ML)
	       N021964 003 Apr 24, 2008
	
  SOLUTION;SUBCUTANEOUS
	
    RELISTOR
	
      + SALIX PHARMS
	           12MG/0.6ML (12MG/0.6ML)
	       N021964 001 Apr 24, 2008
	
METHYLPHENIDATE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    DAYTRANA
	
          NOVEN PHARMS INC		    10MG/9HR      (1.1MG/HR)
        N021514   001    Apr   06,   2006

                                15MG/9HR      (1.6MG/HR)
        N021514   002    Apr   06,   2006

                                20MG/9HR      (2.2MG/HR)
        N021514   003    Apr   06,   2006

      +		                       30MG/9HR      (3.3MG/HR)
	       N021514   004    Apr   06,   2006
	
METHYLPHENIDATE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    METHYLPHENIDATE HYDROCHLORIDE
	
AB1      BARR LABS INC          10MG                             A079031   004    Oct   15,   2014

AB1                             20MG                             A079031   001    Jul   13,   2012

AB1                             30MG                             A079031   002    Jul   13,   2012

AB1                             40MG                             A079031   003    Jul   13,   2012

AB1      WATSON LABS INC        20MG                             A078458   001    Dec   01,   2011

AB1                             30MG                             A078458   002    Dec   01,   2011

AB1                             40MG                             A078458   003    Dec   01,   2011
	
    RITALIN LA
AB1      NOVARTIS               10MG                             N021284   004    Apr   10,   2004

AB1                             20MG                             N021284   001    Jun   05,   2002

AB1                             30MG                             N021284   002    Jun   05,   2002

AB1 +                           40MG                             N021284   003    Jun   05,   2002
	
    METADATE CD
AB2      UCB INC                10MG                             N021259   003    May   27,   2003

AB2                             20MG                             N021259   001    Apr   03,   2001

AB2                             30MG                             N021259   002    Jun   19,   2003

AB2                             40MG                             N021259   004    Feb   19,   2006

AB2                             50MG                             N021259   005    Feb   19,   2006

AB2 +                           60MG                             N021259   006    Feb   19,   2006
	
    METHYLPHENIDATE HYDROCHLORIDE
	
AB2      TEVA PHARMS            10MG
	                           A077707 001 Jul 19, 2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-242(of 371)


METHYLPHENIDATE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    METHYLPHENIDATE HYDROCHLORIDE
	
AB2                              20MG                          A077707   002     Jul   19,   2012

AB2                              30MG                          A077707   003     Jul   19,   2012

AB2                              40MG                          A078873   001     Jul   19,   2012

AB2                              50MG                          A078873   002     Jul   19,   2012

AB2                              60MG                          A078873   003     Jul   19,   2012
	
    RITALIN LA
	
         NOVARTIS                60MG                          N021284 005 Oct 27, 2014
	
  FOR SUSPENSION, EXTENDED RELEASE;ORAL
	
    QUILLIVANT XR
	
      + NEXTWAVE PHARMS          5MG/ML                        N202100 001 Sep 27, 2012

  SOLUTION;ORAL

    METHYLIN
	
AA    + MALLINCKRODT             5MG/5ML                       N021419 001 Dec 19, 2002

AA    +                          10MG/5ML                      N021419 002 Dec 19, 2002

    METHYLPHENIDATE HYDROCHLORIDE
	
AA       SUN PHARM INDS INC      5MG/5ML                       A201466   001     Nov   12,   2013

AA                               10MG/5ML                      A201466   002     Nov   12,   2013

AA       TRIS PHARMA INC         5MG/5ML                       A091601   001     Jul   23,   2010

AA                               10MG/5ML                      A091601   002     Jul   23,   2010
	
  TABLET;ORAL

    METHYLPHENIDATE HYDROCHLORIDE
	
AB       ACTAVIS LABS FL INC     5MG                           A040220   001     Aug   29,   1997

AB                               10MG                          A040220   002     Aug   29,   1997

AB                               20MG                          A040220   003     Aug   29,   1997

AB       COREPHARMA              5MG                           A091159   001     Mar   12,   2014

AB                               10MG                          A091159   002     Mar   12,   2014

AB                               20MG                          A091159   003     Mar   12,   2014

AB       MALLINCKRODT            5MG                           A040300   001     Nov   27,   1998

AB                               10MG                          A040300   002     Nov   27,   1998

AB                               20MG                          A040300   003     Nov   27,   1998

AB       SUN PHARM INDS INC      5MG                           A090710   001     Mar   15,   2012

AB                               10MG                          A090710   002     Mar   15,   2012

AB                               20MG                          A090710   003     Mar   15,   2012

AB       UCB INC                 5MG                           A086429   001
	
AB                               10MG                          A085799   001
	
AB                               20MG                          A086428   001
	
AB       VINTAGE PHARMS          5MG                           A202892   001     Sep 23, 2014

AB                               10MG                          A202892   002     Sep 23, 2014

AB                               20MG                          A202892   003     Sep 23, 2014

    RITALIN
	
AB       NOVARTIS                5MG                           N010187 003
	
AB                               10MG                          N010187 006
	
AB    +                          20MG                          N010187 010
	
  TABLET, CHEWABLE;ORAL
	
    METHYLIN
	
         MALLINCKRODT            2.5MG                         N021475 001 Apr 15, 2003

                                 5MG                           N021475 002 Apr 15, 2003

      +                          10MG                          N021475 003 Apr 15, 2003

  TABLET, EXTENDED RELEASE;ORAL

    METADATE ER
	
AB    + UCB INC                  20MG                          A089601 001 Jun 01, 1988

    METHYLIN ER
	
AB       MALLINCKRODT INC        20MG                          A075629 002 May 09, 2000

    RITALIN-SR
	
AB       NOVARTIS                20MG                          N018029 001 Mar 30, 1982
	
    METHYLPHENIDATE HYDROCHLORIDE
	
BX       KUDCO IRELAND           18MG                          A091695   001     Jul   09,   2013
	
BX                               27MG                          A091695   002     Jul   09,   2013
	
BX                               36MG                          A091695   003     Sep   23,   2013

BX                               54MG                          A091695   004     Sep   23,   2013

BX       MALLINCKRODT INC        27MG                          A202608   001     Dec   28,   2012
	
BX                               36MG                          A202608   002     Dec   28,   2012
	
BX                               54MG                          A202608   003     Dec   28,   2012
	
    CONCERTA
	
         JANSSEN PHARMS		        18MG                          N021121   001     Aug   01,   2000

                                 27MG                          N021121   004     Apr   01,   2002

                                 36MG                          N021121   002     Aug   01,   2000

      +                          54MG		                        N021121   003     Dec   08,   2000
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-243(of 371)


METHYLPHENIDATE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    METHYLIN ER
	
         MALLINCKRODT INC        10MG                          A075629 001 May 09, 2000
	
METHYLPREDNISOLONE
	
  TABLET;ORAL

    MEDROL
	
AB       PHARMACIA AND UPJOHN      2MG                         N011153   002
	
AB                                 4MG                         N011153   001
	
AB                                 8MG                         N011153   004
	
AB                                 16MG                        N011153   003
	
AB    +                            32MG                        N011153   006
	
    METHYLPREDNISOLONE
	
AB       DURAMED PHARMS BARR       4MG                         A088497   001     Feb   21,   1984

AB       JUBILANT CADISTA          4MG                         A040189   001     Oct   31,   1997

AB                                 8MG                         A040189   002     Oct   31,   1997

AB                                 16MG                        A040189   003     Jul   20,   2007

AB                                 32MG                        A040189   004     Jul   20,   2007

AB       SANDOZ                    4MG                         A040194   001     Oct   31,   1997

AB       VINTAGE PHARMS            4MG                         A040183   001     Dec   22,   1998

AB       WATSON LABS               4MG                         A040232   001     Oct   16,   1997
	
METHYLPREDNISOLONE ACETATE
	
  INJECTABLE;INJECTION

    DEPO-MEDROL
	
AB    + PHARMACIA AND UPJOHN       40MG/ML                     N011757 001
	
AB    +                            80MG/ML                     N011757 004
	
    METHYLPREDNISOLONE ACETATE
	
AB       SANDOZ                    40MG/ML                     A040719   001     Jan   29,   2009

AB                                 40MG/ML                     A040794   001     Mar   05,   2009

AB                                 80MG/ML                     A040719   002     Jan   29,   2009

AB                                 80MG/ML                     A040794   002     Mar   05,   2009

AB       TEVA PHARMS USA           40MG/ML                     A040557   001     Feb   23,   2005

AB                                 40MG/ML                     A040620   001     Oct   27,   2006

AB                                 80MG/ML                     A040557   002     Feb   23,   2005

AB                                 80MG/ML                     A040620   002     Oct   27,   2006
	
    DEPO-MEDROL
	
      + PHARMACIA AND UPJOHN       20MG/ML                     N011757 002
	
METHYLPREDNISOLONE SODIUM SUCCINATE
	
  INJECTABLE;INJECTION

    A-METHAPRED
	
AP       HOSPIRA                EQ 40MG BASE/VIAL              A040664   001     Dec   20,   2005

AP                              EQ 125MG BASE/VIAL             A040665   001     Dec   20,   2005

AP       HOSPIRA INC            EQ 40MG BASE/VIAL              A040793   001     Nov   25,   2008

AP                              EQ 125MG BASE/VIAL             A040827   001     Nov   25,   2008

    METHYLPREDNISOLONE SODIUM SUCCINATE
	
AP       FRESENIUS KABI USA     EQ 1GM BASE/VIAL               A040612   001     Aug   12,   2004

AP                              EQ 40MG BASE/VIAL              A040583   001     Jul   30,   2004

AP                              EQ 125MG BASE/VIAL             A040583   002     Jul   30,   2004

AP       MUSTAFA NEVSAT         EQ 1GM BASE/VIAL               A040888   004     Jul   18,   2011

AP                              EQ 2GM BASE/VIAL               A040888   005     Jul   18,   2011

AP                              EQ 40MG BASE/VIAL              A040888   001     Jul   18,   2011

AP                              EQ 125MG BASE/VIAL             A040888   002     Jul   18,   2011

AP                              EQ 500MG BASE/VIAL             A040888   003     Jul   18,   2011

    SOLU-MEDROL
	
AP    + PHARMACIA AND UPJOHN    EQ 1GM BASE/VIAL               N011856   006
	
AP    +                         EQ 2GM BASE/VIAL               N011856   007 Feb 27, 1985

AP    +                         EQ 40MG BASE/VIAL              N011856   003
	
AP    +                         EQ 125MG BASE/VIAL             N011856   004
	
AP    +                         EQ 500MG BASE/VIAL             N011856   005
	
METHYLTESTOSTERONE
	
  CAPSULE;ORAL
	
    TESTRED
	
      + VALEANT PHARM INTL         10MG                        A083976 001
	
  TABLET;ORAL
	
    ANDROID 10
	
BP       VALEANT PHARM INTL        10MG                        A086450 001
	
    ANDROID 25
	
BP       VALEANT PHARM INTL        25MG                        A087147 001
	
    METHYLTESTOSTERONE
	
BP       IMPAX LABS                10MG                        A080767 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-244(of 371)


METHYLTESTOSTERONE
	
  TABLET;ORAL
	
    METHYLTESTOSTERONE
	
BP                               25MG                           A084310 001
	
METIPRANOLOL HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    METIPRANOLOL
	
AT       ALCON RES LTD           0.3%                           A075720 001 Aug 06, 2001

    OPTIPRANOLOL
	
AT    + BAUSCH AND LOMB          0.3%                           N019907 001 Dec 29, 1989
	
METOCLOPRAMIDE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    METOCLOPRAMIDE
	
AP       EMCURE PHARMS LTD         EQ 5MG BASE/ML               A204756 001 Dec 20, 2013

    METOCLOPRAMIDE HYDROCHLORIDE
	
AP       BD RX                  EQ 5MG BASE/ML                  A091392 001 Apr 19, 2013

AP       HOSPIRA                EQ 5MG BASE/ML                  A073118 001 Jan 17, 1991

AP       TEVA PHARMS USA        EQ 5MG BASE/ML                  A073135 001 Nov 27, 1991

    REGLAN
	
AP    + BAXTER HLTHCARE CORP    EQ 5MG BASE/ML                  N017862 001
	
  SOLUTION;ORAL

    METOCLOPRAMIDE HYDROCHLORIDE
	
AA       ANI PHARMS             EQ 5MG BASE/5ML                 A071402   001    Jun   25,   1993

AA       PHARM ASSOC            EQ 5MG BASE/5ML                 A072744   001    May   28,   1991

AA       SILARX                 EQ 5MG BASE/5ML                 A073680   001    Oct   27,   1992

AA       VISTAPHARM             EQ 5MG BASE/5ML                 A075051   001    Jan   26,   2001

AA    + WOCKHARDT               EQ 5MG BASE/5ML                 A074703   001    Oct   31,   1997
	
  TABLET;ORAL

    METOCLOPRAMIDE HYDROCHLORIDE
	
AB       IPCA LABS LTD          EQ 5MG BASE                     A078807   001    Jun   12,   2008

AB                              EQ 10MG BASE                    A078807   002    Jun   12,   2008

AB       MUTUAL PHARM           EQ 5MG BASE                     A071536   002    Jan   16,   1997

AB       NORTHSTAR HLTHCARE     EQ 5MG BASE                     A078374   001    Nov   30,   2007

AB                              EQ 10MG BASE                    A078374   002    Nov   30,   2007

AB       PAR PHARM INC          EQ 10MG BASE                    A070581   001    Oct   17,   1985

AB       TEVA                   EQ 5MG BASE                     A072801   001    Jun   15,   1993

AB                              EQ 10MG BASE                    A070184   001    Jul   29,   1985

AB       VINTAGE PHARMS         EQ 5MG BASE                     A077878   001    Aug   28,   2006

AB                              EQ 10MG BASE                    A077878   002    Aug   28,   2006

AB       WATSON LABS            EQ 5MG BASE                     A072750   001    Dec   28,   1995

AB                              EQ 10MG BASE                    A071250   001    Feb   03,   1988

    REGLAN
	
AB       ANI PHARMS             EQ 5MG BASE                     N017854 002 May 05, 1987

AB    +                         EQ 10MG BASE                    N017854 001
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    METOCLOPRAMIDE HYDROCHLORIDE
	
AB       NOVEL LABS INC         EQ 5MG BASE                     A202191 001 Aug 15, 2014

    METOZOLV ODT
	
AB    + SALIX PHARMS            EQ 5MG BASE                     N022246 001 Sep 04, 2009

    METOCLOPRAMIDE HYDROCHLORIDE
	
         NOVEL LABS INC         EQ 10MG BASE                    A202191 002 Aug 15, 2014
	
METOLAZONE
	
  TABLET;ORAL

    METOLAZONE
	
AB       MYLAN                   2.5MG                          A076698   001    Dec   23,   2003

AB                               5MG                            A076698   002    Oct   19,   2004

AB                               10MG                           A076698   003    Oct   19,   2004

AB       SANDOZ                  2.5MG                          A076732   001    Dec   19,   2003

AB                               5MG                            A076466   001    Dec   19,   2003

AB                               10MG                           A076466   002    Dec   19,   2003

    ZAROXOLYN
	
AB       UCB INC                 2.5MG                          N017386 001
	
AB    +                          5MG                            N017386 002
	
AB    +                          10MG                           N017386 003
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-245(of 371)


METOPROLOL SUCCINATE
	
  TABLET, EXTENDED RELEASE;ORAL

     METOPROLOL SUCCINATE
	
AB        ACTAVIS LABS FL INC
	  EQ    25MG TARTRATE
            A077118   001    Aug   03,   2009

AB
	                             EQ    50MG TARTRATE
            A076862   001    Aug   03,   2009

AB
	                             EQ    100MG TARTRATE
           A077298   001    Apr   15,   2010

AB
	                             EQ    200MG TARTRATE
           A077298   002    Apr   15,   2010

AB        DR REDDYS LABS LTD
	   EQ    25MG TARTRATE
            A090617   001    Aug   01,   2012

AB
	                             EQ    50MG TARTRATE
            A090617   002    Aug   01,   2012

AB        MYLAN PHARMS INC
	     EQ    25MG TARTRATE
            A202033   001    Dec   15,   2011

AB
	                             EQ    50MG TARTRATE
            A202033   002    Dec   15,   2011

AB
	                             EQ    100MG TARTRATE
           A202033   003    Dec   15,   2011

AB
	                             EQ    200MG TARTRATE
           A202033   004    Dec   15,   2011

AB        REDDYS
	               EQ    100MG TARTRATE
           A078889   001    Aug   15,   2012

AB
	                             EQ    200MG TARTRATE
           A078889   002    Aug   15,   2012

AB        WOCKHARDT
	            EQ    25MG TARTRATE
            A090615   001    Jul   22,   2010

AB
	                             EQ    50MG TARTRATE
            A090615   002    Jul   22,   2010

AB
	                             EQ    100MG TARTRATE
           A090615   003    Jul   22,   2010

AB
	                             EQ    200MG TARTRATE
	          A090615   004    Jul   22,   2010
	
     TOPROL-XL
	
AB        ASTRAZENECA PHARMS     EQ    25MG TARTRATE
            N019962   004    Feb   05,   2001

AB     +                         EQ    50MG TARTRATE
            N019962   001    Jan   10,   1992

AB                               EQ    100MG TARTRATE
           N019962   002    Jan   10,   1992

AB     +                         EQ    200MG TARTRATE
	          N019962   003    Jan   10,   1992
	
METOPROLOL TARTRATE
	
  INJECTABLE;INJECTION

     LOPRESSOR
	
AP     + NOVARTIS
	                 1MG/ML
	                     N018704 001 Mar 30, 1984
	
     METOPROLOL TARTRATE
	
AP         BEDFORD LABS
	           1MG/ML
                      A076495   001    Jul   07,   2003

AP         CLARIS LIFESCIENCES
	    1MG/ML
                      A078950   001    Apr   29,   2013

AP         FRESENIUS KABI USA
	     1MG/ML
                      A091045   001    Oct   25,   2010

AP         GLAND PHARMA LTD
	       1MG/ML
                      A204205   001    Aug   27,   2014

AP         HIKMA FARMACEUTICA
	     1MG/ML
                      A077761   001    May   30,   2007

AP         HOSPIRA
	                1MG/ML
                      A074133   001    Dec   21,   1993

AP
	                                1MG/ML
                      A075160   001    Jul   06,   1998

AP
	                                1MG/ML
                      A078085   001    Apr   29,   2008

AP         LUITPOLD
	               1MG/ML
                      A090386   001    Sep   30,   2009

AP
	                                1MG/ML
                      A091307   001    Dec   29,   2010

AP         SAGENT STRIDES
	         1MG/ML
                      A090317   001    Apr   19,   2010

AP         SANDOZ
	                 1MG/ML
	                     A077360   001    Oct   02,   2007
	
  TABLET;ORAL

     LOPRESSOR
	
AB         US PHARMS HOLDINGS I
	   50MG
	                       N017963 001
	
AB
	                                100MG
	                      N017963 002
	
     METOPROLOL TARTRATE
	
AB         ALEMBIC PHARMS LTD
	     25MG
	                       A202871   001    May   28,   2013

AB
	                                50MG
	                       A202871   002    May   28,   2013

AB
	                                100MG
	                      A202871   003    May   28,   2013

AB         AUROBINDO PHARMA
	       25MG
	                       A077739   001    Sep   11,   2007

AB
	                                50MG
	                       A077739   002    Sep   11,   2007

AB
	                                100MG
	                      A077739   003    Sep   11,   2007

AB         IPCA LABS LTD
	          25MG
	                       A078459   001    Jun   17,   2008

AB
	                                50MG
	                       A078459   002    Jun   17,   2008

AB
	                                100MG
	                      A078459   003    Jun   17,   2008

AB         MUTUAL PHARM
	           25MG
	                       A073654   002    Jul   15,   2009

AB
	                                50MG
	                       A073653   001    Dec   21,   1993

AB
	                                100MG
	                      A073654   001    Dec   21,   1993

AB         MYLAN
	                  25MG
	                       A076704   001    Jan   16,   2004

AB
	                                50MG
	                       A076704   002    Jan   16,   2004

AB     +
	                          100MG
	                      A076704   003    Jan   16,   2004

AB         RUBICON RES PVT LTD
	    25MG
	                       A200981   001    Oct   28,   2014

AB
	                                50MG
	                       A200981   002    Oct   28,   2014

AB
	                                100MG
	                      A200981   003    Oct   28,   2014

AB         SANDOZ
	                 50MG
	                       A073288   001    Mar   25,   1994

AB
	                                100MG
	                      A073289   001    Mar   25,   1994

AB         SUN PHARM INDS INC
	     25MG
	                       A076670   001    Jan   15,   2004

AB
	                                50MG
	                       A074644   001    Dec   10,   1996

AB
	                                100MG
	                      A074644   002    Dec   10,   1996

AB         TEVA
	                   50MG
	                       A074141   001    Jan   31,   1995

AB
	                                100MG
	                      A074141   002    Jan   31,   1995

AB         WATSON LABS
	            50MG
	                       A074217   001    May   27,   1994
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-246(of 371)


METOPROLOL TARTRATE
	
  TABLET;ORAL

    METOPROLOL TARTRATE
	
AB                              100MG                           A074217 002 May 27, 1994
	
METRONIDAZOLE
	
  CAPSULE;ORAL

    FLAGYL
	
AB    + GD SEARLE LLC            375MG                          N020334 001 May 03, 1995

    METRONIDAZOLE
	
AB       ALEMBIC LTD             375MG                          A079065 001 Jun 23, 2009

AB       PAR PHARM               375MG                          A076522 001 Jan 29, 2004
	
  CREAM;TOPICAL

    METROCREAM
	
AB    + GALDERMA LABS LP         0.75%                          N020531 001 Sep 20, 1995

    METRONIDAZOLE
	
AB       FOUGERA PHARMS          0.75%                          A076408 001 May 28, 2004

AB       G AND W LABS            0.75%                          A077549 001 Dec 19, 2007
	
    NORITATE
	
      + VALEANT BERMUDA          1%                             N020743 001 Sep 26, 1997

  GEL;TOPICAL

    METROGEL
	
AB    + GALDERMA LABS LP         0.75%                          N019737 001 Nov 22, 1988

AB    +                          1%                             N021789 001 Jun 30, 2005

    METRONIDAZOLE
	
AB       FOUGERA PHARMS          0.75%                          A077018   001    Jun   06,   2006

AB       G AND W LABS INC        0.75%                          A078178   001    Jan   19,   2011

AB       TARO                    0.75%                          A077819   001    Jul   18,   2006

AB       TOLMAR                  0.75%                          A077547   001    Jul   13,   2006

AB                               1%                             A090903   001    Jul   22,   2011
	
  GEL;VAGINAL

    METROGEL-VAGINAL
	
AB    + MEDICIS                  0.75%                          N020208 001 Aug 17, 1992

    METRONIDAZOLE
	
AB       TOLMAR                  0.75%                          A077264 001 Oct 31, 2006
	
    VANDAZOLE
	
BX       TEVA PHARMS             0.75%                          N021806 001 May 20, 2005

    METRONIDAZOLE
	
      + WATSON LABS INC          1.3%                           N205223 001 Mar 24, 2014
	
  INJECTABLE;INJECTION

    FLAGYL I.V. RTU IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE          500MG/100ML                    N018657 001
	
AP    + PFIZER                   500MG/100ML                    N018353 002
	
    METRO I.V. IN PLASTIC CONTAINER
	
AP    + B BRAUN                  500MG/100ML                    N018900 001 Sep 29, 1983

    METRONIDAZOLE IN PLASTIC CONTAINER
	
AP       CLARIS LIFESCIENCES     500MG/100ML                    A078084 001 Mar 31, 2008

AP    + HOSPIRA                  500MG/100ML                    N018890 002 Nov 18, 1983
	
  LOTION;TOPICAL

    METROLOTION
	
AB    + GALDERMA LABS LP         0.75%                          N020901 001 Nov 24, 1998

    METRONIDAZOLE
	
AB       FOUGERA PHARMS          0.75%                          A077197 001 May 24, 2006

  TABLET;ORAL

    FLAGYL
	
AB       GD SEARLE LLC           250MG                          N012623 001
	
AB    +                          500MG                          N012623 003
	
    METRONIDAZOLE
	
AB       ALEMBIC PHARMS LTD      250MG                          A079067   001    Mar   13,   2009

AB                               500MG                          A079067   002    Mar   13,   2009

AB       MUTUAL PHARM            250MG                          A070772   001    Jul   16,   1986

AB                               500MG                          A070773   001    Jul   16,   1986

AB       PLIVA                   500MG                          A070033   001    Dec   06,   1984

AB       TEVA PHARMS USA         250MG                          A070027   001    Nov   06,   1984

AB       UNICHEM LABS LTD        250MG                          A203458   001    Jan   22,   2014

AB                               500MG                          A203458   002    Jan   22,   2014

AB       WATSON LABS             250MG                          A070035   001    Dec   20,   1984

AB       WATSON LABS INC         500MG                          A070044   001    Feb   08,   1985
	
  TABLET, EXTENDED RELEASE;ORAL

    FLAGYL ER
	
AB    + GD SEARLE LLC            750MG                          N020868 001 Nov 26, 1997
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-247(of 371)


METRONIDAZOLE
	
  TABLET, EXTENDED RELEASE;ORAL

    METRONIDAZOLE
	
AB       ALEMBIC LTD
	           750MG
	                         A090222 001 May 05, 2010
	
METYRAPONE
	
  CAPSULE;ORAL
	
    METOPIRONE
	
      + HRA PHARMA
	             250MG
	                         N012911 002 Aug 09, 1996
	
METYROSINE
	
  CAPSULE;ORAL
	
    DEMSER
	
      + ATON PHARMA VPNA
	       250MG
	                         N017871 001
	
MEXILETINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    MEXILETINE HYDROCHLORIDE
	
         TEVA
	                  150MG
	                         A074377 001 May 16, 1995

                                 200MG
	                         A074377 002 May 16, 1995

     +
	                         250MG
	                         A074377 003 May 16, 1995
	
MICAFUNGIN SODIUM
	
  INJECTABLE;IV (INFUSION)

    MYCAMINE
	
      + ASTELLAS
	               50MG/VIAL
                      N021506 002 Mar 16, 2005
	
      +
	                        100MG/VIAL
	                    N021506 003 Jun 27, 2006
	
MICONAZOLE
	
  TABLET;BUCCAL
	
    ORAVIG
	
      + BIOALLIANCE PHARMA
	     50MG
	                          N022404 001 Apr 16, 2010
	
MICONAZOLE NITRATE
	
  SUPPOSITORY;VAGINAL

    MICONAZOLE NITRATE
AB       ACTAVIS MID ATLANTIC    200MG
	                         A073508 001 Nov 19, 1993
	
    MONISTAT 3
AB    + MEDTECH PRODUCTS         200MG
	                         N018888 001 Aug 15, 1984
	
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE
	
  OINTMENT;TOPICAL
	
    VUSION
	
      + DELCOR ASSET
	          0.25%;81.35%;15%
	               N021026 001 Feb 16, 2006
	
MIDAZOLAM HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    MIDAZOLAM HYDROCHLORIDE
	
AP       AKORN INC              EQ 1MG BASE/ML
                  A075494   001    Jun   30,   2000

AP                              EQ 5MG BASE/ML
                  A075481   001    Jun   30,   2000

AP                              EQ 5MG BASE/ML
                  A075494   002    Jun   30,   2000

AP       BEDFORD                EQ 1MG BASE/ML
                  A075247   002    Jun   23,   2000

AP                              EQ 5MG BASE/ML
                  A075247   001    Jun   23,   2000

AP       BEDFORD LABS           EQ 1MG BASE/ML
                  A075421   002    Jun   20,   2000

AP                              EQ 5MG BASE/ML
                  A075421   001    Jun   20,   2000

AP       FRESENIUS KABI USA     EQ 1MG BASE/ML
                  A075154   002    Jun   20,   2000

AP                              EQ 5MG BASE/ML
                  A075154   001    Jun   20,   2000

AP       GLAND PHARMA LTD       EQ 1MG BASE/ML
                  A090696   001    Feb   29,   2012

AP                              EQ 5MG BASE/ML
                  A090850   001    Jan   25,   2012

AP       HIKMA MAPLE            EQ 1MG BASE/ML
                  A075243   001    Jun   20,   2000

AP                              EQ 1MG BASE/ML
                  A075324   001    Jun   20,   2000

AP                              EQ 5MG BASE/ML
                  A075243   002    Jun   20,   2000

AP                              EQ 5MG BASE/ML
                  A075324   002    Jun   20,   2000

AP    + HOSPIRA                 EQ 1MG BASE/ML
                  A075293   001    Jun   20,   2000

AP                              EQ 1MG BASE/ML
                  A075856   001    Jun   13,   2002

AP    +                         EQ 5MG BASE/ML
                  A075293   002    Jun   20,   2000

AP                              EQ 5MG BASE/ML
                  A075856   002    Jun   13,   2002

AP       WOCKHARDT              EQ 1MG BASE/ML
                  A078141   001    May   30,   2008

AP                              EQ 1MG BASE/ML
                  A078511   001    Nov   10,   2008

AP                              EQ 5MG BASE/ML
                  A078141   002    May   30,   2008

AP                              EQ 5MG BASE/ML
	                 A078511   002    Nov   10,   2008
	
    MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
	
AP       BD RX                  EQ 1MG BASE/ML
                  A203460   001    Aug   22,   2014

AP                              EQ 5MG BASE/ML
                  A203460   002    Aug   22,   2014

AP    + HOSPIRA                 EQ 1MG BASE/ML
                  A075857   001    Jul   22,   2002

AP    +                         EQ 5MG BASE/ML
	                 A075857   002    Jul   22,   2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                            3-248(of 371)


MIDAZOLAM HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
	
AP        SAGENT STRIDES
	       EQ 1MG BASE/ML
                        A090315 001 Nov 29, 2010

AP
	                             EQ 5MG BASE/ML
	                       A090315 002 Nov 29, 2010
	
     MIDOZALAM HYDROCHLORIDE
	
AP        SAGENT STRIDES
	       EQ 1MG BASE/ML
                        A090316 001 May 04, 2011

AP
	                             EQ 5MG BASE/ML
	                       A090316 002 May 04, 2011
	
  SYRUP;ORAL

     MIDAZOLAM HYDROCHLORIDE
	
AA        HI TECH PHARMA         EQ 2MG BASE/ML
                        A075958   001    Sep   04,   2003

AA        PADDOCK LLC            EQ 2MG BASE/ML
                        A076379   001    May   02,   2005

AA        RANBAXY                EQ 2MG BASE/ML
                        A076058   001    Mar   15,   2002

AA     + ROXANE                  EQ 2MG BASE/ML
	                       A075873   001    Apr   30,   2002
	
MIDODRINE HYDROCHLORIDE
	
  TABLET;ORAL

     MIDODRINE HYDROCHLORIDE
	
AB         APOTEX INC
	            2.5MG
	                              A077746   001    Sep   12,   2006

AB
	                               5MG
	                                A077746   002    Sep   12,   2006

AB
	                               10MG
	                               A077746   003    Sep   12,   2006

AB         IMPAX PHARMS
	          2.5MG
	                              A076449   001    May   27,   2004

AB
	                               5MG
	                                A076449   002    May   27,   2004

AB
	                               10MG
	                               A076449   003    Dec   16,   2005

AB         MYLAN PHARMS INC
	      2.5MG
	                              A076577   001    Sep   10,   2003

AB     +
	                         5MG
	                                A076577   002    Sep   10,   2003

AB
	                               10MG
	                               A076577   003    Sep   10,   2003

AB         SANDOZ
	                2.5MG
	                              A076514   001    Sep   11,   2003

AB
	                               5MG
	                                A076514   002    Sep   11,   2003

AB
	                               10MG
	                               A076514   003    Jul   02,   2004
	
     ORVATEN
	
AB         UPSHER SMITH
	          2.5MG
	                              A076725 001 Nov 03, 2004

AB
	                               5MG
	                                A076725 002 Nov 03, 2004

AB
	                               10MG
	                               A076725 003 Nov 03, 2004
	
MIFEPRISTONE
	
  TABLET;ORAL
	
    KORLYM
	
      + CORCEPT THERAP
	           300MG
	                              N202107 001 Feb 17, 2012
	
    MIFEPREX
	
      + DANCO LABS LLC
	           200MG
	                              N020687 001 Sep 28, 2000
	
MIGLITOL
	
  TABLET;ORAL
	
    GLYSET
	
          PHARMACIA AND UPJOHN
	   25MG
	                               N020682 001 Dec 18, 1996
	
                                   50MG
	                               N020682 002 Dec 18, 1996
	
     +
	                           100MG
	                              N020682 003 Dec 18, 1996
	
MIGLUSTAT
	
  CAPSULE;ORAL
	
    ZAVESCA
	
      + ACTELION PHARMS LTD
	      100MG
	                              N021348 001 Jul 31, 2003
	
MILNACIPRAN HYDROCHLORIDE
	
  TABLET;ORAL
	
    SAVELLA
	
         CYPRESS BIOSCIENCE
	      12.5MG
	                             N022256   001    Jan   14,   2009
	
                                   25MG
	                               N022256   002    Jan   14,   2009
	
     +
	                           50MG
	                               N022256   003    Jan   14,   2009
	
                                   100MG
	                              N022256   004    Jan   14,   2009
	
MILRINONE LACTATE
	
  INJECTABLE;INJECTION

    MILRINONE LACTATE
	
AP    + BEDFORD
	               EQ 1MG BASE/ML
                         A075660   001    May   28,   2002

AP       FRESENIUS KABI USA
	   EQ 1MG BASE/ML
                         A075936   001    May   28,   2002

AP       GLAND PHARMA LTD
	     EQ 1MG BASE/ML
                         A077190   001    Oct   31,   2006

AP       HIKMA FARMACEUTICA
	   EQ 1MG BASE/ML
                         A077966   001    Dec   03,   2010

AP       HIKMA MAPLE
	          EQ 1MG BASE/ML
                         A075530   001    May   28,   2002

AP       HOSPIRA INC
	          EQ 1MG BASE/ML
                         A203280   001    Sep   03,   2014

AP       INTL MEDICATED
	       EQ 1MG BASE/ML
	                        A076013   001    Aug   02,   2002
	
    MILRINONE LACTATE IN DEXTROSE 5%
	
AP       APOTEX INC             EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)   A077151 002 Jul 20, 2005
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-249(of 371)


MILRINONE LACTATE
	
  INJECTABLE;INJECTION

    MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
AP       B BRAUN                EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A076414   001    Aug   18,   2004

AP    + BAXTER HLTHCARE         EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A075834   001    May   28,   2002

AP    +                         EQ 40MG BASE/200ML (EQ 0.2MG   BASE/ML)   A075834   002    May   28,   2002

AP       BEDFORD LABS           EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A078113   001    May   21,   2008

AP                              EQ 40MG BASE/200ML (EQ 0.2MG   BASE/ML)   A078113   002    May   21,   2008

AP       HOSPIRA                EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A075885   001    May   28,   2002

AP                              EQ 40MG BASE/200ML (EQ 0.2MG   BASE/ML)   A075885   002    May   28,   2002

    MILRINONE LACTATE IN PLASTIC CONTAINER
	
AP       HIKMA FARMACEUTICA     EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A090038 001 Jan 21, 2010

AP                              EQ 40MG BASE/200ML (EQ 0.2MG   BASE/ML)   A090038 002 Jan 21, 2010
	
MILTEFOSINE
	
  CAPSULE;ORAL
	
    IMPAVIDO
	
      + KNIGHT THERAPS          50MG                                      N204684 001 Mar 19, 2014
	
MINOCYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    DYNACIN
	
AB       CNTY LINE PHARMS        EQ   75MG BASE                           A063067 002 Sep 15, 1999

AB                               EQ   100MG BASE                          A063067 001 Jul 31, 1990

    MINOCIN
	
AB       PRECISION DERMAT        EQ   50MG BASE                           N050649 001 May 31, 1990

AB                               EQ   100MG BASE                          N050649 002 May 31, 1990

    MINOCYCLINE HYDROCHLORIDE
	
AB       AUROBINDO PHARMA        EQ   50MG BASE                           A065470   001    Mar   11,   2008

AB                               EQ   75MG BASE                           A065470   002    Mar   11,   2008

AB                               EQ   100MG BASE                          A065470   003    Mar   11,   2008

AB       IMPAX LABS              EQ   50MG BASE                           A065005   001    Mar   23,   1999

AB                               EQ   75MG BASE                           A065005   003    Apr   18,   2001

AB                               EQ   100MG BASE                          A065005   002    Mar   23,   1999

AB       RANBAXY                 EQ   50MG BASE                           A065062   001    Nov   30,   2000

AB                               EQ   75MG BASE                           A065062   002    Nov   30,   2000

AB                               EQ   100MG BASE                          A065062   003    Nov   30,   2000

AB       SUN PHARM INDS INC      EQ   50MG BASE                           A090867   001    May   13,   2013

AB                               EQ   75MG BASE                           A090867   002    May   13,   2013

AB                               EQ   100MG BASE                          A090867   003    May   13,   2013

AB       TEVA                    EQ   50MG BASE                           A063011   001    Mar   02,   1992

AB                               EQ   75MG BASE                           A063009   002    Aug   12,   2003

AB    +                          EQ   100MG BASE                          A063009   001    Mar   02,   1992

AB       WATSON LABS             EQ   50MG BASE                           A063181   001    Dec   30,   1991

AB                               EQ   75MG BASE                           A063065   002    Jun   10,   1999

AB                               EQ   100MG BASE                          A063065   001    Dec   30,   1991
	
  INJECTABLE;INJECTION
	
    MINOCIN
	
      + REMPEX PHARMS INC        EQ   100MG BASE/VIAL                     N050444 001
	
  POWDER, EXTENDED RELEASE;DENTAL
	
    ARESTIN
	
      + ORAPHARMA                EQ   1MG BASE                            N050781 001 Feb 16, 2001
	
  TABLET;ORAL

    MINOCYCLINE HYDROCHLORIDE
	
AB       DR REDDYS LABS LTD      EQ   50MG BASE                           A065436   001    Dec   26,   2007

AB                               EQ   75MG BASE                           A065436   002    Dec   26,   2007

AB                               EQ   100MG BASE                          A065436   003    Dec   26,   2007

AB       PAR PHARM               EQ   50MG BASE                           A065131   001    Apr   16,   2003

AB                               EQ   75MG BASE                           A065131   002    Apr   16,   2003

AB    +                          EQ   100MG BASE                          A065131   003    Apr   16,   2003

AB       RANBAXY                 EQ   50MG BASE                           A065156   001    Jan   06,   2004

AB                               EQ   75MG BASE                           A065156   002    Jan   06,   2004

AB                               EQ   100MG BASE                          A065156   003    Jan   06,   2004
	
  TABLET, EXTENDED RELEASE;ORAL

    MINOCYCLINE HYDROCHLORIDE
	
AB       AUROBINDO PHARMA LTD    EQ   45MG BASE                           A202261   001    Nov   19,   2012

AB                               EQ   90MG BASE                           A202261   003    Nov   19,   2012

AB                               EQ   135MG BASE                          A202261   005    Nov   19,   2012

AB       BARR LABS INC           EQ   45MG BASE                           A065485   001    Mar   17,   2009

AB                               EQ   65MG BASE                           A065485   004    May   18,   2012

AB                               EQ   90MG BASE                           A065485   002    Mar   17,   2009

AB                               EQ   115MG BASE                          A065485   005    May   18,   2012

AB                               EQ   135MG BASE                          A065485   003    Mar   17,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-250(of 371)


MINOCYCLINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    MINOCYCLINE HYDROCHLORIDE
	
AB       IMPAX LABS INC          EQ   45MG BASE                 A090024   001    Feb   03,   2009

AB                               EQ   90MG BASE                 A090024   002    Feb   03,   2009

AB                               EQ   135MG BASE                A090024   003    Feb   03,   2009

AB       LUPIN LTD               EQ   45MG BASE                 A091424   001    Nov   30,   2011

AB                               EQ   90MG BASE                 A091424   003    Nov   30,   2011

AB                               EQ   135MG BASE                A091424   004    Nov   30,   2011

AB       MYLAN PHARMS INC        EQ   45MG BASE                 A090911   001    Jul   20,   2010

AB                               EQ   80MG BASE                 A203443   002    Aug   22,   2014

AB                               EQ   90MG BASE                 A090911   002    Jul   20,   2010

AB                               EQ   105MG BASE                A203443   003    Aug   22,   2014

AB                               EQ   135MG BASE                A090911   003    Jul   20,   2010

AB       RANBAXY LABS LTD        EQ   45MG BASE                 A091118   001    Sep   25,   2014

AB                               EQ   80MG BASE                 A091118   004    Sep   25,   2014

AB                               EQ   90MG BASE                 A091118   005    Sep   25,   2014

AB                               EQ   105MG BASE                A091118   006    Sep   25,   2014

AB                               EQ   135MG BASE                A091118   008    Sep   25,   2014

AB       SANDOZ                  EQ   45MG BASE                 A090422   001    Aug   13,   2009

AB                               EQ   90MG BASE                 A090422   002    Aug   13,   2009

AB                               EQ   135MG BASE                A090422   003    Aug   13,   2009

    SOLODYN
	
AB       MEDICIS                 EQ   65MG BASE                 N050808   004    Jul   23,   2009

AB    +                          EQ   80MG BASE                 N050808   007    Aug   27,   2010

AB                               EQ   105MG BASE                N050808   006    Aug   27,   2010

AB                               EQ   115MG BASE                N050808   005    Jul   23,   2009
	
      +                          EQ   55MG BASE                 N050808   008    Aug   27,   2010
	
MINOXIDIL
	
  TABLET;ORAL

    MINOXIDIL
	
AB       MUTUAL PHARM           2.5MG                           A072708   001    Dec   14,   1995

AB                              10MG                            A072709   001    Dec   14,   1995

AB       PAR PHARM              2.5MG                           A071826   001    Nov   14,   1988

AB                              10MG                            A071839   001    Nov   14,   1988

AB       WATSON LABS            2.5MG                           A071344   001    Mar   03,   1987

AB    +                         10MG                            A071345   001    Mar   03,   1987
	
MIPOMERSEN SODIUM
	
  SOLUTION;SUBCUTANEOUS
	
    KYNAMRO
	
      + GENZYME CORP            200MG/ML (200MG/ML)             N203568 001 Jan 29, 2013
	
MIRABEGRON
	
  TABLET, EXTENDED RELEASE;ORAL
	
    MYRBETRIQ
	
         APGDI                   25MG                           N202611 001 Jun 28, 2012
	
      +                          50MG                           N202611 002 Jun 28, 2012
	
MIRTAZAPINE
	
  TABLET;ORAL

    MIRTAZAPINE
	
AB       ACTAVIS LABS FL INC    15MG                            A076336   001    Jun   20,   2003

AB                              30MG                            A076336   002    Jun   20,   2003

AB                              45MG                            A076336   003    Jun   20,   2003

AB       APOTEX INC             15MG                            A077666   001    Aug   22,   2007

AB                              30MG                            A077666   002    Aug   22,   2007

AB                              45MG                            A077666   003    Aug   22,   2007

AB       AUROBINDO              7.5MG                           A076921   001    Oct   22,   2004

AB                              15MG                            A076921   002    Oct   22,   2004

AB                              30MG                            A076921   003    Oct   22,   2004

AB                              45MG                            A076921   004    Oct   22,   2004

AB       MYLAN                  15MG                            A076122   001    Jun   19,   2003

AB                              30MG                            A076122   002    Jun   19,   2003

AB                              45MG                            A076122   003    Jun   19,   2003

AB       MYLAN PHARMS INC       15MG                            A076176   001    Jun   19,   2003

AB                              30MG                            A076176   002    Jun   19,   2003

AB                              45MG                            A076176   003    Jun   19,   2003

AB       SANDOZ                 15MG                            A076219   001    Jun   19,   2003

AB                              30MG                            A076219   002    Jun   19,   2003

AB                              45MG                            A076219   003    Jun   19,   2003

AB       SUN PHARM INDS INC     7.5MG                           A076541   004    Apr   22,   2004

AB                              15MG                            A076541   001    Apr   22,   2004
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                     3-251(of 371)


MIRTAZAPINE
	
  TABLET;ORAL

    MIRTAZAPINE
	
AB                              30MG                                          A076541   002    Apr   22,   2004

AB                              45MG                                          A076541   003    Apr   22,   2004

AB       TEVA                   15MG                                          A076119   001    Jan   24,   2003

AB                              30MG                                          A076119   002    Jan   24,   2003

AB                              45MG                                          A076119   003    Jun   19,   2003

AB       WATSON LABS            15MG                                          A076312   001    Jun   19,   2003

AB                              30MG                                          A076312   002    Jun   19,   2003

AB                              45MG                                          A076312   003    Jun   19,   2003

    REMERON
	
AB    + ORGANON USA INC         15MG                                          N020415 001 Jun 14, 1996

AB                              30MG                                          N020415 002 Jun 14, 1996

AB                              45MG                                          N020415 003 Mar 17, 1997
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    MIRTAZAPINE
	
AB       ACTAVIS LABS FL INC    15MG                                          A076307   001    Dec   17,   2003

AB                              30MG                                          A076307   002    Dec   17,   2003

AB                              45MG                                          A076307   003    Feb   28,   2006

AB       AUROBINDO PHARMA LTD   15MG                                          A077376   002    Dec   08,   2005

AB                              30MG                                          A077376   003    Dec   08,   2005

AB                              45MG                                          A077376   004    Feb   28,   2006

AB       TEVA                   15MG                                          A076901   001    Jun   28,   2005

AB                              30MG                                          A076901   002    Jun   28,   2005

AB                              45MG                                          A076901   003    Jun   28,   2005

    REMERON SOLTAB
	
AB    + ORGANON USA INC         15MG                                          N021208 001 Jan 12, 2001

AB                              30MG                                          N021208 002 Jan 12, 2001

AB                              45MG                                          N021208 003 Jan 12, 2001
	
MISOPROSTOL
	
  TABLET;ORAL

    CYTOTEC
	
AB       GD SEARLE LLC             0.1MG                                      N019268 003 Sep 21, 1990

AB    +                            0.2MG                                      N019268 001 Dec 27, 1988

    MISOPROSTOL
	
AB       IVAX SUB TEVA PHARMS      0.1MG                                      A076095   001    Jul   10,   2002

AB                                 0.2MG                                      A076095   002    Jul   10,   2002

AB       NOVEL LABS INC            0.1MG                                      A091667   001    Jul   25,   2012

AB                                 0.2MG                                      A091667   002    Jul   25,   2012
	
MITOMYCIN
	
  FOR SOLUTION;TOPICAL
	
    MITOSOL
	
      + MOBIUS THERAP              0.2MG/VIAL                                 N022572 001 Feb 07, 2012
	
  INJECTABLE;INJECTION

    MITOMYCIN
	
AP    + ACCORD HLTHCARE            5MG/VIAL                                   A064144   001    Apr   30,   1998

AP    +                            20MG/VIAL                                  A064144   002    Apr   30,   1998

AP    +                            40MG/VIAL                                  A064144   003    Aug   11,   2009

AP       BEDFORD                   5MG/VIAL                                   A064117   001    Apr   19,   1995

AP                                 20MG/VIAL                                  A064117   002    Apr   19,   1995

AP       HIKMA MAPLE               5MG/VIAL                                   A064180   001    Dec   23,   1999

AP                                 20MG/VIAL                                  A064180   002    Dec   23,   1999
	
MITOTANE
	
  TABLET;ORAL
	
    LYSODREN
	
      + BRISTOL MYERS SQUIBB       500MG                                      N016885 001
	
MITOXANTRONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    MITOXANTRONE HYDROCHLORIDE
	
AP       EUROHLTH INTL             EQ   20MG   BASE/10ML (EQ 2MG BASE/ML)     A076611   001    Apr   11,   2006

AP                                 EQ   25MG   BASE/12.5ML (EQ 2MG BASE/ML)   A076611   002    Apr   11,   2006

AP                                 EQ   30MG   BASE/15ML (EQ 2MG BASE/ML)     A076611   003    Apr   11,   2006

AP       FRESENIUS KABI USA        EQ   20MG   BASE/10ML (EQ 2MG BASE/ML)     A077496   001    Apr   11,   2006

AP                                 EQ   25MG   BASE/12.5ML (EQ 2MG BASE/ML)   A077496   002    Apr   11,   2006

AP                                 EQ   30MG   BASE/15ML (EQ 2MG BASE/ML)     A077496   003    Apr   11,   2006

AP    + HOSPIRA                    EQ   20MG   BASE/10ML (EQ 2MG BASE/ML)     A076871   001    Apr   11,   2006

AP    +                            EQ   25MG   BASE/12.5ML (EQ 2MG BASE/ML)   A076871   002    Apr   11,   2006

AP    +                            EQ   30MG   BASE/15ML (EQ 2MG BASE/ML)     A076871   003    Apr   11,   2006

AP       MYLAN INSTITUTIONAL       EQ   20MG   BASE/10ML (EQ 2MG BASE/ML)     A078980   001    Apr   13,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                     3-252(of 371)


MITOXANTRONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    MITOXANTRONE HYDROCHLORIDE
	
AP                                 EQ   30MG   BASE/15ML (EQ 2MG BASE/ML)     A078980   002    Apr   13,   2009

AP       ONCO THERAPIES LTD        EQ   20MG   BASE/10ML (EQ 2MG BASE/ML)     A201014   001    Dec   11,   2012

AP       TEVA PHARMS USA           EQ   20MG   BASE/10ML (EQ 2MG BASE/ML)     A077356   001    Apr   11,   2006

AP                                 EQ   25MG   BASE/12.5ML (EQ 2MG BASE/ML)   A077356   002    Apr   11,   2006

AP                                 EQ   30MG   BASE/15ML (EQ 2MG BASE/ML)     A077356   003    Apr   11,   2006
	
MODAFINIL
	
  TABLET;ORAL

    MODAFINIL
	
AB       ALEMBIC LTD               100MG                                      A202700   001    Oct   18,   2012

AB                                 200MG                                      A202700   002    Oct   18,   2012

AB       APOTEX INC                100MG                                      A077667   001    Feb   03,   2014

AB                                 200MG                                      A077667   002    Feb   03,   2014

AB       AUROBINDO PHARMA LTD      100MG                                      A202566   001    Sep   27,   2012

AB                                 200MG                                      A202566   002    Sep   27,   2012

AB       CARLSBAD                  100MG                                      A076715   001    Nov   01,   2012

AB                                 200MG                                      A076715   002    Nov   01,   2012

AB       HIKMA PHARMS              100MG                                      A090543   001    Sep   26,   2012

AB                                 200MG                                      A090543   002    Sep   26,   2012

AB       MYLAN PHARMS INC          100MG                                      A076594   001    Jul   16,   2012

AB                                 200MG                                      A076594   002    Jul   16,   2012

AB       ORCHID HLTHCARE           100MG                                      A078963   001    Sep   26,   2012

AB                                 200MG                                      A078963   002    Sep   26,   2012

    PROVIGIL
	
AB       CEPHALON                  100MG                                      N020717 001 Dec 24, 1998

AB    +                            200MG                                      N020717 002 Dec 24, 1998
	
MOEXIPRIL HYDROCHLORIDE
	
  TABLET;ORAL

    MOEXIPRIL HYDROCHLORIDE
	
AB       APOTEX INC                7.5MG                                      A078454   001    Jun   02,   2008

AB                                 15MG                                       A078454   002    Jun   02,   2008

AB       GLENMARK GENERICS         7.5MG                                      A090416   001    Mar   30,   2010

AB                                 15MG                                       A090416   002    Mar   30,   2010

AB       PADDOCK LLC               7.5MG                                      A077536   001    Nov   30,   2006

AB                                 15MG                                       A077536   002    Nov   30,   2006

AB       TEVA                      7.5MG                                      A076204   001    May   08,   2003

AB                                 15MG                                       A076204   002    May   08,   2003

    UNIVASC
	
AB       UCB INC                   7.5MG                                      N020312 001 Apr 19, 1995

AB    +                            15MG                                       N020312 002 Apr 19, 1995
	
MOMETASONE FUROATE
	
  AEROSOL, METERED;INHALATION
	
    ASMANEX HFA
	
         MERCK SHARP DOHME         0.10MG/INH                                 N205641 001 Apr 25, 2014

      +                            0.20MG/INH                                 N205641 002 Apr 25, 2014

  CREAM;TOPICAL

    ELOCON
	
AB    + MERCK SHARP DOHME          0.1%                                       N019625 001 May 06, 1987

AB                                 0.1%                                       N019625 002 Apr 19, 2013

    MOMETASONE FUROATE
	
AB       FOUGERA PHARMS            0.1%                                       A076171   001    Apr   08,   2005

AB       G AND W LABS              0.1%                                       A077447   001    May   22,   2006

AB       GLENMARK GENERICS         0.1%                                       A078541   001    May   28,   2008

AB       TARO                      0.1%                                       A076679   001    Dec   21,   2004

AB       TOLMAR                    0.1%                                       A076591   001    Apr   18,   2007

  LOTION;TOPICAL

    ELOCON
	
AB    + MERCK SHARP DOHME          0.1%                                       N019796 001 Mar 30, 1989

    MOMETASONE FUROATE
	
AB       FOUGERA PHARMS            0.1%                                       A075919   001    Nov   29,   2007

AB       G AND W LABS              0.1%                                       A077678   001    Nov   21,   2007

AB       GLENMARK GENERICS         0.1%                                       A090506   001    Aug   09,   2010

AB       PERRIGO                   0.1%                                       A077180   001    Apr   06,   2005

AB       TARO                      0.1%                                       A076788   001    Mar   15,   2006

AB       TOLMAR                    0.1%                                       A076499   001    Nov   21,   2007
	
  OINTMENT;TOPICAL

    ELOCON
	
AB    + MERCK SHARP DOHME          0.1%                                       N019543 001 Apr 30, 1987
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-253(of 371)


MOMETASONE FUROATE
	
  OINTMENT;TOPICAL

    MOMETASONE FUROATE
AB        FOUGERA PHARMS            0.1%
	                       A077061   001    Mar   28,   2005

AB        G AND W LABS              0.1%
	                       A077401   001    Jun   20,   2006

AB        GLENMARK GENERICS         0.1%
	                       A078571   001    May   28,   2008

AB        PERRIGO NEW YORK          0.1%
	                       A076067   001    Mar   18,   2002

AB        TOLMAR                    0.1%
	                       A076481   001    Nov   14,   2003
	
  POWDER;INHALATION
	
    ASMANEX TWISTHALER
	
          MERCK SHARP DOHME
	       0.11MG/INH
                  N021067 002 Feb 01, 2008
	
      +
	                           0.22MG/INH
	                 N021067 001 Mar 30, 2005
	
MOMETASONE FUROATE MONOHYDRATE
	
  SPRAY, METERED;NASAL
	
    NASONEX
	
      + MERCK SHARP DOHME
	      EQ 0.05MG BASE/SPRAY
	          N020762 001 Oct 01, 1997
	
MONTELUKAST SODIUM
	
  GRANULE;ORAL

     MONTELUKAST SODIUM
	
AB         DR REDDYS LABS LTD
	     EQ 4MG BASE/PACKET
          A202906 001 Sep 17, 2012

AB         MYLAN PHARMS INC
	       EQ 4MG BASE/PACKET
          A202776 001 Dec 18, 2012

AB         TEVA PHARMS
	            EQ 4MG BASE/PACKET
	         A090955 001 Aug 03, 2012
	
     SINGULAIR
	
AB     + MERCK
	                    EQ 4MG BASE/PACKET
	         N021409 001 Jul 26, 2002
	
  TABLET;ORAL

     MONTELUKAST SODIUM
	
AB         ACCORD HLTHCARE
	        EQ   10MG   BASE
            A202717   001    Sep   21,   2012

AB         APOTEX CORP
	            EQ   10MG   BASE
            A201294   001    Aug   03,   2012

AB         AUROBINDO PHARMA LTD
	   EQ   10MG   BASE
            A202468   001    Aug   03,   2012

AB         DR REDDYS LABS LTD
	     EQ   10MG   BASE
            A201582   001    Aug   06,   2012

AB         GLENMARK GENERICS
	      EQ   10MG   BASE
            A090926   001    Aug   03,   2012

AB         HETERO LABS LTD V
	      EQ   10MG   BASE
            A202843   001    Sep   10,   2014

AB         KUDCO IRELAND
	          EQ   10MG   BASE
            A201522   001    Aug   03,   2012

AB         MACLEODS PHARMS LTD
	    EQ   10MG   BASE
            A203366   001    Sep   11,   2014

AB         MYLAN PHARMS INC
	       EQ   10MG   BASE
            A079103   001    Aug   03,   2012

AB         ROXANE
	                 EQ   10MG   BASE
            A090655   001    Aug   03,   2012

AB         SANDOZ INC
	             EQ   10MG   BASE
            A200889   001    Aug   03,   2012

AB         TEVA PHARMS
	            EQ   10MG   BASE
            A078605   001    Aug   03,   2012

AB         TORRENT PHARMS LTD
	     EQ   10MG   BASE
            A201515   001    Aug   03,   2012

AB         UNIMARK REMEDIES LTD
	   EQ   10MG   BASE
            A202859   001    Oct   30,   2014

AB         VINTAGE PHARMS LLC
	     EQ   10MG   BASE
	           A091576   001    Aug   03,   2012
	
     SINGULAIR
	
AB     + MERCK
	                    EQ 10MG BASE
	               N020829 002 Feb 20, 1998
	
  TABLET, CHEWABLE;ORAL

     MONTELUKAST SODIUM
	
AB         APOTEX INC
	             EQ   4MG   BASE
             A201508   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A201508   002    Aug   03,   2012

AB         AUROBINDO PHARMA LTD
	   EQ   4MG   BASE
             A202096   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A202096   002    Aug   03,   2012

AB         DR REDDYS LABS LTD
	     EQ   4MG   BASE
             A201581   001    Aug   06,   2012

AB
	                                EQ   5MG   BASE
             A201581   002    Aug   06,   2012

AB         KUDCO IRELAND
	          EQ   4MG   BASE
             A200405   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A200405   002    Aug   03,   2012

AB         MYLAN PHARMS INC
	       EQ   4MG   BASE
             A079142   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A079142   002    Aug   03,   2012

AB         ROXANE
	                 EQ   4MG   BASE
             A091128   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A091128   002    Aug   03,   2012

AB         SANDOZ INC
	             EQ   4MG   BASE
             A091414   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A091414   002    Aug   03,   2012

AB         TEVA PHARMS
	            EQ   4MG   BASE
             A078723   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A078723   002    Aug   03,   2012

AB         TORRENT PHARMS LTD
	     EQ   4MG   BASE
             A090984   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
             A090984   002    Aug   03,   2012

AB         UNIMARK REMEDIES LTD
	   EQ   4MG   BASE
             A203037   001    Oct   30,   2014

AB
	                                EQ   5MG   BASE
             A203037   002    Oct   30,   2014

AB         VINTAGE PHARMS LLC
	     EQ   4MG   BASE
             A091588   001    Aug   03,   2012

AB
	                                EQ   5MG   BASE
	            A091588   002    Aug   03,   2012
	
     SINGULAIR
	
AB         MERCK
	                  EQ 4MG BASE
                 N020830 002 Mar 03, 2000

AB     +
	                          EQ 5MG BASE
	                N020830 001 Feb 20, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-254(of 371)


MORPHINE SULFATE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    KADIAN
	
AB1 + WATSON LABS INC           10MG                           N020616   008    Apr   20,   2007

AB1                             20MG                           N020616   001    Jul   03,   1996

AB1                             30MG                           N020616   004    Mar   09,   2001

AB1                             50MG                           N020616   002    Jul   03,   1996

AB1                             60MG                           N020616   005    Mar   09,   2001

AB1                             80MG                           N020616   006    Oct   27,   2006

AB1 +                           100MG                          N020616   003    Jul   03,   1996

AB1 +                           200MG                          N020616   007    Feb   27,   2007

    MORPHINE SULFATE
	
AB1      PAR PHARM INC          20MG                           A200812   001    Nov   10,   2011

AB1                             30MG                           A200812   002    Nov   10,   2011

AB1                             50MG                           A200812   003    Nov   10,   2011

AB1                             60MG                           A200812   004    Nov   10,   2011

AB1                             80MG                           A200812   005    Nov   10,   2011

AB1                             100MG                          A200812   006    Nov   10,   2011

AB1      TEVA PHARMS USA        20MG                           A202718   001    Dec   29,   2014

AB1                             30MG                           A202718   002    Dec   29,   2014

AB1                             50MG                           A202718   003    Dec   29,   2014

AB1                             60MG                           A202718   004    Dec   29,   2014

AB1                             80MG                           A202718   005    Dec   29,   2014

AB1                             100MG                          A202718   006    Dec   29,   2014

AB1      UPSHER SMITH           10MG                           A202104   001    Jun   03,   2013

AB1                             20MG                           A202104   002    Jun   03,   2013

AB1                             30MG                           A202104   003    Jun   03,   2013

AB1                             50MG                           A202104   004    Jun   03,   2013

AB1                             60MG                           A202104   005    Jun   03,   2013

AB1                             80MG                           A202104   006    Jun   03,   2013

AB1                             100MG                          A202104   007    Jun   03,   2013

    AVINZA
	
AB2      KING PHARMS LLC        30MG                           N021260   001    Mar   20,   2002

AB2                             45MG                           N021260   005    Dec   18,   2008

AB2                             60MG                           N021260   002    Mar   20,   2002

AB2                             75MG                           N021260   006    Dec   18,   2008

AB2                             90MG                           N021260   003    Mar   20,   2002

AB2 +                           120MG                          N021260   004    Mar   20,   2002

    MORPHINE SULFATE
	
AB2      ACTAVIS ELIZABETH      30MG                           A079040   001    Jan   16,   2013

AB2                             45MG                           A079040   002    Jan   16,   2013

AB2                             60MG                           A079040   003    Jan   16,   2013

AB2                             75MG                           A079040   004    Jan   16,   2013

AB2                             90MG                           A079040   005    Jan   16,   2013

AB2                             120MG                          A079040   006    Jan   16,   2013
	
    KADIAN
	
         WATSON LABS INC        40MG                           N020616   009    Jul   09,   2012
	
                                70MG                           N020616   010    Jul   09,   2012
	
                                130MG                          N020616   011    Jul   09,   2012
	
                                150MG                          N020616   012    Jul   09,   2012
	
  INJECTABLE;INJECTION

    ASTRAMORPH PF
	
AP       FRESENIUS KABI USA     0.5MG/ML                       A071050   001    Oct   07,   1986

AP                              0.5MG/ML                       A071051   001    Oct   07,   1986

AP                              1MG/ML                         A071052   001    Oct   07,   1986

AP                              1MG/ML                         A071053   001    Oct   07,   1986

    DURAMORPH PF
	
AP    + HIKMA MAPLE             0.5MG/ML                       N018565 001 Sep 18, 1984

AP    +                         1MG/ML                         N018565 002 Sep 18, 1984

    MORPHINE SULFATE
	
AP       HOSPIRA                0.5MG/ML                       A071849   001    May   11,   1988

AP                              0.5MG/ML                       A073509   001    Sep   30,   1992

AP                              1MG/ML                         A071850   001    May   11,   1988

AP                              1MG/ML                         A073510   001    Sep   30,   1992

AP    +                         1MG/ML                         N019916   001    Oct   30,   1992
	
    INFUMORPH
	
      + HIKMA MAPLE             10MG/ML                        N018565 003 Jul 19, 1991
	
      +                         25MG/ML                        N018565 004 Jul 19, 1991
	
    MORPHINE SULFATE
	
      + HOSPIRA                 5MG/ML                         N019916 002 Oct 27, 2006
	
      + HOSPIRA INC             2MG/ML                         N202515 001 Nov 14, 2011
	
      +                         4MG/ML                         N202515 002 Nov 14, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-255(of 371)


MORPHINE SULFATE
	
  INJECTABLE;INJECTION
	
    MORPHINE SULFATE
	
      +                          8MG/ML                        N202515   003    Nov   14,   2011
	
      +                          10MG/ML                       N202515   004    Nov   14,   2011
	
      +                          15MG/ML                       N202515   005    Nov   14,   2011
	
      + MERIDIAN MEDCL TECHN     15MG/ML                       N019999   001    Jul   12,   1990
	
  SOLUTION;INTRAMUSCULAR, INTRAVENOUS
	
    MORPHINE SULFATE
	
      + BD RX                    2MG/ML (2MG/ML)               N204223   001    Oct   30,   2013
	
      +                          4MG/ML (4MG/ML)               N204223   002    Oct   30,   2013
	
      +                          5MG/ML (5MG/ML)               N204223   003    Oct   30,   2013
	
      +                          8MG/ML (8MG/ML)               N204223   004    Oct   30,   2013
	
      +                          10MG/ML (10MG/ML)             N204223   005    Oct   30,   2013
	
  SOLUTION;ORAL

    MORPHINE SULFATE
	
AA       MALLINCKRODT INC        100MG/5ML                     A202348   001    Jul   15,   2011

AA       PADDOCK LLC             100MG/5ML                     A201574   001    Aug   06,   2012

AA       ROXANE                  10MG/5ML                      N022195   001    Mar   17,   2008

AA                               20MG/5ML                      N022195   002    Mar   17,   2008

AA    +                          100MG/5ML                     N022195   003    Jan   25,   2010

AA       SUN PHARM INDS INC      10MG/5ML                      A201011   001    Feb   05,   2014

AA                               20MG/5ML                      A201011   002    Feb   05,   2014

AA       VISTAPHARM              10MG/5ML                      A201947   001    Jan   05,   2012

AA                               20MG/5ML                      A201947   002    Jan   05,   2012
	
         LANNETT HOLDINGS INC    100MG/5ML                     N201517   001    Jun   23,   2011
	
  TABLET;ORAL
	
    MORPHINE SULFATE
	
         ROXANE                  15MG                          N022207 001 Mar 17, 2008
	
      +                          30MG                          N022207 002 Mar 17, 2008
	
  TABLET, EXTENDED RELEASE;ORAL

    MORPHINE SULFATE
	
AB       DAVA PHARMS INC         15MG                          A075407   001    Jan   28,   2000

AB       MALLINCKRODT            15MG                          A076412   001    Jul   31,   2003

AB                               30MG                          A076412   002    Jul   31,   2003

AB                               60MG                          A076412   003    Jul   31,   2003

AB                               100MG                         A076438   001    Jul   03,   2003

AB                               200MG                         A076438   002    Jul   03,   2003

AB       MYLAN PHARMS INC        15MG                          A200824   001    Oct   18,   2011

AB                               30MG                          A200824   002    Oct   18,   2011

AB                               60MG                          A200824   003    Oct   18,   2011

AB                               100MG                         A200824   004    Oct   18,   2011

AB                               200MG                         A200824   005    Oct   18,   2011

AB       NESHER PHARMS           15MG                          A076733   001    May   19,   2004

AB                               30MG                          A076720   002    Dec   23,   2005

AB                               60MG                          A076720   001    May   19,   2004

AB                               100MG                         A077855   001    Sep   27,   2007

AB                               200MG                         A077855   002    Sep   27,   2007

AB       RANBAXY LABS LTD        15MG                          A078761   001    May   11,   2012

AB                               30MG                          A078761   002    May   11,   2012

AB                               60MG                          A078761   003    May   11,   2012

AB                               100MG                         A078761   004    May   11,   2012

AB                               200MG                         A078761   005    May   11,   2012

AB       RHODES PHARMS           15MG                          A074862   001    Jul   07,   1998

AB                               30MG                          A074862   002    Jul   07,   1998

AB                               60MG                          A074862   003    Jul   07,   1998

AB                               100MG                         A074769   001    Jul   02,   1998

AB                               200MG                         A074769   002    Jul   02,   1998

AB       VINTAGE PHARMS LLC      15MG                          A075295   001    Oct   28,   1998

AB                               30MG                          A075295   002    Oct   28,   1998

AB                               60MG                          A075295   003    Oct   28,   1998

AB                               100MG                         A075295   004    Sep   15,   2000

AB                               200MG                         A075295   005    Sep   15,   2000

    MS CONTIN
	
AB       PURDUE PHARMA LP        15MG                          N019516   003    Sep   12,   1989

AB                               30MG                          N019516   001    May   29,   1987

AB                               60MG                          N019516   002    Apr   08,   1988

AB    +                          100MG                         N019516   004    Jan   16,   1990

AB                               200MG                         N019516   005    Nov   08,   1993
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-256(of 371)


MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    EMBEDA
	
          ALPHARMA PHARMS		     20MG;0.8MG                     N022321   001    Aug   13,   2009

                                30MG;1.2MG                     N022321   002    Aug   13,   2009

                                50MG;2MG                       N022321   003    Aug   13,   2009

      +		                       60MG;2.4MG                     N022321   004    Aug   13,   2009

                                80MG;3.2MG                     N022321   005    Aug   13,   2009

                                100MG;4MG                      N022321   006    Aug   13,   2009
	
MOXIFLOXACIN HYDROCHLORIDE
	
  INJECTABLE;IV (INFUSION)

    AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
	
      + BAYER HLTHCARE           160MG/100ML                   N021277 001 Nov 30, 2001
	
  SOLUTION/DROPS;OPHTHALMIC

    MOXIFLOXACIN HYDROCHLORIDE
	
AT       LUPIN LTD               EQ 0.5% BASE                  A202867 001 Sep 04, 2014

    VIGAMOX
	
AT    + ALCON PHARMS LTD         EQ 0.5% BASE                  N021598 001 Apr 15, 2003

    MOXEZA
	
      + ALCON PHARMS LTD         EQ 0.5% BASE                  N022428 001 Nov 19, 2010
	
  TABLET;ORAL

    AVELOX
	
AB    + BAYER HLTHCARE           EQ 400MG BASE                 N021085 001 Dec 10, 1999

    MOXIFLOXACIN HYDROCHLORIDE
	
AB       AUROBINDO PHARMA LTD    EQ 400MG BASE                 A202632   001    Mar   04,   2014

AB       DR REDDYS LABS LTD      EQ 400MG BASE                 A076938   001    Mar   04,   2014

AB       TEVA PHARMS USA         EQ 400MG BASE                 A077437   001    Feb   18,   2014

AB       TORRENT PHARMS LTD      EQ 400MG BASE                 A200160   001    Apr   03,   2014
	
MUPIROCIN
	
  OINTMENT;TOPICAL

    BACTROBAN
	
AB    + GLAXOSMITHKLINE         2%                             N050591 001 Dec 31, 1987

    MUPIROCIN
	
AB       FOUGERA PHARMS         2%                             A065192   001    Nov   30,   2005

AB       GLENMARK PHARMS        2%                             A090480   001    Jun   08,   2011

AB       PERRIGO NEW YORK       2%                             A065123   001    Nov   07,   2003

AB       TARO                   2%                             A065170   001    Sep   23,   2005

AB       TEVA                   2%                             A065085   001    Nov   07,   2003
	
    CENTANY
	
BX       PERRIGO NEW YORK       2%                             N050788 001 Dec 04, 2002
	
MUPIROCIN CALCIUM
	
  CREAM;TOPICAL

    BACTROBAN
	
AB    + GLAXOSMITHKLINE         EQ 2% BASE                     N050746 001 Dec 11, 1997

    MUPIROCIN
	
AB       GLENMARK GENERICS      EQ 2% BASE                     A201587 001 Jan 24, 2013
	
  OINTMENT;NASAL
	
    BACTROBAN
	
      + GLAXOSMITHKLINE         EQ 2% BASE		                   N050703 001 Sep 18, 1995
	
MYCOPHENOLATE MOFETIL
	
  CAPSULE;ORAL

    CELLCEPT
	
AB    + ROCHE PALO              250MG                          N050722 001 May 03, 1995

    MYCOPHENOLATE MOFETIL
	
AB       ACCORD HLTHCARE        250MG                          A090253   001    May   04,   2009

AB       ALKEM LABS LTD         250MG                          A200197   001    Jun   13,   2013

AB       APOTEX CORP            250MG                          A090419   001    Apr   22,   2009

AB       CADISTA PHARMS         250MG                          A090762   001    Dec   15,   2014

AB       DR REDDYS LABS LTD     250MG                          A091315   001    Oct   27,   2011

AB       MYLAN                  250MG                          A065520   001    May   04,   2009

AB       ROXANE                 250MG                          A065410   001    Jul   29,   2008

AB       SANDOZ                 250MG                          A065379   001    Oct   15,   2008

AB       STRIDES PHARMA         250MG                          A090055   001    Jun   10,   2010

AB       TEVA PHARMS            250MG                          A065491   001    May   06,   2009

AB       VINTAGE PHARMS LLC     250MG                          A090111   001    Dec   22,   2009
	
  SUSPENSION;ORAL
    CELLCEPT
AB    + ROCHE PALO              200MG/ML                       N050759 001 Oct 01, 1998
    MYCOPHENOLATE MOFETIL
AB       ALKEM LABS LTD         200MG/ML                       A203005 001 Nov 14, 2014
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-257(of 371)


MYCOPHENOLATE MOFETIL
	
  TABLET;ORAL

    CELLCEPT
	
AB    + ROCHE PALO                500MG                        N050723 001 Jun 19, 1997

    MYCOPHENOLATE MOFETIL
	
AB       ACCORD HLTHCARE          500MG                        A065416   001    May   04,   2009

AB       ALKEM LABS LTD           500MG                        A091249   001    Nov   04,   2011

AB       APOTEX                   500MG                        A090499   001    Apr   22,   2009

AB       CADISTA PHARMS           500MG                        A090661   001    Dec   15,   2014

AB       MYLAN                    500MG                        A065521   001    May   04,   2009

AB       ROXANE                   500MG                        A065413   001    Jul   29,   2008

AB       SANDOZ                   500MG                        A065451   001    Oct   15,   2008

AB       STRIDES PHARMA           500MG                        A090456   001    Jun   10,   2010

AB       TEVA PHARMS              500MG                        A065457   001    May   04,   2009

AB       VINTAGE PHARMS LLC       500MG                        A090606   001    Jul   16,   2010
	
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CELLCEPT
	
      + ROCHE PALO              500MG/VIAL                     N050758 001 Aug 12, 1998
	
MYCOPHENOLIC ACID
	
  TABLET, DELAYED RELEASE;ORAL

    MYCOPHENOLIC ACID
	
AB       APOTEX INC               180MG                        A091558   001    Aug   21,   2012

AB                                360MG                        A091558   002    Aug   19,   2014

AB       MYLAN PHARMS INC         180MG                        A091248   002    Jan   08,   2014

AB                                360MG                        A091248   001    Jan   08,   2014

AB       TEVA PHARMS USA          180MG                        A202720   001    Oct   30,   2014

AB                                360MG                        A202720   002    Oct   30,   2014

    MYFORTIC
	
AB       NOVARTIS                 180MG                        N050791 001 Feb 27, 2004

AB    +                           360MG                        N050791 002 Feb 27, 2004
	
NABILONE
	
  CAPSULE;ORAL
	
    CESAMET
	
      + MEDA PHARMS               1MG                          N018677 001 Dec 26, 1985
	
NABUMETONE
	
  TABLET;ORAL

    NABUMETONE
	
AB       APOTEX INC               500MG                        A090427   001    Dec   30,   2011

AB                                750MG                        A090427   002    Dec   30,   2011

AB       INVAGEN PHARMS           500MG                        A078671   001    Mar   07,   2008

AB                                750MG                        A078671   002    Mar   07,   2008

AB       LUPIN LTD                500MG                        A090445   001    Jan   12,   2011

AB                                750MG                        A090445   002    Jan   12,   2011

AB       MYLAN PHARMS INC         500MG                        A090516   001    Jul   12,   2010

AB                                750MG                        A090516   002    Jul   12,   2010

AB       PAR PHARM                500MG                        A076009   001    Jan   24,   2003

AB                                750MG                        A076009   002    Jan   24,   2003

AB       SANDOZ                   500MG                        A075280   001    Feb   25,   2002

AB                                750MG                        A075280   002    Feb   25,   2002

AB       TEVA                     500MG                        A075189   001    May   26,   2000

AB    +                           750MG                        A075189   002    Sep   24,   2001

AB       WATSON LABS              500MG                        A091083   001    Jun   13,   2011

AB                                750MG                        A091083   002    Jun   13,   2011
	
NADOLOL
	
  TABLET;ORAL

    CORGARD
	
AB        KING PHARMS             20MG                         N018063 005 Oct 28, 1986

AB                                40MG                         N018063 001
	
AB    +                           80MG                         N018063 002
	
    NADOLOL
	
AB        IVAX SUB TEVA PHARMS    20MG                         A074229   001    Aug   30,   1996

AB                                40MG                         A074229   002    Aug   30,   1996

AB                                80MG                         A074255   001    Jan   24,   1996

AB        MYLAN                   20MG                         A074172   001    Oct   31,   1993

AB                                40MG                         A074172   002    Oct   31,   1993

AB                                80MG                         A074172   003    Oct   31,   1993

AB        SANDOZ                  20MG                         A074501   001    Nov   09,   1995

AB                                40MG                         A074501   002    Nov   09,   1995

AB                                80MG                         A074501   003    Nov   09,   1995
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-258(of 371)


NAFARELIN ACETATE
	
  SPRAY, METERED;NASAL
	
    SYNAREL
	
      + GD SEARLE LLC            EQ 0.2MG BASE/SPRAY            N019886 001 Feb 13, 1990
	
NAFCILLIN SODIUM
	
  INJECTABLE;INJECTION

    NAFCILLIN SODIUM
	
AP       AGILA SPECLTS          EQ    1GM BASE/VIAL             A200002   001    Apr   07,   2014

AP                              EQ    2GM BASE/VIAL             A200002   002    Apr   07,   2014

AP       ANTIBIOTICE            EQ    1GM BASE/VIAL             A090560   001    Oct   03,   2011

AP                              EQ    2GM BASE/VIAL             A090560   002    Oct   03,   2011

AP       AUROBINDO PHARMA LTD   EQ    1GM BASE/VIAL             A091613   001    Dec   26,   2012

AP                              EQ    2GM BASE/VIAL             A091613   002    Dec   26,   2012

AP                              EQ    10GM BASE/VIAL            A091614   001    Dec   26,   2012

AP       ISTITUTO BIO ITA SPA   EQ    1GM BASE/VIAL             A090002   001    Jun   30,   2011

AP                              EQ    2GM BASE/VIAL             A090002   002    Jun   30,   2011

AP                              EQ    10GM BASE/VIAL            A090005   001    Apr   20,   2011

AP       SAGENT PHARMS          EQ    1GM BASE/VIAL             A090582   001    Aug   24,   2012

AP                              EQ    2GM BASE/VIAL             A090582   002    Aug   24,   2012

AP                              EQ    10GM BASE/VIAL            A090580   001    Aug   24,   2012

AP    + SANDOZ                  EQ    1GM BASE/VIAL             A062527   002    Aug   02,   1984

AP    +                         EQ    1GM BASE/VIAL             A062732   001    Dec   23,   1986

AP    +                         EQ    2GM BASE/VIAL             A062527   003    Aug   02,   1984

AP    +                         EQ    2GM BASE/VIAL             A062732   002    Dec   23,   1986

AP    +                         EQ    10GM BASE/VIAL            A062527   004    Aug   02,   1984

    NALLPEN IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         EQ    2GM BASE/100ML            N050655 002 Oct 31, 1989
	
      +                         EQ    20MG BASE/ML              N050655 001 Oct 31, 1989
	
NAFTIFINE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    NAFTIN
	
      + MERZ PHARMS              1%                             N019599 001 Feb 29, 1988
	
      +                          2%                             N019599 002 Jan 13, 2012
	
  GEL;TOPICAL
	
    NAFTIN
	
      + MERZ PHARMS              1%                             N019356 001 Jun 18, 1990
	
      +                          2%                             N204286 001 Jun 27, 2013
	
NALBUPHINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    NALBUPHINE HYDROCHLORIDE
	
AP    + HOSPIRA                  10MG/ML                        A070914   001    Feb   03,   1989

AP    +                          10MG/ML                        A070915   001    Feb   03,   1989

AP    +                          20MG/ML                        A070916   001    Feb   03,   1989

AP    +                          20MG/ML                        A070918   001    Feb   03,   1989
	
NALOXEGOL OXALATE
	
  TABLET;ORAL
	
    MOVANTIK
	
         ASTRAZENECA PHARMS      EQ 12.5MG BASE                 N204760 001 Sep 16, 2014

      +                          EQ 25MG BASE                   N204760 002 Sep 16, 2014
	
NALOXONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    NALOXONE HYDROCHLORIDE
	
AP    + HOSPIRA                 0.4MG/ML                        A070172   001    Sep   24,   1986

AP    +                         0.4MG/ML                        A070254   001    Jan   07,   1987

AP    +                         0.4MG/ML                        A070256   001    Jan   07,   1987

AP    +                         0.4MG/ML                        A070257   001    Jan   07,   1987

AP       INTL MEDICATION        0.4MG/ML                        A070639   001    Sep   24,   1986

AP    +                         1MG/ML                          A072076   001    Mar   24,   1988

AP       MYLAN INSTITUTIONAL    0.4MG/ML                        A204997   001    Mar   06,   2014
	
  SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
	
    EVZIO
	
      + KALEO INC               0.4MG/0.4ML                     N205787 001 Apr 03, 2014
	
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
	
  TABLET;ORAL

    NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
	
AB       GAVIS PHARMS           EQ 0.5MG BASE;EQ 50MG BASE      A075735 001 Jul 11, 2001

AB       RANBAXY                EQ 0.5MG BASE;EQ 50MG BASE      A075523 001 Mar 17, 2000

AB    + WATSON LABS             EQ 0.5MG BASE;EQ 50MG BASE      A074736 001 Jan 21, 1997
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-259(of 371)


NALTREXONE
	
  FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
	
    VIVITROL
	
      + ALKERMES                380MG/VIAL                      N021897 001 Apr 13, 2006
	
NALTREXONE HYDROCHLORIDE
	
  TABLET;ORAL

    NALTREXONE HYDROCHLORIDE
	
AB       ACCORD HLTHCARE          50MG                          A091205   001    Aug   17,   2011

AB       BARR                     50MG                          A074918   001    May   08,   1998

AB       ELITE LABS               50MG                          A075274   001    May   26,   1999

AB       MALLINCKRODT             50MG                          A076264   002    Mar   22,   2002

AB       SUN PHARMA GLOBAL        50MG                          A090356   001    Feb   24,   2012

    REVIA
	
AB    + TEVA WOMENS               50MG                          N018932 001 Nov 20, 1984
	
    NALTREXONE HYDROCHLORIDE
	
         MALLINCKRODT             25MG                          A076264 001 Mar 22, 2002
	
                                  100MG                         A076264 003 Mar 22, 2002
	
NANDROLONE DECANOATE
	
  INJECTABLE;INJECTION
	
    NANDROLONE DECANOATE
	
      + PHARMAFORCE               200MG/ML                      A091252 001 Aug 30, 2010
	
NAPHAZOLINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    NAPHAZOLINE HYDROCHLORIDE
	
      + AKORN INC                 0.1%                          A083590 001
	
NAPROXEN
	
  SUSPENSION;ORAL

    NAPROSYN
	
AB    + ROCHE PALO                25MG/ML                       N018965 001 Mar 23, 1987

    NAPROXEN
	
AB        ROXANE                  25MG/ML                       A074190 001 Mar 30, 1994
	
  TABLET;ORAL

    NAPROSYN
	
AB        ROCHE PALO              250MG                         N017581 002
	
AB                                375MG                         N017581 003
	
AB    +                           500MG                         N017581 004 Apr 15, 1982

    NAPROXEN
	
AB        AMNEAL PHARMS NY        250MG                         A075927   001    Dec   18,   2001

AB                                375MG                         A075927   002    Dec   18,   2001

AB                                500MG                         A075927   003    Dec   18,   2001

AB        AUROBINDO PHARMA USA    250MG                         A200429   001    Nov   08,   2011

AB                                375MG                         A200429   002    Nov   08,   2011

AB                                500MG                         A200429   003    Nov   08,   2011

AB        GLENMARK GENERICS       250MG                         A078250   001    Mar   28,   2007

AB                                375MG                         A078250   002    Mar   28,   2007

AB                                500MG                         A078250   003    Mar   28,   2007

AB        HIKMA INTL PHARMS       250MG                         A076494   001    Jan   14,   2004

AB                                375MG                         A076494   002    Jan   14,   2004

AB                                500MG                         A076494   003    Jan   14,   2004

AB        INVAGEN PHARMS          250MG                         A091305   001    Aug   24,   2011

AB                                375MG                         A091305   002    Aug   24,   2011

AB                                500MG                         A091305   003    Aug   24,   2011

AB        MARKSANS PHARMA         250MG                         A091416   001    Feb   14,   2011

AB                                375MG                         A091416   002    Feb   14,   2011

AB                                500MG                         A091416   003    Feb   14,   2011

AB        MYLAN                   250MG                         A074121   001    Dec   21,   1993

AB                                375MG                         A074121   002    Dec   21,   1993

AB                                500MG                         A074121   003    Dec   21,   1993

AB        PERRIGO R AND D         250MG                         A077339   001    Apr   27,   2005

AB                                375MG                         A077339   002    Apr   27,   2005

AB                                500MG                         A077339   003    Apr   27,   2005

AB        SANDOZ                  250MG                         A074140   001    Dec   21,   1993

AB                                375MG                         A074140   002    Dec   21,   1993

AB                                500MG                         A074140   003    Dec   21,   1993

AB        TEVA                    250MG                         A074201   001    Dec   21,   1993

AB                                375MG                         A074201   002    Dec   21,   1993

AB                                500MG                         A074201   003    Dec   21,   1993

AB        ZYDUS PHARMS USA        250MG                         A078620   001    Jun   07,   2007

AB                                375MG                         A078620   002    Jun   07,   2007

AB                                500MG                         A078620   003    Jun   07,   2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-260(of 371)


NAPROXEN
	
  TABLET, DELAYED RELEASE;ORAL

    EC-NAPROSYN
	
AB    + ROCHE PALO                375MG                        N020067 002 Oct 14, 1994

AB    +                           500MG                        N020067 003 Oct 14, 1994

    NAPROXEN
	
AB        INVAGEN PHARMS          375MG                        A091432   001    Sep   19,   2011

AB                                500MG                        A091432   002    Sep   19,   2011

AB        MYLAN PHARMS INC        375MG                        A075390   001    Apr   19,   2001

AB                                500MG                        A075390   002    Apr   19,   2001

AB        PLIVA                   375MG                        A075337   001    May   26,   1999

AB                                500MG                        A075337   002    May   26,   1999

AB        SANDOZ                  375MG                        A075061   001    Feb   18,   1998

AB                                500MG                        A075061   002    Feb   18,   1998

AB        TEVA                    375MG                        A075227   001    Jun   30,   1998

AB                                500MG                        A075227   002    Jun   30,   1998
	
NAPROXEN SODIUM
	
  TABLET;ORAL

    ANAPROX
	
AB       HOFFMANN LA ROCHE       EQ    250MG BASE              N018164 001
	
    ANAPROX DS
	
AB    + HOFFMANN LA ROCHE        EQ    500MG BASE              N018164 003 Sep 30, 1987

    NAPROXEN SODIUM
	
AB       AMNEAL PHARMS NY        EQ    250MG   BASE            A078432   001    Apr   25,   2007

AB                               EQ    500MG   BASE            A078432   002    Apr   25,   2007

AB       AUROBINDO PHARMA LTD    EQ    250MG   BASE            A200629   001    Oct   31,   2011

AB                               EQ    500MG   BASE            A200629   002    Oct   31,   2011

AB       DR REDDYS LABS LTD      EQ    250MG   BASE            A078486   001    Jul   26,   2007

AB                               EQ    500MG   BASE            A078486   002    Jul   26,   2007

AB       GLENMARK GENERICS       EQ    250MG   BASE            A078314   001    Apr   27,   2007

AB                               EQ    500MG   BASE            A078314   002    Apr   27,   2007

AB       HIKMA                   EQ    250MG   BASE            A074480   002    Feb   18,   1998

AB                               EQ    500MG   BASE            A074480   001    May   14,   1996

AB       TEVA                    EQ    250MG   BASE            A074198   001    Dec   21,   1993

AB                               EQ    500MG   BASE            A074198   002    Dec   21,   1993
	
  TABLET, EXTENDED RELEASE;ORAL

    NAPRELAN
	
AB       ALMATICA PHARMA INC     EQ    375MG BASE              N020353 001 Jan 05, 1996

AB                               EQ    500MG BASE              N020353 002 Jan 05, 1996

    NAPROXEN SODIUM
	
AB       ACTAVIS LABS FL INC     EQ    375MG BASE              A075416 002 Apr 23, 2003

AB                               EQ    500MG BASE              A075416 001 Aug 27, 2002

    NAPRELAN
	
      + ALMATICA PHARMA INC      EQ    750MG BASE              N020353 003 Jan 05, 1996
	
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
	
  TABLET;ORAL
	
    TREXIMET
	
      + PERNIX IRELAND LTD      500MG;EQ 85MG BASE             N021926 001 Apr 15, 2008
	
NARATRIPTAN HYDROCHLORIDE
	
  TABLET;ORAL

    AMERGE
	
AB       GLAXOSMITHKLINE LLC      EQ 1MG BASE                  N020763 002 Feb 10, 1998

AB    +                           EQ 2.5MG BASE                N020763 001 Feb 10, 1998

    NARATRIPTAN
	
AB       APOTEX CORP              EQ   1MG BASE                A091373   001    Apr   22,   2011

AB                                EQ   2.5MG BASE              A091373   002    Apr   22,   2011

AB       HERITAGE PHARMS INC      EQ   1MG BASE                A200502   001    Feb   28,   2011

AB                                EQ   2.5MG BASE              A200502   002    Feb   28,   2011

AB       MYLAN PHARMS INC         EQ   1MG BASE                A202431   001    May   31,   2012

AB                                EQ   2.5MG BASE              A202431   002    May   31,   2012

AB       ORCHID HLTHCARE          EQ   1MG BASE                A091441   001    Apr   30,   2012

AB                                EQ   2.5MG BASE              A091441   002    Apr   30,   2012

AB       PADDOCK LLC              EQ   1MG BASE                A091326   001    Jul   08,   2010

AB                                EQ   2.5MG BASE              A091326   002    Jul   08,   2010

AB       ROXANE                   EQ   1MG BASE                A090381   001    Jul   07,   2010

AB                                EQ   2.5MG BASE              A090381   002    Jul   07,   2010

AB       SANDOZ                   EQ   1MG BASE                A090288   001    Jul   07,   2010

AB                                EQ   2.5MG BASE              A090288   002    Jul   07,   2010

AB       SUN PHARM INDS LTD       EQ   2.5MG BASE              A091552   001    Feb   14,   2011

AB       TEVA PHARMS              EQ   1MG BASE                A078751   001    Jul   07,   2010

AB                                EQ   2.5MG BASE              A078751   002    Jul   07,   2010
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-261(of 371)


NATAMYCIN
	
  SUSPENSION;OPHTHALMIC
	
    NATACYN
	
      + ALCON
	                   5%
	                           N050514 001
	
NATEGLINIDE
	
  TABLET;ORAL

     NATEGLINIDE
	
AB         DR REDDYS LABS LTD
	   60MG
	                         A077461   001    Sep   09,   2009

AB
	                              120MG
	                        A077461   002    Sep   09,   2009

AB         PAR PHARM
	            60MG
	                         A077463   001    Sep   09,   2009

AB
	                              120MG
	                        A077463   002    Sep   09,   2009

AB         WATSON LABS
	          60MG
	                         A077462   001    Mar   30,   2011

AB
	                              120MG
	                        A077462   002    Mar   30,   2011
	
     STARLIX
	
AB         NOVARTIS
	             60MG
	                         N021204 001 Dec 22, 2000

AB     +
	                        120MG
	                        N021204 002 Dec 22, 2000
	
NEBIVOLOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    BYSTOLIC
	
         FOREST LABS
	            EQ     2.5MG BASE
	            N021742   002    Dec   17,   2007
	
                                  EQ     5MG BASE
	              N021742   003    Dec   17,   2007
	
                                  EQ     10MG BASE
	             N021742   004    Dec   17,   2007
	
      +
	                         EQ     20MG BASE
	             N021742   005    Oct   08,   2008
	
NEDOCROMIL SODIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    ALOCRIL
	
AT    + ALLERGAN
	                2%
	                           N021009 001 Dec 08, 1999
	
    NEDOCROMIL SODIUM
	
AT       AKORN
	                  2%
	                           A090638 001 Aug 22, 2012
	
NEFAZODONE HYDROCHLORIDE
	
  TABLET;ORAL

    NEFAZODONE HYDROCHLORIDE
	
AB       RANBAXY                  50MG
	                         A076409   001    Sep   16,   2003

AB                                100MG
	                        A076409   002    Sep   16,   2003

AB                                150MG
	                        A076409   003    Sep   16,   2003

AB                                200MG
	                        A076409   004    Sep   16,   2003

AB                                250MG
	                        A076409   005    Sep   16,   2003

AB       TEVA                     50MG
	                         A076037   001    Sep   16,   2003

AB                                100MG
	                        A076037   002    Sep   16,   2003

AB                                150MG
	                        A076037   003    Sep   16,   2003

AB                                200MG
	                        A076037   004    Sep   16,   2003

AB    +                           250MG
	                        A076037   005    Sep   16,   2003

BX       DR REDDYS LABS INC       50MG
	                         A076309   001    Sep   16,   2003

BX                                100MG
	                        A076309   002    Sep   16,   2003

BX                                150MG
	                        A076309   003    Sep   16,   2003

BX                                200MG
	                        A076309   004    Sep   16,   2003

BX                                250MG
	                        A076309   005    Sep   16,   2003
	
NELARABINE
	
  INJECTABLE;IV (INFUSION)

    ARRANON
	
      + SMITHKLINE BEECHAM
	      250MG/50ML (5MG/ML)
	          N021877 001 Oct 28, 2005
	
NELFINAVIR MESYLATE
	
  TABLET;ORAL
	
    VIRACEPT
	
      + AGOURON
	                 EQ 250MG BASE
	                N020779 001 Mar 14, 1997
	
      +
	                         EQ 625MG BASE
	                N021503 001 Apr 30, 2003
	
NEOMYCIN SULFATE
	
  SOLUTION;ORAL
	
    NEO-FRADIN
	
      + X GEN PHARMS
	            EQ 87.5MG BASE/5ML
	           A065010 001 May 23, 2002
	
  TABLET;ORAL

    NEOMYCIN SULFATE
	
AA       OMAN PHARM PRODUCTS
	    500MG
	                        A065468 001 Mar 29, 2010

AA    + TEVA
	                    500MG
	                        A060304 001
	
AA       X GEN PHARMS
	           500MG
	                        A065220 001 Jul 28, 2006
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                           3-262(of 371)


NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  SOLUTION;IRRIGATION

    NEOMYCIN AND POLYMYXIN B SULFATE
	
AT       WATSON LABS            EQ 40MG     BASE/ML;200,000 UNITS/ML   A062664 001 Apr 08, 1986

AT       X GEN PHARMS           EQ 40MG     BASE/ML;200,000 UNITS/ML   A065106 001 Jan 31, 2006

AT                              EQ 40MG     BASE/ML;200,000 UNITS/ML   A065108 001 Jan 31, 2006

    NEOSPORIN G.U. IRRIGANT
	
AT    + MONARCH PHARMS          EQ 40MG   BASE/ML;200,000 UNITS/ML     A060707 001
	
NEOSTIGMINE METHYLSULFATE
	
  SOLUTION;INTRAVENOUS
	
    BLOXIVERZ
	
      + ECLAT PHARMS LLC         5MG/10ML (0.5MG/ML)                   N204078 001 May 31, 2013

      +                          10MG/10ML (1MG/ML)                    N204078 002 May 31, 2013
	
NEPAFENAC
	
  SUSPENSION/DROPS;OPHTHALMIC

    ILEVRO
	
      + ALCON RES LTD            0.3%                                  N203491 001 Oct 16, 2012
	
    NEVANAC
	
      + ALCON PHARMS LTD         0.1%                                  N021862 001 Aug 19, 2005
	
NESIRITIDE RECOMBINANT
	
  FOR SOLUTION;INTRAVENOUS
	
    NATRECOR
	
      + SCIOS LLC                1.5MG/VIAL                            N020920 001 Aug 10, 2001
	
NETUPITANT; PALONOSETRON HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    AKYNZEO
	
      + HELSINN HLTHCARE        300MG;EQ 0.5MG BASE                    N205718 001 Oct 10, 2014
	
NEVIRAPINE
	
  SUSPENSION;ORAL

    NEVIRAPINE
	
AA       AUROBINDO               50MG/5ML                              A077702 001 May 22, 2012

    VIRAMUNE
	
AA    + BOEHRINGER INGELHEIM     50MG/5ML                              N020933 001 Sep 11, 1998

  TABLET;ORAL

    NEVIRAPINE
	
AB       APOTEX INC              200MG                                 A203021   001    May   22,   2012

AB       AUROBINDO               200MG                                 A077521   001    May   22,   2012

AB       CIPLA                   200MG                                 A077956   001    May   22,   2012

AB       HETERO LABS LTD III     200MG                                 A078584   001    May   22,   2012

AB       MICRO LABS LTD          200MG                                 A203080   001    May   22,   2012

AB       MYLAN LABS              200MG                                 A078864   001    May   22,   2012

AB       MYLAN PHARMS INC        200MG                                 A202523   001    May   22,   2012

AB       PRINSTON INC            200MG                                 A078644   001    May   22,   2012

AB       SCIEGEN PHARMS INC      200MG                                 A203176   001    May   22,   2012

AB       STRIDES PHARMA          200MG                                 A078195   001    May   22,   2012

    VIRAMUNE
	
AB    + BOEHRINGER INGELHEIM     200MG                                 N020636 001 Jun 21, 1996
	
  TABLET, EXTENDED RELEASE;ORAL

    NEVIRAPINE
	
AB       APOTEX INC              400MG                                 A205258 001 Apr 03, 2014

AB       MYLAN PHARMS INC        400MG                                 A205651 001 Oct 27, 2014

AB       SANDOZ                  400MG                                 A203411 001 Apr 03, 2014

    VIRAMUNE XR
	
AB    + BOEHRINGER INGELHEIM     400MG                                 N201152 001 Mar 25, 2011
	
                                 100MG                                 N201152 002 Nov 08, 2012
	
NIACIN
	
  TABLET;ORAL

    NIACIN
	
AA       WOCKHARDT               500MG                                 A081134 001 Apr 28, 1992

    NIACOR
	
AA    + UPSHER SMITH             500MG                                 A040378 001 May 03, 2000

  TABLET, EXTENDED RELEASE;ORAL

    NIACIN
	
AB       BARR                    1GM                                   A076250   001    Apr   14,   2005

AB                               500MG                                 A076378   001    Apr   26,   2005

AB                               750MG                                 A076378   002    Apr   26,   2005

AB       LUPIN LTD               1GM                                   A090446   001    Mar   20,   2014

AB                               500MG                                 A090860   001    Mar   20,   2014

AB                               750MG                                 A090892   001    Mar   20,   2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-263(of 371)


NIACIN
	
  TABLET, EXTENDED RELEASE;ORAL

    NIACIN
	
AB       SUN PHARMA GLOBAL       1GM                           A200484 002 Apr 23, 2014

AB                               500MG                         A200484 001 Apr 23, 2014

AB                               750MG                         A201273 001 Apr 23, 2014

    NIASPAN
	
AB    + ABBVIE                   1GM                           N020381 004 Jul 28, 1997

AB                               500MG                         N020381 002 Jul 28, 1997

AB    +                          750MG                         N020381 003 Jul 28, 1997
	
NIACIN; SIMVASTATIN
	
  TABLET, EXTENDED RELEASE;ORAL
	
    SIMCOR
	
      + ABBVIE                   1GM;20MG                      N022078   003    Feb   15,   2008
	
      +                          1GM;40MG                      N022078   005    Jul   28,   2010
	
      +                          500MG;20MG                    N022078   001    Feb   15,   2008
	
      +                          500MG;40MG                    N022078   004    Jul   28,   2010
	
      +                          750MG;20MG                    N022078   002    Feb   15,   2008
	
NICARDIPINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    CARDENE
	
AB       CHIESI USA INC         20MG                           N019488 001 Dec 21, 1988

AB    +                         30MG                           N019488 002 Dec 21, 1988

    NICARDIPINE HYDROCHLORIDE
	
AB       ANI PHARMS INC         20MG                           A074439   001    Dec   10,   1996

AB                              20MG                           A074540   001    Oct   28,   1996

AB                              30MG                           A074439   002    Dec   10,   1996

AB                              30MG                           A074540   002    Oct   28,   1996

AB       EPIC PHARMA            20MG                           A074928   001    Mar   19,   1998

AB                              30MG                           A074928   002    Mar   19,   1998

AB       MYLAN                  20MG                           A074642   001    Jul   18,   1996

AB                              30MG                           A074642   002    Jul   18,   1996
	
  INJECTABLE;INJECTION

    CARDENE
	
AP    + CHIESI USA INC          25MG/10ML (2.5MG/ML)           N019734 001 Jan 30, 1992

    NICARDIPINE HYDROCHLORIDE
	
AP       BEDFORD                25MG/10ML (2.5MG/ML)           A078714   001    Dec   28,   2009

AP       EXELA PHARMA SCIENCE   25MG/10ML (2.5MG/ML)           N022276   001    Jul   24,   2008

AP       LUITPOLD               25MG/10ML (2.5MG/ML)           A090534   001    Nov   17,   2009

AP       MYLAN INSTITUTIONAL    25MG/10ML (2.5MG/ML)           A090664   001    Nov   17,   2009

AP       NAVINTA LLC            25MG/10ML (2.5MG/ML)           A090125   001    Nov   17,   2009

AP       SUN PHARMA GLOBAL      25MG/10ML (2.5MG/ML)           N078405   001    Nov   17,   2009

AP       WOCKHARDT              25MG/10ML (2.5MG/ML)           A090671   001    Nov   17,   2009
	
  INJECTABLE;INTRAVENOUS
	
    CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
	
      + CHIESI USA INC          40MG/200ML (0.2MG/ML)          N019734 004 Nov 07, 2008
	
    CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
	
      + CHIESI USA INC          20MG/200ML (0.1MG/ML)          N019734 003 Jul 31, 2008
	
    CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
	
      + CHIESI USA INC          20MG/200ML (0.1MG/ML)          N019734 002 Jul 31, 2008
	
    CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
	
      + CHIESI USA INC          40MG/200ML (0.2MG/ML)          N019734 005 Nov 07, 2008
	
NICOTINE
	
  INHALANT;ORAL
	
    NICOTROL
	
      + PHARMACIA AND UPJOHN    4MG/CARTRIDGE                  N020714 001 May 02, 1997

  SPRAY, METERED;NASAL
	
    NICOTROL
	
      + PFIZER INC              0.5MG/SPRAY                    N020385 001 Mar 22, 1996
	
NIFEDIPINE
	
  CAPSULE;ORAL

    NIFEDIPINE
	
AB       ACTAVIS ELIZABETH      10MG                           A072579   001    Jan   08,   1991

AB                              20MG                           A072556   001    Sep   20,   1990

AB       EMCURE PHARMS USA      10MG                           A202644   001    Apr   25,   2013

AB                              20MG                           A202644   002    Apr   25,   2013

AB       INTERGEL PHARM         10MG                           A072781   001    Jul   30,   1993

    PROCARDIA
	
AB    + PFIZER                  10MG                           N018482 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-264(of 371)


NIFEDIPINE
	
  TABLET, EXTENDED RELEASE;ORAL

    ADALAT CC
	
AB1      BAYER HLTHCARE          30MG                           N020198 001 Apr 21, 1993

AB1 +                            60MG                           N020198 002 Apr 21, 1993

AB1 +                            90MG                           N020198 003 Apr 21, 1993

    AFEDITAB CR
	
AB1      WATSON LABS             30MG                           A075128 001 Mar 10, 2000

AB1                              60MG                           A075659 001 Oct 26, 2001

    NIFEDIPINE
	
AB1      MYLAN                   30MG                           A201071   001    Dec   03,   2010

AB1                              60MG                           A201071   002    Dec   03,   2010

AB1                              90MG                           A201071   003    Dec   03,   2010

AB1      PAR PHARM               30MG                           A077899   001    Dec   13,   2006

AB1                              60MG                           A077899   002    Dec   13,   2006

AB1                              90MG                           A077899   003    May   25,   2012

AB1      VALEANT INTL            30MG                           A075269   001    Dec   04,   2000

AB1                              60MG                           A075269   002    Dec   04,   2000

AB1                              90MG                           A076070   001    Aug   16,   2002

AB2      MATRIX LABS LTD         30MG                           A090602   001    Sep   13,   2010

AB2                              60MG                           A090602   002    Sep   13,   2010

AB2                              90MG                           A090602   003    Sep   13,   2010

AB2      MYLAN                   30MG                           A090649   001    Jun   21,   2010

AB2                              60MG                           A090649   002    Jun   21,   2010

AB2                              90MG                           A090649   003    Jun   21,   2010

AB2      OSMOTICA PHARM          30MG                           A077127   001    Nov   21,   2005

AB2                              60MG                           A077127   002    Nov   21,   2005

AB2                              90MG                           A077410   001    Oct   03,   2007

AB2      TWI PHARMS INC          30MG                           A203126   001    Apr   03,   2014

AB2                              60MG                           A203126   002    Apr   03,   2014

AB2                              90MG                           A203126   003    Apr   03,   2014

AB2      VALEANT INTL            30MG                           A075289   002    Feb   06,   2001

AB2                              60MG                           A075289   001    Sep   27,   2000

    PROCARDIA XL
	
AB2      PFIZER                  30MG                           N019684 001 Sep 06, 1989

AB2                              60MG                           N019684 002 Sep 06, 1989

AB2 +                            90MG                           N019684 003 Sep 06, 1989
	
NILOTINIB HYDROCHLORIDE MONOHYDRATE
	
  CAPSULE;ORAL
	
    TASIGNA
	
         NOVARTIS               EQ 150MG BASE                   N022068 002 Jun 17, 2010
	
      +                         EQ 200MG BASE                   N022068 001 Oct 29, 2007
	
NILUTAMIDE
	
  TABLET;ORAL
	
    NILANDRON
	
      + COVIS PHARMA SARL         150MG                         N020169 002 Apr 30, 1999
	
NIMODIPINE
	
  CAPSULE;ORAL

    NIMODIPINE
	
AB    + BANNER PHARMACAPS         30MG                          A076740   001    Jan   17,   2008

AB       BARR LABS INC            30MG                          A077811   001    May   02,   2007

AB       SUN PHARM INDS INC       30MG                          A077067   001    Apr   17,   2007

AB       THEPHARMANETWORK LLC     30MG                          A090103   001    Apr   07,   2014

  SOLUTION;ORAL
	
    NYMALIZE
	
      + ARBOR PHARMS LLC          60MG/20ML                     N203340 001 May 10, 2013
	
NINTEDANIB
	
  CAPSULE;ORAL
	
    OFEV
	
           BOEHRINGER INGELHEIM   100MG                         N205832 001 Oct 15, 2014
	
      +                           150MG                         N205832 002 Oct 15, 2014
	
NISOLDIPINE
	
  TABLET, EXTENDED RELEASE;ORAL

    NISOLDIPINE
	
AB       MYLAN                   8.5MG                          A091001 001 Jan 26, 2011

AB                               17MG                           A091001 002 Jan 26, 2011

AB                               34MG                           A091001 004 Jan 26, 2011

    SULAR
	
AB    + SHIONOGI INC             8.5MG                          N020356 008 Jan 02, 2008

AB    +                          17MG                           N020356 007 Jan 02, 2008
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                        3-265(of 371)


NISOLDIPINE
	
  TABLET, EXTENDED RELEASE;ORAL

    SULAR
	
AB    +                          34MG                            N020356 005 Jan 02, 2008
	
    NISOLDIPINE
	
         MYLAN                   20MG                            A079051   001    Jul   25,   2008
	
                                 25.5MG                          A091001   003    Jan   26,   2011
	
      +                          30MG                            A079051   002    Jul   25,   2008
	
      +                          40MG                            A079051   003    Jul   25,   2008
	
NITAZOXANIDE
	
  FOR SUSPENSION;ORAL
	
    ALINIA
	
      + ROMARK                  100MG/5ML                        N021498 001 Nov 22, 2002
	
  TABLET;ORAL
	
    ALINIA
	
      + ROMARK                  500MG                            N021497 001 Jul 21, 2004
	
NITISINONE
	
  CAPSULE;ORAL
	
    ORFADIN
	
         SWEDISH ORPHAN         2MG                              N021232 001 Jan 18, 2002
	
                                5MG                              N021232 002 Jan 18, 2002
	
     +                          10MG                             N021232 003 Jan 18, 2002
	
NITRIC OXIDE
	
  GAS;INHALATION
	
    INOMAX
	
         INO                    100PPM                           N020845 002 Dec 23, 1999
	
      +                         800PPM                           N020845 003 Dec 23, 1999
	
NITROFURANTOIN
	
  SUSPENSION;ORAL

    FURADANTIN
	
AB    + SHIONOGI INC            25MG/5ML                         N009175 001
	
    NITROFURANTOIN
	
AB       AMNEAL PHARMS          25MG/5ML                         A201679 001 May 11, 2011

AB       NOVEL LABS INC         25MG/5ML                         A201693 001 Sep 08, 2014

AB       SUN PHARM INDS INC     25MG/5ML                         A201355 001 Aug 14, 2013
	
NITROFURANTOIN, MACROCRYSTALLINE
	
  CAPSULE;ORAL

    MACRODANTIN
	
AB       ALVOGEN INC            50MG                             N016620 001
	
AB    +                         100MG                            N016620 002
	
    NITROFURANTOIN
	
AB       IVAX SUB TEVA PHARMS   50MG                             A073671   001    Jan   28,   1993

AB                              100MG                            A073652   001    Jan   28,   1993

AB       MYLAN                  50MG                             A074967   001    Jul   09,   1997

AB                              100MG                            A077025   001    Aug   18,   2004

    MACRODANTIN
	
         ALVOGEN INC            25MG                             N016620 003
	
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
	
  CAPSULE;ORAL

    MACROBID
	
AB    + ALVOGEN INC             75MG;25MG                        N020064 001 Dec 24, 1991

    NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

AB       MYLAN                  75MG;25MG                        A076648 001 Mar 22, 2004

AB       SANDOZ                 75MG;25MG                        A077066 001 Apr 05, 2005
	
NITROGLYCERIN
	
  AEROSOL, METERED;SUBLINGUAL
	
    NITROMIST
	
      + MIST PHARMS LLC         0.4MG/SPRAY                      N021780 001 Nov 02, 2006
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    MINITRAN
	
AB1      MEDICIS                0.2MG/HR                         A089772   001    Aug   30,   1996

AB1                             0.4MG/HR                         A089773   001    Aug   30,   1996

AB1      VALEANT PHARM NORTH    0.1MG/HR                         A089771   001    Aug   30,   1996

AB1                             0.6MG/HR                         A089774   001    Aug   30,   1996

    NITRO-DUR
	
AB1 + MERCK SHARP DOHME         0.1MG/HR                         N020145   001    Apr   04,   1995

AB1 +                           0.2MG/HR                         N020145   002    Apr   04,   1995

AB1 +                           0.4MG/HR                         N020145   004    Apr   04,   1995

AB1 +                           0.6MG/HR                         N020145   005    Apr   04,   1995
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-266(of 371)


NITROGLYCERIN
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    NITROGLYCERIN
	
AB2      HERCON PHARM           0.2MG/HR                        A089884   001    Oct   30,   1998

AB2                             0.4MG/HR                        A089885   001    Oct   30,   1998

AB2                             0.6MG/HR                        A089886   001    Oct   30,   1998

AB2 + MYLAN TECHNOLOGIES        0.2MG/HR                        A074559   003    Aug   30,   1996

AB2 +                           0.4MG/HR                        A074559   002    Aug   30,   1996

AB2 +                           0.6MG/HR                        A074559   001    Aug   30,   1996

    NITRO-DUR
	
      + MERCK SHARP DOHME       0.3MG/HR                        N020145 003 Apr 04, 1995

      +                         0.8MG/HR                        N020145 006 Apr 04, 1995

    NITROGLYCERIN
	
      + MYLAN TECHNOLOGIES      0.1MG/HR                        A074559 004 Feb 06, 1998
	
  INJECTABLE;INJECTION

    NITROGLYCERIN IN DEXTROSE 5%
	
AP    + BAXTER HLTHCARE         10MG/100ML                      N019970   001    Dec   29,   1989

AP    +                         20MG/100ML                      N019970   002    Dec   29,   1989

AP    +                         40MG/100ML                      N019970   003    Dec   29,   1989

AP       HOSPIRA                10MG/100ML                      A071846   001    Aug   31,   1990

AP                              20MG/100ML                      A071847   001    Aug   31,   1990

AP                              40MG/100ML                      A071848   001    Aug   31,   1990

    NITROGLYCERIN
	
      + LUITPOLD                5MG/ML                          A072034 001 May 24, 1988

  OINTMENT;INTRA-ANAL
	
    RECTIV
	
      + FOREST LABS INC         0.4%                            N021359 001 Jun 21, 2011
	
  OINTMENT;TRANSDERMAL
	
    NITROGLYCERIN
	
      + FOUGERA                 2%                              A087355 001 Jul 08, 1988
	
  SPRAY, METERED;SUBLINGUAL

    NITROGLYCERIN
	
AB       PERRIGO ISRAEL         0.4MG/SPRAY                     A091496 001 Sep 20, 2013

    NITROLINGUAL PUMPSPRAY
	
AB    + POHL BOSKAMP            0.4MG/SPRAY                     N018705 002 Jan 10, 1997
	
  TABLET;SUBLINGUAL
	
    NITROSTAT
	
         PFIZER PHARMS          0.3MG                           N021134 001 May 01, 2000

                                0.4MG                           N021134 002 May 01, 2000

      +                         0.6MG                           N021134 003 May 01, 2000
	
NIZATIDINE
	
  CAPSULE;ORAL

    NIZATIDINE
	
AB         ANI PHARMS INC         150MG                         A075668   001    Sep   12,   2002

AB                                300MG                         A075668   002    Sep   12,   2002

AB         DR REDDYS LABS LTD     150MG                         A077314   001    Sep   15,   2005

AB                                300MG                         A077314   002    Sep   15,   2005

AB         GLENMARK GENERICS      150MG                         A090618   001    Jul   15,   2011

AB                                300MG                         A090618   002    Jul   15,   2011

AB         MYLAN PHARMS INC       150MG                         A075806   001    Jul   05,   2002

AB    +                           300MG                         A075806   002    Jul   05,   2002

AB         SANDOZ                 150MG                         A076178   001    Jul   05,   2002

AB                                300MG                         A076178   002    Jul   05,   2002

AB         WATSON LABS            150MG                         A075616   001    Jul   09,   2002

AB                                300MG                         A075616   002    Jul   09,   2002
	
  SOLUTION;ORAL

    AXID
	
AA    + BRAINTREE                 15MG/ML                       N021494 001 May 25, 2004

    NIZATIDINE
	
AA         AMNEAL PHARMS          15MG/ML                       A090576 001 Nov 18, 2009
	
NOREPINEPHRINE BITARTRATE
	
  INJECTABLE;INJECTION

    LEVOPHED
	
AP    + HOSPIRA                   EQ 1MG BASE/ML                N007513 001
	
    NOREPINEPHRINE BITARTRATE
	
AP       BEDFORD                  EQ 1MG BASE/ML                A040462 001 Oct 31, 2003

AP       CLARIS LIFESCIENCES      EQ 1MG BASE/ML                A040859 001 Mar 27, 2012

AP       TEVA PHARMS USA          EQ 1MG BASE/ML                A040455 001 Mar 03, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-267(of 371)


NORETHINDRONE
	
  TABLET;ORAL-28

    CAMILA
	
AB1      BARR                    0.35MG                         A076177 001 Oct 21, 2002

    HEATHER
	
AB1      GLENMARK GENERICS       0.35MG                         A090454 001 Apr 23, 2010

    NOR-QD

AB1 + WATSON LABS (UTAH)         0.35MG                         N017060 001
	
    NORETHINDRONE
	
AB1      FAMY CARE LTD           0.35MG                         A201483   001     Jun   24,   2013

AB1      HAUPT PHARMA            0.35MG                         A202260   001     Aug   01,   2013

AB1      LUPIN LTD               0.35MG                         A091325   001     Sep   19,   2011

AB1      NOVAST LABS LTD         0.35MG                         A202014   001     Sep   13,   2013

    ERRIN
	
AB2      BARR                    0.35MG                         A076225 001 Oct 21, 2002

    JENCYCLA
	
AB2      LUPIN LTD               0.35MG                         A091323 001 Mar 28, 2013

    MICRONOR
	
AB2 + JANSSEN PHARMS             0.35MG                         N016954 001
	
    NORETHINDRONE
	
AB2      FAMY CARE LTD           0.35MG                         A200980 001 Jun 12, 2013

AB2      GLENMARK GENERICS       0.35MG                         A091209 001 Jul 21, 2010

AB2      NOVAST LABS             0.35MG                         A200961 001 Sep 13, 2013
	
NORETHINDRONE ACETATE
	
  TABLET;ORAL

    AYGESTIN
	
AB    + DURAMED RES              5MG                            N018405 001 Apr 21, 1982

    NORETHINDRONE ACETATE
	
AB       AMNEAL PHARMS           5MG                            A200275 001 Jul 30, 2012

AB       BARR                    5MG                            A075951 001 May 25, 2001

AB       GLENMARK GENERICS       5MG                            A091090 001 Jul 21, 2010
	
NORTRIPTYLINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    NORTRIPTYLINE HYDROCHLORIDE
	
AB       MYLAN                    EQ   10MG   BASE              A074234   001     Jul   26,   1993

AB                                EQ   25MG   BASE              A074234   002     Jul   26,   1993

AB                                EQ   50MG   BASE              A074234   003     Jul   26,   1993

AB                                EQ   75MG   BASE              A074234   004     Jul   26,   1993

AB       TARO                     EQ   10MG   BASE              A075520   004     May   08,   2000

AB                                EQ   25MG   BASE              A075520   003     May   08,   2000

AB                                EQ   50MG   BASE              A075520   001     May   08,   2000

AB                                EQ   75MG   BASE              A075520   002     May   08,   2000

AB       TEVA                     EQ   10MG   BASE              A074132   001     Mar   27,   1995

AB                                EQ   25MG   BASE              A074132   002     Mar   27,   1995

AB                                EQ   50MG   BASE              A074132   003     Mar   27,   1995

AB                                EQ   75MG   BASE              A074132   004     Mar   27,   1995

AB       WATSON LABS              EQ   10MG   BASE              A073553   001     Mar   30,   1992

AB                                EQ   25MG   BASE              A073554   001     Mar   30,   1992

AB                                EQ   50MG   BASE              A073555   001     Mar   30,   1992

AB                                EQ   75MG   BASE              A073556   001     Mar   30,   1992

    PAMELOR
	
AB       MALLINCKRODT LLC         EQ   10MG   BASE              N018013   001
	
AB                                EQ   25MG   BASE              N018013   002
	
AB                                EQ   50MG   BASE              N018013   004
	
AB    +                           EQ   75MG   BASE              N018013   003
	
  SOLUTION;ORAL

    NORTRIPTYLINE HYDROCHLORIDE
	
AA    + PHARM ASSOC               EQ   10MG BASE/5ML            A075606 001 Aug 28, 2000

AA       TARO                     EQ   10MG BASE/5ML            A077965 001 Jun 20, 2006
	
NYSTATIN
	
  CREAM;TOPICAL

    NYSTATIN
	
AT        ACTAVIS MID ATLANTIC   100,000      UNITS/GM          A062949   001 Jun 13, 1988

AT        FOUGERA PHARMS         100,000      UNITS/GM          A062129   001
	
AT        PERRIGO NEW YORK       100,000      UNITS/GM          A062225   001
	
AT    + TARO                     100,000      UNITS/GM          A064022   001 Jan 29, 1993

AT        VINTAGE                100,000      UNITS/GM          A065315   001 May 31, 2006

  OINTMENT;TOPICAL

    NYSTATIN
	
AT        ACTAVIS MID ATLANTIC   100,000 UNITS/GM               A062840 001 Nov 13, 1987

AT    + FOUGERA PHARMS           100,000 UNITS/GM               A062124 002 Sep 23, 1982
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-268(of 371)


NYSTATIN
	
  OINTMENT;TOPICAL

    NYSTATIN
	
AT        PERRIGO NEW YORK       100,000 UNITS/GM              A062472 001 Feb 13, 1984
	
  POWDER;TOPICAL

    NYSTATIN
	
AT    + COASTAL PHARMS           100,000   UNITS/GM            A065203   001    Jul   15,   2004

AT        GAVIS PHARMS           100,000   UNITS/GM            A065138   001    Jul   23,   2004

AT        UPSHER SMITH           100,000   UNITS/GM            A065183   001    May   03,   2005

AT        X GEN PHARMS           100,000   UNITS/GM            A065175   001    Dec   17,   2004

    NYSTOP
	
AT        PADDOCK LLC            100,000 UNITS/GM              A064118 001 Aug 16, 1996

  SUSPENSION;ORAL

    NYSTATIN
	
AA        ACTAVIS MID ATLANTIC   100,000   UNITS/ML            A062349   001    Jul   14,   1982

AA        FOUGERA                100,000   UNITS/ML            A062517   001    Jun   07,   1984

AA        HI TECH PHARMA         100,000   UNITS/ML            A064042   001    Feb   28,   1994

AA        TARO                   100,000   UNITS/ML            A062876   001    Feb   29,   1988

AA        VINTAGE PHARMS         100,000   UNITS/ML            A065148   001    Jun   28,   2005

AA        VISTAPHARM             100,000   UNITS/ML            A064142   001    Jun   25,   1998

AA                               100,000   UNITS/ML            A065422   001    Mar   07,   2011

AA    + WOCKHARDT                100,000   UNITS/ML            A062512   001    Oct   29,   1984
	
  TABLET;ORAL

    NYSTATIN
	
AA        HERITAGE PHARMS INC    500,000 UNITS                 A062474 001 Dec 22, 1983

AA        MUTUAL PHARM           500,000 UNITS                 A062838 001 Dec 22, 1988

AA    + TEVA                     500,000 UNITS                 A062506 001 Jan 16, 1984
	
  TABLET;VAGINAL
	
    NYSTATIN
	
      + ODYSSEY PHARMS           100,000 UNITS                 A062615 001 Oct 17, 1985
	
NYSTATIN; TRIAMCINOLONE ACETONIDE
	
  CREAM;TOPICAL

    NYSTATIN AND TRIAMCINOLONE ACETONIDE
	
AT       FOUGERA                100,000 UNITS/GM;0.1%          A062599 001 Oct 08, 1985

AT    + TARO                    100,000 UNITS/GM;0.1%          A062364 001 Dec 22, 1987
	
  OINTMENT;TOPICAL

    NYSTATIN AND TRIAMCINOLONE ACETONIDE
	
AT       FOUGERA                100,000 UNITS/GM;0.1%          A062602 001 Oct 09, 1985

AT    + TARO                    100,000 UNITS/GM;0.1%          A063305 001 Mar 29, 1993
	
OCTREOTIDE ACETATE
	
  INJECTABLE;INJECTION

    OCTREOTIDE ACETATE
	
AP    + EUROHLTH INTL           EQ 0.2MG BASE/ML               A076330   001    Apr   08,   2005

AP    +                         EQ 1MG BASE/ML                 A076330   002    Apr   08,   2005

AP       FRESENIUS KABI USA     EQ 0.2MG BASE/ML               A077450   001    Feb   10,   2006

AP                              EQ 1MG BASE/ML                 A077450   002    Feb   10,   2006

AP       SAGENT PHARMS          EQ 0.2MG BASE/ML               A091041   001    Nov   12,   2013

AP                              EQ 1MG BASE/ML                 A091041   002    Nov   12,   2013

AP       SUN PHARM INDS         EQ 0.05MG BASE/ML              A077329   001    Mar   04,   2008

AP                              EQ 0.05MG BASE/ML              A077372   001    Aug   14,   2007

AP                              EQ 0.1MG BASE/ML               A077329   002    Mar   04,   2008

AP                              EQ 0.1MG BASE/ML               A077372   002    Aug   14,   2007

AP                              EQ 0.2MG BASE/ML               A077330   001    Mar   04,   2008

AP                              EQ 0.2MG BASE/ML               A077373   001    Aug   14,   2007

AP                              EQ 0.5MG BASE/ML               A077329   003    Mar   04,   2008

AP                              EQ 0.5MG BASE/ML               A077372   003    Aug   14,   2007

AP                              EQ 1MG BASE/ML                 A077331   001    Mar   04,   2008

AP                              EQ 1MG BASE/ML                 A077373   002    Aug   14,   2007

AP       TEVA PHARMS USA        EQ 0.05MG BASE/ML              A075957   001    Oct   03,   2005

AP                              EQ 0.1MG BASE/ML               A075957   002    Oct   03,   2005

AP                              EQ 0.2MG BASE/ML               A075959   001    Nov   21,   2005

AP                              EQ 0.5MG BASE/ML               A075957   003    Oct   03,   2005

AP                              EQ 1MG BASE/ML                 A075959   002    Nov   21,   2005

AP       WOCKHARDT USA          EQ 0.2MG BASE/ML               A090986   001    May   11,   2011

AP                              EQ 1MG BASE/ML                 A090986   002    May   11,   2011

    OCTREOTIDE ACETATE (PRESERVATIVE FREE)

AP    + EUROHLTH INTL           EQ 0.05MG BASE/ML              A076313   001    Mar   28,   2005

AP    +                         EQ 0.1MG BASE/ML               A076313   003    Mar   28,   2005

AP    +                         EQ 0.5MG BASE/ML               A076313   002    Mar   28,   2005

AP       FRESENIUS KABI USA     EQ 0.05MG BASE/ML              A077457   001    Feb   10,   2006

AP                              EQ 0.1MG BASE/ML               A077457   002    Feb   10,   2006
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-269(of 371)


OCTREOTIDE ACETATE
	
  INJECTABLE;INJECTION

    OCTREOTIDE ACETATE (PRESERVATIVE FREE)

AP                              EQ 0.5MG BASE/ML               A077457   003    Feb   10,   2006

AP       MYLAN INSTITUTIONAL    EQ 0.05MG BASE/ML              A079198   001    Feb   10,   2011

AP                              EQ 0.1MG BASE/ML               A079198   002    Feb   10,   2011

AP                              EQ 0.5MG BASE/ML               A079198   003    Feb   10,   2011

AP       SAGENT PHARMS          EQ 0.05MG BASE/ML              A090834   001    Nov   12,   2013

AP                              EQ 0.1MG BASE/ML               A090834   002    Nov   12,   2013

AP                              EQ 0.5MG BASE/ML               A090834   003    Nov   12,   2013

AP       WOCKHARDT USA          EQ 0.05MG BASE/ML              A090985   001    May   11,   2011

AP                              EQ 0.1MG BASE/ML               A090985   002    May   11,   2011

AP                              EQ 0.5MG BASE/ML               A090985   003    May   11,   2011

    SANDOSTATIN
	
AP    + NOVARTIS                EQ 0.05MG BASE/ML              N019667   001    Oct   21,   1988

AP    +                         EQ 0.1MG BASE/ML               N019667   002    Oct   21,   1988

AP    +                         EQ 0.2MG BASE/ML               N019667   004    Jun   12,   1991

AP    +                         EQ 0.5MG BASE/ML               N019667   003    Oct   21,   1988

AP    +                         EQ 1MG BASE/ML                 N019667   005    Jun   12,   1991
	
    SANDOSTATIN LAR
	
         NOVARTIS               EQ 10MG BASE/VIAL              N021008 001 Nov 25, 1998
	
                                EQ 20MG BASE/VIAL              N021008 002 Nov 25, 1998
	
      +                         EQ 30MG BASE/VIAL              N021008 003 Nov 25, 1998
	
OFLOXACIN
	
  SOLUTION/DROPS;OPHTHALMIC

    OCUFLOX
	
AT    + ALLERGAN                0.3%                           N019921 001 Jul 30, 1993

    OFLOXACIN
	
AT       AKORN                  0.3%                           A076407   001    Apr   15,   2008

AT       ALCON PHARMS LTD       0.3%                           A076231   001    May   14,   2004

AT       ALTAIRE PHARMS INC     0.3%                           A202692   001    Apr   29,   2013

AT       BAUSCH AND LOMB        0.3%                           A076622   001    May   14,   2004

AT       FDC LTD                0.3%                           A078559   001    Feb   25,   2009

AT       FERA PHARMS            0.3%                           A076830   001    Aug   31,   2004

AT       HI TECH PHARMA         0.3%                           A076615   001    May   14,   2004

  SOLUTION/DROPS;OTIC

    FLOXIN OTIC
	
AT    + DAIICHI                 0.3%                           N020799 001 Dec 16, 1997

    OFLOXACIN
	
AT       ALCON PHARMS LTD       0.3%                           A078222   001    Mar   17,   2008

AT       APOTEX INC             0.3%                           A076527   001    Sep   28,   2007

AT       BAUSCH AND LOMB        0.3%                           A076128   001    Mar   17,   2008

AT       FERA PHARMS            0.3%                           A090395   001    Aug   11,   2009

AT       HI TECH PHARMA         0.3%                           A076616   001    Mar   17,   2008
	
  TABLET;ORAL

    OFLOXACIN
	
AB       CADILA PHARMS LTD      200MG                          A091656   001    Sep   18,   2014

AB                              300MG                          A091656   002    Sep   18,   2014

AB                              400MG                          A091656   003    Sep   18,   2014

AB       DR REDDYS LABS LTD     200MG                          A077098   001    Feb   10,   2006

AB                              300MG                          A077098   002    Feb   10,   2006

AB                              400MG                          A077098   003    Feb   10,   2006

AB       TEVA                   200MG                          A076182   001    Sep   02,   2003

AB                              300MG                          A076182   002    Sep   02,   2003

AB    +                         400MG                          A076182   003    Sep   02,   2003
	
OLANZAPINE
	
  INJECTABLE;INTRAMUSCULAR

    OLANZAPINE
	
AP       LUITPOLD               10MG/VIAL                      A201741 001 Mar 20, 2012

AP       SANDOZ INC             10MG/VIAL                      A201588 001 Oct 24, 2011

    ZYPREXA
	
AP    + LILLY                   10MG/VIAL                      N021253 001 Mar 29, 2004
	
  TABLET;ORAL

    OLANZAPINE
	
AB       APOTEX INC             2.5MG                          A090798   001    Apr   23,   2012

AB                              5MG                            A090798   002    Apr   23,   2012

AB                              7.5MG                          A090798   003    Apr   23,   2012

AB                              10MG                           A090798   004    Apr   23,   2012

AB                              15MG                           A090798   005    Apr   23,   2012

AB                              20MG                           A090798   006    Apr   23,   2012

AB       AUROBINDO PHARMA LTD   2.5MG                          A202050   001    Apr   23,   2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-270(of 371)


OLANZAPINE
	
  TABLET;ORAL

    OLANZAPINE
	
AB                              5MG                            A202050   002    Apr   23,   2012

AB                              7.5MG                          A202050   003    Apr   23,   2012

AB                              10MG                           A202050   004    Apr   23,   2012

AB                              15MG                           A202050   005    Apr   23,   2012

AB                              20MG                           A202050   006    Apr   23,   2012

AB       DR REDDYS LABS LTD     2.5MG                          A076255   001    Apr   23,   2012

AB                              5MG                            A076255   002    Apr   23,   2012

AB                              7.5MG                          A076255   003    Apr   23,   2012

AB                              10MG                           A076255   004    Apr   23,   2012

AB                              15MG                           A076133   001    Apr   23,   2012

AB                              20MG                           A076133   002    Oct   24,   2011

AB       MACLEODS PHARMS LTD    2.5MG                          A202862   001    Aug   15,   2014

AB                              5MG                            A202862   002    Aug   15,   2014

AB                              7.5MG                          A202862   003    Aug   15,   2014

AB                              10MG                           A202862   004    Aug   15,   2014

AB                              15MG                           A202862   005    Aug   15,   2014

AB                              20MG                           A202862   006    Aug   15,   2014

AB       MYLAN                  2.5MG                          A076866   001    Apr   23,   2012

AB                              5MG                            A076866   002    Apr   23,   2012

AB                              7.5MG                          A076866   003    Apr   23,   2012

AB                              10MG                           A076866   004    Apr   23,   2012

AB                              15MG                           A076866   005    Apr   23,   2012

AB                              20MG                           A076866   006    Apr   23,   2012

AB       ORCHID HLTHCARE        2.5MG                          A202287   001    Apr   23,   2012

AB                              5MG                            A202287   002    Apr   23,   2012

AB                              7.5MG                          A202287   003    Apr   23,   2012

AB                              10MG                           A202287   004    Apr   23,   2012

AB                              15MG                           A202287   005    Apr   23,   2012

AB                              20MG                           A202287   006    Apr   23,   2012

AB       SUN PHARM INDS         2.5MG                          A091038   001    Apr   23,   2012

AB                              5MG                            A091038   002    Apr   23,   2012

AB                              7.5MG                          A091038   003    Apr   23,   2012

AB                              10MG                           A091038   004    Apr   23,   2012

AB                              15MG                           A091038   005    Apr   23,   2012

AB                              20MG                           A091038   006    Apr   23,   2012

AB       TEVA PHARMS            2.5MG                          A076000   001    Oct   24,   2011

AB                              5MG                            A076000   002    Oct   24,   2011

AB                              7.5MG                          A076000   003    Oct   24,   2011

AB                              10MG                           A076000   004    Oct   24,   2011

AB                              15MG                           A076000   005    Oct   24,   2011

AB       TORRENT PHARMS LTD     2.5MG                          A091434   001    Apr   23,   2012

AB                              5MG                            A091434   002    Apr   23,   2012

AB                              7.5MG                          A091434   003    Apr   23,   2012

AB                              10MG                           A091434   004    Apr   23,   2012

AB                              15MG                           A091434   005    Apr   23,   2012

AB                              20MG                           A091434   006    Apr   23,   2012

    ZYPREXA
	
AB       LILLY                  2.5MG                          N020592   001    Sep   30,   1996

AB    +                         5MG                            N020592   002    Sep   30,   1996

AB                              7.5MG                          N020592   003    Sep   30,   1996

AB                              10MG                           N020592   004    Sep   30,   1996

AB                              15MG                           N020592   005    Sep   09,   1997

AB                              20MG                           N020592   006    Sep   09,   1997

  TABLET, ORALLY DISINTEGRATING;ORAL

    OLANZAPINE
	
AB       APOTEX INC             5MG                            A091265   001    Oct   24,   2011

AB                              10MG                           A091265   002    Oct   24,   2011

AB                              15MG                           A091265   003    Oct   24,   2011

AB                              20MG                           A091265   004    Oct   24,   2011

AB       AUROBINDO PHARMA LTD   5MG                            A203708   001    May   15,   2014

AB                              10MG                           A203708   002    May   15,   2014

AB                              15MG                           A203708   003    May   15,   2014

AB                              20MG                           A203708   004    May   15,   2014

AB       BARR LABS INC          5MG                            A077243   001    Jan   30,   2012

AB                              10MG                           A077243   002    Jan   30,   2012

AB                              15MG                           A077243   003    Jan   30,   2012

AB                              20MG                           A077243   004    Jan   30,   2012

AB       DR REDDYS LABS LTD     5MG                            A076534   001    Oct   24,   2011

AB                              10MG                           A076534   002    Oct   24,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                                3-271(of 371)


OLANZAPINE
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    OLANZAPINE
	
AB                              15MG
	                                      A076534   003    Oct   24,   2011

AB                              20MG
	                                      A076534   004    Oct   24,   2011

AB       JUBILANT GENERICS      5MG
	                                       A200221   001    Sep   12,   2012

AB                              10MG
	                                      A200221   002    Sep   12,   2012

AB                              15MG
	                                      A200221   003    Sep   12,   2012

AB                              20MG
	                                      A200221   004    Sep   12,   2012

AB       MYLAN PHARMS INC       5MG
	                                       A202285   001    May   12,   2014

AB                              10MG
	                                      A202285   002    May   12,   2014

AB                              15MG
	                                      A202285   003    May   12,   2014

AB                              20MG
	                                      A202285   004    May   12,   2014

AB       PAR PHARM              5MG
	                                       A078109   001    Oct   24,   2011

AB                              10MG
	                                      A078109   002    Oct   24,   2011

AB                              15MG
	                                      A078109   003    Oct   24,   2011

AB                              20MG
	                                      A078109   004    Oct   24,   2011

AB       SUN PHARM INDS         5MG
	                                       A090881   001    Feb   28,   2012

AB                              10MG
	                                      A090881   002    Feb   28,   2012

AB                              15MG
	                                      A090881   003    Feb   28,   2012

AB                              20MG
	                                      A090881   004    Feb   28,   2012

AB       TORRENT PHARMS LLC     5MG
	                                       A091415   001    Oct   25,   2011

AB                              10MG
	                                      A091415   002    Oct   25,   2011

AB                              15MG
	                                      A091415   003    Oct   25,   2011

AB                              20MG
	                                      A091415   004    Oct   25,   2011
	
    ZYPREXA ZYDIS
	
AB    + LILLY                   5MG                                         N021086   001    Apr   06,   2000

AB                              10MG                                        N021086   002    Apr   06,   2000

AB                              15MG                                        N021086   003    Apr   06,   2000

AB                              20MG                                        N021086   004    Apr   06,   2000
	
OLANZAPINE PAMOATE
	
  SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
	
    ZYPREXA RELPREVV
	
          ELI LILLY CO
	        EQ 210MG BASE/VIAL
                         N022173 001 Dec 11, 2009
	
                                EQ 300MG BASE/VIAL
                         N022173 002 Dec 11, 2009
	
      +
	                       EQ 405MG BASE/VIAL
	                        N022173 003 Dec 11, 2009
	
OLAPARIB
	
  CAPSULE;ORAL
	
    OLAPARIB
	
          ASTRAZENECA PHARMS
	   50MG
	                                     N206162 001 Dec 19, 2014
	
OLIVE OIL; SOYBEAN OIL
	
  INJECTABLE;INJECTION
	
    CLINOLIPID 20%
	
      + BAXTER HLTHCARE
	        16%(160GM/1000ML);4%     (40GM/1000ML)
	   N204508 001 Oct 03, 2013
	
OLMESARTAN MEDOXOMIL
	
  TABLET;ORAL
	
    BENICAR
	
         DAIICHI SANKYO
	        5MG
	                                      N021286 001 Apr 25, 2002

                                 20MG
	                                     N021286 003 Apr 25, 2002

     +
	                         40MG
	                                     N021286 004 Apr 25, 2002
	
OLODATEROL HYDROCHLORIDE
	
  SPRAY, METERED;INHALATION
	
    STRIVERDI RESPIMAT
	
      + BOEHRINGER INGELHEIM
	   EQ 0.0025MG BASE/INH
	                     N203108 001 Jul 31, 2014
	
OLOPATADINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    PATADAY
	
      + ALCON PHARMS LTD
	       EQ 0.2% BASE
	                             N021545 001 Dec 22, 2004
	
    PATANOL
	
      + ALCON
	                  EQ 0.1% BASE
	                             N020688 001 Dec 18, 1996
	
  SPRAY, METERED;NASAL

    OLOPATADINE HYDROCHLORIDE
AB       APOTEX INC              0.665MG/SPRAY
	                            A091572 001 Oct 08, 2014
	
    PATANASE
AB    + ALCON PHARMS LTD         0.665MG/SPRAY
	                            N021861 001 Apr 15, 2008
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                                   3-272(of 371)


OLSALAZINE SODIUM
	
  CAPSULE;ORAL
	
    DIPENTUM
	
      + MEDA PHARMS                250MG		                                     N019715 001 Jul 31, 1990
	
OMACETAXINE MEPESUCCINATE
	
  POWDER;SUBCUTANEOUS
	
    SYNRIBO
	
      + IVAX INTL                  3.5MG/VIAL		                                N203585 001 Oct 26, 2012
	
OMEGA-3-ACID ETHYL ESTERS
	
  CAPSULE;ORAL

    LOVAZA
	
AB    + SMITHKLINE BEECHAM         1GM CONTAINS AT LEAST 900MG OF THE          N021654 001 Nov 10, 2004

                                   ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
	
     OMEGA-3-ACID ETHYL ESTERS
	
AB        APOTEX INC               1GM CONTAINS   AT   LEAST 900MG OF THE      A090973 001 Sep 30, 2014

                                   ETHYL ESTERS   OF   OMEGA-3 FATTY ACIDS
	
AB        PAR PHARM INC            1GM CONTAINS   AT   LEAST 900MG OF THE      A091018 001 Jun 24, 2014

                                   ETHYL ESTERS   OF   OMEGA-3 FATTY ACIDS
	
AB        TEVA PHARMS USA          1GM CONTAINS   AT   LEAST 900MG OF THE      A091028 001 Apr 07, 2014

                                   ETHYL ESTERS   OF   OMEGA-3 FATTY ACIDS
	
     OMTRYG
	
       +		 TRYGG                   1.2GM CONTAINS AT LEAST 900MG OF THE        N204977 001 Apr 23, 2014

                                   ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
	
OMEGA-3-CARBOXYLIC ACIDS
	
  CAPSULE;ORAL
	
    EPANOVA
	
      +		 ASTRAZENECA PHARMS       1GM CONTAINS AT LEAST 850MG OF              N205060 001 May 05, 2014

                                   POLYUNSATURATED FATTY ACIDS
	
OMEPRAZOLE
	
  CAPSULE, DELAYED REL PELLETS;ORAL

    OMEPRAZOLE
	
AB       ACTAVIS LABS FL INC    10MG                                           A075347   001    May   30,   2008

AB                              20MG                                           A075347   002    May   30,   2008

AB                              40MG                                           A075347   003    May   30,   2008

AB       APOTEX                 10MG                                           A076048   001    Oct   22,   2007

AB                              20MG                                           A076048   002    Oct   22,   2007

AB                              40MG                                           A076048   003    Jan   21,   2009

AB       DR REDDYS LABS LTD     10MG                                           A075576   003    Oct   22,   2007

AB                              10MG                                           A078490   002    Mar   16,   2009

AB                              20MG                                           A075576   002    Oct   22,   2007

AB                              20MG                                           A078490   003    Mar   16,   2009

AB                              40MG                                           A075576   001    Jan   21,   2009

AB                              40MG                                           A078490   001    Apr   17,   2009

AB       GLENMARK GENERICS      10MG                                           A091672   001    Oct   31,   2014

AB                              20MG                                           A091672   002    Oct   31,   2014

AB                              40MG                                           A091672   003    Oct   31,   2014

AB       IMPAX LABS             10MG                                           A075785   001    Oct   22,   2007

AB                              20MG                                           A075785   002    Oct   22,   2007

AB                              40MG                                           A075785   003    Jan   21,   2009

AB       KREMERS URBAN PHARMS   10MG                                           A075410   001    Nov   01,   2002

AB                              20MG                                           A075410   002    Nov   01,   2002

AB                              40MG                                           A075410   003    Jan   23,   2009

AB       MYLAN                  10MG                                           A075876   001    May   29,   2003

AB                              20MG                                           A075876   002    May   29,   2003

AB                              40MG                                           A075876   003    Jan   21,   2009

AB       SANDOZ                 10MG                                           A075757   001    Jan   28,   2003

AB                              20MG                                           A075757   002    Jan   28,   2003

AB                              40MG                                           A076515   001    Jan   21,   2009

AB       ZYDUS PHARMS USA INC   10MG                                           A091352   001    Nov   19,   2012

AB                              20MG                                           A091352   002    Nov   19,   2012

AB                              40MG                                           A091352   003    Nov   19,   2012

    PRILOSEC
	
AB       ASTRAZENECA PHARMS     10MG                                           N019810 003 Oct 05, 1995

AB    +                         20MG                                           N019810 001 Sep 14, 1989

AB    +                         40MG                                           N019810 002 Jan 15, 1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                     3-273(of 371)


OMEPRAZOLE MAGNESIUM
	
  FOR SUSPENSION, DELAYED RELEASE;ORAL
	
    PRILOSEC
         ASTRAZENECA PHARMS     EQ 2.5MG BASE/PACKET            N022056 001 Mar 20, 2008
	
      +                         EQ 10MG BASE/PACKET             N022056 002 Mar 20, 2008
	
OMEPRAZOLE; SODIUM BICARBONATE
  CAPSULE;ORAL
    OMEPRAZOLE AND SODIUM BICARBONATE
	
AB        PAR PHARM             20MG;1.1GM
                     A078966 001 May 25, 2010

AB                              40MG;1.1GM
	                    A078966 002 May 25, 2010
	
    ZEGERID
AB        SANTARUS INC          20MG;1.1GM
                     N021849 001 Feb 27, 2006

AB    +                         40MG;1.1GM
	                    N021849 002 Feb 27, 2006
	
  FOR SUSPENSION;ORAL
	
    ZEGERID
	
          SANTARUS INC
	        20MG/PACKET;1.68GM/PACKET
      N021636 001 Jun 15, 2004
	
      +
	                       40MG/PACKET;1.68GM/PACKET
	     N021636 002 Dec 21, 2004
	
ONDANSETRON
	
  FILM;ORAL
	
    ZUPLENZ
	
         GALENA BIOPHARMA INC   4MG
	                           N022524 001 Jul 02, 2010
	
      +                         8MG
	                           N022524 002 Jul 02, 2010
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    ONDANSETRON
AB       AUROBINDO PHARMA       4MG
	                           A090469   001    Apr   12,   2010

AB                              8MG
	                           A090469   002    Apr   12,   2010

AB       BARR                   4MG
	                           A076693   001    Jun   25,   2007

AB                              8MG
	                           A076693   002    Jun   25,   2007

AB       GLENMARK GENERICS      4MG
	                           A078152   001    Jun   27,   2007

AB                              8MG
	                           A078152   002    Jun   27,   2007

AB       MYLAN                  4MG
	                           A078139   001    Jun   25,   2007

AB                              8MG
	                           A078139   002    Jun   25,   2007

AB       RANBAXY                4MG
	                           A078602   001    Feb   24,   2011

AB                              8MG
	                           A078602   002    Feb   24,   2011

AB       SANDOZ                 4MG
	                           A078050   001    Aug   13,   2007

AB                              8MG
	                           A078050   002    Aug   13,   2007

AB       SUN PHARM INDS         4MG
	                           A077557   001    Aug   02,   2007

AB                              8MG
	                           A077557   002    Aug   02,   2007

AB       TEVA                   4MG
	                           A076810   001    Jun   25,   2007

AB                              8MG
	                           A076810   002    Jun   25,   2007
	
    ZOFRAN ODT
AB       GLAXOSMITHKLINE        4MG
	                           N020781 001 Jan 27, 1999

AB    +                         8MG
	                           N020781 002 Jan 27, 1999
	
ONDANSETRON HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     ONDANSETRON HYDROCHLORIDE
	
AP        AGILA SPECLTS
	        EQ 2MG BASE/ML
                A078257   001    Apr   23,   2008

AP        AUROBINDO PHARMA LTD
	 EQ 2MG BASE/ML
                A202599   001    Dec   21,   2012

AP        BEDFORD
	              EQ 2MG BASE/ML
                A076967   001    Dec   26,   2006

AP        CLARIS LIFESCIENCES
	  EQ 2MG BASE/ML
                A078288   001    Feb   22,   2013

AP        EMCURE PHARMS
	        EQ 2MG BASE/ML
                A090424   001    Apr   16,   2010

AP        FRESENIUS KABI USA
	   EQ 2MG BASE/ML
                A076974   001    Dec   26,   2006

AP        GLAND PHARMA LTD
	     EQ 2MG BASE/ML
                A079224   001    Sep   25,   2009

AP
	                             EQ 2MG BASE/ML
                A090648   001    Jun   15,   2012

AP        HIKMA FARMACEUTICA
	   EQ 2MG BASE/ML
                A076781   001    Dec   26,   2006

AP        HIKMA MAPLE
	          EQ 2MG BASE/ML
                A077365   001    Dec   26,   2006

AP        HOSPIRA
	              EQ 2MG BASE/ML
                A077473   001    Dec   26,   2006

AP
	                             EQ 2MG BASE/ML
                A077840   001    Jan   19,   2007

AP        LANNETT
	              EQ 2MG BASE/ML
                A090883   001    Aug   05,   2010

AP        LUITPOLD
	             EQ 2MG BASE/ML
                A079039   001    Nov   18,   2008

AP        QILU PHARM CO LTD
     EQ 2MG BASE/ML
                A203711   001    Sep   08,   2014

AP        SANDOZ
	               EQ 2MG BASE/ML
                A077430   001    Jun   27,   2007

AP        SUN PHARM INDS (IN)
   EQ 2MG BASE/ML
                A077172   001    Dec   26,   2006

AP        TEVA
	                 EQ 2MG BASE/ML
                A076876   001    Nov   22,   2006

AP        WOCKHARDT
	            EQ 2MG BASE/ML
	               A077577   001    Dec   26,   2006
	
     ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
	
AP        AGILA SPECLTS          EQ 2MG BASE/ML
                A078244   001    Apr   23,   2008

AP        AUROBINDO PHARMA LTD   EQ 2MG BASE/ML
                A202600   001    Dec   21,   2012

AP        BD RX                  EQ 2MG BASE/ML
                A202253   001    Jul   19,   2013

AP        BEDFORD LABS           EQ 2MG BASE/ML
                A077011   001    Dec   26,   2006

AP        CLARIS LIFESCIENCES    EQ 2MG BASE/ML
	               A078287   001    Feb   22,   2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-274(of 371)


ONDANSETRON HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
	
AP         EMCURE PHARMS LTD
	   EQ 2MG BASE/ML
                A078945   001    Jan   03,   2013

AP         FRESENIUS KABI USA
	  EQ 2MG BASE/ML
                A076972   001    Dec   26,   2006

AP         HIKMA FARMACEUTICA
	  EQ 2MG BASE/ML
                A076780   001    Dec   26,   2006

AP         HIKMA MAPLE
	         EQ 2MG BASE/ML
                A077541   001    Dec   26,   2006

AP         HOSPIRA
	             EQ 2MG BASE/ML
                A077548   001    Dec   26,   2006

AP         LUITPOLD
	            EQ 2MG BASE/ML
                A079032   001    Nov   18,   2008

AP         SANDOZ
	              EQ 2MG BASE/ML
                A077551   001    Jun   27,   2007

AP         SUN PHARM INDS LTD
	  EQ 2MG BASE/ML
                A077173   001    Dec   26,   2006

AP         TARO PHARMS IRELAND
	 EQ 2MG BASE/ML
                A078014   001    Mar   21,   2008

AP         TEVA
	                EQ 2MG BASE/ML
                A076759   001    Nov   22,   2006

AP         WOCKHARDT
	           EQ 2MG BASE/ML
	               A077716   001    Dec   26,   2006
	
     ZOFRAN
	
AP     + GLAXOSMITHKLINE
	       EQ 2MG BASE/ML
	               N020007 001 Jan 04, 1991
	
     ZOFRAN PRESERVATIVE FREE
	
AP     + GLAXOSMITHKLINE
	       EQ 2MG BASE/ML
	               N020007 003 Dec 10, 1993
	
  SOLUTION;ORAL

     ONDANSETRON HYDROCHLORIDE
	
AA         AMNEAL PHARMS
	       EQ 4MG BASE/5ML
               A091483   001    Jan   31,   2011

AA         APOTEX
	              EQ 4MG BASE/5ML
               A078127   001    Jun   25,   2007

AA         AUROBINDO PHARMA
	    EQ 4MG BASE/5ML
               A078776   001    Nov   28,   2007

AA         ROXANE
	              EQ 4MG BASE/5ML
               A076960   001    Dec   26,   2006

AA         SILARX
	              EQ 4MG BASE/5ML
               A091342   001    Jan   27,   2011

AA         TARO
	                EQ 4MG BASE/5ML
	              A077009   001    Nov   30,   2007
	
     ZOFRAN
	
AA     + GLAXOSMITHKLINE
	       EQ 4MG BASE/5ML
	              N020605 001 Jan 24, 1997
	
  TABLET;ORAL

     ONDANSETRON HYDROCHLORIDE
	
AB         APOTEX
	              EQ 4MG BASE
                   A077306   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A077306   002    Jun   25,   2007

AB         AUROBINDO PHARMA
	    EQ 4MG BASE
                   A078539   001    Jul   31,   2007

AB
	                             EQ 8MG BASE
                   A078539   002    Jul   31,   2007

AB
	                             EQ 24MG BASE
                  A078539   003    Jul   31,   2007

AB         DR REDDYS LABS LTD
	  EQ 4MG BASE
                   A076183   003    Dec   26,   2006

AB
	                             EQ 8MG BASE
                   A076183   002    Dec   26,   2006

AB
	                             EQ 24MG BASE
                  A076183   001    Dec   26,   2006

AB         GLENMARK GENERICS
	   EQ 4MG BASE
                   A077535   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A077535   002    Jun   25,   2007

AB
	                             EQ 24MG BASE
                  A077535   003    Jun   25,   2007

AB         IPCA LABS LTD
	       EQ 4MG BASE
                   A203761   001    Jan   23,   2014

AB
	                             EQ 8MG BASE
                   A203761   002    Jan   23,   2014

AB         MYLAN
	               EQ 4MG BASE
                   A076930   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A076930   002    Jun   25,   2007

AB
	                             EQ 24MG BASE
                  A076930   004    Jun   25,   2007

AB         NATCO PHARMA LTD
	    EQ 4MG BASE
                   A077851   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A077851   002    Jun   25,   2007

AB         PLIVA HRVATSKA DOO
	  EQ 4MG BASE
                   A077112   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A077112   002    Jun   25,   2007

AB
	                             EQ 24MG BASE
                  A077112   003    Jun   25,   2007

AB         SANDOZ
	              EQ 4MG BASE
                   A077517   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A077517   002    Jun   25,   2007

AB
	                             EQ 24MG BASE
                  A077517   003    Jun   25,   2007

AB         SUN PHARM INDS (IN)
  EQ 4MG BASE
                   A077050   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A077050   002    Jun   25,   2007

AB         TEVA
	                EQ 4MG BASE
                   A076252   001    Jun   25,   2007

AB
	                             EQ 8MG BASE
                   A076252   002    Jun   25,   2007

AB
	                             EQ 24MG BASE
	                 A076252   003    Jun   25,   2007
	
     ZOFRAN
	
AB         GLAXOSMITHKLINE
	     EQ 4MG BASE
                   N020103 001 Dec 31, 1992

AB
	                             EQ 8MG BASE
                   N020103 002 Dec 31, 1992

AB     +
	                       EQ 24MG BASE
	                 N020103 003 Aug 27, 1999
	
     ONDANSETRON HYDROCHLORIDE
	
           DR REDDYS LABS LTD
	  EQ 16MG BASE
	                 A076183 004 Dec 26, 2006
	
ORITAVANCIN DIPHOSPHATE
	
  POWDER;IV (INFUSION)

    ORBACTIV
	
      + MEDICINES CO             EQ 400MG BASE/VIAL             N206334 001 Aug 06, 2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-275(of 371)


ORLISTAT
	
  CAPSULE;ORAL
	
    XENICAL
	
      + HOFFMANN LA ROCHE       120MG                           N020766 001 Apr 23, 1999
	
ORPHENADRINE CITRATE
	
  INJECTABLE;INJECTION

    NORFLEX
	
AP    + MEDICIS                  30MG/ML                        N013055 001
	
    ORPHENADRINE CITRATE
	
AP       AKORN                   30MG/ML                        A040484   001     May   24,   2006

AP       EUROHLTH INTL           30MG/ML                        A040463   001     Mar   04,   2003

AP       SAGENT PHARMS           30MG/ML                        A090585   001     Aug   30,   2011

AP       WATSON LABS             30MG/ML                        A084779   001     Mar   15,   1982
	
  TABLET, EXTENDED RELEASE;ORAL

    ORPHENADRINE CITRATE
	
AB       GAVIS PHARMS            100MG                          A040284   001     Jun   19,   1998

AB       IMPAX PHARMS            100MG                          A040368   001     Jun   23,   2000

AB       INVAGEN PHARMS          100MG                          A091158   001     Jul   27,   2012

AB    + SANDOZ                   100MG                          A040327   001     Feb   15,   2000

AB       TEDOR PHARMA INC        100MG                          A040249   001     Jan   29,   1999
	
OSELTAMIVIR PHOSPHATE
	
  CAPSULE;ORAL
	
    TAMIFLU
	
         ROCHE                  EQ 30MG BASE                    N021087 003 Jul 02, 2007
	
                                EQ 45MG BASE                    N021087 002 Jul 02, 2007
	
     +                          EQ 75MG BASE                    N021087 001 Oct 27, 1999
	
 FOR SUSPENSION;ORAL
	
   TAMIFLU
	
     + ROCHE                    EQ 6MG BASE/ML                  N021246 002 Mar 21, 2011
	
OSPEMIFENE
	
  TABLET;ORAL
	
    OSPHENA
	
      + SHIONOGI INC            60MG                            N203505 001 Feb 26, 2013
	
OXACILLIN SODIUM
	
  INJECTABLE;INJECTION

    OXACILLIN SODIUM
	
AP       AGILA SPECLTS          EQ 1GM BASE/VIAL                A091486   001     Aug   25,   2014

AP                              EQ 2GM BASE/VIAL                A091486   002     Aug   25,   2014

AP       AUROBINDO PHARMA LTD   EQ 1GM BASE/VIAL                A201539   001     Jan   18,   2013

AP                              EQ 2GM BASE/VIAL                A201539   002     Jan   18,   2013

AP                              EQ 10GM BASE/VIAL               A201538   001     Jan   18,   2013

AP       SAGENT PHARMS          EQ 1GM BASE/VIAL                A091246   001     Mar   30,   2012

AP                              EQ 2GM BASE/VIAL                A091246   002     Mar   30,   2012

AP                              EQ 10GM BASE/VIAL               A091245   001     Mar   30,   2012

AP    + SANDOZ                  EQ 1GM BASE/VIAL                A061490   003
	
AP    +                         EQ 2GM BASE/VIAL                A061490   004
	
AP    +                         EQ 10GM BASE/VIAL               A061490   006     May 09, 1991

    BACTOCILL IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         EQ 20MG BASE/ML                 N050640 001 Oct 26, 1989
	
      +                         EQ 40MG BASE/ML                 N050640 002 Oct 26, 1989
	
  POWDER;INTRAVENOUS

    OXACILLIN SODIUM
	
AP    + SANDOZ                  EQ 1GM BASE/VIAL                A062737 001 Dec 23, 1986

AP    +                         EQ 2GM BASE/VIAL                A062737 002 Dec 23, 1986
	
OXALIPLATIN
	
  INJECTABLE;IV (INFUSION)

    ELOXATIN
	
AP    + SANOFI AVENTIS US       50MG/10ML (5MG/ML)              N021759 001 Jan 31, 2005

AP    +                         100MG/20ML (5MG/ML)             N021759 002 Jan 31, 2005

    OXALIPLATIN
	
AP       ACTAVIS TOTOWA         50MG/VIAL                       A078803   001     Aug   08,   2012

AP                              100MG/VIAL                      A078803   002     Aug   08,   2012

AP       EBEWE PHARMA           50MG/10ML (5MG/ML)              A078812   001     Aug   07,   2009

AP                              100MG/20ML (5MG/ML)             A078812   002     Aug   07,   2009

AP       FRESENIUS KABI ONCOL   50MG/10ML (5MG/ML)              A078811   001     Jun   10,   2010

AP                              100MG/20ML (5MG/ML)             A078811   002     Jun   10,   2010

AP                              50MG/VIAL                       A078810   001     Aug   07,   2009

AP                              100MG/VIAL                      A078810   002     Aug   07,   2009

AP       FRESENIUS KABI USA     50MG/VIAL                       A078819   001     Jun   02,   2010

AP                              100MG/VIAL                      A078819   002     Jun   02,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                   3-276(of 371)


OXALIPLATIN
	
  INJECTABLE;IV (INFUSION)

    OXALIPLATIN
	
AP       HOSPIRA INC             50MG/VIAL                     A078815   001    Sep   30,   2009

AP                               100MG/VIAL                    A078815   002    Sep   30,   2009

AP       HOSPIRA WORLDWIDE       50MG/10ML (5MG/ML)            A078813   001    Aug   07,   2009

AP                               100MG/20ML (5MG/ML)           A078813   002    Aug   07,   2009

AP       JIANGSU HENGRUI MED     50MG/10ML (5MG/ML)            A203869   001    Jun   18,   2014

AP                               100MG/20ML (5MG/ML)           A203869   002    Jun   18,   2014

AP       ONCO THERAPIES LTD      50MG/10ML (5MG/ML)            A091358   001    Aug   07,   2012

AP                               50MG/VIAL                     A200979   001    Aug   08,   2012

AP                               100MG/20ML (5MG/ML)           A091358   002    Aug   07,   2012

AP                               100MG/VIAL                    A200979   002    Aug   08,   2012

AP       SANDOZ                  50MG/10ML (5MG/ML)            A078817   001    Jan   24,   2011

AP                               100MG/20ML (5MG/ML)           A078817   002    Jan   24,   2011

AP    + SUN PHARMA GLOBAL        50MG/VIAL                     A078818   001    Aug   07,   2009

AP                               50MG/10ML (5MG/ML)            A202922   001    Apr   08,   2014

AP    +                          100MG/VIAL                    A078818   002    Aug   07,   2009

AP                               100MG/20ML (5MG/ML)           A202922   002    Apr   08,   2014

AP    + TEVA PHARMS              50MG/10ML (5MG/ML)            N022160   001    Aug   07,   2009

AP    +                          100MG/20ML (5MG/ML)           N022160   002    Aug   07,   2009

    ELOXATIN
	
      + SANOFI AVENTIS US        200MG/40ML (5MG/ML)           N021759 003 Nov 17, 2006
	
OXANDROLONE
	
  TABLET;ORAL

    OXANDRIN
	
AB       CREALTA PHARMS LLC      2.5MG                         N013718 001
	
AB    +                          10MG                          N013718 002 Nov 05, 2001

    OXANDROLONE
	
AB       PAR PHARM               2.5MG                         A077827   001    Jun   22,   2007

AB                               10MG                          A077827   002    Jun   22,   2007

AB       UPSHER SMITH            2.5MG                         A076761   001    Dec   01,   2006

AB                               10MG                          A078033   001    Mar   22,   2007
	
OXAPROZIN
	
  TABLET;ORAL

    DAYPRO
	
AB    + GD SEARLE                600MG                         N018841 004 Oct 29, 1992

    OXAPROZIN
	
AB       APOTEX INC              600MG                         A075987   001    Sep   02,   2004

AB       DR REDDYS LABS LTD      600MG                         A075855   001    Jan   31,   2001

AB       IVAX SUB TEVA PHARMS    600MG                         A075846   001    May   13,   2002

AB       SANDOZ                  600MG                         A075845   001    Jan   31,   2001

AB       SUN PHARM INDS INC      600MG                         A075844   001    Jan   03,   2002

AB       TEVA                    600MG                         A075849   001    Jul   03,   2002
	
OXAZEPAM
	
  CAPSULE;ORAL

    OXAZEPAM
	
AB        ACTAVIS ELIZABETH      10MG                          A072251   001    Apr   14,   1988

AB                               15MG                          A072252   001    Apr   14,   1988

AB    +                          30MG                          A072253   001    Apr   14,   1988

AB        SANDOZ                 10MG                          A071813   001    Apr   19,   1988

AB                               15MG                          A071756   001    Apr   19,   1988

AB                               30MG                          A071814   001    Apr   19,   1988
	
OXCARBAZEPINE
	
  SUSPENSION;ORAL

    OXCARBAZEPINE
	
AB       AMNEAL PHARMS           300MG/5ML                     A202961 001 Sep 17, 2012

AB       RANBAXY                 300MG/5ML                     A078734 001 Jun 26, 2009

AB       ROXANE                  300MG/5ML                     A201193 001 Oct 03, 2012

    TRILEPTAL
	
AB    + NOVARTIS                 300MG/5ML                     N021285 001 May 25, 2001

  TABLET;ORAL

    OXCARBAZEPINE
	
AB       APOTEX INC              150MG                         A077747   001    Apr   09,   2008

AB                               300MG                         A077747   002    Apr   09,   2008

AB                               600MG                         A077747   003    Apr   09,   2008

AB       BRECKENRIDGE PHARM      150MG                         A078069   001    Jan   11,   2008

AB                               300MG                         A078069   002    Jan   11,   2008

AB                               600MG                         A078069   003    Jan   11,   2008

AB       CADISTA PHARMS          150MG                         A090239   001    Jan   25,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-277(of 371)


OXCARBAZEPINE
	
  TABLET;ORAL

    OXCARBAZEPINE
	
AB                               300MG                         A090239   002    Jan   25,   2010

AB                               600MG                         A090239   003    Jan   25,   2010

AB       GLENMARK GENERICS       150MG                         A077802   001    Oct   09,   2007

AB                               300MG                         A077802   002    Oct   09,   2007

AB                               600MG                         A077802   003    Oct   09,   2007

AB       ROXANE                  150MG                         A077795   001    Oct   09,   2007

AB                               300MG                         A077795   002    Oct   09,   2007

AB                               600MG                         A077795   003    Oct   09,   2007

AB       SUN PHARM INDS          150MG                         A077794   001    Oct   09,   2007

AB                               300MG                         A077794   002    Oct   09,   2007

AB                               600MG                         A077794   003    Oct   09,   2007

AB       TARO                    150MG                         A077801   001    Nov   15,   2007

AB                               300MG                         A077801   002    Nov   15,   2007

AB                               600MG                         A077801   003    Nov   15,   2007

    TRILEPTAL
	
AB       NOVARTIS                150MG                         N021014 001 Jan 14, 2000

AB                               300MG                         N021014 002 Jan 14, 2000

AB    +                          600MG                         N021014 003 Jan 14, 2000
	
  TABLET, EXTENDED RELEASE;ORAL
	
    OXTELLAR XR
	
         SUPERNUS PHARMS         150MG                         N202810 001 Oct 19, 2012
	
                                 300MG                         N202810 002 Oct 19, 2012
	
      +                          600MG                         N202810 003 Oct 19, 2012
	
OXICONAZOLE NITRATE
	
  CREAM;TOPICAL
	
    OXISTAT
	
      + FOUGERA PHARMS          EQ 1% BASE                     N019828 001 Dec 30, 1988
	
  LOTION;TOPICAL
	
    OXISTAT
	
      + FOUGERA PHARMS          EQ 1% BASE                     N020209 001 Sep 30, 1992
	
OXTRIPHYLLINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    CHOLEDYL SA
	
      + WARNER CHILCOTT LLC      400MG                         A087863 001 May 24, 1983

      +                          600MG                         A086742 001
	
OXYBUTYNIN
	
  FILM, EXTENDED RELEASE;TRANSDERMAL

    OXYBUTYNIN
	
AB       BARR LABS DIV TEVA     3.9MG/24HR                     A090526 001 Mar 04, 2014

    OXYTROL
	
AB    + WATSON LABS (UTAH)      3.9MG/24HR                     N021351 002 Feb 26, 2003
	
  GEL, METERED;TRANSDERMAL
	
    GELNIQUE 3%
	
      + WATSON LABS INC         3%                             N202513 001 Dec 07, 2011
	
OXYBUTYNIN CHLORIDE
	
  GEL;TRANSDERMAL
	
    GELNIQUE
	
      + WATSON LABS              10%(100MG/PACKET)             N022204 001 Jan 27, 2009
	
  SYRUP;ORAL

    OXYBUTYNIN CHLORIDE
	
AA       PHARM ASSOC             5MG/5ML                       A075137   001    Dec   18,   1998

AA       SILARX                  5MG/5ML                       A074520   001    Mar   29,   1996

AA       VINTAGE PHARMS          5MG/5ML                       A076682   001    Dec   28,   2004

AA    + WOCKHARDT                5MG/5ML                       A074868   001    Feb   12,   1997
	
  TABLET;ORAL

    OXYBUTYNIN CHLORIDE
	
AB       TEVA PHARMS USA         5MG                           A071655 001 Nov 14, 1988

AB       USL PHARMA              5MG                           A074625 001 Jul 31, 1996

AB    + VINTAGE PHARMS           5MG                           A075079 001 Oct 31, 1997
	
  TABLET, EXTENDED RELEASE;ORAL

    DITROPAN XL
	
AB       JANSSEN PHARMS          5MG                           N020897 001 Dec 16, 1998

AB                               10MG                          N020897 002 Dec 16, 1998

AB    +                          15MG                          N020897 003 Jun 22, 1999

    OXYBUTYNIN CHLORIDE
	
AB       IMPAX PHARMS            5MG                           A076745 002 May 09, 2007

AB                               10MG                          A076745 003 May 09, 2007
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-278(of 371)


OXYBUTYNIN CHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

     OXYBUTYNIN CHLORIDE
	
AB
	                             15MG
	                          A076745   001    Nov   09,   2006

AB        MYLAN
	                5MG
	                           A076702   001    Nov   09,   2006

AB        MYLAN PHARMS INC
	     10MG
	                          A076644   001    Nov   09,   2006

AB
	                             15MG
	                          A076644   002    May   10,   2007

AB        OSMOTICA PHARM
	       5MG
	                           A078503   001    Feb   04,   2009

AB
	                             10MG
	                          A078503   002    Feb   04,   2009

AB
	                             15MG
	                          A078503   003    Feb   04,   2009
	
OXYCODONE HYDROCHLORIDE
	
  CAPSULE;ORAL

     OXYCODONE HYDROCHLORIDE
	
AB         COASTAL PHARMS           5MG
	                        A203107 001 Jul 26, 2012

AB         LANNETT HOLDINGS INC     5MG
	                        A203823 001 Aug 01, 2014

AB     + LEHIGH VALLEY              5MG
	                        N200534 001 Oct 20, 2010
	
  SOLUTION;ORAL

     OXYCODONE HYDROCHLORIDE
	
AA         COASTAL PHARMS
	         100MG/5ML
                   A204092   001    Jun   05,   2014

AA         LANNETT HOLDINGS INC
	   100MG/5ML
                   A204085   001    Sep   09,   2014

AA         LEHIGH VALLEY
	          5MG/5ML
                     N200535   002    Aug   22,   2013

AA     +
	                          100MG/5ML
                   N200535   001    Oct   20,   2010

AA         ROXANE
	                 5MG/5ML
                     A204037   001    Jul   15,   2013

AA
	                                100MG/5ML
                   A203208   001    Jul   12,   2013

AA     + VISTAPHARM
	               5MG/5ML
                     N201194   001    Jan   12,   2012

AA
	                                100MG/5ML
	                  A202537   001    Jul   30,   2012
	
  TABLET;ORAL

     OXYCODONE HYDROCHLORIDE
	
AB         ACTAVIS ELIZABETH
	      15MG
	                       A076636   001    Feb   06,   2004

AB
	                                30MG
	                       A076636   002    Feb   06,   2004

AB         ALVOGEN INC
	            5MG
	                        A202116   001    Dec   30,   2011

AB
	                                15MG
	                       A202116   002    Dec   30,   2011

AB
	                                30MG
	                       A202116   003    Dec   30,   2011

AB         AMNEAL PHARMS
	          5MG
	                        A203638   001    Jun   03,   2014

AB
	                                10MG
	                       A203638   002    Jun   03,   2014

AB
	                                15MG
	                       A203638   003    Jun   03,   2014

AB
	                                20MG
	                       A203638   004    Jun   03,   2014

AB
	                                30MG
	                       A203638   005    Jun   03,   2014

AB         AUROLIFE PHARMA LLC
	    5MG
	                        A202160   001    Nov   19,   2012

AB
	                                15MG
	                       A202160   002    Nov   19,   2012

AB
	                                30MG
	                       A202160   003    Nov   19,   2012

AB         AVANTHI INC
	            5MG
	                        A091393   001    Aug   31,   2009

AB
	                                10MG
	                       A091393   002    Aug   31,   2009

AB
	                                15MG
	                       A091393   003    Aug   31,   2009

AB
	                                20MG
	                       A091393   004    Aug   31,   2009

AB
	                                30MG
	                       A091393   005    Aug   31,   2009

AB         COASTAL PHARMS
	         5MG
	                        A091313   001    Feb   18,   2011

AB
	                                15MG
	                       A091313   002    Feb   18,   2011

AB
	                                30MG
	                       A091313   003    Feb   18,   2011

AB         COREPHARMA
	             5MG
	                        A090895   001    Aug   24,   2009

AB
	                                15MG
	                       A090895   002    Aug   24,   2009

AB
	                                30MG
	                       A090895   003    Aug   24,   2009

AB         MALLINCKRODT INC
	       5MG
	                        A076758   003    Mar   19,   2007

AB
	                                15MG
	                       A076758   001    Jun   30,   2004

AB
	                                30MG
	                       A076758   002    Jun   30,   2004

AB         NESHER PHARMS
	          5MG
	                        A077290   001    Dec   08,   2005

AB
	                                10MG
	                       A077290   002    Dec   08,   2005

AB
	                                15MG
	                       A077290   003    Dec   08,   2005

AB
	                                20MG
	                       A077290   004    Dec   08,   2005

AB
	                                30MG
	                       A077290   005    Dec   08,   2005

AB         RHODES PHARMS
	          5MG
	                        A091490   001    Mar   09,   2011

AB
	                                10MG
	                       A091490   002    Mar   09,   2011

AB
	                                15MG
	                       A091490   003    Mar   09,   2011

AB
	                                20MG
	                       A091490   004    Mar   09,   2011

AB
	                                30MG
	                       A091490   005    Mar   09,   2011

AB         SUN PHARM INDS INC
	     5MG
	                        A090659   001    Apr   10,   2009

AB
	                                10MG
	                       A090659   005    Nov   06,   2012

AB
	                                15MG
	                       A090659   002    Apr   10,   2009

AB
	                                20MG
	                       A090659   004    Nov   06,   2012

AB
	                                30MG
	                       A090659   003    Apr   10,   2009

AB         VINTAGE PHARMS
	         5MG
	                        A077712   003    Mar   02,   2009

AB
	                                15MG
	                       A077712   001    Jan   31,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-279(of 371)


OXYCODONE HYDROCHLORIDE
	
  TABLET;ORAL

     OXYCODONE HYDROCHLORIDE
	
AB
	                             30MG
	                         A077712 002 Jan 31, 2007
	
     ROXICODONE
	
AB         MALLINCKRODT INC
	    5MG
	                          N021011 003 May 15, 2009

AB     +
	                       15MG
	                         N021011 001 Aug 31, 2000

AB
	                             30MG
	                         N021011 002 Aug 31, 2000
	
     OXECTA
	
           ACURA PHARMS INC
	    5MG
	                          N202080 001 Jun 17, 2011
	
                                 7.5MG
	                        N202080 002 Jun 17, 2011
	
  TABLET, EXTENDED RELEASE;ORAL
	
    OXYCONTIN
	
          PURDUE PHARMA LP
	     10MG
	                         N022272   001    Apr   05,   2010

                                 15MG
	                         N022272   002    Apr   05,   2010

                                 20MG
	                         N022272   003    Apr   05,   2010

                                 30MG
	                         N022272   004    Apr   05,   2010

      +
	                        40MG
	                         N022272   005    Apr   05,   2010

                                 60MG
	                         N022272   006    Apr   05,   2010

                                 80MG
	                         N022272   007    Apr   05,   2010
	
OXYMETHOLONE
	
  TABLET;ORAL
	
    ANADROL-50
	
      + MEDA PHARMS
	            50MG
	                         N016848 001
	
OXYMORPHONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
     OPANA
	
       + ENDO PHARMS
	           1MG/ML
	                       N011707 002
	
  TABLET;ORAL

     OPANA
	
AB         ENDO PHARMS
	         5MG
	                          N021611 001 Jun 22, 2006

AB     +
	                       10MG
	                         N021611 002 Jun 22, 2006
	
     OXYMORPHONE HYDROCHLORIDE
	
AB         AVANTHI INC
	         5MG
	                          A203601   001    Jan   30,   2013

AB
	                             10MG
	                         A203601   002    Jan   30,   2013

AB         COREPHARMA
	          5MG
	                          A201187   001    Dec   15,   2014

AB
	                             10MG
	                         A201187   002    Dec   15,   2014

AB         MALLINCKRODT INC
	    5MG
	                          A202321   001    Apr   25,   2013

AB
	                             10MG
	                         A202321   002    Apr   25,   2013

AB         ROXANE
	              5MG
	                          A090964   001    Sep   27,   2010

AB
	                             10MG
	                         A090964   002    Sep   27,   2010

AB         TEVA
	                5MG
	                          A091443   002    Feb   15,   2011

AB
	                             10MG
	                         A091443   001    Feb   15,   2011
	
  TABLET, EXTENDED RELEASE;ORAL

     OXYMORPHONE HYDROCHLORIDE
	
AB         ACTAVIS ELIZABETH
	   5MG
	                          A079046   003    Jul   11,   2013

AB
	                             7.5MG
	                        A079046   001    Dec   13,   2010

AB
	                             10MG
	                         A079046   004    Jul   11,   2013

AB
	                             15MG
	                         A079046   002    Dec   13,   2010

AB
	                             20MG
	                         A079046   005    Jul   11,   2013

AB
	                             30MG
	                         A079046   006    Jul   11,   2013

AB
	                             40MG
	                         A079046   007    Jul   11,   2013

AB         IMPAX LABS
	          5MG
	                          A079087   001    Jun   14,   2010

AB
	                             7.5MG
	                        A079087   002    Dec   21,   2010

AB
	                             10MG
	                         A079087   003    Jun   14,   2010

AB
	                             15MG
	                         A079087   004    Dec   21,   2010

AB
	                             20MG
	                         A079087   005    Jun   14,   2010

AB
	                             30MG
	                         A079087   006    Jul   22,   2010

AB
	                             40MG
	                         A079087   007    Jun   14,   2010

AB         MALLINCKRODT INC
	    5MG
	                          A202946   001    Jun   27,   2014

AB
	                             7.5MG
	                        A202946   002    Jun   27,   2014

AB
	                             10MG
	                         A202946   003    Jun   27,   2014

AB
	                             15MG
	                         A202946   004    Jun   27,   2014

AB
	                             20MG
	                         A202946   005    Jun   27,   2014

AB
	                             30MG
	                         A202946   006    Jun   27,   2014

AB
	                             40MG
	                         A202946   007    Jun   27,   2014

AB         PAR PHARM
	           5MG
	                          A200792   001    Oct   24,   2014

AB
	                             7.5MG
	                        A200792   002    Oct   24,   2014

AB
	                             10MG
	                         A200792   003    Oct   24,   2014

AB
	                             15MG
	                         A200792   004    Oct   24,   2014

AB
	                             20MG
	                         A200792   005    Oct   24,   2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                              3-280(of 371)


OXYMORPHONE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    OXYMORPHONE HYDROCHLORIDE
	
AB                               30MG                                  A200792   006     Oct   24,   2014

AB                               40MG                                  A200792   007     Oct   24,   2014

AB       ROXANE                  5MG                                   A200822   002     Jul   15,   2013

AB                               7.5MG                                 A200822   003     Jul   15,   2013

AB                               10MG                                  A200822   004     Jul   15,   2013

AB                               15MG                                  A200822   005     Jul   15,   2013

AB                               20MG                                  A200822   006     Jul   15,   2013

AB                               30MG                                  A200822   007     Jul   15,   2013

AB                               40MG                                  A200822   001     Jul   15,   2013
	
    OPANA ER
	
         ENDO PHARMS		           5MG                                   N201655   001     Dec   09,   2011
	
                                 7.5MG                                 N201655   002     Dec   09,   2011
	
                                 10MG                                  N201655   003     Dec   09,   2011
	
                                 15MG                                  N201655   004     Dec   09,   2011
	
                                 20MG                                  N201655   005     Dec   09,   2011
	
                                 30MG                                  N201655   006     Dec   09,   2011
	
      +                          40MG                                  N201655   007     Dec   09,   2011
	
OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    TERRAMYCIN W/ POLYMYXIN B SULFATE

      + PFIZER		                EQ 5MG BASE/GM;10,000 UNITS/GM         A061015 001
	
OXYTOCIN
	
  INJECTABLE;INJECTION

    OXYTOCIN
	
AP    + FRESENIUS KABI USA        10USP UNITS/ML (10USP UNITS/ML)      N018248   001
	
AP    +                           100USP UNITS/10ML (10USP UNITS/ML)   N018248   002
	
AP        HIKMA FARMACEUTICA      10USP UNITS/ML (10USP UNITS/ML)      A200219   001     Feb 13, 2013

AP    + HIKMA MAPLE               10USP UNITS/ML (10USP UNITS/ML)      N018243   001
	
AP    +                           100USP UNITS/10ML (10USP UNITS/ML)   N018243   002     Jan 10, 2007

AP        SAGENT PHARMS           10USP UNITS/ML (10USP UNITS/ML)      A091676   001     Oct 29, 2014

AP                                100USP UNITS/10ML (10USP UNITS/ML)   A091676   002     Oct 29, 2014

    PITOCIN
	
AP    + PAR STERILE PRODUCTS      10USP UNITS/ML (10USP UNITS/ML)      N018261 001
	
AP                                100USP UNITS/10ML (10USP UNITS/ML)   N018261 002 Jul 27, 2007
	
    OXYTOCIN
	
      + FRESENIUS KABI USA        300USP UNITS/30ML (10USP UNITS/ML)   N018248 003 Jul 27, 2007
	
    PITOCIN
	
          PAR STERILE PRODUCTS    500USP UNITS/50ML (10USP UNITS/ML)   N018261 003 Sep 05, 2012
	
PACLITAXEL
	
  FOR SUSPENSION;IV (INFUSION)

    ABRAXANE
	
      + ABRAXIS BIOSCIENCE        100MG/VIAL                           N021660 001 Jan 07, 2005
	
  INJECTABLE;INJECTION

    PACLITAXEL
	
AP       ACTAVIS TOTOWA           6MG/ML                               A090130   001     Dec   09,   2009

AP       EBEWE PHARMA             6MG/ML                               A078167   001     Dec   26,   2007

AP       EUROHLTH INTL            6MG/ML                               A075190   001     Jan   28,   2002

AP       FRESENIUS KABI ONCOL     6MG/ML                               A077574   001     Nov   27,   2006

AP    + HOSPIRA                   6MG/ML                               A076131   001     May   08,   2002

AP       ONCO THERAPIES LTD       6MG/ML                               A091540   001     Sep   29,   2011

AP       TEVA PHARMS              6MG/ML                               A075184   001     Jan   25,   2002

    TAXOL
	
AP       HQ SPCLT PHARMA          6MG/ML                               N020262 001 Dec 29, 1992
	
PALIPERIDONE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    INVEGA
	
          JANSSEN PHARMS         1.5MG                                 N021999   006     Aug   26,   2008

                                 3MG                                   N021999   001     Dec   19,   2006
	
      +		                        6MG                                   N021999   002     Dec   19,   2006
	
                                 9MG                                   N021999   003     Dec   19,   2006
	
PALIPERIDONE PALMITATE
	
  SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
    INVEGA SUSTENNA
         JANSSEN PHARMS         39MG/0.25ML (39MG/0.25ML)              N022264   001     Jul   31,   2009
                                78MG/0.5ML (78MG/0.5ML)                N022264   002     Jul   31,   2009
      +                         117MG/0.75ML (117MG/0.75ML)            N022264   003     Jul   31,   2009
                                156MG/ML (156MG/ML)                    N022264   004     Jul   31,   2009
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                  3-281(of 371)


PALIPERIDONE PALMITATE
	
  SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
	
    INVEGA SUSTENNA
	
                                234MG/1.5ML (156MG/ML)                     N022264 005 Jul 31, 2009
	
PALONOSETRON HYDROCHLORIDE
	
  INJECTABLE;INTRAVENOUS
	
    ALOXI
	
      +		 HELSINN HLTHCARE      EQ 0.075MG BASE/1.5ML (EQ 0.05MG           N021372 002 Feb 29, 2008

                                BASE/ML)

     +		                        EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)     N021372 001 Jul 25, 2003
	
PAMIDRONATE DISODIUM
	
  INJECTABLE;INJECTION

    PAMIDRONATE DISODIUM
	
AP       AGILA SPECLTS          30MG/10ML   (3MG/ML)                       A078520   001    Oct   31,   2008

AP                              90MG/10ML   (9MG/ML)                       A078520   002    Oct   31,   2008

AP       AREVA PHARMS           30MG/VIAL                                  A077433   001    Nov   26,   2008

AP                              60MG/VIAL                                  A077433   002    Nov   26,   2008

AP                              90MG/VIAL                                  A077433   003    Nov   26,   2008

AP       EUROHLTH INTL          30MG/VIAL                                  A075290   001    Apr   30,   2001

AP    +                         30MG/10ML   (3MG/ML)                       N021113   001    Mar   04,   2002

AP                              90MG/VIAL                                  A075290   003    Apr   30,   2001

AP    +                         90MG/10ML   (9MG/ML)                       N021113   002    Mar   04,   2002

AP       FRESENIUS KABI USA     30MG/VIAL                                  A075773   001    May   06,   2002

AP                              30MG/10ML   (3MG/ML)                       A076207   001    May   17,   2002

AP                              90MG/VIAL                                  A075773   002    May   06,   2002

AP                              90MG/10ML   (9MG/ML)                       A076207   002    May   17,   2002

AP    + HOSPIRA                 30MG/10ML   (3MG/ML)                       A075841   001    Jun   27,   2002

AP    +                         60MG/10ML   (6MG/ML)                       A075841   002    Jun   27,   2002

AP    +                         90MG/10ML   (9MG/ML)                       A075841   003    Jun   27,   2002

AP       LUITPOLD               30MG/10ML   (3MG/ML)                       A078942   001    Jul   25,   2008

AP                              90MG/10ML   (9MG/ML)                       A078942   002    Jul   25,   2008

AP       MUSTAFA NEVZAT         30MG/10ML   (3MG/ML)                       A078373   001    Dec   23,   2008

AP                              90MG/10ML   (9MG/ML)                       A078373   002    Dec   23,   2008

AP       PLIVA LACHEMA          30MG/10ML   (3MG/ML)                       A078156   001    Aug   19,   2008

AP                              60MG/10ML   (6MG/ML)                       A078156   002    Aug   19,   2008

AP                              90MG/10ML   (9MG/ML)                       A078156   003    Aug   19,   2008

AP       SUN PHARMA GLOBAL      30MG/VIAL                                  A077703   001    Dec   24,   2008

AP                              90MG/VIAL                                  A077703   002    Dec   24,   2008

AP       TEVA PHARMS USA        30MG/10ML   (3MG/ML)                       A076153   001    Mar   27,   2002

AP                              90MG/10ML   (9MG/ML)                       A076153   002    Mar   27,   2002
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

  CAPSULE, DELAYED RELEASE;ORAL
	
    CREON
	
          ABBVIE                 12,000USP UNITS\;38,000USP                N020725 002 Apr 30, 2009

                                 UNITS\;60,000USP UNITS\

                                 15,000USP UNITS\;3,000USP                 N020725 004 Jul 12, 2011

                                 UNITS\;9,500USP UNITS\

                                 19,000USP UNITS\;30,000USP                N020725 001 Apr 30, 2009

                                 UNITS\;6,000USP UNITS\

                                 114,000USP UNITS;180,000USP               N020725 005 Mar 14, 2013

                                 UNITS;36,000USP UNITS
	
      +		                        120,000USP UNITS\;24,000USP               N020725 003 Apr 30, 2009

                                 UNITS\;76,000USP UNITS\

    PANCREAZE
	
          JANSSEN PHARMS		       10,850USP UNITS;2,600USP UNITS;6,200USP   N022523 005 Mar 07, 2014

                                 UNITS
	
                                 17,500USP UNITS;4,200USP                  N022523 001 Apr 12, 2010

                                 UNITS;10,000USP UNITS

                                 43,750USP UNITS;10,500USP                 N022523 002 Apr 12, 2010

                                 UNITS;25,000USP UNITS
	
      +		                        61,000USP UNITS;21,000USP                 N022523 003 Apr 12, 2010

                                 UNITS;37,000USP UNITS

                                 70,000USP UNITS;16,800USP                 N022523 004 Apr 12, 2010

                                 UNITS;40,000USP UNITS

    PERTZYE
	
          DIGESTIVE CARE INC     30,250USP UNITS;8,000USP                  N022175 001 May 17, 2012

                                 UNITS;28,750USP UNITS
	
      +		                        60,500USP UNITS;16,000USP                 N022175 002 May 17, 2012

                                 UNITS;57,500USP UNITS

    ULTRESA
	
          FOREST LABS INC		      13,800USP UNITS;27,600USP                 N022222 001 Mar 01, 2012

                                 UNITS;27,600USP UNITS

                                 20,700USP UNITS;41,400USP                 N022222 002 Mar 01, 2012

                                 UNITS;41,400USP UNITS
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                           3-282(of 371)


PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

  CAPSULE, DELAYED RELEASE;ORAL
	
    ULTRESA
	
      +		                        23,000USP UNITS;46,000USP           N022222 003 Mar 01, 2012

                                 UNITS;46,000USP UNITS

    ZENPEP
	
          FOREST LABS INC		      218,000USP UNITS; 40,00USP UNITS;   N022210 007 Mar 25, 2014

                                 136,000 USP UNITS

                                 10,000USP UNITS;16,000USP           N022210 005 Jun 15, 2011

                                 UNITS;3,000USP UNITS

                                 10,000USP UNITS;34,000USP           N022210 002 Aug 27, 2009

                                 UNITS;55,000USP UNITS

                                 15,000USP UNITS;51,000USP           N022210 003 Aug 27, 2009

                                 UNITS;82,000USP UNITS

                                 17,000USP UNITS;27,000USP           N022210 001 Aug 27, 2009

                                 UNITS;5,000USP UNITS

                                 109,000USP UNITS;20,000USP          N022210 004 Aug 27, 2009

                                 UNITS;68,000USP UNITS
	
      +		                        136,000USP UNITS;25,000USP          N022210 006 Jul 13, 2011

                                 UNITS;85,000USP UNITS

  TABLET;ORAL
	
    VIOKACE
	
          FOREST LABS INC        10440USPU;39150USPU;39150USPU       N022542 001 Mar 01, 2012
	
      +		                        20880USPU;78300USPU;78300USPU       N022542 002 Mar 01, 2012
	
PANCURONIUM BROMIDE
	
  INJECTABLE;INJECTION

    PANCURONIUM BROMIDE
	
AP       HOSPIRA                1MG/ML                               A072320 001 Jan 19, 1989

AP    + TEVA PHARMS USA         1MG/ML                               A072759 001 Jul 31, 1990

AP    +                         2MG/ML                               A072760 001 Jul 31, 1990
	
PANTOPRAZOLE SODIUM
	
  FOR SUSPENSION, DELAYED RELEASE;ORAL
	
    PROTONIX
	
      + WYETH PHARMS INC        EQ 40MG    BASE                      N022020 001 Nov 14, 2007
	
  INJECTABLE;IV (INFUSION)

    PANTOPRAZOLE SODIUM
	
AP       AKORN INC              EQ 40MG    BASE/VIAL                 A079197 001 Nov 08, 2012

    PROTONIX IV
	
AP    + WYETH PHARMS INC        EQ 40MG    BASE/VIAL                 N020988 001 Mar 22, 2001
	
  TABLET, DELAYED RELEASE;ORAL

    PANTOPRAZOLE SODIUM
	
AB       ACTAVIS TOTOWA         EQ 20MG    BASE                      A090797   001    Feb   07,   2011

AB                              EQ 40MG    BASE                      A090797   002    Feb   07,   2011

AB       APOTEX INC             EQ 20MG    BASE                      A090807   001    May   02,   2012

AB                              EQ 40MG    BASE                      A090807   002    May   02,   2012

AB       AUROBINDO PHARMA LTD   EQ 20MG    BASE                      A202038   001    Sep   28,   2012

AB                              EQ 40MG    BASE                      A202038   002    Sep   28,   2012

AB       DR REDDYS LABS LTD     EQ 20MG    BASE                      A077619   001    Jan   19,   2011

AB                              EQ 40MG    BASE                      A077619   002    Jan   19,   2011

AB       HETERO LABS LTD V      EQ 20MG    BASE                      A202882   001    Sep   10,   2014

AB                              EQ 40MG    BASE                      A202882   002    Sep   10,   2014

AB       JUBILANT GENERICS      EQ 20MG    BASE                      A090901   001    Aug   30,   2011

AB                              EQ 40MG    BASE                      A090901   002    Aug   30,   2011

AB       KUDCO IRELAND          EQ 20MG    BASE                      A078281   001    Jan   20,   2011

AB                              EQ 40MG    BASE                      A078281   002    Jan   20,   2011

AB       MACLEODS PHARMS LTD    EQ 20MG    BASE                      A200821   001    Feb   16,   2012

AB                              EQ 40MG    BASE                      A200821   002    Feb   16,   2012

AB       MYLAN PHARMS INC       EQ 20MG    BASE                      A090970   001    Jan   19,   2011

AB                              EQ 40MG    BASE                      A090970   002    Jan   19,   2011

AB       ORCHID HLTHCARE        EQ 20MG    BASE                      A202052   001    Dec   02,   2014

AB                              EQ 40MG    BASE                      A202052   002    Dec   02,   2014

AB       PERRIGO R AND D        EQ 20MG    BASE                      A203024   001    May   07,   2014

AB       RANBAXY LABS LTD       EQ 20MG    BASE                      A200794   001    May   02,   2012

AB                              EQ 40MG    BASE                      A200794   002    May   02,   2012

AB       SUN PHARMA GLOBAL      EQ 20MG    BASE                      A077058   001    Sep   10,   2007

AB                              EQ 40MG    BASE                      A077058   002    Sep   10,   2007

AB       TEVA                   EQ 20MG    BASE                      A077056   001    Aug   02,   2007

AB                              EQ 40MG    BASE                      A077056   002    Aug   02,   2007

AB       TORRENT PHARMS         EQ 20MG    BASE                      A090074   001    Jan   19,   2011

AB                              EQ 40MG    BASE                      A090074   002    Jan   19,   2011

AB       WOCKHARDT              EQ 20MG    BASE                      A091231   001    Jan   19,   2011

AB                              EQ 40MG    BASE                      A091231   002    Jan   19,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-283(of 371)


PANTOPRAZOLE SODIUM
	
  TABLET, DELAYED RELEASE;ORAL

    PROTONIX
	
AB       WYETH PHARMS INC       EQ 20MG BASE                    N020987 002 Jun 12, 2001

AB    +                         EQ 40MG BASE                    N020987 001 Feb 02, 2000
	
PARICALCITOL
	
  CAPSULE;ORAL

    PARICALCITOL
	
AB       BANNER PHARMACAPS       1MCG                           A202539   001    Mar   27,   2014

AB                               2MCG                           A202539   002    Mar   27,   2014

AB                               4MCG                           A202539   003    Mar   27,   2014

AB       DR REDDYS LABS LTD      1MCG                           A091412   001    Jun   24,   2014

AB                               2MCG                           A091412   002    Jun   24,   2014

AB                               4MCG                           A091412   003    Jun   24,   2014

AB       RISING PHARMS INC       1MCG                           A202124   001    Jun   24,   2014

AB                               2MCG                           A202124   002    Jun   24,   2014

AB                               4MCG                           A202124   003    Jun   24,   2014

AB       TEVA PHARMS USA         1MCG                           A090829   001    Sep   27,   2013

AB                               2MCG                           A090829   002    Sep   27,   2013

AB                               4MCG                           A090829   003    Sep   27,   2013

    ZEMPLAR
	
AB       ABBVIE                  1MCG                           N021606 001 May 26, 2005

AB                               2MCG                           N021606 002 May 26, 2005

AB    +                          4MCG                           N021606 003 May 26, 2005

  SOLUTION;INTRAVENOUS

    PARICALCITOL
	
AP       HIKMA PHARMS            0.002MG/ML     (0.002MG/ML)    N205917   001    Nov   18,   2014

AP                               0.005MG/ML     (0.005MG/ML)    N205917   002    Nov   18,   2014

AP                               0.01MG/2ML     (0.005MG/ML)    N205917   003    Nov   18,   2014

AP       HOSPIRA INC             0.002MG/ML     (0.002MG/ML)    N201657   001    Oct   21,   2014

AP                               0.005MG/ML     (0.005MG/ML)    N201657   002    Oct   21,   2014

AP                               0.01MG/2ML     (0.005MG/ML)    N201657   003    Oct   21,   2014

AP       SANDOZ CANADA INC       0.002MG/ML     (0.002MG/ML)    A091108   001    Jul   27,   2011

AP                               0.005MG/ML     (0.005MG/ML)    A091108   002    Jul   27,   2011

AP                               0.01MG/2ML     (0.005MG/ML)    A091108   003    Jul   27,   2011

    ZEMPLAR
	
AP    + ABBVIE                   0.002MG/ML (0.002MG/ML)        N020819 002 Feb 01, 2000

AP    +                          0.005MG/ML (0.005MG/ML)        N020819 001 Apr 17, 1998

AP    +                          0.01MG/2ML (0.005MG/ML)        N020819 003 Feb 01, 2000
	
PAROMOMYCIN SULFATE
	
  CAPSULE;ORAL

    PAROMOMYCIN SULFATE
	
AA       HERITAGE PHARMS INC     EQ 250MG BASE                  A065173 001 Dec 14, 2007

AA    + SUN PHARM INDS INC       EQ 250MG BASE                  A064171 001 Jun 30, 1997
	
PAROXETINE HYDROCHLORIDE
	
  SUSPENSION;ORAL

    PAXIL
	
AB    + APOTEX TECHNOLOGIES      EQ 10MG BASE/5ML               N020710 001 Jun 25, 1997
	
  TABLET;ORAL

    PAROXETINE
	
AB       PRINSTON INC            EQ   10MG   BASE               A203854   001    Oct   31,   2014

AB                               EQ   20MG   BASE               A203854   002    Oct   31,   2014

AB                               EQ   30MG   BASE               A203854   003    Oct   31,   2014

AB                               EQ   40MG   BASE               A203854   004    Oct   31,   2014

    PAROXETINE HYDROCHLORIDE
	
AB       APOTEX                  EQ   10MG   BASE               A075356   001    Jul   30,   2003

AB                               EQ   20MG   BASE               A075356   002    Jul   30,   2003

AB                               EQ   30MG   BASE               A075356   003    Jul   30,   2003

AB                               EQ   40MG   BASE               A075356   004    Jul   30,   2003

AB       AUROBINDO PHARMA        EQ   10MG   BASE               A078406   001    Jul   25,   2007

AB                               EQ   20MG   BASE               A078406   002    Jul   25,   2007

AB                               EQ   30MG   BASE               A078406   003    Jul   25,   2007

AB                               EQ   40MG   BASE               A078406   004    Jul   25,   2007

AB       MYLAN                   EQ   10MG   BASE               A078902   001    Mar   13,   2008

AB                               EQ   20MG   BASE               A078902   002    Mar   13,   2008

AB                               EQ   30MG   BASE               A078902   003    Mar   13,   2008

AB                               EQ   40MG   BASE               A078902   004    Mar   13,   2008

AB       MYLAN PHARMS INC        EQ   10MG   BASE               A075716   001    Mar   08,   2004

AB                               EQ   20MG   BASE               A075716   002    Mar   08,   2004

AB                               EQ   30MG   BASE               A075716   003    Mar   08,   2004

AB                               EQ   40MG   BASE               A075716   004    Mar   08,   2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                              3-284(of 371)


PAROXETINE HYDROCHLORIDE
	
  TABLET;ORAL

     PAROXETINE HYDROCHLORIDE
	
AB         PROSAM LABS
	         EQ    10MG   BASE
                       A076968   001    Jun   21,   2010

AB
	                             EQ    20MG   BASE
                       A076968   002    Jun   21,   2010

AB
	                             EQ    30MG   BASE
                       A076968   003    Jun   21,   2010

AB
	                             EQ    40MG   BASE
                       A076968   004    Jun   21,   2010

AB         SUN PHARM INDS INC
	  EQ    10MG   BASE
                       A078194   001    Jun   29,   2007

AB
	                             EQ    20MG   BASE
                       A078194   002    Jun   29,   2007

AB
	                             EQ    30MG   BASE
                       A078194   003    Jun   29,   2007

AB
	                             EQ    40MG   BASE
                       A078194   004    Jun   29,   2007

AB         TEVA
	                EQ    10MG   BASE
                       A076618   001    Aug   15,   2005

AB
	                             EQ    20MG   BASE
                       A076618   002    Aug   15,   2005

AB
	                             EQ    30MG   BASE
                       A076618   003    Aug   15,   2005

AB
	                             EQ    40MG   BASE
                       A076618   004    Aug   15,   2005

AB         ZYDUS PHARMS USA
	    EQ    10MG   BASE
                       A077584   001    Mar   07,   2007

AB
	                             EQ    20MG   BASE
                       A077584   002    Mar   07,   2007

AB
	                             EQ    30MG   BASE
                       A077584   003    Mar   07,   2007

AB
	                             EQ    40MG   BASE
	                      A077584   004    Mar   07,   2007
	
     PAXIL
	
AB         APOTEX TECHNOLOGIES
	 EQ    10MG   BASE
                       N020031   001    Dec   29,   1992

AB
	                             EQ    20MG   BASE
                       N020031   002    Dec   29,   1992

AB
	                             EQ    30MG   BASE
                       N020031   003    Dec   29,   1992

AB     +
	                       EQ    40MG   BASE
	                      N020031   005    Dec   29,   1992
	
  TABLET, EXTENDED RELEASE;ORAL

     PAROXETINE HYDROCHLORIDE
	
AB         MYLAN
	               EQ    12.5MG BASE
                       A077873 001 Jun 29, 2007

AB
	                             EQ    25MG BASE
                         A077873 002 Jun 29, 2007

AB
	                             EQ    37.5MG BASE
	                      A091427 001 Apr 14, 2011
	
     PAXIL CR
	
AB         APOTEX TECHNOLOGIES
	 EQ    12.5MG BASE
                       N020936 001 Feb 16, 1999

AB
	                             EQ    25MG BASE
                         N020936 002 Feb 16, 1999

AB     +
	                       EQ    37.5MG BASE
	                      N020936 003 Dec 06, 2000
	
PAROXETINE MESYLATE
	
  CAPSULE;ORAL
	
    BRISDELLE
	
      + NOVEN THERAP
	            EQ 7.5MG BASE
	                         N204516 001 Jun 28, 2013
	
  TABLET;ORAL
	
    PEXEVA
	
         NOVEN THERAP
	           EQ   10MG   BASE
	                      N021299   001    Jul   03,   2003
	
                                  EQ   20MG   BASE
	                      N021299   002    Jul   03,   2003
	
                                  EQ   30MG   BASE
	                      N021299   003    Jul   03,   2003
	
     +
	                          EQ   40MG   BASE
	                      N021299   004    Jul   03,   2003
	
PASIREOTIDE DIASPARTATE
	
  SOLUTION;SUBCUTANEOUS
	
    SIGNIFOR
	
         NOVARTIS
	               EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML)
    N200677 001 Dec 14, 2012
	
                                  EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML)
    N200677 002 Dec 14, 2012
	
     +
	                          EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)
	   N200677 003 Dec 14, 2012
	
PASIREOTIDE PAMOATE
	
  POWDER;INTRAMUSCULAR
	
    SIGNIFOR LAR
	
         NOVARTIS PHARMS CORP
	   EQ 20MG BASE/VIAL
                      N203255 001 Dec 15, 2014
	
                                  EQ 40MG BASE/VIAL
                      N203255 002 Dec 15, 2014
	
     +
	                          EQ 60MG BASE/VIAL
	                     N203255 003 Dec 15, 2014
	
PAZOPANIB HYDROCHLORIDE
	
  TABLET;ORAL
	
    VOTRIENT
	
      + GLAXOSMITHKLINE
	         EQ 200MG BASE
	                         N022465 001 Oct 19, 2009
	
                                  EQ 400MG BASE
	                         N022465 002 Oct 19, 2009
	
PEGADEMASE BOVINE
	
  INJECTABLE;INJECTION
	
    ADAGEN
	
      + SIGMA TAU
	               250 UNITS/ML
	                          N019818 001 Mar 21, 1990
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                          3-285(of 371)


PEGAPTANIB SODIUM
	
  INJECTABLE;INTRAVITREAL
	
    MACUGEN
	
      + VALEANT PHARMS LLC       EQ 0.3MG ACID/0.09ML                 N021756 001 Dec 17, 2004
	
PEGVISOMANT
	
  INJECTABLE;SUBCUTANEOUS
	
    SOMAVERT
	
      + PHARMACIA AND UPJOHN     10MG/VIAL                            N021106   001    Mar   25,   2003
	
      +                          15MG/VIAL                            N021106   002    Mar   25,   2003
	
      +                          20MG/VIAL                            N021106   003    Mar   25,   2003
	
      +                          25MG/VIAL                            N021106   004    Jul   31,   2014
	
      +                          30MG/VIAL                            N021106   005    Jul   31,   2014
	
PEMETREXED DISODIUM
	
  INJECTABLE;IV (INFUSION)

    ALIMTA
	
      + LILLY                    EQ 100MG BASE/VIAL                   N021462 002 Sep 07, 2007

      +                          EQ 500MG BASE/VIAL                   N021462 001 Feb 04, 2004
	
PENCICLOVIR SODIUM
	
  CREAM;TOPICAL
	
    DENAVIR
	
      + DENCO ASSET              1%                                   N020629 001 Sep 24, 1996
	
PENICILLAMINE
	
  CAPSULE;ORAL
	
    CUPRIMINE
	
      + ATON                     250MG                                N019853 001
	
  TABLET;ORAL
	
    DEPEN
	
      + MEDA PHARMS              250MG                                N019854 001
	
PENICILLIN G BENZATHINE
	
  INJECTABLE;INJECTION
	
    BICILLIN L-A
	
BC    + KING PHARMS              600,000 UNITS/ML                     N050141 001
	
    PERMAPEN
	
BC       PFIZER                  600,000 UNITS/ML                     A060014 001
	
    BICILLIN L-A
	
      + KING PHARMS              300,000 UNITS/ML                     N050141 003
	
PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE
	
  INJECTABLE;INJECTION
	
    BICILLIN C-R
	
      + KING PHARMS             150,000 UNITS/ML;150,000 UNITS/ML     N050138 002
	
      +                         300,000 UNITS/ML;300,000 UNITS/ML     N050138 001
	
    BICILLIN C-R 900/300

      + KING PHARMS             900,000 UNITS/2ML;300,000 UNITS/2ML   N050138 003
	
PENICILLIN G POTASSIUM
	
  INJECTABLE;INJECTION

    PENICILLIN G POTASSIUM
	
AP       HANFORD GC             5,000,000 UNITS/VIAL                  A065149   002    Jul   23,   2009

AP                              20,000,000 UNITS/VIAL                 A065149   003    Jul   23,   2009

AP       ISTITUTO BIO ITA SPA   5,000,000 UNITS/VIAL                  A065448   001    Aug   18,   2009

AP                              20,000,000 UNITS/VIAL                 A065448   002    Aug   18,   2009

AP       SANDOZ                 5,000,000 UNITS/VIAL                  A065079   002    Aug   30,   2002

AP                              20,000,000 UNITS/VIAL                 A065079   003    Aug   30,   2002

    PFIZERPEN
	
AP    + PFIZER                  5,000,000 UNITS/VIAL                  A060657 002
	
AP    +                         20,000,000 UNITS/VIAL                 A060657 003
	
    PENICILLIN G POTASSIUM
	
         HANFORD GC             1,000,000 UNITS/VIAL                  A065149 001 Jul 23, 2009
	
    PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         20,000 UNITS/ML                       N050638 001 Jun 25, 1990
	
      +                         40,000 UNITS/ML                       N050638 002 Jun 25, 1990
	
      +                         60,000 UNITS/ML                       N050638 003 Jun 25, 1990
	
PENICILLIN G PROCAINE
	
  INJECTABLE;INJECTION
	
    PENICILLIN G PROCAINE
	
      + KING PHARMS              300,000 UNITS/ML                     A060101 002
	
      +                          600,000 UNITS/ML                     A060101 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-286(of 371)


PENICILLIN G SODIUM
	
  INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
	
    PENICILLIN G SODIUM
	
      + SANDOZ
	                5,000,000 UNITS/VIAL
	          A065068 001 Feb 26, 2001
	
PENICILLIN V POTASSIUM
	
  FOR SOLUTION;ORAL

     PENICILLIN V POTASSIUM
AA         DAVA PHARMS INC       EQ 125MG BASE/5ML
             A062981 001 Feb 10, 1989

AA                               EQ 250MG BASE/5ML
	            A062981 002 Feb 10, 1989
	
     PENICILLIN-VK
AA         TEVA                  EQ 125MG BASE/5ML
             A060456 001
	
AA     +                         EQ 250MG BASE/5ML
	            A060456 002
	
  TABLET;ORAL

     PENICILLIN V POTASSIUM
	
AB         AUROBINDO PHARMA
	    EQ   250MG   BASE
             A065435   001    Apr   29,   2008

AB
	                             EQ   500MG   BASE
             A065435   002    Apr   29,   2008

AB         DAVA PHARMS INC
	     EQ   250MG   BASE
             A062936   001    Nov   25,   1988

AB
	                             EQ   500MG   BASE
             A062935   001    Nov   23,   1988

AB         HIKMA PHARMS
	        EQ   250MG   BASE
             A090549   001    Oct   11,   2013

AB
	                             EQ   500MG   BASE
             A090549   002    Oct   11,   2013

AB         SANDOZ
	              EQ   250MG   BASE
             A064071   001    Nov   30,   1995

AB     +
	                       EQ   500MG   BASE
	            A064071   002    Nov   30,   1995
	
     PENICILLIN-VK
	
AB         TEVA
	                EQ 250MG BASE
                 A060711 002
	
AB
	                             EQ 500MG BASE
	                A060711 003
	
PENTAMIDINE ISETHIONATE
	
  FOR SOLUTION;INHALATION
	
    NEBUPENT
	
      + FRESENIUS KABI USA
	     300MG/VIAL
	                   N019887 001 Jun 15, 1989
	
  INJECTABLE;INJECTION
	
    PENTAM
	
      + FRESENIUS KABI USA
	     300MG/VIAL
	                   N019264 001 Oct 16, 1984
	
PENTAZOCINE LACTATE
	
  INJECTABLE;INJECTION
	
    TALWIN
	
      + HOSPIRA
	                EQ 30MG BASE/ML
	              N016194 001
	
PENTOBARBITAL SODIUM
	
  INJECTABLE;INJECTION
	
    NEMBUTAL SODIUM
	
      + OAK PHARMS
	             50MG/ML
	                      A083246 001
	
PENTOSAN POLYSULFATE SODIUM
	
  CAPSULE;ORAL
	
    ELMIRON
	
      + JANSSEN PHARMS
	         100MG
	                        N020193 001 Sep 26, 1996
	
PENTOSTATIN
	
  INJECTABLE;INJECTION

    NIPENT
	
AP    + HOSPIRA INC
	            10MG/VIAL
	                    N020122 001 Oct 11, 1991
	
    PENTOSTATIN
	
AP       EUROHLTH INTL
	         10MG/VIAL
                     A077841 001 Aug 07, 2007

AP       MYLAN INSTITUTIONAL
	   10MG/VIAL
	                    A203554 001 Sep 19, 2014
	
PENTOXIFYLLINE
	
  TABLET, EXTENDED RELEASE;ORAL

    PENTOXIFYLLINE
	
AB       APOTEX
	                400MG
	                        A075191   001    Jun   09,   1999

AB       IMPAX LABS
	            400MG
	                        A075093   001    Aug   10,   1999

AB       MYLAN
	                 400MG
	                        A074425   001    Jul   08,   1997

AB       PLIVA
	                 400MG
	                        A074874   001    May   25,   1999

AB       VALEANT BERMUDA
	       400MG
	                        A075028   001    Jul   20,   1998
	
    PENTOXIL
	
AB       UPSHER SMITH
	          400MG
	                        A074962 001 Mar 31, 1999
	
PERAMIVIR
	
  SOLUTION;IV (INFUSION)

    RAPIVAB
	
      + BIOCRYST
	               200MG/20ML (10MG/ML)
	         N206426 001 Dec 19, 2014
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                     3-287(of 371)


PERAMPANEL
	
  TABLET;ORAL
	
    FYCOMPA
	
         EISAI INC
	               2MG
	                           N202834   001    Oct   22,   2012
	
                                   4MG
	                           N202834   002    Oct   22,   2012
	
                                   6MG
	                           N202834   003    Oct   22,   2012
	
                                   8MG
	                           N202834   004    Oct   22,   2012
	
                                   10MG
	                          N202834   005    Oct   22,   2012
	
      +
	                          12MG
	                          N202834   006    Oct   22,   2012
	
PERFLUTREN
	
  INJECTABLE;INTRAVENOUS
	
    DEFINITY
	
      + LANTHEUS MEDCL
	           6.52MG/ML
	                     N021064 001 Jul 31, 2001
	
PERINDOPRIL ERBUMINE
	
  TABLET;ORAL

     ACEON
	
AB         SYMPLMED PHARMS LLC
	   2MG
	                           N020184 001 Dec 30, 1993

AB
	                               4MG
	                           N020184 002 Dec 30, 1993

AB     +
	                         8MG
	                           N020184 003 Dec 30, 1993
	
     PERINDOPRIL ERBUMINE
	
AB         ANI PHARMS INC
	        2MG
	                           A078138   001    Nov   10,   2009

AB
	                               4MG
	                           A078138   002    Nov   10,   2009

AB
	                               8MG
	                           A078138   003    Nov   10,   2009

AB         APOTEX
	                2MG
	                           A090463   001    Aug   30,   2010

AB
	                               4MG
	                           A090463   002    Aug   30,   2010

AB
	                               8MG
	                           A090463   003    Aug   30,   2010

AB         AUROBINDO PHARMA
	      2MG
	                           A079070   001    Nov   10,   2009

AB
	                               4MG
	                           A079070   002    Nov   10,   2009

AB
	                               8MG
	                           A079070   003    Nov   10,   2009

AB         LUPIN LTD
	             2MG
	                           A078263   001    Jan   27,   2010

AB
	                               4MG
	                           A078263   002    Jan   27,   2010

AB
	                               8MG
	                           A078263   003    Jan   27,   2010

AB         ROXANE
	                2MG
	                           A090072   001    Nov   10,   2009

AB
	                               4MG
	                           A090072   002    Nov   10,   2009

AB
	                               8MG
	                           A090072   003    Nov   10,   2009
	
PERMETHRIN
	
  CREAM;TOPICAL

    ELIMITE
	
AB    + RENAISSANCE PHARMA
	       5%
	                            N019855 001 Aug 25, 1989
	
    PERMETHRIN
	
AB       ACTAVIS MID ATLANTIC
	    5%
	                            A074806 001 Jan 23, 1998

AB       PERRIGO NEW YORK
	        5%
	                            A076369 001 Apr 21, 2003
	
PERPHENAZINE
	
  TABLET;ORAL

     PERPHENAZINE
	
AB         SANDOZ
	                2MG
	                           A089683   001    Dec   08,   1988

AB
	                               4MG
	                           A089684   001    Dec   08,   1988

AB
	                               8MG
	                           A089685   001    Dec   08,   1988

AB     +
	                         16MG
	                          A089686   001    Dec   08,   1988

AB         VINTAGE PHARMS
	        2MG
	                           A040226   001    Dec   31,   1998

AB
	                               4MG
	                           A040226   002    Dec   31,   1998

AB
	                               8MG
	                           A040226   003    Dec   31,   1998

AB
	                               16MG
	                          A040226   004    Dec   31,   1998
	
PHENDIMETRAZINE TARTRATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    BONTRIL
BC       VALEANT                105MG                              A088021 001 Sep 21, 1982
	
    PHENDIMETRAZINE TARTRATE
BC    + SANDOZ                  105MG                              N018074 001
	
  TABLET;ORAL
    BONTRIL PDM
AA    + VALEANT                 35MG                               A085272 001
	
    PHENDIMETRAZINE TARTRATE
AA       ELITE LABS INC         35MG                               A040762   001 Jan 28, 2008

AA       KVK TECH               35MG                               A091042   001 Aug 31, 2010

AA       MIKART                 35MG                               A089452   001 Oct 30, 1991

AA       SANDOZ                 35MG                               A085588   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-288(of 371)


PHENELZINE SULFATE
	
  TABLET;ORAL

    NARDIL
	
AB    + PARKE DAVIS             EQ 15MG BASE                    N011909 002
	
    PHENELZINE SULFATE
	
AB       NOVEL LABS INC         EQ 15MG BASE                    A200181 001 Dec 08, 2010
	
PHENOXYBENZAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    DIBENZYLINE
	
AB    + COVIS PHARMA SARL        10MG                           N008708 001
	
    PHENOXYBENZAMINE HYDROCHLORIDE
	
AB       ROXANE                  10MG                           A201050 001 Jul 16, 2012
	
PHENTERMINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    ADIPEX-P
	
AA    + TEVA                    37.5MG                          A088023 001 Aug 02, 1983

    PHENTERMINE HYDROCHLORIDE
	
AA       BARR                   15MG                            A090591   001     Mar   18,   2010

AA                              30MG                            A090591   002     Mar   18,   2010

AA       ELITE LABS             15MG                            A202248   001     Sep   28,   2012

AA                              30MG                            A202248   002     Sep   28,   2012

AA       INVAGEN PHARMS         15MG                            A202858   001     Feb   14,   2014

AA                              30MG                            A202858   002     Feb   14,   2014

AA                              30MG                            A204414   001     May   05,   2014

AA                              37.5MG                          A202846   001     Feb   05,   2014

AA       KEN LIFESCIENCE        15MG                            A205019   001     Dec   05,   2014

AA                              30MG                            A205019   002     Dec   05,   2014

AA                              37.5MG                          A205017   001     Sep   25,   2014

AA       KVK TECH               15MG                            A040886   002     Mar   31,   2008

AA                              30MG                            A040875   001     Mar   21,   2008

AA                              30MG                            A040886   001     Mar   31,   2008

AA                              37.5MG                          A040887   001     Apr   24,   2008

AA       LANNETT                15MG                            A087022   002     Jan   20,   2012

AA                              30MG                            A087022   001     Feb   03,   1983

AA                              30MG                            A091359   001     Jul   16,   2010

AA       LANNETT HOLDINGS INC   37.5MG                          A201961   001     Jul   20,   2011

AA       MUTUAL PHARM           30MG                            A040525   001     Oct   23,   2003

AA    + SANDOZ                  15MG                            A087190   002
	
AA    +                         30MG                            A086945   001     Jul 20, 1983

AA    +                         30MG                            A087190   001
	
  TABLET;ORAL

    ADIPEX-P
	
AA    + TEVA                    37.5MG                          A085128 001
	
    PHENTERMINE HYDROCHLORIDE
	
AA       AUROLIFE PHARMA LLC    37.5MG                          A203068   001     Aug   06,   2014

AA       BARR                   37.5MG                          A090470   001     Aug   31,   2009

AA       ELITE LABS             37.5MG                          A200272   001     Jan   31,   2011

AA       INVAGEN PHARMS         37.5MG                          A202942   001     Feb   05,   2014

AA       KEN LIFESCIENCE        37.5MG                          A205008   001     Sep   25,   2014

AA       KVK TECH               37.5MG                          A040876   001     Mar   31,   2008

AA       LANNETT                37.5MG                          A040555   001     Apr   15,   2005

AA       MIKAH PHARMA           37.5MG                          A040190   001     May   30,   1997

AA       MIRROR PHARMS          37.5MG                          A091451   001     Sep   21,   2012

AA       MUTUAL PHARM           37.5MG                          A040526   001     Oct   23,   2003

AA       SUN PHARM INDS INC     37.5MG                          A040790   001     Aug   21,   2007

AA       VINTAGE PHARMS         37.5MG                          A040377   001     Jan   04,   2002
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    SUPRENZA
	
         CITIUS PHARMS          15MG                            N202088 001 Jun 13, 2011
	
                                30MG                            N202088 002 Jun 13, 2011
	
      +                         37.5MG                          N202088 003 Mar 27, 2012
	
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    QSYMIA
	
         VIVUS                  EQ 3.75MG BASE;23MG             N022580   001     Jul   17,   2012
	
                                EQ 7.5MG BASE;46MG              N022580   002     Jul   17,   2012
	
                                EQ 11.25MG BASE;69MG            N022580   003     Jul   17,   2012
	
      +                         EQ 15MG BASE;92MG               N022580   004     Jul   17,   2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                       3-289(of 371)


PHENTERMINE RESIN COMPLEX
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    PHENTERMINE RESIN COMPLEX
	
      + LANNETT HOLDINGS INC    EQ 15MG BASE		                     A040872 001 Jul 28, 2011
	
      +                         EQ 30MG BASE		                     A040872 002 Jul 28, 2011
	
PHENTOLAMINE MESYLATE
	
  INJECTABLE;INJECTION

    PHENTOLAMINE MESYLATE
	
AP       EUROHLTH INTL           5MG/VIAL                          A040235 001 Mar 11, 1998

    REGITINE
	
AP    + NOVARTIS                 5MG/VIAL                          N008278 003
	
    ORAVERSE
	
      + SEPTODONT HOLDING        0.4MG/1.7ML                       N022159 001 May 09, 2008
	
PHENYLEPHRINE HYDROCHLORIDE
	
  SOLUTION;IV (INFUSION)

    PHENYLEPHRINE HYDROCHLORIDE
	
      + WEST WARD PHARM CORP      10MG/ML (10MG/ML)                N203826 001 Dec 20, 2012
	
    VAZCULEP
	
         ECLAT PHARMS LLC		       10MG/ML (10MG/ML)                N204300 001 Jun 27, 2014
	
                                  50MG/5ML (10MG/ML)               N204300 002 Jun 27, 2014
	
      +                           100MG/10ML (10MG/ML)             N204300 003 Jun 27, 2014
	
  SOLUTION/DROPS;OPHTHALMIC

    PHENYLEPHRINE HYDROCHLORIDE
	
         PARAGON BIOTECK          2.5%                             N203510 001 Mar 21, 2013
	
      +                           10%		                            N203510 002 Mar 21, 2013
	
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL

    PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
	
AA       HI-TECH PHARMACAL      5MG/5ML;6.25MG/5ML		               A040675 001 Dec 23, 2014

AA       VINTAGE                5MG/5ML;6.25MG/5ML                 A040654 001 Dec 07, 2006

    PROMETH VC PLAIN
	
AA    + ACTAVIS MID ATLANTIC    5MG/5ML;6.25MG/5ML                 A088761 001 Nov 08, 1984

    PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE
	
AA       AMNEAL PHARMS          5MG/5ML;6.25MG/5ML                 A040902 001 Aug 25, 2009
PHENYTOIN
  SUSPENSION;ORAL
    DILANTIN-125
AB    + PARKE DAVIS              125MG/5ML                         N008762 001
    PHENYTOIN
AB       TARO                    125MG/5ML                         A040521   001    Mar   08,   2004
AB       VISTAPHARM              125MG/5ML                         A040342   001    Jan   31,   2001
AB                               125MG/5ML                         A040610   001    Aug   18,   2005
AB       WOCKHARDT               125MG/5ML                         A040420   001    Apr   19,   2002
  TABLET, CHEWABLE;ORAL
    DILANTIN
AB    + PFIZER PHARMS            50MG                              A084427 001
    PHENYTOIN
AB       COREPHARMA              50MG                              A040884 001 Nov 28, 2014
AB       MYLAN PHARMS INC        50MG                              A200691 001 Dec 26, 2012
AB       TARO                    50MG                              A200565 001 Apr 17, 2014
PHENYTOIN SODIUM
  CAPSULE;ORAL
    DILANTIN
AB    + PARKE DAVIS              30MG EXTENDED                     A084349 001
AB    +                          100MG EXTENDED                    A084349 002
    EXTENDED PHENYTOIN SODIUM
AB       AMNEAL PHARMS NY        100MG EXTENDED                    A040765   001    Nov   12,   2008
AB       MYLAN                   100MG EXTENDED                    A040298   001    Dec   28,   1998
AB       SUN PHARM INDS          200MG EXTENDED                    A040731   001    Jun   30,   2008
AB                               300MG EXTENDED                    A040731   002    Jun   30,   2008
AB       SUN PHARM INDS (IN)     100MG EXTENDED                    A040621   001    Dec   11,   2006
AB       TARO                    100MG EXTENDED                    A040684   001    Sep   05,   2006
AB       WOCKHARDT               30MG EXTENDED                     A040759   001    Dec   18,   2007
AB       WOCKHARDT USA           100MG EXTENDED                    A040732   001    Jan   30,   2008
    PHENYTEK
AB       MYLAN                   200MG EXTENDED                    A040298 002 Dec 06, 2001
AB    +                          300MG EXTENDED                    A040298 003 Dec 06, 2001
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-290(of 371)


PHENYTOIN SODIUM
	
  INJECTABLE;INJECTION

    PHENYTOIN SODIUM
	
AP    + HIKMA MAPLE                50MG/ML                      A084307   001
	
AP       HOSPIRA                   50MG/ML                      A089521   001 Mar 17, 1987

AP       LUITPOLD                  50MG/ML                      A040781   001 Dec 04, 2007

AP       X-GEN PHARMS              50MG/ML                      A040573   001 Sep 13, 2006
	
PHYTONADIONE
	
  INJECTABLE;INJECTION
	
    PHYTONADIONE
	
BP    + INTL MEDICATION            1MG/0.5ML                    A083722 001
	
    VITAMIN K1
	
BP    + HOSPIRA                    1MG/0.5ML                    A087954 001 Jul 25, 1983
	
      +                            10MG/ML		                    A087955 001 Jul 25, 1983
	
  TABLET;ORAL
	
    MEPHYTON
	
      + VALEANT PHARMS             5MG                          N010104 003
	
PILOCARPINE HYDROCHLORIDE
	
  GEL;OPHTHALMIC
	
    PILOPINE HS
	
      + ALCON                      4%                           N018796 001 Oct 01, 1984
	
  SOLUTION;OPHTHALMIC
	
    ISOPTO CARPINE
	
         ALCON RES		               1%                           N200890 001 Jun 22, 2010
	
                                   2%                           N200890 002 Jun 22, 2010
	
      +                            4%                           N200890 003 Jun 22, 2010
	
  TABLET;ORAL

    PILOCARPINE HYDROCHLORIDE
	
AB       COREPHARMA                5MG                          A076746   001    Nov   16,   2004

AB       IMPAX LABS                5MG                          A077248   001    Mar   31,   2006

AB                                 7.5MG                        A077248   002    Mar   31,   2006

AB       LANNETT                   5MG                          A077220   001    Oct   14,   2005

AB                                 7.5MG                        A077220   002    May   06,   2009

AB       ROXANE                    5MG                          A076963   001    Dec   22,   2004

AB                                 7.5MG                        A076963   002    Feb   27,   2007

    SALAGEN
	
AB       EISAI INC                 5MG                          N020237 001 Mar 22, 1994

AB    +                            7.5MG                        N020237 002 Apr 18, 2003
	
PIMECROLIMUS
	
  CREAM;TOPICAL
	
    ELIDEL
	
      + VALEANT BERMUDA            1%		                         N021302 001 Dec 13, 2001
	
PIMOZIDE
	
  TABLET;ORAL
	
    ORAP
	
           TEVA                    1MG                          N017473 003 Aug 27, 1997

      +                            2MG		                        N017473 001 Jul 31, 1984
	
PINDOLOL
	
  TABLET;ORAL

    PINDOLOL
	
AB        MUTUAL PHARM             5MG                          A074063   001    Jan   27,   1994

AB                                 10MG                         A074063   002    Jan   27,   1994

AB        MYLAN PHARMS INC         5MG                          A074019   001    Sep   03,   1992

AB    +                            10MG                         A074019   002    Sep   03,   1992
	
PIOGLITAZONE HYDROCHLORIDE
	
  TABLET;ORAL

    ACTOS
	
AB       TAKEDA PHARMS USA         EQ 15MG BASE                 N021073 001 Jul 15, 1999

AB                                 EQ 30MG BASE                 N021073 002 Jul 15, 1999

AB    +                            EQ 45MG BASE                 N021073 003 Jul 15, 1999

    PIOGLITAZONE HYDROCHLORIDE
	
AB       ACCORD HLTHCARE           EQ     15MG   BASE           A200044   001    Feb   13,   2013

AB                                 EQ     30MG   BASE           A200044   002    Feb   13,   2013

AB                                 EQ     45MG   BASE           A200044   003    Feb   13,   2013

AB       AUROBINDO PHARMA LTD      EQ     15MG   BASE           A200268   001    Feb   13,   2013

AB                                 EQ     30MG   BASE           A200268   002    Feb   13,   2013

AB                                 EQ     45MG   BASE           A200268   003    Feb   13,   2013

AB       BRECKENRIDGE PHARM        EQ     15MG   BASE           A078472   001    Feb   13,   2013

AB                                 EQ     30MG   BASE           A078472   002    Feb   13,   2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-291(of 371)


PIOGLITAZONE HYDROCHLORIDE
	
  TABLET;ORAL

    PIOGLITAZONE HYDROCHLORIDE
	
AB                                 EQ   45MG   BASE                       A078472   003    Feb   13,   2013

AB       DR REDDYS LABS LTD        EQ   15MG   BASE                       A078383   001    Mar   12,   2013

AB                                 EQ   30MG   BASE                       A078383   002    Mar   12,   2013

AB                                 EQ   45MG   BASE                       A078383   003    Mar   12,   2013

AB       LUPIN LTD                 EQ   15MG   BASE                       A204133   001    Apr   07,   2014

AB                                 EQ   30MG   BASE                       A204133   002    Apr   07,   2014

AB                                 EQ   45MG   BASE                       A204133   003    Apr   07,   2014

AB       MACLEODS PHARMS LTD       EQ   15MG   BASE                       A202467   001    Feb   06,   2013

AB                                 EQ   30MG   BASE                       A202467   002    Feb   06,   2013

AB                                 EQ   45MG   BASE                       A202467   003    Feb   06,   2013

AB       MYLAN PHARMS INC          EQ   15MG   BASE                       A076801   001    Aug   17,   2012

AB                                 EQ   30MG   BASE                       A076801   002    Aug   17,   2012

AB                                 EQ   45MG   BASE                       A076801   003    Aug   17,   2012

AB       SANDOZ                    EQ   15MG   BASE                       A078670   001    Feb   13,   2013

AB                                 EQ   30MG   BASE                       A078670   002    Feb   13,   2013

AB                                 EQ   45MG   BASE                       A078670   003    Feb   13,   2013

AB       TEVA PHARMS USA           EQ   15MG   BASE                       A077210   001    Jan   10,   2014

AB                                 EQ   30MG   BASE                       A077210   002    Jan   10,   2014

AB                                 EQ   45MG   BASE                       A077210   003    Jan   10,   2014

AB       TORRENT PHARMS LTD        EQ   15MG   BASE                       A091298   001    Feb   13,   2013

AB                                 EQ   30MG   BASE                       A091298   002    Feb   13,   2013

AB                                 EQ   45MG   BASE                       A091298   003    Feb   13,   2013

AB       WATSON LABS               EQ   15MG   BASE                       A076798   001    Oct   26,   2012

AB                                 EQ   30MG   BASE                       A076798   002    Oct   26,   2012

AB                                 EQ   45MG   BASE                       A076798   003    Oct   26,   2012

AB       ZYDUS PHARMS USA INC      EQ   15MG   BASE                       A202456   001    Feb   13,   2013

AB                                 EQ   30MG   BASE                       A202456   002    Feb   13,   2013

AB                                 EQ   45MG   BASE                       A202456   003    Feb   13,   2013
	
PIPERACILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    PIPERACILLIN
	
      + ISTITUTO BIO ITA SPA       EQ   2GM BASE/VIAL                     A065114   001    Nov   14,   2003
	
      +                            EQ   3GM BASE/VIAL                     A065114   002    Nov   14,   2003
	
      +                            EQ   4GM BASE/VIAL                     A065114   003    Nov   14,   2003
	
      +                            EQ   40GM BASE/VIAL                    A065157   001    Jul   12,   2004
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
	
  INJECTABLE;INJECTION

    PIPERACILLIN AND TAZOBACTAM
	
AP       AGILA SPECLTS            EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     A065458   001    Aug   15,   2014

AP                                EQ 3MG BASE/VIAL;EQ 375MG BASE/VIAL     A065458   002    Aug   15,   2014

AP                                EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     A065458   003    Aug   15,   2014

AP       AUROBINDO PHARMA LTD     EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     A065498   001    May   23,   2011

AP                                EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL     A065498   002    May   23,   2011

AP                                EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     A065498   003    May   23,   2011

AP       HOSPIRA INC              EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     A065386   001    Sep   15,   2009

AP                                EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL     A065386   002    Sep   15,   2009

AP                                EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     A065386   003    Sep   15,   2009

AP                                EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL    A065446   001    Sep   15,   2009

AP       ISTITUTO BIO ITA SPA     EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     A065523   001    May   31,   2011

AP                                EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL     A065523   002    May   31,   2011

AP                                EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     A065523   003    May   31,   2011

AP                                EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL    A090498   001    May   31,   2011

AP       SANDOZ                   EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     A065362   001    Oct   21,   2010

AP                                EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     A065363   001    Oct   21,   2010

AP                                EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL     A065362   002    Oct   21,   2010

AP                                EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL     A065363   002    Oct   21,   2010

AP                                EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     A065362   003    Oct   21,   2010

AP                                EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     A065363   003    Oct   21,   2010

    ZOSYN
	
AP    + WYETH PHARMS INC          EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL     N050684   001    Oct   22,   1993

AP    +                           EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL     N050684   002    Oct   22,   1993

AP    +                           EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL     N050684   003    Oct   22,   1993

AP    +                           EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL    N050684   004    Oct   22,   1993
	
    ZOSYN IN PLASTIC CONTAINER
	
      + WYETH PHARMS INC          EQ 4GM BASE/100ML;EQ 500MG BASE/100ML   N050750 003 Feb 24, 1998
	
      +                           EQ 40MG BASE/ML;EQ 5MG BASE/ML          N050750 001 Feb 24, 1998
	
      +                           EQ 60MG BASE/ML;EQ 7.5MG BASE/ML        N050750 002 Feb 24, 1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                             3-292(of 371)


PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
	
  INJECTABLE;IV (INFUSION)

    PIPERACILLIN AND TAZOBACTAM
	
         SANDOZ
	                 EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL
	   A203557 001 Oct 29, 2014
	
PIRBUTEROL ACETATE
	
  AEROSOL, METERED;INHALATION
	
    MAXAIR
	
      + MEDICIS
	                  EQ 0.2MG BASE/INH
	                     N020014 001 Nov 30, 1992
	
PIRFENIDONE
	
  CAPSULE;ORAL
	
    ESBRIET
	
      + INTERMUNE INC
	            267MG
	                                 N022535 001 Oct 15, 2014
	
PIROXICAM
	
  CAPSULE;ORAL

    FELDENE
AB       PFIZER                    10MG
	                                  N018147 002 Apr 06, 1982

AB    +                            20MG
	                                  N018147 003 Apr 06, 1982
	
    PIROXICAM
AB       MUTUAL PHARM              10MG
	                                  A073535   001    Mar   12,   1993

AB       MYLAN                     10MG
	                                  A074102   001    Jul   31,   1992

AB                                 20MG
	                                  A074102   002    Jul   31,   1992

AB       NOSTRUM LABS              10MG
	                                  A074116   001    Jun   15,   1993

AB                                 20MG
	                                  A074118   001    Jun   15,   1993

AB       TEVA                      10MG
	                                  A074131   001    Dec   11,   1992

AB                                 20MG
	                                  A074131   002    Dec   11,   1992
	
PITAVASTATIN CALCIUM
	
  TABLET;ORAL
	
    LIVALO
	
         KOWA CO
	                 EQ 1MG BASE
	                           N022363 001 Aug 03, 2009

                                   EQ 2MG BASE
	                           N022363 002 Aug 03, 2009

     +
	                           EQ 4MG BASE
	                           N022363 003 Aug 03, 2009
	
PLERIXAFOR
	
  SOLUTION;SUBCUTANEOUS
	
    MOZOBIL
	
      + GENZYME
	                  24MG/1.2ML (20MG/ML)
	                  N022311 001 Dec 15, 2008
	
PODOFILOX
	
  GEL;TOPICAL
	
    CONDYLOX
	
      + WATSON PHARMS
	            0.5%
	                                  N020529 001 Mar 13, 1997
	
  SOLUTION;TOPICAL

    CONDYLOX
	
AT    + WATSON PHARMS
	            0.5%
	                                  N019795 001 Dec 13, 1990
	
    PODOFILOX
	
AT       PADDOCK LLC
	             0.5%
	                                  A075600 001 Jan 29, 2002

AT       PRECISION DERMAT
	        0.5%
	                                  A090184 001 Jul 21, 2010
	
POLIDOCANOL
	
  SOLUTION;INTRAVENOUS
	
    ASCLERA
	
          CHEMISCH FBRK KRSSLR
	   10MG/2ML (5MG/ML)
                      N021201 001 Mar 30, 2010
	
      +
	                          20MG/2ML (10MG/ML)
	                    N021201 002 Mar 30, 2010
	
    VARITHENA
	
      + PROVENSIS
	                180MG/18ML (10MG/ML)
	                  N205098 001 Nov 25, 2013
	
POLYETHYLENE GLYCOL 3350
	
  FOR SOLUTION;ORAL

    GLYCOLAX
	
AA       KREMERS URBAN PHARMS
	    17GM/SCOOPFUL
	                         A076652 001 Jul 02, 2004
	
    POLYETHYLENE GLYCOL 3350
	
AA       BRECKENRIDGE PHARM
	      17GM/SCOOPFUL
                          A077736 001 May 26, 2006

AA       NEXGEN PHARMA INC
	       17GM/SCOOPFUL
                          A077706 001 Sep 27, 2006

AA       PADDOCK LLC
	             17GM/SCOOPFUL
	                         A077893 001 May 26, 2006
	
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
	
  FOR SOLUTION;ORAL

    LAX-LYTE WITH FLAVOR PACKS
AA       PADDOCK LLC            420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/   A079232 001 Feb 25, 2010
                                BOT
    NULYTELY
AA    + BRAINTREE               420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/   N019797 001 Apr 22, 1991
                                BOT
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                               3-293(of 371)


POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
	
  FOR SOLUTION;ORAL

    NULYTELY-FLAVORED
	
AA    + BRAINTREE               420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/   N019797 002 Nov 18, 1994

                                BOT
	
    PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE

AA       MYLAN                  420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/   A090409 001 Apr 02, 2010

                                BOT
	
AA       NOVEL LABS INC         420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/   A090019 001 May 27, 2009

                                BOT
	
    TRILYTE
	
AA       MEDA PHARMS            420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/   A076491 001 Feb 05, 2004

                                BOT
	
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM       SULFATE

ANHYDROUS
	
  FOR SOLUTION;ORAL

    GOLYTELY
	
AA    + BRAINTREE               236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/   N019011 001 Jul       13, 1984

                                BOT;22.74GM/BOT

    PEG 3350 AND ELECTROLYTES
	
AA        MYLAN                 236GM;2.97GM;6.74GM;5.86GM;22.74GM        A090928 001 Jan       28, 2010

AA        NOVEL LABS INC        236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/   A090231 001 Jun       01, 2009

                                BOT;22.74GM/BOT

AA                              240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/   A090186 001 Jun       01, 2009

                                BOT;22.72GM/BOT

    COLYTE
	
          MEDA PHARMS           227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53G   N018983 010 Jan       31, 1989

                                M/BOT;21.5GM/BOT

    COLYTE WITH FLAVOR PACKS
	
          MEDA PHARMS           240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/   N018983 012 Oct       08, 1998

                                BOT;22.72GM/BOT

    GOLYTELY
	
      +		 BRAINTREE             227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC   N019011 002 Jun       02, 1992

                                KET;5.53GM/PACKET;21.5GM/PACKET
	
POLYMYXIN B SULFATE
	
  INJECTABLE;INJECTION

    POLYMYCIN B SULFATE
	
AP       SAGENT STRIDES        EQ 500,000 UNITS BASE/VIAL                A090110 001 Jun 29, 2011

    POLYMYXIN B SULFATE
	
AP    + EUROHLTH INTL          EQ   500,000   UNITS   BASE/VIAL          A060716   001
	
AP       FRESENIUS KABI USA    EQ   500,000   UNITS   BASE/VIAL          A065372   001 Jan 10, 2008

AP       X GEN PHARMS          EQ   500,000   UNITS   BASE/VIAL          A063000   001 Sep 30, 1994

AP       XELLIA PHARMS APS     EQ   500,000   UNITS   BASE/VIAL          A202766   001 Jan 15, 2014
	
POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
	
  SOLUTION/DROPS;OPHTHALMIC

    POLYTRIM
	
AT    + ALLERGAN                10,000 UNITS/ML;EQ      1MG BASE/ML      N050567 001 Oct 20, 1988

    TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
	
AT       AKORN INC              10,000 UNITS/ML;EQ     1MG BASE/ML       A065006 001 Dec 17, 1998

AT       BAUSCH AND LOMB        10,000 UNITS/ML;EQ     1MG BASE/ML       A064120 001 Feb 14, 1997

AT       FALCON PHARMS          10,000 UNITS/ML;EQ     1MG BASE/ML       A064211 001 Apr 13, 1998
	
POMALIDOMIDE
	
  CAPSULE;ORAL
	
    POMALYST
	
         CELGENE		             1MG                                       N204026   001    Feb   08,   2013
	
                               2MG                                       N204026   002    Feb   08,   2013
	
                               3MG                                       N204026   003    Feb   08,   2013
	
     +                         4MG		                                     N204026   004    Feb   08,   2013
	
PONATINIB HYDROCHLORIDE
	
  TABLET;ORAL
	
    ICLUSIG
	
         ARIAD                 EQ 15MG BASE                              N203469 001 Dec 14, 2012
	
      +                        EQ 45MG BASE		                            N203469 002 Dec 14, 2012
	
PORACTANT ALFA
	
  SUSPENSION;INTRATRACHEAL
	
    CUROSURF
	
      + CHIESI USA INC         80MG/ML		                                 N020744 001 Nov 18, 1999
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-294(of 371)


PORFIMER SODIUM
	
  INJECTABLE;INJECTION
	
    PHOTOFRIN
	
         CONCORDIA LABS INC     75MG/VIAL                      N020451 001 Dec 27, 1995
	
POSACONAZOLE
	
  SOLUTION;IV (INFUSION)

    NOXAFIL
	
      + MERCK SHARP DOHME        300MG/16.7ML (18MG/ML)        N205596 001 Mar 13, 2014
	
  SUSPENSION;ORAL
	
    NOXAFIL
	
      + SCHERING                 40MG/ML                       N022003 001 Sep 15, 2006

  TABLET, DELAYED RELEASE;ORAL
	
    NOXAFIL
	
      + MERCK SHARP DOHME        100MG                         N205053 001 Nov 25, 2013
	
POTASSIUM ACETATE
	
  INJECTABLE;INJECTION
	
    POTASSIUM ACETATE IN PLASTIC CONTAINER
	
      + HOSPIRA                 2MEQ/ML                        N018896 001 Jul 20, 1984
	
POTASSIUM CHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    MICRO-K
	
AB       NESHER PHARMS           8MEQ                          N018238 001
	
    MICRO-K 10
	
AB       NESHER PHARMS           10MEQ                         N018238 002 May 14, 1984

    POTASSIUM CHLORIDE
	
AB       ACTAVIS LABS FL INC     8MEQ                          A077419   001     Jun   02,   2008

AB    +                          10MEQ                         A077419   002     Jun   02,   2008

AB       AMNEAL PHARMS           10MEQ                         A202128   001     Feb   22,   2013

AB       ANCHEN PHARMS           8MEQ                          A202886   001     Dec   26,   2013

AB                               10MEQ                         A202886   002     Dec   26,   2013

AB       PADDOCK LLC             8MEQ                          A200185   001     May   18,   2011

AB                               10MEQ                         A200185   002     May   18,   2011

  INJECTABLE;INJECTION

    POTASSIUM CHLORIDE
	
AP       B BRAUN                 2MEQ/ML                       A085870   001
	
AP       BAXTER HLTHCARE         2MEQ/ML                       A085499   001
	
AP       FRESENIUS KABI USA      2MEQ/ML                       A080225   001
	
AP    + HOSPIRA                  2MEQ/ML                       A080205   001
	
    POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER

AP    + BAXTER HLTHCARE          14.9MG/ML                     N019904   001     Dec   26,   1989

AP    +                          746MG/100ML                   N019904   005     Dec   17,   1990

AP       HOSPIRA                 14.9MG/ML                     N020161   005     Nov   30,   1992

AP                               745MG/100ML                   N020161   001     Nov   30,   1992

    POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER

AP    + BAXTER HLTHCARE          1.49GM/100ML                  N019904   006     Dec   17,   1990

AP    +                          29.8MG/ML                     N019904   002     Dec   26,   1989

AP       HOSPIRA                 1.49GM/100ML                  N020161   002     Nov   30,   1992

AP    +                          29.8MG/ML                     N020161   006     Aug   11,   1998

    POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER

AP    + BAXTER HLTHCARE          2.24GM/100ML                  N019904 003 Dec 26, 1989

AP    + HOSPIRA                  2.24GM/100ML                  N020161 003 Aug 11, 1998

    POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER

AP    + BAXTER HLTHCARE          2.98GM/100ML                  N019904 004 Dec 26, 1989

AP    + HOSPIRA                  2.98GM/100ML                  N020161 004 Aug 11, 1998

    POTASSIUM CHLORIDE IN PLASTIC CONTAINER
	
AP       FRESENIUS KABI USA      2MEQ/ML                       A088901 001 Jan 25, 1985

AP                               2MEQ/ML                       A088908 001 Jan 25, 1985
	
    POTASSIUM CHLORIDE
	
      + FRESENIUS KABI USA       3MEQ/ML                       A080225 003
	
  SOLUTION;ORAL
	
    POTASSIUM CHLORIDE
	
         PHARMA-MED INC          20MEQ/15ML                    N206814 001 Dec 22, 2014
	
      +                          40MEQ/15ML                    N206814 002 Dec 22, 2014
	
  TABLET, EXTENDED RELEASE;ORAL

    KLOR-CON M10
	
AB1      UPSHER SMITH LABS       10MEQ                         A074726 002 Aug 09, 2000

    KLOR-CON M20
	
AB1 + UPSHER SMITH LABS          20MEQ                         A074726 001 Nov 20, 1998

    POTASSIUM CHLORIDE
	
AB1      ACTAVIS LABS FL INC     10MEQ                         A075604 001 Apr 10, 2002

AB1                              20MEQ                         A075604 002 Apr 10, 2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                   3-295(of 371)


POTASSIUM CHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    POTASSIUM CHLORIDE
	
AB1      EURAND                  20MEQ                                     A076368 001 Aug 18, 2004

    KLOR-CON
	
AB2      UPSHER-SMITH LABS       8MEQ                                      N019123 001 Apr 17, 1986

AB2 +                            10MEQ                                     N019123 002 Apr 17, 1986

    POTASSIUM CHLORIDE
	
AB2      MYLAN PHARMS INC        8.0MEQ                                    A204662 001 Aug 21, 2014

AB2                              10.0MEQ                                   A204662 002 Aug 21, 2014

    K-TAB
	
BC       ABBVIE                  8MEQ                                      N018279 002 Aug 01, 1988
BC                               10MEQ                                     N018279 001
BC    +                          20MEQ                                     N018279 003 Nov 25, 2013
    KLOR-CON M15
         UPSHER SMITH LABS       15MEQ                                     A074726 003 Jun 06, 2003
POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION

    POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
AP       HOSPIRA                149MG/100ML;450MG/100ML                     A078446   001 Sep 10, 2008

    POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
AP    + BAXTER HLTHCARE         150MG/100ML;450MG/100ML                     N017648   005 Nov 26, 2002

    POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP       B BRAUN                150MG/100ML;900MG/100ML                     N019708   004 Sep 29, 1989

AP       BAXTER HLTHCARE        150MG/100ML;900MG/100ML                     N017648   001
	
    POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        300MG/100ML;900MG/100ML                     N017648   002
	
    POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       HOSPIRA                149MG/100ML;900MG/100ML                     N019686   001 Oct 17, 1988

    POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

AP       HOSPIRA                298MG/100ML;900MG/100ML                     N019686   002 Oct 17, 1988
	
    POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%
	
         BAXTER HLTHCARE        224MG/100ML;900MG/100ML                     N017648   003
	
POTASSIUM CITRATE
	
  TABLET, EXTENDED RELEASE;ORAL

    POTASSIUM CITRATE
	
AB       COREPHARMA              5MEQ                                      A077440    001     Jun   09,   2006

AB                               10MEQ                                     A077440    002     Jun   09,   2006

AB       ZYDUS PHARMS USA INC    5MEQ                                      A203546    001     Aug   06,   2014

AB                               10MEQ                                     A203546    002     Aug   06,   2014

AB                               15MEQ                                     A203546    003     Aug   06,   2014

    UROCIT-K
	
AB       MISSION PHARMA          5MEQ                                      N019071 001 Aug 30, 1985

AB                               10MEQ                                     N019071 002 Aug 31, 1992

AB    +                          15MEQ                                     N019071 003 Dec 30, 2009
	
POVIDONE-IODINE
	
  SOLUTION/DROPS;OPHTHALMIC

    BETADINE
	
      + ALCON PHARMS LTD        5%                                         N018634 001 Dec 17, 1986
	
PRALATREXATE
	
  SOLUTION;INTRAVENOUS
	
    FOLOTYN
	
         ALLOS                  20MG/ML (20MG/ML)                          N022468 001 Sep 24, 2009

      +                         40MG/2ML (20MG/ML)                         N022468 002 Sep 24, 2009
	
PRALIDOXIME CHLORIDE
	
  INJECTABLE;INJECTION
	
    PRALIDOXIME CHLORIDE
	
      + MERIDIAN MEDCL TECHN    300MG/ML                                   N018986 001 Apr 26, 1983

    PROTOPAM CHLORIDE
	
      + BAXTER HLTHCARE CORP    1GM/VIAL                                   N014134 001
	
PRAMIPEXOLE DIHYDROCHLORIDE
	
  TABLET;ORAL

    MIRAPEX
	
AB       BOEHRINGER INGELHEIM   0.125MG                                    N020667    001     Jul   01,   1997

AB    +                         0.25MG                                     N020667    002     Jul   01,   1997

AB                              0.5MG                                      N020667    006     Feb   12,   1998

AB                              0.75MG                                     N020667    007     Jul   30,   2007

AB                              1MG                                        N020667    003     Jul   01,   1997

AB                              1.5MG                                      N020667    005     Jul   01,   1997
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-296(of 371)


PRAMIPEXOLE DIHYDROCHLORIDE
	
  TABLET;ORAL

    PRAMIPEXOLE DIHYDROCHLORIDE
	
AB       ACTAVIS GRP PTC          0.125MG                       A091254   001    Nov   30,   2010

AB                                0.25MG                        A091254   002    Nov   30,   2010

AB                                0.5MG                         A091254   003    Nov   30,   2010

AB                                0.75MG                        A091254   004    Nov   30,   2010

AB                                1MG                           A091254   005    Nov   30,   2010

AB                                1.5MG                         A091254   006    Nov   30,   2010

AB       ALEMBIC LTD              0.125MG                       A078894   001    Oct   08,   2010

AB                                0.25MG                        A078894   002    Oct   08,   2010

AB                                0.5MG                         A078894   003    Oct   08,   2010

AB                                1MG                           A078894   004    Oct   08,   2010

AB                                1.5MG                         A078894   005    Oct   08,   2010

AB       APOTEX INC               0.125MG                       A090151   001    Apr   30,   2012

AB                                0.25MG                        A090151   002    Apr   30,   2012

AB                                0.5MG                         A090151   003    Apr   30,   2012

AB                                0.75MG                        A090151   006    Apr   30,   2012

AB                                1MG                           A090151   004    Apr   30,   2012

AB                                1.5MG                         A090151   005    Apr   30,   2012

AB       AUROBINDO PHARMA LTD     0.125MG                       A202633   001    Oct   26,   2012

AB                                0.25MG                        A202633   002    Oct   26,   2012

AB                                0.5MG                         A202633   003    Oct   26,   2012

AB                                0.75MG                        A202633   004    Oct   26,   2012

AB                                1MG                           A202633   005    Oct   26,   2012

AB                                1.5MG                         A202633   006    Oct   26,   2012

AB       BARR                     0.125MG                       A077724   001    Feb   19,   2008

AB                                0.25MG                        A077724   002    Feb   19,   2008

AB                                0.5MG                         A077724   003    Feb   19,   2008

AB                                1MG                           A077724   004    Feb   19,   2008

AB                                1.5MG                         A077724   005    Feb   19,   2008

AB       BRECKENRIDGE PHARM       0.125MG                       A091450   001    Oct   08,   2010

AB                                0.25MG                        A091450   002    Oct   08,   2010

AB                                0.5MG                         A091450   003    Oct   08,   2010

AB                                1MG                           A091450   004    Oct   08,   2010

AB                                1.5MG                         A091450   005    Oct   08,   2010

AB       GLENMARK GENERICS        0.125MG                       A090781   001    Oct   08,   2010

AB                                0.25MG                        A090781   002    Oct   08,   2010

AB                                0.5MG                         A090781   003    Oct   08,   2010

AB                                1MG                           A090781   004    Oct   08,   2010

AB                                1.5MG                         A090781   005    Oct   08,   2010

AB       MACLEODS PHARMS LTD      0.125MG                       A202164   001    Sep   20,   2012

AB                                0.25MG                        A202164   002    Sep   20,   2012

AB                                0.5MG                         A202164   003    Sep   20,   2012

AB                                1MG                           A202164   004    Sep   20,   2012

AB                                1.5MG                         A202164   005    Sep   20,   2012

AB       MYLAN                    0.125MG                       A077854   001    Oct   08,   2010

AB                                0.25MG                        A077854   002    Oct   08,   2010

AB                                0.5MG                         A077854   003    Oct   08,   2010

AB                                0.75MG                        A090764   001    Apr   09,   2010

AB                                1MG                           A077854   004    Oct   08,   2010

AB                                1.5MG                         A077854   005    Oct   08,   2010

AB       SANDOZ                   0.125MG                       A090190   001    Jul   06,   2010

AB                                0.25MG                        A090190   002    Jul   06,   2010

AB                                0.5MG                         A090190   003    Jul   06,   2010

AB                                0.75MG                        A090190   006    Oct   08,   2010

AB                                1MG                           A090190   004    Jul   06,   2010

AB                                1.5MG                         A090190   005    Jul   06,   2010

AB       SCIEGEN PHARMS INC       0.125MG                       A203855   001    Oct   28,   2014

AB                                0.25MG                        A203855   002    Oct   28,   2014

AB                                0.5MG                         A203855   003    Oct   28,   2014

AB                                0.75MG                        A203855   004    Oct   28,   2014

AB                                1MG                           A203855   005    Oct   28,   2014

AB                                1.5MG                         A203855   006    Oct   28,   2014

AB       STRIDES PHARMA           0.125MG                       A202702   001    Jun   03,   2014

AB                                0.25MG                        A202702   002    Jun   03,   2014

AB                                0.5MG                         A202702   003    Jun   03,   2014

AB                                0.75MG                        A202702   004    Jun   03,   2014

AB                                1MG                           A202702   005    Jun   03,   2014

AB                                1.5MG                         A202702   006    Jun   03,   2014

AB       SUN PHARM INDS INC       0.125MG                       A091683   001    Mar   27,   2013

AB                                0.25MG                        A091683   002    Mar   27,   2013
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST
	                             3-297(of 371)


PRAMIPEXOLE DIHYDROCHLORIDE
	
  TABLET;ORAL

     PRAMIPEXOLE DIHYDROCHLORIDE
	
AB
	                               0.5MG
	                                  A091683   003    Mar   27,   2013

AB
	                               0.75MG
	                                 A091683   004    Mar   27,   2013

AB
	                               1MG
	                                    A091683   005    Mar   27,   2013

AB
	                               1.5MG
	                                  A091683   006    Mar   27,   2013

AB        TEVA PHARMS
	            0.125MG
	                                A090241   001    Oct   08,   2010

AB
	                               0.25MG
	                                 A090241   002    Oct   08,   2010

AB
	                               0.5MG
	                                  A090241   003    Oct   08,   2010

AB
	                               0.75MG
	                                 A090241   004    Oct   08,   2010

AB
	                               1MG
	                                    A090241   005    Oct   08,   2010

AB
	                               1.5MG
	                                  A090241   006    Oct   08,   2010

AB        TORRENT PHARMS
	         0.125MG
	                                A090865   001    Oct   08,   2010

AB
	                               0.25MG
	                                 A090865   002    Oct   08,   2010

AB
	                               0.5MG
	                                  A090865   003    Oct   08,   2010

AB
	                               0.75MG
	                                 A090865   004    Oct   08,   2010

AB
	                               1MG
	                                    A090865   005    Oct   08,   2010

AB
	                               1.5MG
	                                  A090865   006    Oct   08,   2010

AB        ZYDUS PHARMS USA INC
	 0.125MG
	                                  A078920   001    Jul   06,   2010

AB
	                               0.25MG
	                                 A078920   002    Jul   06,   2010

AB
	                               0.5MG
	                                  A078920   003    Jul   06,   2010

AB
	                               1MG
	                                    A078920   004    Jul   06,   2010

AB
	                               1.5MG
	                                  A078920   005    Jul   06,   2010
	
  TABLET, DELAYED RELEASE;ORAL

     PRAMIPEXOLE DIHYDROCHLORIDE
	
AB        SANDOZ
	                 0.375MG
	                                A202353   001    Dec   04,   2014

AB
	                               0.75MG
	                                 A202353   002    Dec   04,   2014

AB
	                               1.5MG
	                                  A202353   003    Dec   04,   2014

AB
	                               3MG
	                                    A202353   004    Dec   04,   2014

AB
	                               4.5MG
	                                  A202353   005    Dec   04,   2014
	
  TABLET, EXTENDED RELEASE;ORAL

     MIRAPEX ER
	
AB     + BOEHRINGER INGELHEIM
	 0.375MG
	                                   N022421   001    Feb   19,   2010

AB
	                               0.75MG
	                                 N022421   002    Feb   19,   2010

AB
	                               1.5MG
	                                  N022421   003    Feb   19,   2010

AB
	                               2.25MG
	                                 N022421   006    Jun   17,   2011

AB
	                               3MG
	                                    N022421   004    Feb   19,   2010

AB
	                               3.75MG
	                                 N022421   007    Jun   17,   2011

AB
	                               4.5MG
	                                  N022421   005    Feb   19,   2010
	
     PRAMIPEXOLE DIHYDROCHLORIDE
	
AB        ANCHEN PHARMS
	          0.375MG
	                                A202206   001    Feb   06,   2014

AB
	                               0.75MG
	                                 A202206   002    Feb   06,   2014

AB
	                               1.5MG
	                                  A202206   003    Feb   06,   2014

AB
	                               2.25MG
	                                 A202206   004    Feb   06,   2014

AB
	                               3MG
	                                    A202206   005    Feb   06,   2014

AB
	                               3.75MG
	                                 A202206   006    Feb   06,   2014

AB
	                               4.5MG
	                                  A202206   007    Feb   06,   2014
	
PRAMLINTIDE ACETATE
	
  INJECTABLE;SUBCUTANEOUS
	
    SYMLIN
	
          ASTRAZENECA AB
	         EQ 1.5MG BASE/1.5ML (EQ 1MG BASE/ML)
    N021332 002 Sep 25, 2007

      +
	                          EQ 2.7MG BASE/2.7ML (EQ 1MG BASE/ML)
	   N021332 003 Sep 25, 2007
	
PRASUGREL HYDROCHLORIDE
	
  TABLET;ORAL
	
    EFFIENT
	
          ELI LILLY AND CO
	       EQ 5MG BASE
	                            N022307 001 Jul 10, 2009
	
      +
	                          EQ 10MG BASE
	                           N022307 002 Jul 10, 2009
	
PRAVASTATIN SODIUM
	
  TABLET;ORAL

     PRAVACHOL
	
AB         BRISTOL MYERS SQUIBB
   20MG
	                                   N019898 003 Oct 31, 1991

AB
	                               40MG
	                                   N019898 004 Mar 22, 1993

AB     +
	                         80MG
	                                   N019898 008 Dec 18, 2001
	
     PRAVASTATIN SODIUM
	
AB         APOTEX
	                10MG
	                                   A076341   001    Oct   23,   2006

AB
	                               20MG
	                                   A076341   002    Oct   23,   2006

AB
	                               40MG
	                                   A076341   003    Oct   23,   2006

AB
	                               80MG
	                                   A076341   004    Dec   28,   2007

AB         CIPLA LTD
	             10MG
	                                   A077904   001    Oct   23,   2006

AB
	                               20MG
	                                   A077904   002    Oct   23,   2006
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-298(of 371)


PRAVASTATIN SODIUM
	
  TABLET;ORAL

    PRAVASTATIN SODIUM
	
AB                              40MG
	                          A077904   003    Oct   23,   2006

AB       DR REDDYS LABS INC     10MG
	                          A076714   001    Oct   23,   2006

AB                              20MG
	                          A076714   002    Oct   23,   2006

AB                              40MG
	                          A076714   003    Oct   23,   2006

AB                              80MG
	                          A076714   004    Dec   28,   2007

AB       GLENMARK GENERICS      10MG
	                          A077987   001    May   11,   2007

AB                              20MG
	                          A077987   002    May   11,   2007

AB                              40MG
	                          A077987   003    May   11,   2007

AB                              80MG
	                          A077987   004    Dec   28,   2007

AB       LUPIN PHARMS           10MG
	                          A077917   001    Jan   08,   2008

AB                              20MG
	                          A077917   002    Jan   08,   2008

AB                              40MG
	                          A077917   003    Jan   08,   2008

AB                              80MG
	                          A077917   004    Jan   08,   2008

AB       MYLAN                  10MG
	                          A077013   001    Oct   23,   2006

AB                              20MG
	                          A077013   002    Oct   23,   2006

AB                              40MG
	                          A077013   003    Oct   23,   2006

AB                              80MG
	                          A077013   004    Dec   28,   2007

AB       MYLAN PHARMS INC       10MG
	                          A079187   001    May   27,   2010

AB                              20MG
	                          A079187   002    May   27,   2010

AB                              40MG
	                          A079187   003    May   27,   2010

AB                              80MG
	                          A079187   004    May   27,   2010

AB       SANDOZ                 10MG
	                          A076397   003    Oct   23,   2006

AB                              20MG
	                          A076397   002    Oct   23,   2006

AB                              40MG
	                          A076397   001    Oct   23,   2006

AB                              80MG
	                          A077491   001    Feb   11,   2008

AB       TEVA                   10MG
	                          A076056   001    Apr   24,   2006

AB                              20MG
	                          A076056   002    Apr   24,   2006

AB                              40MG
	                          A076056   003    Apr   24,   2006

AB       TEVA PHARMS            80MG
	                          A077793   001    Jan   15,   2008

AB       WATSON LABS            10MG
	                          A076939   004    Oct   23,   2006

AB                              20MG
	                          A076939   003    Oct   23,   2006

AB                              40MG
	                          A076939   002    Oct   23,   2006

AB                              80MG
	                          A076939   001    Dec   28,   2007

AB       ZYDUS PHARMS USA       10MG
	                          A077751   001    Apr   30,   2008

AB                              20MG
	                          A077751   002    Apr   30,   2008

AB                              40MG
	                          A077751   003    Apr   30,   2008

AB                              80MG
	                          A077751   004    Apr   30,   2008
	
PRAZIQUANTEL
	
  TABLET;ORAL
	
    BILTRICIDE
	
      + BAYER HLTHCARE          600MG
	                         N018714 001 Dec 29, 1982
	
PRAZOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL

    MINIPRESS
	
AB       PFIZER                 EQ 1MG BASE
                    N017442 002
	
AB    +                         EQ 2MG BASE
                    N017442 003
	
AB                              EQ 5MG BASE
                    N017442 001
	
    PRAZOSIN HYDROCHLORIDE
	
AB       IVAX SUB TEVA PHARMS   EQ   1MG   BASE
                A071994   001    Sep   12,   1988

AB       MYLAN                  EQ   1MG   BASE
                A072575   003    May   16,   1989

AB                              EQ   2MG   BASE
                A072575   002    May   16,   1989

AB                              EQ   5MG   BASE
                A072575   001    May   16,   1989

AB       TEVA PHARMS            EQ   2MG   BASE
                A071995   001    Sep   12,   1988

AB                              EQ   5MG   BASE
	               A071745   001    Sep   12,   1988
	
PREDNICARBATE
	
  CREAM;TOPICAL

    DERMATOP E EMOLLIENT
	
AB    + VALEANT BERMUDA         0.1%
	                          N020279 001 Oct 29, 1993
	
    PREDNICARBATE
	
AB       FOUGERA PHARMS         0.1%
	                          A077287 001 Sep 19, 2006
	
  OINTMENT;TOPICAL

    DERMATOP
	
AB    + VALEANT BERMUDA         0.1%
	                          N019568 001 Sep 23, 1991
	
    PREDNICARBATE
	
AB       FOUGERA PHARMS         0.1%
	                          A077236 001 Mar 09, 2007
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-299(of 371)


PREDNISOLONE
	
  SYRUP;ORAL

    PREDNISOLONE
	
AA       ALPHARMA                15MG/5ML                      A040323   001    May   13,   1999

AA    + HI TECH PHARMA CO        15MG/5ML                      A040401   001    Feb   27,   2003

AA       PHARM ASSOC             15MG/5ML                      A040399   001    Mar   05,   2003

AA       VINTAGE                 15MG/5ML                      A040775   001    Sep   21,   2007

AA       WOCKHARDT               15MG/5ML                      A040313   001    Sep   10,   2003

    PRELONE
	
AA       TEVA                    15MG/5ML                      A089081 001 Feb 04, 1986
	
  TABLET;ORAL
	
    PREDNISOLONE
	
      + WATSON LABS              5MG                           A080354 001
	
PREDNISOLONE ACETATE
	
  SUSPENSION;ORAL
	
    FLO-PRED
	
      + TARO                     EQ 15MG BASE/5ML              N022067 002 Jan 17, 2008
	
  SUSPENSION/DROPS;OPHTHALMIC

    OMNIPRED
	
AB       ALCON                   1%                            N017469 001
	
    PRED FORTE
	
AB    + ALLERGAN                 1%                            N017011 001
	
    PRED MILD
	
      + ALLERGAN                 0.12%                         N017100 001
	
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
	
  OINTMENT;OPHTHALMIC
	
    BLEPHAMIDE S.O.P.
	
      + ALLERGAN                0.2%;10%                       A087748 001 Dec 03, 1986
	
  SUSPENSION;OPHTHALMIC
	
    BLEPHAMIDE
	
      + ALLERGAN                0.2%;10%                       N012813 002
	
PREDNISOLONE SODIUM PHOSPHATE
	
  SOLUTION;ORAL

    ORAPRED
	
AA    + CONCORDIA PHARMS INC    EQ 15MG BASE/5ML               A075117 001 Dec 14, 2000

    PEDIAPRED
	
AA    + SETON PHARM             EQ 5MG BASE/5ML                N019157 001 May 28, 1986

    PREDNISOLONE SODIUM PHOSPHATE
	
AA       AMNEAL PHARMS          EQ 15MG BASE/5ML               A078345   001    Mar   10,   2009

AA       HI TECH PHARMA         EQ 5MG BASE/5ML                A075183   001    Mar   26,   2003

AA       PADDOCK LLC            EQ 5MG BASE/5ML                A075988   001    May   25,   2004

AA       PHARM ASSOC            EQ 15MG BASE/5ML               A076913   001    Apr   25,   2005

AA       VINTAGE                EQ 15MG BASE/5ML               A079010   001    May   26,   2009

AA       WOCKHARDT              EQ 5MG BASE/5ML                A075099   001    Jun   28,   2002

AA                              EQ 15MG BASE/5ML               A076895   001    Oct   04,   2004
	
      + MISSION PHARMA          EQ 25MG BASE/5ML               A091396   001    Sep   13,   2010

      + PHARM ASSOC             EQ 10MG BASE/5ML               A078465   001    Mar   07,   2008
	
      +                         EQ 20MG BASE/5ML               A078988   001    Jun   09,   2008
	
  SOLUTION/DROPS;OPHTHALMIC

    PREDNISOLONE SODIUM PHOSPHATE
	
      + BAUSCH AND LOMB         EQ 0.9% PHOSPHATE              A040070 001 Jul 29, 1994
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    ORAPRED ODT
	
AB       CONCORDIA PHARMS INC   EQ 10MG BASE                   N021959 001 Jun 01, 2006

AB                              EQ 15MG BASE                   N021959 002 Jun 01, 2006

AB    +                         EQ 30MG BASE                   N021959 003 Jun 01, 2006

    PREDNISOLONE SODIUM PHOSPHATE
	
AB       MYLAN PHARMS INC       EQ 10MG BASE                   A202179 001 Apr 10, 2013

AB                              EQ 15MG BASE                   A202179 002 Apr 10, 2013

AB                              EQ 30MG BASE                   A202179 003 Apr 10, 2013
	
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
	
AT       ALCON PHARMS LTD       EQ 0.23% PHOSPHATE;10%         A073630 001 May 27, 1993

AT    + BAUSCH AND LOMB         EQ 0.23% PHOSPHATE;10%         A074449 001 Dec 29, 1995
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-300(of 371)


PREDNISONE
	
  SOLUTION;ORAL
	
    PREDNISONE
	
      + ROXANE                     5MG/5ML                     A088703 001 Nov 08, 1984
	
    PREDNISONE INTENSOL
	
      + ROXANE                     5MG/ML                      A088810 001 Feb 20, 1985
	
  TABLET;ORAL

    PREDNISONE
	
AB       CONTRACT PHARMACAL        5MG                         A080209   001
	
AB       HIKMA PHARMS              1MG                         A040890   001     Nov 01, 2010

AB                                 2.5MG                       A040538   001     Jan 08, 2004

AB                                 5MG                         A080292   001
	
AB                                 10MG                        A088832   001     Dec 04, 1985

AB                                 20MG                        A083677   001
	
AB                                 50MG                        A088465   001     Jun   01,   1984

AB       JUBILANT CADISTA          1MG                         A040611   001     Jun   06,   2005

AB                                 5MG                         A040362   002     Aug   29,   2001

AB                                 10MG                        A040362   001     Aug   29,   2001

AB                                 20MG                        A040362   003     Jun   29,   2005

AB       MUTUAL PHARM              5MG                         A089245   001     Dec   04,   1985

AB                                 10MG                        A089246   001     Dec   04,   1985

AB                                 20MG                        A089247   001     Dec   04,   1985

AB    + ROXANE                     1MG                         A087800   001     Apr   22,   1982

AB    +                            2.5MG                       A087801   001     Apr   22,   1982

AB    +                            5MG                         A080352   001
	
AB    +                            10MG                        A084122   001
	
AB    +                            20MG                        A087342   001
	
AB    +                            50MG                        A084283   001
	
AB       VINTAGE PHARMS            1MG                         A040584   001     Dec   21,   2004

AB                                 2.5MG                       A040581   001     Dec   21,   2004

AB                                 5MG                         A040256   001     Jul   12,   2002

AB                                 10MG                        A040256   002     Jul   12,   2002

AB                                 20MG                        A040392   001     Feb   12,   2003

AB       WATSON LABS               5MG                         A080356   001
	
AB                                 10MG                        A085162   001
	
AB                                 20MG                        A085161   001
	
  TABLET, DELAYED RELEASE;ORAL
	
    RAYOS
	
         HORIZON PHARMA            1MG                         N202020 001 Jul 26, 2012
	
                                   2MG                         N202020 002 Jul 26, 2012
	
     +                             5MG                         N202020 003 Jul 26, 2012
	
PREGABALIN
	
  CAPSULE;ORAL

    LYRICA
	
AB       PF PRISM CV               25MG                        N021446   001     Dec   30,   2004

AB                                 50MG                        N021446   002     Dec   30,   2004

AB                                 75MG                        N021446   003     Dec   30,   2004

AB                                 100MG                       N021446   004     Dec   30,   2004

AB                                 150MG                       N021446   005     Dec   30,   2004

AB                                 200MG                       N021446   006     Dec   30,   2004

AB                                 225MG                       N021446   007     Dec   30,   2004

AB    +                            300MG                       N021446   008     Dec   30,   2004

    PREGABALIN
	
AB       LUPIN LTD                 25MG                        A091040   001     Jul   03,   2012

AB                                 50MG                        A091040   002     Jul   03,   2012

AB                                 75MG                        A091040   003     Jul   03,   2012

AB                                 100MG                       A091040   004     Jul   03,   2012

AB                                 150MG                       A091040   005     Jul   03,   2012

AB                                 200MG                       A091040   006     Jul   03,   2012

AB                                 225MG                       A091040   007     Jul   03,   2012

AB                                 300MG                       A091040   008     Jul   03,   2012

AB       TEVA PHARMS               25MG                        A091219   001     Jul   03,   2012

AB                                 50MG                        A091219   002     Jul   03,   2012

AB                                 75MG                        A091224   001     Jul   03,   2012

AB                                 100MG                       A091224   002     Jul   03,   2012

AB                                 150MG                       A091224   003     Jul   03,   2012

AB                                 200MG                       A091224   004     Jul   03,   2012

AB                                 225MG                       A091224   005     Jul   03,   2012

AB                                 300MG                       A091224   006     Jul   03,   2012

AB       WATSON LABS INC           25MG                        A091221   001     Jul   03,   2012

AB                                 50MG                        A091221   002     Jul   03,   2012

AB                                 75MG                        A091221   003     Jul   03,   2012
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST
	                   3-301(of 371)


PREGABALIN
	
  CAPSULE;ORAL

     PREGABALIN
	
AB
	                              100MG
	                         A091221   004     Jul   03,   2012

AB
	                              150MG
	                         A091221   005     Jul   03,   2012

AB
	                              200MG
	                         A091221   006     Jul   03,   2012

AB
	                              225MG
	                         A091221   007     Jul   03,   2012

AB
	                              300MG
	                         A091221   008     Jul   03,   2012
	
  SOLUTION;ORAL
	
     LYRICA
	
       + PF PRISM CV
	            20MG/ML
	                       N022488 001 Jan 04, 2010
	
PRILOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PRILOCAINE HYDROCHLORIDE
	
      + SEPTODONT INC
	           4%
	                            A079235 001 Sep 29, 2010
	
PRIMAQUINE PHOSPHATE
	
  TABLET;ORAL

    PRIMAQUINE

AB    + SANOFI AVENTIS US         EQ 15MG BASE
	                  N008316 001
	
    PRIMAQUINE PHOSPHATE
AB       ALVOGEN INC              EQ 15MG BASE
                   A203924 001 Feb 03, 2014

AB       BAYSHORE PHARMS LLC      EQ 15MG BASE
	                  A204476 001 Feb 25, 2014
	
PRIMIDONE
	
  TABLET;ORAL

     MYSOLINE
	
AB     + VALEANT
	                50MG
	                          N009170 003
	
AB
	                              250MG
	                         N009170 002
	
     PRIMIDONE
	
AB        AMNEAL PHARM
	          50MG
	                          A040866   001     Apr   23,   2008

AB
	                              250MG
	                         A040866   002     Apr   23,   2008

AB        HIKMA PHARMS LLC
	      250MG
	                         A040667   002     Jul   27,   2006

AB        IMPAX LABS
	            50MG
	                          A040717   001     Feb   12,   2008

AB
	                              250MG
	                         A040717   002     Feb   12,   2008

AB        LANNETT
	               50MG
	                          A084903   002     May   24,   2001

AB
	                              250MG
	                         A084903   001
	
AB        MUTUAL PHARM
	          50MG
	                          A040626   001     Sep   29,   2005

AB
	                              250MG
	                         A040626   002     Sep   29,   2005

AB        VINTAGE PHARMS
	        50MG
	                          A040586   001     Feb   24,   2005

AB
	                              250MG
	                         A040586   002     Feb   24,   2005

AB        WATSON LABS
	           250MG
	                         A083551   001
	
PROBENECID
	
  TABLET;ORAL

    PROBALAN
	
AB       LANNETT
	                500MG
	                         A080966 001
	
    PROBENECID
	
AB    + MYLAN
	                   500MG
	                         A084211 002
	
AB       WATSON LABS
	            500MG
	                         A084442 004 Mar 29, 1983
	
PROCAINAMIDE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PROCAINAMIDE HYDROCHLORIDE
	
      + HOSPIRA
	                100MG/ML
                        A089069 001 Feb 12, 1986
	
      +
	                        500MG/ML
	                       A089070 001 Feb 12, 1986
	
PROCARBAZINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    MATULANE
	
      + SIGMA TAU
	               EQ 50MG BASE
	                  N016785 001
	
PROCHLORPERAZINE
	
  SUPPOSITORY;RECTAL

    COMPRO
	
AB       PADDOCK LLC
	            25MG
	                          A040246 001 Jun 28, 2000
	
    PROCHLORPERAZINE
	
AB    + G AND W LABS
	            25MG
	                          A040058 001 Nov 24, 1993
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-302(of 371)


PROCHLORPERAZINE EDISYLATE
	
  INJECTABLE;INJECTION

    PROCHLORPERAZINE EDISYLATE
	
AP       BEDFORD
	               EQ 5MG BASE/ML
                 A040540 001 May 28, 2004

AP       EMCURE PHARMS LTD
	     EQ 5MG BASE/ML
                 A204147 001 Oct 15, 2013

AP    + HIKMA MAPLE
	            EQ 5MG BASE/ML
	                A089903 001 Aug 29, 1989
	
PROCHLORPERAZINE MALEATE
	
  TABLET;ORAL

     PROCHLORPERAZINE MALEATE
	
AB         MYLAN
	                  EQ     5MG BASE
             A040185   002    Oct   28,   1996

AB
	                                EQ     10MG BASE
            A040185   001    Oct   28,   1996

AB         SANDOZ
	                 EQ     5MG BASE
             A040101   001    Jul   19,   1996

AB     +
	                          EQ     10MG BASE
            A040101   002    Jul   19,   1996

AB         TEVA PHARMS
	            EQ     5MG BASE
             A040120   001    Jul   11,   1996

AB
	                                EQ     10MG BASE
	           A040120   002    Jul   11,   1996
	
     PROCOMP
	
AB         JUBILANT CADISTA
	       EQ 5MG BASE
                 A040268 001 Feb 27, 1998

AB
	                                EQ 10MG BASE
	               A040268 002 Feb 27, 1998
	
PROGESTERONE
	
  CAPSULE;ORAL

     PROGESTERONE
	
AB         BANNER PHARMACAPS
	      100MG
	                      A200900   001    Aug   16,   2013

AB
	                                200MG
	                      A200900   002    Aug   16,   2013

AB         SOFGEN PHARMS
	          100MG
	                      A200456   001    Sep   28,   2012

AB
	                                200MG
	                      A200456   002    Sep   28,   2012

AB         TEVA PHARMS
	            100MG
	                      A202121   001    Feb   29,   2012

AB
	                                200MG
	                      A202121   002    Feb   29,   2012
	
     PROMETRIUM
	
AB         ABBVIE INC
	             100MG
	                      N019781 001 May 14, 1998

AB     +
	                          200MG
	                      N019781 002 Oct 15, 1999
	
  GEL;VAGINAL
	
     CRINONE
	
           WATSON LABS
	            4%
	                         N020701 001 Jul 31, 1997
	
       +
	                          8%
	                         N020701 002 Jul 31, 1997
	
  INJECTABLE;INJECTION

     PROGESTERONE
	
AO         FRESENIUS KABI USA
	     50MG/ML
                     A075906   001 Apr 25, 2001

AO         HIKMA FARMACEUTICA
	     50MG/ML
                     A091033   001 Oct 28, 2010

AO         LUITPOLD
	               50MG/ML
                     A090845   001 Jun 22, 2009

AO     + WATSON LABS (UTAH)
        50MG/ML
	                    N017362   002
	
  INSERT;VAGINAL
	
     ENDOMETRIN
	
       + FERRING
	                  100MG
	                      N022057 001 Jun 21, 2007
	
PROMETHAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     PROMETHAZINE HYDROCHLORIDE
	
AP     + HIKMA MAPLE
	              25MG/ML
                     A083312   001
	
AP     +
	                          50MG/ML
                     A083312   002
	
AP         X-GEN PHARMS
	           25MG/ML
                     A040737   001 Apr 24, 2008

AP
	                                50MG/ML
	                    A040737   002 Apr 24, 2008
	
  SUPPOSITORY;RECTAL

     PROMETHAZINE HYDROCHLORIDE
	
AB         G AND W LABS
	           12.5MG
	                     A040428   002    Mar   31,   2003

AB     +
	                          25MG
	                       A040428   001    Feb   05,   2002

AB         PERRIGO NEW YORK
	       12.5MG
	                     A040500   001    Jun   30,   2003

AB
	                                25MG
	                       A040500   002    Jun   30,   2003

AB         TARO
	                   12.5MG
	                     A040603   001    Oct   26,   2006

AB
	                                25MG
	                       A040603   002    Oct   26,   2006

AB         WATSON LABS INC
	        12.5MG
	                     A040479   001    Jun   24,   2003

AB
	                                25MG
	                       A040479   002    Jun   24,   2003
	
     PROMETHEGAN
	
       + G AND W LABS
	             50MG
	                       A087165 001 Aug 14, 1987
	
  SYRUP;ORAL

     PROMETHAZINE HYDROCHLORIDE
	
AA         AMNEAL PHARMS
	          6.25MG/5ML
                  A040882   001    Dec   30,   2009

AA         HI TECH PHARMA
	         6.25MG/5ML
                  A040026   001    Sep   25,   1998

AA         SUN PHARM INDS INC
	     6.25MG/5ML
                  A040891   001    Mar   13,   2009

AA         TARO
	                   6.25MG/5ML
                  A040718   001    Apr   04,   2007

AA         TRIS PHARMA INC
	        6.25MG/5ML
                  A091675   001    Jun   28,   2012

AA         VINTAGE
	                6.25MG/5ML
	                 A040643   001    Apr   26,   2006
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-303(of 371)


PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL

    PROMETHAZINE PLAIN
	
AA    + WOCKHARDT                  6.25MG/5ML                   A087953 001 Nov 15, 1982
	
  TABLET;ORAL

    PROMETHAZINE HYDROCHLORIDE
	
AB       AMNEAL PHARMS NY          12.5MG                       A091179   001     Dec   13,   2010

AB                                 25MG                         A091179   002     Dec   13,   2010

AB                                 50MG                         A091179   003     Dec   13,   2010

AB       EMCURE PHARMS USA         12.5MG                       A040673   001     Mar   05,   2008

AB                                 25MG                         A040673   002     Mar   05,   2008

AB                                 50MG                         A040673   003     Mar   05,   2008

AB       IMPAX LABS                12.5MG                       A040724   001     Feb   12,   2008

AB                                 25MG                         A040724   002     Feb   12,   2008

AB                                 50MG                         A040791   001     May   20,   2008

AB       KVK TECH                  12.5MG                       A040712   002     May   04,   2007

AB                                 25MG                         A040712   001     Jul   31,   2006

AB                                 50MG                         A040713   001     Jul   31,   2006

AB       MYLAN                     12.5MG                       A091054   001     Aug   30,   2011

AB                                 25MG                         A091054   002     Aug   30,   2011

AB                                 50MG                         A091054   003     Aug   30,   2011

AB       SANDOZ                    25MG                         A084176   003
	
AB    +                            50MG                         A084176   001
	
AB       SUN PHARM INDS INC        12.5MG                       A040863   001     Dec   30,   2008

AB                                 25MG                         A040863   002     Dec   30,   2008

AB                                 50MG                         A040863   003     Dec   30,   2008

AB       VINTAGE PHARMS            12.5MG                       A040622   001     Jul   18,   2006

AB                                 25MG                         A040622   002     Jul   18,   2006

AB                                 50MG                         A040622   003     Jul   18,   2006

AB       WATSON LABS               25MG                         A083426   001
	
AB                                 50MG                         A083711   001
	
AB       ZYDUS PHARMS USA          12.5MG                       A040596   001     Nov 18, 2005

AB                                 25MG                         A040596   002     Nov 18, 2005

AB                                 50MG                         A040596   003     Nov 18, 2005
	
PROPAFENONE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    PROPAFENONE HYDROCHLORIDE
	
AB       PAR PHARM              225MG                           A078540 001 Oct 18, 2010

AB                              325MG                           A078540 002 Oct 18, 2010

AB                              425MG                           A078540 003 Oct 18, 2010

    RYTHMOL SR
	
AB       GLAXOSMITHKLINE LLC    225MG                           N021416 001 Sep 04, 2003

AB                              325MG                           N021416 002 Sep 04, 2003

AB    +                         425MG                           N021416 003 Sep 04, 2003

  TABLET;ORAL

    PROPAFENONE HYDROCHLORIDE
	
AB       ANI PHARMS INC         150MG                           A076550   001     Apr   23,   2004

AB                              225MG                           A076550   002     Apr   23,   2004

AB                              300MG                           A076550   003     Apr   23,   2004

AB       MUTUAL PHARM           150MG                           A075998   001     Nov   29,   2001

AB                              225MG                           A075998   002     Nov   29,   2001

AB                              300MG                           A075998   003     Nov   29,   2001

AB       VINTAGE PHARMS         150MG                           A075938   001     Oct   17,   2002

AB                              225MG                           A075938   002     Oct   17,   2002

AB                              300MG                           A075938   003     Oct   17,   2002

AB       WATSON LABS            150MG                           A075203   001     Oct   24,   2000

AB                              225MG                           A075203   002     Oct   24,   2000

    RYTHMOL
	
AB       GLAXOSMITHKLINE LLC    150MG                           N019151 001 Nov 27, 1989

AB                              225MG                           N019151 003 Nov 20, 1992

AB    +                         300MG                           N019151 002 Nov 27, 1989
	
PROPANTHELINE BROMIDE
	
  TABLET;ORAL
	
    PROPANTHELINE BROMIDE
	
      + ROXANE                     15MG                         A080927 002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-304(of 371)


PROPARACAINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    ALCAINE
	
AT    + ALCON                    0.5%                          A080027 001
	
    PROPARACAINE HYDROCHLORIDE
	
AT       AKORN INC               0.5%                          A040277 001 Mar 16, 2000

AT       BAUSCH AND LOMB         0.5%                          A040074 001 Sep 29, 1995
	
PROPOFOL
	
  INJECTABLE;INJECTION

    DIPRIVAN
	
AB    + FRESENIUS KABI USA      10MG/ML                        N019627 002 Jun 11, 1996

    PROPOFOL
	
AB        HOSPIRA               10MG/ML                        A077908 001 Mar 17, 2006

AB        TEVA PHARMS USA       10MG/ML                        A075102 001 Jan 04, 1999
	
PROPOXYPHENE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    PROPOXYPHENE HYDROCHLORIDE
	
         PVT FORM                32MG                          A083464 001
	
PROPRANOLOL HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    INDERAL LA
	
AB       CRANFORD PHARMS LLC    60MG                           N018553   004     Mar   18,   1987

AB                              80MG                           N018553   002     Apr   19,   1983

AB                              120MG                          N018553   003     Apr   19,   1983

AB    +                         160MG                          N018553   001     Apr   19,   1983

    PROPRANOLOL HYDROCHLORIDE
	
AB       ACTAVIS ELIZABETH      60MG                           A078494   001     Aug   10,   2007

AB                              80MG                           A078494   002     Aug   10,   2007

AB                              120MG                          A078494   003     Aug   10,   2007

AB                              160MG                          A078494   004     Aug   10,   2007

AB       APTALIS PHARMATECH     60MG                           A078703   001     Jul   15,   2011

AB                              80MG                           A078703   002     Jul   15,   2011

AB                              120MG                          A078703   003     Jul   15,   2011

AB                              160MG                          A078703   004     Jul   15,   2011

AB       MYLAN                  60MG                           A078022   001     Feb   15,   2007

AB                              80MG                           A078022   002     Feb   15,   2007

AB                              120MG                          A078022   003     Feb   15,   2007

AB                              160MG                          A078022   004     Feb   15,   2007

AB       NORTEC DEV ASSOC       60MG                           A078065   001     Jan   26,   2007

AB                              80MG                           A078065   002     Jan   26,   2007

AB                              120MG                          A078065   003     Jan   26,   2007

AB                              160MG                          A078065   004     Jan   26,   2007

AB       UPSHER SMITH           60MG                           A078311   001     Mar   06,   2009

AB                              80MG                           A078311   002     Mar   06,   2009

AB                              120MG                          A078311   003     Mar   06,   2009

AB                              160MG                          A078311   004     Mar   06,   2009

AB       ZYDUS PHARMS USA INC   60MG                           A090321   001     Mar   25,   2011

AB                              80MG                           A090321   002     Mar   25,   2011

AB                              120MG                          A090321   003     Mar   25,   2011

AB                              160MG                          A090321   004     Mar   25,   2011
	
    INNOPRAN XL
	
BX       GLAXOSMITHKLINE LLC    80MG                           N021438 001 Mar 12, 2003
	
BX                              120MG                          N021438 002 Mar 12, 2003
	
  INJECTABLE;INJECTION

    PROPRANOLOL HYDROCHLORIDE
	
AP    + BAXTER HLTHCARE CORP    1MG/ML                         N016419   001
	
AP       BEDFORD                1MG/ML                         A075792   001     Aug   29,   2000

AP       FRESENIUS KABI USA     1MG/ML                         A075826   001     Aug   31,   2001

AP       HIKMA FARMACEUTICA     1MG/ML                         A077760   001     Jan   31,   2008

AP       SANDOZ                 1MG/ML                         A076400   001     Feb   26,   2003
	
  SOLUTION;ORAL
	
    HEMANGEOL
	
      + PIERRE FABRE DERMA      4.28MG/ML                      N205410 001 Mar 14, 2014
	
    PROPRANOLOL HYDROCHLORIDE
	
      + ROXANE                  20MG/5ML                       A070979 001 May 15, 1987

      +                         40MG/5ML                       A070690 001 May 15, 1987

  TABLET;ORAL

    PROPRANOLOL HYDROCHLORIDE
	
AB       IPCA LABS LTD          10MG                           A078955 001 Jun 02, 2008

AB                              20MG                           A078955 002 Jun 02, 2008

AB                              40MG                           A078955 003 Jun 02, 2008
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-305(of 371)


PROPRANOLOL HYDROCHLORIDE
	
  TABLET;ORAL

    PROPRANOLOL HYDROCHLORIDE
	
AB                                 60MG
	                        A078955   004    Jun   02,   2008

AB                                 80MG
	                        A078955   005    Jun   02,   2008

AB       MYLAN                     10MG
	                        A070213   002    Nov   19,   1985

AB                                 20MG
	                        A070213   003    Nov   19,   1985

AB                                 40MG
	                        A070213   001    Nov   19,   1985

AB                                 60MG
	                        A070213   005    Apr   08,   2011

AB                                 80MG
	                        A070213   004    Nov   19,   1985

AB       NORTHSTAR HLTHCARE        10MG
	                        A078213   001    Jan   10,   2008

AB                                 20MG
	                        A078213   002    Jan   10,   2008

AB                                 40MG
	                        A078213   003    Jan   10,   2008

AB                                 60MG
	                        A078213   004    Jan   10,   2008

AB                                 80MG
	                        A078213   005    Jan   10,   2008

AB       PLIVA                     10MG
	                        A071972   001    Apr   06,   1988

AB                                 20MG
	                        A071973   001    Apr   06,   1988

AB                                 40MG
	                        A071974   001    Apr   06,   1988

AB                                 60MG
	                        A071975   001    Apr   06,   1988

AB    +                            80MG
	                        A071976   001    Apr   06,   1988

AB       VINTAGE PHARMS            10MG
	                        A070217   001    Aug   01,   1986

AB                                 20MG
	                        A070218   001    Aug   01,   1986

AB                                 40MG
	                        A070219   001    Aug   01,   1986

AB                                 60MG
	                        A070220   001    Sep   24,   1986

AB                                 80MG
	                        A070221   001    Apr   14,   1986

AB       WATSON LABS               10MG
	                        A070175   001    May   13,   1986

AB                                 20MG
	                        A070176   001    May   13,   1986

AB                                 40MG
	                        A070177   001    May   13,   1986

AB                                 80MG
	                        A070178   001    May   13,   1986
	
PROPYLTHIOURACIL
	
  TABLET;ORAL
	
    PROPYLTHIOURACIL
	
BD       ACTAVIS ELIZABETH
	       50MG
	                        A080172 001
	
BD    + DAVA PHARMS INC
	          50MG
	                        N006188 001
	
PROTAMINE SULFATE
	
  INJECTABLE;INJECTION
	
    PROTAMINE SULFATE
	
      + FRESENIUS KABI USA
	       10MG/ML
	                     A089454 001 Apr 07, 1987
	
PROTRIPTYLINE HYDROCHLORIDE
	
  TABLET;ORAL

     PROTRIPTYLINE HYDROCHLORIDE
	
AB         EPIC PHARMA LLC
	       5MG
	                         A202220   001    Nov   19,   2012

AB
	                               10MG
	                        A202220   002    Nov   19,   2012

AB         ROXANE
	                5MG
	                         A078913   001    Sep   16,   2008

AB
	                               10MG
	                        A078913   002    Sep   16,   2008

AB         SIGMAPHARM LABS LLC
	   5MG
	                         A090462   001    May   03,   2010

AB
	                               10MG
	                        A090462   002    May   03,   2010
	
     VIVACTIL
	
AB         ODYSSEY PHARMS
	        5MG
	                         A073644 001 Aug 24, 1995

AB     +
	                         10MG
	                        A073645 001 Aug 24, 1995
	
PYRAZINAMIDE
	
  TABLET;ORAL

    PYRAZINAMIDE
	
AB    + DAVA PHARMS INC
	          500MG
	                       A080157 001
	
AB       MIKART
	                  500MG
	                       A081319 001 Jun 30, 1992
	
PYRIDOSTIGMINE BROMIDE
	
  INJECTABLE;INJECTION

    MESTINON
	
AP    + VALEANT PHARM INTL
	       5MG/ML
	                      N009830 001
	
    REGONOL
	
AP       SANDOZ
	                  5MG/ML
	                      N017398 001
	
  SYRUP;ORAL
	
    MESTINON
	
      + VALEANT PHARM NORTH
	      60MG/5ML
	                    N015193 001
	
  TABLET;ORAL

    MESTINON
	
AB    + VALEANT PHARMS LLC
	       60MG
	                        N009829 002
	
    PYRIDOSTIGMINE BROMIDE
	
AB       IMPAX LABS
	              60MG
	                        A040502 001 Apr 24, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-306(of 371)


PYRIDOSTIGMINE BROMIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    MESTINON
	
      + VALEANT PHARMS LLC
	     180MG
	                        N011665 001
	
PYRIDOXINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PYRIDOXINE HYDROCHLORIDE
	
      + FRESENIUS KABI USA
	     100MG/ML
	                     A080618 001
	
PYRIMETHAMINE
	
  TABLET;ORAL
	
    DARAPRIM
	
      + AMEDRA PHARMS
	          25MG
	                         N008578 001
	
QUAZEPAM
	
  TABLET;ORAL
	
    DORAL
	
      + SCIECURE PHARMA INC
	    15MG
	                         N018708 001 Dec 27, 1985
	
QUETIAPINE FUMARATE
	
  TABLET;ORAL

    QUETIAPINE FUMARATE

AB       ACCORD HLTHCARE         EQ   25MG BASE
                A202152   001    Mar   27,   2012

AB                               EQ   50MG BASE
                A202152   002    Mar   27,   2012

AB                               EQ   100MG BASE
               A202152   003    Mar   27,   2012

AB                               EQ   200MG BASE
               A202152   004    Mar   27,   2012

AB                               EQ   300MG BASE
               A202152   005    Mar   27,   2012

AB                               EQ   400MG BASE
               A202152   006    Mar   27,   2012

AB       ACTAVIS GRP PTC         EQ   25MG BASE
                A201762   001    Feb   27,   2013

AB                               EQ   50MG BASE
                A201762   002    Feb   27,   2013

AB                               EQ   100MG BASE
               A201762   003    Feb   27,   2013

AB                               EQ   150MG BASE
               A201762   004    Feb   27,   2013

AB                               EQ   200MG BASE
               A201762   005    Feb   27,   2013

AB                               EQ   300MG BASE
               A201762   006    Feb   27,   2013

AB                               EQ   400MG BASE
               A201762   007    Feb   27,   2013

AB       ALEMBIC PHARMS LTD      EQ   25MG BASE
                A203390   001    Oct   28,   2014

AB                               EQ   50MG BASE
                A203390   002    Oct   28,   2014

AB                               EQ   100MG BASE
               A203390   003    Oct   28,   2014

AB                               EQ   200MG BASE
               A203390   004    Oct   28,   2014

AB                               EQ   300MG BASE
               A203390   005    Oct   28,   2014

AB                               EQ   400MG BASE
               A203390   006    Oct   28,   2014

AB       ALKEM LABS LTD          EQ   25MG BASE
                A201504   001    Feb   12,   2013

AB                               EQ   50MG BASE
                A201504   002    Feb   12,   2013

AB                               EQ   100MG BASE
               A201504   003    Feb   12,   2013

AB                               EQ   150MG BASE
               A201504   004    Feb   12,   2013

AB                               EQ   200MG BASE
               A201504   005    Feb   12,   2013

AB                               EQ   300MG BASE
               A201504   006    Feb   12,   2013

AB                               EQ   400MG BASE
               A201504   007    Feb   12,   2013

AB       APOTEX INC              EQ   25MG BASE
                A090960   001    Mar   27,   2012

AB                               EQ   50MG BASE
                A090960   002    Mar   27,   2012

AB                               EQ   100MG BASE
               A090960   003    Mar   27,   2012

AB                               EQ   200MG BASE
               A090960   004    Mar   27,   2012

AB                               EQ   300MG BASE
               A090960   005    Mar   27,   2012

AB                               EQ   400MG BASE
               A090960   006    Mar   27,   2012

AB       AUROBINDO PHARMA LTD    EQ   25MG BASE
                A091388   001    Mar   27,   2012

AB                               EQ   50MG BASE
                A091388   002    Mar   27,   2012

AB                               EQ   100MG BASE
               A091388   003    Mar   27,   2012

AB                               EQ   150MG BASE
               A091388   004    Mar   27,   2012

AB                               EQ   200MG BASE
               A091388   005    Mar   27,   2012

AB                               EQ   300MG BASE
               A091388   006    Mar   27,   2012

AB                               EQ   400MG BASE
               A091388   007    Mar   27,   2012

AB       DR REDDYS LABS LTD      EQ   25MG BASE
                A077380   001    Mar   27,   2012

AB                               EQ   50MG BASE
                A077380   002    Mar   27,   2012

AB                               EQ   100MG BASE
               A077380   003    Mar   27,   2012

AB                               EQ   150MG BASE
               A077380   004    Mar   27,   2012

AB                               EQ   200MG BASE
               A077380   005    Mar   27,   2012

AB                               EQ   300MG BASE
               A077380   006    Mar   27,   2012

AB                               EQ   400MG BASE
               A077380   007    Mar   27,   2012

AB       JUBILANT GENERICS       EQ   25MG BASE
                A203150   001    Nov   26,   2013

AB       LUPIN LTD               EQ   25MG BASE
                A201109   001    Mar   27,   2012

AB                               EQ   50MG BASE
                A201109   002    Mar   27,   2012

AB                               EQ   100MG BASE
               A201109   003    Mar   27,   2012

AB                               EQ   200MG BASE
	              A201109   004    Mar   27,   2012
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-307(of 371)


QUETIAPINE FUMARATE
	
  TABLET;ORAL

     QUETIAPINE FUMARATE

AB                               EQ      300MG BASE
             A201109   005    Mar   27,   2012

AB                               EQ      400MG BASE
             A201109   006    Mar   27,   2012

AB         MYLAN PHARMS INC      EQ      25MG BASE
              A090323   001    Mar   27,   2012

AB         ROXANE                EQ      25MG BASE
              A090120   001    Mar   27,   2012

AB                               EQ      50MG BASE
              A090749   001    Mar   27,   2012

AB                               EQ      100MG BASE
             A090749   002    Mar   27,   2012

AB                               EQ      200MG BASE
             A090749   003    Mar   27,   2012

AB                               EQ      300MG BASE
             A090749   004    Mar   27,   2012

AB                               EQ      400MG BASE
             A090749   005    Mar   27,   2012

AB         SANDOZ                EQ      25MG BASE
              A078679   001    Dec   14,   2012

AB                               EQ      50MG BASE
              A078679   002    Dec   14,   2012

AB                               EQ      100MG BASE
             A078679   003    Dec   14,   2012

AB                               EQ      150MG BASE
             A078679   004    Dec   14,   2012

AB                               EQ      200MG BASE
             A078679   005    Dec   14,   2012

AB                               EQ      300MG BASE
             A078679   006    Dec   14,   2012

AB                               EQ      400MG BASE
             A078679   007    Dec   14,   2012

AB         SUN PHARMA GLOBAL
	   EQ      25MG BASE
              A201190   001    Mar   27,   2012

AB
	                             EQ      50MG BASE
              A201190   002    Mar   27,   2012

AB
	                             EQ      100MG BASE
             A201190   003    Mar   27,   2012

AB
	                             EQ      200MG BASE
             A201190   004    Mar   27,   2012

AB
	                             EQ      300MG BASE
             A201190   005    Mar   27,   2012

AB
	                             EQ      400MG BASE
             A201190   006    Mar   27,   2012

AB         TEVA PHARMS
	         EQ      25MG BASE
              A077745   001    Mar   27,   2012

AB
	                             EQ      50MG BASE
              A077745   002    Mar   27,   2012

AB
	                             EQ      100MG BASE
             A077745   003    Mar   27,   2012

AB
	                             EQ      150MG BASE
             A077745   004    Mar   27,   2012

AB
	                             EQ      200MG BASE
             A077745   005    Mar   27,   2012

AB
	                             EQ      300MG BASE
             A077745   006    Mar   27,   2012

AB
	                             EQ      400MG BASE
             A077745   007    Mar   27,   2012

AB         TORRENT PHARMS LTD
	  EQ      25MG BASE
              A200363   001    Mar   27,   2012

AB
	                             EQ      50MG BASE
              A200363   002    Mar   27,   2012

AB
	                             EQ      100MG BASE
             A200363   003    Mar   27,   2012

AB
	                             EQ      200MG BASE
             A200363   004    Mar   27,   2012

AB
	                             EQ      300MG BASE
             A200363   005    Mar   27,   2012

AB
	                             EQ      400MG BASE
	            A200363   006    Mar   27,   2012
	
     SEROQUEL

AB     + ASTRAZENECA             EQ      25MG BASE
              N020639   001    Sep   26,   1997

AB                               EQ      50MG BASE
              N020639   007    Oct   04,   2005

AB                               EQ      100MG BASE
             N020639   002    Sep   26,   1997

AB                               EQ      200MG BASE
             N020639   003    Sep   26,   1997

AB     +                         EQ      300MG BASE
             N020639   005    Jul   26,   2000

AB                               EQ      400MG BASE
	            N020639   006    Oct   04,   2005
	
  TABLET, EXTENDED RELEASE;ORAL
	
     SEROQUEL XR
	
           ASTRAZENECA
	         EQ      50MG BASE
	             N022047   001    May   17,   2007

                                 EQ      150MG BASE
	            N022047   005    Aug   11,   2008

       +
	                       EQ      200MG BASE
	            N022047   002    May   17,   2007

                                 EQ      300MG BASE
	            N022047   003    May   17,   2007

                                 EQ      400MG BASE
	            N022047   004    May   17,   2007
	
QUINAPRIL HYDROCHLORIDE
	
  TABLET;ORAL

     ACCUPRIL
	
AB         PFIZER PHARMS
	          EQ   5MG BASE
               N019885   001    Nov   19,   1991

AB
	                                EQ   10MG BASE
              N019885   002    Nov   19,   1991

AB
	                                EQ   20MG BASE
              N019885   003    Nov   19,   1991

AB     +
	                          EQ   40MG BASE
	             N019885   004    Nov   19,   1991
	
     QUINAPRIL HYDROCHLORIDE

AB         ACTAVIS LABS FL INC
	    EQ   5MG BASE
               A076049   001    Jan   14,   2005

AB
	                                EQ   10MG BASE
              A076049   002    Jan   14,   2005

AB
	                                EQ   20MG BASE
              A076049   003    Jan   14,   2005

AB
	                                EQ   40MG BASE
              A076049   004    Jan   14,   2005

AB         AUROBINDO PHARMA LTD
	   EQ   5MG BASE
               A202725   001    Apr   29,   2013

AB
	                                EQ   10MG BASE
              A202725   002    Apr   29,   2013

AB
	                                EQ   20MG BASE
              A202725   003    Apr   29,   2013

AB
	                                EQ   40MG BASE
              A202725   004    Apr   29,   2013

AB         INVAGEN PHARMS
	         EQ   5MG BASE
               A078457   001    Aug   24,   2007

AB
	                                EQ   10MG BASE
              A078457   002    Aug   24,   2007

AB
	                                EQ   20MG BASE
              A078457   003    Aug   24,   2007

AB
	                                EQ   40MG BASE
	             A078457   004    Aug   24,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-308(of 371)


QUINAPRIL HYDROCHLORIDE
	
  TABLET;ORAL

     QUINAPRIL HYDROCHLORIDE

AB        LUPIN
	                EQ   5MG BASE
                 A077690   001    Jun   20,   2006

AB
	                             EQ   10MG BASE
                A077690   002    Jun   20,   2006

AB
	                             EQ   20MG BASE
                A077690   003    Jun   20,   2006

AB
	                             EQ   40MG BASE
                A077690   004    Jun   20,   2006

AB        MYLAN
	                EQ   5MG BASE
                 A076694   001    Dec   23,   2004

AB
	                             EQ   10MG BASE
                A076694   002    Dec   23,   2004

AB
	                             EQ   20MG BASE
                A076694   003    Dec   23,   2004

AB
	                             EQ   40MG BASE
                A076694   004    Dec   23,   2004

AB        RANBAXY
	              EQ   5MG BASE
                 A076607   001    Dec   15,   2004

AB
	                             EQ   10MG BASE
                A076607   002    Dec   15,   2004

AB
	                             EQ   20MG BASE
                A076607   003    Dec   15,   2004

AB
	                             EQ   40MG BASE
                A076607   004    Dec   15,   2004

AB        SUN PHARM INDS LTD
	   EQ   5MG BASE
                 A090800   001    Jun   18,   2009

AB
	                             EQ   10MG BASE
                A090800   002    Jun   18,   2009

AB
	                             EQ   20MG BASE
                A090800   003    Jun   18,   2009

AB
	                             EQ   40MG BASE
                A090800   004    Jun   18,   2009

AB        TEVA
	                 EQ   5MG BASE
                 A075504   001    Aug   24,   2007

AB
	                             EQ   10MG BASE
                A075504   002    Aug   24,   2007

AB
	                             EQ   20MG BASE
                A075504   003    Aug   24,   2007

AB
	                             EQ   40MG BASE
	               A075504   004    Aug   24,   2007
	
QUINIDINE GLUCONATE
	
  INJECTABLE;INJECTION
	
    QUINIDINE GLUCONATE
	
      + LILLY
	                  80MG/ML
	                      N007529 002 Feb 10, 1989
	
  TABLET, EXTENDED RELEASE;ORAL
	
    QUINIDINE GLUCONATE
	
BX    + MUTUAL PHARM
	           324MG
	                        A089338 001 Feb 11, 1987
	
QUINIDINE SULFATE
	
  TABLET;ORAL

    QUINIDINE SULFATE

AB       MUTUAL PHARM            200MG
	                        A081030   001 Apr 14, 1989

AB                               300MG
	                        A081031   001 Apr 14, 1989

AB       SANDOZ                  200MG
	                        A088072   002
	
AB                               300MG
	                        A088072   001 Sep 26, 1983

AB    + WATSON LABS              200MG
	                        A083288   001
	
AB    +                          300MG
	                        A085583   001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    QUINIDINE SULFATE
	
      + TEVA PHARMS
	            300MG
	                        A040045 001 Jun 30, 1994
	
QUININE SULFATE
	
  CAPSULE;ORAL

    QUALAQUIN

AB    + MUTUAL PHARM CO INC
	    324MG
	                        N021799 001 Aug 12, 2005
	
    QUININE SULFATE

AB       MYLAN PHARMS INC
	      324MG
	                        A202581 001 Dec 14, 2012

AB       TEVA PHARMS
	           324MG
	                        A091661 001 Sep 28, 2012
	
RABEPRAZOLE SODIUM
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    ACIPHEX SPRINKLE
	
          EISAI INC
	            5MG
	                          N204736 001 Mar 26, 2013
	
      +
	                        10MG
	                         N204736 002 Mar 26, 2013
	
  TABLET, DELAYED RELEASE;ORAL

    ACIPHEX
	
AB    + EISAI INC
	              20MG
	                         N020973 002 Aug 19, 1999
	
    RABEPRAZOLE SODIUM
	
AB        DR REDDYS LABS LTD
	   20MG
	                         A076824   001    Nov   08,   2013

AB        KREMERS URBAN DEV
	    20MG
	                         A090678   001    Nov   08,   2013

AB        LUPIN LTD
	            20MG
	                         A078964   001    Nov   08,   2013

AB        MYLAN PHARMS INC
	     20MG
	                         A076885   001    Nov   08,   2013

AB        TEVA PHARMS USA
	      20MG
	                         A076822   001    Nov   08,   2013

AB        TORRENT PHARMS LTD
	   20MG
	                         A202376   001    Nov   08,   2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-309(of 371)


RADIUM RA-223 DICHLORIDE
	
  SOLUTION;INTRAVENOUS
	
    XOFIGO
	
      + BAYER HLTHCARE           162mCi/6ML (27mCi/ML)          N203971 001 May 15, 2013
	
RALOXIFENE HYDROCHLORIDE
	
  TABLET;ORAL

    EVISTA
	
AB    + LILLY                    60MG                           N020815 001 Dec 09, 1997

    RALOXIFENE HYDROCHLORIDE
	
AB       INVAGEN PHARMS          60MG                           A090842 001 Sep 24, 2014

AB       TEVA PHARMS USA         60MG                           A078193 001 Mar 04, 2014
	
RALTEGRAVIR POTASSIUM
	
  POWDER;ORAL
	
    ISENTRESS
	
      + MERCK SHARP DOHME        EQ 100MG BASE/PACKET           N205786 001 Dec 20, 2013
	
  TABLET;ORAL
	
    ISENTRESS
	
      + MERCK SHARP DOHME        EQ 400MG BASE                  N022145 001 Oct 12, 2007
	
  TABLET, CHEWABLE;ORAL
	
    ISENTRESS
	
         MERCK SHARP DOHME       EQ 25MG BASE                   N203045 001 Dec 21, 2011
	
      +                          EQ 100MG BASE                  N203045 002 Dec 21, 2011
	
RAMELTEON
	
  TABLET;ORAL

    RAMELTEON
	
AB       TEVA PHARMS USA         8MG                            A091693 001 Jul 26, 2013

    ROZEREM
	
AB    + TAKEDA PHARMS USA        8MG                            N021782 001 Jul 22, 2005
	
RAMIPRIL
	
  CAPSULE;ORAL

    ALTACE
	
AB        KING PHARMS            1.25MG                         N019901   001    Jan   28,   1991

AB                               2.5MG                          N019901   002    Jan   28,   1991

AB                               5MG                            N019901   003    Jan   28,   1991

AB    +                          10MG                           N019901   004    Jan   28,   1991

    RAMIPRIL
	
AB        ACCORD HLTHCARE INC    1.25MG                         A202392   001    Apr   15,   2014

AB                               2.5MG                          A202392   002    Apr   15,   2014

AB                               5MG                            A202392   003    Apr   15,   2014

AB                               10MG                           A202392   004    Apr   15,   2014

AB        APOTEX                 1.25MG                         A079116   001    Jun   20,   2008

AB                               2.5MG                          A079116   002    Jun   20,   2008

AB                               5MG                            A079116   003    Jun   20,   2008

AB                               10MG                           A079116   004    Jun   20,   2008

AB        AUROBINDO PHARMA LTD   1.25MG                         A091604   001    Jun   08,   2011

AB                               2.5MG                          A091604   002    Jun   08,   2011

AB                               5MG                            A091604   003    Jun   08,   2011

AB                               10MG                           A091604   004    Jun   08,   2011

AB        DR REDDYS LABS LTD     1.25MG                         A078191   001    Jun   18,   2008

AB                               2.5MG                          A078191   002    Jun   18,   2008

AB                               5MG                            A078191   003    Jun   18,   2008

AB                               10MG                           A078191   004    Jun   18,   2008

AB        INVAGEN PHARMS         1.25MG                         A078745   001    Jun   18,   2008

AB                               2.5MG                          A078745   002    Jun   18,   2008

AB                               5MG                            A078745   003    Jun   18,   2008

AB                               10MG                           A078745   004    Jun   18,   2008

AB        LUPIN                  1.25MG                         A077626   001    Jun   09,   2008

AB                               2.5MG                          A077626   002    Jun   09,   2008

AB                               5MG                            A077626   003    Jun   09,   2008

AB                               10MG                           A077626   004    Jun   09,   2008

AB        ROXANE                 1.25MG                         A077900   001    Jun   18,   2008

AB                               2.5MG                          A077900   002    Jun   18,   2008

AB                               5MG                            A077900   003    Jun   18,   2008

AB                               10MG                           A077900   004    Jun   18,   2008

AB        SANDOZ                 1.25MG                         A077514   001    Jun   18,   2008

AB                               2.5MG                          A077514   002    Jun   18,   2008

AB                               5MG                            A077514   003    Jun   18,   2008

AB                               10MG                           A077514   004    Jun   18,   2008

AB        TEVA PHARMS            1.25MG                         A077470   001    Jun   18,   2008

AB                               2.5MG                          A077470   002    Jun   18,   2008
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-310(of 371)


RAMIPRIL
	
  CAPSULE;ORAL

     RAMIPRIL
AB                                  5MG
	                        A077470   003    Jun   18,   2008

AB                                  10MG
	                       A077470   004    Jun   18,   2008

AB        WATSON LABS               1.25MG
	                     A076549   001    Oct   24,   2005

AB                                  2.5MG
	                      A076549   002    Oct   24,   2005

AB                                  5MG
	                        A076549   003    Oct   24,   2005

AB                                  10MG
	                       A076549   004    Oct   24,   2005

AB        ZYDUS PHARMS USA          1.25MG
	                     A078832   001    Sep   02,   2008

AB                                  2.5MG
	                      A078832   002    Sep   02,   2008

AB                                  5MG
	                        A078832   003    Sep   02,   2008

AB                                  10MG
	                       A078832   004    Sep   02,   2008
	
  TABLET;ORAL

     RAMIPRIL
	
AB        MYLAN PHARMS INC
	        1.25MG
	                     A090650   001    Jun   30,   2011

AB
	                                2.5MG
	                      A090650   002    Jun   30,   2011

AB
	                                5MG
	                        A090650   003    Jun   30,   2011

AB
	                                10MG
	                       A090650   004    Jun   30,   2011

AB        ZYDUS PHARMS USA INC
	    1.25MG
	                     A090697   001    Sep   24,   2009

AB
	                                2.5MG
	                      A090697   002    Sep   24,   2009

AB
	                                5MG
	                        A090697   003    Sep   24,   2009

AB
	                                10MG
	                       A090697   004    Sep   24,   2009
	
RANITIDINE HYDROCHLORIDE
	
  CAPSULE;ORAL

     RANITIDINE HYDROCHLORIDE
	
AB         DR REDDYS LABS LTD
	     EQ   150MG   BASE
           A075742   001    Nov   29,   2000

AB
	                                EQ   300MG   BASE
           A075742   002    Nov   29,   2000

AB         SANDOZ
	                 EQ   150MG   BASE
           A074655   001    Oct   22,   1997

AB     +
	                          EQ   300MG   BASE
	          A074655   002    Oct   22,   1997
	
  INJECTABLE;INJECTION

     RANITIDINE HYDROCHLORIDE
	
AP         EUROHLTH INTL
	          EQ 25MG BASE/ML
             A074777 001 Mar 02, 2005

AP
	                                EQ 25MG BASE/ML
             A077458 001 Feb 16, 2006

AP         ZYDUS PHARMS USA INC
	   25MG/ML
	                    A091534 001 Feb 22, 2013
	
     ZANTAC
	
AP     + COVIS INJECTABLES
	        EQ 25MG BASE/ML
	            N019090 001 Oct 19, 1984
	
  SYRUP;ORAL

     RANITIDINE HYDROCHLORIDE
	
AA         ACTAVIS MID ATLANTIC
	   EQ   15MG   BASE/ML
         A076124   001    Feb   21,   2007

AA         AMNEAL PHARMS
	          EQ   15MG   BASE/ML
         A078312   001    Sep   02,   2008

AA         AUROBINDO PHARM
	        EQ   15MG   BASE/ML
         A090623   001    Jul   28,   2010

AA         BIO PHARM INC
	          EQ   15MG   BASE/ML
         A090102   001    May   26,   2009

AA         BRECKENRIDGE PHARM
	     EQ   15MG   BASE/ML
         A078684   001    Aug   27,   2009

AA         CARACO
	                 EQ   15MG   BASE/ML
         A091091   001    Sep   20,   2011

AA         HI TECH PHARMA
	         EQ   15MG   BASE/ML
         A091078   001    Mar   22,   2011

AA         PHARM ASSOC
	            EQ   15MG   BASE/ML
         A077405   001    Sep   21,   2007

AA         SILARX
	                 EQ   15MG   BASE/ML
         A091288   001    Dec   09,   2010

AA         TARO
	                   EQ   15MG   BASE/ML
         A077476   001    Jun   13,   2011

AA         TOLMAR
	                 EQ   15MG   BASE/ML
         A090054   001    Nov   15,   2010

AA         VINTAGE PHARMS
	         EQ   15MG   BASE/ML
         A078890   001    Jul   01,   2010

AA         WOCKHARDT
	              EQ   15MG   BASE/ML
         A079211   001    May   26,   2009

AA
	                                EQ   15MG   BASE/ML
	        A079212   001    Feb   23,   2009
	
     ZANTAC
	
AA     + GLAXO GRP LTD
	            EQ 15MG BASE/ML
	            N019675 001 Dec 30, 1988
	
  TABLET;ORAL

     RANITIDINE HYDROCHLORIDE
	
AB         AMNEAL PHARMS NY
	       EQ   150MG   BASE
           A077824   001    Oct   13,   2006

AB
	                                EQ   300MG   BASE
           A077824   002    Oct   13,   2006

AB         APOTEX
	                 EQ   150MG   BASE
           A074680   001    Sep   12,   1997

AB
	                                EQ   300MG   BASE
           A074680   002    Sep   12,   1997

AB         DR REDDYS LABS INC
	     EQ   150MG   BASE
           A076705   001    Jul   27,   2005

AB
	                                EQ   300MG   BASE
           A076705   002    Jul   27,   2005

AB         GLENMARK GENERICS
	      EQ   150MG   BASE
           A078542   001    Nov   19,   2008

AB
	                                EQ   300MG   BASE
           A078542   002    Nov   19,   2008

AB         IVAX SUB TEVA PHARMS
	   EQ   150MG   BASE
           A075165   001    Sep   30,   1998

AB
	                                EQ   300MG   BASE
           A075165   002    Sep   30,   1998

AB         MYLAN
	                  EQ   150MG   BASE
           A074023   001    Aug   22,   1997

AB
	                                EQ   300MG   BASE
           A074023   002    Aug   22,   1997

AB         PAR PHARM
	              EQ   150MG   BASE
           A075180   001    Jan   28,   1999

AB
	                                EQ   300MG   BASE
           A075180   002    Jan   28,   1999

AB         SANDOZ
	                 EQ   150MG   BASE
	          A074467   001    Aug   29,   1997
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-311(of 371)


RANITIDINE HYDROCHLORIDE
	
  TABLET;ORAL

     RANITIDINE HYDROCHLORIDE
	
AB
	                                EQ   300MG   BASE
           A074467   002    Aug   29,   1997

AB        TEVA
	                    EQ   150MG   BASE
           A074488   001    Jul   31,   1997

AB
	                                EQ   300MG   BASE
           A074488   002    Jul   31,   1997

AB        WOCKHARDT
	               EQ   150MG   BASE
           A075208   001    Dec   17,   1998

AB
	                                EQ   300MG   BASE
	          A075208   002    Dec   17,   1998
	
     ZANTAC 150
	
AB        GLAXO GRP LTD
	           EQ 150MG BASE
	              N018703 001 Jun 09, 1983
	
     ZANTAC 300
	
AB     + GLAXO GRP LTD
	            EQ 300MG BASE
	              N018703 002 Dec 09, 1985
	
RANOLAZINE
	
  TABLET, EXTENDED RELEASE;ORAL

     RANEXA
	
AB     + GILEAD
	                1GM
	                           N021526 001 Feb 12, 2007

AB
	                             500MG
	                         N021526 002 Jan 27, 2006
	
     RANOLAZINE
	
AB        LUPIN LTD
	            500MG
	                         A201046 001 Jul 29, 2013

AB
	                             1GM
	                           A201046 002 Jul 29, 2013
	
RASAGILINE MESYLATE
	
  TABLET;ORAL

     AZILECT
	
AB         TEVA
	                   EQ 0.5MG BASE
               N021641 001 May 16, 2006

AB     +
	                          EQ 1MG BASE
	                N021641 002 May 16, 2006
	
     RASAGILINE MESYLATE
	
AB         APOTEX INC
	             EQ 0.5MG BASE
               A201950 001 Sep 12, 2013

AB
	                                EQ 1MG BASE
	                A201950 002 Sep 12, 2013
	
REGADENOSON
	
  SOLUTION;INTRAVENOUS
	
    LEXISCAN
	
      + ASTELLAS
	                  0.4MG/5ML (0.08MG/ML)
	      N022161 001 Apr 10, 2008
	
REGORAFENIB
	
  TABLET;ORAL
	
    STIVARGA
	
      + BAYER HLTHCARE
	            40MG
	                       N203085 001 Sep 27, 2012
	
REMIFENTANIL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ULTIVA
	
         MYLAN INSTITUTIONAL
	      EQ 1MG BASE/VIAL
            N020630 001 Jul 12, 1996
	
                                    EQ 2MG BASE/VIAL
            N020630 002 Jul 12, 1996
	
      +
	                           EQ 5MG BASE/VIAL
	           N020630 003 Jul 12, 1996
	
REPAGLINIDE
	
  TABLET;ORAL

     PRANDIN
	
AB         NOVO NORDISK INC
	       0.5MG
	                      N020741 001 Dec 22, 1997

AB
	                                1MG
	                        N020741 002 Dec 22, 1997

AB     +
	                          2MG
	                        N020741 003 Dec 22, 1997
	
     REPAGLINIDE
	
AB         ACTAVIS TOTOWA
	         0.5MG
	                      A090008   001    Jan   22,   2014

AB
	                                1MG
	                        A090008   002    Jan   22,   2014

AB
	                                2MG
	                        A090008   003    Jan   22,   2014

AB         AUROBINDO PHARMA LTD
	   0.5MG
	                      A203820   001    Jan   22,   2014

AB
	                                1MG
	                        A203820   002    Jan   22,   2014

AB
	                                2MG
	                        A203820   003    Jan   22,   2014

AB         MYLAN PHARMS INC
	       0.5MG
	                      A090252   001    Aug   23,   2013

AB
	                                1MG
	                        A090252   002    Jan   22,   2014

AB
	                                2MG
	                        A090252   003    Jan   22,   2014

AB         PADDOCK LLC
	            0.5MG
	                      A201189   001    Jul   17,   2013

AB
	                                1MG
	                        A201189   002    Jan   22,   2014

AB
	                                2MG
	                        A201189   003    Jan   22,   2014

AB         SANDOZ
	                 0.5MG
	                      A078555   001    Nov   22,   2013

AB
	                                1MG
	                        A078555   002    Jan   22,   2014

AB
	                                2MG
	                        A078555   003    Jan   22,   2014

AB         SUN PHARM INDS INC
	     1MG
	                        A077571   002    Jul   11,   2013

AB
	                                2MG
	                        A077571   003    Jul   11,   2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                               3-312(of 371)


RESERPINE
	
  TABLET;ORAL
	
    RESERPINE
	
BP       SANDOZ                  0.1MG                                     N009838 001
	
BP    +                          0.25MG                                    N009838 002
	
RETAPAMULIN
	
  OINTMENT;TOPICAL
	
    ALTABAX
	
      + GLAXO GRP LTD            1%		                                      N022055 001 Apr 12, 2007
	
RIBAVIRIN
	
  CAPSULE;ORAL

    REBETOL
	
AB    + MERCK SHARP DOHME        200MG                                     N020903 002 Jul 25, 2001

    RIBASPHERE
	
AB        THREE RIVERS PHARMS    200MG                                     A076203 001 Apr 06, 2004

    RIBAVARIN
	
AB        AUROBINDO PHARMA       200MG                                     A079117 001 Sep 17, 2009

    RIBAVIRIN
	
AB        SANDOZ                 200MG                                     A076192 001 Apr 06, 2004

AB        TEVA                   200MG                                     A076277 001 Oct 04, 2004

AB        ZYDUS PHARMS USA       200MG                                     A077224 001 Oct 28, 2005
	
    REBETOL
	
      +		 MERCK SHARP DOHME      200MG**Indicated for use and comarketed   N020903 001 Jun 03, 1998

                                 with Interferon ALFA-2B, Recombinant

                                 (INTRON A), as Rebetron Combination

                                 Therapy**

  FOR SOLUTION;INHALATION
	
    VIRAZOLE
	
      + VALEANT PHARM INTL       6GM/VIAL		                                N018859 001 Dec 31, 1985
	
  SOLUTION;ORAL
	
    REBETOL
	
      + SCHERING                 40MG/ML                                   N021546 001 Jul 29, 2003
	
  TABLET;ORAL

    COPEGUS
	
AB       ROCHE                   200MG                                     N021511 001 Dec 03, 2002

    RIBAVIRIN
	
AB       AUROBINDO PHARMA        200MG                                     A079111   001    Sep   17,   2009

AB       SANDOZ                  200MG                                     A077743   001    Oct   03,   2006

AB                               200MG                                     A202546   001    Aug   12,   2014

AB                               400MG                                     A202546   002    Aug   12,   2014

AB                               500MG                                     A202546   003    Aug   12,   2014

AB                               600MG                                     A202546   004    Aug   12,   2014

AB       TEVA                    200MG                                     A077053   001    Dec   05,   2005

AB       THREE RIVERS PHARMS     200MG                                     A077456   001    Dec   05,   2005

AB                               400MG                                     A077456   002    Dec   05,   2005

AB    +                          600MG                                     A077456   003    Dec   05,   2005

AB       ZYDUS PHARMS USA        200MG                                     A077094   001    Dec   05,   2005

AB                               400MG                                     A077094   002    Mar   16,   2007

AB                               500MG                                     A077094   004    Apr   18,   2008

AB                               600MG                                     A077094   003    Mar   16,   2007
	
RIFABUTIN
	
  CAPSULE;ORAL

    MYCOBUTIN
	
AB    + PHARMACIA AND UPJOHN     150MG                                     N050689 001 Dec 23, 1992

    RIFABUTIN
	
AB       LUPIN LTD               150MG                                     A090033 001 Feb 24, 2014
	
RIFAMPIN
	
  CAPSULE;ORAL

    RIFADIN
	
AB        SANOFI AVENTIS US      150MG                                     A062303 001
	
AB    +                          300MG                                     N050420 001
	
    RIFAMPIN
	
AB        LANNETT                150MG                                     A065390   001    Mar   28,   2008

AB                               300MG                                     A065390   002    Mar   28,   2008

AB        LUPIN PHARMS           150MG                                     A090034   001    Aug   21,   2013

AB                               300MG                                     A090034   002    Aug   21,   2013

AB        SANDOZ                 150MG                                     A064150   002    Jan   02,   1998

AB                               300MG                                     A064150   001    May   28,   1997

AB        VERSAPHARM             150MG                                     A065028   001    Mar   14,   2001

AB                               300MG                                     A065028   002    Mar   14,   2001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-313(of 371)


RIFAMPIN
	
  CAPSULE;ORAL

    RIMACTANE
	
AB        PROSAM LABS             300MG                         N050429 001
	
  INJECTABLE;INJECTION

    RIFADIN
	
AP    + SANOFI AVENTIS US         600MG/VIAL                    N050627 001 May 25, 1989

    RIFAMPIN
	
AP        AGILA SPECLTS           600MG/VIAL                    A065421   001    May   22,   2008

AP        BEDFORD                 600MG/VIAL                    A064217   001    Oct   29,   1999

AP        EMCURE PHARMS LTD       600MG/VIAL                    A204101   001    Aug   18,   2014

AP        FRESENIUS KABI USA      600MG/VIAL                    A091181   001    Aug   21,   2014

AP        VERSAPHARM INC          600MG/VIAL                    A065502   001    Sep   21,   2010
	
RIFAPENTINE
	
  TABLET;ORAL
	
    PRIFTIN
	
      + SANOFI AVENTIS US         150MG                         N021024 001 Jun 22, 1998
	
RIFAXIMIN
	
  TABLET;ORAL
	
    XIFAXAN
	
      + SALIX PHARMS              200MG		                       N021361 001 May 25, 2004

      +                           550MG                         N022554 001 Mar 24, 2010
	
RILPIVIRINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    EDURANT
	
      + JANSSEN PRODS             EQ 25MG BASE		                N202022 001 May 20, 2011
	
RILUZOLE
	
  TABLET;ORAL

    RILUTEK
	
AB    + COVIS PHARMA SARL         50MG                          N020599 001 Dec 12, 1995

    RILUZOLE
	
AB        APOTEX CORP             50MG                          A091300   001    Jun   18,   2013

AB        GLENMARK GENERICS       50MG                          A091394   001    Jun   18,   2013

AB        IMPAX LABS              50MG                          A076173   001    Jan   29,   2003

AB        MYLAN PHARMS INC        50MG                          A203042   001    Jul   01,   2013

AB        SUN PHARM INDS LTD      50MG                          A091417   001    Jun   18,   2013
	
RIMANTADINE HYDROCHLORIDE
	
  TABLET;ORAL

    FLUMADINE
	
AB    + CARACO                    100MG                         N019649 001 Sep 17, 1993

    RIMANTADINE HYDROCHLORIDE
	
AB       IMPAX LABS               100MG                         A076132 001 Aug 30, 2002
	
RIMEXOLONE
	
  SUSPENSION/DROPS;OPHTHALMIC

    VEXOL
	
      + ALCON                     1%		                          N020474 001 Dec 30, 1994
	
RIOCIGUAT
	
  TABLET;ORAL
	
    ADEMPAS
	
         BAYER HLTHCARE		         0.5MG                         N204819   001    Oct   08,   2013
	
                                  1MG                           N204819   002    Oct   08,   2013
	
                                  1.5MG                         N204819   003    Oct   08,   2013
	
                                  2MG                           N204819   004    Oct   08,   2013
	
     +                            2.5MG		                       N204819   005    Oct   08,   2013
	
RISEDRONATE SODIUM
	
  TABLET;ORAL

    ACTONEL
	
AB       WARNER CHILCOTT LLC      5MG                           N020835   002    Apr   14,   2000

AB                                30MG                          N020835   001    Mar   27,   1998

AB    +                           35MG                          N020835   003    May   25,   2002

AB    +                           150MG                         N020835   005    Apr   22,   2008

    RISEDRONATE SODIUM
	
AB       APOTEX INC               75MG                          A090877   002    Jun   10,   2014

AB                                150MG                         A090877   003    Jun   10,   2014

AB       MYLAN PHARMS INC         75MG                          A200477   004    Jun   10,   2014

AB                                150MG                         A200477   005    Jun   10,   2014

AB       SUN PHARMA GLOBAL        75MG                          A090886   004    Jun   10,   2014

AB                                150MG                         A090886   005    Jun   10,   2014
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-314(of 371)


RISEDRONATE SODIUM
	
  TABLET;ORAL

     RISEDRONATE SODIUM
	
AB        TEVA PHARMS
	            5MG
	                         A077132   001    Oct   05,   2007

AB
	                               30MG
	                        A077132   002    Oct   05,   2007

AB
	                               35MG
	                        A077132   003    Oct   05,   2007

AB        TEVA PHARMS USA
	        150MG
	                       A079215   001    Jun   13,   2014
	
  TABLET, DELAYED RELEASE;ORAL
	
     ATELVIA
	
       + WARNER CHILCOTT LLC
	     35MG
	                        N022560 001 Oct 08, 2010
	
RISPERIDONE
	
  INJECTABLE;INTRAMUSCULAR
	
    RISPERDAL CONSTA
	
          JANSSEN PHARMS
	         12.5MG/VIAL
                  N021346   004    Apr   12,   2007

      +
	                          25MG/VIAL
                    N021346   001    Oct   29,   2003
	
                                   37.5MG/VIAL
                  N021346   002    Oct   29,   2003
	
                                   50MG/VIAL
	                   N021346   003    Oct   29,   2003
	
  SOLUTION;ORAL

     RISPERDAL
	
AA     + JANSSEN PHARMS
	          1MG/ML
	                      N020588 001 Jun 10, 1996
	
     RISPERIDONE
	
AA         AMNEAL PHARMS
	         1MG/ML
                       A091384   001    May   25,   2011

AA         ANI PHARMS INC
	        1MG/ML
                       A076440   001    Jan   30,   2009

AA         APOTEX INC
	            1MG/ML
                       A077719   001    Jul   29,   2009

AA         AUROBINDO PHARMA
	      1MG/ML
                       A078452   001    Sep   04,   2009

AA         BIO PHARM INC
	         1MG/ML
                       A078909   001    Jul   29,   2009

AA         PRECISION DOSE
	        1MG/ML
                       A076797   001    Jun   28,   2010

AA         ROXANE
	                1MG/ML
                       A076904   001    Jul   29,   2009

AA         SILARX PHARMS INC
	     1MG/ML
                       A202386   001    Jan   12,   2015

AA         TARO
	                  1MG/ML
                       A090347   001    Feb   07,   2011

AA         TRIS PHARMA INC
	       1MG/ML
                       A079059   001    Dec   12,   2012

AA         VINTAGE
	               1MG/ML
                       A079158   001    Dec   03,   2010

AA         WOCKHARDT
	             1MG/ML
	                      A078744   001    Oct   08,   2009
	
  TABLET;ORAL

     RISPERDAL
	
AB         JANSSEN PHARMS
	        0.25MG
	                      N020272   008    May   10,   1999

AB
	                               0.5MG
	                       N020272   007    Jan   27,   1999

AB     +
	                         1MG
	                         N020272   001    Dec   29,   1993

AB
	                               2MG
	                         N020272   002    Dec   29,   1993

AB
	                               3MG
	                         N020272   003    Dec   29,   1993

AB
	                               4MG
	                         N020272   004    Dec   29,   1993
	
     RISPERIDONE
	
AB         AJANTA PHARMA LTD
	     0.25MG
	                      A201003   001    Aug   24,   2011

AB
	                               0.5MG
	                       A201003   002    Aug   24,   2011

AB
	                               1MG
	                         A201003   003    Aug   24,   2011

AB
	                               2MG
	                         A201003   004    Aug   24,   2011

AB
	                               3MG
	                         A201003   005    Aug   24,   2011

AB
	                               4MG
	                         A201003   006    Aug   24,   2011

AB         APOTEX INC
	            0.25MG
	                      A077953   001    Sep   15,   2008

AB
	                               0.5MG
	                       A077953   002    Sep   15,   2008

AB
	                               1MG
	                         A077953   003    Sep   15,   2008

AB
	                               2MG
	                         A077953   004    Sep   15,   2008

AB
	                               3MG
	                         A077953   005    Sep   15,   2008

AB
	                               4MG
	                         A077953   006    Sep   15,   2008

AB         AUROBINDO PHARMA
	      0.25MG
	                      A078269   001    Oct   08,   2008

AB
	                               0.5MG
	                       A078269   002    Oct   08,   2008

AB
	                               1MG
	                         A078269   003    Oct   08,   2008

AB
	                               2MG
	                         A078269   004    Oct   08,   2008

AB
	                               3MG
	                         A078269   005    Oct   08,   2008

AB
	                               4MG
	                         A078269   006    Oct   08,   2008

AB         CIPLA
	                 0.25MG
	                      A077543   001    May   18,   2011

AB
	                               0.5MG
	                       A077543   002    May   18,   2011

AB
	                               1MG
	                         A077543   003    May   18,   2011

AB
	                               2MG
	                         A077543   004    May   18,   2011

AB
	                               3MG
	                         A077543   005    May   18,   2011

AB
	                               4MG
	                         A077543   006    May   18,   2011

AB         DR REDDYS LABS LTD
	    0.25MG
	                      A076879   001    Oct   24,   2008

AB
	                               0.5MG
	                       A076879   002    Oct   24,   2008

AB
	                               1MG
	                         A076879   003    Oct   24,   2008

AB
	                               2MG
	                         A076879   004    Oct   24,   2008

AB
	                               3MG
	                         A076879   005    Oct   24,   2008

AB
	                               4MG
	                         A076879   006    Oct   24,   2008
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                       3-315(of 371)


RISPERIDONE
	
  TABLET;ORAL

    RISPERIDONE
	
AB       MYLAN                  0.25MG                         A076288   001    Sep   15,   2008

AB                              0.5MG                          A076288   002    Sep   15,   2008

AB                              1MG                            A076288   003    Sep   15,   2008

AB                              2MG                            A076288   004    Sep   15,   2008

AB                              3MG                            A076288   005    Sep   15,   2008

AB                              4MG                            A076288   006    Sep   15,   2008

AB       PLIVA HRVATSKA DOO     0.25MG                         A077769   001    Oct   16,   2008

AB                              0.5MG                          A077769   002    Oct   16,   2008

AB                              1MG                            A077769   003    Oct   16,   2008

AB                              2MG                            A077769   004    Oct   16,   2008

AB                              3MG                            A077769   005    Oct   16,   2008

AB                              4MG                            A077769   006    Oct   16,   2008

AB       PRINSTON INC           0.25MG                         A077493   001    Nov   29,   2011

AB                              0.5MG                          A077493   002    Nov   29,   2011

AB                              1MG                            A077493   003    Nov   29,   2011

AB                              2MG                            A077493   004    Nov   29,   2011

AB                              3MG                            A077493   005    Nov   29,   2011

AB                              4MG                            A077493   006    Nov   29,   2011

AB       PROSAM LABS            0.25MG                         A078071   001    Jun   17,   2009

AB                              0.5MG                          A078071   002    Jun   17,   2009

AB                              1MG                            A078071   003    Jun   17,   2009

AB                              2MG                            A078071   004    Jun   17,   2009

AB                              3MG                            A078071   005    Jun   17,   2009

AB                              4MG                            A078071   006    Jun   17,   2009

AB       SANDOZ                 0.25MG                         A078528   001    Oct   16,   2009

AB                              0.5MG                          A078528   002    Oct   16,   2009

AB                              1MG                            A078528   003    Oct   16,   2009

AB                              2MG                            A078528   004    Oct   16,   2009

AB                              3MG                            A078528   005    Oct   16,   2009

AB                              4MG                            A078528   006    Oct   16,   2009

AB       SUN PHARM INDS INC     0.25MG                         A078036   001    Mar   10,   2014

AB                              0.5MG                          A078036   002    Mar   10,   2014

AB                              1MG                            A078036   003    Mar   10,   2014

AB                              2MG                            A078036   004    Mar   10,   2014

AB                              3MG                            A078036   005    Mar   10,   2014

AB                              4MG                            A078036   006    Mar   10,   2014

AB       TEVA                   0.25MG                         A076228   001    Jun   30,   2008

AB                              0.5MG                          A076228   002    Jun   30,   2008

AB                              1MG                            A076228   003    Jun   30,   2008

AB                              2MG                            A076228   004    Jun   30,   2008

AB                              3MG                            A076228   005    Jun   30,   2008

AB                              4MG                            A076228   006    Jun   30,   2008

AB       TORRENT PHARMS         0.25MG                         A079088   001    Oct   30,   2008

AB                              0.5MG                          A079088   002    Oct   30,   2008

AB                              1MG                            A079088   003    Oct   30,   2008

AB                              2MG                            A079088   004    Oct   30,   2008

AB                              3MG                            A079088   005    Oct   30,   2008

AB                              4MG                            A079088   006    Oct   30,   2008

AB       VINTAGE                0.25MG                         A078707   001    Dec   29,   2008

AB                              0.5MG                          A078707   002    Dec   29,   2008

AB                              1MG                            A078707   003    Dec   29,   2008

AB                              2MG                            A078707   004    Dec   29,   2008

AB                              3MG                            A078707   005    Dec   29,   2008

AB                              4MG                            A078707   006    Dec   29,   2008

AB       WOCKHARDT              0.25MG                         A078871   001    Oct   09,   2008

AB                              0.5MG                          A078871   002    Oct   09,   2008

AB                              1MG                            A078871   003    Oct   09,   2008

AB                              2MG                            A078871   004    Oct   09,   2008

AB                              3MG                            A078871   005    Oct   09,   2008

AB                              4MG                            A078871   006    Oct   09,   2008

AB       ZYDUS PHARMS USA INC   0.25MG                         A078040   001    Oct   16,   2008

AB                              0.5MG                          A078040   002    Oct   16,   2008

AB                              1MG                            A078040   003    Oct   16,   2008

AB                              2MG                            A078040   004    Oct   16,   2008

AB                              3MG                            A078040   005    Oct   16,   2008

AB                              4MG                            A078040   006    Oct   16,   2008
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    RISPERDAL
	
AB       JANSSEN PHARMS         0.5MG                          N021444 001 Apr 02, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                     3-316(of 371)


RISPERIDONE
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    RISPERDAL
AB    +                         1MG
	                           N021444   002    Apr   02,   2003

AB                              2MG
	                           N021444   003    Apr   02,   2003

AB                              3MG
	                           N021444   004    Dec   23,   2004

AB                              4MG
	                           N021444   005    Dec   23,   2004
	
    RISPERIDONE
AB       ACTAVIS LABS FL INC    0.5MG
	                         A076996   001    Apr   19,   2011

AB                              1MG
	                           A076996   002    Apr   19,   2011

AB                              2MG
	                           A076996   003    Apr   19,   2011

AB                              3MG
	                           A076996   004    Apr   19,   2011

AB                              4MG
	                           A076996   005    Apr   19,   2011

AB       DR REDDYS LABS LTD     0.5MG
	                         A077328   001    Feb   24,   2009

AB                              1MG
	                           A077328   002    Oct   05,   2009

AB                              2MG
	                           A077328   003    Feb   24,   2009

AB       JUBILANT GENERICS      0.5MG
	                         A090839   001    Nov   04,   2011

AB                              1MG
	                           A090839   002    Nov   04,   2011

AB                              2MG
	                           A090839   003    Nov   04,   2011

AB                              3MG
	                           A090839   004    Nov   04,   2011

AB                              4MG
	                           A090839   005    Nov   04,   2011

AB       MYLAN PHARMS INC       0.25MG
	                        A091537   006    Feb   12,   2013

AB                              0.5MG
	                         A091537   001    Mar   30,   2011

AB                              1MG
	                           A091537   002    Mar   30,   2011

AB                              2MG
	                           A091537   003    Mar   30,   2011

AB                              3MG
	                           A091537   004    Mar   30,   2011

AB                              4MG
	                           A091537   005    Mar   30,   2011

AB       PAR PHARM              0.25MG
	                        A077494   001    Apr   30,   2009

AB                              0.5MG
	                         A077494   002    Apr   30,   2009

AB                              1MG
	                           A077494   003    Oct   26,   2009

AB                              2MG
	                           A077494   004    Apr   30,   2009

AB                              3MG
	                           A077494   005    Apr   30,   2009

AB                              4MG
	                           A077494   006    Apr   30,   2009

AB       RANBAXY                0.5MG
	                         A077542   001    Aug   06,   2010

AB                              1MG
	                           A077542   002    Aug   06,   2010

AB                              2MG
	                           A077542   003    Aug   06,   2010

AB                              3MG
	                           A078474   001    Aug   06,   2010

AB                              4MG
	                           A078474   002    Aug   06,   2010

AB       SANDOZ                 0.5MG
	                         A078116   001    Dec   22,   2009

AB                              1MG
	                           A078116   002    Dec   22,   2009

AB                              2MG
	                           A078116   003    Dec   22,   2009

AB                              3MG
	                           A078116   004    Dec   22,   2009

AB                              4MG
	                           A078116   005    Dec   22,   2009

AB       SUN PHARM INDS LTD     0.5MG
	                         A078464   001    Apr   08,   2013

AB                              1MG
	                           A078464   002    Apr   08,   2013

AB                              2MG
	                           A078464   003    Apr   08,   2013

AB                              3MG
	                           A078464   004    Apr   08,   2013

AB                              4MG
	                           A078464   005    Apr   08,   2013

AB       TEVA                   0.5MG
	                         A076908   001    Mar   12,   2012

AB                              1MG
	                           A076908   002    Mar   12,   2012

AB                              2MG
	                           A076908   003    Mar   12,   2012

AB       ZYDUS PHARMS USA       0.5MG
	                         A078516   001    May   01,   2009

AB                              2MG
	                           A078516   003    May   01,   2009
	
RITONAVIR
	
  CAPSULE;ORAL
	
    NORVIR
	
      + ABBVIE
	                100MG
	                         N020945 001 Jun 29, 1999
	
  SOLUTION;ORAL
	
    NORVIR
	
      + ABBVIE
	                80MG/ML
	                       N020659 001 Mar 01, 1996
	
  TABLET;ORAL

    NORVIR
	
AB    + ABBVIE
	                100MG
	                         N022417 001 Feb 10, 2010
	
    RITONAVIR
	
AB       ROXANE
	               100MG
	                         A202573 001 Jan 15, 2015
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-317(of 371)


RIVAROXABAN
	
  TABLET;ORAL
	
    XARELTO
	
      +		 JANSSEN PHARMS        10MG                            N022406 001 Jul 01, 2011
	
                                15MG                            N022406 002 Nov 04, 2011
	
     +		                        20MG                            N022406 003 Nov 04, 2011
	
RIVASTIGMINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    EXELON
	
          NOVARTIS              4.6MG/24HR                      N022083 001 Jul 06, 2007
	
      +		                       9.5MG/24HR                      N022083 002 Jul 06, 2007
	
                                13.3MG/24HR                     N022083 005 Aug 31, 2012
	
RIVASTIGMINE TARTRATE
	
  CAPSULE;ORAL

    EXELON
	
AB    + NOVARTIS                EQ   1.5MG BASE                 N020823   003    Apr   21,   2000

AB                              EQ   3MG BASE                   N020823   004    Apr   21,   2000

AB                              EQ   4.5MG BASE                 N020823   005    Apr   21,   2000

AB                              EQ   6MG BASE                   N020823   006    Apr   21,   2000

    RIVASTIGMINE TARTRATE
	
AB       ALEMBIC PHARMS LTD     EQ   1.5MG BASE                 A091689   001    Jun   12,   2012

AB                              EQ   3MG BASE                   A091689   002    Jun   12,   2012

AB                              EQ   4.5MG BASE                 A091689   003    Jun   12,   2012

AB                              EQ   6MG BASE                   A091689   004    Jun   12,   2012

AB       APOTEX INC             EQ   1.5MG BASE                 A091072   001    May   16,   2013

AB                              EQ   3MG BASE                   A091072   002    May   16,   2013

AB                              EQ   4.5MG BASE                 A091072   003    May   16,   2013

AB                              EQ   6MG BASE                   A091072   004    May   16,   2013

AB       DR REDDYS LABS INC     EQ   1.5MG BASE                 A077130   001    Oct   31,   2007

AB                              EQ   3MG BASE                   A077130   002    Oct   31,   2007

AB                              EQ   4.5MG BASE                 A077130   003    Oct   31,   2007

AB                              EQ   6MG BASE                   A077130   004    Oct   31,   2007

AB       MACLEODS PHARMS LTD    EQ   1.5MG BASE                 A203148   001    Aug   22,   2014

AB                              EQ   3MG BASE                   A203148   002    Aug   22,   2014

AB                              EQ   4.5MG BASE                 A203148   003    Aug   22,   2014

AB                              EQ   6MG BASE                   A203148   004    Aug   22,   2014

AB       SUN PHARM INDS         EQ   1.5MG BASE                 A077131   001    Oct   22,   2007

AB                              EQ   3MG BASE                   A077131   002    Oct   22,   2007

AB                              EQ   4.5MG BASE                 A077131   003    Oct   22,   2007

AB                              EQ   6MG BASE                   A077131   004    Oct   22,   2007

AB       WATSON LABS            EQ   1.5MG BASE                 A077129   001    Jan   08,   2008

AB                              EQ   3MG BASE                   A077129   002    Jan   08,   2008

AB                              EQ   4.5MG BASE                 A077129   003    Jan   08,   2008

AB                              EQ   6MG BASE                   A077129   004    Jan   08,   2008
	
RIZATRIPTAN BENZOATE
	
  TABLET;ORAL

    MAXALT
	
AB       MERCK                  EQ 5MG BASE                     N020864 001 Jun 29, 1998

AB    +                         EQ 10MG BASE                    N020864 002 Jun 29, 1998

    RIZATRIPTAN BENZOATE
	
AB       APOTEX INC             EQ   5MG BASE                   A202244   001    Dec   31,   2012

AB                              EQ   10MG BASE                  A202244   002    Dec   31,   2012

AB       AUROBINDO PHARMA LTD   EQ   5MG BASE                   A202490   001    Dec   31,   2012

AB                              EQ   10MG BASE                  A202490   002    Dec   31,   2012

AB       CIPLA LTD              EQ   5MG BASE                   A077526   001    Mar   26,   2013

AB                              EQ   10MG BASE                  A077526   002    Mar   26,   2013

AB       EMCURE PHARMS LTD      EQ   5MG BASE                   A204090   001    Nov   26,   2013

AB                              EQ   10MG BASE                  A204090   002    Nov   26,   2013

AB       GLENMARK GENERICS      EQ   5MG BASE                   A201967   001    Dec   31,   2012

AB                              EQ   10MG BASE                  A201967   002    Dec   31,   2012

AB       INVAGEN PHARMS         EQ   5MG BASE                   A204339   001    Jul   01,   2013

AB                              EQ   10MG BASE                  A204339   002    Jul   01,   2013

AB       JUBILANT GENERICS      EQ   5MG BASE                   A203252   001    Dec   31,   2014

AB                              EQ   10MG BASE                  A203252   002    Dec   31,   2014

AB       MACLEODS PHARMS LTD    EQ   5MG BASE                   A203147   001    Feb   11,   2014

AB                              EQ   10MG BASE                  A203147   002    Feb   11,   2014

AB       MYLAN PHARMS INC       EQ   5MG BASE                   A201993   001    Dec   31,   2012

AB                              EQ   10MG BASE                  A201993   002    Dec   31,   2012

AB       NATCO PHARMA LTD       EQ   5MG BASE                   A200482   001    Dec   31,   2012

AB                              EQ   10MG BASE                  A200482   002    Dec   31,   2012

AB       SANDOZ                 EQ   5MG BASE                   A079230   001    Dec   31,   2012
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-318(of 371)


RIZATRIPTAN BENZOATE
	
  TABLET;ORAL

    RIZATRIPTAN BENZOATE
	
AB                              EQ 10MG BASE                    A079230   002    Dec   31,   2012

AB       SUN PHARMA GLOBAL      EQ 5MG BASE                     A202047   001    Dec   31,   2012

AB                              EQ 10MG BASE                    A202047   002    Dec   31,   2012

AB       TEVA PHARMS            EQ 5MG BASE                     A077263   001    Dec   31,   2012

AB                              EQ 10MG BASE                    A077263   002    Dec   31,   2012
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    MAXALT-MLT
	
AB       MERCK                  EQ 5MG BASE                     N020865 001 Jun 29, 1998

AB    +                         EQ 10MG BASE                    N020865 002 Jun 29, 1998

    RIZATRIPTAN BENZOATE
	
AB       APOTEX INC             EQ 5MG BASE                     A202477   001    Jul   01,   2013

AB                              EQ 10MG BASE                    A202477   002    Jul   01,   2013

AB       AUROBINDO PHARMA LTD   EQ 5MG BASE                     A203062   001    Jul   01,   2013

AB                              EQ 10MG BASE                    A203062   002    Jul   01,   2013

AB       GLENMARK GENERICS      EQ 5MG BASE                     A201914   001    Jul   01,   2013

AB                              EQ 10MG BASE                    A201914   002    Jul   01,   2013

AB       MACLEODS PHARMS LTD    EQ 5MG BASE                     A203146   001    Sep   19,   2014

AB                              EQ 10MG BASE                    A203146   002    Sep   19,   2014

AB       MYLAN PHARMS INC       EQ 5MG BASE                     A078173   001    Dec   31,   2012

AB                              EQ 10MG BASE                    A078173   002    Dec   31,   2012

AB       NATCO PHARMA LTD       EQ 5MG BASE                     A203478   001    Jul   01,   2013

AB                              EQ 10MG BASE                    A203478   002    Jul   01,   2013

AB       SANDOZ                 EQ 5MG BASE                     A078739   001    Jul   01,   2013

AB                              EQ 10MG BASE                    A078739   002    Jul   01,   2013
	
ROCURONIUM BROMIDE
	
  INJECTABLE;INJECTION

    ROCURONIUM BROMIDE
	
AP       FRESENIUS KABI USA      50MG/5ML (10MG/ML)             A078651   001    Dec   29,   2008

AP                               100MG/10ML (10MG/ML)           A078651   002    Dec   29,   2008

AP       HOSPIRA                 50MG/5ML (10MG/ML)             A078519   001    Nov   26,   2008

AP                               100MG/10ML (10MG/ML)           A078519   002    Nov   26,   2008

AP       MYLAN INSTITUTIONAL     50MG/5ML (10MG/ML)             A079199   001    Nov   26,   2008

AP                               100MG/10ML (10MG/ML)           A079199   002    Nov   26,   2008

AP       SAGENT STRIDES          50MG/5ML (10MG/ML)             A091458   001    Jul   28,   2010

AP                               100MG/10ML (10MG/ML)           A091458   002    Jul   28,   2010

AP    + SANDOZ                   50MG/5ML (10MG/ML)             A079195   001    Dec   05,   2008

AP    +                          100MG/10ML (10MG/ML)           A079195   002    Dec   05,   2008

AP       TAMARANG                50MG/5ML (10MG/ML)             A091115   001    Aug   27,   2012

AP                               100MG/10ML (10MG/ML)           A091115   002    Aug   27,   2012

AP       TEVA PHARMS             50MG/5ML (10MG/ML)             A078717   001    Nov   26,   2008

AP                               100MG/10ML (10MG/ML)           A078717   002    Nov   26,   2008
	
ROFLUMILAST
	
  TABLET;ORAL
	
    DALIRESP
	
      + FOREST RES INST INC      500MCG                         N022522 001 Feb 28, 2011
	
ROMIDEPSIN
	
  POWDER;IV (INFUSION)

    ISTODAX
	
      + CELGENE                  10MG/VIAL                      N022393 001 Nov 05, 2009
	
ROPINIROLE HYDROCHLORIDE
	
  TABLET;ORAL

    REQUIP

AB    + GLAXOSMITHKLINE LLC      EQ   0.25MG BASE               N020658   001    Sep   19,   1997

AB                               EQ   0.5MG BASE                N020658   002    Sep   19,   1997

AB                               EQ   1MG BASE                  N020658   003    Sep   19,   1997

AB                               EQ   2MG BASE                  N020658   004    Sep   19,   1997

AB                               EQ   3MG BASE                  N020658   006    Jan   27,   1999

AB                               EQ   4MG BASE                  N020658   007    Jan   27,   1999

AB                               EQ   5MG BASE                  N020658   005    Sep   19,   1997

    ROPINIROLE HYDROCHLORIDE
	
AB       ALEMBIC LTD             EQ   0.25MG BASE               A090429   001    Mar   24,   2010

AB                               EQ   0.5MG BASE                A090429   002    Mar   24,   2010

AB                               EQ   1MG BASE                  A090429   003    Mar   24,   2010

AB                               EQ   2MG BASE                  A090429   004    Mar   24,   2010

AB                               EQ   3MG BASE                  A090429   005    Mar   24,   2010

AB                               EQ   4MG BASE                  A090429   006    Mar   24,   2010

AB                               EQ   5MG BASE                  A090429   007    Mar   24,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-319(of 371)


ROPINIROLE HYDROCHLORIDE
	
  TABLET;ORAL

    ROPINIROLE HYDROCHLORIDE
	
AB       APOTEX                  EQ   0.25MG BASE              A079165   001    Feb   07,   2012

AB                               EQ   0.5MG BASE               A079165   002    Feb   07,   2012

AB                               EQ   1MG BASE                 A079165   003    Feb   07,   2012

AB                               EQ   2MG BASE                 A079165   004    Feb   07,   2012

AB                               EQ   3MG BASE                 A079165   005    Feb   07,   2012

AB                               EQ   4MG BASE                 A079165   006    Feb   07,   2012

AB                               EQ   5MG BASE                 A079165   007    Feb   07,   2012

AB       GLENMARK GENERICS       EQ   0.25MG BASE              A090135   001    Feb   25,   2010

AB                               EQ   0.5MG BASE               A090135   002    Feb   25,   2010

AB                               EQ   1MG BASE                 A090135   003    Feb   25,   2010

AB                               EQ   2MG BASE                 A090135   004    Feb   25,   2010

AB                               EQ   3MG BASE                 A090135   005    Feb   25,   2010

AB                               EQ   4MG BASE                 A090135   006    Feb   25,   2010

AB                               EQ   5MG BASE                 A090135   007    Feb   25,   2010

AB       MYLAN                   EQ   0.25MG BASE              A078881   001    May   05,   2008

AB                               EQ   0.5MG BASE               A078881   002    May   05,   2008

AB                               EQ   1MG BASE                 A078881   003    May   05,   2008

AB                               EQ   2MG BASE                 A078881   004    May   05,   2008

AB                               EQ   3MG BASE                 A078881   005    May   05,   2008

AB                               EQ   4MG BASE                 A078881   006    May   05,   2008

AB                               EQ   5MG BASE                 A078881   007    May   19,   2008

AB       ORCHID HLTHCARE         EQ   0.25MG BASE              A079229   001    Nov   28,   2012

AB                               EQ   0.5MG BASE               A079229   002    Nov   28,   2012

AB                               EQ   1MG BASE                 A079229   003    Nov   28,   2012

AB                               EQ   2MG BASE                 A079229   004    Nov   28,   2012

AB                               EQ   3MG BASE                 A079229   005    Nov   28,   2012

AB                               EQ   4MG BASE                 A079229   006    Nov   28,   2012

AB                               EQ   5MG BASE                 A079229   007    Nov   28,   2012

AB       PRINSTON INC            EQ   0.25MG BASE              A078110   001    May   05,   2008

AB                               EQ   0.5MG BASE               A078110   002    May   05,   2008

AB                               EQ   1MG BASE                 A078110   003    May   05,   2008

AB                               EQ   2MG BASE                 A078110   004    May   05,   2008

AB                               EQ   3MG BASE                 A078110   005    May   05,   2008

AB                               EQ   4MG BASE                 A078110   006    May   05,   2008

AB                               EQ   5MG BASE                 A078110   007    Jul   11,   2008

AB       ROXANE                  EQ   0.25MG BASE              A077852   001    May   05,   2008

AB                               EQ   0.5MG BASE               A077852   002    May   05,   2008

AB                               EQ   1MG BASE                 A077852   003    May   05,   2008

AB                               EQ   2MG BASE                 A077852   004    May   05,   2008

AB                               EQ   3MG BASE                 A077852   005    May   05,   2008

AB                               EQ   4MG BASE                 A077852   006    May   05,   2008

AB                               EQ   5MG BASE                 A077852   007    May   19,   2008

AB       TEVA                    EQ   0.25MG BASE              A077460   001    May   05,   2008

AB                               EQ   0.5MG BASE               A077460   002    May   05,   2008

AB                               EQ   1MG BASE                 A077460   003    May   05,   2008

AB                               EQ   2MG BASE                 A077460   004    May   05,   2008

AB                               EQ   3MG BASE                 A077460   005    May   05,   2008

AB                               EQ   4MG BASE                 A077460   006    May   05,   2008

AB                               EQ   5MG BASE                 A077460   007    May   19,   2008

AB       WOCKHARDT               EQ   0.25MG BASE              A079050   001    May   29,   2008

AB                               EQ   0.5MG BASE               A079050   002    May   29,   2008

AB                               EQ   1MG BASE                 A079050   003    May   29,   2008

AB                               EQ   2MG BASE                 A079050   004    May   29,   2008

AB                               EQ   3MG BASE                 A079050   005    May   29,   2008

AB                               EQ   4MG BASE                 A079050   006    May   29,   2008

AB                               EQ   5MG BASE                 A079050   007    May   29,   2008

AB       ZYDUS PHARMS USA INC    EQ   0.25MG BASE              A090411   001    Jun   01,   2009

AB                               EQ   0.5MG BASE               A090411   002    Jun   01,   2009

AB                               EQ   1MG BASE                 A090411   003    Jun   01,   2009

AB                               EQ   2MG BASE                 A090411   004    Jun   01,   2009

AB                               EQ   3MG BASE                 A090411   005    Jun   01,   2009

AB                               EQ   4MG BASE                 A090411   006    Jun   01,   2009

AB                               EQ   5MG BASE                 A090411   007    Jun   01,   2009
	
  TABLET, EXTENDED RELEASE;ORAL

    REQUIP XL

AB    + GLAXOSMITHKLINE LLC      EQ   2MG   BASE               N022008   001    Jun   13,   2008

AB                               EQ   4MG   BASE               N022008   003    Jun   13,   2008

AB                               EQ   6MG   BASE               N022008   006    Apr   10,   2009

AB                               EQ   8MG   BASE               N022008   004    Jun   13,   2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST
	                   3-320(of 371)


ROPINIROLE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

     REQUIP XL

AB
	                             EQ   12MG BASE
	                 N022008 005 Oct 31, 2008
	
     ROPINIROLE HYDROCHLORIDE
	
AB        ACTAVIS ELIZABETH
	    EQ   2MG BASE
                   A090869   001    May   17,   2012

AB
	                             EQ   4MG BASE
                   A090869   002    May   17,   2012

AB
	                             EQ   6MG BASE
                   A090869   003    May   17,   2012

AB
	                             EQ   8MG BASE
                   A090869   004    May   17,   2012

AB
	                             EQ   12MG BASE
                  A090869   005    May   17,   2012

AB        ALEMBIC LTD
	          EQ   2MG BASE
                   A202786   001    Apr   22,   2013

AB
	                             EQ   4MG BASE
                   A202786   002    Apr   22,   2013

AB
	                             EQ   6MG BASE
                   A202786   003    Apr   22,   2013

AB
	                             EQ   8MG BASE
                   A202786   004    Apr   22,   2013

AB
	                             EQ   12MG BASE
                  A202786   005    Apr   22,   2013

AB        DR REDDYS LABS LTD
	   EQ   2MG BASE
                   A201576   001    Jun   06,   2012

AB
	                             EQ   4MG BASE
                   A201576   002    Jun   06,   2012

AB
	                             EQ   6MG BASE
                   A201576   003    Jun   06,   2012

AB
	                             EQ   8MG BASE
                   A201576   004    Jun   06,   2012

AB
	                             EQ   12MG BASE
                  A201576   005    Jun   06,   2012

AB        MYLAN PHARMS INC
	     EQ   2MG BASE
                   A200462   001    Oct   15,   2012

AB
	                             EQ   4MG BASE
                   A200462   003    Oct   15,   2012

AB
	                             EQ   6MG BASE
                   A200462   004    Oct   15,   2012

AB
	                             EQ   8MG BASE
                   A200462   005    Oct   15,   2012

AB
	                             EQ   12MG BASE
                  A200462   006    Oct   15,   2012

AB        SANDOZ INC
	           EQ   2MG BASE
                   A201047   001    Jun   06,   2012

AB
	                             EQ   4MG BASE
                   A201047   003    Jun   06,   2012

AB
	                             EQ   6MG BASE
                   A201047   004    Jun   06,   2012

AB
	                             EQ   8MG BASE
                   A201047   005    Jun   06,   2012

AB
	                             EQ   12MG BASE
                  A201047   006    Jun   06,   2012

AB        WATSON LABS INC
	      EQ   2MG BASE
                   A200431   001    Jun   06,   2012

AB
	                             EQ   4MG BASE
                   A200431   002    Jun   06,   2012

AB
	                             EQ   6MG BASE
                   A200431   003    Jun   06,   2012

AB
	                             EQ   8MG BASE
                   A200431   004    Jun   06,   2012

AB
	                             EQ   12MG BASE
                  A200431   005    Jun   06,   2012

AB        WOCKHARDT LTD
	        EQ   2MG BASE
                   A091395   001    Aug   27,   2012

AB
	                             EQ   4MG BASE
                   A091395   002    Aug   27,   2012

AB
	                             EQ   6MG BASE
                   A091395   003    Aug   27,   2012

AB
	                             EQ   8MG BASE
                   A091395   004    Aug   27,   2012

AB
	                             EQ   12MG BASE
                  A091395   005    Aug   27,   2012

          MYLAN PHARMS INC
	     EQ   3MG BASE
	                  A200462   002    Oct   15,   2012
	
ROPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

     NAROPIN
	
AP         FRESENIUS KABI USA
	    2MG/ML
                        N020533   001    Sep   24,   1996

AP
	                               5MG/ML
                        N020533   003    Sep   24,   1996

AP
	                               7.5MG/ML
                      N020533   004    Sep   24,   1996

AP     +
	                         10MG/ML
	                      N020533   005    Sep   24,   1996
	
     ROPIVACAINE HYDROCHLORIDE
	
AP         HOSPIRA
	               2MG/ML
                        A090194   001    Sep   23,   2014

AP
	                               5MG/ML
                        A090194   002    Sep   23,   2014

AP
	                               7.5MG/ML
                      A090194   003    Sep   23,   2014

AP
	                               10MG/ML
                       A090194   004    Sep   23,   2014

AP         NAVINTA LLC
	           5MG/ML
                        A078601   002    Jul   17,   2014

AP
	                               10MG/ML
                       A078601   003    Jul   17,   2014

AP         SAGENT STRIDES
	        2MG/ML
                        A090318   001    Sep   23,   2014

AP
	                               5MG/ML
                        A090318   002    Sep   23,   2014

AP
	                               7.5MG/ML
                      A090318   003    Sep   23,   2014

AP
	                               10MG/ML
	                      A090318   004    Sep   23,   2014
	
ROSIGLITAZONE MALEATE
	
  TABLET;ORAL

     AVANDIA
	
AB         SB PHARMCO
	            EQ 2MG BASE
                   N021071 002 May 25, 1999

AB
	                               EQ 4MG BASE
                   N021071 003 May 25, 1999

AB     +
	                         EQ 8MG BASE
	                  N021071 004 May 25, 1999
	
     ROSIGLITAZONE MALEATE
	
AB         TEVA
	                  EQ 2MG BASE
                   A076747 001 Jan 25, 2013

AB
	                               EQ 4MG BASE
                   A076747 002 Jan 25, 2013

AB
	                               EQ 8MG BASE
	                  A076747 003 Jan 25, 2013
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                      3-321(of 371)


ROSUVASTATIN CALCIUM
	
  TABLET;ORAL
	
    CRESTOR
	
         IPR                    5MG
	                             N021366   002    Aug   12,   2003

                                10MG
	                            N021366   003    Aug   12,   2003

                                20MG
	                            N021366   004    Aug   12,   2003

     +		                        40MG
	                            N021366   005    Aug   12,   2003
	
ROTIGOTINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    NEUPRO
	
          UCB INC               1MG/24HR
                         N021829   004    Apr   02,   2012

      +		                       2MG/24HR
                         N021829   001    May   09,   2007

                                3MG/24HR
                         N021829   005    Apr   02,   2012

                                4MG/24HR
                         N021829   002    May   09,   2007

                                6MG/24HR
                         N021829   003    May   09,   2007

                                8MG/24HR
	                        N021829   006    Apr   02,   2012
	
RUBIDIUM CHLORIDE RB-82
	
  INJECTABLE;INJECTION
	
    CARDIOGEN-82
	
         BRACCO                 N/A
	                             N019414 001 Dec 29, 1989
	
RUFINAMIDE
	
  SUSPENSION;ORAL
	
    BANZEL
	
      + EISAI INC               40MG/ML
                          N201367 001 Mar 03, 2011
	
  TABLET;ORAL
	
    BANZEL
	
          EISAI INC             200MG
	                           N021911 002 Nov 14, 2008
	
      +		                       400MG
	                           N021911 003 Nov 14, 2008
	
RUXOLITINIB PHOSPHATE
	
  TABLET;ORAL
	
    JAKAFI
	
         INCYTE CORP		          EQ   5MG BASE
	                   N202192   001    Nov   16,   2011
	
                                EQ   10MG BASE
	                  N202192   002    Nov   16,   2011
	
                                EQ   15MG BASE
	                  N202192   003    Nov   16,   2011
	
                                EQ   20MG BASE
	                  N202192   004    Nov   16,   2011
	
     +                          EQ   25MG BASE
	                  N202192   005    Nov   16,   2011
	
SACROSIDASE
	
  SOLUTION;ORAL
	
    SUCRAID
	
      + QOL MEDCL               8,500 IU/ML
	                     N020772 001 Apr 09, 1998
	
SALMETEROL XINAFOATE
	
  POWDER;INHALATION
	
    SEREVENT
	
      + GLAXOSMITHKLINE         EQ 0.05MG BASE/INH
	              N020692 001 Sep 19, 1997
	
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
	
  INJECTABLE;INJECTION
	
    QUADRAMET
	
      + LANTHEUS MEDICAL        50mCi/ML
	                        N020570 001 Mar 28, 1997
	
SAPROPTERIN DIHYDROCHLORIDE
	
  POWDER;ORAL
	
    KUVAN
	
      + BIOMARIN PHARM		        100MG/PACKET
                     N205065 001 Dec 19, 2013
	
  TABLET;ORAL
	
    KUVAN
	
      + BIOMARIN PHARM          100MG
	                           N022181 001 Dec 13, 2007
	
SAQUINAVIR MESYLATE
	
  CAPSULE;ORAL
	
    INVIRASE
	
      + HOFFMANN LA ROCHE		     EQ 200MG BASE
	                   N020628 001 Dec 06, 1995
	
  TABLET;ORAL
	
    INVIRASE
	
      + HOFFMAN LA ROCHE		      EQ 500MG BASE
	                   N021785 001 Dec 17, 2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	                   3-322(of 371)


SAXAGLIPTIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    ONGLYZA
	
          ASTRAZENECA AB          EQ 2.5MG BASE
	                N022350 001 Jul 31, 2009
	
      +		                         EQ 5MG BASE
	                  N022350 002 Jul 31, 2009
	
SCOPOLAMINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    TRANSDERM SCOP
	
      + NOVARTIS
	              1MG/72HR
	                       N017874 001
	
SECOBARBITAL SODIUM
	
  CAPSULE;ORAL
	
    SECONAL SODIUM
	
      + MARATHON PHARMS
	         50MG
	                         A086101 001 Oct 03, 1983
	
      +
	                         100MG
	                        A086101 002 Oct 03, 1983
	
SECRETIN SYNTHETIC HUMAN
	
  FOR SOLUTION;INTRAVENOUS
	
    CHIRHOSTIM
	
      + CHIRHOCLIN
	              16MCG/VIAL
                    N021256 001 Apr 09, 2004

                                  40MCG/VIAL
	                   N021256 002 Jun 21, 2007
	
SELEGILINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    EMSAM
	
      +		 SOMERSET              6MG/24HR
                        N021336 001 Feb 27, 2006
	
                                9MG/24HR
                        N021336 002 Feb 27, 2006
	
                                12MG/24HR
	                      N021336 003 Feb 27, 2006
	
SELEGILINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    ELDEPRYL
	
AB    + SOMERSET                5MG
	                            N020647 001 May 15, 1996
	
    SELEGILINE HYDROCHLORIDE
	
AB       APOTEX                 5MG
	                            A075321 001 Dec 04, 1998

AB       DAVA PHARMS INC        5MG
	                            A075352 001 Nov 30, 1998
	
  TABLET;ORAL

    SELEGILINE HYDROCHLORIDE
	
AB    + APOTEX INC              5MG                              A074871 001 Jun 06, 1997

AB       MYLAN                  5MG                              A074866 001 Nov 26, 1997

AB       STASON                 5MG                              A074912 001 Apr 30, 1998
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    ZELAPAR
	
      + VALEANT PHARM INTL
	    1.25MG
	                         N021479 001 Jun 14, 2006
	
SELENIUM SULFIDE
	
  LOTION/SHAMPOO;TOPICAL

    SELENIUM SULFIDE
	
AT       PERRIGO NEW YORK         2.5%
	                         A089996 001 Jan 10, 1991

AT       WOCKHARDT                2.5%
	                         A088228 001 Sep 01, 1983
	
    SELSUN
AT    + CHATTEM                   2.5%
	                         N007936 001
	
SERTACONAZOLE NITRATE
	
  CREAM;TOPICAL
	
    ERTACZO
	
      + VALEANT LUXEMBOURG
	      2%
	                           N021385 001 Dec 10, 2003
	
SERTRALINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL

     SERTRALINE HYDROCHLORIDE
	
AA        AUROBINDO PHARMA
	      EQ 20MG BASE/ML
	              A078861 001 Oct 31, 2008
	
     ZOLOFT
	
AA     + PFIZER
	                 EQ 20MG BASE/ML
	              N020990 001 Dec 07, 1999
	
  TABLET;ORAL

     SERTRALINE HYDROCHLORIDE
	
AB        ACCORD HLTHCARE
	       EQ     25MG BASE
              A202825   001    Nov   07,   2014

AB
	                              EQ     50MG BASE
              A202825   002    Nov   07,   2014

AB
	                              EQ     100MG BASE
             A202825   003    Nov   07,   2014

AB        APOTEX INC
	            EQ     25MG BASE
              A076882   001    Feb   06,   2007

AB
	                              EQ     50MG BASE
              A076882   002    Feb   06,   2007

AB
	                              EQ     100MG BASE
             A076882   003    Feb   06,   2007

AB        AUROBINDO PHARMA
	      EQ     25MG BASE
              A077206   001    Feb   06,   2007

AB
	                              EQ     50MG BASE
              A077206   002    Feb   06,   2007

AB
	                              EQ     100MG BASE
	            A077206   003    Feb   06,   2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-323(of 371)


SERTRALINE HYDROCHLORIDE
	
  TABLET;ORAL

    SERTRALINE HYDROCHLORIDE
	
AB       AUSTARPHARMA LLC        EQ   25MG BASE                 A078677   001    Mar   04,   2009

AB                               EQ   50MG BASE                 A078677   002    Mar   04,   2009

AB                               EQ   100MG BASE                A078677   003    Mar   04,   2009

AB       HIKMA PHARMS            EQ   25MG BASE                 A077864   001    Aug   10,   2009

AB                               EQ   50MG BASE                 A077864   002    Aug   10,   2009

AB                               EQ   100MG BASE                A077864   003    Aug   10,   2009

AB       INVAGEN PHARMS          EQ   25MG BASE                 A077397   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A077397   002    Feb   06,   2007

AB                               EQ   100MG BASE                A077397   003    Feb   06,   2007

AB       LUPIN                   EQ   25MG BASE                 A077670   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A077670   002    Feb   06,   2007

AB                               EQ   100MG BASE                A077670   003    Feb   06,   2007

AB       MYLAN                   EQ   25MG BASE                 A076671   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A076671   002    Feb   06,   2007

AB                               EQ   100MG BASE                A076671   003    Feb   06,   2007

AB       MYLAN PHARMS INC        EQ   25MG BASE                 A078626   001    Jan   31,   2008

AB                               EQ   50MG BASE                 A078626   002    Jan   31,   2008

AB                               EQ   100MG BASE                A078626   003    Jan   31,   2008

AB       PROSAM LABS             EQ   25MG BASE                 A078175   001    Jul   21,   2010

AB                               EQ   50MG BASE                 A078175   002    Jul   21,   2010

AB                               EQ   100MG BASE                A078175   003    Jul   21,   2010

AB       RANBAXY                 EQ   25MG BASE                 A077977   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A077977   002    Feb   06,   2007

AB                               EQ   100MG BASE                A077977   003    Feb   06,   2007

AB       SUN PHARM INDS (IN)     EQ   25MG BASE                 A078108   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A078108   002    Feb   06,   2007

AB                               EQ   100MG BASE                A078108   003    Feb   06,   2007

AB       TEVA                    EQ   25MG BASE                 A076465   001    Aug   11,   2006

AB                               EQ   50MG BASE                 A076465   002    Aug   11,   2006

AB                               EQ   100MG BASE                A076465   003    Aug   11,   2006

AB       TORRENT PHARMS          EQ   25MG BASE                 A077765   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A077765   002    Feb   06,   2007

AB                               EQ   100MG BASE                A077765   003    Feb   06,   2007

AB       WOCKHARDT               EQ   25MG BASE                 A078403   001    Jan   08,   2008

AB                               EQ   50MG BASE                 A078403   002    Jan   08,   2008

AB                               EQ   100MG BASE                A078403   003    Jan   08,   2008

AB       ZYDUS PHARMS USA        EQ   25MG BASE                 A077106   001    Feb   06,   2007

AB                               EQ   50MG BASE                 A077106   002    Feb   06,   2007

AB                               EQ   100MG BASE                A077106   003    Feb   06,   2007

    ZOLOFT
	
AB       PFIZER                  EQ 25MG BASE                   N019839 005 Mar 06, 1996

AB                               EQ 50MG BASE                   N019839 001 Dec 30, 1991

AB    +                          EQ 100MG BASE                  N019839 002 Dec 30, 1991
	
    SERTRALINE HYDROCHLORIDE
	
         RANBAXY                 EQ 150MG BASE                  A077977 004 Feb 06, 2007
	
                                 EQ 200MG BASE                  A077977 005 Feb 06, 2007
	
SEVELAMER CARBONATE
	
  FOR SUSPENSION;ORAL
	
    RENVELA
	
      +		 GENZYME                2.4GM/PACKET                   N022318 002 Feb 18, 2009
	
                                 800MG/PACKET                   N022318 001 Aug 12, 2009

 TABLET;ORAL
	
   RENVELA
	
     + GENZYME                   800MG		                        N022127 001 Oct 19, 2007
	
SEVELAMER HYDROCHLORIDE
	
  TABLET;ORAL
	
    RENAGEL
	
         GENZYME                 400MG                          N021179 001 Jul 12, 2000
	
      +                          800MG                          N021179 002 Jul 12, 2000
	
SEVOFLURANE
	
  LIQUID;INHALATION

    SEVOFLURANE
	
AN       BAXTER HLTHCARE         100%                           A075895 001 Jul 02, 2002

AN       HALOCARBON PRODS        100%                           A078650 001 Nov 19, 2007

    SOJOURN
	
AN       PIRAMAL CRITICAL        100%                           A077867 001 May 02, 2007
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                                 3-324(of 371)


SEVOFLURANE
	
  LIQUID;INHALATION

    ULTANE
	
AN    + ABBVIE
	                  100%
	                                     N020478 001 Jun 07, 1995
	
SILDENAFIL CITRATE
	
  FOR SUSPENSION;ORAL
	
    REVATIO
	
      + PFIZER
	                  EQ 10MG BASE/ML
	                          N203109 001 Aug 30, 2012
	
  SOLUTION;INTRAVENOUS
	
    REVATIO
	
      + PFIZER
	                  EQ 10MG BASE/12.5ML (EQ 0.8MG BASE/ML)
	   N022473 001 Nov 18, 2009
	
  TABLET;ORAL

    REVATIO
	
AB    + PFIZER
	                  EQ 20MG BASE
	                             N021845 001 Jun 03, 2005
	
    SILDENAFIL CITRATE
	
AB       ACTAVIS GRP PTC
	        EQ     20MG   BASE
                        A200149   001    Feb   25,   2013

AB       AMNEAL PHARMS
	          EQ     20MG   BASE
                        A202025   001    Feb   28,   2013

AB       APOTEX CORP
	            EQ     20MG   BASE
                        A091379   001    Nov   06,   2012

AB       DR REDDYS LABS LTD
	     EQ     20MG   BASE
                        A202598   001    Nov   06,   2012

AB       HETERO LABS LTD V
	      EQ     20MG   BASE
                        A203623   001    Nov   26,   2014

AB       MACLEODS PHARMS LTD
	    EQ     20MG   BASE
                        A203814   001    Dec   17,   2013

AB       MYLAN PHARMS INC
	       EQ     20MG   BASE
                        A201150   001    Nov   09,   2012

AB       TEVA PHARMS
	            EQ     20MG   BASE
                        A078380   001    Jan   07,   2013

AB       TORRENT PHARMS LTD
	     EQ     20MG   BASE
                        A091479   001    Nov   06,   2012

AB       WATSON LABS INC
	        EQ     20MG   BASE
	                       A202503   001    Nov   06,   2012
	
    VIAGRA
	
         PFIZER IRELAND
	         EQ 25MG BASE
	                             N020895 001 Mar 27, 1998
	
                                  EQ 50MG BASE
	                             N020895 002 Mar 27, 1998
	
     +
	                          EQ 100MG BASE
	                            N020895 003 Mar 27, 1998
	
SILODOSIN
	
  CAPSULE;ORAL
	
    RAPAFLO
	
      + WATSON LABS
	             4MG
	                                      N022206 001 Oct 08, 2008
	
                                  8MG
	                                      N022206 002 Oct 08, 2008
	
SILVER SULFADIAZINE
	
  CREAM;TOPICAL

    SILVADENE
	
AB    + KING PHARMS               1%
	                                       N017381 001
	
    SSD
AB       DR REDDYS LA             1%
	                                       N018578 001 Feb 25, 1982
	
    THERMAZENE
	
AB       THEPHARMANETWORK LLC
	   1%
	                                       N018810 001 Dec 23, 1985
	
    SSD AF
	
BX       DR REDDYS LA
	           1%
	                                       N018578 003 Jul 11, 1990
	
SIMEPREVIR SODIUM
	
  CAPSULE;ORAL
	
    OLYSIO
	
      + JANSSEN PRODS
	           EQ 150MG BASE
	                            N205123 001 Nov 22, 2013
	
SIMVASTATIN
	
  TABLET;ORAL

     SIMVASTATIN
	
AB        ACCORD HLTHCARE
	       5MG
	                                      A078155   005    Apr   05,   2013

AB
	                              10MG
	                                     A078155   002    Feb   26,   2008

AB
	                              20MG
	                                     A078155   003    Feb   26,   2008

AB
	                              40MG
	                                     A078155   004    Feb   26,   2008

AB
	                              80MG
	                                     A078155   001    Feb   26,   2008

AB        AUROBINDO PHARMA
	      5MG
	                                      A077691   001    Dec   20,   2006

AB
	                              10MG
	                                     A077691   002    Dec   20,   2006

AB
	                              20MG
	                                     A077691   003    Dec   20,   2006

AB
	                              40MG
	                                     A077691   004    Dec   20,   2006

AB
	                              80MG
	                                     A077691   005    Dec   20,   2006

AB        BLU CARIBE
	            5MG
	                                      A078034   001    Dec   20,   2006

AB
	                              10MG
	                                     A078034   002    Dec   20,   2006

AB
	                              20MG
	                                     A078034   003    Dec   20,   2006

AB
	                              40MG
	                                     A078034   004    Dec   20,   2006

AB
	                              80MG
	                                     A078034   005    Dec   20,   2006

AB        DR REDDYS LABS INC
	    5MG
	                                      A077752   005    Jan   23,   2008

AB
	                              10MG
	                                     A077752   001    Dec   20,   2006

AB
	                              20MG
	                                     A077752   002    Dec   20,   2006

AB
	                              40MG
	                                     A077752   003    Dec   20,   2006
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                     3-325(of 371)


SIMVASTATIN
	
  TABLET;ORAL

    SIMVASTATIN
	
AB                              80MG
	                          A077752   004    Dec   20,   2006

AB       HETERO LABS LTD III    5MG
	                           A200895   001    Nov   25,   2014

AB                              10MG
	                          A200895   002    Nov   25,   2014

AB                              20MG
	                          A200895   003    Nov   25,   2014

AB                              40MG
	                          A200895   004    Nov   25,   2014

AB                              80MG
	                          A200895   005    Nov   25,   2014

AB       IVAX SUB TEVA PHARMS   5MG
	                           A076052   001    Jun   23,   2006

AB                              10MG
	                          A076052   002    Jun   23,   2006

AB                              20MG
	                          A076052   003    Jun   23,   2006

AB                              40MG
	                          A076052   004    Jun   23,   2006

AB                              80MG
	                          A076052   005    Dec   20,   2006

AB       LUPIN                  5MG
	                           A078103   005    Apr   14,   2009

AB                              10MG
	                          A078103   001    May   11,   2007

AB                              20MG
	                          A078103   002    May   11,   2007

AB                              40MG
	                          A078103   003    May   11,   2007

AB                              80MG
	                          A078103   004    May   11,   2007

AB       MICRO LABS LTD         5MG
	                           A090383   001    Sep   16,   2011

AB                              10MG
	                          A090383   002    Sep   16,   2011

AB                              20MG
	                          A090383   003    Sep   16,   2011

AB                              40MG
	                          A090383   004    Sep   16,   2011

AB                              80MG
	                          A090383   005    Sep   16,   2011

AB       MYLAN PHARMS INC       5MG
	                           A090868   001    Jun   08,   2010

AB                              10MG
	                          A090868   002    Jun   08,   2010

AB                              20MG
	                          A090868   003    Jun   08,   2010

AB                              40MG
	                          A090868   004    Jun   08,   2010

AB                              80MG
	                          A090868   005    Jun   08,   2010

AB       PROSAM LABS            5MG
	                           A078735   001    Aug   30,   2010

AB                              10MG
	                          A078735   002    Aug   30,   2010

AB                              20MG
	                          A078735   003    Aug   30,   2010

AB                              40MG
	                          A078735   004    Aug   30,   2010

AB                              80MG
	                          A078735   005    Aug   30,   2010

AB       RANBAXY                5MG
	                           A076285   001    Dec   20,   2006

AB                              10MG
	                          A076285   002    Dec   20,   2006

AB                              20MG
	                          A076285   003    Dec   20,   2006

AB                              40MG
	                          A076285   004    Dec   20,   2006

AB                              80MG
	                          A076285   005    Jun   23,   2006

AB       WATSON LABS            5MG
	                           A076685   001    Dec   20,   2006

AB                              10MG
	                          A076685   002    Dec   20,   2006

AB                              20MG
	                          A076685   003    Dec   20,   2006

AB                              40MG
	                          A076685   004    Dec   20,   2006

AB                              80MG
	                          A076685   005    Dec   20,   2006

AB       ZYDUS PHARMS USA       5MG
	                           A077837   001    Dec   20,   2006

AB                              10MG
	                          A077837   002    Dec   20,   2006

AB                              20MG
	                          A077837   003    Dec   20,   2006

AB                              40MG
	                          A077837   004    Dec   20,   2006

AB                              80MG
	                          A077837   005    Dec   20,   2006
	
    ZOCOR
	
AB       MERCK                  5MG
	                           N019766   001    Dec   23,   1991

AB                              10MG
	                          N019766   002    Dec   23,   1991

AB                              20MG
	                          N019766   003    Dec   23,   1991

AB                              40MG
	                          N019766   004    Dec   23,   1991

AB    +                         80MG
	                          N019766   005    Jul   10,   1998
	
SINCALIDE
	
  INJECTABLE;INJECTION
	
    KINEVAC
	
      + BRACCO                  0.005MG/VIAL
	                  N017697 001
	
SINECATECHINS
	
  OINTMENT;TOPICAL
	
    VEREGEN
	
      + MEDIGENE AG             15%
	                           N021902 001 Oct 31, 2006
	
SIROLIMUS
	
  SOLUTION;ORAL
	
    RAPAMUNE
	
      + PF PRISM CV             1MG/ML
                         N021083 001 Sep 15, 1999
	
  TABLET;ORAL

    RAPAMUNE
	
AB       PF PRISM CV            0.5MG
	                         N021110 004 Jan 25, 2010

AB                              1MG
	                           N021110 001 Aug 25, 2000
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-326(of 371)


SIROLIMUS
	
  TABLET;ORAL

    RAPAMUNE
	
AB    +                         2MG                              N021110 002 Aug 22, 2002

    SIROLIMUS
	
AB       DR REDDYS LABS LTD     1MG                              A201578 001 Oct 27, 2014

AB                              2MG                              A201578 002 Oct 27, 2014

AB       ZYDUS PHARMS USA INC   0.5MG                            A201676 003 Jan 08, 2014
	
SITAGLIPTIN PHOSPHATE
	
  TABLET;ORAL
	
    JANUVIA
	
         MERCK SHARP DOHME      EQ 25MG BASE                     N021995 001 Oct 16, 2006
                                EQ 50MG BASE                     N021995 002 Oct 16, 2006
     +                          EQ 100MG BASE                    N021995 003 Oct 16, 2006
SODIUM ACETATE ANHYDROUS
	
  INJECTABLE;INJECTION
	
    SODIUM ACETATE IN PLASTIC CONTAINER
	
      + HOSPIRA                 2MEQ/ML                          N018893 001 May 04, 1983
	
SODIUM BENZOATE; SODIUM PHENYLACETATE
	
  SOLUTION;IV (INFUSION)

    AMMONUL
	
      + MEDICIS                 10%;10% (5GM/50ML;5GM/50ML)      N020645 001 Feb 17, 2005
	
SODIUM BICARBONATE
	
  INJECTABLE;INJECTION
	
    SODIUM BICARBONATE
	
      + HOSPIRA		               0.9MEQ/ML                        A077394 001 Nov 09, 2005
	
      +		                       1MEQ/ML                          A077394 002 Nov 09, 2005
	
SODIUM CHLORIDE
	
  INJECTABLE;INJECTION

    BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP        FRESENIUS KABI USA    9MG/ML                           A088911 001 Feb 07, 1985

AP    + HOSPIRA                 9MG/ML                           N018800 001 Oct 29, 1982

    SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
AP        B BRAUN               450MG/100ML                      N019635   001 Mar 09, 1988

AP        BAXTER HLTHCARE       450MG/100ML                      N018016   001
	
AP        HOSPIRA               450MG/100ML                      N018090   001
	
AP                              450MG/100ML                      N019759   001 Jun 08, 1988

    SODIUM CHLORIDE 0.9%
	
AP        HIKMA (MAPLE)         9MG/ML                           A201850 001 Jan 20, 2012

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 900MG/100ML                      N017464   001
	
AP    +                         900MG/100ML                      N019635   002     Mar 09, 1988

AP    + BAXTER HLTHCARE         9MG/ML                           N016677   004     Oct 30, 1985

AP                              9MG/ML                           N020178   002     Dec 07, 1992

AP    +                         900MG/100ML                      N016677   001
	
AP    +                         900MG/100ML                      N020178   001     Dec   07,   1992

AP    + FRESENIUS KABI USA      9MG/ML                           A088912   001     Jan   10,   1985

AP        FRESENIUS MEDCL       900MG/100ML                      A078177   001     Apr   12,   2007

AP        HAEMONETICS           900MG/100ML                      A076316   001     Oct   27,   2004

AP    + HOSPIRA                 9MG/ML                           N018803   001     Oct   29,   1982

AP    +                         9MG/ML                           N019217   001     Jul   13,   1984

AP                              9MG/ML                           N019465   002     Jul   15,   1985

AP    +                         900MG/100ML                      N016366   001
	
AP    +                         900MG/100ML                      N019465   001     Jul 15, 1985

AP    +                         900MG/100ML                      N019480   001     Sep 17, 1985

AP    + TARO PHARMS IRELAND     9MG/ML                           A077407   001     Aug 11, 2006

    SODIUM CHLORIDE 0.9%
	
          MEDEFIL INC           90MG/10ML (9MG/ML)               N202832 006 Jan 06, 2012
	
    SODIUM CHLORIDE 0.9%
	
          HIKMA MAPLE           9MG/ML                           A201833 001 Sep 24, 2013

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
      +		 MALLINCKRODT          45MG/50ML (9MG/ML)               N021569 001 Jul 27, 2006
	
                                112.5MG/125ML (9MG/ML)           N021569 002 Jul 27, 2006
	
    SODIUM CHLORIDE 3% IN PLASTIC CONTAINER
	
          BAXTER HLTHCARE       3GM/100ML                        N019022 001 Nov 01, 1983
	
    SODIUM CHLORIDE 5% IN PLASTIC CONTAINER
	
          BAXTER HLTHCARE       5GM/100ML                        N019022 002 Nov 01, 1983
	
    SODIUM CHLORIDE IN PLASTIC CONTAINER
	
          HOSPIRA               2.5MEQ/ML                        N018897 001 Jul 20, 1984
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                                3-327(of 371)


SODIUM CHLORIDE
	
  SOLUTION;IRRIGATION

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
AT       B BRAUN                 900MG/100ML                              N016733   001
	
AT       BAXTER HLTHCARE         900MG/100ML                              N017427   001
	
AT                               900MG/100ML                              N017867   001
	
AT       HOSPIRA                 900MG/100ML                              N017514   001
	
AT                               900MG/100ML                              N018314   001
	
  SOLUTION FOR SLUSH;IRRIGATION
	
    SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER
	
         BAXTER HLTHCARE         900MG/100ML                              N019319 002 May 17, 1985
	
SODIUM FERRIC GLUCONATE COMPLEX
	
  INJECTABLE;INJECTION

    FERRLECIT
	
AB    + SANOFI AVENTIS US        62.5MG/5ML                               N020955 001 Feb 18, 1999

    SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE
	
AB       HIKMA PHARMS            62.5MG/5ML                               A078215 001 Mar 31, 2011
	
SODIUM FLUORIDE F-18
	
  INJECTABLE;INTRAVENOUS

    SODIUM FLUORIDE F-18
	
AP        BIOMEDCL RES FDN      10-200mCi/ML                              A204351   001     Jan   09,   2015

AP        ESSENTIAL ISOTOPES    10-200mCi/ML                              A204541   001     Oct   29,   2014

AP        GLOBAL ISOTOPES LLC   10-200mCi/ML                              A204464   001     Oct   21,   2014

AP    + HOUSTON CYCLOTRON       10-200mCi/ML                              A203544   001     Dec   26,   2012

AP        NCM USA BRONX LLC     10-200mCi/ML                              A204513   001     Nov   28,   2014

AP        SHERTECH LABS LLC     10-200mCi/ML                              A204315   001     Sep   22,   2014

AP        UCSF RODIOPHARM       10-200mCi/ML                              A204437   001     Mar   13,   2014

AP        UNIV TX MD ANDERSON   10-200mCi/ML                              A203247   001     Dec   23,   2013
	
      +		 MCPRF                 10-91.5mCi/ML                             A203605   001     Jun   28,   2013
	
          THE FEINSTEIN INST    20-600mCi/ML                              A204328   001     Nov   19,   2014
	
SODIUM IODIDE I-123
	
  CAPSULE;ORAL

    SODIUM IODIDE I 123
	
AA    + CARDINAL HLTH 414       100uCi                                    N018671   001     May   27,   1982

AA    +                         200uCi                                    N018671   002     May   27,   1982

AA       MALLINCKRODT           100uCi                                    A071909   001     Feb   28,   1989

AA                              200uCi                                    A071910   001     Feb   28,   1989
	
SODIUM IODIDE I-131
	
  CAPSULE;ORAL
	
    SODIUM IODIDE I 131
	
      + MALLINCKRODT            0.8-100mCi                                N016517 001
	
    SODIUM IODIDE I-131
	
          JUBILANT DRAXIMAGE    0.009-0.1mCi                              N021305 006 May 19, 2005

  SOLUTION;ORAL
	
    HICON
	
      + JUBILANT DRAXIMAGE      250-1000mCi                               N021305 007 Dec 05, 2011
	
    SODIUM IODIDE I 131
	
      +		 MALLINCKRODT          3.5-150mCi/VIAL                           N016515 001
	
SODIUM LACTATE
	
  INJECTABLE;INJECTION

    SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
	
AP       BAXTER HLTHCARE        1.87GM/100ML                              N016692 001
	
    SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER

AP       B BRAUN                1.87GM/100ML                              N020004 001 Apr 21, 1992

    SODIUM LACTATE IN PLASTIC CONTAINER
	
      + HOSPIRA                 5MEQ/ML		                                 N018947 001 Sep 05, 1984
	
SODIUM NITRITE
	
  SOLUTION;INTRAVENOUS
	
    SODIUM NITRITE
	
      + HOPE PHARMS             300MG/10ML (30MG/ML)		                    N203922 001 Feb 14, 2012
	
SODIUM NITRITE; SODIUM THIOSULFATE
	
  SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS
	
    NITHIODOTE
	
      +		 HOPE PHARMS           300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML   N201444 001 Jan 14, 2011

                                (250MG/ML)
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                                 3-328(of 371)


SODIUM NITROPRUSSIDE
	
  INJECTABLE;INJECTION
	
    NITROPRESS
	
      + HOSPIRA                25MG/ML                                    A071961 001 Aug 01, 1988
	
SODIUM OXYBATE
	
  SOLUTION;ORAL
	
    XYREM
	
      + JAZZ PHARMS            500MG/ML                                   N021196 001 Jul 17, 2002
	
SODIUM PHENYLBUTYRATE
	
  POWDER;ORAL

    BUPHENYL
	
AB    + HYPERION THERAPS INC   3GM/TEASPOONFUL                            N020573 001 Apr 30, 1996

    SODIUM PHENYLBUTYRATE
	
AB       SIGMAPHARM LABS LLC   3GM/TEASPOONFUL                            A202819 001 Mar 22, 2013
	
  TABLET;ORAL

    BUPHENYL
	
AB    + HYPERION THERAPS INC   500MG                                      N020572 001 May 13, 1996

    SODIUM PHENYLBUTYRATE
	
AB       AMPOLGEN              500MG                                      A090910 001 Nov 18, 2011
	
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
	
  TABLET;ORAL
	
    OSMOPREP
	
      + SALIX PHARMS            0.398GM;1.102GM                           N021892 001 Mar 16, 2006
	
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
	
  INJECTABLE;INJECTION
	
    SODIUM PHOSPHATES IN PLASTIC CONTAINER
	
      + HOSPIRA                 142MG/ML;276MG/ML                         N018892 001 May 10, 1983
	
SODIUM POLYSTYRENE SULFONATE
	
  POWDER;ORAL, RECTAL

    KALEXATE
	
AA        KVK TECH              454GM/BOT                                 A040905 001 Mar 30, 2009

    KAYEXALATE
	
AA    + COVIS PHARMA SARL       453.6GM/BOT                               N011287 001
	
    KIONEX
	
AA        PADDOCK LLC           454GM/BOT                                 A040029 001 Feb 06, 1998

    SODIUM POLYSTYRENE SULFONATE
	
AA        CAROLINA MEDCL        454GM/BOT                                 A089910   001    Jan   19,   1989

AA        CEDAR PHARMS          453.6GM/BOT                               A090313   001    Dec   21,   2011

AA        EPIC PHARMA LLC       453.6GM/BOT                               A202333   001    Mar   19,   2014

AA        NUVO PHARM INC        454GM/BOT                                 A204071   001    Nov   28,   2014
	
                                15GM/BOT                                  A204071   002    Nov   28,   2014
	
  SUSPENSION;ORAL, RECTAL

    KIONEX
	
AA        PADDOCK LLC           15GM/60ML                                 A040028 001 Sep 17, 2007

    SODIUM POLYSTYRENE SULFONATE
	
AA        PADDOCK LLC           15GM/60ML                                 A090590 001 May 13, 2011

AA        ROXANE                15GM/60ML                                 A089049 001 Nov 17, 1986

    SPS
	
AA    + CAROLINA MEDCL          15GM/60ML                                 A087859 001 Dec 08, 1982
	
SODIUM TETRADECYL SULFATE
	
  INJECTABLE;INJECTION
	
    SOTRADECOL
	
         MYLAN INSTITUTIONAL   20MG/2ML (10MG/ML)                         A040541 001 Nov 12, 2004
	
      +                        60MG/2ML (30MG/ML)                         A040541 002 Nov 12, 2004
	
SODIUM THIOSULFATE
	
  SOLUTION;INTRAVENOUS
	
    SODIUM THIOSULFATE
	
      + HOPE PHARMS            12.5GM/50ML (250MG/ML)                     N203923 001 Feb 14, 2012
	
SOFOSBUVIR
	
  TABLET;ORAL
	
    SOVALDI
	
      + GILEAD SCIENCES INC    400MG                                      N204671 001 Dec 06, 2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-329(of 371)


SOLIFENACIN SUCCINATE
	
  TABLET;ORAL

    SOLIFENACIN SUCCINATE
	
AB       TEVA PHARMS USA         5MG                            A091464 001 Apr 02, 2014

AB                               10MG                           A091464 002 Apr 02, 2014

    VESICARE
	
AB       ASTELLAS                5MG                            N021518 001 Nov 19, 2004

AB    +                          10MG                           N021518 002 Nov 19, 2004
	
SOMATROPIN RECOMBINANT
	
  INJECTABLE;INJECTION
	
    GENOTROPIN
	
BX    + PHARMACIA AND UPJOHN     5.8MG/VIAL                     N020280 006 Aug 24, 1995

    GENOTROPIN PRESERVATIVE FREE
	
BX        PHARMACIA AND UPJOHN   1.5MG/VIAL                     N020280 004 Aug 24, 1995

    HUMATROPE
	
BX    + LILLY                    5MG/VIAL                       N019640 004 Mar 08, 1987
	
BX                               6MG/VIAL                       N019640 005 Feb 04, 1999
	
    NORDITROPIN FLEXPRO
	
BX        NOVO NORDISK INC       5MG/1.5ML                      N021148 008 Mar 01, 2010
	
BX                               10MG/1.5ML                     N021148 009 Mar 01, 2010
	
    NUTROPIN
	
BX        GENENTECH              5MG/VIAL                       N020168 001 Nov 17, 1993
	
    OMNITROPE
	
BX        SANDOZ                 1.5MG/VIAL                     N021426   002    May   30,   2006

BX                               5MG/1.5ML                      N021426   003    Jan   16,   2008
	
BX                               5.8MG/VIAL                     N021426   001    May   30,   2006

BX                               10MG/1.5ML                     N021426   004    Aug   25,   2008

    SAIZEN
	
BX        EMD SERONO             5MG/VIAL                       N019764 002 Oct 08, 1996
	
    SEROSTIM
	
BX        EMD SERONO             4MG/VIAL                       N020604 003 Jul 25, 1997
	
BX                               5MG/VIAL                       N020604 002 Aug 23, 1996

BX                               6MG/VIAL                       N020604 001 Aug 23, 1996

    TEV-TROPIN
	
BX    + FERRING                  5MG/VIAL                       N019774 002 Jan 04, 2002
	
    VALTROPIN
	
BX        LG LIFE                5MG/VIAL                       N021905 001 Apr 19, 2007

    GENOTROPIN
	
      + PHARMACIA AND UPJOHN     13.8MG/VIAL                    N020280 007 Oct 23, 1996
	
    GENOTROPIN PRESERVATIVE FREE
	
          PHARMACIA AND UPJOHN		 0.2MG/VIAL                     N020280   001    Jan   27,   1998
	
                                 0.4MG/VIAL                     N020280   002    Jan   27,   1998
	
                                 0.6MG/VIAL                     N020280   003    Jan   27,   1998
	
                                 0.8MG/VIAL                     N020280   005    Jan   27,   1998
	
                                 1MG/VIAL                       N020280   008    Jan   27,   1998
	
                                 1.2MG/VIAL                     N020280   009    Jan   27,   1998
	
                                 1.4MG/VIAL                     N020280   010    Jan   27,   1998
	
                                 1.6MG/VIAL                     N020280   011    Jan   27,   1998
	
                                 1.8MG/VIAL                     N020280   012    Jan   27,   1998
	
      +                          2MG/VIAL                       N020280   013    Jan   27,   1998
	
    HUMATROPE
	
      + LILLY                    12MG/VIAL		                    N019640 006 Feb 04, 1999
	
      +                          24MG/VIAL                      N019640 007 Feb 04, 1999
	
    NORDITROPIN FLEXPRO
	
          NOVO NORDISK INC       15MG/1.5ML                     N021148 010 Mar 01, 2010
	
    NORDITROPIN NORDIFLEX
	
          NOVO NORDISK INC       30MG/3ML                       N021148 007 Mar 10, 2009
	
    NUTROPIN
	
      + GENENTECH                10MG/VIAL                      N020168 002 Nov 17, 1993
	
    NUTROPIN AQ
	
      + GENENTECH                5MG/2ML (2.5MG/ML)		           N020522 003 Jan 03, 2008
	
      +		                        10MG/2ML (5MG/ML)              N020522 001 Dec 29, 1995
	
      +                          20MG/2ML (10MG/ML)             N020522 004 Jan 03, 2008
	
    NUTROPIN AQ PEN
	
      + GENENTECH                10MG/2ML (5MG/ML)              N020522 002 Apr 22, 2002

    SAIZEN
	
      + EMD SERONO               8.8MG/VIAL                     N019764 003 Aug 29, 2000

    ZORBTIVE
	
      + EMD SERONO               8.8MG/VIAL		                   N021597 004 Dec 01, 2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-330(of 371)


SORAFENIB TOSYLATE
	
  TABLET;ORAL
	
    NEXAVAR
	
      + BAYER HLTHCARE          EQ 200MG BASE
	                 N021923 001 Dec 20, 2005
	
SORBITOL
	
  SOLUTION;IRRIGATION
	
    SORBITOL 3% IN PLASTIC CONTAINER
	
          BAXTER HLTHCARE       3GM/100ML
                      N017863 001
	
    SORBITOL 3.3% IN PLASTIC CONTAINER
	
          B BRAUN
	             3.3GM/100ML
	                   N016741 001
	
SOTALOL HYDROCHLORIDE
	
  SOLUTION;INTRAVENOUS
	
     SOTALOL HYDROCHLORIDE
	
       + ACADEMIC PHARMS
	      150MG/10ML (15MG/ML)
	          N022306 001 Jul 02, 2009
	
  SOLUTION;ORAL
	
     SOTYLIZE
	
       + ARBOR PHARMS LLC
	     5MG/ML (5MG/ML)
	               N205108 001 Oct 22, 2014
	
  TABLET;ORAL

     BETAPACE
	
AB1       BAYER HLTHCARE
	      80MG
	                          N019865   001    Oct   30,   1992

AB1
	                           120MG
	                         N019865   005    Apr   20,   1994

AB1 +
	                         160MG
	                         N019865   002    Oct   30,   1992

AB1
	                           240MG
	                         N019865   003    Oct   30,   1992
	
     SORINE
	
AB1       UPSHER SMITH
	        80MG
	                          A075500   001    Apr   27,   2001

AB1
	                           120MG
	                         A075500   004    Apr   27,   2001

AB1
	                           160MG
	                         A075500   002    Apr   27,   2001

AB1
	                           240MG
	                         A075500   003    Apr   27,   2001
	
     SOTALOL HYDROCHLORIDE
	
AB1       APOTEX INC
	          80MG
	                          A076140   001    Sep   26,   2002

AB1
	                           120MG
	                         A076140   002    Sep   26,   2002

AB1
	                           160MG
	                         A076140   003    Sep   26,   2002

AB1
	                           240MG
	                         A076140   004    Sep   26,   2002

AB1       IMPAX PHARMS
	        80MG
	                          A075663   001    Nov   07,   2000

AB1
	                           120MG
	                         A075663   002    Nov   07,   2000

AB1
	                           160MG
	                         A075663   003    Nov   07,   2000

AB1
	                           240MG
	                         A075663   004    Nov   07,   2000

AB1       MYLAN
	               80MG
	                          A075237   001    May   01,   2000

AB1
	                           80MG
	                          A075725   001    Dec   19,   2000

AB1
	                           120MG
	                         A075237   002    May   01,   2000

AB1
	                           120MG
	                         A075725   002    Dec   19,   2000

AB1
	                           160MG
	                         A075237   003    May   01,   2000

AB1
	                           160MG
	                         A075725   003    Dec   19,   2000

AB1
	                           240MG
	                         A075237   004    May   01,   2000

AB1
	                           240MG
	                         A075725   004    Dec   19,   2000

AB1       SANDOZ
	              80MG
	                          A075366   001    May   01,   2000

AB1
	                           120MG
	                         A075366   002    May   01,   2000

AB1
	                           160MG
	                         A075366   003    May   01,   2000

AB1
	                           240MG
	                         A075366   004    May   01,   2000

AB1       TEVA
	                80MG
	                          A075429   001    May   01,   2000

AB1
	                           120MG
	                         A075429   002    May   01,   2000

AB1
	                           160MG
	                         A075429   003    May   01,   2000

AB1
	                           240MG
	                         A075429   004    May   01,   2000

AB1       VINTAGE PHARMS
	      80MG
	                          A075563   001    Nov   07,   2003

AB1
	                           120MG
	                         A075563   002    Nov   07,   2003

AB1
	                           160MG
	                         A075563   003    Nov   07,   2003

AB1
	                           240MG
	                         A075563   004    Nov   07,   2003
	
     BETAPACE AF
	
AB2       COVIS PHARMA SARL
	   80MG
	                          N021151 001 Feb 22, 2000

AB2
	                           120MG
	                         N021151 002 Feb 22, 2000

AB2 +
	                         160MG
	                         N021151 003 Feb 22, 2000
	
     SOTALOL HYDROCHLORIDE
	
AB2       APOTEX
	              80MG
	                          A076214   001    Aug   27,   2003

AB2
	                           120MG
	                         A076214   002    Aug   27,   2003

AB2
	                           160MG
	                         A076214   003    Aug   27,   2003

AB2       EPIC PHARMA INC
	     80MG
	                          A077070   001    Nov   04,   2005

AB2
	                           120MG
	                         A077070   002    Nov   04,   2005

AB2
	                           160MG
	                         A077070   003    Nov   04,   2005

AB2       MYLAN
	               80MG
	                          A077616   001    Feb   07,   2007

AB2
	                           120MG
	                         A077616   002    Feb   07,   2007

AB2
	                           160MG
	                         A077616   003    Feb   07,   2007
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               PRESCRIPTION DRUG PRODUCT LIST
	                   3-331(of 371)


SOTALOL HYDROCHLORIDE
	
  TABLET;ORAL

     SOTALOL HYDROCHLORIDE
	
AB2       TEVA
	                  80MG
	                          A076883 001 Jul 26, 2004

AB2
	                             120MG
	                         A076883 002 Jul 26, 2004

AB2
	                             160MG
	                         A076883 003 Jul 26, 2004
	
SOYBEAN OIL
	
  INJECTABLE;INJECTION

    INTRALIPID 10%
	
AP    + FRESENIUS
	               10%
	                           N017643 001
	
    INTRALIPID 20%
	
AP    + FRESENIUS
	               20%
	                           N018449 001
	
AP    +
	                         20%
	                           N020248 001 Aug 07, 1996
	
    INTRALIPID 30%
	
AP    + FRESENIUS
	               30%
	                           N019942 001 Dec 30, 1993
	
    NUTRILIPID 10%
	
AP    + B BRAUN
	                 10%
	                           N019531 001 May 28, 1993
	
    NUTRILIPID 20%
	
AP    + B BRAUN
	                 20%
	                           N019531 002 May 28, 1993
	
SPINOSAD
	
  SUSPENSION;TOPICAL
	
    NATROBA
	
      + PARAPRO LLC
	             0.9%
	                          N022408 001 Jan 18, 2011
	
SPIRONOLACTONE
	
  TABLET;ORAL

     ALDACTONE
	
AB         GD SEARLE LLC
	        25MG
	                          N012151 009 Dec 30, 1983

AB
	                              50MG
	                          N012151 008 Dec 30, 1982

AB     +
	                        100MG
	                         N012151 010 Dec 30, 1983
	
     SPIRONOLACTONE
	
AB         ACTAVIS ELIZABETH
	    25MG
	                          A040353   003     Mar   15,   2006

AB
	                              50MG
	                          A040353   001     Jul   29,   1999

AB
	                              100MG
	                         A040353   002     Jul   29,   1999

AB         AMNEAL PHARMS
	        25MG
	                          A091426   001     Jun   08,   2010

AB
	                              50MG
	                          A091426   002     Jun   08,   2010

AB
	                              100MG
	                         A091426   003     Jun   08,   2010

AB         JUBILANT GENERICS
	    25MG
	                          A203253   001     Apr   23,   2014

AB
	                              50MG
	                          A203253   002     Apr   23,   2014

AB
	                              100MG
	                         A203253   003     Apr   23,   2014

AB         MUTUAL PHARM
	         25MG
	                          A089424   001     Jul   23,   1986

AB
	                              50MG
	                          A089424   002     Aug   11,   1999

AB
	                              100MG
	                         A089424   003     Aug   11,   1999

AB         MYLAN
	                25MG
	                          A040424   001     Aug   20,   2001

AB
	                              50MG
	                          A040424   002     Aug   20,   2001

AB
	                              100MG
	                         A040424   003     Aug   20,   2001

AB         ORION CORP ORION
	     25MG
	                          A202187   001     Mar   06,   2014

AB
	                              50MG
	                          A202187   002     Mar   06,   2014

AB
	                              100MG
	                         A202187   003     Mar   06,   2014

AB         SANDOZ
	               25MG
	                          A086809   001
	
AB         VINTAGE
	              25MG
	                          A040750   001     Aug 29, 2006

AB
	                              50MG
	                          A040750   002     Aug 29, 2006

AB
	                              100MG
	                         A040750   003     Aug 29, 2006
	
STAVUDINE
	
  CAPSULE;ORAL

     STAVUDINE
	
AB        AUROBINDO PHARMA
	      15MG
	                          A077672   003     Dec   29,   2008

AB
	                              20MG
	                          A077672   004     Dec   29,   2008

AB
	                              30MG
	                          A077672   001     Dec   29,   2008

AB
	                              40MG
	                          A077672   002     Dec   29,   2008

AB        HETERO LABS LTD III     15MG                            A078957   001     Dec   29,   2008

AB                                20MG                            A078957   002     Dec   29,   2008

AB                                30MG                            A078957   003     Dec   29,   2008

AB                                40MG                            A078957   004     Dec   29,   2008

AB        MATRIX LABS LTD         30MG                            A078775   001     Jan   05,   2009

AB                                40MG                            A078775   002     Jan   05,   2009

AB        MYLAN                   15MG                            A079069   001     Dec   29,   2008

AB                                20MG                            A079069   002     Dec   29,   2008

AB                                30MG                            A079069   003     Dec   29,   2008

AB                                40MG                            A079069   004     Dec   29,   2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-332(of 371)


STAVUDINE
	
  CAPSULE;ORAL

    ZERIT
	
AB       BRISTOL MYERS SQUIBB    15MG                           N020412   002     Jun   24,   1994

AB                               20MG                           N020412   003     Jun   24,   1994

AB                               30MG                           N020412   004     Jun   24,   1994

AB    +                          40MG                           N020412   005     Jun   24,   1994
	
  FOR SOLUTION;ORAL

    STAVUDINE
	
AA       AUROBINDO PHARMA        1MG/ML                         A077774 001 Dec 29, 2008

AA       CIPLA LTD               1MG/ML                         A078030 001 Mar 20, 2009

    ZERIT
	
AA    + BRISTOL MYERS SQUIBB     1MG/ML                         N020413 001 Sep 06, 1996
	
STERILE WATER FOR INJECTION
	
  LIQUID;N/A

    BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
	
AP    + HOSPIRA                 100%                            N018802 001 Oct 27, 1982

    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER
	
AP    + B BRAUN                 100%                            N019633   001     Feb   29,   1988

AP    + BAXTER HLTHCARE         100%                            N018632   001     Jun   30,   1982

AP    +                         100%                            N018632   002     Apr   19,   1988

AP       FRESENIUS KABI USA     100%                            A088400   001     Jan   16,   1984

AP    + HOSPIRA                 100%                            N018233   001
	
AP    +                         100%                            N018801   001     Oct 27, 1982

AP    +                         100%                            N019869   001     Dec 26, 1989

AP       TARO PHARMS IRELAND    100%                            A077393   001     Aug 11, 2006
	
STERILE WATER FOR IRRIGATION
	
  LIQUID;IRRIGATION

    STERILE WATER
	
AT       BAXTER HLTHCARE        100%                            N017428 001
	
    STERILE WATER IN PLASTIC CONTAINER
	
AT       B BRAUN                100%                            N016734   001
	
AT       BAXTER HLTHCARE        100%                            N017866   001
	
AT       HOSPIRA                100%                            N017513   001
	
AT                              100%                            N018313   001
	
STREPTOMYCIN SULFATE
	
  INJECTABLE;INJECTION
	
    STREPTOMYCIN SULFATE
	
      + X GEN PHARMS             EQ 1GM BASE/VIAL               A064210 001 Jun 30, 1998
	
STREPTOZOCIN
	
  INJECTABLE;INJECTION
	
    ZANOSAR
	
      + TEVA PHARMS USA          1GM/VIAL                       N050577 001 May 07, 1982
	
STRONTIUM CHLORIDE SR-89
	
  INJECTABLE;INJECTION

    METASTRON
	
AP    + GE HEALTHCARE            1mCi/ML                        N020134 001 Jun 18, 1993

    STRONTIUM CHLORIDE SR-89
	
AP       BIO NUCLEONICS          1mCi/ML                        A075941 001 Jan 06, 2003
	
SUCCIMER
	
  CAPSULE;ORAL
	
    CHEMET
	
      + RECORDATI RARE           100MG                          N019998 002 Jan 30, 1991
	
SUCCINYLCHOLINE CHLORIDE
	
  INJECTABLE;INJECTION

    ANECTINE
	
AP    + SANDOZ                  20MG/ML                         N008453 002
	
    QUELICIN

AP    + HOSPIRA                 20MG/ML                         N008845 006
	
    QUELICIN PRESERVATIVE FREE

AP    + HOSPIRA                 20MG/ML                         N008845 001
	
      +                         100MG/ML                        N008845 004
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                  3-333(of 371)


SUCRALFATE
	
  SUSPENSION;ORAL
	
    CARAFATE
	
      + FOREST LABS INC           1GM/10ML                       N019183 001 Dec 16, 1993
	
  TABLET;ORAL

    CARAFATE
	
AB    + FOREST LABS INC           1GM                            N018333 001
	
    SUCRALFATE
	
AB       NOSTRUM LABS             1GM                            A074415 001 Jun 08, 1998

AB       TEVA                     1GM                            A070848 001 Mar 29, 1996
	
SUCROFERRIC OXYHYDROXIDE
	
  TABLET, CHEWABLE;ORAL
	
    VELPHORO
	
      + VIFOR FRESENIUS           500MG                          N205109 001 Nov 27, 2013
	
SUFENTANIL CITRATE
	
  INJECTABLE;INJECTION

    SUFENTA PRESERVATIVE FREE
	
AP    + AKORN                     EQ 0.05MG BASE/ML              N019050 001 May 04, 1984

    SUFENTANIL CITRATE
	
AP       HIKMA MAPLE              EQ 0.05MG BASE/ML              A074413 001 Dec 15, 1995

AP       HOSPIRA                  EQ 0.05MG BASE/ML              A074534 001 Dec 11, 1996
	
SULCONAZOLE NITRATE
	
  CREAM;TOPICAL
	
    EXELDERM
	
      + RANBAXY                   1%                             N018737 001 Feb 28, 1989
	
  SOLUTION;TOPICAL
	
    EXELDERM
	
      + RANBAXY                   1%                             N018738 001 Aug 30, 1985
	
SULFACETAMIDE SODIUM
	
  LOTION;TOPICAL

    KLARON
	
AB    + VALEANT BERMUDA           10%                            N019931 001 Dec 23, 1996

    SULFACETAMIDE SODIUM
	
AB       FOUGERA PHARMS           10%                            A077015 001 Nov 17, 2006

AB       PERRIGO CO TENNESSEE     10%                            A078649 001 Mar 23, 2009

AB       TARO                     10%                            A078668 001 May 20, 2009

  OINTMENT;OPHTHALMIC

    CETAMIDE
	
AT    + ALCON                     10%                            A080021 001
	
    SULFACETAMIDE SODIUM
	
AT       PERRIGO CO TENNESSEE     10%                            A080029 001
	
  SOLUTION/DROPS;OPHTHALMIC

    BLEPH-10
	
AT    + ALLERGAN                  10%                            A080028 001
	
    SULFACETAMIDE SODIUM
	
AT       ALCON PHARMS LTD         10%                            A089560 001 Oct 18, 1988

AT       BAUSCH AND LOMB          10%                            A040066 001 Dec 28, 1994
	
SULFADIAZINE
	
  TABLET;ORAL
	
    SULFADIAZINE
	
      + SANDOZ                    500MG                          A040091 001 Jul 29, 1994
	
SULFAMETHOXAZOLE; TRIMETHOPRIM
	
  INJECTABLE;INJECTION
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM
	
      + TEVA PHARMS USA          80MG/ML;16MG/ML                 A073303 001 Oct 31, 1991
	
  SUSPENSION;ORAL

    SULFAMETHOXAZOLE AND TRIMETHOPRIM
	
AB       AUROBINDO PHARMA        200MG/5ML;40MG/5ML              A091348 001 Jun 08, 2010

AB    + HI TECH PHARMA           200MG/5ML;40MG/5ML              A074650 001 Dec 29, 1997

AB       VINTAGE                 200MG/5ML;40MG/5ML              A077785 001 Jan 24, 2007

    SULFATRIM PEDIATRIC
	
AB       STI PHARMA LLC          200MG/5ML;40MG/5ML              N018615 001 Jan 07, 1983
	
  TABLET;ORAL

    BACTRIM
	
AB       MUTUAL PHARM            400MG;80MG                      N017377 001
	
    BACTRIM DS
	
AB    + MUTUAL PHARM             800MG;160MG                     N017377 002
	
    SEPTRA
	
AB       MONARCH PHARMS          400MG;80MG                      N017376 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-334(of 371)


SULFAMETHOXAZOLE; TRIMETHOPRIM
	
  TABLET;ORAL

    SEPTRA DS
	
AB       MONARCH PHARMS          800MG;160MG                   N017376 002
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM
	
AB       AMNEAL PHARMS NY        400MG;80MG                    A076899   001    Jan   27,   2005

AB                               800MG;160MG                   A076899   002    Jan   27,   2005

AB       AUROBINDO PHARMA        400MG;80MG                    A090624   001    Feb   16,   2010

AB                               800MG;160MG                   A090624   002    Feb   16,   2010

AB       GLENMARK GENERICS       400MG;80MG                    A090828   002    Dec   22,   2010

AB                               800MG;160MG                   A090828   001    Dec   22,   2010

AB       MUTUAL PHARM            800MG;160MG                   A071017   001    Aug   25,   1986

AB       VINTAGE                 400MG;80MG                    A078060   002    Jan   25,   2007

AB                               800MG;160MG                   A078060   001    Jan   25,   2007

AB       VISTA PHARMS            400MG;80MG                    A076817   001    Oct   07,   2005

AB                               800MG;160MG                   A076817   002    Oct   07,   2005

    SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
	
AB       TEVA                    800MG;160MG                   A070037 001 Jun 02, 1987

    SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH
	
AB       TEVA PHARMS             400MG;80MG                    A070030 001 Jun 02, 1987
	
SULFANILAMIDE
	
  CREAM;VAGINAL
	
    AVC
	
      + MEDA PHARMS               15%                          N006530 003 Jan 27, 1987
	
SULFASALAZINE
	
  SUSPENSION;ORAL
	
    AZULFIDINE
	
      + PHARMACIA AND UPJOHN      250MG/5ML                    A086983 001
	
  TABLET;ORAL

    AZULFIDINE
	
AB    + PHARMACIA AND UPJOHN      500MG                        N007073 001
	
    SULFASALAZINE
	
AB       VINTAGE PHARMS           500MG                        A040349 001 Jan 11, 2002

AB       WATSON LABS              500MG                        A085828 001
	
  TABLET, DELAYED RELEASE;ORAL

    AZULFIDINE EN-TABS
	
AB    + PHARMACIA AND UPJOHN      500MG                        N007073 002 Apr 06, 1983

    SULFASALAZINE
	
AB       VINTAGE PHARMS           500MG                        A075339 001 Jan 11, 2002
	
SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES
	
  FOR SUSPENSION;INTRAVENOUS
	
    LUMASON
	
      + BRACCO                  60.7MG/25MG                    N203684 001 Oct 15, 2014
	
SULINDAC
	
  TABLET;ORAL

    CLINORIL
	
AB    + MERCK                     200MG                        N017911 002
	
    SULINDAC
	
AB        EPIC PHARMA             150MG                        A072710   001    Mar   25,   1991

AB                                200MG                        A072711   001    Mar   25,   1991

AB        HERITAGE PHARMS INC     150MG                        A073262   002    Sep   06,   1991

AB                                200MG                        A073262   001    Sep   06,   1991

AB        MUTUAL PHARM            150MG                        A072050   001    Apr   17,   1991

AB                                200MG                        A072051   001    Apr   17,   1991

AB        MYLAN                   150MG                        A073039   002    Jun   22,   1993

AB                                200MG                        A073039   001    Jun   22,   1993

AB        WATSON LABS             150MG                        A071891   001    Apr   03,   1990

AB                                200MG                        A071795   001    Apr   03,   1990
	
SUMATRIPTAN
	
  SPRAY;NASAL
	
    IMITREX
	
      + GLAXOSMITHKLINE           5MG/SPRAY                    N020626 001 Aug 26, 1997

      +                           20MG/SPRAY                   N020626 003 Aug 26, 1997
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                                         3-335(of 371)


SUMATRIPTAN SUCCINATE
	
  INJECTABLE;SUBCUTANEOUS

     IMITREX STATDOSE
	
AB     + GLAXOSMITHKLINE
	          EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
	             N020080 003 Dec 23, 1996
	
     SUMATRIPTAN SUCCINATE
	
AB         DR REDDYS LABS INC
	     EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
              A090495 001 Jan 29, 2014

AB         SUN PHARMA GLOBAL
	      EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
	             A090358 001 Jun 21, 2011
	
     IMITREX
	
AP     + GLAXOSMITHKLINE
	          EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
	             N020080 001 Dec 28, 1992
	
     SUMATRIPTAN SUCCINATE
	
AP         AGILA SPECLTS
	          EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A203322   001    Apr   14,   2014

AP         AUROBINDO PHARMA LTD
	   EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A202758   001    Apr   23,   2013

AP         BEDFORD
	                EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A079123   001    Feb   06,   2009

AP         FRESENIUS KABI USA
	     EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A079242   001    Mar   02,   2009

AP         HIKMA FARMACEUTICA
	     EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A200183   001    Sep   16,   2013

AP         INJECTALIA
	             EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A090310   001    Aug   11,   2010

AP         PAR PHARM
	              EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A077332   001    Oct   09,   2009

AP         PAR STERILE PRODUCTS
	   EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A077871   001    Jul   09,   2009

AP         SAGENT AGILA
	           EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A090641   001    Jul   28,   2010

AP         SAGENT STRIDES
	         EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A090314   001    Jun   10,   2010

AP         TEVA PHARMS USA
	        EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
    A077907   001    Feb   06,   2009

AP         WOCKHARDT
	              EQ   6MG   BASE/0.5ML   (EQ   12MG   BASE/ML)
	   A078593   001    Feb   06,   2009
	
     ALSUMA
	
BX         MERIDIAN MEDCL
	         EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
	             N022377 001 Jun 29, 2010
	
     IMITREX STATDOSE
	
BX     + GLAXOSMITHKLINE
	          EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
	              N020080 002 Feb 01, 2006
	
     SUMAVEL DOSEPRO
	
BX     + ENDO VENTURES LTD
	        EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
               N022239 002 Nov 26, 2013
	
BX     +
	                          EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
	             N022239 001 Jul 15, 2009
	
  SYSTEM;IONTOPHORESIS
	
     ZECUITY
	
       + TEVA BRANDED PHARM
	       EQ 6.5MG BASE/4HR
	                               N202278 001 Jan 17, 2013
	
  TABLET;ORAL

     IMITREX
	
AB         GLAXOSMITHKLINE
	        EQ 25MG BASE
                                     N020132 002 Jun 01, 1995

AB
	                                EQ 50MG BASE
                                     N020132 003 Jun 01, 1995

AB     +
	                          EQ 100MG BASE
	                                   N020132 001 Jun 01, 1995
	
     SUMATRIPTAN SUCCINATE
	
AB         APOTEX INC
	             EQ   25MG BASE
                                   A200263   001    Jun   19,   2012

AB
	                                EQ   50MG BASE
                                   A200263   002    Jun   19,   2012

AB
	                                EQ   100MG BASE
                                  A200263   003    Jun   19,   2012

AB         AUROBINDO PHARMA
	       EQ   25MG BASE
                                   A078327   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A078327   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A078327   003    Aug   10,   2009

AB         DR REDDYS LABS INC
	     EQ   25MG BASE
                                   A076847   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A076847   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A076847   003    Aug   10,   2009

AB         HIKMA PHARMS
	           EQ   25MG BASE
                                   A078298   001    May   21,   2013

AB
	                                EQ   50MG BASE
                                   A078298   002    May   21,   2013

AB
	                                EQ   100MG BASE
                                  A078298   003    May   21,   2013

AB         MYLAN
	                  EQ   25MG BASE
                                   A077744   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A077744   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A077744   003    Aug   10,   2009

AB         ORCHID HLTHCARE
	        EQ   25MG BASE
                                   A078284   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A078284   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A078284   003    Aug   10,   2009

AB         RANBAXY
	                EQ   25MG BASE
                                   A076554   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A076554   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A076572   001    Feb   09,   2009

AB         SANDOZ
	                 EQ   25MG BASE
                                   A076976   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A076976   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A076976   003    Aug   10,   2009

AB         SUN PHARM INDS
	         EQ   25MG BASE
                                   A078295   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A078295   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
                                  A078295   003    Aug   10,   2009

AB         WATSON LABS
	            EQ   25MG BASE
                                   A076933   001    Aug   10,   2009

AB
	                                EQ   50MG BASE
                                   A076933   002    Aug   10,   2009

AB
	                                EQ   100MG BASE
	                                 A076933   003    Aug   10,   2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                      3-336(of 371)


SUNITINIB MALATE
	
  CAPSULE;ORAL

    SUNITINIB MALATE
	
AB       MYLAN PHARMS INC      EQ   12.5MG BASE                 A201275   001    Jan   30,   2014

AB                             EQ   25MG BASE                   A201275   002    Jan   30,   2014

AB                             EQ   37.5MG BASE                 A201275   003    Jan   30,   2014

AB                             EQ   50MG BASE                   A201275   004    Jan   30,   2014

    SUTENT
	
AB       CPPI CV               EQ   12.5MG BASE                 N021938   001    Jan   26,   2006

AB                             EQ   25MG BASE                   N021938   002    Jan   26,   2006

AB                             EQ   37.5MG BASE                 N021938   004    Mar   31,   2009

AB    +                        EQ   50MG BASE                   N021938   003    Jan   26,   2006
	
SUVOREXANT
	
  TABLET;ORAL
	
    BELSOMRA
	
         MERCK SHARP DOHME		   5MG                              N204569   001    Aug   13,   2014

                               10MG                             N204569   002    Aug   13,   2014

                               15MG                             N204569   003    Aug   13,   2014

     +                         20MG		                           N204569   004    Aug   13,   2014
	
TACROLIMUS
	
  CAPSULE;ORAL

    PROGRAF
	
AB       ASTELLAS               EQ 0.5MG BASE                   N050708 003 Aug 24, 1998

AB                              EQ 1MG BASE                     N050708 001 Apr 08, 1994

AB    +                         EQ 5MG BASE                     N050708 002 Apr 08, 1994

    TACROLIMUS
	
AB       ACCORD HLTHCARE        EQ 0.5MG BASE                   A091195   001    Aug   31,   2011

AB                              EQ 1MG BASE                     A091195   002    Aug   31,   2011

AB                              EQ 5MG BASE                     A091195   003    Aug   31,   2011

AB       DR REDDYS LABS LTD     EQ 0.5MG BASE                   A090509   001    May   12,   2010

AB                              EQ 1MG BASE                     A090509   002    May   12,   2010

AB                              EQ 5MG BASE                     A090509   003    May   12,   2010

AB       MYLAN                  EQ 0.5MG BASE                   A090596   001    Sep   17,   2010

AB                              EQ 1MG BASE                     A090596   002    Sep   17,   2010

AB                              EQ 5MG BASE                     A090596   003    Sep   17,   2010

AB       PANACEA BIOTEC LTD     EQ 0.5MG BASE                   A090802   001    Sep   28,   2012

AB                              EQ 1MG BASE                     A090802   002    Sep   28,   2012

AB                              EQ 5MG BASE                     A090802   003    Sep   28,   2012

AB       SANDOZ                 EQ 0.5MG BASE                   A065461   001    Aug   10,   2009

AB                              EQ 1MG BASE                     A065461   002    Aug   10,   2009

AB                              EQ 5MG BASE                     A065461   003    Aug   10,   2009

AB       STRIDES PHARMA         EQ 0.5MG BASE                   A090687   001    Jul   22,   2014

AB                              EQ 1MG BASE                     A090687   002    Jul   22,   2014

AB                              EQ 5MG BASE                     A090687   003    Jul   22,   2014
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    ASTAGRAF XL
	
         ASTELLAS               EQ 0.5MG BASE                   N204096 001 Jul 19, 2013
	
                                EQ 1MG BASE                     N204096 002 Jul 19, 2013
	
      +                         EQ 5MG BASE		                   N204096 003 Jul 19, 2013
	
  INJECTABLE;INJECTION
	
    PROGRAF
	
      + ASTELLAS                EQ 5MG BASE/ML                  N050709 001 Apr 08, 1994

  OINTMENT;TOPICAL

    PROTOPIC
	
AB    + ASTELLAS                0.03%                           N050777 001 Dec 08, 2000

AB    +                         0.1%                            N050777 002 Dec 08, 2000

    TACROLIMUS
	
AB       FOUGERA PHARMS INC     0.03%                           A200744 001 Sep 09, 2014

AB                              0.1%                            A200744 002 Sep 09, 2014
	
TADALAFIL
	
  TABLET;ORAL
	
    ADCIRCA
	
      + ELI LILLY CO           20MG                             N022332 001 May 22, 2009

    CIALIS
	
         LILLY		               2.5MG                            N021368   004    Jan   07,   2008
	
                               5MG                              N021368   001    Nov   21,   2003
	
                               10MG                             N021368   002    Nov   21,   2003
	
     +                         20MG		                           N021368   003    Nov   21,   2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-337(of 371)


TAFLUPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    ZIOPTAN
	
      + OAK PHARMS INC
	          0.0015%
	                     N202514 001 Feb 10, 2012
	
TALC
	
  AEROSOL, METERED;INTRAPLEURAL
	
    SCLEROSOL
	
       + BRYAN
	                 400MG/SPRAY
	                  N020587 001 Dec 24, 1997
	
  POWDER;INTRAPLEURAL
	
    TALC
	
       + BRYAN
	                 5GM/BOT
	                      N021388 001 Dec 15, 2003
	
TALIGLUCERASE ALFA
	
  POWDER;IV (INFUSION)

    ELELYSO
	
      + PFIZER
	                  200 UNITS/VIAL
	              N022458 001 May 01, 2012
	
TAMOXIFEN CITRATE
	
  SOLUTION;ORAL
	
    SOLTAMOX
	
         DARA BIOSCIENCES
	       EQ 10MG BASE/5ML
	            N021807 001 Oct 29, 2005
	
  TABLET;ORAL

    TAMOXIFEN CITRATE
AB       ACTAVIS LABS FL INC      EQ   10MG   BASE
             A070929   001    Feb   20,   2003

AB                                EQ   10MG   BASE
             A076179   001    Feb   20,   2003

AB                                EQ   20MG   BASE
             A070929   002    Feb   20,   2003

AB                                EQ   20MG   BASE
             A076179   002    Feb   20,   2003

AB       APOTEX                   EQ   10MG   BASE
             A090878   001    Sep   23,   2011

AB                                EQ   20MG   BASE
             A090878   002    Sep   23,   2011

AB       MYLAN                    EQ   10MG   BASE
             A074732   002    Feb   20,   2003

AB                                EQ   20MG   BASE
             A074732   001    Feb   20,   2003

AB       TEVA                     EQ   10MG   BASE
             A075797   001    Feb   20,   2003

AB    + TEVA PHARMS               EQ   20MG   BASE
	            A074858   001    Feb   20,   2003
	
TAMSULOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL

    FLOMAX
	
AB    + BOEHRINGER INGELHEIM
	    0.4MG
	                       N020579 001 Apr 15, 1997
	
    TAMSULOSIN HYDROCHLORIDE
	
AB       ANCHEN PHARMS
	          0.4MG
	                       A202010   001    Jan   04,   2013

AB       AUROBINDO PHARMA LTD
	   0.4MG
	                       A202433   001    Apr   30,   2013

AB       IMPAX LABS
	             0.4MG
	                       A090377   001    Mar   02,   2010

AB       MYLAN
	                  0.4MG
	                       A090408   001    Apr   27,   2010

AB       SANDOZ
	                 0.4MG
	                       A078015   001    Apr   27,   2010

AB       SUN PHARM INDS LTD
	     0.4MG
	                       A090931   001    Jul   15,   2010

AB       SYNTHON PHARMS
	         0.4MG
	                       A078801   001    Apr   27,   2010

AB       TEVA PHARMS
	            0.4MG
	                       A077630   001    Apr   27,   2010

AB       WOCKHARDT
	              0.4MG
	                       A078938   001    Apr   27,   2010

AB       ZYDUS PHARMS USA INC
	   0.4MG
	                       A078225   001    Apr   27,   2010
	
TAPENTADOL HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    NUCYNTA
	
      + JANSSEN PHARMS
	          EQ 20MG BASE/ML
	             N203794 001 Oct 15, 2012
	
  TABLET;ORAL
	
    NUCYNTA
	
         JANSSEN PHARMS
	       EQ 50MG BASE
	                  N022304 001 Nov 20, 2008
	
                                EQ 75MG BASE
	                  N022304 002 Nov 20, 2008
	
     +
	                        EQ 100MG BASE
	                 N022304 003 Nov 20, 2008
	
 TABLET, EXTENDED RELEASE;ORAL
	
   NUCYNTA ER
	
         JANSSEN PHARMS
	       EQ 50MG BASE
	                  N200533   001    Aug   25,   2011

                                EQ 100MG BASE
	                 N200533   002    Aug   25,   2011

                                EQ 150MG BASE
	                 N200533   003    Aug   25,   2011

                                EQ 200MG BASE
	                 N200533   004    Aug   25,   2011

     +
	                        EQ 250MG BASE
	                 N200533   005    Aug   25,   2011
	
TASIMELTEON
	
  CAPSULE;ORAL
	
    HETLIOZ
	
      + VANDA PHARMS INC
	        20MG
	                        N205677 001 Jan 31, 2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                 3-338(of 371)

TAVABOROLE
  SOLUTION;TOPICAL
    KERYDIN
      + ANACOR PHARMS INC       5%                             N204427 001 Jul 07, 2014
TAZAROTENE
  AEROSOL, FOAM;TOPICAL
    FABIOR
      + STIEFEL LABS INC        0.1%                           N202428 001 May 11, 2012
  CREAM;TOPICAL
    AVAGE
      + ALLERGAN                0.1%                           N021184 003 Sep 30, 2002
    TAZORAC
      + ALLERGAN                0.05%                          N021184 001 Sep 29, 2000
      +                         0.1%                           N021184 002 Sep 29, 2000
  GEL;TOPICAL
    TAZORAC
      + ALLERGAN                0.05%                          N020600 001 Jun 13, 1997
      +                         0.1%                           N020600 002 Jun 13, 1997
TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT
	
  INJECTABLE;INJECTION
	
    PULMOLITE
	
BS       JUBILANT DRAXIMAGE     N/A                            N017776 001
	
    TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT
	
BS       DRAXIMAGE              N/A                            N017881 001 Dec 30, 1987
	
TECHNETIUM TC-99M BICISATE KIT
	
  INJECTABLE;INJECTION
	
    NEUROLITE
	
         LANTHEUS MEDCL          N/A                           N020256 001 Nov 23, 1994
	
TECHNETIUM TC-99M DISOFENIN KIT
	
  INJECTABLE;INJECTION
	
    HEPATOLITE
	
         PHARMALUCENCE           N/A                           N018467 001 Mar 16, 1982
	
TECHNETIUM TC-99M EXAMETAZIME KIT
	
  INJECTABLE;INJECTION
	
    CERETEC
	
      + GE HEALTHCARE           N/A                            N019829 001 Dec 30, 1988
	
TECHNETIUM TC-99M MEBROFENIN KIT
	
  INJECTABLE;INJECTION

    CHOLETEC
	
AP    + BRACCO                  N/A                            N018963 001 Jan 21, 1987

    TECHNETIUM TC-99M MEBROFENIN
	
AP       PHARMALUCENCE          N/A                            A078242 001 Jan 29, 2008
	
TECHNETIUM TC-99M MEDRONATE
	
  INJECTABLE;INJECTION
	
    DRAXIMAGE MDP-25
	
      + JUBILANT DRAXIMAGE      N/A                            N018035 002 Feb 27, 2004
	
TECHNETIUM TC-99M MEDRONATE KIT
	
  INJECTABLE;INJECTION

    CIS-MDP
	
AP       PHARMALUCENCE           N/A                           N018124 001
	
    MDP-BRACCO
	
AP       BRACCO                  N/A                           N018107 001
	
TECHNETIUM TC-99M MERTIATIDE KIT
	
  INJECTABLE;INJECTION
	
    TECHNESCAN MAG3
	
      + MALLINCKRODT            N/A                            N019882 001 Jun 15, 1990
	
TECHNETIUM TC-99M OXIDRONATE KIT
	
  INJECTABLE;INJECTION
	
    TECHNESCAN
	
      + MALLINCKRODT            N/A                            N018321 001
	
TECHNETIUM TC-99M PENTETATE KIT
	
  INJECTABLE;INJECTION

    AN-DTPA
	
AP         JUBILANT DRAXIMAGE    N/A                           N017714 001
	
    DTPA
	
AP         DRAXIMAGE             N/A                           N018511 001 Dec 29, 1989
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                    3-339(of 371)


TECHNETIUM TC-99M PYROPHOSPHATE KIT
	
  INJECTABLE;INJECTION

    CIS-PYRO
AP       PHARMALUCENCE          N/A                             N019039 001 Jun 30, 1987
    TECHNESCAN PYP KIT
AP       MALLINCKRODT           N/A                             N017538 001
TECHNETIUM TC-99M RED BLOOD CELL KIT
	
  INJECTABLE;INJECTION
	
    ULTRATAG
	
         MALLINCKRODT           N/A                             N019981 001 Jun 10, 1991
	
TECHNETIUM TC-99M SESTAMIBI KIT
	
  INJECTABLE;INJECTION

    CARDIOLITE
	
AP    + LANTHEUS MEDCL            N/A                           N019785 001 Dec 21, 1990

    TECHNETIUM TC 99M SESTAMIBI
	
AP       CARDINAL HEALTH 414      N/A                           A078809 001 Apr 28, 2009

AP       DRAXIMAGE                N/A                           A078806 001 Apr 29, 2009

AP       PHARMALUCENCE            10-30mCi                      A079157 001 Jul 10, 2009

    TECHNETIUM TC-99M SESTAMIBI
	
AP       MALLINCKRODT             N/A                           A078098 001 Sep 22, 2008
	
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR
	
  SOLUTION;INTRAVENOUS
	
    TECHNELITE
	
      + LANTHEUS MEDCL            1-20 CI/GENERATOR             N017771 002 Feb 12, 2014
	
    ULTRA-TECHNEKOW FM
	
      + MALLINCKRODT              1-19 CI/GENERATOR             N017243 003 Feb 18, 2014
	
  SOLUTION;INTRAVENOUS, ORAL
	
    TECHNETIUM TC 99M GENERATOR
	
      + GE HEALTHCARE             68-2703mCi/GENERATOR          N017693 002 Dec 13, 2013
	
TECHNETIUM TC-99M SUCCIMER KIT
	
  INJECTABLE;INJECTION
	
    MPI DMSA KIDNEY REAGENT
	
         GE HEALTHCARE           N/A                            N017944 001 May 18, 1982
	
TECHNETIUM TC-99M SULFUR COLLOID KIT
	
  SOLUTION;INJECTION, ORAL
	
    AN-SULFUR COLLOID
	
      + PHARMALUCENCE           N/A                             N017858 001
	
TECHNETIUM TC-99M TETROFOSMIN KIT
	
  INJECTABLE;INJECTION
	
    MYOVIEW
	
      + GE HEALTHCARE           N/A                             N020372 001 Feb 09, 1996
	
    MYOVIEW 30ML
	
      + GE HEALTHCARE           N/A                             N020372 002 Jul 07, 2005
	
TECHNETIUM TC-99M TILMANOCEPT
	
  INJECTABLE;INJECTION
	
    LYMPHOSEEK KIT
	
      + NAVIDEA BIOPHARMS         N/A                           N202207 001 Mar 13, 2013
	
TEDIZOLID PHOSPHATE
	
  POWDER;IV (INFUSION)

    SIVEXTRO
	
      + CUBIST PHARMS INC         200MG/VIAL                    N205436 001 Jun 20, 2014
	
  TABLET;ORAL
	
    SIVEXTRO
	
      + CUBIST PHARMS INC         200MG                         N205435 001 Jun 20, 2014
	
TEDUGLUTIDE RECOMBINANT
	
  POWDER;SUBCUTANEOUS
	
    GATTEX KIT
	
      + NPS PHARMS INC            5MG/VIAL                      N203441 001 Dec 21, 2012
	
TELAPREVIR
	
  TABLET;ORAL
	
    INCIVEK
	
      + VERTEX PHARMS             375MG                         N201917 001 May 23, 2011
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-340(of 371)


TELAVANCIN HYDROCHLORIDE
	
  POWDER;IV (INFUSION)

    VIBATIV
	
         THERAVANCE BIOPHARMA   EQ 250MG BASE/VIAL             N022110 001 Sep 11, 2009

      +                         EQ 750MG BASE/VIAL             N022110 002 Sep 11, 2009
	
TELBIVUDINE
	
  TABLET;ORAL
	
    TYZEKA
	
      + NOVARTIS                600MG                          N022011 001 Oct 25, 2006
	
TELITHROMYCIN
	
  TABLET;ORAL
	
    KETEK
	
         SANOFI AVENTIS US      300MG                          N021144 002 Feb 09, 2005
	
      +                         400MG                          N021144 001 Apr 01, 2004
	
TELMISARTAN
	
  TABLET;ORAL

    MICARDIS
	
AB       BOEHRINGER INGELHEIM   20MG                           N020850 003 Apr 04, 2000

AB                              40MG                           N020850 001 Nov 10, 1998

AB    +                         80MG                           N020850 002 Nov 10, 1998

    TELMISARTAN
	
AB       ALEMBIC PHARMS LTD     20MG                           A202130   001    Jul   07,   2014

AB                              40MG                           A202130   002    Jul   07,   2014

AB                              80MG                           A202130   003    Jul   07,   2014

AB       GLENMARK GENERICS      20MG                           A090032   001    Jul   07,   2014

AB                              40MG                           A090032   002    Jul   07,   2014

AB                              80MG                           A090032   003    Jul   07,   2014

AB       MYLAN PHARMS INC       20MG                           A202397   001    Jul   07,   2014

AB                              40MG                           A202397   002    Jul   07,   2014

AB                              80MG                           A202397   003    Jul   07,   2014

AB       SANDOZ                 20MG                           A203867   001    Nov   03,   2014

AB                              40MG                           A203867   002    Nov   03,   2014

AB                              80MG                           A203867   003    Nov   03,   2014

AB       TORRENT PHARMS LTD     20MG                           A203171   001    Jul   07,   2014

AB                              40MG                           A203171   002    Jul   07,   2014

AB                              80MG                           A203171   003    Jul   07,   2014

AB       WATSON LABS            20MG                           A078710   001    Jan   08,   2014

AB                              40MG                           A078710   002    Jan   08,   2014

AB                              80MG                           A078710   003    Jan   08,   2014

AB       ZYDUS PHARMS USA INC   20MG                           A203325   001    Aug   26,   2014

AB                              40MG                           A203325   002    Aug   26,   2014

AB                              80MG                           A203325   003    Aug   26,   2014
	
TEMAZEPAM
	
  CAPSULE;ORAL

    RESTORIL
	
AB       MALLINCKRODT INC       7.5MG                          N018163   003 Oct 25, 1991

AB                              15MG                           N018163   001
	
AB                              22.5MG                         N018163   004 Nov 02, 2004

AB    +                         30MG                           N018163   002
	
    TEMAZEPAM
	
AB       ACTAVIS ELIZABETH      15MG                           A071638   001    Aug   07,   1987

AB                              30MG                           A071620   001    Aug   07,   1987

AB       MUTUAL PHARM           7.5MG                          A078581   001    Sep   08,   2009

AB                              22.5MG                         A071175   002    Sep   14,   2009

AB       MYLAN                  7.5MG                          A070920   002    May   21,   2010

AB                              15MG                           A070920   004    Jul   07,   1986

AB                              22.5MG                         A070920   003    Jun   12,   2009

AB                              30MG                           A070920   001    Jul   10,   1986

AB       NOVEL LABS INC         7.5MG                          A071457   002    Jun   22,   2012

AB                              15MG                           A071456   001    Apr   21,   1987

AB                              22.5MG                         A071457   003    Jun   22,   2012

AB                              30MG                           A071457   001    Apr   21,   1987

AB       SANDOZ                 15MG                           A071427   001    Jan   12,   1988

AB                              30MG                           A071428   001    Jan   12,   1988
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-341(of 371)


TEMOZOLOMIDE
	
  CAPSULE;ORAL

     TEMODAR
	
AB         MERCK SHARP DOHME
	    5MG
	                          N021029   001    Aug   11,   1999

AB
	                              20MG
	                         N021029   002    Aug   11,   1999

AB
	                              100MG
	                        N021029   003    Aug   11,   1999

AB
	                              140MG
	                        N021029   005    Oct   19,   2006

AB
	                              180MG
	                        N021029   006    Oct   19,   2006

AB     +
	                        250MG
	                        N021029   004    Aug   11,   1999
	
     TEMOZOLOMIDE
	
AB         BARR
	                 5MG
	                          A078879   001    Mar   01,   2010

AB
	                              20MG
	                         A078879   002    Mar   01,   2010

AB
	                              100MG
	                        A078879   003    Mar   01,   2010

AB
	                              140MG
	                        A078879   005    Mar   01,   2010

AB
	                              180MG
	                        A078879   006    Mar   01,   2010

AB
	                              250MG
	                        A078879   004    Mar   01,   2010

AB         SUN PHARMA GLOBAL
	    5MG
	                          A201742   001    Feb   12,   2014

AB
	                              20MG
	                         A201742   002    Feb   12,   2014

AB
	                              100MG
	                        A201742   003    Feb   12,   2014

AB
	                              140MG
	                        A201742   004    Feb   12,   2014

AB
	                              180MG
	                        A201742   005    Feb   12,   2014

AB
	                              250MG
	                        A201742   006    Feb   12,   2014
	
  POWDER;INTRAVENOUS
	
     TEMODAR
	
       + MERCK SHARP DOHME
	      100MG/VIAL
	                   N022277 001 Feb 27, 2009
	
TEMSIROLIMUS
	
  SOLUTION;INTRAVENOUS
	
    TORISEL
	
      + PF PRISM CV
	             25MG/ML (25MG/ML)
	            N022088 001 May 30, 2007
	
TENIPOSIDE
	
  INJECTABLE;INJECTION
	
    VUMON
	
      + HQ SPECLT PHARMA
	        10MG/ML
	                      N020119 001 Jul 14, 1992
	
TENOFOVIR DISOPROXIL FUMARATE
	
  POWDER;ORAL
	
    VIREAD
	
      + GILEAD SCIENCES INC
	     40MG/SCOOPFUL
	                N022577 001 Jan 18, 2012
	
  TABLET;ORAL
	
    VIREAD
	
         GILEAD SCIENCES INC
	    150MG
	                        N021356   002    Jan   18,   2012
	
                                  200MG
	                        N021356   003    Jan   18,   2012
	
                                  250MG
	                        N021356   004    Jan   18,   2012
	
      +
	                         300MG
	                        N021356   001    Oct   26,   2001
	
TERAZOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL

    TERAZOSIN HYDROCHLORIDE
	
AB       APOTEX                   EQ   1MG BASE
                 A075498   001    Apr   12,   2001

AB                                EQ   2MG BASE
                 A075498   002    Apr   12,   2001

AB                                EQ   5MG BASE
                 A075498   003    Apr   12,   2001

AB                                EQ   10MG BASE
                A075498   004    Apr   12,   2001

AB       IVAX SUB TEVA PHARMS     EQ   1MG BASE
                 A075614   002    Jan   30,   2001

AB                                EQ   2MG BASE
                 A075614   001    Jan   30,   2001

AB                                EQ   5MG BASE
                 A075614   003    Jan   30,   2001

AB                                EQ   10MG BASE
                A075614   004    Jan   30,   2001

AB       JUBILANT CADISTA         EQ   1MG BASE
                 A075317   001    Dec   20,   2004

AB                                EQ   2MG BASE
                 A075317   002    Dec   20,   2004

AB                                EQ   5MG BASE
                 A075317   003    Dec   20,   2004

AB                                EQ   10MG BASE
                A075317   004    Dec   20,   2004

AB       MYLAN                    EQ   1MG BASE
                 A075140   002    Feb   11,   2000

AB                                EQ   2MG BASE
                 A075140   003    Feb   11,   2000

AB                                EQ   5MG BASE
                 A075140   001    Feb   11,   2000

AB                                EQ   10MG BASE
                A075140   004    Feb   11,   2000

AB       SANDOZ                   EQ   1MG BASE
                 A074823   001    Mar   30,   1998

AB    +                           EQ   2MG BASE
                 A074823   002    Mar   30,   1998

AB                                EQ   5MG BASE
                 A074823   003    Mar   30,   1998

AB                                EQ   10MG BASE
	               A074823   004    Mar   30,   1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-342(of 371)


TERBINAFINE HYDROCHLORIDE
	
  GRANULE;ORAL
	
    LAMISIL
	
         NOVARTIS                 EQ 125MG BASE/PACKET         N022071 001 Sep 28, 2007

      +                           EQ 187.5MG BASE/PACKET       N022071 002 Sep 28, 2007

  TABLET;ORAL

    LAMISIL
	
AB    + NOVARTIS                  EQ 250MG BASE                N020539 001 May 10, 1996

    TERBINAFINE HYDROCHLORIDE
	
AB       APOTEX                   EQ   250MG   BASE            A078199   001    Jul   02,   2007

AB       AUROBINDO PHARMA         EQ   250MG   BASE            A078297   001    Jul   02,   2007

AB       BRECKENRIDGE PHARM       EQ   250MG   BASE            A077714   001    Jun   04,   2010

AB       CIPLA LTD                EQ   250MG   BASE            A077137   001    Jul   02,   2007

AB       DR REDDYS LABS INC       EQ   250MG   BASE            A076390   001    Jul   02,   2007

AB       GLENMARK GENERICS        EQ   250MG   BASE            A078157   001    Jul   02,   2007

AB       HARRIS PHARM             EQ   250MG   BASE            A077919   001    Jul   02,   2007

AB       INVAGEN PHARMS           EQ   250MG   BASE            A077533   001    Jul   02,   2007

AB       MYLAN                    EQ   250MG   BASE            A077195   001    Jul   02,   2007

AB       ORCHID HLTHCARE          EQ   250MG   BASE            A078163   001    Jul   02,   2007

AB       TEVA                     EQ   250MG   BASE            A076377   001    Jul   02,   2007

AB       WOCKHARDT                EQ   250MG   BASE            A078229   001    Jul   02,   2007
	
TERBUTALINE SULFATE
	
  INJECTABLE;INJECTION

    TERBUTALINE SULFATE
	
AP       AKORN                    1MG/ML                       A078151   001    Jan   07,   2008

AP    + BEDFORD                   1MG/ML                       A076770   001    Apr   23,   2004

AP       FRESENIUS KABI USA       1MG/ML                       A076887   001    May   26,   2004

AP       HIKMA FARMACEUTICA       1MG/ML                       A078630   001    May   20,   2009

AP       UNITED BIOMEDCL          1MG/ML                       A200122   001    Nov   08,   2013
	
  TABLET;ORAL

    TERBUTALINE SULFATE
	
AB       IMPAX LABS               2.5MG                        A075877   001    Jun   26,   2001

AB    +                           5MG                          A075877   002    Jun   26,   2001

AB       LANNETT                  2.5MG                        A077152   001    Mar   25,   2005

AB                                5MG                          A077152   002    Mar   25,   2005
	
TERCONAZOLE
	
  CREAM;VAGINAL

    TERAZOL 3
	
AB    + JANSSEN PHARMS            0.8%                         N019964 001 Feb 21, 1991

    TERAZOL 7
	
AB    + JANSSEN PHARMS            0.4%                         N019579 001 Dec 31, 1987

    TERCONAZOLE
	
AB       FOUGERA PHARMS           0.4%                         A076712   001    Feb   18,   2005

AB       TARO                     0.4%                         A076043   001    Jan   19,   2005

AB                                0.8%                         A075953   001    Apr   06,   2004

BX    + NYCOMED US                0.8%                         N021735   001    Oct   01,   2004
	
  SUPPOSITORY;VAGINAL

    TERAZOL 3
	
AB    + JANSSEN PHARMS            80MG                         N019641 001 May 24, 1988

    TERCONAZOLE
	
AB       PERRIGO NEW YORK         80MG                         A077149 001 Mar 17, 2006
	
TERIFLUNOMIDE
	
  TABLET;ORAL
	
    AUBAGIO
	
         SANOFI AVENTIS US        7MG                          N202992 001 Sep 12, 2012

      +                           14MG                         N202992 002 Sep 12, 2012
	
TERIPARATIDE RECOMBINANT HUMAN
	
  INJECTABLE;SUBCUTANEOUS
	
    FORTEO
	
      + LILLY                    0.6MG/2.4ML (0.25MG/ML)       N021318 002 Jun 25, 2008
	
TESAMORELIN ACETATE
	
  POWDER;SUBCUTANEOUS
	
    EGRIFTA
	
      + THERATECHNOLOGIES         EQ 1MG BASE/VIAL             N022505 001 Nov 10, 2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                         3-343(of 371)


TESTOSTERONE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    ANDRODERM
	
      + ACTAVIS LABS UT INC      2MG/24HR                           N020489 003 Oct 20, 2011
	
      +                          4MG/24HR                           N020489 004 Oct 20, 2011
	
  GEL;TRANSDERMAL

    ANDROGEL
	
AB       ABBVIE                  25MG/2.5GM PACKET                  N021015 001 Feb 28, 2000

AB    +                          50MG/5GM PACKET                    N021015 002 Feb 28, 2000

    TESTOSTERONE
	
AB       PERRIGO ISRAEL          25MG/2.5GM PACKET                  N203098 002 Jan 31, 2013

AB                               50MG/5GM PACKET                    N203098 003 Jan 31, 2013
	
    TESTIM
	
BX    + AUXILIUM PHARMS          1% (50MG/5GM PACKET)               N021454 001 Oct 31, 2002
	
    TESTOSTERONE
	
BX       TEVA PHARMS             25MG/2.5GM PACKET                  N202763 001 Feb 14, 2012
	
BX                               50MG/5GM PACKET                    N202763 002 Feb 14, 2012
	
    ANDROGEL
	
         ABBVIE                  1.62% (20.25MG/1.25GM PACKET)      N022309 002 Sep 07, 2012

      +                          1.62% (40.5MG/2.5GM PACKET)        N022309 003 Sep 07, 2012

    VOGELXO
	
         UPSHER SMITH            50MG/5GM PACKET                    N204399 002 Jun 04, 2014
	
  GEL, METERED;NASAL
	
    NATESTO
	
         ENDO VENTURES LTD       5.5MG/0.122GM ACTUATION            N205488 001 May 28, 2014

  GEL, METERED;TRANSDERMAL

    ANDROGEL
	
AB    + ABBVIE                   12.5MG/1.25GM ACTUATION            N021015 003 Sep 26, 2003

    TESTOSTERONE
	
AB       PERRIGO ISRAEL          12.5MG/1.25GM ACTUATION            N203098 001 Jan 31, 2013
	
    VOGELXO
	
BX       UPSHER SMITH            12.5MG/1.25GM ACTUATION            N204399 003 Jun 04, 2014
	
    ANDROGEL
	
      + ABBVIE                   1.62% (20.25MG/1.25GM ACTUATION)   N022309 001 Apr 29, 2011

    FORTESTA
	
      + ENDO PHARMS              10MG/0.5GM ACTUATION               N021463 001 Dec 29, 2010
	
  PELLET;IMPLANTATION
	
    TESTOPEL
	
      + ACTIENT PHARMS           75MG                               A080911 001
	
  SOLUTION, METERED;TRANSDERMAL
	
    AXIRON
	
      + ELI LILLY AND CO         30MG/1.5ML ACTUATION               N022504 001 Nov 23, 2010
	
  TABLET, EXTENDED RELEASE;BUCCAL
	
    STRIANT
	
      + AUXILIUM PHARMS LLC      30MG                               N021543 001 Jun 19, 2003
	
TESTOSTERONE CYPIONATE
	
  INJECTABLE;INJECTION

    DEPO-TESTOSTERONE
	
AO    + PHARMACIA AND UPJOHN    100MG/ML                            A085635 002
	
AO    +                         200MG/ML                            A085635 003
	
    TESTOSTERONE CYPIONATE
	
AO       BEDFORD                100MG/ML                            A090387   001     Jul   15,   2010

AO                              200MG/ML                            A090387   002     Jul   15,   2010

AO       HIKMA FARMACEUTICA     200MG/ML                            A091244   001     May   01,   2012

AO       MYLAN INSTITUTIONAL    200MG/ML                            A040652   001     Dec   11,   2006

AO       PADDOCK LLC            200MG/ML                            A040530   001     Jan   31,   2005

AO       SANDOZ                 100MG/ML                            A040615   001     Aug   10,   2006

AO                              200MG/ML                            A040615   002     Aug   10,   2006

AO       SUN PHARM INDS LTD     100MG/ML                            A201720   001     Jun   03,   2013

AO                              200MG/ML                            A201720   002     Jun   03,   2013

AO       WATSON LABS            200MG/ML                            A086030   001
	
TESTOSTERONE ENANTHATE
	
  INJECTABLE;INJECTION

    DELATESTRYL
	
AO    + ENDO PHARMS             200MG/ML                            N009165 003
	
    TESTOSTERONE ENANTHATE
	
AO       HIKMA FARMACEUTICA     200MG/ML                            A091120   001 Sep 18, 2012

AO       MYLAN INSTITUTIONAL    200MG/ML                            A040647   001 Oct 05, 2009

AO       PADDOCK LLC            200MG/ML                            A040575   001 Jun 14, 2006

AO       WATSON LABS            200MG/ML                            A085598   001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                       3-344(of 371)


TESTOSTERONE UNDECANOATE
	
  INJECTABLE;INTRAMUSCULAR
	
    AVEED
	
      + ENDO PHARMS INC		          750MG/3ML (250MG/ML)          N022219 001 Mar 04, 2014
	
TETRABENAZINE
	
  TABLET;ORAL
	
    XENAZINE
	
          VALEANT BERMUDA          12.5MG                        N021894 001 Aug 15, 2008

      +		                          25MG                          N021894 002 Aug 15, 2008
	
TETRACYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL

    ACHROMYCIN V
	
AB       HERITAGE PHARMS INC       250MG		                       N050278 003
	
AB                                 500MG		                       N050278 001
	
    TETRACYCLINE HYDROCHLORIDE
	
AB       IMPAX LABS                250MG                         A060469   001
AB                                 500MG                         A060469   003
AB       IVAX SUB TEVA PHARMS      250MG                         A060704   001
AB    +                            500MG                         A060704   002
AB       WATSON LABS               250MG                         A061837   001
AB                                 500MG                         A061837   002
         IMPAX LABS                100MG                         A060469   002
TETRAHYDROZOLINE HYDROCHLORIDE
	
  SOLUTION;NASAL
	
    TYZINE
	
      +		 FOUGERA PHARMS         0.05%                           A086576 002
	
                                 0.1%                            A086576 001
	
  SPRAY;NASAL
	
    TYZINE
	
      + FOUGERA PHARMS		         0.1%                            A086576 003
	
THALIDOMIDE
	
  CAPSULE;ORAL
	
    THALOMID
	
         CELGENE		                 50MG                          N020785   001    Jul   16,   1998
	
                                   100MG                         N020785   002    Jan   17,   2003
	
                                   150MG                         N020785   004    Jan   10,   2007
	
     +		                           200MG                         N020785   003    Jan   17,   2003
	
THALLOUS CHLORIDE TL-201
	
  INJECTABLE;INJECTION

    THALLOUS CHLORIDE TL 201
	
AP    + GE HEALTHCARE              1mCi/ML		                     N018110 002 Feb 27, 1996

AP    + LANTHEUS MEDCL             1mCi/ML		                     N017806 001
	
AP    + MALLINCKRODT               1mCi/ML		                     N018150 001
	
  INJECTABLE;INTRAVENOUS

    THALLOUS CHLORIDE TL 201
	
AP    + LANTHEUS MEDCL             2mCi/ML                       N017806 002 Oct 09, 1998
	
THEOPHYLLINE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    THEO-24
	
         ACTIENT PHARMS		       100MG                            A087942   001    Aug   22,   1983

                                200MG                            A087943   001    Aug   22,   1983

                                300MG                            A087944   001    Aug   22,   1983

      +                         400MG                            A081034   001    Feb   28,   1992
	
  INJECTABLE;INJECTION

    THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 40MG/100ML                       N019826 001 Aug 14, 1992

    THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
AP    + B BRAUN                 80MG/100ML                       N019826 002 Aug 14, 1992
    THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
AP    + B BRAUN                 160MG/100ML                      N019826 003 Aug 14, 1992
    THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER
AP    + B BRAUN                 320MG/100ML                      N019826 006 Aug 14, 1992
    THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
AP    + HOSPIRA INC             4MG/ML                           N019211   007    Dec   14,   1984
AP    +                         40MG/100ML                       N019211   001    Dec   14,   1984
AP    +                         160MG/100ML                      N019211   003    Dec   14,   1984
AP    +                         320MG/100ML                      N019211   006    Jan   20,   1988
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-345(of 371)


THEOPHYLLINE
	
  SOLUTION;ORAL

    THEOPHYLLINE
	
AA    + SILARX                   80MG/15ML                      A091156 001 Apr 13, 2011

AA       TRIS PHARMA INC         80MG/15ML                      A091586 001 Jun 15, 2012
	
  SOLUTION, ELIXIR;ORAL
	
    ELIXOPHYLLIN
	
      + SUN PHARM INDS INC       80MG/15ML                      A085186 001
	
  TABLET;ORAL
	
    THEOLAIR
	
      + MEDICIS                  125MG                          A086399 001
	
      +                          250MG                          A086399 002
	
  TABLET, EXTENDED RELEASE;ORAL

    THEOCHRON
	
AB       SUN PHARM INDS INC      100MG                          A088320 001 Feb 21, 1985

AB                               200MG                          A088321 001 Feb 21, 1985

    THEOPHYLLINE
	
AB       ALEMBIC LTD             300MG                          A090430   001     Oct   27,   2010

AB                               450MG                          A090430   002     Oct   27,   2010

AB       GLENMARK GENERICS       400MG                          A090355   001     Jul   13,   2010

AB                               600MG                          A090355   002     Jul   13,   2010

AB       NOSTRUM                 400MG                          A040595   001     Apr   21,   2006

AB    +                          600MG                          A040560   002     Apr   21,   2006

AB    + PLIVA                    100MG                          A089807   001     Apr   30,   1990

AB    +                          200MG                          A089808   001     Apr   30,   1990

AB                               300MG                          A089763   001     Apr   30,   1990

AB       RHODES PHARMS           600MG                          A040086   001     Apr   15,   1996

AB    + TEVA PHARMS              450MG                          A081236   001     Nov   09,   1992

    UNIPHYL
	
AB       RHODES PHARMS           400MG                          A087571 001 Sep 01, 1982
	
THIAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    THIAMINE HYDROCHLORIDE
	
AP    + FRESENIUS KABI USA         100MG/ML                     A080556 001
	
AP       MYLAN INSTITUTIONAL       100MG/ML                     A091623 001 Jun 25, 2012
	
THIOGUANINE
	
  TABLET;ORAL
	
    THIOGUANINE
	
      + ASPEN GLOBAL INC           40MG                         N012429 001
	
THIORIDAZINE HYDROCHLORIDE
	
  TABLET;ORAL

    THIORIDAZINE HYDROCHLORIDE
	
AB       MUTUAL PHARM              10MG                         A089953   004     Aug   01,   1986

AB                                 25MG                         A089953   003     Aug   01,   1986

AB                                 50MG                         A089953   002     Aug   01,   1986

AB                                 100MG                        A089953   001     Oct   07,   1988

AB       MYLAN                     10MG                         A088004   002     Mar   15,   1983

AB                                 25MG                         A088004   003     Mar   15,   1983

AB                                 50MG                         A088004   004     Mar   15,   1983

AB    +                            100MG                        A088004   001     Nov   18,   1983
	
THIOTEPA
	
  INJECTABLE;INJECTION
	
    THIOTEPA
	
          EUROHLTH INTL            15MG/VIAL                    A075547 001 Apr 02, 2001
	
THIOTHIXENE
	
  CAPSULE;ORAL

    NAVANE
	
AB       PFIZER                    1MG                          N016584   001
	
AB                                 2MG                          N016584   002
	
AB    +                            5MG                          N016584   003
	
AB                                 10MG                         N016584   004
	
    THIOTHIXENE
	
AB       MYLAN                     1MG                          A071093   002     Jun   23,   1987

AB                                 2MG                          A071093   003     Jun   23,   1987

AB                                 5MG                          A071093   004     Jun   23,   1987

AB                                 10MG                         A071093   001     Jun   23,   1987

AB       SANDOZ                    1MG                          A071610   001     Jun   24,   1987

AB                                 2MG                          A071570   001     Jun   24,   1987

AB                                 5MG                          A071529   001     Jun   24,   1987

AB                                 10MG                         A071530   001     Jun   24,   1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                    3-346(of 371)


THYROTROPIN ALFA
	
  INJECTABLE;INJECTION
	
    THYROGEN
	
      + GENZYME                   1.1MG/VIAL		                  N020898 001 Nov 30, 1998
	
TIAGABINE HYDROCHLORIDE
	
  TABLET;ORAL

    GABITRIL
	
AB       CEPHALON                 2MG                           N020646 005 Apr 16, 1999

AB    +                           4MG                           N020646 001 Sep 30, 1997

    TIAGABINE HYDROCHLORIDE
	
AB       SUN PHARM INDS           2MG                           A077555 001 Nov 04, 2011

AB                                4MG                           A077555 002 Nov 04, 2011
	
    GABITRIL
	
         CEPHALON                 12MG                          N020646 002 Sep 30, 1997

                                  16MG                          N020646 003 Sep 30, 1997
	
TICAGRELOR
	
  TABLET;ORAL
	
    BRILINTA
	
      + ASTRAZENECA LP            90MG		                        N022433 001 Jul 20, 2011
	
TICLOPIDINE HYDROCHLORIDE
	
  TABLET;ORAL

    TICLOPIDINE HYDROCHLORIDE
	
AB       APOTEX                   250MG                         A075089 001 Jul 01, 1999

AB       SUN PHARM INDS INC       250MG                         A075526 001 Sep 26, 2002

AB    + TEVA                      250MG                         A075149 001 Aug 20, 1999
	
TIGECYCLINE
	
  INJECTABLE;IV (INFUSION)

    TYGACIL
	
      + PF PRISM CV               50MG/VIAL                     N021821 001 Jun 15, 2005
	
TIMOLOL
	
  SOLUTION/DROPS;OPHTHALMIC

    BETIMOL
	
      + OAK PHARMS INC            EQ 0.25% BASE		               N020439 001 Mar 31, 1995
	
      +                           EQ 0.5% BASE		                N020439 002 Mar 31, 1995
	
TIMOLOL MALEATE
	
  SOLUTION, GEL FORMING/DROPS;OPHTHALMIC

    TIMOLOL MALEATE
	
AB       ALCON RES LTD          EQ 0.25% BASE                   N020963 001 Oct 21, 1998

AB                              EQ 0.5% BASE                    N020963 002 Oct 21, 1998

    TIMOPTIC-XE
	
AB    + VALEANT PHARMS LLC      EQ 0.25% BASE                   N020330 001 Nov 04, 1993

AB    +                         EQ 0.5% BASE                    N020330 002 Nov 04, 1993
	
  SOLUTION/DROPS;OPHTHALMIC

    TIMOLOL MALEATE
	
AT       AKORN                  EQ 0.5% BASE                    A074466   001    Mar   25,   1997

AT                              EQ 0.5% BASE                    A074516   001    Mar   25,   1997

AT       ALCON RES LTD          EQ 0.25% BASE                   A074261   001    Apr   28,   1995

AT                              EQ 0.5% BASE                    A074262   001    Apr   28,   1995

AT       BAUSCH AND LOMB        EQ 0.25% BASE                   A074778   001    Mar   25,   1997

AT                              EQ 0.5% BASE                    A074776   001    Mar   25,   1997

AT       FDC LTD                EQ 0.25% BASE                   A077259   001    Apr   30,   2008

AT                              EQ 0.5% BASE                    A077259   002    Apr   30,   2008

AT       HI TECH PHARMA         EQ 0.5% BASE                    A075163   001    Sep   10,   2002

AT       PACIFIC PHARMA         EQ 0.25% BASE                   A074746   001    Mar   25,   1997

AT                              EQ 0.5% BASE                    A074747   001    Mar   25,   1997

AT       WOCKHARDT              EQ 0.25% BASE                   A078771   001    Sep   28,   2009

AT                              EQ 0.5% BASE                    A078771   002    Sep   28,   2009

    TIMOPTIC
	
AT    + ATON                    EQ 0.25% BASE                   N018086 001
	
AT    +                         EQ 0.5% BASE                    N018086 002
	
    ISTALOL
	
BT    + BAUSCH AND LOMB         EQ 0.5% BASE                    N021516 001 Jun 04, 2004
	
    TIMOPTIC IN OCUDOSE
	
      + ATON                    EQ 0.25% BASE		                 N019463 001 Nov 05, 1986
	
      +                         EQ 0.5% BASE                    N019463 002 Nov 05, 1986
	
  TABLET;ORAL
	
    TIMOLOL MALEATE
	
         MYLAN		                5MG                             A072668 002 Jun 08, 1990
	
                                10MG                            A072668 003 Jun 08, 1990
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                PRESCRIPTION DRUG PRODUCT LIST
	                            3-347(of 371)


TIMOLOL MALEATE
	
  TABLET;ORAL
	
    TIMOLOL MALEATE
	
      +
	                          20MG
	                                   A072668 001 Jun 08, 1990
	
TINIDAZOLE
	
  TABLET;ORAL

     TINDAMAX
	
AB         MISSION PHARMA
	        250MG
	                                  N021618 001 May 17, 2004

AB     +
	                         500MG
	                                  N021618 002 May 17, 2004
	
     TINIDAZOLE
	
AB         NOVEL LABS INC
	        250MG
	                                  A202044   001    Apr   30,   2012

AB
	                               500MG
	                                  A202044   002    Apr   30,   2012

AB         ROXANE
	                250MG
	                                  A201172   001    Apr   30,   2012

AB
	                               500MG
	                                  A201172   002    Apr   30,   2012

AB         UNIQUE PHARM LABS
      250MG
	                                  A202489   001    Oct   09,   2013

AB
	                               500MG
	                                  A202489   002    Oct   09,   2013
	
TIOPRONIN
	
  TABLET;ORAL
	
    THIOLA
	
      + MISSION PHARMA
	           100MG
	                                  N019569 001 Aug 11, 1988
	
TIOTROPIUM BROMIDE
	
  POWDER;INHALATION
	
    SPIRIVA
	
      + BOEHRINGER INGELHEIM
	     EQ 0.018MG BASE/INH
	                    N021395 001 Jan 30, 2004
	
  SPRAY, METERED;INHALATION
	
    SPIRIVA RESPIMAT
	
      + BOEHRINGER INGELHEIM
	     EQ 0.0025MG BASE/INH
	                   N021936 001 Sep 24, 2014
	
TIPRANAVIR
	
  CAPSULE;ORAL
	
    APTIVUS
	
      + BOEHRINGER INGELHEIM
	     250MG
	                                  N021814 001 Jun 22, 2005
	
  SOLUTION;ORAL
	
    APTIVUS
	
      + BOEHRINGER INGELHEIM
	     100MG/ML
	                               N022292 001 Jun 23, 2008
	
TIROFIBAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    AGGRASTAT
	
          MEDICURE
	               EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML)
   N020913 002 May 17, 2002

      +
	                          EQ 12.5MG BASE/250ML (EQ 0.05MG
         N020913 003 Apr 20, 2000
	
                                   BASE/ML)
	
TIZANIDINE HYDROCHLORIDE
	
  CAPSULE;ORAL

     TIZANIDINE HYDROCHLORIDE
	
AB         APOTEX INC
	            EQ   2MG   BASE
                         A078868   001    Feb   03,   2012

AB
	                               EQ   4MG   BASE
                         A078868   002    Feb   03,   2012

AB
	                               EQ   6MG   BASE
                         A078868   003    Feb   03,   2012

AB         MYLAN PHARMS INC
	      EQ   2MG   BASE
                         A091502   001    Nov   09,   2012

AB
	                               EQ   4MG   BASE
                         A091502   002    Nov   09,   2012

AB
	                               EQ   6MG   BASE
	                        A091502   003    Nov   09,   2012
	
     ZANAFLEX
	
AB         ACORDA
	                EQ 2MG BASE
                             N021447 001 Aug 29, 2002

AB
	                               EQ 4MG BASE
                             N021447 002 Aug 29, 2002

AB     +
	                         EQ 6MG BASE
	                            N021447 003 Aug 29, 2002
	
  TABLET;ORAL

     TIZANIDINE HYDROCHLORIDE
	
AB         APOTEX
	                EQ   2MG   BASE
                         A076533   001    Jan   16,   2004

AB
	                               EQ   4MG   BASE
                         A076533   002    Jan   16,   2004

AB         COREPHARMA
	            EQ   2MG   BASE
                         A076347   001    Oct   11,   2002

AB
	                               EQ   4MG   BASE
                         A076347   002    Oct   11,   2002

AB         DR REDDYS LABS INC
	    EQ   2MG   BASE
                         A076286   001    Jul   03,   2002

AB
	                               EQ   4MG   BASE
                         A076286   002    Jul   03,   2002

AB         MYLAN
	                 EQ   2MG   BASE
                         A076354   001    Mar   28,   2003

AB
	                               EQ   4MG   BASE
                         A076354   002    Mar   28,   2003

AB         PROSAM LABS
	           EQ   2MG   BASE
                         A076281   001    Oct   20,   2003

AB
	                               EQ   4MG   BASE
                         A076281   002    Oct   20,   2003

AB         SANDOZ INC
	            EQ   2MG   BASE
                         A076280   001    Nov   26,   2002

AB
	                               EQ   4MG   BASE
                         A076280   002    Jun   27,   2002

AB         SUN PHARM INDS INC
	    EQ   2MG   BASE
                         A076416   001    Sep   29,   2003

AB
	                               EQ   4MG   BASE
                         A076416   002    Sep   29,   2003

AB         TEVA
	                  EQ   2MG   BASE
	                        A076284   001    Jul   03,   2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                              3-348(of 371)


TIZANIDINE HYDROCHLORIDE
	
  TABLET;ORAL

    TIZANIDINE HYDROCHLORIDE
	
AB                               EQ 4MG BASE                            A076284 002 Jul 03, 2002

AB       UNICHEM LABS LTD        EQ 2MG BASE                            A091283 001 Nov 28, 2012

AB                               EQ 4MG BASE                            A091283 002 Nov 28, 2012

    ZANAFLEX
	
AB    + ACORDA                   EQ 4MG BASE                            N020397 001 Nov 27, 1996
	
TOBRAMYCIN
	
  OINTMENT;OPHTHALMIC
	
    TOBREX
	
      + ALCON                    0.3%                                   N050555 001
	
  POWDER;INHALATION
	
    TOBI PODHALER
	
      + NOVARTIS                 28MG                                   N201688 001 Mar 22, 2013
	
  SOLUTION;INHALATION

    TOBI
	
AN    + NOVARTIS PHARMS          300MG/5ML                              N050753 001 Dec 22, 1997

    TOBRAMYCIN
	
AN         AKORN INC             300MG/5ML                              A201422 001 May 28, 2014

AN         TEVA PHARMS USA       300MG/5ML                              A091589 001 Oct 10, 2013
	
    BETHKIS
	
           CHIESI USA INC        300MG/4ML                              N201820 001 Oct 12, 2012
	
    KITABIS PAK
	
      + PULMOFLOW INC            300MG/5ML                              N205433 001 Dec 02, 2014
	
  SOLUTION/DROPS;OPHTHALMIC

    AKTOB
	
AT         AKORN                 0.3%                                   A064096 001 Jan 31, 1996

    TOBRAMYCIN
	
AT         BAUSCH AND LOMB       0.3%                                   A064052 001 Nov 29, 1993

AT         FERA PHARMS           0.3%                                   A065026 001 Sep 11, 2001

    TOBREX
	
AT         ALCON                 0.3%                                   A062535 001 Dec 13, 1984

AT    + FALCON PHARMS            0.3%                                   N050541 001
	
TOBRAMYCIN SULFATE
	
  INJECTABLE;INJECTION

    TOBRAMYCIN SULFATE
	
AP       AGILA SPECLTS          EQ 40MG BASE/ML                         A065407   001    Mar   11,   2008

AP       AKORN                  EQ 40MG BASE/ML                         A205179   001    Sep   16,   2014

AP       FRESENIUS KABI USA     EQ 1.2GM BASE/VIAL                      N050789   001    Jul   13,   2004

AP                              EQ 10MG BASE/ML                         A065122   001    Nov   29,   2002

AP    +                         EQ 40MG BASE/ML                         A065122   002    Nov   29,   2002

AP       HIKMA MAPLE            EQ 40MG BASE/ML                         A063117   001    Apr   26,   1991

AP    + HOSPIRA                 EQ 10MG BASE/ML                         A063112   001    Apr   30,   1991

AP                              EQ 40MG BASE/ML                         A063111   001    Apr   30,   1991

AP    +                         EQ 40MG BASE/ML                         A063116   001    May   18,   1992

AP       TEVA PHARMS USA        EQ 40MG BASE/ML                         A063100   001    Jan   30,   1992

AP    + X GEN PHARMS            EQ 1.2GM BASE/VIAL                      A065013   001    Aug   17,   2001

AP       XELLIA PHARMS APS      EQ 1.2GM BASE/VIAL                      A205685   001    Sep   16,   2014

    TOBRAMYCIN SULFATE (PHARMACY BULK)

AP       FRESENIUS KABI USA     EQ 40MG BASE/ML                         A065120 001 Nov 29, 2002
	
    TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
      + HOSPIRA                 EQ 1.2MG BASE/ML                        A063081 003 Jul 31, 1990
	
      +                         EQ 1.6MG BASE/ML                        A063081 006 Jun 02, 1993
	
      +                         EQ 80MG BASE/100ML                      A063081 001 Jul 31, 1990
	
TOFACITINIB CITRATE
	
  TABLET;ORAL
	
    XELJANZ
	
      + PF PRISM CV              EQ 5MG BASE                            N203214 001 Nov 06, 2012
	
TOLAZAMIDE
	
  TABLET;ORAL
	
    TOLAZAMIDE
	
         MYLAN PHARMS INC        250MG                                  A070259 001 Jan 02, 1986
	
      +                          500MG                                  A070259 003 Mar 17, 1986
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-349(of 371)


TOLBUTAMIDE
	
  TABLET;ORAL
	
    TOLBUTAMIDE
	
      + MYLAN PHARMS INC        500MG                          A086445 001
	
TOLCAPONE
	
  TABLET;ORAL
	
    TASMAR
	
      + VALEANT PHARMS LLC      100MG		                        N020697 001 Jan 29, 1998
	
TOLMETIN SODIUM
	
  CAPSULE;ORAL

    TOLMETIN SODIUM
	
AB       MYLAN                  EQ 400MG BASE                  A073393 001 May 27, 1993

AB    + TEVA                    EQ 400MG BASE                  A073290 001 Nov 27, 1991
	
  TABLET;ORAL

    TOLMETIN SODIUM
	
AB       MUTUAL PHARM           EQ 200MG BASE                  A073310 001 Nov 27, 1991

AB    + MYLAN                   EQ 600MG BASE                  A074473 001 Aug 30, 1994
	
TOLTERODINE TARTRATE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    DETROL LA
	
AB       PHARMACIA AND UPJOHN   2MG                            N021228 001 Dec 22, 2000

AB    +                         4MG                            N021228 002 Dec 22, 2000

    TOLTERODINE TARTRATE
	
AB       MYLAN PHARMS INC       2MG                            A201486 001 Oct 31, 2013

AB                              4MG                            A201486 002 Oct 31, 2013
	
  TABLET;ORAL

    DETROL
	
AB       PHARMACIA AND UPJOHN   1MG                            N020771 001 Mar 25, 1998

AB    +                         2MG                            N020771 002 Mar 25, 1998

    TOLTERODINE TARTRATE
	
AB       APOTEX CORP            1MG                            A200164   001    Sep   25,   2012

AB                              2MG                            A200164   002    Sep   25,   2012

AB       MYLAN PHARMS INC       1MG                            A202641   001    Nov   27,   2012

AB                              2MG                            A202641   002    Nov   27,   2012
	
TOLVAPTAN
	
  TABLET;ORAL
	
    SAMSCA
	
         OTSUKA AMERICA PHARM   15MG                           N022275 001 May 19, 2009

      +                         30MG		                         N022275 002 May 19, 2009
	
TOPIRAMATE
	
  CAPSULE;ORAL

    TOPAMAX
	
AB       JANSSEN PHARMS         15MG                           N020844 001 Oct 26, 1998

AB    +                         25MG                           N020844 002 Oct 26, 1998

    TOPIRAMATE
	
AB       MYLAN                  15MG                           A078418   001    Oct   14,   2009

AB                              25MG                           A078418   002    Oct   14,   2009

AB       TEVA                   15MG                           A076575   001    Apr   17,   2009

AB                              25MG                           A076575   002    Apr   17,   2009

AB       WATSON LABS            15MG                           A077868   001    Apr   15,   2009

AB                              25MG                           A077868   002    Apr   15,   2009

AB       ZYDUS PHARMS USA INC   15MG                           A078877   001    Oct   14,   2009

AB                              25MG                           A078877   002    Oct   14,   2009
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    QUDEXY XR
	
         UPSHER SMITH		         25MG                           N205122   001    Mar   11,   2014
	
                                50MG                           N205122   002    Mar   11,   2014
	
                                100MG                          N205122   003    Mar   11,   2014
	
                                150MG                          N205122   004    Mar   11,   2014
	
      +                         200MG                          N205122   005    Mar   11,   2014
	
    TROKENDI XR
	
         SUPERNUS PHARMS		      25MG                           N201635   001    Aug   16,   2013

                                50MG                           N201635   002    Aug   16,   2013

                                100MG                          N201635   003    Aug   16,   2013

      +                         200MG                          N201635   004    Aug   16,   2013

  TABLET;ORAL

    TOPAMAX
	
AB       JANSSEN PHARMS         25MG                           N020505 004 Dec 24, 1996

AB                              50MG                           N020505 005 Dec 24, 1996

AB    +                         100MG                          N020505 001 Dec 24, 1996
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST
	                     3-350(of 371)


TOPIRAMATE
  TABLET;ORAL
    TOPAMAX
AB                              200MG                          N020505 002 Dec 24, 1996
	
    TOPIRAMATE
AB       ACCORD HLTHCARE        25MG                           A076311   001    Mar   27,   2009

AB                              50MG                           A076311   002    Mar   27,   2009

AB                              100MG                          A076311   003    Mar   27,   2009

AB                              200MG                          A076311   004    Mar   27,   2009

AB       ACTIVIS TOTOWA LLC     25MG                           A078637   001    Feb   27,   2013

AB                              50MG                           A078637   002    Feb   27,   2013

AB                              100MG                          A078637   003    Feb   27,   2013

AB                              200MG                          A078637   004    Feb   27,   2013

AB       APOTEX INC             25MG                           A077733   001    Mar   27,   2009

AB                              50MG                           A077733   002    Mar   27,   2009

AB                              100MG                          A077733   003    Mar   27,   2009

AB                              200MG                          A077733   004    Mar   27,   2009

AB       AUROBINDO PHARMA       25MG                           A078462   001    Mar   27,   2009

AB                              50MG                           A078462   002    Mar   27,   2009

AB                              100MG                          A078462   003    Mar   27,   2009

AB                              200MG                          A078462   004    Mar   27,   2009

AB       CIPLA LTD              25MG                           A076343   001    Mar   27,   2009

AB                              50MG                           A076343   002    Mar   27,   2009

AB                              100MG                          A076343   003    Mar   27,   2009

AB                              200MG                          A076343   004    Mar   27,   2009

AB       GLENMARK GENERICS      25MG                           A077627   001    Mar   27,   2009

AB                              50MG                           A077627   002    Mar   27,   2009

AB                              100MG                          A077627   003    Mar   27,   2009

AB                              200MG                          A077627   004    Mar   27,   2009

AB       INVAGEN PHARMS         25MG                           A079162   001    Mar   27,   2009

AB                              50MG                           A079162   002    Mar   27,   2009

AB                              100MG                          A079162   003    Mar   27,   2009

AB                              200MG                          A079162   004    Mar   27,   2009

AB       LUPIN                  25MG                           A078410   001    Sep   11,   2013

AB                              50MG                           A078410   002    Sep   11,   2013

AB                              100MG                          A078410   003    Sep   11,   2013

AB                              200MG                          A078410   004    Sep   11,   2013

AB       MYLAN                  25MG                           A076314   001    Mar   27,   2009

AB                              50MG                           A076314   002    Mar   27,   2009

AB                              100MG                          A076314   003    Mar   27,   2009

AB                              200MG                          A076314   004    Mar   27,   2009

AB       RANBAXY                25MG                           A076327   001    Mar   27,   2009

AB                              100MG                          A076327   002    Mar   27,   2009

AB                              200MG                          A076327   003    Mar   27,   2009

AB       SUN PHARMA GLOBAL      25MG                           A090278   001    Mar   27,   2009

AB                              50MG                           A090278   002    Mar   27,   2009

AB                              100MG                          A090278   003    Mar   27,   2009

AB                              200MG                          A090278   004    Mar   27,   2009

AB       TEVA                   25MG                           A076317   001    Mar   27,   2009

AB                              50MG                           A076317   002    Mar   27,   2009

AB                              100MG                          A076317   003    Mar   27,   2009

AB                              200MG                          A076317   004    Mar   27,   2009

AB       TORRENT PHARMS         25MG                           A079153   001    Mar   27,   2009

AB                              50MG                           A079153   002    Mar   27,   2009

AB                              100MG                          A079153   003    Mar   27,   2009

AB                              200MG                          A079153   004    Mar   27,   2009

AB       UNICHEM LABS LTD       25MG                           A090162   001    Mar   27,   2009

AB                              50MG                           A090162   002    Mar   27,   2009

AB                              100MG                          A090162   003    Mar   27,   2009

AB                              200MG                          A090162   004    Feb   19,   2013

AB       UPSHER SMITH           25MG                           A078499   001    Jan   07,   2010

AB                              50MG                           A078499   002    Jan   07,   2010

AB                              100MG                          A078499   003    Jan   07,   2010

AB                              200MG                          A078499   004    Jan   07,   2010

AB       WOCKHARDT USA          25MG                           A090353   001    Sep   01,   2010

AB                              50MG                           A090353   002    Sep   01,   2010

AB                              100MG                          A090353   003    Sep   01,   2010

AB                              200MG                          A090353   004    Sep   01,   2010

AB       ZYDUS PHARMS USA INC   25MG                           A078235   001    Mar   27,   2009

AB                              50MG                           A078235   002    Mar   27,   2009

AB                              100MG                          A078235   003    Mar   27,   2009

AB                              200MG                          A078235   004    Mar   27,   2009
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST                           3-351(of 371)


TOPIRAMATE
	
  TABLET;ORAL

    TOPIRAMATE
	
AB       HIKMA PHARMS           25MG                               A091185   001    Nov   25,   2013

AB                              50MG                               A091185   002    Nov   25,   2013

AB                              100MG                              A091185   003    Nov   25,   2013

AB                              200MG                              A091185   004    Nov   25,   2013
	
TOPOTECAN HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    HYCAMTIN
	
         GLAXO WELLCOME         EQ 0.25MG BASE                     N020981 001 Oct 11, 2007
	
      +                         EQ 1MG BASE                        N020981 002 Oct 11, 2007
	
  INJECTABLE;INJECTION

    HYCAMTIN
	
AP    + GLAXOSMITHKLINE         EQ 4MG BASE/VIAL                   N020671 001 May 28, 1996

    TOPOTECAN HYDROCHLORIDE
	
AP       ACCORD HLTHCARE        EQ   4MG   BASE/VIAL               A202351   001    Jun   26,   2013

AP       ACTAVIS TOTOWA         EQ   4MG   BASE/VIAL               A090620   001    Dec   02,   2010

AP       CIPLA LTD              EQ   4MG   BASE/VIAL               A091199   001    Dec   01,   2010

AP       DR REDDYS LABS LTD     EQ   4MG   BASE/VIAL               A201191   001    Mar   09,   2011

AP       FRESENIUS KABI USA     EQ   4MG   BASE/VIAL               A091089   001    Nov   29,   2010

AP       INNOPHARMA LICENSING   EQ   4MG   BASE/VIAL               A201166   001    Aug   08,   2012

AP       ONCO THERAPIES LTD     EQ   4MG   BASE/VIAL               A091542   001    Aug   28,   2012

AP       SAGENT PHARMS          EQ   4MG   BASE/VIAL               A091284   001    Jan   26,   2011

AP       SUN PHARM INDS LTD     EQ   4MG   BASE/VIAL               A202203   001    Aug   29,   2013

  SOLUTION;INTRAVENOUS

    TOPOTECAN HYDROCHLORIDE
	
AP    + HOSPIRA INC             EQ 4MG BASE/4ML (EQ 1MG BASE/ML)   N200582 001 Feb 02, 2011

AP       TEVA PHARMS USA        EQ 4MG BASE/4ML (EQ 1MG BASE/ML)   N022453 001 Dec 20, 2012
	
TOREMIFENE CITRATE
	
  TABLET;ORAL
	
    FARESTON
	
      + PROSTRAKAN INC          EQ 60MG BASE                       N020497 001 May 29, 1997
	
TORSEMIDE
	
  INJECTABLE;INJECTION

    TORSEMIDE
	
AP    + EUROHLTH INTL           20MG/2ML     (10MG/ML)             A078007   001    Jun   11,   2008

AP    +                         50MG/5ML     (10MG/ML)             A078007   002    Jun   11,   2008

AP       LUITPOLD               20MG/2ML     (10MG/ML)             A090656   001    Apr   21,   2010

AP                              50MG/5ML     (10MG/ML)             A090656   002    Apr   21,   2010

  TABLET;ORAL

    DEMADEX
	
AB       MEDA PHARMS            5MG                                N020136   001    Aug   23,   1993

AB                              10MG                               N020136   002    Aug   23,   1993

AB    +                         20MG                               N020136   003    Aug   23,   1993

AB                              100MG                              N020136   004    Aug   23,   1993

    TORSEMIDE
	
AB       APOTEX INC             5MG                                A076894   001    May   31,   2005

AB                              10MG                               A076894   002    May   31,   2005

AB                              20MG                               A076894   003    May   31,   2005

AB                              100MG                              A076894   004    May   31,   2005

AB       AUROBINDO PHARMA       5MG                                A078249   001    Oct   17,   2007

AB                              10MG                               A078249   002    Oct   17,   2007

AB                              20MG                               A078249   003    Oct   17,   2007

AB                              100MG                              A078249   004    Oct   17,   2007

AB       HETERO LABS LTD III    5MG                                A079234   001    Jan   27,   2009

AB                              10MG                               A079234   002    Jan   27,   2009

AB                              20MG                               A079234   003    Jan   27,   2009

AB                              100MG                              A079234   004    Jan   27,   2009

AB       PAR PHARM              5MG                                A076226   001    May   27,   2003

AB                              10MG                               A076226   002    May   27,   2003

AB                              20MG                               A076226   003    May   27,   2003

AB                              100MG                              A076226   004    May   27,   2003

AB       PLIVA PHARM IND        5MG                                A076346   001    May   30,   2003

AB                              10MG                               A076346   002    May   30,   2003

AB                              20MG                               A076346   003    May   30,   2003

AB                              100MG                              A076346   004    Oct   19,   2004

AB       ROXANE                 5MG                                A076943   001    Mar   01,   2005

AB                              10MG                               A076943   002    Mar   01,   2005

AB                              20MG                               A076943   003    Mar   01,   2005

AB       SUN PHARM INDS         5MG                                A078478   001    Feb   26,   2008
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-352(of 371)


TORSEMIDE
	
  TABLET;ORAL

     TORSEMIDE
AB                               10MG
	                         A078478   002    Feb   26,   2008

AB                               20MG
	                         A078478   003    Feb   26,   2008

AB                               100MG
	                        A078478   004    Feb   26,   2008

AB        TEVA                   5MG
	                          A076110   001    May   14,   2002

AB                               10MG
	                         A076110   002    May   14,   2002

AB                               20MG
	                         A076110   003    May   14,   2002

AB                               100MG
	                        A076110   004    May   14,   2002

AB        VINTAGE PHARMS         5MG
	                          A090613   001    Mar   22,   2011

AB                               10MG
	                         A090613   002    Mar   22,   2011

AB                               20MG
	                         A090613   003    Mar   22,   2011

AB
	                             100MG
	                        A090613   004    Mar   22,   2011
	
TRAMADOL HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
     CONZIP
	
       + CIPHER PHARMS INC
	     100MG
	                        N022370   001    May   07,   2010

                                 150MG
	                        N022370   004    Aug   01,   2011

                                 200MG
	                        N022370   002    May   07,   2010

                                 300MG
	                        N022370   003    May   07,   2010
	
  TABLET;ORAL

     TRAMADOL HYDROCHLORIDE
	
AB        ACCORD HLTHCARE INC
	  50MG
	                         A202390   001    May   16,   2013

AB        ALLIED PHARMA INC
	    50MG
	                         A202075   001    Nov   28,   2011

AB        AMNEAL PHARMS
	        50MG
	                         A076003   001    Jun   20,   2002

AB        APOTEX
	               50MG
	                         A075981   001    Jul   10,   2002

AB        AUROBINDO PHARMA LTD
	 50MG
	                         A203494   001    Mar   31,   2014

AB        CSPC OUYI PHARM CO
	   50MG
	                         A091498   001    Mar   29,   2013

AB        IPCA LABS LTD
	        50MG
	                         A201973   001    Nov   16,   2012

AB        MALLINCKRODT
	         50MG
	                         A075983   001    Jun   25,   2002

AB        MUTUAL PHARM
	         50MG
	                         A076100   001    Jun   20,   2002

AB        MYLAN
	                50MG
	                         A075986   001    Jun   21,   2002

AB        MYLAN PHARMS INC
	     50MG
	                         A075980   001    Nov   21,   2002

AB        NORTHSTAR HLTHCARE
	   50MG
	                         A078935   001    May   26,   2010

AB        PLIVA
	                50MG
	                         A075982   001    Jul   01,   2002

AB        SUN PHARM INDS INC
	   50MG
	                         A075964   001    Jun   19,   2002

AB        TEVA
	                 50MG
	                         A075977   001    Jun   19,   2002

AB        ZYDUS PHARMS USA INC
	 50MG
	                         A090404   001    Jan   31,   2011
	
     ULTRAM
	
AB     + JANSSEN PHARMS
	        50MG
	                         N020281 002 Mar 03, 1995
	
  TABLET, EXTENDED RELEASE;ORAL

     TRAMADOL HYDROCHLORIDE
	
AB1       LUPIN LTD
	            100MG
	                        A200503   001    Aug   29,   2011

AB1
	                            200MG
	                        A200503   002    Aug   29,   2011

AB1
	                            300MG
	                        A200503   003    Aug   29,   2011

AB1       PAR PHARM INC
	        100MG
	                        A078783   001    Nov   13,   2009

AB1
	                            200MG
	                        A078783   002    Nov   13,   2009

AB1
	                            300MG
	                        A078783   003    Sep   20,   2011

AB1       SUN PHARMA GLOBAL
	    100MG
	                        A201384   001    Dec   07,   2011

AB1
	                            200MG
	                        A201384   002    Dec   07,   2011

AB1
	                            300MG
	                        A201384   003    Dec   07,   2011
	
     ULTRAM ER
	
AB1 + VALEANT INTL
	             100MG
	                        N021692 001 Sep 08, 2005

AB1
	                            200MG
	                        N021692 002 Sep 08, 2005

AB1
	                            300MG
	                        N021692 003 Sep 08, 2005
	
     TRAMADOL HYDROCHLORIDE
	
AB2       ACTAVIS ELIZABETH
	    100MG
	                        A091609   001    Jun   27,   2012

AB2
	                            200MG
	                        A091609   002    Jun   27,   2012

AB2
	                            300MG
	                        A091609   003    Jun   27,   2012

AB2       ANCHEN PHARMS
	        100MG
	                        A200491   001    Jun   27,   2012

AB2
	                            200MG
	                        A200491   002    Jun   27,   2012

AB2
	                            300MG
	                        A200491   003    Jun   27,   2012

AB2 + SUN PHARMA GLOBAL
	        100MG
	                        A091607   001    Dec   30,   2011

AB2
	                            200MG
	                        A091607   002    Dec   30,   2011

AB2
	                            300MG
	                        A091607   003    Dec   30,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                       3-353(of 371)


TRAMETINIB DIMETHYL SULFOXIDE
	
  TABLET;ORAL
	
    MEKINIST
	
         GLAXOSMITHKLINE LLC      EQ 0.5MG NON-SOLVATED PARENT   N204114 001 May 29, 2013

                                  EQ 1MG NON-SOLVATED PARENT     N204114 002 May 29, 2013

     +                            EQ 2MG NON-SOLVATED PARENT     N204114 003 May 29, 2013
	
TRANDOLAPRIL
	
  TABLET;ORAL

    MAVIK
	
AB       ABBVIE                   1MG                            N020528 001 Apr 26, 1996

AB                                2MG                            N020528 002 Apr 26, 1996

AB    +                           4MG                            N020528 003 Apr 26, 1996

    TRANDOLAPRIL
	
AB       AUROBINDO PHARMA         1MG                            A078438   001    Jun   12,   2007

AB                                2MG                            A078438   002    Jun   12,   2007

AB                                4MG                            A078438   003    Jun   12,   2007

AB       EPIC PHARMA              1MG                            A078508   003    Jun   18,   2008

AB                                2MG                            A078508   001    Jun   18,   2008

AB                                4MG                            A078508   002    Jun   18,   2008

AB       INVAGEN PHARMS           1MG                            A078320   001    Jun   12,   2007

AB                                2MG                            A078320   002    Jun   12,   2007

AB                                4MG                            A078320   003    Jun   12,   2007

AB       LUPIN                    1MG                            A077522   001    Jun   12,   2007

AB                                2MG                            A077522   002    Jun   12,   2007

AB                                4MG                            A077522   003    Jun   12,   2007

AB       MYLAN                    1MG                            A078346   001    Apr   28,   2008

AB                                2MG                            A078346   002    Apr   28,   2008

AB                                4MG                            A078346   003    Apr   28,   2008

AB       TEVA PHARMS              1MG                            A077489   001    Dec   12,   2006

AB                                2MG                            A077489   002    Dec   12,   2006

AB                                4MG                            A077489   003    Dec   12,   2006

AB       WATSON LABS              1MG                            A077805   001    Jun   12,   2007

AB                                2MG                            A077805   002    Jun   12,   2007

AB                                4MG                            A077805   003    Jun   12,   2007
	
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL

    TARKA
	
AB       ABBVIE                  1MG;240MG                       N020591   003    Oct   22,   1996

AB                               2MG;180MG                       N020591   001    Oct   22,   1996

AB                               2MG;240MG                       N020591   004    Oct   22,   1996

AB    +                          4MG;240MG                       N020591   002    Oct   22,   1996

    TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
	
AB       GLENMARK GENERICS       1MG;240MG                       A079135   004    Aug   30,   2010

AB                               2MG;180MG                       A079135   001    May   26,   2010

AB                               2MG;240MG                       A079135   002    May   26,   2010

AB                               4MG;240MG                       A079135   003    May   05,   2010
	
TRANEXAMIC ACID
	
  INJECTABLE;INJECTION

    CYKLOKAPRON
	
AP    + PHARMACIA AND UPJOHN      100MG/ML                       N019281 001 Dec 30, 1986

    TRANEXAMIC ACID
	
AP       ACIC FINE CHEMS          100MG/ML                       A202436   001    Feb   11,   2014

AP       EMCURE PHARMS LTD        100MG/ML                       A203521   001    Aug   12,   2014

AP       LUITPOLD                 100MG/ML                       A201885   001    Aug   10,   2011

AP       MYLAN INSTITUTIONAL      100MG/ML                       A091657   001    Nov   03,   2011

AP       VERSAPHARM INC           100MG/ML                       A202373   001    Nov   17,   2011

AP       X-GEN PHARMS INC         100MG/ML                       A201580   001    Jun   14,   2013
	
  TABLET;ORAL

    LYSTEDA
	
AB    + FERRING PHARMS AS         650MG                          N022430 001 Nov 13, 2009

    TRANEXAMIC ACID
	
AB       ACTAVIS LABS FL INC      650MG                          A202093 001 Dec 27, 2012

AB       APOTEX INC               650MG                          A202286 001 Jan 27, 2014
	
TRANYLCYPROMINE SULFATE
	
  TABLET;ORAL

    PARNATE
	
AB    + COVIS PHARMA              EQ 10MG BASE                   N012342 003 Aug 16, 1985

    TRANYLCYPROMINE SULFATE
	
AB       PAR PHARM                EQ 10MG BASE                   A040640 001 Jun 29, 2006
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-354(of 371)


TRAVOPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    IZBA
	
      + ALCON LABS INC          0.003%                         N204822 001 May 15, 2014

    TRAVATAN Z
	
      + ALCON PHARMS LTD        0.004%                         N021994 001 Sep 21, 2006

    TRAVOPROST
	
      + PAR PHARM               0.004%		                       A091340 001 Mar 01, 2013
	
TRAZODONE HYDROCHLORIDE
	
  TABLET;ORAL

    TRAZODONE HYDROCHLORIDE
	
AB        ALVOGEN                50MG                          A071636   001    Apr   18,   1988

AB                               100MG                         A071514   001    Apr   18,   1988

AB        APOTEX                 50MG                          A071258   001    Mar   25,   1987

AB    + APOTEX INC               100MG                         A071196   001    Mar   25,   1987

AB                               150MG                         A071196   002    Apr   26,   1999

AB                               300MG                         A071196   003    Apr   26,   1999

AB        MUTUAL PHARM           50MG                          A073137   002    Mar   24,   1993

AB                               100MG                         A073137   001    Mar   24,   1993

AB                               150MG                         A073137   003    Dec   22,   1995

AB        MYLAN PHARMS INC       50MG                          A090514   001    Jun   02,   2009

AB                               100MG                         A090514   002    Jun   02,   2009

AB                               150MG                         A090514   003    Jun   02,   2009

AB                               300MG                         A090514   004    Jun   02,   2009

AB        PLIVA                  150MG                         A071525   001    Mar   09,   1988

AB        TEVA PHARMS USA        50MG                          A071523   001    Dec   11,   1987

AB                               100MG                         A071524   001    Dec   11,   1987

AB        TORRENT PHARMS LTD     50MG                          A202180   001    Nov   27,   2013

AB                               100MG                         A202180   002    Nov   27,   2013

AB                               150MG                         A202180   003    Nov   27,   2013

AB                               300MG                         A202180   004    Nov   27,   2013

AB        VINTAGE                50MG                          A072192   001    Feb   02,   1989

AB                               100MG                         A072193   001    Feb   02,   1989
	
  TABLET, EXTENDED RELEASE;ORAL
	
    OLEPTRO
	
      +		 ANGELINI PHARMA        150MG                         N022411 001 Feb 02, 2010
	
                                 300MG                         N022411 002 Feb 02, 2010
	
TREPROSTINIL
	
  INJECTABLE;IV (INFUSION), SUBCUTANEOUS

    REMODULIN
	
         UNITED THERAP		        1MG/ML                         N021272   001    May   21,   2002

                                2.5MG/ML                       N021272   002    May   21,   2002

                                5MG/ML                         N021272   003    May   21,   2002

      +                         10MG/ML		                      N021272   004    May   21,   2002

  SOLUTION;INHALATION
	
    TYVASO
	
      + UNITED THERAP           0.6MG/ML		                     N022387 001 Jul 30, 2009
	
TREPROSTINIL DIOLAMINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ORENITRAM
	
         UNITED THERAP		         EQ   0.125MG BASE             N203496   001    Dec   20,   2013
	
                                 EQ   0.25MG BASE              N203496   002    Dec   20,   2013
	
                                 EQ   1MG BASE                 N203496   003    Dec   20,   2013
	
      +                          EQ   2.5MG BASE		             N203496   004    Dec   20,   2013
	
TRETINOIN
	
  CAPSULE;ORAL

    TRETINOIN
	
AB       ANCHEN PHARMS          10MG                           A201687 001 Oct 24, 2012

AB    + BARR LABS INC           10MG                           A077684 001 Jun 22, 2007
	
  CREAM;TOPICAL

    AVITA
	
AB       MYLAN PHARMS INC       0.025%                         N020404 003 Jan 14, 1997

    RETIN-A
	
AB    + VALEANT BERMUDA         0.025%                         N019049 001 Sep 16, 1988

AB    +                         0.1%                           N017340 001
	
    TRETINOIN
	
AB       MATAWAN PHARMS         0.025%                         A075264 001 Dec 24, 1998

AB                              0.1%                           A075213 001 Dec 24, 1998

    RETIN-A
	
AB1 + VALEANT BERMUDA           0.05%                          N017522 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST                     3-355(of 371)


TRETINOIN
	
  CREAM;TOPICAL

    TRETINOIN
	
AB1      MATAWAN PHARMS         0.05%                          A075265 001 Dec 24, 1998

    RENOVA
	
AB2 + VALEANT INTL              0.05%                          N019963 001 Dec 29, 1995

    TRETINOIN
	
AB2      SUNEVA MEDCL           0.05%                          A076498 001 Sep 15, 2005

    RENOVA
	
      + VALEANT INTL            0.02%                          N021108 001 Aug 31, 2000

    TRETINOIN
	
      + WATSON LABS INC         0.0375%                        A090098 001 Mar 22, 2010
	
                                0.075%                         A202209 001 Oct 11, 2012
	
  GEL;TOPICAL

    RETIN-A
	
AB    + VALEANT INTL            0.01%                          N017955 001
	
AB    +                         0.025%                         N017579 002
	
    RETIN-A MICRO
	
AB    + VALEANT INTL            0.04%                          N020475 002 May 10, 2002

AB    +                         0.1%                           N020475 001 Feb 07, 1997

    TRETINOIN
	
AB       MATAWAN PHARMS         0.01%                          A075589   001     Jun   11,   2002

AB                              0.025%                         A075529   001     Feb   22,   2000

AB       SPEAR PHARMS INC       0.04%                          A202567   001     Jul   17,   2013

AB                              0.1%                           A202026   001     Jul   17,   2013
	
    AVITA
	
BT       MYLAN                  0.025%                         N020400 001 Jan 29, 1998
	
    ATRALIN
	
      + DOW PHARM               0.05%                          N022070 001 Jul 26, 2007
	
    RETIN-A-MICRO
	
      + VALEANT INTL            0.08%                          N020475 003 Jan 28, 2014
	
  SOLUTION;TOPICAL
	
    RETIN-A
	
      + VALEANT INTL            0.05%                          N016921 001
	
TRIAMCINOLONE ACETONIDE
	
  CREAM;TOPICAL

    TRIAMCINOLONE ACETONIDE
	
AT    + FOUGERA PHARMS          0.025%                         A085692   001
	
AT    +                         0.1%                           A085692   003
	
AT    +                         0.5%                           A085692   002
	
AT       PERRIGO NEW YORK       0.025%                         A086415   001
	
AT                              0.1%                           A086414   001
	
AT                              0.5%                           A086413   001
	
AT       TARO                   0.1%                           A040039   001 Nov 26, 1997

AT       VINTAGE                0.025%                         A040671   001 Jun 09, 2006

AT                              0.1%                           A040671   002 Jun 09, 2006

    TRIDERM
	
AT       CROWN LABS             0.1%                           A088042 001 Mar 19, 1984
	
  INJECTABLE;INJECTION
	
    KENALOG-10
	
         APOTHECON              10MG/ML                        N012041 001
	
    KENALOG-40
	
      + APOTHECON               40MG/ML                        N014901 001
	
  INJECTABLE;INTRAVITREAL
	
    TRIESENCE
	
      + ALCON                   40MG/ML (40MG/ML)              N022048 001 Nov 29, 2007
	
  LOTION;TOPICAL

    TRIAMCINOLONE ACETONIDE
	
AT       FOUGERA PHARMS         0.025%                         A040467   001     Apr   21,   2003

AT                              0.1%                           A040467   002     Apr   21,   2003

AT       VERSAPHARM INC         0.025%                         A202374   001     May   08,   2013

AT                              0.1%                           A202374   002     May   08,   2013

AT       VINTAGE                0.1%                           A040672   002     Dec   13,   2006

AT    + WOCKHARDT               0.1%                           A088451   001     Apr   03,   1985

AT    + WOCKHARDT EU OPERATN    0.025%                         A088450   001     Apr   01,   1985

  OINTMENT;TOPICAL

    TRIAMCINOLONE ACETONIDE
	
AT       FOUGERA PHARMS         0.025%                         A085691   001
	
AT                              0.1%                           A085691   003
	
AT                              0.5%                           A085691   002
	
AT    + PERRIGO NEW YORK        0.025%                         A087356   001
	
AT    +                         0.1%                           A087357   001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                    3-356(of 371)


TRIAMCINOLONE ACETONIDE
	
  OINTMENT;TOPICAL

    TRIAMCINOLONE ACETONIDE
AT    +                         0.5%                             A087385 001
	
AT       TARO                   0.1%                             A040037 001 Sep 30, 1994
	
    TRIAMCINOLONE ACETONIDE IN ABSORBASE
      + CAROLINA MEDCL
	        0.05%
	                          A089595 001 Mar 23, 1995
	
  PASTE;DENTAL

    TRIAMCINOLONE ACETONIDE
	
AT       LYNE
	                 0.1%
	                           A040771 001 Jul 01, 2010

AT    + TARO
	                  0.1%
	                           A070730 001 Oct 01, 1986
	
  SPRAY;TOPICAL
	
    KENALOG
	
      + RANBAXY
	               0.147MG/GM
	                     N012104 001
	
  SPRAY, METERED;NASAL
	
    TRIAMCINOLONE ACETONIDE
	
         TEVA PHARMS
	          0.055MG/SPRAY
	                  A078104 001 Jul 30, 2009
	
TRIAMCINOLONE HEXACETONIDE
	
  INJECTABLE;INJECTION
	
    ARISTOSPAN
	
      + SANDOZ
	                    5MG/ML
                      N016466 001
	
      +
	                           20MG/ML
	                    N016466 002
	
TRIAMTERENE
	
  CAPSULE;ORAL
	
    DYRENIUM
	
          COVIS PHARMA SARL
	       50MG
	                       N013174 001
	
      +
	                           100MG
	                      N013174 002
	
TRIAZOLAM
	
  TABLET;ORAL

     HALCION
	
AB         PHARMACIA AND UPJOHN
	   0.125MG
	                    N017892 003 Apr 26, 1985

AB     +
	                          0.25MG
	                     N017892 001 Nov 15, 1982
	
     TRIAZOLAM
	
AB         MYLAN PHARMS INC
	       0.125MG
	                    A074031   001     Mar   25,   1994

AB
	                                0.25MG
	                     A074031   002     Mar   25,   1994

AB         ROXANE
	                 0.125MG
	                    A074224   001     Jun   01,   1994

AB
	                                0.25MG
	                     A074224   002     Jun   01,   1994
	
TRIENTINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    SYPRINE
	
      + ATON
	                      250MG
	                      N019194 001 Nov 08, 1985
	
TRIFLUOPERAZINE HYDROCHLORIDE
	
  TABLET;ORAL

    TRIFLUOPERAZINE HYDROCHLORIDE
	
AB       MYLAN                  EQ         1MG BASE
             A040209   001     Jul   07,   1997

AB                              EQ         2MG BASE
             A040209   002     Jul   07,   1997

AB                              EQ         5MG BASE
             A040209   003     Jul   07,   1997

AB    +                         EQ         10MG BASE
            A040209   004     Jul   07,   1997

AB       SANDOZ                 EQ         1MG BASE
             A085785   001
	
AB                              EQ         2MG BASE
             A085786   001
	
AB                              EQ         5MG BASE
             A085789   001
	
AB                              EQ         10MG BASE
	           A085788   001
	
TRIFLURIDINE
	
  SOLUTION/DROPS;OPHTHALMIC

    TRIFLURIDINE
	
AT       ALCON PHARMS LTD           1%
	                         A074311 001 Oct 06, 1995
	
    VIROPTIC
	
AT    + MONARCH PHARMS              1%
	                         N018299 001
	
TRIHEXYPHENIDYL HYDROCHLORIDE
	
  ELIXIR;ORAL

    TRIHEXYPHENIDYL HYDROCHLORIDE
	
AA       MIKART                 2MG/5ML
                         A040251 001 Sep 27, 1999

AA    + PHARM ASSOC             2MG/5ML
                         A040177 001 Apr 17, 1997
	
  TABLET;ORAL

    TRIHEXYPHENIDYL HYDROCHLORIDE
	
AA       NATCO PHARMA LTD       2MG
	                            A091630   001     Nov   17,   2010

AA                              5MG
	                            A091630   002     Nov   17,   2010

AA       VINTAGE PHARMS         2MG
	                            A040254   001     Dec   24,   1998

AA                              5MG
	                            A040254   002     Dec   24,   1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST
	               3-357(of 371)


TRIHEXYPHENIDYL HYDROCHLORIDE
	
  TABLET;ORAL

    TRIHEXYPHENIDYL HYDROCHLORIDE
	
AA    + WATSON LABS             2MG
	                            A084363 001
	
AA    +                         5MG
	                            A084364 001
	
TRIMETHADIONE
	
  TABLET;ORAL
	
    TRIDIONE
	
      + ABBVIE                   150MG
	                         N005856 009
	
TRIMETHOBENZAMIDE HYDROCHLORIDE
	
  CAPSULE;ORAL

    TIGAN
	
AB    + KING PHARMS              300MG
	                         N017531 006 Dec 13, 2001
	
    TRIMETHOBENZAMIDE HYDROCHLORIDE
	
AB       GAVIS PHARMS            300MG
	                         A076546 001 Aug 20, 2003

AB       MUTUAL PHARMA           300MG
	                         A076570 001 Aug 28, 2003
	
  INJECTABLE;INJECTION

    TIGAN
	
AP    + PAR STERILE PRODUCTS     100MG/ML
                       N017530 001
	
    TRIMETHOBENZAMIDE HYDROCHLORIDE
	
AP       LUITPOLD                100MG/ML
                       A091330 001 Mar 08, 2011
	
    TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE
	
AP       LUITPOLD
	              100MG/ML
	                      A091329 001 Mar 08, 2011
	
TRIMETHOPRIM
	
  TABLET;ORAL

    TRIMETHOPRIM
	
AB       NOVEL LABS INC          100MG
	                         A091437 001 Jun 15, 2011

AB    + TEVA                     100MG
	                         N018679 001 Jul 30, 1982

AB       WATSON LABS             100MG
	                         A070049 001 Jun 06, 1985
	
TRIMETHOPRIM HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    PRIMSOL
	
      + FSC
	                    EQ 50MG BASE/5ML
	              N074973 001 Jan 24, 2000
	
TRIMIPRAMINE MALEATE
	
  CAPSULE;ORAL

     SURMONTIL
	
AB         ODYSSEY PHARMS
	      EQ 25MG BASE
                   N016792 001
	
AB
	                             EQ 50MG BASE
                   N016792 002
	
AB     +
	                       EQ 100MG BASE
	                 N016792 003 Sep 15, 1982
	
     TRIMIPRAMINE MALEATE
	
AB         MIKAH PHARMA
	        EQ 25MG BASE
                   A077361 001 Aug 02, 2006

AB
	                             EQ 50MG BASE
                   A077361 002 Aug 02, 2006

AB
	                             EQ 100MG BASE
	                 A077361 003 Aug 02, 2006
	
TRIPTORELIN PAMOATE
	
  INJECTABLE;INTRAMUSCULAR
	
    TRELSTAR
	
      + WATSON LABS
	            EQ 3.75MG BASE/VIAL
            N020715 001 Jun 15, 2000
	
      +
	                        EQ 11.25MG BASE/VIAL
           N021288 001 Jun 29, 2001
	
      +
	                        EQ 22.5MG BASE/VIAL
	           N022437 001 Mar 10, 2010
	
TROMETHAMINE
	
  INJECTABLE;INJECTION
	
    THAM
	
      + HOSPIRA
	                3.6GM/100ML
	                   N013025 002
	
TROPICAMIDE
	
  SOLUTION/DROPS;OPHTHALMIC

     MYDRIACYL
	
AT     + ALCON
	                 0.5%
	                          A084305 001
	
AT     +
	                       1%
	                            A084306 001
	
     TROPICACYL
	
AT         AKORN
	               0.5%
	                          A040314 001 Sep 29, 2000

AT
	                             1%
	                            A040315 001 Sep 29, 2000
	
     TROPICAMIDE
	
AT         BAUSCH AND LOMB
	     0.5%
	                          A040067 001 Jul 27, 1994

AT
	                             1%
	                            A040064 001 Jul 27, 1994
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              PRESCRIPTION DRUG PRODUCT LIST                      3-358(of 371)


TROSPIUM CHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    SANCTURA XR
	
AB    + ALLERGAN                60MG                              N022103 001 Aug 03, 2007

    TROSPIUM CHLORIDE
	
AB       ACTAVIS LABS FL INC    60MG                              A091289 001 Oct 12, 2012

AB       PADDOCK LLC            60MG                              A201291 001 May 24, 2013

  TABLET;ORAL

    SANCTURA
	
AB    + ALLERGAN                20MG                              N021595 001 May 28, 2004

    TROSPIUM CHLORIDE
	
AB       APOTEX                 20MG                              A091513 001 Dec 06, 2011

AB       GLENMARK GENERICS      20MG                              A091575 001 Aug 13, 2010

AB       PADDOCK LLC            20MG                              A091573 001 Nov 17, 2010
	
TRYPAN BLUE
	
  SOLUTION;OPHTHALMIC
	
    MEMBRANEBLUE
	
      + DORC                     0.15%                            N022278 001 Feb 20, 2009
	
    VISIONBLUE
	
      + DORC                     0.06%		                          N021670 001 Dec 16, 2004
	
ULIPRISTAL ACETATE
	
  TABLET;ORAL
	
    ELLA
	
      + LAB HRA PHARMA           30MG		                           N022474 001 Aug 13, 2010
	
UMECLIDINIUM BROMIDE
	
  POWDER;INHALATION
	
    INCRUSE ELLIPTA
	
      + GLAXO GRP ENGLAND        EQ 62.5MCG BASE/INH		            N205382 001 Apr 30, 2014
	
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
	
  POWDER;INHALATION
	
    ANORO ELLIPTA
	
      +		 GLAXOSMITHKLINE       EQ 0.0625MG BASE/INH;EQ 0.025MG   N203975 001 Dec 18, 2013

                                BASE/INH
	
UNOPROSTONE ISOPROPYL
	
  SOLUTION/DROPS;OPHTHALMIC

    RESCULA
	
      + SUCAMPO PHARMS           0.15%		                          N021214 001 Aug 03, 2000
	
UREA, C-14
	
  CAPSULE;ORAL
	
    PYTEST
	
      + AVENT                    1uCi                             N020617 001 May 09, 1997

    PYTEST KIT
	
      + AVENT                    1uCi		                           N020617 002 May 09, 1997
	
UROFOLLITROPIN
	
  INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
	
    BRAVELLE
	
      + FERRING                 75 IU/VIAL		                      N021289 001 May 06, 2002
	
URSODIOL
	
  CAPSULE;ORAL

    ACTIGALL
	
AB    + WATSON PHARMS            300MG                            N019594 002 Dec 31, 1987

    URSODIOL
	
AB        COREPHARMA             300MG                            A077895   001    Jul   27,   2006

AB        EPIC PHARMA            300MG                            A075517   001    Mar   14,   2000

AB        LANNETT                300MG                            A079082   001    Dec   15,   2008

AB        MYLAN                  300MG                            A090530   001    Feb   17,   2010

AB        TEVA PHARMS            300MG                            A075592   001    May   25,   2000

  TABLET;ORAL

    URSO 250
	
AB        FOREST LABS INC        250MG                            N020675 001 Dec 10, 1997

    URSO FORTE
	
AB    + FOREST LABS INC          500MG                            N020675 002 Jul 21, 2004

    URSODIOL
	
AB        GLENMARK GENERICS      250MG                            A090801   001    Jul   12,   2011

AB                               500MG                            A090801   002    Jul   12,   2011

AB        IMPAX LABS INC         250MG                            A200826   001    Dec   23,   2011

AB                               500MG                            A200826   002    Dec   23,   2011

AB        PAR PHARM              250MG                            A202540   001    Feb   14,   2013

AB                               500MG                            A202540   002    Feb   14,   2013
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST
	                     3-359(of 371)


VALACYCLOVIR HYDROCHLORIDE
	
  TABLET;ORAL

    VALACYCLOVIR HYDROCHLORIDE
AB       APOTEX INC              EQ   1GM BASE
                 A090500   002    Apr   04,   2014

AB                               EQ   500MG BASE
               A090500   001    Apr   04,   2014

AB       AUROBINDO PHARMA        EQ   1GM BASE
                 A090682   002    May   24,   2010

AB                               EQ   500MG BASE
               A090682   001    May   24,   2010

AB       CIPLA LTD               EQ   1GM BASE
                 A077135   002    May   24,   2010

AB                               EQ   500MG BASE
               A077135   001    May   24,   2010

AB       DR REDDYS LABS LTD      EQ   1GM BASE
                 A079012   002    May   24,   2010

AB                               EQ   500MG BASE
               A079012   001    May   24,   2010

AB       JUBILANT GENERICS       EQ   1GM BASE
                 A201506   002    Apr   03,   2012

AB                               EQ   500MG BASE
               A201506   001    Apr   03,   2012

AB       MYLAN                   EQ   1GM BASE
                 A078070   002    May   24,   2010

AB                               EQ   500MG BASE
               A078070   001    May   24,   2010

AB       MYLAN PHARMS INC        EQ   1GM BASE
                 A078518   002    May   24,   2010

AB                               EQ   500MG BASE
               A078518   001    May   24,   2010

AB       RANBAXY                 EQ   1GM BASE
                 A076588   002    Jan   31,   2007

AB                               EQ   500MG BASE
               A076588   001    Jan   31,   2007

AB       ROXANE                  EQ   1GM BASE
                 A078656   002    May   24,   2010

AB                               EQ   500MG BASE
               A078656   001    May   24,   2010

AB       SANDOZ                  EQ   1GM BASE
                 A077478   002    May   24,   2010

AB                               EQ   500MG BASE
               A077478   001    May   24,   2010

AB       TEVA PHARMS             EQ   1GM BASE
                 A077655   002    May   24,   2010

AB                               EQ   500MG BASE
               A077655   001    May   24,   2010

AB       WATSON LABS INC         EQ   1GM BASE
                 A090370   002    Mar   16,   2011

AB                               EQ   500MG BASE
               A090370   001    Mar   16,   2011

AB       WOCKHARDT               EQ   1GM BASE
                 A090216   002    May   24,   2010

AB                               EQ   500MG BASE
	              A090216   001    May   24,   2010
	
    VALTREX
AB    + GLAXOSMITHKLINE          EQ 1GM BASE
                   N020487 002 Jun 23, 1995

AB                               EQ 500MG BASE
	                N020487 001 Jun 23, 1995
	
VALGANCICLOVIR HYDROCHLORIDE
	
  FOR SOLUTION;ORAL
	
    VALCYTE
	
      + HOFFMANN LA ROCHE
	     50MG/ML
	                       N022257 001 Aug 28, 2009
	
  TABLET;ORAL

    VALCYTE
	
AB    + HOFFMANN LA ROCHE
	     EQ 450MG BASE
	                 N021304 001 Mar 29, 2001
	
    VALGANCICLOVIR HYDROCHLORIDE
	
AB       DR REDDYS LABS LTD
	   EQ 450MG BASE
                  A203511 001 Nov 04, 2014

AB       ENDO PHARMS INC
	      EQ 450MG BASE
	                 A200790 001 Nov 04, 2014
	
VALPROATE SODIUM
	
  INJECTABLE;INJECTION

    DEPACON
AP    + ABBVIE                   EQ 100MG BASE/ML
	             N020593 001 Dec 30, 1996
	
    VALPROATE SODIUM
AP       BEDFORD                 EQ 100MG BASE/ML
              A076295 001 Nov 14, 2002

AP       FRESENIUS KABI USA      EQ 100MG BASE/ML
              A076539 001 Jun 26, 2003

AP       HIKMA FARMACEUTICA      EQ 100MG BASE/ML
	             A078523 001 Feb 17, 2010
	
VALPROIC ACID
	
  CAPSULE;ORAL

    DEPAKENE
	
AB    + ABBVIE
	                 250MG
	                        N018081 001
	
    VALPROIC ACID
	
AB       BANNER PHARMACAPS
	     250MG
	                        A073484 001 Jun 29, 1993

AB       CATALENT
	              250MG
	                        A073229 001 Oct 29, 1991

AB       SUN PHARM INDS LTD
	    250MG
	                        A091037 001 Feb 22, 2013
	
  SYRUP;ORAL

    DEPAKENE
	
AA    + ABBVIE
	                 250MG/5ML
	                    N018082 001
	
    VALPROIC ACID
	
AA       ALPHARMA
	              250MG/5ML
                     A075782   001    Dec   22,   2000

AA       ANI PHARMS INC
	        250MG/5ML
                     A073178   001    Aug   25,   1992

AA       HIGH TECH PHARMA
	      250MG/5ML
                     A074060   001    Jan   13,   1995

AA       PHARM ASSOC
	           250MG/5ML
                     A075379   001    Dec   15,   2000

AA       SUN PHARM INDS INC
	    250MG/5ML
                     A090517   001    May   28,   2010

AA       VINTAGE
	               250MG/5ML
                     A077960   001    Oct   13,   2006

AA       WOCKHARDT
	             250MG/5ML
	                    A070868   001    Jul   01,   1986
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-360(of 371)


VALRUBICIN
	
  SOLUTION;INTRAVESICAL
	
    VALSTAR PRESERVATIVE FREE
	
      + ENDO PHARM
	              40MG/ML
	                     N020892 001 Sep 25, 1998
	
VALSARTAN
	
  TABLET;ORAL

    DIOVAN
AB       NOVARTIS                 40MG
	                        N021283   004    Aug   14,   2002

AB                                80MG
	                        N021283   001    Jul   18,   2001

AB                                160MG
	                       N021283   002    Jul   18,   2001

AB    +                           320MG
	                       N021283   003    Jul   18,   2001
	
    VALSARTAN
AB       ALEMBIC PHARMS LTD       40MG
	                        A091367   001    Jan   05,   2015

AB                                80MG
	                        A091367   002    Jan   05,   2015

AB                                160MG
	                       A091367   003    Jan   05,   2015

AB                                320MG
	                       A091367   004    Jan   05,   2015

AB       AUROBINDO PHARMA LTD     40MG
	                        A202223   001    Jan   05,   2015

AB                                80MG
	                        A202223   002    Jan   05,   2015

AB                                160MG
	                       A202223   003    Jan   05,   2015

AB                                320MG
	                       A202223   004    Jan   05,   2015

AB       HETERO LABS LTD V        40MG
	                        A203311   001    Jan   05,   2015

AB                                80MG
	                        A203311   002    Jan   05,   2015

AB                                160MG
	                       A203311   003    Jan   05,   2015

AB                                320MG
	                       A203311   004    Jan   05,   2015

AB       IVAX PHARMS              40MG
	                        A077530   001    Jan   05,   2015

AB                                80MG
	                        A077530   002    Jan   05,   2015

AB                                160MG
	                       A077530   003    Jan   05,   2015

AB                                320MG
	                       A077530   004    Jan   05,   2015

AB       JUBILANT GENERICS        40MG
	                        A203536   001    Jan   05,   2015

AB                                80MG
	                        A203536   002    Jan   05,   2015

AB                                160MG
	                       A203536   003    Jan   05,   2015

AB                                320MG
	                       A203536   004    Jan   05,   2015

AB       LUPIN LTD                40MG
	                        A201677   001    Jan   05,   2015

AB                                80MG
	                        A201677   002    Jan   05,   2015

AB                                160MG
	                       A201677   003    Jan   05,   2015

AB                                320MG
	                       A201677   004    Jan   05,   2015

AB       MYLAN LABS LTD           40MG
	                        A090866   001    Jan   05,   2015

AB                                80MG
	                        A090866   002    Jan   05,   2015

AB                                160MG
	                       A090866   003    Jan   05,   2015

AB                                320MG
	                       A090866   004    Jan   05,   2015

AB       OHM LABS INC             40MG
	                        A077492   001    Jun   26,   2014

AB                                80MG
	                        A077492   002    Jun   26,   2014

AB                                160MG
	                       A077492   003    Jun   26,   2014

AB                                320MG
	                       A077492   004    Jun   26,   2014

AB       TORRENT PHARMS LTD       40MG
	                        A202728   001    Jan   05,   2015

AB                                80MG
	                        A202728   002    Jan   05,   2015

AB                                160MG
	                       A202728   003    Jan   05,   2015

AB                                320MG
	                       A202728   004    Jan   05,   2015

AB       WATSON LABS INC          40MG
	                        A090642   001    Jan   05,   2015

AB                                80MG
	                        A090642   002    Jan   05,   2015

AB                                160MG
	                       A090642   003    Jan   05,   2015

AB                                320MG
	                       A090642   004    Jan   05,   2015
	
VANCOMYCIN HYDROCHLORIDE
	
  CAPSULE;ORAL

     VANCOCIN HYDROCHLORIDE
	
AB         ANI PHARMS INC
	       EQ 125MG BASE
                N050606 001 Apr 15, 1986

AB     +
	                        EQ 250MG BASE
	               N050606 002 Apr 15, 1986
	
     VANCOMYCIN HYDROCHLORIDE
	
AB         AKORN
	                EQ   125MG   BASE
            A065478   001    Apr   09,   2012

AB
	                              EQ   250MG   BASE
            A065478   002    Apr   09,   2012

AB         FRESENIUS KABI USA
	   EQ   125MG   BASE
            A065453   001    Jun   18,   2012

AB
	                              EQ   250MG   BASE
            A065453   002    Jun   18,   2012

AB         STRIDES PHARMA
	       EQ   125MG   BASE
            A065490   001    Apr   09,   2012

AB
	                              EQ   250MG   BASE
            A065490   002    Apr   09,   2012

AB         WATSON LABS
	          EQ   125MG   BASE
            A065510   001    Apr   09,   2012

AB
	                              EQ   250MG   BASE
	           A065510   002    Apr   09,   2012
	
  INJECTABLE;INJECTION

     VANCOMYCIN HYDROCHLORIDE
	
AP         AGILA SPECLTS
	        EQ 1GM BASE/VIAL
             A065397 002 Dec 30, 2008

AP
	                              EQ 5GM BASE/VIAL
             A065432 001 Dec 30, 2008

AP
	                              EQ 10GM BASE/VIAL
	           A091469 001 Jul 01, 2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                       3-361(of 371)


VANCOMYCIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION

    VANCOMYCIN HYDROCHLORIDE
	
AP                              EQ 10GM BASE/VIAL               A091554   001    Sep   19,   2011

AP                              EQ 500MG BASE/VIAL              A065397   001    Dec   30,   2008

AP       EMCURE PHARMS LTD      EQ 1GM BASE/VIAL                A202275   002    Oct   31,   2013

AP                              EQ 10GM BASE/VIAL               A202464   001    Oct   09,   2013

AP                              EQ 5GM BASE/VIAL                A202274   001    Oct   31,   2013

AP                              EQ 500MG BASE/VIAL              A202275   001    Oct   31,   2013

AP    + FRESENIUS KABI USA      EQ 1GM BASE/VIAL                A062663   002    Jul   31,   1987

AP    +                         EQ 5GM BASE/VIAL                A062663   003    Jun   03,   1988

AP    +                         EQ 10GM BASE/VIAL               A062663   004    Nov   28,   1997

AP    +                         EQ 500MG BASE/VIAL              A062663   001    Mar   17,   1987

AP    + HOSPIRA                 EQ 1GM BASE/VIAL                A062912   001    Aug   04,   1988

AP    +                         EQ 1GM BASE/VIAL                A062933   001    Oct   29,   1992

AP    +                         EQ 5GM BASE/VIAL                A063076   001    Dec   21,   1990

AP    +                         EQ 500MG BASE/VIAL              A062911   001    Aug   04,   1988

AP    +                         EQ 500MG BASE/VIAL              A062931   001    Oct   29,   1992

AP    +                         EQ 750MG BASE/VIAL              A062912   002    Jan   07,   2009

AP    +                         EQ 750MG BASE/VIAL              A062933   002    May   27,   2009

AP       HOSPIRA INC            EQ 10GM BASE/VIAL               A065455   001    Apr   29,   2009

AP       MUSTAFA NEVZAT ILAC    EQ 1GM BASE/VIAL                A065401   002    Jun   30,   2008

AP                              EQ 500MG BASE/VIAL              A065401   001    Jun   30,   2008

AP       SAGENT PHARMS          EQ 5GM BASE/VIAL                A200837   001    Aug   10,   2012

AP                              EQ 10GM BASE/VIAL               A200837   002    Sep   02,   2014

AP       SANDOZ                 EQ 1GM BASE/VIAL                A090250   002    Apr   27,   2010

AP                              EQ 500MG BASE/VIAL              A090250   001    Apr   27,   2010

AP       SANDOZ INC             EQ 5GM BASE/VIAL                A201048   001    Aug   10,   2012

AP                              EQ 10GM BASE/VIAL               A201048   002    Aug   10,   2012

    VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER
	
      + BAXTER HLTHCARE         EQ 500MG BASE/100ML             N050671 001 Apr 29, 1993

      +                         EQ 750MG BASE/150ML             N050671 002 Dec 20, 2010
	
VANDETANIB
	
  TABLET;ORAL
	
    CAPRELSA
	
         IPR PHARMS INC         100MG                           N022405 001 Apr 06, 2011

      +                         300MG                           N022405 002 Apr 06, 2011
	
VARDENAFIL HYDROCHLORIDE
	
  TABLET;ORAL

    LEVITRA
	
AB       BAYER HLTHCARE         2.5MG                           N021400   003    Aug   19,   2003

AB                              5MG                             N021400   001    Aug   19,   2003

AB                              10MG                            N021400   002    Aug   19,   2003

AB    +                         20MG                            N021400   004    Aug   19,   2003

    VARDENAFIL HYDROCHLORIDE
	
AB       TEVA PHARMS            2.5MG                           A091347   001    May   03,   2012

AB                              5MG                             A091347   002    May   03,   2012

AB                              10MG                            A091347   003    May   03,   2012

AB                              20MG                            A091347   004    May   03,   2012

  TABLET, ORALLY DISINTEGRATING;ORAL
	
    STAXYN
	
      + BAYER HLTHCARE          10MG                            N200179 001 Jun 17, 2010
	
VARENICLINE TARTRATE
	
  TABLET;ORAL
	
    CHANTIX
	
         PFIZER INC             EQ 0.5MG BASE                   N021928 001 May 10, 2006

      +                         EQ 1MG BASE                     N021928 002 May 10, 2006
	
VASOPRESSIN
	
  SOLUTION;IV (INFUSION)

    VASOSTRICT
	
      + PAR STERILE PRODUCTS    20UNITS/ML (20UNITS/ML)         N204485 001 Apr 17, 2014
	
VECURONIUM BROMIDE
	
  INJECTABLE;INJECTION

    VECURONIUM BROMIDE
	
AP       AGILA SPECLTS          10MG/VIAL                       A090243   001    May   11,   2010

AP                              20MG/VIAL                       A090243   002    May   11,   2010

AP       BEDFORD                10MG/VIAL                       A075549   001    Jun   13,   2000

AP                              20MG/VIAL                       A075549   002    Jun   13,   2000

AP       HOSPIRA                10MG/VIAL                       A075164   001    Oct   21,   1999

AP                              20MG/VIAL                       A075164   002    Oct   21,   1999
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            PRESCRIPTION DRUG PRODUCT LIST
	                    3-362(of 371)


VECURONIUM BROMIDE
	
  INJECTABLE;INJECTION

    VECURONIUM BROMIDE
	
AP       MUSTAFA NEVZAT          10MG/VIAL
                     A078274   001    Dec   29,   2008

AP                               20MG/VIAL
                     A078274   002    Dec   29,   2008

AP    + SUN PHARMA GLOBAL        10MG/VIAL
                     A079001   001    Jun   17,   2009

AP    +                          20MG/VIAL
                     A079001   002    Jun   17,   2009

AP       TEVA PHARMS USA         10MG/VIAL
                     A074688   001    Aug   25,   1999

AP                               20MG/VIAL
	                    A074688   002    Aug   25,   1999
	
VELAGLUCERASE ALFA
	
  INJECTABLE;IV (INFUSION)

    VPRIV
	
         SHIRE HUMAN GENETIC
	   400 UNITS/VIAL
	               N022575 001 Feb 26, 2010
	
VEMURAFENIB
	
  TABLET;ORAL
	
    ZELBORAF
	
      + HOFFMANN LA ROCHE
	      240MG
	                        N202429 001 Aug 17, 2011
	
VENLAFAXINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

     EFFEXOR XR
	
AB         WYETH PHARMS INC
	     EQ   37.5MG BASE
             N020699 001 Oct 20, 1997

AB
	                              EQ   75MG BASE
               N020699 002 Oct 20, 1997

AB     +
	                        EQ   150MG BASE
	             N020699 004 Oct 20, 1997
	
     VENLAFAXINE HYDROCHLORIDE
	
AB         ANCHEN PHARMS
	        EQ   37.5MG BASE
             A078087   001    Mar   16,   2012

AB
	                              EQ   75MG BASE
               A078087   002    Mar   16,   2012

AB
	                              EQ   150MG BASE
              A078087   003    Mar   16,   2012

AB         AUROBINDO PHARMA LTD
	 EQ   37.5MG BASE
             A200834   001    Apr   14,   2011

AB
	                              EQ   75MG BASE
               A200834   002    Apr   14,   2011

AB
	                              EQ   150MG BASE
              A200834   003    Apr   14,   2011

AB         DR REDDYS LABS LTD
	   EQ   37.5MG BASE
             A078421   001    May   06,   2011

AB
	                              EQ   75MG BASE
               A078421   002    May   06,   2011

AB
	                              EQ   150MG BASE
              A078421   003    May   06,   2011

AB         MYLAN
	                EQ   37.5MG BASE
             A078789   001    Jun   01,   2011

AB
	                              EQ   75MG BASE
               A078789   002    Jun   01,   2011

AB
	                              EQ   150MG BASE
              A078789   003    Jun   01,   2011

AB         ORCHID HLTHCARE
	      EQ   37.5MG BASE
             A091123   001    Jul   11,   2011

AB
	                              EQ   75MG BASE
               A091123   002    Jul   11,   2011

AB
	                              EQ   150MG BASE
              A091123   003    Jul   11,   2011

AB         TEVA
	                 EQ   37.5MG BASE
             A076565   001    Jun   28,   2010

AB
	                              EQ   75MG BASE
               A076565   002    Jun   28,   2010

AB
	                              EQ   150MG BASE
              A076565   003    Jun   28,   2010

AB         TORRENT PHARMS LLC
	   EQ   37.5MG BASE
             A090899   001    Jun   01,   2011

AB
	                              EQ   75MG BASE
               A090899   002    Jun   01,   2011

AB
	                              EQ   150MG BASE
              A090899   003    Jun   01,   2011

AB         VALEANT BERMUDA
	      EQ   37.5MG BASE
             A090071   001    Apr   15,   2011

AB
	                              EQ   75MG BASE
               A090071   002    Apr   15,   2011

AB
	                              EQ   150MG BASE
              A090071   003    Apr   15,   2011

AB         WOCKHARDT
	            EQ   37.5MG BASE
             A078865   001    Apr   14,   2011

AB
	                              EQ   75MG BASE
               A078865   002    Apr   14,   2011

AB
	                              EQ   150MG BASE
              A078865   003    Apr   14,   2011

AB         ZYDUS PHARMS USA INC
	 EQ   37.5MG BASE
             A090174   001    Apr   14,   2011

AB
	                              EQ   75MG BASE
               A090174   002    Apr   14,   2011

AB
	                              EQ   150MG BASE
	             A090174   003    Apr   14,   2011
	
  TABLET;ORAL

     VENLAFAXINE HYDROCHLORIDE
	
AB         ALEMBIC PHARMS LTD
	   EQ   25MG BASE
               A078932   001    Dec   14,   2010

AB
	                              EQ   37.5MG BASE
             A078932   002    Dec   14,   2010

AB
	                              EQ   50MG BASE
               A078932   003    Dec   14,   2010

AB
	                              EQ   75MG BASE
               A078932   004    Dec   14,   2010

AB
	                              EQ   100MG BASE
              A078932   005    Dec   14,   2010

AB         AMNEAL PHARMS
	        EQ   25MG BASE
               A079098   001    May   11,   2010

AB
	                              EQ   37.5MG BASE
             A079098   002    May   11,   2010

AB
	                              EQ   50MG BASE
               A079098   003    May   11,   2010

AB
	                              EQ   75MG BASE
               A079098   004    May   11,   2010

AB
	                              EQ   100MG BASE
              A079098   005    May   11,   2010

AB         AUROBINDO PHARMA
	     EQ   25MG BASE
               A090555   001    Apr   07,   2010

AB
	                              EQ   37.5MG BASE
             A090555   002    Apr   07,   2010

AB
	                              EQ   50MG BASE
               A090555   003    Apr   07,   2010

AB
	                              EQ   75MG BASE
               A090555   004    Apr   07,   2010

AB
	                              EQ   100MG BASE
	             A090555   005    Apr   07,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-363(of 371)


VENLAFAXINE HYDROCHLORIDE
	
  TABLET;ORAL

    VENLAFAXINE HYDROCHLORIDE
	
AB       DR REDDYS LABS LTD      EQ   25MG BASE                A078301   001    Jun   13,   2008

AB                               EQ   37.5MG BASE              A078301   002    Jun   13,   2008

AB                               EQ   50MG BASE                A078301   003    Jun   13,   2008

AB                               EQ   75MG BASE                A078301   004    Jun   13,   2008

AB                               EQ   100MG BASE               A078301   005    Jun   13,   2008

AB       HERITAGE PHARMS INC     EQ   25MG BASE                A078554   001    Jan   09,   2009

AB                               EQ   37.5MG BASE              A078554   002    Jan   09,   2009

AB                               EQ   50MG BASE                A078554   003    Jan   09,   2009

AB                               EQ   75MG BASE                A078554   004    Jan   09,   2009

AB                               EQ   100MG BASE               A078554   005    Jan   09,   2009

AB       MYLAN                   EQ   25MG BASE                A077166   001    Jun   13,   2008

AB                               EQ   37.5MG BASE              A077166   002    Jun   13,   2008

AB                               EQ   50MG BASE                A077166   003    Jun   13,   2008

AB                               EQ   75MG BASE                A077166   004    Jun   13,   2008

AB                               EQ   100MG BASE               A077166   005    Jun   13,   2008

AB       SUN PHARM INDS INC      EQ   25MG BASE                A078627   001    Jun   13,   2008

AB                               EQ   37.5MG BASE              A078627   002    Jun   13,   2008

AB                               EQ   50MG BASE                A078627   003    Jun   13,   2008

AB                               EQ   75MG BASE                A078627   004    Jun   13,   2008

AB                               EQ   100MG BASE               A078627   005    Jun   13,   2008

AB       TEVA                    EQ   25MG BASE                A076690   001    Aug   03,   2006

AB                               EQ   37.5MG BASE              A076690   002    Aug   03,   2006

AB    +                          EQ   50MG BASE                A076690   003    Aug   03,   2006

AB                               EQ   75MG BASE                A076690   004    Aug   03,   2006

AB                               EQ   100MG BASE               A076690   005    Aug   03,   2006

AB       VINTAGE                 EQ   25MG BASE                A090027   001    Aug   04,   2010

AB                               EQ   37.5MG BASE              A090027   002    Aug   04,   2010

AB                               EQ   50MG BASE                A090027   003    Aug   04,   2010

AB                               EQ   75MG BASE                A090027   004    Aug   04,   2010

AB                               EQ   100MG BASE               A090027   005    Aug   04,   2010

AB       ZYDUS PHARMS USA        EQ   25MG BASE                A077653   001    Jun   13,   2008

AB                               EQ   37.5MG BASE              A077653   002    Jun   13,   2008

AB                               EQ   50MG BASE                A077653   003    Jun   13,   2008

AB                               EQ   75MG BASE                A077653   004    Jun   13,   2008

AB                               EQ   100MG BASE               A077653   005    Jun   13,   2008
	
  TABLET, EXTENDED RELEASE;ORAL

    VENLAFAXINE HYDROCHLORIDE
	
AB       OSMOTICA PHARM          EQ   37.5MG BASE              N022104   001    May   20,   2008

AB                               EQ   75MG BASE                N022104   002    May   20,   2008

AB    +                          EQ   150MG BASE               N022104   003    May   20,   2008

AB       SUN PHARMA GLOBAL       EQ   37.5MG BASE              A091272   001    Aug   18,   2010

AB                               EQ   75MG BASE                A091272   002    Aug   18,   2010

AB                               EQ   150MG BASE               A091272   003    Aug   18,   2010

         OSMOTICA PHARM          EQ   225MG BASE               N022104   004    May   20,   2008
	
VERAPAMIL HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL

    VERAPAMIL HYDROCHLORIDE
	
AB       MYLAN                  100MG                          A078306   001    Aug   09,   2007

AB                              120MG                          A075138   001    Apr   20,   1999

AB                              180MG                          A075138   002    Apr   20,   1999

AB                              200MG                          A078306   002    Aug   09,   2007

AB                              240MG                          A075138   003    Apr   20,   1999

AB                              300MG                          A078306   003    Aug   09,   2007

    VERELAN
	
AB       ALKERMES GAINESVILLE   120MG                          N019614 001 May 29, 1990

AB                              180MG                          N019614 003 Jan 09, 1992

AB                              240MG                          N019614 002 May 29, 1990

    VERELAN PM
	
AB       ALKERMES GAINESVILLE   100MG                          N020943 001 Nov 25, 1998

AB                              200MG                          N020943 002 Nov 25, 1998

AB    +                         300MG                          N020943 003 Nov 25, 1998
	
    VERELAN
	
      + ALKERMES GAINESVILLE    360MG                          N019614 004 May 10, 1996

  SOLUTION;INTRAVENOUS

    VERAPAMIL HYDROCHLORIDE
	
AP    + HOSPIRA                 10MG/4ML (2.5MG/ML)            A070738   001    May   06,   1987

AP    +                         5MG/2ML (2.5MG/ML)             A075136   001    Oct   20,   1998

AP    +                         5MG/2ML (2.5MG/ML)             A070737   001    May   06,   1987

AP    +                         10MG/4ML (2.5MG/ML)            A070737   002    May   06,   1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-364(of 371)


VERAPAMIL HYDROCHLORIDE
	
  TABLET;ORAL

    CALAN
	
AB       GD SEARLE LLC           40MG                           N018817 003 Feb 23, 1988

AB                               80MG                           N018817 001 Sep 10, 1984

AB    +                          120MG                          N018817 002 Sep 10, 1984

    VERAPAMIL HYDROCHLORIDE
	
AB       HERITAGE PHARMS INC     80MG                           A071880   001    Apr   05,   1988

AB                               120MG                          A071881   001    Apr   05,   1988

AB       MYLAN                   80MG                           A071483   002    Feb   15,   1989

AB                               120MG                          A071483   001    Feb   15,   1989

AB       WATSON LABS             40MG                           A072924   001    Jun   29,   1993

AB                               80MG                           A070995   001    Oct   01,   1986

AB                               120MG                          A070994   001    Oct   01,   1986
	
  TABLET, EXTENDED RELEASE;ORAL

    CALAN SR
	
AB    + PFIZER                   120MG                          N019152 003 Mar 06, 1991

AB    +                          180MG                          N019152 002 Dec 15, 1989

AB    +                          240MG                          N019152 001 Dec 16, 1986

    VERAPAMIL HYDROCHLORIDE
	
AB       APOTEX CORP             120MG                          A200878   001    Apr   20,   2012

AB                               180MG                          A200878   002    Apr   20,   2012

AB                               240MG                          A200878   003    Apr   20,   2012

AB       GLENMARK GENERICS       120MG                          A090700   001    Aug   03,   2011

AB                               180MG                          A090700   002    Aug   03,   2011

AB                               240MG                          A078906   001    Sep   17,   2009

AB       IVAX SUB TEVA PHARMS    120MG                          A073568   002    Oct   10,   1997

AB                               180MG                          A074330   001    Jan   31,   1994

AB                               240MG                          A073568   001    Jul   31,   1992

AB       MYLAN                   120MG                          A074587   002    Feb   21,   1997

AB                               180MG                          A074587   003    Sep   09,   1997

AB                               240MG                          A074587   001    Mar   23,   1996

AB       PAR PHARM               120MG                          A075072   001    May   25,   1999

AB                               240MG                          A075072   003    May   25,   1999

AB       SUN PHARM INDS INC      120MG                          A090529   001    Dec   30,   2011

AB                               180MG                          A090529   002    Dec   30,   2011

AB                               240MG                          A090529   003    Dec   30,   2011
	
    COVERA-HS
	
BC    + GD SEARLE LLC            180MG                          N020552 001 Feb 26, 1996
	
BC    +                          240MG                          N020552 002 Feb 26, 1996
	
VERTEPORFIN
	
  INJECTABLE;INJECTION
	
    VISUDYNE
	
      + VALEANT PHARMS INC      15MG/VIAL                       N021119 001 Apr 12, 2000
	
VIGABATRIN
	
  FOR SOLUTION;ORAL
	
    SABRIL
	
      + LUNDBECK LLC            500MG/PACKET		                  N022006 001 Aug 21, 2009

  TABLET;ORAL
	
    SABRIL
	
      + LUNDBECK LLC            500MG                           N020427 001 Aug 21, 2009
	
VILAZODONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    VIIBRYD
	
      +		 FOREST LABS INC       10MG                            N022567 001 Jan 21, 2011
	
                                20MG                            N022567 002 Jan 21, 2011
	
                                40MG                            N022567 003 Jan 21, 2011
	
VINBLASTINE SULFATE
	
  INJECTABLE;INJECTION
	
    VINBLASTINE SULFATE
	
      + EUROHLTH INTL           10MG/VIAL		                     A089395 001 Apr 09, 1987

      + FRESENIUS KABI USA      1MG/ML		                        A089515 001 Apr 29, 1987
	
VINCRISTINE SULFATE
	
  INJECTABLE;INJECTION

    VINCRISTINE SULFATE PFS
	
AP    + HOSPIRA                 1MG/ML                          A071484 001 Apr 19, 1988

AP       TEVA PHARMS USA        1MG/ML                          A075493 001 Sep 01, 1999
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                PRESCRIPTION DRUG PRODUCT LIST
	                   3-365(of 371)


VINCRISTINE SULFATE
	
  INJECTABLE, LIPOSOMAL;INTRAVENOUS
	
    MARQIBO KIT
	
      + TALON THERAP
	          5MG/5ML (1MG/ML)
	                 N202497 001 Aug 09, 2012
	
VINORELBINE
	
  INJECTABLE;INJECTION

    VINORELBINE
	
AP       ONCO THERAPIES LTD
	      EQ 10MG BASE/ML
	               A200148 001 Aug 31, 2012
	
VINORELBINE TARTRATE
	
  INJECTABLE;INJECTION

    NAVELBINE
AP    + PIERRE FABRE               EQ 10MG BASE/ML
	               N020388 001 Dec 23, 1994
	
    VINORELBINE TARTRATE
AP       ACTAVIS TOTOWA            EQ   10MG   BASE/ML
            A078011   001    Jul   22,   2009

AP       BEDFORD                   EQ   10MG   BASE/ML
            A076461   001    Dec   11,   2003

AP       DR REDDYS LABS LTD        EQ   10MG   BASE/ML
            A202017   001    Sep   12,   2013

AP       FRESENIUS KABI USA        EQ   10MG   BASE/ML
            A076849   001    Apr   18,   2005

AP       HIKMA MAPLE               EQ   10MG   BASE/ML
            A075992   001    Jun   10,   2003

AP       HOSPIRA                   EQ   10MG   BASE/ML
            A076827   001    Jun   02,   2005

AP       JIANGSU HANSOH PHARM      EQ   10MG   BASE/ML
            A091106   001    Sep   26,   2012

AP       TEVA PHARMS USA           EQ   10MG   BASE/ML
	           A076028   001    Feb   03,   2003
	
VISMODEGIB
	
  CAPSULE;ORAL
	
    ERIVEDGE
	
      + GENENTECH
	                150MG
	                         N203388 001 Jan 30, 2012
	
VITAMIN A PALMITATE
	
  INJECTABLE;INJECTION
	
    AQUASOL A
	
      + HOSPIRA
	                  EQ 50,000 UNITS BASE/ML
	       N006823 001
	
VORAPAXAR SULFATE
	
  TABLET;ORAL
	
    ZONTIVITY
	
      + MERCK SHARP DOHME
	        EQ 2.08MG BASE
	                N204886 001 May 08, 2014
	
VORICONAZOLE
	
  FOR SUSPENSION;ORAL

     VFEND
	
AB     + PF PRISM CV
	             200MG/5ML
	                     N021630 001 Dec 19, 2003
	
     VORICONAZOLE
	
AB         MYLAN PHARMS INC
	      200MG/5ML
	                     A202361 001 May 28, 2013
	
  INJECTABLE;IV (INFUSION)

     VFEND
	
AP     + PF PRISM CV
	             200MG/VIAL
	                    N021267 001 May 24, 2002
	
     VORICONAZOLE
	
AP         SANDOZ INC
	            200MG/VIAL
	                    A090862 001 May 30, 2012
	
  TABLET;ORAL

     VFEND
	
AB         PF PRISM CV
	           50MG
	                          N021266 001 May 24, 2002

AB     +
	                         200MG
	                         N021266 002 May 24, 2002
	
     VORICONAZOLE
	
AB         MYLAN PHARMS INC
	      50MG
	                          A090547   001    Apr   22,   2010

AB
	                               200MG
	                         A090547   002    Apr   22,   2010

AB         SANDOZ INC
	            50MG
	                          A200265   001    Dec   12,   2011

AB
	                               200MG
	                         A200265   002    Dec   12,   2011

AB         TEVA PHARMS
	           50MG
	                          A091658   001    Apr   06,   2012

AB
	                               200MG
	                         A091658   002    Apr   06,   2012
	
VORINOSTAT
	
  CAPSULE;ORAL
	
    ZOLINZA
	
      + MERCK
	                    100MG
	                         N021991 001 Oct 06, 2006
	
VORTIOXETINE HYDROBROMIDE
	
  TABLET;ORAL
	
    BRINTELLIX
	
         TAKEDA PHARMS USA
	       EQ   5MG BASE
	                 N204447   001    Sep   30,   2013

                                   EQ   10MG BASE
	                N204447   002    Sep   30,   2013

                                   EQ   15MG BASE
	                N204447   003    Sep   30,   2013

     +
	                           EQ   20MG BASE
	                N204447   004    Sep   30,   2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          PRESCRIPTION DRUG PRODUCT LIST
	                     3-366(of 371)


WARFARIN SODIUM
	
  TABLET;ORAL

    COUMADIN
AB       BRISTOL MYERS SQUIBB   1MG                            N009218   022     Mar 01, 1990

AB                              2MG                            N009218   013
	
AB                              2.5MG                          N009218   018
	
AB                              3MG                            N009218   025     Nov 18, 1996

AB                              4MG                            N009218   023     Aug 24, 1993

AB                              5MG                            N009218   007
	
AB                              6MG                            N009218   026     Nov 18, 1996

AB                              7.5MG                          N009218   016
	
AB    +                         10MG                           N009218   005
	
    JANTOVEN
AB       USL PHARMA             1MG                            A040416   001     Oct   02,   2003

AB                              2MG                            A040416   002     Oct   02,   2003

AB                              2.5MG                          A040416   003     Oct   02,   2003

AB                              3MG                            A040416   004     Oct   02,   2003

AB                              4MG                            A040416   005     Oct   02,   2003

AB                              5MG                            A040416   006     Oct   02,   2003

AB                              6MG                            A040416   007     Oct   02,   2003

AB                              7.5MG                          A040416   008     Oct   02,   2003

AB                              10MG                           A040416   009     Oct   02,   2003
	
    WARFARIN SODIUM
AB       AMNEAL PHARMS          1MG                            A202202   001     Mar   04,   2013

AB                              2MG                            A202202   002     Mar   04,   2013

AB                              2.5MG                          A202202   003     Mar   04,   2013

AB                              3MG                            A202202   004     Mar   04,   2013

AB                              4MG                            A202202   005     Mar   04,   2013

AB                              5MG                            A202202   006     Mar   04,   2013

AB                              6MG                            A202202   007     Mar   04,   2013

AB                              7.5MG                          A202202   008     Mar   04,   2013

AB                              10MG                           A202202   009     Mar   04,   2013

AB       BARR                   1MG                            A040145   001     Mar   26,   1997

AB                              2MG                            A040145   002     Mar   26,   1997

AB                              2.5MG                          A040145   003     Mar   26,   1997

AB                              3MG                            A040145   008     Nov   05,   1998

AB                              4MG                            A040145   004     Mar   26,   1997

AB                              5MG                            A040145   005     Mar   26,   1997

AB                              6MG                            A040145   009     Nov   05,   1998

AB                              7.5MG                          A040145   006     Mar   26,   1997

AB                              10MG                           A040145   007     Mar   26,   1997

AB       INVAGEN PHARMS         1MG                            A090935   001     May   25,   2011

AB                              2MG                            A090935   002     May   25,   2011

AB                              2.5MG                          A090935   003     May   25,   2011

AB                              3MG                            A090935   004     May   25,   2011

AB                              4MG                            A090935   005     May   25,   2011

AB                              5MG                            A090935   006     May   25,   2011

AB                              6MG                            A090935   007     May   25,   2011

AB                              7.5MG                          A090935   008     May   25,   2011

AB                              10MG                           A090935   009     May   25,   2011

AB       IPCA LABS LTD          1MG                            A200104   001     Jun   27,   2013

AB                              2MG                            A200104   002     Jun   27,   2013

AB                              2.5MG                          A200104   003     Jun   27,   2013

AB                              3MG                            A200104   004     Jun   27,   2013

AB                              4MG                            A200104   005     Jun   27,   2013

AB                              5MG                            A200104   006     Jun   27,   2013

AB                              6MG                            A200104   007     Jun   27,   2013

AB                              7.5MG                          A200104   008     Jun   27,   2013

AB                              10MG                           A200104   009     Jun   27,   2013

AB       MYLAN                  1MG                            A040415   001     Sep   27,   2004

AB                              2MG                            A040415   002     Sep   27,   2004

AB                              2.5MG                          A040415   003     Sep   29,   2004

AB                              3MG                            A040415   004     Sep   27,   2004

AB                              4MG                            A040415   005     Sep   27,   2004

AB                              5MG                            A040415   006     Sep   27,   2004

AB                              6MG                            A040415   007     Sep   27,   2004

AB                              7.5MG                          A040415   008     Sep   27,   2004

AB                              10MG                           A040415   009     Sep   27,   2004

AB       PLIVA                  1MG                            A040616   009     Jul   05,   2006

AB                              2MG                            A040616   001     Jul   05,   2006

AB                              2.5MG                          A040616   002     Jul   05,   2006

AB                              3MG                            A040616   003     Jul   05,   2006
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-367(of 371)


WARFARIN SODIUM
	
  TABLET;ORAL

    WARFARIN SODIUM
AB                              4MG                             A040616   004    Jul   05,   2006

AB                              5MG                             A040616   005    Jul   05,   2006

AB                              6MG                             A040616   006    Jul   05,   2006

AB                              7.5MG                           A040616   007    Jul   05,   2006

AB                              10MG                            A040616   008    Jul   05,   2006

AB       TARO                   1MG                             A040301   002    Jul   15,   1999

AB                              2MG                             A040301   003    Jul   15,   1999

AB                              2.5MG                           A040301   004    Jul   15,   1999

AB                              3MG                             A040301   005    Jul   15,   1999

AB                              4MG                             A040301   006    Jul   15,   1999

AB                              5MG                             A040301   007    Jul   15,   1999

AB                              6MG                             A040301   008    Jul   15,   1999

AB                              7.5MG                           A040301   009    Jul   15,   1999

AB                              10MG                            A040301   001    Jul   15,   1999

AB       ZYDUS PHARMS USA       1MG                             A040663   001    May   30,   2006

AB                              2MG                             A040663   002    May   30,   2006

AB                              2.5MG                           A040663   003    May   30,   2006

AB                              3MG                             A040663   004    May   30,   2006

AB                              4MG                             A040663   005    May   30,   2006

AB                              5MG                             A040663   006    May   30,   2006

AB                              6MG                             A040663   007    May   30,   2006

AB                              7.5MG                           A040663   008    May   30,   2006

AB                              10MG                            A040663   009    May   30,   2006
	
XENON XE-133
	
  GAS;INHALATION

    XENON XE 133
	
AA       LANTHEUS MEDCL         20mCi/VIAL
                     N017284 002
	
                                10mCi/VIAL
	                    N017284 001
	
ZAFIRLUKAST
	
  TABLET;ORAL

    ACCOLATE
	
AB       ASTRAZENECA            10MG
	                          N020547 003 Sep 17, 1999

AB    +                         20MG
	                          N020547 001 Sep 26, 1996
	
    ZAFIRLUKAST
	
AB       DR REDDYS LABS LTD     10MG
	                          A090372 001 Nov 18, 2010

AB                              20MG
	                          A090372 002 Nov 18, 2010
	
ZALEPLON
	
  CAPSULE;ORAL

    SONATA
	
AB        PFIZER                5MG
	                           N020859 001 Aug 13, 1999

AB    +                         10MG
	                          N020859 002 Aug 13, 1999
	
    ZALEPLON
	
AB        AUROBINDO PHARMA      5MG
	                           A078829   001    Jun   06,   2008

AB                              10MG
	                          A078829   002    Jun   06,   2008

AB        CIPLA LTD             5MG
	                           A077505   001    Jun   20,   2008

AB                              10MG
	                          A077505   002    Jun   20,   2008

AB        HIKMA PHARMS LLC      5MG
	                           A078147   001    Nov   25,   2008

AB                              10MG
	                          A078147   002    Nov   25,   2008

AB        MYLAN                 5MG
	                           A077238   001    Jun   06,   2008

AB                              10MG
	                          A077238   002    Jun   06,   2008

AB        ORCHID HLTHCARE       5MG
	                           A090374   001    Sep   17,   2009

AB                              10MG
	                          A090374   002    Sep   17,   2009

AB        ROXANE                5MG
	                           A077237   001    Jun   06,   2008

AB                              10MG
	                          A077237   002    Jun   06,   2008

AB        TEVA PHARMS           5MG
	                           A077239   001    Jun   06,   2008

AB                              10MG
	                          A077239   002    Jun   06,   2008

AB        UNICHEM               5MG
	                           A078989   001    Jun   06,   2008

AB                              10MG
	                          A078989   002    Jun   06,   2008

AB        UPSHER SMITH          5MG
	                           A078706   001    Jun   06,   2008

AB                              10MG
	                          A078706   002    Jun   06,   2008
	
ZANAMIVIR
	
  POWDER;INHALATION
	
    RELENZA
	
      + GLAXOSMITHKLINE         5MG
	                           N021036 001 Jul 26, 1999
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                     3-368(of 371)


ZICONOTIDE ACETATE
	
  INJECTABLE;INTRATHECAL
	
    PRIALT
	
      + JAZZ PHARMS INTL          100MCG/1ML (100MCG/ML)        N021060 002 Dec 28, 2004
	
      +                           500MCG/20ML (25MCG/ML)        N021060 001 Dec 28, 2004
	
      +                           500MCG/5ML (100MCG/ML)        N021060 004 Dec 28, 2004
	
ZIDOVUDINE
	
  CAPSULE;ORAL

    RETROVIR
	
AB    + VIIV HLTHCARE             100MG                         N019655 001 Mar 19, 1987

    ZIDOVUDINE
	
AB       AUROBINDO PHARMA LTD     100MG                         A078128 001 Mar 27, 2006

AB       CIPLA LTD                100MG                         A078349 001 May 23, 2007

  INJECTABLE;INJECTION

    RETROVIR
	
AP    + VIIV HLTHCARE             10MG/ML                       N019951 001 Feb 02, 1990

    ZIDOVUDINE
	
AP       LUITPOLD                 10MG/ML                       A091457 001 May 06, 2010

  SYRUP;ORAL

    RETROVIR
	
AA    + VIIV HLTHCARE             50MG/5ML                      N019910 001 Sep 28, 1989

    ZIDOVUDINE
	
AA       AUROBINDO                50MG/5ML                      A077268 001 Sep 19, 2005

AA       CIPLA LTD                50MG/5ML                      A077981 001 Jun 26, 2008
	
  TABLET;ORAL

    ZIDOVUDINE
	
AB       AUROBINDO                300MG                         A077267   001    Sep   19,   2005

AB       CIPLA                    300MG                         A090561   001    Oct   27,   2010

AB    + HETERO LABS LTD III       300MG                         A090092   001    Apr   25,   2008

AB       MYLAN PHARMS INC         300MG                         A078922   001    Feb   14,   2008

AB       ROXANE                   300MG                         A076844   001    Sep   19,   2005

AB       SUNSHINE LAKE            300MG                         A202058   001    Oct   07,   2011
	
ZILEUTON
	
  TABLET;ORAL
	
    ZYFLO
	
      + CHIESI USA INC           600MG                          N020471 003 Dec 09, 1996
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ZYFLO CR
	
      + CHIESI USA INC           600MG                          N022052 001 May 30, 2007
	
ZINC ACETATE
	
  CAPSULE;ORAL
	
    GALZIN
	
         TEVA                     EQ 25MG ZINC                  N020458 001 Jan 28, 1997
	
      +                           EQ 50MG ZINC                  N020458 002 Jan 28, 1997
	
ZINC CHLORIDE
	
  INJECTABLE;INJECTION
	
    ZINC CHLORIDE IN PLASTIC CONTAINER
	
      + HOSPIRA                 EQ 1MG ZINC/ML                  N018959 001 Jun 26, 1986
	
ZIPRASIDONE HYDROCHLORIDE
	
  CAPSULE;ORAL

    GEODON
	
AB    + PFIZER                    EQ   20MG   BASE              N020825   001    Feb   05,   2001

AB                                EQ   40MG   BASE              N020825   002    Feb   05,   2001

AB                                EQ   60MG   BASE              N020825   003    Feb   05,   2001

AB                                EQ   80MG   BASE              N020825   004    Feb   05,   2001

    ZIPRASIDONE HYDROCHLORIDE
	
AB       APOTEX CORP              EQ   20MG   BASE              A077561   001    Mar   02,   2012

AB                                EQ   40MG   BASE              A077561   002    Mar   02,   2012

AB                                EQ   60MG   BASE              A077561   003    Mar   02,   2012

AB                                EQ   80MG   BASE              A077561   004    Mar   02,   2012

AB       DR REDDYS LABS INC       EQ   20MG   BASE              A077565   001    Mar   02,   2012

AB                                EQ   40MG   BASE              A077565   002    Mar   02,   2012

AB                                EQ   60MG   BASE              A077565   003    Mar   02,   2012

AB                                EQ   80MG   BASE              A077565   004    Mar   02,   2012

AB       LUPIN PHARMS             EQ   20MG   BASE              A077560   001    Mar   02,   2012

AB                                EQ   40MG   BASE              A077560   002    Mar   02,   2012

AB                                EQ   60MG   BASE              A077560   003    Mar   02,   2012

AB                                EQ   80MG   BASE              A077560   004    Mar   02,   2012

AB       MYLAN PHARMS INC         EQ   20MG   BASE              A202395   001    Oct   10,   2013

AB                                EQ   40MG   BASE              A202395   002    Oct   10,   2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST                    3-369(of 371)


ZIPRASIDONE HYDROCHLORIDE
	
  CAPSULE;ORAL

    ZIPRASIDONE HYDROCHLORIDE
	
AB                                EQ   60MG   BASE             A202395   003    Oct   10,   2013

AB                                EQ   80MG   BASE             A202395   004    Oct   10,   2013

AB       SANDOZ INC               EQ   20MG   BASE             A077562   001    Jun   01,   2012

AB                                EQ   40MG   BASE             A077562   002    Jun   01,   2012

AB                                EQ   60MG   BASE             A077562   003    Jun   01,   2012

AB                                EQ   80MG   BASE             A077562   004    Jun   01,   2012

AB       WOCKHARDT LTD            EQ   20MG   BASE             A090348   001    Sep   05,   2012

AB                                EQ   40MG   BASE             A090348   002    Sep   05,   2012

AB                                EQ   60MG   BASE             A090348   003    Sep   05,   2012

AB                                EQ   80MG   BASE             A090348   004    Sep   05,   2012

  SUSPENSION;ORAL
	
    GEODON
	
      + PFIZER INC                EQ 10MG BASE/ML              N021483 001 Mar 29, 2006
	
ZIPRASIDONE MESYLATE
	
  INJECTABLE;INTRAMUSCULAR
	
    GEODON
	
      + PFIZER                    EQ 20MG BASE/ML              N020919 001 Jun 21, 2002
	
ZOLEDRONIC ACID
	
  INJECTABLE;IV (INFUSION)

    RECLAST
	
AP    + NOVARTIS                  EQ 5MG BASE/100ML            N021817 001 Apr 16, 2007

    ZOLEDRONIC ACID
	
AP       ACS DOBFAR INFO SA       EQ   4MG   BASE/100ML        N203231   001    Aug   02,   2013

AP                                EQ   5MG   BASE/100ML        A202828   001    Sep   23,   2013

AP       ACTAVIS INC              EQ   4MG   BASE/5ML          A202472   001    Mar   04,   2013

AP       AGILA SPECLTS            EQ   4MG   BASE/5ML          A202650   001    Mar   04,   2013

AP       AKORN                    EQ   5MG   BASE/100ML        A200918   001    Aug   21,   2014

AP       AKORN INC                EQ   4MG   BASE/5ML          A202548   001    May   22,   2014

AP       DR REDDYS LABS LTD       EQ   4MG   BASE/5ML          A091186   001    Mar   04,   2013

AP                                EQ   5MG   BASE/100ML        A091363   001    Mar   29,   2013

AP       EMCURE PHARMS LTD        EQ   4MG   BASE/5ML          A201783   001    Mar   12,   2013

AP                                EQ   5MG   BASE/100ML        A201801   001    Mar   29,   2013

AP       GLAND PHARMA LTD         EQ   4MG   BASE/5ML          A202930   001    Aug   05,   2013

AP       HIKMA FARMACEUTICA       EQ   4MG   BASE/5ML          A202182   001    Jun   03,   2013

AP       HOSPIRA INC              EQ   5MG   BASE/100ML        A202837   001    Apr   05,   2013

AP       PHARMACEUTICS            EQ   4MG   BASE/5ML          A091170   001    Mar   04,   2013

AP                                EQ   5MG   BASE/100ML        A202163   001    Aug   05,   2013

AP       PHARMS                   EQ   4MG   BASE/5ML          A202571   001    May   07,   2013

AP       SAGENT PHARMS            EQ   4MG   BASE/5ML          A091493   001    Nov   24,   2014

AP    + SUN PHARMA GLOBAL         EQ   4MG   BASE/VIAL         A090018   001    Mar   04,   2013

AP                                EQ   4MG   BASE/5ML          A202746   001    Mar   04,   2013

AP       USV NORTH AMERICA        EQ   4MG   BASE/VIAL         A202923   001    Sep   04,   2014

    ZOMETA
	
AP    + NOVARTIS                  EQ 4MG BASE/5ML              N021223 002 Mar 07, 2003

AP    +                           EQ 4MG BASE/100ML            N021223 003 Jun 17, 2011
	
ZOLMITRIPTAN
	
  SPRAY;NASAL
	
    ZOMIG
	
         ASTRAZENECA              2.5MG/SPRAY                  N021450 003 Sep 16, 2013

      +                           5MG/SPRAY                    N021450 004 Sep 30, 2003

  TABLET;ORAL

    ZOLMITRIPTAN
	
AB       APOTEX INC               2.5MG                        A202078   001    May   14,   2013

AB                                5MG                          A202078   002    May   14,   2013

AB       GLENMARK GENERICS        2.5MG                        A201779   001    May   14,   2013

AB                                5MG                          A201779   002    May   14,   2013

AB       INVAGEN PHARMS           2.5MG                        A204284   001    Apr   09,   2014

AB                                5MG                          A204284   002    Apr   09,   2014

AB       JUBILANT GENERICS        2.5MG                        A202279   001    Nov   20,   2014

AB                                5MG                          A202279   002    Nov   20,   2014

AB       MYLAN PHARMS INC         2.5MG                        A203186   001    May   14,   2013

AB                                5MG                          A203186   002    May   14,   2013

AB       SUN PHARMA GLOBAL        2.5MG                        A203476   001    Nov   13,   2014

AB                                5MG                          A203476   002    Nov   13,   2014

AB       TEVA PHARMS USA          2.5MG                        A090861   001    Mar   04,   2014

AB                                5MG                          A090861   002    Mar   04,   2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           PRESCRIPTION DRUG PRODUCT LIST                      3-370(of 371)


ZOLMITRIPTAN
	
  TABLET;ORAL

    ZOMIG
	
AB       IPR                    2.5MG                          N020768 001 Nov 25, 1997

AB    +                         5MG                            N020768 002 Nov 25, 1997
	
  TABLET, ORALLY DISINTEGRATING;ORAL

    ZOLMITRIPTAN
	
AB       APOTEX INC             2.5MG                          A202476   001    May   14,   2013

AB                              5MG                            A202476   002    May   14,   2013

AB       GLENMARK GENERICS      2.5MG                          A202560   001    May   14,   2013

AB                              5MG                            A202560   002    May   14,   2013

AB       ZYDUS PHARMS USA INC   2.5MG                          A202890   001    May   15,   2013

AB                              5MG                            A202890   002    May   15,   2013

    ZOMIG-ZMT
	
AB       ASTRAZENECA            2.5MG                          N021231 001 Feb 13, 2001

AB    +                         5MG                            N021231 002 Sep 17, 2001
	
ZOLPIDEM TARTRATE
	
  SPRAY, METERED;ORAL
	
    ZOLPIMIST
	
      + NOVADEL                  5MG/SPRAY                     N022196 001 Dec 19, 2008
	
  TABLET;ORAL

    AMBIEN
	
AB       SANOFI AVENTIS US       5MG                           N019908 001 Dec 16, 1992

AB    +                          10MG                          N019908 002 Dec 16, 1992

    ZOLPIDEM TARTRATE
	
AB       APOTEX INC              5MG                           A077884   001    Apr   23,   2007

AB                               10MG                          A077884   002    Apr   23,   2007

AB       AUROBINDO PHARMA        5MG                           A078413   001    May   04,   2007

AB                               10MG                          A078413   002    May   04,   2007

AB       CARLSBAD                5MG                           A077990   001    Apr   23,   2007

AB                               10MG                          A077990   002    Apr   23,   2007

AB       CIPLA LTD               5MG                           A077388   001    Jul   30,   2012

AB                               10MG                          A077388   002    Jul   30,   2012

AB       HIKMA                   5MG                           A078129   001    Apr   30,   2008

AB                               10MG                          A078129   002    Apr   30,   2008

AB       INVAGEN PHARMS          5MG                           A078184   001    Sep   07,   2007

AB                               10MG                          A078184   002    Sep   07,   2007

AB       LEK PHARMS DD           5MG                           A077322   001    Apr   23,   2007

AB                               10MG                          A077322   002    Apr   23,   2007

AB       MYLAN                   5MG                           A076578   001    Apr   23,   2007

AB                               10MG                          A076578   002    Apr   23,   2007

AB       RANBAXY                 5MG                           A078055   001    Apr   23,   2007

AB                               10MG                          A078055   002    Apr   23,   2007

AB       ROXANE                  5MG                           A077214   001    Apr   23,   2007

AB                               10MG                          A077214   002    Apr   23,   2007

AB       SUN PHARM INDS INC      5MG                           A077359   001    Apr   23,   2007

AB                               10MG                          A077359   002    Apr   23,   2007

AB       TEVA                    5MG                           A076410   001    Apr   23,   2007

AB                               10MG                          A076410   002    Apr   23,   2007

AB       TORRENT PHARMS          5MG                           A077903   001    Aug   17,   2007

AB                               10MG                          A077903   002    Aug   17,   2007

AB       VINTAGE                 5MG                           A078616   001    Nov   21,   2008

AB                               10MG                          A078616   002    Nov   21,   2008

AB       WOCKHARDT               5MG                           A078426   001    May   15,   2007

AB                               10MG                          A078426   002    May   15,   2007

  TABLET;SUBLINGUAL
	
    EDLUAR
	
         MEDA PHARMS             5MG                           N021997 001 Mar 13, 2009
	
      +                          10MG                          N021997 002 Mar 13, 2009
	
    INTERMEZZO
	
         PURDUE PHARMA           1.75MG                        N022328 001 Nov 23, 2011
	
      +                          3.5MG                         N022328 002 Nov 23, 2011
	
  TABLET, EXTENDED RELEASE;ORAL

    AMBIEN CR
	
AB       SANOFI AVENTIS US       6.25MG                        N021774 002 Sep 02, 2005

AB    +                          12.5MG                        N021774 001 Sep 02, 2005

    ZOLPIDEM TARTRATE
	
AB       ACTAVIS ELIZABETH       6.25MG                        A078179   002    Oct   13,   2010

AB                               12.5MG                        A078179   001    Jun   06,   2011

AB       ACTAVIS LABS FL INC     6.25MG                        A090153   001    Mar   25,   2013

AB                               12.5MG                        A090153   002    Mar   25,   2013

AB       ANCHEN PHARMS           6.25MG                        A078148   002    Apr   14,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             PRESCRIPTION DRUG PRODUCT LIST
	                   3-371(of 371)


ZOLPIDEM TARTRATE
	
  TABLET, EXTENDED RELEASE;ORAL

     ZOLPIDEM TARTRATE
	
AB
	                             12.5MG
	                       A078148   001    Dec   03,   2010

AB        APOTEX INC
	           6.25MG
	                       A200266   001    Sep   10,   2013

AB
	                             12.5MG
	                       A200266   002    Sep   10,   2013

AB        LUPIN LTD
	            6.25MG
	                       A078970   001    Sep   11,   2013

AB
	                             12.5MG
	                       A078970   002    Sep   11,   2013

AB        SANDOZ
	               6.25MG
	                       A090107   001    Jul   01,   2011

AB
	                             12.5MG
	                       A090107   002    Jul   01,   2011

AB        SYNTHON PHARMS
	       6.25MG
	                       A078483   001    Apr   12,   2011

AB
	                             12.5MG
	                       A078483   002    Jun   06,   2011
	
ZONISAMIDE
	
  CAPSULE;ORAL

     ZONEGRAN
	
AB         EISAI INC
	            25MG
	                        N020789 003 Aug 22, 2003

AB
	                              50MG
	                        N020789 002 Aug 22, 2003

AB     +
	                        100MG
	                       N020789 001 Mar 27, 2000
	
     ZONISAMIDE
	
AB         APOTEX INC
	           25MG
	                        A077642   001    Dec   22,   2005

AB
	                              50MG
	                        A077642   002    Dec   22,   2005

AB
	                              100MG
	                       A077642   003    Dec   22,   2005

AB         BANNER PHARMACAPS
	    25MG
	                        A077813   001    Aug   16,   2006

AB
	                              50MG
	                        A077813   002    Aug   16,   2006

AB
	                              100MG
	                       A077813   003    Aug   16,   2006

AB         GLENMARK GENERICS
	    25MG
	                        A077651   001    Jan   30,   2006

AB
	                              50MG
	                        A077651   002    Jan   30,   2006

AB
	                              100MG
	                       A077651   003    Jan   30,   2006

AB         INVAGEN PHARMS
	       25MG
	                        A077869   001    May   31,   2006

AB
	                              50MG
	                        A077869   002    May   31,   2006

AB
	                              100MG
	                       A077869   003    May   31,   2006

AB         MYLAN
	                25MG
	                        A077637   001    Dec   22,   2005

AB
	                              50MG
	                        A077637   002    Dec   22,   2005

AB
	                              100MG
	                       A077637   003    Dec   22,   2005

AB         MYLAN PHARMS INC
	     25MG
	                        A077647   001    Dec   22,   2005

AB
	                              50MG
	                        A077647   002    Dec   22,   2005

AB
	                              100MG
	                       A077647   003    Dec   22,   2005

AB         SUN PHARM INDS (IN)
   25MG
	                        A077634   001    Mar   17,   2006

AB
	                              50MG
	                        A077634   002    Mar   17,   2006

AB
	                              100MG
	                       A077634   003    Mar   17,   2006

AB         WOCKHARDT
	            25MG
	                        A077636   003    Jul   27,   2006

AB
	                              50MG
	                        A077636   002    Jul   27,   2006

AB
	                              100MG
	                       A077636   001    Dec   22,   2005

AB         ZYDUS PHARMS USA
	     25MG
	                        A077625   001    Oct   16,   2006

AB
	                              50MG
	                        A077625   002    Oct   16,   2006

AB
	                              100MG
	                       A077625   003    Oct   16,   2006
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST
	                        4-1(of 17)


ACETAMINOPHEN
	
  SUPPOSITORY;RECTAL
	
    ACEPHEN
	
         G AND W LABS
	         120MG
	                          N018060   001
	
                                325MG
	                          A072344   001 Mar 27, 1992
	
                                325MG
	                          N018060   003 Dec 18, 1986
	
                                650MG
	                          A072237   001 Mar 27, 1992
	
                                650MG
	                          N018060   002
	
   ACETAMINOPHEN
	
        PERRIGO NEW YORK
	      120MG
	                          A070607   001 Apr 06, 1987

                                650MG
	                          A070608   001 Dec 01, 1986
	
         TARO PHARMS NORTH
	    120MG
	                          N018337   003 Sep 12, 1983

                                325MG
	                          N018337   002
	
     +
	                        650MG
	                          N018337   001
	
   INFANTS' FEVERALL
	
         TARO PHARMS NORTH
	    80MG
	                           N018337 004 Aug 26, 1992
	
   NEOPAP
	
         POLYMEDICA
	           120MG
	                          N016401 001
	
 TABLET, EXTENDED RELEASE;ORAL
	
   ACETAMINOPHEN
	
         OHM LABS
	             650MG
	                          A076200 001 Mar 19, 2002
	
         PERRIGO
	              650MG
	                          A075077 001 Feb 25, 2000
	
         RANBAXY LABS LTD
	     650MG
	                          A078569 001 Dec 14, 2011
	
   TYLENOL
	
     + MCNEIL CONS
	            650MG
	                          N019872 001 Jun 08, 1994
	
     +
	                        650MG
	                          N019872 002 Jan 11, 2001
	
ACETAMINOPHEN; ASPIRIN; CAFFEINE
	
  TABLET;ORAL
	
    ACETAMINOPHEN, ASPIRIN AND CAFFEINE
	
         PERRIGO                250MG;250MG;65MG
	               A075794 001 Nov 26, 2001
	
    EXCEDRIN (MIGRAINE)

      + NOVARTIS                250MG;250MG;65MG
	               N020802 001 Jan 14, 1998
	
ALCOHOL; CHLORHEXIDINE GLUCONATE
	
  SOLUTION;TOPICAL
	
    AVAGARD
	
      + 3M                      61%;1%
	                         N021074 001 Jun 07, 2001
	
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
	
  TABLET, CHEWABLE;ORAL
	
    FOAMCOAT
	
         GUARDIAN DRUG          80MG;20MG
	                      A071793 001 Sep 04, 1987
	
    GAVISCON
	
         SANOFI AVENTIS US      80MG;20MG
	                      N018685 001 Dec 09, 1983
	
      +                         160MG;40MG
	                     N018685 002 Dec 09, 1983
	
ASPIRIN
	
  CAPSULE;ORAL
	
    ASPIRIN
	
      + PLX PHARMA              325MG
	                          N203697 001 Jan 14, 2013
	
AVOBENZONE; ECAMSULE; OCTOCRYLENE
	
  CREAM;TOPICAL
	
    ANTHELIOS SX
	
      + LOREAL USA              2%;2%;10%
	                      N021502 001 Jul 21, 2006
	
    CAPITAL SOLEIL 15
	
      + LOREAL USA              2%;3%;10%
	                      N021501 001 Oct 02, 2006
	
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
	
  CREAM;TOPICAL
	
    ANTHELIOS 20
	
      + LOREAL USA              2%;2%;10%;2%
	                   N021471 001 Oct 05, 2006
	
    ANTHELIOS 40
	
      + LOREAL USA              2%;3%;10%;5%
	                   N022009 001 Mar 31, 2008
	
      +                         2%;3%;10%;5%
	                   N022009 002 Oct 29, 2009
	
AVOBENZONE; OCTINOXATE; OXYBENZONE
	
  LOTION;TOPICAL
	
    SHADE UVAGUARD
	
      + SCHERING PLOUGH         3%;7.5%;3%
	                     N020045 001 Dec 07, 1992
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST                         4-2(of 17)

BENTOQUATAM
  LOTION;TOPICAL
    IVY BLOCK
      + STAND HOMEOPATH         5%                             N020532 001 Aug 26, 1996
BUTENAFINE HYDROCHLORIDE
  CREAM;TOPICAL
    LOTRIMIN ULTRA
      + SCHERING PLOUGH         1%                             N021307 001 Dec 07, 2001
BUTOCONAZOLE NITRATE
  CREAM;VAGINAL
    FEMSTAT 3
      + BAYER                   2%                             N020421 001 Dec 21, 1995
CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
	
  TABLET, CHEWABLE;ORAL
	
    CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE
	
         PERRIGO R AND D        800MG;10MG;165MG               A077355 001 Feb 06, 2008
	
    PEPCID COMPLETE
	
      + MCNEIL CONS             800MG;10MG;165MG		             N020958 001 Oct 16, 2000
	
CETIRIZINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    CETIRIZINE HYDROCHLORIDE ALLERGY
	
         BANNER PHARMACAPS      5MG                            N022429 001 Jul 23, 2009
	
      +                         10MG		                         N022429 004 Jul 23, 2009
	
    CETIRIZINE HYDROCHLORIDE HIVES RELIEF
	
         BANNER PHARMACAPS      5MG                            N022429 003 Jul 23, 2009
	
      +                         10MG                           N022429 002 Jul 23, 2009
	
  SYRUP;ORAL
	
    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
	
         AMNEAL PHARMS          5MG/5ML                        A090765   002   Oct   07,   2009
	
         AUROBINDO PHARMA       5MG/5ML                        A090750   002   Feb   02,   2010
	
         BIO PHARM INC          5MG/5ML                        A090474   002   Mar   30,   2009
	
         CYPRESS PHARM          5MG/5ML                        A090300   001   Oct   10,   2008
	
         PERRIGO R AND D        5MG/5ML                        A204226   001   Sep   09,   2013

                                5MG/5ML                        A090254   002   Apr   09,   2008

         SILARX                 5MG/5ML                        A091130   001   Apr   22,   2011

         SUN PHARM INDS INC     5MG/5ML                        A091327   001   Oct   17,   2011
	
         TARO                   5MG/5ML                        A090182   002   Apr   22,   2008

                                5MG/5ML                        A201546   001   May   20,   2011

         TRIS PHARMA INC        5MG/5ML                        A090572   001   Nov   16,   2012
	
    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
	
         AMNEAL PHARMS          5MG/5ML                        A090765   001   Oct   07,   2009
	
         AUROBINDO PHARMA       5MG/5ML                        A090750   001   Feb   02,   2010
	
         BIO PHARM INC          5MG/5ML                        A090474   001   Mar   30,   2009
	
         CYPRESS PHARM          5MG/5ML                        A090300   002   Oct   10,   2008
	
         PERRIGO R AND D        5MG/5ML                        A090254   001   Apr   09,   2008

         SILARX                 5MG/5ML                        A091130   002   Apr   22,   2011

         SUN PHARM INDS INC     5MG/5ML                        A091327   002   Oct   17,   2011
	
         TARO                   5MG/5ML                        A090182   001   Apr   22,   2008

                                5MG/5ML                        A201546   002   May   20,   2011

         TRIS PHARMA INC        5MG/5ML                        A090572   002   Nov   16,   2012
	
    CHILDREN'S ZYRTEC ALLERGY
	
      + MCNEIL CONSUMER         5MG/5ML                        N022155 002 Nov 16, 2007
	
    CHILDREN'S ZYRTEC HIVES RELIEF
	
      + MCNEIL CONSUMER         5MG/5ML                        N022155 001 Nov 16, 2007
	
  TABLET;ORAL
	
    CETIRIZINE HYDROCHLORIDE ALLERGY
	
         AMNEAL PHARMS NY       5MG                            A078780   001   Jan   21,   2010
	
                                10MG                           A078780   004   Jan   21,   2010
	
         APOTEX INC             5MG                            A078317   001   Dec   27,   2007
	
                                10MG                           A078317   002   Dec   27,   2007
	
         CADISTA PHARMS         5MG                            A078933   001   Jun   15,   2010
	
                                10MG                           A078933   002   Jun   15,   2010
	
         CIPLA LTD              5MG                            A077318   001   Jul   25,   2013
	
                                10MG                           A077318   002   Jul   25,   2013
	
         CONTRACT PHARMACAL     5MG                            A076047   001   Dec   27,   2007
	
                                10MG                           A076047   002   Dec   27,   2007
	
         DR REDDYS LABS LTD     5MG                            A078343   004   Jan   15,   2008
	
                                10MG                           A078343   003   Jan   15,   2008
	
         IPCA LABS LTD		        5MG                            A202277   002   Mar   11,   2014
	
                                10MG                           A202277   004   Mar   11,   2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST
	                       4-3(of 17)


CETIRIZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    CETIRIZINE HYDROCHLORIDE ALLERGY
	
         MYLAN
	                5MG
	                          A076677   001   Dec   27,   2007
	
                                10MG
	                         A076677   002   Dec   27,   2007
	
         ORCHID HLTHCARE
	      5MG
	                          A078862   001   Feb   19,   2009
	
                                10MG
	                         A078862   002   Feb   19,   2009
	
         PERRIGO R AND D
	      5MG
	                          A078336   001   Dec   27,   2007
	
                                10MG
	                         A078336   002   Dec   27,   2007
	
         RANBAXY
	              5MG
	                          A077498   001   Dec   27,   2007
	
                                10MG
	                         A077498   002   Dec   27,   2007
	
         SANDOZ
	               5MG
	                          A077946   001   Dec   27,   2007
	
                                10MG
	                         A077946   002   Dec   27,   2007
	
         SUN PHARM INDS INC
	   5MG
	                          A077499   001   Dec   27,   2007
	
                                10MG
	                         A077499   002   Dec   27,   2007
	
         TARO
	                 5MG
	                          A078072   001   Jul   22,   2009
	
                                5MG
	                          A078072   003   Jul   22,   2009
	
         TORRENT PHARMS LLC
	   5MG
	                          A079191   001   Apr   15,   2010

                                10MG
	                         A079191   004   Apr   15,   2010

         UNICHEM
	              5MG
	                          A078680   003   Jun   26,   2009
	
                                10MG
	                         A078680   004   Jun   26,   2009
	
         UNIQUE PHARM LABS
	    5MG
	                          A077829   001   Aug   26,   2009

                                10MG
	                         A077829   004   Aug   26,   2009

         WOCKHARDT
	            5MG
	                          A078427   003   Dec   28,   2007
	
                                10MG
	                         A078427   004   Dec   28,   2007
	
    CETIRIZINE HYDROCHLORIDE HIVES
	
         CADISTA PHARMS
	       5MG
	                          A078933   003   Jun   15,   2010
	
                                10MG
	                         A078933   004   Jun   15,   2010
	
         DR REDDYS LABS LTD
	   5MG
	                          A078343   001   Jan   15,   2008
	
                                10MG
	                         A078343   002   Jan   15,   2008
	
         IPCA LABS LTD
	        5MG
	                          A202277   001   Mar   11,   2014
	
                                10MG
	                         A202277   003   Mar   11,   2014
	
         MYLAN
	                5MG
	                          A076677   004   Dec   27,   2007
	
                                10MG
	                         A076677   003   Dec   27,   2007
	
         ORCHID HLTHCARE
	      5MG
	                          A078862   003   Feb   19,   2009
	
                                10MG
	                         A078862   004   Feb   19,   2009
	
         PERRIGO R AND D
	      5MG
	                          A078336   003   Dec   27,   2007
	
                                10MG
	                         A078336   004   Dec   27,   2007
	
         RANBAXY
	              5MG
	                          A077498   003   Dec   27,   2007
	
                                10MG
	                         A077498   004   Dec   27,   2007
	
         SUN PHARM INDS INC
	   5MG
	                          A077499   003   Dec   27,   2007
	
                                10MG
	                         A077499   004   Dec   27,   2007
	
         UNICHEM
	              5MG
	                          A078680   001   Jun   26,   2009
	
                                10MG
	                         A078680   002   Jun   26,   2009
	
         UNIQUE PHARM LABS
	    5MG
	                          A077829   003   Aug   26,   2009

                                10MG
	                         A077829   002   Aug   26,   2009
	
    CETIRIZINE HYDROCHLORIDE HIVES RELIEF
	
         AMNEAL PHARMS NY       5MG                            A078780   003   Jan   21,   2010
	
                                10MG                           A078780   002   Jan   21,   2010
	
         TARO                   10MG                           A078072   002   Jul   22,   2009
	
                                10MG                           A078072   004   Jul   22,   2009
	
         TORRENT PHARMS LLC     5MG                            A079191   003   Apr   15,   2010

                                10MG                           A079191   002   Apr   15,   2010
	
    ZYRTEC ALLERGY
         MCNEIL CONSUMER        5MG                            N019835 003 Nov 16, 2007
	
      +                         10MG                           N019835 004 Nov 16, 2007
	
    ZYRTEC HIVES RELIEF
         MCNEIL CONSUMER        5MG                            N019835 005 Nov 16, 2007
	
      +                         10MG                           N019835 006 Nov 16, 2007
	
  TABLET, CHEWABLE;ORAL
    CETIRIZINE HYDROCHLORIDE ALLERGY
	
         SANDOZ                 5MG
	                          A078692 001 Feb 14, 2008
	
      +                         10MG
	                         A078692 002 Feb 14, 2008
	
    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
	
         SUN PHARMA GLOBAL      5MG
	                          A090142 001 Aug 30, 2011

                                10MG
	                         A090142 002 Aug 30, 2011
	
    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
	
         SUN PHARMA GLOBAL      5MG
	                          A090142 003 Aug 30, 2011

                                10MG
	                         A090142 004 Aug 30, 2011
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    ZYRTEC ALLERGY
	
      + MCNEIL CONSUMER         10MG
	                         N022578 001 Sep 03, 2010
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                   OTC DRUG PRODUCT LIST
	                         4-4(of 17)


CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
         IVAX SUB TEVA PHARMS
	 5MG;120MG
	                        A077170 001 Feb 25, 2008
	
         SANDOZ
	                5MG;120MG
	                       A077991 001 Mar 05, 2008
	
         SUN PHARM INDS LTD
	    5MG;120MG
	                       A090922 001 Sep 28, 2012
	
    ZYRTEC-D 12 HOUR
	
      + MCNEIL
	                 5MG;120MG
	                       N021150 002 Nov 09, 2007
	
CHLORHEXIDINE GLUCONATE
	
  AEROSOL, METERED;TOPICAL
	
    EXIDINE
	
      + XTTRIUM
	                4%
	                              N019127 001 Dec 24, 1984
	
  CLOTH;TOPICAL
	
    CHLORHEXIDINE GLUCONATE
	
      + SAGE PRODS
	             2%
	                              N021669 001 Apr 25, 2005
	
  SOLUTION;TOPICAL
	
    BRIAN CARE
	
         SOAPCO
	                4%
	                              A071419 001 Dec 17, 1987
	
    CHG SCRUB
	
         ECOLAB
	                4%
	                              N019258 002 Jul 22, 1986
	
    CIDA-STAT
	
         ECOLAB
	                2%
	                              N019258 001 Jul 22, 1986
	
    DYNA-HEX
	
         BAJAJ MEDICAL LLC
	     0.75%
	                           N020111 001 Sep 11, 1997
	
    EXIDINE
	
      + XTTRIUM
	                2%
	                              N019422 001 Dec 17, 1985
	
                                 4%
	                              N019125 001 Dec 24, 1984
	
    HIBICLENS
	
      + MOLNLYCKE HLTH
	         4%
	                              N017768 001
	
    HIBISTAT
	
      + MOLNLYCKE HLTH
	         0.5%
	                            N018300 001
	
  SPONGE;TOPICAL
	
    BIOSCRUB
	
         GRIFFEN
	               4%
	                              N019822 001 Mar 31, 1989
	
    CHLORHEXIDINE GLUCONATE
	
         BECTON DICKINSON
	      4%
	                              A072525 001 Oct 24, 1989
	
    PHARMASEAL SCRUB CARE
	
      + CAREFUSION
	             4%
	                              N019793 001 Dec 02, 1988
	
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
	
  SPONGE;TOPICAL
	
    CHLORAPREP ONE-STEP
	
      + CAREFUSION
	              2%;70% (3ML)
                    N020832 001 Jul 14, 2000
	
      +
	                         2%;70% (10.5ML)
                 N020832 004 Aug 20, 2003

      +
	                         2%;70% (26ML)
	                  N020832 006 Nov 21, 2006
	
    CHLORAPREP ONE-STEP FREPP
	
      + CAREFUSION
	              2%;70% (1.5ML)
	                 N020832 003 Apr 26, 2002
	
    CHLORAPREP WITH TINT
	
      + CAREFUSION
	              2%;70% (26ML)
                   N020832 002 May 03, 2005

      +
	                         2%;70% (10.5ML)
                 N020832 005 Apr 03, 2006

      +
	                         2%;70% (3ML)
	                   N020832 007 Oct 10, 2006
	
  SWAB;TOPICAL
	
    CHLORAPREP ONE-STEP SEPP
	
      + CAREFUSION
	              2%;70% (0.67ML)
	                N021555 001 Oct 07, 2002
	
    CHLORAPREP SINGLE SWABSTICK
	
      + CAREFUSION
	              2%;70% (1.75ML)
	                N021555 002 May 10, 2005
	
    CHLORAPREP TRIPLE SWABSTICK
	
      + CAREFUSION
	              2%;70% (5.25ML)
	                N021555 003 Jun 10, 2009
	
    PREVANTICS MAXI SWABSTICK
	
      + PROF DSPLS
	              3.15%;70% (5.1ML)
	              N021524 003 Jun 03, 2005
	
    PREVANTICS SWAB
	
      + PROF DSPLS
	              3.15%;70% (1ML)
	                N021524 001 Jun 03, 2005
	
    PREVANTICS SWABSTICK
	
      + PROF DSPLS
	              3.15%;70% (1.6ML)
	              N021524 002 Jun 03, 2005
	
CHLORPHENIRAMINE MALEATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    CHLOR-TRIMETON
	
      + SCHERING PLOUGH
	        12MG
	                            N007638 002
	
    CHLORPHENIRAMINE MALEATE
	
         AVANTHI INC
	           12MG
	                            A040829 001 May 13, 2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                   OTC DRUG PRODUCT LIST
	                              4-5(of 17)


CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ADVIL ALLERGY AND CONGESTION RELIEF
	
      + PFIZER                  4MG;200MG;10MG
	                       N022113 001 Dec 21, 2011
	
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  SUSPENSION;ORAL
	
    CHILDREN'S ADVIL ALLERGY SINUS
	
      + PFIZER		                1MG/5ML;100MG/5ML;15MG/5ML
            N021587 001 Feb 24, 2004
	
  TABLET;ORAL
	
    ADVIL ALLERGY SINUS
	
      + PFIZER                  2MG;200MG;30MG
	                       N021441 001 Dec 19, 2002
	
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    CHLOR-TRIMETON
	
      + SCHERING PLOUGH
	        8MG;120MG
	                           N018397 001
	
CIMETIDINE
	
  TABLET;ORAL
	
    CIMETIDINE
	
         APOTEX
	                 100MG
	                              A074948   001   Jun   19,   1998
	
                                  200MG
	                              A074948   002   Jul   26,   2002
	
         CONTRACT PHARMACAL
	     200MG
	                              A074961   001   Jun   19,   1998
	
                                  200MG
	                              A074963   001   Jun   19,   1998
	
         IVAX SUB TEVA PHARMS
	   200MG
	                              A075345   001   Jun   16,   1999
	
         PERRIGO
	                200MG
	                              A075285   001   Oct   29,   1998
	
    TAGAMET HB
	
      + MEDTECH PRODUCTS
	        200MG
	                              N020238 002 Aug 21, 1996
	
CLEMASTINE FUMARATE
	
  TABLET;ORAL
	
    CLEMASTINE FUMARATE
	
          PERRIGO
	               1.34MG
	                             A074512 001 Nov 22, 1995
	
          SANDOZ
	                1.34MG
	                             A073458 001 Oct 31, 1993
	
    TAVIST-1
	
      +		 NOVARTIS
	              1.34MG
	                             N020925 001 Aug 21, 1992
	
CLOTRIMAZOLE
	
  CREAM;VAGINAL
	
    CLOTRIMAZOLE
	
          ACTAVIS MID ATLANTIC
	 1%
	                                  A074165 001 Jul 16, 1993
	
          TARO
	                 1%
	                                  A072641 001 Dec 04, 1995
	
    GYNE-LOTRIMIN
	
      + SCHERING PLOUGH
	        1%
	                                  N018052 002 Nov 30, 1990
	
    GYNE-LOTRIMIN 3
	
      + SCHERING PLOUGH
	        2%
	                                  N020574 001 Nov 24, 1998
	
    MYCELEX-7
	
          BAYER HEALTHCARE LLC
	 1%
	                                  N018230 002 Dec 26, 1991
	
    TRIVAGIZOLE 3
	
          TARO
	                 2%
	                                  N021143 001 Apr 12, 2000
	
  CREAM, TABLET;TOPICAL, VAGINAL
	
    GYNE-LOTRIMIN 3 COMBINATION PACK
	
      + BAYER HEALTHCARE LLC     200MG;200MG
	                         N020526 002 Jul 29, 1996
	
    GYNE-LOTRIMIN COMBINATION PACK
	
      + SCHERING PLOUGH          100MG;100MG
	                         N020289 002 Apr 26, 1993
	
    MYCELEX-7 COMBINATION PACK
	
          BAYER HEALTHCARE LLC
	 1%;100MG
	                            N020389 002 Jun 23, 1994
	
  TABLET;VAGINAL
	
    GYNE-LOTRIMIN
	
      + SCHERING PLOUGH
	        100MG
	                               N017717 002 Nov 30, 1990
	
    GYNE-LOTRIMIN 3
	
      +		 BAYER HEALTHCARE LLC
	 200MG
	                               N020525 001 Jul 29, 1996
	
    MYCELEX-7
	
          BAYER HEALTHCARE LLC
	 100MG
	                               N018182 002 Dec 26, 1991
	
CROMOLYN SODIUM
	
  SPRAY, METERED;NASAL
	
    CROMOLYN SODIUM
	
      +		 BAUSCH AND LOMB
	       5.2MG/SPRAY
                         A075702 001 Jul 03, 2001
	
          PERRIGO
	               5.2MG/SPRAY
	                        A075427 001 Dec 12, 2001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST                                  4-6(of 17)


DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE
	
      + AVANTHI INC              6MG;120MG                              A078648 001 Feb 27, 2013
	
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
	
  TABLET, EXTENDED RELEASE;ORAL
	
    MUCINEX DM
         RECKITT BENCKISER       30MG;600MG                             N021620 002 Apr 29, 2004
      +                          60MG;1.2GM                             N021620 001 Apr 29, 2004
DEXTROMETHORPHAN POLISTIREX
  SUSPENSION, EXTENDED RELEASE;ORAL
    DELSYM
      + RECKITT BENCKISER       EQ 30MG HBR/5ML                         N018658 001 Oct 08, 1982
    DEXTROMETHORPHAN POLISTIREX
         TRIS PHARMA INC        EQ 30MG HBR/5ML                         A091135 001 May 25, 2012
DIPHENHYDRAMINE CITRATE; IBUPROFEN
  TABLET;ORAL
    ADVIL PM
      + PFIZER                  38MG;200MG                              N021394 001 Dec 21, 2005
    IBUPROFEN AND DIPHENHYDRAMINE CITRATE
         DR REDDYS LABS LTD     38MG;200MG                              A090619 001 Jul 08, 2009
         PERRIGO R AND D        38MG;200MG                              A079113 001 Dec 22, 2008
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
  CAPSULE;ORAL
    ADVIL PM
      + PFIZER                  25MG;EQ 200MG FREE ACID AND POTASSIUM   N021393 001 Dec 21, 2005
                                SALT
    IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
         BANNER PHARMACAPS      25MG;EQ 200MG FREE ACID AND POTASSIUM   A090397 001 Nov 22, 2010
                                SALT
         STRIDES PHARMA         25MG;EQ 200MG FREE ACID AND POTASSIUM   A200888 001 Mar 05, 2012
                                SALT
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
  TABLET;ORAL
    ALEVE PM
      + BAYER HLTHCARE          25MG;220MG                              N205352 001 Jan 17, 2014
DOCOSANOL
  CREAM;TOPICAL
    ABREVA
      + GLAXOSMITHKLINE         10%                                     N020941 001 Jul 25, 2000
DOXYLAMINE SUCCINATE
  TABLET;ORAL
    DOXYLAMINE SUCCINATE
         LNK                    25MG                                    A040564 001 Aug 27, 2004
         PERRIGO                25MG                                    A040167 001 Sep 18, 1996
    UNISOM
      + CHATTEM                 25MG                                    N018066 001
ESOMEPRAZOLE MAGNESIUM
  CAPSULE, DELAYED RELEASE;ORAL
    NEXIUM 24HR
      + ASTRAZENECA LP          EQ 20MG BASE                            N204655 001 Mar 28, 2014
FAMOTIDINE
  TABLET;ORAL
    FAMOTIDINE
         DR REDDYS LABS LTD     10MG                                    A075758   001   Aug   17,   2001
                                20MG                                    A077367   001   Sep   25,   2006
        IVAX SUB TEVA PHARMS    10MG                                    A075512   001   Jul   26,   2001
        MYLAN                   10MG                                    A075674   001   Dec   21,   2001
        PERRIGO                 10MG                                    A075400   001   Mar   18,   2005
                                20MG                                    A077351   001   Sep   25,   2006
        RANBAXY                 10MG                                    A090283   001   Nov   17,   2009
                                20MG                                    A090283   002   Nov   17,   2009
        TEVA                    10MG                                    A075312   001   May   31,   2001
        WOCKHARDT               10MG                                    A077146   001   Mar   07,   2005
                                20MG                                    A090837   001   Aug   04,   2010
   PEPCID AC
        MCNEIL CONS             10MG                                    N020325 001 Apr 28, 1995
     +                          20MG                                    N020325 002 Sep 23, 2003
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                 OTC DRUG PRODUCT LIST                          4-7(of 17)

FAMOTIDINE
  TABLET;ORAL
    PEPCID AC
         MCNEIL CONS           10MG                            N020902 001 Aug 05, 1999
  TABLET, CHEWABLE;ORAL
    FAMOTIDINE
         PERRIGO               10MG                            A075715 001 Aug 22, 2003
    PEPCID AC
      + MCNEIL CONS            20MG                            N020801 002 Dec 17, 2007
FEXOFENADINE HYDROCHLORIDE
  SUSPENSION;ORAL
    CHILDREN'S ALLEGRA ALLERGY
      + SANOFI AVENTIS US       30MG/5ML                       N201373 001 Jan 24, 2011
    CHILDREN'S ALLEGRA HIVES
      + SANOFI AVENTIS US       30MG/5ML                       N201373 002 Jan 24, 2011
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE   ALLERGY
         ACTAVIS MID ATLANTIC   30MG/5ML                       A203330 001 Nov 18, 2014
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE   HIVES
         ACTAVIS MID ATLANTIC   30MG/5ML                       A203330 002 Nov 18, 2014
  TABLET;ORAL
    ALLEGRA ALLERGY
         SANOFI AVENTIS US      60MG                           N020872 007 Jan 24, 2011
      +                         180MG                          N020872 010 Jan 24, 2011
    ALLEGRA HIVES
         SANOFI AVENTIS US      60MG                           N020872 008 Jan 24, 2011
      +                         180MG                          N020872 009 Jan 24, 2011
    CHILDREN'S ALLEGRA ALLERGY
         SANOFI AVENTIS US      30MG                           N020872 005 Jan 24, 2011
    CHILDREN'S ALLEGRA HIVES
         SANOFI AVENTIS US      30MG                           N020872 006 Jan 24, 2011
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE   ALLERGY
         AUROLIFE PHARMA LLC    30MG                           A202039   001   Nov   19,   2014
         DR REDDYS LABS LTD     30MG                           A076502   004   Apr   12,   2011
         MYLAN                  30MG                           A077081   004   Jul   21,   2011
         SUN PHARM INDS         30MG                           A091567   002   Feb   06,   2012
         TEVA                   30MG                           A076447   004   Apr   13,   2011
         WOCKHARDT LTD          30MG                           A079112   002   Feb   08,   2012
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE   HIVES
         DR REDDYS LABS LTD     30MG                           A076502   005   Apr   12,   2011
         MYLAN                  30MG                           A077081   005   Jul   21,   2011
         SUN PHARM INDS         30MG                           A091567   001   Feb   06,   2012
         TEVA                   30MG                           A076447   005   Apr   13,   2011
         WOCKHARDT LTD          30MG                           A079112   001   Feb   08,   2012
    FEXOFENADINE HYDROCHLORIDE ALLERGY
         AUROLIFE PHARMA LLC    60MG                           A202039   002   Nov   19,   2014
                                180MG                          A202039   003   Nov   19,   2014
         DR REDDYS LABS LTD     60MG                           A076502   006   Apr   12,   2011
                                180MG                          A076502   008   Apr   12,   2011
         MYLAN                  60MG                           A077081   006   Jul   21,   2011
                                180MG                          A077081   008   Jul   21,   2011
         SUN PHARM INDS         60MG                           A091567   004   Feb   06,   2012
                                180MG                          A091567   006   Feb   06,   2012
         TEVA                   60MG                           A076447   006   Apr   13,   2011
                                180MG                          A076447   008   Apr   13,   2011
         WOCKHARDT LTD          60MG                           A079112   004   Feb   08,   2012
                                180MG                          A079112   006   Feb   08,   2012
    FEXOFENADINE HYDROCHLORIDE HIVES
         DR REDDYS LABS LTD     60MG                           A076502   007   Apr   12,   2011
                                180MG                          A076502   009   Apr   12,   2011
         MYLAN                  60MG                           A077081   007   Jul   21,   2011
                                180MG                          A077081   009   Jul   21,   2011
         SUN PHARM INDS         60MG                           A091567   003   Feb   06,   2012
                                180MG                          A091567   005   Feb   06,   2012
         TEVA                   60MG                           A076447   007   Apr   13,   2011
                                180MG                          A076447   009   Apr   13,   2011
         WOCKHARDT LTD          60MG                           A079112   003   Feb   08,   2012
                                180MG                          A079112   005   Feb   08,   2012
  TABLET, ORALLY DISINTEGRATING;ORAL
    CHILDREN'S ALLEGRA ALLERGY
      + SANOFI AVENTIS US       30MG                           N021909 002 Jan 24, 2011
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                   OTC DRUG PRODUCT LIST
	                                      4-8(of 17)


FEXOFENADINE HYDROCHLORIDE
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    CHILDREN'S ALLEGRA HIVES
	
      + SANOFI AVENTIS US       30MG
	                                         N021909 003 Jan 24, 2011
	
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
	
         DR REDDYS LABS LTD     30MG
	                                         A202978 001 Jan 18, 2013
	
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
	
         DR REDDYS LABS LTD     30MG
	                                         A202978 002 Jan 18, 2013
	
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
	
      + SANOFI AVENTIS US        60MG;120MG
	                                  N020786 002 Jan 24, 2011
	
    ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
	
      + SANOFI AVENTIS US        180MG;240MG
	                                 N021704 002 Jan 24, 2011
	
    FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
         DR REDDYS LABS LTD
	    60MG;120MG
	                                  A076667 001 Nov 18, 2014
	
                                 180MG;240MG
	                                 A079043 002 Jun 22, 2011
	
FLUTICASONE PROPIONATE
	
  SPRAY, METERED;NASAL
	
    FLONASE ALLERGY RELIEF
	
      + GLAXOSMITHKLINE CONS
	    0.05MG/SPRAY
	                               N205434 001 Jul 23, 2014
	
GUAIFENESIN
	
  TABLET, EXTENDED RELEASE;ORAL
	
    GUAIFENESIN
	
         PERRIGO R AND D
	       600MG
	                                       A078912 001 Nov 23, 2011
	
    MUCINEX
	
      + RECKITT BENCKISER
	      1.2GM
	                                       N021282 002 Dec 18, 2002
	
                                 600MG
	                                       N021282 001 Jul 12, 2002
	
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    MUCINEX D
	
      + RECKITT BENCKISER
	      1.2GM;120MG
	                                 N021585 002 Jun 22, 2004
	
                                 600MG;60MG
	                                  N021585 001 Jun 22, 2004
	
IBUPROFEN
	
  CAPSULE;ORAL
	
    ADVIL LIQUI-GELS
	
      + PFIZER
	                  EQ 200MG FREE ACID AND POTASSIUM SALT
	      N020402 001 Apr 20, 1995
	
    ADVIL MIGRAINE LIQUI-GELS
	
      + PFIZER
	                  EQ 200MG FREE ACID AND POTASSIUM SALT
	      N020402 002 Mar 16, 2000
	
    IBUPROFEN
	
         AMNEAL PHARMS
	          EQ 200MG    FREE ACID AND POTASSIUM SALT
	   A202300   001   Dec   23,   2011
	
         BANNER PHARMACAPS
	      EQ 200MG    FREE ACID AND POTASSIUM SALT
	   A078682   001   Mar   24,   2009
	
      + CONTRACT PHARMACAL
	      200MG
	                                      A074782   001   Jul   06,   1998
	
         MARKSANS PHARMA
	        EQ 200MG    FREE ACID AND POTASSIUM SALT
	   A079205   001   Jun   26,   2009
	
         P AND L DEV LLC
	        EQ 200MG    FREE ACID AND POTASSIUM SALT
	   A077338   001   Jul   10,   2009
	
    MIDOL LIQUID GELS
	
      + BANNER PHARMACAPS
	       200MG
	                                      N021472 001 Oct 18, 2002
	
  SUSPENSION;ORAL
	
    CHILDREN'S ADVIL
	
         PFIZER
	                 100MG/5ML
	                                  N020589 001 Jun 27, 1996
	
    CHILDREN'S ADVIL-FLAVORED
	
         PFIZER
	                 100MG/5ML
	                                  N020589 002 Nov 07, 1997
	
    CHILDREN'S ELIXSURE
	
         MOBERG PHARMA NORTH
	    100MG/5ML
	                                  N021604 001 Jan 07, 2004
	
    CHILDREN'S IBUPROFEN
	
         PERRIGO
	                100MG/5ML
	                                  A074937 001 Dec 22, 1998
	
    CHILDREN'S MOTRIN
	
      + MCNEIL
	                  100MG/5ML
	                                  N020516 001 Jun 16, 1995
	
    IBUPROFEN
	
         ACTAVIS MID ATLANTIC
	   100MG/5ML
                                   A074916 001 Apr 30, 1999

         AMNEAL PHARMS
	          100MG/5ML
	                                  A200457 001 Aug 18, 2011
	
  SUSPENSION/DROPS;ORAL

    CHILDREN'S MOTRIN
	
      + MCNEIL CONS
	             40MG/ML
	                                    N020603 001 Jun 10, 1996
	
    IBUPROFEN
	
         PERRIGO
	                40MG/ML
                                     A075217 001 Dec 16, 1998
	
         TRIS PHARMA INC
	        40MG/ML
	                                    A079058 001 Aug 31, 2009
	
    PEDIATRIC ADVIL
	
      + PFIZER
	                  100MG/2.5ML
	                                N020812 001 Jan 30, 1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                   OTC DRUG PRODUCT LIST
	                       4-9(of 17)


IBUPROFEN
	
  TABLET;ORAL
	
    ADVIL
	
         PFIZER
	                200MG
	                        N018989 001 May 18, 1984
	
    IBU-TAB 200
	
         ALRA
	                  200MG
	                        A071057 001 Aug 11, 1988
	
    IBUPROFEN
	
         AMNEAL PHARMS
	         200MG
	                        A079233   001   Mar   18,   2014
	
         AMNEAL PHARMS NY
	      200MG
	                        A071333   001   Feb   17,   1987
	
                                 200MG
	                        A072199   001   May   23,   1988

         AVEMA PHARMA
	          200MG
	                        A076460   001   Nov   26,   2003
	
         CONTRACT PHARMACAL
	    200MG
	                        A071732   001   Sep   10,   1987

                                 200MG
	                        A071735   001   Sep   10,   1987

                                 200MG
	                        A072299   001   Jul   01,   1988
	
                                 200MG
	                        A074931   001   Jul   20,   1998
	
         DR REDDYS LA
	          200MG
	                        A075661   001   Dec   12,   2001
	
         DR REDDYS LABS INC
	    100MG
	                        A076117   001   Nov   20,   2001
	
         GRANULES INDIA
	        200MG
	                        A079174   001   Dec   10,   2010
	
         LNK
	                   100MG
	                        A076741   001   Jun   17,   2004
	
                                 200MG
	                        A075010   001   Mar   01,   1999
	
                                 200MG
	                        A075139   001   Mar   01,   1999
	
         MARKSANS PHARMA
	       200MG
	                        A091237   001   Feb   08,   2011
	
                                 200MG
	                        A091239   001   Feb   01,   2011
	
         MCNEIL
	                200MG
	                        A073019   001   Mar   30,   1994
	
         MERRO PHARM
	           200MG
	                        A070985   001   Oct   02,   1987
	
         OHM
	                   200MG
	                        A071163   001   Jul   15,   1986
	
         PAR PHARM
	             200MG
	                        A070481   001   Sep   24,   1986

         PERRIGO
	               200MG
	                        A072096   001   Dec   08,   1987
	
                                 200MG
	                        A075995   001   Mar   14,   2002
	
         PERRIGO R AND D
	       200MG
	                        A077349   001   Jun   21,   2005
	
         SVADS HOLDINGS SA
	     200MG
	                        A079129   001   Mar   28,   2011
	
                                 200MG
	                        A091355   001   Apr   04,   2011

         VINTAGE PHARMS
	        200MG
	                        A071229   001   Apr   01,   1987

                                 200MG
	                        A071639   001   Feb   02,   1988
	
   IBUPROHM
	
        OHM LABS
	               200MG
	                        A071214 001 Dec 01, 1986
	
   JUNIOR STRENGTH ADVIL
	
        PFIZER
	                 100MG
	                        N020267 002 Dec 13, 1996
	
   JUNIOR STRENGTH IBUPROFEN
	
        PERRIGO
	                100MG
	                        A075367 001 Apr 22, 1999
	
   JUNIOR STRENGTH MOTRIN
	
        MCNEIL CONS
	            100MG
	                        N020602 001 Jun 10, 1996
	
   MOTRIN IB
	
     + MCNEIL
	                  200MG
	                        N019012 003 Dec 17, 1990
	
   MOTRIN MIGRAINE PAIN
	
     + MCNEIL
	                  200MG
	                        N019012 004 Feb 25, 2000
	
   PROFEN
	
        CONTRACT PHARMACAL
	     200MG
	                        A071265 001 Oct 15, 1986
	
   TAB-PROFEN
	
        PERRIGO
	                200MG
	                        A072095 001 Dec 08, 1987
	
 TABLET, CHEWABLE;ORAL
	
   CHILDREN'S ADVIL
	
        PFIZER
	                 50MG
	                         N020944 001 Dec 18, 1998
	
   CHILDREN'S MOTRIN
	
        MCNEIL CONS
	            50MG
	                         N020601 001 Nov 15, 1996
	
   IBUPROFEN
	
        PERRIGO
	                50MG
	                         A076359 001 Jan 16, 2004
	
                                 100MG
	                        A076359 002 Jan 16, 2004
	
   JUNIOR STRENGTH ADVIL
	
        PFIZER
	                 100MG
	                        N020944 002 Dec 18, 1998
	
   JUNIOR STRENGTH MOTRIN
	
     + MCNEIL CONS
	             100MG
	                        N020601 003 Nov 15, 1996
	
IBUPROFEN SODIUM
	
  TABLET;ORAL
	
    ADVIL
	
      + PFIZER CONS HLTHCARE
	   EQ 200MG BASE
	                N201803 001 Jun 12, 2012
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST
	                           4-10(of 17)


IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ADVIL CONGESTION RELIEF
	
      + PFIZER                  200MG;10MG
	                           N022565 001
	 May 27, 2010
	
    IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE
	
         PERRIGO R AND D        200MG;10MG
	                           A203200 001
	 Jul 03, 2014
	
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    ADVIL COLD AND SINUS
	
      + PFIZER
	                EQ 200MG FREE ACID AND POTASSIUM
      N021374 001
	 May 30, 2002
	
                                SALT;30MG
	
  SUSPENSION;ORAL
	
    CHILDREN'S ADVIL COLD
	
         PFIZER
	               100MG/5ML;15MG/5ML
	                   N021373 001
	 Apr 18, 2002
	
    CHILDREN'S MOTRIN COLD
	
      + MCNEIL CONS
	           100MG/5ML;15MG/5ML
	                   N021128 001
	 Aug 01, 2000
	
    IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
         PERRIGO                100MG/5ML;15MG/5ML
                    A076478 001
	 Nov 05, 2003
	
  TABLET;ORAL
	
    ADVIL COLD AND SINUS
	
      + PFIZER                  200MG;30MG
	                           N019771 001
	 Sep 19, 1989
	
    IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
         CONTRACT PHARMACAL
	   200MG;30MG
	                           A075588 001
	 Apr 08, 2002

         DR REDDYS LABS LTD
	   200MG;30MG
	                           A077628 001
	 Aug 14, 2006
	
    IBUPROHM COLD AND SINUS
	
         OHM LABS
	             200MG;30MG
	                           A074567 001
	 Apr 17, 2001
	
    SINE-AID IB
	
         MCNEIL CONS
	          200MG;30MG
	                           N019899 001
	 Dec 31, 1992
	
INSULIN RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN R
	
      + LILLY
	                 100 UNITS/ML
	                         N018780 001
	 Oct 28, 1982
	
    HUMULIN R PEN
	
      + LILLY
	                 100 UNITS/ML
	                         N018780 005
	 Aug 06, 1998
	
    NOVOLIN R
	
      + NOVO NORDISK INC
	      100 UNITS/ML
	                         N019938 001
	 Jun 25, 1991
	
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN 70/30

      + LILLY                   30 UNITS/ML;70 UNITS/ML
               N019717 001
	 Apr 25, 1989
	
    HUMULIN 70/30 PEN

      + LILLY                   30 UNITS/ML;70 UNITS/ML
               N019717 002
	 Aug 06, 1998
	
    NOVOLIN 70/30

      + NOVO NORDISK INC        30 UNITS/ML;70 UNITS/ML
	              N019991 001
	 Jun 25, 1991
	
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN N
	
      + LILLY                   100 UNITS/ML
                          N018781 001
	 Oct 28, 1982
	
    NOVOLIN N
	
      + NOVO NORDISK INC        100 UNITS/ML
	                         N019959 001
	 Jul 01, 1991
	
IODINE POVACRYLEX; ISOPROPYL ALCOHOL
	
  SPONGE;TOPICAL
	
    DURAPREP
	
      + 3M
	                    EQ 0.7% IODINE;74% (6ML)
              N021586 001
	 Sep 29, 2006

      +
	                       EQ 0.7% IODINE;74% (26ML)
	            N021586 002
	 Sep 29, 2006
	
KETOCONAZOLE
	
  SHAMPOO;TOPICAL
	
    NIZORAL A-D
	
      + JOHNSON AND JOHNSON
	   1%
	                                   N020310 001
	 Oct 10, 1997
	
KETOTIFEN FUMARATE
	
  SOLUTION/DROPS;OPHTHALMIC

    ALAWAY
	
      + BAUSCH AND LOMB
	       EQ 0.025% BASE
	                       N021996 001
	 Dec 01, 2006
	
    KETOTIFEN FUMARATE
	
         AKORN
	                EQ 0.025% BASE
	                       A077958 001
	 Jul 26, 2007
	
         ALCON PHARMS LTD
	     EQ 0.025% BASE
	                       A077200 001
	 Sep 02, 2008
	
    ZADITOR
	
      + ALCON PHARMA
	          EQ 0.025% BASE
	                       N021066 002
	 Oct 19, 2006
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST                        4-11(of 17)


LANSOPRAZOLE
	
  CAPSULE, DELAYED REL PELLETS;ORAL
	
    LANSOPRAZOLE
	
         DR REDDYS LABS LTD     15MG                           A202194 001 May 18, 2012

         PERRIGO R AND D        15MG                           A202319 001 May 18, 2012

         WOCKHARDT LTD          15MG                           A202727 001 May 18, 2012

    PREVACID 24 HR
	
      + NOVARTIS                15MG                           N022327 001 May 18, 2009
	
LEVONORGESTREL
	
  TABLET;ORAL
	
    FALLBACK SOLO
	
         LUPIN LTD              1.5MG                          A201446 001 Jun 19, 2014
	
    LEVONORGESTREL
	
         FAMY CARE LTD          1.5MG                          A202739   001   Oct   31,   2014
         NOVEL LABS INC         1.5MG                          A202508   001   Feb   22,   2013
         PERRIGO R AND D        0.75MG                         A090740   001   Dec   30,   2010
                                1.5MG                          A202334   001   Aug   20,   2014
     +  WATSON LABS             0.75MG                         A078665   001   Aug   28,   2009
        WATSON LABS INC         1.5MG                          A200670   001   Jul   12,   2012
   OPCICON ONE-STEP
        SUN PHARM INDS LTD      1.5MG                          A202635 001 Sep 11, 2014
   PLAN B
     + TEVA BRANDED PHARM       0.75MG                         N021045 002 Aug 24, 2006
   PLAN B ONE-STEP
     + TEVA BRANDED PHARM       1.5MG                          N021998 001 Jul 10, 2009
LOPERAMIDE HYDROCHLORIDE
  CAPSULE;ORAL
    LOPERAMIDE HYDROCHLORIDE
         BANNER PHARMACAPS      1MG                            N021855 001 Aug 04, 2005
      +                         2MG                            N021855 002 Aug 04, 2005
  SOLUTION;ORAL
    IMODIUM A-D
      + MCNEIL CONS             1MG/5ML                        N019487 001 Mar 01, 1988
    LOPERAMIDE HYDROCHLORIDE
         HI TECH PHARMA         1MG/5ML                        A074352   001   Nov   17,   1995
         PERRIGO                1MG/5ML                        A073243   001   Jan   21,   1992
         ROXANE                 1MG/5ML                        A073079   001   Apr   30,   1992
         WOCKHARDT              1MG/5ML                        A074730   001   Aug   28,   1997
  SUSPENSION;ORAL
    IMODIUM A-D
      + MCNEIL CONS             1MG/7.5ML                      N019487 002 Jul 08, 2004
    LOPERAMIDE HYDROCHLORIDE
         PERRIGO R AND D        1MG/7.5ML                      A091292 001 May 20, 2011
  TABLET;ORAL
    IMODIUM A-D
      + MCNEIL CONS             2MG                            N019860 001 Nov 22, 1989
    LOPERAMIDE HYDROCHLORIDE
         CONTRACT PHARMACAL     2MG                            A073254   001   Jul   30,   1993
         LNK                    2MG                            A076497   001   Jun   10,   2003
         OHM LABS               2MG                            A074091   001   Dec   10,   1992
         PERRIGO                2MG                            A075232   001   Jan   06,   2000
  TABLET, CHEWABLE;ORAL
    IMODIUM A-D EZ CHEWS
      + MCNEIL                  2MG                            N020448 001 Jul 24, 1997
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
	
  TABLET;ORAL
	
    IMODIUM MULTI-SYMPTOM RELIEF
	
      + MCNEIL CONS             2MG;125MG                      N021140 001 Nov 30, 2000
	
    LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
	
         RANBAXY                2MG;125MG                      A077500 001 Sep 06, 2006

  TABLET, CHEWABLE;ORAL
	
    IMODIUM MULTI-SYMPTOM RELIEF
	
      + MCNEIL                  2MG;125MG                      N020606 001 Jun 26, 1996
	
    LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE
	
         PERRIGO                2MG;125MG                      A076029 001 Aug 30, 2002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                 OTC DRUG PRODUCT LIST                         4-12(of 17)

LORATADINE
  CAPSULE;ORAL
    CLARITIN
      + SCHERING PLOUGH        10MG                            N021952 001 Jun 16, 2008
  SUSPENSION;ORAL
    LORATADINE
      + TARO                   1MG/ML                          N021734 001 Oct 04, 2005
  SYRUP;ORAL
    CLARITIN
      + SCHERING PLOUGH        1MG/ML                          N020641 002 Nov 27, 2002
    LORATADINE
         PERRIGO               1MG/ML                          A075728   001   Aug   20,   2004
         SILARX                1MG/ML                          A077421   001   Jun   29,   2006
         TARO                  1MG/ML                          A076805   001   Aug   20,   2004
         TEVA                  1MG/ML                          A075505   001   Nov   07,   2003
         WOCKHARDT             1MG/ML                          A075815   001   Aug   20,   2004
  TABLET;ORAL
    CLARITIN
      + BAYER HEALTHCARE LLC   10MG                            N019658 002 Nov 27, 2002
    CLARITIN HIVES RELIEF
      + BAYER HEALTHCARE LLC   10MG                            N019658 003 Nov 19, 2003
    LORATADINE
         APOTEX INC            10MG                            A076471   001   Feb   14,   2006
         MYLAN                 10MG                            A075790   001   Nov   07,   2008
                               10MG                            A076154   001   Aug   20,   2003
                               10MG                            A078447   001   Aug   12,   2011
        PERRIGO                10MG                            A076301   001   Jun   25,   2004
        RANBAXY                10MG                            A076134   001   Aug   18,   2003
        SANDOZ                 10MG                            A075209   001   Jan   21,   2003
 TABLET, CHEWABLE;ORAL
   CHILDREN'S CLARITIN
     + SCHERING PLOUGH         5MG                             N021891 001 Aug 23, 2006
 TABLET, ORALLY DISINTEGRATING;ORAL
   ALAVERT
        PFIZER                 10MG                            N021375 001 Dec 19, 2002
   CLARITIN HIVES RELIEF REDITAB
     + BAYER HEALTHCARE LLC    10MG                            N020704 003 Nov 19, 2003
   CLARITIN REDITABS
     + BAYER HEALTHCARE LLC    10MG                            N020704 002 Nov 27, 2002
     + SCHERING PLOUGH         5MG                             N021993 001 Dec 12, 2006
   LORATADINE
        ACTAVIS LABS FL INC    10MG                            A075990 001 Nov 03, 2003
        IMPAX LABS             10MG                            A076011 001 Sep 29, 2003
        PFIZER                 10MG                            A075822 001 Feb 10, 2003
   LORATADINE REDIDOSE
        RANBAXY                10MG                            A077153 001 Apr 11, 2007
LORATADINE; PSEUDOEPHEDRINE SULFATE
  TABLET, EXTENDED RELEASE;ORAL
    CLARITIN-D
      + SCHERING PLOUGH         5MG;120MG                      N019670 002 Nov 27, 2002
    CLARITIN-D 24 HOUR
      + SCHERING PLOUGH         10MG;240MG                     N020470 002 Nov 27, 2002
    LORATADINE AND PSEUDOEPHEDRINE SULFATE
         ACTAVIS LABS FL INC    10MG;240MG                     A075706   001   Feb   21,   2003
         IMPAX LABS             5MG;120MG                      A076050   001   Jan   30,   2003
                                10MG;240MG                     A075989   001   Mar   04,   2004
         RANBAXY                10MG;240MG                     A076557   001   Sep   22,   2004
MENTHOL; METHYL SALICYLATE
  PATCH;TOPICAL
    SALONPAS
      + HISAMITSU PHARM CO     3%;10%                          N022029 001 Feb 20, 2008
                               3%;10%                          N022029 002 Nov 05, 2012
MICONAZOLE NITRATE
  CREAM;TOPICAL, VAGINAL
    MICONAZOLE 3 COMBINATION PACK
         PERRIGO                2%;4%                          A076357 001 Mar 30, 2004
    MONISTAT 3 COMBINATION PACK
         MEDTECH PRODUCTS       2%;4%                          N021261 003 Jun 17, 2003
    MONISTAT 3 COMBINATION PACK (PREFILLED)
      + MEDTECH PRODUCTS        2%;4%                          N021261 001 Feb 02, 2001
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                   OTC DRUG PRODUCT LIST                        4-13(of 17)


MICONAZOLE NITRATE
	
  CREAM;VAGINAL
	
    MICONAZOLE 3
	
         TARO                     4%                            A076773 001 Mar 02, 2005
	
    MICONAZOLE 7
	
         ACTAVIS MID ATLANTIC     2%                            A074164 001 Mar 29, 1996
	
    MICONAZOLE NITRATE
	
         G AND W LABS INC         2%                            A074366   001   Feb   22,   1996
	
         PERRIGO                  2%                            A074760   001   May   15,   1997

         PERRIGO R AND D          4%                            A091366   001   Jan   15,   2010
	
         TARO                     2%                            A074444   001   Jan   13,   1997
	
    MONISTAT 3
	
      + MEDTECH PRODUCTS          4%                            N020827 001 Mar 30, 1998
	
    MONISTAT 7
	
      + MEDTECH PRODUCTS          2%                            N017450 002 Feb 15, 1991
	
  CREAM, SUPPOSITORY;TOPICAL, VAGINAL
	
    M-ZOLE 3 COMBINATION PACK
	
         ACTAVIS MID ATLANTIC     2%;200MG                      A074926 001 Apr 16, 1999

    MICONAZOLE 7 COMBINATION PACK
	
         G AND W LABS             100MG;2%                      A076585 001 Mar 26, 2004
	
    MICONAZOLE NITRATE
	
         PERRIGO R AND D          1.2GM;2%                      A079114 001 Jun 02, 2010
	
    MICONAZOLE NITRATE COMBINATION PACK
	
         PERRIGO                  200MG;200MG                   A075329 001 Apr 20, 1999

    MONISTAT 1 COMBINATION PACK
	
      + MEDTECH PRODUCTS          1.2GM;2%                      N021308 001 Jun 29, 2001
	
    MONISTAT 7 COMBINATION PACK
	
      + MEDTECH PRODUCTS          100MG;2%                      N020288 002 Apr 26, 1993

    MONISTAT-3 COMBINATION PACK
	
      + MEDTECH PRODUCTS          2%;200MG                      N020670 002 Apr 16, 1996

  SUPPOSITORY;VAGINAL
	
    MICONAZOLE NITRATE
	
         ACTAVIS MID ATLANTIC     100MG                         A073507 001 Nov 19, 1993
         G AND W LABS             100MG                         A074414 001 Apr 30, 1997
      + PERRIGO                   100MG                         A074395 001 Mar 20, 1997
    MONISTAT 7
      + MEDTECH PRODUCTS          100MG                         N018520 002 Feb 15, 1991
MINOXIDIL
  AEROSOL, FOAM;TOPICAL
    MEN'S ROGAINE
      + JOHNSON AND JOHNSON     5%                              N021812 001 Jan 20, 2006
    MINOXIDIL
         PERRIGO ISRAEL         5%                              A091344 001 Apr 28, 2011
    WOMEN'S ROGAINE
      + JOHNSON AND JOHNSON     5%                              N021812 002 Feb 28, 2014
  SOLUTION;TOPICAL
    MINOXIDIL (FOR MEN)
         ACTAVIS MID ATLANTIC   2%                              A074588   001   Apr   05,   1996
         HI TECH PHARMA         2%                              A074731   001   Dec   24,   1996
         PERRIGO                2%                              A075357   001   Jul   30,   1999
         WOCKHARDT              2%                              A074767   001   Feb   28,   1997
    MINOXIDIL (FOR WOMEN)
         HI TECH PHARMA         2%                              A074731 002 May 11, 2005
         PERRIGO                2%                              A075357 002 Jul 30, 1999
    MINOXIDIL EXTRA STRENGTH (FOR MEN)
         ACTAVIS MID ATLANTIC   5%                              A075518   001   Nov   17,   2000
         AVACOR PRODS           5%                              A075619   001   Nov   17,   2000
         PERRIGO                5%                              A075598   001   Jun   13,   2001
         PERRIGO NEW YORK       5%                              A075737   001   Mar   15,   2002
         WOCKHARDT              5%                              A075438   001   Feb   27,   2003
    ROGAINE (FOR MEN)
      + JOHNSON AND JOHNSON     2%                              N019501 002 Feb 09, 1996
    ROGAINE (FOR WOMEN)
      + JOHNSON AND JOHNSON     2%                              N019501 003 Feb 09, 1996
    ROGAINE EXTRA STRENGTH (FOR MEN)
      + JOHNSON AND JOHNSON     5%                              N020834 001 Nov 14, 1997
    THEROXIDIL
         EI INC                 2%                              A078176 001 Nov 09, 2007
                                5%                              A076239 001 Aug 24, 2004
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                  OTC DRUG PRODUCT LIST                        4-14(of 17)


NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE
	
  SOLUTION/DROPS;OPHTHALMIC

    NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
	
         AKORN INC              0.025%;0.3%                    A202795 001 Jan 24, 2013
	
         ALTAIRE PHARMS INC     0.02675%;0.315%                A078208 001 Sep 27, 2010

    NAPHCON-A
	
      + ALCON                   0.025%;0.3%                    N020226 001 Jun 08, 1994
	
    OPCON-A
	
      + BAUSCH AND LOMB         0.02675%;0.315%                N020065 001 Jun 08, 1994
	
    VISINE-A
	
      + JOHNSON AND JOHNSON     0.025%;0.3%                    N020485 001 Jan 31, 1996
	
NAPROXEN SODIUM
	
  CAPSULE;ORAL
	
    NAPROXEN SODIUM
	
      + BANNER PHARMACAPS       EQ 200MG BASE                  N021920 001 Feb 17, 2006
	
  TABLET;ORAL
	
    ALEVE
	
      + BAYER                   EQ 200MG BASE                  N020204 002 Jan 11, 1994
	
    NAPROXEN SODIUM
	
         AMNEAL PHARMS NY       EQ   200MG   BASE              A079096   001   Dec   16,   2008
	
         CONTRACT PHARMACAL     EQ   200MG   BASE              A074635   001   Jan   13,   1997
	
                                EQ   200MG   BASE              A074789   001   Feb   27,   1997
	
         DR REDDYS LABS INC     EQ   200MG   BASE              A075168   001   Jul   28,   1998
	
         GRANULES INDIA         EQ   200MG   BASE              A091353   001   Sep   20,   2011

         MARKSANS PHARMA        EQ   200MG   BASE              A090545   001   Mar   16,   2011
	
         PERRIGO                EQ   200MG   BASE              A074661   001   Jan   13,   1997
	
         RANBAXY LABS LTD       EQ   200MG   BASE              A091183   001   May   20,   2011
	
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ALEVE-D SINUS & COLD
	
      + BAYER                    200MG;120MG                   N021076 001 Nov 29, 1999
	
    NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
         DR REDDYS LABS INC      EQ 220MG BASE;120MG           A077381 001 Sep 27, 2006

         PERRIGO                 EQ 200MG BASE;120MG           A076518 001 Mar 17, 2004
	
NICOTINE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    HABITROL
	
      + DR REDDYS LABS INC      7MG/24HR                       N020076 004 Nov 12, 1999
      +                         14MG/24HR                      N020076 005 Nov 12, 1999
      +                         21MG/24HR                      N020076 006 Nov 12, 1999
    NICODERM CQ
      + SANOFI AVENTIS US       7MG/24HR                       N020165 006 Aug 02, 1996
      +                         14MG/24HR                      N020165 005 Aug 02, 1996
      +                         21MG/24HR                      N020165 004 Aug 02, 1996
    NICOTINE
          AVEVA                 7MG/24HR                       A074612 002 Jul 28, 2003
                                14MG/24HR                      A074612 003 Oct 20, 1997
                                21MG/24HR                      A074612 001 Oct 20, 1997
NICOTINE POLACRILEX
  GUM, CHEWING;BUCCAL
    NICORETTE
      + GLAXOSMITHKLINE         EQ   2MG   BASE                N018612   002   Feb   09,   1996
                                EQ   2MG   BASE                N018612   004   Sep   25,   2000
     +                          EQ   4MG   BASE                N020066   002   Feb   09,   1996
                                EQ   4MG   BASE                N020066   004   Sep   25,   2000
   NICORETTE (MINT)
        GLAXOSMITHKLINE         EQ 2MG BASE                    N018612 003 Dec 23, 1998
                                EQ 4MG BASE                    N020066 003 Dec 23, 1998
   NICOTINE POLACRILEX
        ACTAVIS LABS NY INC     EQ   2MG   BASE                A074507   001   Mar   15,   1999
                                EQ   2MG   BASE                A076569   001   Jul   29,   2004
                                EQ   2MG   BASE                A078699   001   Dec   29,   2008
                                EQ   2MG   BASE                A079216   001   Jul   08,   2009
                                EQ   4MG   BASE                A074707   001   Mar   19,   1999
                                EQ   4MG   BASE                A076568   002   Jul   29,   2004
                                EQ   4MG   BASE                A078697   001   Dec   29,   2008
                                EQ   4MG   BASE                A079038   001   Jul   08,   2009
                                EQ   4MG   BASE                A079219   001   Jul   08,   2009
         IVAX SUB TEVA PHARMS   EQ   2MG   BASE                A076880   001   Feb   18,   2009
                                EQ   4MG   BASE                A077850   001   Feb   18,   2009
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                     OTC DRUG PRODUCT LIST
	                    4-15(of 17)


NICOTINE POLACRILEX
	
  GUM, CHEWING;BUCCAL
	
    NICOTINE POLACRILEX
	
         PERRIGO
	                 EQ   2MG   BASE
	            A076775   001   Sep   16,   2004

                                   EQ   2MG   BASE
	            A076776   001   Sep   16,   2004

                                   EQ   2MG   BASE
	            A076777   001   Sep   16,   2004

                                   EQ   4MG   BASE
	            A076778   001   Sep   16,   2004

                                   EQ   4MG   BASE
	            A076779   001   Sep   16,   2004

                                   EQ   4MG   BASE
	            A076789   001   Sep   16,   2004

         PERRIGO R AND D
	         EQ   2MG   BASE
	            A078325   001   Oct   30,   2006
	
                                   EQ   2MG   BASE
	            A078547   001   May   24,   2007

                                   EQ   2MG   BASE
	            A078967   001   Apr   23,   2008

                                   EQ   2MG   BASE
	            A091349   001   Jul   20,   2011
	
                                   EQ   4MG   BASE
	            A078326   001   Oct   30,   2006
	
                                   EQ   4MG   BASE
	            A078546   001   May   24,   2007

                                   EQ   4MG   BASE
	            A078968   001   Apr   23,   2008

                                   EQ   4MG   BASE
	            A091354   001   Jul   20,   2011
	
         WATSON LABS
	             EQ   2MG   BASE
	            A079044   001   Jul   08,   2009
	
    THRIVE
	
         NOVARTIS
	                EQ 2MG BASE
	                A077658 001 Jun 19, 2007
	
                                   EQ 4MG BASE
	                A077656 001 Jun 19, 2007
	
  TROCHE/LOZENGE;ORAL

    COMMIT
	
          GLAXOSMITHKLINE CONS
	   EQ 2MG BASE
	                N021330 001 Oct 31, 2002
	
      +
	                          EQ 4MG BASE
	                N021330 002 Oct 31, 2002
	
    NICORETTE
	
          GLAXOSMITHKLINE CONS
	   EQ 2MG BASE
	                N022360 001 May 18, 2009

      +
	                          EQ 4MG BASE
	                N022360 002 May 18, 2009
	
    NICOTINE POLACRILEX
	
          PERRIGO R AND D
	        EQ   2MG   BASE
	            A077007   001   Jan   31,   2006
	
                                   EQ   2MG   BASE
	            A090711   001   Jul   10,   2009
	
                                   EQ   2MG   BASE
	            A090821   001   Jul   10,   2009
	
                                   EQ   2MG   BASE
	            A203690   001   Oct   09,   2012
	
                                   EQ   4MG   BASE
	            A077007   002   Jan   31,   2006
	
                                   EQ   4MG   BASE
	            A090711   002   Jul   10,   2009
	
                                   EQ   4MG   BASE
	            A090821   002   Jul   10,   2009
	
                                   EQ   4MG   BASE
	            A203690   002   Oct   09,   2012
	
NIZATIDINE
	
  TABLET;ORAL
	
    AXID AR
	
      + PFIZER
	                   75MG
	                       N020555 001 May 09, 1996
	
NONOXYNOL-9
	
  SPONGE;VAGINAL
	
    TODAY
	
      + MAYER LABS INC
	           1GM
	                        N018683 001 Apr 01, 1983
	
OMEPRAZOLE
	
  TABLET, DELAYED RELEASE;ORAL
	
    OMEPRAZOLE
	
      + DEXCEL PHARMA
	          20MG
	                         N022032 001 Dec 04, 2007
	
OMEPRAZOLE MAGNESIUM
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    OMEPRAZOLE MAGNESIUM
	
      + DR REDDYS LABS LTD
	     EQ 20MG BASE
	                 A078878 001 Jun 05, 2009
	
  TABLET, DELAYED RELEASE;ORAL
	
    PRILOSEC OTC
	
      + ASTRAZENECA PHARMS
	     EQ 20MG BASE
	                 N021229 001 Jun 20, 2003
	
OMEPRAZOLE; SODIUM BICARBONATE
	
  CAPSULE;ORAL
	
    ZEGERID OTC
	
      + MSD CONSUMER
	           20MG;1.1GM
	                   N022281 001 Dec 01, 2009
	
  FOR SUSPENSION;ORAL
	
    ZEGERID OTC
	
      + MSD CONSUMER
	           20MG/PACKET;1.68GM/PACKET
	    N022283 001 Jun 17, 2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                 OTC DRUG PRODUCT LIST                         4-16(of 17)


ORLISTAT
	
  CAPSULE;ORAL
	
    ALLI
	
      + GLAXOSMITHKLINE CONS    60MG                           N021887 001 Feb 07, 2007
	
OXYBUTYNIN
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    OXYTROL FOR WOMEN
      + BAYER HEALTHCARE LLC    3.9MG/24HR                     N202211 001 Jan 25, 2013
OXYMETAZOLINE HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    OCUCLEAR
         SCHERING PLOUGH        0.025%                         N018471 001 May 30, 1986
    VISINE L.R.
      + JOHNSON AND JOHNSON     0.025%                         N019407 001 Mar 31, 1989
PERMETHRIN
  LOTION;TOPICAL
    NIX
      + MEDTECH PRODUCTS        1%                             N019918 001 May 02, 1990
    PERMETHRIN
         ACTAVIS MID ATLANTIC   1%                             A075014 001 Mar 28, 2000
         PERRIGO NEW YORK       1%                             A076090 001 Dec 20, 2001
POLYETHYLENE GLYCOL 3350
  FOR SOLUTION;ORAL
    GLYCOLAX
         KREMERS URBAN PHARMS   17GM/PACKET                    A090600 001 Oct 06, 2009
                                17GM/SCOOPFUL                  A090600 002 Oct 06, 2009
   MIRALAX
     + SCHERING PLOUGH          17GM/SCOOPFUL                  N022015 001 Oct 06, 2006
   POLYETHYLENE GLYCOL 3350
        EMCURE PHARMS USA       17GM/SCOOPFUL                  A202071   001   Dec   28,   2012
        MYLAN                   17GM/PACKET                    A078915   001   Oct   06,   2009
                                17GM/SCOOPFUL                  A078915   002   Oct   06,   2009
        NEXGEN PHARMA           17GM/SCOOPFUL                  A090812   001   Oct   07,   2009
        NOVEL LABS INC          17GM/SCOOPFUL                  A091077   001   Oct   06,   2009
        PAR PHARM               17GM/SCOOPFUL                  A079214   001   Jan   31,   2013
        PERRIGO R AND D         17GM/PACKET                    A090685   001   Oct   06,   2009
                                17GM/SCOOPFUL                  A090685   002   Oct   06,   2009
POTASSIUM IODIDE
  SOLUTION;ORAL
    THYROSHIELD
      + ARCO PHARMS LLC         65MG/ML                        A077218 001 Jan 12, 2005
  TABLET;ORAL
    IOSAT
         ANBEX                  65MG                           N018664 002 May 12, 2011
      +                         130MG                          N018664 001 Oct 14, 1982
    THYROSAFE
      + RECIP                   65MG                           A076350 001 Sep 10, 2002
POVIDONE-IODINE
  SOLUTION;TOPICAL
    POVIDONE IODINE
      + ALLEGIANCE HLTHCARE     1%                             N019522 001 Mar 31, 1989
  SPONGE;TOPICAL
    E-Z SCRUB 201
      + BECTON DICKINSON        20%                            N019240 001 Nov 29, 1985
    E-Z SCRUB 241
      + BECTON DICKINSON        10%                            N019476 001 Jan 07, 1987
PSEUDOEPHEDRINE HYDROCHLORIDE
  TABLET, EXTENDED RELEASE;ORAL
    PSEUDOEPHEDRINE HYDROCHLORIDE
         PERRIGO                120MG                          A075153 001 Feb 26, 1999
         RANBAXY                120MG                          A077442 001 Sep 28, 2005
    SUDAFED 12 HOUR
      + MCNEIL CONS             120MG                          A073585 001 Oct 31, 1991
    SUDAFED 24 HOUR
      + MCNEIL CONS             240MG                          N020021 002 Dec 15, 1992
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                    OTC DRUG PRODUCT LIST
	                        4-17(of 17)


PSEUDOEPHEDRINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    AFRINOL
	
      + SCHERING PLOUGH
	        120MG
	                           N018191 001
	
PURIFIED WATER
	
  SOLUTION;OPHTHALMIC
	
    PUR-WASH
	
      + NIAGARA PHARMS
	          98.3%
	                          N022305 001 Sep 01, 2011
	
RANITIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    RANITIDINE HYDROCHLORIDE
	
         APOTEX INC
	             EQ     150MG BASE
	              A200172   001   May   31,   2012

         CONTRACT PHARMACAL
	     EQ     75MG BASE
	               A075094   001   Jun   21,   1999
	
         DR REDDYS LABS LTD
	     EQ     75MG BASE
	               A075294   001   Mar   28,   2000
	
                                  EQ     150MG BASE
	              A078192   001   Aug   31,   2007

         IVAX SUB TEVA PHARMS
	   EQ     75MG BASE
	               A075296   001   Jan   14,   2000
	
         MYLAN
	                  EQ     75MG BASE
	               A075497   001   Jan   14,   2000
	
         PERRIGO
	                EQ     75MG BASE
	               A076195   001   Aug   30,   2002

         PERRIGO R AND D
	        EQ     150MG BASE
	              A091429   001   May   11,   2011

                                  EQ     150MG BASE
	              A091429   002   May   11,   2011

         SHASUN CHEMS
	           EQ     75MG BASE
	               A201745   001   Feb   29,   2012
	
         SVADS HOLDINGS SA
	      EQ     150MG BASE
	              A200536   001   Jun   28,   2011
	
         TORPHARM
	               EQ     75MG BASE
	               A075167   001   May   04,   2000

         WOCKHARDT
	              EQ     75MG BASE
	               A076760   001   Feb   24,   2006
	
                                  EQ     75MG BASE
	               A078884   001   Jul   31,   2008
	
    ZANTAC 150
	
      + BOEHRINGER INGELHEIM
	    EQ 150MG BASE
	                  N021698 001 Aug 31, 2004

                                  EQ 150MG BASE
	                  N021698 002 Mar 13, 2007
	
    ZANTAC 75
	
         BOEHRINGER INGELHEIM
	   EQ 75MG BASE
	                   N020520 001 Dec 19, 1995
	
SODIUM CHLORIDE
	
  AEROSOL, METERED;INHALATION
	
    BRONCHO SALINE
	
      + BLAIREX
	                 0.9%
	                           N019912 001 Sep 03, 1992
	
SODIUM FLUORIDE; TRICLOSAN
	
  PASTE;DENTAL
	
    COLGATE TOTAL
	
      + COLGATE PALMOLIVE
	       0.24%;0.3%
	                     N020231 001 Jul 11, 1997
	
TERBINAFINE
	
  GEL;TOPICAL
	
    LAMISIL AT
	
      + NOVARTIS
	                1%
	                             N021958 001 Jul 24, 2006
	
TERBINAFINE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    LAMISIL
	
      + NOVARTIS
	                1%
	                             N020980 001 Mar 09, 1999
	
    TERBINAFINE HYDROCHLORIDE
	
         TARO
	                   1%
	                             A077511 001 Jul 02, 2007
	
  SOLUTION;TOPICAL
	
    LAMISIL AT
	
      + NOVARTIS
	                1%
	                             N021124 001 Mar 17, 2000
	
  SPRAY;TOPICAL
	
    LAMISIL AT
	
      + NOVARTIS
	                1%
	                             N021124 002 Mar 17, 2000
	
TIOCONAZOLE
	
  OINTMENT;VAGINAL
	
    TIOCONAZOLE
	
         PERRIGO
	                6.5%
	                           A075915 001 Nov 21, 2001
	
    VAGISTAT-1
	
      + NOVARTIS
	                6.5%
	                           N020676 001 Feb 11, 1997
	
TRIAMCINOLONE ACETONIDE
	
  SPRAY, METERED;NASAL
	
    NASACORT ALLERGY 24 HOUR
	
      + SANOFI AVENTIS US
	       0.055MG/SPRAY
	                  N020468 002 Oct 11, 2013
	
               35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                           5 - 1 of 4

          DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT 

    ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST


ANTICOAGULANT 4% SODIUM CITRATE SOLUTION USP
  INJECTABLE; INJECTION
    NONE
      HAEMONETICS                                                    N760305           Jun 30, 1978
      MANUFACTURING INC

ANTICOAGULANT CITRATE DEXTROSE SOLUTION (ACD)
  INJECTABLE; INJECTION
      CITRA LABS LLC                                                 N020037           Aug 26, 2003
    ACD-A SOLUTION
      TERUMO BCT INC                                                 A010228    ANDA   Feb 25, 2002
    ADSOL WITH ACD-A
      FENWAL INC                                                     N000922           Aug 29, 2002
    ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A
      HAEMONETICS CORP                                               A980728    ANDA   Feb 06, 2002
    AS3 SOLUTION/ACD-A
      TERUMO BCT INC                                                 N001214           May 29, 2002
    NONE
      HAEMONETICS                                                    A710497    ANDA   Nov 06, 1987
      MANUFACTURING INC

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP
  INJECTABLE; INJECTION
    NONE
      FENWAL INC                                                     N160918           Mar 17, 1978

ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD-A)
  INJECTABLE; INJECTION
    NONE
      ARTERIOCYTE MEDICAL                                            A110057           May 11, 2012
      SYSTEMS, INC

ANTICOAGULANT CITRATE PHOSPHATE 2X DEXTROSE SOLUTION (CP2D)
  INJECTABLE; INJECTION
    CITRATE PHOSPHATE DOUBLE DEXTROSE/ADDITIVE SOLUTION 3
      HAEMONETICS CORP                                               N000127           Jan 18, 2002

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION
  INJECTABLE; INJECTION
    NONE
      TERUMO MEDICAL CORP                                            N820528           Nov 03, 1982

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION (CPDA)
  INJECTABLE; INJECTION
    CPDA-1 BLOOD-PACK UNIT (PL 146 PLASTIC) 250, 450, 500 ML BLOOD PACK UNITS
      FENWAL INC                                                     N770420           May 12, 1978

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SOLUTION USP
  INJECTABLE; INJECTION
    BLOOD PACK UNIT CPDA-1 IN PLASTIC CONTAINER
      FENWAL INC                                                     N940404           Jul 28, 1994

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE-1 SOLUTION
  INJECTABLE; INJECTION
    NONE
      HAEMONETICS                                                    N800077           Nov 06, 1980
      MANUFACTURING INC
               35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                        5 - 2 of 4

          DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT 

    ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST


ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION
  INJECTABLE; INJECTION
    ADSOL IN PLASTIC CONTAINER
      FENWAL INC                                                    N900223         Dec 27, 1991

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION (CPD)
  INJECTABLE; INJECTION
    CPD ANTICOAGULANT IN PL 2209 PLASTIC CONTAINER
      FENWAL INC                                                     N900224        Dec 27, 1991
    MACOPRODUCTIONS SAS CPD/AS-1: MACOPHARMA LEUCOFLEX MTL1 LEUKOREDUCTION SYSTEM FOR BLOOD
    COMPONENTS KNOWN AS MTL1-WB
      MACOPRODUCTIONS SAS                                            N040083        Nov 21, 2005
    NONE
      TERUMO BCT INC                                                 A070025        Jan 06, 2008

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP
  INJECTABLE; INJECTION
    NONE
      FENWAL INC                                                    N170401         Dec 06, 1977
                                                                    N811012         Jun 28, 1983
      HAEMONETICS                                                   N800222         Aug 23, 1982
      MANUFACTURING INC
      TERUMO MEDICAL CORP                                           N781211         Jun 10, 1981

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-1:
 DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
  INJECTABLE; INJECTION
    ADSOL RED BLOOD CELL PRESERVATIVE SOLUTION
       FENWAL INC                                                   N811104         May 16, 1983

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-5:
 DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
  INJECTABLE; INJECTION
    OPTISOL RED BLOOD CELL PRESERVATIVE SOLUTION
      TERUMO MEDICAL CORP                                           N880217         Oct 07, 1988

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION WITH: 

AS-3: CITRIC ACID USP; MONOBASIC SODIUM PHOSPHATE USP; SODIUM CHLORIDE USP; ADENINE; 

DEXTROSE USP; SODIUM CITRATE USP

  INJECTABLE; INJECTION
    AS-3 NUTRICEL ADDITIVE SYSTEM
      HAEMONETICS           0.042GM/100ML;0.276GM/100ML;            N820915         Oct 19, 1984
      MANUFACTURING INC     0.410GM/100ML;0.30GM/100ML;
                            1.10GM/100ML;0.588GM/100ML

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION WITH:

AS-2: CITRIC ACID USP; DIBASIC SODIUM PHOSPHATE USP; SODIUM CHLORIDE USP; ADENINE; 

DEXTROSE USP; SODIUM CITRATE USP

  INJECTABLE; INJECTION
    AS-2 NUTRICEL ADDITIVE SYSTEM
      MEDSEP CORP           0.042GM/100ML;0.285GM/100ML;            N820915         Sep 22, 1983
                            0.718GM/100ML;0.017GM/100ML;
                            0.396GM/100ML;0.588GM/100ML

ANTICOAGULANT SODIUM CITRATE 4% SOLUTION
  INJECTABLE; INJECTION
    NONE
      HAEMONETICS                                                   N980123         Mar 03, 2000
      CORPORATION
               35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      5 - 3 of 4

          DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT 

    ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST


ANTICOAGULANT SODIUM CITRATE SOLUTION
  INJECTABLE; INJECTION
    TRICITRASOL
      CYTOSOL                                                    N010409          Jul 10, 2003
      LABORATORIES INC

ANTICOAGULANT SODIUM CITRATE SOLUTION USP
  INJECTABLE; INJECTION
    NONE
      FENWAL INC                                                 N770923          Jan 20, 1978
      TERUMO MEDICAL CORP                                        N781214          Feb 08, 1980

DEXTRAN 1 IN SODIUM CHLORIDE 0.6%
  INJECTABLE; INJECTION
    PROMIT
      MEDA AB                                                    N830715          Oct 30, 1984

DEXTRAN 40, 10% IN DEXTROSE 5%
  INJECTABLE; INJECTION
    LMD IN GLASS BOTTLE
      HOSPIRA INC           10GM/100ML;5GM/100ML                 A720563   ANDA   Oct 30, 1992
    NONE
      B BRAUN MEDICAL INC   10GM/100ML;5GM/100ML                 N160767          Apr 06, 1970

DEXTRAN 40, 10% IN SODIUM CHLORIDE 0.9%
  INJECTABLE; INJECTION
    LMD IN PLASTIC CONTAINER
      HOSPIRA INC            10GM/100ML;0.9GM/100ML              A720562   ANDA   Oct 30, 1992
    NONE
      B BRAUN MEDICAL INC    10GM/100ML;0.9GM/100ML              N160767          Apr 06, 1970

DEXTRAN 70, 6% IN SODIUM CHLORIDE 0.9%
  INJECTABLE; INJECTION
    NONE
      B BRAUN MEDICAL INC   6GM/100ML;0.9 GM/100ML               N090024          Aug 18, 1969

HETASTARCH 6% IN LACTATED ELECTROLYTE INJECTION
  INJECTABLE; INJECTION
    HEXTEND
      BIOTIME INC           6GM/100ML                            N200952          Mar 31, 1999

HETASTARCH 6% IN SODIUM CHLORIDE 0.9%
  INJECTABLE; INJECTION
    6% HETASTARCH IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
      HOSPIRA INC           6GM/100ML;0.9GM/100ML                A740193   ANDA   Jan 30, 1995
    HESPAN IN PLASTIC CONTAINER
      B BRAUN MEDICAL INC   6GM/100ML;0.9GM/100ML                N890105          Apr 04, 1991
    NONE
      B BRAUN MEDICAL INC   6GM/100ML;0.9GM/100ML                A740283   ANDA   Oct 21, 1998
      TEVA PARENTERAL       6GM/100ML;0.9GM/100ML                A740592   ANDA   Nov 12, 1998
      MEDICINES INC
               35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                          5 - 4 of 4

          DRUG PRODUCTS WITH APPROVAL UNDER SECTION 505 OF THE ACT 

    ADMINISTERED BY THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH LIST


HYDROXYETHYL STARCH 130/0.4 IN 6% SODIUM CHLORIDE 0.9%
  INJECTABLE; INJECTION
    NONE
      B. BRAUN MEDICAL                                               A110013   ANDA   Jan 09, 2015
    VOLUVEN
      FRESENIUS KABI        6GM/100ML;0.9GM/100ML                    N070012   NDA    Dec 27, 2007
      DEUTSCHLAND GMBH

ISOPLATE SOLUTION IN THE 500 ML EXCEL CONTAINER
  INJECTABLE; INJECTION
    ISOPLATE SOLUTION
      HAEMONETICS CORP                                                N90067          Mar 05, 2013

LEUKOCYTE REDUCTION FILTRATION SYSTEM FOR WHOLE BLOOD WITH CPD ANTICOAGULANT AND
SOLX ADDITIVE
  INJECTABLE; INJECTION
    LEUKOSEP HWB-600-XL
      HAEMONETICS CORP                                               N110059          Apr 25, 2013

PENTASTARCH 10% IN SODIUM CHLORIDE 0.9%
  INJECTABLE; INJECTION
    PENTASPAN IN PLASTIC CONTAINER
      B BRAUN MEDICAL INC   10GM/100ML;0.9GM/100ML                   N890104          Apr 04, 1991

RED BLOOD CELL PROCESSING SOLUTION
  INJECTABLE; INJECTION
    REJUVESOL
      CITRA LABS LLC                                                 N950522          Feb 26, 1997

SODIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE,
DIABASIC ANHYDROUS; SODIUM PHOSPHATE MONOBASIC, MONOHYDRATE
  INJECTABLE; INJECTION
    INTERSOL SOLUTION
      FENWAL INC.           2.26G/500ML; 2.21G/500ML; 1.59G/500ML;   N080041          Dec 09, 2009
                            1.53G/500ML; 0.465G/500ML
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                     6-1(of 337)


ABARELIX
	
  INJECTABLE;INTRAMUSCULAR
	
    PLENAXIS
	
          SPECIALITY EUROPEAN
	   100MG/VIAL
	                  N021320 001 Nov 25, 2003
	
ACEBUTOLOL HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    ACEBUTOLOL HYDROCHLORIDE
	
         WATSON LABS
	            EQ 200MG BASE
	               A074007 001 Oct 18, 1995
	
                                  EQ 400MG BASE
	               A074007 002 Oct 18, 1995
	
ACETAMINOPHEN
	
  INJECTABLE;INJECTION
	
    INJECTAPAP
	
         ORTHO MCNEIL PHARM
	     100MG/ML
	                    N017785 001 Mar 07, 1986
	
  SUPPOSITORY;RECTAL
	
    ACEPHEN
	
         G AND W LABS
	           120MG
	                       A072218 001 Mar 27, 1992
	
    ACETAMINOPHEN
	
         ABLE
	                   120MG
	                       A073106   001   Feb   27,   1995
	
                                  325MG
	                       A073107   001   Feb   27,   1995
	
                                  650MG
	                       A073108   001   Feb   27,   1995
	
         ROXANE
	                 120MG
	                       A071010   001   May   12,   1987

                                  650MG
	                       A071011   001   May   12,   1987
	
    TYLENOL
	
         MCNEIL CONS
	           120MG
	                        N017756 002
	
                                 650MG
	                        N017756 001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ACETAMINOPHEN
	
         RANBAXY
	               650MG
	                        A090205 001 Nov 18, 2009
	
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE
	
  CAPSULE;ORAL
	
    ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE
	
         MIKART		               150MG;180MG;15MG
	              A081095 001 Oct 26, 1990
	
                                150MG;180MG;30MG
	              A081096 001 Oct 26, 1990
	
                                150MG;180MG;60MG
	              A081097 001 Oct 26, 1990
	
    CODEINE, ASPIRIN, APAP FORMULA NO. 2
	
         SCHERER LABS           150MG;180MG;15MG
	              A085640 001
	
    CODEINE, ASPIRIN, APAP FORMULA NO. 3
	
         SCHERER LABS           150MG;180MG;30MG
	              A085639 001
	
    CODEINE, ASPIRIN, APAP FORMULA NO. 4
	
         SCHERER LABS           150MG;180MG;60MG
	              A085638 001
	
ACETAMINOPHEN; BUTALBITAL
	
  CAPSULE;ORAL
	
    BANCAP
	
         FOREST PHARMS
	        325MG;50MG
	                    A088889 001 Jan 16, 1986
	
    BUCET
	
         MALLINCKRODT
	         650MG;50MG
	                    A088991 001 Jun 28, 1985
	
    PHRENILIN FORTE
	
         VALEANT
	              650MG;50MG
	                    A088831 001 Jun 19, 1985
	
    TENCON
	
         MALLINCKRODT
	         650MG;50MG
	                    A089405 001 May 15, 1990
	
    TRIAPRIN
	
         DUNHALL
	              325MG;50MG
	                    A089268 001 Jul 02, 1987
	
  TABLET;ORAL
	
    BUTALBITAL AND ACETAMINOPHEN
	
         HALSEY                 325MG;50MG
	                    A089568 001 Oct 05, 1988
	
         WATSON LABS            325MG;50MG
	                    A087550 001 Oct 19, 1984
	
    BUTAPAP
	
         MIKART                 650MG;50MG
	                    A089988 001 Oct 26, 1992
	
    PHRENILIN
	
         VALEANT                325MG;50MG
	                    A087811 001 Jun 19, 1985
	
    SEDAPAP
	
         MAYRAND                650MG;50MG
	                    A088944 001 Oct 17, 1985
	
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
	
  CAPSULE;ORAL
	
    ANOQUAN
	
         SHIRE                  325MG;50MG;40MG
	               A087628 001 Oct 01, 1986
	
    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
	
         GRAHAM DM		            325MG;50MG;40MG
	               A088743 001 Jul 18, 1985
	
                                325MG;50MG;40MG
	               A088765 001 Mar 27, 1985
	
                                325MG;50MG;40MG
	               A089067 001 Apr 19, 1985
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                             6-2(of 337)

ACETAMINOPHEN; BUTALBITAL; CAFFEINE
  CAPSULE;ORAL
    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
          HIKMA PHARMS LLC      500MG;50MG;40MG                     A040261 001 Oct 28, 1998
          MALLINCKRODT          325MG;50MG;40MG                     A088758 001 Mar 27, 1985
    BUTALIBITAL, ACETAMINOPHEN AND CAFFEINE
          GILBERT LABS          325MG;50MG;40MG                     A088825 001 Dec 05, 1984
    ESGIC-PLUS
          MIKART                500MG;50MG;40MG                     A040085 001 Mar 28, 1996
    FEMCET
          MALLINCKRODT          325MG;50MG;40MG                     A089102 001 Jun 19, 1985
    MEDIGESIC PLUS
          US CHEM               325MG;50MG;40MG                     A089115 001 Jan 14, 1986
    TRIAD
          MALLINCKRODT          325MG;50MG;40MG                     A089023 001 Jun 19, 1985
  TABLET;ORAL
    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
          ABLE                  325MG;50MG;40MG                     A040390   001   Jul   23,   2001
                                500MG;50MG;40MG                     A040394   001   Jul   23,   2001
          GILBERT LABS          325MG;50MG;40MG                     A087629   001   Nov   13,   1984
          HIKMA PHARMS LLC      500MG;50MG;40MG                     A040336   001   Aug   18,   1999
          MIKART                750MG;50MG;40MG                     A040496   001   Dec   23,   2003
          MIRROR PHARMS         325MG;50MG;40MG                     A040864   001   Dec   01,   2008
          MIRROR PHARMS LLC     500MG;50MG;40MG                     A040883   001   Dec   23,   2008
          MUTUAL PHARM          325MG;50MG;40MG                     A040601   001   Jul   29,   2005
          VINTAGE PHARMS        500MG;50MG;40MG                     A040513   001   Aug   25,   2003
          WATSON LABS           325MG;50MG;40MG                     A089536   001   Feb   16,   1988
                                500MG;50MG;40MG                     A040267   001   Jul   30,   1998
    ESGIC
         FOREST PHARMS          325MG;50MG;40MG                     A089660 001 Dec 23, 1988
    ESGIC-PLUS
         MIKART                 500MG;50MG;40MG                     A089451 001 May 23, 1988
    FIORICET
         WATSON PHARMS          325MG;50MG;40MG                     A088616 001 Nov 09, 1984
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
  CAPSULE;ORAL
    BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
         ABLE                   325MG;50MG;40MG;30MG                A076528 001 Aug 21, 2003
    PHRENILIN WITH CAFFEINE AND CODEINE
         VALEANT                325MG;50MG;40MG;30MG                A074911 001 Aug 22, 2001
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
  CAPSULE;ORAL
    ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
         MIKART                 356.4MG;30MG;16MG                   A040109 001 Aug 26, 1997
         WRASER PHARMS LLC      356.4MG;30MG;16MG                   A040688 001 Apr 03, 2007
    DHC PLUS
         PHARM RES ASSOC        356.4MG;30MG;16MG                   A088584 001 Mar 04, 1986
    SYNALGOS-DC-A
         LEITNER PHARMS         356.4MG;30MG;16MG                   A089166 001 May 14, 1986
  TABLET;ORAL
    ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
         BOCA PHARMA LLC        712.8MG;60MG;32MG                   A040701 001 Apr 03, 2007
         MIKART                 712.8MG;60MG;32MG                   A040316 001 Apr 28, 1999
         WEST-WARD PHARM CORP   712.8MG;60MG;32MG                   A040637 001 Sep 22, 2006
ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE
  TABLET;ORAL
    TAVIST ALLERGY/SINUS/HEADACHE
         NOVARTIS               500MG;EQ 0.25MG BASE;30MG           N021082 001 Mar 01, 2001
ACETAMINOPHEN; CODEINE PHOSPHATE
  CAPSULE;ORAL
    ACETAMINOPHEN AND CODEINE PHOSPHATE
         TEVA                   300MG;15MG                          A088537 001 Jun 04, 1984
                                300MG;30MG                          A088324 001 Dec 29, 1983
                                300MG;60MG                          A088599 001 Jun 01, 1984
    PHENAPHEN W/ CODEINE NO. 2
         ROBINS AH              325MG;15MG                          A084444 001
    PHENAPHEN W/ CODEINE NO. 3
         ROBINS AH              325MG;30MG                          A084445 001
    PHENAPHEN W/ CODEINE NO. 4
         ROBINS AH              325MG;60MG                          A084446 001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                   6-3(of 337)

ACETAMINOPHEN; CODEINE PHOSPHATE
  CAPSULE;ORAL
    PROVAL #3
         SOLVAY                 325MG;30MG                                A085685 001
    TYLENOL W/ CODEINE NO. 3
         ORTHO MCNEIL PHARM     300MG;30MG                                A087422 001
    TYLENOL W/ CODEINE NO. 4
         ORTHO MCNEIL PHARM     300MG;60MG                                A087421 001
  SOLUTION;ORAL
    ACETAMINOPHEN AND CODEINE PHOSPHATE
         ACTAVIS MID ATLANTIC   120MG/5ML;12MG/5ML                        A085861 001
         DAVA PHARMS INC        120MG/5ML;12MG/5ML                        A040098 001 Sep 20, 1996
         ROXANE                 120MG/5ML;12MG/5ML                        A086366 001
    TYLENOL W/ CODEINE
         ORTHO MCNEIL PHARM     120MG/5ML;12MG/5ML                        A085057 001
  SUSPENSION;ORAL
    CAPITAL AND CODEINE
         ACTAVIS MID ATLANTIC   120MG/5ML;12MG/5ML                        A085883 001
  TABLET;ORAL
    ACETAMINOPHEN AND CODEINE PHOSPHATE
         ABLE                   300MG;30MG                                A040452   001   Aug   01,   2002
                                300MG;60MG                                A040459   001   Aug   01,   2002
         AM THERAP              300MG;15MG                                A089478   001   Mar   03,   1987
                                300MG;15MG                                A089481   001   Mar   03,   1987
                                300MG;30MG                                A089479   001   Mar   03,   1987
                                300MG;30MG                                A089482   001   Mar   03,   1987
                                300MG;60MG                                A089480   001   Mar   03,   1987
                                300MG;60MG                                A089483   001   Mar   03,   1987
         DURAMED PHARMS BARR    300MG;15MG                                A040223   001   Nov   18,   1997
                                300MG;15MG                                A088353   001   Feb   06,   1984
                                300MG;30MG                                A040223   002   Nov   18,   1997
                                300MG;30MG                                A088354   001   Feb   06,   1984
                                300MG;60MG                                A040223   003   Nov   18,   1997
                                300MG;60MG                                A088355   001   Feb   06,   1984
         EVERYLIFE              325MG;30MG                                A085217   001
         HALSEY                 300MG;15MG                                A083871   001
                                300MG;30MG                                A083872   001
                                300MG;60MG                                A086549   001
         KV PHARM               300MG;30MG                                A085288   001
                                300MG;60MG                                A085365   001
                                325MG;15MG                                A085364   001
                                325MG;45MG **Federal Register             A085363   001
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
         LEDERLE                300MG;30MG                                A087141   001
         MIKART                 300MG;30MG                                A089238   001   Feb   25,   1986
                                300MG;60MG                                A089244   001   Feb   25,   1986
                                650MG;30MG                                A089231   001   Mar   03,   1986
                                650MG;60MG                                A089363   001   Sep   09,   1991
         MUTUAL PHARM           300MG;15MG                                A085795   001
                                300MG;15MG                                A089671   001   Feb 10, 1988
                                300MG;30MG                                A085794   001
                                300MG;30MG                                A089672   001   Feb   10,   1988
                                300MG;60MG                                A087653   001   Apr   13,   1982
                                300MG;60MG                                A089673   001   Feb   10,   1988
         PURACAP PHARM          300MG;30MG                                A087762   001   Dec   10,   1982
         PUREPAC PHARM          300MG;30MG                                A086681   001
                                300MG;30MG                                A089080   001   Jul 17, 1986
                                300MG;60MG                                A086683   001
         ROXANE                 300MG;15MG                                A084659   001
                                300MG;30MG                                A084656   001
                                300MG;60MG                                A084667   001
                                500MG;15MG                                A089511   001   Apr 25, 1989
                                500MG;30MG                                A089512   001   Apr 25, 1989
                                500MG;60MG                                A089513   001   Apr 25, 1989
         SANDOZ                 300MG;15MG                                A087433   001
                                300MG;30MG                                A081250   001   Jul 16, 1992
                                300MG;30MG                                A085291   002
                                300MG;30MG                                A085917   001
                                300MG;60MG                                A081249   001   Jul 16, 1992
                                300MG;60MG                                A085964   001
                                300MG;60MG                                A087423   001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                              6-4(of 337)

ACETAMINOPHEN; CODEINE PHOSPHATE
  TABLET;ORAL
    ACETAMINOPHEN AND CODEINE PHOSPHATE
         SUPERPHARM             300MG;15MG                           A089183   001   Oct   18,   1985
                                300MG;30MG                           A089184   001   Oct   18,   1985
                                300MG;30MG                           A089253   001   May   19,   1986
                                300MG;60MG                           A089185   001   Oct   18,   1985
                                300MG;60MG                           A089254   001   May   19,   1986
         USL PHARMA             300MG;30MG                           A087919   001   Jun   22,   1982
                                300MG;60MG                           A087920   001   Jun   22,   1982
         VALEANT PHARM INTL     300MG;30MG                           A085896   001
         VITARINE               300MG;30MG                           A085676   001
         WARNER CHILCOTT        300MG;15MG                           A085992   001
                                300MG;30MG                           A085218   002
                                300MG;60MG                           A087306   001
         WATSON LABS            300MG;15MG                           A087277   001   May   26,   1982
                                300MG;15MG                           A089997   001   Dec   28,   1994
                                300MG;30MG                           A087276   001   May   26,   1982
                                300MG;30MG                           A089998   001   Dec   28,   1994
                                300MG;60MG                           A087275   001   May   26,   1982
                                300MG;60MG                           A089999   001   Dec   28,   1994
         WATSON LABS FLORIDA    300MG;15MG                           A040443   001   Jan   22,   2003
                                300MG;30MG                           A040443   002   Jan   22,   2003
                                300MG;60MG                           A040443   003   Jan   22,   2003
         WHITEWORTH TOWN PLSN   300MG;30MG                           A084360   001
                                300MG;60MG                           A085607   001
    CAPITAL AND CODEINE
         CARNRICK               325MG;30MG                           A083643 001
    CODRIX
         WATSON LABS FLORIDA    500MG;15MG                           A040447 001 Feb 26, 2003
                                500MG;30MG                           A040441 001 Mar 27, 2003
                                500MG;60MG                           A040488 001 Mar 28, 2003
    EMPRACET W/ CODEINE PHOSPHATE #3
         GLAXOSMITHKLINE        300MG;30MG                           A083951 001
    EMPRACET W/ CODEINE PHOSPHATE #4
         GLAXOSMITHKLINE        300MG;60MG                           A083951 002
    PAPA-DEINE #3
         VANGARD                300MG;30MG                           A088037 001 Mar 20, 1984
    PAPA-DEINE #4
         VANGARD                300MG;60MG                           A088715 001 Mar 20, 1984
    PHENAPHEN-650 W/ CODEINE
         ROBINS AH              650MG;30MG                           A085856 001
    TYLENOL W/ CODEINE
         ORTHO MCNEIL PHARM     325MG;7.5MG                          A085056   001
                                325MG;15MG                           A085056   002
                                325MG;30MG                           A085056   003
                                325MG;60MG                           A085056   004
    TYLENOL W/ CODEINE NO. 1
         JANSSEN PHARMS         300MG;7.5MG                          A085055 001
    TYLENOL W/ CODEINE NO. 2
         JANSSEN PHARMS         300MG;15MG                           A085055 002
ACETAMINOPHEN; DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
  TABLET, EXTENDED RELEASE;ORAL
    DRIXORAL PLUS
         SCHERING PLOUGH        500MG;3MG;60MG                       N019453 001 May 22, 1987
ACETAMINOPHEN; HYDROCODONE BITARTRATE
  CAPSULE;ORAL
    ACETAMINOPHEN AND HYDROCODONE BITARTRATE
          CENT PHARMS           500MG;5MG                            A088898 001 Mar 27, 1985
    ALLAY
         IVAX PHARMS            500MG;5MG                            A089907 001 Jan 13, 1989
    BANCAP HC
         FOREST PHARMS          500MG;5MG                            A087961 001 Mar 17, 1983
    CO-GESIC
         CENT PHARMS            500MG;5MG                            A089360 001 Mar 02, 1988
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
         MALLINCKRODT           500MG;5MG                            A088956   001   Jul   19,   1985
                                500MG;5MG                            A089006   001   Aug   09,   1985
         MIKART                 500MG;5MG                            A081067   001   Nov   30,   1989
                                500MG;5MG                            A081068   001   Nov   30,   1989
                                500MG;5MG                            A081069   001   Nov   30,   1989
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                        6-5(of 337)

ACETAMINOPHEN; HYDROCODONE BITARTRATE
  CAPSULE;ORAL
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
                                500MG;5MG                      A081070 001 Nov 30, 1989
                                500MG;5MG                      A089008 001 Feb 21, 1986
    LORCET-HD
         MALLINCKRODT           500MG;5MG                      A087336 001 Jul 08, 1982
  SOLUTION;ORAL
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
         MALLINCKRODT           500MG/15ML;7.5MG/15ML          A040418   001   Jun   27,   2001
         MALLINCKRODT INC       500MG/15ML;10MG/15ML           A040508   001   Aug   29,   2003
         MIKART                 500MG/15ML;5MG/15ML            A081226   001   Oct   27,   1992
                                500MG/15ML;5MG/15ML            A089557   001   Apr   29,   1992
                                500MG/15ML;7.5MG/15ML          A081051   001   Aug   28,   1992
         NESHER PHARMS          500MG/15ML;7.5MG/15ML          A040366   001   Jan   23,   2002
         PHARM ASSOC            500MG/15ML;7.5MG/15ML          A040182   001   Mar   13,   1998
         VINTAGE PHARMS         500MG/15ML;7.5MG/15ML          A040520   001   Oct   30,   2003
  TABLET;ORAL
    ANEXSIA
         MALLINCKRODT           500MG;5MG                      A089160 001 Apr 23, 1987
                                750MG;10MG                     A040468 001 Oct 31, 2002
    ANEXSIA 7.5/650
         MALLINCKRODT           650MG;7.5MG                    A089725 001 Sep 30, 1987
    CO-GESIC
         UCB INC                500MG;5MG                      A087757 001 May 03, 1982
    DURADYNE DHC
         FOREST PHARMS          500MG;5MG                      A087809 001 Mar 17, 1983
    HY-PHEN
         ASCHER                 500MG;5MG                      A087677 001 May 03, 1982
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
         ABLE                   325MG;5MG                      A040478   001   Nov   08,   2002
                                325MG;7.5MG                    A040464   001   Oct   23,   2002
                                325MG;10MG                     A040464   002   Oct   23,   2002
                                500MG;5MG                      A040477   001   Nov   06,   2002
                                500MG;7.5MG                    A040490   001   May   21,   2003
                                500MG;10MG                     A040473   001   Nov   06,   2002
                                650MG;7.5MG                    A040474   001   Jan   02,   2003
                                650MG;10MG                     A040476   001   Oct   23,   2002
                                750MG;7.5MG                    A040469   001   Oct   25,   2002
         ACTAVIS LABS FL INC    500MG;10MG                     A040148   002   Feb   14,   1997
         AMNEAL PHARMS NY       500MG;5MG                      A040729   001   Aug   25,   2006
                                500MG;7.5MG                    A040748   001   Aug   25,   2006
                                500MG;10MG                     A040813   001   Feb   23,   2007
                                650MG;7.5MG                    A040754   001   Aug   25,   2006
                                650MG;10MG                     A040757   001   Aug   25,   2006
                                750MG;7.5MG                    A040769   001   Aug   28,   2006
         BARR                   500MG;2.5MG                    A040307   001   Jul   26,   2000
                                500MG;5MG                      A040308   001   Jul   26,   2000
                                500MG;5MG                      A088577   001   Dec   21,   1984
                                500MG;7.5MG                    A040307   002   Jul   26,   2000
                                500MG;10MG                     A040309   001   Jul   26,   2000
                                650MG;7.5MG                    A040307   003   Jul   26,   2000
                                650MG;10MG                     A040307   004   Jul   26,   2000
                                750MG;7.5MG                    A040308   002   Jul   26,   2000
         CARACO                 500MG;5MG                      A090265   001   Dec   23,   2008
                                500MG;7.5MG                    A090265   002   Dec   23,   2008
                                500MG;10MG                     A090265   003   Dec   23,   2008
                                650MG;7.5MG                    A090380   001   Dec   23,   2008
                                650MG;10MG                     A090380   002   Dec   23,   2008
                                660MG;10MG                     A090380   003   Dec   23,   2008
                                750MG;7.5MG                    A090380   004   Dec   23,   2008
         HALSEY                 500MG;5MG                      A089554   001   Jun   12,   1987
         IVAX PHARMS            500MG;5MG                      A089696   001   Apr   21,   1988
         MALLINCKRODT           500MG;5MG                      A040084   002   Jun   01,   1995
                                500MG;7.5MG                    A040201   001   Feb   27,   1998
                                500MG;10MG                     A040201   002   Feb   27,   1998
                                650MG;10MG                     A040084   004   Oct   16,   1996
                                660MG;10MG                     A040084   003   Jul   29,   1996
                                750MG;7.5MG                    A040084   001   Jun   01,   1995
         MIKART                 500MG;2.5MG                    A089698   001   Aug   25,   1989
                                500MG;5MG                      A089271   001   Jul   16,   1986
                                500MG;5MG                      A089697   001   Jan   28,   1992
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                     6-6(of 337)


ACETAMINOPHEN; HYDROCODONE BITARTRATE
	
  TABLET;ORAL
	
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN
	
                                500MG;7.5MG
	                  A089699   001   Aug   25,   1989

                                650MG;5MG
	                    A040849   001   Jun   09,   2010
	
                                650MG;7.5MG
	                  A089689   001   Jun   29,   1988
	
                                650MG;10MG
	                   A081223   001   May   29,   1992

         MUTUAL PHARM
	         500MG;5MG
	                    A040236   001   Sep   25,   1997

                                650MG;7.5MG
	                  A040240   002   Nov   26,   1997
	
                                650MG;10MG
	                   A040240   001   Nov   26,   1997
	
                                750MG;7.5MG
	                  A040236   002   Sep   25,   1997

         RANBAXY
	              500MG;5MG
	                    A040825   001   Aug   16,   2007

                                500MG;10MG
	                   A040824   001   Aug   16,   2007

         RANBAXY LABS LTD
	     325MG;10MG
	                   A040826   001   Aug   16,   2007

                                750MG;7.5MG
	                  A040822   001   Aug   16,   2007

         SANDOZ
	               500MG;5MG
	                    A040149   001   Jan   27,   1997
	
                                750MG;7.5MG
	                  A040149   002   Jan   27,   1997
	
         UCB INC
	              500MG;10MG
	                   A040210   001   Aug   13,   1997

                                650MG;7.5MG
	                  A040134   001   Nov   21,   1996
	
         USL PHARMA
	           500MG;5MG
	                    A089290   001   May   29,   1987

                                500MG;5MG
	                    A089291   001   May   29,   1987

         VINTAGE PHARMS
	       500MG;2.5MG
	                  A040144   002   Apr   25,   1997

                                500MG;5MG
	                    A089831   001   Sep   07,   1988

                                500MG;5MG
	                    A089971   001   Dec   02,   1988
	
                                500MG;7.5MG
	                  A040144   001   Feb   22,   1996
	
                                500MG;10MG
	                   A040356   001   May   31,   2000

                                650MG;7.5MG
	                  A040155   001   Apr   14,   1997

                                650MG;10MG
	                   A040143   001   Feb   22,   1996
	
                                660MG;10MG
	                   A040358   001   May   31,   2000

                                750MG;7.5MG
	                  A040157   001   Apr   12,   1996

         VINTAGE PHARMS LLC
	   500MG;5MG
	                    A040281   001   Sep   30,   1998

                                500MG;7.5MG
	                  A040280   001   Sep   30,   1998

                                650MG;7.5MG
	                  A040280   002   Sep   30,   1998

                                650MG;10MG
	                   A040280   003   Sep   30,   1998

                                750MG;7.5MG
	                  A040281   002   Sep   30,   1998

         WATSON LABS
	          325MG;7.5MG
	                  A040248   001   Apr   28,   2000

                                325MG;10MG
	                   A040248   002   Apr   28,   2000

                                500MG;2.5MG
	                  A040123   003   Mar   04,   1996
	
                                500MG;2.5MG
	                  A081079   001   Aug   30,   1991

                                500MG;5MG
	                    A040122   001   Mar   04,   1996
	
                                500MG;5MG
	                    A089883   001   Dec   01,   1988
	
                                500MG;7.5MG
	                  A040123   004   Mar   04,   1996
	
                                500MG;7.5MG
	                  A081080   001   Aug   30,   1991

                                650MG;7.5MG
	                  A040094   001   Sep   29,   1995

                                650MG;7.5MG
	                  A040123   001   Mar   04,   1996
	
                                650MG;10MG
	                   A040094   002   Sep   29,   1995

                                650MG;10MG
	                   A040123   002   Mar   04,   1996
	
                                660MG;10MG
	                   A040094   003   Aug   08,   2000

                                750MG;7.5MG
	                  A040122   002   Mar   04,   1996
	
                                750MG;7.5MG
	                  A081083   001   Aug   30,   1991

                                750MG;10MG
	                   A040094   004   Mar   22,   1999
	
         WATSON LABS FLORIDA
	  500MG;5MG
	                    A040493   001   May   28,   2003

                                660MG;10MG
	                   A040495   001   May   28,   2003

                                750MG;7.5MG
	                  A040494   001   May   28,   2003
	
    LORTAB
	
         UCB INC
	              500MG;5MG
	                    A087722 001 Jul 09, 1982
	
                                500MG;10MG
	                   A040100 001 Jan 26, 1996
	
    NORCET
	
         ABANA
	                500MG;5MG
	                    A088871 001 May 15, 1986
	
    TYCOLET
	
         ORTHO MCNEIL PHARM
	   500MG;5MG
	                    A089385 001 Aug 27, 1986
	
    VICODIN
	
         ABBOTT
	               500MG;5MG
	                    A085667 001
	
         ABBVIE
	               500MG;5MG
	                    A088058 001 Jan 07, 1983
	
    VICODIN ES
	
         ABBVIE
	               750MG;7.5MG
	                  A089736 001 Dec 09, 1988
	
    VICODIN HP
	
         ABBVIE
	               660MG;10MG
	                   A040117 001 Sep 23, 1996
	
    ZYDONE
	
         VINTAGE PHARMS LLC
	   400MG;5MG
	                    A040288 001 Nov 27, 1998
	
                                400MG;7.5MG
	                  A040288 002 Nov 27, 1998
	
                                400MG;10MG
	                   A040288 003 Nov 27, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                           6-7(of 337)

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
  CAPSULE;ORAL
    OXYCODONE AND ACETAMINOPHEN
          ACTAVIS ELIZABETH     500MG;5MG                         A040199   001   Dec   30,   1998
          BARR                  500MG;5MG                         A040304   001   Oct   02,   2000
          DURAMED PHARMS BARR   500MG;5MG                         A040289   001   Mar   16,   1999
          HALSEY                500MG;5MG                         A089994   001   May   04,   1989
          MALLINCKRODT          500MG;5MG                         A040257   001   Aug   04,   1998
          MUTUAL PHARM          500MG;5MG                         A040219   001   Jan   22,   1998
          VINTAGE PHARMS        500MG;5MG                         A040106   001   Jul   30,   1996
          VINTAGE PHARMS LLC    500MG;5MG                         A040303   001   Dec   30,   1999
          WATSON LABS           500MG;5MG                         A040234   001   Oct   30,   1997
    ROXILOX
          ROXANE                500MG;5MG                         A040061 001 Jul 03, 1995
    TYLOX
         JANSSEN PHARMS         500MG;5MG                         A088790 001 Dec 12, 1984
    TYLOX-325
         ORTHO MCNEIL PHARM     325MG;5MG                         A088246 001 Nov 08, 1984
  SOLUTION;ORAL
    OXYCODONE AND ACETAMINOPHEN
         MALLINCKRODT INC       325MG/5ML;5MG/5ML                 A040680 001 Sep 29, 2006
  TABLET;ORAL
    OXYCODONE 2.5/APAP 500
         BRISTOL MYERS SQUIBB   500MG;2.5MG                       A085910 001
    OXYCODONE 5/APAP 500
         BRISTOL MYERS SQUIBB   500MG;5MG                         A085911 001
    OXYCODONE AND ACETAMINOPHEN
         ACTAVIS ELIZABETH      325MG;5MG                         A040203   001   Mar   15,   1999
                                325MG;7.5MG                       A040800   001   Apr   03,   2012
                                325MG;10MG                        A040800   002   Apr   03,   2012
         AMNEAL PHARMS NY       500MG;7.5MG                       A040789   001   Nov   27,   2007
                                650MG;10MG                        A040789   002   Nov   27,   2007
         BARR                   325MG;5MG                         A087406   001
         COASTAL PHARMS         500MG;7.5MG                       A090177   005   Oct   20,   2008
                                650MG;10MG                        A090177   006   Oct   20,   2008
         DURAMED PHARMS BARR    325MG;5MG                         A040272   001   Jun   30,   1998
         MALLINCKRODT           500MG;7.5MG                       A040550   001   Jun   30,   2004
                                650MG;10MG                        A040550   002   Jun   30,   2004
         MIKART                 400MG;2.5MG                       A040679   001   May   16,   2006
                                400MG;5MG                         A040687   001   Apr   27,   2006
                                400MG;7.5MG                       A040698   001   Apr   27,   2006
                                400MG;10MG                        A040692   001   Apr   27,   2006
                                500MG;10MG                        A040676   001   Apr   19,   2006
         WATSON LABS            500MG;7.5MG                       A040371   001   Dec   29,   2000
                                650MG;10MG                        A040371   002   Dec   29,   2000
    PERCOCET
         VINTAGE PHARMS LLC     325MG;5MG                         A085106 002
                                500MG;7.5MG                       A040341 001 Jul 26, 1999
                                650MG;10MG                        A040341 002 Jul 26, 1999
    ROXICET 5/500
         ROXANE                 500MG;5MG                         A089775 001 Jan 12, 1989
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE
  CAPSULE;ORAL
    TYLOX
          ORTHO MCNEIL PHARM    500MG;4.5MG;0.38MG                A085375 001
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE
  TABLET;ORAL
    ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE
         GAVIS PHARMS           650MG;EQ 25MG BASE                A076202 001 Aug 02, 2002
         WATSON LABS            650MG;EQ 25MG BASE                A074699 001 Mar 24, 2000
    TALACEN
         SANOFI AVENTIS US      650MG;EQ 25MG BASE                N018458 001 Sep 23, 1982
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
  TABLET;ORAL
    DARVOCET
         AAIPHARMA LLC          325MG;32.5MG                      N016844 001
    DOLENE AP-65
         LEDERLE                650MG;65MG                        A085100 001
    PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN
         MYLAN                  650MG;65MG                        A083978 001
         SANDOZ                 650MG;65MG                        A089959 001 Jul 18, 1989
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                 6-8(of 337)

ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
  TABLET;ORAL
    PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN
         VINTAGE PHARMS         650MG;65MG                              A040507 001 Jul 30, 2003
         WATSON LABS            650MG;65MG                              A040139 001 Dec 16, 1996
    WYGESIC
         CARACO                 650MG;65MG                              A084999 001
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
  TABLET;ORAL
    DARVOCET A500
         XANODYNE PHARM         500MG;100MG                             A076429 001 Sep 10, 2003
    DARVOCET-N 100
         XANODYNE PHARM         650MG;100MG                             N017122 002
    DARVOCET-N 50
         XANODYNE PHARM         325MG;50MG                              N017122 001
    PROPACET 100
         TEVA                   650MG;100MG                             A070107 001 Jun 12, 1985
    PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
         ABLE                   650MG;100MG                             A075838   001   Jul   11,   2001
         ACTAVIS ELIZABETH      650MG;100MG                             A070910   001   Jan   02,   1987
         CORNERSTONE            325MG;100MG                             A076743   001   May   07,   2004
                                500MG;100MG                             A076750   001   Jun   28,   2004
         HALSEY                 325MG;50MG                              A072105   001   May   13,   1988
                                650MG;100MG                             A072106   001   May   13,   1988
         IVAX SUB TEVA PHARMS   650MG;100MG                             A070146   001   Aug   02,   1985
         MALLINCKRODT           650MG;100MG                             A075738   001   Feb   02,   2001
         MIRROR PHARMS          650MG;100MG                             A077821   001   Feb   11,   2008
         MUTUAL PHARM           325MG;50MG                              A070115   001   Jun   12,   1985
                                650MG;100MG                             A070116   001   Jun   12,   1985
                                650MG;100MG                             A070615   001   Mar   21,   1986
                                650MG;100MG                             A070771   001   Mar   21,   1986
                                650MG;100MG                             A070775   001   Mar   21,   1986
         MYLAN                  650MG;100MG                             A072195   001   Feb   16,   1988
         MYLAN PHARMS INC       650MG;100MG                             A070145   001   Jun   12,   1985
         SANDOZ                 650MG;100MG                             A070443   001   Jan   23,   1986
         SUPERPHARM             650MG;100MG                             A071319   001   Jan   06,   1987
         TEVA                   650MG;100MG                             A070732   001   Jan   03,   1986
                                650MG;100MG                             A074119   001   Dec   19,   1994
         VINTAGE PHARMS         325MG;50MG                              A074843   002   Feb   15,   2001
                                650MG;100MG                             A074843   001   Feb   12,   1997
         WATSON LABS            325MG;50MG                              A070398   001   Dec   18,   1986
                                650MG;100MG                             A070399   001   Dec   18,   1986
         WATSON LABS FLORIDA    500MG;100MG                             A077196   001   Jun   28,   2005
                                650MG;100MG                             A076609   001   Nov   16,   2004
         WOCKHARDT LTD          325MG;50MG                              A077677   001   Mar   16,   2007
                                650MG;100MG                             A077677   002   Mar   16,   2007
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
  TABLET;ORAL
    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN
         WATSON LABS            325MG;37.5MG                            A076914 001 Jul 26, 2006
ACETAZOLAMIDE
  TABLET;ORAL
    ACETAZOLAMIDE
         ALRA                  250MG                                    A083320   001
         ASCOT                 250MG                                    A087686   001   Oct 20, 1982
         MUTUAL PHARM          250MG                                    A089753   001   Jun 22, 1988
         VANGARD               250MG                                    A087654   001   Feb 05, 1982
         WATSON LABS           250MG                                    A084498   002
                               250MG                                    A088882   001   Oct 22, 1985
   DIAMOX
        TEVA BRANDED PHARM     125MG **Federal Register determination   N008943 001
                               that product was not discontinued or
                               withdrawn for safety or efficacy
                               reasons**
                               250MG **Federal Register determination   N008943 002
                               that product was not discontinued or
                               withdrawn for safety or efficacy
                               reasons**
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                  6-9(of 337)

ACETAZOLAMIDE SODIUM
  INJECTABLE;INJECTION
    ACETAZOLAMIDE SODIUM
         HOSPIRA                 EQ 500MG BASE/VIAL                        A040108 001 Oct 30, 1995
    DIAMOX
         TEVA WOMENS             EQ 500MG BASE/VIAL **Federal Register     N009388 001 Dec 05, 1990
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
ACETIC ACID, GLACIAL
  SOLUTION/DROPS;OTIC
    ACETASOL
          ACTAVIS MID ATLANTIC   2%                                        A087146 001
    ACETIC ACID
          KV PHARM               2%                                        A085493 001
    ORLEX
          WARNER CHILCOTT        2%                                        A086845 001
ACETIC ACID, GLACIAL; ALUMINUM ACETATE
  SOLUTION/DROPS;OTIC
    BOROFAIR
         PHARMAFAIR             2%;0.79%                                   A088606 001 Aug 21, 1985
    DOMEBORO
         BAYER PHARMS           2%;0.79%                                   A084476 001
ACETIC ACID, GLACIAL; DESONIDE
  SOLUTION/DROPS;OTIC
    TRIDESILON
         BAYER PHARMS          2%;0.05%                                    N017914 001
ACETIC ACID, GLACIAL; HYDROCORTISONE
  SOLUTION/DROPS;OTIC
    ACETIC ACID W/ HYDROCORTISONE
         KV PHARM               2%;1%                                      A085492 001
    HYDROCORTISONE AND ACETIC ACID
         BAUSCH AND LOMB        2%;1%                                      A040097 001 Oct 31, 1994
         WOCKHARDT              2%;1%                                      A040168 001 Aug 30, 1996
    ORLEX HC
         WARNER CHILCOTT        2%;1%                                      A086844 001
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
  SUSPENSION/DROPS;OTIC
    NEO-CORT-DOME
         BAYER PHARMS           2%;1%;EQ 0.35% BASE                        N050238 001
ACETOHEXAMIDE
  TABLET;ORAL
    ACETOHEXAMIDE
         BARR                    250MG                                     A070869   001   Feb   09,   1987
                                 500MG                                     A070870   001   Feb   09,   1987
         USL PHARMA              250MG                                     A070753   001   Nov   03,   1986
                                 500MG                                     A070754   001   Nov   03,   1986
         WATSON LABS             250MG                                     A071893   001   Nov   25,   1987
                                 500MG                                     A071894   001   Nov   25,   1987
   DYMELOR
        LILLY                    250MG                                     N013378 002
                                 500MG                                     N013378 001
ACETOPHENAZINE MALEATE
  TABLET;ORAL
    TINDAL
         SCHERING                20MG                                      N012254 002
ACETRIZOATE SODIUM
  SOLUTION;INTRAUTERINE
    SALPIX
         ORTHO MCNEIL PHARM      53%                                       N009008 001
ACETYLCHOLINE CHLORIDE
  FOR SOLUTION;OPHTHALMIC
    MIOCHOL
         NOVARTIS                20MG/VIAL                                 N016211 001
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-10(of 337)


ACETYLCYSTEINE
	
  SOLUTION;INHALATION, ORAL
	
    ACETYLCYSTEINE
	
         HOSPIRA                10%                                      A071364   001   May   01,   1989

                                20%                                      A071365   001   May   01,   1989

         ROXANE		               10%                                      A072323   001   Apr   30,   1992

                                10%                                      A072621   001   Sep   30,   1992

                                20%                                      A072324   001   Apr   30,   1992

                                20%                                      A072622   001   Sep   30,   1992

    MUCOMYST
	
         APOTHECON              10%                                      N013601 002
	
                                20%                                      N013601 001
	
    MUCOSIL-10
	
         DEY                    10%                                      A070575 001 Oct 14, 1986
	
    MUCOSIL-20
	
         DEY                    20%                                      A070576 001 Oct 14, 1986
	
ACETYLCYSTEINE; ISOPROTERENOL HYDROCHLORIDE
	
  SOLUTION;INHALATION
	
    MUCOMYST W/ ISOPROTERENOL

         MEAD JOHNSON           10%;0.05%                                N017366 001
	
ACETYLDIGITOXIN
	
  TABLET;ORAL
	
    ACYLANID
	
         NOVARTIS		             0.1MG                                    N009436 001
	
ACRISORCIN
	
  CREAM;TOPICAL
	
    AKRINOL
	
         SCHERING               2MG/GM                                   N012470 001
	
ACYCLOVIR
	
  CAPSULE;ORAL
	
    ACYCLOVIR
	
         ACTAVIS ELIZABETH      200MG                                    A074906   001   Aug   26,   1997

         DAVA PHARMS INC        200MG                                    A074872   001   Apr   22,   1997

         HERITAGE PHARMS INC    200MG                                    A074889   001   Oct   31,   1997
	
         IVAX SUB TEVA PHARMS   200MG                                    A074674   001   Apr   22,   1997

         LEK PHARM              200MG                                    A074750   001   Apr   22,   1997

         MYLAN                  200MG                                    A074977   001   Apr   13,   1998

         ROXANE                 200MG                                    A074570   002   Apr   22,   1997

         TEVA                   200MG                                    A074828   001   Apr   22,   1997

         TEVA PHARMS            200MG                                    A074914   001   Nov   26,   1997
	
         WATSON LABS            200MG                                    A075101   001   Apr   15,   1998

  TABLET;ORAL
	
    ACYCLOVIR
	
         ACTAVIS ELIZABETH      400MG                                    A074870   001   Jun   05,   1997
	
                                800MG                                    A074870   002   Jun   05,   1997
	
         DAVA PHARMS INC        400MG                                    A074834   001   Apr   24,   1997

                                800MG                                    A074834   002   Apr   24,   1997

         HERITAGE PHARMS INC    400MG                                    A074891   001   Oct   31,   1997
	
                                800MG                                    A074891   002   Oct   31,   1997
	
         IVAX SUB TEVA PHARMS   400MG                                    A074836   001   Apr   22,   1997

                                800MG                                    A074836   002   Apr   22,   1997

         LEK PHARM              400MG                                    A074658   001   Apr   22,   1997

                                800MG                                    A074658   002   Apr   22,   1997

         MYLAN                  400MG                                    A074976   001   Apr   13,   1998

                                800MG                                    A074976   002   Apr   13,   1998

         TEVA		                 200MG **Federal Register determination   A074556   001   Apr   22,   1997

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
         TEVA PHARMS		          400MG                                    A075021 001 Mar 18, 1998
	
                                800MG                                    A075021 002 Mar 18, 1998
	
ACYCLOVIR SODIUM
	
  INJECTABLE;INJECTION
	
    ACYCLOVIR
	
         ABBVIE                 EQ 50MG BASE/ML                          A075114 001 Jul 26, 1999
	
    ACYCLOVIR SODIUM
	
         APOTHECON              EQ   1GM BASE/VIAL                       A074897   002   Feb   27,   1998
	
                                EQ   500MG BASE/VIAL                     A074897   001   Feb   27,   1998
	
         HIKMA MAPLE            EQ   1GM BASE/VIAL                       A074913   002   Oct   15,   1997
	
                                EQ   500MG BASE/VIAL                     A074913   001   Oct   15,   1997
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                6-11(of 337)

ACYCLOVIR SODIUM
  INJECTABLE;INJECTION
    ACYCLOVIR SODIUM
         HOSPIRA                EQ   1GM BASE/VIAL                        A074663   002   Apr   22,   1997
                                EQ   1GM BASE/VIAL                        A074758   002   Apr   22,   1997
                                EQ   25MG BASE/ML                         A074720   001   Apr   22,   1997
                                EQ   50MG BASE/ML                         A075065   001   Feb   25,   1999
                                EQ   500MG BASE/VIAL                      A074663   001   Apr   22,   1997
                                EQ   500MG BASE/VIAL                      A074758   001   Apr   22,   1997
        TEVA PARENTERAL         EQ   1GM BASE/VIAL                        A074969   002   Aug   26,   1997
                                EQ   50MG BASE/ML                         A075627   001   Mar   28,   2001
                                EQ   500MG BASE/VIAL                      A074969   001   Aug   26,   1997
   ZOVIRAX
        GLAXOSMITHKLINE         EQ 1GM BASE/VIAL **Federal Register       N018603 002 Jun 29, 1989
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
                                EQ 250MG BASE/VIAL **Federal Register     N018603 003 Aug 30, 1983
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
                                EQ 500MG BASE/VIAL **Federal Register     N018603 001 Oct 22, 1982
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
ADAPALENE
  SOLUTION;TOPICAL
    DIFFERIN
         GALDERMA LABS LP       0.1%                                      N020338 001 May 31, 1996
ADENOSINE
  INJECTABLE;INJECTION
    ADENOSINE
         HIKMA MAPLE            3MG/ML                                    A076501 001 Jun 16, 2004
         TEVA PHARMS USA        3MG/ML                                    A076564 001 Jun 16, 2004
                                3MG/ML                                    A078676 001 Jul 31, 2008
ALATROFLOXACIN MESYLATE
  INJECTABLE;INJECTION
    TROVAN PRESERVATIVE FREE
         PFIZER                 EQ 200MG BASE/VIAL                        N020760 001 Dec 18, 1997
                                EQ 300MG BASE/VIAL                        N020760 002 Dec 18, 1997
ALBUMIN CHROMATED CR-51 SERUM
  INJECTABLE;INJECTION
    CHROMALBIN
         ISO TEX                100uCi/VIAL                               N017835 001
                                250uCi/VIAL                               N017835 002
                                500uCi/VIAL                               N017835 003
ALBUMIN IODINATED I-125 SERUM
  INJECTABLE;INJECTION
    RADIO-IODINATED (I 125) SERUM ALBUMIN (HUMAN)
         BAYER PHARMS           2.5uCi/AMP                                N017846 001
    RADIOIODINATED SERUM ALBUMIN (HUMAN) IHSA I 125
         MALLINCKRODT           6.67uCi/ML                                N017844 003
                                10uCi/ML                                  N017844 001
                                100uCi/ML                                 N017844 002
ALBUMIN IODINATED I-131 SERUM
  INJECTABLE;INJECTION
    MEGATOPE
         ISO TEX                2mCi/VIAL                                 N017837 003
                                5uCi/AMP                                  N017837 004
                                20uCi/AMP                                 N017837 005
ALBUTEROL
  AEROSOL, METERED;INHALATION
    ALBUTEROL
         ARMSTRONG PHARMS       0.09MG/INH                                A072273   001   Aug   14,   1996
         GENPHARM               0.09MG/INH                                A073045   001   Aug   19,   1997
         IVAX SUB TEVA PHARMS   0.09MG/INH                                A073272   001   Dec   28,   1995
         PLIVA                  0.09MG/INH                                A074072   001   Aug   01,   1996
    PROVENTIL
         SCHERING               0.09MG/INH                                N017559 001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                       6-12(of 337)

ALBUTEROL
  AEROSOL, METERED;INHALATION
    VENTOLIN
         GLAXOSMITHKLINE        0.09MG/INH                     N018473 001
ALBUTEROL SULFATE
  CAPSULE;INHALATION
    VENTOLIN ROTACAPS
         GLAXOSMITHKLINE        EQ 0.2MG BASE                  N019489 001 May 04, 1988
  SOLUTION;INHALATION
    ALBUTEROL SULFATE
         ACTAVIS MID ATLANTIC   EQ   0.083% BASE               A073533   001   Sep   26,   1995
         APOTEX INC             EQ   0.021% BASE               A078623   001   Apr   05,   2010
                                EQ   0.042% BASE               A078623   002   Apr   05,   2010
                                EQ   0.083% BASE               A075717   001   Feb   02,   2007
                                EQ   0.5% BASE                 A076391   001   Apr   01,   2003
        BAUSCH AND LOMB         EQ   0.083% BASE               A075358   001   Mar   29,   2000
        COPLEY PHARM            EQ   0.083% BASE               A073495   001   May   28,   1993
                                EQ   0.5% BASE                 A073307   001   Nov   27,   1991
        ROXANE                  EQ   0.083% BASE               A075129   001   Feb   13,   2001
        WOCKHARDT EU OPERATN    EQ   0.083% BASE               A075394   001   Nov   22,   1999
   PROVENTIL
        SCHERING                EQ 0.083% BASE                 N019243 002 Jan 14, 1987
                                EQ 0.5% BASE                   N019243 001 Jan 14, 1987
   VENTOLIN
        GLAXOSMITHKLINE         EQ 0.083% BASE                 N019773 001 Apr 23, 1992
                                EQ 0.5% BASE                   N019269 002 Jan 16, 1987
 SYRUP;ORAL
   ALBUTEROL SULFATE
        ACTAVIS MID ATLANTIC    EQ 2MG BASE/5ML                A075262 001 Mar 30, 1999
        MOVA                    EQ 2MG BASE/5ML                A074302 001 Sep 30, 1994
        WATSON LABS             EQ 2MG BASE/5ML                A073165 001 Apr 29, 1993
   PROVENTIL
        SCHERING                EQ 2MG BASE/5ML                N018062 001 Jan 19, 1983
   VENTOLIN
        GLAXOSMITHKLINE         EQ 2MG BASE/5ML                N019621 001 Jun 10, 1987
 TABLET;ORAL
   ALBUTEROL SULFATE
        AM THERAP               EQ   2MG   BASE                A072449   001   Dec   05,   1989
                                EQ   4MG   BASE                A072450   001   Dec   05,   1989
        COPLEY PHARM            EQ   2MG   BASE                A072966   001   Nov   22,   1991
                                EQ   4MG   BASE                A072967   001   Nov   22,   1991
        DAVA PHARMS INC         EQ   2MG   BASE                A072859   001   Dec   20,   1989
                                EQ   4MG   BASE                A072860   001   Dec   20,   1989
        PLIVA                   EQ   2MG   BASE                A072316   001   Dec   05,   1989
                                EQ   4MG   BASE                A072317   001   Dec   05,   1989
        SANDOZ                  EQ   2MG   BASE                A072151   001   Dec   05,   1989
                                EQ   4MG   BASE                A072152   001   Dec   05,   1989
        TEVA                    EQ   2MG   BASE                A072619   001   Dec   05,   1989
                                EQ   2MG   BASE                A072779   001   Jun   25,   1993
                                EQ   2MG   BASE                A072938   001   Mar   30,   1990
                                EQ   4MG   BASE                A072620   001   Dec   05,   1989
                                EQ   4MG   BASE                A072780   001   Jun   25,   1993
                                EQ   4MG   BASE                A072939   001   Mar   30,   1990
        UCB INC                 EQ   2MG   BASE                A073120   001   Sep   29,   1992
                                EQ   4MG   BASE                A073121   001   Sep   29,   1992
        WARNER CHILCOTT         EQ   2MG   BASE                A072817   001   Jan   09,   1990
                                EQ   4MG   BASE                A072818   001   Jan   09,   1990
        WATSON LABS             EQ   2MG   BASE                A072629   001   Jan   31,   1991
                                EQ   2MG   BASE                A072764   001   Aug   28,   1991
                                EQ   4MG   BASE                A072630   001   Jan   31,   1991
                                EQ   4MG   BASE                A072765   001   Aug   28,   1991
   PROVENTIL
        SCHERING                EQ 2MG BASE                    N017853 001 May 07, 1982
                                EQ 4MG BASE                    N017853 002 May 07, 1982
   VENTOLIN
        GLAXOSMITHKLINE         EQ 2MG BASE                    N019112 001 Jul 10, 1986
                                EQ 4MG BASE                    N019112 002 Jul 10, 1986
 TABLET, EXTENDED RELEASE;ORAL
   PROVENTIL
        SCHERING               EQ 4MG BASE                     N019383 001 Jul 13, 1987
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                 6-13(of 337)

ALBUTEROL SULFATE
  TABLET, EXTENDED RELEASE;ORAL
    VOLMAX
         MURO                   EQ 4MG BASE                                 N019604 002 Dec 23, 1992
                                EQ 8MG BASE                                 N019604 001 Dec 23, 1992
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
  SOLUTION;INHALATION
    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
         APOTEX INC             EQ 0.083% BASE;0.017%                       A077117 001 Dec 31, 2007
         SANDOZ INC             EQ 0.083% BASE;0.017%                       A076867 001 Dec 21, 2006
ALCLOMETASONE DIPROPIONATE
  CREAM;TOPICAL
    ACLOVATE
         FOUGERA PHARMS         0.05%                                       N018707 001 Dec 14, 1982
  OINTMENT;TOPICAL
    ACLOVATE
         FOUGERA PHARMS         0.05%                                       N018702 001 Dec 14, 1982
ALCOHOL
  INJECTABLE;INJECTION
    ALCOHOL 5% IN DEXTROSE 5%
         MILES                  5ML/100ML                                   A083483 001
ALCOHOL; DEXTROSE
  INJECTABLE;INJECTION
    ALCOHOL 5% IN D5-W
         HOSPIRA                5ML/100ML;5GM/100ML                         A083263 001
    ALCOHOL 5% IN DEXTROSE 5% IN WATER
         BAXTER HLTHCARE        5ML/100ML;5GM/100ML                         A083256 001
ALENDRONATE SODIUM
  TABLET;ORAL
    ALENDRONATE SODIUM
         MYLAN                  EQ   35MG BASE                              A078638   001   Aug   04,   2008
                                EQ   70MG BASE                              A078638   002   Aug   04,   2008
        SANDOZ                  EQ   5MG BASE                               A075871   001   Apr   22,   2009
                                EQ   10MG BASE                              A075871   002   Apr   22,   2009
                                EQ   35MG BASE                              A075871   004   Apr   22,   2009
                                EQ   40MG BASE                              A075871   003   Apr   22,   2009
                                EQ   70MG BASE                              A075871   005   Apr   22,   2009
        TEVA PHARMS             EQ   35MG BASE                              A076184   002   Aug   04,   2008
                                EQ   70MG BASE                              A076184   001   Feb   06,   2008
   FOSAMAX
        MERCK AND CO INC        EQ 5MG BASE **Federal Register              N020560 003 Apr 25, 1997
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
                                EQ 10MG BASE **Federal Register             N020560 001 Sep 29, 1995
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
                                EQ 35MG BASE **Federal Register             N020560 004 Oct 20, 2000
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
                                EQ 40MG BASE **Federal Register             N020560 002 Sep 29, 1995
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
ALGLUCERASE
  INJECTABLE;INJECTION
    CEREDASE
         GENZYME                10 UNITS/ML                                 N020057 004 May 08, 1992
                                80 UNITS/ML                                 N020057 003 Apr 05, 1991
ALISKIREN HEMIFUMARATE; VALSARTAN
  TABLET;ORAL
    VALTURNA
         NOVARTIS               EQ 150MG BASE;160MG                         N022217 001 Sep 16, 2009
                                EQ 300MG BASE;320MG                         N022217 002 Sep 16, 2009
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                6-14(of 337)

ALKAVERVIR
  TABLET;ORAL
    VERILOID
         3M                     2MG                                      N007336 002
                                3MG                                      N007336 003
ALLOPURINOL
  TABLET;ORAL
    ALLOPURINOL
         MUTUAL PHARM           100MG                                    A070466   001   Dec   24,   1985
                                300MG                                    A070467   001   Dec   24,   1985
        PURACAP PHARM           100MG                                    A070150   001   Dec   10,   1985
                                300MG                                    A070147   001   Dec   10,   1985
        PUREPAC PHARM           100MG                                    A070579   001   Apr   14,   1986
                                300MG                                    A070580   001   Apr   14,   1986
        SANDOZ                  100MG                                    A070268   001   Dec   31,   1985
                                300MG                                    A070269   001   Dec   31,   1985
        SUPERPHARM              100MG                                    A070950   001   Nov   30,   1988
                                300MG                                    A070951   001   Nov   30,   1988
        WATSON LABS             100MG                                    N018241   001   Nov   16,   1984
                                100MG                                    N018785   001   Sep   28,   1984
                                300MG                                    N018241   002   Nov   16,   1984
                                300MG                                    N018785   002   Sep   28,   1984
   LOPURIN
        ABBOTT                  100MG                                    N018297 001
                                300MG                                    N018297 002
ALPRAZOLAM
  SOLUTION;ORAL
    ALPRAZOLAM
         ROXANE                 0.5MG/5ML                                A074314 001 Oct 31, 1993
  TABLET;ORAL
    ALPRAZOLAM
         IVAX SUB TEVA PHARMS   0.25MG                                   A074294   001   Jul   29,   1994
                                0.5MG                                    A074294   002   Jul   29,   1994
                                1MG                                      A074294   003   Jul   29,   1994
                                2MG                                      A074294   004   Jul   29,   1994
        ROXANE                  0.25MG                                   A074199   001   Oct   19,   1993
                                0.5MG                                    A074199   002   Oct   19,   1993
                                1MG                                      A074199   003   Oct   19,   1993
        TEVA                    0.25MG                                   A074085   001   Feb   16,   1994
                                0.5MG                                    A074085   002   Feb   16,   1994
                                1MG                                      A074085   003   Feb   16,   1994
                                2MG                                      A074085   004   Feb   26,   1996
        WATSON LABS             0.25MG                                   A074456   001   Aug   31,   1995
                                0.25MG                                   A074479   001   Jan   21,   1997
                                0.5MG                                    A074456   002   Aug   31,   1995
                                0.5MG                                    A074479   002   Jan   21,   1997
                                1MG                                      A074456   003   Aug   31,   1995
                                1MG                                      A074479   003   Jan   21,   1997
 TABLET, EXTENDED RELEASE;ORAL
   ALPRAZOLAM
        ANI PHARMS INC         0.5MG                                     A077979   001   Feb   28,   2007
                               1MG                                       A077979   002   Feb   28,   2007
                               2MG                                       A077979   003   Feb   28,   2007
                               3MG                                       A077979   004   Feb   28,   2007
        SANDOZ INC             0.5MG                                     A077777   001   Jun   30,   2006
                               1MG                                       A077777   002   Jun   30,   2006
                               2MG                                       A077777   003   Jun   30,   2006
                               3MG                                       A077777   004   Jun   30,   2006
        VINTAGE PHARMS         0.5MG                                     A078442   001   Oct   15,   2007
                               1MG                                       A078442   002   Oct   15,   2007
                               2MG                                       A078442   003   Oct   15,   2007
                               3MG                                       A078442   004   Oct   15,   2007
 TABLET, ORALLY DISINTEGRATING;ORAL
   NIRAVAM
        UCB INC                0.25MG **Federal Register determination   N021726 001 Jan 19, 2005
                               that product was not discontinued or
                               withdrawn for safety or efficacy
                               reasons**
                               0.5MG **Federal Register determination    N021726 002 Jan 19, 2005
                               that product was not discontinued or
                               withdrawn for safety or efficacy
                               reasons**
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                          6-15(of 337)

ALPRAZOLAM
  TABLET, ORALLY DISINTEGRATING;ORAL
    NIRAVAM
                                1MG **Federal Register determination   N021726 003 Jan 19, 2005
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                2MG **Federal Register determination   N021726 004 Jan 19, 2005
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
ALPROSTADIL
  INJECTABLE;INJECTION
    CAVERJECT
         PFIZER                 0.005MG/ML                             N020755 001 Oct 31, 1997
                                0.01MG/ML                              N020755 002 Oct 01, 1997
                                0.02MG/ML                              N020755 003 Oct 01, 1997
   EDEX
          AUXILIUM PHARMS LLC   0.005MG/VIAL                           N020649 001 Jun 12, 1997
ALSEROXYLON
  TABLET;ORAL
    RAUTENSIN
         NOVARTIS               2MG                                    N009215 001
    RAUWILOID
         3M                     2MG                                    N008867 001
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
  TABLET, CHEWABLE;ORAL
    ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE
         PENNEX                 80MG;20MG                              A089449 001 Nov 27, 1987
    FOAMICON
         NOVARTIS               80MG;20MG                              A072687 001 Jun 28, 1989
AMANTADINE HYDROCHLORIDE
  CAPSULE;ORAL
    AMANTADINE HYDROCHLORIDE
         ACTAVIS ELIZABETH      100MG                                  A077659 001 Feb 23, 2006
         WATSON LABS            100MG                                  A071382 001 Jan 21, 1987
    SYMADINE
         SOLVAY                 100MG                                  A071000 001 Sep 04, 1986
    SYMMETREL
         ENDO PHARMS            100MG                                  N016020 001
  SYRUP;ORAL
    AMANTADINE HYDROCHLORIDE
         ACTAVIS MID ATLANTIC   50MG/5ML                               A072655 001 Oct 30, 1990
         TEVA PHARMS            50MG/5ML                               A073115 001 Aug 23, 1991
    SYMMETREL
         ENDO PHARMS            50MG/5ML                               N016023 002
  TABLET;ORAL
    SYMMETREL
         ENDO PHARMS            100MG                                  N018101 001
AMBENONIUM CHLORIDE
  TABLET;ORAL
    MYTELASE
         SANOFI AVENTIS US      10MG                                   N010155 002
AMCINONIDE
  CREAM;TOPICAL
    CYCLOCORT
         ASTELLAS               0.025%                                 N018116 001
                                0.1%                                   N018116 002
 LOTION;TOPICAL
   CYCLOCORT
        ASTELLAS                0.1%                                   N019729 001 Jun 13, 1988
 OINTMENT;TOPICAL
   CYCLOCORT
        ASTELLAS                0.1%                                   N018498 001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                          6-16(of 337)

AMDINOCILLIN
  INJECTABLE;INJECTION
    COACTIN
         ROCHE                  1GM/VIAL                             N050565 003 Dec 21, 1984
                                250MG/VIAL                           N050565 001 Dec 21, 1984
                                500MG/VIAL                           N050565 002 Dec 21, 1984
AMIFOSTINE
  INJECTABLE;INJECTION
    ETHYOL
         CLINIGEN HLTHCARE      375MG/VIAL                           N020221 002 Sep 10, 1999
AMIKACIN SULFATE
  INJECTABLE;INJECTION
    AMIKACIN SULFATE
         ABBOTT                  EQ 250MG BASE/ML                    A063265   001   Nov   30,   1994
                                 EQ 250MG BASE/ML                    A063266   001   Oct   31,   1994
        ASTRAZENECA              EQ 50MG BASE/ML                     A063167   001   Dec   14,   1995
                                 EQ 250MG BASE/ML                    A063169   001   Dec   14,   1995
        HIKMA MAPLE              EQ 50MG BASE/ML                     A063274   001   May   18,   1992
                                 EQ 250MG BASE/ML                    A063275   001   May   18,   1992
        HOSPIRA                  EQ 50MG BASE/ML                     A063263   001   Nov   30,   1994
                                 EQ 50MG BASE/ML                     A063350   001   Jul   30,   1993
                                 EQ 62.5MG BASE/ML                   A063283   001   Oct   31,   1994
                                 EQ 250MG BASE/ML                    A063264   001   Nov   30,   1994
                                 EQ 250MG BASE/ML                    A063350   002   Jul   30,   1993
                                 EQ 250MG BASE/ML                    A064098   001   Jun   26,   1995
                                 EQ 250MG BASE/ML                    A064099   001   Jun   20,   1995
        TEVA PHARMS   USA        EQ 50MG BASE/ML                     A064045   001   Sep   28,   1993
   AMIKACIN SULFATE   IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
        HOSPIRA                  EQ 500MG BASE/100ML                 A064146 001 Apr 02, 1997
   AMIKIN
        APOTHECON              EQ   50MG BASE/ML                     A062311   001
                               EQ   50MG BASE/ML                     A062562   001 Sep 20, 1984
                               EQ   50MG BASE/ML                     N050495   001
                               EQ   250MG BASE/ML                    A062311   002
                               EQ   250MG BASE/ML                    A062562   002 Sep 20, 1984
                               EQ   250MG BASE/ML                    N050495   002
   AMIKIN IN SODIUM CHLORIDE 0.9%   IN PLASTIC CONTAINER
        APOTHECON              EQ   5MG BASE/ML                      N050618 002 Nov 30, 1987
                               EQ   10MG BASE/ML                     N050618 001 Nov 30, 1987
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
  TABLET;ORAL
    AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
         SANDOZ                 EQ 5MG ANHYDROUS;50MG                A073357 001 Nov 27, 1991
         TEVA                   EQ 5MG ANHYDROUS;50MG                A070795 001 Apr 17, 1988
         WATSON LABS            EQ 5MG ANHYDROUS;50MG                A073334 001 Jul 19, 1991
    HYDRO-RIDE
         PAR PHARM              EQ 5MG ANHYDROUS;50MG                A070347 001 Dec 25, 1990
    MODURETIC 5-50
         MERCK                  EQ 5MG ANHYDROUS;50MG                N018201 001
AMINO ACIDS
  INJECTABLE;INJECTION
    AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE
         HOSPIRA                5.2% (5.2GM/100ML)                   N018901 001 Apr 06, 1984
    AMINOSYN 3.5% IN PLASTIC CONTAINER
         ABBOTT                 3.5% (3.5GM/100ML)                   N018804 001 May 15, 1984
                                3.5% (3.5GM/100ML)                   N018875 001 Aug 08, 1984
    AMINOSYN II 3.5%
         HOSPIRA                3.5% (3.5GM/100ML)                   N019438 001 Apr 03, 1986
    AMINOSYN II 3.5% IN PLASTIC CONTAINER
         ABBOTT                 3.5% (3.5GM/100ML)                   N019491 001 Oct 10, 1986
    AMINOSYN II 5%
         HOSPIRA                5% (5GM/100ML)                       N019438 002 Apr 03, 1986
    AMINOSYN-HBC 7% IN PLASTIC CONTAINER
         ABBOTT                 7% (7GM/100ML)                       N019400 001 Jul 23, 1986
    BRANCHAMIN 4%
         BAXTER HLTHCARE        4% (4GM/100ML)                       N018678 001 Sep 28, 1984
    FREAMINE 8.5%
         B BRAUN                8.5% (8.5GM/100ML)                   N016822 001
    FREAMINE II 8.5%
         B BRAUN                8.5% (8.5GM/100ML)                   N016822 002
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-17(of 337)


AMINO ACIDS
	
  INJECTABLE;INJECTION
	
    HEPATASOL 8%
	
         BAXTER HLTHCARE        8% (8GM/100ML)
                            A020360 001 Apr 04, 1996
	
    NEOPHAM 6.4%
	
         HOSPIRA                6.4% (6.4GM/100ML)
                        N018792 001 Jan 17, 1984
	
    NOVAMINE 11.4%
	
         HOSPIRA INC            11.4% (11.4GM/100ML)
                      N017957 003 Aug 09, 1982
	
    NOVAMINE 15%
	
         HOSPIRA INC            15% (75GM/500ML)
                          N017957 004 Nov 28, 1986
	
    NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        15% (15GM/100ML)
                          N020107 001 Feb 05, 1993
	
    NOVAMINE 8.5%
	
         HOSPIRA INC            8.5% (8.5GM/100ML)
                        N017957 002 Aug 09, 1982
	
    RENAMIN W/O ELECTROLYTES

         BAXTER HLTHCARE        6.5% (6.5GM/100ML)
                        N017493 007 Oct 15, 1982
	
    TRAVASOL 10% W/O ELECTROLYTES

         BAXTER HLTHCARE        10% (10GM/100ML)
                          N017493 006
	
    TRAVASOL 5.5% W/O ELECTROLYTES

         BAXTER HLTHCARE        5.5% (5.5GM/100ML)
                        N017493 004
	
    TRAVASOL 8.5% W/O ELECTROLYTES

         BAXTER HLTHCARE        8.5% (8.5GM/100ML)
	                       N017493 005
	
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM

PHOSPHATE, DIBASIC; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

         ABBOTT                 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML   N019714 001
	 Sep 12, 1988
	
                                ;22.4MG/100ML;261MG/100ML;205MG/100ML
	

        HOSPIRA INC		           3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML    N019683 001
	 Nov 07, 1988
	
                                ;22.4MG/100ML;261MG/100ML;205MG/100ML
	

   AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER

        ABBOTT                 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M   N019714 002
	 Sep 12, 1988
	
                               L;22.4MG/100ML;261MG/100ML;205MG/100ML
	

        HOSPIRA INC		           4.25%;36.8MG/100ML;20GM/100ML;51MG/100M    N019683 002
	 Nov 07, 1988
	
                                L;22.4MG/100ML;261MG/100ML;205MG/100ML
	

   AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

        ABBOTT                 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M   N019714 004
	 Sep 12, 1988
	
                               L;22.4MG/100ML;261MG/100ML;205MG/100ML
	

        HOSPIRA INC		           4.25%;36.8MG/100ML;25GM/100ML;51MG/100M    N019683 003
	 Nov 07, 1988
	
                                L;22.4MG/100ML;261MG/100ML;205MG/100ML
	

   AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER

        ABBOTT                 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2   N019714 003
	 Sep 12, 1988
	
                               2.4MG/100ML;261MG/100ML;205MG/100ML
        HOSPIRA INC            5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2   N019683 004
	 Nov 07, 1988
	
                               2.4MG/100ML;261MG/100ML;205MG/100ML
AMINO ACIDS; DEXTROSE
  INJECTABLE;INJECTION
    AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER

         ABBOTT                 3.5%;25GM/100ML
                           N019118 001
	 Oct 11, 1984
	
    AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER

         ABBOTT                 3.5%;5GM/100ML
                            N019120 001
	 Oct 11, 1984
	
    AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER

         ABBOTT                 4.25%;25GM/100ML
                          N019119 001
	 Oct 11, 1984
	
    AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
	
         ABBOTT                 3.5%;25GM/100ML
                           N019505 002
	 Nov 07, 1986
	
                                3.5%;25GM/100ML
                           N019713 006
	 Sep 09, 1988

         HOSPIRA                3.5%;25GM/100ML
                           N019681 001
	 Nov 01, 1988
	
    AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         ABBOTT                 3.5%;5GM/100ML
                            N019506 001
	 Nov 07, 1986
	
                                3.5%;5GM/100ML
                            N019713 002
	 Sep 09, 1988

         HOSPIRA                3.5%;5GM/100ML
                            N019681 002
	 Nov 01, 1988
	
    AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
	
         ABBOTT                 4.25%;10GM/100ML
                          N019713 001
	 Sep 09, 1988

         HOSPIRA                4.25%;10GM/100ML
                          N019681 004
	 Nov 01, 1988
	
    AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
	
         ABBOTT                 4.25%;20GM/100ML
                          N019713 004
	 Sep 09, 1988

         HOSPIRA                4.25%;20GM/100ML
	                         N019681 005
	 Nov 01, 1988
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                              6-18(of 337)


AMINO ACIDS; DEXTROSE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
	
         ABBOTT                 4.25%;25GM/100ML
                           N019504 002
	 Nov 07, 1986
	
                                4.25%;25GM/100ML
                           N019713 005
	 Sep 09, 1988

         HOSPIRA                4.25%;25GM/100ML
                           N019681 003
	 Nov 01, 1988
	
    AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
	
         ABBOTT                 5%;25GM/100ML
                              N019565 001
	 Dec 17, 1986
	
                                5%;25GM/100ML
                              N019713 003
	 Sep 09, 1988

         HOSPIRA                5%;25GM/100ML
                              N019681 006
	 Nov 01, 1988
	
    TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        2.75%;10GM/100ML
                           N019520 002
	 Sep 23, 1988
	
    TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        2.75%;15GM/100ML
                           N019520 003
	 Sep 23, 1988
	
    TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        2.75%;20GM/100ML
                           N019520 004
	 Sep 23, 1988
	
    TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        2.75%;25GM/100ML
                           N019520 005
	 Sep 23, 1988
	
    TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        2.75%;5GM/100ML
                            N019520 001
	 Sep 23, 1988
	
    TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4.25%;10GM/100ML
                           N019520 007
	 Sep 23, 1988
	
    TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4.25%;15GM/100ML
                           N019520 008
	 Sep 23, 1988
	
    TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4.25%;20GM/100ML
                           N019520 009
	 Sep 23, 1988
	
    TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4.25%;25GM/100ML
                           N019520 010
	 Sep 23, 1988
	
    TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4.25%;5GM/100ML
	                           N019520 006
	 Sep 23, 1988
	
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; POTASSIUM

PHOSPHATE, DIBASIC; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER

         ABBOTT		               4.25%;10GM/100ML;51MG/100ML;176.5MG/100   N019712 002 Sep 08, 1988

                                ML;22.4MG/100ML;104.5MG/100ML;205MG/100

                                ML
	
         HOSPIRA INC		          4.25%;10GM/100ML;51MG/100ML;176.5MG/100   N019682 003 Nov 01, 1988

                                ML;22.4MG/100ML;104.5MG/100ML;205MG/100

                                ML
	
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;

SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER

         ABBOTT                 3.5%;25GM/100ML;51MG/100ML;22.4MG/100ML    N019564 002
	 Dec 16, 1986
	
                                ;261MG/100ML;205MG/100ML

    AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER

         ABBOTT                 4.25%;25GM/100ML;51MG/100ML;22.4MG/100M    N019564 004
	 Dec 16, 1986
	
                                L;261MG/100ML;205MG/100ML
	
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE,

DIBASIC, HEPTAHYDRATE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         ABBOTT		               3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12
  N019564 001 Dec 16, 1986
	
                                0MG/100ML;49.3MG/100ML

                                3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12
  N019712 001 Sep 08, 1988
	
                                0MG/100ML;49.3MG/100ML

         HOSPIRA INC            3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12
  N019682 001 Nov 01, 1988
	
                                0MG/100ML;49.3MG/100ML

    AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
	
         ABBOTT                 4.25%;10GM/100ML;30MG/100ML;97MG/100ML;
  N019564 003 Dec 16, 1986
	
                                120MG/100ML;49.3MG/100ML

         HOSPIRA INC            4.25%;5GM/100ML;30MG/100ML;97MG/100ML;1
  N019682 002 Nov 01, 1988
	
                                20MG/100ML;49.3MG/100ML
	
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM

CHLORIDE
	
  INJECTABLE;INJECTION
	
    TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       2.75%;10GM/100ML;51MG/100ML;261MG/100ML   N020147 002
	 Oct 23, 1995
	
                                ;216MG/100ML;112MG/100ML

    TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       2.75%;15GM/100ML;51MG/100ML;261MG/100ML   N020147 003
	 Oct 23, 1995
	
                                ;216MG/100ML;112MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-19(of 337)


AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM

CHLORIDE
	
  INJECTABLE;INJECTION
	
    TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       2.75%;20GM/100ML;51MG/100ML;261MG/100ML   N020147 004
	 Oct 23, 1995
	
                                ;216MG/100ML;112MG/100ML

    TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       2.75%;25GM/100ML;51MG/100ML;261MG/100ML   N020147 005
	 Oct 23, 1995
	
                                ;216MG/100ML;112MG/100ML

    TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       2.75%;5GM/100ML;51MG/100ML;261MG/100ML;   N020147 001
	 Oct 23, 1995
	
                                216MG/100ML;112MG/100ML

    TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       4.25%;10GM/100ML;51MG/100ML;261MG/100ML   N020147 007
	 Oct 23, 1995
	
                                ;297MG/100ML;77MG/100ML

    TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       4.25%;15GM/100ML;51MG/100ML;261MG/100ML   N020147 008
	 Oct 23, 1995
	
                                ;297MG/100ML;77MG/100ML

    TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       4.25%;20GM/100ML;51MG/100ML;261MG/100ML   N020147 009
	 Oct 23, 1995
	
                                ;297MG/100ML;77MG/100ML

    TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       4.25%;25GM/100ML;51MG/100ML;261MG/100ML   N020147 010
	 Oct 23, 1995
	
                                ;297MG/100ML;77MG/100ML

    TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER

          BAXTER HLTHCARE       4.25%;5GM/100ML;51MG/100ML;261MG/100ML;   N020147 006
	 Oct 23, 1995
	
                                297MG/100ML;77MG/100ML
	
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN 3.5% M IN PLASTIC CONTAINER
	
         ABBOTT                 3.5%;21MG/100ML;40MG/100ML;128MG/100ML;   N018804 002
	 May 15, 1984
	
                                234MG/100ML

                                3.5%;21MG/100ML;40MG/100ML;128MG/100ML;   N018875 002
	 Aug 08, 1984
	
                                234MG/100ML
	
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN 3.5% M
	
         HOSPIRA                3.5%;21MG/100ML;128MG/100ML;234MG/100ML    N017789 005
	
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC,

HEPTAHYDRATE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 3.5% M IN PLASTIC CONTAINER
	
         ABBOTT                 3.5%;32MG/100ML;128MG/100ML;222MG/100ML   N019493 001 Oct 16, 1986

                                ;49MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
	
  INJECTABLE;INJECTION
	
    VEINAMINE 8%
	
         HOSPIRA INC            8%;61MG/100ML;211MG/100ML;56MG/100ML;38   N017957 001
	
                                8MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 7% W/ ELECTROLYTES

         HOSPIRA                7%;102MG/100ML;45MG/100ML;522MG/100ML;4   N019437 006 Apr 03, 1986

                                10MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC,

HEPTAHYDRATE
	
  INJECTABLE;INJECTION
	
    AMINOSYN II 3.5% M
	
         HOSPIRA                3.5%;30MG/100ML;97MG/100ML;120MG/100ML;   N019437 007 Apr 03, 1986

                                49MG/100ML
	
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    TRAVASOL 3.5% W/ ELECTROLYTES

         BAXTER HLTHCARE        3.5%;51MG/100ML;131MG/100ML;218MG/100ML
  N017493 003
	
                                ;35MG/100ML

    TRAVASOL 5.5% W/ ELECTROLYTES

         BAXTER HLTHCARE        5.5%;102MG/100ML;522MG/100ML;431MG/100M
  N017493 001
	
                                L;224MG/100ML

    TRAVASOL 8.5% W/ ELECTROLYTES

         BAXTER HLTHCARE        8.5%;102MG/100ML;522MG/100ML;594MG/100M
  N017493 002
	
                                L;154MG/100ML
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                                6-20(of 337)


AMINOCAPROIC ACID
	
  INJECTABLE;INJECTION
	
    AMICAR
	
         CLOVER PHARMS           250MG/ML **Federal Register
               N015229 002
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

   AMINOCAPROIC ACID
	
        ABRAXIS PHARM            250MG/ML
                                  A070522 001
	 Jun 17, 1986
	
        BAXTER HLTHCARE          250MG/ML
                                  N018590 001
	 Oct 29, 1982
	
        HOSPIRA                  250MG/ML
	                                 A070888 001
	 Jun 16, 1988
	
AMINOGLUTETHIMIDE
	
  TABLET;ORAL
	
    CYTADREN
	
         NOVARTIS                250MG
	                                    N018202 001
	
AMINOHIPPURATE SODIUM
	
  INJECTABLE;INJECTION
	
    AMINOHIPPURATE SODIUM
	
         MERCK                   20%
	                                      N005619 001
	
AMINOPHYLLINE
	
  ENEMA;RECTAL
	
    SOMOPHYLLIN
	
         FISONS                  300MG/5ML
                                 N018232 001
	 Apr 02, 1982
	
  INJECTABLE;INJECTION
	
    AMINOPHYLLIN
	
         GD SEARLE LLC           25MG/ML
                                   A087243 001
	 May 24, 1982

                                 25MG/ML
                                   A087621 001
	 May 24, 1982
	
   AMINOPHYLLINE
	
        ABRAXIS PHARM          25MG/ML
                                     A084568   001
	
                               25MG/ML
                                     A087200   001
	
                               25MG/ML
                                     A087250   001
	   Jan 06, 1982
	
                               25MG/ML
                                     A087886   001
	   Aug 30, 1983

                               25MG/ML
                                     A088407   001
	   Jan 25, 1984
	
        ELKINS SINN            25MG/ML
                                     A087239   001
	
        HOSPIRA                25MG/ML
                                     A087601   001
	   Jul   23,   1982
	
        INTL MEDICATION        25MG/ML
                                     A087209   001
	   Feb   01,   1982
	
                               25MG/ML
                                     A087867   001
	   Nov   10,   1983
	
                               25MG/ML
                                     A087868   001
	   Nov   10,   1983
	
        KING PHARMS            25MG/ML
                                     A086606   001
	
        LUITPOLD               25MG/ML
                                     A087240   001
	
        LYPHOMED               25MG/ML
                                     A087431   001
	
        PHARMA SERVE NY        25MG/ML
                                     A087387   001
	   Jun   03,   1983
	
                               25MG/ML
                                     A087392   001
	   Dec   15,   1983
	
        SMITH AND NEPHEW       25MG/ML
                                     A088429   001
	   May   30,   1985

                               25MG/ML
                                     A088749   001
	   May   30,   1985

        TEVA PARENTERAL        25MG/ML
                                     A081142   001
	   Sep   25,   1991
	
   AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
	
        HOSPIRA                100MG/100ML
                                 A088147 002
	 May 03, 1983

                               200MG/100ML
                                 A088147 003
	 May 03, 1983
	
   AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
        HOSPIRA		              100MG/100ML
                                 N018924   001
	   Dec   12,   1984
	
                               200MG/100ML
                                 N018924   002
	   Dec   12,   1984
	
                               400MG/100ML
                                 N018924   003
	   Dec   12,   1984
	
                               500MG/100ML
                                 N018924   004
	   Dec   12,   1984
	
 SOLUTION;ORAL
	
   AMINOPHYLLINE
	
        MORTON GROVE           105MG/5ML
                                   A088156 001
	 Dec 05, 1983
	
        ROXANE                 105MG/5ML
                                   A088126 001
	 Aug 19, 1983
	
   AMINOPHYLLINE DYE FREE
	
        ACTAVIS MID ATLANTIC   105MG/5ML
                                   A087727 001
	 Apr 16, 1982
	
   SOMOPHYLLIN
	
        FISONS                 105MG/5ML
                                   A086466 001
	
   SOMOPHYLLIN-DF
	
        FISONS                 105MG/5ML
                                   A087045 001
	
 SUPPOSITORY;RECTAL
	
   TRUPHYLLINE
	
        G AND W LABS           250MG
	                                      A085498 001
	 Mar 23, 1983
	
                               500MG
	                                      A085498 002
	 Jan 03, 1983
	
 TABLET;ORAL
	
   AMINOPHYLLIN
	
        GD SEARLE LLC          100MG
	                                      N002386 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                        6-21(of 337)


AMINOPHYLLINE
	
  TABLET;ORAL
	
    AMINOPHYLLIN
	
                                  200MG
	                         N002386 003
	
    AMINOPHYLLINE
	
         ASCOT
	                  100MG
	                         A087522   001     Feb   12,   1982
	
                                  200MG
	                         A087523   001     Feb   12,   1982
	
         BARR
	                   100MG
	                         A088297   001     Aug   19,   1983

                                  200MG
	                         A088298   001     Aug   19,   1983

         DURAMED PHARMS BARR
	    100MG
	                         A088182   001     Mar   31,   1983
	
                                  200MG
	                         A088183   001     Mar   31,   1983
	
         HALSEY
	                 100MG
	                         A084674   001
	
         HIKMA INTL PHARMS
	      100MG
	                         A084540   001
	
                                  200MG
	                         A085003   001
	
         IMPAX LABS
	             100MG
	                         A084574   001
	
                                  200MG
	                         A084576   001
	
         KV PHARM
	               100MG
	                         A085284   001
	
                                  200MG
	                         A085289   001
	
         LANNETT
	                100MG
	                         A084588   001
	
                                  200MG
	                         A084588   002
	
         PAL PAK
	                100MG
	                         A084533   001
	
         PANRAY
	                 100MG
	                         A084552   001
	
                                  200MG
	                         A084552   002
	
         PUREPAC PHARM
	          100MG
	                         A084699   001
	
                                  200MG
	                         A085333   001
	
         ROXANE
	                 100MG
	                         A087500   001     Feb 09, 1982
	
                                  200MG
	                         A087501   001     Feb 09, 1982
	
         SANDOZ
	                 100MG
	                         A085261   003
	
                                  100MG
	                         A085262   002
	
                                  200MG
	                         A085261   002
	
         VALEANT PHARM INTL
	     200MG
	                         A084563   001
	
         VANGARD
	                100MG
	                         A088314   001     Oct 03, 1983
	
                                  200MG
	                         A088319   001     Oct 03, 1983
	
         VINTAGE PHARMS
	         100MG
	                         A085409   001
	
                                  200MG
	                         A085410   001
	
         WATSON LABS
	            100MG
	                         A085567   001
	
                                  200MG
	                         A085564   001
	
  TABLET, DELAYED RELEASE;ORAL
	
    AMINOPHYLLINE
	
         IMPAX LABS
	            100MG
	                          A084577   001
	
                                 200MG
	                          A084575   001
	
         TABLICAPS
	             100MG
	                          A084632   002
	
         VALE
	                  100MG
	                          A084531   001
	
                                 200MG
	                          A084530   001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    PHYLLOCONTIN
	
         PHARM RES ASSOC
	       225MG
	                          A086760 001
	
AMINOSALICYLATE SODIUM
	
  POWDER;ORAL
	
    P.A.S. SODIUM
	
         CENTURY PHARMS
	         4GM/PACKET
	                    A080947 001
	
    SODIUM AMINOSALICYLATE
	
         HEXCEL
	                 100%
	                          A080097 001
	
  TABLET;ORAL
	
    PARASAL SODIUM
	
         PANRAY
	                 1GM
	                           N006811 011
	
                                  500MG
	                         N006811 006
	
    SODIUM P.A.S.
	
         LANNETT
	                500MG
	                         A080138 002
	
    TEEBACIN
	
         CONSOLIDATED MIDLAND
	   500MG
	                         N007320 002
	
AMINOSALICYLATE SODIUM; AMINOSALICYLIC ACID
	
  TABLET;ORAL
	
    NEOPASALATE
	
         MEDPOINTE PHARM HLC    846MG;112MG
	                     A080059 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-22(of 337)

AMINOSALICYLIC ACID
  TABLET;ORAL
    PARASAL
         PANRAY                   1GM                             N006811 002
                                  500MG                           N006811 001
AMINOSALICYLIC ACID RESIN COMPLEX
  POWDER;ORAL
    REZIPAS
         BRISTOL MYERS SQUIBB   EQ 500MG BASE/GM                  N009052 001
AMIODARONE HYDROCHLORIDE
  INJECTABLE;INJECTION
    AMIODARONE HYDROCHLORIDE
         BEDFORD                  50MG/ML                         A076018   001   Oct   15,   2002
         BEDFORD LABS             50MG/ML                         A076299   001   Oct   24,   2002
         BEN VENUE                50MG/ML                         A076088   001   Oct   15,   2002
         HOSPIRA                  50MG/ML                         A076108   001   Oct   15,   2002
         INTL MEDICATION SYS      50MG/ML                         N021594   001   Feb   04,   2004
         PAR STERILE PRODUCTS     50MG/ML                         A076394   001   Apr   25,   2003
         TEVA PHARMS USA          50MG/ML                         A076163   001   Sep   05,   2003
    CORDARONE
         WYETH PHARMS INC         50MG/ML                         N020377 001 Aug 03, 1995
  TABLET;ORAL
    AMIODARONE HYDROCHLORIDE
         TEVA                     200MG                           A074895 001 Apr 16, 1999
AMITRIPTYLINE HYDROCHLORIDE
  CONCENTRATE;ORAL
    ENDEP
          ROCHE                   40MG/ML                         A085749 001
  INJECTABLE;INJECTION
    AMITRIPTYLINE HYDROCHLORIDE
          WATSON LABS             10MG/ML                         A085594 001
    ELAVIL
          ASTRAZENECA             10MG/ML                         N012704 001
  TABLET;ORAL
    AMITID
          BRISTOL MYERS SQUIBB    10MG                            A086454   001
                                  25MG                            A086454   002
                                  50MG                            A086454   003
                                  75MG                            A086454   004
                                  100MG                           A086454   005
   AMITRIL
        WARNER CHILCOTT           10MG                            A083939   001
                                  25MG                            A083937   001
                                  50MG                            A083938   002
                                  75MG                            A084957   001
                                  100MG                           A085093   001
                                  150MG                           A086295   001
   AMITRIPTYLINE HYDROCHLORIDE
        AM THERAP              25MG                               A088672   001   Nov   20,   1984
                               50MG                               A088673   001   Nov   20,   1984
                               75MG                               A088674   001   Nov   20,   1984
                               100MG                              A088675   001   Nov   20,   1984
        COPLEY PHARM           10MG                               A088421   001   Apr   30,   1984
                               25MG                               A088422   001   Apr   30,   1984
                               50MG                               A088423   001   Apr   30,   1984
                               75MG                               A088424   001   Apr   30,   1984
                               100MG                              A088425   001   Apr   30,   1984
                               150MG                              A088426   001   Apr   30,   1984
        HALSEY                 10MG                               A085923   001
                               25MG                               A085922   001
                               50MG                               A085925   001
                               50MG                               A087557   001   Mar 05, 1982
                               75MG                               A085926   001   May 20, 1983
                               100MG                              A085927   001   May 20, 1983
        LEDERLE                10MG                               A086744   001
                               10MG                               A087366   001   Jan 04, 1982
                               25MG                               A086746   001
                               25MG                               A087367   001   May 03, 1982
                               50MG                               A086743   001
                               50MG                               A087181   001   Jan 04, 1982
                               75MG                               A086745   001
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                        6-23(of 337)


AMITRIPTYLINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    AMITRIPTYLINE HYDROCHLORIDE
	
                                    75MG                          A087369   001     Jan 04, 1982
	
                                    100MG                         A086747   001
	
                                    100MG                         A087368   001     May 03, 1982

                                    150MG                         A087370   001     Jan 04, 1982
	
         MUTUAL PHARM               10MG                          A085744   001
	
                                    25MG                          A085627   001
	
                                    50MG                          A085745   001
	
                                    75MG                          A085743   001
	
                                    100MG                         A085742   002     May   11,   1982

                                    150MG                         A089423   001     Feb   17,   1987
	
         PAR PHARM                  10MG                          A088697   001     Sep   25,   1984

                                    25MG                          A088698   001     Sep   25,   1984

                                    50MG                          A088699   001     Sep   25,   1984

                                    75MG                          A088700   001     Sep   25,   1984

                                    100MG                         A088701   001     Sep   25,   1984

                                    150MG                         A088702   001     Sep   25,   1984

         PLIVA                      10MG                          A088883   001     Sep   26,   1984

                                    25MG                          A088884   001     Sep   26,   1984

                                    50MG                          A088885   001     Sep   26,   1984

                                    75MG                          A088886   001     Sep   26,   1984

                                    100MG                         A088887   001     Sep   26,   1984

                                    150MG                         A088888   001     Sep   26,   1984

         PUREPAC PHARM              10MG                          A088075   001     Sep   16,   1983

                                    10MG                          A088084   001     Jul   18,   1983
	
                                    25MG                          A088076   001     May   20,   1983

                                    25MG                          A088085   001     Jul   18,   1983
	
                                    50MG                          A088077   001     Sep   16,   1983

                                    50MG                          A088105   001     Jul   18,   1983
	
                                    75MG                          A088078   001     Sep   16,   1983

                                    75MG                          A088106   001     Jul   18,   1983
	
                                    100MG                         A088079   001     Sep   16,   1983

                                    100MG                         A088107   001     Jul   18,   1983
	
         ROXANE                     10MG                          A086002   001
	
                                    10MG                          A086144   001
	
                                    25MG                          A085944   001
	
                                    25MG                          A086145   001
	
                                    50MG                          A085945   001
	
                                    50MG                          A086143   001
	
                                    75MG                          A086004   001
	
                                    75MG                          A086147   001
	
                                    100MG                         A086003   001
	
                                    100MG                         A086146   001
	
                                    150MG                         A086090   001
	
                                    150MG                         A086148   001
	
         SUPERPHARM                 10MG                          A088853   001     Nov   13,   1984
	
                                    25MG                          A088854   001     Nov   13,   1984
	
                                    50MG                          A088855   001     Nov   13,   1984
	
                                    75MG                          A088856   001     Nov   13,   1984
	
                                    100MG                         A088857   001     Nov   13,   1984
	
         TEVA                       10MG                          A084910   003
	
                                    10MG                          A086610   001
	
                                    25MG                          A085031   001
	
                                    25MG                          A086859   001
	
                                    50MG                          A085032   001
	
                                    50MG                          A086857   001
	
                                    75MG                          A085030   001
	
                                    75MG                          A086860   001
	
                                    100MG                         A085836   001
	
                                    100MG                         A086854   001
	
                                    150MG                         A086853   001
	
         UCB INC                    10MG                          A085864   001
	
                                    25MG                          A085935   001
	
                                    50MG                          A085936   001
	
                                    75MG                          A086337   001
	
                                    100MG                         A086336   001
	
                                    150MG                         A086335   001
	
         USL PHARMA                 25MG                          A087775   001     Feb 10, 1982
	
         VANGARD                    10MG                          A087632   001     Feb 01, 1982
	
                                    50MG                          A087616   001     Feb 08, 1982
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                        6-24(of 337)

AMITRIPTYLINE HYDROCHLORIDE
  TABLET;ORAL
    AMITRIPTYLINE HYDROCHLORIDE
                                  75MG                             A087617   001   Feb 05, 1982
                                  100MG                            A087639   001   Feb 08, 1982
           WATSON LABS            10MG                             A085816   001
                                  10MG                             A088620   001   Mar 02, 1984
                                  25MG                             A085817   001
                                  25MG                             A088621   001   Mar 02, 1984
                                  50MG                             A085815   001
                                  50MG                             A088622   001   Mar 02, 1984
                                  75MG                             A085819   001
                                  75MG                             A088633   001   Mar 02, 1984
                                  100MG                            A085820   001
                                  100MG                            A088634   001   Mar 02, 1984
                                  150MG                            A085821   001
                                  150MG                            A088635   001   Mar 02, 1984
           WEST WARD              10MG                             A087647   001   Mar 05, 1982
                                  25MG                             A087278   001
   ELAVIL
        ASTRAZENECA               10MG                             N012703   001
                                  25MG                             N012703   003
                                  50MG                             N012703   004
                                  75MG                             N012703   005
                                  100MG                            N012703   006
                                  150MG                            N012703   007
   ENDEP
           ROCHE                  10MG                             A083639   001
                                  25MG                             A083639   002
                                  50MG                             A083639   003
                                  75MG                             A083639   004
                                  100MG                            A083639   005
                                  150MG                            A085303   001
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE
  TABLET;ORAL
    CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE
         MUTUAL PHARM           EQ 12.5MG BASE;5MG                 A070765   001   Dec   10,   1986
                                EQ 25MG BASE;10MG                  A070766   001   Dec   10,   1986
         PAR PHARM              EQ 12.5MG BASE;5MG                 A072277   001   May   09,   1988
                                EQ 25MG BASE;10MG                  A072278   001   May   09,   1988
         USL PHARMA             EQ 12.5MG BASE;5MG                 A070477   001   Jan   12,   1988
                                EQ 25MG BASE;10MG                  A070478   001   Jan   12,   1988
         WATSON LABS            EQ 12.5MG BASE;5MG                 A072052   001   Dec   16,   1988
                                EQ 25MG BASE;10MG                  A072053   001   Dec   16,   1988
    LIMBITROL
         VALEANT PHARM INTL     EQ 12.5MG BASE;5MG                 N016949 001
    LIMBITROL DS
         VALEANT PHARM INTL     EQ 25MG BASE;10MG                  N016949 002
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
  TABLET;ORAL
    ETRAFON 2-10
         SCHERING               10MG;2MG                           N014713 007
    ETRAFON 2-25
         SCHERING               25MG;2MG                           N014713 004
    ETRAFON-A
         SCHERING               10MG;4MG                           N014713 002
    ETRAFON-FORTE
         SCHERING               25MG;4MG                           N014713 006
    PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
         IVAX SUB TEVA PHARMS   10MG;2MG                           A070935   001   Sep   11,   1986
                                10MG;4MG                           A070937   001   Sep   11,   1986
                                25MG;2MG                           A070936   001   Sep   11,   1986
                                25MG;4MG                           A070938   001   Sep   11,   1986
                                50MG;4MG                           A070939   001   Sep   12,   1986
         MUTUAL PHARM           10MG;2MG                           A071077   001   Nov   12,   1986
                                10MG;4MG                           A071078   001   Nov   12,   1986
                                25MG;2MG                           A070297   001   Nov   12,   1986
                                25MG;4MG                           A071079   001   Nov   12,   1986
         PAR PHARM              10MG;2MG                           A070565   001   Sep   11,   1986
                                10MG;4MG                           A070620   001   Sep   11,   1986
                                25MG;2MG                           A070621   001   Sep   11,   1986
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                       6-25(of 337)

AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE
  TABLET;ORAL
    PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
                                25MG;4MG                       A070595   001   Sep   11,   1986
                                50MG;4MG                       A070574   001   Sep   11,   1986
         SANDOZ                 10MG;2MG                       A071062   001   Nov   27,   1987
                                10MG;4MG                       A071862   001   Dec   21,   1987
                                25MG;2MG                       A071063   001   Nov   27,   1987
                                25MG;4MG                       A071064   001   Nov   27,   1987
                                50MG;4MG                       A071863   001   Dec   21,   1987
         WATSON LABS            10MG;2MG                       A070373   001   Aug   25,   1986
                                10MG;2MG                       A072539   001   Feb   15,   1989
                                10MG;2MG                       A073007   001   Oct   17,   1991
                                10MG;4MG                       A070375   001   Aug   25,   1986
                                10MG;4MG                       A072540   001   Feb   15,   1989
                                10MG;4MG                       A073009   001   Oct   17,   1991
                                25MG;2MG                       A070374   001   Aug   25,   1986
                                25MG;2MG                       A072541   001   Feb   15,   1989
                                25MG;2MG                       A073008   001   Oct   17,   1991
                                25MG;4MG                       A070376   001   Aug   25,   1986
                                25MG;4MG                       A072134   001   Feb   15,   1989
                                25MG;4MG                       A073010   001   Oct   17,   1991
                                50MG;4MG                       A070377   001   Nov   04,   1986
                                50MG;4MG                       A071558   001   Mar   02,   1987
                                50MG;4MG                       A072135   001   Feb   15,   1989
    TRIAVIL 2-10
         NEW RIVER              10MG;2MG                       N014715 004
    TRIAVIL 2-25
         NEW RIVER              25MG;2MG                       N014715 002
    TRIAVIL 4-10
         NEW RIVER              10MG;4MG                       N014715 003
    TRIAVIL 4-25
         NEW RIVER              25MG;4MG                       N014715 005
    TRIAVIL 4-50
         NEW RIVER              50MG;4MG                       N014715 006
AMLEXANOX
  PASTE;DENTAL
    APHTHASOL
         ULURU                 5%                              N020511 001 Dec 17, 1996
  PATCH;TOPICAL
    AMLEXANOX
         ULURU                 2MG                             N021727 001 Sep 29, 2004
AMLODIPINE BESYLATE
  TABLET;ORAL
    AMLODIPINE BESYLATE
         GEDEON RICHTER USA    EQ 2.5MG BASE                   A077333   001   Jul   17,   2007
                               EQ 5MG BASE                     A077333   002   Jul   17,   2007
                               EQ 10MG BASE                    A077333   003   Jul   17,   2007
        GENPHARM               EQ 2.5MG BASE                   A077362   001   Jul   09,   2007
                               EQ 5MG BASE                     A077362   002   Jul   09,   2007
                               EQ 10MG BASE                    A077362   003   Jul   09,   2007
        MUTUAL PHARMA          EQ 2.5MG BASE                   A078081   001   Jan   31,   2008
                               EQ 5MG BASE                     A078081   002   Jan   31,   2008
                               EQ 10MG BASE                    A078081   003   Jan   31,   2008
        PURACAP PHARM          EQ 2.5MG BASE                   A078131   001   Sep   04,   2007
                               EQ 5MG BASE                     A078131   002   Sep   04,   2007
                               EQ 10MG BASE                    A078131   003   Sep   04,   2007
        SANDOZ                 EQ 2.5MG BASE                   A076859   001   Sep   10,   2007
                               EQ 5MG BASE                     A076859   002   Sep   10,   2007
                               EQ 10MG BASE                    A076859   003   Sep   10,   2007
        SYNTHON PHARMS         EQ 2.5MG BASE                   A077080   001   Jun   27,   2007
                               EQ 5MG BASE                     A077080   002   Jun   27,   2007
                               EQ 10MG BASE                    A077080   003   Jun   27,   2007
 TABLET, ORALLY DISINTEGRATING;ORAL
   AMLODIPINE BESYLATE
        SYNTHON PHARMS         EQ 2.5MG BASE                   N022026 001 Sep 27, 2007
                               EQ 5MG BASE                     N022026 002 Sep 27, 2007
                               EQ 10MG BASE                    N022026 003 Sep 27, 2007
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                        6-26(of 337)


AMLODIPINE MALEATE
	
  TABLET;ORAL
	
    AMVAZ
	
         DR REDDYS LABS INC		    2.5MG
	                           N021435 001 Oct 31, 2003
	
                                 5MG
	                             N021435 002 Oct 31, 2003
	
                                 10MG
	                            N021435 003 Oct 31, 2003
	
AMMONIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    AMMONIUM CHLORIDE
	
         ABBOTT                 5MEQ/ML
                           A083130 001
	
         GD SEARLE LLC          3MEQ/ML
                           A086205 001
	
    AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE
	
         MCGAW                  900MG/100ML
                       N006580 001
	
    AMMONIUM CHLORIDE 2.14%
	
         B BRAUN                40MEQ/100ML
	                      A085734 001
	
AMODIAQUINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    CAMOQUIN HYDROCHLORIDE
	
         PARKE DAVIS             EQ 200MG BASE
	                   N006441 001
	
AMOXAPINE
	
  TABLET;ORAL
	
    AMOXAPINE
	
         SANDOZ		                25MG
	                            A072943   001     Jun   28,   1991
	
                                 50MG
	                            A072944   001     Jun   28,   1991
	
                                 100MG
	                           A072878   001     Jun   28,   1991
	
                                 150MG
	                           A072879   001     Jun   28,   1991
	
         WATSON LABS		           25MG
	                            A072418   001     May   11,   1989

                                 50MG
	                            A072419   001     May   11,   1989

                                 100MG
	                           A072420   001     May   11,   1989

                                 150MG
	                           A072421   001     May   11,   1989
	
    ASENDIN
	
         LEDERLE		               25MG
	                            N018021   001
	
                                 50MG
	                            N018021   002
	
                                 100MG
	                           N018021   003
	
                                 150MG
	                           N018021   004
	
AMOXICILLIN
	
  CAPSULE;ORAL
	
    AMOXICILLIN
	
         LABS ATRAL              250MG
	                           A062528   001     Aug 07, 1985

                                 500MG
	                           A062528   002     Aug 07, 1985

         MYLAN                   250MG
	                           A062067   001
	
                                 500MG
	                           A062067   002
	
         TEVA                    250MG
	                           A062853   001     Dec   22,   1987
	
                                 250MG
	                           A063030   001     Feb   28,   1989
	
                                 500MG
	                           A062854   001     Dec   22,   1987
	
                                 500MG
	                           A063031   001     Feb   28,   1989
	
    AMOXIL
	
         GLAXOSMITHKLINE         250MG
	                           N050459 001
	
                                 500MG
	                           N050459 002
	
    TRIMOX
	
         APOTHECON		             250MG
	                           A061885   001
	
                                 250MG
	                           A062098   001
	
                                 250MG
	                           A062152   001
	
                                 250MG
	                           A063099   001 Mar 20, 1992
	
                                 500MG
	                           A061885   002
	
                                 500MG
	                           A062098   002
	
                                 500MG
	                           A062152   002
	
                                 500MG
	                           A063099   002 Mar 20, 1992
	
    UTIMOX
	
         PARKE DAVIS             250MG
	                           A062107 001
	
                                 500MG
	                           A062107 002
	
    WYMOX
	
         WYETH AYERST            250MG
	                           A062120 001
	
                                 500MG
	                           A062120 002
	
  FOR SUSPENSION;ORAL
	
    AMOXICILLIN
	
         AM ANTIBIOTICS          125MG/5ML
                        A062059   001
	
                                 250MG/5ML
                        A062059   002
	
         MYLAN                   125MG/5ML
                        A062090   001
	
                                 250MG/5ML
	                       A062090   002
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                        6-27(of 337)

AMOXICILLIN
  FOR SUSPENSION;ORAL
    AMOXICILLIN
         RANBAXY               200MG/5ML                         A065113   001   Nov   29,   2002
                               400MG/5ML                         A065113   002   Nov   29,   2002
           TEVA                125MG/5ML                         A062946   001   Nov   01,   1988
                               250MG/5ML                         A063001   001   Jan   06,   1989
   AMOXIL
        GLAXOSMITHKLINE        50MG/ML                           N050460 005
                               125MG/5ML                         N050460 001
                               250MG/5ML                         N050460 002
   LAROTID
        GLAXOSMITHKLINE        50MG/ML                           N050460 006
   POLYMOX
        APOTHECON              125MG/5ML                         A061851   001
                               125MG/5ML                         A062323   001
                               250MG/5ML                         A061851   002
                               250MG/5ML                         A062323   002
   TRIMOX
        APOTHECON              50MG/ML                           A061886   001
                               125MG/5ML                         A061886   002
                               125MG/5ML                         A062099   001
                               125MG/5ML                         A062154   001
                               125MG/5ML                         A062885   001 Mar 08, 1988
                               250MG/5ML                         A061886   003
                               250MG/5ML                         A062099   002
                               250MG/5ML                         A062154   002
                               250MG/5ML                         A062885   002 Mar 08, 1988
   UTIMOX
        PARKE DAVIS            125MG/5ML                         A062127 001
                               250MG/5ML                         A062127 002
   WYMOX
           WYETH AYERST        125MG/5ML                         A062131 001
                               250MG/5ML                         A062131 002
 TABLET;ORAL
   AMOXICILLIN
        DAVA PHARMS INC        875MG                             A065344 001 Jan 15, 2009
 TABLET, CHEWABLE;ORAL
   AMOXICILLIN
        APOTHECON              125MG                             A064131   001   May   06,   1996
                               250MG                             A064131   002   May   06,   1996
        DAVA PHARMS INC        125MG                             A064139   001   Jan   29,   1996
                               250MG                             A064139   002   Jan   29,   1996
        RANBAXY                200MG                             A065060   001   Nov   29,   2000
                               400MG                             A065060   002   Nov   29,   2000
        TEVA                   125MG                             A064031   001   Dec   19,   1996
                               250MG                             A064031   002   Dec   19,   1996
   AMOXIL
        DR REDDYS LABS INC     200MG                             N050761 001 Apr 15, 1999
                               400MG                             N050761 002 Apr 15, 1999
 TABLET, FOR SUSPENSION;ORAL
   AMOXICILLIN
        AUROBINDO PHARMA LTD   200MG                             A065324 001 Jan 17, 2007
                               400MG                             A065324 002 Jan 17, 2007
   DISPERMOX
        RANBAXY LABS LTD       200MG                             A065080 002 Aug 11, 2003
                               400MG                             A065080 001 Aug 11, 2003
                               600MG                             A065159 001 Dec 04, 2003
AMOXICILLIN; CLAVULANATE POTASSIUM
  TABLET;ORAL
    AMOXICILLIN AND CLAVULANATE POTASSIUM
         APOTEX INC             250MG;EQ 125MG   BASE            A065333   001   Feb   24,   2009
                                500MG;EQ 125MG   BASE            A065333   002   Feb   24,   2009
                                875MG;EQ 125MG   BASE            A065317   003   Oct   20,   2008
         RANBAXY LABS           500MG;EQ 125MG   BASE            A065109   001   Nov   04,   2002
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                6-28(of 337)


AMPHETAMINE ADIPATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE ADIPATE; DEXTROAMPHETAMINE SULFATE
	
  CAPSULE;ORAL
	
    DELCOBESE
         TEVA                   1.25MG;1.25MG;1.25MG;1.25MG **Federal     A083564 001
                                Register determination that product was
                                not discontinued or withdrawn for
                                safety or efficacy reasons**
                                2.5MG;2.5MG;2.5MG;2.5MG **Federal         A083564 002
                                Register determination that product was
                                not discontinued or withdrawn for
                                safety or efficacy reasons**
                                3.75MG;3.75MG;3.75MG;3.75MG **Federal     A083564 003
                                Register determination that product was
                                not discontinued or withdrawn for
                                safety or efficacy reasons**
                                5MG;5MG;5MG;5MG **Federal Register        A083564 004
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
  TABLET;ORAL
    DELCOBESE
         TEVA                   1.25MG;1.25MG;1.25MG;1.25MG               A083563 004
                                2.5MG;2.5MG;2.5MG;2.5MG                   A083563 003
                                3.75MG;3.75MG;3.75MG;3.75MG               A083563 002
                                5MG;5MG;5MG;5MG                           A083563 001
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE

SULFATE
	
  TABLET;ORAL
	
    ADDERALL 10
	
          TEVA WOMENS           2.5MG;2.5MG;2.5MG;2.5MG                   N011522 007 Feb 13,   1996
	
    ADDERALL 12.5
	
          TEVA WOMENS           3.125MG;3.125MG;3.125MG;3.125MG           N011522 012 Aug 31,   2000

    ADDERALL 15
	
          TEVA WOMENS           3.75MG;3.75MG;3.75MG;3.75MG               N011522 013 Aug 31,   2000

    ADDERALL 20
	
          TEVA WOMENS           5MG;5MG;5MG;5MG                           N011522 008 Feb 13,   1996
	
    ADDERALL 30
	
          TEVA WOMENS           7.5MG;7.5MG;7.5MG;7.5MG                   N011522 010 May 12,   1997

    ADDERALL 5
	
          TEVA WOMENS           1.25MG;1.25MG;1.25MG;1.25MG               N011522 009 May 12,   1997

    ADDERALL 7.5
	
          TEVA WOMENS           1.875MG;1.875MG;1.875MG;1.875MG           N011522 011 Aug 31,   2000

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
	
          TEVA PHARMS		         1.25MG;1.25MG;1.25MG;1.25MG               A040472 001 Sep 30,   2003

                                2.5MG;2.5MG;2.5MG;2.5MG                   A040472 002 Sep 30,   2003

                                5MG;5MG;5MG;5MG                           A040472 003 Sep 30,   2003

                                7.5MG;7.5MG;7.5MG;7.5MG                   A040472 004 Sep 30,   2003
	
AMPHETAMINE RESIN COMPLEX; DEXTROAMPHETAMINE RESIN COMPLEX
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    BIPHETAMINE 12.5
	
         UCB INC                EQ 6.25MG BASE;EQ 6.25MG BASE             N010093 007
	
    BIPHETAMINE 20
	
         UCB INC                EQ 10MG BASE;EQ 10MG BASE                 N010093 003
	
    BIPHETAMINE 7.5
	
         UCB INC                EQ 3.75MG BASE;EQ 3.75MG BASE             N010093 009
	
AMPHETAMINE SULFATE
	
  TABLET;ORAL
	
    AMPHETAMINE SULFATE
	
         LANNETT                5MG                                       A083901 001 Aug 31, 1984

                                10MG                                      A083901 002 Aug 31, 1984
	
AMPHOTERICIN B
	
  CREAM;TOPICAL
	
    FUNGIZONE
	
         APOTHECON              3%                                        N050314 001
	
  INJECTABLE;INJECTION
	
    AMPHOTERICIN B
	
         ABBOTT                 50MG/VIAL                                 A064141 001 Dec 23, 1996
	
         ABRAXIS PHARM          50MG/VIAL                                 A062728 001 Apr 13, 1987

         TEVA PARENTERAL        50MG/VIAL                                 A064062 001 Mar 31, 1995
	
    FUNGIZONE
	
         APOTHECON              50MG/VIAL                                 A060517 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                        6-29(of 337)


AMPHOTERICIN B
	
  LOTION;TOPICAL
	
    FUNGIZONE
	
         APOTHECON              3%
	                              A060570 001
	
  OINTMENT;TOPICAL
	
    FUNGIZONE
	
         APOTHECON              3%
	                              N050313 001
	
  SUSPENSION;ORAL
	
    FUNGIZONE
	
         BRISTOL MYERS SQUIBB   100MG/ML
	                        N050341 003
	
AMPICILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    AMPICILLIN SODIUM
	
         APOTHECON              EQ     1GM BASE/VIAL
             A062860   004     Feb   05,   1988
	
                                EQ     2GM BASE/VIAL
             A062860   005     Feb   05,   1988
	
                                EQ     125MG BASE/VIAL
           A062860   001     Feb   05,   1988
	
                                EQ     250MG BASE/VIAL
           A062860   002     Feb   05,   1988
	
                                EQ     500MG BASE/VIAL
           A062860   003     Feb   05,   1988
	
         CONSOLIDATED PHARM     EQ     1GM BASE/VIAL
             A061936   003
	
                                EQ     2GM BASE/VIAL
             A061936   004
	
                                EQ     125MG BASE/VIAL
           A061936   005
	
                                EQ     250MG BASE/VIAL
           A061936   001
	
                                EQ     500MG BASE/VIAL
           A061936   002
	
         HANFORD GC             EQ     1GM BASE/VIAL
             A063139   001     Apr   15,   1993

                                EQ     2GM BASE/VIAL
             A063141   001     Apr   15,   1993

                                EQ     125MG BASE/VIAL
           A063143   001     Apr   15,   1993

                                EQ     500MG BASE/VIAL
           A063147   001     Apr   15,   1993

         HIKMA MAPLE            EQ     1GM BASE/VIAL
             A062692   004     Jun   24,   1986
	
                                EQ     2GM BASE/VIAL
             A062692   005     Jun   24,   1986
	
                                EQ     10GM BASE/VIAL
            A062692   006     Jun   24,   1986
	
                                EQ     125MG BASE/VIAL
           A062692   001     Jun   24,   1986
	
                                EQ     250MG BASE/VIAL
           A062692   002     Jun   24,   1986
	
                                EQ     500MG BASE/VIAL
           A062692   003     Jun   24,   1986
	
         INTL MEDICATION        EQ     1GM BASE/VIAL
             A062634   002     Jan   09,   1987
	
                                EQ     2GM BASE/VIAL
             A062634   003     Jan   09,   1987
	
         LILLY                  EQ     1GM BASE/VIAL
             A062565   002     Apr   04,   1985

                                EQ     2GM BASE/VIAL
             A062565   003     Jun   24,   1986
	
                                EQ     500MG BASE/VIAL
           A062565   001     Apr   04,   1985

         WATSON LABS INC        EQ     1GM BASE/VIAL
             A062816   004     Oct   24,   1988
	
                                EQ     2GM BASE/VIAL
             A062816   005     Oct   24,   1988
	
                                EQ     10GM BASE/VIAL
            A062994   001     Sep   15,   1988

                                EQ     125MG BASE/VIAL
           A062816   001     Oct   24,   1988
	
                                EQ     250MG BASE/VIAL
           A062816   002     Oct   24,   1988
	
                                EQ     500MG BASE/VIAL
           A062816   003     Oct   24,   1988
	
   OMNIPEN-N
	
        WYETH AYERST            EQ     1GM BASE/VIAL
             A060626   004
	
                                EQ     1GM BASE/VIAL
             A062718   004     Dec 16, 1986
	
                                EQ     2GM BASE/VIAL
             A060626   005
	
                                EQ     2GM BASE/VIAL
             A062718   005     Dec 16, 1986
	
                                EQ     125MG BASE/VIAL
           A060626   001
	
                                EQ     125MG BASE/VIAL
           A062718   001     Dec 16, 1986
	
                                EQ     250MG BASE/VIAL
           A060626   002
	
                                EQ     250MG BASE/VIAL
           A062718   002     Dec 16, 1986
	
                                EQ     500MG BASE/VIAL
           A060626   003
	
                                EQ     500MG BASE/VIAL
           A062718   003     Dec 16, 1986
	
   PENBRITIN-S
	
        WYETH AYERST            EQ     1GM BASE/VIAL
             N050072   004
	
                                EQ     2GM BASE/VIAL
             N050072   005
	
                                EQ     4GM BASE/VIAL
             N050072   006
	
                                EQ     125MG BASE/VIAL
           N050072   001
	
                                EQ     250MG BASE/VIAL
           N050072   002
	
                                EQ     500MG BASE/VIAL
           N050072   003
	
   POLYCILLIN-N
	
        BRISTOL                 EQ     1GM BASE/VIAL
             N050309   004
	
                                EQ     2GM BASE/VIAL
             N050309   005
	
                                EQ     125MG BASE/VIAL
           N050309   001
	
                                EQ     250MG BASE/VIAL
           N050309   002
	
                                EQ     500MG BASE/VIAL
           N050309   003
	
   TOTACILLIN-N
	
        GLAXOSMITHKLINE         EQ 1GM BASE/VIAL
                 A060677 004
	
                                EQ 1GM BASE/VIAL
                 A062727 001 Dec 19, 1986
	
                                EQ 2GM BASE/VIAL
	                A060677 005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                                 6-30(of 337)


AMPICILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    TOTACILLIN-N
	
                                EQ   2GM BASE/VIAL
                       A062727   002 Dec 19, 1986
	
                                EQ   10GM BASE/VIAL
                      A060677   006
	
                                EQ   125MG BASE/VIAL
                     A060677   001
	
                                EQ   250MG BASE/VIAL
                     A060677   002
	
                                EQ   500MG BASE/VIAL
	                    A060677   003
	
AMPICILLIN SODIUM; SULBACTAM SODIUM
	
  INJECTABLE;INJECTION
	
    UNASYN
	
         PFIZER                 EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL
	   N050608 003 Dec 31, 1986
	
AMPICILLIN/AMPICILLIN TRIHYDRATE

  CAPSULE;ORAL
	
    AMCILL
	
         PARKE DAVIS
	          EQ 250MG   BASE
	                         A062041 001
	
                                EQ 500MG   BASE
	                         A062041 002
	
    AMPICILLIN TRIHYDRATE
	
         AM ANTIBIOTICS
	       EQ 250MG   BASE
	                         A061602   001
	
                                EQ 500MG   BASE
	                         A061602   002
	
         IVAX SUB TEVA PHARMS
	 EQ 250MG   BASE
	                         A060765   001
	
                                EQ 500MG   BASE
	                         A060765   002
	
         LEDERLE
	              EQ 250MG   BASE
	                         A062208   001
	
                                EQ 500MG   BASE
	                         A062208   002
	
         MYLAN
	                EQ 250MG   BASE
	                         A061755   001
	
                                EQ 500MG   BASE
	                         A061755   002
	
         PUREPAC PHARM
	        EQ 250MG   BASE
	                         A061853   001
	
                                EQ 500MG   BASE
	                         A061853   002
	
         TEVA
	                 EQ 250MG   BASE
	                         A061502   001
	
                                EQ 500MG   BASE
	                         A061502   002
	
         VITARINE
	             EQ 250MG   BASE
	                         A061387   001
	
                                EQ 500MG   BASE
	                         A061387   003
	
    OMNIPEN (AMPICILLIN)

         WYETH AYERST
	         250MG
	                                   A060624 001
	
                                500MG
	                                   A060624 002
	
    PENBRITIN
	
         WYETH AYERST
	         EQ 250MG   BASE
	                         A060908 001
	
                                EQ 500MG   BASE
	                         A060908 002
	
    PFIZERPEN-A
	
         PFIZER
	               EQ 250MG   BASE
	                         A062050 001
	
                                EQ 500MG   BASE
	                         A062050 002
	
    POLYCILLIN
	
         BRISTOL
	              EQ 250MG   BASE
	                         N050310 001
	
                                EQ 500MG   BASE
	                         N050310 002
	
    PRINCIPEN
	
         APOTHECON
	            EQ 250MG   BASE
	                         A062888   001 Mar 04, 1988
	
                                EQ 500MG   BASE
	                         A062888   002 Mar 04, 1988
	
         BRISTOL MYERS SQUIBB
	 EQ 250MG   BASE
	                         A061392   001
	
                                EQ 500MG   BASE
	                         A061392   002
	
    PRINCIPEN '250'
	
         APOTHECON
	            EQ 250MG   BASE
	                         A062157 002
	
                                EQ 250MG   BASE
	                         N050056 001
	
    PRINCIPEN '500'
	
         APOTHECON
	            EQ 500MG   BASE
	                         A062157 001
	
                                EQ 500MG   BASE
	                         N050056 002
	
    TOTACILLIN
	
         GLAXOSMITHKLINE
	      EQ 250MG   BASE
	                         A060060   001
	
                                EQ 250MG   BASE
	                         A062212   001
	
                                EQ 500MG   BASE
	                         A060060   002
	
                                EQ 500MG   BASE
	                         A062212   002
	
  FOR SUSPENSION;ORAL
	
    AMCILL
	
         PARKE DAVIS
	          EQ 125MG   BASE/5ML
                      A062030 001
	
                                EQ 250MG   BASE/5ML
	                     A062030 002
	
    AMPICILLIN TRIHYDRATE
	
         AM ANTIBIOTICS
	       EQ 125MG   BASE/5ML
                      A061601   001
	
                                EQ 250MG   BASE/5ML
                      A061601   002
	
         MYLAN
	                EQ 125MG   BASE/5ML
                      A061829   002
	
                                EQ 250MG   BASE/5ML
                      A061829   001
	
         PUREPAC PHARM
	        EQ 125MG   BASE/5ML
                      A061980   001
	
                                EQ 250MG   BASE/5ML
	                     A061980   002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                                 6-31(of 337)


AMPICILLIN/AMPICILLIN TRIHYDRATE

  FOR SUSPENSION;ORAL
	
    AMPICILLIN TRIHYDRATE
	
         TEVA
	                 EQ 125MG BASE/5ML
                          A061370 001
	
                                EQ 250MG BASE/5ML
	                         A061370 002
	
    OMNIPEN (AMPICILLIN)

         WYETH AYERST
	         100MG/ML
                                   A060625   001
	
                                125MG/5ML
                                  A060625   002
	
                                250MG/5ML
                                  A060625   003
	
                                500MG/5ML
	                                 A060625   004
	
    PENBRITIN
	
         WYETH AYERST
	         EQ 100MG BASE/ML
                           N050019 001
	
                                EQ 125MG BASE/5ML
                          N050019 002
	
                                EQ 250MG BASE/5ML
	                         N050019 003
	
    PFIZERPEN-A
	
         PFIZER
	               EQ 125MG BASE/5ML
                          A062049 001
	
                                EQ 250MG BASE/5ML
	                         A062049 002
	
    POLYCILLIN
	
         APOTHECON
	            EQ 125MG BASE/5ML
                          A062297   001
	
                                EQ 250MG BASE/5ML
                          A062297   002
	
         BRISTOL
	              EQ 100MG BASE/ML
                           N050308   004
	
                                EQ 125MG BASE/5ML
                          N050308   001
	
                                EQ 250MG BASE/5ML
                          N050308   002
	
                                EQ 500MG BASE/5ML
	                         N050308   003
	
    PRINCIPEN
	
         APOTHECON
	            EQ 100MG BASE/ML
                           A061394 001
	
                                EQ 125MG BASE/5ML
                          A061394 002
	
                                EQ 250MG BASE/5ML
	                         A061394 003
	
    PRINCIPEN '125'
	
         APOTHECON
	            EQ 125MG BASE/5ML
                          A060127 002
	
                                EQ 125MG BASE/5ML
	                         A062151 001
	
    PRINCIPEN '250'
	
         APOTHECON
	            EQ 250MG BASE/5ML
                          A060127 001
	
                                EQ 250MG BASE/5ML
	                         A062151 002
	
    TOTACILLIN
	
         GLAXOSMITHKLINE
	      EQ 125MG BASE/5ML
                          A060666   001
	
                                EQ 125MG BASE/5ML
                          A062223   001
	
                                EQ 250MG BASE/5ML
                          A060666   002
	
                                EQ 250MG BASE/5ML
	                         A062223   002
	
  TABLET, CHEWABLE;ORAL
	
    POLYCILLIN
	
         BRISTOL
	              EQ 125MG BASE
	                             N050093 001
	
AMPICILLIN/AMPICILLIN TRIHYDRATE; PROBENECID

  CAPSULE;ORAL
	
    PRINCIPEN W/ PROBENECID

         APOTHECON
	            EQ 389MG BASE;111MG
	                       A062150 001
	
                                EQ 389MG BASE;111MG
	                       N050488 001
	
  FOR SUSPENSION;ORAL
	
    POLYCILLIN-PRB
	
         APOTHECON
	            EQ 3.5GM BASE/BOT;1GM/BOT
                  A061898 001
	
         BRISTOL
	              EQ 3.5GM BASE/BOT;1GM/BOT
	                 N050457 001
	
    PROBAMPACIN
	
         TEVA
	                 EQ 3.5GM BASE/BOT;1GM/BOT
	                 A061741 001
	
AMPRENAVIR
	
  CAPSULE;ORAL
	
    AGENERASE
	
         GLAXOSMITHKLINE
	       50MG
	                                     N021007 001
	 Apr 15, 1999

                                 150MG
	                                    N021007 002
	 Apr 15, 1999
	
 SOLUTION;ORAL
	
   AGENERASE
	
        GLAXOSMITHKLINE
	        15MG/ML **Federal Register
                N021039 001
	 Apr 15, 1999
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
ANAGRELIDE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    AGRYLIN
	
         SHIRE LLC
	             EQ 1MG BASE
	                              N020333 002
	 Mar 14, 1997
	
    ANAGRELIDE HYDROCHLORIDE
	
         ROXANE
	                EQ 0.5MG BASE
	                            A076489 001
	 Apr 18, 2005

                                 EQ 1MG BASE
	                              A076489 002
	 Apr 18, 2005
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                                 6-32(of 337)


ANAGRELIDE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    ANAGRELIDE HYDROCHLORIDE
	
         SANDOZ INC
	             EQ   0.5MG BASE
	                          A076683   001
	   Apr   18,   2005

                                  EQ   1MG BASE
	                            A076683   002
	   Apr   18,   2005

         WATSON LABS
	            EQ   0.5MG BASE
	                          A076417   001
	   Apr   18,   2005

                                  EQ   1MG BASE
	                            A076417   002
	   Apr   18,   2005
	
ANASTROZOLE
	
  TABLET;ORAL
	
    ANASTROZOLE
	
         IMPAX LABS INC
	         1MG
	                                      A091242   001
	   May   31,   2012

         KUDCO IRELAND
	          1MG
	                                      A091331   001
	   Jan   05,   2011
	
         SYNTHON PHARMS
	         1MG
	                                      A078322   001
	   Jun   28,   2010
	
         WATSON LABS
	            1MG
	                                      A078984   001
	   Jun   28,   2010
	
ANILERIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    LERITINE
	
         MERCK
	                  EQ 25MG BASE
	                             N010585 002
	
ANILERIDINE PHOSPHATE
	
  INJECTABLE;INJECTION
	
    LERITINE
	
         MERCK
	                  25MG/ML
	                                  N010520 003
	
ANISINDIONE
	
  TABLET;ORAL
	
    MIRADON
	
         SCHERING
	               50MG
	                                     N010909 003
	
ANISOTROPINE METHYLBROMIDE
	
  TABLET;ORAL
	
    ANISOTROPINE METHYLBROMIDE
	
         WATSON LABS
	           50MG
	                                      A086046 001
	
    VALPIN 50
	
         ENDO PHARMS
	           50MG
	                                      N013428 001
	
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    VASOCON-A
	
         NOVARTIS
	             0.5%;0.05%
	                                 N018746 002
	 Jul 11, 1994
	
APOMORPHINE HYDROCHLORIDE
	
  INJECTABLE;SUBCUTANEOUS
	
    APOKYN
	
         US WORLDMEDS
	           20MG/2ML (10MG/ML)
	                       N021264 001
	 Apr 20, 2004
	
APROTININ
	
  INJECTABLE;INJECTION
	
    TRASYLOL
	
         BAYER HLTHCARE
	         10,000KIU/ML
	                             N020304 001
	 Dec 29, 1993
	
ARBUTAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    GENESA
	
         GENSIA AUTOMEDICS
	      0.05MG/ML
	                                N020420 001
	 Sep 12, 1997
	
ARDEPARIN SODIUM
	
  INJECTABLE;INJECTION
	
    NORMIFLO
	
         PHARMACIA AND UPJOHN
	   5,000 UNITS/0.5ML **Federal Register
      N020227 002
	 May 23, 1997
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

                                  10,000 UNITS/0.5ML **Federal Register
     N020227 001
	 May 23, 1997
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**
	
ARGATROBAN
	
  SOLUTION;IV (INFUSION)

    ARGATROBAN IN DEXTROSE
	
         SANDOZ
	                 125MG/125ML (1MG/ML)
	                     N201743 001
	 May 09, 2011
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                             6-33(of 337)


ARIPIPRAZOLE
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    ABILIFY
	
         OTSUKA
	               20MG **Federal Register determination
   N021729 004 Jun 07, 2006
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                30MG **Federal Register determination
   N021729 005 Jun 07, 2006
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
ARMODAFINIL
	
  TABLET;ORAL
	
    ARMODAFINIL
	
         MYLAN PHARMS INC
	      50MG
	                                  A200043   001   Jun   01,   2012
	
                                 150MG
	                                 A200043   002   Jun   01,   2012
	
                                 250MG
	                                 A200043   003   Jun   01,   2012
	
         WATSON LABS INC
	       100MG
	                                 A200156   002   Aug   29,   2012

                                 200MG
	                                 A200156   004   Aug   29,   2012
	
   NUVIGIL
	
        CEPHALON
	               100MG
	                                 N021875 002 Mar 26, 2009
	
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A

PALMITATE; VITAMIN E
  INJECTABLE;INJECTION
    BEROCCA PN
         ROCHE                  50MG/ML;0.03MG/ML;0.0025MG/ML;7.5MG/ML;   N006071 003 Oct 10, 1985
                                100
                                IU/ML;0.2MG/ML;20MG/ML;2MG/ML;1.8MG/ML;
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A;

VITAMIN E
	
  INJECTABLE;INJECTION
	
    M.V.C. 9+3
	
         ABRAXIS PHARM		        10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2   N018440 002 Aug 08, 1985

                                0
	
                                IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/

    M.V.I.-12
	
         HOSPIRA		              10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2   N008809 004 Aug 08, 1985

                                0
	
                                IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/

    MVC PLUS
	
         WATSON LABS		          10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2   N018439 002 Aug 08, 1985

                                0
	
                                IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/
	
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
	
  INJECTABLE;INJECTION
	
    M.V.I.-12
	
         HOSPIRA		              20MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2   N008809 005 Apr 22, 2004

                                0
	
                                IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36MG/M
	
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE;

PYRIDOXINE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE; VITAMIN A; VITAMIN E
	
  INJECTABLE;INJECTION
	
    M.V.I.-12 LYOPHILIZED
	
         ASTRAZENECA		          100MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M   N018933 002 Aug 08, 1985

                                G/VIAL;5MCG/VIAL;0.4MG/VIAL;40MG/VIAL;4

                                MG/VIAL;3.6MG/VIAL;3MG/VIAL;1MG/VIAL;10

                                MG/VIAL
	
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID;

PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E
	
  INJECTABLE;INJECTION
	
    VITAPED
	
         HOSPIRA		              N/A,80MG/VIAL;N/A,0.02MG/VIAL;N/A,0.001   N020176 001 Dec 29, 1993

                                MG/VIAL;400

                                IU/10ML,N/A;N/A,0.14MG/VIAL;N/A,17MG/VI

                                AL;N/A,5MG/VIAL;0.2MG/10ML,N/A;N/A,1MG/

                                VIAL;N/A,1.4MG/VIAL;N/A,1.2MG/VIAL;EQ

                                2,300 UNITS BASE/10ML,N/A;7 IU/10ML,N/A
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                 6-34(of 337)


ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE;

SODIUM SULFATE
	
  FOR SOLUTION;ORAL
	
    MOVIPREP
	
         NOVEL LABS INC         4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM
	 A090145 001 Jan 25, 2012
	
ASPIRIN
	
  TABLET;ORAL
	
    BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
	
          BAYER                  500MG
	                                  N021317 001 Oct 18, 2001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    8-HOUR BAYER
	
          BAYER                  650MG
	                                  N016030 001
	
    MEASURIN
	
          BAYER                  650MG
	                                  N016030 002
	
ASPIRIN; BUTALBITAL
	
  TABLET;ORAL
	
    AXOTAL
	
         SAVAGE LABS              650MG;50MG
	                            A088305 001 Oct 13, 1983
	
ASPIRIN; BUTALBITAL; CAFFEINE
	
  CAPSULE;ORAL
	
    BUTALBITAL, ASPIRIN AND CAFFEINE
	
         MUTUAL PHARM           325MG;50MG;40MG
	                         A078149 001 Jun 13, 2007
	
         WATSON LABS            325MG;50MG;40MG
	                         A086231 002 Feb 12, 1985
	
  TABLET;ORAL
	
    BUTALBITAL, ASPIRIN AND CAFFEINE
	
         ACTAVIS ELIZABETH
	    325MG;50MG;40MG
	                         A086710   002   Aug   23,   1983

         HALSEY
	               325MG;50MG;40MG
	                         A089448   001   Dec   01,   1986
	
         IVAX PHARMS
	          325MG;50MG;40MG
	                         A085441   002   Oct   31,   1984
	
         PURACAP PHARM
	        325MG;50MG;40MG
	                         A087048   002   Dec   09,   1983
	
         QUANTUM PHARMICS
	     325MG;50MG;40MG
	                         A088972   001   Jun   18,   1985
	
         SANDOZ
	               325MG;50MG;40MG
	                         A086398   002   Apr   06,   1984

         WATSON LABS
	          325MG;50MG;40MG
	                         A086237   002   Mar   23,   1984
	
    FIORINAL
	
         WATSON LABS INC
	      325MG;50MG;40MG
	                         N017534 003 Apr 16, 1986
	
    LANORINAL
	
         LANNETT
	              325MG;50MG;40MG
	                         A086986 002 Oct 18, 1985
	
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
	
  CAPSULE;ORAL
	
    BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
	
         VINTAGE PHARMS LLC     325MG;50MG;40MG;30MG
	                    A075351 001 Mar 05, 1999
	
         WATSON LABS            325MG;50MG;40MG;30MG
	                    A074359 001 Aug 31, 1995
	
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
	
  TABLET;ORAL
	
    INVAGESIC
	
         SANDOZ                 385MG;30MG;25MG
	                         A074817 001 Nov 27, 1996
	
    INVAGESIC FORTE
	
         SANDOZ                 770MG;60MG;50MG
	                         A074817 002 Nov 27, 1996
	
    ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
	
         STEVENS J              385MG;30MG;25MG
	                         A074988 001 Apr 30, 1999

                                770MG;60MG;50MG
	                         A074988 002 Apr 30, 1999
	
    ORPHENGESIC
	
         PRINSTON INC           385MG;30MG;25MG
	                         A075141 001 May 29, 1998
	
    ORPHENGESIC FORTE
	
         PRINSTON INC           770MG;60MG;50MG
	                         A075141 002 May 29, 1998
	
ASPIRIN; CAFFEINE; PROPOXYPHENE   HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    COMPOUND 65
	
         ALRA
	                   389MG;32.4MG;65MG
	                     A084553 002 Aug 17, 1983
	
    DARVON COMPOUND
	
         XANODYNE PHARM
	         389MG;32.4MG;32MG
	                     N010996 006 Mar 08, 1983
	
    DARVON COMPOUND-65
	
         XANODYNE PHARM
	         389MG;32.4MG;65MG
	                     N010996 007 Mar 08, 1983
	
    PROPOXYPHENE COMPOUND 65
	
         IVAX SUB TEVA PHARMS
	   389MG;32.4MG;65MG
	                     A083077 002 Dec 07, 1984
	
         SANDOZ
	                 389MG;32.4MG;65MG
	                     A080044 002 Sep 16, 1983

         TEVA
	                   389MG;32.4MG;65MG
	                     A089025 001 Mar 29, 1985
	
    PROPOXYPHENE COMPOUND-65
	
         SANDOZ
	                 389MG;32.4MG;65MG
	                     A083101 002 Jun 24, 1985
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                              6-35(of 337)

ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
  CAPSULE;ORAL
    PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE
         WATSON LABS            389MG;32.4MG;65MG                         A085732 002 Sep 03, 1984
ASPIRIN; CARISOPRODOL
  TABLET;ORAL
    CARISOPRODOL COMPOUND
         WATSON LABS             325MG;200MG                              A088809 001 Oct 03, 1985
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
  TABLET;ORAL
    CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
         MIRROR PHARMS          325MG;200MG;16MG                          A040860 001 Jan 07, 2010
         PROSAM LABS            325MG;200MG;16MG                          A040283 001 Dec 29, 1998
ASPIRIN; HYDROCODONE BITARTRATE
  TABLET;ORAL
    AZDONE
         SCHWARZ PHARMA         500MG;5MG **Federal Register              A089420 001 Jan 25, 1988
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
    VICOPRIN
         ABBOTT                 500MG;5MG                                 A086333 001 Sep 14, 1983
ASPIRIN; MEPROBAMATE
  TABLET;ORAL
    EQUAGESIC
         CARACO                  325MG;200MG                              N011702 003 Dec 29, 1983
    MEPRO-ASPIRIN
         SANDOZ                  325MG;200MG                              A089127 001 Mar 02, 1987
    MEPROBAMATE AND ASPIRIN
         PAR PHARM               325MG;200MG                              A089126 001 Aug 19, 1986
    MICRAININ
         MEDPOINTE PHARM HLC     325MG;200MG                              A084978 001
    Q-GESIC
         QUANTUM PHARMICS        325MG;200MG                              A088740 001 Jun 01, 1984
ASPIRIN; METHOCARBAMOL
  TABLET;ORAL
    METHOCARBAMOL AND ASPIRIN
         IVAX SUB TEVA PHARMS    325MG;400MG                              A087211 001 Dec 22, 1982
         MCNEIL                  325MG;400MG                              A089193 001 Feb 12, 1986
         PAR PHARM               325MG;400MG                              A089657 001 Nov 04, 1988
    ROBAXISAL
         ROBINS AH               325MG;400MG                              N012281 001
ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE
  TABLET;ORAL
    CODOXY
         HALSEY                 325MG;4.5MG;0.38MG                        A087464 001 Jul 01, 1982
    OXYCODONE AND ASPIRIN
         MUTUAL PHARM           325MG;4.5MG;0.38MG                        A040260 001 Jul 17, 1998
                                325MG;4.5MG;0.38MG                        A087794 001 May 26, 1982
         WATSON LABS            325MG;4.5MG;0.38MG                        A040255 001 Feb 27, 1998
    OXYCODONE AND ASPIRIN (HALF-STRENGTH)
         ROXANE                 325MG;2.25MG;0.19MG                       A087742 001 Jun 04, 1982
    PERCODAN
         ENDO PHARMS            325MG;4.5MG;0.38MG                        N007337 006
    PERCODAN-DEMI
         ENDO PHARMS            325MG;2.25MG;0.19MG                       N007337 005
    ROXIPRIN
         ROXANE                 325MG;4.5MG;0.38MG                        A087743 001 Jun 04, 1982
ASPIRIN; PENTAZOCINE HYDROCHLORIDE
  TABLET;ORAL
    TALWIN COMPOUND
         SANOFI AVENTIS US      325MG;EQ 12.5MG BASE                      N016891 001
ASPIRIN; PRAVASTATIN SODIUM
  TABLET, TABLET;ORAL
    PRAVIGARD PAC (COPACKAGED)
         BRISTOL MYERS SQUIBB    325MG,N/A;N/A,80MG                       N021387 006 Jun 24, 2003
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                   6-36(of 337)

ASPIRIN; PRAVASTATIN SODIUM
  TABLET, TABLET, TABLET;ORAL
    PRAVIGARD PAC (COPACKAGED)
         BRISTOL MYERS SQUIBB    81MG,N/A;N/A,20MG                         N021387   001   Jun   24,   2003
                                 81MG,N/A;N/A,40MG                         N021387   002   Jun   24,   2003
                                 81MG,N/A;N/A,80MG                         N021387   003   Jun   24,   2003
                                 325MG,N/A;N/A,20MG                        N021387   004   Jun   24,   2003
                                 325MG,N/A;N/A,40MG                        N021387   005   Jun   24,   2003
ASPIRIN; PROPOXYPHENE HYDROCHLORIDE
  CAPSULE;ORAL
    DARVON W/ ASA
         XANODYNE PHARM         325MG;65MG                                 N010996 005
ASPIRIN; PROPOXYPHENE NAPSYLATE
  CAPSULE;ORAL
    DARVON-N W/ ASA
         AAIPHARMA LLC          325MG;100MG                                N016829 001
  TABLET;ORAL
    DARVON-N W/ ASA
         AAIPHARMA LLC          325MG;100MG                                N016863 001
ATAZANAVIR SULFATE
  CAPSULE;ORAL
    REYATAZ
         BRISTOL MYERS SQUIBB    EQ 100MG BASE **Federal Register          N021567 001 Jun 20, 2003
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
ATENOLOL
  INJECTABLE;INJECTION
    TENORMIN
         ASTRAZENECA             0.5MG/ML **Federal Register               N019058 001 Sep 13, 1989
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
 TABLET;ORAL
   ATENOLOL
        ABLE                     25MG                                      A076907   001   Jul   30,   2004
                                 50MG                                      A076907   002   Jul   30,   2004
                                 100MG                                     A076907   003   Jul   30,   2004
        APOTHECON                50MG                                      A073317   001   Mar   20,   1992
                                 100MG                                     A073318   001   Mar   20,   1992
        MYLAN                    25MG                                      A074126   003   Aug   26,   1998
                                 50MG                                      A074126   001   Mar   23,   1994
                                 100MG                                     A074126   002   Mar   23,   1994
        NOSTRUM LABS             50MG                                      A074127   001   Feb   21,   1995
                                 100MG                                     A074127   002   Feb   21,   1995
        PLIVA                    25MG                                      A074101   001   Jul   17,   1997
                                 50MG                                      A074101   002   Jul   17,   1997
                                 100MG                                     A074101   003   Jul   17,   1997
        SANDOZ                   25MG                                      A074265   001   Feb   28,   1994
                                 50MG                                      A074265   002   Feb   28,   1994
                                 100MG                                     A074265   003   Feb   28,   1994
        SCS                      50MG                                      A073676   001   Oct   30,   1992
                                 100MG                                     A073676   002   Oct   30,   1992
        TEVA                     50MG                                      A073315   001   May   28,   1993
                                 100MG                                     A073316   001   May   28,   1993
        TEVA PHARMS              50MG                                      A074120   001   Feb   24,   1995
                                 100MG                                     A074120   002   Feb   24,   1995
        WATSON LABS              50MG                                      A073352   001   Dec   27,   1991
                                 100MG                                     A073353   001   Dec   27,   1991
ATENOLOL; CHLORTHALIDONE
  TABLET;ORAL
    ATENOLOL AND CHLORTHALIDONE
         NOSTRUM LABS           50MG;25MG                                  A074404   001   May   14,   1998
                                100MG;25MG                                 A074404   002   May   14,   1998
         PLIVA                  50MG;25MG                                  A074107   001   Sep   24,   1997
                                100MG;25MG                                 A074107   002   Sep   24,   1997
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-37(of 337)

ATOMOXETINE HYDROCHLORIDE
  CAPSULE;ORAL
    ATOMOXETINE HYDROCHLORIDE
         ZYDUS PHARMS USA INC     18MG                                     A079017   001   Sep   17,   2010
                                  25MG                                     A079017   002   Sep   17,   2010
                                  40MG                                     A079017   003   Sep   17,   2010
                                  60MG                                     A079017   004   Sep   17,   2010
                                  80MG                                     A079017   005   Sep   17,   2010
                                  100MG                                    A079017   006   Sep   17,   2010
   STRATTERA
        LILLY                     5MG                                      N021411 001 Nov 26, 2002
ATORVASTATIN CALCIUM
  TABLET;ORAL
    ATORVASTATIN CALCIUM
         TEVA PHARMS              EQ   10MG   BASE                         A078773   001   May   29,   2012
                                  EQ   20MG   BASE                         A078773   002   May   29,   2012
                                  EQ   40MG   BASE                         A078773   003   May   29,   2012
                                  EQ   80MG   BASE                         A078773   004   May   29,   2012
ATOVAQUONE
  TABLET;ORAL
    MEPRON
         GLAXOSMITHKLINE LLC      250MG **Federal Register determination   N020259 001 Nov 25, 1992
                                  that product was not discontinued or
                                  withdrawn for safety or efficacy
                                  reasons**
ATRACURIUM BESYLATE
  INJECTABLE;INJECTION
    ATRACURIUM BESYLATE
         BAXTER HLTHCARE       10MG/ML                                     A074824   001   Sep   30,   1997
         BAXTER HLTHCARE CORP  10MG/ML                                     A074753   001   Jan   23,   1997
         HOSPIRA               10MG/ML                                     A074632   001   Dec   23,   1996
                               10MG/ML                                     A074740   001   Mar   28,   1997
        TEVA PARENTERAL        10MG/ML                                     A074784   001   Jun   11,   1997
        WATSON LABS INC        10MG/ML                                     A074945   001   Jul   28,   1998
   ATRACURIUM BESYLATE PRESERVATIVE FREE
        BAXTER HLTHCARE        10MG/ML                                     A074825   001   Sep   30,   1997
        BAXTER HLTHCARE CORP   10MG/ML                                     A074768   001   Jan   23,   1997
        HOSPIRA                10MG/ML                                     A074633   001   Dec   23,   1996
                               10MG/ML                                     A074639   001   Mar   25,   1997
                               10MG/ML                                     A074741   001   Mar   28,   1997
        WATSON LABS INC        10MG/ML                                     A074944   001   Jul   28,   1998
   TRACRIUM
        HOSPIRA                10MG/ML **Federal Register                  N018831 002 Jun 20, 1985
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
   TRACRIUM PRESERVATIVE FREE
        HOSPIRA                10MG/ML **Federal Register                  N018831 001 Nov 23, 1983
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
ATROPINE
  INJECTABLE;INJECTION
    ATROPINE
         ABBVIE                   EQ 2MG SULFATE/0.7ML                     A071295 001 Jan 30, 1987
ATROPINE SULFATE
  AEROSOL, METERED;INHALATION
    ATROPINE SULFATE
         US ARMY                  EQ 0.36MG BASE/INH                       N020056 001 Sep 19, 1990
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
  TABLET;ORAL
    MOTOFEN HALF-STRENGTH
         VALEANT                0.025MG;0.5MG                              N017744 001
ATROPINE SULFATE; DIPHENOXYLATE   HYDROCHLORIDE
  CAPSULE;ORAL
    DIPHENOXYLATE HYDROCHLORIDE   W/ ATROPINE SULFATE
         SCHERER RP               0.025MG;2.5MG                            A086440 001
  SOLUTION;ORAL
    COLONAID
         MEDPOINTE PHARM HLC      0.025MG/5ML;2.5MG/5ML                    A085735 001
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                              6-38(of 337)


ATROPINE SULFATE; DIPHENOXYLATE   HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    LOMANATE
	
         ALPHARMA US PHARMS
	     0.025MG/5ML;2.5MG/5ML
	                A085746 001
	
    LOMOTIL
	
         GD SEARLE LLC
	          0.025MG/5ML;2.5MG/5ML
	                N012699 001
	
  TABLET;ORAL
	
    COLONAID
	
         MEDPOINTE PHARM HLC
	    0.025MG;2.5MG
	                        A085737 001
	
    DI-ATRO
	
         MD PHARM
	               0.025MG;2.5MG
	                        A085266 001
	
    DIPHENOXYLATE HYDROCHLORIDE   AND ATROPINE SULFATE
	
         ABLE
	                   0.025MG;2.5MG
	                        A040395   001     Nov 27, 2000
	
         ASCOT
	                  0.025MG;2.5MG
	                        A087934   001     Jul 19, 1983
	
         HEATHER
	                0.025MG;2.5MG
	                        A086798   001
	
         HIKMA PHARMS LLC
	       0.025MG;2.5MG
	                        A087765   001     Mar 15, 1982
	
         INWOOD LABS
	            0.025MG;2.5MG
	                        A085509   001
	
         IVAX PHARMS
	            0.025MG;2.5MG
	                        A086727   001
	
         KV PHARM
	               0.025MG;2.5MG
	                        A085659   001
	
         LEDERLE
	                0.025MG;2.5MG
	                        A086950   001
	
         MUTUAL PHARM
	           0.025MG;2.5MG
	                        A085506   001
	
         PARKE DAVIS
	            0.025MG;2.5MG
	                        A087131   001
	
         PVT FORM
	               0.025MG;2.5MG
	                        A085766   001
	
         R AND S PHARMA
	         0.025MG;2.5MG
	                        A085035   001
	
         ROXANE
	                 0.025MG;2.5MG
	                        A086057   001
	
         SANDOZ
	                 0.025MG;2.5MG
	                        A086173   001
	
         USL PHARMA
	             0.025MG;2.5MG
	                        A087842   001     Mar 29, 1982
	
         VALEANT PHARM INTL
	     0.025MG;2.5MG
	                        A087195   001     Feb 16, 1982
	
         WATSON LABS
	            0.025MG;2.5MG
	                        A085876   001
	
    LO-TROL
	
         VANGARD
	                0.025MG;2.5MG
	                        A088009 001 Mar 25, 1983
	
    LOGEN
	
         SUPERPHARM
	             0.025MG;2.5MG
	                        A088962 001 May 10, 1985
	
    LOW-QUEL
	
         HALSEY
	                 0.025MG;2.5MG
	                        A085211 001
	
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ENLON-PLUS
	
         MYLAN INSTITUTIONAL    0.14MG/ML;10MG/ML
	                      N019677 001 Nov 06, 1991
	
ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ATROPINE AND DEMEROL
	
         ABBVIE		               0.4MG/ML;50MG/ML
                        A087853 001 Nov 26, 1982
	
                                0.4MG/ML;75MG/ML
                        A087847 001 Nov 26, 1982
	
                                0.4MG/ML;100MG/ML
                       A087848 001 Nov 26, 1982
	
    MEPERIDINE AND ATROPINE SULFATE
	
         WYETH AYERST		         0.4MG/ML;50MG/ML
                        A085121 001
	
                                0.4MG/ML;75MG/ML
                        A085121 002
	
                                0.4MG/ML;100MG/ML
	                      A085121 003
	
ATROPINE; PRALIDOXIME CHLORIDE
	
  INJECTABLE;INTRAMUSCULAR
	
    ATNAA
	
         US ARMY                 2.1MG/0.7ML;600MG/0.7ML;600MG/0.7ML
	   N021175 001 Jan 17, 2002
	
AZATADINE MALEATE
	
  TABLET;ORAL
	
    OPTIMINE
	
         SCHERING                 1MG
	                                  N017601 001
	
AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TRINALIN
	
         SCHERING
	              1MG;120MG
	                             N018506 001 Mar 23, 1982
	
AZATHIOPRINE
	
  TABLET;ORAL
	
    IMURAN
	
         PROMETHEUS LABS
	        25MG
	                                 N016324 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                                  6-39(of 337)


AZATHIOPRINE SODIUM
	
  INJECTABLE;INJECTION
	
    IMURAN
	
         PROMETHEUS LABS
	        EQ 100MG BASE/VIAL
	                       N017391 001
	
AZELASTINE HYDROCHLORIDE
	
  SPRAY, METERED;NASAL
	
    ASTEPRO
	
         MEDA PHARMS
	            EQ 0.125MG BASE/SPRAY
	                    N022203 001
	 Oct 15, 2008
	
AZITHROMYCIN
	
  CAPSULE;ORAL
	
    ZITHROMAX
	
         PFIZER
	                 EQ 250MG BASE **Federal Register
          N050670 001
	 Nov 01, 1991
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**
	
  FOR SUSPENSION;ORAL
	
    AZITHROMYCIN
	
         SANDOZ
	                 EQ 100MG BASE/5ML
                         A065297 001
	 Sep 18, 2006

                                  EQ 200MG BASE/5ML
	                        A065297 002
	 Sep 18, 2006
	
  INJECTABLE;INJECTION
	
    AZITHROMYCIN
	
         PLIVA HRVATSKA DOO		     EQ 500MG BASE/VIAL
                        A065265 001
	 Jan 18, 2007
	
         TEVA PARENTERAL		        EQ 2.5GM BASE/VIAL
                        N050809 002
	 Dec 19, 2006
	
                                  EQ 500MG BASE/VIAL
	                       N050809 001
	 Dec 19, 2006
	
AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE
	
  FOR SUSPENSION, TABLET;ORAL
	
    TROVAN/ZITHROMAX COMPLIANCE PAK

         PFIZER
	               EQ 1GM BASE,N/A;N/A,EQ 100MG BASE
	          N050762 001
	 Dec 18, 1998
	
AZLOCILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    AZLIN
	
         BAYER PHARMS
	           EQ   2GM   BASE/VIAL
                      A062388   001
	   Sep   08,   1982

                                  EQ   2GM   BASE/VIAL
                      A062417   001
	   Oct   12,   1982
	
                                  EQ   2GM   BASE/VIAL
                      N050562   001
	   Sep   03,   1982

                                  EQ   3GM   BASE/VIAL
                      A062388   002
	   Sep   08,   1982

                                  EQ   3GM   BASE/VIAL
                      A062417   002
	   Oct   12,   1982
	
                                  EQ   3GM   BASE/VIAL
                      N050562   002
	   Sep   03,   1982

                                  EQ   4GM   BASE/VIAL
                      A062388   003
	   Sep   08,   1982

                                  EQ   4GM   BASE/VIAL
                      A062417   003
	   Oct   12,   1982
	
                                  EQ   4GM   BASE/VIAL
	                     N050562   003
	   Sep   03,   1982
	
AZTREONAM
	
  INJECTABLE;INJECTION
	
    AZACTAM
	
         BRISTOL MYERS SQUIBB   500MG/VIAL
                                  N050580 001
	 Dec 31, 1986
	
    AZACTAM IN PLASTIC CONTAINER
	
         BRISTOL MYERS SQUIBB
	 10MG/ML
	                                    N050632 003
	 May 24, 1989
	
BACAMPICILLIN HYDROCHLORIDE
	
  FOR SUSPENSION;ORAL
	
    SPECTROBID
	
         PFIZER
	                 125MG/5ML
	                                N050556 001
	 Mar 23, 1982
	
  TABLET;ORAL
	
    SPECTROBID
	
         PFIZER
	                 400MG
	                                    N050520 001
	
                                  800MG
	                                    N050520 002
	 Sep 12, 1983
	
BACITRACIN
	
  INJECTABLE;INJECTION
	
    BACITRACIN
	
         PFIZER
	                 50,000 UNITS/VIAL
	                        A060282 001
	
  OINTMENT;OPHTHALMIC
	
    BACIGUENT
	
         PHARMACIA AND UPJOHN
	   500 UNITS/GM
	                             A060734 001
	
    BACITRACIN
	
         LILLY
	                  500 UNITS/GM
                              A060687 001
	
         PHARMADERM
	             500 UNITS/GM
                              A062158 001
	
         PHARMAFAIR
	             500 UNITS/GM
	                             A062453 001
	 Mar 28, 1984
	
  OINTMENT;TOPICAL
	
    BACITRACIN
	
         COMBE
	                  500 UNITS/GM
                              A062799 001
	 May 14, 1987

         NASKA
	                  500 UNITS/GM
	                             A062857 001
	 Nov 13, 1987
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                                6-40(of 337)


BACITRACIN
	
  POWDER;FOR RX COMPOUNDING
	
    BACI-RX
	
         X GEN PHARMS           5,000,000 UNITS/BOT
                       A061580 001
	
    BACITRACIN
	
         APOTHEKERNES           5,000,000 UNITS/BOT
                       A061699 001
	
         PADDOCK LLC            5,000,000 UNITS/BOT
	                      A062456 001 Jul 27, 1983
	
BACITRACIN ZINC
	
  POWDER;FOR RX COMPOUNDING
	
    ZIBA-RX
	
         X GEN PHARMS           500,000 UNITS/BOT
	                        A061737 001
	
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    CORTISPORIN
	
         CITRON PHARMA LLC      400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000
    N050416 002
	
                                UNITS/GM

    ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE
	
         PHARMAFAIR             400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000
    A062389 001 Jul 02, 1982
	
                                UNITS/GM

  OINTMENT;TOPICAL
	
    NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE
	
         PHARMAFAIR             400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000
     A062381 001 Sep 06, 1985
	
                                UNITS/GM
	
BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;TOPICAL
	
    LANABIOTIC
	
         COMBE                  400 UNITS/GM;40MG/GM;EQ 5MG
               A062499 001 Jun 03, 1985
	
                                BASE/GM;5,000 UNITS/GM
	
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
	
         PHARMAFAIR             400 UNITS/GM;EQ 3.5MG BASE/GM;10,000
      A062386 001 Sep 09, 1982
	
                                UNITS/GM

    BACITRACIN-NEOMYCIN-POLYMYXIN
	
         PHARMADERM             400 UNITS/GM;EQ 3.5MG BASE/GM;5,000
       A062167 001
	
                                UNITS/GM

    NEO-POLYCIN
	
         DOW PHARM              500 UNITS/GM;EQ 3.5MG BASE/GM;10,000
      A060647 001
	
                                UNITS/GM

    NEOSPORIN
	
         CITRON PHARMA LLC      400 UNITS/GM;EQ 3.5MG BASE/GM;10,000
      N050417 001
	
                                UNITS/GM

  OINTMENT;TOPICAL
	
    BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
	
         NASKA                  400 UNITS/GM;EQ 3.5MG BASE/GM;5,000
       A062833 001 Nov 09, 1987
	
                                UNITS/GM
	
BACITRACIN ZINC; POLYMYXIN B SULFATE
	
  AEROSOL;TOPICAL
	
    POLYSPORIN
	
         GLAXOSMITHKLINE        10,000 UNITS/GM;2,000,000 UNITS/GM
        N050167 002 Mar 01, 1985
	
  OINTMENT;OPHTHALMIC
	
    OCUMYCIN
	
         PHARMAFAIR             500 UNITS/GM;10,000 UNITS/GM
              A062430 001 Apr 08, 1983
	
    POLYSPORIN
	
         MONARCH PHARMS         500 UNITS/GM;10,000 UNITS/GM
              A061229 001
	
  OINTMENT;TOPICAL
	
    BACITRACIN ZINC-POLYMYXIN B SULFATE
	
         NASKA                  500 UNITS/GM;10,000 UNITS/GM
	             A062849 001 Nov 13, 1987
	
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE

         ALTANA                 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000
   A060731 002
	
                                UNITS/GM
	
BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    MYCITRACIN
	
         PHARMACIA AND UPJOHN   500 UNITS/GM;EQ 3.5MG BASE/GM;10,000
      A061048 001
	
                                UNITS/GM
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                      6-41(of 337)


BACITRACIN; POLYMYXIN B SULFATE
	
  DISC;TOPICAL
	
    LANABIOTIC
	
         COMBE                   500 UNITS/GM;5,000 UNITS/GM
	    N050598 001 Sep 22, 1986
	
BACLOFEN
	
  TABLET;ORAL
	
    BACLOFEN
	
          TEVA                    10MG
	                          A073043   001   Feb   27,   1992
	
                                  20MG
	                          A073044   001   Feb   27,   1992
	
         USL PHARMA               10MG
	                          A071260   001   May   06,   1988

                                  20MG
	                          A071261   001   May   06,   1988

         WATSON LABS              10MG
	                          A073092   001   Jan   28,   1994
	
                                  10MG
	                          A074698   001   Aug   20,   1996

                                  20MG
	                          A073093   001   Jan   28,   1994
	
                                  20MG
	                          A074698   002   Aug   20,   1996
	
    LIORESAL
	
         NOVARTIS               10MG
	                            N017851 001
	
                                20MG
	                            N017851 003 Jan 20, 1982
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    KEMSTRO
	
         UCB INC
	              10MG
	                            N021589 001 Oct 30, 2003
	
                                20MG
	                            N021589 002 Oct 30, 2003
	
BECLOMETHASONE DIPROPIONATE
	
  AEROSOL, METERED;INHALATION
	
    BECLOVENT
	
         GLAXOSMITHKLINE
	        0.042MG/INH
	                   N018153 001
	
    VANCERIL
	
         SCHERING
	               0.042MG/INH
	                   N017573 001
	
    VANCERIL DOUBLE STRENGTH
	
         SCHERING
	               0.084MG/INH
	                   N020486 001 Dec 24, 1996
	
  AEROSOL, METERED;NASAL
	
    BECONASE
	
         GLAXOSMITHKLINE
	        0.042MG/INH
	                   N018584 001
	
    VANCENASE
	
         SCHERING
	               0.042MG/INH
	                   N018521 001
	
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
	
  SPRAY, METERED;NASAL
	
    VANCENASE AQ
	
         SCHERING               EQ 0.042MG DIPROP/SPRAY
          N019589 001 Dec 23, 1987
	
                                EQ 0.084MG DIPROP/SPRAY
	         N020469 001 Jun 26, 1996
	
BENAZEPRIL HYDROCHLORIDE
	
  TABLET;ORAL
	
    BENAZEPRIL HYDROCHLORIDE
	
         GENPHARM		               5MG
	                           A076476   001   Feb   11,   2004
	
                                  10MG
	                          A076476   002   Feb   11,   2004
	
                                  20MG
	                          A076476   003   Feb   11,   2004
	
                                  40MG
	                          A076476   004   Feb   11,   2004
	
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
         MYLAN PHARMS INC
	     5MG;6.25MG
	                      A076612   001   Feb   11,   2004
	
                                10MG;12.5MG
	                     A076612   002   Feb   11,   2004
	
                                20MG;12.5MG
	                     A076612   003   Feb   11,   2004
	
                                20MG;25MG
	                       A076612   004   Feb   11,   2004
	
BENDROFLUMETHIAZIDE
	
  TABLET;ORAL
	
    NATURETIN-10
	
         APOTHECON
	              10MG
	                          N012164 003
	
    NATURETIN-2.5
	
         APOTHECON
	              2.5MG
	                         N012164 001
	
    NATURETIN-5
	
         APOTHECON
	              5MG
	                           N012164 002
	
BENOXINATE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    BENOXINATE HYDROCHLORIDE
	
         SOLA BARNES HIND
	       0.4%
	                          A084149 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                   6-42(of 337)


BENTIROMIDE
	
  SOLUTION;ORAL
	
    CHYMEX
	
         SAVAGE LABS
	            500MG/7.5ML
	                  N018366 001 Dec 29, 1983
	
BENZONATATE
	
  CAPSULE;ORAL
	
    BENZONATATE
	
         NESHER PHARMS
	          100MG
	                        A040795 001 Oct 31, 2007
	
                                  200MG
	                        A040795 002 Oct 31, 2007
	
    TESSALON
	
         PFIZER
	                 200MG
	                        N011210 003 Jun 25, 1999
	
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
	
  GEL;TOPICAL
	
    BENZACLIN
	
         VALEANT BERMUDA
	      5%;EQ 1% BASE
	                  N050756 002 Apr 20, 2007
	
BENZPHETAMINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    BENZPHETAMINE HYDROCHLORIDE
	
         COREPHARMA
	             50MG
	                         A040714 001 Oct 29, 2007
	
    DIDREX
	
         PHARMACIA AND UPJOHN
	 25MG
	                           N012427 003
	
BENZQUINAMIDE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    EMETE-CON
	
         PFIZER
	                 EQ 50MG BASE/VIAL
	            N016820 001
	
  SUPPOSITORY;RECTAL
	
    EMETE-CON
	
         ROERIG
	                 EQ 100MG BASE
	                N016818 006
	
BENZTHIAZIDE
	
  TABLET;ORAL
	
    AQUATAG
	
         SOLVAY
	                 25MG
	                         N016001 001
	
                                  50MG
	                         N016001 002
	
    BENZTHIAZIDE
	
           PVT FORM
	             50MG
	                         A083206 001
	
    EXNA
	
           AH ROBINS INC
	        50MG
	                         N012489 001
	
    FOVANE
	
           PFIZER
	               50MG
	                         N012128 002
	
    URESE
	
           PFIZER
	               25MG
	                         N012128 003
	
BENZTROPINE MESYLATE
	
  TABLET;ORAL
	
    BENZTROPINE MESYLATE
	
         LANNETT HOLDINGS INC
	   0.5MG
	                        A088877   001   Apr   11,   1985

                                  1MG
	                          A088894   001   Apr   11,   1985

                                  2MG
	                          A088895   001   Apr   11,   1985

         MUTUAL PHARM
	           1MG
	                          A081264   001   Jan   23,   1992
	
                                  2MG
	                          A081265   001   Jan   23,   1992
	
         PROSAM LABS
	            0.5MG
	                        A040699   001   Feb   14,   2008
	
                                  1MG
	                          A040705   001   Feb   14,   2008
	
                                  2MG
	                          A040706   001   Feb   14,   2008
	
         QUANTUM PHARMICS
	       0.5MG
	                        A088514   001   Jan   31,   1984
	
                                  1MG
	                          A088510   001   Jan   31,   1984
	
                                  2MG
	                          A088511   001   Jan   31,   1984
	
         USL PHARMA
	             0.5MG
	                        A089211   001   Jun   14,   1988
	
                                  1MG
	                          A089212   001   Jun   14,   1988
	
                                  2MG
	                          A089213   001   Jun   14,   1988
	
    COGENTIN
	
         MERCK
	                  0.5MG
	                        N009193 004
	
                                  1MG
	                          N009193 003
	
                                  2MG
	                          N009193 002
	
BENZYL BENZOATE
	
  EMULSION;TOPICAL
	
    BENZYL BENZOATE
	
         LANNETT
	                50%
	                          A084535 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-43(of 337)


BEPRIDIL HYDROCHLORIDE
	
  TABLET;ORAL
	
    BEPADIN
	
         MEDPOINTE PHARM HLC
	   200MG
	                        N019001 001 Dec 28, 1990
	
                                 300MG
	                        N019001 002 Dec 28, 1990
	
                                 400MG
	                        N019001 003 Dec 28, 1990
	
    VASCOR
	
         JOHNSON AND JOHNSON
	   200MG
	                        N019002 001 Dec 28, 1990
	
                                 300MG
	                        N019002 002 Dec 28, 1990
	
                                 400MG
	                        N019002 003 Dec 28, 1990
	
BETA CAROTENE
	
  CAPSULE;ORAL
	
    SOLATENE
	
         ROCHE
	                 30MG
	                         N017589 001
	
BETAMETHASONE
	
  CREAM;TOPICAL
	
    CELESTONE
	
         SCHERING
	              0.2%
	                         N014762 001
	
  SYRUP;ORAL
	
    CELESTONE
	
         MERCK SHARP DOHME
	     0.6MG/5ML
	                    N014215 002
	
  TABLET;ORAL
	
    CELESTONE
	
         SCHERING
	              0.6MG
	                        N012657 003
	
BETAMETHASONE BENZOATE
	
  CREAM;TOPICAL
	
    UTICORT
	
         PARKE DAVIS
	           0.025%
	                       N016998 002
	
  GEL;TOPICAL
	
    UTICORT
	
         PARKE DAVIS
	           0.025%
	                       N017244 001
	
  LOTION;TOPICAL
	
    UTICORT
	
         PARKE DAVIS
	           0.025%
	                       N017528 001
	
  OINTMENT;TOPICAL
	
    UTICORT
	
         PARKE DAVIS
	           0.025%
	                       N018089 001
	
BETAMETHASONE DIPROPIONATE
	
  CREAM;TOPICAL
	
    ALPHATREX
	
         SAVAGE LABS
	           EQ 0.05% BASE
	                N019138 001 Jun 26, 1984
	
    BETAMETHASONE DIPROPIONATE
	
         PERRIGO NEW YORK
	      EQ 0.05% BASE
	                A072536   001   Jan   31,   1990
	
                                 EQ 0.05% BASE
	                A074579   001   Nov   26,   1997
	
         PHARMADERM
	            EQ 0.05% BASE
	                N019136   001   Jun   26,   1984
	
         TARO
	                  EQ 0.05% BASE
	                A071143   001   Jun   17,   1987
	
         TEVA
	                  EQ 0.05% BASE
	                A071476   001   Aug   10,   1987
	
    DIPROSONE
	
         SCHERING
	              EQ 0.05% BASE
	                N017536 001
	
  CREAM, AUGMENTED;TOPICAL
	
    DIPROLENE
	
         SCHERING
	              EQ 0.05% BASE
	                N019408 001 Jan 31, 1986
	
  DISC;TOPICAL
	
    DIPROSONE
	
         SCHERING
	              EQ 0.1% BASE
	                 N017829 001
	
  GEL, AUGMENTED;TOPICAL
	
    DIPROLENE
	
         SCHERING
	              EQ 0.05% BASE
	                N019408 002 Nov 22, 1991
	
  LOTION;TOPICAL
	
    ALPHATREX
	
         SAVAGE LABS
	           EQ 0.05% BASE
	                A070273 001 Aug 12, 1985
	
    BETAMETHASONE DIPROPIONATE
	
         ALPHARMA US PHARMS
	    EQ 0.05% BASE
	                A071085   001   Feb   03,   1987
	
         PHARMADERM
	            EQ 0.05% BASE
	                A070274   001   Aug   12,   1985

         TARO
	                  EQ 0.05% BASE
	                A072276   001   Aug   24,   1988

                                 EQ 0.05% BASE
	                A074272   001   Sep   30,   1994

         TEVA PHARMS
	           EQ 0.05% BASE
	                A071882   001   Jun   06,   1988
	
    DIPROSONE
	
         SCHERING
	              EQ 0.05% BASE
	                N017781 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-44(of 337)

BETAMETHASONE DIPROPIONATE
  OINTMENT;TOPICAL
    ALPHATREX
         SAVAGE LABS             EQ 0.05% BASE                            N019143 001 Sep 04, 1984
    BETAMETHASONE DIPROPIONATE
         PERRIGO NEW YORK        EQ 0.05% BASE                            A072526 001 Jan 31, 1990
         PHARMADERM              EQ 0.05% BASE                            N019140 001 Sep 04, 1984
         TEVA                    EQ 0.05% BASE                            A071477 001 Aug 10, 1987
    DIPROSONE
         SCHERING                EQ 0.05% BASE                            N017691 001
BETAMETHASONE SODIUM PHOSPHATE
  INJECTABLE;INJECTION
    BETAMETHASONE SODIUM PHOSPHATE
         WATSON LABS            EQ 3MG BASE/ML                            A085738 001
    CELESTONE
         SCHERING               EQ 3MG BASE/ML **Federal Register         N017561 001
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
BETAMETHASONE VALERATE
  CREAM;TOPICAL
    BETADERM
         ROACO                   EQ 0.1% BASE                             N018839 001 Jun 30, 1983
    BETAMETHASONE VALERATE
         PERRIGO NEW YORK        EQ   0.1%   BASE                         A070053   001   Jun   10,   1986
         PHARMADERM              EQ   0.1%   BASE                         N018860   002   Aug   31,   1983
         PHARMAFAIR              EQ   0.1%   BASE                         A070485   001   May   29,   1987
         TARO                    EQ   0.1%   BASE                         A070062   001   May   14,   1985
    BETATREX
         SAVAGE LABS             EQ 0.1% BASE                             N018862 001 Aug 31, 1983
    VALISONE
         SCHERING                EQ 0.01% BASE                            N016322 002
                                 EQ 0.1% BASE                             N016322 001
 LOTION;TOPICAL
   BETAMETHASONE VALERATE
        PHARMADERM               EQ 0.1% BASE                             N018870 001 Aug 31, 1983
        PHARMAFAIR               EQ 0.1% BASE                             A070484 001 May 29, 1987
        TEVA PHARMS              EQ 0.1% BASE                             A071883 001 Apr 22, 1988
   BETATREX
        SAVAGE LABS              EQ 0.1% BASE                             N018867 001 Aug 31, 1983
   VALISONE
        SCHERING                 EQ 0.1% BASE                             N016932 001
 OINTMENT;TOPICAL
   BETA-VAL
        TEVA                     EQ 0.1% BASE                             A070069 001 Dec 19, 1985
   BETAMETHASONE VALERATE
        PERRIGO NEW YORK         EQ 0.1% BASE                             A071478 001 Dec 23, 1987
        PHARMADERM               EQ 0.1% BASE                             N018864 001 Aug 31, 1983
        PHARMAFAIR               EQ 0.1% BASE                             A070486 001 May 29, 1987
   BETATREX
        SAVAGE LABS              EQ 0.1% BASE                             N018863 001 Aug 31, 1983
   VALISONE
        SCHERING                 EQ 0.1% BASE                             N016740 001
BETAXOLOL HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    BETAXOLOL HYDROCHLORIDE
         APOTEX INC              EQ 0.5% BASE                             A075446 001 Sep 28, 2000
  TABLET;ORAL
    KERLONE
         SANOFI AVENTIS US       10MG                                     N019507 001 Oct 27, 1989
                                 20MG                                     N019507 002 Oct 27, 1989
BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
  TABLET;ORAL
    KERLEDEX
         SANOFI AVENTIS US      5MG;12.5MG                                N019807 001 Oct 30, 1992
                                10MG;12.5MG                               N019807 002 Oct 30, 1992
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                6-45(of 337)

BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE
  SUSPENSION/DROPS;OPHTHALMIC
    BETOPTIC PILO
         ALCON                  EQ 0.25% BASE;1.75%                       N020619 001 Apr 17, 1997
BETAZOLE HYDROCHLORIDE
  INJECTABLE;INJECTION
    HISTALOG
         LILLY                  50MG/ML                                   N009344 001
BETHANECHOL CHLORIDE
  INJECTABLE;INJECTION
    URECHOLINE
         ODYSSEY PHARMS         5MG/ML **Federal Register determination   N006536 001
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
 TABLET;ORAL
   BETHANECHOL CHLORIDE
        ABLE                    5MG                                       A040492   001   Jul   27,   2004
                                10MG                                      A040483   001   Jul   27,   2004
                                25MG                                      A040485   001   Jul   27,   2004
                                50MG                                      A040509   001   Jul   27,   2004
        ACTAVIS ELIZABETH       5MG                                       A040552   001   Oct   28,   2004
                                10MG                                      A040553   001   Oct   28,   2004
                                25MG                                      A040554   001   Oct   28,   2004
                                50MG                                      A040551   001   Oct   28,   2004
        ASCOT                   10MG                                      A088288   001   Jun   08,   1983
                                25MG                                      A088289   001   Jun   08,   1983
        IVAX SUB TEVA PHARMS    25MG                                      A084689   001
        LANNETT                 5MG                                       A084702   001
                                10MG                                      A084712   001
                                25MG                                      A084074   001
        LANNETT HOLDINGS INC    5MG                                       A040703   001   Mar 27, 2008
                                50MG                                      A040677   001   Mar 27, 2008
        SANDOZ                  5MG                                       A084353   001
                                10MG                                      A084378   001
                                10MG                                      A084379   001
                                25MG                                      A084383   001
                                25MG                                      A084384   001
        WATSON LABS             5MG                                       A084402   001
                                5MG                                       A085230   002
                                5MG                                       A085841   001
                                10MG                                      A084408   001
                                10MG                                      A085228   001
                                10MG                                      A085842   001
                                25MG                                      A084441   001
                                25MG                                      A085229   001
                                25MG                                      A085839   001
                                50MG                                      A087397   001
                                50MG                                      A087444   001
   DUVOID
        WELLSPRING PHARM        10MG                                      A086262 001
                                25MG                                      A086263 001
                                50MG                                      A085882 003
   MYOTONACHOL
        GLENWOOD                5MG                                       A084188 001
                                10MG                                      A084188 003
                                25MG                                      A084188 004
   URECHOLINE
        ODYSSEY PHARMS          5MG                                       N006536   003
                                10MG                                      N006536   002
                                25MG                                      N006536   004
                                50MG                                      N006536   005
BETHANIDINE SULFATE
  TABLET;ORAL
    TENATHAN
         ROBINS AH              10MG                                      N017675 001
                                25MG                                      N017675 002
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                6-46(of 337)


BEXAROTENE
	
  CAPSULE;ORAL
	
    BEXAROTENE
	
         BANNER PHARMACAPS        75MG                                     A203174 001 Aug 12, 2014
	
BICALUTAMIDE
	
  TABLET;ORAL
	
    BICALUTAMIDE
	
         KUDCO IRELAND            50MG                                     A077995 001 Jul 06, 2009
	
         ROXANE                   50MG                                     A078285 001 Mar 24, 2011
	
         SYNTHON PHARMS           50MG                                     A077973 001 Jul 06, 2009
	
BIMATOPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    LUMIGAN
	
         ALLERGAN                 0.03% **Federal Register determination   N021275 001 Mar 16, 2001

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
BIPERIDEN LACTATE
	
  INJECTABLE;INJECTION
	
    AKINETON
	
         ABBVIE                   5MG/ML                                   N012418 002
	
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
	
  FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL
	
    HALFLYTELY
	
         BRAINTREE              5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM   N021551 003 Jul 16, 2010

                                ;N/A,5.6GM
	
BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
	
  TABLET, CHEWABLE, TABLET, CAPSULE;ORAL
	
    HELIDAC
	
         PROMETHEUS LABS        262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,5    N050719 001 Aug 15, 1996

                                00MG
	
BISOPROLOL FUMARATE
	
  TABLET;ORAL
	
    BISOPROLOL FUMARATE
	
         MUTUAL PHARM             5MG                                      A075474 001 Oct 25, 2002
	
                                  10MG                                     A075474 002 Oct 25, 2002
	
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
	
         ACTAVIS ELIZABETH		    2.5MG;6.25MG                               A075672   001   Sep   25,   2000

                                5MG;6.25MG                                 A075672   002   Sep   25,   2000

                                10MG;6.25MG                                A075672   003   Sep   25,   2000

         APOTHECON		            2.5MG;6.25MG                               A075642   002   Dec   27,   2000
	
                                5MG;6.25MG                                 A075642   001   Dec   27,   2000
	
                                10MG;6.25MG                                A075642   003   Dec   27,   2000
	
         IVAX SUB TEVA PHARMS		 2.5MG;6.25MG                               A075632   001   Sep   27,   2000

                                5MG;6.25MG                                 A075632   002   Sep   27,   2000

                                10MG;6.25MG                                A075632   003   Sep   27,   2000

         SANDOZ		               2.5MG;6.25MG                               A075527   001   Sep   25,   2000

                                5MG;6.25MG                                 A075527   003   Sep   25,   2000

                                10MG;6.25MG                                A075527   002   Sep   25,   2000

         TEVA		                 2.5MG;6.25MG                               A075686   001   Jan   19,   2001
	
                                5MG;6.25MG                                 A075686   002   Jan   19,   2001
	
                                10MG;6.25MG                                A075686   003   Jan   19,   2001
	
         WATSON LABS		          2.5MG;6.25MG                               A075469   001   Sep   25,   2000

                                5MG;6.25MG                                 A075469   002   Sep   25,   2000

                                10MG;6.25MG                                A075469   003   Sep   25,   2000
	
BITOLTEROL MESYLATE
	
  AEROSOL, METERED;INHALATION
	
    TORNALATE
	
         SANOFI AVENTIS US        0.37MG/INH                               N018770 001 Dec 28, 1984
	
  SOLUTION;INHALATION
	
    TORNALATE
	
         SANOFI AVENTIS US        0.2%                                     N019548 001 Feb 19, 1992
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                    6-47(of 337)

BLEOMYCIN SULFATE
  INJECTABLE;INJECTION
    BLENOXANE
         BRISTOL MYERS SQUIBB   EQ 15 UNITS BASE/VIAL          N050443 001
                                EQ 30 UNITS BASE/VIAL          N050443 002 Sep 07, 1995
   BLEOMYCIN SULFATE
        PHARMACHEMIE BV         EQ 15 UNITS BASE/VIAL          A065201 001 Dec 13, 2007
        TEVA PARENTERAL         EQ 15 UNITS BASE/VIAL          A064084 001 Jun 01, 1996
                                EQ 30 UNITS BASE/VIAL          A064084 002 Jun 01, 1996
BRETYLIUM TOSYLATE
  INJECTABLE;INJECTION
    BRETYLIUM TOSYLATE
         ABRAXIS PHARM         50MG/ML                         A070134   001   Apr   29,   1986
                               100MG/ML                        A071298   001   Feb   13,   1987
        ASTRAZENECA            50MG/ML                         A071151   001   Aug   10,   1987
                               50MG/ML                         A071152   001   Aug   10,   1987
                               50MG/ML                         A071153   001   Aug   10,   1987
        HIKMA MAPLE            50MG/ML                         A070545   001   May   14,   1986
                               50MG/ML                         A070546   001   May   14,   1986
        HOSPIRA                50MG/ML                         N019030   001   Apr   29,   1986
                               50MG/ML                         N019033   001   Apr   29,   1986
        INTL MEDICATION        50MG/ML                         A070119   001   Apr   29,   1986
        LUITPOLD               50MG/ML                         A070891   001   Jul   26,   1988
   BRETYLIUM TOSYLATE IN DEXTROSE 5%
        ABBOTT                 200MG/100ML                     N019005 002 Apr 29, 1986
                               400MG/100ML                     N019005 003 Apr 29, 1986
                               800MG/100ML                     N019005 001 Apr 29, 1986
   BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
        BAXTER HLTHCARE        200MG/100ML                     N019837   002   Apr   12,   1989
                               400MG/100ML                     N019837   001   Apr   12,   1989
        HOSPIRA INC            200MG/100ML                     N019008   002   Apr   29,   1986
                               400MG/100ML                     N019008   003   Apr   29,   1986
                               800MG/100ML                     N019008   001   Apr   29,   1986
   BRETYLOL
        HOSPIRA                50MG/ML                         N017954 001
BRIMONIDINE TARTRATE
  SOLUTION/DROPS;OPHTHALMIC
    ALPHAGAN
         ALLERGAN               0.2%                           N020613 001 Sep 06, 1996
                                0.5%                           N020490 001 Mar 13, 1997
   BRIMONIDINE TARTRATE
        TEVA PARENTERAL         0.2%                           A076372 001 Sep 10, 2004
BROMFENAC SODIUM
  SOLUTION/DROPS;OPHTHALMIC
    XIBROM
         BAUSCH AND LOMB INC    EQ 0.09% ACID                  N021664 001 Mar 24, 2005
BROMOCRIPTINE MESYLATE
  CAPSULE;ORAL
    BROMOCRIPTINE MESYLATE
         LEK PHARM              EQ 5MG BASE                    A075100 001 Dec 10, 1998
BROMODIPHENHYDRAMINE HYDROCHLORIDE
  CAPSULE;ORAL
    AMBODRYL
         PARKE DAVIS            25MG                           N007984 001
BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE
  SYRUP;ORAL
    AMBENYL
         FOREST LABS            12.5MG/5ML;10MG/5ML            N009319 006 Jan 10, 1984
    BROMANYL
         ALPHARMA US PHARMS     12.5MG/5ML;10MG/5ML            A088343 001 Aug 15, 1984
    BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE
         WOCKHARDT              12.5MG/5ML;10MG/5ML            A088626 001 Oct 12, 1984
BROMPHENIRAMINE MALEATE
  ELIXIR;ORAL
    BROMPHENIRAMINE MALEATE
         ALPHARMA US PHARMS     2MG/5ML                        A086936   001
         KV PHARM               2MG/5ML                        A085466   001
         PHARM ASSOC            2MG/5ML                        A087517   001
         USL PHARMA             2MG/5ML                        A087964   001 Jan 25, 1983
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                6-48(of 337)


BROMPHENIRAMINE MALEATE
	
  INJECTABLE;INJECTION
	
    BROMPHENIRAMINE MALEATE
	
         WATSON LABS             10MG/ML                                  A083821 001
	
                                 100MG/ML                                 A083820 001
	
   DIMETANE-TEN
	
        WYETH AYERST             10MG/ML                                  N011418 002
	
 TABLET;ORAL
	
   BROMPHENIRAMINE MALEATE
	
        BARR                     4MG                                      A084468   001
	
        IVAX SUB TEVA PHARMS     4MG                                      A084351   001
	
        NEWTRON PHARMS           4MG                                      A086987   001
	
        NEXGEN PHARMA INC        4MG                                      A086187   001
	
        PAR PHARM                4MG                                      A087009   001
	
        PIONEER PHARMS           4MG                                      A088604   001 Jul 13, 1984
	
        SANDOZ                   4MG                                      A083215   001
	
        VITARINE                 4MG                                      A085850   001
	
        WATSON LABS              4MG                                      A083123   001
	
                                 4MG                                      A085769   001
	
   DIMETANE
	
        WYETH CONS              4MG                                       N010799 003
	
 TABLET, EXTENDED RELEASE;ORAL
	
   DIMETANE
	
        WYETH CONS              8MG                                       N010799 010 Jun 10, 1983
	
                                12MG                                      N010799 011 Jun 10, 1983
	
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    BROMANATE DM
	
         ALPHARMA US PHARMS     2MG/5ML;10MG/5ML;30MG/5ML                 A088722 001 Mar 07, 1985
	
    BROMFED-DM
	
         WOCKHARDT              2MG/5ML;10MG/5ML;30MG/5ML                 A089681 001 Dec 22, 1988
	
    DIMETANE-DX
	
         ROBINS AH              2MG/5ML;10MG/5ML;30MG/5ML                 N019279 001 Aug 24, 1984
	
BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE

         ALZA                    16MG;240MG                               N019672 001 Mar 29, 1996
	
BUCLIZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    BUCLADIN-S
	
         STUART PHARMS           50MG                                     N010911 006
	
BUDESONIDE
	
  AEROSOL, METERED;NASAL
	
    RHINOCORT
	
         ASTRAZENECA             0.032MG/INH                              N020233 001 Feb 14, 1994
	
  POWDER, METERED;INHALATION
	
    PULMICORT
	
         ASTRAZENECA             0.16MG/INH                               N020441 002 Jun 24, 1997
	
                                 0.32MG/INH                               N020441 003 Jun 24, 1997
	
 SPRAY, METERED;NASAL
	
   RHINOCORT
	
        ASTRAZENECA PHARMS       0.064MG/INH                              N020746 002 Oct 01, 1999
	
 SUSPENSION;INHALATION
	
   BUDESONIDE
	
        APOTEX INC               0.25MG/2ML                               A078202 001 Mar 30, 2009
	
                                 0.5MG/2ML                                A078202 002 Mar 30, 2009
	
BUMETANIDE
	
  INJECTABLE;INJECTION
	
    BUMETANIDE
	
         HOSPIRA                 0.25MG/ML                                A074160 001 Oct 30, 1997
	
         TEVA PARENTERAL         0.25MG/ML                                A074613 001 Nov 18, 1997
	
    BUMEX
	
         VALIDUS PHARMS INC      0.25MG/ML                                N018226 001 Feb 28, 1983
	
  TABLET;ORAL
	
    BUMEX
	
         VALIDUS PHARMS INC      0.5MG                                    N018225 002 Feb 28, 1983
	
                                 1MG                                      N018225 001 Feb 28, 1983
	
                                 2MG                                      N018225 003 Jun 14, 1985
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-49(of 337)

BUPIVACAINE
  INJECTABLE, LIPOSOMAL;INJECTION
    EXPAREL
         PACIRA PHARMS INC      133MG/10ML (13.3MG/ML)          N022496 001 Oct 28, 2011
BUPIVACAINE HYDROCHLORIDE
  INJECTABLE;INJECTION
    BUPIVACAINE HYDROCHLORIDE
         HOSPIRA                0.75%                           A070587 001 Mar 03, 1987
    BUPIVACAINE HYDROCHLORIDE KIT
         HOSPIRA                0.075%                          N019978 001 Sep 03, 1992
                                0.114%                          N019978 002 Sep 03, 1992
                                0.23%                           N019978 003 Sep 03, 1992
    BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE
         INTL MEDICATED         0.25%                           A076012 001 Jan 09, 2002
                                0.5%                            A076012 002 Jan 09, 2002
                                0.75%                           A076012 003 Jan 09, 2002
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
  INJECTABLE;INJECTION
    BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
         HOSPIRA                0.25%;0.005MG/ML                A071166 001 Jun 16, 1988
                                0.5%;0.005MG/ML                 A071169 001 Jun 16, 1988
                                0.75%;0.005MG/ML                A071171 001 Jun 16, 1988
BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE
  INJECTABLE;INJECTION
    DUOCAINE
         AMPHASTAR PHARMS INC   EQ 0.375% (37.5MG/10ML);EQ 1%   N021496 001 May 23, 2003
                                (100MG/10ML)
BUPRENORPHINE HYDROCHLORIDE
  TABLET;SUBLINGUAL
    SUBUTEX
         RECKITT BENCKISER       EQ 2MG BASE                    N020732 002 Oct 08, 2002
                                 EQ 8MG BASE                    N020732 003 Oct 08, 2002
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
  TABLET;SUBLINGUAL
    SUBOXONE
         RECKITT BENCKISER      EQ 2MG BASE;EQ 0.5MG BASE       N020733 001 Oct 08, 2002
                                EQ 8MG BASE;EQ 2MG BASE         N020733 002 Oct 08, 2002
BUPROPION HYDROCHLORIDE
  TABLET;ORAL
    BUPROPION HYDROCHLORIDE
         SANDOZ                  75MG                           A075613   002   Oct   10,   2000
                                 100MG                          A075613   001   Oct   10,   2000
        TEVA                     75MG                           A075310   001   Nov   29,   1999
                                 100MG                          A075310   002   Nov   29,   1999
   WELLBUTRIN
        GLAXOSMITHKLINE          50MG                           N018644 001 Dec 30, 1985
 TABLET, EXTENDED RELEASE;ORAL
   BUPROPION HYDROCHLORIDE
        ACTAVIS LABS FL INC      300MG                          A077715   002   Jun   13,   2007
        IMPAX LABS               300MG                          A077415   002   Dec   15,   2006
        SANDOZ                   100MG                          A076845   001   Jul   14,   2005
                                 150MG                          A076834   001   Jul   14,   2005
                                 150MG                          A076845   002   Jul   14,   2005
   WELLBUTRIN SR
         GLAXOSMITHKLINE         50MG                           N020358 001 Oct 04, 1996
   ZYBAN
        GLAXOSMITHKLINE          100MG                          N020711 002 May 14, 1997
BUSPIRONE HYDROCHLORIDE
  CAPSULE;ORAL
    BUSPAR
         BRISTOL MYERS SQUIBB    5MG                            N021190   001   Dec   20,   2000
                                 7.5MG                          N021190   002   Dec   20,   2000
                                 10MG                           N021190   003   Dec   20,   2000
                                 15MG                           N021190   004   Dec   20,   2000
 TABLET;ORAL
   BUSPAR
        BRISTOL MYERS SQUIBB     5MG                            N018731 001 Sep 29, 1986
                                 10MG                           N018731 002 Sep 29, 1986
                                 15MG                           N018731 003 Apr 22, 1996
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                        6-50(of 337)


BUSPIRONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    BUSPAR
	
                                  30MG
	                         N018731 004 Apr 22, 1996
	
   BUSPIRONE HYDROCHLORIDE
	
        APOTEX
	                  5MG
	                          A075521   001     Apr   05,   2002

                                  10MG
	                         A075521   002     Apr   05,   2002

                                  15MG
	                         A075521   003     Apr   05,   2002

         EGIS
	                   5MG
	                          A075119   001     Mar   14,   2002
	
                                  10MG
	                         A075119   002     Mar   14,   2002
	
                                  15MG
	                         A075119   003     Jan   23,   2003
	
         IVAX SUB TEVA PHARMS
	   5MG
	                          A075385   001     Mar   01,   2002
	
                                  10MG
	                         A075385   002     Mar   01,   2002
	
                                  15MG
	                         A075385   003     Mar   01,   2002
	
         NESHER PHARMS
	          5MG
	                          A075572   001     Feb   27,   2002
	
                                  10MG
	                         A075572   002     Feb   27,   2002
	
                                  15MG
	                         A075572   003     Feb   27,   2002
	
         PROSAM LABS
	            5MG
	                          A075388   001     May   09,   2002

                                  10MG
	                         A075388   002     May   09,   2002

                                  15MG
	                         A075388   003     May   09,   2002

         SANDOZ
	                 5MG
	                          A075413   001     Mar   19,   2002
	
                                  10MG
	                         A075413   002     Mar   19,   2002
	
                                  15MG
	                         A075413   003     Mar   19,   2002
	
BUTABARBITAL SODIUM
	
  CAPSULE;ORAL
	
    BUTICAPS
	
         MEDPOINTE PHARM HLC
	    15MG
	                         A085381   001
	
                                  30MG
	                         A085381   002
	
                                  50MG
	                         A085381   003
	
                                  100MG
	                        A085381   004
	
 ELIXIR;ORAL
	
   BUTABARB
	
        ALPHARMA US PHARMS
	      30MG/5ML
	                     A085873 001
	
   BUTABARBITAL SODIUM
	
        WOCKHARDT
	               30MG/5ML
	                     A085383 001
	
   BUTALAN
	
        LANNETT
	                 33.3MG/5ML
	                   A085880 001
	
   SARISOL
	
        HALSEY
	                  30MG/5ML
	                     A084723 001
	
 TABLET;ORAL
	
   BUTABARBITAL
	
        BUNDY
	                   30MG
	                         A085550 001
	
   BUTABARBITAL SODIUM
	
        SANDOZ
	                  15MG
	                         A084292   003 Feb 09, 1982
	
                                  15MG
	                         A085938   001
	
                                  30MG
	                         A084272   002
	
                                  30MG
	                         A085934   001
	
         SOLVAY
	                 16.2MG
	                       A083606   001
	
                                  32.4MG
	                       A083898   001
	
                                  48.6MG
	                       A083897   001
	
                                  97.2MG
	                       A083896   001
	
         TEVA
	                   15MG
	                         A088632   001 May 18, 1985

                                  30MG
	                         A088631   001 May 01, 1985

         WATSON LABS
	            15MG
	                         A085764   001
	
                                  30MG
	                         A085772   001
	
         WHITEWORTH TOWN PLSN
	   15MG
	                         A083325   002
	
                                  30MG
	                         A083337   001
	
   BUTISOL SODIUM
	
        MEDA PHARMS
	             15MG
	                         N000793 002
	
                                  100MG
	                        N000793 005
	
   SARISOL NO. 1
	
        HALSEY
	                  15MG
	                         A084719 001
	
   SARISOL NO. 2
	
        HALSEY
	                  30MG
	                         A084719 002
	
   SODIUM BUTABARBITAL
	
        HIKMA PHARMS LLC
	        15MG
	                         A085418   001
	
                                  30MG
	                         A085432   001
	
         IVAX SUB TEVA PHARMS
	   15MG
	                         A083484   001
	
                                  30MG
	                         A084040   001
	
         LANNETT
	                15MG
	                         A085849   001
	
                                  30MG
	                         A085866   001
	
                                  100MG
	                        A085881   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                                  6-51(of 337)


BUTABARBITAL SODIUM
	
  TABLET;ORAL
	
    SODIUM BUTABARBITAL
	
         MARSHALL PHARMA
	        16.2MG
	                                   A083524 001
	
                                  32.4MG
	                                   A083858 001
	
BUTENAFINE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    MENTAX-TC
	
         MYLAN
	                  1%
	                                       N021408 001
	 Oct 17, 2002
	
BUTOCONAZOLE NITRATE
	
  CREAM;VAGINAL
	
    FEMSTAT
	
         ROCHE PALO
	             2%
	                                       N019215 001
	 Nov 25, 1985
	
    GYNAZOLE-1
	
         ELAN PHARMA INTL LTD
	   2%
	                                       N019881 001
	 Feb 07, 1997
	
  SUPPOSITORY;VAGINAL
	
    FEMSTAT
	
         ROCHE PALO
	             100MG
	                                    N019359 001
	 Nov 25, 1985
	
BUTORPHANOL TARTRATE
	
  INJECTABLE;INJECTION
	
    BUTORPHANOL TARTRATE
	
         APOTEX INC
	          2MG/ML
                                       A075697   001
	   Oct   23,   2001
	
         HIKMA FARMACEUTICA
	  2MG/ML
                                       A078247   001
	   Apr   29,   2009

         HOSPIRA
	             1MG/ML
                                       A075342   001
	   Nov   04,   1999
	
                               1MG/ML
                                       A075559   001
	   Mar   20,   2000
	
                               2MG/ML
                                       A075342   002
	   Nov   04,   1999
	
                               2MG/ML
	                                      A075559   002
	   Mar   20,   2000
	
   BUTORPHANOL TARTRATE PRESERVATIVE FREE
	
        APOTEX INC
	           1MG/ML
                                       A075695   001
	   Oct   23,   2001
	
                               2MG/ML
                                       A075695   002
	   Oct   23,   2001
	
        HOSPIRA
	              1MG/ML
                                       A074620   001
	   Jan   22,   1997
	
                               1MG/ML
                                       A075170   001
	   Sep   28,   1998

                               2MG/ML
                                       A074620   002
	   Jan   22,   1997
	
                               2MG/ML
	                                      A075170   002
	   Sep   28,   1998
	
   STADOL
	
        APOTHECON
	            2MG/ML
	                                      N017857 004
	
   STADOL PRESERVATIVE FREE
	
        APOTHECON
	            1MG/ML
                                       N017857 001
	
                               2MG/ML
	                                      N017857 002
	
 SPRAY, METERED;NASAL
	
   STADOL
	
        BRISTOL MYERS SQUIBB
	 1MG/SPRAY
	                                   N019890 001
	 Dec 12, 1991
	
CABERGOLINE
	
  TABLET;ORAL
	
    DOSTINEX
	
         PHARMACIA AND UPJOHN
	   0.5MG
	                                    N020664 001
	 Dec 23, 1996
	
CAFFEINE; ERGOTAMINE TARTRATE
	
  SUPPOSITORY;RECTAL
	
    CAFERGOT
	
         NOVARTIS
	               100MG;2MG
	                                N009000 002
	
  TABLET;ORAL
	
    CAFERGOT
	
         NOVARTIS
	               100MG;1MG
	                                N006620 001
	
    WIGRAINE
	
         ORGANON USA INC
	        100MG;1MG
	                                A086562 001
	
CALCIFEDIOL
	
  CAPSULE;ORAL
	
    CALDEROL
	
         ORGANON USA INC
	        0.02MG
	                                   N018312 001
	
                                  0.05MG
	                                   N018312 002
	
CALCIPOTRIENE
	
  OINTMENT;TOPICAL
	
    DOVONEX
	
         LEO PHARMA AS
	          0.005%
	                                   N020273 001
	 Dec 29, 1993
	
  SOLUTION;TOPICAL
	
    DOVONEX
	
         LEO PHARM
	              0.005% **Federal Register determination
   N020611 001
	 Mar 03, 1997
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                                6-52(of 337)


CALCIPOTRIENE
	
  SOLUTION;TOPICAL
	
    DOVONEX
	
                                 reasons**
	
CALCITONIN HUMAN
	
  INJECTABLE;INJECTION
	
    CIBACALCIN
	
         NOVARTIS
	              0.5MG/VIAL
	                              N018470 001
	 Oct 31, 1986
	
CALCITONIN SALMON
	
  INJECTABLE;INJECTION
	
    CALCIMAR
	
         SANOFI AVENTIS US
	     200 IU/ML
                                N017769 001
	
                                 400 IU/VIAL
	                             N017497 001
	
    CALCITONIN-SALMON
	
         ASTRAZENECA
	           200 IU/ML
	                               A073690 001
	 Apr 14, 1995
	
    MIACALCIN
	
         SEBELA IRELAND LTD
	    100 IU/ML
	                               N017808 001
	 Jul 03, 1986
	
CALCITRIOL
	
  INJECTABLE;INJECTION
	
    CALCITRIOL
	
         HOSPIRA
	               0.001MG/ML
                               A075816   001
	   Jan   16,   2004
	
                                 0.002MG/ML
                               A075816   002
	   Jan   16,   2004
	
         TEVA PARENTERAL
	       0.001MG/ML
                               A075823   001
	   Mar   31,   2003
	
                                 0.002MG/ML
	                              A075823   002
	   Mar   31,   2003
	
CALCIUM ACETATE
	
  CAPSULE;ORAL
	
    PHOSLO
	
         FRESENIUS MEDCL
	       EQ 84.5MG CALCIUM
	                       N021160 001
	 Apr 02, 2001

                                 EQ 169MG CALCIUM
	                        N021160 002
	 Apr 02, 2001
	
  TABLET;ORAL
	
    CALCIUM ACETATE
	
         ROXANE
	                EQ 169MG CALCIUM
	                        A077693 001
	 Jan 30, 2008
	
    PHOSLO
	
         FRESENIUS MEDCL
	       EQ 169MG CALCIUM
	                        N019976 001
	 Dec 10, 1990
	
CALCIUM CARBONATE; RISEDRONATE SODIUM
	
  TABLET, TABLET;ORAL
	
    ACTONEL WITH CALCIUM (COPACKAGED)

         WARNER CHILCOTT        EQ 500MG BASE,N/A;N/A,35MG **Federal
      N021823 001
	 Aug 12, 2005
	
                                Register determination that product was

                                not discontinued or withdrawn for
	
                                safety or efficacy reasons**
	
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM

BICARBONATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER

         GAMBRO RENAL PRODS     3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;
  N021703 012 Oct          10, 2008
	
                                3.05GM/1000ML;0.157GM/1000ML;2.21GM/100

                                0ML;7.07GM/1000ML

    PRISMASOL BGK 4/0 IN PLASTIC CONTAINER

         GAMBRO RENAL PRODS     N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0
  N021703 005 Oct          25, 2006
	
                                5GM/1000ML;0.314GM/1000ML;3.09GM/1000ML

                                ;6.46GM/1000ML

    PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER

         GAMBRO RENAL PRODS     5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;
  N021703 008 Oct          25, 2006
	
                                2.03GM/1000ML;0.314GM/1000ML;3.09GM/100

                                0ML;6.46GM/1000ML

    PRISMASOL BK 0/0 IN PLASTIC CONTAINER

         GAMBRO RENAL PRODS     N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05
  N021703 007 Oct          25, 2006
	
                                GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46

                                GM/1000ML

    PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER

         GAMBRO RENAL PRODS     3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3
  N021703 009 Oct          25, 2006
	
                                .05GM/1000ML;0.314GM/1000ML;3.09GM/1000

                                ML;6.46GM/1000ML
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM

CHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER

          B BRAUN               37MG/100ML;5GM/100ML;31MG/100ML;120MG/1   N018271 001
	
                                00ML;330MG/100ML;88MG/100ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                   6-53(of 337)


CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM

CHLORIDE; SODIUM CITRATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                35MG/100ML;5GM/100ML;30MG/100ML;74MG/10   N019867 001
	 Dec 20, 1993
	
                                0ML;640MG/100ML;500MG/100ML;74MG/100ML
	

   ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER

        B BRAUN                35MG/100ML;5GM/100ML;30MG/100ML;74MG/10     N018269 002
	 Jan 17, 1983
	
                               0ML;640MG/100ML;500MG/100ML;74MG/100ML
	

CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  SOLUTION;INTRAPERITONEAL
	
    DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER

         B BRAUN                29MG/100ML;2.5GM/100ML;15MG/100ML;610MG
  N018460 006
	 Jan 29, 1986
	
                                /100ML;560MG/100ML

    DIALYTE W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

         B BRAUN                29MG/100ML;1.5GM/100ML;15MG/100ML;610MG
  N018460 001
	
                                /100ML;560MG/100ML

    DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

         B BRAUN                29MG/100ML;4.25GM/100ML;15MG/100ML;610M
  N018460 003
	
                                G/100ML;560MG/100ML
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  SOLUTION;INTRAPERITONEAL
	
    DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER

         B BRAUN                26MG/100ML;1.5GM/100ML;15MG/100ML;560MG
  N018460   002
	
                                /100ML;390MG/100ML

    DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER

         B BRAUN                26MG/100ML;5GM/100ML;5MG/100ML;530MG/10
  N018460   008
	 Jan 29, 1986
	
                                0ML;450MG/100ML

    DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER

         B BRAUN                26MG/100ML;4.25GM/100ML;15MG/100ML;560M
  N018460   004
	
                                G/100ML;390MG/100ML

    INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

         FRESENIUS              18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;5
  A020374   001
	 Jun 13, 1994
	
                                38MG/100ML;448MG/100ML

    INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

         FRESENIUS              18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;5
  A020374   002
	 Jun 13, 1994
	
                                38MG/100ML;448MG/100ML

    INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER

         FRESENIUS              18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;5
  A020374   003
	 Jun 13, 1994
	
                                38MG/100ML;448MG/100ML

    INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

         FRESENIUS              18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;
  A020374   004
	 Jun 13, 1994
	
                                538MG/100ML;448MG/100ML
	
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER
	
         B BRAUN                33MG/100ML;5GM/100ML;30MG/100ML;860MG/1
   N018256 001
	
                                00ML
	
         BAXTER HLTHCARE        33MG/100ML;5GM/100ML;30MG/100ML;860MG/1
   N016695 001
	
                                00ML
	
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
	
         B BRAUN		              4MG/100ML;4GM/100ML;6MG/100ML;120MG/100
  N019634 002
	 Feb    24, 1988
	
                                ML;62MG/100ML

    DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER
	
         B BRAUN		              20MG/100ML;5GM/100ML;30MG/100ML;600MG/1
  N017510 001
	
                                00ML;310MG/100ML

         MILES		                20MG/100ML;5GM/100ML;30MG/100ML;600MG/1
  N018499 001
	
                                00ML;310MG/100ML
	
    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
         HOSPIRA		              20MG/100ML;5GM/100ML;104MG/100ML;600MG/   N019685 005
	 Oct    17, 1988
	
                                100ML;310MG/100ML

                                20MG/100ML;5GM/100ML;179MG/100ML;600MG/   N019685 006
	 Oct    17, 1988
	
                                100ML;310MG/100ML

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
         HOSPIRA                20MG/100ML;5GM/100ML;254MG/100ML;600MG/   N019685 007
	 Oct    17, 1988
	
                                100ML;310MG/100ML

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
         HOSPIRA                20MG/100ML;5GM/100ML;254MG/100ML;600MG/   N019685 003
	 Oct    17, 1988
	
                                100ML;310MG/100ML
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                6-54(of 337)


CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
	
         HOSPIRA                20MG/100ML;5GM/100ML;104MG/100ML;600MG/   N019685 001 Oct 17, 1988

                                100ML;310MG/100ML
	
CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE
	
  SOLUTION;INTRAPERITONEAL
	
    INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

         FRESENIUS MEDCL        25.7MG/100ML;1.5GM/100ML;538MG/100ML;44    N019395 001 Mar 26, 1986

                                8MG/100ML

    INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

         FRESENIUS MEDCL        25.7MG/100ML;2.5GM/100ML;538MG/100ML;44    N019395 002 Mar 26, 1986

                                8MG/100ML

    INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER

         FRESENIUS MEDCL        25.7MG/100ML;4.25GM/100ML;538MG/100ML;4    N019395 003 Mar 26, 1986

                                48MG/100ML
	
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    TPN ELECTROLYTES IN PLASTIC CONTAINER
	
         ABBOTT                 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;   N019399 001 Jun 16, 1986

                                16.1MG/ML
	
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM

CITRATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE E IN PLASTIC CONTAINER
	
          B BRAUN               35MG/100ML;30MG/100ML;74MG/100ML;640MG/
  N018899 001 Oct 31, 1983
	
                                100ML;500MG/100ML;74MG/100ML
	
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ACETATED RINGER'S IN PLASTIC CONTAINER
	
         B BRAUN                20MG/100ML;30MG/100ML;380MG/100ML;600MG
   N018725 001 Nov 29, 1982
	
                                /100ML
	
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    RINGER'S IN PLASTIC CONTAINER
	
         B BRAUN                33MG/100ML;30MG/100ML;860MG/100ML
         N018721 001 Nov 09, 1982
	
  SOLUTION;IRRIGATION
	
    RINGER'S IN PLASTIC CONTAINER
	
         ABBOTT                 33MG/100ML;30MG/100ML;860MG/100ML
	        N018462 001
	
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    LACTATED RINGER'S IN PLASTIC CONTAINER
	
         ABBOTT
	               20MG/100ML;30MG/100ML;600MG/100ML;310MG
   N019485 001 Oct 24, 1985
	
                                /100ML

         B BRAUN
	              20MG/100ML;30MG/100ML;600MG/100ML;310MG
   N018023 001
	
                                /100ML

         MILES
	                20MG/100ML;30MG/100ML;600MG/100ML;310MG
   N018417 001
	
                                /100ML
	
CALCIUM GLUCEPTATE
	
  INJECTABLE;INJECTION
	
    CALCIUM GLUCEPTATE
	
         ABBOTT
	               EQ   90MG   CALCIUM/5ML
                   A080001   001
	
                                EQ   90MG   CALCIUM/5ML
                   A083159   001
	
         ABRAXIS PHARM
	        EQ   90MG   CALCIUM/5ML
                   A089373   001 Apr 30, 1987

         LILLY
	                EQ   90MG   CALCIUM/5ML
	                  N006470   001
	
CALCIUM METRIZOATE; MEGLUMINE METRIZOATE; METRIZOATE MAGNESIUM; METRIZOATE SODIUM
	
  INJECTABLE;INJECTION
	
    ISOPAQUE 440
	
         GE HEALTHCARE          0.78MG/ML;75.9MG/ML;0.15MG/ML;16.6MG/ML
	 N016847 001
	
CALCIUM; MEGLUMINE; METRIZOIC ACID
	
  INJECTABLE;INJECTION
	
    ISOPAQUE 280
	
         GE HEALTHCARE          0.35MG/ML;140.1MG/ML;461.8MG/ML
	          N017506 001
	
CANDICIDIN
	
  OINTMENT;VAGINAL
	
    VANOBID
	
         SANOFI AVENTIS US      0.6MG/GM
	                                 A061596 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                    6-55(of 337)


CANDICIDIN
	
  TABLET;VAGINAL
	
    VANOBID
	
         SANOFI AVENTIS US      3MG
	                            A061613 001
	
CAPTOPRIL
	
  TABLET;ORAL
	
    CAPOTEN
	
         PAR PHARM              37.5MG
	                         N018343 006 Sep 17, 1986

                                75MG
	                           N018343 007 Jun 13, 1995
	
                                150MG
	                          N018343 004 Jun 13, 1995
	
   CAPTOPRIL
	
        APOTHECON               12.5MG
	                         A074472   001   Mar   31,   1995
	
                                25MG
	                           A074472   002   Mar   31,   1995
	
                                50MG
	                           A074472   003   Mar   31,   1995
	
                                100MG
	                          A074472   004   Mar   31,   1995
	
        DAVA PHARMS INC         12.5MG
	                         A074423   001   Feb   13,   1996
	
                                25MG
	                           A074423   002   Feb   13,   1996
	
                                50MG
	                           A074423   003   Feb   13,   1996
	
                                100MG
	                          A074423   004   Feb   13,   1996
	
        EGIS PHARMS             12.5MG
	                         A074748   004   May   29,   1997

                                25MG
	                           A074748   002   May   29,   1997

                                50MG
	                           A074748   001   May   29,   1997

                                100MG
	                          A074748   003   May   29,   1997

        IVAX SUB TEVA PHARMS    12.5MG
	                         A074590   004   Aug   30,   1996

                                25MG
	                           A074590   002   Aug   30,   1996

                                50MG
	                           A074590   001   Aug   30,   1996

                                100MG
	                          A074590   003   Aug   30,   1996

        PAR PHARM               12.5MG
	                         A074493   001   Feb   13,   1996
	
                                25MG
	                           A074493   002   Feb   13,   1996
	
                                50MG
	                           A074493   003   Feb   13,   1996
	
                                100MG
	                          A074493   004   Feb   13,   1996
	
        PRINSTON INC            12.5MG
	                         A074477   001   Feb   13,   1996
	
                                25MG
	                           A074477   002   Feb   13,   1996
	
                                50MG
	                           A074477   003   Feb   13,   1996
	
                                100MG
	                          A074477   004   Feb   13,   1996
	
        PUREPAC PHARM           12.5MG
	                         A074640   001   Mar   31,   1997
	
                                25MG
	                           A074640   002   Mar   31,   1997
	
                                50MG
	                           A074640   003   Mar   31,   1997
	
                                100MG
	                          A074640   004   Mar   31,   1997
	
        SANDOZ                  12.5MG
	                         A074481   001   Feb   13,   1996
	
                                12.5MG
	                         A074519   001   Feb   13,   1996
	
                                25MG
	                           A074481   002   Feb   13,   1996
	
                                25MG
	                           A074519   002   Feb   13,   1996
	
                                50MG
	                           A074481   003   Feb   13,   1996
	
                                50MG
	                           A074519   003   Feb   13,   1996
	
                                100MG
	                          A074481   004   Feb   13,   1996
	
                                100MG
	                          A074519   004   Feb   13,   1996
	
        TEVA                    12.5MG
	                         A074433   001   Feb   13,   1996
	
                                12.5MG
	                         A074483   001   Feb   13,   1996
	
                                25MG
	                           A074433   002   Feb   13,   1996
	
                                25MG
	                           A074483   002   Feb   13,   1996
	
                                50MG
	                           A074433   003   Feb   13,   1996
	
                                50MG
	                           A074483   003   Feb   13,   1996
	
                                100MG
	                          A074433   004   Feb   13,   1996
	
                                100MG
	                          A074483   004   Feb   13,   1996
	
        TEVA PHARMS             12.5MG
	                         A074462   001   Feb   13,   1996
	
                                25MG
	                           A074462   002   Feb   13,   1996
	
                                50MG
	                           A074462   003   Feb   13,   1996
	
                                100MG
	                          A074462   004   Feb   13,   1996
	
        VINTAGE PHARMS LLC      12.5MG
	                         A074418   001   Feb   13,   1996
	
                                25MG
	                           A074418   002   Feb   13,   1996
	
                                50MG
	                           A074418   003   Feb   13,   1996
	
                                100MG
	                          A074418   004   Feb   13,   1996
	
        WATSON LABS             12.5MG
	                         A074451   001   Feb   13,   1996
	
                                12.5MG
	                         A074576   001   Apr   23,   1996

                                25MG
	                           A074451   002   Feb   13,   1996
	
                                25MG
	                           A074576   002   Apr   23,   1996

                                50MG
	                           A074451   003   Feb   13,   1996
	
                                50MG
	                           A074576   003   Apr   23,   1996

                                100MG
	                          A074451   004   Feb   13,   1996
	
                                100MG
	                          A074576   004   Apr   23,   1996
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                                6-56(of 337)

CAPTOPRIL; HYDROCHLOROTHIAZIDE
  TABLET;ORAL
    CAPOZIDE 25/15
         APOTHECON              25MG;15MG **Federal Register                N018709 001 Oct 12, 1984
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
    CAPOZIDE 25/25
         APOTHECON              25MG;25MG **Federal Register                N018709 002 Oct 12, 1984
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
    CAPOZIDE 50/15
         APOTHECON              50MG;15MG **Federal Register                N018709 004 Oct 12, 1984
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
    CAPOZIDE 50/25
         APOTHECON              50MG;25MG **Federal Register                N018709 003 Oct 12, 1984
                                determination that product was not
                                discontinued or withdrawn for safety   or
                                efficacy reasons**
    CAPTOPRIL AND HYDROCHLOROTHIAZIDE
         IVAX SUB TEVA PHARMS   25MG;15MG                                   A075055   001   Jun   18,   1998
                                25MG;25MG                                   A075055   002   Jun   18,   1998
                                50MG;15MG                                   A075055   004   Jun   18,   1998
                                50MG;25MG                                   A075055   003   Jun   18,   1998
         VINTAGE PHARMS LLC     25MG;15MG                                   A074788   001   Dec   29,   1997
                                25MG;25MG                                   A074788   002   Dec   29,   1997
                                50MG;15MG                                   A074788   004   Dec   29,   1997
                                50MG;25MG                                   A074788   003   Dec   29,   1997
         WATSON LABS            50MG;25MG                                   A074832   001   Dec   29,   1997
CARBACHOL
  SOLUTION;INTRAOCULAR
    CARBACHOL
         PHARMAFAIR              0.01%                                      A070292 001 May 21, 1986
    CARBASTAT
         NOVARTIS                0.01%                                      A073677 001 Apr 28, 1995
CARBAMAZEPINE
  SUSPENSION;ORAL
    CARBAMAZEPINE
          TARO                   100MG/5ML                                  A075875 001 Dec 21, 2000
  TABLET;ORAL
    CARBAMAZEPINE
          ACTAVIS ELIZABETH      200MG                                      A071696   001   Nov   09,   1987
          INWOOD LABS            200MG                                      A070231   001   Aug   14,   1986
          PLIVA                  200MG                                      A071479   001   Jul   24,   1987
          USL PHARMA             200MG                                      A070300   001   May   15,   1986
          WARNER CHILCOTT        200MG                                      A070429   001   Jan   02,   1987
    TERIL
         TARO                    200MG                                      A076525 001 Sep 26, 2003
  TABLET, CHEWABLE;ORAL
    CARBAMAZEPINE
         JUBILANT CADISTA        100MG                                      A071940 001 Feb 01, 1988
CARBENICILLIN DISODIUM
  INJECTABLE;INJECTION
    GEOPEN
         ROERIG                  EQ   1GM BASE/VIAL                         N050306   001
                                 EQ   2GM BASE/VIAL                         N050306   004
                                 EQ   5GM BASE/VIAL                         N050306   002
                                 EQ   10GM BASE/VIAL                        N050306   006
                                 EQ   30GM BASE/VIAL                        N050306   007
   PYOPEN
        GLAXOSMITHKLINE          EQ   1GM BASE/VIAL                         N050298   001
                                 EQ   2GM BASE/VIAL                         N050298   002
                                 EQ   5GM BASE/VIAL                         N050298   003
                                 EQ   10GM BASE/VIAL                        N050298   006
                                 EQ   20GM BASE/VIAL                        N050298   007
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-57(of 337)

CARBENICILLIN INDANYL SODIUM
  TABLET;ORAL
    GEOCILLIN
         PFIZER                 EQ 382MG BASE                             N050435 001
CARBIDOPA; LEVODOPA
  TABLET;ORAL
    CARBIDOPA AND LEVODOPA
         SANDOZ                 10MG;100MG                                A073586   001   Jun   29,   1995
                                25MG;100MG                                A073587   001   Jun   29,   1995
                                25MG;250MG                                A073620   001   Jun   29,   1995
        SCS                     10MG;100MG                                A074080   001   Mar   25,   1994
                                25MG;100MG                                A074080   002   Mar   25,   1994
                                25MG;250MG                                A074080   003   Mar   25,   1994
        WATSON LABS             10MG;100MG                                A073381   001   Sep   28,   1993
                                25MG;100MG                                A073382   001   Sep   28,   1993
                                25MG;250MG                                A073383   001   Sep   28,   1993
 TABLET, EXTENDED RELEASE;ORAL
   CARBIDOPA AND LEVODOPA
        KV PHARM               50MG;200MG                                 A076663 001 Jun 24, 2004
 TABLET, FOR SUSPENSION;ORAL
   CARBILEV
        RANBAXY                10MG;100MG                                 A076643 001 Jun 10, 2005
                               25MG;100MG                                 A076643 002 Jun 10, 2005
                               25MG;250MG                                 A076643 003 Jun 10, 2005
 TABLET, ORALLY DISINTEGRATING;ORAL
   CARBIDOPA AND LEVODOPA
        IMPAX LABS             10MG;100MG                                 A090631 001 Jun 08, 2010
                               25MG;100MG                                 A090631 002 Jun 08, 2010
                               25MG;250MG                                 A090631 003 Jun 08, 2010
   PARCOPA
        UCB INC                10MG;100MG **Federal Register              A076699 001 Aug 27, 2004
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
                               25MG;100MG **Federal Register              A076699 002 Aug 27, 2004
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
                               25MG;250MG **Federal Register              A076699 003 Aug 27, 2004
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
CARBINOXAMINE MALEATE
  ELIXIR;ORAL
    CLISTIN
         MCNEIL                 4MG/5ML **Federal Register                N008955 001
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
 TABLET;ORAL
   CLISTIN
        ORTHO MCNEIL PHARM      4MG                                       N008915 001
CARBOPLATIN
  INJECTABLE;INJECTION
    CARBOPLATIN
         CIPLA LTD              50MG/VIAL                                 A077383   001   Jan   27,   2006
                                150MG/VIAL                                A077383   002   Jan   27,   2006
                                450MG/VIAL                                A077383   003   Jan   27,   2006
        EUROHLTH INTL           50MG/VIAL                                 A076099   001   Oct   14,   2004
                                150MG/VIAL                                A076099   002   Oct   14,   2004
                                450MG/VIAL                                A076099   003   Oct   14,   2004
        FRESENIUS KABI USA      50MG/VIAL                                 A076235   001   Oct   14,   2004
                                150MG/VIAL                                A076235   002   Oct   14,   2004
                                450MG/VIAL                                A076235   003   Oct   14,   2004
        HOSPIRA                 50MG/VIAL                                 A076473   001   Oct   27,   2004
                                150MG/VIAL                                A076473   002   Oct   27,   2004
                                450MG/VIAL                                A076473   003   Oct   27,   2004
        ONCO THERAPIES LTD      50MG/VIAL                                 A091510   001   May   29,   2012
                                150MG/VIAL                                A091510   002   May   29,   2012
                                450MG/VIAL                                A091510   003   May   29,   2012
        PLIVA                   50MG/VIAL                                 A076602   001   Nov   16,   2004
                                150MG/VIAL                                A076602   002   Nov   16,   2004
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                      6-58(of 337)

CARBOPLATIN
  INJECTABLE;INJECTION
    CARBOPLATIN
                                450MG/VIAL                       A076602   003   Nov   16,   2004
          SANDOZ                50MG/VIAL                        A076959   001   Mar   18,   2005
                                150MG/VIAL                       A076959   002   Mar   18,   2005
                                450MG/VIAL                       A076959   003   Mar   18,   2005
          WATSON LABS           50MG/VIAL                        A076162   001   Oct   14,   2004
                                150MG/VIAL                       A076162   002   Oct   14,   2004
                                450MG/VIAL                       A076162   003   Oct   14,   2004
   PARAPLATIN
        CORDEN PHARMA           50MG/VIAL                        N019880 001 Mar 03, 1989
                                150MG/VIAL                       N019880 002 Mar 03, 1989
                                450MG/VIAL                       N019880 003 Mar 03, 1989
 INJECTABLE;IV (INFUSION)
   CARBOPLATIN
        FRESENIUS KABI USA      50MG/5ML (10MG/ML)               A077247   001   Oct   21,   2004
                                50MG/5ML (10MG/ML)               A077266   001   Feb   15,   2006
                                150MG/15ML (10MG/ML)             A077247   002   Oct   21,   2004
                                150MG/15ML (10MG/ML)             A077266   002   Feb   15,   2006
          PHARMACHEMIE BV       50MG/5ML (10MG/ML)               A077679   001   Feb   25,   2009
                                150MG/15ML (10MG/ML)             A077679   002   Feb   25,   2009
                                450MG/45ML (10MG/ML)             A077679   003   Feb   25,   2009
          TEVA PARENTERAL       50MG/5ML (10MG/ML)               A077389   001   Mar   30,   2007
                                150MG/15ML (10MG/ML)             A077389   002   Mar   30,   2007
                                450MG/45ML (10MG/ML)             A077389   003   Mar   30,   2007
   PARAPLATIN
        CORDENPHARMA            50MG/5ML (10MG/ML)               N020452   001   Jul   14,   2003
                                150MG/15ML (10MG/ML)             N020452   002   Jul   14,   2003
                                450MG/45ML (10MG/ML)             N020452   003   Jul   14,   2003
                                600MG/60ML (10MG/ML)             N020452   004   Jan   15,   2004
CARISOPRODOL
  CAPSULE;ORAL
    SOMA
         MEDA PHARMS            250MG                            N011792 003
  TABLET;ORAL
    CARISOPRODOL
         ABLE                   350MG                            A040421   001   Jun   21,   2001
         COREPHARMA             350MG                            A040397   001   Sep   21,   2000
         HIKMA INTL PHARMS      350MG                            A040124   001   Jan   24,   1996
         PIONEER PHARMS         350MG                            A089390   001   Oct   13,   1988
         PROSAM LABS            350MG                            A040188   001   Mar   07,   1997
         SANDOZ                 350MG                            A081025   001   Apr   13,   1989
                                350MG                            A089566   001   Aug   30,   1988
          WATSON LABS           350MG                            A040152   001   Dec   03,   1996
                                350MG                            A085433   001
                                350MG                            A086179   001
   RELA
          SCHERING              350MG                            N012155 001
CARPHENAZINE MALEATE
  CONCENTRATE;ORAL
    PROKETAZINE
         WYETH AYERST           50MG/ML                          N014173 001
  TABLET;ORAL
    PROKETAZINE
         WYETH AYERST           12.5MG                           N012768 001
                                25MG                             N012768 002
                                50MG                             N012768 004
CARPROFEN
  TABLET;ORAL
    RIMADYL
         ROCHE                  100MG                            N018550 002 Dec 31, 1987
                                150MG                            N018550 003 Dec 31, 1987
CARTEOLOL HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    CARTEOLOL HYDROCHLORIDE
         APOTEX INC             1%                               A076097 001 Feb 06, 2002
  TABLET;ORAL
    CARTROL
         ABBVIE                 2.5MG                            N019204 001 Dec 28, 1988
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-59(of 337)

CARTEOLOL HYDROCHLORIDE
  TABLET;ORAL
    CARTROL
                               5MG                              N019204 002 Dec 28, 1988
                               10MG                             N019204 003 Dec 28, 1988
CARVEDILOL
  TABLET;ORAL
    CARVEDILOL
         WOCKHARDT LTD         3.125MG                          A078786   001   Dec   22,   2009
                               6.25MG                           A078786   002   Dec   22,   2009
                               12.5MG                           A078786   003   Dec   22,   2009
                               25MG                             A078786   004   Dec   22,   2009
CEFACLOR
  CAPSULE;ORAL
    CECLOR
         LILLY                 EQ 250MG BASE                    N050521 001
                               EQ 500MG BASE                    N050521 002
   CEFACLOR
        CEPH INTL              EQ   250MG   BASE                A062205   001
                               EQ   500MG   BASE                A062205   002
        DAVA PHARMS INC        EQ   250MG   BASE                A064107   001   Apr   27,   1995
                               EQ   500MG   BASE                A064107   002   Apr   27,   1995
        IVAX SUB TEVA PHARMS   EQ   250MG   BASE                A064061   001   Apr   27,   1995
                               EQ   500MG   BASE                A064061   002   Apr   27,   1995
        RANBAXY                EQ   250MG   BASE                A064156   001   Aug   28,   1997
                               EQ   500MG   BASE                A064156   002   Aug   28,   1997
        TEVA                   EQ   250MG   BASE                A064081   001   Sep   16,   1996
                               EQ   250MG   BASE                A064145   001   Jun   24,   1996
                               EQ   500MG   BASE                A064081   002   Sep   16,   1996
                               EQ   500MG   BASE                A064145   002   Jun   24,   1996
        WATSON LABS INC        EQ   250MG   BASE                A064148   001   May   23,   1996
                               EQ   500MG   BASE                A064148   002   May   23,   1996
 FOR SUSPENSION;ORAL
   CECLOR
        LILLY                  EQ 125MG BASE/5ML                N050522 001
                               EQ 250MG BASE/5ML                N050522 002
   CEFACLOR
        DAVA PHARMS INC        EQ   125MG   BASE/5ML            A064114   001   Apr   28,   1995
                               EQ   187MG   BASE/5ML            A064115   001   Apr   28,   1995
                               EQ   250MG   BASE/5ML            A064116   001   Apr   28,   1995
                               EQ   375MG   BASE/5ML            A064110   001   Apr   28,   1995
        FACTA FARMA            EQ   125MG   BASE/5ML            A062206   001
                               EQ   187MG   BASE/5ML            A062206   003   Apr 20, 1988
                               EQ   250MG   BASE/5ML            A062206   002
                               EQ   375MG   BASE/5ML            A062206   004   Apr   20,   1988
        IVAX SUB TEVA PHARMS   EQ   125MG   BASE/5ML            A064087   001   Apr   28,   1995
                               EQ   187MG   BASE/5ML            A064086   001   Apr   28,   1995
                               EQ   250MG   BASE/5ML            A064085   001   Apr   28,   1995
                               EQ   375MG   BASE/5ML            A064070   001   Apr   28,   1995
        RANBAXY                EQ   125MG   BASE/5ML            A064166   001   Oct   02,   1997
                               EQ   187MG   BASE/5ML            A064165   001   Oct   02,   1997
                               EQ   250MG   BASE/5ML            A064164   001   Oct   02,   1997
                               EQ   375MG   BASE/5ML            A064155   001   Oct   02,   1997
        WATSON LABS INC        EQ   125MG   BASE/5ML            A064204   001   Feb   18,   1998
                               EQ   187MG   BASE/5ML            A064205   001   Feb   18,   1998
                               EQ   250MG   BASE/5ML            A064206   001   Feb   18,   1998
                               EQ   375MG   BASE/5ML            A064207   001   Feb   18,   1998
 TABLET, CHEWABLE;ORAL
   RANICLOR
        RANBAXY LABS LTD       EQ   125MG   BASE                A065092   001   Dec   22,   2003
                               EQ   187MG   BASE                A065092   002   Dec   22,   2003
                               EQ   250MG   BASE                A065092   003   Dec   22,   2003
                               EQ   375MG   BASE                A065092   004   Dec   22,   2003
 TABLET, EXTENDED RELEASE;ORAL
   CECLOR CD
        LILLY                  EQ 375MG BASE                    N050673 001 Jun 28, 1996
                               EQ 500MG BASE                    N050673 002 Jun 28, 1996
   CEFACLOR
        WORLD GEN              EQ 500MG BASE                    A065057 001 Jan 05, 2001
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                               6-60(of 337)


CEFADROXIL/CEFADROXIL HEMIHYDRATE

  CAPSULE;ORAL
	
    CEFADROXIL
	
         IVAX SUB TEVA PHARMS
	 EQ   500MG   BASE
	                       A062766   001
	   Mar   03,   1987
	
         PUREPAC PHARM
	        EQ   500MG   BASE
	                       A063017   001
	   Jan   05,   1989
	
         RANBAXY LABS LTD
	     EQ   500MG   BASE
	                       A065015   001
	   Jun   22,   1999
	
         TEVA
	                 EQ   500MG   BASE
	                       A062695   001
	   Feb   10,   1989
	
    DURICEF
	
         WARNER CHILCOTT
	      EQ   250MG BASE
	                         N050512 002
	
                                EQ   500MG BASE
	                         N050512 001
	
    ULTRACEF
	
         BRISTOL
	              EQ   500MG BASE
	                         A062378 001
	 Mar 16, 1982
	
  FOR SUSPENSION;ORAL
	
    CEFADROXIL
	
         ANI PHARMS INC
	       EQ   125MG   BASE/5ML
                    A062698   001
	   Mar   01,   1989
	
                                EQ   250MG   BASE/5ML
                    A062698   002
	   Mar   01,   1989
	
                                EQ   250MG   BASE/5ML
                    A065278   001
	   Jan   20,   2006
	
                                EQ   500MG   BASE/5ML
                    A062698   003
	   Mar   01,   1989
	
                                EQ   500MG   BASE/5ML
                    A065278   002
	   Jan   20,   2006
	
         APOTHECON
	            EQ   125MG   BASE/5ML
                    A062334   001
	
                                EQ   250MG   BASE/5ML
                    A062334   002
	
                                EQ   500MG   BASE/5ML
	                   A062334   003
	
    DURICEF
	
         WARNER CHILCOTT
	      EQ   125MG BASE/5ML
                      N050527 002
	
                                EQ   250MG BASE/5ML
                      N050527 003
	
                                EQ   500MG BASE/5ML
	                     N050527 001
	
    ULTRACEF
	
         BRISTOL
	              EQ   125MG BASE/5ML
                      A062376 001
	 Mar 16, 1982
	
                                EQ   250MG BASE/5ML
                      A062376 002
	 Mar 16, 1982
	
                                EQ   500MG BASE/5ML
	                     A062376 003
	 Mar 16, 1982
	
  TABLET;ORAL
	
    CEFADROXIL
	
         RANBAXY
	              EQ   1GM BASE
	                           A065018 001
	 Apr 23, 1999
	
    DURICEF
	
         WARNER CHILCOTT
	      EQ   1GM BASE
	                           N050528 001
	
    ULTRACEF
	
         APOTHECON
	            EQ   1GM BASE
	                           A062390 001
	 Jun 10, 1982
	
         BRISTOL
	              EQ   1GM BASE
	                           A062408 001
	 Aug 31, 1982
	
CEFAMANDOLE NAFATE
	
  INJECTABLE;INJECTION
	
    MANDOL
	
         LILLY
	                EQ   1GM BASE/VIAL
                       A062560   001
	 Sep 10, 1985
	
                                EQ   1GM BASE/VIAL
                       N050504   002
	
                                EQ   2GM BASE/VIAL
                       A062560   002
	 Sep 10, 1985
	
                                EQ   2GM BASE/VIAL
                       N050504   003
	
                                EQ   10GM BASE/VIAL
                      N050504   004
	
                                EQ   500MG BASE/VIAL
	                    N050504   001
	
CEFAZOLIN SODIUM
	
  INJECTABLE;INJECTION
	
    ANCEF
	
         GLAXOSMITHKLINE
	     EQ 1GM BASE/VIAL
                          N050461 003
	
                               EQ 5GM BASE/VIAL **Federal Register
       N050461 004
	
                               determination that product was not

                               discontinued or withdrawn for safety or

                               efficacy reasons**

                               EQ 10GM BASE/VIAL
                         N050461 005
	
                               EQ 250MG BASE/VIAL **Federal Register
     N050461 001
	
                               determination that product was not

                               discontinued or withdrawn for safety or

                               efficacy reasons**

                               EQ 500MG BASE/VIAL
	                       N050461 002
	
   ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        BAXTER HLTHCARE        EQ 10MG BASE/ML
                           N050566 003
	 Jun 08, 1983
	
                               EQ 20MG BASE/ML
                           N050566 004
	 Jun 08, 1983
	
   ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
        BAXTER HLTHCARE
	      EQ 10MG BASE/ML
                           N050566 001
	 Jun 08, 1983
	
                               EQ 20MG BASE/ML
	                          N050566 002
	 Jun 08, 1983
	
   CEFAZOLIN AND DEXTROSE
	
        B BRAUN
	              EQ 500MG BASE/VIAL
	                       N050779 001
	 Jul 27, 2000
	
   CEFAZOLIN SODIUM
	
        ABRAXIS PHARM
	        EQ 1GM BASE/VIAL
                          A062688 003
	 Nov 17, 1986
	
                               EQ 10GM BASE/VIAL
	                        A062688 004
	 Nov 17, 1986
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                               6-61(of 337)


CEFAZOLIN SODIUM
	
  INJECTABLE;INJECTION
	
    CEFAZOLIN SODIUM
	
                                 EQ   20GM BASE/VIAL
                      A062688   005
	   Aug   03,   1987

                                 EQ   500MG BASE/VIAL
                     A062688   002
	   Nov   17,   1986
	
         AUROBINDO PHARMA		      EQ   1GM BASE/VIAL
                       A065395   002
	   Aug   08,   2008

                                 EQ   500MG BASE/VIAL
                     A065395   001
	   Aug   08,   2008

         BEDFORD		               EQ   1GM BASE/VIAL
                       A062894   003
	   Jul   21,   1988
	
                                 EQ   5GM BASE/VIAL
                       A062894   004
	   Jul   21,   1988
	
                                 EQ   10GM BASE/VIAL
                      A062894   005
	   Jul   21,   1988
	
                                 EQ   250MG BASE/VIAL
                     A062894   001
	   Jul   21,   1988
	
                                 EQ   500MG BASE/VIAL
                     A062894   002
	   Jul   21,   1988
	
         CEPHAZONE PHARMA		      EQ   1GM BASE/VIAL
                       A065280   002
	   Mar   18,   2009
	
                                 EQ   10GM BASE/VIAL
                      A065295   001
	   Mar   18,   2009
	
                                 EQ   20GM BASE/VIAL
                      A065296   001
	   Mar   18,   2009
	
                                 EQ   500MG BASE/VIAL
                     A065280   001
	   Mar   18,   2009
	
         FRESENIUS KABI USA		    EQ   1GM BASE/VIAL
                       A064169   002
	   Aug   14,   1998

                                 EQ   10GM BASE/VIAL
                      A064170   001
	   Mar   18,   1998
	
                                 EQ   20GM BASE/VIAL
                      A064170   002
	   Mar   18,   1998
	
                                 EQ   500MG BASE/VIAL
                     A064169   001
	   Aug   14,   1998

         GLAXOSMITHKLINE		       EQ   1GM BASE/VIAL
                       A064033   001
	   Oct   31,   1993
	
         HIKMA MAPLE		           EQ   1GM BASE/VIAL
                       A062807   003
	   Jan   12,   1988
	
                                 EQ   5GM BASE/VIAL
                       A062807   004
	   Jan   12,   1988
	
                                 EQ   10GM BASE/VIAL
                      A062807   005
	   Jan   12,   1988
	
                                 EQ   20GM BASE/VIAL
                      A062807   006
	   Jan   12,   1988
	
                                 EQ   250MG BASE/VIAL
                     A062807   001
	   Jan   12,   1988
	
                                 EQ   500MG BASE/VIAL
                     A062807   002
	   Jan   12,   1988
	
         STERI PHARMA		          EQ   1GM BASE/VIAL
                       A063208   001
	   Dec   27,   1991
	
                                 EQ   500MG BASE/VIAL
                     A063216   001
	   Dec   27,   1991
	
         TEVA PHARMS		           EQ   1GM BASE/VIAL
                       A063016   003
	   Mar   14,   1989
	
                                 EQ   5GM BASE/VIAL
                       A063018   001
	   Mar   05,   1990
	
                                 EQ   10GM BASE/VIAL
                      A063018   002
	   Mar   05,   1990
	
                                 EQ   250MG BASE/VIAL
                     A063016   001
	   Mar   14,   1989
	
                                 EQ   500MG BASE/VIAL
                     A063016   002
	   Mar   14,   1989
	
         WATSON LABS INC		       EQ   1GM BASE/VIAL
                       A062988   003
	   Dec   29,   1989
	
                                 EQ   5GM BASE/VIAL
                       A062989   001
	   Dec   29,   1989
	
                                 EQ   10GM BASE/VIAL
                      A062989   002
	   Dec   29,   1989
	
                                 EQ   20GM BASE/VIAL
                      A062989   003
	   Dec   29,   1989
	
                                 EQ   250MG BASE/VIAL
                     A062988   001
	   Dec   29,   1989
	
                                 EQ   500MG BASE/VIAL
                     A062988   002
	   Dec   29,   1989
	
   KEFZOL
	
        ACS DOBFAR               EQ   20GM BASE/VIAL
                      A061773   005
	 Sep 08, 1987
	
                                 EQ   250MG BASE/VIAL
                     A061773   001
	
         LILLY                   EQ   1GM BASE/VIAL
                       A062557   002
	 Sep 10, 1985

                                 EQ   500MG BASE/VIAL
	                    A062557   001
	 Sep 10, 1985
	
CEFDINIR
	
  CAPSULE;ORAL
	
    OMNICEF
	
          ABBVIE                 300MG
	                                   N050739 001
	 Dec 04, 1997
	
  FOR SUSPENSION;ORAL
	
    OMNICEF
	
          ABBVIE                 125MG/5ML
                                N050749 001
	 Dec 04, 1997
	
                                 250MG/5ML
	                               N050749 002
	 Jul 29, 2004
	
CEFEPIME HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CEFEPIME HYDROCHLORIDE
	
         SANDOZ		                EQ 1GM BASE/VIAL
                         A090291 002
	 Dec 21, 2010
	
                                 EQ 2GM BASE/VIAL
                         A090291 003
	 Dec 21, 2010
	
                                 EQ 500MG BASE/VIAL
	                      A090291 001
	 Dec 21, 2010
	
CEFIXIME
	
  FOR SUSPENSION;ORAL
	
    SUPRAX
	
          LEDERLE                100MG/5ML
                                N050622 001
	 Apr 28, 1989
	
  TABLET;ORAL
	
    SUPRAX
	
          LEDERLE                200MG **Federal Register determination
   N050621 001
	 Apr 28, 1989
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 400MG
	                                   N050621 002
	 Apr 28, 1989
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-62(of 337)

CEFMENOXIME HYDROCHLORIDE
  INJECTABLE;INJECTION
    CEFMAX
         TAP PHARM              EQ 1GM BASE/VIAL                         N050571 002 Dec 30, 1987
                                EQ 2GM BASE/VIAL                         N050571 003 Dec 30, 1987
                                EQ 500MG BASE/VIAL                       N050571 001 Dec 30, 1987
CEFMETAZOLE SODIUM
  INJECTABLE;INJECTION
    ZEFAZONE
         PHARMACIA AND UPJOHN  EQ 1GM BASE/VIAL                          N050637 001 Dec 11, 1989
                               EQ 2GM BASE/VIAL                          N050637 002 Dec 11, 1989
   ZEFAZONE IN PLASTIC CONTAINER
        PHARMACIA AND UPJOHN   EQ 20MG BASE/ML **Federal Register        N050683 001 Dec 29, 1992
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
                               EQ 40MG BASE/ML **Federal Register        N050683 002 Dec 29, 1992
                               determination that product was not
                               discontinued or withdrawn for safety or
                               efficacy reasons**
CEFONICID SODIUM
  INJECTABLE;INJECTION
    MONOCID
         GLAXOSMITHKLINE        EQ   1GM BASE/VIAL                       A063295   001   Jul   26,   1993
                                EQ   1GM BASE/VIAL                       N050579   002   May   23,   1984
                                EQ   2GM BASE/VIAL                       N050579   003   May   23,   1984
                                EQ   10GM BASE/VIAL                      N050579   004   May   23,   1984
                                EQ   500MG BASE/VIAL                     N050579   001   May   23,   1984
CEFOPERAZONE SODIUM
  INJECTABLE;INJECTION
    CEFOBID
         PFIZER                EQ    1GM BASE/VIAL                       A063333   001   Mar   31,   1995
                               EQ    1GM BASE/VIAL                       N050551   001   Nov   18,   1982
                               EQ    2GM BASE/VIAL                       A063333   002   Mar   31,   1995
                               EQ    2GM BASE/VIAL                       N050551   002   Nov   18,   1982
                               EQ    10GM BASE/VIAL                      N050551   003   Mar   05,   1990
   CEFOBID IN PLASTIC CONTAINER
        PFIZER                 EQ    20MG BASE/ML                        N050613 002 Jul 31, 1987
                               EQ    40MG BASE/ML                        N050613 001 Jul 23, 1986
CEFORANIDE
  INJECTABLE;INJECTION
    PRECEF
         APOTHECON              1GM/VIAL                                 A062579   002   Nov   26,   1984
                                2GM/VIAL                                 A062579   003   Nov   26,   1984
                                10GM/VIAL                                A062579   004   Nov   26,   1984
                                20GM/VIAL                                A062579   005   Nov   26,   1984
                                500MG/VIAL                               A062579   001   Nov   26,   1984
        BRISTOL                 1GM/VIAL                                 N050554   002   May   24,   1984
                                2GM/VIAL                                 N050554   003   May   24,   1984
                                10GM/VIAL                                N050554   004   May   24,   1984
                                20GM/VIAL                                N050554   005   May   24,   1984
                                500MG/VIAL                               N050554   001   May   24,   1984
CEFOTAXIME SODIUM
  INJECTABLE;INJECTION
    CEFOTAXIME
         FRESENIUS KABI USA    EQ 1GM BASE/VIAL                          A064200   002   Mar   24,   2000
                               EQ 2GM BASE/VIAL                          A064200   003   Mar   24,   2000
                               EQ 10GM BASE/VIAL                         A064201   001   Mar   24,   2000
                               EQ 20GM BASE/VIAL                         A064201   002   Mar   24,   2000
                               EQ 500MG BASE/VIAL                        A064200   001   Mar   24,   2000
   CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER
        B BRAUN                EQ 2GM BASE                               N050792 001 Jul 29, 2004
   CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER
        B BRAUN                EQ 1GM BASE                               N050792 002 Jul 29, 2004
   CEFOTAXIME SODIUM
        AUROBINDO PHARMA       EQ 1GM BASE/VIAL                          A065517   002   Nov   06,   2009
                               EQ 2GM BASE/VIAL                          A065517   003   Nov   06,   2009
                               EQ 500MG BASE/VIAL                        A065517   001   Nov   06,   2009
        AUROBINDO PHARMA LTD   EQ 10GM BASE/VIAL                         A065516   001   Nov   06,   2009
        CEPHAZONE PHARMA       EQ 10GM BASE/VIAL                         A065348   001   Jan   25,   2010
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                       6-63(of 337)

CEFOTAXIME SODIUM
  INJECTABLE;INJECTION
    CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
         SANOFI AVENTIS US      EQ 20MG BASE/ML                  N050596 001 May 20, 1985
                                EQ 40MG BASE/ML                  N050596 003 May 20, 1985
CEFOTETAN DISODIUM
  INJECTABLE;INJECTION
    CEFOTAN
         ASTRAZENECA           EQ   1GM BASE/VIAL                A063293   001   Apr   29,   1993
                               EQ   1GM BASE/VIAL                N050588   001   Dec   27,   1985
                               EQ   2GM BASE/VIAL                A063293   002   Apr   29,   1993
                               EQ   2GM BASE/VIAL                N050588   002   Dec   27,   1985
                               EQ   10GM BASE/VIAL               N050588   003   Apr   25,   1988
   CEFOTAN IN PLASTIC CONTAINER
        ASTRAZENECA            EQ   20MG BASE/ML                 N050694 002 Jul 30, 1993
                               EQ   40MG BASE/ML                 N050694 001 Jul 30, 1993
CEFOTIAM HYDROCHLORIDE
  INJECTABLE;INJECTION
    CERADON
         TAKEDA                  EQ 1GM BASE/VIAL                N050601 001 Dec 30, 1988
CEFOXITIN SODIUM
  INJECTABLE;INJECTION
    CEFOXITIN
         FRESENIUS KABI USA      EQ 1GM BASE/VIAL                A065012 001 Jul 03, 2000
                                 EQ 2GM BASE/VIAL                A065012 002 Jul 03, 2000
                                 EQ 10GM BASE/VIAL               A065011 001 Jul 03, 2000
   MEFOXIN
        MYLAN INSTITUTIONAL       EQ 1GM BASE/VIAL               A062757   001 Jan 08, 1987
                                  EQ 1GM BASE/VIAL               N050517   001
                                  EQ 2GM BASE/VIAL               A062757   002 Jan 08, 1987
                                  EQ 2GM BASE/VIAL               N050517   002
                                  EQ 10GM BASE/VIAL              N050517   003
   MEFOXIN IN    DEXTROSE 5% IN PLASTIC CONTAINER
        MERCK                     EQ 20MG BASE/ML                N050581 003 Sep 20, 1984
                                  EQ 40MG BASE/ML                N050581 004 Sep 20, 1984
   MEFOXIN IN    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
        MERCK                     EQ 20MG BASE/ML                N050581 002 Sep 20, 1984
                                  EQ 40MG BASE/ML                N050581 001 Sep 20, 1984
CEFPIRAMIDE SODIUM
  INJECTABLE;INJECTION
    CEFPIRAMIDE SODIUM
         WYETH AYERST            EQ 1GM BASE/VIAL                N050633 002 Jan 31, 1989
                                 EQ 2GM BASE/VIAL                N050633 003 Jan 31, 1989
                                 EQ 10GM BASE/VIAL               N050633 005 Jan 31, 1989
CEFPODOXIME PROXETIL
  FOR SUSPENSION;ORAL
    BANAN
          SANKYO                 EQ 50MG BASE/5ML                N050688 002 Aug 07, 1992
                                 EQ 100MG BASE/5ML               N050688 001 Aug 07, 1992
   VANTIN
        PHARMACIA AND UPJOHN     EQ 50MG BASE/5ML                N050675 001 Aug 07, 1992
                                 EQ 100MG BASE/5ML               N050675 002 Aug 07, 1992
 TABLET;ORAL
   BANAN
        SANKYO                   EQ 100MG BASE                   N050687 001 Aug 07, 1992
                                 EQ 200MG BASE                   N050687 002 Aug 07, 1992
   VANTIN
        PHARMACIA AND UPJOHN     EQ 100MG BASE                   N050674 001 Aug 07, 1992
                                 EQ 200MG BASE                   N050674 002 Aug 07, 1992
CEFPROZIL
  FOR SUSPENSION;ORAL
    CEFPROZIL
         RANBAXY LABS LTD        125MG/5ML                       A065202 001 Jun 30, 2006
                                 250MG/5ML                       A065202 002 Jun 30, 2006
   CEFZIL
        CORDEN PHARMA            125MG/5ML                       N050665 001 Dec 23, 1991
                                 250MG/5ML                       N050665 002 Dec 23, 1991
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                     6-64(of 337)

CEFPROZIL
  TABLET;ORAL
    CEFPROZIL
         RANBAXY LABS LTD       250MG                          A065198 001 Dec 13, 2006
                                500MG                          A065198 002 Dec 13, 2006
   CEFZIL
        CORDEN PHARMA           250MG                          N050664 001 Dec 23, 1991
                                500MG                          N050664 002 Dec 23, 1991
CEFTAZIDIME
  INJECTABLE;INJECTION
    CEFTAZIDIME
         AUROBINDO PHARMA LTD   1GM/VIAL                       A065481   002   May   28,   2010
                                2GM/VIAL                       A065481   003   May   28,   2010
                                6GM/VIAL                       A065482   001   May   28,   2010
                                500MG/VIAL                     A065481   001   May   28,   2010
   CEPTAZ
        GLAXOSMITHKLINE         1GM/VIAL                       N050646   002   Sep   27,   1990
                                2GM/VIAL                       N050646   003   Sep   27,   1990
                                10GM/VIAL                      N050646   004   Sep   27,   1990
                                500MG/VIAL                     N050646   001   Sep   27,   1990
   PENTACEF
        GLAXOSMITHKLINE         1GM/VIAL                       A063322   001   Nov   07,   1995
                                1GM/VIAL                       A064006   001   Mar   31,   1992
                                2GM/VIAL                       A063322   002   Nov   07,   1995
                                2GM/VIAL                       A064006   002   Mar   31,   1992
                                6GM/VIAL                       A064008   001   Mar   31,   1992
                                10GM/VIAL                      A064008   002   Mar   31,   1992
   TAZIDIME
        LILLY                  1GM/VIAL                        A062655 001 Nov 20, 1985
                               2GM/VIAL                        A062655 002 Nov 20, 1985
   TAZIDIME IN PLASTIC CONTAINER
        LILLY                  1GM/VIAL                        A062739 001 Jul 10, 1986
                               2GM/VIAL                        A062739 002 Jul 10, 1986
CEFTAZIDIME SODIUM
  INJECTABLE;INJECTION
    CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
         BAXTER HLTHCARE        EQ 10MG BASE/ML                A063221 001 Apr 29, 1993
                                EQ 20MG BASE/ML                A063221 002 Apr 29, 1993
                                EQ 40MG BASE/ML                A063221 003 Apr 29, 1993
    FORTAZ IN PLASTIC CONTAINER
         COVIS INJECTABLES      EQ 10MG BASE/ML                N050634 001 Apr 28, 1989
CEFTIZOXIME SODIUM
  INJECTABLE;INJECTION
    CEFIZOX
         ASTELLAS              EQ 1GM BASE/VIAL                A063294   002   Mar   31,   1994
                               EQ 1GM BASE/VIAL                N050560   002   Sep   15,   1983
                               EQ 2GM BASE/VIAL                A063294   003   Mar   31,   1994
                               EQ 2GM BASE/VIAL                N050560   003   Sep   15,   1983
                               EQ 10GM BASE/VIAL               N050560   005   Mar   19,   1993
                               EQ 500MG BASE/VIAL              N050560   001   Sep   15,   1983
   CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
        ASTELLAS               EQ 20MG BASE/ML                 N050589 001 Oct 03, 1984
                               EQ 40MG BASE/ML                 N050589 002 Oct 03, 1984
   CEFIZOX IN PLASTIC CONTAINER
        ASTELLAS               EQ 20MG BASE/ML                 N050589 003 Apr 13, 1995
                               EQ 40MG BASE/ML                 N050589 004 Apr 13, 1995
CEFTRIAXONE SODIUM
  INJECTABLE;INJECTION
    CEFTRIAXONE
         AGILA SPECLTS          EQ   10GM   BASE/VIAL          A091068   001   Jan   07,   2013
         AUROBINDO PHARMA LTD   EQ   10GM   BASE/VIAL          A065504   001   Jul   31,   2008
         FRESENIUS KABI USA     EQ   10GM   BASE/VIAL          A065252   001   Feb   15,   2006
         TEVA                   EQ   10GM   BASE/VIAL          A065274   001   May   01,   2006
    ROCEPHIN
         HOFFMANN LA ROCHE      EQ   1GM BASE/VIAL             A062654   002   Apr   30,   1987
                                EQ   2GM BASE/VIAL             A062654   003   Apr   30,   1987
                                EQ   10GM BASE/VIAL            N050585   005   Dec   21,   1984
                                EQ   250MG BASE/VIAL           A063239   001   Aug   13,   1993
                                EQ   500MG BASE/VIAL           A062654   001   Apr   30,   1987
        ROCHE                   EQ   1GM BASE/VIAL             A062510   003   Mar   12,   1985
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                      6-65(of 337)

CEFTRIAXONE SODIUM
  INJECTABLE;INJECTION
    ROCEPHIN
                               EQ 250MG BASE/VIAL               A062510 001 Mar 12, 1985
                               EQ 500MG BASE/VIAL               A062510 002 Mar 12, 1985
   ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER
        HOFFMANN LA ROCHE      EQ 10MG BASE/ML                  N050624 001 Feb 11, 1987
                               EQ 20MG BASE/ML                  N050624 002 Feb 11, 1987
                               EQ 40MG BASE/ML                  N050624 003 Feb 11, 1987
 INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
   CEFTRIAXONE
        AUROBINDO PHARMA LTD   EQ 1GM BASE/VIAL                 A065505   003   Jul   31,   2008
                               EQ 2GM BASE/VIAL                 A065505   004   Jul   31,   2008
                               EQ 250MG BASE/VIAL               A065505   001   Jul   31,   2008
                               EQ 500MG BASE/VIAL               A065505   002   Jul   31,   2008
        CEPHAZONE PHARMA       EQ 1GM BASE/VIAL                 A065294   003   Mar   26,   2007
                               EQ 2GM BASE/VIAL                 A065294   004   Mar   26,   2007
                               EQ 250MG BASE/VIAL               A065294   001   Mar   26,   2007
                               EQ 500MG BASE/VIAL               A065294   002   Mar   26,   2007
        FRESENIUS KABI USA     EQ 1GM BASE/VIAL                 A065245   003   Feb   15,   2006
                               EQ 2GM BASE/VIAL                 A065245   004   Feb   15,   2006
                               EQ 500MG BASE/VIAL               A065245   002   Feb   15,   2006
        STERI PHARMA           EQ 1GM BASE/VIAL                 A065268   001   Feb   28,   2007
                               EQ 2GM BASE/VIAL                 A065268   002   Feb   28,   2007
        TEVA                   EQ 1GM BASE/VIAL                 A065262   001   Jun   29,   2006
                               EQ 2GM BASE/VIAL                 A065262   002   Jun   29,   2006
        TEVA PHARMS USA        EQ 1GM BASE/VIAL                 A065227   003   Mar   15,   2007
                               EQ 2GM BASE/VIAL                 A065227   004   Mar   15,   2007
                               EQ 250MG BASE/VIAL               A065227   001   Mar   15,   2007
                               EQ 500MG BASE/VIAL               A065227   002   Mar   15,   2007
   ROCEPHIN
        HOFFMANN LA ROCHE      EQ 1GM BASE/VIAL                 N050585   003   Dec   21,   1984
                               EQ 2GM BASE/VIAL                 N050585   004   Dec   21,   1984
                               EQ 250MG BASE/VIAL               N050585   001   Dec   21,   1984
                               EQ 500MG BASE/VIAL               N050585   002   Dec   21,   1984
CEFTRIAXONE SODIUM; LIDOCAINE
  INJECTABLE;INJECTION
    ROCEPHIN KIT
         HOFFMANN LA ROCHE      EQ 1GM BASE/VIAL,N/A;N/A,1%     N050585 006 May 08, 1996
                                EQ 500MG BASE/VIAL,N/A;N/A,1%   N050585 007 May 08, 1996
CEFUROXIME AXETIL
  TABLET;ORAL
    CEFUROXIME AXETIL
         RANBAXY LABS LTD       EQ   125MG   BASE               A065043   003   Feb   15,   2002
                                EQ   250MG   BASE               A065043   002   Feb   15,   2002
                                EQ   500MG   BASE               A065043   001   Feb   15,   2002
        SANDOZ                  EQ   250MG   BASE               A065126   001   Oct   28,   2003
                                EQ   500MG   BASE               A065126   002   Oct   28,   2003
CEFUROXIME SODIUM
  INJECTABLE;INJECTION
    CEFUROXIME SODIUM
         FRESENIUS KABI USA    EQ 1.5GM BASE/VIAL               A065001   002   May   30,   2001
                               EQ 7.5GM BASE/VIAL               A065002   001   Sep   28,   1998
        TEVA PHARMS            EQ 7.5GM BASE/VIAL               A064191   001   Apr   16,   1998
        WATSON LABS INC        EQ 1.5GM BASE/VIAL               A064035   002   Feb   26,   1993
                               EQ 7.5GM BASE/VIAL               A064036   001   Feb   26,   1993
   CEFUROXIME SODIUM IN PLASTIC CONTAINER
        SAMSON MEDCL           EQ 75GM BASE/VIAL                A065251 001 Dec 30, 2009
                               EQ 225GM BASE/VIAL               A065251 002 Dec 30, 2009
   KEFUROX
        ACS DOBFAR             EQ 1.5GM BASE/VIAL               A062591 002 Jan 10, 1986
                               EQ 7.5GM BASE/VIAL               A062591 003 Dec 17, 1987
        LILLY                  EQ 1.5GM BASE/VIAL               A062592 002 Jan 10, 1986
   KEFUROX IN PLASTIC CONTAINER
        LILLY                  EQ 1.5GM BASE/VIAL               A062590 002 Jan 10, 1986
   ZINACEF IN PLASTIC CONTAINER
        COVIS INJECTABLES      EQ 15MG BASE/ML                  N050643 001 Apr 28, 1989
 INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
   CEFUROXIME SODIUM
        FRESENIUS KABI USA     EQ 750MG BASE/VIAL               A065001 001 May 30, 2001
        TEVA PHARMS            EQ 1.5GM BASE/VIAL               A064192 001 Apr 16, 1998
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                        6-66(of 337)


CEFUROXIME SODIUM
	
  INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
	
    CEFUROXIME SODIUM
	
                                EQ 750MG     BASE/VIAL
          A064192 002 Apr 16, 1998

         WATSON LABS INC        EQ 750MG     BASE/VIAL
          A064035 001 Feb 26, 1993
	
    KEFUROX
	
         ACS DOBFAR             EQ 750MG     BASE/VIAL
          A062591 001 Jan 10, 1986
	
  INJECTABLE;INTRAVENOUS
	
    KEFUROX
	
         LILLY                  EQ 750MG     BASE/VIAL
          A062592 001 Jan 10, 1986
	
    KEFUROX IN PLASTIC CONTAINER
	
         LILLY                  EQ 750MG     BASE/VIAL
	         A062590 001 Jan 10, 1986
	
CELLULOSE SODIUM PHOSPHATE
	
  POWDER;ORAL
	
    CALCIBIND
	
         MISSION PHARMA         2.5GM/PACKET
                    N018757 002 Dec 28, 1982
	
                                300GM/BOT
	                      N018757 003 Oct 16, 1984
	
CEPHALEXIN
	
  CAPSULE;ORAL
	
    CEPHALEXIN
	
         APOTHECON              EQ   250MG   BASE
	              A062973   001     Nov   08,   1988
	
                                EQ   250MG   BASE
	              A063063   001     Sep   29,   1989

                                EQ   250MG   BASE
	              A063186   001     Dec   30,   1994
	
                                EQ   500MG   BASE
	              A062974   001     Nov   23,   1988
	
                                EQ   500MG   BASE
	              A063063   002     Sep   29,   1989

                                EQ   500MG   BASE
	              A063186   002     Dec   30,   1994
	
         BARR                   EQ   250MG   BASE
	              A062773   001     Jun   26,   1987
	
                                EQ   500MG   BASE
	              A062775   001     Apr   22,   1987

         FACTA FARMA            EQ   250MG   BASE
	              A062118   001
	
                                EQ   500MG   BASE
	              A062118   002
	
         IVAX SUB TEVA PHARMS   EQ   250MG   BASE
	              A061969   001
	
                                EQ   500MG   BASE
	              A061969   002
	
         PUREPAC PHARM          EQ   250MG   BASE
	              A062809   001     Apr   22,   1987

                                EQ   500MG   BASE
	              A062809   002     Apr   22,   1987

         STEVENS J              EQ   250MG   BASE
	              A062870   001     Mar   17,   1988
	
                                EQ   500MG   BASE
	              A062869   001     Mar   17,   1988
	
         TEVA                   EQ   250MG   BASE
	              A062760   001     Apr   24,   1987

                                EQ   250MG   BASE
	              A062821   001     Feb   05,   1988
	
                                EQ   500MG   BASE
	              A062761   001     Apr   24,   1987

                                EQ   500MG   BASE
	              A062823   001     Feb   05,   1988
	
         YOSHITOMI              EQ   250MG   BASE
	              A062872   001     Jun   20,   1988
	
                                EQ   500MG   BASE
	              A062871   001     Jul   05,   1988
	
   KEFLEX
	
        SHIONOGI INC            EQ 333MG BASE
	                  N050405 004 May 12, 2006
	
 FOR SUSPENSION;ORAL
	
   CEPHALEXIN
	
        APOTHECON               EQ   125MG   BASE/5ML
           A062986   001     Apr   18,   1991

                                EQ   250MG   BASE/5ML
           A062987   001     Jul   25,   1989
	
         BARR                   EQ   125MG   BASE/5ML
           A062778   001     Aug   06,   1987

                                EQ   250MG   BASE/5ML
           A062777   001     Aug   06,   1987

         FACTA FARMA		          EQ   100MG   BASE/ML
            A062117   001
	
                                EQ   125MG   BASE/5ML
           A062117   002
	
                                EQ   250MG   BASE/5ML
           A062117   003
	
         HIKMA PHARMS           EQ   125MG   BASE/5ML
           A065444   001     Aug   28,   2009

                                EQ   250MG   BASE/5ML
           A065444   002     Aug   28,   2009

         RANBAXY                EQ   125MG   BASE/5ML
           A065081   001     Jul   27,   2001
	
                                EQ   250MG   BASE/5ML
           A065081   002     Jul   27,   2001
	
         TEVA                   EQ   125MG   BASE/5ML
           A062767   001     Jun   16,   1987
	
                                EQ   125MG   BASE/5ML
           A062873   001     May   23,   1988

                                EQ   250MG   BASE/5ML
           A062768   001     Jun   16,   1987
	
                                EQ   250MG   BASE/5ML
           A062867   001     Apr   15,   1988

         VITARINE               EQ   125MG   BASE/5ML
           A062779   001     Dec   22,   1987
	
                                EQ   250MG   BASE/5ML
           A062781   001     Dec   22,   1987
	
         YUNG SHIN PHARM        EQ   125MG   BASE/5ML
           A065336   001     Jul   25,   2007
	
                                EQ   250MG   BASE/5ML
           A065336   002     Jul   25,   2007
	
   KEFLEX
	
        SHIONOGI INC		          EQ 100MG BASE/ML
                N050406 003
	
                                EQ 125MG BASE/5ML
               N050406 001
	
                                EQ 250MG BASE/5ML
	              N050406 002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-67(of 337)

CEPHALEXIN
  TABLET;ORAL
    CEPHALEXIN
         BARR                  EQ   250MG BASE                  A062826   001   Aug   17,   1987
                               EQ   500MG BASE                  A062827   001   Aug   17,   1987
        VITARINE               EQ   1GM BASE                    A062863   003   Aug   11,   1988
                               EQ   250MG BASE                  A062863   001   Aug   11,   1988
                               EQ   500MG BASE                  A062863   002   Aug   11,   1988
   KEFLET
        LILLY                  EQ   1GM BASE                    N050440   002
                               EQ   250MG BASE                  A062745   001 Dec 01, 1986
                               EQ   250MG BASE                  N050440   003 Feb 26, 1987
                               EQ   500MG BASE                  A062745   002 Dec 01, 1986
                               EQ   500MG BASE                  N050440   001
 TABLET, FOR SUSPENSION;ORAL
   PANIXINE DISPERDOSE
        RANBAXY LABS LTD       EQ 125MG BASE                    A065100 002 Sep 11, 2003
                               EQ 250MG BASE                    A065100 001 Sep 11, 2003
CEPHALEXIN HYDROCHLORIDE
  TABLET;ORAL
    KEFTAB
         LILLY                 EQ 250MG BASE                    N050614 001 Oct 29, 1987
                               EQ 333MG BASE                    N050614 003 May 16, 1988
                               EQ 500MG BASE                    N050614 002 Oct 29, 1987
CEPHALOGLYCIN
  CAPSULE;ORAL
    KAFOCIN
         LILLY                 250MG                            N050219 001
CEPHALOTHIN SODIUM
  INJECTABLE;INJECTION
    CEPHALOTHIN
         INTL MEDICATION       EQ   1GM BASE/VIAL               A062426   002   May   03,   1985
                               EQ   2GM BASE/VIAL               A062426   003   May   03,   1985
                               EQ   4GM BASE/VIAL               A062426   004   May   03,   1985
                               EQ   500MG BASE/VIAL             A062426   001   May   03,   1985
   CEPHALOTHIN SODIUM
        ABBOTT                 EQ 1GM BASE/VIAL                 A062547   001   Sep   11,   1985
                               EQ 1GM BASE/VIAL                 A062548   001   Sep   11,   1985
                               EQ 2GM BASE/VIAL                 A062547   002   Sep   11,   1985
                               EQ 2GM BASE/VIAL                 A062548   002   Sep   11,   1985
        ABRAXIS PHARM          EQ 1GM BASE/VIAL                 A062666   002   Jun   10,   1987
                               EQ 2GM BASE/VIAL                 A062666   001   Jun   10,   1987
        BRISTOL                EQ 1GM BASE/VIAL                 A062464   001   May   07,   1984
                               EQ 2GM BASE/VIAL                 A062464   002   May   07,   1984
                               EQ 4GM BASE/VIAL                 A062464   003   May   07,   1984
   CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
        BAXTER HLTHCARE        EQ 20MG BASE/ML                  A062422   003   Jan   31,   1984
                               EQ 20MG BASE/ML                  A062422   005   Jul   16,   1991
                               EQ 20MG BASE/ML                  A062730   001   Mar   05,   1987
                               EQ 40MG BASE/ML                  A062422   004   Jan   31,   1984
                               EQ 40MG BASE/ML                  A062422   006   Jul   16,   1991
                               EQ 40MG BASE/ML                  A062730   002   Mar   05,   1987
   CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
        BAXTER HLTHCARE        EQ 20MG BASE/ML                  A062422 001 Jan 31, 1984
                               EQ 40MG BASE/ML                  A062422 002 Jan 31, 1984
   KEFLIN
        LILLY                  EQ 1GM BASE/VIAL                 N050482   001
                               EQ 2GM BASE/VIAL                 N050482   002
                               EQ 4GM BASE/VIAL                 N050482   003
                               EQ 20GM BASE/VIAL                N050482   007
   KEFLIN IN PLASTIC CONTAINER
        LILLY                  EQ 1GM BASE/VIAL                 A062549 001 Sep 10, 1985
                               EQ 2GM BASE/VIAL                 A062549 002 Sep 10, 1985
   SEFFIN
        GLAXOSMITHKLINE        EQ 1GM BASE/VIAL                 A062435 001 Nov 15, 1983
                               EQ 2GM BASE/VIAL                 A062435 002 Nov 15, 1983
                               EQ 10GM BASE/VIAL                A062435 003 Nov 15, 1983
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                       6-68(of 337)


CEPHAPIRIN SODIUM
	
  INJECTABLE;INJECTION
	
    CEFADYL
	
         APOTHECON		            EQ   1GM BASE/VIAL
             A061769   001
	
                                EQ   1GM BASE/VIAL
             A062724   001     Dec 23, 1986
	
                                EQ   1GM BASE/VIAL
             A062961   002     Sep 20, 1988

                                EQ   1GM BASE/VIAL
             N050446   001
	
                                EQ   2GM BASE/VIAL
             A061769   002
	
                                EQ   2GM BASE/VIAL
             A062724   002     Dec 23, 1986
	
                                EQ   2GM BASE/VIAL
             A062961   003     Sep 20, 1988

                                EQ   2GM BASE/VIAL
             N050446   002
	
                                EQ   4GM BASE/VIAL
             A061769   003
	
                                EQ   4GM BASE/VIAL
             A062961   004     Sep 20, 1988

                                EQ   4GM BASE/VIAL
             N050446   003
	
                                EQ   20GM BASE/VIAL
            N050446   004
	
                                EQ   500MG BASE/VIAL
           A062961   001     Sep 20, 1988

                                EQ   500MG BASE/VIAL
           N050446   005
	
   CEPHAPIRIN SODIUM
	
        ABRAXIS PHARM		         EQ   1GM BASE/VIAL
             A062723   002     Nov   17,   1986
	
                                EQ   2GM BASE/VIAL
             A062723   003     Nov   17,   1986
	
                                EQ   4GM BASE/VIAL
             A062723   004     Nov   17,   1986
	
                                EQ   20GM BASE/VIAL
            A062723   005     Nov   17,   1986
	
                                EQ   500MG BASE/VIAL
           A062723   001     Nov   17,   1986
	
         HIKMA MAPLE		          EQ   1GM BASE/VIAL
             A062720   002     Jul   02,   1987
	
                                EQ   2GM BASE/VIAL
             A062720   003     Jul   02,   1987
	
                                EQ   20GM BASE/VIAL
            A062720   004     Jul   02,   1987
	
                                EQ   500MG BASE/VIAL
	          A062720   001     Jul   02,   1987
	
CEPHRADINE
	
  CAPSULE;ORAL
	
    ANSPOR
	
         GLAXOSMITHKLINE        250MG
	                         A061859 001
	
                                500MG
	                         A061859 002
	
   CEPHRADINE
	
        BARR                    250MG
	                         A062850   001     Apr   22,   1988

                                500MG
	                         A062851   001     Apr   22,   1988

         IVAX SUB TEVA PHARMS   250MG
	                         A062762   001     Mar   06,   1987
	
                                500MG
	                         A062762   002     Mar   06,   1987
	
         TEVA                   250MG
	                         A062683   001     Jan   09,   1987
	
                                500MG
	                         A062683   002     Jan   09,   1987
	
         VITARINE               250MG
	                         A062813   001     Feb   25,   1988
	
                                500MG
	                         A062813   002     Feb   25,   1988
	
   VELOSEF
	
        APOTHECON               250MG
	                         A061764 001
	
                                500MG
	                         A061764 002
	
   VELOSEF '250'
	
        ERSANA                  250MG
	                         N050548 001
	
   VELOSEF '500'
	
        ERSANA                  500MG
	                         N050548 002
	
 FOR SUSPENSION;ORAL
	
   ANSPOR
	
        GLAXOSMITHKLINE         125MG/5ML
                      A061866 001
	
                                250MG/5ML
                      A061866 002
	
   CEPHRADINE
	
        BARR                    125MG/5ML
                      A062858   001     May   19,   1988

                                250MG/5ML
                      A062859   001     May   19,   1988

         TEVA                   125MG/5ML
                      A062693   001     Jan   09,   1987
	
                                250MG/5ML
                      A062693   002     Jan   09,   1987
	
   VELOSEF '125'
	
        APOTHECON               125MG/5ML
                      A061763 001
	
   VELOSEF '250'
	
        APOTHECON               250MG/5ML
                      A061763 002
	
 INJECTABLE;INJECTION
	
   VELOSEF
	
        APOTHECON		             1GM/VIAL
                       A061976   004
	
                                2GM/VIAL
                       A061976   003
	
                                4GM/VIAL
                       A061976   005
	
                                250MG/VIAL
                     A061976   001
	
                                500MG/VIAL
                     A061976   002
	
 TABLET;ORAL
	
   VELOSEF
	
        BRISTOL MYERS SQUIBB    1GM
	                           N050530 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                6-69(of 337)

CERIVASTATIN SODIUM
  TABLET;ORAL
    BAYCOL
         BAYER PHARMS           0.05MG                                  N020740   001   Jun   26,   1997
                                0.1MG                                   N020740   002   Jun   26,   1997
                                0.2MG                                   N020740   003   Jun   26,   1997
                                0.3MG                                   N020740   004   Jun   26,   1997
                                0.4MG                                   N020740   005   May   24,   1999
                                0.8MG                                   N020740   006   Jul   24,   2000
CERULETIDE DIETHYLAMINE
  INJECTABLE;INJECTION
    TYMTRAN
         PHARMACIA AND UPJOHN   0.02MG/ML                               N018296 001
CETIRIZINE HYDROCHLORIDE
  SYRUP;ORAL
    CETIRIZINE HYDROCHLORIDE
         ACTAVIS MID ATLANTIC   5MG/5ML                                 A078617   001   Feb   02,   2010
         APOTEX INC             5MG/5ML                                 A078412   001   Jun   18,   2008
         AUROBINDO PHARMA LTD   5MG/5ML                                 A090751   001   Dec   16,   2009
         RANBAXY LABS LTD       5MG/5ML                                 A077472   001   Jun   18,   2008
    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
         ACTAVIS MID ATLANTIC   5MG/5ML                                 A090378 002 May 09, 2008
         APOTEX INC             5MG/5ML                                 A090188 002 Apr 22, 2008
         RANBAXY LABS LTD       5MG/5ML                                 A090183 002 Apr 24, 2008
    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
         ACTAVIS MID ATLANTIC   5MG/5ML                                 A090378 001 May 09, 2008
         APOTEX INC             5MG/5ML                                 A090188 001 Apr 22, 2008
         RANBAXY LABS LTD       5MG/5ML                                 A090183 001 Apr 24, 2008
  TABLET;ORAL
    CETIRIZINE HYDROCHLORIDE ALLERGY
         ACTAVIS ELIZABETH      5MG                                     A078615 003 Dec 28, 2007
                                10MG                                    A078615 004 Dec 28, 2007
  TABLET, CHEWABLE;ORAL
    CETIRIZINE HYDROCHLORIDE ALLERGY
         SUN PHARM INDS INC     5MG                                     A077631 004 Jan 11, 2008
                                10MG                                    A077631 003 Jan 11, 2008
    CETIRIZINE HYDROCHLORIDE HIVES RELIEF
         SUN PHARM INDS INC     5MG                                     A077631 001 Jan 11, 2008
                                10MG                                    A077631 002 Jan 11, 2008
    CHILDREN'S ZYRTEC ALLERGY
         MCNEIL CONS            5MG **Federal Register determination    N021621 003 Nov 16, 2007
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                10MG **Federal Register determination   N021621 004 Nov 16, 2007
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
    CHILDREN'S ZYRTEC HIVES RELIEF
         MCNEIL CONS            5MG **Federal Register determination    N021621 005 Nov 16, 2007
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                10MG **Federal Register determination   N021621 006 Nov 16, 2007
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
CETRORELIX
  INJECTABLE;INJECTION
    CETROTIDE
         EMD SERONO INC         EQ 3MG BASE/ML                          N021197 002 Aug 11, 2000
CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL
  FOR SUSPENSION;INTRATRACHEAL
    EXOSURF NEONATAL
         GLAXOSMITHKLINE        12MG/VIAL;108MG/VIAL;8MG/VIAL           N020044 001 Aug 02, 1990
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                      6-70(of 337)


CHENODIOL
	
  TABLET;ORAL
	
    CHENIX
	
         SIGMA TAU
	             250MG
	                           N018513 002 Jul 28, 1983
	
CHLOPHEDIANOL HYDROCHLORIDE
	
  SYRUP;ORAL
	
    ULO
	
          3M
	                   25MG/5ML
	                        N012126 001
	
CHLORAMPHENICOL
	
  CAPSULE;ORAL
	
    AMPHICOL
	
         FERRANTE
	              100MG
	                           A060058 001
	
    CHLOROMYCETIN
	
         PARKEDALE
	             50MG
	                            A060591 001
	
                                 100MG
	                           A060591 003
	
  CREAM;TOPICAL
	
    CHLOROMYCETIN
	
         PARKE DAVIS
	           1%
	                              N050183 001
	
  FOR SOLUTION;OPHTHALMIC
	
    CHLOROMYCETIN
	
         PARKEDALE
	             25MG/VIAL
	                       N050143 001
	
  INJECTABLE;INJECTION
	
    CHLOROMYCETIN
	
         PARKE DAVIS
	           250MG/ML
	                        N050153 001
	
  OINTMENT;OPHTHALMIC
	
    CHLORAMPHENICOL
	
         ALTANA
	                1%
	                              A060133 001
	
    CHLOROFAIR
	
         PHARMAFAIR
	            1%
	                              A062439 001 Apr 21, 1983
	
    CHLOROMYCETIN
	
         PARKEDALE
	             1%
	                              N050156 001
	
    CHLOROPTIC S.O.P.
	
         ALLERGAN
	              1%
	                              A061187 001
	
    ECONOCHLOR
	
         ALCON
	                 1%
	                              A061648 001
	
  SOLUTION/DROPS;OPHTHALMIC

    CHLORAMPHENICOL
	
         AKORN
	                 0.5%
	                            A062042 001
	
         ALCON
	                 0.5%
	                            A062628 001 Sep 25, 1985
	
    CHLOROFAIR
	
         PHARMAFAIR
	            0.5%
	                            A062437 001 Apr 14, 1983
	
    CHLOROPTIC
	
         ALLERGAN
	              0.5%
	                            N050091 001
	
    ECONOCHLOR
	
         ALCON
	                 0.5%
	                            A061645 001
	
    OPHTHOCHLOR
	
         PARKEDALE
	             0.5%
	                            A061220 001
	
    OPTOMYCIN
	
         OPTOPICS
	              0.5%
	                            A062171 001 Mar 31, 1982
	
  SOLUTION/DROPS;OTIC

    CHLOROMYCETIN
	
         PARKEDALE
	             0.5%
	                            N050205 001
	
CHLORAMPHENICOL PALMITATE
	
  SUSPENSION;ORAL
	
    CHLOROMYCETIN PALMITATE
	
         PARKE DAVIS
	           EQ 150MG BASE/5ML
                A062301 001
	
                                 EQ 150MG BASE/5ML
	               N050152 001
	
CHLORAMPHENICOL SODIUM SUCCINATE
	
  INJECTABLE;INJECTION
	
    CHLORAMPHENICOL
	
         ELKINS SINN            EQ 1GM     BASE/VIAL
              A062406 001 Nov 09, 1982
	
    CHLORAMPHENICOL SODIUM SUCCINATE
	
         GRUPPO LEPETIT         EQ 1GM     BASE/VIAL               A062278 001
	
    CHLOROMYCETIN
         PARKEDALE              EQ 1GM     BASE/VIAL               N050155 001
	
    MYCHEL-S
         ANGUS                  EQ 1GM     BASE/VIAL               A060132 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                          6-71(of 337)


CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN
	
  OINTMENT;TOPICAL
	
    ELASE-CHLOROMYCETIN
	
         PARKE DAVIS            10MG/GM;666 UNITS/GM;1 UNITS/GM
	   N050294 001
	
CHLORAMPHENICOL; HYDROCORTISONE ACETATE
	
  FOR SUSPENSION;OPHTHALMIC
	
    CHLOROMYCETIN HYDROCORTISONE
	
         PARKEDALE              12.5MG/VIAL;25MG/VIAL
	             N050202 001
	
CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    OPHTHOCORT
	
         PARKEDALE              10MG/GM;5MG/GM;10,000 UNITS/GM
	    N050201 002
	
CHLORAMPHENICOL; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    CHLOROMYXIN
	
         PARKE DAVIS            1%;10,000 UNITS/GM
	                N050203 002
	
CHLORAMPHENICOL; PREDNISOLONE
	
  OINTMENT;OPHTHALMIC
	
    CHLOROPTIC-P S.O.P.
	
         ALLERGAN                 1%;0.5%
	                         A061188 001
	
CHLORDIAZEPOXIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    LIBRELEASE
	
         VALEANT PHARM INTL     30MG
	                              N017813 001 Sep 12, 1983
	
  TABLET;ORAL
	
    LIBRITABS
	
         VALEANT PHARM INTL		   5MG
	                               A085482 001
	
                                10MG
	                              A085481 001
	
                                25MG
	                              A085488 001
	
CHLORDIAZEPOXIDE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    A-POXIDE
	
         ABBOTT		                5MG
	                              A085447   001
	
                                 5MG
	                              A085517   001
	
                                 10MG
	                             A085447   002
	
                                 10MG
	                             A085518   001
	
                                 25MG
	                             A085447   003
	
                                 25MG
	                             A085513   001
	
    CHLORDIAZACHEL
	
         RACHELLE		              5MG
	                              A085086 001
	
                                 10MG
	                             A084639 001
	
                                 25MG
	                             A085087 001
	
    CHLORDIAZEPOXIDE HYDROCHLORIDE
	
         ASCOT		                 5MG
	                              A087525   001 Jan 07, 1982
	
                                 10MG
	                             A087524   001 Jan 07, 1982
	
                                 25MG
	                             A087512   001 Jan 07, 1982
	
         FERRANTE		              5MG
	                              A085118   001
	
                                 10MG
	                             A085119   001
	
                                 25MG
	                             A085120   001
	
         HALSEY		                5MG
	                              A085340   001
	
                                 10MG
	                             A085339   001
	
                                 25MG
	                             A084685   001
	
         HIKMA PHARMS LLC		      5MG
	                              A085014   001
	
                                 10MG
	                             A085000   001
	
                                 25MG
	                             A085294   001
	
         IMPAX LABS		            5MG
	                              A086213   001
	
                                 10MG
	                             A085113   001
	
                                 25MG
	                             A086212   001
	
         IVAX SUB TEVA PHARMS		 5MG
	                               A083741   001
	
                                 10MG
	                             A083742   001
	
                                 25MG
	                             A083570   001
	
         LEDERLE		               5MG
	                              A086892   001
	
                                 5MG
	                              A087234   001
	
                                 10MG
	                             A086876   001
	
                                 10MG
	                             A087037   001
	
                                 25MG
	                             A086893   001
	
                                 25MG
	                             A087231   001
	
         MAST MM                 10MG
	                             A086217   001
	
         MYLAN                   5MG
	                              A084886   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                      6-72(of 337)


CHLORDIAZEPOXIDE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    CHLORDIAZEPOXIDE HYDROCHLORIDE
	
                                 10MG
	                         A084601   001
	
                                 25MG
	                         A084887   001
	
         PARKE DAVIS
	           5MG
	                          A085163   001
	
                                 10MG
	                         A084598   001
	
                                 25MG
	                         A085164   001
	
         PIONEER PHARMS
	        10MG
	                         A089533   001     Jul 15, 1988
	
                                 25MG
	                         A089558   001     Jul 15, 1988
	
         PUREPAC PHARM
	         5MG
	                          A085155   001
	
                                 10MG
	                         A084939   002
	
                                 25MG
	                         A085144   001
	
         ROXANE
	                5MG
	                          A084706   001
	
                                 10MG
	                         A084700   001
	
                                 25MG
	                         A084705   001
	
         SANDOZ
	                5MG
	                          A084678   001
	
                                 5MG
	                          A084919   001
	
                                 10MG
	                         A084041   001
	
                                 10MG
	                         A084920   001
	
                                 25MG
	                         A084679   002
	
                                 25MG
	                         A084823   001
	
         SUPERPHARM
	            5MG
	                          A088987   001     Apr   25,   1985

                                 10MG
	                         A088986   001     Apr   25,   1985

                                 25MG
	                         A088988   001     Apr   25,   1985

         TEVA
	                  5MG
	                          A088705   001     Jan   18,   1985
	
                                 10MG
	                         A088706   001     Jan   18,   1985
	
                                 25MG
	                         A086494   001
	
                                 25MG
	                         A088707   001     Jan 18, 1985
	
         USL PHARMA
	            5MG
	                          A084644   001
	
                                 25MG
	                         A084645   001
	
         VANGARD
	               5MG
	                          A088129   001     Mar 28, 1983
	
                                 10MG
	                         A088010   001     Mar 28, 1983
	
                                 25MG
	                         A088130   001     Mar 28, 1983
	
         WATSON LABS
	           5MG
	                          A086383   001
	
                                 10MG
	                         A086294   001
	
                                 25MG
	                         A086382   001
	
    LIBRIUM
	
         VALEANT PHARM INTL
	    5MG
	                          N012249 002
	
                                 10MG
	                         N012249 001
	
                                 25MG
	                         N012249 003
	
    LYGEN
	
         ALRA
	                  5MG
	                          A085107 001
	
                                 10MG
	                         A085009 001
	
                                 25MG
	                         A085108 001
	
  INJECTABLE;INJECTION
	
    LIBRIUM
	
         VALEANT PHARMS LLC
	    100MG/AMP
	                    N012301 001
	
CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED
	
  TABLET;ORAL
	
    MENRIUM 10-4
	
         ROCHE
	                10MG;0.4MG
	                    N014740 006
	
    MENRIUM 5-2
	
         ROCHE
	                5MG;0.2MG
	                     N014740 002
	
    MENRIUM 5-4
	
         ROCHE
	                5MG;0.4MG
	                     N014740 004
	
CHLORHEXIDINE GLUCONATE
	
  SOLUTION;DENTAL
	
    CHLORHEXIDINE GLUCONATE
	
         APOTEX INC
	            0.12%
	                        A075561 001 Nov 14, 2000
	
  SOLUTION;TOPICAL
	
    EXIDINE
	
         XTTRIUM
	               2.5%
	                         N019421 001 Dec 17, 1985
	
    MICRODERM
	
         J AND J
	               4%
	                           A072255 001 Apr 15, 1991
	
    PREVACARE R
	
         J AND J
	               0.5%
	                         A072292 001 Jan 28, 1992
	
    STERI-STAT
	
         MATRIX MEDCL
	          4%
	                           A070104 001 Jul 24, 1986
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                            6-73(of 337)

CHLORHEXIDINE GLUCONATE
  SPONGE;TOPICAL
    CHLORHEXIDINE GLUCONATE
         KENDALL IL             4%                                     N019490 001 Mar 27, 1987
    E-Z SCRUB
         BECTON DICKINSON       4%                                     A073416 001 Mar 14, 2000
    HIBICLENS
         MOLNLYCKE HLTH         4% **Federal Register determination    N018423 001
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
   MICRODERM
        J AND J                 4%                                     A072295 001 Feb 28, 1991
CHLORMERODRIN HG-197
  INJECTABLE;INJECTION
    CHLORMERODRIN HG 197
         BRACCO                 0.6-1.4mCi/ML                          N017269 001
CHLORMEZANONE
  TABLET;ORAL
    TRANCOPAL
         SANOFI AVENTIS US      100MG                                  N011467 003
                                200MG                                  N011467 005
CHLOROPROCAINE HYDROCHLORIDE
  INJECTABLE;INJECTION
    NESACAINE-MPF
         FRESENIUS KABI USA     2%                                     N009435 003
                                3%                                     N009435 004
CHLOROQUINE HYDROCHLORIDE
  INJECTABLE;INJECTION
    ARALEN HYDROCHLORIDE
         SANOFI AVENTIS US      EQ 40MG BASE/ML                        N006002 002
CHLOROQUINE PHOSPHATE
  TABLET;ORAL
    CHLOROQUINE PHOSPHATE
         MD PHARM               EQ   150MG   BASE                      A087228   001
         PUREPAC PHARM          EQ   150MG   BASE                      A080886   001
         TEVA                   EQ   150MG   BASE                      A087504   001 Jan 13, 1982
         WATSON LABS            EQ   150MG   BASE                      A087979   001 Dec 21, 1982
                                EQ   300MG   BASE                      A088030   001 Dec 21, 1982
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
  TABLET;ORAL
    ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE
         SANOFI AVENTIS US      EQ 300MG BASE;EQ 45MG BASE             N014860 002
CHLOROTHIAZIDE
  TABLET;ORAL
    CHLOROTHIAZIDE
         ABC HOLDING            250MG                                  A085569   001
         HIKMA INTL PHARMS      250MG                                  A086028   001   Jul 14, 1982
                                500MG                                  A087736   001   Jul 14, 1982
        LEDERLE                 250MG                                  A086940   001
                                500MG                                  A086938   001
        SANDOZ                  250MG                                  A085485   001
        WATSON LABS             250MG                                  A085165   001
                                250MG                                  A085173   001
                                250MG                                  A086795   001   Aug 15, 1983
                                500MG                                  A084026   001   Sep 01, 1982
                                500MG                                  A086796   001   Aug 15, 1983
   DIURIL
        OAK PHARMS AKORN        250MG                                  N011145 004
                                500MG                                  N011145 002
CHLOROTHIAZIDE; METHYLDOPA
  TABLET;ORAL
    ALDOCLOR-150
         MERCK                  150MG;250MG                            N016016 001
    ALDOCLOR-250
         MERCK                  250MG;250MG                            N016016 002
    METHYLDOPA AND CHLOROTHIAZIDE
         PAR PHARM              150MG;250MG                            A070783 001 Nov 06, 1987
                                250MG;250MG                            A070654 001 Nov 06, 1987
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                    6-74(of 337)

CHLOROTHIAZIDE; RESERPINE
  TABLET;ORAL
    CHLOROTHIAZIDE AND RESERPINE
         HIKMA PHARMS LLC       250MG;0.125MG                  A088557 001 Dec 22, 1983
                                500MG;0.125MG                  A088365 001 Dec 22, 1983
    CHLOROTHIAZIDE W/ RESERPINE
         WATSON LABS            250MG;0.125MG                  A084853 001
                                500MG;0.125MG                  A088151 001 Jun 09, 1983
    CHLOROTHIAZIDE-RESERPINE
         MYLAN                  250MG;0.125MG                  A087744 001 May 06, 1982
                                500MG;0.125MG                  A087745 001 May 06, 1982
    DIUPRES-250
         MERCK                  250MG;0.125MG                  N011635 003 Aug 26, 1987
    DIUPRES-500
         MERCK                  500MG;0.125MG                  N011635 006 Aug 26, 1987
CHLOROTRIANISENE
  CAPSULE;ORAL
    CHLOROTRIANISENE
         BANNER PHARMACAPS      12MG                           A084652 001
    TACE
         SANOFI AVENTIS US      12MG                           N008102 004
                                25MG                           N011444 001
                                72MG                           N016235 001
CHLOROXINE
  SHAMPOO;TOPICAL
    CAPITROL
         WESTWOOD SQUIBB        2%                             N017594 001
CHLORPHENESIN CARBAMATE
  TABLET;ORAL
    MAOLATE
         PHARMACIA AND UPJOHN   400MG                          N014217 002
CHLORPHENIRAMINE MALEATE
  CAPSULE, EXTENDED RELEASE;ORAL
    CHLORPHENIRAMINE MALEATE
         SANDOZ                 12MG                           A070797 001 Aug 12, 1988
    TELDRIN
         GLAXOSMITHKLINE        8MG                            N017369 001
                                12MG                           N017369 002
  INJECTABLE;INJECTION
    CHLOR-TRIMETON
         SCHERING PLOUGH        10MG/ML                        N008826 001
                                100MG/ML                       N008794 001
    CHLORPHENIRAMINE MALEATE
         BEL MAR                10MG/ML                        A080821   001
         ELKINS SINN            10MG/ML                        A080797   001
         WATSON LABS            10MG/ML                        A083593   001
                                10MG/ML                        A086096   001
                                100MG/ML                       A086095   001
    PYRIDAMAL 100
         BEL MAR                100MG/ML                       A083733 001
  SYRUP;ORAL
    CHLOR-TRIMETON
         SCHERING               2MG/5ML                        N006921 006
    CHLORPHENIRAMINE MALEATE
         PHARM ASSOC            2MG/5ML                        A087520 001 Feb 10, 1982
  TABLET;ORAL
    ANTAGONATE
         BAYER PHARMS           4MG                            A083381 001
    CHLOR-TRIMETON
         SCHERING               4MG                            N006921 002
    CHLORPHENIRAMINE MALEATE
         ANABOLIC               4MG                            A083078   001
         BELL PHARMA            4MG                            A083062   001
         ELKINS SINN            4MG                            A080938   001
         IMPAX LABS             4MG                            A080809   001
         IVAX SUB TEVA PHARMS   4MG                            A080779   001
         KV PHARM               4MG                            A087164   001
         LEDERLE                4MG                            A086941   001
         MUTUAL PHARM           4MG                            A080700   001
         NEWTRON PHARMS         4MG                            A086519   001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                               6-75(of 337)

CHLORPHENIRAMINE MALEATE
  TABLET;ORAL
    CHLORPHENIRAMINE MALEATE
         PANRAY                4MG                                      A083243   001
         PHARMAVITE            4MG                                      A085104   001
         PHARMERAL             4MG                                      A083753   001
         PIONEER PHARMS        4MG                                      A088556   001 Jul 13, 1984
         PUREPAC PHARM         4MG                                      A086306   001
         PVT FORM              4MG                                      A080786   001
         ROXANE                4MG                                      A080626   001
         SANDOZ                4MG                                      A080961   001
         VITARINE              4MG                                      A085837   001
         WATSON LABS           4MG                                      A080696   001
                               4MG                                      A080791   001
                               4MG                                      A085139   001
        WEST WARD              4MG                                      A083787   001
   KLOROMIN
        HALSEY                 4MG                                      A083629 001
   PHENETRON
        LANNETT                4MG                                      A080846 001
 TABLET, EXTENDED RELEASE;ORAL
   CHLOR-TRIMETON
        SCHERING PLOUGH        8MG                                      N007638 001
   EFIDAC 24 CHLORPHENIRAMINE MALEATE
        ALZA                   16MG                                     N019746 002 Nov 18, 1994
CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
  CAPSULE, EXTENDED RELEASE;ORAL
    COLD CAPSULE IV
         GRAHAM DM              12MG;75MG                               N018793 001 Apr 25, 1985
    COLD CAPSULE V
         GRAHAM DM              8MG;75MG                                N018794 001 Apr 23, 1985
  TABLET, EXTENDED RELEASE;ORAL
    TRIAMINIC-12
         NOVARTIS               12MG;75MG                               N018115 001
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
  CAPSULE, EXTENDED RELEASE;ORAL
    CODIMAL-L.A. 12
         SCHWARZ PHARMA         12MG;120MG                              N018935 001 Apr 15, 1985
    ISOCLOR
         FISONS                 8MG;120MG                               N018747 001 Mar 06, 1986
    PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE
         CENT PHARMS            8MG;120MG                               N019428   001   Aug   02,   1988
         GRAHAM DM              8MG;120MG                               N018844   001   Mar   20,   1985
                                12MG;120MG                              N018843   001   Mar   18,   1985
         KV PHARM               12MG;120MG                              A071455   001   Mar   01,   1989
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
  SUSPENSION, EXTENDED RELEASE;ORAL
    CODEPREX
         UCB INC                EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML     N021369 001 Jun 21, 2004
    PENNTUSS
         FISONS                 EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML     N018928 001 Aug 14, 1985
CHLORPHENTERMINE HYDROCHLORIDE
  TABLET;ORAL
    PRE-SATE
         PARKE DAVIS           EQ 65MG BASE                             N014696 001
CHLORPROMAZINE
  SUPPOSITORY;RECTAL
    THORAZINE
         GLAXOSMITHKLINE       25MG **Federal Register determination    N009149 024
                               that product was not discontinued or
                               withdrawn for safety or efficacy
                               reasons**
                               100MG **Federal Register determination   N009149 033
                               that product was not discontinued or
                               withdrawn for safety or efficacy
                               reasons**
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                  6-76(of 337)

CHLORPROMAZINE HYDROCHLORIDE
  CAPSULE, EXTENDED RELEASE;ORAL
    THORAZINE
         GLAXOSMITHKLINE        30MG                                      N011120   016
                                75MG                                      N011120   017
                                150MG                                     N011120   018
                                200MG                                     N011120   019
                                300MG                                     N011120   020
  CONCENTRATE;ORAL
    CHLORPROMAZINE HYDROCHLORIDE
         ACTAVIS MID ATLANTIC   100MG/ML                                  A086863   001
         PHARM ASSOC            30MG/ML                                   A040231   001 Dec 30, 1999
                                100MG/ML                                  A040224   001 Jan 26, 1999
         WOCKHARDT              30MG/ML                                   A087032   001 Jul 08, 1982
                                100MG/ML                                  A087053   001
    CHLORPROMAZINE HYDROCHLORIDE INTENSOL
         ROXANE                 30MG/ML                                   A088157 001 Apr 27, 1983
                                100MG/ML                                  A088158 001 Apr 27, 1983
    SONAZINE
         SANDOZ                 30MG/ML                                   A080983 004
                                100MG/ML                                  A080983 005
    THORAZINE
         GLAXOSMITHKLINE        30MG/ML **Federal Register                N009149 032
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
                                100MG/ML **Federal Register               N009149 043
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
  INJECTABLE;INJECTION
    CHLORPROMAZINE HYDROCHLORIDE
         ABRAXIS PHARM          25MG/ML                                   A084911   001
         MARSAM PHARMS LLC      25MG/ML                                   A089563   001 Apr 15, 1988
         WATSON LABS            25MG/ML                                   A080365   001
                                25MG/ML                                   A085591   001
         WYETH AYERST           25MG/ML                                   A080370   001
    THORAZINE
         GLAXOSMITHKLINE        25MG/ML                                   N009149 011
  SYRUP;ORAL
    CHLORPROMAZINE HYDROCHLORIDE
         ALPHARMA US PHARMS     10MG/5ML                                  A086712 001
    SONAZINE
         SANDOZ                 10MG/5ML                                  A083040 001
    THORAZINE
         GLAXOSMITHKLINE        10MG/5ML **Federal Register               N009149 022
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
  TABLET;ORAL
    CHLORPROMAZINE HYDROCHLORIDE
         ABBOTT                 10MG                                      A084414   001
                                25MG                                      A084415   001
                                50MG                                      A084411   001
                                100MG                                     A084412   001
                                200MG                                     A084413   001
         IVAX SUB TEVA PHARMS   10MG                                      A083549   001
                                25MG                                      A083549   002
                                50MG                                      A083549   003
                                100MG                                     A083574   001
                                200MG                                     A083575   001
         KV PHARM               10MG                                      A085750   002 Jan 04, 1982
                                25MG                                      A085751   001
                                50MG                                      A085484   001
                                100MG                                     A085752   001
                                200MG                                     A085748   002 Jan 04, 1982
         LEDERLE                10MG                                      A084803   001
                                25MG                                      A084801   001
                                50MG                                      A084800   001
                                100MG                                     A084789   001
                                200MG                                     A084802   001
         PUREPAC PHARM          10MG                                      A080403   004
                                25MG                                      A080403   001
                                50MG                                      A080403   002
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                        6-77(of 337)


CHLORPROMAZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    CHLORPROMAZINE HYDROCHLORIDE
	
                                100MG
	                           A080403   003
	
                                200MG
	                           A080403   005
	
         PVT FORM               25MG
	                            A080340   001
	
                                50MG
	                            A080340   002
	
                                200MG
	                           A080340   003
	
         ROXANE                 10MG
	                            A085331   001
	
                                25MG
	                            A085331   002
	
                                50MG
	                            A085331   003
	
                                100MG
	                           A085331   004
	
                                200MG
	                           A085331   005
	
         VANGARD                10MG
	                            A088038   001     Aug 16, 1982

                                25MG
	                            A087645   001
	
                                50MG
	                            A087646   001
	
         WATSON LABS            10MG
	                            A085959   001
	
                                25MG
	                            A085956   001
	
                                50MG
	                            A085960   001
	
                                100MG
	                           A085957   001
	
                                200MG
	                           A085958   001
	
         WEST WARD              10MG
	                            A087783   001     Sep   16,   1982

                                25MG
	                            A087865   001     Sep   16,   1982

                                50MG
	                            A087878   001     Sep   15,   1982

                                100MG
	                           A087884   001     Sep   15,   1982

                                200MG
	                           A087880   001     Sep   16,   1982
	
    PROMAPAR
	
         PARKE DAVIS            10MG
	                            A086886   001
	
                                25MG
	                            A084423   001
	
                                50MG
	                            A086887   001
	
                                100MG
	                           A086888   001
	
                                200MG
	                           A086885   001
	
    THORAZINE
	
         GLAXOSMITHKLINE        10MG
	                            N009149   002
	
                                25MG
	                            N009149   007
	
                                50MG
	                            N009149   013
	
                                100MG
	                           N009149   018
	
                                200MG
	                           N009149   020
	
CHLORPROPAMIDE
	
  TABLET;ORAL
	
    CHLORPROPAMIDE
	
         ANI PHARMS INC         100MG
	                           A088768   001     Oct   11,   1984
	
                                100MG
	                           A088812   001     Oct   19,   1984
	
                                100MG
	                           A088840   001     Oct   25,   1984
	
                                100MG
	                           A088918   001     Oct   16,   1984
	
                                100MG
	                           A089446   001     Nov   17,   1986
	
                                250MG
	                           A088813   001     Oct   19,   1984
	
                                250MG
	                           A088919   001     Oct   16,   1984
	
                                250MG
	                           A089447   001     Nov   17,   1986
	
         DAVA PHARMS INC        100MG
	                           A089561   001     Sep   04,   1987

                                250MG
	                           A089562   001     Sep   04,   1987

         HALSEY                 100MG
	                           A089321   001     Jan   16,   1986
	
                                250MG
	                           A088662   001     Jan   09,   1986
	
         PAR PHARM              100MG
	                           A088175   001     Feb   27,   1984
	
                                250MG
	                           A088176   001     Feb   27,   1984
	
         SANDOZ                 100MG
	                           A088725   001     Aug   31,   1984

                                250MG
	                           A084669   001
	
                                250MG
	                           A088726   001     Aug 31, 1984

         SUPERPHARM             100MG
	                           A088694   001     Sep 17, 1984

                                250MG
	                           A088695   001     Sep 17, 1984

         TEVA PHARMS USA        250MG
	                           A087353   001
	
         USL PHARMA             100MG
	                           A088708   001     Aug   30,   1984

                                250MG
	                           A088709   001     Aug   30,   1984

         WATSON LABS            100MG
	                           A086865   001     Sep   24,   1984

                                100MG
	                           A088608   001     Apr   12,   1984

                                250MG
	                           A086866   001
	
                                250MG
	                           A088568   001     Apr 12, 1984

         WATSON LABS INC        100MG
	                           A088852   001     Sep 26, 1984

                                250MG
	                           A088826   001     Sep 26, 1984
	
   GLUCAMIDE
	
        TEVA PHARMS USA         250MG
	                           A088641 001 Oct 11, 1984
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                        6-78(of 337)


CHLORPROTHIXENE
	
  CONCENTRATE;ORAL
	
    TARACTAN
	
         ROCHE                   100MG/5ML
                        N016149 002
	
  INJECTABLE;INJECTION
	
    TARACTAN
	
         ROCHE                   12.5MG/ML
                        N012487 001
	
  TABLET;ORAL
	
    TARACTAN
	
         ROCHE		                 10MG
	                            N012486   005
	
                                 25MG
	                            N012486   004
	
                                 50MG
	                            N012486   003
	
                                 100MG
	                           N012486   001
	
CHLORTETRACYCLINE HYDROCHLORIDE
	
  OINTMENT;OPHTHALMIC
	
    AUREOMYCIN
	
         LEDERLE                 1%
	                              N050404 001
	
CHLORTHALIDONE
	
  TABLET;ORAL
	
    CHLORTHALIDONE
	
         ABBOTT                  25MG
	                            A087364   001
	
                                 50MG
	                            A087384   001
	
         ASCOT                   25MG
	                            A087698   001     Oct   20,   1982
	
                                 50MG
	                            A087699   001     Oct   20,   1982
	
         BARR LABS INC           25MG
	                            A088902   001     Sep   19,   1985

                                 50MG
	                            A088903   001     Sep   19,   1985

         DAVA PHARMS INC         25MG
	                            A087451   001
	
                                 50MG
	                            A087450   001
	
         IVAX PHARMS             25MG
	                            A087555   001
	
                                 25MG
	                            A088164   001     Jan 09, 1984
	
                                 50MG
	                            A087176   001
	
                                 50MG
	                            A087947   001     Feb 27, 1984
	
         KV PHARM                25MG
	                            A087311   001
	
                                 50MG
	                            A087312   001
	
         MUTUAL PHARM            25MG
	                            A087292   001
	
                                 25MG
	                            A089285   001     Jul 21, 1986
	
                                 25MG
	                            A089738   001     Sep 19, 1988

                                 50MG
	                            A087293   001
	
                                 50MG
	                            A089286   001     Jul   21,   1986
	
                                 50MG
	                            A089739   001     Sep   19,   1988

         PIONEER PHARMS          50MG
	                            A089591   001     Jul   21,   1988
	
         PUREPAC PHARM           25MG
	                            A088139   001     Jul   16,   1986
	
                                 50MG
	                            A088140   001     Aug   11,   1983

         SANDOZ                  25MG
	                            A087380   001
	
                                 50MG
	                            A087118   001
	
                                 50MG
	                            A087381   001
	
         SUPERPHARM              25MG
	                            A087473   001     Feb   09,   1983
	
                                 50MG
	                            A087247   001     Feb   09,   1983
	
         TEVA                    50MG
	                            A088651   001     May   30,   1985

         USL PHARMA              25MG
	                            A089051   001     Jun   01,   1987
	
                                 50MG
	                            A089052   001     Jun   01,   1987
	
         VANGARD                 25MG
	                            A088012   001     Jul   14,   1982
	
                                 50MG
	                            A088073   001     Mar   25,   1983
	
         WARNER CHILCOTT         25MG
	                            A087515   001     Jan   24,   1983
	
                                 50MG
	                            A087516   001     Feb   09,   1983
	
         WATSON LABS             25MG
	                            A087050   001
	
                                 25MG
	                            A087100   001
	
                                 25MG
	                            A087296   001
	
                                 25MG
	                            A087706   001
	
                                 50MG
	                            A087029   001
	
                                 50MG
	                            A087082   001
	
                                 50MG
	                            A087521   001
	
                                 50MG
	                            A087689   001
	
    HYGROTON
	
         SANOFI AVENTIS US       25MG
	                            N012283 004
	
                                 50MG
	                            N012283 003
	
    THALITONE
	
         CITRON PHARMA LLC       25MG
	                            N019574 002 Feb 12, 1992
	
         MONARCH PHARMS          25MG
	                            A088051 001 Nov 12, 1982
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-79(of 337)

CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
  TABLET;ORAL
    CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE
         PAR PHARM              15MG;0.1MG                               A071179 001 Dec 16, 1987
                                15MG;0.2MG                               A071178 001 Dec 16, 1987
                                15MG;0.3MG                               A071142 001 Dec 16, 1987
    COMBIPRES
         BOEHRINGER INGELHEIM   15MG;0.1MG                               N017503 001
                                15MG;0.2MG                               N017503 002
                                15MG;0.3MG                               N017503 003 Apr 10, 1984
CHLORTHALIDONE; METOPROLOL TARTRATE
  CAPSULE;ORAL
    LOPRESSIDONE
         NOVARTIS               25MG;100MG                               N019451 001 Dec 31, 1987
                                25MG;200MG                               N019451 002 Dec 31, 1987
CHLORTHALIDONE; RESERPINE
  TABLET;ORAL
    DEMI-REGROTON
         SANOFI AVENTIS US      25MG;0.125MG                             N015103 002
    REGROTON
         SANOFI AVENTIS US      50MG;0.25MG                              N015103 001
CHLORZOXAZONE
  TABLET;ORAL
    CHLORZOXAZONE
         ACTAVIS ELIZABETH      250MG                                    A088928   001   May   08,   1987
                                500MG                                    A040113   001   Sep   29,   1995
        MUTUAL PHARM            500MG                                    A089970   001   Sep   27,   1990
        OHM LABS                250MG                                    A081298   001   Dec   29,   1993
                                500MG                                    A081299   001   Dec   29,   1993
        PAR PHARM               250MG                                    A087981   001   Sep   20,   1983
        PIONEER PHARMS          250MG                                    A089592   001   Jan   06,   1989
                                500MG                                    A089948   001   Jan   06,   1989
        SANDOZ                  250MG                                    A089852   001   May   04,   1988
                                500MG                                    A089853   001   May   04,   1988
        WATSON LABS             250MG                                    A086901   001
                                250MG                                    A086948   001   Aug   09,   1982
                                500MG                                    A040137   001   Aug   09,   1996
                                500MG                                    A081019   001   Jul   29,   1991
                                500MG                                    A081040   001   Aug   22,   1989
   PARAFLEX
        ORTHO MCNEIL PHARM      250MG **Federal Register determination   N011300 003
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
   STRIFON FORTE DSC
        FERNDALE LABS           500MG                                    A081008 001 Dec 23, 1988
CHOLESTYRAMINE
  BAR, CHEWABLE;ORAL
    CHOLYBAR
         PARKE DAVIS            EQ 4GM RESIN/BAR                         A071621 001 May 26, 1988
                                EQ 4GM RESIN/BAR                         A071739 001 May 26, 1988
 POWDER;ORAL
   CHOLESTYRAMINE
        IVAX SUB TEVA PHARMS    EQ   4GM   RESIN/PACKET                  A074771   001   Jul   09,   1997
                                EQ   4GM   RESIN/SCOOPFUL                A074771   002   Jul   09,   1997
        TEVA                    EQ   4GM   RESIN/PACKET                  A074347   001   May   28,   1998
                                EQ   4GM   RESIN/SCOOPFUL                A074347   002   May   28,   1998
        TEVA PHARMS             EQ   4GM   RESIN/PACKET                  A074554   001   Oct   02,   1996
                                EQ   4GM   RESIN/SCOOPFUL                A074554   002   Oct   02,   1996
   CHOLESTYRAMINE LIGHT
        TEVA                    EQ   4GM   RESIN/PACKET                  A074348   001   May   28,   1998
                                EQ   4GM   RESIN/SCOOPFUL                A074348   002   May   28,   1998
        TEVA PHARMS             EQ   4GM   RESIN/PACKET                  A074555   001   Sep   30,   1998
                                EQ   4GM   RESIN/SCOOPFUL                A074555   002   Sep   30,   1998
   LOCHOLEST
        SANDOZ                  EQ 4GM RESIN/PACKET                      A074561 001 Aug 15, 1996
                                EQ 4GM RESIN/SCOOPFUL                    A074561 002 Aug 15, 1996
   LOCHOLEST LIGHT
        SANDOZ                  EQ 4GM RESIN/PACKET                      A074562 001 Aug 15, 1996
                                EQ 4GM RESIN/SCOOPFUL                    A074562 002 Aug 15, 1996
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-80(of 337)

CHOLESTYRAMINE
  POWDER;ORAL
    QUESTRAN
         BRISTOL MYERS          EQ 4GM RESIN/PACKET                       N016640 001
                                EQ 4GM RESIN/SCOOPFUL                     N016640 003
   QUESTRAN LIGHT
        BRISTOL MYERS           EQ 4GM RESIN/PACKET                       N019669 001 Dec 05, 1988
                                EQ 4GM RESIN/SCOOPFUL                     N019669 003 Dec 05, 1988
 TABLET;ORAL
   QUESTRAN
        APOTHECON               EQ 1GM RESIN                              A073403 001 Apr 28, 1994
                                EQ 800MG RESIN                            A073403 002 Dec 27, 1999
CHORIOGONADOTROPIN ALFA
  INJECTABLE;INJECTION
    OVIDREL
         EMD SERONO             0.25MG/VIAL                               N021149 001 Sep 20, 2000
CHROMIC CHLORIDE
  INJECTABLE;INJECTION
    CHROMIC CHLORIDE
         ABRAXIS PHARM          EQ 0.004MG CHROMIUM/ML                    N019271 001 May 05, 1987
CHROMIC PHOSPHATE P-32
  INJECTABLE;INJECTION
    PHOSPHOCOL P32
         MALLINCKRODT           5mCi/ML                                   N017084 001
CHYMOPAPAIN
  INJECTABLE;INJECTION
    CHYMODIACTIN
         CHART MEDCL            4,000 UNITS/VIAL                          N018663 002 Aug 21, 1984
                                10,000 UNITS/VIAL **Federal Register      N018663 001 Nov 10, 1982
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
   DISCASE
        ABBOTT                  12,500 UNITS/VIAL                         N018625 001 Jan 18, 1984
CHYMOTRYPSIN
  FOR SOLUTION;OPHTHALMIC
    ALPHA CHYMAR
         SOLA BARNES HIND       750 UNITS/VIAL                            N011837 001
    CATARASE
         CIBA                   300 UNITS/VIAL                            N016938 001
         NOVARTIS               150 UNITS/VIAL                            N018121 001
    ZOLYSE
         ALCON                  750 UNITS/VIAL                            N011903 001
CICLOPIROX
  SOLUTION;TOPICAL
    CICLOPIROX
         APOTEX INC             8%                                        A078172 001 Sep 18, 2007
         MYLAN PHARMS INC       8%                                        A078567 001 Sep 18, 2007
         TEVA PHARMS            8%                                        A078079 001 Sep 18, 2007
CILASTATIN SODIUM; IMIPENEM
  INJECTABLE;INJECTION
    PRIMAXIN
         MERCK                  EQ 250MG BASE/VIAL;250MG/VIAL             A062756 001 Jan 08, 1987
                                EQ 500MG BASE/VIAL;500MG/VIAL             A062756 002 Jan 08, 1987
 POWDER;INTRAMUSCULAR
   PRIMAXIN
        MERCK                   EQ 750MG BASE/VIAL;750MG/VIAL             N050630 002 Dec 14, 1990
CILOSTAZOL
  TABLET;ORAL
    CILOSTAZOL
         ACTAVIS ELIZABETH      100MG                                     A077028   002   Nov   26,   2004
         COREPHARMA             50MG                                      A077150   001   Mar   11,   2005
                                100MG                                     A077022   001   Nov   23,   2004
        IVAX SUB TEVA PHARMS    100MG                                     A077020   002   Mar   01,   2005
        MUTUAL PHARM            50MG                                      A077208   002   Mar   29,   2006
                                100MG                                     A077208   001   Mar   29,   2006
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                            6-81(of 337)


CIMETIDINE
	
  SUSPENSION;ORAL
	
    TAGAMET HB 200
	
         GLAXOSMITHKLINE
	        200MG/20ML
	                            N020951 001 Jul 09, 1999
	
  TABLET;ORAL
	
    CIMETIDINE
	
         CYCLE PHARMS LTD
	       300MG
	                                 A074361   001   Dec   23,   1994
	
                                  400MG
	                                 A074361   002   Dec   23,   1994
	
                                  800MG
	                                 A074371   001   Dec   23,   1994
	
         DAVA PHARMS INC
	        300MG
	                                 A074340   001   Jun   23,   1995
	
                                  400MG
	                                 A074340   002   Jun   23,   1995
	
                                  800MG
	                                 A074339   001   Jun   23,   1995
	
         IVAX SUB TEVA PHARMS
	   200MG
	                                 A074401   001   May   30,   1995

                                  200MG
	                                 A074424   001   Jul   28,   1995
	
                                  300MG
	                                 A074401   002   May   30,   1995

                                  300MG
	                                 A074424   002   Jul   28,   1995
	
                                  400MG
	                                 A074401   003   May   30,   1995

                                  400MG
	                                 A074424   003   Jul   28,   1995
	
                                  800MG
	                                 A074402   001   May   30,   1995

                                  800MG
	                                 A074424   004   Jul   28,   1995
	
         LEK PHARMS
	             100MG
	                                 A075122   001   Jun   19,   1998
	
                                  200MG
	                                 A074250   001   Jun   29,   1995
	
                                  200MG
	                                 A075122   002   Jun   19,   1998
	
                                  300MG
	                                 A074250   002   Jun   29,   1995
	
                                  400MG
	                                 A074250   003   Jun   29,   1995
	
                                  800MG
	                                 A074250   004   Jun   29,   1995
	
         PERRIGO
	                100MG
	                                 A074972   001   Jun   19,   1998
	
         PLIVA
	                  200MG
	                                 A074568   001   Feb   27,   1997
	
                                  300MG
	                                 A074568   002   Feb   27,   1997
	
                                  400MG
	                                 A074568   003   Feb   27,   1997
	
         SANDOZ
	                 200MG
	                                 A074100   001   Jan   31,   1995
	
                                  200MG
	                                 A074506   001   Jan   24,   1996
	
                                  300MG
	                                 A074100   002   Jan   31,   1995
	
                                  300MG
	                                 A074506   002   Jan   24,   1996
	
                                  400MG
	                                 A074100   003   Jan   31,   1995
	
                                  400MG
	                                 A074506   003   Jan   24,   1996
	
                                  800MG
	                                 A074100   004   Jan   31,   1995
	
                                  800MG
	                                 A074506   004   Jan   24,   1996
	
         TEVA
	                   200MG
	                                 A074365   001   Feb   28,   1995
	
                                  300MG
	                                 A074365   002   Feb   28,   1995
	
                                  400MG
	                                 A074365   003   Feb   28,   1995
	
                                  800MG
	                                 A074365   004   Feb   28,   1995
	
         VINTAGE PHARMS LLC
	     200MG
	                                 A074281   001   May   17,   1994

                                  300MG
	                                 A074281   002   May   17,   1994

                                  400MG
	                                 A074281   003   May   17,   1994

                                  800MG
	                                 A074329   001   May   17,   1994

         WATSON LABS
	            200MG
	                                 A075425   001   Jul   29,   1999
	
         WATSON LABS INC
	        200MG
	                                 A074349   001   Aug   30,   1996

                                  300MG
	                                 A074349   002   Aug   30,   1996

                                  400MG
	                                 A074349   003   Aug   30,   1996

                                  800MG
	                                 A074316   001   Feb   28,   1996
	
   TAGAMET
	
        GLAXOSMITHKLINE
	         200MG
	                                 N017920   002
	
                                  300MG
	                                 N017920   003
	
                                  400MG
	                                 N017920   004 Dec 14, 1983
	
                                  800MG
	                                 N017920   005 Apr 30, 1986
	
   TAGAMET HB
	
        MEDTECH PRODUCTS
	        100MG
	                                 N020238 001 Jun 19, 1995
	
CIMETIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CIMETIDINE HYDROCHLORIDE
	
         HOSPIRA
	             EQ 300MG BASE/2ML
                          A074296 001    Mar   28,   1997
	
                               EQ 300MG BASE/2ML
                          A074344 001    Jan   31,   1995
	
                               EQ 300MG BASE/2ML
                          A074345 001    Jan   31,   1995
	
                               EQ 300MG BASE/2ML
                          A074412 001    Mar   28,   1997
	
                               EQ 300MG BASE/2ML
                          A074422 001    Jan   31,   1995
	
        LUITPOLD
	             EQ 300MG BASE/2ML
                          A074353 001    Dec   20,   1994
	
        TEVA PARENTERAL
	      EQ 300MG BASE/2ML
                          A074252 001    Nov   26,   1997
	
        VINTAGE PHARMS LLC
	   EQ 300MG BASE/2ML
	                         A074005 001    Aug   31,   1994
	
   CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
        HOSPIRA                EQ 6MG BASE/ML
                             A074269 001    Dec 27, 1994
	
                               EQ 90MG BASE/100ML
	                        A074468 005    Dec 29, 1994
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                   6-82(of 337)


CIMETIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
                                EQ 120MG BASE/100ML                         A074468   006   Dec   29,   1994
                                EQ 180MG BASE/100ML                         A074468   003   Dec   29,   1994
                                EQ 240MG BASE/100ML                         A074468   004   Dec   29,   1994
                                EQ 360MG BASE/100ML                         A074468   001   Dec   29,   1994
                                EQ 480MG BASE/100ML                         A074468   002   Dec   29,   1994
    TAGAMET
         GLAXOSMITHKLINE        EQ 300MG BASE/2ML                           N017939   002
    TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
         GLAXOSMITHKLINE        EQ 6MG BASE/ML                              N019434   001 Oct 31, 1985
  SOLUTION;ORAL
    CIMETIDINE HYDROCHLORIDE
         ACTAVIS MID ATLANTIC   EQ 300MG BASE/5ML                           A074176   001   Jun   01,   1994
         ANI PHARMS INC         EQ 300MG BASE/5ML                           A074859   001   Jul   09,   1998
                                EQ 300MG BASE/5ML                           A075110   001   Jun   18,   1998
         APOTEX INC             EQ 300MG BASE/5ML                           A075560   001   Mar   15,   2000
         CYCLE PHARMS LTD       EQ 300MG BASE/5ML                           A074541   001   Aug   05,   1997
         VINTAGE PHARMS LLC     EQ 300MG BASE/5ML                           A074251   001   Dec   22,   1994
    TAGAMET
         GLAXOSMITHKLINE        EQ 300MG BASE/5ML                           N017924   001
CINOXACIN
  CAPSULE;ORAL
    CINOBAC
         LILLY                  250MG                                      N018067 001
                                500MG                                      N018067 002
   CINOXACIN
        TEVA                    250MG                                      A073005 001 Feb 28, 1992
                                500MG                                      A073006 001 Feb 28, 1992
CIPROFLOXACIN
  INJECTABLE;INJECTION
    CIPRO
          BAYER HLTHCARE        1200MG/120ML (10MG/ML)                     N019847 003 Dec 26, 1990
    CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
         BAYER PHARMS           200MG/100ML                                N019858 001 Dec 26, 1990
    CIPROFLOXACIN
         BEDFORD LABS           200MG/20ML (10MG/ML)                       A076992    001   Aug   28,   2006
                                400MG/40ML (10MG/ML)                       A076992    002   Aug   28,   2006
                                1200MG/120ML (10MG/ML)                     A076993    001   Aug   28,   2006
         FRESENIUS KABI USA     200MG/20ML (10MG/ML)                       A076484    001   Aug   28,   2006
                                400MG/40ML (10MG/ML)                       A076484    002   Aug   28,   2006
         TEVA PHARMS USA        200MG/20ML (10MG/ML)                       A077782    001   Aug   28,   2006
                                400MG/40ML (10MG/ML)                       A077782    002   Aug   28,   2006
    CIPROFLOXACIN IN DEXTROSE 5%
         HIKMA FARMACEUTICA     200MG/100ML                                A076757 001 Apr 21, 2008
    CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
         BAXTER HLTHCARE        200MG/100ML                                A077888    001   Mar   18,   2008
                                400MG/200ML                                A077888    002   Mar   18,   2008
         BEDFORD                200MG/100ML                                A078114    001   Mar   18,   2008
                                400MG/200ML                                A078114    002   Mar   18,   2008
         TEVA PHARMS            200MG/100ML                                A077138    001   Mar   18,   2008
                                400MG/200ML                                A077138    002   Mar   18,   2008
CIPROFLOXACIN HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    CIPROFLOXACIN HYDROCHLORIDE
         APOTEX INC             EQ 0.3% BASE                               A075928 001 Jun 09, 2004
  TABLET;ORAL
    CIPROFLOXACIN HYDROCHLORIDE
         BARR                   EQ 250MG BASE                              A074124    001   Jun   09,   2004
                                EQ 500MG BASE                              A074124    002   Jun   09,   2004
                                EQ 750MG BASE                              A074124    003   Jun   09,   2004
         NOSTRUM LABS           EQ 250MG BASE                              A076138    001   Jun   09,   2004
                                EQ 500MG BASE                              A076138    002   Jun   09,   2004
                                EQ 750MG BASE                              A076138    003   Jun   09,   2004
         PLIVA                  EQ 100MG BASE                              A076426    001   Jun   15,   2005
                                EQ 250MG BASE                              A076426    002   Jun   15,   2005
                                EQ 500MG BASE                              A076426    003   Jun   15,   2005
                                EQ 750MG BASE                              A076426    004   Jun   15,   2005
         SANDOZ                 EQ 100MG BASE                              A075939    001   Mar   03,   2005
                                EQ 250MG BASE                              A075939    002   Jun   09,   2004
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                   6-83(of 337)

CIPROFLOXACIN HYDROCHLORIDE
  TABLET;ORAL
    CIPROFLOXACIN HYDROCHLORIDE
                                  EQ   250MG   BASE                         A076593   002   Jun   09,   2004
                                  EQ   500MG   BASE                         A075939   003   Jun   09,   2004
                                  EQ   500MG   BASE                         A076593   003   Jun   09,   2004
                                  EQ   750MG   BASE                         A075939   004   Jun   09,   2004
                                  EQ   750MG   BASE                         A076593   004   Jun   09,   2004
        TEVA                      EQ   250MG   BASE                         A076136   001   Jun   09,   2004
                                  EQ   500MG   BASE                         A076136   002   Jun   09,   2004
                                  EQ   750MG   BASE                         A076136   003   Jun   09,   2004
 TABLET, EXTENDED RELEASE;ORAL
   PROQUIN XR
        DEPOMED INC            EQ 500MG BASE                                N021744 001 May 19, 2005
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
  TABLET, EXTENDED RELEASE;ORAL
    CIPRO XR
         BAYER HLTHCARE         212.6MG;EQ       287.5MG BASE               N021473 001 Dec 13, 2002
                                425.2MG;EQ       574.9MG BASE               N021473 002 Aug 28, 2003
    CIPROFLOXACIN EXTENDED RELEASE
         DR REDDYS LABS LTD     212.6MG;EQ       287.5MG BASE               A077701 002 Oct 31, 2007
         SANDOZ                 212.6MG;EQ       287.5MG BASE               A078712 001 Dec 11, 2007
CISAPRIDE MONOHYDRATE
  SUSPENSION;ORAL
    PROPULSID
         JANSSEN PHARMS           EQ 1MG BASE/ML                            N020398 001 Sep 15, 1995
  TABLET;ORAL
    PROPULSID
         JANSSEN PHARMS        EQ 10MG BASE                                 N020210 001 Jul 29, 1993
                               EQ 20MG BASE                                 N020210 002 Dec 23, 1993
 TABLET, ORALLY DISINTEGRATING;ORAL
   PROPULSID QUICKSOLV
        JANSSEN PHARMA         EQ 20MG BASE                                 N020767 001 Nov 07, 1997
CISPLATIN
  INJECTABLE;INJECTION
    CISPLATIN
         BEDFORD                  10MG/VIAL                                 A074713 001 Nov 14, 2000
                                  50MG/VIAL                                 A074713 002 Nov 14, 2000
        TEVA PHARMS USA           1MG/ML                                    A074814 001 May 16, 2000
   PLATINOL
        HQ SPCLT PHARMA           10MG/VIAL                                 N018057 001
                                  50MG/VIAL                                 N018057 002
   PLATINOL-AQ
        HQ SPCLT PHARMA           0.5MG/ML                                  N018057 003 Jul 18, 1984
CITALOPRAM HYDROBROMIDE
  SOLUTION;ORAL
    CELEXA
         FOREST LABS              EQ 10MG BASE/5ML **Federal Register       N021046 001 Dec 22, 1999
                                  determination that product was not
                                  discontinued or withdrawn for safety or
                                  efficacy reasons**
   CITALOPRAM HYDROBROMIDE
        APOTEX INC                EQ 10MG BASE/5ML                          A077601 001 Nov 15, 2005
 TABLET;ORAL
   CELEXA
        FOREST LABS               EQ 60MG BASE                              N020822 004 Jul 17, 1998
   CITALOPRAM HYDROBROMIDE
        ACTAVIS ELIZABETH         EQ   10MG   BASE                          A077033   001   Oct   28,   2004
                                  EQ   20MG   BASE                          A077033   002   Oct   28,   2004
                                  EQ   40MG   BASE                          A077033   003   Oct   28,   2004
        COREPHARMA                EQ   10MG   BASE                          A077036   001   Oct   28,   2004
                                  EQ   20MG   BASE                          A077036   002   Oct   28,   2004
                                  EQ   40MG   BASE                          A077036   003   Oct   28,   2004
        MUTUAL PHARM              EQ   10MG   BASE                          A077052   001   Jul   03,   2006
                                  EQ   20MG   BASE                          A077052   002   Jul   03,   2006
                                  EQ   40MG   BASE                          A077052   003   Jul   03,   2006
        NATCO PHARMA LTD          EQ   20MG   BASE                          A077141   002   Apr   10,   2008
                                  EQ   40MG   BASE                          A077141   001   Apr   10,   2008
        ROXANE                    EQ   10MG   BASE                          A077041   001   Nov   23,   2004
                                  EQ   20MG   BASE                          A077041   002   Nov   23,   2004
                                  EQ   40MG   BASE                          A077041   003   Nov   23,   2004
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                  6-84(of 337)

CITALOPRAM HYDROBROMIDE
  TABLET;ORAL
    CITALOPRAM HYDROBROMIDE
         SANDOZ                EQ 10MG       BASE                         A077035   001   Oct   28,   2004
                               EQ 10MG       BASE                         A077040   001   Aug   17,   2005
                               EQ 20MG       BASE                         A077035   002   Oct   28,   2004
                               EQ 20MG       BASE                         A077040   002   Aug   17,   2005
                               EQ 40MG       BASE                         A077035   003   Oct   28,   2004
                               EQ 40MG       BASE                         A077040   003   Aug   17,   2005
        TARO                   EQ 10MG       BASE                         A077278   001   Mar   22,   2006
                               EQ 20MG       BASE                         A077278   002   Mar   22,   2006
                               EQ 40MG       BASE                         A077278   003   Mar   22,   2006
        TEVA PHARMS            EQ 10MG       BASE                         A077213   001   Mar   31,   2006
                               EQ 20MG       BASE                         A077213   002   Mar   31,   2006
                               EQ 40MG       BASE                         A077213   003   Mar   31,   2006
        WATSON LABS            EQ 10MG       BASE                         A077034   001   Jun   30,   2005
                               EQ 20MG       BASE                         A077034   002   Jun   30,   2005
                               EQ 40MG       BASE                         A077034   003   Jun   30,   2005
 TABLET, ORALLY DISINTEGRATING;ORAL
   CITALOPRAM HYDROBROMIDE
        BIOVAIL LABS INTL      EQ 10MG       BASE                         N021763 001 Dec 20, 2005
                               EQ 20MG       BASE                         N021763 002 Dec 20, 2005
                               EQ 40MG       BASE                         N021763 003 Dec 20, 2005
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
  SOLUTION;IRRIGATION
    IRRIGATING SOLUTION G IN PLASTIC CONTAINER
         BAXTER HLTHCARE        3.24GM/100ML;380MG/100ML;430MG/100ML      N018519 001 Jun 22, 1982
    UROLOGIC G IN PLASTIC CONTAINER
         HOSPIRA                3.24GM/100ML;380MG/100ML;430MG/100ML      N018904 001 May 27, 1983
CLADRIBINE
  INJECTABLE;INJECTION
    LEUSTATIN
         JANSSEN PHARMS         1MG/ML **Federal Register determination   N020229 001 Feb 26, 1993
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
CLARITHROMYCIN
  FOR SUSPENSION;ORAL
    BIAXIN
         ABBVIE                 187MG/5ML                                 N050698 003 Sep 30, 1998
  TABLET;ORAL
    CLARITHROMYCIN
         IVAX SUB TEVA PHARMS   250MG                                     A065137 001 May 31, 2005
                                500MG                                     A065137 002 May 31, 2005
 TABLET, EXTENDED RELEASE;ORAL
   CLARITHROMYCIN
        RANBAXY                1GM                                        A065210 001 Jan 26, 2005
        SANDOZ                 500MG                                      A065250 001 Aug 25, 2005
CLEMASTINE FUMARATE
  SYRUP;ORAL
    CLEMASTINE FUMARATE
         ACTAVIS MID ATLANTIC   EQ   0.5MG   BASE/5ML                     A074075   001   Oct   31,   1993
         APOTEX INC             EQ   0.5MG   BASE/5ML                     A075703   001   Nov   27,   2000
         SILARX                 EQ   0.5MG   BASE/5ML                     A074884   001   Dec   17,   1997
         TEVA PHARMS            EQ   0.5MG   BASE/5ML                     A073095   001   Apr   21,   1992
    TAVIST
         NOVARTIS               EQ 0.5MG BASE/5ML                         N018675 001 Jun 28, 1985
  TABLET;ORAL
    CLEMASTINE FUMARATE
         TEVA                   1.34MG                                    A073282 001 Jan 31, 1992
                                1.34MG                                    A073282 002 Dec 03, 1992
   TAVIST
        NOVARTIS                2.68MG                                    N017661 001
   TAVIST-1
        NOVARTIS                1.34MG                                    N017661 002
                                1.34MG                                    N017661 003 Aug 21, 1992
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                        6-85(of 337)

CLIDINIUM BROMIDE
  CAPSULE;ORAL
    QUARZAN
         ROCHE                  2.5MG                           N010355 001
                                5MG                             N010355 002
CLINDAMYCIN HYDROCHLORIDE
  CAPSULE;ORAL
    CLEOCIN
         PHARMACIA AND UPJOHN   EQ 75MG BASE                    A061809 001
                                EQ 150MG BASE                   A061809 002
   CLINDAMYCIN HYDROCHLORIDE
        TEVA                    EQ 75MG BASE                    A063027 001 Sep 20, 1989
        WATSON LABS             EQ 75MG BASE                    A063082 001 Jul 31, 1991
CLINDAMYCIN PALMITATE HYDROCHLORIDE
  FOR SOLUTION;ORAL
    CLEOCIN
         PHARMACIA AND UPJOHN   EQ 75MG BASE/5ML                A061827 001
CLINDAMYCIN PHOSPHATE
  CREAM;VAGINAL
    CLEOCIN
         PHARMACIA AND UPJOHN   EQ 2% BASE                      N050680 001 Aug 11, 1992
  INJECTABLE;INJECTION
    CLEOCIN PHOSPHATE
         PHARMACIA AND UPJOHN   EQ 150MG BASE/ML                A061839 001
    CLINDAMYCIN PHOSPHATE
         ABRAXIS PHARM         EQ 150MG BASE/ML                 A062747   001   Jun   03,   1988
         ASTRAZENECA           EQ 150MG BASE/ML                 A062928   001   Feb   13,   1989
         BEDFORD               EQ 150MG BASE/ML                 A063163   001   Jun   30,   1994
         BRISTOL MYERS SQUIBB  EQ 150MG BASE/ML                 A062908   001   Feb   01,   1989
         HIKMA MAPLE           EQ 150MG BASE/ML                 A062806   001   Oct   15,   1987
                               EQ 150MG BASE/ML                 A062953   001   Apr   21,   1988
                               EQ 150MG BASE/ML                 A063068   001   Aug   28,   1989
        LOCH                   EQ 150MG BASE/ML                 A062905   001   May   09,   1988
        MARSAM PHARMS LLC      EQ 150MG BASE/ML                 A062913   001   Oct   20,   1988
        SOLOPAK                EQ 150MG BASE/ML                 A062819   001   Mar   15,   1988
                               EQ 150MG BASE/ML                 A062852   001   Mar   17,   1988
        TEVA PARENTERAL        EQ 150MG BASE/ML                 A063041   001   Dec   29,   1989
                               EQ 150MG BASE/ML                 A063282   001   May   29,   1992
        WATSON LABS            EQ 150MG BASE/ML                 A062900   001   Jun   08,   1988
                               EQ 150MG BASE/ML                 A063079   001   Mar   05,   1990
   CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%
        ABRAXIS PHARM          EQ 12MG BASE/ML                  N050636 001 Dec 22, 1989
   CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
        ABBVIE                 EQ 6MG BASE/ML                   A065027   001   Jun   29,   2001
                               EQ 12MG BASE/ML                  A065027   002   Jun   29,   2001
                               EQ 18MG BASE/ML                  A065027   003   Jun   29,   2001
        BAXTER HLTHCARE        EQ 6MG BASE/ML                   N050648   001   Dec   29,   1989
                               EQ 12MG BASE/ML                  N050648   002   Dec   29,   1989
                               EQ 900MG BASE/100ML              N050648   003   Dec   29,   1989
 SOLUTION;TOPICAL
   CLEOCIN T
        PHARMACIA AND UPJOHN   EQ 1% BASE                       A062363 001 Feb 08, 1982
   CLINDAMYCIN PHOSPHATE
        COPLEY PHARM           EQ 1% BASE                       A062944 001 Jan 11, 1989
        RENAISSANCE PHARMA     EQ 1% BASE                       A064108 001 Sep 27, 1996
        VINTAGE PHARMS         EQ 1% BASE                       A062930 001 Jun 28, 1989
CLIOQUINOL; NYSTATIN
  OINTMENT;TOPICAL
    NYSTAFORM
         BAYER PHARMS           10MG/GM;100,000 UNITS/GM        N050235 001
CLOBAZAM
  TABLET;ORAL
    ONFI
         LUNDBECK LLC           5MG                             N202067 001 Oct 21, 2011
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-86(of 337)

CLOBETASOL PROPIONATE
  CREAM;TOPICAL
    CLOBETASOL PROPIONATE
         RENAISSANCE PHARMA     0.05%                                    A075338 001 Feb 09, 2001
         TEVA PHARMS USA        0.05%                                    A074087 001 Feb 16, 1994
    CLOBETASOL PROPIONATE (EMOLLIENT)
         RENAISSANCE PHARMA     0.05%                                    A075733 001 Aug 22, 2001
  OINTMENT;TOPICAL
    CLOBETASOL PROPIONATE
         ACTAVIS MID ATLANTIC   0.05%                                    A074128 001 Aug 03, 1994
         RENAISSANCE PHARMA     0.05%                                    A075057 001 Aug 12, 1998
  SOLUTION;TOPICAL
    CLOBETASOL PROPIONATE
         G AND W LABS INC       0.05%                                    A074331 001 Dec 15, 1995
    TEMOVATE
         FOUGERA PHARMS         0.05% **Federal Register determination   N019966 001 Feb 22, 1990
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
CLOFAZIMINE
  CAPSULE;ORAL
    LAMPRENE
         NOVARTIS                100MG                                   N019500 001 Dec 15, 1986
CLOFIBRATE
  CAPSULE;ORAL
    ATROMID-S
         WYETH AYERST            500MG                                   N016099 002
    CLOFIBRATE
         BANNER PHARMACAPS       500MG                                   A073396   001   Mar   20,   1992
         SANDOZ                  500MG                                   A072191   001   May   02,   1988
         TEVA                    500MG                                   A072600   001   Jul   25,   1991
         USL PHARMA              500MG                                   A070531   001   Jun   16,   1986
         WATSON LABS             500MG                                   A071603   001   Sep   18,   1987
CLOMIPHENE CITRATE
  TABLET;ORAL
    MILOPHENE
         MILEX                   50MG                                    A072196 001 Dec 20, 1988
CLOMIPRAMINE HYDROCHLORIDE
  CAPSULE;ORAL
    CLOMIPRAMINE HYDROCHLORIDE
         SANDOZ                  25MG                                    A074953   001   Jun   25,   1997
                                 50MG                                    A074953   002   Jun   25,   1997
                                 75MG                                    A074953   003   Jun   25,   1997
        TEVA                     25MG                                    A074849   001   Apr   04,   1997
                                 50MG                                    A074849   002   Apr   04,   1997
                                 75MG                                    A074849   003   Apr   04,   1997
        WATSON LABS              25MG                                    A074600   001   Nov   27,   1996
                                 25MG                                    A074751   001   Sep   30,   1998
                                 50MG                                    A074600   002   Nov   27,   1996
                                 50MG                                    A074751   002   Sep   30,   1998
                                 75MG                                    A074600   003   Nov   27,   1996
                                 75MG                                    A074751   003   Sep   30,   1998
CLONAZEPAM
  TABLET;ORAL
    CLONAZEPAM
         APOTEX INC              0.5MG                                   A075468   001   Oct   06,   2000
                                 1MG                                     A075468   002   Oct   06,   2000
                                 2MG                                     A075468   003   Oct   06,   2000
        SANDOZ                   0.5MG                                   A074925   001   Sep   30,   1997
                                 1MG                                     A074925   002   Sep   30,   1997
                                 2MG                                     A074925   003   Sep   30,   1997
        TEVA                     0.5MG                                   A074920   001   Aug   04,   1998
                                 1MG                                     A074920   002   Aug   04,   1998
                                 2MG                                     A074920   003   Aug   04,   1998
   KLONOPIN
        ROCHE                  0.125MG                                   N017533 005 Apr 09, 1997
                               0.25MG                                    N017533 006 Apr 09, 1997
 TABLET, ORALLY DISINTEGRATING;ORAL
   KLONOPIN RAPIDLY DISINTEGRATING
	
        ROCHE                  0.125MG **Federal Register                N020813 001 Dec 23, 1997
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                 6-87(of 337)

CLONAZEPAM
  TABLET, ORALLY DISINTEGRATING;ORAL
    KLONOPIN RAPIDLY DISINTEGRATING
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
                                0.25MG **Federal Register determination   N020813 002 Dec 23, 1997
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                0.5MG **Federal Register determination    N020813 003 Dec 23, 1997
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                1MG **Federal Register determination      N020813 004 Dec 23, 1997
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                2MG **Federal Register determination      N020813 005 Dec 23, 1997
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
CLONIDINE
  SUSPENSION, EXTENDED RELEASE;ORAL
    CLONIDINE
         TRIS PHARMA INC        EQ 0.09MG BASE/ML                         N022499 001 Dec 03, 2009
  TABLET, EXTENDED RELEASE;ORAL
    CLONIDINE
         TRIS PHARMA INC        EQ 0.17MG BASE                            N022500 001 Dec 03, 2009
                                EQ 0.26MG BASE                            N022500 002 Dec 03, 2009
CLONIDINE HYDROCHLORIDE
  TABLET;ORAL
    CLONIDINE HYDROCHLORIDE
         AM THERAP             0.1MG                                      A070881   001   Jul   08,   1986
                               0.2MG                                      A070882   001   Jul   08,   1986
                               0.3MG                                      A070883   001   Jul   08,   1986
        DURAMED PHARMS BARR    0.1MG                                      A071103   001   Aug   14,   1986
                               0.2MG                                      A071102   001   Aug   14,   1986
                               0.3MG                                      A071101   001   Aug   14,   1986
        INTERPHARM             0.1MG                                      A071252   001   Oct   01,   1986
                               0.2MG                                      A071253   001   Oct   01,   1986
                               0.3MG                                      A071254   001   Oct   01,   1986
        PAR PHARM              0.1MG                                      A070461   001   Jul   08,   1986
                               0.2MG                                      A070460   001   Jul   08,   1986
                               0.3MG                                      A070459   001   Jul   08,   1986
        SANDOZ                 0.1MG                                      A070887   001   Aug   31,   1988
                               0.2MG                                      A070886   001   Aug   31,   1988
                               0.3MG                                      A071294   001   Aug   31,   1988
        TEVA                   0.1MG                                      A070747   001   Jul   08,   1986
                               0.2MG                                      A070702   001   Jul   08,   1986
                               0.3MG                                      A070659   001   Jul   08,   1986
        WARNER CHILCOTT        0.1MG                                      A072138   001   Jun   13,   1988
                               0.2MG                                      A072139   001   Jun   13,   1988
                               0.3MG                                      A072140   001   Jun   13,   1988
        WATSON LABS            0.1MG                                      A070395   001   Mar   23,   1987
                               0.1MG                                      A070965   001   Jul   08,   1986
                               0.2MG                                      A070396   001   Mar   23,   1987
                               0.2MG                                      A070964   001   Jul   08,   1986
                               0.3MG                                      A070397   001   Mar   23,   1987
                               0.3MG                                      A070963   001   Jul   08,   1986
 TABLET, EXTENDED RELEASE;ORAL
   JENLOGA
        CONCORDIA PHARMS INC   0.1MG                                      N022331 001 Sep 30, 2009
                               0.2MG                                      N022331 002 May 25, 2010
CLORAZEPATE DIPOTASSIUM
  CAPSULE;ORAL
    CLORAZEPATE DIPOTASSIUM
         ABLE                  3.75MG                                     A071777   001   Jul   14,   1987
                               7.5MG                                      A071778   001   Jul   14,   1987
                               15MG                                       A071779   001   Jul   14,   1987
        AM THERAP              3.75MG                                     A071429   001   Jun   23,   1987
                               7.5MG                                      A071430   001   Jun   23,   1987
                               15MG                                       A071431   001   Jun   23,   1987
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                        6-88(of 337)

CLORAZEPATE DIPOTASSIUM
  CAPSULE;ORAL
    CLORAZEPATE DIPOTASSIUM
         DAVA PHARMS INC        3.75MG                           A071742   001   Dec   14,   1987
                                7.5MG                            A071743   001   Dec   14,   1987
                                15MG                             A071744   001   Dec   14,   1987
        GD SEARLE LLC           3.75MG                           A071727   001   Dec   18,   1987
                                7.5MG                            A071728   001   Dec   18,   1987
                                15MG                             A071729   001   Dec   18,   1987
        MYLAN                   3.75MG                           A071509   001   Oct   19,   1987
                                7.5MG                            A071510   001   Oct   19,   1987
                                15MG                             A071511   001   Oct   19,   1987
        PUREPAC PHARM           3.75MG                           A071924   001   Apr   25,   1988
                                7.5MG                            A071925   001   Apr   25,   1988
                                15MG                             A071926   001   Apr   25,   1988
        QUANTUM PHARMICS        3.75MG                           A071549   001   Sep   12,   1988
                                7.5MG                            A071550   001   Sep   12,   1988
                                15MG                             A071522   001   Sep   12,   1988
        SANDOZ                  3.75MG                           A072219   001   Aug   26,   1988
                                7.5MG                            A072220   001   Aug   26,   1988
                                15MG                             A072112   001   Aug   26,   1988
        USL PHARMA              3.75MG                           A071242   001   Jun   23,   1987
                                7.5MG                            A071243   001   Jun   23,   1987
                                15MG                             A071244   001   Jun   23,   1987
        WARNER CHILCOTT         3.75MG                           A071774   001   Mar   01,   1988
                                7.5MG                            A071775   001   Mar   01,   1988
                                15MG                             A071776   001   Mar   01,   1988
        WATSON LABS             3.75MG                           A071878   001   Mar   15,   1988
                                7.5MG                            A071879   001   Mar   15,   1988
                                15MG                             A071860   001   Mar   15,   1988
   TRANXENE
        RECORDATI RARE          3.75MG                           N017105 001
                                7.5MG                            N017105 002
                                15MG                             N017105 003
 TABLET;ORAL
   CLORAZEPATE DIPOTASSIUM
        ABLE                    3.75MG                           A071780   001   Jun   26,   1987
                                7.5MG                            A071781   001   Jun   26,   1987
                                15MG                             A071782   001   Jun   26,   1987
        AM THERAP               3.75MG                           A071747   001   Jun   23,   1987
                                7.5MG                            A071748   001   Jun   23,   1987
                                15MG                             A071749   001   Jun   23,   1987
        LEDERLE                 3.75MG                           A072013   001   Dec   15,   1987
                                7.5MG                            A072014   001   Dec   15,   1987
                                15MG                             A072015   001   Dec   15,   1987
        PUREPAC PHARM           3.75MG                           A072330   001   Aug   08,   1988
                                7.5MG                            A072331   001   Aug   08,   1988
                                15MG                             A072332   001   Aug   08,   1988
        QUANTUM PHARMICS        3.75MG                           A071730   001   Oct   26,   1987
                                7.5MG                            A071731   001   Oct   26,   1987
                                15MG                             A071702   001   Oct   26,   1987
        SANDOZ                  3.75MG                           A072512   001   May   11,   1990
                                7.5MG                            A072513   001   May   11,   1990
                                15MG                             A072514   001   May   11,   1990
        WARNER CHILCOTT         3.75MG                           A071828   001   Mar   03,   1988
                                7.5MG                            A071829   001   Mar   03,   1988
                                15MG                             A071830   001   Mar   03,   1988
        WATSON LABS             3.75MG                           A071852   001   Feb   09,   1988
                                7.5MG                            A071853   001   Feb   09,   1988
                                15MG                             A071854   001   Feb   09,   1988
   TRANXENE SD
        RECORDATI RARE          11.25MG                          N017105 005
                                22.5MG                           N017105 004
CLOTRIMAZOLE
  CREAM;TOPICAL
    LOTRIMIN
         SCHERING PLOUGH        1%                               N017619 001
    MYCELEX
         BAYER HEALTHCARE LLC   1%                               N018183 001
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                               6-89(of 337)


CLOTRIMAZOLE
	
  LOTION;TOPICAL
	
    LOTRIMIN
	
         SCHERING
	              1%
	                                     N018813 001 Feb 17, 1984
	
  SOLUTION;TOPICAL
	
    LOTRIMIN
	
         SCHERING PLOUGH
	       1%
	                                     N017613 001
	
    MYCELEX
	
         BAYER HLTHCARE
	        1%
	                                     N018181 001
	
  TABLET;VAGINAL
	
    GYNIX
	
         TEVA PHARMS
	           100MG
	                                  A073249 001 Feb 13, 1998
	
    MYCELEX-G
	
         BAYER PHARMS
	          500MG
	                                  N019069 001 Apr 19, 1985
	
  TROCHE/LOZENGE;ORAL

    MYCELEX
	
         BAYER HLTHCARE
	        10MG
	                                   N018713 001 Jun 17, 1983
	
CLOXACILLIN SODIUM
	
  CAPSULE;ORAL
	
    CLOXACILLIN SODIUM
	
         APOTHECON
	             EQ     250MG   BASE
	                    A061452   001
	
                                 EQ     500MG   BASE
	                    A061452   002
	
         TEVA
	                  EQ     250MG   BASE
	                    A062240   001
	
                                 EQ     500MG   BASE
	                    A062240   002
	
    CLOXAPEN
	
         GLAXOSMITHKLINE
	       EQ     250MG   BASE
	                    A061806   001
	
                                 EQ     250MG   BASE
	                    A062233   001
	
                                 EQ     500MG   BASE
	                    A061806   002
	
                                 EQ     500MG   BASE
	                    A062233   002
	
  FOR SOLUTION;ORAL
	
    CLOXACILLIN SODIUM
	
         TEVA
	                  EQ 125MG BASE/5ML
                       A062268 001
	
                                 EQ 125MG BASE/5ML
	                      A062978 001 Apr 06, 1989
	
    TEGOPEN
	
         APOTHECON
	             EQ 125MG BASE/5ML
                       A061453 001
	
                                 EQ 125MG BASE/5ML
	                      N050192 001
	
CLOZAPINE
	
  TABLET;ORAL
	
    CLOZAPINE
	
         PAR PHARM
	            25MG
	                                    A075162   001     Apr   26,   2005

                                100MG
	                                   A075162   002     Apr   26,   2005

         SANDOZ
	               25MG
	                                    A074546   001     Aug   30,   1996

                                100MG
	                                   A074546   002     Aug   30,   1996
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    FAZACLO ODT
	
         JAZZ PHARMS III        50MG
	                                    N021590 003 Jun 03, 2005
	
COBALT CHLORIDE CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
	
  N/A;N/A

    RUBRATOPE-57 KIT
	
         BRACCO                 N/A;N/A;N/A;N/A                           N016089 001
	
COBALT CHLORIDE CO-60; CYANOCOBALAMIN; CYANOCOBALAMIN CO-60; INTRINSIC FACTOR
	
  N/A;N/A

    RUBRATOPE-60 KIT
	
         BRACCO                 N/A;N/A;N/A;N/A                           N016090 001
	
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    PHENERGAN VC W/ CODEINE

         ANI PHARMS
	           10MG/5ML;5MG/5ML;6.25MG/5ML
	             N008306   005 Apr 02, 1984
	
    PHERAZINE VC W/ CODEINE

         HALSEY
	               10MG/5ML;5MG/5ML;6.25MG/5ML
	             A088870   001 Mar 02, 1987
	
    PROMETHAZINE VC W/ CODEINE

         CENCI
	                10MG/5ML;5MG/5ML;6.25MG/5ML
              A088816   001 Nov 22, 1985
	
         WOCKHARDT
	            10MG/5ML;5MG/5ML;6.25MG/5ML
	             A088896   001 Jan 04, 1985
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                                6-90(of 337)


CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    PHENERGAN W/ CODEINE

         ANI PHARMS             10MG/5ML;6.25MG/5ML                       N008306 004 Apr 02, 1984

    PHERAZINE W/ CODEINE

         HALSEY                 10MG/5ML;6.25MG/5ML                       A088739 001 Dec 23, 1988
	
    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
	
         PHARM ASSOC            10MG/5ML;6.25MG/5ML                       A089647 001 Dec 22, 1988
	
    PROMETHAZINE W/ CODEINE

         CENCI                  10MG/5ML;6.25MG/5ML                       A088814 001 Nov 22, 1985
	
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    ACTIFED W/ CODEINE

         GLAXOSMITHKLINE        10MG/5ML;30MG/5ML;1.25MG/5ML              N012575 003 Apr 04, 1984

    TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE

         CENCI                  10MG/5ML;30MG/5ML;1.25MG/5ML              A089018 001 Jul 23, 1986
	
    TRIPROLIDINE HCL, PSEUDOEPHEDRINE HCL AND CODEINE PHOSPHATE
	
         WOCKHARDT              10MG/5ML;30MG/5ML;1.25MG/5ML              A088833 001 Nov 16, 1984
	
COLCHICINE; PROBENECID
	
  TABLET;ORAL
	
    COLBENEMID
	
         MERCK		                  0.5MG;500MG                             N012383 001
	
    PROBEN-C
	
         WATSON LABS		            0.5MG;500MG                             A085552 001
	
    PROBENECID AND COLCHICINE
	
         BEECHAM		                0.5MG;500MG                             A084321   001
	
         IMPAX LABS		             0.5MG;500MG                             A083720   002
	
         IVAX SUB TEVA PHARMS		   0.5MG;500MG                             A083734   001
	
         SANDOZ		                 0.5MG;500MG                             A086130   001
	
    PROBENECID W/ COLCHICINE

         LEDERLE		                0.5MG;500MG                             A086954 001
	
         WATSON LABS		            0.5MG;500MG                             A083221 001
	
COLESEVELAM HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    WELCHOL
	
         DAIICHI SANKYO           375MG                                   N021141 001 May 26, 2000
	
COLISTIN SULFATE
	
  SUSPENSION;ORAL
	
    COLY-MYCIN S
	
         PARKE DAVIS              EQ 25MG BASE/5ML                        N050355 001
	
CONIVAPTAN HYDROCHLORIDE
	
  INJECTABLE;IV (INFUSION)

    VAPRISOL
	
         CUMBERLAND PHARMS        20MG/4ML (5MG/ML)                       N021697 001 Dec 29, 2005
	
COPPER
	
  INTRAUTERINE DEVICE;INTRAUTERINE
	
    CU-7
	
           GD SEARLE LLC        89MG                                      N017408 001
	
    TATUM-T
	
           GD SEARLE LLC        120MG                                     N018205 001
	
CORTICOTROPIN
	
  INJECTABLE;INJECTION
	
    ACTH
	
           PARKEDALE              25 UNITS/VIAL                           N008317 002
	
                                  40 UNITS/VIAL                           N008317 004
	
   ACTHAR
	
        SANOFI AVENTIS US         25 UNITS/VIAL                           N007504 002
	
                                  40 UNITS/VIAL                           N007504 003
	
   CORTICOTROPIN
	
        ORGANICS LAGRANGE         40 UNITS/ML                             N010831 001
	
                                  80 UNITS/ML                             N010831 002
	
        WATSON LABS               40 UNITS/VIAL                           A088772 001 Nov 21, 1984
	
   H.P. ACTHAR GEL
	
        QUESTCOR PHARMS           40 UNITS/ML                             N008372 006
	
   PURIFIED CORTROPHIN GEL
	
        ORGANON USA INC		         40 UNITS/ML                             N008975 001
	
                                  80 UNITS/ML                             N008975 002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                6-91(of 337)

CORTICOTROPIN-ZINC HYDROXIDE
  INJECTABLE;INJECTION
    CORTROPHIN-ZINC
         ORGANON USA INC        40 UNITS/ML                             N009854 001
CORTISONE ACETATE
  INJECTABLE;INJECTION
    CORTISONE ACETATE
         PHARMACIA AND UPJOHN   25MG/ML                                 N008126   002
         WATSON LABS            25MG/ML                                 A083147   003
                                25MG/ML                                 A085677   001
                                50MG/ML                                 A083147   004
                                50MG/ML                                 A085677   002
   CORTONE
        MERCK                   25MG/ML                                 N007110 002
                                50MG/ML                                 N007110 003
 TABLET;ORAL
   CORTISONE ACETATE
        BARR                    25MG                                    A083471   001
        ELKINS SINN             25MG                                    A080836   001
        EVERYLIFE               25MG                                    A084246   001
        HEATHER                 25MG                                    A085736   001
        IMPAX LABS              25MG                                    N009458   001
        INWOOD LABS             25MG                                    A080731   001
        IVAX SUB TEVA PHARMS    25MG                                    A080630   001
                                25MG                                    A083536   001
        LANNETT                 25MG                                    A080694   001
        PANRAY                  5MG                                     N008284   002
                                25MG                                    N008284   001
        PHARMACIA AND UPJOHN    5MG                                     N008126   003
                                10MG                                    N008126   004
                                25MG                                    N008126   001
        PUREPAC PHARM           25MG                                    A080493   001
        VITARINE                25MG                                    A080333   001
        WATSON LABS             25MG                                    A085884   001
        WHITEWORTH TOWN PLSN    25MG                                    A080341   001
   CORTONE
        MERCK                   25MG                                    N007750 003
COSYNTROPIN
  SOLUTION;INTRAVENOUS
    COSYNTROPIN
         SANDOZ                 0.25MG/ML (0.25MG/ML)                   N022028 001 Feb 21, 2008
CROMOLYN SODIUM
  AEROSOL, METERED;INHALATION
    INTAL
          KING PFIZER           0.8MG/INH                               N018887 001 Dec 05, 1985
  CAPSULE;INHALATION
    INTAL
         SANOFI AVENTIS US      20MG **Federal Register determination   N016990 001
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
 CAPSULE;ORAL
   GASTROCROM
         UCB INC                100MG                                   N019188 001 Dec 22, 1989
 CONCENTRATE;ORAL
   CROMOLYN SODIUM
         GENERA PHARMS          100MG/5ML                               A090954 001 Dec 18, 2009
 SOLUTION;INHALATION
   CROMOLYN SODIUM
         ACTAVIS MID ATLANTIC   10MG/ML                                 A075067   001   Jul   19,   1999
         APOTEX INC             10MG/ML                                 A075333   001   Apr   30,   2002
         PHARMASCIENCE INC      10MG/ML                                 A075437   001   Apr   21,   2000
         ROXANE                 10MG/ML                                 A075175   001   Sep   30,   1999
         WATSON LABS            10MG/ML                                 A076469   001   Jun   17,   2005
   INTAL
        KING PHARMS             10MG/ML                                 N018596 001 May 28, 1982
 SOLUTION/DROPS;OPHTHALMIC
   CROMOLYN SODIUM
        APOTEX INC              4%                                      A075615 001 Jan 26, 2001
   CROMOPTIC
        KING PHARMS             4%                                      A075088 001 Apr 27, 1999
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                  6-92(of 337)

CROMOLYN SODIUM
  SOLUTION/DROPS;OPHTHALMIC
    OPTICROM
         ALLERGAN               4%                                        N018155 001 Oct 03, 1984
  SPRAY, METERED;NASAL
    CROMOLYN SODIUM
         ACTAVIS MID ATLANTIC   5.2MG/SPRAY                               A074800 001 Jul 26, 2001
         HH AND P               5.2MG/SPRAY                               A077976 001 Sep 07, 2007
    NASALCROM
         BLACKSMITH BRANDS      5.2MG/SPRAY **Federal Register            N020463 001 Jan 03, 1997
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
CRYPTENAMINE ACETATES
  INJECTABLE;INJECTION
    UNITENSEN
         MEDPOINTE PHARM HLC    260CSR UNIT/ML                            N008814 001
CRYPTENAMINE TANNATES
  TABLET;ORAL
    UNITENSEN
         MEDPOINTE PHARM HLC    260CSR UNIT                               N009217 001
CUPRIC SULFATE
  INJECTABLE;INJECTION
    CUPRIC SULFATE
         ABRAXIS PHARM          EQ 0.4MG COPPER/ML                        N019350 001 May 05, 1987
CYANOCOBALAMIN
  GEL, METERED;NASAL
    NASCOBAL
         PAR PHARM              0.5MG/INH                                 N019722 001 Nov 05, 1996
  INJECTABLE;INJECTION
    BERUBIGEN
         PHARMACIA AND UPJOHN   1MG/ML                                    N006798 001
    BETALIN 12
         LILLY                  0.1MG/ML                                  A080855 001
                                1MG/ML                                    A080855 002
   COBAVITE
        WATSON LABS             0.1MG/ML                                  A083013 001
                                1MG/ML                                    A083064 001
   CYANOCOBALAMIN
        ABRAXIS PHARM           0.03MG/ML                                 A080510   003
                                0.1MG/ML                                  A080510   001
                                1MG/ML                                    A080510   002
        AKORN                   1MG/ML                                    A087969   001 Nov 10, 1983
        DELL LABS               0.03MG/ML                                 A080689   001
                                0.1MG/ML                                  A080689   002
                                1MG/ML                                    A080689   003
        FRESENIUS KABI USA      0.1MG/ML                                  A080557   002
        HIKMA MAPLE             1MG/ML                                    A080515   002
        LUITPOLD                0.03MG/ML                                 A080668   001
        LYPHOMED                1MG/ML                                    A083075   001
        MYLAN INSTITUTIONAL     1MG/ML                                    A040451   001 Sep 23, 2003
        SANOFI AVENTIS US       1MG/ML                                    A080564   001
        SOLOPAK                 1MG/ML                                    A087551   001 Feb 29, 1984
        WARNER CHILCOTT         1MG/ML                                    N007085   002
        WATSON LABS             0.1MG/ML                                  A080573   002
                                0.1MG/ML                                  A083120   001
                                1MG/ML                                    A080573   001
                                1MG/ML                                    A083120   002
        WYETH AYERST            0.1MG/ML                                  A080554   001
                                1MG/ML                                    A080554   002
   REDISOL
        MERCK                   1MG/ML                                    N006668 010
   RUBIVITE
        BEL MAR                 0.03MG/ML                                 N010791   004
                                0.05MG/ML                                 N010791   001
                                0.1MG/ML                                  N010791   002
                                0.12MG/ML                                 N010791   005
                                1MG/ML                                    N010791   003
   RUBRAMIN PC
        BRISTOL MYERS SQUIBB    0.1MG/ML                                  N006799 002
                                1MG/ML                                    N006799 004
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                     6-93(of 337)


CYANOCOBALAMIN
	
  INJECTABLE;INJECTION
	
    RUBRAMIN PC
	
                                1MG/ML
                         N006799 010 Apr 28, 1988
	
   RUVITE
	
        SAVAGE LABS             1MG/ML
                         A080570 002
	
   VI-TWEL
	
        BAYER HLTHCARE          1MG/ML
                         N007012 002
	
 SPRAY, METERED;NASAL
	
   CALOMIST
	
        PAR PHARM               25MCG/SPRAY
                    N022102 001 Jul 27, 2007
	
 TABLET;ORAL
	
   CYANOCOBALAMIN
	
        WEST WARD               1MG
	                           A084264 001
	
CYANOCOBALAMIN CO-57
	
  CAPSULE;ORAL
	
    RUBRATOPE-57
	
         BRACCO                 0.5-1uCi
	                      N016089 002
	
CYANOCOBALAMIN CO-60
	
  CAPSULE;ORAL
	
    RUBRATOPE-60
	
         BRACCO                 0.5-1uCi
	                      N016090 002
	
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
	
  N/A;N/A

    DICOPAC KIT
	
         GE HEALTHCARE          N/A;N/A;N/A
	                   N017406 001
	
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
	
  N/A;N/A

    CYANOCOBALAMIN CO 57 SCHILLING TEST KIT
	
         MALLINCKRODT           0.1MG;0.5uCi;60MG
	             N016635 001
	
CYANOCOBALAMIN; TANNIC ACID; ZINC ACETATE
	
  INJECTABLE;INJECTION
	
    DEPINAR
	
         ARMOUR PHARM           0.5MG/ML;2.3MG/ML;1MG/ML
	      N011208 001
	
CYCLACILLIN
	
  FOR SUSPENSION;ORAL
	
    CYCLAPEN-W
	
         WYETH AYERST		         125MG/5ML
                      N050508 001
	
                                250MG/5ML
                      N050508 002
	
                                500MG/5ML
                      N050508 003
	
 TABLET;ORAL
	
   CYCLACILLIN
	
        TEVA                    250MG
	                         A062895 001 Aug 04, 1988

                                500MG
	                         A062895 002 Aug 04, 1988
	
   CYCLAPEN-W
	
        WYETH AYERST            250MG
	                         N050509 001
	
                                500MG
	                         N050509 002
	
CYCLIZINE LACTATE
	
  INJECTABLE;INJECTION
	
    MAREZINE
	
         GLAXOSMITHKLINE        50MG/ML
	                       N009495 001
	
CYCLOBENZAPRINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    CYCLOBENZAPRINE HYDROCHLORIDE
	
         PROSAM LABS            5MG
	                           A077291   001   Feb   03,   2006
	
         SANDOZ                 5MG
	                           A072854   002   Feb   03,   2006
	
                                10MG
	                          A072854   001   Nov   19,   1991
	
                                10MG
	                          A073683   001   Feb   26,   1993
	
         WATSON LABS            10MG
	                          A073143   001   Nov   27,   1991
	
                                10MG
	                          A074436   001   Nov   30,   1994
	
    FLEXERIL
	
         JANSSEN RES AND DEV    5MG
	                           N017821 001
	
                                10MG
	                          N017821 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-94(of 337)

CYCLOPENTOLATE HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    AK-PENTOLATE
         AKORN                  1%                                A085555 001
    AKPENTOLATE
         AKORN                  2%                                A040165 001 Jan 13, 1997
    CYCLOPENTOLATE HYDROCHLORIDE
         ALCON PHARMS LTD       1%                                A089162 001 Jan 24, 1991
         SOLA BARNES HIND       1%                                A084150 001
                                1%                                A084863 001
    PENTOLAIR
         PHARMAFAIR             0.5%                              A088643 001 Feb 09, 1987
                                1%                                A088150 001 Feb 25, 1983
CYCLOPHOSPHAMIDE
  INJECTABLE;INJECTION
    CYCLOPHOSPHAMIDE
         BAXTER HLTHCARE        1GM/VIAL                          A088374   001   Sep   24,   1986
                                100MG/VIAL                        A088371   001   Jul   03,   1986
                                200MG/VIAL                        A088372   001   Jul   03,   1986
                                500MG/VIAL                        A088373   001   Jul   03,   1986
   CYTOXAN
        BAXTER HLTHCARE         100MG/VIAL                        N012142 001
                                200MG/VIAL                        N012142 002
   CYTOXAN (LYOPHILIZED)
        BAXTER HLTHCARE         1GM/VIAL                          N012142 010 Sep 24, 1985
                                2GM/VIAL                          N012142 009 Dec 10, 1985
                                500MG/VIAL                        N012142 008 Jan 04, 1984
   LYOPHILIZED CYTOXAN
        BAXTER HLTHCARE         100MG/VIAL                        N012142 006 Dec 05, 1985
                                200MG/VIAL                        N012142 007 Dec 10, 1985
   NEOSAR
        BEDFORD                 1GM/VIAL                          A087442   004   Jul   08,   1983
                                2GM/VIAL                          A087442   005   Mar   30,   1989
                                100MG/VIAL                        A087442   001   Feb   16,   1982
                                200MG/VIAL                        A087442   002   Feb   16,   1982
                                500MG/VIAL                        A087442   003   Feb   16,   1982
        TEVA PARENTERAL         1GM/VIAL                          A040015   004   Apr   29,   1993
                                2GM/VIAL                          A040015   005   Apr   29,   1993
                                100MG/VIAL                        A040015   001   Apr   29,   1993
                                200MG/VIAL                        A040015   002   Apr   29,   1993
                                500MG/VIAL                        A040015   003   Apr   29,   1993
 TABLET;ORAL
   CYTOXAN
        BAXTER HLTHCARE         25MG                              N012141 002
                                50MG                              N012141 001
CYCLOSPORINE
  CAPSULE;ORAL
    NEORAL
         NOVARTIS               50MG                              N050715 003 Jul 14, 1995
  SOLUTION;ORAL
    CYCLOSPORINE
         APOTEX INC             100MG/ML                          A065167 001 Jan 05, 2005
CYCLOTHIAZIDE
  TABLET;ORAL
    ANHYDRON
         LILLY                  2MG                               N013157 002
    FLUIDIL
         PHARMACIA AND UPJOHN   2MG                               N018173 001
CYCRIMINE HYDROCHLORIDE
  TABLET;ORAL
    PAGITANE
         LILLY                  1.25MG                            N008951 001
                                2.5MG                             N008951 002
CYPROHEPTADINE HYDROCHLORIDE
  SYRUP;ORAL
    CYPROHEPTADINE HYDROCHLORIDE
	
         ACTAVIS MID ATLANTIC   2MG/5ML                           A086833   001
	
         HALSEY                 2MG/5ML                           A089199   001 Jul 03, 1986
	
         MORTON GROVE           2MG/5ML                           A087001   001 Nov 04, 1982
	
         NASKA                  2MG/5ML                           A089021   001 Dec 21, 1987
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-95(of 337)

CYPROHEPTADINE HYDROCHLORIDE
  SYRUP;ORAL
    PERIACTIN
         MERCK                  2MG/5ML                                  N013220 002
  TABLET;ORAL
    CYPROHEPTADINE HYDROCHLORIDE
         AM THERAP              4MG                                      A088798   001   Feb   15,   1985
         ASCOT                  4MG                                      A087685   001   Oct   25,   1982
         DURAMED PHARMS BARR    4MG                                      A088232   001   Oct   25,   1983
         HALSEY                 4MG                                      A089057   001   Jul   03,   1986
         KV PHARM               4MG                                      A086737   001
         MD PHARM               4MG                                      A087566   001   Nov 10, 1982
         MYLAN                  4MG                                      A086678   001
         PIONEER PHARMS         4MG                                      A087839   001   Feb 08, 1984
         PLIVA                  4MG                                      A088205   001   Jul 26, 1983
         SANDOZ                 4MG                                      A086808   001
         SUPERPHARM             4MG                                      A087405   001
         TG UNITED LABS         4MG                                      A088212   001   May 26, 1983
         VITARINE               4MG                                      A087284   001
         WATSON LABS            4MG                                      A085245   001
                                4MG                                      A086165   001
                                4MG                                      A086580   001
    PERIACTIN
         MERCK                  4MG                                      N012649 001
CYSTEINE HYDROCHLORIDE
  INJECTABLE;INJECTION
    CYSTEINE HYDROCHLORIDE
         HOSPIRA                7.25% **Federal Register determination   N019523 001 Oct 22, 1986
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
CYTARABINE
  INJECTABLE;INJECTION
    CYTARABINE
         TEVA PARENTERAL        1GM/VIAL                                 N016793   003 Dec 21, 1987
                                2GM/VIAL                                 N016793   004 Dec 21, 1987
                                100MG/VIAL                               N016793   001
                                500MG/VIAL                               N016793   002
DACARBAZINE
  INJECTABLE;INJECTION
    DACARBAZINE
         ABRAXIS PHARM          100MG/VIAL                               A070962 001 Aug 28, 1986
                                200MG/VIAL                               A070990 001 Aug 28, 1986
DALFOPRISTIN; QUINUPRISTIN
  INJECTABLE;IV (INFUSION)
    SYNERCID
         KING PHARMS            420MG/VIAL;180MG/VIAL                    N050748 002 Aug 24, 2000
DALTEPARIN SODIUM
  INJECTABLE;INJECTION
    FRAGMIN
         EISAI INC              7,500 IU/0.75ML                          N020287 008 Apr 04, 2002
  INJECTABLE;SUBCUTANEOUS
    FRAGMIN
         EISAI INC              10,000IU/0.4ML (25,000IU/ML)             N020287 002 May 01, 2007
                                95,000IU/9.5ML (10,000IU/ML)             N020287 007 Apr 04, 2002
DANAPAROID SODIUM
  INJECTABLE;INJECTION
    ORGARAN
         AGI                    750 UNITS/0.6ML                          N020430 001 Dec 24, 1996
DANAZOL
  CAPSULE;ORAL
    DANAZOL
         AM THERAP              200MG                                    A071569 001 Dec 30, 1987
    DANOCRINE
         SANOFI AVENTIS US      50MG                                     N017557 003
                                100MG                                    N017557 004
                                200MG                                    N017557 002
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-96(of 337)

DAPIPRAZOLE HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    DAPIPRAZOLE HYDROCHLORIDE
         FERA PHARMS             0.5%                                      N019849 001 Dec 31, 1990
DAPTOMYCIN
  INJECTABLE;IV (INFUSION)
    CUBICIN
         CUBIST                  250MG/VIAL                                N021572 001 Sep 12, 2003
DARUNAVIR ETHANOLATE
  TABLET;ORAL
    PREZISTA
         JANSSEN PRODS           EQ 300MG BASE **Federal Register          N021976 001 Jun 23, 2006
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
                                 EQ 400MG BASE **Federal Register          N021976 003 Oct 21, 2008
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
DAUNORUBICIN HYDROCHLORIDE
  INJECTABLE;INJECTION
    CERUBIDINE
         SANOFI AVENTIS US       EQ 20MG BASE/VIAL                         A061876 001
         WYETH AYERST            EQ 20MG BASE/VIAL                         N050484 001
    DAUNORUBICIN HYDROCHLORIDE
         TEVA PARENTERAL         EQ 20MG BASE/VIAL                         A064212 001 Jun 23, 1998
                                 EQ 50MG BASE/VIAL                         A064212 002 May 03, 1999
DECAMETHONIUM BROMIDE
  INJECTABLE;INJECTION
    SYNCURINE
         GLAXOSMITHKLINE         1MG/ML                                    N006931 002
DEFEROXAMINE MESYLATE
  INJECTABLE;INJECTION
    DEFEROXAMINE MESYLATE
         WATSON LABS             2GM/VIAL                                  A076806 002 Mar 31, 2006
                                 500MG/VIAL                                A076806 001 Mar 31, 2006
DEMECARIUM BROMIDE
  SOLUTION/DROPS;OPHTHALMIC
    HUMORSOL
         MERCK                   0.125%                                    N011860 002
                                 0.25%                                     N011860 001
DEMECLOCYCLINE HYDROCHLORIDE
  CAPSULE;ORAL
    DECLOMYCIN
         LEDERLE                 150MG                                     N050262 001
  SYRUP;ORAL
    DECLOMYCIN
         LEDERLE                 75MG/5ML                                  N050257 001
  TABLET;ORAL
    DECLOMYCIN
         COREPHARMA              75MG                                      N050261 001
                                 150MG                                     N050261 002
                                 300MG                                     N050261 003
DESERPIDINE
  TABLET;ORAL
    HARMONYL
         ABBVIE                  0.1MG                                     N010796 001
                                 0.25MG                                    N010796 002
DESERPIDINE; HYDROCHLOROTHIAZIDE
  TABLET;ORAL
    ORETICYL 25
         ABBVIE                 0.125MG;25MG                               N012148 001
    ORETICYL 50
         ABBVIE                 0.125MG;50MG                               N012148 003
    ORETICYL FORTE
         ABBVIE                 0.25MG;25MG                                N012148 002
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                                  6-97(of 337)


DESERPIDINE; METHYCLOTHIAZIDE
	
  TABLET;ORAL
	
    ENDURONYL
	
         ABBOTT                 0.25MG;5MG
	                               N012775 001
	
    ENDURONYL FORTE
	
         ABBOTT                 0.5MG;5MG
	                                N012775 002
	
    METHYCLOTHIAZIDE AND DESERPIDINE
	
         WATSON LABS
	          0.25MG;5MG
	                               A088486 001
	 Aug 10, 1984

                                0.5MG;5MG
	                                A088452 001
	 Aug 10, 1984
	
DESIPRAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    PERTOFRANE
	
         SANOFI AVENTIS US
	      25MG
	                                   N013621 001
	
                                  50MG
	                                   N013621 002
	
  TABLET;ORAL
	
    DESIPRAMINE HYDROCHLORIDE
	
         ANI PHARMS INC
	         25MG
	                                   A071800   001
	   Dec   08,   1987
	
                                  50MG
	                                   A071801   001
	   Dec   08,   1987
	
                                  75MG
	                                   A071802   001
	   Dec   08,   1987
	
                                  100MG
	                                  A071803   001
	   May   29,   1997

                                  150MG
	                                  A071804   001
	   May   29,   1997

         USL PHARMA
	             25MG
	                                   A071864   001
	   Sep   09,   1987

                                  50MG
	                                   A071865   001
	   Sep   09,   1987

                                  75MG
	                                   A071866   001
	   Sep   09,   1987

                                  100MG
	                                  A071867   001
	   Sep   09,   1987
	
DESLANOSIDE
	
  INJECTABLE;INJECTION
	
    CEDILANID-D
	
         NOVARTIS
	               0.2MG/ML
	                               N009282 002
	
DESMOPRESSIN ACETATE
	
  INJECTABLE;INJECTION
	
    DDAVP
	
         FERRING PHARMS INC
	   0.015MG/ML
	                               N018938 002
	 Apr 25, 1995
	
    DESMOPRESSIN ACETATE
	
         BEDFORD
	              0.004MG/ML
	                               A074575 001
	 Feb 18, 2000
	
    DESMOPRESSIN ACETATE PRESERVATIVE FREE
	
         BEDFORD
	              0.004MG/ML
	                               A074574 001
	 Feb 18, 2000
	
  SOLUTION;NASAL
	
    CONCENTRAID
	
         FERRING
	              0.01%
	                                    N019776 001
	 Dec 26, 1990
	
  SPRAY, METERED;NASAL
	
    DDAVP
	
         FERRING PHARMS INC
	   0.01MG/SPRAY
	                             N017922 002
	 Feb 06, 1989
	
    STIMATE
	
         CSL BEHRING
	          0.15MG/SPRAY
	                             N020355 001
	 Mar 07, 1994
	
DESOGESTREL; ETHINYL ESTRADIOL
	
  TABLET;ORAL-21
	
    DESOGEN
	
         ORGANON USA INC
	       0.15MG;0.03MG
	                           N020071 001
	 Dec 10, 1992
	
    DESOGESTREL AND ETHINYL ESTRADIOL
	
         DURAMED PHARMS BARR
	   0.15MG;0.03MG
	                           A075256 001
	 Aug 12, 1999
	
    ORTHO-CEPT
	
         JANSSEN PHARMS
	        0.15MG;0.03MG
	                           N020301 001
	 Dec 14, 1992
	
  TABLET;ORAL-28
	
    MIRCETTE
	
         TEVA BRANDED PHARM
	    0.15MG,N/A;0.02MG,0.01MG;0.02MG,0.01MG
   N020713 001
	 Apr 22, 1998
	
                                 **Federal Register determination that

                                 product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
DESONIDE
	
  CREAM;TOPICAL
	
    DESONIDE
	
          TEVA PHARMS
	           0.05%
	                                  A074027 001
	 Sep 28, 1992
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                             6-98(of 337)

DESOXIMETASONE
  CREAM;TOPICAL
    TOPICORT
         TARO PHARMS NORTH      0.25% **Federal Register determination    N017856 001
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
   TOPICORT LP
        TARO PHARMS NORTH       0.05%                                     N018309 001
 GEL;TOPICAL
   TOPICORT
        TARO PHARMS NORTH       0.05%                                     N018586 001 Mar 29, 1982
 OINTMENT;TOPICAL
   DESOXIMETASONE
        ALTANA                  0.25%                                     A073440 001 Apr 01, 1998
   TOPICORT
        TARO PHARMS NORTH       0.25%                                     N018763 001 Sep 30, 1983
DESOXYCORTICOSTERONE ACETATE
  INJECTABLE;INJECTION
    DOCA
         ORGANON USA INC        5MG/ML                                    N001104 001
  PELLET;IMPLANTATION
    PERCORTEN
         NOVARTIS               125MG                                     N005151 001
DESOXYCORTICOSTERONE PIVALATE
  INJECTABLE;INJECTION
    PERCORTEN
         NOVARTIS               25MG/ML                                   N008822 001
DESVENLAFAXINE FUMARATE
  TABLET, EXTENDED RELEASE;ORAL
    DESVENLAFAXINE
         TEVA PHARMS USA        EQ 50MG BASE                              N205208 001 Oct 11, 2013
                                EQ 100MG BASE                             N205208 002 Oct 11, 2013
DEXAMETHASONE
  AEROSOL;TOPICAL
    AEROSEB-DEX
         ALLERGAN HERBERT       0.01% **Federal Register determination    A083296 002
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
   DECASPRAY
        MERCK                   0.04% **Federal Register determination    N012731 002
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
 ELIXIR;ORAL
   DECADRON
        MERCK                   0.5MG/5ML                                 N012376 002
   DEXAMETHASONE
        ALPHARMA US PHARMS      0.5MG/5ML                                 A088997 001 Oct 10, 1986
   HEXADROL
        ORGANON USA INC         0.5MG/5ML                                 N012674 001
 GEL;TOPICAL
   DECADERM
        MERCK                   0.1%                                      N013538 001
 SUSPENSION/DROPS;OPHTHALMIC
   DEXAMETHASONE
        WATSON LABS             0.1%                                      A089170 001 May 09, 1989
 TABLET;ORAL
   DECADRON
        MERCK                   0.25MG **Federal Register determination   N011664 004
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                0.5MG **Federal Register determination    N011664 001
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                0.75MG **Federal Register determination   N011664 002
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                1.5MG                                     N011664 003
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-99(of 337)

DEXAMETHASONE
  TABLET;ORAL
    DECADRON
                                 4MG                                       N011664 005
                                 6MG                                       N011664 006 Jul 30, 1982
   DEXAMETHASONE
        IMPAX LABS               0.75MG                                    A085376   001
        MUTUAL PHARM             0.25MG                                    A084013   001
                                 0.25MG                                    A084764   001
                                 0.5MG                                     A084084   001
                                 0.5MG                                     A084766   001
                                 0.75MG                                    A084081   001
                                 0.75MG                                    A084765   001
                                 1.5MG                                     A084086   001
                                 1.5MG                                     A084763   001
        PAR PHARM                0.25MG                                    A088149   001 Apr 28, 1983
        PHOENIX LABS NY          0.75MG                                    A083806   001
        PVT FORM                 0.75MG                                    A083420   001
        ROXANE                   0.25MG                                    A084614   001
        SANDOZ                   0.75MG                                    A080399   001
        UPSHER SMITH             0.75MG                                    A087534   001
                                 1.5MG                                     A087533   001
        WATSON LABS              0.25MG                                    A085455   001
                                 0.5MG                                     A085458   001
                                 0.75MG                                    A080968   001
                                 0.75MG                                    A084457   001
                                 0.75MG                                    A085818   001
                                 1.5MG                                     A085456   001
                                 1.5MG                                     A085840   001
        WHITEWORTH TOWN PLSN     0.75MG                                    A084327   001
   DEXONE 0.5
        SOLVAY                   0.5MG                                     A084991 001
   DEXONE 0.75
        SOLVAY                   0.75MG                                    A084993 001
   DEXONE 1.5
        SOLVAY                   1.5MG                                     A084990 001
   DEXONE 4
        SOLVAY                   4MG                                       A084992 001
   HEXADROL
        ORGANON USA INC          0.5MG                                     N012675   004
                                 0.75MG                                    N012675   007
                                 1.5MG                                     N012675   009
                                 4MG                                       N012675   010
DEXAMETHASONE ACETATE
  INJECTABLE;INJECTION
    DECADRON-LA
         MERCK                   EQ 8MG BASE/ML **Federal Register         N016675 001
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
   DEXAMETHASONE ACETATE
        WATSON LABS              EQ 8MG BASE/ML                            A084315 001
                                 EQ 16MG BASE/ML                           A087711 001 May 24, 1982
DEXAMETHASONE SODIUM PHOSPHATE
  AEROSOL;NASAL
    DEXACORT
         UCB INC                 EQ 0.1MG PHOSPHATE/INH                    N014242 001
  AEROSOL, METERED;INHALATION
    DEXACORT
         UCB INC                 EQ 0.1MG PHOSPHATE/INH                    N013413 001
  CREAM;TOPICAL
    DECADRON
         MERCK                   EQ 0.1% PHOSPHATE                         N011983 002
  INJECTABLE;INJECTION
    DECADRON
         MERCK                   EQ 4MG PHOSPHATE/ML                       N012071 002
                                 EQ 24MG PHOSPHATE/ML **Federal Register   N012071 004
                                 determination that product was not
                                 discontinued or withdrawn for safety or
                                 efficacy reasons**
   DEXACEN-4
        CENT PHARMS              EQ 4MG PHOSPHATE/ML                       A084342 001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                                6-100(of 337)


DEXAMETHASONE SODIUM PHOSPHATE
	
  INJECTABLE;INJECTION
	
    DEXAMETHASONE
	
         ABRAXIS PHARM           EQ 4MG PHOSPHATE/ML
                        A088448 001 Jan 25, 1984
	
         FRESENIUS KABI USA      EQ 10MG PHOSPHATE/ML
                       A088469 001 Jan 25, 1984
	
    DEXAMETHASONE SODIUM PHOSPHATE
	
         AKORN
	                 EQ 4MG PHOSPHATE/ML
                        A084493   001
	
         BEL MAR
	               EQ 4MG PHOSPHATE/ML
                        A084752   001
	
         DELL LABS
	             EQ 4MG PHOSPHATE/ML
                        A083161   001
	
         HIKMA MAPLE
	           EQ 4MG PHOSPHATE/ML
                        A084282   001
	
         INTL MEDICATION
	       EQ 20MG PHOSPHATE/ML
                       A088522   001     Feb 17, 1984
	
         LYPHOMED
	              EQ 4MG PHOSPHATE/ML
                        A087065   001
	
         TEVA PARENTERAL
	       EQ 4MG PHOSPHATE/ML
                        A081125   001     Aug 31, 1990

                                 EQ 10MG PHOSPHATE/ML
                       A081126   001     Aug 31, 1990

         WATSON LABS
	           EQ 4MG PHOSPHATE/ML
                        A083702   001
	
                                 EQ 4MG PHOSPHATE/ML
                        A084355   001
	
                                 EQ 4MG PHOSPHATE/ML
                        A089169   001     Apr 09, 1986

                                 EQ 10MG PHOSPHATE/ML
                       A087668   001     Jul 01, 1982
	
                                 EQ 24MG PHOSPHATE/ML
                       A085606   001
	
         WYETH AYERST
	          EQ 4MG PHOSPHATE/ML
	                       A085641   001
	
    HEXADROL
	
         ORGANON USA INC
	       EQ 4MG PHOSPHATE/ML
                        N014694 002
	
                                 EQ 10MG PHOSPHATE/ML
                       N014694 003
	
                                 EQ 20MG PHOSPHATE/ML
	                      N014694 004
	
  OINTMENT;OPHTHALMIC
	
    DECADRON
	
         MERCK
	                 EQ 0.05% PHOSPHATE
	                        N011977 001
	
    DEXAIR
	
         PHARMAFAIR
	            EQ 0.05% PHOSPHATE
	                        A088071 001 Dec 28, 1982
	
    MAXIDEX
	
         ALCON
	                 EQ 0.05% PHOSPHATE
	                        A083342 001
	
  SOLUTION/DROPS;OPHTHALMIC

    DEXAIR
	
         PHARMAFAIR
	            EQ 0.1% PHOSPHATE
	                         A088433 001 Dec 15, 1983
	
    DEXAMETHASONE SODIUM PHOSPHATE
	
         SOLA BARNES HIND        EQ 0.1% PHOSPHATE
	                         A084170 001
	
                                 EQ 0.1% PHOSPHATE
	                         A084173 001
	
  SOLUTION/DROPS;OPHTHALMIC, OTIC

    DECADRON
	
         MERCK                   EQ 0.1% PHOSPHATE
	                         N011984 001
	
  SOLUTION/DROPS;OTIC

    DEXAMETHASONE SODIUM PHOSPHATE
	
         AKORN                   EQ 0.1% PHOSPHATE
	                         A084855 001
	
DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DECADRON W/ XYLOCAINE

         MERCK                  EQ 4MG PHOSPHATE/ML;10MG/ML
	                N013334 002
	
DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE
	
  OINTMENT;OPHTHALMIC
	
    NEODECADRON
	
         MERCK
	                EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM
	        N050324 001
	
  SOLUTION/DROPS;OPHTHALMIC

    NEODECADRON
	
         MERCK
	                EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
	         N050322 001
	
    NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE
	
         BAUSCH AND LOMB        EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
          A064055 001 Oct 30, 1995
	
    NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
	
         ALCON PHARMS LTD       EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
          A062714 001 Jul 21, 1986
	
         PHARMAFAIR             EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
	         A062539 001 Jan 10, 1985
	
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  OINTMENT;OPHTHALMIC
	
    DEXACIDIN
	
         NOVARTIS
	             0.1%;EQ 3.5MG BASE/GM;10,000    UNITS/GM
	   A062566 001 Feb 22, 1985
	
    DEXASPORIN
	
         PHARMAFAIR
	           0.1%;EQ 3.5MG BASE/GM;10,000    UNITS/GM
	   A062411 001 May 16, 1983
	
  SUSPENSION/DROPS;OPHTHALMIC

    DEXACIDIN
	
         NOVARTIS
	             0.1%;EQ 3.5MG BASE/ML;10,000    UNITS/ML
	   A062544 001 Oct 29, 1984
	
    DEXASPORIN
	
         PHARMAFAIR
	           0.1%;EQ 3.5MG BASE/ML;10,000    UNITS/ML
	   A062428 001 May 18, 1983
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                             6-101(of 337)


DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  SUSPENSION/DROPS;OPHTHALMIC

    NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
	
         ALCON PHARMS LTD       0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
	     A062721 001
	 Nov 17, 1986
	
DEXBROMPHENIRAMINE MALEATE
	
  SYRUP;ORAL
	
    DISOMER
	
         SCHERING                 2MG/5ML
                                  N011814 002
	
  TABLET;ORAL
	
    DISOMER
	
         SCHERING                 2MG
	                                     N011814 001
	
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
	
  TABLET;ORAL
	
    DISOPHROL
	
         SCHERING
	              2MG;60MG
	                                 N012394 002
	
  TABLET, EXTENDED RELEASE;ORAL
	
    BROMPHERIL
	
         COPLEY PHARM
	          6MG;120MG
	                                A089116 001
	 Jan 22, 1987
	
    DISOBROM
	
         SANDOZ
	                6MG;120MG
	                                A070770 001
	 Sep 30, 1991
	
    DISOPHROL
	
         SCHERING PLOUGH
	       6MG;120MG
	                                N013483 004
	 Sep 13, 1982
	
    DRIXORAL
	
         SCHERING PLOUGH
	       6MG;120MG **Federal Register
              N013483 003
	 Sep 13, 1982
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
    RESPORAL
	
         PIONEER PHARMS
	        6MG;120MG
	                                A089139 001
	 Jun 16, 1988
	
DEXCHLORPHENIRAMINE MALEATE
	
  SYRUP;ORAL
	
    POLARAMINE
	
         SCHERING
	               2MG/5ML
	                                 A086837 001
	 Jul 19, 1982
	
  TABLET;ORAL
	
    DEXCHLORPHENIRAMINE MALEATE
	
         ANI PHARMS INC
	         2MG
	                                     A088682 001
	 Jan 17, 1986
	
    POLARAMINE
	
         SCHERING
	               2MG
	                                     A086835 001
	
DEXTROAMPHETAMINE SULFATE
	
  CAPSULE;ORAL
	
    DEXAMPEX
	
         TEVA
	                 15MG
	                                      A085355 001
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    DEXTROAMPHETAMINE SULFATE
	
         ABLE
	                 5MG
	                                       A076814 001
	 Aug 25, 2004

                                10MG
	                                      A076814 002
	 Aug 25, 2004

                                15MG
	                                      A076814 003
	 Aug 25, 2004
	
  ELIXIR;ORAL
	
    DEXEDRINE
	
         GLAXOSMITHKLINE
	      5MG/5ML **Federal Register
                 A083902 001
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
  TABLET;ORAL
	
    DEXAMPEX
	
         TEVA
	                 5MG
	                                       A083735 001
	
                                10MG
	                                      A083735 002
	
    DEXEDRINE
	
         GLAXOSMITHKLINE
	      5MG
	                                       A084935 001
	
    DEXTROAMPHETAMINE SULFATE
	
         HALSEY
	               10MG
	                                      A083930   001
	
         LANNETT
	              5MG
	                                       A083903   001
	
                                10MG
	                                      A083903   003
	
                                15MG
	                                      A085652   001
	
         MAST MM
	              5MG
	                                       A086521   001
	
         NESHER PHARMS
	        5MG
	                                       A040365   001
	 Oct 31, 2002
	
                                10MG
	                                      A040367   001
	 Oct 31, 2002
	
         PUREPAC PHARM
	        5MG
	                                       A084125   001
	
         SANDOZ
	               5MG
	                                       A085370   001
	
                                10MG
	                                      A085371   001
	
         VINTAGE PHARMS LLC
	   5MG
	                                       A040299   001
	 May 13, 1999
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                               6-102(of 337)


DEXTROAMPHETAMINE SULFATE
	
  TABLET;ORAL
	
    DEXTROAMPHETAMINE SULFATE
	
         VITARINE                 5MG                                     A084986 001
	
                                  10MG                                    A085892 001
	
   DEXTROSTAT
	
        SHIRE                     5MG                                     A084051 001
	
                                  10MG                                    A084051 002
	
   FERNDEX
	
        FERNDALE LABS             5MG                                     A084001 001
	
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    PHERAZINE DM
	
         HALSEY                  15MG/5ML;6.25MG/5ML                      A088913 001 Mar 02, 1987
	
    PROMETH W/ DEXTROMETHORPHAN

         ACTAVIS MID ATLANTIC    15MG/5ML;6.25MG/5ML                      A088762 001 Oct 31, 1984
	
    PROMETHAZINE HYDROCHLORIDE AND DESTROMETHORPHAN HYDROBROMIDE
	
         ANI PHARMS              15MG/5ML;6.25MG/5ML                      N011265 002 Apr 02, 1984

    PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
	
         AMNEAL PHARMS           15MG/5ML;6.25MG/5ML                      A090575 001 Feb 08, 2011
         TRIS PHARMA INC         15MG/5ML;6.25MG/5ML                      A091687 001 Jun 28, 2012
DEXTROSE
  INJECTABLE;INJECTION
    DEXTROSE 10% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML                                N018046 001
         MILES                  10GM/100ML                                N018504 001
    DEXTROSE 2.5% IN PLASTIC CONTAINER
         B BRAUN                2.5GM/100ML                               N018358 001
                                2.5GM/100ML                               N019626 001 Feb 02, 1988
    DEXTROSE 38.5% IN PLASTIC CONTAINER
         ABBOTT                 38.5GM/100ML                              N018923 001 Sep 19, 1984
    DEXTROSE 5% IN PLASTIC CONTAINER
         DHL                    5GM/100ML                                 N019971 001 Sep 28, 1995
    DEXTROSE 60%
         B BRAUN                60GM/100ML                                N017995 002 Sep 22, 1982
    DEXTROSE 60% IN PLASTIC CONTAINER
         B BRAUN                60GM/100ML                                N017995 001
         BAXTER HLTHCARE        60GM/100ML                                N020047 002 Jul 02, 1991
         HOSPIRA                60GM/100ML                                N019346 001 Jan 25, 1985
    DEXTROSE 7.7% IN PLASTIC CONTAINER
         B BRAUN                7.7GM/100ML                               N019626 003 Feb 02, 1988
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER

         B BRAUN                5GM/100ML;31MG/100ML;130MG/100ML;26MG/1   N019025 001 Dec 27, 1984

                                00ML;320MG/100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER

         B BRAUN                5GM/100ML;30MG/100ML;97MG/100ML;220MG/1   N018273 001
	
                                00ML;140MG/100ML
	
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM

GLUCONATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER

         B BRAUN                5GM/100ML;30MG/100ML;37MG/100ML;370MG/1   N018274 001
	
                                00ML;530MG/100ML;500MG/100ML
	
DEXTROSE; POTASSIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;37MG/100ML                      N019699 001 Sep 29, 1989

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;75MG/100ML                      N019699 002 Sep 29, 1989

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;110MG/100ML                     N019699 003 Sep 29, 1989

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML                     N018744 003 Nov 09, 1982
	
                                5GM/100ML;220MG/100ML                     N019699 005 Sep 29, 1989
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                6-103(of 337)


DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC

ANHYDROUS
	
  INJECTABLE;INJECTION
	
    IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA                5GM/100ML;111MG/100ML;256MG/100ML;146MG   N019514 001 May 08, 1986

                                /100ML;207MG/100ML
	
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER

         B BRAUN                5GM/100ML;150MG/100ML;130MG/100ML;280MG   N018270 001
	
                                /100ML;91MG/100ML
	
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075%
	
         B BRAUN                5GM/100ML;75MG/100ML;200MG/100ML          N018268 009
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;150MG/100ML;200MG/100ML         N018268 004
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;200MG/100ML         N018268 005
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;300MG/100ML;200MG/100ML         N018268 006
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;75MG/100ML;330MG/100ML          N018268 011 Jan 18,   1986
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;150MG/100ML;330MG/100ML         N018268 012 Jan 18,   1986
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;330MG/100ML         N018268 013 Jan 18,   1986
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;300MG/100ML;330MG/100ML         N018268 014 Jan 18,   1986
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075%
	
         B BRAUN                5GM/100ML;75MG/100ML;450MG/100ML          N018268 010
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;150MG/100ML;450MG/100ML         N018268 001
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;220MG/100ML;450MG/100ML         N018268 002
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML;300MG/100ML;450MG/100ML         N018268 003
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5GM/100ML;224MG/100ML;450MG/100ML         N018008 003
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER

         BAXTER HLTHCARE        5GM/100ML;300MG/100ML;450MG/100ML         N018008 001
	
    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5GM/100ML;75MG/100ML;450MG/100ML          N018008 002
DEXTROSE; SODIUM CHLORIDE
  INJECTABLE;INJECTION
    DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;200MG/100ML                    N018386 001
    DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;450MG/100ML                    N018229 001
    DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
         B BRAUN                10GM/100ML;900MG/100ML                    N018047 001
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
         B BRAUN                2.5GM/100ML;450MG/100ML                   N018030 001
         HOSPIRA                2.5GM/100ML;450MG/100ML                   N018096 001
    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
         B BRAUN                2.5GM/100ML;900MG/100ML                   N018376 001
    DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
         ABBOTT                 3.3GM/100ML;300MG/100ML                   N018055 001
    DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
         B BRAUN                5GM/100ML;110MG/100ML                     N018030 005
    DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
         B BRAUN                5GM/100ML;200MG/100ML                     N018030 004
         MILES                  5GM/100ML;200MG/100ML                     N018399 001
    DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
         ABBOTT                 5GM/100ML;225MG/100ML                     N019482 001 Oct 04, 1985
    DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
         ABBOTT                 5GM/100ML;300MG/100ML                     N019486 001 Oct 04, 1985
         MILES                  5GM/100ML;300MG/100ML                     N018501 001
    DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
         B BRAUN                5GM/100ML;330MG/100ML                     N018030 003
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                   6-104(of 337)


DEXTROSE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         ABBOTT                 5GM/100ML;450MG/100ML
             N019484 001 Oct 04, 1985
	
         B BRAUN                5GM/100ML;450MG/100ML
             N018030 002
	
         MILES                  5GM/100ML;450MG/100ML
             N018400 001
	
    DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         ABBOTT
	               5GM/100ML;900MG/100ML
             N019483 001 Oct 04, 1985
	
         B BRAUN
	              5GM/100ML;900MG/100ML
             N018026 001
	
         MILES
	                5GM/100ML;900MG/100ML
	            N018500 001
	
DEXTROTHYROXINE SODIUM
	
  TABLET;ORAL
	
    CHOLOXIN
	
         ABBVIE
	                1MG
	                             N012302   005
	
                                 2MG
	                             N012302   002
	
                                 4MG
	                             N012302   004
	
                                 6MG
	                             N012302   006
	
DEZOCINE
	
  INJECTABLE;INJECTION
	
    DALGAN
	
          ASTRAZENECA
	          5MG/ML
                           N019082 001 Dec 29, 1989
	
                                 10MG/ML
                          N019082 002 Dec 29, 1989
	
                                 15MG/ML
	                         N019082 003 Dec 29, 1989
	
DIATRIZOATE MEGLUMINE
	
  INJECTABLE;INJECTION
	
    ANGIOVIST 282
	
         BAYER HLTHCARE
	        60%
	                             A087726 001 Sep 23, 1982
	
    CARDIOGRAFIN
	
         BRACCO
	                85%
	                             N011620 002
	
    DIATRIZOATE MEGLUMINE
	
         BRACCO
	                76%
	                             N010040 017
	
    HYPAQUE
	
         GE HEALTHCARE
	         30%
	                             N016403 002
	
                                 60%
	                             N016403 001
	
   RENO-60
	
        BRACCO
	                 60%
	                             N010040 016
	
   RENO-DIP
	
        BRACCO
	                 30%
	                             N010040 012
	
   UROVIST MEGLUMINE DIU/CT

        BAYER HLTHCARE
	         30%
	                             A087739 001 Sep 23, 1982
	
 SOLUTION;URETERAL
	
   RENO-30
	
        BRACCO
	                 30%
	                             N010040 021
	
   UROVIST CYSTO
	
        BAYER HLTHCARE
	         30%
	                             A087729 001 Sep 23, 1982
	
   UROVIST CYSTO PEDIATRIC
	
        BAYER HLTHCARE
	         30%
	                             A087731 001 Sep 23, 1982
	
 SOLUTION;URETHRAL
	
   HYPAQUE-CYSTO
	
        GE HEALTHCARE
	          30%
	                             N016403 003
	
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
	
  INJECTABLE;INJECTION
	
    ANGIOVIST 292
	
         BAYER HLTHCARE
	       52%;8%
	                           A087724 001 Sep 23, 1982
	
    ANGIOVIST 370
	
         BAYER HLTHCARE
	       66%;10%
	                          A087723 001 Sep 23, 1982
	
    DIATRIZOATE-60
	
         INTL MEDICATION
	      52%;8%
	                           A088166 001 Jun 17, 1983
	
    HYPAQUE-76
	
         GE HEALTHCARE
	        66%;10%
	                          A086505 001
	
    HYPAQUE-M,75%
	
         GE HEALTHCARE
	        50%;25%
	                          N010220 003
	
    HYPAQUE-M,90%
	
         GE HEALTHCARE
	        60%;30%
	                          N010220 002
	
    MD-60
	
         MALLINCKRODT
	         52%;8%
	                           A087074 001
	
    MD-76
	
         MALLINCKRODT
	         66%;10%
	                          A087073 001
	
    RENOCAL-76
	
         BRACCO
	               66%;10%
	                          A089347 001 Jun 01, 1988
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-105(of 337)


DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
	
  INJECTABLE;INJECTION
	
    RENOGRAFIN-60
	
         BRACCO                 52%;8%                                     N010040 006
	
    RENOVIST
	
         BRACCO                 34.3%;35%                                  N010040 020
	
    RENOVIST II
	
         BRACCO                 28.5%;29.1%                                N010040 019
	
  SOLUTION;ORAL, RECTAL
	
    GASTROVIST
	
         BAYER HLTHCARE         66%;10%                                    A087728 001 Sep 23, 1982
	
DIATRIZOATE SODIUM
	
  FOR SOLUTION;ORAL, RECTAL
	
    HYPAQUE
	
         GE HEALTHCARE          100%                                       N011386 001
	
  INJECTABLE;INJECTION
	
    HYPAQUE
	
         GE HEALTHCARE          25%                                        N009561 003
	
                                50%                                        N009561 001
	
   MD-50
	
        MALLINCKRODT            50%                                        A087075 001
	
   UROVIST SODIUM 300
	
        BAYER HLTHCARE          50%                                        A087725 001 Sep 23, 1982

 SOLUTION;ORAL, RECTAL
	
   HYPAQUE
	
        GE HEALTHCARE           40%                                        N011386 003
	
 SOLUTION;URETERAL
	
   HYPAQUE SODIUM 20%
	
        GE HEALTHCARE           20%                                        N009561 002
	
DIAZEPAM
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    VALRELEASE
	
          ROCHE                 15MG                                       N018179 001
	
  GEL;RECTAL
	
    DIASTAT
	
          VALEANT PHARMS NORTH  5MG/ML (5MG/ML) **Federal Register         N020648 002 Jul 29, 1997

                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

                                10MG/2ML (5MG/ML)                          N020648 003 Jul 29, 1997
	
                                15MG/3ML (5MG/ML)                          N020648 004 Jul 29, 1997
	
                                20MG/4ML (5MG/ML)                          N020648 005 Jul 29, 1997
	
  INJECTABLE;INJECTION
	
    DIAZEPAM
	
          ABRAXIS PHARM         5MG/ML                                     A070662   001    Jun   25,   1986
	
          HIKMA MAPLE           5MG/ML                                     A070311   001    Dec   16,   1985
	
                                5MG/ML                                     A070312   001    Dec   16,   1985
	
                                5MG/ML                                     A070313   001    Dec   16,   1985
	
                                5MG/ML                                     A071308   001    Jul   17,   1987
	
                                5MG/ML                                     A071309   001    Jul   17,   1987
	
                                5MG/ML                                     A071310   001    Jul   17,   1987
	
          HOSPIRA               5MG/ML                                     A071584   001    Oct   13,   1987
	
          MARSAM PHARMS LLC     5MG/ML                                     A072371   001    Jan   29,   1993
	
          PARENTA PHARMS        5MG/ML                                     A076815   001    Apr   15,   2004

          US ARMY               5MG/ML                                     N020124   001    Dec   05,   1990
	
          WARNER CHILCOTT       5MG/ML                                     A071613   001    Oct   22,   1987
	
                                5MG/ML                                     A071614   001    Oct   22,   1987
	
          WATSON LABS           5MG/ML                                     A070296   001    Feb   12,   1986
	
                                5MG/ML                                     A070911   001    Aug   28,   1986

                                5MG/ML                                     A070912   001    Aug   28,   1986

                                5MG/ML                                     A070930   001    Dec   01,   1986
	
          WATSON LABS INC       5MG/ML                                     A072370   001    Jan   29,   1993
	
                                5MG/ML                                     A072397   001    Jan   29,   1993
	
    DIZAC
	
          PHARMACIA AND UPJOHN  5MG/ML                                     N019287 001 Jun 18, 1993
	
    VALIUM
	
          ROCHE                 5MG/ML                                     N016087 001
	
  TABLET;ORAL
	
    DIAZEPAM
	
          ACTAVIS ELIZABETH		   2MG                                        A070781 001 Mar 19, 1986
	
                                5MG                                        A070706 001 Mar 19, 1986
	
                                10MG                                       A070707 001 Mar 19, 1986
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                              6-106(of 337)


DIAZEPAM
	
  TABLET;ORAL
	
    DIAZEPAM
	
          DAVA PHARMS INC		       2MG                                     A070226   001    Sep   26,   1985

                                  5MG                                     A070227   001    Sep   26,   1985

                                  10MG                                    A070228   001    Sep   26,   1985

         DURAMED PHARMS BARR		    2MG                                     A070894   001    Aug   27,   1986

                                  5MG                                     A070895   001    Aug   27,   1986

                                  10MG                                    A070896   001    Aug   27,   1986

         FERNDALE LABS		          2MG                                     A070903   001    Apr   01,   1987

                                  5MG                                     A070904   001    Apr   01,   1987

                                  10MG                                    A070905   001    Apr   01,   1987

         HALSEY		                 2MG                                     A070987   001    Aug   15,   1986

                                  5MG                                     A070996   001    Aug   15,   1986

                                  10MG                                    A070956   001    Aug   15,   1986

         IVAX SUB TEVA PHARMS		   2MG                                     A070360   001    Sep   04,   1985

                                  5MG                                     A070361   001    Sep   04,   1985

                                  10MG                                    A070362   001    Sep   04,   1985

         MARTEC USA LLC		         10MG                                    A072402   001    Apr   25,   1989

         PAR PHARM		              2MG                                     A070462   001    Feb   25,   1986
	
                                  5MG                                     A070463   001    Feb   25,   1986
	
                                  10MG                                    A070464   001    Feb   25,   1986
	
         PIONEER PHARMS		         2MG                                     A070787   001    Aug   02,   1988

                                  5MG                                     A070788   001    Aug   02,   1988

                                  10MG                                    A070776   001    Aug   02,   1988

         ROXANE		                 2MG                                     A070356   001    Jun   17,   1986
	
                                  5MG                                     A070357   001    Jun   17,   1986
	
                                  10MG                                    A070358   001    Jun   17,   1986
	
         SANDOZ		                 2MG                                     A070302   001    Dec   20,   1985
	
                                  5MG                                     A070303   001    Dec   20,   1985
	
                                  10MG                                    A070304   001    Dec   20,   1985
	
         TEVA PHARMS		            5MG                                     A070153   001    Nov   01,   1985
	
         WARNER CHILCOTT		        2MG                                     A070209   001    Sep   04,   1985

                                  5MG                                     A070210   001    Sep   04,   1985

                                  10MG                                    A070222   001    Sep   04,   1985

         WATSON LABS		            2MG                                     A070456   001    Nov   01,   1985
	
                                  5MG                                     A070457   001    Nov   01,   1985
	
                                  10MG                                    A070458   001    Nov   01,   1985
	
    Q-PAM
	
         QUANTUM PHARMICS		       2MG                                     A070423   001    Dec   12,   1985
	
                                  2MG                                     A072431   001    Apr   29,   1988

                                  5MG                                     A070424   001    Dec   12,   1985
	
                                  5MG                                     A072432   001    Apr   29,   1988

                                  10MG                                    A070425   001    Dec   12,   1985
	
                                  10MG                                    A072433   001    Apr   29,   1988
	
DIAZOXIDE
	
  CAPSULE;ORAL
	
    PROGLYCEM
	
         TEVA BRANDED PHARM       50MG                                    N017425 001
	
                                  100MG                                   N017425 002
	
  INJECTABLE;INJECTION
	
    DIAZOXIDE
	
         ABRAXIS PHARM            15MG/ML                                 A071519 001 Aug 26, 1987

    HYPERSTAT
	
         SCHERING                 15MG/ML                                 N016996 001
	
DIBUCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    HEAVY SOLUTION NUPERCAINE
	
         NOVARTIS                 2.5MG/ML                                N006203 001
	
DICHLORPHENAMIDE
	
  TABLET;ORAL
	
    DARANIDE
	
         TARO                     50MG **Federal Register determination   N011366 001
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-107(of 337)


DICLOFENAC POTASSIUM
	
  TABLET;ORAL
	
    CATAFLAM
	
         NOVARTIS                 25MG **Federal Register determination   N020142 001 Nov 24, 1993

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
    DICLOFENAC POTASSIUM
	
         MUTUAL PHARM             50MG                                    A075470 001 Feb 21, 2002
	
         SANDOZ                   50MG                                    A075582 001 Feb 23, 2001
	
         WATSON LABS              50MG                                    A075152 001 Nov 27, 1998
	
DICLOFENAC SODIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    DICLOFENAC SODIUM
	
         APOTEX INC              0.1%                                     A077600 001 Nov 13, 2008
	
         FALCON PHARMS           0.1%                                     N020809 001 May 04, 1998

  TABLET, DELAYED RELEASE;ORAL
	
    DICLOFENAC SODIUM
	
         NOSTRUM LABS            50MG                                     A074986   001     Feb   26,   1999
	
                                 75MG                                     A074986   002     Feb   26,   1999
	
         PLIVA                   50MG                                     A074432   002     Jul   29,   1999
	
                                 75MG                                     A074432   003     Jul   29,   1999
	
         ROXANE                  25MG                                     A074391   001     Jun   29,   1995
	
                                 50MG                                     A074391   002     Jun   29,   1995
	
                                 75MG                                     A074391   003     Jun   29,   1995
	
         TEVA                    50MG                                     A074723   001     Mar   30,   1999
	
                                 75MG                                     A074390   001     Aug   15,   1996

         TEVA PHARMS             25MG                                     A074459   001     Jun   25,   1997
	
                                 50MG                                     A074459   002     Jun   25,   1997
	
                                 75MG                                     A074459   003     Jun   25,   1997
	
    VOLTAREN
	
         NOVARTIS		              25MG                                     N019201 001 Jul 28, 1988
	
                                 50MG                                     N019201 002 Jul 28, 1988
	
                                 75MG                                     N019201 003 Jul 28, 1988
	
DICLOXACILLIN SODIUM
	
  CAPSULE;ORAL
	
    DYCILL
	
         GLAXOSMITHKLINE		        EQ   250MG   BASE                       A060254   002
	
                                  EQ   250MG   BASE                       A062238   001
	
                                  EQ   500MG   BASE                       A060254   003
	
                                  EQ   500MG   BASE                       A062238   002
	
    PATHOCIL
	
         WYETH AYERST             EQ 250MG BASE                           N050011 002
	
                                  EQ 500MG BASE                           N050011 003 Mar 28, 1983
	
  FOR SUSPENSION;ORAL
	
    DICLOXACILLIN SODIUM
	
         APOTHECON                EQ 62.5MG BASE/5ML                      A061455 001
	
    DYNAPEN
	
         APOTHECON                EQ 62.5MG BASE/5ML                      N050337 002
	
    PATHOCIL
	
         WYETH AYERST             EQ 62.5MG BASE/5ML                      N050092 001
	
DICUMAROL
	
  CAPSULE;ORAL
	
    DICUMAROL
	
         LILLY                    25MG                                    N005509 003
	
                                  50MG                                    N005509 001
	
  TABLET;ORAL
	
    DICUMAROL
	
         ABBVIE		                 25MG                                    N005545 003
	
                                  50MG                                    N005545 004
	
                                  100MG                                   N005545 005
	
DICYCLOMINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    DICYCLOMINE HYDROCHLORIDE
	
         HIKMA PHARMS LLC         10MG                                    A040204   001     Feb   28,   1997
	
         MUTUAL PHARM             10MG                                    A084505   001     Oct   21,   1986
	
         PIONEER PHARMS           10MG                                    A089361   001     Jan   10,   1989
	
         WATSON LABS              10MG                                    A083179   001     Feb   12,   1986
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-108(of 337)


DICYCLOMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DICYCLOMINE HYDROCHLORIDE
	
         WATSON LABS
	            10MG/ML
	                     A080614 001 Feb 11, 1986
	
  SYRUP;ORAL
	
    DICYCLOMINE HYDROCHLORIDE
	
         ALPHARMA US PHARMS
	     10MG/5ML
	                    A084479 001
	
  TABLET;ORAL
	
    DICYCLOMINE HYDROCHLORIDE
	
         HIKMA PHARMS LLC
	       20MG
	                        A040161   001     Oct   01,   1996
	
         MUTUAL PHARM
	           20MG
	                        A084600   001     Jul   29,   1985
	
         PIONEER PHARMS
	         20MG
	                        A088585   001     Aug   20,   1986

         WATSON LABS
	            20MG
	                        A084361   001     Feb   06,   1986
	
DIDANOSINE
	
  FOR SOLUTION;ORAL
	
    VIDEX
	
         BRISTOL MYERS SQUIBB
	   100MG/PACKET
                 N020155   003     Oct   09,   1991
	
                                  167MG/PACKET
                 N020155   004     Oct   09,   1991
	
                                  250MG/PACKET
                 N020155   005     Oct   09,   1991
	
                                  375MG/PACKET
	                N020155   006     Oct   09,   1991
	
  TABLET, CHEWABLE;ORAL
	
    VIDEX
	
         BRISTOL MYERS SQUIBB
	   25MG
	                        N020154   002     Oct   09,   1991
	
                                  50MG
	                        N020154   003     Oct   09,   1991
	
                                  100MG
	                       N020154   004     Oct   09,   1991
	
                                  150MG
	                       N020154   005     Oct   09,   1991
	
                                  200MG
	                       N020154   006     Oct   28,   1999
	
DIENESTROL
	
  CREAM;VAGINAL
	
    DIENESTROL
	
         ORTHO MCNEIL PHARM
	     0.01%
	                       N006110 005
	
    DV
	
         SANOFI AVENTIS US
	      0.01%
	                       A083518 001
	
    ESTRAGUARD
	
         SOLVAY
	                 0.01%
	                       A084436 001
	
  SUPPOSITORY;VAGINAL
	
    DV
	
         SANOFI AVENTIS US
	      0.7MG
	                       A083517 001
	
DIETHYLCARBAMAZINE CITRATE
	
  TABLET;ORAL
	
    HETRAZAN
	
         LEDERLE
	                50MG
	                        N006459 001
	
DIETHYLPROPION HYDROCHLORIDE
	
  TABLET;ORAL
	
    DIETHYLPROPION HYDROCHLORIDE
	
         SANDOZ
	                25MG
	                         A085916   001
	
         TEVA
	                  25MG
	                         A088642   001 Sep 20, 1984

         TG UNITED LABS
	        25MG
	                         A088267   001 Aug 25, 1983

                                 25MG
	                         A088268   001 Aug 25, 1983

         UCB INC
	               25MG
	                         A085544   001
	
         WATSON LABS
	           25MG
	                         A085741   001
	
    TENUATE
	
         SANOFI AVENTIS US
	     25MG
	                         N017668 001
	
    TEPANIL
	
         3M
	                    25MG
	                         N011673 001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TENUATE
	
         SANOFI AVENTIS US
	     75MG
	                         N017669 001
	
    TEPANIL TEN-TAB
	
         3M
	                    75MG
	                         N017956 001
	
DIETHYLSTILBESTROL
	
  INJECTABLE;INJECTION
	
    STILBESTROL
	
         BRISTOL MYERS SQUIBB
	   0.2MG/ML
                     N004056   003
	
                                  0.5MG/ML
                     N004056   004
	
                                  1MG/ML
                       N004056   005
	
                                  5MG/ML
	                      N004056   006
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-109(of 337)


DIETHYLSTILBESTROL
	
  SUPPOSITORY;VAGINAL
	
    DIETHYLSTILBESTROL
	
         LILLY
	                  0.1MG
	                         N004040 001
	
                                  0.5MG
	                         N004040 002
	
   STILBESTROL
	
        BRISTOL MYERS SQUIBB
	    0.1MG
	                         N004056 001
	
                                  0.5MG
	                         N004056 002
	
 TABLET;ORAL
	
   DIETHYLSTILBESTROL
	
        LILLY
	                   0.1MG
	                         N004041   002
	
                                  0.5MG
	                         N004041   003
	
                                  1MG
	                           N004041   004
	
                                  5MG
	                           N004041   005
	
   STILBESTROL
	
        TABLICAPS
	               0.5MG
	                         A083004 001
	
                                  1MG
	                           A083002 001
	
                                  5MG
	                           A083006 001
	
   STILBETIN
	
        BRISTOL MYERS SQUIBB
	    0.1MG
	                         N004056   007
	
                                  0.25MG
	                        N004056   017
	
                                  0.5MG
	                         N004056   008
	
                                  1MG
	                           N004056   009
	
                                  5MG
	                           N004056   010
	
 TABLET, DELAYED RELEASE;ORAL
	
   DIETHYLSTILBESTROL
	
        LILLY
	                 0.1MG
	                           N004039   002
	
                                0.25MG
	                          N004039   005
	
                                0.5MG
	                           N004039   003
	
                                1MG
	                             N004039   004
	
                                5MG
	                             N004039   006
	
   STILBESTROL
	
        TABLICAPS
	             0.5MG
	                           A083003 001
	
                                1MG
	                             A083005 001
	
                                5MG
	                             A083007 001
	
   STILBETIN
	
        BRISTOL MYERS SQUIBB
	 0.1MG
	                            N004056   011
	
                                0.5MG
	                           N004056   012
	
                                1MG
	                             N004056   013
	
                                5MG
	                             N004056   014
	
DIETHYLSTILBESTROL DIPHOSPHATE
	
  INJECTABLE;INJECTION
	
    STILPHOSTROL
	
         BAYER PHARMS
	          250MG/5ML
	                      N010010 001
	
  TABLET;ORAL
	
    STILPHOSTROL
	
         BAYER PHARMS
	          50MG
	                           N010010 002
	
DIFLORASONE DIACETATE
	
  CREAM;TOPICAL
	
    DIFLORASONE DIACETATE
	
         FOUGERA PHARMS
	         0.05%
	                         A075187 001 Mar 30, 1998
	
    FLORONE
	
         PHARMACIA AND UPJOHN
	   0.05%
	                         N017741 001
	
    FLORONE E
	
         PHARMACIA AND UPJOHN
	   0.05%
	                         N019259 001 Aug 28, 1985
	
    PSORCON
	
         TARO PHARMS NORTH
	      0.05%
	                         N020205 001 Nov 20, 1992
	
  OINTMENT;TOPICAL
	
    PSORCON
	
         PHARMACIA AND UPJOHN
	   0.05%
	                         N019260 001 Aug 28, 1985
	
    PSORCON E
	
         PHARMACIA AND UPJOHN
	   0.05%
	                         N017994 001
	
DIFLUNISAL
	
  TABLET;ORAL
	
    DIFLUNISAL
	
         PUREPAC PHARM
	          250MG
	                         A074285   001     May   07,   1996

                                  500MG
	                         A074285   002     May   07,   1996

         ROXANE
	                 250MG
	                         A073562   001     Nov   27,   1992
	
                                  500MG
	                         A073563   001     Nov   27,   1992
	
         SANDOZ
	                 500MG
	                         A074604   001     Jun   10,   1996
	
         TEVA
	                   250MG
	                         A073679   001     Jul   31,   1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                 6-110(of 337)


DIFLUNISAL
	
  TABLET;ORAL
	
    DIFLUNISAL
	
         WATSON LABS              250MG                                    A074400 001 Jul 17, 1997
	
                                  500MG                                    A074400 002 Jul 17, 1997
	
    DOLOBID
	
         MERCK                    250MG **Federal Register determination   N018445 001 Apr 19, 1982

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                                  500MG                                    N018445 002 Apr 19, 1982
	
DIGITOXIN
	
  INJECTABLE;INJECTION
	
    CRYSTODIGIN
	
         LILLY                    0.2MG/ML                                 A084100 005
	
DIGOXIN
	
  CAPSULE;ORAL
	
    LANOXICAPS
	
          GLAXOSMITHKLINE LLC		   0.05MG                                   N018118   002    Jul   26,   1982
	
                                  0.1MG                                    N018118   003    Jul   26,   1982
	
                                  0.15MG                                   N018118   004    Sep   24,   1984

                                  0.2MG                                    N018118   001    Jul   26,   1982
	
  INJECTABLE;INJECTION
	
    DIGOXIN
	
         ABRAXIS PHARM            0.25MG/ML                                A083217   001
	
         HOSPIRA                  0.25MG/ML                                A040093   001 May 16, 1996

                                  0.25MG/ML                                A040206   001 Aug 28, 1998

         WYETH AYERST             0.25MG/ML                                A084386   001
	
    DIGOXIN PEDIATRIC
	
         HOSPIRA                  0.1MG/ML                                 A040092 001 Apr 25, 1996

  TABLET;ORAL
	
    DIGOXIN
	
         SUN PHARM INDS INC       0.125MG                                  A076363 001 Jan 31, 2003
	
                                  0.25MG                                   A076363 002 Jan 31, 2003
	
    LANOXIN
	
         COVIS PHARMA             0.375MG                                  N020405 005 Sep 30, 1997

                                  0.5MG                                    N020405 006 Sep 30, 1997
	
DIHYDROERGOTAMINE MESYLATE; HEPARIN SODIUM; LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    EMBOLEX
	
         NOVARTIS               0.5MG/0.5ML;2,500                          N018885 001 Nov 30, 1984

                                UNITS/0.5ML;5.33MG/0.5ML

                                0.5MG/0.7ML;5,000                          N018885 002 Nov 30, 1984

                                UNITS/0.7ML;7.46MG/0.7ML
	
DILTIAZEM HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    CARDIZEM SR
	
         BIOVAIL		              60MG                                       N019471   001    Jan   23,   1989
	
                                90MG                                       N019471   002    Jan   23,   1989
	
                                120MG                                      N019471   003    Jan   23,   1989
	
                                180MG                                      N019471   004    Jan   23,   1989
	
    DILTIAZEM HYDROCHLORIDE
	
         BIOVAIL		              60MG                                       A074845   001    Sep   15,   1999

                                90MG                                       A074845   002    Sep   15,   1999

                                120MG                                      A074845   003    Sep   15,   1999

                                120MG                                      N020939   001    Jan   28,   2000
	
                                180MG                                      N020939   002    Jan   28,   2000
	
                                240MG                                      N020939   003    Jan   28,   2000
	
                                300MG                                      N020939   004    Jan   28,   2000
	
                                360MG                                      N020939   005    Sep   14,   2001

                                420MG                                      N020939   006    Sep   14,   2001

         NESHER PHARMS		        120MG                                      A076563   002    Sep   12,   2006

                                180MG                                      A076563   003    Sep   12,   2006

                                240MG                                      A076563   004    Sep   12,   2006

                                300MG                                      A076563   005    Sep   12,   2006

                                360MG                                      A076563   006    Sep   12,   2006

                                420MG                                      A076563   001    Sep   12,   2006

         TEVA		                 60MG                                       A074079   001    Nov   30,   1993
	
                                90MG                                       A074079   002    Nov   30,   1993
	
                                120MG                                      A074079   003    Nov   30,   1993
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                  6-111(of 337)


DILTIAZEM HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CARDIZEM
	
         BIOVAIL                  100MG/VIAL                                 N020792 001 Sep 05, 1997

         BIOVAIL LABS INTL        5MG/ML                                     N020027 001 Oct 24, 1991
	
                                  25MG/VIAL **Federal Register               N020027 003 Aug 18, 1995

                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

   DILTIAZEM HYDROCHLORIDE
	
        AGILA SPECLTS             5MG/ML                                     A075375   001     Sep   30,   1999

        HOSPIRA                   5MG/ML                                     A075004   001     Feb   16,   2000
	
                                  5MG/ML                                     A075106   001     Apr   29,   1999

        TEVA PHARMS USA           5MG/ML                                     A074894   001     Aug   26,   1997

 TABLET;ORAL
	
   DILTIAZEM HYDROCHLORIDE
	
        APOTHECON		               30MG                                       A074051   001     Mar   31,   1993
	
                                  60MG                                       A074051   002     Mar   31,   1993
	
                                  90MG                                       A074051   003     Mar   31,   1993
	
                                  120MG                                      A074051   004     Mar   31,   1993
	
         DAVA PHARMS INC		        30MG                                       A074093   001     Nov   05,   1992
	
                                  60MG                                       A074093   002     Nov   05,   1992
	
                                  90MG                                       A074093   003     Nov   05,   1992
	
                                  120MG                                      A074093   004     Nov   05,   1992
	
         IVAX SUB TEVA PHARMS		   30MG                                       A074168   001     Mar   03,   1995
	
                                  60MG                                       A074168   002     Mar   03,   1995
	
                                  90MG                                       A074168   003     Mar   03,   1995
	
                                  120MG                                      A074168   004     Mar   03,   1995
	
         TEVA		                   30MG                                       A074084   001     Feb   25,   1994
	
                                  60MG                                       A074084   002     Feb   25,   1994
	
         TEVA PHARMS		            30MG                                       A074067   001     Nov   05,   1992
	
                                  60MG                                       A074067   002     Nov   05,   1992
	
                                  90MG                                       A074067   003     Nov   05,   1992
	
                                  120MG                                      A074067   004     Nov   05,   1992
	
DILTIAZEM MALATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TIAMATE
	
         MERCK		                 EQ 120MG HCL                                N020506 001 Oct 04, 1996
	
                                 EQ 180MG HCL                                N020506 002 Oct 04, 1996
	
                                 EQ 240MG HCL                                N020506 003 Oct 04, 1996
	
DILTIAZEM MALATE; ENALAPRIL MALEATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TECZEM
	
         BIOVAIL                 EQ 180MG HCL;5MG                            N020507 001 Oct 04, 1996
	
DIMENHYDRINATE
	
  INJECTABLE;INJECTION
	
    DIMENHYDRINATE
	
         BAXTER HLTHCARE          50MG/ML                                    A084767   001
	
         WATSON LABS              50MG/ML                                    A080615   001
	
                                  50MG/ML                                    A083531   001
	
        WYETH AYERST              50MG/ML                                    A084316   001
	
 LIQUID;ORAL
	
   DIMENHYDRINATE
	
        ALRA                      12.5MG/4ML                                 A080715 001
	
 TABLET;ORAL
	
   DIMENHYDRINATE
	
        HEATHER                   50MG                                       A080841 001
	
        NEXGEN PHARMA INC         50MG                                       A085985 001
	
        WATSON LABS               50MG                                       A085166 001
	
DIMYRISTOYL LECITHIN; PERFLEXANE
	
  INJECTABLE;INTRAVENOUS
	
    IMAGENT
	
         IMCOR PHARMS CO        0.92MG/VIAL;0.092MG/VIAL                     N021191 001 May 31, 2002
	
DINOPROST TROMETHAMINE
	
  INJECTABLE;INJECTION
	
    PROSTIN F2 ALPHA
	
         PHARMACIA AND UPJOHN     EQ 5MG BASE/ML                             N017434 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                 6-112(of 337)


DIPHEMANIL METHYLSULFATE
	
  TABLET;ORAL
	
    PRANTAL
	
         SCHERING
	               100MG
	                       N008114 004
	
DIPHENHYDRAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    BENADRYL
	
         MCNEIL CONS
	         25MG
	                           N005845 007
	
                               50MG
	                           N005845 001
	
   DIPHENHYDRAMINE HYDROCHLORIDE
	
        ALRA
	                 25MG
	                           A080519   004
	
                               50MG
	                           A080519   003
	
        ANABOLIC
	             50MG
	                           A083275   001
	
        ELKINS SINN
	          25MG
	                           A085701   001
	
                               50MG
	                           A085701   002
	
        HALSEY
	               50MG
	                           A087914   001     Jun 04, 1984
	
        HEATHER
	              25MG
	                           A084524   001
	
                               50MG
	                           A083953   001
	
        HIKMA PHARMS LLC
	     50MG
	                           A083567   001
	
        IMPAX LABS
	           25MG
	                           A080807   001
	
                               50MG
	                           A080807   002
	
        IVAX SUB TEVA PHARMS
	 25MG
	                           A080762   001
	
                               50MG
	                           A080762   002
	
        LANNETT
	              25MG
	                           A080868   001
	
                               50MG
	                           A080868   002
	
        LEDERLE
	              25MG
	                           A086874   001
	
                               50MG
	                           A086875   001
	
        LNK
	                  25MG
	                           A087977   001     Jan 27, 1983
	
                               50MG
	                           A087978   001     Jan 27, 1983
	
        MK LABS
	              25MG
	                           A083087   001
	
                               50MG
	                           A083087   002
	
        MUTUAL PHARM
	         25MG
	                           A084506   001
	
                               25MG
	                           A089488   001     Jan 02, 1987
	
                               50MG
	                           A089489   001     Jan 02, 1987
	
        NEWTRON PHARMS
	       25MG
	                           A086543   001
	
                               50MG
	                           A086544   001
	
        NEXGEN PHARMA INC
	    25MG
	                           A083634   001
	
        PERRIGO
	              25MG
	                           A083061   001
	
                               50MG
	                           A083061   002
	
        PIONEER PHARMS
	       25MG
	                           A089101   001     Dec 20, 1985
	
                               50MG
	                           A088880   001     Dec 20, 1985
	
        PUREPAC PHARM
	        25MG
	                           A085156   001
	
                               50MG
	                           A085150   001
	
        PVT FORM
	             25MG
	                           A083027   001
	
                               50MG
	                           A083027   002
	
        ROXANE
	               50MG
	                           A080635   001
	
        SANDOZ
	               25MG
	                           A080832   001
	
                               25MG
	                           A080845   002
	
                               50MG
	                           A080832   002
	
                               50MG
	                           A080845   001
	
        SUPERPHARM
	           25MG
	                           A089040   001     May 15, 1985

                               50MG
	                           A089041   001     May 15, 1985

        TEVA
	                 25MG
	                           A085874   001
	
                               50MG
	                           A085874   002
	
        VALEANT PHARM INTL
	   25MG
	                           A080596   001
	
                               50MG
	                           A080592   001
	
        VANGARD
	              25MG
	                           A088034   001     Oct 27, 1982
	
                               50MG
	                           A087630   001
	
        WATSON LABS
	          25MG
	                           A080728   001
	
                               25MG
	                           A083797   001
	
                               25MG
	                           A085138   001
	
                               50MG
	                           A080727   001
	
                               50MG
	                           A083797   002
	
                               50MG
	                           A085083   001
	
        WHITEWORTH TOWN PLSN
	 25MG
	                           A083441   001
	
                               50MG
	                           A080800   001
	
 ELIXIR;ORAL
	
   BELIX
	
        HALSEY
	               12.5MG/5ML
	                     A086586 001 Oct 03, 1983
	
   BENADRYL
	
        MCNEIL CONS
	          12.5MG/5ML
	                     N005845 004
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                  6-113(of 337)


DIPHENHYDRAMINE HYDROCHLORIDE
	
  ELIXIR;ORAL
	
    DIBENIL
	
         CENCI                   12.5MG/5ML
                     A088304 001 Dec 16, 1983
	
    DIPHEN
	
         USL PHARMA              12.5MG/5ML
                     A084640 001
	
    DIPHENHYDRAMINE HYDROCHLORIDE
	
         BUNDY
	                 12.5MG/5ML
                     A083674   001
	
         CENCI
	                 12.5MG/5ML
                     A087941   001 Dec 17, 1982
	
         KV PHARM
	              12.5MG/5ML
                     A085621   001
	
         LANNETT
	               12.5MG/5ML
                     A080939   002
	
         LEDERLE
	               12.5MG/5ML
                     A086937   001
	
         MK LABS
	               12.5MG/5ML
                     A083088   002
	
         NASKA
	                 12.5MG/5ML
                     A088680   001 May 31, 1985

         PERRIGO
	               12.5MG/5ML
                     A083063   001
	
         PUREPAC PHARM
	         12.5MG/5ML
                     A083237   001 Jan 25, 1982
	
         PVT FORM
	              12.5MG/5ML
                     A085287   001
	
         ROXANE
	                12.5MG/5ML
	                    A080643   001
	
    HYDRAMINE
	
         ALPHARMA US PHARMS
	    12.5MG/5ML
	                    A080763 002
	
  INJECTABLE;INJECTION
	
    BENADRYL
	
         MCNEIL CONS
	           10MG/ML
                        N006146 001
	
                                 50MG/ML
	                       N006146 002
	
    BENADRYL PRESERVATIVE FREE
	
         MCNEIL CONS
	           50MG/ML
	                       N009486 001
	
    DIPHENHYDRAMINE HYDROCHLORIDE
	
         BEL MAR                 10MG/ML
                        A080822   001
	
         HIKMA MAPLE             50MG/ML
                        A083183   001
	
         LYPHOMED                10MG/ML
                        A087066   001
	
         WATSON LABS             10MG/ML
                        A083533   001
	
         WATSON LABS INC         10MG/ML
                        A080873   001
	
                                 50MG/ML
                        A080873   002
	
         WYETH AYERST            50MG/ML
                        A080577   001
	
    DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
	
         ABRAXIS PHARM
	         50MG/ML
                        A080586 002
	
         INTL MEDICATION
	       50MG/ML
                        A084094 001
	
         WATSON LABS INC
	       50MG/ML
	                       A080873 003
	
  SYRUP;ORAL
	
    ANTITUSSIVE
	
         PERRIGO
	               12.5MG/5ML
	                    A071292 001 Apr 10, 1987
	
    BELDIN
	
         HALSEY
	                12.5MG/5ML
	                    A089179 001 Jun 05, 1986
	
    BENYLIN
	
         PARKE DAVIS
	           12.5MG/5ML
	                    N006514 004
	
    DIPHEN
	
         MORTON GROVE
	          12.5MG/5ML
	                    A070118 001 Oct 01, 1985
	
    DIPHENHYDRAMINE HYDROCHLORIDE
	
         ALPHARMA US PHARMS
	    12.5MG/5ML
                     A070497 001 Apr 25, 1989

         CUMBERLAND SWAN
	       12.5MG/5ML
                     A073611 001 Aug 20, 1992

         HI TECH PHARMA
	        12.5MG/5ML
	                    A072416 001 Sep 28, 1990
	
    HYDRAMINE
	
         ALPHARMA US PHARMS
	    12.5MG/5ML
	                    A070205 001 Jan 28, 1986
	
    SILPHEN
	
         SILARX
	                12.5MG/5ML
	                    A072646 001 Feb 27, 1992
	
    VICKS FORMULA 44
	
         WARNER CHILCOTT
	       12.5MG/5ML
	                    A070524 001 Jan 14, 1987
	
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    BENYLIN
	
         PARKE DAVIS
	          12.5MG/5ML;30MG/5ML
	            N019014 001 Jun 11, 1985
	
DIPHENIDOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    VONTROL
	
         GLAXOSMITHKLINE
	      EQ 25MG BASE
	                   N016033 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-114(of 337)


DIPHENYLPYRALINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    HISPRIL
         GLAXOSMITHKLINE         5MG                            N011945 001
DIPIVEFRIN HYDROCHLORIDE
  SOLUTION/DROPS;OPHTHALMIC
    AKPRO
          AKORN                  0.1%                           A074382 001 Sep 29, 1995
    DIPIVEFRIN HYDROCHLORIDE
         BAUSCH AND LOMB         0.1%                           A074188 001 May 19, 1995
         FALCON PHARMS           0.1%                           A073636 001 Jun 30, 1994
    PROPINE
         ALLERGAN                0.1%                           N018239 001
DIPYRIDAMOLE
  INJECTABLE;INJECTION
    DIPYRIDAMOLE
         AGILA SPECLTS           5MG/ML                         A075769 001 Nov 27, 2002
         HOSPIRA                 5MG/ML                         A074601 001 Dec 19, 1997
         TEVA PHARMS USA         5MG/ML                         A074952 001 Nov 26, 1997
    IV PERSANTINE
         BOEHRINGER INGELHEIM    5MG/ML                         N019817 001 Dec 13, 1990
  TABLET;ORAL
    DIPYRIDAMOLE
         GLENMARK GENERICS       25MG                           A088999   001    Feb   05,   1991
                                 50MG                           A089000   001    Feb   05,   1991
                                 75MG                           A089001   001    Feb   05,   1991
         PROSAM LABS             25MG                           A040542   001    Apr   21,   2006
                                 50MG                           A040542   002    Apr   21,   2006
                                 75MG                           A040542   003    Apr   21,   2006
         PUREPAC PHARM           50MG                           A089426   001    Jul   12,   1990
                                 75MG                           A089427   001    Jul   12,   1990
         SANDOZ                  25MG                           A086944   002    Apr   16,   1991
                                 50MG                           A087562   001    Feb   25,   1992
                                 75MG                           A087561   001    Feb   25,   1992
         WATSON LABS             50MG                           A087160   001    Jun   07,   1996
DIRITHROMYCIN
  TABLET, DELAYED RELEASE;ORAL
    DYNABAC
         LILLY RES LABS          250MG                          N050678 001 Jun 19, 1995
DISOPYRAMIDE PHOSPHATE
  CAPSULE;ORAL
    DISOPYRAMIDE PHOSPHATE
         INTERPHARM            EQ   100MG   BASE                A071190   001    Jan   15,   1987
                               EQ   150MG   BASE                A071191   001    Jan   15,   1987
        IVAX SUB TEVA PHARMS   EQ   100MG   BASE                A070186   001    Nov   18,   1985
                               EQ   150MG   BASE                A070187   001    Nov   18,   1985
        MUTUAL PHARM           EQ   100MG   BASE                A070351   001    Dec   17,   1985
                               EQ   150MG   BASE                A070352   001    Dec   17,   1985
        MYLAN                  EQ   100MG   BASE                A070138   001    Jun   14,   1985
                               EQ   150MG   BASE                A070139   001    Jun   14,   1985
        SANDOZ                 EQ   100MG   BASE                A070470   001    Dec   10,   1985
                               EQ   150MG   BASE                A070471   001    Dec   10,   1985
        SUPERPHARM             EQ   100MG   BASE                A070940   001    Feb   09,   1987
                               EQ   150MG   BASE                A070941   001    Feb   09,   1987
        WATSON LABS            EQ   100MG   BASE                A070240   001    Feb   02,   1986
                               EQ   150MG   BASE                A070241   001    Feb   02,   1986
 CAPSULE, EXTENDED RELEASE;ORAL
   DISOPYRAMIDE PHOSPHATE
        NESHER PHARMS          EQ   150MG BASE                  A071200 001 Dec 15, 1987
DISULFIRAM
  TABLET;ORAL
    ANTABUSE
         TEVA WOMENS             250MG                          N007883 003
                                 500MG                          N007883 002
   DISULFIRAM
        PAR PHARM                250MG                          A088792   001 Aug 14, 1984
                                 500MG                          A088793   001 Aug 14, 1984
         WATSON LABS             250MG                          A086889   001
                                 250MG                          A087973   001 Aug 05, 1983
                                 500MG                          A086890   001
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                 6-115(of 337)


DISULFIRAM
	
  TABLET;ORAL
	
    DISULFIRAM
	
                                 500MG                                      A087974 001 Aug 05, 1983
	
DIVALPROEX SODIUM
	
  TABLET, DELAYED RELEASE;ORAL
	
    DEPAKOTE CP
	
         ABBOTT                  EQ   250MG BASE                            N019794 001 Jul 11, 1990
	
                                 EQ   500MG BASE                            N019794 002 Jul 11, 1990
	
    DIVALPROEX SODIUM
	
         MYLAN		                 EQ   125MG VALPROIC ACID                   A077254 001 Jul 29, 2008
	
                                 EQ   250MG VALPROIC ACID                   A077254 002 Jul 29, 2008
	
                                 EQ   500MG VALPROIC ACID                   A077254 003 Jul 29, 2008
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DIVALPROEX SODIUM
	
         TEVA PHARMS USA         EQ   500MG VALPROIC ACID                   A078700 001 Aug 03, 2009
	
DOBUTAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DOBUTAMINE HYDROCHLORIDE
	
         ASTRAZENECA            EQ 12.5MG BASE/ML                           A074098   001    Feb   21,   1995
	
         BAXTER HLTHCARE        EQ 12.5MG BASE/ML                           A074381   001    Sep   26,   1996

         HOSPIRA                EQ 1.25GM BASE/100ML                        A074634   001    Sep   27,   1996

         LUITPOLD               EQ 12.5MG BASE/ML                           A074545   001    Jun   25,   1998
	
         TEVA PARENTERAL        EQ 12.5MG BASE/ML                           A074206   001    Oct   19,   1993
	
         WATSON LABS            EQ 12.5MG BASE/ML                           A074114   001    Nov   30,   1993
	
         WATSON LABS INC        EQ 12.5MG BASE/ML                           A074279   001    Feb   18,   1998
	
                                EQ 12.5MG BASE/ML                           A074995   001    Mar   31,   1998
	
    DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
	
         HOSPIRA		              EQ 50MG BASE/100ML                          N020269 001 Oct 19, 1993
	
                                EQ 100MG BASE/100ML                         N020269 002 Oct 19, 1993
	
                                EQ 200MG BASE/100ML                         N020269 003 Oct 19, 1993
	
    DOBUTREX
	
         LILLY                  EQ 12.5MG BASE/ML                           N017820 002
	
DOCETAXEL
	
  INJECTABLE;INJECTION
	
    DOCETAXEL
	
         APOTEX INC              20MG/0.5ML (40MG/ML)                       N022312 001 Jan 11, 2012
	
                                 80MG/2ML (40MG/ML)                         N022312 002 Jan 11, 2012
	
    TAXOTERE
	
         SANOFI AVENTIS US       40MG/ML **Federal Register                 N020449 001 May 14, 1996

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
DONEPEZIL HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    ARICEPT
	
         EISAI INC               5MG/5ML                                    N021719 001 Oct 18, 2004
	
  TABLET;ORAL
	
    DONEPEZIL HYDROCHLORIDE
	
         ACCORD HLTHCARE        5MG                                         A201335 001 Aug 29, 2011

                                10MG                                        A201335 002 Aug 29, 2011

  TABLET, ORALLY DISINTEGRATING;ORAL
	
    DONEPEZIL HYDROCHLORIDE
	
         MUTUAL PHARM           5MG                                         A077975 002 Dec 11, 2009
	
                                10MG                                        A077975 001 Dec 11, 2009
	
DOPAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DOPAMINE HYDROCHLORIDE
	
         ABBOTT                  40MG/ML                                    A070656   001    Jan   24,   1989
	
                                 80MG/ML                                    A070657   001    Jan   24,   1989
	
         ABRAXIS PHARM		         40MG/ML                                    A070012   001    Jun   12,   1985
	
                                 40MG/ML                                    A070058   001    Mar   20,   1985
	
                                 80MG/ML                                    A070013   001    Jun   12,   1985
	
                                 80MG/ML                                    A070059   001    Mar   20,   1985
	
                                 160MG/ML                                   A070364   001    Dec   04,   1985
	
         ASTRAZENECA		           40MG/ML                                    A070087   001    Oct   23,   1985
	
                                 40MG/ML                                    N018656   001    Jun   28,   1983
	
                                 80MG/ML                                    A070089   001    Oct   23,   1985
	
                                 80MG/ML                                    A070090   001    Oct   23,   1985
	
                                 80MG/ML                                    A070091   001    Oct   23,   1985
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-116(of 337)


DOPAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DOPAMINE HYDROCHLORIDE
	
                               160MG/ML                           A070092   001     Oct 23, 1985
	
                               160MG/ML                           A070093   001     Oct 23, 1985
	
                               160MG/ML                           A070094   001     Oct 23, 1985
	
        BAXTER HLTHCARE		      40MG/ML                            N018398   001
	
                               80MG/ML                            N018398   002     Mar 22, 1982
	
        HOSPIRA                40MG/ML                            A074403   001     May 23, 1996

        INTL MEDICATION        40MG/ML                            N018014   001
	
        LYPHOMED               40MG/ML                            N018549   001     Mar   11,   1983
	
        SMITH AND NEPHEW       40MG/ML                            A070011   001     Aug   29,   1985

                               40MG/ML                            A070046   001     Aug   29,   1985

                               80MG/ML                            A070047   001     Aug   29,   1985

        TEVA PARENTERAL        40MG/ML                            A072999   001     Oct   23,   1991
	
                               80MG/ML                            A073000   001     Oct   23,   1991
	
        WARNER CHILCOTT		      40MG/ML                            A070558   001     Sep   20,   1985

                               40MG/ML                            N018138   001
	
                               80MG/ML                            A070559   001     Sep 20, 1985

   DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
	
        HOSPIRA                1.6MG/ML                           N020542 001 Aug 30, 1995

   INTROPIN
	
        HOSPIRA		              40MG/ML                            N017395 001
	
                               80MG/ML                            N017395 002
	
                               160MG/ML                           N017395 003
	
DORZOLAMIDE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    DORZOLAMIDE HYDROCHLORIDE
	
         APOTEX INC               EQ 2% BASE                      A078395 001 Oct 28, 2008
	
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
	
  SOLUTION/DROPS;OPHTHALMIC

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
	
         APOTEX INC             EQ 2% BASE;EQ 0.5% BASE           A078201 001 Oct 28, 2008
	
DOXACURIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    NUROMAX
	
         ABBVIE                   EQ 1MG BASE/ML                  N019946 001 Mar 07, 1991
	
DOXAPRAM HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DOXAPRAM HYDROCHLORIDE
	
         WATSON LABS              20MG/ML                         A073529 001 Jan 30, 1992
	
DOXAZOSIN MESYLATE
	
  TABLET;ORAL
	
    DOXAZOSIN MESYLATE
	
         ACTAVIS ELIZABETH		      EQ   1MG   BASE                 A075574   001     Oct   18,   2000
	
                                  EQ   2MG   BASE                 A075574   002     Oct   18,   2000
	
                                  EQ   4MG   BASE                 A075574   003     Oct   18,   2000
	
                                  EQ   8MG   BASE                 A075574   004     Oct   18,   2000
	
         GENPHARM		               EQ   1MG   BASE                 A075466   001     Oct   18,   2000
	
                                  EQ   2MG   BASE                 A075466   002     Oct   18,   2000
	
                                  EQ   4MG   BASE                 A075466   003     Oct   18,   2000
	
                                  EQ   8MG   BASE                 A075466   004     Oct   18,   2000
	
         IVAX SUB TEVA PHARMS		   EQ   1MG   BASE                 A075453   001     Oct   18,   2000
	
                                  EQ   2MG   BASE                 A075453   002     Oct   18,   2000
	
                                  EQ   4MG   BASE                 A075453   003     Oct   18,   2000
	
                                  EQ   8MG   BASE                 A075453   004     Oct   18,   2000
	
         NESHER PHARMS		          EQ   1MG   BASE                 A075609   001     Oct   18,   2000
	
                                  EQ   2MG   BASE                 A075609   002     Oct   18,   2000
	
                                  EQ   4MG   BASE                 A075609   003     Oct   18,   2000
	
                                  EQ   8MG   BASE                 A075609   004     Oct   18,   2000
	
         SANDOZ		                 EQ   1MG   BASE                 A075432   001     Oct   18,   2000
	
                                  EQ   1MG   BASE                 A075646   001     Oct   18,   2000
	
                                  EQ   2MG   BASE                 A075432   002     Oct   18,   2000
	
                                  EQ   2MG   BASE                 A075646   002     Oct   18,   2000
	
                                  EQ   4MG   BASE                 A075432   003     Oct   18,   2000
	
                                  EQ   4MG   BASE                 A075646   003     Oct   18,   2000
	
                                  EQ   8MG   BASE                 A075432   004     Oct   18,   2000
	
                                  EQ   8MG   BASE                 A075646   004     Oct   18,   2000
	
         TEVA		                   EQ   1MG   BASE                 A075353   001     Jan   12,   2001
	
                                  EQ   2MG   BASE                 A075353   002     Jan   12,   2001
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                     6-117(of 337)


DOXAZOSIN MESYLATE
	
  TABLET;ORAL
	
    DOXAZOSIN MESYLATE
	
                                 EQ   4MG   BASE
	                 A075353   003     Jan   12,   2001
	
                                 EQ   8MG   BASE
	                 A075353   004     Jan   12,   2001
	
         WATSON LABS INC
	       EQ   1MG   BASE
	                 A075426   001     Oct   18,   2000
	
                                 EQ   2MG   BASE
	                 A075426   002     Oct   18,   2000
	
                                 EQ   4MG   BASE
	                 A075426   003     Oct   18,   2000
	
                                 EQ   8MG   BASE
	                 A075426   004     Oct   18,   2000
	
DOXEPIN HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    DOXEPIN HYDROCHLORIDE
	
         DAVA PHARMS INC
	       EQ   10MG BASE
	                  A071685   001     Jan   05,   1988
	
                                 EQ   25MG BASE
	                  A071686   001     Jan   05,   1988
	
                                 EQ   50MG BASE
	                  A071673   001     Jan   05,   1988
	
                                 EQ   75MG BASE
	                  A071674   001     Jan   05,   1988
	
                                 EQ   100MG BASE
	                 A071675   001     Jan   05,   1988
	
                                 EQ   150MG BASE
	                 A071676   001     Jan   05,   1988
	
         MUTUAL PHARM
	          EQ   25MG BASE
	                  A071502   001     Feb   18,   1988
	
                                 EQ   50MG BASE
	                  A071653   001     Feb   18,   1988
	
                                 EQ   75MG BASE
	                  A071654   001     Feb   18,   1988
	
                                 EQ   100MG BASE
	                 A071521   001     Feb   18,   1988
	
         NEW RIVER
	             EQ   10MG BASE
	                  N016987   001
	
                                 EQ   25MG BASE
	                  N016987   002
	
                                 EQ   50MG BASE
	                  N016987   003
	
                                 EQ   75MG BASE
	                  N016987   006
	
                                 EQ   100MG BASE
	                 N016987   004
	
                                 EQ   150MG BASE
	                 N016987   007     Apr   13,   1987

         PAR PHARM
	             EQ   10MG BASE
	                  A071697   001     Nov   09,   1987
	
                                 EQ   25MG BASE
	                  A071437   001     Nov   09,   1987
	
                                 EQ   50MG BASE
	                  A071595   001     Nov   09,   1987
	
                                 EQ   75MG BASE
	                  A071608   001     Nov   09,   1987
	
                                 EQ   100MG BASE
	                 A071422   001     Nov   09,   1987
	
         PUREPAC PHARM
	         EQ   10MG BASE
	                  A073054   001     Dec   28,   1990
	
                                 EQ   25MG BASE
	                  A072109   001     Dec   28,   1990
	
                                 EQ   50MG BASE
	                  A073055   001     Dec   28,   1990
	
                                 EQ   75MG BASE
	                  A072386   001     Sep   08,   1988

                                 EQ   100MG BASE
	                 A072110   001     Sep   08,   1988

                                 EQ   150MG BASE
	                 A072387   001     Sep   08,   1988

         QUANTUM PHARMICS
	      EQ   10MG BASE
	                  A070972   001     Sep   29,   1987

                                 EQ   25MG BASE
	                  A070973   001     Sep   29,   1987

                                 EQ   50MG BASE
	                  A070931   001     Sep   29,   1987

                                 EQ   75MG BASE
	                  A070932   001     Sep   29,   1987

                                 EQ   100MG BASE
	                 A072375   001     Mar   15,   1989
	
                                 EQ   150MG BASE
	                 A072376   001     Mar   15,   1989
	
         SANDOZ
	                EQ   10MG BASE
	                  A071487   001     Mar   02,   1987
	
                                 EQ   25MG BASE
	                  A070827   001     May   15,   1986

                                 EQ   50MG BASE
	                  A070828   001     May   15,   1986

                                 EQ   75MG BASE
	                  A070825   001     May   15,   1986

                                 EQ   100MG BASE
	                 A071562   001     Mar   02,   1987
	
         WATSON LABS
	           EQ   10MG BASE
	                  A070952   001     Mar   04,   1987
	
                                 EQ   10MG BASE
	                  A071485   001     Apr   30,   1987

                                 EQ   10MG BASE
	                  A072985   001     Mar   29,   1991
	
                                 EQ   25MG BASE
	                  A070953   001     May   15,   1986

                                 EQ   25MG BASE
	                  A071486   001     Apr   30,   1987

                                 EQ   25MG BASE
	                  A072986   001     Mar   29,   1991
	
                                 EQ   50MG BASE
	                  A070954   001     May   15,   1986

                                 EQ   50MG BASE
	                  A071238   001     Apr   30,   1987

                                 EQ   50MG BASE
	                  A072987   001     Mar   29,   1991
	
                                 EQ   75MG BASE
	                  A071326   001     Apr   30,   1987

                                 EQ   75MG BASE
	                  A071763   001     Feb   09,   1988
	
                                 EQ   100MG BASE
	                 A070955   001     May   15,   1986

                                 EQ   100MG BASE
	                 A071239   001     Apr   30,   1987

                                 EQ   150MG BASE
	                 A071764   001     Feb   09,   1988
	
   SINEQUAN
	
        PFIZER
	                 EQ   10MG BASE
	                  N016798   003
	
                                 EQ   25MG BASE
	                  N016798   001
	
                                 EQ   50MG BASE
	                  N016798   002
	
                                 EQ   75MG BASE
	                  N016798   006
	
                                 EQ   100MG BASE
	                 N016798   005
	
                                 EQ   150MG BASE
	                 N016798   007
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                      6-118(of 337)


DOXEPIN HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    DOXEPIN HYDROCHLORIDE
	
         PHARM ASSOC              EQ 10MG BASE/ML                 A075924 001 Jan 15, 2004
	
    SINEQUAN
	
         PFIZER                   EQ 10MG BASE/ML                 N017516 001
	
DOXORUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ADRIAMYCIN PFS
	
         PHARMACIA AND UPJOHN		   2MG/ML                          A063165   001     Jan   30,   1991
	
                                  2MG/ML                          N050629   001     Dec   23,   1987
	
                                  200MG/100ML                     A063165   002     Jan   30,   1991
	
                                  200MG/100ML                     N050629   002     May   03,   1988

   ADRIAMYCIN RDF
	
        PHARMACIA AND UPJOHN		    10MG/VIAL                       N050467   001
	
                                  20MG/VIAL                       N050467   003 May 20, 1985

                                  50MG/VIAL                       N050467   002
	
                                  150MG/VIAL                      N050467   004 Jul 22, 1987
	
   RUBEX
	
        BRISTOL MYERS SQUIBB		    10MG/VIAL                       A062926 001 Apr 13, 1989

                                  50MG/VIAL                       A062926 002 Apr 13, 1989

                                  100MG/VIAL                      A062926 003 Apr 13, 1989
	
DOXYCYCLINE
	
  CAPSULE;ORAL
	
    DOXYCYCLINE
	
         PAR PHARM                EQ   75MG BASE                  A065055   004     Apr   18,   2005

         SANDOZ INC               EQ   50MG BASE                  A065032   001     Jun   30,   2000
	
                                  EQ   100MG BASE                 A065032   002     Jun   30,   2000
	
         WATSON LABS              EQ   50MG BASE                  A065041   001     Apr   28,   2000

                                  EQ   100MG BASE                 A065041   002     Apr   28,   2000

 FOR SUSPENSION;ORAL
	
   DOXYCHEL
	
        RACHELLE                  EQ 25MG BASE/5ML                A061720 001
	
 TABLET;ORAL
	
   DOXYCYCLINE
	
        MUTUAL PHARM		            EQ   50MG BASE                  A065471   001     Apr   17,   2009

                                  EQ   75MG BASE                  A065471   002     Apr   17,   2009

                                  EQ   100MG BASE                 A065471   003     Apr   17,   2009

         SANDOZ INC		             EQ   50MG BASE                  A065353   001     Nov   27,   2006
	
                                  EQ   75MG BASE                  A065353   002     Nov   27,   2006
	
                                  EQ   100MG BASE                 A065353   003     Nov   27,   2006
	
DOXYCYCLINE HYCLATE
	
  CAPSULE;ORAL
	
    DOXY-LEMMON
	
         TEVA                     EQ 50MG BASE                    A062497 001 Aug 23, 1984

                                  EQ 100MG BASE                   A062497 002 Jun 15, 1984
	
   DOXYCYCLINE HYCLATE
	
        HALSEY                    EQ   50MG BASE                  A062119   002     May   24,   1985

                                  EQ   100MG BASE                 A062119   001     May   24,   1985

         HEATHER                  EQ   50MG BASE                  A062463   001     Dec   07,   1983
	
                                  EQ   100MG BASE                 A062463   002     Dec   07,   1983
	
         INTERPHARM               EQ   50MG BASE                  A062763   001     Sep   02,   1988

                                  EQ   100MG BASE                 A062763   002     Sep   02,   1988

         MUTUAL PHARM             EQ   50MG BASE                  A062418   001     Jan   28,   1983
	
                                  EQ   100MG BASE                 A062418   002     Jan   28,   1983
	
         PAR PHARM                EQ   50MG BASE                  A062434   001     Oct   19,   1984
	
                                  EQ   100MG BASE                 A062442   001     Dec   22,   1983
	
         PVT FORM                 EQ   50MG BASE                  A062631   001     Jul   24,   1986
	
                                  EQ   100MG BASE                 A062631   002     Jul   24,   1986
	
         RANBAXY                  EQ   50MG BASE                  A062479   001     Dec   23,   1983
	
                                  EQ   100MG BASE                 A062479   002     Dec   23,   1983
	
         SUPERPHARM               EQ   50MG BASE                  A062469   001     Oct   31,   1984
	
                                  EQ   100MG BASE                 A062469   002     Oct   31,   1984
	
         WARNER CHILCOTT          EQ   50MG BASE                  A062594   001     Dec   05,   1985
	
                                  EQ   100MG BASE                 A062594   002     Dec   05,   1985
	
         WATSON LABS		            EQ   50MG BASE                  A061717   001
	
                                  EQ   50MG BASE                  A062142   001
	
                                  EQ   100MG BASE                 A061717   002
	
                                  EQ   100MG BASE                 A062142   002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-119(of 337)


DOXYCYCLINE HYCLATE
	
  CAPSULE;ORAL
	
    PERIOSTAT
	
         COLLAGENEX              EQ 20MG BASE                               N050744 001 Sep 30, 1998

  CAPSULE, COATED PELLETS;ORAL
	
    DOXYCYCLINE HYCLATE
	
         PLIVA                   EQ 100MG BASE                              A063187 001 Jun 30, 1992
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    DORYX
	
         MAYNE PHARMA INTL       EQ 75MG BASE                               N050582 002 Aug 13, 2001

                                 EQ 100MG BASE                              N050582 001 Jul 22, 1985
	
         WARNER CHILCOTT         EQ 100MG BASE                              A062653 001 Oct 30, 1985
	
  INJECTABLE;INJECTION
	
    DOXYCHEL HYCLATE
	
         RACHELLE                EQ 100MG BASE/VIAL                         A061953 001
	
    DOXYCYCLINE
	
         EUROHLTH INTL           EQ 200MG BASE/VIAL                         A062569 002 Mar 09, 1988
	
         HIKMA MAPLE             EQ 100MG BASE/VIAL                         A062450 001 Oct 27, 1983
	
                                 EQ 200MG BASE/VIAL                         A062450 002 Oct 27, 1983
	
    DOXYCYCLINE HYCLATE
	
         HIKMA MAPLE             EQ 100MG BASE/VIAL                         A062992 001 Feb 16, 1989
	
                                 EQ 200MG BASE/VIAL                         A062992 002 Feb 16, 1989
	
    VIBRAMYCIN
	
         PFIZER                  EQ 100MG BASE/VIAL                         N050442 002
	
                                 EQ 200MG BASE/VIAL                         N050442 001
	
  TABLET;ORAL
	
    DOXY-LEMMON
	
         TEVA                    EQ 100MG BASE                              A062581 001 Mar 15, 1985
	
    DOXYCYCLINE HYCLATE
	
         BLU CARIBE INC          EQ 50MG BASE                               A062269   003
	
         HEATHER                 EQ 100MG BASE                              A062462   001     May   11,   1983

         INTERPHARM              EQ 100MG BASE                              A062764   001     Sep   02,   1988

         MUTUAL PHARM            EQ 100MG BASE                              A062391   001     Sep   30,   1982

         SUPERPHARM              EQ 100MG BASE                              A062494   001     Feb   20,   1985
	
         WARNER CHILCOTT         EQ 100MG BASE                              A062593   001     Aug   28,   1985

         WATSON LABS             EQ 50MG BASE                               A062392   001     Mar   31,   1983
	
                                 EQ 100MG BASE                              A062392   002     Mar   31,   1983
	
    PERIOSTAT
	
         GALDERMA LABS LP		      EQ 20MG BASE **Federal Register            N050783 001 Feb 02, 2001

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

    VIBRA-TABS
	
         PFIZER		                EQ 100MG BASE **Federal Register           N050533 001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
DOXYLAMINE SUCCINATE
	
  CAPSULE;ORAL
	
    UNISOM
	
         PFIZER                 25MG                                        N019440 001 Feb 05, 1986
	
  TABLET;ORAL
	
    DECAPRYN
	
         SANOFI AVENTIS US      12.5MG                                      N006412 015
	
                                25MG                                        N006412 014
	
   DOXY-SLEEP-AID
	
        PAR PHARM               25MG                                        A070156 001 Jul 02, 1987
	
   DOXYLAMINE SUCCINATE
	
        COPLEY PHARM            25MG                                        A088900 002 Feb 12, 1988
	
        QUANTUM PHARMICS        25MG                                        A088603 001 Aug 07, 1984
	
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    BENDECTIN
	
         SANOFI AVENTIS US       10MG;10MG **Federal Register               N010598 002
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                             6-120(of 337)


DROMOSTANOLONE PROPIONATE
	
  INJECTABLE;INJECTION
	
    DROLBAN
	
         LILLY                   50MG/ML                                 N012936 001
	
DROPERIDOL
	
  INJECTABLE;INJECTION
	
    DROPERIDOL
	
         ABRAXIS PHARM           2.5MG/ML                                A070992   001    Nov   17,   1986
	
                                 2.5MG/ML                                A070993   001    Nov   17,   1986
	
         ASTRAZENECA		           2.5MG/ML                                A072018   001    Oct   20,   1988
	
                                 2.5MG/ML                                A072019   001    Oct   19,   1988
	
                                 2.5MG/ML                                A072020   001    Oct   19,   1988
	
                                 2.5MG/ML                                A072021   001    Oct   19,   1988
	
         HOSPIRA		               2.5MG/ML                                A071645   001    Apr   07,   1988

                                 2.5MG/ML                                A072272   001    Aug   31,   1995

         LUITPOLD                2.5MG/ML                                A072335   001    Oct   24,   1988
	
         SMITH AND NEPHEW        2.5MG/ML                                A071750   001    Sep   06,   1988

         SOLOPAK                 2.5MG/ML                                A071754   001    Sep   06,   1988

                                 2.5MG/ML		                              A071755   001    Sep   06,   1988

         WATSON LABS		           2.5MG/ML                                A073520   001    Nov   27,   1991
	
                                 2.5MG/ML                                A073521   001    Nov   27,   1991
	
                                 2.5MG/ML                                A073523   001    Nov   27,   1991
	
DROPERIDOL; FENTANYL CITRATE
	
  INJECTABLE;INJECTION
	
    FENTANYL CITRATE AND DROPERIDOL
	
         ASTRAZENECA		          2.5MG/ML;EQ   0.05MG   BASE/ML           A072026   001    Apr   13,   1989

                                2.5MG/ML;EQ   0.05MG   BASE/ML           A072027   001    Apr   13,   1989

                                2.5MG/ML;EQ   0.05MG   BASE/ML           A072028   001    Apr   13,   1989

         HOSPIRA                2.5MG/ML;EQ   0.05MG   BASE/ML           A071982   001    May   04,   1988

    INNOVAR
	
         AKORN MFG              2.5MG/ML;EQ   0.05MG BASE/ML             N016049 001
	
DYCLONINE HYDROCHLORIDE
	
  SOLUTION;TOPICAL
	
    DYCLONE
	
         ASTRAZENECA             0.5% **Federal Register determination   N009925 002
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 1% **Federal Register determination     N009925 001
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
DYDROGESTERONE
	
  TABLET;ORAL
	
    GYNOREST
	
         SOLVAY                  5MG                                     N017388 001
	
                                 10MG                                    N017388 002
	
DYPHYLLINE
	
  ELIXIR;ORAL
	
    NEOTHYLLINE
	
         TEVA                    160MG/15ML                              N007794 003
	
  INJECTABLE;INJECTION
	
    NEOTHYLLINE
	
         TEVA                    250MG/ML                                N009088 001
	
  TABLET;ORAL
	
    DILOR
	
         SAVAGE LABS             200MG                                   A084514 001
	
    DILOR-400
	
         SAVAGE LABS             400MG                                   A084751 001
	
    NEOTHYLLINE
	
         TEVA                    200MG                                   N007794 001
	
                                 400MG                                   N007794 002
	
ECHOTHIOPHATE IODIDE
	
  FOR SOLUTION;OPHTHALMIC
	
    PHOSPHOLINE IODIDE
	
         WYETH PHARMS INC		      0.03%                                   N011963 002
	
                                 0.06%                                   N011963 004
	
                                 0.25%                                   N011963 003
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-121(of 337)


ECONAZOLE NITRATE
	
  CREAM;TOPICAL
	
    SPECTAZOLE
	
         MERZ PHARMS LLC          1%		                                     N018751 001 Dec 23, 1982
	
EDETATE CALCIUM DISODIUM
	
  TABLET;ORAL
	
    CALCIUM DISODIUM VERSENATE
	
         MEDICIS                 500MG                                     N008922 002
	
EDROPHONIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    EDROPHONIUM CHLORIDE
	
         HOSPIRA                10MG/ML                                    A040131 001 Feb 24, 1998
	
         WATSON LABS            10MG/ML                                    A040044 001 Mar 20, 1996
	
    EDROPHONIUM CHLORIDE PRESERVATIVE FREE
	
         WATSON LABS            10MG/ML                                    A040043 001 Mar 20, 1996
	
    REVERSOL
	
         ORGANON USA INC        10MG/ML                                    A089624 001 May 13, 1988
	
EFAVIRENZ
	
  CAPSULE;ORAL
	
    SUSTIVA
	
         BRISTOL MYERS SQUIBB     100MG **Federal Register determination   N020972 002 Sep 17, 1998

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
 TABLET;ORAL
	
   SUSTIVA
	
        BRISTOL MYERS SQUIBB      300MG **Federal Register determination   N021360 001 Feb 01, 2002

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
EFLORNITHINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ORNIDYL
	
         SANOFI AVENTIS US        200MG/ML                                 N019879 002 Nov 28, 1990
	
ENALAPRIL MALEATE
	
  TABLET;ORAL
	
    ENALAPRIL MALEATE
	
         APOTHECON		              2.5MG                                    A075583   001    Aug   22,   2000

                                  5MG                                      A075583   002    Aug   22,   2000

                                  10MG                                     A075583   003    Aug   22,   2000

                                  20MG                                     A075583   004    Aug   22,   2000

         IVAX SUB TEVA PHARMS		   2.5MG                                    A075482   001    Aug   22,   2000

                                  5MG                                      A075482   002    Aug   22,   2000

                                  10MG                                     A075482   003    Aug   22,   2000

                                  20MG                                     A075482   004    Aug   22,   2000

         KRKA DD NOVO MESTO		     2.5MG                                    A075370   001    Aug   22,   2000

                                  5MG                                      A075370   002    Aug   22,   2000

                                  10MG                                     A075369   001    Aug   22,   2000

                                  20MG                                     A075369   002    Aug   22,   2000

         MYLAN		                  2.5MG                                    A075472   001    Aug   22,   2000

                                  5MG                                      A075472   002    Aug   22,   2000

                                  10MG                                     A075472   003    Aug   22,   2000

                                  20MG                                     A075472   004    Aug   22,   2000

         RANBAXY		                2.5MG                                    A075556   001    Aug   22,   2000

                                  5MG                                      A075556   002    Aug   22,   2000

                                  10MG                                     A075556   003    Aug   22,   2000

                                  20MG                                     A075556   004    Aug   22,   2000

         SANDOZ		                 2.5MG                                    A075048   001    Aug   22,   2000

                                  5MG                                      A075048   002    Aug   22,   2000

                                  10MG                                     A075048   003    Aug   22,   2000

                                  20MG                                     A075048   004    Aug   22,   2000

         SANDOZ INC		             2.5MG                                    A075496   001    Aug   22,   2000

                                  2.5MG                                    A075621   001    Aug   22,   2000

                                  5MG                                      A075496   002    Aug   22,   2000

                                  5MG                                      A075621   002    Aug   22,   2000

                                  10MG                                     A075459   001    Aug   22,   2000

                                  10MG                                     A075621   003    Aug   22,   2000

                                  20MG                                     A075459   002    Aug   22,   2000

                                  20MG                                     A075621   004    Aug   22,   2000

         WATSON LABS		            2.5MG                                    A075501   001    Aug   22,   2000

                                  5MG                                      A075501   002    Aug   22,   2000
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                                6-122(of 337)


ENALAPRIL MALEATE
	
  TABLET;ORAL
	
    ENALAPRIL MALEATE
	
                                  10MG                                      A075501 003 Aug 22, 2000

                                  20MG                                      A075501 004 Aug 22, 2000
	
ENALAPRIL MALEATE; FELODIPINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    LEXXEL
	
         ASTRAZENECA             5MG;2.5MG                                  N020668 002 Oct 28, 1998
	
                                 5MG;5MG                                    N020668 001 Dec 27, 1996
	
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
	
         IVAX SUB TEVA PHARMS   5MG;12.5MG                                  A075736   001    Mar   25,   2003
	
                                10MG;25MG                                   A075736   002    Mar   25,   2003
	
         SANDOZ INC             5MG;12.5MG                                  A076116   001    Sep   19,   2001

                                10MG;25MG                                   A076116   002    Sep   19,   2001
	
ENALAPRILAT
	
  INJECTABLE;INJECTION
	
    ENALAPRILAT
	
         HOSPIRA                  1.25MG/ML                                 A075456 001 Aug 22, 2000

                                  1.25MG/ML                                 A075571 001 Aug 22, 2000

   VASOTEC
	
        BIOVAIL LABS INTL         1.25MG/ML                                 N019309 001 Feb 09, 1988
	
ENFLURANE
	
  LIQUID;INHALATION
	
    ENFLURANE
	
         ABBOTT                   99.9%                                     A070803 001 Sep 08, 1987
	
ENOXACIN
	
  TABLET;ORAL
	
    PENETREX
	
          SANOFI AVENTIS US       200MG                                     N019616 004 Dec 31, 1991
	
                                  400MG                                     N019616 005 Dec 31, 1991
	
ENOXAPARIN SODIUM
	
  INJECTABLE;SUBCUTANEOUS
	
    LOVENOX (PRESERVATIVE FREE)

         SANOFI AVENTIS US       90MG/0.6ML (150MG/ML) **Federal            N020164 006 Jun 02, 2000

                                 Register determination that product was

                                 not discontinued or withdrawn for
	
                                 safety or efficacy reasons**
	
EPINEPHRINE
	
  AEROSOL, METERED;INHALATION
	
    BRONKAID MIST
	
         STERLING                 0.25MG/INH                                N016803 001
	
    EPINEPHRINE
	
         ARMSTRONG PHARMS         0.2MG/INH                                 A087907 001 May 23, 1984

    PRIMATENE MIST
	
         WYETH CONS               0.2MG/INH                                 N016126 001
	
  INJECTABLE;INJECTION
	
    SUS-PHRINE SULFITE-FREE
	
         FOREST LABS              1.5MG/AMP                                 N007942 003 Feb 05, 1999
	
                                  5MG/ML                                    N007942 001
	
 INJECTABLE;INTRAMUSCULAR
	
   EPI E Z PEN JR
	
        MYLAN SPECLT              0.15MG/DELIVERY                           N019430 004 Aug 03, 1995

   EPIPEN E Z PEN
	
        MYLAN SPECLT              0.3MG/DELIVERY                            N019430 003 Aug 03, 1995
	
EPINEPHRINE BITARTRATE
	
  AEROSOL, METERED;INHALATION
	
    BRONITIN MIST
	
         WYETH CONS               0.3MG/INH                                 N016126 002
	
    MEDIHALER-EPI
	
         3M                       0.3MG/INH                                 N010374 003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-123(of 337)


EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DURANEST
	
         ASTRAZENECA            0.005MG/ML;1%
                  N017751 006
	
                                0.005MG/ML;1.5%
                N017751 007
	
         DENTSPLY PHARM         0.005MG/ML;1.5%
	               N021384 001
	
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CITANEST FORTE
	
         ASTRAZENECA            0.005MG/ML;4%
	                 N014763 008
	
EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DURANEST
	
         ASTRAZENECA            0.005MG/ML;0.5%
	               N017751 004
	
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE

         CARLISLE                 0.01MG/ML;2%
                 A084720 001
	
                                  0.02MG/ML;2%
                 A084732 001
	
    LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
	
         GRAHAM CHEM              0.01MG/ML;2%
                 A080504   004     Oct 19, 1983
	
                                  0.02MG/ML;2%
                 A080504   005     Oct 19, 1983
	
         HIKMA MAPLE              0.01MG/ML;1%
                 A080406   001
	
                                  0.01MG/ML;2%
                 A080406   002
	
         HOSPIRA                  0.005MG/ML;1%
                A089649   001     Jun 21, 1988
	
                                  0.005MG/ML;1.5%
              A089650   001     Jun 21, 1988
	
    LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE

         ABBOTT
	                 0.01MG/ML;1%
                 A083154   001
	
         BEL MAR
	                0.01MG/ML;1%
                 A080820   001
	
                                  0.01MG/ML;2%
                 A080757   001
	
         DELL LABS
	              0.01MG/ML;1%
                 A083389   001
	
                                  0.01MG/ML;2%
                 A083390   001
	
         INTL MEDICATION
	        0.01MG/ML;1%
                 A086402   001
	
         WATSON LABS
	            0.01MG/ML;1%
                 A080377   003
	
                                  0.01MG/ML;1%
                 A085463   001
	
                                  0.01MG/ML;2%
	                A080377   004
	
    LIDOCATON
	
         PHARMATON
	              0.01MG/ML;2%
                 A084729 001 Aug 17, 1983

                                  0.02MG/ML;2%
	                A084728 001 Aug 17, 1983
	
    XYLOCAINE DENTAL WITH EPINEPHRINE
	
         DENTSPLY PHARM
	         0.01MG/ML;2%
                 N021381 001
	
                                  0.02MG/ML;2%
	                N021381 002
	
    XYLOCAINE W/ EPINEPHRINE

         ASTRAZENECA
	            0.005MG/ML;1%
                N010418   006
	
                                  0.005MG/ML;1.5%
              N010418   010
	
                                  0.005MG/ML;2%
                N010418   008
	
         FRESENIUS KABI USA
	     0.01MG/ML;2%
	                N006488   003
	
  PATCH;IONTOPHORESIS, TOPICAL
	
    LIDOSITE TOPICAL SYSTEM KIT
	
         VYTERIS
	                1.05MG/PATCH;100MG/PATCH
	    N021504 001 May 06, 2004
	
  SOLUTION;IONTOPHORESIS
	
    IONTOCAINE
	
         IOMED
	                  0.01MG/ML;2%
	                N020530 001 Dec 21, 1995
	
  SOLUTION;IONTOPHORESIS, TOPICAL
	
    LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
	
         EMPI                     0.01MG/ML;2%
	                N021486 001 Oct 26, 2004
	
EPINEPHRINE; PROCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PROCAINE HYDROCHLORIDE W/ EPINEPHRINE

         BEL MAR
	              0.02MG/ML;1%
                   A080758 001
	
                                0.02MG/ML;2%
	                  A080759 001
	
EPIRUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    EPIRUBICIN HYDROCHLORIDE
	
         EBEWE PHARMA
	          50MG/25ML (2MG/ML)
            A065339   001     Dec   22,   2009
	
                                 200MG/100ML (2MG/ML)
          A065339   002     Dec   22,   2009
	
         HOSPIRA
	               50MG/25ML (2MG/ML)
            A065343   002     Apr   19,   2007

         MUSTAFA NEVSAT
	        50MG/25ML (2MG/ML)
            A090266   001     Apr   15,   2011

                                 200MG/100ML (2MG/ML)
          A090266   002     Apr   15,   2011

         MYLAN INSTITUTIONAL
	   50MG/25ML (2MG/ML)
	           A065371   001     Nov   28,   2007
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                    6-124(of 337)


EPIRUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    EPIRUBICIN HYDROCHLORIDE
	
                                  200MG/100ML (2MG/ML)
	         A065371 002 Nov 28, 2007
	
  INJECTABLE;IV (INFUSION)

    EPIRUBICIN HYDROCHLORIDE
	
         HOSPIRA
	                50MG/VIAL
                     N050807 001 Sep 15, 2006

                                  200MG/VIAL
	                   N050807 002 Sep 15, 2006
	
EPLERENONE
	
  TABLET;ORAL
	
    INSPRA
	
         GD SEARLE LLC
	          100MG
	                        N021437 003 Sep 27, 2002
	
EPROSARTAN MESYLATE
	
  TABLET;ORAL
	
    TEVETEN
	
         ABBVIE
	                 EQ 300MG BASE
	                N020738 004 Dec 22, 1997
	
ERGOCALCIFEROL
	
  CAPSULE;ORAL
	
    DELTALIN
	
         LILLY
	                  50,000 IU
	                    A080884 001
	
    VITAMIN D
	
         CHASE CHEM
	             50,000     IU
	                A080747   001
	
         EVERYLIFE
	              50,000     IU
	                A080956   001
	
         IMPAX LABS
	             50,000     IU
	                A080951   001
	
         LANNETT
	                50,000     IU
	                A080825   001
	
         VITARINE
	               50,000     IU
	                A084053   001
	
         WEST WARD
	              50,000     IU
	                A083102   001
	
ERGOLOID MESYLATES
	
  CAPSULE;ORAL
	
    HYDERGINE LC
	
         NOVARTIS
	               1MG
	                          N018706 001 Jan 18, 1983
	
  SOLUTION;ORAL
	
    HYDERGINE
	
         NOVARTIS
	               1MG/ML
	                       N018418 001
	
  TABLET;ORAL
	
    ERGOLOID MESYLATES
	
         MUTUAL PHARM
	           1MG
	                          A088891 001 Nov 01, 1985
	
         WATSON LABS
	            1MG
	                          A086433 001 May 27, 1982

                                  1MG
	                          A087244 001 Aug 16, 1982
	
    GERIMAL
	
         WATSON LABS
	            1MG
	                          A088207 001 Mar 22, 1984
	
    HYDERGINE
	
         NOVARTIS
	               0.5MG
	                        N017993 003
	
  TABLET;SUBLINGUAL
	
    ALKERGOT
	
         SANDOZ
	                 0.5MG
	                        A085153 001
	
                                  1MG
	                          A087417 001
	
    CIRCANOL
	
         3M
	                     0.5MG
	                        A084868 001
	
                                  1MG
	                          A085809 001
	
    DEAPRIL-ST
	
         BRISTOL MYERS SQUIBB
	   1MG
	                          A085020 002
	
    ERGOLOID MESYLATES
	
         KV PHARM
	               0.5MG
	                        A085899   001
	
                                  0.5MG
	                        A086265   001
	
                                  1MG
	                          A085900   001
	
                                  1MG
	                          A086264   001
	
         LEDERLE
	                0.5MG
	                        A086984   001
	
                                  1MG
	                          A086985   001
	
         MUTUAL PHARM
	           0.5MG
	                        A087407   001
	
                                  1MG
	                          A087552   001
	
         SUPERPHARM
	             0.5MG
	                        A089233   001     Sep   23,   1986

                                  1MG
	                          A089234   001     Sep   23,   1986

         VANGARD
	                0.5MG
	                        A088013   001     Sep   20,   1982

                                  1MG
	                          A088014   001     Sep   20,   1982

         WATSON LABS
	            0.5MG
	                        A084930   001
	
                                  0.5MG
	                        A087233   001
	
                                  1MG
	                          A085177   001
	
                                  1MG
	                          A087183   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                  6-125(of 337)


ERGOLOID MESYLATES
	
  TABLET;SUBLINGUAL
	
    GERIMAL
	
         WATSON LABS              0.5MG
	                       A086189 001
	
                                  1MG
	                         A086188 001
	
   HYDERGINE
	
        NOVARTIS               0.5MG
	                          N009087 002
	
                               1MG
	                            N009087 001
	
   HYDROGENATED ERGOT ALKALOIDS
	
        IVAX PHARMS            0.5MG
	                          A087186 001
	
                               1MG
	                            A087185 001
	
ERGOTAMINE TARTRATE
	
  AEROSOL, METERED;INHALATION
	
    MEDIHALER ERGOTAMINE
	
         3M
	                     0.36MG/INH
	                  N012102 001
	
  TABLET;SUBLINGUAL
	
    ERGOSTAT
	
         PARKE DAVIS
	            2MG
	                         A088337 001 Jun 08, 1984
	
    WIGRETTES
	
         ORGANON USA INC
	        2MG
	                         A086750 001 Jul 29, 1982
	
ERYTHROMYCIN
	
  CAPSULE, DELAYED REL PELLETS;ORAL
	
    ERYC
	
           PARKE DAVIS
	         250MG
	                        A062546 001 Jul 25, 1985
	
                                 250MG
	                        A062618 001 Sep 25, 1985

           WARNER CHILCOTT LLC
	 250MG
	                        A062338 001
	
    ERYC 125
	
           PARKE DAVIS
	         125MG
	                        A062648 001 Oct 24, 1985
	
    ERYC SPRINKLES
	
           HOSPIRA
	             125MG
	                        N050593 001 Jul 22, 1985
	
    ERYTHROMYCIN
	
           BARR
	                250MG
	                        A063098 001 May 04, 1989
	
  GEL;TOPICAL
	
    E-GLADES
	
           RENAISSANCE PHARMA
	  2%
	                           A065009 001 Mar 18, 2002
	
    EMGEL
	
           ALTANA
	              2%
	                           A063107 001 Aug 23, 1991
	
  LOTION;TOPICAL
	
    E-SOLVE 2
	
           SYOSSET
	             2%
	                           A062467 001 Jul 03, 1985
	
  OINTMENT;OPHTHALMIC
	
    ERYTHROMYCIN
	
           PHARMADERM
	          5MG/GM
                        A062446 001 Sep 26, 1983

           PHARMAFAIR
	          5MG/GM
	                       A062481 001 Apr 05, 1984
	
    ILOTYCIN
	
           DISTA
	               0.5%
	                         N050368 001
	
  POWDER;FOR RX COMPOUNDING
	
    ERYTHROMYCIN
	
           PADDOCK LLC
	         100%
	                         N050610 001 Nov 07, 1986
	
  SOLUTION;TOPICAL
	
    A/T/S

           TARO PHARMS NORTH
	   2%
	                           A062405 001 Nov 18, 1982
	
    ERYDERM
	
           ARBOR PHARMS INC
	    2%
	                           A062290 001
	
    ERYMAX
	
           MERZ PHARMS
	         2%
	                           A062508 002 Jul 11, 1985
	
    ERYTHROMYCIN
	
           ALPHARMA US PHARMS
	  1.5%
	                         A062328   001     Apr   19,   1982

                                 2%
	                           A062326   001     Apr   19,   1982

                                 2%
	                           A062327   001     Apr   19,   1982

                                 2%
	                           A062342   001     Feb   25,   1982
	
                                 2%
	                           A062957   001     Jul   21,   1988
	
           BAUSCH AND LOMB
	     2%
	                           A064039   001     Jan   27,   1994
	
           LILLY
	               2%
	                           N050532   001
	
           PHARMAFAIR
	          1.5%
	                         A062485   001     Jul 11, 1984
	
                                 2%
	                           A062616   001     Jul 25, 1985
	
           RENAISSANCE PHARMA
	  2%
	                           A064127   001     Feb 14, 1997
	
    SANSAC
	
           DOW PHARM
	           2%
	                           A062522 001 Jan 24, 1985
	
    STATICIN
	
           WESTWOOD SQUIBB
	     1.5%
	                         N050526 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                          6-126(of 337)


ERYTHROMYCIN
	
  SOLUTION;TOPICAL
	
    T-STAT
	
         WESTWOOD SQUIBB
	         2%
	                                 A062436 001 Mar 09, 1983
	
  SWAB;TOPICAL
	
    C-SOLVE-2
	
         IVAX SUB TEVA PHARMS
	    2%
	                                 A062751 001 Jul 30, 1993
	
    ERYCETTE
	
         JOHNSON AND JOHNSON
	     2%
	                                 N050594 001 Feb 15, 1985
	
    ERYTHROMYCIN
	
         FOUGERA PHARMS
	          2%
	                                 A065320 001 Jul 25, 2006
	
         RENAISSANCE PHARMA
	      2%
	                                 A064128 001 Jul 03, 1996
	
    T-STAT
	
         WESTWOOD SQUIBB
	         2%
	                                 A062748 001 Jul 23, 1987
	
  TABLET, DELAYED RELEASE;ORAL
	
    E-BASE
	
         BARR
	                    333MG
	                              A063028 001 May 15, 1990

                                   333MG
	                              A063086 001 May 15, 1990

                                   500MG
	                              A062999 001 Nov 25, 1988
	
   E-MYCIN
	
        ARBOR PHARMS INC
	         250MG
	                              A060272 001
	
                                   333MG
	                              A060272 002
	
   ILOTYCIN
	
        DISTA
	                    250MG
	                              A061910 001
	
   R-P MYCIN
	
        SOLVAY
	                   250MG
	                              A061659 001
	
   ROBIMYCIN
	
        ROBINS AH
	                250MG
	                              A061633 001
	
ERYTHROMYCIN ESTOLATE
	
  CAPSULE;ORAL
	
    ERYTHROMYCIN ESTOLATE
	
         BARR
	                    EQ     125MG   BASE
	                A062162   001
	
                                   EQ     250MG   BASE
	                A062162   002
	
        IVAX SUB TEVA PHARMS
	     EQ     250MG   BASE
	                A062237   001
	
        WATSON LABS
	              EQ     250MG   BASE
	                A062087   001
	
   ILOSONE
	
        LILLY
	                    EQ 125MG BASE
	                      A061897 001
	
                                   EQ 250MG BASE
	                      A061897 002
	
 FOR SUSPENSION;ORAL
	
   ILOSONE
	
        DISTA
	                    EQ 125MG BASE/5ML
	                  A061893 001
	
 SUSPENSION;ORAL
	
   ERYTHROMYCIN ESTOLATE
	
        ALPHARMA US PHARMS
	       EQ     125MG   BASE/5ML
             A062353   001     Nov   18,   1982
	
                                   EQ     250MG   BASE/5ML
             A062409   001     Dec   16,   1982
	
         BARR
	                    EQ     125MG   BASE/5ML
             A062169   001     Oct   17,   1990
	
                                   EQ     250MG   BASE/5ML
             A062169   002     Oct   17,   1990
	
        LIFE LABS
	                EQ     250MG   BASE/5ML
	            A062362   001     Dec   17,   1982
	
   ILOSONE
	
        LILLY
	                    EQ     125MG   BASE/5ML
             A061894   001
	
                                   EQ     125MG   BASE/5ML
             N050010   001
	
                                   EQ     250MG   BASE/5ML
             A061894   002
	
                                   EQ     250MG   BASE/5ML
	            N050010   002
	
 SUSPENSION/DROPS;ORAL

   ILOSONE
	
        LILLY
	                    EQ 100MG BASE/ML
	                   A061894 003
	
 TABLET;ORAL
	
   ILOSONE
	
        LILLY
	                    EQ 500MG BASE
	                      A061896 001
	
 TABLET, CHEWABLE;ORAL
	
   ILOSONE
	
        DISTA
	                    EQ 125MG BASE
	                      A061895 001
	
                                   EQ 250MG BASE
	                      A061895 002
	
ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
	
  SUSPENSION;ORAL
	
    ILOSONE SULFA
	
         LILLY                  EQ 125MG BASE/5ML;EQ 600MG BASE/5ML
	   N050599 001 Sep 29, 1989
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                          6-127(of 337)


ERYTHROMYCIN ETHYLSUCCINATE
	
  GRANULE;ORAL
	
    ERYTHROMYCIN ETHYLSUCCINATE
	
         BARR
	                   EQ   200MG BASE/5ML
	                 A062055 001
	
    PEDIAMYCIN
	
         ROSS LABS
	              EQ   200MG BASE/5ML
	                 A062305 001
	
  SUSPENSION;ORAL
	
    E-MYCIN E
	
         PHARMACIA AND UPJOHN
	 EQ     200MG BASE/5ML
                  A062198 001
	
                                  EQ   400MG BASE/5ML
	                 A062198 002
	
    ERYTHROMYCIN ETHYLSUCCINATE
	
         ALPHARMA US PHARMS
	     EQ   200MG   BASE/5ML
                A062200   001
	
                                  EQ   400MG   BASE/5ML
                A062200   002
	
         DISTA
	                  EQ   200MG   BASE/5ML
                A062177   001
	
                                  EQ   400MG   BASE/5ML
                A062177   002
	
         NASKA
	                  EQ   400MG   BASE/5ML
                A062674   001 Mar 10, 1987
	
         PARKE DAVIS
	            EQ   200MG   BASE/5ML
                A062231   001
	
                                  EQ   400MG   BASE/5ML
                A062231   002
	
         PHARMAFAIR
	             EQ   200MG   BASE/5ML
                A062559   001 Mar 15, 1985
	
                                  EQ   400MG   BASE/5ML
	               A062558   001 Mar 15, 1985
	
    WYAMYCIN E
	
         WYETH AYERST
	           EQ   200MG BASE/5ML
                  A062123 002
	
                                  EQ   400MG BASE/5ML
	                 A062123 001
	
  SUSPENSION/DROPS;ORAL

    PEDIAMYCIN
	
         ROSS LABS
	              EQ   100MG BASE/2.5ML
	               A062305 002
	
  TABLET;ORAL
	
    E.E.S. 400
	
         ARBOR PHARMS LLC
	       EQ   400MG BASE
	                     A061905 001
	
    ERYTHROMYCIN ETHYLSUCCINATE
	
         BARR
	                   EQ   400MG BASE
	                     A062256 001
	
         MYLAN
	                  EQ   400MG BASE
	                     A062847 001 Sep 14, 1988
	
  TABLET, CHEWABLE;ORAL
	
    E.E.S.
	
         ARBOR PHARMS INC
	       EQ   200MG BASE
	                     N050297 002
	
    ERYPED
	
         ARBOR PHARMS INC
	       EQ   200MG BASE
	                     N050297 003 Jul 05, 1988
	
    PEDIAMYCIN
	
         ROSS LABS
	              EQ   200MG BASE
	                     A062306 001
	
ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
	
  GRANULE;ORAL
	
    ERYZOLE
	
         ALRA
	                 EQ 200MG BASE/5ML;EQ 600MG BASE/5ML
	   A062758 001 Jun 15, 1988
	
    PEDIAZOLE
	
         ROSS LABS
	            EQ 200MG BASE/5ML;EQ 600MG BASE/5ML
	   N050529 001
	
ERYTHROMYCIN GLUCEPTATE
	
  INJECTABLE;INJECTION
	
    ILOTYCIN GLUCEPTATE
	
         DISTA
	                  EQ 1GM BASE/VIAL
                     N050370 003
	
                                  EQ 250MG BASE/VIAL
                   N050370 001
	
                                  EQ 500MG BASE/VIAL
	                  N050370 002
	
ERYTHROMYCIN LACTOBIONATE
	
  INJECTABLE;INJECTION
	
    ERYTHROCIN
	
         ABBOTT
	                 EQ   1GM BASE/VIAL
                   A062586   002 Jan 04, 1988
	
                                  EQ   500MG BASE/VIAL
                 A062586   001 Jan 04, 1988
	
         HOSPIRA
	                EQ   1GM BASE/VIAL
                   N050182   003
	
                                  EQ   1GM BASE/VIAL
                   N050609   002 Sep 24, 1986

                                  EQ   500MG BASE/VIAL
	                N050182   002
	
    ERYTHROMYCIN
	
         ELKINS SINN
	            EQ 1GM BASE/VIAL
                     A062563 002 Mar 28, 1985
	
                                  EQ 500MG BASE/VIAL
	                  A062563 001 Mar 28, 1985
	
    ERYTHROMYCIN LACTOBIONATE
	
         ABRAXIS PHARM
	          EQ   1GM BASE/VIAL
                   A062604   002    Nov   24,   1986
	
                                  EQ   500MG BASE/VIAL
                 A062604   001    Nov   24,   1986
	
         BAXTER HLTHCARE
	        EQ   1GM BASE/VIAL
                   A062993   002    May   09,   1989

                                  EQ   500MG BASE/VIAL
                 A062993   001    May   09,   1989

         TEVA PARENTERAL
	        EQ   1GM BASE/VIAL
                   A063253   002    Jul   30,   1993
	
                                  EQ   500MG BASE/VIAL
	                A063253   001    Jul   30,   1993
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                             6-128(of 337)


ERYTHROMYCIN STEARATE
	
  TABLET;ORAL
	
    BRISTAMYCIN
	
         BRISTOL                 EQ 250MG BASE                           A061304 001
	
                                 EQ 250MG BASE                           A061887 001
	
   ERYPAR
	
        PARKE DAVIS              EQ 250MG BASE                           A062032 001
	
                                 EQ 500MG BASE                           A062032 002
	
        WARNER CHILCOTT          EQ 250MG BASE                           A062322 001
	
   ERYTHROCIN STEARATE
	
        ARBOR PHARMS LLC         EQ 125MG BASE                           A060359 002
	
                                 EQ 500MG BASE                           A060359 003
	
   ERYTHROMYCIN STEARATE
	
        ANI PHARMS INC		         EQ   250MG   BASE                       A061461   001
	
                                 EQ   250MG   BASE                       A061591   001
	
                                 EQ   500MG   BASE                       A061461   002
	
                                 EQ   500MG   BASE                       A063179   001 May 15, 1990

         LEDERLE                 EQ   250MG   BASE                       A062089   001
	
                                 EQ   500MG   BASE                       A062089   002
	
         MYLAN                   EQ   250MG   BASE                       A061505   001
	
                                 EQ   500MG   BASE                       A061505   002
	
         PUREPAC PHARM           EQ   250MG   BASE                       A061743   001
	
         WATSON LABS             EQ   250MG   BASE                       A062121   002
	
                                 EQ   500MG   BASE                       A062121   001
	
   ETHRIL 250
	
        BRISTOL MYERS SQUIBB     EQ 250MG BASE                           A061605 001
	
   ETHRIL 500
	
        BRISTOL MYERS SQUIBB     EQ 500MG BASE                           A061605 002
	
   PFIZER-E
	
        PFIZER                   EQ 250MG BASE                           A061791 001
	
                                 EQ 500MG BASE                           A061791 002
	
   WYAMYCIN S
	
        WYETH AYERST             EQ 250MG BASE                           A061675 001
	
                                 EQ 500MG BASE                           A061675 002
	
ESCITALOPRAM OXALATE
	
  CAPSULE;ORAL
	
    ESCITALOPRAM OXALATE
	
         MYLAN PHARMS INC		      EQ 5MG BASE                             A077660 001 Jul 31, 2007
	
                                 EQ 10MG BASE                            A077660 002 Jul 31, 2007
	
                                 EQ 20MG BASE                            A077660 003 Jul 31, 2007
	
ESMOLOL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    BREVIBLOC
	
         BAXTER HLTHCARE         10MG/ML                                 N019386 003 Aug 15, 1988

                                 20MG/ML                                 N019386 007 May 28, 2003
	
ESTAZOLAM
	
  TABLET;ORAL
	
    PROSOM
	
         ABBOTT                  1MG **Federal Register determination    N019080 001 Dec 26, 1990

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 2MG **Federal Register determination    N019080 002 Dec 26, 1990

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
ESTRADIOL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    ESCLIM
	
         WOMEN FIRST HLTHCARE		 0.025MG/24HR                             N020847   001    Aug   04,   1998

                                0.0375MG/24HR                            N020847   002    Aug   04,   1998

                                0.05MG/24HR                              N020847   003    Aug   04,   1998

                                0.075MG/24HR                             N020847   004    Aug   04,   1998

                                0.1MG/24HR                               N020847   005    Aug   04,   1998

    ESTRADIOL
	
         ORTHO MCNEIL PHARM		   0.05MG/24HR                              N021048 001 Sep 20, 1999

                                0.075MG/24HR                             N021048 002 Sep 20, 1999

                                0.1MG/24HR                               N021048 003 Sep 20, 1999

    FEMPATCH
	
         PARKE DAVIS            0.025MG/24HR                             N020417 001 Dec 03, 1996
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-129(of 337)


ESTRADIOL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    VIVELLE
         NOVARTIS               0.025MG/24HR                    N020323 005 Aug 16, 2000
                                0.0375MG/24HR                   N020323 001 Oct 28, 1994
                                0.075MG/24HR                    N020323 003 Oct 28, 1994
  GEL;TOPICAL
    ESTROGEL
         ASCEND THERAPS US      0.06%                           N021166 001 Feb 09, 2004
  TABLET;ORAL
    ESTRACE
         BRISTOL MYERS SQUIBB   0.5MG                           A081295 001 Jun 30, 1993
                                1MG                             A084499 001
                                2MG                             A084500 001
    ESTRADIOL
         HERITAGE PHARMS INC    0.5MG                           A040275   001    Dec   29,   1998
                                1MG                             A040275   002    Dec   29,   1998
                                2MG                             A040275   003    Dec   29,   1998
         LANNETT HOLDINGS INC   0.5MG                           A040138   001    Jan   30,   1998
                                1MG                             A040138   002    Jan   30,   1998
                                2MG                             A040138   003    Jan   30,   1998
    GYNODIOL
         DURAMED PHARMS BARR    0.5MG                           A040212   001    Dec   29,   1997
                                1MG                             A040212   002    Dec   29,   1997
                                1.5MG                           A040212   003    Dec   29,   1997
                                2MG                             A040212   004    Dec   29,   1997
    INNOFEM
         NOVO NORDISK INC       0.5MG                           A040312 001 Nov 19, 1999
                                1MG                             A040312 002 Nov 19, 1999
                                2MG                             A040312 003 Nov 19, 1999
  TABLET;VAGINAL
    VAGIFEM
         NOVO NORDISK INC       25MCG                           N020908 001 Mar 26, 1999
ESTRADIOL CYPIONATE
  INJECTABLE;INJECTION
    DEPO-ESTRADIOL
         PHARMACIA AND UPJOHN   1MG/ML                          A085470 001
                                3MG/ML                          A085470 002
   ESTRADIOL CYPIONATE
        WATSON LABS             5MG/ML                          A085620 001
ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE
	
  INJECTABLE;INTRAMUSCULAR
	
    LUNELLE
	
         PHARMACIA AND UPJOHN   5MG/0.5ML;25MG/0.5ML            N020874 001 Oct 05, 2000
	
ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
	
  INJECTABLE;INJECTION
	
    DEPO-TESTADIOL
	
         PHARMACIA AND UPJOHN   2MG/ML;50MG/ML                  N017968 001
	
    TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
	
         WATSON LABS            2MG/ML;50MG/ML                  A085603 001 Mar 13, 1986
	
ESTRADIOL VALERATE
	
  INJECTABLE;INJECTION
	
    ESTRADIOL VALERATE
	
         SANDOZ		               10MG/ML                         A040628   001 Oct 04, 2007
	
                                20MG/ML                         A040628   002 Oct 04, 2007
	
                                40MG/ML                         A040628   003 Oct 04, 2007
	
         WATSON LABS            10MG/ML                         A083546   001
	
                                40MG/ML                         A083714   001
	
         WATSON LABS INC        20MG/ML                         A083547   001
	
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
	
  INJECTABLE;INJECTION
	
    DITATE-DS
	
         SAVAGE LABS            8MG/ML;180MG/ML                 A086423 001
	
    TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE
	
         WATSON LABS            4MG/ML;90MG/ML                  A085865 001
	
                                8MG/ML;180MG/ML                 A085860 001
	
                         35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                               DISCONTINUED DRUG PRODUCT LIST                              6-130(of 337)

ESTRADIOL; NORGESTIMATE
  TABLET;ORAL
    PREFEST
         TEVA WOMENS               1MG,1MG;1MG,1MG;N/A,0.09MG **Federal      N021040 001 Oct 22, 1999
                                   Register determination that product was
                                   not discontinued or withdrawn for
                                   safety or efficacy reasons**
ESTROGENS, CONJUGATED
  TABLET;ORAL
    PREMARIN
         WYETH PHARMS INC          2.5MG                                     N004782 002
ESTROGENS, CONJUGATED SYNTHETIC A
	
  CREAM;VAGINAL
	
    SYNTHETIC CONJUGATED ESTROGENS A
	
         TEVA WOMENS            0.625MG/GM                                   N021788 001 Nov 28, 2008
	
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
	
  TABLET;ORAL-28
	
    PREMPHASE (PREMARIN;CYCRIN 14/14)

         WYETH PHARMS INC       0.625MG;0.625MG;N/A,5MG                      N020303 002 Dec 30, 1994
	
    PREMPRO (PREMARIN;CYCRIN)

         WYETH PHARMS INC       0.625MG;0.625MG;2.5MG;2.5MG                  N020303 001 Dec 30, 1994
	
ESTROGENS, CONJUGATED; MEPROBAMATE
	
  TABLET;ORAL
	
    MILPREM-200
	
         MEDPOINTE PHARM HLC    0.45MG;200MG                                 N011045 002
	
    MILPREM-400
	
         MEDPOINTE PHARM HLC    0.45MG;400MG                                 N011045 001
	
    PMB 200
	
         WYETH AYERST           0.45MG;200MG                                 N010971 005
	
    PMB 400
	
         WYETH AYERST           0.45MG;400MG                                 N010971 003
	
ESTROGENS, ESTERIFIED
	
  TABLET;ORAL
	
    AMNESTROGEN
	
         BRISTOL MYERS SQUIBB		    0.3MG                                     A083266   001
	
                                   0.625MG                                   A083266   002
	
                                   1.25MG                                    A083266   003
	
                                   2.5MG                                     A083266   004
	
   ESTERIFIED ESTROGENS
	
        PVT FORM		                 0.625MG                                   A083414   001
	
                                   1.25MG                                    A083765   001
	
                                   2.5MG                                     A085907   001
	
        SANDOZ                     1.25MG                                    A085302   001
	
   ESTRATAB
	
        SOLVAY		                   0.3MG                                     A086715   001
	
                                   0.625MG                                   A083209   001
	
                                   1.25MG                                    A083856   001
	
                                   2.5MG                                     A083857   001
	
   EVEX
	
            ROCHE PALO             0.625MG                                   A084215 001
	
                                   1.25MG                                    A083376 002
	
   FEMOGEN
	
        PVT FORM		                 0.625MG                                   A085076 001
	
                                   1.25MG                                    A085008 001
	
                                   2.5MG                                     A085007 001
	
ESTRONE
	
  INJECTABLE;INJECTION
	
    ESTROGENIC SUBSTANCE
	
          WYETH AYERST             2MG/ML                                    A083488 001
	
    ESTRONE
	
          WATSON LABS          2MG/ML                                        A083397 001
	
                               5MG/ML                                        A085239 001
	
   NATURAL ESTROGENIC SUBSTANCE-ESTRONE
	
        WATSON LABS            2MG/ML                                        A085237 001 Nov 23, 1982
	
   THEELIN
	
        PARKEDALE		            1MG/ML                                        N003977 001
	
                               2MG/ML                                        N003977 002
	
                               5MG/ML                                        N003977 003
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                6-131(of 337)


ESTROPIPATE
	
  CREAM;VAGINAL
	
    OGEN
	
           PHARMACIA AND UPJOHN    1.5MG/GM                                A084710 001
	
  TABLET;ORAL
	
    ESTROPIPATE
	
           DURAMED PHARMS BARR		   0.75MG                                  A040296   001     Nov   01,   1999
	
                                   1.5MG                                   A040296   002     Nov   01,   1999
	
                                   3MG                                     A040296   003     Nov   01,   1999
	
         MYLAN                     3MG                                     A040359   003     Aug   26,   1999

         WATSON LABS               6MG                                     A081216   001     Sep   23,   1993

    ORTHO-EST
	
         SUN PHARM INDS INC        0.75MG                                  A089567 001 Feb 27, 1991
	
                                   1.5MG                                   A089582 001 Jul 17, 1991
	
ESZOPICLONE
	
  TABLET;ORAL
	
    ESZOPICLONE
	
         WOCKHARDT LTD		           1MG                                     A091165 001 Jul 14, 2011
	
                                   2MG                                     A091165 002 Jul 14, 2011
	
                                   3MG                                     A091165 003 Jul 14, 2011
	
ETHACRYNIC ACID
	
  TABLET;ORAL
	
    EDECRIN
	
         ATON		                    50MG                                    N016092 002
	
ETHAMBUTOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    ETHAMBUTOL HYDROCHLORIDE
	
         VERSAPHARM INC            100MG                                   A075095 001 Nov 30, 1999
	
                                   400MG                                   A075095 002 Nov 30, 1999
	
    MYAMBUTOL
	
         STI PHARMA LLC            200MG                                   N016320 002
	
                                   500MG                                   N016320 004
	
ETHCHLORVYNOL
	
  CAPSULE;ORAL
	
    ETHCHLORVYNOL
	
         BANNER PHARMACAPS		       100MG                                   A084463   001
	
                                   200MG                                   A084463   002
	
                                   500MG                                   A084463   003
	
                                   750MG                                   A084463   004
	
    PLACIDYL
	
         ABBVIE		                  100MG                                   N010021   004
	
                                   200MG                                   N010021   007
	
                                   500MG                                   N010021   002
	
                                   750MG                                   N010021   010
	
ETHINAMATE
	
  CAPSULE;ORAL
	
    VALMID
	
         DISTA                     500MG                                   N009750 001
	
ETHINYL ESTRADIOL
	
  TABLET;ORAL
	
    ESTINYL
	
         SCHERING		                0.02MG                                  N005292 001
	
                                   0.05MG                                  N005292 002
	
                                   0.5MG                                   N005292 003
	
    FEMINONE
	
         PHARMACIA AND UPJOHN      0.05MG                                  N016649 001
	
    LYNORAL
	
         ORGANON USA INC           0.01MG                                  N005490 003
	
                                   0.05MG                                  N005490 002
	
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
	
  TABLET;ORAL-21
	
    DEMULEN 1/35-21

         GD SEARLE LLC          0.035MG;1MG **Federal Register             N018168 001
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

    DEMULEN 1/50-21

         GD SEARLE LLC          0.05MG;1MG                                 N016927 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                            6-132(of 337)


ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
	
  TABLET;ORAL-21
	
    ZOVIA 1/35E-21

         WATSON LABS
	          0.035MG;1MG
	                              A072720 001
	 Dec 30, 1991
	
    ZOVIA 1/50E-21

         WATSON LABS
	          0.05MG;1MG
	                               A072722 001
	 Dec 30, 1991
	
  TABLET;ORAL-28
	
    DEMULEN 1/35-28

         GD SEARLE LLC
	        0.035MG;1MG
	                              N018160 001
	
    DEMULEN 1/50-28

         GD SEARLE LLC
	        0.05MG;1MG
	                               N016936 001
	
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
	
  TABLET;ORAL-28
	
    NORQUEST FE
	
         GD SEARLE LLC          0.035MG;75MG;1MG
	                         N018926 001
	 Jul 18, 1986
	
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
	
  TABLET;ORAL-28
	
    NORLESTRIN FE 1/50

         PARKE DAVIS            0.05MG;75MG;1MG
	                          N016766 001
	
    NORLESTRIN FE 2.5/50

         PARKE DAVIS            0.05MG;75MG;2.5MG
	                        N016854 001
	
ETHINYL ESTRADIOL; LEVONORGESTREL
	
  TABLET;ORAL
	
    LYBREL
	
         WYETH PHARMS INC       0.02MG;0.09MG **Federal Register
          N021864 001
	 May 22, 2007
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

    PREVEN EMERGENCY CONTRACEPTIVE KIT
	
         TEVA BRANDED PHARM
	   0.05MG;0.25MG
	                            N020946 001
	 Sep 01, 1998
	
  TABLET;ORAL-21
	
    ALESSE
	
         WYETH PHARMS
	         0.02MG;0.1MG **Federal Register
           N020683 001
	 Mar 27, 1997
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
    AVIANE-21
	
         DURAMED PHARMS BARR
	  0.02MG;0.1MG
	                             A075796 002
	 Apr 30, 2001
	
    ENPRESSE-21
	
         DURAMED PHARMS BARR
	  0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1
   A075809 001
	 Jul 16, 2001
	
                                25MG
	
    LESSINA-21
	
         BARR
	                 0.02MG;0.1MG
	                             A075803 001
	 Mar 20, 2002
	
    LEVLITE
	
         BAYER HLTHCARE
	       0.02MG;0.1MG
	                             N020860 001
	 Jul 13, 1998
	
    LEVONORGESTREL AND ETHINYL ESTRADIOL
	
         BARR
	                 0.02MG;0.1MG
	                             A075862 001
	 Apr 29, 2003
	
    LEVORA 0.15/30-21

         WATSON LABS
	          0.03MG;0.15MG
	                            A073592 001
	 Dec 13, 1993
	
    NORDETTE-21
	
         TEVA BRANDED PHARM
	   0.03MG;0.15MG
	                            N018668 001
	 May 10, 1982
	
    PORTIA-21
	
         BARR
	                 0.03MG;0.15MG
	                            A075866 001
	 May 23, 2002
	
    TRIPHASIL-21
	
         WYETH PHARMS
	         0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1
   N019192 001
	 Nov 01, 1984
	
                                25MG **Federal Register determination

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
    TRIVORA-21
	
         WATSON LABS
	          0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1
   A074538 001
	 Dec 18, 1997
	
                                25MG
	
  TABLET;ORAL-28
	
    ALESSE
	
         WYETH PHARMS
	         0.02MG;0.1MG
	                             N020683 002
	 Mar 27, 1997
	
    LEVLITE
	
         BAYER HLTHCARE
	       0.02MG;0.1MG
	                             N020860 002
	 Jul 13, 1998
	
    LEVONORGESTREL AND ETHINYL ESTRADIOL
         BARR                   0.02MG;0.1MG                               A075862 002 Apr 29, 2003
    TRIPHASIL-28
         WYETH PHARMS INC       0.03MG;0.03MG;0.04MG;0.05MG;0.075MG;0.1    N019190 001 Nov 01, 1984
                                25MG
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                             6-133(of 337)


ETHINYL ESTRADIOL; NORETHINDRONE
	
  TABLET;ORAL-21
	
    BALZIVA-21
	
         BARR
	                 0.035MG;0.4MG
	                             A076198 001
	 Apr 22, 2004
	
    BREVICON 21-DAY
	
         WATSON LABS
	          0.035MG;0.5MG
	                             N017566 001
	
    GENCEPT 10/11-21

         BARR
	                 0.035MG;0.035MG;0.5MG;1MG
	                 A072694 001
	 Feb 28, 1992
	
    MODICON 21
	
         ORTHO MCNEIL PHARM
	   0.035MG;0.5MG
	                             N017488 001
	
    N.E.E. 1/35 21

         LPI
	                  0.035MG;1MG
	                               A071541 001
	 Dec 14, 1987
	
    NORCEPT-E 1/35 21

         ORTHO MCNEIL PHARM
	   0.035MG;1MG
	                               A071545 001
	 Feb 09, 1989
	
    NORETHIN 1/35E-21

         WATSON LABS
	          0.035MG;1MG
	                               A071480 001
	 Apr 12, 1988
	
    NORETHINDRONE AND ETHINYL ESTRADIOL
	
         WATSON LABS		          0.035MG;0.4MG
	                             A078379 001
	 Feb 23, 2010
	
                                0.035MG;0.5MG
	                             A070684 001
	 Jan 29, 1987
	
                                0.035MG;1MG
	                               A070685 001
	 Jan 29, 1987
	
    NORETHINDRONE AND ETHINYL ESTRADIOL (10/11)

         WATSON LABS            0.035MG;0.035MG;0.5MG;1MG
	                 A071043 001
	 Apr 01, 1988
	
    NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)

         WATSON LABS
	          0.035MG;0.035MG;0.5MG;1MG
	                 A071041 001
	 Sep 24, 1991
	
    NORTREL 0.5/35-21

         BARR
	                 0.035MG;0.5MG
	                             A072692 001
	 Feb 28, 1992
	
    ORTHO-NOVUM 1/35-21

         ORTHO MCNEIL PHARM
	   0.035MG;1MG
	                               N017489 002
	
    ORTHO-NOVUM 10/11-21

         ORTHO MCNEIL JANSSEN
	 0.035MG;0.035MG;0.5MG;1MG
	                 N018354 001
	 Jan 11, 1982
	
    ORTHO-NOVUM 7/14-21

         ORTHO MCNEIL PHARM
	   0.035MG;0.035MG;0.5MG;1MG
	                 N019004 001
	 Apr 04, 1984
	
    ORTHO-NOVUM 7/7/7-21

         JANSSEN PHARMS
	       0.035MG;0.035MG;0.035MG;0.5MG;0.75MG;1M
    N018985 001
	 Apr 04, 1984
	
                                G
	
    OVCON-35
	
         WARNER CHILCOTT
	      0.035MG;0.4MG
	                             N018127 001
	
    OVCON-50
	
         WARNER CHILCOTT
	      0.05MG;1MG
	                                N018128 001
	
    TRI-NORINYL 21-DAY
	
         WATSON LABS
	          0.035MG;0.035MG;0.035MG;0.5MG;0.5MG;1MG
	   N018977 001
	 Apr 13, 1984
	
  TABLET;ORAL-28
	
    GENCEPT 10/11-28

         BARR
	                 0.035MG;0.035MG;0.5MG;1MG
	                 A072697 001
	 Feb 28, 1992
	
    N.E.E. 1/35 28

         LPI
	                  0.035MG;1MG
	                               A071542 001
	 Dec 14, 1987
	
    NORCEPT-E 1/35 28

         ORTHO MCNEIL PHARM
	   0.035MG;1MG
	                               A071546 001
	 Feb 09, 1989
	
    NORETHIN 1/35E-28

         WATSON LABS
	          0.035MG;1MG
	                               A071481 001
	 Apr 12, 1988
	
    NORETHINDRONE AND ETHINYL ESTRADIOL
	
         WATSON LABS            0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1M
    A076393 001
	 Feb 04, 2010
	
                                G
	
    NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)

         WATSON LABS
	          0.035MG,0.035MG;0.035MG,0.035MG;0.5MG,1
    A071042 001
	 Sep 24, 1991
	
                                MG;0.5MG,1MG
	
    ORTHO-NOVUM 10/11-28

         ORTHO MCNEIL JANSSEN
	 0.035MG;0.035MG;0.5MG;1MG
	                 N018354 002
	 Jan 11, 1982
	
    ORTHO-NOVUM 7/14-28

         ORTHO MCNEIL PHARM
	   0.035MG;0.035MG;0.5MG;1MG
	                 N019004 002
	 Apr 04, 1984
	
    OVCON-50
	
         WARNER CHILCOTT LLC
	  0.05MG;1MG
	                                N017576 001
	
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
	
  CAPSULE;ORAL
	
    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
	
         WARNER CHILCOTT
	      0.02MG;1MG
	                                N204426 001
	 Apr 19, 2013
	
  TABLET;ORAL
	
    FEMHRT
	
         WARNER CHILCOTT LLC
	  0.005MG;1MG
	                               N021065 002
	 Oct 15, 1999
	
  TABLET;ORAL-21
	
    ESTROSTEP 21
	
         WARNER CHILCOTT LLC
	  0.02MG;0.035MG;0.03MG;1MG;1MG;1MG
	         N020130 001
	 Oct 09, 1996
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                           6-134(of 337)


ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
	
  TABLET;ORAL-21
	
    NORLESTRIN 21 1/50

         PARKE DAVIS
	          0.05MG;1MG
	                                N016749 001
	
    NORLESTRIN 21 2.5/50

         PARKE DAVIS
	          0.05MG;2.5MG
	                              N016852 001
	
  TABLET;ORAL-28
	
    NORLESTRIN 28 1/50

         PARKE DAVIS
	          0.05MG;1MG
	                                N016723 001
	
ETHINYL ESTRADIOL; NORGESTIMATE
	
  TABLET;ORAL-21
	
    ORTHO CYCLEN-21
	
         JANSSEN PHARMS
	        0.035MG;0.25MG
	                           N019653 001 Dec 29, 1989
	
    ORTHO TRI-CYCLEN
	
         JANSSEN PHARMS
	        0.035MG;0.035MG;0.035MG;0.18MG;0.215MG;
   N019697 002 Jul 03, 1992
	
                                 0.25MG
	
  TABLET;ORAL-28
	
    NORGESTIMATE AND ETHINYL ESTRADIOL
	
         WATSON LABS
	           0.025MG;0.025MG;0.025MG;0.18MG;0.215MG;
   A090479 001 Mar 09, 2011
	
                                 0.25MG
	
                                 0.035MG;0.035MG;0.035MG;0.18MG;0.215MG;
   A076626 001 Aug 17, 2006
	
                                 0.25MG
	
                                 0.035MG;0.25MG
	                           A076627 001 Aug 17, 2006
	
    TRI LO SPRINTEC
	
         BARR LABS INC
	         0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,
   A076784 001 Jun 29, 2009
	
                                 0.25MG
	
ETHINYL ESTRADIOL; NORGESTREL
	
  TABLET;ORAL-21
	
    LO/OVRAL

         WYETH PHARMS INC
	       0.03MG;0.3MG
	                            N017612 001
	
    LOW-OGESTREL-21
	
         WATSON LABS
	            0.03MG;0.3MG
	                            A075288 001 Jul 28, 1999
	
    OGESTREL 0.5/50-21

         WATSON LABS
	            0.05MG;0.5MG
	                            A075406 001 Dec 15, 1999
	
    OVRAL
	
         WYETH PHARMS
	           0.05MG;0.5MG
	                            N016672 001
	
  TABLET;ORAL-28
	
    LOW-OGESTREL-28
	
         WATSON LABS
	            0.03MG;0.3MG
	                            A075288 002 Jul 28, 1999
	
    OVRAL-28
	
         WYETH PHARMS
	           0.05MG;0.5MG
	                            N016806 001
	
ETHOPROPAZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PARSIDOL
	
         PARKE DAVIS
	            10MG
	                                    N009078 003
	
                                  50MG
	                                    N009078 006
	
                                  100MG
	                                   N009078 008
	
ETHOTOIN
	
  TABLET;ORAL
	
    PEGANONE
	
          RECORDATI RARE
	        500MG
	                                   N010841 003
	
ETHOXZOLAMIDE
	
  TABLET;ORAL
	
    CARDRASE
	
         PHARMACIA AND UPJOHN
	   62.5MG
	                                  N011047 002
	
                                  125MG
	                                   N011047 001
	
    ETHAMIDE
	
         ALLERGAN
	               125MG
	                                   N016144 001
	
ETHYLESTRENOL
	
  ELIXIR;ORAL
	
    MAXIBOLIN
	
         ORGANON USA INC
	        2MG/5ML
	                                 N014006 002
	
  TABLET;ORAL
	
    MAXIBOLIN
	
         ORGANON USA INC
	        2MG
	                                     N014005 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-135(of 337)


ETHYNODIOL DIACETATE; MESTRANOL
	
  TABLET;ORAL-20
	
    OVULEN
	
         GD SEARLE LLC           1MG;0.1MG                      N016029 002
	
  TABLET;ORAL-21
	
    OVULEN-21
	
         GD SEARLE LLC           1MG;0.1MG                      N016029 003
	
  TABLET;ORAL-28
	
    OVULEN-28
	
         GD SEARLE LLC           1MG;0.1MG                      N016705 001
	
ETIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DURANEST
	
         ASTRAZENECA            0.5%                            N017751 003
	
                                1%                              N017751 005
	
ETIDRONATE DISODIUM
	
  INJECTABLE;INJECTION
	
    DIDRONEL
	
         MGI PHARMA INC         50MG/ML                         N019545 001 Apr 20, 1987
	
ETODOLAC
	
  CAPSULE;ORAL
	
    ETODOLAC
	
          AAIPHARMA LLC         300MG                           A074929   001    Jan   30,   1998
	
          ANI PHARMS INC        200MG                           A074899   001    Jul   08,   1997
	
                                300MG                           A074899   002    Jul   08,   1997
	
         MYLAN                  200MG                           A074932   001    May   16,   1997

                                200MG                           A075071   001    Sep   30,   1998

                                300MG                           A074932   002    May   16,   1997

                                300MG                           A075071   002    Sep   30,   1998

         SANDOZ                 200MG                           A074840   001    Aug   29,   1997

                                200MG                           A074942   001    Sep   30,   1997

                                300MG                           A074840   002    Aug   29,   1997

                                300MG                           A074942   002    Sep   30,   1997

         VINTAGE PHARMS LLC     200MG                           A074842   001    Jul   17,   1997
	
                                300MG                           A074842   002    Jul   17,   1997
	
         WATSON LABS            200MG                           A074844   001    Dec   23,   1997
	
                                300MG                           A074844   002    Dec   23,   1997
	
   LODINE
	
        WYETH PHARMS INC        200MG                           N018922 002 Jan 31, 1991
	
                                300MG                           N018922 003 Jan 31, 1991
	
 TABLET;ORAL
	
   ETODOLAC
	
        AAIPHARMA LLC           400MG                           A074927   001    Oct   30,   1997
	
        IVAX SUB TEVA PHARMS    400MG                           A074883   001    Feb   28,   1997
	
                                500MG                           A074883   002    Nov   20,   1998
	
         MYLAN                  400MG                           A075012   001    Sep   30,   1998

                                500MG                           A075012   002    Sep   30,   1998

         PROSAM LABS            400MG                           A074819   001    Feb   28,   1997
	
                                500MG                           A074819   002    Apr   28,   1998

         RANBAXY LABS LTD       400MG                           A075226   001    Nov   24,   1998
	
                                500MG                           A075226   002    Nov   24,   1998
	
         SANDOZ                 400MG                           A074839   001    Jul   11,   1997
	
                                400MG                           A074846   001    Feb   28,   1997
	
         TEVA                   400MG                           A074847   001    Apr   23,   1999

                                500MG                           A074847   002    Apr   23,   1999

         VINTAGE PHARMS LLC     400MG                           A074841   001    Jun   27,   1997
	
         WATSON LABS            400MG                           A074892   001    Apr   16,   1997

                                400MG                           A075069   001    Apr   16,   1998

                                500MG                           A074892   002    Oct   29,   1998
	
   LODINE
	
        WYETH PHARMS INC        400MG                           N018922 004 Jul 29, 1993
	
                                500MG                           N018922 005 Jun 28, 1996
	
 TABLET, EXTENDED RELEASE;ORAL
	
   ETODOLAC
	
        ACTAVIS ELIZABETH       400MG                           A075696   001    Jul   31,   2000
	
        SANDOZ                  400MG                           A075943   001    Jul   26,   2002
	
                                500MG                           A075943   002    Jul   26,   2002
	
                                600MG                           A075943   003    Jul   26,   2002
	
        WATSON LABS FLORIDA     400MG                           A075829   001    Nov   30,   2001
	
                                500MG                           A075829   002    Nov   30,   2001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                6-136(of 337)


ETODOLAC
	
  TABLET, EXTENDED RELEASE;ORAL
	
    LODINE XL
	
          WYETH PHARMS INC		     400MG                                   N020584 001 Oct 25, 1996
	
                                 500MG                                   N020584 003 Jan 20, 1998
	
                                 600MG                                   N020584 002 Oct 25, 1996
	
ETOPOSIDE
	
  CAPSULE;ORAL
	
    VEPESID
	
         DAVA PHARMS INC         50MG                                    N019557 001 Dec 30, 1986
	
                                 100MG                                   N019557 002 Dec 30, 1986
	
  INJECTABLE;INJECTION
	
    ETOPOSIDE
	
         HOSPIRA                 20MG/ML                                 A074320   001    Aug   30,   1995

                                 20MG/ML                                 A074351   001    Aug   30,   1995

         PHARMACHEMIE BV         20MG/ML                                 A074227   001    Feb   22,   1996
	
         PIERRE FABRE            20MG/ML                                 A074813   001    Jul   09,   1997
	
         TEVA PARENTERAL         20MG/ML                                 A074510   001    Jun   29,   1995
	
         TEVA PHARMS USA         20MG/ML                                 A074284   001    Feb   10,   1994
	
         WATSON LABS             20MG/ML                                 A074228   001    Oct   15,   1996
	
         WATSON LABS INC         20MG/ML                                 A074968   001    Jan   09,   1998
	
    TOPOSAR
	
         TEVA PARENTERAL         20MG/ML                                 A074166 001 Feb 27, 1995
	
    VEPESID
	
         CORDEN PHARMA           20MG/ML                                 N018768 001 Nov 10, 1983
	
ETOPOSIDE PHOSPHATE
	
  INJECTABLE;INJECTION
	
    ETOPOPHOS PRESERVATIVE FREE
	
         BRISTOL MYERS SQUIBB     EQ 1GM BASE/VIAL                       N020906 002 Feb 27, 1998
	
                                  EQ 500MG BASE/VIAL                     N020906 001 Feb 27, 1998
	
ETRETINATE
	
  CAPSULE;ORAL
	
    TEGISON
	
         ROCHE                   10MG                                    N019369 001 Sep 30, 1986

                                 25MG                                    N019369 002 Sep 30, 1986
	
EVANS BLUE
	
  INJECTABLE;INJECTION
	
    EVANS BLUE
	
         PARKE DAVIS             0.5% **Federal Register determination   N008041 001
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
FAMOTIDINE
	
  INJECTABLE;INJECTION
	
    FAMOTIDINE
	
         APOTEX INC             10MG/ML                                  A075942   001    Aug   02,   2002

         APOTHECON              10MG/ML                                  A075707   001    Apr   16,   2001

         HIKMA MAPLE            10MG/ML                                  A075799   001    Apr   30,   2002

         HOSPIRA                10MG/ML                                  A075705   001    Apr   16,   2001

                                10MG/ML                                  A075870   001    Nov   23,   2001
	
                                10MG/ML                                  A075905   001    Nov   23,   2001
	
    FAMOTIDINE PRESERVATIVE FREE
	
         APOTEX INC             10MG/ML                                  A076324   001    Nov   27,   2002
	
         APOTHECON              10MG/ML                                  A075708   001    Apr   16,   2001

         HIKMA MAPLE            10MG/ML                                  A075789   001    Apr   30,   2002

         HOSPIRA                10MG/ML                                  A075669   001    Apr   16,   2001

    FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK)

         APOTEX INC             10MG/ML                                  A076322 001 Nov 27, 2002
	
    FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
	
         ABBVIE                 0.4MG/ML                                 A075729 001 Dec 17, 2001
	
    PEPCID
	
         MERCK                  10MG/ML                                  N019510 001 Nov 04, 1986
	
    PEPCID PRESERVATIVE FREE
	
         MERCK                  10MG/ML                                  N019510 004 Nov 04, 1986
	
    PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
	
         MERCK SHARP DOHME      0.4MG/ML                                 N020249 001 Feb 18, 1994
	
  TABLET;ORAL
	
    FAMOTIDINE
	
         ACTAVIS ELIZABETH      20MG                                     A075650 001 Sep 14, 2001

                                40MG                                     A075650 002 Sep 14, 2001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                    6-137(of 337)


FAMOTIDINE
	
  TABLET;ORAL
	
    FAMOTIDINE
	
         APOTEX                  10MG
	                          A075610   001    Mar   12,   2002
	
         MUTUAL PHARM            20MG
	                          A075639   002    Dec   12,   2001
	
                                 40MG
	                          A075639   001    Dec   12,   2001
	
         MYLAN PHARMS INC        20MG
	                          A075457   001    Apr   18,   2001

                                 40MG
	                          A075457   002    Apr   18,   2001

         SANDOZ                  10MG
	                          A076101   001    Oct   21,   2002
	
                                 20MG
	                          A075302   001    Apr   16,   2001

                                 20MG
	                          A075607   001    May   10,   2001

                                 20MG
	                          A075793   001    Apr   16,   2001

                                 40MG
	                          A075302   002    Apr   16,   2001

                                 40MG
	                          A075607   002    May   10,   2001

                                 40MG
	                          A075793   002    Apr   16,   2001

         WATSON LABS             10MG
	                          A075404   001    Nov   28,   2001
	
                                 20MG
	                          A075062   002    Apr   16,   2001

                                 40MG
	                          A075062   001    Apr   16,   2001
	
 TABLET, CHEWABLE;ORAL
	
   PEPCID AC
	
        MCNEIL CONS            10MG
	                            N020801 001 Sep 24, 1998
	
 TABLET, ORALLY DISINTEGRATING;ORAL
	
   FLUXID
	
        UCB INC                20MG
	                            N021712 001 Sep 24, 2004

                               40MG
	                            N021712 002 Sep 24, 2004
	
   PEPCID RPD
	
        MERCK                  20MG
	                            N020752 001 May 28, 1998

                               40MG
	                            N020752 002 May 28, 1998
	
FELODIPINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    FELODIPINE
	
         WOCKHARDT LTD		         2.5MG
	                         A091484 001 Aug 15, 2012

                                 5MG
	                           A091484 002 Aug 15, 2012

                                 10MG
	                          A091484 003 Aug 15, 2012
	
FENOFIBRATE
	
  CAPSULE;ORAL
	
    ANTARA (MICRONIZED)

         LUPIN ATLANTIS          87MG
	                          N021695 002 Nov 30, 2004
	
    LIPIDIL
	
         ABBVIE                  100MG
	                         N019304 001 Dec 31, 1993
	
    LIPOFEN
	
         CIPHER PHARMS INC       100MG
	                         N021612 002 Jan 11, 2006
	
    TRICOR (MICRONIZED)

         ABBVIE		                67MG
	                          N019304 002 Feb 09, 1998
	
                                 134MG
	                         N019304 003 Jun 30, 1999
	
                                 200MG
	                         N019304 004 Jun 30, 1999
	
 TABLET;ORAL
	
   FENOFIBRATE
	
        MYLAN                    107MG
	                         A076520 002 Dec 29, 2005
	
   TRICOR
	
        ABBOTT                   54MG
	                          N021203 001 Sep 04, 2001

                                 160MG
	                         N021203 003 Sep 04, 2001
	
   TRIGLIDE
	
        SKYEPHARMA AG            50MG
	                          N021350 001 May 07, 2005
	
FENOLDOPAM MESYLATE
	
  INJECTABLE;INJECTION
	
    FENOLDOPAM MESYLATE
	
         LUITPOLD                EQ 10MG BASE/ML
                A076656 001 Dec 01, 2003
	
         TEVA PARENTERAL         EQ 10MG BASE/ML
	               A077826 001 Mar 07, 2007
	
FENOPROFEN CALCIUM
	
  CAPSULE;ORAL
	
    FENOPROFEN CALCIUM
	
         AM THERAP               EQ   200MG   BASE
	             A072307   001    Aug   22,   1988

                                 EQ   300MG   BASE
	             A072308   001    Aug   22,   1988

         HALSEY                  EQ   200MG   BASE
	             A072355   001    Aug   17,   1988

                                 EQ   300MG   BASE
	             A072356   001    Aug   17,   1988

         PAR PHARM               EQ   200MG   BASE
	             A072437   001    Aug   22,   1988

                                 EQ   300MG   BASE
	             A072438   001    Aug   22,   1988

         QUANTUM PHARMICS        EQ   200MG   BASE
	             A072214   001    Aug   17,   1988

                                 EQ   300MG   BASE
	             A071738   001    Aug   17,   1988
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-138(of 337)


FENOPROFEN CALCIUM
	
  CAPSULE;ORAL
	
    FENOPROFEN CALCIUM
	
         SANDOZ                 EQ   200MG   BASE               A072394   001    Oct   17,   1988
	
                                EQ   300MG   BASE               A072395   001    Oct   17,   1988
	
         WARNER CHILCOTT        EQ   200MG   BASE               A072946   001    Apr   30,   1991

                                EQ   300MG   BASE               A072472   001    Apr   30,   1991

         WATSON LABS            EQ   200MG   BASE               A072294   001    Aug   17,   1988

                                EQ   200MG   BASE               A072981   001    Aug   19,   1991

                                EQ   300MG   BASE               A072293   001    Aug   17,   1988

                                EQ   300MG   BASE               A072982   001    Aug   19,   1991

    NALFON
	
         XSPIRE                 EQ 300MG BASE                   N017604 002
	
  TABLET;ORAL
	
    FENOPROFEN CALCIUM
	
         ACTAVIS ELIZABETH      EQ   600MG   BASE               A072274   001    May   02,   1988

         AM THERAP              EQ   600MG   BASE               A072309   001    Aug   17,   1988

         DAVA PHARMS INC        EQ   600MG   BASE               A072326   001    Aug   17,   1988

         HALSEY                 EQ   600MG   BASE               A072357   001    Aug   17,   1988

         IVAX SUB TEVA PHARMS   EQ   600MG   BASE               A072557   001    Aug   29,   1988

         MUTUAL PHARM           EQ   600MG   BASE               A072902   001    Dec   21,   1990
	
         PAR PHARM              EQ   600MG   BASE               A072429   001    Aug   17,   1988

         QUANTUM PHARMICS       EQ   600MG   BASE               A072194   001    Aug   17,   1988

         SANDOZ                 EQ   600MG   BASE               A072396   001    Oct   17,   1988
	
         USL PHARMA             EQ   600MG   BASE               A072362   001    Aug   17,   1988

         WATSON LABS            EQ   600MG   BASE               A072165   001    Aug   17,   1988

                                EQ   600MG   BASE               A072407   001    Aug   17,   1988

                                EQ   600MG   BASE               A072602   001    Oct   11,   1988
	
    NALFON
	
         DISTA                  EQ 600MG BASE                   N017710 001
	
FENTANYL
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    FENTANYL-100
	
          NOVEN                 100MCG/HR                       A077775 004 Oct 16, 2009
	
    FENTANYL-25
	
          NOVEN                 25MCG/HR                        A077775 001 Oct 16, 2009
	
    FENTANYL-50
	
          NOVEN                 50MCG/HR                        A077775 002 Oct 16, 2009
	
    FENTANYL-75
	
          NOVEN                 75MCG/HR                        A077775 003 Oct 16, 2009
	
FENTANYL CITRATE
	
  FILM;BUCCAL
	
    ONSOLIS
	
         MEDA PHARMS		          EQ   0.2MG   BASE               N022266   001    Jul   16,   2009
	
                                EQ   0.4MG   BASE               N022266   002    Jul   16,   2009
	
                                EQ   0.6MG   BASE               N022266   003    Jul   16,   2009
	
                                EQ   0.8MG   BASE               N022266   004    Jul   16,   2009
	
                                EQ   1.2MG   BASE               N022266   005    Jul   16,   2009
	
  INJECTABLE;INJECTION
	
    FENTANYL CITRATE
	
         ABBOTT                 EQ 0.05MG BASE/ML               A070636 001 Apr 30, 1990

                                EQ 0.05MG BASE/ML               A070637 001 Apr 30, 1990

         WATSON LABS            EQ 0.05MG BASE/ML               A073488 001 Jun 30, 1992
	
    FENTANYL CITRATE PRESERVATIVE FREE
	
         WATSON LABS INC        EQ 0.05MG BASE/ML               A074917 001 Feb 03, 1998
	
  TABLET;BUCCAL, SUBLINGUAL
	
    FENTANYL CITRATE
	
         WATSON LABS		          EQ 0.1MG BASE                   A079075   001    Jan   07,   2011
	
                                EQ 0.2MG BASE                   A079075   002    Jan   07,   2011
	
                                EQ 0.4MG BASE                   A079075   003    Jan   07,   2011
	
                                EQ 0.6MG BASE                   A079075   004    Jan   07,   2011
	
                                EQ 0.8MG BASE                   A079075   005    Jan   07,   2011
	
    FENTORA
	
         CEPHALON               EQ 0.3MG BASE                   N021947 006 Mar 02, 2007
	
  TROCHE/LOZENGE;ORAL

    FENTANYL
	
         CEPHALON		             EQ 0.1MG BASE                   N020195   007    Oct   30,   1995
	
                                EQ 0.2MG BASE                   N020195   001    Oct   04,   1993
	
                                EQ 0.3MG BASE                   N020195   002    Oct   04,   1993
	
                                EQ 0.4MG BASE                   N020195   003    Oct   04,   1993
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                             6-139(of 337)


FENTANYL HYDROCHLORIDE
	
  SYSTEM;IONTOPHORESIS, TRANSDERMAL
	
    IONSYS
	
         INCLINE THERAP
	       10.8MCG
	                                    N021338 001
	 May 22, 2006
	
FERRIC AMMONIUM CITRATE
	
  FOR SOLUTION;ORAL
	
    FERRISELTZ
	
         OTSUKA
	                 600MG/PACKET
	                             N020292 001
	 Oct 14, 1997
	
FERROUS CITRATE, FE-59
	
  INJECTABLE;INJECTION
	
    FERROUS CITRATE FE 59
	
         MALLINCKRODT
	           25uCi/ML
	                                 N016729 001
	
FERROUS SULFATE; FOLIC ACID
	
  CAPSULE;ORAL
	
    FOLVRON
	
         LEDERLE
	                182MG;0.33MG
	                             N006012 003
	
FERUMOXIDES
	
  INJECTABLE;INJECTION
	
    FERIDEX I.V.
	
         AMAG PHARMS INC
	        EQ 11.2MG IRON/ML
	                        N020416 001
	 Aug 30, 1996
	
FERUMOXSIL
	
  SUSPENSION;ORAL
	
    GASTROMARK
	
         AMAG PHARMS INC
	        EQ 0.175MG IRON/ML
	                       N020410 001
	 Dec 06, 1996
	
FEXOFENADINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    ALLEGRA
	
         SANOFI AVENTIS US
	     60MG
	                                      N020625 001
	 Jul 25, 1996
	
    FEXOFENADINE HYDROCHLORIDE
	
         BARR
	                  60MG
	                                      A076169 001
	 Jul 13, 2005
	
FIBRINOGEN, I-125
	
  INJECTABLE;INJECTION
	
    IBRIN
	
         GE HEALTHCARE
	        154uCi/VIAL
	                                N017879 001
	
    RADIONUCLIDE-LABELED (125 I) FIBRINOGEN (HUMAN) SENSOR

         ABBOTT
	               140uCi/ML
	                                  N017787 001
	
FINASTERIDE
	
  TABLET;ORAL
	
    FINASTERIDE
	
         IVAX SUB TEVA PHARMS
	   5MG
	                                      A076340 001
	 Jun 19, 2006
	
FLAVOXATE HYDROCHLORIDE
	
  TABLET;ORAL
	
    URISPAS
	
         ORTHO MCNEIL JANSSEN
	   100MG
	                                    N016769 001
	
FLECAINIDE ACETATE
	
  TABLET;ORAL
	
    FLECAINIDE ACETATE
	
         APOTEX INC
	             50MG
	                                     A079164   001
	   Jul   09,   2009
	
                                  100MG
	                                    A079164   002
	   Jul   09,   2009
	
                                  150MG
	                                    A079164   003
	   Jul   09,   2009
	
         SANDOZ
	                 50MG
	                                     A076030   001
	   Oct   28,   2002
	
                                  100MG
	                                    A076030   002
	   Oct   28,   2002
	
                                  150MG
	                                    A076030   003
	   Oct   28,   2002
	
    TAMBOCOR
	
         CNTY LINE PHARMS
	       50MG
	                                     N018830   004
	   Aug   23,   1988

                                  100MG
	                                    N018830   001
	   Oct   31,   1985
	
                                  150MG
	                                    N018830   003
	   Jun   03,   1988
	
                                  200MG
	                                    N018830   002
	   Oct   31,   1985
	
FLOXURIDINE
	
  INJECTABLE;INJECTION
	
    FUDR
	
           HOSPIRA
	              500MG/VIAL **Federal Register
             N016929 001
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                            6-140(of 337)


FLUCONAZOLE
	
  FOR SUSPENSION;ORAL
	
    FLUCONAZOLE
	
         TARO PHARM INDS        50MG/5ML
                                  A076918 001
	 Dec 18, 2006
	
                                200MG/5ML
                                 A076918 002
	 Dec 18, 2006
	
 INJECTABLE;INJECTION
	
   FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        AGILA SPECLTS          200MG/100ML (2MG/ML)
                       A076888 001
	 Mar 25, 2005
	
                               400MG/200ML (2MG/ML)
                       A076888 002
	 Mar 25, 2005
	
   FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
        AGILA SPECLTS          200MG/100ML (2MG/ML)
                       A076889   001
	   Mar   25,   2005
	
                               400MG/200ML (2MG/ML)
                       A076889   002
	   Mar   25,   2005
	
        HOSPIRA                200MG/100ML (2MG/ML)
                       A076617   001
	   Jul   29,   2004
	
                               400MG/200ML (2MG/ML)
                       A076617   002
	   Jul   29,   2004
	
        TEVA PHARMS            200MG/100ML (2MG/ML)
                       A076837   001
	   Jan   13,   2005
	
                               400MG/200ML (2MG/ML)
                       A076837   002
	   Jan   13,   2005
	
 TABLET;ORAL
	
   FLUCONAZOLE
	
        GEDEON RICHTER USA		   50MG
	                                      A076432   001
	   Jul   29,   2004
	
                               100MG
	                                     A076432   002
	   Jul   29,   2004
	
                               150MG
	                                     A076432   003
	   Jul   29,   2004
	
                               200MG
	                                     A076432   004
	   Jul   29,   2004
	
        HARRIS PHARM		         50MG
	                                      A078423   001
	   Mar   07,   2011
	
                               100MG
	                                     A078423   002
	   Mar   07,   2011
	
                               150MG
	                                     A078423   003
	   Mar   07,   2011
	
                               200MG
	                                     A078423   004
	   Mar   07,   2011
	
        MYLAN PHARMS INC		     50MG
	                                      A076042   001
	   Jul   29,   2004
	
                               100MG
	                                     A076042   002
	   Jul   29,   2004
	
                               150MG
	                                     A076042   003
	   Jul   29,   2004
	
                               200MG
	                                     A076042   004
	   Jul   29,   2004
	
        PLIVA		                50MG
	                                      A076424   001
	   Jul   29,   2004
	
                               100MG
	                                     A076424   002
	   Jul   29,   2004
	
                               150MG
	                                     A076424   003
	   Jul   29,   2004
	
                               200MG
	                                     A076424   004
	   Jul   29,   2004
	
        RANBAXY LABS LTD		     50MG
	                                      A076386   001
	   Jul   29,   2004
	
                               100MG
	                                     A076386   002
	   Jul   29,   2004
	
                               150MG
	                                     A076386   003
	   Jul   29,   2004
	
                               200MG
	                                     A076386   004
	   Jul   29,   2004
	
        ROXANE		               50MG
	                                      A076213   001
	   Jul   29,   2004
	
                               100MG
	                                     A076213   002
	   Jul   29,   2004
	
                               150MG
	                                     A076213   003
	   Jul   29,   2004
	
                               200MG
	                                     A076213   004
	   Jul   29,   2004
	
        SANDOZ		               50MG
	                                      A076086   001
	   Jul   29,   2004
	
                               100MG
	                                     A076086   002
	   Jul   29,   2004
	
                               150MG
	                                     A076086   003
	   Jul   29,   2004
	
                               200MG
	                                     A076086   004
	   Jul   29,   2004
	
FLUDARABINE PHOSPHATE
	
  INJECTABLE;INJECTION
	
    FLUDARA
	
         GENZYME CORP           50MG/VIAL
                                 N020038 001
	 Apr 18, 1991
	
  TABLET;ORAL
	
    OFORTA
	
         SANOFI AVENTIS US      10MG
	                                     N022273 001
	 Dec 18, 2008
	
FLUDEOXYGLUCOSE F-18
	
  INJECTABLE;INJECTION
	
    FLUDEOXYGLUCOSE F 18
	
         DOWNSTATE CLINCL       4-40mCi/ML **Federal Register
             N020306 001
	 Aug 19, 1994
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

                                4-90mCi/ML **Federal Register
             N020306 002
	 Sep 25, 2001
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

 INJECTABLE;INTRAVENOUS
	
   FLUDEOXYGLUCOSE F18
	
        WEILL MEDCL COLL        10-100mCi/ML **Federal Register
           N021768 001
	 Aug 05, 2004
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                  6-141(of 337)


FLUDROCORTISONE ACETATE
	
  TABLET;ORAL
	
    FLORINEF
	
         CITRON PHARMA LLC        0.1MG                                      N010060 001
	
FLUMAZENIL
	
  INJECTABLE;INJECTION
	
    FLUMAZENIL
	
         APOTEX INC               0.5MG/5ML (0.1MG/ML)                       A076755   002    Oct   12,   2004
	
                                  1MG/10ML (0.1MG/ML)                        A076755   001    Oct   12,   2004
	
         TEVA PHARMS USA          0.5MG/5ML (0.1MG/ML)                       A076589   002    Oct   12,   2004
	
                                  1MG/10ML (0.1MG/ML)                        A076589   001    Oct   12,   2004
	
   ROMAZICON
	
        HOFFMANN LA ROCHE         1MG/10ML (0.1MG/ML) **Federal Register     N020073 001 Dec 20, 1991

                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

                                  0.5MG/5ML (0.1MG/ML) **Federal Register    N020073 002 Dec 20, 1991

                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**
	
FLUMETHASONE PIVALATE
	
  CREAM;TOPICAL
	
    LOCORTEN
	
         NOVARTIS                 0.03%                                      N016379 001
	
FLUNISOLIDE
	
  AEROSOL, METERED;INHALATION
	
    AEROBID
	
         ROCHE PALO               0.25MG/INH                                 N018340 001 Aug 17, 1984

  SPRAY, METERED;NASAL
	
    NASALIDE
	
         IVAX RES                 0.025MG/SPRAY                              N018148 001
	
    NASAREL
	
         TEVA BRANDED PHARM       0.029MG/SPRAY                              N020409 001 Mar 08, 1995
	
FLUOCINOLONE ACETONIDE
	
  CREAM;TOPICAL
	
    FLUOCET
	
         ALPHARMA US PHARMS       0.025%                                     A088360 001 Jan 16, 1984
	
    FLUOCINOLONE ACETONIDE
	
         ALPHARMA US PHARMS       0.01%                                      A088361   001    Jan   16,   1984
	
         PERRIGO NEW YORK         0.01%                                      A086810   001    Mar   04,   1982
	
                                  0.025%                                     A086811   001    Mar   04,   1982
	
         PHARMADERM               0.01%                                      A088047   001    Dec   16,   1982
	
                                  0.025%                                     A088045   001    Dec   16,   1982
	
         PHARMAFAIR               0.01%                                      A088499   001    Aug   02,   1984

                                  0.025%                                     A088506   001    Aug   02,   1984

         TARO                     0.01%                                      A040035   001    Oct   31,   1994
	
                                  0.01%                                      A087102   001    Apr   27,   1982

                                  0.025%                                     A040042   001    Oct   31,   1994
	
         USL PHARMA               0.01%                                      A088757   001    Feb   11,   1985
	
                                  0.025%                                     A088756   001    Mar   28,   1985
	
   FLUONID
	
        ALLERGAN HERBERT          0.025%                                     A087156 002 Sep 06, 1984

   FLUOTREX
	
        SAVAGE LABS               0.01%                                      A088174 001 May 06, 1983

                                  0.025%                                     A088173 001 Mar 09, 1983
	
   SYNALAR-HP
	
        MEDIMETRIKS PHARMS        0.2%                                       N016161 002
	
 GEL;TOPICAL
	
   FLUONID
	
        ALLERGAN HERBERT          0.025%                                     A087300 001 May 27, 1982

 OINTMENT;TOPICAL
	
   FLUOCINOLONE ACETONIDE
	
        PHARMADERM                0.025%                                     A088046 001 Dec 16, 1982
	
        PHARMAFAIR                0.025%                                     A088507 001 Feb 27, 1984
	
        USL PHARMA                0.025%                                     A088742 001 Feb 08, 1985
	
   FLUONID
	
        ALLERGAN HERBERT          0.025%                                     A087157 001 Sep 06, 1984

   FLUOTREX
	
        SAVAGE LABS               0.025%                                     A088172 001 Mar 09, 1983
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                6-142(of 337)


FLUOCINOLONE ACETONIDE
	
  SOLUTION;TOPICAL
	
    FLUOCINOLONE ACETONIDE
	
         ALPHARMA US PHARMS      0.01%                                   A087159   001    Jun   16,   1982
	
         BAUSCH AND LOMB         0.01%                                   A040059   001    Dec   20,   1993
	
         MORTON GROVE            0.01%                                   A088312   001    Jan   27,   1984
	
         PHARMADERM              0.01%                                   A088048   001    Dec   16,   1982
	
         PHARMAFAIR              0.01%                                   A088449   001    Feb   08,   1984
	
    FLUONID
	
         ALLERGAN HERBERT        0.01%                                   A087158 001 Mar 17, 1983
	
    FLUOTREX
	
         SAVAGE LABS             0.01%                                   A088171 001 Mar 09, 1983
	
FLUOCINONIDE
	
  CREAM;TOPICAL
	
    FLUOCINONIDE
	
         PERRIGO NEW YORK       0.05%                                    A071790 001 Jul 13, 1988
	
         TARO                   0.05%                                    A071500 001 Jun 10, 1987
	
    FLUOCINONIDE EMULSIFIED BASE
	
         G AND W LABS INC       0.05%                                    A074204 001 Jun 13, 1995
	
    LIDEX
	
         CNTY LINE PHARMS       0.05%                                    N016908 002
	
    LIDEX-E
	
         CNTY LINE PHARMS       0.05%                                    N016908 003
	
  GEL;TOPICAL
	
    LIDEX
	
         CNTY LINE PHARMS		     0.05% **Federal Register determination   N017373 001
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
  OINTMENT;TOPICAL
	
    LIDEX
	
         CNTY LINE PHARMS		     0.05% **Federal Register determination   N016909 002
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
  SOLUTION;TOPICAL
	
    FLUOCINONIDE
	
         TARO                   0.05%                                    A072857 001 Aug 02, 1989

         TEVA PHARMS            0.05%                                    A072522 001 Sep 28, 1990
	
FLUORESCEIN SODIUM
	
  INJECTABLE;INJECTION
	
    FUNDUSCEIN-25
	
         NOVARTIS                25%                                     N017869 001
	
FLUOROMETHOLONE
	
  CREAM;TOPICAL
	
    OXYLONE
	
         PHARMACIA AND UPJOHN    0.025%                                  N011748 001
	
  SUSPENSION/DROPS;OPHTHALMIC

    FLUOR-OP
	
         NOVARTIS                0.1%                                    A070185 001 Feb 27, 1986
	
FLUOROMETHOLONE ACETATE; TOBRAMYCIN
	
  SUSPENSION/DROPS;OPHTHALMIC

    TOBRASONE
	
         ALCON                  0.1%;0.3%                                N050628 001 Jul 21, 1989
	
FLUOROMETHOLONE; SULFACETAMIDE SODIUM
	
  SUSPENSION/DROPS;OPHTHALMIC

    FML-S
	
         ALLERGAN               0.1%;10%                                 N019525 001 Sep 29, 1989
	
FLUOROURACIL
	
  INJECTABLE;INJECTION
	
    ADRUCIL
	
         PHARMACIA AND UPJOHN    50MG/ML                                 A081222   001 Jun 28, 1991
	
                                 50MG/ML                                 N017959   001
	
         TEVA PARENTERAL         50MG/ML                                 A040023   001 Oct 18, 1991
	
                                 50MG/ML                                 A081225   001 Aug 28, 1991

   FLUOROURACIL
	
        ABIC                     50MG/ML                                 A088929   001    Mar   04,   1986
	
        ABRAXIS PHARM            50MG/ML                                 A089152   001    Mar   21,   1986
	
                                 50MG/ML                                 A089428   001    Jan   12,   1987
	
                                 50MG/ML                                 A089519   001    Mar   12,   1987
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                      6-143(of 337)


FLUOROURACIL
	
  INJECTABLE;INJECTION
	
    FLUOROURACIL
	
         BEDFORD                 50MG/ML                         A089508   001     Jan   26,   1988
	
         EBEWE PHARMA            500MG/10ML (50MG/ML)            A040772   001     Aug   11,   2008

         FRESENIUS KABI USA      50MG/ML                         A040291   001     Mar   24,   1999
	
                                 50MG/ML                         A040379   001     Nov   15,   2000
	
         MARCHAR                 50MG/ML                         A087791   001     Jan   18,   1983
	
         SMITH AND NEPHEW        50MG/ML                         A088766   001     Dec   28,   1984
	
                                 50MG/ML		                       A088767   001     Dec   28,   1984
	
                                 50MG/ML                         A089434   001     Mar   26,   1987
	
        SPECTRUM PHARMS          50MG/ML                         A087792   001     Oct   13,   1982
	
        VALEANT                  500MG/10ML (50MG/ML)            N012209   001
	
 SOLUTION;TOPICAL
	
   FLUOROPLEX
	
        ELORAC                   1%                              N016765 001
	
FLUOXETINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    FLUOXETINE
	
         MUTUAL PHARMA           EQ   10MG   BASE                A075787   001     Jan   29,   2002
	
                                 EQ   20MG   BASE                A075787   002     Jan   29,   2002
	
         WATSON LABS             EQ   10MG   BASE                A075662   001     Jan   29,   2002
	
                                 EQ   20MG   BASE                A075662   002     Jan   29,   2002
	
   FLUOXETINE HYDROCHLORIDE
	
        BARR                     EQ   40MG   BASE                A076251   001     May   18,   2005

        CARLSBAD                 EQ   10MG   BASE                A076022   001     Jan   30,   2002
	
                                 EQ   20MG   BASE                A076022   002     Jan   30,   2002
	
         CR DOUBLE CRANE         EQ   10MG   BASE                A076165   001     Feb   01,   2002
	
                                 EQ   20MG   BASE                A076165   002     Feb   01,   2002
	
         PAR PHARM               EQ   10MG   BASE                A076922   001     Dec   16,   2004
	
                                 EQ   20MG   BASE                A076922   002     Dec   16,   2004
	
         SANDOZ                  EQ   10MG   BASE                A075807   001     Jan   29,   2002
	
                                 EQ   20MG   BASE                A075807   002     Jan   29,   2002
	
         WOCKHARDT LTD           EQ   10MG   BASE                A078143   001     Jan   16,   2008
	
                                 EQ   20MG   BASE                A078143   002     Jan   16,   2008
	
                                 EQ   40MG   BASE                A078143   003     Jan   16,   2008
	
   PROZAC
	
        ELI LILLY AND CO         EQ 60MG BASE                    N018936 004 Jun 15, 1999
	
 SOLUTION;ORAL
	
   FLUOXETINE HYDROCHLORIDE
	
        ACTAVIS MID ATLANTIC     EQ 20MG BASE/5ML                A075690 001 Jan 31, 2002
	
        APOTEX INC               EQ 20MG BASE/5ML                A075292 001 Feb 07, 2002
	
        HI TECH PHARMA           EQ 20MG BASE/5ML                A075525 001 Jun 27, 2002
	
   PROZAC
	
        LILLY                    EQ 20MG BASE/5ML                N020101 001 Apr 24, 1991

 TABLET;ORAL
	
   FLUOXETINE HYDROCHLORIDE
	
        BARR                     EQ   10MG   BASE                A075810   001     Feb   01,   2002
	
        IVAX SUB TEVA PHARMS     EQ   10MG   BASE                A075865   001     Feb   28,   2002
	
                                 EQ   40MG   BASE                A075865   003     Aug   30,   2004

        SANDOZ                   EQ   10MG   BASE                A076024   001     Jan   29,   2002
	
   PROZAC
	
        LILLY                    EQ 10MG BASE                    N020974 001 Mar 09, 1999
	
                                 EQ 20MG BASE                    N020974 002 Mar 09, 1999
	
FLUOXYMESTERONE
	
  TABLET;ORAL
	
    ANDROID-F
	
         VALEANT PHARM INTL      10MG                            A087196 001
	
    FLUOXYMESTERONE
	
         VALEANT PHARM INTL      10MG                            A088221   001     May   05,   1983

         WATSON LABS             2MG                             A088260   001     Dec   06,   1983
	
                                 5MG                             A088265   001     Dec   06,   1983
	
                                 10MG                            A088309   001     Dec   06,   1983
	
   HALOTESTIN
	
        PHARMACIA AND UPJOHN		   2MG                             N010611 002
	
                                 5MG                             N010611 006
	
                                 10MG                            N010611 010
	
   ORA-TESTRYL
	
        BRISTOL MYERS SQUIBB     2MG                             N011359 001
	
                                 5MG                             N011359 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                   6-144(of 337)


FLUPHENAZINE DECANOATE
	
  INJECTABLE;INJECTION
	
    FLUPHENAZINE DECANOATE
	
         AGILA SPECLTS             25MG/ML                                   A075918 001 Aug 17, 2001

         HOSPIRA                   25MG/ML                                   A074966 001 Apr 16, 1998

         TEVA PARENTERAL           25MG/ML                                   A074795 001 Sep 10, 1996

    PROLIXIN DECANOATE
	
         BRISTOL MYERS SQUIBB      25MG/ML                                   N016727 001
	
FLUPHENAZINE ENANTHATE
	
  INJECTABLE;INJECTION
	
    PROLIXIN ENANTHATE
	
         APOTHECON		               25MG/ML                                   N016110 001
	
FLUPHENAZINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    FLUPHENAZINE HYDROCHLORIDE
	
         TEVA PHARMS               5MG/ML                                    A073058 001 Aug 30, 1991

    PERMITIL
	
         SCHERING                  5MG/ML                                    N016008 001
	
    PROLIXIN
	
         APOTHECON                 5MG/ML                                    A070533 001 Nov 07, 1985
	
  ELIXIR;ORAL
	
    FLUPHENAZINE HYDROCHLORIDE
	
         ANI PHARMS INC            2.5MG/5ML                                 A081310 001 Apr 29, 1993

    PROLIXIN
	
         APOTHECON                 2.5MG/5ML                                 N012145 003
	
  INJECTABLE;INJECTION
	
    PROLIXIN
	
         APOTHECON                 2.5MG/ML                                  N011751 005
	
  TABLET;ORAL
	
    FLUPHENAZINE HYDROCHLORIDE
	
         WATSON LABS		             1MG                                       A088555   001     Dec   18,   1987
	
                                   2.5MG                                     A088544   001     Dec   18,   1987
	
                                   5MG                                       A088527   001     Dec   18,   1987
	
                                   10MG                                      A088550   001     Dec   18,   1987
	
   PERMITIL
	
        SCHERING		                 0.25MG                                    N012034   001
	
                                   2.5MG                                     N012034   004
	
                                   5MG                                       N012034   005
	
                                   10MG                                      N012034   006
	
   PROLIXIN
	
        APOTHECON		             1MG                                          N011751   004
	
                                2.5MG                                        N011751   001
	
                                5MG                                          N011751   003
	
                                10MG                                         N011751   002
	
 TABLET, EXTENDED RELEASE;ORAL
	
   PERMITIL
	
        SCHERING                1MG                                          N012419 004
	
FLUPREDNISOLONE
	
  TABLET;ORAL
	
    ALPHADROL
	
         PHARMACIA AND UPJOHN      1.5MG                                     N012259 002
	
FLURANDRENOLIDE
	
  LOTION;TOPICAL
	
    FLURANDRENOLIDE
	
         ALPHARMA US PHARMS        0.05%                                     A087203 001 Apr 29, 1982

  OINTMENT;TOPICAL
	
    CORDRAN
	
         AQUA PHARMS               0.025% **Federal Register determination   N012806 004
	
                                   that product was not discontinued or

                                   withdrawn for safety or efficacy

                                   reasons**
	
                                   0.05% **Federal Register determination    N012806 001
	
                                   that product was not discontinued or

                                   withdrawn for safety or efficacy

                                   reasons**
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-145(of 337)


FLURANDRENOLIDE; NEOMYCIN SULFATE
	
  CREAM;TOPICAL
	
    CORDRAN-N
         LILLY                  0.05%;EQ 3.5MG BASE/GM                   N050346 001
  OINTMENT;TOPICAL
    CORDRAN-N
         LILLY                  0.05%;EQ 3.5MG BASE/GM                   N050345 001
FLURAZEPAM HYDROCHLORIDE
  CAPSULE;ORAL
    DALMANE
         VALEANT PHARM INTL     15MG                                     N016721 001
                                30MG                                     N016721 002
   FLURAZEPAM HYDROCHLORIDE
        HALSEY                  15MG                                     A071808   001    Jan   07,   1988
                                30MG                                     A071809   001    Jan   07,   1988
        HIKMA PHARMS LLC        15MG                                     A071107   001    Dec   08,   1986
                                30MG                                     A071108   001    Dec   08,   1986
        MUTUAL PHARM            15MG                                     A070454   001    Aug   04,   1986
                                30MG                                     A070455   001    Aug   04,   1986
        PAR PHARM               15MG                                     A070444   001    Mar   20,   1986
                                30MG                                     A070445   001    Mar   20,   1986
        PUREPAC PHARM           15MG                                     A071927   001    Sep   09,   1987
                                30MG                                     A071551   001    Sep   09,   1987
        SANDOZ                  15MG                                     A071716   001    Jul   31,   1991
                                30MG                                     A071717   001    Jul   31,   1991
        SUPERPHARM              15MG                                     A071659   001    Aug   04,   1988
                                30MG                                     A071660   001    Aug   04,   1988
        USL PHARMA              15MG                                     A070562   001    Jul   09,   1987
                                30MG                                     A070563   001    Jul   09,   1987
        WARNER CHILCOTT         15MG                                     A071767   001    Dec   04,   1987
                                30MG                                     A071768   001    Dec   04,   1987
        WATSON LABS             15MG                                     A071205   001    Nov   25,   1986
                                15MG                                     A072368   001    Mar   30,   1989
                                30MG                                     A071068   001    Nov   25,   1986
                                30MG                                     A072369   001    Mar   30,   1989
FLURBIPROFEN
  TABLET;ORAL
    FLURBIPROFEN
         IVAX SUB TEVA PHARMS   50MG                                     A074411   001    May   31,   1995
                                100MG                                    A074411   002    May   31,   1995
        PLIVA                   50MG                                     A074647   001    Apr   01,   1997
                                100MG                                    A074647   002    Apr   01,   1997
        SANDOZ                  50MG                                     A074448   001    Jul   28,   1995
                                100MG                                    A074448   002    Jul   28,   1995
        TEVA                    50MG                                     A074405   002    May   24,   1995
                                100MG                                    A074405   001    May   24,   1995
        THERAGEN                100MG                                    A074560   002    May   16,   1997
FLUTAMIDE
  CAPSULE;ORAL
    EULEXIN
         SCHERING               125MG                                    N018554 001 Jan 27, 1989
    FLUTAMIDE
         SANDOZ                 125MG                                    A075818 001 Sep 18, 2001
FLUTICASONE PROPIONATE
  AEROSOL, METERED;INHALATION
    FLOVENT
         GLAXOSMITHKLINE        0.044MG/INH                              N020548 001 Mar 27, 1996
                                0.11MG/INH                               N020548 002 Mar 27, 1996
                                0.22MG/INH                               N020548 003 Mar 27, 1996
 CREAM;TOPICAL
   CUTIVATE
        FOUGERA PHARMS          0.05% **Federal Register determination   N019958 001 Dec 18, 1990
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
   FLUTICASONE PROPIONATE
        NESHER PHARMS           0.05%                                    A076865 001 Sep 10, 2004
 OINTMENT;TOPICAL
   FLUTICASONE PROPIONATE
        TARO PHARM INDS         0.005%                                   A077145 001 Jun 14, 2005
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-146(of 337)


FLUTICASONE PROPIONATE
	
  POWDER;INHALATION
	
    FLOVENT
	
         GLAXOSMITHKLINE		        0.044MG/INH                   N020549 001 Nov 07, 1997
	
                                  0.088MG/INH                   N020549 002 Nov 07, 1997
	
                                  0.22MG/INH                    N020549 003 Nov 07, 1997
	
FLUVOXAMINE MALEATE
	
  TABLET;ORAL
	
    FLUVOXAMINE MALEATE
	
         ACTAVIS ELIZABETH		      25MG                          A075901   001     Dec   28,   2000
	
                                  50MG                          A075901   002     Dec   28,   2000
	
                                  100MG                         A075901   003     Dec   28,   2000
	
         IVAX SUB TEVA PHARMS		   25MG                          A075898   001     Mar   12,   2001
	
                                  50MG                          A075898   002     Mar   12,   2001
	
                                  100MG                         A075898   003     Mar   12,   2001
	
         MUTUAL PHARM		           25MG                          A076125   001     Apr   29,   2002

                                  50MG                          A076125   002     Apr   29,   2002

                                  100MG                         A076125   003     Apr   29,   2002

         MYLAN		                  50MG                          A075950   001     Oct   15,   2001
	
                                  100MG                         A075950   002     Oct   15,   2001
	
         SANDOZ		                 25MG                          A075887   001     Jan   05,   2001
	
                                  50MG                          A075887   002     Jan   05,   2001
	
                                  100MG                         A075887   003     Jan   05,   2001
	
         SUN PHARM INDS INC		     25MG                          A075900   001     Feb   23,   2006
	
                                  50MG                          A075900   002     Feb   23,   2006
	
                                  100MG                         A075900   003     Feb   23,   2006
	
         SYNTHON PHARMS		         25MG                          A075899   001     Jan   17,   2001
	
                                  50MG                          A075899   002     Jan   17,   2001
	
                                  100MG                         A075899   003     Jan   17,   2001
	
         WATSON LABS		            25MG                          A075894   001     Apr   18,   2001

                                  50MG                          A075894   002     Apr   18,   2001

                                  100MG                         A075894   003     Apr   18,   2001

   LUVOX
	
        SOLVAY		                  25MG                          N020243   001     Dec   05,   1994
	
                                  50MG                          N020243   002     Dec   05,   1994
	
                                  100MG                         N020243   003     Dec   05,   1994
	
                                  150MG                         N020243   004     Dec   05,   1994
	
FOLIC ACID
	
  INJECTABLE;INJECTION
	
    FOLIC ACID
	
         BEN VENUE                5MG/ML                        A081066 001 Dec 29, 1993
	
    FOLVITE
	
         HIKMA (MAPLE)            5MG/ML                        N005897 008
	
  TABLET;ORAL
	
    FOLIC ACID
	
         BARR                     1MG                           A089177   001     Jan 08, 1986
	
         EVERYLIFE                1MG                           A080755   001
	
         HALSEY                   1MG                           A083598   001
	
         IMPAX LABS               1MG                           A080686   001
	
         IVAX SUB TEVA PHARMS     1MG                           A083000   001
	
         JUBILANT CADISTA         1MG                           A040514   001     Jun 14, 2005
	
         LANNETT                  1MG                           A080816   001
	
         LILLY                    1MG                           N006135   003
	
         MK LABS                  1MG                           A083526   001
	
         MUTUAL PHARM             1MG                           A040582   001     Jul 18, 2005
	
         NEXGEN PHARMA INC        1MG                           A084915   001
	
         PHARMERAL                1MG                           A084158   001
	
         PIONEER PHARMS           1MG                           A088949   001     Sep 13, 1985

         PUREPAC PHARM            1MG                           A080784   001
	
         SANDOZ                   1MG                           A084472   001
	
         TABLICAPS                1MG                           A083133   002
	
         UDL                      1MG                           A088199   001     Mar 29, 1983
	
         USL PHARMA               1MG                           A087828   001     May 13, 1982

         VALEANT PHARM INTL       1MG                           A080903   001
	
         VANGARD                  1MG                           A088730   001     Mar 23, 1984
	
         VINTAGE PHARMS           1MG                           A086296   001
	
         WATSON LABS              1MG                           A083141   001
	
                                  1MG                           A085141   002
	
        WHITEWORTH TOWN PLSN      1MG                           A080691   002
	
   FOLICET
	
        MISSION PHARMA            1MG                           A087438 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                    6-147(of 337)


FOLIC ACID
	
  TABLET;ORAL
	
    FOLVITE
	
         HIKMA (MAPLE)          1MG                            N005897 004
	
FOLLITROPIN ALFA/BETA

  INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
	
    FOLLISTIM
         ORGANON USA INC        75 IU/VIAL                     N020582 001 Sep 29, 1997
                                150 IU/VIAL                    N020582 002 Sep 29, 1997
  INJECTABLE;SUBCUTANEOUS
    FOLLISTIM AQ
         ORGANON USA INC        150 IU/0.18ML                  N021211 003 Feb 11, 2004
    GONAL-F
         EMD SERONO             37.5 IU/VIAL                   N020378   003    May   25,   2000
                                37.5 IU/VIAL                   N021765   001    Mar   25,   2004
                                75 IU/VIAL                     N020378   001    Sep   29,   1997
                                150 IU/VIAL                    N020378   002    Sep   29,   1997
                                150 IU/VIAL                    N021765   003    Mar   25,   2004
FOMEPIZOLE
  INJECTABLE;INJECTION
    FOMEPIZOLE
         MYLAN INSTITUTIONAL    1.5GM/1.5ML (1GM/ML)           A079033 001 Apr 07, 2009
FOMIVIRSEN SODIUM
  INJECTABLE;INJECTION
    VITRAVENE PRESERVATIVE FREE
         NOVARTIS               6.6MG/ML                       N020961 001 Aug 26, 1998
FORMOTEROL FUMARATE
  POWDER;INHALATION
    FORADIL CERTIHALER
         NOVARTIS               0.0085MG/INH                   N021592 001 Dec 15, 2006
FOSAPREPITANT DIMEGLUMINE
  POWDER;INTRAVENOUS
    EMEND
          MERCK AND CO INC      EQ 115MG BASE/VIAL             N022023 001 Jan 25, 2008
FOSINOPRIL SODIUM
  TABLET;ORAL
    FOSINOPRIL SODIUM
         RANBAXY LABS LTD       10MG                           A076580   001    Apr   23,   2004
                                20MG                           A076580   002    Apr   23,   2004
                                40MG                           A076580   003    Apr   23,   2004
         SANDOZ                 10MG                           A076188   001    Oct   08,   2004
                                20MG                           A076188   002    Oct   08,   2004
                                40MG                           A076188   003    Oct   08,   2004
         WATSON LABS            10MG                           A076987   001    Dec   23,   2004
                                10MG                           A077531   001    Aug   31,   2006
                                20MG                           A076987   002    Dec   23,   2004
                                20MG                           A077531   002    Aug   31,   2006
                                40MG                           A076987   003    Dec   23,   2004
                                40MG                           A077531   003    Aug   31,   2006
   MONOPRIL
        BRISTOL MYERS SQUIBB    10MG                           N019915 002 May 16, 1991
                                20MG                           N019915 003 May 16, 1991
                                40MG                           N019915 004 Mar 28, 1995
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
	
         MYLAN                  10MG;12.5MG                    A077705   001    Aug   14,   2006

                                20MG;12.5MG                    A077705   002    Aug   14,   2006

         TEVA                   10MG;12.5MG                    A076945   001    Jul   05,   2006
	
                                20MG;12.5MG                    A076945   002    Jul   05,   2006
	
         WATSON LABS            10MG;12.5MG                    A077144   001    Aug   16,   2005

                                20MG;12.5MG                    A077144   002    Aug   16,   2005

    MONOPRIL-HCT
	
         BRISTOL MYERS SQUIBB   10MG;12.5MG                    N020286 002 Nov 30, 1994
	
                                20MG;12.5MG                    N020286 001 Nov 30, 1994
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                      6-148(of 337)


FOSPHENYTOIN SODIUM
	
  INJECTABLE;INJECTION
	
    FOSPHENYTOIN SODIUM
	
         APOTEX INC
	            EQ 50MG PHENYTOIN NA/ML
          A078126 001 Aug 06, 2007

         TEVA PHARMS USA
	       EQ 50MG PHENYTOIN NA/ML
	         A076886 001 Aug 06, 2007
	
FOSPROPOFOL DISODIUM
	
  SOLUTION;INTRAVENOUS
	
    LUSEDRA
	
         EISAI INC
	             1050MG/30ML (35MG/ML)
	           N022244 001 Dec 12, 2008
	
FURAZOLIDONE
	
  SUSPENSION;ORAL
	
    FUROXONE
	
         SHIRE
	                 50MG/15ML
	                       N011323 002
	
  TABLET;ORAL
	
    FUROXONE
	
         SHIRE
	                 100MG
	                           N011270 002
	
FUROSEMIDE
	
  INJECTABLE;INJECTION
	
    FUROSEMIDE
	
         ABRAXIS PHARM
	         10MG/ML
                          N018507   001     Jul   30,   1982
	
                                 10MG/ML
                          N019036   001     Aug   13,   1984

         ASTRAZENECA
	           10MG/ML
                          A070014   001     Sep   09,   1985

                                 10MG/ML
                          A070095   001     Sep   09,   1985

                                 10MG/ML
                          A070096   001     Sep   09,   1985

         HIKMA MAPLE
	           10MG/ML
                          A071439   001     Sep   14,   1990

                                 10MG/ML
                          N018267   001
	
         HOSPIRA
	               10MG/ML
                          A070578   001     Jul 08, 1987
	
                                 10MG/ML
                          A072080   001     Aug 13, 1991

                                 10MG/ML
                          A074337   001     Oct 31, 1994
	
         INTL MEDICATION
	       10MG/ML
                          N018025   001
	
         MARSAM PHARMS LLC
	     10MG/ML
                          A074017   001     Jun   30,   1994
	
         ORGANON USA INC
	       10MG/ML
                          A070017   001     Dec   15,   1986
	
         SMITH AND NEPHEW
	      10MG/ML
                          A070023   001     Feb   05,   1986
	
                                 10MG/ML
                          A070078   001     Feb   05,   1986
	
         WARNER CHILCOTT
	       10MG/ML
                          N018420   001     Feb   26,   1982
	
         WATSON LABS
	           10MG/ML
                          A070019   001     Sep   22,   1986

                                 10MG/ML
                          A070604   001     Jan   02,   1987
	
         WYETH AYERST
	          10MG/ML
	                         N018670   001     Jul   20,   1982
	
    LASIX
	
         SANOFI AVENTIS US
	     10MG/ML
	                         N016363 001
	
  SOLUTION;ORAL
	
    LASIX
	
         SANOFI AVENTIS US
	     10MG/ML
	                         N017688 001
	
  TABLET;ORAL
	
    FUROSEMIDE
	
         DAVA PHARMS INC
	       20MG
	                            N018415   001     Jul   27,   1982
	
                                 40MG
	                            N018415   002     Jul   27,   1982
	
                                 80MG
	                            N018415   003     Nov   26,   1984
	
         INTL MEDICATION
	       20MG
	                            N018753   001     Feb   28,   1984
	
                                 40MG
	                            N018753   002     Feb   28,   1984
	
         KALAPHARM
	             20MG
	                            N018868   001     Jun   28,   1983
	
                                 40MG
	                            N018868   002     Jun   28,   1983
	
         MUTUAL PHARM
	          20MG
	                            A070043   001     Sep   26,   1985

                                 40MG
	                            N018790   001     Nov   29,   1983
	
                                 80MG
	                            A070100   001     Jan   26,   1988
	
         SANDOZ
	                40MG
	                            N018750   002     Jul   30,   1984
	
         SUPERPHARM
	            20MG
	                            N018370   002     Jun   26,   1984
	
                                 40MG
	                            N018370   001     Feb   10,   1983
	
         WARNER CHILCOTT
	       20MG
	                            N018419   001     Jan   31,   1983
	
                                 40MG
	                            N018419   002     Jan   31,   1983
	
                                 80MG
	                            N018419   003     Nov   13,   1984
	
         WATSON LABS
	           20MG
	                            A070412   001     Feb   26,   1986
	
                                 20MG
	                            A070449   001     Nov   22,   1985
	
                                 20MG
	                            A071379   001     Jan   02,   1987
	
                                 20MG
	                            N018369   001     May   14,   1982

                                 40MG
	                            A070413   001     Feb   26,   1986
	
                                 40MG
	                            A070450   001     Nov   22,   1985
	
                                 40MG
	                            N018369   002     May   14,   1982

                                 80MG
	                            A070528   001     Jan   07,   1986
	
                                 80MG
	                            A071594   001     Feb   09,   1988
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                               6-149(of 337)


GABAPENTIN
	
  CAPSULE;ORAL
	
    GABAPENTIN
	
         IVAX SUB TEVA PHARMS		   100MG                                    A075477   001    Mar   23,   2005
	
                                  300MG                                    A075477   002    Mar   23,   2005
	
                                  400MG                                    A075477   003    Mar   23,   2005
	
         MUTUAL PHARM		           100MG                                    A076537   001    Jun   30,   2005
	
                                  300MG                                    A076537   002    Jun   30,   2005
	
                                  400MG                                    A076537   003    Jun   30,   2005
	
         SANDOZ		                 100MG                                    A075428   001    Jan   24,   2006
	
                                  100MG                                    A075539   001    Apr   06,   2005

                                  300MG                                    A075428   002    Jan   24,   2006
	
                                  300MG                                    A075539   002    Apr   06,   2005

                                  400MG                                    A075428   003    Jan   24,   2006
	
                                  400MG                                    A075539   003    Apr   06,   2005

         WATSON LABS		            100MG                                    A075485   003    May   11,   2007

                                  300MG                                    A075485   002    May   11,   2007

                                  400MG                                    A075485   001    May   11,   2007

 TABLET;ORAL
	
   GABAPENTIN
	
        RANBAXY                   600MG                                    A076605   001    Sep   14,   2005

                                  800MG                                    A076605   002    Sep   14,   2005

         SANDOZ		                 600MG                                    A076120   001    Jan   27,   2006
	
                                  600MG                                    A076877   001    Jul   06,   2006
	
                                  800MG                                    A076120   002    Jan   27,   2006
	
                                  800MG                                    A076877   002    Jul   06,   2006
	
         TEVA		                   600MG                                    A075827   001    Dec   15,   2004
	
                                  800MG                                    A075827   002    Dec   15,   2004
	
GADODIAMIDE
	
  INJECTABLE;INJECTION
	
    OMNISCAN
	
         GE HEALTHCARE            14.35GM/50ML (287MG/ML)                  N022066 001 Sep 05, 2007
	
GALANTAMINE HYDROBROMIDE
	
  TABLET;ORAL
	
    GALANTAMINE HYDROBROMIDE
	
         ACTAVIS ELIZABETH		      EQ   4MG BASE                            A077585   001    Sep   15,   2009

                                  EQ   8MG BASE                            A077585   002    Sep   15,   2009

                                  EQ   12MG BASE                           A077585   003    Sep   15,   2009

         YABAO PHARM		            EQ   4MG BASE                            A077604   001    Feb   06,   2009
	
                                  EQ   8MG BASE                            A077604   002    Feb   06,   2009
	
                                  EQ   12MG BASE                           A077604   003    Feb   06,   2009
	
GALLAMINE TRIETHIODIDE
	
  INJECTABLE;INJECTION
	
    FLAXEDIL
	
         DAVIS AND GECK           20MG/ML                                  N007842 001
	
                                  100MG/ML                                 N007842 002
	
GALLIUM CITRATE GA-67
	
  INJECTABLE;INJECTION
	
    GALLIUM CITRATE GA 67
	
         GE HEALTHCARE            1mCi/ML                                  N017700 001
	
    NEOSCAN
	
         GE HEALTHCARE            2mCi/ML                                  N017655 001
	
GALLIUM NITRATE
	
  INJECTABLE;INJECTION
	
    GANITE
	
         CHAPTER 7 TRUSTEE        25MG/ML                                  N019961 002 Jan 17, 1991
	
GANCICLOVIR
	
  CAPSULE;ORAL
	
    CYTOVENE
	
         ROCHE PALO               250MG **Federal Register determination   N020460 001 Dec 22, 1994

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                                  500MG **Federal Register determination   N020460 002 Dec 12, 1997

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
   GANCICLOVIR
	
        RANBAXY LABS LTD          250MG                                    A076457 001 Jun 27, 2003
	
                                  500MG                                    A076457 002 Jun 27, 2003
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                     6-150(of 337)


GANCICLOVIR
	
  IMPLANT;IMPLANTATION
	
    VITRASERT
	
         BAUSCH AND LOMB       4.5MG
	                           N020569 001 Mar 04, 1996
	
GANCICLOVIR SODIUM
	
  INJECTABLE;INJECTION
	
    GANCICLOVIR SODIUM
	
         EUROHLTH INTL         EQ 500MG BASE/VIAL
	              A076222 001 Jul 16, 2003
	
GATIFLOXACIN
	
  SOLUTION/DROPS;OPHTHALMIC

    GATIFLOXACIN
	
         APOTEX INC            0.3%
	                            A079084 001 Aug 19, 2011
	
GEFITINIB
	
  TABLET;ORAL
	
    IRESSA
	
         ASTRAZENECA           250MG
	                           N021399 001 May 05, 2003
	
GEMFIBROZIL
	
  CAPSULE;ORAL
	
    GEMFIBROZIL
	
         MYLAN                 300MG
	                           A073466 001 Jan 25, 1993
	
         PUREPAC PHARM         300MG
	                           A072929 001 Jan 29, 1993
	
    LOPID
	
         PFIZER PHARMS         200MG
	                           N018422 001
	
                               300MG
	                           N018422 002
	
 TABLET;ORAL
	
   GEMFIBROZIL
	
        MYLAN                  600MG
	                           A074452   001    Feb   16,   1995
	
        PUREPAC PHARM          600MG
	                           A074360   001    Aug   31,   1994

        SANDOZ                 600MG
	                           A074615   001    Sep   29,   1995

        WATSON LABS            600MG
	                           A074156   001    Oct   24,   1994
	
                               600MG
	                           A074442   001    Apr   28,   1995
	
GEMTUZUMAB OZOGAMICIN
	
  INJECTABLE;INJECTION
	
    MYLOTARG
	
         WYETH PHARMS INC      5MG/VIAL
	                        N021174 001 May 17, 2000
	
GENTAMICIN SULFATE
	
  CREAM;TOPICAL
	
    GARAMYCIN
	
         SCHERING              EQ 0.1% BASE
	                    A060462 001
	
    GENTAFAIR
	
         PHARMAFAIR            EQ 0.1% BASE
	                    A062458 001 Sep 01, 1983
	
    GENTAMICIN SULFATE
	
         ALPHARMA US PHARMS    EQ 0.1% BASE
	                    A062471 001 Sep 27, 1983

         G AND W LABS INC      EQ 0.1% BASE
	                    A064056 001 Apr 29, 1994

         PHARMADERM            EQ 1MG BASE/GM
                   A062530 001 Jul 05, 1984
	
  INJECTABLE;INJECTION
	
    APOGEN
	
         KING PHARMS           EQ 10MG BASE/ML
                  A062289 001
	
                               EQ 40MG BASE/ML
                  A062289 002
	
   BRISTAGEN
	
        BRISTOL                EQ 40MG BASE/ML
                  A062288 001
	
   GARAMYCIN
	
        SCHERING		             EQ 1MG BASE/ML
                   A061716 002
	
                               EQ 10MG BASE/ML
                  A061739 001
	
                               EQ 40MG BASE/ML
                  A061716 001
	
   GENTAFAIR
	
        PHARMAFAIR             EQ 40MG BASE/ML
                  A062493 001 Aug 28, 1985
	
   GENTAMICIN
	
        INTL MEDICATION		      EQ 1MG BASE/ML
                   A062325 003 Jun 23, 1982
	
                               EQ 40MG BASE/ML
                  A062325 001
	
                               EQ 100MG BASE/100ML
              A062325 004 Jun 23, 1982
	
   GENTAMICIN SULFATE
	
        ABBOTT		               EQ   1.2MG BASE/ML
               A062413   001    Aug   11,   1983

                               EQ   1.4MG BASE/ML
               A062413   002    Aug   11,   1983

                               EQ   1.6MG BASE/ML
               A062413   003    Aug   11,   1983

                               EQ   1.8MG BASE/ML
               A062413   004    Aug   11,   1983

                               EQ   2MG BASE/ML
                 A062413   005    Aug   11,   1983

                               EQ   60MG BASE/100ML
             A062413   006    Aug   11,   1983

                               EQ   70MG BASE/100ML
	            A062413   007    Aug   11,   1983
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                              6-151(of 337)


GENTAMICIN SULFATE
	
  INJECTABLE;INJECTION
	
    GENTAMICIN SULFATE
	
                               EQ 80MG BASE/100ML                      A062413   008     Aug   11,   1983

                               EQ 90MG BASE/100ML                      A062413   009     Aug   11,   1983

                               EQ 100MG BASE/100ML                     A062413   010     Aug   11,   1983

        FRESENIUS KABI USA     EQ 10MG BASE/ML                         A062356   001     Mar   04,   1982
	
                               EQ 40MG BASE/ML                         A062356   002     Mar   04,   1982
	
        HIKMA MAPLE            EQ 10MG BASE/ML                         A062251   002
	
                               EQ 40MG BASE/ML                         A062251   001
	
        KALAPHARM              EQ 40MG BASE/ML                         A062354   001     Apr   05,   1982

        PHARM SPEC             EQ 40MG BASE/ML                         A062340   001     Mar   28,   1983
	
        SOLOPAK                EQ 10MG BASE/ML                         A062507   001     Jun   06,   1985
	
                               EQ 40MG BASE/ML                         A062507   002     Jun   06,   1985
	
        TEVA PARENTERAL        EQ 10MG BASE/ML                         A063149   001     Nov   21,   1991
	
                               EQ 40MG BASE/ML                         A063106   002     Nov   21,   1991
	
        WATSON LABS            EQ 10MG BASE/ML                         A062318   002
	
                               EQ 40MG BASE/ML                         A062318   001
	
        WYETH AYERST           EQ 10MG BASE/ML                         A062264   001
	
                               EQ 40MG BASE/ML                         A062264   002
	
   GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
        HOSPIRA		              EQ 1.2MG BASE/ML                        A062588   001     Jan   06,   1986
	
                               EQ 1.4MG BASE/ML                        A062588   002     Jan   06,   1986
	
                               EQ 1.6MG BASE/ML                        A062588   003     Jan   06,   1986
	
                               EQ 1.8MG BASE/ML                        A062588   004     Jan   06,   1986
	
                               EQ 2MG BASE/ML                          A062588   005     Jan   06,   1986
	
                               EQ 60MG BASE/100ML                      A062588   006     Jan   06,   1986
	
                               EQ 70MG BASE/100ML                      A062588   007     Jan   06,   1986
	
                               EQ 80MG BASE/100ML                      A062588   008     Jan   06,   1986
	
                               EQ 90MG BASE/100ML                      A062588   009     Jan   06,   1986
	
                               EQ 100MG BASE/100ML                     A062588   010     Jan   06,   1986
	
   U-GENCIN
	
        PHARMACIA AND UPJOHN   EQ 10MG BASE/ML                         A062248 001
	
                               EQ 40MG BASE/ML                         A062248 002
	
 INJECTABLE;INTRATHECAL
	
   GARAMYCIN
	
        SCHERING               EQ 2MG BASE/ML                          N050505 001
	
 OINTMENT;OPHTHALMIC
	
   GARAMYCIN
	
        SCHERING               EQ 0.3% BASE                            N050425 001
	
   GENTACIDIN
	
        NOVARTIS               EQ 0.3% BASE                            A062501 001 Jul 26, 1984
	
   GENTAFAIR
	
        PHARMAFAIR             EQ 3MG BASE/GM                          A062443 001 May 26, 1983

 OINTMENT;TOPICAL
	
   GARAMYCIN
	
        SCHERING               EQ 0.1% BASE                            A060463 001
	
   GENTAFAIR
	
        PHARMAFAIR             EQ 0.1% BASE                            A062444 001 May 26, 1983

   GENTAMICIN SULFATE
	
        ALPHARMA US PHARMS     EQ 0.1% BASE                            A062496 001 Mar 14, 1984
	
        G AND W LABS INC       EQ 0.1% BASE                            A064054 001 Apr 29, 1994

        PHARMADERM             EQ 0.1% BASE                            A062534 001 Oct 10, 1984
	
 SOLUTION/DROPS;OPHTHALMIC

   GARAMYCIN
	
        SCHERING               EQ 0.3% BASE                            N050039 002
	
   GENTACIDIN
	
        NOVARTIS               EQ 0.3% BASE                            A062480 001 Mar 30, 1984
	
   GENTAFAIR
	
        PHARMAFAIR             EQ 0.3% BASE                            A062440 001 May 03, 1983

   GENTAMICIN SULFATE
	
        ALCON PHARMS LTD       EQ 0.3% BASE                            A062523 001 Nov 25, 1985
	
        PACO                   EQ 3MG BASE/ML                          A062932 001 Nov 07, 1988
	
GENTIAN VIOLET
	
  SUPPOSITORY;VAGINAL
	
    GVS
	
          SAVAGE LABS          0.4%                                    A083513 001
	
  TAMPON;VAGINAL
	
    GENAPAX
	
          KEY PHARMS           5MG                                     A085017 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                     6-152(of 337)


GLATIRAMER ACETATE
	
  FOR SOLUTION;SUBCUTANEOUS
	
    COPAXONE
	
         TEVA PHARMS USA         20MG/VIAL                       N020622 001 Dec 20, 1996
	
GLIMEPIRIDE
	
  TABLET;ORAL
	
    GLIMEPIRIDE
	
         COREPHARMA		            1MG                             A077274   001    Oct   06,   2005
	
                                 2MG                             A077274   002    Oct   06,   2005
	
                                 4MG                             A077274   003    Oct   06,   2005
	
         MYLAN		                 1MG                             A077486   001    Feb   10,   2006
	
                                 2MG                             A077486   002    Feb   10,   2006
	
                                 4MG                             A077486   003    Feb   10,   2006
	
         RANBAXY		               3MG                             A077366   001    Oct   06,   2005
	
                                 6MG                             A077366   002    Oct   06,   2005
	
         RANBAXY LABS LTD		      1MG                             A076875   001    Oct   06,   2005
	
                                 2MG                             A076875   002    Oct   06,   2005
	
                                 4MG                             A076875   003    Oct   06,   2005
	
                                 8MG                             A076875   004    Oct   06,   2005
	
         WATSON LABS		           1MG                             A077280   001    Feb   03,   2006
	
                                 2MG                             A077280   002    Feb   03,   2006
	
                                 4MG                             A077280   003    Feb   03,   2006
	
GLIPIZIDE
	
  TABLET;ORAL
	
    GLIPIZIDE
	
         BARR LABS INC           5MG                             A074619   001    Apr   04,   1997

                                 10MG                            A074619   002    Apr   04,   1997

         SANDOZ                  5MG                             A074542   001    Jun   20,   1995
	
                                 10MG                            A074542   002    Jun   20,   1995
	
         TEVA                    5MG                             A074387   001    Mar   04,   1996
	
                                 10MG                            A074387   002    Mar   04,   1996
	
         VINTAGE PHARMS LLC      5MG                             A074378   001    Nov   28,   1994
	
                                 10MG                            A074378   002    Nov   28,   1994
	
         WATSON LABS             5MG                             A074370   001    Nov   22,   1994
	
                                 10MG                            A074370   002    Nov   22,   1994
	
    GLUCOTROL
	
         PFIZER                  2.5MG                           N017783 003 May 11, 1993
	
GLIPIZIDE; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    METAGLIP
	
         BRISTOL MYERS SQUIBB		 2.5MG;250MG                      N021460 001 Oct 21, 2002
	
                                2.5MG;500MG                      N021460 002 Oct 21, 2002
	
                                5MG;500MG                        N021460 003 Oct 21, 2002
	
GLUCAGON HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    GLUCAGON
	
         LILLY                   EQ 1MG BASE/VIAL                N012122 001
	
                                 EQ 10MG BASE/VIAL               N012122 002
	
GLUTETHIMIDE
	
  CAPSULE;ORAL
	
    DORIDEN
	
         SANOFI AVENTIS US       500MG                           N009519 008
	
  TABLET;ORAL
	
    DORIDEN
	
         SANOFI AVENTIS US       250MG                           N009519 002
	
                                 500MG                           N009519 005
	
    GLUTETHIMIDE
	
         HALSEY                  250MG                           A089458   001 Oct 10, 1986
	
                                 500MG                           A089459   001 Oct 10, 1986
	
         LANNETT                 250MG                           A083475   001
	
                                 500MG                           A085571   001
	
         SANDOZ                  500MG                           A083234   002
	
         UCB INC                 500MG                           A085171   001
	
         VITARINE                500MG                           A087297   001
	
         WATSON LABS             500MG                           A084362   001
	
                                 500MG		                         A085763   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                    6-153(of 337)


GLYBURIDE
	
  TABLET;ORAL
	
    GLYBURIDE
	
         ACTAVIS ELIZABETH		     1.5MG                          A075947 001 Nov 14, 2002
	
                                 3MG                            A075947 002 Nov 14, 2002
	
                                 6MG                            A075947 003 Nov 14, 2002
	
   GLYBURIDE (MICRONIZED)

        SANDOZ                   1.5MG                          A075174   001     Jun   22,   1998
	
                                 3MG                            A075174   002     Jun   22,   1998
	
         SANOFI AVENTIS US		     1.5MG                          N020055   001     Apr   17,   1992

                                 3MG                            N020055   002     Apr   17,   1992

                                 6MG                            N020055   003     Mar   08,   2000
	
   GLYNASE
	
        PHARMACIA AND UPJOHN     4.5MG                          N020051 003 Sep 24, 1993

   MICRONASE
	
        PHARMACIA AND UPJOHN		   1.25MG                         N017498 001 May 01, 1984

                                 2.5MG                          N017498 002 May 01, 1984

                                 5MG                            N017498 003 May 01, 1984
	
GLYBURIDE; METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    GLYBURIDE AND METFORMIN HYDROCHLORIDE
	
         TEVA		                 1.25MG;250MG                    A076821 001 Jan 27, 2005
	
                                2.5MG;500MG                     A076821 002 Jan 27, 2005
	
                                5MG;500MG                       A076821 003 Jan 27, 2005
	
GLYCINE
	
  SOLUTION;IRRIGATION
	
    GLYCINE 1.5% IN PLASTIC CONTAINER
	
          BAXTER HLTHCARE       1.5GM/100ML                     N018522 001 Feb 19, 1982
	
          HOSPIRA               1.5GM/100ML                     N017633 001
	
GLYCOPYRROLATE
	
  INJECTABLE;INJECTION
	
    GLYCOPYRROLATE
	
         ABRAXIS PHARM           0.2MG/ML                       A088475   001     Jun   12,   1984
	
         HOSPIRA                 0.2MG/ML                       A089393   001     Jun   15,   1988
	
         TEVA PARENTERAL         0.2MG/ML                       A081169   001     Sep   10,   1991

         WATSON LABS             0.2MG/ML                       A086947   001     Jun   24,   1983
	
    ROBINUL
	
         ROBINS AH               0.2MG/ML                       N014764 001
	
  TABLET;ORAL
	
    GLYCOPYRROLATE
	
         COREPHARMA              1MG                            A040568   001     Dec   22,   2004
	
                                 2MG                            A040568   002     Dec   22,   2004
	
         HIKMA PHARMS LLC        1MG                            A040836   001     Mar   05,   2009
	
                                 2MG                            A040836   002     Mar   05,   2009
	
         WATSON LABS		           1MG                            A085562   001
	
                                 1MG                            A086902   001
	
                                 2MG                            A085563   001
	
                                 2MG                            A086178   001
	
                                 2MG                            A086900   001
	
GONADORELIN ACETATE
	
  INJECTABLE;INJECTION
	
    LUTREPULSE KIT
	
         FERRING                 0.8MG/VIAL                     N019687 001 Oct 10, 1989
	
                                 3.2MG/VIAL                     N019687 002 Oct 10, 1989
	
GONADORELIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    FACTREL
	
         HIKMA (MAPLE)		         EQ 0.1MG BASE/VIAL             N018123 001 Sep 30, 1982

                                 EQ 0.2MG BASE/VIAL             N018123 002 Sep 30, 1982

                                 EQ 0.5MG BASE/VIAL             N018123 003 Sep 30, 1982
	
GONADOTROPIN, CHORIONIC
	
  INJECTABLE;INJECTION
	
    A.P.L.
	
         FERRING		               5,000 UNITS/VIAL               N017055 001
	
                                 10,000 UNITS/VIAL              N017055 002
	
                                 20,000 UNITS/VIAL              N017055 003
	
   CHORIONIC GONADOTROPIN
	
        BEL MAR                  5,000 UNITS/VIAL               N017054 001
	
                                 10,000 UNITS/VIAL              N017054 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                             6-154(of 337)


GONADOTROPIN, CHORIONIC
	
  INJECTABLE;INJECTION
	
    CHORIONIC GONADOTROPIN
	
         FERRING
	                2,000 UNITS/VIAL
                       N017016   009
	 Dec 27, 1984
	
                                  2,000 UNITS/VIAL
                       N017016   011
	 Feb 16, 1990
	
                                  5,000 UNITS/VIAL
                       N017016   006
	
                                  15,000 UNITS/VIAL
                      N017016   010
	 Feb 15, 1985
	
                                  20,000 UNITS/VIAL
                      N017016   004
	
         FRESENIUS KABI USA
	     5,000 UNITS/VIAL
                       N017067   001
	
                                  15,000 UNITS/VIAL
                      N017067   004
	
                                  20,000 UNITS/VIAL
	                     N017067   003
	
   FOLLUTEIN
	
        BRISTOL MYERS SQUIBB		    10,000 UNITS/VIAL
	                     N017056 001
	
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  SOLUTION/DROPS;OPHTHALMIC

    NEO-POLYCIN
	
         DOW PHARM              0.025MG/ML;EQ 1.75MG BASE/ML;10,000
      A060427 001
	
                                UNITS/ML

    NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
	
         IPHARM                 0.025MG/ML;EQ 1.75MG BASE/ML;10,000
      A062818 001
	 Oct 11, 1988
	
                                UNITS/ML

         WATSON LABS            0.025MG/ML;EQ 1.75MG BASE/ML;10,000
      A062788 001
	 Jun 11, 1987
	
                                UNITS/ML

    NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN
	
         PHARMAFAIR             0.025MG/ML;EQ 1.75MG BASE/ML;10,000
      A062383 001
	 Aug 31, 1982
	
                                UNITS/ML
	
GRANISETRON HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    GRANISETRON HYDROCHLORIDE
	
         APOTEX INC		          EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
       A078197   001
	   Dec   31,   2007
	
                               EQ 1MG BASE/ML (EQ 1MG BASE/ML)
           A078198   001
	   Jun   30,   2008
	
                               EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
          A078198   002
	   Jun   30,   2008
	
        SANDOZ                 EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
       A078808   001
	   Apr   29,   2008
	
   GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
	
        TEVA PHARMS USA
	      EQ 1MG BASE/ML (EQ 1MG BASE/ML)
	          A077165 001
	 Dec 31, 2007
	
   KYTRIL
	
        ROCHE
	                EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
       N020239 003
	 Sep 17, 2004
	
                               **Federal Register determination that

                               product was not discontinued or

                               withdrawn for safety or efficacy

                               reasons**
	
                               EQ 1MG BASE/ML (EQ 1MG BASE/ML)
           N020239 004
	 Mar 11, 1994
	
                               **Federal Register determination that

                               product was not discontinued or

                               withdrawn for safety or efficacy

                               reasons**
	
                               EQ 3MG BASE/ML **Federal Register
         N020239 001
	 Dec 29, 1993
	
                               determination that product was not

                               discontinued or withdrawn for safety or

                               efficacy reasons**

                               EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
          N020239 002
	 Mar 11, 1994
	
                               **Federal Register determination that

                               product was not discontinued or

                               withdrawn for safety or efficacy

                               reasons**
	
 SOLUTION;ORAL
	
   GRANISOL
	
        PEDIATRX
	             EQ 2MG BASE/10ML
	                         A078334 001
	 Feb 28, 2008
	
   KYTRIL
	
        ROCHE
	                EQ 2MG BASE/10ML
	                         N021238 001
	 Jun 27, 2001
	
 TABLET;ORAL
	
   GRANISETRON HYDROCHLORIDE
	
        BARR
	                 EQ 1MG BASE
	                              A078221 001
	 Dec 31, 2007
	
   KYTRIL
	
        ROCHE
	                EQ 1MG BASE
	                              N020305 001
	 Mar 16, 1995
	
                               EQ 2MG BASE
	                              N020305 002
	 Jun 15, 1998
	
GREPAFLOXACIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    RAXAR
	
         OTSUKA
	                 EQ 200MG BASE
	                         N020695 001
	 Nov 06, 1997
	
                                  EQ 400MG BASE
	                         N020695 002
	 May 14, 1998

                                  EQ 600MG BASE
	                         N020695 003
	 May 14, 1998
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                 6-155(of 337)


GRISEOFULVIN, MICROCRYSTALLINE
	
  CAPSULE;ORAL
	
    GRISACTIN
	
         WYETH AYERST            125MG                                    N050051 002
	
                                 250MG                                    N050051 001
	
  SUSPENSION;ORAL
	
    GRIFULVIN V
	
         JOHNSON AND JOHNSON     125MG/5ML                                N050448 001
	
  TABLET;ORAL
	
    FULVICIN-U/F

         ELORAC                  250MG                                    A060569 002
	
                                 500MG                                    A060569 001
	
    GRIFULVIN V
	
         J AND J		               125MG                                    A060618   001
	
                                 250MG                                    A060618   002
	
                                 500MG                                    A060618   003
	
         VALEANT LUXEMBOURG		    125MG                                    A062279   001
	
                                 250MG **Federal Register determination   A062279   002
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
    GRISACTIN
	
         WYETH AYERST            500MG                                    A060212 001
	
GRISEOFULVIN, MICROSIZE
	
  SUSPENSION;ORAL
	
    GRIFULVIN V
	
         VALEANT LUXEMBOURG     125MG/5ML                                 A062483 001 Jan 26, 1984
	
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
	
  TABLET;ORAL
	
    FULVICIN P/G
         ELORAC                 125MG                                     A061996 001
                                250MG                                     A061996 002
    FULVICIN P/G 165
         ELORAC                 165MG                                     A061996 003 Apr 06, 1982
    FULVICIN P/G 330
         ELORAC                 330MG                                     A061996 004 Apr 06, 1982
    GRISACTIN ULTRA
         WYETH AYERST           125MG                                     A062178   001
                                165MG                                     A062438   001 Nov 17, 1983
                                250MG                                     A062178   002
                                330MG                                     A062438   002 Nov 17, 1983
    ULTRAGRIS-165
         PLIVA                  165MG                                     A062645 001 Jun 30, 1992
    ULTRAGRIS-330
         PLIVA                  330MG                                     A062646 001 Jun 30, 1992
GUANABENZ ACETATE
  TABLET;ORAL
    GUANABENZ ACETATE
         ANI PHARMS INC         EQ   4MG   BASE                           A074267   001     Jun   01,   1994
                                EQ   8MG   BASE                           A074267   002     Jun   01,   1994
        SANDOZ                  EQ   4MG   BASE                           A074517   001     Sep   30,   1998
                                EQ   8MG   BASE                           A074517   002     Sep   30,   1998
        WATSON LABS             EQ   4MG   BASE                           A074025   001     Feb   28,   1994
                                EQ   8MG   BASE                           A074025   002     Feb   28,   1994
   WYTENSIN
        WYETH AYERST            EQ 4MG BASE                               N018587 001 Sep 07, 1982
                                EQ 8MG BASE                               N018587 002 Sep 07, 1982
                                EQ 16MG BASE                              N018587 003 Sep 07, 1982
GUANADREL SULFATE
  TABLET;ORAL
    HYLOREL
         PHARMACIA AND UPJOHN   10MG                                      N018104 001 Dec 29, 1982
                                25MG                                      N018104 002 Dec 29, 1982
GUANETHIDINE MONOSULFATE
  TABLET;ORAL
    GUANETHIDINE MONOSULFATE
         WATSON LABS            EQ 10MG SULFATE                           A086113 001 Mar 26, 1985
                                EQ 25MG SULFATE                           A086114 001 Mar 26, 1985
   ISMELIN
        NOVARTIS                EQ 10MG SULFATE                           N012329 001
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-156(of 337)


GUANETHIDINE MONOSULFATE
	
  TABLET;ORAL
	
    ISMELIN
	
                                 EQ 25MG SULFATE                N012329 002
	
GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    ESIMIL
         NOVARTIS               10MG;25MG                       N013553 001
GUANFACINE HYDROCHLORIDE
  TABLET;ORAL
    GUANFACINE HYDROCHLORIDE
         WATSON LABS             EQ 1MG BASE                    A074762 001 Jun 25, 1997
                                 EQ 2MG BASE                    A074762 002 Jun 25, 1997
   TENEX
        PROMIUS PHARMA           EQ 3MG BASE                    N019032 003 Nov 07, 1988
HALAZEPAM
  TABLET;ORAL
    PAXIPAM
         SCHERING                20MG                           N017736 003
                                 40MG                           N017736 004
HALCINONIDE
  CREAM;TOPICAL
    HALOG
          WESTWOOD SQUIBB        0.025%                         N017818 001
    HALOG-E
          RANBAXY                0.1%                           N018234 001
  OINTMENT;TOPICAL
    HALOG
          BRISTOL MYERS SQUIBB   0.025%                         N018125 001
  SOLUTION;TOPICAL
    HALOG
          RANBAXY                0.1%                           N017823 001
HALOBETASOL PROPIONATE
  OINTMENT;TOPICAL
    HALOBETASOL PROPIONATE
         FOUGERA PHARMS          0.05%                          A076903 001 Dec 16, 2004
         G AND W LABS INC        0.05%                          A077109 001 Jun 14, 2005
HALOFANTRINE HYDROCHLORIDE
  TABLET;ORAL
    HALFAN
         GLAXOSMITHKLINE         250MG                          N020250 001 Jul 24, 1992
HALOPERIDOL
  TABLET;ORAL
    HALDOL
         ORTHO MCNEIL            0.5MG                          N015921   001
                                 1MG                            N015921   002
                                 2MG                            N015921   003
                                 5MG                            N015921   004
                                 10MG                           N015921   005
                                 20MG                           N015921   006 Feb 02, 1982
   HALDOL SOLUTAB
        ORTHO MCNEIL PHARM       1MG                            N017079 001
   HALOPERIDOL
        DURAMED PHARMS BARR      0.5MG                          A071216   001    Dec   04,   1986
                                 1MG                            A071217   001    Dec   04,   1986
                                 2MG                            A071218   001    Dec   04,   1986
                                 5MG                            A071219   001    Dec   04,   1986
                                 10MG                           A071220   001    Jul   07,   1987
                                 20MG                           A071221   001    Jul   07,   1987
         LEDERLE                 0.5MG                          A072727   001    Sep   19,   1989
                                 1MG                            A072728   001    Sep   19,   1989
                                 2MG                            A072729   001    Sep   19,   1989
                                 5MG                            A072730   001    Sep   19,   1989
                                 10MG                           A072731   001    Sep   19,   1989
                                 20MG                           A072732   001    Sep   19,   1989
         MUTUAL PHARM            0.5MG                          A071156   001    Jan   02,   1987
                                 1MG                            A071157   001    Jan   02,   1987
                                 2MG                            A071172   001    Jan   02,   1987
                                 5MG                            A071212   001    Jan   07,   1988
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                   6-157(of 337)


HALOPERIDOL
	
  TABLET;ORAL
	
    HALOPERIDOL
	
                                 10MG
	                          A071173   001    Jan   07,   1988
	
                                 20MG
	                          A071177   001    Jan   07,   1988
	
         PAR PHARM
	             20MG
	                          A071328   001    Jul   20,   1987
	
         PUREPAC PHARM
	         0.5MG
	                         A071071   001    Nov   03,   1986
	
                                 1MG
	                           A071072   001    Nov   03,   1986
	
                                 2MG
	                           A071073   001    Nov   03,   1986
	
                                 5MG
	                           A071074   001    Nov   03,   1986
	
                                 10MG
	                          A071075   001    Aug   04,   1987

                                 20MG
	                          A071076   001    Aug   04,   1987

         QUANTUM PHARMICS
	      0.5MG
	                         A071255   001    Feb   17,   1987
	
                                 1MG
	                           A071269   001    Feb   17,   1987
	
                                 2MG
	                           A071256   001    Feb   17,   1987
	
                                 5MG
	                           A071257   001    Feb   17,   1987
	
         ROXANE
	                0.5MG
	                         A071128   001    Feb   17,   1987
	
                                 1MG
	                           A071129   001    Feb   17,   1987
	
                                 2MG
	                           A071130   001    Feb   17,   1987
	
                                 5MG
	                           A071131   001    Feb   17,   1987
	
                                 10MG
	                          A071132   001    May   12,   1987

                                 20MG
	                          A071133   001    May   12,   1987

         ROYCE LABS
	            0.5MG
	                         A071722   001    Dec   24,   1987
	
                                 1MG
	                           A071723   001    Dec   24,   1987
	
                                 2MG
	                           A071724   001    Dec   24,   1987
	
                                 5MG
	                           A071725   001    Dec   24,   1987
	
                                 10MG
	                          A072121   001    Dec   24,   1987
	
                                 20MG
	                          A072122   001    Dec   24,   1987
	
         SCS
	                   0.5MG
	                         A070720   001    Jun   10,   1986
	
                                 1MG
	                           A070721   001    Jun   10,   1986
	
                                 2MG
	                           A070722   001    Jun   10,   1986
	
                                 5MG
	                           A070723   001    Jun   10,   1986
	
                                 10MG
	                          A070724   001    Jun   10,   1986
	
                                 20MG
	                          A070725   001    Sep   24,   1986

         VINTAGE
	               0.5MG
	                         A071233   001    Nov   03,   1986
	
                                 1MG
	                           A071234   001    Nov   03,   1986
	
                                 2MG
	                           A071235   001    Nov   03,   1986
	
                                 5MG
	                           A071236   001    Nov   03,   1986
	
                                 10MG
	                          A071237   001    Jul   20,   1987
	
         WATSON LABS
	           0.5MG
	                         A070981   001    Mar   06,   1987
	
                                 0.5MG
	                         A071571   001    Jun   03,   1988
	
                                 1MG
	                           A070982   001    Mar   06,   1987
	
                                 1MG
	                           A071572   001    Jun   03,   1988
	
                                 2MG
	                           A070983   001    Mar   06,   1987
	
                                 2MG
	                           A071573   001    Jun   03,   1988
	
                                 5MG
	                           A070984   001    Mar   06,   1987
	
                                 5MG
	                           A071374   001    Jun   03,   1988
	
                                 10MG
	                          A071375   001    Jun   03,   1988
	
                                 10MG
	                          A072113   001    Aug   27,   1991

                                 20MG
	                          A071376   001    Jun   03,   1988
	
                                 20MG
	                          A072353   001    Aug   27,   1991
	
HALOPERIDOL DECANOATE
	
  INJECTABLE;INJECTION
	
    HALOPERIDOL DECANOATE
	
         HOSPIRA
	               EQ   50MG BASE/ML
              A075176   001    Feb   09,   2000
	
                                 EQ   100MG BASE/ML
             A075176   002    Feb   09,   2000
	
         SANDOZ
	                EQ   50MG BASE/ML
              A076463   001    Jun   24,   2005
	
                                 EQ   100MG BASE/ML
	            A076463   002    Jun   24,   2005
	
HALOPERIDOL LACTATE
	
  CONCENTRATE;ORAL
	
    HALDOL
	
         ORTHO MCNEIL
	          EQ 2MG BASE/ML
	                N015922 001
	
    HALOPERIDOL
	
         ALPHARMA
	              EQ   2MG   BASE/ML
             A070318   001    Apr   11,   1986

         MORTON GROVE
	          EQ   2MG   BASE/ML
             A070710   001    Mar   07,   1986
	
         SCS
	                   EQ   2MG   BASE/ML
             A070726   001    Jun   10,   1986
	
         TEVA
	                  EQ   2MG   BASE/ML
	            A071015   001    Aug   25,   1987
	
    HALOPERIDOL INTENSOL
	
         ROXANE
	                EQ 2MG BASE/ML
	                A072045 001 Apr 12, 1988
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                    6-158(of 337)


HALOPERIDOL LACTATE
	
  INJECTABLE;INJECTION
	
    HALOPERIDOL
	
         ABRAXIS PHARM            EQ     5MG   BASE/ML
          A071187   001     Jan   20,   1987
	
         APOTEX INC               EQ     5MG   BASE/ML
          A076791   001     Aug   25,   2004

                                  EQ     5MG   BASE/ML
          A076828   001     Aug   25,   2004

         MARSAM PHARMS LLC        EQ     5MG   BASE/ML
          A072516   001     Feb   25,   1993
	
                                  EQ     5MG   BASE/ML
          A072517   001     Feb   25,   1993
	
         SANDOZ                   EQ     5MG   BASE/ML
          A076464   001     Sep   29,   2004

         SMITH AND NEPHEW         EQ     5MG   BASE/ML
          A070802   001     Dec   14,   1987
	
         SOLOPAK                  EQ     5MG   BASE/ML
          A070800   001     Dec   14,   1987
	
                                  EQ     5MG   BASE/ML
          A070801   001     Dec   14,   1987
	
                                  EQ     5MG   BASE/ML
          A070864   001     Dec   14,   1987
	
         WATSON LABS              EQ     5MG   BASE/ML
          A070713   001     May   17,   1988

                                  EQ     5MG   BASE/ML
          A070714   001     May   17,   1988

                                  EQ     5MG   BASE/ML
          A070744   001     May   17,   1988
	
 SOLUTION;ORAL
	
   HALOPERIDOL LACTATE
	
        ACTAVIS MID ATLANTIC      EQ 1MG BASE/ML
	               A074536 001 Nov 02, 1995
	
HALOPROGIN
	
  CREAM;TOPICAL
	
    HALOTEX
	
         WESTWOOD SQUIBB          1%
	                           N016942 001
	
  SOLUTION;TOPICAL
	
    HALOTEX
	
         WESTWOOD SQUIBB          1%
	                           N016943 001
	
HALOTHANE
	
  LIQUID;INHALATION
	
    FLUOTHANE
	
         WYETH AYERST             99.99%
	                       N011338 001
	
    HALOTHANE
	
         BH                       99.99%
	                       A084977 001
	
         HALOCARBON               99.99%
	                       A080810 001
	
         HOSPIRA                  99.99%
	                       A083254 001
	
HEPARIN CALCIUM
	
  INJECTABLE;INJECTION
	
    CALCIPARINE
	
         SANOFI AVENTIS US        25,000 UNITS/ML
	              N018237 001
	
HEPARIN SODIUM
	
  INJECTABLE;INJECTION
	
    HEPARIN LOCK FLUSH
	
         HOSPIRA                  100 UNITS/ML
                  N005264   010
	
         INTL MEDICATION          10 UNITS/ML
                   A086357   001
	
                                  500 UNITS/ML
                  A086357   002
	
         LUITPOLD                 10 UNITS/ML
                   A089063   001     Oct 09, 1985
	
                                  100 UNITS/ML
                  A089064   001     Oct 09, 1985
	
         PARKE DAVIS              10 UNITS/ML
                   N017346   006
	
         SMITH AND NEPHEW         10 UNITS/ML
                   A087904   001     Apr   20,   1983

                                  10 UNITS/ML
                   A087958   001     Apr   20,   1983

                                  10 UNITS/ML
                   A088458   001     Jul   26,   1984
	
                                  10 UNITS/ML
                   A088580   001     Oct   25,   1984
	
                                  100 UNITS/ML
                  A087906   001     Apr   20,   1983

                                  100 UNITS/ML
                  A087959   001     Apr   20,   1983

                                  100 UNITS/ML
                  A088460   001     Jul   26,   1984
	
                                  100 UNITS/ML
                  A088581   001     Oct   25,   1984
	
         SOLOPAK		                10 UNITS/ML
                   A087903   001     Apr   20,   1983

                                  10 UNITS/ML
                   A088457   001     Oct   25,   1984
	
                                  100 UNITS/ML
                  A087905   001     Apr   20,   1983

                                  100 UNITS/ML
                  A088459   001     Jul   26,   1984
	
   HEPARIN SODIUM
	
        ABRAXIS PHARM		           1,000 UNITS/ML
                N017033   001
	
                                  1,000 UNITS/ML
                N017979   001
	
                                  5,000 UNITS/ML
                N017979   003
	
                                  10,000 UNITS/ML
               N017979   002
	
         AKORN		                  1,000 UNITS/ML
                N017486   001
	
                                  5,000 UNITS/ML
                N017486   002
	
                                  10,000 UNITS/ML
               N017486   003
	
                                  20,000 UNITS/ML
               N017486   004
	
                                  40,000 UNITS/ML
               N017486   005
	
         BAXTER HLTHCARE CORP		   1,000 UNITS/ML
	               N017007   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                              6-159(of 337)


HEPARIN SODIUM
	
  INJECTABLE;INJECTION
	
    HEPARIN SODIUM
	
                               2,500 UNITS/ML                            N017007   007
	
                               5,000 UNITS/ML                            N017007   002
	
                               5,000 UNITS/0.5ML                         N017007   010
	
                               7,500 UNITS/ML                            N017007   003
	
                               10,000 UNITS/ML                           N017007   004
	
                               15,000 UNITS/ML                           N017007   005
	
                               20,000 UNITS/ML                           N017007   006
	
        CHAMBERLIN PARENTERL   1,000 UNITS/ML                            N017130   001
	
                               5,000 UNITS/ML                            N017130   002
	
                               10,000 UNITS/ML                           N017130   003
	
                               20,000 UNITS/ML                           N017130   004
	
        DELL LABS              1,000 UNITS/ML                            N017540   001
	
                               5,000 UNITS/ML                            N017540   002
	
                               10,000 UNITS/ML                           N017540   003
	
                               20,000 UNITS/ML                           N017540   004
	
                               40,000 UNITS/ML                           N017540   005
	
        FRESENIUS KABI USA     1,000 UNITS/ML                            N017651   005
	
                               5,000 UNITS/ML                            N017029   002
	
                               10,000 UNITS/ML                           N017651   003
	
                               20,000 UNITS/ML                           N017651   008
	
        HIKMA MAPLE            5,000 UNITS/0.5ML                         N017037   013     Apr 07, 1986

        HOSPIRA                2,500 UNITS/ML                            A088099   001     Apr 28, 1983

                               10,000 UNITS/ML                           A040095   001     Jul 26, 1996
	
        LILLY                  1,000 UNITS/ML                            N005521   001
	
                               10,000 UNITS/ML                           N005521   002
	
                               20,000 UNITS/ML                           N005521   004
	
        LUITPOLD               1,000 UNITS/ML                            A087452   001     Oct 31, 1983
	
        ORGANON USA INC        1,000 UNITS/ML                            N000552   008
	
                               5,000 UNITS/ML                            N000552   009
	
                               10,000 UNITS/ML                           N000552   010
	
        PARKE DAVIS            1,000 UNITS/ML                            N017346   001
	
                               5,000 UNITS/ML                            N017346   002
	
                               7,500 UNITS/ML                            N017346   003
	
                               10,000 UNITS/ML                           N017346   004
	
                               20,000 UNITS/ML                           N017346   005
	
        PHARM SPEC             1,000 UNITS/ML                            N017780   001
	
                               5,000 UNITS/ML                            N017780   002
	
                               10,000 UNITS/ML                           N017780   003
	
                               20,000 UNITS/ML                           N017780   004
	
                               40,000 UNITS/ML                           N017780   005
	
        PHARMACIA AND UPJOHN   1,000 UNITS/ML                            N004570   001
	
                               5,000 UNITS/ML                            N004570   002
	
                               10,000 UNITS/ML                           N004570   003
	
        SMITH AND NEPHEW       1,000 UNITS/ML                            A088239   001     Jul 26, 1984
	
        SOLOPAK                1,000 UNITS/ML                            A087043   001
	
                               5,000 UNITS/ML                            A087077   001
	
                               5,000 UNITS/0.5ML                         A087395   001
	
                               10,000 UNITS/ML                           A087107   001
	
                               10,000 UNITS/0.5ML                        A087363   001
	
        WATSON LABS            1,000 UNITS/ML                            N017064   002
	
                               2,500 UNITS/ML                            N017064   015
	
                               3,000 UNITS/ML                            N017064   016
	
                               4,000 UNITS/ML                            N017064   017
	
                               5,000 UNITS/ML                            N017064   003
	
                               6,000 UNITS/ML                            N017064   018
	
                               7,500 UNITS/ML                            N017064   019
	
                               10,000 UNITS/ML                           N017064   004
	
                               20,000 UNITS/ML                           N017064   005
	
                               40,000 UNITS/ML                           N017064   006
	
        WATSON LABS INC        1,000 UNITS/ML                            A040007   001     Jun 07, 1996
	
                               1,000 UNITS/ML                            A040008   001     Oct 10, 1995
	
   HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        MCGAW                  200 UNITS/100ML                           N019130   001 Dec 31, 1984
	
   HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
        B BRAUN                200 UNITS/100ML                           N019042   001 Mar 29, 1985
	
   HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
	
        BAXTER HLTHCARE        2,000 UNITS/100ML                         N018814   002 Jul 09, 1985
	
   HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%
	
        HOSPIRA                10,000 UNITS/100ML                        N018911   006 Jan 30, 1985
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                                6-160(of 337)


HEPARIN SODIUM
	
  INJECTABLE;INJECTION
	
    HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%
	
         HOSPIRA                10,000 UNITS/100ML
                       N018911   001 Jan 30, 1985
	
                                10,000 UNITS/100ML
                       N018916   005 Jan 31, 1984
	
    HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%
	
         HOSPIRA                10,000 UNITS/100ML
                       N018911   003 Jan 30, 1985
	
                                10,000 UNITS/100ML
                       N018916   002 Jan 31, 1984
	
    HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%
	
         HOSPIRA                5,000 UNITS/100ML
                        N018911   007 Jan 30, 1985
	
    HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                5,000 UNITS/100ML                         N019802   001 Jul 20, 1992
	
    HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%
	
         HOSPIRA                5,000 UNITS/100ML                         N018911   005 Jan 30, 1985
	
                                5,000 UNITS/100ML                         N018916   003 Jan 31, 1984
	
    HEPARIN SODIUM 2,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         MCGAW                  200 UNITS/100ML                           N019130   003 Dec 31, 1984
	
    HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                200 UNITS/100ML
                          N019042   002 Mar 29, 1985
	
    HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        4,000 UNITS/100ML
                        N018814   001 Oct 31, 1983
	
    HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        5,000 UNITS/100ML
                        N018814   003 Jul 09, 1985
	
                                10,000 UNITS/100ML
                       N018814   004 Jul 02, 1987
	
    HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
	
         HOSPIRA                5,000 UNITS/100ML
                        N018911   009 Jan 30, 1985
	
                                10,000 UNITS/100ML
                       N018911   008 Jan 30, 1985
	
    HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5,000 UNITS/100ML
	                       N019134   001 Mar 29, 1985
	
    HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                5,000 UNITS/100ML                         N019802   005 Jul 20, 1992
	
                                10,000 UNITS/100ML                        N019802   002 Jul 20, 1992
	
    HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9%
	
         HOSPIRA                5,000 UNITS/100ML                         N018911   004 Jan 30, 1985
	
    HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                5,000 UNITS/100ML                         N019135   001 Mar 29, 1985
	
                                5,000 UNITS/100ML                         N019802   003 Jul 20, 1992
	
         HOSPIRA                5,000 UNITS/100ML                         N018916   009 Jan 31, 1984
	
    HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        500 UNITS/100ML
                          N018609   003 Apr 28, 1982
	
    HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         MCGAW                  1,000 UNITS/100ML
                        N019130   002 Dec 31, 1984
	
    HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%
	
         HOSPIRA                100 UNITS/ML
                             N018911   002 Jan 30, 1985
	
                                100 UNITS/ML
                             N018916   004 Jan 31, 1984
	
    HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%
	
         HOSPIRA                1,000 UNITS/100ML
	                       N018916   001 Jan 31, 1984
	
    HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                1,000 UNITS/100ML
                        N019042   004 Mar 29, 1985
	
    HEPARIN SODIUM PRESERVATIVE FREE
	
         HOSPIRA
	              2,000 UNITS/ML
                           N005264   013 Apr 07, 1986

                                2,500 UNITS/ML
                           N005264   014 Apr 07, 1986

         PHARMA SERVE NY
	      1,000 UNITS/ML
                           A086129   001
	
         WATSON LABS INC
	      1,000 UNITS/ML
	                          A089464   001 Jun 03, 1986
	
    LIPO-HEPIN
	
         3M
	                   1,000 UNITS/0.5ML
                        N017027   001
	
                                1,000 UNITS/ML
                           N017027   006
	
                                5,000 UNITS/0.5ML
                        N017027   002
	
                                5,000 UNITS/ML
                           N017027   008
	
                                7,500 UNITS/0.5ML
                        N017027   010
	
                                10,000 UNITS/0.5ML
                       N017027   003
	
                                10,000 UNITS/ML
                          N017027   009
	
                                15,000 UNITS/0.5ML
                       N017027   011
	
                                20,000 UNITS/0.5ML
                       N017027   004
	
                                20,000 UNITS/ML
                          N017027   007
	
                                40,000 UNITS/ML
	                         N017027   005
	
    LIQUAEMIN LOCK FLUSH
	
         ORGANON USA INC
	      100 UNITS/ML
	                            N000552   007
	
    LIQUAEMIN SODIUM
	
         ORGANON USA INC
	      1,000 UNITS/ML
                           N000552   004
	
                                5,000 UNITS/ML
                           N000552   003
	
                                10,000 UNITS/ML
	                         N000552   005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                   6-161(of 337)


HEPARIN SODIUM
	
  INJECTABLE;INJECTION
	
    LIQUAEMIN SODIUM
	
                               20,000 UNITS/ML
                 N000552 001
	
                               40,000 UNITS/ML
                 N000552 002
	
   LIQUAEMIN SODIUM PRESERVATIVE FREE
	
        ORGANON USA INC
	      1,000 UNITS/ML
                  N000552 011 Apr 11, 1986

                               5,000 UNITS/ML
                  N000552 012 Apr 11, 1986

                               10,000 UNITS/ML
	                N000552 013 Apr 11, 1986
	
   PANHEPRIN
	
        HOSPIRA
	              1,000 UNITS/ML
                  N005264   004
	
                               5,000 UNITS/ML
                  N005264   006
	
                               10,000 UNITS/ML
                 N005264   007
	
                               20,000 UNITS/ML
                 N005264   008
	
                               40,000 UNITS/ML
	                N005264   009
	
   SODIUM HEPARIN
	
        ABRAXIS PHARM
	        5,000 UNITS/ML
                  N017033   002
	
                               10,000 UNITS/ML
                 N017033   003
	
                               20,000 UNITS/ML
                 N017033   004
	
        BAXTER HLTHCARE
	      1,000 UNITS/ML
	                 N017036   001 Mar 04, 1988
	
HETACILLIN
	
  FOR SUSPENSION;ORAL
	
    VERSAPEN
	
         BRISTOL
	              EQ   112.5MG AMPICIL/ML
        A061398   001
	
                                EQ   112.5MG AMPICIL/5ML
       N050060   001
	
                                EQ   112.5MG AMPICIL/ML
        N050060   003
	
                                EQ   225MG AMPICIL/5ML
	        A061398   002
	
HETACILLIN POTASSIUM
	
  CAPSULE;ORAL
	
    VERSAPEN-K
	
         BRISTOL
	              EQ 225MG AMPICIL
	              A061396 001
	
                                EQ 450MG AMPICIL
	              A061396 002
	
HEXACHLOROPHENE
	
  AEROSOL;TOPICAL
	
    SEPTISOL
	
           VESTAL LABS
	        0.23%
	                         N017424 001
	
    TURGEX
	
           XTTRIUM
	            3%
	                            N018375 001
	
  EMULSION;TOPICAL
	
    HEXA-GERM
	
           HUNTINGTON LABS
	    3%
	                            N017411 001
	
    PHISOHEX
	
           SANOFI AVENTIS US
	  3%
	                            N008402 001
	
    SOY-DOME
	
           BAYER PHARMS
	       3%
	                            N017405 001
	
    TURGEX
	
           XTTRIUM
	            3%
	                            N019055 001 Nov 30, 1984
	
  SOAP;TOPICAL
	
    GAMOPHEN
	
           ARBROOK
	            2%
	                            N006270 003
	
  SOLUTION;TOPICAL
	
    DIAL
	
           DIAL
	               0.25%
	                         N017421 002
	
    GERMA-MEDICA
	
           HUNTINGTON LABS
	    1%
	                            N017412 001
	
    GERMA-MEDICA "MG"
	
           HUNTINGTON LABS
	    0.25%
	                         N017412 002
	
    SEPTI-SOFT
	
           CALGON
	             0.25%
	                         N017460 001
	
    SEPTISOL
	
           VESTAL LABS
	        0.25%
	                         N017423 001
	
  SPONGE;TOPICAL
	
    E-Z SCRUB
	
           BECTON DICKINSON
	   450MG
	                         N017452 001
	
    HEXASCRUB
	
           PROF DSPLS
	         3%
	                            N018363 001
	
    PHISO-SCRUB
	
           SANOFI AVENTIS US
	  3%
	                            N017446 001
	
    SCRUBTEAM SURGICAL SPONGEBRUSH
	
           3M                   330MG                           N017413 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                             6-162(of 337)


HEXAFLUORENIUM BROMIDE
	
  INJECTABLE;INJECTION
	
    MYLAXEN
	
         MEDPOINTE PHARM HLC      20MG/ML                                    N009789 003
	
HEXOCYCLIUM METHYLSULFATE
	
  TABLET;ORAL
	
    TRAL
	
           ABBVIE                 25MG                                       N010599 001
	
HEXYLCAINE HYDROCHLORIDE
	
  SOLUTION;TOPICAL
	
    CYCLAINE
	
         MERCK                    5%                                         N008472 001
	
HISTAMINE PHOSPHATE
	
  INJECTABLE;INJECTION
	
    HISTAMINE PHOSPHATE
	
         LILLY		                  EQ 0.1MG BASE/ML                           N000734 003
	
                                  EQ 0.2MG BASE/ML                           N000734 002
	
                                  EQ 1MG BASE/ML                             N000734 001
	
HISTRELIN ACETATE
	
  INJECTABLE;INJECTION
	
    SUPPRELIN
	
         SHIRE		                  EQ 0.2MG BASE/ML                           N019836 001 Dec 24, 1991
	
                                  EQ 0.5MG BASE/ML                           N019836 002 Dec 24, 1991
	
                                  EQ 1MG BASE/ML                             N019836 003 Dec 24, 1991
	
HOMATROPINE METHYLBROMIDE
	
  TABLET;ORAL
	
    HOMAPIN-10
	
         MISSION PHARMA           10MG                                       A086308 001
	
    HOMAPIN-5
	
         MISSION PHARMA           5MG                                        A086309 001
	
  TABLET, CHEWABLE;ORAL
	
    EQUIPIN
	
         MISSION PHARMA           3MG                                        A086310 001
	
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
	
  SYRUP;ORAL
	
    HYCODAN
	
         ENDO PHARMS            1.5MG/5ML;5MG/5ML                            N005213 002 Jul 26, 1988
	
    HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
	
         IVAX SUB TEVA PHARMS   1.5MG/5ML;5MG/5ML                            A040285 001 Jul 19, 1999
	
    HYDROPANE
	
         HALSEY                 1.5MG/5ML;5MG/5ML                            A088066 001 Jun 28, 1985
	
  TABLET;ORAL
	
    HOMATROPRINE METHYLBROMIDE AND HYDROCODONE BITARTRATE
	
         ACTAVIS ELIZABETH      1.5MG;5MG                                    A040295 001 Dec 01, 2000
	
    HYCODAN
	
         ENDO PHARMS            1.5MG;5MG                                    N005213 001 Jul 26, 1988
	
HYALURONIDASE
	
  INJECTABLE;INJECTION
	
    HYDASE
	
         AKORN INC                150 UNITS/ML                               N021716 001 Oct 25, 2005
	
    VITRASE
	
         BAUSCH AND LOMB          6,200 UNITS/VIAL                           N021640 001 May 05, 2004

    WYDASE
	
         BAXTER HLTHCARE          150 UNITS/ML                               N006343 002
	
                                  150 UNITS/VIAL **Federal Register          N006343 006
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

                                  1,500 UNITS/VIAL **Federal Register        N006343 005
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**
	
HYDRALAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    APRESOLINE
	
         NOVARTIS                 20MG/ML                                    N008303 003
	
    HYDRALAZINE HYDROCHLORIDE
	
         ABRAXIS PHARM            20MG/ML                                    A089532 001 Aug 11, 1987

         SMITH AND NEPHEW         20MG/ML                                    A088518 001 Apr 20, 1984
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                     6-163(of 337)


HYDRALAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    HYDRALAZINE HYDROCHLORIDE
	
         SOLOPAK
	                20MG/ML
                         A088517 001 Aug 22, 1985

         TEVA PARENTERAL
	        20MG/ML
	                        A040373 001 Feb 23, 2000
	
  TABLET;ORAL
	
    APRESOLINE
	
         NOVARTIS
	               10MG
	                           N008303   004
	
                                  25MG
	                           N008303   001
	
                                  50MG
	                           N008303   002
	
                                  100MG
	                          N008303   005
	
   DRALZINE
	
        TEVA
	                    25MG
	                           A084301 001
	
   HYDRALAZINE HYDROCHLORIDE
	
        ACTAVIS ELIZABETH
	       25MG
	                           A088560   001     Oct   04,   1984
	
                                  50MG
	                           A088649   001     Oct   18,   1984
	
         ASCOT
	                  25MG
	                           A088310   001     Dec   19,   1984
	
                                  50MG
	                           A088311   001     Dec   19,   1984
	
         HALSEY
	                 10MG
	                           A089218   001     Jan   22,   1986
	
                                  25MG
	                           A089130   001     Jan   15,   1986
	
                                  50MG
	                           A089222   001     Jan   22,   1986
	
                                  100MG
	                          A089178   001     Jan   15,   1986
	
         IMPAX LABS
	             25MG
	                           A084922   001
	
                                  50MG
	                           A084923   001
	
         IVAX SUB TEVA PHARMS
	   10MG
	                           A084443   001
	
                                  25MG
	                           A084437   001
	
                                  50MG
	                           A084469   002
	
                                  100MG
	                          A084581   001
	
         MUTUAL PHARM
	           10MG
	                           A088728   001     Apr 11, 1985

                                  10MG
	                           A089359   001     Jul 25, 1986
	
                                  25MG
	                           A084106   002
	
                                  25MG
	                           A089258   001     May 05, 1986

                                  50MG
	                           A084107   002
	
                                  50MG
	                           A089259   001     May   05,   1986

                                  100MG
	                          A088729   001     Apr   11,   1985

         PUREPAC PHARM
	          25MG
	                           A088177   001     Jul   29,   1983
	
                                  50MG
	                           A088178   001     Aug   15,   1983

         QUANTUM PHARMICS
	       10MG
	                           A088671   001     May   01,   1984

                                  25MG
	                           A088657   001     Jun   15,   1984
	
                                  50MG
	                           A088652   001     May   08,   1984

                                  100MG
	                          A088686   001     May   01,   1984

         SANDOZ
	                 10MG
	                           A083241   001
	
                                  25MG
	                           A083560   001
	
                                  50MG
	                           A083561   001
	
                                  50MG
	                           A085088   001
	
         SUPERPHARM
	             10MG
	                           A088787   001     Aug   28,   1984

                                  25MG
	                           A088788   001     Aug   28,   1984

                                  50MG
	                           A088789   001     Aug   28,   1984

         TG UNITED LABS
	         10MG
	                           A088846   001     Feb   26,   1985
	
                                  25MG
	                           A088847   001     Feb   26,   1985
	
                                  50MG
	                           A088848   001     Feb   26,   1985
	
                                  100MG
	                          A088849   001     Feb   26,   1985
	
         USL PHARMA
	             25MG
	                           A087780   001     Mar   29,   1982
	
                                  50MG
	                           A087751   001     Mar   29,   1982
	
         VANGARD
	                25MG
	                           A087712   001
	
                                  50MG
	                           A087908   001     May 07, 1982

         VITARINE
	               25MG
	                           A086088   001
	
         WATSON LABS
	            25MG
	                           A084504   001
	
                                  25MG
	                           A085532   002     May 24, 1982

                                  50MG
	                           A084503   001
	
                                  50MG
	                           A085533   002     May   25,   1982

         WEST WARD
	              25MG
	                           A088240   001     May   27,   1983

                                  50MG
	                           A088241   001     May   27,   1983

         ZYDUS PHARMS USA
	       10MG
	                           A040858   001     Feb   26,   2010
	
                                  25MG
	                           A040858   002     Feb   26,   2010
	
                                  50MG
	                           A040858   003     Feb   26,   2010
	
                                  100MG
	                          A040858   004     Feb   26,   2010
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                           6-164(of 337)


HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
	
  CAPSULE;ORAL
	
    APRESAZIDE
	
         NOVARTIS		             25MG;25MG
	                           A084735 001
	
                                50MG;50MG
	                           A084810 001
	
                                100MG;50MG
	                          A084811 001
	
    HYDRA-ZIDE
	
         PAR PHARM              100MG;50MG
	                          A088961 001 Oct 21, 1985
	
    HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
         SOLVAY		               25MG;25MG
	                           A087608   001    Feb   08,   1982
	
                                50MG;50MG
	                           A087213   001    Feb   08,   1982
	
                                100MG;50MG
	                          A087609   001    Feb   08,   1982
	
         SUPERPHARM		           25MG;25MG
	                           A089200   001    Feb   09,   1987
	
                                50MG;50MG
	                           A089201   001    Feb   09,   1987
	
         WATSON LABS		          25MG;25MG
	                           A085457   001    Mar   04,   1982
	
                                50MG;50MG
	                           A085446   001    Mar   04,   1982
	
                                100MG;50MG
	                          A085440   001    Mar   04,   1982
	
    HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50

         IVAX PHARMS            100MG;50MG
	                          A088358 001 Apr 10, 1984
	
    HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25

         IVAX PHARMS            25MG;25MG
	                           A088356 001 Apr 10, 1984
	
    HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50

         IVAX PHARMS            50MG;50MG
	                           A088357 001 Apr 10, 1984
	
  TABLET;ORAL
	
    APRESOLINE-ESIDRIX
	
         NOVARTIS               25MG;15MG
	                           N012026 002
	
    HYDRALAZINE AND HYDROCHLORTHIAZIDE
	
         WATSON LABS            25MG;15MG
	                           A085827 001
	
    HYDROCHLOROTHIAZIDE W/ HYDRALAZINE

         WATSON LABS            25MG;15MG
	                           A085373 001
	
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
	
  TABLET;ORAL
	
    CAM-AP-ES
	
         TG UNITED LABS         25MG;15MG;0.1MG
	                     A084897 001
	
    HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE
	
         IVAX SUB TEVA PHARMS   25MG;15MG;0.1MG
	                     A084291 001
	
    HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE
	
         MYLAN                  25MG;15MG;0.1MG
	                     A087085 001
	
    HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE

         WATSON LABS            25MG;15MG;0.1MG
	                     A085771 001
	
    HYDRAP-ES
	
         SANDOZ                 25MG;15MG;0.1MG
	                     A084876 001
	
    HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE

         WATSON LABS            25MG;15MG;0.1MG
	                     A083770 001
	
    HYDROSERPINE PLUS (R-H-H)

         IVAX SUB TEVA PHARMS   25MG;15MG;0.1MG
	                     A083877 001
	
    RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
         MUTUAL PHARM           25MG;15MG;0.1MG
	                     A088570   001 Apr 10, 1984

         SOLVAY                 25MG;15MG;0.1MG
	                     A088376   001 Oct 28, 1983
	
         WATSON LABS            25MG;15MG;0.1MG
	                     A085549   001
	
                                25MG;15MG;0.1MG
	                     A087556   001
	
    RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
	
         LEDERLE                25MG;15MG;0.1MG
	                     A087709 001 May 13, 1982
	
    SER-A-GEN
	
         SOLVAY                 25MG;15MG;0.1MG
	                     A087210 001
	
    SER-AP-ES
	
         NOVARTIS               25MG;15MG;0.1MG
	                     N012193 005
	
    UNIPRES
	
         SOLVAY                 25MG;15MG;0.1MG
	                     A085893 001
	
                                25MG;15MG;0.1MG
	                     A086298 001
	
HYDRALAZINE HYDROCHLORIDE; RESERPINE
	
  TABLET;ORAL
	
    DRALSERP
	
         SANDOZ                 25MG;0.1MG
	                          A084617 001
	
    SERPASIL-APRESOLINE
	
         NOVARTIS               25MG;0.1MG
	                          N009296 004
	
                                50MG;0.2MG
	                          N009296 002
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                  6-165(of 337)


HYDROCHLOROTHIAZIDE
	
  CAPSULE;ORAL
	
    HYDROCHLOROTHIAZIDE
	
         HIKMA INTL PHARMS      12.5MG
	                       A077885 001 Nov 26, 2007
	
  SOLUTION;ORAL
	
    HYDROCHLOROTHIAZIDE
	
         MORTON GROVE           50MG/5ML
                      A089661 001 Jun 20, 1988
	
         ROXANE                 50MG/5ML
                      A088587 001 Jul 02, 1984
	
    HYDROCHLOROTHIAZIDE INTENSOL
	
         ROXANE                 100MG/ML
                      A088588 001 Jul 02, 1984
	
  TABLET;ORAL
	
    ESIDRIX
	
         NOVARTIS		             25MG
	                         N011793 005
	
                                50MG
	                         N011793 008
	
                                100MG
	                        N011793 009
	
    HYDRO-D
	
         HALSEY                 25MG
	                         A086504 001
	
                                50MG
	                         A083891 002
	
    HYDROCHLOROTHIAZIDE
	
         ABC HOLDING            50MG
	                         A085672   001
	
         ACTAVIS ELIZABETH      25MG
	                         A085054   002
	
                                50MG
	                         A085208   001
	
         ALRA                   25MG
	                         A086369   001
	
                                50MG
	                         A083554   001
	
         ASCOT                  25MG
	                         A087539   001     Feb 03, 1982
	
                                50MG
	                         A087540   001     Feb 03, 1982
	
         BARR                   50MG
	                         A084771   001
	
         DAVA PHARMS INC        100MG
	                        A087060   001
	
         ELKINS SINN            50MG
	                         A085152   002
	
         HEATHER                50MG
	                         A084135   001
	
         HIKMA PHARMS LLC       25MG
	                         A084878   002     Jul 12, 2006
	
         IMPAX LABS             25MG
	                         A084029   001
	
                                50MG
	                         A083607   002
	
                                100MG
	                        A085098   001
	
         INWOOD LABS		          25MG
	                         A084776   001
	
                                25MG
	                         A085067   001
	
                                50MG
	                         A084776   002
	
         IVAX SUB TEVA PHARMS   50MG
	                         A084658   001
	
                                100MG
	                        A085022   001
	
         MAST MM                25MG
	                         A086192   001
	
                                50MG
	                         A086192   002
	
         MUTUAL PHARM		         25MG
	                         A083972   001
	
                                50MG
	                         A083972   002
	
                                100MG
	                        A083972   003
	
         MYLAN                  25MG
	                         A084880   001
	
                                50MG
	                         A085112   001
	
         PVT FORM               50MG
	                         A086597   001
	
         ROXANE                 25MG
	                         A085004   001
	
                                50MG
	                         A084536   002
	
                                50MG
	                         A085005   001
	
         SANDOZ                 25MG
	                         A083899   001
	
                                25MG
	                         A087565   001     Mar 09, 1982
	
                                50MG
	                         A084912   001
	
                                50MG
	                         A085219   001
	
         SOLVAY                 25MG                           A085323   001
	
         SUPERPHARM		           25MG
	                         A088827   001     Dec   28,   1984
	
                                50MG
	                         A088828   001     Dec   28,   1984
	
                                100MG
	                        A088829   001     Dec   28,   1984
	
         TEVA                   25MG
	                         A088924   001     Feb   07,   1985
	
                                50MG
	                         A088923   001     Feb   07,   1985
	
         TG UNITED LABS         25MG
	                         A085683   001
	
                                50MG
	                         A083965   001
	
         USL PHARMA             25MG
	                         A087827   001     Apr 19, 1982

                                50MG
	                         A087752   001     Apr 19, 1982

         VANGARD                25MG
	                         A087638   001
	
                                50MG
	                         A087610   001
	
         WARNER CHILCOTT        25MG
	                         A087586   001     May 03, 1982

                                50MG
	                         A087587   001     May 03, 1982

         WATSON LABS            25MG
	                         A081189   001     Jan 24, 1992
	
                                25MG
	                         A083458   001
	
                                25MG
	                         A085232   002
	
                                50MG
	                         A083232   001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                              6-166(of 337)


HYDROCHLOROTHIAZIDE
	
  TABLET;ORAL
	
    HYDROCHLOROTHIAZIDE
	
                                  50MG
	                                    A083456   001
	
                                  50MG
	                                    A085233   001
	
                                  50MG
	                                    A086087   001
	
                                  50MG
	                                    A086594   001
	
                                  100MG
	                                   A081190   001
	 Jan 24, 1992
	
                                  100MG
	                                   A085099   001
	
                                  100MG
	                                   A087002   001
	
         WEST WARD
	              25MG
	                                    A084899   001
	
         WHITEWORTH TOWN PLSN
	   25MG
	                                    A083809   002
	
                                  50MG
	                                    A083809   001
	
                                  100MG
	                                   A085347   001
	
   HYDRODIURIL
	
        MERCK
	                   25MG
	                                    N011835 003
	
                                  50MG
	                                    N011835 006
	
                                  100MG
	                                   N011835 007
	
   ORETIC
	
          ABBVIE
	                25MG
	                                    N011971 001
	
   ZIDE
	
          SOLVAY
	                50MG
	                                    A083925 001
	
HYDROCHLOROTHIAZIDE; IRBESARTAN
	
  TABLET;ORAL
	
    AVALIDE
	
         SANOFI AVENTIS US
	     12.5MG;75MG **Federal Register
            N020758 001
	 Sep 30, 1997
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 25MG;300MG **Federal Register
             N020758 004
	 Mar 15, 2005
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
    IRBESARTAN AND HYDROCHLOROTHIAZIDE
	
         TEVA                    25MG;300MG
	                               A077369 003
	 Mar 30, 2012
	
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    NORMOZIDE
	
         SCHERING               25MG;100MG
	                                N019046   001
	   Apr   06,   1987

                                25MG;200MG
	                                N019046   002
	   Apr   06,   1987

                                25MG;300MG
	                                N019046   003
	   Apr   06,   1987

                                25MG;400MG
	                                N019046   004
	   Apr   06,   1987
	
    TRANDATE HCT
	
         GLAXOSMITHKLINE        25MG;100MG
	                                N019174   001
	   Apr   10,   1987

                                25MG;200MG
	                                N019174   002
	   Apr   10,   1987

                                25MG;300MG
	                                N019174   003
	   Apr   10,   1987

                                25MG;400MG
	                                N019174   004
	   Apr   10,   1987
	
HYDROCHLOROTHIAZIDE; LISINOPRIL
	
  TABLET;ORAL
	
    LISINOPRIL AND HYDROCHLOROTHIAZIDE
	
         SANDOZ                  12.5MG;10MG
	                              A075926   001
	   Jul   01,   2002
	
                                 12.5MG;20MG
	                              A075926   002
	   Jul   01,   2002
	
                                 25MG;20MG
	                                A075926   003
	   Jul   01,   2002
	
         TEVA                    12.5MG;10MG
	                              A075869   001
	   Jul   01,   2002
	
                                 12.5MG;20MG
	                              A075869   002
	   Jul   01,   2002
	
                                 25MG;20MG
	                                A075869   003
	   Jul   01,   2002
	
    PRINZIDE
	
         MERCK                   25MG;20MG
	                                N019778 002
	 Feb 16, 1989
	
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
	
  TABLET;ORAL
	
    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
	
         WATSON LABS
	          12.5MG;50MG
	                               A200180 001
	 Jan 12, 2011
	
                                12.5MG;100MG
	                              A200180 002
	 Jan 12, 2011
	
                                25MG;100MG
	                                A200180 003
	 Jan 12, 2011
	
HYDROCHLOROTHIAZIDE; METHYLDOPA
	
  TABLET;ORAL
	
    ALDORIL 15
	
         MERCK
	                 15MG;250MG
	                               N013402 001
	
    ALDORIL 25
	
         MERCK
	                 25MG;250MG
	                               N013402 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-167(of 337)


HYDROCHLOROTHIAZIDE; METHYLDOPA
	
  TABLET;ORAL
	
    ALDORIL D30
	
         MERCK                   30MG;500MG
	                   N013402 003
	
    ALDORIL D50
	
         MERCK                   50MG;500MG
	                   N013402 004
	
    METHYLDOPA AND HYDROCHLOROTHIAZIDE
	
         DAVA PHARMS INC
	       15MG;250MG
	                   A072507   001    Jun   02,   1989
	
                                 25MG;250MG
	                   A072508   001    Jun   02,   1989
	
                                 30MG;500MG
	                   A072509   001    Jun   02,   1989
	
                                 50MG;500MG
	                   A072510   001    Jun   02,   1989
	
         IVAX SUB TEVA PHARMS
	 15MG;250MG
	                    A071458   001    Mar   08,   1988
	
                                 25MG;250MG
	                   A071459   001    Mar   08,   1988
	
                                 30MG;500MG
	                   A071460   001    Mar   08,   1988
	
                                 50MG;500MG
	                   A071461   001    Mar   08,   1988
	
         PAR PHARM
	             15MG;250MG
	                   A070616   001    Feb   02,   1987
	
                                 25MG;250MG
	                   A070612   001    Feb   02,   1987
	
                                 30MG;500MG
	                   A070613   001    Feb   02,   1987
	
                                 50MG;500MG
	                   A070614   001    Feb   02,   1987
	
         PARKE DAVIS
	           15MG;250MG
	                   A071897   001    Nov   23,   1987
	
                                 25MG;250MG
	                   A071898   001    Nov   23,   1987
	
                                 30MG;500MG
	                   A071899   001    Nov   23,   1987
	
                                 50MG;500MG
	                   A071900   001    Nov   23,   1987
	
         PUREPAC PHARM
	         15MG;250MG
	                   A070853   001    Oct   08,   1986
	
                                 25MG;250MG
	                   A070688   001    Apr   24,   1986

                                 30MG;500MG
	                   A070854   001    Oct   08,   1986
	
                                 50MG;500MG
	                   A070689   001    Apr   24,   1986

         SANDOZ
	                15MG;250MG
	                   A070182   001    Jan   15,   1986
	
                                 15MG;250MG
	                   A070829   001    Mar   09,   1987
	
                                 25MG;250MG
	                   A070183   001    Jan   15,   1986
	
                                 25MG;250MG
	                   A070830   001    Mar   09,   1987
	
                                 30MG;500MG
	                   A070543   001    Jan   15,   1986
	
                                 50MG;500MG
	                   A070544   001    Jan   15,   1986
	
         TEVA
	                  15MG;250MG
	                   A071819   001    Apr   08,   1988

                                 25MG;250MG
	                   A071820   001    Apr   08,   1988

                                 30MG;500MG
	                   A071821   001    Apr   08,   1988

                                 50MG;500MG
	                   A071822   001    Apr   08,   1988

         WATSON LABS
	           15MG;250MG
	                   A070365   001    Mar   19,   1986
	
                                 15MG;250MG
	                   A070958   001    Feb   06,   1989
	
                                 15MG;250MG
	                   A071920   001    Aug   29,   1988

                                 25MG;250MG
	                   A070366   001    Apr   16,   1986

                                 25MG;250MG
	                   A070959   001    Jan   19,   1989
	
                                 25MG;250MG
	                   A071921   001    Aug   29,   1988

                                 30MG;500MG
	                   A070367   001    Mar   19,   1986
	
                                 30MG;500MG
	                   A071069   001    Jan   19,   1989
	
                                 30MG;500MG
	                   A071922   001    Aug   29,   1988

                                 50MG;500MG
	                   A070368   001    Apr   16,   1986

                                 50MG;500MG
	                   A070960   001    Feb   06,   1989
	
                                 50MG;500MG
	                   A071923   001    Aug   29,   1988
	
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
	
  TABLET;ORAL
	
    LOPRESSOR HCT
	
         US PHARMS HOLDINGS I   50MG;100MG
	                    N018303 003 Dec 31, 1984
	
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
	
  TABLET;ORAL
	
    MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
         PADDOCK LLC		          12.5MG;7.5MG
	                  A090096 001 Sep 25, 2008

                                12.5MG;15MG
	                   A090096 002 Sep 25, 2008

                                25MG;15MG
	                     A090096 003 Sep 25, 2008
	
HYDROCHLOROTHIAZIDE; PINDOLOL
	
  TABLET;ORAL
	
    VISKAZIDE
	
         NOVARTIS                 25MG;5MG
	                    N018872 001 Jul 22, 1987
	
                                  25MG;10MG
	                   N018872 002 Jul 22, 1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-168(of 337)


HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    INDERIDE LA 120/50

         WYETH AYERST
	         50MG;120MG
	                    N019059 002 Jul 03, 1985
	
    INDERIDE LA 160/50

         WYETH AYERST
	         50MG;160MG
	                    N019059 003 Jul 03, 1985
	
    INDERIDE LA 80/50

         WYETH AYERST
	         50MG;80MG
	                     N019059 001 Jul 03, 1985
	
  TABLET;ORAL
	
    INDERIDE-80/25

         WYETH PHARMS INC
	     25MG;80MG
	                     N018031 002
	
    PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE
	
         DURAMED PHARMS BARR    25MG;40MG
	                     A071126 001 Mar 02, 1987
	
                                25MG;80MG
	                     A071127 001 Mar 02, 1987
	
    PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
	
         ACTAVIS ELIZABETH
	    25MG;40MG
	                     A070851   001     May   15,   1986

                                25MG;80MG
	                     A070852   001     May   15,   1986

         BARR
	                 25MG;40MG
	                     A070704   001     Oct   01,   1986
	
                                25MG;80MG
	                     A070705   001     Oct   01,   1986
	
         IVAX SUB TEVA PHARMS
	 25MG;40MG
	                     A071552   001     Dec   01,   1988
	
                                25MG;80MG
	                     A071553   001     Dec   01,   1988
	
         SANDOZ
	               25MG;40MG
	                     A071060   001     Aug   26,   1987

                                25MG;80MG
	                     A071061   001     Aug   26,   1987

         WARNER CHILCOTT
	      25MG;40MG
	                     A071771   001     Jan   26,   1988
	
                                25MG;80MG
	                     A071772   001     Jan   26,   1988
	
         WATSON LABS
	          25MG;40MG
	                     A070301   001     Apr   18,   1986

                                25MG;40MG
	                     A071498   001     Dec   18,   1991
	
                                25MG;80MG
	                     A070305   001     Apr   18,   1986

                                25MG;80MG
	                     A071501   001     Dec   18,   1991
	
HYDROCHLOROTHIAZIDE; RESERPINE
	
  TABLET;ORAL
	
    H.R.-50
	
         WHITEWORTH TOWN PLSN
	 50MG;0.125MG
	                  A085338 001
	
    HYDRO-RESERP
	
         ABC HOLDING
	           50MG;0.125MG
	                 A084714 002 Jun 29, 1982
	
    HYDRO-SERP "25"
	
         SANDOZ
	                25MG;0.125MG
	                 A084827 001
	
    HYDRO-SERP "50"
	
         SANDOZ
	                50MG;0.125MG
	                 A085213 001
	
    HYDROCHLOROTHIAZIDE W/ RESERPINE

         IVAX SUB TEVA PHARMS		 25MG;0.1MG
	                    A083572   001
	
                                 25MG;0.125MG
	                 A083571   001
	
                                 50MG;0.1MG
	                   A083568   001
	
                                 50MG;0.125MG
	                 A083573   001
	
         PHARMERAL               25MG;0.125MG
	                 A085421   001
	
                                 50MG;0.125MG
	                 A085420   001
	
         ROXANE                  50MG;0.125MG
	                 A084603   001
	
         WATSON LABS             25MG;0.125MG
	                 A084466   001
	
                                 25MG;0.125MG
	                 A085317   001
	
                                 25MG;0.125MG
	                 A086330   002
	
                                 50MG;0.125MG
	                 A083666   001
	
                                 50MG;0.125MG
	                 A084467   001
	
                                 50MG;0.125MG
	                 A086331   001
	
    HYDROPRES 25
	
         MERCK                   25MG;0.125MG
	                 N011958 002
	
    HYDROPRES 50
	
         MERCK                   50MG;0.125MG
	                 N011958 003
	
    RESERPINE AND HYDROCHLOROTHIAZIDE
	
         BARR                    25MG;0.125MG
	                 A084580 001
	
                                 50MG;0.125MG
	                 A084579 001
	
         SANDOZ                  50MG;0.125MG
	                 A088200 001 Jan 31, 1984
	
    RESERPINE AND HYDROCHLOROTHIAZIDE-50
	
         WEST WARD               50MG;0.125MG
	                 A088189 001 May 10, 1984
	
    SERPASIL-ESIDRIX #1
	
         NOVARTIS                25MG;0.1MG
	                   N011878 003
	
    SERPASIL-ESIDRIX #2
	
         NOVARTIS                50MG;0.1MG
	                   N011878 005
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                6-169(of 337)


HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
	
  TABLET;ORAL
	
    SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
	
         ASCOT                  25MG;25MG
	                      A088025   001 Nov 23, 1984
	
         MUTUAL PHARM           25MG;25MG
	                      A087267   001
	
         PUREPAC PHARM          25MG;25MG
	                      A087999   001 Nov 06, 1985
	
         SANDOZ                 25MG;25MG
	                      A086881   001
	
         SUPERPHARM             25MG;25MG
	                      A089137   001 Aug 26, 1985

         WATSON LABS            25MG;25MG
	                      A087398   001
	
    SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE

         IVAX PHARMS            25MG;25MG
	                      A087004   002 May 24, 1982

         LEDERLE                25MG;25MG
	                      A087511   001
	
         PARKE DAVIS            25MG;25MG
	                      A087948   001 Feb 22, 1983
	
         PUREPAC PHARM          25MG;25MG
	                      A088054   001 Aug 18, 1983

         UPSHER SMITH           25MG;25MG
	                      A087553   001
	
         USL PHARMA             25MG;25MG
	                      A087651   001
	
         VANGARD                25MG;25MG
	                      A087655   001
	
         WATSON LABS            25MG;25MG
	                      A085974   001
	
                                25MG;25MG
	                      A086026   001
	
HYDROCHLOROTHIAZIDE; TIMOLOL MALEATE
	
  TABLET;ORAL
	
    TIMOLIDE 10-25
	
         MERCK                  25MG;10MG
	                      N018061 001
	
HYDROCHLOROTHIAZIDE; TRIAMTERENE
	
  CAPSULE;ORAL
	
    DYAZIDE
	
         GLAXOSMITHKLINE LLC    25MG;50MG
	                      N016042 002
	
    TRIAMTERENE AND HYDROCHLOROTHIAZIDE
	
         BARR                   25MG;37.5MG
	                    A074970 001 Jan 06, 1998
	
         NOVARTIS               25MG;37.5MG
	                    A074857 001 Sep 09, 1997

         VITARINE               25MG;50MG
	                      A071737 001 Feb 12, 1988
	
  TABLET;ORAL
	
    TRIAMTERENE AND HYDROCHLOROTHIAZIDE
	
         AM THERAP              50MG;75MG
	                      A072022 001 Apr 17, 1988

         QUANTUM PHARMICS       50MG;75MG
	                      A071980 001 Apr 17, 1988

         WATSON LABS            50MG;75MG
	                      A071969 001 Apr 17, 1988
	
HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    CODAMINE
	
         ALPHARMA US PHARMS
	   5MG/5ML;25MG/5ML
	               A075103 001 Sep 29, 2000
	
HYDROCORTAMATE HYDROCHLORIDE
	
  OINTMENT;TOPICAL
	
    MAGNACORT
	
         PFIZER
	                0.5%
	                          N010554 001
	
HYDROCORTISONE
	
  AEROSOL;TOPICAL
	
    AEROSEB-HC
	
         ALLERGAN HERBERT
	      0.5%
	                          A085805 001
	
  CREAM;TOPICAL
	
    CORT-DOME
	
         BAYER PHARMS
	          0.5%
	                          N009585 003
	
                                 1%
	                            N009585 001
	
   DERMACORT
	
        MONARCH PHARMS
	         1%
	                            A083011 002
	
   ELDECORT
	
        VALEANT PHARM INTL
	     1%
	                            A080459 001
	
                                 2.5%
	                          A084055 001
	
   FLEXICORT
	
        WESTWOOD SQUIBB
	        0.5%
	                          A087136 003 Apr 08, 1982

                                 1%
	                            A087136 002 Apr 08, 1982

                                 2.5%
	                          A087136 001 Apr 08, 1982
	
   H-CORT
	
        PHARM ASSOC
	            0.5%
	                          A086823 001
	
   HC #1
	
        BAYER PHARMS
	           0.5%
	                          A080438 001
	
   HC #4
	
        BAYER PHARMS
	           1%
	                            A080438 002
	
   HC (HYDROCORTISONE)

        C AND M PHARMA
	         0.5%
	                          A080482 003
	
                                 1%
	                            A080482 004
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                   6-170(of 337)


HYDROCORTISONE
	
  CREAM;TOPICAL
	
    HI-COR
	
         C AND M PHARMA
	        2.5%
	                            A080483 001
	
    HYDROCORTISONE
	
         ALPHARMA US PHARMS
	    2.5%
	                            A089754   001     Feb 01, 1989
	
         ALTANA
	                0.5%
	                            A080848   002
	
                                 1%
	                              A080848   003
	
         AMBIX
	                 1%
	                              A086080   001
	
                                 2.5%
	                            A086271   001
	
         EVERYLIFE
	             0.5%
	                            A080452   001
	
                                 1%
	                              A080452   002
	
         G AND W LABS
	          1%
	                              A084059   001
	
         INGRAM PHARM
	          0.5%
	                            A080456   002
	
                                 1%
	                              A080456   003
	
         IVAX PHARMS
	           1%
	                              A085733   001
	
         NASKA
	                 1%
	                              A089706   001     Mar 10, 1988
	
         PERRIGO NEW YORK
	      0.5%
	                            A084970   002
	
                                 1%
	                              A085026   001
	
         PHARMADERM
	            1%
	                              A088845   001     Feb 27, 1986
	
                                 2.5%
	                            A089413   001     Dec 16, 1986
	
         PHARMAFAIR
	            1%
	                              A087838   001     Jul 28, 1982
	
         STIEFEL
	               1%
	                              A086170   001
	
         SYOSSET
	               0.5%
	                            A085527   001
	
         TARO
	                  0.5%
	                            A086154   001
	
                                 1%
	                              A086155   001
	
         TEVA
	                  0.5%
	                            A080400   002
	
                                 1%
	                              A080400   003
	
                                 1%
	                              A085191   001
	
                                 2.5%
	                            A080400   004
	
         TOPIDERM
	              1%
	                              A089273   001     Feb 17, 1989
	
         USL PHARMA
	            1%
	                              A088027   001     Sep 27, 1983

                                 2.5%
	                            A088029   001     Sep 27, 1983

        WHITEWORTH TOWN PLSN
	   1%
	                              A080496   002
	
   HYTONE
	
        VALEANT INTL
	           1%
	                              A080472 003
	
                                 2.5%
	                            A080472 004
	
   NOGENIC HC
	
        IVAX PHARMS
	            1%
	                              A087427 001 Apr 04, 1988
	
   NUTRACORT
	
        DOW PHARM
	              0.5%
	                            A080442 002
	
                                 1%
	                              A080442 003
	
   PENECORT
	
        ALLERGAN HERBERT
	       1%
	                              A088216 001 Jun 06, 1984
	
   PROCTOCORT
	
        MONARCH PHARMS
	         1%
	                              A083011 001
	
   SYNACORT
	
        MEDICIS
	                0.5%
	                            A087459 001
	
 GEL;TOPICAL
	
   NUTRACORT
	
        HEALTHPOINT
	            1%
	                              A084698 001
	
   PENECORT
	
        ALLERGAN HERBERT
	       1%
	                              A088215 001 Jun 06, 1984
	
 INJECTABLE;INJECTION
	
   CORTEF
	
        PHARMACIA AND UPJOHN
	   50MG/ML
	                         N009864 001
	
 LOTION;TOPICAL
	
   ACTICORT
	
        BAKER NORTON
	           1%
	                              A086535 001
	
   ALA-CORT
	
        CROWN LABS
	             1%
	                              A083201 001
	
   BALNEOL-HC
	
        SOLVAY
	                 1%
	                              A088041 001 Dec 03, 1982
	
   BETA-HC
	
        BETA DERMAC
	            1%
	                              A089495 001 Jan 25, 1988
	
   CETACORT
	
        DOW PHARM
	              0.5%
	                            A080426 002
	
                                 1%
	                              A080426 001
	
   CORT-DOME
	
        BAYER PHARMS
	           0.5%
	                            N009895 003
	
                                 1%
	                              N009895 001
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                    6-171(of 337)


HYDROCORTISONE
	
  LOTION;TOPICAL
	
    DERMACORT
	
         SOLVAY                  0.5%
	                            A084573 002
	
                                 1%
	                              A086462 001
	
    EPICORT
	
         BLULINE                 0.5%
	                            A083219 002
	
    GLYCORT
	
         HERAN                   1%
	                              A087489 001 Oct 03, 1983
	
    H-CORT
	
         PHARM ASSOC             0.5%
	                            A086824 001
	
    HYDROCORTISONE
	
         ALPHARMA US PHARMS      0.5%
	                            A087317   001     Jun 07, 1982
	
                                 1%
	                              A087315   001     Jun 07, 1982
	
         MERICON                 0.5%
	                            A085282   001
	
                                 1%
	                              A085282   002     Feb 26, 1987
	
         NASKA                   1%
	                              A089705   001     Apr 25, 1988

         PERRIGO NEW YORK        0.5%
	                            A085662   001
	
                                 1%
	                              A085663   001
	
         TARO                    1%
	                              A089024   001     Feb 12, 1986
	
    HYTONE
	
         VALEANT INTL            1%
	                              A080473 003
	
                                 2.5%
	                            A080473 004 Nov 30, 1982
	
    NUTRACORT
	
         DOW PHARM               0.5%
	                            A080443 002
	
                                 1%
	                              A080443 003
	
    STIE-CORT
	
         PERRIGO CO              1%
	                              A089066 001 Nov 25, 1985
	
  OINTMENT;TOPICAL
	
    CORTRIL
	
         PFIZER GLOBAL           1%
	                              N009176 001
	
                                 2.5%
	                            N009176 002
	
    HC (HYDROCORTISONE)

         C AND M PHARMA          0.5%
	                            A080481 001
	
                                 1%
	                              A080481 002
	
    HYDROCORTISONE
	
         ALTANA                  0.5%
	                            A080489   002
	
                                 1%
	                              A080489   003
	
         AMBIX                   1%
	                              A086079   001
	
                                 2.5%
	                            A086272   001
	
         NASKA                   1%
	                              A089704   001     Mar 10, 1988
	
         PERRIGO NEW YORK        0.5%
	                            A084969   003
	
                                 1%
	                              A085028   001
	
         PHARMADERM              1%
	                              A088842   001     Feb 09, 1987
	
         TARO                    0.5%
	                            A086256   001
	
                                 2.5%
	                            A040310   001     Dec 29, 2000
	
         USL PHARMA              1%
	                              A088061   001     Sep 27, 1983

                                 2.5%
	                            A088039   001     Sep 27, 1983
	
    HYTONE
	
         DERMIK LABS             1%
	                              A080474 003
	
                                 2.5%
	                            A080474 004
	
    PENECORT
	
         ALLERGAN HERBERT        2.5%
	                            A088217 001 Jun 06, 1984
	
  POWDER;FOR RX COMPOUNDING
	
    H-CORT
	
         TORCH                   100%
	                            A087834 001 Mar 29, 1982
	
    HYDROCORTISONE
	
         PADDOCK LLC             100%
	                            A088082 001 Apr 08, 1983
	
  SOLUTION;TOPICAL
	
    PENECORT
	
         ALLERGAN HERBERT        1%
	                              A088214 001 Jun 06, 1984
	
    TEXACORT
	
         MISSION PHARMA          1%
	                              A080425 001
	
  TABLET;ORAL
	
    CORTRIL
	
         PFIZER                  10MG
	                            N009127 005
	
                                 20MG
	                            N009127 003
	
    HYDROCORTISONE
	
         BARR                    20MG
	                            A083999   001
	
         ELKINS SINN             20MG
	                            A080624   001
	
         FERRANTE                10MG
	                            A080568   001
	
                                 20MG
	                            A080568   002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                            6-172(of 337)


HYDROCORTISONE
	
  TABLET;ORAL
	
    HYDROCORTISONE
	
         HIKMA INTL PHARMS       20MG                                    A083365   001
	
         IMPAX LABS              20MG                                    A080781   001
	
         INWOOD LABS             20MG                                    A080732   001
	
         LANNETT                 20MG                                    A085070   001
	
         NEXGEN PHARMA INC       20MG                                    A083140   001
	
         PANRAY                  10MG                                    N009659   001
	
                                 20MG                                    N009659   002
	
         PARKE DAVIS             20MG                                    A084243   001
	
         PUREPAC PHARM           10MG                                    A084247   003 Aug 31, 1982

                                 20MG		                                  A080395   001
	
                                 20MG                                    A084247   002
	
         ROXANE                  10MG                                    A088539   001 Mar 21, 1984
	
         SANDOZ                  20MG                                    A080642   002
	
         WATSON LABS             20MG                                    A080355   001
	
         WHITEWORTH TOWN PLSN    10MG                                    A080344   001
	
                                 20MG                                    A080344   002
	
   HYDROCORTONE
	
        MERCK                    10MG                                    N008506 007
	
                                 20MG                                    N008506 011
	
 TABLET;VAGINAL
	
   CORTRIL
	
        PFIPHARMECS              10MG                                    N009796 001
	
HYDROCORTISONE ACETATE
	
  CREAM;TOPICAL
	
    HEMSOL-HC
	
         ABLE                    1%                                      A081274 001 Jun 19, 1992
	
    HYDROCORTISONE ACETATE
	
         CENCI                   1%                                      A080419   001 Jan 25, 1982
	
         PARKE DAVIS             1%                                      A089914   001 Jan 03, 1989
	
         PUREPAC PHARM           0.5%                                    A086050   001
	
                                 1%                                      A086052   001
	
 INJECTABLE;INJECTION
	
   CORTEF ACETATE
	
        PHARMACIA AND UPJOHN     50MG/ML                                 N009378 002
	
   CORTRIL
	
        PFIZER                   25MG/ML                                 N009164 001
	
   HYDROCORTISONE ACETATE
	
        AKORN                    25MG/ML                                 N009637   001
	
                                 50MG/ML                                 N009637   002
	
         BEL MAR                 25MG/ML                                 A083739   001
	
                                 50MG/ML                                 A083739   002
	
         WATSON LABS             25MG/ML                                 A083128   001
	
                                 25MG/ML                                 A083759   001
	
                                 50MG/ML                                 A083759   002
	
                                 50MG/ML                                 A085214   001
	
   HYDROCORTONE
	
        MERCK                    25MG/ML                                 N008228 001
	
                                 50MG/ML                                 N008228 004
	
 LOTION;TOPICAL
	
   DRICORT
	
        INGRAM PHARM             0.5%                                    A086207 001
	
 OINTMENT;OPHTHALMIC
	
   HYDROCORTISONE ACETATE
	
        FERA PHARMS              0.5%                                    A080828 001
	
 OINTMENT;OPHTHALMIC, OTIC
	
   HYDROCORTONE
	
        MERCK                    1.5%                                    N009018 003
	
 OINTMENT;TOPICAL
	
   CORTEF ACETATE
	
        PHARMACIA AND UPJOHN		   1%                                      N008917 002
	
                                 2.5% **Federal Register determination   N008917 001
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
 PASTE;TOPICAL
	
   ORABASE HCA
	
        COLGATE                  0.5%                                    A083205 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                   6-173(of 337)


HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
	
  CREAM;TOPICAL
	
    NEO-CORTEF
	
         PHARMACIA AND UPJOHN
	 1%;EQ 3.5MG BASE/GM
             A061049 001
	
                                2.5%;EQ 3.5MG BASE/GM
	          A061049 002
	
  OINTMENT;OPHTHALMIC
	
    NEO-CORTEF
	
         PHARMACIA AND UPJOHN
	 0.5%;EQ 3.5MG BASE/GM
           A060610 001
	
                                1.5%;EQ 3.5MG BASE/GM
	          A060610 002
	
  OINTMENT;TOPICAL
	
    NEO-CORTEF
	
         PHARMACIA AND UPJOHN
	 0.5%;EQ 3.5MG BASE/GM
           A060751 001
	
                                1%;EQ 3.5MG BASE/GM
             A060751 002
	
                                2.5%;EQ 3.5MG BASE/GM
	          A060751 003
	
  SUSPENSION/DROPS;OPHTHALMIC

    COR-OTICIN
	
         AKORN
	                1.5%;EQ 3.5MG BASE/ML
	          A060188 001
	
    NEO-CORTEF
	
         PHARMACIA AND UPJOHN
	 0.5%;EQ 3.5MG BASE/ML
           A060612 002
	
                                1.5%;EQ 3.5MG BASE/ML
	          A060612 001
	
HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE
	
  SUSPENSION;OPHTHALMIC
	
    TERRA-CORTRIL
	
         PFIZER                 1.5%;EQ 5MG BASE/ML
	            A061016 001
	
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
	
  AEROSOL, METERED;TOPICAL
	
    HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
	
         VINTAGE PHARMS
	       1%;1%
	                          A089440 001 May 17, 1988
	
  LOTION;TOPICAL
	
    PRAMOSONE
	
         FERNDALE LABS
	        0.5%;1%
	                        A083213 002
	
HYDROCORTISONE ACETATE; UREA
	
  CREAM;TOPICAL
	
    CARMOL HC
	
         FOUGERA PHARMS
	         1%;10%
	                       A080505 001
	
HYDROCORTISONE BUTYRATE
	
  CREAM;TOPICAL
	
    LOCOID
	
         YAMANOUCHI
	             0.1%
	                         N018795 001 Jan 07, 1983
	
  OINTMENT;TOPICAL
	
    LOCOID
	
         YAMANOUCHI
	             0.1%
	                         N019106 001 Jul 03, 1984
	
  SOLUTION;TOPICAL
	
    LOCOID
	
         YAMANOUCHI
	             0.1%
	                         N019819 001 Sep 15, 1988
	
HYDROCORTISONE CYPIONATE
	
  SUSPENSION;ORAL
	
    CORTEF
	
         PHARMACIA AND UPJOHN
	   EQ 10MG BASE/5ML
	             N009900 001
	
HYDROCORTISONE SODIUM PHOSPHATE
	
  INJECTABLE;INJECTION
	
    HYDROCORTONE
	
         MERCK
	                 EQ 50MG BASE/ML
	               N012052 001
	
HYDROCORTISONE SODIUM SUCCINATE
	
  INJECTABLE;INJECTION
	
    A-HYDROCORT
	
         ABBOTT
	                EQ 1GM BASE/VIAL
               A089580   001     Apr 11, 1989

                                 EQ 100MG BASE/VIAL
             A085928   001
	
                                 EQ 100MG BASE/VIAL
             A089577   001     Apr 11, 1989

                                 EQ 250MG BASE/VIAL
             A089578   001     Apr 11, 1989

                                 EQ 500MG BASE/VIAL
             A089579   001     Apr 11, 1989

         HOSPIRA
	               EQ 1GM BASE/VIAL
               A085932   001
	
                                 EQ 100MG BASE/VIAL
             A085929   001
	
                                 EQ 250MG BASE/VIAL
             A085930   001
	
                                 EQ 500MG BASE/VIAL
	            A085931   001
	
    HYDROCORTISONE SODIUM SUCCINATE
	
         ABRAXIS PHARM           EQ 1GM BASE/VIAL
               A088670 001 Jun 08, 1984
	
                                 EQ 100MG BASE/VIAL
             A088667 001 Jun 08, 1984
	
                                 EQ 100MG BASE/VIAL
	            A088712 001 Jun 08, 1984
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                          6-174(of 337)


HYDROCORTISONE SODIUM SUCCINATE
	
  INJECTABLE;INJECTION
	
    HYDROCORTISONE SODIUM SUCCINATE
	
                                 EQ 250MG BASE/VIAL
                    A088668   001 Jun 08, 1984
	
                                 EQ 500MG BASE/VIAL
                    A088669   001 Jun 08, 1984
	
         BAXTER HLTHCARE
	       EQ 1GM BASE/VIAL
                      A087569   001
	
                                 EQ 100MG BASE/VIAL
                    A086619   001
	
                                 EQ 250MG BASE/VIAL
                    A087567   001
	
                                 EQ 500MG BASE/VIAL
                    A087568   001
	
         INTL MEDICATION
	       EQ 100MG BASE/VIAL
                    A087532   001 Mar 19, 1982
	
         WATSON LABS
	           EQ 1GM BASE/VIAL
                      A084748   001
	
                                 EQ 100MG BASE/VIAL
                    A084737   002
	
                                 EQ 100MG BASE/VIAL
                    A084738   001
	
                                 EQ 250MG BASE/VIAL
                    A084737   001
	
                                 EQ 500MG BASE/VIAL
	                   A084747   001
	
HYDROCORTISONE VALERATE
	
  CREAM;TOPICAL
	
    HYDROCORTISONE VALERATE
	
         TEVA PHARMS
	            0.2%
	                                A074489 001 Aug 12, 1998
	
    WESTCORT
	
         RANBAXY
	                0.2%
	                                N017950 001
	
  OINTMENT;TOPICAL
	
    HYDROCORTISONE VALERATE
	
         FOUGERA PHARMS
	         0.2%
	                                A075085 001 Jul 31, 2001
	
    WESTCORT
	
         RANBAXY
	                0.2%
	                                N018726 001 Aug 08, 1983
	
HYDROCORTISONE; NEOMYCIN SULFATE
	
  CREAM;TOPICAL
	
    NEO-CORT-DOME
	
         BAYER PHARMS           0.5%;EQ 3.5MG BASE/GM
                  N050237 006 Jun 05, 1984
	
                                1%;EQ 3.5MG BASE/GM
	                   N050237 005 Jun 05, 1984
	
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  SOLUTION/DROPS;OTIC

    NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE
	
         PHARMAFAIR             1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML     A062394 001 Sep 29, 1982
	
    OTOCORT
         WATSON LABS            1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML     A060730 002
	
  SUSPENSION/DROPS;OPHTHALMIC
    CORTISPORIN
         MONARCH PHARMS         1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML     N050169 001
	
    NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE
	
         PHARMAFAIR             1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
    A062623 001 Sep 24, 1985
	
  SUSPENSION/DROPS;OTIC

    NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE
	
         PHARMAFAIR             1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
    A062617 001 Sep 18, 1985
	
    OTICAIR
	
         PHARMAFAIR             1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
    A062399 001 Nov 18, 1982
	
    OTOBIONE
	
         SCHERING               1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
    A061816 001
	
    OTOCORT
	
         ACTAVIS LABS FL INC    1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
	   A062521 001 Jul 11, 1985
	
HYDROCORTISONE; POLYMYXIN B SULFATE
	
  SOLUTION/DROPS;OTIC

    OTOBIOTIC
	
         SCHERING               5MG/ML;EQ 10,000 UNITS BASE/ML
         A062302 001
	
    PYOCIDIN
	
         FOREST LABS            5MG/ML;EQ 10,000 UNITS BASE/ML
	        A061606 001
	
HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE
	
  OINTMENT;OPHTHALMIC
	
    ACHROMYCIN
	
         LEDERLE
	              1.5%;1%
	                               N050272 001
	
HYDROCORTISONE; UREA
	
  CREAM;TOPICAL
	
    ALPHADERM
	
         BIOGLAN
	                1%;10%
	                              A086008 001
	
    CALMURID HC
	
         PHARMACIA AND UPJOHN
	   1%;10%
	                              A083947 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                   6-175(of 337)


HYDROFLUMETHIAZIDE
	
  TABLET;ORAL
	
    DIUCARDIN
	
         WYETH AYERST            50MG                                        A083383 001
	
    HYDROFLUMETHIAZIDE
	
         PAR PHARM               50MG                                        A088850 001 May 31, 1985

         WATSON LABS             50MG                                        A088031 001 Apr 06, 1983

                                 50MG		                                      A088528 001 Aug 15, 1984
	
HYDROFLUMETHIAZIDE; RESERPINE
	
  TABLET;ORAL
	
    HYDROFLUMETHIAZIDE AND RESERPINE
	
         USL PHARMA             50MG;0.125MG                                 A088195 001 Oct 26, 1983
	
         WATSON LABS            25MG;0.125MG                                 A088127 001 Mar 22, 1983
	
                                50MG;0.125MG		                               A088110 001 Mar 22, 1983
	
    RESERPINE AND HYDROFLUMETHIAZIDE
	
         IVAX PHARMS            50MG;0.125MG                                 A088932 001 Jan 11, 1985
	
         PAR PHARM              50MG;0.125MG                                 A088907 001 Sep 20, 1985

    SALUTENSIN
	
         SHIRE                  50MG;0.125MG                                 N012359 003
	
    SALUTENSIN-DEMI
	
         SHIRE                  25MG;0.125MG                                 N012359 004
	
HYDROMORPHONE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    PALLADONE
	
         PURDUE PHARMA LP		       12MG                                       N021044   001    Sep   24,   2004

                                  16MG                                       N021044   002    Sep   24,   2004

                                  24MG                                       N021044   003    Sep   24,   2004

                                  32MG                                       N021044   004    Sep   24,   2004

  INJECTABLE;INJECTION
	
    HYDROMORPHONE HYDROCHLORIDE
	
         WATSON LABS              10MG/ML                                    A074317 001 Aug 23, 1995

  TABLET;ORAL
	
    HYDROMORPHONE HYDROCHLORIDE
	
         NESHER PHARMS		          2MG                                        A077311 001 Nov 09, 2005
	
                                  4MG                                        A077311 002 Nov 09, 2005
	
                                  8MG                                        A077311 003 Nov 09, 2005
	
HYDROXOCOBALAMIN
	
  INJECTABLE;INJECTION
	
    ALPHAREDISOL
	
         MERCK                   1MG/ML                                      A080778 001
	
    CYANOKIT
	
         MERCK SANTE SAS         2.5GM/VIAL (5GM/KIT)                        N022041 002 Dec 15, 2006
	
    HYDROXOCOBALAMIN
	
         ABRAXIS PHARM           1MG/ML                                      A084921 001
	
         WATSON LABS             1MG/ML                                      A085528 001
	
    HYDROXOMIN
	
         BEL MAR                 1MG/ML                                      A084629 001
	
HYDROXYAMPHETAMINE HYDROBROMIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    PAREDRINE
	
         PHARMICS                1%                                          N000004 004
	
HYDROXYCHLOROQUINE SULFATE
	
  TABLET;ORAL
	
    HYDROXYCHLOROQUINE SULFATE
	
         SANDOZ                  200MG                                       A040150 001 Jan 27, 1996
	
         WATSON LABS             200MG                                       A040133 001 Nov 30, 1995
	
HYDROXYPROGESTERONE CAPROATE
	
  INJECTABLE;INJECTION
	
    DELALUTIN
	
         BRISTOL MYERS SQUIBB    125MG/ML **Federal Register                 N010347 004
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 125MG/ML **Federal Register                 N016911 001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 250MG/ML **Federal Register                 N010347 002
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                              6-176(of 337)


HYDROXYPROGESTERONE CAPROATE
	
  INJECTABLE;INJECTION
	
    DELALUTIN
	
                               efficacy reasons**

                               250MG/ML **Federal Register                N016911 002
	
                               determination that product was not

                               discontinued or withdrawn for safety or

                               efficacy reasons**

   HYDROXYPROGESTERONE CAPROATE
	
        AKORN                  125MG/ML                                   N018004 001
	
        WATSON LABS            125MG/ML                                   N017439 001
	
                               250MG/ML		                                 N017439 002
	
HYDROXYSTILBAMIDINE ISETHIONATE
	
  INJECTABLE;INJECTION
	
    HYDROXYSTILBAMIDINE ISETHIONATE
	
         SANOFI AVENTIS US       225MG/AMP                                N009166 001
	
HYDROXYUREA
	
  CAPSULE;ORAL
	
    HYDROXYUREA
	
         BARR                     250MG                                   A075143   002     Sep   21,   2000

         BARR LABS INC            250MG                                   A075020   002     Jun   26,   2000
	
                                  500MG                                   A075020   001     Jul   30,   1998
	
        ROXANE                    500MG                                   A074476   001     Aug   18,   1995

 TABLET;ORAL
	
   HYDROXYUREA
	
        BARR                      1GM                                     A075734 001 Aug 29, 2000
	
HYDROXYZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    HYDROXYZINE
	
         BAXTER HLTHCARE          50MG/ML                                 A085551 002
	
    HYDROXYZINE HYDROCHLORIDE
	
         ALTANA                   25MG/ML                                 A087273   001     Apr 20, 1982

                                  50MG/ML                                 A087273   002     Apr 20, 1982

         BAXTER HLTHCARE          25MG/ML                                 A085551   001
	
         FRESENIUS KABI USA       25MG/ML                                 A088184   001     Mar 31, 1983
	
                                  50MG/ML		                               A088185   001     Mar 31, 1983
	
         HOSPIRA		                25MG/ML                                 A087416   001
	
                                  50MG/ML                                 A086821   001
	
                                  50MG/ML                                 A087546   001
	
         PHARMAFAIR		             25MG/ML                                 A088862   001     Feb   14,   1986
	
                                  25MG/ML                                 A089106   001     Feb   14,   1986
	
                                  50MG/ML                                 A088881   001     Feb   14,   1986
	
                                  50MG/ML                                 A089107   001     Feb   14,   1986
	
         SMITH AND NEPHEW		       25MG/ML                                 A087592   001
	
         SOLOPAK		                25MG/ML                                 A086822   001
	
                                  25MG/ML                                 A087591   001
	
                                  50MG/ML                                 A087310   001
	
                                  50MG/ML                                 A087593   001
	
                                  50MG/ML                                 A087595   001
	
                                  50MG/ML                                 A087596   001
	
         WATSON LABS		            25MG/ML                                 A085778   001
	
                                  25MG/ML                                 A087274   001
	
                                  50MG/ML                                 A085779   001
	
                                  50MG/ML                                 A087274   002
	
         WYETH AYERST             25MG/ML                                 A086258   001
	
                                  50MG/ML                                 A086258   002
	
   ORGATRAX
	
        ORGANON USA INC           25MG/ML                                 A087014 001
	
                                  50MG/ML                                 A087014 002
	
   VISTARIL
	
        PFIZER                    25MG/ML                                 N011111 001
	
                                  50MG/ML                                 N011111 002
	
 SYRUP;ORAL
	
   ATARAX
	
        ROERIG                    10MG/5ML                                N010485 001
	
   HYDROXYZINE HYDROCHLORIDE
	
        ALPHARMA US PHARMS        10MG/5ML                                A088785 001 Feb 03, 1988
	
        KV PHARM                  10MG/5ML                                A087730 001 Jul 01, 1982
	
        STI PHARMA LLC            10MG/5ML                                A086880 001
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                       6-177(of 337)


HYDROXYZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ATARAX
	
         PFIZER
	                 10MG
	                           N010392   001
	
                                  25MG
	                           N010392   004
	
                                  50MG
	                           N010392   006
	
                                  100MG
	                          N010392   005
	
   HYDROXYZINE HYDROCHLORIDE
	
        ABLE
	                    10MG
	                           A040559   001     Jul   22,   2004
	
                                  25MG
	                           A040562   001     Jul   22,   2004
	
                                  50MG
	                           A040563   001     Jul   22,   2004
	
         ACTAVIS ELIZABETH
	      10MG
	                           A089071   001     Jul   22,   1986
	
                                  25MG
	                           A089072   001     Jul   22,   1986
	
                                  50MG
	                           A089073   001     Jul   22,   1986
	
         HALSEY
	                 10MG
	                           A089366   001     May   02,   1988

                                  25MG
	                           A089117   001     May   02,   1988

                                  50MG
	                           A089396   001     May   02,   1988

         IVAX PHARMS
	            10MG
	                           A087216   001
	
                                  25MG
	                           A087410   001
	
                                  50MG
	                           A087411   001
	
         KV PHARM
	               10MG
	                           A087819   001     Jun   23,   1982
	
                                  25MG
	                           A087820   001     Jun   23,   1982
	
                                  50MG
	                           A087821   001     Jun   23,   1982
	
                                  100MG
	                          A087822   001     Jun   23,   1982
	
         MIKAH PHARMA
	           10MG
	                           A040600   001     Dec   28,   2004
	
                                  25MG
	                           A040602   001     Dec   28,   2004
	
                                  50MG
	                           A040604   001     Dec   28,   2004
	
         MUTUAL PHARM
	           10MG
	                           A088409   001     Nov   15,   1983
	
                                  25MG
	                           A087857   001     Apr   18,   1983

                                  50MG
	                           A087860   001     Apr   18,   1983

                                  100MG
	                          A087862   001     Apr   18,   1983

         PLIVA
	                  100MG
	                          A081054   001     Sep   25,   1995

         PUREPAC PHARM
	          10MG
	                           A088120   001     Sep   25,   1984

                                  25MG
	                           A088121   001     Sep   25,   1984

                                  50MG
	                           A088122   001     Sep   25,   1984

         QUANTUM PHARMICS
	       10MG
	                           A088540   001     Oct   22,   1985
	
                                  25MG
	                           A088551   001     Oct   22,   1985
	
                                  50MG
	                           A088529   001     Oct   22,   1985
	
         SANDOZ
	                 10MG
	                           A087246   002
	
                                  10MG
	                           A087869   001     Dec 20, 1982
	
                                  25MG
	                           A085247   001
	
                                  25MG
	                           A087870   001     Dec 20, 1982
	
                                  50MG
	                           A087245   001
	
                                  50MG
	                           A087871   001     Dec   20,   1982
	
         SUPERPHARM
	             10MG
	                           A088794   001     Dec   05,   1984
	
                                  25MG
	                           A088795   001     Dec   05,   1984
	
                                  50MG
	                           A088796   001     Dec   05,   1984
	
         USL PHARMA
	             10MG
	                           A089121   001     Mar   20,   1986
	
                                  25MG
	                           A089122   001     Mar   20,   1986
	
                                  50MG
	                           A089123   001     Mar   20,   1986
	
         VINTAGE
	                10MG
	                           A087602   001     Jan   22,   1982
	
                                  25MG
	                           A087603   001     Jan   22,   1982
	
                                  50MG
	                           A087604   001     Jan   22,   1982
	
         WATSON LABS
	            10MG
	                           A081149   001     Mar   18,   1994
	
                                  10MG
	                           A086827   001
	
                                  25MG
	                           A081150   001     Mar 18, 1994
	
                                  25MG
	                           A086829   001
	
                                  50MG
	                           A081151   001     Mar 18, 1994
	
                                  50MG
	                           A086836   001
	
HYDROXYZINE PAMOATE
	
  CAPSULE;ORAL
	
    HY-PAM "25"
	
         TEVA
	                   EQ 25MG HCL
	                    A088713 001 Mar 04, 1985
	
    HYDROXYZINE PAMOATE
	
         DURAMED PHARMS BARR
	    EQ   25MG HCL
	                  A088593   001     Feb   29,   1984
	
                                  EQ   50MG HCL
	                  A088594   001     Feb   29,   1984
	
                                  EQ   100MG HCL
	                 A088595   001     Feb   29,   1984
	
         IVAX SUB TEVA PHARMS
	   EQ   25MG HCL
	                  A087761   001     Mar   05,   1982
	
                                  EQ   50MG HCL
	                  A087760   001     Mar   05,   1982
	
         PAR PHARM
	              EQ   25MG HCL
	                  A087656   001     Jun   11,   1982
	
                                  EQ   25MG HCL
	                  A089145   001     Mar   17,   1986
	
                                  EQ   50MG HCL
	                  A087657   001     Jun   11,   1982
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                             6-178(of 337)


HYDROXYZINE PAMOATE
	
  CAPSULE;ORAL
	
    HYDROXYZINE PAMOATE
	
                                EQ   50MG HCL
	                            A089146   001
	   Mar   17,   1986
	
                                EQ   100MG HCL
	                           A087658   001
	   Jun   11,   1982
	
         SANDOZ
	               EQ   25MG HCL
	                            A081127   001
	   Jun   28,   1991
	
                                EQ   50MG HCL
	                            A081128   001
	   Jun   28,   1991
	
                                EQ   100MG HCL
	                           A081129   001
	   Jun   28,   1991
	
         SUPERPHARM
	           EQ   25MG HCL
	                            A089031   001
	   Jan   02,   1987
	
                                EQ   50MG HCL
	                            A089032   001
	   Jan   02,   1987
	
                                EQ   100MG HCL
	                           A089033   001
	   Jan   02,   1987
	
         VANGARD
	              EQ   25MG HCL
	                            A088392   001
	   Sep   19,   1983

                                EQ   50MG HCL
	                            A088393   001
	   Sep   19,   1983

         WATSON LABS
	          EQ   25MG HYDROCHLORIDE
	                  A081165   001
	   Jul   31,   1991
	
                                EQ   25MG HCL
	                            A086698   001
	
                                EQ   25MG HCL
	                            A086840   001
	   Jul 01, 1982
	
                                EQ   50MG HCL
	                            A086695   001
	
                                EQ   50MG HCL
	                            A086705   001
	   Jul 01, 1982
	
                                EQ   50MG HCL
	                            A087767   001
	   Aug 16, 1982
	
                                EQ   100MG HCL
	                           A086697   001
	
                                EQ   100MG HCL
	                           A086728   001
	   Oct 05, 1982
	
                                EQ   100MG HCL
	                           A087790   001
	   Aug 16, 1982
	
    VISTARIL
	
         PFIZER
	               EQ 100MG HCL
	                             N011459 006
	
  SUSPENSION;ORAL
	
    VISTARIL
	
         PFIZER
	               EQ 25MG HCL/5ML
	                          N011795 001
	
IBANDRONATE SODIUM
	
  TABLET;ORAL
	
    BONIVA
	
         HOFFMANN LA ROCHE
	    EQ 2.5MG BASE **Federal Register
          N021455 001
	 May 16, 2003
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
IBUPROFEN
	
  CAPSULE;ORAL
	
    MIDOL
	
         BAYER
	                200MG **Federal Register determination
    A070626 001
	 Sep 02, 1987
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                200MG **Federal Register determination
    A071002 001
	 Sep 02, 1987
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
  SOLUTION;INTRAVENOUS
	
    CALDOLOR
	
          CUMBERLAND PHARMS
	   400MG/4ML (100MG/ML)
	                     N022348 001
	 Jun 11, 2009
	
  SUSPENSION;ORAL
	
    CHILDREN'S ADVIL
	
          WYETH CONS
	          100MG/5ML
	                                N019833 002
	 Sep 19, 1989
	
    IBU
	
          ABBOTT
	              100MG/5ML
	                                N019784 001
	 Dec 18, 1989
	
    MOTRIN
	
          MCNEIL CONSUMER
	     100MG/5ML
	                                N019842 001
	 Sep 19, 1989
	
  SUSPENSION/DROPS;ORAL

    MOTRIN
	
          MCNEIL
	              40MG/ML
	                                  N020476 001
	 May 25, 1995
	
  TABLET;ORAL
	
    ACHES-N-PAIN
	
          LEDERLE
	             200MG
	                                    A071065 001
	 May 28, 1987
	
    CAP-PROFEN
	
          PERRIGO
	             200MG
	                                    A072097 001
	 Dec 08, 1987
	
    IBU
	
          BASF
	                400MG
	                                    A070083   001
	   Feb 22, 1985
	
                                400MG
	                                    N018197   001
	
                                600MG
	                                    A070088   001
	   Feb 08, 1985
	
                                600MG
	                                    A070099   001
	   Mar 29, 1985
	
                                800MG
	                                    A070745   001
	   Jul 23, 1986
	
    IBU-TAB
	
         ALRA
	                 800MG
	                                    A071965 001
	 Aug 11, 1988
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                        6-179(of 337)


IBUPROFEN
	
  TABLET;ORAL
	
    IBUPRIN
	
         PLIVA
	                  200MG                            A071773 001 Jul 16, 1987
    IBUPROFEN
	
         ABBOTT
	                 600MG                            A070556   001    Jun   14,   1985
                                  800MG                            A071264   001    Jul   25,   1986
         CONTRACT PHARMACAL
	     200MG                            A073691   001    Feb   25,   1994
         HALSEY
	                 200MG                            A071027   001    Sep   29,   1987
                                  300MG                            A071028   001    Mar   23,   1987
                                  400MG                            A071029   001    Mar   23,   1987
                                  600MG                            A071030   001    Mar   23,   1987
                                  800MG                            A072137   001    Feb   05,   1988
         IVAX SUB TEVA PHARMS
	   200MG                            A071144   001    Jan   20,   1987
                                  200MG                            A071154   001    Oct   27,   1987
                                  200MG                            A072040   001    Apr   29,   1988
                                  200MG                            A072901   001    Dec   19,   1991
                                  200MG                            A072903   001    Dec   19,   1991
                                  400MG                            A071145   001    Sep   23,   1986
                                  600MG                            A071146   001    Sep   23,   1986
                                  800MG                            A071769   001    May   08,   1987
         LEDERLE
	                400MG                            A070629   001    Sep   19,   1986
                                  600MG                            A070630   001    Sep   19,   1986
         LEINER
	                 300MG                            A071266   001    Oct   15,   1986
         MCNEIL
	                 400MG                            A070081   001    Jun   16,   1986
                                  600MG                            A070476   001    Jun   16,   1986
         MUTUAL PHARM
	           200MG                            A070493   001    Dec   24,   1985
                                  200MG                            A070908   001    Sep   26,   1986
                                  200MG                            A071462   001    Oct   02,   1986
                                  400MG                            A070079   001    Jul   24,   1985
                                  600MG                            A070080   001    Jul   24,   1985
                                  800MG                            A071448   001    Feb   18,   1987
         MYLAN
	                  200MG                            A071870   001    May   05,   1988
                                  400MG                            A070045   001    Sep   24,   1985
                                  600MG                            A070057   001    Sep   24,   1985
                                  800MG                            A071999   001    Dec   03,   1987
         NORTHSTAR HLTHCARE
	     400MG                            A078132   001    Sep   10,   2007
                                  600MG                            A078132   002    Sep   10,   2007
                                  800MG                            A078132   003    Sep   10,   2007
         OHM LABS
	               400MG                            A070818   001    Dec   26,   1985
         PAR PHARM
	              200MG                            A071575   001    May   08,   1987
                                  300MG                            A070328   001    Aug   06,   1985
                                  400MG                            A070329   001    Aug   06,   1985
                                  600MG                            A070330   001    Aug   06,   1985
                                  800MG                            A070986   001    Jul   25,   1986
         PERRIGO
	                200MG                            A072098   001    Dec   08,   1987
         PLIVA
	                  400MG                            A071666   001    Jun   18,   1987
                                  600MG                            A071667   001    Jun   18,   1987
                                  800MG                            A071668   001    Jun   18,   1987
         PUREPAC PHARM
	          200MG                            A071122   001    Oct   03,   1986
                                  200MG                            A071664   001    Feb   03,   1987
                                  300MG                            A071123   001    Sep   19,   1986
                                  400MG                            A071124   001    Sep   19,   1986
                                  600MG                            A071125   001    Sep   19,   1986
                                  800MG                            A071964   001    Feb   01,   1988
         SANDOZ
	                 200MG                            A070733   001    Sep   19,   1986
                                  200MG                            A071807   001    Feb   25,   1988
                                  200MG                            A074525   001    Dec   15,   1995
                                  200MG                            A074533   001    Dec   15,   1995
                                  300MG                            A070734   001    Jun   12,   1986
                                  400MG                            A070735   001    Jun   12,   1986
                                  400MG                            A072064   001    Jan   14,   1988
                                  600MG                            A070736   001    Jun   12,   1986
                                  600MG                            A072065   001    Jan   14,   1988
                                  800MG                            A071938   001    Jan   14,   1988
                                  800MG                            A072169   001    Dec   11,   1987
         SUPERPHARM
	             600MG                            A070709   001    Apr   25,   1986
         TEVA
	                   200MG                            A073141   001    May   29,   1992
                                  400MG                            A073343   001    Jun   30,   1992
                                  600MG                            A073344   001    Jun   30,   1992
                                  800MG                            A073345   001    Jun   30,   1992
         VINTAGE PHARMS
	         200MG                            A072249   001    Jan   10,   1989
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                      6-180(of 337)

IBUPROFEN
  TABLET;ORAL
    IBUPROFEN
         WATSON LABS              200MG                        A070435   001   Mar   05,   1986
                                  200MG                        A071765   001   Sep   04,   1987
                                  200MG                        A071905   001   Mar   08,   1988
                                  300MG                        A071338   001   Dec   01,   1986
                                  400MG                        A070038   001   Sep   06,   1985
                                  400MG                        A070436   001   Aug   21,   1985
                                  600MG                        A070041   001   Sep   06,   1985
                                  600MG                        A070437   001   Aug   21,   1985
                                  800MG                        A071547   001   Jul   02,   1987
                                  800MG                        A071911   001   Oct   13,   1987
   IBUPROHM
        OHM LABS                  400MG                        A070469 001 Aug 29, 1985
   MEDIPREN
        MCNEIL                    200MG                        A070475 001 Feb 06, 1986
                                  200MG                        A071215 001 Jun 26, 1986
   MIDOL
        BAYER                     200MG                        A070591 001 Sep 02, 1987
                                  200MG                        A071001 001 Sep 02, 1987
   MOTRIN
        MCNEIL CONSUMER           300MG                        N017463   003
                                  400MG                        N017463   002
                                  600MG                        N017463   004
                                  800MG                        N017463   005 May 22, 1985
        MCNEIL PED                100MG                        N020418   001 Nov 16, 1994
   NUPRIN
        BRISTOL MYERS             200MG                        A072035   001   Feb   16,   1988
                                  200MG                        A072036   001   Feb   16,   1988
         MCNEIL                   200MG                        N019012   001   May   18,   1984
                                  200MG                        N019012   002   Jul   29,   1987
   RUFEN
        BASF                      600MG                        N018197 002 Mar 05, 1984
 TABLET, CHEWABLE;ORAL
   MOTRIN
        MCNEIL PED                50MG                         N020135 001 Nov 16, 1994
                                  100MG                        N020135 002 Nov 16, 1994
IBUPROFEN; OXYCODONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    COMBUNOX
	
         FOREST LABS            400MG;5MG                      N021378 001 Nov 26, 2004
	
IDARUBICIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    IDAMYCIN
	
         PHARMACIA AND UPJOHN		   5MG/VIAL                     N050661 002 Sep 27, 1990

                                  10MG/VIAL                    N050661 001 Sep 27, 1990

                                  20MG/VIAL                    N050661 003 Apr 25, 1995

   IDARUBICIN HYDROCHLORIDE
	
        SANDOZ                    1MG/ML                       A091293   001   Mar   29,   2011
	
        TEVA PARENTERAL           5MG/VIAL                     A065037   003   May   01,   2002

                                  10MG/VIAL                    A065037   002   May   01,   2002

                                  20MG/VIAL                    A065037   001   May   01,   2002
	
IDOXURIDINE
	
  OINTMENT;OPHTHALMIC
	
    STOXIL
	
         GLAXOSMITHKLINE          0.5%                         N015868 001
	
  SOLUTION/DROPS;OPHTHALMIC

    STOXIL
	
         GLAXOSMITHKLINE          0.1%                         N013934 001
	
IFOSFAMIDE; MESNA
	
  INJECTABLE;INJECTION
	
    IFEX/MESNEX KIT

         BAXTER HLTHCARE          1GM/VIAL;100MG/ML            N019763 003 Oct 10, 1992
	
                                  3GM/VIAL;100MG/ML            N019763 004 Oct 10, 1992
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                    6-181(of 337)


ILOPROST
	
  SOLUTION;INHALATION
	
    VENTAVIS
	
          ACTELION PHARMS LTD
	   20MCG/2ML (10MCG/ML)
	           N021779 001 Dec 29, 2004
	
IMATINIB MESYLATE
	
  CAPSULE;ORAL
	
    GLEEVEC
	
         NOVARTIS
	               EQ 50MG BASE
	                   N021335 001 May 10, 2001

                                  EQ 100MG BASE
	                  N021335 002 May 10, 2001
	
IMIPRAMINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    IMIPRAMINE HYDROCHLORIDE
	
         NOVARTIS
	               25MG/ML
	                        A086765 001
	
  INJECTABLE;INJECTION
	
    TOFRANIL
	
         NOVARTIS
	               12.5MG/ML
	                      N011838 002
	
  TABLET;ORAL
	
    IMIPRAMINE HYDROCHLORIDE
	
         LEDERLE
	                10MG
	                           A086269   001
	
                                  25MG
	                           A086267   001
	
                                  50MG
	                           A086268   001
	
         PAR PHARM
	              25MG
	                           A089497   001     Jul   14,   1987
	
         PROSAM LABS
	            10MG
	                           A040753   001     Feb   28,   2008
	
                                  25MG
	                           A040752   001     Feb   28,   2008
	
                                  50MG
	                           A040751   001     Feb   28,   2008
	
         ROXANE
	                 10MG
	                           A083799   001
	
                                  25MG
	                           A083799   002
	
                                  50MG
	                           A083799   003
	
         SANDOZ
	                 10MG
	                           A085200   001
	
                                  25MG
	                           A084869   002
	
                                  50MG
	                           A085133   001
	
         TEVA
	                   10MG
	                           A083729   001
	
                                  25MG
	                           A083729   004
	
                                  50MG
	                           A083729   003
	
         USL PHARMA
	             25MG
	                           A087776   001     Feb   10,   1982
	
         VANGARD
	                10MG
	                           A088036   001     Nov   03,   1982
	
                                  25MG
	                           A087619   001     Feb   09,   1982
	
                                  50MG
	                           A087631   001     Jan   04,   1982
	
         WATSON LABS
	            10MG
	                           A085220   001
	
                                  10MG
	                           A085875   001
	
                                  25MG
	                           A084252   002
	
                                  25MG
	                           A085878   001
	
                                  50MG
	                           A085221   001
	
                                  50MG
	                           A085877   001
	
         WEST WARD
	              25MG
	                           A088222   001     May 26, 1983

                                  50MG
	                           A088223   001     May 26, 1983
	
    JANIMINE
	
         ABBOTT
	                 10MG
	                           N017895 001
	
                                  25MG
	                           N017895 002
	
                                  50MG
	                           N017895 003
	
    PRAMINE
	
         ALRA
	                   10MG
	                           A083827 001
	
                                  25MG
	                           A083827 002
	
                                  50MG
	                           A083827 003
	
    PRESAMINE
	
         SANOFI AVENTIS US
	      10MG
	                           N011836 006
	
                                  25MG
	                           N011836 003
	
                                  50MG
	                           N011836 007
	
INAMRINONE LACTATE
	
  INJECTABLE;INJECTION
	
    AMRINONE LACTATE
	
         BAXTER HLTHCARE CORP
	   EQ 5MG BASE/ML
                  A075542 001 May 10, 2000

         HOSPIRA
	                EQ 5MG BASE/ML
	                 A074616 001 Aug 03, 1998
	
    INOCOR
	
         SANOFI AVENTIS US
	      EQ 5MG BASE/ML
	                 N018700 001 Jul 31, 1984
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-182(of 337)


INDAPAMIDE
	
  TABLET;ORAL
	
    INDAPAMIDE
	
         AMERIGEN PHARMS LTD    1.25MG                                    A075201   001    Dec   04,   1998
	
                                2.5MG                                     A075201   002    Dec   04,   1998
	
         SANDOZ                 1.25MG                                    A074594   001    May   23,   1996

                                2.5MG                                     A074594   002    May   23,   1996

         TEVA                   1.25MG                                    A074498   002    Feb   12,   1998
	
                                1.25MG                                    A074665   001    Apr   04,   1997

                                2.5MG                                     A074498   001    Oct   31,   1996
	
                                2.5MG                                     A074665   002    Apr   04,   1997

         WATSON LABS            1.25MG                                    A074585   001    Sep   26,   1996

                                2.5MG                                     A074585   002    Sep   26,   1996

    LOZOL
	
         SANOFI AVENTIS US		    1.25MG **Federal Register determination   N018538 002 Apr 29, 1993

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                2.5MG **Federal Register determination    N018538 001 Jul 06, 1983

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
INDECAINIDE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DECABID
	
         LILLY		                 EQ 50MG BASE                             N019693 001 Dec 29, 1989
	
                                 EQ 75MG BASE                             N019693 002 Dec 29, 1989
	
                                 EQ 100MG BASE                            N019693 003 Dec 29, 1989
	
INDINAVIR SULFATE
	
  CAPSULE;ORAL
	
    CRIXIVAN
	
         MERCK SHARP DOHME      EQ 100MG BASE                             N020685 006 Apr 19, 2000

                                EQ 333MG BASE                             N020685 005 Dec 17, 1998
	
INDOCYANINE GREEN
	
  INJECTABLE;INJECTION
	
    IC-GREEN
	
         AKORN		                10MG/VIAL                                 N011525 003
	
                                40MG/VIAL                                 N011525 004
	
                                50MG/VIAL                                 N011525 002
	
INDOMETHACIN
	
  CAPSULE;ORAL
	
    INDO-LEMMON
	
         TEVA                   25MG                                      A070266 001 Nov 07, 1985
	
                                50MG                                      A070267 001 Nov 07, 1985
	
    INDOCIN
	
         IROKO PHARMS LLC       25MG                                      N016059 001
	
                                50MG                                      N016059 002
	
    INDOMETHACIN
	
         ABLE                   25MG                                      A076666   001    Dec   17,   2003
	
                                50MG                                      A076666   002    Dec   17,   2003
	
         CYCLE PHARMS LTD       25MG                                      A070353   001    Jun   18,   1985
	
                                50MG                                      A070354   001    Jun   18,   1985
	
         DURAMED PHARMS BARR    25MG                                      A070326   001    Oct   18,   1985
	
                                50MG                                      A070327   001    Oct   18,   1985
	
         HALSEY                 25MG                                      A070782   001    Jun   03,   1987
	
                                50MG                                      A070635   001    Jun   03,   1987
	
         IVAX SUB TEVA PHARMS   25MG                                      N018730   001    May   04,   1984

                                50MG                                      N018730   002    May   04,   1984

         MUTUAL PHARM           25MG                                      A070067   001    Oct   03,   1986
	
                                25MG                                      A070899   001    Feb   09,   1987
	
                                50MG                                      A070068   001    Oct   03,   1986
	
                                50MG                                      A070900   001    Feb   09,   1987
	
         MYLAN                  50MG                                      N018858   002    Apr   20,   1984

         PARKE DAVIS            25MG                                      N018806   001    Nov   23,   1984
	
                                50MG                                      N018806   002    Nov   23,   1984
	
         PIONEER PHARMS         25MG                                      A070813   001    Aug   11,   1986

                                50MG                                      A070592   001    Aug   11,   1986

         PLIVA                  25MG                                      A071148   001    Mar   18,   1987
	
                                50MG                                      A071149   001    Mar   18,   1987
	
         SUPERPHARM             25MG                                      A070487   001    Oct   10,   1986
	
                                50MG                                      A070488   001    Oct   10,   1986
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                           6-183(of 337)


INDOMETHACIN
	
  CAPSULE;ORAL
	
    INDOMETHACIN
	
         TEVA                   25MG                                 A071342   001    Apr   18,   1988

                                50MG                                 A071343   001    Apr   18,   1988

         VINTAGE		              25MG                                 N018829   002    Aug   06,   1984

                                50MG                                 A070651   001    Mar   05,   1986
	
                                50MG                                 N018829   001    Aug   06,   1984

         WATSON LABS		          25MG                                 A070529   001    Oct   18,   1985
	
                                25MG                                 A070784   001    Aug   20,   1986

                                25MG                                 A072996   001    Jul   31,   1991
	
                                25MG                                 N018690   001    Jul   31,   1984
	
                                50MG                                 A070530   001    Oct   18,   1985
	
                                50MG                                 A070785   001    Aug   20,   1986

                                50MG                                 A071635   001    May   18,   1987

                                50MG                                 A072997   001    Jul   31,   1991
	
                                50MG                                 N018690   002    Jul   31,   1984
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    INDOCIN SR
	
         IROKO PHARMS           75MG                                 N018185 001 Feb 23, 1982
	
    INDOMETHACIN
	
         ABLE                   75MG                                 A076114 001 Feb 06, 2002
	
         INWOOD LABS            75MG                                 A072410 001 Mar 15, 1989
	
  SUPPOSITORY;RECTAL
	
    INDOCIN
	
         IROKO PHARMS           50MG                                 N017814 001 Aug 13, 1984

  SUSPENSION;ORAL
	
    INDOMETHACIN
	
         CYCLE PHARMS LTD       25MG/5ML                             A071412 001 Mar 18, 1987
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    NOVOLOG MIX 50/50

         NOVO NORDISK INC       50 UNITS/ML;50 UNITS/ML              N021810 001 Aug 26, 2008

    NOVOLOG MIX 70/30 PENFILL

         NOVO NORDISK INC       210 UNITS/3ML;90 UNITS/3ML (70       N021172 002 Nov 01, 2001

                                UNITS/ML; 30 UNITS/ML)

                                210 UNITS/3ML;90 UNITS/3ML (70       N021172 003 Nov 01, 2001

                                UNITS/ML; 30 UNITS/ML)
	
INSULIN ASPART RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    NOVOLOG INNOLET
	
         NOVO NORDISK INC       300 UNITS/3ML (100 UNITS/ML)         N020986 004 Apr 23, 2004
	
INSULIN DETEMIR RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    LEVEMIR INNOLET
	
         NOVO NORDISK INC       300 UNITS/3ML (100 UNITS/ML)         N021536 003 Jun 16, 2005
	
    LEVEMIR PENFILL
	
         NOVO NORDISK INC       300 UNITS/3ML (100 UNITS/ML)         N021536 004 Jun 16, 2005
	
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
	
  INJECTABLE;INJECTION
	
    HUMALOG MIX 50/50 PEN

         LILLY                  50 UNITS/ML;50 UNITS/ML              N021018 003 Dec 22, 1999
	
    HUMALOG MIX 75/25 PEN

         LILLY                  75 UNITS/ML;25 UNITS/ML              N021017 003 Dec 22, 1999
	
INSULIN LISPRO RECOMBINANT
	
  INJECTABLE;INJECTION
	
    HUMALOG PEN
	
         LILLY                  100 UNITS/ML                         N020563 002 Aug 06, 1998
	
INSULIN PORK
	
  INJECTABLE;INJECTION
	
    ILETIN I
	
         LILLY                  500 UNITS/ML                         N017931 001
	
    INSULIN
	
         NOVO NORDISK INC       40 UNITS/ML                          N017926 001
	
    REGULAR INSULIN
	
         NOVO NORDISK INC       100 UNITS/ML                         N017926 003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                        6-184(of 337)


INSULIN PURIFIED BEEF
	
  INJECTABLE;INJECTION
	
    REGULAR ILETIN II
	
         LILLY
	                 100 UNITS/ML
	                           N018478 001
	
INSULIN PURIFIED PORK
	
  INJECTABLE;INJECTION
	
    ILETIN II
	
         LILLY
	                500   UNITS/ML
	                          N018344 002
	
    REGULAR ILETIN II (PORK)

         LILLY                  100   UNITS/ML
                           N018344 001
	
    REGULAR PURIFIED PORK INSULIN
	
         NOVO NORDISK INC       100   UNITS/ML
                           N018381 001
	
    VELOSULIN
	
         NOVO NORDISK INC       100   UNITS/ML
	                          N018193 001
	
INSULIN PURIFIED PORK; INSULIN SUSP ISOPHANE PURIFIED PORK
	
  INJECTABLE;INJECTION
	
    INSULIN NORDISK MIXTARD (PORK)

         NOVO NORDISK INC
	     30 UNITS/ML;70 UNITS/ML
	                 N018195 001
	
INSULIN RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN BR
	
         LILLY
	                 100 UNITS/ML
	                           N019529 001 Apr 28, 1986
	
    VELOSULIN BR
	
         NOVO NORDISK INC
	      100 UNITS/ML
	                           N021028 001 Jul 19, 1999
	
  POWDER;INHALATION
	
    EXUBERA
	
         PFIZER
	                1MG/INH
                                 N021868 001 Jan 27, 2006
	
                                 3MG/INH
	                                N021868 002 Jan 27, 2006
	
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN 50/50

         LILLY                  50 UNITS/ML;50 UNITS/ML
	                 N020100 001 Apr 29, 1992
	
INSULIN RECOMBINANT PURIFIED HUMAN
	
  INJECTABLE;INJECTION
	
    NOVOLIN R
         NOVO NORDISK INC       100 UNITS/ML                              N018778 001 Aug 30, 1983
	
    VELOSULIN BR HUMAN
         NOVO NORDISK INC       100 UNITS/ML                              N019450 001 May 30, 1986
	
INSULIN RECOMBINANT PURIFIED HUMAN; INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN
	
  INJECTABLE;INJECTION
	
    MIXTARD HUMAN 70/30

         BAYER PHARMS
	         30 UNITS/ML;70 UNITS/ML
	                 N019585 001 Mar 11, 1988
	
    NOVOLIN 70/30

         NOVO NORDISK INC
	     30 UNITS/ML;70 UNITS/ML
	                 N019441 001 Jul 11, 1986
	
INSULIN SUSP ISOPHANE BEEF
	
  INJECTABLE;INJECTION
	
    NPH INSULIN
	
         NOVO NORDISK INC
	      40 UNITS/ML
                             N017929 001
	
                                 100 UNITS/ML
	                           N017929 003
	
INSULIN SUSP ISOPHANE BEEF/PORK

  INJECTABLE;INJECTION
	
    NPH ILETIN I (BEEF-PORK)

         LILLY
	                 40 UNITS/ML
                             N017936 001
	
                                 100 UNITS/ML
	                           N017936 002
	
INSULIN SUSP ISOPHANE PURIFIED BEEF
	
  INJECTABLE;INJECTION
	
    NPH ILETIN II
	
         LILLY                  100 UNITS/ML
	                            N018479 001
	
INSULIN SUSP ISOPHANE PURIFIED PORK
	
  INJECTABLE;INJECTION
	
    INSULIN INSULATARD NPH NORDISK
	
         NOVO NORDISK INC       100 UNITS/ML
                             N018194 001
	
    NPH ILETIN II (PORK)

         LILLY                  100 UNITS/ML
                             N018345 001
	
    NPH PURIFIED PORK ISOPHANE INSULIN
	
         NOVO NORDISK INC       100 UNITS/ML
	                            N018623 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                6-185(of 337)


INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN
	
  INJECTABLE;INJECTION
	
    INSULATARD NPH HUMAN
         NOVO NORDISK INC       100 UNITS/ML                    N019449 001 May 30, 1986
	
    NOVOLIN N
         NOVO NORDISK INC       100 UNITS/ML                    N019065 001 Jan 23, 1985
	
INSULIN SUSP PROTAMINE ZINC BEEF/PORK

  INJECTABLE;INJECTION
	
    PROTAMINE ZINC & ILETIN I (BEEF-PORK)

         LILLY                  40 UNITS/ML
                    N017932 001
	
                                100 UNITS/ML
	                  N017932 002
	
INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF
	
  INJECTABLE;INJECTION
	
    PROTAMINE ZINC AND ILETIN II
	
         LILLY                  100 UNITS/ML
                   N018476 001
	
    PROTAMINE ZINC INSULIN
	
         BRISTOL MYERS SQUIBB   40 UNITS/ML
                    N017928 001
	
                                100 UNITS/ML
	                  N017928 003
	
INSULIN SUSP PROTAMINE ZINC PURIFIED PORK
	
  INJECTABLE;INJECTION
	
    PROTAMINE ZINC AND ILETIN II (PORK)

         LILLY                  100 UNITS/ML
	                  N018346 001
	
INSULIN ZINC SUSP BEEF
	
  INJECTABLE;INJECTION
	
    LENTE INSULIN
	
         NOVO NORDISK INC         40 UNITS/ML
                  N017998 001
	
                                  100 UNITS/ML
	                N017998 003
	
INSULIN ZINC SUSP EXTENDED BEEF
	
  INJECTABLE;INJECTION
	
    ULTRALENTE INSULIN
	
         NOVO NORDISK INC        100 UNITS/ML
	                 N017997 003
	
INSULIN ZINC SUSP EXTENDED PURIFIED BEEF
	
  INJECTABLE;INJECTION
	
    ULTRALENTE
	
         NOVO NORDISK INC       100 UNITS/ML
	                  N018385 001
	
INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN U
	
         LILLY                  40 UNITS/ML
                    N019571 001 Jun 10, 1987
	
                                100 UNITS/ML
	                  N019571 002 Jun 10, 1987
	
INSULIN ZINC SUSP PROMPT BEEF
	
  INJECTABLE;INJECTION
	
    SEMILENTE INSULIN
	
         NOVO NORDISK INC         100 UNITS/ML
	                N017996 003
	
INSULIN ZINC SUSP PROMPT PURIFIED PORK
	
  INJECTABLE;INJECTION
	
    SEMILENTE
	
         NOVO NORDISK INC       100 UNITS/ML
	                  N018382 001
	
INSULIN ZINC SUSP PURIFIED BEEF
	
  INJECTABLE;INJECTION
	
    LENTE ILETIN II
	
         LILLY                   100 UNITS/ML
	                 N018477 001
	
INSULIN ZINC SUSP PURIFIED BEEF/PORK

  INJECTABLE;INJECTION
	
    LENTARD
	
         NOVO NORDISK INC       100 UNITS/ML
	                  N018384 001
	
INSULIN ZINC SUSP PURIFIED PORK
	
  INJECTABLE;INJECTION
	
    LENTE
	
         NOVO NORDISK INC        100 UNITS/ML
                  N018383 001
	
    LENTE ILETIN II (PORK)

         LILLY                   100 UNITS/ML
	                 N018347 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	               6-186(of 337)


INSULIN ZINC SUSP RECOMBINANT HUMAN
	
  INJECTABLE;INJECTION
	
    HUMULIN L
         LILLY                  100 UNITS/ML                     N019377 002 Sep 30, 1985
	
    NOVOLIN L
         NOVO NORDISK INC       100 UNITS/ML                     N019965 001 Jun 25, 1991
	
INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN
	
  INJECTABLE;INJECTION
	
    NOVOLIN L
	
         NOVO NORDISK INC       100 UNITS/ML
	                   N018777 001 Aug 30, 1983
	
INULIN
	
  INJECTABLE;INJECTION
	
    INULIN AND SODIUM CHLORIDE
	
         ISO TEX                 100MG/ML
	                      N002282 001
	
INVERT SUGAR
	
  INJECTABLE;INJECTION
	
    TRAVERT 10% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        10GM/100ML
	                     N016717 001
	
IOBENGUANE SULFATE I-131
	
  INJECTABLE;INJECTION
	
    IOBENGUANE SULFATE I 131
	
         PHARMALUCENCE           2.3mCi/ML
	                     N020084 001 Mar 25, 1994
	
IOCETAMIC ACID
	
  TABLET;ORAL
	
    CHOLEBRINE
	
         MALLINCKRODT            750MG
	                         N017129 001
	
IODAMIDE MEGLUMINE
	
  INJECTABLE;INJECTION
	
    RENOVUE-65
	
         BRACCO                  65%
	                           N017902 001
	
    RENOVUE-DIP
	
         BRACCO                  24%
	                           N017903 001
	
IODIPAMIDE MEGLUMINE
	
  INJECTABLE;INJECTION
	
    CHOLOGRAFIN MEGLUMINE
	
         BRACCO                  10.3%
	                         N009321 007
	
IODIPAMIDE SODIUM
	
  INJECTABLE;INJECTION
	
    CHOLOGRAFIN SODIUM
	
         BRACCO                  20%
	                           N009321 001
	
IODOHIPPURATE SODIUM I-123
	
  INJECTABLE;INJECTION
	
    NEPHROFLOW
	
         GE HEALTHCARE           1mCi/ML
	                       N018289 001 Dec 28, 1984
	
IODOHIPPURATE SODIUM I-131
	
  INJECTABLE;INJECTION
	
    HIPPURAN I 131
	
         MALLINCKRODT            0.25mCi/ML
                     N016666 001
	
    HIPPUTOPE
	
         BRACCO                  1-2mCi/VIAL
                    N015419 002
	
    IODOHIPPURATE SODIUM I 131
	
         PHARMALUCENCE           0.2mCi/ML
	                     N017313 001
	
IODOXAMATE MEGLUMINE
	
  INJECTABLE;INJECTION
	
    CHOLOVUE
	
         BRACCO                  9.9%
	                          N018077 001
	
                                 40.3%
	                         N018076 001
	
IOFETAMINE HYDROCHLORIDE I-123
	
  INJECTABLE;INJECTION
	
    SPECTAMINE
	
         IMP                     1mCi/ML
	                       N019432 001 Dec 24, 1987
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                      6-187(of 337)


IOHEXOL
	
  INJECTABLE;INJECTION
	
    OMNIPAQUE 210
	
          GE HEALTHCARE         45.3%                            N018956 006 Jun 30, 1989
	
  SOLUTION;URETHRAL
	
    OMNIPAQUE 70
	
          GE HEALTHCARE         15.1%                            N018956 007 Jun 01, 1994
	
IOPAMIDOL
	
  INJECTABLE;INJECTION
	
    IOPAMIDOL
	
         BAXTER HLTHCARE		      41%                              A074629   001    Nov   06,   1996
	
                                51%                              A074629   004    Mar   31,   1998
	
                                61%                              A074629   002    Nov   06,   1996
	
                                76%                              A074629   003    Nov   06,   1996
	
         HOSPIRA		              61%                              A074734   001    Dec   10,   1996
	
                                76%                              A074734   002    Dec   10,   1996
	
   IOPAMIDOL-200
	
        COOK IMAGING           41%                               A074881 001 Jul 28, 2000
	
        HOSPIRA                41%                               A074898 001 Dec 30, 1997
	
   IOPAMIDOL-200 IN PLASTIC CONTAINER
	
        HOSPIRA                41%                               A074636 001 Dec 30, 1997
	
   IOPAMIDOL-250
	
        COOK IMAGING           51%                               A074881 002 Jul 28, 2000
	
        HOSPIRA                51%                               A074898 002 Dec 30, 1997
	
                               51%                               A075005 001 Feb 24, 1998
	
   IOPAMIDOL-250 IN PLASTIC CONTAINER
	
        HOSPIRA                51%                               A074636 002 Dec 30, 1997
	
   IOPAMIDOL-300
	
        ABBVIE                 61%                               A074638   001    Apr   30,   1997

        COOK IMAGING           61%                               A074881   003    Jul   28,   2000
	
        HOSPIRA                61%                               A074898   003    Dec   30,   1997
	
                               61%                               A075005   002    Feb   24,   1998
	
   IOPAMIDOL-300 IN PLASTIC CONTAINER
	
        HOSPIRA                61%                               A074636 003 Dec 30, 1997
	
                               61%                               A074637 001 Apr 03, 1997

   IOPAMIDOL-370
	
        COOK IMAGING           76%                               A074881 004 Jul 28, 2000
	
        HOSPIRA                76%                               A074898 004 Dec 30, 1997
	
                               76%                               A075005 003 Feb 24, 1998
	
   IOPAMIDOL-370 IN PLASTIC CONTAINER
	
        HOSPIRA                76%                               A074636 004 Dec 30, 1997
	
   ISOVUE-128
	
        BRACCO                 26%                               N018735 005 Oct 21, 1986
	
   ISOVUE-200
	
        BRACCO                 41%                               N020327 001 Oct 12, 1994
	
IOPANOIC ACID
	
  TABLET;ORAL
	
    TELEPAQUE
	
         GE HEALTHCARE		        500MG                            N008032 001
	
IOPHENDYLATE
	
  INJECTABLE;INJECTION
	
    PANTOPAQUE
	
         ALCON                  100%                             N005319 001
	
IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM
	
  INJECTABLE;INJECTION
	
    VASCORAY
	
         MALLINCKRODT           52%;26%                          N016783 001
	
IOTHALAMATE SODIUM
	
  INJECTABLE;INJECTION
	
    ANGIO-CONRAY
	
         MALLINCKRODT           80%                              N013319 001
	
    CONRAY 325
	
         MALLINCKRODT           54.3%                            N017685 001
	
    CONRAY 400
	
         MALLINCKRODT           66.8%                            N014295 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                               6-188(of 337)


IOTROLAN
	
  INJECTABLE;INTRATHECAL
	
    OSMOVIST 190
	
          BAYER HLTHCARE
	        40.6%
	                                   N019580 001 Dec 07, 1989
	
    OSMOVIST 240
	
          BAYER HLTHCARE
	        51.3%
	                                   N019580 002 Dec 07, 1989
	
IOVERSOL
	
  INJECTABLE;INJECTION
	
    OPTIRAY 160
	
          MALLINCKRODT
	          34%
	                                     N019710 003 Dec 30, 1988
	
    OPTIRAY 240
	
          MALLINCKRODT
	          51%
	                                     N020923 001 May 28, 1998
	
    OPTIRAY 320
	
          MALLINCKRODT
	          68%
	                                     N020923 002 May 29, 1998
	
IPODATE CALCIUM
	
  GRANULE;ORAL
	
    ORAGRAFIN CALCIUM
	
         BRACCO
	                 3GM/PACKET
	                              N012968 001
	
IPODATE SODIUM
	
  CAPSULE;ORAL
	
    BILIVIST
	
         BAYER HLTHCARE
	         500MG
	                                   A087768 001 Aug 11, 1982
	
    ORAGRAFIN SODIUM
	
         BRACCO
	                 500MG
	                                   N012967 001
	
IPRATROPIUM BROMIDE
	
  AEROSOL, METERED;INHALATION
	
    ATROVENT
	
         BOEHRINGER INGELHEIM
	   0.018MG/INH
	                             N019085 001 Dec 29, 1986
	
  SOLUTION;INHALATION
	
    ATROVENT
	
         BOEHRINGER INGELHEIM
	   0.02%
	                                   N020228 001 Sep 29, 1993
	
    IPRATROPIUM BROMIDE
	
         ACTAVIS MID ATLANTIC
	   0.02%
	                                   A075111   001     Apr   22,   1999

         APOTEX INC
	             0.02%
	                                   A075441   001     Mar   28,   2001
	
         PHARMASCIENCE INC
	      0.02%
	                                   A075507   001     Jan   19,   2001
	
         ROXANE
	                 0.02%
	                                   A075867   001     Jul   22,   2002
	
         TEVA PHARMS USA
	        0.02%
	                                   A075313   001     Feb   07,   2000
	
  SPRAY, METERED;NASAL
	
    IPRATROPIUM BROMIDE
	
         APOTEX INC
	             0.021MG/SPRAY
                            A076156 001 Apr 18, 2003

                                  0.042MG/SPRAY
	                           A076155 001 Apr 18, 2003
	
IRINOTECAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    IRINOTECAN HYDROCHLORIDE
	
         SANDOZ
	                 40MG/2ML (20MG/ML)
                       A077994 001 Feb 27, 2008
	
                                  100MG/5ML (20MG/ML)
	                     A077994 002 Feb 27, 2008
	
IRON DEXTRAN
	
  INJECTABLE;INJECTION
	
    IRON DEXTRAN
	
         SANOFI AVENTIS US
	      EQ 50MG IRON/ML
	                         N010787 002
	
IRON SUCROSE
	
  INJECTABLE;INTRAVENOUS
	
    VENOFER
	
         LUITPOLD
	               EQ 65MG BASE/3.25ML (EQ 20MG BASE/ML)
    N021135 005 Mar 29, 2013
	
                                  EQ 75MG BASE/3.75ML (EQ 20MG BASE/ML)
	   N021135 003 Mar 29, 2005
	
ISOETHARINE HYDROCHLORIDE
	
  SOLUTION;INHALATION
	
    BETA-2
	
         NEPHRON
	                1%
	                                      A086711 001
	
    BRONKOSOL
	
         SANOFI AVENTIS US
	      0.25%
	                                   N012339 009
	
                                  1%
	                                      N012339 008
	
   ISOETHARINE HYDROCHLORIDE
	
        ALPHARMA US PHARMS
	      1%
	                                      A087101   001
	
        ASTRAZENECA
	             0.062%
	                                  A087937   001     Nov   15,   1982
	
                                  0.062%
	                                  A089614   001     Jun   13,   1991
	
                                  0.125%
	                                  A087938   001     Nov   15,   1982
	
                                  0.125%
	                                  A089615   001     Jun   13,   1991
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                     6-189(of 337)


ISOETHARINE HYDROCHLORIDE
	
  SOLUTION;INHALATION
	
    ISOETHARINE HYDROCHLORIDE
	
                               0.167%
	                           A088470   001     Mar   14,   1984
	
                               0.167%
	                           A089616   001     Jun   13,   1991
	
                               0.2%
	                             A088471   001     Mar   14,   1984
	
                               0.2%
	                             A089617   001     Jun   13,   1991
	
                               0.25%
	                            A088472   001     Mar   14,   1984
	
                               0.25%
	                            A089618   001     Jun   13,   1991
	
        BAXTER HLTHCARE
	      0.08%
	                            A088144   001     Jul   29,   1983
	
                               0.14%
	                            A088145   001     Mar   26,   1984
	
                               0.25%
	                            A088146   001     Aug   01,   1983

        DEY
	                  0.08%
	                            A088187   001     Dec   03,   1982
	
                               0.1%
	                             A087389   001
	
                               0.17%
	                            A087390   001
	
                               0.25%
	                            A088188   001     Dec 03, 1982
	
                               1%
	                               A086763   001
	
        INTL MEDICATION
	      0.077%
	                           A086651   001
	
                               0.08%
	                            A086651   002
	
                               0.1%
	                             A086651   003
	
                               0.143%
	                           A086651   004
	
                               0.167%
	                           A086651   005
	
                               0.2%
	                             A086651   006
	
                               0.25%
	                            A086651   007
	
                               1%
	                               A086651   008
	
        PARKE DAVIS
	          0.5%
	                             A085997   001
	
                               1%
	                               A085889   001
	
        ROXANE
	               0.1%
	                             A087396   001
	
                               0.125%
	                           A087025   001
	
                               0.167%
	                           A088226   001     Sep 16, 1983

                               0.2%
	                             A087324   001
	
                               0.25%
	                            A088275   001     Jun 03, 1983
	
                               1%
	                               A086899   001
	
   ISOETHARINE HYDROCHLORIDE S/F

        DEY
	                  0.08%
	                            A089817   001     Nov   22,   1988
	
                               0.1%
	                             A089818   001     Nov   22,   1988
	
                               0.17%
	                            A089819   001     Nov   22,   1988
	
                               0.25%
	                            A089820   001     Nov   22,   1988
	
                               1%
	                               A089252   001     Sep   15,   1986
	
ISOETHARINE MESYLATE
	
  AEROSOL, METERED;INHALATION
	
    BRONKOMETER
	
         SANOFI AVENTIS US
	      0.34MG/INH
	                    N012339 007
	
    ISOETHARINE MESYLATE
	
         ALPHARMA US PHARMS
	     0.34MG/INH
	                    A087858 001 Aug 21, 1984
	
ISOFLURANE
	
  LIQUID;INHALATION
	
    ISOFLURANE
	
         WATSON LABS INC
	        99.9%
	                         A074393 001 May 12, 1995
	
ISOFLUROPHATE
	
  OINTMENT;OPHTHALMIC
	
    FLOROPRYL
	
         MERCK
	                  0.025%
	                        N010656 001
	
ISONIAZID
	
  INJECTABLE;INJECTION
	
    NYDRAZID
	
         SANDOZ
	                 100MG/ML
	                      N008662 001
	
    RIMIFON
	
         ROCHE
	                  25MG/ML
                        N008420 002
	
                                  100MG/ML
	                      N008420 003
	
 SYRUP;ORAL
	
   ISONIAZID
	
        MIKART
	                  50MG/5ML
	                      A081118 001 Jul 21, 1997
	
   LANIAZID
	
        LANNETT
	                 50MG/5ML
	                      A089243 001 Feb 03, 1986
	
   RIMIFON
	
        ROCHE
	                   50MG/5ML
	                      N008420 001
	
 TABLET;ORAL
	
   DOW-ISONIAZID
	
        DOW PHARM
	               300MG
	                         A080330 002
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                                DISCONTINUED DRUG PRODUCT LIST
	                 6-190(of 337)


ISONIAZID
	
  TABLET;ORAL
	
    HYZYD
	
         MEDPOINTE PHARM HLC
	       100MG
	                       A080134 003
	
                                     300MG
	                       A080134 004
	
    INH
	
         NOVARTIS
	                  300MG
	                       A080935 001
	
    ISONIAZID
	
         DURAMED PHARMS BARR
	       100MG
	                       A088231   001     Mar 17, 1983
	
                                     300MG
	                       A088119   001     Mar 17, 1983
	
            HALSEY
	                 50MG
	                        A083632   001
	
            HIKMA INTL PHARMS
	      100MG
	                       A080212   001
	
                                     300MG
	                       A087425   001
	
            IMPAX LABS
	             100MG
	                       A080153   001
	
            IVAX SUB TEVA PHARMS
	   100MG
	                       A080270   001
	
                                     300MG
	                       A083610   001
	
            LILLY
	                  100MG
	                       N008499   002
	
                                     300MG
	                       N008499   003
	
            MIKART
	                 100MG
	                       A040090   001     Jun 26, 1997
	
                                     300MG
	                       A040090   002     Jun 26, 1997
	
            MK LABS
	                100MG
	                       A080941   001
	
            MUTUAL PHARM
	           100MG
	                       A080136   001
	
                                     300MG
	                       A083633   001
	
            NEXGEN PHARMA INC
	      100MG
	                       A084050   001
	
            PANRAY
	                 50MG
	                        N008428   001
	
                                     100MG
	                       N008428   002
	
                                     300MG
	                       N008428   003
	
            PERRIGO
	                100MG
	                       A083060   001
	
            PHARMAVITE
	             100MG
	                       A085091   001
	
            PHOENIX LABS NY
	        50MG
	                        A080368   001
	
                                     100MG
	                       A080368   002
	
            PUREPAC PHARM
	          50MG
	                        A080132   003     Jul 14, 1982
	
                                     100MG
	                       A080132   004     Jul 14, 1982
	
            WATSON LABS
	            50MG
	                        A080522   001
	
                                     100MG
	                       A080401   001
	
                                     100MG
	                       A080523   001
	
                                     100MG
	                       A085790   001
	
                                     300MG
	                       A080521   001
	
                                     300MG
	                       A083178   001
	
                                     300MG
	                       A085784   001
	
         WHITEWORTH TOWN PLSN
	      100MG
	                       A080120   002
	
    LANIAZID
	
         LANNETT
	                   50MG
	                        A080140 001
	
                                     100MG
	                       A080140 002
	
    NYDRAZID
	
         BRISTOL MYERS SQUIBB
	      100MG
	                       N008392 003
	
    STANOZIDE
	
         EVERYLIFE
	                 100MG
	                       A080126 001
	
                                     300MG
	                       A080126 002
	
ISONIAZID; RIFAMPIN
	
  CAPSULE;ORAL
	
    RIFAMPIN AND ISONIAZID
	
         HIKMA INTL PHARMS
	         150MG;300MG
	                 A065221 001 Jul 29, 2005
	
ISOPROPAMIDE IODIDE
	
  TABLET;ORAL
	
    DARBID
	
         GLAXOSMITHKLINE
	           EQ 5MG BASE
	                 N010744 001
	
ISOPROTERENOL HYDROCHLORIDE
	
  AEROSOL, METERED;INHALATION
	
    ISOPROTERENOL HYDROCHLORIDE
	
         3M
	                     0.12MG/INH
                      N010375 004
	
         ALPHARMA US PHARMS
	     0.12MG/INH
	                     A085904 001
	
    ISUPREL
	
         SANOFI AVENTIS US
	      0.103MG/INH
	                    N011178 001
	
  DISC;INHALATION
	
    NORISODRINE AEROTROL
	
         ABBOTT
	                 0.25%
	                          N016814 001
	
  INJECTABLE;INJECTION
	
    ISOPROTERENOL HYDROCHLORIDE
	
         ABRAXIS PHARM
	          0.2MG/ML
                        A083431 001
	
         BAXTER HLTHCARE
	        0.2MG/ML
	                       A083486 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                              6-191(of 337)


ISOPROTERENOL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ISOPROTERENOL HYDROCHLORIDE
	
         HOSPIRA
	                0.02MG/ML
                              A083283 001
	
                                  0.2MG/ML
                               A083346 001
	
         INTL MEDICATION
	        0.2MG/ML
	                              A083724 001
	
  SOLUTION;INHALATION
	
    AEROLONE
	
         LILLY
	                  0.25%
	                                 N007245 001
	
    ISOPROTERENOL HYDROCHLORIDE
	
         ARMOUR PHARM
	           0.031%
	                                A087935   001 Nov 18, 1982
	
                                  0.062%
	                                A087936   001 Nov 18, 1982
	
         DEY
	                    0.5%
	                                  A086764   001 Jan 04, 1982
	
         PARKE DAVIS
	            0.25%
	                                 A085994   001
	
                                  0.5%
	                                  A085540   001
	
    ISUPREL
	
         SANOFI AVENTIS US
	      0.5%
	                                  N006327 002
	
                                  1%
	                                    N006327 003
	
    VAPO-ISO
	
         FISONS
	                 0.5%
	                                  N016813 001
	
  TABLET;RECTAL, SUBLINGUAL
	
    ISUPREL
	
         SANOFI AVENTIS US
	      10MG
	                                  N006328 001
	
                                  15MG
	                                  N006328 002
	
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
	
  AEROSOL, METERED;INHALATION
	
    DUO-MEDIHALER
	
         3M
	                   0.16MG/INH;0.24MG/INH
	                   N013296 001
	
ISOPROTERENOL SULFATE
	
  AEROSOL, METERED;INHALATION
	
    MEDIHALER-ISO
	
         3M
	                     0.08MG/INH
	                            N010375 003
	
  POWDER;INHALATION
	
    NORISODRINE
	
         ABBVIE
	                 10%
	                                   N006905 003
	
                                  25%
	                                   N006905 002
	
ISOSORBIDE
	
  SOLUTION;ORAL
	
    ISMOTIC
	
         ALCON
	                  100GM/220ML
	                           N017063 001
	
ISOSORBIDE DINITRATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    ISORDIL
	
         WYETH AYERST
	         40MG
	                                    N012882 002 Jul 29, 1988
	
  TABLET;ORAL
	
    ISORDIL
	
         VALEANT BERMUDA
	      10MG
	                                    N012093 002 Jul 29, 1988
	
                                20MG
	                                    N012093 006 Jul 29, 1988
	
                                30MG
	                                    N012093 005 Jul 29, 1988
	
    ISOSORBIDE DINITRATE
	
         MUTUAL PHARM
	         5MG
	                                     A086166   002    Sep   19,   1986

                                10MG
	                                    A086169   001    Sep   19,   1986

                                20MG
	                                    A086167   001    Sep   19,   1986

                                30MG
	                                    A087564   001    Sep   18,   1986

         SUPERPHARM
	           5MG
	                                     A089190   001    Feb   17,   1987
	
                                10MG
	                                    A089191   001    Feb   17,   1987
	
                                20MG
	                                    A089192   001    Feb   17,   1987
	
         WATSON LABS
	          5MG
	                                     A086034   001    Jan   06,   1988
	
                                10MG
	                                    A086032   001    Jan   07,   1988
	
    SORBITRATE
	
         ASTRAZENECA
	          5MG
	                                     N016192   001    Apr   01,   1996

                                10MG
	                                    N016192   002    Apr   01,   1996

                                20MG
	                                    A086405   002    Aug   21,   1990

                                30MG
	                                    A088124   001    Aug   21,   1990

                                40MG
	                                    A088125   001    Aug   21,   1990
	
  TABLET;SUBLINGUAL
	
    ISORDIL
	
         BIOVAIL
	              2.5MG
	                                   N012940 004 Jul 29, 1988
	
                                5MG
	                                     N012940 003 Jul 29, 1988
	
                                10MG **Federal Register determination
	   N012940 005 Jul 29, 1988
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-192(of 337)


ISOSORBIDE DINITRATE
	
  TABLET;SUBLINGUAL
	
    ISORDIL
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
   ISOSORBIDE DINITRATE
	
        HIKMA INTL PHARMS       2.5MG                                    A086054   001    Oct   29,   1987
	
                                5MG                                      A086055   001    Nov   02,   1987
	
         MUTUAL PHARM		         2.5MG                                    A084204   001    Sep   18,   1986

                                5MG                                      A086168   001    Sep   18,   1986

                                10MG                                     A087545   001    Sep   18,   1986

         SANDOZ		               2.5MG                                    A086225   001    Feb   19,   1988
	
                                5MG                                      A086222   001    Feb   19,   1988
	
         WATSON LABS		          2.5MG **Federal Register determination   A086033   001    Feb   26,   1988

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                5MG **Federal Register determination     A086031 001 Sep 29, 1987

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
   SORBITRATE
	
        ASTRAZENECA             2.5MG                                    N016191 002 Apr 01, 1996

                                5MG                                      N016191 001 Apr 01, 1996

 TABLET, CHEWABLE;ORAL
	
   SORBITRATE
	
        ASTRAZENECA             5MG                                      N016776 002 Apr 01, 1996

                                10MG                                     N016776 003 Apr 01, 1996

 TABLET, EXTENDED RELEASE;ORAL
	
   ISORDIL
	
        WYETH AYERST            40MG                                     N012882 001 Jul 29, 1988
	
ISOSORBIDE MONONITRATE
	
  TABLET;ORAL
	
    ISMO
	
           PROMIUS PHARMA        20MG                                    N019091 001 Dec 30, 1991
	
  TABLET, EXTENDED RELEASE;ORAL
	
    IMDUR
	
           SCHERING PLOUGH		     30MG                                    N020225 001 Aug 12, 1993

                                 60MG                                    N020225 002 Aug 12, 1993

                                 120MG                                   N020225 003 Mar 30, 1995
	
    ISOSORBIDE MONONITRATE
	
           ACTAVIS ELIZABETH     30MG                                    A075306   001    Dec   31,   1998
	
                                 60MG                                    A075306   002    Dec   31,   1998
	
           ALKERMES GAINESVILLE  60MG                                    A075041   001    Sep   22,   1998

           IVAX SUB TEVA PHARMS  30MG                                    A075448   002    Aug   07,   2001

                                 60MG                                    A075448   001    Jun   19,   2000
	
                                 120MG                                   A075448   003    Aug   07,   2001

           SKYEPHARMA AG         60MG                                    A075166   001    Oct   07,   1999
	
ISOSULFAN BLUE
	
  INJECTABLE;INJECTION
	
    LYMPHAZURIN
	
         COVIDIEN               1% **Federal Register determination      N018310 001
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
ISOTRETINOIN
	
  CAPSULE;ORAL
	
    ACCUTANE
	
         HOFFMANN LA ROCHE		    10MG                                     N018662 002 May 07, 1982

                                20MG                                     N018662 004 Mar 28, 1983
	
                                40MG                                     N018662 003 May 07, 1982
	
ISRADIPINE
	
  CAPSULE;ORAL
	
    DYNACIRC
	
         SMITHKLINE BEECHAM     2.5MG                                    N019546 001 Dec 20, 1990
	
                                5MG                                      N019546 002 Dec 20, 1990
	
 TABLET, EXTENDED RELEASE;ORAL
	
   DYNACIRC CR
	
        GLAXOSMITHKLINE LLC     5MG **Federal Register determination     N020336 001 Jun 01, 1994

                                that product was not discontinued or

                                withdrawn for safety or efficacy
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-193(of 337)


ISRADIPINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DYNACIRC CR
	
                                 reasons**
	
                                 10MG **Federal Register determination   N020336 002 Jun 01, 1994

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
ITRACONAZOLE
	
  INJECTABLE;INJECTION
	
    SPORANOX
	
         JANSSEN PHARMS          10MG/ML                                 N020966 001 Mar 30, 1999
	
IVERMECTIN
	
  TABLET;ORAL
	
    STROMECTOL
	
         MERCK SHARP DOHME       6MG                                     N050742 001 Nov 22, 1996
	
KANAMYCIN SULFATE
	
  CAPSULE;ORAL
	
    KANTREX
	
         APOTHECON		             EQ 500MG BASE                           A060516 001
	
                                 EQ 500MG BASE                           A061911 001
	
                                 EQ 500MG BASE                           A062726 001 Mar 06, 1987
	
  INJECTABLE;INJECTION
	
    KANAMYCIN
	
         HIKMA MAPLE		           EQ 1GM BASE/3ML                         A062324 003
	
                                 EQ 75MG BASE/2ML                        A062324 001
	
                                 EQ 500MG BASE/2ML                       A062324 002
	
    KANAMYCIN SULFATE
	
         ABRAXIS PHARM		         EQ   1GM BASE/3ML                       A062504   003    Apr   05,   1984

                                 EQ   75MG BASE/2ML                      A062504   001    Apr   05,   1984

                                 EQ   500MG BASE/2ML                     A062504   002    Apr   05,   1984

         INTL MEDICATION		       EQ   1GM BASE/3ML                       A062466   002    Sep   30,   1983

                                 EQ   500MG BASE/2ML                     A062466   001    Sep   30,   1983

         LOCH		                  EQ   1GM BASE/3ML                       A063025   001    Jul   31,   1992
	
                                 EQ   75MG BASE/2ML                      A063021   001    Jul   31,   1992
	
                                 EQ   500MG BASE/2ML                     A063022   001    Jul   31,   1992
	
         PHARMAFAIR		            EQ   1GM BASE/3ML                       A062669   001    May   07,   1987

                                 EQ   75MG BASE/2ML                      A062668   001    May   07,   1987

                                 EQ   500MG BASE/2ML                     A062672   001    May   07,   1987

         SOLOPAK		               EQ   1GM BASE/3ML                       A062605   002    Feb   26,   1986
	
                                 EQ   75MG BASE/2ML                      A062605   003    Feb   26,   1986
	
                                 EQ   500MG BASE/2ML                     A062605   001    Feb   26,   1986
	
         WARNER CHILCOTT         EQ   1GM BASE/3ML                       A063092   001    Oct   11,   1989
	
         WATSON LABS             EQ   1GM BASE/3ML                       A062520   003    May   09,   1985

    KANTREX
	
         APOTHECON		             EQ   1GM BASE/3ML                       A061655   002
	
                                 EQ   1GM BASE/3ML                       A061901   002
	
                                 EQ   1GM BASE/3ML                       A062564   003 Sep 21, 1984

                                 EQ   75MG BASE/2ML                      A061655   003
	
                                 EQ   75MG BASE/2ML                      A061901   003
	
                                 EQ   75MG BASE/2ML                      A062564   001 Sep 21, 1984

                                 EQ   500MG BASE/2ML                     A061655   001
	
                                 EQ   500MG BASE/2ML                     A061901   001
	
                                 EQ   500MG BASE/2ML                     A062564   002 Sep 21, 1984

    KLEBCIL
	
         KING PHARMS		           EQ 1GM BASE/3ML                         A062170 003
	
                                 EQ 75MG BASE/2ML                        A062170 001
	
                                 EQ 500MG BASE/2ML                       A062170 002
	
KETOCONAZOLE
	
  CREAM;TOPICAL
	
    NIZORAL
	
         JANSSEN PHARMA          2%                                      N019084 001 Dec 31, 1985
	
  SUSPENSION;ORAL
	
    NIZORAL
	
         JANSSEN PHARMA          100MG/5ML                               A070767 001 Nov 07, 1986
	
  TABLET;ORAL
	
    KETOCONAZOLE
	
         AAIPHARMA LLC           200MG                                   A075341   001    Jul   27,   1999
	
         APOTEX                  200MG                                   A075912   001    Jan   10,   2002
	
         MUTUAL PHARMA           200MG                                   A075314   001    Jun   15,   1999
	
         PLIVA                   200MG                                   A075362   001    Jun   15,   1999
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                             6-194(of 337)


KETOCONAZOLE
	
  TABLET;ORAL
	
    KETOCONAZOLE
	
         TEVA                    200MG
	                                    A074971 001
	 Jun 15, 1999
	
    NIZORAL
	
         JANSSEN PHARMS          200MG
	                                    N018533 001
	
KETOPROFEN
	
  CAPSULE;ORAL
	
    KETOPROFEN
	
         SANDOZ                  50MG
	                                     A074024 001
	 Dec 29, 1995
	
                                 75MG
	                                     A074024 002
	 Dec 29, 1995
	
         TEVA                    25MG
	                                     A073515 001
	 Dec 22, 1992
	
    ORUDIS
	
         WYETH AYERST		         25MG
	                                      N018754 001
	 Jul 31, 1987
	
                                50MG
	                                      N018754 002
	 Jan 09, 1986
	
                                75MG
	                                      N018754 003
	 Jan 09, 1986
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    KETOPROFEN
	
         ALKERMES GAINESVILLE   200MG
	                                     A074879 001
	 Dec 10, 1997
	
    ORUVAIL
	
         WYETH PHARMS INC		     100MG
	                                     N019816 003
	 Feb 08, 1995
	
                                150MG
	                                     N019816 002
	 Feb 08, 1995
	
                                200MG
	                                     N019816 001
	 Sep 24, 1993
	
  FILM;ORAL
	
    NEXCEDE
	
         NOVARTIS               12.5MG
	                                    N022470 001
	 Nov 25, 2009
	
  TABLET;ORAL
	
    ACTRON
	
         BAYER                  12.5MG
	                                    N020499 001
	 Oct 06, 1995
	
    KETOPROFEN
	
         PERRIGO                12.5MG
	                                    A075364 001
	 Feb 07, 2002
	
    ORUDIS KT
	
         WYETH CONS		           12.5MG **Federal Register determination
    N020429 001
	 Oct 06, 1995
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
KETOROLAC TROMETHAMINE
	
  INJECTABLE;INJECTION
	
    KETOROLAC TROMETHAMINE
	
         AMPHASTAR PHARM         15MG/ML
                                   A076209   001
	   Jul   21,   2004
	
                                 30MG/ML
                                   A076209   002
	   Jul   21,   2004
	
         APOTEX INC		            15MG/ML
                                   A075631   002
	   Jun   29,   2001
	
                                 30MG/ML
                                   A075626   001
	   Jul   24,   2001
	
                                 30MG/ML
                                   A075631   001
	   Jun   29,   2001
	
                                 30MG/ML
                                   A077201   001
	   Oct   14,   2005
	
         APOTHECON		             15MG/ML
                                   A075348   001
	   Nov   28,   2000
	
                                 30MG/ML
                                   A075348   002
	   Nov   28,   2000
	
         BEDFORD		               15MG/ML **Federal Register
                A075222   001
	   Apr   26,   1999
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 15MG/ML
                                   A075230 002
	 Oct 25, 1999
	
                                 30MG/ML **Federal Register
                A075222 002
	 Apr 26, 1999
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 30MG/ML **Federal Register
                A075228 001
	 Apr 26, 1999
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 30MG/ML
                                   A075230   001
	   Oct   25,   1999
	
         GLAND PHARMA LTD        15MG/ML
                                   A076722   001
	   Jul   27,   2004
	
                                 30MG/ML
                                   A076722   002
	   Jul   27,   2004
	
         HIKMA MAPLE             15MG/ML
                                   A075299   001
	   Nov   03,   1999
	
                                 15MG/ML
                                   A075772   001
	   Jul   21,   2004
	
                                 30MG/ML
                                   A075299   002
	   Nov   03,   1999
	
                                 30MG/ML
                                   A075772   002
	   Jul   21,   2004
	
         HOSPIRA                 15MG/ML
                                   A074801   001
	   Jun   05,   1997
	
                                 30MG/ML
                                   A074801   002
	   Jun   05,   1997
	
         LUITPOLD                15MG/ML
                                   A078145   001
	   Jan   14,   2008
	
                                 30MG/ML
                                   A078145   002
	   Jan   14,   2008
	
         SANDOZ                  15MG/ML
                                   A076271   001
	   Oct   06,   2004
	
         SUN PHARMA GLOBAL       15MG/ML
	                                  A078737   001
	   Oct   06,   2008
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                      6-195(of 337)


KETOROLAC TROMETHAMINE
	
  INJECTABLE;INJECTION
	
    KETOROLAC TROMETHAMINE
	
                                  30MG/ML                        A078737 002 Oct 06, 2008
	
        WOCKHARDT                 30MG/ML                        A077943 001 Mar 27, 2007
	
   TORADOL
	
        ROCHE PALO                15MG/ML                        N019698 001 Nov 30, 1989
	
                                  30MG/ML                        N019698 002 Nov 30, 1989
	
 SOLUTION/DROPS;OPHTHALMIC

   ACULAR PRESERVATIVE FREE
	
        ALLERGAN                  0.5%                           N020811 001 Nov 03, 1997
	
   KETOROLAC TROMETHAMINE
	
        AKORN                     0.45%                          A203376 001 Feb 10, 2014
	
 TABLET;ORAL
	
   KETOROLAC TROMETHAMINE
	
        CYCLE PHARMS LTD          10MG                           A074790 001 Jun 26, 1997
	
        WATSON LABS               10MG                           A074955 001 Sep 19, 1997

   TORADOL
	
        ROCHE PALO                10MG                           N019645 001 Dec 20, 1991
	
KETOTIFEN FUMARATE
	
  SOLUTION/DROPS;OPHTHALMIC

    KETOTIFEN FUMARATE
	
         APOTEX INC               EQ 0.025% BASE                 A077354 001 May 09, 2006
	
KRYPTON, KR-81M
	
  GAS;INHALATION
	
    MPI KRYPTON 81M GENERATOR
	
         GE HEALTHCARE            N/A                            N018088 001
	
LABETALOL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    LABETALOL HYDROCHLORIDE
	
         APOTEX INC               5MG/ML                         A076051 001 Jul 05, 2002
	
         APOTHECON                5MG/ML                         A075355 001 Nov 29, 1999
	
         HOSPIRA                  5MG/ML                         A075242 001 Sep 30, 1999

    NORMODYNE
	
         SCHERING                 5MG/ML                         N018686 001 Aug 01, 1984

    TRANDATE
	
         PROMETHEUS LABS          5MG/ML                         N019425 001 Dec 31, 1985
	
  TABLET;ORAL
	
    LABETALOL HYDROCHLORIDE
	
         APOTHECON		              100MG                          A075223   001    Nov   20,   1998
	
                                  200MG                          A075223   002    Nov   20,   1998
	
                                  300MG                          A075223   003    Nov   20,   1998
	
         MUTUAL PHARM		           100MG                          A075215   001    Jul   29,   1999
	
                                  200MG                          A075215   002    Jul   29,   1999
	
                                  300MG                          A075215   003    Jul   29,   1999
	
         TEVA		                   100MG                          A074989   001    Sep   30,   1998

                                  200MG                          A074989   002    Sep   30,   1998

                                  300MG                          A074989   003    Sep   30,   1998

   NORMODYNE
	
        SCHERING		                100MG                          N018687   001    Aug   31,   1987

                                  200MG                          N018687   002    Aug   01,   1984

                                  300MG                          N018687   003    Aug   01,   1984

                                  400MG                          N018687   004    Aug   01,   1984

   TRANDATE
	
        CNTY LINE PHARMS          400MG                          N018716 004 Aug 01, 1984
	
LACTULOSE
	
  SOLUTION;ORAL
	
    CHRONULAC
	
         SANOFI AVENTIS US        10GM/15ML                      N017884 001
	
    DUPHALAC
	
         SOLVAY                   10GM/15ML                      A072372 001 Mar 22, 1989
	
    EVALOSE
	
         TEVA PHARMS              10GM/15ML                      A073497 001 May 28, 1993

    LACTULOSE
	
         APOTEX INC               10GM/15ML                      A075911 001 Feb 21, 2002
	
         MORTON GROVE             10GM/15ML                      A071841 001 Sep 22, 1988

         PACO                     10GM/15ML                      A073160 001 Aug 25, 1992

    LAXILOSE
	
         NOSTRUM LABS             10GM/15ML                      A073686 001 May 28, 1993
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                       6-196(of 337)


LACTULOSE
	
  SOLUTION;ORAL, RECTAL
	
    ACILAC
	
         NOSTRUM LABS           10GM/15ML                         A073685 001 May 28, 1993

    CEPHULAC
	
         SANOFI AVENTIS US      10GM/15ML                         N017657 001
	
    GENERLAC
	
         MORTON GROVE           10GM/15ML                         A071842 001 Sep 27, 1988

    HEPTALAC
	
         TEVA PHARMS            10GM/15ML                         A073504 001 May 28, 1993

    LACTULOSE
	
         APOTEX INC             10GM/15ML                         A076645   001 Jul 28, 2003
	
         PACO                   10GM/15ML                         A072029   001 Aug 25, 1992

         ROXANE                 10GM/15ML                         A073590   001 May 29, 1992

         SOLVAY                 10GM/15ML                         N017906   001
	
    PORTALAC
	
         SOLVAY                 10GM/15ML                         A072374 001 Mar 22, 1989
	
LAMOTRIGINE
	
  TABLET;ORAL
	
    LAMICTAL
	
         GLAXOSMITHKLINE LLC    50MG                              N020241 006 Dec 27, 1994
	
                                250MG                             N020241 004 Dec 27, 1994
	
   LAMOTRIGINE
	
        ACTAVIS TOTOWA		        25MG                              A078669   001    Apr   08,   2011

                                100MG                             A078669   002    Apr   08,   2011

                                150MG                             A078669   003    Apr   08,   2011

                                200MG                             A078669   004    Apr   08,   2011

        MATRIX LABS LTD		       25MG                              A078443   001    Feb   11,   2009
	
                                100MG                             A078443   002    Feb   11,   2009
	
                                150MG                             A078443   003    Feb   11,   2009
	
                                200MG                             A078443   004    Feb   11,   2009
	
        MYLAN		                 25MG                              A077428   001    Jan   27,   2009
	
                                100MG                             A077428   002    Jan   27,   2009
	
                                150MG                             A077428   003    Jan   27,   2009
	
                                200MG                             A077428   004    Jan   27,   2009
	
        PHARMASCIENCE INC		     25MG                              A078310   001    Feb   04,   2009
	
                                100MG                             A078310   002    Feb   04,   2009
	
                                150MG                             A078310   003    Feb   04,   2009
	
                                200MG                             A078310   004    Feb   04,   2009
	
        ROXANE		                25MG                              A077392   001    Jan   27,   2009
	
                                100MG                             A077392   002    Jan   27,   2009
	
                                150MG                             A077392   003    Jan   27,   2009
	
                                200MG                             A077392   004    Jan   27,   2009
	
        SANDOZ		                25MG                              A078645   001    Jan   27,   2009
	
                                100MG                             A078645   002    Jan   27,   2009
	
                                150MG                             A078645   003    Jan   27,   2009
	
                                200MG                             A078645   004    Jan   27,   2009
	
        WOCKHARDT		             25MG                              A078982   001    Jan   27,   2009
	
                                100MG                             A078982   002    Jan   27,   2009
	
                                150MG                             A078982   003    Jan   27,   2009
	
                                200MG                             A078982   004    Jan   27,   2009
	
 TABLET, CHEWABLE;ORAL
	
   LAMICTAL CD
	
        GLAXOSMITHKLINE LLC     100MG                             N020764 003 Aug 24, 1998

   LAMOTRIGINE
	
        SANDOZ                  5MG                               A078409 002 Jan 22, 2009
	
                                25MG                              A078409 003 Jan 22, 2009
	
LANSOPRAZOLE
	
  FOR SUSPENSION, DELAYED RELEASE;ORAL
	
    PREVACID
	
         TAKEDA PHARMS NA       15MG/PACKET                       N021281 001 May 03, 2001

                                30MG/PACKET                       N021281 002 May 03, 2001

  INJECTABLE;INTRAVENOUS
	
    PREVACID IV
	
         TAKEDA PHARMS NA       30MG/VIAL                         N021566 001 May 27, 2004

  TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING;ORAL
	
    LANSOPRAZOLE
	
         ANI PHARMS INC         15MG                              A078730 001 Oct 15, 2010
	
                                30MG                              A078730 002 Oct 15, 2010
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                 6-197(of 337)


LANSOPRAZOLE; NAPROXEN
	
  CAPSULE, DELAYED REL PELLETS, TABLET;ORAL
	
    PREVACID NAPRAPAC 250 (COPACKAGED)

         TAKEDA PHARMS NA       15MG,N/A;N/A,250MG **Federal Register      N021507 002 Nov 14, 2003

                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

    PREVACID NAPRAPAC 375 (COPACKAGED)

         TAKEDA PHARMS NA       15MG,N/A;N/A,375MG                         N021507 003 Nov 14, 2003
	
    PREVACID NAPRAPAC 500 (COPACKAGED)

         TAKEDA PHARMS NA       15MG,N/A;N/A,500MG                         N021507 004 Nov 14, 2003
	
LANTHANUM CARBONATE
	
  TABLET, CHEWABLE;ORAL
	
    FOSRENOL
	
         SHIRE LLC              EQ 250MG BASE                              N021468 001 Oct 26, 2004
	
LAPYRIUM CHLORIDE; UNDECOYLIUM CHLORIDE IODINE COMPLEX
	
  SOLUTION;TOPICAL
	
    VIRAC REX
	
         CHESEBROUGH PONDS      0.5%;1.8%                                  N011914 001
	
LATANOPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    LATANOPROST
	
         APOTEX INC             0.005%                                     A077697 001 Mar 22, 2011
	
LEFLUNOMIDE
	
  TABLET;ORAL
	
    LEFLUNOMIDE
	
         SANDOZ		               10MG                                       A077085   001     Sep   13,   2005

                                10MG                                       A077087   001     Sep   13,   2005

                                20MG                                       A077085   002     Sep   13,   2005

                                20MG                                       A077087   002     Sep   13,   2005
	
LEPIRUDIN RECOMBINANT
	
  INJECTABLE;INJECTION
	
    REFLUDAN
	
         BAYER HLTHCARE         50MG/VIAL                                  N020807 001 Mar 06, 1998
	
LETROZOLE
	
  TABLET;ORAL
	
    LETROZOLE
	
         ACTAVIS TOTOWA         2.5MG                                      A090292 001 Jul 13, 2011
	
         IMPAX LABS             2.5MG                                      A091638 001 Jun 03, 2011
	
         SYNTHON PHARMS         2.5MG                                      A090196 001 Jun 03, 2011
	
LEUCOVORIN CALCIUM
	
  FOR SOLUTION;ORAL
	
    LEUCOVORIN CALCIUM
	
         HOSPIRA                EQ 60MG BASE/VIAL                          N008107 003 Jan 30, 1987
	
  INJECTABLE;INJECTION
	
    LEUCOVORIN CALCIUM
	
         ABIC                   EQ 3MG BASE/ML                             A089352   001     Jun   01,   1988
	
                                EQ 50MG BASE/VIAL                          A089353   001     Jun   01,   1988
	
         ABRAXIS PHARM          EQ 50MG BASE/VIAL                          A088939   001     Dec   01,   1986
	
         ELKINS SINN            EQ 50MG BASE/VIAL                          A070480   001     Jan   02,   1987
	
                                EQ 100MG BASE/VIAL		                       A081224   001     Jun   03,   1994
	
         HOSPIRA		              EQ 3MG BASE/ML                             N008107   001
	
                                EQ 50MG BASE/VIAL                          N008107   002
	
                                EQ 100MG BASE/VIAL                         N008107   004     May   23,   1988

                                EQ 350MG BASE/VIAL                         N008107   005     Apr   05,   1989

         PHARMACHEMIE           EQ 350MG BASE/VIAL                         A040262   001     Dec   15,   1999
	
         PHARMACHEMIE USA       EQ 50MG BASE/VIAL                          A089628   001     Apr   17,   1997

                                EQ 100MG BASE/VIAL                         A089915   001     Apr   17,   1997

         TEVA PARENTERAL        EQ 50MG BASE/VIAL                          A081278   001     Sep   28,   1993

    LEUCOVORIN CALCIUM PRESERVATIVE FREE
	
         HOSPIRA		              EQ 10MG BASE/ML **Federal Register         A040147 001 Jun 25, 1997

                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

         LUITPOLD               EQ 50MG BASE/VIAL                          A040338 001 Jan 31, 2001
	
         TEVA PARENTERAL        EQ 10MG BASE/ML                            A040332 001 Jun 28, 1999
	
    WELLCOVORIN
	
         GLAXOSMITHKLINE		      EQ 5MG BASE/ML                             A087439 001 Oct 19, 1982
	
                                EQ 25MG BASE/VIAL                          A089833 001 Jan 23, 1989
	
                                EQ 50MG BASE/VIAL                          A089465 001 Jan 23, 1989
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                 6-198(of 337)


LEUCOVORIN CALCIUM
	
  INJECTABLE;INJECTION
	
    WELLCOVORIN
	
                                 EQ 100MG BASE/VIAL                         A089834 001 Jan 23, 1989
	
 TABLET;ORAL
	
   LEUCOVORIN CALCIUM
	
        COREPHARMA               EQ   5MG BASE                              A074544   001    Aug   28,   1997

                                 EQ   25MG BASE                             A074544   002    Aug   28,   1997

         PAR PHARM               EQ   5MG BASE                              A071600   001    Oct   14,   1987
	
                                 EQ   25MG BASE                             A071598   001    Oct   14,   1987
	
         PHARMACHEMIE            EQ   5MG BASE                              A073099   001    Mar   28,   1997
	
                                 EQ   25MG BASE                             A073101   001    Mar   28,   1997
	
         SANDOZ                  EQ   15MG BASE                             A075327   001    Mar   24,   1999
	
         XANODYNE PHARM          EQ   5MG BASE                              N018459   001    Jan   30,   1986
	
                                 EQ   10MG BASE                             A071962   001    Nov   19,   1987
	
                                 EQ   15MG BASE                             A071104   001    Mar   04,   1987
	
   WELLCOVORIN
	
        GLAXOSMITHKLINE          EQ 5MG BASE                                N018342 001 Jul 08, 1983
	
                                 EQ 25MG BASE                               N018342 002 Jul 08, 1983
	
LEUPROLIDE ACETATE
	
  IMPLANT;IMPLANTATION
	
    VIADUR
	
         ORTHO MCNEIL JANSSEN    EQ 65MG BASE                               N021088 001 Mar 03, 2000
	
  INJECTABLE;INJECTION
	
    LEUPROLIDE ACETATE
	
         GENZYME                 1MG/0.2ML                                  A075721 001 Nov 29, 2001
	
    LUPRON
	
         ABBVIE ENDOCRINE INC    1MG/0.2ML                                  N019010 001 Apr 09, 1985

    LUPRON DEPOT
	
         ABBVIE ENDOCRINE INC    3.75MG/VIAL **Federal Register             N020011 001 Oct 22, 1990

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

   LUPRON DEPOT-PED
	
        ABBVIE ENDOCRINE INC     3.75MG/VIAL,7.5MG/VIAL;3.75MG/VIAL,7.5M    N020263 003 Apr 16, 1993

                                 G/VIAL **Federal Register determination

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 7.5MG/VIAL,7.5MG/VIAL;7.5MG/VIAL,7.5MG/    N020263 004 Apr 16, 1993

                                 VIAL **Federal Register determination

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
LEVALLORPHAN TARTRATE
	
  INJECTABLE;INJECTION
	
    LORFAN
	
         ROCHE                   1MG/ML                                     N010423 001
	
LEVAMISOLE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ERGAMISOL
	
         JANSSEN PHARMA          EQ 50MG BASE                               N020035 001 Jun 18, 1990
	
LEVETIRACETAM
	
  SOLUTION;ORAL
	
    LEVETIRACETAM
	
         APOTEX INC              100MG/ML                                   A090187 001 Aug 05, 2011

  TABLET;ORAL
	
    LEVETIRACETAM
	
         ACTAVIS LABS FL INC		   250MG                                      A077408   001    Mar   02,   2009
	
                                 500MG                                      A077408   002    Mar   02,   2009
	
                                 750MG                                      A077408   003    Mar   02,   2009
	
         MYLAN		                 1GM                                        A078731   004    Feb   10,   2009
	
                                 250MG                                      A078731   001    Feb   10,   2009
	
                                 500MG                                      A078731   002    Feb   10,   2009
	
                                 750MG                                      A078731   003    Feb   10,   2009
	
         SANDOZ		                1GM                                        A077324   004    Jan   15,   2009
	
                                 250MG                                      A077324   001    Jan   15,   2009
	
                                 500MG                                      A077324   002    Jan   15,   2009
	
                                 750MG                                      A077324   003    Jan   15,   2009
	
         WATSON LABS INC		       1GM                                        A078797   001    Jan   15,   2009
	
                                 250MG                                      A078797   002    Jan   15,   2009
	
                                 500MG                                      A078797   003    Jan   15,   2009
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                          6-199(of 337)


LEVETIRACETAM
	
  TABLET;ORAL
	
    LEVETIRACETAM
	
                                 750MG
	                                   A078797 004
	 Jan 15, 2009
	
  TABLET, EXTENDED RELEASE;ORAL
	
    LEVETIRACETAM
	
         SANDOZ
	                500MG
	                                   A091668 001
	 Nov 01, 2012
	
                                 750MG
	                                   A091668 002
	 Nov 01, 2012
	
LEVOBETAXOLOL HYDROCHLORIDE
	
  SUSPENSION/DROPS;OPHTHALMIC

    BETAXON
	
         ALCON PHARMS LTD
	       EQ 0.5% BASE
	                           N021114 001
	 Feb 23, 2000
	
LEVOBUNOLOL HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    LEVOBUNOLOL HYDROCHLORIDE
	
         APOTEX INC
	             0.25%
	                                  A075473 001
	 Aug 03, 2000

                                  0.5%
	                                   A075475 001
	 Aug 03, 2000
	
LEVOBUPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CHIROCAINE
	
         PURDUE PHARMA LP
	       EQ 2.5MG BASE/ML
                        N020997 001
	 Aug 05, 1999

                                  EQ 5MG BASE/ML
                          N020997 002
	 Aug 05, 1999

                                  EQ 7.5MG BASE/ML
	                       N020997 003
	 Aug 05, 1999
	
LEVOCABASTINE HYDROCHLORIDE
	
  SUSPENSION/DROPS;OPHTHALMIC

    LIVOSTIN
	
         NOVARTIS
	               EQ 0.05% BASE
	                          N020219 001
	 Nov 10, 1993
	
LEVOCARNITINE
	
  SOLUTION;ORAL
	
    CARNITOR
	
         SIGMA TAU
	              1GM/10ML
	                               N018948 002
	 Apr 27, 1988
	
LEVOCETIRIZINE DIHYDROCHLORIDE
	
  TABLET;ORAL
	
    LEVOCETIRIZINE DIHYDROCHLORIDE
	
         SANDOZ
	                5MG
	                                     A090486 001
	 Mar 26, 2013
	
LEVODOPA
	
  CAPSULE;ORAL
	
    BENDOPA
	
          VALEANT PHARM INTL
	    100MG
	                                  N016948 003
	
                                  250MG
	                                  N016948 001
	
                                  500MG
	                                  N016948 002
	
    DOPAR
	
         SHIRE
	                  100MG
	                                  N016913 003
	
                                  250MG
	                                  N016913 001
	
                                  500MG
	                                  N016913 002
	
    LARODOPA
	
         ROCHE
	                  100MG
	                                  N016912 002
	
                                  250MG
	                                  N016912 001
	
                                  500MG
	                                  N016912 006
	
  TABLET;ORAL
	
    DOPAR
	
         SHIRE
	                  250MG
	                                  N016913 004
	
                                  500MG
	                                  N016913 005
	
    LARODOPA
	
         ROCHE
	                  100MG
	                                  N016912 005
	
                                  250MG
	                                  N016912 003
	
                                  500MG
	                                  N016912 004
	
LEVOFLOXACIN
	
  INJECTABLE;INJECTION
	
    LEVOFLOXACIN
	
         AKORN
	                  EQ 500MG/20ML (EQ 25MG/ML)
              A091644 001
	 Jun 20, 2011
	
                                  EQ 750MG/30ML (EQ 25MG/ML)
	             A091644 002
	 Jun 20, 2011
	
  SOLUTION/DROPS;OPHTHALMIC

    IQUIX
	
         SANTEN
	                 1.5% **Federal Register determination
   N021571 001
	 Mar 01, 2004
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                          6-200(of 337)


LEVOFLOXACIN
	
  SOLUTION/DROPS;OPHTHALMIC

    LEVOFLOXACIN
	
         APOTEX INC
	           0.5%
	                                     A078282 001
	 Dec 20, 2010
	
  TABLET;ORAL
	
    LEVOFLOXACIN
	
         WATSON LABS INC
	      250MG
	                                    A201484 001
	 Nov 22, 2013
	
                                500MG
	                                    A201484 002
	 Nov 22, 2013
	
                                750MG
	                                    A201484 003
	 Nov 22, 2013
	
LEVOLEUCOVORIN CALCIUM
	
  SOLUTION;IV (INFUSION)

    FUSILEV
	
         SPECTRUM PHARMS
	      EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML)
    N020140 002
	 Apr 29, 2011
	
                                **Federal Register determination that

                                product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
      N020140 003
	 Apr 29, 2011
	
                                **Federal Register determination that

                                product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
LEVOMEPROMAZINE
	
  INJECTABLE;INJECTION
	
    LEVOPROME
	
         IMMUNEX
	              20MG/ML
	                                  N015865 001
	
LEVOMETHADYL ACETATE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    ORLAAM
	
         ROXANE                 10MG/ML **Federal Register
                N020315 001
	 Jul 09, 1993
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN

         SOLVAY                 0.05MG/ML;2%
                              A085010 001
	
    CARBOCAINE W/ NEO-COBEFRIN

         EASTMAN KODAK          0.05MG/ML;2%
                              N012125 002
	
    ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN

         NOVOCOL                0.05MG/ML;2%
                              A084697 001
	
    MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN

         GRAHAM CHEM            0.05MG/ML;2%
                              A084850 002
	 Oct 21, 1983
	
    POLOCAINE W/ LEVONORDEFRIN

         DENTSPLY PHARM         0.05MG/ML;2%
	                             A089517 001
	 Apr 14, 1988
	
LEVONORDEFRIN; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN

         EASTMAN KODAK          0.05MG/ML;2%;0.4%
	                        N008592 007
	
LEVONORGESTREL
	
  IMPLANT;IMPLANTATION
	
    JADELLE
	
         POPULATION COUNCIL     75MG/IMPLANT **Federal Register
           N020544 001
	 Nov 01, 1996
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

   LEVONORGESTREL
	
        WYETH PHARMS INC       75MG/IMPLANT
                               N020627 001
	 Aug 15, 1996
	
   NORPLANT
	
        POPULATION COUNCIL     36MG/IMPLANT
                               N019897 001
	 Dec 10, 1990
	
   NORPLANT SYSTEM IN PLASTIC CONTAINER
	
        WYETH PHARMS INC
	     36MG/IMPLANT
	                              N020088 001
	 Dec 10, 1990
	
 TABLET;ORAL
	
   LEVONORGESTREL
	
        LUPIN LTD
	            0.75MG
	                                    A091328 001
	 Jan 23, 2013
	
        WATSON LABS
	          0.75MG
	                                    A078666 001
	 Jun 24, 2009
	
   PLAN B
	
        TEVA BRANDED PHARM
	   0.75MG
	                                    N021045 001
	 Jul 28, 1999
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                       6-201(of 337)


LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
	
  CAPSULE;ORAL
	
    NOVRAD
         LILLY                  EQ 50MG BASE                   N012928 006
                                EQ 100MG BASE                  N012928 004
  SUSPENSION;ORAL
    NOVRAD
         LILLY                  EQ 50MG BASE/5ML               N012928 002
LEVORPHANOL TARTRATE
  INJECTABLE;INJECTION
    LEVO-DROMORAN
         VALEANT PHARM INTL    2MG/ML                          N008719 001 Dec 19, 1991
  TABLET;ORAL
    LEVO-DROMORAN
         VALEANT PHARM INTL    2MG                             N008720 001 Dec 19, 1991
LEVOTHYROXINE SODIUM
  TABLET;ORAL
    LEVOLET
         VINTAGE               0.025MG                         N021137   001    Jun   06,   2003
                               0.05MG                          N021137   002    Jun   06,   2003
                               0.075MG                         N021137   003    Jun   06,   2003
                               0.088MG                         N021137   004    Jun   06,   2003
                               0.1MG                           N021137   005    Jun   06,   2003
                               0.112MG                         N021137   006    Jun   06,   2003
                               0.125MG                         N021137   007    Jun   06,   2003
                               0.137MG                         N021137   008    Jun   06,   2003
                               0.15MG                          N021137   009    Jun   06,   2003
                               0.175MG                         N021137   010    Jun   06,   2003
                               0.2MG                           N021137   011    Jun   06,   2003
                               0.3MG                           N021137   012    Jun   06,   2003
   LEVOTHYROXINE SODIUM
        MERCK KGAA             0.025MG                         A076752   001    Jun   16,   2005
                               0.05MG                          A076752   002    Jun   16,   2005
                               0.075MG                         A076752   003    Jun   16,   2005
                               0.088MG                         A076752   004    Jun   16,   2005
                               0.1MG                           A076752   005    Jun   16,   2005
                               0.112MG                         A076752   006    Jun   16,   2005
                               0.125MG                         A076752   007    Jun   16,   2005
                               0.15MG                          A076752   008    Jun   16,   2005
                               0.175MG                         A076752   009    Jun   16,   2005
                               0.2MG                           A076752   010    Jun   16,   2005
                               0.3MG                           A076752   011    Jun   16,   2005
   LEVOXYL
        KING PHARMS R AND D    0.3MG                           N021301 012 May 25, 2001
   NOVOTHYROX
        MERCK KGAA             0.025MG                         N021292   001    May   31,   2002
                               0.05MG                          N021292   002    May   31,   2002
                               0.075MG                         N021292   003    May   31,   2002
                               0.088MG                         N021292   004    May   31,   2002
                               0.1MG                           N021292   005    May   31,   2002
                               0.112MG                         N021292   006    May   31,   2002
                               0.125MG                         N021292   007    May   31,   2002
                               0.137MG                         N021292   008    May   31,   2002
                               0.15MG                          N021292   009    May   31,   2002
                               0.175MG                         N021292   010    May   31,   2002
                               0.2MG                           N021292   011    May   31,   2002
                               0.3MG                           N021292   012    May   31,   2002
LIDOCAINE
  AEROSOL;ORAL
    XYLOCAINE
         ASTRAZENECA            10%                            N014394 001
  FILM, EXTENDED RELEASE;BUCCAL
    DENTIPATCH
         NOVEN                  23MG/PATCH                     N020575 001 May 21, 1996
  OINTMENT;TOPICAL
    ALPHACAINE
         CARLISLE               5%                             A084944 001
                                5%                             A084946 001
                                5%                             A084947 001
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                             6-202(of 337)


LIDOCAINE
	
  OINTMENT;TOPICAL
	
    LIDOCAINE
	
         GRAHAM CHEM
	            5%
	                                      A080210 001
	
    XYLOCAINE
	
         ASTRAZENECA
	            5%
	                                      N008048 001
	
  PATCH;TOPICAL
	
    DENTIPATCH
	
         NOVEN
	                  46.1MG/PATCH
	                            N020575 002 May 21, 1996
	
  SOLUTION;TOPICAL
	
    XYLOCAINE
	
         ASTRAZENECA
	            5%
	                                      N014127 001
	
  SUPPOSITORY;RECTAL
	
    XYLOCAINE
	
         ASTRAZENECA
	            100MG
	                                   N013077 001
	
LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ALPHACAINE HYDROCHLORIDE
	
         CARLISLE
	               2%
	                                      A084721 001
	
    LIDOCAINE HYDROCHLORIDE
	
         ABBOTT
	                 10%
	                                     A087980   001     Feb 02, 1983
	
                                  20%
	                                     A089362   001     May 25, 1988

         ABRAXIS PHARM
	          1%
	                                      A080420   001
	
                                  1%
	                                      A086761   001
	
                                  1.5%
	                                    A080420   005
	
                                  2%
	                                      A080420   002
	
                                  2%
	                                      A080420   004
	
                                  2%
	                                      A086761   002
	
                                  2%
	                                      N017508   001
	
                                  4%
	                                      N017508   002
	
                                  20%
	                                     N017508   004
	
         AKORN
	                  1%
	                                      A085037   001
	
                                  2%
	                                      A085037   002
	
         BEL MAR
	                1%
	                                      A080710   001
	
                                  2%
	                                      A080760   001
	
         DELL LABS
	              1%
	                                      A083387   001
	
                                  2%
	                                      A083388   001
	
         ELKINS SINN
	            0.5%
	                                    A085131   001
	
                                  4%
	                                      A084626   001
	
         GD SEARLE LLC
	          1%
	                                      A083135   001
	
                                  2%
	                                      A083135   002
	
         GRAHAM CHEM
	            2%
	                                      A080504   001
	
         HIKMA MAPLE
	            1%
	                                      A080407   001
	
                                  2%
	                                      A080407   002
	
         HOSPIRA
	                1%
	                                      A040013   001     Jun 23, 1995
	
                                  1.5%
	                                    A088330   001     May 17, 1984

                                  2%
	                                      A088331   001     May 17, 1984

         INTL MEDICATION
	        1%
	                                      N017701   002
	
                                  1GM/VIAL
                                 N018543   001
	
                                  2%
	                                      N017701   001
	
                                  2GM/VIAL
                                 N018543   002
	
         LUITPOLD
	               2%
	                                      A083198   001
	
         LYPHOMED
	               1%
	                                      A080390   001
	
                                  2%
	                                      A080390   002
	
         MILES
	                  1%
	                                      A080414   001
	
                                  2%
	                                      A080414   002
	
         WATSON LABS
	            1%
	                                      A080377   001
	
                                  1%
	                                      A083627   001
	
                                  2%
	                                      A080377   002
	
                                  2%
	                                      A083627   002
	
         WYETH AYERST
	           1%
	                                      A083083   001
	
                                  2%
	                                      A083083   002
	
   LIDOCAINE HYDROCHLORIDE    0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
        BAXTER HLTHCARE           100MG/100ML
                              N018461 001
	
   LIDOCAINE HYDROCHLORIDE    0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
        B BRAUN                   200MG/100ML
                              N018967 001 Mar 30, 1984
	
   LIDOCAINE HYDROCHLORIDE    0.2% IN DEXTROSE 5%
	
        HOSPIRA                   200MG/100ML
                              A083158 005
	
   LIDOCAINE HYDROCHLORIDE    0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        ABBOTT                    200MG/100ML
                              N018954 001 Jul 09, 1985
	
        HOSPIRA                   200MG/100ML
	                             N018388 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                             6-203(of 337)


LIDOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    LIDOCAINE HYDROCHLORIDE   0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                  400MG/100ML
                              N018967 002 Mar 30, 1984
	
    LIDOCAINE HYDROCHLORIDE   0.4% IN DEXTROSE 5%
	
         HOSPIRA                  400MG/100ML
                              A083158 006
	
    LIDOCAINE HYDROCHLORIDE   0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                  800MG/100ML
                              N018967 003 Mar 30, 1984
	
    LIDOCAINE HYDROCHLORIDE   IN PLASTIC CONTAINER
	
         HOSPIRA		                1.5%
	                                    A088326 001 Jul 31, 1984
	
                                  10%
	                                     A088367 001 Jul 31, 1984
	
                                  20%
	                                     A088368 001 Jul 31, 1984
	
    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
	
         HIKMA MAPLE              1%                                        A084625 001
	
                                  2%                                        A084625 002
	
         INTL MEDICATION          4%                                        N017702 002
	
    LIDOCATON
         PHARMATON                2%                                        A084727 001 Aug 17, 1983
	
    LIDOPEN
         MERIDIAN MEDCL TECHN     10%                                       N017549 001
	
    XYLOCAINE
         ASTRAZENECA              1%                                        N010418 005
	
                                  1.5%                                      N010418 009
	
                                  2%                                        N010418 007
	
    XYLOCAINE DENTAL
         DENTSPLY PHARM           2%                                        N021380 001
	
    XYLOCAINE PRESERVATIVE FREE
	
         FRESENIUS KABI USA       10%
	                                     N016801 003
	
  INJECTABLE;SPINAL
	
    XYLOCAINE 1.5% W/ DEXTROSE 7.5%

         FRESENIUS KABI USA       1.5%
	                                    N016297 001
	
    XYLOCAINE 5% W/ GLUCOSE 7.5%

         ASTRAZENECA              5%
	                                      N010496 002 Jul 07, 1982
	
  JELLY;TOPICAL
	
    ANESTACON
	
         BANNER PHARMACAPS        2%
	                                      A080429 001
	
    LIDOCAINE HYDROCHLORIDE
	
         TEVA PHARMS USA          2%
	                                      A081318 001 Apr 29, 1993
	
  SOLUTION;ORAL
	
    LIDOCAINE HYDROCHLORIDE VISCOUS
	
         ACTAVIS MID ATLANTIC     2%
	                                      A086578 001
	
         INTL MEDICATION          2%
	                                      A086389 001 Feb 02, 1982
	
  SOLUTION;TOPICAL
	
    LARYNGOTRACHEAL ANESTHESIA KIT
	
         KENDALL IL               4%
	                                      A087931 001 Jun 10, 1983
	
    LIDOCAINE HYDROCHLORIDE
	
         PACO                     4%
	                                      A089688 001 Jun 30, 1989
	
    LTA II KIT
	
         HOSPIRA                  4%
	                                      A088542 001 Jul 31, 1984
	
    PEDIATRIC LTA KIT
	
         ABBOTT                   2%
	                                      A088572 001 Jul 31, 1984
	
         HOSPIRA                  2%
	                                      A085995 001
	
LIDOCAINE HYDROCHLORIDE; OXYTETRACYCLINE
	
  INJECTABLE;INJECTION
	
    TERRAMYCIN
	
         PFIZER
	               2%;50MG/ML
                                 A060567 001
	
                                2%;125MG/ML
	                               A060567 002
	
LIDOCAINE; PRILOCAINE
	
  DISC;TOPICAL
	
    EMLA
	
           ASTRAZENECA
	          2.5%;2.5%
	                               N020962 001 Feb 04, 1998
	
LINCOMYCIN HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    LINCOCIN
	
         PHARMACIA AND UPJOHN
	   EQ 250MG BASE
	                           N050316 001
	
                                  EQ 500MG BASE
	                           N050316 002
	
  INJECTABLE;INJECTION
	
    LINCOMYCIN HYDROCHLORIDE
	
         WATSON LABS
	            EQ 300MG BASE/ML
	                        A063180 001 Apr 16, 1991
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                           6-204(of 337)


LINDANE
	
  CREAM;TOPICAL
	
    KWELL
	
          REED AND CARNRICK      1%
	                                      A084218 001
	
                                 1%
	                                      N006309 001
	
  LOTION;TOPICAL
	
    GAMENE
	
         SOLA BARNES HIND        1%
	                                      A084989 001
	
    KWELL
	
         REED AND CARNRICK       1%
	                                      A084218 002
	
                                 1%
	                                      N006309 003
	
    SCABENE
	
         STIEFEL                 1%
	                                      A086769 001
	
  SHAMPOO;TOPICAL
	
    GAMENE
	
         SOLA BARNES HIND        1%
	                                      A084988 001
	
    KWELL
	
         REED AND CARNRICK       1%
	                                      A084219 001
	
                                 1%
	                                      N010718 001
	
    SCABENE
	
         STIEFEL                 1%
	                                      A087940 001
	 Apr 08, 1983
	
LINEZOLID
	
  TABLET;ORAL
	
    ZYVOX
	
         PHARMACIA AND UPJOHN    400MG **Federal Register determination
   N021130 001
	 Apr 18, 2000
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
LIOTHYRONINE SODIUM
	
  TABLET;ORAL
	
    LIOTHYRONINE SODIUM
	
         WATSON LABS             EQ 0.025MG BASE
	                         A085755 001
	 Jan 25, 1982
	
                                 EQ 0.05MG BASE
	                          A085753 001
	 Feb 03, 1982
	
LIOTRIX (T4;T3)

  TABLET;ORAL
	
    EUTHROID-0.5
	
         PARKE DAVIS             0.0075MG;0.0075MG
	                       N016680 001
	
    EUTHROID-1
	
         PARKE DAVIS             0.015MG;0.015MG
	                         N016680 002
	
    EUTHROID-2
	
         PARKE DAVIS             0.03MG;0.03MG
	                           N016680 003
	
    EUTHROID-3
	
         PARKE DAVIS             0.045MG;0.045MG
	                         N016680 004
	
    THYROLAR-5
	
         FOREST LABS             0.0625MG;0.25MG
	                         N016807 006
	
LISINOPRIL
	
  TABLET;ORAL
	
    LISINOPRIL
	
         SANDOZ		                2.5MG
	                                   A075903   001
	   Jul   01,   2002
	
                                 2.5MG
	                                   A075999   001
	   Jul   01,   2002
	
                                 5MG
	                                     A075903   002
	   Jul   01,   2002
	
                                 5MG
	                                     A075999   002
	   Jul   01,   2002
	
                                 10MG
	                                    A075903   003
	   Jul   01,   2002
	
                                 10MG
	                                    A075999   003
	   Jul   01,   2002
	
                                 20MG
	                                    A075903   004
	   Jul   01,   2002
	
                                 20MG
	                                    A075999   004
	   Jul   01,   2002
	
                                 30MG
	                                    A075903   005
	   Jul   01,   2002
	
                                 30MG
	                                    A075999   005
	   Jul   01,   2002
	
                                 40MG
	                                    A075903   006
	   Jul   01,   2002
	
                                 40MG
	                                    A075999   006
	   Jul   01,   2002
	
         TEVA		                  2.5MG
	                                   A075783   001
	   Jul   01,   2002
	
                                 5MG
	                                     A075783   002
	   Jul   01,   2002
	
                                 10MG
	                                    A075783   003
	   Jul   01,   2002
	
                                 20MG
	                                    A075783   004
	   Jul   01,   2002
	
                                 30MG
	                                    A075783   005
	   Jul   01,   2002
	
                                 40MG
	                                    A075783   006
	   Jul   01,   2002
	
    PRINIVIL
	
         MERCK                   2.5MG
	                                   N019558 006
	 Jan 28, 1994
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-205(of 337)


LITHIUM CARBONATE
	
  CAPSULE;ORAL
	
    ESKALITH
	
         NOVEN THERAP
	          300MG
	                        N016860 001
	
    LITHIUM CARBONATE
	
         ABLE
	                  150MG
	                        A076823   001    Jun   29,   2004
	
                                 300MG
	                        A076121   001    Sep   27,   2001

                                 300MG
	                        A076823   002    Jun   29,   2004
	
                                 600MG
	                        A076823   003    Jun   29,   2004
	
         APOTEX INC
	            300MG
	                        A076795   001    Nov   22,   2004
	
         HIKMA PHARMS LLC
	      600MG
	                        A078763   001    Apr   15,   2008

         USL PHARMA
	            300MG
	                        A072542   001    Feb   01,   1989
	
         WATSON LABS
	           300MG
	                        A070407   001    Mar   19,   1987
	
    LITHONATE
	
         SOLVAY
	                300MG
	                        N016782 001
	
  TABLET;ORAL
	
    ESKALITH
	
         JDS PHARMS
	            300MG
	                        N017971 001
	
    LITHANE
	
         BAYER PHARMS
	          300MG
	                        N018833 001 Jul 18, 1985
	
    LITHIUM CARBONATE
	
         HIKMA INTL PHARMS
	     300MG
	                        A078715 001 Dec 28, 2010
	
         PFIZER
	                300MG
	                        N016834 001
	
    LITHOTABS
	
         SOLVAY
	                300MG
	                        N016980 001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ESKALITH CR
	
         JDS PHARMS
	            450MG
	                        N018152 001 Mar 29, 1982
	
    LITHIUM CARBONATE
	
         ABLE
	                  300MG
	                        A076382 001 Apr 21, 2003

         BARR
	                  300MG
	                        A076170 001 Jun 10, 2002
	
                                 450MG
	                        A076366 001 Aug 21, 2003
	
LITHIUM CITRATE
	
  SYRUP;ORAL
	
    LITHONATE
	
         SOLVAY
	                EQ 300MG CARBONATE/5ML
	       N017672 001
	
LOMEFLOXACIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    MAXAQUIN
	
         PHARMACIA
	             EQ 400MG BASE
	                N020013 001 Feb 21, 1992
	
LOPERAMIDE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    IMODIUM
	
         MCNEIL PED
	            2MG
	                          N017690 001
	
    LOPERAMIDE HYDROCHLORIDE
	
         ROXANE
	                2MG
	                          A073080 001 Nov 27, 1991
	
         SANDOZ
	                2MG
	                          A072993 001 Aug 28, 1992

         TEVA
	                  2MG
	                          A073122 001 Aug 30, 1991
	
  SOLUTION;ORAL
	
    IMODIUM
	
         JANSSEN PHARMS
	        1MG/5ML
	                      N019037 001 Jul 31, 1984
	
    LOPERAMIDE HYDROCHLORIDE
	
         ALPHARMA US PHARMS
	    1MG/5ML
                       A073187   001    Sep   15,   1992

         DURAMED PHARMS BARR
	   1MG/5ML
                       A074991   001    Dec   29,   1997
	
         TEVA
	                  1MG/5ML
                       A073478   001    Jun   23,   1995
	
         WATSON LABS
	           1MG/5ML
	                      A073062   001    May   28,   1993
	
  TABLET;ORAL
	
    LOPERAMIDE HYDROCHLORIDE
	
         ABLE
	                  2MG
	                          A073528 001 Nov 30, 1993
	
         PERRIGO
	               2MG
	                          A074194 001 Oct 30, 1992
	
LORACARBEF
	
  CAPSULE;ORAL
	
    LORABID
	
         KING PHARMS
	           200MG
	                        N050668 001 Dec 31, 1991
	
                                 400MG
	                        N050668 002 Apr 05, 1996
	
  FOR SUSPENSION;ORAL
	
    LORABID
	
         KING PHARMS
	           100MG/5ML
                     N050667 001 Dec 31, 1991
	
                                 200MG/5ML
	                    N050667 002 Dec 31, 1991
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                               6-206(of 337)


LORATADINE
	
  SYRUP;ORAL
	
    CLARITIN HIVES RELIEF
	
         SCHERING PLOUGH         1MG/ML **Federal Register determination   N020641 003 Nov 19, 2003

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
   LORATADINE
	
        APOTEX INC               1MG/ML                                    A075565 001 Oct 05, 2004
	
        RANBAXY LABS LTD         1MG/ML                                    A076529 001 Aug 20, 2004

 TABLET;ORAL
	
   LORATADINE
	
        PERRIGO                  10MG                                      N021512 001 Jun 24, 2004
	
LORATADINE; PSEUDOEPHEDRINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    LORATADINE AND PSEUDOEPHEDRINE SULFATE
	
         ACTAVIS LABS FL INC     5MG;120MG                                 A076208 001 Jan 28, 2004
	
LORAZEPAM
	
  INJECTABLE;INJECTION
	
    LORAZEPAM
	
         AKORN                   2MG/ML                                    A074974   001    Jul   23,   1998
	
         BEDFORD                 2MG/ML                                    A077076   001    Jul   13,   2005
	
                                 4MG/ML                                    A077076   002    Jul   13,   2005
	
         DAVA PHARMS INC         2MG/ML                                    A074793   001    Mar   16,   2000
	
                                 4MG/ML                                    A074793   002    Mar   16,   2000
	
         HIKMA MAPLE             2MG/ML                                    A074496   001    Sep   28,   1998

                                 4MG/ML                                    A074496   002    Sep   28,   1998

         HOSPIRA                 2MG/ML                                    A074280   001    May   27,   1994

                                 2MG/ML                                    A074300   001    Apr   12,   1994

                                 4MG/ML                                    A074280   002    May   27,   1994

                                 4MG/ML                                    A074300   003    Mar   19,   1997
	
         WATSON LABS             2MG/ML                                    A074276   001    Apr   15,   1994

                                 4MG/ML                                    A074276   002    Apr   15,   1994

         WATSON LABS INC         1MG/0.5ML                                 A074551   003    Sep   12,   1996

                                 2MG/ML                                    A074535   001    Sep   12,   1996

                                 2MG/ML                                    A074551   001    Sep   12,   1996

                                 4MG/ML                                    A074535   002    Sep   12,   1996

                                 4MG/ML                                    A074551   002    Sep   12,   1996

 SOLUTION;ORAL
	
   LORAZEPAM
	
        ROXANE                   0.5MG/5ML                                 A074648 001 Mar 18, 1997
	
 TABLET;ORAL
	
   LORAZ
	
        QUANTUM PHARMICS         0.5MG                                     A070200 001 Aug 09, 1985

                                 1MG                                       A070201 001 Aug 09, 1985

                                 2MG                                       A070202 001 Aug 09, 1985

   LORAZEPAM
	
        AM THERAP                0.5MG                                     A070727   001    Mar   07,   1986
	
                                 1MG                                       A070728   001    Mar   07,   1986
	
                                 2MG                                       A070729   001    Mar   07,   1986
	
         HALSEY                  0.5MG                                     A071434   001    Sep   01,   1987

                                 1MG                                       A071435   001    Sep   01,   1987

                                 2MG                                       A071436   001    Sep   01,   1987

         MUTUAL PHARM            0.5MG                                     A070472   001    Dec   10,   1985
	
                                 0.5MG                                     A072553   001    Mar   29,   1991
	
                                 1MG                                       A070473   001    Dec   10,   1985
	
                                 1MG                                       A072554   001    Mar   29,   1991
	
                                 2MG                                       A070474   001    Dec   10,   1985
	
                                 2MG                                       A072555   001    Mar   29,   1991
	
         PAR PHARM               0.5MG                                     A070675   001    Dec   01,   1986
	
                                 1MG                                       A070676   001    Dec   01,   1986
	
                                 2MG                                       A070677   001    Dec   01,   1986
	
         SANDOZ                  0.5MG                                     A071193   001    Apr   15,   1988

                                 1MG                                       A071194   001    Apr   15,   1988

                                 2MG                                       A071195   001    Apr   15,   1988

         SUPERPHARM              0.5MG                                     A071245   001    Feb   09,   1987
	
                                 1MG                                       A071246   001    Feb   09,   1987
	
                                 2MG                                       A071247   001    Feb   09,   1987
	
         USL PHARMA              1MG                                       A070539   001    Dec   22,   1986
	
                                 2MG                                       A070540   001    Dec   22,   1986
	
         WARNER CHILCOTT         1MG                                       A071038   001    Jan   12,   1988
	
                                 2MG                                       A071039   001    Jan   12,   1988
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                         6-207(of 337)


LORAZEPAM
	
  TABLET;ORAL
	
    LORAZEPAM
	
         WATSON LABS
	           0.5MG
	                                 A071086   001
	   Mar   23,   1987
	
                                 0.5MG
	                                 A071117   001
	   Jul   24,   1986
	
                                 1MG
	                                   A071087   001
	   Mar   23,   1987
	
                                 1MG
	                                   A071118   001
	   Jul   24,   1986
	
                                 2MG
	                                   A071088   001
	   Mar   23,   1987
	
                                 2MG
	                                   A071110   001
	   Jul   24,   1986
	
LOSARTAN POTASSIUM
	
  TABLET;ORAL
	
    LOSARTAN POTASSIUM
	
         WATSON LABS
	           25MG
	                                  A091129 001
	 Oct 06, 2010
	
                                 50MG
	                                  A091129 002
	 Oct 06, 2010
	
                                 100MG
	                                 A091129 003
	 Oct 06, 2010
	
LOTEPREDNOL ETABONATE
	
  SUSPENSION/DROPS;OPHTHALMIC

    LOTEMAX
	
         PHARMOS
	               0.5%
	                                  N020841 001
	 Mar 09, 1998
	
LOVASTATIN
	
  TABLET;ORAL
	
    MEVACOR
	
         MERCK
	                 10MG
	                                  N019643 002
	 Mar 28, 1991
	
                                 20MG
	                                  N019643 003
	 Aug 31, 1987

                                 40MG
	                                  N019643 004
	 Dec 14, 1988
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ALTOPREV
	
         ANDRX LABS LLC
	        10MG
	                                  N021316 001
	 Jun 26, 2002
	
LOXAPINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    LOXITANE C
	
         WATSON LABS
	           EQ 25MG BASE/ML
	                       N017658 001
	
  INJECTABLE;INJECTION
	
    LOXITANE IM
	
         WATSON LABS
	           EQ 50MG BASE/ML
	                       N018039 001
	
LOXAPINE SUCCINATE
	
  CAPSULE;ORAL
	
    LOXITANE
	
         WATSON LABS
	           EQ   5MG BASE
	                         N017525   001
	
                                 EQ   10MG BASE
	                        N017525   002
	
                                 EQ   25MG BASE
	                        N017525   003
	
                                 EQ   50MG BASE
	                        N017525   004
	
  TABLET;ORAL
	
    LOXITANE
	
         WATSON LABS
	           EQ 10MG BASE
	                          N017525 006
	
                                 EQ 25MG BASE
	                          N017525 007
	
                                 EQ 50MG BASE
	                          N017525 008
	
LUTROPIN ALFA
	
  INJECTABLE;SUBCUTANEOUS
	
    LUVERIS
	
         EMD SERONO
	            75 IU/VIAL
	                            N021322 001
	 Oct 08, 2004
	
LYPRESSIN
	
  SOLUTION;NASAL
	
    DIAPID
	
         NOVARTIS
	              0.185MG/ML
	                            N016755 001
	
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM

CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
	
  INJECTABLE;INJECTION
	
    ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
	
         B BRAUN                30MG/100ML;37MG/100ML;0.82MG/100ML;370M   N019006 001 Apr 04, 1984

                                G/100ML;530MG/100ML;500MG/100ML;12MG/10

                                0ML
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                             6-208(of 337)


MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
	
  INJECTABLE;INJECTION
    ISOLYTE S IN PLASTIC CONTAINER
         B BRAUN                30MG/100ML;37MG/100ML;370MG/100ML;530MG   N018252 001
                                /100ML;500MG/100ML
  SOLUTION;IRRIGATION
    PHYSIOSOL IN PLASTIC CONTAINER
         HOSPIRA INC            14MG/100ML;37MG/100ML;222MG/100ML;526MG   N018406 001
                                /100ML;502MG/100ML
    PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
         HOSPIRA INC            30MG/100ML;37MG/100ML;222MG/100ML;526MG   N018406 002 Jul 08, 1982
                                /100ML;502MG/100ML
    SYNOVALYTE IN PLASTIC CONTAINER
         BAXTER HLTHCARE        30MG/100ML;37MG/100ML;368MG/100ML;526MG   N019326 001 Jan 25, 1985
                                /100ML;502MG/100ML
MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE
  TABLET;ORAL
    MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE
         SANTARUS               343MG;20MG;750MG                         N022456 001 Dec 04, 2009
                                343MG;40MG;750MG                         N022456 002 Dec 04, 2009
  TABLET, CHEWABLE;ORAL
    ZEGERID
         SANTARUS               700MG;20MG;600MG                         N021850 001 Mar 24, 2006
                                700MG;40MG;600MG                         N021850 002 Mar 24, 2006
MALATHION
  LOTION;TOPICAL
    MALATHION
         MYLAN PHARMS INC      0.5%                                      A078743 001 Mar 06, 2009
MANGAFODIPIR TRISODIUM
  INJECTABLE;INJECTION
    TESLASCAN
         GE HEALTHCARE         37.9MG/ML                                 N020652 001 Nov 26, 1997
MANGANESE CHLORIDE TETRAHYDRATE
  FOR SOLUTION;ORAL
    LUMENHANCE
         BRACCO                 3.49MG/GM                                N020686 001 Dec 19, 1997
MANGANESE SULFATE
  INJECTABLE;INJECTION
    MANGANESE SULFATE
         ABRAXIS PHARM         EQ 0.1MG MANGANESE/ML                     N019228 001 May 05, 1987
MANNITOL
  INJECTABLE;INJECTION
    MANNITOL 10%
         HOSPIRA               10GM/100ML                                N016269 002
         MILES                 10GM/100ML                                N016472 002
    MANNITOL 15%
         HOSPIRA               15GM/100ML                                N016269 003
         MILES                 15GM/100ML                                N016472 005
    MANNITOL 20%
         B BRAUN               20GM/100ML                                N014738 001
         HOSPIRA               20GM/100ML                                N016269 004
         MILES                 20GM/100ML                                N016472 004
    MANNITOL 25%
         ABRAXIS PHARM         12.5GM/50ML                               A086754   001
         ASTRAZENECA           12.5GM/50ML                               A089239   001 May 06, 1987
                               12.5GM/50ML                               A089240   001 May 06, 1987
        HOSPIRA                12.5GM/50ML                               N016269   005
        MERCK                  12.5GM/50ML                               N005620   001
        WATSON LABS            12.5GM/50ML                               A087460   001 Jun 27, 1983
   MANNITOL 5%
        HOSPIRA                5GM/100ML                                 N016269 001
 POWDER;INHALATION
   ARIDOL KIT
        PHARMAXIS LTD          N/A,5MG,10MG,20MG,40MG                    N022368 001 Oct 05, 2010
 SOLUTION;IRRIGATION
   RESECTISOL
        B BRAUN                5GM/100ML                                 N016704 002
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                            6-209(of 337)


MANNITOL; SORBITOL
	
  SOLUTION;IRRIGATION
	
    SORBITOL-MANNITOL
	
         HOSPIRA                540MG/100ML;2.7GM/100ML                A080224 001
	
    SORBITOL-MANNITOL IN PLASTIC CONTAINER
	
         HOSPIRA                540MG/100ML;2.7GM/100ML                N017636 001
MAPROTILINE HYDROCHLORIDE
  TABLET;ORAL
    LUDIOMIL
         NOVARTIS               25MG                                   N017543 001
                                50MG                                   N017543 002
                                75MG                                   N017543 003 Sep 30, 1982
   MAPROTILINE HYDROCHLORIDE
        AM THERAP               25MG                                   A072129   001    Jan   14,   1988
                                50MG                                   A072130   001    Jan   14,   1988
                                75MG                                   A072131   001    Jan   14,   1988
         WATSON LABS            25MG                                   A071943   001    Dec   30,   1987
                                25MG                                   A072162   001    Jun   01,   1988
                                50MG                                   A071944   001    Dec   30,   1987
                                50MG                                   A072163   001    Jun   01,   1988
                                75MG                                   A071945   001    Dec   30,   1987
                                75MG                                   A072164   001    Jun   01,   1988
MASOPROCOL
  CREAM;TOPICAL
    ACTINEX
         UNIV AZ CANCER CTR     10%                                    N019940 001 Sep 04, 1992
MAZINDOL
  TABLET;ORAL
    MAZANOR
         WYETH AYERST           1MG                                    N017980 002
                                2MG                                    N017980 001
   SANOREX
        NOVARTIS                1MG **Federal Register determination   N017247 001
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                2MG **Federal Register determination   N017247 002
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
MEBENDAZOLE
  TABLET, CHEWABLE;ORAL
    VERMOX
         JANSSEN PHARMS         100MG                                  N017481 001
MEBUTAMATE
  TABLET;ORAL
    DORMATE
         MEDPOINTE PHARM HLC    600MG                                  N017374 001
MECAMYLAMINE HYDROCHLORIDE
  TABLET;ORAL
    INVERSINE
         TARGACEPT              2.5MG                                  N010251 001
MECASERMIN RINFABATE RECOMBINANT
	
  INJECTABLE;SUBCUTANEOUS
	
    IPLEX
	
         INSMED                 36MG/0.6ML                             N021884 001 Dec 12, 2005
	
MECLIZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ANTIVERT
	
         CITRON PHARMA LLC		    12.5MG                                 N010721 006
	
                                25MG                                   N010721 004
	
                                50MG                                   N010721 001 Jan 20, 1982
	
   MECLIZINE HYDROCHLORIDE
	
        ABC HOLDING             12.5MG                                 A085253   001
	
                                25MG                                   A085252   001
	
         AMNEAL PHARMS          50MG                                   A201451   003 Feb 23, 2011
	
         ANABOLIC               25MG                                   A085891   001
	
         BUNDY                  12.5MG                                 A084382   001
	
                                25MG		                                 A084872   001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                   6-210(of 337)


MECLIZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    MECLIZINE HYDROCHLORIDE
	
         IVAX SUB TEVA PHARMS		   12.5MG                                     A083784   001
	
                                  12.5MG                                     A084975   001
	
                                  25MG                                       A084657   001
	
         KV PHARM		               12.5MG                                     A085524   001
	
                                  25MG                                       A085523   001
	
         MYLAN PHARMS INC         50MG                                       A202640   003     Sep   17,   2012

         PAR PHARM                50MG                                       A089674   001     Mar   31,   1988
	
         PLIVA                    12.5MG                                     A088732   001     Dec   11,   1985
	
                                  25MG                                       A088734   001     Dec   11,   1985
	
         SUPERPHARM               12.5MG                                     A089113   001     Aug   20,   1985

                                  25MG                                       A089114   001     Aug   20,   1985

         UDL                      12.5MG                                     A088256   001     Jun   13,   1983
	
                                  25MG                                       A088257   001     Jun   13,   1983
	
         VANGARD                  12.5MG                                     A087877   001     Apr   20,   1982

                                  25MG                                       A087620   001     Jan   04,   1982
	
         WATSON LABS		            12.5MG                                     A085195   001
	
                                  12.5MG                                     A085269   001
	
                                  25MG                                       A085740   001
	
 TABLET, CHEWABLE;ORAL
	
   ANTIVERT
	
        CITRON PHARMA LLC         25MG                                       N010721 005
	
   MECLIZINE HYDROCHLORIDE
	
        IVAX SUB TEVA PHARMS      25MG                                       A084976 001
	
        NEXGEN PHARMA INC         25MG                                       A086392 001
	
        PLIVA                     25MG                                       A088733 001 Dec 11, 1985
	
MECLOCYCLINE SULFOSALICYLATE
	
  CREAM;TOPICAL
	
    MECLAN
	
         JOHNSON AND JOHNSON      1%                                         N050518 001
	
MECLOFENAMATE SODIUM
	
  CAPSULE;ORAL
	
    MECLODIUM
	
         QUANTUM PHARMICS         EQ 50MG BASE                               A071380 001 Jul 14, 1987
	
                                  EQ 100MG BASE                              A071381 001 Jul 14, 1987
	
   MECLOFENAMATE SODIUM
	
        AM THERAP                 EQ   50MG BASE                             A071362   001     Feb   10,   1987
	
                                  EQ   100MG BASE                            A071363   001     Feb   10,   1987
	
         BARR                     EQ   50MG BASE                             A072848   001     Mar   20,   1989
	
                                  EQ   100MG BASE                            A072809   001     Mar   20,   1989
	
         PAR PHARM                EQ   50MG BASE                             A072077   001     Mar   10,   1988
	
                                  EQ   100MG BASE                            A072078   001     Mar   10,   1988
	
         SANDOZ                   EQ   50MG BASE                             A072262   001     Nov   29,   1988
	
                                  EQ   100MG BASE                            A072263   001     Nov   29,   1988
	
         USL PHARMA               EQ   50MG BASE                             A071007   001     Mar   25,   1988
	
                                  EQ   100MG BASE                            A071008   001     Mar   25,   1988
	
         VITARINE                 EQ   50MG BASE                             A071710   001     Jun   15,   1988
	
                                  EQ   100MG BASE                            A071684   001     Jun   15,   1988
	
         WATSON LABS              EQ   50MG BASE                             A070400   001     Nov   25,   1986
	
                                  EQ   50MG BASE                             A071468   001     Apr   15,   1987

                                  EQ   50MG BASE                             A071640   001     Aug   11,   1987

                                  EQ   100MG BASE                            A070401   001     Nov   25,   1986
	
                                  EQ   100MG BASE                            A071469   001     Apr   15,   1987

                                  EQ   100MG BASE                            A071641   001     Aug   11,   1987

   MECLOMEN
	
        PARKE DAVIS               EQ 50MG BASE                               N018006 001
	
                                  EQ 100MG BASE                              N018006 002
	
MEDROXYPROGESTERONE ACETATE
	
  INJECTABLE;INJECTION
	
    DEPO-PROVERA
	
         PHARMACIA AND UPJOHN     100MG/ML **Federal Register                N012541 002
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

   MEDROXYPROGESTERONE ACETATE
	
          TEVA PHARMS USA        150MG/ML                                    A076552 001 Oct 27, 2004
	
 TABLET;ORAL
	
   AMEN
	
          AMARIN PHARMS          10MG                                        A083242 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                       6-211(of 337)


MEDROXYPROGESTERONE ACETATE
	
  TABLET;ORAL
	
    CURRETAB
	
         SOLVAY                  10MG                             A085686 001
	
    CYCRIN
	
         ESI		                   2.5MG                            A081239 001 Oct 30, 1992
	
                                 5MG                              A081240 001 Oct 30, 1992
	
                                 10MG                             A089386 001 Sep 09, 1987

   MEDROXYPROGESTERONE ACETATE
	
        DURAMED PHARMS BARR		    2.5MG                            A040311   001    Dec   01,   1999
	
                                 5MG                              A040311   002    Dec   01,   1999
	
                                 10MG                             A040311   003    Dec   01,   1999
	
        USL PHARMA		             10MG                             A088484   001    Jul   26,   1984
	
MEDRYSONE
	
  SUSPENSION;OPHTHALMIC
	
    HMS
	
          ALLERGAN               1%                               N016624 003
	
MEFLOQUINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    LARIAM
	
         ROCHE                   250MG                            N019591 001 May 02, 1989

    MEFLOQUINE HYDROCHLORIDE
	
         HIKMA PHARMS LLC        250MG                            A077699 001 Apr 21, 2010

         US ARMY WALTER REED     250MG                            N019578 001 May 02, 1989
	
MEGESTROL ACETATE
	
  SUSPENSION;ORAL
	
    MEGESTROL ACETATE
	
         APOTEX INC              40MG/ML                          A077404 001 Feb 16, 2006
	
  TABLET;ORAL
	
    MEGACE
	
         BRISTOL MYERS SQUIBB    20MG                             N016979 001
	
                                 40MG                             N016979 002
	
   MEGESTROL ACETATE
	
        TEVA                     40MG                             A074745 001 Feb 27, 1998
	
        USL PHARMA               20MG                             A070646 001 Oct 02, 1987
	
                                 40MG		                           A070647 001 Oct 02, 1987
	
MELOXICAM
	
  TABLET;ORAL
	
    MELOXICAM
	
         COREPHARMA              7.5MG                            A077930   001    Jul   19,   2006
	
                                 15MG                             A077930   002    Jul   19,   2006
	
         CR DOUBLE CRANE         7.5MG                            A078039   001    Dec   14,   2006
	
                                 15MG                             A078039   002    Dec   14,   2006
	
         MUTUAL PHARM            7.5MG                            A077935   001    Jul   19,   2006
	
                                 15MG                             A077935   002    Jul   19,   2006
	
         MYLAN                   7.5MG                            A077934   001    Jul   20,   2006
	
                                 15MG                             A077934   002    Jul   20,   2006
	
         ROXANE                  7.5MG                            A077925   001    Jul   19,   2006
	
                                 15MG                             A077925   002    Jul   19,   2006
	
         YABAO PHARM             7.5MG                            A077933   001    Jul   19,   2006
	
                                 15MG                             A077933   002    Jul   19,   2006
	
MELPHALAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    MELPHALAN HYDROCHLORIDE
	
         MYLAN INSTITUTIONAL     EQ 50MG BASE/VIAL                A090299 001 Oct 27, 2009
	
MEMANTINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    MEMANTINE
	
         SUN PHARMA GLOBAL       5MG                              A090058 001 May 05, 2010

                                 10MG                             A090058 002 May 05, 2010

   MEMANTINE HYDROCHLORIDE
	
        DR REDDYS LABS LTD       5MG                              A090048   001    Apr   14,   2010

                                 10MG                             A090048   002    Apr   14,   2010

         ORCHID HLTHCARE         5MG                              A090044   001    Mar   12,   2012
	
                                 10MG                             A090044   002    Mar   12,   2012
	
         TEVA PHARMS             5MG                              A090052   001    Oct   25,   2011
	
                                 10MG                             A090052   002    Oct   25,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                   6-212(of 337)


MENADIOL SODIUM DIPHOSPHATE
	
  INJECTABLE;INJECTION
	
    KAPPADIONE
	
         LILLY                   10MG/ML
                       N005725 001
	
    SYNKAYVITE
	
         ROCHE		                 5MG/ML
                        N003718 004
	
                                 10MG/ML
                       N003718 006
	
                                 37.5MG/ML
                     N003718 008
	
  TABLET;ORAL
	
    SYNKAYVITE
	
         ROCHE                   5MG
	                          N003718 010
	
MENADIONE
	
  TABLET;ORAL
	
    MENADIONE
	
         LILLY                   5MG
	                          N002139 003
	
MENOTROPINS (FSH;LH)

  INJECTABLE;INJECTION
	
    HUMEGON
	
         ORGANON USA INC         75 IU/VIAL;75 IU/VIAL
         N020328 001 Sep 01, 1994

                                 150 IU/VIAL;150 IU/VIAL
       N020328 002 Sep 01, 1994
	
    MENOTROPINS
	
         FERRING                 75 IU/VIAL;75 IU/VIAL
         A073598 001 Jan 30, 1997
	
                                 150 IU/VIAL;150 IU/VIAL
       A073599 001 Jan 30, 1997
	
    PERGONAL
	
         SERONO                  75 IU/AMP;75 IU/AMP
           N017646 001
	
                                 150 IU/AMP;150 IU/AMP
         N017646 002 May 20, 1985
	
    REPRONEX
	
         FERRING                 150 IU/VIAL;150 IU/VIAL
	      N021047 002 Aug 27, 1999
	
MEPENZOLATE BROMIDE
	
  SOLUTION;ORAL
	
    CANTIL
	
         SANOFI AVENTIS US       25MG/5ML
	                     N010679 004
	
MEPERIDINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    DEMEROL
	
         SANOFI AVENTIS US		     25MG/ML
                       N005010   007
	
                                 50MG/ML
                       N005010   002
	
                                 75MG/ML
                       N005010   009
	
                                 100MG/ML
                      N005010   003
	
    MEPERIDINE HYDROCHLORIDE
	
         ABBOTT		               25MG/ML
                        A080388   001
	
                                50MG/ML
                        A080385   001
	
                                50MG/ML
                        A080387   001
	
                                75MG/ML
                        A080389   001
	
                                100MG/ML
                       A080386   001
	
         ASTRAZENECA		          25MG/ML
                        A089781   001     Mar   31,   1989
	
                                50MG/ML
                        A089782   001     Mar   31,   1989
	
                                50MG/ML
                        A089783   001     Mar   31,   1989
	
                                50MG/ML
                        A089784   001     Mar   31,   1989
	
                                75MG/ML
                        A089785   001     Mar   31,   1989
	
                                100MG/ML
                       A089786   001     Mar   31,   1989
	
                                100MG/ML
                       A089787   001     Mar   31,   1989
	
                                100MG/ML
                       A089788   001     Mar   31,   1989
	
         BAXTER HLTHCARE		      25MG/ML
                        A088279   001     Jun   15,   1984
	
                                50MG/ML
                        A088280   001     Jun   15,   1984
	
                                75MG/ML
                        A088281   001     Jun   15,   1984
	
                                100MG/ML
                       A088282   001     Jun   15,   1984
	
         INTL MEDICATION		      10MG/ML
                        A086332   001
	
         PARKE DAVIS		          50MG/ML
                        A080364   002
	
                                75MG/ML
                        A080364   003
	
                                100MG/ML
                       A080364   001
	
         WATSON LABS            50MG/ML
                        A073444   001     Mar 17, 1992
	
                                100MG/ML
                       A073445   001     Mar 17, 1992
	
    MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
	
         HOSPIRA                10MG/ML                         A040305   001     Mar   10,   1999
	
         INTL MEDICATION        10MG/ML                         A081309   001     Aug   30,   1993

         MALLINCKRODT           10MG/ML                         A040163   001     May   12,   1997

         WATSON LABS            10MG/ML                         A073443   001     Mar   17,   1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                6-213(of 337)


MEPERIDINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    DEMEROL
	
         SANOFI AVENTIS US        50MG/5ML                                 N005010 005
	
  TABLET;ORAL
	
    MEPERIDINE HYDROCHLORIDE
	
         DURAMED PHARMS BARR      50MG                                     A040318   001     Oct 05, 1999
	
                                  100MG                                    A040318   002     Oct 05, 1999
	
         MUTUAL PHARM             50MG                                     A080448   001
	
                                  100MG                                    A080448   002
	
         WATSON LABS              50MG                                     A040186   001     Jun 30, 1997
	
                                  100MG                                    A040186   002     Jun 30, 1997
	
         WYETH AYERST             50MG                                     A080454   001
	
MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    MEPERGAN
	
         BAXTER HLTHCARE CORP   25MG/ML;25MG/ML                            N011730 001
	
MEPHENTERMINE SULFATE
	
  INJECTABLE;INJECTION
	
    WYAMINE SULFATE
	
         BAXTER HLTHCARE CORP     EQ 15MG BASE/ML                          N008248 002
	
                                  EQ 30MG BASE/ML                          N008248 001
	
MEPHENYTOIN
	
  TABLET;ORAL
	
    MESANTOIN
	
         NOVARTIS                 100MG **Federal Register determination   N006008 001
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
MEPIVACAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ARESTOCAINE HYDROCHLORIDE
	
         SOLVAY                   3%                                       A084777 002 Apr 18, 1982

    CARBOCAINE
	
         EASTMAN KODAK            3%                                       N012125 003
	
    MEPIVACAINE HYDROCHLORIDE
	
         GRAHAM CHEM              3%                                       A083559   001
	
         INTL MEDICATION          1%                                       A087509   001 Oct 05, 1982
	
         WATSON LABS              1%                                       A088769   001 Nov 20, 1984
	
                                  2%                                       A088770   001 Nov 20, 1984
	
   POLOCAINE
	
        DENTSPLY PHARM            3%                                       A088653 001 Aug 21, 1984
	
MEPREDNISONE
	
  TABLET;ORAL
	
    BETAPAR
	
         SCHERING                 4MG                                      N016053 002
	
MEPROBAMATE
	
  CAPSULE;ORAL
	
    EQUANIL
	
         WYETH AYERST           400MG                                      N012455 002
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    MEPROSPAN
	
         MEDPOINTE PHARM HLC    200MG                                      N011284 001
	
                                400MG                                      N011284 002
	
  TABLET;ORAL
	
    AMOSENE
	
         FERNDALE LABS          400MG                                      A084030 001
	
    BAMATE
	
         ALRA                   200MG                                      A080380 001
	
                                400MG                                      A080380 002
	
    EQUANIL
	
         WYETH AYERST           200MG                                      N010028 005
	
                                400MG                                      N010028 004
	
    MEPRIAM
	
         TEVA                   400MG                                      N016069 001
	
    MEPROBAMATE
	
         BARR                   600MG                                      A084230   001
	
         ELKINS SINN            200MG                                      N015426   002
	
                                400MG                                      N015426   001
	
         HEATHER                400MG                                      N016928   003
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                   6-214(of 337)


MEPROBAMATE
	
  TABLET;ORAL
	
    MEPROBAMATE
	
                                 600MG
	                          A084329   001
	
         IMPAX LABS              200MG
	                          N014322   002
	
                                 400MG
	                          N014322   001
	
         IVAX SUB TEVA PHARMS    200MG
	                          N015438   001
	
                                 400MG
	                          N015438   002
	
                                 600MG
	                          A084181   001
	
         IVC INDS                400MG
	                          A084153   001
	
         LANNETT                 200MG
	                          N014882   002
	
                                 400MG
	                          N014882   001
	
         LEDERLE                 400MG
	                          A086299   001
	
         LEE KM                  400MG
	                          A089538   001     Nov 25, 1987
	
         MALLARD                 400MG
	                          N015072   002
	
         MK LABS                 200MG
	                          N014368   004
	
                                 400MG
	                          N014368   002
	
         MUTUAL PHARM            200MG
	                          A080699   001
	
                                 400MG
	                          A080699   002
	
         MYLAN                   400MG
	                          A083618   001
	
         NEXGEN PHARMA INC       200MG
	                          A084220   001
	
                                 400MG
	                          A084589   001
	
         PARKE DAVIS             200MG
	                          A084744   001
	
                                 400MG
	                          A084744   002
	
         PERRIGO                 200MG
	                          A084546   001
	
                                 400MG
	                          A084547   001
	
         PHARMAVITE              400MG
	                          A084438   001
	
         PUREPAC PHARM           200MG
	                          A084804   001
	
                                 400MG
	                          A084804   002
	
         PVT FORM                400MG
	                          N014601   001
	
         ROXANE                  600MG
	                          A084332   001
	
         SANDOZ                  200MG
	                          N014547   002
	
                                 400MG
	                          A080655   001
	
                                 400MG
	                          N014547   001
	
         SCHERER LABS            400MG
	                          A083343   001
	
         SOLVAY                  200MG
	                          A084435   001
	
         STANLABS PHARM          200MG
	                          N014474   002
	
                                 400MG
	                          N014474   004
	
         TABLICAPS               400MG
	                          A083494   001
	
         TARO                    200MG
	                          A200998   001     May   23,   2011

                                 400MG
	                          A200998   002     May   23,   2011

         USL PHARMA              200MG
	                          A087825   001     Mar   18,   1982
	
                                 400MG
	                          A087826   001     Mar   18,   1982
	
         VALEANT PHARM INTL      200MG
	                          N015139   006
	
                                 400MG
	                          N015139   005
	
         VANGARD                 400MG
	                          A088011   001     Jul 14, 1982
	
         WATSON LABS             200MG
	                          A085720   001
	
                                 400MG
	                          A085721   001
	
                                 600MG
	                          A084274   001
	
                                 600MG
	                          A085719   001
	
         WEST WARD               200MG
	                          N015417   003
	
                                 400MG
	                          N015417   002
	
         WHITEWORTH TOWN PLSN    200MG
	                          A083830   001
	
                                 400MG
	                          A083442   001
	
    MILTOWN
	
         MEDPOINTE PHARM HLC		   200MG
	                          N009698 004
	
                                 400MG
	                          N009698 002
	
                                 600MG
	                          A083919 001
	
    NEURAMATE
	
         HALSEY                  200MG
	                          N014359 002
	
                                 400MG
	                          N014359 001
	
    TRANMEP
	
         SOLVAY                  400MG
	                          A084369 001
	
                                 400MG
	                          N016249 001
	
MEQUINOL; TRETINOIN
	
  SOLUTION;TOPICAL
	
    SOLAGE
	
         AQUA PHARMS             2%;0.01%
	                       N020922 001 Dec 10, 1999
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                 6-215(of 337)


MERCAPTOPURINE
	
  TABLET;ORAL
	
    PURINETHOL
	
         TEVA
	                   50MG
	                        N009053 002
	
MERSALYL SODIUM; THEOPHYLLINE
	
  INJECTABLE;INJECTION
	
    MERSALYL-THEOPHYLLINE
	
         WATSON LABS
	            100MG/ML;50MG/ML
	            A084875 001
	
MESALAMINE
	
  SUPPOSITORY;RECTAL
	
    CANASA
	
         FOREST LABS INC
	        500MG
	                       N021252 001 Jan 05, 2001
	
    ROWASA
	
         MEDA PHARMS
	            500MG
	                       N019919 001 Dec 18, 1990
	
MESORIDAZINE BESYLATE
	
  CONCENTRATE;ORAL
	
    SERENTIL
	
         NOVARTIS
	               EQ 25MG BASE/ML
	             N016997 001
	
  INJECTABLE;INJECTION
	
    SERENTIL
	
         NOVARTIS
	               EQ 25MG BASE/ML
	             N016775 001
	
  TABLET;ORAL
	
    SERENTIL
	
         NOVARTIS
	               EQ   10MG BASE
	              N016774   001
	
                                  EQ   25MG BASE
	              N016774   002
	
                                  EQ   50MG BASE
	              N016774   003
	
                                  EQ   100MG BASE
	             N016774   004
	
MESTRANOL; NORETHINDRONE
	
  TABLET;ORAL-20
	
    NORINYL
	
         WATSON LABS
	            0.1MG;2MG
	                   N013625 004
	
  TABLET;ORAL-21
	
    NORETHIN 1/50M-21

         WATSON LABS
	            0.05MG;1MG
	                  A071539 001 Apr 12, 1988
	
    NORETHINDRONE AND MESTRANOL
	
         WATSON LABS
	            0.05MG;1MG
	                  A070758 001 Jul 01, 1988
	
    NORINYL 1+50 21-DAY
	
         WATSON LABS
	            0.05MG;1MG
	                  N013625 002
	
    NORINYL 1+80 21-DAY
	
         GD SEARLE LLC
	          0.08MG;1MG
	                  N016724 001
	
    ORTHO-NOVUM 1/50 21

         ORTHO MCNEIL PHARM
	     0.05MG;1MG
	                  N012728 004
	
    ORTHO-NOVUM 1/80 21

         ORTHO MCNEIL PHARM
	     0.08MG;1MG
	                  N016715 001
	
    ORTHO-NOVUM 10-21
	
         ORTHO MCNEIL PHARM
	     0.06MG;10MG
	                 N012728 001
	
    ORTHO-NOVUM 2-21
	
         ORTHO MCNEIL PHARM
	     0.1MG;2MG
	                   N012728 005
	
  TABLET;ORAL-28
	
    NORETHIN 1/50M-28

         WATSON LABS
	            0.05MG;1MG
	                  A071540 001 Apr 12, 1988
	
    NORETHINDRONE AND MESTRANOL
	
         WATSON LABS
	            0.05MG;1MG
	                  A070759 001 Jul 01, 1988
	
    NORINYL 1+80 28-DAY
	
         GD SEARLE LLC
	          0.08MG;1MG
	                  N016725 001
	
    ORTHO-NOVUM 1/50 28

         ORTHO MCNEIL JANSSEN
	 0.05MG;1MG
	                    N016709 001
	
    ORTHO-NOVUM 1/80 28

         ORTHO MCNEIL PHARM
	     0.08MG;1MG
	                  N016715 002
	
MESTRANOL; NORETHYNODREL
	
  TABLET;ORAL
	
    ENOVID
	
         GD SEARLE LLC
	          0.075MG;5MG
	                 N010976 008
	
                                  0.15MG;9.85MG
	               N010976 005
	
  TABLET;ORAL-20
	
    ENOVID
	
         GD SEARLE LLC
	          0.075MG;5MG
	                 N010976 004
	
    ENOVID-E
	
         GD SEARLE LLC
	          0.1MG;2.5MG
	                 N010976 006
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                6-216(of 337)


MESTRANOL; NORETHYNODREL
	
  TABLET;ORAL-21
	
    ENOVID-E 21
	
         GD SEARLE LLC            0.1MG;2.5MG                              N010976 007
	
METAPROTERENOL SULFATE
	
  AEROSOL, METERED;INHALATION
	
    ALUPENT
	
         BOEHRINGER INGELHEIM     0.65MG/INH                               N016402 001
	
  SOLUTION;INHALATION
	
    ALUPENT
	
         BOEHRINGER INGELHEIM		   0.4%                                     N018761 002 Oct 10, 1986
	
                                  0.6%                                     N018761 001 Jun 30, 1983
	
                                  5%                                       N017659 001
	
   METAPROTERENOL SULFATE
	
        APOTEX INC                0.4%                                     A075402   001     Feb   28,   2001
	
                                  0.6%                                     A075403   001     Feb   28,   2001
	
         ASTRAZENECA              0.4%                                     A071275   001     Jul   27,   1988
	
                                  0.6%                                     A071018   001     Jul   27,   1988
	
         DEY                      0.33%                                    A071806   001     Aug   05,   1988

                                  0.5%                                     A071805   001     Aug   05,   1988

                                  5%                                       A070805   001     Aug   17,   1987

         NEPHRON                  0.4%                                     A071855   001     Jul   14,   1988
	
                                  0.6%                                     A071726   001     Jul   14,   1988
	
        WOCKHARDT                 5%                                       A072190   001     Jun   07,   1988
	
   PROMETA
	
        MURO                      5%                                       A073340 001 Mar 30, 1992
	
 SYRUP;ORAL
	
   ALUPENT
	
        BOEHRINGER INGELHEIM      10MG/5ML                                 N017571 001
	
   METAPROTERENOL SULFATE
	
        APOTEX INC                10MG/5ML                                 A075235   001     Jan   27,   2000
	
        MORTON GROVE              10MG/5ML                                 A071656   001     Oct   13,   1987
	
        TEVA                      10MG/5ML                                 A072761   001     Feb   27,   1992
	
        TEVA PHARMS               10MG/5ML                                 A073034   001     Aug   30,   1991

        WOCKHARDT                 10MG/5ML                                 A074702   001     Mar   24,   1997
	
   PROMETA
	
        MURO                      10MG/5ML                                 A072023 001 Sep 15, 1988

 TABLET;ORAL
	
   ALUPENT
	
        BOEHRINGER INGELHEIM      10MG                                     N015874 002
	
                                  20MG                                     N015874 001
	
   METAPROTERENOL SULFATE
	
        AM THERAP                 10MG                                     A072054   001     Jun   23,   1988
	
                                  20MG                                     A072055   001     Jun   23,   1988
	
         TEVA                     10MG                                     A072519   001     Mar   30,   1990
	
                                  20MG                                     A072520   001     Mar   30,   1990
	
         USL PHARMA               10MG                                     A071013   001     Jan   25,   1988
	
                                  20MG                                     A071014   001     Jan   25,   1988
	
         WATSON LABS              10MG                                     A073013   001     Jan   31,   1991
	
                                  20MG                                     A072795   001     Jan   31,   1991
	
METARAMINOL BITARTRATE
	
  INJECTABLE;INJECTION
	
    ARAMINE
	
         MERCK                    EQ 10MG BASE/ML                          N009509 002 Dec 22, 1987
	
    METARAMINOL BITARTRATE
	
         ABRAXIS PHARM            EQ   10MG   BASE/ML                      A080431   001
	
         ELKINS SINN              EQ   10MG   BASE/ML                      A083363   001
	
         GD SEARLE LLC            EQ   10MG   BASE/ML                      A086418   001
	
                                  EQ   20MG   BASE/ML		                    A086418   002
	
METAXALONE
	
  TABLET;ORAL
	
    SKELAXIN
	
         KING PHARMS              400MG **Federal Register determination   N013217 001
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-217(of 337)


METFORMIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    GLUCOPHAGE
	
         BRISTOL MYERS SQUIBB   625MG                                      N020357 003 Nov 05, 1998
	
                                750MG                                      N020357 004 Nov 05, 1998
	
   METFORMIN HYDROCHLORIDE
	
        BARR		                  1GM                                        A075971   003    Jan   25,   2002
	
                                500MG                                      A075971   001    Jan   25,   2002
	
                                850MG                                      A075971   002    Jan   25,   2002
	
        IPCA LABS LTD		         1GM                                        A078422   003    Aug   06,   2007

                                500MG                                      A078422   001    Aug   06,   2007

                                850MG                                      A078422   002    Aug   06,   2007

        IVAX SUB TEVA PHARMS		 1GM                                         A075975   003    Jan   24,   2002
	
                                500MG                                      A075975   001    Jan   24,   2002
	
                                625MG                                      A075975   004    Jan   24,   2002
	
                                750MG                                      A075975   005    Jan   24,   2002
	
                                850MG                                      A075975   002    Jan   24,   2002
	
        TEVA		                  1GM                                        A076328   003    Dec   16,   2002
	
                                500MG                                      A076328   001    Dec   16,   2002
	
                                850MG                                      A076328   002    Dec   16,   2002
	
        WATSON LABS		           1GM                                        A075979   003    Jan   24,   2002
	
                                500MG                                      A075979   001    Jan   24,   2002
	
                                850MG                                      A075979   002    Jan   24,   2002
	
 TABLET, EXTENDED RELEASE;ORAL
	
   METFORMIN HYDROCHLORIDE
	
        ACTAVIS ELIZABETH       500MG                                      A076450   001    Oct   01,   2004
	
                                750MG                                      A076878   001    Apr   13,   2005

        BARR                    500MG                                      A076496   001    Nov   25,   2005
	
        IVAX SUB TEVA PHARMS    500MG                                      A076545   001    Dec   01,   2003
	
        MUTUAL PHARM            500MG                                      A077124   001    Dec   21,   2005
	
        RANBAXY LABS LTD        500MG                                      A076413   001    Jun   18,   2004
	
                                750MG                                      A077211   001    Jun   29,   2005
	
        SANDOZ                  500MG                                      A076223   001    Dec   14,   2004
	
        TORRENT PHARMS LTD      750MG                                      A079226   001    Feb   18,   2010
	
        WATSON LABS INC         500MG                                      A076818   001    Dec   14,   2004
	
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
	
  TABLET;ORAL
	
    AVANDAMET
	
         SB PHARMCO             500MG;EQ 1MG BASE **Federal Register       N021410 001 Oct 10, 2002

                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
METHACYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    RONDOMYCIN
	
         MEDPOINTE PHARM HLC    EQ 140MG BASE                              A060641 001
	
                                EQ 280MG BASE                              A060641 002
	
 SYRUP;ORAL
	
   RONDOMYCIN
	
        MEDPOINTE PHARM HLC     EQ 70MG BASE/5ML                           A060641 003
	
METHADONE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    DOLOPHINE HYDROCHLORIDE
	
         ROXANE                 10MG/30ML                                  N006134 004
	
  TABLET;ORAL
	
    METHADONE HYDROCHLORIDE
	
         ROXANE		               5MG                                        A088108   001    Mar   08,   1983
	
                                10MG                                       A088109   001    Mar   08,   1983
	
                                40MG                                       A074081   001    Apr   28,   1995

        SANDOZ                  5MG                                        A040241   001    May   29,   1998

 TABLET, DISPERSIBLE;ORAL
	
   WESTADONE
	
        SANDOZ                  2.5MG                                      N017108 001
	
 TABLET, EFFERVESCENT;ORAL
	
   WESTADONE
	
        SANDOZ		                5MG                                        N017108 002
	
                                10MG                                       N017108 003
	
                                40MG                                       N017108 004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-218(of 337)


METHAMPHETAMINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    METHAMPEX
	
         TEVA                    10MG
	                         A083889 001
	
    METHAMPHETAMINE HYDROCHLORIDE
	
         ABLE                    5MG
	                          A040529   001 Feb 25, 2004
	
         REXAR                   5MG
	                          A084931   001
	
                                 10MG
	                         A084931   002
	
         TEVA                    5MG
	                          A086359   001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DESOXYN
	
         RECORDATI RARE		        5MG
	                          N005378 004
	
                                 10MG
	                         N005378 003
	
                                 15MG
	                         N005378 005
	
METHANTHELINE BROMIDE
	
  TABLET;ORAL
	
    BANTHINE
	
         SHIRE                   50MG
	                         N007390 001
	
METHARBITAL
	
  TABLET;ORAL
	
    GEMONIL
	
         ABBVIE                  100MG
	                        N008322 001
	
METHAZOLAMIDE
	
  TABLET;ORAL
	
    METHAZOLAMIDE
	
         APPLIED ANAL            25MG
	                         A040011   001     Jul   17,   1997
	
                                 50MG
	                         A040011   002     Jul   17,   1997
	
         SANDOZ                  25MG
	                         A040102   001     Aug   28,   1996

                                 50MG
	                         A040102   002     Aug   28,   1996
	
    NEPTAZANE
	
         LEDERLE                 25MG
	                         N011721 002 Nov 25, 1991
	
                                 50MG
	                         N011721 001
	
METHDILAZINE
	
  TABLET, CHEWABLE;ORAL
	
    TACARYL
	
         WESTWOOD SQUIBB         3.6MG
	                        N011950 009
	
METHDILAZINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    METHDILAZINE HYDROCHLORIDE
	
         ALPHARMA US PHARMS      4MG/5ML
                       A087122 001
	
    TACARYL
	
         WESTWOOD SQUIBB         4MG/5ML
                       N011950 007
	
  TABLET;ORAL
	
    TACARYL
	
         WESTWOOD SQUIBB         8MG
	                          N011950 006
	
METHICILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    STAPHCILLIN
	
         APOTHECON		             EQ   3.6GM   BASE/VIAL
        A061449   002
	
                                 EQ   3.6GM   BASE/VIAL
        N050117   002
	
                                 EQ   5.4GM   BASE/VIAL
        A061449   003
	
                                 EQ   5.4GM   BASE/VIAL
        N050117   003
	
                                 EQ   900MG   BASE/VIAL
        A061449   001
	
                                 EQ   900MG   BASE/VIAL
	       N050117   001
	
METHIMAZOLE
	
  TABLET;ORAL
	
    METHIMAZOLE
	
         CEDAR PHARMS            15MG
	                         A040619 003 Jul 12, 2005
	
                                 20MG
	                         A040547 004 Feb 18, 2005
	
         MYLAN                   20MG
	                         A040350 003 Jun 07, 2001
	
    TAPAZOLE
	
         KING PHARMS             5MG
	                          N007517 002
	
                                 10MG
	                         N007517 004
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                     6-219(of 337)


METHIXENE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TREST
	
         NOVARTIS               1MG
	                             N013420 001
	
METHOCARBAMOL
	
  INJECTABLE;INJECTION
	
    METHOCARBAMOL
	
         MARSAM PHARMS LLC      100MG/ML
                         A089849 001 Dec 27, 1991
	
         WATSON LABS            100MG/ML
                         A086459 001
	
  TABLET;ORAL
	
    DELAXIN
	
         FERNDALE LABS          500MG
	                           A085454 001
	
    FORBAXIN
	
         FOREST LABS            750MG
	                           A085136 001
	
    METHOCARBAMOL
	
         ABLE                   500MG
	                           A040413   001     Mar   17,   2003
	
                                750MG
	                           A040413   002     Mar   17,   2003
	
         AM THERAP              500MG
	                           A089417   001     Feb   11,   1987
	
                                750MG
	                           A089418   001     Feb   11,   1987
	
         ASCOT                  500MG
	                           A087660   001     Oct   27,   1982
	
                                750MG
	                           A087661   001     Oct   27,   1982
	
         CLONMEL HLTHCARE       500MG
	                           A085961   001
	
                                750MG
	                           A085963   001
	
         HEATHER                500MG
	                           A084675   001
	
                                750MG
	                           A084924   001
	
         IMPAX LABS             500MG
	                           A084927   001
	
                                750MG
	                           A084928   001
	
         INWOOD LABS            500MG
	                           A085137   001
	
         IVAX SUB TEVA PHARMS   500MG
	                           A084648   001
	
                                750MG
	                           A084649   001
	
         KV PHARM               500MG
	                           A085660   001
	
                                750MG
	                           A085658   001
	
         MUTUAL PHARM           500MG
	                           A084488   001
	
                                750MG
	                           A084486   001
	
         MYLAN                  500MG
	                           A084259   001
	
                                750MG
	                           A084323   001
	
         NYLOS                  750MG
	                           A085033   001
	
         PIONEER PHARMS         500MG
	                           A088731   001     Dec 13, 1985
	
                                750MG
	                           A089082   001     Dec 13, 1985
	
         PURACAP PHARM          500MG
	                           A084231   002
	
                                750MG
	                           A084471   001
	
         PUREPAC PHARM          500MG
	                           A085718   001
	
                                750MG
	                           A085718   002
	
         ROXANE                 500MG
	                           A088646   001     Feb 29, 1984
	
                                750MG
	                           A088647   001     Feb 29, 1984
	
         SANDOZ                 500MG
	                           A087283   001
	
                                750MG
	                           A087282   001
	
         SOLVAY                 500MG
	                           A084448   001
	
                                750MG
	                           A084449   001
	
         SUPERPHARM             500MG
	                           A087589   001     Jan 22, 1982
	
                                750MG
	                           A087590   001     Jan 22, 1982
	
         TABLICAPS              500MG
	                           A084846   001
	
         UPSHER SMITH           500MG
	                           A087453   001
	
                                750MG
	                           A087454   001
	
         WATSON LABS            500MG
	                           A083605   001
	
                                500MG
	                           A085180   001
	
                                750MG
	                           A083605   002
	
                                750MG
	                           A085192   001
	
METHOHEXITAL SODIUM
	
  INJECTABLE;INJECTION
	
    BREVITAL SODIUM
	
         PAR STERILE PRODUCTS   5GM/VIAL
	                        N011559 003
	
METHOTREXATE SODIUM
	
  INJECTABLE;INJECTION
	
    ABITREXATE
	
         ABIC		                 EQ   25MG BASE/ML
                A089161   001     Mar   10,   1987
	
                                EQ   50MG BASE/VIAL
              A089354   001     Jul   17,   1987
	
                                EQ   100MG BASE/VIAL
             A089355   001     Jul   17,   1987
	
                                EQ   250MG BASE/VIAL
	            A089356   001     Jul   17,   1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                               6-220(of 337)


METHOTREXATE SODIUM
	
  INJECTABLE;INJECTION
	
    FOLEX
	
         PHARMACIA AND UPJOHN		   EQ   25MG BASE/VIAL                      A087695   001     Apr   08,   1983

                                  EQ   50MG BASE/VIAL                      A087695   002     Apr   08,   1983

                                  EQ   100MG BASE/VIAL                     A087695   003     Apr   08,   1983

                                  EQ   250MG BASE/VIAL                     A088954   001     Oct   24,   1985
	
    FOLEX PFS
	
         PHARMACIA AND UPJOHN     EQ 25MG BASE/ML                          A081242 001 Aug 23, 1991

                                  EQ 25MG BASE/ML                          A089180 001 Jan 03, 1986
	
    METHOTREXATE LPF
	
         HOSPIRA                EQ 25MG BASE/ML                            N011719 007 Mar 31, 1982
	
    METHOTREXATE PRESERVATIVE FREE
	
         FRESENIUS KABI USA     EQ 25MG BASE/ML                            A040265   001     Feb   26,   1999
	
         HOSPIRA                EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)      N011719   011     Apr   13,   2005

                                EQ 20MG BASE/2ML (EQ 10MG BASE/ML)         N011719   014     Apr   13,   2005

                                EQ 500MG BASE/20ML (EQ 25MG BASE/ML)       N011719   013     Apr   13,   2005

                                **Federal Register determination that

                                product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
    METHOTREXATE SODIUM
	
         ABRAXIS PHARM		        EQ 2.5MG BASE/ML                           A089323   001     Jun   13,   1986
	
                                EQ 20MG BASE/VIAL                          A088935   001     Oct   11,   1985
	
                                EQ 25MG BASE/ML                            A089263   001     Jun   13,   1986
	
                                EQ 25MG BASE/ML                            A089322   001     Jun   13,   1986
	
                                EQ 50MG BASE/VIAL                          A088936   001     Oct   11,   1985
	
                                EQ 100MG BASE/VIAL                         A088937   001     Oct   11,   1985
	
         HOSPIRA		              EQ 2.5MG BASE/ML                           N011719   004
	
                                EQ 20MG BASE/VIAL                          N011719   001
	
                                EQ 25MG BASE/ML                            N011719   005
	
                                EQ 50MG BASE/VIAL                          N011719   003
	
                                EQ 100MG BASE/VIAL                         N011719   006
	
         NORBROOK               EQ 25MG BASE/ML                            A088648   001     May 09, 1986

         PHARMACHEMIE USA       EQ 25MG BASE/ML                            A089158   001     Jul 08, 1988
	
    METHOTREXATE SODIUM PRESERVATIVE FREE
	
         HOSPIRA                EQ 1GM BASE/VIAL                           N011719 009 Apr 07, 1988

    MEXATE
	
         BRISTOL		              EQ 20MG BASE/VIAL                          A086358   001
	
                                EQ 50MG BASE/VIAL                          A086358   002
	
                                EQ 100MG BASE/VIAL                         A086358   003
	
                                EQ 250MG BASE/VIAL                         A086358   004
	
    MEXATE-AQ
	
         BRISTOL MYERS          EQ 25MG BASE/ML                            A088760 001 Feb 14, 1985
	
    MEXATE-AQ PRESERVED
	
         BRISTOL MYERS SQUIBB   EQ 25MG BASE/ML                            A089887 001 Apr 14, 1989

  TABLET;ORAL
	
    METHOTREXATE SODIUM
	
         DURAMED PHARMS BARR    EQ 2.5MG BASE                              A040233 001 Jun 17, 1999
	
METHOXAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    VASOXYL
	
         GLAXOSMITHKLINE          10MG/ML                                  N006772 002
	
                                  20MG/ML                                  N006772 001
	
METHOXSALEN
	
  CAPSULE;ORAL
	
    METHOXSALEN
	
         SANDOZ                   10MG                                     A087781 001 Jun 08, 1982
	
METHSCOPOLAMINE BROMIDE
	
  TABLET;ORAL
	
    METHSCOPOLAMINE BROMIDE
	
         PVT FORM                 2.5MG                                    A080970 001
	
METHYCLOTHIAZIDE
	
  TABLET;ORAL
	
    AQUATENSEN
	
         MEDPOINTE PHARM HLC      5MG                                      N017364 001
	
    ENDURON
	
         ABBVIE                   2.5MG **Federal Register determination   N012524 001
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-221(of 337)

METHYCLOTHIAZIDE
  TABLET;ORAL
    ENDURON
                                5MG                               N012524 004
    METHYCLOTHIAZIDE
         IVAX PHARMS            2.5MG                             A087913   001   Jun   03,   1982
                                5MG                               A087786   001   May   18,   1982
         MYLAN                  2.5MG                             A087671   001   Aug   17,   1982
         PAR PHARM              2.5MG                             A089135   001   Feb   12,   1986
                                5MG                               A089136   001   Feb   12,   1986
         SANDOZ                 2.5MG                             A089835   001   Aug   18,   1988
                                5MG                               A089837   001   Aug   18,   1988
         USL PHARMA             5MG                               A088745   001   Mar   21,   1985
         WATSON LABS            2.5MG                             A085487   001   Mar   11,   1982
                                2.5MG                             A088750   001   Sep   06,   1984
                                5MG                               A085476   001   Mar   11,   1982
                                5MG                               A088724   001   Sep   06,   1984
METHYCLOTHIAZIDE; PARGYLINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    EUTRON
	
         ABBOTT                 5MG;25MG                          N016047 001
	
METHYCLOTHIAZIDE; RESERPINE
	
  TABLET;ORAL
	
    DIUTENSEN-R
	
         MEDPOINTE PHARM HLC    2.5MG;0.1MG                       N012708 005
	
METHYL AMINOLEVULINATE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    METVIXIA
	
         GALDERMA LABS LP       EQ 16.8% BASE                     N021415 001 Jul 27, 2004
	
METHYLDOPA
	
  SUSPENSION;ORAL
	
    ALDOMET
	
         MERCK                  250MG/5ML                         N018389 001
	
  TABLET;ORAL
	
    ALDOMET
	
         MERCK                  125MG                             N013400 003
	
                                250MG                             N013400 001
	
                                500MG                             N013400 002
	
    METHYLDOPA
	
         ACCORD HLTHCARE        125MG                             A070070   003   Oct   15,   1985
	
         DURAMED PHARMS BARR    250MG                             A071006   001   Dec   16,   1986
	
                                500MG                             A071009   001   Dec   16,   1986
	
         HALSEY                 125MG                             A071751   001   Mar   28,   1988
	
                                250MG                             A071752   001   Mar   28,   1988
	
                                500MG                             A071753   001   Mar   28,   1988
	
         MUTUAL PHARM           125MG                             A070073   001   Oct   09,   1986
	
                                250MG                             A070060   001   Oct   09,   1986
	
                                500MG                             A070074   001   Oct   09,   1986
	
         PAR PHARM              125MG                             A070535   001   Jan   02,   1987
	
                                250MG                             A070536   001   Jan   02,   1987
	
                                500MG                             A070537   001   Jan   02,   1987
	
         PARKE DAVIS            125MG                             A070331   001   Apr   15,   1986

                                250MG                             A070332   001   Apr   15,   1986

                                500MG                             A070333   001   Apr   15,   1986

         PLIVA                  125MG                             A072126   001   Jul   07,   1988
	
                                250MG                             A072127   001   Jul   07,   1988
	
                                500MG                             A072128   001   Jul   07,   1988
	
         PUREPAC PHARM          125MG                             A070749   001   Feb   07,   1986
	
                                250MG                             A070750   001   Feb   07,   1986
	
                                500MG                             A070452   001   Feb   07,   1986
	
         ROXANE                 125MG                             A070192   001   Apr   25,   1986

                                250MG                             A070193   001   Apr   25,   1986

                                500MG                             A070194   001   Apr   25,   1986

         SANDOZ                 125MG                             A071700   001   Mar   02,   1988
	
                                250MG                             N018934   001   Jun   29,   1984
	
                                500MG                             N018934   002   Jun   29,   1984
	
         SUPERPHARM             250MG                             A070669   001   Jun   23,   1989
	
                                500MG                             A070670   001   Jun   23,   1989
	
         TEVA                   125MG                             A071105   001   Dec   05,   1986
	
                                250MG                             A071106   001   Dec   05,   1986
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-222(of 337)


METHYLDOPA
	
  TABLET;ORAL
	
    METHYLDOPA
	
                                   500MG                        A071067   001     Dec   05,   1986
	
         WATSON LABS		             125MG                        A070245   001     Feb   25,   1986
	
                                   125MG                        A070260   001     Jun   24,   1985
	
                                   250MG                        A070246   001     Feb   25,   1986
	
                                   250MG                        A070261   001     Jun   24,   1985
	
                                   250MG                        A070703   001     Jun   06,   1986
	
                                   500MG                        A070247   001     Feb   25,   1986
	
                                   500MG                        A070262   001     Jun   24,   1985
	
METHYLDOPATE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ALDOMET
	
         MERCK                     50MG/ML                      N013401 001
	
    METHYLDOPATE HYDROCHLORIDE
	
         ABRAXIS PHARM             50MG/ML                      A070652   001     Jun   03,   1986
	
         BAXTER HLTHCARE           50MG/ML                      A070291   001     Jul   01,   1986
	
         HOSPIRA                   50MG/ML                      A070691   001     Jun   19,   1987
	
                                   50MG/ML                      A070698   001     Jun   15,   1987
	
                                   50MG/ML                      A070699   001     Jun   15,   1987
	
                                   50MG/ML                      A070849   001     Jun   19,   1987
	
         MARSAM PHARMS LLC         50MG/ML                      A071812   001     Dec   22,   1987
	
         SMITH AND NEPHEW          50MG/ML                      A070841   001     Jan   02,   1987
	
         TEVA PARENTERAL           50MG/ML                      A072974   001     Nov   22,   1991
	
METHYLPHENIDATE HYDROCHLORIDE
	
  TABLET;ORAL
	
    METHYLPHENIDATE HYDROCHLORIDE
	
         ABLE		                  5MG                            A040404   001     Mar   29,   2001
	
                                 10MG                           A040404   002     Mar   29,   2001
	
                                 20MG                           A040404   003     Mar   29,   2001
	
         ACTAVIS ELIZABETH		     5MG                            A040321   001     Feb   05,   2002
	
                                 10MG                           A040321   002     Feb   05,   2002
	
                                 20MG                           A040321   003     Feb   05,   2002
	
  TABLET, EXTENDED RELEASE;ORAL
	
    METADATE ER
	
         UCB INC                 10MG                           A040306 001 Oct 20, 1999
	
    METHYLPHENIDATE HYDROCHLORIDE
	
         ABLE                    20MG                           A076032 001 May 09, 2001

         ACTAVIS ELIZABETH       20MG                           A075450 001 Dec 21, 2001
	
         WATSON LABS             20MG                           A040410 001 Feb 09, 2001
	
METHYLPREDNISOLONE
	
  TABLET;ORAL
	
    MEDROL
	
         PHARMACIA AND UPJOHN      24MG                         N011153 005
	
    METHYLPREDNISOLONE
	
         HEATHER                   4MG                          A085650   001
	
         PAR PHARM                 16MG                         A089207   001     Apr 25, 1988

                                   24MG		                       A089208   001     Apr 25, 1988

                                   32MG                         A089209   001     Apr 25, 1988

         SANDOZ                    4MG                          A087341   001
	
         WATSON LABS               4MG                          A086161   001     Feb 09, 1982
	
                                   16MG		                       A086159   001     Feb 09, 1982
	
METHYLPREDNISOLONE ACETATE
	
  ENEMA;RECTAL
	
    MEDROL
	
         PHARMACIA AND UPJOHN      40MG/BOT                     N018102 001
	
  INJECTABLE;INJECTION
	
    M-PREDROL
	
         BEL MAR                   40MG/ML                      A086666 001
	
                                   80MG/ML                      A087135 001
	
    METHYLPREDNISOLONE ACETATE
	
         AKORN                   40MG/ML                        A086903   001 Oct 20, 1982
	
                                 80MG/ML                        A086903   002 Oct 20, 1982
	
         WATSON LABS		           20MG/ML                        A085597   001
	
                                 20MG/ML                        A087248   001
	
                                 40MG/ML                        A085374   001
	
                                 40MG/ML                        A085600   001
	
                                 80MG/ML                        A085595   001
	
                                 80MG/ML                        A086507   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                     6-223(of 337)


METHYLPREDNISOLONE ACETATE
	
  OINTMENT;TOPICAL
	
    MEDROL ACETATE
	
         PHARMACIA AND UPJOHN   0.25%                           N012421 001
	
                                1%                              N012421 002
	
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
	
  CREAM;TOPICAL
	
    NEO-MEDROL ACETATE
	
         PHARMACIA AND UPJOHN   0.25%;EQ 3.5MG BASE/GM          A060611 002
	
                                1%;EQ 3.5MG BASE/GM             A060611 001
	
METHYLPREDNISOLONE SODIUM SUCCINATE
	
  INJECTABLE;INJECTION
	
    A-METHAPRED
	
         ABBOTT		               EQ 1GM BASE/VIAL                A089576   001     Feb   22,   1991
	
                                EQ 40MG BASE/VIAL               A089573   001     Feb   22,   1991
	
                                EQ 125MG BASE/VIAL              A089574   001     Feb   22,   1991
	
                                EQ 500MG BASE/VIAL              A089575   001     Feb   22,   1991
	
         HOSPIRA		              EQ 1GM BASE/VIAL                A085852   001
	
                                EQ 1GM BASE/VIAL                A089174   001     Aug 18, 1987

                                EQ 40MG BASE/VIAL               A085853   001
	
                                EQ 125MG BASE/VIAL              A085855   001
	
                                EQ 500MG BASE/VIAL              A085854   001
	
                                EQ 500MG BASE/VIAL              A089173   001     Aug 18, 1987

    METHYLPREDNISOLONE
	
         ELKINS SINN		          EQ 1GM BASE/VIAL                A086906   004
	
                                EQ 125MG BASE/VIAL              A086906   002
	
                                EQ 500MG BASE/VIAL              A086906   003
	
         ORGANON USA INC        EQ 1GM BASE/VIAL                A087535   002 Jun 25, 1982
	
                                EQ 500MG BASE/VIAL              A087535   001 Jun 25, 1982
	
    METHYLPREDNISOLONE SODIUM SUCCINATE
	
         ABRAXIS PHARM		        EQ 1GM BASE/VIAL                A088679   001     Jun   08,   1984
	
                                EQ 1GM BASE/VIAL                A089188   001     Mar   28,   1986
	
                                EQ 1GM BASE/VIAL                A089189   001     Mar   28,   1986
	
                                EQ 40MG BASE/VIAL               A088676   001     Jun   08,   1984
	
                                EQ 40MG BASE/VIAL               A089143   001     Mar   28,   1986
	
                                EQ 125MG BASE/VIAL              A088677   001     Jun   08,   1984
	
                                EQ 125MG BASE/VIAL              A089144   001     Mar   28,   1986
	
                                EQ 500MG BASE/VIAL              A088678   001     Jun   08,   1984
	
                                EQ 500MG BASE/VIAL              A089186   001     Mar   28,   1986
	
                                EQ 500MG BASE/VIAL              A089187   001     Mar   28,   1986
	
         BEDFORD LABS		         EQ 1GM BASE/VIAL                A040641   004     Feb   21,   2007
	
                                EQ 1GM BASE/VIAL                A040709   002     Feb   21,   2007
	
                                EQ 40MG BASE/VIAL               A040662   001     Feb   21,   2007
	
                                EQ 125MG BASE/VIAL              A040641   002     Feb   21,   2007
	
                                EQ 500MG BASE/VIAL              A040641   003     Feb   21,   2007
	
                                EQ 500MG BASE/VIAL              A040709   001     Feb   21,   2007
	
         ELKINS SINN		          EQ 40MG BASE/VIAL               A086906   001
	
         INTL MEDICATION		      EQ 1GM BASE/VIAL                A087852   001     Feb   09,   1983
	
                                EQ 40MG BASE/VIAL               A087812   001     Feb   09,   1983
	
                                EQ 125MG BASE/VIAL              A087813   001     Feb   09,   1983
	
                                EQ 500MG BASE/VIAL              A087851   001     Feb   09,   1983
	
         TEVA PARENTERAL		      EQ 1GM BASE/VIAL                A081268   001     Nov   30,   1992
	
                                EQ 125MG BASE/VIAL              A081266   001     Nov   30,   1992
	
                                EQ 500MG BASE/VIAL              A081267   001     Nov   30,   1992
	
         WATSON LABS		          EQ 1GM BASE/VIAL                A088524   001     Jul   24,   1984
	
                                EQ 40MG BASE/VIAL               A086953   001     Jul   22,   1982
	
                                EQ 125MG BASE/VIAL              A087030   001     Jul   22,   1982
	
                                EQ 500MG BASE/VIAL              A088523   001     Jul   24,   1984
	
METHYLPREDNISOLONE; NEOMYCIN SULFATE
	
  OINTMENT;OPHTHALMIC
	
    NEO-MEDROL
	
         PHARMACIA AND UPJOHN   0.1%;EQ 3.5MG BASE/GM           A060645 001
	
METHYLTESTOSTERONE
	
  CAPSULE;ORAL
	
    METHYLTESTOSTERONE
	
         HEATHER                10MG                            A084967 001
	
    VIRILON
	
         STAR PHARMS FL         10MG                            A087750 001 Nov 24, 1982
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-224(of 337)


METHYLTESTOSTERONE
	
  TABLET;BUCCAL
	
    ANDROID 5
	
         VALEANT PHARM INTL     5MG
	                             A087222 001
	
    ORETON
	
         SCHERING               10MG
	                            A080281 001
	
  TABLET;BUCCAL, SUBLINGUAL
	
    METANDREN
	
         NOVARTIS		             5MG
	                             N003240   004
	
                                10MG
	                            N003240   001
	
                                10MG
	                            N003240   005
	
                                25MG
	                            N003240   003
	
    METHYLTESTOSTERONE
	
         IMPAX LABS             10MG
	                            A084287   001
	
         LILLY                  10MG
	                            A080256   001
	
                                25MG
	                            A080256   002
	
         PUREPAC PHARM		        10MG
	                            A080308   001
	
                                10MG
	                            A080475   001
	
                                10MG
	                            A080475   002
	
                                25MG
	                            A080475   003
	
         PVT FORM               5MG
	                             A083836   001
	
         TABLICAPS              10MG
	                            A085125   001
	
         USL PHARMA             10MG
	                            A080271   001
	
  TABLET;ORAL
	
    METHYLTESTOSTERONE
	
         INWOOD LABS            10MG
	                            A080839   001
	
                                25MG
	                            A080973   001
	
         KV PHARM               10MG
	                            A084312   001
	
         LANNETT                10MG
	                            A087092   001 Nov 05, 1982
	
                                25MG
	                            A087111   001 Jan 27, 1983
	
         PARKE DAVIS            10MG
	                            A084244   001
	
                                25MG
	                            A084241   001
	
         PUREPAC PHARM          10MG
	                            A080309   001
	
                                25MG
	                            A080310   001
	
         PVT FORM		             5MG
	                             A080214   001
	
                                10MG
	                            A080214   002
	
                                25MG
	                            A080214   003
	
         TABLICAPS              10MG
	                            A080313   001
	
                                25MG
	                            A085270   001
	
         WATSON LABS            10MG
	                            A080933   001
	
                                25MG
	                            A080931   001
	
         WEST WARD              10MG
	                            A084331   001
	
                                25MG
	                            A084331   002
	
                                25MG
	                            A084642   001
	
    ORETON METHYL
	
         SCHERING               10MG
	                            N003158 001
	
                                25MG
	                            N003158 002
	
METHYPRYLON
	
  CAPSULE;ORAL
	
    NOLUDAR
	
         ROCHE                  300MG
	                           N009660 008
	
  ELIXIR;ORAL
	
    NOLUDAR
	
         ROCHE                  50MG/5ML
                         N009660 007
	
  TABLET;ORAL
	
    NOLUDAR
	
         ROCHE                  50MG
	                            N009660 002
	
                                200MG
	                           N009660 004
	
METHYSERGIDE MALEATE
	
  TABLET;ORAL
	
    SANSERT
	
         NOVARTIS               2MG
	                             N012516 001
	
METOCLOPRAMIDE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    METOCLOPRAMIDE INTENSOL
	
         ROXANE                 EQ   10MG BASE/ML
                A072995 001 Jan 30, 1992
	
  INJECTABLE;INJECTION
	
    METOCLOPRAMIDE HYDROCHLORIDE
	
         BEDFORD                EQ   5MG BASE/ML                  A072155 001 Mar 30, 1992
	
                                EQ   5MG BASE/ML                  A072244 001 Mar 30, 1992
	
                                EQ   5MG BASE/ML                  A072247 001 May 18, 1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                  6-225(of 337)


METOCLOPRAMIDE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    METOCLOPRAMIDE HYDROCHLORIDE
	
         HOSPIRA		              EQ 5MG BASE/ML                             A070505   001    Jun   23,   1989
	
                                EQ 5MG BASE/ML                             A070506   001    Jun   22,   1989
	
                                EQ 5MG BASE/ML                             A070847   001    Nov   07,   1988
	
                                EQ 5MG BASE/ML                             A071291   001    Mar   03,   1989
	
                                EQ 5MG BASE/ML                             A071990   001    Jan   18,   1989
	
                                EQ 5MG BASE/ML                             A073117   001    Jan   17,   1991
	
                                EQ 5MG BASE/ML                             A074147   001    Aug   02,   1996

         LYPHOMED               EQ 10MG BASE/2ML                           A070293   001    Jan   24,   1986
	
         NORBROOK               EQ 10MG BASE/2ML                           A070892   001    Aug   26,   1988

         SMITH AND NEPHEW       EQ 5MG BASE/ML                             A070623   001    Mar   02,   1987
	
                                EQ 10MG BASE/2ML                           A070622   001    Mar   02,   1987
	
    REGLAN
	
         BAXTER HLTHCARE CORP   EQ 10MG BASE/ML                            N017862 004 May 28, 1987

  SOLUTION;ORAL
	
    METOCLOPRAMIDE HYDROCHLORIDE
	
         ACTAVIS MID ATLANTIC   EQ 5MG BASE/5ML                            A071340   001    Aug   18,   1988

         MORTON GROVE           EQ 5MG BASE/5ML                            A070949   001    Mar   06,   1987
	
         PACO                   EQ 5MG BASE/5ML                            A071665   001    Dec   05,   1988
	
         ROXANE                 EQ 5MG BASE/5ML                            A072038   001    Dec   05,   1988
	
         TEVA                   EQ 5MG BASE/5ML                            A070819   001    Jul   10,   1987
	
                                EQ 5MG BASE/5ML                            A071315   001    Jun   30,   1993
	
    REGLAN
	
         ROBINS AH		            EQ 5MG BASE/5ML **Federal Register         N018821 001 Mar 25, 1983

                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

  TABLET;ORAL
	
    CLOPRA
	
         QUANTUM PHARMICS       EQ 5MG BASE                                A072384 001 Jun 02, 1988
	
                                EQ 10MG BASE                               A070294 001 Jul 29, 1985
	
    CLOPRA-"YELLOW"
	
         QUANTUM PHARMICS       EQ 10MG BASE                               A070632 001 Oct 28, 1985
	
    MAXOLON
	
         KING PHARMS            EQ 10MG BASE                               A070106 001 Mar 04, 1986
	
    METOCLOPRAMIDE HYDROCHLORIDE
	
         CLONMEL                EQ 10MG BASE                               A072639   001    May   09,   1991

         HALSEY                 EQ 10MG BASE                               A070906   001    Oct   28,   1986
	
         INTERPHARM             EQ 10MG BASE                               A071213   001    Sep   24,   1986

         MUTUAL PHARM           EQ 10MG BASE                               A070660   001    Feb   10,   1987
	
                                EQ 10MG BASE                               A071536   001    Apr   28,   1993

         PAR PHARM              EQ 10MG BASE                               A070342   001    Mar   25,   1986
	
         SANDOZ                 EQ 5MG BASE                                A072436   001    Jun   22,   1989
	
                                EQ 5MG BASE                                A074478   001    Oct   05,   1995
	
                                EQ 10MG BASE                               A070850   001    Feb   03,   1987
	
                                EQ 10MG BASE                               A072215   001    Jan   30,   1990
	
                                EQ 10MG BASE                               A074478   002    Oct   05,   1995
	
         SCHERING               EQ 10MG BASE                               A070598   001    Feb   02,   1987
	
         SUPERPHARM             EQ 10MG BASE                               A070926   001    Jun   26,   1987
	
         USL PHARMA             EQ 10MG BASE                               A070339   001    Jul   29,   1985
	
         WATSON LABS            EQ 10MG BASE                               A070363   001    Mar   02,   1987
	
                                EQ 10MG BASE                               A070453   001    Jun   06,   1986
	
                                EQ 10MG BASE                               A070511   001    Jan   22,   1986
	
                                EQ 10MG BASE                               A070645   001    May   11,   1987

  TABLET, ORALLY DISINTEGRATING;ORAL
	
    METOZOLV ODT
	
         SALIX PHARMS		         EQ 10MG BASE **Federal Register            N022246 002 Sep 04, 2009

                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

    REGLAN ODT
	
         MEDA PHARMS            EQ 5MG BASE                                N021793 001 Jun 10, 2005
	
                                EQ 10MG BASE                               N021793 002 Jun 10, 2005
	
METOCURINE IODIDE
	
  INJECTABLE;INJECTION
	
    METUBINE IODIDE
	
         LILLY                  2MG/ML                                     N006632 003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-226(of 337)


METOLAZONE
	
  TABLET;ORAL
	
    DIULO
	
         GD SEARLE LLC          2.5MG
	                         N018535 001
	
                                5MG
	                           N018535 002
	
                                10MG
	                          N018535 003
	
   METOLAZONE
	
        ROXANE                  10MG
	                          A076482   002    Apr   29,   2004

        TEVA                    2.5MG
	                         A076600   001    Jan   06,   2004
	
                                5MG
	                           A076833   001    Mar   01,   2004
	
                                10MG
	                          A075543   003    Dec   24,   2003
	
        WATSON LABS             10MG
	                          A076891   001    Jul   21,   2004
	
   MYKROX
	
        UCB INC                 0.5MG
	                         N019532 001 Oct 30, 1987
	
METOPROLOL FUMARATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    LOPRESSOR
	
         NOVARTIS                EQ   100MG   TARTRATE
	        N019786   001    Dec   27,   1989
	
                                 EQ   200MG   TARTRATE
	        N019786   002    Dec   27,   1989
	
                                 EQ   300MG   TARTRATE
	        N019786   003    Dec   27,   1989
	
                                 EQ   400MG   TARTRATE
	        N019786   004    Dec   27,   1989
	
METOPROLOL SUCCINATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    METOPROLOL SUCCINATE
	
         NESHER PHARMS           EQ   25MG TARTRATE
	           A077779   001    Mar   20,   2008
	
                                 EQ   50MG TARTRATE
	           A077176   001    May   14,   2008

                                 EQ   100MG TARTRATE
	          A076640   002    May   18,   2007

                                 EQ   200MG TARTRATE
	          A076640   001    May   18,   2007

         SANDOZ                  EQ   25MG TARTRATE
	           A076969   001    Jul   31,   2006
	
                                 EQ   50MG TARTRATE
	           A076969   002    May   18,   2007

                                 EQ   100MG TARTRATE
	          A076969   003    Mar   20,   2008
	
                                 EQ   200MG TARTRATE
	          A076969   004    Mar   20,   2008
	
METOPROLOL TARTRATE
	
  INJECTABLE;INJECTION
	
    METOPROLOL TARTRATE
	
         WATSON LABS            1MG/ML
                         A074032 001 Dec 21, 1993
	
  TABLET;ORAL
	
    METOPROLOL TARTRATE
	
         APOTHECON              50MG
	                          A074258   001    Jan   27,   1994
	
                                100MG
	                         A074258   002    Jan   27,   1994
	
         MYLAN                  50MG
	                          A073666   001    Dec   21,   1993
	
                                100MG
	                         A073666   002    Dec   21,   1993
	
         PRINSTON INC           50MG
	                          A074453   001    Apr   27,   1995

                                100MG
	                         A074453   002    Apr   27,   1995

         PUREPAC PHARM          50MG
	                          A074380   001    Jul   29,   1994
	
                                100MG
	                         A074380   002    Jul   29,   1994
	
         TEVA                   50MG
	                          A074143   001    Sep   30,   1994

                                100MG
	                         A074143   002    Sep   30,   1994

         TEVA PHARMS            50MG
	                          A074333   001    Jan   27,   1994
	
                                100MG
	                         A074333   002    Jan   27,   1994
	
METRIZAMIDE
	
  INJECTABLE;INJECTION
	
    AMIPAQUE
	
         GE HEALTHCARE          2.5GM/VIAL
                     N017982   003 Sep 12, 1983

                                3.75GM/VIAL
                    N017982   001
	
                                6.75GM/VIAL
                    N017982   002
	
                                13.5GM/VIAL
	                   N017982   004 Sep 12, 1983
	
METRONIDAZOLE
	
  CAPSULE;ORAL
	
    METRONIDAZOLE
	
         ABLE                   375MG
	                         A076505 001 Nov 13, 2003
	
  INJECTABLE;INJECTION
	
    METRO I.V.
	
         B BRAUN                500MG/100ML
                    N018674 001 Aug 31, 1982
	
    METRONIDAZOLE
	
         ABBOTT                 500MG/100ML
                    N018889   001    Nov   18,   1983
	
         ABRAXIS PHARM          500MG/100ML
                    A070071   001    Dec   03,   1984
	
         HIKMA MAPLE            500MG/100ML
                    N018907   001    Mar   30,   1984
	
         INTL MEDICATION        500MG/100ML
                    A070004   001    May   08,   1985

         WATSON LABS            500MG/100ML
	                   A070042   001    Dec   20,   1984
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-227(of 337)


METRONIDAZOLE
	
  INJECTABLE;INJECTION
	
    METRONIDAZOLE
	
                                  500MG/100ML                     A070170 001 Apr 01, 1986

 TABLET;ORAL
	
   METROMIDOL
	
        LABS AF                   250MG                           A074523 001 Oct 24, 1996
	
                                  500MG                           A074523 002 Oct 24, 1996
	
   METRONIDAZOLE
	
        ABLE                      250MG                           A076519   001     Jun   27,   2003
	
                                  500MG                           A076519   002     Jun   27,   2003
	
         HALSEY                   250MG                           A070021   001     Apr   02,   1985

                                  500MG                           A070593   001     Feb   27,   1986
	
         IVAX SUB TEVA PHARMS		   250MG                           N018517   001
	
                                  500MG                           N018517   002     May   05,   1982

         LNK                      250MG                           N019029   001     Apr   10,   1984

         MUTUAL PHARM             250MG                           N018818   001     Feb   16,   1983
	
                                  500MG                           N018818   002     Feb   16,   1983
	
         PAR PHARM                250MG                           N018845   001     Aug   18,   1983

                                  500MG                           N018930   001     Aug   18,   1983

         SANDOZ                   250MG                           N018620   001     Mar   04,   1982
	
                                  250MG                           N018740   001     Oct   22,   1982
	
                                  500MG                           N018620   002     Jun   02,   1983
	
                                  500MG                           N018740   002     Oct   22,   1982
	
         SUPERPHARM               250MG                           A070008   001     Dec   11,   1984
	
                                  500MG                           A070009   001     Dec   11,   1984
	
         VIVIMED LABS             250MG                           A070040   001     Jan   29,   1985
	
                                  500MG                           A070039   001     Jan   29,   1985
	
         WATSON LABS              250MG                           N018599   001     Sep   17,   1982

                                  250MG                           N018764   001     Sep   17,   1982

                                  500MG                           N018599   002     Feb   13,   1984
	
                                  500MG                           N018764   002     Dec   20,   1982
	
   PROTOSTAT
	
        ORTHO MCNEIL PHARM        250MG                           N018871 001 Mar 02, 1983
	
                                  500MG                           N018871 002 Mar 02, 1983
	
   SATRIC
	
        SAVAGE LABS             250MG                             A070029 001 Mar 19, 1985
	
                                500MG                             A070731 001 Jun 08, 1987
	
 TABLET, EXTENDED RELEASE;ORAL
	
   METRONIDAZOLE
	
        ABLE                    750MG                             A076462 001 Jun 25, 2003
	
METRONIDAZOLE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    FLAGYL I.V.
	
         PFIZER                   EQ 500MG BASE/VIAL              N018353 001
	
    METRONIDAZOLE HYDROCHLORIDE
	
         ABRAXIS PHARM            EQ 500MG BASE/VIAL              A070295 001 Oct 15, 1985
	
METYRAPONE
	
  TABLET;ORAL
	
    METOPIRONE
	
         HRA PHARMA               250MG                           N012911 001
	
MEXILETINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    MEXILETINE HYDROCHLORIDE
	
         SANDOZ		                 150MG                           A074450   001     May   16,   1996

                                  200MG                           A074450   002     May   16,   1996

                                  250MG                           A074450   003     May   16,   1996

         WATSON LABS		            150MG                           A074711   001     Feb   26,   1997
	
                                  150MG                           A074865   001     Apr   13,   1998

                                  200MG                           A074711   002     Feb   26,   1997
	
                                  200MG                           A074865   002     Apr   13,   1998

                                  250MG                           A074711   003     Feb   26,   1997
	
                                  250MG                           A074865   003     Apr   13,   1998

   MEXITIL
	
        BOEHRINGER INGELHEIM		    150MG                           N018873 002 Dec 30, 1985
	
                                  200MG                           N018873 003 Dec 30, 1985
	
                                  250MG                           N018873 004 Dec 30, 1985
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                        6-228(of 337)


MEZLOCILLIN SODIUM MONOHYDRATE
	
  INJECTABLE;INJECTION
	
    MEZLIN
	
         BAYER PHARMS		          EQ   1GM BASE/VIAL              A062333   001
	
                                 EQ   1GM BASE/VIAL              A062372   005     Jan 13, 1983
	
                                 EQ   1GM BASE/VIAL              N050549   001
	
                                 EQ   2GM BASE/VIAL              A062333   002
	
                                 EQ   2GM BASE/VIAL              A062372   001     May 13, 1982

                                 EQ   2GM BASE/VIAL              N050549   002
	
                                 EQ   3GM BASE/VIAL              A062333   003
	
                                 EQ   3GM BASE/VIAL              A062372   002     May 13, 1982

                                 EQ   3GM BASE/VIAL              A062697   001     Jan 22, 1987
	
                                 EQ   3GM BASE/VIAL              N050549   003
	
                                 EQ   4GM BASE/VIAL              A062333   004
	
                                 EQ   4GM BASE/VIAL              A062372   003     May 13, 1982

                                 EQ   4GM BASE/VIAL              A062697   002     Jan 22, 1987
	
                                 EQ   4GM BASE/VIAL              N050549   004
	
                                 EQ   20GM BASE/VIAL             A062372   004     Mar 02, 1988
	
                                 EQ   20GM BASE/VIAL             N050549   005     Mar 02, 1988
	
MICONAZOLE
	
  INJECTABLE;INJECTION
	
    MONISTAT
	
         JANSSEN PHARMA         10MG/ML                          N018040 001
	
MICONAZOLE NITRATE
	
  CREAM;TOPICAL
	
    MONISTAT-DERM
	
         INSIGHT PHARMS         2%                               N017494 001
	
  CREAM;VAGINAL
	
    MICONAZOLE NITRATE
	
         TEVA                   2%                               A074136 001 Jan 04, 1995
	
         TEVA PHARMS            2%                               A074030 001 Oct 30, 1992
	
  CREAM, SUPPOSITORY;TOPICAL, VAGINAL
	
    M-ZOLE 7 DUAL PACK
	
         ACTAVIS MID ATLANTIC   2%,100MG                         A074586 001 Jul 17, 1997
	
  LOTION;TOPICAL
	
    MONISTAT-DERM
	
         INSIGHT PHARMS         2%                               N017739 001
	
  TAMPON;VAGINAL
	
    MONISTAT 5
	
         PERSONAL PRODS         100MG                            N018592 001 Oct 27, 1989
	
MIDAZOLAM HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    MIDAZOLAM HYDROCHLORIDE
	
         APOTEX INC             EQ    1MG   BASE/ML              A075637   001     Oct   31,   2000
	
                                EQ    5MG   BASE/ML              A075637   002     Oct   31,   2000
	
         APOTHECON              EQ    1MG   BASE/ML              A075620   001     Nov   01,   2000
	
                                EQ    5MG   BASE/ML              A075620   002     Nov   01,   2000
	
                                EQ    5MG   BASE/ML              A075641   001     Oct   19,   2000
	
         ASTRAZENECA            EQ    5MG   BASE/ML              A075263   001     Jun   26,   2000
	
         BEDFORD                EQ    5MG   BASE/ML              A075249   001     Jun   23,   2000
	
         BEN VENUE              EQ    5MG   BASE/ML              A075455   001     Jun   20,   2000
	
         HOSPIRA                EQ    1MG   BASE/ML              A075396   001     Jun   20,   2000
	
                                EQ    5MG   BASE/ML              A075396   002     Jun   20,   2000
	
                                EQ    5MG   BASE/ML              A075484   001     Jun   20,   2000
	
         HOSPIRA INC            EQ    1MG   BASE/ML              A075409   002     Jun   20,   2000
	
                                EQ    5MG   BASE/ML              A075409   001     Jun   20,   2000
	
         INTL MEDICATED         EQ    1MG   BASE/ML              A076144   001     Jan   26,   2005
	
                                EQ    5MG   BASE/ML              A076144   002     Jan   26,   2005
	
         INTL MEDICATION        EQ    1MG   BASE/ML              A076020   001     Jul   16,   2004
	
                                EQ    5MG   BASE/ML              A076020   002     Jul   16,   2004
	
   VERSED
	
        HLR                     EQ 1MG BASE/ML                   N018654 002 May 26, 1987

                                EQ 5MG BASE/ML                   N018654 001 Dec 20, 1985
	
 SYRUP;ORAL
	
   MIDAZOLAM HYDROCHLORIDE
	
        APOTEX INC              EQ 2MG BASE/ML                   A077115 001 Sep 09, 2005

   VERSED
	
        ROCHE                   EQ 2MG BASE/ML                   N020942 001 Oct 15, 1998
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                             6-229(of 337)


MIDODRINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PROAMATINE
	
         SHIRE LLC		             2.5MG                                   N019815 001 Sep 06, 1996

                                 5MG                                     N019815 002 Sep 06, 1996

                                 10MG                                    N019815 003 Mar 20, 2002
	
MILRINONE LACTATE
	
  INJECTABLE;INJECTION
	
    MILRINONE LACTATE
	
         APOTEX INC            EQ 1MG BASE/ML                            A076427   001    Sep   21,   2004

         HIKMA MAPLE           EQ 1MG BASE/ML                            A075852   001    May   28,   2002

         HOSPIRA               EQ 1MG BASE/ML                            A075830   001    May   28,   2002

                               EQ 1MG BASE/ML                            A075884   001    May   28,   2002

        MYLAN INSTITUTIONAL    EQ 1MG BASE/ML                            A076428   001    Jun   16,   2003
	
   MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        APOTEX INC             EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A077151 001 Jul 20, 2005
	
        BAXTER HLTHCARE        EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A076259 001 Aug 08, 2002

        HIKMA MAPLE            EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   A075510 001 May 28, 2002

   PRIMACOR
	
        SANOFI AVENTIS US      EQ 1MG BASE/ML                            N019436 001 Dec 31, 1987
	
   PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        SANOFI AVENTIS US		    EQ 10MG BASE/100ML                        N020343   001    Aug   09,   1994

                               EQ 15MG BASE/100ML                        N020343   002    Aug   09,   1994

                               EQ 20MG BASE/100ML (EQ 0.2MG   BASE/ML)   N020343   003    Aug   09,   1994

                               EQ 40MG BASE/200ML (EQ 0.2MG   BASE/ML)   N020343   004    Aug   09,   1994
	
MINOCYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    DYNACIN
	
         CNTY LINE PHARMS        EQ 50MG BASE                            A063066 001 Aug 14, 1990

    MINOCIN
	
         PRECISION DERMAT       EQ 75MG BASE                             N050649 003 Feb 12, 2001
	
         TRIAX PHARMS           EQ 50MG BASE                             N050315 002
	
                                EQ 100MG BASE                            N050315 001
	
 CAPSULE, EXTENDED RELEASE;ORAL
	
   XIMINO
	
        RANBAXY LABS LTD		      EQ 45MG BASE                             N201922   001    Jul   11,   2012
	
                                EQ 67.5MG BASE                           N201922   002    Jul   11,   2012
	
                                EQ 90MG BASE                             N201922   003    Jul   11,   2012
	
                                EQ 112.5MG BASE                          N201922   004    Jul   11,   2012
	
                                EQ 135MG BASE                            N201922   005    Jul   11,   2012
	
 INJECTABLE;INJECTION
	
   MINOCIN
	
        LEDERLE                 EQ 100MG BASE/VIAL                       A062139 001
	
 SUSPENSION;ORAL
	
   MINOCIN
	
        PRECISION DERMAT        EQ 50MG BASE/5ML                         N050445 001
	
 TABLET;ORAL
	
   MINOCYCLINE HYDROCHLORIDE
	
        TRIAX PHARMS            EQ 50MG BASE                             N050451 003 Aug 10, 1982

                                EQ 100MG BASE                            N050451 002 Aug 10, 1982

 TABLET, EXTENDED RELEASE;ORAL
	
   MINOCYCLINE HYDROCHLORIDE
	
        LUPIN LTD               EQ 55MG BASE                             A091424 002 Nov 30, 2011
	
   SOLODYN
	
        MEDICIS		               EQ 45MG BASE                             N050808 001 May 08, 2006

                                EQ 90MG BASE                             N050808 002 May 08, 2006

                                EQ 135MG BASE                            N050808 003 May 08, 2006
	
MINOXIDIL
	
  SOLUTION;TOPICAL
	
    MINOXIDIL (FOR MEN)

         APOTEX INC             2%                                       A074924   001    Apr   29,   1998

         BAUSCH AND LOMB        2%                                       A074643   001    Apr   09,   1996

         COPLEY PHARM           2%                                       A074500   001    May   23,   1996

         SIGHT PHARMS           2%                                       A074743   002    Oct   18,   1996
	
         TEVA                   2%                                       A074589   001    Apr   05,   1996

    MINOXIDIL (FOR WOMEN)

         APOTEX INC             2%                                       A074924 002 Apr 29, 1998

         SIGHT PHARMS           2%                                       A074743 001 Oct 18, 1996
	
    MINOXIDIL EXTRA STRENGTH (FOR MEN)

         APOTEX INC             5%                                       A075839 001 Oct 01, 2001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                6-230(of 337)


MINOXIDIL
	
  TABLET;ORAL
	
    LONITEN
	
         PHARMACIA AND UPJOHN   2.5MG                                     N018154 001
	
                                10MG                                      N018154 003
	
   MINODYL
	
        QUANTUM PHARMICS        2.5MG                                     A072153 001 Jul 13, 1988
	
                                10MG                                      A071534 001 Mar 19, 1987
	
   MINOXIDIL
	
        ROYCE LABS              2.5MG                                     A071799 001 Nov 10, 1987
	
                                10MG                                      A071796 001 Nov 10, 1987
	
         USL PHARMA             2.5MG                                     A071537 001 Dec 16, 1988
	
MIRTAZAPINE
	
  TABLET;ORAL
	
    MIRTAZAPINE
	
         ACTAVIS ELIZABETH		   15MG                                       A076241   001    Jun   25,   2003
	
                               15MG                                       A076308   001    Jun   20,   2003
	
                               30MG                                       A076241   002    Jun   25,   2003
	
                               30MG                                       A076308   002    Jun   20,   2003
	
                               45MG                                       A076241   003    Jun   25,   2003
	
                               45MG                                       A076308   003    Jun   20,   2003
	
        IVAX SUB TEVA PHARMS		 15MG                                       A076244   001    Dec   22,   2003
	
                               30MG                                       A076244   002    Dec   22,   2003
	
                               45MG                                       A076244   003    Dec   22,   2003
	
        ROXANE		               15MG                                       A076270   001    Jun   19,   2003
	
                               30MG                                       A076270   002    Jun   19,   2003
	
                               45MG                                       A076270   003    Jun   19,   2003
	
        SANDOZ		               15MG                                       A076189   001    Jun   19,   2003
	
                               30MG                                       A076189   002    Jun   19,   2003
	
                               45MG                                       A076189   003    Jun   19,   2003
	
 TABLET, ORALLY DISINTEGRATING;ORAL
	
   MIRTAZAPINE
	
        ACTAVIS ELIZABETH		    15MG                                       A076689   001    Aug   31,   2005

                               15MG                                       A077959   001    Feb   14,   2011
	
                               30MG                                       A076689   002    Aug   31,   2005

                               30MG                                       A077959   002    Feb   14,   2011
	
                               45MG                                       A076689   003    Aug   31,   2005

                               45MG                                       A077959   003    Feb   14,   2011
	
MITOMYCIN
	
  INJECTABLE;INJECTION
	
    MITOMYCIN
	
         HOSPIRA                20MG/VIAL                                 A064106 001 Nov 29, 1995
	
    MITOZYTREX
	
         SUPERGEN               5MG/VIAL                                  N050763 001 Nov 14, 2002
	
    MUTAMYCIN
	
         BRISTOL                5MG/VIAL                                  N050450   001
	
                                20MG/VIAL                                 N050450   002
	
         BRISTOL MYERS		        5MG/VIAL                                  A062336   001
	
                                20MG/VIAL                                 A062336   002
	
                                40MG/VIAL                                 A062336   003 Mar 10, 1988
	
MITOXANTRONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    MITOXANTRONE HYDROCHLORIDE
	
         FRESENIUS KABI ONCOL		 EQ    20MG BASE/10ML (EQ 2MG BASE/ML)     A078606 001 May 14, 2008

                                 EQ   25MG BASE/12.5ML (EQ 2MG BASE/ML)   A078606 002 May 14, 2008

                                 EQ   30MG BASE/15ML (EQ 2MG BASE/ML)     A078606 003 May 14, 2008

    NOVANTRONE
	
         EMD SERONO		            EQ   20MG BASE/10ML (EQ 2MG BASE/ML)     N019297 001 Dec 23, 1987
	
                                 EQ   25MG BASE/12.5ML (EQ 2MG BASE/ML)   N019297 002 Dec 23, 1987
	
                                 EQ   30MG BASE/15ML (EQ 2MG BASE/ML)     N019297 003 Dec 23, 1987
	
MIVACURIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    MIVACRON
	
         ABBVIE                 EQ 2MG BASE/ML                            N020098 001 Jan 22, 1992
	
    MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         ABBVIE                 EQ 0.5MG BASE/ML                          N020098 002 Jan 22, 1992
	
                                EQ 50MG BASE/100ML                        N020098 003 Jan 22, 1992
	
    MIVACURIUM CHLORIDE
	
         AGILA SPECLTS          EQ 2MG BASE/ML                            A078562 001 Apr 30, 2009
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-231(of 337)


MOLINDONE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    MOBAN
	
         ENDO PHARMS            5MG **Federal Register determination     N017111 001
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                10MG **Federal Register determination    N017111 002
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                25MG **Federal Register determination    N017111 003
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
 CONCENTRATE;ORAL
	
   MOBAN
	
        ENDO PHARMS             20MG/ML                                  N017938 001
	
 TABLET;ORAL
	
   MOBAN
	
        ENDO PHARMS             5MG **Federal Register determination     N017111 004
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                10MG **Federal Register determination    N017111 005
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                25MG **Federal Register determination    N017111 006
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                50MG **Federal Register determination    N017111 007
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                                100MG **Federal Register determination   N017111 008
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
MOMETASONE FUROATE
	
  OINTMENT;TOPICAL
	
    MOMETASONE FUROATE
	
         TARO                   0.1%                                     A076624 001 Dec 03, 2004
	
MONOBENZONE
	
  CREAM;TOPICAL
	
    BENOQUIN
	
         VALEANT PHARM INTL     20%                                      N008173 003
	
MONOCTANOIN
	
  LIQUID;PERFUSION, BILIARY
	
    MOCTANIN
	
         ETHITEK                100%                                     N019368 001 Oct 29, 1985
	
MORICIZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ETHMOZINE
	
         SHIRE                  200MG                                    N019753 001 Jun 19, 1990
	
                                250MG                                    N019753 002 Jun 19, 1990
	
                                300MG                                    N019753 003 Jun 19, 1990
	
MORPHINE SULFATE
	
  INJECTABLE;INJECTION
	
    MORPHINE SULFATE
	
         HOSPIRA               0.5MG/ML                                  N019917   001    Oct   30,   1992
	
         MALLINCKRODT          1MG/ML                                    N020631   001    Jul   03,   1996
	
                               2MG/ML                                    N020631   002    Jul   03,   1996
	
        WATSON LABS            0.5MG/ML                                  A073373   001    Sep   30,   1991

                               0.5MG/ML                                  A073375   001    Sep   30,   1991

                               1MG/ML                                    A073374   001    Sep   30,   1991

                               1MG/ML                                    A073376   001    Sep   30,   1991

 INJECTABLE, LIPOSOMAL;EPIDURAL
	
   DEPODUR
	
        PACIRA PHARMS INC      10MG/ML (10MG/ML)                         N021671 001 May 18, 2004

                               15MG/1.5ML (10MG/ML)                      N021671 002 May 18, 2004

                               20MG/2ML (10MG/ML)                        N021671 003 May 18, 2004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-232(of 337)


MORPHINE SULFATE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    MORPHINE SULFATE
	
         WATSON LABS             100MG                          A075656 001 Jan 30, 2001
	
    ORAMORPH SR
	
         XANODYNE PHARMS INC		   15MG                           N019977   004     Nov   23,   1994
	
                                 30MG                           N019977   001     Aug   15,   1991

                                 60MG                           N019977   002     Aug   15,   1991

                                 100MG                          N019977   003     Aug   15,   1991
	
MOXALACTAM DISODIUM
	
  INJECTABLE;INJECTION
	
    MOXAM
	
         LILLY		                EQ   1GM BASE/VIAL              N050550   003
	
                                EQ   2GM BASE/VIAL              N050550   004
	
                                EQ   10GM BASE/VIAL             N050550   008
	
                                EQ   250MG BASE/VIAL            N050550   001
	
                                EQ   500MG BASE/VIAL            N050550   002
	
MYCOPHENOLATE MOFETIL
	
  CAPSULE;ORAL
	
    MYCOPHENOLATE MOFETIL
	
         ZYDUS PHARMS USA INC   250MG                           A065433 001 May 04, 2009

  TABLET;ORAL
	
    MYCOPHENOLATE MOFETIL
	
         DR REDDYS LABS LTD     500MG                           A090464 001 Sep 13, 2010

         ZYDUS PHARMS USA INC   500MG                           A065477 001 May 04, 2009
	
NABUMETONE
	
  TABLET;ORAL
	
    NABUMETONE
	
         COPLEY PHARM           750MG                           A075179   001     Jun   06,   2000
	
         DR REDDYS LABS LTD     500MG                           A078420   001     Sep   24,   2008

                                750MG                           A078420   002     Sep   24,   2008

         PROSAM LABS            500MG                           A079093   001     Feb   27,   2009
	
                                750MG                           A079093   002     Feb   27,   2009
	
         SANDOZ                 500MG                           A075590   001     Feb   25,   2002
	
                                750MG                           A075590   002     Feb   25,   2002
	
   RELAFEN
	
        SMITHKLINE BEECHAM      500MG                           N019583 001 Dec 24, 1991
                                750MG                           N019583 002 Dec 24, 1991
NADOLOL
  TABLET;ORAL
    CORGARD
         KING PHARMS            120MG                           N018063 003
                                160MG                           N018063 004
   NADOLOL
        IVAX SUB TEVA PHARMS    120MG                           A074255   002     Jan   24,   1996
                                160MG                           A074255   003     Jan   24,   1996
         TEVA PHARMS            80MG                            A074368   001     Aug   31,   1994
                                120MG                           A074368   002     Aug   31,   1994
                                160MG                           A074368   003     Aug   31,   1994
NAFCILLIN SODIUM
  CAPSULE;ORAL
    UNIPEN
         WYETH AYERST           EQ 250MG BASE                   N050111 001
  FOR SOLUTION;ORAL
    UNIPEN
         WYETH AYERST           EQ 250MG BASE/5ML               N050199 001
  INJECTABLE;INJECTION
    NAFCILLIN SODIUM
         APOTHECON              EQ   1GM BASE/VIAL              A061984   002
                                EQ   2GM BASE/VIAL              A061984   003
                                EQ   4GM BASE/VIAL              A061984   005
                                EQ   500MG BASE/VIAL            A061984   001
         SANDOZ                 EQ   500MG BASE/VIAL            A062527   001     Aug   02,   1984
         WATSON LABS INC        EQ   1GM BASE/VIAL              A062844   002     Oct   26,   1988
                                EQ   1.5GM BASE/VIAL            A062844   003     Oct   26,   1988
                                EQ   2GM BASE/VIAL              A062844   004     Oct   26,   1988
                                EQ   4GM BASE/VIAL              A062844   005     Oct   26,   1988
                                EQ   10GM BASE/VIAL             A063008   001     Sep   29,   1988
                                EQ   500MG BASE/VIAL            A062844   001     Oct   26,   1988
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-233(of 337)


NAFCILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    NALLPEN
	
         GLAXOSMITHKLINE		      EQ   1GM BASE/VIAL              A061999   002
	
                                EQ   1GM BASE/VIAL              A062755   001 Dec 19, 1986
	
                                EQ   2GM BASE/VIAL              A061999   003
	
                                EQ   2GM BASE/VIAL              A062755   002 Dec 19, 1986
	
                                EQ   10GM BASE/VIAL             A061999   004
	
                                EQ   500MG BASE/VIAL            A061999   001
	
   UNIPEN
	
        WYETH AYERST		          EQ   1GM BASE/VIAL              A062717   002 Dec 16, 1986
	
                                EQ   2GM BASE/VIAL              A062717   004 Dec 16, 1986
	
                                EQ   2GM BASE/VIAL              N050320   003
	
                                EQ   4GM BASE/VIAL              N050320   004
	
                                EQ   10GM BASE/VIAL             N050320   005
	
                                EQ   20GM BASE/VIAL             N050320   006
	
                                EQ   500MG BASE/VIAL            A062717   001 Dec 16, 1986
	
                                EQ   500MG BASE/VIAL            N050320   001
	
   UNIPEN IN PLASTIC CONTAINER
	
        WYETH AYERST             EQ 1GM BASE/VIAL               N050320 002
	
 TABLET;ORAL
	
   UNIPEN
	
        WYETH AYERST             EQ 500MG BASE                  N050462 001
	
NALBUPHINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    NALBUPHINE
	
         ABRAXIS PHARM          10MG/ML                         A070751 001 Jul 02, 1986
	
                                20MG/ML                         A070752 001 Sep 24, 1986

   NALBUPHINE HYDROCHLORIDE
	
        ABBOTT                  20MG/ML                         A070917   001    Feb   03,   1989
	
        ABBVIE                  1.5MG/ML                        N020200   001    Mar   12,   1993
	
        ASTRAZENECA             10MG/ML                         A072070   001    Apr   10,   1989

                                10MG/ML                         A072071   001    Apr   10,   1989

                                10MG/ML                         A072072   001    Apr   10,   1989

                                20MG/ML                         A072073   001    Apr   10,   1989

                                20MG/ML                         A072074   001    Apr   10,   1989

                                20MG/ML                         A072075   001    Apr   10,   1989

         BARR                   10MG/ML                         A074471   001    Mar   19,   1998
	
                                20MG/ML                         A074471   002    Mar   19,   1998
	
   NUBAIN
	
        ENDO PHARMS             10MG/ML                         N018024 001
	
                                20MG/ML                         N018024 002 May 27, 1982
	
NALIDIXIC ACID
	
  SUSPENSION;ORAL
	
    NEGGRAM
	
         SANOFI AVENTIS US      250MG/5ML                       N017430 001
	
  TABLET;ORAL
	
    NALIDIXIC ACID
	
         MUTUAL PHARM		         1GM                             A070272   001    Jun   29,   1988
	
                                250MG                           A070270   001    Jun   29,   1988
	
                                500MG                           A070271   001    Jun   29,   1988
	
         WATSON LABS		          1GM                             A071919   001    Jun   29,   1988
	
                                250MG                           A071936   001    Jun   29,   1988
	
                                500MG                           A072061   001    Jun   29,   1988
	
   NEGGRAM
	
        SANOFI AVENTIS US		     1GM                             N014214 005
	
                                250MG                           N014214 002
	
                                500MG                           N014214 004
	
NALMEFENE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    REVEX
	
         BAXTER HLTHCARE CORP   EQ 0.1MG BASE/ML                N020459 001 Apr 17, 1995

                                EQ 1MG BASE/ML                  N020459 002 Apr 17, 1995
	
NALOXONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    NALOXONE
	
         HIKMA MAPLE		          0.4MG/ML                        A070298   001    Sep   24,   1986

                                0.4MG/ML                        A070299   001    Sep   24,   1986

                                0.4MG/ML                        A070496   001    Sep   24,   1986

         WYETH AYERST		         0.02MG/ML                       A070188   001    Sep   24,   1986
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                 6-234(of 337)


NALOXONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    NALOXONE
	
                                 0.02MG/ML                                  A070189 001 Sep 24, 1986

                                 0.4MG/ML                                   A070190 001 Sep 24, 1986

                                 0.4MG/ML                                   A070191 001 Sep 24, 1986

   NALOXONE HYDROCHLORIDE
	
        ABRAXIS PHARM            0.02MG/ML                                  A070648   001    Nov   17,   1986
	
                                 0.02MG/ML                                  A070661   001    Nov   17,   1986
	
                                 0.4MG/ML                                   A070649   001    Nov   17,   1986
	
                                 1MG/ML                                     A071604   001    Dec   16,   1988
	
         ASTRAZENECA             0.02MG/ML                                  A072081   001    Apr   11,   1989

                                 0.02MG/ML                                  A072082   001    Apr   11,   1989

                                 0.02MG/ML                                  A072083   001    Apr   11,   1989

                                 0.02MG/ML                                  A072084   001    Apr   11,   1989

                                 0.02MG/ML                                  A072085   001    Apr   11,   1989

                                 0.4MG/ML                                   A072086   001    Apr   11,   1989

                                 0.4MG/ML                                   A072087   001    Apr   11,   1989

                                 0.4MG/ML                                   A072088   001    Apr   11,   1989

                                 0.4MG/ML                                   A072089   001    Apr   11,   1989

                                 0.4MG/ML                                   A072090   001    Apr   11,   1989

                                 1MG/ML                                     A072091   001    Apr   11,   1989

                                 1MG/ML                                     A072092   001    Apr   11,   1989

                                 1MG/ML                                     A072093   001    Apr   11,   1989

         HIKMA MAPLE             0.02MG/ML                                  A071272   001    May   24,   1988

                                 1MG/ML                                     A071273   001    May   24,   1988

                                 1MG/ML                                     A071274   001    May   24,   1988

                                 1MG/ML                                     A071287   001    May   24,   1988

         HOSPIRA                 0.02MG/ML                                  A070171   001    Sep   24,   1986

                                 0.02MG/ML                                  A070252   001    Jan   16,   1987
	
                                 0.02MG/ML                                  A070253   001    Jan   16,   1987
	
                                 0.4MG/ML                                   A070255   001    Jan   07,   1987
	
         INTL MEDICATION         0.4MG/ML                                   A070417   001    Sep   24,   1986

                                 1MG/ML                                     A072115   001    Apr   27,   1988

         MARSAM PHARMS LLC       0.4MG/ML                                   A071811   001    Jul   19,   1988
	
         SMITH AND NEPHEW        0.02MG/ML                                  A071671   001    Nov   17,   1987
	
                                 0.4MG/ML                                   A071681   001    Nov   17,   1987
	
                                 0.4MG/ML                                   A071682   001    Nov   17,   1987
	
         SOLOPAK                 0.02MG/ML                                  A071672   001    Nov   17,   1987
	
                                 0.4MG/ML                                   A071683   001    Nov   17,   1987
	
        WATSON LABS              0.4MG/ML                                   A071339   001    Nov   18,   1987
	
   NARCAN
	
        BRISTOL MYERS SQUIBB		   0.4MG/ML                                   A071083   001 Jul 28, 1988
	
                                 1MG/ML                                     A071084   001 Jul 28, 1988
	
                                 1MG/ML                                     A071311   001 Jul 28, 1988
	
         ENDO PHARMS		           0.02MG/ML **Federal Register               N016636   002
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 0.4MG/ML **Federal Register                N016636 001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 1MG/ML **Federal Register determination    N016636 003 Jun 14, 1982

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TARGINIQ
	
         PURDUE PHARMA LP		      5MG;10MG                                   N205777 001 Jul 23, 2014
	
                                 10MG;20MG                                  N205777 002 Jul 23, 2014
	
                                 20MG;40MG                                  N205777 003 Jul 23, 2014
	
NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TALWIN NX
	
         SANOFI AVENTIS US      EQ 0.5MG BASE;EQ 50MG BASE                  N018733 001 Dec 16, 1982
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                              6-235(of 337)


NALTREXONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    NALTREXONE HYDROCHLORIDE
	
         SANDOZ                   50MG                                    A075434 001 Mar 08, 2000
	
NANDROLONE DECANOATE
	
  INJECTABLE;INJECTION
	
    DECA-DURABOLIN
	
         AGI		                    50MG/ML                                 N013132 001 Jun 12, 1986
	
                                  100MG/ML                                N013132 002 Jun 12, 1986
	
                                  200MG/ML                                N013132 003 Jun 12, 1986
	
    NANDROLONE DECANOATE
	
         ABRAXIS PHARM            100MG/ML                                A088290   001    Oct   03,   1983
	
                                  200MG/ML                                A088317   001    Oct   14,   1983
	
         AKORN                    100MG/ML                                A087519   001    Sep   28,   1983

         WATSON LABS              50MG/ML                                 A086385   001    Jan   13,   1984
	
                                  50MG/ML                                 A087598   001    Oct   06,   1983
	
                                  50MG/ML                                 A088554   001    Feb   10,   1986
	
                                  100MG/ML                                A086598   001    Jan   13,   1984
	
                                  100MG/ML                                A087599   001    Oct   06,   1983
	
                                  200MG/ML                                A088128   001    Dec   05,   1983
	
NANDROLONE PHENPROPIONATE
	
  INJECTABLE;INJECTION
	
    DURABOLIN
	
         ORGANON USA INC          25MG/ML                                 N011891 001
	
                                  50MG/ML                                 N011891 002
	
    NANDROLONE PHENPROPIONATE
	
         WATSON LABS              25MG/ML                                 A086386 001 Jun 17, 1983
	
                                  50MG/ML                                 A087488 001 Jun 17, 1983
	
NAPHAZOLINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    ALBALON
	
         ALLERGAN                 0.1% **Federal Register determination   A080248 001
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
    NAFAZAIR
	
         BAUSCH AND LOMB          0.1%                                    A040073 001 May 25, 1994

         PHARMAFAIR               0.1%                                    A088101 001 Apr 15, 1983

    NAPHCON FORTE
	
         ALCON                    0.1%                                    A080229 001
	
    OPCON
	
         BAUSCH AND LOMB          0.1%                                    A087506 001
	
    VASOCON
	
         NOVARTIS                 0.1%                                    A080235 002 Mar 24, 1983
	
NAPROXEN
	
  TABLET;ORAL
	
    NAPROXEN
	
          DAVA PHARMS INC		       250MG                                   A074105   001    Dec   21,   1993
	
                                  250MG                                   A074410   001    Apr   28,   1995

                                  375MG                                   A074105   002    Dec   21,   1993
	
                                  375MG                                   A074410   002    Apr   28,   1995

                                  500MG                                   A074105   003    Dec   21,   1993
	
                                  500MG                                   A074410   003    Apr   28,   1995

         HAMILTON PHARMS		        250MG                                   A074110   001    Oct   30,   1992
	
                                  375MG                                   A074110   002    Oct   30,   1992
	
                                  500MG                                   A074110   003    Oct   30,   1992
	
         IVAX SUB TEVA PHARMS		   250MG                                   A074111   001    Feb   28,   1995
	
                                  375MG                                   A074111   002    Feb   28,   1995
	
                                  500MG                                   A074111   003    Feb   28,   1995
	
         PLIVA		                  250MG                                   A074182   001    Jun   27,   1996
	
                                  375MG                                   A074182   002    Jun   27,   1996
	
                                  500MG                                   A074182   003    Jun   27,   1996
	
         PUREPAC PHARM		          250MG                                   A074263   001    Dec   21,   1993
	
                                  375MG                                   A074263   002    Dec   21,   1993
	
                                  500MG                                   A074263   003    Dec   21,   1993
	
         ROXANE		                 250MG                                   A074211   001    Feb   28,   1994
	
                                  375MG                                   A074211   002    Feb   28,   1994
	
                                  500MG                                   A074211   003    Feb   28,   1994
	
         TEVA		                   250MG                                   A074129   001    Dec   21,   1993
	
                                  250MG                                   A074216   001    Apr   11,   1996

                                  375MG                                   A074129   002    Dec   21,   1993
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-236(of 337)


NAPROXEN
	
  TABLET;ORAL
	
    NAPROXEN
	
                                  375MG                         A074216   002    Apr   11,   1996

                                  500MG                         A074129   003    Dec   21,   1993
	
                                  500MG                         A074216   003    Apr   11,   1996

         TEVA PHARMS		            250MG                         A074207   001    Dec   21,   1993
	
                                  375MG                         A074207   002    Dec   21,   1993
	
                                  500MG                         A074207   003    Dec   21,   1993
	
         WATSON LABS		            250MG                         A074163   001    Feb   10,   1995
	
                                  250MG                         A074457   001    May   31,   1995

                                  375MG                         A074163   002    Feb   10,   1995
	
                                  375MG                         A074457   002    May   31,   1995

                                  500MG                         A074163   003    Feb   10,   1995
	
                                  500MG                         A074457   003    May   31,   1995

  TABLET, DELAYED RELEASE;ORAL
	
    NAPROXEN
	
         ACTAVIS ELIZABETH       375MG                          A074936 001 Feb 24, 1998
	
                                 500MG                          A074936 002 Feb 24, 1998
	
NAPROXEN SODIUM
	
  TABLET;ORAL
	
    NAPROXEN SODIUM
	
         ABLE                     EQ   250MG   BASE             A076544   001    Aug   22,   2003

                                  EQ   500MG   BASE             A076544   002    Aug   22,   2003

         HAMILTON PHARMS          EQ   250MG   BASE             A074106   001    Aug   31,   1993

                                  EQ   500MG   BASE             A074106   002    Aug   31,   1993

         IVAX SUB TEVA PHARMS     EQ   250MG   BASE             A074230   001    Mar   14,   1995
	
                                  EQ   500MG   BASE             A074230   002    Mar   14,   1995
	
         MYLAN                    EQ   250MG   BASE             A074367   001    Aug   31,   1994

                                  EQ   500MG   BASE             A074367   002    Aug   31,   1994

         PLIVA                    EQ   250MG   BASE             A074242   001    Jun   20,   1996
	
                                  EQ   500MG   BASE             A074242   002    Jun   20,   1996
	
         PUREPAC PHARM            EQ   250MG   BASE             A074319   001    Mar   20,   1995
	
                                  EQ   500MG   BASE             A074319   002    Mar   20,   1995
	
         ROXANE                   EQ   250MG   BASE             A074257   001    Dec   21,   1993
	
                                  EQ   500MG   BASE             A074257   002    Dec   21,   1993
	
         SANDOZ                   EQ   200MG   BASE             A074646   001    Jan   13,   1997
	
                                  EQ   250MG   BASE             A074162   001    Dec   21,   1993
	
                                  EQ   250MG   BASE             A074495   001    Dec   05,   1994
	
                                  EQ   500MG   BASE             A074162   002    Dec   21,   1993
	
                                  EQ   500MG   BASE             A074495   002    Dec   05,   1994
	
         TEVA                     EQ   250MG   BASE             A074142   001    Dec   21,   1993
	
                                  EQ   500MG   BASE             A074142   002    Dec   21,   1993
	
         TEVA PHARMS              EQ   250MG   BASE             A074289   001    Jan   27,   1994
	
                                  EQ   500MG   BASE             A074289   002    Jan   27,   1994
	
         WATSON LABS              EQ   250MG   BASE             A074195   001    Dec   21,   1993
	
                                  EQ   250MG   BASE             A074455   001    May   31,   1995

                                  EQ   500MG   BASE             A074195   002    Dec   21,   1993
	
                                  EQ   500MG   BASE             A074455   002    May   31,   1995
	
NATEGLINIDE
	
  TABLET;ORAL
	
    NATEGLINIDE
	
         TEVA PHARMS              60MG                          A077467 001 Sep 09, 2009

                                  120MG                         A077467 002 Sep 09, 2009
	
NEDOCROMIL SODIUM
	
  AEROSOL, METERED;INHALATION
	
    TILADE
	
         KING PHARMS              1.75MG/INH                    N019660 001 Dec 30, 1992
	
  SOLUTION;INHALATION
	
    TILADE
	
         SANOFI AVENTIS US        0.5%                          N020750 001 Oct 01, 1997
	
NEFAZODONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    NEFAZODONE HYDROCHLORIDE
	
         IVAX SUB TEVA PHARMS		   50MG                          A075763   001    Sep   16,   2003

                                  100MG                         A075763   002    Sep   16,   2003

                                  150MG                         A075763   003    Sep   16,   2003

                                  200MG                         A075763   004    Sep   16,   2003

                                  250MG                         A075763   005    Sep   16,   2003

         MYLAN		                  100MG                         A076129   002    Sep   16,   2003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                            6-237(of 337)


NEFAZODONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    NEFAZODONE HYDROCHLORIDE
	
                                 150MG                               A076129   003     Sep   16,   2003

                                 200MG                               A076129   004     Sep   16,   2003

                                 250MG                               A076129   005     Sep   16,   2003

         ROXANE		                50MG                                A076196   001     Sep   16,   2003

                                 100MG                               A076196   002     Sep   16,   2003

                                 150MG                               A076196   003     Sep   16,   2003

                                 200MG                               A076196   004     Sep   16,   2003

                                 250MG                               A076196   005     Sep   16,   2003

         SANDOZ		                50MG                                A076072   001     Sep   16,   2003

                                 50MG                                A076302   001     Sep   16,   2003

                                 100MG                               A076072   002     Sep   16,   2003

                                 100MG                               A076302   002     Sep   16,   2003

                                 150MG                               A076072   003     Sep   16,   2003

                                 150MG                               A076302   003     Sep   16,   2003

                                 200MG                               A076072   004     Sep   16,   2003

                                 200MG                               A076302   004     Sep   16,   2003

                                 250MG                               A076072   005     Sep   16,   2003

                                 250MG                               A076302   005     Sep   16,   2003

         WATSON LABS		           100MG                               A076073   002     Sep   16,   2003

                                 150MG                               A076073   003     Sep   16,   2003

                                 200MG                               A076073   004     Sep   16,   2003

                                 250MG                               A076073   005     Sep   16,   2003

   SERZONE
	
        BRISTOL MYERS SQUIBB		   50MG                                N020152   001     Dec   22,   1994
	
                                 100MG                               N020152   002     Dec   22,   1994
	
                                 150MG                               N020152   003     Dec   22,   1994
	
                                 200MG                               N020152   004     Dec   22,   1994
	
                                 250MG                               N020152   005     Dec   22,   1994
	
                                 300MG                               N020152   006     Dec   22,   1994
	
NELFINAVIR MESYLATE
	
  POWDER;ORAL
	
    VIRACEPT
	
         AGOURON                 EQ 50MG BASE/SCOOPFUL               N020778 001 Mar 14, 1997
	
NEOMYCIN SULFATE
	
  POWDER;FOR RX COMPOUNDING
	
    NEO-RX
	
         X GEN PHARMS            100%                                A061579 001
	
  SOLUTION;ORAL
	
    MYCIFRADIN
	
         PHARMACIA AND UPJOHN    EQ 87.5MG BASE/5ML                  N050285 001
	
  TABLET;ORAL
	
    MYCIFRADIN
	
         PHARMACIA AND UPJOHN    EQ 350MG BASE                       A060520 001
	
    NEOBIOTIC
	
         PFIZER                  EQ 350MG BASE                       A060475 001
	
    NEOMYCIN SULFATE
	
         BRISTOL MYERS SQUIBB    500MG                               A060365   001
	
         LANNETT                 500MG                               A060607   001
	
         LILLY                   500MG                               A060385   001
	
         ROXANE                  500MG                               A062173   001
	
         SANDOZ                  500MG                               A061586   001
	
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
	
  CREAM;TOPICAL
	
    NEOSPORIN
	
         GLAXOSMITHKLINE        EQ 3.5MG   BASE/GM;10,000 UNITS/GM   N050176 002 Jan 14, 1985
	
  OINTMENT;OPHTHALMIC
	
    STATROL
	
         ALCON                  EQ 3.5MG   BASE/GM;10,000 UNITS/GM   N050344 002
	
  SOLUTION/DROPS;OPHTHALMIC

    STATROL
	
         ALCON                  EQ 3.5MG   BASE/ML;16,250 UNITS/ML   A062339 001 Nov 30, 1984
	
                                EQ 3.5MG   BASE/ML;16,250 UNITS/ML   N050456 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                           6-238(of 337)


NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
	
  SUSPENSION/DROPS;OPHTHALMIC

    POLY-PRED
	
         ALLERGAN               EQ 0.35% BASE;10,000 UNITS/ML;0.5%
	    N050081 002
	
NEOMYCIN SULFATE; PREDNISOLONE ACETATE
	
  OINTMENT;OPHTHALMIC
	
    NEO-DELTA-CORTEF
         PHARMACIA AND UPJOHN   EQ 3.5MG BASE/GM;0.25%                  A061039 002
	
                                EQ 3.5MG BASE/GM;0.5%                   A061039 001
	
  SUSPENSION/DROPS;OPHTHALMIC
    NEO-DELTA-CORTEF
         PHARMACIA AND UPJOHN   EQ 3.5MG BASE/ML;0.25%                  A061037 001
	
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE
	
  OINTMENT;OPHTHALMIC
	
    NEO-HYDELTRASOL
	
         MERCK                  EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE
	   N050378 001
	
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
	
  CREAM;TOPICAL
	
    MYTREX A
	
         SAVAGE LABS            EQ 3.5MG BASE/GM;0.1%
                  A062598 001 Jul 21, 1986
	
    NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
	
         FOUGERA                EQ 3.5MG BASE/GM;0.1%
                  A062600 001 Jul 21, 1986
	
         PHARMADERM             EQ 3.5MG BASE/GM;0.1%
                  A062595 001 Jul 21, 1986
	
  OINTMENT;TOPICAL
	
    MYTREX A
	
         SAVAGE LABS            EQ 3.5MG BASE/GM;0.1%
                  A062609 001 May 23, 1986
	
    NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
	
         FOUGERA
	              EQ 3.5MG BASE/GM;0.1%
                  A062608 001 May 23, 1986

         PHARMADERM
	           EQ 3.5MG BASE/GM;0.1%
	                 A062607 001 May 23, 1986
	
NETILMICIN SULFATE
	
  INJECTABLE;INJECTION
	
    NETROMYCIN
	
         SCHERING
	               EQ 10MG BASE/ML
                      N050544 001 Feb 28, 1983
	
                                  EQ 25MG BASE/ML
                      N050544 002 Feb 28, 1983
	
                                  EQ 100MG BASE/ML
	                    N050544 003 Feb 28, 1983
	
NIACIN
	
  CAPSULE;ORAL
	
    WAMPOCAP
	
         MEDPOINTE PHARM HLC
	    500MG
	                               N011073 003
	
  TABLET;ORAL
	
    NIACIN
	
         EVERYLIFE
	              500MG
	                               A083203   001
	
         HALSEY
	                 500MG
	                               A083453   001
	
         HIKMA PHARMS LLC
	       500MG
	                               A083718   001
	
         IMPAX LABS
	             500MG
	                               A083115   001
	
         IVAX SUB TEVA PHARMS
	   500MG
	                               A083180   001
	
         MK LABS
	                500MG
	                               A083525   001
	
         PUREPAC PHARM
	          500MG
	                               A083271   001
	
         SANDOZ
	                 500MG
	                               A083306   001
	
         TABLICAPS
	              500MG
	                               A084237   001
	
         WATSON LABS
	            500MG
	                               A083136   001
	
                                  500MG
	                               A083305   001
	
                                  500MG
	                               A085172   001
	
   NICOLAR
	
        SANOFI AVENTIS US
	     500MG
	                                 A083823 001
	
 TABLET, EXTENDED RELEASE;ORAL
	
   NIASPAN
	
        ABBVIE
	                375MG
	                                 N020381 001 Jul 28, 1997
	
   NIASPAN TITRATION STARTER PACK
	
        ABBVIE                  375MG
	                                 N020381 005 Jul 28, 1997
	
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; TYROSINE
	
  SUSPENSION;ORAL
	
    TPN
	
          INTL MINERALS         15MG/5ML;3.75MG/5ML;600MG/5ML
	         N008378 003
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-239(of 337)


NICARDIPINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    NICARDIPINE HYDROCHLORIDE
	
         WATSON LABS           20MG                                       A074670 001 Oct 28, 1996
	
                               30MG                                       A074670 002 Oct 28, 1996
	
 CAPSULE, EXTENDED RELEASE;ORAL
	
   CARDENE SR
        CHIESI USA INC         30MG                                       N020005 001 Feb 21, 1992
                               45MG                                       N020005 002 Feb 21, 1992
                               60MG                                       N020005 003 Feb 21, 1992
NICLOSAMIDE
  TABLET, CHEWABLE;ORAL
    NICLOCIDE
         BAYER PHARMS             500MG                                   N018669 001 May 14, 1982
NICOTINE
  FILM, EXTENDED RELEASE;TRANSDERMAL
    NICOTROL
         MCNEIL CONS            15MG/16HR                                 N020536 001 Jul 03, 1996
    PROSTEP
         AVEVA                  11MG/24HR                                 N019983 003 Dec 23, 1998
                                22MG/24HR                                 N019983 004 Dec 23, 1998
NICOTINE POLACRILEX
  GUM, CHEWING;BUCCAL
    NICOTINE POLACRILEX
         ACTAVIS LABS NY INC      EQ 2MG BASE                             A076568 001 Jul 29, 2004
                                  EQ 4MG BASE                             A076569 002 Jul 29, 2004
NIFEDIPINE
  CAPSULE;ORAL
    ADALAT
         BAYER PHARMS             10MG                                    N019478 001 Nov 27, 1985
                                  20MG                                    N019478 002 Sep 17, 1986
   NIFEDIPINE
        CATALENT                  10MG                                    A073250   001    Oct   08,   1991
                                  20MG                                    A074045   001    Apr   30,   1992
         CHASE LABS NJ            10MG                                    A072409   001    Jul   04,   1990
                                  20MG                                    A073421   001    Jun   19,   1991
        TEVA                      10MG                                    A072651   001    Feb   19,   1992
   PROCARDIA
        PFIZER                 20MG                                       N018482 002 Jul 24, 1986
 TABLET, EXTENDED RELEASE;ORAL
   NIFEDIPINE
        MARTEC USA LLC         90MG                                       A075414 003 Mar 23, 2004
        MYLAN                  30MG                                       A075108 001 Dec 17, 1999
NILUTAMIDE
  TABLET;ORAL
    NILANDRON
         COVIS PHARMA SARL        50MG                                    N020169 001 Sep 19, 1996
NIMODIPINE
  CAPSULE;ORAL
    NIMOTOP
         BAYER PHARMS             30MG **Federal Register determination   N018869 001 Dec 28, 1988
                                  that product was not discontinued or
                                  withdrawn for safety or efficacy
                                  reasons**
NISOLDIPINE
  TABLET, EXTENDED RELEASE;ORAL
    SULAR
          SHIONOGI INC          10MG **Federal Register determination     N020356 001 Feb 02, 1995
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                20MG **Federal Register determination     N020356 002 Feb 02, 1995
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                25.5MG **Federal Register determination   N020356 006 Jan 02, 2008
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
                                30MG **Federal Register determination     N020356 003 Feb 02, 1995
                                that product was not discontinued or
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-240(of 337)


NISOLDIPINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    SULAR
	
                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 40MG **Federal Register determination   N020356 004 Feb 02, 1995

                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
NITROFURANTOIN
	
  CAPSULE;ORAL
	
    NITROFURANTOIN
	
         WATSON LABS            50MG                                     A084326 001
	
                                100MG                                    A084326 002
	
 TABLET;ORAL
	
   FURADANTIN
	
        PROCTER AND GAMBLE      50MG                                     N008693 001
	
                                100MG                                    N008693 002
	
   FURALAN
	
        LANNETT                 50MG                                     A080017 001
	
                                100MG                                    A080017 002
	
   NITROFURANTOIN
	
        ELKINS SINN             50MG                                     A080003   001
	
                                100MG                                    A080003   002
	
        IVAX SUB TEVA PHARMS    50MG                                     A080078   002
	
                                100MG                                    A080078   001
	
        SANDOZ                  50MG                                     A080043   001
	
                                100MG                                    A080043   002
	
        WATSON LABS             50MG                                     A080447   001
	
                                50MG                                     A085797   001
	
                                100MG                                    A080447   002
	
                                100MG                                    A085796   001
	
        WHITEWORTH TOWN PLSN    100MG                                    A084085   002
	
NITROFURANTOIN SODIUM
	
  INJECTABLE;INJECTION
	
    IVADANTIN
	
         PROCTER AND GAMBLE     EQ 180MG BASE/VIAL                       N012402 001
	
NITROFURANTOIN, MACROCRYSTALLINE
	
  CAPSULE;ORAL
	
    NITROFURANTOIN
         MYLAN                  100MG                                    A074967   002     Jul   09,   1997
         SANDOZ                 25MG                                     A074336   001     Jan   25,   1995
                                50MG                                     A074336   002     Jan   25,   1995
                                100MG                                    A074336   003     Jan   25,   1995
         WATSON LABS            25MG                                     A073696   001     Dec   31,   1992
                                50MG                                     A073696   002     Dec   31,   1992
                                100MG                                    A073696   003     Dec   31,   1992
    NITROFURANTOIN MACROCRYSTALLINE
         WATSON LABS            50MG                                     A070248 001 Jun 24, 1988
                                100MG                                    A070249 001 Jun 24, 1988
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
  CAPSULE;ORAL
    NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
         RANBAXY LABS LTD       75MG;25MG                                A076951 001 Mar 30, 2005
NITROFURAZONE
  CREAM;TOPICAL
    FURACIN
         SHIRE                  0.2%                                     A083789 001
  DRESSING;TOPICAL
    ACTIN-N
         SHERWOOD MEDCL         0.2%                                     N017343 001
  OINTMENT;TOPICAL
    FURACIN
         SHIRE                  0.2%                                     N005795 001
    NITROFURAZONE
         AMBIX                  0.2%                                     A086077   001
         LANNETT                0.2%                                     A084393   001
         PERRIGO NEW YORK       0.2%                                     A084968   001
         TARO                   0.2%                                     A086156   001
         WENDT                  0.2%                                     A086766   001
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-241(of 337)


NITROFURAZONE
	
  POWDER;TOPICAL
	
    FURACIN
	
         SHIRE                  0.2%                              A083791 001
	
  SOLUTION;TOPICAL
	
    NITROFURAZONE
	
         PERRIGO NEW YORK       0.2%                              A085130 001
	
         WENDT                  0.2%                              A087081 001
	
NITROGLYCERIN
	
  AEROSOL;SUBLINGUAL
	
    NITROLINGUAL
	
         POHL BOSKAMP           0.4MG/SPRAY                       N018705 001 Oct 31, 1985
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    NITROGLYCERIN
	
         KREMERS URBAN PHARMS   0.2MG/HR                          A075115   001     Aug   10,   2004

                                0.4MG/HR                          A075115   002     Aug   10,   2004

         MYLAN TECHNOLOGIES		   0.1MG/HR                          A074992   004     Nov   12,   1999
	
                                0.2MG/HR                          A074992   003     Nov   12,   1999
	
                                0.4MG/HR                          A074992   002     Nov   12,   1999
	
                                0.6MG/HR                          A074992   001     Nov   12,   1999
	
    TRANSDERM-NITRO
	
         NOVARTIS		             0.1MG/HR                          N020144   001     Feb   27,   1996
	
                                0.2MG/HR                          N020144   002     Feb   27,   1996
	
                                0.4MG/HR                          N020144   003     Feb   27,   1996
	
                                0.6MG/HR                          N020144   004     Feb   27,   1996
	
                                0.8MG/HR                          N020144   005     Feb   27,   1996
	
  INJECTABLE;INJECTION
	
    NITRO IV
	
         POHL BOSKAMP           5MG/ML                            N018672 002 Aug 30, 1983

    NITRO-BID
	
         SANOFI AVENTIS US      5MG/ML                            N018621 001 Jan 05, 1982
	
                                10MG/ML                           A071159 001 Feb 28, 1990
	
    NITROGLYCERIN
	
         ABRAXIS PHARM          5MG/ML                            A070077   001     Dec 13, 1985
	
                                5MG/ML                            A071203   001     May 08, 1987

         HOSPIRA                5MG/ML                            N018531   001
	
         INTL MEDICATION        5MG/ML                            A070026   001     Sep   10,   1985

         LUITPOLD               5MG/ML                            A071492   001     May   24,   1988

         SMITH AND NEPHEW       5MG/ML                            A070633   001     Jun   19,   1986
	
                                5MG/ML                            A070634   001     Jun   19,   1986
	
    NITROGLYCERIN IN DEXTROSE 5%
	
         HOSPIRA                0.1MG/ML                          A074083 001 Oct 26, 1994
	
    NITROL
	
         RORER                  0.8MG/ML                          N018774 001 Jan 19, 1983
	
    NITRONAL
	
         POHL BOSKAMP           1MG/ML                            N018672 001 Aug 30, 1983

    NITROSTAT
	
         PARKE DAVIS		          0.8MG/ML                          N018588   001
	
                                5MG/ML                            A070863   001     Jan   08,   1987
	
                                5MG/ML                            N018588   002     Dec   23,   1983
	
                                10MG/ML                           A070871   001     Jan   08,   1987
	
                                10MG/ML                           A070872   001     Jan   08,   1987
	
    TRIDIL
	
         HOSPIRA                0.5MG/ML                          N018537 002 Jun 16, 1983
	
                                5MG/ML                            N018537 001
	
NIZATIDINE
	
  CAPSULE;ORAL
	
    AXID
	
           SMITHKLINE BEECHAM   150MG                             N019508 001 Apr 12, 1988

                                300MG                             N019508 002 Apr 12, 1988

    NIZATIDINE
	
         ANI PHARMS INC         150MG                             A075461   001     Jul   08,   2002
	
                                300MG                             A075461   002     Jul   08,   2002
	
         APOTEX INC             150MG                             A076383   001     Jan   23,   2003
	
                                300MG                             A076383   002     Jan   23,   2003
	
         MYLAN PHARMS INC       150MG                             A075934   001     Jul   09,   2002
	
                                300MG                             A075934   002     Jul   09,   2002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                   6-242(of 337)


NONOXYNOL-9
	
  AEROSOL;VAGINAL
	
    DELFEN
	
         PERSONAL PRODS           12.5%                                     N014349 002
	
NOREPINEPHRINE BITARTRATE
	
  INJECTABLE;INJECTION
	
    NOREPINEPHRINE BITARTRATE
	
         METRICS PHARM            EQ 1MG BASE/ML                            A040522 001 Sep 30, 2004
	
NOREPINEPHRINE BITARTRATE; PROCAINE HYDROCHLORIDE; PROPOXYCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    RAVOCAINE AND NOVOCAIN W/ LEVOPHED

         EASTMAN KODAK          EQ 0.033MG BASE/ML;2%;0.4%                N008592 003
	
NORETHINDRONE
	
  TABLET;ORAL
	
    NORLUTIN
	
         PARKE DAVIS              5MG                                       N010895 002
	
NORETHINDRONE ACETATE
	
  TABLET;ORAL
	
    NORLUTATE
	
         PARKE DAVIS              5MG                                       N012184 002
	
NORFLOXACIN
	
  SOLUTION/DROPS;OPHTHALMIC

    CHIBROXIN
	
         MERCK                    0.3%                                      N019757 001 Jun 17, 1991
	
  TABLET;ORAL
	
    NOROXIN
	
         MERCK                    400MG                                     N019384 002 Oct 31, 1986
	
NORGESTREL
	
  TABLET;ORAL
	
    OVRETTE
	
         WYETH PHARMS             0.075MG                                   N017031 001
	
NORTRIPTYLINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    AVENTYL HYDROCHLORIDE
	
         LILLY                    EQ 10MG BASE                              N014684 001
	
                                  EQ 25MG BASE                              N014684 002
	
   NORTRIPTYLINE HYDROCHLORIDE
	
        SANDOZ		                 EQ 10MG BASE                               A074054   001    Dec   31,   1992
	
                                 EQ 10MG BASE                               A074835   001    Jun   30,   1997
	
                                 EQ 25MG BASE                               A074054   002    Dec   31,   1992
	
                                 EQ 25MG BASE                               A074835   002    Jun   30,   1997
	
                                 EQ 50MG BASE                               A074054   003    Dec   31,   1992
	
                                 EQ 50MG BASE                               A074835   003    Jun   30,   1997
	
                                 EQ 75MG BASE                               A074054   004    Dec   31,   1992
	
                                 EQ 75MG BASE                               A074835   004    Jun   30,   1997
	
        TEVA		                   EQ 10MG BASE                               A073667   001    Apr   11,   1996

                                 EQ 25MG BASE                               A073667   002    Apr   11,   1996

                                 EQ 50MG BASE                               A073667   003    Apr   11,   1996

                                 EQ 75MG BASE                               A073667   004    Apr   11,   1996

 SOLUTION;ORAL
	
   AVENTYL
	
        RANBAXY		                EQ 10MG BASE/5ML **Federal Register        N014685 001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

   PAMELOR
	
        MALLINCKRODT INC         EQ 10MG BASE/5ML                           N018012 001
	
NYSTATIN
	
  CREAM;TOPICAL
	
    CANDEX
	
          BAYER PHARMS            100,000 UNITS/GM                          A061810 001
	
    MYCOSTATIN
	
          DELCOR ASSET CORP       100,000 UNITS/GM                          A060575 001
	
    MYKINAC
	
          ALPHARMA US PHARMS      100,000 UNITS/GM                          A062387 001 Jul 29, 1982
	
    NILSTAT
	
          LEDERLE                 100,000 UNITS/GM                          A061445 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-243(of 337)


NYSTATIN
	
  CREAM;TOPICAL
	
    NYSTATIN
	
          G AND W LABS INC
	       100,000 UNITS/GM
            A061966 001
	
          TARO
	                   100,000 UNITS/GM
	           A062457 001 Jul 28, 1983
	
  LOTION;TOPICAL
	
    CANDEX
	
          BAYER PHARMS
	           100,000 UNITS/ML
	           N050233 001
	
  OINTMENT;TOPICAL
	
    MYCOSTATIN
	
          DELCOR ASSET CORP
	      100,000 UNITS/GM
	           A060571 001
	
    MYKINAC
	
          ALPHARMA US PHARMS
	     100,000 UNITS/GM
	           A062731 001 Sep 22, 1986
	
    NILSTAT
	
          LEDERLE
	                100,000 UNITS/GM
	           A061444 001
	
  PASTILLE;ORAL
	
    MYCOSTATIN
	
          BRISTOL MYERS SQUIBB
	   200,000 UNITS
	              N050619 001 Apr 09, 1987
	
  POWDER;ORAL
	
    BARSTATIN 100
	
          BARLAN
	                 100%
	                       A062489 001 Apr 27, 1988
	
    NILSTAT
	
          DAVA PHARMS INC
	        100%
	                       N050576 001 Dec 22, 1983
	
    NYSTATIN
	
          PADDOCK LLC
	            100%
	                       A062613 001 Nov 26, 1985
	
  POWDER;TOPICAL
	
    MYCOSTATIN
	
          DELCOR ASSET CORP
	      100,000 UNITS/GM
	           A060578 001
	
    NYSTATIN
	
          NESHER PHARMS
	          100,000 UNITS/GM
	           A065321 001 Aug 18, 2006
	
  SUPPOSITORY;VAGINAL
	
    NYSERT
	
          WARNER CHILCOTT
	        100,000 UNITS
	              N050478 001
	
  SUSPENSION;ORAL
	
    MYCOSTATIN
	
          DELCOR ASSET CORP
	      100,000 UNITS/ML
	           A061533 001
	
    NILSTAT
	
          GLENMARK GENERICS
	      100,000 UNITS/ML
	           N050299 001
	
    NYSTATIN
	
          ALPHARMA US PHARMS
	     100,000   UNITS/ML
          A062571   001     Oct   29,   1985
	
          MORTON GROVE
	           100,000   UNITS/ML
          A062835   001     Nov   19,   1987
	
          PHARMADERM
	             100,000   UNITS/ML
          A062518   001     Jul   06,   1984
	
          PHARMAFAIR
	             100,000   UNITS/ML
          A062541   001     Jan   16,   1985
	
          ROXANE
	                 100,000   UNITS/ML
          A062832   001     Dec   27,   1991
	
          TEVA
	                   100,000   UNITS/ML
          A062670   001     Jun   18,   1987
	
                                   100,000   UNITS/ML
	         A062776   001     Dec   17,   1987
	
    NYSTEX
	
         SAVAGE LABS
	             100,000 UNITS/ML
	           A062519 001 Jul 06, 1984
	
  TABLET;ORAL
	
    MYCOSTATIN
	
         DELCOR ASSET CORP
	       500,000 UNITS
	              A060574 001
	
    NILSTAT
	
         LEDERLE
	                 500,000 UNITS
	              A061151 001
	
    NYSTATIN
	
         QUANTUM PHARMICS
	        500,000   UNITS
	            A062525   001 Oct 29, 1984
	
         SANDOZ
	                  500,000   UNITS
	            A062065   001
	
         USL PHARMA
	              500,000   UNITS
	            A062524   001 Nov 26, 1985
	
         WATSON LABS
	             500,000   UNITS
	            A062402   001 Dec 16, 1982
	
  TABLET;VAGINAL
	
    KOROSTATIN
	
         HOLLAND RANTOS
	          100,000 UNITS
	              A061718 001
	
    MYCOSTATIN
	
         DELCOR ASSET CORP
	       100,000 UNITS
	              A060577 001
	
    NILSTAT
	
         LEDERLE
	                 100,000 UNITS
	              A061325 001
	
    NYSTATIN
	
         FOUGERA
	                 100,000   UNITS
	            A062459   001     Nov 09, 1983
	
         PHARMADERM
	              100,000   UNITS
	            A062460   001     Nov 09, 1983
	
         QUANTUM PHARMICS
	        100,000   UNITS
	            A062509   001     Apr 03, 1984

         SANDOZ
	                  100,000   UNITS
	            A061965   001
	
         TEVA
	                    100,000   UNITS
	            A062502   001     Dec 23, 1983
	
         WATSON LABS
	             100,000   UNITS
	            A062176   001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                      6-244(of 337)


NYSTATIN; TRIAMCINOLONE ACETONIDE
	
  CREAM;TOPICAL
	
    MYCO-TRIACET II
	
         TEVA                   100,000 UNITS/GM;0.1%          A061954 002 Sep 20, 1985

    MYCOLOG-II
	
         DELCOR ASSET CORP      100,000 UNITS/GM;0.1%          A060576 002 May 01, 1985

                                100,000 UNITS/GM;0.1%          A062606 001 May 15, 1985

    MYKACET
	
         G AND W LABS INC       100,000 UNITS/GM;0.1%          A062367 001 May 28, 1985

    MYTREX F
	
         SAVAGE LABS            100,000 UNITS/GM;0.1%          A062597 001 Oct 08, 1985
	
    NYSTATIN AND TRIAMCINOLONE ACETONIDE
	
         ALPHARMA US PHARMS     100,000 UNITS/GM;0.1%          A063010   001    Dec   20,   1988
	
         PERRIGO NEW YORK       100,000 UNITS/GM;0.1%          A062186   002    Jun   06,   1985
	
         PHARMAFAIR             100,000 UNITS/GM;0.1%          A062657   001    Jul   30,   1986
	
         TARO                   100,000 UNITS/GM;0.1%          A062347   001    Mar   30,   1987
	
    NYSTATIN-TRIAMCINOLONE ACETONIDE
	
         PHARMADERM             100,000 UNITS/GM;0.1%          A062596 001 Oct 08, 1985
	
  OINTMENT;TOPICAL
	
    MYCO-TRIACET II
	
         TEVA                   100,000 UNITS/GM;0.1%          A062045 002 Nov 26, 1985
	
    MYCOLOG-II
	
         DELCOR ASSET CORP      100,000 UNITS/GM;0.1%          A060572 001 Jun 28, 1985
	
    MYKACET
	
         G AND W LABS INC       100,000 UNITS/GM;0.1%          A062733 001 Mar 09, 1987
	
    MYTREX F
	
         SAVAGE LABS            100,000 UNITS/GM;0.1%          A062601 001 Oct 09, 1985
	
    NYSTATIN AND TRIAMCINOLONE ACETONIDE
	
         PERRIGO NEW YORK       100,000 UNITS/GM;0.1%          A062280 002 Oct 10, 1985
	
         PHARMAFAIR             100,000 UNITS/GM;0.1%          A062656 001 Jul 30, 1986
	
    NYSTATIN-TRIAMCINOLONE ACETONIDE
	
         PHARMADERM             100,000 UNITS/GM;0.1%          A062603 001 Oct 09, 1985
	
OFLOXACIN
	
  INJECTABLE;INJECTION
	
    FLOXIN
	
         ORTHO MCNEIL PHARM     20MG/ML                        N020087 002 Mar 31, 1992
	
                                40MG/ML                        N020087 003 Mar 31, 1992
	
   FLOXIN IN DEXTROSE 5%
	
        ORTHO MCNEIL PHARM     400MG/100ML                     N020087 001 Mar 31, 1992
	
   FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
	
        ORTHO MCNEIL PHARM     4MG/ML                          N020087 004 Mar 31, 1992
	
                               400MG/100ML                     N020087 005 Mar 31, 1992
	
   OFLOXACIN
	
        BEDFORD                40MG/ML                         A075762 001 Jan 16, 2002
	
 SOLUTION/DROPS;OPHTHALMIC

   OFLOXACIN
	
        APOTEX INC             0.3%                            A076513 001 May 14, 2004

        SANDOZ                 0.3%                            A076848 001 Nov 25, 2008
	
 TABLET;ORAL
	
   FLOXIN
	
        JANSSEN PHARMS		       200MG                           N019735 001 Dec 28, 1990
	
                               300MG                           N019735 002 Dec 28, 1990
	
                               400MG                           N019735 003 Dec 28, 1990
	
   OFLOXACIN
	
        LARKEN LABS		          200MG                           A076093   001    Sep   02,   2003

                               300MG                           A076093   002    Sep   02,   2003

                               400MG                           A076093   003    Sep   02,   2003

        RANBAXY LABS LTD		     200MG                           A076220   001    Sep   02,   2003

                               300MG                           A076220   002    Sep   02,   2003

                               400MG                           A076220   003    Sep   02,   2003
	
OMEPRAZOLE; SODIUM BICARBONATE
	
  FOR SUSPENSION;ORAL
	
    OMEPRAZOLE AND SODIUM BICARBONATE
	
         PAR PHARM               20MG/PACKET;1.68GM/PACKET     A079182 001 Apr 19, 2013

                                 40MG/PACKET;1.68GM/PACKET     A079182 002 Apr 19, 2013
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-245(of 337)


ONDANSETRON
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    ONDANSETRON
         NESHER PHARMS          4MG                                      A077717   001    Jun   25,   2007
                                8MG                                      A077717   002    Jun   25,   2007
         PAR PHARM              4MG                                      A076506   001    Dec   26,   2006
                                8MG                                      A076506   002    Dec   26,   2006
                                16MG                                     A077406   001    Dec   26,   2006
                                24MG                                     A077406   002    Dec   26,   2006
ONDANSETRON HYDROCHLORIDE
  INJECTABLE;INJECTION
    ONDANSETRON HYDROCHLORIDE
         APOTEX INC             EQ 2MG BASE/ML                           A077368   001    Dec   26,   2006
         HOSPIRA                EQ 2MG BASE/ML                           A076695   001    Dec   26,   2006
         LANNETT                EQ 2MG BASE/ML                           A090116   001    Apr   14,   2010
         LUITPOLD               EQ 2MG BASE/ML                           A077582   001    Dec   26,   2006
         PLIVA HRVATSKA DOO     EQ 2MG BASE/ML                           A077544   001    Dec   26,   2006
         SAGENT PHARMS          EQ 2MG BASE/ML                           A078180   001    Mar   26,   2007
    ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
         BEDFORD LABS           EQ 0.64MG BASE/ML                        A078291   001    Apr   13,   2009
         CLARIS LIFESCIENCES    EQ 0.64MG BASE/ML                        A078308   001    Mar   17,   2008
         HOSPIRA                EQ 0.64MG BASE/ML                        A076978   001    Feb   26,   2007
                                EQ 0.64MG BASE/ML                        A077348   001    Feb   01,   2007
         TEVA PHARMS            EQ 0.64MG BASE/ML                        A077480   001    Nov   22,   2006
    ONDANSETRON HYDROCHLORIDE AND SODIUM CHLORIDE IN PLASTIC CONTAINER
         BAXTER HLTHCARE        EQ 0.64MG BASE/ML                        N021915 002 Dec 27, 2006
    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
         APOTEX INC             EQ 2MG BASE/ML                           A077343 001 Dec 26, 2006
         HOSPIRA                EQ 2MG BASE/ML                           A076696 001 Dec 26, 2006
         LUITPOLD               EQ 2MG BASE/ML                           A077387 001 Dec 26, 2006
    ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER
         GLAXOSMITHKLINE        EQ 0.64MG BASE/ML                        N020403 001 Jan 31, 1995
  TABLET;ORAL
    ONDANSETRON HYDROCHLORIDE
         HIKMA PHARMS LLC       EQ 4MG BASE                              A077545   001    Sep   06,   2007
                                EQ 8MG BASE                              A077545   002    Sep   06,   2007
                                EQ 24MG BASE                             A077545   003    Sep   06,   2007
         PAR PHARM              EQ 4MG BASE                              A077303   001    Jun   25,   2007
                                EQ 8MG BASE                              A077303   002    Jun   25,   2007
                                EQ 24MG BASE                             A077303   004    Jun   25,   2007
         TARO                   EQ 4MG BASE                              A077729   001    Mar   28,   2011
                                EQ 8MG BASE                              A077729   002    Mar   28,   2011
                                EQ 24MG BASE                             A077729   003    Mar   28,   2011
ORPHENADRINE CITRATE
  INJECTABLE;INJECTION
    ORPHENADRINE CITRATE
         WATSON LABS              30MG/ML                                A087062 001
  TABLET, EXTENDED RELEASE;ORAL
    NORFLEX
         MEDICIS                  100MG                                  N012157 001
    ORPHENADRINE CITRATE
         ASCOT                    100MG                                  A088067 001 Apr 06, 1983
         SANDOZ                   100MG                                  A085046 001
         WATSON LABS              100MG                                  A084303 001
ORPHENADRINE HYDROCHLORIDE
  TABLET;ORAL
    DISIPAL
         3M                       50MG                                   N010653 001
OSELTAMIVIR PHOSPHATE
  FOR SUSPENSION;ORAL
    TAMIFLU
         ROCHE                    EQ 12MG BASE/ML                        N021246 001 Dec 14, 2000
OXACILLIN SODIUM
  CAPSULE;ORAL
    BACTOCILL
         GLAXOSMITHKLINE          EQ   250MG   BASE                      A061336   001
                                  EQ   250MG   BASE                      A062241   001
                                  EQ   500MG   BASE                      A061336   002
                                  EQ   500MG   BASE                      A062241   002
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                   6-246(of 337)


OXACILLIN SODIUM
	
  CAPSULE;ORAL
	
    OXACILLIN SODIUM
	
         APOTHECON                EQ   250MG   BASE
	            A061450   002
	
                                  EQ   500MG   BASE
	            A061450   001
	
         TEVA                     EQ   250MG   BASE
	            A062222   001
	
                                  EQ   500MG   BASE
	            A062222   002
	
    PROSTAPHLIN
	
         APOTHECON                EQ 500MG BASE
	                N050118 002
	
  FOR SOLUTION;ORAL
	
    BACTOCILL
	
         GLAXOSMITHKLINE          EQ 250MG BASE/5ML
             A062321 001
	
    OXACILLIN SODIUM
	
         APOTHECON                EQ 250MG BASE/5ML
             A061457 001
	
         TEVA                     EQ 250MG BASE/5ML
             A062252 001
	
    PROSTAPHLIN
	
         APOTHECON                EQ 250MG BASE/5ML
             N050194 001
	
  INJECTABLE;INJECTION
	
    BACTOCILL
	
         GLAXOSMITHKLINE		        EQ   1GM BASE/VIAL
            A061334   006     Mar   26,   1982
	
                                  EQ   1GM BASE/VIAL
            A062736   001     Dec   19,   1986
	
                                  EQ   2GM BASE/VIAL
            A061334   007     Mar   26,   1982
	
                                  EQ   2GM BASE/VIAL
            A062736   002     Dec   19,   1986
	
                                  EQ   4GM BASE/VIAL
            A061334   008     Mar   26,   1982
	
                                  EQ   10GM BASE/VIAL
           A061334   010
	
                                  EQ   500MG BASE/VIAL
          A061334   009     Mar 26, 1982
	
    OXACILLIN SODIUM
	
         APOTHECON		              EQ   1GM BASE/VIAL
            N050195   003
	
                                  EQ   2GM BASE/VIAL
            N050195   004
	
                                  EQ   4GM BASE/VIAL
            N050195   005
	
                                  EQ   250MG BASE/VIAL
          N050195   001
	
                                  EQ   500MG BASE/VIAL
          N050195   002
	
         ELKINS SINN		            EQ   1GM BASE/VIAL
            A062711   003     Feb   03,   1989
	
                                  EQ   2GM BASE/VIAL
            A062711   004     Feb   03,   1989
	
                                  EQ   4GM BASE/VIAL
            A062711   005     Feb   03,   1989
	
                                  EQ   10GM BASE/VIAL
           A062711   006     Feb   03,   1989
	
                                  EQ   250MG BASE/VIAL
          A062711   001     Feb   03,   1989
	
                                  EQ   500MG BASE/VIAL
          A062711   002     Feb   03,   1989
	
         ISTITUTO BIO ITA SPA		   EQ   1GM BASE/VIAL
            A062798   001     Dec   11,   1995
	
                                  EQ   2GM BASE/VIAL
            A062798   002     Dec   11,   1995
	
                                  EQ   125MG BASE/VIAL
          A062798   003     Dec   11,   1995
	
                                  EQ   250MG BASE/VIAL
          A062798   004     Dec   11,   1995
	
                                  EQ   500MG BASE/VIAL
          A062798   005     Dec   11,   1995
	
         SANDOZ		                 EQ   250MG BASE/VIAL
          A061490   001
	
                                  EQ   500MG BASE/VIAL
          A061490   002
	
         WATSON LABS INC		        EQ   1GM BASE/VIAL
            A062856   003     Oct   26,   1988
	
                                  EQ   2GM BASE/VIAL
            A062856   004     Oct   26,   1988
	
                                  EQ   4GM BASE/VIAL
            A062856   005     Oct   26,   1988
	
                                  EQ   10GM BASE/VIAL
           A062984   001     Sep   29,   1988

                                  EQ   250MG BASE/VIAL
          A062856   001     Oct   26,   1988
	
                                  EQ   500MG BASE/VIAL
	         A062856   002     Oct   26,   1988
	
OXALIPLATIN
	
  INJECTABLE;IV (INFUSION)

    ELOXATIN
	
         SANOFI AVENTIS US        50MG/VIAL
                     N021492 001 Aug 09, 2002

                                  100MG/VIAL
                    N021492 002 Aug 09, 2002
	
    OXALIPLATIN
	
         SANDOZ                   50MG/VIAL
                     A090849 001 Apr 28, 2011

                                  100MG/VIAL
	                   A090849 002 Apr 28, 2011
	
OXAMNIQUINE
	
  CAPSULE;ORAL
	
    VANSIL
	
         PFIZER                   250MG
	                        N018069 001
	
OXANDROLONE
	
  TABLET;ORAL
	
    OXANDROLONE
	
         ROXANE                   2.5MG
	                        A077249   001     Jul   10,   2007
	
                                  10MG
	                         A077249   002     Jul   10,   2007
	
         SANDOZ                   2.5MG
	                        A076897   001     Dec   01,   2006
	
                                  10MG
	                         A076897   002     Dec   01,   2006
	
                        35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                        6-247(of 337)


OXAPROZIN
	
  TABLET;ORAL
	
    OXAPROZIN
	
         ACTAVIS ELIZABETH        600MG                             A075843   001    Oct   03,   2001
	
         MYLAN                    600MG                             A075851   001    Aug   17,   2001

         MYLAN PHARMS INC         600MG                             A075847   001    Feb   28,   2001
	
         SANDOZ                   600MG                             A075842   001    Apr   12,   2001

                                  600MG                             A075850   001    Apr   27,   2001

         WATSON LABS              600MG                             A075848   001    Feb   09,   2001
	
OXAPROZIN POTASSIUM
	
  TABLET;ORAL
	
    DAYPRO ALTA
	
         GD SEARLE                600MG                             N020776 001 Oct 17, 2002
	
OXAZEPAM
	
  CAPSULE;ORAL
	
    OXAZEPAM
	
          AM THERAP		             10MG                              A071955   001    Mar   03,   1988
	
                                  15MG                              A071956   001    Mar   03,   1988
	
                                  30MG                              A071957   001    Mar   03,   1988
	
         IVAX SUB TEVA PHARMS		   10MG                              A070943   001    Aug   03,   1987

                                  15MG                              A070944   001    Aug   03,   1987

                                  30MG                              A070945   001    Aug   03,   1987

         MUTUAL PHARM		           10MG                              A071026   002    Aug   10,   1987

                                  15MG                              A071026   003    Aug   10,   1987

                                  30MG                              A071026   001    Aug   10,   1987

         MYLAN		                  10MG                              A071713   001    Oct   20,   1987
	
                                  15MG                              A071714   001    Oct   20,   1987
	
                                  30MG                              A071715   001    Oct   20,   1987
	
         WATSON LABS		            10MG                              A072952   001    Sep   28,   1990

                                  15MG                              A072953   001    Sep   28,   1990

                                  30MG                              A072954   001    Sep   28,   1990

    SERAX
	
         ALPHARMA US PHARMS		     10MG                              N015539 002
	
                                  15MG                              N015539 004
	
                                  30MG                              N015539 006
	
    ZAXOPAM
	
         QUANTUM PHARMICS		       10MG                              A070650 001 Mar 01, 1988
	
                                  15MG                              A070640 001 Mar 01, 1988
	
                                  30MG                              A070641 001 Mar 01, 1988
	
  TABLET;ORAL
	
    OXAZEPAM
	
         MUTUAL PHARM             15MG                              A070683 001 Jan 16, 1987
	
         PARKE DAVIS              15MG                              A071508 001 Feb 02, 1987
	
         WATSON LABS              15MG                              A071494 001 Apr 21, 1987

    SERAX
	
         ALPHARMA US PHARMS       15MG                              N015539 008
	
OXCARBAZEPINE
	
  TABLET;ORAL
	
    OXCARBAZEPINE
	
         ANI PHARMS INC		         150MG                             A078005 001 Dec 11, 2007
	
                                  300MG                             A078005 002 Dec 11, 2007
	
                                  600MG                             A078005 003 Dec 11, 2007
	
OXPRENOLOL HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    TRASICOR
	
         NOVARTIS		               20MG                              N018166   001    Dec   28,   1983
	
                                  40MG                              N018166   002    Dec   28,   1983
	
                                  80MG                              N018166   003    Dec   28,   1983
	
                                  160MG                             N018166   004    Dec   28,   1983
	
OXTRIPHYLLINE
	
  SOLUTION;ORAL
	
    CHOLEDYL
	
         PARKE DAVIS              100MG/5ML                         N009268 012 Nov 27, 1984
	
    OXTRIPHYLLINE
	
         MORTON GROVE             100MG/5ML                         A088243 001 Dec 05, 1983
	
  SYRUP;ORAL
	
    CHOLEDYL
	
         PARKE DAVIS              50MG/5ML                          N009268 011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-248(of 337)


OXTRIPHYLLINE
	
  SYRUP;ORAL
	
    OXTRIPHYLLINE PEDIATRIC
	
         MORTON GROVE
	          50MG/5ML
	                     A088242 001 Dec 05, 1983
	
  TABLET, DELAYED RELEASE;ORAL
	
    CHOLEDYL
	
         PARKE DAVIS
	           100MG
	                        N009268 003
	
                                 200MG
	                        N009268 007
	
    OXTRIPHYLLINE
	
         WATSON LABS
	           100MG
	                        A087866 001 Aug 25, 1983

                                 200MG
	                        A087835 001 Aug 25, 1983
	
OXYBUTYNIN CHLORIDE
	
  SYRUP;ORAL
	
    DITROPAN
	
         ORTHO MCNEIL JANSSEN
	   5MG/5ML
	                     N018211 001
	
    OXYBUTYNIN CHLORIDE
	
         APOTEX INC
	             5MG/5ML
                      A074997 001 Oct 15, 1997
	
         MIKART
	                 5MG/5ML
	                     A075039 001 Jan 29, 1999
	
  TABLET;ORAL
	
    DITROPAN
	
         JANSSEN PHARMS
	         5MG
	                         N017577 001
	
    OXYBUTYNIN CHLORIDE
	
         QUANTUM PHARMICS
	       5MG
	                         A072296 001 Dec 08, 1988
	
         USL PHARMA
	             5MG
	                         A070746 001 Mar 10, 1988
	
         WATSON LABS
	            5MG
	                         A072485 001 Apr 19, 1989
	
OXYCODONE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    ROXICODONE
	
         ROXANE
	                10MG
	                         N020932 001 Oct 26, 1998
	
                                 30MG
	                         N020932 002 Oct 26, 1998
	
OXYMORPHONE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    OPANA
	
         ENDO PHARMS
	           1.5MG/ML
	                     N011707 001
	
  SUPPOSITORY;RECTAL
	
    NUMORPHAN
	
         ENDO PHARMS
	           5MG
	                          N011738 004
	
  TABLET, EXTENDED RELEASE;ORAL
	
    OPANA ER
	
         ENDO PHARMS
	           5MG
	                          N021610   001    Jun   22,   2006
	
                                 7.5MG
	                        N021610   005    Feb   29,   2008
	
                                 10MG
	                         N021610   002    Jun   22,   2006
	
                                 15MG
	                         N021610   006    Feb   29,   2008
	
                                 20MG
	                         N021610   003    Jun   22,   2006
	
                                 30MG
	                         N021610   007    Feb   29,   2008
	
                                 40MG
	                         N021610   004    Jun   22,   2006
	
OXYPHENBUTAZONE
	
  TABLET;ORAL
	
    OXYPHENBUTAZONE
	
         WATSON LABS
	            100MG
	                       A088399 001 Sep 17, 1984
	
    TANDEARIL
	
         NOVARTIS
	               100MG
	                       N012542 004 Sep 03, 1982
	
OXYPHENCYCLIMINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    DARICON
	
         PFIZER
	                10MG
	                         N011612 001
	
OXYPHENONIUM BROMIDE
	
  TABLET;ORAL
	
    ANTRENYL
	
         NOVARTIS
	               5MG
	                         N008492 002
	
OXYTETRACYCLINE
	
  TABLET;ORAL
	
    TERRAMYCIN
	
         PFIZER
	                 250MG
	                       N050287 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                            6-249(of 337)


OXYTETRACYCLINE CALCIUM
	
  SYRUP;ORAL
	
    TERRAMYCIN
	
         PFIZER
	               EQ 125MG BASE/5ML
	                        A060595 001
	
OXYTETRACYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    OXY-KESSO-TETRA
	
         FERRANTE
	             EQ    250MG BASE
	                         A060179 001
	
    OXYTETRACYCLINE HYDROCHLORIDE
	
         HIKMA PHARMS LLC
	     EQ    250MG   BASE
	                       A060770   001
	
         IMPAX LABS
	           EQ    250MG   BASE
	                       A060760   001
	
         PROTER
	               EQ    250MG   BASE
	                       A060869   001
	
         PUREPAC PHARM
	        EQ    250MG   BASE
	                       A060634   001
	
    TERRAMYCIN
	
         PFIZER
	               EQ    125MG BASE
	                         N050286 001
	
                                EQ    250MG BASE
	                         N050286 002
	
  INJECTABLE;INJECTION
	
    TERRAMYCIN
	
         PFIZER
	               EQ    250MG BASE/VIAL
                     A060586 001
	
                                EQ    500MG BASE/VIAL
	                    A060586 002
	
OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE
	
  OINTMENT;OTIC
	
    TERRAMYCIN W/ POLYMYXIN

         PFIZER                 EQ 5MG BASE/GM;10,000 UNITS/GM
            A061841 001
	
  TABLET;VAGINAL
	
    TERRAMYCIN-POLYMYXIN
	
         PFIZER                 EQ 100MG BASE;100,000 UNITS
	              A061009 001
	
OXYTOCIN
	
  INJECTABLE;INJECTION
	
    OXYTOCIN
	
          TEVA PHARMS USA      10USP UNITS/ML (10USP UNITS/ML)
            A077453 001
	 Jan 24, 2008
	
                               100USP UNITS/10ML (10USP UNITS/ML)
         A077453 002
	 Jan 24, 2008
	
   OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
	
        ABBOTT                 1USP UNITS/100ML
                           N019185 004
	 Mar 29, 1985
	
                               2USP UNITS/100ML
                           N019185 003
	 Mar 29, 1985
	
   OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
	
        ABBOTT                 2USP UNITS/100ML
                           N019185 002
	 Mar 29, 1985
	
   OXYTOCIN 5 USP UNITS IN DEXTROSE 5%
	
        ABBOTT
	               1USP UNITS/100ML
	                          N019185 001
	 Mar 29, 1985
	
   SYNTOCINON
	
        NOVARTIS
	             10USP UNITS/ML
	                            N018245 001
	
 SOLUTION;NASAL
	
   SYNTOCINON
	
        RETROPHIN INC
	        40USP UNITS/ML
	                            N012285 001
	
PACLITAXEL
	
  INJECTABLE;INJECTION
	
    PACLITAXEL
	
         ACCORD HLTHCARE
	      6MG/ML
                                    A075436   001
	   Nov   12,   2004
	
         HOSPIRA
	              6MG/ML
                                    A076233   001
	   Aug   01,   2002

         MYLAN
	                6MG/ML
                                    A075278   001
	   Jan   25,   2002
	
         PLIVA LACHEMA
	        6MG/ML
                                    A077413   001
	   Mar   12,   2008
	
         TEVA PHARMS USA
	      6MG/ML
	                                   A075297   001
	   Jan   25,   2002
	
PALIPERIDONE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    INVEGA
	
         JANSSEN PHARMS
	        12MG **Federal Register determination
    N021999 004
	 Dec 19, 2006
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
PALONOSETRON HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    ALOXI
	
         HELSINN HLTHCARE
	     EQ 0.5MG BASE **Federal Register
          N022233 001
	 Aug 22, 2008
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                 6-250(of 337)

PAMIDRONATE DISODIUM
  INJECTABLE;INJECTION
    AREDIA
         NOVARTIS              30MG/VIAL                                   N020036 001 Oct 31, 1991
                               60MG/VIAL                                   N020036 003 May 06, 1993
                               90MG/VIAL                                   N020036 004 May 06, 1993
    PAMIDRONATE DISODIUM
         AESGEN                30MG/VIAL                                   A075594   001   May   06,   2002
                               90MG/VIAL                                   A075594   002   May   06,   2002
         MN PHARMS             30MG/VIAL                                   A078300   001   Mar   10,   2009
                               90MG/VIAL                                   A078300   002   Mar   10,   2009
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

  CAPSULE;ORAL
	
    COTAZYM
	
         ORGANON USA INC        30000USPU;30000USPU;8000USPU               N020580 001 Dec 09, 1996
	
PANCURONIUM BROMIDE
	
  INJECTABLE;INJECTION
	
    PANCURONIUM BROMIDE
	
         ASTRAZENECA		         1MG/ML                                      A072210   001   Mar   31,   1988
	
                               2MG/ML                                      A072211   001   Mar   31,   1988
	
                               2MG/ML                                      A072212   001   Mar   31,   1988
	
                               2MG/ML                                      A072213   001   Mar   31,   1988
	
         ELKINS SINN		         1MG/ML                                      A072058   001   Mar   23,   1988
	
                               2MG/ML                                      A072059   001   Mar   23,   1988
	
                               2MG/ML                                      A072060   001   Mar   23,   1988
	
         HOSPIRA               2MG/ML                                      A072321   001   Jan   19,   1989
	
    PAVULON
	
         ORGANON USA INC       1MG/ML                                      N017015 002
	
                               2MG/ML                                      N017015 001
	
PARAMETHADIONE
	
  CAPSULE;ORAL
	
    PARADIONE
	
         ABBVIE                150MG                                       N006800 003
	
                               300MG                                       N006800 001
	
  SOLUTION;ORAL
	
    PARADIONE
	
         ABBVIE                300MG/ML                                    N006800 002
	
PARAMETHASONE ACETATE
	
  TABLET;ORAL
	
    HALDRONE
	
         LILLY                 1MG                                         N012772 005
	
                               2MG                                         N012772 006
	
PARGYLINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    EUTONYL
	
         ABBOTT		              10MG                                        N013448 002
	
                               25MG                                        N013448 003
	
                               50MG                                        N013448 004
	
PAROMOMYCIN SULFATE
	
  CAPSULE;ORAL
	
    HUMATIN
	
         KING PFIZER           EQ 250MG BASE                               A062310 001
	
         PARKEDALE             EQ 250MG BASE                               A060521 001
	
  SYRUP;ORAL
	
    HUMATIN
	
         PARKE DAVIS           EQ 125MG BASE/5ML                           A060522 001
	
PAROXETINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    PAXIL
	
         APOTEX TECHNOLOGIES   EQ 10MG BASE **Federal Register             N020885 001 Oct 09, 1998

                               determination that product was not

                               discontinued or withdrawn for safety or

                               efficacy reasons**

                               EQ 20MG BASE **Federal Register             N020885 002 Oct 09, 1998

                               determination that product was not

                               discontinued or withdrawn for safety or

                               efficacy reasons**

                               EQ 30MG BASE **Federal Register             N020885 003 Oct 09, 1998

                               determination that product was not

                               discontinued or withdrawn for safety or
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                 6-251(of 337)


PAROXETINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    PAXIL
	
                                 efficacy reasons**

                                 EQ 40MG BASE **Federal Register            N020885 004 Oct 09, 1998

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

  SUSPENSION;ORAL
	
    PAROXETINE HYDROCHLORIDE
	
         APOTEX INC              EQ 10MG BASE/5ML                           A077395 001 Dec 05, 2006
	
  TABLET;ORAL
	
    PAROXETINE HYDROCHLORIDE
	
         ROXANE		                EQ   10MG   BASE                           A078026   001    Jun   29,   2007
	
                                 EQ   20MG   BASE                           A078026   002    Jun   29,   2007
	
                                 EQ   30MG   BASE                           A078026   003    Jun   29,   2007
	
                                 EQ   40MG   BASE                           A078026   004    Jun   29,   2007
	
          SANDOZ		               EQ   10MG   BASE                           A075566   001    Mar   08,   2004
	
                                 EQ   20MG   BASE                           A075566   002    Mar   08,   2004
	
                                 EQ   30MG   BASE                           A075566   003    Mar   08,   2004
	
                                 EQ   40MG   BASE                           A075566   004    Mar   08,   2004
	
          TEVA PHARMS		          EQ   10MG   BASE                           A077082   001    Jun   29,   2007
	
                                 EQ   20MG   BASE                           A077082   002    Jun   29,   2007
	
                                 EQ   30MG   BASE                           A077082   003    Jun   29,   2007
	
                                 EQ   40MG   BASE                           A077082   004    Jun   29,   2007
	
    PAXIL
	
         APOTEX TECHNOLOGIES     EQ 50MG BASE                               N020031 004 Dec 29, 1992
	
PEGINESATIDE ACETATE
	
  SOLUTION;INTRAVENOUS, SUBCUTANEOUS
	
    OMONTYS
	
         TAKEDA PHARMS USA      EQ 10MG BASE/ML (EQ 10MG BASE/ML)           N202799 007 Mar 27, 2012
	
                                EQ 20MG BASE/2ML (EQ 10MG BASE/ML)          N202799 008 Mar 27, 2012
	
    OMONTYS PRESERVATIVE FREE
	
         TAKEDA PHARMS USA		    EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML)       N202799   001    Mar   27,   2012
	
                                EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML)       N202799   002    Mar   27,   2012
	
                                EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)       N202799   003    Mar   27,   2012
	
                                EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML)       N202799   004    Mar   27,   2012
	
                                EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML)       N202799   005    Mar   27,   2012
	
                                EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML)       N202799   006    Mar   27,   2012
	
PEMIROLAST POTASSIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    ALAMAST
	
         SANTEN                  0.1%                                       N021079 001 Sep 24, 1999
	
PEMOLINE
	
  TABLET;ORAL
	
    CYLERT
	
          ABBOTT		               18.75MG                                    N016832 001
	
                                 37.5MG                                     N016832 002
	
                                 75MG                                       N016832 003
	
    PEMOLINE
	
         ACTAVIS ELIZABETH		     18.75MG                                    A075595   001    Feb   28,   2000
	
                                 37.5MG                                     A075595   002    Feb   28,   2000
	
                                 75MG                                       A075595   003    Feb   28,   2000
	
          MALLINCKRODT		         18.75MG                                    A075726   003    Mar   30,   2001
	
                                 37.5MG                                     A075726   002    Mar   30,   2001
	
                                 75MG                                       A075726   001    Mar   30,   2001
	
          SANDOZ		               18.75MG                                    A075286   001    Dec   27,   1999
	
                                 37.5MG                                     A075286   002    Jun   30,   1999
	
                                 75MG                                       A075286   003    Jun   30,   1999
	
          TEVA PHARMS		          18.75MG                                    A075030   003    Feb   22,   2000
	
                                 37.5MG                                     A075030   001    Jan   29,   1999
	
                                 75MG                                       A075030   002    Jan   29,   1999
	
          VINTAGE PHARMS		       18.75MG                                    A075328   001    Apr   19,   2000

                                 37.5MG                                     A075328   002    Apr   19,   2000

                                 75MG                                       A075328   003    Apr   19,   2000

          WATSON LABS		          18.75MG                                    A075287   001    Jun   13,   2001
	
                                 37.5MG                                     A075287   002    Sep   18,   2000

                                 75MG                                       A075287   003    Sep   18,   2000

  TABLET, CHEWABLE;ORAL
	
    CYLERT
	
         ABBOTT                  37.5MG                                     N017703 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                             6-252(of 337)


PEMOLINE
	
  TABLET, CHEWABLE;ORAL
	
    PEMOLINE
	
          ACTAVIS ELIZABETH      37.5MG
	                                    A075678 001
	 Jul 26, 2000
	
          TEVA PHARMS            37.5MG
	                                    A075555 001
	 Feb 18, 2000
	
PENBUTOLOL SULFATE
	
  TABLET;ORAL
	
    LEVATOL
	
         AUXILIUM PHARMS LLC     10MG **Federal Register determination
      N018976 001
	 Dec 30, 1987
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 20MG **Federal Register determination
      N018976 004
	 Jan 05, 1989
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
PENICILLAMINE
	
  CAPSULE;ORAL
	
    CUPRIMINE
	
         ATON                    125MG
	                                     N019853 002
	
PENICILLIN G BENZATHINE
	
  INJECTABLE;INJECTION
	
    BICILLIN L-A
	
         WYETH AYERST            300,000 UNITS/ML
                           N050131 001
	
  SUSPENSION;ORAL
	
    BICILLIN
	
         WYETH AYERST            300,000 UNITS/5ML
                          N050126 002
	
  TABLET;ORAL
	
    BICILLIN
	
         WYETH AYERST            200,000 UNITS
	                             N050128 001
	
PENICILLIN G POTASSIUM
	
  FOR SOLUTION;ORAL
	
    PENICILLIN
	
         TEVA                    200,000 UNITS/5ML
                          A060307 002
	
                                 400,000 UNITS/5ML
                          A060307 004
	
    PENICILLIN G POTASSIUM
	
         MYLAN		                 200,000    UNITS/5ML
                       A060752   003
	
                                 250,000    UNITS/5ML
                       A060752   002
	
                                 400,000    UNITS/5ML
                       A060752   001
	
         PUREPAC PHARM           250,000    UNITS/5ML
                       A061740   001
	
                                 400,000    UNITS/5ML
                       A061740   002
	
    PENICILLIN-2
	
         TEVA                    250,000 UNITS/5ML
                          A060307 003
	
    PENTIDS '200'
	
         APOTHECON               200,000 UNITS/5ML
                          A062149 001
	
    PENTIDS '400'
	
         APOTHECON               400,000 UNITS/5ML
                          A062149 002
	
    PFIZERPEN G
	
         PFIZER                  400,000 UNITS/5ML
                          A060587 001
	
  INJECTABLE;INJECTION
	
    PENICILLIN G POTASSIUM
	
         APOTHECON		             1,000,000 UNITS/VIAL
                       A060362   001
	
                                 5,000,000 UNITS/VIAL
                       A060362   003
	
                                 10,000,000 UNITS/VIAL
                      A060362   004
	
                                 20,000,000 UNITS/VIAL
                      A060362   002
	
         CONSOLIDATED PHARM		    500,000 UNITS/VIAL
                         A060806   001
	
                                 1,000,000 UNITS/VIAL
                       A060806   002
	
                                 5,000,000 UNITS/VIAL
                       A060806   003
	
                                 10,000,000 UNITS/VIAL
                      A060806   004
	
         LILLY		                 200,000 UNITS/VIAL
                         A060384   004
	
                                 500,000 UNITS/VIAL
                         A060384   003
	
                                 1,000,000 UNITS/VIAL
                       A060384   002
	
                                 5,000,000 UNITS/VIAL
                       A060384   001
	
                                 20,000,000 UNITS/VIAL
                      A060384   005
	
                                 20,000,000 UNITS/VIAL
                      A060601   001
	
         PARKE DAVIS		           1,000,000 UNITS/VIAL
                       A062003   001
	
                                 5,000,000 UNITS/VIAL
                       A062003   002
	
         PFIZER                  20,000,000 UNITS/VIAL
                      A060074   003
	
         SANDOZ                  1,000,000 UNITS/VIAL **Federal Register
    A065079   001
	 Aug 30, 2002
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                            6-253(of 337)


PENICILLIN G POTASSIUM
	
  INJECTABLE;INJECTION
	
    PENICILLIN G POTASSIUM
	
                                efficacy reasons**

         WATSON LABS INC		      1,000,000 UNITS/VIAL
                      A062991   001
	   Sep   13,   1988

                                5,000,000 UNITS/VIAL
                      A062991   002
	   Sep   13,   1988

                                10,000,000 UNITS/VIAL
                     A062991   003
	   Sep   13,   1988

                                20,000,000 UNITS/VIAL
                     A062991   004
	   Sep   13,   1988
	
   PFIZERPEN
	
        PFIZER		                1,000,000 UNITS/VIAL **Federal Register
   A060657 001
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

 TABLET;ORAL
	
   PENICILLIN G POTASSIUM
	
        APOTHECON               250,000   UNITS
	                          A060392   003
	
        IVAX SUB TEVA PHARMS    400,000   UNITS
	                          A060073   004
	
        LILLY                   250,000   UNITS
	                          A060403   001
	
        MYLAN                   200,000   UNITS
	                          A060781   001
	
                                250,000   UNITS
	                          A060781   002
	
                                400,000   UNITS
	                          A060781   003
	
                                500,000   UNITS
	                          A060781   005
	
                                800,000   UNITS
	                          A060781   004
	
         PUREPAC PHARM          200,000   UNITS
	                          A061588   001
	
                                250,000   UNITS
	                          A061588   002
	
                                400,000   UNITS
	                          A061588   003
	
         TEVA                   200,000   UNITS
	                          A060306   001
	
                                250,000   UNITS
	                          A060306   002
	
                                400,000   UNITS
	                          A060306   003
	
                                500,000   UNITS
	                          A060306   004
	
         WYETH AYERST           200,000   UNITS
	                          A060413   001
	
                                250,000   UNITS
	                          A060413   002
	
                                400,000   UNITS
	                          A060413   003
	
   PENTIDS '200'
	
        APOTHECON               200,000 UNITS
	                            A062155 001
	
   PENTIDS '250'
	
        APOTHECON               250,000 UNITS
	                            A062155 002
	
   PENTIDS '400'
	
        APOTHECON               400,000 UNITS
	                            A060392 004
	
                                400,000 UNITS
	                            A062155 003
	
   PENTIDS '800'
	
        APOTHECON               800,000 UNITS
	                            A060392 005
	
                                800,000 UNITS
	                            A062155 004
	
   PFIZERPEN G
	
        PFIZER		                50,000 UNITS
	                             A060075   001
	
                                100,000 UNITS
	                            A060075   002
	
                                200,000 UNITS
	                            A060075   003
	
                                250,000 UNITS
	                            A060075   004
	
                                400,000 UNITS
	                            A060075   005
	
                                800,000 UNITS
	                            A060075   006
	
PENICILLIN G PROCAINE
	
  INJECTABLE;INJECTION
	
    DURACILLIN A.S.
	
         LILLY                  300,000 UNITS/ML
                          A060093 001
	
    PENICILLIN G PROCAINE
	
         CONSOLIDATED PHARM     300,000 UNITS/ML
                          A060800   001
	
                                600,000 UNITS/1.2ML
                       A060800   002
	
         PARKE DAVIS            300,000 UNITS/ML
                          A062029   001
	
         PFIZER                 300,000 UNITS/VIAL
                        A060099   001
	
                                1,500,000 UNITS/VIAL
                      A060099   002
	
   PFIZERPEN-AS
	
        PFIZER                  300,000 UNITS/ML
                          A060286 001
	
                                600,000 UNITS/ML
	                         A060286 002
	
PENICILLIN G SODIUM
	
  INJECTABLE;INJECTION
	
    PENICILLIN G SODIUM
	
         BRISTOL MYERS SQUIBB   5,000,000 UNITS/VIAL
                      A061935 001
	
         COPANOS                5,000,000 UNITS/VIAL
                      A061051 001
	
         PHARMACIA AND UPJOHN   1,000,000 UNITS/VIAL
	                     A061046 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-254(of 337)


PENICILLIN G SODIUM
	
  INJECTABLE;INTRAMUSCULAR, INTRAVENOUS
	
    PENICILLIN G SODIUM
	
         WATSON LABS INC        5,000,000 UNITS/VIAL
	            A063014 001 Sep 13, 1988
	
PENICILLIN V
	
  FOR SUSPENSION;ORAL
	
    V-CILLIN
	
         LILLY                    125MG/0.6ML
	                   A060002 001
	
PENICILLIN V POTASSIUM
	
  FOR SOLUTION;ORAL
	
    BEEPEN-VK
	
         GLAXOSMITHKLINE          EQ 125MG BASE/5ML
              A062270 001
	
                                  EQ 250MG BASE/5ML
              A062270 002
	
   BETAPEN-VK
	
        APOTHECON                 EQ 125MG BASE/5ML
              A061149 001
	
                                  EQ 250MG BASE/5ML
              A061149 002
	
   LEDERCILLIN VK
	
        LEDERLE                   EQ 125MG BASE/5ML
              A060136 001
	
                                  EQ 250MG BASE/5ML
              A060136 002
	
   PEN-VEE K
	
        WYETH AYERST              EQ 125MG BASE/5ML
              A060007 001
	
                                  EQ 250MG BASE/5ML
              A060007 002
	
   PENAPAR-VK
	
        PARKE DAVIS               EQ 125MG BASE/5ML
              A062002 001
	
                                  EQ 250MG BASE/5ML
              A062002 002
	
   PENICILLIN V POTASSIUM
	
        AM ANTIBIOTICS            EQ   125MG   BASE/5ML
          A061529   001
	
                                  EQ   250MG   BASE/5ML
          A061529   002
	
         MYLAN                    EQ   125MG   BASE/5ML
          A061624   002
	
                                  EQ   250MG   BASE/5ML
          A061624   001
	
         PUREPAC PHARM            EQ   125MG   BASE/5ML
          A061758   001
	
                                  EQ   250MG   BASE/5ML
          A061758   002
	
   PFIZERPEN VK
	
        PFIZER                    EQ 125MG BASE/5ML
              A061815 001
	
                                  EQ 250MG BASE/5ML
              A061815 002
	
   V-CILLIN K
	
        LILLY                     EQ 125MG BASE/5ML
              A060004 001
	
                                  EQ 250MG BASE/5ML
              A060004 002
	
   VEETIDS
	
        APOTHECON                 EQ 125MG BASE/5ML
              A061410 001
	
                                  EQ 250MG BASE/5ML
              A061410 002
	
   VEETIDS '125'
	
        APOTHECON                 EQ 125MG BASE/5ML
              A061206 001
	
                                  EQ 125MG BASE/5ML
              A062153 001
	
   VEETIDS '250'
	
        APOTHECON                 EQ 250MG BASE/5ML
              A061206 002
	
                                  EQ 250MG BASE/5ML
              A062153 002
	
 TABLET;ORAL
	
   BEEPEN-VK
	
        GLAXOSMITHKLINE           EQ 250MG BASE
	                 A062273 001
	
                                  EQ 500MG BASE
	                 A062273 002
	
   BETAPEN-VK
	
        BRISTOL                   EQ 250MG BASE
	                 A061150 001
	
                                  EQ 500MG BASE
	                 A061150 002
	
   LEDERCILLIN VK
	
        LEDERLE                   EQ 250MG BASE
	                 A060134 001
	
                                  EQ 500MG BASE
	                 A060134 002
	
   PEN-VEE K
	
        WYETH AYERST		            EQ 125MG BASE
	                 A060006 001
	
                                  EQ 250MG BASE
	                 A060006 002
	
                                  EQ 500MG BASE
	                 A060006 003
	
   PENAPAR-VK
	
        PARKE DAVIS               EQ 250MG BASE
	                 A062001 001
	
                                  EQ 500MG BASE
	                 A062001 002
	
   PENICILLIN V POTASSIUM
	
        AM ANTIBIOTICS            EQ   250MG   BASE
	             A061528   001
	
                                  EQ   500MG   BASE
	             A061528   002
	
         IVAX SUB TEVA PHARMS		   EQ   125MG   BASE
	             A060518   001
	
                                  EQ   250MG   BASE
	             A060518   002
	
                                  EQ   500MG   BASE
	             A060518   003
	
         MYLAN		                  EQ   250MG   BASE
	             A061530   001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                              6-255(of 337)


PENICILLIN V POTASSIUM
	
  TABLET;ORAL
	
    PENICILLIN V POTASSIUM
	
                                 EQ   500MG   BASE
	                        A061530   002
	
         PUREPAC PHARM
	         EQ   125MG   BASE
	                        A061571   001
	
                                 EQ   250MG   BASE
	                        A061571   002
	
                                 EQ   500MG   BASE
	                        A061571   003
	
   PFIZERPEN VK
	
        PFIZER
	                 EQ 250MG BASE
	                            A061836 001
	
                                 EQ 500MG BASE
	                            A061836 002
	
   UTICILLIN VK
	
        PHARMACIA AND UPJOHN
	   EQ 250MG BASE
	                            A061651 001
	
                                 EQ 500MG BASE
	                            A061651 002
	
   V-CILLIN K
	
        LILLY
	                  EQ 125MG BASE
	                            A060003 001
	
                                 EQ 250MG BASE
	                            A060003 002
	
                                 EQ 500MG BASE
	                            A060003 003
	
   VEETIDS
	
        APOTHECON
	              EQ 250MG BASE
	                            A061411 001
	
                                 EQ 500MG BASE
	                            A061411 002
	
   VEETIDS '250'
	
        APOTHECON
	              EQ 250MG BASE
	                            A061164 001
	
                                 EQ 250MG BASE
	                            A062156 002
	
   VEETIDS '500'
	
        APOTHECON
	              EQ 500MG BASE
	                            A061164 002
	
                                 EQ 500MG BASE
	                            A062156 001
	
PENTAGASTRIN
	
  INJECTABLE;INJECTION
	
    PEPTAVLON
	
         WYETH AYERST
	          0.25MG/ML **Federal Register
              N017048 001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
PENTAMIDINE ISETHIONATE
	
  FOR SOLUTION;INHALATION
	
    NEBUPENT
	
         FRESENIUS KABI USA
	    600MG/VIAL
	                               N019887 002 Mar 22, 1996
	
  INJECTABLE;INJECTION
	
    PENTACARINAT
	
         ARMOUR PHARM
	          300MG/VIAL
	                               A073447 001 Apr 28, 1994
	
    PENTAMIDINE ISETHIONATE
	
         BAXTER HLTHCARE
	       300MG/VIAL
                                A073617 001 Dec 18, 1995
	
         HOSPIRA
	               300MG/VIAL
                                A073479 001 Jun 30, 1992
	
         WATSON LABS
	           300MG/VIAL
	                               A074303 001 Aug 17, 1995
	
PENTAZOCINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TALWIN 50
	
         SANOFI AVENTIS US
	     EQ 50MG BASE
	                             N016732 001
	
PENTETATE CALCIUM TRISODIUM
	
  SOLUTION;INHALATION, INTRAVENOUS
	
    PENTETATE CALCIUM TRISODIUM
	
         HAMELN PHARMS		          EQ 1GM BASE/5ML (EQ 200MG BASE/ML)
       N021749 001 Aug 11, 2004
	
                                  **Federal Register determination that

                                  product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
PENTETATE CALCIUM TRISODIUM YB-169
	
  INJECTABLE;INJECTION
	
    YTTERBIUM YB 169 DTPA
	
         3M                     2mCi/ML
	                                   N017518 001
	
PENTETATE ZINC TRISODIUM
	
  SOLUTION;INHALATION, INTRAVENOUS
	
    PENTETATE ZINC TRISODIUM
	
         HAMELN PHARMS          EQ 1GM BASE/5ML (EQ 200MG BASE/ML)
         N021751 001 Aug 11, 2004
	
                                **Federal Register determination that

                                product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                         6-256(of 337)


PENTOBARBITAL
	
  ELIXIR;ORAL
	
    NEMBUTAL
	
         OAK PHARMS
	             18.2MG/5ML
	                        A083244 001
	
PENTOBARBITAL SODIUM
	
  CAPSULE;ORAL
	
    NEMBUTAL SODIUM
	
         OAK PHARMS
	             30MG
	                              A084095 001
	
                                  50MG
	                              A084093 001
	
                                  100MG
	                             A083245 001
	
    PENTOBARBITAL SODIUM
	
         LANNETT
	                50MG
	                              A085937   001
	
                                  100MG
	                             A085915   001
	
         VITARINE
	               100MG
	                             A083284   001
	
         WHITEWORTH TOWN PLSN
	   100MG
	                             A083338   001
	
    SODIUM PENTOBARBITAL
	
         ANABOLIC
	               100MG
	                             A084590   001
	
         ELKINS SINN
	            100MG
	                             A083368   001
	
         EVERYLIFE
	              100MG
	                             A083259   001
	
         HALSEY
	                 100MG
	                             A084677   001
	
         IVAX SUB TEVA PHARMS
	   50MG
	                              A083461   001
	
                                  100MG
	                             A083461   002
	
         PARKE DAVIS
	            100MG
	                             A084156   001
	
         PERRIGO
	                100MG
	                             A084560   001
	
         PUREPAC PHARM
	          100MG
	                             A083301   001
	
         VALEANT PHARM INTL
	     100MG
	                             A083264   001
	
         WATSON LABS
	            100MG
	                             A085791   001
	
         WYETH AYERST
	           100MG
	                             A083239   001
	
  INJECTABLE;INJECTION
	
    PENTOBARBITAL SODIUM
	
         ELKINS SINN
	            50MG/ML
	                           A083270 001
	
    SODIUM PENTOBARBITAL
	
         WYETH AYERST
	           50MG/ML
	                           A083261 001
	
  SUPPOSITORY;RECTAL
	
    NEMBUTAL
	
         OAK PHARMS
	             30MG
	                              A083247   001     Jan   25,   1982
	
                                  60MG
	                              A083247   002     Jan   25,   1982
	
                                  120MG
	                             A083247   003     Jan   25,   1982
	
                                  200MG
	                             A083247   004     Jan   25,   1982
	
  TABLET;ORAL
	
    PENTOBARBITAL SODIUM
	
         VITARINE
	               100MG
	                             A083285 001
	
    SODIUM PENTOBARBITAL
	
         NEXGEN PHARMA INC
	      100MG
	                             A084238 001
	
PENTOLINIUM TARTRATE
	
  INJECTABLE;INJECTION
	
    ANSOLYSEN
	
         WYETH AYERST
	           10MG/ML
	                           N009372 001
	
PENTOXIFYLLINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    PENTOXIFYLLINE
	
         ACTAVIS ELIZABETH
	     400MG
	                              A074878   001     Jul   09,   1997
	
         HERITAGE PHARMS INC
	   400MG
	                              A074877   001     Jul   08,   1997
	
         TEVA
	                  400MG
	                              A075199   001     Sep   03,   1999

         WATSON LABS
	           400MG
	                              A075107   001     Sep   04,   1998
	
    TRENTAL
	
         SANOFI AVENTIS US
	     400MG
	                              N018631 001 Aug 30, 1984
	
PERFLUBRON
	
  LIQUID;ORAL
	
    IMAGENT
	
         ALLIANCE PHARM
	         100%
	                              N020091 001 Aug 13, 1993
	
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE
	
  PASTE;TOPICAL
	
    SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS
	
         US ARMY                50%;50%
	                             N021084 001 Feb 17, 2000
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                            6-257(of 337)


PERGOLIDE MESYLATE
	
  TABLET;ORAL
	
    PERGOLIDE MESYLATE
	
         IVAX SUB TEVA PHARMS
	   EQ     0.05MG BASE
	                      A076094   001
	   Sep   04,   2003

                                  EQ     0.25MG BASE
	                      A076094   002
	   Sep   04,   2003

                                  EQ     1MG BASE
	                         A076094   003
	   Sep   04,   2003

         PAR PHARM
	              EQ     0.05MG BASE
	                      A076061   001
	   Nov   27,   2002
	
                                  EQ     0.25MG BASE
	                      A076061   002
	   Nov   27,   2002
	
                                  EQ     1MG BASE
	                         A076061   003
	   Nov   27,   2002
	
    PERMAX
	
         VALEANT PHARM INTL
	     EQ 0.05MG BASE
	                          N019385 001
	 Dec 30, 1988
	
                                  EQ 0.25MG BASE
	                          N019385 002
	 Dec 30, 1988
	
                                  EQ 1MG BASE
	                             N019385 003
	 Dec 30, 1988
	
PERMETHRIN
	
  LOTION;TOPICAL
	
    NIX
	
          GLAXOSMITHKLINE
	       1%
	                                      N019435 001
	 Mar 31, 1986
	
PERPHENAZINE
	
  CONCENTRATE;ORAL
	
    PERPHENAZINE
	
         PHARM ASSOC
	            16MG/5ML
	                                A040360 001
	 May 25, 2001
	
    TRILAFON
	
         SCHERING
	               16MG/5ML
	                                N011557 001
	
  INJECTABLE;INJECTION
	
    TRILAFON
	
         SCHERING
	               5MG/ML
	                                  N011213 002
	
  SYRUP;ORAL
	
    TRILAFON
	
         SCHERING
	               2MG/5ML
	                                 N011294 002
	
  TABLET;ORAL
	
    PERPHENAZINE
	
         ANI PHARMS INC
	         8MG
	                                     A089456   001
	   Sep   10,   1987

         TEVA PHARMS USA
	        2MG
	                                     A089707   001
	   Sep   10,   1987

                                  4MG
	                                     A089708   001
	   Sep   10,   1987

                                  16MG
	                                    A089457   001
	   Sep   10,   1987
	
    TRILAFON
	
         SCHERING
	              2MG
	                                      N010775   001
	
                                 4MG
	                                      N010775   002
	
                                 8MG
	                                      N010775   003
	
                                 16MG
	                                     N010775   004
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TRILAFON
	
         SCHERING
	              8MG
	                                      N011361 002
	
PHENACEMIDE
	
  TABLET;ORAL
	
    PHENURONE
	
         ABBVIE
	                 500MG **Federal Register determination
   N007707 001
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE
	
  TABLET;ORAL
	
    AZO GANTANOL
	
         ROCHE                  100MG;500MG **Federal Register
             N013294 001
	 Sep 10, 1987
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM
	
  TABLET;ORAL
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PENAZOPYRIDINE HYDROCHLORIDE
	
         ABLE                   200MG;800MG;160MG
	                         N021105 001
	 Jun 26, 2001
	
PHENAZOPYRIDINE HYDROCHLORIDE; SULFISOXAZOLE
	
  TABLET;ORAL
	
    AZO GANTRISIN
	
         ROCHE                  50MG;500MG **Federal Register
              N019358 001
	 Aug 31, 1990
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                   6-258(of 337)


PHENDIMETRAZINE TARTRATE
	
  CAPSULE;ORAL
	
    PHENAZINE
	
         MAST MM
	              35MG
	                            A086523 001
	
                                35MG
	                            A086524 001
	
                                35MG
	                            A086525 001
	
   PHENDIMETRAZINE TARTRATE
	
        SANDOZ
	                35MG
	                            A085633   001
	
                                35MG
	                            A085694   001
	
                                35MG
	                            A085695   001
	
                                35MG
	                            A085702   001
	
         VITARINE
	             35MG
	                            A085634   001
	
                                35MG
	                            A085645   001
	
                                35MG
	                            A085670   001
	
                                35MG
	                            A086403   001
	
                                35MG
	                            A086408   001
	
                                35MG
	                            A086410   001
	
                                35MG
	                            A087424   001
	
   SPRX-3
	
        SOLVAY
	               35MG
	                             A085897 001
	
   STATOBEX
	
        TEVA
	                 35MG
	                             A085507 001
	
   X-TROZINE
	
        SHIRE RICHWOOD
	       35MG
	                             A087394 001 Sep 22, 1982
	
 CAPSULE, EXTENDED RELEASE;ORAL
	
   MELFIAT-105
	
        NUMARK
	               105MG
	                            A087487 001 Oct 13, 1982
	
   PHENDIMETRAZINE TARTRATE
	
        GRAHAM DM
	            105MG
	                            A087214   001     May   26,   1982

                               105MG
	                            A088020   001     Aug   16,   1982

                               105MG
	                            A088028   001     Aug   16,   1982

                               105MG
	                            A088062   001     Sep   13,   1982

                               105MG
	                            A088063   001     Sep   10,   1982

                               105MG
	                            A088111   001     Oct   18,   1982
	
        SANDOZ
	               105MG
	                            A087378   001
	
   SPRX-105
	
        NUMARK
	               105MG
	                            A088024 001 Dec 22, 1982
	
   X-TROZINE L.A.
	
        SHIRE RICHWOOD
	       105MG
	                            A087371 001 Aug 24, 1982
	
 TABLET;ORAL
	
   ADPHEN
	
        FERNDALE LABS
	        35MG
	                             A083655 001
	
   ALPHAZINE
	
        SANDOZ
	               35MG
	                             A085034 001
	
   CAM-METRAZINE
	
        ABC HOLDING
	          35MG
	                             A085511   001
	
        CAMALL
	               35MG
	                             A085756   001
	
        TG UNITED LABS
	       35MG
	                             A083922   001
	
                               35MG
	                             A085318   001
	
                               35MG
	                             A085320   001
	
                               35MG
	                             A085321   001
	
   DI-METREX
	
        PVT FORM
	             35MG
	                             A085698 001
	
   MELFIAT
	
        NUMARK
	               35MG
	                             A083790 002
	
   METRA
	
        FOREST PHARMS
	        35MG
	                             A083754 001
	
   PHENAZINE
	
        MAST MM
	              35MG
	                             A087305 001
	
   PHENAZINE-35
	
        ABC HOLDING
	          35MG
	                             A085512 001
	
   PHENDIMETRAZINE TARTRATE
	
        BARR
	                 35MG
	                             A083644   001
	
                               35MG
	                             A083684   001
	
                               35MG
	                             A083686   001
	
                               35MG
	                             A083687   001
	
                               35MG
	                             A084831   001
	
                               35MG
	                             A084834   001
	
                               35MG
	                             A084835   001
	
        FERNDALE LABS
	        35MG
	                             A086834   001 Sep 15, 1983

        INWOOD LABS
	          35MG
	                             A084740   001
	
                               35MG
	                             A084741   001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                     6-259(of 337)


PHENDIMETRAZINE TARTRATE
	
  TABLET;ORAL
	
    PHENDIMETRAZINE TARTRATE
	
                                  35MG
	                          A084742   001
	
                                  35MG
	                          A084743   001
	
         IVAX PHARMS
	            35MG
	                          A085611   001
	
                                  35MG
	                          A085612   001
	
         IVAX SUB TEVA PHARMS
	   35MG
	                          A083682   001
	
         KV PHARM
	               35MG
	                          A084138   001
	
                                  35MG
	                          A084141   001
	
                                  35MG
	                          A085525   001
	
         MFG CHEMISTS
	           35MG
	                          A085914   001
	
         NEXGEN PHARMA INC
	      35MG
	                          A086020   001
	
         NUMARK
	                 35MG
	                          A083790   001
	
         PVT FORM
	               35MG
	                          A085199   001
	
                                  35MG
	                          A085697   001
	
         SANDOZ
	                 35MG
	                          A085402   001
	
                                  35MG
	                          A085497   001
	
                                  35MG
	                          A085830   001
	
                                  35MG
	                          A086365   001
	
                                  35MG
	                          A086370   001
	
         SOLVAY
	                 35MG
	                          A083993   001
	
         TG UNITED LABS
	         35MG
	                          A085761   001
	
                                  35MG
	                          A085941   001 Jun 27, 1983
	
         USL PHARMA
	             35MG
	                          A083805   001
	
                                  35MG
	                          A084398   001
	
                                  35MG
	                          A084399   001
	
         VITARINE
	               35MG
	                          A085519   001
	
                                  35MG
	                          A086005   001
	
                                  35MG
	                          A086106   001
	
         WATSON LABS
	            35MG
	                          A085767   001
	
                                  35MG
	                          A085768   001
	
                                  35MG
	                          A085770   001
	
                                  35MG
	                          A085773   001
	
    PLEGINE
	
         WYETH AYERST
	           35MG
	                          N012248 001
	
    STATOBEX
	
         TEVA
	                   35MG
	                          A086013 001
	
    STATOBEX-G
	
         TEVA
	                   35MG
	                          A085095 001
	
    X-TROZINE
	
         SHIRE RICHWOOD
	         35MG
	                          A086550   001
	
                                  35MG
	                          A086551   001
	
                                  35MG
	                          A086552   001
	
                                  35MG
	                          A086553   001
	
                                  35MG
	                          A086554   001
	
PHENINDIONE
	
  TABLET;ORAL
	
    HEDULIN
	
         SANOFI AVENTIS US
	      50MG
	                          N008767 002
	
PHENMETRAZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PRELUDIN
	
         BOEHRINGER INGELHEIM
	 25MG
	                            N010460 005
	
  TABLET, EXTENDED RELEASE;ORAL
	
    PRELUDIN
	
         BOEHRINGER INGELHEIM
	 50MG
	                            N011752 004
	
                                 75MG
	                           N011752 003
	
PHENPROCOUMON
	
  TABLET;ORAL
	
    LIQUAMAR
	
         ORGANON USA INC
	        3MG
	                           N011228 001
	
PHENSUXIMIDE
	
  CAPSULE;ORAL
	
    MILONTIN
	
         PARKE DAVIS
	            500MG
	                         N008855 004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                  6-260(of 337)


PHENTERMINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    FASTIN
	
         GLAXOSMITHKLINE         30MG                           N017352 001
	
    OBESTIN-30
	
         FERNDALE LABS           30MG                           A087144 001
	
    OBY-TRIM
	
         SHIRE RICHWOOD          30MG                           A087764 001 Mar 18, 1982
	
    ONA-MAST
	
         MAST MM                 30MG                           A086511 001
	
                                 30MG                           A086516 001
	
   PHENTERMINE HYDROCHLORIDE
	
        ABC HOLDING              30MG                           A085411   001
	
        ABLE                     15MG                           A040497   001     Mar 13, 2003
	
                                 30MG                           A040403   001     Aug 30, 2001

                                 30MG                           A040427   001     Aug 30, 2001

         CAMALL                  15MG                           A086735   001
	
                                 30MG                           A087226   001
	
         DURAMED PHARMS BARR     30MG                           A088948   001     Apr 25, 1986

         IVAX PHARMS             30MG                           A086329   001
	
         MIKAH PHARMA            15MG                           A040460   001     Jan   14,   2003
	
                                 30MG                           A040227   001     Jun   18,   1997
	
                                 30MG                           A040448   001     Jan   22,   2003
	
                                 37.5MG                         A040228   001     Jun   19,   1997
	
         MUTUAL PHARM            37.5MG                         A040527   001     Oct   23,   2003
	
         SANDOZ		                30MG                           A087208   001
	
                                 30MG                           A087223   001
	
                                 37.5MG                         A088414   001     Oct 19, 1983
	
         TEVA		                  30MG                           A086911   001
	
                                 30MG                           A087126   001
	
                                 30MG                           A087777   001     Nov   01,   1985
	
                                 30MG                           A088612   001     Apr   04,   1984

                                 30MG                           A088613   001     Apr   09,   1984

                                 30MG                           A088614   001     Apr   09,   1984

         TG UNITED INC		         30MG                           A040083   001     Mar   07,   1997
	
         TG UNITED LABS		        18.75MG                        A088576   001     May   23,   1984

                                 30MG                           A085417   001
	
                                 30MG                           A086732   002
	
                                 30MG                           A087215   001
	
                                 37.5MG                         A087915   001     Dec   22,   1983
	
                                 37.5MG                         A087918   001     Dec   22,   1983
	
                                 37.5MG                         A087930   001     Oct   14,   1983
	
                                 37.5MG                         A088610   001     Jun   04,   1984
	
                                 37.5MG                         A088611   001     Jun   04,   1984
	
                                 37.5MG                         A088625   001     Aug   23,   1984

         USL PHARMA		            30MG                           A084487   001     Apr   09,   1982

                                 30MG                           A088430   001     Mar   27,   1984
	
                                 30MG                           A088797   001     Dec   10,   1984
	
         VITARINE                30MG                           A087202   001
	
                                 30MG                           A087235   001
	
        WATSON LABS              30MG                           A086740   001     Mar 21, 1985
	
 TABLET;ORAL
	
   ONA-MAST
	
        MAST MM                  8MG                            A086260 001
	
   PHENTERMINE HYDROCHLORIDE
	
        ABLE                     37.5MG                         A040402   001     Aug 30, 2001

        ACTAVIS ELIZABETH        37.5MG                         A040276   001     Nov 25, 1998
	
        IVAX PHARMS              8MG                            A085553   001
	
        SANDOZ                   8MG                            A085671   001
	
                                 8MG                            A085689   001
	
         SANDOZ INC              30MG                           A088605   001     Sep 28, 1987

         TG UNITED LABS          8MG                            A083923   001
	
                                 8MG                            A085319   001
	
                                 37.5MG                         A087805   001     Dec 06, 1982
	
                                 37.5MG                         A088596   001     Apr 04, 1984

         USL PHARMA		            8MG                            A083804   001
	
                                 37.5MG                         A088910   001     Jul 17, 1985
	
                                 37.5MG                         A088917   001     Jul 17, 1985
	
         VITARINE                8MG                            A086453   001
	
                                 8MG                            A086456   001
	
         WATSON LABS             8MG                            A085739   001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                             6-261(of 337)


PHENTERMINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TORA
	
           SOLVAY                8MG                                     A084035 001
	
    WILPO
	
           SANDOZ                8MG **Federal Register determination    N012737 001
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
PHENTERMINE RESIN COMPLEX
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    IONAMIN
         UCB INC                EQ 15MG BASE                             N011613 004
                                EQ 30MG BASE                             N011613 002
    PHENTERMINE RESIN 30
         QUANTUM PHARMICS       EQ 30MG BASE                             A089120 001 Feb 04, 1988
PHENYL AMINOSALICYLATE
  POWDER;ORAL
    PHENY-PAS-TEBAMIN
         PHARM RES ASSOC         50%                                     N011695 002
  TABLET;ORAL
    PHENY-PAS-TEBAMIN
         PHARM RES ASSOC         500MG                                   N011695 003
PHENYLBUTAZONE
  CAPSULE;ORAL
    AZOLID
         SANOFI AVENTIS US       100MG                                   A087260 001
    BUTAZOLIDIN
         NOVARTIS                100MG                                   N008319 009
    PHENYLBUTAZONE
         IVAX PHARMS             100MG                                   A088218   001    Jun   24,   1983
         MUTUAL PHARM            100MG                                   A088994   001    Dec   04,   1985
         SANDOZ                  100MG                                   A087774   001    Jun   16,   1982
         WATSON LABS             100MG                                   A087756   001    Dec   17,   1982
  TABLET;ORAL
    AZOLID
         SANOFI AVENTIS US       100MG                                   A087091 001
    BUTAZOLIDIN
         NOVARTIS                100MG                                   N008319 008
    PHENYLBUTAZONE
         MUTUAL PHARM            100MG                                   A088863   001 Dec 04, 1985
         SANDOZ                  100MG                                   A084339   001
         WATSON LABS             100MG                                   A086151   001
                                 100MG                                   A087674   001 Apr 21, 1982
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    PHENERGAN VC
	
         ANI PHARMS             5MG/5ML;6.25MG/5ML                       N008604 003 Apr 02, 1984

    PHERAZINE VC
	
         HALSEY                 5MG/5ML;6.25MG/5ML                       A088868 001 Mar 02, 1987
	
    PROMETHAZINE VC PLAIN
	
         CENCI                  5MG/5ML;6.25MG/5ML                       A088815 001 Nov 22, 1985
	
         WOCKHARDT              5MG/5ML;6.25MG/5ML                       A088897 001 Jan 04, 1985
	
PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
	
  SOLUTION/DROPS;OPHTHALMIC

    PREFRIN-A
	
         ALLERGAN               0.12%;0.1%                               N007953 001
	
PHENYTOIN
	
  SUSPENSION;ORAL
	
    DILANTIN-30
	
         PARKE DAVIS             30MG/5ML                                N008762 002
	
    PHENYTOIN
	
         ACTAVIS MID ATLANTIC    125MG/5ML                               A089892 001 Sep 25, 1992
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                      6-262(of 337)


PHENYTOIN SODIUM
	
  CAPSULE;ORAL
	
    DIPHENYLAN SODIUM
	
         LANNETT                 30MG PROMPT                    A080857 001
	
                                 100MG PROMPT                   A080857 002
	
   EXTENDED PHENYTOIN SODIUM
	
        ANI PHARMS INC           100MG EXTENDED                 A040435 001 Jun 20, 2003
	
                                 100MG EXTENDED                 A089441 001 Dec 18, 1986
	
   PHENYTEX
	
        WATSON LABS              100MG EXTENDED                 A088711 001 Dec 21, 1984
	
   PHENYTOIN SODIUM
	
        PHARMERAL                100MG PROMPT                   A085435 001
	
        WATSON LABS              100MG PROMPT                   A085894 001
	
   PROMPT PHENYTOIN SODIUM
	
        ANI PHARMS INC           100MG PROMPT                   A080259 001
	
        WATSON LABS              100MG PROMPT                   A080905 001
	
 INJECTABLE;INJECTION
	
   DILANTIN
	
        PARKE DAVIS              50MG/ML                        N010151 001
	
   PHENYTOIN SODIUM
	
        FRESENIUS KABI USA       50MG/ML                        A089003   001     May   31,   1985

        HOSPIRA                  50MG/ML                        A089744   001     Dec   18,   1987
	
        MARSAM PHARMS LLC        50MG/ML                        A089501   001     Oct   13,   1987
	
                                 50MG/ML                        A089779   001     Nov   27,   1992
	
         SMITH AND NEPHEW        50MG/ML                        A088519   001     Dec   19,   1984
	
                                 50MG/ML                        A088521   001     Dec   18,   1984
	
         SOLOPAK                 50MG/ML                        A088520   001     Dec   17,   1984
	
         WARNER CHILCOTT         50MG/ML                        A089900   001     Mar   30,   1990
	
         WATSON LABS             50MG/ML                        A085434   001
	
PHYTONADIONE
	
  INJECTABLE;INJECTION
	
    AQUAMEPHYTON
	
         BIOVAIL TECHNOLOGIES    1MG/0.5ML                      N012223 002
	
                                 10MG/ML                        N012223 001
	
   KONAKION
	
        ROCHE                    1MG/0.5ML                      N011745 001
	
                                 10MG/ML                        N011745 003
	
   PHYTONADIONE
	
        GLAXOSMITHKLINE          1MG/0.5ML                      A084060 001
	
                                 10MG/ML                        A084060 002
	
   VITAMIN K1
	
        HOSPIRA                  10MG/ML                        A087956 001 Jul 25, 1983
	
PILOCARPINE
	
  INSERT, EXTENDED RELEASE;OPHTHALMIC
	
    OCUSERT PILO-20
	
         AKORN                  5MG                             N017431 001
	
    OCUSERT PILO-40
	
         AKORN                  11MG                            N017548 001
	
PINACIDIL
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    PINDAC
	
         LEO PHARM              12.5MG                          N019456 001 Dec 28, 1989
	
                                25MG                            N019456 002 Dec 28, 1989
	
PINDOLOL
	
  TABLET;ORAL
	
    PINDOLOL
	
          IVAX SUB TEVA PHARMS   5MG                            A073687   001     Feb   26,   1993
	
                                 10MG                           A073687   002     Feb   26,   1993
	
         MYLAN PHARMS INC        5MG                            A074013   001     Sep   24,   1992

                                 10MG                           A074018   001     Sep   24,   1992

         NOSTRUM LABS            5MG                            A074474   001     Oct   28,   1996
	
                                 10MG                           A074474   002     Oct   28,   1996
	
         PUREPAC PHARM           5MG                            A074125   001     Apr   28,   1993

                                 10MG                           A074125   002     Apr   28,   1993

         SANDOZ                  5MG                            A073608   001     Mar   29,   1993
	
                                 10MG                           A073609   001     Mar   29,   1993
	
         TEVA                    5MG                            A073661   001     Oct   31,   1993
	
                                 5MG                            A074123   001     Apr   17,   1997

                                 10MG                           A073661   002     Oct   31,   1993
	
                                 10MG                           A074123   002     Apr   17,   1997
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                     6-263(of 337)


PINDOLOL
	
  TABLET;ORAL
	
    PINDOLOL
	
          WATSON LABS
	           5MG
	                            A074437 001 Feb 27, 1995
	
                                  10MG
	                           A074437 002 Feb 27, 1995
	
    VISKEN
	
         NOVARTIS
	               5MG
	                            N018285 001 Sep 03, 1982

                                  10MG
	                           N018285 002 Sep 03, 1982
	
PIPECURONIUM BROMIDE
	
  INJECTABLE;INJECTION
	
    ARDUAN
	
         ORGANON USA INC
	        10MG/VIAL
	                      N019638 001 Jun 26, 1990
	
PIPERACETAZINE
	
  TABLET;ORAL
	
    QUIDE
	
         DOW PHARM
	              10MG
	                           N013615 001
	
                                  25MG
	                           N013615 002
	
PIPERACILLIN SODIUM
	
  INJECTABLE;INJECTION
	
    PIPRACIL
	
         WYETH PHARMS INC
	       EQ   2GM BASE/VIAL
              A062750   001     Oct 13, 1987
	
                                  EQ   2GM BASE/VIAL
              N050545   002
	
                                  EQ   3GM BASE/VIAL
              A062750   002     Oct 13, 1987
	
                                  EQ   3GM BASE/VIAL
              N050545   003
	
                                  EQ   4GM BASE/VIAL
              A062750   003     Oct 13, 1987
	
                                  EQ   4GM BASE/VIAL
              N050545   004
	
                                  EQ   40GM BASE/VIAL
	            N050545   006     Sep 30, 1985
	
PIPERAZINE CITRATE
	
  SYRUP;ORAL
	
    ANTEPAR
	
         GLAXOSMITHKLINE
	        EQ 500MG BASE/5ML
	              N009102 001
	
    BRYREL
	
         SANOFI AVENTIS US
	      EQ 500MG BASE/5ML
	              N017796 001
	
    MULTIFUGE
	
         BLULINE
	                EQ 500MG BASE/5ML
	              N009452 001
	
    PIPERAZINE CITRATE
	
         ALPHARMA US PHARMS
	     EQ 500MG BASE/5ML
               A080774 001
	
         LANNETT
	                EQ 500MG BASE/5ML
               A080963 001
	
         LUITPOLD
	               EQ 500MG BASE/5ML
	              A080671 001
	
    VERMIDOL
	
         SOLVAY
	                 EQ 500MG BASE/5ML
	              A080992 001
	
  TABLET;ORAL
	
    ANTEPAR
	
         GLAXOSMITHKLINE
	        EQ 500MG BASE
	                  N009102 003
	
    PIPERAZINE CITRATE
	
         IMPAX LABS
	             EQ 250MG BASE
	                  A080874 001
	
PIPERONYL BUTOXIDE; PYRETHRINS
	
  AEROSOL;TOPICAL
	
    RID MOUSSE
	
         BAYER HEALTHCARE LLC
	 4%;EQ 0.33% BASE
	                 N021043 001 Mar 07, 2000
	
PIPOBROMAN
	
  TABLET;ORAL
	
    VERCYTE
	
         ABBOTT
	                 10MG
	                           N016245 001
	
                                  25MG
	                           N016245 002
	
PIRBUTEROL ACETATE
	
  AEROSOL, METERED;INHALATION
	
    MAXAIR
	
         VALEANT PHARM NORTH
	    EQ 0.2MG BASE/INH
	              N019009 001 Dec 30, 1986
	
PIROXICAM
	
  CAPSULE;ORAL
	
    PIROXICAM
	
         CYCLE PHARMS LTD
	       10MG
	                           A073651   001     Feb   26,   1993
	
                                  20MG
	                           A073651   002     Feb   26,   1993
	
         EGIS
	                   10MG
	                           A074808   001     Jul   08,   1997
	
                                  20MG
	                           A074808   002     Jul   08,   1997
	
         IVAX SUB TEVA PHARMS
	   10MG
	                           A074148   001     Jun   03,   1996
	
                                  20MG
	                           A074148   002     Jun   03,   1996
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-264(of 337)


PIROXICAM
	
  CAPSULE;ORAL
	
    PIROXICAM
	
         MUTUAL PHARM            20MG                                    A073536   001    Mar   12,   1993
	
         MYLAN                   10MG                                    A074043   001    Sep   22,   1992

                                 20MG                                    A074043   002    Sep   22,   1992

         SCS                     10MG                                    A074036   001    May   29,   1992

                                 20MG                                    A074036   002    May   29,   1992

         TEVA                    10MG                                    A073637   001    Jan   28,   1994
	
                                 20MG                                    A073638   001    Jan   28,   1994
	
         TEVA PHARMS             10MG                                    A074103   001    Aug   28,   1992

                                 20MG                                    A074103   002    Aug   28,   1992

         WATSON LABS             10MG                                    A074287   001    May   16,   1996

                                 10MG                                    A074460   001    Sep   29,   1995

                                 20MG                                    A074287   002    May   16,   1996

                                 20MG                                    A074460   002    Sep   29,   1995
	
PLICAMYCIN
	
  INJECTABLE;INJECTION
	
    MITHRACIN
	
         PFIZER                  2.5MG/VIAL                              N050109 001
	
POLYESTRADIOL PHOSPHATE
	
  INJECTABLE;INJECTION
	
    ESTRADURIN
	
         WYETH AYERST            40MG/AMP                                N010753 001
	
POLYETHYLENE GLYCOL 3350
	
  FOR SOLUTION;ORAL
	
    POLYETHYLENE GLYCOL 3350
	
         PADDOCK LLC             17GM/SCOOPFUL                           A090567 001 Oct 15, 2009
	
         TEVA PHARMS             17GM/SCOOPFUL                           A077445 001 May 04, 2006
	
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
	
  FOR SOLUTION;ORAL
	
    CLENZ-LYTE
	
          PADDOCK LLC           236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/   A090769 001 Jun 07, 2010

                                BOT;22.74GM/BOT

  SOLUTION;ORAL
	
    OCL
	
          HOSPIRA               6GM/100ML;75MG/100ML;168MG/100ML;146MG/   N019284 001 Apr 30, 1986

                                100ML;1.29GM/100ML
	
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM       SULFATE

ANHYDROUS
	
  FOR SOLUTION;ORAL
	
    COLYTE
	
         MEDA PHARMS		          120GM/PACKET;1.49GM/PACKET;3.36GM/PACKE   N018983 005 Oct       26, 1984

                                T;2.92GM/PACKET;11.36GM/PACKET

                                227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC   N018983 004 Oct       26, 1984

                                KET;5.53GM/PACKET;21.5GM/PACKET

                                240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/   N018983 007 Jun       12, 1987

                                BOT;22.72GM/BOT

                                360GM/PACKET;4.47GM/PACKET;10.08GM/PACK   N018983 006 Oct       26, 1984

                                ET;8.76GM/PACKET;34.08GM/PACKET

    COLYTE-FLAVORED
	
         MEDA PHARMS		          227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53G   N018983 008 Nov       14, 1991

                                M/BOT;21.5GM/BOT

                                240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/   N018983 009 Nov       14, 1991

                                BOT;22.72GM/BOT

    POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
	
         PADDOCK LLC            240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/   A090712 001 Feb       25, 2010

                                BOT;22.72GM/BOT

  FOR SUSPENSION;ORAL
	
    CO-LAV
	
         VINTAGE PHARMS         240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/   A073428 001 Jan       28, 1992

                                BOT;22.72GM/BOT

    COLOVAGE
	
         DYNAPHARM              227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC   A071320 001 Apr       20, 1988

                                KET;5.53GM/PACKET;21.5GM/PACKET

    E-Z-EM PREP LYTE
	
         E Z EM                 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/   A071278 001 Nov       21, 1988

                                BOT;22.74GM/BOT

    GLYCOPREP
	
         GOLDLINE               236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/   A072319 001 Dec       23, 1988

                                BOT;22.74GM/BOT
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                              6-265(of 337)


POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE

ANHYDROUS
	
  FOR SUSPENSION;ORAL
	
    GO-EVAC
	
         VINTAGE PHARMS
	       236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/
  A073433 001 Apr 28, 1992
	
                                BOT;22.74GM/BOT
	
    PEG-LYTE
	
         SANDOZ
	               236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/
  A073098 001 Aug 31, 1993
	
                                BOT;22.74GM/BOT
	
POLYMYXIN B SULFATE
	
  INJECTABLE;INJECTION
	
    AEROSPORIN
	
         GLAXOSMITHKLINE
	        EQ 500,000 U BASE/VIAL
	                A062036 001
	
  POWDER;FOR RX COMPOUNDING
	
    POLY-RX
	
         X GEN PHARMS
	           100,000,000 UNITS/BOT
	                 A061578 001
	
    POLYMYXIN B SULFATE
	
         PADDOCK LLC
	            100,000,000 UNITS/BOT
	                 A062455 001 Jul 27, 1983
	
POLYTHIAZIDE
	
  TABLET;ORAL
	
    RENESE
	
         PFIZER
	                 1MG
	                                   N012845 001
	
                                  2MG
	                                   N012845 002
	
                                  4MG
	                                   N012845 003
	
POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    MINIZIDE
	
         PFIZER
	               0.5MG;EQ 1MG BASE
	                       N017986 001
	
                                0.5MG;EQ 2MG BASE
	                       N017986 002
	
                                0.5MG;EQ 5MG BASE
	                       N017986 003
	
POLYTHIAZIDE; RESERPINE
	
  TABLET;ORAL
	
    RENESE-R
	
         PFIZER
	                 2MG;0.25MG
	                            N013636 001
	
POTASSIUM AMINOSALICYLATE
	
  CAPSULE;ORAL
	
    PASKALIUM
	
         GLENWOOD
	               500MG
	                                 N009395 004
	
  POWDER;ORAL
	
    POTASSIUM AMINOSALICYLATE
	
         HEXCEL
	                 100%
	                                  A080098 001
	
  TABLET;ORAL
	
    PASKALIUM
	
         GLENWOOD
	               1GM
	                                   N009395 003
	
POTASSIUM CHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    K-LEASE
	
         SAVAGE LABS            8MEQ
	                                    A073398 001 Jan 28, 1992
	
                                10MEQ
	                                   A072427 001 Mar 28, 1990
	
    POTASSIUM CHLORIDE
	
         NESHER PHARMS          10MEQ
	                                   A070980 001 Feb 17, 1987
	
         TEVA                   8MEQ
	                                    A073531 001 Apr 26, 1996

                                10MEQ
	                                   A073532 001 Apr 26, 1996
	
  FOR SUSPENSION, EXTENDED RELEASE;ORAL
	
    MICRO-K LS
	
         KV PHARM
	             20MEQ/PACKET
	                            N019561 003 Aug 26, 1988
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE
	
         ABRAXIS PHARM
	        2MEQ/ML
                                  A080204   001
	
                                2MEQ/ML
                                  A084290   001
	
                                2MEQ/ML
                                  A086713   001
	
                                2MEQ/ML
                                  A086714   001
	
                                2MEQ/ML
                                  A087787   001     Apr 20, 1982

                                2MEQ/ML
                                  A087885   001     Feb 03, 1983
	
         AKORN
	                2MEQ/ML
                                  A088286   001     Sep 05, 1985

         BAXTER HLTHCARE
	      2MEQ/ML
                                  A080203   001
	
         FRESENIUS KABI USA
	   2MEQ/ML
                                  A087817   001     Oct 20, 1982
	
         GD SEARLE LLC
	        1MEQ/ML
                                  A086219   001
	
                                2MEQ/ML
                                  A086219   002
	
                                2MEQ/ML
	                                 A086220   002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                                   6-266(of 337)


POTASSIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE
	
                                3MEQ/ML                                    A086219    003
                                3MEQ/ML                                    A086220    001
                                4MEQ/ML                                    A086219    004
          HOSPIRA
	             1MEQ/ML                                    A080205    003
                                1MEQ/ML                                    A083345    003
                                1.5MEQ/ML                                  A083345    001
                                2MEQ/ML                                    A083345    002
                                2.4MEQ/ML                                  A080205    004
                                3.2MEQ/ML                                  A080205    005
          INTL MEDICATION
	     2MEQ/ML                                    A083163    001
          LILLY
	               2MEQ/ML                                    N007865    002
          LUITPOLD
	            2MEQ/ML                                    A080221    001
                                2MEQ/ML                                    A080736    001
                                2MEQ/ML                                    A087584    001
                                2MEQ/ML                                    A087585    001
          MILES
	               1MEQ/ML                                    A080195    002
                                2MEQ/ML                                    A080195    001
                                3MEQ/ML                                    A080195    003
                                4MEQ/ML                                    A080195    004
          PHARMA SERVE NY
	     2MEQ/ML                                    A086297    001
                                2MEQ/ML                                    A087362    001 Mar 08, 1983
          WATSON LABS
	         2MEQ/ML                                    A086208    001
                                2MEQ/ML                                    A089163    001 Mar 10, 1988
                                2MEQ/ML                                    A089421    001 Jan 02, 1987
                                3MEQ/ML                                    A086210    001
 TABLET, EXTENDED RELEASE;ORAL
	
   K+10
	
          FUTURE PAK
	          10MEQ                                      A070999 001 Oct 22, 1987
   K+8
	
          FUTURE PAK
	          8MEQ                                       A070998 001 Jan 25, 1993
   KAON CL
	
          SAVAGE LABS
	         6.7MEQ                                     N017046 001
   KAON CL-10
	
          SAVAGE LABS
	         10MEQ                                      N017046 002
   KLOTRIX
	
          APOTHECON
	           10MEQ                                      N017850 001
   POTASSIUM CHLORIDE
	
          COPLEY PHARM
	        8MEQ                                       A070618    001    Sep   09,   1987
          NESHER PHARMS
	       20MEQ                                      A076044    001    Apr   05,   2002
          SCHERING
	            10MEQ                                      N019439    002    Jun   13,   1986
                                20MEQ                                      N019439    001    Jun   13,   1986
   SLOW-K
	
          NOVARTIS
	            8MEQ                                       N017476 002
   TEN-K
	
          NOVARTIS
	            10MEQ                                      N019381 001 Apr 16, 1986
POTASSIUM CHLORIDE; SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                37MG/100ML;900MG/100ML                      N019708   001 Sep 29, 1989

    POTASSIUM CHLORIDE 0.075% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                75MG/100ML;900MG/100ML                      N019708   002 Sep 29, 1989

    POTASSIUM CHLORIDE 0.11% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                110MG/100ML;900MG/100ML                     N019708   003 Sep 29, 1989

    POTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                220MG/100ML;900MG/100ML                     N019708   005 Sep 29, 1989

    POTASSIUM CHLORIDE 0.3% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         B BRAUN                300MG/100ML;900MG/100ML                     N019708   006 Sep 29, 1989

    SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
	
         B BRAUN                75MG/100ML;900MG/100ML                      N018722   001 Nov 09, 1982
	
         BAXTER HLTHCARE        75MG/100ML;900MG/100ML                      N017648   004
	
    SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
	
         B BRAUN                150MG/100ML;900MG/100ML                     N018722   002 Nov 09, 1982
	
    SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER
	
         B BRAUN                220MG/100ML;900MG/100ML                     N018722   003 Nov 09, 1982
	
    SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
	
         B BRAUN                300MG/100ML;900MG/100ML                     N018722   004 Nov 09, 1982
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                6-267(of 337)


POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE
	
  INJECTABLE;INJECTION
	
    THAM-E
         HOSPIRA                370MG/VIAL;1.75GM/VIAL;36GM/VIAL          N013025 001
POTASSIUM CITRATE
  FOR SOLUTION;ORAL
    POTASSIUM CITRATE
         UT SW MEDCTR           10MEQ/PACKET **Federal Register           N019647 002 Oct 13, 1988
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
                                20MEQ/PACKET **Federal Register           N019647 001 Oct 13, 1988
                                determination that product was not
                                discontinued or withdrawn for safety or
                                efficacy reasons**
POTASSIUM IODIDE
  SOLUTION;ORAL
    POTASSIUM IODIDE
         ROXANE                 1GM/ML                                    N018551 001 Feb 19, 1982
  TABLET;ORAL
    THYRO-BLOCK
         MEDPOINTE PHARM HLC    130MG                                     N018307 001
POTASSIUM PERCHLORATE
  CAPSULE;ORAL
    PERCHLORACAP
         MALLINCKRODT           200MG                                     N017551 001
POVIDONE-IODINE
  SOLUTION;TOPICAL
    E-Z PREP
         CLINIPAD               10%                                       N019382 001 Jul 25, 1989
  SPONGE;TOPICAL
    E-Z PREP
         CLINIPAD               5%                                        N019382 002 Jul 25, 1989
    E-Z PREP 220
         CLINIPAD               5%                                        N019382 003 Jul 25, 1989
PRALIDOXIME CHLORIDE
  INJECTABLE;INJECTION
    PRALIDOXIME CHLORIDE
         BAXTER HLTHCARE CORP   300MG/ML                                  N018799 001 Dec 13, 1982
  TABLET;ORAL
    PROTOPAM CHLORIDE
         WYETH AYERST           500MG                                     N014122 002
PRAMIPEXOLE DIHYDROCHLORIDE
  TABLET;ORAL
    MIRAPEX
         BOEHRINGER INGELHEIM   1.25MG                                    N020667 004 Jul 01, 1997
    PRAMIPEXOLE DIHYDROCHLORIDE
         WATSON LABS            0.125MG                                   A078551   001    Oct   08,   2010
                                0.25MG                                    A078551   002    Oct   08,   2010
                                0.5MG                                     A078551   003    Oct   08,   2010
                                1MG                                       A078551   004    Oct   08,   2010
                                1.5MG                                     A078551   005    Oct   08,   2010
PRAMLINTIDE ACETATE
  INJECTABLE;SUBCUTANEOUS
    SYMLIN
         ASTRAZENECA AB         EQ 3MG BASE/5ML (EQ 600MCG BASE/ML)       N021332 001 Mar 16, 2005
PRAVASTATIN SODIUM
  TABLET;ORAL
    PRAVACHOL
         BRISTOL MYERS SQUIBB   10MG                                      N019898 002 Oct 31, 1991
    PRAVASTATIN SODIUM
         PLIVA HRVATSKA DOO     10MG                                      A077730   001    Nov   21,   2006
                                20MG                                      A077730   002    Nov   21,   2006
                                30MG                                      A077730   003    Nov   21,   2006
                                40MG                                      A077730   005    Nov   21,   2006
        RANBAXY LABS LTD        10MG                                      A076445   001    Apr   23,   2007
                                20MG                                      A076445   002    Apr   23,   2007
                                40MG                                      A076445   003    Apr   23,   2007
                                80MG                                      A076445   004    Apr   23,   2007
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-268(of 337)


PRAZEPAM
	
  CAPSULE;ORAL
	
    CENTRAX
	
          PARKE DAVIS		         5MG                               N018144 001
	
                                10MG                              N018144 002
	
                                20MG                              N018144 003 May 10, 1982

    PRAZEPAM
	
         USL PHARMA             5MG                               A070427 001 Nov 06, 1987
	
                                10MG                              A070428 001 Nov 06, 1987
	
  TABLET;ORAL
	
    CENTRAX
	
         PARKE DAVIS            10MG                              N017415 001
	
PRAZOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    PRAZOSIN HYDROCHLORIDE
	
         AM THERAP		             EQ 1MG   BASE                    A072782   001     May   16,   1989

                                 EQ 2MG   BASE                    A072783   001     May   16,   1989

                                 EQ 5MG   BASE                    A072784   001     May   16,   1989

         DAVA PHARMS INC		       EQ 1MG   BASE                    A072705   001     May   16,   1989

                                 EQ 2MG   BASE                    A072706   001     May   16,   1989

                                 EQ 5MG   BASE                    A072707   001     May   16,   1989

         PUREPAC PHARM		         EQ 1MG   BASE                    A072991   001     May   16,   1989

                                 EQ 2MG   BASE                    A072921   001     May   16,   1989

                                 EQ 5MG   BASE                    A072992   001     May   16,   1989

         SANDOZ		                EQ 1MG   BASE                    A072576   001     May   16,   1989

                                 EQ 2MG   BASE                    A072577   001     May   16,   1989

                                 EQ 5MG   BASE                    A072578   001     May   16,   1989

         WATSON LABS		           EQ 1MG   BASE                    A072352   001     May   16,   1989

                                 EQ 2MG   BASE                    A072333   001     May   16,   1989

                                 EQ 5MG   BASE                    A072609   001     May   16,   1989

  TABLET, EXTENDED RELEASE;ORAL
	
    MINIPRESS XL
	
         PFIZER                  2.5MG                            N019775 001 Jan 29, 1992
	
                                 5MG                              N019775 002 Jan 29, 1992
	
PREDNISOLONE
	
  CREAM;TOPICAL
	
    METI-DERM
	
         SCHERING               0.5%                              N010209 002
	
  SYRUP;ORAL
	
    PREDNISOLONE
	
         APOTEX INC             5MG/5ML                           A040570   001     Aug   25,   2005

                                15MG/5ML                          A040571   001     Aug   25,   2005

         IVAX SUB TEVA PHARMS   15MG/5ML                          A040287   001     May   28,   1999

         NESHER PHARMS          5MG/5ML                           A040423   001     Oct   22,   2001
	
                                15MG/5ML                          A040364   001     Apr   10,   2002

         TEVA PHARMS            15MG/5ML                          A040322   001     Jan   19,   2000
	
         WE PHARMS              15MG/5ML                          A040192   001     May   28,   1998

    PRELONE
	
         MURO                   5MG/5ML                           A089654 001 Jan 17, 1989
	
  TABLET;ORAL
	
    CORTALONE
	
         HALSEY		               1MG                               A080304 003
	
                                2.5MG                             A080304 002
	
                                5MG                               A080304 001
	
    DELTA-CORTEF
	
         PHARMACIA AND UPJOHN   5MG                               N009987 004
	
    FERNISOLONE-P
	
         FERNDALE LABS          5MG                               A083941 001
	
    PREDNISOLONE
	
         BARR                   5MG                               A084426   002
	
         BUNDY                  5MG                               A083675   001
	
         ELKINS SINN            5MG                               A080625   001
	
         EVERYLIFE              1MG                               A084439   001
	
                                2.5MG                             A084439   002
	
                                5MG                               A084439   003
	
         FERRANTE               2.5MG                             A080562   001
	
                                5MG                               A080562   002
	
         HEATHER                5MG                               A080326   001
	
         IMPAX LABS             5MG                               A080780   001
	
         INWOOD LABS            5MG                               A080748   001
	
         IVAX SUB TEVA PHARMS   5MG                               A080378   001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                  6-269(of 337)


PREDNISOLONE
	
  TABLET;ORAL
	
    PREDNISOLONE
	
         LANNETT
	               5MG
	                           A080531   002
	
         MARSHALL PHARMA
	       5MG
	                           A080307   001
	
         PANRAY
	                1MG
	                           A080351   001
	
                                 5MG
	                           A080351   002
	
         PERRIGO
	               5MG
	                           A084542   001
	
         PHOENIX LABS NY
	       5MG
	                           A080322   001
	
         PUREPAC PHARM
	         5MG
	                           A080325   001
	
         PVT FORM
	              5MG
	                           A080211   001
	
         ROXANE
	                5MG
	                           A080327   002
	
         SANDOZ
	                5MG
	                           A080339   001
	
                                 5MG
	                           A084773   001
	
         SPERTI
	                1MG
	                           A080358   001
	
                                 2.5MG
	                         A080358   002
	
                                 5MG
	                           A080358   003
	
         SUPERPHARM
	            5MG
	                           A088892   001 Feb 26, 1985
	
         TABLICAPS
	             5MG
	                           A085170   001
	
         TEVA
	                  5MG
	                           A080398   001
	
         UDL
	                   5MG
	                           A087987   001 Jan 18, 1983
	
         VALEANT PHARM INTL
	    5MG
	                           A080236   001
	
         VITARINE
	              5MG
	                           A080534   001
	
         WATSON LABS
	           5MG
	                           A085085   002
	
                                 5MG
	                           A085415   001
	
                                 5MG
	                           A085416   001
	
        WEST WARD
	              5MG
	                           A080324   001
	
        WHITEWORTH TOWN PLSN
	   5MG
	                           A080342   001
	
   STERANE
	
        PFIZER
	                 5MG
	                           N009996 001
	
PREDNISOLONE ACETATE
	
  INJECTABLE;INJECTION
	
    METICORTELONE
	
         SCHERING
	              25MG/ML
	                       N010255 002
	
    PREDNISOLONE ACETATE
	
         AKORN
	                 25MG/ML
                        A083032   001
	
                                 50MG/ML
                        A084492   001
	
         BEL MAR
	               25MG/ML
                        A083738   001
	
                                 50MG/ML
                        A083738   002
	
         CENT PHARMS
	           25MG/ML
                        A084717   001
	
                                 50MG/ML
                        A084717   002
	
         WATSON LABS
	           25MG/ML
                        A083398   001
	
                                 25MG/ML
                        A083654   001
	
                                 40MG/ML
                        A083767   001
	
                                 50MG/ML
                        A083764   001
	
                                 50MG/ML
	                       A085781   001
	
   STERANE
	
        PFIZER
	                 25MG/ML
	                       N011446 001
	
 SUSPENSION;ORAL
	
   FLO-PRED
	
        TARO
	                   EQ 5MG BASE/5ML
	               N022067 001 Jan 17, 2008
	
 SUSPENSION/DROPS;OPHTHALMIC

   ECONOPRED
	
        ALCON
	                  0.125%
	                        N017468 001
	
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
	
  OINTMENT;OPHTHALMIC
	
    CETAPRED
	
         ALCON
	                0.25%;10%
	                      A087771 001 Aug 06, 1993
	
    METIMYD
	
         SCHERING
	             0.5%;10%
	                       N010210 002 Sep 09, 1984
	
    PREDSULFAIR
	
         PHARMAFAIR
	           0.5%;10%
	                       A088032 001 Apr 15, 1983
	
    VASOCIDIN
	
         NOVARTIS
	             0.5%;10%
	                       A088791 001 Oct 05, 1984
	
  SUSPENSION;OPHTHALMIC
	
    ISOPTO CETAPRED
	
         ALCON
	                0.25%;10%
	                      A087547 001
	
  SUSPENSION/DROPS;OPHTHALMIC

    METIMYD
	
         SCHERING
	             0.5%;10%
	                       N010210 001
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                     6-270(of 337)


PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
	
  SUSPENSION/DROPS;OPHTHALMIC

    PREDAMIDE
	
         AKORN
	                0.5%;10%
	                         A088059 001 Jul 29, 1983
	
    PREDSULFAIR
	
         PHARMAFAIR
	           0.5%;10%
	                         A088007 001 Apr 19, 1983
	
    PREDSULFAIR II
	
         PHARMAFAIR
	           0.2%;10%
	                         A088837 001 Dec 24, 1985
	
    SULPHRIN
	
         BAUSCH AND LOMB
	      0.5%;10%
	                         A088089 001 Dec 28, 1982
	
PREDNISOLONE SODIUM PHOSPHATE
	
  INJECTABLE;INJECTION
	
    HYDELTRASOL
	
         MERCK
	                EQ    20MG PHOSPHATE/ML
	          N011583 002
	
    PREDNISOLONE SODIUM PHOSPHATE
	
         WATSON LABS            EQ    20MG PHOSPHATE/ML
           A080517 001
	
  OINTMENT;OPHTHALMIC, OTIC
	
    HYDELTRASOL
	
         MERCK                  EQ    0.25% PHOSPHATE
	            N011028 001
	
  SOLUTION;ORAL
	
    PREDNISOLONE SODIUM PHOSPHATE
	
         MEDICIS PHARMS
	       EQ    15MG BASE/5ML
               A075250   001    Jul   12,   2002
	
         NESHER PHARMS
	        EQ    5MG BASE/5ML
                A076982   001    May   24,   2005

                                EQ    15MG BASE/5ML
               A076988   001    May   24,   2005

         PHARM ASSOC
	          EQ    5MG BASE/5ML
                A076123   001    Dec   23,   2002
	
         VINTAGE PHARMS
	       EQ    5MG BASE/5ML
                A078416   001    Oct   31,   2007
	
         WE PHARMS
	            EQ    5MG BASE/5ML
	               A075181   001    Dec   23,   2002
	
  SOLUTION/DROPS;OPHTHALMIC

    INFLAMASE FORTE
	
         NOVARTIS
	             EQ    0.9% PHOSPHATE
	             A080751 002
	
    INFLAMASE MILD
	
         NOVARTIS
	             EQ    0.11% PHOSPHATE
	            A080751 001
	
    METRETON
	
         SCHERING
	             EQ    0.5% PHOSPHATE
	             A083834 001
	
    PREDAIR
	
         PHARMAFAIR
	           EQ    0.11% PHOSPHATE
	            A088415 001 Feb 29, 1984
	
    PREDAIR FORTE
	
         PHARMAFAIR
	           EQ    0.9% PHOSPHATE
	             A088165 001 Mar 28, 1983
	
    PREDNISOLONE SODIUM PHOSPHATE
	
         AKORN
	                EQ    0.11% PHOSPHATE
	            A083358   001
	
                                EQ    0.9% PHOSPHATE
	             A083358   002
	
         ALCON PHARMS LTD
	     EQ    0.11% PHOSPHATE
	            A081043   001 Oct 24, 1991
	
                                EQ    0.9% PHOSPHATE
	             A081044   001 Oct 24, 1991
	
         BAUSCH AND LOMB
	      EQ    0.11% PHOSPHATE
	            A040065   001 Jul 29, 1994
	
         SOLA BARNES HIND
	     EQ    0.11% PHOSPHATE
	            A084171   001
	
                                EQ    0.9% PHOSPHATE
	             A084168   001
	
                                EQ    0.9% PHOSPHATE
	             A084169   001
	
                                EQ    0.9% PHOSPHATE
	             A084172   001
	
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
	
  SOLUTION/DROPS;OPHTHALMIC

    SULSTER
	
         AKORN
	                EQ 0.23% PHOSPHATE;10%
	           A074511 001 Jul 30, 1996
	
    VASOCIDIN
	
         NOVARTIS
	             EQ 0.23% PHOSPHATE;10%
	           N018988 001 Aug 26, 1988
	
PREDNISOLONE TEBUTATE
	
  INJECTABLE;INJECTION
	
    HYDELTRA-TBA
	
         MERCK
	                 20MG/ML
	                         N010562 001
	
    PREDNISOLONE TEBUTATE
	
         WATSON LABS
	           20MG/ML
	                         A083362 001 Feb 17, 1984
	
PREDNISONE
	
  SOLUTION;ORAL
	
    PREDNISONE
	
         WOCKHARDT
	             5MG/5ML
	                         A089726 001 Aug 02, 1988
	
  SYRUP;ORAL
	
    LIQUID PRED
	
         MURO
	                  5MG/5ML
	                         A087611 002 Sep 07, 1982
	
  TABLET;ORAL
	
    CORTAN
	
         HALSEY
	                20MG
	                            A087480 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                   6-271(of 337)


PREDNISONE
	
  TABLET;ORAL
	
    DELTA-DOME
	
         BAYER PHARMS           5MG
	                           A080293 001
	
    DELTASONE
	
         PHARMACIA AND UPJOHN   2.5MG
	                         N009986   005
	
                                5MG
	                           N009986   002
	
                                10MG
	                          N009986   006
	
                                20MG
	                          N009986   007
	
                                50MG
	                          N009986   008
	
   FERNISONE
	
        FERNDALE LABS           5MG
	                           A083364 001
	
   METICORTEN
	
        SCHERING                1MG
	                           N009766 002
	
                                5MG
	                           N009766 001
	
   ORASONE
	
        SOLVAY                  1MG
	                           A083009   001
	
                                5MG
	                           A083009   002
	
                                10MG
	                          A083009   003
	
                                20MG
	                          A083009   004
	
                                50MG
	                          A085999   001
	
   PARACORT
	
        PARKE DAVIS             5MG
	                           N010962 002
	
   PREDNICEN-M
	
        SCHWARZ PHARMA          5MG
	                           A084655 001
	
   PREDNISONE
	
        AM THERAP               5MG
	                           A089387   001     Nov   06,   1986
	
                                10MG
	                          A089388   001     Nov   06,   1986
	
                                20MG
	                          A089389   001     Nov   06,   1986
	
        AMNEAL PHARMS NY        5MG
	                           A089597   001     Oct   05,   1987
	
                                10MG
	                          A089598   001     Oct   05,   1987
	
                                20MG
	                          A089599   001     Oct   05,   1987
	
        BUNDY                   5MG
	                           A083676   001
	
        DURAMED PHARMS BARR     5MG
	                           A088394   001     Oct 04, 1983
	
                                10MG
	                          A088395   001     Oct 04, 1983
	
                                20MG
	                          A088396   001     Oct 04, 1983
	
        ELKINS SINN             5MG
	                           A080491   001
	
                                20MG
	                          A085811   001
	
        EVERYLIFE               1MG
	                           A084440   001
	
                                2.5MG
	                         A084440   002
	
                                5MG
	                           A084440   003
	
        FERRANTE                2.5MG
	                         A080563   001
	
                                5MG
	                           A080563   002
	
        HALSEY                  5MG
	                           A080300   001
	
        HEATHER                 5MG
	                           A080320   001
	
                                10MG
	                          A084341   001
	
                                20MG
	                          A084417   001
	
                                20MG
	                          A085543   001
	
                                50MG
	                          A086946   001
	
        IMPAX LABS              5MG
	                           A080782   001
	
        INWOOD LABS             1MG
	                           A080328   001
	
                                2.5MG
	                         A080306   001
	
                                5MG
	                           A080279   001
	
        IVAX SUB TEVA PHARMS    5MG
	                           A080283   001
	
                                10MG
	                          A084133   001
	
                                20MG
	                          A084134   001
	
        KV PHARM                5MG
	                           A084236   001
	
        LANNETT                 5MG
	                           A080514   001
	
                                20MG
	                          A084275   001
	
        LEDERLE                 5MG
	                           A086968   001
	
        MARSHALL PHARMA         5MG
	                           A080301   001
	
        MUTUAL PHARM            5MG
	                           A080701   001
	
                                10MG
	                          A086595   001
	
                                20MG
	                          A084634   001
	
                                50MG
	                          A086596   001
	
        NYLOS                   5MG
	                           A085115   001
	
        PANRAY                  1MG
	                           A080350   001
	
                                2.5MG
	                         A080350   002
	
                                5MG
	                           A080350   003
	
        PERRIGO                 5MG
	                           A083059   001
	
        PHARMAVITE              5MG
	                           A084662   002
	
        PHOENIX LABS NY         5MG
	                           A080321   001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                  6-272(of 337)


PREDNISONE
	
  TABLET;ORAL
	
    PREDNISONE
	
                                  20MG
	                          A083807   001
	
         PUREPAC PHARM
	          5MG
	                           A080353   001
	
                                  10MG
	                          A086062   001
	
                                  20MG
	                          A086061   001
	
         PVT FORM
	               20MG
	                          A085151   001
	
         REXALL
	                 5MG
	                           A080232   001
	
         ROXANE
	                 20MG
	                          N017109   001
	
                                  25MG
	                          A087833   001     May 04, 1982

         SANDOZ
	                 5MG
	                           A080336   002
	
                                  5MG
	                           A084774   001
	
                                  10MG
	                          A089983   001     Jan 12, 1989
	
                                  20MG
	                          A085813   001
	
                                  50MG
	                          A089984   001     Jan 12, 1989
	
         SCHERER LABS
	           5MG
	                           A080371   001
	
         SPERTI
	                 1MG
	                           A080359   001
	
                                  2.5MG
	                         A080359   002
	
                                  5MG
	                           A080359   003
	
         SUPERPHARM
	             5MG
	                           A088865   001     Oct 25, 1984
	
                                  10MG
	                          A088866   001     Oct 25, 1984
	
                                  20MG
	                          A088867   001     Oct 25, 1984
	
         TEVA
	                   5MG
	                           A080397   001
	
         UDL
	                    5MG
	                           A087984   001     Jan 18, 1983
	
                                  10MG
	                          A087985   001     Jan 18, 1983
	
                                  20MG
	                          A087986   001     Jan 18, 1983
	
         UPSHER SMITH
	           5MG
	                           A087471   001
	
                                  20MG
	                          A087470   001
	
         VALEANT PHARM INTL
	     5MG
	                           A080237   001
	
         VANGARD
	                5MG
	                           A087682   001     Jan 15, 1982
	
                                  20MG
	                          A087701   001     Jan 15, 1982
	
         VITARINE
	               5MG
	                           A080334   001
	
                                  5MG
	                           A080506   001
	
         WATSON LABS
	            5MG
	                           A085084   002
	
                                  10MG
	                          A087773   001     Jul 13, 1982
	
                                  20MG
	                          A086813   001
	
                                  50MG
	                          A086867   001
	
                                  50MG
	                          A087772   001     Jul 13, 1982
	
         WHITEWORTH TOWN PLSN
	   2.5MG
	                         A084913   001
	
                                  5MG
	                           A080343   001
	
                                  10MG
	                          A089028   001     Jul 24, 1986
	
                                  20MG
	                          A084913   002
	
    SERVISONE
	
         LEDERLE
	                5MG
	                           A080223 001
	
PRILOCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CITANEST
	
         ASTRAZENECA
	            1%
	                            N014763 004
	
                                  2%
	                            N014763 005
	
                                  3%
	                            N014763 003
	
    CITANEST PLAIN
	
         ASTRAZENECA
	            4%
	                            N014763 007
	
    CITANEST PLAIN DENTAL
	
         DENTSPLY PHARM
	         4%
	                            N021382 001
	
PRIMIDONE
	
  SUSPENSION;ORAL
	
    MYSOLINE
	
         NURO PHARMA
	            250MG/5ML
	                     N010401 001
	
  TABLET;ORAL
	
    PRIMIDONE
	
         DR REDDYS LABS LTD
	     50MG
	                          A040862   001 Oct 03, 2008
	
                                  250MG
	                         A040862   002 Oct 03, 2008
	
         HIKMA PHARMS LLC
	       50MG
	                          A040667   001 Jul 27, 2006
	
         WATSON LABS
	            250MG
	                         A085052   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                    6-273(of 337)


PROBENECID
	
  TABLET;ORAL
	
    BENEMID
	
         MERCK
	                  500MG
	                       N007898 004
	
    PROBENECID
	
         IVAX SUB TEVA PHARMS
	   500MG
	                       A083740 001 May 09, 1984

         LEDERLE
	                500MG
	                       A086917 001
	
         WATSON LABS
	            500MG
	                       A086150 002 Apr 23, 1982
	
PROBUCOL
	
  TABLET;ORAL
	
    LORELCO
	
          SANOFI AVENTIS US
	     250MG
	                       N017535 001
	
                                  500MG
	                       N017535 002 Jul 06, 1988
	
PROCAINAMIDE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    PROCAINAMIDE HYDROCHLORIDE
	
         ASCOT
	                 250MG
	                        A087542   001     Jan 08, 1982
	
                                 375MG
	                        A087697   001     Mar 01, 1983
	
                                 500MG
	                        A087543   001     Jan 08, 1982
	
         IVAX SUB TEVA PHARMS
	 250MG
	                         A084604   001
	
                                 375MG
	                        A084595   001
	
                                 500MG
	                        A084606   001
	
         LANNETT
	               250MG
	                        A083693   001
	
                                 500MG
	                        A084696   001
	
         LEDERLE
	               250MG
	                        A086942   001
	
                                 375MG
	                        A086952   001
	
                                 500MG
	                        A086943   001
	
         ROXANE
	                250MG
	                        A088989   001     Apr   26,   1985

                                 500MG
	                        A088990   001     Apr   26,   1985

         SANDOZ
	                250MG
	                        A089219   001     Jul   01,   1986
	
                                 375MG
	                        A089220   001     Jul   01,   1986
	
                                 500MG
	                        A089221   001     Jul   01,   1986
	
         VANGARD
	               250MG
	                        A087643   001     Jun   01,   1982
	
                                 500MG
	                        A087875   001     Jun   01,   1982
	
         WATSON LABS
	           250MG
	                        A083287   001
	
                                 250MG
	                        A083795   001
	
                                 250MG
	                        A085167   001
	
                                 375MG
	                        A084403   001
	
                                 375MG
	                        A087020   001
	
                                 500MG
	                        A084280   001
	
                                 500MG
	                        A084357   001
	
                                 500MG
	                        A087021   001
	
    PROCAN
	
         PARKE DAVIS
	           250MG
	                        A085804 001
	
                                 375MG
	                        A087502 001
	
                                 500MG
	                        A085079 001
	
    PROCAPAN
	
         PANRAY
	                250MG
	                        A083553 002
	
    PRONESTYL
	
         APOTHECON
	             250MG
	                        N007335 001
	
                                 375MG
	                        N007335 004
	
                                 500MG
	                        N007335 003
	
  INJECTABLE;INJECTION
	
    PROCAINAMIDE HYDROCHLORIDE
	
         ABRAXIS PHARM
	         100MG/ML
                      A089415   001     Nov   17,   1986
	
                                 500MG/ML
                      A089416   001     Nov   17,   1986
	
         HIKMA MAPLE
	           100MG/ML
                      A089029   001     Apr   17,   1986

                                 500MG/ML
                      A089030   001     Apr   17,   1986

         HOSPIRA
	               500MG/ML
                      A089537   001     Aug   25,   1987

         INTL MEDICATION
	       100MG/ML
                      A088636   001     Jul   31,   1984
	
                                 500MG/ML
                      A088637   001     Jul   31,   1984
	
         PHARMAFAIR
	            100MG/ML
                      A088824   001     Nov   20,   1985
	
                                 500MG/ML
                      A088830   001     Nov   20,   1985
	
         SMITH AND NEPHEW
	      100MG/ML
                      A088530   001     Mar   04,   1985
	
                                 500MG/ML
                      A088531   001     Mar   04,   1985
	
         SOLOPAK
	               500MG/ML
                      A088532   001     Mar   04,   1985
	
         WARNER CHILCOTT
	       100MG/ML
                      A089528   001     May   03,   1988

                                 500MG/ML
                      A089529   001     May   03,   1988

         WATSON LABS
	           100MG/ML
                      A087079   001
	
                                 500MG/ML
	                     A087080   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                     6-274(of 337)


PROCAINAMIDE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PRONESTYL
	
         APOTHECON              100MG/ML
                       N007335 002
	
                                500MG/ML
                       N007335 005
	
 TABLET;ORAL
	
   PRONESTYL
	
        APOTHECON               250MG
	                         N017371 001
	
                                375MG
	                         N017371 002
	
                                500MG
	                         N017371 003
	
 TABLET, EXTENDED RELEASE;ORAL
	
   PROCAINAMIDE HYDROCHLORIDE
	
        ANI PHARMS INC          1GM
	                           A040111   001     Dec   13,   1996
	
                                250MG
	                         A088958   001     Dec   02,   1985
	
                                500MG
	                         A088959   001     Dec   02,   1985
	
                                500MG
	                         A088974   001     Jul   22,   1985
	
                                750MG
	                         A089438   001     Mar   23,   1987
	
        INWOOD LABS             500MG
	                         A089840   001     Mar   06,   1989
	
        SANDOZ                  250MG
	                         A089369   001     Aug   14,   1987

                                500MG
	                         A089284   001     Jun   23,   1986
	
                                500MG
	                         A089370   001     Jan   09,   1987
	
                                750MG
	                         A089371   001     Aug   14,   1987

        WATSON LABS             1GM
	                           A089520   001     Jan   15,   1987
	
                                250MG
	                         A088533   001     Dec   03,   1984
	
                                250MG
	                         A089026   001     Oct   22,   1985
	
                                500MG
	                         A088534   001     Dec   03,   1984
	
                                500MG
	                         A089027   001     Oct   22,   1985
	
                                750MG
	                         A088535   001     Nov   03,   1984
	
                                750MG
	                         A089042   001     Oct   22,   1985
	
   PROCAN SR
	
        PARKE DAVIS             250MG
	                         A086468   001
	
        PARKEDALE               1GM
	                           A088489   001 Jan 16, 1985
	
                                500MG
	                         A086065   001
	
                                750MG
	                         A087510   001 Apr 01, 1982
	
   PROCANBID
	
        KING PHARMS             1GM
	                           N020545 002 Jan 31, 1996
	
                                500MG
	                         N020545 001 Jan 31, 1996
	
   PRONESTYL-SR
	
        APOTHECON               500MG
	                         A087361 001
	
PROCAINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    NOVOCAIN
	
         HOSPIRA                1%
	                            A085362 003
	
                                2%
	                            A085362 004
	
                                10%
	                           A086797 001
	
   PROCAINE HYDROCHLORIDE
	
        ABRAXIS PHARM           1%
	                            A080384   002
	
                                1%
	                            A080421   001
	
                                2%
	                            A080384   003
	
                                2%
	                            A080421   002
	
         BEL MAR                1%
	                            A080711   001
	
                                2%
	                            A080756   001
	
         ELKINS SINN            1%
	                            A083315   001
	
                                2%
	                            A083315   002
	
         GD SEARLE LLC          1%
	                            A086202   001
	
                                2%
	                            A086202   002
	
         HOSPIRA                1%
	                            A080416   001
	
                                2%
	                            A080416   002
	
         MILES                  1%
	                            A080415   001
	
                                2%
	                            A080415   002
	
         WATSON LABS            1%
	                            A080658   001
	
                                1%
	                            A083535   001
	
                                2%
	                            A080658   002
	
                                2%
	                            A083535   002
	
PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    ACHROMYCIN
	
         LEDERLE                40MG/VIAL;100MG/VIAL
           N050276 001
	
                                40MG/VIAL;250MG/VIAL
           N050276 003
	
    TETRACYN
	
         PFIZER                 40MG/VIAL;100MG/VIAL
	          A060285 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                   6-275(of 337)


PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    TETRACYN
	
                                40MG/VIAL;250MG/VIAL
	          A060285 003
	
PROCAINE MERETHOXYLLINE; THEOPHYLLINE
	
  INJECTABLE;INJECTION
	
    DICURIN PROCAINE
	
         LILLY
	                100MG/ML;50MG/ML
	              N008869 001
	
PROCHLORPERAZINE
	
  SUPPOSITORY;RECTAL
	
    COMPAZINE
	
         GLAXOSMITHKLINE
	         2.5MG
	                      N011127 003
	
                                   5MG
	                        N011127 001
	
                                   25MG
	                       N011127 002
	
   PROCHLORPERAZINE
	
        ABLE
	                     2.5MG
	                      A040407 001 Jul 11, 2001
	
                                   5MG
	                        A040407 002 Jul 11, 2001
	
                                   25MG
	                       A040407 003 Jul 11, 2001
	
PROCHLORPERAZINE EDISYLATE
	
  CONCENTRATE;ORAL
	
    COMPAZINE
	
         GLAXOSMITHKLINE
	         EQ 10MG BASE/ML
	            N011276 001
	
    PROCHLORPERAZINE
	
         ALPHARMA US PHARMS
	      EQ 10MG BASE/ML
	            A087153 001 Jun 08, 1982
	
    PROCHLORPERAZINE EDISYLATE
	
         MORTON GROVE
	            EQ 10MG BASE/ML
	            A088598 001 Oct 25, 1984
	
  INJECTABLE;INJECTION
	
    COMPAZINE
	
         GLAXOSMITHKLINE
	         EQ 5MG BASE/ML
	             N010742 002
	
    PROCHLORPERAZINE
	
         BAXTER HLTHCARE
	         EQ 5MG BASE/ML
	             A087759 001 Oct 01, 1982
	
    PROCHLORPERAZINE EDISYLATE
	
         HIKMA MAPLE
	             EQ   5MG   BASE/ML
          A089523   001     May   03,   1988

         HOSPIRA
	                 EQ   5MG   BASE/ML
          A089703   001     Apr   07,   1988

         MARSAM PHARMS LLC
	       EQ   5MG   BASE/ML
          A089675   001     Dec   05,   1988
	
         SMITH AND NEPHEW
	        EQ   5MG   BASE/ML
          A089251   001     Dec   04,   1986
	
         TEVA PARENTERAL
	         EQ   5MG   BASE/ML
          A040505   001     May   30,   2003

         WATSON LABS
	             EQ   5MG   BASE/ML
          A089530   001     Jul   08,   1987
	
                                   EQ   5MG   BASE/ML
          A089605   001     Jul   08,   1987
	
                                   EQ   5MG   BASE/ML
          A089606   001     Jul   08,   1987
	
        WYETH AYERST
	             EQ   5MG   BASE/ML
	         A086348   001
	
 SYRUP;ORAL
	
   COMPAZINE
	
        GLAXOSMITHKLINE
	       EQ 5MG BASE/5ML
	               N011188 001
	
   PROCHLORPERAZINE EDISYLATE
	
        ALPHARMA US PHARMS
	    EQ 5MG BASE/5ML
                A087154 001 Sep 01, 1982

        MORTON GROVE
	          EQ 5MG BASE/5ML
	               A088597 001 Oct 25, 1984
	
PROCHLORPERAZINE MALEATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    COMPAZINE
	
         GLAXOSMITHKLINE
	      EQ      10MG   BASE
	           N011000   001
	
                                EQ      10MG   BASE
	           N021019   001 Oct 06, 1999
	
                                EQ      15MG   BASE
	           N011000   002
	
                                EQ      15MG   BASE
	           N021019   002 Oct 06, 1999
	
                                EQ      30MG   BASE
	           N011000   003
	
                                EQ      75MG   BASE
	           N011000   004
	
  TABLET;ORAL
	
    COMPAZINE
	
         GLAXOSMITHKLINE
	      EQ      5MG BASE
	              N010571 001
	
                                EQ      10MG BASE
	             N010571 002
	
                                EQ      25MG BASE
	             N010571 003
	
    PROCHLORPERAZINE
	
         WATSON LABS
	          EQ      5MG BASE
	              A085580 001
	
                                EQ      10MG BASE
	             A085178 001
	
                                EQ      25MG BASE
	             A085579 001
	
    PROCHLORPERAZINE MALEATE
	
         DURAMED PHARMS BARR
	  EQ      5MG BASE
	              A040207   001     May   01,   1997

                                EQ      5MG BASE
	              A089484   001     Jan   20,   1987
	
                                EQ      10MG BASE
	             A040207   002     May   01,   1997

                                EQ      10MG BASE
	             A089485   001     Jan   20,   1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                      6-276(of 337)


PROCHLORPERAZINE MALEATE
	
  TABLET;ORAL
	
    PROCHLORPERAZINE MALEATE
	
                                  EQ   25MG BASE                A089486   001    Jan   20,   1987
	
         IVAX SUB TEVA PHARMS
	   EQ   5MG BASE                 A040162   001    Jan   20,   1998
	
                                  EQ   10MG BASE                A040162   002    Jan   20,   1998
	
         SANDOZ
	                 EQ   25MG BASE                A040101   003    Jul   19,   1996
	
PROCYCLIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    KEMADRIN
	
         MONARCH PHARMS
	         2MG                           N009818 005
	
                                  5MG                           N009818 003
	
PROGESTERONE
	
  CAPSULE;ORAL
	
    PROMETRIUM
	
         ABBVIE INC
	             300MG                         N019781 003 Oct 15, 1999
	
  INJECTABLE;INJECTION
	
    PROGESTERONE
	
         LILLY
	               25MG/ML                          N009238 002
	
                               50MG/ML                          N009238 001
	
 INSERT, EXTENDED RELEASE;INTRAUTERINE
	
   PROGESTASERT
	
        ALZA
	                 38MG                             N017553 001
PROMAZINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    SPARINE
	
         WYETH AYERST
	           30MG/ML                       N010942 001
                                  100MG/ML                      N010942 004
 INJECTABLE;INJECTION
	
   PROMAZINE HYDROCHLORIDE
	
        WATSON LABS
	             25MG/ML                       A084510 001
                                  50MG/ML                       A084517 001
   SPARINE
	
        BAXTER HLTHCARE CORP
	    25MG/ML                       N010349 008
                                  50MG/ML                       N010349 006
 SYRUP;ORAL
	
   SPARINE
	
        WYETH AYERST
	            10MG/5ML                      N010942 003
 TABLET;ORAL
	
   SPARINE
	
        WYETH AYERST
	            10MG                          N010348   006
                                  25MG                          N010348   001
                                  50MG                          N010348   002
                                  100MG                         N010348   003
                                  200MG                         N010348   004
PROMETHAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PHENERGAN
	
         WYETH AYERST
	           25MG/ML                       N008857 002
                                  50MG/ML                       N008857 003
   PROMETHAZINE HYDROCHLORIDE
	
        ABBOTT
	                25MG/ML                         A084223   001
                                50MG/ML                         A084222   001
        AKORN
	                 25MG/ML                         A083955   002
                                50MG/ML                         A083955   001
        BEDFORD LABS
	          25MG/ML                         A040524   001    Mar   17,   2004
                                50MG/ML                         A040524   002    Mar   17,   2004
        HOSPIRA
	               25MG/ML                         A040372   001    Jun   08,   2000
                                50MG/ML                         A040372   002    Jun   08,   2000
                                50MG/ML                         A083838   002
        LUITPOLD
	              25MG/ML                         A040515   001    Mar   19,   2003
        MARSAM PHARMS LLC
	     25MG/ML                         A089463   001    May   02,   1988
                                50MG/ML                         A089477   001    May   02,   1988
        MYLAN INSTITUTIONAL
	   25MG/ML                         A040471   001    Nov   21,   2002
        SANDOZ
	                25MG/ML                         A040593   001    Nov   08,   2006
                                50MG/ML                         A040593   002    Nov   08,   2006
        TEVA PHARMS USA
	       25MG/ML                         A040454   001    Aug   22,   2002
                                50MG/ML                         A040454   002    Aug   22,   2002
        WATSON LABS
	           25MG/ML                         A083532   001
                                25MG/ML                         A084591   001
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-277(of 337)


PROMETHAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PROMETHAZINE HYDROCHLORIDE
	
                                   50MG/ML                                 A080629   002
	
                                   50MG/ML                                 A083532   002
	
         WOCKHARDT                 25MG/ML                                 A040785   001 Sep 26, 2008

                                   50MG/ML                                 A040785   002 Sep 26, 2008

   ZIPAN-25
	
        ALTANA                     25MG/ML                                 A083997 001
	
   ZIPAN-50
	
        ALTANA                     50MG/ML                                 A083997 002
	
 SUPPOSITORY;RECTAL
	
   PHENERGAN
	
        DELCOR ASSET CORP          50MG                                    N011689 001
	
        SHIONOGI INC               12.5MG                                  N010926 002
	
                                   25MG                                    N010926 001
	
   PROMETHACON
	
        POLYMEDICA                 25MG                                    A084901 001
	
                                   50MG                                    A084902 001
	
   PROMETHAZINE HYDROCHLORIDE
	
        ABLE		                  12.5MG                                     A040504 001 Apr 11, 2003

                                25MG                                       A040504 002 Apr 11, 2003

                                50MG                                       A040449 001 Feb 27, 2003
	
 SYRUP;ORAL
	
   MYMETHAZINE FORTIS
	
        USL PHARMA              25MG/5ML                                   A087996 001 Jan 18, 1983
	
   PROMETH FORTIS
	
        ALPHARMA US PHARMS      25MG/5ML                                   A084772 001
	
   PROMETH PLAIN
	
        ACTAVIS MID ATLANTIC    6.25MG/5ML                                 A085953 001
	
   PROMETHAZINE
	
        CENCI                   6.25MG/5ML                                 A089013 001 Sep 20, 1985

   PROMETHAZINE HYDROCHLORIDE
	
        KV PHARM                6.25MG/5ML                                 A085388   001
	
                                25MG/5ML                                   A085385   001
	
        PHARM ASSOC             6.25MG/5ML                                 A087518   001
	
        WHITEWORTH TOWN PLSN    6.25MG/5ML                                 A086395   001
	
   PROMETHAZINE HYDROCHLORIDE PLAIN
	
        ANI PHARMS		            6.25MG/5ML                                 N008381 004 Apr 18, 1984

                                25MG/5ML **Federal Register                N008381 003
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

 TABLET;ORAL
	
   PHENERGAN
	
        DELCOR ASSET CORP		     12.5MG                                     N007935 002
	
                                25MG                                       N007935 003
	
                                50MG                                       N007935 004
	
   PROMETHAZINE HYDROCHLORIDE
	
        ABBOTT		                12.5MG                                     A084160   001
	
                                25MG                                       A084166   001
	
                                50MG                                       A084539   001
	
        ABLE		                  12.5MG                                     A040558   001     Jul   01,   2004
	
                                25MG                                       A040558   002     Jul   01,   2004
	
                                50MG                                       A040558   003     Jul   01,   2004
	
        IMPAX LABS		            25MG                                       A084214   002     Jul   07,   1982
	
        IVAX SUB TEVA PHARMS		 12.5MG                                      A083604   001
	
                                25MG                                       A083603   001
	
                                50MG                                       A083613   001
	
        LANNETT		               12.5MG                                     A080949   001
	
                                25MG                                       A080949   002
	
                                50MG                                       A080949   003
	
        MUTUAL PHARM		          12.5MG                                     A084555   001
	
                                25MG                                       A084554   001
	
                                50MG                                       A084557   001
	
        PVT FORM		              12.5MG                                     A083214   001
	
                                25MG                                       A083658   001
	
        SANDOZ		                12.5MG                                     A084176   002     May 22, 2009

                                12.5MG                                     A084233   001
	
                                25MG                                       A085146   001
	
                                50MG                                       A085146   002
	
        TABLICAPS		             12.5MG                                     A084080   001
	
                                25MG                                       A084027   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-278(of 337)


PROMETHAZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PROMETHAZINE HYDROCHLORIDE
	
         TEVA                    25MG                                       A089109   001 Sep 10, 1985

         WATSON LABS             12.5MG                                     A083401   001
	
                                 12.5MG                                     A083712   001
	
                                 12.5MG                                     A085986   001
	
                                 25MG                                       A083204   001
	
                                 25MG                                       A085684   001
	
                                 50MG                                       A083403   001
	
                                 50MG                                       A085664   001
	
    REMSED
	
         BRISTOL MYERS SQUIBB    25MG                                       A083176 002
	
                                 50MG                                       A083176 001
	
PROPAFENONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PROPAFENONE HYDROCHLORIDE
	
         NESHER PHARMS		           150MG                                    A076193 001 Feb 07, 2002
	
                                   225MG                                    A076193 002 Feb 07, 2002
	
                                   300MG                                    A076193 003 Feb 07, 2002
	
PROPANTHELINE BROMIDE
	
  INJECTABLE;INJECTION
	
    PRO-BANTHINE
	
         GD SEARLE LLC             30MG/VIAL                                N008843 001
	
  TABLET;ORAL
	
    PRO-BANTHINE
	
         SHIRE                     7.5MG **Federal Register determination   N008732 003
	
                                   that product was not discontinued or

                                   withdrawn for safety or efficacy

                                   reasons**
	
                                   15MG                                     N008732 002
	
   PROPANTHELINE BROMIDE
	
        ASCOT                      15MG                                     A087663   001 Oct 25, 1982
	
        HEATHER                    15MG                                     A085780   001
	
        IMPAX LABS                 15MG                                     A084541   002
	
        MYLAN                      15MG                                     A083706   001
	
        PAR PHARM                  15MG                                     A088377   001 Dec 08, 1983
	
        PVT FORM                   15MG                                     A080977   001
	
        ROXANE                     7.5MG                                    A080927   001
	
        SANDOZ                     15MG                                     A080928   001
	
        TABLICAPS                  15MG                                     A084428   001
	
        WATSON LABS                15MG                                     A083029   002
	
                                   15MG		                                   A083151   001
	
PROPARACAINE HYDROCHLORIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    KAINAIR
	
         PHARMAFAIR                0.5%                                     A088087 001 Jun 07, 1983
	
    OPHTHAINE
	
         APOTHECON                 0.5%                                     N008883 001
	
    OPHTHETIC
	
         ALLERGAN                  0.5%                                     N012583 001
	
    PARACAINE
	
         OPTOPICS                  0.5%                                     A087681 001 Aug 05, 1982

    PROPARACAINE HYDROCHLORIDE
	
         SOLA BARNES HIND          0.5%                                     A084144 001
	
                                   0.5%                                     A084151 001
	
PROPIOLACTONE
	
  SOLUTION;IRRIGATION
	
    BETAPRONE
	
         FOREST LABS               N/A                                      N011657 001
	
PROPIOMAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    LARGON
	
         HIKMA MAPLE               20MG/ML                                  N012382 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-279(of 337)


PROPOFOL
	
  INJECTABLE;INJECTION
	
    DIPRIVAN
	
          FRESENIUS KABI USA
	     10MG/ML
	                    N019627 001 Oct 02, 1989
	
    PROPOFOL
	
          EUROHLTH INTL
	          10MG/ML
                     A074848 001 Apr 19, 2005

          TEVA PARENTERAL
	        10MG/ML
	                    A075392 001 Sep 19, 2000
	
PROPOXYPHENE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    DARVON
	
         XANODYNE PHARM
	          32MG
	                       N010997 001
	
                                   65MG
	                       N010997 003
	
    DOLENE
	
         HERITAGE PHARMS INC
	     65MG
	                       A080530 001
	
    KESSO-GESIC
	
         MK LABS
	                 65MG
	                       A083544 001
	
    PROPHENE 65
	
         HALSEY
	                  65MG
	                       A083538 002
	
    PROPOXYPHENE HYDROCHLORIDE
	
         ALRA
	                 65MG
	                          A083184   001
	
         IMPAX LABS
	           65MG
	                          A083317   001
	
         IVAX SUB TEVA PHARMS
	 32MG
	                          A083597   001
	
         MUTUAL PHARM
	         65MG
	                          A083186   001
	
         MYLAN
	                32MG
	                          A083528   001
	
                                65MG
	                          A040569   001 Dec 16, 2004
	
                                65MG
	                          A083299   001
	
         NEXGEN PHARMA INC
	    65MG
	                          A083185   001
	
         PAR PHARM
	            65MG
	                          A080269   001
	
         PUREPAC PHARM
	        65MG
	                          A083278   001
	
         PVT FORM
	             65MG
	                          A083113   001
	
         ROXANE
	               32MG
	                          A083089   001
	
                                65MG
	                          A083089   002
	
         SANDOZ
	               32MG
	                          A084014   001
	
                                65MG
	                          A083125   002
	
                                65MG
	                          A083688   001
	
                                65MG
	                          A083870   002
	
                                65MG
	                          A086495   001
	
         TEVA
	                 65MG
	                          A088615   001 Oct 22, 1984
	
         VALEANT PHARM INTL
	   65MG
	                          A080783   001
	
         VINTAGE PHARMS
	       65MG
	                          A040908   001 Jul 17, 2009
	
         WATSON LABS
	          65MG
	                          A080908   002
	
                                65MG
	                          A085190   001
	
         WEST WARD
	            65MG
	                          A083501   001
	
         WHITEWORTH TOWN PLSN
	 65MG
	                          A084551   001
	
    PROPOXYPHENE HYDROCHLORIDE 65
	
         WARNER CHILCOTT        65MG
	                          A083786 001
	
PROPOXYPHENE NAPSYLATE
	
  SUSPENSION;ORAL
	
    DARVON-N
	
         AAIPHARMA LLC             50MG/5ML
                    N016861 001
	
  TABLET;ORAL
	
    DARVON-N
	
         XANODYNE PHARM            100MG
	                      N016862 002
	
PROPRANOLOL HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    PROPRANOLOL HYDROCHLORIDE
	
         INWOOD LABS		          60MG
	                          A072499   001    Apr   11,   1989

                                80MG
	                          A072500   001    Apr   11,   1989

                                120MG
	                         A072501   001    Apr   11,   1989

                                160MG
	                         A072502   001    Apr   11,   1989
	
  CONCENTRATE;ORAL
	
    PROPRANOLOL HYDROCHLORIDE INTENSOL
	
         ROXANE
	               80MG/ML
	                       A071388 001 May 15, 1987
	
  INJECTABLE;INJECTION
	
    PROPRANOLOL HYDROCHLORIDE
	
         SMITH AND NEPHEW
	     1MG/ML
                         A070135 001 Apr 15, 1986

                                1MG/ML
                         A070137 001 Apr 15, 1986

         SOLOPAK
	              1MG/ML
	                        A070136 001 Apr 15, 1986
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                               6-280(of 337)


PROPRANOLOL HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    PROPRANOLOL HYDROCHLORIDE
	
         MORTON GROVE             20MG/5ML                                A071984 001 Mar 03, 1989
	
                                  40MG/5ML                                A071985 001 Mar 03, 1989
	
 SUSPENSION;ORAL
	
   INDERAL
	
        WYETH AYERST              10MG/ML                                 N019536 001 Dec 12, 1986
	
 TABLET;ORAL
	
   INDERAL
	
        WYETH PHARMS INC		        10MG                                    N016418   001
	
                                  20MG                                    N016418   003
	
                                  40MG                                    N016418   002
	
                                  60MG                                    N016418   009 Oct 18, 1982
	
                                  80MG **Federal Register determination   N016418   004
	
                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
                                  90MG **Federal Register determination   N016418 010 Oct 18, 1982

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
   PROPRANOLOL HYDROCHLORIDE
	
        ANI PHARMS INC            90MG                                    A071977   001    Apr   06,   1988

        DAVA PHARMS INC           10MG                                    A070125   001    Jul   30,   1985
	
                                  20MG                                    A070126   001    Jul   30,   1985
	
                                  40MG                                    A070127   001    Jul   30,   1985
	
                                  60MG                                    A071495   001    Dec   31,   1987
	
                                  80MG                                    A070128   001    Jul   30,   1985
	
                                  90MG                                    A071496   001    Dec   31,   1987
	
         DURAMED PHARMS BARR      10MG                                    A070306   001    Sep   09,   1985

                                  20MG                                    A070307   001    Sep   09,   1985

                                  40MG                                    A070308   001    Sep   09,   1985

                                  60MG                                    A070309   001    Oct   01,   1986
	
                                  80MG                                    A070310   001    Sep   09,   1985

                                  90MG                                    A071327   001    Oct   01,   1986
	
         INTERPHARM               10MG                                    A071368   001    May   05,   1987

                                  20MG                                    A071369   001    May   05,   1987

                                  40MG                                    A071370   001    May   05,   1987

                                  80MG                                    A071371   001    May   05,   1987

         IVAX SUB TEVA PHARMS     10MG                                    A072063   001    Jul   29,   1988
	
                                  20MG                                    A072066   001    Jul   29,   1988
	
                                  40MG                                    A072067   001    Jul   29,   1988
	
                                  60MG                                    A072068   001    Jul   29,   1988
	
                                  80MG                                    A072069   001    Jul   29,   1988
	
         LEDERLE                  10MG                                    A072117   001    Jun   23,   1988
	
                                  20MG                                    A072118   001    Jun   23,   1988
	
                                  40MG                                    A072119   001    Jun   23,   1988
	
                                  80MG                                    A072120   001    Jun   23,   1988
	
         MUTUAL PHARM             10MG                                    A070319   001    Oct   22,   1985
	
                                  20MG                                    A070320   001    Oct   22,   1985
	
                                  40MG                                    A070103   001    Oct   22,   1985
	
                                  60MG                                    A070321   001    Sep   24,   1986

                                  80MG                                    A070322   001    Aug   04,   1986

         MYLAN                    60MG                                    A072275   001    Jun   09,   1989
	
         PAR PHARM                90MG                                    A071288   001    Oct   22,   1986
	
         PUREPAC PHARM            10MG                                    A070814   001    Nov   03,   1986
	
                                  20MG                                    A070815   001    Nov   03,   1986
	
                                  40MG                                    A070816   001    Nov   03,   1986
	
                                  60MG                                    A070817   001    Nov   03,   1986
	
                                  80MG                                    A070757   001    Nov   03,   1986
	
         ROXANE                   10MG                                    A070516   001    Jul   07,   1986
	
                                  20MG                                    A070517   001    Jul   07,   1986
	
                                  40MG                                    A070518   001    Jul   07,   1986
	
                                  60MG                                    A070519   001    Sep   24,   1986

                                  80MG                                    A070520   001    Jul   07,   1986
	
                                  90MG                                    A070521   001    Sep   24,   1986

         SANDOZ                   10MG                                    A070663   001    Jun   13,   1986
	
                                  10MG                                    A071658   001    Jul   05,   1988
	
                                  20MG                                    A070664   001    Jun   13,   1986
	
                                  20MG                                    A071687   001    Jul   05,   1988
	
                                  40MG                                    A070665   001    Jun   13,   1986
	
                                  40MG                                    A071688   001    Jul   05,   1988
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                      6-281(of 337)


PROPRANOLOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    PROPRANOLOL HYDROCHLORIDE
	
                                  60MG
	                          A070666   001     Oct   10,   1986
	
                                  60MG
	                          A072197   001     Jul   05,   1988
	
                                  80MG
	                          A070667   001     Jun   13,   1986
	
                                  80MG
	                          A071689   001     Jul   05,   1988
	
                                  90MG
	                          A072198   001     Jul   05,   1988
	
         SCHERING                 10MG
	                          A070120   001     Aug   06,   1985

                                  20MG
	                          A070121   001     Aug   06,   1985

                                  40MG
	                          A070122   001     Aug   06,   1985

                                  60MG
	                          A070123   001     Oct   29,   1986
	
                                  80MG
	                          A070124   001     Aug   06,   1985

         SUPERPHARM               10MG
	                          A071515   001     Jun   08,   1988
	
                                  20MG
	                          A071516   001     Jun   08,   1988
	
                                  40MG
	                          A071517   001     Jun   08,   1988
	
                                  80MG
	                          A071518   001     Jun   08,   1988
	
         TEVA                     10MG
	                          A070232   001     Oct   07,   1987
	
                                  20MG
	                          A070233   001     Jun   23,   1986
	
                                  40MG
	                          A070234   001     Jun   23,   1986
	
         WARNER CHILCOTT          10MG
	                          A070438   001     Sep   15,   1986

                                  20MG
	                          A070439   001     Sep   15,   1986

                                  40MG
	                          A070440   001     Sep   15,   1986

                                  60MG
	                          A070441   001     Sep   24,   1986

                                  80MG
	                          A070442   001     Sep   15,   1986

         WATSON LABS              10MG
	                          A070140   001     Jul   30,   1985
	
                                  10MG
	                          A070378   001     Mar   19,   1987
	
                                  10MG
	                          A070548   001     Jul   10,   1986
	
                                  20MG
	                          A070141   001     Jul   30,   1985
	
                                  20MG
	                          A070379   001     Mar   19,   1987
	
                                  20MG
	                          A070549   001     Apr   11,   1986

                                  40MG
	                          A070142   001     Jul   30,   1985
	
                                  40MG
	                          A070380   001     Mar   19,   1987
	
                                  40MG
	                          A070550   001     Apr   11,   1986

                                  60MG
	                          A070143   001     Jan   15,   1987
	
                                  60MG
	                          A070381   001     Mar   19,   1987
	
                                  60MG
	                          A071098   001     Oct   06,   1986
	
                                  60MG
	                          A071791   001     Jul   15,   1987
	
                                  80MG
	                          A070144   001     Jul   30,   1985
	
                                  80MG
	                          A070382   001     Mar   19,   1987
	
                                  80MG
	                          A070551   001     Jul   10,   1986
	
                                  90MG
	                          A071183   001     Oct   06,   1986
	
                                  90MG
	                          A071792   001     Jul   15,   1987
	
PROPYLIODONE
	
  SUSPENSION;INTRATRACHEAL
	
    DIONOSIL AQUEOUS
	
         GLAXOSMITHKLINE          50%
	                           N009309 001
	
    DIONOSIL OILY
	
         GLAXOSMITHKLINE          60%
	                           N009309 002
	
PROPYLTHIOURACIL
	
  TABLET;ORAL
	
    PROPYLTHIOURACIL
	
         ABBOTT                   50MG
	                          A084075   001
	
         ANABOLIC                 50MG
	                          A080285   001
	
         ANI PHARMS INC           50MG
	                          A080215   001
	
         HALSEY                   50MG
	                          A080015   001
	
         HIKMA PHARMS LLC         50MG
	                          A080154   001
	
         IMPAX LABS               50MG
	                          A080159   001
	
         LANNETT                  50MG
	                          A080016   001
	
         LILLY                    50MG
	                          N006213   001
	
         MUTUAL PHARM             50MG
	                          A083982   001
	
         PERRIGO                  50MG
	                          A084543   001
	
         TABLICAPS                50MG
	                          A080840   001
	
         WATSON LABS              50MG
	                          A080932   001
	
                                  50MG
	                          A085201   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                           6-282(of 337)


PROTAMINE SULFATE
	
  INJECTABLE;INJECTION
	
    PROTAMINE SULFATE
	
         HIKMA MAPLE            10MG/ML                                  A089474   001 Nov 05, 1986
	
                                10MG/ML                                  A089475   001 Nov 05, 1986
	
         LILLY                  10MG/ML                                  N006460   002
	
         PHARMACIA AND UPJOHN   50MG/VIAL                                N007413   001
	
                                250MG/VIAL                               N007413   002 Aug 02, 1984
	
PROTEIN HYDROLYSATE
	
  INJECTABLE;INJECTION
	
    AMINOSOL 5%
	
         ABBVIE                 5%                                       N005932 012 Jan 31, 1985
	
    HYPROTIGEN 5%
	
         B BRAUN                5%                                       N006170 003 Jan 10, 1984
	
PROTIRELIN
	
  INJECTABLE;INJECTION
	
    THYPINONE
	
         ABBOTT                 0.5MG/ML                                 N017638 001
	
    THYREL TRH
	
         FERRING                0.5MG/ML                                 N018087 001
	
PROTOKYLOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    VENTAIRE
	
         SANOFI AVENTIS US      2MG                                      A083459 001
	
PROTRIPTYLINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    VIVACTIL
	
         TEVA WOMENS            5MG                                      N016012 001
	
                                10MG                                     N016012 002
	
PSEUDOEPHEDRINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    NOVAFED
	
         SANOFI AVENTIS US      120MG                                    N017603 001
	
    SUDAFED 12 HOUR
	
         GLAXOSMITHKLINE        120MG **Federal Register determination   N017941 002
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    ACTIFED
	
         GLAXOSMITHKLINE        120MG;5MG                                N018996 001 Jun 17, 1985
	
    TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES
	
         KV PHARM               120MG;5MG                                A071798 001 Mar 16, 1989
	
  SYRUP;ORAL
	
    ACTAHIST
	
         CENCI                  30MG/5ML;1.25MG/5ML                      A088344 001 Feb 09, 1984
	
    HISTAFED
	
         CENCI                  30MG/5ML;1.25MG/5ML                      A088283 001 Apr 20, 1984

    MYFED
	
         USL PHARMA             30MG/5ML;1.25MG/5ML                      A088116 001 Mar 04, 1983
	
    TRILITRON
	
         NEWTRON PHARMS         30MG/5ML;1.25MG/5ML                      A088474 001 Feb 12, 1985
	
  TABLET;ORAL
	
    ALLERFED
	
         PVT FORM               60MG;2.5MG                               A088860 001 Jan 31, 1985
	
    CORPHED
	
         SANDOZ                 60MG;2.5MG                               A088602 001 Apr 11, 1985

    PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE
	
         SANDOZ                 60MG;2.5MG                               A088193 001 May 17, 1983

    TRILITRON
	
         NEWTRON PHARMS         60MG;2.5MG                               A088515 001 Jan 09, 1985
	
    TRIPHED
	
         TEVA                   60MG;2.5MG                               A088630 001 May 17, 1984

    TRIPROLIDINE AND PSEUDOEPHEDRINE
	
         WATSON LABS            60MG;2.5MG                               A088318 002 Jan 13, 1984
	
         WEST WARD              60MG;2.5MG                               A088117 001 Apr 19, 1983

    TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
	
         IVAX SUB TEVA PHARMS   60MG;2.5MG                               A085273 001 Dec 12, 1984
	
         SUPERPHARM             60MG;2.5MG                               A088578 001 Feb 21, 1985
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-283(of 337)


PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES
	
         KV PHARM                120MG;5MG
	                    A072758 001 Nov 25, 1991
	
PSEUDOEPHEDRINE POLISTIREX
	
  SUSPENSION, EXTENDED RELEASE;ORAL
	
    PSEUDO-12
	
         UCB INC
	              EQ 60MG HCL/5ML
	               N019401 001 Jun 19, 1987
	
PYRIDOSTIGMINE BROMIDE
	
  TABLET;ORAL
	
    PYRIDOSTIGMINE BROMIDE
	
         BARR
	                   30MG
	                        A040512   002    Jul   20,   2005
	
                                  60MG
	                        A040512   001    Oct   08,   2003
	
         COREPHARMA
	             60MG
	                        A040457   001    Dec   26,   2002
	
         SOLVAY
	                 30MG
	                        A089572   001    Nov   27,   1990
	
         US ARMY
	                30MG
	                        N020414   001    Feb   05,   2003
	
PYRIDOXINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    HEXA-BETALIN
	
         LILLY
	                  100MG/ML
	                    A080854 001
	
    PYRIDOXINE HYDROCHLORIDE
	
         AKORN
	                  100MG/ML
                     A087967   001 Oct 01, 1982
	
         BEL MAR
	                100MG/ML
                     A080761   001
	
         DELL LABS
	              50MG/ML
                      A083771   001
	
                                  100MG/ML
                     A083772   001
	
         ELKINS SINN
	            100MG/ML
                     A080581   001
	
         LUITPOLD
	               100MG/ML
                     A080669   001
	
         WATSON LABS
	            100MG/ML
                     A080572   001
	
                                  100MG/ML
	                    A083760   001
	
PYRILAMINE MALEATE
	
  TABLET;ORAL
	
    PYRILAMINE MALEATE
	
         IMPAX LABS
	             25MG
	                        A080808 001
	
         WATSON LABS
	            25MG
	                        A085231 001
	
PYRIMETHAMINE; SULFADOXINE
	
  TABLET;ORAL
	
    FANSIDAR
	
         ROCHE
	                  25MG;500MG
	                  N018557 001
	
PYRITHIONE ZINC
	
  LOTION;TOPICAL
	
    HEAD & SHOULDERS CONDITIONER
	
         WARNER CHILCOTT
	      0.3%
	                          N019412 002 Mar 10, 1986
	
PYRVINIUM PAMOATE
	
  SUSPENSION;ORAL
	
    POVAN
	
         PARKE DAVIS
	            EQ 50MG BASE/5ML
	            N011964 001
	
  TABLET;ORAL
	
    POVAN
	
         PARKE DAVIS
	            EQ 50MG BASE
	                N012485 002
	
QUAZEPAM
	
  TABLET;ORAL
	
    DORAL
	
          SCIECURE PHARMA INC
	   7.5MG
	                       N018708 003 Feb 26, 1987
	
QUETIAPINE FUMARATE
	
  TABLET;ORAL
	
    SEROQUEL
	
         ASTRAZENECA
	            EQ 150MG BASE
	               N020639 004 Dec 20, 1998
	
QUINAPRIL HYDROCHLORIDE
	
  TABLET;ORAL
	
    QUINAPRIL HYDROCHLORIDE
	
         ACTAVIS ELIZABETH
	      EQ   5MG BASE
	               A076459   001    Dec   22,   2004
	
                                  EQ   10MG BASE
	              A076459   002    Dec   22,   2004
	
                                  EQ   20MG BASE
	              A076459   003    Dec   22,   2004
	
                                  EQ   40MG BASE
	              A076459   004    Dec   22,   2004
	
         APOTEX INC
	             EQ   5MG BASE
	               A076240   001    Jan   26,   2006
	
                                  EQ   10MG BASE
	              A076240   002    Jan   26,   2006
	
                                  EQ   20MG BASE
	              A076240   003    Jan   26,   2006
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-284(of 337)


QUINAPRIL HYDROCHLORIDE
	
  TABLET;ORAL
	
    QUINAPRIL HYDROCHLORIDE
	
                                 EQ   40MG BASE
	                 A076240   004     Jan   26,   2006
	
         MYLAN
	                 EQ   5MG BASE
	                  A076036   001     Jan   28,   2005
	
                                 EQ   10MG BASE
	                 A076036   002     Jan   28,   2005
	
                                 EQ   20MG BASE
	                 A076036   003     Jan   28,   2005
	
                                 EQ   40MG BASE
	                 A076036   004     Jan   28,   2005
	
         SANDOZ
	                EQ   5MG BASE
	                  A076803   001     Mar   02,   2005
	
                                 EQ   10MG BASE
	                 A076803   002     Mar   02,   2005
	
                                 EQ   20MG BASE
	                 A076803   003     Mar   02,   2005
	
                                 EQ   40MG BASE
	                 A076803   004     Mar   02,   2005
	
QUINESTROL
	
  TABLET;ORAL
	
    ESTROVIS
	
         PARKE DAVIS
	           0.1MG
	                          N016768 002
	
                                 0.2MG
	                          N016768 003
	
QUINETHAZONE
	
  TABLET;ORAL
	
    HYDROMOX
	
         LEDERLE
	               50MG
	                           N013264 001
	
QUINETHAZONE; RESERPINE
	
  TABLET;ORAL
	
    HYDROMOX R
	
         LEDERLE
	               50MG;0.125MG
	                   N013927 001
	
QUINIDINE GLUCONATE
	
  TABLET;ORAL
	
    QUINACT
	
         BAYER HLTHCARE
	        266MG
	                          A085978 001
	
                                 400MG
	                          A086099 001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    DURAQUIN
	
         WARNER CHILCOTT
	       330MG
	                          N017917 001
	
    QUINAGLUTE
	
         BAYER HLTHCARE
	        324MG
	                          N016647 001
	
    QUINALAN
	
         LANNETT
	               324MG
	                          A088081 001 Feb 10, 1986
	
    QUINATIME
	
         WATSON LABS
	           324MG
	                          A087448 001
	
    QUINIDINE GLUCONATE
	
         ASCOT
	                 324MG
	                          A088582   001     Jun   17,   1985
	
         HALSEY
	                324MG
	                          A089476   001     Apr   10,   1987

         ROXANE
	                324MG
	                          A088431   001     Jan   06,   1984
	
         SANDOZ
	                324MG
	                          A089894   001     Dec   15,   1988
	
         SUPERPHARM
	            324MG
	                          A089164   001     Nov   21,   1985
	
         WATSON LABS
	           324MG
	                          A087785   001     Jan   24,   1983
	
                                 324MG
	                          A087810   001     Sep   29,   1982
	
QUINIDINE POLYGALACTURONATE
	
  TABLET;ORAL
	
    CARDIOQUIN
	
         PHARM RES ASSOC
	       275MG
	                          N011642 002
	
QUINIDINE SULFATE
	
  CAPSULE;ORAL
	
    CIN-QUIN
	
         SOLVAY
	                200MG
	                          A085296 001
	
                                 300MG
	                          A085297 001
	
    QUINIDINE SULFATE
	
         LILLY
	                 200MG
	                          A085103 001
	
  TABLET;ORAL
	
    CIN-QUIN
	
         SOLVAY
	                100MG
	                          A085299 001
	
                                 200MG
	                          A084932 001
	
                                 300MG
	                          A085298 001
	
    QUINIDINE SULFATE
	
         BARR
	                  200MG
	                          A084177   001
	
         CONTRACT PHARMACAL
	    200MG
	                          A083808   001
	
         DAVA PHARMS INC
	       200MG
	                          A087011   001
	
         ELKINS SINN
	           200MG
	                          A083622   001
	
         EVERYLIFE
	             200MG
	                          A083439   001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                          6-285(of 337)


QUINIDINE SULFATE
	
  TABLET;ORAL
	
    QUINIDINE SULFATE
	
         HALSEY
	                 200MG
	                                 A083583   001
	
         HIKMA PHARMS LLC
	       200MG
	                                 A083862   001
	
         IMPAX LABS
	             200MG
	                                 A083347   001
	
         IVAX SUB TEVA PHARMS
	   200MG
	                                 A084549   001
	
         KING PHARMS
	            200MG
	                                 A085175   001
	
         KV PHARM
	               200MG
	                                 A085276   001
	
         LANNETT
	                200MG
	                                 A083743   001
	
         LEDERLE
	                200MG
	                                 A086176   001
	
         LILLY
	                  200MG
	                                 A085038   001
	
         MUTUAL PHARM
	           100MG
	                                 A081029   001
	   Apr 14, 1989
	
         PERRIGO
	                200MG
	                                 A085322   001
	
         PHARMAVITE
	             200MG
	                                 A084627   001
	
         PUREPAC PHARM
	          200MG
	                                 A084003   001
	
         ROXANE
	                 200MG
	                                 A083640   001
	
                                  300MG
	                                 A085632   001
	
         SANDOZ
	                 200MG
	                                 A084631   001
	
                                  200MG
	                                 A084914   001
	
                                  300MG
	                                 A089839   001
	   Sep 29, 1988
	
         SCHERER LABS
	           200MG
	                                 A085068   001
	
         SUPERPHARM
	             200MG
	                                 A088973   001
	   Apr 10, 1985

         USL PHARMA
	             200MG
	                                 A087837   001
	   Apr 14, 1982
	
         VALEANT PHARM INTL
	     200MG
	                                 A083393   001
	
         VANGARD
	                200MG
	                                 A087909   001
	   Jul 13, 1982
	
         VINTAGE PHARMS
	         200MG
	                                 A083963   001
	
         WARNER CHILCOTT
	        200MG
	                                 A083879   001
	
         WATSON LABS
	            100MG
	                                 A085584   001
	
                                  200MG
	                                 A085140   002
	
         WHITEWORTH TOWN PLSN
	   200MG
	                                 A085444   001
	
    QUINORA
	
         KEY PHARMS
	            200MG
	                                  A083576 001
	
         SCHERING
	              300MG
	                                  A085222 001
	
  TABLET, EXTENDED RELEASE;ORAL
	
    QUINIDEX
	
         WYETH PHARMS INC
	      300MG
	                                  N012796 002
	
RABEPRAZOLE SODIUM
	
  TABLET, DELAYED RELEASE;ORAL
	
    ACIPHEX
	
         EISAI INC
	             10MG **Federal Register determination
   N020973 001
	 May 29, 2002
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
RAMIPRIL
	
  CAPSULE;ORAL
	
    RAMIPRIL
	
          ACTAVIS ELIZABETH
	     1.25MG
	                                A077513   001
	   Jun   18,   2008
	
                                  2.5MG
	                                 A077513   002
	   Jun   18,   2008
	
                                  5MG
	                                   A077513   003
	   Jun   18,   2008
	
                                  10MG
	                                  A077513   004
	   Jun   18,   2008
	
         CIPLA
	                  1.25MG
	                                A077004   001
	   Aug   07,   2008

                                  2.5MG
	                                 A077004   002
	   Aug   07,   2008

                                  5MG
	                                   A077004   003
	   Aug   07,   2008

                                  10MG
	                                  A077004   004
	   Aug   07,   2008

         RANBAXY LABS LTD
	       5MG
	                                   A078849   001
	   Mar   06,   2009
	
                                  10MG
	                                  A078849   002
	   Mar   06,   2009
	
  TABLET;ORAL
	
    ALTACE
	
         KING PFIZER
	            1.25MG
	                                N022021   001
	   Feb   27,   2007
	
                                  2.5MG
	                                 N022021   002
	   Feb   27,   2007
	
                                  5MG
	                                   N022021   003
	   Feb   27,   2007
	
                                  10MG
	                                  N022021   004
	   Feb   27,   2007
	
RANITIDINE BISMUTH CITRATE
	
  TABLET;ORAL
	
    TRITEC
	
         GLAXOSMITHKLINE
	        400MG
	                                 N020559 001
	 Aug 08, 1996
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                                  6-286(of 337)


RANITIDINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    RANITIDINE HYDROCHLORIDE
	
         MYLAN                   EQ   150MG   BASE                          A075564   001    Oct   27,   2000
	
                                 EQ   300MG   BASE                          A075564   002    Oct   27,   2000
	
         TEVA                    EQ   150MG   BASE                          A075557   001    Oct   31,   2003
	
                                 EQ   300MG   BASE                          A075557   002    Oct   31,   2003
	
   ZANTAC 150
	
        GLAXOSMITHKLINE          EQ 150MG BASE                              N020095 001 Mar 08, 1994
	
   ZANTAC 300
	
        GLAXOSMITHKLINE          EQ 300MG BASE                              N020095 002 Mar 08, 1994
	
 GRANULE, EFFERVESCENT;ORAL
	
   ZANTAC 150
	
        GLAXO GRP LTD            EQ 150MG BASE/PACKET                       N020251 002 Mar 31, 1994
	
 INJECTABLE;INJECTION
	
   RANITIDINE HYDROCHLORIDE
	
        BEDFORD                  EQ 25MG BASE/ML                            A074764 001 Nov 19, 2004
	
   ZANTAC IN PLASTIC CONTAINER
	
        COVIS INJECTABLES        EQ 1MG BASE/ML                             N019593 002 Sep 27, 1991

                                 EQ 50MG BASE/100ML                         N019593 001 Dec 17, 1986
	
 SYRUP;ORAL
	
   RANITIDINE HYDROCHLORIDE
	
        APOTEX INC               EQ 15MG BASE/ML                            A077602 001 Sep 17, 2007

        RANBAXY                  EQ 15MG BASE/ML                            A078448 001 Dec 13, 2007
	
 TABLET;ORAL
	
   RANITIDINE HYDROCHLORIDE
	
        BOEHRINGER INGELHEIM     EQ 150MG BASE                              A074662   001    Aug   29,   1997

                                 EQ 300MG BASE                              A074662   002    Aug   29,   1997

        MYLAN                    EQ 150MG BASE                              A074552   001    Jul   30,   1998
	
                                 EQ 300MG BASE                              A074552   002    Jul   30,   1998
	
        RANBAXY                  EQ 75MG BASE                               A075132   001    Jan   14,   2000
	
                                 EQ 75MG BASE                               A075254   001    Jan   14,   2000
	
                                 EQ 150MG BASE                              A075000   001    Jan   30,   1998
	
                                 EQ 150MG BASE                              A075439   001    Apr   19,   2000

                                 EQ 300MG BASE                              A075000   002    Jan   30,   1998
	
                                 EQ 300MG BASE                              A075439   002    Apr   19,   2000

        SANDOZ                   EQ 75MG BASE                               A075519   001    Sep   26,   2002

        WATSON LABS              EQ 75MG BASE                               A075212   001    Jan   14,   2000
	
                                 EQ 150MG BASE                              A074864   001    Oct   20,   1997
	
                                 EQ 300MG BASE                              A074864   002    Oct   20,   1997
	
        WATSON LABS INC          EQ 150MG BASE                              A077426   001    Dec   19,   2005
	
                                 EQ 300MG BASE                              A077426   002    Dec   19,   2005
	
        WOCKHARDT                EQ 150MG BASE                              A078653   001    Nov   26,   2007
	
                                 EQ 150MG BASE                              A078701   001    Nov   12,   2009
	
                                 EQ 300MG BASE                              A078701   002    Dec   11,   2009
	
 TABLET, EFFERVESCENT;ORAL
	
   ZANTAC 150
	
        GLAXO GRP LTD            EQ 150MG BASE                              N020251 001 Mar 31, 1994
	
   ZANTAC 25
	
        GLAXO GRP LTD            EQ 25MG BASE                               N020251 003 Apr 01, 2004

   ZANTAC 75
	
        BOEHRINGER INGELHEIM		 EQ 75MG BASE **Federal Register              N020745 001 Feb 26, 1998

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
RAPACURONIUM BROMIDE
	
  INJECTABLE;INJECTION
	
    RAPLON
	
         ORGANON USA INC         100MG/VIAL                                 N020984 001 Aug 18, 1999

                                 200MG/VIAL                                 N020984 002 Aug 18, 1999
	
RASAGILINE MESYLATE
	
  TABLET;ORAL
	
    RASAGILINE MESYLATE
	
         WATSON LABS INC         EQ 0.5MG BASE                              A201823 001 Jul 01, 2013
	
                                 EQ 1MG BASE                                A201823 002 Jul 01, 2013
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                       6-287(of 337)


RAUWOLFIA SERPENTINA ROOT
	
  TABLET;ORAL
	
    HIWOLFIA
	
         BOWMAN PHARMS
	          50MG                             N009276 003
                                  50MG                             N009276 005
                                  100MG                            N009276 004
    HYSERPIN
	
         PHYS PRODS VA
	          50MG                             N010581 001
    KOGLUCOID
	
         PANRAY
	                 50MG                             N009278 001
                                  100MG                            N009278 002
    RAUDIXIN
	
         APOTHECON
	              50MG                             N008842 001
                                  100MG                            N008842 002
    RAUSERPIN
	
         FERNDALE LABS
	          50MG                             N009926 002
                                  100MG                            N009926 004
    RAUVAL
	
         PAL PAK
	                50MG                             N009108 002
                                  100MG                            N009108 004
    RAUWOLFIA SERPENTINA
	
         BUNDY
	                  50MG                             N009477   001
                                  100MG                            N009477   002
         HALSEY
	                 50MG                             A080498   001
                                  100MG                            A080498   002
         IMPAX LABS
	             50MG                             N009273   001
                                  100MG                            N009273   002
         IVAX SUB TEVA PHARMS
	   50MG                             N011521   001
                                  100MG                            N011521   002
         PUREPAC PHARM
	          50MG                             A080842   001
                                  100MG                            A080842   002
         PVT FORM
	               50MG                             A080583   001
                                  100MG                            A080583   002
         SOLVAY
	                 50MG                             A080500   001
                                  100MG                            A080500   002
         TABLICAPS
	              50MG                             A083867   001
                                  100MG                            A083444   001
         VALEANT PHARM INTL
	     50MG                             N009668   001
                                  100MG                            N009668   002
         WATSON LABS
	            50MG                             A080907   001
                                  100MG                            A080914   001
    WOLFINA
	
         FOREST PHARMS
	          50MG                             N009255 008
                                  100MG                            N009255 006
RESCINNAMINE
	
  CAPSULE;ORAL
	
    CINNASIL
	
         PANRAY
	                 0.5MG                            A084736 001
  TABLET;ORAL
	
    MODERIL
	
         PFIZER
	                 0.25MG                           N010686 003
                                  0.5MG                            N010686 006
RESERPINE
	
  ELIXIR;ORAL
	
    SERPASIL
	
         NOVARTIS
	               0.2MG/4ML                        N009115 005
  INJECTABLE;INJECTION
	
    SANDRIL
	
         LILLY
	                  2.5MG/ML                         N010012 001
    SERPASIL
	
         NOVARTIS
	               2.5MG/ML                         N009434 002
  TABLET;ORAL
	
    HISERPIA
	
         BOWMAN PHARMS
	          0.1MG                            N009631 002
                                  0.25MG                           N009631 004
    RAU-SED
	
         BRISTOL MYERS SQUIBB
	   0.1MG                            N009357   001
                                  0.25MG                           N009357   004
                                  0.5MG                            N009357   006
                                  1MG                              N009357   008
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                  6-288(of 337)


RESERPINE
	
  TABLET;ORAL
	
    RESERPINE
	
         BARR                    0.25MG
	                         A080721   002
	
         BELL PHARMA             0.1MG
	                          A083058   001
	
                                 0.25MG
	                         A083058   002
	
        BUNDY                    0.1MG
	                          N009663   001
	
                                 0.25MG
	                         N009663   003
	
        CYCLE PHARMS LTD         0.1MG
	                          N009859   001
	
                                 0.25MG
	                         N009859   002
	
        ELKINS SINN              0.1MG
	                          A083145   001
	
                                 0.25MG
	                         A083145   002
	
        EVERYLIFE		              0.1MG
	                          N010441   001
	
                                 0.25MG
	                         N010441   002
	
                                 0.5MG
	                          N010441   003
	
                                 1MG
	                            N010441   004
	
        HALSEY		                 0.1MG
	                          A080457   002
	
                                 0.25MG
	                         A080457   001
	
                                 1MG
	                            A080457   003
	
        HIKMA PHARMS LLC		       0.1MG
	                          A080975   001
	
                                 0.25MG
	                         A080975   002
	
                                 1MG
	                            A080975   003
	
        IMPAX LABS               0.1MG
	                          N009627   001
	
                                 0.25MG
	                         N009627   002
	
        IVAX SUB TEVA PHARMS     0.1MG
	                          N011185   001
	
                                 0.25MG
	                         N011185   002
	
        MARSHALL PHARMA          0.1MG
	                          A080492   001
	
                                 0.25MG
	                         A080492   002
	
        MK LABS                  0.1MG
	                          A080525   002
	
                                 0.25MG
	                         A080525   001
	
        MYLAN                    1MG
	                            A084974   001
	
        PHARMAVITE               0.25MG
	                         A084663   001
	
        PUREPAC PHARM            0.1MG
	                          A080753   002
	
                                 0.25MG
	                         A080753   001
	
        PVT FORM		               0.1MG
	                          A086117   001
	
                                 0.25MG
	                         A080582   001
	
                                 0.25MG
	                         A085775   001
	
                                 1MG
	                            A080582   002
	
        REXALL                   0.25MG
	                         A080637   001
	
        SOLVAY                   0.25MG
	                         A080446   001
	
        TABLICAPS                0.25MG
	                         A085207   001
	
        TEVA                     0.1MG
	                          A089020   001 Mar 07, 1985
	
                                 0.25MG
	                         A089019   001 Mar 07, 1985
	
        VALEANT PHARM INTL       0.1MG
	                          N009667   001
	
                                 0.25MG
	                         N009667   002
	
        WATSON LABS		            0.1MG
	                          A080679   001
	
                                 0.25MG
	                         A080393   001
	
                                 0.25MG
	                         A085401   001
	
                                 1MG
	                            A080749   001
	
        WHITEWORTH TOWN PLSN		   0.1MG
	                          A080723   001
	
                                 0.25MG
	                         A080723   002
	
                                 1MG
	                            A080723   003
	
   SANDRIL
	
        LILLY                    0.1MG
	                          N009376 004
	
                                 0.25MG
	                         N009376 001
	
   SERPALAN
	
        LANNETT                  0.1MG
	                          N010124 001
	
                                 0.25MG
	                         N010124 002
	
   SERPANRAY
	
        PANRAY		                 0.1MG
	                          N009391 001
	
                                 0.25MG
	                         N009391 002
	
                                 1MG
	                            N009391 004
	
   SERPASIL
	
        NOVARTIS		               0.1MG
	                          N009115 001
	
                                 0.25MG
	                         N009115 003
	
                                 1MG
	                            N009115 004
	
   SERPATE
	
        VALE                     0.1MG
	                          N009453 001
	
                                 0.25MG
	                         N009453 002
	
   SERPIVITE
	
        VITARINE                 0.25MG
	                         N009645 002
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                               6-289(of 337)


RESERPINE; TRICHLORMETHIAZIDE
	
  TABLET;ORAL
	
    METATENSIN #2
	
         SANOFI AVENTIS US      0.1MG;2MG                               N012972 001
	
    METATENSIN #4
	
         SANOFI AVENTIS US      0.1MG;4MG                               N012972 002
	
    NAQUIVAL
	
         SCHERING               0.1MG;4MG                               N012265 003
	
    TRICHLORMETHIAZIDE W/ RESERPINE

         WATSON LABS            0.1MG;4MG                               A085248 001
RIBAVIRIN
  TABLET;ORAL
    COPEGUS
         ROCHE                  400MG                                   N021511 002 Jun 21, 2005
RIMANTADINE HYDROCHLORIDE
  SYRUP;ORAL
    FLUMADINE
         FOREST LABS            50MG/5ML                                N019650 001 Sep 17, 1993
  TABLET;ORAL
    RIMANTADINE HYDROCHLORIDE
         ACTAVIS ELIZABETH      100MG                                   A076375 001 Jan 14, 2003
         COREPHARMA             100MG                                   A075916 001 Nov 02, 2001
RISEDRONATE SODIUM
  TABLET;ORAL
    ACTONEL
         WARNER CHILCOTT LLC    75MG **Federal Register determination   N020835 004 Apr 16, 2007
                                that product was not discontinued or
                                withdrawn for safety or efficacy
                                reasons**
RISPERIDONE
  TABLET;ORAL
    RISPERDAL
         JANSSEN PHARMS         5MG                                     N020272 005 Dec 29, 1993
    RISPERIDONE
         CADISTA PHARMS         0.25MG                                  A078828   001    Mar   23,   2009
                                0.5MG                                   A078828   002    Mar   23,   2009
                                1MG                                     A078828   003    Mar   23,   2009
                                2MG                                     A078828   004    Mar   23,   2009
                                3MG                                     A078828   005    Mar   23,   2009
                                4MG                                     A078828   006    Mar   23,   2009
        RATIOPHARM              0.25MG                                  A077784   001    Jun   08,   2010
                                0.5MG                                   A077784   002    Jun   08,   2010
                                1MG                                     A077784   003    Jun   08,   2010
                                2MG                                     A077784   004    Jun   08,   2010
                                3MG                                     A077784   005    Jun   08,   2010
                                4MG                                     A077784   006    Jun   08,   2010
        SYNTHON PHARMS          0.25MG                                  A078187   001    Oct   22,   2009
                                0.5MG                                   A078187   002    Oct   22,   2009
                                1MG                                     A078187   003    Oct   22,   2009
                                2MG                                     A078187   004    Oct   22,   2009
                                3MG                                     A078187   005    Oct   22,   2009
                                4MG                                     A078187   006    Oct   22,   2009
        WATSON LABS             0.25MG                                  A077860   001    Dec   05,   2008
                                0.5MG                                   A077860   002    Dec   05,   2008
                                1MG                                     A077860   003    Dec   05,   2008
                                2MG                                     A077860   004    Dec   05,   2008
                                3MG                                     A077860   005    Dec   05,   2008
                                4MG                                     A077860   006    Dec   05,   2008
        WEST WARD PHARMS        0.25MG                                  A078740   001    May   29,   2009
                                0.5MG                                   A078740   002    May   29,   2009
                                1MG                                     A078740   003    May   29,   2009
                                2MG                                     A078740   004    May   29,   2009
                                3MG                                     A078740   005    May   29,   2009
                                4MG                                     A078740   006    May   29,   2009
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                 6-290(of 337)


RITODRINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    RITODRINE HYDROCHLORIDE
	
         ABRAXIS PHARM          10MG/ML                                     A071188   001    Jul   23,   1987
	
                                15MG/ML                                     A071189   001    Jul   23,   1987
	
         HOSPIRA                10MG/ML                                     A071618   001    Feb   28,   1991
	
                                15MG/ML                                     A071619   001    Feb   28,   1991
	
    RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA                30MG/100ML                                  A071438 001 Jan 22, 1991
	
    YUTOPAR
	
         ASTRAZENECA            10MG/ML                                     N018580 001
	
                                15MG/ML                                     N018580 002
	
  TABLET;ORAL
	
    YUTOPAR
	
         ASTRAZENECA            10MG                                        N018555 001
	
RITONAVIR
	
  CAPSULE;ORAL
	
    NORVIR
	
         ABBOTT                  100MG                                      N020680 001 Mar 01, 1996
	
RIVASTIGMINE TARTRATE
	
  SOLUTION;ORAL
	
    EXELON
	
         NOVARTIS                EQ 2MG BASE/ML                             N021025 001 Apr 21, 2000
	
ROCURONIUM BROMIDE
	
  INJECTABLE;INJECTION
	
    ZEMURON
	
         ORGANON USA INC         50MG/5ML (10MG/ML) **Federal Register      N020214 001 Mar 17, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 10MG/ML (10MG/ML) **Federal Register       N020214 002 Mar 17, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**

                                 100MG/10ML (10MG/ML) **Federal Register    N020214 003 Mar 17, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
ROFECOXIB
	
  SUSPENSION;ORAL
	
    VIOXX
	
         MERCK                   12.5MG/5ML                                 N021052 001 May 20, 1999

                                 25MG/5ML                                   N021052 002 May 20, 1999

  TABLET;ORAL
	
    VIOXX
	
         MERCK		                 12.5MG                                     N021042 001 May 20, 1999

                                 25MG                                       N021042 002 May 20, 1999

                                 50MG                                       N021042 003 Feb 25, 2000
	
ROPINIROLE HYDROCHLORIDE
	
  TABLET;ORAL
	
    ROPINIROLE HYDROCHLORIDE
	
         COREPHARMA		            EQ   0.25MG BASE                           A078230   001    May   20,   2008

                                 EQ   0.5MG BASE                            A078230   002    May   20,   2008

                                 EQ   1MG BASE                              A078230   003    May   20,   2008

                                 EQ   2MG BASE                              A078230   004    May   20,   2008

                                 EQ   3MG BASE                              A078230   005    May   20,   2008

                                 EQ   4MG BASE                              A078230   006    May   20,   2008

                                 EQ   5MG BASE                              A078230   007    May   20,   2008

  TABLET, EXTENDED RELEASE;ORAL
	
    REQUIP XL
	
         GLAXOSMITHKLINE LLC     EQ   3MG BASE                              N022008 002 Jun 13, 2008
	
ROSE BENGAL SODIUM I-131
	
  INJECTABLE;INJECTION
	
    ROBENGATOPE
	
         BRACCO		                0.5mCi/VIAL                                N016224 001
	
                                 1mCi/VIAL                                  N016224 002
	
                                 2mCi/VIAL                                  N016224 003
	
    SODIUM ROSE BENGAL I 131
	
         SORIN                   0.5mCi/ML                                  N017318 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-291(of 337)


RUFINAMIDE
	
  TABLET;ORAL
	
    BANZEL
	
         EISAI INC                100MG **Federal Register determination   N021911 001 Nov 14, 2008

                                  that product was not discontinued or

                                  withdrawn for safety or efficacy

                                  reasons**
	
SAFFLOWER OIL
	
  INJECTABLE;INJECTION
	
    LIPOSYN 10%
	
         ABBOTT                   10% (10GM/100ML)                         N018203 001
	
    LIPOSYN 20%
	
         ABBOTT                   20% (20GM/100ML)                         N018614 001
	
SAFFLOWER OIL; SOYBEAN OIL
	
  INJECTABLE;INJECTION
	
    LIPOSYN II 10%
	
         HOSPIRA                  5%;5% (5GM/100ML)                        N018997 001 Aug 27, 1984

    LIPOSYN II 20%
	
         HOSPIRA                  10%;10% (10GM/100ML)                     N018991 001 Aug 27, 1984
	
SALMETEROL XINAFOATE
	
  AEROSOL, METERED;INHALATION
	
    SEREVENT
	
         GLAXOSMITHKLINE          EQ 0.021MG BASE/INH                      N020236 001 Feb 04, 1994
	
SAQUINAVIR
	
  CAPSULE;ORAL
	
    FORTOVASE
	
         HOFFMANN LA ROCHE        200MG                                    N020828 001 Nov 07, 1997
	
SARALASIN ACETATE
	
  INJECTABLE;INJECTION
	
    SARENIN
	
         PROCTER AND GAMBLE       EQ 0.6MG BASE/ML                         N018009 001
	
SECOBARBITAL SODIUM
	
  CAPSULE;ORAL
	
    SECOBARBITAL SODIUM
	
         ANABOLIC                 100MG                                    A084422   001
	
         BARR                     100MG                                    A084225   001
	
         EVERYLIFE                100MG                                    A085895   001
	
         HALSEY                   100MG                                    A084676   001
	
         IVAX PHARMS              100MG                                    A085869   001
	
         KV PHARM                 100MG                                    A085285   001
	
         LANNETT                  50MG                                     A085909   001
	
                                  100MG                                    A085903   001
	
         PARKE DAVIS              100MG                                    A084762   001
	
         PERRIGO                  100MG                                    A084561   001
	
         PUREPAC PHARM            100MG                                    A085867   001
	
         VALEANT PHARM INTL       100MG                                    A085477   001
	
         VITARINE                 100MG                                    A085898   001
	
                                  100MG                                    A086273   001
	
        WATSON LABS               100MG                                    A085792   001
	
        WEST WARD                 100MG                                    A084926   001
	
        WHITEWORTH TOWN PLSN      100MG                                    A085798   001
	
        WYETH AYERST              100MG                                    A086390   001
	
 INJECTABLE;INJECTION
	
   SECOBARBITAL SODIUM
	
        ELKINS SINN               100MG/VIAL                               A083281 001
	
        WYETH AYERST              50MG/ML                                  A083262 001
	
   SECONAL SODIUM
	
        LILLY                     50MG/ML                                  N007392 002
	
 SUPPOSITORY;RECTAL
	
   SECONAL SODIUM
	
        LILLY		                   30MG                                     A086530   001
	
                                  60MG                                     A086530   002
	
                                  120MG                                    A086530   003
	
                                  200MG                                    A086530   004
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                              6-292(of 337)


SECRETIN
	
  INJECTABLE;INJECTION
	
    SECRETIN-FERRING
	
          FERRING
	               75CU/VIAL
	                                N018290 001
	
SECRETIN SYNTHETIC PORCINE
	
  FOR SOLUTION;INTRAVENOUS
	
    SECREFLO
	
         CHIRHOCLIN
	             16MCG/VIAL
	                               N021136 001
	 Apr 04, 2002
	
SELEGILINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    SELEGILINE HYDROCHLORIDE
	
         LANNETT HOLDINGS INC
	   5MG
	                                      A075145 001
	 Sep 15, 2003
	
  TABLET;ORAL
	
    SELEGILINE HYDROCHLORIDE
	
         DAVA PHARMS INC
	        5MG
	                                      A074641   001
	   Aug   02,   1996

         IVAX SUB TEVA PHARMS
	   5MG
	                                      A074756   001
	   Nov   25,   1998
	
         SIEGFRIED
	              5MG
	                                      A074672   001
	   Apr   01,   1997

         SOMERSET
	               5MG
	                                      N019334   001
	   Jun   05,   1989
	
         TEVA
	                   5MG
	                                      A074537   001
	   Aug   02,   1996

                                  5MG
	                                      A074744   001
	   Jan   27,   1997
	
         VINTAGE PHARMS LLC
	     5MG
	                                      A074565   001
	   Aug   02,   1996
	
SELENIUM SULFIDE
	
  LOTION/SHAMPOO;TOPICAL

    EXSEL
	
         ALLERGAN HERBERT
	       2.5%
	                                     A083892 001
	
    SELENIUM SULFIDE
	
         ACTAVIS MID ATLANTIC
	   2.5%
	                                     A084394 001
	
         G AND W LABS INC
	       2.5%
	                                     A086209 001
	
         IVAX PHARMS
	            2.5%
	                                     A085777 001
	
SELENOMETHIONINE SE-75
	
  INJECTABLE;INJECTION
	
    SELENOMETHIONINE SE 75
	
         GE HEALTHCARE
	          250uCi/ML
                                 N017257 001
	
         MALLINCKRODT
	           100uCi/ML
                                 N017098 001
	
         PHARMALUCENCE
	          500uCi/ML
	                                N017322 001
	
    SETHOTOPE
	
         BRACCO
	                 85-550uCi/ML
	                             N017047 001
	
SERACTIDE ACETATE
	
  INJECTABLE;INJECTION
	
    ACTHAR GEL-SYNTHETIC
	
         ARMOUR PHARM
	           40 UNITS/ML
                               N017861 001
	
                                  80 UNITS/ML
	                              N017861 002
	
SERMORELIN ACETATE
	
  INJECTABLE;INJECTION
	
    GEREF
	
         EMD SERONO
	             EQ 0.05MG BASE/AMP **Federal Register
     N019863 001
	 Dec 28, 1990
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

         EMD SERONO INC
	         EQ 0.5MG BASE/VIAL **Federal Register
     N020443 001
	 Sep 26, 1997
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

                                  EQ 1MG BASE/VIAL **Federal Register
       N020443 002
	 Sep 26, 1997
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**
	
SERTRALINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    SERTRALINE HYDROCHLORIDE
	
         RANBAXY LABS LTD
	       EQ 20MG BASE/ML
                           A078053 001
	 Feb 05, 2007
	
         ROXANE
	                 EQ 20MG BASE/ML
	                          A076934 001
	 Jun 30, 2006
	
  TABLET;ORAL
	
    SERTRALINE HYDROCHLORIDE
	
         ACTAVIS ELIZABETH
	      EQ   25MG BASE
	                           A077345   001
	   Feb   06,   2007
	
                                  EQ   50MG BASE
	                           A077345   002
	   Feb   06,   2007
	
                                  EQ   100MG BASE
	                          A077345   003
	   Feb   06,   2007
	
         CIPLA LTD
	              EQ   25MG BASE
	                           A077162   001
	   Feb   06,   2007
	
                                  EQ   50MG BASE
	                           A077162   002
	   Feb   06,   2007
	
                                  EQ   100MG BASE
	                          A077162   003
	   Feb   06,   2007
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                      6-293(of 337)


SERTRALINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    SERTRALINE HYDROCHLORIDE
	
         DR REDDYS LABS LTD      EQ   25MG BASE                   A076442   001    Apr   30,   2007

                                 EQ   50MG BASE                   A076442   002    Apr   30,   2007

                                 EQ   100MG BASE                  A076442   003    Apr   30,   2007

         IVAX SUB TEVA PHARMS    EQ   25MG BASE                   A075719   003    Jun   30,   2006
	
                                 EQ   50MG BASE                   A075719   001    Jun   30,   2006
	
                                 EQ   100MG BASE                  A075719   002    Jun   30,   2006
	
         MUTUAL PHARM            EQ   25MG BASE                   A077818   001    Feb   06,   2007
	
                                 EQ   50MG BASE                   A077818   002    Feb   06,   2007
	
                                 EQ   100MG BASE                  A077818   003    Feb   06,   2007
	
         MYLAN PHARMS INC        EQ   25MG BASE                   A076540   001    Mar   20,   2007
	
                                 EQ   50MG BASE                   A076540   002    Mar   20,   2007
	
                                 EQ   100MG BASE                  A076540   003    Mar   20,   2007
	
         PLIVA HRVATSKA DOO      EQ   25MG BASE                   A077299   001    Feb   06,   2007
	
                                 EQ   50MG BASE                   A077299   002    Feb   06,   2007
	
                                 EQ   100MG BASE                  A077299   003    Feb   06,   2007
	
         ROXANE                  EQ   25MG BASE                   A076881   001    Feb   06,   2007
	
                                 EQ   50MG BASE                   A076881   002    Feb   06,   2007
	
                                 EQ   100MG BASE                  A076881   003    Feb   06,   2007
	
         SANDOZ                  EQ   25MG BASE                   A077713   001    Feb   06,   2007
	
                                 EQ   50MG BASE                   A077713   002    Feb   06,   2007
	
                                 EQ   100MG BASE                  A077713   003    Feb   06,   2007
	
         WATSON LABS             EQ   25MG BASE                   A077663   001    Feb   06,   2007
	
                                 EQ   50MG BASE                   A077663   002    Feb   06,   2007
	
                                 EQ   100MG BASE                  A077663   003    Feb   06,   2007
	
   ZOLOFT
	
        PFIZER                   EQ 150MG BASE                    N019839 003 Dec 30, 1991
	
                                 EQ 200MG BASE                    N019839 004 Dec 30, 1991
	
SEVELAMER HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    RENAGEL
	
         GENZYME                 403MG                            N020926 001 Oct 30, 1998
	
SIBUTRAMINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    MERIDIA
	
         ABBOTT                  5MG                              N020632 001 Nov 22, 1997
	
                                 10MG                             N020632 002 Nov 22, 1997
	
                                 15MG                             N020632 003 Nov 22, 1997
	
SILVER SULFADIAZINE
	
  DRESSING;TOPICAL
	
    SILDAFLO
	
         FRANKLIN PHARMS         1%                               N019608 001 Nov 30, 1989
	
SIMETHICONE-CELLULOSE
	
  SUSPENSION;ORAL
	
    SONORX
	
         BRACCO                  7.5MG/ML                         N020773 001 Oct 29, 1998
	
SIMVASTATIN
	
  TABLET;ORAL
	
    SIMVASTATIN
	
         SANDOZ INC            5MG                                A077766   001    Dec   20,   2006
	
                               10MG                               A077766   002    Dec   20,   2006
	
                               20MG                               A077766   003    Dec   20,   2006
	
                               40MG                               A077766   004    Dec   20,   2006
	
                               80MG                               A077766   005    Dec   20,   2006
	
 TABLET, ORALLY DISINTEGRATING;ORAL
	
   SIMVASTATIN
	
        SYNTHON PHARMS         10MG                               N021961   001    Oct   09,   2007
	
                               20MG                               N021961   002    Oct   09,   2007
	
                               40MG                               N021961   003    Oct   09,   2007
	
                               80MG                               N021961   004    Oct   09,   2007
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE
	
  TABLET;ORAL
	
    JUVISYNC
	
         MERCK SHARP DOHME      10MG;EQ   50MG BASE               N202343   004    Sep   18,   2012

                                10MG;EQ   100MG BASE              N202343   001    Oct   07,   2011
	
                                20MG;EQ   50MG BASE               N202343   005    Sep   18,   2012

                                20MG;EQ   100MG BASE              N202343   002    Oct   07,   2011
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                             6-294(of 337)


SIMVASTATIN; SITAGLIPTIN PHOSPHATE
	
  TABLET;ORAL
	
    JUVISYNC
	
                                40MG;EQ 50MG BASE                       N202343 006 Sep 18, 2012

                                40MG;EQ 100MG BASE                      N202343 003 Oct 07, 2011
	
SIROLIMUS
	
  TABLET;ORAL
	
    RAPAMUNE
	
         PF PRISM CV            5MG **Federal Register determination    N021110 003 Feb 23, 2004

                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
SODIUM BENZOATE; SODIUM PHENYLACETATE
	
  SOLUTION;ORAL
	
    UCEPHAN
	
         B BRAUN                100MG/ML;100MG/ML                       N019530 001 Dec 23, 1987
	
SODIUM BICARBONATE
	
  INJECTABLE;INJECTION
	
    SODIUM BICARBONATE IN PLASTIC CONTAINER
	
         ABBOTT                 0.9MEQ/ML                               N019443 001 Jun 03, 1986
	
                                1MEQ/ML                                 N019443 002 Jun 03, 1986
	
SODIUM BICARBONATE; TARTARIC ACID
	
  GRANULE, EFFERVESCENT;ORAL
	
    BAROS
	
         MALLINCKRODT INC       460MG/GM;420MG/GM                       N018509 001 Aug 07, 1985
	
SODIUM CHLORIDE
	
  INJECTABLE;INJECTION
	
    BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         ABRAXIS PHARM          9MG/ML                                  A088909 001 Feb 07, 1985
	
    SODIUM CHLORIDE
	
         ABBOTT                 20GM/100ML                              N017013 001
	
         B BRAUN                20GM/100ML                              N017038 001
	
    SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         B BRAUN                450MG/100ML                             N018184 001
	
         MILES                  450MG/100ML                             N018503 001
	
    SODIUM CHLORIDE 0.9%
	
         MEDEFIL INC		          18MG/2ML (9MG/ML)                       N202832   002    Jan   06,   2012
	
                                22.5MG/2.5ML (9MG/ML)                   N202832   003    Jan   06,   2012
	
                                27MG/3ML (9MG/ML)                       N202832   004    Jan   06,   2012
	
                                45MG/5ML (9MG/ML)                       N202832   005    Jan   06,   2012
	
    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
	
         ABBOTT                 9MG/ML                                  N019218 001 Jul 13, 1984
	
         MEDEFIL INC            9MG/ML (9MG/ML)                         N202832 001 Jan 06, 2012
	
         MILES                  900MG/100ML                             N018502 001
	
    SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER
	
         ABRAXIS PHARM          234MG/ML                                N019329 001 Apr 22, 1987

    SODIUM CHLORIDE 3% IN PLASTIC CONTAINER
	
         B BRAUN                3GM/100ML                               N019635 003 Mar 09, 1988
	
    SODIUM CHLORIDE 5% IN PLASTIC CONTAINER
	
         B BRAUN                5GM/100ML                               N019635 004 Mar 09, 1988
	
  SOLUTION;IRRIGATION
	
    SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE        450MG/100ML                             N017864   001
	
                                450MG/100ML                             N018497   001 Feb 19, 1982
	
         HOSPIRA                450MG/100ML                             N017670   001
	
                                450MG/100ML                             N018380   001
	
    SODIUM CHLORIDE IN PLASTIC CONTAINER
	
         MILES                  900MG/100ML                             N018247 001
	
SODIUM CHROMATE CR-51
	
  INJECTABLE;INJECTION
	
    CHROMITOPE SODIUM
	
         BRACCO                 2mCi/VIAL                               N013993 002
	
                                200uCi/ML                               N013993 001
	
   SODIUM CHROMATE CR 51
	
        MALLINCKRODT            100uCi/ML                               N016708 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                              6-295(of 337)


SODIUM FLUORIDE F-18
	
  INJECTABLE;INTRAVENOUS
	
    FLUORINE F-18
	
         GE HEALTHCARE          2mCi/ML **Federal Register                 N017042 001
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

   SODIUM FLUORIDE F 18
	
        NIH NCI DCTD            10-200mCi/ML                               N022494 001 Jan 26, 2011
	
SODIUM IODIDE I-123
	
  CAPSULE;ORAL
	
    SODIUM IODIDE I 123
	
         CARDINAL HLTH 414      400uCi                                     N018671 003 May 27, 1982

         GE HEALTHCARE          100uCi                                     N017630 001
	
  SOLUTION;ORAL
	
    SODIUM IODIDE I 123
	
         GE HEALTHCARE          2mCi/ML                                    N017630 002
	
SODIUM IODIDE I-131
	
  CAPSULE;ORAL
	
    IODOTOPE
	
         BRACCO                 1-130mCi                                   N010929 001
	
                                1-150mCi                                   N010929 003
	
   SODIUM IODIDE I 131
	
        CIS                     50uCi                                      N017316   001
	
                                100uCi                                     N017316   002
	
         MALLINCKRODT           0.8-100mCi                                 N016515   002
	
                                15-100uCi                                  N016517   002
	
   SODIUM IODIDE I-131
	
        JUBILANT DRAXIMAGE      2-200mCi                                   N021305 004 Nov 18, 2004
	
 SOLUTION;ORAL
	
   HICON
	
        JUBILANT DRAXIMAGE      1-250mCi/0.25ML                            N021305 002 Jan 24, 2003
	
                                1-500mCi/0.5ML                             N021305 003 Jan 24, 2003
	
                                1-1000mCi/ML                               N021305 005 Apr 04, 2006

   IODOTOPE
	
        BRACCO                  7-106mCi/BOT                               N010929 002
	
   SODIUM IODIDE I 131
	
        CIS                     50mCi/ML                                   N017315 001
	
SODIUM LACTATE
	
  INJECTABLE;INJECTION
	
    SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
	
         B BRAUN                1.87GM/100ML                               N018186 001
	
         HOSPIRA                1.87GM/100ML                               N018249 001
	
SODIUM MONOFLUOROPHOSPHATE
	
  GEL;DENTAL
	
    EXTRA-STRENGTH AIM
	
         CHESEBROUGH PONDS      1.2%                                       N019518 002 Aug 06, 1986

  PASTE;DENTAL
	
    EXTRA-STRENGTH AIM
	
         CHESEBROUGH PONDS      1.2%                                       N019518 001 Jun 03, 1987
	
SODIUM NITROPRUSSIDE
	
  INJECTABLE;INJECTION
	
    NIPRIDE
	
         ROCHE                  50MG/VIAL                                  N017546 001
	
    NITROPRESS
	
         ABBOTT                 50MG/VIAL                                  A071555 001 Nov 16, 1987
	
         ABBVIE                 50MG/VIAL                                  N018450 001
	
         HOSPIRA                50MG/VIAL                                  A070566 001 Jun 09, 1986
	
    SODIUM NITROPRUSSIDE
	
         ABRAXIS PHARM          50MG/VIAL                                  A070031 001 Jan 17, 1985
	
         BAXTER HLTHCARE        50MG/VIAL                                  N018581 001 Jul 28, 1982
	
         TEVA PARENTERAL        25MG/ML                                    A073465 001 Mar 30, 1992
	
SODIUM PHOSPHATE P-32
	
  SOLUTION;INJECTION, ORAL
	
    PHOSPHOTOPE
	
         BRACCO                 1-8mCi/VIAL                                N010927 001
	
    SODIUM PHOSPHATE P 32
	
         MALLINCKRODT           0.67mCi/ML                                 N011777 001
	
                                1.5mCi/VIAL                                N011777 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                              6-296(of 337)


SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
	
  TABLET;ORAL
	
    VISICOL
	
         SALIX PHARMS           0.398GM;1.102GM                           N021097 001 Sep 21, 2000
	
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
	
  TABLET;ORAL
	
    MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
	
         NOVEL LABS INC         0.398GM;1.102GM                           A079247 001 Dec 30, 2011
	
SODIUM POLYSTYRENE SULFONATE
	
  POWDER;ORAL, RECTAL
	
    SODIUM POLYSTYRENE SULFONATE
	
         CITRUSPHRMA            454GM/BOT                                 A040909 001 Dec 03, 2008
	
         WOCKHARDT              453.6GM/BOT                               A088786 001 Sep 11, 1984

  SUSPENSION;ORAL, RECTAL
	
    SODIUM POLYSTYRENE SULFONATE
	
         MORTON GROVE           15GM/60ML                                 A088717 001 Sep 11, 1984

         ROXANE                 15GM/60ML                                 A088453 001 Nov 17, 1983
	
SODIUM SUCCINATE
	
  INJECTABLE;INJECTION
	
    SODIUM SUCCINATE
	
         ELKINS SINN             30%                                      A080516 001
	
SODIUM TETRADECYL SULFATE
	
  INJECTABLE;INJECTION
	
    SOTRADECOL
	
         ELKINS SINN             1% **Federal Register determination      N005970 004
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
                                 3% **Federal Register determination      N005970 005
	
                                 that product was not discontinued or

                                 withdrawn for safety or efficacy

                                 reasons**
	
SODIUM THIOSULFATE
	
  INJECTABLE;INJECTION
	
    SODIUM THIOSULFATE
	
         US ARMY                 250MG/ML                                 N020166 001 Feb 14, 1992
	
SOMATREM
	
  INJECTABLE;INJECTION
	
    PROTROPIN
	
          GENENTECH              5MG/VIAL                                 N019107 001 Oct 17, 1985
	
                                 10MG/VIAL                                N019107 002 Oct 24, 1989
	
SOMATROPIN
	
  INJECTABLE;INJECTION
	
    ASELLACRIN 10
	
         SERONO                  10 IU/VIAL                               N017726 001
	
    ASELLACRIN 2
	
         SERONO                  2 IU/VIAL                                N017726 002 Jul 21, 1983
	
    CRESCORMON
	
         GENENTECH               4 IU/VIAL                                N017992 001
	
SOMATROPIN RECOMBINANT
	
  INJECTABLE;INJECTION
	
    ACCRETROPIN
	
         EMERGENT                5MG/ML (5MG/ML)                          N021538 001 Jan 23, 2008
	
    BIO-TROPIN
	
         FERRING                 4.8MG/VIAL                               N019774 001 May 25, 1995

    HUMATROPE
	
         LILLY                   2MG/VIAL                                 N019640 001 Jun 23, 1987
	
    NORDITROPIN
	
         NOVO NORDISK INC		      4MG/VIAL                                 N019721   001    May   08,   1995

                                 5MG/1.5ML                                N021148   001    Jun   20,   2000
	
                                 8MG/VIAL                                 N019721   002    May   08,   1995

                                 10MG/1.5ML                               N021148   002    Jun   20,   2000
	
                                 15MG/1.5ML                               N021148   003    Jun   20,   2000
	
   NORDITROPIN NORDIFLEX
	
        NOVO NORDISK INC		       5MG/1.5ML                                N021148 004 Oct 01, 2004
	
                                 10MG/1.5ML                               N021148 005 Oct 01, 2004
	
                                 15MG/1.5ML                               N021148 006 Oct 01, 2004
	
   NUTROPIN DEPOT
	
        GENENTECH                13.5MG/VIAL                              N021075 001 Dec 22, 1999
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                    6-297(of 337)


SOMATROPIN RECOMBINANT
	
  INJECTABLE;INJECTION
	
    NUTROPIN DEPOT
	
                                 18MG/VIAL
                       N021075 002 Dec 22, 1999
	
                                 22.5MG/VIAL
                     N021075 003 Dec 22, 1999
	
    SAIZEN
	
         EMD SERONO              4MG/VIAL
                        N019764 005 Jan 16, 2007
	
                                 6MG/VIAL
                        N019764 001 Oct 08, 1996
	
    SEROSTIM
	
         EMD SERONO              8.8MG/VIAL
                      N020604 004 Sep 06, 2001
	
    ZORBTIVE
	
         EMD SERONO		            4MG/VIAL
                        N021597 001 Dec 01, 2003
	
                                 5MG/VIAL
                        N021597 002 Dec 01, 2003
	
                                 6MG/VIAL
                        N021597 003 Dec 01, 2003
	
  INJECTABLE;SUBCUTANEOUS
	
    SEROSTIM LQ
	
         EMD SERONO              6MG/0.5ML (6MG/0.5ML)
	          N020604 005 Feb 11, 2005
	
SORBITOL
	
  SOLUTION;IRRIGATION
	
    SORBITOL 3% IN PLASTIC CONTAINER
	
          BAXTER HLTHCARE       3GM/100ML
	                       N018512 001 May 27, 1982
	
SOTALOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    BETAPACE
	
         BAYER HLTHCARE          320MG
	                          N019865 004 Oct 30, 1992
	
    BETAPACE AF
	
         COVIS PHARMA SARL		     40MG
	                           N021151 006 Apr 02, 2003

                                 60MG
	                           N021151 007 Apr 02, 2003

                                 100MG
	                          N021151 005 Mar 14, 2003
	
    SOTALOL HYDROCHLORIDE
	
         MUTUAL PHARM		          80MG
	                           A075515   001    Oct   15,   2001
	
                                 80MG
	                           A076576   001    Apr   08,   2004

                                 120MG
	                          A075515   004    Oct   15,   2001
	
                                 120MG
	                          A076576   002    Apr   08,   2004

                                 160MG
	                          A075515   002    Oct   15,   2001
	
                                 160MG
	                          A076576   003    Apr   08,   2004

                                 240MG
	                          A075515   003    Oct   15,   2001
	
         WATSON LABS		           80MG
	                           A075238   001    Jul   13,   2000
	
                                 120MG
	                          A075238   002    Jul   13,   2000
	
                                 160MG
	                          A075238   003    Jul   13,   2000
	
                                 240MG
	                          A075238   004    Jul   13,   2000
	
SOYBEAN OIL
	
  INJECTABLE;INJECTION
	
    LIPOSYN III 10%
	
         HOSPIRA                 10%
	                            N018969 001 Sep 24, 1984
	
    LIPOSYN III 20%
	
         HOSPIRA                 20%
	                            N018970 001 Sep 25, 1984
	
    LIPOSYN III 30%
	
         HOSPIRA                 30%
	                            N020181 001 Jan 13, 1998
	
    SOYACAL 10%
	
         ALPHA THERA             10%
	                            N018465 001 Jun 29, 1983
	
    SOYACAL 20%
	
         ALPHA THERA             20%
	                            N018786 001 Jun 29, 1983
	
    TRAVAMULSION 10%
	
         BAXTER HLTHCARE         10%
	                            N018660 001 Feb 26, 1982
	
    TRAVAMULSION 20%
	
         BAXTER HLTHCARE         20%
	                            N018758 001 Feb 15, 1983
	
SPARFLOXACIN
	
  TABLET;ORAL
	
    ZAGAM
	
         MYLAN                   200MG
	                          N020677 001 Dec 19, 1996
	
SPECTINOMYCIN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    TROBICIN
	
         PFIZER                  EQ 2GM BASE/VIAL
                N050347 001
	
                                 EQ 4GM BASE/VIAL
	               N050347 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                   6-298(of 337)


SPIRAPRIL HYDROCHLORIDE
	
  TABLET;ORAL
	
    RENORMAX
	
         SCHERING
	             3MG
	                           N020240   001     Dec   29,   1994
	
                                6MG
	                           N020240   002     Dec   29,   1994
	
                                12MG
	                          N020240   003     Dec   29,   1994
	
                                24MG
	                          N020240   004     Dec   29,   1994
	
SPIRONOLACTONE
	
  TABLET;ORAL
	
    SPIRONOLACTONE
	
         ASCOT
	                25MG
	                          A087687   001     Oct 20, 1982
	
         IVAX PHARMS
	          25MG
	                          A087108   001
	
         LEDERLE
	              25MG
	                          A087634   001
	
         MUTUAL PHARM
	         25MG
	                          A087265   001
	
         MYLAN
	                25MG
	                          A087086   001
	
         PUREPAC PHARM
	        25MG
	                          A087998   001     Oct 14, 1983
	
                                25MG
	                          A088053   001     Aug 25, 1983

         SUPERPHARM
	           25MG
	                          A089364   001     Nov 07, 1986
	
         UPSHER SMITH
	         25MG
	                          A087554   001
	
         VANGARD
	              25MG
	                          A087648   001     Feb 01, 1982
	
         WARNER CHILCOTT
	      25MG
	                          A087952   001     Nov 18, 1982
	
         WATSON LABS
	          25MG
	                          A086898   002     Mar 02, 1982
	
                                25MG
	                          A087078   001
	
STANOZOLOL
	
  TABLET;ORAL
	
    WINSTROL
	
         LUNDBECK INC
	         2MG
	                           N012885 001 May 14, 1984
	
STAVUDINE
	
  CAPSULE;ORAL
	
    ZERIT
	
         BRISTOL MYERS SQUIBB   5MG
	                           N020412 001 Jun 24, 1994
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    ZERIT XR
	
         BRISTOL MYERS SQUIBB		 37.5MG
	                        N021453   001     Dec   31,   2002
	
                                50MG
	                          N021453   002     Dec   31,   2002
	
                                75MG
	                          N021453   003     Dec   31,   2002
	
                                100MG
	                         N021453   004     Dec   31,   2002
	
STERILE WATER FOR INJECTION
	
  LIQUID;N/A

    BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER
	
         ABRAXIS PHARM          100%
	                          A089099 001 Dec 29, 1987
	
                                100%
	                          A089100 001 Dec 29, 1987
	
    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER
	
         B BRAUN                100%
	                          N019077 001 Mar 02, 1984
	
STERILE WATER FOR IRRIGATION
	
  LIQUID;IRRIGATION
	
    STERILE WATER IN PLASTIC CONTAINER
	
         MILES
	                100%
	                          N018246 001
	
STREPTOMYCIN SULFATE
	
  INJECTABLE;INJECTION
	
    STREPTOMYCIN SULFATE
	
         COPANOS
	              EQ   500MG BASE/ML
             A060684   001
	
         LILLY
	                EQ   1GM BASE/VIAL
             A060107   001
	
                                EQ   1GM BASE/2ML
              A060404   001
	
                                EQ   5GM BASE/VIAL
             A060107   002
	
         PFIZER
	               EQ   1GM BASE/VIAL
             A060076   001
	
                                EQ   1GM BASE/2.5ML
            A060111   001
	
                                EQ   5GM BASE/VIAL
	            A060076   002
	
SUCCINYLCHOLINE CHLORIDE
	
  INJECTABLE;INJECTION
	
    ANECTINE
	
         SANDOZ
	               1GM/VIAL
                       N008453 004
	
                                50MG/ML
                        N008453 003
	
                                500MG/VIAL
	                    N008453 001
	
   QUELICIN PRESERVATIVE FREE
	
        HOSPIRA
	               50MG/ML
	                       N008845 002
	
   SUCCINYLCHOLINE CHLORIDE
	
        INTL MEDICATION
	       100MG/VIAL
                     A085400 001 Feb 04, 1982
	
        ORGANON USA INC
	       20MG/ML
	                       A080997 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                    6-299(of 337)


SUCCINYLCHOLINE CHLORIDE
	
  INJECTABLE;INJECTION
	
    SUCOSTRIN
	
         APOTHECON               20MG/ML
                         N008847 001
	
                                 100MG/ML
	                       N008847 003
	
SUFENTANIL CITRATE
	
  INJECTABLE;INJECTION
	
    SUFENTANIL CITRATE
	
         WATSON LABS             EQ 0.05MG BASE/ML
	              A074406 001 Dec 15, 1995
	
SULFACETAMIDE SODIUM
	
  OINTMENT;OPHTHALMIC
	
    BLEPH-10
	
         ALLERGAN                10%
	                            A084015 001
	
    SODIUM SULAMYD
	
         SCHERING                10%
	                            N005963 002
	
    SULFAIR 10
	
         PHARMAFAIR              10%
	                            A088000 001 Dec 22, 1982
	
  SOLUTION/DROPS;OPHTHALMIC

    BLEPH-30
	
         ALLERGAN                30%
	                            A080028 002
	
    ISOPTO CETAMIDE
	
         ALCON                   15%
	                            A080020 002
	
    OCUSULF-10
	
         MIZA PHARMS USA         10%
	                            A080660 001
	
    OCUSULF-30
	
         MIZA PHARMS USA         30%
	                            A080660 002
	
    SODIUM SULAMYD
	
         SCHERING                10%
	                            N005963 001
	
                                 30%
	                            N005963 003
	
   SODIUM SULFACETAMIDE
	
        AKORN		                  10%
	                            A083021   001
	
                                 15%
	                            A083021   002
	
                                 30%
	                            A083021   003
	
         SOLA BARNES HIND		      10%
	                            A084143   001
	
                                 10%
	                            A084145   001
	
                                 30%
	                            A084146   001
	
                                 30%
	                            A084147   001
	
   SULF-10
	
        NOVARTIS                 10%
	                            A080025 001
	
   SULF-15
	
        NOVARTIS                 15%
	                            A089047 001 Oct 31, 1995
	
   SULFACEL-15
	
        OPTOPICS                 15%
	                            A080024 001
	
   SULFACETAMIDE SODIUM
	
        AKORN                    10%
	                            A040215   001     May   25,   1999

                                 30%
	                            A040216   001     May   25,   1999

        ALCON PHARMS LTD         30%
	                            A089068   001     May   05,   1987

        PHARMAFAIR               10%
	                            A088947   001     May   17,   1985
	
   SULFAIR 10
	
        PHARMAFAIR               10%
	                            A087949 001 Dec 13, 1982
	
   SULFAIR FORTE
	
        PHARMAFAIR               30%
	                            A088385 001 Oct 13, 1983
	
   SULFAIR-15
	
        PHARMAFAIR               15%
	                            A088186 001 May 25, 1983
	
   SULTEN-10
	
        BAUSCH AND LOMB          10%
	                            A087818 001 Feb 03, 1983
	
SULFACYTINE
	
  TABLET;ORAL
	
    RENOQUID
	
         GLENWOOD                250MG
	                          N017569 001
	
SULFADIAZINE
	
  TABLET;ORAL
	
    SULFADIAZINE
	
         ABBVIE                  300MG
	                          N004125   005
	
         EVERYLIFE               500MG
	                          A080088   001
	
         IMPAX LABS              500MG
	                          A080081   001
	
         LANNETT                 500MG
	                          A080084   001
	
         LEDERLE                 500MG
	                          N004054   001
	
         LILLY                   500MG
	                          N004122   002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                      6-300(of 337)


SULFADIAZINE SODIUM
	
  INJECTABLE;INJECTION
	
    SULFADIAZINE SODIUM
	
         LEDERLE
	               250MG/ML
	                       N004054 002
	
SULFADIAZINE; SULFAMERAZINE
	
  SUSPENSION;ORAL
	
    SULFONAMIDES DUPLEX
	
         LILLY
	                 250MG/5ML;250MG/5ML
	            N006317 007
	
SULFAMETER
	
  TABLET;ORAL
	
    SULLA
	
         BAYER HLTHCARE
	        500MG
	                          N016000 002
	
SULFAMETHIZOLE
	
  TABLET;ORAL
	
    MICROSUL
	
         FOREST PHARMS
	         1GM
	                            A086012 001
	
    PROKLAR
	
         FOREST PHARMS
	         500MG
	                          A080273 001
	
    THIOSULFIL
	
         WYETH AYERST
	          250MG
	                          N008565 001
	
                                 500MG
	                          N008565 004
	
SULFAMETHOXAZOLE
	
  SUSPENSION;ORAL
	
    GANTANOL
	
         ROCHE
	                 500MG/5ML
	                      N013664 002
	
  TABLET;ORAL
	
    GANTANOL
	
         ROCHE
	                 500MG
	                          N012715 002
	
    GANTANOL-DS
	
         ROCHE
	                 1GM
	                            N012715 003
	
    SULFAMETHOXAZOLE
	
         ASCOT
	                 500MG
	                          A087662   001 Oct 20, 1982
	
         BARR
	                  500MG
	                          A087189   001 Jul 25, 1983
	
         HEATHER
	               500MG
	                          A086163   001
	
         SANDOZ
	                500MG
	                          A085844   001
	
         WATSON LABS
	           1GM
	                            A086000   001
	
                                 500MG
	                          A085053   001
	
    UROBAK
	
         SHIONOGI
	              500MG
	                          A087307 001
	
SULFAMETHOXAZOLE; TRIMETHOPRIM
	
  INJECTABLE;INJECTION
	
    BACTRIM
	
         MUTUAL PHARM
	          80MG/ML;16MG/ML
	                N018374 001
	
    SEPTRA
	
         MONARCH PHARMS
	        80MG/ML;16MG/ML
	                N018452 001
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM
	
         ABRAXIS PHARM
	         80MG/ML;16MG/ML
                 A070223   001    Dec   29,   1987
	
         BEDFORD
	               80MG/ML;16MG/ML
                 A072383   001    Apr   29,   1992

         HIKMA MAPLE
	           80MG/ML;16MG/ML
                 A070627   001    Dec   29,   1987
	
                                 80MG/ML;16MG/ML
                 A070628   001    Dec   29,   1987
	
         HOSPIRA
	               80MG/ML;16MG/ML
                 A073199   001    Sep   11,   1992

         WATSON LABS
	           80MG/ML;16MG/ML
	                A071556   001    Dec   29,   1987
	
  SUSPENSION;ORAL
	
    BACTRIM
	
         MUTUAL PHARM
	          200MG/5ML;40MG/5ML
	             N017560 001
	
    BACTRIM PEDIATRIC
	
         MUTUAL PHARM
	          200MG/5ML;40MG/5ML
	             N017560 002
	
    SEPTRA
	
         MONARCH PHARMS
	        200MG/5ML;40MG/5ML
	             N017598 001
	
    SEPTRA GRAPE
	
         MONARCH PHARMS
	        200MG/5ML;40MG/5ML
	             N017598 002 Feb 12, 1986
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM
	
         TEVA
	                  200MG/5ML;40MG/5ML
              A070028   001    Jun   02,   1987
	
                                 200MG/5ML;40MG/5ML
              N018812   001    Jan   28,   1983
	
                                 200MG/5ML;40MG/5ML
              N018812   002    Jun   10,   1983
	
         TEVA PHARMS
	           200MG/5ML;40MG/5ML
	             A077612   001    Nov   13,   2006
	
    SULFATRIM
	
         STI PHARMA LLC
	        200MG/5ML;40MG/5ML
	             N018615 002 Jan 07, 1983
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                      6-301(of 337)


SULFAMETHOXAZOLE; TRIMETHOPRIM
	
  SUSPENSION;ORAL
	
    SULMEPRIM
	
         USL PHARMA              200MG/5ML;40MG/5ML             A070063 001 Aug 01, 1986

    SULMEPRIM PEDIATRIC
	
         USL PHARMA              200MG/5ML;40MG/5ML             A070064 001 Aug 01, 1986

    TRIMETH/SULFA

         ALPHARMA US PHARMS      200MG/5ML;40MG/5ML             A072289 001 May 23, 1988

                                 200MG/5ML;40MG/5ML             A072398 001 May 23, 1988

         NASKA                   200MG/5ML;40MG/5ML             A072399 001 May 23, 1988

  TABLET;ORAL
	
    COTRIM
	
         TEVA                    400MG;80MG                     A070034 001 May 16, 1985

    COTRIM D.S.
	
         TEVA                    800MG;160MG                    A070048 001 Mar 18, 1985
	
    SULFAMETHOPRIM
	
         NOVEL LABS INC          400MG;80MG                     A070022 001 Feb 15, 1985
	
    SULFAMETHOPRIM-DS
	
         NOVEL LABS INC          800MG;160MG                    A070032 001 Feb 15, 1985
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM
	
         HEATHER                 400MG;80MG                     N018946   001     Aug   10,   1984

                                 800MG;160MG                    N018946   002     Aug   10,   1984

         INTERPHARM              400MG;80MG                     A071299   001     Oct   27,   1987
	
                                 800MG;160MG                    A071300   001     Oct   27,   1987
	
         MARTEC USA LLC          400MG;80MG                     A072408   001     Dec   07,   1988
	
         MUTUAL PHARM            400MG;80MG                     A070006   001     Nov   14,   1984
	
                                 400MG;80MG                     A071016   001     Aug   25,   1986

         PLIVA                   400MG;80MG                     A070215   001     Sep   10,   1985

                                 800MG;160MG                    A070216   001     Sep   10,   1985

         ROXANE                  400MG;80MG                     A072768   001     Aug   30,   1991

         SANDOZ                  400MG;80MG                     A070889   001     Nov   13,   1986
	
                                 400MG;80MG                     N018598   003     May   19,   1982

                                 800MG;160MG                    A070890   001     Nov   13,   1986
	
         TEVA                    400MG;80MG                     N018242   001
	
                                 800MG;160MG                    N018242   002
	
         USL PHARMA              400MG;80MG                     A070203   001     Nov   08,   1985
	
                                 800MG;160MG                    A070204   001     Nov   08,   1985
	
         WATSON LABS		           400MG;80MG                     A070002   001     Nov   07,   1984
	
                                 400MG;80MG                     N018852   001     May   09,   1983

                                 800MG;160MG                    A070000   001     Nov   07,   1984
	
    SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
	
         MARTEC USA LLC          800MG;160MG                    A072417   001     Dec   07,   1988
	
         MUTUAL PHARM            800MG;160MG                    A070007   001     Nov   14,   1984
	
         ROXANE                  800MG;160MG                    A072769   001     Aug   30,   1991

         SANDOZ                  800MG;160MG                    N018598   004     May   19,   1982

         WATSON LABS             800MG;160MG                    N018854   001     May   09,   1983

    SULFATRIM-DS
	
         SUPERPHARM              800MG;160MG                    A070066 001 Jun 24, 1985
	
    SULFATRIM-SS
	
         SUPERPHARM              400MG;80MG                     A070065 002 Jun 24, 1985
	
    UROPLUS DS
	
         SHIONOGI                800MG;160MG                    A071816 001 Sep 28, 1987

    UROPLUS SS
	
         SHIONOGI                400MG;80MG                     A071815 001 Sep 28, 1987
	
SULFANILAMIDE
	
  CREAM;VAGINAL
	
    SULFANILAMIDE
	
          TEVA                  15%                             A088718 001 Sep 19, 1985

  SUPPOSITORY;VAGINAL
	
    AVC
	
          MEDA PHARMS           1.05GM                          N006530 004 Jan 27, 1987
	
SULFAPHENAZOLE
	
  SUSPENSION;ORAL
	
    SULFABID
	
         PHARM RES ASSOC        500MG/5ML                       N013093 001
	
  TABLET;ORAL
	
    SULFABID
	
         PURDUE FREDERICK       500MG                           N013092 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-302(of 337)


SULFAPYRIDINE
	
  TABLET;ORAL
	
    SULFAPYRIDINE
	
         LILLY                  500MG                                    N000159 001
	
SULFASALAZINE
	
  SUSPENSION;ORAL
	
    AZULFIDINE
	
         PHARMACIA AND UPJOHN   250MG/5ML                                N018605 001
	
  TABLET;ORAL
	
    S.A.S.-500
	
         SOLVAY                 500MG                                    A083450 001
	
    SULFASALAZINE
	
         HERITAGE PHARMS INC    500MG                                    A080197   001
	
         MUTUAL PHARM           500MG                                    A089590   001 Oct 19, 1987
	
         SANDOZ                 500MG                                    A086184   001
	
         SUPERPHARM             500MG                                    A089339   001 Oct 26, 1987
	
         WATSON LABS            500MG                                    A084964   001
	
                                500MG                                    A087197   001
	
  TABLET, DELAYED RELEASE;ORAL
	
    SULFASALAZINE
	
         WATSON LABS             500MG                                   A088052 001 May 24, 1983
	
SULFINPYRAZONE
	
  CAPSULE;ORAL
	
    ANTURANE
	
         NOVARTIS               200MG **Federal Register determination   N011556 004
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
    SULFINPYRAZONE
	
         BARR                   200MG                                    A087666   001     Sep   17,   1982

         IVAX PHARMS            200MG                                    A087770   001     Nov   19,   1982
	
         PAR PHARM              200MG                                    A088934   001     Sep   06,   1985

         VANGARD                200MG                                    A088666   001     Feb   17,   1984
	
  TABLET;ORAL
	
    ANTURANE
	
         NOVARTIS		             100MG **Federal Register determination   N011556 003
	
                                that product was not discontinued or

                                withdrawn for safety or efficacy

                                reasons**
	
    SULFINPYRAZONE
	
         BARR                   100MG                                    A087665   001     Sep   17,   1982

         IVAX PHARMS            100MG                                    A087769   001     Jun   01,   1982
	
         PAR PHARM              100MG                                    A088933   001     Sep   06,   1985

         WATSON LABS            100MG                                    A087667   001     May   26,   1982
	
SULFISOXAZOLE
	
  TABLET;ORAL
	
    GANTRISIN
	
         ROCHE                  500MG                                    N006525 001
	
    SOSOL
	
         MK LABS                500MG                                    A080036 001
	
    SOXAZOLE
	
         ALRA                   500MG                                    A080366 001
	
    SULFALAR
	
         PARKE DAVIS            500MG                                    A084955 001
	
    SULFISOXAZOLE
	
         BARR                   500MG                                    A084031   001
	
         HEATHER                500MG                                    A080189   001
	
         IMPAX LABS             500MG                                    A080109   001
	
         IVAX SUB TEVA PHARMS   500MG                                    A080142   001
	
         LANNETT                500MG                                    A080085   001
	
         LEDERLE                500MG                                    A087649   001
	
         PHARMERAL              500MG                                    A084385   001
	
         PUREPAC PHARM          500MG                                    A080087   001
	
         ROXANE                 500MG                                    A080082   001
	
         SANDOZ                 500MG                                    A085628   001
	
         VALEANT PHARM INTL     500MG                                    A080268   002
	
         VITARINE               500MG                                    A087332   001
	
         WATSON LABS            500MG                                    A085534   001
	
         WEST WARD              500MG                                    A080379   001
	
    SULSOXIN
	
         SOLVAY                 500MG                                    A080040 001
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                                   6-303(of 337)


SULFISOXAZOLE ACETYL
	
  EMULSION;ORAL
	
    LIPO GANTRISIN
	
         ROCHE
	                 EQ 1GM BASE/5ML
	                               N009182 009
	
  SUSPENSION;ORAL
	
    GANTRISIN PEDIATRIC
	
         ROCHE
	                 EQ 500MG BASE/5ML
	                             N009182 004
	
  SYRUP;ORAL
	
    GANTRISIN
	
         ROCHE
	                 EQ 500MG BASE/5ML
	                             N009182 002
	
SULFISOXAZOLE DIOLAMINE
	
  INJECTABLE;INJECTION
	
    GANTRISIN
	
         ROCHE
	                 EQ 400MG BASE/ML
	                              N006917 001
	
  OINTMENT;OPHTHALMIC
	
    GANTRISIN
	
         ROCHE
	                 EQ 4% BASE
	                                    N008414 002
	
  SOLUTION/DROPS;OPHTHALMIC

    GANTRISIN
	
         ROCHE
	                 EQ 4% BASE
	                                    N007757 002
	
    SULFISOXAZOLE DIOLAMINE
	
         SOLA BARNES HIND
	      EQ 4% BASE
	                                    A084148 001
	
SULFOXONE SODIUM
	
  TABLET, DELAYED RELEASE;ORAL
	
    DIASONE SODIUM
	
         ABBVIE
	                165MG
	                                         N006044 003
	
SULFUR
	
  POWDER;TOPICAL
	
    BENSULFOID
	
         POYTHRESS
	             33.32%
	                                        N002918 001
	
SULINDAC
	
  TABLET;ORAL
	
    CLINORIL
	
          MERCK
	                150MG
	                                         N017911 001
	
    SULINDAC
	
          SANDOZ
	               150MG
	                                         A072712   001    Aug   30,   1991

                                 200MG
	                                         A072713   001    Aug   30,   1991

          TEVA
	                 150MG
	                                         A072972   001    Feb   28,   1992
	
                                 200MG
	                                         A072973   001    Feb   28,   1992
	
SUMATRIPTAN
	
  SPRAY;NASAL
	
    IMITREX
	
         GLAXOSMITHKLINE
	       10MG/SPRAY
	                                    N020626 002 Aug 26, 1997
	
SUMATRIPTAN SUCCINATE
	
  INJECTABLE;SUBCUTANEOUS
	
    SUMATRIPTAN SUCCINATE
	
         FRESENIUS KABI USA
	    EQ   6MG   BASE/0.5ML   (EQ   12MG BASE/ML)
    A079240   002    Sep   18,   2009

                                 EQ   4MG   BASE/0.5ML   (EQ   8MG BASE/ML)
     A079240   001    Sep   18,   2009

          SANDOZ
	               EQ   4MG   BASE/0.5ML   (EQ   8MG BASE/ML)
     A078067   002    Feb   06,   2009
	
                                 EQ   6MG   BASE/0.5ML   (EQ   12MG BASE/ML)
    A078067   001    Feb   06,   2009
	
          TEVA PARENTERAL
	      EQ   4MG   BASE/0.5ML   (EQ   8MG BASE/ML)
     A078318   001    Feb   06,   2009
	
                                 EQ   6MG   BASE/0.5ML   (EQ   12MG BASE/ML)
	   A078318   002    Feb   06,   2009
	
  TABLET;ORAL
	
    SUMATRIPTAN SUCCINATE
	
         MYLAN
	                 EQ   25MG BASE
	                                A077163   001    Nov   02,   2009
	
                                 EQ   50MG BASE
	                                A077163   002    Nov   02,   2009
	
                                 EQ   100MG BASE
	                               A077163   003    Nov   02,   2009
	
          ROXANE
	               EQ   25MG BASE
	                                A078241   001    Aug   10,   2009

                                 EQ   50MG BASE
	                                A078241   002    Aug   10,   2009

                                 EQ   100MG BASE
	                               A078241   003    Aug   10,   2009

          TEVA
	                 EQ   25MG BASE
	                                A076840   001    Feb   09,   2009
	
                                 EQ   50MG BASE
	                                A076840   002    Feb   09,   2009
	
                                 EQ   100MG BASE
	                               A076840   003    Feb   09,   2009
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                                6-304(of 337)


SUPROFEN
	
  SOLUTION/DROPS;OPHTHALMIC

    PROFENAL
	
          ALCON                  1%                                         N019387 001 Dec 23, 1988
	
SUTILAINS
	
  OINTMENT;TOPICAL
	
    TRAVASE
	
         ABBOTT                  82,000 UNITS/GM **Federal Register         N012828 001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
TACRINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    COGNEX
	
         SHIONOGI INC            EQ   10MG   BASE                           N020070   001    Sep   09,   1993

                                 EQ   20MG   BASE                           N020070   002    Sep   09,   1993

                                 EQ   30MG   BASE                           N020070   003    Sep   09,   1993

                                 EQ   40MG   BASE                           N020070   004    Sep   09,   1993
	
TACROLIMUS
	
  CAPSULE;ORAL
	
    TACROLIMUS
	
         WATSON LABS             EQ 5MG BASE                                A090402 001 Jul 01, 2010
	
TALBUTAL
	
  TABLET;ORAL
	
    LOTUSATE
	
          SANOFI AVENTIS US      120MG                                      N009410 005
	
TAMOXIFEN CITRATE
	
  TABLET;ORAL
	
    NOLVADEX
	
         ASTRAZENECA             EQ 10MG BASE                               N017970 001
	
                                 EQ 20MG BASE                               N017970 002 Mar 21, 1994
	
    TAMOXIFEN CITRATE
	
         AEGIS PHARMS            EQ   10MG   BASE                           A076398   001    Mar   31,   2003
	
                                 EQ   20MG   BASE                           A076398   002    Mar   31,   2003
	
         IVAX SUB TEVA PHARMS    EQ   10MG   BASE                           A075740   001    Feb   20,   2003
	
                                 EQ   20MG   BASE                           A075740   002    Feb   20,   2003
	
         PHARMACHEMIE            EQ   10MG   BASE                           A074539   001    Mar   31,   2003
	
         ROXANE                  EQ   10MG   BASE                           A076027   001    Feb   20,   2003
	
                                 EQ   20MG   BASE                           A076027   002    Feb   20,   2003
	
         TEVA                    EQ   10MG   BASE                           A074504   001    Apr   28,   2003

                                 EQ   20MG   BASE                           A074504   002    Apr   28,   2003
	
TECHNETIUM TC-99M ALBUMIN AGGREGATED
	
  INJECTABLE;INJECTION
	
    TC 99M-LUNGAGGREGATE
	
         GE HEALTHCARE          5mCi/ML                                     N017848 001
	
TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT
	
  INJECTABLE;INJECTION
	
    A-N STANNOUS AGGREGATED ALBUMIN
	
         SYNCOR PHARMS          N/A                                         N017916 001
	
    AN-MAA
	
         PHARMALUCENCE          N/A                                         N017792 001
	
    LUNGAGGREGATE REAGENT
	
         GE HEALTHCARE          N/A                                         N017838 001
	
    MACROTEC
	
         BRACCO                 N/A                                         N017833 001
	
    TECHNESCAN MAA
	
         MALLINCKRODT           N/A                                         N017842 001
	
    TECHNETIUM TC 99M MAA
	
         GE HEALTHCARE          N/A                                         N017773 001
	
TECHNETIUM TC-99M ALBUMIN COLLOID KIT
	
  INJECTABLE;INJECTION
	
    MICROLITE
	
         PHARMALUCENCE          N/A                                         N018263 001 Mar 25, 1983
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                6-305(of 337)


TECHNETIUM TC-99M ALBUMIN KIT
	
  INJECTABLE;INJECTION
	
    TECHNETIUM TC 99M HSA
	
         GE HEALTHCARE            N/A
	                         N017775 001
	
TECHNETIUM TC-99M ALBUMIN MICROSPHERES KIT
	
  INJECTABLE;INJECTION
	
    INSTANT MICROSPHERES
	
         3M                     N/A
	                           N017832 001
	
TECHNETIUM TC-99M APCITIDE
	
  INJECTABLE;INJECTION
	
    ACUTECT
	
         CIS BIO INTL SA          N/A
	                         N020887 001 Sep 14, 1998
	
TECHNETIUM TC-99M DEPREOTIDE
	
  INJECTABLE;INJECTION
	
    NEO TECT KIT
	
         CIS BIO INTL SA          N/A
	                         N021012 001 Aug 03, 1999
	
TECHNETIUM TC-99M ETIDRONATE KIT
	
  INJECTABLE;INJECTION
	
    CINTICHEM TECHNETIUM 99M HEDSPA
	
         GE HEALTHCARE           N/A
                           N017653 001
	
    MPI STANNOUS DIPHOSPHONATE
	
         GE HEALTHCARE           N/A
                           N017667 001
	
    OSTEOSCAN
	
         MALLINCKRODT            N/A
                           N017454 001
	
    TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
	
         GE HEALTHCARE           N/A
	                          N017562 001
	
TECHNETIUM TC-99M FERPENTETATE KIT
	
  INJECTABLE;INJECTION
	
    RENOTEC
	
         BRACCO                 N/A
	                           N017045 001
	
TECHNETIUM TC-99M GLUCEPTATE KIT
	
  INJECTABLE;INJECTION
	
    GLUCOSCAN
	
         BRISTOL MYERS SQUIBB   N/A
                            N017907 001
	
    TECHNESCAN GLUCEPTATE
	
         DRAXIMAGE              N/A
	                           N018272 001 Jan 27, 1982
	
TECHNETIUM TC-99M LIDOFENIN KIT
	
  INJECTABLE;INJECTION
	
    TECHNESCAN HIDA
	
         DRAXIMAGE               N/A
	                          N018489 001 Oct 31, 1986
	
TECHNETIUM TC-99M MEDRONATE
	
  INJECTABLE;INJECTION
	
    DRAXIMAGE MDP-10
	
         JUBILANT DRAXIMAGE       N/A
	                         N018035 001
	
TECHNETIUM TC-99M MEDRONATE KIT
	
  INJECTABLE;INJECTION
	
    AMERSCAN MDP KIT
	
         GE HEALTHCARE           N/A
                           N018335 001 Aug 05, 1982
	
    OSTEOLITE
	
         PHARMALUCENCE           N/A
                           N017972 001
	
    TECHNETIUM TC 99M MPI MDP
	
         GE HEALTHCARE           N/A
                           N018141 001
	
                                 N/A
	                          N018141 002 Jun 12, 1989
	
TECHNETIUM TC-99M PENTETATE KIT
	
  INJECTABLE;INJECTION
	
    MPI DTPA KIT - CHELATE
	
         GE HEALTHCARE           N/A
                           N017255 001
	
    TECHNETIUM TC-99M PENTETATE KIT
	
         GE HEALTHCARE           N/A
	                          N017264 002
	
TECHNETIUM TC-99M POLYPHOSPHATE KIT
	
  INJECTABLE;INJECTION
	
    SODIUM POLYPHOSPHATE-TIN KIT
	
         GE HEALTHCARE          N/A
	                           N017664 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                             6-306(of 337)


TECHNETIUM TC-99M PYRO/TRIMETA PHOSPHATES KIT

  INJECTABLE;INJECTION
	
    PYROLITE
	
         PHARMALUCENCE          N/A
	                                        N017684 001
	
TECHNETIUM TC-99M PYROPHOSPHATE KIT
	
  INJECTABLE;INJECTION
	
    PHOSPHOTEC
	
         BRACCO                 N/A
	                                        N017680 001
	
TECHNETIUM TC-99M RED BLOOD CELL KIT
	
  INJECTABLE;INJECTION
	
    RBC-SCAN
	
         CADEMA                 N/A
	                                        N020063 001 Jun 11, 1992
	
TECHNETIUM TC-99M SESTAMIBI KIT
	
  INJECTABLE;INJECTION
	
    MIRALUMA
	
         LANTHEUS MEDCL          N/A
	                                       N019785 003 May 23, 1997
	
TECHNETIUM TC-99M SODIUM PERTECHNETATE
	
  SOLUTION;INJECTION, ORAL
	
    SODIUM PERTECHNETATE TC 99M
	
         GE HEALTHCARE            2-100mCi/ML **Federal Register notice
     N017471 001
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

         MALLINCKRODT             10-60mCi/ML **Federal Register
            N017725 001
	
                                  determination that product was not

                                  discontinued or withdrawn for safety or

                                  efficacy reasons**

         PHARMALUCENCE		          12mCi/ML
                                  N017321 001
	
                                  24mCi/ML
                                  N017321 002
	
                                  48mCi/ML
	                                 N017321 003
	
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR
	
  SOLUTION;INJECTION, ORAL
	
    MINITEC
	
         BRACCO                   0.22-2.22 CI/GENERATOR
	                   N017339 001
	
  SOLUTION;INTRAVENOUS
	
    TECHNELITE
	
         LANTHEUS MEDCL           0.0083-2.7 CI/GENERATOR
                   N017771 001
	
    ULTRA-TECHNEKOW FM
	
         MALLINCKRODT             0.25-3 CI/GENERATOR
                       N017243 002
	
  SOLUTION;INTRAVENOUS, ORAL
	
    TECHNETIUM TC 99M GENERATOR
	
         GE HEALTHCARE            830-16600mCi/GENERATOR
	                   N017693 001
	
TECHNETIUM TC-99M SULFUR COLLOID
	
  SOLUTION;INJECTION, ORAL
	
    TECHNETIUM TC 99M SULFUR COLLOID
	
         GE HEALTHCARE          4mCi/ML
                                     N017456 001
	
  SOLUTION;ORAL
	
    TECHNETIUM TC 99M SULFUR COLLOID
	
         MALLINCKRODT           3mCi/ML
	                                    N017724 001
	
TECHNETIUM TC-99M SULFUR COLLOID KIT
	
  SOLUTION;INJECTION, ORAL
	
    TECHNECOLL
	
         MALLINCKRODT           N/A
                                         N017059 001
	
    TECHNETIUM TC 99M TSC
	
         GE HEALTHCARE          N/A
                                         N017784 001
	
    TESULOID
	
         BRACCO                 N/A
	                                        N016923 001
	
TECHNETIUM TC-99M TEBOROXIME KIT
	
  INJECTABLE;INJECTION
	
    CARDIOTEC
	
         BRACCO                 N/A
	                                        N019928 001 Dec 19, 1990
	
TEGASEROD MALEATE
	
  TABLET;ORAL
	
    ZELNORM
	
         NOVARTIS                EQ 2MG BASE
	                               N021200 001 Jul 24, 2002
	
                                 EQ 6MG BASE
	                               N021200 002 Jul 24, 2002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                                  6-307(of 337)


TELBIVUDINE
	
  SOLUTION;ORAL
	
    TYZEKA
	
         NOVARTIS                100MG/5ML                                    N022154 001 Apr 28, 2009
	
TEMAZEPAM
	
  CAPSULE;ORAL
	
    TEMAZ
	
         QUANTUM PHARMICS        15MG                                         A070564 001 Oct 15, 1985
	
                                 30MG                                         A070547 001 Oct 15, 1985
	
   TEMAZEPAM
	
        DURAMED PHARMS BARR      15MG                                         A071708   001    Sep   29,   1988

                                 30MG                                         A071709   001    Sep   29,   1988

         MUTUAL PHARM            15MG                                         A071174   001    Jul   10,   1986
	
                                 30MG                                         A071175   001    Jul   10,   1986
	
         USL PHARMA              15MG                                         A070489   001    Jul   07,   1986
	
                                 30MG                                         A070490   001    Jul   07,   1986
	
         WATSON LABS             15MG                                         A070383   001    Mar   23,   1987
	
                                 15MG                                         A071446   001    May   21,   1993

                                 30MG                                         A070384   001    Mar   23,   1987
	
                                 30MG                                         A071447   001    May   21,   1993
	
TERAZOSIN HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    HYTRIN
	
         ABBOTT                  EQ 1MG BASE **Federal Register               N020347 001 Dec 14, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety   or

                                 efficacy reasons**

                                 EQ 2MG BASE **Federal Register               N020347 002 Dec 14, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety   or

                                 efficacy reasons**

                                 EQ 5MG BASE **Federal Register               N020347 003 Dec 14, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety   or

                                 efficacy reasons**

                                 EQ 10MG BASE **Federal Register              N020347 004 Dec 14, 1994

                                 determination that product was not

                                 discontinued or withdrawn for safety   or

                                 efficacy reasons**

   TERAZOSIN HYDROCHLORIDE
	
        MYLAN TECHNOLOGIES		     EQ   1MG BASE                                A075384   001    Dec   01,   2000
	
                                 EQ   2MG BASE                                A075384   002    Dec   01,   2000
	
                                 EQ   5MG BASE                                A075384   003    Dec   01,   2000
	
                                 EQ   10MG BASE                               A075384   004    Dec   01,   2000
	
         RANBAXY LABS LTD		      EQ   1MG BASE                                A076021   001    Aug   22,   2002

                                 EQ   2MG BASE                                A076021   002    Aug   22,   2002

                                 EQ   5MG BASE                                A076021   003    Aug   22,   2002

                                 EQ   10MG BASE                               A076021   004    Aug   22,   2002

         SANDOZ		                EQ   1MG BASE                                A075667   001    Jul   28,   2000
	
                                 EQ   2MG BASE                                A075667   002    Jul   28,   2000
	
                                 EQ   5MG BASE                                A075667   003    Jul   28,   2000
	
                                 EQ   10MG BASE                               A075667   004    Jul   28,   2000
	
 TABLET;ORAL
	
   HYTRIN
	
        ABBOTT		                 EQ   1MG BASE                                N019057   001    Aug   07,   1987

                                 EQ   2MG BASE                                N019057   002    Aug   07,   1987

                                 EQ   5MG BASE                                N019057   003    Aug   07,   1987

                                 EQ   10MG BASE                               N019057   004    Aug   07,   1987

   TERAZOSIN HYDROCHLORIDE
	
        IVAX SUB TEVA PHARMS		   EQ   1MG BASE                                A074530   001    Apr   21,   2000

                                 EQ   2MG BASE                                A074530   002    Apr   21,   2000

                                 EQ   5MG BASE                                A074530   003    Apr   21,   2000

                                 EQ   10MG BASE                               A074530   004    Apr   21,   2000

         SANDOZ		                EQ   1MG BASE                                A074315   001    Dec   31,   1998
	
                                 EQ   1MG BASE                                A074657   001    Apr   28,   2000

                                 EQ   2MG BASE                                A074315   002    Dec   31,   1998
	
                                 EQ   2MG BASE                                A074657   002    Apr   28,   2000

                                 EQ   5MG BASE                                A074315   003    Dec   31,   1998
	
                                 EQ   5MG BASE                                A074657   003    Apr   28,   2000

                                 EQ   10MG BASE                               A074315   004    Dec   31,   1998
	
                                 EQ   10MG BASE                               A074657   004    Apr   28,   2000

         TEVA		                  EQ   1MG BASE                                A074446   001    May   18,   2000

                                 EQ   2MG BASE                                A074446   002    May   18,   2000
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                  6-308(of 337)


TERAZOSIN HYDROCHLORIDE
	
  TABLET;ORAL
	
    TERAZOSIN HYDROCHLORIDE
	
                                  EQ 5MG BASE
	                   A074446 003 May 18, 2000

                                  EQ 10MG BASE
	                  A074446 004 May 18, 2000
	
TERBINAFINE
	
  GEL;TOPICAL
	
    LAMISIL
	
         NOVARTIS
	               1%
	                            N020846 001 Apr 29, 1998
	
TERBINAFINE HYDROCHLORIDE
	
  CREAM;TOPICAL
	
    LAMISIL
	
         NOVARTIS
	               1%
	                            N020192 001 Dec 30, 1992
	
  SOLUTION;TOPICAL
	
    LAMISIL
	
         NOVARTIS
	               1%
	                            N020749 001 Oct 17, 1997
	
  TABLET;ORAL
	
    TERBINAFINE HYDROCHLORIDE
	
         GEDEON RICHTER USA
	     EQ 250MG BASE
	                 A077065 001 Jul 02, 2007
	
         MYLAN
	                  EQ 250MG BASE
	                 A077136 001 Jul 02, 2007
	
         ROXANE
	                 EQ 250MG BASE
	                 A077223 001 Jul 02, 2007
	
TERBUTALINE SULFATE
	
  AEROSOL, METERED;INHALATION
	
    BRETHAIRE
	
         NOVARTIS
	               0.2MG/INH
	                     N018762 001 Aug 17, 1984
	
    BRICANYL
	
         SANOFI AVENTIS US
	      0.2MG/INH
	                     N018000 001 Mar 19, 1985
	
  INJECTABLE;INJECTION
	
    BRETHINE
	
         AAIPHARMA LLC
	          1MG/ML
	                        N018571 001
	
    BRICANYL
	
         SANOFI AVENTIS US
	      1MG/ML
	                        N017466 001
	
    TERBUTALINE SULFATE
	
         TEVA PHARMS USA
	        1MG/ML
	                        A076853 001 Jul 20, 2004
	
  TABLET;ORAL
	
    BRETHINE
	
         LEHIGH VALLEY
	          2.5MG
	                         N017849 001
	
                                  5MG
	                           N017849 002
	
    BRICANYL
	
         SANOFI AVENTIS US
	      2.5MG
	                         N017618 001
	
                                  5MG
	                           N017618 002
	
TERCONAZOLE
	
  SUPPOSITORY;VAGINAL
	
    TERCONAZOLE
	
         FOUGERA PHARMS
	         80MG
	                          A076850 001 Jul 12, 2006
	
         TARO
	                   80MG
	                          A077553 001 Mar 09, 2007
	
TERIPARATIDE ACETATE
	
  INJECTABLE;INJECTION
	
    PARATHAR
	
         SANOFI AVENTIS US
	      200 UNITS/VIAL
	                N019498 001 Dec 23, 1987
	
TERIPARATIDE RECOMBINANT HUMAN
	
  INJECTABLE;SUBCUTANEOUS
	
    FORTEO
	
         LILLY
	                 0.75MG/3ML (0.25MG/ML)
	         N021318 001 Nov 26, 2002
	
TESAMORELIN ACETATE
	
  POWDER;SUBCUTANEOUS
	
    EGRIFTA
	
         THERATECHNOLOGIES
	      EQ 2MG BASE/VIAL
	              N022505 002 Nov 29, 2011
	
TESTOLACTONE
	
  INJECTABLE;INJECTION
	
    TESLAC
	
         BRISTOL MYERS SQUIBB
	   100MG/ML
	                      N016119 001
	
  TABLET;ORAL
	
    TESLAC
	
         BRISTOL MYERS SQUIBB
	   50MG
	                          N016118 001
	
                                  250MG
	                         N016118 002
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-309(of 337)


TESTOSTERONE
	
  FILM, EXTENDED RELEASE;TRANSDERMAL
	
    ANDRODERM
	
         ACTAVIS LABS UT INC
	  2.5MG/24HR
                     N020489 001 Sep 29, 1995

                                5MG/24HR
	                      N020489 002 May 02, 1997
	
    TESTODERM
	
         ALZA
	                 4MG/24HR
                       N019762 001 Oct 12, 1993
	
                                6MG/24HR
	                      N019762 002 Oct 12, 1993
	
    TESTODERM TTS
	
         ALZA
	                 5MG/24HR
	                      N020791 001 Dec 18, 1997
	
  GEL;TRANSDERMAL
	
    TESTOSTERONE
	
         PAR PHARM
	            1% (2.5GM/PACKET)
              A076744   001     May   23,   2007

                                1% (5GM/PACKET)
                A076744   002     May   23,   2007

         WATSON LABS
	          1% (2.5GM/PACKET)
              A076737   001     Jan   27,   2006
	
                                1% (5GM/PACKET)
	               A076737   002     Jan   27,   2006
	
  INJECTABLE;INJECTION
	
    TESTOSTERONE
	
         WATSON LABS
	          25MG/ML
                        A086420 001 May 10, 1983

                                50MG/ML
                        A086419 001 Aug 23, 1983

                                100MG/ML
	                      A086417 001 Jul 07, 1983
	
TESTOSTERONE CYPIONATE
	
  INJECTABLE;INJECTION
	
    DEPO-TESTOSTERONE
	
         PHARMACIA AND UPJOHN
	   50MG/ML
	                     A085635 001
	
    TESTOSTERONE CYPIONATE
	
         WATSON LABS
	            100MG/ML
                     A084401 001
	
                                  100MG/ML
                     A086029 001
	
                                  200MG/ML
	                    A084401 002
	
TESTOSTERONE ENANTHATE
	
  INJECTABLE;INJECTION
	
    DELATESTRYL
	
         ENDO PHARMS
	            200MG/ML
	                    N009165 001
	
    TESTOSTERONE ENANTHATE
	
         WATSON LABS
	            100MG/ML
                     A083667 001
	
                                  100MG/ML
                     A085599 001
	
                                  200MG/ML
	                    A083667 002
	
TESTOSTERONE PROPIONATE
	
  INJECTABLE;INJECTION
	
    TESTOSTERONE PROPIONATE
	
         BEL MAR
	                25MG/ML
                      A080741   001
	
                                  50MG/ML
                      A080742   001
	
                                  100MG/ML
                     A080743   001
	
         ELKINS SINN
	            25MG/ML
                      A080276   001
	
         LILLY
	                  50MG/ML
                      A080254   002
	
         WATSON LABS
	            25MG/ML
                      A080188   001
	
                                  25MG/ML
                      A085490   001
	
                                  50MG/ML
                      A080188   002
	
                                  50MG/ML
                      A085490   002
	
                                  100MG/ML
                     A080188   003
	
                                  100MG/ML
	                    A083595   003
	
TETRACYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    BRISTACYCLINE
	
         BRISTOL
	                250MG
	                       A061658   001
	
                                  250MG
	                       A061888   001
	
                                  500MG
	                       A061658   002
	
                                  500MG
	                       A061888   002
	
   CYCLOPAR
	
        WARNER CHILCOTT
	         250MG
	                       A061725   001
	
                                  250MG
	                       A062175   001
	
                                  250MG
	                       A062332   001
	
                                  500MG
	                       A061725   002
	
                                  500MG
	                       A062332   002
	
   PANMYCIN
	
        PHARMACIA AND UPJOHN
	    250MG
	                       A060347 001
	
   RETET
	
        SOLVAY
	                  250MG
	                       A061443 001
	
                                  500MG
	                       A061443 002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-310(of 337)


TETRACYCLINE HYDROCHLORIDE
	
  CAPSULE;ORAL
	
    ROBITET
	
         WYETH AYERST           250MG
	                           A061734 001
	
                                500MG
	                           A061734 002
	
   SUMYCIN
	
        APOTHECON		             100MG
	                           A060429   002
	
                                125MG
	                           A060429   004
	
                                250MG
	                           A060429   001
	
                                500MG
	                           A060429   003
	
   TETRACHEL
	
        ANGUS                   250MG
	                           A060343 001
	
                                500MG
	                           A060343 003
	
   TETRACYCLINE HYDROCHLORIDE
	
        ABBOTT                  250MG
	                           A061802   001
	
                                500MG
	                           A061802   002
	
        ELKINS SINN             250MG
	                           A060059   001
	
        FERRANTE                125MG
	                           A060173   001
	
                                250MG
	                           A060173   002
	
        HEATHER                 250MG
	                           A061148   001
	
                                500MG
	                           A061148   002
	
        HIKMA PHARMS LLC        250MG
	                           A060768   001
	
                                500MG
	                           A060768   002
	
        LABS ATRAL              250MG
	                           A062752   001     Aug 12, 1988

                                500MG
	                           A062752   002     Aug 12, 1988

        MAST MM                 250MG
	                           A062085   001
	
        MUTUAL PHARM            250MG
	                           A060736   001
	
                                500MG
	                           A060736   002
	
        MYLAN                   250MG
	                           A060783   001
	
                                500MG
	                           A060783   002
	
        PUREPAC PHARM           250MG
	                           A060290   001
	
                                500MG
	                           A060290   002
	
        PVT FORM                250MG
	                           A062686   001     Jul 24, 1986
	
                                500MG
	                           A062686   002     Jul 24, 1986
	
        ROXANE                  500MG
	                           A061214   002
	
        SANDOZ                  250MG
	                           A061471   001
	
        SUPERPHARM              250MG
	                           A062540   001     Mar 21, 1985
	
                                500MG
	                           A062540   002     Mar 21, 1985
	
        VALEANT PHARM INTL      250MG
	                           A060471   001
	
                                500MG
	                           A060471   002
	
        WARNER CHILCOTT         250MG
	                           A062300   001
	
                                500MG
	                           A062300   002
	
        WATSON LABS             250MG
	                           A062103   001
	
                                250MG
	                           A062343   001
	
                                500MG
	                           A062103   002
	
                                500MG
	                           A062343   002
	
        WYETH AYERST            250MG
	                           A061685   001
	
                                500MG
	                           A061685   002
	
   TETRACYN
	
        PFIPHARMECS             250MG
	                           A060082 003
	
                                500MG
	                           A060082 004
	
 FIBER, EXTENDED RELEASE;PERIODONTAL
	
   ACTISITE
	
        SCHIFF AND CO           12.7MG/FIBER
                     N050653 001 Mar 25, 1994
	
 FOR SOLUTION;TOPICAL
	
   TOPICYCLINE
	
        SHIRE                   2.2MG/ML
                         N050493 001
	
 INJECTABLE;INJECTION
	
   ACHROMYCIN
	
        LEDERLE                 250MG/VIAL
                       N050273 002
	
                                500MG/VIAL
                       N050273 003
	
   TETRACYN
	
        PFIZER                  250MG/VIAL
                       A060096 001
	
                                500MG/VIAL
                       A060096 002
	
 OINTMENT;OPHTHALMIC
	
   ACHROMYCIN
	
        STORZ                   10MG/GM
                          N050266 001
	
 SUSPENSION;ORAL
	
   ACHROMYCIN V
	
        LEDERLE                 125MG/5ML
                        N050263 002
	
   SUMYCIN
	
        PAR PHARM               125MG/5ML
	                       A060400 001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-311(of 337)


TETRACYCLINE HYDROCHLORIDE
	
  SUSPENSION;ORAL
	
    TETRACYCLINE HYDROCHLORIDE
	
         ALPHARMA US PHARMS
	      125MG/5ML
                     A060633   001
	
         FERRANTE
	                125MG/5ML
                     A060174   001
	
         PROTER
	                  125MG/5ML
                     A060446   001
	
         PUREPAC PHARM
	           125MG/5ML
	                    A060291   001
	
    TETRACYN
	
         PFIPHARMECS
	             125MG/5ML
	                    A060095 001
	
    TETRAMED
	
         IVAX SUB TEVA PHARMS
	    125MG/5ML
	                    A061468 001
	
  SUSPENSION/DROPS;OPHTHALMIC

    ACHROMYCIN
	
         STORZ
	                   1%
	                           N050268 001
	
  TABLET;ORAL
	
    PANMYCIN
	
         PHARMACIA AND UPJOHN
	    250MG
	                        A061705 001
	
                                   500MG
	                        A061705 002
	
   SUMYCIN
	
        PAR PHARM
	                50MG
	                         A061147   003
	
                                   100MG
	                        A061147   002
	
                                   250MG
	                        A061147   001
	
                                   500MG
	                        A061147   004
	
TETRACYCLINE PHOSPHATE COMPLEX
	
  CAPSULE;ORAL
	
    TETREX
	
         BRISTOL
	               EQ       100MG   HCL
	           A061653   001
	
                                 EQ       250MG   HCL
	           A061653   002
	
                                 EQ       250MG   HCL
	           A061889   002
	
                                 EQ       250MG   HCL
	           N050212   002
	
                                 EQ       500MG   HCL
	           A061653   003
	
                                 EQ       500MG   HCL
	           A061889   001
	
                                 EQ       500MG   HCL
	           N050212   003
	
THALLOUS CHLORIDE TL-201
	
  INJECTABLE;INJECTION
	
    THALLOUS CHLORIDE TL 201
	
         BRACCO
	                  1mCi/ML
                       N018548 001 Dec 30, 1982
	
         TRACE LIFE
	              1mCi/ML
	                      A075569 001 Nov 21, 2001
	
  INJECTABLE;INTRAVENOUS
	
    THALLOUS CHLORIDE TL 201
	
         MALLINCKRODT
	            2mCi/ML
	                      A077698 001 Nov 09, 2006
	
THEOPHYLLINE
	
  CAPSULE;ORAL
	
    BRONKODYL
	
         SANOFI AVENTIS US
	       100MG
	                        A085264 001
	
                                   200MG
	                        A085264 002
	
   ELIXOPHYLLIN
	
        FOREST LABS
	              100MG
	                        A085545 001 Jul 31, 1984
	
                                   200MG
	                        A083921 001 Jul 31, 1984
	
   SOMOPHYLLIN-T
	
        FISONS
	                   100MG
	                        A087155 001 Feb 25, 1985
	
                                   200MG
	                        A087155 002 Feb 25, 1985
	
                                   250MG
	                        A087155 003 Feb 25, 1985
	
   THEOPHYLLINE
	
        KV PHARM
	             100MG
	                            A085263   001
	
                               200MG
	                            A085263   002
	
        SCHERER RP
	           100MG
	                            A084731   002 Nov 07, 1986
	
                               200MG
	                            A084731   001 Nov 07, 1986
	
                               250MG
	                            A084731   003 Nov 07, 1986
	
 CAPSULE, EXTENDED RELEASE;ORAL
	
   AEROLATE III
	
        FLEMING PHARMS
	       65MG
	                             A085075 003 Nov 24, 1986
	
   AEROLATE JR
	
        FLEMING PHARMS
	       130MG
	                            A085075 002 Nov 24, 1986
	
   AEROLATE SR
	
        FLEMING PHARMS
	       260MG
	                            A085075 001 Nov 24, 1986
	
   ELIXOPHYLLIN SR
	
        FOREST LABS
	          125MG
	                            A086826 001 Jan 29, 1985
	
                               250MG
	                            A086826 002 Jan 29, 1985
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                          DISCONTINUED DRUG PRODUCT LIST                       6-312(of 337)


THEOPHYLLINE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    SLO-BID
         SANOFI AVENTIS US      50MG                           A088269   001    Jan   31,   1985
                                75MG                           A089539   001    May   10,   1989
                                100MG                          A087892   001    Jan   31,   1985
                                125MG                          A089540   001    May   10,   1989
                                200MG                          A087893   001    Jan   31,   1985
                                300MG                          A087894   001    Jan   31,   1985
    SLO-PHYLLIN
         SANOFI AVENTIS US      60MG                           A085206 001 May 24, 1982
                                125MG                          A085203 001 May 24, 1982
                                250MG                          A085205 001 May 24, 1982
    SOMOPHYLLIN-CRT
         GRAHAM DM              50MG                           A087763   001 Feb 27, 1985
                                100MG                          A087194   001
                                200MG                          A088382   001 Feb 27, 1985
                                250MG                          A087193   001
                                300MG                          A088383   001 Feb 27, 1985
    THEO-DUR
         SCHERING               50MG                           A088022   001    Sep   10,   1985
                                75MG                           A088015   001    Sep   10,   1985
                                125MG                          A088016   001    Sep   10,   1985
                                200MG                          A087995   001    Sep   10,   1985
    THEOBID
         WHITBY                 260MG                          A085983 001 Mar 20, 1985
    THEOBID JR.
         WHITBY                 130MG                          A087854 001 Mar 20, 1985
    THEOCLEAR L.A.-130
         SCHWARZ PHARMA         130MG                          A086569 001 May 27, 1982
    THEOCLEAR L.A.-260
         SCHWARZ PHARMA         260MG                          A086569 002 May 27, 1982
    THEOPHYL-SR
         ORTHO MCNEIL PHARM     125MG                          A086480 001 Feb 08, 1985
                                250MG                          A086471 001 Feb 08, 1985
    THEOPHYLLINE
         CENT PHARMS            125MG                          A088654   001    Feb   12,   1985
                                250MG                          A088689   001    Feb   12,   1985
         HOSPIRA                100MG                          A089976   001    Jan   04,   1995
                                200MG                          A089977   001    Jan   04,   1995
                                300MG                          A089932   001    Jan   04,   1995
         INWOOD LABS            100MG                          A040052   001    Feb   14,   1994
                                125MG                          A040052   002    Feb   14,   1994
                                200MG                          A040052   003    Feb   14,   1994
                                300MG                          A040052   004    Feb   14,   1994
         SANDOZ                 260MG                          A087462   001    May   11,   1982
    THEOPHYLLINE-SR
         SCHERER RP             300MG                          A088255 001 Jun 12, 1986
    THEOVENT
         SCHERING               125MG                          A087010 001 Jan 31, 1985
                                250MG                          A087910 001 Jan 31, 1985
  ELIXIR;ORAL
    ELIXOMIN
         CENCI                  80MG/15ML                      A088303 001 Jan 25, 1984
    LANOPHYLLIN
         LANNETT                80MG/15ML                      A084578 001
    THEOLIXIR
         PANRAY                 80MG/15ML                      A084559 001
    THEOPHYL-225
         ORTHO MCNEIL PHARM     112.5MG/15ML                   A086485 001
    THEOPHYLLINE
         ALPHARMA US PHARMS     80MG/15ML                      A089223   001 May 27, 1988
         CENCI                  80MG/15ML                      A087679   001 Apr 15, 1982
         HALSEY                 80MG/15ML                      A085169   001
         PERRIGO                80MG/15ML                      A085952   001
         PHARM ASSOC            80MG/15ML                      A086720   001
         PRECISION DOSE         80MG/15ML                      A085863   001
         ROXANE                 80MG/15ML                      A084739   001
         TARO                   80MG/15ML                      A089626   001 Oct 28, 1988
         WOCKHARDT              80MG/15ML                      A086748   001
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-313(of 337)


THEOPHYLLINE
	
  INJECTABLE;INJECTION
	
    THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                 40MG/100ML                     N019083 001 Nov 07, 1984
	
    THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                 80MG/100ML                     N019083 002 Nov 07, 1984
	
    THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                 160MG/100ML                    N019083 003 Nov 07, 1984
	
    THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN                 200MG/100ML                    N019212 001 Nov 07, 1984
	
                                 200MG/100ML                    N019826 004 Aug 14, 1992

    THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         B BRAUN		               4MG/ML                         N019212 003 Nov 07, 1984
	
                                 400MG/100ML                    N019212 002 Nov 07, 1984
	
                                 400MG/100ML                    N019826 005 Aug 14, 1992

    THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
	
         BAXTER HLTHCARE		       4MG/ML                         N018649   007    Jul   26,   1982
	
                                 40MG/100ML                     N018649   001    Jul   26,   1982
	
                                 80MG/100ML                     N018649   002    Jul   26,   1982
	
                                 160MG/100ML                    N018649   003    Jul   26,   1982
	
                                 200MG/100ML                    N018649   004    Jul   26,   1982
	
                                 320MG/100ML                    N018649   006    Nov   13,   1985
	
                                 400MG/100ML                    N018649   005    Jul   26,   1982
	
    THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
	
         HOSPIRA INC		           80MG/100ML                     N019211 002 Dec 14, 1984
	
                                 200MG/100ML                    N019211 004 Dec 14, 1984
	
                                 400MG/100ML                    N019211 005 Dec 14, 1984
	
  SOLUTION;ORAL
	
    AEROLATE
	
         FLEMING PHARMS          150MG/15ML                     A089141 001 Dec 03, 1986
	
    THEOLAIR
	
         3M                      80MG/15ML                      A086107 001
	
    THEOPHYLLINE
	
         ROXANE                  80MG/15ML                      A087449 001 Sep 15, 1983

  SUSPENSION;ORAL
	
    ELIXICON
	
         FOREST LABS             100MG/5ML                      A085502 001
	
  SYRUP;ORAL
	
    ACCURBRON
	
         SANOFI AVENTIS US       150MG/15ML                     A088746 001 Nov 22, 1985
	
    AQUAPHYLLIN
	
         FERNDALE LABS           80MG/15ML                      A087917 001 Jan 18, 1983
	
    SLO-PHYLLIN
	
         SANOFI AVENTIS US       80MG/15ML                      A085187 001
	
    THEOCLEAR-80
	
         CENT PHARMS             80MG/15ML                      A087095 001 Mar 01, 1982
	
    THEOPHYLLINE
	
         ALPHARMA US PHARMS      80MG/15ML                      A086001 001
	
                                 150MG/15ML                     A086545 001
	
  TABLET;ORAL
	
    QUIBRON-T
	
         MONARCH PHARMS          300MG                          A088656 001 Aug 22, 1985

    SLO-PHYLLIN
	
         SANOFI AVENTIS US       100MG                          A085202 001
	
                                 200MG                          A085204 001
	
    THEOCLEAR-100
	
         CENT PHARMS             100MG                          A085353 002
	
    THEOCLEAR-200
	
         CENT PHARMS             200MG                          A085353 001
	
    THEOPHYL-225
	
         ORTHO MCNEIL PHARM      225MG                          A084726 001
	
  TABLET, CHEWABLE;ORAL
	
    THEOPHYL
	
         ORTHO MCNEIL PHARM      100MG                          A086506 001 Sep 12, 1985

  TABLET, EXTENDED RELEASE;ORAL
	
    DURAPHYL
	
         FOREST LABS		           100MG                          A088503 001 Apr 03, 1985

                                 200MG                          A088504 001 Apr 03, 1985

                                 300MG                          A088505 001 Apr 03, 1985

    LABID
	
         WARNER CHILCOTT         250MG                          A087225 001
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-314(of 337)


THEOPHYLLINE
	
  TABLET, EXTENDED RELEASE;ORAL
	
    QUIBRON-T/SR

         MONARCH PHARMS
	        300MG
	                        A087563 001 Jun 21, 1983
	
    SUSTAIRE
	
         ROERIG
	                100MG
	                        A085665 001
	
                                 300MG
	                        A085665 002
	
    T-PHYL
	
         PHARM RES ASSOC
	       200MG
	                        A088253 001 Aug 17, 1983
	
    THEO-DUR
	
         SCHERING
	              100MG
	                        A085328   001
	
                                 200MG
	                        A086998   001
	
                                 300MG
	                        A085328   002
	
                                 450MG
	                        A089131   001 Jun 25, 1986
	
    THEOCHRON
	
         SUN PHARM INDS INC
	    300MG
	                        A087400 002 Jan 11, 1983
	
    THEOLAIR-SR
	
         3M
	                    200MG
	                        A088369   001    Jul   16,   1987
	
                                 250MG
	                        A086363   002    Jul   16,   1987
	
                                 300MG
	                        A088364   001    Jul   16,   1987
	
                                 500MG
	                        A089132   001    Jul   16,   1987
	
    THEOPHYLLINE
	
         ABLE
	                  300MG
	                        A040548   001    Apr   30,   2004

                                 400MG
	                        A040543   001    Apr   27,   2004

                                 450MG
	                        A040546   001    Apr   30,   2004

                                 600MG
	                        A040539   001    Apr   27,   2004

         INWOOD LABS
	           450MG
	                        A040034   001    Apr   28,   1995
	
    UNI-DUR
	
         SCHERING
	              400MG
	                        A089822 001 Jan 04, 1995
	
                                 600MG
	                        A089823 001 Jan 04, 1995
	
THEOPHYLLINE SODIUM GLYCINATE
	
  ELIXIR;ORAL
	
    SYNOPHYLATE
	
         CENT PHARMS
	            EQ 165MG BASE/15ML
	          N006333 008
	
  TABLET;ORAL
	
    ASBRON
	
         NOVARTIS
	               EQ 150MG BASE
	               A085148 001
	
THIABENDAZOLE
	
  SUSPENSION;ORAL
	
    MINTEZOL
	
         MERCK SHARP DOHME
	      500MG/5ML
	                   N016097 001
	
  TABLET, CHEWABLE;ORAL
	
    MINTEZOL
	
         MERCK SHARP DOHME
	      500MG
	                       N016096 001
	
THIAMINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    BETALIN S
	
         LILLY
	                  100MG/ML
	                    A080853 001
	
    THIAMINE HYDROCHLORIDE
	
         ABRAXIS PHARM
	          100MG/ML
                     A080509   001
	
         AKORN
	                  100MG/ML
                     A087968   001 Oct 01, 1982
	
         BEL MAR
	                100MG/ML
                     A080718   001
	
                                  200MG/ML
                     A080712   001
	
         DELL LABS
	              100MG/ML
                     A083775   001
	
         HIKMA MAPLE
	            100MG/ML
                     A080575   001
	
         HOSPIRA
	                100MG/ML
                     A040079   001 May 03, 1996

         LUITPOLD
	               100MG/ML
                     A080667   001
	
         PARKE DAVIS
	            100MG/ML
                     A080770   001
	
         WATSON LABS
	            100MG/ML
                     A080571   001
	
                                  100MG/ML
                     A083534   001
	
                                  200MG/ML
                     A080571   002
	
                                  200MG/ML
                     A083534   002
	
         WYETH AYERST
	           100MG/ML
	                    A080553   001
	
THIAMYLAL SODIUM
	
  INJECTABLE;INJECTION
	
    SURITAL
	
         PARKEDALE
	              1GM/VIAL
                     N007600 003
	
                                  5GM/VIAL
                     N007600 005
	
                                  10GM/VIAL
	                   N007600 009
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                       6-315(of 337)


THIETHYLPERAZINE MALATE
	
  INJECTABLE;INJECTION
	
    TORECAN
	
         NOVARTIS                  5MG/ML                         N012754 002
	
THIETHYLPERAZINE MALEATE
	
  SUPPOSITORY;RECTAL
	
    TORECAN
	
         NOVARTIS                  10MG                           N013247 001
	
  TABLET;ORAL
	
    TORECAN
	
         NOVARTIS                  10MG                           N012753 001
	
THIOPENTAL SODIUM
	
  SUSPENSION;RECTAL
	
    PENTOTHAL
	
         ABBOTT                    400MG/GM                       N011679 001
	
THIORIDAZINE
	
  SUSPENSION;ORAL
	
    MELLARIL-S
	
         NOVARTIS                  EQ 25MG HCL/5ML                N017923 001
	
                                   EQ 100MG HCL/5ML               N017923 002
	
THIORIDAZINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    MELLARIL
	
         NOVARTIS                  30MG/ML                        N011808 012
	
                                   100MG/ML                       N011808 018
	
    THIORIDAZINE HYDROCHLORIDE
	
         ACTAVIS MID ATLANTIC    100MG/ML                         A088229   001     Aug   23,   1983

         ALPHARMA US PHARMS      30MG/ML                          A087766   001     Apr   26,   1983

         ANI PHARMS INC          100MG/ML                         A089603   001     Nov   09,   1987
	
         HI TECH PHARMA          30MG/ML                          A040125   001     Aug   16,   1996

                                 100MG/ML                         A040126   001     Aug   16,   1996

         PHARM ASSOC             30MG/ML                          A040187   001     Aug   28,   1997

                                 100MG/ML                         A040213   001     May   29,   1998

         SANDOZ                  30MG/ML                          A088307   001     Nov   23,   1983
	
                                 100MG/ML                         A088308   001     Nov   23,   1983
	
         TEVA PHARMS             30MG/ML                          A089602   001     Nov   09,   1987
	
         WOCKHARDT               30MG/ML                          A088258   001     Jul   25,   1983
	
                                 100MG/ML                         A088227   001     Jul   05,   1983
	
    THIORIDAZINE HYDROCHLORIDE INTENSOL
	
         ROXANE                  30MG/ML                          A088941 001 Dec 16, 1985
	
                                 100MG/ML                         A088942 001 Dec 16, 1985
	
  TABLET;ORAL
	
    MELLARIL
	
         NOVARTIS		              10MG                             N011808   003
	
                                 15MG                             N011808   016
	
                                 25MG                             N011808   006
	
                                 50MG                             N011808   011
	
                                 100MG                            N011808   009
	
                                 150MG                            N011808   017
	
                                 200MG                            N011808   015
	
    THIORIDAZINE HYDROCHLORIDE
	
         ANI PHARMS INC		        10MG                             A088270   001     Apr   14,   1983

                                 10MG                             A088493   001     May   17,   1985

                                 15MG                             A088271   001     Apr   14,   1983

                                 25MG                             A088272   001     Apr   14,   1983

                                 50MG                             A088194   001     Apr   14,   1983

                                 100MG                            A088273   001     Oct   03,   1983
	
                                 100MG                            A088456   001     May   17,   1985

         MUTUAL PHARM		          10MG                             A088375   001     Nov   18,   1983
	
                                 15MG                             A088461   001     Nov   18,   1983
	
                                 25MG                             A087264   001     Nov   18,   1983
	
                                 50MG                             A088370   001     Nov   18,   1983
	
                                 100MG                            A088379   001     Nov   16,   1983
	
                                 150MG                            A088737   001     Sep   26,   1984

                                 200MG                            A088738   001     Oct   16,   1984
	
         MYLAN		                 10MG                             A088332   001     Jun   27,   1983
	
                                 25MG                             A088333   001     Jun   27,   1983
	
                                 50MG                             A088334   001     Jun   27,   1983
	
                                 100MG                            A088335   001     Nov   18,   1983
	
         PAR PHARM		             10MG                             A088351   001     Dec   05,   1983
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                      6-316(of 337)


THIORIDAZINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    THIORIDAZINE HYDROCHLORIDE
	
                                   15MG
	                         A088352   001    Dec   05,   1983
	
                                   25MG
	                         A088336   001    Dec   05,   1983
	
                                   50MG
	                         A088322   001    Dec   05,   1983
	
                                   100MG
	                        A088480   001    Dec   29,   1983
	
                                   150MG
	                        A089764   001    Feb   09,   1988
	
                                   200MG
	                        A089765   001    Feb   09,   1988
	
         ROXANE                    10MG
	                         A088663   001    Mar   15,   1984
	
                                   25MG
	                         A088664   001    Mar   15,   1984
	
                                   50MG
	                         A088665   001    Mar   15,   1984
	
                                   100MG
	                        A089048   001    Feb   26,   1985
	
         SANDOZ                    10MG
	                         A088131   001    Aug   30,   1983

                                   15MG
	                         A088132   001    Aug   30,   1983

                                   25MG
	                         A088133   001    Aug   30,   1983

                                   50MG
	                         A088134   001    Aug   30,   1983

                                   100MG
	                        A088135   001    Nov   20,   1984
	
                                   150MG
	                        A088136   001    Sep   17,   1986

                                   200MG
	                        A088137   001    Sep   17,   1986

         SUPERPHARM                10MG
	                         A089103   001    Jul   02,   1985
	
                                   25MG
	                         A089104   001    Jul   02,   1985
	
                                   50MG
	                         A089105   001    Jul   02,   1985
	
         WATSON LABS               10MG
	                         A088412   001    Sep   12,   1983

                                   10MG
	                         A088476   001    Nov   08,   1983
	
                                   10MG
	                         A088561   001    May   11,   1984

                                   15MG
	                         A088345   001    Jul   28,   1983
	
                                   15MG
	                         A088477   001    Nov   08,   1983
	
                                   15MG
	                         A088562   001    May   11,   1984

                                   25MG
	                         A088296   001    Jul   28,   1983
	
                                   25MG
	                         A088478   001    Nov   08,   1983
	
                                   25MG
	                         A088567   001    May   11,   1984

                                   25MG
	                         A088755   001    Jul   24,   1984
	
                                   50MG
	                         A088323   001    Jul   28,   1983
	
                                   50MG
	                         A088479   001    Nov   08,   1983
	
                                   50MG
	                         A088563   001    May   11,   1984

                                   100MG
	                        A088284   001    Aug   25,   1983

                                   100MG
	                        A088564   001    May   11,   1984

                                   100MG
	                        A088736   001    Jul   24,   1984
	
                                   150MG
	                        A088410   001    Mar   05,   1984
	
                                   150MG
	                        A088869   001    Jun   28,   1985
	
                                   200MG
	                        A088381   001    Mar   14,   1984
	
                                   200MG
	                        A088872   001    Apr   26,   1985

         WEST WARD                 10MG
	                         A088658   001    Mar   26,   1984
	
                                   15MG
	                         A088659   001    Mar   26,   1984
	
                                   25MG
	                         A088660   001    Mar   26,   1984
	
                                   50MG
	                         A088661   001    Mar   26,   1984
	
THIOTEPA
	
  INJECTABLE;INJECTION
	
    THIOPLEX
	
          IMMUNEX                  15MG/VIAL
                     N020058 001 Dec 22, 1994
	
    THIOTEPA
	
          FRESENIUS KABI USA       15MG/VIAL
                     A075698   001 Sep 20, 2001

          IMMUNEX                  15MG/VIAL
                     N011683   001
	
          TEVA PARENTERAL          15MG/VIAL
                     A075730   001 Apr 20, 2001

                                   30MG/VIAL
	                    A075730   002 Apr 20, 2001
	
THIOTHIXENE
	
  CAPSULE;ORAL
	
    NAVANE
	
         PFIZER                    20MG
	                         N016584 005
	
    THIOTHIXENE
	
         AM THERAP                 1MG
	                          A071884   001    Aug   12,   1987

                                   2MG
	                          A071885   001    Aug   12,   1987

                                   5MG
	                          A071886   001    Aug   12,   1987

                                   10MG
	                         A071887   001    Aug   12,   1987

                                   20MG
	                         A072200   001    Dec   17,   1987
	
         WATSON LABS               1MG
	                          A070600   001    Jun   05,   1987
	
                                   2MG
	                          A070601   001    Jun   05,   1987
	
                                   2MG
	                          A071626   001    Jun   25,   1987
	
                                   5MG
	                          A070602   001    Jun   05,   1987
	
                                   5MG
	                          A071627   001    Jun   25,   1987
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                      6-317(of 337)


THIOTHIXENE
	
  CAPSULE;ORAL
	
    THIOTHIXENE
	
                                  10MG                            A070603 001 Jun 05, 1987
	
                                  10MG                            A071628 001 Jun 25, 1987
	
THIOTHIXENE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    NAVANE
	
         PFIZER                   EQ 5MG BASE/ML                  N016758 001
	
    THIOTHIXENE HYDROCHLORIDE
	
         ALPHARMA US PHARMS     EQ 5MG BASE/ML                    A070969   001     Oct   16,   1987
	
         PACO                   EQ 1MG BASE/ML                    A071917   001     Sep   20,   1989

                                EQ 5MG BASE/ML                    A071939   001     Dec   16,   1988
	
         TEVA                   EQ 5MG BASE/ML                    A071184   001     Jun   22,   1987
	
         TEVA PHARMS            EQ 5MG BASE/ML                    A071554   001     Oct   16,   1987
	
    THIOTHIXENE HYDROCHLORIDE INTENSOL
	
         CYCLE PHARMS LTD       EQ 5MG BASE/ML                    A073494 001 Jun 30, 1992
	
  INJECTABLE;INJECTION
	
    NAVANE
	
         PFIZER                 EQ 2MG BASE/ML                    N016904 001
	
                                EQ 10MG BASE/VIAL                 N016904 002
	
THYROGLOBULIN
	
  TABLET;ORAL
	
    PROLOID
	
         PARKE DAVIS		            16MG                            N002245   009
	
                                  32MG                            N002245   005
	
                                  65MG                            N002245   002
	
                                  100MG                           N002245   008
	
                                  130MG                           N002245   010
	
                                  200MG                           N002245   007
	
                                  325MG                           N002245   004
	
    THYROGLOBULIN
	
         IMPAX LABS               64.8MG                          A080151 001
	
THYROTROPIN
	
  INJECTABLE;INJECTION
	
    THYTROPAR
	
         SANOFI AVENTIS US        10 IU/VIAL                      N008682 001
	
TIAGABINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    GABITRIL
	
         CEPHALON		               6MG                             N020646   006     Nov   29,   2005
	
                                  8MG                             N020646   007     Nov   29,   2005
	
                                  10MG                            N020646   008     Nov   29,   2005
	
                                  20MG                            N020646   004     Sep   30,   1997
	
TICARCILLIN DISODIUM
	
  INJECTABLE;INJECTION
	
    TICAR
	
         GLAXOSMITHKLINE		        EQ   1GM BASE/VIAL              N050497   001
	
                                  EQ   3GM BASE/VIAL              A062690   001 Dec 19, 1986
	
                                  EQ   3GM BASE/VIAL              N050497   002
	
                                  EQ   6GM BASE/VIAL              N050497   003
	
                                  EQ   20GM BASE/VIAL             N050497   004
	
                                  EQ   30GM BASE/VIAL             N050497   005 Apr 04, 1984
	
TICLOPIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TICLID
	
         ROCHE PALO               125MG                           N019979 001 Mar 24, 1993
	
                                  250MG                           N019979 002 Oct 31, 1991
	
    TICLOPIDINE HYDROCHLORIDE
	
         ACTAVIS ELIZABETH        250MG                           A075253   001     Aug   20,   1999

         MYLAN                    250MG                           A075161   001     Sep   13,   1999

                                  250MG                           A075316   001     Nov   02,   1999
	
         SANDOZ                   250MG                           A075318   001     Aug   20,   1999

                                  250MG                           A075326   001     Aug   20,   1999

         WATSON LABS              250MG                           A075309   001     Apr   26,   2000
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST                                6-318(of 337)


TILUDRONATE DISODIUM
	
  TABLET;ORAL
	
    SKELID
	
         SANOFI AVENTIS US       EQ 200MG BASE                              N020707 001 Mar 07, 1997
	
TIMOLOL MALEATE
	
  SOLUTION/DROPS;OPHTHALMIC

    TIMOLOL MALEATE
	
         AKORN                   EQ   0.25% BASE                            A074465   001    Mar   25,   1997
	
                                 EQ   0.25% BASE                            A074515   001    Mar   25,   1997
	
         APOTEX INC              EQ   0.25% BASE                            A075411   001    Sep   08,   2000

                                 EQ   0.5% BASE                             A075412   001    Sep   08,   2000

         FOUGERA                 EQ   0.25% BASE                            A074667   001    Mar   25,   1997
	
                                 EQ   0.5% BASE                             A074668   001    Mar   25,   1997
	
  TABLET;ORAL
	
    BLOCADREN
	
         MERCK		                 5MG                                        N018017 001
	
                                 10MG                                       N018017 002
	
                                 20MG                                       N018017 004
	
    TIMOLOL MALEATE
	
         QUANTUM PHARMICS		      5MG                                        A072466   001    May   19,   1989

                                 10MG                                       A072467   001    May   19,   1989

                                 20MG                                       A072468   001    May   19,   1989

         SANDOZ		                5MG                                        A072550   001    Apr   13,   1989

                                 10MG                                       A072551   001    Apr   13,   1989

                                 20MG                                       A072552   001    Apr   13,   1989

         TEVA		                  5MG                                        A072648   001    Jun   16,   1993
	
                                 10MG                                       A072649   001    Jun   16,   1993
	
                                 20MG                                       A072650   001    Jun   16,   1993
	
         USL PHARMA		            5MG                                        A072001   001    Apr   11,   1989

                                 10MG                                       A072002   001    Apr   11,   1989

                                 20MG                                       A072003   001    Apr   11,   1989

         WATSON LABS		           5MG                                        A072269   001    Apr   11,   1989

                                 5MG                                        A072917   001    Jul   31,   1991
	
                                 10MG                                       A072270   001    Apr   11,   1989

                                 10MG                                       A072918   001    Jul   31,   1991
	
                                 20MG                                       A072271   001    Apr   11,   1989

                                 20MG                                       A072919   001    Jul   31,   1991
	
TINZAPARIN SODIUM
	
  INJECTABLE;INJECTION
	
    INNOHEP
	
         LEO PHARMA AS           20,000 IU/ML                               N020484 001 Jul 14, 2000
	
TIOCONAZOLE
	
  CREAM;TOPICAL
	
    TZ-3
	
           PFIZER                1%                                         N018682 001 Feb 18, 1983
	
TIROFIBAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    AGGRASTAT
	
         MEDICURE                EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML)    N020912 001 May 14, 1998

                                 EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML)     N020913 001 May 14, 1998
	
TIZANIDINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TIZANIDINE HYDROCHLORIDE
	
         ACTAVIS ELIZABETH       EQ   2MG   BASE                            A076283   001    Jul   12,   2002
	
                                 EQ   4MG   BASE                            A076283   002    Jul   12,   2002
	
         BARR                    EQ   2MG   BASE                            A076371   001    Apr   09,   2003

                                 EQ   4MG   BASE                            A076371   002    Apr   09,   2003

         IVAX SUB TEVA PHARMS    EQ   2MG   BASE                            A076321   001    Sep   30,   2004

                                 EQ   4MG   BASE                            A076321   002    Sep   30,   2004

         MYLAN PHARMS INC        EQ   2MG   BASE                            A076282   001    Dec   16,   2003
	
                                 EQ   4MG   BASE                            A076282   002    Dec   16,   2003
	
    ZANAFLEX
	
         ACORDA                  EQ 2MG BASE **Federal Register             N020397 002 Feb 04, 2000

                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                               6-319(of 337)


TOBRAMYCIN
	
  SOLUTION/DROPS;OPHTHALMIC

    TOBRAMYCIN
	
         ALCON PHARMS LTD       0.3%                                     A063176 001 May 25, 1994

         APOTEX INC             0.3%                                     A065087 001 Feb 25, 2002
	
TOBRAMYCIN SULFATE
	
  INJECTABLE;INJECTION
	
    NEBCIN
	
         LILLY                  EQ   1.2GM BASE/VIAL                     N050519   001
	
                                EQ   10MG BASE/ML                        A062008   004
	
                                EQ   10MG BASE/ML                        A062707   001 Apr 29, 1987

                                EQ   10MG BASE/ML                        N050477   005
	
                                EQ   40MG BASE/ML                        A062008   001
	
    TOBRAMYCIN SULFATE
	
         APOTHECON              EQ   10MG   BASE/ML                      A064021   001    May   31,   1994

                                EQ   40MG   BASE/ML                      A064021   002    May   31,   1994

                                EQ   40MG   BASE/ML                      A064026   001    May   31,   1994

         ASTRAZENECA            EQ   10MG   BASE/ML                      A063119   001    Oct   31,   1994
	
                                EQ   40MG   BASE/ML                      A063120   001    Oct   31,   1994
	
                                EQ   40MG   BASE/ML                      A063121   001    Oct   31,   1994
	
                                EQ   40MG   BASE/ML                      A063122   001    Oct   31,   1994
	
         HIKMA MAPLE            EQ   10MG   BASE/ML                      A063113   001    Apr   26,   1991

                                EQ   10MG   BASE/ML                      A063128   001    Nov   27,   1991
	
                                EQ   40MG   BASE/ML                      A063118   001    Jul   29,   1991
	
                                EQ   40MG   BASE/ML                      A063127   001    Nov   27,   1991
	
         HOSPIRA                EQ   10MG   BASE/ML                      A063080   001    Apr   30,   1991

                                EQ   40MG   BASE/ML                      A063161   001    May   29,   1991

         WATSON LABS INC        EQ   10MG   BASE/ML                      A062945   001    Aug   09,   1989

                                EQ   40MG   BASE/ML                      A062945   002    Aug   09,   1989
	
TOCAINIDE HYDROCHLORIDE
	
  TABLET;ORAL
	
    TONOCARD
	
         ASTRAZENECA            400MG                                    N018257 001 Nov 09, 1984
	
                                600MG                                    N018257 002 Nov 09, 1984
	
TOLAZAMIDE
	
  TABLET;ORAL
	
    TOLAZAMIDE
	
         BARR                   100MG                                    A070162   001    Jan   14,   1986
	
                                250MG                                    A070163   001    Jan   14,   1986
	
                                500MG                                    A070164   001    Jan   14,   1986
	
         DURAMED PHARMS BARR    100MG                                    A070165   001    Jan   10,   1986
	
                                250MG                                    A070166   001    Jan   10,   1986
	
                                500MG                                    A070167   001    Jan   10,   1986
	
         INTERPHARM             250MG                                    A071270   001    Sep   23,   1986

                                500MG                                    A071271   001    Sep   23,   1986

         IVAX SUB TEVA PHARMS   100MG                                    N018894   001    Nov   02,   1984
	
                                250MG                                    N018894   002    Nov   02,   1984
	
                                500MG                                    N018894   003    Nov   02,   1984
	
         MUTUAL PHARM           100MG                                    A071357   001    Jul   16,   1987
	
                                250MG                                    A071358   001    Jul   16,   1987
	
                                500MG                                    A071359   001    Jul   16,   1987
	
         PAR PHARM              100MG                                    A070159   001    Jan   06,   1986
	
                                250MG                                    A070160   001    Jan   06,   1986
	
                                500MG                                    A070161   001    Jan   06,   1986
	
         SANDOZ                 100MG                                    A071633   001    Dec   09,   1987
	
                                250MG                                    A070289   001    Mar   13,   1986
	
                                500MG                                    A070290   001    Mar   13,   1986
	
         SUPERPHARM             250MG                                    A070763   001    Jun   16,   1986
	
                                500MG                                    A070764   001    Jun   16,   1986
	
         USL PHARMA             100MG                                    A071355   001    Jan   11,   1988
	
                                250MG                                    A070168   001    Apr   02,   1986

                                500MG                                    A070169   001    Apr   02,   1986

         WATSON LABS            100MG                                    A070242   001    Aug   01,   1986

                                100MG                                    A070513   001    Jan   09,   1986
	
                                250MG                                    A070243   001    Aug   01,   1986

                                250MG                                    A070514   001    Jan   09,   1986
	
                                500MG                                    A070244   001    Aug   01,   1986

                                500MG                                    A070515   001    Jan   09,   1986
	
    TOLINASE
	
         PHARMACIA AND UPJOHN   100MG **Federal Register determination   N015500 002
	
                                that product was not discontinued or
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                         6-320(of 337)


TOLAZAMIDE
	
  TABLET;ORAL
	
    TOLINASE
	
                                  withdrawn for safety or efficacy

                                  reasons**
	
                                  250MG
	                             N015500 004
	
                                  500MG
	                             N015500 005
	
TOLAZOLINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    PRISCOLINE
	
         NOVARTIS
	               25MG/ML
	                           N006403 005 Feb 22, 1985
	
TOLBUTAMIDE
	
  TABLET;ORAL
	
    ORINASE
	
         PHARMACIA AND UPJOHN
	   250MG
	                             N010670 002
	
                                  500MG
	                             N010670 001
	
    TOLBUTAMIDE
	
         ALRA
	                   500MG
	                             A086141   001
	
         ASCOT
	                  500MG
	                             A087541   001     Mar 01, 1983
	
         BARR
	                   500MG
	                             A087121   001
	
         DAVA PHARMS INC
	        500MG
	                             A086926   001
	
         IVAX PHARMS
	            500MG
	                             A087093   001
	
         PARKE DAVIS
	            500MG
	                             A086047   001
	
         PUREPAC PHARM
	          500MG
	                             A088950   001     Jun 17, 1985
	
         SANDOZ
	                 500MG
	                             A086574   001
	
                                  500MG
	                             N012678   001
	
         SUPERPHARM
	             500MG
	                             A088893   001     Nov 19, 1984
	
         VANGARD
	                500MG
	                             A087876   001     Apr 20, 1982

         WATSON LABS
	            250MG
	                             A089110   001     May 29, 1987

                                  500MG
	                             A086109   001
	
                                  500MG
	                             A087318   001
	
                                  500MG
	                             A089111   001     May 29, 1987
	
TOLBUTAMIDE SODIUM
	
  INJECTABLE;INJECTION
	
    ORINASE DIAGNOSTIC
	
         PHARMACIA AND UPJOHN
	   EQ 1GM BASE/VIAL
	                  N012095 001
	
TOLCAPONE
	
  TABLET;ORAL
	
    TASMAR
	
         VALEANT PHARMS LLC
	     200MG
	                             N020697 002 Jan 29, 1998
	
TOLMETIN SODIUM
	
  CAPSULE;ORAL
	
    TOLECTIN DS
	
         ORTHO MCNEIL JANSSEN
	   EQ 400MG BASE
	                     N018084 001
	
    TOLMETIN SODIUM
	
         ACTAVIS ELIZABETH
	      EQ   400MG   BASE
	                 A073308   001     Jan   24,   1992
	
         IVAX SUB TEVA PHARMS
	   EQ   400MG   BASE
	                 A073392   001     Jan   24,   1992
	
         MUTUAL PHARM
	           EQ   400MG   BASE
	                 A073311   001     Nov   27,   1991
	
         SANDOZ
	                 EQ   400MG   BASE
	                 A073462   001     Apr   30,   1992

         TEVA
	                   EQ   400MG   BASE
	                 A073519   001     May   29,   1992
	
  TABLET;ORAL
	
    TOLECTIN
	
         ORTHO MCNEIL JANSSEN
	   EQ 200MG BASE
	                     N017628 001
	
    TOLECTIN 600
	
         ORTHO MCNEIL JANSSEN
	   EQ 600MG BASE
	                     N017628 002 Mar 08, 1989
	
    TOLMETIN SODIUM
	
         ACTAVIS ELIZABETH
	      EQ   600MG   BASE
	                 A073527   001     Jun   30,   1992
	
         IVAX SUB TEVA PHARMS
	   EQ   600MG   BASE
	                 A074399   001     Mar   28,   1996
	
         SANDOZ
	                 EQ   200MG   BASE
	                 A073588   001     Jul   31,   1992
	
                                  EQ   600MG   BASE
	                 A074002   001     Sep   27,   1993

         TEVA
	                   EQ   600MG   BASE
	                 A074729   001     Feb   27,   1997
	
TOLVAPTAN
	
  TABLET;ORAL
	
    SAMSCA
	
         OTSUKA AMERICA PHARM
	   60MG
	                              N022275 003 May 19, 2009
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                          6-321(of 337)


TOPIRAMATE
	
  CAPSULE;ORAL
	
    TOPAMAX SPRINKLE
	
         JANSSEN PHARMS         50MG                               N020844 003 Oct 26, 1998
	
    TOPIRAMATE
	
         BARR                   15MG                               A076448   001    Apr   15,   2009

                                25MG                               A076448   002    Apr   15,   2009

         SANDOZ                 15MG                               A079206   001    Oct   14,   2009
	
                                25MG                               A079206   002    Oct   14,   2009
	
  TABLET;ORAL
	
    TOPAMAX
	
         JANSSEN PHARMS         300MG                              N020505 003 Dec 24, 1996
	
                                400MG                              N020505 006 Dec 24, 1996
	
    TOPIRAMATE
	
         BARR		                 25MG                               A076315   001    Mar   27,   2009
	
                                100MG                              A076315   002    Mar   27,   2009
	
                                200MG                              A076315   003    Mar   27,   2009
	
         PLIVA HRVATSKA DOO		   25MG                               A077905   001    Mar   30,   2009
	
                                50MG                               A077905   002    Mar   30,   2009
	
                                100MG                              A077905   003    Mar   30,   2009
	
                                200MG                              A077905   004    Mar   30,   2009
	
         ROXANE		               25MG                               A076306   001    Mar   27,   2009
	
                                50MG                               A076306   002    Mar   27,   2009
	
                                100MG                              A076306   003    Mar   27,   2009
	
                                200MG                              A076306   004    Mar   27,   2009
	
         WATSON LABS		          25MG                               A077643   001    Mar   27,   2009
	
                                50MG                               A077643   002    Mar   27,   2009
	
                                100MG                              A077643   003    Mar   27,   2009
	
                                200MG                              A077643   004    Mar   27,   2009
	
TOPOTECAN HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    TOPOTECAN HYDROCHLORIDE
	
         FRESENIUS KABI ONCOL   EQ 4MG BASE/VIAL                   A091376 001 Nov 29, 2010
	
  SOLUTION;INTRAVENOUS
	
    TOPOTECAN
	
         SANDOZ INC		           EQ 1MG BASE/ML (EQ 1MG BASE/ML)    N200199 001 Feb 25, 2011
	
                                EQ 3MG BASE/3ML (EQ 1MG BASE/ML)   N200199 002 Feb 25, 2011
	
                                EQ 4MG BASE/4ML (EQ 1MG BASE/ML)   N200199 003 Feb 25, 2011
	
TORSEMIDE
	
  INJECTABLE;INJECTION
	
    DEMADEX
	
         ROCHE                  50MG/5ML (10MG/ML)                 N020137 002 Aug 23, 1993

                                20MG/2ML (10MG/ML)                 N020137 001 Aug 23, 1993
	
TRAMADOL HYDROCHLORIDE
	
  TABLET;ORAL
	
    TRAMADOL HYDROCHLORIDE
	
         ACTAVIS ELIZABETH       50MG                              A075960   001    Jun   19,   2002
	
         ASTA                    50MG                              A075974   001    Jul   12,   2002
	
         IVAX SUB TEVA PHARMS    50MG                              A075963   001    Jul   03,   2002
	
         SANDOZ                  50MG                              A075968   001    Jun   25,   2002
	
         WATSON LABS             50MG                              A075962   001    Jun   24,   2002
	
    ULTRAM
	
         JANSSEN PHARMS          100MG                             N020281 001 Mar 03, 1995
	
  TABLET, EXTENDED RELEASE;ORAL
	
    RYZOLT
	
         PURDUE PHARMA		         100MG                             N021745 001 Dec 30, 2008
	
                                 200MG                             N021745 002 Dec 30, 2008
	
                                 300MG                             N021745 003 Dec 30, 2008
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    RYBIX ODT
	
         SHIONOGI INC            50MG                              N021693 001 May 05, 2005
	
TRANDOLAPRIL
	
  TABLET;ORAL
	
    TRANDOLAPRIL
	
         CIPLA		                1MG                                A077307   002    Jun   12,   2007
	
                                2MG                                A077307   001    Jun   12,   2007
	
                                4MG                                A077307   003    Jun   12,   2007
	
         COREPHARMA		           1MG                                A077256   001    Jun   12,   2007
	
                                2MG                                A077256   002    Jun   12,   2007
	
                                4MG                                A077256   003    Jun   12,   2007
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                        6-322(of 337)


TRANDOLAPRIL
	
  TABLET;ORAL
	
    TRANDOLAPRIL
	
         DR REDDYS LABS LTD		   1MG                               A078493 001 Aug 25, 2008

                                2MG                               A078493 002 Aug 25, 2008

                                4MG                               A078493 003 Aug 25, 2008
	
TRANEXAMIC ACID
	
  INJECTABLE;INJECTION
	
    TRANEXAMIC ACID
	
         FRESENIUS KABI USA     100MG/ML                          A091596 001 Mar 02, 2012
	
  TABLET;ORAL
	
    CYKLOKAPRON
	
         PHARMACIA AND UPJOHN   500MG                             N019280 001 Dec 30, 1986
	
TRAVOPROST
	
  SOLUTION/DROPS;OPHTHALMIC

    TRAVATAN
	
         ALCON PHARMS LTD       0.004%                            N021257 001 Mar 16, 2001
	
TRAZODONE HYDROCHLORIDE
	
  TABLET;ORAL
	
    DESYREL
	
         APOTHECON		            50MG                              N018207   001
	
                                100MG                             N018207   002
	
                                150MG                             N018207   003 Mar 25, 1985
	
                                300MG                             N018207   004 Nov 07, 1988
	
    TRAZODONE HYDROCHLORIDE
	
         AM THERAP              50MG                              A071139   001     Oct   29,   1986
	
                                100MG                             A071140   001     Oct   29,   1986
	
         MYLAN                  50MG                              A071405   001     Feb   27,   1991
	
                                100MG                             A071406   001     Feb   27,   1991
	
         QUANTUM PHARMICS       100MG                             A070921   001     Dec   01,   1986
	
         SANDOZ                 50MG                              A072484   001     Apr   30,   1990

                                100MG                             A072483   001     Apr   30,   1990

         TEVA                   150MG                             A074357   001     Apr   30,   1997

         USL PHARMA             50MG                              A070491   001     Apr   29,   1987

                                100MG                             A070492   001     Apr   29,   1987

         WATSON LABS            50MG                              A070857   001     Oct   10,   1986
	
                                50MG                              A071112   001     Nov   17,   1986
	
                                100MG                             A070858   001     Oct   10,   1986
	
                                100MG                             A071113   001     Nov   17,   1986
	
    TRIALODINE
	
         QUANTUM PHARMICS       50MG                              A070942 001 Dec 01, 1986
	
TRETINOIN
	
  CAPSULE;ORAL
	
    VESANOID
	
         ROCHE                  10MG                              N020438 001 Nov 22, 1995
	
  SOLUTION;TOPICAL
	
    TRETINOIN
	
         TEVA PHARMS            0.05%                             A074873 001 Jun 19, 1998
	
         WOCKHARDT              0.05%                             A075260 001 Jan 25, 1999
	
  SWAB;TOPICAL
	
    RETIN-A
	
         VALEANT INTL           0.05%                             N016921 002
	
TRIAMCINOLONE
	
  TABLET;ORAL
	
    ARISTOCORT
	
         ASTELLAS		             1MG                               N011161   009
	
                                2MG                               N011161   004
	
                                4MG                               N011161   007
	
                                8MG                               N011161   011
	
                                16MG                              N011161   010
	
    KENACORT
	
         DELCOR ASSET CORP		    1MG                               N011283   003
	
                                2MG                               N011283   008
	
                                4MG                               N011283   006
	
                                8MG                               N011283   010
	
    TRIAMCINOLONE
	
         BARR		                 2MG                               A084286   001
	
                                2MG                               A084318   001
	
                                4MG                               A084267   001
	
                                4MG                               A084319   001
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-323(of 337)


TRIAMCINOLONE
	
  TABLET;ORAL
	
    TRIAMCINOLONE
	
                                  8MG
	                           A084268   001
	
                                  8MG
	                           A084320   001
	
         IMPAX LABS
	             4MG
	                           A084340   001
	
         IVAX SUB TEVA PHARMS
	   4MG
	                           A083750   001
	
         MYLAN
	                  2MG
	                           A084406   001
	
         PUREPAC PHARM
	          2MG
	                           A084020   002
	
                                  4MG
	                           A084020   003
	
         ROXANE
	                 2MG
	                           A084708   001
	
                                  4MG
	                           A084709   001
	
                                  8MG
	                           A084707   001
	
         SANDOZ
	                 4MG
	                           A085601   001
	
         TEVA
	                   4MG
	                           A084775   001
	
         WATSON LABS
	            4MG
	                           A084270   001
	
                                  4MG
	                           A085834   001
	
TRIAMCINOLONE ACETONIDE
	
  AEROSOL, METERED;INHALATION
	
    AZMACORT
	
         ABBVIE
	                 0.1MG/INH
	                     N018117 001 Apr 23, 1982
	
  AEROSOL, METERED;NASAL
	
    NASACORT
	
         SANOFI AVENTIS US
	      0.055MG/INH
	                   N019798 001 Jul 11, 1991
	
  CREAM;TOPICAL
	
    ARISTOCORT
	
         ASTELLAS
	               0.025%
	                        A083017 003
	
                                  0.1%
	                          A083016 004
	
                                  0.5%
	                          A083015 002
	
    ARISTOCORT A
	
         ASTELLAS
	               0.025%
	                        A083017   004
	
                                  0.025%
	                        A088818   001 Oct 16, 1984
	
                                  0.1%
	                          A083016   005
	
                                  0.1%
	                          A088819   001 Oct 16, 1984
	
                                  0.5%
	                          A083015   003
	
                                  0.5%
	                          A088820   001 Oct 16, 1984
	
    FLUTEX
	
         IVAX PHARMS
	            0.025%
	                        A085539 001
	
                                  0.1%
	                          A085539 002
	
                                  0.5%
	                          A085539 003
	
    KENALOG
	
         DELCOR ASSET CORP
	      0.025%
	                        N011601 003
	
                                  0.1%
	                          N011601 006
	
                                  0.5%
	                          A083943 001
	
    KENALOG-H
	
         DELCOR ASSET CORP
	      0.1%
	                          A086240 001
	
    TRIACET
	
         TEVA
	                   0.025%
	                        A084908 001
	
                                  0.1%
	                          A084908 002
	
                                  0.5%
	                          A084908 003
	
    TRIACORT
	
         SOLVAY
	                 0.1%
	                          A087113 001
	
    TRIAMCINOLONE ACETONIDE
	
         ACTAVIS MID ATLANTIC
	   0.1%
	                          A087798   001     Jun   04,   1982
	
         ALPHARMA US PHARMS
	     0.025%
	                        A087797   001     Jun   07,   1982
	
         AMBIX
	                  0.025%
	                        A087932   001     May   09,   1983

         G AND W LABS
	           0.025%
	                        A089797   001     May   31,   1991

                                  0.1%
	                          A089798   001     May   31,   1991

         MORTON GROVE
	           0.025%
	                        A088094   001     Sep   01,   1983

                                  0.1%
	                          A088095   001     Sep   01,   1983

                                  0.5%
	                          A088096   001     Sep   01,   1983

         PHARMADERM
	             0.025%
	                        A087990   001     Jul   07,   1983
	
                                  0.1%
	                          A087991   001     Jul   07,   1983
	
                                  0.5%
	                          A087992   001     Jul   07,   1983
	
         PHARMAFAIR
	             0.025%
	                        A087921   001     Aug   10,   1982

                                  0.1%
	                          A087912   001     Aug   10,   1982

                                  0.5%
	                          A087922   001     Aug   10,   1982

         TARO
	                   0.025%
	                        A040038   001     Oct   26,   1994
	
                                  0.025%
	                        A086277   001
	
                                  0.1%
	                          A086276   001
	
                                  0.5%
	                          A086275   001
	
         TOPIDERM
	               0.025%
	                        A089274   001     Feb 21, 1989
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST                       6-324(of 337)


TRIAMCINOLONE ACETONIDE
	
  CREAM;TOPICAL
	
    TRIAMCINOLONE ACETONIDE
	
                                0.1%                            A089275 001 Feb 21, 1989
	
                                0.5%                            A089276 001 Feb 21, 1989
	
   TRIATEX
	
        IVAX PHARMS		           0.025%                          A087430 001 Nov 01, 1988
	
                                0.1%                            A087429 001 Nov 01, 1988
	
                                0.5%                            A087428 001 Nov 01, 1988
	
   TRYMEX
	
        SAVAGE LABS		           0.025%                          A088196 001 Mar 25, 1983
	
                                0.1%                            A088197 001 Mar 25, 1983
	
                                0.5%                            A088198 001 Mar 25, 1983
	
 GEL;TOPICAL
	
   ARISTOGEL
	
        ASTELLAS               0.1%                             A083380 001
	
 INJECTABLE;INJECTION
	
   TRIAMCINOLONE ACETONIDE
	
        PARNELL                3MG/ML                           N019503   001 Oct 16, 1987
	
        SANDOZ                 10MG/ML                          A090166   001 May 27, 2009

        SANDOZ CANADA INC      40MG/ML                          A090164   001 Jun 01, 2009
	
        WATSON LABS            40MG/ML                          A085825   001
	
 INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
	
   TRIVARIS
	
        ALLERGAN               8MG/0.1ML (8MG/0.1ML)            N022220 001 Jun 16, 2008
	
 LOTION;TOPICAL
	
   KENALOG
	
        DELCOR ASSET CORP		    0.025%                           A084343   001
	
                               0.025%                           N011602   003
	
                               0.1%                             A084343   002
	
                               0.1%                             N011602   001
	
   TRIAMCINOLONE ACETONIDE
	
        ALPHARMA US PHARMS     0.025%                           A087191 001 Sep 08, 1982

                               0.1%                             A087192 001 Sep 08, 1982

        G AND W LABS INC       0.1%                             A089129 001 Aug 14, 1986

 OINTMENT;TOPICAL
	
   ARISTOCORT
	
        ASTELLAS               0.1%                             A080750 004
	
                               0.5%                             A080745 002
	
   ARISTOCORT A
	
        ASTELLAS		             0.1%                             A080750   003
	
                               0.1%                             A088780   001 Oct 01, 1984
	
                               0.5%                             A080745   003
	
                               0.5%                             A088781   001 Oct 05, 1984
	
   FLUTEX
	
        IVAX PHARMS		          0.025%                           A087375 001 Nov 01, 1988
	
                               0.1%                             A087377 001 Nov 01, 1988
	
                               0.5%                             A087376 001 Nov 01, 1988
	
   KENALOG
	
        DELCOR ASSET CORP		    0.025%                           N011600 003
	
                               0.1%                             N011600 001
	
                               0.5%                             A083944 001
	
   TRIAMCINOLONE ACETONIDE
	
        ACTAVIS MID ATLANTIC   0.1%                             A087799   001     Jun   07,   1982
	
        ALPHARMA US PHARMS     0.5%                             A089913   001     Dec   23,   1988
	
        G AND W LABS           0.025%                           A089795   001     Dec   23,   1988
	
                               0.1%		                           A089796   001     Dec   23,   1988
	
        MORTON GROVE		         0.025%                           A088090   001     Sep   01,   1983

                               0.1%                             A088091   001     Sep   01,   1983

                               0.5%                             A088092   001     Sep   01,   1983

        PHARMADERM		           0.025%                           A088692   001     Aug   02,   1984

                               0.1%                             A088690   001     Aug   02,   1984

        TARO		                 0.025%                           A040040   001     Sep   30,   1994

                               0.025%                           A040374   001     Jun   05,   2001
	
                               0.1%                             A087902   001     Dec   27,   1982
	
                               0.5%                             A040386   001     Jun   05,   2001
	
   TRYMEX
	
        SAVAGE LABS            0.025%                           A088693 001 Aug 02, 1984

                               0.1%                             A088691 001 Aug 02, 1984

 PASTE;DENTAL
	
   KENALOG IN ORABASE
	
        DELCOR ASSET CORP      0.1%                             N012097 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                            6-325(of 337)


TRIAMCINOLONE ACETONIDE
	
  PASTE;DENTAL
	
    ORALONE
	
         TARO                   0.1%
	                                     A071383 001
	 Jul 06, 1987
	
  SPRAY, METERED;NASAL
	
    ALLERNAZE
	
         LUPIN ATLANTIS         0.05MG/SPRAY
                              N020120 001
	 Feb 04, 2000
	
    NASACORT HFA
	
         SANOFI AVENTIS US      0.055MG/SPRAY
	                            N020784 001
	 Apr 07, 2004
	
TRIAMCINOLONE DIACETATE
	
  INJECTABLE;INJECTION
	
    ARISTOCORT
	
         SANDOZ                 25MG/ML
                                   N011685 003
	
                                40MG/ML **Federal Register
                N012802 001
	
                                determination that product was not

                                discontinued or withdrawn for safety or

                                efficacy reasons**

   TRIAMCINOLONE DIACETATE
	
        AKORN                   25MG/ML
                                   A085122   001
	
                                40MG/ML
                                   A086394   001
	
         WATSON LABS            40MG/ML
                                   A084072   001
	
                                40MG/ML
                                   A085529   001
	
 SYRUP;ORAL
	
   ARISTOCORT
	
        ASTELLAS                2MG/5ML
                                   N011960 004
	
   KENACORT
	
        DELCOR ASSET CORP       EQ 4MG BASE/5ML
	                          N012515 001
	
TRIAZOLAM
	
  TABLET;ORAL
	
    HALCION
	
         PHARMACIA AND UPJOHN   0.5MG
	                                    N017892 002
	 Nov 15, 1982
	
    TRIAZOLAM
	
         WATSON LABS            0.125MG
	                                  A074445 001
	 Oct 20, 1995
	
                                0.25MG
	                                   A074445 002
	 Oct 20, 1995
	
TRICHLORMETHIAZIDE
	
  TABLET;ORAL
	
    METAHYDRIN
	
         SANOFI AVENTIS US      2MG
	                                      N012594 001
	 Jun 16, 1988
	
                                4MG
	                                      N012594 002
	 Jun 16, 1988
	
   NAQUA
	
        SCHERING                2MG
	                                      N012265 001
	
                                4MG
	                                      N012265 002
	
   TRICHLOREX
	
        LANNETT                 4MG
	                                      A083436 001
	
                                4MG
	                                      A085630 001
	
   TRICHLORMAS
	
        MAST MM                 4MG
	                                      A086259 001
	
   TRICHLORMETHIAZIDE
	
        IMPAX LABS              4MG
	                                      A083967   001
	
        PAR PHARM               2MG
	                                      A087007   001
	
                                4MG
	                                      A087005   001
	
         SANDOZ                 4MG
	                                      A086171   001
	
         TG UNITED LABS         4MG
	                                      A085568   001
	
         WATSON LABS            2MG
	                                      A083847   001
	
                                2MG
	                                      A086458   001
	
                                4MG
	                                      A083462   001
	
                                4MG
	                                      A083855   001
	
                                4MG
	                                      A085962   001
	
TRICLOFOS SODIUM
	
  SOLUTION;ORAL
	
    TRICLOS
	
         SANOFI AVENTIS US      1.5GM/15ML
                                N016830 001
	
  TABLET;ORAL
	
    TRICLOS
	
         SANOFI AVENTIS US      750MG
	                                    N016809 002
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                      6-326(of 337)


TRIDIHEXETHYL CHLORIDE
	
  INJECTABLE;INJECTION
	
    PATHILON
	
         LEDERLE
	                10MG/ML
	                        N009729 001
	
  TABLET;ORAL
	
    PATHILON
	
         LEDERLE
	                25MG
	                           N009489 005
	
TRIFLUOPERAZINE HYDROCHLORIDE
	
  CONCENTRATE;ORAL
	
    STELAZINE
	
         GLAXOSMITHKLINE
	      EQ    10MG BASE/ML
	               N011552 006
	
    TRIFLUOPERAZINE HYDROCHLORIDE
	
         SANDOZ
	               EQ    10MG BASE/ML
                A085787 001 Apr 15, 1982

         WOCKHARDT
	            EQ    10MG BASE/ML
	               A088143 001 Jul 26, 1983
	
  INJECTABLE;INJECTION
	
    STELAZINE
	
         GLAXOSMITHKLINE
	      EQ    2MG BASE/ML
	                N011552 005
	
  TABLET;ORAL
	
    STELAZINE
	
         GLAXOSMITHKLINE
	      EQ    1MG BASE
	                   N011552   001
	
                                EQ    2MG BASE
	                   N011552   002
	
                                EQ    5MG BASE
	                   N011552   003
	
                                EQ    10MG BASE
	                  N011552   004
	
    TRIFLUOPERAZINE HYDROCHLORIDE
	
         DURAMED PHARMS BARR
	  EQ    1MG BASE
	                   A088967   001     Apr   23,   1985

                                EQ    2MG BASE
	                   A088968   001     Apr   23,   1985

                                EQ    5MG BASE
	                   A088969   001     Apr   23,   1985

                                EQ    10MG BASE
	                  A088970   001     Apr   23,   1985

         IVAX PHARMS
	          EQ    1MG BASE
	                   A087612   001     Nov   19,   1982
	
                                EQ    2MG BASE
	                   A087613   001     Nov   19,   1982
	
                                EQ    5MG BASE
	                   A087328   001     Nov   19,   1982
	
                                EQ    10MG BASE
	                  A087614   001     Nov   19,   1982
	
         SANDOZ
	               EQ    1MG BASE
	                   A040153   001     Oct   25,   1996
	
                                EQ    2MG BASE
	                   A040153   002     Oct   25,   1996
	
                                EQ    5MG BASE
	                   A040153   003     Oct   25,   1996
	
                                EQ    10MG BASE
	                  A040153   004     Oct   25,   1996
	
         WATSON LABS
	          EQ    1MG BASE
	                   A085975   001     Jun   23,   1988
	
                                EQ    2MG BASE
	                   A085976   001     Jun   23,   1988
	
                                EQ    5MG BASE
	                   A085973   001     Jun   23,   1988
	
                                EQ    10MG BASE
	                  A088710   001     Jun   23,   1988
	
TRIFLUPROMAZINE
	
  SUSPENSION;ORAL
	
    VESPRIN
	
         APOTHECON
	              EQ 50MG HCL/5ML
	                N011491 004
	
TRIFLUPROMAZINE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    VESPRIN
	
         APOTHECON
	              3MG/ML
                          N011325 005
	
                                  10MG/ML
                         N011325 004
	
                                  20MG/ML
	                        N011325 001
	
  TABLET;ORAL
	
    VESPRIN
	
         BRISTOL MYERS SQUIBB
	   10MG
	                           N011123 001
	
                                  25MG
	                           N011123 002
	
                                  50MG
	                           N011123 003
	
TRIHEXYPHENIDYL HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    ARTANE
	
         LEDERLE                5MG
	                              N006773 010
	
                                5MG
	                              N012947 001
	
  ELIXIR;ORAL
	
    ARTANE
	
         LEDERLE                2MG/5ML
                           N006773 009
	
    TRIHEXYPHENIDYL HYDROCHLORIDE
	
         PHARM VENTURES         2MG/5ML
                           A089514 001 Apr 07, 1989
	
  TABLET;ORAL
	
    ARTANE
	
         LEDERLE                2MG
	                              N006773 005
	
                                5MG
	                              N006773 003
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                    6-327(of 337)


TRIHEXYPHENIDYL HYDROCHLORIDE
	
  TABLET;ORAL
	
    TREMIN
	
         SCHERING               2MG
	                           A080381 001
	
                                5MG
	                           A080381 003
	
    TRIHEXYPHENIDYL HYDROCHLORIDE
	
         HIKMA PHARMS LLC       2MG
	                           A040337   002     Feb 16, 2000
	
                                5MG
	                           A040337   001     Feb 16, 2000
	
         NYLOS                  5MG
	                           A085622   001
	
         VANGARD                2MG
	                           A088035   001     Jul 30, 1982
	
         WATSON LABS            2MG
	                           A040184   001     Feb 06, 1998
	
                                2MG
	                           A085117   001
	
                                5MG
	                           A040184   002     Feb 06, 1998
	
                                5MG
	                           A085105   001
	
TRILOSTANE
	
  CAPSULE;ORAL
	
    MODRASTANE
	
         BIOENVISION              30MG
	                        N018719 002 Dec 31, 1984
	
                                  60MG
	                        N018719 001 Dec 31, 1984
	
TRIMEPRAZINE TARTRATE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    TEMARIL
	
         ALLERGAN HERBERT
	     EQ   5MG BASE
	                 N011316 004
	
  SYRUP;ORAL
	
    TEMARIL
	
         ALLERGAN HERBERT
	     EQ   2.5MG BASE/5ML
	           N011316 003
	
    TRIMEPRAZINE TARTRATE
	
         ALPHARMA US PHARMS
	   EQ   2.5MG BASE/5ML
            A085015 001 Feb 18, 1982
	
         MORTON GROVE
	         EQ   2.5MG BASE/5ML
	           A088285 001 Apr 11, 1985
	
  TABLET;ORAL
	
    TEMARIL
	
         ALLERGAN HERBERT
	     EQ   2.5MG BASE
	               N011316 001
	
TRIMETHADIONE
	
  CAPSULE;ORAL
	
    TRIDIONE
	
         ABBVIE
	                 300MG
	                       N005856 005
	
  SOLUTION;ORAL
	
    TRIDIONE
	
         ABBVIE
	                 200MG/5ML
	                   N005856 002
	
TRIMETHAPHAN CAMSYLATE
	
  INJECTABLE;INJECTION
	
    ARFONAD
	
         ROCHE
	                  50MG/ML
	                     N008983 001
	
TRIMETHOBENZAMIDE HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    TRIMETHOBENZAMIDE HYDROCHLORIDE
	
         HOSPIRA
	               100MG/ML
                      A088804   001     Apr   03,   1987

         SMITH AND NEPHEW
	      100MG/ML
                      A088960   001     Apr   04,   1986

                                 100MG/ML
                      A089043   001     Apr   04,   1986

         SOLOPAK
	               100MG/ML
                      A089094   001     Apr   04,   1986

         WATSON LABS
	           100MG/ML
                      A086577   001     Oct   19,   1982
	
                                 100MG/ML
	                     A087939   001     Dec   28,   1982
	
TRIMETHOPRIM
	
  TABLET;ORAL
	
    PROLOPRIM
	
         MONARCH PHARMS
	         100MG
	                       N017943 001
	
                                  200MG
	                       N017943 003 Jul 14, 1982
	
    TRIMETHOPRIM
	
         MUTUAL PHARM
	           100MG
	                       A070494 001 Jan 22, 1986
	
                                  200MG
	                       A070495 001 Sep 24, 1986

         TEVA
	                   200MG
	                       A071259 001 Jun 18, 1987
	
    TRIMPEX
	
         ROCHE
	                  100MG
	                       N017952 001
	
    TRIMPEX 200
	
         ROCHE
	                  200MG
	                       N017952 002 Nov 09, 1982
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                 6-328(of 337)


TRIMETHOPRIM HYDROCHLORIDE
	
  SOLUTION;ORAL
	
    PRIMSOL
	
         FSC
	                   EQ 25MG BASE/5ML
	             A074374 001 Jun 23, 1995
	
TRIMETREXATE GLUCURONATE
	
  INJECTABLE;INJECTION
	
    NEUTREXIN
	
         MEDIMMUNE ONCOLOGY
	    EQ 25MG BASE/VIAL
             N020326 001 Dec 17, 1993
	
                                 EQ 200MG BASE/VIAL
	           N020326 002 Jul 31, 1998
	
TRIMIPRAMINE MALEATE
	
  CAPSULE;ORAL
	
    TRIMIPRAMINE MALEATE
	
         USL PHARMA
	            EQ 25MG BASE
	                 A071283 001 Dec 08, 1987
	
                                 EQ 50MG BASE
	                 A071284 001 Dec 08, 1987
	
                                 EQ 100MG BASE
	                A071285 001 Dec 08, 1987
	
TRIOXSALEN
	
  TABLET;ORAL
	
    TRISORALEN
	
         VALEANT PHARM INTL
	    5MG
	                          N012697 001
	
TRIPELENNAMINE CITRATE
	
  ELIXIR;ORAL
	
    PBZ
	
          NOVARTIS
	             EQ 25MG HCL/5ML
	              N005914 004
	
TRIPELENNAMINE HYDROCHLORIDE
	
  TABLET;ORAL
	
    PBZ
	
          NOVARTIS
	            25MG
	                          A083149 001
	
                                50MG
	                          N005914 002
	
   TRIPELENNAMINE HYDROCHLORIDE
	
        ANABOLIC
	              50MG
	                          A083037   001
	
        BARR
	                  50MG
	                          A080744   001
	
        HEATHER
	               50MG
	                          A083989   001
	
        IMPAX LABS
	            50MG
	                          A080785   001
	
        LANNETT
	               50MG
	                          A083557   001
	
        NYLOS
	                 50MG
	                          A085412   001
	
        PARKE DAVIS
	           25MG
	                          A083625   001
	
                                50MG
	                          A083626   001
	
        WATSON LABS
	           50MG
	                          A080713   001
	
                                50MG
	                          A080790   001
	
                                50MG
	                          A085188   001
	
 TABLET, EXTENDED RELEASE;ORAL
	
   PBZ-SR
	
        NOVARTIS
	              50MG
	                          N010533 002
	
                                100MG
	                         N010533 001
	
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)

  CREAM;VAGINAL
	
    GYNE-SULF
	
         G AND W LABS
	         2.86%;3.42%;3.7%
	              A088607 001 Jun 09, 1986
	
    SULTRIN
	
         ORTHO MCNEIL PHARM
	   2.86%;3.42%;3.7%
	              N005794 001
	
    TRIPLE SULFA
	
         ALPHARMA US PHARMS
	   2.86%;3.42%;3.7%
	              A087864 001 Sep 01, 1982

         FOUGERA
	              2.86%;3.42%;3.7%
	              A086424 001
	
         PERRIGO NEW YORK
	     2.86%;3.42%;3.7%
	              A087285 001 Nov 15, 1982
	
    TRYSUL
	
         SAVAGE LABS
	          2.86%;3.42%;3.7%
	              A087887 001 Jul 23, 1982
	
    VAGILIA
	
         TEVA
	                 3.42%;3.42%;3.42%
	             A088821 001 Nov 09, 1987
	
  TABLET;VAGINAL
	
    SULTRIN
	
         ORTHO MCNEIL PHARM
	   143.75MG;172.5MG;184MG
	        N005794 002
	
    TRIPLE SULFA
	
         FOUGERA
	              172.5MG;172.5MG;172.5MG
	       A088463 001 Jan 03, 1985
	
         PHARMADERM
	           172.5MG;172.5MG;172.5MG
	       A088462 001 Jan 03, 1985
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                   6-329(of 337)


TRIPROLIDINE HYDROCHLORIDE
	
  SYRUP;ORAL
	
    ACTIDIL
	
         GLAXOSMITHKLINE
	         1.25MG/5ML
	                    N011496 002 Jul 01, 1983
	
    MYIDYL
	
         USL PHARMA
	              1.25MG/5ML
	                    A087963 001 Jan 18, 1983
	
    TRIPROLIDINE HYDROCHLORIDE
	
         ALPHARMA US PHARMS
	      1.25MG/5ML
                     A085940 001
	
         HALSEY
	                  1.25MG/5ML
                     A088735 001 Jan 17, 1985
	
         PHARM ASSOC
	             1.25MG/5ML
	                    A087514 001 Feb 10, 1982
	
  TABLET;ORAL
	
    ACTIDIL
	
         GLAXOSMITHKLINE
	         2.5MG
	                         N011110 002 Jul 01, 1983
	
    TRIPROLIDINE HYDROCHLORIDE
	
         VITARINE
	                2.5MG
	                         A085610 001
	
         WATSON LABS
	             2.5MG
	                         A085094 001
	
TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)

  SUSPENSION;ORAL
	
    LANTRISUL
	
         LANNETT
	              167MG/5ML;167MG/5ML;167MG/5ML
	    A080123 002
	
    NEOTRIZINE
	
         LILLY
	                167MG/5ML;167MG/5ML;167MG/5ML
	    N006317 012
	
    SULFALOID
	
         FOREST PHARMS
	        167MG/5ML;167MG/5ML;167MG/5ML
	    A080100 001
	
    SULFOSE
	
         WYETH AYERST
	         167MG/5ML;167MG/5ML;167MG/5ML
	    A080013 002
	
    TERFONYL
	
         BRISTOL MYERS SQUIBB
	 167MG/5ML;167MG/5ML;167MG/5ML
	    N006904 002
	
    TRIPLE SULFA
	
         ALPHARMA US PHARMS
	   167MG/ML;167MG/ML;167MG/ML
	       A080280 001
	
    TRIPLE SULFAS
	
         LEDERLE
	              167MG/5ML;167MG/5ML;167MG/5ML
	    N006920 003
	
  TABLET;ORAL
	
    NEOTRIZINE
	
         LILLY
	                167MG;167MG;167MG
	                N006317 011
	
    SULFA-TRIPLE #2
	
         IMPAX LABS
	           167MG;167MG;167MG
	                A080079 001
	
    SULFALOID
	
         FOREST PHARMS
	        167MG;167MG;167MG
	                A080099 001
	
    SULFOSE
	
         WYETH AYERST
	         167MG;167MG;167MG
	                A080013 001
	
    TERFONYL
	
         BRISTOL MYERS SQUIBB
	 167MG;167MG;167MG
	                N006904 001
	
    TRIPLE SULFA
	
         PUREPAC PHARM
	        167MG;167MG;167MG
	                A080086 001
	
    TRIPLE SULFAS
	
         LEDERLE
	              167MG;167MG;167MG
	                N006920 002
	
    TRIPLE SULFOID
	
         PAL PAK
	              167MG;167MG;167MG
	                A080094 001
	
TROGLITAZONE
	
  TABLET;ORAL
	
    PRELAY
	
         SANKYO
	                  200MG
	                         N020719 001 Jan 29, 1997
	
                                   300MG
	                         N020719 003 Aug 04, 1997

                                   400MG
	                         N020719 002 Jan 29, 1997
	
    REZULIN
	
         PFIZER PHARMS
	           200MG
	                         N020720 001 Jan 29, 1997
	
                                   300MG
	                         N020720 003 Aug 04, 1997

                                   400MG
	                         N020720 002 Jan 29, 1997
	
TROLAMINE POLYPEPTIDE OLEATE CONDENSATE
	
  SOLUTION/DROPS;OTIC

    CERUMENEX
	
         PHARM RES ASSOC        10%
	                              N011340 002
	
TROLEANDOMYCIN
	
  CAPSULE;ORAL
	
    TAO
	
          PFIZER                   EQ 250MG BASE
	                 N050336 002
	
  SUSPENSION;ORAL
	
    TAO
	
          PFIZER                   EQ 125MG BASE/5ML
	             N050332 001
	
                       35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                     6-330(of 337)


TROPICAMIDE
	
  SOLUTION/DROPS;OPHTHALMIC

    MYDRIACYL
	
         ALCON
	                  0.5%
	                           N012111 002
	
                                  1%
	                             N012111 004
	
    MYDRIAFAIR
	
         PHARMAFAIR
	             0.5%
	                           A088274 001 Sep 16, 1983

                                  1%
	                             A088230 001 Sep 16, 1983
	
    TROPICAMIDE
	
         AKORN
	                  1%
	                             A088447   001    Aug   28,   1985

         ALCON PHARMS LTD
	       1%
	                             A089172   001    Dec   28,   1990
	
         MIZA PHARMS USA
	        0.5%
	                           A087636   001    Jul   30,   1982
	
                                  1%
	                             A087637   001    Aug   09,   1982

         WATSON LABS
	            0.5%
	                           A089171   001    Dec   28,   1990
	
TROVAFLOXACIN MESYLATE
	
  TABLET;ORAL
	
    TROVAN
	
         PFIZER
	                 EQ 100MG BASE
	                  N020759 001 Dec 18, 1997
	
                                  EQ 200MG BASE
	                  N020759 002 Dec 18, 1997
	
TUBOCURARINE CHLORIDE
	
  INJECTABLE;INJECTION
	
    TUBOCURARINE CHLORIDE
	
         BRISTOL MYERS SQUIBB
	   3MG/ML
                          N005657 001
	
         HOSPIRA
	                3MG/ML
                          N006095 001
	
         LILLY
	                  3MG/ML
	                         N006325 001
	
TYROPANOATE SODIUM
	
  CAPSULE;ORAL
	
    BILOPAQUE
	
         GE HEALTHCARE
	          750MG
	                          N013731 001
	
URACIL MUSTARD
	
  CAPSULE;ORAL
	
    URACIL MUSTARD
	
         SHIRE
	                  1MG
	                            N012892 001
	
UREA
	
  INJECTABLE;INJECTION
	
    STERILE UREA
	
         HOSPIRA
	                40GM/VIAL
	                      N017698 001
	
    UREAPHIL
	
         HOSPIRA
	                40GM/VIAL
	                      N012154 001
	
UREA C-13
	
  FOR SOLUTION;ORAL
	
    BREATHTEK UBT FOR H-PYLORI
	
         OTSUKA AMERICA
	        EQ 75MG/POUCH
	                   N020586 002 May 10, 2001
	
    HELICOSOL
	
         METABOLIC SOLUTIONS
	   125MG/VIAL
	                      N021092 001 Dec 17, 1999
	
    MERETEK UBT KIT (W/ PRANACTIN)

         OTSUKA AMERICA
	        125MG/VIAL
	                      N020586 001 Sep 17, 1996
	
    PYLORI-CHEK BREATH TEST
	
         DXS DEVICES
	           100MG/VIAL
	                      N020900 001 Feb 04, 1999
	
UROFOLLITROPIN
	
  INJECTABLE;INTRAMUSCULAR
	
    METRODIN
	
         SERONO
	                 75 IU/AMP
                       N019415 002 Sep 18, 1986

                                  150 IU/AMP
	                     N019415 003 Sep 18, 1986
	
  INJECTABLE;SUBCUTANEOUS
	
    FERTINEX
	
         SERONO
	                 75 IU/AMP
                       N019415 005 Aug 23, 1996

                                  150 IU/AMP
	                     N019415 004 Aug 23, 1996
	
UROKINASE
	
  INJECTABLE;INJECTION
	
    KINLYTIC
	
         MICROBIX BIOSYSTEMS
	    5,000 IU/VIAL
                   N021846 003
	
                                  9,000 IU/VIAL
                   N021846 002
	
                                  250,000 IU/VIAL
	                N021846 001
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                       6-331(of 337)


URSODIOL
	
  CAPSULE;ORAL
	
    ACTIGALL
	
          WATSON PHARMS         150MG                            N019594 001 Dec 31, 1987
	
  TABLET;ORAL
	
    URSODIOL
	
          TEVA PHARMS USA       250MG                            A079184 001 May 13, 2009

                                500MG                            A079184 002 May 13, 2009
	
VALDECOXIB
	
  TABLET;ORAL
	
    BEXTRA
	
         GD SEARLE              10MG                             N021341 002 Nov 16, 2001
	
                                20MG                             N021341 003 Nov 16, 2001
	
VALPROIC ACID
	
  CAPSULE;ORAL
	
    VALPROIC ACID
	
         PAR PHARM               250MG                           A070431 001 Feb 28, 1986
	
         SCHERER RP              250MG                           A070195 001 Jul 02, 1987
	
         USL PHARMA              250MG                           A070631 001 Jun 11, 1987
	
  CAPSULE, DELAYED RELEASE;ORAL
	
    STAVZOR
	
         BANNER PHARMACAPS		     125MG                           N022152 001 Jul 29, 2008
	
                                 250MG                           N022152 002 Jul 29, 2008
	
                                 500MG                           N022152 003 Jul 29, 2008
	
  SYRUP;ORAL
	
    VALPROIC ACID
	
         APOTEX INC              250MG/5ML                       A077105 001 Jul 29, 2005
	
VALSARTAN
	
  CAPSULE;ORAL
	
    DIOVAN
	
         NOVARTIS               80MG                             N020665 001 Dec 23, 1996
	
                                160MG                            N020665 002 Dec 23, 1996
	
VANCOMYCIN HYDROCHLORIDE
	
  FOR SOLUTION;ORAL
	
    VANCOCIN HYDROCHLORIDE
	
         ANI PHARMS INC         EQ 250MG BASE/5ML                A061667 002 Jul 13, 1983
	
                                EQ 500MG BASE/6ML                A061667 001
	
   VANCOLED
	
        LEDERLE                 EQ 250MG BASE/5ML                A063321 002 Oct 15, 1993
	
                                EQ 500MG BASE/6ML                A063321 003 Oct 15, 1993
	
 INJECTABLE;INJECTION
	
   VANCOCIN HYDROCHLORIDE
	
        ANI PHARMS INC		        EQ   1GM BASE/VIAL               A060180   002     Mar   21,   1986
	
                                EQ   1GM BASE/VIAL               A062476   002     Mar   21,   1986
	
                                EQ   1GM BASE/VIAL               A062716   002     Mar   13,   1987
	
                                EQ   1GM BASE/VIAL               A062812   002     Nov   17,   1987
	
                                EQ   10GM BASE/VIAL              A062812   003     Nov   17,   1987
	
                                EQ   500MG BASE/VIAL             A060180   001
	
                                EQ   500MG BASE/VIAL             A062476   001     Mar 15, 1984
	
                                EQ   500MG BASE/VIAL             A062716   001     Mar 13, 1987
	
                                EQ   500MG BASE/VIAL             A062812   001     Nov 17, 1987
	
   VANCOLED
	
        HIKMA MAPLE		           EQ   1GM BASE/VIAL               A062682   002     Mar   30,   1988
	
                                EQ   2GM BASE/VIAL               A062682   003     May   11,   1988

                                EQ   5GM BASE/VIAL               A062682   004     May   11,   1988

                                EQ   10GM BASE/VIAL              A062682   005     May   11,   1988

                                EQ   500MG BASE/VIAL             A062682   001     Jul   22,   1986
	
   VANCOMYCIN HYDROCHLORIDE
	
        HIKMA MAPLE             EQ 1GM BASE/VIAL                 A062879 002 Aug 02, 1988

                                EQ 500MG BASE/VIAL               A062879 001 Aug 02, 1988

   VANCOR
	
        PHARMACIA AND UPJOHN    EQ 1GM BASE/VIAL                 A062956 002 Aug 01, 1988

                                EQ 500MG BASE/VIAL               A062956 001 Aug 01, 1988
	
VASOPRESSIN TANNATE
	
  INJECTABLE;INJECTION
	
    PITRESSIN TANNATE
	
         PARKE DAVIS            5PRESSOR UNITS/ML                N003402 001
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST                                  6-332(of 337)


VECURONIUM BROMIDE
	
  INJECTABLE;INJECTION
	
    NORCURON
	
         ORGANON USA INC        10MG/VIAL                                    N018776 002 Apr 30, 1984

                                20MG/VIAL                                    N018776 003 Jan 03, 1992
	
   VECURONIUM BROMIDE
	
        HIKMA MAPLE             10MG/VIAL                                    A075218   001    Aug   23,   1999

                                20MG/VIAL                                    A075218   002    Aug   23,   1999

         HOSPIRA                4MG/VIAL                                     A075558   001    Sep   11,   2001

         WATSON LABS            10MG/VIAL                                    A074334   001    Aug   31,   1995

                                20MG/VIAL		                                  A074334   002    Aug   31,   1995
	
VELAGLUCERASE ALFA
	
  POWDER;IV (INFUSION)

    VPRIV
	
         SHIRE HUMAN GENETIC    200 UNITS/VIAL                               N022575 002 Feb 26, 2010
	
VENLAFAXINE HYDROCHLORIDE
	
  CAPSULE, EXTENDED RELEASE;ORAL
	
    EFFEXOR XR
	
         WYETH PHARMS INC       EQ 100MG BASE                                N020699 003 Oct 20, 1997
	
  TABLET;ORAL
	
    EFFEXOR
	
         WYETH PHARMS INC       EQ 12.5MG BASE **Federal Register            N020151 001 Dec 28, 1993

                                determination that product was not

                                discontinued or withdrawn for safety   or

                                efficacy reasons**

                                EQ 25MG BASE **Federal Register              N020151 002 Dec 28, 1993

                                determination that product was not

                                discontinued or withdrawn for safety   or

                                efficacy reasons**

                                EQ 37.5MG BASE **Federal Register            N020151 006 Dec 28, 1993

                                determination that product was not

                                discontinued or withdrawn for safety   or

                                efficacy reasons**

                                EQ 50MG BASE **Federal Register              N020151 003 Dec 28, 1993

                                determination that product was not

                                discontinued or withdrawn for safety   or

                                efficacy reasons**

                                EQ 75MG BASE **Federal Register              N020151 004 Dec 28, 1993

                                determination that product was not

                                discontinued or withdrawn for safety   or

                                efficacy reasons**

                                EQ 100MG BASE **Federal Register             N020151 005 Dec 28, 1993

                                determination that product was not

                                discontinued or withdrawn for safety   or

                                efficacy reasons**

    VENLAFAXINE HYDROCHLORIDE
	
         PLIVA HRVATSKA DOO		   EQ 25MG BASE                                 A078517   001    Jun   13,   2008
	
                                EQ 37.5MG BASE                               A078517   002    Jun   13,   2008
	
                                EQ 50MG BASE                                 A078517   003    Jun   13,   2008
	
                                EQ 75MG BASE                                 A078517   004    Jun   13,   2008
	
                                EQ 100MG BASE                                A078517   005    Jun   13,   2008
	
         SANDOZ		               EQ 25MG BASE                                 A077515   001    Jun   13,   2008
	
                                EQ 37.5MG BASE                               A077515   002    Jun   13,   2008
	
                                EQ 50MG BASE                                 A077515   003    Jun   13,   2008
	
                                EQ 75MG BASE                                 A077515   004    Jun   13,   2008
	
                                EQ 100MG BASE                                A077515   005    Jun   13,   2008
	
VERAPAMIL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    CALAN
	
         GD SEARLE LLC          2.5MG/ML                                     N018925 001 Mar 30, 1984
	
                                2.5MG/ML                                     N019038 001 Mar 30, 1984
	
   ISOPTIN
	
        FSC                     2.5MG/ML                                     N018485 001
	
   VERAPAMIL HYDROCHLORIDE
	
        ABRAXIS PHARM           2.5MG/ML                                     A070348   001    May   01,   1986

        BEDFORD                 2.5MG/ML                                     A072888   001    Jul   28,   1995
	
        HOSPIRA                 2.5MG/ML                                     A070577   001    Feb   02,   1987
	
                                2.5MG/ML		                                   A070739   001    May   06,   1987

                                2.5MG/ML                                     A070740   001    May   06,   1987

         INTL MEDICATION        2.5MG/ML                                     A070451   001    Dec   16,   1985
	
         LUITPOLD               2.5MG/ML                                     A070225   001    Nov   12,   1985
	
                                2.5MG/ML                                     A070617   001    Nov   12,   1985
	
         MARSAM PHARMS LLC      2.5MG/ML                                     A072233   001    Feb   26,   1993
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST                      6-333(of 337)


VERAPAMIL HYDROCHLORIDE
	
  INJECTABLE;INJECTION
	
    VERAPAMIL HYDROCHLORIDE
	
                                2.5MG/ML                        A073485   001    Sep   27,   1993

         SMITH AND NEPHEW       2.5MG/ML                        A070696   001    Jul   31,   1987
	
                                2.5MG/ML                        A070697   001    Jul   31,   1987
	
        SOLOPAK                 2.5MG/ML                        A070695   001    Jul   31,   1987
	
 TABLET;ORAL
	
   CALAN
	
        GD SEARLE LLC           160MG                           N018817 004 Feb 23, 1988
	
   ISOPTIN
	
        FSC		                   40MG                            N018593 003 Nov 23, 1987
	
                                80MG                            N018593 001 Mar 08, 1982
	
                                120MG                           N018593 002 Mar 08, 1982
	
   VERAPAMIL HYDROCHLORIDE
	
        ACTAVIS ELIZABETH       80MG                            A071019   001    Sep   24,   1986

                                120MG                           A070468   001    Sep   24,   1986

        MUTUAL PHARM		          80MG                            A070482   001    Sep   24,   1986

                                80MG                            A071489   002    Jan   13,   1988
	
                                120MG                           A070483   001    Sep   24,   1986

                                120MG                           A071489   001    Jan   13,   1988
	
        PLIVA		                 40MG                            A072751   001    Feb   23,   1996
	
                                80MG                            A072124   001    Jan   26,   1989
	
                                120MG                           A072125   001    Jan   26,   1989
	
        SANDOZ		                40MG                            A073168   001    Jul   31,   1992
	
                                80MG                            A071423   001    May   24,   1988

                                120MG                           A071424   001    May   25,   1988

        WARNER CHILCOTT		       80MG                            A070340   001    Sep   24,   1986

                                120MG                           A070341   001    Sep   24,   1986

        WATSON LABS		           40MG                            A072799   001    Apr   28,   1989

                                40MG                            A072923   001    Jun   29,   1993
	
                                80MG                            A070855   001    Sep   24,   1986

                                80MG                            A071366   001    Oct   01,   1986
	
                                120MG                           A070856   001    Sep   24,   1986

                                120MG                           A071367   001    Oct   01,   1986
	
 TABLET, EXTENDED RELEASE;ORAL
	
   VERAPAMIL HYDROCHLORIDE
	
        PLIVA                   240MG                           A072922 001 Mar 01, 1996
	
VERATRUM VIRIDE ROOT
	
  TABLET;ORAL
	
    VERTAVIS
	
         MEDPOINTE PHARM HLC    130CSR UNIT                     N005691 002
	
VIDARABINE
	
  INJECTABLE;INJECTION
	
    VIRA-A
	
         PARKEDALE              EQ 187.4MG BASE/ML              N050523 001
	
  OINTMENT;OPHTHALMIC
	
    VIRA-A
	
         PARKEDALE              3%                              N050486 001
	
VINBLASTINE SULFATE
	
  INJECTABLE;INJECTION
	
    VELBAN
	
         LILLY                  10MG/VIAL                       N012665 001
	
    VINBLASTINE SULFATE
	
         ABRAXIS PHARM          10MG/VIAL                       A089011 001 Nov 18, 1985
	
         HOSPIRA                10MG/VIAL                       A089565 001 Aug 18, 1987
	
VINCRISTINE SULFATE
	
  INJECTABLE;INJECTION
	
    ONCOVIN
	
         LILLY		                1MG/VIAL                        N014103 001
	
                                1MG/ML                          N014103 003 Mar 07, 1984
	
                                5MG/VIAL                        N014103 002
	
   VINCASAR PFS
	
        TEVA PARENTERAL         1MG/ML                          A071426 001 Jul 17, 1987
	
   VINCREX
	
        BRISTOL MYERS SQUIBB    5MG/VIAL                        A070867 001 Jul 12, 1988
	
   VINCRISTINE SULFATE
	
        ABIC                    1MG/ML                          A070873 001 Feb 19, 1987
	
        ABRAXIS PHARM           1MG/ML                          A070411 001 Sep 10, 1986

        FRESENIUS KABI USA      1MG/ML                          A076296 001 Dec 20, 2002
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                             DISCONTINUED DRUG PRODUCT LIST
	                     6-334(of 337)


VINCRISTINE SULFATE
	
  INJECTABLE;INJECTION
	
    VINCRISTINE SULFATE
	
                                1MG/ML
                           A076401   001     Oct   28,   2003
	
         HOSPIRA		              1MG/VIAL
                         A071559   001     Apr   11,   1988

                                2MG/VIAL
                         A071560   001     Apr   11,   1988

                                5MG/VIAL
	                        A071561   001     Apr   11,   1988
	
VINORELBINE TARTRATE
	
  INJECTABLE;INJECTION
	
    VINORELBINE TARTRATE
	
         EBEWE PHARMA           EQ 10MG BASE/ML
	                 A078408 001 Feb 13, 2008
	
VIOMYCIN SULFATE
	
  INJECTABLE;INJECTION
	
    VIOCIN SULFATE
	
         PFIZER                 EQ 1GM BASE/VIAL
                 A061086 001
	
                                EQ 5GM BASE/VIAL
	                A061086 002
	
VITAMIN A
	
  CAPSULE;ORAL
	
    AQUASOL A
	
         ASTRAZENECA            25,000USP UNITS
	                 A083080 002
	
                                50,000USP UNITS
	                 A083080 001
	
   VITAMIN A
	
        BANNER PHARMACAPS       50,000USP UNITS
	                 A083973   001
	
        CHASE CHEM              50,000 IU
	                       A083351   001
	
        EVERYLIFE               50,000 IU
	                       A083134   001
	
        IMPAX LABS              50,000USP UNITS
	                 A080952   001
	
        WEST WARD               50,000USP UNITS
	                 A080985   001
	
VITAMIN A PALMITATE
	
  CAPSULE;ORAL
	
    AFAXIN
	
         STERLING WINTHROP      EQ 50,000 UNITS BASE
	            A083187 001
	
    ALPHALIN
	
         LILLY                  EQ 50,000 UNITS BASE
	            A080883 001
	
    DEL-VI-A
	
         DEL RAY LABS           EQ 50,000 UNITS BASE
	            A080830 001
	
    VI-DOM-A
	
         BAYER PHARMS           EQ 50,000 UNITS BASE
	            A080972 001
	
    VITAMIN A
	
         BANNER PHARMACAPS      EQ   50,000   UNITS   BASE
	      A080702   001
	
         BRISTOL MYERS SQUIBB   EQ   50,000   UNITS   BASE
	      A080860   001
	
         CHASE CHEM             EQ   50,000   UNITS   BASE
	      A080746   001
	
                                EQ   50,000   UNITS   BASE
	      A083207   001
	
         ELKINS SINN            EQ   50,000   UNITS   BASE
	      A085479   001
	
         EVERYLIFE              EQ   50,000   UNITS   BASE
	      A080943   001
	
                                EQ   50,000   UNITS   BASE
	      A083114   001
	
         IMPAX LABS             EQ   50,000   UNITS   BASE
	      A080953   001
	
                                EQ   50,000   UNITS   BASE
	      A080955   001
	
         IVAX SUB TEVA PHARMS   EQ   50,000   UNITS   BASE
	      A083035   001
	
                                EQ   50,000   UNITS   BASE
	      A083190   001
	
         MK LABS                EQ   25,000   UNITS   BASE
	      A083457   002
	
                                EQ   50,000   UNITS   BASE
	      A083457   001
	
        WEST WARD               EQ   50,000   UNITS   BASE
	      A080967   001
	
        WHARTON LABS            EQ   50,000   UNITS   BASE
	      A083665   001
	
   VITAMIN A PALMITATE
	
        ARCUM                   EQ   50,000   UNITS   BASE
	      A083311   001
	
                                EQ   50,000   UNITS   BASE
	      A083321   001
	
         BANNER PHARMACAPS      EQ   50,000   UNITS   BASE
	      A083948   001
	
                                EQ   50,000   UNITS   BASE
	      A083981   001
	
   VITAMIN A SOLUBILIZED
	
        TEVA                    EQ 50,000 UNITS BASE
	            A080921 001
	
 INJECTABLE;INJECTION
	
   VITAMIN A PALMITATE
	
        BEL MAR                 EQ 50,000 UNITS BASE/ML
	         A080819 001
	
WARFARIN POTASSIUM
	
  TABLET;ORAL
	
    ATHROMBIN-K
	
         PHARM RES ASSOC		      2MG
	                             N011771   007
	
                                5MG
	                             N011771   004
	
                                10MG
	                            N011771   005
	
                                25MG
	                            N011771   006
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                           DISCONTINUED DRUG PRODUCT LIST
	                      6-335(of 337)


WARFARIN SODIUM
	
  INJECTABLE;INJECTION
	
    COUMADIN
	
         BRISTOL MYERS SQUIBB   5MG/VIAL
                        N009218 024 Feb 07, 1995
	
                                50MG/VIAL
                       N009218 020
	
                                75MG/VIAL
                       N009218 012
	
 TABLET;ORAL
	
   ATHROMBIN
	
        PHARM RES ASSOC         5MG
	                            N011771 003
	
                                10MG
	                           N011771 002
	
                                25MG
	                           N011771 001
	
   PANWARFIN
	
        ABBOTT                  2MG
	                            N017020   001
	
                                2.5MG
	                          N017020   002
	
                                5MG
	                            N017020   003
	
                                7.5MG
	                          N017020   004
	
                                10MG
	                           N017020   005
	
   WARFARIN SODIUM
	
        SANDOZ                  1MG
	                            A040196   001     Sep   30,   1997

                                2MG
	                            A040196   002     Sep   30,   1997

                                2.5MG
	                          A040196   003     Sep   30,   1997

                                3MG
	                            A040196   008     Jul   26,   2000
	
                                4MG
	                            A040196   004     Sep   30,   1997

                                5MG
	                            A040196   005     Sep   30,   1997

                                6MG
	                            A040196   009     Jul   26,   2000
	
                                7.5MG
	                          A040196   006     Sep   30,   1997

                                10MG
	                           A040196   007     Sep   30,   1997

        USL PHARMA              2MG
	                            A088719   001     Jun   27,   1985
	
                                2.5MG
	                          A088720   001     Aug   06,   1985

                                5MG
	                            A088721   001     Jul   02,   1985
	
        WATSON LABS             2MG
	                            A086123   001     Aug   17,   1982

                                2.5MG
	                          A086120   001     Aug   17,   1982

                                5MG
	                            A086119   001     Aug   17,   1982

                                7.5MG
	                          A086118   001     Aug   17,   1982

                                10MG
	                           A086122   001     Aug   17,   1982
	
XENON XE-127
	
  GAS;INHALATION
	
    XENON XE 127
	
         MALLINCKRODT           5mCi/VIAL
                       N018536 001 Oct 01, 1982
	
                                10mCi/VIAL
	                     N018536 002 Oct 01, 1982
	
XENON XE-133
	
  GAS;INHALATION
	
    XENON XE 133
	
         GE HEALTHCARE          1 CI/AMP
                        N017256   002
	
                                10mCi/VIAL
                      N017687   002
	
                                20mCi/VIAL
                      N017687   003
	
        GEN ELECTRIC            5-100 CI/CYLINDER
               N017550   001
	
                                0.25-5 CI/AMP
                   N017550   003
	
        MALLINCKRODT            10mCi/VIAL
                      N018327   001 Mar 09, 1982
	
                                20mCi/VIAL
                      N018327   002 Mar 09, 1982
	
   XENON XE 133-V.S.S.
	
        GE HEALTHCARE          10mCi/VIAL
                       N017687 001
	
 INJECTABLE;INJECTION
	
   XENON XE 133
	
        GE HEALTHCARE          1.3-1.7 CI/AMP
                   N017256 001
	
        LANTHEUS MEDCL         6.3mCi/ML
                        N017283 001
	
 SOLUTION;INHALATION, INJECTION
	
   XENEISOL
	
        MALLINCKRODT           18-25mCi/AMP
	                    N017262 002
	
XYLOSE
	
  POWDER;ORAL
	
    XYLO-PFAN
	
         SAVAGE LABS            25GM/BOT
                        N017605 001
	
    XYLOSE
	
         LYNE                   25GM/BOT
	                       N018856 001 Mar 26, 1987
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                              DISCONTINUED DRUG PRODUCT LIST
	                            6-336(of 337)


ZALCITABINE
	
  TABLET;ORAL
	
    HIVID
	
         ROCHE                   0.375MG
	                                  N020199 001
	 Jun 19, 1992
	
                                 0.75MG
	                                   N020199 002
	 Jun 19, 1992
	
ZALEPLON
	
  CAPSULE;ORAL
	
    ZALEPLON
	
          SANDOZ                 5MG
	                                      A078095 001
	 Jun 06, 2008
	
                                 10MG
	                                     A078095 002
	 Jun 06, 2008
	
ZICONOTIDE ACETATE
	
  INJECTABLE;INTRATHECAL
	
    PRIALT
	
         JAZZ PHARMS INTL        200MCG/2ML (100MCG/ML)
	                   N021060 003
	 Dec 28, 2004
	
ZIDOVUDINE
	
  INJECTABLE;INJECTION
	
    ZIDOVUDINE
	
         LIAONING CHENGDA        10MG/ML
                                   A204538 001
	 Nov 26, 2013
	
  TABLET;ORAL
	
    RETROVIR
	
         VIIV HLTHCARE           200MG
	                                    N020518 001
	 Dec 19, 1995
	
                                 300MG
	                                    N020518 002
	 Oct 04, 1996
	
    ZIDOVUDINE
	
         AUROBINDO PHARMA        60MG
	                                     N022294 001
	 Jul 23, 2009
	
         MATRIX LABS LTD         100MG
	                                    N200732 001
	 Feb 23, 2011
	
         RANBAXY LABS LTD        300MG
	                                    A077327 001
	 Sep 19, 2005
	
ZILEUTON
	
  TABLET;ORAL
	
    ZYFLO
	
          CHIESI USA INC         300MG
	                                    N020471 001
	 Dec 09, 1996
	
ZINC SULFATE
	
  INJECTABLE;INJECTION
	
    ZINC SULFATE
	
         ABRAXIS PHARM           EQ 1MG ZINC/ML
	                           N019229 002
	 May 05, 1987
	
ZOLEDRONIC ACID
	
  INJECTABLE;IV (INFUSION)

    ZOMETA
	
         NOVARTIS                EQ 4MG BASE/VIAL **Federal Register
       N021223 001
	 Aug 20, 2001
	
                                 determination that product was not

                                 discontinued or withdrawn for safety or

                                 efficacy reasons**
	
ZOLPIDEM TARTRATE
	
  TABLET;ORAL
	
    ZOLPIDEM TARTRATE
	
         DR REDDYS LABS LTD     5MG
	                                       A077985   001
	   Apr   23,   2007

                                10MG
	                                      A077985   002
	   Apr   23,   2007

         MUTUAL PHARMA          5MG
	                                       A077288   001
	   Apr   23,   2007

                                10MG
	                                      A077288   002
	   Apr   23,   2007

         MYLAN PHARMS INC       5MG
	                                       A078016   001
	   Apr   23,   2007

                                10MG
	                                      A078016   002
	   Apr   23,   2007

         SYNTHON PHARMS         5MG
	                                       A077540   001
	   Apr   23,   2007

                                10MG
	                                      A077540   002
	   Apr   23,   2007

         VIVIMED LABS           5MG
	                                       A076062   001
	   Apr   23,   2007

                                10MG
	                                      A076062   002
	   Apr   23,   2007

         WATSON LABS            5MG
	                                       A077773   001
	   Apr   23,   2007

                                10MG
	                                      A077773   002
	   Apr   23,   2007
	
  TABLET, ORALLY DISINTEGRATING;ORAL
	
    TOVALT ODT
	
         BIOVAIL LABS INTL      5MG
	                                       N021412 001
	 Apr 25, 2007

                                10MG
	                                      N021412 002
	 Apr 25, 2007
	
ZONISAMIDE
	
  CAPSULE;ORAL
	
    ZONISAMIDE
	
         ANI PHARMS INC		        25MG
	                                     A077639   001
	   Dec   22,   2005
	
                                 25MG
	                                     A077641   003
	   Dec   22,   2005
	
                                 50MG
	                                     A077639   002
	   Dec   22,   2005
	
                                 50MG
	                                     A077641   002
	   Dec   22,   2005
	
                                 100MG
	                                    A077639   003
	   Dec   22,   2005
	
                                 100MG
	                                    A077641   001
	   Dec   22,   2005
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	
                            DISCONTINUED DRUG PRODUCT LIST
	                      6-337(of 337)


ZONISAMIDE
	
  CAPSULE;ORAL
	
    ZONISAMIDE
	
         COREPHARMA             25MG
	                            A077876   001    Feb   21,   2007
	
                                50MG
	                            A077876   002    Feb   21,   2007
	
                                100MG
	                           A077876   003    Feb   21,   2007
	
        DR REDDYS LABS LTD      25MG
	                            A077645   002    Sep   29,   2006

                                50MG
	                            A077645   003    Sep   29,   2006

                                100MG
	                           A077645   001    Dec   22,   2005
	
        MUTUAL PHARM            25MG
	                            A077635   001    Dec   22,   2005
	
                                50MG
	                            A077635   002    Dec   22,   2005
	
                                100MG
	                           A077635   003    Dec   22,   2005
	
        ROXANE                  25MG
	                            A077648   001    Dec   22,   2005
	
                                50MG
	                            A077648   002    Dec   22,   2005
	
                                100MG
	                           A077648   003    Dec   22,   2005
	
        SANDOZ                  25MG
	                            A077644   001    Dec   22,   2005
	
                                50MG
	                            A077644   002    Dec   22,   2005
	
                                100MG
	                           A077644   003    Dec   22,   2005
	
        WATSON LABS             25MG
	                            A077650   001    Apr   20,   2006

                                50MG
	                            A077650   002    Apr   20,   2006

                                100MG
	                           A077650   003    Apr   20,   2006
	
                35TH EDITION - 2015 - APPROVED DRUG PRODUCTS LIST
                                                                                         7-1




              ORPHAN PRODUCT DESIGNATIONS AND APPROVALS LIST


The list of List of Orphan Designations and Approvals is available at:
http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/default.htm
          35TH EDITION - 2015 - APPROVED DRUG PRODUCTS LIST
                                                                               8-1


DRUG PRODUCTS WHICH MUST DEMONSTRATE IN VIVO BIOAVAILABILITY
   ONLY IF PRODUCT FAILS TO ACHIEVE ADEQUATE DISSOLUTION


  ACETAMINOPHEN;ASPIRIN;BUTALBITAL            ASPIRIN;CAFFEINE;CARISOPRODOL;
  CAPSULE OR TABLET; ORAL                     CODEINE PHOSPHATE
  160-165MG;160-165MG;50MG                    TABLET; ORAL
  325MG;325MG;50MG                            160MG;32MG;200MG;16MG


  ACETAMINOPHEN;ASPIRIN;BUTALBITAL;           ASPIRIN;CARISOPRODOL
  CAFFEINE                                    TABLET; ORAL
  CAPSULE OR TABLET; ORAL                     325MG;200MG
  160-165MG;160-165MG;50MG;40MG
  325MG;325MG;50MG;40MG
                                              ASPIRIN;CARISOPRODOL;
                                              CODEINE PHOSPHATE
  ACETAMINOPHEN;BUTALBITAL                    TABLET; ORAL
  CAPSULE OR TABLET; ORAL                     325MG;200MG;16MG
  325MG;50MG

                                              ASPIRIN;MEPROBAMATE
  ACETAMINOPHEN;BUTALBITAL;CAFFEINE           TABLET; ORAL
  CAPSULE OR TABLET; ORAL                     325MG;200MG
  325MG;50MG;40MG

                                              ASPIRIN;METHOCARBAMOL
  AMINOPHYLLINE                               TABLET; ORAL
  TABLET; ORAL                                325MG;400MG
  100MG;200MG

                                              CHLOROTHIAZIDE
  ASPIRIN;BUTALBITAL                          TABLET; ORAL
  CAPSULE OR TABLET; ORAL                     250MG
  325MG;50MG
  650MG;50MG
                                              HYDROXYZINE HYDROCHLORIDE
                                              TABLET; ORAL
  ASPIRIN;BUTALBITAL;CAFFEINE                 10MG;25MG;
  CAPSULE OR TABLET; ORAL                     50MG;100MG
  325MG;50MG;40MG
  650MG;50MG;40MG
                                              PREDNISONE
                                              TABLET; ORAL
  ASPIRIN;CAFFEINE;CARISOPRODOL               1MG;2.5MG;5MG;10MG;
  TABLET; ORAL                                20MG;25MG;50MG
  160MG;32MG;200MG
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST     A - 1


                        APPENDIX A     -        PRODUCT NAME INDEX

                                           **    8   **

8-MOP,   METHOXSALEN

                                           **    A   **

A-HYDROCORT, HYDROCORTISONE SODIUM SUCCINATE

A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE

ABACAVIR SULFATE, ABACAVIR SULFATE

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE, ABACAVIR SULFATE

ABELCET, AMPHOTERICIN B

ABILIFY, ARIPIPRAZOLE

ABILIFY MAINTENA KIT, ARIPIPRAZOLE

ABLAVAR, GADOFOSVESET TRISODIUM

ABRAXANE, PACLITAXEL

ABREVA, DOCOSANOL    (OTC)

ABSORICA, ISOTRETINOIN

ABSTRAL, FENTANYL CITRATE

ACAMPROSATE CALCIUM, ACAMPROSATE CALCIUM

ACANYA, BENZOYL PEROXIDE

ACARBOSE, ACARBOSE

ACCOLATE, ZAFIRLUKAST

ACCUNEB, ALBUTEROL SULFATE

ACCUPRIL, QUINAPRIL HYDROCHLORIDE

ACCURETIC, HYDROCHLOROTHIAZIDE

ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE

ACEON, PERINDOPRIL ERBUMINE

ACEPHEN, ACETAMINOPHEN    (OTC)

ACETADOTE, ACETYLCYSTEINE

ACETAMINOPHEN, ACETAMINOPHEN     (OTC)

ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN   (OTC)

ACETASOL HC, ACETIC ACID, GLACIAL

ACETAZOLAMIDE, ACETAZOLAMIDE

ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM

ACETAZOLAMIDE SODIUM , ACETAZOLAMIDE SODIUM

ACETIC ACID, ACETIC ACID, GLACIAL

ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL

ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE, ACETIC ACID, GLACIAL

ACETYLCYSTEINE, ACETYLCYSTEINE

ACHROMYCIN V, TETRACYCLINE HYDROCHLORIDE

ACIPHEX, RABEPRAZOLE SODIUM

ACIPHEX SPRINKLE, RABEPRAZOLE SODIUM

ACITRETIN, ACITRETIN

ACOVA, ARGATROBAN

ACTHREL, CORTICORELIN OVINE TRIFLUTATE

ACTICLATE, DOXYCYCLINE HYCLATE

ACTIGALL, URSODIOL

ACTIQ, FENTANYL CITRATE

ACTIVELLA, ESTRADIOL

ACTONEL, RISEDRONATE SODIUM

ACTOPLUS MET, METFORMIN HYDROCHLORIDE

ACTOPLUS MET XR, METFORMIN HYDROCHLORIDE

ACTOS, PIOGLITAZONE HYDROCHLORIDE

ACULAR, KETOROLAC TROMETHAMINE

ACULAR LS, KETOROLAC TROMETHAMINE

ACUVAIL, KETOROLAC TROMETHAMINE

ACYCLOVIR, ACYCLOVIR

ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE, ACYCLOVIR SODIUM

ACYCLOVIR SODIUM, ACYCLOVIR SODIUM

ACZONE, DAPSONE

ADAGEN, PEGADEMASE BOVINE

ADALAT CC, NIFEDIPINE

ADAPALENE, ADAPALENE

ADASUVE, LOXAPINE

ADCIRCA, TADALAFIL

ADDERALL XR 10, AMPHETAMINE ASPARTATE

ADDERALL XR 15, AMPHETAMINE ASPARTATE

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST       A - 2


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    A   **

ADDERALL XR 20, AMPHETAMINE ASPARTATE

ADDERALL XR 25, AMPHETAMINE ASPARTATE

ADDERALL XR 30, AMPHETAMINE ASPARTATE

ADDERALL XR 5, AMPHETAMINE ASPARTATE

ADEFOVIR DIPIVOXIL, ADEFOVIR DIPIVOXIL

ADEMPAS, RIOCIGUAT

ADENOCARD, ADENOSINE

ADENOSCAN, ADENOSINE

ADENOSINE, ADENOSINE

ADIPEX-P, PHENTERMINE HYDROCHLORIDE

ADRENACLICK, EPINEPHRINE

ADRENALIN, EPINEPHRINE HYDROCHLORIDE

ADREVIEW, IOBENGUANE SULFATE I-123

ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE

ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE

ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE

ADVAIR HFA, FLUTICASONE PROPIONATE

ADVICOR, LOVASTATIN

ADVIL, IBUPROFEN    (OTC)

ADVIL, IBUPROFEN SODIUM     (OTC)

ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE   (OTC)

ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE        (OTC)

ADVIL COLD AND SINUS, IBUPROFEN     (OTC)

ADVIL CONGESTION RELIEF, IBUPROFEN      (OTC)

ADVIL LIQUI-GELS, IBUPROFEN     (OTC)

ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN      (OTC)

ADVIL PM, DIPHENHYDRAMINE CITRATE      (OTC)

ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE       (OTC)

AEROSPAN HFA, FLUNISOLIDE

AFEDITAB CR, NIFEDIPINE

AFINITOR, EVEROLIMUS

AFINITOR DISPERZ, EVEROLIMUS

AFREZZA, INSULIN RECOMBINANT HUMAN

AFRINOL, PSEUDOEPHEDRINE SULFATE      (OTC)

AGGRASTAT, TIROFIBAN HYDROCHLORIDE

AGGRENOX, ASPIRIN

AGRYLIN, ANAGRELIDE HYDROCHLORIDE

AK-FLUOR 10%, FLUORESCEIN SODIUM

AK-FLUOR 25%, FLUORESCEIN SODIUM

AKBETA, LEVOBUNOLOL HYDROCHLORIDE

AKINETON, BIPERIDEN HYDROCHLORIDE

AKNE-MYCIN, ERYTHROMYCIN

AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE

AKTEN, LIDOCAINE HYDROCHLORIDE

AKTOB, TOBRAMYCIN

AKYNZEO, NETUPITANT

ALA-CORT, HYDROCORTISONE

ALA-SCALP, HYDROCORTISONE

ALAVERT, LORATADINE    (OTC)

ALAWAY, KETOTIFEN FUMARATE     (OTC)

ALBENZA, ALBENDAZOLE

ALBUTEROL SULFATE, ALBUTEROL SULFATE

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE

ALCAINE, PROPARACAINE HYDROCHLORIDE

ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE

ALCOHOL 10% AND DEXTROSE 5%, ALCOHOL

ALCOHOL 5% AND DEXTROSE 5%, ALCOHOL

ALDACTAZIDE, HYDROCHLOROTHIAZIDE

ALDACTONE, SPIRONOLACTONE

ALDARA, IMIQUIMOD

ALENDRONATE SODIUM, ALENDRONATE SODIUM

ALEVE, NAPROXEN SODIUM     (OTC)

ALEVE PM, DIPHENHYDRAMINE HYDROCHLORIDE       (OTC)

ALEVE-D SINUS & COLD, NAPROXEN SODIUM      (OTC)

ALFENTA, ALFENTANIL HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST             A - 3


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    A   **

ALFENTANIL, ALFENTANIL HYDROCHLORIDE

ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

ALIMTA, PEMETREXED DISODIUM

ALINIA, NITAZOXANIDE

ALKERAN, MELPHALAN

ALKERAN, MELPHALAN HYDROCHLORIDE

ALLEGRA, FEXOFENADINE HYDROCHLORIDE

ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE    (OTC)

ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE   (OTC)

ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE   (OTC)

ALLI, ORLISTAT    (OTC)

ALLOPURINOL, ALLOPURINOL

ALLOPURINOL SODIUM, ALLOPURINOL SODIUM

ALOCRIL, NEDOCROMIL SODIUM

ALOMIDE, LODOXAMIDE TROMETHAMINE

ALOPRIM, ALLOPURINOL SODIUM

ALORA, ESTRADIOL

ALOXI, PALONOSETRON HYDROCHLORIDE

ALPHAGAN P, BRIMONIDINE TARTRATE

ALPRAZOLAM, ALPRAZOLAM

ALPROSTADIL, ALPROSTADIL

ALREX, LOTEPREDNOL ETABONATE

ALSUMA, SUMATRIPTAN SUCCINATE

ALTABAX, RETAPAMULIN

ALTACE, RAMIPRIL

ALTAVERA, ETHINYL ESTRADIOL

ALTOPREV, LOVASTATIN

ALVESCO, CICLESONIDE

ALYACEN 1/35, ETHINYL ESTRADIOL

ALYACEN 7/7/7, ETHINYL ESTRADIOL

AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

AMARYL, GLIMEPIRIDE

AMBIEN, ZOLPIDEM TARTRATE

AMBIEN CR, ZOLPIDEM TARTRATE

AMBISOME, AMPHOTERICIN B

AMCINONIDE, AMCINONIDE

AMERGE, NARATRIPTAN HYDROCHLORIDE

AMICAR, AMINOCAPROIC ACID

AMIDATE, ETOMIDATE

AMIFOSTINE, AMIFOSTINE

AMIKACIN SULFATE, AMIKACIN SULFATE

AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE

AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE

AMINO ACIDS, AMINO ACIDS

AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE

AMINOCAPROIC, AMINOCAPROIC ACID

AMINOCAPROIC ACID, AMINOCAPROIC ACID

AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID

AMINOPHYLLINE, AMINOPHYLLINE

AMINOSYN 10%, AMINO ACIDS

AMINOSYN 10% (PH6), AMINO ACIDS

AMINOSYN 3.5%, AMINO ACIDS

AMINOSYN 3.5% M, AMINO ACIDS

AMINOSYN 5%, AMINO ACIDS

AMINOSYN 7%, AMINO ACIDS

AMINOSYN 7% (PH6), AMINO ACIDS

AMINOSYN 7% W/ ELECTROLYTES, AMINO ACIDS

AMINOSYN 8.5%, AMINO ACIDS

AMINOSYN 8.5% (PH6), AMINO ACIDS

AMINOSYN 8.5% W/ ELECTROLYTES, AMINO ACIDS

AMINOSYN II 10%, AMINO ACIDS

AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS

AMINOSYN II 10% W/ ELECTROLYTES, AMINO ACIDS

AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                   A - 4


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    A   **

AMINOSYN II 7%, AMINO ACIDS

AMINOSYN II 8.5%, AMINO ACIDS

AMINOSYN II 8.5% W/ ELECTROLYTES, AMINO ACIDS

AMINOSYN-HBC 7%, AMINO ACIDS

AMINOSYN-HF 8%, AMINO ACIDS

AMINOSYN-PF 10%, AMINO ACIDS

AMINOSYN-PF 7%, AMINO ACIDS

AMINOSYN-RF 5.2%, AMINO ACIDS

AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

AMITIZA, LUBIPROSTONE

AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM, AMLODIPINE BESYLATE

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

AMLODIPINE BESYLATE AND VALSARTAN, AMLODIPINE BESYLATE

AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE

AMMONIA N 13, AMMONIA N-13

AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE

AMMONIUM LACTATE, AMMONIUM LACTATE

AMMONUL, SODIUM BENZOATE

AMNESTEEM, ISOTRETINOIN

AMOXAPINE, AMOXAPINE

AMOXICILLIN, AMOXICILLIN

AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

AMOXICILLIN PEDIATRIC, AMOXICILLIN

AMOXIL, AMOXICILLIN

AMPHADASE, HYALURONIDASE

AMPHETAMINE ASP AMPHETAMINE SULF DEXTROAMPHET SACCHARATE & DEXTR SULF, AMPHETAMINE

AMPHETAMINE SULFATE, AMPHETAMINE SULFATE

AMPHOTEC, AMPHOTERICIN B

AMPHOTERICIN B, AMPHOTERICIN B

AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

AMPICILLIN SODIUM, AMPICILLIN SODIUM

AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE

AMPYRA, DALFAMPRIDINE

AMRINONE LACTATE, INAMRINONE LACTATE

AMRIX, CYCLOBENZAPRINE HYDROCHLORIDE

AMTURNIDE, ALISKIREN HEMIFUMARATE

AMYVID, FLORBETAPIR F-18

AN-DTPA, TECHNETIUM TC-99M PENTETATE KIT

AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT

ANADROL-50, OXYMETHOLONE

ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE

ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE

ANAPROX, NAPROXEN SODIUM

ANAPROX DS, NAPROXEN SODIUM

ANASTROZOLE, ANASTROZOLE

ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM

ANCOBON, FLUCYTOSINE

ANDRODERM, TESTOSTERONE

ANDROGEL, TESTOSTERONE

ANDROID 10, METHYLTESTOSTERONE

ANDROID 25, METHYLTESTOSTERONE

ANECTINE, SUCCINYLCHOLINE CHLORIDE

ANEXSIA 5/325, ACETAMINOPHEN

ANEXSIA 7.5/325, ACETAMINOPHEN

ANGELIQ, DROSPIRENONE

ANGIOMAX, BIVALIRUDIN

ANORO ELLIPTA, UMECLIDINIUM BROMIDE

ANSAID, FLURBIPROFEN

ANTABUSE, DISULFIRAM

ANTARA (MICRONIZED), FENOFIBRATE

ANTHELIOS 20, AVOBENZONE    (OTC)

ANTHELIOS 40, AVOBENZONE    (OTC)

ANTHELIOS SX, AVOBENZONE    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST            A - 5


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    A   **

ANTIZOL, FOMEPIZOLE

ANUSOL HC, HYDROCORTISONE

ANZEMET, DOLASETRON MESYLATE

APIDRA, INSULIN GLULISINE RECOMBINANT

APIDRA SOLOSTAR, INSULIN GLULISINE RECOMBINANT

APLENZIN, BUPROPION HYDROBROMIDE

APOKYN, APOMORPHINE HYDROCHLORIDE

APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE

APREPITANT, APREPITANT

APRISO, MESALAMINE

APTIOM, ESLICARBAZEPINE ACETATE

APTIVUS, TIPRANAVIR

AQUASOL A, VITAMIN A PALMITATE

ARALEN, CHLOROQUINE PHOSPHATE

ARANELLE, ETHINYL ESTRADIOL

ARAVA, LEFLUNOMIDE

ARCAPTA NEOHALER, INDACATEROL MALEATE

ARESTIN, MINOCYCLINE HYDROCHLORIDE

ARGATROBAN, ARGATROBAN

ARGATROBAN IN 0.9% SODIUM CHLORIDE, ARGATROBAN

ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN

ARICEPT, DONEPEZIL HYDROCHLORIDE

ARICEPT ODT, DONEPEZIL HYDROCHLORIDE

ARIMIDEX, ANASTROZOLE

ARISTOSPAN, TRIAMCINOLONE HEXACETONIDE

ARIXTRA, FONDAPARINUX SODIUM

ARNUITY ELLIPTA, FLUTICASONE FUROATE

AROMASIN, EXEMESTANE

ARRANON, NELARABINE

ARTHROTEC, DICLOFENAC SODIUM

ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, ARTICAINE HYDROCHLORIDE

ASACOL, MESALAMINE

ASACOL HD, MESALAMINE

ASCLERA, POLIDOCANOL

ASMANEX HFA, MOMETASONE FUROATE

ASMANEX TWISTHALER, MOMETASONE FUROATE

ASPIRIN, ASPIRIN    (OTC)

ASPIRIN AND DIPYRIDAMOLE, ASPIRIN

ASTAGRAF XL, TACROLIMUS

ASTELIN, AZELASTINE HYDROCHLORIDE

ASTEPRO, AZELASTINE HYDROCHLORIDE

ASTRAMORPH PF, MORPHINE SULFATE

ATACAND, CANDESARTAN CILEXETIL

ATACAND HCT, CANDESARTAN CILEXETIL

ATAZANAVIR SULFATE, ATAZANAVIR SULFATE

ATELVIA, RISEDRONATE SODIUM

ATENOLOL, ATENOLOL

ATENOLOL AND CHLORTHALIDONE, ATENOLOL

ATIVAN, LORAZEPAM

ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

ATOVAQUONE, ATOVAQUONE

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE

ATRACURIUM BESYLATE, ATRACURIUM BESYLATE

ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE

ATRALIN, TRETINOIN

ATRIDOX, DOXYCYCLINE HYCLATE

ATRIPLA, EFAVIRENZ

ATROPEN, ATROPINE

ATROPINE SULFATE, ATROPINE SULFATE

ATROPINE SULFATE ANSYR PLASTIC SYRINGE, ATROPINE SULFATE

ATROVENT, IPRATROPIUM BROMIDE

ATROVENT HFA, IPRATROPIUM BROMIDE

AUBAGIO, TERIFLUNOMIDE

AUGMENTIN '125', AMOXICILLIN

AUGMENTIN '200', AMOXICILLIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      A - 6


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    A   **

AUGMENTIN '250', AMOXICILLIN

AUGMENTIN '400', AMOXICILLIN

AUGMENTIN '500', AMOXICILLIN

AUGMENTIN '875', AMOXICILLIN

AUGMENTIN ES-600, AMOXICILLIN

AUGMENTIN XR, AMOXICILLIN

AUVI-Q, EPINEPHRINE

AVAGARD, ALCOHOL    (OTC)

AVAGE, TAZAROTENE

AVALIDE, HYDROCHLOROTHIAZIDE

AVANDAMET, METFORMIN HYDROCHLORIDE

AVANDARYL, GLIMEPIRIDE

AVANDIA, ROSIGLITAZONE MALEATE

AVAPRO, IRBESARTAN

AVC, SULFANILAMIDE

AVEED, TESTOSTERONE UNDECANOATE

AVELOX, MOXIFLOXACIN HYDROCHLORIDE

AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER,       MOXIFLOXACIN HYDROCHLORIDE

AVIANE-28, ETHINYL ESTRADIOL

AVINZA, MORPHINE SULFATE

AVITA, TRETINOIN

AVODART, DUTASTERIDE

AXERT, ALMOTRIPTAN MALATE

AXID, NIZATIDINE

AXID AR, NIZATIDINE    (OTC)

AXIRON, TESTOSTERONE

AYGESTIN, NORETHINDRONE ACETATE

AZACITIDINE, AZACITIDINE

AZACTAM, AZTREONAM

AZACTAM IN PLASTIC CONTAINER, AZTREONAM

AZASAN, AZATHIOPRINE

AZASITE, AZITHROMYCIN

AZATHIOPRINE, AZATHIOPRINE

AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM

AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

AZELEX, AZELAIC ACID

AZILECT, RASAGILINE MESYLATE

AZITHROMYCIN, AZITHROMYCIN

AZOPT, BRINZOLAMIDE

AZOR, AMLODIPINE BESYLATE

AZTREONAM, AZTREONAM

AZULFIDINE, SULFASALAZINE

AZULFIDINE EN-TABS, SULFASALAZINE

                                           **    B   **

BACIIM, BACITRACIN

BACITRACIN, BACITRACIN

BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC

BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN

BACLOFEN, BACLOFEN

BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM

BACTRIM, SULFAMETHOXAZOLE

BACTRIM DS, SULFAMETHOXAZOLE

BACTROBAN, MUPIROCIN

BACTROBAN, MUPIROCIN CALCIUM

BAL, DIMERCAPROL

BALANCED SALT, CALCIUM CHLORIDE

BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM

BALZIVA-28, ETHINYL ESTRADIOL

BANZEL, RUFINAMIDE

BARACLUDE, ENTECAVIR

BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE

BELEODAQ, BELINOSTAT

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                A - 7


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    B   **

BELSOMRA, SUVOREXANT

BELVIQ, LORCASERIN HYDROCHLORIDE

BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

BENICAR, OLMESARTAN MEDOXOMIL

BENICAR HCT, HYDROCHLOROTHIAZIDE

BENTYL, DICYCLOMINE HYDROCHLORIDE

BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE

BENZACLIN, BENZOYL PEROXIDE

BENZAMYCIN, BENZOYL PEROXIDE

BENZAMYCIN PAK, BENZOYL PEROXIDE

BENZONATATE, BENZONATATE

BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

BEPREVE, BEPOTASTINE BESILATE

BESIVANCE, BESIFLOXACIN HYDROCHLORIDE

BETA-VAL, BETAMETHASONE VALERATE

BETADINE, POVIDONE-IODINE

BETAGAN, LEVOBUNOLOL HYDROCHLORIDE

BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE

BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

BETAMETHASONE VALERATE, BETAMETHASONE VALERATE

BETAPACE, SOTALOL HYDROCHLORIDE

BETAPACE AF, SOTALOL HYDROCHLORIDE

BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE

BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

BETHKIS, TOBRAMYCIN

BETIMOL, TIMOLOL

BETOPTIC, BETAXOLOL HYDROCHLORIDE

BETOPTIC S, BETAXOLOL HYDROCHLORIDE

BEYAZ, DROSPIRENONE

BIAXIN, CLARITHROMYCIN

BIAXIN XL, CLARITHROMYCIN

BICALUTAMIDE, BICALUTAMIDE

BICILLIN C-R, PENICILLIN G BENZATHINE

BICILLIN C-R 900/300, PENICILLIN G BENZATHINE

BICILLIN L-A, PENICILLIN G BENZATHINE

BICNU, CARMUSTINE

BIDIL, HYDRALAZINE HYDROCHLORIDE

BILTRICIDE, PRAZIQUANTEL

BIMATOPROST, BIMATOPROST

BINOSTO, ALENDRONATE SODIUM

BIOSCRUB, CHLORHEXIDINE GLUCONATE    (OTC)

BISOPROLOL FUMARATE, BISOPROLOL FUMARATE

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE

BLEOMYCIN SULFATE, BLEOMYCIN SULFATE

BLEPH-10, SULFACETAMIDE SODIUM

BLEPHAMIDE, PREDNISOLONE ACETATE

BLEPHAMIDE S.O.P., PREDNISOLONE ACETATE

BLOXIVERZ, NEOSTIGMINE METHYLSULFATE

BONIVA, IBANDRONATE SODIUM

BONTRIL, PHENDIMETRAZINE TARTRATE

BONTRIL PDM, PHENDIMETRAZINE TARTRATE

BOSULIF, BOSUTINIB MONOHYDRATE

BRANCHAMIN 4% IN PLASTIC CONTAINER, AMINO ACIDS

BRAVELLE, UROFOLLITROPIN

BREO ELLIPTA, FLUTICASONE FUROATE

BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, BRETYLIUM TOSYLATE

BREVIBLOC, ESMOLOL HYDROCHLORIDE

BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE

BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE

BREVICON 28-DAY, ETHINYL ESTRADIOL

BREVITAL SODIUM, METHOHEXITAL SODIUM

BRIAN CARE, CHLORHEXIDINE GLUCONATE    (OTC)

BRIELLYN, ETHINYL ESTRADIOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                     A - 8


                       APPENDIX A       -        PRODUCT NAME INDEX

                                            **    B   **

BRILINTA, TICAGRELOR

BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE

BRINTELLIX, VORTIOXETINE HYDROBROMIDE

BRISDELLE, PAROXETINE MESYLATE

BROMDAY, BROMFENAC SODIUM

BROMFED-DM, BROMPHENIRAMINE MALEATE

BROMFENAC SODIUM, BROMFENAC SODIUM

BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE,

BRONCHO SALINE, SODIUM CHLORIDE    (OTC)

BROVANA, ARFORMOTEROL TARTRATE

BSS, CALCIUM CHLORIDE

BSS PLUS, CALCIUM CHLORIDE

BUDESONIDE, BUDESONIDE

BUMETANIDE, BUMETANIDE

BUNAVAIL, BUPRENORPHINE HYDROCHLORIDE

BUPHENYL, SODIUM PHENYLBUTYRATE

BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

BUPRENEX, BUPRENORPHINE HYDROCHLORIDE

BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE , BUPRENORPHINE HYDROCHLORIDE

BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

BUSULFEX, BUSULFAN

BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN

BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN

BUTAPAP, ACETAMINOPHEN

BUTISOL SODIUM, BUTABARBITAL SODIUM

BUTOCONAZOLE NITRATE, BUTOCONAZOLE NITRATE

BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE

BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE
BUTRANS, BUPRENORPHINE
BYDUREON, EXENATIDE SYNTHETIC
BYETTA, EXENATIDE SYNTHETIC
BYSTOLIC, NEBIVOLOL HYDROCHLORIDE
                                            **    C   **
C-SOLVE-2, ERYTHROMYCIN
CABERGOLINE, CABERGOLINE
CADUET, AMLODIPINE BESYLATE
CAFCIT, CAFFEINE CITRATE
CAFERGOT, CAFFEINE
CAFFEINE CITRATE, CAFFEINE CITRATE
CALAN, VERAPAMIL HYDROCHLORIDE
CALAN SR, VERAPAMIL HYDROCHLORIDE
CALCIJEX, CALCITRIOL
CALCIPOTRIENE, CALCIPOTRIENE
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

CALCITONIN-SALMON, CALCITONIN SALMON

CALCITRIOL, CALCITRIOL

CALCIUM ACETATE, CALCIUM ACETATE

CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE, CALCIUM CARBONATE    (OTC)

CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM

CALDOLOR, IBUPROFEN

CAMBIA, DICLOFENAC POTASSIUM

CAMILA, NORETHINDRONE

CAMPRAL, ACAMPROSATE CALCIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                 A - 9


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    C   **

CAMPTOSAR, IRINOTECAN HYDROCHLORIDE

CANASA, MESALAMINE

CANCIDAS, CASPOFUNGIN ACETATE

CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL

CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL

CANTIL, MEPENZOLATE BROMIDE

CAPASTAT SULFATE, CAPREOMYCIN SULFATE

CAPECITABINE, CAPECITABINE

CAPEX, FLUOCINOLONE ACETONIDE

CAPITAL AND CODEINE, ACETAMINOPHEN

CAPITAL SOLEIL 15, AVOBENZONE    (OTC)

CAPOTEN, CAPTOPRIL

CAPRELSA, VANDETANIB

CAPTOPRIL, CAPTOPRIL

CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL

CARAC, FLUOROURACIL

CARAFATE, SUCRALFATE

CARBAGLU, CARGLUMIC ACID

CARBAMAZEPINE, CARBAMAZEPINE

CARBATROL, CARBAMAZEPINE

CARBIDOPA, CARBIDOPA

CARBIDOPA AND LEVODOPA, CARBIDOPA

CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA

CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE

CARBOCAINE, MEPIVACAINE HYDROCHLORIDE

CARBOPLATIN, CARBOPLATIN

CARDENE, NICARDIPINE HYDROCHLORIDE

CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82

CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT

CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE

CARDIZEM, DILTIAZEM HYDROCHLORIDE

CARDIZEM CD, DILTIAZEM HYDROCHLORIDE

CARDIZEM LA, DILTIAZEM HYDROCHLORIDE

CARDURA, DOXAZOSIN MESYLATE

CARDURA XL, DOXAZOSIN MESYLATE

CARISOPRODOL, CARISOPRODOL

CARISOPRODOL AND ASPIRIN, ASPIRIN

CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN

CARNITOR, LEVOCARNITINE

CARNITOR SF, LEVOCARNITINE

CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE

CARTIA XT, DILTIAZEM HYDROCHLORIDE

CARVEDILOL, CARVEDILOL

CASODEX, BICALUTAMIDE

CATAFLAM, DICLOFENAC POTASSIUM

CATAPRES, CLONIDINE HYDROCHLORIDE

CATAPRES-TTS-1, CLONIDINE

CATAPRES-TTS-2, CLONIDINE

CATAPRES-TTS-3, CLONIDINE

CAVERJECT, ALPROSTADIL

CAVERJECT IMPULSE, ALPROSTADIL

CAYSTON, AZTREONAM

CEDAX, CEFTIBUTEN DIHYDRATE

CEFACLOR, CEFACLOR

CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

CEFAZOLIN AND DEXTROSE, CEFAZOLIN SODIUM

CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

CEFDINIR, CEFDINIR

CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE

CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE

CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      A - 10


                       APPENDIX A       -        PRODUCT NAME INDEX

                                            **    C   **

CEFOTAXIME, CEFOTAXIME SODIUM

CEFOTAXIME SODIUM, CEFOTAXIME SODIUM

CEFOTETAN, CEFOTETAN DISODIUM

CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, CEFOTETAN DISODIUM

CEFOXITIN, CEFOXITIN SODIUM

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, CEFOXITIN SODIUM

CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL

CEFPROZIL, CEFPROZIL

CEFTAZIDIME, CEFTAZIDIME

CEFTAZIDIME IN DEXTROSE CONTAINER, CEFTAZIDIME

CEFTIN, CEFUROXIME AXETIL

CEFTRIAXONE, CEFTRIAXONE SODIUM

CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, CEFTRIAXONE SODIUM

CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CEFUROXIME SODIUM

CEFUROXIME AXETIL, CEFUROXIME AXETIL

CEFUROXIME SODIUM, CEFUROXIME SODIUM

CELEBREX, CELECOXIB

CELECOXIB, CELECOXIB

CELESTONE SOLUSPAN, BETAMETHASONE ACETATE

CELEXA, CITALOPRAM HYDROBROMIDE

CELLCEPT, MYCOPHENOLATE MOFETIL

CELLCEPT, MYCOPHENOLATE MOFETIL HYDROCHLORIDE

CELONTIN, METHSUXIMIDE

CENESTIN, ESTROGENS, CONJUGATED SYNTHETIC A

CENTANY, MUPIROCIN

CEPHALEXIN, CEPHALEXIN

CERDELGA, ELIGLUSTAT TARTRATE

CEREBYX, FOSPHENYTOIN SODIUM

CERETEC, TECHNETIUM TC-99M EXAMETAZIME KIT

CEREZYME, IMIGLUCERASE

CERUBIDINE, DAUNORUBICIN HYDROCHLORIDE

CERVIDIL, DINOPROSTONE

CESAMET, NABILONE

CETAMIDE, SULFACETAMIDE SODIUM

CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE     (OTC)

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE    (OTC)

CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE     (OTC)

CETRAXAL, CIPROFLOXACIN HYDROCHLORIDE

CETROTIDE, CETRORELIX

CEVIMELINE, CEVIMELINE HYDROCHLORIDE

CEVIMELINE HYDROCHLORIDE, CEVIMELINE HYDROCHLORIDE

CHANTIX, VARENICLINE TARTRATE

CHEMET, SUCCIMER

CHENODIOL, CHENODIOL

CHG SCRUB, CHLORHEXIDINE GLUCONATE     (OTC)

CHILDREN'S ADVIL, IBUPROFEN    (OTC)

CHILDREN'S ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE    (OTC)

CHILDREN'S ADVIL COLD, IBUPROFEN    (OTC)

CHILDREN'S ADVIL-FLAVORED, IBUPROFEN     (OTC)

CHILDREN'S ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

CHILDREN'S ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE    (OTC)

CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE      (OTC)

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE      (OTC)

CHILDREN'S CLARITIN, LORATADINE    (OTC)

CHILDREN'S ELIXSURE, IBUPROFEN    (OTC)

CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE      (OTC)

CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE      (OTC)

CHILDREN'S IBUPROFEN, IBUPROFEN    (OTC)

CHILDREN'S MOTRIN, IBUPROFEN    (OTC)

CHILDREN'S MOTRIN COLD, IBUPROFEN     (OTC)

CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST              A - 11


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    C   **

CHIRHOSTIM, SECRETIN SYNTHETIC HUMAN

CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE     (OTC)

CHLORAMPHENICOL SODIUM SUCCINATE, CHLORAMPHENICOL SODIUM SUCCINATE

CHLORAPREP ONE-STEP, CHLORHEXIDINE GLUCONATE     (OTC)

CHLORAPREP ONE-STEP FREPP, CHLORHEXIDINE GLUCONATE      (OTC)

CHLORAPREP ONE-STEP SEPP, CHLORHEXIDINE GLUCONATE     (OTC)

CHLORAPREP SINGLE SWABSTICK, CHLORHEXIDINE GLUCONATE      (OTC)

CHLORAPREP TRIPLE SWABSTICK, CHLORHEXIDINE GLUCONATE      (OTC)

CHLORAPREP WITH TINT, CHLORHEXIDINE GLUCONATE     (OTC)

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE

CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE     (OTC)

CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE

CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE

CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE

CHLOROTHIAZIDE, CHLOROTHIAZIDE

CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM

CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE      (OTC)

CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE

CHLORPROPAMIDE, CHLORPROPAMIDE

CHLORTHALIDONE, CHLORTHALIDONE

CHLORZOXAZONE, CHLORZOXAZONE

CHOLAC, LACTULOSE

CHOLEDYL SA, OXTRIPHYLLINE

CHOLESTYRAMINE, CHOLESTYRAMINE

CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE

CHOLETEC, TECHNETIUM TC-99M MEBROFENIN KIT

CHOLINE C-11, CHOLINE C-11

CHOLOGRAFIN MEGLUMINE, IODIPAMIDE MEGLUMINE

CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC

CHROMIC CHLORIDE IN PLASTIC CONTAINER, CHROMIC CHLORIDE

CIALIS, TADALAFIL

CICLOPIROX, CICLOPIROX

CIDA-STAT, CHLORHEXIDINE GLUCONATE    (OTC)

CIDOFOVIR, CIDOFOVIR

CILOSTAZOL, CILOSTAZOL

CILOXAN, CIPROFLOXACIN HYDROCHLORIDE

CIMETIDINE, CIMETIDINE    (OTC)

CIMETIDINE, CIMETIDINE

CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE

CIPRO, CIPROFLOXACIN

CIPRO, CIPROFLOXACIN HYDROCHLORIDE

CIPRO HC, CIPROFLOXACIN HYDROCHLORIDE

CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

CIPRODEX, CIPROFLOXACIN

CIPROFLOXACIN, CIPROFLOXACIN

CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN

CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

CIS-MDP, TECHNETIUM TC-99M MEDRONATE KIT

CIS-PYRO, TECHNETIUM TC-99M PYROPHOSPHATE KIT

CISATRACURIUM BESYLATE, CISATRACURIUM BESYLATE

CISATRACURIUM BESYLATE PRESERVATIVE FREE, CISATRACURIUM BESYLATE

CISPLATIN, CISPLATIN

CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

CITANEST FORTE DENTAL, EPINEPHRINE BITARTRATE

CLADRIBINE, CLADRIBINE

CLAFORAN, CEFOTAXIME SODIUM

CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CEFOTAXIME SODIUM

CLARAVIS, ISOTRETINOIN

CLARINEX, DESLORATADINE

CLARINEX D 24 HOUR, DESLORATADINE

CLARINEX-D 12 HOUR, DESLORATADINE

CLARITHROMYCIN, CLARITHROMYCIN

CLARITIN, LORATADINE    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                     A - 12


                       APPENDIX A       -        PRODUCT NAME INDEX

                                            **    C   **

CLARITIN HIVES RELIEF, LORATADINE    (OTC)

CLARITIN HIVES RELIEF REDITAB, LORATADINE    (OTC)

CLARITIN REDITABS, LORATADINE    (OTC)

CLARITIN-D, LORATADINE    (OTC)

CLARITIN-D 24 HOUR, LORATADINE    (OTC)

CLEMASTINE FUMARATE, CLEMASTINE FUMARATE    (OTC)

CLEMASTINE FUMARATE, CLEMASTINE FUMARATE

CLEOCIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE

CLEOCIN, CLINDAMYCIN PHOSPHATE

CLEOCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE

CLEOCIN T, CLINDAMYCIN PHOSPHATE

CLEVIPREX, CLEVIDIPINE

CLIMARA, ESTRADIOL

CLIMARA PRO, ESTRADIOL

CLINDA-DERM, CLINDAMYCIN PHOSPHATE

CLINDAGEL, CLINDAMYCIN PHOSPHATE

CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE

CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE

CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, CLINDAMYCIN PHOSPHATE

CLINDESSE, CLINDAMYCIN PHOSPHATE

CLINDETS, CLINDAMYCIN PHOSPHATE

CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, AMINO ACIDS

CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,

CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER,

CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS

CLINOLIPID 20%, OLIVE OIL

CLINORIL, SULINDAC

CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE

CLOBEX, CLOBETASOL PROPIONATE

CLODERM, CLOCORTOLONE PIVALATE

CLOLAR, CLOFARABINE

CLOMID, CLOMIPHENE CITRATE

CLOMIPHENE CITRATE, CLOMIPHENE CITRATE

CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE

CLONAZEPAM, CLONAZEPAM

CLONIDINE, CLONIDINE

CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

CLONIDINE HYDROCHLORIDE , CLONIDINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST        A - 13


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    C   **

CLOPIDOGREL, CLOPIDOGREL

CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM

CLORPRES, CHLORTHALIDONE

CLOTRIMAZOLE, CLOTRIMAZOLE    (OTC)

CLOTRIMAZOLE, CLOTRIMAZOLE

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

CLOZAPINE, CLOZAPINE

CLOZARIL, CLOZAPINE

COARTEM, ARTEMETHER

CODEINE SULFATE, CODEINE SULFATE

COGENTIN, BENZTROPINE MESYLATE

COL-PROBENECID, COLCHICINE

COLAZAL, BALSALAZIDE DISODIUM

COLCRYS, COLCHICINE

COLESTID, COLESTIPOL HYDROCHLORIDE

COLESTIPOL HYDROCHLORIDE, COLESTIPOL HYDROCHLORIDE

COLGATE TOTAL, SODIUM FLUORIDE    (OTC)

COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM

COLOCORT, HYDROCORTISONE

COLY-MYCIN M, COLISTIMETHATE SODIUM

COLY-MYCIN S, COLISTIN SULFATE

COLYTE, POLYETHYLENE GLYCOL 3350

COLYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350

COMBIGAN, BRIMONIDINE TARTRATE

COMBIPATCH, ESTRADIOL

COMBIVENT, ALBUTEROL SULFATE

COMBIVENT RESPIMAT, ALBUTEROL SULFATE

COMBIVIR, LAMIVUDINE

COMETRIQ, CABOZANTINIB S-MALATE

COMMIT, NICOTINE POLACRILEX    (OTC)

COMPLERA, EMTRICITABINE

COMPRO, PROCHLORPERAZINE

COMTAN, ENTACAPONE

CONCERTA, METHYLPHENIDATE HYDROCHLORIDE

CONDYLOX, PODOFILOX

CONRAY, IOTHALAMATE MEGLUMINE

CONRAY 30, IOTHALAMATE MEGLUMINE

CONRAY 43, IOTHALAMATE MEGLUMINE

CONSTILAC, LACTULOSE

CONSTULOSE, LACTULOSE

CONTRAVE, BUPROPION HYDROCHLORIDE

CONZIP, TRAMADOL HYDROCHLORIDE

COPAXONE, GLATIRAMER ACETATE

COPEGUS, RIBAVIRIN

CORDARONE, AMIODARONE HYDROCHLORIDE

CORDRAN, FLURANDRENOLIDE

CORDRAN SP, FLURANDRENOLIDE

COREG, CARVEDILOL

COREG CR, CARVEDILOL PHOSPHATE

CORGARD, NADOLOL

CORLOPAM, FENOLDOPAM MESYLATE

CORMAX, CLOBETASOL PROPIONATE

CORTEF, HYDROCORTISONE

CORTENEMA, HYDROCORTISONE

CORTIFOAM, HYDROCORTISONE ACETATE

CORTISONE ACETATE, CORTISONE ACETATE

CORTISPORIN, BACITRACIN ZINC

CORTISPORIN, HYDROCORTISONE

CORTISPORIN, HYDROCORTISONE ACETATE

CORTROSYN, COSYNTROPIN

CORVERT, IBUTILIDE FUMARATE

CORZIDE, BENDROFLUMETHIAZIDE

COSMEGEN, DACTINOMYCIN

COSOPT, DORZOLAMIDE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 14


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    C   **

COSOPT PF, DORZOLAMIDE HYDROCHLORIDE

COSYNTROPIN, COSYNTROPIN

COUMADIN, WARFARIN SODIUM

COVERA-HS, VERAPAMIL HYDROCHLORIDE

COZAAR, LOSARTAN POTASSIUM

CREON, PANCRELIPASE (AMYLASE

CRESTOR, ROSUVASTATIN CALCIUM

CRINONE, PROGESTERONE

CRIXIVAN, INDINAVIR SULFATE

CROLOM, CROMOLYN SODIUM

CROMOLYN SODIUM, CROMOLYN SODIUM    (OTC)

CROMOLYN SODIUM, CROMOLYN SODIUM

CROTAN, CROTAMITON

CRYSELLE, ETHINYL ESTRADIOL

CUBICIN, DAPTOMYCIN

CUPRIC CHLORIDE IN PLASTIC CONTAINER, CUPRIC CHLORIDE

CUPRIMINE, PENICILLAMINE

CUROSURF, PORACTANT ALFA

CUTIVATE, FLUTICASONE PROPIONATE

CUVPOSA, GLYCOPYRROLATE

CYANOCOBALAMIN, CYANOCOBALAMIN

CYANOKIT, HYDROXOCOBALAMIN

CYCLAFEM 1/35, ETHINYL ESTRADIOL

CYCLAFEM 7/7/7, ETHINYL ESTRADIOL

CYCLESSA, DESOGESTREL

CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE

CYCLOMYDRIL, CYCLOPENTOLATE HYDROCHLORIDE

CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE

CYCLOSET, BROMOCRIPTINE MESYLATE

CYCLOSPORINE, CYCLOSPORINE

CYKLOKAPRON, TRANEXAMIC ACID

CYMBALTA, DULOXETINE HYDROCHLORIDE

CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

CYSTADANE, BETAINE HYDROCHLORIDE

CYSTAGON, CYSTEAMINE BITARTRATE

CYSTARAN, CYSTEAMINE HYDROCHLORIDE

CYSTO-CONRAY II, IOTHALAMATE MEGLUMINE

CYSTOGRAFIN, DIATRIZOATE MEGLUMINE

CYSTOGRAFIN DILUTE, DIATRIZOATE MEGLUMINE

CYSVIEW KIT, HEXAMINOLEVULINATE HYDROCHLORIDE

CYTARABINE, CYTARABINE

CYTOMEL, LIOTHYRONINE SODIUM

CYTOSAR-U, CYTARABINE

CYTOTEC, MISOPROSTOL

CYTOVENE, GANCICLOVIR SODIUM

CYTOXAN (LYOPHILIZED), CYCLOPHOSPHAMIDE

                                           **    D   **

D.H.E. 45, DIHYDROERGOTAMINE MESYLATE

DACARBAZINE, DACARBAZINE

DACOGEN, DECITABINE

DACTINOMYCIN, DACTINOMYCIN

DALIRESP, ROFLUMILAST

DALVANCE, DALBAVANCIN HYDROCHLORIDE

DANAZOL, DANAZOL

DANTRIUM, DANTROLENE SODIUM

DANTROLENE SODIUM, DANTROLENE SODIUM

DAPSONE, DAPSONE

DAPTOMYCIN, DAPTOMYCIN

DARAPRIM, PYRIMETHAMINE

DASETTA 1/35, ETHINYL ESTRADIOL

DASETTA 7/7/7, ETHINYL ESTRADIOL

DATSCAN, IOFLUPANE I-123

DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 15


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    D   **

DAUNOXOME, DAUNORUBICIN CITRATE

DAYPRO, OXAPROZIN

DAYSEE, ETHINYL ESTRADIOL

DAYTRANA, METHYLPHENIDATE

DDAVP, DESMOPRESSIN ACETATE

DDAVP (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

DECITABINE, DECITABINE

DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE

DEFINITY, PERFLUTREN

DELATESTRYL, TESTOSTERONE ENANTHATE

DELESTROGEN, ESTRADIOL VALERATE

DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DELSYM, DEXTROMETHORPHAN POLISTIREX    (OTC)

DELZICOL, MESALAMINE

DEMADEX, TORSEMIDE

DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE

DEMEROL, MEPERIDINE HYDROCHLORIDE

DEMSER, METYROSINE

DENAVIR, PENCICLOVIR SODIUM

DENDRID, IDOXURIDINE

DEPACON, VALPROATE SODIUM

DEPAKENE, VALPROIC ACID

DEPAKOTE, DIVALPROEX SODIUM

DEPAKOTE ER, DIVALPROEX SODIUM

DEPEN, PENICILLAMINE

DEPO-ESTRADIOL, ESTRADIOL CYPIONATE

DEPO-MEDROL, METHYLPREDNISOLONE ACETATE

DEPO-PROVERA, MEDROXYPROGESTERONE ACETATE

DEPO-SUBQ PROVERA 104, MEDROXYPROGESTERONE ACETATE

DEPO-TESTOSTERONE, TESTOSTERONE CYPIONATE

DEPOCYT, CYTARABINE

DERMA-SMOOTHE/FS, FLUOCINOLONE ACETONIDE

DERMABET, BETAMETHASONE VALERATE

DERMATOP, PREDNICARBATE

DERMATOP E EMOLLIENT, PREDNICARBATE

DERMOTIC, FLUOCINOLONE ACETONIDE

DESFERAL, DEFEROXAMINE MESYLATE

DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE

DESLORATADINE, DESLORATADINE

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, DESLORATADINE

DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

DESOGEN, DESOGESTREL

DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL

DESONATE, DESONIDE

DESONIDE, DESONIDE

DESOWEN, DESONIDE

DESOXIMETASONE, DESOXIMETASONE

DESOXYN, METHAMPHETAMINE HYDROCHLORIDE

DESVENLAFAXINE, DESVENLAFAXINE

DESVENLAFAXINE, DESVENLAFAXINE FUMARATE

DETROL, TOLTERODINE TARTRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 16


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    D   **

DETROL LA, TOLTERODINE TARTRATE

DEXAMETHASONE, DEXAMETHASONE

DEXAMETHASONE INTENSOL, DEXAMETHASONE

DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

DEXASPORIN, DEXAMETHASONE

DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE, DEXBROMPHENIRAMINE MALEATE   (OTC)

DEXCHLORPHENIRAMINE MALEATE, DEXCHLORPHENIRAMINE MALEATE

DEXEDRINE, DEXTROAMPHETAMINE SULFATE

DEXFERRUM, IRON DEXTRAN

DEXILANT, DEXLANSOPRAZOLE

DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE

DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE

DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

DEXTROMETHORPHAN POLISTIREX, DEXTROMETHORPHAN POLISTIREX    (OTC)

DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 25%, DEXTROSE

DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ, DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K), DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ, DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K), DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ, DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ, DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ, DEXTROSE

DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K), DEXTROSE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                     A - 17


                       APPENDIX A       -        PRODUCT NAME INDEX

                                            **    D   **

DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER,

DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER,

DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER,

DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER,

DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER,

DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER,

DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER,

DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 60% IN PLASTIC CONTAINER, DEXTROSE

DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE

DIABETA, GLYBURIDE

DIABINESE, CHLORPROPAMIDE

DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIAMOX, ACETAZOLAMIDE

DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

DIASTAT, DIAZEPAM

DIASTAT ACUDIAL, DIAZEPAM

DIAZEPAM, DIAZEPAM

DIAZEPAM INTENSOL, DIAZEPAM

DIBENZYLINE, PHENOXYBENZAMINE HYDROCHLORIDE

DICLEGIS, DOXYLAMINE SUCCINATE

DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM

DICLOFENAC SODIUM, DICLOFENAC SODIUM

DICLOFENAC SODIUM , DICLOFENAC SODIUM

DICLOFENAC SODIUM AND MISOPROSTOL, DICLOFENAC SODIUM

DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM

DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE

DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE), DICYCLOMINE HYDROCHLORIDE

DIDANOSINE, DIDANOSINE

DIDREX, BENZPHETAMINE HYDROCHLORIDE

DIDRONEL, ETIDRONATE DISODIUM

DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE

DIFFERIN, ADAPALENE

DIFICID, FIDAXOMICIN

DIFLORASONE DIACETATE, DIFLORASONE DIACETATE

DIFLUCAN, FLUCONAZOLE

DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE

DIFLUCAN IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

DIFLUNISAL, DIFLUNISAL

DIGOXIN, DIGOXIN

DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE

DILACOR XR, DILTIAZEM HYDROCHLORIDE

DILANTIN, PHENYTOIN

DILANTIN, PHENYTOIN SODIUM

DILANTIN-125, PHENYTOIN

DILATRATE-SR, ISOSORBIDE DINITRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                       A - 18


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    D   **

DILAUDID, HYDROMORPHONE HYDROCHLORIDE

DILAUDID-HP, HYDROMORPHONE HYDROCHLORIDE

DILT-CD, DILTIAZEM HYDROCHLORIDE

DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

DILTZAC, DILTIAZEM HYDROCHLORIDE

DIMENHYDRINATE, DIMENHYDRINATE

DIMETHYL SULFOXIDE, DIMETHYL SULFOXIDE

DIOVAN, VALSARTAN

DIOVAN HCT, HYDROCHLOROTHIAZIDE

DIPENTUM, OLSALAZINE SODIUM

DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE

DIPRIVAN, PROPOFOL

DIPROLENE, BETAMETHASONE DIPROPIONATE

DIPROLENE AF, BETAMETHASONE DIPROPIONATE

DIPYRIDAMOLE, DIPYRIDAMOLE

DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE

DISULFIRAM, DISULFIRAM

DISULFIRAM , DISULFIRAM

DITROPAN XL, OXYBUTYNIN CHLORIDE

DIURIL, CHLOROTHIAZIDE

DIURIL, CHLOROTHIAZIDE SODIUM

DIVALPROEX SODIUM, DIVALPROEX SODIUM

DIVIGEL, ESTRADIOL

DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE

DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE

DOCEFREZ, DOCETAXEL

DOCETAXEL, DOCETAXEL

DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE

DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%, DOPAMINE HYDROCHLORIDE

DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE

DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE

DOPRAM, DOXAPRAM HYDROCHLORIDE

DORAL, QUAZEPAM

DORIBAX, DORIPENEM

DORYX, DOXYCYCLINE HYCLATE

DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

DOTAREM, GADOTERATE MEGLUMINE

DOVONEX, CALCIPOTRIENE

DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE

DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

DOXERCALCIFEROL, DOXERCALCIFEROL

DOXIL (LIPOSOMAL), DOXORUBICIN HYDROCHLORIDE

DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL), DOXORUBICIN HYDROCHLORIDE

DOXTERIC, DOXYCYCLINE HYCLATE

DOXY 100, DOXYCYCLINE HYCLATE

DOXY 200, DOXYCYCLINE HYCLATE

DOXYCYCLINE, DOXYCYCLINE

DOXYCYCLINE, DOXYCYCLINE HYCLATE

DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE    (OTC)

DRAXIMAGE MDP-25, TECHNETIUM TC-99M MEDRONATE

DRISDOL, ERGOCALCIFEROL

DRONABINOL, DRONABINOL

DROPERIDOL, DROPERIDOL

DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE

DROXIA, HYDROXYUREA

DTIC-DOME, DACARBAZINE

DTPA, TECHNETIUM TC-99M PENTETATE KIT

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 19


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    D   **

DUAC, BENZOYL PEROXIDE

DUAVEE, BAZEDOXIFENE ACETATE

DUETACT, GLIMEPIRIDE

DUEXIS, FAMOTIDINE

DULERA, FORMOTEROL FUMARATE

DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

DUODOTE, ATROPINE

DUONEB, ALBUTEROL SULFATE

DURACLON, CLONIDINE HYDROCHLORIDE

DURAGESIC-100, FENTANYL

DURAGESIC-12, FENTANYL

DURAGESIC-25, FENTANYL

DURAGESIC-50, FENTANYL

DURAGESIC-75, FENTANYL

DURAMORPH PF, MORPHINE SULFATE

DURAPREP, IODINE POVACRYLEX    (OTC)

DUREZOL, DIFLUPREDNATE

DUTASTERIDE, DUTASTERIDE

DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE, DUTASTERIDE

DUTOPROL, HYDROCHLOROTHIAZIDE

DYAZIDE, HYDROCHLOROTHIAZIDE

DYLOJECT, DICLOFENAC SODIUM

DYMISTA, AZELASTINE HYDROCHLORIDE

DYNA-HEX, CHLORHEXIDINE GLUCONATE     (OTC)

DYNACIN, MINOCYCLINE HYDROCHLORIDE

DYRENIUM, TRIAMTERENE

                                           **    E   **

E-Z SCRUB 201, POVIDONE-IODINE    (OTC)

E-Z SCRUB 241, POVIDONE-IODINE    (OTC)

E.E.S., ERYTHROMYCIN ETHYLSUCCINATE

E.E.S. 200, ERYTHROMYCIN ETHYLSUCCINATE

E.E.S. 400, ERYTHROMYCIN ETHYLSUCCINATE

EC-NAPROSYN, NAPROXEN

ECONAZOLE NITRATE, ECONAZOLE NITRATE

ECOZA, ECONAZOLE NITRATE

EDARBI, AZILSARTAN KAMEDOXOMIL

EDARBYCLOR, AZILSARTAN KAMEDOXOMIL

EDECRIN, ETHACRYNATE SODIUM

EDECRIN, ETHACRYNIC ACID

EDEX, ALPROSTADIL

EDLUAR, ZOLPIDEM TARTRATE

EDURANT, RILPIVIRINE HYDROCHLORIDE

EFFEXOR XR, VENLAFAXINE HYDROCHLORIDE

EFFIENT, PRASUGREL HYDROCHLORIDE

EFUDEX, FLUOROURACIL

EGRIFTA, TESAMORELIN ACETATE

ELDEPRYL, SELEGILINE HYDROCHLORIDE

ELELYSO, TALIGLUCERASE ALFA

ELESTAT, EPINASTINE HYDROCHLORIDE

ELESTRIN, ESTRADIOL

ELIDEL, PIMECROLIMUS

ELIGARD, LEUPROLIDE ACETATE

ELIMITE, PERMETHRIN

ELINEST, ETHINYL ESTRADIOL

ELIPHOS, CALCIUM ACETATE

ELIQUIS, APIXABAN

ELIXOPHYLLIN, THEOPHYLLINE

ELLA, ULIPRISTAL ACETATE

ELLENCE, EPIRUBICIN HYDROCHLORIDE

ELLIOTTS B SOLUTION, CALCIUM CHLORIDE

ELMIRON, PENTOSAN POLYSULFATE SODIUM

ELOCON, MOMETASONE FUROATE

ELOXATIN, OXALIPLATIN

EMADINE, EMEDASTINE DIFUMARATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 20


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    E   **

EMBEDA, MORPHINE SULFATE

EMBELINE, CLOBETASOL PROPIONATE

EMBELINE E, CLOBETASOL PROPIONATE

EMCYT, ESTRAMUSTINE PHOSPHATE SODIUM

EMEND, APREPITANT

EMEND, FOSAPREPITANT DIMEGLUMINE

EMLA, LIDOCAINE

EMOQUETTE, DESOGESTREL

EMSAM, SELEGILINE

EMTRIVA, EMTRICITABINE

ENABLEX, DARIFENACIN HYDROBROMIDE

ENALAPRIL MALEATE, ENALAPRIL MALEATE

ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE

ENALAPRILAT, ENALAPRILAT

ENDOMETRIN, PROGESTERONE

ENDOSOL EXTRA, CALCIUM CHLORIDE

ENFLURANE, ENFLURANE

ENJUVIA, ESTROGENS, CONJUGATED SYNTHETIC B

ENLON, EDROPHONIUM CHLORIDE

ENLON-PLUS, ATROPINE SULFATE

ENOXAPARIN SODIUM, ENOXAPARIN SODIUM

ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM

ENPRESSE-28, ETHINYL ESTRADIOL

ENSKYCE, DESOGESTREL

ENTACAPONE, ENTACAPONE

ENTECAVIR, ENTECAVIR

ENTEREG, ALVIMOPAN

ENTOCORT EC, BUDESONIDE

ENULOSE, LACTULOSE

EOVIST, GADOXETATE DISODIUM

EPANED KIT, ENALAPRIL MALEATE

EPANOVA, OMEGA-3-CARBOXYLIC ACIDS

EPIDUO, ADAPALENE

EPIFOAM, HYDROCORTISONE ACETATE

EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE

EPINEPHRINE, EPINEPHRINE HYDROCHLORIDE

EPIPEN, EPINEPHRINE

EPIPEN JR., EPINEPHRINE

EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

EPITOL, CARBAMAZEPINE

EPIVIR, LAMIVUDINE

EPIVIR-HBV, LAMIVUDINE

EPLERENONE, EPLERENONE

EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM

EPROSARTAN MESYLATE, EPROSARTAN MESYLATE

EPZICOM, ABACAVIR SULFATE

EQUETRO, CARBAMAZEPINE

ERAXIS, ANIDULAFUNGIN

ERGOCALCIFEROL, ERGOCALCIFEROL

ERGOLOID MESYLATES, ERGOLOID MESYLATES

ERGOMAR, ERGOTAMINE TARTRATE

ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE

ERIVEDGE, VISMODEGIB

ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE

ERRIN, NORETHINDRONE

ERTACZO, SERTACONAZOLE NITRATE

ERY-TAB, ERYTHROMYCIN

ERYC, ERYTHROMYCIN

ERYGEL, ERYTHROMYCIN

ERYPED, ERYTHROMYCIN ETHYLSUCCINATE

ERYTHRA-DERM, ERYTHROMYCIN

ERYTHRO-STATIN, ERYTHROMYCIN

ERYTHROCIN, ERYTHROMYCIN LACTOBIONATE

ERYTHROCIN STEARATE, ERYTHROMYCIN STEARATE

ERYTHROMYCIN, ERYTHROMYCIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                  A - 21


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    E   **

ERYTHROMYCIN AND BENZOYL PEROXIDE, BENZOYL PEROXIDE

ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE

ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYTHROMYCIN ETHYLSUCCINATE

ESBRIET, PIRFENIDONE

ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE

ESOMEPRAZOLE SODIUM, ESOMEPRAZOLE SODIUM

ESOMEPRAZOLE STRONTIUM, ESOMEPRAZOLE STRONTIUM

ESTARYLLA, ETHINYL ESTRADIOL

ESTAZOLAM, ESTAZOLAM

ESTRACE, ESTRADIOL

ESTRADERM, ESTRADIOL

ESTRADIOL, ESTRADIOL

ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL

ESTRADIOL AND NORGESTIMATE, ESTRADIOL

ESTRADIOL VALERATE, ESTRADIOL VALERATE

ESTRASORB, ESTRADIOL HEMIHYDRATE

ESTRING, ESTRADIOL

ESTROGEL, ESTRADIOL

ESTROPIPATE, ESTROPIPATE

ESTROSTEP FE, ETHINYL ESTRADIOL

ESZOPICLONE, ESZOPICLONE

ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE

ETHAMOLIN, ETHANOLAMINE OLEATE

ETHOSUXIMIDE, ETHOSUXIMIDE

ETHRANE, ENFLURANE

ETHYOL, AMIFOSTINE

ETIDRONATE DISODIUM, ETIDRONATE DISODIUM

ETODOLAC, ETODOLAC

ETOMIDATE, ETOMIDATE

ETOPOPHOS PRESERVATIVE FREE, ETOPOSIDE PHOSPHATE

ETOPOSIDE, ETOPOSIDE

EURAX, CROTAMITON

EVAMIST, ESTRADIOL

EVISTA, RALOXIFENE HYDROCHLORIDE

EVOCLIN, CLINDAMYCIN PHOSPHATE

EVOXAC, CEVIMELINE HYDROCHLORIDE

EVZIO, NALOXONE HYDROCHLORIDE

EXALGO, HYDROMORPHONE HYDROCHLORIDE

EXCEDRIN (MIGRAINE), ACETAMINOPHEN    (OTC)

EXELDERM, SULCONAZOLE NITRATE

EXELON, RIVASTIGMINE

EXELON, RIVASTIGMINE TARTRATE

EXEMESTANE, EXEMESTANE

EXFORGE, AMLODIPINE BESYLATE

EXFORGE HCT, AMLODIPINE BESYLATE

EXIDINE, CHLORHEXIDINE GLUCONATE    (OTC)

EXJADE, DEFERASIROX

EXPAREL, BUPIVACAINE

EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

EXTINA, KETOCONAZOLE

EXTRANEAL, ICODEXTRIN

                                           **    F   **

FABIOR, TAZAROTENE

FACTIVE, GEMIFLOXACIN MESYLATE

FALLBACK SOLO, LEVONORGESTREL    (OTC)

FALMINA, ETHINYL ESTRADIOL

FAMCICLOVIR, FAMCICLOVIR

FAMOTIDINE, FAMOTIDINE    (OTC)

FAMOTIDINE, FAMOTIDINE

FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE

FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER,         FAMOTIDINE

FAMVIR, FAMCICLOVIR

FANAPT, ILOPERIDONE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 22


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    F   **

FARESTON, TOREMIFENE CITRATE

FARXIGA, DAPAGLIFLOZIN

FASLODEX, FULVESTRANT

FAZACLO ODT, CLOZAPINE

FELBAMATE, FELBAMATE

FELBATOL, FELBAMATE

FELDENE, PIROXICAM

FELODIPINE, FELODIPINE

FEMARA, LETROZOLE

FEMCON FE, ETHINYL ESTRADIOL

FEMHRT, ETHINYL ESTRADIOL

FEMRING, ESTRADIOL ACETATE

FEMSTAT 3, BUTOCONAZOLE NITRATE    (OTC)

FEMTRACE, ESTRADIOL ACETATE

FENOFIBRATE, FENOFIBRATE

FENOFIBRATE (MICRONIZED), FENOFIBRATE

FENOFIBRIC ACID, CHOLINE FENOFIBRATE

FENOGLIDE, FENOFIBRATE

FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE

FENOPROFEN CALCIUM, FENOPROFEN CALCIUM

FENTANYL CITRATE, FENTANYL CITRATE

FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE

FENTANYL-100, FENTANYL

FENTANYL-12, FENTANYL

FENTANYL-25, FENTANYL

FENTANYL-37, FENTANYL

FENTANYL-50, FENTANYL

FENTANYL-62, FENTANYL

FENTANYL-75, FENTANYL

FENTANYL-87, FENTANYL

FENTORA, FENTANYL CITRATE

FERAHEME, FERUMOXYTOL

FERRIC CITRATE, FERRIC CITRATE

FERRIPROX, DEFERIPRONE

FERRLECIT, SODIUM FERRIC GLUCONATE COMPLEX

FETZIMA, LEVOMILNACIPRAN HYDROCHLORIDE

FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)

FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)

FIBRICOR, FENOFIBRIC ACID

FINACEA, AZELAIC ACID

FINASTERIDE, FINASTERIDE

FIORICET W/ CODEINE, ACETAMINOPHEN

FIORINAL, ASPIRIN

FIORINAL W/CODEINE, ASPIRIN

FIRAZYR, ICATIBANT ACETATE

FIRMAGON, DEGARELIX ACETATE

FLAGYL, METRONIDAZOLE

FLAGYL ER, METRONIDAZOLE

FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE

FLAREX, FLUOROMETHOLONE ACETATE

FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE

FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE

FLECAINIDE ACETATE, FLECAINIDE ACETATE

FLECTOR, DICLOFENAC EPOLAMINE

FLO-PRED, PREDNISOLONE ACETATE

FLOLAN, EPOPROSTENOL SODIUM

FLOMAX, TAMSULOSIN HYDROCHLORIDE

FLONASE, FLUTICASONE PROPIONATE

FLONASE ALLERGY RELIEF, FLUTICASONE PROPIONATE    (OTC)

FLOVENT DISKUS 100, FLUTICASONE PROPIONATE

FLOVENT DISKUS 250, FLUTICASONE PROPIONATE

FLOVENT DISKUS 50, FLUTICASONE PROPIONATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST      A - 23


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    F   **

FLOVENT HFA, FLUTICASONE PROPIONATE

FLOXIN OTIC, OFLOXACIN

FLOXURIDINE, FLOXURIDINE

FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

FLUCONAZOLE, FLUCONAZOLE

FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

FLUCYTOSINE, FLUCYTOSINE

FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE

FLUMADINE, RIMANTADINE HYDROCHLORIDE

FLUMAZENIL, FLUMAZENIL

FLUNISOLIDE, FLUNISOLIDE

FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

FLUOCINONIDE, FLUOCINONIDE

FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE

FLUORESCITE, FLUORESCEIN SODIUM

FLUOROPLEX, FLUOROURACIL

FLUOROURACIL, FLUOROURACIL

FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

FLUOXYMESTERONE, FLUOXYMESTERONE

FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE

FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE

FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE

FLURBIPROFEN, FLURBIPROFEN

FLURBIPROFEN SODIUM, FLURBIPROFEN SODIUM

FLUTAMIDE, FLUTAMIDE

FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

FLUVASTATIN SODIUM, FLUVASTATIN SODIUM

FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

FML, FLUOROMETHOLONE

FML FORTE, FLUOROMETHOLONE

FOAMCOAT, ALUMINUM HYDROXIDE    (OTC)

FOCALIN, DEXMETHYLPHENIDATE HYDROCHLORIDE

FOCALIN XR, DEXMETHYLPHENIDATE HYDROCHLORIDE

FOLIC ACID, FOLIC ACID

FOLLISTIM AQ, FOLLITROPIN ALFA/BETA

FOLOTYN, PRALATREXATE

FOMEPIZOLE, FOMEPIZOLE

FONDAPARINUX SODIUM, FONDAPARINUX SODIUM

FORADIL, FORMOTEROL FUMARATE

FORANE, ISOFLURANE

FORFIVO XL, BUPROPION HYDROCHLORIDE

FORTAMET, METFORMIN HYDROCHLORIDE

FORTAZ, CEFTAZIDIME

FORTAZ IN PLASTIC CONTAINER, CEFTAZIDIME SODIUM

FORTEO, TERIPARATIDE RECOMBINANT HUMAN

FORTESTA, TESTOSTERONE

FORTICAL, CALCITONIN SALMON RECOMBINANT

FOSAMAX, ALENDRONATE SODIUM

FOSAMAX PLUS D, ALENDRONATE SODIUM

FOSCARNET SODIUM, FOSCARNET SODIUM

FOSCAVIR, FOSCARNET SODIUM

FOSINOPRIL SODIUM, FOSINOPRIL SODIUM

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

FOSRENOL, LANTHANUM CARBONATE

FRAGMIN, DALTEPARIN SODIUM

FREAMINE HBC 6.9%, AMINO ACIDS

FREAMINE III 10%, AMINO ACIDS

FREAMINE III 3% W/ ELECTROLYTES, AMINO ACIDS

FREAMINE III 8.5%, AMINO ACIDS

FREAMINE III 8.5% W/ ELECTROLYTES, AMINO ACIDS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      A - 24


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    F   **

FROVA, FROVATRIPTAN SUCCINATE

FROVATRIPTAN SUCCINATE, FROVATRIPTAN SUCCINATE

FULYZAQ, CROFELEMER

FURADANTIN, NITROFURANTOIN

FUROSEMIDE, FUROSEMIDE

FUSILEV, LEVOLEUCOVORIN CALCIUM

FUZEON, ENFUVIRTIDE

FYCOMPA, PERAMPANEL

                                           **    G   **

GABAPENTIN, GABAPENTIN

GABITRIL, TIAGABINE HYDROCHLORIDE

GABLOFEN, BACLOFEN

GADAVIST, GADOBUTROL

GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67

GALZIN, ZINC ACETATE

GANCICLOVIR, GANCICLOVIR SODIUM

GANIRELIX ACETATE, GANIRELIX ACETATE

GASTROCROM, CROMOLYN SODIUM

GASTROGRAFIN, DIATRIZOATE MEGLUMINE

GATIFLOXACIN, GATIFLOXACIN

GATTEX KIT, TEDUGLUTIDE RECOMBINANT

GAVISCON, ALUMINUM HYDROXIDE    (OTC)

GELNIQUE, OXYBUTYNIN CHLORIDE

GELNIQUE 3%, OXYBUTYNIN

GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

GEMFIBROZIL, GEMFIBROZIL

GEMZAR, GEMCITABINE HYDROCHLORIDE

GEN-XENE, CLORAZEPATE DIPOTASSIUM

GENERLAC, LACTULOSE

GENGRAF, CYCLOSPORINE

GENOPTIC, GENTAMICIN SULFATE

GENOTROPIN, SOMATROPIN RECOMBINANT

GENOTROPIN PRESERVATIVE FREE, SOMATROPIN RECOMBINANT

GENTAK, GENTAMICIN SULFATE

GENTAMICIN SULFATE, GENTAMICIN SULFATE

GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,   GENTAMICIN SULFATE

GEODON, ZIPRASIDONE HYDROCHLORIDE

GEODON, ZIPRASIDONE MESYLATE

GIAZO, BALSALAZIDE DISODIUM

GILDAGIA, ETHINYL ESTRADIOL

GILDESS 1.5/30, ETHINYL ESTRADIOL

GILDESS 1/20, ETHINYL ESTRADIOL

GILDESS 24 FE, ETHINYL ESTRADIOL

GILDESS FE 1.5/30, ETHINYL ESTRADIOL

GILDESS FE 1/20, ETHINYL ESTRADIOL

GILENYA, FINGOLIMOD

GILOTRIF, AFATINIB DIMALEATE

GLEEVEC, IMATINIB MESYLATE

GLEOSTINE, LOMUSTINE

GLIADEL, CARMUSTINE

GLIMEPIRIDE, GLIMEPIRIDE

GLIPIZIDE, GLIPIZIDE

GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

GLOFIL-125, IOTHALAMATE SODIUM I-125

GLUCAGEN, GLUCAGON HYDROCHLORIDE RECOMBINANT

GLUCAGON, GLUCAGON RECOMBINANT

GLUCOPHAGE, METFORMIN HYDROCHLORIDE

GLUCOPHAGE XR, METFORMIN HYDROCHLORIDE

GLUCOTROL, GLIPIZIDE

GLUCOTROL XL, GLIPIZIDE

GLUCOVANCE, GLYBURIDE

GLUMETZA, METFORMIN HYDROCHLORIDE

GLYBURIDE, GLYBURIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 25


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    G   **

GLYBURIDE (MICRONIZED), GLYBURIDE

GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE

GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE

GLYCOLAX, POLYETHYLENE GLYCOL 3350    (OTC)

GLYCOLAX, POLYETHYLENE GLYCOL 3350

GLYCOPYRROLATE, GLYCOPYRROLATE

GLYDO, LIDOCAINE HYDROCHLORIDE

GLYNASE, GLYBURIDE

GLYSET, MIGLITOL

GOLYTELY, POLYETHYLENE GLYCOL 3350

GONAL-F, FOLLITROPIN ALFA/BETA

GONAL-F RFF, FOLLITROPIN ALFA/BETA

GONAL-F RFF REDI-JECT, FOLLITROPIN ALFA/BETA

GRALISE, GABAPENTIN

GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE

GRANISTERON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

GRIFULVIN V, GRISEOFULVIN, MICROSIZE

GRIS-PEG, GRISEOFULVIN, ULTRAMICROSIZE

GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

GRISEOFULVIN, ULTRAMICROSIZE, GRISEOFULVIN, ULTRAMICROSIZE

GRISEOFULVIN,ULTRAMICROSIZE, GRISEOFULVIN, ULTRAMICROSIZE

GUAIFENESIN, GUAIFENESIN    (OTC)

GUANABENZ ACETATE, GUANABENZ ACETATE

GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE

GUANIDINE HYDROCHLORIDE, GUANIDINE HYDROCHLORIDE

GYNE-LOTRIMIN, CLOTRIMAZOLE    (OTC)

GYNE-LOTRIMIN 3, CLOTRIMAZOLE    (OTC)

GYNE-LOTRIMIN 3 COMBINATION PACK, CLOTRIMAZOLE    (OTC)

GYNE-LOTRIMIN COMBINATION PACK, CLOTRIMAZOLE   (OTC)

                                           **    H   **

H.P. ACTHAR GEL, CORTICOTROPIN

HABITROL, NICOTINE    (OTC)

HALAVEN, ERIBULIN MESYLATE

HALCION, TRIAZOLAM

HALDOL, HALOPERIDOL DECANOATE

HALDOL, HALOPERIDOL LACTATE

HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE

HALOG, HALCINONIDE

HALOPERIDOL, HALOPERIDOL

HALOPERIDOL, HALOPERIDOL LACTATE

HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE

HARVONI, LEDIPASVIR

HEATHER, NORETHINDRONE

HECTOROL, DOXERCALCIFEROL

HEMABATE, CARBOPROST TROMETHAMINE

HEMANGEOL, PROPRANOLOL HYDROCHLORIDE

HEPARIN SODIUM, HEPARIN SODIUM

HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM

HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM

HEPATAMINE 8%, AMINO ACIDS

HEPATOLITE, TECHNETIUM TC-99M DISOFENIN KIT

HEPSERA, ADEFOVIR DIPIVOXIL

HERPLEX, IDOXURIDINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                     A - 26


                       APPENDIX A       -        PRODUCT NAME INDEX

                                            **    H   **

HETLIOZ, TASIMELTEON

HEXABRIX, IOXAGLATE MEGLUMINE

HEXALEN, ALTRETAMINE

HIBICLENS, CHLORHEXIDINE GLUCONATE    (OTC)

HIBISTAT, CHLORHEXIDINE GLUCONATE    (OTC)

HICON, SODIUM IODIDE I-131

HIPREX, METHENAMINE HIPPURATE

HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, HOMATROPINE METHYLBROMIDE

HORIZANT, GABAPENTIN ENACARBIL

HUMALOG, INSULIN LISPRO RECOMBINANT

HUMALOG KWIKPEN, INSULIN LISPRO RECOMBINANT

HUMALOG MIX 50/50, INSULIN LISPRO PROTAMINE RECOMBINANT

HUMALOG MIX 50/50 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT

HUMALOG MIX 75/25, INSULIN LISPRO PROTAMINE RECOMBINANT

HUMALOG MIX 75/25 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT

HUMATROPE, SOMATROPIN RECOMBINANT

HUMULIN 70/30, INSULIN RECOMBINANT HUMAN     (OTC)

HUMULIN 70/30 PEN, INSULIN RECOMBINANT HUMAN     (OTC)

HUMULIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN      (OTC)

HUMULIN R, INSULIN RECOMBINANT HUMAN    (OTC)

HUMULIN R, INSULIN RECOMBINANT HUMAN

HUMULIN R PEN, INSULIN RECOMBINANT HUMAN     (OTC)

HYCAMTIN, TOPOTECAN HYDROCHLORIDE

HYDERGINE, ERGOLOID MESYLATES

HYDRA-ZIDE, HYDRALAZINE HYDROCHLORIDE

HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

HYDREA, HYDROXYUREA

HYDRO-RX, HYDROCORTISONE

HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE

HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE

HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE, HYDROCODONE BITARTRATE

HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE,

HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE ,

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX, CHLORPHENIRAMINE POLISTIREX

HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX, CHLORPHENIRAMINE POLISTIREX

HYDROCORTISONE, HYDROCORTISONE

HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE

HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL

HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE

HYDROCORTISONE IN ABSORBASE, HYDROCORTISONE

HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE

HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

HYDROXOCOBALAMIN, HYDROXOCOBALAMIN

HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

HYDROXYUREA, HYDROXYUREA

HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE

HYLENEX RECOMBINANT, HYALURONIDASE RECOMBINANT HUMAN

HYSINGLA, HYDROCODONE BITARTRATE

HYZAAR, HYDROCHLOROTHIAZIDE

                                            **    I   **

IBANDRONATE SODIUM, IBANDRONATE SODIUM

IBU-TAB, IBUPROFEN

IBU-TAB 200, IBUPROFEN    (OTC)

IBUPROFEN, IBUPROFEN    (OTC)

IBUPROFEN, IBUPROFEN

IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE   (OTC)

IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE    (OTC)

IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE, IBUPROFEN   (OTC)

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN   (OTC)

IBUPROHM, IBUPROFEN    (OTC)

IBUPROHM COLD AND SINUS, IBUPROFEN    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 27


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    I   **

IBUTILIDE FUMARATE, IBUTILIDE FUMARATE

IC-GREEN, INDOCYANINE GREEN

ICLUSIG, PONATINIB HYDROCHLORIDE

IDAMYCIN PFS, IDARUBICIN HYDROCHLORIDE

IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE

IDARUBICIN HYDROCHLORIDE PFS, IDARUBICIN HYDROCHLORIDE

IDKIT:HP, CITRIC ACID

IFEX, IFOSFAMIDE

IFOSFAMIDE, IFOSFAMIDE

IFOSFAMIDE/MESNA KIT, IFOSFAMIDE

ILEVRO, NEPAFENAC

ILUVIEN, FLUOCINOLONE ACETONIDE

IMBRUVICA, IBRUTINIB

IMIPENEM AND CILASTATIN, CILASTATIN SODIUM

IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE

IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE

IMIQUIMOD, IMIQUIMOD

IMITREX, SUMATRIPTAN

IMITREX, SUMATRIPTAN SUCCINATE

IMITREX STATDOSE, SUMATRIPTAN SUCCINATE

IMODIUM, LOPERAMIDE HYDROCHLORIDE

IMODIUM A-D, LOPERAMIDE HYDROCHLORIDE    (OTC)

IMODIUM A-D EZ CHEWS, LOPERAMIDE HYDROCHLORIDE   (OTC)

IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE   (OTC)

IMPAVIDO, MILTEFOSINE

IMPLANON, ETONOGESTREL

IMURAN, AZATHIOPRINE

INAPSINE, DROPERIDOL

INCIVEK, TELAPREVIR

INCRELEX, MECASERMIN RECOMBINANT

INCRUSE ELLIPTA , UMECLIDINIUM BROMIDE

INDAPAMIDE, INDAPAMIDE

INDERAL LA, PROPRANOLOL HYDROCHLORIDE

INDERIDE-40/25, HYDROCHLOROTHIAZIDE

INDICLOR, INDIUM IN-111 CHLORIDE

INDIUM IN 111 CHLORIDE, INDIUM IN-111 CHLORIDE

INDIUM IN-111 OXYQUINOLINE, INDIUM IN-111 OXYQUINOLINE

INDOCIN, INDOMETHACIN

INDOCIN, INDOMETHACIN SODIUM

INDOCYANINE GREEN, INDOCYANINE GREEN

INDOMETHACIN, INDOMETHACIN

INDOMETHACIN SODIUM, INDOMETHACIN SODIUM

INFANTS' FEVERALL, ACETAMINOPHEN    (OTC)

INFASURF PRESERVATIVE FREE, CALFACTANT

INFED, IRON DEXTRAN

INFUMORPH, MORPHINE SULFATE

INFUVITE ADULT, ALPHA-TOCOPHEROL ACETATE

INFUVITE PEDIATRIC, ASCORBIC ACID

INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), ASCORBIC ACID

INJECTAFER, FERRIC CARBOXYMALTOSE

INLYTA, AXITINIB

INNOPRAN XL, PROPRANOLOL HYDROCHLORIDE

INOMAX, NITRIC OXIDE

INSPRA, EPLERENONE

INTEGRILIN, EPTIFIBATIDE

INTELENCE, ETRAVIRINE

INTERMEZZO, ZOLPIDEM TARTRATE

INTRALIPID 10%, SOYBEAN OIL

INTRALIPID 20%, SOYBEAN OIL

INTRALIPID 30%, SOYBEAN OIL

INTROVALE, ETHINYL ESTRADIOL

INTUNIV, GUANFACINE HYDROCHLORIDE

INVANZ, ERTAPENEM SODIUM

INVEGA, PALIPERIDONE

INVEGA SUSTENNA, PALIPERIDONE PALMITATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST     A - 28


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    I   **

INVIRASE, SAQUINAVIR MESYLATE

INVOKAMET, CANAGLIFLOZIN

INVOKANA, CANAGLIFLOZIN

IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

IOPAMIDOL-250, IOPAMIDOL

IOPAMIDOL-300, IOPAMIDOL

IOPAMIDOL-370, IOPAMIDOL

IOPIDINE, APRACLONIDINE HYDROCHLORIDE

IOSAT, POTASSIUM IODIDE    (OTC)

IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

IPRIVASK, DESIRUDIN RECOMBINANT

IRBESARTAN, IRBESARTAN

IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

ISENTRESS, RALTEGRAVIR POTASSIUM

ISOCAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE

ISOFLURANE, ISOFLURANE

ISOLYTE E IN PLASTIC CONTAINER, CALCIUM CHLORIDE

ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

ISOLYTE S IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

ISOLYTE S PH 7.4 IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

ISONIAZID, ISONIAZID

ISOPTO CARPINE, PILOCARPINE HYDROCHLORIDE

ISORDIL, ISOSORBIDE DINITRATE

ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE

ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

ISOSULFAN BLUE, ISOSULFAN BLUE

ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER, GENTAMICIN SULFATE

ISOVUE-200, IOPAMIDOL

ISOVUE-250, IOPAMIDOL

ISOVUE-300, IOPAMIDOL

ISOVUE-370, IOPAMIDOL

ISOVUE-M 200, IOPAMIDOL

ISOVUE-M 300, IOPAMIDOL

ISRADIPINE, ISRADIPINE

ISTALOL, TIMOLOL MALEATE

ISTODAX, ROMIDEPSIN

ISUPREL, ISOPROTERENOL HYDROCHLORIDE

ITRACONAZOLE, ITRACONAZOLE

IVERMECTIN, IVERMECTIN

IVY BLOCK, BENTOQUATAM    (OTC)

IXEMPRA KIT, IXABEPILONE

IZBA, TRAVOPROST

                                           **    J   **

JAKAFI, RUXOLITINIB PHOSPHATE

JALYN, DUTASTERIDE

JANTOVEN, WARFARIN SODIUM

JANUMET, METFORMIN HYDROCHLORIDE

JANUMET XR, METFORMIN HYDROCHLORIDE

JANUVIA, SITAGLIPTIN PHOSPHATE

JARDIANCE, EMPAGLIFLOZIN

JEANATOPE, ALBUMIN IODINATED I-125 SERUM

JENCYCLA, NORETHINDRONE

JENTADUETO, LINAGLIPTIN

JEVTANA KIT, CABAZITAXEL

JUBLIA, EFINACONAZOLE

JUNEL 1.5/30, ETHINYL ESTRADIOL

JUNEL 1/20, ETHINYL ESTRADIOL

JUNEL FE 1.5/30, ETHINYL ESTRADIOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST         A - 29


                        APPENDIX A      -        PRODUCT NAME INDEX

                                            **    J   **

JUNEL FE 1/20, ETHINYL ESTRADIOL

JUNIOR STRENGTH ADVIL, IBUPROFEN   (OTC)

JUNIOR STRENGTH IBUPROFEN, IBUPROFEN    (OTC)

JUNIOR STRENGTH MOTRIN, IBUPROFEN    (OTC)

JUXTAPID, LOMITAPIDE MESYLATE

                                            **    K   **

K-TAB, POTASSIUM CHLORIDE

KABIVEN IN PLASTIC CONTAINER, AMINO ACIDS

KADIAN, MORPHINE SULFATE

KALETRA, LOPINAVIR

KALEXATE, SODIUM POLYSTYRENE SULFONATE

KALYDECO, IVACAFTOR

KANAMYCIN SULFATE, KANAMYCIN SULFATE

KAPVAY, CLONIDINE HYDROCHLORIDE

KARBINAL ER, CARBINOXAMINE MALEATE

KARIVA, DESOGESTREL

KAYEXALATE, SODIUM POLYSTYRENE SULFONATE

KAZANO, ALOGLIPTIN BENZOATE

KEFLEX, CEPHALEXIN

KEFZOL, CEFAZOLIN SODIUM

KELNOR, ETHINYL ESTRADIOL

KENALOG, TRIAMCINOLONE ACETONIDE

KENALOG-10, TRIAMCINOLONE ACETONIDE

KENALOG-40, TRIAMCINOLONE ACETONIDE

KEPPRA, LEVETIRACETAM

KEPPRA XR, LEVETIRACETAM

KERYDIN, TAVABOROLE

KETALAR, KETAMINE HYDROCHLORIDE

KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE

KETEK, TELITHROMYCIN

KETOCONAZOLE, KETOCONAZOLE

KETOPROFEN, KETOPROFEN

KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

KETOTIFEN FUMARATE, KETOTIFEN FUMARATE    (OTC)

KETOZOLE, KETOCONAZOLE

KHEDEZLA, DESVENLAFAXINE

KINEVAC, SINCALIDE

KIONEX, SODIUM POLYSTYRENE SULFONATE

KITABIS PAK, TOBRAMYCIN

KLARON, SULFACETAMIDE SODIUM

KLONOPIN, CLONAZEPAM

KLOR-CON, POTASSIUM CHLORIDE

KLOR-CON M10, POTASSIUM CHLORIDE

KLOR-CON M15, POTASSIUM CHLORIDE

KLOR-CON M20, POTASSIUM CHLORIDE

KOMBIGLYZE XR, METFORMIN HYDROCHLORIDE

KORLYM, MIFEPRISTONE

KURVELO, ETHINYL ESTRADIOL

KUVAN, SAPROPTERIN DIHYDROCHLORIDE

KYNAMRO, MIPOMERSEN SODIUM

KYPROLIS, CARFILZOMIB

                                            **    L   **

LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

LABETALOL HYDROCLORIDE, LABETALOL HYDROCHLORIDE

LAC-HYDRIN, AMMONIUM LACTATE

LACRISERT, HYDROXYPROPYL CELLULOSE

LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

LACTULOSE, LACTULOSE

LAMICTAL, LAMOTRIGINE

LAMICTAL CD, LAMOTRIGINE

LAMICTAL ODT, LAMOTRIGINE

LAMICTAL XR, LAMOTRIGINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST              A - 30


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    L   **

LAMISIL, TERBINAFINE HYDROCHLORIDE    (OTC)

LAMISIL, TERBINAFINE HYDROCHLORIDE

LAMISIL AT, TERBINAFINE    (OTC)

LAMISIL AT, TERBINAFINE HYDROCHLORIDE    (OTC)

LAMIVUDINE, LAMIVUDINE

LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE

LAMOTRIGINE, LAMOTRIGINE

LAMPRENE, CLOFAZIMINE

LANIAZID, ISONIAZID

LANORINAL, ASPIRIN

LANOXIN, DIGOXIN

LANOXIN PEDIATRIC, DIGOXIN

LANSOPRAZOLE, LANSOPRAZOLE    (OTC)

LANSOPRAZOLE, LANSOPRAZOLE

LANSOPRAZOLE , LANSOPRAZOLE

LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN, AMOXICILLIN

LANTUS, INSULIN GLARGINE RECOMBINANT

LANTUS SOLOSTAR, INSULIN GLARGINE RECOMBINANT

LARIN 1.5/30, ETHINYL ESTRADIOL

LARIN 1/20, ETHINYL ESTRADIOL

LARIN FE 1.5/30, ETHINYL ESTRADIOL

LARIN FE 1/20, ETHINYL ESTRADIOL

LAROTID, AMOXICILLIN

LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE

LASIX, FUROSEMIDE

LASTACAFT, ALCAFTADINE

LATANOPROST, LATANOPROST

LATISSE, BIMATOPROST

LATUDA, LURASIDONE HYDROCHLORIDE

LAX-LYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350

LAZANDA, FENTANYL CITRATE

LEFLUNOMIDE, LEFLUNOMIDE

LESCOL, FLUVASTATIN SODIUM

LESCOL XL, FLUVASTATIN SODIUM

LESSINA-28, ETHINYL ESTRADIOL

LETAIRIS, AMBRISENTAN

LETROZOLE, LETROZOLE

LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM

LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM

LEUKERAN, CHLORAMBUCIL

LEUPROLIDE ACETATE, LEUPROLIDE ACETATE

LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE

LEVAQUIN, LEVOFLOXACIN

LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN

LEVEMIR, INSULIN DETEMIR RECOMBINANT

LEVEMIR FLEXPEN, INSULIN DETEMIR RECOMBINANT

LEVEMIR FLEXTOUCH, INSULIN DETEMIR RECOMBINANT

LEVETIRACETAM, LEVETIRACETAM

LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM

LEVITRA, VARDENAFIL HYDROCHLORIDE

LEVO-T, LEVOTHYROXINE SODIUM **

LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE

LEVOCARNITINE, LEVOCARNITINE

LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

LEVOFLOXACIN, LEVOFLOXACIN

LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN

LEVONEST, ETHINYL ESTRADIOL

LEVONORGESTREL, LEVONORGESTREL    (OTC)

LEVONORGESTREL, LEVONORGESTREL

LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

LEVOPHED, NOREPINEPHRINE BITARTRATE

LEVORA 0.15/30-28, ETHINYL ESTRADIOL

LEVORPHANOL TARTRATE, LEVORPHANOL TARTRATE

LEVOTHROID, LEVOTHYROXINE SODIUM **

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 31


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    L   **

LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM **

LEVOXYL, LEVOTHYROXINE SODIUM **

LEVULAN, AMINOLEVULINIC ACID HYDROCHLORIDE

LEXAPRO, ESCITALOPRAM OXALATE

LEXISCAN, REGADENOSON

LEXIVA, FOSAMPRENAVIR CALCIUM

LIALDA, MESALAMINE

LIBRIUM, CHLORDIAZEPOXIDE HYDROCHLORIDE

LIDEX, FLUOCINONIDE

LIDOCAINE, LIDOCAINE

LIDOCAINE AND PRILOCAINE, LIDOCAINE

LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE

LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

LIDOCAINE HYDROCHLORIDE VISCOUS, LIDOCAINE HYDROCHLORIDE

LIDOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE

LIDODERM, LIDOCAINE

LIGNOSPAN FORTE, EPINEPHRINE BITARTRATE

LIGNOSPAN STANDARD, EPINEPHRINE BITARTRATE

LINCOCIN, LINCOMYCIN HYDROCHLORIDE

LINDANE, LINDANE

LINEZOLID, LINEZOLID

LINZESS, LINACLOTIDE

LIORESAL, BACLOFEN

LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM

LIPIODOL, ETHIODIZED OIL

LIPITOR, ATORVASTATIN CALCIUM

LIPOFEN, FENOFIBRATE

LIPTRUZET, ATORVASTATIN CALCIUM

LISINOPRIL, LISINOPRIL

LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

LITHIUM CARBONATE, LITHIUM CARBONATE

LITHIUM CITRATE, LITHIUM CITRATE

LITHOBID, LITHIUM CARBONATE

LITHOSTAT, ACETOHYDROXAMIC ACID

LIVALO, PITAVASTATIN CALCIUM

LO LOESTRIN FE, ETHINYL ESTRADIOL

LO MINASTRIN FE, ETHINYL ESTRADIOL

LO/OVRAL-28, ETHINYL ESTRADIOL

LOCOID, HYDROCORTISONE BUTYRATE

LOCOID LIPOCREAM, HYDROCORTISONE BUTYRATE

LODOSYN, CARBIDOPA

LOESTRIN 21 1.5/30, ETHINYL ESTRADIOL

LOESTRIN 21 1/20, ETHINYL ESTRADIOL

LOESTRIN 24 FE, ETHINYL ESTRADIOL

LOESTRIN FE 1.5/30, ETHINYL ESTRADIOL

LOESTRIN FE 1/20, ETHINYL ESTRADIOL

LOMOTIL, ATROPINE SULFATE

LONOX, ATROPINE SULFATE

LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE

LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE   (OTC)

LOPID, GEMFIBROZIL

LOPRESSOR, METOPROLOL TARTRATE

LOPRESSOR HCT, HYDROCHLOROTHIAZIDE

LOPROX, CICLOPIROX

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST         A - 32


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    L   **

LOPURIN, ALLOPURINOL

LORATADINE, LORATADINE    (OTC)

LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE   (OTC)

LORATADINE REDIDOSE, LORATADINE    (OTC)

LORAZEPAM, LORAZEPAM

LORAZEPAM INTENSOL, LORAZEPAM

LORAZEPAM PRESERVATIVE FREE, LORAZEPAM

LORYNA, DROSPIRENONE

LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

LOSEASONIQUE, ETHINYL ESTRADIOL

LOTEMAX, LOTEPREDNOL ETABONATE

LOTENSIN, BENAZEPRIL HYDROCHLORIDE

LOTENSIN HCT, BENAZEPRIL HYDROCHLORIDE

LOTREL, AMLODIPINE BESYLATE

LOTRIMIN ULTRA, BUTENAFINE HYDROCHLORIDE    (OTC)

LOTRISONE, BETAMETHASONE DIPROPIONATE

LOTRONEX, ALOSETRON HYDROCHLORIDE

LOVASTATIN, LOVASTATIN

LOVAZA, OMEGA-3-ACID ETHYL ESTERS

LOVENOX, ENOXAPARIN SODIUM

LOVENOX (PRESERVATIVE FREE), ENOXAPARIN SODIUM

LOXAPINE SUCCINATE, LOXAPINE SUCCINATE

LTA II KIT, LIDOCAINE HYDROCHLORIDE

LUFYLLIN, DYPHYLLINE

LUMASON, SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

LUMIGAN, BIMATOPROST

LUNESTA, ESZOPICLONE

LUPANETA PACK, LEUPROLIDE ACETATE

LUPRON DEPOT, LEUPROLIDE ACETATE

LUPRON DEPOT-PED, LEUPROLIDE ACETATE

LUVOX, FLUVOXAMINE MALEATE

LUVOX CR, FLUVOXAMINE MALEATE

LUXIQ, BETAMETHASONE VALERATE

LUZU, LULICONAZOLE

LYMPHOSEEK KIT, TECHNETIUM TC-99M TILMANOCEPT

LYRICA, PREGABALIN

LYSODREN, MITOTANE

LYSTEDA, TRANEXAMIC ACID

                                           **    M   **

M-ZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

M.V.I. ADULT, ASCORBIC ACID

M.V.I. ADULT (PHARMACY BULK PACKAGE), ASCORBIC ACID

M.V.I. PEDIATRIC, ASCORBIC ACID

M.V.I.-12 (WITHOUT VITAMIN K), ASCORBIC ACID

MACROBID, NITROFURANTOIN

MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE

MACUGEN, PEGAPTANIB SODIUM

MAFENIDE ACETATE, MAFENIDE ACETATE

MAGNESIUM SULFATE, MAGNESIUM SULFATE

MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE

MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE

MAGNEVIST, GADOPENTETATE DIMEGLUMINE

MAKENA, HYDROXYPROGESTERONE CAPROATE

MALARONE, ATOVAQUONE

MALARONE PEDIATRIC, ATOVAQUONE

MALATHION, MALATHION

MANGANESE CHLORIDE IN PLASTIC CONTAINER, MANGANESE CHLORIDE

MANNITOL 10%, MANNITOL

MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL

MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, MANNITOL

MANNITOL 15%, MANNITOL

MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL

MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                   A - 33


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    M   **

MANNITOL 20%, MANNITOL

MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL

MANNITOL 25%, MANNITOL

MANNITOL 5%, MANNITOL

MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL

MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, MANNITOL

MAPROTILINE HYDROCHLORIDE, MAPROTILINE HYDROCHLORIDE

MARCAINE, BUPIVACAINE HYDROCHLORIDE

MARCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE

MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

MARCAINE HYDROCHLORIDE W/ EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

MARINOL, DRONABINOL

MARLISSA, ETHINYL ESTRADIOL

MARPLAN, ISOCARBOXAZID

MARQIBO KIT, VINCRISTINE SULFATE

MATULANE, PROCARBAZINE HYDROCHLORIDE

MAVIK, TRANDOLAPRIL

MAXAIR, PIRBUTEROL ACETATE

MAXALT, RIZATRIPTAN BENZOATE

MAXALT-MLT, RIZATRIPTAN BENZOATE

MAXIDEX, DEXAMETHASONE

MAXIPIME, CEFEPIME HYDROCHLORIDE

MAXITROL, DEXAMETHASONE

MAXZIDE, HYDROCHLOROTHIAZIDE

MAXZIDE-25, HYDROCHLOROTHIAZIDE

MD-76R, DIATRIZOATE MEGLUMINE

MD-GASTROVIEW, DIATRIZOATE MEGLUMINE

MDP-BRACCO, TECHNETIUM TC-99M MEDRONATE KIT

MEBENDAZOLE, MEBENDAZOLE

MECAMYLAMINE HYDROCHLORIDE, MECAMYLAMINE HYDROCHLORIDE

MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM

MEDROL, METHYLPREDNISOLONE

MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE

MEFENAMIC ACID, MEFENAMIC ACID

MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE

MEFOXIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM

MEGACE, MEGESTROL ACETATE

MEGACE ES, MEGESTROL ACETATE

MEGATOPE, ALBUMIN IODINATED I-131 SERUM

MEGESTROL ACETATE, MEGESTROL ACETATE

MEKINIST, TRAMETINIB DIMETHYL SULFOXIDE

MELOXICAM, MELOXICAM

MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE

MEMBRANEBLUE, TRYPAN BLUE

MEN'S ROGAINE, MINOXIDIL    (OTC)

MENEST, ESTROGENS, ESTERIFIED

MENOPUR, MENOTROPINS (FSH

MENOSTAR, ESTRADIOL

MENTAX, BUTENAFINE HYDROCHLORIDE

MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE

MEPHYTON, PHYTONADIONE

MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE

MEPROBAMATE, MEPROBAMATE

MEPRON, ATOVAQUONE

MERCAPTOPURINE, MERCAPTOPURINE

MEROPENEM, MEROPENEM

MERREM, MEROPENEM

MESALAMINE, MESALAMINE

MESNA, MESNA

MESNEX, MESNA

MESTINON, PYRIDOSTIGMINE BROMIDE

METADATE CD, METHYLPHENIDATE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST         A - 34


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    M   **

METADATE ER, METHYLPHENIDATE HYDROCHLORIDE

METAPROTERENOL SULFATE, METAPROTERENOL SULFATE

METARAMINOL BITARTRATE, METARAMINOL BITARTRATE

METASTRON, STRONTIUM CHLORIDE SR-89

METAXALONE, METAXALONE

METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

METHADONE HYDROCHLORIDE INTENSOL, METHADONE HYDROCHLORIDE

METHADOSE, METHADONE HYDROCHLORIDE

METHAMPHETAMINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE

METHAZOLAMIDE, METHAZOLAMIDE

METHENAMINE HIPPURATE, METHENAMINE HIPPURATE

METHERGINE, METHYLERGONOVINE MALEATE

METHIMAZOLE, METHIMAZOLE

METHOCARBAMOL, METHOCARBAMOL

METHOCARBAMOL AND ASPIRIN, ASPIRIN

METHOTREXATE PRESERVATIVE FREE, METHOTREXATE SODIUM

METHOTREXATE SODIUM, METHOTREXATE SODIUM

METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

METHOXSALEN, METHOXSALEN

METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE

METHYCLOTHIAZIDE, METHYCLOTHIAZIDE

METHYLDOPA, METHYLDOPA

METHYLDOPA AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE

METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE

METHYLIN, METHYLPHENIDATE HYDROCHLORIDE

METHYLIN ER, METHYLPHENIDATE HYDROCHLORIDE

METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

METHYLPREDNISOLONE, METHYLPREDNISOLONE

METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE

METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE

METHYLTESTOSTERONE, METHYLTESTOSTERONE

METIPRANOLOL, METIPRANOLOL HYDROCHLORIDE

METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE

METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

METOLAZONE, METOLAZONE

METOPIRONE, METYRAPONE

METOPROLOL SUCCINATE, METOPROLOL SUCCINATE

METOPROLOL TARTRATE, METOPROLOL TARTRATE

METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

METOZOLV ODT, METOCLOPRAMIDE HYDROCHLORIDE

METRO I.V. IN PLASTIC CONTAINER, METRONIDAZOLE

METROCREAM, METRONIDAZOLE

METROGEL, METRONIDAZOLE

METROGEL-VAGINAL, METRONIDAZOLE

METROLOTION, METRONIDAZOLE

METRONIDAZOLE, METRONIDAZOLE

METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE

MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE

MIACALCIN, CALCITONIN SALMON

MICARDIS, TELMISARTAN

MICARDIS HCT, HYDROCHLOROTHIAZIDE

MICONAZOLE 3, MICONAZOLE NITRATE    (OTC)

MICONAZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

MICONAZOLE 7, MICONAZOLE NITRATE    (OTC)

MICONAZOLE 7 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

MICONAZOLE NITRATE, MICONAZOLE NITRATE     (OTC)

MICONAZOLE NITRATE, MICONAZOLE NITRATE

MICONAZOLE NITRATE COMBINATION PACK, MICONAZOLE NITRATE     (OTC)

MICORT-HC, HYDROCORTISONE ACETATE

MICRO-K, POTASSIUM CHLORIDE

MICRO-K 10, POTASSIUM CHLORIDE

MICROGESTIN 1.5/30, ETHINYL ESTRADIOL

MICROGESTIN 1/20, ETHINYL ESTRADIOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST         A - 35


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    M   **

MICROGESTIN FE 1.5/30, ETHINYL ESTRADIOL

MICROGESTIN FE 1/20, ETHINYL ESTRADIOL

MICRONOR, NORETHINDRONE

MICROZIDE, HYDROCHLOROTHIAZIDE

MIDAMOR, AMILORIDE HYDROCHLORIDE

MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE

MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE

MIDOL LIQUID GELS, IBUPROFEN    (OTC)

MIDOZALAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

MIFEPREX, MIFEPRISTONE

MIGERGOT, CAFFEINE

MIGRANAL, DIHYDROERGOTAMINE MESYLATE

MILRINONE LACTATE, MILRINONE LACTATE

MILRINONE LACTATE IN DEXTROSE 5%, MILRINONE LACTATE

MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE

MILRINONE LACTATE IN PLASTIC CONTAINER, MILRINONE LACTATE

MINASTRIN 24 FE, ETHINYL ESTRADIOL

MINIPRESS, PRAZOSIN HYDROCHLORIDE

MINIRIN, DESMOPRESSIN ACETATE

MINITRAN, NITROGLYCERIN

MINIVELLE, ESTRADIOL

MINOCIN, MINOCYCLINE HYDROCHLORIDE

MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

MINOXIDIL, MINOXIDIL    (OTC)

MINOXIDIL, MINOXIDIL

MINOXIDIL (FOR MEN), MINOXIDIL    (OTC)

MINOXIDIL (FOR WOMEN), MINOXIDIL    (OTC)

MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL    (OTC)

MIOCHOL-E, ACETYLCHOLINE CHLORIDE

MIOSTAT, CARBACHOL

MIRALAX, POLYETHYLENE GLYCOL 3350    (OTC)

MIRAPEX, PRAMIPEXOLE DIHYDROCHLORIDE

MIRAPEX ER, PRAMIPEXOLE DIHYDROCHLORIDE

MIRENA, LEVONORGESTREL

MIRTAZAPINE, MIRTAZAPINE

MIRVASO, BRIMONIDINE TARTRATE

MISOPROSTOL, MISOPROSTOL

MITIGARE, COLCHICINE

MITOMYCIN, MITOMYCIN

MITOSOL, MITOMYCIN

MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

MOBIC, MELOXICAM

MODAFINIL, MODAFINIL

MODICON 28, ETHINYL ESTRADIOL

MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE, HYDROCHLOROTHIAZIDE

MOMETASONE FUROATE, MOMETASONE FUROATE

MONISTAT 1 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

MONISTAT 3, MICONAZOLE NITRATE    (OTC)

MONISTAT 3, MICONAZOLE NITRATE

MONISTAT 3 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

MONISTAT 3 COMBINATION PACK (PREFILLED), MICONAZOLE NITRATE   (OTC)

MONISTAT 7, MICONAZOLE NITRATE    (OTC)

MONISTAT 7 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

MONISTAT-3 COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

MONO-LINYAH, ETHINYL ESTRADIOL

MONODOX, DOXYCYCLINE

MONOKET, ISOSORBIDE MONONITRATE

MONTELUKAST SODIUM, MONTELUKAST SODIUM

MONUROL, FOSFOMYCIN TROMETHAMINE

MORPHINE SULFATE, MORPHINE SULFATE

MOTOFEN, ATROPINE SULFATE

MOTRIN IB, IBUPROFEN    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      A - 36


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    M   **

MOTRIN MIGRAINE PAIN, IBUPROFEN    (OTC)

MOVANTIK, NALOXEGOL OXALATE

MOVIPREP, ASCORBIC ACID

MOXATAG, AMOXICILLIN

MOXEZA, MOXIFLOXACIN HYDROCHLORIDE

MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE

MOZOBIL, PLERIXAFOR

MPI DMSA KIDNEY REAGENT, TECHNETIUM TC-99M SUCCIMER KIT

MPI INDIUM DTPA IN 111, INDIUM IN-111 PENTETATE DISODIUM

MS CONTIN, MORPHINE SULFATE

MUCINEX, GUAIFENESIN    (OTC)

MUCINEX D, GUAIFENESIN    (OTC)

MUCINEX DM, DEXTROMETHORPHAN HYDROBROMIDE    (OTC)

MULTAQ, DRONEDARONE HYDROCHLORIDE

MULTIHANCE, GADOBENATE DIMEGLUMINE

MULTIHANCE MULTIPACK, GADOBENATE DIMEGLUMINE

MUPIROCIN, MUPIROCIN

MUPIROCIN, MUPIROCIN CALCIUM

MUSE, ALPROSTADIL

MUSTARGEN, MECHLORETHAMINE HYDROCHLORIDE

MYAMBUTOL, ETHAMBUTOL HYDROCHLORIDE

MYCAMINE, MICAFUNGIN SODIUM

MYCELEX-7, CLOTRIMAZOLE    (OTC)

MYCELEX-7 COMBINATION PACK, CLOTRIMAZOLE    (OTC)

MYCOBUTIN, RIFABUTIN

MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

MYCOPHENOLIC ACID, MYCOPHENOLIC ACID

MYDRIACYL, TROPICAMIDE

MYFORTIC, MYCOPHENOLIC ACID

MYLERAN, BUSULFAN

MYORISAN, ISOTRETINOIN

MYOVIEW, TECHNETIUM TC-99M TETROFOSMIN KIT

MYOVIEW 30ML, TECHNETIUM TC-99M TETROFOSMIN KIT

MYRBETRIQ, MIRABEGRON

MYSOLINE, PRIMIDONE

MYZILRA, ETHINYL ESTRADIOL

                                           **    N   **

NABUMETONE, NABUMETONE

NADOLOL, NADOLOL

NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE

NAFCILLIN SODIUM, NAFCILLIN SODIUM

NAFTIN, NAFTIFINE HYDROCHLORIDE

NALBUPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE

NALFON, FENOPROFEN CALCIUM

NALLPEN IN PLASTIC CONTAINER, NAFCILLIN SODIUM

NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE

NAMENDA, MEMANTINE HYDROCHLORIDE

NAMENDA XR, MEMANTINE HYDROCHLORIDE

NAMZARIC, DONEPEZIL HYDROCHLORIDE

NANDROLONE DECANOATE, NANDROLONE DECANOATE

NAPHAZOLINE HYDROCHLORIDE, NAPHAZOLINE HYDROCHLORIDE

NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, NAPHAZOLINE HYDROCHLORIDE    (OTC)

NAPHCON-A, NAPHAZOLINE HYDROCHLORIDE    (OTC)

NAPRELAN, NAPROXEN SODIUM

NAPROSYN, NAPROXEN

NAPROXEN, NAPROXEN

NAPROXEN AND ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM

NAPROXEN SODIUM, NAPROXEN SODIUM    (OTC)

NAPROXEN SODIUM, NAPROXEN SODIUM

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM   (OTC)

NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

NARDIL, PHENELZINE SULFATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                       A - 37


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    N   **

NAROPIN, ROPIVACAINE HYDROCHLORIDE

NASACORT ALLERGY 24 HOUR, TRIAMCINOLONE ACETONIDE    (OTC)

NASCOBAL, CYANOCOBALAMIN

NASONEX, MOMETASONE FUROATE MONOHYDRATE

NATACYN, NATAMYCIN

NATAZIA, DIENOGEST

NATEGLINIDE, NATEGLINIDE

NATESTO, TESTOSTERONE

NATRECOR, NESIRITIDE RECOMBINANT

NATROBA, SPINOSAD

NAVANE, THIOTHIXENE

NAVELBINE, VINORELBINE TARTRATE

NAVSTEL, CALCIUM CHLORIDE

NEBUPENT, PENTAMIDINE ISETHIONATE

NEDOCROMIL SODIUM, NEDOCROMIL SODIUM

NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE

NEMBUTAL SODIUM, PENTOBARBITAL SODIUM

NEO-FRADIN, NEOMYCIN SULFATE

NEO-SYNALAR, FLUOCINOLONE ACETONIDE

NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE

NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC

NEOMYCIN SULFATE, NEOMYCIN SULFATE

NEOPAP, ACETAMINOPHEN    (OTC)

NEOPROFEN, IBUPROFEN LYSINE

NEORAL, CYCLOSPORINE

NEOSPORIN, GRAMICIDIN

NEOSPORIN G.U. IRRIGANT, NEOMYCIN SULFATE

NEPHRAMINE 5.4%, AMINO ACIDS

NESACAINE, CHLOROPROCAINE HYDROCHLORIDE

NESACAINE-MPF, CHLOROPROCAINE HYDROCHLORIDE

NESINA, ALOGLIPTIN BENZOATE

NEUPRO, ROTIGOTINE

NEURACEQ, FLORBETABEN F-18

NEUROLITE, TECHNETIUM TC-99M BICISATE KIT

NEURONTIN, GABAPENTIN

NEVANAC, NEPAFENAC

NEVIRAPINE, NEVIRAPINE

NEXAVAR, SORAFENIB TOSYLATE

NEXIUM, ESOMEPRAZOLE MAGNESIUM

NEXIUM 24HR, ESOMEPRAZOLE MAGNESIUM    (OTC)

NEXIUM IV, ESOMEPRAZOLE SODIUM

NEXPLANON, ETONOGESTREL

NEXTERONE, AMIODARONE HYDROCHLORIDE

NIACIN, NIACIN

NIACOR, NIACIN

NIASPAN, NIACIN

NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

NICODERM CQ, NICOTINE    (OTC)

NICORETTE, NICOTINE POLACRILEX    (OTC)

NICORETTE (MINT), NICOTINE POLACRILEX    (OTC)

NICOTINE, NICOTINE    (OTC)

NICOTINE POLACRILEX, NICOTINE POLACRILEX    (OTC)

NICOTROL, NICOTINE

NIFEDIPINE, NIFEDIPINE

NIKKI, DROSPIRENONE

NILANDRON, NILUTAMIDE

NIMBEX, CISATRACURIUM BESYLATE

NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE

NIMODIPINE, NIMODIPINE

NIPENT, PENTOSTATIN

NISOLDIPINE, NISOLDIPINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 38


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    N   **

NITHIODOTE, SODIUM NITRITE

NITRO-DUR, NITROGLYCERIN

NITROFURANTOIN, NITROFURANTOIN

NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE

NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN

NITROGLYCERIN, NITROGLYCERIN

NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN

NITROLINGUAL PUMPSPRAY, NITROGLYCERIN

NITROMIST, NITROGLYCERIN

NITROPRESS, SODIUM NITROPRUSSIDE

NITROSTAT, NITROGLYCERIN

NIX, PERMETHRIN    (OTC)

NIZATIDINE, NIZATIDINE

NIZORAL, KETOCONAZOLE

NIZORAL A-D, KETOCONAZOLE    (OTC)

NOR-QD, NORETHINDRONE

NORCO, ACETAMINOPHEN

NORDETTE-28, ETHINYL ESTRADIOL

NORDITROPIN FLEXPRO, SOMATROPIN RECOMBINANT

NORDITROPIN NORDIFLEX, SOMATROPIN RECOMBINANT

NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE

NORETHINDRONE, NORETHINDRONE

NORETHINDRONE ACETATE, NORETHINDRONE ACETATE

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

NORETHINDRONE AND ETHINYL ESTRADIOL (10/11), ETHINYL ESTRADIOL

NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

NORFLEX, ORPHENADRINE CITRATE

NORGESIC, ASPIRIN

NORGESIC FORTE, ASPIRIN

NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

NORINYL 1+35 21-DAY, ETHINYL ESTRADIOL

NORINYL 1+35 28-DAY, ETHINYL ESTRADIOL

NORINYL 1+50 28-DAY, MESTRANOL

NORITATE, METRONIDAZOLE

NORMOCARB HF 25, MAGNESIUM CHLORIDE

NORMOCARB HF 35, MAGNESIUM CHLORIDE

NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

NORMOSOL-R IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

NORPACE, DISOPYRAMIDE PHOSPHATE

NORPACE CR, DISOPYRAMIDE PHOSPHATE

NORPRAMIN, DESIPRAMINE HYDROCHLORIDE

NORTHERA, DROXIDOPA

NORTREL 0.5/35-28, ETHINYL ESTRADIOL

NORTREL 1/35-21, ETHINYL ESTRADIOL

NORTREL 1/35-28, ETHINYL ESTRADIOL

NORTREL 7/7/7, ETHINYL ESTRADIOL

NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

NORVASC, AMLODIPINE BESYLATE

NORVIR, RITONAVIR

NOVOLIN 70/30, INSULIN RECOMBINANT HUMAN    (OTC)

NOVOLIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN    (OTC)

NOVOLIN R, INSULIN RECOMBINANT HUMAN    (OTC)

NOVOLOG, INSULIN ASPART RECOMBINANT

NOVOLOG FLEXPEN, INSULIN ASPART RECOMBINANT

NOVOLOG FLEXTOUCH, INSULIN ASPART RECOMBINANT

NOVOLOG MIX 70/30, INSULIN ASPART PROTAMINE RECOMBINANT

NOVOLOG MIX 70/30 FLEXPEN, INSULIN ASPART PROTAMINE RECOMBINANT

NOVOLOG PENFILL, INSULIN ASPART RECOMBINANT

NOXAFIL, POSACONAZOLE

NUCYNTA, TAPENTADOL HYDROCHLORIDE

NUCYNTA ER, TAPENTADOL HYDROCHLORIDE

NUEDEXTA, DEXTROMETHORPHAN HYDROBROMIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST       A - 39


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    N   **

NULYTELY, POLYETHYLENE GLYCOL 3350

NULYTELY-FLAVORED, POLYETHYLENE GLYCOL 3350

NUTRACORT, HYDROCORTISONE

NUTRESTORE, GLUTAMINE

NUTRILIPID 10%, SOYBEAN OIL

NUTRILIPID 20%, SOYBEAN OIL

NUTROPIN, SOMATROPIN RECOMBINANT

NUTROPIN AQ, SOMATROPIN RECOMBINANT

NUTROPIN AQ PEN, SOMATROPIN RECOMBINANT

NUVARING, ETHINYL ESTRADIOL

NUVIGIL, ARMODAFINIL

NYMALIZE, NIMODIPINE

NYSTATIN, NYSTATIN

NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN

NYSTOP, NYSTATIN

                                           **    O   **

OBREDON, GUAIFENESIN

OCTOCAINE, EPINEPHRINE

OCTREOSCAN, INDIUM IN-111 PENTETREOTIDE KIT

OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE

OCUCLEAR, OXYMETAZOLINE HYDROCHLORIDE    (OTC)

OCUFEN, FLURBIPROFEN SODIUM

OCUFLOX, OFLOXACIN

OCUPRESS, CARTEOLOL HYDROCHLORIDE

OFEV, NINTEDANIB

OFIRMEV, ACETAMINOPHEN

OFLOXACIN, OFLOXACIN

OGEN .625, ESTROPIPATE

OGEN 1.25, ESTROPIPATE

OGEN 2.5, ESTROPIPATE

OGEN 5, ESTROPIPATE

OGESTREL 0.5/50-28, ETHINYL ESTRADIOL

OLANZAPINE, OLANZAPINE

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

OLAPARIB, OLAPARIB

OLEPTRO, TRAZODONE HYDROCHLORIDE

OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE

OLUX, CLOBETASOL PROPIONATE

OLUX E, CLOBETASOL PROPIONATE

OLYSIO, SIMEPREVIR SODIUM

OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS

OMEPRAZOLE, OMEPRAZOLE    (OTC)

OMEPRAZOLE, OMEPRAZOLE

OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN, AMOXICILLIN

OMEPRAZOLE AND SODIUM BICARBONATE, OMEPRAZOLE

OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM    (OTC)

OMIDRIA, KETOROLAC TROMETHAMINE

OMNARIS, CICLESONIDE

OMNIPAQUE 140, IOHEXOL

OMNIPAQUE 180, IOHEXOL

OMNIPAQUE 240, IOHEXOL

OMNIPAQUE 300, IOHEXOL

OMNIPAQUE 350, IOHEXOL

OMNIPRED, PREDNISOLONE ACETATE

OMNISCAN, GADODIAMIDE

OMNITROPE, SOMATROPIN RECOMBINANT

OMTRYG, OMEGA-3-ACID ETHYL ESTERS

ONDANSETRON, ONDANSETRON

ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

ONEXTON, BENZOYL PEROXIDE

ONFI, CLOBAZAM

ONGLYZA, SAXAGLIPTIN HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 40


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    O   **

ONMEL, ITRACONAZOLE

OPANA, OXYMORPHONE HYDROCHLORIDE

OPANA ER, OXYMORPHONE HYDROCHLORIDE

OPCICON ONE-STEP, LEVONORGESTREL    (OTC)

OPCON-A, NAPHAZOLINE HYDROCHLORIDE    (OTC)

OPSUMIT, MACITENTAN

OPTIMARK, GADOVERSETAMIDE

OPTIMARK IN PLASTIC CONTAINER, GADOVERSETAMIDE

OPTIPRANOLOL, METIPRANOLOL HYDROCHLORIDE

OPTIRAY 240, IOVERSOL

OPTIRAY 300, IOVERSOL

OPTIRAY 320, IOVERSOL

OPTIRAY 350, IOVERSOL

OPTISON, ALBUMIN HUMAN

OPTIVAR, AZELASTINE HYDROCHLORIDE

ORABLOC, ARTICAINE HYDROCHLORIDE

ORACEA, DOXYCYCLINE

ORAP, PIMOZIDE

ORAPRED, PREDNISOLONE SODIUM PHOSPHATE

ORAPRED ODT, PREDNISOLONE SODIUM PHOSPHATE

ORAQIX, LIDOCAINE

ORAVERSE, PHENTOLAMINE MESYLATE

ORAVIG, MICONAZOLE

ORBACTIV, ORITAVANCIN DIPHOSPHATE

ORENITRAM, TREPROSTINIL DIOLAMINE

ORETIC, HYDROCHLOROTHIAZIDE

ORFADIN, NITISINONE

ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN

ORSYTHIA, ETHINYL ESTRADIOL

ORTHO CYCLEN-28, ETHINYL ESTRADIOL

ORTHO EVRA, ETHINYL ESTRADIOL

ORTHO TRI-CYCLEN, ETHINYL ESTRADIOL

ORTHO TRI-CYCLEN LO, ETHINYL ESTRADIOL

ORTHO-CEPT, DESOGESTREL

ORTHO-NOVUM 1/35-28, ETHINYL ESTRADIOL

ORTHO-NOVUM 7/7/7-28, ETHINYL ESTRADIOL

ORVATEN, MIDODRINE HYDROCHLORIDE

OSENI, ALOGLIPTIN BENZOATE

OSMITROL 10% IN WATER, MANNITOL

OSMITROL 10% IN WATER IN PLASTIC CONTAINER, MANNITOL

OSMITROL 15% IN WATER, MANNITOL

OSMITROL 15% IN WATER IN PLASTIC CONTAINER, MANNITOL

OSMITROL 20% IN WATER, MANNITOL

OSMITROL 20% IN WATER IN PLASTIC CONTAINER, MANNITOL

OSMITROL 5% IN WATER, MANNITOL

OSMITROL 5% IN WATER IN PLASTIC CONTAINER, MANNITOL

OSMOPREP, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

OSPHENA, OSPEMIFENE

OTEZLA, APREMILAST

OTICAIR, HYDROCORTISONE

OTREXUP, METHOTREXATE

OVCON-35, ETHINYL ESTRADIOL

OVIDE, MALATHION

OVIDREL, CHORIOGONADOTROPIN ALFA

OXACILLIN SODIUM, OXACILLIN SODIUM

OXALIPLATIN, OXALIPLATIN

OXANDRIN, OXANDROLONE

OXANDROLONE, OXANDROLONE

OXAPROZIN, OXAPROZIN

OXAZEPAM, OXAZEPAM

OXCARBAZEPINE, OXCARBAZEPINE

OXECTA, OXYCODONE HYDROCHLORIDE

OXILAN-300, IOXILAN

OXILAN-350, IOXILAN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 41


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    O   **

OXISTAT, OXICONAZOLE NITRATE

OXSORALEN, METHOXSALEN

OXSORALEN-ULTRA, METHOXSALEN

OXTELLAR XR, OXCARBAZEPINE

OXYBUTYNIN, OXYBUTYNIN

OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

OXYCET, ACETAMINOPHEN

OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

OXYCODONE AND ASPIRIN, ASPIRIN

OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN

OXYCONTIN, OXYCODONE HYDROCHLORIDE

OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

OXYTOCIN, OXYTOCIN

OXYTROL, OXYBUTYNIN

OXYTROL FOR WOMEN, OXYBUTYNIN    (OTC)

OZURDEX, DEXAMETHASONE

                                           **    P   **

PACERONE, AMIODARONE HYDROCHLORIDE

PACLITAXEL, PACLITAXEL

PAMELOR, NORTRIPTYLINE HYDROCHLORIDE

PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

PAMINE, METHSCOPOLAMINE BROMIDE

PAMINE FORTE, METHSCOPOLAMINE BROMIDE

PANCREAZE, PANCRELIPASE (AMYLASE

PANCURONIUM BROMIDE, PANCURONIUM BROMIDE

PANDEL, HYDROCORTISONE PROBUTATE

PANRETIN, ALITRETINOIN

PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

PARAFON FORTE DSC, CHLORZOXAZONE

PARAGARD T 380A, COPPER

PAREMYD, HYDROXYAMPHETAMINE HYDROBROMIDE

PARICALCITOL, PARICALCITOL

PARLODEL, BROMOCRIPTINE MESYLATE

PARNATE, TRANYLCYPROMINE SULFATE

PAROEX, CHLORHEXIDINE GLUCONATE

PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE

PAROXETINE, PAROXETINE HYDROCHLORIDE

PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

PASER, AMINOSALICYLIC ACID

PATADAY, OLOPATADINE HYDROCHLORIDE

PATANASE, OLOPATADINE HYDROCHLORIDE

PATANOL, OLOPATADINE HYDROCHLORIDE

PAXIL, PAROXETINE HYDROCHLORIDE

PAXIL CR, PAROXETINE HYDROCHLORIDE

PCE, ERYTHROMYCIN

PEDIAMYCIN, ERYTHROMYCIN ETHYLSUCCINATE

PEDIAMYCIN 400, ERYTHROMYCIN ETHYLSUCCINATE

PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE

PEDIATRIC ADVIL, IBUPROFEN    (OTC)

PEDIOTIC, HYDROCORTISONE

PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350

PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL, BISACODYL

PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350

PEGANONE, ETHOTOIN

PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM

PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, PENICILLIN G POTASSIUM

PENICILLIN G PROCAINE, PENICILLIN G PROCAINE

PENICILLIN G SODIUM, PENICILLIN G SODIUM

PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM

PENICILLIN-VK, PENICILLIN V POTASSIUM

PENLAC, CICLOPIROX

PENNSAID, DICLOFENAC SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 42


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    P   **

PENTAM, PENTAMIDINE ISETHIONATE

PENTASA, MESALAMINE

PENTOLAIR, CYCLOPENTOLATE HYDROCHLORIDE

PENTOSTATIN, PENTOSTATIN

PENTOXIFYLLINE, PENTOXIFYLLINE

PENTOXIL, PENTOXIFYLLINE

PEPCID, FAMOTIDINE

PEPCID AC, FAMOTIDINE    (OTC)

PEPCID AC , FAMOTIDINE    (OTC)

PEPCID COMPLETE, CALCIUM CARBONATE    (OTC)

PERCOCET, ACETAMINOPHEN

PERCODAN, ASPIRIN

PERFOROMIST, FORMOTEROL FUMARATE

PERIDEX, CHLORHEXIDINE GLUCONATE

PERIKABIVEN IN PLASTIC CONTAINER, AMINO ACIDS

PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE

PERIOCHIP, CHLORHEXIDINE GLUCONATE

PERIOGARD, CHLORHEXIDINE GLUCONATE

PERMAPEN, PENICILLIN G BENZATHINE

PERMETHRIN, PERMETHRIN    (OTC)

PERMETHRIN, PERMETHRIN

PERPHENAZINE, PERPHENAZINE

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

PERSANTINE, DIPYRIDAMOLE

PERTZYE, PANCRELIPASE (AMYLASE

PEXEVA, PAROXETINE MESYLATE

PFIZERPEN, PENICILLIN G POTASSIUM

PHARMASEAL SCRUB CARE, CHLORHEXIDINE GLUCONATE    (OTC)

PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE

PHENELZINE SULFATE, PHENELZINE SULFATE

PHENOXYBENZAMINE HYDROCHLORIDE, PHENOXYBENZAMINE HYDROCHLORIDE

PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

PHENTERMINE RESIN COMPLEX, PHENTERMINE RESIN COMPLEX

PHENTOLAMINE MESYLATE, PHENTOLAMINE MESYLATE

PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE

PHENYTEK, PHENYTOIN SODIUM

PHENYTOIN, PHENYTOIN

PHENYTOIN SODIUM, PHENYTOIN SODIUM

PHILITH, ETHINYL ESTRADIOL

PHISOHEX, HEXACHLOROPHENE

PHOSLO GELCAPS, CALCIUM ACETATE

PHOSLYRA, CALCIUM ACETATE

PHOSPHOLINE IODIDE, ECHOTHIOPHATE IODIDE

PHOTOFRIN, PORFIMER SODIUM

PHYSIOLYTE IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

PHYSIOSOL IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

PHYTONADIONE, PHYTONADIONE

PICATO, INGENOL MEBUTATE

PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE

PILOPINE HS, PILOCARPINE HYDROCHLORIDE

PIMTREA, DESOGESTREL

PINDOLOL, PINDOLOL

PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE, GLIMEPIRIDE

PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

PIPERACILLIN, PIPERACILLIN SODIUM

PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM

PIRMELLA 1/35, ETHINYL ESTRADIOL

PIRMELLA 7/7/7, ETHINYL ESTRADIOL

PIROXICAM, PIROXICAM

PITOCIN, OXYTOCIN

PLAN B, LEVONORGESTREL    (OTC)

PLAN B, LEVONORGESTREL

PLAN B ONE-STEP, LEVONORGESTREL    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 43


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    P   **

PLAQUENIL, HYDROXYCHLOROQUINE SULFATE

PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

PLASMA-LYTE 56 IN PLASTIC CONTAINER, MAGNESIUM ACETATE TETRAHYDRATE

PLASMA-LYTE A IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PLASMA-LYTE R IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PLAVIX, CLOPIDOGREL BISULFATE

PLEGISOL IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PLENDIL, FELODIPINE

PLETAL, CILOSTAZOL

PLIAGLIS, LIDOCAINE

PODOFILOX, PODOFILOX

POLOCAINE, MEPIVACAINE HYDROCHLORIDE

POLOCAINE-MPF, MEPIVACAINE HYDROCHLORIDE

POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350

POLYMYCIN B SULFATE, POLYMYXIN B SULFATE

POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

POLYTRIM, POLYMYXIN B SULFATE

POMALYST, POMALIDOMIDE

PONSTEL, MEFENAMIC ACID

PORTIA-28, ETHINYL ESTRADIOL

POTASSIUM ACETATE IN PLASTIC CONTAINER, POTASSIUM ACETATE

POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 44


                         APPENDIX A      -        PRODUCT NAME INDEX

                                             **    P   **

POTASSIUM CHLORIDE   0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.224% IN SODIUM CHLORIDE 0.9%, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

POTASSIUM CHLORIDE   10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

POTASSIUM CHLORIDE   20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

POTASSIUM CHLORIDE   30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

POTASSIUM CHLORIDE   40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CHLORIDE   5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM

POTASSIUM CHLORIDE   5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

POTASSIUM CHLORIDE   IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

POTASSIUM CITRATE,    POTASSIUM CITRATE

POTIGA, EZOGABINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST            A - 45


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    P   **

POVIDONE IODINE, POVIDONE-IODINE    (OTC)

PRADAXA, DABIGATRAN ETEXILATE MESYLATE

PRALIDOXIME CHLORIDE, PRALIDOXIME CHLORIDE

PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

PRAMOSONE, HYDROCORTISONE ACETATE

PRANDIMET, METFORMIN HYDROCHLORIDE

PRANDIN, REPAGLINIDE

PRAVACHOL, PRAVASTATIN SODIUM

PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE

PRE-OP, HEXACHLOROPHENE

PRE-OP II, HEXACHLOROPHENE

PRE-PEN, BENZYLPENICILLOYL POLYLYSINE

PRECEDEX, DEXMEDETOMIDINE HYDROCHLORIDE

PRECOSE, ACARBOSE

PRED FORTE, PREDNISOLONE ACETATE

PRED MILD, PREDNISOLONE ACETATE

PRED-G, GENTAMICIN SULFATE

PREDNICARBATE, PREDNICARBATE

PREDNISOLONE, PREDNISOLONE

PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

PREDNISONE, PREDNISONE

PREDNISONE INTENSOL, PREDNISONE

PREGABALIN, PREGABALIN

PREGNYL, GONADOTROPIN, CHORIONIC

PRELONE, PREDNISOLONE

PREMARIN, ESTROGENS, CONJUGATED

PREMASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS

PREMASOL 6% IN PLASTIC CONTAINER, AMINO ACIDS

PREMPHASE 14/14, ESTROGENS, CONJUGATED

PREMPRO, ESTROGENS, CONJUGATED

PREPIDIL, DINOPROSTONE

PREPOPIK, CITRIC ACID

PREVACID, LANSOPRAZOLE

PREVACID 24 HR, LANSOPRAZOLE    (OTC)

PREVALITE, CHOLESTYRAMINE

PREVANTICS MAXI SWABSTICK, CHLORHEXIDINE GLUCONATE      (OTC)

PREVANTICS SWAB, CHLORHEXIDINE GLUCONATE      (OTC)

PREVANTICS SWABSTICK, CHLORHEXIDINE GLUCONATE      (OTC)

PREVIFEM, ETHINYL ESTRADIOL

PREVPAC, AMOXICILLIN

PREZISTA, DARUNAVIR ETHANOLATE

PRIALT, ZICONOTIDE ACETATE

PRIFTIN, RIFAPENTINE

PRILOCAINE HYDROCHLORIDE, PRILOCAINE HYDROCHLORIDE

PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, EPINEPHRINE BITARTRATE

PRILOSEC, OMEPRAZOLE

PRILOSEC, OMEPRAZOLE MAGNESIUM

PRILOSEC OTC, OMEPRAZOLE MAGNESIUM     (OTC)

PRIMAQUINE, PRIMAQUINE PHOSPHATE

PRIMAQUINE PHOSPHATE, PRIMAQUINE PHOSPHATE

PRIMAXIN, CILASTATIN SODIUM

PRIMIDONE, PRIMIDONE

PRIMSOL, TRIMETHOPRIM HYDROCHLORIDE

PRINIVIL, LISINOPRIL

PRINZIDE, HYDROCHLOROTHIAZIDE

PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL BGK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    A - 46


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    P   **

PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

PRISTIQ, DESVENLAFAXINE SUCCINATE

PROAIR HFA, ALBUTEROL SULFATE

PROBALAN, PROBENECID

PROBENECID, PROBENECID

PROBENECID AND COLCHICINE, COLCHICINE

PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE

PROCALAMINE, AMINO ACIDS

PROCARDIA, NIFEDIPINE

PROCARDIA XL, NIFEDIPINE

PROCHLORPERAZINE, PROCHLORPERAZINE

PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE

PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE

PROCOMP, PROCHLORPERAZINE MALEATE

PROCTOFOAM HC, HYDROCORTISONE ACETATE

PROCYSBI, CYSTEAMINE BITARTRATE

PROFEN, IBUPROFEN    (OTC)

PROFERDEX, IRON DEXTRAN

PROGESTERONE, PROGESTERONE

PROGLYCEM, DIAZOXIDE

PROGRAF, TACROLIMUS

PROHANCE, GADOTERIDOL

PROHANCE MULTIPACK, GADOTERIDOL

PROLENSA, BROMFENAC SODIUM

PROMACTA, ELTROMBOPAG OLAMINE

PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE PHOSPHATE

PROMETH VC PLAIN, PHENYLEPHRINE HYDROCHLORIDE

PROMETH VC W/ CODEINE, CODEINE PHOSPHATE

PROMETHAZINE DM, DEXTROMETHORPHAN HYDROBROMIDE

PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN

PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE

PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE

PROMETHAZINE PLAIN, PROMETHAZINE HYDROCHLORIDE

PROMETHAZINE W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE

PROMETHAZINE WITH CODEINE, CODEINE PHOSPHATE

PROMETHEGAN, PROMETHAZINE HYDROCHLORIDE

PROMETRIUM, PROGESTERONE

PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE

PROPANTHELINE BROMIDE, PROPANTHELINE BROMIDE

PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE

PROPECIA, FINASTERIDE

PROPOFOL, PROPOFOL

PROPOXYPHENE HYDROCHLORIDE, PROPOXYPHENE HYDROCHLORIDE

PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

PROPYLTHIOURACIL, PROPYLTHIOURACIL

PROSCAR, FINASTERIDE

PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS

PROSTIN E2, DINOPROSTONE

PROSTIN VR PEDIATRIC, ALPROSTADIL

PROTAMINE SULFATE, PROTAMINE SULFATE

PROTONIX, PANTOPRAZOLE SODIUM

PROTONIX IV, PANTOPRAZOLE SODIUM

PROTOPAM CHLORIDE, PRALIDOXIME CHLORIDE

PROTOPIC, TACROLIMUS

PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE

PROVENTIL-HFA, ALBUTEROL SULFATE

PROVERA, MEDROXYPROGESTERONE ACETATE

PROVIGIL, MODAFINIL

PROVOCHOLINE, METHACHOLINE CHLORIDE

PROZAC, FLUOXETINE HYDROCHLORIDE

PROZAC WEEKLY, FLUOXETINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST     A - 47


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    P   **

PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE   (OTC)

PULMICORT FLEXHALER, BUDESONIDE

PULMICORT RESPULES, BUDESONIDE

PULMOLITE, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT

PUR-WASH, PURIFIED WATER    (OTC)

PURIXAN, MERCAPTOPURINE

PYLERA, BISMUTH SUBCITRATE POTASSIUM

PYRAZINAMIDE, PYRAZINAMIDE

PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE

PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE

PYTEST, UREA, C-14

PYTEST KIT, UREA, C-14

                                           **    Q   **

QNASL, BECLOMETHASONE DIPROPIONATE

QOLIANA, BRIMONIDINE TARTRATE

QSYMIA, PHENTERMINE HYDROCHLORIDE

QUADRAMET, SAMARIUM SM-153 LEXIDRONAM PENTASODIUM

QUALAQUIN, QUININE SULFATE

QUARTETTE, ETHINYL ESTRADIOL

QUASENSE, ETHINYL ESTRADIOL

QUDEXY XR, TOPIRAMATE

QUELICIN, SUCCINYLCHOLINE CHLORIDE

QUELICIN PRESERVATIVE FREE, SUCCINYLCHOLINE CHLORIDE

QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

QUILLIVANT XR, METHYLPHENIDATE HYDROCHLORIDE

QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

QUINARETIC, HYDROCHLOROTHIAZIDE

QUINIDINE GLUCONATE, QUINIDINE GLUCONATE

QUINIDINE SULFATE, QUINIDINE SULFATE

QUININE SULFATE, QUININE SULFATE

QUIXIN, LEVOFLOXACIN

QUTENZA, CAPSAICIN

QVAR 40, BECLOMETHASONE DIPROPIONATE

QVAR 80, BECLOMETHASONE DIPROPIONATE

                                           **    R   **

R-GENE 10, ARGININE HYDROCHLORIDE

RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

RADIOGARDASE (PRUSSIAN BLUE), FERRIC HEXACYANOFERRATE(II)

RALOXIFENE HYDROCHLORIDE, RALOXIFENE HYDROCHLORIDE

RAMELTEON, RAMELTEON

RAMIPRIL, RAMIPRIL

RANEXA, RANOLAZINE

RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE   (OTC)

RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

RANOLAZINE, RANOLAZINE

RAPAFLO, SILODOSIN

RAPAMUNE, SIROLIMUS

RAPIVAB, PERAMIVIR

RASAGILINE MESYLATE, RASAGILINE MESYLATE

RASUVO, METHOTREXATE

RAVICTI, GLYCEROL PHENYLBUTYRATE

RAYOS, PREDNISONE

RAZADYNE, GALANTAMINE HYDROBROMIDE

RAZADYNE ER, GALANTAMINE HYDROBROMIDE

REBETOL, RIBAVIRIN

RECLAST, ZOLEDRONIC ACID

RECTIV, NITROGLYCERIN

REGITINE, PHENTOLAMINE MESYLATE

REGLAN, METOCLOPRAMIDE HYDROCHLORIDE

REGONOL, PYRIDOSTIGMINE BROMIDE

RELENZA, ZANAMIVIR

RELISTOR, METHYLNALTREXONE BROMIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 48


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    R   **

RELPAX, ELETRIPTAN HYDROBROMIDE

REMERON, MIRTAZAPINE

REMERON SOLTAB, MIRTAZAPINE

REMODULIN, TREPROSTINIL

RENACIDIN, CITRIC ACID

RENAGEL, SEVELAMER HYDROCHLORIDE

RENOGRAFIN-76, DIATRIZOATE MEGLUMINE

RENOVA, TRETINOIN

RENVELA, SEVELAMER CARBONATE

REPAGLINIDE, REPAGLINIDE

REPREXAIN, HYDROCODONE BITARTRATE

REPRONEX, MENOTROPINS (FSH

REQUIP, ROPINIROLE HYDROCHLORIDE

REQUIP XL, ROPINIROLE HYDROCHLORIDE

RESCRIPTOR, DELAVIRDINE MESYLATE

RESCULA, UNOPROSTONE ISOPROPYL

RESECTISOL IN PLASTIC CONTAINER, MANNITOL

RESERPINE, RESERPINE

RESTASIS, CYCLOSPORINE

RESTORIL, TEMAZEPAM

RETIN-A, TRETINOIN

RETIN-A MICRO, TRETINOIN

RETIN-A-MICRO, TRETINOIN

RETISERT, FLUOCINOLONE ACETONIDE

RETROVIR, ZIDOVUDINE

REVATIO, SILDENAFIL CITRATE

REVIA, NALTREXONE HYDROCHLORIDE

REVLIMID, LENALIDOMIDE

REVONTO, DANTROLENE SODIUM

REYATAZ, ATAZANAVIR SULFATE

REZIRA, HYDROCODONE BITARTRATE

RHINOCORT, BUDESONIDE

RIBASPHERE, RIBAVIRIN

RIBAVARIN, RIBAVIRIN

RIBAVIRIN, RIBAVIRIN

RIDAURA, AURANOFIN

RIFABUTIN, RIFABUTIN

RIFADIN, RIFAMPIN

RIFAMATE, ISONIAZID

RIFAMPIN, RIFAMPIN

RIFATER, ISONIAZID

RILUTEK, RILUZOLE

RILUZOLE, RILUZOLE

RIMACTANE, RIFAMPIN

RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE

RIMSO-50, DIMETHYL SULFOXIDE

RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

RIOMET, METFORMIN HYDROCHLORIDE

RISEDRONATE SODIUM, RISEDRONATE SODIUM

RISPERDAL, RISPERIDONE

RISPERDAL CONSTA, RISPERIDONE

RISPERIDONE, RISPERIDONE

RITALIN, METHYLPHENIDATE HYDROCHLORIDE

RITALIN LA, METHYLPHENIDATE HYDROCHLORIDE

RITALIN-SR, METHYLPHENIDATE HYDROCHLORIDE

RITONAVIR, RITONAVIR

RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE

RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

ROBAXIN, METHOCARBAMOL

ROBAXIN-750, METHOCARBAMOL

ROBINUL, GLYCOPYRROLATE

ROBINUL FORTE, GLYCOPYRROLATE

ROCALTROL, CALCITRIOL

ROCEPHIN, CEFTRIAXONE SODIUM

ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST           A - 49


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    R   **

ROGAINE (FOR MEN), MINOXIDIL    (OTC)

ROGAINE (FOR WOMEN), MINOXIDIL    (OTC)

ROGAINE EXTRA STRENGTH (FOR MEN), MINOXIDIL    (OTC)

ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE

ROSIGLITAZONE MALEATE, ROSIGLITAZONE MALEATE

ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

ROWASA, MESALAMINE

ROXICET, ACETAMINOPHEN

ROXICODONE, OXYCODONE HYDROCHLORIDE

ROZEREM, RAMELTEON

RYANODEX, DANTROLENE SODIUM

RYTHMOL, PROPAFENONE HYDROCHLORIDE

RYTHMOL SR, PROPAFENONE HYDROCHLORIDE

                                           **    S   **

SABRIL, VIGABATRIN

SAFYRAL, DROSPIRENONE

SAIZEN, SOMATROPIN RECOMBINANT

SALAGEN, PILOCARPINE HYDROCHLORIDE

SALONPAS, MENTHOL    (OTC)

SALURON, HYDROFLUMETHIAZIDE

SAMSCA, TOLVAPTAN

SANCTURA, TROSPIUM CHLORIDE

SANCTURA XR, TROSPIUM CHLORIDE

SANCUSO, GRANISETRON

SANDIMMUNE, CYCLOSPORINE

SANDOSTATIN, OCTREOTIDE ACETATE

SANDOSTATIN LAR, OCTREOTIDE ACETATE

SAPHRIS, ASENAPINE MALEATE

SARAFEM, FLUOXETINE HYDROCHLORIDE

SAVELLA, MILNACIPRAN HYDROCHLORIDE

SAXENDA, LIRAGLUTIDE RECOMBINANT

SCANDONEST L, LEVONORDEFRIN

SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE

SCANLUX-300, IOPAMIDOL

SCANLUX-370, IOPAMIDOL

SCLEROSOL, TALC

SEASONALE, ETHINYL ESTRADIOL

SEASONIQUE, ETHINYL ESTRADIOL

SECONAL SODIUM, SECOBARBITAL SODIUM

SECTRAL, ACEBUTOLOL HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE

SELENIUM SULFIDE, SELENIUM SULFIDE

SELFEMRA, FLUOXETINE HYDROCHLORIDE

SELSUN, SELENIUM SULFIDE

SELZENTRY, MARAVIROC

SEMPREX-D, ACRIVASTINE

SENSIPAR, CINACALCET HYDROCHLORIDE

SENSORCAINE, BUPIVACAINE HYDROCHLORIDE

SEPTOCAINE, ARTICAINE HYDROCHLORIDE

SEPTRA, SULFAMETHOXAZOLE

SEPTRA DS, SULFAMETHOXAZOLE

SEREVENT, SALMETEROL XINAFOATE

SEROMYCIN, CYCLOSERINE

SEROPHENE, CLOMIPHENE CITRATE

SEROQUEL, QUETIAPINE FUMARATE

SEROQUEL XR, QUETIAPINE FUMARATE

SEROSTIM, SOMATROPIN RECOMBINANT

SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

SETLAKIN, ETHINYL ESTRADIOL

SEVOFLURANE, SEVOFLURANE

SFROWASA, MESALAMINE

SHADE UVAGUARD, AVOBENZONE    (OTC)

SIGNIFOR, PASIREOTIDE DIASPARTATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                A - 50


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    S   **

SIGNIFOR LAR, PASIREOTIDE PAMOATE

SILDENAFIL CITRATE, SILDENAFIL CITRATE

SILENOR, DOXEPIN HYDROCHLORIDE

SILVADENE, SILVER SULFADIAZINE

SIMBRINZA, BRIMONIDINE TARTRATE

SIMCOR, NIACIN

SIMVASTATIN, SIMVASTATIN

SINE-AID IB, IBUPROFEN    (OTC)

SINEMET, CARBIDOPA

SINEMET CR, CARBIDOPA

SINGULAIR, MONTELUKAST SODIUM

SINOGRAFIN, DIATRIZOATE MEGLUMINE

SIROLIMUS, SIROLIMUS

SIRTURO, BEDAQUILINE FUMARATE

SITAVIG, ACYCLOVIR

SIVEXTRO, TEDIZOLID PHOSPHATE

SKELAXIN, METAXALONE

SKLICE, IVERMECTIN

SKYLA, LEVONORGESTREL

SODIUM ACETATE IN PLASTIC CONTAINER, SODIUM ACETATE ANHYDROUS

SODIUM BICARBONATE, SODIUM BICARBONATE

SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE

SODIUM CHLORIDE 0.9%, SODIUM CHLORIDE

SODIUM CHLORIDE 0.9% , SODIUM CHLORIDE

SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE

SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE

SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE

SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM CHLORIDE

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, SODIUM FERRIC GLUCONATE COMPLEX

SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

SODIUM IODIDE I 123, SODIUM IODIDE I-123

SODIUM IODIDE I 131, SODIUM IODIDE I-131

SODIUM IODIDE I-131, SODIUM IODIDE I-131

SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE

SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE

SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM LACTATE

SODIUM NITRITE, SODIUM NITRITE

SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE

SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

SODIUM THIOSULFATE, SODIUM THIOSULFATE

SOJOURN, SEVOFLURANE

SOLARAZE, DICLOFENAC SODIUM

SOLIFENACIN SUCCINATE, SOLIFENACIN SUCCINATE

SOLODYN, MINOCYCLINE HYDROCHLORIDE

SOLTAMOX, TAMOXIFEN CITRATE

SOLU-CORTEF, HYDROCORTISONE SODIUM SUCCINATE

SOLU-MEDROL, METHYLPREDNISOLONE SODIUM SUCCINATE

SOMA, CARISOPRODOL

SOMA COMPOUND, ASPIRIN

SOMA COMPOUND W/ CODEINE, ASPIRIN

SOMATULINE DEPOT, LANREOTIDE ACETATE

SOMAVERT, PEGVISOMANT

SONATA, ZALEPLON

SOOLANTRA, IVERMECTIN

SORBITOL 3% IN PLASTIC CONTAINER, SORBITOL

SORBITOL 3.3% IN PLASTIC CONTAINER, SORBITOL

SORBITOL-MANNITOL IN PLASTIC CONTAINER, MANNITOL

SORIATANE, ACITRETIN

SORILUX, CALCIPOTRIENE

SORINE, SOTALOL HYDROCHLORIDE

SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

SOTRADECOL, SODIUM TETRADECYL SULFATE

SOTRET, ISOTRETINOIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      A - 51


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    S   **

SOTYLIZE, SOTALOL HYDROCHLORIDE

SOVALDI, SOFOSBUVIR

SPECTRACEF, CEFDITOREN PIVOXIL

SPIRIVA, TIOTROPIUM BROMIDE

SPIRIVA RESPIMAT, TIOTROPIUM BROMIDE

SPIRONOLACTONE, SPIRONOLACTONE

SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

SPORANOX, ITRACONAZOLE

SPRINTEC, ETHINYL ESTRADIOL

SPRIX, KETOROLAC TROMETHAMINE

SPRYCEL, DASATINIB

SPS, SODIUM POLYSTYRENE SULFONATE

SSD, SILVER SULFADIAZINE

SSD AF, SILVER SULFADIAZINE

STALEVO 100, CARBIDOPA

STALEVO 125, CARBIDOPA

STALEVO 150, CARBIDOPA

STALEVO 200, CARBIDOPA

STALEVO 50, CARBIDOPA

STALEVO 75, CARBIDOPA

STARLIX, NATEGLINIDE

STAVUDINE, STAVUDINE

STAXYN, VARDENAFIL HYDROCHLORIDE

STENDRA, AVANAFIL

STERILE WATER, STERILE WATER FOR IRRIGATION

STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION

STIE-CORT, HYDROCORTISONE

STIMATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

STIVARGA, REGORAFENIB

STRATTERA, ATOMOXETINE HYDROCHLORIDE

STREPTOMYCIN SULFATE, STREPTOMYCIN SULFATE

STRIANT, TESTOSTERONE

STRIBILD, COBICISTAT

STRIVERDI RESPIMAT, OLODATEROL HYDROCHLORIDE

STROMECTOL, IVERMECTIN

STRONTIUM CHLORIDE SR-89, STRONTIUM CHLORIDE SR-89

SUBLIMAZE PRESERVATIVE FREE, FENTANYL CITRATE

SUBOXONE, BUPRENORPHINE HYDROCHLORIDE

SUBSYS, FENTANYL

SUCLEAR, MAGNESIUM SULFATE

SUCRAID, SACROSIDASE

SUCRALFATE, SUCRALFATE

SUDAFED 12 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE    (OTC)

SUDAFED 24 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE    (OTC)

SUFENTA PRESERVATIVE FREE, SUFENTANIL CITRATE

SUFENTANIL CITRATE, SUFENTANIL CITRATE

SULAR, NISOLDIPINE

SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM

SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

SULFADIAZINE, SULFADIAZINE

SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE

SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH, SULFAMETHOXAZOLE

SULFAMYLON, MAFENIDE ACETATE

SULFASALAZINE, SULFASALAZINE

SULFATRIM PEDIATRIC, SULFAMETHOXAZOLE

SULINDAC, SULINDAC

SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

SUMAVEL DOSEPRO, SUMATRIPTAN SUCCINATE

SUNITINIB MALATE, SUNITINIB MALATE

SUPPRELIN LA, HISTRELIN ACETATE

SUPRANE, DESFLURANE

SUPRAX, CEFIXIME

SUPRENZA, PHENTERMINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                   A - 52


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    S   **

SUPREP BOWEL PREP KIT, MAGNESIUM SULFATE ANHYDROUS

SURFAXIN, LUCINACTANT

SURMONTIL, TRIMIPRAMINE MALEATE

SURVANTA, BERACTANT

SUSTIVA, EFAVIRENZ

SUTENT, SUNITINIB MALATE

SYEDA, DROSPIRENONE

SYMBICORT, BUDESONIDE

SYMBYAX, FLUOXETINE HYDROCHLORIDE

SYMLIN, PRAMLINTIDE ACETATE

SYNACORT, HYDROCORTISONE

SYNALAR, FLUOCINOLONE ACETONIDE

SYNALGOS-DC, ASPIRIN

SYNAREL, NAFARELIN ACETATE

SYNERA, LIDOCAINE

SYNERCID, DALFOPRISTIN

SYNRIBO, OMACETAXINE MEPESUCCINATE

SYNTHROID, LEVOTHYROXINE SODIUM **

SYPRINE, TRIENTINE HYDROCHLORIDE

                                           **    T   **

TAB-PROFEN, IBUPROFEN    (OTC)

TACLONEX, BETAMETHASONE DIPROPIONATE

TACROLIMUS, TACROLIMUS

TAFINLAR, DABRAFENIB MESYLATE

TAGAMET HB, CIMETIDINE    (OTC)

TALC, TALC

TALWIN, PENTAZOCINE LACTATE

TAMIFLU, OSELTAMIVIR PHOSPHATE

TAMOXIFEN CITRATE, TAMOXIFEN CITRATE

TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

TAPAZOLE, METHIMAZOLE

TARCEVA, ERLOTINIB HYDROCHLORIDE

TARGRETIN, BEXAROTENE

TARKA, TRANDOLAPRIL

TASIGNA, NILOTINIB HYDROCHLORIDE MONOHYDRATE

TASMAR, TOLCAPONE

TAVIST-1, CLEMASTINE FUMARATE    (OTC)

TAXOL, PACLITAXEL

TAXOTERE, DOCETAXEL

TAZICEF, CEFTAZIDIME

TAZORAC, TAZAROTENE

TAZTIA XT, DILTIAZEM HYDROCHLORIDE

TECFIDERA, DIMETHYL FUMARATE

TECHNELITE, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

TECHNESCAN, TECHNETIUM TC-99M OXIDRONATE KIT

TECHNESCAN MAG3, TECHNETIUM TC-99M MERTIATIDE KIT

TECHNESCAN PYP KIT, TECHNETIUM TC-99M PYROPHOSPHATE KIT

TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT

TECHNETIUM TC 99M GENERATOR, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT

TECHNETIUM TC-99M MEBROFENIN, TECHNETIUM TC-99M MEBROFENIN KIT

TECHNETIUM TC-99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT

TEFLARO, CEFTAROLINE FOSAMIL

TEGRETOL, CARBAMAZEPINE

TEGRETOL-XR, CARBAMAZEPINE

TEKAMLO, ALISKIREN HEMIFUMARATE

TEKTURNA, ALISKIREN HEMIFUMARATE

TEKTURNA HCT, ALISKIREN HEMIFUMARATE

TELMISARTAN, TELMISARTAN

TELMISARTAN AND AMLODIPINE, AMLODIPINE BESYLATE

TELMISARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

TEMAZEPAM, TEMAZEPAM

TEMODAR, TEMOZOLOMIDE

TEMOVATE, CLOBETASOL PROPIONATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST      A - 53


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    T   **

TEMOVATE E, CLOBETASOL PROPIONATE

TEMOZOLOMIDE, TEMOZOLOMIDE

TENEX, GUANFACINE HYDROCHLORIDE

TENORETIC 100, ATENOLOL

TENORETIC 50, ATENOLOL

TENORMIN, ATENOLOL

TENSILON, EDROPHONIUM CHLORIDE

TENSILON PRESERVATIVE FREE, EDROPHONIUM CHLORIDE

TENUATE, DIETHYLPROPION HYDROCHLORIDE

TENUATE DOSPAN, DIETHYLPROPION HYDROCHLORIDE

TERAZOL 3, TERCONAZOLE

TERAZOL 7, TERCONAZOLE

TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE

TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE    (OTC)

TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

TERBUTALINE SULFATE, TERBUTALINE SULFATE

TERCONAZOLE, TERCONAZOLE

TERIL, CARBAMAZEPINE

TERRAMYCIN W/ POLYMYXIN B SULFATE, OXYTETRACYCLINE HYDROCHLORIDE

TESSALON, BENZONATATE

TESTIM, TESTOSTERONE

TESTOPEL, TESTOSTERONE

TESTOSTERONE, TESTOSTERONE

TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE

TESTRED, METHYLTESTOSTERONE

TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE

TEV-TROPIN, SOMATROPIN RECOMBINANT

TEVETEN, EPROSARTAN MESYLATE

TEVETEN HCT, EPROSARTAN MESYLATE

TEXACORT, HYDROCORTISONE

THALITONE, CHLORTHALIDONE

THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201

THALOMID, THALIDOMIDE

THAM, TROMETHAMINE

THEO-24, THEOPHYLLINE

THEOCHRON, THEOPHYLLINE

THEOLAIR, THEOPHYLLINE

THEOPHYLLINE, THEOPHYLLINE

THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

THERMAZENE, SILVER SULFADIAZINE

THEROXIDIL, MINOXIDIL    (OTC)

THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE

THIOGUANINE, THIOGUANINE

THIOLA, TIOPRONIN

THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE

THIOTEPA, THIOTEPA

THIOTHIXENE, THIOTHIXENE

THRIVE, NICOTINE POLACRILEX     (OTC)

THYROGEN, THYROTROPIN ALFA

THYROLAR-0.25, LIOTRIX (T4

THYROLAR-0.5, LIOTRIX (T4

THYROLAR-1, LIOTRIX (T4

THYROLAR-2, LIOTRIX (T4

THYROLAR-3, LIOTRIX (T4

THYROSAFE, POTASSIUM IODIDE     (OTC)

THYROSHIELD, POTASSIUM IODIDE     (OTC)

TIAGABINE HYDROCHLORIDE, TIAGABINE HYDROCHLORIDE

TIAZAC, DILTIAZEM HYDROCHLORIDE

TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE

TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      A - 54


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    T   **

TIKOSYN, DOFETILIDE

TIMENTIN, CLAVULANATE POTASSIUM

TIMENTIN IN PLASTIC CONTAINER, CLAVULANATE POTASSIUM

TIMOLOL MALEATE, TIMOLOL MALEATE

TIMOPTIC, TIMOLOL MALEATE

TIMOPTIC IN OCUDOSE, TIMOLOL MALEATE

TIMOPTIC-XE, TIMOLOL MALEATE

TINDAMAX, TINIDAZOLE

TINIDAZOLE, TINIDAZOLE

TIOCONAZOLE, TIOCONAZOLE     (OTC)

TIROSINT, LEVOTHYROXINE SODIUM

TIS-U-SOL, MAGNESIUM SULFATE

TIS-U-SOL IN PLASTIC CONTAINER, MAGNESIUM SULFATE

TIVICAY, DOLUTEGRAVIR SODIUM

TIVORBEX, INDOMETHACIN

TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

TOBI, TOBRAMYCIN

TOBI PODHALER, TOBRAMYCIN

TOBRADEX, DEXAMETHASONE

TOBRADEX ST, DEXAMETHASONE

TOBRAMYCIN, TOBRAMYCIN

TOBRAMYCIN AND DEXAMETHASONE, DEXAMETHASONE

TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

TOBRAMYCIN SULFATE (PHARMACY BULK), TOBRAMYCIN SULFATE

TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,   TOBRAMYCIN SULFATE

TOBREX, TOBRAMYCIN

TODAY, NONOXYNOL-9    (OTC)

TOFRANIL, IMIPRAMINE HYDROCHLORIDE

TOFRANIL-PM, IMIPRAMINE PAMOATE

TOLAZAMIDE, TOLAZAMIDE

TOLBUTAMIDE, TOLBUTAMIDE

TOLMETIN SODIUM, TOLMETIN SODIUM

TOLTERODINE TARTRATE, TOLTERODINE TARTRATE

TOPAMAX, TOPIRAMATE

TOPICORT, DESOXIMETASONE

TOPIRAMATE, TOPIRAMATE

TOPIRAMATE , TOPIRAMATE

TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

TOPROL-XL, METOPROLOL SUCCINATE

TORISEL, TEMSIROLIMUS

TORSEMIDE, TORSEMIDE

TOTECT, DEXRAZOXANE HYDROCHLORIDE

TOVIAZ, FESOTERODINE FUMARATE

TPN ELECTROLYTES IN PLASTIC CONTAINER, CALCIUM CHLORIDE

TRACLEER, BOSENTAN

TRADJENTA, LINAGLIPTIN

TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

TRANDATE, LABETALOL HYDROCHLORIDE

TRANDOLAPRIL, TRANDOLAPRIL

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL

TRANEXAMIC ACID, TRANEXAMIC ACID

TRANSDERM SCOP, SCOPOLAMINE

TRANXENE, CLORAZEPATE DIPOTASSIUM

TRANYLCYPROMINE SULFATE, TRANYLCYPROMINE SULFATE

TRAVASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS

TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER,   AMINO ACIDS

TRAVASOL 5.5% IN PLASTIC CONTAINER, AMINO ACIDS

TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER,   AMINO ACIDS

TRAVASOL 8.5% IN PLASTIC CONTAINER, AMINO ACIDS

TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER,   AMINO ACIDS

TRAVATAN Z, TRAVOPROST

TRAVOPROST, TRAVOPROST

TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

TREANDA, BENDAMUSTINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                   A - 55


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    T   **

TRECATOR, ETHIONAMIDE

TRELSTAR, TRIPTORELIN PAMOATE

TRETINOIN, TRETINOIN

TREXALL, METHOTREXATE SODIUM

TREXIMET, NAPROXEN SODIUM

TREZIX, ACETAMINOPHEN

TRI-ESTARYLLA, ETHINYL ESTRADIOL

TRI-LEGEST 21, ETHINYL ESTRADIOL

TRI-LEGEST FE, ETHINYL ESTRADIOL

TRI-LINYAH, ETHINYL ESTRADIOL

TRI-LUMA, FLUOCINOLONE ACETONIDE

TRI-NORINYL 28-DAY, ETHINYL ESTRADIOL

TRI-PREVIFEM, ETHINYL ESTRADIOL

TRI-SPRINTEC, ETHINYL ESTRADIOL

TRIACIN-C, CODEINE PHOSPHATE

TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE IN ABSORBASE, TRIAMCINOLONE ACETONIDE

TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

TRIAZOLAM, TRIAZOLAM

TRIBENZOR, AMLODIPINE BESYLATE

TRICOR, FENOFIBRATE

TRIDERM, TRIAMCINOLONE ACETONIDE

TRIDIONE, TRIMETHADIONE

TRIESENCE, TRIAMCINOLONE ACETONIDE

TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE

TRIFLURIDINE, TRIFLURIDINE

TRIGLIDE, FENOFIBRATE

TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE

TRILEPTAL, OXCARBAZEPINE

TRILIPIX, CHOLINE FENOFIBRATE

TRILYTE, POLYETHYLENE GLYCOL 3350

TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE

TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE, TRIMETHOBENZAMIDE HYDROCHLORIDE

TRIMETHOPRIM, TRIMETHOPRIM

TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

TRIMIPRAMINE MALEATE, TRIMIPRAMINE MALEATE

TRIOSTAT, LIOTHYRONINE SODIUM

TRISENOX, ARSENIC TRIOXIDE

TRIUMEQ, ABACAVIR SULFATE

TRIVAGIZOLE 3, CLOTRIMAZOLE    (OTC)

TRIVORA-28, ETHINYL ESTRADIOL

TRIZIVIR, ABACAVIR SULFATE

TROKENDI XR, TOPIRAMATE

TROPHAMINE, AMINO ACIDS

TROPHAMINE 10%, AMINO ACIDS

TROPICACYL, TROPICAMIDE

TROPICAMIDE, TROPICAMIDE

TROSPIUM CHLORIDE, TROSPIUM CHLORIDE

TRUSOPT, DORZOLAMIDE HYDROCHLORIDE

TRUVADA, EMTRICITABINE

TUDORZA PRESSAIR, ACLIDINIUM BROMIDE

TUSSICAPS, CHLORPHENIRAMINE POLISTIREX

TUSSIGON, HOMATROPINE METHYLBROMIDE

TUSSIONEX PENNKINETIC, CHLORPHENIRAMINE POLISTIREX

TWINJECT 0.15, EPINEPHRINE

TWINJECT 0.3, EPINEPHRINE

TWYNSTA, AMLODIPINE BESYLATE

TYBOST, COBICISTAT

TYGACIL, TIGECYCLINE

TYKERB, LAPATINIB DITOSYLATE

TYLENOL , ACETAMINOPHEN    (OTC)

TYLENOL W/ CODEINE NO. 3, ACETAMINOPHEN

TYLENOL W/ CODEINE NO. 4, ACETAMINOPHEN

TYVASO, TREPROSTINIL

TYZEKA, TELBIVUDINE

                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST       A - 56


                         APPENDIX A         -        PRODUCT NAME INDEX

                                                **    T   **

TYZINE,   TETRAHYDROZOLINE HYDROCHLORIDE

                                                **    U   **

U-CORT, HYDROCORTISONE ACETATE

UCERIS, BUDESONIDE

ULESFIA, BENZYL ALCOHOL

ULORIC, FEBUXOSTAT

ULTANE, SEVOFLURANE

ULTIVA, REMIFENTANIL HYDROCHLORIDE

ULTRA-TECHNEKOW FM, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

ULTRACET, ACETAMINOPHEN

ULTRAM, TRAMADOL HYDROCHLORIDE

ULTRAM ER, TRAMADOL HYDROCHLORIDE

ULTRATAG, TECHNETIUM TC-99M RED BLOOD CELL KIT

ULTRAVATE, HALOBETASOL PROPIONATE

ULTRAVIST (PHARMACY BULK), IOPROMIDE

ULTRAVIST 150, IOPROMIDE

ULTRAVIST 240, IOPROMIDE

ULTRAVIST 300, IOPROMIDE

ULTRAVIST 300 IN PLASTIC CONTAINER, IOPROMIDE

ULTRAVIST 370, IOPROMIDE

ULTRESA, PANCRELIPASE (AMYLASE

UNASYN, AMPICILLIN SODIUM

UNIPHYL, THEOPHYLLINE

UNIRETIC, HYDROCHLOROTHIAZIDE

UNISOM, DOXYLAMINE SUCCINATE    (OTC)

UNITHROID, LEVOTHYROXINE SODIUM **

UNIVASC, MOEXIPRIL HYDROCHLORIDE

URECHOLINE, BETHANECHOL CHLORIDE

UREX, METHENAMINE HIPPURATE

UROCIT-K, POTASSIUM CITRATE

UROXATRAL, ALFUZOSIN HYDROCHLORIDE

URSO 250, URSODIOL

URSO FORTE, URSODIOL

URSODIOL, URSODIOL

UVADEX, METHOXSALEN

                                                **    V   **

VAGIFEM, ESTRADIOL

VAGISTAT-1, TIOCONAZOLE    (OTC)

VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

VALCHLOR, MECHLORETHAMINE HYDROCHLORIDE

VALCYTE, VALGANCICLOVIR HYDROCHLORIDE

VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR HYDROCHLORIDE

VALIUM, DIAZEPAM

VALNAC, BETAMETHASONE VALERATE

VALPROATE SODIUM, VALPROATE SODIUM

VALPROIC ACID, VALPROIC ACID

VALSARTAN, VALSARTAN

VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

VALSTAR PRESERVATIVE FREE, VALRUBICIN

VALTREX, VALACYCLOVIR HYDROCHLORIDE

VALTROPIN, SOMATROPIN RECOMBINANT

VANCOCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER, VANCOMYCIN HYDROCHLORIDE

VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

VANDAZOLE, METRONIDAZOLE

VANIQA, EFLORNITHINE HYDROCHLORIDE

VANOS, FLUOCINONIDE

VANTAS, HISTRELIN ACETATE

VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER, CONIVAPTAN HYDROCHLORIDE

VARDENAFIL HYDROCHLORIDE, VARDENAFIL HYDROCHLORIDE

VARITHENA, POLIDOCANOL

VASCEPA, ICOSAPENT ETHYL

VASERETIC, ENALAPRIL MALEATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 57


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    V   **

VASOSTRICT, VASOPRESSIN

VASOTEC, ENALAPRIL MALEATE

VAZCULEP, PHENYLEPHRINE HYDROCHLORIDE

VECTICAL, CALCITRIOL

VECURONIUM BROMIDE, VECURONIUM BROMIDE

VELCADE, BORTEZOMIB

VELETRI, EPOPROSTENOL SODIUM

VELIVET, DESOGESTREL

VELPHORO, SUCROFERRIC OXYHYDROXIDE

VELTIN, CLINDAMYCIN PHOSPHATE

VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

VENOFER, IRON SUCROSE

VENTAVIS, ILOPROST

VENTOLIN HFA, ALBUTEROL SULFATE

VERAMYST, FLUTICASONE FUROATE

VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

VERDESO, DESONIDE

VEREGEN, SINECATECHINS

VERELAN, VERAPAMIL HYDROCHLORIDE

VERELAN PM, VERAPAMIL HYDROCHLORIDE

VERSACLOZ, CLOZAPINE

VESICARE, SOLIFENACIN SUCCINATE

VEXOL, RIMEXOLONE

VFEND, VORICONAZOLE

VIAGRA, SILDENAFIL CITRATE

VIBATIV, TELAVANCIN HYDROCHLORIDE

VIBISONE, CYANOCOBALAMIN

VIBRAMYCIN, DOXYCYCLINE

VIBRAMYCIN, DOXYCYCLINE CALCIUM

VIBRAMYCIN, DOXYCYCLINE HYCLATE

VICOPROFEN, HYDROCODONE BITARTRATE

VICTOZA, LIRAGLUTIDE RECOMBINANT

VICTRELIS, BOCEPREVIR

VIDAZA, AZACITIDINE

VIDEX, DIDANOSINE

VIDEX EC, DIDANOSINE

VIEKIRA PAK (COPACKAGED), DASABUVIR SODIUM

VIGAMOX, MOXIFLOXACIN HYDROCHLORIDE

VIIBRYD, VILAZODONE HYDROCHLORIDE

VIMOVO, ESOMEPRAZOLE MAGNESIUM

VIMPAT, LACOSAMIDE

VINBLASTINE SULFATE, VINBLASTINE SULFATE

VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE

VINORELBINE, VINORELBINE

VINORELBINE TARTRATE, VINORELBINE TARTRATE

VIOKACE, PANCRELIPASE (AMYLASE

VIORELE, DESOGESTREL

VIRACEPT, NELFINAVIR MESYLATE

VIRAMUNE, NEVIRAPINE

VIRAMUNE XR, NEVIRAPINE

VIRAZOLE, RIBAVIRIN

VIREAD, TENOFOVIR DISOPROXIL FUMARATE

VIROPTIC, TRIFLURIDINE

VISINE L.R., OXYMETAZOLINE HYDROCHLORIDE    (OTC)

VISINE-A, NAPHAZOLINE HYDROCHLORIDE    (OTC)

VISIONBLUE, TRYPAN BLUE

VISIPAQUE 270, IODIXANOL

VISIPAQUE 320, IODIXANOL

VISTARIL, HYDROXYZINE PAMOATE

VISTIDE, CIDOFOVIR

VISUDYNE, VERTEPORFIN

VITAMIN D, ERGOCALCIFEROL

VITAMIN K1, PHYTONADIONE

VITEKTA, ELVITEGRAVIR

VITRASE, HYALURONIDASE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST     A - 58


                        APPENDIX A       -        PRODUCT NAME INDEX

                                             **    V   **
VITUZ, CHLORPHENIRAMINE MALEATE
VIVACTIL, PROTRIPTYLINE HYDROCHLORIDE
VIVELLE, ESTRADIOL
VIVELLE-DOT, ESTRADIOL
VIVITROL, NALTREXONE
VIZAMYL, FLUTEMETAMOL F-18
VOGELXO, TESTOSTERONE
VOLTAREN, DICLOFENAC SODIUM
VOLTAREN-XR, DICLOFENAC SODIUM
VORICONAZOLE, VORICONAZOLE
VOSOL, ACETIC ACID, GLACIAL
VOSOL HC, ACETIC ACID, GLACIAL
VOSPIRE ER, ALBUTEROL SULFATE
VOTRIENT, PAZOPANIB HYDROCHLORIDE
VPRIV, VELAGLUCERASE ALFA
VUMON, TENIPOSIDE
VUSION, MICONAZOLE NITRATE
VYFEMLA, ETHINYL ESTRADIOL
VYTORIN, EZETIMIBE
VYVANSE, LISDEXAMFETAMINE DIMESYLATE
                                             **    W   **
WARFARIN SODIUM, WARFARIN SODIUM
WELCHOL, COLESEVELAM HYDROCHLORIDE
WELLBUTRIN, BUPROPION HYDROCHLORIDE
WELLBUTRIN SR, BUPROPION HYDROCHLORIDE
WELLBUTRIN XL, BUPROPION HYDROCHLORIDE
WERA, ETHINYL ESTRADIOL
WOMEN'S ROGAINE, MINOXIDIL   (OTC)
                                             **    X   **
XALATAN, LATANOPROST
XALKORI, CRIZOTINIB
XANAX, ALPRAZOLAM
XANAX XR, ALPRAZOLAM
XARELTO, RIVAROXABAN
XARTEMIS XR, ACETAMINOPHEN
XELJANZ, TOFACITINIB CITRATE
XELODA, CAPECITABINE
XENAZINE, TETRABENAZINE
XENICAL, ORLISTAT
XENON XE 133, XENON XE-133
XERESE, ACYCLOVIR
XIFAXAN, RIFAXIMIN
XIGDUO XR, DAPAGLIFLOZIN
XOFIGO, RADIUM RA-223 DICHLORIDE
XOLEGEL, KETOCONAZOLE
XOPENEX, LEVALBUTEROL HYDROCHLORIDE
XOPENEX HFA, LEVALBUTEROL TARTRATE
XTANDI, ENZALUTAMIDE
XTORO, FINAFLOXACIN
XULANE, ETHINYL ESTRADIOL
XYLOCAINE, LIDOCAINE HYDROCHLORIDE
XYLOCAINE 4% PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

XYLOCAINE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

XYLOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE

XYLOCAINE W/ EPINEPHRINE, EPINEPHRINE

XYREM, SODIUM OXYBATE

XYZAL, LEVOCETIRIZINE DIHYDROCHLORIDE

                                             **    Y   **

YAELA, DROSPIRENONE

YASMIN, DROSPIRENONE

YAZ, DROSPIRENONE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   A - 59


                       APPENDIX A      -        PRODUCT NAME INDEX

                                           **    Z   **

ZADITOR, KETOTIFEN FUMARATE    (OTC)

ZAFIRLUKAST, ZAFIRLUKAST

ZALEPLON, ZALEPLON

ZANAFLEX, TIZANIDINE HYDROCHLORIDE

ZANOSAR, STREPTOZOCIN

ZANTAC, RANITIDINE HYDROCHLORIDE

ZANTAC 150, RANITIDINE HYDROCHLORIDE   (OTC)

ZANTAC 150, RANITIDINE HYDROCHLORIDE

ZANTAC 300, RANITIDINE HYDROCHLORIDE

ZANTAC 75, RANITIDINE HYDROCHLORIDE   (OTC)

ZARONTIN, ETHOSUXIMIDE

ZAROXOLYN, METOLAZONE

ZAVESCA, MIGLUSTAT

ZEBETA, BISOPROLOL FUMARATE

ZECUITY, SUMATRIPTAN SUCCINATE

ZEGERID, OMEPRAZOLE

ZEGERID OTC, OMEPRAZOLE    (OTC)

ZELAPAR, SELEGILINE HYDROCHLORIDE

ZELBORAF, VEMURAFENIB

ZEMPLAR, PARICALCITOL

ZENATANE, ISOTRETINOIN

ZENPEP, PANCRELIPASE (AMYLASE

ZERBAXA, CEFTOLOZANE SULFATE

ZERIT, STAVUDINE

ZESTORETIC, HYDROCHLOROTHIAZIDE

ZESTRIL, LISINOPRIL

ZETIA, EZETIMIBE

ZETONNA, CICLESONIDE

ZIAC, BISOPROLOL FUMARATE

ZIAGEN, ABACAVIR SULFATE

ZIANA, CLINDAMYCIN PHOSPHATE

ZIDOVUDINE, ZIDOVUDINE

ZINACEF, CEFUROXIME SODIUM

ZINACEF IN PLASTIC CONTAINER, CEFUROXIME SODIUM

ZINC CHLORIDE IN PLASTIC CONTAINER, ZINC CHLORIDE

ZINECARD, DEXRAZOXANE HYDROCHLORIDE

ZINGO, LIDOCAINE HYDROCHLORIDE

ZIOPTAN, TAFLUPROST

ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE

ZIPSOR, DICLOFENAC POTASSIUM

ZIRGAN, GANCICLOVIR

ZITHROMAX, AZITHROMYCIN

ZMAX, AZITHROMYCIN

ZOCOR, SIMVASTATIN

ZOFRAN, ONDANSETRON HYDROCHLORIDE

ZOFRAN ODT, ONDANSETRON

ZOFRAN PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

ZOHYDRO ER, HYDROCODONE BITARTRATE

ZOLADEX, GOSERELIN ACETATE

ZOLEDRONIC ACID, ZOLEDRONIC ACID

ZOLINZA, VORINOSTAT

ZOLMITRIPTAN, ZOLMITRIPTAN

ZOLOFT, SERTRALINE HYDROCHLORIDE

ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

ZOLPIMIST, ZOLPIDEM TARTRATE

ZOMETA, ZOLEDRONIC ACID

ZOMIG, ZOLMITRIPTAN

ZOMIG-ZMT, ZOLMITRIPTAN

ZONALON, DOXEPIN HYDROCHLORIDE

ZONEGRAN, ZONISAMIDE

ZONISAMIDE, ZONISAMIDE

ZONTIVITY, VORAPAXAR SULFATE

ZORBTIVE, SOMATROPIN RECOMBINANT

ZORTRESS, EVEROLIMUS

ZORVOLEX, DICLOFENAC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST    A - 60


                        APPENDIX A      -        PRODUCT NAME INDEX

                                            **    Z   **

ZOSYN, PIPERACILLIN SODIUM

ZOSYN IN PLASTIC CONTAINER, PIPERACILLIN SODIUM

ZOVIA 1/35E-28, ETHINYL ESTRADIOL

ZOVIA 1/50E-28, ETHINYL ESTRADIOL

ZOVIRAX, ACYCLOVIR

ZUBSOLV, BUPRENORPHINE HYDROCHLORIDE

ZUPLENZ, ONDANSETRON

ZUTRIPRO, CHLORPHENIRAMINE MALEATE

ZYBAN, BUPROPION HYDROCHLORIDE

ZYCLARA, IMIQUIMOD

ZYDELIG, IDELALISIB

ZYFLO, ZILEUTON

ZYFLO CR, ZILEUTON

ZYKADIA, CERITINIB

ZYLET, LOTEPREDNOL ETABONATE

ZYLOPRIM, ALLOPURINOL

ZYMAR, GATIFLOXACIN

ZYMAXID, GATIFLOXACIN

ZYPREXA, OLANZAPINE

ZYPREXA RELPREVV, OLANZAPINE PAMOATE

ZYPREXA ZYDIS, OLANZAPINE

ZYRTEC, CETIRIZINE HYDROCHLORIDE

ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

ZYRTEC-D 12 HOUR, CETIRIZINE HYDROCHLORIDE    (OTC)

ZYTIGA, ABIRATERONE ACETATE

ZYVOX, LINEZOLID

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 1


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                           **   3   **

3M

*	 3M CO

    PERIDEX, CHLORHEXIDINE GLUCONATE

*	 3M HEALTH CARE INC

    AVAGARD, ALCOHOL    (OTC)

    DURAPREP, IODINE POVACRYLEX   (OTC)

*	 3M PHARMACEUTICALS INC

    PROVENTIL-HFA, ALBUTEROL SULFATE

                                           **   A   **

AAIPHARMA LLC

*	 AAIPHARMA LLC

    AZASAN, AZATHIOPRINE

ABBVIE

*	 ABBVIE INC

    ADVICOR, LOVASTATIN

    AKINETON, BIPERIDEN HYDROCHLORIDE

    ANDROGEL, TESTOSTERONE

    BIAXIN XL, CLARITHROMYCIN

    BIAXIN, CLARITHROMYCIN

    CALCIJEX, CALCITRIOL

    CREON, PANCRELIPASE (AMYLASE

    CYCLOSPORINE, CYCLOSPORINE

    DEPACON, VALPROATE SODIUM

    DEPAKENE, VALPROIC ACID

    DEPAKOTE ER, DIVALPROEX SODIUM

    DEPAKOTE, DIVALPROEX SODIUM

    GENGRAF, CYCLOSPORINE

    K-TAB, POTASSIUM CHLORIDE

    KALETRA, LOPINAVIR

    MARINOL, DRONABINOL

    MAVIK, TRANDOLAPRIL

    NIASPAN, NIACIN

    NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE

    NIMBEX, CISATRACURIUM BESYLATE

    NORVIR, RITONAVIR

    ORETIC, HYDROCHLOROTHIAZIDE

    SIMCOR, NIACIN

    SURVANTA, BERACTANT

    SYNTHROID, LEVOTHYROXINE SODIUM **

    TARKA, TRANDOLAPRIL

    TEVETEN HCT, EPROSARTAN MESYLATE

    TEVETEN, EPROSARTAN MESYLATE

    TRICOR, FENOFIBRATE

    TRIDIONE, TRIMETHADIONE

    TRILIPIX, CHOLINE FENOFIBRATE

    ULTANE, SEVOFLURANE

    VICOPROFEN, HYDROCODONE BITARTRATE

    ZEMPLAR, PARICALCITOL

ABBVIE ENDOCRINE

*	 ABBVIE ENDOCRINE INC

    LUPANETA PACK, LEUPROLIDE ACETATE

ABBVIE ENDOCRINE INC

*	 ABBVIE ENDOCRINE INC

    LUPRON DEPOT, LEUPROLIDE ACETATE

    LUPRON DEPOT-PED, LEUPROLIDE ACETATE

ABBVIE INC

*	 ABBVIE INC

    PROMETRIUM, PROGESTERONE

    VIEKIRA PAK (COPACKAGED), DASABUVIR SODIUM

ABRAXIS BIOSCIENCE

*	 ABRAXIS BIOSCIENCE LLC

    ABRAXANE, PACLITAXEL

ABRAXIS PHARM

* ABRAXIS PHARMACEUTICAL PRODUCTS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 2


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ABRAXIS PHARMACEUTICAL PRODUCTS

    CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, CLINDAMYCIN PHOSPHATE

ACADEMIC PHARMS

*	 ACADEMIC PHARMACEUTICALS INC

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

ACCELRX LABS

*	 ACCELRX LABS LLC

    CARISOPRODOL, CARISOPRODOL

ACCORD HLTHCARE

*	 ACCORD HEALTHCARE INC

    ALLOPURINOL, ALLOPURINOL

    AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ANASTROZOLE, ANASTROZOLE

    BICALUTAMIDE, BICALUTAMIDE

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CLONAZEPAM, CLONAZEPAM

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DOCETAXEL, DOCETAXEL

    DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    ETOPOSIDE, ETOPOSIDE

    FINASTERIDE, FINASTERIDE

    FLUOROURACIL, FLUOROURACIL

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    GLIMEPIRIDE, GLIMEPIRIDE

    GLIPIZIDE, GLIPIZIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LETROZOLE, LETROZOLE

    LEVETIRACETAM, LEVETIRACETAM

    LISINOPRIL, LISINOPRIL

    METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

    METHYLDOPA, METHYLDOPA

    MITOMYCIN, MITOMYCIN

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SIMVASTATIN, SIMVASTATIN

    TACROLIMUS, TACROLIMUS

    TOPIRAMATE, TOPIRAMATE

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

ACCORD HLTHCARE INC

*	 ACCORD HEALTHCARE INC USA

    FINASTERIDE, FINASTERIDE

    RAMIPRIL, RAMIPRIL

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

ACELLA PHARMS LLC

*	 ACELLA PHARMACEUTICALS LLC

    GABAPENTIN, GABAPENTIN

ACI HEALTHCARE LTD

*	 ACI HEALTHCARE LTD

    GABAPENTIN, GABAPENTIN

ACIC FINE CHEMS

*	 ACIC FINE CHEMICALS INC

    TRANEXAMIC ACID, TRANEXAMIC ACID

ACORDA

*	 ACORDA THERAPEUTICS INC

    AMPYRA, DALFAMPRIDINE

    QUTENZA, CAPSAICIN

    ZANAFLEX, TIZANIDINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 3


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **
ACS DOBFAR
* ACS DOBFAR SPA
    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM
    CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

    CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE

    CEFOXITIN, CEFOXITIN SODIUM

    CEFTAZIDIME, CEFTAZIDIME

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    IMIPENEM AND CILASTATIN, CILASTATIN SODIUM

    KEFZOL, CEFAZOLIN SODIUM

    MEROPENEM, MEROPENEM

ACS DOBFAR INFO SA

*	 ACS DOBFAR INFO SA

    CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

    FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

ACS DOBFAR SPA

*	 ACS DOBFAR SPA

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

ACTAVIS

*	 ACTAVIS SOUTHATLANTIC LLC

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

ACTAVIS ELIZABETH

*	 ACTAVIS ELIZABETH LLC

    ALPRAZOLAM, ALPRAZOLAM

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CLONAZEPAM, CLONAZEPAM

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    GABAPENTIN, GABAPENTIN

    GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE

    GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    INDAPAMIDE, INDAPAMIDE

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    LOVASTATIN, LOVASTATIN

    MORPHINE SULFATE, MORPHINE SULFATE

    NIFEDIPINE, NIFEDIPINE

    OXAZEPAM, OXAZEPAM

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    PROPYLTHIOURACIL, PROPYLTHIOURACIL

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SPIRONOLACTONE, SPIRONOLACTONE

    TEMAZEPAM, TEMAZEPAM

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

ACTAVIS GRP PTC

*	 ACTAVIS GROUP PTC EHF

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                    B - 4


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ACTAVIS GROUP PTC EHF

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

ACTAVIS INC

*	 ACTAVIS INC

    DOCETAXEL, DOCETAXEL

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

ACTAVIS LABS FL INC

*	 ACTAVIS LABORATORIES FL INC

    ALPRAZOLAM, ALPRAZOLAM

    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CABERGOLINE, CABERGOLINE

    CARTIA XT, DILTIAZEM HYDROCHLORIDE

    CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN

    CLARITHROMYCIN, CLARITHROMYCIN

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DICLOFENAC SODIUM AND MISOPROSTOL, DICLOFENAC SODIUM

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    FLUTAMIDE, FLUTAMIDE

    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

    FOSINOPRIL SODIUM, FOSINOPRIL SODIUM

    GLIMEPIRIDE, GLIMEPIRIDE

    HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    KETOPROFEN, KETOPROFEN

    LEVETIRACETAM, LEVETIRACETAM

    LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE    (OTC)

    LORATADINE, LORATADINE    (OTC)

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    METOPROLOL SUCCINATE, METOPROLOL SUCCINATE

    MIRTAZAPINE, MIRTAZAPINE

    NAPROXEN SODIUM, NAPROXEN SODIUM

    NORCO, ACETAMINOPHEN

    OMEPRAZOLE, OMEPRAZOLE

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    TAMOXIFEN CITRATE, TAMOXIFEN CITRATE

    TAZTIA XT, DILTIAZEM HYDROCHLORIDE

    TRANEXAMIC ACID, TRANEXAMIC ACID

    TROSPIUM CHLORIDE, TROSPIUM CHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

ACTAVIS LABS NY INC

*	 ACTAVIS LABORATORIES NY INC

    NICOTINE POLACRILEX, NICOTINE POLACRILEX    (OTC)

ACTAVIS LABS UT INC

*	 ACTAVIS LABORATORIES UT INC

    ANDRODERM, TESTOSTERONE

ACTAVIS MID ATLANTIC

*	 ACTAVIS MID ATLANTIC LLC

    ACETASOL HC, ACETIC ACID, GLACIAL

    ACYCLOVIR, ACYCLOVIR

    ADAPALENE, ADAPALENE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    BETAMETHASONE VALERATE, BETAMETHASONE VALERATE

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 5


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ACTAVIS MID ATLANTIC LLC

    CICLOPIROX, CICLOPIROX

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CLOTRIMAZOLE, CLOTRIMAZOLE      (OTC)

    CONSTULOSE, LACTULOSE

    ENULOSE, LACTULOSE

    FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

    GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

    HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE

    HYDROCORTISONE, HYDROCORTISONE

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN     (OTC)

    LEVETIRACETAM, LEVETIRACETAM

    M-ZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE        (OTC)

    MICONAZOLE 7, MICONAZOLE NITRATE       (OTC)

    MICONAZOLE NITRATE, MICONAZOLE NITRATE

    MICONAZOLE NITRATE, MICONAZOLE NITRATE        (OTC)

    MINOXIDIL (FOR MEN), MINOXIDIL      (OTC)

    MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL        (OTC)

    NYSTATIN, NYSTATIN

    PERMETHRIN, PERMETHRIN

    PERMETHRIN, PERMETHRIN     (OTC)

    PROMETH VC PLAIN, PHENYLEPHRINE HYDROCHLORIDE

    PROMETH VC W/ CODEINE, CODEINE PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    VALNAC, BETAMETHASONE VALERATE

ACTAVIS TOTOWA

*	 ACTAVIS TOTOWA LLC

    BICALUTAMIDE, BICALUTAMIDE

    CARBOPLATIN, CARBOPLATIN

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    FINASTERIDE, FINASTERIDE

    FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    OXALIPLATIN, OXALIPLATIN

    PACLITAXEL, PACLITAXEL

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    REPAGLINIDE, REPAGLINIDE

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

ACTELION PHARMS LTD

*	 ACTELION PHARMACEUTICALS LTD

    OPSUMIT, MACITENTAN

    TRACLEER, BOSENTAN

    VALCHLOR, MECHLORETHAMINE HYDROCHLORIDE

    VELETRI, EPOPROSTENOL SODIUM

    VENTAVIS, ILOPROST

    ZAVESCA, MIGLUSTAT

ACTIENT PHARMS

*	 ACTIENT PHARMACEUTICALS LLC

    TESTOPEL, TESTOSTERONE

    THEO-24, THEOPHYLLINE

ACTIVIS TOTOWA LLC

*	 ACTIVIS TOTOWA LLC

    TOPIRAMATE, TOPIRAMATE

ACURA PHARMS INC

*	 ACURA PHARMACEUTICALS INC

    OXECTA, OXYCODONE HYDROCHLORIDE

AEGERION

* AEGERION PHARMACEUTICALS INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 6


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AEGERION PHARMACEUTICALS INC

    JUXTAPID, LOMITAPIDE MESYLATE

AGILA SPECLTS

*	 AGILA SPECIALTIES PRIVATE LTD

    ADENOSINE, ADENOSINE

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

    DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

    DOXYCYCLINE, DOXYCYCLINE HYCLATE

    ETOMIDATE, ETOMIDATE

    FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE

    FLUMAZENIL, FLUMAZENIL

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE

    HALOPERIDOL, HALOPERIDOL LACTATE

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    MESNA, MESNA

    NAFCILLIN SODIUM, NAFCILLIN SODIUM

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXACILLIN SODIUM, OXACILLIN SODIUM

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM

    RIFAMPIN, RIFAMPIN

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    VECURONIUM BROMIDE, VECURONIUM BROMIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

AGOURON

*	 AGOURON PHARMACEUTICALS INC

    VIRACEPT, NELFINAVIR MESYLATE

AJANTA PHARMA

*	 AJANTA PHARMA LTD

    LEVETIRACETAM, LEVETIRACETAM

AJANTA PHARMA LTD

*	 AJANTA PHARMA LTD

    RISPERIDONE, RISPERIDONE

AKORN

*	 AKORN INC

    ADENOSINE, ADENOSINE

    AK-FLUOR 10%, FLUORESCEIN SODIUM

    AK-FLUOR 25%, FLUORESCEIN SODIUM

    AKBETA, LEVOBUNOLOL HYDROCHLORIDE

    AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE

    AKTEN, LIDOCAINE HYDROCHLORIDE

    AKTOB, TOBRAMYCIN

    ALFENTA, ALFENTANIL HYDROCHLORIDE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    ATROPINE SULFATE, ATROPINE SULFATE

    BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC

    BAL, DIMERCAPROL

    BALANCED SALT, CALCIUM CHLORIDE

    BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE

    BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE

    CALCITRIOL, CALCITRIOL

    CAPASTAT SULFATE, CAPREOMYCIN SULFATE

    CARBOPLATIN, CARBOPLATIN

    CROMOLYN SODIUM, CROMOLYN SODIUM

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    ENDOSOL EXTRA, CALCIUM CHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 7


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AKORN INC

    ERYTHROMYCIN, ERYTHROMYCIN

    GENTAK, GENTAMICIN SULFATE

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    IC-GREEN, INDOCYANINE GREEN

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    KETOTIFEN FUMARATE, KETOTIFEN FUMARATE    (OTC)

    LATANOPROST, LATANOPROST

    LEVOFLOXACIN, LEVOFLOXACIN

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LORAZEPAM, LORAZEPAM

    NEDOCROMIL SODIUM, NEDOCROMIL SODIUM

    NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC

    NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC

    OFLOXACIN, OFLOXACIN

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

    PAREMYD, HYDROXYAMPHETAMINE HYDROBROMIDE

    SUBLIMAZE PRESERVATIVE FREE, FENTANYL CITRATE

    SUFENTA PRESERVATIVE FREE, SUFENTANIL CITRATE

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

    TIMOLOL MALEATE, TIMOLOL MALEATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    TROPICACYL, TROPICAMIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

AKORN INC

*	 AKORN INC

    APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE

    DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DRONABINOL, DRONABINOL

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    INAPSINE, DROPERIDOL

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, NAPHAZOLINE HYDROCHLORIDE   (OTC)

    NAPHAZOLINE HYDROCHLORIDE, NAPHAZOLINE HYDROCHLORIDE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE

    TOBRAMYCIN, TOBRAMYCIN

    TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

ALARA PHARM

*	 ALARA PHARMACEUTICAL CORPORATION

    LEVO-T, LEVOTHYROXINE SODIUM **

ALCON

*	 ALCON INC

    TRIESENCE, TRIAMCINOLONE ACETONIDE

*	 ALCON LABORATORIES INC

    ALCAINE, PROPARACAINE HYDROCHLORIDE

    ALOMIDE, LODOXAMIDE TROMETHAMINE

    BETOPTIC S, BETAXOLOL HYDROCHLORIDE

    BETOPTIC, BETAXOLOL HYDROCHLORIDE

    BSS PLUS, CALCIUM CHLORIDE

    BSS, CALCIUM CHLORIDE

    CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE

    CETAMIDE, SULFACETAMIDE SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 8


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ALCON LABORATORIES INC

    CROMOLYN SODIUM, CROMOLYN SODIUM

    CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE

    CYCLOMYDRIL, CYCLOPENTOLATE HYDROCHLORIDE

    DENDRID, IDOXURIDINE

    EMADINE, EMEDASTINE DIFUMARATE

    FLAREX, FLUOROMETHOLONE ACETATE

    IOPIDINE, APRACLONIDINE HYDROCHLORIDE

    MAXIDEX, DEXAMETHASONE

    MAXITROL, DEXAMETHASONE

    MIOSTAT, CARBACHOL

    MYDRIACYL, TROPICAMIDE

    NAPHCON-A, NAPHAZOLINE HYDROCHLORIDE    (OTC)

    NATACYN, NATAMYCIN

    OMNIPRED, PREDNISOLONE ACETATE

    PATANOL, OLOPATADINE HYDROCHLORIDE

    PILOPINE HS, PILOCARPINE HYDROCHLORIDE

    TOBRADEX, DEXAMETHASONE

    TOBREX, TOBRAMYCIN

    VEXOL, RIMEXOLONE

ALCON LABS INC

*	 ALCON LABORATORIES INC

    CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE

    IZBA, TRAVOPROST

ALCON PHARMA

*	 ALCON RESEARCH LTD

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

    ZADITOR, KETOTIFEN FUMARATE    (OTC)

ALCON PHARMS LTD

*	 ALCON PHARMACEUTICALS LTD

    AZOPT, BRINZOLAMIDE

    BETADINE, POVIDONE-IODINE

    BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE

    CILOXAN, CIPROFLOXACIN HYDROCHLORIDE

    CIPRO HC, CIPROFLOXACIN HYDROCHLORIDE

    CIPRODEX, CIPROFLOXACIN

    DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

    DUREZOL, DIFLUPREDNATE

    FLUORESCITE, FLUORESCEIN SODIUM

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    KETOTIFEN FUMARATE, KETOTIFEN FUMARATE    (OTC)

    MOXEZA, MOXIFLOXACIN HYDROCHLORIDE

    NAVSTEL, CALCIUM CHLORIDE

    NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE

    NEVANAC, NEPAFENAC

    OFLOXACIN, OFLOXACIN

    PATADAY, OLOPATADINE HYDROCHLORIDE

    PATANASE, OLOPATADINE HYDROCHLORIDE

    QOLIANA, BRIMONIDINE TARTRATE

    SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM

    TOBRADEX ST, DEXAMETHASONE

    TRAVATAN Z, TRAVOPROST

    TRIFLURIDINE, TRIFLURIDINE

    VIGAMOX, MOXIFLOXACIN HYDROCHLORIDE

ALCON RES

*	 ALCON RESEARCH LTD

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    ISOPTO CARPINE, PILOCARPINE HYDROCHLORIDE

    LATANOPROST, LATANOPROST

ALCON RES LTD

*	 ALCON RESEARCH LTD

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 9


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ALCON RESEARCH LTD

    ILEVRO, NEPAFENAC

    LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE

    METIPRANOLOL, METIPRANOLOL HYDROCHLORIDE

    SIMBRINZA, BRIMONIDINE TARTRATE

    TIMOLOL MALEATE, TIMOLOL MALEATE

    XTORO, FINAFLOXACIN

ALEMBIC LTD

*	 ALEMBIC LTD

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LITHIUM CARBONATE, LITHIUM CARBONATE

    METRONIDAZOLE, METRONIDAZOLE

    MODAFINIL, MODAFINIL

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    THEOPHYLLINE, THEOPHYLLINE

    VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

ALEMBIC PHARMS LTD

*	 ALEMBIC PHARMACEUTICALS LTD

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    DESVENLAFAXINE, DESVENLAFAXINE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    FAMOTIDINE, FAMOTIDINE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    LAMOTRIGINE, LAMOTRIGINE

    LEFLUNOMIDE, LEFLUNOMIDE

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MEPROBAMATE, MEPROBAMATE

    METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    METRONIDAZOLE, METRONIDAZOLE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE

    TELMISARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TELMISARTAN, TELMISARTAN

    VALSARTAN, VALSARTAN

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

ALIMERA SCIENCES INC

*	 ALIMERA SCIENCES INC

    ILUVIEN, FLUOCINOLONE ACETONIDE

ALKEM

*	 ALKEM LABORATORIES LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    GABAPENTIN, GABAPENTIN

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

ALKEM LABS LTD

*	 ALKEM LABORATORIES LTD

    CEFUROXIME AXETIL, CEFUROXIME AXETIL

    CEPHALEXIN, CEPHALEXIN

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    LAMOTRIGINE, LAMOTRIGINE

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

ALKERMES

*	 ALKERMES INC

    VIVITROL, NALTREXONE

ALKERMES GAINESVILLE

*	 ALKERMES GAINESVILLE LLC

    VERELAN PM, VERAPAMIL HYDROCHLORIDE

    VERELAN, VERAPAMIL HYDROCHLORIDE

ALKOPHARMA USA

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 10


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ALKOPHARMA USA INC

    AMPHOTEC, AMPHOTERICIN B

ALLEGIANCE HLTHCARE

*	 ALLEGIANCE HEALTHCARE CORP

    POVIDONE IODINE, POVIDONE-IODINE    (OTC)

ALLERGAN

*	 ALLERGAN

    ACULAR LS, KETOROLAC TROMETHAMINE

    ALPHAGAN P, BRIMONIDINE TARTRATE

    BLEPH-10, SULFACETAMIDE SODIUM

    GENOPTIC, GENTAMICIN SULFATE

    ZYMAXID, GATIFLOXACIN

*	 ALLERGAN INC

    ACULAR, KETOROLAC TROMETHAMINE

    ACUVAIL, KETOROLAC TROMETHAMINE

    ACZONE, DAPSONE

    ALOCRIL, NEDOCROMIL SODIUM

    ALPHAGAN P, BRIMONIDINE TARTRATE

    AVAGE, TAZAROTENE

    AZELEX, AZELAIC ACID

    COMBIGAN, BRIMONIDINE TARTRATE

    ELESTAT, EPINASTINE HYDROCHLORIDE

    LASTACAFT, ALCAFTADINE

    LATISSE, BIMATOPROST

    LUMIGAN, BIMATOPROST

    OCUFLOX, OFLOXACIN

    OZURDEX, DEXAMETHASONE

    POLYTRIM, POLYMYXIN B SULFATE

    RESTASIS, CYCLOSPORINE

    SANCTURA XR, TROSPIUM CHLORIDE

    SANCTURA, TROSPIUM CHLORIDE

    TAZORAC, TAZAROTENE

    ZYMAR, GATIFLOXACIN

*	 ALLERGAN PHARMACEUTICAL

    BETAGAN, LEVOBUNOLOL HYDROCHLORIDE

    BLEPHAMIDE S.O.P., PREDNISOLONE ACETATE

    BLEPHAMIDE, PREDNISOLONE ACETATE

    FML FORTE, FLUOROMETHOLONE

    FML, FLUOROMETHOLONE

    HERPLEX, IDOXURIDINE

    OCUFEN, FLURBIPROFEN SODIUM

    PRED FORTE, PREDNISOLONE ACETATE

    PRED MILD, PREDNISOLONE ACETATE

    PRED-G, GENTAMICIN SULFATE

ALLERQUEST

*	 ALLERQUEST LLC

    PRE-PEN, BENZYLPENICILLOYL POLYLYSINE

ALLIED PHARMA INC

*	 ALLIED PHARMA INC

    CLARITHROMYCIN, CLARITHROMYCIN

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

ALLOS

*	 ALLOS THERAPEUTICS INC

    FOLOTYN, PRALATREXATE

ALMATICA PHARMA INC

*	 ALMATICA PHARMA INC

    NAPRELAN, NAPROXEN SODIUM

ALPHARMA

*	 ALPHARMA USPD INC

    PREDNISOLONE, PREDNISOLONE

    VALPROIC ACID, VALPROIC ACID

ALPHARMA PHARMS

*	 ALPHARMA PHARMACEUTICALS LLC

    EMBEDA, MORPHINE SULFATE

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                    B - 11

              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT
                                        **   A   **
ALRA
* ALRA LABORATORIES INC
    CHOLAC, LACTULOSE
    CONSTILAC, LACTULOSE
    GEN-XENE, CLORAZEPATE DIPOTASSIUM
    IBU-TAB 200, IBUPROFEN    (OTC)
    IBU-TAB, IBUPROFEN
ALTAIRE PHARMS INC
* ALTAIRE PHARMACEUTICALS INC
    NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, NAPHAZOLINE HYDROCHLORIDE   (OTC)
    OFLOXACIN, OFLOXACIN
ALVOGEN
* ALVOGEN INC
    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
ALVOGEN INC
* ALVOGEN INC
    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE
    EXEMESTANE, EXEMESTANE
    MACROBID, NITROFURANTOIN
    MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE
    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN
    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
    PRIMAQUINE PHOSPHATE, PRIMAQUINE PHOSPHATE
ALVOGEN PINE BROOK
* ALVOGEN PINE BROOK INC
    DISULFIRAM , DISULFIRAM
AM ANTIBIOTICS
* AMERICAN ANTIBIOTICS INC
    AMOXICILLIN, AMOXICILLIN
AMAG PHARMS INC
* AMAG PHARMACEUTICALS INC
    FERAHEME, FERUMOXYTOL
AMARIN PHARMS
* AMARIN PHARMACEUTICALS IRELAND LTD
    VASCEPA, ICOSAPENT ETHYL
AMEDRA PHARMS
* AMEDRA PHARMACEUTICALS LLC
    ADRENACLICK, EPINEPHRINE
    ALBENZA, ALBENDAZOLE
    DARAPRIM, PYRIMETHAMINE
    DEXEDRINE, DEXTROAMPHETAMINE SULFATE
    HYDROCORTISONE, HYDROCORTISONE
    TWINJECT 0.15, EPINEPHRINE
    TWINJECT 0.3, EPINEPHRINE
AMEDRA PHARMS LLC
* AMEDRA PHARMACEUTICALS LLC
    MEBENDAZOLE, MEBENDAZOLE
AMERIGEN PHARMS LTD
* AMERIGEN PHARMACEUTICALS LTD
    CARBIDOPA, CARBIDOPA
AMGEN
* AMGEN INC
    SENSIPAR, CINACALCET HYDROCHLORIDE
AMNEAL PHARM
* AMNEAL PHARMACEUTICAL
    ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE
    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE
    DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE
    FLECAINIDE ACETATE, FLECAINIDE ACETATE
    FOLIC ACID, FOLIC ACID
    GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE
    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE
    PRIMIDONE, PRIMIDONE
AMNEAL PHARMS
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 12


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AMNEAL PHARMACEUTICALS

    ACYCLOVIR, ACYCLOVIR

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ATOVAQUONE, ATOVAQUONE

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE , BUPRENORPHINE HYDROCHLORIDE

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    CALCIUM ACETATE, CALCIUM ACETATE

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE     (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE     (OTC)

    CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE

    CLOPIDOGREL, CLOPIDOGREL

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FELBAMATE, FELBAMATE

    GABAPENTIN, GABAPENTIN

    IBUPROFEN, IBUPROFEN    (OTC)

    INDOMETHACIN, INDOMETHACIN

    LEVETIRACETAM, LEVETIRACETAM

    LORAZEPAM, LORAZEPAM

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    METAXALONE, METAXALONE

    NITROFURANTOIN, NITROFURANTOIN

    NIZATIDINE, NIZATIDINE

    NORETHINDRONE ACETATE, NORETHINDRONE ACETATE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXCARBAZEPINE, OXCARBAZEPINE

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    SPIRONOLACTONE, SPIRONOLACTONE

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    WARFARIN SODIUM, WARFARIN SODIUM

*	 AMNEAL PHARMACEUTICALS LLC

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

*	 AMNEAL PHARMACEUTICALS OF NEW YORK LLC

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

    NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

AMNEAL PHARMS CO

*	 AMNEAL PHARMACEUTICALS CO GMBH

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

AMNEAL PHARMS LLC

*	 AMNEAL PHARMACEUTICALS LLC

    ACTIVELLA, ESTRADIOL

    AZATHIOPRINE, AZATHIOPRINE

AMNEAL PHARMS NY

*	 AMNEAL PHARMACEUTICALS NY LLC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    ALPRAZOLAM, ALPRAZOLAM

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

    GABAPENTIN, GABAPENTIN

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 13


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AMNEAL PHARMACEUTICALS NY LLC

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    NAPROXEN SODIUM, NAPROXEN SODIUM

    NAPROXEN SODIUM, NAPROXEN SODIUM    (OTC)

    NAPROXEN, NAPROXEN

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    REPREXAIN, HYDROCODONE BITARTRATE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

AMPHASTAR PHARM

*	 AMPHASTAR PHARMACEUTICAL INC

    AMPHADASE, HYALURONIDASE

    ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM

AMPHASTAR PHARMS INC

*	 AMPHASTAR PHARMACEUTICALS INC

    CORTROSYN, COSYNTROPIN

AMPOLGEN

*	 AMPOLGEN PHARMACEUTICALS LLC

    SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE

ANACOR PHARMS INC

*	 ANACOR PHARMACEUTICALS INC

    KERYDIN, TAVABOROLE

ANBEX

*	 ANBEX INC

    IOSAT, POTASSIUM IODIDE     (OTC)

ANCHEN PHARMS

*	 ANCHEN PHARMACEUTICALS INC

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CLONIDINE HYDROCHLORIDE , CLONIDINE HYDROCHLORIDE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE, DUTASTERIDE

    FENOFIBRIC ACID, CHOLINE FENOFIBRATE

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRETINOIN, TRETINOIN

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

*	 ANCHEN PHARMACEUTICALS TAIWAN INC

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

*	 ANCHEN PHARMACEUTICALS, INC

    ALPRAZOLAM, ALPRAZOLAM

    CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

ANDRX LABS LLC

*	 ANDRX LABS LLC

    ALTOPREV, LOVASTATIN

    FORTAMET, METFORMIN HYDROCHLORIDE

ANGELINI PHARMA

*	 ANGELINI PHARMA INC

    OLEPTRO, TRAZODONE HYDROCHLORIDE

ANI PHARMS

*	 ANI PHARMACEUTICALS INC

    CORTENEMA, HYDROCORTISONE

    LACTULOSE, LACTULOSE

    LUVOX, FLUVOXAMINE MALEATE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    REGLAN, METOCLOPRAMIDE HYDROCHLORIDE

ANI PHARMS INC

* ANI PHARMACEUTICALS INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 14


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ANI PHARMACEUTICALS INC

    ALPRAZOLAM, ALPRAZOLAM

    CHLORPROPAMIDE, CHLORPROPAMIDE

    CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE

    ETODOLAC, ETODOLAC

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    GUANABENZ ACETATE, GUANABENZ ACETATE

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    LITHOBID, LITHIUM CARBONATE

    METHAZOLAMIDE, METHAZOLAMIDE

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    NIZATIDINE, NIZATIDINE

    PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE

    PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    VALPROIC ACID, VALPROIC ACID

    VANCOCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

ANTARES PHARMA INC

*	 ANTARES PHARMA INC

    OTREXUP, METHOTREXATE

ANTIBIOTICE

*	 ANTIBIOTICE SA

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

    NAFCILLIN SODIUM, NAFCILLIN SODIUM

ANTIBIOTICOS BRASIL

*	 ANTIBIOTICOS DO BRASIL LTDA

    CEFOXITIN, CEFOXITIN SODIUM

APGDI

*	 ASTELLAS PHARMA GLOBAL DEVELOPMENT INC

    MYRBETRIQ, MIRABEGRON

APOPHARMA INC

*	 APOPHARMA INC

    FERRIPROX, DEFERIPRONE

APOTEX

*	 APOTEX CORP

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

*	 APOTEX INC

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    CAPTOPRIL, CAPTOPRIL

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CEFUROXIME AXETIL, CEFUROXIME AXETIL

    CIMETIDINE, CIMETIDINE

    CIMETIDINE, CIMETIDINE    (OTC)

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CYCLOSPORINE, CYCLOSPORINE

    DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM

    DILT-CD, DILTIAZEM HYDROCHLORIDE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

    ENALAPRIL MALEATE, ENALAPRIL MALEATE

    EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE

    EPLERENONE, EPLERENONE

    ETODOLAC, ETODOLAC

    FAMCICLOVIR, FAMCICLOVIR

    FAMOTIDINE, FAMOTIDINE

    FLUCONAZOLE, FLUCONAZOLE

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    GEMFIBROZIL, GEMFIBROZIL

    GLIPIZIDE, GLIPIZIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LAMIVUDINE, LAMIVUDINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		             B - 15


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 APOTEX INC

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    OMEPRAZOLE, OMEPRAZOLE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PENTOXIFYLLINE, PENTOXIFYLLINE

    PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE

    RAMIPRIL, RAMIPRIL

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

    TAMOXIFEN CITRATE, TAMOXIFEN CITRATE

    TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE

    TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

    TROSPIUM CHLORIDE, TROSPIUM CHLORIDE

APOTEX CORP

*	 APOTEX CORP

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AZITHROMYCIN, AZITHROMYCIN

    CABERGOLINE, CABERGOLINE

    CLARITHROMYCIN, CLARITHROMYCIN

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    RILUZOLE, RILUZOLE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    TOLTERODINE TARTRATE, TOLTERODINE TARTRATE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

    ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE

APOTEX INC

*	 APOTEX INC

    ABACAVIR SULFATE, ABACAVIR SULFATE

    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

    ALPRAZOLAM, ALPRAZOLAM

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    ANASTROZOLE, ANASTROZOLE

    ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

    BIMATOPROST, BIMATOPROST

    BROMFENAC SODIUM, BROMFENAC SODIUM

    CALCITONIN-SALMON, CALCITONIN SALMON

    CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL

    CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL

    CARBAMAZEPINE, CARBAMAZEPINE

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CEFPROZIL, CEFPROZIL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CEVIMELINE, CEVIMELINE HYDROCHLORIDE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FENOFIBRATE (MICRONIZED), FENOFIBRATE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    IMIQUIMOD, IMIQUIMOD

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST   B - 16

              APPENDIX B     -   PRODUCT NAME SORTED BY APPLICANT
                                        **   A   **
* APOTEX INC
   IRBESARTAN, IRBESARTAN
   LAMIVUDINE, LAMIVUDINE
   LAMOTRIGINE, LAMOTRIGINE
   LETROZOLE, LETROZOLE
   LEVETIRACETAM, LEVETIRACETAM
   LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE
   LEVOFLOXACIN, LEVOFLOXACIN
   LOVASTATIN, LOVASTATIN
   MILRINONE LACTATE IN DEXTROSE 5%, MILRINONE LACTATE
   MODAFINIL, MODAFINIL
   MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE
   MONTELUKAST SODIUM, MONTELUKAST SODIUM
   MYCOPHENOLIC ACID, MYCOPHENOLIC ACID
   NABUMETONE, NABUMETONE
   NEVIRAPINE, NEVIRAPINE
   OFLOXACIN, OFLOXACIN
   OLANZAPINE, OLANZAPINE
   OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE
   OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS
   OXCARBAZEPINE, OXCARBAZEPINE
   PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
   PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
   QUETIAPINE FUMARATE, QUETIAPINE FUMARATE
   RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE   (OTC)
   RASAGILINE MESYLATE, RASAGILINE MESYLATE
   RISEDRONATE SODIUM, RISEDRONATE SODIUM
   RISPERIDONE, RISPERIDONE
   RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE
   RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE
   SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
   SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
   TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE
   TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN
   TRANEXAMIC ACID, TRANEXAMIC ACID
   TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
   TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
   VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
   VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
   ZOLMITRIPTAN, ZOLMITRIPTAN
   ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
* APOTEX INC ETOBICOKE SITE
   ACYCLOVIR, ACYCLOVIR
   ALLOPURINOL, ALLOPURINOL
   BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM
   BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE
   BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE
   CARBAMAZEPINE, CARBAMAZEPINE
   CARVEDILOL, CARVEDILOL
   CILOSTAZOL, CILOSTAZOL
   CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE
   DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE
   DILTZAC, DILTIAZEM HYDROCHLORIDE
   ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE
   ETODOLAC, ETODOLAC
   FOSINOPRIL SODIUM, FOSINOPRIL SODIUM
   GABAPENTIN, GABAPENTIN
   LEFLUNOMIDE, LEFLUNOMIDE
   LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
   LISINOPRIL, LISINOPRIL
   LORATADINE, LORATADINE    (OTC)
   MELOXICAM, MELOXICAM
   MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE
   MIRTAZAPINE, MIRTAZAPINE
   OXAPROZIN, OXAPROZIN
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		      B - 17


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 APOTEX INC ETOBICOKE SITE

    SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

    TORSEMIDE, TORSEMIDE

    ZONISAMIDE, ZONISAMIDE

*	 APOTEX INC RICHMOND HILL

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

    BUDESONIDE, BUDESONIDE

    DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

    FLUNISOLIDE, FLUNISOLIDE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    RISPERIDONE, RISPERIDONE

*	 APOTEX INC.

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

APOTEX TECHNOLOGIES

*	 APOTEX TECHNOLOGIES INC

    PAXIL CR, PAROXETINE HYDROCHLORIDE

    PAXIL, PAROXETINE HYDROCHLORIDE

APOTHECON

*	 APOTHECON INC DIV BRISTOL MYERS SQUIBB

    KENALOG-10, TRIAMCINOLONE ACETONIDE

    KENALOG-40, TRIAMCINOLONE ACETONIDE

APP PHARMS

*	 APP PHARMACEUTICALS LLC

    DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

APTALIS PHARMA US

*	 APTALIS PHARMA US INC

    BENTYL, DICYCLOMINE HYDROCHLORIDE

APTALIS PHARMATECH

*	 APTALIS PHARMATECH INC

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

AQUA PHARMS

*	 AQUA PHARMACEUTICALS

    CORDRAN SP, FLURANDRENOLIDE

    CORDRAN, FLURANDRENOLIDE

    MONODOX, DOXYCYCLINE

    VERDESO, DESONIDE

*	 AQUA PHARMACEUTICALS LLC

    FLUOROPLEX, FLUOROURACIL

    XOLEGEL, KETOCONAZOLE

AQUA PHARMS LLC

*	 AQUA PHARMACEUTICALS LLC

    ACTICLATE, DOXYCYCLINE HYCLATE

ARBOR PHARMS IRELAND

*	 ARBOR PHARMACEUTICALS IRELAND LTD

    EDARBI, AZILSARTAN KAMEDOXOMIL

    EDARBYCLOR, AZILSARTAN KAMEDOXOMIL

ARBOR PHARMS LLC

*	 ARBOR PHARMACEUTICALS LLC

    AMPHETAMINE SULFATE, AMPHETAMINE SULFATE

    BIDIL, HYDRALAZINE HYDROCHLORIDE

    E.E.S. 200, ERYTHROMYCIN ETHYLSUCCINATE

    E.E.S. 400, ERYTHROMYCIN ETHYLSUCCINATE

    E.E.S., ERYTHROMYCIN ETHYLSUCCINATE

    ERY-TAB, ERYTHROMYCIN

    ERYPED, ERYTHROMYCIN ETHYLSUCCINATE

    ERYTHROCIN STEARATE, ERYTHROMYCIN STEARATE

    ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE

    ERYTHROMYCIN, ERYTHROMYCIN

    GLIADEL, CARMUSTINE

    NYMALIZE, NIMODIPINE

    PCE, ERYTHROMYCIN

    PEDIAMYCIN 400, ERYTHROMYCIN ETHYLSUCCINATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 18


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ARBOR PHARMACEUTICALS LLC

    PEDIAMYCIN, ERYTHROMYCIN ETHYLSUCCINATE

    SOTYLIZE, SOTALOL HYDROCHLORIDE

ARCO PHARMS LLC

*	 ARCO PHARMACEUTICALS LLC

    THYROSHIELD, POTASSIUM IODIDE    (OTC)

AREVA PHARMS

*	 AREVA PHARMACEUTICALS INC

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

ARIAD

*	 ARIAD PHARMACEUTICALS INC

    ICLUSIG, PONATINIB HYDROCHLORIDE

ASCEND THERAPS US

*	 ASCEND THERAPEUTICS US LLC

    ESTROGEL, ESTRADIOL

ASPEN GLOBAL

*	 ASPEN GLOBAL INC

    MYLERAN, BUSULFAN

ASPEN GLOBAL INC

*	 ASPEN GLOBAL INC

    LEUKERAN, CHLORAMBUCIL

    THIOGUANINE, THIOGUANINE

ASTELLAS

*	 ASTELLAS PHARMA US INC

    ADENOCARD, ADENOSINE

    ADENOSCAN, ADENOSINE

    AMBISOME, AMPHOTERICIN B

    ASTAGRAF XL, TACROLIMUS

    LEXISCAN, REGADENOSON

    MYCAMINE, MICAFUNGIN SODIUM

    PROGRAF, TACROLIMUS

    PROTOPIC, TACROLIMUS

    VESICARE, SOLIFENACIN SUCCINATE

    XTANDI, ENZALUTAMIDE

ASTRAZENECA

*	 ASTRAZENECA LP

    ENTOCORT EC, BUDESONIDE

    PULMICORT FLEXHALER, BUDESONIDE

    SEROQUEL, QUETIAPINE FUMARATE

    SYMBICORT, BUDESONIDE

    TENORMIN, ATENOLOL

*	 ASTRAZENECA PHARMACEUTICALS LP

    ATACAND HCT, CANDESARTAN CILEXETIL

    ATACAND, CANDESARTAN CILEXETIL

    FASLODEX, FULVESTRANT

    PLENDIL, FELODIPINE

    SEROQUEL XR, QUETIAPINE FUMARATE

    TENORETIC 100, ATENOLOL

    TENORETIC 50, ATENOLOL

    ZOMIG, ZOLMITRIPTAN

    ZOMIG-ZMT, ZOLMITRIPTAN

*	 ASTRAZENECA UK LTD

    ACCOLATE, ZAFIRLUKAST

    ARIMIDEX, ANASTROZOLE

    CASODEX, BICALUTAMIDE

    MERREM, MEROPENEM

    ZESTORETIC, HYDROCHLOROTHIAZIDE

    ZESTRIL, LISINOPRIL

    ZOLADEX, GOSERELIN ACETATE

ASTRAZENECA AB

*	 ASTRAZENECA AB

    BYDUREON, EXENATIDE SYNTHETIC

    BYETTA, EXENATIDE SYNTHETIC

    FARXIGA, DAPAGLIFLOZIN

    KOMBIGLYZE XR, METFORMIN HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 19


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 ASTRAZENECA AB

    ONGLYZA, SAXAGLIPTIN HYDROCHLORIDE

    SYMLIN, PRAMLINTIDE ACETATE

    XIGDUO XR, DAPAGLIFLOZIN

ASTRAZENECA LP

*	 ASTRAZENECA LP

    BRILINTA, TICAGRELOR

    NEXIUM 24HR, ESOMEPRAZOLE MAGNESIUM    (OTC)

ASTRAZENECA PHARMS

*	 ASTRAZENECA PHARMACEUTICALS LP

    EPANOVA, OMEGA-3-CARBOXYLIC ACIDS

    MOVANTIK, NALOXEGOL OXALATE

    NEXIUM IV, ESOMEPRAZOLE SODIUM

    NEXIUM, ESOMEPRAZOLE MAGNESIUM

    OLAPARIB, OLAPARIB

    PRILOSEC OTC, OMEPRAZOLE MAGNESIUM    (OTC)

    PRILOSEC, OMEPRAZOLE

    PRILOSEC, OMEPRAZOLE MAGNESIUM

    PULMICORT RESPULES, BUDESONIDE

    RHINOCORT, BUDESONIDE

    TOPROL-XL, METOPROLOL SUCCINATE

ATLAS PHARMS LLC

*	 ATLAS PHARMACEUTICALS LLC

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

ATON

*	 ATON PHARMA INC

    CUPRIMINE, PENICILLAMINE

    EDECRIN, ETHACRYNATE SODIUM

    EDECRIN, ETHACRYNIC ACID

    LACRISERT, HYDROXYPROPYL CELLULOSE

    LODOSYN, CARBIDOPA

    SYPRINE, TRIENTINE HYDROCHLORIDE

    TIMOPTIC IN OCUDOSE, TIMOLOL MALEATE

    TIMOPTIC, TIMOLOL MALEATE

ATON PHARMA VPNA

*	 ATON PHARMA DIV VALEANT PHARMACEUTICALS NORTH AMERICA LLC

    DEMSER, METYROSINE

AUROBINDO

*	 AUROBINDO PHARMA LTD

    AMOXICILLIN, AMOXICILLIN

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLARITHROMYCIN, CLARITHROMYCIN

    DIDANOSINE, DIDANOSINE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    MIRTAZAPINE, MIRTAZAPINE

    NEVIRAPINE, NEVIRAPINE

    ZIDOVUDINE, ZIDOVUDINE

AUROBINDO PHARM

*	 AUROBINDO PHARMA USA INC

    FLUCONAZOLE, FLUCONAZOLE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    GABAPENTIN, GABAPENTIN

    LEVETIRACETAM, LEVETIRACETAM

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

AUROBINDO PHARMA

*	 AUROBINDO PHARMA

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

*	 AUROBINDO PHARMA LTD

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 20


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AUROBINDO PHARMA LTD

    ATENOLOL, ATENOLOL

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BISOPROLOL FUMARATE, BISOPROLOL FUMARATE

    CARISOPRODOL, CARISOPRODOL

    CARVEDILOL, CARVEDILOL

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CEFDINIR, CEFDINIR

    CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL

    CEFPROZIL, CEFPROZIL

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DIDANOSINE, DIDANOSINE

    FINASTERIDE, FINASTERIDE

    FLUCONAZOLE, FLUCONAZOLE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

    GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE

    GLYBURIDE, GLYBURIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MELOXICAM, MELOXICAM

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON, ONDANSETRON

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM

    PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE

    QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    RIBAVARIN, RIBAVIRIN

    RIBAVIRIN, RIBAVIRIN

    RISPERIDONE, RISPERIDONE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SIMVASTATIN, SIMVASTATIN

    STAVUDINE, STAVUDINE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

    TORSEMIDE, TORSEMIDE

    TRANDOLAPRIL, TRANDOLAPRIL

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    ZALEPLON, ZALEPLON

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

AUROBINDO PHARMA LTD

*	 AUROBINDO PHARMA LIMITED

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    FOSINOPRIL SODIUM, FOSINOPRIL SODIUM

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    LEVOFLOXACIN, LEVOFLOXACIN

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

*	 AUROBINDO PHARMA LTD

    ABACAVIR SULFATE, ABACAVIR SULFATE

    ACYCLOVIR SODIUM, ACYCLOVIR SODIUM

    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 21


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AUROBINDO PHARMA LTD

    AMOXICILLIN, AMOXICILLIN

    BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

    CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL

    CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FAMCICLOVIR, FAMCICLOVIR

    FELODIPINE, FELODIPINE

    FINASTERIDE, FINASTERIDE

    GABAPENTIN, GABAPENTIN

    GLIMEPIRIDE, GLIMEPIRIDE

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE

    LAMIVUDINE, LAMIVUDINE

    LEVOFLOXACIN, LEVOFLOXACIN

    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MODAFINIL, MODAFINIL

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE

    NAFCILLIN SODIUM, NAFCILLIN SODIUM

    NAPROXEN SODIUM, NAPROXEN SODIUM

    OLANZAPINE, OLANZAPINE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXACILLIN SODIUM, OXACILLIN SODIUM

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RAMIPRIL, RAMIPRIL

    REPAGLINIDE, REPAGLINIDE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    VALSARTAN, VALSARTAN

*	 AUROBINDO PHARMA LTD INC

    CEFPROZIL, CEFPROZIL

    CEFUROXIME AXETIL, CEFUROXIME AXETIL

    CEPHALEXIN, CEPHALEXIN

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    MIRTAZAPINE, MIRTAZAPINE

    ZIDOVUDINE, ZIDOVUDINE

AUROBINDO PHARMA USA

*	 AUROBINDO PHARMA USA INC

    ALPRAZOLAM, ALPRAZOLAM

    NAPROXEN, NAPROXEN

AUROLIFE PHARMA LLC

*	 AUROLIFE PHARMA LLC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

    GLYCOPYRROLATE, GLYCOPYRROLATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 22


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   A   **

*	 AUROLIFE PHARMA LLC

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

AUSTARPHARMA LLC

*	 AUSTARPHARMA LLC

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    METHOCARBAMOL, METHOCARBAMOL

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

AUXILIUM PHARMS

*	 AUXILIUM PHARMACEUTICALS INC

    TESTIM, TESTOSTERONE

AUXILIUM PHARMS LLC

*	 AUXILIUM PHARMACEUTICALS LLC

    DILATRATE-SR, ISOSORBIDE DINITRATE

    EDEX, ALPROSTADIL

    ROBAXIN, METHOCARBAMOL

    ROBAXIN-750, METHOCARBAMOL

    SEMPREX-D, ACRIVASTINE

    STRIANT, TESTOSTERONE

AVACOR PRODS

*	 AVACOR PRODUCTS LLC

    MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL    (OTC)

AVANIR PHARMS

*	 AVANIR PHARMACEUTICALS INC

    NUEDEXTA, DEXTROMETHORPHAN HYDROBROMIDE

AVANTHI INC

*	 AVANTHI INC

    CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE    (OTC)

    DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE, DEXBROMPHENIRAMINE MALEATE

    DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE

    INDOMETHACIN, INDOMETHACIN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

AVEMA PHARMA

*	 AVEMA PHARMA SOLUTIONS

    IBUPROFEN, IBUPROFEN     (OTC)

AVENT

*	 AVENT INC

    PYTEST KIT, UREA, C-14

    PYTEST, UREA, C-14

AVEVA

*	 AVEVA DRUG DELIVERY SYSTEMS INC

    CLONIDINE, CLONIDINE

    FENTANYL-100, FENTANYL

    FENTANYL-25, FENTANYL

    FENTANYL-50, FENTANYL

    FENTANYL-75, FENTANYL

    NICOTINE, NICOTINE     (OTC)

AVID RADIOPHARMS INC

*	 AVID RADIOPHARMACEUTICALS INC

    AMYVID, FLORBETAPIR F-18

                                         **   B   **

B BRAUN

*	 B BRAUN MEDICAL INC

    ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL

    ALCOHOL 10% AND DEXTROSE 5%, ALCOHOL

    ALCOHOL 5% AND DEXTROSE 5%, ALCOHOL

    AMINO ACIDS, AMINO ACIDS

    BALANCED SALT, CALCIUM CHLORIDE

    BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, BRETYLIUM TOSYLATE

    CEFAZOLIN AND DEXTROSE, CEFAZOLIN SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 23


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 B BRAUN MEDICAL INC

    CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE

    CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, CEFOTETAN DISODIUM

    CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, CEFOXITIN SODIUM

    CEFTAZIDIME IN DEXTROSE CONTAINER, CEFTAZIDIME

    CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, CEFTRIAXONE SODIUM

    CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CEFUROXIME SODIUM

    DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM

    DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE

    DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%, DOPAMINE HYDROCHLORIDE

    FREAMINE HBC 6.9%, AMINO ACIDS

    FREAMINE III 10%, AMINO ACIDS

    FREAMINE III 3% W/ ELECTROLYTES, AMINO ACIDS

    FREAMINE III 8.5% W/ ELECTROLYTES, AMINO ACIDS

    FREAMINE III 8.5%, AMINO ACIDS

    GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE

    GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE

    HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN

    HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPATAMINE 8%, AMINO ACIDS

    ISOLYTE E IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    ISOLYTE S IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    ISOLYTE S PH 7.4 IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, MANNITOL

    MANNITOL 10%, MANNITOL

    MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL

    MANNITOL 15%, MANNITOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 24


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 B BRAUN MEDICAL INC

    MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 20%, MANNITOL

    MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, MANNITOL

    MANNITOL 5%, MANNITOL

    METRO I.V. IN PLASTIC CONTAINER, METRONIDAZOLE

    MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE

    NEPHRAMINE 5.4%, AMINO ACIDS

    NUTRILIPID 10%, SOYBEAN OIL

    NUTRILIPID 20%, SOYBEAN OIL

    PHYSIOLYTE IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER,

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 25


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 B BRAUN MEDICAL INC

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PROCALAMINE, AMINO ACIDS

    RESECTISOL IN PLASTIC CONTAINER, MANNITOL

    RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE

    SORBITOL 3.3% IN PLASTIC CONTAINER, SORBITOL

    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

    STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION

    THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

    THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

    THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

    THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

    TROPHAMINE 10%, AMINO ACIDS

    TROPHAMINE, AMINO ACIDS

BAJAJ MEDICAL LLC

*	 BAJAJ MECICAL LLC

    DYNA-HEX, CHLORHEXIDINE GLUCONATE    (OTC)

BANNER PHARMACAPS

*	 BANNER PHARMACAPS INC

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    BENZONATATE, BENZONATATE

    CALCITRIOL, CALCITRIOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

    ETHOSUXIMIDE, ETHOSUXIMIDE

    GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE    (OTC)

    IBUPROFEN, IBUPROFEN    (OTC)

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    MIDOL LIQUID GELS, IBUPROFEN    (OTC)

    NAPROXEN SODIUM, NAPROXEN SODIUM    (OTC)

    NIMODIPINE, NIMODIPINE

    PARICALCITOL, PARICALCITOL

    PROGESTERONE, PROGESTERONE

    VALPROIC ACID, VALPROIC ACID

    VITAMIN D, ERGOCALCIFEROL

    ZONISAMIDE, ZONISAMIDE

BARR

*	 BARR LABORATORIES INC

    AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE

    ARANELLE, ETHINYL ESTRADIOL

    ASPIRIN AND DIPYRIDAMOLE, ASPIRIN

    BALZIVA-28, ETHINYL ESTRADIOL

    BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    CAMILA, NORETHINDRONE

    CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE

    CHLORZOXAZONE, CHLORZOXAZONE

    CLONAZEPAM, CLONAZEPAM

    CLONIDINE, CLONIDINE

    DANAZOL, DANAZOL

    DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    DIAZEPAM, DIAZEPAM

    DIDANOSINE, DIDANOSINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                    B - 26


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BARR LABORATORIES INC

    DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE

    DUTASTERIDE, DUTASTERIDE

    ERRIN, NORETHINDRONE

    ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYTHROMYCIN ETHYLSUCCINATE

    ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL

    ESTRADIOL AND NORGESTIMATE, ESTRADIOL

    ESTROPIPATE, ESTROPIPATE

    ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE

    FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE

    FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

    FLECAINIDE ACETATE, FLECAINIDE ACETATE

    FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    HYDROXYUREA, HYDROXYUREA

    HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE

    ISONIAZID, ISONIAZID

    JUNEL 1.5/30, ETHINYL ESTRADIOL

    JUNEL 1/20, ETHINYL ESTRADIOL

    JUNEL FE 1.5/30, ETHINYL ESTRADIOL

    JUNEL FE 1/20, ETHINYL ESTRADIOL

    KARIVA, DESOGESTREL

    KELNOR, ETHINYL ESTRADIOL

    LEFLUNOMIDE, LEFLUNOMIDE

    LESSINA-28, ETHINYL ESTRADIOL

    MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE

    MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE

    MEGESTROL ACETATE, MEGESTROL ACETATE

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE

    NIACIN, NIACIN

    NORETHINDRONE ACETATE, NORETHINDRONE ACETATE

    NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

    NORTREL 0.5/35-28, ETHINYL ESTRADIOL

    NORTREL 1/35-21, ETHINYL ESTRADIOL

    NORTREL 1/35-28, ETHINYL ESTRADIOL

    NORTREL 7/7/7, ETHINYL ESTRADIOL

    ONDANSETRON, ONDANSETRON

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PORTIA-28, ETHINYL ESTRADIOL

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    SPRINTEC, ETHINYL ESTRADIOL

    TEMOZOLOMIDE, TEMOZOLOMIDE

    TREXALL, METHOTREXATE SODIUM

    TRI-LEGEST 21, ETHINYL ESTRADIOL

    TRI-LEGEST FE, ETHINYL ESTRADIOL

    TRI-SPRINTEC, ETHINYL ESTRADIOL

    WARFARIN SODIUM, WARFARIN SODIUM

*	 BARR PHARMACEUTICALS

    LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM

BARR LABS DIV TEVA

*	 BARR LABORATORIES INC SUB TEVA PHARMACEUTICALS USA

    ACAMPROSATE CALCIUM, ACAMPROSATE CALCIUM

    BUDESONIDE, BUDESONIDE

    OXYBUTYNIN, OXYBUTYNIN

BARR LABS INC

* BARR LABORATORIES INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 27


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BARR LABORATORIES INC

    ACITRETIN, ACITRETIN

    DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

    ESTRADIOL, ESTRADIOL

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    NIMODIPINE, NIMODIPINE

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    OLANZAPINE, OLANZAPINE

    OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN

    TRETINOIN, TRETINOIN

BAUSCH AND LOMB

*	 BAUSCH AND LOMB INC

    ALAWAY, KETOTIFEN FUMARATE    (OTC)

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ALREX, LOTEPREDNOL ETABONATE

    BESIVANCE, BESIFLOXACIN HYDROCHLORIDE

    CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

    FLURBIPROFEN SODIUM, FLURBIPROFEN SODIUM

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

    ISTALOL, TIMOLOL MALEATE

    LATANOPROST, LATANOPROST

    LOTEMAX, LOTEPREDNOL ETABONATE

    MIOCHOL-E, ACETYLCHOLINE CHLORIDE

    OFLOXACIN, OFLOXACIN

    OPCON-A, NAPHAZOLINE HYDROCHLORIDE     (OTC)

    PROLENSA, BROMFENAC SODIUM

    RETISERT, FLUOCINOLONE ACETONIDE

    TIMOLOL MALEATE, TIMOLOL MALEATE

    VITRASE, HYALURONIDASE

    ZIRGAN, GANCICLOVIR

    ZYLET, LOTEPREDNOL ETABONATE

*	 BAUSCH AND LOMB PHARMACEUTICALS INC

    ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE, ACETIC ACID, GLACIAL

    BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC

    BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE

    CROLOM, CROMOLYN SODIUM

    CROMOLYN SODIUM, CROMOLYN SODIUM

    CROMOLYN SODIUM, CROMOLYN SODIUM     (OTC)

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

    DEXASPORIN, DEXAMETHASONE

    ERYTHROMYCIN, ERYTHROMYCIN

    FLUNISOLIDE, FLUNISOLIDE

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

    LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE

    NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC

    NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE

    NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN

    NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE

    NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC

    OFLOXACIN, OFLOXACIN

    OPTIPRANOLOL, METIPRANOLOL HYDROCHLORIDE

    OTICAIR, HYDROCORTISONE

    PENTOLAIR, CYCLOPENTOLATE HYDROCHLORIDE

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE

    SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM

    TIMOLOL MALEATE, TIMOLOL MALEATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 28


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BAUSCH AND LOMB PHARMACEUTICALS INC

    TOBRAMYCIN AND DEXAMETHASONE, DEXAMETHASONE

    TOBRAMYCIN, TOBRAMYCIN

    TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

    TROPICAMIDE, TROPICAMIDE

BAUSCH AND LOMB INC

*	 BAUSCH AND LOMB INC

    BEPREVE, BEPOTASTINE BESILATE

    BROMDAY, BROMFENAC SODIUM

    LOTEMAX, LOTEPREDNOL ETABONATE

BAXTER HLTHCARE

*	 BAXTER HEALTHCARE CORP

    ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL

    AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE

    ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM

    BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM

    BRANCHAMIN 4% IN PLASTIC CONTAINER, AMINO ACIDS

    BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE

    BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE

    BREVIBLOC, ESMOLOL HYDROCHLORIDE

    CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE

    CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM

    CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, AMINO ACIDS

    CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC

    CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC

    CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER,

    CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC

    CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC

    CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC

    CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER,

    CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER,

    CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER,

    CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER,

    CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER,

    CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER,

    CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS

    CLINOLIPID 20%, OLIVE OIL

    CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE

    CYTOXAN (LYOPHILIZED), CYCLOPHOSPHAMIDE

    DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 29


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BAXTER HEALTHCARE CORP

    DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ, DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K), DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K), DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ, DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ, DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ, DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K), DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ, DEXTROSE

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER,

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER,

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER,

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER,

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER,

    DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER,

    DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC

    DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 60% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE

    DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE

    DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE

    ETHRANE, ENFLURANE

    EXTRANEAL, ICODEXTRIN

    FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER, FAMOTIDINE

    FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    FORANE, ISOFLURANE

    HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN

    HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN

    IFEX, IFOSFAMIDE

    ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER, GENTAMICIN SULFATE

    LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    MESNEX, MESNA

    MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE

    NALLPEN IN PLASTIC CONTAINER, NAFCILLIN SODIUM

    NEXTERONE, AMIODARONE HYDROCHLORIDE

    NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN

    OSMITROL 10% IN WATER IN PLASTIC CONTAINER, MANNITOL

    OSMITROL 10% IN WATER, MANNITOL

    OSMITROL 15% IN WATER IN PLASTIC CONTAINER, MANNITOL

    OSMITROL 15% IN WATER, MANNITOL

    OSMITROL 20% IN WATER IN PLASTIC CONTAINER, MANNITOL

    OSMITROL 20% IN WATER, MANNITOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 30


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **
* BAXTER HEALTHCARE CORP
    OSMITROL 5% IN WATER IN PLASTIC CONTAINER, MANNITOL
    OSMITROL 5% IN WATER, MANNITOL
    PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, PENICILLIN G POTASSIUM

    PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    PLASMA-LYTE 56 IN PLASTIC CONTAINER, MAGNESIUM ACETATE TETRAHYDRATE

    PLASMA-LYTE A IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PLASMA-LYTE R IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PREMASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS

    PREMASOL 6% IN PLASTIC CONTAINER, AMINO ACIDS

    RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    SEVOFLURANE, SEVOFLURANE

    SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE

    SORBITOL 3% IN PLASTIC CONTAINER, SORBITOL

    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

    STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION

    STERILE WATER, STERILE WATER FOR IRRIGATION

    SUPRANE, DESFLURANE

    TIS-U-SOL IN PLASTIC CONTAINER, MAGNESIUM SULFATE

    TIS-U-SOL, MAGNESIUM SULFATE

    TRAVASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS

    TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS

    TRAVASOL 5.5% IN PLASTIC CONTAINER, AMINO ACIDS

    TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS

    TRAVASOL 8.5% IN PLASTIC CONTAINER, AMINO ACIDS

    TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS

    VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER, VANCOMYCIN HYDROCHLORIDE

*	 BAXTER HEALTHCARE INTERNATI0NAL SPECIALTY THERAPIES DIV

    PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS

BAXTER HLTHCARE CORP

*	 BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE

    PROTOPAM CHLORIDE, PRALIDOXIME CHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 31


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BAXTER HEALTHCARE CORP ANESTHESIA CRITICAL CARE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    REGLAN, METOCLOPRAMIDE HYDROCHLORIDE

BAYER

*	 BAYER HEALTHCARE LLC

    ALEVE, NAPROXEN SODIUM    (OTC)

    ALEVE-D SINUS & COLD, NAPROXEN SODIUM      (OTC)

    FEMSTAT 3, BUTOCONAZOLE NITRATE     (OTC)

BAYER HEALTHCARE LLC

*	 BAYER HEALTHCARE LLC

    CLARITIN HIVES RELIEF REDITAB, LORATADINE      (OTC)

    CLARITIN HIVES RELIEF, LORATADINE     (OTC)

    CLARITIN REDITABS, LORATADINE     (OTC)

    CLARITIN, LORATADINE    (OTC)

    GYNE-LOTRIMIN 3 COMBINATION PACK, CLOTRIMAZOLE       (OTC)

    GYNE-LOTRIMIN 3, CLOTRIMAZOLE     (OTC)

    MYCELEX-7 COMBINATION PACK, CLOTRIMAZOLE      (OTC)

    MYCELEX-7, CLOTRIMAZOLE    (OTC)

    OXYTROL FOR WOMEN, OXYBUTYNIN     (OTC)

BAYER HLTHCARE

*	 BAYER HEALTHCARE CONSUMER CARE

    ALEVE PM, DIPHENHYDRAMINE HYDROCHLORIDE      (OTC)

*	 BAYER HEALTHCARE PHARMACEUTICALS INC

    ADALAT CC, NIFEDIPINE

    ADEMPAS, RIOCIGUAT

    ANGELIQ, DROSPIRENONE

    AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER, MOXIFLOXACIN HYDROCHLORIDE

    AVELOX, MOXIFLOXACIN HYDROCHLORIDE

    BETAPACE, SOTALOL HYDROCHLORIDE

    BEYAZ, DROSPIRENONE

    BILTRICIDE, PRAZIQUANTEL

    CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

    CIPRO, CIPROFLOXACIN

    CIPRO, CIPROFLOXACIN HYDROCHLORIDE

    CLIMARA PRO, ESTRADIOL

    CLIMARA, ESTRADIOL

    DESONATE, DESONIDE

    DTIC-DOME, DACARBAZINE

    EOVIST, GADOXETATE DISODIUM

    FINACEA, AZELAIC ACID

    GADAVIST, GADOBUTROL

    LEVITRA, VARDENAFIL HYDROCHLORIDE

    MAGNEVIST, GADOPENTETATE DIMEGLUMINE

    MENOSTAR, ESTRADIOL

    MIRENA, LEVONORGESTREL

    NATAZIA, DIENOGEST

    NEXAVAR, SORAFENIB TOSYLATE

    PRECOSE, ACARBOSE

    SAFYRAL, DROSPIRENONE

    SKYLA, LEVONORGESTREL

    STAXYN, VARDENAFIL HYDROCHLORIDE

    STIVARGA, REGORAFENIB

    ULTRAVIST (PHARMACY BULK), IOPROMIDE

    ULTRAVIST 150, IOPROMIDE

    ULTRAVIST 240, IOPROMIDE

    ULTRAVIST 300 IN PLASTIC CONTAINER, IOPROMIDE

    ULTRAVIST 300, IOPROMIDE

    ULTRAVIST 370, IOPROMIDE

    XOFIGO, RADIUM RA-223 DICHLORIDE

    YASMIN, DROSPIRENONE

    YAZ, DROSPIRENONE

BAYSHORE PHARMS LLC

*	 BAYSHORE PHARMACEUTICALS LLC

    METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE

    PRIMAQUINE PHOSPHATE, PRIMAQUINE PHOSPHATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                 B - 32


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

BD RX

*	 BD RX INC

    DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

BECTON DICKINSON

*	 BECTON DICKINSON AND CO

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE    (OTC)

    E-Z SCRUB 201, POVIDONE-IODINE    (OTC)

    E-Z SCRUB 241, POVIDONE-IODINE    (OTC)

BEDFORD

*	 BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC

    ACYCLOVIR SODIUM, ACYCLOVIR SODIUM

    ADENOSINE, ADENOSINE

    BUMETANIDE, BUMETANIDE

    BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE

    BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE

    ENALAPRILAT, ENALAPRILAT

    ETOMIDATE, ETOMIDATE

    FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MILRINONE LACTATE, MILRINONE LACTATE

    MITOMYCIN, MITOMYCIN

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    RIFAMPIN, RIFAMPIN

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

    VALPROATE SODIUM, VALPROATE SODIUM

    VECURONIUM BROMIDE, VECURONIUM BROMIDE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

BEDFORD LABS

*	 BEDFORD LABORATORIES

    DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE

    FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    FLUMAZENIL, FLUMAZENIL

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LORAZEPAM PRESERVATIVE FREE, LORAZEPAM

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

BELCHER PHARMS

*	 BELCHER PHARMACEUTICALS LLC

    CEPHALEXIN, CEPHALEXIN

    DESLORATADINE, DESLORATADINE

BELCHER PHARMS LLC

*	 BELCHER PHARMACEUTICALS LLC

    EPINEPHRINE, EPINEPHRINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 33


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

BEXIMCO USA

*	 BEXIMCO PHARMACEUTICALS USA INC

    CARVEDILOL, CARVEDILOL

BICON PHARM

*	 BICON PHARMACEUTICAL INC

    FOLIC ACID, FOLIC ACID

BIO NUCLEONICS

*	 BIO NUCLEONICS INC

    STRONTIUM CHLORIDE SR-89, STRONTIUM CHLORIDE SR-89

BIO PHARM INC

*	 BIO PHARM INC

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

BIOALLIANCE PHARMA

*	 BIOALLIANCE PHARMA

    ORAVIG, MICONAZOLE

BIOCODEX INC

*	 BIOCODEX INC

    TOTECT, DEXRAZOXANE HYDROCHLORIDE

BIOCRYST

*	 BIOCRYST PHARMACEUTICALS INC

    RAPIVAB, PERAMIVIR

BIODELIVERY SCI INTL

*	 BIODELIVERY SCIENCES INTERNATIONAL INC

    BUNAVAIL, BUPRENORPHINE HYDROCHLORIDE

BIOGEN IDEC INC

*	 BIOGEN IDEC INC

    TECFIDERA, DIMETHYL FUMARATE

BIOKEY

*	 BIOKEY INC

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    CILOSTAZOL, CILOSTAZOL

BIOMARIN PHARM

*	 BIOMARIN PHARMACEUTICAL INC

    KUVAN, SAPROPTERIN DIHYDROCHLORIDE

BIOMEDCL RES FDN

*	 BIOMEDICAL RESEARCH FOUNDATION NORTHWEST LOUISANA

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

BLAIREX

*	 BLAIREX LABORATORIES INC

    BRONCHO SALINE, SODIUM CHLORIDE    (OTC)

BLU CARIBE

*	 BLU CARIBE INC

    GEMFIBROZIL, GEMFIBROZIL

    SIMVASTATIN, SIMVASTATIN

BLU CARIBE INC

*	 BLU CARIBE INC

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

BOEHRINGER INGELHEIM

*	 BOEHRINGER INGELHEIM

    CATAPRES, CLONIDINE HYDROCHLORIDE

    CATAPRES-TTS-1, CLONIDINE

    CATAPRES-TTS-2, CLONIDINE

    CATAPRES-TTS-3, CLONIDINE

    GILOTRIF, AFATINIB DIMALEATE

    MICARDIS HCT, HYDROCHLOROTHIAZIDE

    MICARDIS, TELMISARTAN

    MIRAPEX, PRAMIPEXOLE DIHYDROCHLORIDE

    ZANTAC 150, RANITIDINE HYDROCHLORIDE    (OTC)

    ZANTAC 75, RANITIDINE HYDROCHLORIDE    (OTC)

* BOEHRINGER INGELHEIM PHARMACEUTICALS INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 34


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BOEHRINGER INGELHEIM PHARMACEUTICALS INC

    AGGRENOX, ASPIRIN

    APTIVUS, TIPRANAVIR

    ATROVENT HFA, IPRATROPIUM BROMIDE

    ATROVENT, IPRATROPIUM BROMIDE

    COMBIVENT RESPIMAT, ALBUTEROL SULFATE

    COMBIVENT, ALBUTEROL SULFATE

    FLOMAX, TAMSULOSIN HYDROCHLORIDE

    JARDIANCE, EMPAGLIFLOZIN

    JENTADUETO, LINAGLIPTIN

    MIRAPEX ER, PRAMIPEXOLE DIHYDROCHLORIDE

    MOBIC, MELOXICAM

    OFEV, NINTEDANIB

    PERSANTINE, DIPYRIDAMOLE

    PRADAXA, DABIGATRAN ETEXILATE MESYLATE

    SPIRIVA RESPIMAT, TIOTROPIUM BROMIDE

    SPIRIVA, TIOTROPIUM BROMIDE

    STRIVERDI RESPIMAT, OLODATEROL HYDROCHLORIDE

    TRADJENTA, LINAGLIPTIN

    TWYNSTA, AMLODIPINE BESYLATE

    VIRAMUNE XR, NEVIRAPINE

    VIRAMUNE, NEVIRAPINE

BRACCO

*	 BRACCO DIAGNOSTICS INC

    CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82

    CHOLETEC, TECHNETIUM TC-99M MEBROFENIN KIT

    CHOLOGRAFIN MEGLUMINE, IODIPAMIDE MEGLUMINE

    CYSTOGRAFIN DILUTE, DIATRIZOATE MEGLUMINE

    CYSTOGRAFIN, DIATRIZOATE MEGLUMINE

    GASTROGRAFIN, DIATRIZOATE MEGLUMINE

    ISOVUE-200, IOPAMIDOL

    ISOVUE-250, IOPAMIDOL

    ISOVUE-300, IOPAMIDOL

    ISOVUE-370, IOPAMIDOL

    ISOVUE-M 200, IOPAMIDOL

    ISOVUE-M 300, IOPAMIDOL

    KINEVAC, SINCALIDE

    LUMASON, SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

    MDP-BRACCO, TECHNETIUM TC-99M MEDRONATE KIT

    MULTIHANCE MULTIPACK, GADOBENATE DIMEGLUMINE

    MULTIHANCE, GADOBENATE DIMEGLUMINE

    PROHANCE MULTIPACK, GADOTERIDOL

    PROHANCE, GADOTERIDOL

    RENOGRAFIN-76, DIATRIZOATE MEGLUMINE

    SINOGRAFIN, DIATRIZOATE MEGLUMINE

BRAINTREE

*	 BRAINTREE LABORATORIES INC

    AXID, NIZATIDINE

    GOLYTELY, POLYETHYLENE GLYCOL 3350

    NULYTELY, POLYETHYLENE GLYCOL 3350

    NULYTELY-FLAVORED, POLYETHYLENE GLYCOL 3350

BRAINTREE LABS

*	 BRAINTREE LABORATORIES INC

    SUCLEAR, MAGNESIUM SULFATE

    SUPREP BOWEL PREP KIT, MAGNESIUM SULFATE ANHYDROUS

BRECKENRIDGE PHARM

*	 BRECKENRIDGE PHARMACEUTICAL INC

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CILOSTAZOL, CILOSTAZOL

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE

    ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL

    LEVETIRACETAM, LEVETIRACETAM

    MEFENAMIC ACID, MEFENAMIC ACID

    MELOXICAM, MELOXICAM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		     B - 35


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   B   **

*	 BRECKENRIDGE PHARMACEUTICAL INC

    METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE

    OXCARBAZEPINE, OXCARBAZEPINE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

BRIGHAM WOMENS

*	 BRIGHAM AND WOMENS HOSP

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

BRIGHAM WOMENS HOSP

*	 BRIGHAM AND WOMENS HOSP INC

    AMMONIA N 13, AMMONIA N-13

BRISTOL MYERS SQUIBB

*	 BRISTOL MYERS SQUIBB

    AZACTAM, AZTREONAM

    BARACLUDE, ENTECAVIR

    GLUCOVANCE, GLYBURIDE

    LYSODREN, MITOTANE

    MEGACE, MEGESTROL ACETATE

    PRAVACHOL, PRAVASTATIN SODIUM

*	 BRISTOL MYERS SQUIBB CO

    AZACTAM IN PLASTIC CONTAINER, AZTREONAM

    DROXIA, HYDROXYUREA

    GLUCOPHAGE XR, METFORMIN HYDROCHLORIDE

    HYDREA, HYDROXYUREA

    IXEMPRA KIT, IXABEPILONE

    REYATAZ, ATAZANAVIR SULFATE

    SPRYCEL, DASATINIB

    SUSTIVA, EFAVIRENZ

    VIDEX EC, DIDANOSINE

*	 BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE

    ELIQUIS, APIXABAN

    ETOPOPHOS PRESERVATIVE FREE, ETOPOSIDE PHOSPHATE

    GLUCOPHAGE, METFORMIN HYDROCHLORIDE

    VIDEX, DIDANOSINE

    ZERIT, STAVUDINE

*	 BRISTOL MYERS SQUIBB PHARMA CO

    COUMADIN, WARFARIN SODIUM

BRYAN

*	 BRYAN CORP

    SCLEROSOL, TALC

    TALC, TALC

                                         **   C   **

CADENCE PHARMS

*	 CADENCE PHARMACEUTICALS INC

    OFIRMEV, ACETAMINOPHEN

CADILA PHARMS LTD

*	 CADILA PHARMACEUTICALS LTD

    ACYCLOVIR, ACYCLOVIR

    FOLIC ACID, FOLIC ACID

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    OFLOXACIN, OFLOXACIN

CADISTA PHARMS

*	 CADISTA PHARMACEUTICALS INC

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE   (OTC)

    LAMOTRIGINE, LAMOTRIGINE

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    OXCARBAZEPINE, OXCARBAZEPINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 36


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   C   **

CARACO

*	 CARACO PHARMACEUTICAL LABORATORIES LTD

    BACLOFEN, BACLOFEN

    FLUMADINE, RIMANTADINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    SYNALGOS-DC, ASPIRIN

CARDINAL HEALTH 414

*	 CARDINAL HEALTH 414 LLC

    TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT

*	 CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES

    AMMONIA N 13, AMMONIA N-13

CARDINAL HLTH 414

*	 CARDINAL HEALTH 414

    SODIUM IODIDE I 123, SODIUM IODIDE I-123

CAREFUSION

*	 CAREFUSION 213 LLC

    CHLORAPREP ONE-STEP FREPP, CHLORHEXIDINE GLUCONATE     (OTC)

    CHLORAPREP ONE-STEP SEPP, CHLORHEXIDINE GLUCONATE    (OTC)

    CHLORAPREP ONE-STEP, CHLORHEXIDINE GLUCONATE    (OTC)

    CHLORAPREP SINGLE SWABSTICK, CHLORHEXIDINE GLUCONATE     (OTC)

    CHLORAPREP TRIPLE SWABSTICK, CHLORHEXIDINE GLUCONATE     (OTC)

    CHLORAPREP WITH TINT, CHLORHEXIDINE GLUCONATE    (OTC)

    PHARMASEAL SCRUB CARE, CHLORHEXIDINE GLUCONATE    (OTC)

CARLSBAD

*	 CARLSBAD TECHNOLOGY INC

    ACYCLOVIR, ACYCLOVIR

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    FAMOTIDINE, FAMOTIDINE

    GLIMEPIRIDE, GLIMEPIRIDE

    LOVASTATIN, LOVASTATIN

    MELOXICAM, MELOXICAM

    MODAFINIL, MODAFINIL

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

CAROLINA MEDCL

*	 CAROLINA MEDICAL PRODUCTS CO

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    HYDROCORTISONE IN ABSORBASE, HYDROCORTISONE

    ISONIAZID, ISONIAZID

    SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

    SPS, SODIUM POLYSTYRENE SULFONATE

    TRIAMCINOLONE ACETONIDE IN ABSORBASE, TRIAMCINOLONE ACETONIDE

CATALENT

*	 CATALENT PHARMA SOLUTIONS LLC

    VALPROIC ACID, VALPROIC ACID

CEDAR PHARMS

*	 CEDAR PHARMACEUTICALS LLC

    METHIMAZOLE, METHIMAZOLE

    SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

CELGENE

*	 CELGENE CORP

    ISTODAX, ROMIDEPSIN

    POMALYST, POMALIDOMIDE

    REVLIMID, LENALIDOMIDE

    THALOMID, THALIDOMIDE

    VIDAZA, AZACITIDINE

CELGENE CORP

*	 CELGENE CORP

    OTEZLA, APREMILAST

CEPHALON

*	 CEPHALON INC

    ACTIQ, FENTANYL CITRATE

    FENTORA, FENTANYL CITRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 37


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   C   **

*	 CEPHALON INC

    GABITRIL, TIAGABINE HYDROCHLORIDE

    NUVIGIL, ARMODAFINIL

    PROVIGIL, MODAFINIL

    TREANDA, BENDAMUSTINE HYDROCHLORIDE

    TRISENOX, ARSENIC TRIOXIDE

CEREXA

*	 CEREXA INC

    TEFLARO, CEFTAROLINE FOSAMIL

CHARTWELL LIFE SCI

*	 CHARTWELL LIFE SCIENCE LLC

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DOXYCYCLINE, DOXYCYCLINE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

CHATTEM

*	 CHATTEM INC

    SELSUN, SELENIUM SULFIDE

    UNISOM, DOXYLAMINE SUCCINATE    (OTC)

CHEMISCH FBRK KRSSLR

*	 CHEMISCHE FABRIK KREUSSLER & CO. GMBH

    ASCLERA, POLIDOCANOL

CHIESI USA INC

*	 CHIESI USA INC

    BETHKIS, TOBRAMYCIN

    CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

    CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

    CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

    CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE

    CARDENE, NICARDIPINE HYDROCHLORIDE

    CUROSURF, PORACTANT ALFA

    ZYFLO CR, ZILEUTON

    ZYFLO, ZILEUTON

CHILDRENS HOSP MI

*	 CHILDRENS HOSP MICHIGAN

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

CHIRHOCLIN

*	 CHIRHOCLIN INC

    CHIRHOSTIM, SECRETIN SYNTHETIC HUMAN

CIPHER PHARMS INC

*	 CIPHER PHARMACEUTICALS INC

    CONZIP, TRAMADOL HYDROCHLORIDE

    LIPOFEN, FENOFIBRATE

CIPLA

*	 CIPLA LTD

    NEVIRAPINE, NEVIRAPINE

    RISPERIDONE, RISPERIDONE

    ZIDOVUDINE, ZIDOVUDINE

CIPLA LTD

*	 CIPLA LTD

    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ANASTROZOLE, ANASTROZOLE

    CARBOPLATIN, CARBOPLATIN

    CARVEDILOL, CARVEDILOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CICLOPIROX, CICLOPIROX

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    FAMCICLOVIR, FAMCICLOVIR

    FINASTERIDE, FINASTERIDE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 38


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   C   **

*	 CIPLA LTD

    IRBESARTAN, IRBESARTAN

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LAMOTRIGINE, LAMOTRIGINE

    LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE

    LEVOFLOXACIN, LEVOFLOXACIN

    MELOXICAM, MELOXICAM

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    STAVUDINE, STAVUDINE

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    ZALEPLON, ZALEPLON

    ZIDOVUDINE, ZIDOVUDINE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

CITIUS PHARMS

*	 CITIUS PHARMACEUTICALS LLC

    SUPRENZA, PHENTERMINE HYDROCHLORIDE

CITRON PHARMA LLC

*	 CITRON PHARMA LLC

    CORTISPORIN, HYDROCORTISONE

    THALITONE, CHLORTHALIDONE

CLARIS LIFESCIENCES

*	 CLARIS LIFESCIENCES LIMITED

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

*	 CLARIS LIFESCIENCES LTD

    CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

    CIPROFLOXACIN, CIPROFLOXACIN

    FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

    FUROSEMIDE, FUROSEMIDE

    LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN

    LEVOFLOXACIN, LEVOFLOXACIN

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE

    NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE

CLINIGEN HLTHCARE

*	 CLINIGEN HEALTHCARE LTD

    ETHYOL, AMIFOSTINE

    FOSCAVIR, FOSCARNET SODIUM

CLOVER PHARMS

*	 CLOVER PHARMACEUTICALS CORP

    AMICAR, AMINOCAPROIC ACID

CNTY LINE PHARMS

*	 COUNTY LINE PHARMACEUTICALS LLC

    DYNACIN, MINOCYCLINE HYDROCHLORIDE

    LIDEX, FLUOCINONIDE

    LOPROX, CICLOPIROX

    TRANDATE, LABETALOL HYDROCHLORIDE

    UREX, METHENAMINE HIPPURATE

COASTAL PHARMS

*	 COASTAL PHARMACEUTICALS

    BROMFENAC SODIUM, BROMFENAC SODIUM

    LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM

    METHAMPHETAMINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE

    NYSTATIN, NYSTATIN

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE AND ASPIRIN, ASPIRIN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

COLGATE

* COLGATE ORAL PHARMACEUTICALS INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                    B - 39


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   C   **

*	 COLGATE ORAL PHARMACEUTICALS INC

    PERIOGARD, CHLORHEXIDINE GLUCONATE

COLGATE PALMOLIVE

*	 COLGATE PALMOLIVE

    COLGATE TOTAL, SODIUM FLUORIDE    (OTC)

CONCORDIA LABS INC

*	 CONCORDIA LABORATORIES INC

    PHOTOFRIN, PORFIMER SODIUM

CONCORDIA PHARMS INC

*	 CONCORDIA PHARMACEUTICALS INC

    KAPVAY, CLONIDINE HYDROCHLORIDE

    ORAPRED ODT, PREDNISOLONE SODIUM PHOSPHATE

    ORAPRED, PREDNISOLONE SODIUM PHOSPHATE

CONTRACT PHARMACAL

*	 CONTRACT PHARMACAL CORP

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CIMETIDINE, CIMETIDINE     (OTC)

    FOLIC ACID, FOLIC ACID

    IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN    (OTC)

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN     (OTC)

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    NAPROXEN SODIUM, NAPROXEN SODIUM    (OTC)

    PREDNISONE, PREDNISONE

    PROFEN, IBUPROFEN    (OTC)

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

CORCEPT THERAP

*	 CORCEPT THERAPEUTICS INC

    KORLYM, MIFEPRISTONE

CORDEN PHARMA

*	 CORDEN PHARMA LATINA SPA

    GLEOSTINE, LOMUSTINE

COREPHARMA

*	 COREPHARMA LLC

    ALPRAZOLAM, ALPRAZOLAM

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE,   AMPHETAMINE

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

    GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE

    GLYBURIDE, GLYBURIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE

    LEVOCARNITINE, LEVOCARNITINE

    METHENAMINE HIPPURATE, METHENAMINE HIPPURATE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    PHENYTOIN, PHENYTOIN

    PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE

    POTASSIUM CITRATE, POTASSIUM CITRATE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    URSODIOL, URSODIOL

COVIS INJECTABLES

*	 COVIS INJECTABLES SARL

    FORTAZ IN PLASTIC CONTAINER, CEFTAZIDIME SODIUM

    FORTAZ, CEFTAZIDIME

    LANOXIN PEDIATRIC, DIGOXIN

    LANOXIN, DIGOXIN

    ZANTAC, RANITIDINE HYDROCHLORIDE

    ZINACEF IN PLASTIC CONTAINER, CEFUROXIME SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 40


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   C   **

*	 COVIS INJECTABLES SARL

    ZINACEF, CEFUROXIME SODIUM

COVIS PHARMA

*	 COVIS PHARMA SARL

    LANOXIN, DIGOXIN

    PARNATE, TRANYLCYPROMINE SULFATE

COVIS PHARMA SARL

*	 COVIS PHARMA SARL

    BETAPACE AF, SOTALOL HYDROCHLORIDE

    DIBENZYLINE, PHENOXYBENZAMINE HYDROCHLORIDE

    DUTOPROL, HYDROCHLOROTHIAZIDE

    DYRENIUM, TRIAMTERENE

    KAYEXALATE, SODIUM POLYSTYRENE SULFONATE

    NILANDRON, NILUTAMIDE

    RILUTEK, RILUZOLE

    UROXATRAL, ALFUZOSIN HYDROCHLORIDE

CPDC

*	 CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

CPPI CV

*	 CP PHARMACEUTICALS INTERNATIONAL CV

    SUTENT, SUNITINIB MALATE

CRANFORD PHARMS LLC

*	 CRANFORD PHARMACEUTICALS LLC

    INDERAL LA, PROPRANOLOL HYDROCHLORIDE

CREALTA PHARMS LLC

*	 CREALTA PHARMACEUTICALS LLC

    MIGERGOT, CAFFEINE

    OXANDRIN, OXANDROLONE

CROWN LABS

*	 CROWN LABORATORIES INC

    ALA-CORT, HYDROCORTISONE

    ALA-SCALP, HYDROCORTISONE

    TRIDERM, TRIAMCINOLONE ACETONIDE

CSL BEHRING

*	 CSL BEHRING LLC

    STIMATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

CSPC OUYI PHARM CO

*	 CSPC OUYI PHARMACEUTICAL CO LTD

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

CUBIST

*	 CUBIST PHARMACEUTICALS INC

    CUBICIN, DAPTOMYCIN

CUBIST PHARMS

*	 CUBIST PHARMACEUTICALS INC

    DIFICID, FIDAXOMICIN

    ENTEREG, ALVIMOPAN

    ZERBAXA, CEFTOLOZANE SULFATE

CUBIST PHARMS INC

*	 CUBIST PHARMACEUTICALS INC

    SIVEXTRO, TEDIZOLID PHOSPHATE

CUMBERLAND PHARMS

*	 CUMBERLAND PHARMACEUTICALS INC

    ACETADOTE, ACETYLCYSTEINE

    CALDOLOR, IBUPROFEN

    LACTULOSE, LACTULOSE

    VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER, CONIVAPTAN HYDROCHLORIDE

CYPRESS BIOSCIENCE

*	 CYPRESS BIOSCIENCE INC

    SAVELLA, MILNACIPRAN HYDROCHLORIDE

CYPRESS PHARM

* CYPRESS PHARMACEUTICAL INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 41


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   C   **

*	 CYPRESS PHARMACEUTICAL INC

    CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    ELIPHOS, CALCIUM ACETATE

    REZIRA, HYDROCODONE BITARTRATE

    VITUZ, CHLORPHENIRAMINE MALEATE

    ZUTRIPRO, CHLORPHENIRAMINE MALEATE

                                         **   D   **

DAIICHI

*	 DAIICHI PHARMACEUTICAL CORP

    FLOXIN OTIC, OFLOXACIN

DAIICHI SANKYO

*	 DAIICHI SANKYO INC

    AZOR, AMLODIPINE BESYLATE

    BENICAR HCT, HYDROCHLOROTHIAZIDE

    BENICAR, OLMESARTAN MEDOXOMIL

    EVOXAC, CEVIMELINE HYDROCHLORIDE

    TRIBENZOR, AMLODIPINE BESYLATE

    WELCHOL, COLESEVELAM HYDROCHLORIDE

DANCO LABS LLC

*	 DANCO LABORATORIES LLC

    MIFEPREX, MIFEPRISTONE

DARA BIOSCIENCES

*	 DARA BIOSCIENCES INC

    SOLTAMOX, TAMOXIFEN CITRATE

DAVA INTL INC

*	 DAVA INTERNATIONAL INC

    ALPRAZOLAM, ALPRAZOLAM

DAVA PHARMS INC

*	 DAVA PHARMACEUTICALS INC

    ACYCLOVIR, ACYCLOVIR

    AMOXICILLIN, AMOXICILLIN

    AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE

    ATENOLOL, ATENOLOL

    CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

    GEMFIBROZIL, GEMFIBROZIL

    GLYBURIDE (MICRONIZED), GLYBURIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    MORPHINE SULFATE, MORPHINE SULFATE

    PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM

    PROPYLTHIOURACIL, PROPYLTHIOURACIL

    PYRAZINAMIDE, PYRAZINAMIDE

    SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE

    VOSPIRE ER, ALBUTEROL SULFATE

DAVIS AND GECK

*	 DAVIS AND GECK DIV AMERICAN CYANAMID CO

    PRE-OP II, HEXACHLOROPHENE

    PRE-OP, HEXACHLOROPHENE

DELCOR ASSET

*	 DELCOR ASSET CORP

    EVOCLIN, CLINDAMYCIN PHOSPHATE

    LUXIQ, BETAMETHASONE VALERATE

    OLUX E, CLOBETASOL PROPIONATE

    OLUX, CLOBETASOL PROPIONATE

    VUSION, MICONAZOLE NITRATE

    ZOVIRAX, ACYCLOVIR

DELCOR ASSET CORP

*	 DELCOR ASSET CORP

    ERYGEL, ERYTHROMYCIN

    EXTINA, KETOCONAZOLE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 42


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   D   **

DENCO ASSET

*	 DENCO ASSET LLC

    DENAVIR, PENCICLOVIR SODIUM

DENTSPLY PHARM

*	 DENTSPLY PHARMACEUTICAL INC

    CITANEST FORTE DENTAL, EPINEPHRINE BITARTRATE

    ORAQIX, LIDOCAINE

DEPOMED INC

*	 DEPOMED INC

    CAMBIA, DICLOFENAC POTASSIUM

    GRALISE, GABAPENTIN

    LAZANDA, FENTANYL CITRATE

    ZIPSOR, DICLOFENAC POTASSIUM

DEPROCO

*	 DEPROCO INC

    LIGNOSPAN FORTE, EPINEPHRINE BITARTRATE

    LIGNOSPAN STANDARD, EPINEPHRINE BITARTRATE

    SCANDONEST L, LEVONORDEFRIN

    SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE

    SEPTOCAINE, ARTICAINE HYDROCHLORIDE

DEXCEL LTD

*	 DEXCEL LTD

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

DEXCEL PHARMA

*	 DEXCEL PHARMA TECHNOLOGIES LTD

    OMEPRAZOLE, OMEPRAZOLE     (OTC)

    PERIOCHIP, CHLORHEXIDINE GLUCONATE

DIALYSIS SUPS

*	 DIALYSIS SUPPLIES INC

    NORMOCARB HF 25, MAGNESIUM CHLORIDE

    NORMOCARB HF 35, MAGNESIUM CHLORIDE

DIGESTIVE CARE INC

*	 DIGESTIVE CARE INC

    PERTZYE, PANCRELIPASE (AMYLASE

DISCOVERY LABS

*	 DISCOVERY LABORATORIES INC

    SURFAXIN, LUCINACTANT

DORADO PHARMA

*	 DORADO PHARMA LLC

    KETOPROFEN, KETOPROFEN

DORC

*	 DORC INTERNATIONAL BV

    MEMBRANEBLUE, TRYPAN BLUE

    VISIONBLUE, TRYPAN BLUE

DOUGLAS PHARMS

*	 DOUGLAS PHARMACEUTICALS AMERICA LTD

    MYORISAN, ISOTRETINOIN

DOW PHARM

*	 DOW PHARMACEUTICAL SCIENCES

    ACANYA, BENZOYL PEROXIDE

    AKNE-MYCIN, ERYTHROMYCIN

    ATRALIN, TRETINOIN

    JUBLIA, EFINACONAZOLE

    NUTRACORT, HYDROCORTISONE

    ONEXTON, BENZOYL PEROXIDE

    OXSORALEN-ULTRA, METHOXSALEN

DR REDDYS LA

*	 DR REDDYS LABORATORIES LOUISIANA LLC

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN    (OTC)

    LOPURIN, ALLOPURINOL

    SSD AF, SILVER SULFADIAZINE

    SSD, SILVER SULFADIAZINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 43


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   D   **

DR REDDYS LABS INC

*	 DR REDDYS LABORATORIES INC

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    AMOXIL, AMOXICILLIN

    AUGMENTIN '125', AMOXICILLIN

    AUGMENTIN '200', AMOXICILLIN

    AUGMENTIN '250', AMOXICILLIN

    AUGMENTIN '400', AMOXICILLIN

    AUGMENTIN '500', AMOXICILLIN

    AUGMENTIN '875', AMOXICILLIN

    AUGMENTIN ES-600, AMOXICILLIN

    AUGMENTIN XR, AMOXICILLIN

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    FINASTERIDE, FINASTERIDE

    FLUCONAZOLE, FLUCONAZOLE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    HABITROL, NICOTINE    (OTC)

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN    (OTC)

    LAROTID, AMOXICILLIN

    LEVOFLOXACIN, LEVOFLOXACIN

    MELOXICAM, MELOXICAM

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM    (OTC)

    NAPROXEN SODIUM, NAPROXEN SODIUM    (OTC)

    NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE

    SIMVASTATIN, SIMVASTATIN

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE

DR REDDYS LABS LTD

*	 DR REDDYS LABORATORIES LIMITED

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

*	 DR REDDYS LABORATORIES LTD

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM, AMLODIPINE BESYLATE

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ANASTROZOLE, ANASTROZOLE

    ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

    AZACITIDINE, AZACITIDINE

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL

    CARVEDILOL, CARVEDILOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE    (OTC)

    CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DECITABINE, DECITABINE

    DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, DESLORATADINE

    DESLORATADINE, DESLORATADINE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DOCETAXEL, DOCETAXEL

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE

    ESZOPICLONE, ESZOPICLONE

    FAMOTIDINE, FAMOTIDINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		             B - 44


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   D   **

*	 DR REDDYS LABORATORIES LTD

    FAMOTIDINE, FAMOTIDINE     (OTC)

    FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE     (OTC)

    FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE

    FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE     (OTC)

    FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

    FINASTERIDE, FINASTERIDE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FONDAPARINUX SODIUM, FONDAPARINUX SODIUM

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    GLIMEPIRIDE, GLIMEPIRIDE

    GLYCOPYRROLATE, GLYCOPYRROLATE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE     (OTC)

    IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN    (OTC)

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LAMOTRIGINE, LAMOTRIGINE

    LANSOPRAZOLE, LANSOPRAZOLE

    LANSOPRAZOLE, LANSOPRAZOLE     (OTC)

    LATANOPROST, LATANOPROST

    LETROZOLE, LETROZOLE

    LEVETIRACETAM, LEVETIRACETAM

    METOPROLOL SUCCINATE, METOPROLOL SUCCINATE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NAPROXEN AND ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM

    NAPROXEN SODIUM, NAPROXEN SODIUM

    NATEGLINIDE, NATEGLINIDE

    NIZATIDINE, NIZATIDINE

    OFLOXACIN, OFLOXACIN

    OLANZAPINE, OLANZAPINE

    OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM    (OTC)

    OMEPRAZOLE, OMEPRAZOLE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXAPROZIN, OXAPROZIN

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PARICALCITOL, PARICALCITOL

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

    RAMIPRIL, RAMIPRIL

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

    RISPERIDONE, RISPERIDONE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    SIROLIMUS, SIROLIMUS

    TACROLIMUS, TACROLIMUS

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR HYDROCHLORIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

    ZAFIRLUKAST, ZAFIRLUKAST

    ZENATANE, ISOTRETINOIN

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

DR REDDYS LABS SA

*	 DR REDDYS LABORATORIES SA

    FENOFIBRATE (MICRONIZED), FENOFIBRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 45


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   D   **

DRAXIMAGE

*	 DRAXIMAGE INC

    DTPA, TECHNETIUM TC-99M PENTETATE KIT

    TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT

    TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT

DUCHESNAY

*	 DUCHESNAY INC

    DICLEGIS, DOXYLAMINE SUCCINATE

DURAMED PHARMS BARR

*	 DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC

    AVIANE-28, ETHINYL ESTRADIOL

    CRYSELLE, ETHINYL ESTRADIOL

    DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL

    DIAMOX, ACETAZOLAMIDE

    ENPRESSE-28, ETHINYL ESTRADIOL

    METHYLPREDNISOLONE, METHYLPREDNISOLONE

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    VELIVET, DESOGESTREL

DURAMED RES

*	 DURAMED RESEARCH INC

    AYGESTIN, NORETHINDRONE ACETATE

DURATA THERAPS INTL

*	 DURATA THERAPEUTICS INTERNATIONAL BV

    DALVANCE, DALBAVANCIN HYDROCHLORIDE

DUSA

*	 DUSA PHARMACEUTICALS INC

    LEVULAN, AMINOLEVULINIC ACID HYDROCHLORIDE

REDDYS

*	 DOCTOR REDDYS LABORATORIES LTD

    DESLORATADINE, DESLORATADINE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    METOPROLOL SUCCINATE, METOPROLOL SUCCINATE

                                         **   E   **

EAGLE PHARMS

*	 EAGLE PHARMACEUTICALS INC

     ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN

     DICLOFENAC SODIUM AND MISOPROSTOL, DICLOFENAC SODIUM

     RYANODEX, DANTROLENE SODIUM

EASTMAN KODAK

*	 EASTMAN KODAK CO

     LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE

EBEWE PHARMA

*	 EBEWE PHARMA GES MBH NFG KG

     CARBOPLATIN, CARBOPLATIN

     IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

     METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

     OXALIPLATIN, OXALIPLATIN

     PACLITAXEL, PACLITAXEL

ECLAT PHARMS LLC

*	 ECLAT PHARMACEUTICALS LLC

     BLOXIVERZ, NEOSTIGMINE METHYLSULFATE

     VAZCULEP, PHENYLEPHRINE HYDROCHLORIDE

ECOLAB

*	 ECOLAB INC

     CHG SCRUB, CHLORHEXIDINE GLUCONATE    (OTC)

     CIDA-STAT, CHLORHEXIDINE GLUCONATE    (OTC)

ECR

*	 ECR PHARMACEUTICALS

     DEXAMETHASONE, DEXAMETHASONE

ECR PHARMA

*	 ECR PHARMA

     TUSSICAPS, CHLORPHENIRAMINE POLISTIREX

EDENBRIDGE PHARMS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 46


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   E   **

*	 EDENBRIDGE PHARMACEUTICALS LLC

    IVERMECTIN, IVERMECTIN

EDGEMONT PHARMS LLC

*	 EDGEMONT PHARMACEUTICALS LLC

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FORFIVO XL, BUPROPION HYDROCHLORIDE

EDISON THERAPS LLC

*	 EDISON THERAPEUTICS LLC

    METHERGINE, METHYLERGONOVINE MALEATE

EI INC

*	 EI INC

    THEROXIDIL, MINOXIDIL    (OTC)

EISAI INC

*	 EISAI INC

    ACIPHEX SPRINKLE, RABEPRAZOLE SODIUM

    ACIPHEX, RABEPRAZOLE SODIUM

    ARICEPT ODT, DONEPEZIL HYDROCHLORIDE

    ARICEPT, DONEPEZIL HYDROCHLORIDE

    BANZEL, RUFINAMIDE

    BELVIQ, LORCASERIN HYDROCHLORIDE

    DACOGEN, DECITABINE

    FRAGMIN, DALTEPARIN SODIUM

    FYCOMPA, PERAMPANEL

    HALAVEN, ERIBULIN MESYLATE

    HEXALEN, ALTRETAMINE

    PANRETIN, ALITRETINOIN

    SALAGEN, PILOCARPINE HYDROCHLORIDE

    ZONEGRAN, ZONISAMIDE

ELAN PHARMA INTL LTD

*	 ELAN PHARMA INTERNATIONAL LTD

    CLINDESSE, CLINDAMYCIN PHOSPHATE

    EVAMIST, ESTRADIOL

ELI LILLY AND CO

*	 ELI LILLY AND CO

    AXIRON, TESTOSTERONE

    EFFIENT, PRASUGREL HYDROCHLORIDE

    PROZAC, FLUOXETINE HYDROCHLORIDE

    SARAFEM, FLUOXETINE HYDROCHLORIDE

ELI LILLY CO

*	 ELI LILLY CO

    ADCIRCA, TADALAFIL

    ZYPREXA RELPREVV, OLANZAPINE PAMOATE

ELITE LABS

*	 ELITE LABORATORIES INC

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

ELITE LABS INC

*	 ELITE LABORATORIES INC

    PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE

EMCURE PHARMS

*	 EMCURE PHARMACEUTICALS LTD

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

EMCURE PHARMS INDIA

*	 EMCURE PHARMACEUTICALS LTD INDIA

    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

EMCURE PHARMS LTD

*	 EMCURE PHARMACEUTICALS LTD

    ACARBOSE, ACARBOSE

    ACETAZOLAMIDE SODIUM , ACETAZOLAMIDE SODIUM

    ADENOSINE, ADENOSINE

    AMIKACIN SULFATE, AMIKACIN SULFATE

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

    BICNU, CARMUSTINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 47


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   E   **

*	 EMCURE PHARMACEUTICALS LTD

    CIDOFOVIR, CIDOFOVIR

    COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM

    ETOMIDATE, ETOMIDATE

    FUROSEMIDE, FUROSEMIDE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LEVOFLOXACIN, LEVOFLOXACIN

    METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE

    RIFAMPIN, RIFAMPIN

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    TRANEXAMIC ACID, TRANEXAMIC ACID

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

EMCURE PHARMS USA

*	 EMCURE PHARMACEUTICALS USA INC

    DIFLUNISAL, DIFLUNISAL

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE

    METHIMAZOLE, METHIMAZOLE

    NIFEDIPINE, NIFEDIPINE

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

EMCURE USA

*	 EMCURE PHARMACEUTICALS USA INC

    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

EMD SERONO

*	 EMD SERONO INC

    GONAL-F RFF REDI-JECT, FOLLITROPIN ALFA/BETA

    GONAL-F RFF, FOLLITROPIN ALFA/BETA

    GONAL-F, FOLLITROPIN ALFA/BETA

    OVIDREL, CHORIOGONADOTROPIN ALFA

    SAIZEN, SOMATROPIN RECOMBINANT

    SEROPHENE, CLOMIPHENE CITRATE

    SEROSTIM, SOMATROPIN RECOMBINANT

    ZORBTIVE, SOMATROPIN RECOMBINANT

EMD SERONO INC

*	 EMD SERONO INC

    CETROTIDE, CETRORELIX

EMMAUS MEDCL

*	 EMMAUS MEDICAL INC

    NUTRESTORE, GLUTAMINE

ENDO PHARM

*	 ENDO PHARMACEUTICAL SOLUTIONS INC

    SUPPRELIN LA, HISTRELIN ACETATE

    VALSTAR PRESERVATIVE FREE, VALRUBICIN

    VANTAS, HISTRELIN ACETATE

ENDO PHARMS

*	 ENDO PHARMACEUTICALS INC

    DELATESTRYL, TESTOSTERONE ENANTHATE

    FORTESTA, TESTOSTERONE

    FROVA, FROVATRIPTAN SUCCINATE

    OPANA ER, OXYMORPHONE HYDROCHLORIDE

    OPANA, OXYMORPHONE HYDROCHLORIDE

    PERCODAN, ASPIRIN

ENDO PHARMS INC

*	 ENDO PHARMACEUTICALS INC

    AVEED, TESTOSTERONE UNDECANOATE

    VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR HYDROCHLORIDE

ENDO VENTURES LTD

*	 ENDO VENTURES LTD

    NATESTO, TESTOSTERONE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 48


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   E   **

*	 ENDO VENTURES LTD IRELAND

    SUMAVEL DOSEPRO, SUMATRIPTAN SUCCINATE

EPIC PHARMA

*	 EPIC PHARMA INC

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

*	 EPIC PHARMA LLC

    BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE

    SULINDAC, SULINDAC

    TRANDOLAPRIL, TRANDOLAPRIL

    URSODIOL, URSODIOL

EPIC PHARMA INC

*	 EPIC PHARMA INC

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

EPIC PHARMA LLC

*	 EPIC PHARMA LLC

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE

    SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

ERGOJECT

*	 ERGOJECT LLC

    METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE

ESSENTIAL ISOTOPES

*	 ESSENTIAL ISOTOPES LLC

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

ETHYPHARM

*	 ETHYPHARM

    BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

EURAND

*	 EURAND AMERICA INC

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

EUROHLTH INTL

*	 EUROHEALTH INTERNATIONAL SARL

    ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM

    ALLOPURINOL SODIUM, ALLOPURINOL SODIUM

    ALPROSTADIL, ALPROSTADIL

    AMIKACIN SULFATE, AMIKACIN SULFATE

    AMRINONE LACTATE, INAMRINONE LACTATE

    ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE

    ATRACURIUM BESYLATE, ATRACURIUM BESYLATE

    AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM

    AZTREONAM, AZTREONAM

    BLEOMYCIN SULFATE, BLEOMYCIN SULFATE

    BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    CAFCIT, CAFFEINE CITRATE

    CARBOPLATIN, CARBOPLATIN

    CERUBIDINE, DAUNORUBICIN HYDROCHLORIDE

    CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE

    CISPLATIN, CISPLATIN

    CLADRIBINE, CLADRIBINE

    CYCLOSPORINE, CYCLOSPORINE

    CYTARABINE, CYTARABINE

    DACARBAZINE, DACARBAZINE

    DACTINOMYCIN, DACTINOMYCIN

    DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE

    DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE

    DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE

    DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE), DICYCLOMINE HYDROCHLORIDE

    DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 49


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   E   **

*	 EUROHEALTH INTERNATIONAL SARL

    DOXYCYCLINE, DOXYCYCLINE HYCLATE

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE

    ETOPOSIDE, ETOPOSIDE

    FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE

    FLOXURIDINE, FLOXURIDINE

    FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE

    HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE

    HALOPERIDOL, HALOPERIDOL LACTATE

    IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE

    IFOSFAMIDE, IFOSFAMIDE

    INDOMETHACIN SODIUM, INDOMETHACIN SODIUM

    KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM

    LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM

    LEVOCARNITINE, LEVOCARNITINE

    MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE

    MESNA, MESNA

    METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

    OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE

    OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

    PACLITAXEL, PACLITAXEL

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    PENTOSTATIN, PENTOSTATIN

    PHENTOLAMINE MESYLATE, PHENTOLAMINE MESYLATE

    POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    THIOTEPA, THIOTEPA

    TORSEMIDE, TORSEMIDE

    VINBLASTINE SULFATE, VINBLASTINE SULFATE

EXALENZ BIOSCIENCE

*	 EXALENZ BIOSCIENCE LTD

    IDKIT:HP, CITRIC ACID

EXCELLIUM

*	 EXCELLIUM PHARMACEUTICAL INC

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    FOLIC ACID, FOLIC ACID

    FUROSEMIDE, FUROSEMIDE

    GLYCOPYRROLATE, GLYCOPYRROLATE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE

    LORAZEPAM, LORAZEPAM

EXELA PHARMA SCIENCE

*	 EXELA PHARMA SCIENCES

    CAFFEINE CITRATE, CAFFEINE CITRATE

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

EXELA PHARMA SCS LLC

*	 EXELA PHARMA SCIENCES LLC

    CAFFEINE CITRATE, CAFFEINE CITRATE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    MAGNESIUM SULFATE, MAGNESIUM SULFATE

EXELIXIS

*	 EXELIXIS INC

    COMETRIQ, CABOZANTINIB S-MALATE

FOUGERA

*	 E FOUGERA DIV ALTANA INC

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    BETAMETHASONE VALERATE, BETAMETHASONE VALERATE

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 50


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   E   **

*	 E FOUGERA DIV ALTANA INC

    FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

    FLUOCINONIDE, FLUOCINONIDE

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    HYDROCORTISONE, HYDROCORTISONE

    LIDOCAINE, LIDOCAINE

    NITROGLYCERIN, NITROGLYCERIN

    NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN

    NYSTATIN, NYSTATIN

LILLY

*	 ELI LILLY AND CO

    ALIMTA, PEMETREXED DISODIUM

    CIALIS, TADALAFIL

    CYMBALTA, DULOXETINE HYDROCHLORIDE

    EVISTA, RALOXIFENE HYDROCHLORIDE

    FORTEO, TERIPARATIDE RECOMBINANT HUMAN

    GEMZAR, GEMCITABINE HYDROCHLORIDE

    GLUCAGON, GLUCAGON RECOMBINANT

    HUMALOG KWIKPEN, INSULIN LISPRO RECOMBINANT

    HUMALOG MIX 50/50 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT

    HUMALOG MIX 50/50, INSULIN LISPRO PROTAMINE RECOMBINANT

    HUMALOG MIX 75/25 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT

    HUMALOG MIX 75/25, INSULIN LISPRO PROTAMINE RECOMBINANT

    HUMALOG, INSULIN LISPRO RECOMBINANT

    HUMATROPE, SOMATROPIN RECOMBINANT

    HUMULIN 70/30 PEN, INSULIN RECOMBINANT HUMAN    (OTC)

    HUMULIN 70/30, INSULIN RECOMBINANT HUMAN    (OTC)

    HUMULIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN     (OTC)

    HUMULIN R PEN, INSULIN RECOMBINANT HUMAN    (OTC)

    HUMULIN R, INSULIN RECOMBINANT HUMAN

    HUMULIN R, INSULIN RECOMBINANT HUMAN    (OTC)

    PROZAC WEEKLY, FLUOXETINE HYDROCHLORIDE

    QUINIDINE GLUCONATE, QUINIDINE GLUCONATE

    STRATTERA, ATOMOXETINE HYDROCHLORIDE

    SYMBYAX, FLUOXETINE HYDROCHLORIDE

    ZYPREXA ZYDIS, OLANZAPINE

    ZYPREXA, OLANZAPINE

                                         **   F   **

FALCON PHARMS

*	 FALCON PHARMACEUTICALS LTD

    LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE

    MAXITROL, DEXAMETHASONE

    TOBREX, TOBRAMYCIN

    TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

FAMY CARE LTD

*	 FAMY CARE LTD

    DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL

    LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    LEVONORGESTREL, LEVONORGESTREL    (OTC)

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL

    NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    NORETHINDRONE, NORETHINDRONE

FDC LTD

*	 FDC LTD

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    OFLOXACIN, OFLOXACIN

    TIMOLOL MALEATE, TIMOLOL MALEATE

FEINSTEIN

*	 FEINSTEIN INSTITUTE MEDICAL RESEARCH

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

FERA PHARMS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 51


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   F   **

*	 FERA PHARMACEUTICALS LLC

    OFLOXACIN, OFLOXACIN

    TOBRAMYCIN, TOBRAMYCIN

FERNDALE LABS

*	 FERNDALE LABORATORIES INC

    HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE

FERRING

*	 FERRING PHARMACEUTICALS INC

    ACTHREL, CORTICORELIN OVINE TRIFLUTATE

    BRAVELLE, UROFOLLITROPIN

    CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    ENDOMETRIN, PROGESTERONE

    FIRMAGON, DEGARELIX ACETATE

    MENOPUR, MENOTROPINS (FSH

    MINIRIN, DESMOPRESSIN ACETATE

    REPRONEX, MENOTROPINS (FSH

    TEV-TROPIN, SOMATROPIN RECOMBINANT

FERRING CONTROLLED

*	 FERRING CONTROLLED THERAPEUTICS LTD

    CERVIDIL, DINOPROSTONE

FERRING PHARMS AS

*	 FERRING PHARMACEUTICALS AS

    LYSTEDA, TRANEXAMIC ACID

    PREPOPIK, CITRIC ACID

FERRING PHARMS INC

*	 FERRING PHARMACEUTICALS INC

    DDAVP (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

    DDAVP, DESMOPRESSIN ACETATE

FOREST LABS

*	 FOREST LABORATORIES INC

    BYSTOLIC, NEBIVOLOL HYDROCHLORIDE

    CAMPRAL, ACAMPROSATE CALCIUM

    CELEXA, CITALOPRAM HYDROBROMIDE

    LEXAPRO, ESCITALOPRAM OXALATE

    NAMENDA XR, MEMANTINE HYDROCHLORIDE

    NAMENDA, MEMANTINE HYDROCHLORIDE

    THYROLAR-0.25, LIOTRIX (T4

    THYROLAR-0.5, LIOTRIX (T4

    THYROLAR-1, LIOTRIX (T4

    THYROLAR-2, LIOTRIX (T4

    THYROLAR-3, LIOTRIX (T4

FOREST LABS INC

*	 FOREST LABORATORIES INC

    BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE

    BENTYL, DICYCLOMINE HYDROCHLORIDE

    CANASA, MESALAMINE

    CARAFATE, SUCRALFATE

    FETZIMA, LEVOMILNACIPRAN HYDROCHLORIDE

    LINZESS, LINACLOTIDE

    NAMZARIC, DONEPEZIL HYDROCHLORIDE

    PYLERA, BISMUTH SUBCITRATE POTASSIUM

    RECTIV, NITROGLYCERIN

    SAPHRIS, ASENAPINE MALEATE

    TUDORZA PRESSAIR, ACLIDINIUM BROMIDE

    ULTRESA, PANCRELIPASE (AMYLASE

    URSO 250, URSODIOL

    URSO FORTE, URSODIOL

    VIIBRYD, VILAZODONE HYDROCHLORIDE

    VIOKACE, PANCRELIPASE (AMYLASE

    ZENPEP, PANCRELIPASE (AMYLASE

FOREST RES INST INC

*	 FOREST RESEARCH INSTITUTE INC

    DALIRESP, ROFLUMILAST

FOUGERA PHARMS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		          B - 52


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   F   **

*	 FOUGERA PHARMACEUTICALS INC

    ADAPALENE, ADAPALENE

    ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE

    AMCINONIDE, AMCINONIDE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    C-SOLVE-2, ERYTHROMYCIN

    CALCIPOTRIENE, CALCIPOTRIENE

    CICLOPIROX, CICLOPIROX

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CLOTRIMAZOLE, CLOTRIMAZOLE

    CUTIVATE, FLUTICASONE PROPIONATE

    DESONIDE, DESONIDE

    DESOXIMETASONE, DESOXIMETASONE

    DIFLORASONE DIACETATE, DIFLORASONE DIACETATE

    ECONAZOLE NITRATE, ECONAZOLE NITRATE

    ERYTHROMYCIN, ERYTHROMYCIN

    FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE

    FLUOCINONIDE, FLUOCINONIDE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE

    HYDROCORTISONE, HYDROCORTISONE

    IMIQUIMOD, IMIQUIMOD

    KETOCONAZOLE, KETOCONAZOLE

    LIDOCAINE AND PRILOCAINE, LIDOCAINE

    METRONIDAZOLE, METRONIDAZOLE

    MOMETASONE FUROATE, MOMETASONE FUROATE

    MUPIROCIN, MUPIROCIN

    NYSTATIN, NYSTATIN

    OXISTAT, OXICONAZOLE NITRATE

    PAMINE FORTE, METHSCOPOLAMINE BROMIDE

    PAMINE, METHSCOPOLAMINE BROMIDE

    PANDEL, HYDROCORTISONE PROBUTATE

    PREDNICARBATE, PREDNICARBATE

    SOLARAZE, DICLOFENAC SODIUM

    SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM

    TEMOVATE E, CLOBETASOL PROPIONATE

    TEMOVATE, CLOBETASOL PROPIONATE

    TERCONAZOLE, TERCONAZOLE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

    TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE

    ZONALON, DOXEPIN HYDROCHLORIDE

FOUGERA PHARMS INC

*	 FOUGERA PHARMACEUTICALS INC

    FLUOCINONIDE, FLUOCINONIDE

    TACROLIMUS, TACROLIMUS

FRESENIUS

*	 FRESENIUS KABI DEUTSCHLAND GMBH

    INTRALIPID 10%, SOYBEAN OIL

    INTRALIPID 20%, SOYBEAN OIL

    INTRALIPID 30%, SOYBEAN OIL

FRESENIUS KABI

*	 FRESENIUS KABI AUSTRIA GMBH

    LACTULOSE, LACTULOSE

FRESENIUS KABI ONCOL

*	 FRESENIUS KABI ONCOLOGY PLC

    ANASTROZOLE, ANASTROZOLE

    BICALUTAMIDE, BICALUTAMIDE

    CARBOPLATIN, CARBOPLATIN

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LETROZOLE, LETROZOLE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		            B - 53


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   F   **

*	 FRESENIUS KABI ONCOLOGY PLC

    OXALIPLATIN, OXALIPLATIN

    PACLITAXEL, PACLITAXEL

FRESENIUS KABI USA

*	 FRESENIUS KABI USA LLC

    ACYCLOVIR SODIUM, ACYCLOVIR SODIUM

    ADENOSINE, ADENOSINE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    ASTRAMORPH PF, MORPHINE SULFATE

    AZITHROMYCIN, AZITHROMYCIN

    AZTREONAM, AZTREONAM

    BACITRACIN, BACITRACIN

    BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    BLEOMYCIN SULFATE, BLEOMYCIN SULFATE

    CAFFEINE CITRATE, CAFFEINE CITRATE

    CALCITRIOL, CALCITRIOL

    CARBOPLATIN, CARBOPLATIN

    CEFOTETAN, CEFOTETAN DISODIUM

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CHLORAMPHENICOL SODIUM SUCCINATE, CHLORAMPHENICOL SODIUM SUCCINATE

    CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM

    CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC

    CISPLATIN, CISPLATIN

    CLADRIBINE, CLADRIBINE

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM

    CYTARABINE, CYTARABINE

    DACARBAZINE, DACARBAZINE

    DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE

    DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE

    DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

    DIMENHYDRINATE, DIMENHYDRINATE

    DIPRIVAN, PROPOFOL

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    DOXY 100, DOXYCYCLINE HYCLATE

    DOXY 200, DOXYCYCLINE HYCLATE

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE

    ETOPOSIDE, ETOPOSIDE

    FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE

    FLOXURIDINE, FLOXURIDINE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

    FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

    FLUMAZENIL, FLUMAZENIL

    FLUOROURACIL, FLUOROURACIL

    FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE

    FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE

    FOLIC ACID, FOLIC ACID

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    FUROSEMIDE, FUROSEMIDE

    GANCICLOVIR, GANCICLOVIR SODIUM

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE

    HALOPERIDOL, HALOPERIDOL LACTATE

    HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM

    HEPARIN SODIUM, HEPARIN SODIUM

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 54


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   F   **

*	 FRESENIUS KABI USA LLC

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE

    IFOSFAMIDE, IFOSFAMIDE

    INDOMETHACIN, INDOMETHACIN

    IOPAMIDOL-250, IOPAMIDOL

    IOPAMIDOL-300, IOPAMIDOL

    IOPAMIDOL-370, IOPAMIDOL

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    KABIVEN IN PLASTIC CONTAINER, AMINO ACIDS

    KANAMYCIN SULFATE, KANAMYCIN SULFATE

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN

    LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM

    LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

    MAGNESIUM SULFATE, MAGNESIUM SULFATE

    MANNITOL 25%, MANNITOL

    MESNA, MESNA

    METARAMINOL BITARTRATE, METARAMINOL BITARTRATE

    METHOTREXATE PRESERVATIVE FREE, METHOTREXATE SODIUM

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MILRINONE LACTATE, MILRINONE LACTATE

    MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

    NAROPIN, ROPIVACAINE HYDROCHLORIDE

    NEBUPENT, PENTAMIDINE ISETHIONATE

    NESACAINE, CHLOROPROCAINE HYDROCHLORIDE

    NESACAINE-MPF, CHLOROPROCAINE HYDROCHLORIDE

    OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE

    OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXALIPLATIN, OXALIPLATIN

    OXYTOCIN, OXYTOCIN

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    PENTAM, PENTAMIDINE ISETHIONATE

    PERIKABIVEN IN PLASTIC CONTAINER, AMINO ACIDS

    POLOCAINE, MEPIVACAINE HYDROCHLORIDE

    POLOCAINE-MPF, MEPIVACAINE HYDROCHLORIDE

    POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

    POTASSIUM CHLORIDE IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PROGESTERONE, PROGESTERONE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    PROTAMINE SULFATE, PROTAMINE SULFATE

    PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE

    RIFAMPIN, RIFAMPIN

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

    SENSORCAINE, BUPIVACAINE HYDROCHLORIDE

    SENSORCAINE, BUPIVACAINE HYDROCHLORIDE

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

    THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE

    TOBRAMYCIN SULFATE (PHARMACY BULK), TOBRAMYCIN SULFATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VALPROATE SODIUM, VALPROATE SODIUM

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 55


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   F   **

*	 FRESENIUS KABI USA LLC

     VIBISONE, CYANOCOBALAMIN

     VINBLASTINE SULFATE, VINBLASTINE SULFATE

     VINORELBINE TARTRATE, VINORELBINE TARTRATE

     XYLOCAINE 4% PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

     XYLOCAINE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

     XYLOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE

     XYLOCAINE W/ EPINEPHRINE, EPINEPHRINE

     XYLOCAINE, LIDOCAINE HYDROCHLORIDE

FRESENIUS MEDCL

*	 FRESENIUS MEDICAL CARE NORTH AMERICA

     CALCITRIOL, CALCITRIOL

     DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM

     DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM

     DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM

     DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

     PHOSLO GELCAPS, CALCIUM ACETATE

     PHOSLYRA, CALCIUM ACETATE

     SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

FSC

*	 FSC LABORATORIES INC

     PRIMSOL, TRIMETHOPRIM HYDROCHLORIDE

                                         **   G   **

G AND W LABS

*	 G AND W LABORATORIES INC

    ACEPHEN, ACETAMINOPHEN    (OTC)

    CICLOPIROX, CICLOPIROX

    FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE

    INDOMETHACIN, INDOMETHACIN

    METRONIDAZOLE, METRONIDAZOLE

    MICONAZOLE 7 COMBINATION PACK, MICONAZOLE NITRATE   (OTC)

    MICONAZOLE NITRATE, MICONAZOLE NITRATE   (OTC)

    MOMETASONE FUROATE, MOMETASONE FUROATE

    PROCHLORPERAZINE, PROCHLORPERAZINE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    PROMETHEGAN, PROMETHAZINE HYDROCHLORIDE

G AND W LABS INC

*	 G AND W LABORATORIES INC

    CALCIPOTRIENE, CALCIPOTRIENE

    CICLOPIROX, CICLOPIROX

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    FLUOCINONIDE, FLUOCINONIDE

    METRONIDAZOLE, METRONIDAZOLE

    MICONAZOLE NITRATE, MICONAZOLE NITRATE   (OTC)

GALDERMA LABS

*	 GALDERMA LABORATORIES INC

    CLOBEX, CLOBETASOL PROPIONATE

GALDERMA LABS LP

*	 GALDERMA LABORATORIES L P

    CLOBEX, CLOBETASOL PROPIONATE

* GALDERMA LABORATORIES LP

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		               B - 56


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   G   **

*	 GALDERMA LABORATORIES LP

    CAPEX, FLUOCINOLONE ACETONIDE

    CLOBEX, CLOBETASOL PROPIONATE

    DESOWEN, DESONIDE

    DIFFERIN, ADAPALENE

    EPIDUO, ADAPALENE

    METROCREAM, METRONIDAZOLE

    METROGEL, METRONIDAZOLE

    METROLOTION, METRONIDAZOLE

    MIRVASO, BRIMONIDINE TARTRATE

    ORACEA, DOXYCYCLINE

    PLIAGLIS, LIDOCAINE

    SOOLANTRA, IVERMECTIN

    TRI-LUMA, FLUOCINOLONE ACETONIDE

    VECTICAL, CALCITRIOL

GALEN (UK)

*	 GALEN LTD

    DAUNOXOME, DAUNORUBICIN CITRATE

GALEN SPECIALTY

*	 GALEN SPECIALTY PHARMA US LLC

    SYNERA, LIDOCAINE

GALENA BIOPHARMA

*	 GALENA BIOPHARMA

    ABSTRAL, FENTANYL CITRATE

GALENA BIOPHARMA INC

*	 GALENA BIOPHARMA INC

    ZUPLENZ, ONDANSETRON

GAMBRO RENAL PRODS

*	 GAMBRO RENAL PRODUCTS

    PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BGK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE

GASTROENTERO

*	 GASTROENTERO LOGIC LLC

    OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN, AMOXICILLIN

GATE PHARMS

*	 GATE PHARMACEUTICALS

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

GAVIS PHARMS

*	 GAVIS PHARMACEUTICALS LLC

    NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

    NYSTATIN, NYSTATIN

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

    QUINARETIC, HYDROCHLOROTHIAZIDE

    TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE

GAVIS PHARMS LLC

*	 GAVIS PHARMACEUTICALS LLC

    EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE

GD SEARLE

*	 GD SEARLE LLC

    CELEBREX, CELECOXIB

    DAYPRO, OXAPROZIN

GD SEARLE LLC

*	 GD SEARLE LLC

    ALDACTAZIDE, HYDROCHLOROTHIAZIDE

    ALDACTONE, SPIRONOLACTONE

    ARTHROTEC, DICLOFENAC SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 57


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   G   **

*	 GD SEARLE LLC

    CALAN, VERAPAMIL HYDROCHLORIDE

    COVERA-HS, VERAPAMIL HYDROCHLORIDE

    CYTOTEC, MISOPROSTOL

    FLAGYL ER, METRONIDAZOLE

    FLAGYL, METRONIDAZOLE

    INSPRA, EPLERENONE

    LOMOTIL, ATROPINE SULFATE

    NORPACE CR, DISOPYRAMIDE PHOSPHATE

    NORPACE, DISOPYRAMIDE PHOSPHATE

    SYNAREL, NAFARELIN ACETATE

GE HEALTHCARE

*	 GE HEALTHCARE

    ADREVIEW, IOBENGUANE SULFATE I-123

    CERETEC, TECHNETIUM TC-99M EXAMETAZIME KIT

    INDICLOR, INDIUM IN-111 CHLORIDE

    INDIUM IN-111 OXYQUINOLINE, INDIUM IN-111 OXYQUINOLINE

    METASTRON, STRONTIUM CHLORIDE SR-89

    MPI DMSA KIDNEY REAGENT, TECHNETIUM TC-99M SUCCIMER KIT

    MPI INDIUM DTPA IN 111, INDIUM IN-111 PENTETATE DISODIUM

    MYOVIEW 30ML, TECHNETIUM TC-99M TETROFOSMIN KIT

    MYOVIEW, TECHNETIUM TC-99M TETROFOSMIN KIT

    OMNIPAQUE 140, IOHEXOL

    OMNIPAQUE 180, IOHEXOL

    OMNIPAQUE 240, IOHEXOL

    OMNIPAQUE 300, IOHEXOL

    OMNIPAQUE 350, IOHEXOL

    OMNISCAN, GADODIAMIDE

    OPTISON, ALBUMIN HUMAN

    TECHNETIUM TC 99M GENERATOR, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

    THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201

    VISIPAQUE 270, IODIXANOL

    VISIPAQUE 320, IODIXANOL

    VIZAMYL, FLUTEMETAMOL F-18

GE HLTHCARE INC

*	 GE HEALTHCARE INC

    DATSCAN, IOFLUPANE I-123

GEDEON RICHTER USA

*	 GEDEON RICHTER USA INC

    FINASTERIDE, FINASTERIDE

GENENTECH

*	 GENENTECH INC

    ERIVEDGE, VISMODEGIB

    NUTROPIN AQ PEN, SOMATROPIN RECOMBINANT

    NUTROPIN AQ, SOMATROPIN RECOMBINANT

    NUTROPIN, SOMATROPIN RECOMBINANT

GENZYME

*	 GENZYME CORP

    CEREZYME, IMIGLUCERASE

    CLOLAR, CLOFARABINE

    MOZOBIL, PLERIXAFOR

    RENAGEL, SEVELAMER HYDROCHLORIDE

    RENVELA, SEVELAMER CARBONATE

    THYROGEN, THYROTROPIN ALFA

GENZYME CORP

*	 GENZYME CORP

    CERDELGA, ELIGLUSTAT TARTRATE

    HECTOROL, DOXERCALCIFEROL

    KYNAMRO, MIPOMERSEN SODIUM

GILEAD

*	 GILEAD SCIENCES INC

    ATRIPLA, EFAVIRENZ

    CAYSTON, AZTREONAM

    EMTRIVA, EMTRICITABINE

    HEPSERA, ADEFOVIR DIPIVOXIL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 58


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   G   **

*	 GILEAD SCIENCES INC

    LETAIRIS, AMBRISENTAN

    RANEXA, RANOLAZINE

    TRUVADA, EMTRICITABINE

GILEAD SCIENCES INC

*	 GILEAD SCIENCES INC

    COMPLERA, EMTRICITABINE

    HARVONI, LEDIPASVIR

    SOVALDI, SOFOSBUVIR

    STRIBILD, COBICISTAT

    TYBOST, COBICISTAT

    VIREAD, TENOFOVIR DISOPROXIL FUMARATE

    VISTIDE, CIDOFOVIR

    VITEKTA, ELVITEGRAVIR

    ZYDELIG, IDELALISIB

GLAND PHARMA LTD

*	 GLAND PHARMA LTD

    ADENOSINE, ADENOSINE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AZITHROMYCIN, AZITHROMYCIN

    HALOPERIDOL, HALOPERIDOL LACTATE

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MILRINONE LACTATE, MILRINONE LACTATE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

GLAXO GRP ENGLAND

*	 GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

    INCRUSE ELLIPTA , UMECLIDINIUM BROMIDE

GLAXO GRP LTD

*	 GLAXO GROUP LTD DBA GLAXOSMITHKLINE

    ALTABAX, RETAPAMULIN

    FLOVENT HFA, FLUTICASONE PROPIONATE

*	 GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

    ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE

    ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE

    ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE

    ADVAIR HFA, FLUTICASONE PROPIONATE

    BREO ELLIPTA, FLUTICASONE FUROATE

    FLOVENT DISKUS 100, FLUTICASONE PROPIONATE

    FLOVENT DISKUS 250, FLUTICASONE PROPIONATE

    FLOVENT DISKUS 50, FLUTICASONE PROPIONATE

    ZANTAC 150, RANITIDINE HYDROCHLORIDE

    ZANTAC 300, RANITIDINE HYDROCHLORIDE

    ZANTAC, RANITIDINE HYDROCHLORIDE

GLAXO WELLCOME

*	 GLAXOSMITHKLINE

    HYCAMTIN, TOPOTECAN HYDROCHLORIDE

GLAXOSMITHKLINE

*	 GLAXOSMITHKLINE

    ABREVA, DOCOSANOL    (OTC)

    ALKERAN, MELPHALAN

    ALKERAN, MELPHALAN HYDROCHLORIDE

    AVODART, DUTASTERIDE

    BACTROBAN, MUPIROCIN

    BACTROBAN, MUPIROCIN CALCIUM

    BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE

    CEFTIN, CEFUROXIME AXETIL

    EPIVIR-HBV, LAMIVUDINE

    FLONASE, FLUTICASONE PROPIONATE

    HYCAMTIN, TOPOTECAN HYDROCHLORIDE

    IMITREX STATDOSE, SUMATRIPTAN SUCCINATE

    IMITREX, SUMATRIPTAN

    IMITREX, SUMATRIPTAN SUCCINATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 59


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   G   **

*	 GLAXOSMITHKLINE

    JALYN, DUTASTERIDE

    MALARONE PEDIATRIC, ATOVAQUONE

    MALARONE, ATOVAQUONE

    NICORETTE (MINT), NICOTINE POLACRILEX    (OTC)

    NICORETTE, NICOTINE POLACRILEX    (OTC)

    POTIGA, EZOGABINE

    PROMACTA, ELTROMBOPAG OLAMINE

    RELENZA, ZANAMIVIR

    TAFINLAR, DABRAFENIB MESYLATE

    TIMENTIN IN PLASTIC CONTAINER, CLAVULANATE POTASSIUM

    TIMENTIN, CLAVULANATE POTASSIUM

    VALTREX, VALACYCLOVIR HYDROCHLORIDE

    VERAMYST, FLUTICASONE FUROATE

    VOTRIENT, PAZOPANIB HYDROCHLORIDE

    WELLBUTRIN SR, BUPROPION HYDROCHLORIDE

    WELLBUTRIN, BUPROPION HYDROCHLORIDE

    ZOFRAN ODT, ONDANSETRON

    ZOFRAN PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ZOFRAN, ONDANSETRON HYDROCHLORIDE

    ZYBAN, BUPROPION HYDROCHLORIDE

*	 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND

    ANORO ELLIPTA, UMECLIDINIUM BROMIDE

    ARNUITY ELLIPTA, FLUTICASONE FUROATE

*	 GLAXOSMITHKLINE INTELLECTUAL PROPERTY LTD ENGLAND

    SEREVENT, SALMETEROL XINAFOATE

    VENTOLIN HFA, ALBUTEROL SULFATE

*	 GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND

    TIMENTIN, CLAVULANATE POTASSIUM

GLAXOSMITHKLINE CONS

*	 GLAXOSMITHKLINE CONSUMER HEALTHCARE

    ALLI, ORLISTAT    (OTC)

    COMMIT, NICOTINE POLACRILEX    (OTC)

    FLONASE ALLERGY RELIEF, FLUTICASONE PROPIONATE    (OTC)

    NICORETTE, NICOTINE POLACRILEX    (OTC)

GLAXOSMITHKLINE LLC

*	 GLAXOSMITHKLINE LLC

    AMERGE, NARATRIPTAN HYDROCHLORIDE

    DYAZIDE, HYDROCHLOROTHIAZIDE

    FLOLAN, EPOPROSTENOL SODIUM

    INNOPRAN XL, PROPRANOLOL HYDROCHLORIDE

    LAMICTAL CD, LAMOTRIGINE

    LAMICTAL ODT, LAMOTRIGINE

    LAMICTAL XR, LAMOTRIGINE

    LAMICTAL, LAMOTRIGINE

    MEKINIST, TRAMETINIB DIMETHYL SULFOXIDE

    MEPRON, ATOVAQUONE

    REQUIP XL, ROPINIROLE HYDROCHLORIDE

    REQUIP, ROPINIROLE HYDROCHLORIDE

    RYTHMOL SR, PROPAFENONE HYDROCHLORIDE

    RYTHMOL, PROPAFENONE HYDROCHLORIDE

GLENMARK GENERICS

*	 GLENMARK GENERICS INC USA

    ADAPALENE, ADAPALENE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CALCIPOTRIENE, CALCIPOTRIENE

    IMIQUIMOD, IMIQUIMOD

    MOMETASONE FUROATE, MOMETASONE FUROATE

    MUPIROCIN, MUPIROCIN CALCIUM

    NIZATIDINE, NIZATIDINE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    ZONISAMIDE, ZONISAMIDE

*	 GLENMARK GENERICS LIMITED

    BRIELLYN, ETHINYL ESTRADIOL

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		       B - 60


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   G   **

*	 GLENMARK GENERICS LIMITED

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

*	 GLENMARK GENERICS LTD

    ACAMPROSATE CALCIUM, ACAMPROSATE CALCIUM

    ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE

    ALYACEN 1/35, ETHINYL ESTRADIOL

    ALYACEN 7/7/7, ETHINYL ESTRADIOL

    ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE

    CARVEDILOL, CARVEDILOL

    CICLOPIROX, CICLOPIROX

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    DESOXIMETASONE, DESOXIMETASONE

    ESZOPICLONE, ESZOPICLONE

    FELODIPINE, FELODIPINE

    FLUCONAZOLE, FLUCONAZOLE

    FLUOCINONIDE, FLUOCINONIDE

    GABAPENTIN, GABAPENTIN

    HEATHER, NORETHINDRONE

    HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVOFLOXACIN, LEVOFLOXACIN

    LITHIUM CARBONATE, LITHIUM CARBONATE

    MARLISSA, ETHINYL ESTRADIOL

    MELOXICAM, MELOXICAM

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE

    MOMETASONE FUROATE, MOMETASONE FUROATE

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    NAPROXEN SODIUM, NAPROXEN SODIUM

    NAPROXEN, NAPROXEN

    NORETHINDRONE, NORETHINDRONE

    NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    OMEPRAZOLE, OMEPRAZOLE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON, ONDANSETRON

    OXCARBAZEPINE, OXCARBAZEPINE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    RILUZOLE, RILUZOLE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

    TELMISARTAN, TELMISARTAN

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    THEOPHYLLINE, THEOPHYLLINE

    TOPIRAMATE, TOPIRAMATE

    TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL

    TROSPIUM CHLORIDE, TROSPIUM CHLORIDE

    URSODIOL, URSODIOL

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

    VIORELE, DESOGESTREL

    ZOLMITRIPTAN, ZOLMITRIPTAN

*	 GLENMARK GENERICS LTD INDIA

    INDOMETHACIN, INDOMETHACIN

    LITHIUM CARBONATE, LITHIUM CARBONATE

    NORETHINDRONE ACETATE, NORETHINDRONE ACETATE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

GLENMARK PHARMS

*	 GLENMARK PHARMACEUTICALS INC USA

    CICLOPIROX, CICLOPIROX

    CLOTRIMAZOLE, CLOTRIMAZOLE

    MUPIROCIN, MUPIROCIN

*	 GLENMARK PHARMACEUTICALS LTD

    MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

GLENMARK PHARMS LTD

* GLENMARK PHARMACEUTICALS LTD

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 61


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   G   **

*	 GLENMARK PHARMACEUTICALS LTD

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

GLOBAL ISOTOPES LLC

*	 GLOBAL ISOTOPES LLC DBA ZEVACOR MOLECULAR

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

GRANULES INDIA

*	 GRANULES INDIA LTD

    IBUPROFEN, IBUPROFEN    (OTC)

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    NAPROXEN SODIUM, NAPROXEN SODIUM    (OTC)

GUARDIAN DRUG

*	 GUARDIAN DRUG CO INC

    FOAMCOAT, ALUMINUM HYDROXIDE    (OTC)

GUERBET

*	 GUERBET LLC

    DOTAREM, GADOTERATE MEGLUMINE

    HEXABRIX, IOXAGLATE MEGLUMINE

    LIPIODOL, ETHIODIZED OIL

    OXILAN-300, IOXILAN

    OXILAN-350, IOXILAN

HANFORD GC

*	 GC HANFORD MANUFACTURING CO

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

    PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM

                                         **   H   **

HAEMONETICS

*	 HAEMONETICS CORP

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

HALOCARBON PRODS

*	 HALOCARBON PRODUCTS CORP

    ISOFLURANE, ISOFLURANE

    SEVOFLURANE, SEVOFLURANE

HALOZYME THERAP

*	 HALOZYME THERAPEUTICS INC

    HYLENEX RECOMBINANT, HYALURONIDASE RECOMBINANT HUMAN

HAMELN RDS GMBH

*	 HAMELN RDS GMBH

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

HANMI PHARM CO LTD

*	 HANMI PHARMACEUTICAL CO LTD

    ESOMEPRAZOLE STRONTIUM, ESOMEPRAZOLE STRONTIUM

HARRIS PHARM

*	 HARRIS PHARMACEUTICAL INC

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

HAUPT PHARMA

*	 HAUPT PHARMA INC

    LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    NORETHINDRONE, NORETHINDRONE

HELSINN HLTHCARE

*	 HELSINN HEALTHCARE SA

    AKYNZEO, NETUPITANT

    ALOXI, PALONOSETRON HYDROCHLORIDE

HERCON PHARM

*	 HERCON PHARMACEUTICAL LLC

    NITROGLYCERIN, NITROGLYCERIN

HERITAGE PHARMS INC

*	 HERITAGE PHARMACEUTICALS INC

    ACETAZOLAMIDE, ACETAZOLAMIDE

    ACHROMYCIN V, TETRACYCLINE HYDROCHLORIDE

    CARISOPRODOL AND ASPIRIN, ASPIRIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 62


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HERITAGE PHARMACEUTICALS INC

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DOXYCYCLINE, DOXYCYCLINE

    FELODIPINE, FELODIPINE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

    GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE

    GLYBURIDE, GLYBURIDE

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    INDOMETHACIN, INDOMETHACIN

    LEFLUNOMIDE, LEFLUNOMIDE

    MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE, HYDROCHLOROTHIAZIDE

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    NYSTATIN, NYSTATIN

    PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE

    SULINDAC, SULINDAC

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

HETERO LABS LTD III

*	 HETERO LABS LTD UNIT III

    ABACAVIR SULFATE, ABACAVIR SULFATE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FINASTERIDE, FINASTERIDE

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    INDOMETHACIN, INDOMETHACIN

    LEVETIRACETAM, LEVETIRACETAM

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

    LITHIUM CARBONATE, LITHIUM CARBONATE

    METHOCARBAMOL, METHOCARBAMOL

    NEVIRAPINE, NEVIRAPINE

    SIMVASTATIN, SIMVASTATIN

    STAVUDINE, STAVUDINE

    TORSEMIDE, TORSEMIDE

    ZIDOVUDINE, ZIDOVUDINE

HETERO LABS LTD V

*	 HETERO LABS LTD UNIT V

    ACYCLOVIR, ACYCLOVIR

    FAMCICLOVIR, FAMCICLOVIR

    IRBESARTAN, IRBESARTAN

    LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE

    LAMIVUDINE, LAMIVUDINE

    LEVOFLOXACIN, LEVOFLOXACIN

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    VALSARTAN, VALSARTAN

HEYL CHEMISCH

*	 HEYL CHEMISCH PHARMAZEUTISHE FABRIK

    RADIOGARDASE (PRUSSIAN BLUE), FERRIC HEXACYANOFERRATE(II)

HI TECH PHARMA

*	 HI TECH PHARMACAL CO INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    ACYCLOVIR, ACYCLOVIR

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    CALCIPOTRIENE, CALCIPOTRIENE

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE

    CICLOPIROX, CICLOPIROX

    CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE

    CORMAX, CLOBETASOL PROPIONATE

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 63


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HI TECH PHARMACAL CO INC

    EMBELINE E, CLOBETASOL PROPIONATE

    EMBELINE, CLOBETASOL PROPIONATE

    ERYTHRO-STATIN, ERYTHROMYCIN

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    GABAPENTIN, GABAPENTIN

    HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    LACTULOSE, LACTULOSE

    LEVOCARNITINE, LEVOCARNITINE

    LEVOFLOXACIN, LEVOFLOXACIN

    LIDOCAINE AND PRILOCAINE, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MINOXIDIL (FOR MEN), MINOXIDIL    (OTC)

    MINOXIDIL (FOR WOMEN), MINOXIDIL    (OTC)

    NYSTATIN, NYSTATIN

    OFLOXACIN, OFLOXACIN

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

    TIMOLOL MALEATE, TIMOLOL MALEATE

    VOSOL HC, ACETIC ACID, GLACIAL

    VOSOL, ACETIC ACID, GLACIAL

HI TECH PHARMA CO

*	 HI TECH PHARMACAL CO INC

    FLUNISOLIDE, FLUNISOLIDE

    PREDNISOLONE, PREDNISOLONE

HI-TECH PHARMA CO

*	 HI-TECH PHARMACAL CO INC

    FAMOTIDINE, FAMOTIDINE

    GATIFLOXACIN, GATIFLOXACIN

    LORAZEPAM, LORAZEPAM

    PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE

HI-TECH PHARMACAL

*	 HI-TECH PHARMACAL CO INC

    BROMFENAC SODIUM, BROMFENAC SODIUM

    LEVETIRACETAM, LEVETIRACETAM

    PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE

HIGH TECH PHARMA

*	 HIGH TECHNOLOGY PHARMACAL CO INC

    VALPROIC ACID, VALPROIC ACID

HIKMA

*	 HIKMA FARMACEUTICA LDA

    CEFOTAXIME, CEFOTAXIME SODIUM

*	 HIKMA PHARMACEUTICALS

    AMOXICILLIN, AMOXICILLIN

    CARVEDILOL, CARVEDILOL

    CEFACLOR, CEFACLOR

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CEPHALEXIN, CEPHALEXIN

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    GABAPENTIN, GABAPENTIN

    GLYBURIDE (MICRONIZED), GLYBURIDE

    NAPROXEN SODIUM, NAPROXEN SODIUM

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

HIKMA (MAPLE)

*	 HIKMA (MAPLE) LTD

    SODIUM CHLORIDE 0.9%, SODIUM CHLORIDE

HIKMA FARMACEUTICA

* HIKMA FARMACEUTICA (PORTUGAL) SA

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 64


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HIKMA FARMACEUTICA (PORTUGAL) SA

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE

    CEFOXITIN, CEFOXITIN SODIUM

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

    CIPROFLOXACIN, CIPROFLOXACIN

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    ENALAPRILAT, ENALAPRILAT

    FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    FLUMAZENIL, FLUMAZENIL

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    GLYCOPYRROLATE, GLYCOPYRROLATE

    GRANISTERON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MILRINONE LACTATE IN PLASTIC CONTAINER, MILRINONE LACTATE

    MILRINONE LACTATE, MILRINONE LACTATE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PROGESTERONE, PROGESTERONE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

    VALPROATE SODIUM, VALPROATE SODIUM

*	 HIKMA FARMACEUTICA PORTUGAL LDA

    CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

    CEFUROXIME SODIUM, CEFUROXIME SODIUM

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

*	 HIKMA FARMACEUTICA PORTUGAL SA

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    OXYTOCIN, OXYTOCIN

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE

*	 HIKMA FARMACEUTICA SA

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

HIKMA INTL PHARMS

*	 HIKMA INTERNATIONAL PHARMACEUTICALS LLC

    BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN

    BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN

    CORTISONE ACETATE, CORTISONE ACETATE

    DIGOXIN, DIGOXIN

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE

    ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LITHIUM CARBONATE, LITHIUM CARBONATE

    METHOCARBAMOL, METHOCARBAMOL

    NAPROXEN, NAPROXEN

HIKMA MAPLE

*	 HIKMA MAPLE LTD

    ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE, ACYCLOVIR SODIUM

    ADENOSINE, ADENOSINE

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    ATIVAN, LORAZEPAM

    BUMETANIDE, BUMETANIDE

    CEFOXITIN, CEFOXITIN SODIUM

    CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		              B - 65


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HIKMA MAPLE LTD

    DIGOXIN, DIGOXIN

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DOPRAM, DOXAPRAM HYDROCHLORIDE

    DURAMORPH PF, MORPHINE SULFATE

    FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE

    FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE

    FLUMAZENIL, FLUMAZENIL

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    HEPARIN SODIUM, HEPARIN SODIUM

    INFUMORPH, MORPHINE SULFATE

    MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MILRINONE LACTATE, MILRINONE LACTATE

    MITOMYCIN, MITOMYCIN

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXYTOCIN, OXYTOCIN

    PHENYTOIN SODIUM, PHENYTOIN SODIUM

    PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    ROBAXIN, METHOCARBAMOL

    ROBINUL, GLYCOPYRROLATE

    SODIUM CHLORIDE 0.9% , SODIUM CHLORIDE

    SUFENTANIL CITRATE, SUFENTANIL CITRATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

HIKMA PHARM CO LTD

*	 HIKMA PHARM CO LTD

    ARGATROBAN, ARGATROBAN

HIKMA PHARMS

*	 HIKMA PHARMACEUTICALS

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    AMOXICILLIN, AMOXICILLIN

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE

    GABAPENTIN, GABAPENTIN

    GEMFIBROZIL, GEMFIBROZIL

    GLIMEPIRIDE, GLIMEPIRIDE

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    LAMOTRIGINE, LAMOTRIGINE

    MODAFINIL, MODAFINIL

    PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TOPIRAMATE , TOPIRAMATE

*	 HIKMA PHARMACEUTICALS CO LTD

    PARICALCITOL, PARICALCITOL

*	 HIKMA PHARMACEUTICALS LLC

    PREDNISONE, PREDNISONE

    SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, SODIUM FERRIC GLUCONATE COMPLEX

HIKMA PHARMS LLC

*	 HIKMA PHARMACEUTICALS LLC

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

    CAPTOPRIL, CAPTOPRIL

    CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE

    DOXERCALCIFEROL, DOXERCALCIFEROL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 66


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HIKMA PHARMACEUTICALS LLC

    FOLIC ACID, FOLIC ACID

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    MITIGARE, COLCHICINE

    PRIMIDONE, PRIMIDONE

    ZALEPLON, ZALEPLON

HILL DERMAC

*	 HILL DERMACEUTICALS INC

    DERMA-SMOOTHE/FS, FLUOCINOLONE ACETONIDE

    DERMOTIC, FLUOCINOLONE ACETONIDE

HISAMITSU PHARM CO

*	 HISAMITSU PHARMACEUTICAL CO INC

    SALONPAS, MENTHOL     (OTC)

HISUN PHARM HANGZHOU

*	 HISUN PHARMACEUTICAL (HANGZHOU) CO LTD

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

HOFFMAN LA ROCHE

*	 HOFFMAN LA ROCHE INC

    INVIRASE, SAQUINAVIR MESYLATE

HOFFMANN LA ROCHE

*	 HOFFMANN LA ROCHE INC

    ANAPROX DS, NAPROXEN SODIUM

    ANAPROX, NAPROXEN SODIUM

    BONIVA, IBANDRONATE SODIUM

    INVIRASE, SAQUINAVIR MESYLATE

    ROCEPHIN, CEFTRIAXONE SODIUM

    VALCYTE, VALGANCICLOVIR HYDROCHLORIDE

    XELODA, CAPECITABINE

    XENICAL, ORLISTAT

    ZELBORAF, VEMURAFENIB

HOPE PHARMS

*	 HOPE PHARMACEUTICALS

    NITHIODOTE, SODIUM NITRITE

    SODIUM NITRITE, SODIUM NITRITE

    SODIUM THIOSULFATE, SODIUM THIOSULFATE

HORIZON PHARMA

*	 HORIZON PHARMA INC

    DUEXIS, FAMOTIDINE

    RAYOS, PREDNISONE

    VIMOVO, ESOMEPRAZOLE MAGNESIUM

*	 HORIZON PHARMA IRELAND LTD

    PENNSAID, DICLOFENAC SODIUM

HOSPIRA

*	 HOSPIRA INC

    A-HYDROCORT, HYDROCORTISONE SODIUM SUCCINATE

    A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE

    ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL

    ACETYLCYSTEINE, ACETYLCYSTEINE

    ALFENTANIL, ALFENTANIL HYDROCHLORIDE

    AMIDATE, ETOMIDATE

    AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID

    AMINOPHYLLINE, AMINOPHYLLINE

    AMINOSYN 10% (PH6), AMINO ACIDS

    AMINOSYN 10%, AMINO ACIDS

    AMINOSYN 3.5% M, AMINO ACIDS

    AMINOSYN 3.5%, AMINO ACIDS

    AMINOSYN 5%, AMINO ACIDS

    AMINOSYN 7% (PH6), AMINO ACIDS

    AMINOSYN 7% W/ ELECTROLYTES, AMINO ACIDS

    AMINOSYN 7%, AMINO ACIDS

    AMINOSYN 8.5% (PH6), AMINO ACIDS

    AMINOSYN 8.5% W/ ELECTROLYTES, AMINO ACIDS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 67


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HOSPIRA INC

    AMINOSYN 8.5%, AMINO ACIDS

    AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS

    AMINOSYN II 10% W/ ELECTROLYTES, AMINO ACIDS

    AMINOSYN II 10%, AMINO ACIDS

    AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS

    AMINOSYN II 7%, AMINO ACIDS

    AMINOSYN II 8.5% W/ ELECTROLYTES, AMINO ACIDS

    AMINOSYN II 8.5%, AMINO ACIDS

    AMINOSYN-HBC 7%, AMINO ACIDS

    AMINOSYN-HF 8%, AMINO ACIDS

    AMINOSYN-PF 10%, AMINO ACIDS

    AMINOSYN-PF 7%, AMINO ACIDS

    AMINOSYN-RF 5.2%, AMINO ACIDS

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE

    AQUASOL A, VITAMIN A PALMITATE

    ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, ARTICAINE HYDROCHLORIDE

    ATROPINE SULFATE ANSYR PLASTIC SYRINGE, ATROPINE SULFATE

    AZITHROMYCIN, AZITHROMYCIN

    BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

    BLEOMYCIN SULFATE, BLEOMYCIN SULFATE

    BUMETANIDE, BUMETANIDE

    BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

    BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

    BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE

    BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE

    CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    CARBOCAINE, MEPIVACAINE HYDROCHLORIDE

    CARBOPLATIN, CARBOPLATIN

    CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE

    CHROMIC CHLORIDE IN PLASTIC CONTAINER, CHROMIC CHLORIDE

    CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN

    CIPROFLOXACIN, CIPROFLOXACIN

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CORLOPAM, FENOLDOPAM MESYLATE

    CUPRIC CHLORIDE IN PLASTIC CONTAINER, CUPRIC CHLORIDE

    CYTARABINE, CYTARABINE

    DACARBAZINE, DACARBAZINE

    DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE

    DEMEROL, MEPERIDINE HYDROCHLORIDE

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 25%, DEXTROSE

    DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE

    DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE

    DIAZEPAM, DIAZEPAM

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

    DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE

    DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE

    DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE

    DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 68


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HOSPIRA INC

    DROPERIDOL, DROPERIDOL

    ENALAPRILAT, ENALAPRILAT

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    ERYTHROCIN, ERYTHROMYCIN LACTOBIONATE

    FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE

    FENTANYL CITRATE, FENTANYL CITRATE

    FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    FOSCARNET SODIUM, FOSCARNET SODIUM

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    FUROSEMIDE, FUROSEMIDE

    GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE

    HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN

    HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN

    HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN

    HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM

    HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN

    HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM

    HEPARIN SODIUM, HEPARIN SODIUM

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    ISOFLURANE, ISOFLURANE

    ISUPREL, ISOPROTERENOL HYDROCHLORIDE

    KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    LEVOPHED, NOREPINEPHRINE BITARTRATE

    LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE

    LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, LIDOCAINE

    LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LORAZEPAM, LORAZEPAM

    LTA II KIT, LIDOCAINE HYDROCHLORIDE

    M.V.I. ADULT (PHARMACY BULK PACKAGE), ASCORBIC ACID

    M.V.I. ADULT, ASCORBIC ACID

    M.V.I. PEDIATRIC, ASCORBIC ACID

    M.V.I.-12 (WITHOUT VITAMIN K), ASCORBIC ACID

    MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE

    MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE

    MAGNESIUM SULFATE, MAGNESIUM SULFATE

    MANGANESE CHLORIDE IN PLASTIC CONTAINER, MANGANESE CHLORIDE

    MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL

    MANNITOL 25%, MANNITOL

    MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL

    MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

    MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

    MARCAINE HYDROCHLORIDE W/ EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

    MARCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE

    MARCAINE, BUPIVACAINE HYDROCHLORIDE

    MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 69


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HOSPIRA INC

    METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE

    MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE

    MORPHINE SULFATE, MORPHINE SULFATE

    NALBUPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE

    NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

    NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN

    NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    NORMOSOL-R IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PACLITAXEL, PACLITAXEL

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    PANCURONIUM BROMIDE, PANCURONIUM BROMIDE

    PHENYTOIN SODIUM, PHENYTOIN SODIUM

    PHYSIOSOL IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE

    PLEGISOL IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    POTASSIUM ACETATE IN PLASTIC CONTAINER, POTASSIUM ACETATE

    POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE

    POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE

    POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PRECEDEX, DEXMEDETOMIDINE HYDROCHLORIDE

    PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 70


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **
* HOSPIRA INC
    PROPOFOL, PROPOFOL
    QUELICIN PRESERVATIVE FREE, SUCCINYLCHOLINE CHLORIDE
    QUELICIN, SUCCINYLCHOLINE CHLORIDE

    RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

    ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE

    SODIUM ACETATE IN PLASTIC CONTAINER, SODIUM ACETATE ANHYDROUS

    SODIUM BICARBONATE, SODIUM BICARBONATE

    SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM CHLORIDE

    SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM LACTATE

    SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

    SORBITOL-MANNITOL IN PLASTIC CONTAINER, MANNITOL

    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

    STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION

    SUFENTANIL CITRATE, SUFENTANIL CITRATE

    TALWIN, PENTAZOCINE LACTATE

    TAZICEF, CEFTAZIDIME

    THAM, TROMETHAMINE

    TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, TOBRAMYCIN SULFATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    TPN ELECTROLYTES IN PLASTIC CONTAINER, CALCIUM CHLORIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    VECURONIUM BROMIDE, VECURONIUM BROMIDE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

    VITAMIN K1, PHYTONADIONE

    ZINC CHLORIDE IN PLASTIC CONTAINER, ZINC CHLORIDE

*	 HOSPIRA WORLDWIDE, INC

    DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE

    FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

    NITROPRESS, SODIUM NITROPRUSSIDE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE

HOSPIRA INC

*	 HOSPIRA INC

    A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE

    ADENOSINE, ADENOSINE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE

    ATRACURIUM BESYLATE, ATRACURIUM BESYLATE

    CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

    CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE

    CEFOTAXIME SODIUM, CEFOTAXIME SODIUM

    CEFOXITIN, CEFOXITIN SODIUM

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CEFUROXIME SODIUM, CEFUROXIME SODIUM

    DAPTOMYCIN, DAPTOMYCIN

    DOCETAXEL, DOCETAXEL

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    HEPARIN SODIUM, HEPARIN SODIUM

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    IMIPENEM AND CILASTATIN, CILASTATIN SODIUM

    LEVETIRACETAM, LEVETIRACETAM

    MAXIPIME, CEFEPIME HYDROCHLORIDE

    MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE

    MEROPENEM, MEROPENEM

    MILRINONE LACTATE, MILRINONE LACTATE

    MORPHINE SULFATE, MORPHINE SULFATE

    NIPENT, PENTOSTATIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 71


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   H   **

*	 HOSPIRA INC

    OXALIPLATIN, OXALIPLATIN

    PARICALCITOL, PARICALCITOL

    PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM

    THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

HOSPIRA WORLDWIDE

*	 HOSPIRA WORLDWIDE PTY

    OXALIPLATIN, OXALIPLATIN

HOT SHOTS NM LLC

*	 HOT SHOTS NUCLEAR MEDICINE LLC

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

HOUSTON CYCLOTRON

*	 HOUSTON CYCLOTRON PARTNERS LP

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

HQ SPCLT PHARMA

*	 HQ SPECIALTY PHARMA CORP

    CISPLATIN, CISPLATIN

    TAXOL, PACLITAXEL

HQ SPECIALITY PHARMA

*	 HQ SPECIALITY PHARMA LLC

    LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM

HQ SPECLT PHARMA

*	 HQ SPECIALTY PHARMA

    VUMON, TENIPOSIDE

HRA PHARMA

*	 HRA PHARMA LLC

    METOPIRONE, METYRAPONE

HYPERION THERAP INC

*	 HYPERION THERAPEUTICS INC

    RAVICTI, GLYCEROL PHENYLBUTYRATE

HYPERION THERAPS INC

*	 HYPERION THERAPEUTICS INC

    BUPHENYL, SODIUM PHENYLBUTYRATE

ROCHE

*	 HOFFMANN LA ROCHE INC

    BONIVA, IBANDRONATE SODIUM

    COPEGUS, RIBAVIRIN

    FUZEON, ENFUVIRTIDE

    KLONOPIN, CLONAZEPAM

    TAMIFLU, OSELTAMIVIR PHOSPHATE

    VALIUM, DIAZEPAM

                                         **   I   **

IDENTI PHARMS INC

*	 IDENTI PHARMACEUTICALS INC

    FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

IGI LABS INC

*	 IGI LABORATORIES INC

    BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    ECONAZOLE NITRATE, ECONAZOLE NITRATE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

IMPAX LABS

*	 IMPAX LABORATORIES INC

    ACARBOSE, ACARBOSE

    ALPRAZOLAM, ALPRAZOLAM

    ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE

    BACLOFEN, BACLOFEN

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		               B - 72


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   I   **

*	 IMPAX LABORATORIES INC

    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    COLESTIPOL HYDROCHLORIDE, COLESTIPOL HYDROCHLORIDE

    DANTROLENE SODIUM, DANTROLENE SODIUM

    DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE

    DIGOXIN, DIGOXIN

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    FENOFIBRATE (MICRONIZED), FENOFIBRATE

    FENOFIBRATE, FENOFIBRATE

    FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE    (OTC)

    LORATADINE, LORATADINE    (OTC)

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHYLTESTOSTERONE, METHYLTESTOSTERONE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE

    OMEPRAZOLE, OMEPRAZOLE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    PENTOXIFYLLINE, PENTOXIFYLLINE

    PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE

    PRIMIDONE, PRIMIDONE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE

    RILUZOLE, RILUZOLE

    RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

    TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE

IMPAX LABS INC

*	 IMPAX LABORATORIES INC

    CABERGOLINE, CABERGOLINE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DOXYCYCLINE, DOXYCYCLINE

    LAMOTRIGINE, LAMOTRIGINE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    URSODIOL, URSODIOL

IMPAX PHARMS

*	 IMPAX PHARMACEUTICALS

    FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE,   FEXOFENADINE

    FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE

    GEMFIBROZIL, GEMFIBROZIL

    MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

INCYTE CORP

*	 INCYTE CORP

    JAKAFI, RUXOLITINIB PHOSPHATE

INDICUS PHARMA

*	 INDICUS PHARMA LLC

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    LETROZOLE, LETROZOLE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

INDOCO REMEDIES

*	 INDOCO REMEDIES LTD

    BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE

    GLIMEPIRIDE, GLIMEPIRIDE

INJECTALIA

* INJECTALIA SRL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		      B - 73


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   I   **

*	 INJECTALIA SRL

     SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

INNOCUTIS HOLDINGS

*	 INNOCUTIS HOLDINGS LLC

     SITAVIG, ACYCLOVIR

INNOPHARMA LICENSING

*	 INNOPHARMA LICENSING LLC

     ACETYLCYSTEINE, ACETYLCYSTEINE

     TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

INO

*	 INO THERAPEUTICS INC

     INOMAX, NITRIC OXIDE

INST BIOCHEM

*	 INSTITUT BIOCHEMIQUE SA

     FLECTOR, DICLOFENAC EPOLAMINE

INST BIOCHIMIQUE

*	 INSTITUTE BIOCHIMIQUE SA (IBSA)

     TIROSINT, LEVOTHYROXINE SODIUM

INSTITUT BIOCHIMIQUE

*	 INSTITUT BIOCHIMIQUE SA IBSA

     TIROSINT, LEVOTHYROXINE SODIUM

INSYS THERAP

*	 INSYS THERAPEUTICS INC

     DRONABINOL, DRONABINOL

     SUBSYS, FENTANYL

INTELLIPHARMACEUTICS

*	 INTELLIPHARMACEUTICS CORP

     DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE

INTERGEL PHARM

*	 INTERGEL PHARMACEUTICAL INC

     NIFEDIPINE, NIFEDIPINE

INTERMUNE INC

*	 INTERMUNE INC

     ESBRIET, PIRFENIDONE

INTL MEDICATED

*	 INTERNATIONAL MEDICATED SYSTEMS LTD

     MILRINONE LACTATE, MILRINONE LACTATE

INTL MEDICATION

*	 INTERNATIONAL MEDICATION SYSTEM

     LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE

     LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE

     LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

     MANNITOL 25%, MANNITOL

     NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

     PHYTONADIONE, PHYTONADIONE

*	 INTERNATIONAL MEDICATION SYSTEMS LTD

     DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

INTL MEDICATION SYS

*	 INTERNATIONAL MEDICATION SYSTEMS LTD

     LORAZEPAM, LORAZEPAM

INVAGEN PHARMS

*	 INVAGEN PHARMACEUTICALS INC

     ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

     AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

     BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

     CALCIUM ACETATE, CALCIUM ACETATE

     CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE

     CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

     CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

     ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

     FOLIC ACID, FOLIC ACID

     FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

     FOSINOPRIL SODIUM, FOSINOPRIL SODIUM

     GABAPENTIN, GABAPENTIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		        B - 74


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   I   **

*	 INVAGEN PHARMACEUTICALS INC

     GEMFIBROZIL, GEMFIBROZIL

     GLIMEPIRIDE, GLIMEPIRIDE

     HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

     HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

     LEVETIRACETAM, LEVETIRACETAM

     LISINOPRIL, LISINOPRIL

     MEPROBAMATE, MEPROBAMATE

     NABUMETONE, NABUMETONE

     NAPROXEN, NAPROXEN

     ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

     PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

     QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

     QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

     RALOXIFENE HYDROCHLORIDE, RALOXIFENE HYDROCHLORIDE

     RAMIPRIL, RAMIPRIL

     RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

     SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

     TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

     TOPIRAMATE, TOPIRAMATE

     TRANDOLAPRIL, TRANDOLAPRIL

     WARFARIN SODIUM, WARFARIN SODIUM

     ZOLMITRIPTAN, ZOLMITRIPTAN

     ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

     ZONISAMIDE, ZONISAMIDE

INVENTIA HLTHCARE

*	 INVENTIA HEALTHCARE PRIVATE LTD

     METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

IPCA LABS LTD

*	 IPCA LABORATORIES LTD

     ALLOPURINOL, ALLOPURINOL

     ATENOLOL, ATENOLOL

     CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

     CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE    (OTC)

     CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE

     FUROSEMIDE, FUROSEMIDE

     HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

     HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

     LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

     LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

     METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

     METOPROLOL TARTRATE, METOPROLOL TARTRATE

     ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

     PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

     TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

     WARFARIN SODIUM, WARFARIN SODIUM

IPR

*	 IPR PHARMACEUTICALS INC

     ATENOLOL AND CHLORTHALIDONE, ATENOLOL

     ATENOLOL, ATENOLOL

     CRESTOR, ROSUVASTATIN CALCIUM

     ZOMIG, ZOLMITRIPTAN

IPR PHARMS INC

*	 IPR PHARMACEUTICALS INC

     CAPRELSA, VANDETANIB

IPSEN INC

*	 IPSEN BIOPHARMACEUTICALS INC

     INCRELEX, MECASERMIN RECOMBINANT

IPSEN PHARMA

*	 IPSEN PHARMA BIOTECH SAS

     SOMATULINE DEPOT, LANREOTIDE ACETATE

IROKO PHARMS

*	 IROKO PHARMACEUTICALS LLC

     INDOCIN, INDOMETHACIN

IROKO PHARMS LLC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 75


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   I   **

*	 IROKO PHARMACEUTICALS LLC

    TIVORBEX, INDOMETHACIN

    ZORVOLEX, DICLOFENAC

ISO TEX

*	 ISO TEX DIAGNOSTICS INC

    JEANATOPE, ALBUMIN IODINATED I-125 SERUM

    MEGATOPE, ALBUMIN IODINATED I-131 SERUM

ISOTEX

*	 ISOTEX DIAGNOSTICS

    GLOFIL-125, IOTHALAMATE SODIUM I-125

ISTITUTO BIO ITA SPA

*	 ISTITUTO BIOCHIMICO ITALIANO SPA

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

    NAFCILLIN SODIUM, NAFCILLIN SODIUM

    PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM

    PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM

    PIPERACILLIN, PIPERACILLIN SODIUM

IVAX INTL

*	 IVAX INTERNATIONAL GMBH

    AMRIX, CYCLOBENZAPRINE HYDROCHLORIDE

    SYNRIBO, OMACETAXINE MEPESUCCINATE

IVAX PHARMS

*	 IVAX PHARMACEUTICALS INC

    VALSARTAN, VALSARTAN

IVAX SUB TEVA PHARMS

*	 IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA

    ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE

    BACLOFEN, BACLOFEN

    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BUMETANIDE, BUMETANIDE

    CABERGOLINE, CABERGOLINE

    CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CIMETIDINE, CIMETIDINE    (OTC)

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLOZAPINE, CLOZAPINE

    CYCLOSPORINE, CYCLOSPORINE

    CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

    DIAZEPAM, DIAZEPAM

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    FAMOTIDINE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE    (OTC)

    FLUCONAZOLE, FLUCONAZOLE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUTAMIDE, FLUTAMIDE

    FUROSEMIDE, FUROSEMIDE

    GABAPENTIN, GABAPENTIN

    GLIPIZIDE, GLIPIZIDE

    GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE

    GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    INDAPAMIDE, INDAPAMIDE

    INDOMETHACIN, INDOMETHACIN

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LORAZEPAM, LORAZEPAM

    METHYLDOPA, METHYLDOPA

    MISOPROSTOL, MISOPROSTOL

    NADOLOL, NADOLOL

    NICOTINE POLACRILEX, NICOTINE POLACRILEX    (OTC)

    NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE

    OXAPROZIN, OXAPROZIN

    PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 76


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   I   **

*	 IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

    SIMVASTATIN, SIMVASTATIN

    TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE

    TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

                                         **   J   **

JACOBUS

*	 JACOBUS PHARMACEUTICAL CO

    DAPSONE, DAPSONE

    PASER, AMINOSALICYLIC ACID

JANSSEN BIOTECH

*	 JANSSEN BIOTECH INC

    ZYTIGA, ABIRATERONE ACETATE

JANSSEN PHARMS

*	 JANSSEN PHARMACEUTICALS INC

    AXERT, ALMOTRIPTAN MALATE

    CONCERTA, METHYLPHENIDATE HYDROCHLORIDE

    DITROPAN XL, OXYBUTYNIN CHLORIDE

    DURAGESIC-100, FENTANYL

    DURAGESIC-12, FENTANYL

    DURAGESIC-25, FENTANYL

    DURAGESIC-50, FENTANYL

    DURAGESIC-75, FENTANYL

    ELMIRON, PENTOSAN POLYSULFATE SODIUM

    HALDOL, HALOPERIDOL DECANOATE

    HALDOL, HALOPERIDOL LACTATE

    INVEGA SUSTENNA, PALIPERIDONE PALMITATE

    INVEGA, PALIPERIDONE

    INVOKAMET, CANAGLIFLOZIN

    INVOKANA, CANAGLIFLOZIN

    LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER,       LEVOFLOXACIN

    LEVAQUIN, LEVOFLOXACIN

    MICRONOR, NORETHINDRONE

    MODICON 28, ETHINYL ESTRADIOL

    NIZORAL, KETOCONAZOLE

    NUCYNTA ER, TAPENTADOL HYDROCHLORIDE

    NUCYNTA, TAPENTADOL HYDROCHLORIDE

    ORTHO CYCLEN-28, ETHINYL ESTRADIOL

    ORTHO EVRA, ETHINYL ESTRADIOL

    ORTHO TRI-CYCLEN LO, ETHINYL ESTRADIOL

    ORTHO TRI-CYCLEN, ETHINYL ESTRADIOL

    ORTHO-CEPT, DESOGESTREL

    ORTHO-NOVUM 1/35-28, ETHINYL ESTRADIOL

    ORTHO-NOVUM 7/7/7-28, ETHINYL ESTRADIOL

    PANCREAZE, PANCRELIPASE (AMYLASE

    RAZADYNE ER, GALANTAMINE HYDROBROMIDE

    RAZADYNE, GALANTAMINE HYDROBROMIDE

    RISPERDAL CONSTA, RISPERIDONE

    RISPERDAL, RISPERIDONE

    SPORANOX, ITRACONAZOLE

    TERAZOL 3, TERCONAZOLE

    TERAZOL 7, TERCONAZOLE

    TOPAMAX, TOPIRAMATE

    TYLENOL W/ CODEINE NO. 3, ACETAMINOPHEN

    TYLENOL W/ CODEINE NO. 4, ACETAMINOPHEN

    ULTRACET, ACETAMINOPHEN

    ULTRAM, TRAMADOL HYDROCHLORIDE

    XARELTO, RIVAROXABAN

JANSSEN PRODS

*	 JANSSEN PRODUCTS LP

    EDURANT, RILPIVIRINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		      B - 77


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   J   **

*	 JANSSEN PRODUCTS LP

    OLYSIO, SIMEPREVIR SODIUM

    PREZISTA, DARUNAVIR ETHANOLATE

JANSSEN R AND D

*	 JANSSEN RESEARCH AND DEVELOPMENT LLC

    INTELENCE, ETRAVIRINE

    PARAFON FORTE DSC, CHLORZOXAZONE

JANSSEN RES AND DEV

*	 JANSSEN RESEARCH AND DEVELOPMENT LLC

    DOXIL (LIPOSOMAL), DOXORUBICIN HYDROCHLORIDE

JANSSEN THERAP

*	 JANSSEN THERAPEUTICS DIV JANSSEN PRODUCTS LP

    SIRTURO, BEDAQUILINE FUMARATE

JAVELIN PHARMS INC

*	 JAVELIN PHARMACEUTICALS INC A WHOLLY OWNED SUDSIDIARY OF HOSPIRA INC

    DYLOJECT, DICLOFENAC SODIUM

JAZZ PHARMS

*	 JAZZ PHARMACEUTICALS INC

    LUVOX CR, FLUVOXAMINE MALEATE

    XYREM, SODIUM OXYBATE

JAZZ PHARMS III

*	 JAZZ PHARMACEUTICALS III INTERNATIONAL LTD

    FAZACLO ODT, CLOZAPINE

*	 JAZZ PHARMACEUTICALS INTERNATIONAL III

    VERSACLOZ, CLOZAPINE

JAZZ PHARMS INTL

*	 JAZZ PHARMACEUTICALS INTERNATIONAL LTD

    PRIALT, ZICONOTIDE ACETATE

JIANGSU HANSOH PHARM

*	 JIANGSU HANSOH PHARMACEUTICAL CO LTD

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

JIANGSU HENGRUI MED

*	 JIANGSU HENGRUI MEDICINE CO LTD

    CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LETROZOLE, LETROZOLE

    OXALIPLATIN, OXALIPLATIN

JOHNS HOPKINS UNIV

*	 JOHNS HOPKINS UNIV

    AMMONIA N 13, AMMONIA N-13

JOHNSON AND JOHNSON

*	 JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES

    MEN'S ROGAINE, MINOXIDIL    (OTC)

    ROGAINE (FOR MEN), MINOXIDIL    (OTC)

    ROGAINE (FOR WOMEN), MINOXIDIL     (OTC)

    ROGAINE EXTRA STRENGTH (FOR MEN), MINOXIDIL     (OTC)

    VISINE-A, NAPHAZOLINE HYDROCHLORIDE     (OTC)

    WOMEN'S ROGAINE, MINOXIDIL    (OTC)

*	 JOHNSON AND JOHNSON HEALTHCARE PRODUCTS

    VISINE L.R., OXYMETAZOLINE HYDROCHLORIDE     (OTC)

*	 JOHNSON AND JOHNSON HEALTHCARE PRODUCTS DIV MCNEIL-PPC INC

    NIZORAL A-D, KETOCONAZOLE    (OTC)

JUBILANT CADISTA

*	 JUBILANT CADISTA PHARMACEUTICALS INC

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    METHYLPREDNISOLONE, METHYLPREDNISOLONE

    PREDNISONE, PREDNISONE

    PROCOMP, PROCHLORPERAZINE MALEATE

    TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE

JUBILANT DRAXIMAGE

* JUBILANT DRAXIMAGE INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 78


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   J   **

*	 JUBILANT DRAXIMAGE INC

    AN-DTPA, TECHNETIUM TC-99M PENTETATE KIT

    DRAXIMAGE MDP-25, TECHNETIUM TC-99M MEDRONATE

    HICON, SODIUM IODIDE I-131

    PULMOLITE, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT

    SODIUM IODIDE I-131, SODIUM IODIDE I-131

JUBILANT GENERICS

*	 JUBILANT GENERICS LTD

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    LAMOTRIGINE, LAMOTRIGINE

    OLANZAPINE, OLANZAPINE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RISPERIDONE, RISPERIDONE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    SPIRONOLACTONE, SPIRONOLACTONE

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VALSARTAN, VALSARTAN

    ZOLMITRIPTAN, ZOLMITRIPTAN

STEVENS J

*	 JEROME STEVENS PHARMACEUTICALS INC

    BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN

    DIGOXIN, DIGOXIN

    METHOCARBAMOL AND ASPIRIN, ASPIRIN

    UNITHROID, LEVOTHYROXINE SODIUM **

                                         **   K   **

GRIFFEN

*	 KW GRIFFEN CO

    BIOSCRUB, CHLORHEXIDINE GLUCONATE    (OTC)

KALEO INC

*	 KALEO INC

    EVZIO, NALOXONE HYDROCHLORIDE

KEN LIFESCIENCE

*	 KEN LIFESCIENCE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

KERYX BIOPHARMS

*	 KERYX BIOPHARMACEUTICALS INC

    FERRIC CITRATE, FERRIC CITRATE

KING PHARMS

*	 KING PHARMACEUTICALS INC

    ALTACE, RAMIPRIL

    BICILLIN C-R 900/300, PENICILLIN G BENZATHINE

    BICILLIN C-R, PENICILLIN G BENZATHINE

    BICILLIN L-A, PENICILLIN G BENZATHINE

    CORGARD, NADOLOL

    CORZIDE, BENDROFLUMETHIAZIDE

    PENICILLIN G PROCAINE, PENICILLIN G PROCAINE

    SILVADENE, SILVER SULFADIAZINE

    SKELAXIN, METAXALONE

    SYNERCID, DALFOPRISTIN

    TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE

*	 KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC SUB KING PHARMACEUTICALS INC

    TAPAZOLE, METHIMAZOLE

    TUSSIGON, HOMATROPINE METHYLBROMIDE

KING PHARMS LLC

*	 KING PHARMACEUTICALS LLC

    AVINZA, MORPHINE SULFATE

KING PHARMS R AND D

*	 KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC

    CYTOMEL, LIOTHYRONINE SODIUM

    LEVOXYL, LEVOTHYROXINE SODIUM **

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		     B - 79


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   K   **

KNIGHT THERAPS

*	 KNIGHT THERAPEUTICS USA INC

    IMPAVIDO, MILTEFOSINE

KOWA CO

*	 KOWA CO LTD

    LIVALO, PITAVASTATIN CALCIUM

KREITCHMAN PET CTR

*	 KREITCHMAN PET CENTER

    AMMONIA N 13, AMMONIA N-13

KREMERS URBAN DEV

*	 KREMERS URBAN DEVELOPMENT CO

    RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

KREMERS URBAN PHARMS

*	 KREMERS URBAN PHARMACEUTICALS INC

    GLYCOLAX, POLYETHYLENE GLYCOL 3350

    GLYCOLAX, POLYETHYLENE GLYCOL 3350   (OTC)

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    MONOKET, ISOSORBIDE MONONITRATE

    OMEPRAZOLE, OMEPRAZOLE

KRKA TOVARNA ZDRAVIL

*	 KRKA TOVARNA ZDRAVIL DD NOVO MESTO

    LANSOPRAZOLE , LANSOPRAZOLE

KUDCO IRELAND

*	 KUDCO IRELAND LTD

    ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

    LETROZOLE, LETROZOLE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

KVK TECH

*	 KVK TECH INC

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

    BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    KALEXATE, SODIUM POLYSTYRENE SULFONATE

    PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

                                         **   L   **

L PERRIGO CO

*	 L PERRIGO CO

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

LAB HRA PHARMA

*	 LABORATOIRE HRA PHARMA

    ELLA, ULIPRISTAL ACETATE

LANDELA PHARM

*	 LANDELA PHARMACEUTICAL

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

LANNETT

*	 LANNETT CO INC

    ACETAZOLAMIDE, ACETAZOLAMIDE

    DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE

    DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE

    LANIAZID, ISONIAZID

    LANORINAL, ASPIRIN

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PRIMIDONE, PRIMIDONE

    PROBALAN, PROBENECID

*	 LANNETT HOLDINGS INC

    BACLOFEN, BACLOFEN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 80


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   L   **

*	 LANNETT HOLDINGS INC

    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    DANAZOL, DANAZOL

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DOXYCYCLINE, DOXYCYCLINE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE

    RIFAMPIN, RIFAMPIN

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

    URSODIOL, URSODIOL

LANNETT HOLDINGS INC

*	 LANNETT HOLDINGS INC

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

    CODEINE SULFATE, CODEINE SULFATE

    DIAZEPAM, DIAZEPAM

    DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LETROZOLE, LETROZOLE

    LOXAPINE SUCCINATE, LOXAPINE SUCCINATE

    METHOCARBAMOL, METHOCARBAMOL

    MORPHINE SULFATE, MORPHINE SULFATE

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PHENTERMINE RESIN COMPLEX, PHENTERMINE RESIN COMPLEX

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

LANTHEUS MEDCL

*	 LANTHEUS MEDICAL IMAGING INC

    ABLAVAR, GADOFOSVESET TRISODIUM

    CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT

    DEFINITY, PERFLUTREN

    GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67

    NEUROLITE, TECHNETIUM TC-99M BICISATE KIT

    TECHNELITE, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

    THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201

    XENON XE 133, XENON XE-133

LANTHEUS MEDICAL

*	 LANTHEUS MEDICAL IMAGING INC

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    QUADRAMET, SAMARIUM SM-153 LEXIDRONAM PENTASODIUM

LARKEN LABS

*	 LARKEN LABORATORIES INC

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

LAVIPHARM LABS

*	 LAVIPHARM LABORATORIES INC

    FENTANYL-100, FENTANYL

    FENTANYL-25, FENTANYL

    FENTANYL-50, FENTANYL

    FENTANYL-75, FENTANYL

LEHIGH VALLEY

*	 LEHIGH VALLEY TECHNOLOGIES INC

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

LEK PHARMS

*	 LEK PHARMACEUTICALS D D

    BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE

LEK PHARMS DD

*	 LEK PHARMACEUTICALS DD

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 81


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   L   **

LEO PHARMA AS

*	 LEO PHARMA AS

     DOVONEX, CALCIPOTRIENE

     PICATO, INGENOL MEBUTATE

     TACLONEX, BETAMETHASONE DIPROPIONATE

LG LIFE

*	 LG LIFE SCIENCES LTD

     VALTROPIN, SOMATROPIN RECOMBINANT

LG LIFE SCIENCES

*	 LG LIFE SCIENCES LTD

     FACTIVE, GEMIFLOXACIN MESYLATE

LLOYD

*	 LLOYD INC

     LEVOTHROID, LEVOTHYROXINE SODIUM **

LNK

*	 LNK INTERNATIONAL INC

     DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE    (OTC)

     IBUPROFEN, IBUPROFEN    (OTC)

     LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

LOREAL USA

*	 LOREAL USA PRODUCTS INC

     ANTHELIOS 20, AVOBENZONE    (OTC)

     ANTHELIOS 40, AVOBENZONE    (OTC)

     ANTHELIOS SX, AVOBENZONE    (OTC)

     CAPITAL SOLEIL 15, AVOBENZONE    (OTC)

LOTUS PHARM CO LTD

*	 LOTUS PHARMACEUTICAL CO LTD

     LEVETIRACETAM, LEVETIRACETAM

LUITPOLD

*	 LUITPOLD PHARMACEUTICALS INC

     ACETYLCYSTEINE, ACETYLCYSTEINE

     ADENOSINE, ADENOSINE

     AMINOCAPROIC ACID, AMINOCAPROIC ACID

     AMINOPHYLLINE, AMINOPHYLLINE

     BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

     BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE

     BROMFENAC SODIUM, BROMFENAC SODIUM

     BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

     CAFFEINE CITRATE, CAFFEINE CITRATE

     CALCITRIOL, CALCITRIOL

     CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM

     CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

     CYANOCOBALAMIN, CYANOCOBALAMIN

     CYCLOSPORINE, CYCLOSPORINE

     DACTINOMYCIN, DACTINOMYCIN

     DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE

     DEXFERRUM, IRON DEXTRAN

     DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE

     DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

     DROPERIDOL, DROPERIDOL

     ESTRADIOL VALERATE, ESTRADIOL VALERATE

     ETOMIDATE, ETOMIDATE

     FOMEPIZOLE, FOMEPIZOLE

     FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

     FUROSEMIDE, FUROSEMIDE

     GANCICLOVIR, GANCICLOVIR SODIUM

     GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

     GLYCOPYRROLATE, GLYCOPYRROLATE

     GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

     HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

     HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

     IBUTILIDE FUMARATE, IBUTILIDE FUMARATE

     INJECTAFER, FERRIC CARBOXYMALTOSE

     LATANOPROST, LATANOPROST

     LEVETIRACETAM, LEVETIRACETAM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 82


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   L   **

*	 LUITPOLD PHARMACEUTICALS INC

    LEVOCARNITINE, LEVOCARNITINE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    MANNITOL 25%, MANNITOL

    METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE

    METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN

    NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    NITROGLYCERIN, NITROGLYCERIN

    OLANZAPINE, OLANZAPINE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    PHENYTOIN SODIUM, PHENYTOIN SODIUM

    PROGESTERONE, PROGESTERONE

    SPRIX, KETOROLAC TROMETHAMINE

    TORSEMIDE, TORSEMIDE

    TRANEXAMIC ACID, TRANEXAMIC ACID

    TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE, TRIMETHOBENZAMIDE HYDROCHLORIDE

    TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE

    VENOFER, IRON SUCROSE

    ZIDOVUDINE, ZIDOVUDINE

LUKARE MEDICAL LLC

*	 LUKARE MEDICAL LLC

    ELLIOTTS B SOLUTION, CALCIUM CHLORIDE

LUMARA HEALTH INC

*	 LUMARA HEALTH INC

    MAKENA, HYDROXYPROGESTERONE CAPROATE

LUNDBECK LLC

*	 LUNDBECK LLC

    ONFI, CLOBAZAM

    SABRIL, VIGABATRIN

LUNDBECK NA LTD

*	 LUNDBECK NA LTD

    NORTHERA, DROXIDOPA

LUPIN

*	 LUPIN LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    CARVEDILOL, CARVEDILOL

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CEFDINIR, CEFDINIR

    CEFOTAXIME SODIUM, CEFOTAXIME SODIUM

    CEFPROZIL, CEFPROZIL

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CEFUROXIME AXETIL, CEFUROXIME AXETIL

    CEPHALEXIN, CEPHALEXIN

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN, LEVOFLOXACIN

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LOVASTATIN, LOVASTATIN

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RAMIPRIL, RAMIPRIL

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SIMVASTATIN, SIMVASTATIN

    TOPIRAMATE, TOPIRAMATE

    TRANDOLAPRIL, TRANDOLAPRIL

LUPIN ATLANTIS

*	 LUPIN ATLANTIS HOLDINGS SA

    ANTARA (MICRONIZED), FENOFIBRATE

LUPIN LTD

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		        B - 83


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   L   **

*	 LUPIN LIMITED

    LEVETIRACETAM, LEVETIRACETAM

    LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

*	 LUPIN LTD

    ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE, ABACAVIR SULFATE

    CELECOXIB, CELECOXIB

    CIPROFLOXACIN, CIPROFLOXACIN

    DAYSEE, ETHINYL ESTRADIOL

    DOXYCYCLINE, DOXYCYCLINE

    DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ENSKYCE, DESOGESTREL

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    ESZOPICLONE, ESZOPICLONE

    FALLBACK SOLO, LEVONORGESTREL    (OTC)

    FAMOTIDINE, FAMOTIDINE

    FENOFIBRATE, FENOFIBRATE

    FENOFIBRIC ACID, CHOLINE FENOFIBRATE

    GATIFLOXACIN, GATIFLOXACIN

    IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE

    IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    JENCYCLA, NORETHINDRONE

    KURVELO, ETHINYL ESTRADIOL

    LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE

    LAMIVUDINE, LAMIVUDINE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    LORAZEPAM, LORAZEPAM

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MEFENAMIC ACID, MEFENAMIC ACID

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE

    NABUMETONE, NABUMETONE

    NIACIN, NIACIN

    NIKKI, DROSPIRENONE

    NORETHINDRONE, NORETHINDRONE

    PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    PIRMELLA 1/35, ETHINYL ESTRADIOL

    PIRMELLA 7/7/7, ETHINYL ESTRADIOL

    PREGABALIN, PREGABALIN

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

    RANOLAZINE, RANOLAZINE

    RIFABUTIN, RIFABUTIN

    SUPRAX, CEFIXIME

    TELMISARTAN AND AMLODIPINE, AMLODIPINE BESYLATE

    TELMISARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    VALSARTAN, VALSARTAN

    VYFEMLA, ETHINYL ESTRADIOL

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

LUPIN PHARMS

*	 LUPIN PHARMACEUTICALS INC

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    DESLORATADINE, DESLORATADINE

    MELOXICAM, MELOXICAM

    NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		             B - 84


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   L   **

*	 LUPIN PHARMACEUTICALS INC

    RIFAMPIN, RIFAMPIN

    SUPRAX, CEFIXIME

    ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE

LYNE

*	 LYNE LABORATORIES INC

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE

    CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE

    CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

    DEXAMETHASONE, DEXAMETHASONE

    HYDROCORTISONE, HYDROCORTISONE

    LEVOCARNITINE, LEVOCARNITINE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

PERRIGO

*	 L PERRIGO CO

    ACETAMINOPHEN, ACETAMINOPHEN      (OTC)

    ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN       (OTC)

    CHILDREN'S IBUPROFEN, IBUPROFEN      (OTC)

    CROMOLYN SODIUM, CROMOLYN SODIUM      (OTC)

    DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE       (OTC)

    FAMOTIDINE, FAMOTIDINE     (OTC)

    IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN       (OTC)

    IBUPROFEN, IBUPROFEN    (OTC)

    LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE   (OTC)

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE       (OTC)

    LORATADINE, LORATADINE     (OTC)

    MICONAZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE       (OTC)

    MICONAZOLE NITRATE, MICONAZOLE NITRATE       (OTC)

    MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL       (OTC)

    NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM   (OTC)

    NAPROXEN SODIUM, NAPROXEN SODIUM      (OTC)

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE       (OTC)

    TAB-PROFEN, IBUPROFEN     (OTC)

    TIOCONAZOLE, TIOCONAZOLE     (OTC)

                                         **   M   **

MA GENERAL HOSP

*	 MASSACHUSETTS GENERAL HOSP

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

MACLEODS PHARMS LTD

*	 MACLEODS PHARMACEUTICALS LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FAMCICLOVIR, FAMCICLOVIR

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    LEVOFLOXACIN, LEVOFLOXACIN

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    OLANZAPINE, OLANZAPINE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

MALLINCKRODT

*	 MALLINCKRODT CHEMICAL INC

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    METHADOSE, METHADONE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                    B - 85


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MALLINCKRODT INC

    ANEXSIA 5/325, ACETAMINOPHEN

    ANEXSIA 7.5/325, ACETAMINOPHEN

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    FENTANYL CITRATE, FENTANYL CITRATE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    METHYLIN, METHYLPHENIDATE HYDROCHLORIDE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE

    OPTIMARK IN PLASTIC CONTAINER, GADOVERSETAMIDE

    OPTIMARK, GADOVERSETAMIDE

    OXYCET, ACETAMINOPHEN

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    TECHNETIUM TC-99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

*	 MALLINCKRODT MEDICAL INC

    CONRAY 30, IOTHALAMATE MEGLUMINE

    CONRAY 43, IOTHALAMATE MEGLUMINE

    CONRAY, IOTHALAMATE MEGLUMINE

    CYSTO-CONRAY II, IOTHALAMATE MEGLUMINE

    GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67

    INDIUM IN 111 CHLORIDE, INDIUM IN-111 CHLORIDE

    MD-76R, DIATRIZOATE MEGLUMINE

    MD-GASTROVIEW, DIATRIZOATE MEGLUMINE

    OCTREOSCAN, INDIUM IN-111 PENTETREOTIDE KIT

    OPTIRAY 240, IOVERSOL

    OPTIRAY 300, IOVERSOL

    OPTIRAY 320, IOVERSOL

    OPTIRAY 350, IOVERSOL

    SODIUM IODIDE I 123, SODIUM IODIDE I-123

    SODIUM IODIDE I 131, SODIUM IODIDE I-131

    TECHNESCAN MAG3, TECHNETIUM TC-99M MERTIATIDE KIT

    TECHNESCAN PYP KIT, TECHNETIUM TC-99M PYROPHOSPHATE KIT

    TECHNESCAN, TECHNETIUM TC-99M OXIDRONATE KIT

    THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201

    ULTRA-TECHNEKOW FM, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

    ULTRATAG, TECHNETIUM TC-99M RED BLOOD CELL KIT

MALLINCKRODT INC

*	 MALLINCKRODT INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE,   AMPHETAMINE

    EXALGO, HYDROMORPHONE HYDROCHLORIDE

    FENTANYL-100, FENTANYL

    FENTANYL-25, FENTANYL

    FENTANYL-50, FENTANYL

    FENTANYL-75, FENTANYL

    GABLOFEN, BACLOFEN

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    METHYLIN ER, METHYLPHENIDATE HYDROCHLORIDE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    RESTORIL, TEMAZEPAM

    ROXICODONE, OXYCODONE HYDROCHLORIDE

    TOFRANIL, IMIPRAMINE HYDROCHLORIDE

    TOFRANIL-PM, IMIPRAMINE PAMOATE

                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		    B - 86


               APPENDIX B       -   PRODUCT NAME SORTED BY APPLICANT

                                           **   M   **

*	 MALLINCKRODT INC

    XARTEMIS XR, ACETAMINOPHEN

MALLINCKRODT LLC

*	 MALLINCKRODT LLC

    ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE

    PAMELOR, NORTRIPTYLINE HYDROCHLORIDE

MARATHON PHARMS

*	 MARATHON PHARMACEUTICALS LLC

    PEPCID, FAMOTIDINE

    SECONAL SODIUM, SECOBARBITAL SODIUM

MARATHON PHARMS LLC

*	 MARATHON PHARMACEUTICALS LLC

    IPRIVASK, DESIRUDIN RECOMBINANT

MARKSANS PHARMA

*	 MARKSANS PHARMA LTD

    GABAPENTIN, GABAPENTIN

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN     (OTC)

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    NAPROXEN SODIUM, NAPROXEN SODIUM      (OTC)

    NAPROXEN, NAPROXEN

MATAWAN PHARMS

*	 MATAWAN PHARMACEUTICALS LLC

    TRETINOIN, TRETINOIN

MATRIX LABS LTD

*	 MATRIX LABORATORIES LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    NIFEDIPINE, NIFEDIPINE

    STAVUDINE, STAVUDINE

MAYER LABS INC

*	 MAYER LABORATORIES INC

    TODAY, NONOXYNOL-9     (OTC)

MAYNE PHARMA

*	 MAYNE PHARMA INTERNATIONAL PTY LTD

    DORYX, DOXYCYCLINE HYCLATE

    DOXTERIC, DOXYCYCLINE HYCLATE

    ERYC, ERYTHROMYCIN

MCNEIL

*	 MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC

    CHILDREN'S MOTRIN, IBUPROFEN      (OTC)

    IBUPROFEN, IBUPROFEN     (OTC)

    IMODIUM A-D EZ CHEWS, LOPERAMIDE HYDROCHLORIDE       (OTC)

    IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE       (OTC)

    MOTRIN IB, IBUPROFEN     (OTC)

    MOTRIN MIGRAINE PAIN, IBUPROFEN      (OTC)

    ZYRTEC-D 12 HOUR, CETIRIZINE HYDROCHLORIDE       (OTC)

MCNEIL CONS

*	 MCNEIL CONSUMER HEALTHCARE

    CHILDREN'S MOTRIN COLD, IBUPROFEN      (OTC)

    CHILDREN'S MOTRIN, IBUPROFEN      (OTC)

    IMODIUM A-D, LOPERAMIDE HYDROCHLORIDE       (OTC)

    IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE       (OTC)

    IMODIUM, LOPERAMIDE HYDROCHLORIDE

    JUNIOR STRENGTH MOTRIN, IBUPROFEN      (OTC)

    PEPCID AC , FAMOTIDINE     (OTC)

    PEPCID AC, FAMOTIDINE     (OTC)

    PEPCID COMPLETE, CALCIUM CARBONATE       (OTC)

    SINE-AID IB, IBUPROFEN     (OTC)

    SUDAFED 12 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE       (OTC)

    SUDAFED 24 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE       (OTC)

    TYLENOL , ACETAMINOPHEN     (OTC)

MCNEIL CONSUMER

*	 MCNEIL CONSUMER HEALTHCARE DIV MCNEIL PPC INC

    CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE       (OTC)

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		    B - 87


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                        **   M   **

*	 MCNEIL CONSUMER HEALTHCARE DIV MCNEIL PPC INC

    CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

    ZYRTEC, CETIRIZINE HYDROCHLORIDE

MCPRF

*	 MAYO CLINIC PET RADIOCHEMISTRY FACILITY

    AMMONIA N 13, AMMONIA N-13

    CHOLINE C-11, CHOLINE C-11

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

MEDA PHARMS

*	 MEDA PHARMACEUTICALS

    DYMISTA, AZELASTINE HYDROCHLORIDE

    EDLUAR, ZOLPIDEM TARTRATE

*	 MEDA PHARMACEUTICALS INC

    ANADROL-50, OXYMETHOLONE

    ASTELIN, AZELASTINE HYDROCHLORIDE

    ASTEPRO, AZELASTINE HYDROCHLORIDE

    AVC, SULFANILAMIDE

    BUTISOL SODIUM, BUTABARBITAL SODIUM

    CESAMET, NABILONE

    COLYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350

    COLYTE, POLYETHYLENE GLYCOL 3350

    CORTIFOAM, HYDROCORTISONE ACETATE

    DEMADEX, TORSEMIDE

    DEPEN, PENICILLAMINE

    DIPENTUM, OLSALAZINE SODIUM

    ELESTRIN, ESTRADIOL

    EPIFOAM, HYDROCORTISONE ACETATE

    FELBATOL, FELBAMATE

    GASTROCROM, CROMOLYN SODIUM

    LUFYLLIN, DYPHYLLINE

    MUSE, ALPROSTADIL

    OPTIVAR, AZELASTINE HYDROCHLORIDE

    PROCTOFOAM HC, HYDROCORTISONE ACETATE

    ROWASA, MESALAMINE

    SFROWASA, MESALAMINE

    TRILYTE, POLYETHYLENE GLYCOL 3350

*	 MEDA PHARMACEUTICALS MEDA PHARMACEUTICALS INC

    SOMA COMPOUND W/ CODEINE, ASPIRIN

    SOMA COMPOUND, ASPIRIN

    SOMA, CARISOPRODOL

MEDA PHARMS INC

*	 MEDA PHARMACEUTICALS INC

    AEROSPAN HFA, FLUNISOLIDE

MEDAC PHARMA INC

*	 MEDAC PHARMA INC

    RASUVO, METHOTREXATE

MEDEFIL INC

*	 MEDEFIL INC

    SODIUM CHLORIDE 0.9%, SODIUM CHLORIDE

MEDICIS

*	 MEDICIS PHARMACEUTICAL CORP

    ALDARA, IMIQUIMOD

    AMMONUL, SODIUM BENZOATE

    CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    ESTRASORB, ESTRADIOL HEMIHYDRATE

    LOPROX, CICLOPIROX

    LUZU, LULICONAZOLE

    MAXAIR, PIRBUTEROL ACETATE

    METROGEL-VAGINAL, METRONIDAZOLE

    MINITRAN, NITROGLYCERIN

    NORFLEX, ORPHENADRINE CITRATE

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		       B - 88


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                        **   M   **

*	 MEDICIS PHARMACEUTICAL CORP

    NORGESIC FORTE, ASPIRIN

    NORGESIC, ASPIRIN

    SOLODYN, MINOCYCLINE HYDROCHLORIDE

    SYNACORT, HYDROCORTISONE

    THEOLAIR, THEOPHYLLINE

    VANOS, FLUOCINONIDE

    ZIANA, CLINDAMYCIN PHOSPHATE

    ZYCLARA, IMIQUIMOD

MEDICURE

*	 MEDICURE INTERNATIONAL INC

    AGGRASTAT, TIROFIBAN HYDROCHLORIDE

MEDIGENE AG

*	 MEDIGENE AG

    VEREGEN, SINECATECHINS

MEDIMETRIKS PHARMS

*	 MEDIMETRIKS PHARMACEUTICALS INC

    LOPROX, CICLOPIROX

    NEO-SYNALAR, FLUOCINOLONE ACETONIDE

    SYNALAR, FLUOCINOLONE ACETONIDE

MEDTECH PRODUCTS

*	 MEDTECH PRODUCTS INC

    MONISTAT 1 COMBINATION PACK, MICONAZOLE NITRATE   (OTC)

    MONISTAT 3 COMBINATION PACK (PREFILLED), MICONAZOLE NITRATE   (OTC)

    MONISTAT 3 COMBINATION PACK, MICONAZOLE NITRATE   (OTC)

    MONISTAT 3, MICONAZOLE NITRATE

    MONISTAT 3, MICONAZOLE NITRATE    (OTC)

    MONISTAT 7 COMBINATION PACK, MICONAZOLE NITRATE   (OTC)

    MONISTAT 7, MICONAZOLE NITRATE    (OTC)

    MONISTAT-3 COMBINATION PACK, MICONAZOLE NITRATE   (OTC)

    NIX, PERMETHRIN    (OTC)

    TAGAMET HB, CIMETIDINE     (OTC)

MEDTRONIC NEURO

*	 MEDTRONIC NEUROMODULATION

    LIORESAL, BACLOFEN

MERCK

*	 MERCK AND CO INC

    CANCIDAS, CASPOFUNGIN ACETATE

    EMEND, APREPITANT

    FOSAMAX PLUS D, ALENDRONATE SODIUM

    FOSAMAX, ALENDRONATE SODIUM

    MAXALT, RIZATRIPTAN BENZOATE

    MAXALT-MLT, RIZATRIPTAN BENZOATE

    PRIMAXIN, CILASTATIN SODIUM

    PROSCAR, FINASTERIDE

    SINGULAIR, MONTELUKAST SODIUM

    ZOLINZA, VORINOSTAT

*	 MERCK RESEARCH LABORATORIES DIV MERCK CO INC

    CLINORIL, SULINDAC

    PRINIVIL, LISINOPRIL

    PRINZIDE, HYDROCHLOROTHIAZIDE

    PROPECIA, FINASTERIDE

    SINGULAIR, MONTELUKAST SODIUM

    TRUSOPT, DORZOLAMIDE HYDROCHLORIDE

    ZOCOR, SIMVASTATIN

MERCK AND CO INC

*	 MERCK AND CO INC

    EMEND, FOSAPREPITANT DIMEGLUMINE

    FOSAMAX, ALENDRONATE SODIUM

MERCK SANTE SAS

*	 MERCK SANTE SAS

    CYANOKIT, HYDROXOCOBALAMIN

MERCK SHARP DOHME

*	 MERCK SHARP AND DOHME CORP

    ASMANEX HFA, MOMETASONE FUROATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 89


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MERCK SHARP AND DOHME CORP

    ASMANEX TWISTHALER, MOMETASONE FUROATE

    BELSOMRA, SUVOREXANT

    CELESTONE SOLUSPAN, BETAMETHASONE ACETATE

    CLARINEX D 24 HOUR, DESLORATADINE

    CLARINEX, DESLORATADINE

    CLARINEX-D 12 HOUR, DESLORATADINE

    COZAAR, LOSARTAN POTASSIUM

    CRIXIVAN, INDINAVIR SULFATE

    DIPROLENE AF, BETAMETHASONE DIPROPIONATE

    DIPROLENE, BETAMETHASONE DIPROPIONATE

    DULERA, FORMOTEROL FUMARATE

    ELOCON, MOMETASONE FUROATE

    GUANIDINE HYDROCHLORIDE, GUANIDINE HYDROCHLORIDE

    HYZAAR, HYDROCHLOROTHIAZIDE

    INVANZ, ERTAPENEM SODIUM

    ISENTRESS, RALTEGRAVIR POTASSIUM

    JANUMET XR, METFORMIN HYDROCHLORIDE

    JANUMET, METFORMIN HYDROCHLORIDE

    JANUVIA, SITAGLIPTIN PHOSPHATE

    LIPTRUZET, ATORVASTATIN CALCIUM

    LOTRISONE, BETAMETHASONE DIPROPIONATE

    NASONEX, MOMETASONE FUROATE MONOHYDRATE

    NITRO-DUR, NITROGLYCERIN

    NOXAFIL, POSACONAZOLE

    REBETOL, RIBAVIRIN

    SINEMET CR, CARBIDOPA

    SINEMET, CARBIDOPA

    STROMECTOL, IVERMECTIN

    TEMODAR, TEMOZOLOMIDE

    VICTRELIS, BOCEPREVIR

    ZONTIVITY, VORAPAXAR SULFATE

MERIDIAN MEDCL

*	 MERIDIAN MEDICAL TECHNOLOGIES INC

    DUODOTE, ATROPINE

*	 MERIDIAN MEDICAL TECHNOLOGIES INC SUB KING PHARMACEUTICALS INC

    ALSUMA, SUMATRIPTAN SUCCINATE

MERIDIAN MEDCL TECHN

*	 MERIDIAN MEDICAL TECHNOLOGIES INC

    ATROPEN, ATROPINE

    MORPHINE SULFATE, MORPHINE SULFATE

    PRALIDOXIME CHLORIDE, PRALIDOXIME CHLORIDE

MERRO PHARM

*	 MERRO PHARMACEUTICAL CO LTD

    IBUPROFEN, IBUPROFEN     (OTC)

MERZ PHARMS

*	 MERZ PHARMACEUTICALS LLC

    CUVPOSA, GLYCOPYRROLATE

    NAFTIN, NAFTIFINE HYDROCHLORIDE

    ONMEL, ITRACONAZOLE

METHAPHARM

*	 METHAPHARM INC

    LEVETIRACETAM, LEVETIRACETAM

    PROVOCHOLINE, METHACHOLINE CHLORIDE

MICRO LABS LTD

*	 MICRO LABS LTD

    MEFENAMIC ACID, MEFENAMIC ACID

    NEVIRAPINE, NEVIRAPINE

    SIMVASTATIN, SIMVASTATIN

MICRO LABS LTD INDIA

*	 MICRO LABS LTD INDIA

    CROMOLYN SODIUM, CROMOLYN SODIUM

    GLIMEPIRIDE, GLIMEPIRIDE

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 90


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MICRO LABS LTD INDIA

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

MIKAH PHARMA

*	 MIKAH PHARMA LLC

    DANTROLENE SODIUM, DANTROLENE SODIUM

    ISRADIPINE, ISRADIPINE

    LOXAPINE SUCCINATE, LOXAPINE SUCCINATE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    TRIMIPRAMINE MALEATE, TRIMIPRAMINE MALEATE

MIKART

*	 MIKART INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    AMINOCAPROIC ACID, AMINOCAPROIC ACID

    AMINOCAPROIC, AMINOCAPROIC ACID

    BENZONATATE, BENZONATATE

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

    BUTAPAP, ACETAMINOPHEN

    CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE

    CHLORZOXAZONE, CHLORZOXAZONE

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE

    ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE

    ETHOSUXIMIDE, ETHOSUXIMIDE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    METHAZOLAMIDE, METHAZOLAMIDE

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE

    PYRAZINAMIDE, PYRAZINAMIDE

    TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE

MILLENNIUM PHARMS

*	 MILLENNIUM PHARMACEUTICALS INC

    VELCADE, BORTEZOMIB

MIPS CRF

*	 MIPS CYCLOTRON AND RADIOCHEMISTRY FACILITY

    AMMONIA N 13, AMMONIA N-13

MIRROR PHARMS

*	 MIRROR PHARMACEUTICALS LLC

    CARISOPRODOL AND ASPIRIN, ASPIRIN

    CARISOPRODOL, CARISOPRODOL

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PROBENECID AND COLCHICINE, COLCHICINE

MISSION PHARMA

*	 MISSION PHARMACAL CO

    BINOSTO, ALENDRONATE SODIUM

    LITHOSTAT, ACETOHYDROXAMIC ACID

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    TEXACORT, HYDROCORTISONE

    THIOLA, TIOPRONIN

    TINDAMAX, TINIDAZOLE

    UROCIT-K, POTASSIUM CITRATE

MISSION PHARMACAL CO

*	 MISSION PHARMACAL CO

    CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE

MIST PHARMS LLC

*	 MIST PHARMACEUTICALS LLC

    NITROMIST, NITROGLYCERIN

MOBERG PHARMA NORTH

*	 MOBERG PHARMA NORTH AMERICA LLC

    CHILDREN'S ELIXSURE, IBUPROFEN    (OTC)

MOBIUS THERAP

* MOBIUS THERAPEUTICS LLC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 91


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MOBIUS THERAPEUTICS LLC

    MITOSOL, MITOMYCIN

MOLNLYCKE HLTH

*	 MOLNLYCKE HEALTH CARE

    HIBICLENS, CHLORHEXIDINE GLUCONATE    (OTC)

    HIBISTAT, CHLORHEXIDINE GLUCONATE    (OTC)

MONARCH PHARMS

*	 MONARCH PHARMACEUTICALS INC

    CORTISPORIN, BACITRACIN ZINC

    CORTISPORIN, HYDROCORTISONE ACETATE

    CORTISPORIN, HYDROCORTISONE

    MENEST, ESTROGENS, ESTERIFIED

    NEOSPORIN G.U. IRRIGANT, NEOMYCIN SULFATE

    NEOSPORIN, GRAMICIDIN

    PEDIOTIC, HYDROCORTISONE

    SEPTRA DS, SULFAMETHOXAZOLE

    SEPTRA, SULFAMETHOXAZOLE

    VIROPTIC, TRIFLURIDINE

MORTON GROVE

*	 MORTON GROVE PHARMACEUTICALS INC

    LACTULOSE, LACTULOSE

MORTON GROVE PHARMS

*	 MORTON GROVE PHARMACEUTICALS INC

    GENERLAC, LACTULOSE

MSD CONSUMER

*	 MSD CONSUMER CARE INC

    ZEGERID OTC, OMEPRAZOLE     (OTC)

MSD INTL

*	 MSD INTERNATIONAL GMBH

    VYTORIN, EZETIMIBE

MSD INTL GMBH

*	 MSD INTERNATIONAL GMBH

    ZETIA, EZETIMIBE

MURTY PHARMS

*	 MURTY PHARMACEUTICALS INC

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    DIPYRIDAMOLE, DIPYRIDAMOLE

MUSTAFA NEVSAT

*	 MUSTAFA NEVSAT ILAC SANAYII AS

    METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE

MUSTAFA NEVZAT

*	 MUSTAFA NEVZAT ILAC SANAYII AS

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    VECURONIUM BROMIDE, VECURONIUM BROMIDE

MUSTAFA NEVZAT ILAC

*	 MUSTAFA NEVZAT ILAC SANAYII AS (MN PHARMACEUTICALS)

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

MUTUAL PHARM

*	 MUTUAL PHARMACEUTICAL CO INC

    ACETAZOLAMIDE, ACETAZOLAMIDE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ALLOPURINOL, ALLOPURINOL

    AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    ATENOLOL AND CHLORTHALIDONE, ATENOLOL

    ATENOLOL, ATENOLOL

    BACTRIM DS, SULFAMETHOXAZOLE

    BACTRIM, SULFAMETHOXAZOLE

    CARISOPRODOL, CARISOPRODOL

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 92


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MUTUAL PHARMACEUTICAL CO INC

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    ERGOLOID MESYLATES, ERGOLOID MESYLATES

    FELODIPINE, FELODIPINE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE

    LOVASTATIN, LOVASTATIN

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    METRONIDAZOLE, METRONIDAZOLE

    MINOXIDIL, MINOXIDIL

    NYSTATIN, NYSTATIN

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PINDOLOL, PINDOLOL

    PIROXICAM, PIROXICAM

    PREDNISONE, PREDNISONE

    PRIMIDONE, PRIMIDONE

    PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE

    QUINIDINE GLUCONATE, QUINIDINE GLUCONATE

    QUINIDINE SULFATE, QUINIDINE SULFATE

    SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    SPIRONOLACTONE, SPIRONOLACTONE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

    SULINDAC, SULINDAC

    TEMAZEPAM, TEMAZEPAM

    THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE

    TOLMETIN SODIUM, TOLMETIN SODIUM

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

MUTUAL PHARM CO INC

*	 MUTUAL PHARMACEUTICAL CO INC

    FIBRICOR, FENOFIBRIC ACID

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    LEVETIRACETAM, LEVETIRACETAM

    QUALAQUIN, QUININE SULFATE

MUTUAL PHARMA

*	 MUTUAL PHARMACAL CO

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE

MYLAN

*	 MYLAN LABORATORIES INC

    ACYCLOVIR, ACYCLOVIR

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE

    CAPTOPRIL, CAPTOPRIL

    ETODOLAC, ETODOLAC

    OLANZAPINE, OLANZAPINE

    TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE

*	 MYLAN PHARMACEUTICALS

    METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

*	 MYLAN PHARMACEUTICALS INC

    ACARBOSE, ACARBOSE

    ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE

    ACYCLOVIR, ACYCLOVIR

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

    ALLOPURINOL, ALLOPURINOL

    ALPRAZOLAM, ALPRAZOLAM

    AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                    B - 93


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN PHARMACEUTICALS INC

    ANASTROZOLE, ANASTROZOLE

    ATENOLOL AND CHLORTHALIDONE, ATENOLOL

    ATENOLOL, ATENOLOL

    AVITA, TRETINOIN

    AZATHIOPRINE, AZATHIOPRINE

    AZITHROMYCIN, AZITHROMYCIN

    BACLOFEN, BACLOFEN

    BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM

    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BICALUTAMIDE, BICALUTAMIDE

    BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE

    BISOPROLOL FUMARATE, BISOPROLOL FUMARATE

    BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE

    BUDESONIDE, BUDESONIDE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE

    CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CARVEDILOL, CARVEDILOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)

    CHLOROTHIAZIDE, CHLOROTHIAZIDE

    CHLORPROPAMIDE, CHLORPROPAMIDE

    CHLORTHALIDONE, CHLORTHALIDONE

    CILOSTAZOL, CILOSTAZOL

    CIMETIDINE, CIMETIDINE

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLARITHROMYCIN, CLARITHROMYCIN

    CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE

    CLONAZEPAM, CLONAZEPAM

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM

    CLORPRES, CHLORTHALIDONE

    CLOZAPINE, CLOZAPINE

    CYSTAGON, CYSTEAMINE BITARTRATE

    DIAZEPAM, DIAZEPAM

    DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DOXYCYCLINE, DOXYCYCLINE

    ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE

    ENALAPRIL MALEATE, ENALAPRIL MALEATE

    ESTRADIOL, ESTRADIOL

    ESTROPIPATE, ESTROPIPATE

    ETIDRONATE DISODIUM, ETIDRONATE DISODIUM

    ETOPOSIDE, ETOPOSIDE

    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

    FAMCICLOVIR, FAMCICLOVIR

    FAMOTIDINE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE    (OTC)

    FELODIPINE, FELODIPINE

    FENOFIBRATE, FENOFIBRATE

    FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

    FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 94


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN PHARMACEUTICALS INC

    FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

    FINASTERIDE, FINASTERIDE

    FLUCONAZOLE, FLUCONAZOLE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE

    FLURBIPROFEN, FLURBIPROFEN

    FLUTAMIDE, FLUTAMIDE

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    FUROSEMIDE, FUROSEMIDE

    GABAPENTIN, GABAPENTIN

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GLIMEPIRIDE, GLIMEPIRIDE

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

    GLIPIZIDE, GLIPIZIDE

    GLYBURIDE (MICRONIZED), GLYBURIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE

    HALOPERIDOL, HALOPERIDOL

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    INDAPAMIDE, INDAPAMIDE

    INDOMETHACIN, INDOMETHACIN

    KETOCONAZOLE, KETOCONAZOLE

    KETOPROFEN, KETOPROFEN

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    LAMOTRIGINE, LAMOTRIGINE

    LATANOPROST, LATANOPROST

    LETROZOLE, LETROZOLE

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN, LEVOFLOXACIN

    LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM **

    LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE

    LORATADINE, LORATADINE    (OTC)

    LORAZEPAM, LORAZEPAM

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    LOVASTATIN, LOVASTATIN

    LOXAPINE SUCCINATE, LOXAPINE SUCCINATE

    MAPROTILINE HYDROCHLORIDE, MAPROTILINE HYDROCHLORIDE

    MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM

    MELOXICAM, MELOXICAM

    MENTAX, BUTENAFINE HYDROCHLORIDE

    MERCAPTOPURINE, MERCAPTOPURINE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHIMAZOLE, METHIMAZOLE

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    METHYLDOPA AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    METHYLDOPA, METHYLDOPA

    METOLAZONE, METOLAZONE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MIRTAZAPINE, MIRTAZAPINE

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE

    NADOLOL, NADOLOL

    NAPROXEN, NAPROXEN

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    NIFEDIPINE, NIFEDIPINE

    NISOLDIPINE, NISOLDIPINE

    NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 95


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN PHARMACEUTICALS INC

    NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE

    NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

    OMEPRAZOLE, OMEPRAZOLE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON, ONDANSETRON

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350

    PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL

    PENTOXIFYLLINE, PENTOXIFYLLINE

    PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    PHENYTEK, PHENYTOIN SODIUM

    PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    PIROXICAM, PIROXICAM

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE

    PROBENECID, PROBENECID

    PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

    RISPERIDONE, RISPERIDONE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

    SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    SPIRONOLACTONE, SPIRONOLACTONE

    STAVUDINE, STAVUDINE

    SULINDAC, SULINDAC

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TACROLIMUS, TACROLIMUS

    TAMOXIFEN CITRATE, TAMOXIFEN CITRATE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TEMAZEPAM, TEMAZEPAM

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE

    THIOTHIXENE, THIOTHIXENE

    TIMOLOL MALEATE, TIMOLOL MALEATE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    TOLMETIN SODIUM, TOLMETIN SODIUM

    TOPIRAMATE, TOPIRAMATE

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRANDOLAPRIL, TRANDOLAPRIL

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE

    URSODIOL, URSODIOL

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

    WARFARIN SODIUM, WARFARIN SODIUM

    ZALEPLON, ZALEPLON

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

    ZONISAMIDE, ZONISAMIDE

MYLAN INSTITUTIONAL

* MYLAN INSTITUTIONAL INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		       B - 96


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN INSTITUTIONAL INC

    SULFAMYLON, MAFENIDE ACETATE

*	 MYLAN INSTITUTIONAL LLC

    ALOPRIM, ALLOPURINOL SODIUM

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    ARGATROBAN, ARGATROBAN

    CARBOPLATIN, CARBOPLATIN

    CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM

    CIDOFOVIR, CIDOFOVIR

    COSYNTROPIN, COSYNTROPIN

    DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE

    DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE

    DIMETHYL SULFOXIDE, DIMETHYL SULFOXIDE

    DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

    DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    DURACLON, CLONIDINE HYDROCHLORIDE

    ENLON, EDROPHONIUM CHLORIDE

    ENLON-PLUS, ATROPINE SULFATE

    ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE

    FOMEPIZOLE, FOMEPIZOLE

    IBUTILIDE FUMARATE, IBUTILIDE FUMARATE

    ISOSULFAN BLUE, ISOSULFAN BLUE

    KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE

    MEFOXIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM

    MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE

    MESNA, MESNA

    METHOCARBAMOL, METHOCARBAMOL

    MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

    NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE

    PENTOSTATIN, PENTOSTATIN

    RIMSO-50, DIMETHYL SULFOXIDE

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

    SOTRADECOL, SODIUM TETRADECYL SULFATE

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

    TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE

    THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE

    TRANEXAMIC ACID, TRANEXAMIC ACID

    ULTIVA, REMIFENTANIL HYDROCHLORIDE

MYLAN IRELAND LTD

*	 MYLAN IRELAND LTD

    ARIXTRA, FONDAPARINUX SODIUM

MYLAN LABS

*	 MYLAN LABORATORIES LTD

    CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL

    NEVIRAPINE, NEVIRAPINE

MYLAN LABS LTD

*	 MYLAN LABORATORIES LTD

    VALSARTAN, VALSARTAN

MYLAN PHARMS INC

*	 MYLAN PHARMACEUTICALS INC

    ABACAVIR SULFATE, ABACAVIR SULFATE

    ACAMPROSATE CALCIUM, ACAMPROSATE CALCIUM

    ACYCLOVIR, ACYCLOVIR

    ALPRAZOLAM, ALPRAZOLAM

    AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM, AMLODIPINE BESYLATE

    AMNESTEEM, ISOTRETINOIN

    ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE

    ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

    ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE

    AVITA, TRETINOIN

    BACLOFEN, BACLOFEN

    CABERGOLINE, CABERGOLINE

    CAPECITABINE, CAPECITABINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 97


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN PHARMACEUTICALS INC

    CELECOXIB, CELECOXIB

    CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    CILOSTAZOL, CILOSTAZOL

    CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE

    CLONAZEPAM, CLONAZEPAM

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DESLORATADINE, DESLORATADINE

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DIDANOSINE, DIDANOSINE

    DIGOXIN, DIGOXIN

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    DOXYCYCLINE, DOXYCYCLINE

    ENTACAPONE, ENTACAPONE

    EPROSARTAN MESYLATE, EPROSARTAN MESYLATE

    ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE

    ESZOPICLONE, ESZOPICLONE

    FENOFIBRATE (MICRONIZED), FENOFIBRATE

    FENOFIBRATE, FENOFIBRATE

    FENOFIBRIC ACID, CHOLINE FENOFIBRATE

    FENOPROFEN CALCIUM, FENOPROFEN CALCIUM

    FINASTERIDE, FINASTERIDE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE

    FROVATRIPTAN SUCCINATE, FROVATRIPTAN SUCCINATE

    GABAPENTIN, GABAPENTIN

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE

    INDAPAMIDE, INDAPAMIDE

    INDOMETHACIN, INDOMETHACIN

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    ITRACONAZOLE, ITRACONAZOLE

    LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE

    LAMIVUDINE, LAMIVUDINE

    LANSOPRAZOLE, LANSOPRAZOLE

    LEVETIRACETAM, LEVETIRACETAM

    LITHIUM CARBONATE, LITHIUM CARBONATE

    MAXZIDE, HYDROCHLOROTHIAZIDE

    MAXZIDE-25, HYDROCHLOROTHIAZIDE

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHYCLOTHIAZIDE, METHYCLOTHIAZIDE

    METOPROLOL SUCCINATE, METOPROLOL SUCCINATE

    MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MIRTAZAPINE, MIRTAZAPINE

    MODAFINIL, MODAFINIL

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MORPHINE SULFATE, MORPHINE SULFATE

    MYCOPHENOLIC ACID, MYCOPHENOLIC ACID

    NABUMETONE, NABUMETONE

    NAPROXEN, NAPROXEN

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    NEVIRAPINE, NEVIRAPINE

    OLANZAPINE, OLANZAPINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 98


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN PHARMACEUTICALS INC

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PHENYTOIN, PHENYTOIN

    PINDOLOL, PINDOLOL

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    QUININE SULFATE, QUININE SULFATE

    RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

    RAMIPRIL, RAMIPRIL

    REPAGLINIDE, REPAGLINIDE

    RILUZOLE, RILUZOLE

    RISEDRONATE SODIUM, RISEDRONATE SODIUM

    RISPERIDONE, RISPERIDONE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    SIMVASTATIN, SIMVASTATIN

    SUNITINIB MALATE, SUNITINIB MALATE

    TELMISARTAN AND AMLODIPINE, AMLODIPINE BESYLATE

    TELMISARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TELMISARTAN, TELMISARTAN

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    TOLAZAMIDE, TOLAZAMIDE

    TOLBUTAMIDE, TOLBUTAMIDE

    TOLTERODINE TARTRATE, TOLTERODINE TARTRATE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

    TRIAZOLAM, TRIAZOLAM

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    VORICONAZOLE, VORICONAZOLE

    ZIDOVUDINE, ZIDOVUDINE

    ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE

    ZOLMITRIPTAN, ZOLMITRIPTAN

    ZONISAMIDE, ZONISAMIDE

*	 MYLAN PHARMACEUTICALS INC.

    FLUVASTATIN SODIUM, FLUVASTATIN SODIUM

    NIZATIDINE, NIZATIDINE

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

MYLAN SPECLT

*	 MYLAN SPECIALTY LP

    ACCUNEB, ALBUTEROL SULFATE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    CROMOLYN SODIUM, CROMOLYN SODIUM

    DUONEB, ALBUTEROL SULFATE

    EPIPEN JR., EPINEPHRINE

    EPIPEN, EPINEPHRINE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

    LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE

    METAPROTERENOL SULFATE, METAPROTERENOL SULFATE

    PERFOROMIST, FORMOTEROL FUMARATE

MYLAN TECHNOLOGIES

*	 MYLAN TECHNOLOGIES

    XULANE, ETHINYL ESTRADIOL

*	 MYLAN TECHNOLOGIES INC

    CLONIDINE, CLONIDINE

    ESTRADIOL, ESTRADIOL

    FENTANYL-100, FENTANYL

    FENTANYL-12, FENTANYL

    FENTANYL-25, FENTANYL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 99


              APPENDIX B      -     PRODUCT NAME SORTED BY APPLICANT

                                         **   M   **

*	 MYLAN TECHNOLOGIES INC

    FENTANYL-37, FENTANYL

    FENTANYL-50, FENTANYL

    FENTANYL-62, FENTANYL

    FENTANYL-75, FENTANYL

    FENTANYL-87, FENTANYL

    NITROGLYCERIN, NITROGLYCERIN

                                         **   N   **

NATCO PHARMA

*	 NATCO PHARMA LTD

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

NATCO PHARMA LTD

*	 NATCO PHARMA LIMITED

    CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE

*	 NATCO PHARMA LTD

    ANASTROZOLE, ANASTROZOLE

    CARISOPRODOL, CARISOPRODOL

    CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE

    LANSOPRAZOLE, LANSOPRAZOLE

    LETROZOLE, LETROZOLE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE

NAVIDEA BIOPHARMS

*	 NAVIDEA BIOPHARMACEUTICALS INC

    LYMPHOSEEK KIT, TECHNETIUM TC-99M TILMANOCEPT

NAVINTA LLC

*	 NAVINTA LLC

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    FAMOTIDINE, FAMOTIDINE

    FOMEPIZOLE, FOMEPIZOLE

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE

NCM USA BRONX LLC

*	 NCM USA BRONX LLC

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

NEOS THERAP INC

*	 NEOS THERAPEUTICS INC

    HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX, CHLORPHENIRAMINE POLISTIREX

NEPHRON

*	 NEPHRON CORP

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

*	 NEPHRON PHARMACEUTICALS CORP

    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

NESHER PHARMS

*	 NESHER PHARMACEUTICALS USA LLC

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    MICRO-K 10, POTASSIUM CHLORIDE

    MICRO-K, POTASSIUM CHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

NEW RIVER

*	 NEW RIVER PHARMACEUTICALS INC

    PROFERDEX, IRON DEXTRAN

NEXGEN PHARMA

*	 NEXGEN PHARMA INC

    BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

    CHENODIOL, CHENODIOL

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 100


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   N   **

*	 NEXGEN PHARMA INC

    GLYCOPYRROLATE, GLYCOPYRROLATE

    MECAMYLAMINE HYDROCHLORIDE, MECAMYLAMINE HYDROCHLORIDE

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

NEXGEN PHARMA INC

*	 NEXGEN PHARMA INC

    BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN

    BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350

NEXTWAVE PHARMS

*	 NEXTWAVE PHARMACEUTICALS INC

    QUILLIVANT XR, METHYLPHENIDATE HYDROCHLORIDE

NEXUS PHARMS

*	 NEXUS PHARMACEUTICALS INC

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    LEVOFLOXACIN, LEVOFLOXACIN

NIAGARA PHARMS

*	 NIAGARA PHARMACEUTICALS INC

    PUR-WASH, PURIFIED WATER     (OTC)

NORTEC DEV ASSOC

*	 NORTEC DEVELOPMENT ASSOC INC

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

NORTHSTAR HLTHCARE

*	 NORTHSTAR HEALTHCARE HOLDINGS LTD

    ALLOPURINOL, ALLOPURINOL

    ATENOLOL, ATENOLOL

    BACLOFEN, BACLOFEN

    GEMFIBROZIL, GEMFIBROZIL

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

NOSTRUM

*	 NOSTRUM PHARMACEUTICALS INC

    CARBAMAZEPINE, CARBAMAZEPINE

    THEOPHYLLINE, THEOPHYLLINE

NOSTRUM LABS

*	 NOSTRUM LABORATORIES INC

    PIROXICAM, PIROXICAM

    SUCRALFATE, SUCRALFATE

NOSTRUM PHARMS LLC

*	 NOSTRUM PHARMACEUTICALS LLC

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

NOVA LABS LTD

*	 NOVA LABORATORIES LTD

    PURIXAN, MERCAPTOPURINE

NOVADEL

*	 NOVADEL PHARMA INC

    ZOLPIMIST, ZOLPIDEM TARTRATE

NOVARTIS

*	 NOVARTIS CONSUMER HEALTH INC

    EXCEDRIN (MIGRAINE), ACETAMINOPHEN      (OTC)

    LAMISIL AT, TERBINAFINE     (OTC)

    LAMISIL AT, TERBINAFINE HYDROCHLORIDE      (OTC)

    LAMISIL, TERBINAFINE HYDROCHLORIDE      (OTC)

    PREVACID 24 HR, LANSOPRAZOLE     (OTC)

    THRIVE, NICOTINE POLACRILEX     (OTC)

    TRANSDERM SCOP, SCOPOLAMINE

    VAGISTAT-1, TIOCONAZOLE     (OTC)

    VOLTAREN, DICLOFENAC SODIUM

*	 NOVARTIS PHARMACEUTICALS CORP

    AFINITOR, EVEROLIMUS

    AMTURNIDE, ALISKIREN HEMIFUMARATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 101


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   N   **

*	 NOVARTIS PHARMACEUTICALS CORP

    ARCAPTA NEOHALER, INDACATEROL MALEATE

    CATAFLAM, DICLOFENAC POTASSIUM

    CLOZARIL, CLOZAPINE

    COARTEM, ARTEMETHER

    DESFERAL, DEFEROXAMINE MESYLATE

    DIOVAN HCT, HYDROCHLOROTHIAZIDE

    DIOVAN, VALSARTAN

    ESTRADERM, ESTRADIOL

    EXELON, RIVASTIGMINE

    EXELON, RIVASTIGMINE TARTRATE

    EXFORGE HCT, AMLODIPINE BESYLATE

    EXFORGE, AMLODIPINE BESYLATE

    EXJADE, DEFERASIROX

    FAMVIR, FAMCICLOVIR

    FANAPT, ILOPERIDONE

    FOCALIN XR, DEXMETHYLPHENIDATE HYDROCHLORIDE

    FOCALIN, DEXMETHYLPHENIDATE HYDROCHLORIDE

    FORADIL, FORMOTEROL FUMARATE

    GILENYA, FINGOLIMOD

    GLEEVEC, IMATINIB MESYLATE

    HYDERGINE, ERGOLOID MESYLATES

    LAMISIL, TERBINAFINE HYDROCHLORIDE

    LAMPRENE, CLOFAZIMINE

    LESCOL XL, FLUVASTATIN SODIUM

    LESCOL, FLUVASTATIN SODIUM

    LOPRESSOR, METOPROLOL TARTRATE

    LOTREL, AMLODIPINE BESYLATE

    MYFORTIC, MYCOPHENOLIC ACID

    NEORAL, CYCLOSPORINE

    OCUPRESS, CARTEOLOL HYDROCHLORIDE

    RECLAST, ZOLEDRONIC ACID

    REGITINE, PHENTOLAMINE MESYLATE

    RITALIN LA, METHYLPHENIDATE HYDROCHLORIDE

    RITALIN, METHYLPHENIDATE HYDROCHLORIDE

    RITALIN-SR, METHYLPHENIDATE HYDROCHLORIDE

    SANDIMMUNE, CYCLOSPORINE

    SANDOSTATIN LAR, OCTREOTIDE ACETATE

    SANDOSTATIN, OCTREOTIDE ACETATE

    SIGNIFOR, PASIREOTIDE DIASPARTATE

    STARLIX, NATEGLINIDE

    TASIGNA, NILOTINIB HYDROCHLORIDE MONOHYDRATE

    TAVIST-1, CLEMASTINE FUMARATE    (OTC)

    TEGRETOL, CARBAMAZEPINE

    TEGRETOL-XR, CARBAMAZEPINE

    TEKAMLO, ALISKIREN HEMIFUMARATE

    TEKTURNA HCT, ALISKIREN HEMIFUMARATE

    TEKTURNA, ALISKIREN HEMIFUMARATE

    TOBI PODHALER, TOBRAMYCIN

    TRILEPTAL, OXCARBAZEPINE

    TYZEKA, TELBIVUDINE

    VIVELLE, ESTRADIOL

    VIVELLE-DOT, ESTRADIOL

    VOLTAREN, DICLOFENAC SODIUM

    VOLTAREN-XR, DICLOFENAC SODIUM

    ZOMETA, ZOLEDRONIC ACID

    ZORTRESS, EVEROLIMUS

NOVARTIS PHARM

*	 NOVARTIS PHARMACEUTICAL CORP

    AFINITOR DISPERZ, EVEROLIMUS

NOVARTIS PHARMS

*	 NOVARTIS PHARMACEUTICALS CORP

    FEMARA, LETROZOLE

    TOBI, TOBRAMYCIN

NOVARTIS PHARMS CORP

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 102


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   N   **

*	 NOVARTIS PHARMACEUTICALS CORP

    SIGNIFOR LAR, PASIREOTIDE PAMOATE

    ZYKADIA, CERITINIB

NOVAST LABS

*	 NOVAST LABORATORIES CHINA LTD

    NORETHINDRONE, NORETHINDRONE

NOVAST LABS LTD

*	 NOVAST LABORATORIES LTD

    DASETTA 1/35, ETHINYL ESTRADIOL

    DASETTA 7/7/7, ETHINYL ESTRADIOL

    DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL

    ELINEST, ETHINYL ESTRADIOL

    FALMINA, ETHINYL ESTRADIOL

    LARIN 1.5/30, ETHINYL ESTRADIOL

    LARIN 1/20, ETHINYL ESTRADIOL

    LARIN FE 1.5/30, ETHINYL ESTRADIOL

    LARIN FE 1/20, ETHINYL ESTRADIOL

    LEVONEST, ETHINYL ESTRADIOL

    MONO-LINYAH, ETHINYL ESTRADIOL

    NORETHINDRONE, NORETHINDRONE

    PHILITH, ETHINYL ESTRADIOL

    PIMTREA, DESOGESTREL

    SETLAKIN, ETHINYL ESTRADIOL

    TRI-LINYAH, ETHINYL ESTRADIOL

    WERA, ETHINYL ESTRADIOL

    YAELA, DROSPIRENONE

NOVEL LABS INC

*	 NOVEL LABORATORIES INC

    FAMOTIDINE, FAMOTIDINE

    HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, HOMATROPINE METHYLBROMIDE

    LEVONORGESTREL, LEVONORGESTREL

    LEVONORGESTREL, LEVONORGESTREL    (OTC)

    METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    MISOPROSTOL, MISOPROSTOL

    NITROFURANTOIN, NITROFURANTOIN

    PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350

    PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL,

    PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL

    PHENELZINE SULFATE, PHENELZINE SULFATE

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

    TEMAZEPAM, TEMAZEPAM

    TINIDAZOLE, TINIDAZOLE

    TRIMETHOPRIM, TRIMETHOPRIM

NOVEN

*	 NOVEN PHARMACEUTICALS INC

    MINIVELLE, ESTRADIOL

NOVEN PHARMS INC

*	 NOVEN PHARMACEUTICALS INC

    COMBIPATCH, ESTRADIOL

    DAYTRANA, METHYLPHENIDATE

NOVEN THERAP

*	 NOVEN THERAPEUTICS LLC

    BRISDELLE, PAROXETINE MESYLATE

    PEXEVA, PAROXETINE MESYLATE

NOVEX

*	 NOVEX PHARMA

    BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE

NOVO NORDISK

*	 NOVO NORDISK PHARMACEUTICALS INC

    GLUCAGEN, GLUCAGON HYDROCHLORIDE RECOMBINANT

NOVO NORDISK INC

*	 NOVO NORDISK INC

    LEVEMIR FLEXPEN, INSULIN DETEMIR RECOMBINANT

    LEVEMIR FLEXTOUCH, INSULIN DETEMIR RECOMBINANT

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 103


              APPENDIX B      -    PRODUCT NAME SORTED BY APPLICANT

                                          **   N   **

*	 NOVO NORDISK INC

    LEVEMIR, INSULIN DETEMIR RECOMBINANT

    NORDITROPIN FLEXPRO, SOMATROPIN RECOMBINANT

    NORDITROPIN NORDIFLEX, SOMATROPIN RECOMBINANT

    NOVOLIN 70/30, INSULIN RECOMBINANT HUMAN   (OTC)

    NOVOLIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN   (OTC)

    NOVOLIN R, INSULIN RECOMBINANT HUMAN   (OTC)

    NOVOLOG FLEXPEN, INSULIN ASPART RECOMBINANT

    NOVOLOG FLEXTOUCH, INSULIN ASPART RECOMBINANT

    NOVOLOG MIX 70/30 FLEXPEN, INSULIN ASPART PROTAMINE RECOMBINANT

    NOVOLOG MIX 70/30, INSULIN ASPART PROTAMINE RECOMBINANT

    NOVOLOG PENFILL, INSULIN ASPART RECOMBINANT

    NOVOLOG, INSULIN ASPART RECOMBINANT

    PRANDIMET, METFORMIN HYDROCHLORIDE

    PRANDIN, REPAGLINIDE

    SAXENDA, LIRAGLUTIDE RECOMBINANT

    VAGIFEM, ESTRADIOL

    VICTOZA, LIRAGLUTIDE RECOMBINANT

NOVOCOL

*	 NOVOCOL PHARMACEUTICAL INC

    ISOCAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE

NOVOCOL INC

*	 NOVOCOL INC

    LIDOCAINE, LIDOCAINE

NPS PHARMS INC

*	 NPS PHARMACEUTICALS INC

    GATTEX KIT, TEDUGLUTIDE RECOMBINANT

NU PHARM

*	 NU PHARM INC

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

NUVO PHARM INC

*	 NUVO PHARMACEUTICAL INC

    SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

NUVO RES INC

*	 NUVO RESEARCH INC

    PENNSAID, DICLOFENAC SODIUM

NYCOMED US

*	 NYCOMED US INC

    TERCONAZOLE, TERCONAZOLE

                                          **   O   **

OAK PHARMS

*	 OAK PHARMACEUTICALS INC

    NEMBUTAL SODIUM, PENTOBARBITAL SODIUM

    XYLOCAINE, LIDOCAINE HYDROCHLORIDE

OAK PHARMS AKORN

*	 OAK PHARMACEUTICALS INC SUB AKORN INC

    COGENTIN, BENZTROPINE MESYLATE

    DIURIL, CHLOROTHIAZIDE SODIUM

OAK PHARMS INC

*	 OAK PHARMACEUTICALS INC

    ZIOPTAN, TAFLUPROST

*	 OAK PHARMACEUTICALS INC SUBSIDIARY OF AKORN INC

    AZASITE, AZITHROMYCIN

    BETIMOL, TIMOLOL

    COSOPT PF, DORZOLAMIDE HYDROCHLORIDE

    COSOPT, DORZOLAMIDE HYDROCHLORIDE

    XOPENEX, LEVALBUTEROL HYDROCHLORIDE

ODYSSEY PHARMS

*	 ODYSSEY PHARMACEUTICALS INC

    ANTABUSE, DISULFIRAM

    NYSTATIN, NYSTATIN

    SURMONTIL, TRIMIPRAMINE MALEATE

    URECHOLINE, BETHANECHOL CHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		        B - 104


              APPENDIX B       -   PRODUCT NAME SORTED BY APPLICANT

                                          **   O   **

*	 ODYSSEY PHARMACEUTICALS INC

     VIVACTIL, PROTRIPTYLINE HYDROCHLORIDE

OHM

*	 OHM CORP

     IBUPROFEN, IBUPROFEN    (OTC)

OHM LABS

*	 OHM LABORATORIES INC

     ACETAMINOPHEN, ACETAMINOPHEN    (OTC)

     IBUPROHM COLD AND SINUS, IBUPROFEN     (OTC)

     IBUPROHM, IBUPROFEN    (OTC)

     LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

OHM LABS INC

*	 OHM LABORATORIES INC

     VALSARTAN, VALSARTAN

OLTA PHARMS

*	 OLTA PHARMACEUTICALS CORP

     LINDANE, LINDANE

OMAN PHARM PRODUCTS

*	 OMAN PHARMACEUTICAL PRODUCTS CO LLC

     NEOMYCIN SULFATE, NEOMYCIN SULFATE

OMEROS

*	 OMEROS CORP

     OMIDRIA, KETOROLAC TROMETHAMINE

ONCO THERAPIES LTD

*	 ONCO THERAPIES LTD

     CARBOPLATIN, CARBOPLATIN

     CISPLATIN, CISPLATIN

     CLADRIBINE, CLADRIBINE

     CYTARABINE, CYTARABINE

     DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

     EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

     FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

     FLUOROURACIL, FLUOROURACIL

     GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

     IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE

     IFOSFAMIDE, IFOSFAMIDE

     METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

     MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

     OXALIPLATIN, OXALIPLATIN

     PACLITAXEL, PACLITAXEL

     TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

     VINORELBINE, VINORELBINE

ONY

*	 ONY INC

     INFASURF PRESERVATIVE FREE, CALFACTANT

ONYX PHARMS

*	 ONYX PHARMACEUTICALS INC

     KYPROLIS, CARFILZOMIB

ORAPHARMA

*	 ORAPHARMA INC

     ARESTIN, MINOCYCLINE HYDROCHLORIDE

ORCHID HLTHCARE

*	 ORCHID HEALTHCARE

     AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

     CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

     CEFDINIR, CEFDINIR

     CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL

     CEFPROZIL, CEFPROZIL

     CEFUROXIME AXETIL, CEFUROXIME AXETIL

     CEPHALEXIN, CEPHALEXIN

     CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE     (OTC)

     CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE     (OTC)

     DESLORATADINE, DESLORATADINE

     DIVALPROEX SODIUM, DIVALPROEX SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 105


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   O   **

*	 ORCHID HEALTHCARE

    ESZOPICLONE, ESZOPICLONE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN, LEVOFLOXACIN

    MODAFINIL, MODAFINIL

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    OLANZAPINE, OLANZAPINE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    ZALEPLON, ZALEPLON

OREXO AB

*	 OREXO AB

    ZUBSOLV, BUPRENORPHINE HYDROCHLORIDE

ORGANON USA INC

*	 ORGANON USA INC

    CYCLESSA, DESOGESTREL

    DESOGEN, DESOGESTREL

    FOLLISTIM AQ, FOLLITROPIN ALFA/BETA

    GANIRELIX ACETATE, GANIRELIX ACETATE

    IMPLANON, ETONOGESTREL

    NEXPLANON, ETONOGESTREL

    NUVARING, ETHINYL ESTRADIOL

    PREGNYL, GONADOTROPIN, CHORIONIC

    REMERON SOLTAB, MIRTAZAPINE

    REMERON, MIRTAZAPINE

ORIENT PHARMA CO LTD

*	 ORIENT PHARMA CO LTD

    CARISOPRODOL, CARISOPRODOL

ORION CORP ORION

*	 ORION CORP ORION PHARMA

    SPIRONOLACTONE, SPIRONOLACTONE

ORION PHARMA

*	 ORION PHARMA

    COMTAN, ENTACAPONE

    STALEVO 100, CARBIDOPA

    STALEVO 125, CARBIDOPA

    STALEVO 150, CARBIDOPA

    STALEVO 200, CARBIDOPA

    STALEVO 50, CARBIDOPA

    STALEVO 75, CARBIDOPA

ORIT LABS LLC

*	 ORIT LABORATORIES LLC

    BENZONATATE, BENZONATATE

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    ERGOCALCIFEROL, ERGOCALCIFEROL

    LEVETIRACETAM, LEVETIRACETAM

ORPHAN EUROPE

*	 ORPHAN EUROPE

    CARBAGLU, CARGLUMIC ACID

OSI PHARMS

*	 OSI PHARMACEUTICALS INC

    TARCEVA, ERLOTINIB HYDROCHLORIDE

OSMOTICA PHARM

*	 OSMOTICA PHARMACEUTICAL CORP

    NIFEDIPINE, NIFEDIPINE

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

OSMOTICA PHARM CORP

* OSMOTICA PHARMACEUTICAL CORP

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 106


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   O   **

*	 OSMOTICA PHARMACEUTICAL CORP

    KHEDEZLA, DESVENLAFAXINE

OTSUKA

*	 OTSUKA PHARMACEUTICAL CO LTD

    ABILIFY, ARIPIPRAZOLE

    PLETAL, CILOSTAZOL

*	 OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC

    ABILIFY, ARIPIPRAZOLE

OTSUKA AMERICA PHARM

*	 OTSUKA AMERICA PHARMACEUTICAL INC

    SAMSCA, TOLVAPTAN

OTSUKA PHARM

*	 OTSUKA PHARMACEUTICAL CO LTD

    BUSULFEX, BUSULFAN

OTSUKA PHARM CO LTD

*	 OTSUKA PHARMACEUTICAL CO LTD

    ABILIFY MAINTENA KIT, ARIPIPRAZOLE

OUTLOOK PHARMS

*	 OUTLOOK PHARMACEUTICALS INC

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

                                         **   P   **

P AND L DEV LLC

*	 P AND L DEVELOPMENT LLC DBA PLD DEVELOPMENTS LLC

    IBUPROFEN, IBUPROFEN     (OTC)

PACIFIC PHARMA

*	 PACIFIC PHARMA

    TIMOLOL MALEATE, TIMOLOL MALEATE

*	 PACIFIC PHARMA INC

    TIMOLOL MALEATE, TIMOLOL MALEATE

PACIRA PHARMS INC

*	 PACIRA PHARMACEUTICALS INC

    DEPOCYT, CYTARABINE

    EXPAREL, BUPIVACAINE

PACK PHARMS LLC

*	 PACK PHARMACEUTICALS LLC

    CEVIMELINE HYDROCHLORIDE, CEVIMELINE HYDROCHLORIDE

    CROMOLYN SODIUM, CROMOLYN SODIUM

PADDOCK

*	 PADDOCK LABORATORIES INC

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

PADDOCK LABS

*	 PADDOCK LABORATORIES INC

    CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE

PADDOCK LLC

*	 PADDOCK LABORATORIES LLC

    BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE

    BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN

    CALCIUM ACETATE, CALCIUM ACETATE

    CICLOPIROX, CICLOPIROX

    CLINDA-DERM, CLINDAMYCIN PHOSPHATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CLOTRIMAZOLE, CLOTRIMAZOLE

    COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM

    COLOCORT, HYDROCORTISONE

    COMPRO, PROCHLORPERAZINE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE

    ERYTHRA-DERM, ERYTHROMYCIN

    FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE

    HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE, HYDROCODONE BITARTRATE

    HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE ,

    INDOMETHACIN, INDOMETHACIN

    KIONEX, SODIUM POLYSTYRENE SULFONATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		        B - 107


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PADDOCK LABORATORIES LLC

    LAX-LYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350

    LORAZEPAM, LORAZEPAM

    MIDAMOR, AMILORIDE HYDROCHLORIDE

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    NYSTOP, NYSTATIN

    PODOFILOX, PODOFILOX

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    REPAGLINIDE, REPAGLINIDE

    SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

    TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE

    TROSPIUM CHLORIDE, TROSPIUM CHLORIDE

PALADIN LABS

*	 PALADIN LABS USA INC

    ANTIZOL, FOMEPIZOLE

PANACEA BIOTEC LTD

*	 PANACEA BIOTEC LTD

    TACROLIMUS, TACROLIMUS

PAR FORM

*	 PAR FORMULATIONS PRIVATE LTD

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    MAFENIDE ACETATE, MAFENIDE ACETATE

PAR PHARM

*	 PAR PHARMACEUTICAL

    NABUMETONE, NABUMETONE

    OMEPRAZOLE AND SODIUM BICARBONATE, OMEPRAZOLE

    PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE

*	 PAR PHARMACEUTICAL INC

    ALPRAZOLAM, ALPRAZOLAM

    AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    CABERGOLINE, CABERGOLINE

    CALCITONIN-SALMON, CALCITONIN SALMON

    CAPOTEN, CAPTOPRIL

    CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE

    CHOLESTYRAMINE, CHOLESTYRAMINE

    CLOMIPHENE CITRATE, CLOMIPHENE CITRATE

    CLONAZEPAM, CLONAZEPAM

    CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

    DEXAMETHASONE, DEXAMETHASONE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

    DOXYCYCLINE, DOXYCYCLINE

    ESTAZOLAM, ESTAZOLAM

    FENTANYL CITRATE, FENTANYL CITRATE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUTAMIDE, FLUTAMIDE

    GLIPIZIDE, GLIPIZIDE

    GLYCOPYRROLATE, GLYCOPYRROLATE

    HYDRA-ZIDE, HYDRALAZINE HYDROCHLORIDE

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    HYDROXYUREA, HYDROXYUREA

    IBUPROFEN, IBUPROFEN     (OTC)

    IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE

    ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		    B - 108


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PAR PHARMACEUTICAL INC

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    MEGACE ES, MEGESTROL ACETATE

    MEGESTROL ACETATE, MEGESTROL ACETATE

    METAPROTERENOL SULFATE, METAPROTERENOL SULFATE

    METRONIDAZOLE, METRONIDAZOLE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MINOXIDIL, MINOXIDIL

    NASCOBAL, CYANOCOBALAMIN

    NATEGLINIDE, NATEGLINIDE

    NIFEDIPINE, NIFEDIPINE

    OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    OLANZAPINE, OLANZAPINE

    OXANDROLONE, OXANDROLONE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TORSEMIDE, TORSEMIDE

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    TRANYLCYPROMINE SULFATE, TRANYLCYPROMINE SULFATE

    TRAVOPROST, TRAVOPROST

    URSODIOL, URSODIOL

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

PAR PHARM INC

*	 PAR PHARMACEUTICAL INC

    AMLODIPINE BESYLATE AND VALSARTAN, AMLODIPINE BESYLATE

    FENTANYL-100, FENTANYL

    FENTANYL-25, FENTANYL

    FENTANYL-50, FENTANYL

    FENTANYL-75, FENTANYL

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

PAR STERILE PRODUCTS

*	 PAR STERILE PRODUCTS LLC

    ADRENALIN, EPINEPHRINE HYDROCHLORIDE

    ARGATROBAN, ARGATROBAN

    BREVITAL SODIUM, METHOHEXITAL SODIUM

    COLY-MYCIN M, COLISTIMETHATE SODIUM

    COLY-MYCIN S, COLISTIN SULFATE

    DANTRIUM, DANTROLENE SODIUM

    DELESTROGEN, ESTRADIOL VALERATE

    DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE

    ETOMIDATE, ETOMIDATE

    FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE

    KETALAR, KETAMINE HYDROCHLORIDE

    PITOCIN, OXYTOCIN

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE

    TRIOSTAT, LIOTHYRONINE SODIUM

    VASOSTRICT, VASOPRESSIN

PARAGON BIOTECK

*	 PARAGON BIOTECK INC

    PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE

PARAPRO LLC

*	 PARAPRO LLC

    NATROBA, SPINOSAD

PARKE DAVIS

*	 PARKE DAVIS DIV WARNER LAMBERT CO

    CELONTIN, METHSUXIMIDE

    CEREBYX, FOSPHENYTOIN SODIUM

    DILANTIN, PHENYTOIN SODIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 109


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PARKE DAVIS DIV WARNER LAMBERT CO

    DILANTIN-125, PHENYTOIN

    NARDIL, PHENELZINE SULFATE

    NEURONTIN, GABAPENTIN

    ZARONTIN, ETHOSUXIMIDE

*	 PARKE DAVIS PHARMACEUTICAL RESEARCH DIV WARNER LAMBERT CO

    ZARONTIN, ETHOSUXIMIDE

PERNIX IRELAND LTD

*	 PERNIX IRELAND LTD

    TREXIMET, NAPROXEN SODIUM

PERNIX THERAP

*	 PERNIX THERAPEUTICS LLC

    CEDAX, CEFTIBUTEN DIHYDRATE

PERNIX THERAPS LLC

*	 PERNIX THERAPEUTICS LLC

    SILENOR, DOXEPIN HYDROCHLORIDE

PERRIGO

*	 PERRIGO CO

    BETAMETHASONE VALERATE, BETAMETHASONE VALERATE

    CICLOPIROX, CICLOPIROX

    CIMETIDINE, CIMETIDINE     (OTC)

    CLEMASTINE FUMARATE, CLEMASTINE FUMARATE      (OTC)

    CLINDETS, CLINDAMYCIN PHOSPHATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    ERYTHROMYCIN, ERYTHROMYCIN

    FAMOTIDINE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE     (OTC)

    HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE

    IBUPROFEN, IBUPROFEN     (OTC)

    JUNIOR STRENGTH IBUPROFEN, IBUPROFEN      (OTC)

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    MICONAZOLE NITRATE COMBINATION PACK, MICONAZOLE NITRATE    (OTC)

    MINOXIDIL (FOR MEN), MINOXIDIL     (OTC)

    MINOXIDIL (FOR WOMEN), MINOXIDIL     (OTC)

    MOMETASONE FUROATE, MOMETASONE FUROATE

    NICOTINE POLACRILEX, NICOTINE POLACRILEX      (OTC)

    PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE    (OTC)

    STIE-CORT, HYDROCORTISONE

PERRIGO CO TENNESSEE

*	 PERRIGO CO TENNESSEE INC

    BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC

    BACITRACIN, BACITRACIN

    BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN

    ERYTHROMYCIN, ERYTHROMYCIN

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

    NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC

    NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE

    SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM

PERRIGO ISRAEL

*	 PERRIGO ISRAEL PHARMACEUTICALS

    FLUOCINONIDE, FLUOCINONIDE

*	 PERRIGO ISRAEL PHARMACEUTICALS LTD

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

    BUTOCONAZOLE NITRATE, BUTOCONAZOLE NITRATE

    CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE

    IMIQUIMOD, IMIQUIMOD

    KETOCONAZOLE, KETOCONAZOLE

    MESALAMINE, MESALAMINE

    MINOXIDIL, MINOXIDIL     (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                        B - 110


              APPENDIX B       -   PRODUCT NAME SORTED BY APPLICANT

                                          **   P   **

*	 PERRIGO ISRAEL PHARMACEUTICALS LTD

    NITROGLYCERIN, NITROGLYCERIN

    TESTOSTERONE, TESTOSTERONE

PERRIGO NEW YORK

*	 PERRIGO NEW YORK INC

    ACETAMINOPHEN, ACETAMINOPHEN     (OTC)

    AMMONIUM LACTATE, AMMONIUM LACTATE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CENTANY, MUPIROCIN

    CICLOPIROX, CICLOPIROX

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    DESONIDE, DESONIDE

    DESOXIMETASONE, DESOXIMETASONE

    ECONAZOLE NITRATE, ECONAZOLE NITRATE

    ERYTHROMYCIN, ERYTHROMYCIN

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE

    HYDROCORTISONE, HYDROCORTISONE

    KETOCONAZOLE, KETOCONAZOLE

    MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL    (OTC)

    MOMETASONE FUROATE, MOMETASONE FUROATE

    MUPIROCIN, MUPIROCIN

    NYSTATIN, NYSTATIN

    PERMETHRIN, PERMETHRIN

    PERMETHRIN, PERMETHRIN    (OTC)

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    SELENIUM SULFIDE, SELENIUM SULFIDE

    TERCONAZOLE, TERCONAZOLE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

PERRIGO R AND D

*	 PERRIGO R AND D CO

    CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE, CALCIUM CARBONATE      (OTC)

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE     (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE     (OTC)

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE      (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE      (OTC)

    DESLORATADINE, DESLORATADINE

    GUAIFENESIN, GUAIFENESIN    (OTC)

    IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE      (OTC)

    IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE, IBUPROFEN    (OTC)

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN    (OTC)

    LANSOPRAZOLE, LANSOPRAZOLE     (OTC)

    LEVONORGESTREL, LEVONORGESTREL

    LEVONORGESTREL, LEVONORGESTREL     (OTC)

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    MICONAZOLE NITRATE, MICONAZOLE NITRATE    (OTC)

    NAPROXEN, NAPROXEN

    NICOTINE POLACRILEX, NICOTINE POLACRILEX    (OTC)

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350    (OTC)

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

PERRIGO UK FINCO

*	 PERRIGO UK FINCO LTD PARTNERSHIP

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

PETNET

*	 PETNET SOLUTIONS INC

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

PF PRISM CV

*	 PF PRISM CV

    LYRICA, PREGABALIN

    RAPAMUNE, SIROLIMUS

    TORISEL, TEMSIROLIMUS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 111


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PF PRISM CV

    TYGACIL, TIGECYCLINE

    VFEND, VORICONAZOLE

    XALKORI, CRIZOTINIB

    XELJANZ, TOFACITINIB CITRATE

    ZMAX, AZITHROMYCIN

PFIZER

*	 PFIZER CENTRAL RESEARCH

    DIFLUCAN, FLUCONAZOLE

    ZITHROMAX, AZITHROMYCIN

*	 PFIZER CHEMICALS DIV PFIZER INC

    DIFLUCAN, FLUCONAZOLE

    ZITHROMAX, AZITHROMYCIN

*	 PFIZER INC

    ACOVA, ARGATROBAN

    ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE    (OTC)

    ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE        (OTC)

    ADVIL COLD AND SINUS, IBUPROFEN     (OTC)

    ADVIL CONGESTION RELIEF, IBUPROFEN      (OTC)

    ADVIL LIQUI-GELS, IBUPROFEN     (OTC)

    ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN      (OTC)

    ADVIL PM, DIPHENHYDRAMINE CITRATE      (OTC)

    ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE       (OTC)

    ADVIL, IBUPROFEN    (OTC)

    ALAVERT, LORATADINE     (OTC)

    AXID AR, NIZATIDINE     (OTC)

    CADUET, AMLODIPINE BESYLATE

    CALAN SR, VERAPAMIL HYDROCHLORIDE

    CARDURA XL, DOXAZOSIN MESYLATE

    CHILDREN'S ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE    (OTC)

    CHILDREN'S ADVIL COLD, IBUPROFEN      (OTC)

    CHILDREN'S ADVIL, IBUPROFEN     (OTC)

    CHILDREN'S ADVIL-FLAVORED, IBUPROFEN      (OTC)

    DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE

    DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE

    DIFLUCAN IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

    ELELYSO, TALIGLUCERASE ALFA

    FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE

    GEODON, ZIPRASIDONE HYDROCHLORIDE

    GEODON, ZIPRASIDONE MESYLATE

    GLUCOTROL XL, GLIPIZIDE

    GLUCOTROL, GLIPIZIDE

    HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM

    HEPARIN SODIUM, HEPARIN SODIUM

    INLYTA, AXITINIB

    JUNIOR STRENGTH ADVIL, IBUPROFEN      (OTC)

    LIPITOR, ATORVASTATIN CALCIUM

    LORATADINE, LORATADINE     (OTC)

    NAVANE, THIOTHIXENE

    NORVASC, AMLODIPINE BESYLATE

    PEDIATRIC ADVIL, IBUPROFEN     (OTC)

    PROCARDIA, NIFEDIPINE

    REVATIO, SILDENAFIL CITRATE

    SONATA, ZALEPLON

    TESSALON, BENZONATATE

    TOVIAZ, FESOTERODINE FUMARATE

    UNASYN, AMPICILLIN SODIUM

    ZITHROMAX, AZITHROMYCIN

*	 PFIZER LABORATORIES DIV PFIZER INC

    CARDURA, DOXAZOSIN MESYLATE

    DIABINESE, CHLORPROPAMIDE

    FELDENE, PIROXICAM

    MINIPRESS, PRAZOSIN HYDROCHLORIDE

    PERMAPEN, PENICILLIN G BENZATHINE

    PFIZERPEN, PENICILLIN G POTASSIUM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 112


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PFIZER LABORATORIES DIV PFIZER INC

    PROCARDIA XL, NIFEDIPINE

    TERRAMYCIN W/ POLYMYXIN B SULFATE, OXYTETRACYCLINE HYDROCHLORIDE

    UNASYN, AMPICILLIN SODIUM

    VIBRAMYCIN, DOXYCYCLINE

    VIBRAMYCIN, DOXYCYCLINE CALCIUM

    VIBRAMYCIN, DOXYCYCLINE HYCLATE

    VISTARIL, HYDROXYZINE PAMOATE

*	 PFIZER PHARMACEUTICALS INC

    ZOLOFT, SERTRALINE HYDROCHLORIDE

*	 PFIZER PHARMACEUTICALS PRODUCTION CORP LTD

    TIKOSYN, DOFETILIDE

PFIZER CONS HLTHCARE

*	 PFIZER CONSUMER HEALTHCARE

    ADVIL, IBUPROFEN SODIUM    (OTC)

PFIZER INC

*	 PFIZER INC

    CAMPTOSAR, IRINOTECAN HYDROCHLORIDE

    CHANTIX, VARENICLINE TARTRATE

    ELLENCE, EPIRUBICIN HYDROCHLORIDE

    GEODON, ZIPRASIDONE HYDROCHLORIDE

    NICOTROL, NICOTINE

PFIZER IRELAND

*	 PFIZER IRELAND PHARMACEUTICALS

    RELPAX, ELETRIPTAN HYDROBROMIDE

    VIAGRA, SILDENAFIL CITRATE

PFIZER LABS

*	 PFIZER LABS

    DOCETAXEL, DOCETAXEL

PFIZER PHARMS

*	 PFIZER PHARMACEUTICALS LTD

    ACCUPRIL, QUINAPRIL HYDROCHLORIDE

    ACCURETIC, HYDROCHLOROTHIAZIDE

    DILANTIN, PHENYTOIN

    LOPID, GEMFIBROZIL

    NEURONTIN, GABAPENTIN

    NITROSTAT, NITROGLYCERIN

PHARM ASSOC

*	 PHARMACEUTICAL ASSOC INC

    CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    LORAZEPAM, LORAZEPAM

    NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

*	 PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE

    DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE

    ETHOSUXIMIDE, ETHOSUXIMIDE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE

    HALOPERIDOL, HALOPERIDOL LACTATE

    LACTULOSE, LACTULOSE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    PREDNISOLONE, PREDNISOLONE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE

    VALPROIC ACID, VALPROIC ACID

*	 PHARMACEUTICAL ASSOCIATES INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

PHARMA-MED INC

*	 PHARMA-MED INC

    POTASSIUM CHLORIDE, POTASSIUM CHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		               B - 113


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

PHARMACEUTICS

*	 PHARMACEUTICS INTERNATIONAL INC

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

PHARMACHEMIE BV

*	 PHARMACHEMIE BV

    CARBOPLATIN, CARBOPLATIN

    CISPLATIN, CISPLATIN

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    METHOTREXATE PRESERVATIVE FREE, METHOTREXATE SODIUM

    METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM

PHARMACIA AND UPJOHN

*	 PHARMACIA AND UPJOHN

    XANAX XR, ALPRAZOLAM

*	 PHARMACIA AND UPJOHN CO

    ANSAID, FLURBIPROFEN

    AROMASIN, EXEMESTANE

    AZULFIDINE EN-TABS, SULFASALAZINE

    AZULFIDINE, SULFASALAZINE

    BACITRACIN, BACITRACIN

    CAVERJECT IMPULSE, ALPROSTADIL

    CAVERJECT, ALPROSTADIL

    CLEOCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE

    CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CLEOCIN T, CLINDAMYCIN PHOSPHATE

    CLEOCIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE

    CLEOCIN, CLINDAMYCIN PHOSPHATE

    COLESTID, COLESTIPOL HYDROCHLORIDE

    CORTEF, HYDROCORTISONE

    CORVERT, IBUTILIDE FUMARATE

    CYKLOKAPRON, TRANEXAMIC ACID

    DEPO-ESTRADIOL, ESTRADIOL CYPIONATE

    DEPO-MEDROL, METHYLPREDNISOLONE ACETATE

    DEPO-PROVERA, MEDROXYPROGESTERONE ACETATE

    DEPO-TESTOSTERONE, TESTOSTERONE CYPIONATE

    DETROL LA, TOLTERODINE TARTRATE

    DETROL, TOLTERODINE TARTRATE

    DIDREX, BENZPHETAMINE HYDROCHLORIDE

    EMCYT, ESTRAMUSTINE PHOSPHATE SODIUM

    ESTRING, ESTRADIOL

    FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE

    GENOTROPIN PRESERVATIVE FREE, SOMATROPIN RECOMBINANT

    GENOTROPIN, SOMATROPIN RECOMBINANT

    GLYNASE, GLYBURIDE

    GLYSET, MIGLITOL

    HALCION, TRIAZOLAM

    HEMABATE, CARBOPROST TROMETHAMINE

    IDAMYCIN PFS, IDARUBICIN HYDROCHLORIDE

    LINCOCIN, LINCOMYCIN HYDROCHLORIDE

    MEDROL, METHYLPREDNISOLONE

    MYCOBUTIN, RIFABUTIN

    NICOTROL, NICOTINE

    OGEN .625, ESTROPIPATE

    OGEN 1.25, ESTROPIPATE

    OGEN 2.5, ESTROPIPATE

    OGEN 5, ESTROPIPATE

    PREPIDIL, DINOPROSTONE

    PROSTIN E2, DINOPROSTONE

    PROSTIN VR PEDIATRIC, ALPROSTADIL

    PROVERA, MEDROXYPROGESTERONE ACETATE

    R-GENE 10, ARGININE HYDROCHLORIDE

    SOLU-CORTEF, HYDROCORTISONE SODIUM SUCCINATE

    SOLU-MEDROL, METHYLPREDNISOLONE SODIUM SUCCINATE

    SOMAVERT, PEGVISOMANT

    XALATAN, LATANOPROST

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 114


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PHARMACIA AND UPJOHN CO

    XANAX, ALPRAZOLAM

    ZINECARD, DEXRAZOXANE HYDROCHLORIDE

    ZYVOX, LINEZOLID

*	 PHARMACIA AND UPJOHN SUB PFIZER INC

    DEPO-SUBQ PROVERA 104, MEDROXYPROGESTERONE ACETATE

PHARMACYCLICS INC

*	 PHARMACYCLICS INC

    IMBRUVICA, IBRUTINIB

PHARMAFORCE

*	 PHARMAFORCE INC

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    NANDROLONE DECANOATE, NANDROLONE DECANOATE

PHARMALUCENCE

*	 PHARMALUCENCE INC

    AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT

    CIS-MDP, TECHNETIUM TC-99M MEDRONATE KIT

    CIS-PYRO, TECHNETIUM TC-99M PYROPHOSPHATE KIT

    HEPATOLITE, TECHNETIUM TC-99M DISOFENIN KIT

    TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT

    TECHNETIUM TC-99M MEBROFENIN, TECHNETIUM TC-99M MEBROFENIN KIT

PHARMAX

*	 PHARMAX GROUP INC

    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

PHARMS

*	 PHARMACEUTICALS INTERNATIONAL

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

PHOTOCURE ASA

*	 PHOTOCURE ASA

    CYSVIEW KIT, HEXAMINOLEVULINATE HYDROCHLORIDE

PIERRE FABRE

*	 PIERRE FABRE MEDICAMENT

    NAVELBINE, VINORELBINE TARTRATE

PIERRE FABRE DERMA

*	 PIERRE FABRE DERMATOLOGIE

    HEMANGEOL, PROPRANOLOL HYDROCHLORIDE

PIERREL

*	 PIERREL S.P.A.

    ORABLOC, ARTICAINE HYDROCHLORIDE

PIRAMAL CRITICAL

*	 PIRAMAL CRITICAL CARE INC

    ENFLURANE, ENFLURANE

    ISOFLURANE, ISOFLURANE

    SOJOURN, SEVOFLURANE

PIRAMAL ENT

*	 PIRAMAL ENTERPRISES LTD

    ISOFLURANE, ISOFLURANE

PIRAMAL IMAGING

*	 PIRAMAL IMAGING SA

    NEURACEQ, FLORBETABEN F-18

PLIVA

*	 PLIVA INC

    AZITHROMYCIN, AZITHROMYCIN

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    CIMETIDINE, CIMETIDINE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    METRONIDAZOLE, METRONIDAZOLE

    NAPROXEN, NAPROXEN

    PENTOXIFYLLINE, PENTOXIFYLLINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 115


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PLIVA INC

    PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    THEOPHYLLINE, THEOPHYLLINE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    WARFARIN SODIUM, WARFARIN SODIUM

PLIVA HRVATSKA DOO

*	 PLIVA HRVATSKA DOO

    ADAPALENE, ADAPALENE

    CARVEDILOL, CARVEDILOL

    CILOSTAZOL, CILOSTAZOL

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

PLIVA LACHEMA

*	 PLIVA LACHEMA AS

    CARBOPLATIN, CARBOPLATIN

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

PLIVA PHARM IND

*	 PLIVA PHARMACEUTICAL INDUSTRY INC

    TORSEMIDE, TORSEMIDE

PLX PHARMA

*	 PLX PHARMA INC

    ASPIRIN, ASPIRIN    (OTC)

POHL BOSKAMP

*	 POHL BOSKAMP

    NITROLINGUAL PUMPSPRAY, NITROGLYCERIN

POLYMEDICA

*	 POLYMEDICA INDUSTRIES INC

    NEOPAP, ACETAMINOPHEN     (OTC)

POWDER PHARMS

*	 POWDER PHARMACEUTICALS INC

    ZINGO, LIDOCAINE HYDROCHLORIDE

PRAGMA PHARMS LLC

*	 PRAGMA PHARMACEUTICALS LLC

    MOXATAG, AMOXICILLIN

PRECISION DERMAT

*	 PRECISION DERMATOLOGY INC

    CLINDAGEL, CLINDAMYCIN PHOSPHATE

    LOCOID LIPOCREAM, HYDROCORTISONE BUTYRATE

    LOCOID, HYDROCORTISONE BUTYRATE

    MINOCIN, MINOCYCLINE HYDROCHLORIDE

    PODOFILOX, PODOFILOX

PRECISION DOSE

*	 PRECISION DOSE INC

    RISPERIDONE, RISPERIDONE

PRINSTON INC

*	 PRINSTON PHARMACEUTICAL INC

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    LEVETIRACETAM, LEVETIRACETAM

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    METHOCARBAMOL, METHOCARBAMOL

    NEVIRAPINE, NEVIRAPINE

    PAROXETINE, PAROXETINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 116


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

PROCTER AND GAMBLE

*	 PROCTER AND GAMBLE PHARMACEUTICALS INC SUB PROCTER AND GAMBLE CO

    DIDRONEL, ETIDRONATE DISODIUM

PROF DSPLS

*	 PROFESSIONAL DISPOSABLES INC

    PREVANTICS MAXI SWABSTICK, CHLORHEXIDINE GLUCONATE    (OTC)

    PREVANTICS SWAB, CHLORHEXIDINE GLUCONATE    (OTC)

    PREVANTICS SWABSTICK, CHLORHEXIDINE GLUCONATE    (OTC)

PROMETHEUS LABS

*	 PROMETHEUS LABORATORIES INC

    IMURAN, AZATHIOPRINE

    LOTRONEX, ALOSETRON HYDROCHLORIDE

    MERCAPTOPURINE, MERCAPTOPURINE

    RIDAURA, AURANOFIN

    ZYLOPRIM, ALLOPURINOL

PROMIUS PHARMA

*	 PROMIUS PHARMA LLC

    SECTRAL, ACEBUTOLOL HYDROCHLORIDE

    TENEX, GUANFACINE HYDROCHLORIDE

PROMIUS PHARMA LLC

*	 PROMIUS PHARMA LLC

    CLODERM, CLOCORTOLONE PIVALATE

PROSAM LABS

*	 PROSAM LABS LLC

    BACLOFEN, BACLOFEN

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CARISOPRODOL AND ASPIRIN, ASPIRIN

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    RIMACTANE, RIFAMPIN

    RISPERIDONE, RISPERIDONE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SIMVASTATIN, SIMVASTATIN

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

PROSTRAKAN INC

*	 PROSTRAKAN INC

    FARESTON, TOREMIFENE CITRATE

    SANCUSO, GRANISETRON

PROVENSIS

*	 PROVENSIS LTD

    VARITHENA, POLIDOCANOL

PROVIDENT PHARM

*	 PROVIDENT PHARMACEUTICAL INC

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

PULMOFLOW INC

*	 PULMOFLOW INC

    KITABIS PAK, TOBRAMYCIN

PULSION MEDCL

*	 PULSION MEDICAL SYSTEMS AG

    INDOCYANINE GREEN, INDOCYANINE GREEN

PURACAP PHARM

*	 PURACAP PHARMACEUTICAL LLC

    MELOXICAM, MELOXICAM

PURDUE GMP

*	 PURDUE GMP CENTER LLC DBA THE CHAO CENTER INDUSTRIAL PHARMACY

    SEROMYCIN, CYCLOSERINE

PURDUE PHARM PRODS

*	 PURDUE PHARMACEUTICAL PRODUCTS LP

    DILAUDID, HYDROMORPHONE HYDROCHLORIDE

    DILAUDID-HP, HYDROMORPHONE HYDROCHLORIDE

PURDUE PHARMA

*	 PURDUE PHARMA PRODUCTS LP

    INTERMEZZO, ZOLPIDEM TARTRATE

PURDUE PHARMA LP

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		             B - 117


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   P   **

*	 PURDUE PHARMA LP

    BUTRANS, BUPRENORPHINE

    HYSINGLA, HYDROCODONE BITARTRATE

    MS CONTIN, MORPHINE SULFATE

    OXYCONTIN, OXYCODONE HYDROCHLORIDE

PUREPAC PHARM

*	 PUREPAC PHARMACEUTICAL CO

    DIPYRIDAMOLE, DIPYRIDAMOLE

PVT FORM

*	 PRIVATE FORMULATIONS INC

    PROPOXYPHENE HYDROCHLORIDE, PROPOXYPHENE HYDROCHLORIDE

                                         **   Q   **

QILU PHARM CO LTD

*	 QILU PHARMACEUTICAL CO LTD

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

QOL MEDCL

*	 QOL MEDICAL LLC

    ETHAMOLIN, ETHANOLAMINE OLEATE

    SUCRAID, SACROSIDASE

QUESTCOR PHARMS

* QUESTCOR PHARMACEUTICALS INC

    H.P. ACTHAR GEL, CORTICOTROPIN

                                         **   R   **

RANBAXY

*	 RANBAXY INC

    ABSORICA, ISOTRETINOIN

    GLYCOPYRROLATE, GLYCOPYRROLATE

*	 RANBAXY LABORATORIES INC

    EURAX, CROTAMITON

    EXELDERM, SULCONAZOLE NITRATE

    FAMOTIDINE, FAMOTIDINE    (OTC)

    HALOG, HALCINONIDE

    KENALOG, TRIAMCINOLONE ACETONIDE

    LAC-HYDRIN, AMMONIUM LACTATE

    RISPERIDONE, RISPERIDONE

    ULTRAVATE, HALOBETASOL PROPIONATE

*	 RANBAXY LABORATORIES LTD

    ACYCLOVIR, ACYCLOVIR

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    AMOXICILLIN, AMOXICILLIN

    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    CARVEDILOL, CARVEDILOL

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL

    CEFUROXIME AXETIL, CEFUROXIME AXETIL

    CEPHALEXIN, CEPHALEXIN

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE     (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE     (OTC)

    CLARITHROMYCIN, CLARITHROMYCIN

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXYCYCLINE, DOXYCYCLINE

    FENOFIBRATE, FENOFIBRATE

    FLECAINIDE ACETATE, FLECAINIDE ACETATE

    FLUCONAZOLE, FLUCONAZOLE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

    GABAPENTIN, GABAPENTIN

    LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE    (OTC)

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		               B - 118


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   R   **

*	 RANBAXY LABORATORIES LTD

    LORATADINE REDIDOSE, LORATADINE      (OTC)

    LORATADINE, LORATADINE     (OTC)

    LORAZEPAM, LORAZEPAM

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE

    ONDANSETRON, ONDANSETRON

    OXCARBAZEPINE, OXCARBAZEPINE

    PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE   (OTC)

    QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SIMVASTATIN, SIMVASTATIN

    SOTRET, ISOTRETINOIN

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TOPIRAMATE, TOPIRAMATE

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

*	 RANBAXY PHARMACEUTICALS INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    AMOXICILLIN, AMOXICILLIN

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

    RIOMET, METFORMIN HYDROCHLORIDE

    SOTRET, ISOTRETINOIN

RANBAXY LABS LTD

*	 RANBAXY LABORATORIES LIMITED

    NAPROXEN SODIUM, NAPROXEN SODIUM      (OTC)

*	 RANBAXY LABORATORIES LTD

    ACETAMINOPHEN, ACETAMINOPHEN      (OTC)

    ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

    FELODIPINE, FELODIPINE

    FENOFIBRATE, FENOFIBRATE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

RAPTOR INC

*	 RAPTOR PHARMACEUTICALS INC

    PROCYSBI, CYSTEAMINE BITARTRATE

RARE DIS THERAP

*	 RARE DISEASE THERAPEUTICS INC

    CYSTADANE, BETAINE HYDROCHLORIDE

RECIP

*	 RECIP AB

    THYROSAFE, POTASSIUM IODIDE     (OTC)

RECKITT BENCKISER

*	 RECKITT BENCKISER LLC

    DELSYM, DEXTROMETHORPHAN POLISTIREX      (OTC)

    MUCINEX D, GUAIFENESIN     (OTC)

    MUCINEX DM, DEXTROMETHORPHAN HYDROBROMIDE       (OTC)

    MUCINEX, GUAIFENESIN     (OTC)

*	 RECKITT BENCKISER PHARMACEUTICALS INC

    BUPRENEX, BUPRENORPHINE HYDROCHLORIDE

    SUBOXONE, BUPRENORPHINE HYDROCHLORIDE

RECORDATI RARE

*	 RECORDATI RARE DISEASES INC

    CHEMET, SUCCIMER

    COSMEGEN, DACTINOMYCIN

    DESOXYN, METHAMPHETAMINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 119


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   R   **

*	 RECORDATI RARE DISEASES INC

    INDOCIN, INDOMETHACIN SODIUM

    MUSTARGEN, MECHLORETHAMINE HYDROCHLORIDE

    NEOPROFEN, IBUPROFEN LYSINE

    PEGANONE, ETHOTOIN

    TRANXENE, CLORAZEPATE DIPOTASSIUM

REMPEX PHARMS INC

*	 REMPEX PHARMACEUTICALS INC

    MINOCIN, MINOCYCLINE HYDROCHLORIDE

RENAISSANCE PHARMA

*	 RENAISSANCE PHARMA US HOLDINGS INC

    ELIMITE, PERMETHRIN

RHODES PHARMS

*	 RHODES PHARMACEUTICALS LP

    MORPHINE SULFATE, MORPHINE SULFATE

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    THEOPHYLLINE, THEOPHYLLINE

    UNIPHYL, THEOPHYLLINE

RICONPHARMA LLC

*	 RICONPHARMA LLC

    GRISEOFULVIN, ULTRAMICROSIZE, GRISEOFULVIN, ULTRAMICROSIZE

RISING PHARMS INC

*	 RISING PHARMACEUTICALS INC

    PARICALCITOL, PARICALCITOL

ROCHE PALO

*	 ROCHE PALO ALTO LLC

    CELLCEPT, MYCOPHENOLATE MOFETIL

    CELLCEPT, MYCOPHENOLATE MOFETIL HYDROCHLORIDE

    CYTOVENE, GANCICLOVIR SODIUM

    EC-NAPROSYN, NAPROXEN

    NAPROSYN, NAPROXEN

ROCKWELL MEDCL

*	 ROCKWELL MEDICAL TECHNOLOGIES INC

    CALCITRIOL, CALCITRIOL

ROMARK

*	 ROMARK LABORATORIES

    ALINIA, NITAZOXANIDE

ROSEDALE THERAPEUTIC

*	 ROSEDALE THERAPEUTICS

    ERGOMAR, ERGOTAMINE TARTRATE

ROUSES POINT PHARMS

*	 ROUSES POINT PHARMACEUTICALS LLC

    LEVETIRACETAM, LEVETIRACETAM

ROXANE

*	 ROXANE LABORATORIES INC

    ACARBOSE, ACARBOSE

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    ALPRAZOLAM, ALPRAZOLAM

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ANASTROZOLE, ANASTROZOLE

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

    BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE

    CALCITRIOL, CALCITRIOL

    CALCIUM ACETATE, CALCIUM ACETATE

    CEVIMELINE HYDROCHLORIDE, CEVIMELINE HYDROCHLORIDE

    CILOSTAZOL, CILOSTAZOL

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLARITHROMYCIN, CLARITHROMYCIN

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    CLOTRIMAZOLE, CLOTRIMAZOLE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		       B - 120


              APPENDIX B       -   PRODUCT NAME SORTED BY APPLICANT

                                          ** 	 R   **

*	 ROXANE LABORATORIES INC

    CODEINE SULFATE, CODEINE SULFATE

    CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE

    DEXAMETHASONE INTENSOL, DEXAMETHASONE

    DEXAMETHASONE, DEXAMETHASONE

    DIAZEPAM INTENSOL, DIAZEPAM

    DIAZEPAM, DIAZEPAM

    DIGOXIN, DIGOXIN

    DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, 
 ATROPINE SULFATE

    DISULFIRAM, DISULFIRAM

    DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXERCALCIFEROL, DOXERCALCIFEROL

    ESZOPICLONE, ESZOPICLONE

    EXEMESTANE, EXEMESTANE

    FAMCICLOVIR, FAMCICLOVIR

    FLECAINIDE ACETATE, FLECAINIDE ACETATE

    FLUCONAZOLE, FLUCONAZOLE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    FUROSEMIDE, FUROSEMIDE

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE

    IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    LACTULOSE, LACTULOSE

    LETROZOLE, LETROZOLE

    LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM

    LEVETIRACETAM, LEVETIRACETAM

    LEVORPHANOL TARTRATE, LEVORPHANOL TARTRATE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE

    LITHIUM CARBONATE, LITHIUM CARBONATE

    LITHIUM CITRATE, LITHIUM CITRATE

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE     (OTC)

    LORAZEPAM INTENSOL, LORAZEPAM

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE

    MEGESTROL ACETATE, MEGESTROL ACETATE

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    MERCAPTOPURINE, MERCAPTOPURINE

    METHADONE HYDROCHLORIDE INTENSOL, METHADONE HYDROCHLORIDE

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    METHOTREXATE SODIUM, METHOTREXATE SODIUM

    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MORPHINE SULFATE, MORPHINE SULFATE

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NAPROXEN, NAPROXEN

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXCARBAZEPINE, OXCARBAZEPINE

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE

    PHENOXYBENZAMINE HYDROCHLORIDE, PHENOXYBENZAMINE HYDROCHLORIDE

    PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE

    PREDNISONE INTENSOL, PREDNISONE

    PREDNISONE, PREDNISONE

    PROPANTHELINE BROMIDE, PROPANTHELINE BROMIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 121


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   R   **

*	 ROXANE LABORATORIES INC

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RAMIPRIL, RAMIPRIL

    RISPERIDONE, RISPERIDONE

    RITONAVIR, RITONAVIR

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    ROXICET, ACETAMINOPHEN

    SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE

    TINIDAZOLE, TINIDAZOLE

    TORSEMIDE, TORSEMIDE

    TRIAZOLAM, TRIAZOLAM

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    ZALEPLON, ZALEPLON

    ZIDOVUDINE, ZIDOVUDINE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

RUBICON RES PVT LTD

*	 RUBICON RESEARCH PVT LTD

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

                                         **   S   **

SAGE PRODS

*	 SAGE PRODUCTS INC

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE    (OTC)

SAGENT AGILA

*	 SAGENT AGILA LLC

    ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM

    BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE

    BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

SAGENT PHARMS

*	 SAGENT PHARMACEUTICALS INC

    ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE

    ATRACURIUM BESYLATE, ATRACURIUM BESYLATE

    CAFFEINE CITRATE, CAFFEINE CITRATE

    CALCITRIOL, CALCITRIOL

    CARBOPLATIN, CARBOPLATIN

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    FLUMAZENIL, FLUMAZENIL

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    GLYDO, LIDOCAINE HYDROCHLORIDE

    HALOPERIDOL, HALOPERIDOL LACTATE

    HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM

    HEPARIN SODIUM, HEPARIN SODIUM

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN, LEVOFLOXACIN

    MESNA, MESNA

    NAFCILLIN SODIUM, NAFCILLIN SODIUM

    OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE

    OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

    OXACILLIN SODIUM, OXACILLIN SODIUM

    OXYTOCIN, OXYTOCIN

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

SAGENT STRIDES

*	 SAGENT STRIDES LLC

    ADENOSINE, ADENOSINE

    AZITHROMYCIN, AZITHROMYCIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 122


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SAGENT STRIDES LLC

    BACITRACIN, BACITRACIN

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    LABETALOL HYDROCLORIDE, LABETALOL HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE

    MIDOZALAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE

    POLYMYCIN B SULFATE, POLYMYXIN B SULFATE

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

    ROPIVACAINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

SALIX PHARMS

*	 SALIX PHARMACEUTICALS INC

    ANUSOL HC, HYDROCORTISONE

    APRISO, MESALAMINE

    COLAZAL, BALSALAZIDE DISODIUM

    DIURIL, CHLOROTHIAZIDE

    FULYZAQ, CROFELEMER

    GIAZO, BALSALAZIDE DISODIUM

    METOZOLV ODT, METOCLOPRAMIDE HYDROCHLORIDE

    MOVIPREP, ASCORBIC ACID

    OSMOPREP, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

    PEPCID, FAMOTIDINE

    RELISTOR, METHYLNALTREXONE BROMIDE

    XIFAXAN, RIFAXIMIN

SALIX PHARMS INC

*	 SALIX PHARMACEUTICALS INC

    UCERIS, BUDESONIDE

SAMSON MEDCL

*	 SAMSON MEDICAL TECHNOLOGIES LLC

    CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

    CEFTRIAXONE, CEFTRIAXONE SODIUM

SANDOZ

*	 SANDOZ

    DOCETAXEL, DOCETAXEL

*	 SANDOZ CANADA INC

    ANECTINE, SUCCINYLCHOLINE CHLORIDE

    ARISTOSPAN, TRIAMCINOLONE HEXACETONIDE

    BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE

    DIGOXIN, DIGOXIN

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

    FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE

    FLUMAZENIL, FLUMAZENIL

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    INFUVITE ADULT, ALPHA-TOCOPHEROL ACETATE

    INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), ASCORBIC ACID

    INFUVITE PEDIATRIC, ASCORBIC ACID

    ISONIAZID, ISONIAZID

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE

    METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    REGONOL, PYRIDOSTIGMINE BROMIDE

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

*	 SANDOZ INC

    ALPRAZOLAM, ALPRAZOLAM

    ALTAVERA, ETHINYL ESTRADIOL

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 123


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SANDOZ INC

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    AMOXICILLIN, AMOXICILLIN

    AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

    AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE

    ANASTROZOLE, ANASTROZOLE

    APREPITANT, APREPITANT

    ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN

    ATENOLOL, ATENOLOL

    AZITHROMYCIN, AZITHROMYCIN

    BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BICALUTAMIDE, BICALUTAMIDE

    BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE

    BISOPROLOL FUMARATE, BISOPROLOL FUMARATE

    BUDESONIDE, BUDESONIDE

    BUMETANIDE, BUMETANIDE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CAFERGOT, CAFFEINE

    CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL

    CAPTOPRIL, CAPTOPRIL

    CARISOPRODOL AND ASPIRIN, ASPIRIN

    CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN

    CARVEDILOL, CARVEDILOL

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

    CEFDINIR, CEFDINIR

    CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL

    CEFPROZIL, CEFPROZIL

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE

    CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE

    CHOLESTYRAMINE, CHOLESTYRAMINE

    CILOSTAZOL, CILOSTAZOL

    CLARITHROMYCIN, CLARITHROMYCIN

    CLEMASTINE FUMARATE, CLEMASTINE FUMARATE

    CLEMASTINE FUMARATE, CLEMASTINE FUMARATE    (OTC)

    CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE

    CLONAZEPAM, CLONAZEPAM

    COSYNTROPIN, COSYNTROPIN

    CYCLOSPORINE, CYCLOSPORINE

    DECITABINE, DECITABINE

    DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE

    DESLORATADINE, DESLORATADINE

    DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE

    DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM

    DICLOFENAC SODIUM AND MISOPROSTOL, DICLOFENAC SODIUM

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DOXERCALCIFEROL, DOXERCALCIFEROL

    ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM

    EPLERENONE, EPLERENONE

    ESTARYLLA, ETHINYL ESTRADIOL

    ETODOLAC, ETODOLAC

    FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

    FLUOROURACIL, FLUOROURACIL

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		    B - 124


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SANDOZ INC

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM

    FOSINOPRIL SODIUM, FOSINOPRIL SODIUM

    FUROSEMIDE, FUROSEMIDE

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GLIPIZIDE, GLIPIZIDE

    GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

    HALOPERIDOL, HALOPERIDOL

    HEPARIN SODIUM, HEPARIN SODIUM

    HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

    HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE

    IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE

    INDOMETHACIN, INDOMETHACIN

    INTROVALE, ETHINYL ESTRADIOL

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    ISONIAZID, ISONIAZID

    ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE

    ITRACONAZOLE, ITRACONAZOLE

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

    LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN, AMOXICILLIN

    LANSOPRAZOLE, LANSOPRAZOLE

    LEUPROLIDE ACETATE, LEUPROLIDE ACETATE

    LEVOFLOXACIN, LEVOFLOXACIN

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LISINOPRIL, LISINOPRIL

    LONOX, ATROPINE SULFATE

    LORATADINE, LORATADINE    (OTC)

    LORAZEPAM, LORAZEPAM

    LORYNA, DROSPIRENONE

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    LOVASTATIN, LOVASTATIN

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE

    MEROPENEM, MEROPENEM

    METAXALONE, METAXALONE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    METHAZOLAMIDE, METHAZOLAMIDE

    METHIMAZOLE, METHIMAZOLE

    METHOCARBAMOL, METHOCARBAMOL

    METHYLPREDNISOLONE, METHYLPREDNISOLONE

    METOLAZONE, METOLAZONE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MIRTAZAPINE, MIRTAZAPINE

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NABUMETONE, NABUMETONE

    NADOLOL, NADOLOL

    NAFCILLIN SODIUM, NAFCILLIN SODIUM

    NAPROXEN, NAPROXEN

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    NEVIRAPINE, NEVIRAPINE

    NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN

    NIZATIDINE, NIZATIDINE

    OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    OMEPRAZOLE, OMEPRAZOLE

    OMNITROPE, SOMATROPIN RECOMBINANT

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON, ONDANSETRON

    ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                   B - 125


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SANDOZ INC

    OXACILLIN SODIUM, OXACILLIN SODIUM

    OXALIPLATIN, OXALIPLATIN

    OXAPROZIN, OXAPROZIN

    OXAZEPAM, OXAZEPAM

    PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM

    PENICILLIN G SODIUM, PENICILLIN G SODIUM

    PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM

    PERPHENAZINE, PERPHENAZINE

    PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE, GLIMEPIRIDE

    PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    QUINIDINE SULFATE, QUINIDINE SULFATE

    RAMIPRIL, RAMIPRIL

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    REPAGLINIDE, REPAGLINIDE

    RESERPINE, RESERPINE

    RIBAVIRIN, RIBAVIRIN

    RIFAMPIN, RIFAMPIN

    RISPERIDONE, RISPERIDONE

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

    SPIRONOLACTONE, SPIRONOLACTONE

    SULFADIAZINE, SULFADIAZINE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    SYEDA, DROSPIRENONE

    TACROLIMUS, TACROLIMUS

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TELMISARTAN, TELMISARTAN

    TEMAZEPAM, TEMAZEPAM

    TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE

    THIOTHIXENE, THIOTHIXENE

    TRI-ESTARYLLA, ETHINYL ESTRADIOL

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

SANDOZ CANADA INC

*	 SANDOZ CANADA INC

    PARICALCITOL, PARICALCITOL

SANDOZ INC

*	 SANDOZ INC

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CISATRACURIUM BESYLATE PRESERVATIVE FREE, CISATRACURIUM BESYLATE

    CISATRACURIUM BESYLATE, CISATRACURIUM BESYLATE

    CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    ENOXAPARIN SODIUM, ENOXAPARIN SODIUM

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    OLANZAPINE, OLANZAPINE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 126


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                        **   S   **

*	 SANDOZ INC

    VORICONAZOLE, VORICONAZOLE

    ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE

SANOCHEMIA CORP USA

*	 SANOCHEMIA CORP USA

    SCANLUX-300, IOPAMIDOL

    SCANLUX-370, IOPAMIDOL

SANOFI AVENTIS

*	 SANOFI AVENTIS

    AFREZZA, INSULIN RECOMBINANT HUMAN

SANOFI AVENTIS US

*	 SANOFI AVENTIS US INC

    JEVTANA KIT, CABAZITAXEL

*	 SANOFI AVENTIS US LLC

    ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

    ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE    (OTC)

    ALLEGRA, FEXOFENADINE HYDROCHLORIDE

    ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE   (OTC)

    ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE   (OTC)

    AMARYL, GLIMEPIRIDE

    AMBIEN CR, ZOLPIDEM TARTRATE

    AMBIEN, ZOLPIDEM TARTRATE

    ANZEMET, DOLASETRON MESYLATE

    APIDRA SOLOSTAR, INSULIN GLULISINE RECOMBINANT

    APIDRA, INSULIN GLULISINE RECOMBINANT

    ARALEN, CHLOROQUINE PHOSPHATE

    ARAVA, LEFLUNOMIDE

    AUBAGIO, TERIFLUNOMIDE

    AUVI-Q, EPINEPHRINE

    AVALIDE, HYDROCHLOROTHIAZIDE

    AVAPRO, IRBESARTAN

    CANTIL, MEPENZOLATE BROMIDE

    CHILDREN'S ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE     (OTC)

    CHILDREN'S ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE     (OTC)

    CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CEFOTAXIME SODIUM

    CLAFORAN, CEFOTAXIME SODIUM

    CLOMID, CLOMIPHENE CITRATE

    DDAVP, DESMOPRESSIN ACETATE

    DEMEROL, MEPERIDINE HYDROCHLORIDE

    DIABETA, GLYBURIDE

    DRISDOL, ERGOCALCIFEROL

    ELOXATIN, OXALIPLATIN

    FERRLECIT, SODIUM FERRIC GLUCONATE COMPLEX

    GAVISCON, ALUMINUM HYDROXIDE    (OTC)

    HIPREX, METHENAMINE HIPPURATE

    KETEK, TELITHROMYCIN

    LANTUS SOLOSTAR, INSULIN GLARGINE RECOMBINANT

    LANTUS, INSULIN GLARGINE RECOMBINANT

    LASIX, FUROSEMIDE

    LOVENOX (PRESERVATIVE FREE), ENOXAPARIN SODIUM

    LOVENOX, ENOXAPARIN SODIUM

    MULTAQ, DRONEDARONE HYDROCHLORIDE

    NASACORT ALLERGY 24 HOUR, TRIAMCINOLONE ACETONIDE     (OTC)

    NICODERM CQ, NICOTINE    (OTC)

    NORPRAMIN, DESIPRAMINE HYDROCHLORIDE

    PHISOHEX, HEXACHLOROPHENE

    PLAQUENIL, HYDROXYCHLOROQUINE SULFATE

    PLAVIX, CLOPIDOGREL BISULFATE

    PRIFTIN, RIFAPENTINE

    PRIMAQUINE, PRIMAQUINE PHOSPHATE

    RIFADIN, RIFAMPIN

    RIFAMATE, ISONIAZID

    RIFATER, ISONIAZID

    TAXOTERE, DOCETAXEL

SANOFI PASTEUR INC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 127


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SANOFI PASTEUR INC

    SKLICE, IVERMECTIN

SANTARUS INC

*	 SANTARUS INC

    FENOGLIDE, FENOFIBRATE

    GLUMETZA, METFORMIN HYDROCHLORIDE

    UCERIS, BUDESONIDE

    ZEGERID, OMEPRAZOLE

SANTEN

*	 SANTEN INC

    QUIXIN, LEVOFLOXACIN

SANTOS BIOTECH

*	 SANTOS BIOTECH INDUSTRIES INC

    ANASTROZOLE, ANASTROZOLE

SB PHARMCO

*	 SB PHARMCO PUERTO RICO INC

    AVANDAMET, METFORMIN HYDROCHLORIDE

    AVANDARYL, GLIMEPIRIDE

    AVANDIA, ROSIGLITAZONE MALEATE

    COREG CR, CARVEDILOL PHOSPHATE

SCHERING

*	 SCHERING CORP

    INTEGRILIN, EPTIFIBATIDE

    NOXAFIL, POSACONAZOLE

    REBETOL, RIBAVIRIN

SCHERING PLOUGH

*	 SCHERING PLOUGH HEALTHCARE PRODUCTS INC

    AFRINOL, PSEUDOEPHEDRINE SULFATE      (OTC)

    CHILDREN'S CLARITIN, LORATADINE     (OTC)

    CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE      (OTC)

    CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE      (OTC)

    CLARITIN REDITABS, LORATADINE     (OTC)

    CLARITIN, LORATADINE    (OTC)

    CLARITIN-D 24 HOUR, LORATADINE     (OTC)

    CLARITIN-D, LORATADINE     (OTC)

    GYNE-LOTRIMIN 3, CLOTRIMAZOLE     (OTC)

    GYNE-LOTRIMIN COMBINATION PACK, CLOTRIMAZOLE      (OTC)

    GYNE-LOTRIMIN, CLOTRIMAZOLE     (OTC)

    LOTRIMIN ULTRA, BUTENAFINE HYDROCHLORIDE      (OTC)

    MIRALAX, POLYETHYLENE GLYCOL 3350      (OTC)

    OCUCLEAR, OXYMETAZOLINE HYDROCHLORIDE      (OTC)

    SHADE UVAGUARD, AVOBENZONE     (OTC)

SCIECURE PHARMA INC

*	 SCIECURE PHARMA INC

    DORAL, QUAZEPAM

SCIEGEN PHARMS INC

*	 SCIEGEN PHARMACEUTICALS INC

    CARISOPRODOL, CARISOPRODOL

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    NEVIRAPINE, NEVIRAPINE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

SCIOS LLC

*	 SCIOS LLC

    NATRECOR, NESIRITIDE RECOMBINANT

SEBELA IRELAND LTD

*	 SEBELA IRELAND LTD

    MIACALCIN, CALCITONIN SALMON

    MICORT-HC, HYDROCORTISONE ACETATE

    PRAMOSONE, HYDROCORTISONE ACETATE

SECAN PHARMS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		              B - 128


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SECAN PHARMACEUTICALS INC

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

SEPTODONT

*	 SEPTODONT INC

    BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE

    OCTOCAINE, EPINEPHRINE

SEPTODONT HOLDING

*	 SEPTODONT HOLDING SAS

    ORAVERSE, PHENTOLAMINE MESYLATE

SEPTODONT INC

*	 SEPTODONT INC

    PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, EPINEPHRINE BITARTRATE

    PRILOCAINE HYDROCHLORIDE, PRILOCAINE HYDROCHLORIDE

SETON PHARM

*	 SETON PHARMACEUTICAL LLC

    PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE

SHASUN CHEMS

*	 SHASUN CHEMICALS AND DRUGS LTD

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE   (OTC)

SHASUN USA

*	 SHASUN USA INC

    IBUPROFEN, IBUPROFEN

SHENZHEN TECHDOW

*	 SHENZHEN TECHDOW PHARMACEUTICAL CO LTD

    HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM

    HEPARIN SODIUM, HEPARIN SODIUM

SHERTECH LABS LLC

*	 SHERTECH LABORATORIES LLC

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

SHIONOGI INC

*	 SHIONOGI INC

    DORIBAX, DORIPENEM

    FURADANTIN, NITROFURANTOIN

    KEFLEX, CEPHALEXIN

    OSPHENA, OSPEMIFENE

    PONSTEL, MEFENAMIC ACID

    ROBINUL FORTE, GLYCOPYRROLATE

    ROBINUL, GLYCOPYRROLATE

    SULAR, NISOLDIPINE

    ULESFIA, BENZYL ALCOHOL

SHIRE

*	 SHIRE DEVELOPMENT INC

    ADDERALL XR 10, AMPHETAMINE ASPARTATE

    ADDERALL XR 15, AMPHETAMINE ASPARTATE

    ADDERALL XR 20, AMPHETAMINE ASPARTATE

    ADDERALL XR 25, AMPHETAMINE ASPARTATE

    ADDERALL XR 30, AMPHETAMINE ASPARTATE

    ADDERALL XR 5, AMPHETAMINE ASPARTATE

    CARBATROL, CARBAMAZEPINE

    INTUNIV, GUANFACINE HYDROCHLORIDE

    LIALDA, MESALAMINE

    PENTASA, MESALAMINE

SHIRE DEV LLC

*	 SHIRE DEVELOPMENT LLC

    FOSRENOL, LANTHANUM CARBONATE

SHIRE DEVELOPMENT

*	 SHIRE DEVELOPMENT INC

    VYVANSE, LISDEXAMFETAMINE DIMESYLATE

SHIRE HUMAN GENETIC

*	 SHIRE HUMAN GENETIC THERAPIES INC

    VPRIV, VELAGLUCERASE ALFA

SHIRE LLC

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 129


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SHIRE DEVELOPMENT LLC

    AGRYLIN, ANAGRELIDE HYDROCHLORIDE

    FOSRENOL, LANTHANUM CARBONATE

    SALURON, HYDROFLUMETHIAZIDE

SHIRE ORPHAN THERAP

*	 SHIRE ORPHAN THERAPIES INC

    FIRAZYR, ICATIBANT ACETATE

SIGMA TAU

*	 SIGMA TAU PHARMACEUTICALS INC

    ABELCET, AMPHOTERICIN B

    ADAGEN, PEGADEMASE BOVINE

    CARNITOR SF, LEVOCARNITINE

    CARNITOR, LEVOCARNITINE

    CYSTARAN, CYSTEAMINE HYDROCHLORIDE

    MATULANE, PROCARBAZINE HYDROCHLORIDE

SIGMAPHARM LABS LLC

*	 SIGMAPHARM LABORATORIES LLC

    ADEFOVIR DIPIVOXIL, ADEFOVIR DIPIVOXIL

    AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE

    DISULFIRAM, DISULFIRAM

    ERGOCALCIFEROL, ERGOCALCIFEROL

    FLUCYTOSINE, FLUCYTOSINE

    GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

    GRISEOFULVIN,ULTRAMICROSIZE, GRISEOFULVIN, ULTRAMICROSIZE

    LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM

    PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE

    SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE

SILARX

*	 SILARX PHARMACEUTICALS INC

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    HALOPERIDOL, HALOPERIDOL LACTATE

    LEVETIRACETAM, LEVETIRACETAM

    LORATADINE, LORATADINE     (OTC)

    METAPROTERENOL SULFATE, METAPROTERENOL SULFATE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    THEOPHYLLINE, THEOPHYLLINE

SILARX PHARMS INC

*	 SILARX PHARMACEUTICALS INC

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    LAMIVUDINE, LAMIVUDINE

    RISPERIDONE, RISPERIDONE

SILVERGATE PHARMS

*	 SILVERGATE PHARMACEUTICALS INC

    EPANED KIT, ENALAPRIL MALEATE

SKINMEDICA

*	 SKINMEDICA INC

    VANIQA, EFLORNITHINE HYDROCHLORIDE

SKYEPHARMA AG

*	 SKYEPHARMA AG

    TRIGLIDE, FENOFIBRATE

SMITHKLINE BEECHAM

*	 SMITHKLINE BEECHAM

    LOVAZA, OMEGA-3-ACID ETHYL ESTERS

*	 SMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINE

    ARRANON, NELARABINE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 130


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINE

    COREG, CARVEDILOL

    TYKERB, LAPATINIB DITOSYLATE

SOAPCO

*	 SOAPCO INC

    BRIAN CARE, CHLORHEXIDINE GLUCONATE    (OTC)

SOFGEN PHARMS

*	 SOFGEN PHARMACEUTICALS LLC

    PROGESTERONE, PROGESTERONE

SOMERSET

*	 SOMERSET PHARMACEUTICALS INC

    ELDEPRYL, SELEGILINE HYDROCHLORIDE

    EMSAM, SELEGILINE

SOVEREIGN PHARMS

*	 SOVEREIGN PHARMACEUTICALS LLC

    OBREDON, GUAIFENESIN

SPEAR PHARMS

*	 SPEAR PHARMACEUTICALS INC

    FLUOROURACIL, FLUOROURACIL

SPEAR PHARMS INC

*	 SPEAR PHARMACEUTICALS INC

    TRETINOIN, TRETINOIN

SPECTRUM PHARMS

*	 SPECTRUM PHARMACEUTICALS INC

    BELEODAQ, BELINOSTAT

    FUSILEV, LEVOLEUCOVORIN CALCIUM

STAND HOMEOPATH

*	 STANDARD HOMEOPATHIC CO

    IVY BLOCK, BENTOQUATAM     (OTC)

STASON

*	 STASON INDUSTRIAL CORP

    ACYCLOVIR, ACYCLOVIR

    CAPTOPRIL, CAPTOPRIL

    SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE

STASON PHARMS

*	 STASON PHARMACEUTICALS INC

    CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE

    GLYCOPYRROLATE, GLYCOPYRROLATE

STERI PHARMA

*	 STERI PHARMA LLC

    CEFAZOLIN SODIUM, CEFAZOLIN SODIUM

    CEFTRIAXONE, CEFTRIAXONE SODIUM

    CEFUROXIME SODIUM, CEFUROXIME SODIUM

STI PHARMA LLC

*	 STI PHARMA LLC

    BETAMETHASONE VALERATE, BETAMETHASONE VALERATE

    DEXAMETHASONE, DEXAMETHASONE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    MYAMBUTOL, ETHAMBUTOL HYDROCHLORIDE

    SULFATRIM PEDIATRIC, SULFAMETHOXAZOLE

    TRIACIN-C, CODEINE PHOSPHATE

STIEFEL

*	 STIEFEL LABORATORIES INC

    DUAC, BENZOYL PEROXIDE

STIEFEL GSK

*	 STIEFEL A GSK CO

    VELTIN, CLINDAMYCIN PHOSPHATE

STIEFEL LABS INC

*	 STIEFEL LABORATORIES INC

    FABIOR, TAZAROTENE

    SORIATANE, ACITRETIN

    SORILUX, CALCIPOTRIENE

STRIDES ARCOLAB LTD

* STRIDES ARCOLAB LTD

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                      B - 131


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 STRIDES ARCOLAB LTD

    AMPICILLIN SODIUM, AMPICILLIN SODIUM

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CALCITRIOL, CALCITRIOL

STRIDES PHARMA

*	 STRIDES PHARMA GLOBAL PTE LTD

    ACARBOSE, ACARBOSE

    ERGOCALCIFEROL, ERGOCALCIFEROL

    HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE

    IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE    (OTC)

    IMIQUIMOD, IMIQUIMOD

    MELOXICAM, MELOXICAM

    METHOXSALEN, METHOXSALEN

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NEVIRAPINE, NEVIRAPINE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    TACROLIMUS, TACROLIMUS

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

SUCAMPO PHARMA LLC

*	 SUCAMPO PHARMA AMERICAS LLC

    AMITIZA, LUBIPROSTONE

SUCAMPO PHARMS

*	 SUCAMPO PHARMACEUTICALS INC

    RESCULA, UNOPROSTONE ISOPROPYL

SUMMERS

*	 SUMMERS LABORATORIES INC

    CROTAN, CROTAMITON

SUN PHARM INDS

*	 SUN PHARMACEUTICAL INDUSTRIES LTD

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE    (OTC)

    DESLORATADINE, DESLORATADINE

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE

    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

    FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE    (OTC)

    FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)

    METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

    OLANZAPINE, OLANZAPINE

    ONDANSETRON, ONDANSETRON

    OXCARBAZEPINE, OXCARBAZEPINE

    RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TIAGABINE HYDROCHLORIDE, TIAGABINE HYDROCHLORIDE

    TORSEMIDE, TORSEMIDE

SUN PHARM INDS (IN)

*	 SUN PHARMACEUTICAL INDUSTRIES LTD

    CEPHALEXIN, CEPHALEXIN

    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    ZONISAMIDE, ZONISAMIDE

SUN PHARM INDS INC

*	 SUN PHARMACEUTICAL INDUSTRIES INC

    ALLOPURINOL, ALLOPURINOL

    AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ATENOLOL, ATENOLOL

    BACLOFEN, BACLOFEN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 132


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SUN PHARMACEUTICAL INDUSTRIES INC

    BENZONATATE, BENZONATATE

    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

    CARVEDILOL, CARVEDILOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLONAZEPAM, CLONAZEPAM

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    CLOZAPINE, CLOZAPINE

    ELIXOPHYLLIN, THEOPHYLLINE

    ERGOCALCIFEROL, ERGOCALCIFEROL

    FLURBIPROFEN, FLURBIPROFEN

    FUROSEMIDE, FUROSEMIDE

    GEMFIBROZIL, GEMFIBROZIL

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

    GLIPIZIDE, GLIPIZIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    INDOMETHACIN, INDOMETHACIN

    ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE

    LITHIUM CARBONATE, LITHIUM CARBONATE

    MELOXICAM, MELOXICAM

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METHIMAZOLE, METHIMAZOLE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MIRTAZAPINE, MIRTAZAPINE

    MORPHINE SULFATE, MORPHINE SULFATE

    NIMODIPINE, NIMODIPINE

    NITROFURANTOIN, NITROFURANTOIN

    OXAPROZIN, OXAPROZIN

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    REPAGLINIDE, REPAGLINIDE

    RISPERIDONE, RISPERIDONE

    THEOCHRON, THEOPHYLLINE

    TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    VALPROIC ACID, VALPROIC ACID

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

SUN PHARM INDS LTD

*	 SUN PHARMACEUTICAL INDUSTRIES LTD

    AZITHROMYCIN, AZITHROMYCIN

    CARISOPRODOL, CARISOPRODOL

    CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    GABAPENTIN, GABAPENTIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 133


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SUN PHARMACEUTICAL INDUSTRIES LTD

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    LETROZOLE, LETROZOLE

    LEVETIRACETAM, LEVETIRACETAM

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    OPCICON ONE-STEP, LEVONORGESTREL    (OTC)

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RILUZOLE, RILUZOLE

    RISPERIDONE, RISPERIDONE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VALPROIC ACID, VALPROIC ACID

*	 SUN PHARMACEUTICAL INDUSTRIES LTD.

    ANASTROZOLE, ANASTROZOLE

SUN PHARMA GLOBAL

*	 SUN PHARMA GLOBAL FZE

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CAFFEINE CITRATE, CAFFEINE CITRATE

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DECITABINE, DECITABINE

    DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE

    DESVENLAFAXINE, DESVENLAFAXINE FUMARATE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DOCEFREZ, DOCETAXEL

    DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL), DOXORUBICIN HYDROCHLORIDE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ENTACAPONE, ENTACAPONE

    ESOMEPRAZOLE SODIUM, ESOMEPRAZOLE SODIUM

    ESZOPICLONE, ESZOPICLONE

    FINASTERIDE, FINASTERIDE

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    LANSOPRAZOLE, LANSOPRAZOLE

    LEUPROLIDE ACETATE, LEUPROLIDE ACETATE

    LEVETIRACETAM, LEVETIRACETAM

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

    NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE

    NIACIN, NIACIN

    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE

    OXALIPLATIN, OXALIPLATIN

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RISEDRONATE SODIUM, RISEDRONATE SODIUM

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TEMOZOLOMIDE, TEMOZOLOMIDE

    TOPIRAMATE, TOPIRAMATE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    VECURONIUM BROMIDE, VECURONIUM BROMIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

    ZOLMITRIPTAN, ZOLMITRIPTAN

*	 SUN PHARMA GLOBAL INC

    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

    ALPRAZOLAM, ALPRAZOLAM

    AMIFOSTINE, AMIFOSTINE

    AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 134


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   S   **

*	 SUN PHARMA GLOBAL INC

    BICALUTAMIDE, BICALUTAMIDE

    CARBOPLATIN, CARBOPLATIN

    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

SUNEVA MEDCL

*	 SUNEVA MEDICAL INC

    TRETINOIN, TRETINOIN

SUNOVION

*	 SUNOVION PHARMACEUTICALS INC

    BROVANA, ARFORMOTEROL TARTRATE

    XOPENEX HFA, LEVALBUTEROL TARTRATE

SUNOVION PHARMS INC

*	 SUNOVION PHARMACEUTICALS INC

    APTIOM, ESLICARBAZEPINE ACETATE

    LATUDA, LURASIDONE HYDROCHLORIDE

    LUNESTA, ESZOPICLONE

SUNSHINE LAKE

*	 SUNSHINE LAKE PHARMA CO LTD

    ZIDOVUDINE, ZIDOVUDINE

SUNSTAR AMERICAS

*	 SUNSTAR AMERICAS INC

    PAROEX, CHLORHEXIDINE GLUCONATE

SUPERNUS PHARMS

*	 SUPERNUS PHARMACEUTICALS INC

    OXTELLAR XR, OXCARBAZEPINE

    TROKENDI XR, TOPIRAMATE

SUVEN LIFE

*	 SUVEN LIFE SCIENCES LTD

    MALATHION, MALATHION

SVADS HOLDINGS SA

*	 SVADS HOLDINGS SA

    IBUPROFEN, IBUPROFEN    (OTC)

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

SVC PHARMA

*	 SVC PHARMA LP

    DRONABINOL, DRONABINOL

SWEDISH ORPHAN

*	 SWEDISH ORPHAN BIOVITRUM AB PUBL

    ORFADIN, NITISINONE

SYMPLMED PHARMS LLC

*	 SYMPLMED PHARMACEUTICALS LLC

    ACEON, PERINDOPRIL ERBUMINE

SYNTHON PHARMS

*	 SYNTHON PHARMACEUTICALS INC

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

                                         **   T   **

MEDICINES CO

*	 THE MEDICINES CO

    ANGIOMAX, BIVALIRUDIN

    CLEVIPREX, CLEVIDIPINE

    ORBACTIV, ORITAVANCIN DIPHOSPHATE

RITEDOSE CORP

*	 THE RITEDOSE CORP

    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE,    ALBUTEROL SULFATE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

TAKEDA GMBH

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                      B - 135


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TAKEDA GMBH

    ALVESCO, CICLESONIDE

    OMNARIS, CICLESONIDE

    ZETONNA, CICLESONIDE

TAKEDA PHARMS USA

*	 TAKEDA PHARMACEUTICALS USA INC

    ACTOPLUS MET XR, METFORMIN HYDROCHLORIDE

    ACTOPLUS MET, METFORMIN HYDROCHLORIDE

    ACTOS, PIOGLITAZONE HYDROCHLORIDE

    BRINTELLIX, VORTIOXETINE HYDROBROMIDE

    COLCRYS, COLCHICINE

    CONTRAVE, BUPROPION HYDROCHLORIDE

    DEXILANT, DEXLANSOPRAZOLE

    DUETACT, GLIMEPIRIDE

    KAZANO, ALOGLIPTIN BENZOATE

    NESINA, ALOGLIPTIN BENZOATE

    OSENI, ALOGLIPTIN BENZOATE

    PREVACID, LANSOPRAZOLE

    PREVPAC, AMOXICILLIN

    ROZEREM, RAMELTEON

    ULORIC, FEBUXOSTAT

TALON THERAP

*	 TALON THERAPEUTICS INC

    MARQIBO KIT, VINCRISTINE SULFATE

TAMARANG

*	 TAMARANG SA

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

TARO

*	 TARO PHARMACEUTICAL INDUSTRIES LTD

    ACETAZOLAMIDE, ACETAZOLAMIDE

    CARBAMAZEPINE, CARBAMAZEPINE

    CARVEDILOL, CARVEDILOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

    CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE

    DESONIDE, DESONIDE

    ENALAPRIL MALEATE, ENALAPRIL MALEATE

    ETODOLAC, ETODOLAC

    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

    FLUCONAZOLE, FLUCONAZOLE

    FLUOROURACIL, FLUOROURACIL

    GABAPENTIN, GABAPENTIN

    HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE

    IMIQUIMOD, IMIQUIMOD

    KETOCONAZOLE, KETOCONAZOLE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    LORATADINE, LORATADINE    (OTC)

    MELOXICAM, MELOXICAM

    METRONIDAZOLE, METRONIDAZOLE

    NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    OXCARBAZEPINE, OXCARBAZEPINE

    PHENYTOIN, PHENYTOIN

*	 TARO PHARMACEUTICALS INC

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CLOTRIMAZOLE, CLOTRIMAZOLE

    CLOTRIMAZOLE, CLOTRIMAZOLE     (OTC)

    DIFLORASONE DIACETATE, DIFLORASONE DIACETATE

    FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

    FLUOCINONIDE, FLUOCINONIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		          B - 136


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TARO PHARMACEUTICALS INC

    HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE

    MICONAZOLE NITRATE, MICONAZOLE NITRATE      (OTC)

    NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

    TOPICORT, DESOXIMETASONE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

    WARFARIN SODIUM, WARFARIN SODIUM

*	 TARO PHARMACEUTICALS USA INC

    ACETIC ACID, ACETIC ACID, GLACIAL

    ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    AMMONIUM LACTATE, AMMONIUM LACTATE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CICLOPIROX, CICLOPIROX

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM

    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CLOTRIMAZOLE, CLOTRIMAZOLE

    DERMABET, BETAMETHASONE VALERATE

    DESONIDE, DESONIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DIFLORASONE DIACETATE, DIFLORASONE DIACETATE

    ECONAZOLE NITRATE, ECONAZOLE NITRATE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FLO-PRED, PREDNISOLONE ACETATE

    FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE

    FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE

    FLUOCINONIDE, FLUOCINONIDE

    FLUOROURACIL, FLUOROURACIL

    GENTAMICIN SULFATE, GENTAMICIN SULFATE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE

    HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL

    HYDROCORTISONE, HYDROCORTISONE

    KETOZOLE, KETOCONAZOLE

    LIDOCAINE, LIDOCAINE

    LORATADINE, LORATADINE     (OTC)

    MICONAZOLE 3, MICONAZOLE NITRATE     (OTC)

    MOMETASONE FUROATE, MOMETASONE FUROATE

    MUPIROCIN, MUPIROCIN

    NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN

    NYSTATIN, NYSTATIN

    PHENYTOIN, PHENYTOIN

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE    (OTC)

    TERCONAZOLE, TERCONAZOLE

    TERIL, CARBAMAZEPINE

    TOPICORT, DESOXIMETASONE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

    TRIVAGIZOLE 3, CLOTRIMAZOLE     (OTC)

    U-CORT, HYDROCORTISONE ACETATE

*	 TARO PHARMACEUTICALS, INC.

    HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE

    TOPICORT, DESOXIMETASONE

TARO PHARM INDS

*	 TARO PHARMACEUTICAL INDUSTRIES LTD

    AMCINONIDE, AMCINONIDE

    CARBAMAZEPINE, CARBAMAZEPINE

    CICLOPIROX, CICLOPIROX

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                     B - 137


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TARO PHARMACEUTICAL INDUSTRIES LTD

    ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE

    ETODOLAC, ETODOLAC

    HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

TARO PHARMS IRELAND

*	 TARO PHARMACEUTICALS IRELAND LTD

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE

    STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION

TARO PHARMS NORTH

*	 TARO PHARMACEUTICALS NORTH AMERICA INC

    ACETAMINOPHEN, ACETAMINOPHEN     (OTC)

    INFANTS' FEVERALL, ACETAMINOPHEN     (OTC)

    OVIDE, MALATHION

    TOPICORT, DESOXIMETASONE

TEDOR PHARM

*	 TEDOR PHARMA INC

    BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE

TEDOR PHARMA INC

*	 TEDOR PHARMA INC

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

TEIKOKU PHARMA USA

*	 TEIKOKU PHARMA USA INC

    LIDODERM, LIDOCAINE

TEVA

*	 TEVA NEUROSCIENCE INC

    AZILECT, RASAGILINE MESYLATE

*	 TEVA PHARMACEUTICALS USA INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    ACYCLOVIR, ACYCLOVIR

    ADIPEX-P, PHENTERMINE HYDROCHLORIDE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    AMOXICILLIN PEDIATRIC, AMOXICILLIN

    AMOXICILLIN, AMOXICILLIN

    AMPHETAMINE ASP AMPHETAMINE SULF DEXTROAMPHET SACCHARATE & DEXTR SULF, AMPHETAMINE

    ATENOLOL, ATENOLOL

    AZITHROMYCIN, AZITHROMYCIN

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BETA-VAL, BETAMETHASONE VALERATE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    BICALUTAMIDE, BICALUTAMIDE

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CALCITRIOL, CALCITRIOL

    CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL

    CAPTOPRIL, CAPTOPRIL

    CARBIDOPA AND LEVODOPA, CARBIDOPA

    CARVEDILOL, CARVEDILOL

    CEFACLOR, CEFACLOR

    CEFPROZIL, CEFPROZIL

    CEFUROXIME AXETIL, CEFUROXIME AXETIL

    CELECOXIB, CELECOXIB

    CEPHALEXIN, CEPHALEXIN

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)

    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE

    CILOSTAZOL, CILOSTAZOL

    CIMETIDINE, CIMETIDINE

    CLARITHROMYCIN, CLARITHROMYCIN

    CLEMASTINE FUMARATE, CLEMASTINE FUMARATE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		         B - 138


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TEVA PHARMACEUTICALS USA INC

    CLONAZEPAM, CLONAZEPAM

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    CLOTRIMAZOLE, CLOTRIMAZOLE

    DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM

    DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM

    DIFLUNISAL, DIFLUNISAL

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE

    ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE

    ENALAPRIL MALEATE, ENALAPRIL MALEATE

    ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM

    EPITOL, CARBAMAZEPINE

    ESTAZOLAM, ESTAZOLAM

    ESZOPICLONE, ESZOPICLONE

    ETODOLAC, ETODOLAC

    FAMOTIDINE, FAMOTIDINE

    FAMOTIDINE, FAMOTIDINE    (OTC)

    FENOFIBRATE (MICRONIZED), FENOFIBRATE

    FENOFIBRATE, FENOFIBRATE

    FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)

    FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)

    FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE

    FINASTERIDE, FINASTERIDE

    FLUCONAZOLE, FLUCONAZOLE

    FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE

    FLUOCINONIDE, FLUOCINONIDE

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLURBIPROFEN, FLURBIPROFEN

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    FOSINOPRIL SODIUM, FOSINOPRIL SODIUM

    GALZIN, ZINC ACETATE

    GEMFIBROZIL, GEMFIBROZIL

    GLIMEPIRIDE, GLIMEPIRIDE

    GLYBURIDE (MICRONIZED), GLYBURIDE

    GLYBURIDE, GLYBURIDE

    HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    KETOCONAZOLE, KETOCONAZOLE

    KETOPROFEN, KETOPROFEN

    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE

    LAMOTRIGINE, LAMOTRIGINE

    LEVOFLOXACIN, LEVOFLOXACIN

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE

    LORATADINE, LORATADINE    (OTC)

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    LOVASTATIN, LOVASTATIN

    MESALAMINE, MESALAMINE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MIRTAZAPINE, MIRTAZAPINE

    MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE

    MUPIROCIN, MUPIROCIN

    NABUMETONE, NABUMETONE

    NAPROXEN SODIUM, NAPROXEN SODIUM

    NAPROXEN, NAPROXEN

    NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE

    NEOMYCIN SULFATE, NEOMYCIN SULFATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		             B - 139


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TEVA PHARMACEUTICALS USA INC

    NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

    NYSTATIN, NYSTATIN

    OFLOXACIN, OFLOXACIN

    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE

    ONDANSETRON, ONDANSETRON

    ORAP, PIMOZIDE

    OXAPROZIN, OXAPROZIN

    OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PENICILLIN-VK, PENICILLIN V POTASSIUM

    PIROXICAM, PIROXICAM

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PRELONE, PREDNISOLONE

    QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RIBAVIRIN, RIBAVIRIN

    RISPERIDONE, RISPERIDONE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    ROSIGLITAZONE MALEATE, ROSIGLITAZONE MALEATE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

    SUCRALFATE, SUCRALFATE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE

    TAMOXIFEN CITRATE, TAMOXIFEN CITRATE

    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE

    TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    TOLMETIN SODIUM, TOLMETIN SODIUM

    TOPIRAMATE, TOPIRAMATE

    TORSEMIDE, TORSEMIDE

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    TRIMETHOPRIM, TRIMETHOPRIM

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

TEVA BRANDED PHARM

*	 TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC

    CENESTIN, ESTROGENS, CONJUGATED SYNTHETIC A

    LOSEASONIQUE, ETHINYL ESTRADIOL

    NORDETTE-28, ETHINYL ESTRADIOL

    PLAN B ONE-STEP, LEVONORGESTREL    (OTC)

    PLAN B, LEVONORGESTREL

    PLAN B, LEVONORGESTREL    (OTC)

    PROAIR HFA, ALBUTEROL SULFATE

    PROGLYCEM, DIAZOXIDE

    QNASL, BECLOMETHASONE DIPROPIONATE

    QUARTETTE, ETHINYL ESTRADIOL

    QVAR 40, BECLOMETHASONE DIPROPIONATE

    QVAR 80, BECLOMETHASONE DIPROPIONATE

    SEASONALE, ETHINYL ESTRADIOL

    SEASONIQUE, ETHINYL ESTRADIOL

    ZECUITY, SUMATRIPTAN SUCCINATE

TEVA PARENTERAL

*	 TEVA PARENTERAL MEDICINES INC

    LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE

TEVA PHARMS

*	 TEVA PHARMACEUTICALS USA

    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 140


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TEVA PHARMACEUTICALS USA

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE

    ANASTROZOLE, ANASTROZOLE

    AZITHROMYCIN, AZITHROMYCIN

    BISOPROLOL FUMARATE, BISOPROLOL FUMARATE

    BUDESONIDE, BUDESONIDE

    CARBAMAZEPINE, CARBAMAZEPINE

    CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE

    CEFDINIR, CEFDINIR

    CEFPROZIL, CEFPROZIL

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    CROMOLYN SODIUM, CROMOLYN SODIUM

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

    DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

    ETHOSUXIMIDE, ETHOSUXIMIDE

    FAMCICLOVIR, FAMCICLOVIR

    FLUVASTATIN SODIUM, FLUVASTATIN SODIUM

    GABAPENTIN, GABAPENTIN

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    HALOPERIDOL, HALOPERIDOL LACTATE

    HYDROCORTISONE, HYDROCORTISONE

    HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

    IRBESARTAN, IRBESARTAN

    LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE

    LANSOPRAZOLE, LANSOPRAZOLE

    LEFLUNOMIDE, LEFLUNOMIDE

    LETROZOLE, LETROZOLE

    LEVETIRACETAM, LEVETIRACETAM

    LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE

    LINEZOLID, LINEZOLID

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    MEGESTROL ACETATE, MEGESTROL ACETATE

    MELOXICAM, MELOXICAM

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE

    OLANZAPINE AND FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    OLANZAPINE, OLANZAPINE

    OXALIPLATIN, OXALIPLATIN

    PACLITAXEL, PACLITAXEL

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE

    PREGABALIN, PREGABALIN

    PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE

    PROGESTERONE, PROGESTERONE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    QUINIDINE SULFATE, QUINIDINE SULFATE

    QUININE SULFATE, QUININE SULFATE

    RAMIPRIL, RAMIPRIL

    RISEDRONATE SODIUM, RISEDRONATE SODIUM

    RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE

    ROCURONIUM BROMIDE, ROCURONIUM BROMIDE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 141


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TEVA PHARMACEUTICALS USA

    SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH, SULFAMETHOXAZOLE

    TAMOXIFEN CITRATE, TAMOXIFEN CITRATE

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TESTOSTERONE, TESTOSTERONE

    THEOPHYLLINE, THEOPHYLLINE

    TRANDOLAPRIL, TRANDOLAPRIL

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

    URSODIOL, URSODIOL

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VANDAZOLE, METRONIDAZOLE

    VARDENAFIL HYDROCHLORIDE, VARDENAFIL HYDROCHLORIDE

    VORICONAZOLE, VORICONAZOLE

    ZALEPLON, ZALEPLON

TEVA PHARMS USA

*	 TEVA PHARMACEUTICALS USA

    ACITRETIN, ACITRETIN

    ADENOSINE, ADENOSINE

    ALPROSTADIL, ALPROSTADIL

    AMIKACIN SULFATE, AMIKACIN SULFATE

    ARGATROBAN IN 0.9% SODIUM CHLORIDE, ARGATROBAN

    ATAZANAVIR SULFATE, ATAZANAVIR SULFATE

    BLEOMYCIN SULFATE, BLEOMYCIN SULFATE

    BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE

    CARBOPLATIN, CARBOPLATIN

    CLARAVIS, ISOTRETINOIN

    COPAXONE, GLATIRAMER ACETATE

    CYTOSAR-U, CYTARABINE

    DACARBAZINE, DACARBAZINE

    DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE

    DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE

    DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ENALAPRILAT, ENALAPRILAT

    ENTECAVIR, ENTECAVIR

    EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE

    EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    ETOPOSIDE, ETOPOSIDE

    FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE

    FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE

    FLUOROURACIL, FLUOROURACIL

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE

    HALOPERIDOL, HALOPERIDOL LACTATE

    IDARUBICIN HYDROCHLORIDE PFS, IDARUBICIN HYDROCHLORIDE

    IFOSFAMIDE, IFOSFAMIDE

    IFOSFAMIDE/MESNA KIT, IFOSFAMIDE

    IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE

    LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN, AMOXICILLIN

    LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM

    LEUPROLIDE ACETATE, LEUPROLIDE ACETATE

    LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE

    LEVOCARNITINE, LEVOCARNITINE

    MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE

    MESNA, MESNA

    METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE

    MYCOPHENOLIC ACID, MYCOPHENOLIC ACID

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 142


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TEVA PHARMACEUTICALS USA

    NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE

    OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

    OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS

    PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM

    PANCURONIUM BROMIDE, PANCURONIUM BROMIDE

    PARICALCITOL, PARICALCITOL

    PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    PROPOFOL, PROPOFOL

    RALOXIFENE HYDROCHLORIDE, RALOXIFENE HYDROCHLORIDE

    RAMELTEON, RAMELTEON

    RISEDRONATE SODIUM, RISEDRONATE SODIUM

    SOLIFENACIN SUCCINATE, SOLIFENACIN SUCCINATE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

    TOBRAMYCIN, TOBRAMYCIN

    TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    VECURONIUM BROMIDE, VECURONIUM BROMIDE

    VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE

    VINORELBINE TARTRATE, VINORELBINE TARTRATE

    ZANOSAR, STREPTOZOCIN

    ZOLMITRIPTAN, ZOLMITRIPTAN

*	 TEVA PHARMACEUTICALS USA INC

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    CAPECITABINE, CAPECITABINE

    ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL

    IMIQUIMOD, IMIQUIMOD

    METRONIDAZOLE, METRONIDAZOLE

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

    SELFEMRA, FLUOXETINE HYDROCHLORIDE

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

TEVA PHARMS USA INC

*	 TEVA PHARMACEUTICALS USA INC

    ADASUVE, LOXAPINE

TEVA WOMENS

*	 TEVA WOMENS HEALTH INC

    ENJUVIA, ESTROGENS, CONJUGATED SYNTHETIC B

    PARAGARD T 380A, COPPER

    REVIA, NALTREXONE HYDROCHLORIDE

    ZEBETA, BISOPROLOL FUMARATE

    ZIAC, BISOPROLOL FUMARATE

THE FEINSTEIN INST

*	 THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

THE PHARMA NETWORK

*	 THE PHARMA NETWORK LLC

    BENZONATATE, BENZONATATE

THE PHARMANETWORK

*	 THE PHARMANETWORK LLC

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

THEPHARMANETWORK LLC

*	 THEPHARMANETWORK LLC

    BENZONATATE, BENZONATATE

    ISONIAZID, ISONIAZID

    NIMODIPINE, NIMODIPINE

    THERMAZENE, SILVER SULFADIAZINE

THERAKOS

*	 THERAKOS INC

    UVADEX, METHOXSALEN

THERATECHNOLOGIES

*	 THERATECHNOLOGIES INC

    EGRIFTA, TESAMORELIN ACETATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 143


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

THERAVANCE BIOPHARMA

*	 THERAVANCE BIOPHARMA ANTIBIOTICS INC

    VIBATIV, TELAVANCIN HYDROCHLORIDE

THREE RIVERS PHARMS

*	 THREE RIVERS PHARMACEUTICALS LLC

    RIBASPHERE, RIBAVIRIN

    RIBAVIRIN, RIBAVIRIN

TOLMAR

*	 TOLMAR INC

    ADAPALENE, ADAPALENE

    ATRIDOX, DOXYCYCLINE HYCLATE

    BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE

    CALCIPOTRIENE, CALCIPOTRIENE

    CICLOPIROX, CICLOPIROX

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    DICLOFENAC SODIUM , DICLOFENAC SODIUM

    ERYTHROMYCIN AND BENZOYL PEROXIDE, BENZOYL PEROXIDE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    IMIQUIMOD, IMIQUIMOD

    KETOCONAZOLE, KETOCONAZOLE

    LEVETIRACETAM, LEVETIRACETAM

    LIDOCAINE AND PRILOCAINE, LIDOCAINE

    METRONIDAZOLE, METRONIDAZOLE

    MOMETASONE FUROATE, MOMETASONE FUROATE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

TOLMAR THERAP

*	 TOLMAR THERAPEUTICS INC

    ELIGARD, LEUPROLIDE ACETATE

TORPHARM

*	 TORPHARM INC

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE    (OTC)

TORRENT PHARM

*	 TORRENT PHARMA INC

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

TORRENT PHARMS

*	 TORRENT PHARMACEUTICALS LIMITED

    LEVOFLOXACIN, LEVOFLOXACIN

*	 TORRENT PHARMACEUTICALS LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    CARBAMAZEPINE, CARBAMAZEPINE

    CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

*	 TORRENT PHARMACEUTICALS LTD.

    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE

TORRENT PHARMS LLC

*	 TORRENT PHARMACEUTICALS LLC

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE   (OTC)

    OLANZAPINE, OLANZAPINE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

TORRENT PHARMS LTD

* TORRENT PHARMACEUTICALS LTD

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 144


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   T   **

*	 TORRENT PHARMACEUTICALS LTD

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    FELODIPINE, FELODIPINE

    FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE

    OLANZAPINE, OLANZAPINE

    PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    QUETIAPINE FUMARATE, QUETIAPINE FUMARATE

    RABEPRAZOLE SODIUM, RABEPRAZOLE SODIUM

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    TELMISARTAN AND AMLODIPINE, AMLODIPINE BESYLATE

    TELMISARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TELMISARTAN, TELMISARTAN

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

    VALSARTAN, VALSARTAN

TRIS PHARMA INC

*	 TRIS PHARMA INC

    CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE    (OTC)

    CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE    (OTC)

    DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE

    DEXTROMETHORPHAN POLISTIREX, DEXTROMETHORPHAN POLISTIREX    (OTC)

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE, HYDROCODONE BITARTRATE

    HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE,

    HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX, CHLORPHENIRAMINE POLISTIREX

    IBUPROFEN, IBUPROFEN    (OTC)

    KARBINAL ER, CARBINOXAMINE MALEATE

    LEVETIRACETAM, LEVETIRACETAM

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    THEOPHYLLINE, THEOPHYLLINE

TRUSTEES UNIV PA

*	 TRUSTEES OF THE UNIV OF PENNSYLVANIA

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

TRYGG

*	 TRYGG PHARMA INC

    OMTRYG, OMEGA-3-ACID ETHYL ESTERS

TWI PHARMS INC

*	 TWI PHARMACEUTICALS INC

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    MEGESTROL ACETATE, MEGESTROL ACETATE

    NIFEDIPINE, NIFEDIPINE

                                         **   U   **

UCB INC

*	 UCB INC

    KEPPRA XR, LEVETIRACETAM

    KEPPRA, LEVETIRACETAM

    METADATE CD, METHYLPHENIDATE HYDROCHLORIDE

    METADATE ER, METHYLPHENIDATE HYDROCHLORIDE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    NEUPRO, ROTIGOTINE

    TUSSIONEX PENNKINETIC, CHLORPHENIRAMINE POLISTIREX

    UNIRETIC, HYDROCHLOROTHIAZIDE

    UNIVASC, MOEXIPRIL HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		     B - 145


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   U   **

*	 UCB INC

    VIMPAT, LACOSAMIDE

    XYZAL, LEVOCETIRIZINE DIHYDROCHLORIDE

    ZAROXOLYN, METOLAZONE

UCLA BIOMEDICAL

*	 UCLA BIOMEDICAL CYCLOTRON

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

UCSF RODIOPHARM

*	 UCSF RADIOPHARMACEUTICAL FACILITY

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

UIHC PET IMAGING

*	 UNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

UNICHEM

*	 UNICHEM LABORATORIES LTD

    BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE   (OTC)

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    MELOXICAM, MELOXICAM

    ZALEPLON, ZALEPLON

UNICHEM LABS LTD

*	 UNICHEM LABORATORIES LIMITED

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

*	 UNICHEM LABORATORIES LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    LAMOTRIGINE, LAMOTRIGINE

    METRONIDAZOLE, METRONIDAZOLE

    TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

UNICHEM PHARMS (USA)

*	 UNICHEM PHARMACEUTICALS (USA) INC

    BISOPROLOL FUMARATE, BISOPROLOL FUMARATE

UNIMARK REMEDIES LTD

*	 UNIMARK REMEDIES LTD

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

UNIQUE PHARM LABS

*	 UNIQUE PHARMACEUTICAL LABORATORIES

    ATENOLOL, ATENOLOL

    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)

    CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE   (OTC)

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    FLUCONAZOLE, FLUCONAZOLE

    TINIDAZOLE, TINIDAZOLE

UNITED BIOMEDCL

*	 UNITED BIOMEDICAL INC

    TERBUTALINE SULFATE, TERBUTALINE SULFATE

UNITED GUARDIAN

*	 UNITED GUARDIAN INC

    RENACIDIN, CITRIC ACID

UNITED THERAP

*	 UNITED THERAPEUTICS CORP

    ORENITRAM, TREPROSTINIL DIOLAMINE

    REMODULIN, TREPROSTINIL

    TYVASO, TREPROSTINIL

UNIV TX MD ANDERSON

*	 UNIV TEXAS MD ANDERSON CANCER CENTER

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 146


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   U   **

*	 UNIV TEXAS MD ANDERSON CANCER CENTER

    SODIUM FLUORIDE F-18, SODIUM FLUORIDE F-18

UPSHER SMITH

*	 UPSHER SMITH LABORATORIES INC

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    FORTICAL, CALCITONIN SALMON RECOMBINANT

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    MORPHINE SULFATE, MORPHINE SULFATE

    NIACOR, NIACIN

    NYSTATIN, NYSTATIN

    ORVATEN, MIDODRINE HYDROCHLORIDE

    OXANDROLONE, OXANDROLONE

    PACERONE, AMIODARONE HYDROCHLORIDE

    PENTOXIL, PENTOXIFYLLINE

    PREVALITE, CHOLESTYRAMINE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    QUDEXY XR, TOPIRAMATE

    SORINE, SOTALOL HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

    VOGELXO, TESTOSTERONE

    ZALEPLON, ZALEPLON

UPSHER SMITH LABS

*	 UPSHER SMITH LABORATORIES INC

    KLOR-CON M10, POTASSIUM CHLORIDE

    KLOR-CON M15, POTASSIUM CHLORIDE

    KLOR-CON M20, POTASSIUM CHLORIDE

UPSHER-SMITH LABS

*	 UPSHER-SMITH LABORATORIES INC

    KLOR-CON, POTASSIUM CHLORIDE

US PHARMS HOLDINGS I

*	 US PHARMACEUTICALS HOLDINGS I LLC

    LOPRESSOR HCT, HYDROCHLOROTHIAZIDE

    LOPRESSOR, METOPROLOL TARTRATE

    LOTENSIN HCT, BENAZEPRIL HYDROCHLORIDE

    LOTENSIN, BENAZEPRIL HYDROCHLORIDE

    PARLODEL, BROMOCRIPTINE MESYLATE

US WORLDMEDS

*	 US WORLDMEDS LLC

    APOKYN, APOMORPHINE HYDROCHLORIDE

    REVONTO, DANTROLENE SODIUM

USL PHARMA

*	 USL PHARMA INC

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    BACLOFEN, BACLOFEN

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE

    CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE

    ESTRADIOL, ESTRADIOL

    FLUOXYMESTERONE, FLUOXYMESTERONE

    JANTOVEN, WARFARIN SODIUM

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

USV NORTH AMERICA

*	 USV NORTH AMERICA INC

    ZOLEDRONIC ACID, ZOLEDRONIC ACID

                                         **   V   **

VALEANT

*	 VALEANT PHARMACEUTICALS INTERNATIONAL

    ANCOBON, FLUCYTOSINE

    BONTRIL PDM, PHENDIMETRAZINE TARTRATE

    BONTRIL, PHENDIMETRAZINE TARTRATE

    D.H.E. 45, DIHYDROERGOTAMINE MESYLATE

    MIGRANAL, DIHYDROERGOTAMINE MESYLATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 147


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   V   **

*	 VALEANT PHARMACEUTICALS INTERNATIONAL

    MOTOFEN, ATROPINE SULFATE

    MYSOLINE, PRIMIDONE

VALEANT BERMUDA

*	 VALEANT INTERNATIONAL BERMUDA

    APLENZIN, BUPROPION HYDROBROMIDE

    BENZACLIN, BENZOYL PEROXIDE

    CARAC, FLUOROURACIL

    DERMATOP E EMOLLIENT, PREDNICARBATE

    DERMATOP, PREDNICARBATE

    ELIDEL, PIMECROLIMUS

    ISORDIL, ISOSORBIDE DINITRATE

    KLARON, SULFACETAMIDE SODIUM

    NORITATE, METRONIDAZOLE

    PENLAC, CICLOPIROX

    PENTOXIFYLLINE, PENTOXIFYLLINE

    RETIN-A, TRETINOIN

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    XENAZINE, TETRABENAZINE

    XERESE, ACYCLOVIR

    ZOVIRAX, ACYCLOVIR

VALEANT INTL

*	 VALEANT INTERNATIONAL BARBADOS SRL

    ATIVAN, LORAZEPAM

    CARDIZEM CD, DILTIAZEM HYDROCHLORIDE

    CARDIZEM LA, DILTIAZEM HYDROCHLORIDE

    CARDIZEM, DILTIAZEM HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE

    FENOFIBRATE, FENOFIBRATE

    NIFEDIPINE, NIFEDIPINE

    RENOVA, TRETINOIN

    RETIN-A MICRO, TRETINOIN

    RETIN-A, TRETINOIN

    RETIN-A-MICRO, TRETINOIN

    TIAZAC, DILTIAZEM HYDROCHLORIDE

    ULTRAM ER, TRAMADOL HYDROCHLORIDE

    VASERETIC, ENALAPRIL MALEATE

    VASOTEC, ENALAPRIL MALEATE

    WELLBUTRIN XL, BUPROPION HYDROCHLORIDE

*	 VALEANT INTERNATIONAL SRL

    BENZAMYCIN, BENZOYL PEROXIDE

VALEANT LUXEMBOURG

*	 VALEANT PHARMACEUTICALS LUXEMBOURG SARL

    BENZAMYCIN PAK, BENZOYL PEROXIDE

    ERTACZO, SERTACONAZOLE NITRATE

    GRIFULVIN V, GRISEOFULVIN, MICROSIZE

    TARGRETIN, BEXAROTENE

VALEANT PHARM INTL

*	 VALEANT PHARMACEUTICALS INTERNATIONAL

    8-MOP, METHOXSALEN

    ANDROID 10, METHYLTESTOSTERONE

    ANDROID 25, METHYLTESTOSTERONE

    EFUDEX, FLUOROURACIL

    LIBRIUM, CHLORDIAZEPOXIDE HYDROCHLORIDE

    MESTINON, PYRIDOSTIGMINE BROMIDE

    OXSORALEN, METHOXSALEN

    TESTRED, METHYLTESTOSTERONE

    VIRAZOLE, RIBAVIRIN

    ZELAPAR, SELEGILINE HYDROCHLORIDE

VALEANT PHARM NORTH

*	 VALEANT PHARMACEUTICAL NORTH AMERICA LLC

    MESTINON, PYRIDOSTIGMINE BROMIDE

    MINITRAN, NITROGLYCERIN

VALEANT PHARMS

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 148


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   V   **

*	 VALEANT PHARMACEUTICALS NORTH AMERICA

    MEPHYTON, PHYTONADIONE

    TENSILON PRESERVATIVE FREE, EDROPHONIUM CHLORIDE

    TENSILON, EDROPHONIUM CHLORIDE

VALEANT PHARMS INC

*	 VALEANT PHARMACEUTICALS INTERNATIONAL INC

    GRIS-PEG, GRISEOFULVIN, ULTRAMICROSIZE

    VISUDYNE, VERTEPORFIN

VALEANT PHARMS LLC

*	 VALEANT PHARMACEUTICALS NORTH AMERICA LLC

    CAPITAL AND CODEINE, ACETAMINOPHEN

    MACUGEN, PEGAPTANIB SODIUM

    MESTINON, PYRIDOSTIGMINE BROMIDE

    TASMAR, TOLCAPONE

    TIMOPTIC-XE, TIMOLOL MALEATE

VALEANT PHARMS NORTH

*	 VALEANT PHARMACEUTICALS NORTH AMERICA LLC

    DIASTAT ACUDIAL, DIAZEPAM

    DIASTAT, DIAZEPAM

VALIDUS PHARMS

*	 VALIDUS PHARMACEUTICALS LLC

    ROCALTROL, CALCITRIOL

VALIDUS PHARMS INC

*	 VALIDUS PHARMACEUTICALS INC

    EQUETRO, CARBAMAZEPINE

    MARPLAN, ISOCARBOXAZID

VANDA PHARMS INC

*	 VANDA PHARMACEUTICALS INC

    HETLIOZ, TASIMELTEON

VANSEN PHARMA

*	 VANSEN PHARMA

    SPECTRACEF, CEFDITOREN PIVOXIL

VELDANA MEDICAL SA

*	 VELDANA MEDICAL SA

    ECOZA, ECONAZOLE NITRATE

VEROSCIENCE

*	 VEROSCIENCE LLC

    CYCLOSET, BROMOCRIPTINE MESYLATE

VERSAPHARM

*	 VERSAPHARM INC

    CICLOPIROX, CICLOPIROX

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE

    DESOXIMETASONE, DESOXIMETASONE

    ERYTHROMYCIN, ERYTHROMYCIN

    ETHOSUXIMIDE, ETHOSUXIMIDE

    RIFAMPIN, RIFAMPIN

VERSAPHARM INC

*	 VERSAPHARM INC

    DESOXIMETASONE, DESOXIMETASONE

    RIFAMPIN, RIFAMPIN

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

*	 VERSAPHARM INCORPORATED

    TRANEXAMIC ACID, TRANEXAMIC ACID

VERTEX PHARMS

*	 VERTEX PHARMACEUTICALS INC

    INCIVEK, TELAPREVIR

    KALYDECO, IVACAFTOR

VERTICAL PHARMS LLC

*	 VERTICAL PHARMACEUTICALS LLC

    DIVIGEL, ESTRADIOL

VICURON

*	 VICURON PHARMACEUTICALS INC

    ERAXIS, ANIDULAFUNGIN

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                 B - 149


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   V   **

VIFOR FRESENIUS

*	 VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE

    VELPHORO, SUCROFERRIC OXYHYDROXIDE

VIIV HLTHCARE

*	 VIIV HEALTHCARE CO

    COMBIVIR, LAMIVUDINE

    EPIVIR, LAMIVUDINE

    EPZICOM, ABACAVIR SULFATE

    LEXIVA, FOSAMPRENAVIR CALCIUM

    RESCRIPTOR, DELAVIRDINE MESYLATE

    RETROVIR, ZIDOVUDINE

    SELZENTRY, MARAVIROC

    TIVICAY, DOLUTEGRAVIR SODIUM

    TRIUMEQ, ABACAVIR SULFATE

    TRIZIVIR, ABACAVIR SULFATE

    ZIAGEN, ABACAVIR SULFATE

VINTAGE

*	 VINTAGE PHARMACEUTICALS LLC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    ACETIC ACID, ACETIC ACID, GLACIAL

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ALPRAZOLAM, ALPRAZOLAM

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    BENZTROPINE MESYLATE, BENZTROPINE MESYLATE

    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    FOLIC ACID, FOLIC ACID

    GLIMEPIRIDE, GLIMEPIRIDE

    GLYCOPYRROLATE, GLYCOPYRROLATE

    HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL

    HYDROCORTISONE, HYDROCORTISONE

    LIDOCAINE HYDROCHLORIDE VISCOUS, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LISINOPRIL, LISINOPRIL

    NYSTATIN, NYSTATIN

    PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    PREDNISOLONE, PREDNISOLONE

    PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE

    PROMETHAZINE DM, DEXTROMETHORPHAN HYDROBROMIDE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    PROMETHAZINE WITH CODEINE, CODEINE PHOSPHATE

    RISPERIDONE, RISPERIDONE

    SPIRONOLACTONE, SPIRONOLACTONE

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

    TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

    VALPROIC ACID, VALPROIC ACID

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE

VINTAGE PHARMS

*	 VINTAGE PHARMACEUTICALS

    ALPRAZOLAM, ALPRAZOLAM

    BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN

    CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE

    DISULFIRAM, DISULFIRAM

    GILDAGIA, ETHINYL ESTRADIOL

    GILDESS 24 FE, ETHINYL ESTRADIOL

    GLYCOPYRROLATE, GLYCOPYRROLATE

    GRISEOFULVIN, GRISEOFULVIN, MICROSIZE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    LEVETIRACETAM, LEVETIRACETAM

    METHIMAZOLE, METHIMAZOLE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 150


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   V   **

*	 VINTAGE PHARMACEUTICALS

    METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

*	 VINTAGE PHARMACEUTICALS INC

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    ALLOPURINOL, ALLOPURINOL

    AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE

    BACLOFEN, BACLOFEN

    BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN

    BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN

    CARISOPRODOL, CARISOPRODOL

    CLONAZEPAM, CLONAZEPAM

    CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE

    DEXAMETHASONE, DEXAMETHASONE

    DIAZEPAM, DIAZEPAM

    DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE

    FUROSEMIDE, FUROSEMIDE

    HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE

    HYDROCORTISONE, HYDROCORTISONE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    IBUPROFEN, IBUPROFEN

    IBUPROFEN, IBUPROFEN    (OTC)

    ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE

    LACTULOSE, LACTULOSE

    LEVETIRACETAM, LEVETIRACETAM

    LORAZEPAM, LORAZEPAM

    MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE

    MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE

    METHOCARBAMOL, METHOCARBAMOL

    METHYLPREDNISOLONE, METHYLPREDNISOLONE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    NYSTATIN, NYSTATIN

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    PERPHENAZINE, PERPHENAZINE

    PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE

    PREDNISONE, PREDNISONE

    PRIMIDONE, PRIMIDONE

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE

    SULFASALAZINE, SULFASALAZINE

    TORSEMIDE, TORSEMIDE

    TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE

VINTAGE PHARMS LLC

*	 VINTAGE PHARMACEUTICALS LLC

    CYCLAFEM 1/35, ETHINYL ESTRADIOL

    CYCLAFEM 7/7/7, ETHINYL ESTRADIOL

    EMOQUETTE, DESOGESTREL

    FELODIPINE, FELODIPINE

    GILDESS 1.5/30, ETHINYL ESTRADIOL

    GILDESS 1/20, ETHINYL ESTRADIOL

    GILDESS FE 1.5/30, ETHINYL ESTRADIOL

    GILDESS FE 1/20, ETHINYL ESTRADIOL

    LETROZOLE, LETROZOLE

    LEVETIRACETAM, LEVETIRACETAM

    MEFENAMIC ACID, MEFENAMIC ACID

    MONTELUKAST SODIUM, MONTELUKAST SODIUM

    MORPHINE SULFATE, MORPHINE SULFATE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 151


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   V   **

*	 VINTAGE PHARMACEUTICALS LLC

    MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL

    MYZILRA, ETHINYL ESTRADIOL

    ORSYTHIA, ETHINYL ESTRADIOL

    PERCOCET, ACETAMINOPHEN

    PREVIFEM, ETHINYL ESTRADIOL

    TRI-PREVIFEM, ETHINYL ESTRADIOL

VIRTUS PHARM

*	 VIRTUS PHARMACEUTICAL INC

    ACARBOSE, ACARBOSE

VISTA PHARMS

*	 VISTA PHARMACEUTICALS INC

    SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE

VISTAPHARM

*	 VISTAPHARM INC

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN

    LACTULOSE, LACTULOSE

    METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    MORPHINE SULFATE, MORPHINE SULFATE

    NYSTATIN, NYSTATIN

    OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE

    PHENYTOIN, PHENYTOIN

VIVIMED LABS

*	 VIVIMED LABS ALATHUR PRIVATE LTD

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

VIVUS

*	 VIVUS INC

    QSYMIA, PHENTERMINE HYDROCHLORIDE

    STENDRA, AVANAFIL

                                         **   W   **

WA UNIV SCH MED

*	 WASHINGTON UNIV SCHOOL MEDICINE

    AMMONIA N 13, AMMONIA N-13

WARNER CHILCOTT

*	 WARNER CHILCOTT CO LLC

    LO MINASTRIN FE, ETHINYL ESTRADIOL

    NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE,   ETHINYL ESTRADIOL

*	 WARNER CHILCOTT INC

    LOESTRIN 24 FE, ETHINYL ESTRADIOL

    LOESTRIN FE 1/20, ETHINYL ESTRADIOL

WARNER CHILCOTT LLC

*	 WARNER CHILCOTT CO LLC

    ACTONEL, RISEDRONATE SODIUM

    ASACOL HD, MESALAMINE

    ASACOL, MESALAMINE

    ATELVIA, RISEDRONATE SODIUM

    CHOLEDYL SA, OXTRIPHYLLINE

    DELZICOL, MESALAMINE

    ENABLEX, DARIFENACIN HYDROBROMIDE

    ESTROSTEP FE, ETHINYL ESTRADIOL

    FEMCON FE, ETHINYL ESTRADIOL

    FEMHRT, ETHINYL ESTRADIOL

    FEMTRACE, ESTRADIOL ACETATE

    LO LOESTRIN FE, ETHINYL ESTRADIOL

    LOESTRIN 21 1.5/30, ETHINYL ESTRADIOL

    LOESTRIN 21 1/20, ETHINYL ESTRADIOL

    LOESTRIN FE 1.5/30, ETHINYL ESTRADIOL

    MINASTRIN 24 FE, ETHINYL ESTRADIOL

    OVCON-35, ETHINYL ESTRADIOL

    SARAFEM, FLUOXETINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		        B - 152


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   W   **

WARNER CHILCOTT US

*	 WARNER CHILCOTT US LLC

    ESTRACE, ESTRADIOL

WARNER IRELAND

*	 WARNER CHILCOTT IRELAND LTD

    FEMRING, ESTRADIOL ACETATE

WATSON LABS

*	 WATSON LABORATORIES

    FOLIC ACID, FOLIC ACID

    LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    MICROGESTIN 1.5/30, ETHINYL ESTRADIOL

    MICROGESTIN 1/20, ETHINYL ESTRADIOL

    MICROGESTIN FE 1.5/30, ETHINYL ESTRADIOL

    MICROGESTIN FE 1/20, ETHINYL ESTRADIOL

    NORCO, ACETAMINOPHEN

    NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE

*	 WATSON LABORATORIES INC

    ACARBOSE, ACARBOSE

    AFEDITAB CR, NIFEDIPINE

    ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    ALENDRONATE SODIUM, ALENDRONATE SODIUM

    ALLOPURINOL, ALLOPURINOL

    ALORA, ESTRADIOL

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    AMOXAPINE, AMOXAPINE

    ATENOLOL AND CHLORTHALIDONE, ATENOLOL

    BACLOFEN, BACLOFEN

    BREVICON 28-DAY, ETHINYL ESTRADIOL

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CAPTOPRIL, CAPTOPRIL

    CARISOPRODOL, CARISOPRODOL

    CHLORZOXAZONE, CHLORZOXAZONE

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    CLONAZEPAM, CLONAZEPAM

    COL-PROBENECID, COLCHICINE

    CRINONE, PROGESTERONE

    CYCLOSPORINE, CYCLOSPORINE

    DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL

    DIAZEPAM, DIAZEPAM

    DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE

    DILACOR XR, DILTIAZEM HYDROCHLORIDE

    DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE

    DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE

    ESTAZOLAM, ESTAZOLAM

    ESTRADIOL, ESTRADIOL

    ESTROPIPATE, ESTROPIPATE

    FENTANYL-100, FENTANYL

    FENTANYL-25, FENTANYL

    FENTANYL-50, FENTANYL

    FENTANYL-75, FENTANYL

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GELNIQUE, OXYBUTYNIN CHLORIDE

    GLIPIZIDE, GLIPIZIDE

    GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE

    HYDROXOCOBALAMIN, HYDROXOCOBALAMIN

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE

    IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE

    ISRADIPINE, ISRADIPINE

    LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                B - 153


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   W   **

*	 WATSON LABORATORIES INC

    LAMOTRIGINE, LAMOTRIGINE

    LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    LEVONORGESTREL, LEVONORGESTREL

    LEVONORGESTREL, LEVONORGESTREL    (OTC)

    LEVORA 0.15/30-28, ETHINYL ESTRADIOL

    LISINOPRIL, LISINOPRIL

    LORAZEPAM, LORAZEPAM

    LOXAPINE SUCCINATE, LOXAPINE SUCCINATE

    MEPROBAMATE, MEPROBAMATE

    METHOCARBAMOL, METHOCARBAMOL

    METHYLDOPA, METHYLDOPA

    METHYLPREDNISOLONE, METHYLPREDNISOLONE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    METOPROLOL TARTRATE, METOPROLOL TARTRATE

    METRONIDAZOLE, METRONIDAZOLE

    MICROZIDE, HYDROCHLOROTHIAZIDE

    MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE

    MINOXIDIL, MINOXIDIL

    MIRTAZAPINE, MIRTAZAPINE

    NABUMETONE, NABUMETONE

    NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

    NATEGLINIDE, NATEGLINIDE

    NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE

    NICOTINE POLACRILEX, NICOTINE POLACRILEX    (OTC)

    NIZATIDINE, NIZATIDINE

    NORETHINDRONE AND ETHINYL ESTRADIOL (10/11), ETHINYL ESTRADIOL

    NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL

    NORINYL 1+35 21-DAY, ETHINYL ESTRADIOL

    NORINYL 1+35 28-DAY, ETHINYL ESTRADIOL

    NORINYL 1+50 28-DAY, MESTRANOL

    NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE

    OGESTREL 0.5/50-28, ETHINYL ESTRADIOL

    ORPHENADRINE CITRATE, ORPHENADRINE CITRATE

    OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN

    OXYCODONE AND ASPIRIN, ASPIRIN

    OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PREDNISOLONE, PREDNISOLONE

    PREDNISONE, PREDNISONE

    PRIMIDONE, PRIMIDONE

    PROBENECID, PROBENECID

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    QUASENSE, ETHINYL ESTRADIOL

    QUINIDINE SULFATE, QUINIDINE SULFATE

    RAMIPRIL, RAMIPRIL

    RAPAFLO, SILODOSIN

    RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE

    SIMVASTATIN, SIMVASTATIN

    SULFASALAZINE, SULFASALAZINE

    SULINDAC, SULINDAC

    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE

    TELMISARTAN, TELMISARTAN

    TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE

    TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE

    TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE

    TOPIRAMATE, TOPIRAMATE

    TRANDOLAPRIL, TRANDOLAPRIL

    TRELSTAR, TRIPTORELIN PAMOATE

    TRI-NORINYL 28-DAY, ETHINYL ESTRADIOL

    TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE

    TRIMETHOPRIM, TRIMETHOPRIM

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 154


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   W   **

*	 WATSON LABORATORIES INC

    TRIVORA-28, ETHINYL ESTRADIOL

    VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE

    VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE

    ZOVIA 1/35E-28, ETHINYL ESTRADIOL

    ZOVIA 1/50E-28, ETHINYL ESTRADIOL

*	 WATSON LABS INC

    LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

WATSON LABS (UTAH)

*	 WATSON LABORATORIES INC

    INFED, IRON DEXTRAN

    NOR-QD, NORETHINDRONE

    OXYTROL, OXYBUTYNIN

    PROGESTERONE, PROGESTERONE

WATSON LABS FLORIDA

*	 WATSON LABORATORIES INC FLORIDA

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

WATSON LABS INC

*	 WATSON LABORATORIES INC

    ALBUTEROL SULFATE, ALBUTEROL SULFATE

    AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE

    AMMONIUM LACTATE, AMMONIUM LACTATE

    BUDESONIDE, BUDESONIDE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE

    CLONIDINE, CLONIDINE

    CORDRAN, FLURANDRENOLIDE

    CYCLOSPORINE, CYCLOSPORINE

    DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE

    DICLOFENAC SODIUM, DICLOFENAC SODIUM

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

    EMLA, LIDOCAINE

    FIORICET W/ CODEINE, ACETAMINOPHEN

    FIORINAL W/CODEINE, ASPIRIN

    FIORINAL, ASPIRIN

    GELNIQUE 3%, OXYBUTYNIN

    IBANDRONATE SODIUM, IBANDRONATE SODIUM

    INDOMETHACIN, INDOMETHACIN

    IRBESARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    IRBESARTAN, IRBESARTAN

    KADIAN, MORPHINE SULFATE

    LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE

    LEVOFLOXACIN, LEVOFLOXACIN

    LEVONORGESTREL, LEVONORGESTREL

    LEVONORGESTREL, LEVONORGESTREL    (OTC)

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LIDOCAINE, LIDOCAINE

    METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE

    METRONIDAZOLE, METRONIDAZOLE

    PREGABALIN, PREGABALIN

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SILDENAFIL CITRATE, SILDENAFIL CITRATE

    TRETINOIN, TRETINOIN

    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE

    VALSARTAN AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    VALSARTAN, VALSARTAN

WATSON PHARMS

*	 WATSON PHARMACEUTICALS

    TENUATE DOSPAN, DIETHYLPROPION HYDROCHLORIDE

    TENUATE, DIETHYLPROPION HYDROCHLORIDE

*	 WATSON PHARMACEUTICALS INC

    ACTIGALL, URSODIOL

    CONDYLOX, PODOFILOX

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		                  B - 155


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   W   **

WEST WARD PHARM CORP

*	 WEST WARD PHARMACEUTICAL CORP

    PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE

WEST-WARD PHARM CORP

*	 WEST-WARD PHARMACEUTICAL CORP

    CEFOTETAN, CEFOTETAN DISODIUM

WI MEDCL CYCLOTRON

*	 WISCONSIN MEDICAL CYCLOTRON LLC

    AMMONIA N 13, AMMONIA N-13

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

WILSHIRE PHARMS INC

*	 WILSHIRE PHARMACEUTICALS INC

    LAMOTRIGINE, LAMOTRIGINE

WOCKHARDT

*	 WOCKHARDT AMERICAS INC

    CAPTOPRIL, CAPTOPRIL

    FAMOTIDINE, FAMOTIDINE

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

*	 WOCKHARDT EU OPERATIONS (SWISS) AG

    ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN

    ACETIC ACID, ACETIC ACID, GLACIAL

    AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE

    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN

    AMOXICILLIN, AMOXICILLIN

    BROMFED-DM, BROMPHENIRAMINE MALEATE

    CARBAMAZEPINE, CARBAMAZEPINE

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE

    CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE

    CLEMASTINE FUMARATE, CLEMASTINE FUMARATE

    CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE

    CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE

    CROMOLYN SODIUM, CROMOLYN SODIUM

    CYCLOSPORINE, CYCLOSPORINE

    DEXCHLORPHENIRAMINE MALEATE, DEXCHLORPHENIRAMINE MALEATE

    DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE

    ERYTHROMYCIN, ERYTHROMYCIN

    FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE

    FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE

    FUROSEMIDE, FUROSEMIDE

    HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE

    HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE

    LEVETIRACETAM, LEVETIRACETAM

    LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE

    LINDANE, LINDANE

    LITHIUM CITRATE, LITHIUM CITRATE

    LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE    (OTC)

    LORATADINE, LORATADINE    (OTC)

    MEGESTROL ACETATE, MEGESTROL ACETATE

    METAPROTERENOL SULFATE, METAPROTERENOL SULFATE

    METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE

    MINOXIDIL (FOR MEN), MINOXIDIL     (OTC)

    MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL    (OTC)

    NYSTATIN, NYSTATIN

    OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE

    PHENYTOIN, PHENYTOIN

    PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE

    PREDNISOLONE, PREDNISOLONE

    PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE

    PROMETHAZINE PLAIN, PROMETHAZINE HYDROCHLORIDE

    PROMETHAZINE W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE

    SELENIUM SULFIDE, SELENIUM SULFIDE

    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE

    VALPROIC ACID, VALPROIC ACID

*	 WOCKHARDT LTD

    ADENOSINE, ADENOSINE

                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                      B - 156

              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT
                                        **   W   **
* WOCKHARDT LTD
    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE
    AZITHROMYCIN, AZITHROMYCIN
    BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE
    BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE
    CEFOTAXIME SODIUM, CEFOTAXIME SODIUM
    CEFOTAXIME, CEFOTAXIME SODIUM
    CEFPROZIL, CEFPROZIL
    CEFTAZIDIME, CEFTAZIDIME
    CEFTRIAXONE, CEFTRIAXONE SODIUM
    CEFUROXIME AXETIL, CEFUROXIME AXETIL
    CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE   (OTC)
    CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE
    CLARITHROMYCIN, CLARITHROMYCIN
    DIVALPROEX SODIUM, DIVALPROEX SODIUM
    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM
    FAMOTIDINE, FAMOTIDINE    (OTC)
    FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM
    FUROSEMIDE, FUROSEMIDE
    KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE
    LEVETIRACETAM, LEVETIRACETAM
    LEVOFLOXACIN, LEVOFLOXACIN
    LISINOPRIL, LISINOPRIL
    METOPROLOL SUCCINATE, METOPROLOL SUCCINATE
    MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
    NIACIN, NIACIN
    NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE
    ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE
    ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
    PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE   (OTC)
    RISPERIDONE, RISPERIDONE
    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
    SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE
    TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
    TIMOLOL MALEATE, TIMOLOL MALEATE
    VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
    ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
    ZONISAMIDE, ZONISAMIDE
WOCKHARDT EU OPERATN
* WOCKHARDT EU OPERATIONS SWISS AG
    AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN
    DEXAMETHASONE, DEXAMETHASONE
    TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
WOCKHARDT LTD
* WOCKHARDT LTD
    ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE
    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE
    CARBIDOPA, LEVODOPA AND ENTACAPONE, CARBIDOPA
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)
    CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)
    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE
    ENTACAPONE, ENTACAPONE
    FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE   (OTC)
    FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE   (OTC)
    LAMOTRIGINE, LAMOTRIGINE
    LANSOPRAZOLE, LANSOPRAZOLE    (OTC)
    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
    ZIPRASIDONE HYDROCHLORIDE, ZIPRASIDONE HYDROCHLORIDE
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 157


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   W   **

WOCKHARDT USA

*	 WOCKHARDT USA INC

    EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM

    GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE

    OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE

    OCTREOTIDE ACETATE, OCTREOTIDE ACETATE

*	 WOCKHARDT USA LLC

    ENALAPRIL MALEATE, ENALAPRIL MALEATE

    LANSOPRAZOLE, LANSOPRAZOLE

    TOPIRAMATE, TOPIRAMATE

WRASER PHARMS

*	 WRASER PHARMACEUTICALS LLC

    CETRAXAL, CIPROFLOXACIN HYDROCHLORIDE

WRASER PHARMS LLC

*	 WRASER PHARMACEUTICALS LLC

    TREZIX, ACETAMINOPHEN

WUSM CYCLOTRON

*	 WASHINGTON UNIV SCH MEDICINE CYCLOTRON FACILITY

    FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18

WYETH PHARMS

*	 WYETH PHARMACEUTICALS INC SUB PFIZER INC

    LO/OVRAL-28, ETHINYL ESTRADIOL

WYETH PHARMS INC

*	 WYETH PHARMACEUTICALS INC

    BOSULIF, BOSUTINIB MONOHYDRATE

    CORDARONE, AMIODARONE HYDROCHLORIDE

    EFFEXOR XR, VENLAFAXINE HYDROCHLORIDE

    INDERIDE-40/25, HYDROCHLOROTHIAZIDE

    PHOSPHOLINE IODIDE, ECHOTHIOPHATE IODIDE

    PREMARIN, ESTROGENS, CONJUGATED

    PREMPHASE 14/14, ESTROGENS, CONJUGATED

    PREMPRO, ESTROGENS, CONJUGATED

    PRISTIQ, DESVENLAFAXINE SUCCINATE

    PROTONIX IV, PANTOPRAZOLE SODIUM

    PROTONIX, PANTOPRAZOLE SODIUM

    TRECATOR, ETHIONAMIDE

    ZOSYN IN PLASTIC CONTAINER, PIPERACILLIN SODIUM

    ZOSYN, PIPERACILLIN SODIUM

WYETH PHARMS PFIZER

*	 WYETH PHARMACEUTICALS INC WHOLLY OWNED SUB PFIZER INC

    DUAVEE, BAZEDOXIFENE ACETATE

                                         **   X   **

X GEN PHARMS

*	 X GEN PHARMACEUTICALS INC

    ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM

    AMPHOTERICIN B, AMPHOTERICIN B

    BACIIM, BACITRACIN

    COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM

    HYDRO-RX, HYDROCORTISONE

    HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE

    LEVETIRACETAM, LEVETIRACETAM

    LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM

    NEO-FRADIN, NEOMYCIN SULFATE

    NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE

    NEOMYCIN SULFATE, NEOMYCIN SULFATE

    NYSTATIN, NYSTATIN

    POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

    STREPTOMYCIN SULFATE, STREPTOMYCIN SULFATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

X-GEN PHARMS

*	 X-GEN PHARMACEUTICALS INC

    PHENYTOIN SODIUM, PHENYTOIN SODIUM

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		           B - 158


              APPENDIX B       -   PRODUCT NAME SORTED BY APPLICANT

                                          **     X   **

X-GEN PHARMS INC

*	 X-GEN PHARMACEUTICALS INC

    TRANEXAMIC ACID, TRANEXAMIC ACID

XELLIA PHARMS APS

*	 XELLIA PHARMACEUTICALS APS

    BACITRACIN, BACITRACIN

    POLYMYXIN B SULFATE, POLYMYXIN B SULFATE

    TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE

XENOPORT INC

*	 XENOPORT INC

    HORIZANT, GABAPENTIN ENACARBIL

XSPIRE

*	 XSPIRE LLC

    NALFON, FENOPROFEN CALCIUM

XTTRIUM

*	 XTTRIUM LABORATORIES INC

    CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE

    EXIDINE, CHLORHEXIDINE GLUCONATE   (OTC)

                                          **     Y   **

YUNG SHIN PHARM

*	 YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD

    CEFACLOR, CEFACLOR

    CEPHALEXIN, CEPHALEXIN

                                          **     Z   **

ZACH SYSTEMS

*	 ZACH SYSTEMS SPA

    DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE

    DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE

ZAMBON SPA

*	 ZAMBON SPA ITALY

    MONUROL, FOSFOMYCIN TROMETHAMINE

ZOGENIX INC

*	 ZOGENIX INC

    ZOHYDRO ER, HYDROCODONE BITARTRATE

ZYDUS HLTHCARE

*	 ZYDUS HEALTHCARE USA LLC

    LANSOPRAZOLE, LANSOPRAZOLE

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

ZYDUS PHARMS USA

*	 ZYDUS PHARMACEUTICALS USA INC

    AMLODIPINE BESYLATE, AMLODIPINE BESYLATE

    ATENOLOL, ATENOLOL

    AZATHIOPRINE, AZATHIOPRINE

    BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE

    BENZONATATE, BENZONATATE

    CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE

    HALOPERIDOL, HALOPERIDOL

    LAMOTRIGINE, LAMOTRIGINE

    MELOXICAM, MELOXICAM

    METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE

    NAPROXEN, NAPROXEN

    PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE

    PRAVASTATIN SODIUM, PRAVASTATIN SODIUM

    PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE

    RAMIPRIL, RAMIPRIL

    RIBAVIRIN, RIBAVIRIN

    RISPERIDONE, RISPERIDONE

    SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE

    SIMVASTATIN, SIMVASTATIN

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    WARFARIN SODIUM, WARFARIN SODIUM

    ZONISAMIDE, ZONISAMIDE

                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST		   B - 159


              APPENDIX B      -   PRODUCT NAME SORTED BY APPLICANT

                                         **   Z   **

ZYDUS PHARMS USA INC

*	 ZYDUS PHARMACEUTICALS USA INC

    ACETAZOLAMIDE, ACETAZOLAMIDE

    ACYCLOVIR, ACYCLOVIR

    ALPRAZOLAM, ALPRAZOLAM

    AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE

    ANASTROZOLE, ANASTROZOLE

    BICALUTAMIDE, BICALUTAMIDE

    BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE

    BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE

    BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE

    CARVEDILOL, CARVEDILOL

    CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE

    CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE

    DIPYRIDAMOLE, DIPYRIDAMOLE

    DIVALPROEX SODIUM, DIVALPROEX SODIUM

    DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE

    DULOXETINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE

    ESCITALOPRAM OXALATE, ESCITALOPRAM OXALATE

    ETHOSUXIMIDE, ETHOSUXIMIDE

    ETODOLAC, ETODOLAC

    ETOMIDATE, ETOMIDATE

    FINASTERIDE, FINASTERIDE

    GABAPENTIN, GABAPENTIN

    GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE

    GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE

    HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE

    INDOMETHACIN, INDOMETHACIN

    IRBESARTAN, IRBESARTAN

    LAMOTRIGINE, LAMOTRIGINE

    LEVETIRACETAM, LEVETIRACETAM

    LEVOFLOXACIN, LEVOFLOXACIN

    LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE

    LOSARTAN POTASSIUM, LOSARTAN POTASSIUM

    OMEPRAZOLE, OMEPRAZOLE

    PIOGLITAZONE HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE

    POTASSIUM CITRATE, POTASSIUM CITRATE

    PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE

    PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE

    RAMIPRIL, RAMIPRIL

    RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE

    RISPERIDONE, RISPERIDONE

    ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE

    SIROLIMUS, SIROLIMUS

    TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE

    TELMISARTAN, TELMISARTAN

    TOPIRAMATE, TOPIRAMATE

    TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN

    TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE

    VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE

    ZOLMITRIPTAN, ZOLMITRIPTAN

                 35TH EDITION - 2015 - APPROVED DRUG PRODUCTS LIST                   C-1

                                           APPENDIX C
                                        UNIFORM TERMS

                                         DOSAGE FORMS


AEROSOL                                            OIL
AEROSOL, FOAM                                      OIL/DROPS
AEROSOL, METERED                                   OINTMENT
CAPSULE                                            OINTMENT, AUGMENTED
CAPSULE, DELAYED REL PELLETS                       PASTE
CAPSULE, DELAYED RELEASE                           PATCH
CAPSULE, EXTENDED RELEASE                          PELLET
CLOTH                                              POWDER
CONCENTRATE                                        POWDER, EXTENDED RELEASE
CREAM                                              POWDER, METERED
CREAM, AUGMENTED                                   RING
ELIXIR                                             SHAMPOO
EMULSION                                           SOLUTION
ENEMA                                              SOLUTION FOR SLUSH
FILM                                               SOLUTION, GEL FORMING/DROPS
FILM, EXTENDED RELEASE                             SOLUTION, METERED
FOR SOLUTION                                       SOLUTION/DROPS
FOR SUSPENSION                                     SPONGE
FOR SUSPENSION, DELAYED RELEASE                    SPRAY
FOR SUSPENSION, EXTENDED RELEASE                   SPRAY, METERED
GAS                                                SUPPOSITORY
GEL                                                SUSPENSION
GEL, AUGMENTED                                     SUSPENSION, EXTENDED RELEASE
GEL, METERED                                       SUSPENSION/DROPS
GRANULE                                            SWAB
GRANULE, DELAYED RELEASE                           SYRUP
GUM, CHEWING                                       SYSTEM
IMPLANT                                            SYSTEM, EXTENDED RELEASE
INHALANT                                           TABLET
INJECTABLE                                         TABLET, CHEWABLE
INJECTABLE, LIPID COMPLEX                          TABLET, COATED PARTICLES
INJECTABLE, LIPOSOMAL                              TABLET, DELAYED RELEASE
INSERT                                             TABLET, DELAYED RELEASE, ORALLY
INSERT, EXTENDED RELEASE                             DISINTEGRATING
INTRAUTERINE DEVICE                                TABLET, EFFERVESCENT
JELLY                                              TABLET, EXTENDED RELEASE
LIQUID                                             TABLET, FOR SUSPENSION
LOTION                                             TABLET, ORALLY DISINTEGRATING
LOTION, AUGMENTED                                  TAPE
LOTION/SHAMPOO                                     TROCHE/LOZENGE



Note: Terms comprise currently marketed products
          35TH EDITION - 2015 - APPROVED DRUG PRODUCTS LIST             C-2

                                   APPENDIX C

                                UNIFORM TERMS

                       ROUTES OF ADMINISTRATION

 BUCCAL                                            IRRIGATION
 DENTAL                                            IV (INFUSION)
 ENDOCERVICAL                                      N/A
 FOR RX COMPOUNDING                                NASAL
 IMPLANTATION                                      OPHTHALMIC
 INHALATION                                        ORAL
 INJECTION                                         ORAL-21
 INTRA-ANAL                                        ORAL-28
 INTRACRANIAL                                      OTIC
 INTRADERMAL                                       PERFUSION, CARDIAC
 INTRAMUSCULAR                                     PERIODONTAL
 INTRAOCULAR                                       RECTAL
 INTRAPERITONEAL                                   SPINAL
 INTRAPLEURAL                                      SUBCUTANEOUS
 INTRATHECAL                                       SUBLINGUAL
 INTRATRACHEAL                                     TOPICAL
 INTRAUTERINE                                      TRANSDERMAL
 INTRAVENOUS                                       TRANSMUCOSAL
 INTRAVESICAL                                      URETHRAL
 INTRAVITREAL                                      VAGINAL
 IONTOPHORESIS

Note: Terms comprise currently marketed products
35TH EDITION - 2015 - APPROVED DRUG PRODUCTS LIST     C-3

                 APPENDIX
                UNIFORM TERMS

                ABBREVIATIONS




      AMP                AMPULE
      AMPICIL            AMPICILLIN
      APPROX             APPROXIMATELY
      BOT                BOTTLE
      CI                 CURIE
      CSR                CAROTID SINUS REFLEX
      CU                 CLINICAL UNITS
      DIPROP             DIPROPIONATE
      ELECT              ELECTROLYTE
      EQ                 EQUIVALENT TO
      ER                 EXTENDED RELEASE
      GM                 GRAM
      HBR                HYDROBROMIDE
      HCL                HYDROCHLORIDE
      HR                 HOUR
      IM                 INTRAMUSCULAR
      INH                INHALATION
      IU                 INTERNATIONAL UNITS
      IV                 INTRAVENOUS
      KIU                KALLIKREIN INHIBITOR UNITS
      MCG                MICROGRAM
      MCI                MILLICURIE
      MEQ                MILLIEQUIVALENT
      MG                 MILLIGRAM
      ML                 MILLILITER
      N/A                NOT APPLICABLE
      PPM                PARTS PER MILLION
      REL                RELEASE
      SC                 SUBCUTANEOUS
      SQ CM              SQUARE CENTIMETER
      U                  UNITS
      UCI                MICROCURIE
      UMOLAR             MICROMOLAR
      USP                UNITED STATES PHARMACOPEIA
         PATENT AND EXCLUSIVITY INFORMATION ADDENDUM



    This Addendum identifies drugs that qualify under the Drug Price
Competition and Patent Term Restoration Act (1984 Amendments) for periods of
exclusivity, during which abbreviated new drug applications (ANDAs) and
applications described in Section 505(b)(2) of the Federal Food, Drug, and
Cosmetic Act (the Act) for those drug products may, in some instances, not be
submitted or made effective as described below, and provides patent
information concerning the listed drug products. Those drugs that have
qualified for Orphan Drug Exclusivity pursuant to Section 527 of the Act,
those drugs that have qualified for Pediatric Exclusivity pursuant to Section
505A of the Act, and those drugs that have qualified for Generating
Antibiotics Incentives Now (GAIN) exclusivity pursuant to Section 505E of the
Act are also included in this Addendum. This section is arranged in
alphabetical order by active ingredient name followed by the trade name.
Active ingredient headings for multiple ingredient (combination) drug
products are arranged alphabetically. For an explanation of the codes used
in the Addendum, see the Patent and Exclusivity Terms Section. Exclusivity
prevents the submission or effective approval of ANDAs or applications
described in Section 505(b)(2) of the Act. It does not prevent the
submission or approval of a second 505(b)(1) application except in the case
of Orphan Drug exclusivity. Applications qualifying for periods of
exclusivity are:

(1)    A new drug application approved after September 24, 1984, for a drug
      product (including an ester or salt of the active ingredient) of which
      has never been approved in any other new drug application under Section
      505 (b) of the Act. No subsequent ANDA or application described in
      Section 505(b)(2) of the Act for the same drug may be submitted for a
      period of five years from the date of approval of the original
      application, except that such an application may be submitted after four
      years if it contains a certification that a patent claiming the drug is
      invalid or will not be infringed by the product for which approval is
      sought.

(2)   A new drug application approved after September 24, 1984, for a drug
      product containing an active ingredient (including any ester or salt of
      that active ingredient) that has been approved in an earlier new drug
      application and that includes reports of new clinical investigations
      (other than bioavailability studies). Such investigations must have
      been conducted or sponsored by the applicant and must have been
      essential to approval of the application. If these requirements are
      met, the approval of a subsequent ANDA or an application described in
      Section 505(b)(2) of the Act may not be made effective for the same drug
      or use, if for a new indication, before the expiration of three years
      from the date of approval of the original application. If an applicant
      has exclusivity for a new application or 505(b)(2) application for the
      drug product with indications or use, this does not preclude the
      approval of an ANDA or 505(b)(2) application not covered by the
      exclusivity.

 (3) A supplement to a new drug application for a drug containing a
     previously approved active ingredient including (any ester or salt of
     the active ingredient) approved after September 24, 1984, that contains
     reports of new clinical investigations (other than bioavailability
     studies) essential to the approval of the supplement and conducted or

                                      AD 1
     sponsored by the applicant. The approval of a subsequent ANDA or
     505(b)(2) application for a change approved in the supplement may not be
     made effective for three years from the date of approval of the original
     supplement.


     The Act requires that patent information be filed with all newly
submitted Section 505(b) drug applications. No NDA may be approved after
September 24, 1984, without the submission of patent information to the
Agency. Effective August 18, 2003, this information must be filed using FDA
Form 3524a “Patent Information Submitted with the Filing of an NDA, Amendment
or Supplement”.

        Effective August 18, 2003, upon approval of an application, patent
information for purposes of listing in the Orange Book must be submitted to
the agency within 30 days of approval on FDA Form 3542 “Patent Information
Submitted Upon and After Approval of an NDA or Supplement”. Patent
information on unapproved applications or on patents beyond the scope of the
Act (i.e., process or manufacturing patents) will not be published. FDA form
3542 will be the only form used for the purposes of this publication.

    The patents that FDA regards as covered by the statutory provisions for
submission of patent information are: patents that claim the active
ingredient(s); drug product patents which include formulation/composition
patents; use patents for a particular approved indication or method of using
the product; and certain other patents as detailed on FDA Form 3542. This
information, as provided by the sponsor on FDA form 3542, will be published
as described above.

      A requirement for submission of patent information to FDA for certain
old antibiotics became effective October 7, 2008 under section 4(b)(1) of the
Q1 Act. A guidance for industry on this subject is available at
http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM048345.pdf

      Upon approval, patent numbers and expiration dates, in addition to
certain other information on appropriate patents claiming drug products that
are the subject of approved applications, will be published daily in the
Electronic Orange Book Query. The Addendum lists patent and exclusivity
information up to January of the Edition year. The monthly Cumulative
Supplements to the annual edition list patent and exclusivity information
changes since the Annual Edition Addendum. Since all parts of this
publication are subject to changes, additions, or deletions, the Electronic
Orange Book, updated daily, should be consulted for the most recent patent
and exclusivity information.




                                     AD 2
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 1 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION            PATENT         DELIST          EXCLUSIVITY    EXPIRATION
	
                                       DATE                CODES        REQUESTED          CODE(S)         DATE
	
ABACAVIR SULFATE - ZIAGEN
 N 020977 001   6294540            May 14, 2018        DS DP U-65
ABACAVIR SULFATE - ZIAGEN
 N 020978 001   6294540            May 14, 2018        DS DP U-65
                6641843            Feb 04, 2019           DP
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE -       TRIUMEQ
 N 205551 001   5905082          May 18, 2016    DS       DP                               NCE         Aug 12, 2018
                5905082*PED      Nov 18, 2016
                6294540          May 14, 2018    DS       DP U-1572
                6294540*PED      Nov 14, 2018
                6417191          Mar 28, 2016             DP U-1572
                8129385          Oct 05, 2027    DS       DP
ABACAVIR SULFATE; LAMIVUDINE - EPZICOM
 N 021652 001   5905082          May 18, 2016          DS DP
                6294540          May 14, 2018          DS DP U-257
                6417191          Mar 28, 2016             DP U-257
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE - TRIZIVIR
 N 021205 001   5905082          May 18, 2016    DS DP U-248
                6294540          May 14, 2018    DS DP U-65
                6417191          Mar 28, 2016       DP U-248
ABARELIX - PLENAXIS
 N 021320 001   5843901            Dec   01,   2015    DS DP
                5968895            Dec   11,   2016       DP
                6180608            Dec   11,   2016       DP U-549
                6423686            Jun   07,   2015    DS
                6455499            Jun   07,   2015          U-549
                6699833            Dec   11,   2016       DP
ABIRATERONE ACETATE - ZYTIGA
 N 202379 001   5604213            Dec   13,   2016    DS DP U-1126                        I-663       Dec 10, 2015
                5604213            Dec   13,   2016    DS DP U-1314                        NCE         Apr 28, 2016
                8822438            Aug   24,   2027          U-1579
                8822438            Aug   24,   2027          U-1580
ACETAMINOPHEN - OFIRMEV
 N 022450 001   6028222            Aug 05, 2017           DP
                6992218            Jun 06, 2021           DP
ACETAMINOPHEN; ASPIRIN; CAFFEINE - EXCEDRIN (MIGRAINE)
 N 020802 001   5972916          Jul 14, 2017          U-296
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE -       XARTEMIS XR
 N 204031 001   6488962          Jun 20,       2020        DP                              NP          Mar 11, 2017
                7976870          Jun 01,       2027           U-1498
                8372432          Mar 11,       2029        DP U-1499
                8377453          Nov 19,       2029        DP U-1499
                8394408          Mar 11,       2029        DP
                8597681          Dec 21,       2030        DP
                8658631          May 16,       2032        DP
                8668929          Mar 11,       2029           U-1499
                8741885          May 16,       2032        DP U-1499
ACETYLCYSTEINE - ACETADOTE
 N 021539 001   8148356            May   21,   2026       DP
                8399445            Aug   24,   2025            U-1373
                8653061            Aug   24,   2025            U-1373
                8722738            Apr   06,   2032            U-1373
ACLIDINIUM BROMIDE - TUDORZA PRESSAIR
 N 202450 001   5840279          Jun 21,       2016       DP                               NCE         Jul 23, 2017
                6071498          Jun 21,       2016       DP
                6681768          Aug 07,       2022       DP
                6750226          Sep 05,       2020    DS DP U-1264
                7078412          Jul 16,       2020    DS DP U-1263
                8051851          Apr 22,       2027       DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 2 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY    EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)         DATE
	
ACYCLOVIR - SITAVIG
 N 203791 001   8592434            Jun 16, 2030          DP U-1460                         NP          Apr 12, 2016
                8747896            Jun 03, 2027          DP U-1460
                8791127            Mar 23, 2027          DP U-1460
ACYCLOVIR; HYDROCORTISONE - XERESE
 N 022436 001   6514980          Jan     24,   2019      DP   U-1006                       NPP         Jan 22, 2017
                6514980          Jan     24,   2019      DP   U-1484
                7223387          May     13,   2023      DP   U-1006
                7223387          May     13,   2023      DP   U-1484
                RE39264          Aug     02,   2016      DP   U-1006
                RE39264          Aug     02,   2016      DP   U-1484
ADAPALENE - ADAPALENE
 A 200298 001                                                                              PC          Oct 25, 2014
ADAPALENE - DIFFERIN
 N 021753 001   7579377            Feb   23,   2025           U-818
                7737181            Aug   29,   2024      DP
                7834060            Mar   12,   2023           U-1078
                7838558            Mar   12,   2023      DP
                7868044            Mar   12,   2023           U-1078
                8703820            Mar   12,   2023           U-1078
ADAPALENE - DIFFERIN
 N 022502 001   7998467            May 31, 2028          DP U-1078
                8435502            Sep 15, 2026          DP U-1078
                8709392            Sep 15, 2026          DP U-1078
ADAPALENE; BENZOYL PEROXIDE - EPIDUO
 N 022320 001   7820186          Nov 23, 2025            DP                                NPP         Feb 01, 2016
                7964202          Sep 01, 2024            DP U-1078
                8071644          Jul 18, 2027            DP U-1078
                8080537          Jul 18, 2027               U-1078
                8105618          Dec 23, 2022               U-1078
                8129362          Jul 18, 2027               U-1078
                8241649          Dec 23, 2022            DP
                8445543          Jul 12, 2027               U-1078
                8809305          Dec 23, 2022               U-1078
ADEFOVIR DIPIVOXIL - HEPSERA
 N 021449 001   5663159            Sep 02, 2014       DS DP
                6451340            Jul 23, 2018       DS DP U-470
ADENOSINE - ADENOSCAN
 N 020059 001   5731296            Mar 24, 2015               U-221
ADENOSINE - ADENOSCAN
 N 020059 002   5731296            Mar 24, 2015               U-221
AFATINIB DIMALEATE - GILOTRIF
 N 201292 001   6251912            Jul   29,   2018   DS DP U-1067                         NCE         Jul 12, 2018
                8426586            Oct   10,   2029   DS DP                                ODE         Jul 12, 2020
                8545884            Dec   19,   2029      DP
                RE43431            Jan   22,   2022   DS DP
AFATINIB DIMALEATE - GILOTRIF
 N 201292 002   6251912            Jul   29,   2018   DS DP U-1067                         NCE         Jul 12, 2018
                8426586            Oct   10,   2029   DS DP                                ODE         Jul 12, 2020
                8545884            Dec   19,   2029      DP
                RE43431            Jan   22,   2022   DS DP
AFATINIB DIMALEATE - GILOTRIF
 N 201292 003   6251912            Jul   29,   2018   DS DP U-1067                         NCE         Jul 12, 2018
                8426586            Oct   10,   2029   DS DP                                ODE         Jul 12, 2020
                8545884            Dec   19,   2029      DP
                RE43431            Jan   22,   2022   DS DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 3 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY    EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)         DATE
	
ALATROFLOXACIN MESYLATE - TROVAN PRESERVATIVE FREE
 N 020760 001   5763454          Jun 15, 2015                 U-282
                6080756          Jul 05, 2016
                6194429          Jul 23, 2018
ALATROFLOXACIN MESYLATE - TROVAN PRESERVATIVE FREE
 N 020760 002   5763454          Jun 15, 2015                 U-282
                6080756          Jul 05, 2016
                6194429          Jul 23, 2018
ALBUMIN HUMAN - OPTISON
 N 020899 001   6723303            Apr 20, 2021          DP                                M-120       Aug 17, 2015
ALBUTEROL SULFATE - PROVENTIL-HFA
 N 020503 001   5775321          Jul 07, 2015            DP
                6006745          Dec 28, 2016            DP
ALBUTEROL SULFATE - ACCUNEB
 N 020949 001   6702997            Dec 28, 2021               U-558
ALBUTEROL SULFATE - ACCUNEB
 N 020949 002   6702997            Dec 28, 2021               U-558
ALBUTEROL SULFATE - VENTOLIN HFA
 N 020983 001   6161724          Jan 16, 2018            DP
                6170717          Dec 23, 2017            DP
                6315173          Dec 23, 2017            DP
                6431168          Jun 08, 2018            DP
                6435372          Jan 16, 2018            DP
                6510969          Dec 23, 2017            DP
                6558651          Dec 19, 2016            DP U-716
                6596260          Aug 10, 2014            DP
                6743413          Jun 01, 2021               U-716
                6938796          Jan 16, 2018            DP
                6966467          Dec 23, 2017            DP
                6997349          Jan 16, 2018            DP
                7107986          Jun 08, 2018            DP
                7143908          Jan 16, 2018            DP
                7350676          Aug 24, 2018            DP
                7500444          Feb 26, 2026            DP
                7500444*PED      Aug 26, 2026
                7832351          Jun 19, 2023            DP
ALBUTEROL SULFATE - PROAIR HFA
 N 021457 001   6446627            Dec   18,   2017      DP
                7105152            Sep   12,   2023      DP
                7566445            Jun   04,   2017      DP
                8132712            Sep   07,   2028      DP
                8834849            Jun   04,   2017      DP
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - COMBIVENT
 N 020291 001   5603918          Jun 09, 2015
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - DUONEB
 N 020950 001   6632842          Dec 28, 2021                 U-532
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 4 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION      PATENT              DELIST           EXCLUSIVITY    EXPIRATION
	
                                       DATE          CODES             REQUESTED           CODE(S)         DATE
	
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - COMBIVENT RESPIMAT
 N 021747 001   5662271          Sep 02, 2014       DP                                     NP          Oct 07, 2014
                5964416          Oct 04, 2016       DP
                6149054          Dec 19, 2016       DP
                6176442          Oct 04, 2016       DP
                6453795          Dec 05, 2016       DP
                6726124          Oct 04, 2016       DP
                6846413          Aug 28, 2018       DP
                6977042          Aug 28, 2018       DP
                6988496          Feb 23, 2020       DP
                7104470          Oct 04, 2016       DP
                7246615          May 31, 2016       DP
                7284474          Aug 26, 2024       DP
                7396341          Oct 10, 2026       DP
                7802568          Feb 26, 2019       DP
                7837235          Mar 13, 2028       DP
                7896264          May 26, 2025       DP
                7988001          Aug 04, 2021       DP
ALCAFTADINE - LASTACAFT
 N 022134 001   5468743            Apr 20, 2016       DS DP                                NCE         Jul 28, 2015
                8664215            Oct 05, 2029               U-1493
ALCOHOL; CHLORHEXIDINE GLUCONATE   - AVAGARD
 N 021074 001   5897031            Jun 21, 2016
                6090395            Jun 22, 2015          DP
                6534069            Jun 22, 2015          DP
                6623744            Jun 23, 2015             U-1008
                7081246            Aug 03, 2016          DP
                7566460            Jun 22, 2015          DP U-1008
ALENDRONATE SODIUM - FOSAMAX
 N 021575 001   5994329            Jul 17, 2018                               Y
                6015801            Jul 17, 2018                               Y
                6225294            Jul 17, 2018                               Y
ALENDRONATE SODIUM - BINOSTO
 N 202344 001   7488496            Aug 11, 2023       DS DP
                7964212            Mar 06, 2023       DS DP
ALENDRONATE SODIUM; CHOLECALCIFEROL - FOSAMAX PLUS D
 N 021762 001   5994329          Jul 17, 2018                 U-647           Y
ALFUZOSIN HYDROCHLORIDE - UROXATRAL
 N 021287 001   6149940          Aug 22, 2017
ALISKIREN HEMIFUMARATE - TEKTURNA
 N 021985 001   5559111          Jul 21, 2018         DS DP U-3
                8617595          Feb 19, 2026            DP
ALISKIREN HEMIFUMARATE - TEKTURNA
 N 021985 002   5559111          Jul 21, 2018         DS DP U-3
                8617595          Feb 19, 2026            DP
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO
 N 022545 001   5559111          Jul 21, 2018    DS DP U-3
                8613949          Dec 21, 2029       DP
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO
 N 022545 002   5559111          Jul 21, 2018    DS DP U-3
                8613949          Dec 21, 2029       DP
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO
 N 022545 003   5559111          Jul 21, 2018    DS DP U-3
                8613949          Dec 21, 2029       DP
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO
 N 022545 004   5559111          Jul 21, 2018    DS DP U-3
                8613949          Dec 21, 2029       DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                             ADA 5 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                             PATENT                         PATENT                     EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION         PATENT        DELIST       EXCLUSIVITY    EXPIRATION
	
                                        DATE             CODES       REQUESTED       CODE(S)         DATE
	
ALISKIREN HEMIFUMARATE;     AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE
	
 N 200045 001   5559111              Jul 21, 2018    DS DP U-3
	
                8183295              May 16, 2023       DP
	
                8618174              Nov 15, 2021       DP
	
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE
	
 N 200045 002   5559111          Jul 21, 2018    DS DP U-3
	
                8183295          May 16, 2023       DP
	
                8618174          Nov 15, 2021       DP
	
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE
	
 N 200045 003   5559111          Jul 21, 2018    DS DP U-3
	
                8183295          May 16, 2023       DP
	
                8618174          Nov 15, 2021       DP
	
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE
	
 N 200045 004   5559111          Jul 21, 2018    DS DP U-3
	
                8183295          May 16, 2023       DP
	
                8618174          Nov 15, 2021       DP
	
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE
	
 N 200045 005   5559111          Jul 21, 2018    DS DP U-3
	
                8183295          May 16, 2023       DP
	
                8618174          Nov 15, 2021       DP
	
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT
	
 N 022107 001   5559111          Jul 21, 2018    DS DP U-3
	
                8618172          Jul 13, 2028       DP
	
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT
	
 N 022107 002   5559111          Jul 21, 2018    DS DP U-3
	
                8618172          Jul 13, 2028       DP
	
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT
	
 N 022107 003   5559111          Jul 21, 2018    DS DP U-3
	
                8618172          Jul 13, 2028       DP
	
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT
	
 N 022107 004   5559111          Jul 21, 2018    DS DP U-3
	
                8618172          Jul 13, 2028       DP
	
ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA
	
 N 022217 001   5559111          Jul 21, 2018         DS DP U-3
	
                8168616          Jul 03, 2026            DP
	
ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA
	
 N 022217 002   5559111          Jul 21, 2018         DS DP U-3
	
                8168616          Jul 03, 2026            DP
	
ALITRETINOIN - PANRETIN
	
 N 020886 001   5932622             Aug 03, 2016             U-562
	
ALMOTRIPTAN MALATE - AXERT
	
 N 021001 001   5565447             May 07, 2015      DS DP U-969
	
ALMOTRIPTAN MALATE - AXERT
	
 N 021001 002   5565447             May 07, 2015      DS DP U-969
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 6 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT                                PATENT                     EXCLUSIVITY
	
     NO          PATENT NO
	      EXPIRATION           PATENT              DELIST      EXCLUSIVITY    EXPIRATION
	
                                     DATE               CODES            REQUESTED       CODE(S)         DATE
	
ALOGLIPTIN BENZOATE - NESINA
	
 N 022271 001   6150383
	        Jun   19,   2016             U-1330                     NCE         Jan 25, 2018
	
                6211205
	        Jun   19,   2016             U-1331
	
                6303640
	        Aug   09,   2016             U-1332
	
                6303661
	        Apr   24,   2017             U-1333
	
                6329404
	        Jun   19,   2016        DP U-1334
	
                6890898
	        Feb   02,   2019             U-1335
	
                7078381
	        Feb   02,   2019             U-1335
	
                7459428
	        Feb   02,   2019             U-1336
	
                7807689
	        Jun   27,   2028   DS DP U-1337
	
                8173663
	        Mar   15,   2025             U-1338
	
                8288539
	        Mar   15,   2025   DS
	
                8697125
	        Jan   22,   2029        DP
	
ALOGLIPTIN BENZOATE - NESINA
	
 N 022271 002   6150383
	        Jun   19,   2016             U-1330                     NCE         Jan 25, 2018
	
                6211205
	        Jun   19,   2016             U-1331
	
                6303640
	        Aug   09,   2016             U-1332
	
                6303661
	        Apr   24,   2017             U-1333
	
                6329404
	        Jun   19,   2016        DP U-1334
	
                6890898
	        Feb   02,   2019             U-1335
	
                7078381
	        Feb   02,   2019             U-1335
	
                7459428
	        Feb   02,   2019             U-1336
	
                7807689
	        Jun   27,   2028   DS DP U-1337
	
                8173663
	        Mar   15,   2025             U-1338
	
                8288539
	        Mar   15,   2025   DS
	
                8697125
	        Jan   22,   2029        DP
	
ALOGLIPTIN BENZOATE - NESINA
	
 N 022271 003   6150383
	        Jun   19,   2016             U-1330                     NCE         Jan 25, 2018
	
                6211205
	        Jun   19,   2016             U-1331
	
                6303640
	        Aug   09,   2016             U-1332
	
                6303661
	        Apr   24,   2017             U-1333
	
                6329404
	        Jun   19,   2016        DP U-1334
	
                6890898
	        Feb   02,   2019             U-1335
	
                7078381
	        Feb   02,   2019             U-1335
	
                7459428
	        Feb   02,   2019             U-1336
	
                7807689
	        Jun   27,   2028   DS DP U-1337
	
                8173663
	        Mar   15,   2025             U-1338
	
                8288539
	        Mar   15,   2025   DS
	
                8697125
	        Jan   22,   2029        DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 7 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                         See report footnote for information regarding report content

 APPL/PROD                           PATENT                            PATENT                         EXCLUSIVITY
	
     NO           PATENT NO        EXPIRATION        PATENT            DELIST           EXCLUSIVITY    EXPIRATION
	
                                      DATE            CODES           REQUESTED           CODE(S)         DATE
	
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE - KAZANO
	
 N 203414 001   5965584          Jun 19, 2016              U-1339                         NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016              U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8900638          May 24, 2029         DP
	
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE - KAZANO
	
 N 203414 002   5965584          Jun 19, 2016              U-1339                         NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016              U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8900638          May 24, 2029         DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 8 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                         See report footnote for information regarding report content

 APPL/PROD                           PATENT                            PATENT                         EXCLUSIVITY
	
     NO           PATENT NO        EXPIRATION        PATENT            DELIST           EXCLUSIVITY    EXPIRATION
	
                                      DATE            CODES           REQUESTED           CODE(S)         DATE
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE - OSENI
	
 N 022426 001   5965584          Jun 19, 2016         DP U-1339                           NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6271243          Jun 19, 2016              U-1344
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016         DP U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8637079          Jan 23, 2029         DP
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE - OSENI
	
 N 022426 002   5965584          Jun 19, 2016         DP U-1339                           NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6271243          Jun 19, 2016              U-1344
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016         DP U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8637079          Jan 23, 2029         DP
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE - OSENI
	
 N 022426 003   5965584          Jun 19, 2016         DP U-1339                           NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6271243          Jun 19, 2016              U-1344
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016         DP U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8637079          Jan 23, 2029         DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 9 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                         See report footnote for information regarding report content

 APPL/PROD                         PATENT                              PATENT                         EXCLUSIVITY
	
     NO           PATENT NO      EXPIRATION          PATENT            DELIST           EXCLUSIVITY    EXPIRATION
	
                                    DATE              CODES           REQUESTED           CODE(S)         DATE
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE - OSENI
	
 N 022426 004   5965584          Jun 19, 2016         DP U-1339                           NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6271243          Jun 19, 2016              U-1344
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016         DP U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8637079          Jan 23, 2029         DP
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE - OSENI
	
 N 022426 005   5965584          Jun 19, 2016         DP U-1339                           NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6271243          Jun 19, 2016              U-1344
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016         DP U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8637079          Jan 23, 2029         DP
	
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE - OSENI
	
 N 022426 006   5965584          Jun 19, 2016         DP U-1339                           NC          Jan 25, 2016
	
                6150383          Jun 19, 2016              U-1330                         NCE         Jan 25, 2018
	
                6150384          Jun 19, 2016              U-1340
	
                6166042          Jun 19, 2016              U-1341
	
                6166043          Jun 19, 2016              U-1342
	
                6172090          Jun 19, 2016              U-1343
	
                6211205          Jun 19, 2016              U-1331
	
                6271243          Jun 19, 2016              U-1344
	
                6303640          Aug 09, 2016              U-1332
	
                6303661          Apr 24, 2017              U-1333
	
                6329404          Jun 19, 2016         DP U-1334
	
                6890898          Feb 02, 2019              U-1335
	
                7078381          Feb 02, 2019              U-1335
	
                7459428          Feb 02, 2019              U-1336
	
                7807689          Jun 27, 2028    DS DP U-1337
	
                8173663          Mar 15, 2025              U-1338
	
                8288539          Mar 15, 2025    DS
	
                8637079          Jan 23, 2029         DP
	
ALOSETRON HYDROCHLORIDE - LOTRONEX
	
 N 021107 001   6284770          Oct 05, 2018               U-405
	
ALOSETRON HYDROCHLORIDE - LOTRONEX
	
 N 021107 002   6284770          Oct 05, 2018               U-405
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 10 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
	
ALPRAZOLAM - NIRAVAM
 N 021726 001   6024981            Apr 09, 2018            DP
                6221392            Apr 09, 2018            DP
ALPRAZOLAM - NIRAVAM
 N 021726 002   6024981            Apr 09, 2018            DP
                6221392            Apr 09, 2018            DP
ALPRAZOLAM - NIRAVAM
 N 021726 003   6024981            Apr 09, 2018            DP
                6221392            Apr 09, 2018            DP
ALPRAZOLAM - NIRAVAM
 N 021726 004   6024981            Apr 09, 2018            DP
                6221392            Apr 09, 2018            DP
ALPROSTADIL - CAVERJECT
 N 020379 001   5741523            Apr 21, 2015
ALPROSTADIL - CAVERJECT
 N 020379 002   5741523            Apr 21, 2015
ALPROSTADIL - CAVERJECT
 N 020379 003   5741523            Apr 21, 2015
ALPROSTADIL - CAVERJECT
 N 020379 004   5741523            Apr 21, 2015
ALPROSTADIL - MUSE
 N 020700 001   5886039            Mar 23, 2016            DP U-155
ALPROSTADIL - MUSE
 N 020700 002   5886039            Mar 23, 2016            DP U-155
ALPROSTADIL - MUSE
 N 020700 003   5886039            Mar 23, 2016            DP U-155
ALPROSTADIL - MUSE
 N 020700 004   5886039            Mar 23, 2016            DP U-155
ALPROSTADIL - CAVERJECT IMPULSE
 N 021212 001   5716338            Feb 10, 2015            DP
ALPROSTADIL - CAVERJECT IMPULSE
 N 021212 002   5716338            Feb 10, 2015            DP
ALVIMOPAN - ENTEREG
 N 021775 001   5250542            Mar   29,   2016   DS DP U-878                          M-128        Oct 18, 2016
                6469030            Nov   29,   2020         U-879
                8112290            Jul   31,   2030         U-1443
                8645160            Jun   18,   2029         U-1485
AMBRISENTAN - LETAIRIS
 N 022081 001   5703017            Dec   30,   2014   DS
                5840722            Nov   24,   2015             U-821
                5840722            Nov   24,   2015             U-1297
                7109205            Oct   07,   2015   DS DP
                7601730            Oct   07,   2015             U-1080
                8349843            Oct   07,   2015   DS DP
                RE42462            Jul   29,   2018   DS
AMBRISENTAN - LETAIRIS
 N 022081 002   5703017            Dec   30,   2014   DS
                5840722            Nov   24,   2015             U-821
                5840722            Nov   24,   2015             U-1297
                7109205            Oct   07,   2015   DS DP
                7601730            Oct   07,   2015             U-1080
                8349843            Oct   07,   2015   DS DP
                RE42462            Jul   29,   2018   DS
AMIFOSTINE - ETHYOL
 N 020221 001   5994409            Dec 08, 2017                 U-305
AMIFOSTINE - ETHYOL
 N 020221 002   5994409            Dec 08, 2017                 U-305
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 11 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                                   PATENT                     EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT                DELIST     EXCLUSIVITY      EXPIRATION
	
                                    DATE               CODES               REQUESTED     CODE(S)           DATE
	
AMINOLEVULINIC ACID HYDROCHLORIDE - LEVULAN
	
 N 020965 001   5954703          Oct 31, 2017                    U-289
	
                6709446          May 01, 2018                    U-289
	
                7723910          Jun 17, 2019                    U-289
	
                8216289          May 01, 2018                    U-289
	
                8758418          May 01, 2018                    U-289
	
AMIODARONE HYDROCHLORIDE - NEXTERONE
	
 N 022325 001   6869939          May 04, 2022             DP
	
                7635773          Mar 13, 2029             DP
	
AMIODARONE HYDROCHLORIDE - NEXTERONE
	
 N 022325 002   6869939          May 04, 2022             DP
	
                7635773          Mar 13, 2029             DP
	
AMIODARONE HYDROCHLORIDE - NEXTERONE
	
 N 022325 003   6869939          May 04, 2022             DP
	
                7635773          Mar 13, 2029             DP
	
AMLODIPINE BESYLATE - AMLODIPINE BESYLATE
	
 N 022026 001   6828339          Nov 20, 2022      DS
	
AMLODIPINE BESYLATE - AMLODIPINE BESYLATE
	
 N 022026 002   6828339          Nov 20, 2022      DS
	
AMLODIPINE BESYLATE - AMLODIPINE BESYLATE
	
 N 022026 003   6828339          Nov 20, 2022      DS
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 12 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)           DATE
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 001   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 002   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 003   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 004   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 005   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 006   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 007   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 008   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 009   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 010   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET
	
 N 021540 011   5686104          Nov 11, 2014         DP U-213
	
                5969156          Jul 08, 2016    DS
	
                6455574          Aug 11, 2018            U-552
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL
	
 N 020364 002   6162802          Dec 19, 2017            U-367
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL
	
 N 020364 003   6162802          Dec 19, 2017            U-367
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL
	
 N 020364 004   6162802          Dec 19, 2017            U-367
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL
	
 N 020364 005   6162802          Dec 19, 2017            U-367
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL
	
 N 020364 006   6162802          Dec 19, 2017    DS DP U-185
	
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL
	
 N 020364 007   6162802          Dec 19, 2017    DS DP U-185
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 13 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                         PATENT                              EXCLUSIVITY
	
     NO         PATENT NO        EXPIRATION         PATENT        DELIST              EXCLUSIVITY      EXPIRATION
	
                                    DATE             CODES       REQUESTED              CODE(S)           DATE
	
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR
 N 200175 001   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR
 N 200175 002   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR
 N 200175 003   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR
 N 200175 004   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR
 N 200175 005   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN   - EXFORGE HCT
 N 022314 001   6294197          Jun 18, 2017         DP U-3
                8101599          May 16, 2023         DP
                8475839          May 16, 2023         DP
                8475839*PED      Nov 16, 2023
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN   - EXFORGE HCT
 N 022314 002   6294197          Jun 18, 2017         DP U-3
                8101599          May 16, 2023         DP
                8475839          May 16, 2023         DP
                8475839*PED      Nov 16, 2023
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN   - EXFORGE HCT
 N 022314 003   6294197          Jun 18, 2017         DP U-3
                8101599          May 16, 2023         DP
                8475839          May 16, 2023         DP
                8475839*PED      Nov 16, 2023
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN   - EXFORGE HCT
 N 022314 004   6294197          Jun 18, 2017         DP U-3
                8101599          May 16, 2023         DP
                8475839          May 16, 2023         DP
                8475839*PED      Nov 16, 2023
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN   - EXFORGE HCT
 N 022314 005   6294197          Jun 18, 2017         DP U-3
                8101599          May 16, 2023         DP
                8475839          May 16, 2023         DP
                8475839*PED      Nov 16, 2023
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR
 N 022100 001   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR
 N 022100 002   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR
 N 022100 003   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR
 N 022100 004   5616599          Apr 25, 2016    DS DP U-3
AMLODIPINE BESYLATE; VALSARTAN - AMLODIPINE BESYLATE AND VALSARTAN
 A 090011 001                                                                           PC           Mar 29, 2015
AMLODIPINE BESYLATE; VALSARTAN - AMLODIPINE BESYLATE AND VALSARTAN
 A 090011 002                                                                           PC           Mar 29, 2015
AMLODIPINE BESYLATE; VALSARTAN - AMLODIPINE BESYLATE AND VALSARTAN
 A 090011 004                                                                           PC           Mar 29, 2015
AMLODIPINE BESYLATE; VALSARTAN - AMLODIPINE BESYLATE AND VALSARTAN
 A 090144 001                                                                           PC           Mar 29, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 14 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION            PATENT          DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                CODES         REQUESTED         CODE(S)           DATE
	
AMLODIPINE BESYLATE; VALSARTAN - EXFORGE
	
 N 021990 002   6294197          Jun 18, 2017             DP U-3
	
                6395728          Jul 08, 2019             DP
	
AMLODIPINE BESYLATE; VALSARTAN - EXFORGE
	
 N 021990 003   6294197          Jun 18, 2017             DP U-3
	
                6395728          Jul 08, 2019             DP
	
AMLODIPINE BESYLATE; VALSARTAN - EXFORGE
	
 N 021990 004   6294197          Jun 18, 2017             DP U-3
	
                6395728          Jul 08, 2019             DP
	
AMLODIPINE BESYLATE; VALSARTAN - EXFORGE
	
 N 021990 005   6294197          Jun 18, 2017             DP U-3
	
                6395728          Jul 08, 2019             DP
	
AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN - AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE
	
 A 200435 001                                                                    PC                     May 30, 2015

                                                                                 PC                     May 30, 2015
	
AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN - AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE
	
 A 200435 002                                                                    PC                     May 30, 2015

                                                                                 PC                     May 30, 2015
	
AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN - AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE
	
 A 200435 003                                                                    PC                     May 30, 2015

                                                                                 PC                     May 30, 2015
	
AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN - AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE
	
 A 200435 004                                                                    PC                     May 30, 2015

                                                                                 PC                     May 30, 2015
	
AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN - AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE
	
 A 200435 005                                                                    PC                     May 30, 2015

                                                                                 PC                     May 30, 2015
	
AMOXICILLIN - MOXATAG
	
 N 050813 001   6544555            Oct   13,   2020   DS DP U-897
	
                6669948            Oct   13,   2020   DS DP U-897
	
                6723341            Oct   13,   2020   DS DP U-897
	
                8299052            May   07,   2027           U-1304
	
                8357394            Dec   08,   2026      DP
	
AMOXICILLIN; CLAVULANATE POTASSIUM -     AUGMENTIN XR
	
 N 050785 001   6746692          Apr     04, 2020         DP
	
                6783773          Apr     04, 2020         DP
	
                6878386          Apr     04, 2020            U-926
	
                7217430          Apr     04, 2020         DP U-926
	
                7250176          Apr     04, 2020            U-926
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 10
	
 N 011522 007   6384020          Jul 06, 2020
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 20
	
 N 011522 008   6384020          Jul 06, 2020
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 5
	
 N 011522 009   6384020          Jul 06, 2020
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 30
	
 N 011522 010   6384020          Jul 06, 2020
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 7.5
	
 N 011522 011   6384020          Jul 06, 2020
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 12.5
	
 N 011522 012   6384020          Jul 06, 2020
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL 15
	
 N 011522 013   6384020          Jul 06, 2020
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                         ADA 15 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                     PATENT                      EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION     PATENT        DELIST      EXCLUSIVITY      EXPIRATION
	
                                        DATE         CODES       REQUESTED      CODE(S)           DATE
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL XR 10
	
 N 021303 001		 6322819          Oct 21, 2018
	
                 6605300         Oct 21, 2018
	
                 RE41148         Oct 21, 2018       DP
	
                 RE42096         Oct 21, 2018       DP
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL XR 20
	
 N 021303 002		 6322819          Oct 21, 2018
	
                 6605300         Oct 21, 2018
	
                 RE41148         Oct 21, 2018       DP
	
                 RE42096         Oct 21, 2018       DP
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL XR 30
	
 N 021303 003		 6322819          Oct 21, 2018
	
                 6605300         Oct 21, 2018
	
                 RE41148         Oct 21, 2018       DP
	
                 RE42096         Oct 21, 2018       DP
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL XR 25
	
 N 021303 004		 6322819          Oct 21, 2018
	
                 6605300         Oct 21, 2018
	
                 RE41148         Oct 21, 2018       DP
	
                 RE42096         Oct 21, 2018       DP
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL XR 5
	
 N 021303 005		 6322819          Oct 21, 2018
	
                6605300          Oct 21, 2018
	
                RE41148          Oct 21, 2018       DP
	
                RE42096          Oct 21, 2018       DP
	
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE -
ADDERALL XR 15
	
 N 021303 006		 6322819          Oct 21, 2018
	
                 6605300         Oct 21, 2018
	
                 RE41148         Oct 21, 2018       DP
	
                 RE42096         Oct 21, 2018       DP
	
AMPHOTERICIN B - ABELCET
	
 N 050724 001		 6406713             Jun 18, 2019       DS
	
AMPHOTERICIN B - AMBISOME
	
 N 050740 001		 5874104             Feb 23, 2016              DP U-922
	
                5965156             Oct 12, 2016              DP U-922
	
AMPRENAVIR - AGENERASE
	
 N 021007 001   5646180             Jul 08, 2014                   U-257
                5723490             Mar 03, 2015                   U-257
                6730679             Nov 11, 2017              DP
AMPRENAVIR - AGENERASE
 N 021007 002   5646180             Jul 08, 2014                   U-257
                5723490             Mar 03, 2015                   U-257
                6730679             Nov 11, 2017              DP
AMPRENAVIR - AGENERASE
 N 021039 001   5646180             Jul 08, 2014                   U-257
                5723490             Mar 03, 2015                   U-257
ANIDULAFUNGIN - ERAXIS
 N 021632 001   5965525             Feb 17, 2020       DS DP U-540
                6960564             Apr 12, 2021          DP U-540
                7709444             Apr 12, 2021          DP U-540
ANIDULAFUNGIN - ERAXIS
 N 021632 002   5965525             Feb 17, 2020       DS DP U-540
                6960564             Apr 12, 2021          DP U-540
                7709444             Apr 12, 2021          DP U-540
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 16 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                                 PATENT
	                    EXCLUSIVITY
	
     NO          PATENT NO
	      EXPIRATION
	             PATENT            DELIST
	    EXCLUSIVITY      EXPIRATION
	
                                     DATE
	                 CODES          REQUESTED
	     CODE(S)           DATE
	
APIXABAN - ELIQUIS
	
 N 202155 001   6413980
	        Dec   22,   2019
	   DS   DP   U-1200
	                   I-661        Aug   21,   2017

                6413980
	        Dec   22,   2019
	   DS   DP   U-1301
	                   I-681        Mar   03,   2017
	
                6413980
	        Dec   22,   2019
	   DS   DP   U-1302
	                   I-690        Aug   21,   2017

                6413980
	        Dec   22,   2019
	   DS   DP   U-1501
	                   I-691        Aug   21,   2017

                6967208
	        Feb   03,   2023
	   DS   DP   U-1167
	                   NCE          Dec   28,   2017
	
                6967208
	        Feb   03,   2023
	   DS   DP   U-1200
	
                6967208
	        Feb   03,   2023
	   DS   DP   U-1301
	
                6967208
	        Feb   03,   2023
	   DS   DP   U-1302
	
                6967208
	        Feb   03,   2023
	   DS   DP   U-1323
	
                6967208
	        Feb   03,   2023
	   DS   DP   U-1501
	
                6967208
	        Feb   03,   2023
	   DS   DP   U-1502
	
APIXABAN - ELIQUIS
	
 N 202155 002   6413980
	        Dec 22, 2019
	       DS DP U-1200
	                       I-661        Aug   21,   2017

                6967208
	        Feb 03, 2023
	       DS DP U-1200
	                       I-690        Aug   21,   2017

                6967208
	        Feb 03, 2023
	       DS DP U-1323
	                       I-691        Aug   21,   2017

                                                                                           NCE          Dec   28,   2017
	
APREMILAST - OTEZLA
	
 N 205437 001   6020358
	        Oct   30,   2018
	   DS DP U-1504
	                       I-694        Sep 23, 2017

                6962940
	        Mar   19,   2023
	           U-1504
	                     NCE          Mar 21, 2019
	
                7208516
	        Mar   19,   2023
	           U-1505
	
                7427638
	        Nov   17,   2024
	   DS DP
	
                7659302
	        Mar   19,   2023
	           U-1505
	
                7659302
	        Mar   19,   2023
	           U-1595
	
                7893101
	        Dec   09,   2023
	   DS DP
	
                8455536
	        Mar   19,   2023
	           U-1505
	
                8455536
	        Mar   19,   2023
	           U-1595
	
                8802717
	        Mar   19,   2023
	           U-1561
	
APREMILAST - OTEZLA
	
 N 205437 002   6020358
	        Oct   30,   2018
	   DS DP U-1504
	                       I-694        Sep 23, 2017

                6962940
	        Mar   19,   2023
	           U-1504
	                     NCE          Mar 21, 2019
	
                7208516
	        Mar   19,   2023
	           U-1505
	
                7427638
	        Nov   17,   2024
	   DS DP
	
                7659302
	        Mar   19,   2023
	           U-1505
	
                7659302
	        Mar   19,   2023
	           U-1595
	
                7893101
	        Dec   09,   2023
	   DS DP
	
                8455536
	        Mar   19,   2023
	           U-1505
	
                8455536
	        Mar   19,   2023
	           U-1595
	
                8802717
	        Mar   19,   2023
	           U-1561
	
APREMILAST - OTEZLA
	
 N 205437 003   6020358
	        Oct   30,   2018
	   DS DP U-1504
	                       I-694        Sep 23, 2017

                6962940
	        Mar   19,   2023
	           U-1504
	                     NCE          Mar 21, 2019
	
                7208516
	        Mar   19,   2023
	           U-1505
	
                7427638
	        Nov   17,   2024
	   DS DP
	
                7659302
	        Mar   19,   2023
	           U-1505
	
                7659302
	        Mar   19,   2023
	           U-1595
	
                7893101
	        Dec   09,   2023
	   DS DP
	
                8455536
	        Mar   19,   2023
	           U-1505
	
                8455536
	        Mar   19,   2023
	           U-1595
	
                8802717
	        Mar   19,   2023
	           U-1561
	
APREPITANT - EMEND
	
 N 021549 001   5719147
	        Apr   17,   2015
    DS DP U-853
	
                6096742
	        Jul   01,   2018
	   DS DP U-745
	
                8258132
	        Sep   26,   2027
       DP U-901
	
                8258132
	        Sep   26,   2027
	      DP U-1282
	
APREPITANT - EMEND
	
 N 021549 002   5719147
	        Apr   17,   2015
    DS DP U-853
	
                6096742
	        Jul   01,   2018
	   DS DP U-745
	
                8258132
	        Sep   26,   2027
       DP U-901
	
                8258132
	        Sep   26,   2027
	      DP U-1282
	
APREPITANT - EMEND
	
 N 021549 003   5719147
	        Apr   17,   2015
    DS DP U-853
	
                6096742
	        Jul   01,   2018
	   DS DP U-745
	
                8258132
	        Sep   26,   2027
       DP U-901
	
                8258132
	        Sep   26,   2027
	      DP U-1282
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 17 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                                   PATENT                     EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT                DELIST     EXCLUSIVITY      EXPIRATION
	
                                     DATE               CODES               REQUESTED     CODE(S)           DATE
	
ARFORMOTEROL TARTRATE - BROVANA
	
 N 021912 001   6040344           Nov 12, 2016      DS
	
                6472563           Nov 09, 2021      DS
	
                6667344           Jun 22, 2021             DP
	
                6720453           Nov 09, 2021      DS
	
                6814953           Jun 22, 2021                    U-793
	
                7145036           Nov 09, 2021      DS
	
                7348362           Jun 22, 2021             DP U-793
	
                7462645           Jun 22, 2021                  U-793
	
                7465756           Jun 22, 2021             DP
	
                7473710           Jun 22, 2021                  U-793
	
                7541385           Jun 22, 2021                  U-793
	
                8110706           Nov 09, 2021             DP
	
ARGATROBAN - ARGATROBAN IN SODIUM CHLORIDE
	
 N 022434 001   7589106          Sep 26, 2027              DP U-1163
	
                7687516          Sep 26, 2027              DP U-1164
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 18 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                              PATENT
	                     EXCLUSIVITY
	
     NO          PATENT NO
	      EXPIRATION
	           PATENT           DELIST
	     EXCLUSIVITY      EXPIRATION
	
                                     DATE
	               CODES         REQUESTED
	      CODE(S)           DATE
	
ARIPIPRAZOLE - ABILIFY
	
 N 021436 001   5006528
	        Oct   20,   2014
	   DS DP U-761
	                      I-700        Dec 12, 2017
	
                7053092
	        Jan   28,   2022
	           U-839
	                    M-137        Jun 09, 2017
	
                8017615
	        Jun   16,   2024
	      DP
	
                8017615*PED
	    Dec   16,   2024
	
                8580796
	        Sep   25,   2022
    DS
	
                8580796*PED
	    Mar   25,   2023
	
                8642600
	        Jan   28,   2022
	          U-1492
	
                8642600*PED
	    Jul   28,   2022
	
                8642760
	        Sep   25,   2022
    DS
	
                8642760*PED
	    Mar   25,   2023
	
                8759350
	        Mar   02,   2027
	          U-1529
	
ARIPIPRAZOLE - ABILIFY
	
 N 021436 002   5006528
	        Oct   20,   2014
	   DS DP U-761
	                      I-700        Dec 12, 2017
	
                7053092
	        Jan   28,   2022
	           U-839
	                    M-137        Jun 09, 2017
	
                8017615
	        Jun   16,   2024
	      DP
	
                8017615*PED
	    Dec   16,   2024
	
                8580796
	        Sep   25,   2022
    DS
	
                8580796*PED
	    Mar   25,   2023
	
                8642600
	        Jan   28,   2022
	          U-1492
	
                8642600*PED
	    Jul   28,   2022
	
                8642760
	        Sep   25,   2022
    DS
	
                8642760*PED
	    Mar   25,   2023
	
                8759350
	        Mar   02,   2027
	          U-1529
	
ARIPIPRAZOLE - ABILIFY
	
 N 021436 003   5006528
	        Oct   20,   2014
	   DS DP U-761
	                      I-700        Dec 12, 2017
	
                7053092
	        Jan   28,   2022
	           U-839
	                    M-137        Jun 09, 2017
	
                8017615
	        Jun   16,   2024
	      DP
	
                8017615*PED
	    Dec   16,   2024
	
                8580796
	        Sep   25,   2022
    DS
	
                8580796*PED
	    Mar   25,   2023
	
                8642600
	        Jan   28,   2022
	          U-1492
	
                8642600*PED
	    Jul   28,   2022
	
                8642760
	        Sep   25,   2022
    DS
	
                8642760*PED
	    Mar   25,   2023
	
                8759350
	        Mar   02,   2027
	          U-1529
	
ARIPIPRAZOLE - ABILIFY
	
 N 021436 004   5006528
	        Oct   20,   2014
	   DS DP U-761
	                      I-700        Dec 12, 2017
	
                7053092
	        Jan   28,   2022
	           U-839
	                    M-137        Jun 09, 2017
	
                8017615
	        Jun   16,   2024
	      DP
	
                8017615*PED
	    Dec   16,   2024
	
                8580796
	        Sep   25,   2022
    DS
	
                8580796*PED
	    Mar   25,   2023
	
                8642600
	        Jan   28,   2022
	          U-1492
	
                8642600*PED
	    Jul   28,   2022
	
                8642760
	        Sep   25,   2022
    DS
	
                8642760*PED
	    Mar   25,   2023
	
                8759350
	        Mar   02,   2027
	          U-1529
	
ARIPIPRAZOLE - ABILIFY
	
 N 021436 005   5006528
	        Oct   20,   2014
	   DS DP U-761
	                      I-700        Dec 12, 2017
	
                7053092
	        Jan   28,   2022
	           U-839
	                    M-137        Jun 09, 2017
	
                8017615
	        Jun   16,   2024
	      DP
	
                8017615*PED
	    Dec   16,   2024
	
                8580796
	        Sep   25,   2022
    DS
	
                8580796*PED
	    Mar   25,   2023
	
                8642600
	        Jan   28,   2022
	          U-1492
	
                8642600*PED
	    Jul   28,   2022
	
                8642760
	        Sep   25,   2022
    DS
	
                8642760*PED
	    Mar   25,   2023
	
                8759350
	        Mar   02,   2027
	          U-1529
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 19 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                               PATENT                        EXCLUSIVITY
     NO         PATENT NO        EXPIRATION             PATENT          DELIST        EXCLUSIVITY      EXPIRATION
                                    DATE                CODES         REQUESTED         CODE(S)           DATE
ARIPIPRAZOLE - ABILIFY
 N 021436 006   5006528         Oct   20,   2014   DS DP U-761                          I-700        Dec 12, 2017
                7053092         Jan   28,   2022         U-839                          M-137        Jun 09, 2017
                8017615         Jun   16,   2024      DP
                8017615*PED     Dec   16,   2024
                8580796         Sep   25,   2022   DS
                8580796*PED     Mar   25,   2023
                8642600         Jan   28,   2022             U-1492
                8642600*PED     Jul   28,   2022
                8642760         Sep   25,   2022   DS
                8642760*PED     Mar   25,   2023
                8759350         Mar   02,   2027             U-1529
ARIPIPRAZOLE - ABILIFY
 N 021713 001   5006528         Oct   20,   2014   DS DP U-761                          M-137        Jun 09, 2017
                6977257         Apr   24,   2022   DS DP
                7053092         Jan   28,   2022         U-839
                8642600         Jan   28,   2022         U-1492
                8642600*PED     Jul   28,   2022
                8759350         Mar   02,   2027             U-1529
ARIPIPRAZOLE - ABILIFY
 N 021729 002   5006528         Oct   20,   2014   DS DP U-761                          I-700        Dec 12, 2017
                7053092         Jan   28,   2022         U-839                          M-137        Jun 09, 2017
                8017615         Jun   16,   2024      DP
                8017615*PED     Dec   16,   2024
                8518421         Jan   24,   2021        DP
                8518421*PED     Jul   24,   2021
                8580796         Sep   25,   2022   DS
                8580796*PED     Mar   25,   2023
                8642600         Jan   28,   2022             U-1492
                8642600*PED     Jul   28,   2022
                8642760         Sep   25,   2022   DS
                8642760*PED     Mar   25,   2023
                8759350         Mar   02,   2027             U-1529
ARIPIPRAZOLE - ABILIFY
 N 021729 003   5006528         Oct   20,   2014   DS DP U-761                          I-700        Dec 12, 2017
                7053092         Jan   28,   2022         U-839                          M-137        Jun 09, 2017
                8017615         Jun   16,   2024      DP
                8017615*PED     Dec   16,   2024
                8518421         Jan   24,   2021        DP
                8518421*PED     Jul   24,   2021
                8580796         Sep   25,   2022   DS
                8580796*PED     Mar   25,   2023
                8642600         Jan   28,   2022             U-1492
                8642600*PED     Jul   28,   2022
                8642760         Sep   25,   2022   DS
                8642760*PED     Mar   25,   2023
                8759350         Mar   02,   2027             U-1529
ARIPIPRAZOLE - ABILIFY
 N 021729 004   5006528         Oct   20,   2014   DS DP U-761                          I-700        Dec 12, 2017
                7053092         Jan   28,   2022         U-839                          M-137        Jun 09, 2017
                8017615         Jun   16,   2024      DP
                8017615*PED     Dec   16,   2024
                8518421         Jan   24,   2021        DP
                8518421*PED     Jul   24,   2021
                8580796         Sep   25,   2022   DS
                8580796*PED     Mar   25,   2023
                8642600         Jan   28,   2022             U-1492
                8642600*PED     Jul   28,   2022
                8642760         Sep   25,   2022   DS
                8642760*PED     Mar   25,   2023
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                          ADA 20 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT
	                                     PATENT
	                    EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION
	           PATENT                  DELIST
	    EXCLUSIVITY      EXPIRATION
	
                                        DATE
	               CODES                REQUESTED
	     CODE(S)           DATE
	
ARIPIPRAZOLE - ABILIFY
	
 N 021729 005		 5006528             Oct   20,   2014
	   DS DP U-761
	                            I-700        Dec 12, 2017
	
                7053092             Jan   28,   2022
	           U-839
	                          M-137        Jun 09, 2017
	
                8017615             Jun   16,   2024
	      DP
	
                8017615*PED         Dec   16,   2024
	
                8518421             Jan   24,   2021
	          DP
	
                8518421*PED         Jul   24,   2021
	
                8580796             Sep   25,   2022
    DS
	
                8580796*PED         Mar   25,   2023
	
                8642600             Jan   28,   2022
	                 U-1492
	
                8642600*PED         Jul   28,   2022
	
                8642760             Sep   25,   2022
    DS
	
                8642760*PED         Mar   25,   2023
	
ARIPIPRAZOLE - ABILIFY
	
 N 021866 001		 5006528             Oct 20, 2014
	       DS DP U-763
	                            I-700        Dec 12, 2017
	
                7115587             Jul 21, 2024
	       DS DP U-764
	                            M-137        Jun 09, 2017
	
                7550445             Jul 21, 2024
	          DP
	
ARIPIPRAZOLE - ABILIFY MAINTENA KIT
	
 N 202971 001		 5006528          Apr 20, 2015
           DS DP U-543
	                            M-150        Dec 05, 2017
	
                7807680          Oct 19, 2024
	               DP
	                                NDF          Feb 28, 2016
	
                8030313          Oct 19, 2024
	                    U-543
	
                8338427          Mar 15, 2025
	               DP U-543
	
                8338428          Aug 06, 2023
                DP U-543
	
                8399469          Dec 29, 2023
	          DS
	
                8722679          Oct 19, 2024
	               DP
	
                8759351          Aug 06, 2023
	               DP U-1530
	
ARIPIPRAZOLE - ABILIFY MAINTENA KIT
	
 N 202971 002		 5006528          Apr 20, 2015
           DS DP U-543
	                            M-150        Dec 05, 2017
	
                7807680          Oct 19, 2024
	               DP
	                                NDF          Feb 28, 2016
	
                8030313          Oct 19, 2024
	                    U-543
	
                8338427          Mar 15, 2025
	               DP U-543
	
                8338428          Aug 06, 2023
                DP U-543
	
                8399469          Dec 29, 2023
	          DS
	
                8722679          Oct 19, 2024
	               DP
	
                8759351          Aug 06, 2023
	               DP U-1530
	
ARIPIPRAZOLE - ABILIFY MAINTENA KIT
	
 N 202971 003		 5006528          Apr 20, 2015
           DS DP U-1530
	                           M-150        Dec 05, 2017
	
                7807680          Oct 19, 2024
	               DP
	                                NDF          Feb 28, 2016
	
                8030313          Oct 19, 2024
	                    U-543
	
                8338427          Mar 15, 2025
	               DP U-1530
	
                8338428          Aug 06, 2023
                DP U-1530
	
                8399469          Dec 29, 2023
	          DS
	
                8722679          Oct 19, 2024
	               DP
	
                8759351          Aug 06, 2023
	               DP U-1530
	
ARIPIPRAZOLE - ABILIFY MAINTENA KIT
	
 N 202971 004		 5006528          Apr 20, 2015
           DS DP U-1530
	                           M-150        Dec 05, 2017
	
                7807680          Oct 19, 2024
	               DP
	                                NDF          Feb 28, 2016
	
                8030313          Oct 19, 2024
	                    U-543
	
                8338427          Mar 15, 2025
	               DP U-1530
	
                8338428          Aug 06, 2023
                DP U-1530
	
                8399469          Dec 29, 2023
	          DS
	
                8722679          Oct 19, 2024
	               DP
	
                8759351          Aug 06, 2023
	               DP U-1530
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 21 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT           DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES          REQUESTED         CODE(S)           DATE
	
ARMODAFINIL - NUVIGIL
	
 N 021875 001		 7132570            Dec 18, 2023       DS DP
	
                7297346            Nov 29, 2023          DP
	
                RE37516            Oct 06, 2014          DP U-820
	
ARMODAFINIL - NUVIGIL
	
 N 021875 002		 7132570            Dec 18, 2023       DS DP
	
                7297346            Nov 29, 2023          DP
	
                RE37516            Oct 06, 2014          DP U-820
	
ARMODAFINIL - NUVIGIL
	
 N 021875 003		 7132570            Dec 18, 2023       DS DP
	
                7297346            Nov 29, 2023          DP
	
                RE37516            Oct 06, 2014          DP U-820
	
ARMODAFINIL - NUVIGIL
	
 N 021875 004		 7132570            Dec 18, 2023       DS DP
	
                7297346            Nov 29, 2023          DP
	
                RE37516            Oct 06, 2014          DP U-820
	
ARMODAFINIL - NUVIGIL
	
 N 021875 005		 7132570            Dec 18, 2023       DS DP
	
                7297346            Nov 29, 2023          DP
	
                RE37516            Oct 06, 2014          DP U-820
	
ARSENIC TRIOXIDE - TRISENOX
	
 N 021248 001		 6723351            Nov   10,   2018           U-573
	
                6855339            Nov   10,   2018           U-617
	
                6861076            Nov   10,   2018           U-617
	
                6884439            Nov   10,   2018           U-651
	
                6982096            Nov   10,   2018           U-651
	
                8273379            Nov   10,   2018           U-1291
	
ARTEMETHER; LUMEFANTRINE - COARTEM
	
 N 022268 001		 5677331          Oct 14, 2014            DP U-977                          ODE          Apr 07, 2016
	
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM

SULFATE - MOVIPREP
	
 N 021881 001   7169381          Sep 01, 2024    DS DP
	
                7658914          Sep 01, 2024    DS DP
	
ASENAPINE MALEATE - SAPHRIS
	
 N 022117 001   5763476            Jun 09, 2020          DP U-326                          NCE          Aug 13, 2014
                7741358            Apr 06, 2026       DS DP U-1064
                8022228            Apr 06, 2026       DS DP
ASENAPINE MALEATE - SAPHRIS
 N 022117 002   5763476            Jun 09, 2020          DP U-326                          NCE          Aug 13, 2014
                7741358            Apr 06, 2026       DS DP U-1064
                8022228            Apr 06, 2026       DS DP
ASPIRIN - ASPIRIN
 N 203697 001   8865187            Mar 23, 2022          DP
ASPIRIN; DIPYRIDAMOLE - AGGRENOX
 N 020884 001   6015577          Jan 18, 2017                 U-302
ATAZANAVIR SULFATE - REYATAZ
 N 021567 001   5849911            Jun 20, 2017       DS DP U-167
                6087383            Dec 21, 2018       DS DP
ATAZANAVIR SULFATE - REYATAZ
 N 021567 002   5849911            Jun 20, 2017       DS DP U-167
                6087383            Dec 21, 2018       DS DP
ATAZANAVIR SULFATE - REYATAZ
 N 021567 003   5849911            Jun 20, 2017       DS DP U-167
                6087383            Dec 21, 2018       DS DP
ATAZANAVIR SULFATE - REYATAZ
 N 021567 004   5849911            Jun 20, 2017       DS DP U-167
                6087383            Dec 21, 2018       DS DP
ATAZANAVIR SULFATE - REYATAZ
 N 206352 001   5849911            Jun 20, 2017       DS DP U-167                          NP           Jun 02, 2017
                6087383            Dec 21, 2018       DS DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 22 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT       DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES      REQUESTED           CODE(S)           DATE
	
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 001   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 002   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 003   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 004   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 005   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 006   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 007   5658590          Nov 26, 2016                 U-494
ATOMOXETINE HYDROCHLORIDE - STRATTERA
 N 021411 008   5658590          Nov 26, 2016                 U-494
ATORVASTATIN CALCIUM - LIPITOR
 N 020702 001   5686104            Nov 11, 2014            DP U-213
                5969156            Jul 08, 2016       DS
ATORVASTATIN CALCIUM - LIPITOR
 N 020702 002   5686104            Nov 11, 2014            DP U-213
                5969156            Jul 08, 2016       DS
ATORVASTATIN CALCIUM - LIPITOR
 N 020702 003   5686104            Nov 11, 2014            DP U-213
                5969156            Jul 08, 2016       DS
ATORVASTATIN CALCIUM - LIPITOR
 N 020702 004   5686104            Nov 11, 2014            DP U-213
                5969156            Jul 08, 2016       DS
ATORVASTATIN CALCIUM; EZETIMIBE - LIPTRUZET
 N 200153 001   5686104          Nov 11, 2014              DP U-1400                       NC           May 03, 2016
                5686104*PED      May 11, 2015
                5969156          Jul 08, 2016         DS
                5969156*PED      Jan 08, 2017
                RE42461          Oct 25, 2016         DS DP U-1400
                RE42461*PED      Apr 25, 2017
ATORVASTATIN CALCIUM; EZETIMIBE - LIPTRUZET
 N 200153 002   5686104          Nov 11, 2014              DP U-1400                       NC           May 03, 2016
                5686104*PED      May 11, 2015
                5969156          Jul 08, 2016         DS
                5969156*PED      Jan 08, 2017
                RE42461          Oct 25, 2016         DS DP U-1400
                RE42461*PED      Apr 25, 2017
ATORVASTATIN CALCIUM; EZETIMIBE - LIPTRUZET
 N 200153 003   5686104          Nov 11, 2014              DP U-1400                       NC           May 03, 2016
                5686104*PED      May 11, 2015
                5969156          Jul 08, 2016         DS
                5969156*PED      Jan 08, 2017
                RE42461          Oct 25, 2016         DS DP U-1400
                RE42461*PED      Apr 25, 2017
ATORVASTATIN CALCIUM; EZETIMIBE - LIPTRUZET
 N 200153 004   5686104          Nov 11, 2014              DP U-1400                       NC           May 03, 2016
                5686104*PED      May 11, 2015
                5969156          Jul 08, 2016         DS
                5969156*PED      Jan 08, 2017
                RE42461          Oct 25, 2016         DS DP U-1400
                RE42461*PED      Apr 25, 2017
ATOVAQUONE - MEPRON
 N 020500 001   6649659            Jul 10, 2016       DS DP U-69
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 23 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                               PATENT                        EXCLUSIVITY
     NO          PATENT NO          EXPIRATION             PATENT          DELIST        EXCLUSIVITY      EXPIRATION
                                       DATE                CODES         REQUESTED         CODE(S)           DATE
AVANAFIL - STENDRA
 N 202276 001   6656935            Sep 13, 2020       DS DP U-155                          D-140        Sep 17, 2017
                7501409            May 05, 2023          DP                                NCE          Apr 27, 2017
AVANAFIL - STENDRA
 N 202276 002   6656935            Sep 13, 2020       DS DP U-155                          D-140        Sep 17, 2017
                7501409            May 05, 2023          DP                                NCE          Apr 27, 2017
AVANAFIL - STENDRA
 N 202276 003   6656935            Sep 13, 2020       DS DP U-155                          D-140        Sep 17, 2017
                7501409            May 05, 2023          DP                                NCE          Apr 27, 2017
AXITINIB - INLYTA
 N 202324 001   6534524            Jun 30, 2020       DS DP                                NCE          Jan 27, 2017
                7141581            Jun 30, 2020                 U-1220
                8791140            Aug 05, 2030       DS
AXITINIB - INLYTA
 N 202324 002   6534524            Jun 30, 2020       DS DP                                NCE          Jan 27, 2017
                7141581            Jun 30, 2020                 U-1220
                8791140            Aug 05, 2030       DS
AZELAIC ACID - FINACEA
 N 021470 001   6534070            Nov 18, 2018
AZELASTINE HYDROCHLORIDE - ASTEPRO
 N 022203 001   8071073          Jun 04, 2028              DP                              M-129        Aug 30, 2016
                8518919          Nov 22, 2025                   U-1430                     NPP          Aug 30, 2016
AZELASTINE HYDROCHLORIDE - ASTEPRO
 N 022371 001   8071073          Jun 04, 2028              DP
                8518919          Nov 22, 2025                   U-1430
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE - DYMISTA
 N 202236 001   8163723          Aug 29, 2023           U-77                               NC           May 01, 2015
                8163723          Aug 29, 2023           U-81
                8163723          Aug 29, 2023           U-644
                8163723          Aug 29, 2023           U-707
                8168620          Feb 24, 2026       DP
AZILSARTAN KAMEDOXOMIL - EDARBI
 N 200796 001   7157584            May 22, 2025       DS                                   NCE          Feb 25, 2016
                7572920            Jan 07, 2025            DP U-3
AZILSARTAN KAMEDOXOMIL - EDARBI
 N 200796 002   7157584            May 22, 2025       DS                                   NCE          Feb 25, 2016
                7572920            Jan 07, 2025            DP U-3
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE - EDARBYCLOR
 N 202331 001   7157584          May 22, 2025    DS                                        NC           Dec 20, 2014
                7572920          Jan 07, 2025       DP U-3                                 NCE          Feb 25, 2016
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE - EDARBYCLOR
 N 202331 002   7157584          May 22, 2025    DS                                        NC           Dec 20, 2014
                7572920          Jan 07, 2025       DP U-3                                 NCE          Feb 25, 2016
AZITHROMYCIN - ZITHROMAX
 N 050693 001   6268489            Jul 31, 2018       DS
AZITHROMYCIN - ZITHROMAX
 N 050710 001   6268489            Jul 31, 2018       DS
AZITHROMYCIN - ZITHROMAX
 N 050710 002   6268489            Jul 31, 2018       DS
AZITHROMYCIN - ZITHROMAX
 N 050711 001   6268489            Jul 31, 2018       DS
AZITHROMYCIN - ZITHROMAX
 N 050730 001   6268489            Jul 31, 2018       DS
AZITHROMYCIN - ZITHROMAX
 N 050733 001   6268489            Jul 31, 2018       DS
AZITHROMYCIN - ZITHROMAX
 N 050784 001   6268489            Jul 31, 2018       DS
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 24 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT        DELIST          EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES       REQUESTED          CODE(S)           DATE
	
AZITHROMYCIN - ZMAX
 N 050797 001   6068859            May   30,   2017        DP
                6268489            Jul   31,   2018   DS
                6984403            Feb   14,   2024        DP U-282
                7887844            Feb   14,   2024        DP
AZITHROMYCIN - AZASITE
 N 050810 001   6159458            Nov   04,   2017        DP U-709
                6239113            Mar   31,   2019           U-709
                6569443            Mar   31,   2019        DP U-709
                6861411            Nov   25,   2018           U-709
                7056893            Mar   31,   2019        DP U-709
AZTREONAM - CAYSTON
 N 050814 001   7208141            Dec   20,   2021        DP U-1031                       ODE          Feb 22, 2017
                7214364            Dec   20,   2021        DP
                7427633            Dec   20,   2021        DP U-1031
                8399496            Dec   20,   2021        DP U-1377
BACLOFEN - KEMSTRO
 N 021589 001   6024981            Apr 09, 2018            DP
                6221392            Apr 09, 2018            DP
BACLOFEN - KEMSTRO
 N 021589 002   6024981            Apr 09, 2018            DP
                6221392            Apr 09, 2018            DP
BALSALAZIDE DISODIUM - COLAZAL
 N 020610 001   7452872            Aug 24, 2026                 U-141
                7625884            Aug 24, 2026                 U-141
BALSALAZIDE DISODIUM - GIAZO
 N 022205 001   6197341            Mar   13,   2018        DP U-1229                       NDF          Feb 03, 2015
                7452872            Aug   24,   2026           U-1229
                7625884            Aug   24,   2026           U-1229
                8497256            Jun   23,   2031           U-1229
BAZEDOXIFENE ACETATE; ESTROGENS,   CONJUGATED - DUAVEE
 N 022247 001   5998402            Apr 04, 2017    DS DP U-594                             NP           Oct 03, 2016
                6479535            May 06, 2019        DP U-594
                6479535            May 06, 2019        DP U-904
                7138392            Apr 04, 2017    DS DP U-594
                7683051            Mar 10, 2027    DS DP U-594
                7683051            Mar 10, 2027    DS DP U-904
                8815934            May 06, 2019        DP
BECLOMETHASONE DIPROPIONATE - QVAR 80
 N 020911 001   5683677          Nov 04, 2014              DP
                5776432          Jul 07, 2015              DP U-645
                6446627          Dec 18, 2017              DP
BECLOMETHASONE DIPROPIONATE - QVAR 40
 N 020911 002   5683677          Nov 04, 2014              DP
                5776432          Jul 07, 2015              DP U-645
                6446627          Dec 18, 2017              DP
BECLOMETHASONE DIPROPIONATE - QNASL
 N 202813 001   5683677          Nov 04, 2014              DP                              NP           Mar 23, 2015
                5776432          Jul 07, 2015              DP
                7780038          Jan 24, 2027              DP
BECLOMETHASONE DIPROPIONATE - QNASL
 N 202813 002   5776432          Jul 07, 2015              DP                              NP           Mar 23, 2015
                7780038          Jan 24, 2027              DP                              NS           Dec 17, 2017
BEDAQUILINE FUMARATE - SIRTURO
 N 204384 001   7498343            Oct 02, 2024       DS DP U-1321                         NCE          Dec 28, 2017
                8546428            Mar 19, 2029       DS DP U-1321                         ODE          Dec 28, 2019
BELINOSTAT - BELEODAQ
 N 206256 001   6888027            Sep 27, 2021       DS DP U-1544                         NCE          Jul 03, 2019
                8835501            Oct 27, 2027          DP                                ODE          Jul 03, 2021
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 25 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT
	                                  PATENT
	                    EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION
	           PATENT               DELIST
	    EXCLUSIVITY      EXPIRATION
	
                                     DATE
	               CODES             REQUESTED
	     CODE(S)           DATE
	
BENDAMUSTINE HYDROCHLORIDE - TREANDA
	
 N 022249 001		 8436190          Oct 26,     2030
	          DP
	                           ODE          Mar   20,   2015
	
                8436190*PED      Apr 26,     2031
                                          ODE          Oct   31,   2015
	
                8445524          Mar 26,     2029
	   DS DP U-1402
	                        PED          Sep   20,   2015

                8445524*PED      Sep 26,     2029
                                          PED          May   01,   2016
	
                8609863          Jan 12,     2026
	          DP
	
                8609863*PED      Jul 12,     2026
	
                8669279          Mar 26,     2029
	          DP U-1402
	
                8669279*PED      Sep 26,     2029

                8791270          Jan 12,     2026
	          DP U-1542
	
                8791270*PED      Jul 12,     2026
	
                8883836          Mar 26,     2029
	          DP U-1402
	
                8883836*PED      Sep 26,     2029

                8895756          Jan 12,     2026
	          DP
	
                8895756*PED      Jul 12,     2026
	
BENDAMUSTINE HYDROCHLORIDE - TREANDA
	
 N 022249 002		 8436190          Oct 26,     2030
	          DP
	                           ODE          Mar   20,   2015
	
                8436190*PED      Apr 26,     2031
                                          ODE          Oct   31,   2015
	
                8445524          Mar 26,     2029
	   DS DP U-1402
	                        PED          Sep   20,   2015

                8445524*PED      Sep 26,     2029
                                          PED          May   01,   2016
	
                8609863          Jan 12,     2026
	          DP
	
                8609863*PED      Jul 12,     2026
	
                8669279          Mar 26,     2029
	          DP U-1402
	
                8669279*PED      Sep 26,     2029

                8791270          Jan 12,     2026
	          DP U-1542
	
                8791270*PED      Jul 12,     2026
	
                8883836          Mar 26,     2029
	          DP U-1402
	
                8883836*PED      Sep 26,     2029

                8895756          Jan 12,     2026
	          DP
	
                8895756*PED      Jul 12,     2026
	
BENDAMUSTINE HYDROCHLORIDE - TREANDA
	
 N 022249 003		 8344006          Sep 23,     2029
           DP U-1402
	                    ODE          Mar   20,   2015
	
                8344006*PED      Mar 23,     2030
	                                         ODE          Oct   31,   2015
	
                8445524          Mar 26,     2029
	   DS
	                                  PED          Sep   20,   2015

                8445524*PED      Sep 26,     2029
                                          PED          May   01,   2016
	
                8791270          Jan 12,     2026
	          DP U-1542
	
                8791270*PED      Jul 12,     2026
	
BENDAMUSTINE HYDROCHLORIDE - TREANDA
	
 N 022249 004		 8344006          Sep 23,     2029
           DP U-1402
	                    ODE          Mar   20,   2015
	
                8344006*PED      Mar 23,     2030
	                                         ODE          Oct   31,   2015
	
                8445524          Mar 26,     2029
	   DS
	                                  PED          Sep   20,   2015

                8445524*PED      Sep 26,     2029
                                          PED          May   01,   2016
	
                8791270          Jan 12,     2026
	          DP U-1542
	
                8791270*PED      Jul 12,     2026
	
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - ACANYA
	
 N 050819 001		 5733886          Mar 31, 2015
	              DP U-124
	
                5733886          Mar 31, 2015
	              DP
	
                8288434          Aug 05, 2029
               DP U-124
	
                8663699          Jun 03, 2029
	                   U-124
	
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - ONEXTON
	
 N 050819 002		 5733886          Mar 31, 2015
	              DP
	
                8288434          Aug 05, 2029
               DP U-124
	
                8288434          Aug 05, 2029
               DP U-134
	
                8288434          Aug 05, 2029
               DP U-818
	
                8288434          Aug 05, 2029
               DP U-916
	
                8288434          Aug 05, 2029
               DP U-921
	
                8288434          Aug 05, 2029
	              DP U-1033
	
BENZYL ALCOHOL - ULESFIA
	
 N 022129 001		 5858383          Aug   11,   2017
              U-970
	
                6139859          Aug   11,   2017
              U-970
	
                6793931          Jul   11,   2022
	          DP U-970
	
                7294342          May   19,   2024
	             U-970
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 26 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                 PATENT                      EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT              DELIST      EXCLUSIVITY      EXPIRATION
	
                                        DATE               CODES             REQUESTED      CODE(S)           DATE
	
BEPOTASTINE BESILATE - BEPREVE
	
 N 022288 001   6780877             Sep 19, 2019       DS DP                                NCE          Sep 08, 2014

                8784789             Sep 05, 2024          DP
	
                8877168             Jul 30, 2023          DP
	
BESIFLOXACIN HYDROCHLORIDE - BESIVANCE
	
 N 022308 001   5447926          Apr 13,        2016   DS DP U-80
	
                6685958          Jun 29,        2021        DP U-80
	
                6699492          Mar 31,        2019        DP U-80
	
                8415342          Nov 07,        2030             U-80
	
                8481526          Jan 09,        2031   DS
	
                8604020          Mar 12,        2030        DP
	
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE - CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
	
 A 201615 001                                                                    PC          Sep 27, 2014
	
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE -       TACLONEX
	
 N 021852 001   5763426          Jun 09, 2015    DS       DP                                NPP          Dec 23, 2017
	
                6753013          Jan 27, 2020             DP U-88
	
                6753013          Jan 27, 2020             DP U-193
	
                RE39706          Jun 09, 2015    DS       DP
	
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE -       TACLONEX
	
 N 022185 001   6753013          Jan 27, 2020             DP U-88                           I-659        Oct 17, 2015
	
                6753013          Jan 27, 2020             DP U-193                          NPP          Aug 29, 2017

                6787529          Jan 27, 2020             DP U-88
	
                6787529          Jan 27, 2020             DP U-193
	
                RE39706          Jun 09, 2015    DS       DP
	
BETAMETHASONE VALERATE - LUXIQ
	
 N 020934 001   6126920             Mar 01, 2016                  U-484
	
                7078058             May 24, 2017           DP
	
BEXAROTENE - TARGRETIN
	
 N 021055 001   5780676             Jul 14, 2015                  U-509
	
                5962731             Oct 05, 2016                  U-475
	
BEXAROTENE - TARGRETIN
	
 N 021056 001   5780676             Jul 14, 2015                  U-510
	
                5962731             Oct 05, 2016
	
BIMATOPROST - LUMIGAN
	
 N 021275 001   5688819             Aug 19, 2014                  U-446
	
BIMATOPROST - LUMIGAN
	
 N 022184 001   5688819             Aug   19,   2014              U-1081
	
                7851504             Jun   13,   2027   DS DP
	
                8278353             Mar   16,   2025      DP
	
                8299118             Mar   16,   2025          U-1295
	
                8309605             Mar   16,   2025          U-1293
	
                8309605             Mar   16,   2025          U-1294
	
                8338479             Mar   16,   2025       DP U-1295
	
                8524777             Mar   16,   2025          U-1235
	
                8586630             Mar   16,   2025          U-1458
	
                8772338             Mar   16,   2025       DP U-1528
	
BIMATOPROST - LATISSE
	
 N 022369 001   7351404             May   25,   2024         U-939                          M-140        Sep 04, 2017

                7388029             Jan   21,   2022         U-938
	
                8038988             Aug   25,   2023   DS DP U-1208
	
                8101161             May   25,   2024         U-1217
	
                8101161             May   25,   2024         U-1218
	
                8263054             Jan   15,   2023         U-1277
	
                8541466             Jan   21,   2022         U-1217
	
                8632760             Jan   15,   2023         U-1487
	
                8758733             Jan   15,   2023         U-1487
	
                8906962             Jan   31,   2021         U-1217
	
                8926953             Jan   15,   2023         U-1217
	
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - HALFLYTELY
	
 N 021551 003   7291324          Oct 22, 2022           U-837
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 27 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                       PATENT                                EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION      PATENT         DELIST                EXCLUSIVITY      EXPIRATION
	
                                       DATE          CODES       REQUESTED                 CODE(S)           DATE
	
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE - PYLERA
 N 050786 001   6350468          Dec 14, 2018           U-932
                6350468          Dec 14, 2018           U-956
BIVALIRUDIN - ANGIOMAX
 N 020873 001   5196404            Dec   15,   2014   DS DP U-1040
                5196404            Dec   15,   2014   DS DP U-1232
                7582727            Jul   27,   2028      DP
                7598343            Jul   27,   2028      DP
BOCEPREVIR - VICTRELIS
 N 202258 001   7772178            Nov 11, 2027          DP U-1128                         M-126        Feb 27, 2016
                8119602            Mar 17, 2027             U-1233                         NCE          May 13, 2016
                RE43298            Feb 22, 2022       DS DP U-1128                         NPP          Feb 13, 2016
BORTEZOMIB - VELCADE
 N 021602 001   5780454            May   03,   2017   DS DP                                D-141        Oct   08,   2017
                6083903            Oct   28,   2014      DP U-515                          D-142        Oct   08,   2017
                6297217            Oct   28,   2014         U-515                          I-695        Oct   08,   2017
                6297217            Oct   28,   2014         U-884                          M-139        Aug   08,   2017
                6297217            Oct   28,   2014         U-885                          NR           Jan   23,   2015
                6617317            Oct   28,   2014   DS DP                                ODE          Jun   20,   2015
                6713446            Jan   25,   2022   DS DP                                ODE          Oct   08,   2021
                6747150            Oct   28,   2014      DP
                6958319            Jan   25,   2022   DS DP
                7119080            Oct   28,   2014      DP
BOSENTAN - TRACLEER
 N 021290 001   5292740            Nov 20, 2015
BOSENTAN - TRACLEER
 N 021290 002   5292740            Nov 20, 2015
BOSUTINIB MONOHYDRATE - BOSULIF
 N 203341 001   6002008            Mar   27,   2018   DS DP U-1284                         NCE          Sep 04, 2017
                7417148            Jan   23,   2026         U-1283                         ODE          Sep 04, 2019
                7767678            Nov   23,   2026   DS DP
                7919625            Dec   11,   2025      DP
                RE42376            Sep   24,   2019   DS
BOSUTINIB MONOHYDRATE - BOSULIF
 N 203341 002   6002008            Mar   27,   2018   DS DP U-1284                         NCE          Sep 04, 2017
                7417148            Jan   23,   2026         U-1283                         ODE          Sep 04, 2019
                7767678            Nov   23,   2026   DS DP
                7919625            Dec   11,   2025      DP
                RE42376            Sep   24,   2019   DS
BRIMONIDINE TARTRATE - ALPHAGAN P
 N 021262 001   6562873          Jul     10,   2021
                6627210          Jul     18,   2021      DP
                6641834          Jul     28,   2021      DP
                6673337          Jul     26,   2021      DP
BRIMONIDINE TARTRATE - QOLIANA
 N 021764 001   7265117            Aug 19, 2025          DP
BRIMONIDINE TARTRATE - ALPHAGAN P
 N 021770 001   6562873          Jul     10,   2021      DP
                6627210          Jul     18,   2021      DP
                6641834          Jul     28,   2021      DP
                6673337          Jul     26,   2021      DP
                8858961          Sep     02,   2023      DP
                8858961*PED      Mar     02,   2024
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 28 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT                       EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY      EXPIRATION
	
                                        DATE               CODES            REQUESTED       CODE(S)           DATE
	
BRIMONIDINE TARTRATE - MIRVASO
	
 N 204708 001		 7439241             Aug   25,   2025           U-1428                       NDF          Aug 23, 2016

                8053427             Jun   13,   2031      DP U-1428
	
                8163725             Jun   13,   2031      DP
	
                8231885             May   24,   2025      DP
	
                8410102             May   24,   2025           U-1428
	
                8426410             May   24,   2025           U-1428
	
                8513247             Mar   25,   2031      DP U-1428
	
                8513249             Mar   25,   2031      DP U-1428
	
                8859551             May   25,   2024           U-1428
	
BRIMONIDINE TARTRATE; BRINZOLAMIDE - SIMBRINZA
	
 N 204251 001		 6316441          Dec 07, 2019                    U-778                      NC           Apr 19, 2016
	
BRIMONIDINE TARTRATE; TIMOLOL MALEATE - COMBIGAN
	
 N 021398 001		 7030149          Apr 19, 2022            U-849
	
                7320976          Apr 19, 2022            U-849
	
                7323463          Jan 19, 2023         DP                          Y
	
                7642258          Apr 19, 2022      DS DP U-1024
	
                8133890          Apr 19, 2022            U-1235
	
                8354409          Apr 19, 2022         DP U-1371
	
                8748425          Apr 19, 2022         DP U-1524
	
BROMFENAC SODIUM - PROLENSA
	
 N 203168 001		 8129431             Sep   11,   2025   DS DP                                NP           Apr 05, 2016

                8669290             Jan   16,   2024      DP
	
                8754131             Jan   16,   2024      DP
	
                8871813             Jan   16,   2024      DP
	
                8927606             Jan   16,   2024             U-100
	
                8927606             Jan   16,   2024             U-810
	
                8927606             Jan   16,   2024             U-1095
	
BROMOCRIPTINE MESYLATE - CYCLOSET
	
 N 020866 001		 5679685          Oct      21,   2014      DP
	
                5716957          Feb      10,   2015         U-976
	
                7888310          Jul      25,   2023         U-1433
	
                8137992          Jul      25,   2023         U-1433
	
                8137993          Jul      25,   2023         U-1433
	
                8137994          Jul      25,   2023         U-1433
	
                8431155          Apr      30,   2032      DP U-976
	
                8613947          Apr      30,   2032      DP U-976
	
BUDESONIDE - RHINOCORT
	
 N 020746 001		 6291445             Apr 29, 2017                                  Y
	
                6686346             Apr 29, 2017          DP U-557                Y
	
                6986904             Apr 29, 2017          DP U-699                Y
	
BUDESONIDE - RHINOCORT
	
 N 020746 002		 6291445             Apr 29, 2017

                6686346             Apr 29, 2017          DP U-557
	
                6986904             Apr 29, 2017          DP U-699
	
BUDESONIDE - PULMICORT RESPULES
	
 N 020929 001		 6598603           Dec 23, 2018               U-529
	
                6899099           Dec 23, 2018               U-529
	
                7524834           Nov 11, 2018            DP U-966
	
BUDESONIDE - PULMICORT RESPULES
	
 N 020929 002		 6598603           Dec 23, 2018               U-529
	
                6899099           Dec 23, 2018               U-529
	
                7524834           Nov 11, 2018            DP U-966
	
BUDESONIDE - PULMICORT RESPULES
	
 N 020929 003		 6598603           Dec 23, 2018               U-529
	
                6899099           Dec 23, 2018               U-529
	
                7524834           Nov 11, 2018            DP U-966
	
BUDESONIDE - ENTOCORT EC
	
 N 021324 001		 5643602             Jul 01, 2014                 U-655
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 29 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                             PATENT                          EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
                                          DATE               CODES        REQUESTED           CODE(S)           DATE
BUDESONIDE - PULMICORT FLEXHALER
 N 021949    001   6027714            Jan   09,   2018      DP U-787
                   6142145            May   08,   2018      DP
                   6287540            Jan   09,   2018      DP
                   7143764            Mar   13,   2018      DP
BUDESONIDE - PULMICORT FLEXHALER
 N 021949 002   6027714               Jan   09,   2018      DP U-787
                6142145               May   08,   2018      DP
                6287540               Jan   09,   2018      DP
                7143764               Mar   13,   2018      DP
BUDESONIDE - UCERIS
 N 203634 001   7410651               Jun   09,   2020      DP U-1325                         NDF          Jan 14, 2016
                7431943               Jun   09,   2020      DP
                8293273               Jun   09,   2020      DP
                8784888               Jun   09,   2020      DP
                8895064               Sep   07,   2031      DP
                RE43799               Jun   09,   2020      DP U-1325
BUDESONIDE - UCERIS
 N 205613 001                                                                                 NP           Oct 07, 2017
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT
 N 021929 001   5674860          Oct 07, 2014       DP          U-1075
                6123924          Sep 26, 2017       DP
                7367333          Nov 11, 2018       DP
                7587988          Apr 10, 2026       DP
                7759328          Jan 29, 2023       DP          U-1073
                7967011          Aug 11, 2021       DP
                8143239          Jan 29, 2023       DP          U-1073
                8387615          Nov 10, 2024       DP
                8528545          Oct 16, 2028       DP
                8575137          Jan 29, 2023       DP          U-1073
                8616196          Apr 07, 2029       DP
                8875699          Nov 10, 2024       DP
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT
 N 021929 002   5674860          Oct 07, 2014       DP          U-1075
                6123924          Sep 26, 2017       DP
                7367333          Nov 11, 2018       DP
                7587988          Apr 10, 2026       DP
                7759328          Jan 29, 2023       DP          U-1073
                7897646          Sep 09, 2018                   U-1118
                7967011          Aug 11, 2021       DP
                8143239          Jan 29, 2023       DP          U-1073
                8387615          Nov 10, 2024       DP
                8461211          Sep 09, 2018                   U-1118
                8528545          Oct 16, 2028       DP
                8575137          Jan 29, 2023       DP          U-1073
                8616196          Apr 07, 2029       DP
                8875699          Nov 10, 2024       DP
BUPIVACAINE - EXPAREL
 N 022496 001   8182835               Sep 18, 2018          DP U-1246                         NP           Oct 28, 2014
                8834921               Sep 18, 2018          DP U-1587
BUPIVACAINE - EXPAREL
 N 022496 002   8182835               Sep 18, 2018          DP U-1246                         NP           Oct 28, 2014
                8834921               Sep 18, 2018          DP U-1587
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 30 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                                PATENT                       EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT             DELIST       EXCLUSIVITY      EXPIRATION
	
                                     DATE               CODES            REQUESTED       CODE(S)           DATE
	
BUPRENORPHINE - BUTRANS
	
 N 021306 001   6264980          Dec   18,   2015      DP
	
                6344211          Dec   18,   2015             U-1072
	
                6344211          Dec   18,   2015             U-1556
	
                RE41408          Sep   29,   2017             U-1072
	
                RE41408          Sep   29,   2017             U-1556
	
                RE41489          Sep   29,   2017             U-1072
	
                RE41489          Sep   29,   2017             U-1556
	
                RE41571          Sep   29,   2017             U-1072
	
                RE41571          Sep   29,   2017             U-1556
	
BUPRENORPHINE - BUTRANS
	
 N 021306 002   6264980          Dec   18,   2015      DP
	
                6344211          Dec   18,   2015             U-1072
	
                6344211          Dec   18,   2015             U-1556
	
                RE41408          Sep   29,   2017             U-1072
	
                RE41408          Sep   29,   2017             U-1556
	
                RE41489          Sep   29,   2017             U-1072
	
                RE41489          Sep   29,   2017             U-1556
	
                RE41571          Sep   29,   2017             U-1072
	
                RE41571          Sep   29,   2017             U-1556
	
BUPRENORPHINE - BUTRANS
	
 N 021306 003   6264980          Dec   18,   2015      DP
	
                6344211          Dec   18,   2015             U-1072
	
                6344211          Dec   18,   2015             U-1556
	
                RE41408          Sep   29,   2017             U-1072
	
                RE41408          Sep   29,   2017             U-1556
	
                RE41489          Sep   29,   2017             U-1072
	
                RE41489          Sep   29,   2017             U-1556
	
                RE41571          Sep   29,   2017             U-1072
	
                RE41571          Sep   29,   2017             U-1556
	
BUPRENORPHINE - BUTRANS
	
 N 021306 004   6264980          Dec   18,   2015      DP
	
                6344211          Dec   18,   2015             U-1072
	
                6344211          Dec   18,   2015             U-1556
	
                RE41408          Sep   29,   2017             U-1072
	
                RE41408          Sep   29,   2017             U-1556
	
                RE41489          Sep   29,   2017             U-1072
	
                RE41489          Sep   29,   2017             U-1556
	
                RE41571          Sep   29,   2017             U-1072
	
                RE41571          Sep   29,   2017             U-1556
	
BUPRENORPHINE - BUTRANS
	
 N 021306 005   6264980          Dec   18,   2015      DP
	
                6344211          Dec   18,   2015             U-1072
	
                6344211          Dec   18,   2015             U-1556
	
                RE41408          Sep   29,   2017             U-1072
	
                RE41408          Sep   29,   2017             U-1556
	
                RE41489          Sep   29,   2017             U-1072
	
                RE41489          Sep   29,   2017             U-1556
	
                RE41571          Sep   29,   2017             U-1072
	
                RE41571          Sep   29,   2017             U-1556
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 31 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION        PATENT              DELIST         EXCLUSIVITY      EXPIRATION
	
                                     DATE            CODES             REQUESTED         CODE(S)           DATE
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - SUBOXONE
	
 N 022410 001   8017150          Feb 13, 2023       DP
	
                8475832          Mar 26, 2030       DP U-1411
	
                8603514          Apr 03, 2024       DP U-1464
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE    - SUBOXONE
	
 N 022410 002   8017150          Feb 13, 2023          DP
	
                8475832          Mar 26, 2030          DP U-1411
	
                8603514          Apr 03, 2024          DP
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE    - SUBOXONE
	
 N 022410 003   8017150          Feb 13, 2023          DP
	
                8475832          Mar 26, 2030          DP U-1411
	
                8603514          Apr 03, 2024          DP
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE    - SUBOXONE
	
 N 022410 004   8017150          Feb 13, 2023          DP
	
                8475832          Mar 26, 2030          DP U-1411
	
                8603514          Apr 03, 2024          DP
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - ZUBSOLV
	
 N 204242 001   8454996          Sep 24, 2019           U-1421
	
                8470361          Oct 14, 2029       DP U-1425
	
                8658198          Dec 03, 2027       DP U-1494
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - ZUBSOLV
	
 N 204242 002   8454996          Sep 24, 2019           U-1421
	
                8470361          Oct 14, 2029       DP U-1425
	
                8658198          Dec 03, 2027       DP U-1494
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - ZUBSOLV
	
 N 204242 003   8454996          Sep 24, 2019           U-1421
	
                8470361          Oct 14, 2029       DP U-1425
	
                8658198          Dec 03, 2027       DP U-1494
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE - ZUBSOLV
	
 N 204242 004   8454996          Sep 24, 2019           U-1421
	
                8470361          Oct 14, 2029       DP U-1425
	
                8658198          Dec 03, 2027       DP U-1494
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE    - BUNAVAIL
	
 N 205637 001   6159498          Oct 18, 2016          DP                                NP           Jun 06, 2017
	
                7579019          Jan 22, 2020               U-1521
	
                8147866          Jul 23, 2027          DP U-1521
	
                8703177          Aug 20, 2032          DP
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE    - BUNAVAIL
	
 N 205637 002   6159498          Oct 18, 2016          DP                                NP           Jun 06, 2017
	
                7579019          Jan 22, 2020               U-1521
	
                8147866          Jul 23, 2027          DP U-1521
	
                8703177          Aug 20, 2032          DP
	
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE    - BUNAVAIL
	
 N 205637 003   6159498          Oct 18, 2016          DP                                NP           Jun 06, 2017
	
                7579019          Jan 22, 2020               U-1521
	
                8147866          Jul 23, 2027          DP U-1521
	
                8703177          Aug 20, 2032          DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 32 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
	
BUPROPION HYDROBROMIDE - APLENZIN
 N 022108 001   7241805          Jun     27,   2026        DP
                7569610          Jun     27,   2026             U-997
                7572935          Jun     27,   2026        DP
                7585897          Jun     27,   2026        DP
                7645802          Jun     27,   2026        DP
                7649019          Jun     27,   2026        DP
                7662407          Jun     27,   2026        DP
                7671094          Jun     27,   2026        DP
BUPROPION HYDROBROMIDE - APLENZIN
 N 022108 002   7241805          Jun     27,   2026        DP
                7569610          Jun     27,   2026             U-997
                7572935          Jun     27,   2026        DP
                7585897          Jun     27,   2026        DP
                7645802          Jun     27,   2026        DP
                7649019          Jun     27,   2026        DP
                7662407          Jun     27,   2026        DP
                7671094          Jun     27,   2026        DP
BUPROPION HYDROBROMIDE - APLENZIN
 N 022108 003   7241805          Jun     27,   2026        DP
                7569610          Jun     27,   2026             U-997
                7572935          Jun     27,   2026        DP
                7585897          Jun     27,   2026        DP
                7645802          Jun     27,   2026        DP
                7649019          Jun     27,   2026        DP
                7662407          Jun     27,   2026        DP
                7671094          Jun     27,   2026        DP
BUPROPION HYDROCHLORIDE - WELLBUTRIN XL
 N 021515 001   6096341          Oct 30, 2018
BUPROPION HYDROCHLORIDE - WELLBUTRIN XL
 N 021515 002   6096341          Oct 30, 2018
BUPROPION HYDROCHLORIDE - FORFIVO XL
 N 022497 001   7674479          Jun 25, 2027              DP
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE - CONTRAVE
 N 200063 001   7375111          Mar 26, 2025       DP                                     NC           Sep 10, 2017
                7462626          Jul 20, 2024           U-1583
                8088786          Feb 03, 2029       DP
                8318788          Nov 08, 2027           U-1584
                8722085          Nov 08, 2027           U-1585
                8815889          Jul 20, 2024           U-1586
BUTOCONAZOLE NITRATE - GYNAZOLE-1
 N 019881 001   5993856          Nov 17, 2017              DP U-457
CABAZITAXEL - JEVTANA KIT
 N 201023 001   5847170            Mar   26,   2021   DS DP                                NCE          Jun 17, 2015
                6331635            Mar   26,   2016   DS DP
                6372780            Mar   26,   2016             U-1067
                6387946            Mar   26,   2016             U-1067
                7241907            Dec   10,   2025   DS
                8927592            Oct   27,   2030             U-1630
CABOZANTINIB S-MALATE - COMETRIQ
 N 203756 001   7579473          Sep 24, 2024         DS DP                                NCE          Nov 29, 2017
                8877776          Oct 08, 2030         DS DP U-1617                         ODE          Nov 29, 2019
CABOZANTINIB S-MALATE - COMETRIQ
 N 203756 002   7579473          Sep 24, 2024         DS DP                                NCE          Nov 29, 2017
                8877776          Oct 08, 2030         DS DP U-1617                         ODE          Nov 29, 2019
CALCIPOTRIENE - DOVONEX
 N 020554 001   5763426            Jun 09, 2015       DS DP
                RE39706            Jun 09, 2015       DS DP
CALCIPOTRIENE - DOVONEX
 N 020611 001   5763426            Jun 09, 2015       DS DP
                RE39706            Jun 09, 2015       DS DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 33 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES         REQUESTED          CODE(S)           DATE
	
CALCIPOTRIENE - SORILUX
	
 N 022563 001   8263580            Sep 27, 2028          DP U-1280                         I-657        Sep 27, 2015

                8269128            May 26, 2026          DP U-1280
	
CALCITONIN SALMON - MIACALCIN
	
 N 020313 002   5733569            Mar 31, 2015              U-227
	
                5759565            Mar 31, 2015
	
CALCITONIN SALMON RECOMBINANT - FORTICAL
	
 N 021406 001   6440392          Feb 02, 2021            DP U-227
	
                RE40812          Feb 02, 2021            DP
	
                RE43580          Feb 02, 2021            DP U-227
	
CALCITRIOL - CALCIJEX
	
 N 018874 001   6051567            Aug 02, 2019

                6265392            Aug 02, 2019

                6274169            Aug 02, 2019
	
CALCITRIOL - CALCIJEX
	
 N 018874 002   6051567            Aug 02, 2019

                6265392            Aug 02, 2019

                6274169            Aug 02, 2019
	
CALCIUM ACETATE - PHOSLO
	
 N 021160 002   6576665            Apr 03, 2021
	
CALCIUM ACETATE - PHOSLO GELCAPS
	
 N 021160 003   6576665           Apr 03, 2021
	
CALCIUM ACETATE - PHOSLYRA
	
 N 022581 001   8591938            Feb 23, 2030          DP U-1469
	
                8592480            Jul 20, 2027             U-1469
	
CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE - PEPCID COMPLETE
	
 N 020958 001   5989588          Sep 30, 2015            U-349
	
                6814978          Aug 26, 2021       DP
	
CALCIUM CARBONATE; RISEDRONATE SODIUM - ACTONEL WITH CALCIUM (COPACKAGED)
	
 N 021823 001   5994329          Jul 17, 2018            U-353
	
                6015801          Jul 17, 2018            U-353
	
                6165513          Jun 10, 2018       DP
	
                6432932          Jul 17, 2018            U-595
	
                6465443          Aug 14, 2018       DP
	
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE;

SODIUM CHLORIDE; SODIUM PHOSPHATE - NAVSTEL
	
 N 022193 001   7084130          Nov 29, 2021       DP U-891
	
CANAGLIFLOZIN - INVOKANA
	
 N 204042 001   7943582            Feb   26,   2029   DS DP U-493                          NCE          Mar 29, 2018
	
                7943788            Jul   14,   2027   DS DP
	
                8222219            Jul   30,   2024           U-493
	
                8513202            Dec   03,   2027   DS DP U-493
	
CANAGLIFLOZIN - INVOKANA
	
 N 204042 002   7943582            Feb   26,   2029   DS DP U-493                          NCE          Mar 29, 2018
	
                7943788            Jul   14,   2027   DS DP
	
                8222219            Jul   30,   2024           U-493
	
                8513202            Dec   03,   2027   DS DP U-493
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 34 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                PATENT                       EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION            PATENT            DELIST       EXCLUSIVITY      EXPIRATION
	
                                       DATE                CODES           REQUESTED       CODE(S)           DATE
	
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE -    INVOKAMET
	
 N 204353 001   7943582          Feb 26,    2029    DS    DP U-493                         NC           Aug 08, 2017

                7943788          Jul 14,    2027    DS    DP                               NCE          Mar 29, 2018
	
                8222219          Jul 30,    2024               U-493
	
                8513202          Dec 03,    2027    DS    DP U-493
	
                8785403          Jul 30,    2024          DP
	
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE -    INVOKAMET
	
 N 204353 002   7943582          Feb 26,    2029    DS    DP U-493                         NC           Aug 08, 2017

                7943788          Jul 14,    2027    DS    DP                               NCE          Mar 29, 2018
	
                8222219          Jul 30,    2024               U-493
	
                8513202          Dec 03,    2027    DS    DP U-493
	
                8785403          Jul 30,    2024          DP
	
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE -    INVOKAMET
	
 N 204353 003   7943582          Feb 26,    2029    DS    DP U-493                         NC           Aug 08, 2017

                7943788          Jul 14,    2027    DS    DP                               NCE          Mar 29, 2018
	
                8222219          Jul 30,    2024               U-493
	
                8513202          Dec 03,    2027    DS    DP U-493
	
                8785403          Jul 30,    2024          DP
	
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE -    INVOKAMET
	
 N 204353 004   7943582          Feb 26,    2029    DS    DP U-493                         NC           Aug 08, 2017

                7943788          Jul 14,    2027    DS    DP                               NCE          Mar 29, 2018
	
                8222219          Jul 30,    2024               U-493
	
                8513202          Dec 03,    2027    DS    DP U-493
	
                8785403          Jul 30,    2024          DP
	
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT
	
 N 021093 001   5721263          Feb 24, 2015       DP U-3
	
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT
	
 N 021093 002   5721263          Feb 24, 2015       DP U-3
	
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT
	
 N 021093 003   5721263          Feb 24, 2015       DP U-3
	
CAPECITABINE - XELODA
	
 N 020896 001                                                                              M-131        Dec 10, 2016
	
                                                                                           PED          Jun 10, 2017
	
CAPECITABINE - XELODA
	
 N 020896 002                                                                              M-131        Dec 10, 2016
	
                                                                                           PED          Jun 10, 2017
	
CAPSAICIN - QUTENZA
	
 N 022395 001   6239180            Nov 06, 2016           DP                               NCE          Nov 16, 2014
	
                                                                                           ODE          Nov 16, 2016
	
CARBAMAZEPINE - CARBATROL
	
 N 020712 001   5912013            Jun 15, 2016                  U-277
	
CARBAMAZEPINE - CARBATROL
	
 N 020712 002   5912013            Jun 15, 2016                  U-277
	
CARBAMAZEPINE - CARBATROL
	
 N 020712 003   5912013            Jun 15, 2016                  U-277
	
CARBAMAZEPINE - EQUETRO
	
 N 021710 001   5912013            Jun 15, 2016           DP
	
                6977253            May 19, 2024                  U-693
	
CARBAMAZEPINE - EQUETRO
	
 N 021710 002   5912013            Jun 15, 2016           DP
	
                6977253            May 19, 2024                  U-693
	
CARBAMAZEPINE - EQUETRO
	
 N 021710 003   5912013            Jun 15, 2016           DP
	
                6977253            May 19, 2024                  U-693
	
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 50
	
 N 021485 001   6500867          Jun 29, 2020             DP U-219
	
                6797732          Jun 29, 2020             DP
	
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 100
	
 N 021485 002   6500867          Jun 29, 2020             DP U-219
	
                6797732          Jun 29, 2020             DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 35 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 150
 N 021485 003   6500867          Jun 29, 2020            DP U-219
                6797732          Jun 29, 2020            DP
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 200
 N 021485 004   6500867          Jun 29, 2020            DP U-219
                6797732          Jun 29, 2020            DP
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 75
 N 021485 005   6500867          Jun 29, 2020            DP U-219
                6797732          Jun 29, 2020            DP
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 125
 N 021485 006   6500867          Jun 29, 2020            DP U-219
                6797732          Jun 29, 2020            DP
CARBINOXAMINE MALEATE - KARBINAL ER
 N 022556 001   8062667          Mar 29, 2029            DP
CARFILZOMIB - KYPROLIS
 N 202714 001   7232818            Apr   14,   2025   DS DP                                NCE          Jul 20, 2017
                7417042            Jun   07,   2026   DS DP                                ODE          Jul 20, 2019
                7491704            Apr   14,   2025           U-1260
                7737112            Dec   07,   2027      DP
                8129346            Dec   25,   2026           U-1260
                8207125            Apr   14,   2025   DS DP
                8207126            Apr   14,   2025      DP
                8207127            Apr   14,   2025           U-1260
                8207297            Apr   14,   2025   DS DP
CARGLUMIC ACID - CARBAGLU
 N 022562 001                                                                              NCE          Mar 18, 2015
                                                                                           ODE          Mar 18, 2017
CARVEDILOL - COREG
 N 020297 001   RE40000            Jun 07, 2015               U-233
CARVEDILOL - COREG
 N 020297 002   RE40000            Jun 07, 2015               U-233
CARVEDILOL - COREG
 N 020297 003   RE40000            Jun 07, 2015               U-233
CARVEDILOL - COREG
 N 020297 004   RE40000            Jun 07, 2015               U-233
CARVEDILOL PHOSPHATE - COREG CR
 N 022012 001   6022562            Oct   17,   2015      DP                   Y
                7268156            Jun   27,   2023   DS DP U-3
                7268156            Jun   27,   2023   DS DP U-313
                8101209            Sep   11,   2025      DP
                RE40000            Jun   07,   2015         U-777
CARVEDILOL PHOSPHATE - COREG CR
 N 022012 002   6022562            Oct   17,   2015      DP                   Y
                7268156            Jun   27,   2023   DS DP U-3
                7268156            Jun   27,   2023   DS DP U-313
                8101209            Sep   11,   2025      DP
                RE40000            Jun   07,   2015         U-777
CARVEDILOL PHOSPHATE - COREG CR
 N 022012 003   6022562            Oct   17,   2015      DP                   Y
                7268156            Jun   27,   2023   DS DP U-3
                7268156            Jun   27,   2023   DS DP U-313
                8101209            Sep   11,   2025      DP
                RE40000            Jun   07,   2015         U-777
CARVEDILOL PHOSPHATE - COREG CR
 N 022012 004   6022562            Oct   17,   2015      DP                   Y
                7268156            Jun   27,   2023   DS DP U-3
                7268156            Jun   27,   2023   DS DP U-313
                8101209            Sep   11,   2025      DP
                RE40000            Jun   07,   2015         U-777
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 36 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                          PATENT                                PATENT                      EXCLUSIVITY
	
     NO         PATENT NO         EXPIRATION              PATENT          DELIST      EXCLUSIVITY      EXPIRATION
	
                                     DATE                  CODES         REQUESTED      CODE(S)           DATE
	
CASPOFUNGIN ACETATE - CANCIDAS
 N 021227 001   5514650           Jan 26, 2015             DP U-607
                5952300           Mar 28, 2017             DP
                6136783           Mar 28, 2017                U-607
CASPOFUNGIN ACETATE - CANCIDAS
 N 021227 002   5514650           Jan 26, 2015             DP U-607
                5952300           Mar 28, 2017             DP
                6136783           Mar 28, 2017                U-607
CEFDITOREN PIVOXIL - SPECTRACEF
 N 021222 001   5958915           Oct 14, 2016
CEFDITOREN PIVOXIL - SPECTRACEF
 N 021222 002   5958915           Oct 14, 2016             DP
CEFTAROLINE FOSAMIL - TEFLARO
 N 200327 001   6417175           Dec   17,   2018      DS DP U-282                     NCE          Oct 29, 2015
                6906055           Dec   15,   2021      DS DP
                7419973           Dec   15,   2021         DP
                8247400           Feb   10,   2031         DP U-282
CEFTAROLINE FOSAMIL - TEFLARO
 N 200327 002   6417175           Dec   17,   2018      DS DP U-282                     NCE          Oct 29, 2015
                6906055           Dec   15,   2021      DS DP
                7419973           Dec   15,   2021         DP
                8247400           Feb   10,   2031         DP U-282
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM -      ZERBAXA
 N 206829 001   7129232          Oct 21,      2024      DS DP U-36                      NCE          Dec 19, 2019
                8476425          Sep 27,      2032      DS                              GAIN         Dec 19, 2024
                8685957          Sep 27,      2032      DS    U-36
                8906898          May 28,      2034      DS DP
CELECOXIB - CELEBREX
 N 020998 001   5760068           Jun   02,   2015              U-672
                RE44048           Jun   02,   2015              U-247
                RE44048           Jun   02,   2015              U-1348
                RE44048           Jun   02,   2015              U-1349
                RE44048           Jun   02,   2015              U-1350
                RE44048           Jun   02,   2015              U-1351
                RE44048           Jun   02,   2015              U-1352
                RE44048*PED       Dec   02,   2015
CELECOXIB - CELEBREX
 N 020998 002   5760068           Jun   02,   2015              U-672
                RE44048           Jun   02,   2015              U-247
                RE44048           Jun   02,   2015              U-1348
                RE44048           Jun   02,   2015              U-1349
                RE44048           Jun   02,   2015              U-1350
                RE44048           Jun   02,   2015              U-1351
                RE44048           Jun   02,   2015              U-1352
                RE44048*PED       Dec   02,   2015
CELECOXIB - CELEBREX
 N 020998 003   5760068           Jun   02,   2015              U-672
                RE44048           Jun   02,   2015              U-247
                RE44048           Jun   02,   2015              U-1348
                RE44048           Jun   02,   2015              U-1349
                RE44048           Jun   02,   2015              U-1350
                RE44048           Jun   02,   2015              U-1351
                RE44048           Jun   02,   2015              U-1352
                RE44048*PED       Dec   02,   2015
CELECOXIB - CELEBREX
 N 020998 004   5760068           Jun   02,   2015              U-672
                RE44048           Jun   02,   2015              U-247
                RE44048           Jun   02,   2015              U-1348
                RE44048           Jun   02,   2015              U-1349
                RE44048           Jun   02,   2015              U-1350
                RE44048           Jun   02,   2015              U-1351
                RE44048           Jun   02,   2015              U-1352
                RE44048*PED       Dec   02,   2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 37 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
	
CERITINIB - ZYKADIA
 N 205755 001   7153964            Feb   26,   2021   DS   DP                              NCE          Apr 29, 2019
                7893074            Apr   25,   2026   DS   DP                              ODE          Apr 29, 2021
                7964592            Jan   13,   2027   DS   DP
                8039474            Jun   29,   2030   DS   DP
                8039479            Jun   29,   2030   DS   DP
                8377921            Nov   20,   2027             U-1179
                8703787            Feb   02,   2032             U-1179
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC ALLERGY
 N 021621 003   6455533          Jul 02, 2018        DP U-295
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC ALLERGY
 N 021621 004   6455533          Jul 02, 2018        DP U-295
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC HIVES RELIEF
 N 021621 005   6455533          Jul 02, 2018       DP U-295
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC HIVES RELIEF
 N 021621 006   6455533          Jul 02, 2018       DP U-295
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ZYRTEC-D 12 HOUR
 N 021150 002   6469009          Jul 13, 2019       DP U-295
                6489329          Apr 08, 2016       DP
                7014867          Jun 10, 2022       DP
                7226614          Jun 10, 2022           U-295
CETRORELIX - CETROTIDE
 N 021197 001   6319192            Apr 23, 2019                 U-426
CETRORELIX - CETROTIDE
 N 021197 002   6319192            Apr 23, 2019                 U-426
CHLORHEXIDINE GLUCONATE - CHLORHEXIDINE GLUCONATE
 N 021669 001   7066916          Feb 17, 2024                 U-737
                7427574          Apr 25, 2026              DP
                7595021          May 12, 2023              DP U-1022
                7717889          Feb 27, 2025              DP U-1022
                7935093          Oct 02, 2027              DP U-1022
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP
 N 020832 001   5690958          Sep 30, 2016       DP
                6536975          Nov 10, 2020       DP
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT
 N 020832 002   5690958          Sep 30, 2016       DP
                6729786          Mar 14, 2023       DP
                6991394          Jan 31, 2024       DP
                7182536          Dec 30, 2023       DP
                7241065          Mar 14, 2023       DP
                7422388          Apr 25, 2027       DP U-1397
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP FREPP
 N 020832 003   5538353          Aug 25, 2015       DP
                5690958          Sep 30, 2016       DP
                5772346          Apr 22, 2017       DP
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP
 N 020832 004   5690958          Sep 30, 2016       DP
                6536975          Nov 10, 2020       DP
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT
 N 020832 005   5690958          Sep 30, 2016       DP
                6536975          Nov 10, 2020       DP
                6729786          Mar 14, 2023       DP
                7241065          Mar 14, 2023       DP
                7422388          Apr 25, 2027       DP U-1397
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP
 N 020832 006   5690958          Sep 30, 2016       DP
                6991394          Jan 31, 2024       DP
                7182536          Dec 30, 2023       DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 38 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                        PATENT                               EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION      PATENT          DELIST               EXCLUSIVITY      EXPIRATION
	
                                       DATE          CODES       REQUESTED                 CODE(S)           DATE
	
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT
	
 N 020832 007   5690958          Sep 30, 2016       DP
	
                6536975          Nov 10, 2020       DP
	
                6729786          Mar 14, 2023       DP
	
                7241065          Mar 14, 2023       DP
	
                7422388          Apr 25, 2027       DP U-1397
	
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - PREVANTICS MAXI SWABSTICK
	
 N 021524 003   D468424          Jan 07, 2017
	
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP SEPP
	
 N 021555 001   5690958          Sep 30, 2016       DP
	
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE - ADVIL ALLERGY SINUS
	
 N 021441 001   7863287          Feb 28, 2027       DP
	
CHOLINE C-11 - CHOLINE C-11
	
 N 203155 001                                                                              NCE          Sep 12, 2017

                                                                                           W            Sep 12, 2017
	
CHOLINE FENOFIBRATE - TRILIPIX
	
 N 022224 001   7259186            Jan 07, 2025       DS
	
CHOLINE FENOFIBRATE - TRILIPIX
	
 N 022224 002   7259186            Jan 07, 2025       DS
	
CHORIOGONADOTROPIN ALFA - OVIDREL
	
 N 021149 001   5767251          Jun 16, 2015
	
CHORIOGONADOTROPIN ALFA - OVIDREL
	
 N 021149 002   5767251          Jun 16, 2015         DS
	
                6706681          Mar 16, 2021                DP
	
CICLESONIDE - ALVESCO
	
 N 021658 002   5482934            Oct   24,   2017   DS DP U-1002                         M-125        Dec 17, 2015
	
                5683677            Nov   04,   2014      DP
	
                5775321            Jul   07,   2015      DP
	
                6006745            Dec   28,   2016      DP
	
                6120752            May   13,   2018      DP
	
                6264923            May   13,   2018      DP
	
                8371292            Aug   25,   2027           U-1355
	
CICLESONIDE - ALVESCO
	
 N 021658 003   5482934            Oct   24,   2017   DS DP U-1002                         M-125        Dec 17, 2015
	
                5683677            Nov   04,   2014      DP
	
                5775321            Jul   07,   2015      DP
	
                6006745            Dec   28,   2016      DP
	
                6120752            May   13,   2018      DP
	
                6264923            May   13,   2018      DP
	
                8371292            Aug   25,   2027           U-1355
	
CICLESONIDE - OMNARIS
	
 N 022004 001   5482934            Oct   24,   2017   DS DP U-557
	
                6767901            Oct   21,   2020      DP
	
                6939559            Apr   21,   2019      DP
	
                7235247            Apr   21,   2019      DP
	
                8371292            Aug   25,   2027           U-1356
	
                8383611            Oct   20,   2020      DP
	
CICLESONIDE - ZETONNA
	
 N 202129 001   5482934            Oct   24,   2017   DS DP U-1002                         NP           Jan 20, 2015
	
                5683677            Nov   04,   2014      DP
	
                5775321            Jul   07,   2015      DP
	
                6006745            Dec   28,   2016      DP
	
                6120752            May   13,   2018      DP
	
                6264923            May   13,   2018      DP
	
                8371292            Aug   25,   2027           U-1357
	
CICLOPIROX - LOPROX
 N 020519 001   7018656            Sep 05, 2018              DP
                7026337            Nov 21, 2016                     U-714
CICLOPIROX - LOPROX
 N 021159 001   7981909            Sep 16, 2017                     U-1162
                8227490            Sep 16, 2017                     U-1256
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 39 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
CINACALCET HYDROCHLORIDE - SENSIPAR
 N 021688 001   6011068          Mar    08,   2018    DS DP                                ODE          Feb 25, 2018
                6031003          Dec    14,   2016          U-559                          ODE          Nov 21, 2021
                6211244          Oct    23,   2015    DS DP U-560
                6313146          Dec    14,   2016    DS DP
                7829595          Sep    22,   2026       DP U-1098
CINACALCET HYDROCHLORIDE - SENSIPAR
 N 021688 002   6011068          Mar    08,   2018    DS DP                                ODE          Feb 25, 2018
                6031003          Dec    14,   2016                                         ODE          Nov 21, 2021
                6211244          Oct    23,   2015    DS DP U-560
                6313146          Dec    14,   2016    DS DP
                7829595          Sep    22,   2026       DP U-1098
CINACALCET HYDROCHLORIDE - SENSIPAR
 N 021688 003   6011068          Mar    08,   2018    DS DP                                ODE          Feb 25, 2018
                6031003          Dec    14,   2016          U-559                          ODE          Nov 21, 2021
                6211244          Oct    23,   2015    DS DP U-560
                6313146          Dec    14,   2016    DS DP
                7829595          Sep    22,   2026       DP U-1098
CIPROFLOXACIN - CIPRO
 N 020780 001   5695784            Dec 09, 2014
CIPROFLOXACIN - CIPRO
 N 020780 002   5695784            Dec 09, 2014
CIPROFLOXACIN HYDROCHLORIDE - PROQUIN XR
 N 021744 001   5972389          Sep 19,      2016       DP U-663
                6340475          Sep 19,      2016       DP U-663
                6488962          Jun 20,      2020       DP
                6635280          Sep 19,      2016       DP U-663
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE - CIPRO HC
 N 020805 001   5843930          Jun 06, 2015          U-646
                5965549          Jun 06, 2015       DP
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE - CIPRO XR
 N 021473 001   7709022          Jun 23, 2021       DP
                8187632          Jun 23, 2021       DP
                8187632*PED      Dec 23, 2021
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE - CIPRO XR
 N 021473 002   7709022          Jun 23, 2021       DP
                8187632          Jun 23, 2021       DP
                8187632*PED      Dec 23, 2021
CIPROFLOXACIN; DEXAMETHASONE - CIPRODEX
 N 021537 001   6284804          Aug 10, 2020
                6359016          Aug 10, 2020
                8846650          Jun 04, 2025            DP U-1578
CISAPRIDE MONOHYDRATE - PROPULSID QUICKSOLV
 N 020767 001   5648093          Jul 15, 2014
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE - PREPOPIK
 N 202535 001   8450338          Oct 10, 2028       DP                                     NP           Jul 16, 2015
                8481083          Oct 10, 2028       DP
CLARITHROMYCIN - BIAXIN XL
 N 050775 001   6010718            Apr 11, 2017          DP U-924
                6551616            Jun 15, 2017             U-924
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 40 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO           PATENT NO         EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
CLEVIDIPINE - CLEVIPREX
 N 022156 001   5739152            Apr 14, 2015          DP U-893
                5856346            Jan 05, 2021       DS DP U-893
                8658676            Oct 10, 2031          DP
CLEVIDIPINE - CLEVIPREX
 N 022156 002   5739152            Apr 14, 2015          DP U-893
                5856346            Jan 05, 2021       DS DP U-893
                8658676            Oct 10, 2031          DP
CLEVIDIPINE - CLEVIPREX
 N 022156 003   5739152            Apr 14, 2015          DP U-893
                5856346            Jan 05, 2021       DS DP U-893
                8658676            Oct 10, 2031          DP
CLINDAMYCIN PHOSPHATE - CLEOCIN
 N 050767 001   6495157            Jul 20, 2020          DP
CLINDAMYCIN PHOSPHATE - CLINDAGEL
 N 050782 001   6387383          Aug 03, 2020            DP U-818
CLINDAMYCIN PHOSPHATE - CLINDESSE
 N 050793 001   5993856          Nov 17, 2017            DP U-137
                6899890          Apr 27, 2023            DP U-137
CLINDAMYCIN PHOSPHATE - EVOCLIN
 N 050801 001   7141237            Jan 23, 2024       DS DP
                7374747            Aug 09, 2026       DS DP U-921
CLINDAMYCIN PHOSPHATE; TRETINOIN - ZIANA
 N 050802 001   6387383          Aug 03, 2020            DP U-916
                RE41134          Feb 24, 2015            DP U-1033
CLINDAMYCIN PHOSPHATE; TRETINOIN - VELTIN
 N 050803 001   5690923          Nov 25, 2014            DP
CLOBAZAM - ONFI
 N 202067 001                                                                              NCE          Oct 21, 2016
                                                                                           ODE          Oct 21, 2018
CLOBAZAM - ONFI
 N 202067 002                                                                              NCE          Oct 21, 2016
                                                                                           ODE          Oct 21, 2018
CLOBAZAM - ONFI
 N 202067 003                                                                              NCE          Oct 21, 2016
                                                                                           ODE          Oct 21, 2018
CLOBAZAM - ONFI
 N 203993 001                                                                              NCE          Oct 21, 2016
                                                                                           ODE          Oct 21, 2018
CLOBETASOL PROPIONATE - OLUX
 N 021142 001   6126920            Mar 01, 2016               U-484
CLOBETASOL PROPIONATE - CLOBEX
 N 021535 001   6106848            Sep 22, 2017
CLOBETASOL PROPIONATE - CLOBEX
 N 021644 001   7316810            Jun   17,   2019      DP
                7700081            Jan   03,   2022           U-1044
                8066975            Jun   17,   2019      DP
                8066976            Jun   17,   2019      DP
CLOBETASOL PROPIONATE - CLOBEX
 N 021835 001   5972920            Feb 12, 2018          DP
                5990100            Mar 24, 2018          DP U-742
CLOBETASOL PROPIONATE - OLUX E
 N 022013 001   6730288            Sep 08, 2019          DP
                7029659            Sep 08, 2019          DP
                8460641            Nov 05, 2028          DP U-1410
CLOFARABINE - CLOLAR
 N 021673 001   5661136            Jan 14, 2018               U-626
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                     ADA 41 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                             PATENT                           PATENT
	                           EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION          PATENT         DELIST           EXCLUSIVITY
	      EXPIRATION
	
                                        DATE              CODES        REQUESTED           CODE(S)
	           DATE
	
CLONIDINE HYDROCHLORIDE - KAPVAY
	
 N 022331 003		                                                                            M-149
	        Nov 20, 2017
	
CLONIDINE HYDROCHLORIDE - KAPVAY
	
 N 022331 004		                                                                            M-149
	        Nov 20, 2017
	
CLOPIDOGREL BISULFATE - PLAVIX
	
 N 020839 001		 6429210            Jun 10, 2019       DS DP                                PED
	          Nov 06, 2014
	
                6504030            Jun 10, 2019       DS
	
CLOPIDOGREL BISULFATE - PLAVIX
	
 N 020839 002		 6429210            Jun 10, 2019       DS DP                                PED
	          Nov 06, 2014
	
                6504030            Jun 10, 2019       DS
	
CLOZAPINE - FAZACLO ODT
	
 N 021590 001		 6024981            Apr 09, 2018          DP
	
                6106861            Dec 05, 2017          DP
	
                6221392            Apr 09, 2018          DP
	
CLOZAPINE - FAZACLO ODT
	
 N 021590 002		 6024981            Apr 09, 2018          DP
	
                6106861            Dec 05, 2017          DP
	
                6221392            Apr 09, 2018          DP
	
CLOZAPINE - FAZACLO ODT
	
 N 021590 003		 6024981            Apr 09, 2018          DP
	
                6106861            Dec 05, 2017          DP
	
                6221392            Apr 09, 2018          DP
	
CLOZAPINE - FAZACLO ODT
	
 N 021590 004		 6024981            Apr 09, 2018          DP
	
                6106861            Dec 05, 2017          DP
	
                6221392            Apr 09, 2018          DP
	
CLOZAPINE - FAZACLO ODT
	
 N 021590 005		 6024981            Apr 09, 2018          DP
	
                6106861            Dec 05, 2017          DP
	
                6221392            Apr 09, 2018          DP
	
CLOZAPINE - FAZACLO ODT
	
 N 021590 006		 6024981            Apr 09, 2018          DP
	
                6106861            Dec 05, 2017          DP
	
                6221392            Apr 09, 2018          DP
	
COBICISTAT - TYBOST
	
 N 203094 001		 8148374            Sep 03, 2029       DS DP U-1279                         NP
	           Sep 24, 2017
	
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - STRIBILD
	
 N 203100 001		 5814639          Sep 29, 2015    DS DP                           NP
	                     Aug 27, 2015
	
                5914331          Jul 02, 2017    DS
	
                5922695          Jul 25, 2017    DS      U-257
	
                5935946          Jul 25, 2017    DS DP U-257
	
                5977089          Jul 25, 2017    DS DP U-257
	
                6043230          Jul 25, 2017            U-257
	
                6642245          Nov 04, 2020            U-257
	
                6703396          Mar 09, 2021    DS DP
	
                7176220          Nov 20, 2023    DS DP U-257
	
                7635704          Oct 26, 2026    DS DP U-257
	
                8148374          Sep 03, 2029    DS DP U-1279
	
                8592397          Jan 13, 2024         DP U-257
	
                8633219          Oct 11, 2031         DP U-257
	
                8716264          Jan 13, 2024         DP U-257
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 42 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                   PATENT                     EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION              PATENT             DELIST     EXCLUSIVITY      EXPIRATION
	
                                       DATE                  CODES            REQUESTED     CODE(S)           DATE
	
COLCHICINE - COLCRYS
	
 N 022352 001   7601758             Feb   10,   2029               U-1007                   ODE          Jul 29, 2016
	
                7619004             Dec   03,   2028               U-1020
	
                7820681             Feb   17,   2029               U-1020
	
                7906519             Feb   17,   2029               U-1116
	
                7915269             Feb   17,   2029               U-1007
	
                7935731             Dec   03,   2028               U-1116
	
                7964647             Oct   06,   2028               U-1007
	
                7964648             Oct   06,   2028               U-1161
	
                7981938             Oct   06,   2028               U-1166
	
                8093296             Oct   06,   2028               U-1007
	
                8093297             Oct   06,   2028               U-1161
	
                8093298             Oct   06,   2028               U-1116
	
                8097655             Oct   06,   2028               U-1020
	
                8415395             Oct   06,   2028               U-1007
	
                8415396             Oct   06,   2028               U-1007
	
                8440721             Feb   17,   2029               U-1007
	
                8440722             Feb   17,   2029               U-1020
	
COLESEVELAM HYDROCHLORIDE - WELCHOL
	
 N 021141 001   5693675          Dec 02, 2014
	
COLESEVELAM HYDROCHLORIDE - WELCHOL
	
 N 021176 001   5693675          Dec 02, 2014          DS
	
                7229613          Apr 17, 2022                      U-851
	
COLESEVELAM HYDROCHLORIDE - WELCHOL
	
 N 022362 001   5693675          Dec 02, 2014          DS
	
                7229613          Apr 17, 2022                      U-493
	
COLESEVELAM HYDROCHLORIDE - WELCHOL
	
 N 022362 002   5693675          Dec 02, 2014          DS
	
                7229613          Apr 17, 2022                      U-493
	
CONIVAPTAN HYDROCHLORIDE - VAPRISOL
	
 N 021697 001   5723606          Dec 15, 2019          DS DP U-698
	
                5723606          Dec 15, 2019          DS DP U-868
	
CONIVAPTAN HYDROCHLORIDE - VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
	
 N 021697 002   5723606          Dec 15, 2019    DS DP U-698
	
                5723606          Dec 15, 2019    DS DP U-868
	
CORTICOTROPIN - H.P. ACTHAR GEL
	
 N 008372 008                                                                               ODE          Oct 15, 2017
	
CRIZOTINIB - XALKORI
	
 N 202570 001   7230098             Mar   01,   2025   DS                                   NCE          Aug 26, 2016

                7825137             May   12,   2027               U-1179                   ODE          Aug 26, 2018

                7858643             Oct   08,   2029   DS DP
	
                8217057             Nov   06,   2029   DS DP
	
                8785632             Mar   01,   2025   DS
	
CRIZOTINIB - XALKORI
	
 N 202570 002   7230098             Mar   01,   2025   DS                                   NCE          Aug 26, 2016

                7825137             May   12,   2027               U-1179                   ODE          Aug 26, 2018

                7858643             Oct   08,   2029   DS DP
	
                8217057             Nov   06,   2029   DS DP
	
                8785632             Mar   01,   2025   DS
	
CROFELEMER - FULYZAQ
	
 N 202292 001   7323195             Jun 07, 2018              DP                            NCE          Dec 31, 2017
	
                7341744             Jun 16, 2018                   U-1319
	
                8574634             Jan 11, 2018                   U-1319
	
CYANOCOBALAMIN - NASCOBAL
	
 N 021642 001   7229636             Jun   11,   2024          DP U-817
	
                7404489             Mar   12,   2024          DP
	
                7879349             Jun   01,   2024          DP U-1152
	
                8003353             Jun   11,   2024               U-817
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 43 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
CYCLOBENZAPRINE HYDROCHLORIDE - AMRIX
 N 021777 001   7387793          Feb 26,       2025      DP
                7544372          Nov 14,       2023           U-979
                7790199          Nov 14,       2023      DP
                7820203          Nov 14,       2023      DP
                7829121          Nov 14,       2023           U-1088
CYCLOBENZAPRINE HYDROCHLORIDE - AMRIX
 N 021777 002   7387793          Feb 26,       2025      DP
                7544372          Nov 14,       2023           U-979
                7790199          Nov 14,       2023      DP
                7820203          Nov 14,       2023      DP
                7829121          Nov 14,       2023           U-1088
CYCLOSPORINE - NEORAL
 N 050715 001   5985321            Sep 26, 2014          DP
CYCLOSPORINE - NEORAL
 N 050715 002   5985321            Sep 26, 2014          DP
CYCLOSPORINE - NEORAL
 N 050715 003   5985321            Sep 26, 2014          DP
CYCLOSPORINE - NEORAL
 N 050716 001   5985321            Sep 26, 2014          DP
CYCLOSPORINE - RESTASIS
 N 050790 001   8629111            Aug   27,   2024      DP
                8633162            Aug   27,   2024           U-1479
                8642556            Aug   27,   2024      DP
                8648048            Aug   27,   2024           U-1483
                8685930            Aug   27,   2024      DP
CYSTEAMINE BITARTRATE - PROCYSBI
 N 203389 001   8026284          Sep 22, 2027                 U-1399                       NDF          Apr 30, 2016
                8129433          Jan 26, 2027            DP                                ODE          Apr 30, 2020
CYSTEAMINE BITARTRATE - PROCYSBI
 N 203389 002   8026284          Sep 22, 2027                 U-1399                       NDF          Apr 30, 2016
                8129433          Jan 26, 2027            DP                                ODE          Apr 30, 2020
CYSTEAMINE HYDROCHLORIDE - CYSTARAN
 N 200740 001                                                                              NP           Oct 02, 2015
                                                                                           ODE          Oct 02, 2019
CYTARABINE - DEPOCYT
 N 021041 001   5723147            Mar 03, 2015          DP U-806
DABIGATRAN ETEXILATE MESYLATE - PRADAXA
 N 022512 001   6087380          Feb 18, 2018         DS DP U-1089                         I-682        Apr 04, 2017
                7866474          Aug 31, 2027            DP                                I-683        Apr 04, 2017
                7932273          Sep 07, 2025         DS DP                                NCE          Oct 19, 2015
DABIGATRAN ETEXILATE MESYLATE - PRADAXA
 N 022512 002   6087380          Feb 18, 2018         DS DP U-1089                         I-682        Apr 04, 2017
                7866474          Aug 31, 2027            DP                                I-683        Apr 04, 2017
                7932273          Sep 07, 2025         DS DP                                NCE          Oct 19, 2015
DABRAFENIB MESYLATE - TAFINLAR
 N 202806 001   7994185            Jan 20, 2030       DS DP U-1406                         I-678        Jan   08,   2017
                8415345            Jan 20, 2030       DS DP U-1406                         NCE          May   29,   2018
                                                                                           ODE          May   29,   2020
                                                                                           ODE          Jan   09,   2021
DABRAFENIB MESYLATE - TAFINLAR
 N 202806 002   7994185            Jan 20, 2030       DS DP U-1406                         I-678        Jan   08,   2017
                8415345            Jan 20, 2030       DS DP U-1406                         NCE          May   29,   2018
                                                                                           ODE          May   29,   2020
                                                                                           ODE          Jan   09,   2021
DALBAVANCIN HYDROCHLORIDE - DALVANCE
 N 021883 001   6900175          Dec 25, 2023                 U-1517                       NCE          May 23, 2019
                7115564          Nov 14, 2023            DP                                GAIN         May 23, 2024
                7119061          Nov 14, 2023            DP
                8143212          Nov 14, 2023                 U-1517
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 44 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                          EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES         REQUESTED          CODE(S)           DATE
	
DALFAMPRIDINE - AMPYRA
 N 022250 001   5540938            Jul   30,   2018            U-1030                      NCE          Jan 22, 2015
                8007826            May   26,   2027            U-1030                      ODE          Jan 22, 2017
                8354437            Dec   22,   2026            U-1030
                8440703            Apr   08,   2025            U-1030
                8663685            Jan   18,   2025            U-1030
DANTROLENE SODIUM - RYANODEX
 N 205579 001   7758890            Jul   01,   2025       DP
                8110225            Dec   24,   2022       DP
                8604072            Dec   24,   2022       DP
                8685460            Feb   15,   2023            U-1546
DAPAGLIFLOZIN - FARXIGA
 N 202293 001   6414126            Oct   04,   2020    DS DP U-493                         NCE          Jan 08, 2019
                6515117            Oct   04,   2020    DS DP U-493
                6936590            Oct   04,   2020          U-493
                7851502            Aug   19,   2028       DP
                7919598            Dec   16,   2029    DS
                8221786            Mar   21,   2028       DP
                8361972            Mar   21,   2028          U-493
                8501698            Jun   20,   2027       DP U-493
                8685934            May   26,   2030          U-1522
                8716251            Mar   21,   2028       DP
DAPAGLIFLOZIN - FARXIGA
 N 202293 002   6414126            Oct   04,   2020    DS DP U-493                         NCE          Jan 08, 2019
                6515117            Oct   04,   2020    DS DP U-493
                6936590            Oct   04,   2020          U-493
                7851502            Aug   19,   2028       DP
                7919598            Dec   16,   2029    DS
                8221786            Mar   21,   2028       DP
                8361972            Mar   21,   2028          U-493
                8501698            Jun   20,   2027       DP U-493
                8685934            May   26,   2030          U-1522
                8716251            Mar   21,   2028       DP
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE -       XIGDUO XR
 N 205649 001   6414126          Oct 04,       2020    DS DP U-493                         NCE          Jan 08, 2019
                6515117          Oct 04,       2020    DS DP U-493
                6936590          Oct 04,       2020          U-493
                7919598          Dec 16,       2029    DS
                8501698          Jun 20,       2027       DP U-493
                8685934          May 26,       2030          U-1522
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE -       XIGDUO XR
 N 205649 002   6414126          Oct 04,       2020    DS DP U-493                         NCE          Jan 08, 2019
                6515117          Oct 04,       2020    DS DP U-493
                6936590          Oct 04,       2020          U-493
                7919598          Dec 16,       2029    DS
                8501698          Jun 20,       2027       DP U-493
                8685934          May 26,       2030          U-1522
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE -       XIGDUO XR
 N 205649 003   6414126          Oct 04,       2020    DS DP U-493                         NCE          Jan 08, 2019
                6515117          Oct 04,       2020    DS DP U-493
                6936590          Oct 04,       2020          U-493
                7919598          Dec 16,       2029    DS
                8501698          Jun 20,       2027       DP U-493
                8685934          May 26,       2030          U-1522
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE -       XIGDUO XR
 N 205649 004   6414126          Oct 04,       2020    DS DP U-493                         NCE          Jan 08, 2019
                6515117          Oct 04,       2020    DS DP U-493
                6936590          Oct 04,       2020          U-493
                7919598          Dec 16,       2029    DS
                8501698          Jun 20,       2027       DP U-493
                8685934          May 26,       2030          U-1522
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 45 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT
	                             PATENT                        EXCLUSIVITY
     NO          PATENT NO           EXPIRATION
	          PATENT           DELIST        EXCLUSIVITY     EXPIRATION
                                        DATE
	              CODES         REQUESTED         CODE(S)           DATE
DAPSONE - ACZONE
	
 N 021794 001		 5863560             Sep 11, 2016
           DP
                 6060085            Sep 11, 2016
                U-124
                 6620435            Sep 11, 2016
	          DP
DAPTOMYCIN - CUBICIN
	
 N 021572 001		 6468967             Sep 24, 2019
                U-282
                6852689             Sep 24, 2019
                U-282
                8058238             Nov 28, 2020
	       DS DP
DAPTOMYCIN - CUBICIN
	
 N 021572 002		 6468967             Sep   24,   2019
            U-282
                6852689             Sep   24,   2019
            U-282
                8003673             Sep   04,   2028
            U-1180
                8058238             Nov   28,   2020
	   DS DP
                8129342             Nov   28,   2020
	   DS DP
                RE39071             Jun   15,   2016
	   DS DP U-728
DARIFENACIN HYDROBROMIDE - ENABLEX
	
 N 021513 001		 5096890          Mar 13, 2015
	          DS DP U-631
                6106864          Aug 21, 2016
	             DP U-630
DARIFENACIN HYDROBROMIDE - ENABLEX
	
 N 021513 002		 5096890          Mar 13, 2015
	          DS DP U-631
                6106864          Aug 21, 2016
	             DP U-630
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 46 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                          PATENT                               PATENT                       EXCLUSIVITY
	
     NO         PATENT NO         EXPIRATION              PATENT         DELIST       EXCLUSIVITY      EXPIRATION
	
                                     DATE                  CODES        REQUESTED       CODE(S)           DATE
	
DARUNAVIR ETHANOLATE - PREZISTA
 N 021976 001   5843946           Dec   01,   2015        DP   U-744                    D-135        Feb   01,   2016
                5843946           Dec   01,   2015        DP   U-903                    NPP          Dec   16,   2014
                5843946           Dec   01,   2015        DP   U-935                    PED          Jun   16,   2015
                5843946           Dec   01,   2015        DP   U-1209                   PED          Aug   01,   2016
                5843946           Dec   01,   2015        DP   U-1305
                6037157           Jun   26,   2016             U-935
                6037157           Jun   26,   2016             U-1209
                6037157           Jun   26,   2016             U-1305
                6248775           Aug   13,   2014   DS
                6703403           Jun   26,   2016             U-935
                6703403           Jun   26,   2016             U-1209
                6703403           Jun   26,   2016             U-1305
                7470506           Jun   23,   2019             U-935
                7470506           Jun   23,   2019             U-1209
                7470506           Jun   23,   2019             U-1305
                7700645           Dec   26,   2026   DS DP
                8518987           Feb   16,   2024   DS DP
                8518987*PED       Aug   16,   2024
                8597876           Jun   23,   2019             U-1305
                8597876*PED       Dec   23,   2019
                RE42889           Oct   19,   2016      DP
                RE43596           May   09,   2017   DS DP
                RE43802           Oct   19,   2016             U-1305
DARUNAVIR ETHANOLATE - PREZISTA
 N 021976 002   5843946           Dec   01,   2015        DP   U-744                    D-135        Feb   01,   2016
                5843946           Dec   01,   2015        DP   U-903                    NPP          Dec   16,   2014
                5843946           Dec   01,   2015        DP   U-935                    PED          Jun   16,   2015
                5843946           Dec   01,   2015        DP   U-1209                   PED          Aug   01,   2016
                5843946           Dec   01,   2015        DP   U-1305
                6037157           Jun   26,   2016             U-935
                6037157           Jun   26,   2016             U-1209
                6037157           Jun   26,   2016             U-1305
                6248775           Aug   13,   2014   DS
                6703403           Jun   26,   2016             U-935
                6703403           Jun   26,   2016             U-1209
                6703403           Jun   26,   2016             U-1305
                7470506           Jun   23,   2019             U-935
                7470506           Jun   23,   2019             U-1209
                7470506           Jun   23,   2019             U-1305
                7700645           Dec   26,   2026   DS DP
                8518987           Feb   16,   2024   DS DP
                8518987*PED       Aug   16,   2024
                8597876           Jun   23,   2019             U-1305
                8597876*PED       Dec   23,   2019
                RE42889           Oct   19,   2016      DP
                RE43596           May   09,   2017   DS DP
                RE43802           Oct   19,   2016             U-1305
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 47 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
     NO            PATENT NO        EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
DARUNAVIR ETHANOLATE - PREZISTA
 N 021976    003   5843946         Dec   01,   2015        DP   U-744                      D-135        Feb   01,   2016
                   5843946         Dec   01,   2015        DP   U-903                      NPP          Dec   16,   2014
                   5843946         Dec   01,   2015        DP   U-935                      PED          Jun   16,   2015
                   5843946         Dec   01,   2015        DP   U-1209                     PED          Aug   01,   2016
                   5843946         Dec   01,   2015        DP   U-1305
                   6037157         Jun   26,   2016             U-935
                   6037157         Jun   26,   2016             U-1209
                   6037157         Jun   26,   2016             U-1305
                   6248775         Aug   13,   2014   DS
                   6703403         Jun   26,   2016             U-935
                   6703403         Jun   26,   2016             U-1209
                   6703403         Jun   26,   2016             U-1305
                   7470506         Jun   23,   2019             U-935
                   7470506         Jun   23,   2019             U-1209
                   7470506         Jun   23,   2019             U-1305
                   7700645         Dec   26,   2026   DS DP
                   8518987         Feb   16,   2024   DS DP
                   8518987*PED     Aug   16,   2024
                   8597876         Jun   23,   2019             U-1305
                   8597876*PED     Dec   23,   2019
                   RE42889         Oct   19,   2016      DP
                   RE43596         May   09,   2017   DS DP
                   RE43802         Oct   19,   2016             U-1305
DARUNAVIR ETHANOLATE - PREZISTA
 N 021976 004   5843946            Dec   01,   2015        DP   U-744                      D-135        Feb   01,   2016
                5843946            Dec   01,   2015        DP   U-903                      NPP          Dec   16,   2014
                5843946            Dec   01,   2015        DP   U-935                      PED          Jun   16,   2015
                5843946            Dec   01,   2015        DP   U-1209                     PED          Aug   01,   2016
                5843946            Dec   01,   2015        DP   U-1305
                6037157            Jun   26,   2016             U-935
                6037157            Jun   26,   2016             U-1209
                6037157            Jun   26,   2016             U-1305
                6248775            Aug   13,   2014   DS
                6703403            Jun   26,   2016             U-935
                6703403            Jun   26,   2016             U-1209
                6703403            Jun   26,   2016             U-1305
                7470506            Jun   23,   2019             U-935
                7470506            Jun   23,   2019             U-1209
                7470506            Jun   23,   2019             U-1305
                7700645            Dec   26,   2026   DS DP
                8518987            Feb   16,   2024   DS DP
                8518987*PED        Aug   16,   2024
                8597876            Jun   23,   2019             U-1305
                8597876*PED        Dec   23,   2019
                RE42889            Oct   19,   2016      DP
                RE43596            May   09,   2017   DS DP
                RE43802            Oct   19,   2016             U-1305
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 48 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
     NO            PATENT NO        EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
DARUNAVIR ETHANOLATE - PREZISTA
 N 021976    005   5843946         Dec   01,   2015        DP   U-744                      D-135        Feb   01,   2016
                   5843946         Dec   01,   2015        DP   U-903                      NPP          Dec   16,   2014
                   5843946         Dec   01,   2015        DP   U-935                      PED          Jun   16,   2015
                   5843946         Dec   01,   2015        DP   U-1209                     PED          Aug   01,   2016
                   5843946         Dec   01,   2015        DP   U-1305
                   6037157         Jun   26,   2016             U-935
                   6037157         Jun   26,   2016             U-1209
                   6037157         Jun   26,   2016             U-1305
                   6248775         Aug   13,   2014   DS
                   6703403         Jun   26,   2016             U-935
                   6703403         Jun   26,   2016             U-1209
                   6703403         Jun   26,   2016             U-1305
                   7470506         Jun   23,   2019             U-935
                   7470506         Jun   23,   2019             U-1209
                   7470506         Jun   23,   2019             U-1305
                   7700645         Dec   26,   2026   DS DP
                   8518987         Feb   16,   2024   DS DP
                   8518987*PED     Aug   16,   2024
                   8597876         Jun   23,   2019             U-1305
                   8597876*PED     Dec   23,   2019
                   RE42889         Oct   19,   2016      DP
                   RE43596         May   09,   2017   DS DP
                   RE43802         Oct   19,   2016             U-1305
DARUNAVIR ETHANOLATE - PREZISTA
 N 021976 006   5843946            Dec   01,   2015        DP   U-744                      D-135        Feb   01,   2016
                5843946            Dec   01,   2015        DP   U-903                      NPP          Dec   16,   2014
                5843946            Dec   01,   2015        DP   U-935                      PED          Jun   16,   2015
                5843946            Dec   01,   2015        DP   U-1209                     PED          Aug   01,   2016
                5843946            Dec   01,   2015        DP   U-1305
                6037157            Jun   26,   2016             U-935
                6037157            Jun   26,   2016             U-1209
                6037157            Jun   26,   2016             U-1305
                6248775            Aug   13,   2014   DS
                6703403            Jun   26,   2016             U-935
                6703403            Jun   26,   2016             U-1209
                6703403            Jun   26,   2016             U-1305
                7470506            Jun   23,   2019             U-935
                7470506            Jun   23,   2019             U-1209
                7470506            Jun   23,   2019             U-1305
                7700645            Dec   26,   2026   DS DP
                8518987            Feb   16,   2024   DS DP
                8518987*PED        Aug   16,   2024
                8597876            Jun   23,   2019             U-1305
                8597876*PED        Dec   23,   2019
                RE42889            Oct   19,   2016      DP
                RE43596            May   09,   2017   DS DP
                RE43802            Oct   19,   2016             U-1305
DARUNAVIR ETHANOLATE - PREZISTA
 N 202895 001   5843946            Dec   01,   2015        DP U-1209                       D-135        Feb   01,   2016
                5843946            Dec   01,   2015        DP U-1305                       NDF          Dec   16,   2014
                6037157            Jun   26,   2016           U-1209                       PED          Jun   16,   2015
                6037157            Jun   26,   2016           U-1305                       PED          Aug   01,   2016
                6248775            Aug   13,   2014   DS
                6703403            Jun   26,   2016             U-1209
                6703403            Jun   26,   2016             U-1305
                7470506            Jun   23,   2019             U-1209
                7470506            Jun   23,   2019             U-1305
                7700645            Dec   26,   2026   DS DP
                8518987            Feb   16,   2024   DS DP
                8518987*PED        Aug   16,   2024
                8597876            Jun   23,   2019             U-1305
                8597876*PED        Dec   23,   2019
                RE42889            Oct   19,   2016      DP
                RE43596            May   09,   2017   DS DP
                RE43802            Oct   19,   2016             U-1305
                        35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                ADA 49 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                               See report footnote for information regarding report content

 APPL/PROD                                 PATENT                 PATENT
	                                EXCLUSIVITY
	
     NO              PATENT NO           EXPIRATION PATENT        DELIST      EXCLUSIVITY
	                EXPIRATION
	
                                            DATE     CODES       REQUESTED      CODE(S)
	                     DATE
	
DASABUVIR SODIUM ; OMBITASVIR; PARITAPREVIR; RITONAVIR - VIEKIRA PAK (COPACKAGED)
	
 N 206619 001		                                                                  NCE
	                   Dec 19, 2019
	
DASATINIB - SPRYCEL
	
 N 021986 001		 6596746                 Jun   28,   2020   DS DP U-748
	
                6596746                 Jun   28,   2020   DS DP U-780
	
                7125875                 Apr   13,   2020           U-779
	
                7125875                 Apr   13,   2020           U-780
	
                7153856                 Apr   28,   2020           U-780
	
                7491725                 Mar   28,   2026   DS DP
	
                8680103                 Feb   04,   2025      DP
	
DASATINIB - SPRYCEL
	
 N 021986 002		 6596746                 Jun   28,   2020   DS DP U-748
	
                6596746                 Jun   28,   2020   DS DP U-780
	
                7125875                 Apr   13,   2020           U-779
	
                7125875                 Apr   13,   2020           U-780
	
                7153856                 Apr   28,   2020           U-780
	
                7491725                 Mar   28,   2026   DS DP
	
                8680103                 Feb   04,   2025      DP
	
DASATINIB - SPRYCEL
	
 N 021986    003		   6596746            Jun   28,   2020   DS DP U-748
	
                     6596746            Jun   28,   2020   DS DP U-780
	
                     7125875            Apr   13,   2020           U-779
	
                     7125875            Apr   13,   2020           U-780
	
                     7153856            Apr   28,   2020           U-780
	
                     7491725            Mar   28,   2026   DS DP
	
                     8680103            Feb   04,   2025      DP
	
DASATINIB - SPRYCEL
	
 N 021986 004		 6596746                 Jun   28,   2020   DS DP U-748
	
                6596746                 Jun   28,   2020   DS DP U-780
	
                7125875                 Apr   13,   2020           U-779
	
                7125875                 Apr   13,   2020           U-780
	
                7153856                 Apr   28,   2020           U-780
	
                7491725                 Mar   28,   2026   DS DP
	
                8680103                 Feb   04,   2025      DP
	
DASATINIB - SPRYCEL
	
 N 021986 005		 6596746                 Jun   28,   2020   DS DP U-748
	
                6596746                 Jun   28,   2020   DS DP U-780
	
                7125875                 Apr   13,   2020           U-779
	
                7125875                 Apr   13,   2020           U-780
	
                7153856                 Apr   28,   2020           U-780
	
                7491725                 Mar   28,   2026   DS DP
	
                8680103                 Feb   04,   2025      DP
	
DASATINIB - SPRYCEL
	
 N 021986 006		 6596746                 Jun   28,   2020   DS DP U-748
	
                6596746                 Jun   28,   2020   DS DP U-780
	
                7125875                 Apr   13,   2020           U-779
	
                7125875                 Apr   13,   2020           U-780
	
                7153856                 Apr   28,   2020           U-780
	
                7491725                 Mar   28,   2026   DS DP
	
                8680103                 Feb   04,   2025      DP
	
DEFERASIROX - EXJADE
	
 N 021882 001		 6465504                 Apr 05, 2019       DS DP                              I-665
	    Jan 23, 2016
	
                6596750                 Jun 24, 2017       DS    U-735
	
DEFERASIROX - EXJADE
	
 N 021882 002		 6465504                 Apr 05, 2019       DS DP                              I-665
	    Jan 23, 2016
	
                6596750                 Jun 24, 2017       DS    U-735
	
DEFERASIROX - EXJADE
	
 N 021882 003		 6465504                 Apr 05, 2019       DS DP                              I-665
	    Jan 23, 2016
	
                6596750                 Jun 24, 2017       DS    U-735
	
DEFERIPRONE - FERRIPROX
	
 N 021825 001		                                                                               NCE
	      Oct 14, 2016
	
                                                                                              ODE
	      Oct 14, 2018
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 50 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION              PATENT        DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                  CODES       REQUESTED         CODE(S)           DATE
	
DEGARELIX ACETATE - FIRMAGON
 N 022201 001   5925730            May 18, 2021        DS DP U-943
DEGARELIX ACETATE - FIRMAGON
 N 022201 002   5925730            May 18, 2021        DS DP U-943
DELAVIRDINE MESYLATE - RESCRIPTOR
 N 020705 002   6177101          Jun 07, 2019
DESIRUDIN RECOMBINANT - IPRIVASK
 N 021271 001   5733874          Mar 31, 2015
DESLORATADINE - CLARINEX
 N 021165 001   6100274            Jul   07,   2019
                7211582            Dec   30,   2014              U-809
                7214683            Dec   30,   2014         DP
                7214684            Dec   30,   2014              U-138
                7405223            Jul   07,   2019              U-886
DESLORATADINE - CLARINEX
 N 021300 001   6514520            Jun   01,   2018         DP
                7211582            Dec   30,   2014              U-809
                7214683            Dec   30,   2014         DP
                7214684            Dec   30,   2014              U-138
DESLORATADINE - CLARINEX
 N 021312 001   5607697            Jun   07,   2015         DP
                6100274            Jul   07,   2019         DP
                7211582            Dec   30,   2014              U-809
                7214683            Dec   30,   2014         DP
                7214684            Dec   30,   2014            U-138
                7618649            Dec   19,   2020         DP U-1017
DESLORATADINE - CLARINEX
 N 021312 002   5607697            Jun   07,   2015         DP
                6100274            Jul   07,   2019         DP
                7211582            Dec   30,   2014              U-809
                7214683            Dec   30,   2014         DP
                7214684            Dec   30,   2014            U-138
                7618649            Dec   19,   2020         DP U-1017
DESLORATADINE; PSEUDOEPHEDRINE SULFATE -       CLARINEX-D   12 HOUR
 N 021313 001   6100274          Jul 07,       2019         DP
                6709676          Feb 18,       2021         DP U-707
                7214683          Dec 30,       2014         DP
                7214684          Dec 30,       2014             U-138
                7618649          Dec 19,       2020         DP U-1017
                8187630          Dec 19,       2020         DP U-1017
DESLORATADINE; PSEUDOEPHEDRINE SULFATE -       CLARINEX D 24 HOUR
 N 021605 001   6100274          Jul 07,       2019       DP
                6979463          Mar 28,       2022       DP
                7214683          Dec 30,       2014       DP
                7214684          Dec 30,       2014           U-138
                7618649          Dec 19,       2020       DP U-1017
                7820199          Mar 28,       2022       DP
DESMOPRESSIN ACETATE - DDAVP
 N 019955 001   7022340            Apr 30, 2023             DP                 Y
DESMOPRESSIN ACETATE - DDAVP
 N 019955 002   7022340            Apr 30, 2023             DP                 Y
DESONIDE - DESONATE
 N 021844 001   6387383            Aug 03, 2020        DS DP U-783
DESONIDE - VERDESO
 N 021978 001   6730288            Sep 08, 2019             DP
                7029659            Sep 08, 2019             DP
                8460641            Nov 05, 2028             DP U-1412
DESOXIMETASONE - TOPICORT
 N 204141 001   5990100            Mar 24, 2018             DP U-1408                      NDF          Apr 11, 2016
                8277780            Sep 01, 2028             DP U-1408
                8715624            May 26, 2026             DP U-1408
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 51 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT       DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES      REQUESTED           CODE(S)           DATE
	
DESVENLAFAXINE SUCCINATE - PRISTIQ
 N 021992 001   6673838          Mar 01, 2022         DS      U-860                        I-675        Feb 14, 2016
                6673838          Mar 01, 2022         DS      U-1364
                8269040          Jul 05, 2027         DS
DESVENLAFAXINE SUCCINATE - PRISTIQ
 N 021992 002   6673838          Mar 01, 2022         DS      U-860                        I-675        Feb 14, 2016
                6673838          Mar 01, 2022         DS      U-1364
                8269040          Jul 05, 2027         DS
DEXAMETHASONE - OZURDEX
 N 022315 001   6726918            Oct   20,   2020        DP U-1204                       I-686        Jun 29, 2017
                6726918            Oct   20,   2020        DP U-1205                       ODE          Sep 24, 2017
                6899717            Nov   01,   2023           U-1206
                7033605            Oct   20,   2020        DP
                7767223            Nov   28,   2021        DP
                8034366            Jan   09,   2023        DP U-1204
                8034366            Jan   09,   2023        DP U-1205
                8034370            Jan   09,   2023        DP
                8043628            Oct   20,   2020        DP U-1205
                8063031            Oct   20,   2020        DP
                8088407            Oct   20,   2020        DP U-1205
                8506987            Jan   09,   2023           U-1204
                8506987            Jan   09,   2023           U-1205
DEXAMETHASONE; TOBRAMYCIN - TOBRADEX ST
 N 050818 001   7795316          Aug 03, 2028              DP U-1082
                8101582          Dec 19, 2027              DP U-1082
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                     ADA 52 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                                      PATENT                     EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION               PATENT               DELIST     EXCLUSIVITY      EXPIRATION
	
                                     DATE                   CODES              REQUESTED     CODE(S)           DATE
	
DEXLANSOPRAZOLE - DEXILANT
	
 N 022287 001   6462058          Jun   15,   2020     DS     DP     U-949
	
                6462058          Jun   15,   2020     DS     DP     U-950
	
                6462058          Jun   15,   2020     DS     DP     U-951
	
                6664276          Jan   30,   2023     DS     DP     U-949
	
                6664276          Jan   30,   2023     DS     DP     U-950
	
                6664276          Jan   30,   2023     DS     DP     U-951
	
                6664276          Jan   30,   2023     DS     DP     U-1507
	
                6664276*PED      Jul   30,   2023
	
                6939971          Jun   15,   2020                   U-949
	
                6939971          Jun   15,   2020                   U-950
	
                6939971          Jun   15,   2020                   U-951
	
                7285668          Jun   15,   2020     DS
	
                7790755          Aug   02,   2026            DP
	
                8105626          Sep   27,   2026            DP
	
                8173158          Mar   17,   2030                   U-949
	
                8173158          Mar   17,   2030                   U-950
	
                8173158          Mar   17,   2030                   U-951
	
                8461187          Jan   17,   2026            DP
	
                8461187*PED      Jul   17,   2026
	
                8722084          Oct   15,   2023            DP
	
                8784885          Oct   15,   2023            DP U-1552
	
                8784885          Oct   15,   2023            DP U-1553
	
                8784885          Oct   15,   2023            DP U-1554
	
                8871273          Jan   11,   2028            DP
	
DEXLANSOPRAZOLE - DEXILANT
	
 N 022287 002   6462058          Jun   15,   2020     DS     DP     U-949
	
                6462058          Jun   15,   2020     DS     DP     U-950
	
                6462058          Jun   15,   2020     DS     DP     U-951
	
                6664276          Jan   30,   2023     DS     DP     U-949
	
                6664276          Jan   30,   2023     DS     DP     U-950
	
                6664276          Jan   30,   2023     DS     DP     U-951
	
                6664276          Jan   30,   2023     DS     DP     U-1507
	
                6664276*PED      Jul   30,   2023
	
                6939971          Jun   15,   2020                   U-949
	
                6939971          Jun   15,   2020                   U-950
	
                6939971          Jun   15,   2020                   U-951
	
                7285668          Jun   15,   2020     DS
	
                7790755          Aug   02,   2026            DP
	
                8105626          Sep   27,   2026            DP
	
                8173158          Mar   17,   2030                   U-949
	
                8173158          Mar   17,   2030                   U-950
	
                8173158          Mar   17,   2030                   U-951
	
                8461187          Jan   17,   2026            DP
	
                8461187*PED      Jul   17,   2026
	
                8722084          Oct   15,   2023            DP
	
                8722084*PED      Apr   15,   2024

                8871273          Jan   11,   2028            DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 53 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                           PATENT                              PATENT                        EXCLUSIVITY
	
     NO          PATENT NO         EXPIRATION          PATENT            DELIST        EXCLUSIVITY      EXPIRATION
	
                                      DATE              CODES           REQUESTED        CODE(S)           DATE
	
DEXMEDETOMIDINE HYDROCHLORIDE - PRECEDEX
	
 N 021038 001   6716867          Mar 31, 2019                 U-1472                     M-61         Jun 17, 2016
	
                6716867*PED      Oct 01, 2019                                            PED          Dec 17, 2016
	
DEXMEDETOMIDINE HYDROCHLORIDE - PRECEDEX
	
 N 021038 002   6716867          Mar 31, 2019                 U-1472                     M-61         Jun 17, 2016
	
                6716867*PED      Oct 01, 2019                                            PED          Dec 17, 2016
	
                8242158          Jan 04, 2032          DP
	
                8242158*PED      Jul 04, 2032
	
                8338470          Jan 04, 2032          DP
	
                8338470*PED      Jul 04, 2032
	
                8455527          Jan 04, 2032                 U-421
	
                8455527*PED      Jul 04, 2032
	
                8648106          Jan 04, 2032          DP
	
                8648106*PED      Jul 04, 2032
	
DEXMEDETOMIDINE HYDROCHLORIDE - PRECEDEX
	
 N 021038 003   6716867          Mar 31, 2019                 U-1472                     M-61         Jun 17, 2016
	
                6716867*PED      Oct 01, 2019                                            PED          Dec 17, 2016
	
                8242158          Jan 04, 2032          DP
	
                8242158*PED      Jul 04, 2032
	
                8338470          Jan 04, 2032          DP
	
                8338470*PED      Jul 04, 2032
	
                8455527          Jan 04, 2032                 U-421
	
                8455527*PED      Jul 04, 2032
	
                8648106          Jan 04, 2032          DP
	
                8648106*PED      Jul 04, 2032
	
DEXMETHYLPHENIDATE HYDROCHLORIDE - DEXMETHYLPHENIDATE HYDROCHLORIDE
	
 A 078908 001                                                                            PC           May 09, 2015
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN
	
 N 021278 001   5908850            Dec 04, 2015               U-422
	
                6355656            Dec 04, 2015
	
                6528530            Dec 04, 2015     DS DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN
	
 N 021278 002   5908850            Dec 04, 2015               U-422
	
                6355656            Dec 04, 2015
	
                6528530            Dec 04, 2015     DS DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN
	
 N 021278 003   5908850            Dec 04, 2015               U-422
	
                6355656            Dec 04, 2015
	
                6528530            Dec 04, 2015     DS DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 54 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                           PATENT                           PATENT                          EXCLUSIVITY
	
     NO         PATENT NO          EXPIRATION         PATENT          DELIST          EXCLUSIVITY      EXPIRATION
	
                                      DATE             CODES         REQUESTED          CODE(S)           DATE
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 001   5837284            Dec 04, 2015       DP
	
                5908850            Dec 04, 2015            U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 002   5837284            Dec 04, 2015       DP
	
                5908850            Dec 04, 2015            U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 003   5837284            Dec 04, 2015       DP
	
                5908850            Dec 04, 2015            U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 004   5837284            Dec 04, 2015       DP
	
                5908850            Dec 04, 2015            U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 005   5837284            Dec 04, 2015       DP
	
                5908850            Dec 04, 2015       DP U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 006   5837284            Dec 04, 2015       DP U-677
	
                5908850            Dec 04, 2015       DP U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
DEXMETHYLPHENIDATE HYDROCHLORIDE   - FOCALIN XR
	
 N 021802 007   5837284            Dec 04, 2015       DP
	
                5908850            Dec 04, 2015       DP U-678
	
                6228398            Nov 01, 2019       DP U-676
	
                6355656            Dec 04, 2015       DP
	
                6528530            Dec 04, 2015       DP
	
                6635284            Dec 04, 2015       DP U-677
	
                6730325            Nov 01, 2019       DP U-676
	
                7431944            Dec 04, 2015       DP
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 55 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                         PATENT                                   PATENT                          EXCLUSIVITY
     NO            PATENT NO     EXPIRATION                 PATENT          DELIST          EXCLUSIVITY      EXPIRATION
                                    DATE                     CODES        REQUESTED           CODE(S)           DATE
DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR
 N 021802    008   5837284            Dec   04,   2015      DP
                   5908850            Dec   04,   2015      DP   U-678
                   6228398            Nov   01,   2019      DP   U-676
                   6355656            Dec   04,   2015      DP
                   6528530            Dec   04,   2015      DP
                   6635284            Dec   04,   2015      DP   U-677
                   6730325            Nov   01,   2019      DP   U-676
                   7431944            Dec   04,   2015      DP
DEXRAZOXANE HYDROCHLORIDE - TOTECT
 N 022025 001   6727253          Mar 13, 2020                    U-829                        ODE          Sep 06, 2014
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN - MUCINEX DM
 N 021620 001   6372252          Apr 28, 2020       DP
                6955821          Apr 28, 2020       DP U-685
                7838032          Apr 28, 2020       DP
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN - MUCINEX DM
 N 021620 002   6372252          Apr 28, 2020       DP
                6955821          Apr 28, 2020       DP U-685
                7838032          Apr 28, 2020       DP
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE - NUEDEXTA
 N 021879 001   7659282          Aug 13, 2026           U-1093
                8227484          Jul 17, 2023           U-1093
                RE38115          Jan 26, 2016       DP                           Y
DEXTROMETHORPHAN POLISTIREX - DELSYM
 N 018658 001   5980882          Apr 16, 2017               DP
DICLOFENAC - ZORVOLEX
 N 204592 001   8679544               Apr 23, 2030          DP                                I-692        Aug 22, 2017
                                                                                              NP           Oct 18, 2016
DICLOFENAC - ZORVOLEX
 N 204592 002   8679544               Apr 23, 2030          DP                                I-692        Aug 22, 2017
                                                                                              NP           Oct 18, 2016
DICLOFENAC EPOLAMINE - FLECTOR
 N 021234 001   5607690               Apr 13, 2019          DP
DICLOFENAC POTASSIUM - CAMBIA
 N 022165 001   6974595               May   15,   2017         U-436
                7482377               May   15,   2017   DS DP U-436
                7759394               Jun   16,   2026   DS DP U-436
                8097651               Jun   16,   2026   DS DP U-436
DICLOFENAC POTASSIUM - ZIPSOR
 N 022202 001   6287594               Jan   15,   2019      DP
                6365180               Jul   15,   2019      DP U-980
                7662858               Feb   24,   2029         U-1035
                7884095               Feb   24,   2029         U-1111
                7939518               Feb   24,   2029         U-980
                8110606               Feb   24,   2029         U-980
                8623920               Feb   24,   2029         U-1482
DICLOFENAC SODIUM - DICLOFENAC SODIUM
 A 202027 001                                                                                 PC           Nov 23, 2014
DICLOFENAC SODIUM - DICLOFENAC SODIUM
 N 020809 001   5603929          Nov 16, 2014                    U-239
                5653972          Nov 16, 2014                    U-239
DICLOFENAC SODIUM - PENNSAID
 N 020947 001   8217078               Jul   10,   2029           U-1248
                8546450               Aug   09,   2030           U-1435
                8546450               Aug   09,   2030           U-1436
                8618164               Jul   10,   2029           U-1477
                8741956               Jul   10,   2029           U-1435
DICLOFENAC SODIUM - SOLARAZE
 N 021005 001   5792753               Aug 11, 2015
                5914322               Aug 11, 2015
                5985850               Aug 11, 2015          DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 56 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)           DATE
	
DICLOFENAC SODIUM - DYLOJECT
	
 N 022396 001                                                                            NP           Dec 23, 2017
	
DICLOFENAC SODIUM - PENNSAID
	
 N 204623 001   8217078          Jul   10,   2029         U-1477                         NP           Jan 16, 2017
	
                8252838          Apr   21,   2028      DP U-1489
	
                8546450          Aug   09,   2030         U-1435
	
                8546450          Aug   09,   2030         U-1436
	
                8563613          Oct   17,   2027      DP U-1488
	
                8618164          Jul   10,   2029         U-1477
	
                8741956          Jul   10,   2029         U-1435
	
                8871809          Oct   17,   2027         U-1614
	
DIENOGEST; DIENOGEST; DIENOGEST; ESTRADIOL VALERATE; ESTRADIOL VALERATE; ESTRADIOL VALERATE; ESTRADIOL

VALERATE; ESTRADIOL VALERATE - NATAZIA
	
 N 022252 001   6133251          Oct 25, 2016       DP U-1             Y         I-648       Mar 14, 2015
                6133251          Oct 25, 2016       DP U-112           Y
                6133251          Oct 25, 2016       DP U-828           Y
                6884793          Oct 25, 2016       DP                 Y
                8071577          May 13, 2026       DP U-1
                8153616          Jan 30, 2028           U-1240
DIFLUPREDNATE - DUREZOL
 N 022212 001   6114319          May 18, 2019          DP                                I-653        Jun   13,   2015
                6114319*PED      Nov 18, 2019                                            M-127        Mar   22,   2016
                                                                                         ODE          Jun   13,   2019
                                                                                         PED          Dec   13,   2015
                                                                                         PED          Sep   22,   2016
                                                                                         PED          Dec   13,   2019
DILTIAZEM HYDROCHLORIDE - CARDIZEM LA
 N 021392 001   6923984          Feb 25, 2021          DP
                7108866          Dec 17, 2019          DP U-107
DILTIAZEM HYDROCHLORIDE - CARDIZEM LA
 N 021392 002   6923984          Feb 25, 2021          DP
                7108866          Dec 17, 2019          DP U-107
DILTIAZEM HYDROCHLORIDE - CARDIZEM LA
 N 021392 003   6923984          Feb 25, 2021          DP
                7108866          Dec 17, 2019          DP U-107
DILTIAZEM HYDROCHLORIDE - CARDIZEM LA
 N 021392 004   6923984          Feb 25, 2021          DP
                7108866          Dec 17, 2019          DP U-107
DILTIAZEM HYDROCHLORIDE - CARDIZEM LA
 N 021392 005   6923984          Feb 25, 2021          DP
                7108866          Dec 17, 2019          DP U-107
DILTIAZEM HYDROCHLORIDE - CARDIZEM LA
 N 021392 006   6923984          Feb 25, 2021          DP
                7108866          Dec 17, 2019          DP U-107
DIMETHYL FUMARATE - TECFIDERA
 N 204063 001   6509376          Oct   29,   2019      DP                                NCE          Mar 27, 2018
                7320999          May   18,   2020           U-1384
                7619001          Apr   01,   2018           U-1384
                7803840          Apr   01,   2018           U-1385
                8399514          Feb   07,   2028           U-1384
                8524773          Apr   01,   2018           U-1384
                8759393          Oct   29,   2019      DP
DIMETHYL FUMARATE - TECFIDERA
 N 204063 002   6509376          Oct   29,   2019      DP                                NCE          Mar 27, 2018
                7320999          May   18,   2020           U-1384
                7619001          Apr   01,   2018           U-1384
                7803840          Apr   01,   2018           U-1385
                8399514          Feb   07,   2028           U-1384
                8524773          Apr   01,   2018           U-1384
                8759393          Oct   29,   2019      DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 57 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
DIMYRISTOYL LECITHIN; PERFLEXANE   - IMAGENT
 N 021191 001   5695741            Dec 09, 2014               U-458
                5720938            Feb 24, 2015
                5798091            Aug 25, 2015               U-458
DIPHENHYDRAMINE CITRATE; IBUPROFEN - ADVIL PM
 N 021394 001   8263647          May 30, 2022            DP
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN - ADVIL PM
 N 021393 001   8883849          Jan 17, 2022                 U-1618
DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM - ALEVE PM
 N 205352 001                                                                              NC           Jan 17, 2017
DIVALPROEX SODIUM - DEPAKOTE ER
 N 021168 001   6419953            Dec   18,   2018
                6511678            Dec   18,   2018
                6528090            Dec   18,   2018      DP
                6528091            Dec   18,   2018         U-106
                6713086            Dec   18,   2018      DP U-579
                6720004            Dec   18,   2018      DP
DIVALPROEX SODIUM - DEPAKOTE ER
 N 021168 002   6511678            Dec   18,   2018
                6528090            Dec   18,   2018      DP
                6713086            Dec   18,   2018      DP U-579
                6720004            Dec   18,   2018      DP
DOFETILIDE - TIKOSYN
 N 020931 001   6124363            Oct 09, 2018
DOFETILIDE - TIKOSYN
 N 020931 002   6124363            Oct 09, 2018
DOFETILIDE - TIKOSYN
 N 020931 003   6124363            Oct 09, 2018
DOLUTEGRAVIR SODIUM - TIVICAY
 N 204790 001   8129385            Oct 05, 2027       DS DP                                NCE          Aug 12, 2018
DONEPEZIL HYDROCHLORIDE - ARICEPT ODT
 N 021720 001   7727548          Jun 23, 2022            DP U-1062
                7727552          Mar 26, 2018            DP
DONEPEZIL HYDROCHLORIDE - ARICEPT ODT
 N 021720 002   7727548          Jun 23, 2022            DP U-1062
                7727552          Mar 26, 2018            DP
DONEPEZIL HYDROCHLORIDE - ARICEPT
 N 022568 001   8481565          Oct 04, 2026            DP
DORIPENEM - DORIBAX
 N 022106 001   5317016            Jun 05, 2015       DS DP U-282
                8247402            Mar 30, 2021       DS DP
DORIPENEM - DORIBAX
 N 022106 002   5317016            Jun 05, 2015       DS DP U-282
                8247402            Mar 30, 2021       DS DP
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE - COSOPT PF
 N 202667 001                                                                              NP           Feb 01, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 58 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
DOXEPIN HYDROCHLORIDE - SILENOR
 N 022036 001   5585115            Jan   09,   2015      DP
                5725884            Jan   09,   2015      DP
                5866166            Jan   09,   2015      DP
                5948438            Jan   09,   2015      DP
                6103219            Jan   09,   2015      DP
                6211229            Feb   17,   2020           U-620
                6217909            Jan   09,   2015      DP
                7915307            Aug   24,   2027           U-620
                8513299            Apr   14,   2030           U-620
DOXEPIN HYDROCHLORIDE - SILENOR
 N 022036 002   5585115            Jan   09,   2015      DP
                5725884            Jan   09,   2015      DP
                5866166            Jan   09,   2015      DP
                5948438            Jan   09,   2015      DP
                6103219            Jan   09,   2015      DP
                6211229            Feb   17,   2020           U-620
                6217909            Jan   09,   2015      DP
                7915307            Aug   24,   2027           U-620
                8513299            Apr   14,   2030           U-620
DOXERCALCIFEROL - HECTOROL
 N 020862 001   6903083            Jul 18, 2021       DS DP                   Y
DOXERCALCIFEROL - HECTOROL
 N 020862 002   6903083            Jul 18, 2021       DS DP                   Y
DOXYCYCLINE - ORACEA
 N 050805 001   5789395            Aug   30,   2016           U-925           Y
                5919775            Aug   30,   2016           U-925           Y
                7211267            Apr   05,   2022           U-925
                7232572            Apr   05,   2022           U-925
                7749532            Dec   19,   2027      DP   U-1063
                8206740            Dec   24,   2025      DP   U-925
                8394405            Apr   07,   2024      DP   U-925
                8394406            Apr   07,   2024      DP   U-925
                8470364            Apr   07,   2024      DP   U-925
                8603506            Apr   05,   2022           U-1063
                8709478            Apr   07,   2024           U-1063
DOXYCYCLINE HYCLATE - DORYX
 N 050795 001   6958161            Dec 15, 2022          DP U-918
                8715724            Feb 03, 2028          DP
DOXYCYCLINE HYCLATE - DORYX
 N 050795 002   6958161            Dec 15, 2022          DP U-918
                8715724            Feb 03, 2028          DP
DOXYCYCLINE HYCLATE - DORYX
 N 050795 003   6958161            Dec 15, 2022          DP U-918
                8715724            Feb 03, 2028          DP
DOXYCYCLINE HYCLATE - DORYX
 N 050795 004   6958161            Dec 15, 2022          DP U-918
                8715724            Feb 03, 2028          DP
DOXYCYCLINE HYCLATE - DORYX
 N 050795 005   6958161            Dec 15, 2022          DP U-918                          D-136        Apr 11, 2016
                8715724            Feb 03, 2028          DP                                NS           Apr 11, 2016
DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE - DICLEGIS
 N 021876 001   6340695          Jun 21, 2021       DP U-1382                              NP           Apr 08, 2016
                7560122          Jan 25, 2019       DP
DRONEDARONE HYDROCHLORIDE - MULTAQ
 N 022425 001   5223510          Jul     26,   2016   DS DP U-992                          NCE          Jul 01, 2014
                5223510          Jul     26,   2016   DS DP U-1261
                7323493          Jun     19,   2018      DP
                8318800          Jun     19,   2018      DP
                8410167          Apr     16,   2029         U-1387
                8410167          Apr     16,   2029         U-1388
                8602215          Jun     30,   2031         U-1473
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 59 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT        DELIST          EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES       REQUESTED          CODE(S)           DATE
	
DROSPIRENONE; ESTRADIOL - ANGELIQ
 N 021355 001   8906890          Oct 22, 2031              DP                              NS           Mar 01, 2015
DROSPIRENONE; ESTRADIOL - ANGELIQ
 N 021355 002   6933395          Aug 11, 2017         DS
DROSPIRENONE; ETHINYL ESTRADIOL - YASMIN
 N 021098 001   6787531          Aug 31, 2020              DP
                6933395          Aug 11, 2017         DS
DROSPIRENONE; ETHINYL ESTRADIOL - YAZ
 N 021676 001   5798338          Jul 10,    2015           DP
                6787531          Aug 31,    2020           DP
                6933395          Aug 11,    2017           DP
                6958326          Dec 20,    2021           DP
                6987101          Dec 22,    2017                U-758
                7163931          Dec 20,    2021                U-1
DROSPIRENONE; ETHINYL ESTRADIOL;   LEVOMEFOLATE CALCIUM - BEYAZ
 N 022532 001   5798338            Jul 10, 2015       DP
                6441168            Apr 17, 2020    DS
                6958326            Dec 20, 2021       DP
                7163931            Mar 03, 2022           U-1
                8617597            Feb 08, 2030       DP
DROSPIRENONE; ETHINYL ESTRADIOL;   LEVOMEFOLATE CALCIUM - SAFYRAL
 N 022574 001   5798338            Jul 10, 2015       DP
                6441168            Apr 17, 2020    DS
                6958326            Dec 20, 2021       DP
                7163931            Mar 03, 2022           U-1
                8617597            Feb 08, 2030       DP
DROXIDOPA - NORTHERA
 N 203202 001                                                                              NCE          Feb 18, 2019
                                                                                           ODE          Feb 18, 2021
DROXIDOPA - NORTHERA
 N 203202 002                                                                              NCE          Feb 18, 2019
                                                                                           ODE          Feb 18, 2021
DROXIDOPA - NORTHERA
 N 203202 003                                                                              NCE          Feb 18, 2019
                                                                                           ODE          Feb 18, 2021
DULOXETINE HYDROCHLORIDE - CYMBALTA
 N 021427 001   5508276          Jul 18, 2014              DP                              M-61         Oct   18,   2015
                6596756          Sep 10, 2019                   U-882                      NPP          Oct   16,   2017
                                                                                           NPP          Oct   16,   2017
                                                                                           PED          Apr   18,   2016
DULOXETINE HYDROCHLORIDE - CYMBALTA
 N 021427 002   5508276          Jul 18, 2014              DP                              M-61         Oct   18,   2015
                6596756          Sep 10, 2019                   U-882                      NPP          Oct   16,   2017
                                                                                           NPP          Oct   16,   2017
                                                                                           PED          Apr   18,   2016
DULOXETINE HYDROCHLORIDE - CYMBALTA
 N 021427 004   5508276          Jul 18, 2014              DP                              M-61         Oct   18,   2015
                6596756          Sep 10, 2019                   U-882                      NPP          Oct   16,   2017
                                                                                           NPP          Oct   16,   2017
                                                                                           PED          Apr   18,   2016
DUTASTERIDE - AVODART
 N 021319 001   5565467            Nov 20, 2015       DS DP
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE - JALYN
 N 022460 001   5565467          Nov 20, 2015         DS DP
ECONAZOLE NITRATE - ECOZA
 N 205175 001   5993830            Jan 16, 2018            DP U-1449                       NDF          Oct 24, 2016
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 60 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT                             PATENT                          EXCLUSIVITY
     NO          PATENT NO
	      EXPIRATION             PATENT        DELIST          EXCLUSIVITY      EXPIRATION
                                     DATE                 CODES       REQUESTED          CODE(S)           DATE
EFAVIRENZ - SUSTIVA
	
 N 020972 001   5663169
	        Sep   02,   2014             U-257                      NPP          May 02, 2016
                5663169*PED
	    Mar   02,   2015                                        PED          Nov 02, 2016
                6238695
	        Apr   06,   2019        DP
                6238695*PED
	    Oct   06,   2019
                6555133
	        Apr   06,   2019             U-248
                6555133*PED
	    Oct   06,   2019
                6639071
	        Feb   14,   2018   DS
                6639071*PED
	    Aug   14,   2018
                6939964
	        Jan   20,   2018   DS
                6939964*PED
	    Jul   20,   2018
EFAVIRENZ - SUSTIVA
	
 N 020972 002   5663169
	        Sep   02,   2014             U-257
                5663169*PED
	    Mar   02,   2015
                6238695
	        Apr   06,   2019        DP
                6238695*PED
	    Oct   06,   2019
                6555133
	        Apr   06,   2019             U-248
                6555133*PED
	    Oct   06,   2019
                6639071
	        Feb   14,   2018   DS
                6639071*PED
	    Aug   14,   2018
                6939964
	        Jan   20,   2018   DS
                6939964*PED
	    Jul   20,   2018
EFAVIRENZ - SUSTIVA
	
 N 020972 003   5663169
	        Sep   02,   2014             U-257                      NPP          May 02, 2016
                5663169*PED
	    Mar   02,   2015                                        PED          Nov 02, 2016
                6238695
	        Apr   06,   2019        DP
                6238695*PED
	    Oct   06,   2019
                6555133
	        Apr   06,   2019             U-248
                6555133*PED
	    Oct   06,   2019
                6639071
	        Feb   14,   2018   DS
                6639071*PED
	    Aug   14,   2018
                6939964
	        Jan   20,   2018   DS
                6939964*PED
	    Jul   20,   2018
EFAVIRENZ - SUSTIVA
	
 N 021360 001   5663169
	        Sep   02,   2014
                5663169*PED
	    Mar   02,   2015
                6639071
	        Feb   14,   2018   DS
                6639071*PED
	    Aug   14,   2018
                6939964
	        Jan   20,   2018   DS
                6939964*PED
	    Jul   20,   2018
EFAVIRENZ - SUSTIVA
	
 N 021360 002   5663169
	        Sep   02,   2014             U-248                      NPP          May 02, 2016
                5663169*PED
	    Mar   02,   2015                                        PED          Nov 02, 2016
                6639071
	        Feb   14,   2018   DS
                6639071*PED
	    Aug   14,   2018
                6939964
	        Jan   20,   2018   DS
                6939964*PED
	    Jul   20,   2018
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 61 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                      PATENT                                 EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION      PATENT        DELIST                 EXCLUSIVITY      EXPIRATION
	
                                       DATE          CODES       REQUESTED                 CODE(S)           DATE
	
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - ATRIPLA
 N 021937 001   5663169          Sep 02, 2014           U-750
                5663169          Sep 02, 2014           U-1170
                5663169*PED      Mar 02, 2015
                5814639          Sep 29, 2015    DS DP
                5914331          Jul 02, 2017    DS
                5922695          Jul 25, 2017    DS     U-750
                5922695          Jul 25, 2017    DS     U-1170
                5935946          Jul 25, 2017    DS DP U-750
                5935946          Jul 25, 2017    DS DP U-1170
                5977089          Jul 25, 2017    DS DP U-750
                5977089          Jul 25, 2017    DS DP U-1170
                6043230          Jul 25, 2017           U-750
                6043230          Jul 25, 2017           U-1170
                6639071          Feb 14, 2018    DS
                6639071*PED      Aug 14, 2018
                6642245          Nov 04, 2020           U-750
                6642245          Nov 04, 2020           U-1170
                6703396          Mar 09, 2021    DS DP
                6939964          Jan 20, 2018    DS
                6939964*PED      Jul 20, 2018
                8592397          Jan 13, 2024       DP U-750
                8592397          Jan 13, 2024       DP U-1170
                8598185          May 01, 2028       DP
                8716264          Jan 13, 2024       DP U-257
EFINACONAZOLE - JUBLIA
 N 203567 001   7214506            Oct 05, 2021                 U-281                      NCE          Jun 06, 2019
                8039494            Jul 08, 2030                 U-281
                8486978            Oct 24, 2030            DP
EFLORNITHINE HYDROCHLORIDE - VANIQA
 N 021145 001   5648394          Jul 15, 2014                   U-334
ELETRIPTAN HYDROBROMIDE - RELPAX
 N 021016 001   5545644          Dec 26, 2016         DS DP U-876
                6110940          Aug 29, 2017
ELETRIPTAN HYDROBROMIDE - RELPAX
 N 021016 002   5545644          Dec 26, 2016         DS DP U-876
                6110940          Aug 29, 2017
ELIGLUSTAT TARTRATE - CERDELGA
 N 205494 001   6916802            Apr 29, 2022                 U-1571                     NCE          Aug 19, 2019
                7196205            Apr 29, 2022       DS                                   ODE          Aug 19, 2021
                7615573            Apr 29, 2022                 U-1571
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 62 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                          PATENT
	                                  PATENT                    EXCLUSIVITY
	
     NO          PATENT NO
	       EXPIRATION
	              PATENT            DELIST    EXCLUSIVITY      EXPIRATION
	
                                      DATE
	                  CODES          REQUESTED     CODE(S)           DATE
	
ELTROMBOPAG OLAMINE - PROMACTA
	
 N 022291 001   6280959
	          Oct   30,   2018
	   DS   DP   U-930                    I-664        Nov 16, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1306                   ODE          Nov 20, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1575                   ODE          Aug 26, 2021

                7160870
	          Nov   20,   2022
	   DS   DP   U-930
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1306
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1575
	
                7332481
	          May   24,   2021
              U-930
	
                7332481
	          May   24,   2021
              U-1306
	
                7332481
	          May   24,   2021
              U-1575
	
                7452874
	          May   24,   2021
    DS   DP
	
                7473686
	          May   24,   2021
    DS   DP U-930
	
                7473686
	          May   24,   2021
    DS   DP U-1306
	
                7473686
	          May   24,   2021
    DS   DP U-1575
	
                7547719
	          Jul   13,   2025
	   DS   DP U-930
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1306
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1575
	
                7790704
	          May   24,   2021
              U-930
	
                7790704
	          May   24,   2021
              U-1306
	
                7790704
	          May   24,   2021
              U-1575
	
                7795293
	          May   21,   2023
              U-930
	
                7795293
	          May   21,   2023
              U-1306
	
                7795293
	          May   21,   2023
              U-1575
	
                8052993
	          Aug   01,   2027
         DP U-930
	
                8052993
	          Aug   01,   2027
         DP U-1306
	
                8052993
	          Aug   01,   2027
         DP U-1575
	
                8828430
	          Aug   01,   2027
         DP U-1306
	
                8828430
	          Aug   01,   2027
	        DP U-1619
	
ELTROMBOPAG OLAMINE - PROMACTA
	
 N 022291 002   6280959
	          Oct   30,   2018
	   DS   DP   U-930                    I-664        Nov 16, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1306                   ODE          Nov 20, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1575                   ODE          Aug 26, 2021

                7160870
	          Nov   20,   2022
	   DS   DP   U-930
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1306
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1575
	
                7332481
	          May   24,   2021
              U-930
	
                7332481
	          May   24,   2021
              U-1306
	
                7332481
	          May   24,   2021
              U-1575
	
                7452874
	          May   24,   2021
    DS   DP
	
                7473686
	          May   24,   2021
    DS   DP U-930
	
                7473686
	          May   24,   2021
    DS   DP U-1306
	
                7473686
	          May   24,   2021
    DS   DP U-1575
	
                7547719
	          Jul   13,   2025
	   DS   DP U-930
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1306
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1575
	
                7790704
	          May   24,   2021
              U-930
	
                7790704
	          May   24,   2021
              U-1306
	
                7790704
	          May   24,   2021
              U-1575
	
                7795293
	          May   21,   2023
              U-930
	
                7795293
	          May   21,   2023
              U-1306
	
                7795293
	          May   21,   2023
              U-1575
	
                8052994
	          Aug   01,   2027
         DP U-930
	
                8052994
	          Aug   01,   2027
         DP U-1306
	
                8052994
	          Aug   01,   2027
         DP U-1575
	
                8828430
	          Aug   01,   2027
         DP U-1306
	
                8828430
	          Aug   01,   2027
	        DP U-1619
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 63 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                          PATENT
	                                  PATENT                    EXCLUSIVITY
	
     NO          PATENT NO
	       EXPIRATION
	              PATENT            DELIST    EXCLUSIVITY      EXPIRATION
	
                                      DATE
	                  CODES          REQUESTED     CODE(S)           DATE
	
ELTROMBOPAG OLAMINE - PROMACTA
	
 N 022291 003   6280959
	          Oct   30,   2018
	   DS   DP   U-930                    I-664        Nov 16, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1306                   ODE          Nov 20, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1575                   ODE          Aug 26, 2021

                7160870
	          Nov   20,   2022
	   DS   DP   U-930
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1306
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1575
	
                7332481
	          May   24,   2021
              U-930
	
                7332481
	          May   24,   2021
              U-1306
	
                7332481
	          May   24,   2021
              U-1575
	
                7452874
	          May   24,   2021
    DS   DP
	
                7473686
	          May   24,   2021
    DS   DP U-930
	
                7473686
	          May   24,   2021
    DS   DP U-1306
	
                7473686
	          May   24,   2021
    DS   DP U-1575
	
                7547719
	          Jul   13,   2025
	   DS   DP U-930
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1306
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1575
	
                7790704
	          May   24,   2021
              U-930
	
                7790704
	          May   24,   2021
              U-1306
	
                7790704
	          May   24,   2021
              U-1575
	
                7795293
	          May   21,   2023
              U-930
	
                7795293
	          May   21,   2023
              U-1306
	
                7795293
	          May   21,   2023
              U-1575
	
                8062665
	          Aug   01,   2027
         DP U-930
	
                8062665
	          Aug   01,   2027
         DP U-1306
	
                8062665
	          Aug   01,   2027
         DP U-1575
	
                8828430
	          Aug   01,   2027
         DP U-1306
	
                8828430
	          Aug   01,   2027
	        DP U-1619
	
ELTROMBOPAG OLAMINE - PROMACTA
	
 N 022291 004   6280959
	          Oct   30,   2018
	   DS   DP   U-930                    I-664        Nov 16, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1306                   ODE          Nov 20, 2015
	
                6280959
	          Oct   30,   2018
	   DS   DP   U-1575                   ODE          Aug 26, 2021

                7160870
	          Nov   20,   2022
	   DS   DP   U-930
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1306
	
                7160870
	          Nov   20,   2022
	   DS   DP   U-1575
	
                7332481
	          May   24,   2021
              U-930
	
                7332481
	          May   24,   2021
              U-1306
	
                7332481
	          May   24,   2021
              U-1575
	
                7452874
	          May   24,   2021
    DS   DP
	
                7473686
	          May   24,   2021
    DS   DP U-930
	
                7473686
	          May   24,   2021
    DS   DP U-1306
	
                7473686
	          May   24,   2021
    DS   DP U-1575
	
                7547719
	          Jul   13,   2025
	   DS   DP U-930
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1306
	
                7547719
	          Jul   13,   2025
	   DS   DP U-1575
	
                7790704
	          May   24,   2021
              U-930
	
                7790704
	          May   24,   2021
              U-1306
	
                7790704
	          May   24,   2021
              U-1575
	
                7795293
	          May   21,   2023
              U-930
	
                7795293
	          May   21,   2023
              U-1306
	
                7795293
	          May   21,   2023
              U-1575
	
                8071129
	          Aug   01,   2027
         DP U-930
	
                8071129
	          Aug   01,   2027
         DP U-1306
	
                8071129
	          Aug   01,   2027
         DP U-1575
	
                8828430
	          Aug   01,   2027
         DP U-1306
	
                8828430
	          Aug   01,   2027
	        DP U-1619
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                      ADA 64 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT
	                       EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION             PATENT           DELIST       EXCLUSIVITY
	      EXPIRATION
	
                                        DATE                 CODES          REQUESTED       CODE(S)
            DATE
	
ELTROMBOPAG OLAMINE - PROMACTA
	
 N 022291 005   6280959             Oct   30,   2018   DS   DP   U-930                      I-664
	        Nov 16, 2015
	
                6280959             Oct   30,   2018   DS   DP   U-1306                     ODE
	          Nov 20, 2015
	
                6280959             Oct   30,   2018   DS   DP   U-1575                     ODE
	          Aug 26, 2021
	
                7160870             Nov   20,   2022   DS   DP   U-930
	
                7160870             Nov   20,   2022   DS   DP   U-1306
	
                7160870             Nov   20,   2022   DS   DP   U-1575
	
                7332481             May   24,   2021             U-930
	
                7332481             May   24,   2021             U-1306
	
                7332481             May   24,   2021             U-1575
	
                7452874             May   24,   2021   DS   DP
	
                7473686             May   24,   2021   DS   DP U-930
	
                7473686             May   24,   2021   DS   DP U-1306
	
                7473686             May   24,   2021   DS   DP U-1575
	
                7547719             Jul   13,   2025   DS   DP U-930
	
                7547719             Jul   13,   2025   DS   DP U-1306
	
                7547719             Jul   13,   2025   DS   DP U-1575
	
                7790704             May   24,   2021             U-930
	
                7790704             May   24,   2021             U-1306
	
                7790704             May   24,   2021             U-1575
	
                7795293             May   21,   2023             U-930
	
                7795293             May   21,   2023             U-1306
	
                7795293             May   21,   2023             U-1575
	
                8052995             Aug   01,   2027        DP U-1306
	
                8052995             Aug   01,   2027        DP U-1575
	
ELVITEGRAVIR - VITEKTA
	
 N 203093 001   7176220             Nov 20, 2023       DS DP U-257                          NP
	           Sep 24, 2017
	
                7635704             Oct 26, 2026       DS DP U-257
	
ELVITEGRAVIR - VITEKTA
	
 N 203093 002   7176220             Nov 20, 2023       DS DP U-257                          NP
	           Sep 24, 2017
	
                7635704             Oct 26, 2026       DS DP U-257
	
EMPAGLIFLOZIN - JARDIANCE
	
 N 204629 001   7579449             Nov 05, 2025       DS                                   NCE
	          Aug 01, 2019
	
                7713938             Apr 15, 2027       DS DP
	
EMPAGLIFLOZIN - JARDIANCE
	
 N 204629 002   7579449             Nov 05, 2025       DS                                   NCE
	          Aug 01, 2019
	
                7713938             Apr 15, 2027       DS DP
	
EMTRICITABINE - EMTRIVA
	
 N 021500 001   5814639             Sep   29,   2015   DS DP
	
                5914331             Jul   02,   2017   DS
	
                6642245             Nov   04,   2020             U-257
	
                6642245             Nov   04,   2020             U-541
	
                6703396             Mar   09,   2021   DS DP
	
EMTRICITABINE - EMTRIVA
	
 N 021896 001   5814639             Sep   29,   2015   DS DP
	
                5914331             Jul   02,   2017   DS
	
                6642245             Nov   04,   2020             U-257
	
                6703396             Mar   09,   2021   DS DP
	
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR         DISOPROXIL FUMARATE - COMPLERA
	
 N 202123 001   5814639          Sep 29, 2015    DS         DP                           NCE
	             May 20, 2016

                5914331          Jul 02, 2017    DS                                      NPP
	             Dec 13, 2016
	
                5922695          Jul 25, 2017    DS              U-257
	
                5935946          Jul 25, 2017    DS         DP U-257
	
                5977089          Jul 25, 2017    DS         DP U-257
	
                6043230          Jul 25, 2017                    U-257
	
                6642245          Nov 04, 2020                    U-257
	
                6703396          Mar 09, 2021    DS         DP
	
                6838464          Feb 26, 2021    DS         DP
	
                7067522          Dec 20, 2019    DS         DP
	
                7125879          Apr 14, 2023    DS         DP U-257
	
                8080551          Apr 11, 2023    DS         DP
	
                8101629          Aug 09, 2022               DP
	
                8592397          Jan 13, 2024               DP U-257
	
                8716264          Jan 13, 2024               DP U-257
	
                8841310          Dec 09, 2025               DP U-257
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 65 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION      PATENT                DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE          CODES               REQUESTED         CODE(S)           DATE
	
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE - TRUVADA
 N 021752 001   5814639          Sep 29, 2015    DS DP
                5914331          Jul 02, 2017    DS DP U-248
                5922695          Jul 25, 2017    DS     U-248
                5922695          Jul 25, 2017    DS     U-541
                5922695          Jul 25, 2017    DS     U-1170
                5922695          Jul 25, 2017    DS     U-1259
                5935946          Jul 25, 2017    DS DP U-248
                5935946          Jul 25, 2017    DS DP U-541
                5935946          Jul 25, 2017    DS DP U-1170
                5935946          Jul 25, 2017    DS DP U-1259
                5977089          Jul 25, 2017    DS DP U-248
                5977089          Jul 25, 2017    DS DP U-541
                5977089          Jul 25, 2017    DS DP U-1170
                5977089          Jul 25, 2017    DS DP U-1259
                6043230          Jul 25, 2017       DP U-248
                6043230          Jul 25, 2017       DP U-541
                6043230          Jul 25, 2017       DP U-1170
                6043230          Jul 25, 2017       DP U-1259
                6642245          Nov 04, 2020           U-248
                6642245          Nov 04, 2020           U-541
                6642245          Nov 04, 2020           U-1170
                6703396          Mar 09, 2021    DS DP
                8592397          Jan 13, 2024       DP U-248
                8592397          Jan 13, 2024       DP U-541
                8592397          Jan 13, 2024       DP U-1170
                8716264          Jan 13, 2024       DP U-257
ENALAPRIL MALEATE - EPANED KIT
 N 204308 001   8568747            Nov 06, 2032            DP
                8778366            Nov 06, 2032                 U-3
                8778366            Nov 06, 2032                 U-185
ENFUVIRTIDE - FUZEON
 N 021481 001   6133418            Nov 17, 2014       DS DP
                6475491            Jun 07, 2015                 U-248
ENTACAPONE - COMTAN
 N 020796 001   6599530            Sep 14, 2018            DP U-219
ENTECAVIR - ENTECAVIR
 A 202122 001                                                                              PC           Feb 21, 2015
ENTECAVIR - ENTECAVIR
 A 202122 002                                                                              PC           Feb 21, 2015
ENTECAVIR - BARACLUDE
 N 021797 001   5206244            Feb 21, 2015       DS                                   NPP          Oct   12,   2015
                5206244*PED        Aug 21, 2015                                            NPP          Mar   20,   2017
                                                                                           PED          Apr   12,   2016
                                                                                           PED          Sep   20,   2017
ENTECAVIR - BARACLUDE
 N 021797 002   5206244            Feb 21, 2015       DS                                   NPP          Oct   12,   2015
                5206244*PED        Aug 21, 2015                                            NPP          Mar   20,   2017
                                                                                           PED          Apr   12,   2016
                                                                                           PED          Sep   20,   2017
ENTECAVIR - BARACLUDE
 N 021798 001   5206244            Feb 21, 2015       DS                                   NPP          Oct   12,   2015
                5206244*PED        Aug 21, 2015                                            NPP          Mar   20,   2017
                                                                                           PED          Apr   12,   2016
                                                                                           PED          Sep   20,   2017
ENZALUTAMIDE - XTANDI
 N 203415 001   7709517            Aug 13, 2027       DS DP                                I-693        Sep 10, 2017
                8183274            May 15, 2026                 U-1281                     NCE          Aug 31, 2017
                8183274            May 15, 2026                 U-1588
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 66 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
EPINEPHRINE - EPIPEN
	
 N 019430 001   7449012            Sep   11,   2025      DP
	
                7794432            Sep   11,   2025      DP
	
                8048035            Sep   11,   2025      DP
	
                8870827            Sep   11,   2025      DP
	
EPINEPHRINE - EPIPEN JR.
	
 N 019430 002   7449012            Sep   11,   2025      DP
	
                7794432            Sep   11,   2025      DP
	
                8048035            Sep   11,   2025      DP
	
                8870827            Sep   11,   2025      DP
	
EPINEPHRINE - TWINJECT 0.3
	
 N 020800 001   7297136            Jan 18, 2025          DP
	
                7621891            Feb 04, 2025          DP
	
EPINEPHRINE - TWINJECT 0.15
	
 N 020800 002   7297136            Jan 18, 2025          DP
	
                7621891            Feb 04, 2025          DP
	
EPINEPHRINE - AUVI-Q
	
 N 201739 001   7731686            Jun   01,   2026      DP
	
                7731690            Jan   15,   2025      DP
	
                7749194            Oct   30,   2028      DP
	
                7918823            Nov   23,   2024      DP
	
                7947017            Mar   12,   2028      DP
	
                8016788            Mar   21,   2025      DP
	
                8021344            Nov   02,   2029      DP
	
                8206360            Feb   27,   2027      DP
	
                8226610            Apr   10,   2029      DP
	
                8231573            Nov   25,   2028      DP
	
                8313466            Nov   23,   2024      DP
	
                8361029            Nov   23,   2024      DP
	
                8425462            Nov   23,   2024      DP
	
EPINEPHRINE - AUVI-Q
	
 N 201739 002   7731686            Jun   01,   2026      DP
	
                7731690            Jan   15,   2025      DP
	
                7749194            Oct   30,   2028      DP
	
                7918823            Nov   23,   2024      DP
	
                7947017            Mar   12,   2028      DP
	
                8016788            Mar   21,   2025      DP
	
                8021344            Nov   02,   2029      DP
	
                8206360            Feb   27,   2027      DP
	
                8226610            Apr   10,   2029      DP
	
                8231573            Nov   25,   2028      DP
	
                8313466            Nov   23,   2024      DP
	
                8361029            Nov   23,   2024      DP
	
                8425462            Nov   23,   2024      DP
	
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE - LIDOSITE TOPICAL SYSTEM KIT
	
 N 021504 001   6629968          Jun 30, 2020    DS DP
	
                6635045          Jun 29, 2021    DS DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 67 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                               PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT            DELIST        EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES           REQUESTED        CODE(S)           DATE
	
EPLERENONE - INSPRA
	
 N 021437 001   6410054            Dec   08,   2019         U-3
	
                6410054            Dec   08,   2019         U-537
	
                6410524            Nov   05,   2019         U-467
	
                6495165            Dec   08,   2019         U-3
	
                6495165            Dec   08,   2019         U-537
	
                6534093            Dec   08,   2019         U-3
	
                6534093            Dec   08,   2019         U-537
	
                6558707            Dec   08,   2019      DP U-537
	
                6747020            Nov   05,   2019         U-587
	
                7157101            Dec   08,   2019      DP U-664
	
EPLERENONE - INSPRA
	
 N 021437 002   6410054            Dec   08,   2019         U-3
	
                6410054            Dec   08,   2019         U-537
	
                6410524            Nov   05,   2019         U-467
	
                6495165            Dec   08,   2019         U-3
	
                6495165            Dec   08,   2019         U-537
	
                6534093            Dec   08,   2019         U-3
	
                6534093            Dec   08,   2019         U-537
	
                6558707            Dec   08,   2019      DP U-537
	
                6747020            Nov   05,   2019         U-587
	
                7157101            Dec   08,   2019      DP U-664
	
EPLERENONE - INSPRA
	
 N 021437 003   6410054            Dec   08,   2019         U-3
	
                6410054            Dec   08,   2019         U-537
	
                6410524            Nov   05,   2019         U-467
	
                6495165            Dec   08,   2019         U-3
	
                6495165            Dec   08,   2019         U-537
	
                6534093            Dec   08,   2019         U-3
	
                6534093            Dec   08,   2019         U-537
	
                6558707            Dec   08,   2019      DP U-537
	
                6747020            Nov   05,   2019         U-587
	
                7157101            Dec   08,   2019      DP U-664
	
EPOPROSTENOL SODIUM - VELETRI
	
 N 022260 001   8318802            Mar 15, 2027          DP
	
                8598227            Feb 02, 2027
	
EPOPROSTENOL SODIUM - VELETRI
	
 N 022260 002   8318802            Mar 15, 2027          DP
	
                8598227            Feb 02, 2027
	
EPROSARTAN MESYLATE - TEVETEN
	
 N 020738 004   5656650            Aug 12, 2014                 U-3
	
EPROSARTAN MESYLATE - TEVETEN
	
 N 020738 005   5656650            Aug 12, 2014                 U-3
	
EPROSARTAN MESYLATE - TEVETEN
	
 N 020738 006   5656650            Aug 12, 2014                 U-3
	
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE - TEVETEN HCT
	
 N 021268 001   5656650          Aug 12, 2014            U-3
	
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE - TEVETEN HCT
	
 N 021268 002   5656650          Aug 12, 2014            U-3
	
EPTIFIBATIDE - INTEGRILIN
	
 N 020718 001   5686570            Nov   11,   2014
	
                5747447            May   05,   2015

                5756451            Nov   11,   2014
	
                5807825            Sep   15,   2015             U-244
	
                5968902            Jun   02,   2015             U-453
	
EPTIFIBATIDE - INTEGRILIN
	
 N 020718 002   5686570            Nov   11,   2014
	
                5747447            May   05,   2015

                5756451            Nov   11,   2014
	
                5807825            Sep   15,   2015             U-244
	
                5968902            Jun   02,   2015             U-453
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 68 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
	
                                     DATE                 CODES        REQUESTED         CODE(S)           DATE
	
ERIBULIN MESYLATE - HALAVEN
 N 201532 001   6214865          Jun   16,   2019   DS                                   NCE          Nov 15, 2015
                6469182          Jun   16,   2019             U-1096
                7470720          Jun   16,   2019        DP
                8097648          Jan   22,   2021             U-1096
ERLOTINIB HYDROCHLORIDE - TARCEVA
 N 021743 001   5747498          Nov   08,   2018   DS   DP   U-659                      I-671        May 14, 2016
                6900221          Nov   09,   2020   DS   DP   U-659
                6900221          Nov   09,   2020   DS   DP   U-875
                6900221          Nov   09,   2020   DS   DP   U-1046
                6900221          Nov   09,   2020   DS   DP   U-1403
                7087613          Nov   09,   2020             U-659
                7087613          Nov   09,   2020             U-1045
                7087613          Nov   09,   2020             U-1403
                RE41065          Nov   08,   2018   DS DP
ERLOTINIB HYDROCHLORIDE - TARCEVA
 N 021743 002   5747498          Nov   08,   2018   DS   DP   U-659                      I-671        May 14, 2016
                6900221          Nov   09,   2020   DS   DP   U-659
                6900221          Nov   09,   2020   DS   DP   U-875
                6900221          Nov   09,   2020   DS   DP   U-1046
                6900221          Nov   09,   2020   DS   DP   U-1403
                7087613          Nov   09,   2020             U-659
                7087613          Nov   09,   2020             U-1045
                7087613          Nov   09,   2020             U-1403
                RE41065          Nov   08,   2018   DS DP
ERLOTINIB HYDROCHLORIDE - TARCEVA
 N 021743 003   5747498          Nov   08,   2018   DS   DP   U-659                      I-671        May 14, 2016
                6900221          Nov   09,   2020   DS   DP   U-659
                6900221          Nov   09,   2020   DS   DP   U-875
                6900221          Nov   09,   2020   DS   DP   U-1046
                6900221          Nov   09,   2020   DS   DP   U-1403
                7087613          Nov   09,   2020             U-659
                7087613          Nov   09,   2020             U-1045
                7087613          Nov   09,   2020             U-1403
                RE41065          Nov   08,   2018   DS DP
ERTAPENEM SODIUM - INVANZ
 N 021337 001   5478820          Nov 21, 2015       DS DP U-160
                5952323          May 15, 2017          DP
ESCITALOPRAM OXALATE - LEXAPRO
 N 021323 001   6916941          Aug 12, 2022       DS DP
                7420069          Aug 12, 2022          DP
ESCITALOPRAM OXALATE - LEXAPRO
 N 021323 002   6916941          Aug 12, 2022       DS DP
                7420069          Aug 12, 2022          DP
ESCITALOPRAM OXALATE - LEXAPRO
 N 021323 003   6916941          Aug 12, 2022       DS DP
                7420069          Aug 12, 2022          DP
ESLICARBAZEPINE ACETATE - APTIOM
 N 022416 001   5753646          Jun 27, 2016       DS DP U-1451                         NCE          Nov 08, 2018
                8372431          Apr 17, 2030          DP
ESLICARBAZEPINE ACETATE - APTIOM
 N 022416 002   5753646          Jun 27, 2016       DS DP U-1451                         NCE          Nov 08, 2018
                8372431          Apr 17, 2030          DP
ESLICARBAZEPINE ACETATE - APTIOM
 N 022416 003   5753646          Jun 27, 2016       DS DP U-1451                         NCE          Nov 08, 2018
                8372431          Apr 17, 2030          DP
ESLICARBAZEPINE ACETATE - APTIOM
 N 022416 004   5753646          Jun 27, 2016       DS DP U-1451                         NCE          Nov 08, 2018
                8372431          Apr 17, 2030          DP
ESMOLOL HYDROCHLORIDE - BREVIBLOC IN PLASTIC CONTAINER
	
 N 019386 004   6310094          Jan 12, 2021
	
                6528540          Jan 12, 2021
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 69 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                    PATENT                                   EXCLUSIVITY
     NO            PATENT NO           EXPIRATION   PATENT         DELIST                   EXCLUSIVITY      EXPIRATION
                                          DATE       CODES       REQUESTED                    CODE(S)           DATE
ESMOLOL HYDROCHLORIDE - BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER
 N 019386    005   6310094            Jan 12, 2021
	
                   6528540            Jan 12, 2021
	
ESMOLOL HYDROCHLORIDE - BREVIBLOC
	
 N 019386 006   6310094          Jan 12, 2021
	
                6528540          Jan 12, 2021
	
ESMOLOL HYDROCHLORIDE - BREVIBLOC
	
 N 019386 007   6310094          Jan 12, 2021
	
                6528540          Jan 12, 2021
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 70 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                            PATENT                                   PATENT                     EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION                PATENT           DELIST     EXCLUSIVITY      EXPIRATION
	
                                       DATE                    CODES          REQUESTED     CODE(S)           DATE
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 021153 001   5690960             Nov   25,   2014          DP   U-373
	
                5690960             Nov   25,   2014          DP   U-729
	
                5690960             Nov   25,   2014          DP   U-770
	
                5714504             Feb   03,   2015          DP   U-373
	
                5714504             Feb   03,   2015          DP   U-729
	
                5714504             Feb   03,   2015          DP   U-770
	
                5900424             May   04,   2016     DS        U-373
	
                5900424             May   04,   2016     DS        U-729
	
                5900424             May   04,   2016     DS        U-770
	
                6147103             Oct   09,   2018
	
                6166213             Oct   09,   2018
	
                6191148             Oct   09,   2018
	
                6369085             May   25,   2018     DS DP U-729
	
                6369085             May   25,   2018     DS DP U-770
	
                6428810             Nov   03,   2019          DP U-469
	
                6428810             Nov   03,   2019          DP U-729
	
                6428810             Nov   03,   2019          DP U-770
	
                7411070             May   25,   2018     DS
	
                8466175             May   25,   2018             U-1417
	
                8466175*PED         Nov   25,   2018
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 021153 002   5690960             Nov   25,   2014          DP   U-373
	
                5690960             Nov   25,   2014          DP   U-729
	
                5690960             Nov   25,   2014          DP   U-770
	
                5714504             Feb   03,   2015          DP   U-373
	
                5714504             Feb   03,   2015          DP   U-729
	
                5714504             Feb   03,   2015          DP   U-770
	
                5900424             May   04,   2016     DS        U-373
	
                5900424             May   04,   2016     DS        U-729
	
                5900424             May   04,   2016     DS        U-770
	
                6147103             Oct   09,   2018
	
                6166213             Oct   09,   2018
	
                6191148             Oct   09,   2018
	
                6369085             May   25,   2018     DS DP U-729
	
                6369085             May   25,   2018     DS DP U-770
	
                6428810             Nov   03,   2019          DP U-469
	
                6428810             Nov   03,   2019          DP U-729
	
                6428810             Nov   03,   2019          DP U-770
	
                7411070             May   25,   2018     DS
	
                8466175             May   25,   2018             U-1417
	
                8466175*PED         Nov   25,   2018
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 021957 001   5690960             Nov   25,   2014          DP   U-729
	
                5690960             Nov   25,   2014          DP   U-773
	
                5690960             Nov   25,   2014          DP   U-1207
	
                5714504             Feb   03,   2015          DP   U-729
	
                5714504             Feb   03,   2015          DP   U-773
	
                5714504             Feb   03,   2015          DP   U-1207
	
                5900424             May   04,   2016     DS        U-729
	
                5900424             May   04,   2016     DS        U-773
	
                5900424             May   04,   2016     DS        U-1207
	
                6369085             May   25,   2018     DS DP     U-729
	
                6369085             May   25,   2018     DS DP     U-773
	
                6369085             May   25,   2018     DS DP     U-1207
	
                6428810             Nov   03,   2019          DP   U-729
	
                6428810             Nov   03,   2019          DP   U-773
	
                6428810             Nov   03,   2019          DP   U-1207
	
                7411070             May   25,   2018     DS
	
                8466175             May   25,   2018               U-1417
	
                8466175*PED         Nov   25,   2018
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 71 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                            PATENT                                   PATENT                     EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION              PATENT             DELIST     EXCLUSIVITY      EXPIRATION
	
                                       DATE                  CODES            REQUESTED     CODE(S)           DATE
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 021957 002		 5690960             Nov   25,   2014         DP    U-729
	
                5690960             Nov   25,   2014         DP    U-773
	
                5690960             Nov   25,   2014         DP    U-1207
	
                5714504             Feb   03,   2015         DP    U-729
	
                5714504             Feb   03,   2015         DP    U-773
	
                5714504             Feb   03,   2015         DP    U-1207
	
                5900424             May   04,   2016     DS        U-729
	
                5900424             May   04,   2016     DS        U-773
	
                5900424             May   04,   2016     DS        U-1207
	
                6369085             May   25,   2018     DS DP     U-729
	
                6369085             May   25,   2018     DS DP     U-773
	
                6369085             May   25,   2018     DS DP     U-1207
	
                6428810             Nov   03,   2019          DP   U-729
	
                6428810             Nov   03,   2019          DP   U-773
	
                6428810             Nov   03,   2019          DP   U-1207
	
                7411070             May   25,   2018     DS
	
                8466175             May   25,   2018               U-1417
	
                8466175*PED         Nov   25,   2018
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 021957 003		 5690960           Nov 25, 2014                DP U-1207
	
                5714504           Feb 03, 2015                DP U-1207
	
                5900424           May 04, 2016           DS      U-1207
	
                6369085           May 25, 2018           DS DP U-1207
	
                6428810           Nov 03, 2019                DP U-1207
	
                7411070           May 25, 2018           DS
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 021957 004		 5690960           Nov 25, 2014                DP U-1207
	
                5714504           Feb 03, 2015                DP U-1207
	
                5900424           May 04, 2016           DS      U-1207
	
                6369085           May 25, 2018           DS DP U-1207
	
                6428810           Nov 03, 2019                DP U-1207
	
                7411070           May 25, 2018           DS
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM
	
 N 022101 001		 5690960           Nov 25, 2014                DP U-858
	
                5714504           Feb 03, 2015                DP U-858
	
                5900424           May 04, 2016           DS      U-858
	
                6369085           May 25, 2018           DS DP U-858
	
                6428810           Nov 03, 2019                DP U-858
	
                7411070           May 25, 2018           DS
	
ESOMEPRAZOLE MAGNESIUM - NEXIUM 24HR
	
 N 204655 001		 5690960          Nov 25,        2014          DP U-1509                     RTO          Mar 28, 2017
	
                5714504          Feb 03,        2015          DP U-1509
	
                5900424          May 04,        2016     DS      U-1509
	
                6369085          May 25,        2018     DS DP U-1509
	
                6428810          Nov 03,        2019          DP U-1509
	
                7411070          May 25,        2018     DS
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 72 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
ESOMEPRAZOLE MAGNESIUM; NAPROXEN - VIMOVO
 N 022511 001   5714504          Feb 03, 2015            DP   U-1053
                5900424          May 04, 2016         DS      U-1053
                6369085          May 25, 2018         DS DP   U-1053
                6926907          Feb 28, 2023            DP   U-1052
                7411070          May 25, 2018         DS      U-1053
                7745466          Oct 13, 2018            DP   U-1053
                8557285          May 31, 2022            DP
                8852636          May 31, 2022            DP   U-1052
                8858996          May 31, 2022            DP   U-1052
ESOMEPRAZOLE MAGNESIUM; NAPROXEN - VIMOVO
 N 022511 002   5714504          Feb 03, 2015            DP   U-1053
                5900424          May 04, 2016         DS      U-1053
                6369085          May 25, 2018         DS DP   U-1053
                6926907          Feb 28, 2023            DP   U-1052
                7411070          May 25, 2018         DS      U-1053
                7745466          Oct 13, 2018            DP   U-1053
                8557285          May 31, 2022            DP
                8852636          May 31, 2022            DP   U-1052
                8858996          May 31, 2022            DP   U-1052
ESOMEPRAZOLE SODIUM - NEXIUM IV
 N 021689 001   5877192*PED        Nov 27, 2014                                            D-138        Mar 04, 2017
                6143771            May 27, 2015          DP U-643                          I-679        Mar 04, 2017
                6143771            May 27, 2015          DP U-1495
ESOMEPRAZOLE SODIUM - NEXIUM IV
 N 021689 002   5877192*PED        Nov 27, 2014                                            D-138        Mar 04, 2017
                6143771            May 27, 2015          DP U-643                          I-679        Mar 04, 2017
                6143771            May 27, 2015          DP U-1495
ESTRADIOL - VIVELLE-DOT
 N 020538 005   5656286            Aug 12, 2014
ESTRADIOL - VIVELLE-DOT
 N 020538 006   5656286            Aug 12, 2014
ESTRADIOL - VIVELLE-DOT
 N 020538 007   5656286            Aug 12, 2014
ESTRADIOL - VIVELLE-DOT
 N 020538 008   5656286            Aug 12, 2014
ESTRADIOL - VIVELLE-DOT
 N 020538 009   5656286            Aug 12, 2014          DP
ESTRADIOL - VAGIFEM
 N 020908 002   5860946            Jul 01, 2017          DP
                7018992            Sep 17, 2022               U-1023
ESTRADIOL - MENOSTAR
 N 021674 001   5891868            Nov 21, 2017          DP U-594
                6692763            Nov 21, 2017          DP U-594
ESTRADIOL - ELESTRIN
 N 021813 001   7198801            Jun 25, 2022          DP
                7470433            Aug 03, 2021          DP
ESTRADIOL - EVAMIST
 N 022014 001   6299900            Feb   19,   2017      DP   U-888
                6299900            Feb   19,   2017      DP   U-889
                6818226            Feb   19,   2017      DP   U-888
                6818226            Feb   19,   2017      DP   U-889
                6923983            Feb   19,   2017      DP   U-888
                6923983            Feb   19,   2017      DP   U-889
                6978945            Jul   31,   2022      DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 73 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                               PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT            DELIST        EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES           REQUESTED        CODE(S)           DATE
	
ESTRADIOL - MINIVELLE
	
 N 203752 001   5656286            Aug 12, 2014       DS DP
	
                6841716            Apr 27, 2020          DP
	
                8231906            Jul 04, 2030       DS DP
	
ESTRADIOL - MINIVELLE
	
 N 203752 002   5656286            Aug 12, 2014       DS DP
	
                6841716            Apr 27, 2020          DP
	
                8231906            Jul 04, 2030       DS DP
	
ESTRADIOL - MINIVELLE
	
 N 203752 003   5656286            Aug 12, 2014       DS DP
	
                6841716            Apr 27, 2020          DP
	
                8231906            Jul 04, 2030       DS DP
	
ESTRADIOL - MINIVELLE
	
 N 203752 004   5656286            Aug 12, 2014       DS DP
	
                6841716            Apr 27, 2020          DP
	
                8231906            Jul 04, 2030       DS DP
	
ESTRADIOL ACETATE - FEMRING
	
 N 021367 001   5855906            Dec 19, 2015                 U-508
	
ESTRADIOL ACETATE - FEMRING
	
 N 021367 002   5855906            Dec 19, 2015                 U-508
	
ESTRADIOL ACETATE - FEMTRACE
	
 N 021633 001   6962908            Dec 21, 2021          DP
	
                7572779            Oct 02, 2025                 U-904
	
                7799771            Dec 21, 2021          DP
	
ESTRADIOL ACETATE - FEMTRACE
	
 N 021633 002   6962908            Dec 21, 2021          DP
	
                7572779            Oct 02, 2025                 U-904
	
                7799771            Dec 21, 2021          DP
	
ESTRADIOL ACETATE - FEMTRACE
	
 N 021633 003   6962908            Dec 21, 2021          DP
	
                7572779            Oct 02, 2025                 U-904
	
                7799771            Dec 21, 2021          DP
	
ESTRADIOL HEMIHYDRATE - ESTRASORB
	
 N 021371 001   5629021          Jan 31, 2015            DP
	
ESTRADIOL; ESTRADIOL; NORGESTIMATE - PREFEST
	
 N 021040 001   6747019          Mar 20, 2020               U-311
	
                7320970          Mar 30, 2020            DP U-844
	
ESTRADIOL; LEVONORGESTREL - CLIMARA PRO
	
 N 021258 001   5676968          Oct 14, 2014            DP
	
ESTRADIOL; NORETHINDRONE ACETATE - COMBIPATCH
	
 N 020870 001   5656286          Aug 12, 2014
	
ESTRADIOL; NORETHINDRONE ACETATE - COMBIPATCH
	
 N 020870 002   5656286          Aug 12, 2014
	
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN
	
 N 020992 001   5908638          Jul 26, 2015            DP
	
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN
	
 N 020992 002   5908638          Jul 26, 2015
	
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN
	
 N 020992 003   5908638          Jul 26, 2015
	
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN
	
 N 020992 004   5908638          Jul 26, 2015
	
ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN
	
 N 020992 005   5908638          Jul 26, 2015
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 74 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                               PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT          DELIST        EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES         REQUESTED        CODE(S)           DATE
	
ESTROGENS, CONJUGATED SYNTHETIC B - ENJUVIA
	
 N 021443 001   6660726          Mar 08, 2021         DS   DP   U-904
	
                6660726          Mar 08, 2021         DS   DP   U-905
	
                6855703          Feb 12, 2021         DS   DP   U-904
	
                6855703          Feb 12, 2021         DS   DP   U-905
	
ESTROGENS, CONJUGATED SYNTHETIC B - ENJUVIA
	
 N 021443 002   6660726          Mar 08, 2021         DS   DP   U-904
	
                6660726          Mar 08, 2021         DS   DP   U-905
	
                6855703          Feb 12, 2021         DS   DP   U-904
	
                6855703          Feb 12, 2021         DS   DP   U-905
	
ESTROGENS, CONJUGATED SYNTHETIC B - ENJUVIA
	
 N 021443 003   6660726          Mar 08, 2021         DS   DP   U-904
	
                6660726          Mar 08, 2021         DS   DP   U-905
	
                6855703          Feb 12, 2021         DS   DP   U-904
	
                6855703          Feb 12, 2021         DS   DP   U-905
	
ESTROGENS, CONJUGATED SYNTHETIC B - ENJUVIA
	
 N 021443 004   6660726          Mar 08, 2021         DS   DP   U-904
	
                6660726          Mar 08, 2021         DS   DP   U-905
	
                6855703          Feb 12, 2021         DS   DP   U-904
	
                6855703          Feb 12, 2021         DS   DP   U-905
	
ESTROGENS, CONJUGATED SYNTHETIC B - ENJUVIA
	
 N 021443 005   6660726          Mar 08, 2021         DS   DP   U-904
	
                6660726          Mar 08, 2021         DS   DP   U-905
	
                6855703          Feb 12, 2021         DS   DP   U-904
	
                6855703          Feb 12, 2021         DS   DP   U-905
	
ESTROGENS, CONJUGATED; ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPHASE 14/14
	
 N 020527 002   5547948          Jan 17, 2015
	
ESTROGENS, CONJUGATED; ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE -
PREMPRO
	
 N 020527 001   5547948          Jan 17, 2015
	
ESTROGENS, CONJUGATED; ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE -
PREMPRO
	
 N 020527 003   5547948          Jan 17, 2015
	
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO
	
 N 020527 004   5547948          Jan 17, 2015
	
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO
	
 N 020527 005   5547948          Jan 17, 2015
	
ESZOPICLONE - LUNESTA
	
 N 021476 001                                                                              M-61         Oct 10, 2015
	
                                                                                           PED          Apr 10, 2016
	
ESZOPICLONE - LUNESTA
	
 N 021476 002                                                                              M-61         Oct 10, 2015
	
                                                                                           PED          Apr 10, 2016
	
ESZOPICLONE - LUNESTA
	
 N 021476 003                                                                              M-61         Oct 10, 2015
	
                                                                                           PED          Apr 10, 2016
	
ETHINYL ESTRADIOL; ETHINYL ESTRADIOL; ETHINYL ESTRADIOL; NORGESTIMATE; NORGESTIMATE; NORGESTIMATE - ORTHO

TRI-CYCLEN LO
	
 N 021241 001   6214815          Jun 09, 2019           U-112
	
ETHINYL ESTRADIOL; ETHINYL ESTRADIOL; LEVONORGESTREL - SEASONIQUE
	
 N 021840 001   7320969          Jan 30, 2024            U-828
	
                7615545          Jun 15, 2023            U-1
	
                7855190          Dec 05, 2028            U-1
	
                7858605          Jun 23, 2023       DP
	
ETHINYL ESTRADIOL; ETHINYL ESTRADIOL; LEVONORGESTREL - LOSEASONIQUE
	
 N 022262 001   7615545          Jun 15, 2023            U-1
	
                7855190          Dec 05, 2028            U-1
	
                7858605          Jun 23, 2023       DP
	
ETHINYL ESTRADIOL; ETONOGESTREL - NUVARING
	
 N 021187 001   5989581          Apr 08, 2018
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 75 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                           PATENT                       PATENT                               EXCLUSIVITY
	
     NO          PATENT NO         EXPIRATION       PATENT        DELIST               EXCLUSIVITY      EXPIRATION
	
                                      DATE           CODES       REQUESTED               CODE(S)           DATE
	
ETHINYL ESTRADIOL; LEVONORGESTREL - PREVEN EMERGENCY CONTRACEPTIVE KIT
	
 N 020946 001   6156742          Dec 05, 2020           U-374
	
ETHINYL ESTRADIOL; LEVONORGESTREL - SEASONALE
	
 N 021544 001   5898032          Jun 23, 2017                   U-1
	
                RE39861          Jun 23, 2017                   U-828
	
ETHINYL ESTRADIOL; LEVONORGESTREL - LYBREL
	
 N 021864 001   6500814          Sep 03, 2018                   U-1
	
ETHINYL ESTRADIOL; LEVONORGESTREL - QUARTETTE
	
 N 204061 001   8415332          Mar 11, 2029            DP                              NP           Mar 28, 2016
	
                8450299          Oct 07, 2025                   U-1
	
ETHINYL ESTRADIOL; NORELGESTROMIN - ORTHO EVRA
	
 N 021180 001   5876746          Nov 20, 2015            DP U-514
	
                5972377          Jun 07, 2015               U-514
	
ETHINYL ESTRADIOL; NORETHINDRONE - FEMCON FE
	
 N 021490 001   6667050          Apr 06, 2019            DP U-1
	
ETHINYL ESTRADIOL; NORETHINDRONE - NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
	
 N 022573 001   5552394          Jul 22, 2014           U-828
	
                6667050          Apr 06, 2019       DP U-828
	
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - LOESTRIN 24 FE
	
 N 021871 001   5552394          Jul 22, 2014           U-1
	
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - LO LOESTRIN FE
	
 N 022501 001   5552394          Jul 22, 2014           U-1090
	
                7704984          Feb 02, 2029           U-1090
	
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - MINASTRIN 24 FE
	
 N 203667 001   5552394          Jul 22, 2014           U-1                              NDF          May 08, 2016

                6667050          Apr 06, 2019       DP U-1
	
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
	
 N 204426 001   5552394          Jul 22, 2014            U-1
	
                6652880          Mar 29, 2020       DP
	
ETHINYL ESTRADIOL; NORETHINDRONE   ACETATE   - LO MINASTRIN FE
	
 N 204654 001   5552394            Jul 22,   2014           U-1
	
                6667050            Apr 06,   2019       DP U-1
	
                7704984            Feb 02,   2029           U-1
	
ETHIODIZED OIL - LIPIODOL
	
 N 009190 001                                                                            ODE          Apr 04, 2021
	
ETONOGESTREL - NEXPLANON
	
 N 021529 002   8722037            Sep 28, 2027          DP
	
                8888745            Aug 28, 2026          DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 76 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                               PATENT
	                    EXCLUSIVITY
	
     NO          PATENT NO
	      EXPIRATION
	           PATENT            DELIST
	    EXCLUSIVITY      EXPIRATION
	
                                     DATE
	               CODES          REQUESTED
	     CODE(S)           DATE
	
ETRAVIRINE - INTELENCE
	
 N 022187 001   6878717
	        Nov   05,   2019
	           U-256
	                    NPP          Mar 26, 2015
	
                6878717
	        Nov   05,   2019
	           U-1016
	
                6878717
	        Nov   05,   2019
	           U-1237
	
                7037917
	        Dec   13,   2020
	   DS DP U-256
	
                7037917
	        Dec   13,   2020
	   DS DP U-1016
	
                7037917
	        Dec   13,   2020
	   DS DP U-1237
	
                7887845
	        Mar   25,   2019
	      DP
	
                8003789
	        Nov   01,   2019
	   DS DP
	
ETRAVIRINE - INTELENCE
	
 N 022187 002   6878717
	        Nov   05,   2019
	           U-256
	                    NPP          Mar 26, 2015
	
                6878717
	        Nov   05,   2019
	           U-1016
	
                6878717
	        Nov   05,   2019
	           U-1237
	
                7037917
	        Dec   13,   2020
	   DS DP U-256
	
                7037917
	        Dec   13,   2020
	   DS DP U-1016
	
                7037917
	        Dec   13,   2020
	   DS DP U-1237
	
                7887845
	        Mar   25,   2019
	      DP
	
                8003789
	        Nov   01,   2019
	   DS DP
	
ETRAVIRINE - INTELENCE
	
 N 022187 003   6878717
	        Nov   05,   2019
	           U-256
	                    NPP          Mar 26, 2015
	
                6878717
	        Nov   05,   2019
	           U-1016
	
                6878717
	        Nov   05,   2019
	           U-1237
	
                7037917
	        Dec   13,   2020
	   DS DP U-1237
	
                7887845
	        Mar   25,   2019
	      DP
	
                8003789
	        Nov   01,   2019
	   DS DP
	
EVEROLIMUS - ZORTRESS
	
 N 021560 001   5665772
	        Sep   09,   2019
    DS DP U-1049
	                     I-668        Feb 15, 2016
	
                5665772
	        Sep   09,   2019
    DS DP U-1365
	                     PED          Sep 30, 2014
	
                5665772*PED
	    Mar   09,   2020
	
                6004973
	        Jul   12,   2016
	      DP U-1049
	
                6004973
	        Jul   12,   2016
	      DP U-1365
	
                6004973*PED
	    Jan   12,   2017
	
                6239124
	        Aug   11,   2017
           U-1049
	
                6455518
	        Jul   29,   2017
	          U-1049
	
                6455518
	        Jul   29,   2017
	          U-1365
	
                6455518*PED
	    Jan   29,   2018
	
EVEROLIMUS - ZORTRESS
	
 N 021560 002   5665772
	        Sep   09,   2019
    DS DP U-1049
	                     I-668        Feb 15, 2016
	
                5665772
	        Sep   09,   2019
    DS DP U-1365
	                     PED          Sep 30, 2014
	
                5665772*PED
	    Mar   09,   2020
	
                6004973
	        Jul   12,   2016
	      DP U-1049
	
                6004973
	        Jul   12,   2016
	      DP U-1365
	
                6004973*PED
	    Jan   12,   2017
	
                6239124
	        Aug   11,   2017
           U-1049
	
                6455518
	        Jul   29,   2017
	          U-1049
	
                6455518
	        Jul   29,   2017
	          U-1365
	
                6455518*PED
	    Jan   29,   2018
	
EVEROLIMUS - ZORTRESS
	
 N 021560 003   5665772
	        Sep   09,   2019
    DS DP U-1049
	                     I-668        Feb 15, 2016
	
                5665772
	        Sep   09,   2019
    DS DP U-1365
	                     PED          Sep 30, 2014
	
                5665772*PED
	    Mar   09,   2020
	
                6004973
	        Jul   12,   2016
	      DP U-1049
	
                6004973
	        Jul   12,   2016
	      DP U-1365
	
                6004973*PED
	    Jan   12,   2017
	
                6239124
	        Aug   11,   2017
           U-1049
	
                6455518
	        Jul   29,   2017
	          U-1049
	
                6455518
	        Jul   29,   2017
	          U-1365
	
                6455518*PED
	    Jan   29,   2018
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 77 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                          PATENT                           EXCLUSIVITY
	
     NO          PATENT NO
	      EXPIRATION
	          PATENT        DELIST           EXCLUSIVITY      EXPIRATION
	
                                     DATE
	              CODES       REQUESTED           CODE(S)           DATE
	
EVEROLIMUS - AFINITOR
	
 N 022334 001   5665772
	        Sep   09,   2019
    DS DP                              I-650        Apr   26,   2015

                6004973
	        Jul   12,   2016
	      DP                              I-655        Jul   20,   2015
	
                7297703
	        Dec   06,   2019
	      DP                              ODE          Oct   29,   2017
	
                7741338
	        Dec   06,   2019
	      DP                              ODE          May   05,   2018

                8410131
	        May   22,   2025
    DS DP U-1368                       ODE          Apr   26,   2019

                8410131*PED
	    Nov   22,   2025
	                                      PED          Sep   30,   2014

                8436010
	        Feb   22,   2022
	   DS DP U-1396                       PED          Nov   05,   2014
	
                8436010*PED
	    Aug   22,   2022
                                       PED          Oct   26,   2015
	
                8778962
	        Feb   18,   2022
	         U-1541                       PED          Apr   29,   2018

                8778962*PED
	    Aug   18,   2022
	                                      PED          Nov   05,   2018
	
                                                                                         PED          Oct   26,   2019
	
EVEROLIMUS - AFINITOR
	
 N 022334 002   5665772
	        Sep   09,   2019
    DS DP                              I-650        Apr   26,   2015

                6004973
	        Jul   12,   2016
	      DP                              I-655        Jul   20,   2015
	
                7297703
	        Dec   06,   2019
	      DP                              ODE          Oct   29,   2017
	
                7741338
	        Dec   06,   2019
	      DP                              ODE          May   05,   2018

                8410131
	        May   22,   2025
    DS DP U-1368                       ODE          Apr   26,   2019

                8410131*PED
	    Nov   22,   2025
	                                      PED          Sep   30,   2014

                8436010
	        Feb   22,   2022
	   DS DP U-1396                       PED          Nov   05,   2014
	
                8436010*PED
	    Aug   22,   2022
                                       PED          Oct   26,   2015
	
                8778962
	        Feb   18,   2022
	         U-1541                       PED          Apr   29,   2018

                8778962*PED
	    Aug   18,   2022
	                                      PED          Nov   05,   2018
	
                                                                                         PED          Oct   26,   2019
	
EVEROLIMUS - AFINITOR
	
 N 022334 003   5665772
	        Sep   09,   2019
    DS DP                              I-650        Apr   26,   2015

                6004973
	        Jul   12,   2016
	      DP                              I-655        Jul   20,   2015
	
                7297703
	        Dec   06,   2019
	      DP                              ODE          Oct   29,   2017
	
                7741338
	        Dec   06,   2019
	      DP                              ODE          May   05,   2018

                8410131
	        May   22,   2025
    DS DP U-1368                       ODE          Apr   26,   2019

                8410131*PED
	    Nov   22,   2025
	                                      PED          Sep   30,   2014

                8436010
	        Feb   22,   2022
	   DS DP U-1396                       PED          Nov   05,   2014
	
                8436010*PED
	    Aug   22,   2022
                                       PED          Oct   26,   2015
	
                8778962
	        Feb   18,   2022
	         U-1541                       PED          Apr   29,   2018

                8778962*PED
	    Aug   18,   2022
	                                      PED          Nov   05,   2018
	
                                                                                         PED          Oct   26,   2019
	
EVEROLIMUS - AFINITOR
	
 N 022334 004   5665772
	        Sep   09,   2019
    DS DP                              I-650        Apr   26,   2015

                6004973
	        Jul   12,   2016
	      DP                              I-655        Jul   20,   2015
	
                7297703
	        Dec   06,   2019
	      DP                              ODE          Oct   29,   2017
	
                7741338
	        Dec   06,   2019
	      DP                              ODE          May   05,   2018

                8410131
	        May   22,   2025
    DS DP U-1368                       ODE          Apr   26,   2019

                8410131*PED
	    Nov   22,   2025
	                                      PED          Sep   30,   2014

                8436010
	        Feb   22,   2022
	   DS DP U-1396                       PED          Nov   05,   2014
	
                8436010*PED
	    Aug   22,   2022
                                       PED          Oct   26,   2015
	
                8778962
	        Feb   18,   2022
	         U-1541                       PED          Apr   29,   2018

                8778962*PED
	    Aug   18,   2022
	                                      PED          Nov   05,   2018
	
                                                                                         PED          Oct   26,   2019
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 78 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                          EXCLUSIVITY
     NO         PATENT NO        EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
                                    DATE              CODES         REQUESTED           CODE(S)           DATE
EVEROLIMUS - AFINITOR DISPERZ
 N 203985 001   5665772         Sep   09,   2019   DS DP                                ODE          Oct 29, 2017
                6004973         Jul   12,   2016      DP                                PED          Sep 30, 2014
                7297703         Dec   06,   2019      DP                                PED          Apr 29, 2018
                8617598         Sep   27,   2022      DP
                8617598*PED     Mar   27,   2023
                8778962         Feb   18,   2022           U-1541
                8778962*PED     Aug   18,   2022
EVEROLIMUS - AFINITOR DISPERZ
 N 203985 002   5665772         Sep   09,   2019   DS DP                                ODE          Oct 29, 2017
                6004973         Jul   12,   2016      DP                                PED          Sep 30, 2014
                7297703         Dec   06,   2019      DP                                PED          Apr 29, 2018
                8617598         Sep   27,   2022      DP
                8617598*PED     Mar   27,   2023
                8778962         Feb   18,   2022           U-1541
                8778962*PED     Aug   18,   2022
EVEROLIMUS - AFINITOR DISPERZ
 N 203985 003   5665772         Sep   09,   2019   DS DP                                ODE          Oct 29, 2017
                6004973         Jul   12,   2016      DP                                PED          Sep 30, 2014
                7297703         Dec   06,   2019      DP                                PED          Apr 29, 2018
                8617598         Sep   27,   2022      DP
                8617598*PED     Mar   27,   2023
                8778962         Feb   18,   2022           U-1541
                8778962*PED     Aug   18,   2022
EXENATIDE SYNTHETIC - BYETTA
 N 021773 001   5424286         Dec   01,   2016           U-653                        M-111        Oct 19, 2014
                5424286         Dec   01,   2016           U-1108                       M-113        Oct 19, 2014
                6858576         Jan   06,   2017           U-656                        M-148        Nov 24, 2017
                6858576         Jan   06,   2017           U-1108
                6872700         Jan   14,   2020           U-654
                6902744         Jan   14,   2020      DP
                6956026         Jan   07,   2018           U-687
                6956026         Jan   07,   2018           U-1074
                6956026         Jan   07,   2018           U-1623
                7297761         Oct   15,   2017      DP
                7521423         Oct   15,   2017      DP
                7741269         Jan   07,   2018           U-653
                7741269         Jan   07,   2018           U-1074
                7741269         Jan   07,   2018           U-1108
EXENATIDE SYNTHETIC - BYETTA
 N 021773 002   5424286         Dec   01,   2016           U-653                        M-111        Oct 19, 2014
                5424286         Dec   01,   2016           U-1108                       M-113        Oct 19, 2014
                6858576         Jan   06,   2017           U-656                        M-148        Nov 24, 2017
                6858576         Jan   06,   2017           U-1108
                6872700         Jan   14,   2020           U-654
                6902744         Jan   14,   2020      DP
                6956026         Jan   07,   2018           U-687
                6956026         Jan   07,   2018           U-1074
                6956026         Jan   07,   2018           U-1623
                7297761         Oct   15,   2017      DP
                7521423         Oct   15,   2017      DP
                7741269         Jan   07,   2018           U-653
                7741269         Jan   07,   2018           U-1074
                7741269         Jan   07,   2018           U-1108
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                ADA 79 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)           DATE
	
EXENATIDE SYNTHETIC - BYDUREON
 N 022200 001   5424286          Dec   01,   2016           U-1108                       NP           Jan 27, 2015
                6479065          Aug   10,   2020      DP
                6495164          May   25,   2020      DP
                6667061          May   25,   2020      DP
                6824822          Oct   09,   2022      DP
                6858576          Jan   06,   2017           U-656
                6872700          Jan   14,   2020           U-654
                6956026          Jan   07,   2018           U-687
                7223440          Aug   31,   2021      DP
                7456254          Jun   30,   2025      DP U-1223
                7563871          Apr   15,   2024      DP
                7612176          Apr   13,   2025      DP U-1223
                7741269          Jan   07,   2018         U-1224
                8216180          Jan   12,   2028      DP
                8329648          Aug   18,   2026         U-1313
                8431685          Apr   13,   2025      DP U-412
                8439864          Mar   25,   2028      DP
                8461105          Apr   13,   2025      DP U-412
                8906851          Aug   18,   2026         U-1313
EZETIMIBE - ZETIA
 N 021445 001   7030106          Jan   25,   2022      DP                                M-109        Jan 24, 2015
                7612058          Oct   30,   2025           U-1027
                7612058          Oct   30,   2025           U-1173
                7612058*PED      Apr   30,   2026
                RE37721          Oct   25,   2016   DS DP U-473
                RE42461          Oct   25,   2016   DS DP U-473
                RE42461          Oct   25,   2016   DS DP U-1173
EZETIMIBE; SIMVASTATIN - VYTORIN
 N 021687 001   RE37721          Oct 25, 2016       DS DP U-473                          M-109        Jan 24, 2015
                RE42461          Oct 25, 2016       DS DP U-473
EZETIMIBE; SIMVASTATIN - VYTORIN
 N 021687 002   RE37721          Oct 25, 2016       DS DP U-473                          M-109        Jan 24, 2015
                RE42461          Oct 25, 2016       DS DP U-473
EZETIMIBE; SIMVASTATIN - VYTORIN
 N 021687 003   RE37721          Oct 25, 2016       DS DP U-473                          M-109        Jan 24, 2015
                RE42461          Oct 25, 2016       DS DP U-473
EZETIMIBE; SIMVASTATIN - VYTORIN
 N 021687 004   RE37721          Oct 25, 2016       DS DP U-473                          M-109        Jan 24, 2015
                RE42461          Oct 25, 2016       DS DP U-473
EZOGABINE - POTIGA
 N 022345 001                                                                            NCE          Jun 10, 2016
EZOGABINE - POTIGA
 N 022345 002                                                                            NCE          Jun 10, 2016
EZOGABINE - POTIGA
 N 022345 003                                                                            NCE          Jun 10, 2016
EZOGABINE - POTIGA
 N 022345 004                                                                            NCE          Jun 10, 2016
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 80 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                            PATENT                           EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
                                          DATE               CODES        REQUESTED           CODE(S)           DATE
FAMCICLOVIR - FAMVIR
 N 020363    001   5840763            Sep   01,   2015           U-96                         M-112        Feb 09, 2015
                   5866581            Oct   04,   2014           U-96
                   5916893            Sep   01,   2015           U-96
                   6124304            Oct   04,   2014           U-96
FAMCICLOVIR - FAMVIR
 N 020363 002   5840763               Sep   01,   2015           U-96                         M-112        Feb 09, 2015
                5866581               Oct   04,   2014           U-96
                5916893               Sep   01,   2015           U-96
                6124304               Oct   04,   2014           U-96
FAMCICLOVIR - FAMVIR
 N 020363 003   5840763               Sep   01,   2015           U-96                         M-112        Feb 09, 2015
                5866581               Oct   04,   2014           U-96
                5916893               Sep   01,   2015           U-96
                6124304               Oct   04,   2014           U-96
FAMOTIDINE - PEPCID AC
 N 020325 001   5854267               Dec 29, 2015               U-267
FAMOTIDINE - PEPCID AC
 N 020801 001   5667794               May 02, 2015                               Y
                5854267               Dec 29, 2015               U-267
FAMOTIDINE - PEPCID AC
 N 020801 002   6814978               Aug 26, 2021          DP
FAMOTIDINE - PEPCID AC
 N 020902 001   5854267               Dec 29, 2015               U-368
FAMOTIDINE - FLUXID
 N 021712 001   6024981               Apr 09, 2018          DP
                6221392               Apr 09, 2018          DP
FAMOTIDINE - FLUXID
 N 021712 002   6024981               Apr 09, 2018          DP
                6221392               Apr 09, 2018          DP
FAMOTIDINE; IBUPROFEN - DUEXIS
 N 022519 001   8067033               Jul   18,   2026      DP
                8067451               Jul   18,   2026      DP U-1196
                8309127               Jul   18,   2026      DP
                8318202               Jul   18,   2026      DP
                8449910               Jul   18,   2026      DP
                8501228               Jul   18,   2026         U-1196
FEBUXOSTAT - ULORIC
 N 021856 001   5614520               Mar   25,   2019   DS DP U-954
                6225474               Jun   18,   2019   DS
                7361676               Mar   08,   2024      DP
                8372872               Sep   08,   2031         U-1346
FEBUXOSTAT - ULORIC
 N 021856 002   5614520               Mar   25,   2019   DS DP U-954
                6225474               Jun   18,   2019   DS
                7361676               Mar   08,   2024      DP
                8372872               Sep   08,   2031         U-1346
FENOFIBRATE - TRICOR
 N 021203 001   6074670               Jan   09,   2018
                6277405               Jan   09,   2018
                6589552               Jan   09,   2018
                6652881               Jan   09,   2018      DP
                7037529               Jan   09,   2018      DP
                7041319               Jan   09,   2018      DP
FENOFIBRATE - TRICOR
 N 021203 003   6074670               Jan   09,   2018
                6277405               Jan   09,   2018
                6589552               Jan   09,   2018
                6652881               Jan   09,   2018      DP
                7037529               Jan   09,   2018      DP
                7041319               Jan   09,   2018      DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                      ADA 81 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                    PATENT                     EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT                 DELIST     EXCLUSIVITY      EXPIRATION
	
                                        DATE               CODES                REQUESTED     CODE(S)           DATE
	
FENOFIBRATE - TRIGLIDE
	
 N 021350 001   6696084             Sep 11, 2021       DS DP U-680
	
FENOFIBRATE - TRIGLIDE
	
 N 021350 002   6696084             Sep 11, 2021       DS DP U-680
	
FENOFIBRATE - LIPOFEN
	
 N 021612 001   5545628             Jan 10, 2015              DP U-701
	
FENOFIBRATE - LIPOFEN
	
 N 021612 002   5545628             Jan 10, 2015              DP U-701
	
FENOFIBRATE - LIPOFEN
	
 N 021612 003   5545628             Jan 10, 2015              DP U-701
	
FENOFIBRATE - TRICOR
	
 N 021656 001   6277405             Jan   09,   2018   DS
	
                6375986             Sep   21,   2020          DP U-615
	
                6652881             Jan   09,   2018   DS
	
                7037529             Jan   09,   2018          DP
	
                7041319             Jan   09,   2018          DP
	
                7276249             Feb   21,   2023          DP
	
                7320802             Feb   21,   2023                 U-847
	
FENOFIBRATE - TRICOR
	
 N 021656 002   6277405             Jan   09,   2018   DS
	
                6375986             Sep   21,   2020          DP U-615
	
                6652881             Jan   09,   2018   DS
	
                7037529             Jan   09,   2018          DP
	
                7041319             Jan   09,   2018          DP
	
                7276249             Feb   21,   2023          DP
	
                7320802             Feb   21,   2023                 U-847
	
FENOFIBRATE - ANTARA (MICRONIZED)
	
 N 021695 001   7101574          Aug 20, 2020          DS DP
	
                7863331          Aug 08, 2020                        U-1106
	
                7863331          Aug 08, 2020                        U-1107
	
FENOFIBRATE - ANTARA (MICRONIZED)
	
 N 021695 003   7101574          Aug 20, 2020          DS DP
	
                7863331          Aug 08, 2020                        U-1106
	
                7863331          Aug 08, 2020                        U-1107
	
FENOFIBRATE - ANTARA (MICRONIZED)
	
 N 021695 004   8026281          Apr 22, 2025                        U-1447
	
                8026281          Apr 22, 2025                        U-1448
	
FENOFIBRATE - ANTARA (MICRONIZED)
	
 N 021695 005   8026281          Apr 22, 2025                        U-1447
	
                8026281          Apr 22, 2025                        U-1448
	
FENOFIBRATE - FENOGLIDE
	
 N 022118 001   7658944             Dec 09, 2024              DP
	
                8124125             Oct 01, 2024              DP U-1234
	
                8481078             Oct 01, 2024              DP U-1416
	
FENOFIBRATE - FENOGLIDE
	
 N 022118 002   7658944             Dec 09, 2024              DP
	
                8124125             Oct 01, 2024              DP U-1234
	
                8481078             Oct 01, 2024              DP U-1416
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 82 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT           DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES          REQUESTED         CODE(S)           DATE
	
FENOFIBRIC ACID - FIBRICOR
	
 N 022418 001   7569612            Aug   20,   2027           U-1000
	
                7741373            Aug   20,   2027           U-1059
	
                7741374            Aug   20,   2027           U-1060
	
                7741374            Aug   20,   2027           U-1061
	
                7915247            Aug   20,   2027           U-1000
	
                7915247            Aug   20,   2027           U-1059
	
                7915247            Aug   20,   2027           U-1061
	
FENOFIBRIC ACID - FIBRICOR
	
 N 022418 002   7569612            Aug   20,   2027           U-1000
	
                7741373            Aug   20,   2027           U-1059
	
                7741374            Aug   20,   2027           U-1060
	
                7741374            Aug   20,   2027           U-1061
	
                7915247            Aug   20,   2027           U-1000
	
                7915247            Aug   20,   2027           U-1059
	
                7915247            Aug   20,   2027           U-1061
	
FENTANYL - SUBSYS
	
 N 202788 001   8486972            Apr   27,   2030      DP                                NP           Jan 04, 2015
	
                8486973            Apr   27,   2030           U-55
	
                8835459            Jan   25,   2027      DP
	
                8835460            Jan   25,   2027      DP U-55
	
FENTANYL - SUBSYS
	
 N 202788 002   8486972            Apr 27, 2030          DP                                NP           Jan 04, 2015
	
                8486973            Apr 27, 2030             U-55
	
                8835460            Jan 25, 2027          DP U-55
	
FENTANYL - SUBSYS
	
 N 202788 003   8486972            Apr   27,   2030      DP                                NP           Jan 04, 2015
	
                8486973            Apr   27,   2030           U-55
	
                8835459            Jan   25,   2027      DP
	
                8835460            Jan   25,   2027      DP U-55
	
FENTANYL - SUBSYS
	
 N 202788 004   8486972            Apr   27,   2030      DP                                NP           Jan 04, 2015
	
                8486973            Apr   27,   2030           U-55
	
                8835459            Jan   25,   2027      DP
	
                8835460            Jan   25,   2027      DP U-55
	
FENTANYL - SUBSYS
	
 N 202788 005   8486972            Apr 27, 2030          DP                                NP           Jan 04, 2015
	
                8486973            Apr 27, 2030             U-55
	
                8835460            Jan 25, 2027          DP U-55
	
FENTANYL - SUBSYS
	
 N 202788 006   8486972            Apr   27,   2030      DP                                NP           Jan 04, 2015
	
                8486973            Apr   27,   2030           U-55
	
                8835459            Jan   25,   2027      DP
	
                8835460            Jan   25,   2027      DP U-55
	
FENTANYL - SUBSYS
	
 N 202788 007   8486972            Apr   27,   2030      DP                                NP           Jan 04, 2015
	
                8486973            Apr   27,   2030           U-55
	
                8835459            Jan   25,   2027      DP
	
                8835460            Jan   25,   2027      DP U-55
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 83 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                          EXCLUSIVITY
     NO         PATENT NO        EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
                                    DATE              CODES         REQUESTED           CODE(S)           DATE
FENTANYL CITRATE - FENTORA
 N 021947 001   6200604         Mar   26,   2019           U-767
                6974590         Mar   26,   2019           U-767
                7862832         Jun   15,   2028      DP
                7862833         Jun   15,   2028      DP
                8092832         Dec   30,   2024      DP
                8728441         Mar   26,   2019           U-1514
                8753611         Mar   26,   2019           U-1514
                8765100         Mar   26,   2019      DP
FENTANYL CITRATE - FENTORA
 N 021947 002   6200604         Mar   26,   2019           U-767
                6974590         Mar   26,   2019           U-767
                7862832         Jun   15,   2028      DP
                7862833         Jun   15,   2028      DP
                8092832         Dec   30,   2024      DP
                8119158         Dec   30,   2024      DP
                8728441         Mar   26,   2019           U-1514
                8753611         Mar   26,   2019           U-1514
                8765100         Mar   26,   2019      DP
FENTANYL CITRATE - FENTORA
 N 021947 003   6200604         Mar   26,   2019           U-767
                6974590         Mar   26,   2019           U-767
                7862832         Jun   15,   2028      DP
                7862833         Jun   15,   2028      DP
                8092832         Dec   30,   2024      DP
                8119158         Dec   30,   2024      DP
                8728441         Mar   26,   2019           U-1514
                8753611         Mar   26,   2019           U-1514
                8765100         Mar   26,   2019      DP
FENTANYL CITRATE - FENTORA
 N 021947 004   6200604         Mar   26,   2019           U-767
                6974590         Mar   26,   2019           U-767
                7862832         Jun   15,   2028      DP
                7862833         Jun   15,   2028      DP
                8092832         Dec   30,   2024      DP
                8119158         Dec   30,   2024      DP
                8728441         Mar   26,   2019           U-1514
                8753611         Mar   26,   2019           U-1514
                8765100         Mar   26,   2019      DP
FENTANYL CITRATE - FENTORA
 N 021947 005   6200604         Mar   26,   2019           U-767
                6974590         Mar   26,   2019           U-767
                7862832         Jun   15,   2028      DP
                7862833         Jun   15,   2028      DP
                8092832         Dec   30,   2024      DP
                8119158         Dec   30,   2024      DP
                8728441         Mar   26,   2019           U-1514
                8753611         Mar   26,   2019           U-1514
                8765100         Mar   26,   2019      DP
FENTANYL CITRATE - FENTORA
 N 021947 006   6200604         Mar 26, 2019               U-767
                6974590         Mar 26, 2019               U-767
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 84 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                               PATENT                        EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT            DELIST        EXCLUSIVITY      EXPIRATION
	
                                     DATE               CODES           REQUESTED        CODE(S)           DATE
	
FENTANYL CITRATE - ONSOLIS
	
 N 022266 001   6159498          Oct 18, 2016          DP
	
                7579019          Jan 22, 2020                 U-767
	
FENTANYL CITRATE - ONSOLIS
	
 N 022266 002   6159498          Oct 18, 2016          DP
	
                7579019          Jan 22, 2020                 U-767
	
FENTANYL CITRATE - ONSOLIS
	
 N 022266 003   6159498          Oct 18, 2016          DP
	
                7579019          Jan 22, 2020                 U-767
	
FENTANYL CITRATE - ONSOLIS
	
 N 022266 004   6159498          Oct 18, 2016          DP
	
                7579019          Jan 22, 2020                 U-767
	
FENTANYL CITRATE - ONSOLIS
	
 N 022266 005   6159498          Oct 18, 2016          DP
	
                7579019          Jan 22, 2020                 U-767
	
FENTANYL CITRATE - ABSTRAL
	
 N 022510 001   6759059          Sep 24, 2019          DP U-767
	
                6761910          Sep 24, 2019          DP U-767
	
                7910132          Sep 24, 2019          DP U-767
	
FENTANYL CITRATE - ABSTRAL
	
 N 022510 002   6759059          Sep 24, 2019          DP U-767
	
                6761910          Sep 24, 2019          DP U-767
	
                7910132          Sep 24, 2019          DP U-767
	
FENTANYL CITRATE - ABSTRAL
	
 N 022510 003   6759059          Sep 24, 2019          DP U-767
	
                6761910          Sep 24, 2019          DP U-767
	
                7910132          Sep 24, 2019          DP U-767
	
FENTANYL CITRATE - ABSTRAL
	
 N 022510 004   6759059          Sep 24, 2019          DP U-767
	
                6761910          Sep 24, 2019          DP U-767
	
                7910132          Sep 24, 2019          DP U-767
	
FENTANYL CITRATE - ABSTRAL
	
 N 022510 005   6759059          Sep 24, 2019          DP U-767
	
                6761910          Sep 24, 2019          DP U-767
	
                7910132          Sep 24, 2019          DP U-767
	
FENTANYL CITRATE - ABSTRAL
	
 N 022510 006   6759059          Sep 24, 2019          DP U-767
	
                6761910          Sep 24, 2019          DP U-767
	
                7910132          Sep 24, 2019          DP U-767
	
FENTANYL CITRATE - LAZANDA
	
 N 022569 001   6432440          Apr 20, 2018          DP U-1169
	
                8216604          Oct 03, 2024             U-767
	
                8889176          Jan 16, 2024             U-767
	
FENTANYL CITRATE - LAZANDA
	
 N 022569 002   6432440          Apr 20, 2018          DP U-1169
	
                8216604          Oct 03, 2024             U-767
	
                8889176          Jan 16, 2024             U-767
	
FENTANYL HYDROCHLORIDE - IONSYS
	
 N 021338 001   5697896           Dec 16, 2014         DP
	
                5843014           Dec 01, 2015         DP
	
                6169920           Jan 02, 2018         DP
	
                6171294           Jun 05, 2015              U-736
	
                6181963           Nov 02, 2019         DP
	
                6195582           Jan 28, 2019         DP U-736
	
                6216033           Jun 05, 2015         DP
	
                6425892           Jun 05, 2015              U-736
	
                6842640           Jun 02, 2015         DP
	
                6881208           Apr 19, 2022              U-736
	
                6975902           Apr 01, 2024         DP
	
                7018370           Jun 05, 2015              U-736
	
                7027859           Sep 26, 2014         DP
	
                7302293           Jun 05, 2015         DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 85 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
FERRIC CARBOXYMALTOSE - INJECTAFER
 N 203565 001   7612109          Feb 05, 2024         DS DP                                NP           Jul 25, 2016
                7754702          Feb 13, 2027            DP U-1432
                8895612          Jan 08, 2027            DP U-1620
FERRIC CITRATE - FERRIC CITRATE
 N 205874 001   5753706            Feb   03,   2017      DP U-1577
                7767851            Feb   18,   2024   DS DP
                8093423            Apr   21,   2026         U-1577
                8299298            Feb   18,   2024      DP
                8338642            Feb   18,   2024   DS DP U-1577
                8609896            Feb   18,   2024      DP
                8754257            Feb   18,   2024      DP
                8754258            Feb   18,   2024      DP
                8846976            Feb   18,   2024         U-1577
FERUMOXYTOL - FERAHEME
 N 022180 001   6599498            Jun   30,   2023   DS DP
                7553479            Mar   08,   2020   DS DP
                7871597            Mar   08,   2020   DS DP
                8501158            Mar   08,   2020           U-1422
                8591864            Mar   08,   2020      DP
                8926947            Mar   08,   2020   DS DP
FESOTERODINE FUMARATE - TOVIAZ
 N 022030 001   6858650            Jul   03,   2022   DS    U-913
                7384980            May   11,   2019   DS DP U-913
                7807715            Jun   07,   2027      DP U-913
                7855230            May   11,   2019         U-913
                7985772            May   11,   2019   DS DP U-913
                8088398            Jun   07,   2027      DP U-913
                8338478            May   11,   2019   DS DP U-913
                8501723            Jun   07,   2027      DP
FESOTERODINE FUMARATE - TOVIAZ
 N 022030 002   6858650            Jul   03,   2022   DS    U-913
                7384980            May   11,   2019   DS DP U-913
                7807715            Jun   07,   2027      DP U-913
                7855230            May   11,   2019         U-913
                7985772            May   11,   2019   DS DP U-913
                8088398            Jun   07,   2027      DP U-913
                8338478            May   11,   2019   DS DP U-913
                8501723            Jun   07,   2027      DP
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY
 A 203330 001                                                                              PC           Jun 20, 2015
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES
 A 203330 002                                                                              PC           Jun 20, 2015
FEXOFENADINE HYDROCHLORIDE - ALLEGRA
 N 020625 001   5738872          Feb 28, 2015
                5855912          Feb 28, 2015
                5932247          Feb 28, 2015
                6037353          Mar 14, 2017                 U-138
                6113942          Feb 28, 2015
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY
 N 020872 005   5855912          Feb 28, 2015       DP
                5932247          Feb 28, 2015       DP
                6037353          Mar 14, 2017           U-1160
                6113942          Feb 28, 2015       DP
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES
 N 020872 006   5855912          Feb 28, 2015       DP
                5932247          Feb 28, 2015       DP
                6037353          Mar 14, 2017          U-1160
                6113942          Feb 28, 2015       DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 86 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                  PATENT                     EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT             DELIST     EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES            REQUESTED     CODE(S)           DATE
	
FEXOFENADINE HYDROCHLORIDE - ALLEGRA ALLERGY
	
 N 020872 007   5855912          Feb 28, 2015              DP
	
                5932247          Feb 28, 2015              DP
	
                6037353          Mar 14, 2017                     U-1160
	
                6113942          Feb 28, 2015              DP
	
FEXOFENADINE HYDROCHLORIDE - ALLEGRA HIVES
	
 N 020872 008   5855912          Feb 28, 2015              DP
	
                5932247          Feb 28, 2015              DP
	
                6037353          Mar 14, 2017                     U-1160
	
                6113942          Feb 28, 2015              DP
	
FEXOFENADINE HYDROCHLORIDE - ALLEGRA HIVES
	
 N 020872 009   5855912          Feb 28, 2015              DP
	
                5932247          Feb 28, 2015              DP
	
                6037353          Mar 14, 2017                     U-1160
	
                6113942          Feb 28, 2015              DP
	
FEXOFENADINE HYDROCHLORIDE - ALLEGRA ALLERGY
	
 N 020872 010   5855912          Feb 28, 2015              DP
	
                5932247          Feb 28, 2015              DP
	
                6037353          Mar 14, 2017                     U-1160
	
                6113942          Feb 28, 2015              DP
	
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY
	
 N 021909 002   5738872          Feb 28, 2015       DP
	
                6037353          Mar 14, 2017            U-1158
	
                6037353          Mar 14, 2017            U-1466
	
                6723348          Nov 26, 2021       DP U-1466
	
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES
	
 N 021909 003   5738872          Feb 28, 2015       DP
	
                6037353          Mar 14, 2017
	
                6723348          Nov 26, 2021       DP
	
FEXOFENADINE HYDROCHLORIDE - ALLEGRA
	
 N 021963 001   6037353          Mar 14, 2017                     U-772
	
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY
	
 N 201373 001   6037353          Mar 14, 2017           U-1157
	
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES
	
 N 201373 002   6037353          Mar 14, 2017                     U-1157
	
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
	
 N 020786 002   5855912          Feb 28, 2015       DP
	
                6037353          Mar 14, 2017            U-1159
	
                6039974          Jul 31, 2018       DP
	
                6113942          Feb 28, 2015       DP
	
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
	
 N 021704 002   6037353          Mar 14, 2017            U-1159
	
                6613357          Dec 25, 2020       DP U-1159
	
                RE39069          May 29, 2018       DP
	
FIDAXOMICIN - DIFICID
	
 N 201699 001   7378508            Jul   31,   2027   DS DP                                NCE          May 27, 2016
                7863249            Jul   31,   2027   DS DP
                7906489            Mar   04,   2027               U-319
                8586551            Apr   12,   2024   DS DP
                8859510            Jul   31,   2027               U-319
FINAFLOXACIN - XTORO
 N 206307 001                                                                              NCE          Dec 17, 2019
                                                                                           PED          Jun 17, 2020
FINASTERIDE - PROSCAR
 N 020180 001   5942519            Oct 23, 2018                   U-280
FINGOLIMOD - GILENYA
 N 022527 001   5604229            Feb 18, 2019       DS          U-1086                   M-106        Jul 20, 2014
                6004565            Sep 23, 2017                   U-1086                   NCE          Sep 21, 2015
                8324283            Mar 29, 2026
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 87 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                              PATENT                         EXCLUSIVITY
     NO            PATENT NO           EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
                                          DATE                 CODES        REQUESTED         CODE(S)           DATE
FLORBETABEN F-18 - NEURACEQ
 N 204677 001   7807135               Mar 18, 2029       DS DP U-1497                         NCE          Mar 21, 2019
FLORBETAPIR F-18 - AMYVID
 N 202008    001   7687052            Apr 30, 2027       DS DP                                NCE          Apr 06, 2017
                   8506929            Apr 30, 2027       DS DP U-1423
FLORBETAPIR F-18 - AMYVID
 N 202008 002   7687052               Apr 30, 2027       DS DP                                NCE          Apr 06, 2017
                8506929               Apr 30, 2027       DS DP U-1423
FLORBETAPIR F-18 - AMYVID
 N 202008 003   7687052               Apr 30, 2027       DS DP                                NCE          Apr 06, 2017
                8506929               Apr 30, 2027       DS DP U-1423
FLUDARABINE PHOSPHATE - OFORTA
 N 022273 001   7148207               Dec 20, 2022            DP U-944                        ODE          Dec 18, 2015
                7547776               Dec 10, 2018       DS
FLUNISOLIDE - AEROSPAN HFA
 N 021247 001   5776433               Jul 07, 2015            DP                              M-128        Aug 28, 2016
FLUOCINOLONE ACETONIDE - RETISERT
 N 021737    001   6217895            Mar 22, 2019            DP U-708
                   6548078            Mar 22, 2019            DP U-708
FLUOCINOLONE ACETONIDE - ILUVIEN
 N 201923 001   6217895          Mar 22, 2019                 DP U-1597                       NP           Sep 26, 2017
                6375972          Apr 26, 2020                 DP U-1597
                6548078          Mar 22, 2019                 DP U-1597
                8252307          Jun 27, 2019                 DP
                8871241          Aug 12, 2027                 DP
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN - TRI-LUMA
 N 021112 001   7915243          Mar 22, 2026       DP
                7939516          May 04, 2025       DP
                8247395          Oct 22, 2022       DP
                8653053          Oct 25, 2022       DP
FLUOCINONIDE - FLUOCINONIDE
 A 090256 001                                                                                 PC           Jul 13, 2014
FLUOCINONIDE - VANOS
 N 021758 001   6765001               Dec   21,   2021        DP
                7220424               Jan   07,   2023             U-861
                7794738               Sep   11,   2022             U-1084
                8232264               Mar   09,   2023        DP
FLUOROURACIL - CARAC
 N 020985 001   6670335               Jun 02, 2021            DP U-68
FLUOXETINE HYDROCHLORIDE - PROZAC
 N 018936 001   6960577          Nov 01, 2017                      U-963                      NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE - PROZAC
 N 018936 003   6960577          Nov 01, 2017                      U-963                      NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE - PROZAC
 N 018936 004                                                                                 NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE - PROZAC
 N 018936 006   6960577          Nov 01, 2017                      U-963                      NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE - PROZAC WEEKLY
 N 021235 001   5910319          May 29,          2017           U-396
                5985322          May 29,          2017           U-397
                RE39030          May 29,          2017        DP U-396
                RE39030          May 29,          2017        DP U-397
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 88 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)           DATE
	
FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX
 N 021520 001   6960577          Nov 01, 2017               U-962                       M-142        Oct 10, 2017
                                                                                        NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX
 N 021520 002   5945416          Mar 24, 2017       DS DP                  Y            M-142        Oct 10, 2017
                6960577          Nov 01, 2017               U-962                       NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX
 N 021520 003   5945416          Mar 24, 2017       DS DP                  Y            M-142        Oct 10, 2017
                6960577          Nov 01, 2017               U-962                       NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX
 N 021520 004   5945416          Mar 24, 2017       DS DP                  Y            M-142        Oct 10, 2017
                6960577          Nov 01, 2017               U-962                       NPP          Jul 26, 2016
FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX
 N 021520 005   5945416          Mar 24, 2017       DS DP                  Y            M-142        Oct 10, 2017
                6960577          Nov 01, 2017               U-962                       NPP          Jul 26, 2016
FLUTEMETAMOL F-18 - VIZAMYL
 N 203137 001   7270800          Jan   24,   2023   DS DP U-336                         NCE          Oct 25, 2018
                7351401          Jan   24,   2023   DS DP U-336
                8236282          May   21,   2024   DS DP
                8691185          Jan   24,   2023         U-336
FLUTEMETAMOL F-18 - VIZAMYL
 N 203137 002   7270800          Jan   24,   2023   DS DP U-336                         NCE          Oct 25, 2018
                7351401          Jan   24,   2023   DS DP U-336
                8236282          May   21,   2024   DS DP
                8691185          Jan   24,   2023         U-336
FLUTICASONE FUROATE - VERAMYST
 N 022051 001   6858596          Aug   03,   2021      DP U-808
                7101866          Aug   03,   2021   DS DP U-808
                7541350          Aug   03,   2021      DP U-988
                8062264          Apr   05,   2026      DP
                8147461          Oct   15,   2028      DP
                8347879          Jul   15,   2028      DP
                8752543          Apr   05,   2026      DP
FLUTICASONE FUROATE - ARNUITY ELLIPTA
 N 205625 001   5873360          Feb 23,     2016      DP                               NP           Aug 20, 2017
                7101866          Aug 03,     2021   DS DP U-1559
                7629335          Aug 03,     2021      DP
                8113199          Oct 23,     2027      DP
                8161968          Feb 05,     2028      DP
                8201556          Feb 05,     2029      DP
                8534281          Aug 10,     2029      DP
                8746242          Oct 11,     2030      DP
FLUTICASONE FUROATE - ARNUITY ELLIPTA
 N 205625 002   5873360          Feb 23,     2016      DP                               NP           Aug 20, 2017
                7101866          Aug 03,     2021   DS DP U-1559
                7629335          Aug 03,     2021      DP
                8113199          Oct 23,     2027      DP
                8161968          Feb 05,     2028      DP
                8201556          Feb 05,     2029      DP
                8534281          Aug 10,     2029      DP
                8746242          Oct 11,     2030      DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 89 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT           DELIST         EXCLUSIVITY      EXPIRATION
	
                                    DATE               CODES          REQUESTED         CODE(S)           DATE
	
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE -   BREO ELLIPTA
	
 N 204275 001   5873360          Feb 23, 2016         DP                                NP           May 10, 2016

                6537983          Aug 03, 2021         DP U-1401
	
                6759398          Aug 03, 2021         DP U-1401
	
                6878698          Aug 03, 2021              U-1401
	
                7101866          Aug 03, 2021      DS DP U-1401
	
                7439393          Sep 11, 2022      DS DP U-1401
	
                7629335          Aug 03, 2021         DP
	
                7776895          Sep 11, 2022         DP
	
                8113199          Oct 23, 2027         DP
	
                8161968          Feb 05, 2028         DP
	
                8511304          Nov 11, 2025         DP U-1424
	
                8534281          Aug 10, 2029         DP
	
                8746242          Oct 11, 2030         DP
	
                RE44874          Mar 23, 2023      DS DP U-1548
	
FLUTICASONE PROPIONATE - FLOVENT DISKUS 50
	
 N 020833 001   5873360          Feb 23, 2016          DP
	
FLUTICASONE PROPIONATE - FLOVENT DISKUS 100
	
 N 020833 002   5873360          Feb 23, 2016          DP
	
FLUTICASONE PROPIONATE - FLOVENT DISKUS 250
	
 N 020833 003   5873360          Feb 23, 2016          DP
	
FLUTICASONE PROPIONATE - CUTIVATE
	
 N 021152 001   7300669          Oct 20, 2019          DP U-835
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 90 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                          EXCLUSIVITY
     NO            PATENT NO        EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
FLUTICASONE PROPIONATE - FLOVENT HFA
 N 021433    001   5658549         Aug   19,   2014      DP U-710
                   5674472         Oct   07,   2014      DP
                   6161724         Jan   16,   2018      DP
                   6170717         Dec   23,   2017      DP
                   6315173         Dec   23,   2017      DP
                   6431168         Jun   08,   2018      DP
                   6435372         Jan   16,   2018      DP
                   6510969         Dec   23,   2017      DP
                   6596260         Aug   10,   2014      DP
                   6743413         Jun   01,   2021         U-581
                   6938796         Jan   16,   2018      DP
                   6966467         Dec   23,   2017      DP
                   6997349         Jan   16,   2018      DP
                   7107986         Jun   08,   2018      DP
                   7107986*PED     Dec   08,   2018
                   7143908         Jan   16,   2018      DP
                   7350676         Aug   24,   2018      DP
                   7500444         Feb   26,   2026      DP
                   7500444*PED     Aug   26,   2026
                   7832351         Jun   19,   2023      DP
FLUTICASONE PROPIONATE - FLOVENT   HFA
 N 021433 002   5658549            Aug   19,   2014      DP U-710
                5674472            Oct   07,   2014      DP
                6161724            Jan   16,   2018      DP
                6170717            Dec   23,   2017      DP
                6315173            Dec   23,   2017      DP
                6431168            Jun   08,   2018      DP
                6435372            Jan   16,   2018      DP
                6510969            Dec   23,   2017      DP
                6596260            Aug   10,   2014      DP
                6743413            Jun   01,   2021         U-581
                6938796            Jan   16,   2018      DP
                6966467            Dec   23,   2017      DP
                6997349            Jan   16,   2018      DP
                7107986            Jun   08,   2018      DP
                7107986*PED        Dec   08,   2018
                7143908            Jan   16,   2018      DP
                7350676            Aug   24,   2018      DP
                7500444            Feb   26,   2026      DP
                7500444*PED        Aug   26,   2026
                7832351            Jun   19,   2023      DP
FLUTICASONE PROPIONATE - FLOVENT   HFA
 N 021433 003   5658549            Aug   19,   2014      DP U-710
                5674472            Oct   07,   2014      DP
                6161724            Jan   16,   2018      DP
                6170717            Dec   23,   2017      DP
                6315173            Dec   23,   2017      DP
                6431168            Jun   08,   2018      DP
                6435372            Jan   16,   2018      DP
                6510969            Dec   23,   2017      DP
                6596260            Aug   10,   2014      DP
                6743413            Jun   01,   2021         U-581
                6938796            Jan   16,   2018      DP
                6966467            Dec   23,   2017      DP
                6997349            Jan   16,   2018      DP
                7107986            Jun   08,   2018      DP
                7107986*PED        Dec   08,   2018
                7143908            Jan   16,   2018      DP
                7350676            Aug   24,   2018      DP
                7500444            Feb   26,   2026      DP
                7500444*PED        Aug   26,   2026
                7832351            Jun   19,   2023      DP
FLUTICASONE PROPIONATE - FLONASE ALLERGY RELIEF
 N 205434 001                                                                              M-147        Jul 23, 2017
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 100/50
	
 N 021077 001   5873360          Feb 23, 2016       DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 91 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                        PATENT                               EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION        PATENT        DELIST               EXCLUSIVITY      EXPIRATION
	
                                     DATE            CODES       REQUESTED               CODE(S)           DATE
	
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 250/50
	
 N 021077 002   5873360          Feb 23, 2016       DP
	
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 500/50
	
 N 021077 003   5873360          Feb 23, 2016       DP
	
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA
	
 N 021254 001   5658549          Aug 19, 2014       DP U-738
	
                5674472          Oct 07, 2014       DP
	
                6161724          Jan 16, 2018       DP
	
                6170717          Dec 23, 2017       DP
	
                6315173          Dec 23, 2017       DP
	
                6431168          Jun 08, 2018       DP
	
                6435372          Jan 16, 2018       DP
	
                6510969          Dec 23, 2017
	
                6596260          Aug 10, 2014       DP
	
                6743413          Jun 01, 2021            U-1591
	
                6743413*PED      Dec 01, 2021
	
                6938796          Jan 16, 2018       DP
	
                6966467          Dec 23, 2017       DP
	
                6997349          Jan 16, 2018       DP
	
                7107986          Jun 08, 2018       DP
	
                7143908          Jan 16, 2018       DP
	
                7350676          Aug 24, 2018       DP
	
                7500444          Feb 26, 2026       DP
	
                7500444*PED      Aug 26, 2026

                7832351          Jun 19, 2023       DP
	
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA
	
 N 021254 002   5658549          Aug 19, 2014       DP U-738
	
                5674472          Oct 07, 2014       DP
	
                6161724          Jan 16, 2018       DP
	
                6170717          Dec 23, 2017       DP
	
                6315173          Dec 23, 2017       DP
	
                6431168          Jun 08, 2018       DP
	
                6435372          Jan 16, 2018       DP
	
                6510969          Dec 23, 2017       DP
	
                6596260          Aug 10, 2014       DP
	
                6743413          Jun 01, 2021            U-1591
	
                6743413*PED      Dec 01, 2021
	
                6938796          Jan 16, 2018       DP
	
                6966467          Dec 23, 2017       DP
	
                6997349          Jan 16, 2018       DP
	
                7107986          Jun 08, 2018       DP
	
                7143908          Jan 16, 2018       DP
	
                7350676          Aug 24, 2018       DP
	
                7500444          Feb 26, 2026       DP
	
                7500444*PED      Aug 26, 2026

                7832351          Jun 19, 2023       DP
	
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA
	
 N 021254 003   5658549          Aug 19, 2014       DP U-738
	
                5674472          Oct 07, 2014       DP
	
                6161724          Jan 16, 2018       DP
	
                6170717          Dec 23, 2017       DP
	
                6315173          Dec 23, 2017       DP
	
                6431168          Jun 08, 2018       DP
	
                6435372          Jan 16, 2018       DP
	
                6510969          Dec 23, 2017       DP
	
                6596260          Aug 10, 2014       DP
	
                6743413          Jun 01, 2021            U-1591
	
                6743413*PED      Dec 01, 2021
	
                6938796          Jan 16, 2018       DP
	
                6966467          Dec 23, 2017       DP
	
                6997349          Jan 16, 2018       DP
	
                7107986          Jun 08, 2018       DP
	
                7143908          Jan 16, 2018       DP
	
                7350676          Aug 24, 2018       DP
	
                7500444          Feb 26, 2026       DP
	
                7500444*PED      Aug 26, 2026

                7832351          Jun 19, 2023       DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 92 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                           PATENT                              PATENT                        EXCLUSIVITY
	
     NO          PATENT NO         EXPIRATION          PATENT            DELIST        EXCLUSIVITY      EXPIRATION
	
                                      DATE              CODES           REQUESTED        CODE(S)           DATE
	
FLUVASTATIN SODIUM - LESCOL XL
	
 N 021192 001   6242003            Apr 13, 2020
	
FLUVOXAMINE MALEATE - LUVOX CR
	
 N 022033 001   7465462            May 10, 2020            DP U-929
	
FLUVOXAMINE MALEATE - LUVOX CR
	
 N 022033 002   7465462            May 10, 2020            DP U-929
	
FOLLITROPIN ALFA/BETA - GONAL-F
	
 N 020378 001   5767251           Jun 16, 2015      DS
	
FOLLITROPIN ALFA/BETA - GONAL-F
	
 N 020378 002   5767251           Jun 16, 2015      DS
	
FOLLITROPIN ALFA/BETA - GONAL-F
	
 N 020378 003   5767251           Jun 16, 2015      DS
	
FOLLITROPIN ALFA/BETA - GONAL-F
	
 N 020378 004   5767067           Jun 16, 2015      DS
	
                5767251           Jun 16, 2015      DS
	
                7563763           Aug 23, 2019             DP
	
FOLLITROPIN ALFA/BETA - GONAL-F
	
 N 020378 005   5767067           Jun 16, 2015      DS
	
                5767251           Jun 16, 2015      DS
	
                7563763           Aug 23, 2019             DP
	
FOLLITROPIN ALFA/BETA - FOLLISTIM
	
 N 020582 001   5767251          Jun 16, 2015
	
FOLLITROPIN ALFA/BETA - FOLLISTIM
	
 N 020582 002   5767251          Jun 16, 2015
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 93 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                             PATENT                          EXCLUSIVITY
     NO            PATENT NO           EXPIRATION             PATENT        DELIST          EXCLUSIVITY      EXPIRATION
                                          DATE                CODES       REQUESTED           CODE(S)           DATE
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ
 N 021211    001   5767251            Jun   16,   2015   DS                                   D-133        Aug 22, 2014
                   5929028            Jan   14,   2018        DP U-567
                   5929028            Jan   14,   2018        DP U-1366
                   7446090            Aug   23,   2019        DP
                   7563763            Aug   23,   2019           U-993
                   7563763            Aug   23,   2019           U-1183
                   7563763            Aug   23,   2019           U-1367
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ
 N 021211    002   5767251            Jun   16,   2015   DS                                   D-133        Aug 22, 2014
                   5929028            Jan   14,   2018        DP U-567
                   5929028            Jan   14,   2018        DP U-1366
                   7446090            Aug   23,   2019        DP
                   7563763            Aug   23,   2019           U-993
                   7563763            Aug   23,   2019           U-1183
                   7563763            Aug   23,   2019           U-1367
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ
 N 021211 003   5767251          Jun        16,   2015   DS                                   D-133        Aug 22, 2014
                5929028          Jan        14,   2018        DP U-567
                5929028          Jan        14,   2018        DP U-1366
                7446090          Aug        23,   2019        DP
                7563763          Aug        23,   2019           U-993
                7563763          Aug        23,   2019           U-1183
                7563763          Aug        23,   2019           U-1367
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ
 N 021211 004   5767251          Jun        16,   2015   DS                                   D-133        Aug 22, 2014
                5929028          Jan        14,   2018        DP U-567
                5929028          Jan        14,   2018        DP U-1366
                7446090          Aug        23,   2019        DP
                7563763          Aug        23,   2019           U-993
                7563763          Aug        23,   2019           U-1183
                7563763          Aug        23,   2019           U-1367
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ
 N 021273 001   5767251          Jun 16, 2015            DS
                5929028          Jan 14, 2018                 DP U-1366
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ
 N 021273 002   5767251          Jun 16, 2015            DS
                5929028          Jan 14, 2018                 DP U-1366
FOLLITROPIN ALFA/BETA - GONAL-F RFF REDI-JECT
 N 021684 001   5767067          Jun 16, 2015            DS
                5767251          Jun 16, 2015            DS
                7446090          Aug 23, 2019                 DP
                7741268          Apr 02, 2024                 DP
FOLLITROPIN ALFA/BETA - GONAL-F RFF REDI-JECT
 N 021684 002   5767067          Jun 16, 2015            DS
                5767251          Jun 16, 2015            DS
                7446090          Aug 23, 2019                 DP
                7741268          Apr 02, 2024                 DP
FOLLITROPIN ALFA/BETA - GONAL-F RFF REDI-JECT
 N 021684 003   5767067          Jun 16, 2015            DS
                5767251          Jun 16, 2015            DS
                7446090          Aug 23, 2019                 DP
                7741268          Apr 02, 2024                 DP
FOLLITROPIN ALFA/BETA - GONAL-F
 N 021765 001   5767251               Jun 16, 2015       DS
FOLLITROPIN ALFA/BETA - GONAL-F RFF
 N 021765 002   5767067          Jun 16, 2015            DS
                5767251          Jun 16, 2015            DS
FOLLITROPIN ALFA/BETA - GONAL-F
 N 021765 003   5767251               Jun 16, 2015       DS
FOMEPIZOLE - ANTIZOL
 N 020696 001   7553863               Jun 30, 2027       DS DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 94 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
FORMOTEROL FUMARATE - FORADIL
 N 020831 001   6488027            Mar 08, 2019
                6887459            Nov 28, 2020               U-762
FORMOTEROL FUMARATE - PERFOROMIST
 N 022007 001   6667344          Jun     22,   2021      DP
                6814953          Jun     22,   2021      DP U-813
                7348362          Jun     22,   2021      DP
                7462645          Jun     22,   2021      DP U-813
                8623922          Jun     22,   2021      DP
FORMOTEROL FUMARATE; MOMETASONE FUROATE - DULERA
 N 022518 001   6068832          Aug 27, 2017            DP U-1068
                7067502          May 21, 2020            DP U-1068
                7566705          May 21, 2020            DP U-1068
FORMOTEROL FUMARATE; MOMETASONE FUROATE - DULERA
 N 022518 002   6068832          Aug 27, 2017            DP U-1068
                7067502          May 21, 2020            DP U-1068
                7566705          May 21, 2020            DP U-1068
FOSAMPRENAVIR CALCIUM - LEXIVA
 N 021548 001   6436989            Dec 24, 2017       DS DP U-257                          NPP          Apr 27, 2015
                6514953            Jul 15, 2019       DS DP U-257                          PED          Oct 27, 2015
FOSAMPRENAVIR CALCIUM - LEXIVA
 N 022116 001   6436989            Dec 24, 2017       DS DP U-257                          NPP          Apr 27, 2015
                                                                                           PED          Oct 27, 2015
FOSAPREPITANT DIMEGLUMINE - EMEND
 N 022023 001   5691336          Mar 04, 2019         DS DP
                5716942          Feb 10, 2015                 U-850
FOSAPREPITANT DIMEGLUMINE - EMEND
 N 022023 002   5691336          Mar 04, 2019         DS DP
                5716942          Feb 10, 2015                 U-850
FOSPROPOFOL DISODIUM - LUSEDRA
 N 022244 001   6204257            Jul 01, 2022       DS DP U-945
                6872838            Aug 07, 2018       DS
FROVATRIPTAN SUCCINATE - FROVA
 N 021006 001   5464864            Nov 07, 2015               U-436
                5827871            Oct 27, 2015               U-436
FULVESTRANT - FASLODEX
 N 021344 001   6774122            Jan   09,   2021           U-596                        M-123        Nov 09, 2015
                7456160            Jan   09,   2021           U-596                        PED          Nov 17, 2014
                8329680            Jan   09,   2021           U-596
                8466139            Jan   09,   2021           U-596
                8466139*PED        Jul   09,   2021
GABAPENTIN - NEURONTIN
 N 020235 001   6054482            Apr 25, 2017
GABAPENTIN - NEURONTIN
 N 020235 002   6054482            Apr 25, 2017
GABAPENTIN - NEURONTIN
 N 020235 003   6054482            Apr 25, 2017
GABAPENTIN - NEURONTIN
 N 020882 001   6054482            Apr 25, 2017
GABAPENTIN - NEURONTIN
 N 020882 002   6054482            Apr 25, 2017
GABAPENTIN - NEURONTIN
 N 021129 001   6054482            Apr 25, 2017
                7256216            May 28, 2022          DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 95 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                           EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY      EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)           DATE
	
GABAPENTIN - GRALISE
 N 022544 001   6340475            Sep   19,   2016      DP                                ODE          Jan 28, 2018
                6488962            Jun   20,   2020      DP
                6635280            Sep   19,   2016      DP
                6723340            Oct   25,   2021      DP
                7438927            Feb   26,   2024         U-1114
                7731989            Oct   25,   2022      DP
                8192756            Oct   25,   2022      DP U-1114
                8252332            Oct   25,   2022      DP U-1114
                8333992            Oct   25,   2022      DP U-1114
GABAPENTIN - GRALISE
 N 022544 002   6340475            Sep   19,   2016      DP                                ODE          Jan 28, 2018
                6488962            Jun   20,   2020      DP
                6635280            Sep   19,   2016      DP
                6723340            Oct   25,   2021      DP
                7438927            Feb   26,   2024         U-1114
                7731989            Oct   25,   2022      DP
                8192756            Oct   25,   2022      DP U-1114
                8252332            Oct   25,   2022      DP U-1114
                8333992            Oct   25,   2022      DP U-1114
GABAPENTIN ENACARBIL - HORIZANT
 N 022399 001   6818787            Nov   06,   2022   DS DP                                I-652        Jun 06, 2015
                8026279            Nov   10,   2026   DS DP                                NCE          Apr 06, 2016
                8048917            Nov   06,   2022   DS DP U-1247                         ODE          Jun 06, 2019
                8114909            Apr   11,   2026         U-1231
                8686034            Jan   24,   2025         U-1231
                8686034            Jan   24,   2025         U-1247
                8795725            Jun   10,   2029      DP U-1231
                8795725            Jun   10,   2029      DP U-1247
GABAPENTIN ENACARBIL - HORIZANT
 N 022399 002   6818787            Nov   06,   2022   DS DP                                I-652        Jun 06, 2015
                8026279            Nov   10,   2026   DS DP                                NCE          Apr 06, 2016
                8048917            Nov   06,   2022   DS DP U-1247                         ODE          Jun 06, 2019
                8114909            Apr   11,   2026         U-1231
                8686034            Jan   24,   2025         U-1231
                8686034            Jan   24,   2025         U-1247
                8795725            Jun   10,   2029      DP U-1231
                8795725            Jun   10,   2029      DP U-1247
GADOBENATE DIMEGLUMINE - MULTIHANCE
 N 021357 001                                                                              I-654        Jul 06, 2015
GADOBENATE DIMEGLUMINE - MULTIHANCE
 N 021357 002                                                                              I-654        Jul 06, 2015
GADOBENATE DIMEGLUMINE - MULTIHANCE
 N 021357 003                                                                              I-654        Jul 06, 2015
GADOBENATE DIMEGLUMINE - MULTIHANCE
 N 021357 004                                                                              I-654        Jul 06, 2015
GADOBENATE DIMEGLUMINE - MULTIHANCE MULTIPACK
 N 021358 001                                                                              I-654        Jul 06, 2015
GADOBENATE DIMEGLUMINE - MULTIHANCE MULTIPACK
 N 021358 002                                                                              I-654        Jul 06, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 96 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
	
GADOBUTROL - GADAVIST
 N 201277 001   5980864            Nov 09, 2016       DS DP U-1119                         I-688        Jun 11, 2017
                                                                                           NCE          Mar 14, 2016
GADOBUTROL - GADAVIST
 N 201277 002   5980864            Nov 09, 2016       DS DP U-1119                         I-688        Jun 11, 2017
                                                                                           NCE          Mar 14, 2016
GADOBUTROL - GADAVIST
 N 201277 003   5980864            Nov 09, 2016       DS DP U-1119                         I-688        Jun 11, 2017
                                                                                           NCE          Mar 14, 2016
GADOBUTROL - GADAVIST
 N 201277 004   5980864            Nov 09, 2016       DS DP U-1119                         I-688        Jun 11, 2017
                                                                                           NCE          Mar 14, 2016
GADOBUTROL - GADAVIST
 N 201277 005   5980864            Nov 09, 2016       DS DP U-1119                         I-688        Jun 11, 2017
                                                                                           NCE          Mar 14, 2016
GADOBUTROL - GADAVIST
 N 201277 006                                                                              I-688        Jun 11, 2017
                                                                                           NCE          Mar 14, 2016
GADOFOSVESET TRISODIUM - ABLAVAR
 N 021711 001   6676929          May 04, 2020              DP
                7011815          Feb 01, 2015                   U-1112
                7060250          May 26, 2015         DS
                7229606          May 26, 2015                   U-1112
                8017105          May 26, 2015         DS
                8394356          Feb 01, 2015                   U-1112
GADOFOSVESET TRISODIUM - ABLAVAR
 N 021711 002   6676929          May 04, 2020              DP
                7011815          Feb 01, 2015                   U-1112
                7060250          May 26, 2015         DS
                7229606          May 26, 2015                   U-1112
                8017105          May 26, 2015         DS
                8394356          Feb 01, 2015                   U-1112
GADOTERATE MEGLUMINE - DOTAREM
 N 204781 001                                                                              NCE          Mar 20, 2018
GADOTERATE MEGLUMINE - DOTAREM
 N 204781 002                                                                              NCE          Mar 20, 2018
GADOTERATE MEGLUMINE - DOTAREM
 N 204781 003                                                                              NCE          Mar 20, 2018
GADOTERATE MEGLUMINE - DOTAREM
 N 204781 004                                                                              NCE          Mar 20, 2018
GADOTERIDOL - PROHANCE
 N 020131 001   5846519            Dec 08, 2015
GADOTERIDOL - PROHANCE MULTIPACK
 N 021489 001   5846519          Dec 08, 2015
GADOXETATE DISODIUM - EOVIST
 N 022090 001   5798092            Aug 25, 2015       DS DP
                6039931            Nov 13, 2021                 U-1239
GALANTAMINE HYDROBROMIDE - RAZADYNE
 N 021169 001   6099863          Jun 06, 2017
                6358527          Jun 06, 2017              DP U-322
GALANTAMINE HYDROBROMIDE - RAZADYNE
 N 021169 002   6099863          Jun 06, 2017
                6358527          Jun 06, 2017              DP U-322
GALANTAMINE HYDROBROMIDE - RAZADYNE
 N 021169 003   6099863          Jun 06, 2017
                6358527          Jun 06, 2017              DP U-322
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 97 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                             PATENT                          EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY      EXPIRATION
                                          DATE               CODES        REQUESTED           CODE(S)           DATE
GALANTAMINE HYDROBROMIDE - RAZADYNE ER
 N 021615    001   7160559            Dec 20, 2019          DP
GALANTAMINE HYDROBROMIDE - RAZADYNE ER
 N 021615 002   7160559          Dec 20, 2019               DP
GALANTAMINE HYDROBROMIDE - RAZADYNE ER
 N 021615 003   7160559          Dec 20, 2019               DP
GANCICLOVIR - ZIRGAN
 N 022211 001                                                                                 ODE          Sep 15, 2016
GANIRELIX ACETATE - GANIRELIX ACETATE
 N 021057 001   5767082          Jun 16, 2015
                6653286          Jun 16, 2018                    U-1354
GATIFLOXACIN - ZYMAR
 N 021493 001   5880283               Dec 05, 2015
                6333045               Aug 20, 2019          DP
GATIFLOXACIN - ZYMAXID
 N 022548 001   5880283               Dec 05, 2015       DS
                6333045               Aug 20, 2019       DS DP
GEFITINIB - IRESSA
 N 021399 001   5770599               May 05, 2017       DS DP U-881
GEMIFLOXACIN MESYLATE - FACTIVE
 N 021158 001   5633262               Jun   15,   2015
                5776944               Apr   04,   2017   DS DP
                5962468               Jun   15,   2015           U-282
                6262071               Sep   21,   2019           U-513
                6331550               Sep   21,   2019           U-511
                6340689               Sep   14,   2019           U-512
                6455540               Sep   21,   2019           U-511
                6723734               Mar   20,   2018   DS DP
                6803376               Sep   21,   2019   DS DP U-608
                6803376               Sep   21,   2019   DS DP U-609
GEMTUZUMAB OZOGAMICIN - MYLOTARG
 N 021174 001   5693762          Dec 02, 2014
                5739116          Apr 14, 2015
                5767285          Jun 16, 2015
                5773001          Jun 30, 2015                    U-320
GLATIRAMER ACETATE - COPAXONE
 N 020622 003   8232250               Aug 19, 2030               U-441                        NP           Jan 28, 2017
                8399413               Aug 19, 2030               U-441
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE - DUETACT
 N 021925 001   6150383          Jun 19, 2016                  U-753
                6211205          Jun 19, 2016                  U-753
                6303640          Aug 09, 2016                  U-753
                6329404          Jun 19, 2016               DP U-753
                7538125          Jun 19, 2016               DP
                7700128          Jan 30, 2027               DP
                8071130          Jun 08, 2028               DP
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE - DUETACT
 N 021925 002   6150383          Jun 19, 2016                  U-753
                6211205          Jun 19, 2016                  U-753
                6303640          Aug 09, 2016                  U-753
                6329404          Jun 19, 2016               DP U-753
                7538125          Jun 19, 2016               DP
                7700128          Jan 30, 2027               DP
                8071130          Jun 08, 2028               DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 98 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY      EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)           DATE
	
GLIMEPIRIDE; ROSIGLITAZONE MALEATE -    AVANDARYL
 N 021700 001   5741803          Apr    21, 2015      DS DP U-690
                5741803          Apr    21, 2015      DS DP U-781
                7358366          Apr    19, 2020      DS
GLIMEPIRIDE; ROSIGLITAZONE MALEATE -    AVANDARYL
 N 021700 002   5741803          Apr    21, 2015      DS DP U-690
                5741803          Apr    21, 2015      DS DP U-781
                7358366          Apr    19, 2020      DS
GLIMEPIRIDE; ROSIGLITAZONE MALEATE -    AVANDARYL
 N 021700 003   5741803          Apr    21, 2015      DS DP U-690
                5741803          Apr    21, 2015      DS DP U-781
                7358366          Apr    19, 2020      DS
GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL
 N 021700 004   7358366          Apr 19, 2020         DS
GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL
 N 021700 005   7358366          Apr 19, 2020         DS
GLIPIZIDE - GLUCOTROL XL
 N 020329 001   RE44459            Mar 26, 2019                 U-1431
GLIPIZIDE - GLUCOTROL XL
 N 020329 002   RE44459            Mar 26, 2019                 U-1431
GLIPIZIDE - GLUCOTROL XL
 N 020329 003   RE44459            Mar 26, 2019                 U-1431
GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE
 N 021178 001   6303146          Jul 14, 2019                   U-412
GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE
 N 021178 002   6303146          Jul 14, 2019                   U-412
GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE
 N 021178 003   6303146          Jul 14, 2019                   U-412
GLYCEROL PHENYLBUTYRATE - RAVICTI
 N 203284 001   5968979          Feb 07, 2015         DS DP U-1378                         NE           Feb 01, 2016
                8404215          Mar 09, 2032               U-1383                         ODE          Feb 01, 2020
                8642012          Sep 22, 2030               U-1383
GLYCOPYRROLATE - ROBINUL
 N 012827 001   7091236            Apr 24, 2024                 U-877          Y
GLYCOPYRROLATE - ROBINUL FORTE
 N 012827 002   7091236            Apr 24, 2024                 U-877          Y
GLYCOPYRROLATE - CUVPOSA
 N 022571 001   7638552            Aug 20, 2023                 U-1076                     ODE          Jul 28, 2017
                7816396            Aug 20, 2023                 U-1076
GOSERELIN ACETATE - ZOLADEX
 N 019726 001   7118552            Apr 13, 2022            DP
                7220247            Apr 09, 2022            DP
                7500964            Feb 26, 2021            DP
GOSERELIN ACETATE - ZOLADEX
 N 020578 001   7118552            Apr 13, 2022            DP
                7220247            Apr 09, 2022            DP
                7500964            Feb 26, 2021            DP
GRANISETRON - SANCUSO
 N 022198 001   7608282            Oct 22, 2024            DP U-1011
GRANISETRON HYDROCHLORIDE - KYTRIL
 N 020239 001   5952340          Sep 14, 2016                   U-519
GRANISETRON HYDROCHLORIDE - KYTRIL
 N 020239 002   5952340          Sep 14, 2016                   U-519
GRANISETRON HYDROCHLORIDE - KYTRIL
 N 020239 004   5952340          Sep 14, 2016                   U-519
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 99 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT
	                              PATENT                       EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT
	           DELIST       EXCLUSIVITY     EXPIRATION
	
                                       DATE               CODES
	          REQUESTED       CODE(S)           DATE
	
GUAIFENESIN - MUCINEX
	
 N 021282 001		 6372252            Apr 28, 2020               U-489
	
                6955821            Apr 28, 2020          DP U-489
	
                7838032            Apr 28, 2020          DP
	
GUAIFENESIN - MUCINEX
	
 N 021282 002		 6372252            Apr 28, 2020               U-489
	
                6955821            Apr 28, 2020          DP U-489
	
                7838032            Apr 28, 2020          DP
	
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE - MUCINEX D
	
 N 021585 001		 6372252          Apr 28, 2020       DP
	
                6955821          Apr 28, 2020       DP U-686
	
                7838032          Apr 28, 2020       DP
	
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE - MUCINEX D
	
 N 021585 002		 6372252          Apr 28, 2020       DP
	
                6955821          Apr 28, 2020       DP U-686
	
                7838032          Apr 28, 2020       DP
	
GUANFACINE HYDROCHLORIDE - INTUNIV
	
 N 022037 001		 5854290          Sep    21,   2015              U-494
	          Y         D-145        Nov 19, 2017
                5854290*PED      Mar    21,   2016
	                                       PED          May 19, 2018
                6287599          Dec    20,   2020       DP
	
                6287599*PED      Jun    20,   2021
	
                6811794          Jul    04,   2022       DP U-494
	
                6811794*PED      Jan    04,   2023
	
GUANFACINE HYDROCHLORIDE - INTUNIV
	
 N 022037 002		 5854290          Sep    21,   2015              U-494
	          Y         D-145        Nov 19, 2017
                5854290*PED      Mar    21,   2016
	                                       PED          May 19, 2018
                6287599          Dec    20,   2020       DP
	
                6287599*PED      Jun    20,   2021
	
                6811794          Jul    04,   2022       DP U-494
	
                6811794*PED      Jan    04,   2023
	
GUANFACINE HYDROCHLORIDE - INTUNIV
	
 N 022037 003		 5854290          Sep    21,   2015              U-494
	          Y         D-145        Nov 19, 2017
                5854290*PED      Mar    21,   2016
	                                       PED          May 19, 2018
                6287599          Dec    20,   2020       DP
	
                6287599*PED      Jun    20,   2021
	
                6811794          Jul    04,   2022       DP U-494
	
                6811794*PED      Jan    04,   2023
	
GUANFACINE HYDROCHLORIDE - INTUNIV
	
 N 022037 004		 5854290          Sep    21,   2015              U-494
	          Y         D-145        Nov 19, 2017
                5854290*PED      Mar    21,   2016
	                                       PED          May 19, 2018
                6287599          Dec    20,   2020       DP
	
                6287599*PED      Jun    20,   2021
	
                6811794          Jul    04,   2022       DP U-494
	
                6811794*PED      Jan    04,   2023
	
HEXAMINOLEVULINATE HYDROCHLORIDE   - CYSVIEW KIT
	
 N 022555 001		 6034267            Mar 08, 2016             U-1087
	
                7247655            Mar 08, 2016          DP U-1087
	
                7348361            Nov 06, 2020          DP U-1087
	
                7530461            Jan 11, 2017          DP U-1087
	
HISTRELIN ACETATE - SUPPRELIN LA
	
 N 022058 001		 8062652           Jun 16, 2026                  U-1197
	
HYALURONIDASE RECOMBINANT HUMAN - HYLENEX RECOMBINANT
	
 N 021859 001		 7767429          Sep 23, 2027    DS DP
	
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE - BIDIL
	
 N 020727 001		 6465463          Sep 08, 2020           U-71
	
                6784177          Sep 08, 2020           U-71
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 100 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
	
HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE
 N 020758 001   5994348          Jun 07, 2015
HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE
 N 020758 002   5994348          Jun 07, 2015
HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE
 N 020758 003   5994348          Jun 07, 2015
HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE
 N 020758 004   5994348          Jun 07, 2015         DP
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT
 N 021532 002   5616599          Apr 25, 2016    DS DP U-500
                6878703          Nov 19, 2021           U-3                Y
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT
 N 021532 003   5616599          Apr 25, 2016    DS DP U-500
                6878703          Nov 19, 2021           U-3                Y
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT
 N 021532 005   5616599          Apr 25, 2016    DS DP U-500
                6878703          Nov 19, 2021           U-3                Y
HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT
 N 021162 001   6358986          Jan 10, 2020
HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT
 N 021162 002   6358986          Jan 10, 2020
HYDROCHLOROTHIAZIDE; VALSARTAN - DIOVAN HCT
 N 020818 001   6294197          Jun 18, 2017              U-3
HYDROCHLOROTHIAZIDE; VALSARTAN - DIOVAN HCT
 N 020818 002   6294197          Jun 18, 2017              U-3
HYDROCHLOROTHIAZIDE; VALSARTAN - DIOVAN HCT
 N 020818 003   6294197          Jun 18, 2017              U-3
HYDROCHLOROTHIAZIDE; VALSARTAN - DIOVAN HCT
 N 020818 004   6294197          Jun 18, 2017              U-3
HYDROCHLOROTHIAZIDE; VALSARTAN - DIOVAN HCT
 N 020818 005   6294197          Jun 18, 2017              U-3
HYDROCODONE BITARTRATE - ZOHYDRO ER
 N 202880 001   6228398          Nov 01, 2019         DP                                NP            Oct 25, 2016
                6902742          Nov 01, 2019         DP
HYDROCODONE BITARTRATE - ZOHYDRO ER
 N 202880 002   6228398          Nov 01, 2019         DP                                NP            Oct 25, 2016
                6902742          Nov 01, 2019         DP
HYDROCODONE BITARTRATE - ZOHYDRO ER
 N 202880 003   6228398          Nov 01, 2019         DP                                NP            Oct 25, 2016
                6902742          Nov 01, 2019         DP
HYDROCODONE BITARTRATE - ZOHYDRO ER
 N 202880 004   6228398          Nov 01, 2019         DP                                NP            Oct 25, 2016
                6902742          Nov 01, 2019         DP
HYDROCODONE BITARTRATE - ZOHYDRO ER
 N 202880 005   6228398          Nov 01, 2019         DP                                NP            Oct 25, 2016
                6902742          Nov 01, 2019         DP
HYDROCODONE BITARTRATE - ZOHYDRO ER
 N 202880 006   6228398          Nov 01, 2019         DP                                NP            Oct 25, 2016
                6902742          Nov 01, 2019         DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 101 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                           EXCLUSIVITY
     NO          PATENT NO       EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 001   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 002   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 003   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 004   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 005   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 006   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE - HYSINGLA
 N 206627 007   8808740          Dec 21, 2031         DP U-1556
HYDROCODONE BITARTRATE; IBUPROFEN - VICOPROFEN
 N 020716 001   6348216          Jun 10, 2017
                6599531          Jun 10, 2017
HYDROCORTISONE BUTYRATE - LOCOID
 N 022076 001   7378405          Dec 19, 2026         DP
                7981877          Jan 23, 2025         DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID-HP
 N 019034 001   6589960          Nov 09, 2020         DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID-HP
 N 019034 002   6589960          Nov 09, 2020         DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019034 003   6589960          Nov 09, 2020      DS DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019034 004   6589960          Nov 09, 2020      DS DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019034 005   6589960          Nov 09, 2020      DS DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019891 001   6589960          Nov 09, 2020      DS DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019892 001   6589960          Nov 09, 2020      DS DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019892 002   6589960          Nov 09, 2020      DS DP
HYDROMORPHONE HYDROCHLORIDE - DILAUDID
 N 019892 003   6589960          Nov 09, 2020      DS DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 102 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
	
HYDROMORPHONE HYDROCHLORIDE - PALLADONE
 N 021044 001   5958452          Nov 04,    2014      DP
                5965161          Nov 04,    2014      DP U-616
                6335033          Nov 04,    2014      DP U-616
                6589960          Nov 09,    2020      DP
                6706281          Nov 04,    2014      DP U-616
                6743442          Nov 04,    2014      DP
HYDROMORPHONE HYDROCHLORIDE - PALLADONE
 N 021044 002   5958452          Nov 04,    2014      DP
                5965161          Nov 04,    2014      DP U-616
                6335033          Nov 04,    2014      DP U-616
                6589960          Nov 09,    2020      DP
                6706281          Nov 04,    2014      DP U-616
                6743442          Nov 04,    2014      DP
HYDROMORPHONE HYDROCHLORIDE - PALLADONE
 N 021044 003   5958452          Nov 04,    2014      DP
                5965161          Nov 04,    2014      DP U-616
                6335033          Nov 04,    2014      DP U-616
                6589960          Nov 09,    2020      DP
                6706281          Nov 04,    2014      DP U-616
                6743442          Nov 04,    2014      DP
HYDROMORPHONE HYDROCHLORIDE - PALLADONE
 N 021044 004   5958452          Nov 04,    2014      DP
                5965161          Nov 04,    2014      DP U-616
                6335033          Nov 04,    2014      DP U-616
                6589960          Nov 09,    2020      DP
                6706281          Nov 04,    2014      DP U-616
                6743442          Nov 04,    2014      DP
HYDROMORPHONE HYDROCHLORIDE - EXALGO
 N 021217 001   5702725          Jul 07, 2014         DP U-1043
                5914131          Jul 07, 2014         DP U-1043
HYDROMORPHONE HYDROCHLORIDE - EXALGO
 N 021217 002   5702725          Jul 07, 2014         DP U-1043
                5914131          Jul 07, 2014         DP U-1043
HYDROMORPHONE HYDROCHLORIDE - EXALGO
 N 021217 003   5702725          Jul 07, 2014         DP U-1043
                5914131          Jul 07, 2014         DP U-1043
HYDROMORPHONE HYDROCHLORIDE - EXALGO
 N 021217 004   5702725          Jul 07, 2014         DP U-1043
                5914131          Jul 07, 2014         DP U-1043
HYDROXOCOBALAMIN - CYANOKIT
 N 022041 001   5834448         Nov 14, 2016          DP
HYDROXOCOBALAMIN - CYANOKIT
 N 022041 002   5834448         Nov 14, 2016          DP U-789
HYDROXYPROGESTERONE CAPROATE - MAKENA
 N 021945 001                                                                           ODE           Feb 03, 2018
IBANDRONATE SODIUM - BONIVA
 N 021455 001   6143326         Apr 21, 2017               U-642
                6294196         Oct 07, 2019          DP
IBANDRONATE SODIUM - BONIVA
 N 021455 002   6294196         Oct   07,   2019      DP
                7192938         May   06,   2023           U-798
                7410957         May   06,   2023           U-887
                7718634         May   06,   2023           U-642
IBANDRONATE SODIUM - BONIVA
 N 021858 001   5662918         Sep 02, 2014          DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 103 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES            REQUESTED       CODE(S)            DATE
	
IBRUTINIB - IMBRUVICA
	
 N 205552 001   7514444             Dec   28,   2026   DS DP                                I-680         Feb   12,   2017
	
                8008309             Dec   28,   2026   DS DP                                I-689         Jul   28,   2017
	
                8476284             Dec   28,   2026             U-1456                     NCE           Nov   13,   2018
	
                8476284             Dec   28,   2026             U-1491                     ODE           Nov   13,   2020
	
                8497277             Dec   28,   2026             U-1456                     ODE           Feb   12,   2021
	
                8497277             Dec   28,   2026             U-1491                     ODE           Jul   28,   2021
	
                8697711             Dec   28,   2026   DS DP
	
                8703780             Dec   28,   2026             U-1491
	
                8735403             Dec   28,   2026   DS DP
	
                8754090             Jun   03,   2031             U-1456
	
                8754091             Dec   28,   2026      DP
	
IBUPROFEN - MIDOL LIQUID GELS
	
 N 021472 001   6251426             Jun 25, 2018
	
IBUPROFEN - CALDOLOR
	
 N 022348 001   6727286             Nov 27, 2021          DP U-981
	
IBUPROFEN - CALDOLOR
	
 N 022348 002   6727286             Nov 27, 2021          DP U-981
	
                8735452             Sep 30, 2029             U-981
	
                8871810             Aug 27, 2030             U-1599
	
IBUPROFEN LYSINE - NEOPROFEN
	
 N 021903 001   6342530             Nov   14,   2020      DP U-794
	
                6342530             Nov   14,   2020      DP U-1127
	
                6344479             Mar   20,   2021   DS DP U-794                Y
	
                8415337             Mar   02,   2032   DS DP
	
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE - CHILDREN'S MOTRIN COLD
	
 N 021128 001   6211246          Jun 10, 2019
	
ICATIBANT ACETATE - FIRAZYR
	
 N 022150 001   5648333             Jul 15, 2015       DS DP U-1187                         NCE           Aug 25, 2016

                                                                                            ODE           Aug 25, 2018
	
ICODEXTRIN - EXTRANEAL
	
 N 021321 001   6077836             Jun 20, 2017                 U-495
	
                6248726             Jun 19, 2018                 U-495
	
ICOSAPENT ETHYL - VASCEPA
	
 N 202057 001   8188146             Jan   27,   2020   DS DP                                NP            Jul 26, 2015
	
                8293727             Feb   09,   2030             U-1287
	
                8293728             Feb   09,   2030             U-1287
	
                8298554             Apr   29,   2030      DP
	
                8314086             Feb   09,   2030             U-1287
	
                8318715             Feb   09,   2030             U-1287
	
                8357677             Feb   09,   2030             U-1287
	
                8367652             Feb   09,   2030             U-1287
	
                8377920             Feb   09,   2030             U-1287
	
                8399446             Feb   09,   2030             U-1287
	
                8415335             Feb   09,   2030             U-1287
	
                8426399             Feb   09,   2030             U-1287
	
                8431560             Feb   09,   2030             U-1287
	
                8440650             Feb   09,   2030             U-1287
	
                8445003             Apr   29,   2030             U-1287
	
                8445013             Apr   29,   2030             U-1287
	
                8501225             Apr   29,   2030             U-1287
	
                8518929             Apr   29,   2030             U-1287
	
                8524698             Apr   29,   2030             U-1287
	
                8546372             Apr   29,   2030             U-1287
	
                8551521             Apr   29,   2030             U-1287
	
                8563608             Apr   29,   2030             U-1287
	
                8617593             Apr   29,   2030             U-1478
	
                8617594             Apr   29,   2030             U-1287
	
                8623406             Apr   29,   2030             U-1478
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 104 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                            PATENT                            EXCLUSIVITY
     NO            PATENT NO           EXPIRATION             PATENT       DELIST           EXCLUSIVITY       EXPIRATION
                                          DATE                 CODES      REQUESTED           CODE(S)            DATE
IDELALISIB - ZYDELIG
 N 205858    001   6800620            Apr   24,   2021   DS      U-1560                       NCE           Jul 23, 2019
                   6949535            Apr   24,   2021   DS      U-1560
                   8138195            Apr   24,   2021   DS DP
                   8492389            Apr   24,   2021   DS DP
                   8637533            Apr   24,   2021   DS DP
                   8865730            Mar   05,   2033   DS DP U-1615
                   RE44599            Jul   21,   2025         U-1558
                   RE44638            Aug   05,   2025   DS DP
IDELALISIB - ZYDELIG
 N 205858 002   6800620               Apr   24,   2021   DS      U-1560                       NCE           Jul 23, 2019
                6949535               Apr   24,   2021   DS      U-1560
                8138195               Apr   24,   2021   DS DP
                8492389               Apr   24,   2021   DS DP
                8637533               Apr   24,   2021   DS DP
                8865730               Mar   05,   2033   DS DP U-1615
                RE44599               Jul   21,   2025         U-1558
                RE44638               Aug   05,   2025   DS DP
ILOPERIDONE - FANAPT
 N 022192 001   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
ILOPERIDONE - FANAPT
 N 022192 002   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
ILOPERIDONE - FANAPT
 N 022192 003   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
ILOPERIDONE - FANAPT
 N 022192 004   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
ILOPERIDONE - FANAPT
 N 022192 005   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
ILOPERIDONE - FANAPT
 N 022192 006   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
ILOPERIDONE - FANAPT
 N 022192 007   8586610               Nov 02, 2027             U-1625
                RE39198               Nov 15, 2016       DS DP U-971
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 105 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
IMATINIB MESYLATE - GLEEVEC
 N 021335 001   5521184            Jan   04,   2015   DS DP
                6894051            May   23,   2019   DS DP U-649
                6958335            Dec   19,   2021         U-791
                RE43932            Jan   16,   2019   DS DP
                RE43932*PED        Jul   16,   2019
IMATINIB MESYLATE - GLEEVEC
 N 021335 002   5521184            Jan   04,   2015   DS DP U-649
                6894051            May   23,   2019   DS DP U-649
                6958335            Dec   19,   2021         U-791
                RE43932            Jan   16,   2019   DS DP
                RE43932*PED        Jul   16,   2019
IMATINIB MESYLATE - GLEEVEC
 N 021588 001   5521184            Jan   04,   2015   DS DP                                I-666         Jan 25, 2016
                6894051            May   23,   2019   DS DP U-649                          ODE           Dec 19, 2015
                6958335            Dec   19,   2021         U-791                          ODE           Jan 25, 2020
                7544799            Jan   16,   2019   DS DP                    Y
                7544799*PED        Jul   16,   2019
                RE43932            Jan   16,   2019   DS DP
                RE43932*PED        Jul   16,   2019
IMATINIB MESYLATE - GLEEVEC
 N 021588 002   5521184            Jan   04,   2015                                        I-666         Jan 25, 2016
                6894051            May   23,   2019   DS DP U-649                          ODE           Dec 19, 2015
                6958335            Dec   19,   2021         U-791                          ODE           Jan 25, 2020
                7544799            Jan   16,   2019   DS DP                    Y
                7544799*PED        Jul   16,   2019
                RE43932            Jan   16,   2019   DS DP
                RE43932*PED        Jul   16,   2019
IMIQUIMOD - ALDARA
 N 020723 001   7696159            Apr 01, 2024       DS        U-1047
                7696159            Apr 01, 2024       DS        U-1048
IMIQUIMOD - ZYCLARA
 N 022483 001   8236816            Dec   11,   2029             U-68
                8299109            Dec   11,   2029             U-68
                8598196            Aug   18,   2029             U-172
                8598196            Aug   18,   2029             U-1455
IMIQUIMOD - ZYCLARA
 N 022483 002   8222270            Dec 11, 2029                 U-68                       NS            Jul 15, 2014
INDACATEROL MALEATE - ARCAPTA NEOHALER
 N 022383 001   6878721          Oct 10, 2020         DS DP U-1168                         NCE           Jul 01, 2016
                8067437          Jun 02, 2020               U-1168
                8479730          Oct 11, 2028            DP
INDINAVIR SULFATE - CRIXIVAN
 N 020685 001   6645961            Mar 04, 2018            DP
                6689761            Feb 10, 2021                 U-554
INDINAVIR SULFATE - CRIXIVAN
 N 020685 003   6645961            Mar 04, 2018            DP
                6689761            Feb 10, 2021                 U-554
INDINAVIR SULFATE - CRIXIVAN
 N 020685 005   6645961            Mar 04, 2018            DP
                6689761            Feb 10, 2021                 U-554
INDINAVIR SULFATE - CRIXIVAN
 N 020685 006   6645961            Mar 04, 2018            DP
                6689761            Feb 10, 2021                 U-554
INDIUM IN-111 PENTETREOTIDE KIT - OCTREOSCAN
 N 020314 001   5753627          May 19, 2015                   U-1125
                5776894          Jul 07, 2015         DS DP
                6123916          Sep 26, 2017                   U-1125
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 106 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                                PATENT
	                        EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION             PATENT           DELIST       EXCLUSIVITY
	       EXPIRATION
	
                                     DATE                 CODES          REQUESTED       CODE(S)
	            DATE
	
INDOMETHACIN - TIVORBEX
	
 N 204768 001		 8734847          Apr 23, 2030            DP                              NP
	            Feb 24, 2017
	
INDOMETHACIN - TIVORBEX
	
 N 204768 002		 8734847          Apr 23, 2030            DP                              NP
	            Feb 24, 2017
	
INGENOL MEBUTATE - PICATO
	
 N 202833 001		 6432452          Aug   19,   2018   DS        U-68                       NCE
	           Jan 23, 2017
	
                6844013          Dec   13,   2018   DS   DP U-1221
	
                7410656          Aug   19,   2018   DS        U-1222
	
                8278292          Feb   20,   2027   DS   DP
	
                8372827          Dec   18,   2026   DS   DP
	
                8372828          Dec   18,   2026   DS   DP
	
                8377919          Dec   18,   2026   DS   DP
	
                8536163          Dec   18,   2026             U-1440
	
                8716271          Dec   18,   2026             U-1440
	
                8735375          Dec   18,   2026             U-1440
	
INGENOL MEBUTATE - PICATO
	
 N 202833 002		 6432452          Aug   19,   2018   DS        U-68                       NCE
	           Jan 23, 2017
	
                6844013          Dec   13,   2018   DS   DP U-1221
	
                7410656          Aug   19,   2018   DS        U-1222
	
                8278292          Feb   20,   2027   DS   DP
	
                8372827          Dec   18,   2026   DS   DP
	
                8372828          Dec   18,   2026   DS   DP
	
                8377919          Dec   18,   2026   DS   DP
	
                8536163          Dec   18,   2026             U-1440
	
                8716271          Dec   18,   2026             U-1440
	
                8735375          Dec   18,   2026             U-1440
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30
	
 N 021172 001		 5866538          Jun 20, 2017       DP
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 PENFILL
	
 N 021172 002		 5866538          Jun 19, 2017       DP
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 PENFILL
	
 N 021172 003		 5866538          Jun 19, 2017       DP
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 FLEXPEN
	
 N 021172 004		 5866538          Jun 20, 2017       DP
	
                6004297          Jan 28, 2019       DP
	
                RE41956          Jan 21, 2021       DP
	
                RE43834          Jan 28, 2019       DP
	
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 50/50
	
 N 021810 001		 5866538          Jun 20, 2017       DP
	
INSULIN ASPART RECOMBINANT - NOVOLOG
	
 N 020986 001		 5866538          Jun 20, 2017            DP
	
INSULIN ASPART RECOMBINANT - NOVOLOG PENFILL
	
 N 020986 002		 5693027          Dec 02, 2014            DP
	
                5866538          Jun 20, 2017            DP
	
INSULIN ASPART RECOMBINANT - NOVOLOG FLEXPEN
	
 N 020986 003		 5866538          Jun 20, 2017            DP
	
                6004297          Jan 28, 2019            DP
	
                RE41956          Jan 21, 2021            DP
	
                RE43834          Jan 28, 2019            DP
	
INSULIN ASPART RECOMBINANT - NOVOLOG INNOLET
	
 N 020986 004		 5866538          Jun 20, 2017            DP
	
                RE41956          Jan 21, 2021            DP
	
INSULIN ASPART RECOMBINANT - NOVOLOG FLEXTOUCH
	
 N 020986 005		 5618913*PED      Dec 07, 2014
	
                5866538          Jun 20, 2017            DP
	
                5866538*PED      Dec 20, 2017
	
                6899699          Jan 02, 2022            DP
	
                7686786          Aug 03, 2026            DP
	
                8672898          Jan 02, 2022            DP
	
                8684969          Oct 20, 2025            DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 107 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
	
INSULIN DETEMIR RECOMBINANT - LEVEMIR
	
 N 021536 001   5750497          Jun 16, 2019       DS DP U-668                          M-115         Apr 06, 2015

                5866538          Jun 20, 2017       DS DP                                M-117         May 18, 2015
	
INSULIN DETEMIR RECOMBINANT - LEVEMIR FLEXPEN
	
 N 021536 002   5750497          Jun 16, 2019       DS DP U-668
	
                5866538          Jun 20, 2017       DS DP
	
                6004297          Jan 28, 2019          DP
	
                RE41956          Jan 21, 2021          DP
	
                RE43834          Jan 28, 2019          DP
	
INSULIN DETEMIR RECOMBINANT - LEVEMIR INNOLET
	
 N 021536 003   5750497          Jun 16, 2019       DS DP U-668
	
                5866538          Jun 20, 2017       DS DP
	
INSULIN DETEMIR RECOMBINANT - LEVEMIR PENFILL
	
 N 021536 004   5750497          Jun 16, 2019       DS DP U-668
	
                5866538          Jun 20, 2017       DS DP
	
INSULIN DETEMIR RECOMBINANT - LEVEMIR FLEXTOUCH
	
 N 021536 005   5750497          Jun 16, 2019     DS DP U-668
	
                5866538          Jun 20, 2017        DP
	
                6899699          Jan 02, 2022        DP
	
                7686786          Aug 03, 2026        DP
	
                8672898          Jan 02, 2022        DP
	
                8684969          Oct 20, 2025        DP
	
INSULIN GLARGINE RECOMBINANT - LANTUS
	
 N 021081 001   5656722          Aug 12,   2014     DS DP U-948
	
                7476652          Jul 23,   2023        DP
	
                7713930          Jun 13,   2023        DP
	
                7918833          Sep 23,   2027        DP
	
INSULIN GLARGINE RECOMBINANT - LANTUS SOLOSTAR
	
 N 021081 002   8512297          Sep 15, 2024          DP
	
                8556864          Mar 03, 2024          DP
	
                8603044          Mar 02, 2024          DP
	
                8679069          Apr 12, 2025          DP
	
INSULIN GLULISINE RECOMBINANT - APIDRA
	
 N 021629 001   6221633          Jun 18,   2018     DS DP U-471
	
                6960561          Jan 25,   2023        DP U-471
	
                7452860          Mar 22,   2022        DP
	
                7696162          Mar 22,   2022        DP U-471
	
INSULIN GLULISINE RECOMBINANT - APIDRA
	
 N 021629 002   6221633          Jun 18,   2018     DS DP U-471
	
                6960561          Jan 25,   2023        DP U-471
	
                7452860          Mar 22,   2022        DP
	
                7696162          Mar 22,   2022        DP U-471
	
INSULIN GLULISINE RECOMBINANT - APIDRA SOLOSTAR
	
 N 021629 003   6221633          Jun 18, 2018     DS DP U-471
	
                6960561          Jan 25, 2023        DP U-471
	
                7452860          Mar 22, 2022        DP
	
                7696162          Mar 22, 2022        DP U-471
	
                7918833          Sep 23, 2027        DP
	
                8512297          Sep 15, 2024        DP
	
                8556864          Mar 03, 2024        DP
	
                8603044          Mar 02, 2024        DP
	
                8679069          Apr 12, 2025        DP
	
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 75/25 KWIKPEN
	
 N 021017 002   7291132          Aug 09, 2024       DP
	
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 50/50 KWIKPEN
	
 N 021018 002   7291132          Aug 09, 2024       DP
	
INSULIN LISPRO RECOMBINANT - HUMALOG
	
 N 020563 001                                                                            NR            Oct 12, 2015
	
INSULIN LISPRO RECOMBINANT - HUMALOG PEN
	
 N 020563 002                                                                            NR            Oct 12, 2015
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 108 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                               PATENT                         EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT            DELIST        EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES           REQUESTED        CODE(S)            DATE
	
INSULIN LISPRO RECOMBINANT - HUMALOG KWIKPEN
	
 N 020563 003   7291132          Aug 09, 2024          DP
	
INSULIN RECOMBINANT HUMAN - EXUBERA
	
 N 021868 001   5740794          Apr 21, 2015          DP
	
                6257233          May 14, 2019                 U-704
	
                6543448          Sep 21, 2014          DP
	
                6546929          May 14, 2019                 U-704
	
                6582728          Jun 24, 2020          DP
	
                6685967          Sep 11, 2018          DP
	
INSULIN RECOMBINANT HUMAN - EXUBERA
	
 N 021868 002   5740794          Apr 21, 2015          DP
	
                6257233          May 14, 2019                 U-704
	
                6543448          Sep 21, 2014          DP
	
                6546929          May 14, 2019                 U-704
	
                6582728          Jun 24, 2020          DP
	
                6685967          Sep 11, 2018          DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 109 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
	
INSULIN RECOMBINANT HUMAN - AFREZZA
 N 022472 001   6071497          May   15,   2015      DP U-1533                         NP            Jun 27, 2017
                6428771          May   15,   2015      DP U-1533
                6444226          Jun   29,   2020      DP U-1534
                6652885          Jun   29,   2020         U-1535
                6663898          Sep   30,   2014      DP
                6906030          Sep   30,   2014      DP
                7276534          Sep   30,   2014      DP U-1536
                7305986          Jan   16,   2023      DP
                7464706          Mar   02,   2023      DP
                7648960          Jun   29,   2020         U-1535
                7943178          Jun   29,   2020      DP U-1535
                7943572          Aug   10,   2026         U-1539
                8119593          Aug   11,   2029         U-1537
                8133514          Sep   30,   2014      DP
                8146588          Apr   24,   2023      DP
                8156936          Jan   16,   2023      DP
                8215300          Nov   24,   2022      DP
                8227409          Mar   08,   2031      DP U-1538
                8258095          Aug   11,   2029         U-1537
                8389470          Jun   29,   2020      DP
                8394414          May   15,   2015      DP U-1533
                8424518          Oct   17,   2031      DP
                8485180          Mar   25,   2030      DP
                8499757          Feb   19,   2032      DP
                8551528          Jun   11,   2030      DP
                8623817          Sep   18,   2029         U-1537
                8636001          Jul   12,   2032      DP
                8729019          Jun   06,   2028      DP
                8734845          Jun   11,   2030      DP
                8778403          Jun   11,   2030      DP U-1538
                8889099          Jun   29,   2020      DP U-1621
INSULIN RECOMBINANT HUMAN - AFREZZA
 N 022472 002   6071497          May   15,   2015      DP U-1533                         NP            Jun 27, 2017
                6428771          May   15,   2015      DP U-1533
                6444226          Jun   29,   2020      DP U-1534
                6652885          Jun   29,   2020         U-1535
                6663898          Sep   30,   2014      DP
                6906030          Sep   30,   2014      DP
                7276534          Sep   30,   2014      DP U-1536
                7305986          Jan   16,   2023      DP
                7464706          Mar   02,   2023      DP
                7648960          Jun   29,   2020         U-1535
                7943178          Jun   29,   2020      DP U-1535
                8119593          Aug   11,   2029         U-1537
                8133514          Sep   30,   2014      DP
                8146588          Apr   24,   2023      DP
                8156936          Jan   16,   2023      DP
                8215300          Nov   24,   2022      DP
                8227409          Mar   08,   2031      DP U-1538
                8258095          Aug   11,   2029         U-1537
                8389470          Jun   29,   2020      DP
                8394414          May   15,   2015      DP U-1533
                8485180          Mar   25,   2030      DP
                8499757          Feb   19,   2032      DP
                8551528          Jun   11,   2030      DP
                8636001          Jul   12,   2032      DP
                8729019          Jun   06,   2028      DP
                8734845          Jun   11,   2030      DP
                8778403          Jun   11,   2030      DP U-1538
                8889099          Jun   29,   2020      DP U-1621
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN - HUMULIN 70/30
	
 N 019717 001   7291132          Aug 09, 2024       DP
	
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN - HUMULIN 70/30 PEN
	
 N 019717 002   7291132          Aug 09, 2024       DP
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                        ADA 110 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT
	                                     PATENT                       EXCLUSIVITY
	
     NO            PATENT NO         EXPIRATION
	           PATENT                  DELIST    EXCLUSIVITY
	       EXPIRATION
	
                                        DATE
	               CODES                REQUESTED     CODE(S)
	            DATE
	
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN - HUMULIN N
	
 N 018781 001   7291132          Aug 09, 2024
	       DP
IOBENGUANE SULFATE I-123 - ADREVIEW
	
 N 022290 001
	                                                                                 I-669
	         Mar 20, 2016
	
                                                                                                ODE
	           Sep 19, 2015
	
IOFLUPANE I-123 - DATSCAN
	
 N 022454 001   5310912             Feb 25, 2015         DS
	                                   NCE
	           Jan 14, 2016
	
IPRATROPIUM BROMIDE - ATROVENT HFA
	
 N 021527 001   5676930          Oct      14,   2014
	          DP
	
                5683677          Nov      04,   2014
	          DP
	
                6739333          May      26,   2020
           DP
	
                6983743          May      26,   2020
	          DP
	
IRBESARTAN - AVAPRO
	
 N 020757 001   6342247             Jun 07, 2015
	
IRBESARTAN - AVAPRO
	
 N 020757 002   6342247             Jun 07, 2015
	
IRBESARTAN - AVAPRO
	
 N 020757 003   6342247             Jun 07, 2015
	
IRINOTECAN HYDROCHLORIDE - CAMPTOSAR
	
 N 020571 001   6403569          Apr 28, 2020
                         U-449
	
                6794370          May 01, 2020
	                        U-606
	
IRINOTECAN HYDROCHLORIDE - CAMPTOSAR
	
 N 020571    002   6403569
	        Apr 28, 2020
                      U-449
	
                   6794370
	        May 01, 2020
	                     U-606
	
IRON DEXTRAN - DEXFERRUM
	
 N 040024 001   5624668
	           Sep 29, 2015
	
IRON SUCROSE - VENOFER
	
 N 021135 001
	                                                                                 NPP
	           Sep 21, 2015
	
IRON SUCROSE - VENOFER
	
 N 021135 002
	                                                                                 NPP
	           Sep 21, 2015
	
IRON SUCROSE - VENOFER
	
 N 021135 005
	                                                                                 NPP
	           Sep 21, 2015
	
ISOTRETINOIN - ABSORICA
	
 N 021951 001   7435427
	           Sep 21, 2021
               DP
	                            NP
	            May 25, 2015
	
                8367102
	           Sep 21, 2021
	                     U-1347
	
ISOTRETINOIN - ABSORICA
	
 N 021951 002   7435427
	           Sep 21, 2021
               DP
	                            NP
	            May 25, 2015
	
                8367102
	           Sep 21, 2021
	                     U-1347
	
ISOTRETINOIN - ABSORICA
	
 N 021951 003   7435427
	           Sep 21, 2021
               DP
	                            NP
	            May 25, 2015
	
                8367102
	           Sep 21, 2021
	                     U-1347
	
ISOTRETINOIN - ABSORICA
	
 N 021951 004   7435427
	           Sep 21, 2021
               DP
	                            NP
	            May 25, 2015
	
                8367102
	           Sep 21, 2021
	                     U-1347
	
ITRACONAZOLE - SPORANOX
	
 N 020657 001   5707975
	           Jan 13, 2015
	
                6407079
	           Jun 18, 2019
	
ITRACONAZOLE - SPORANOX
	
 N 020966 001   6407079
	           Jun 18, 2019
	
ITRACONAZOLE - ONMEL
	
 N 022484 001		 6509038
	           May   12,   2017
           DP     U-1054
	
                7081255
	           May   12,   2017
           DP     U-1054
	
                8486456
	           Oct   03,   2028
	          DP     U-1054
	
                8591948
	           May   12,   2017
	          DP     U-1054
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 111 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT
	                                 PATENT                     EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION             PATENT
	            DELIST    EXCLUSIVITY       EXPIRATION
	
                                        DATE                 CODES
	          REQUESTED     CODE(S)            DATE
	
IVACAFTOR - KALYDECO
	
 N 203188 001		 7495103             May   20,   2027     DS DP
	                            NCE           Jan 31, 2017
	
                8324242             Apr   18,   2027               U-1311
	                 ODE           Jan 31, 2019
	
                8410274             Dec   28,   2026        DP
	
                8754224             Dec   28,   2026     DS DP
	
IVERMECTIN - SKLICE
	
 N 202736 001		 6103248             May 22, 2018            DP
	                            NP            Feb 07, 2015
	
                8791153             Oct 12, 2027            DP
	
IVERMECTIN - SOOLANTRA
	
 N 206255 001
	                                                                             NP            Dec 19, 2017
	
IXABEPILONE - IXEMPRA KIT
	
 N 022065 001		 6670384             Jan   23,   2022        DP U-959
	                      M-61          Oct 18, 2014
	
                6670384             Jan   23,   2022        DP U-960
	                      PED           Apr 18, 2015
	
                7022330             Jan   23,   2022        DP U-958
	
                7125899             May   26,   2018     DS DP U-957
	
                7312237             Aug   21,   2024           U-965
	
                RE41393             Feb   08,   2022           U-961
	
                RE41911             Sep   28,   2020     DS DP U-961
	
IXABEPILONE - IXEMPRA KIT
	
 N 022065 002		 6670384             Jan   23,   2022        DP U-959
	                      M-61          Oct 18, 2014
	
                6670384             Jan   23,   2022        DP U-960
	                      PED           Apr 18, 2015
	
                7022330             Jan   23,   2022        DP U-958
	
                7125899             May   26,   2018     DS DP U-957
	
                7312237             Aug   21,   2024           U-965
	
                RE41393             Feb   08,   2022           U-961
	
                RE41911             Sep   28,   2020     DS DP U-961
	
KETOCONAZOLE - EXTINA
	
 N 021738 001		 7553835             Oct 19, 2018            DP U-245
	
                8026238             Oct 19, 2018            DP U-1213
	
KETOCONAZOLE - XOLEGEL
	
 N 021946 001		 7179475             Dec 04, 2018            DP U-792
	
                8232276             Nov 24, 2020            DP
	
                8735393             Dec 04, 2018            DP
	
KETOROLAC TROMETHAMINE - ACULAR LS
	
 N 021528 001		 8008338          May      24,   2027     DS DP U-1181
	
                8207215          May      28,   2024           U-1251
	
                8377982          May      28,   2024           U-1363
	
                8377982*PED      Nov      28,   2024
	
                8541463          May      28,   2024               U-1441
	
                8541463*PED      Nov      28,   2024
	
                8648107          May      28,   2024        DP
	
                8906950          May      28,   2024               U-1626
	
KETOROLAC TROMETHAMINE - SPRIX
	
 N 022382 001		 6333044             Dec 25, 2018            DP U-1057
	
KETOROLAC TROMETHAMINE - ACUVAIL
	
 N 022427 001		 7842714           Aug 15, 2029           DS DP
	
                8512717           Mar 07, 2028              DP
	
KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE - OMIDRIA
	
 N 205388 001		 8173707          Jul 30, 2023            U-1518
	                           NP            May 30, 2017
	
                8586633          Jul 30, 2023       DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 112 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
LACOSAMIDE - VIMPAT
 N 022253 001   5654301            Aug 05, 2014       DS DP U-914                          D-143         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1566                         D-144         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1567                         I-696         Aug 29, 2017
LACOSAMIDE - VIMPAT
 N 022253 002   5654301            Aug 05, 2014       DS DP U-914                          D-143         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1566                         D-144         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1567                         I-696         Aug 29, 2017
LACOSAMIDE - VIMPAT
 N 022253 003   5654301            Aug 05, 2014       DS DP U-914                          D-143         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1566                         D-144         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1567                         I-696         Aug 29, 2017
LACOSAMIDE - VIMPAT
 N 022253 004   5654301            Aug 05, 2014       DS DP U-914                          D-143         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1566                         D-144         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1567                         I-696         Aug 29, 2017
LACOSAMIDE - VIMPAT
 N 022254 001   5654301            Aug 05, 2014       DS DP U-911                          D-143         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1565                         D-144         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1568                         I-696         Aug 29, 2017
LACOSAMIDE - VIMPAT
 N 022255 001   5654301            Aug 05, 2014       DS DP U-914                          D-143         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1566                         D-144         Aug 29, 2017
                RE38551            Mar 17, 2022       DS DP U-1567                         I-696         Aug 29, 2017
LAMIVUDINE - EPIVIR
 N 020564 001   5905082            May 18, 2016       DS DP U-248
LAMIVUDINE - EPIVIR
 N 020564 003   5905082            May 18, 2016
LAMIVUDINE - EPIVIR
 N 020596 001   6004968            Mar 20, 2018
LAMIVUDINE - EPIVIR-HBV
 N 021003 001   5905082            May 18, 2016
LAMIVUDINE - EPIVIR-HBV
 N 021004 001   6004968            Mar 20, 2018
LAMIVUDINE; ZIDOVUDINE - COMBIVIR
 N 020857 001   5905082          May 18, 2016         DS DP U-248
LAMOTRIGINE - LAMICTAL XR
 N 022115 001   8637512            Jun 14, 2028          DP
LAMOTRIGINE - LAMICTAL XR
 N 022115 002   8637512            Jun 14, 2028          DP
LAMOTRIGINE - LAMICTAL XR
 N 022115 003   8637512            Jun 14, 2028          DP
LAMOTRIGINE - LAMICTAL XR
 N 022115 004   8637512            Jun 14, 2028          DP
LAMOTRIGINE - LAMICTAL XR
 N 022115 005   8637512            Jun 14, 2028          DP
LAMOTRIGINE - LAMICTAL XR
 N 022115 006   8637512            Jun 14, 2028          DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 113 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
LAMOTRIGINE - LAMICTAL ODT
 N 022251 001   7919115            Jan 04, 2029       DS DP
                8840925            Jul 02, 2028          DP U-1596
LAMOTRIGINE - LAMICTAL ODT
 N 022251 002   7919115            Jan 04, 2029       DS DP
                8840925            Jul 02, 2028          DP U-1596
LAMOTRIGINE - LAMICTAL ODT
 N 022251 003   7919115            Jan 04, 2029       DS DP
                8840925            Jul 02, 2028          DP U-1596
LAMOTRIGINE - LAMICTAL ODT
 N 022251 004   7919115            Jan 04, 2029       DS DP
                8840925            Jul 02, 2028          DP U-1596
LANREOTIDE ACETATE - SOMATULINE DEPOT
 N 022074 001   5595760          Mar 08, 2020            DP U-831                          I-701         Dec 19, 2017
                                                                                           ODE           Aug 30, 2014
                                                                                           ODE           Dec 16, 2021
LANREOTIDE ACETATE - SOMATULINE DEPOT
 N 022074 002   5595760          Mar 08, 2020            DP U-831                          I-701         Dec 19, 2017
                                                                                           ODE           Aug 30, 2014
                                                                                           ODE           Dec 16, 2021
LANREOTIDE ACETATE - SOMATULINE DEPOT
 N 022074 003   5595760          Mar 08, 2020            DP U-831                          I-701         Dec 19, 2017
                                                                                           ODE           Aug 30, 2014
                                                                                           ODE           Dec 16, 2021
LANSOPRAZOLE - PREVACID
 N 021428 001   6328994            May   17,   2019
                7399485            May   26,   2018      DP
                7431942            May   17,   2019      DP
                7875292            May   17,   2019      DP
LANSOPRAZOLE - PREVACID
 N 021428 002   6328994            May   17,   2019
                7399485            May   26,   2018      DP
                7431942            May   17,   2019      DP
                7875292            May   17,   2019      DP
LANSOPRAZOLE - PREVACID IV
 N 021566 001   7396841            Aug 17, 2021          DP U-947
LANTHANUM CARBONATE - FOSRENOL
 N 021468 001   5968976            Oct 26, 2018          DP U-613
                7381428            Aug 26, 2024             U-890
                7465465            Aug 26, 2024          DP
LANTHANUM CARBONATE - FOSRENOL
 N 021468 002   5968976            Oct 26, 2018          DP U-613
                7381428            Aug 26, 2024             U-890
                7465465            Aug 26, 2024          DP
LANTHANUM CARBONATE - FOSRENOL
 N 021468 003   5968976            Oct 26, 2018          DP U-613
                7381428            Aug 26, 2024             U-890
                7465465            Aug 26, 2024          DP
LANTHANUM CARBONATE - FOSRENOL
 N 021468 004   5968976            Oct 26, 2018          DP U-613
                7381428            Aug 26, 2024             U-890
                7465465            Aug 26, 2024          DP
LANTHANUM CARBONATE - FOSRENOL
 N 204734 001   5968976            Oct 26, 2018          DP U-1592
                7465465            Aug 26, 2024          DP
LANTHANUM CARBONATE - FOSRENOL
 N 204734 002   5968976            Oct 26, 2018          DP U-1592
                7465465            Aug 26, 2024          DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 114 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                               PATENT                       EXCLUSIVITY
     NO          PATENT NO
	      EXPIRATION
	              PATENT         DELIST      EXCLUSIVITY       EXPIRATION
                                     DATE
	                  CODES        REQUESTED      CODE(S)            DATE
LAPATINIB DITOSYLATE - TYKERB
	
 N 022059 001   6391874
	         Jul   11,   2017
	   DS   DP   U-800
                6391874
	         Jul   11,   2017
	   DS   DP   U-1429
                6713485
	         Sep   29,   2020
    DS   DP   U-800
                6713485
	         Sep   29,   2020
    DS   DP   U-1429
                6727256
	         Jan   08,   2019
	   DS   DP   U-800
                6727256
	         Jan   08,   2019
	   DS   DP   U-1429
                6828320
	         Jul   11,   2017
	             U-800
                6828320
	         Jul   11,   2017
	             U-1429
                7157466
	         Nov   19,   2021
	   DS DP
                8513262
	         Jan   08,   2019
	   DS DP
                8821927
	         Jun   12,   2029
	   DS DP
LEDIPASVIR; SOFOSBUVIR - HARVONI
	
 N 205834 001   7964580
	         Mar   26,   2029
	   DS DP U-1470                      NCE           Oct 10, 2019
                8088368
	         May   12,   2030
    DS DP
                8273341
	         May   12,   2030
          U-1470
                8334270
	         Mar   21,   2028
	   DS DP U-1470
                8580765
	         Mar   21,   2028
	   DS DP U-1470
                8618076
	         Dec   11,   2030
	   DS DP U-1470
                8633309
	         Mar   26,   2029
	   DS DP U-1470
                8735372
	         Mar   21,   2028
	         U-1470
                8822430
	         May   12,   2030
    DS DP U-1470
                8841278
	         May   12,   2030
       DP U-1470
                8889159
	         Mar   26,   2029
	      DP U-1470
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 115 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                     DATE                 CODES        REQUESTED         CODE(S)            DATE
	
LENALIDOMIDE - REVLIMID
	
 N 021880 001   5635517          Oct   04,   2019   DS      U-1211                       I-672         Jun 05, 2016
	
                6045501          Aug   28,   2018           U-1210                       ODE           Jun 05, 2020
	
                6281230          Jul   24,   2016           U-1212
	
                6281230          Jul   24,   2016           U-1414
	
                6315720          Oct   23,   2020           U-1210
	
                6555554          Jul   24,   2016      DP U-1211
	
                6561976          Aug   28,   2018           U-1210
	
                6561977          Oct   23,   2020           U-1210
	
                6755784          Oct   23,   2020           U-1210
	
                6908432          Aug   28,   2018           U-1210
	
                7119106          Jul   24,   2016      DP
	
                7189740          Apr   11,   2023           U-1215
	
                7465800          Apr   27,   2027   DS DP
	
                7468363          Oct   07,   2023           U-1414
	
                7855217          Nov   24,   2024   DS DP
	
                7968569          Oct   07,   2023           U-1216
	
                8204763          Aug   28,   2018           U-1249
	
                8288415          Jul   24,   2016   DS DP
	
                8315886          Oct   23,   2020           U-1249
	
                8404717          Apr   11,   2023           U-1215
	
                8530498          May   15,   2023           U-1216
	
                8589188          Aug   28,   2018           U-1210
	
                8626531          Oct   23,   2020           U-1210
	
                8648095          May   15,   2023           U-1216
	
                8741929          Mar   08,   2028           U-1414
	
LENALIDOMIDE - REVLIMID
	
 N 021880 002   5635517          Oct   04,   2019   DS      U-1211                       I-672         Jun 05, 2016
	
                6045501          Aug   28,   2018           U-1210                       ODE           Jun 05, 2020
	
                6281230          Jul   24,   2016           U-1212
	
                6281230          Jul   24,   2016           U-1414
	
                6315720          Oct   23,   2020           U-1210
	
                6555554          Jul   24,   2016      DP U-1211
	
                6561976          Aug   28,   2018           U-1210
	
                6561977          Oct   23,   2020           U-1210
	
                6755784          Oct   23,   2020           U-1210
	
                6908432          Aug   28,   2018           U-1210
	
                7119106          Jul   24,   2016      DP
	
                7189740          Apr   11,   2023           U-1215
	
                7465800          Apr   27,   2027   DS DP
	
                7468363          Oct   07,   2023           U-1414
	
                7855217          Nov   24,   2024   DS DP
	
                7968569          Oct   07,   2023           U-1216
	
                8204763          Aug   28,   2018           U-1249
	
                8288415          Jul   24,   2016   DS DP
	
                8315886          Oct   23,   2020           U-1249
	
                8404717          Apr   11,   2023           U-1215
	
                8530498          May   15,   2023           U-1216
	
                8589188          Aug   28,   2018           U-1210
	
                8626531          Oct   23,   2020           U-1210
	
                8648095          May   15,   2023           U-1216
	
                8741929          Mar   08,   2028           U-1414
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 116 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                     DATE                 CODES        REQUESTED         CODE(S)            DATE
	
LENALIDOMIDE - REVLIMID
	
 N 021880 003   5635517          Oct   04,   2019   DS      U-1211                       I-672         Jun 05, 2016
	
                6045501          Aug   28,   2018           U-1210                       ODE           Jun 05, 2020
	
                6281230          Jul   24,   2016           U-1212
	
                6281230          Jul   24,   2016           U-1414
	
                6315720          Oct   23,   2020           U-1210
	
                6555554          Jul   24,   2016      DP U-1211
	
                6561976          Aug   28,   2018           U-1210
	
                6561977          Oct   23,   2020           U-1210
	
                6755784          Oct   23,   2020           U-1210
	
                6908432          Aug   28,   2018           U-1210
	
                7119106          Jul   24,   2016      DP
	
                7189740          Apr   11,   2023           U-1215
	
                7465800          Apr   27,   2027   DS DP
	
                7468363          Oct   07,   2023           U-1414
	
                7855217          Nov   24,   2024   DS DP
	
                7968569          Oct   07,   2023           U-1216
	
                8204763          Aug   28,   2018           U-1249
	
                8288415          Jul   24,   2016   DS DP
	
                8315886          Oct   23,   2020           U-1249
	
                8404717          Apr   11,   2023           U-1215
	
                8530498          May   15,   2023           U-1216
	
                8589188          Aug   28,   2018           U-1210
	
                8626531          Oct   23,   2020           U-1210
	
                8648095          May   15,   2023           U-1216
	
                8741929          Mar   08,   2028           U-1414
	
LENALIDOMIDE - REVLIMID
	
 N 021880 004   5635517          Oct   04,   2019   DS      U-1211                       I-672         Jun 05, 2016
	
                6045501          Aug   28,   2018           U-1210                       ODE           Jun 05, 2020
	
                6281230          Jul   24,   2016           U-1212
	
                6281230          Jul   24,   2016           U-1414
	
                6315720          Oct   23,   2020           U-1210
	
                6555554          Jul   24,   2016      DP U-1211
	
                6561976          Aug   28,   2018           U-1210
	
                6561977          Oct   23,   2020           U-1210
	
                6755784          Oct   23,   2020           U-1210
	
                6908432          Aug   28,   2018           U-1210
	
                7119106          Jul   24,   2016      DP
	
                7189740          Apr   11,   2023           U-1215
	
                7465800          Apr   27,   2027   DS DP
	
                7468363          Oct   07,   2023           U-1414
	
                7855217          Nov   24,   2024   DS DP
	
                7968569          Oct   07,   2023           U-1216
	
                8204763          Aug   28,   2018           U-1249
	
                8288415          Jul   24,   2016   DS DP
	
                8315886          Oct   23,   2020           U-1249
	
                8404717          Apr   11,   2023           U-1215
	
                8530498          May   15,   2023           U-1216
	
                8589188          Aug   28,   2018           U-1210
	
                8626531          Oct   23,   2020           U-1210
	
                8648095          May   15,   2023           U-1216
	
                8741929          Mar   08,   2028           U-1414
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 117 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
     NO          PATENT NO          EXPIRATION             PATENT        DELIST          EXCLUSIVITY       EXPIRATION
                                       DATE                CODES       REQUESTED           CODE(S)            DATE
LENALIDOMIDE - REVLIMID
 N 021880 005   5635517            Oct   04,   2019   DS    U-1211                         I-672         Jun 05, 2016
                6045501            Aug   28,   2018         U-1210                         ODE           Jun 05, 2020
                6281230            Jul   24,   2016         U-1212
                6281230            Jul   24,   2016         U-1414
                6315720            Oct   23,   2020         U-1210
                6555554            Jul   24,   2016      DP U-1211
                6561976            Aug   28,   2018         U-1210
                6561977            Oct   23,   2020         U-1210
                6755784            Oct   23,   2020         U-1210
                6908432            Aug   28,   2018         U-1210
                7119106            Jul   24,   2016      DP
                7189740            Apr   11,   2023         U-1215
                7465800            Apr   27,   2027   DS DP
                7468363            Oct   07,   2023         U-1414
                7855217            Nov   24,   2024   DS DP
                7968569            Oct   07,   2023         U-1216
                8204763            Aug   28,   2018         U-1249
                8288415            Jul   24,   2016   DS DP
                8315886            Oct   23,   2020         U-1249
                8404717            Apr   11,   2023         U-1215
                8530498            May   15,   2023         U-1216
                8589188            Aug   28,   2018         U-1210
                8626531            Oct   23,   2020         U-1210
                8648095            May   15,   2023         U-1216
                8741929            Mar   08,   2028         U-1414
LENALIDOMIDE - REVLIMID
 N 021880 006   5635517            Oct   04,   2019   DS DP U-1211                         I-672         Jun 05, 2016
                6045501            Aug   28,   2018         U-1210                         NS            Jun 05, 2016
                6281230            Jul   24,   2016         U-1212                         ODE           Jun 05, 2020
                6281230            Jul   24,   2016         U-1414
                6315720            Oct   23,   2020         U-1210
                6555554            Jul   24,   2016      DP U-1211
                6561976            Aug   28,   2018         U-1210
                6561977            Oct   23,   2020         U-1210
                6755784            Oct   23,   2020         U-1210
                6908432            Aug   28,   2018         U-1210
                7119106            Jul   24,   2016      DP
                7189740            Apr   11,   2023         U-1215
                7465800            Apr   27,   2027   DS DP
                7468363            Oct   07,   2023         U-1414
                7855217            Nov   24,   2024   DS DP
                7968569            Oct   07,   2023         U-1216
                8204763            Aug   28,   2018         U-1249
                8288415            Jul   24,   2016   DS DP
                8315886            Oct   23,   2020         U-1249
                8404717            Apr   11,   2023         U-1215
                8530498            May   15,   2023         U-1216
                8589188            Aug   28,   2018         U-1210
                8626531            Oct   23,   2020         U-1210
                8648095            May   15,   2023         U-1216
                8741929            Mar   08,   2028         U-1414
LEUPROLIDE ACETATE - LUPRON DEPOT
 N 019732 001   6036976          Dec 13, 2016
LEUPROLIDE ACETATE - LUPRON DEPOT-PED
 N 020263 002   6036976          Dec 13, 2016                                              M-107         Oct 08, 2014
LEUPROLIDE ACETATE - LUPRON DEPOT-PED
 N 020263 005   6036976          Dec 13, 2016                                              M-107         Oct 08, 2014
LEUPROLIDE ACETATE - LUPRON DEPOT-PED
 N 020263 006   6036976          Dec 13, 2016                                              M-107         Oct 08, 2014
LEUPROLIDE ACETATE - LUPRON DEPOT-PED
 N 020263 007   6036976          Dec 13, 2016              DP                              NP            Aug 15, 2014
LEUPROLIDE ACETATE - LUPRON DEPOT-PED
 N 020263 008   6036976          Dec 13, 2016              DP                              NP            Aug 15, 2014
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 118 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                                 PATENT                       EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION            PATENT             DELIST      EXCLUSIVITY       EXPIRATION
	
                                     DATE                CODES            REQUESTED      CODE(S)            DATE
	
LEUPROLIDE ACETATE - LUPRON DEPOT
	
 N 020517 001   6036976          Dec 13, 2016
	
LEUPROLIDE ACETATE - LUPRON DEPOT
	
 N 020517 002   6036976          Dec 13, 2016
	
LEUPROLIDE ACETATE - LUPRON DEPOT
	
 N 020517 003   6036976          Dec 13, 2016            DP
	
                7429559          Dec 13, 2016            DP
	
LEUPROLIDE ACETATE - LUPRON DEPOT
	
 N 020708 001   6036976          Dec 13, 2016
	
LEUPROLIDE ACETATE - VIADUR
	
 N 021088 001   5728396          Jan   30,   2017               U-316
	
                5932547          Jun   13,   2017
	
                5985305          Jan   30,   2017
	
                6113938          Jul   24,   2018
	
                6124261          Jun   13,   2017
	
                6132420          Jan   30,   2017
	
                6156331          Jan   30,   2017
	
                6235712          Jun   13,   2017
	
                6375978          Dec   17,   2018
	
                6395292          Jan   30,   2017
	
LEUPROLIDE ACETATE - ELIGARD
	
 N 021343 001   6565874          Oct 28, 2018            DP U-801
	
                6626870          Mar 27, 2020            DP
	
                6773714          Oct 28, 2018            DP U-801
	
LEUPROLIDE ACETATE - ELIGARD
	
 N 021379 001   6565874          Oct 28, 2018            DP U-801
	
                6626870          Mar 27, 2020            DP
	
                6773714          Oct 28, 2018            DP U-801
	
LEUPROLIDE ACETATE - ELIGARD
	
 N 021488 001   6565874          Oct 28, 2018            DP U-801
	
                6626870          Mar 27, 2020            DP
	
                6773714          Oct 28, 2018            DP U-801
	
LEUPROLIDE ACETATE - ELIGARD
	
 N 021731 001   6565874          Oct 28, 2018            DP U-621
	
                6626870          Mar 27, 2020            DP
	
                6773714          Oct 28, 2018                 U-621
	
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE - LUPANETA PACK
	
 N 203696 001   6036976          Dec 13, 2016       DP
	
LEUPROLIDE ACETATE; NORETHINDRONE ACETATE - LUPANETA PACK
	
 N 203696 002   6036976          Dec 13, 2016       DP
	
LEVALBUTEROL HYDROCHLORIDE - XOPENEX
	
 N 020837 001   6451289          Mar 21, 2021
	
LEVALBUTEROL HYDROCHLORIDE - XOPENEX
	
 N 020837 002   6451289          Mar 21, 2021
	
LEVALBUTEROL HYDROCHLORIDE - XOPENEX
	
 N 020837 003   6451289          Mar 21, 2021
	
LEVALBUTEROL HYDROCHLORIDE - XOPENEX
	
 N 020837 004   6451289          Mar 21, 2021            DP
	
LEVALBUTEROL TARTRATE - XOPENEX HFA
	
 N 021730 001   5836299          Nov 17, 2015            DP
	
                7256310          Oct 08, 2024         DS DP U-636
	
                8765153          Dec 08, 2023            DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 119 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
LEVETIRACETAM - KEPPRA
 N 021035 001   8802142            Jun 07, 2031          DP                                NPP           Dec 16, 2014
                8802142*PED        Dec 07, 2031                                            PED           Jun 16, 2015
LEVETIRACETAM - KEPPRA
 N 021035 002   8802142            Jun 07, 2031          DP                                NPP           Dec 16, 2014
                8802142*PED        Dec 07, 2031                                            PED           Jun 16, 2015
LEVETIRACETAM - KEPPRA
 N 021035 003   8802142            Jun 07, 2031          DP                                NPP           Dec 16, 2014
                8802142*PED        Dec 07, 2031                                            PED           Jun 16, 2015
LEVETIRACETAM - KEPPRA
 N 021035 004   8802142            Jun 07, 2031          DP                                NPP           Dec 16, 2014
                8802142*PED        Dec 07, 2031                                            PED           Jun 16, 2015
LEVETIRACETAM - KEPPRA
 N 021505 001                                                                              NPP           Dec 16, 2014
                                                                                           PED           Jun 16, 2015
LEVETIRACETAM - KEPPRA XR
 N 022285 001   7858122            Sep 17, 2028          DP
LEVETIRACETAM - KEPPRA XR
 N 022285 002   7858122            Sep 17, 2028          DP
LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE
 N 020997 001   5708011          Oct 13, 2014                 U-276
LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE
 N 020997 002   5708011          Oct 13, 2014                 U-276
LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE
 N 020997 003   5708011          Oct 13, 2014                 U-276
LEVOCARNITINE - CARNITOR
 N 020182 001   6335369            Jan 18, 2021               U-433
                6429230            Jan 18, 2021               U-433
                6696493            Jan 18, 2021               U-433
LEVOFLOXACIN - LEVAQUIN
 N 021721 001   6806256            Feb 26, 2022          DP
LEVOLEUCOVORIN CALCIUM - FUSILEV
 N 020140 001   6500829          Mar 07, 2022         DS DP                                ODE           Mar 07, 2015
                                                                                           ODE           Apr 29, 2018
LEVOLEUCOVORIN CALCIUM - FUSILEV
 N 020140 002   6500829          Mar 07, 2022         DS DP                                ODE           Mar 07, 2015
                                                                                           ODE           Apr 29, 2018
LEVOLEUCOVORIN CALCIUM - FUSILEV
 N 020140 003   6500829          Mar 07, 2022         DS DP                                ODE           Mar 07, 2015
                                                                                           ODE           Apr 29, 2018
LEVOMILNACIPRAN HYDROCHLORIDE - FETZIMA
 N 204168 001   8481598          Mar 02, 2031                 U-839                        NCE*          Jul 25, 2018
                8865937          May 23, 2032         DS DP
                RE43879          Jun 03, 2023                 U-839
LEVOMILNACIPRAN HYDROCHLORIDE - FETZIMA
 N 204168 002   8481598          Mar 02, 2031                 U-839                        NCE*          Jul 25, 2018
                8865937          May 23, 2032         DS DP
                RE43879          Jun 03, 2023                 U-839
LEVOMILNACIPRAN HYDROCHLORIDE - FETZIMA
 N 204168 003   8481598          Mar 02, 2031                 U-839                        NCE*          Jul 25, 2018
                8865937          May 23, 2032         DS DP
                RE43879          Jun 03, 2023                 U-839
LEVOMILNACIPRAN HYDROCHLORIDE - FETZIMA
 N 204168 004   8481598          Mar 02, 2031                 U-839                        NCE*          Jul 25, 2018
                8865937          May 23, 2032         DS DP
                RE43879          Jun 03, 2023                 U-839
LEVONORGESTREL - MIRENA
 N 021225 001   5785053            Dec 05, 2015          DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 120 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
LEVONORGESTREL - PLAN B ONE-STEP
 N 021998 001                                                                              RTO*          Apr 30, 2016
                                                                                           RTO**         Apr 30, 2016
LEVONORGESTREL - SKYLA
 N 203159 001   5785053            Dec 05, 2015          DP                                NP            Jan 09, 2016
                7252839            Nov 13, 2023          DP
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 001   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 002   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 003   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 004   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 005   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 006   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 007   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 008   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 009   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 010   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 011   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
LEVOTHYROXINE SODIUM - LEVOXYL
 N 021301 012   6555581            Feb 15, 2022
                7067148            Feb 15, 2022          DP
                7101569            Oct 02, 2023               U-759
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 121 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 001   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 002   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 003   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 004   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 005   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 006   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 007   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 008   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 009   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 010   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - LEVO-T
 N 021342 011   6399101            Mar 30, 2020
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 002   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 003   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 004   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 005   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 006   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 007   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 008   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 009   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 021924 010   7723390            Mar 14, 2024          DP
LEVOTHYROXINE SODIUM - TIROSINT
 N 022121 001   7723390            Mar 14, 2024          DP
LIDOCAINE - LIDODERM
 N 020612 001   5827529            Oct 27, 2015               U-486
LIDOCAINE HYDROCHLORIDE - ZINGO
 N 022114 001   5899880            May   04,   2016      DP
                6004286            Mar   17,   2017      DP
                6881200            Jun   11,   2016      DP
                8540665            Oct   22,   2029           U-1438
LIDOCAINE HYDROCHLORIDE - AKTEN
 N 022221 001   8759401            Jul 24, 2026          DP U-1523
LIDOCAINE; PRILOCAINE - ORAQIX
 N 021451 001   6031007            Apr 01, 2017          DP U-553
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 122 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
LIDOCAINE; TETRACAINE - SYNERA
 N 021623 001   5658583            Jul   28,   2015        DP
                5919479            Jul   28,   2015        DP
                6306431            Jul   28,   2015        DP
                6465006            Jul   28,   2015        DP
                6465709            Jul   07,   2020        DP
                6546281            Jul   28,   2015        DP
                6780426            Jul   28,   2015        DP
LIDOCAINE; TETRACAINE - PLIAGLIS
 N 021717 001   5919479          Jul 28, 2015              DP
                6528086          Sep 28, 2019              DP
LINACLOTIDE - LINZESS
 N 202811 001   7304036            Jan   28,   2024   DS   DP U-1278                       NCE           Aug 30, 2017
                7371727            Jan   28,   2024   DS
                7704947            Jan   28,   2024   DS   DP
                7745409            Jan   28,   2024   DS   DP
                8080526            Jan   28,   2024   DS   DP
                8110553            Jan   28,   2024             U-1278
                8748573            Jun   20,   2031             U-1515
                8748573            Jun   20,   2031             U-1516
                8802628            Jul   24,   2031        DP
LINACLOTIDE - LINZESS
 N 202811 002   7304036            Jan   28,   2024   DS   DP U-1278                       NCE           Aug 30, 2017
                7371727            Jan   28,   2024   DS
                7704947            Jan   28,   2024   DS   DP
                7745409            Jan   28,   2024   DS   DP
                8080526            Jan   28,   2024   DS   DP
                8110553            Jan   28,   2024             U-1278
                8748573            Jun   20,   2031             U-1515
                8748573            Jun   20,   2031             U-1516
                8802628            Jul   24,   2031        DP
LINAGLIPTIN - TRADJENTA
 N 201280 001   6303661            Apr   24,   2017             U-774                      M-118         Aug 13, 2015
                6303661            Apr   24,   2017             U-1270                     M-121         Aug 13, 2015
                6890898            Feb   02,   2019             U-493                      NCE           May 02, 2016
                6890898            Feb   02,   2019             U-1270
                7078381            Feb   02,   2019             U-493
                7078381            Feb   02,   2019             U-1270
                7407955            Aug   12,   2023   DS DP
                7459428            Feb   02,   2019             U-493
                7459428            Feb   02,   2019             U-1270
                8119648            Aug   12,   2023             U-774
                8119648            Aug   12,   2023             U-1270
                8178541            Aug   12,   2023             U-775
                8178541            Aug   12,   2023             U-1244
                8178541            Aug   12,   2023             U-1245
                8178541            Aug   12,   2023             U-1270
                8673927            Aug   23,   2027             U-1503
                8846695            Jun   04,   2030             U-1503
                8883805            Nov   26,   2025        DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 123 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT        DELIST          EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES       REQUESTED          CODE(S)            DATE
	
LINAGLIPTIN; METFORMIN HYDROCHLORIDE    - JENTADUETO
 N 201281 001   6303661          Apr    24, 2017           U-802                           M-146         Jul 30, 2017
                6890898          Feb    02, 2019           U-1039                          NC            Jan 30, 2015
                7078381          Feb    02, 2019           U-1039                          NCE           May 02, 2016
                7407955          Aug    12, 2023     DS DP
                7459428          Feb    02, 2019           U-1039
                8119648          Aug    12, 2023           U-802
                8178541          Aug    12, 2023        DP U-775
                8673927          Aug    23, 2027           U-1503
                8846695          Jun    04, 2030           U-1503
                8883805          Nov    26, 2025        DP
LINAGLIPTIN; METFORMIN HYDROCHLORIDE    - JENTADUETO
 N 201281 002   6303661          Apr    24, 2017           U-802                           M-146         Jul 30, 2017
                6890898          Feb    02, 2019           U-1039                          NC            Jan 30, 2015
                7078381          Feb    02, 2019           U-1039                          NCE           May 02, 2016
                7407955          Aug    12, 2023     DS DP
                7459428          Feb    02, 2019           U-1039
                8119648          Aug    12, 2023           U-802
                8178541          Aug    12, 2023        DP U-775
                8673927          Aug    23, 2027           U-1503
                8846695          Jun    04, 2030           U-1503
                8883805          Nov    26, 2025        DP
LINAGLIPTIN; METFORMIN HYDROCHLORIDE    - JENTADUETO
 N 201281 003   6303661          Apr    24, 2017           U-802                           M-146         Jul 30, 2017
                6890898          Feb    02, 2019           U-1039                          NC            Jan 30, 2015
                7078381          Feb    02, 2019           U-1039                          NCE           May 02, 2016
                7407955          Aug    12, 2023     DS DP
                7459428          Feb    02, 2019           U-1039
                8119648          Aug    12, 2023           U-802
                8178541          Aug    12, 2023        DP U-775
                8673927          Aug    23, 2027           U-1503
                8846695          Jun    04, 2030           U-1503
                8883805          Nov    26, 2025        DP
LINEZOLID - ZYVOX
 N 021130 001   5688792            Nov 18, 2014       DS        U-319
                6514529            Mar 15, 2021            DP
                6559305            Jan 29, 2021       DS
LINEZOLID - ZYVOX
 N 021130 002   5688792            Nov 18, 2014       DS        U-319
                6514529            Mar 15, 2021            DP
                6559305            Jan 29, 2021       DS
LINEZOLID - ZYVOX
 N 021131 001   5688792            Nov 18, 2014                 U-319
                6559305            Jan 29, 2021       DS
LINEZOLID - ZYVOX
 N 021132 001   5688792            Nov 18, 2014       DS        U-319
                6559305            Jan 29, 2021       DS
LIRAGLUTIDE RECOMBINANT - VICTOZA
 N 022341 001   6004297          Jan    28,   2019       DP                                M-115         Apr 06, 2015
                6268343          Aug    22,   2022    DS DP U-968                          NCE           Jan 25, 2015
                6458924          Aug    22,   2017    DS DP U-968
                7235627          Aug    22,   2017    DS DP
                8114833          Aug    13,   2025       DP
                RE41956          Jan    21,   2021       DP
                RE43834          Jan    28,   2019       DP
LIRAGLUTIDE RECOMBINANT - SAXENDA
 N 206321 001                                                                              NCE           Jan 25, 2015
                                                                                           NP            Jan 25, 2017
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 124 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES            REQUESTED       CODE(S)            DATE
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 001   7105486          Jun 29,   2023               U-727                     I-645         Jan 31, 2015
	
                7223735          Jun 29,   2023        DP
	
                7655630          Feb 24,   2023    DS
	
                7659253          Feb 24,   2023    DS DP U-727
	
                7659254          Feb 24,   2023              U-1034
	
                7662787          Feb 24,   2023    DS
	
                7662788          Feb 24,   2023              U-727
	
                7671030          Feb 24,   2023         DP U-727
	
                7671031          Feb 28,   2023              U-727
	
                7674774          Mar 18,   2023         DP U-842
	
                7678770          Mar 25,   2023              U-842
	
                7678771          Mar 25,   2023         DP U-842
	
                7687466          Feb 24,   2023         DP
	
                7687467          Apr 08,   2023         DP U-842
	
                7700561          Jun 29,   2023         DP
	
                7713936          Feb 24,   2023              U-727
	
                7718619          Feb 24,   2023         DP U-842
	
                7723305          Feb 24,   2023         DP U-842
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 002   7105486          Jun 29,   2023               U-727                     I-645         Jan 31, 2015
	
                7223735          Jun 29,   2023        DP
	
                7655630          Feb 24,   2023    DS
	
                7659253          Feb 24,   2023    DS DP U-727
	
                7659254          Feb 24,   2023              U-1034
	
                7662787          Feb 24,   2023    DS
	
                7662788          Feb 24,   2023              U-727
	
                7671030          Feb 24,   2023         DP U-727
	
                7671031          Feb 28,   2023              U-727
	
                7674774          Mar 18,   2023         DP U-842
	
                7678770          Mar 25,   2023              U-842
	
                7678771          Mar 25,   2023         DP U-842
	
                7687466          Feb 24,   2023         DP
	
                7687467          Apr 08,   2023         DP U-842
	
                7700561          Jun 29,   2023         DP
	
                7713936          Feb 24,   2023              U-727
	
                7718619          Feb 24,   2023         DP U-842
	
                7723305          Feb 24,   2023         DP U-842
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 003   7105486          Jun 29,   2023               U-727                     I-645         Jan 31, 2015
	
                7223735          Jun 29,   2023        DP
	
                7655630          Feb 24,   2023    DS
	
                7659253          Feb 24,   2023    DS DP U-727
	
                7659254          Feb 24,   2023              U-1034
	
                7662787          Feb 24,   2023    DS
	
                7662788          Feb 24,   2023              U-727
	
                7671030          Feb 24,   2023         DP U-727
	
                7671031          Feb 28,   2023              U-727
	
                7674774          Mar 18,   2023         DP U-842
	
                7678770          Mar 25,   2023              U-842
	
                7678771          Mar 25,   2023         DP U-842
	
                7687466          Feb 24,   2023         DP
	
                7687467          Apr 08,   2023         DP U-842
	
                7700561          Jun 29,   2023         DP
	
                7713936          Feb 24,   2023              U-727
	
                7718619          Feb 24,   2023         DP U-842
	
                7723305          Feb 24,   2023         DP U-842
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 125 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                         PATENT                                 PATENT                        EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION            PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                    DATE                CODES            REQUESTED       CODE(S)            DATE
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 004		 7105486          Jun 29, 2023                  U-842                     I-645         Jan 31, 2015
	
                7223735          Jun 29, 2023           DP
	
                7655630          Feb 24, 2023       DS
	
                7659253          Feb 24, 2023       DS DP U-727
	
                7659254          Feb 24, 2023                 U-1034
	
                7662787          Feb 24, 2023       DS
	
                7662788          Feb 24, 2023                 U-727
	
                7671030          Feb 24, 2023            DP U-727
	
                7671031          Feb 28, 2023                 U-727
	
                7674774          Mar 18, 2023            DP U-842
	
                7678770          Mar 25, 2023                 U-842
	
                7678771          Mar 25, 2023            DP U-842
	
                7687466          Feb 24, 2023            DP
	
                7687467          Apr 08, 2023            DP U-842
	
                7700561          Jun 29, 2023            DP
	
                7713936          Feb 24, 2023                 U-727
	
                7718619          Feb 24, 2023            DP U-842
	
                7723305          Feb 24, 2023            DP U-842
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 005   7105486          Jun 29,   2023                U-842                     I-645         Jan 31, 2015
	
                7223735          Jun 29,   2023         DP
	
                7655630          Feb 24,   2023     DS
	
                7659253          Feb 24,   2023     DS DP U-727
	
                7659254          Feb 24,   2023               U-1034
	
                7662787          Feb 24,   2023     DS
	
                7662788          Feb 24,   2023               U-727
	
                7671030          Feb 24,   2023          DP U-727
	
                7671031          Feb 28,   2023               U-727
	
                7674774          Mar 18,   2023          DP U-842
	
                7678770          Mar 25,   2023               U-842
	
                7678771          Mar 25,   2023          DP U-842
	
                7687466          Feb 24,   2023          DP
	
                7687467          Apr 08,   2023          DP U-842
	
                7700561          Jun 29,   2023          DP
	
                7713936          Feb 24,   2023               U-727
	
                7718619          Feb 24,   2023          DP U-842
	
                7723305          Feb 24,   2023          DP U-842
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 006   7105486          Jun 29,   2023                U-842                     I-645         Jan 31, 2015
	
                7223735          Jun 29,   2023         DP
	
                7655630          Feb 24,   2023     DS
	
                7659253          Feb 24,   2023     DS DP U-727
	
                7659254          Feb 24,   2023               U-1034
	
                7662787          Feb 24,   2023     DS
	
                7662788          Feb 24,   2023               U-727
	
                7671030          Feb 24,   2023          DP U-727
	
                7671031          Feb 28,   2023               U-727
	
                7674774          Mar 18,   2023          DP U-842
	
                7678770          Mar 25,   2023               U-842
	
                7678771          Mar 25,   2023          DP U-842
	
                7687466          Feb 24,   2023          DP
	
                7687467          Apr 08,   2023          DP U-842
	
                7700561          Jun 29,   2023          DP
	
                7713936          Feb 24,   2023               U-727
	
                7718619          Feb 24,   2023          DP U-842
	
                7723305          Feb 24,   2023          DP U-842
	
LISDEXAMFETAMINE DIMESYLATE - VYVANSE
	
 N 021977 007                                                                            I-645         Jan 31, 2015
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                     ADA 126 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                           PATENT                                    PATENT
	                     EXCLUSIVITY
	
     NO          PATENT NO         EXPIRATION              PATENT              DELIST
	    EXCLUSIVITY       EXPIRATION
	
                                      DATE                 CODES             REQUESTED
	     CODE(S)            DATE
	
LOMITAPIDE MESYLATE - JUXTAPID
	
 N 203858 001		 5712279            Feb   21,   2015   DS          U-1317
	                   NCE           Dec 21, 2017
	
                5739135            Apr   14,   2015   DS          U-1317
	                   ODE           Dec 21, 2019
	
                6492365            Dec   10,   2019               U-1318
	
                7932268            Aug   19,   2027               U-1316
	
                8618135            Mar   07,   2025               U-1316
	
LOMITAPIDE MESYLATE - JUXTAPID
	
 N 203858 002		 5712279            Feb   21,   2015   DS          U-1317
	                   NCE           Dec 21, 2017
	
                5739135            Apr   14,   2015   DS          U-1317
	                   ODE           Dec 21, 2019
	
                6492365            Dec   10,   2019               U-1318
	
                7932268            Aug   19,   2027               U-1316
	
                8618135            Mar   07,   2025               U-1316
	
LOMITAPIDE MESYLATE - JUXTAPID
	
 N 203858 003		 5712279            Feb   21,   2015   DS          U-1317
	                   NCE           Dec 21, 2017
	
                5739135            Apr   14,   2015   DS          U-1317
	                   ODE           Dec 21, 2019
	
                6492365            Dec   10,   2019               U-1318
	
                7932268            Aug   19,   2027               U-1316
	
                8618135            Mar   07,   2025               U-1316
	
LOPERAMIDE HYDROCHLORIDE - IMODIUM A-D EZ CHEWS
	
 N 020448 001		 6814978          Aug 26, 2021              DP
	
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE - IMODIUM MULTI-SYMPTOM RELIEF
	
 N 020606 001   5679376          Oct 21, 2014		                                     Y
	
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE - IMODIUM MULTI-SYMPTOM RELIEF
	
 N 021140 001		 6103260          Jul 17, 2017       DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 127 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                   PATENT                      EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT              DELIST     EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES             REQUESTED     CODE(S)            DATE
	
LOPINAVIR; RITONAVIR - KALETRA
	
 N 021226 001   5648497            Jul   15,   2014
	
                5914332            Dec   13,   2015                U-351
	
                6037157            Jun   26,   2016                U-346
	
                6232333            Nov   07,   2017
	
                6284767            Feb   15,   2016         DP U-401
	
                6284767            Feb   15,   2016         DP U-688
	
                6458818            Nov   07,   2017
	
                6521651            Nov   07,   2017         DP
	
                6703403            Jun   26,   2016                U-257
	
                7141593            May   22,   2020         DP
	
                7432294            May   22,   2020         DP
	
LOPINAVIR; RITONAVIR - KALETRA
	
 N 021251 001   5648497            Jul   15,   2014     DS
	
                5914332            Dec   13,   2015     DS DP U-351
	
                5914332            Dec   13,   2015     DS DP U-895
	
                6037157            Jun   26,   2016               U-346
	
                6037157            Jun   26,   2016               U-895
	
                6284767            Feb   15,   2016          DP U-401
	
                6284767            Feb   15,   2016          DP U-895
	
                6703403            Jun   26,   2016               U-257
	
                6703403            Jun   26,   2016               U-895
	
                6911214            Nov   28,   2021          DP U-895
	
                8501219            Nov   28,   2021          DP
	
LOPINAVIR; RITONAVIR - KALETRA
	
 N 021906 001   5648497            Jul   15,   2014     DS DP
	
                5914332            Dec   13,   2015     DS DP U-688
	
                6037157            Jun   26,   2016             U-688
	
                6284767            Feb   15,   2016        DP U-688
	
                6703403            Jun   26,   2016             U-688
	
                7148359            Jul   19,   2019        DP
	
                7364752            Nov   10,   2020        DP U-688
	
                8025899            Dec   14,   2027        DP
	
                8025899*PED        Jun   14,   2028
	
                8268349            Aug   25,   2024         DP
	
                8309613            Dec   24,   2024                U-688
	
                8377952            Oct   22,   2027                U-1372
	
                8377952*PED        Apr   22,   2028

                8399015            Aug   25,   2024         DP
	
                8399015*PED        Feb   25,   2025
	
                8470347            Sep   17,   2026         DP
	
                8470347*PED        Mar   17,   2027
	
                8691878            Aug   25,   2024                U-1513
	
                8691878*PED        Feb   25,   2025
	
LOPINAVIR; RITONAVIR - KALETRA
	
 N 021906 002   5648497            Jul   15,   2014     DS DP
	
                5914332            Dec   13,   2015     DS DP U-688
	
                6037157            Jun   26,   2016             U-688
	
                6284767            Feb   15,   2016        DP U-688
	
                6703403            Jun   26,   2016             U-688
	
                7148359            Jul   19,   2019        DP
	
                7364752            Nov   10,   2020        DP U-688
	
                8025899            Dec   14,   2027        DP
	
                8025899*PED        Jun   14,   2028
	
                8268349            Aug   25,   2024         DP
	
                8309613            Dec   24,   2024                U-688
	
                8377952            Oct   22,   2027                U-1372
	
                8377952*PED        Apr   22,   2028

                8399015            Aug   25,   2024         DP
	
                8399015*PED        Feb   25,   2025
	
                8470347            Sep   17,   2026         DP
	
                8470347*PED        Mar   17,   2027
	
                8691878            Aug   25,   2024                U-1513
	
                8691878*PED        Feb   25,   2025
	
LORATADINE - CLARITIN
	
 N 020641 002   6132758            Jun 01, 2018
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 128 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                  PATENT                      EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT             DELIST     EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES            REQUESTED     CODE(S)            DATE
	
LORCASERIN HYDROCHLORIDE - BELVIQ
	
 N 022529 001   6953787          Apr    10,   2023    DS   DP     U-1252                   NCE           Jun 27, 2017
	
                6953787          Apr    10,   2023    DS   DP     U-1253
	
                6953787          Apr    10,   2023    DS   DP     U-1254
	
                6953787          Apr    10,   2023    DS   DP     U-1255
	
                7514422          Apr    10,   2023                U-1252
	
                7514422          Apr    10,   2023                U-1253
	
                7514422          Apr    10,   2023                U-1254
	
                7514422          Apr    10,   2023                U-1255
	
                7977329          Apr    10,   2023    DS   DP     U-1252
	
                7977329          Apr    10,   2023    DS   DP     U-1253
	
                7977329          Apr    10,   2023    DS   DP     U-1254
	
                7977329          Apr    10,   2023    DS   DP     U-1255
	
                8168624          Apr    18,   2029    DS   DP
	
                8207158          Apr    10,   2023                U-1252
	
                8207158          Apr    10,   2023                U-1253
	
                8207158          Apr    10,   2023                U-1254
	
                8207158          Apr    10,   2023                U-1255
	
                8273734          Apr    10,   2023                U-1254
	
                8273734          Apr    10,   2023                U-1255
	
                8367657          Apr    10,   2023    DS   DP     U-1252
	
                8367657          Apr    10,   2023    DS   DP     U-1253
	
                8367657          Apr    10,   2023    DS   DP     U-1254
	
                8367657          Apr    10,   2023    DS   DP     U-1255
	
                8546379          Apr    10,   2023    DS   DP     U-1252
	
                8546379          Apr    10,   2023    DS   DP     U-1253
	
                8546379          Apr    10,   2023    DS   DP     U-1254
	
                8546379          Apr    10,   2023    DS   DP     U-1255
	
                8575149          Apr    10,   2023                U-1452
	
                8697686          Dec    20,   2025    DS DP
	
LOTEPREDNOL ETABONATE - LOTEMAX
	
 N 200738 001                                                                              PED           Oct 15, 2014
	
LOTEPREDNOL ETABONATE - LOTEMAX
	
 N 202872 001   5800807           Jan 29, 2017             DP                              NDF           Sep 28, 2015
	
LOVASTATIN - ALTOPREV
	
 N 021316 001   5916595             Dec 12, 2017
	
                6080778             Mar 23, 2018                  U-456
	
                6485748             Dec 12, 2017           DP
	
LOVASTATIN - ALTOPREV
	
 N 021316 002   5916595             Dec 12, 2017
	
                6080778             Mar 23, 2018                  U-456
	
                6485748             Dec 12, 2017           DP
	
LOVASTATIN - ALTOPREV
	
 N 021316 003   5916595             Dec 12, 2017
	
                6080778             Mar 23, 2018                  U-456
	
                6485748             Dec 12, 2017           DP
	
LOVASTATIN - ALTOPREV
	
 N 021316 004   5916595             Dec 12, 2017
	
                6080778             Mar 23, 2018                  U-456
	
                6485748             Dec 12, 2017           DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 129 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES         REQUESTED          CODE(S)            DATE
	
LOVASTATIN; NIACIN - ADVICOR
	
 N 021249 001   6080428            May   27,   2017          U-447
	
                6080428            May   27,   2017          U-1132
	
                6080428            May   27,   2017          U-1133
	
                6080428            May   27,   2017          U-1134
	
                6469035            Mar   15,   2018          U-768
	
                6469035            Mar   15,   2018          U-1129
	
                6469035            Mar   15,   2018          U-1130
	
                6469035            Mar   15,   2018          U-1131
	
LOVASTATIN; NIACIN - ADVICOR
	
 N 021249 002   6080428            May   27,   2017          U-447
	
                6080428            May   27,   2017          U-1132
	
                6080428            May   27,   2017          U-1133
	
                6080428            May   27,   2017          U-1134
	
                6469035            Mar   15,   2018          U-768
	
                6469035            Mar   15,   2018          U-1129
	
                6469035            Mar   15,   2018          U-1130
	
                6469035            Mar   15,   2018          U-1131
	
LOVASTATIN; NIACIN - ADVICOR
	
 N 021249 003   6080428            May   27,   2017          U-447
	
                6080428            May   27,   2017          U-1132
	
                6080428            May   27,   2017          U-1133
	
                6080428            May   27,   2017          U-1134
	
                6469035            Mar   15,   2018          U-768
	
                6469035            Mar   15,   2018          U-1129
	
                6469035            Mar   15,   2018          U-1130
	
                6469035            Mar   15,   2018          U-1131
	
LOVASTATIN; NIACIN - ADVICOR
	
 N 021249 004   6080428            May   27,   2017          U-447
	
                6080428            May   27,   2017          U-1132
	
                6080428            May   27,   2017          U-1133
	
                6080428            May   27,   2017          U-1134
	
                6469035            Mar   15,   2018          U-768
	
                6469035            Mar   15,   2018          U-1129
	
                6469035            Mar   15,   2018          U-1130
	
                6469035            Mar   15,   2018          U-1131
	
LOXAPINE - ADASUVE
	
 N 022549 001   6716416            May   20,   2022      DP                                NDF           Dec 21, 2015
	
                7052679            Oct   26,   2021      DP
	
                7078020            Oct   26,   2021      DP U-1375
	
                7090830            Oct   26,   2021      DP
	
                7458374            Aug   18,   2024      DP
	
                7537009            Oct   28,   2024      DP
	
                7585493            Oct   26,   2021      DP
	
                7601337            Oct   26,   2021      DP
	
                8074644            Jul   25,   2022      DP
	
                8173107            Oct   26,   2021      DP
	
                8235037            Oct   26,   2021      DP
	
                8387612            Oct   23,   2026      DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 130 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
LUBIPROSTONE - AMITIZA
 N 021908 001   5284858            Jul   14,   2014   DS                                   I-670         Apr 19, 2016
                6414016            Sep   05,   2020             U-717
                6414016            Sep   05,   2020             U-1392
                6583174            Oct   16,   2020        DP
                6982283            Dec   04,   2022             U-1391
                7064148            Aug   30,   2022             U-739
                7064148            Aug   30,   2022             U-1404
                7417067            Oct   16,   2020        DP
                8026393            Oct   25,   2027        DP
                8071613            Sep   05,   2020             U-1203
                8071613            Sep   05,   2020             U-1393
                8088934            May   18,   2021   DS
                8097649            Oct   16,   2020        DP
                8097653            Nov   14,   2022             U-1214
                8097653            Nov   14,   2022             U-1394
                8114890            Sep   05,   2020        DP
                8338639            Jan   23,   2027        DP
                8389542            Nov   14,   2022        DP U-1345
                8389542            Nov   14,   2022        DP U-1395
                8748481            Sep   01,   2025           U-1520
                8779187            Jul   23,   2027        DP
LUBIPROSTONE - AMITIZA
 N 021908 002   5284858            Jul   14,   2014   DS
                6414016            Sep   05,   2020             U-874
                6583174            Oct   16,   2020        DP
                7064148            Aug   30,   2022             U-739
                7064148            Aug   30,   2022             U-873
                7417067            Oct   16,   2020        DP
                7795312            Sep   17,   2024             U-1085
                8026393            Oct   25,   2027        DP
                8071613            Sep   05,   2020             U-1202
                8088934            May   18,   2021   DS
                8097649            Oct   16,   2020        DP
                8114890            Sep   05,   2020        DP
                8338639            Jan   23,   2027        DP
                8748481            Sep   01,   2025             U-1519
                8779187            Jan   23,   2027        DP
LUCINACTANT - SURFAXIN
 N 021746 001   5407914            Nov 17, 2014       DS DP U-1242
LULICONAZOLE - LUZU
 N 204153 001   5900488            Jul 05, 2016       DS DP U-540                          NCE           Nov 14, 2018
LURASIDONE HYDROCHLORIDE - LATUDA
 N 200603 001   5532372          Jul 02, 2018         DS                                   D-134         Apr 26, 2015
                8729085          May 26, 2026              DP                              I-674         Jun 28, 2016
                8883794          May 26, 2026              DP                              NCE           Oct 28, 2015
LURASIDONE HYDROCHLORIDE - LATUDA
 N 200603 002   5532372          Jul 02, 2018         DS                                   D-134         Apr 26, 2015
                8729085          May 26, 2026              DP                              I-674         Jun 28, 2016
                8883794          May 26, 2026              DP                              NCE           Oct 28, 2015
LURASIDONE HYDROCHLORIDE - LATUDA
 N 200603 003   5532372          Jul 02, 2018         DS                                   D-134         Apr 26, 2015
                8729085          May 26, 2026              DP                              I-674         Jun 28, 2016
                8883794          May 26, 2026              DP                              NCE           Oct 28, 2015
LURASIDONE HYDROCHLORIDE - LATUDA
 N 200603 004   5532372          Jul 02, 2018         DS                                   D-134         Apr 26, 2015
                8729085          May 26, 2026              DP                              I-674         Jun 28, 2016
                8883794          May 26, 2026              DP                              NCE           Oct 28, 2015
LURASIDONE HYDROCHLORIDE - LATUDA
 N 200603 005   5532372          Jul 02, 2018         DS                                   D-134         Apr 26, 2015
                8729085          May 26, 2026              DP                              I-674         Jun 28, 2016
                8883794          May 26, 2026              DP                              NCE           Oct 28, 2015
LUTROPIN ALFA - LUVERIS
 N 021322 001   5767251            Jun 16, 2015       DS
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 131 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES            REQUESTED       CODE(S)            DATE
	
MACITENTAN - OPSUMIT
	
 N 204410 001		 7094781            Oct 12, 2022       DS DP                                NCE           Oct 18, 2018
	
                8268847            Apr 18, 2029             U-1446                         ODE           Oct 18, 2020
	
                8367685            Oct 04, 2028          DP U-1445
	
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - NORMOCARB HF 25
	
 N 021910 001		 5945449          Oct 31, 2017       DP U-785
	
                7300674          Mar 04, 2023       DP U-785
	
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - NORMOCARB HF 35
	
 N 021910 002		 5945449          Oct 31, 2017       DP U-785
	
MAGNESIUM HYDROXIDE; OMEPRAZOLE;   SODIUM BICARBONATE - ZEGERID
	
 N 021850 001		 6489346            Jul 16, 2016    DS DP U-588
	
                6645988            Jul 16, 2016    DS DP U-588
	
                6699885            Jul 16, 2016           U-588
	
                7399772            Jul 16, 2016           U-588
	
MAGNESIUM HYDROXIDE; OMEPRAZOLE;   SODIUM BICARBONATE - ZEGERID
	
 N 021850 002		 6489346            Jul 16, 2016    DS DP U-623
	
                6645988            Jul 16, 2016    DS DP U-623
	
                6699885            Jul 16, 2016           U-623
	
                7399772            Jul 16, 2016           U-623
	
MAGNESIUM HYDROXIDE; OMEPRAZOLE;    SODIUM BICARBONATE - MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM

BICARBONATE
	
 N 022456 001   6489346            Jul   16,   2016      DP U-588
	
                6489346            Jul   16,   2016      DP U-1021
	
                6645988            Jul   16,   2016      DP
	
                6699885            Jul   16,   2016      DP U-588
	
                6699885            Jul   16,   2016      DP U-1021
	
                7399772            Jul   16,   2016      DP U-588
	
                7399772            Jul   16,   2016      DP U-1021
	
MAGNESIUM HYDROXIDE; OMEPRAZOLE;    SODIUM BICARBONATE - MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM

BICARBONATE
	
 N 022456 002   6489346            Jul   16,   2016      DP U-588
	
                6489346            Jul   16,   2016      DP U-1021
	
                6645988            Jul   16,   2016      DP
	
                6699885            Jul   16,   2016      DP U-588
	
                6699885            Jul   16,   2016      DP U-1021
	
                7399772            Jul   16,   2016      DP U-588
	
                7399772            Jul   16,   2016      DP U-1021
	
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE - SUPREP BOWEL PREP KIT
	
 N 022372 001		 6946149          Mar 07, 2023       DP U-837
	
MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM BICARBONATE;

SODIUM CHLORIDE; SODIUM SULFATE - SUCLEAR
	
 N 203595 001                                                                    NC          Jan 18, 2016
	
MALATHION - OVIDE
	
 N 018613 001		 7560445            Feb 01, 2027       DS DP U-986
	
                7977324            Aug 14, 2026          DP
	
MANNITOL - ARIDOL KIT
	
 N 022368 001		 5817028            Feb 23, 2015                 U-1091
	
MARAVIROC - SELZENTRY
	
 N 022128 001		 6586430            Dec   01,   2019   DS DP U-824
	
                6667314            Aug   06,   2021   DS DP U-824
	
                7368460            Nov   25,   2022         U-824
	
                7576097            May   25,   2021   DS
	
MARAVIROC - SELZENTRY
	
 N 022128 002		 6586430            Dec   01,   2019   DS DP U-824
	
                6667314            Aug   06,   2021   DS DP U-824
	
                7368460            Nov   25,   2022         U-824
	
                7576097            May   25,   2021   DS
	
MECASERMIN RECOMBINANT - INCRELEX
	
 N 021839 001   5681814          Sep 18, 2017            DP
	
                5824642          Jul 08, 2014                   U-681
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 132 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
MECASERMIN RINFABATE RECOMBINANT - IPLEX
 N 021884 001   5681818          Oct 28, 2014                 U-697
MECHLORETHAMINE HYDROCHLORIDE - VALCHLOR
 N 202317 001   7838564          Mar 07, 2026            DP                                NDF           Aug 23, 2016
                7872050          Jul 08, 2029                 U-1427                       ODE           Aug 23, 2020
                8450375          Mar 07, 2026            DP
                8501818          Mar 07, 2026            DP
                8501819          Mar 07, 2026                 U-1427
MEDROXYPROGESTERONE ACETATE - DEPO-SUBQ PROVERA 104
 N 021583 001   6495534          May 15, 2020       DP
MEGESTROL ACETATE - MEGACE ES
 N 021778 001   6592903            Sep 21, 2020          DP
                7101576            Apr 22, 2024               U-755
MELOXICAM - MOBIC
 N 021530 001   6184220            Mar 25, 2019          DP
MEMANTINE HYDROCHLORIDE - NAMENDA
 N 021487 001   5061703          Apr 11, 2015                 U-539
                5061703*PED      Oct 11, 2015
MEMANTINE HYDROCHLORIDE - NAMENDA
 N 021487 002   5061703          Apr 11, 2015                 U-539
                5061703*PED      Oct 11, 2015
MEMANTINE HYDROCHLORIDE - NAMENDA
 N 021627 001   5061703          Apr 11, 2015                 U-539
                5061703*PED      Oct 11, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 133 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO         PATENT NO        EXPIRATION            PATENT        DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE                CODES       REQUESTED           CODE(S)            DATE
	
MEMANTINE HYDROCHLORIDE - NAMENDA XR
 N 022525 001   5061703          Apr   11,   2015           U-539                       M-138         Jul 03, 2017
                5061703*PED      Oct   11,   2015                                       PED           Jan 03, 2018
                8039009          Mar   24,   2029           U-539
                8039009*PED      Sep   24,   2029
                8168209          Nov   22,   2025      DP
                8168209*PED      May   22,   2026
                8173708          Nov   22,   2025           U-539
                8173708*PED      May   22,   2026
                8283379          Nov   22,   2025           U-539
                8283379*PED      May   22,   2026
                8329752          Nov   22,   2025      DP
                8329752*PED      May   22,   2026
                8362085          Nov   22,   2025           U-539
                8362085*PED      May   22,   2026
MEMANTINE HYDROCHLORIDE - NAMENDA XR
 N 022525 002   5061703          Apr   11,   2015           U-539                       M-138         Jul 03, 2017
                5061703*PED      Oct   11,   2015                                       PED           Jan 03, 2018
                8039009          Mar   24,   2029           U-539
                8039009*PED      Sep   24,   2029
                8168209          Nov   22,   2025      DP
                8168209*PED      May   22,   2026
                8173708          Nov   22,   2025           U-539
                8173708*PED      May   22,   2026
                8283379          Nov   22,   2025           U-539
                8283379*PED      May   22,   2026
                8329752          Nov   22,   2025      DP
                8329752*PED      May   22,   2026
                8362085          Nov   22,   2025           U-539
                8362085*PED      May   22,   2026
MEMANTINE HYDROCHLORIDE - NAMENDA XR
 N 022525 003   5061703          Apr   11,   2015           U-539                       M-138         Jul 03, 2017
                5061703*PED      Oct   11,   2015                                       PED           Jan 03, 2018
                8039009          Mar   24,   2029           U-539
                8039009*PED      Sep   24,   2029
                8168209          Nov   22,   2025      DP
                8168209*PED      May   22,   2026
                8173708          Nov   22,   2025           U-539
                8173708*PED      May   22,   2026
                8283379          Nov   22,   2025           U-539
                8283379*PED      May   22,   2026
                8329752          Nov   22,   2025      DP
                8329752*PED      May   22,   2026
                8362085          Nov   22,   2025           U-539
                8362085*PED      May   22,   2026
MEMANTINE HYDROCHLORIDE - NAMENDA XR
 N 022525 004   5061703          Apr   11,   2015           U-539                       M-138         Jul 03, 2017
                5061703*PED      Oct   11,   2015                                       PED           Jan 03, 2018
                8039009          Mar   24,   2029           U-539
                8039009*PED      Sep   24,   2029
                8168209          Nov   22,   2025      DP
                8168209*PED      May   22,   2026
                8173708          Nov   22,   2025           U-539
                8173708*PED      May   22,   2026
                8283379          Nov   22,   2025           U-539
                8283379*PED      May   22,   2026
                8329752          Nov   22,   2025      DP
                8329752*PED      May   22,   2026
                8362085          Nov   22,   2025           U-539
                8362085*PED      May   22,   2026
                8598233          Nov   22,   2025      DP
                8598233*PED      May   22,   2026
MENOTROPINS (FSH;LH); MENOTROPINS (FSH;LH) - MENOPUR
 N 021663 001                                                                           D-139         Feb 19, 2017
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 134 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
MENTHOL; METHYL SALICYLATE - SALONPAS
 N 022029 001   8809615          Jan 03, 2030            DP
MENTHOL; METHYL SALICYLATE - SALONPAS
 N 022029 002   8809615          Jan 03, 2030            DP
MEQUINOL; TRETINOIN - SOLAGE
 N 020922 001   6353029            Aug 24, 2020
MERCAPTOPURINE - PURIXAN
 N 205919 001                                                                              ODE           Apr 28, 2021
MESALAMINE - SFROWASA
 N 019618 002   7645801            Jul 24, 2027       DS DP
MESALAMINE - CANASA
 N 021252 002   8217083            Jun 06, 2028          DP
                8436051            Jun 06, 2028          DP
MESALAMINE - ASACOL HD
 N 021830 001   6893662            Nov 15, 2021          DP U-141
                8580302            Nov 15, 2021          DP
MESALAMINE - LIALDA
 N 022000 001   6773720            Jun 08, 2020          DP                                I-640         Jul 14, 2014
MESALAMINE - APRISO
 N 022301 001   6551620            Apr   20,   2018   DS DP U-907
                8337886            Apr   20,   2018      DP U-1310
                8496965            Apr   20,   2018      DP
                8865688            May   01,   2030         U-1310
                8911778            Apr   20,   2018      DP U-1310
MESALAMINE - DELZICOL
 N 204412 001   6649180            Apr 13, 2020          DP
METAXALONE - SKELAXIN
 N 013217 003   7122566            Feb 06, 2026               U-915
                7714006            Dec 03, 2021               U-1050
METFORMIN HYDROCHLORIDE - GLUCOPHAGE XR
 N 021202 001   6475521          Mar 19, 2018
                6660300          Mar 19, 2018                 U-542
METFORMIN HYDROCHLORIDE - GLUCOPHAGE XR
 N 021202 004   6475521          Mar 19, 2018
                6660300          Mar 19, 2018                 U-542
METFORMIN HYDROCHLORIDE - FORTAMET
 N 021574 001   6099859          Mar     20,   2018      DP
                6495162          Mar     20,   2018      DP
                6790459          Mar     17,   2021           U-604
                6866866          Mar     17,   2021      DP
                7919116          Mar     20,   2018      DP
                8475841          Mar     20,   2018           U-604
METFORMIN HYDROCHLORIDE - FORTAMET
 N 021574 002   6099859          Mar     20,   2018      DP
                6495162          Mar     20,   2018      DP
                6790459          Mar     17,   2021           U-604
                6866866          Mar     17,   2021      DP
                7919116          Mar     20,   2018      DP
                8475841          Mar     20,   2018           U-604
METFORMIN HYDROCHLORIDE - RIOMET
 N 021591 001   6890957          Sep 14, 2023            DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 135 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION              PATENT       DELIST          EXCLUSIVITY       EXPIRATION
	
                                    DATE                  CODES      REQUESTED          CODE(S)            DATE
	
METFORMIN HYDROCHLORIDE - GLUMETZA
 N 021748 001   6340475          Sep   19,   2016   DS   DP U-669
                6488962          Jun   20,   2020   DS   DP
                6635280          Sep   19,   2016   DS   DP
                6723340          Oct   25,   2021   DS   DP
METFORMIN HYDROCHLORIDE - GLUMETZA
 N 021748 002   6488962          Jun 20, 2020       DS DP
                7780987          Mar 23, 2025       DS DP
                8323692          Mar 23, 2025          DP
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - ACTOPLUS MET
 N 021842 001   5965584          Jun 19, 2016       DP U-1055                           M-116         May 17, 2015
                6166042          Jun 19, 2016           U-679
                6166043          Jun 19, 2016           U-679
                6172090          Jun 19, 2016           U-679
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - ACTOPLUS MET
 N 021842 002   5965584          Jun 19, 2016       DP U-1055                           M-116         May 17, 2015
                6166042          Jun 19, 2016           U-679
                6166043          Jun 19, 2016           U-679
                6172090          Jun 19, 2016           U-679
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE      - ACTOPLUS MET XR
 N 022024 001   5965584          Jun 19, 2016            DP U-973
                6099859          Mar 20, 2018            DP
                6166042          Jun 19, 2016                U-973
                6166043          Jun 19, 2016                U-973
                6172090          Jun 19, 2016                U-973
                6495162          Mar 20, 2018            DP
                6790459          Mar 17, 2021                U-974
                6866866          Mar 17, 2021            DP
                7785627          Jul 31, 2026            DP
                7919116          Mar 20, 2018                U-973
                7919116          Mar 20, 2018                U-1120
                7959946          Jul 31, 2026            DP
                8470368          Sep 19, 2023            DP
                8475841          Mar 20, 2018                U-973
                8668931          Sep 19, 2023            DP
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE      - ACTOPLUS MET XR
 N 022024 002   5965584          Jun 19, 2016            DP U-973
                6099859          Mar 20, 2018            DP
                6166042          Jun 19, 2016                U-973
                6166043          Jun 19, 2016                U-973
                6172090          Jun 19, 2016                U-973
                6495162          Mar 20, 2018            DP
                6790459          Mar 17, 2021                U-974
                6866866          Mar 17, 2021            DP
                7785627          Jul 31, 2026            DP
                7919116          Mar 20, 2018                U-973
                7919116          Mar 20, 2018                U-1120
                7959946          Jul 31, 2026            DP
                8470368          Sep 19, 2023            DP
                8475841          Mar 20, 2018                U-973
                8668931          Sep 19, 2023            DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 136 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION         PATENT           DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE             CODES          REQUESTED           CODE(S)            DATE
	
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
 N 021410 001   5741803          Apr 21, 2015    DS DP U-493               Y
                5741803          Apr 21, 2015    DS DP U-734               Y
                5965584          Jun 19, 2016           U-493              Y
                6166042          Jun 19, 2016           U-493              Y
                6288095          Feb 11, 2017           U-493              Y
                7358366          Apr 19, 2020    DS
                8236345          Oct 07, 2022       DP
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
 N 021410 002   5741803          Apr 21, 2015    DS DP U-493               Y
                5741803          Apr 21, 2015    DS DP U-734               Y
                5965584          Jun 19, 2016           U-493              Y
                6166042          Jun 19, 2016           U-493              Y
                6288095          Feb 11, 2017           U-493              Y
                7358366          Apr 19, 2020    DS
                8236345          Oct 07, 2022       DP
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
 N 021410 003   5741803          Apr 21, 2015    DS DP U-493               Y
                5741803          Apr 21, 2015    DS DP U-734               Y
                5965584          Jun 19, 2016           U-493              Y
                6166042          Jun 19, 2016           U-493              Y
                6288095          Feb 11, 2017           U-493              Y
                7358366          Apr 19, 2020    DS
                8236345          Oct 07, 2022       DP
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
 N 021410 004   5741803          Apr 21, 2015    DS DP U-493               Y
                5741803          Apr 21, 2015    DS DP U-734               Y
                7358366          Apr 19, 2020    DS
                8236345          Oct 07, 2022       DP
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET
 N 021410 005   5741803          Apr 21, 2015    DS DP U-493               Y
                5741803          Apr 21, 2015    DS DP U-734               Y
                7358366          Apr 19, 2020    DS
                8236345          Oct 07, 2022       DP
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - KOMBIGLYZE XR
 N 200678 001   8628799          Jul 13, 2025       DP                                  M-134         May 24, 2016
                RE44186          Jul 31, 2023    DS DP U-1097                           NCE           Jul 31, 2014
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - KOMBIGLYZE XR
 N 200678 002   RE44186          Jul 31, 2023    DS DP U-1097                           M-134         May 24, 2016
                                                                                        NCE           Jul 31, 2014
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE - KOMBIGLYZE XR
 N 200678 003   RE44186          Jul 31, 2023    DS DP U-1097                           M-134         May 24, 2016
                                                                                        NCE           Jul 31, 2014
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 137 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION        PATENT            DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE            CODES           REQUESTED           CODE(S)            DATE
	
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET
	
 N 022044 001   6303661          Apr 24, 2017           U-802
	
                6699871          Jul 26, 2022    DS DP U-802
	
                6890898          Feb 02, 2019           U-803
	
                6890898          Feb 02, 2019           U-1036
	
                6890898          Feb 02, 2019           U-1038
	
                7078381          Feb 02, 2019           U-803
	
                7078381          Feb 02, 2019           U-1036
	
                7078381          Feb 02, 2019           U-1038
	
                7125873          Jul 26, 2022       DP U-803
	
                7125873          Jul 26, 2022       DP U-1036
	
                7125873          Jul 26, 2022       DP U-1038
	
                7326708          Apr 11, 2026    DS DP U-802
	
                7459428          Feb 02, 2019           U-1036
	
                8414921          Jul 21, 2028       DP U-1036
	
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET
	
 N 022044 002   6303661          Apr 24, 2017           U-802
	
                6699871          Jul 26, 2022    DS DP U-802
	
                6890898          Feb 02, 2019           U-803
	
                6890898          Feb 02, 2019           U-1036
	
                6890898          Feb 02, 2019           U-1038
	
                7078381          Feb 02, 2019           U-803
	
                7078381          Feb 02, 2019           U-1036
	
                7078381          Feb 02, 2019           U-1038
	
                7125873          Jul 26, 2022       DP U-803
	
                7125873          Jul 26, 2022       DP U-1036
	
                7125873          Jul 26, 2022       DP U-1038
	
                7326708          Apr 11, 2026    DS DP U-802
	
                7459428          Feb 02, 2019           U-1036
	
                8414921          Jul 21, 2028       DP U-1036
	
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR
	
 N 202270 001   6303661          Apr 24, 2017            U-1227
	
                6340475          Sep 19, 2016       DP
	
                6635280          Sep 19, 2016       DP
	
                6699871          Jul 26, 2022    DS DP U-1227
	
                6890898          Feb 02, 2019            U-1228
	
                7078381          Feb 02, 2019            U-1227
	
                7125873          Jul 26, 2022       DP U-1227
	
                7326708          Apr 11, 2026    DS DP U-1227
	
                7459428          Feb 02, 2019            U-1227
	
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR
	
 N 202270 002   6303661          Apr 24, 2017            U-1227
	
                6340475          Sep 19, 2016       DP
	
                6635280          Sep 19, 2016       DP
	
                6699871          Jul 26, 2022    DS DP U-1227
	
                6890898          Feb 02, 2019            U-1228
	
                7078381          Feb 02, 2019            U-1227
	
                7125873          Jul 26, 2022       DP U-1227
	
                7326708          Apr 11, 2026    DS DP U-1227
	
                7459428          Feb 02, 2019            U-1227
	
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET XR
	
 N 202270 003   6303661          Apr 24, 2017            U-1227
	
                6340475          Sep 19, 2016       DP
	
                6635280          Sep 19, 2016       DP
	
                6699871          Jul 26, 2022    DS DP U-1227
	
                6890898          Feb 02, 2019            U-1228
	
                7078381          Feb 02, 2019            U-1227
	
                7125873          Jul 26, 2022       DP U-1227
	
                7326708          Apr 11, 2026    DS DP U-1227
	
                7459428          Feb 02, 2019            U-1227
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 138 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
     NO         PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
                                       DATE              CODES         REQUESTED           CODE(S)            DATE
METHOTREXATE - OTREXUP
 N 204824 001   6746429            Apr   12,   2020      DP
                7744582            Aug   10,   2019      DP   U-1442
                7776015            Aug   10,   2019      DP
                8021335            Oct   04,   2026      DP
                8480631            Mar   19,   2030      DP   U-1442
                8562564            Jan   24,   2026      DP
                8579865            Mar   19,   2030      DP   U-1442
                RE44846            Aug   10,   2019      DP
                RE44847            Aug   10,   2019      DP   U-1442
METHOTREXATE - OTREXUP
 N 204824 002   6746429            Apr   12,   2020      DP
                7744582            Aug   10,   2019      DP   U-1442
                7776015            Aug   10,   2019      DP
                8021335            Oct   04,   2026      DP
                8480631            Mar   19,   2030      DP   U-1442
                8562564            Jan   24,   2026      DP
                8579865            Mar   19,   2030      DP   U-1442
                RE44846            Aug   10,   2019      DP
                RE44847            Aug   10,   2019      DP   U-1442
METHOTREXATE - OTREXUP
 N 204824 003   6746429            Apr   12,   2020      DP
                7744582            Aug   10,   2019      DP   U-1442
                7776015            Aug   10,   2019      DP
                8021335            Oct   04,   2026      DP
                8480631            Mar   19,   2030      DP   U-1442
                8562564            Jan   24,   2026      DP
                8579865            Mar   19,   2030      DP   U-1442
                RE44846            Aug   10,   2019      DP
                RE44847            Aug   10,   2019      DP   U-1442
METHOTREXATE - OTREXUP
 N 204824 004   6746429            Apr   12,   2020      DP
                7744582            Aug   10,   2019      DP   U-1442
                7776015            Aug   10,   2019      DP
                8021335            Oct   04,   2026      DP
                8480631            Mar   19,   2030      DP   U-1442
                8562564            Jan   24,   2026      DP
                8579865            Mar   19,   2030      DP   U-1442
                RE44846            Aug   10,   2019      DP
                RE44847            Aug   10,   2019      DP   U-1442
METHOTREXATE - OTREXUP
 N 204824 005   6746429            Apr   12,   2020      DP
                8021335            Oct   04,   2026      DP
                8480631            Mar   19,   2030      DP U-1442
                8562564            Jan   24,   2026      DP
                8579865            Mar   19,   2030      DP U-1442
                RE44846            Aug   10,   2019      DP
                RE44847            Aug   10,   2019      DP U-1442
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 139 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES         REQUESTED          CODE(S)            DATE
	
METHOTREXATE - RASUVO
	
 N 205776 001   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 002   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 003   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 004   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 005   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 006   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 007   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 008   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 009   8664231            Jun 01, 2029              U-1442
	
METHOTREXATE - RASUVO
	
 N 205776 010   8664231            Jun 01, 2029              U-1442
	
METHYL AMINOLEVULINATE HYDROCHLORIDE - METVIXIA
	
 N 021415 001   6034267          Mar 08, 2016                U-804
	
METHYLNALTREXONE BROMIDE - RELISTOR
	
 N 021964 001   6559158          Nov 03, 2017                U-1185
	
                8247425          Dec 31, 2030                U-1185
	
                8420663          Sep 30, 2029                U-1185
	
                8552025          Apr 08, 2024            DP
	
                8822490          Sep 30, 2029            DP U-1185
	
METHYLNALTREXONE BROMIDE - RELISTOR
	
 N 021964 002   6559158          Nov 03, 2017                U-1185
	
                8247425          Dec 31, 2030                U-1185
	
                8420663          Sep 30, 2029                U-1185
	
                8552025          Apr 08, 2024            DP
	
                8822490          Sep 30, 2029            DP U-1185
	
METHYLNALTREXONE BROMIDE - RELISTOR
	
 N 021964 003   8247425          Dec 31, 2030                U-1185
	
                8420663          Sep 30, 2029                U-1185
	
                8552025          Apr 08, 2024            DP
	
                8822490          Sep 30, 2029            DP U-1185
	
METHYLPHENIDATE - DAYTRANA
	
 N 021514 001   6210705            Sep 30, 2018          DP U-727
	
                6348211            Sep 30, 2018          DP U-727
	
                8632802            Oct 07, 2025          DP
	
METHYLPHENIDATE - DAYTRANA
	
 N 021514 002   6210705            Sep 30, 2018          DP U-727
	
                6348211            Sep 30, 2018          DP U-727
	
                8632802            Oct 07, 2025          DP
	
METHYLPHENIDATE - DAYTRANA
	
 N 021514 003   6210705            Sep 30, 2018          DP U-727
	
                6348211            Sep 30, 2018          DP U-727
	
                8632802            Oct 07, 2025          DP
	
METHYLPHENIDATE - DAYTRANA
	
 N 021514 004   6210705            Sep 30, 2018          DP U-727
	
                6348211            Sep 30, 2018          DP U-727
	
                8632802            Oct 07, 2025          DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 140 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                               PATENT                         EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT            DELIST        EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES           REQUESTED        CODE(S)            DATE
	
METHYLPHENIDATE HYDROCHLORIDE - CONCERTA
	
 N 021121 001   6919373          Jul 31, 2017                 U-666
	
                6930129          Jul 31, 2017                 U-666
	
                8163798          Jul 31, 2017          DP
	
                8629179          Jul 31, 2017          DP
	
                8629179*PED      Jan 31, 2018
	
METHYLPHENIDATE HYDROCHLORIDE - CONCERTA
	
 N 021121 002   6919373          Jul 31, 2017                 U-666
	
                6930129          Jul 31, 2017                 U-666
	
                8163798          Jul 31, 2017          DP
	
                8629179          Jul 31, 2017          DP
	
                8629179*PED      Jan 31, 2018
	
METHYLPHENIDATE HYDROCHLORIDE - CONCERTA
	
 N 021121 003   6919373          Jul 31, 2017                 U-666
	
                6930129          Jul 31, 2017                 U-666
	
                8163798          Jul 31, 2017          DP
	
                8629179          Jul 31, 2017          DP
	
                8629179*PED      Jan 31, 2018
	
METHYLPHENIDATE HYDROCHLORIDE - CONCERTA
	
 N 021121 004   6919373          Jul 31, 2017                 U-666
	
                6930129          Jul 31, 2017                 U-666
	
                8163798          Jul 31, 2017          DP
	
                8629179          Jul 31, 2017          DP
	
                8629179*PED      Jan 31, 2018
	
METHYLPHENIDATE HYDROCHLORIDE - METADATE CD
	
 N 021259 001   6344215          Oct 27, 2020          DP
	
METHYLPHENIDATE HYDROCHLORIDE - METADATE CD
	
 N 021259 002   6344215          Oct 27, 2020          DP
	
METHYLPHENIDATE HYDROCHLORIDE - METADATE CD
	
 N 021259 003   6344215          Oct 27, 2020          DP
	
METHYLPHENIDATE HYDROCHLORIDE - METADATE CD
	
 N 021259 004   6344215          Oct 27, 2020          DP
	
METHYLPHENIDATE HYDROCHLORIDE - RITALIN LA
	
 N 021284 001   5837284          Dec 04, 2015          DP
	
                6228398          Nov 01, 2019          DP U-472
	
                6635284          Dec 04, 2015          DP U-591
	
                7431944          Dec 04, 2015          DP
	
METHYLPHENIDATE HYDROCHLORIDE - RITALIN LA
	
 N 021284 002   5837284          Dec 04, 2015          DP
	
                6228398          Nov 01, 2019          DP U-472
	
                6635284          Dec 04, 2015          DP U-591
	
                7431944          Dec 04, 2015          DP
	
METHYLPHENIDATE HYDROCHLORIDE - RITALIN LA
	
 N 021284 003   5837284          Dec 04, 2015          DP
	
                6228398          Nov 01, 2019          DP U-472
	
                6635284          Dec 04, 2015          DP U-591
	
                7431944          Dec 04, 2015          DP
	
METHYLPHENIDATE HYDROCHLORIDE - RITALIN LA
	
 N 021284 004   5837284          Dec 04, 2015          DP
	
                6228398          Nov 01, 2019          DP U-472
	
                6635284          Dec 04, 2015          DP U-591
	
                7431944          Dec 04, 2015          DP
	
METHYLPHENIDATE HYDROCHLORIDE - METHYLIN
	
 N 021419 001   7691880          Oct 07, 2024          DP
	
METHYLPHENIDATE HYDROCHLORIDE - METHYLIN
	
 N 021419 002   7691880          Oct 07, 2024          DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 141 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT        DELIST          EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES       REQUESTED          CODE(S)            DATE
	
METHYLPHENIDATE HYDROCHLORIDE - QUILLIVANT XR
 N 202100 001   8062667          Mar 29, 2029              DP                              NDF           Sep 27, 2015
                8287903          Feb 15, 2031              DP
                8465765          Feb 15, 2031              DP U-1415
                8563033          Feb 15, 2031              DP U-1415
                8778390          Feb 15, 2031              DP U-1543
METOCLOPRAMIDE HYDROCHLORIDE - REGLAN ODT
 N 021793 001   6024981          Apr 09, 2018              DP
                6221392          Apr 09, 2018              DP
METOCLOPRAMIDE HYDROCHLORIDE - REGLAN ODT
 N 021793 002   6024981          Apr 09, 2018              DP
                6221392          Apr 09, 2018              DP
METOCLOPRAMIDE HYDROCHLORIDE - METOZOLV ODT
 N 022246 001   6413549          Jul 11, 2017              DP
METOCLOPRAMIDE HYDROCHLORIDE - METOZOLV ODT
 N 022246 002   6413549          Jul 11, 2017              DP
METRONIDAZOLE - METROGEL
 N 021789 001   6881726            Feb 21, 2022            DP U-743
                7348317            Feb 21, 2022            DP U-743
METRONIDAZOLE - VANDAZOLE
 N 021806 001   7456207            Sep 22, 2024            DP
METRONIDAZOLE - METRONIDAZOLE
 N 205223 001                                                                              NP            Mar 24, 2017
MICAFUNGIN SODIUM - MYCAMINE
 N 021506 002   6107458            Mar   16,   2019   DS   DP   U-650
                6107458            Mar   16,   2019   DS   DP   U-845
                6265536            Sep   29,   2015   DS   DP   U-650
                6265536            Sep   29,   2015   DS   DP   U-845
                6774104            Jan   08,   2021        DP   U-650
                6774104            Jan   08,   2021        DP   U-845
MICAFUNGIN SODIUM - MYCAMINE
 N 021506 003   6107458            Mar   16,   2019   DS   DP   U-650
                6107458            Mar   16,   2019   DS   DP   U-845
                6265536            Sep   29,   2015   DS   DP   U-650
                6265536            Sep   29,   2015   DS   DP   U-845
                6774104            Jan   08,   2021        DP   U-650
                6774104            Jan   08,   2021        DP   U-845
MICONAZOLE - ORAVIG
 N 022404 001   6916485            Sep 11, 2022            DP U-1051
                7651698            Sep 11, 2022               U-1051
                8518442            Sep 11, 2022            DP
MICONAZOLE NITRATE; MICONAZOLE NITRATE - MONISTAT 1 COMBINATION PACK
 N 021308 001   6153635          Nov 28, 2020                                 Y
MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE - VUSION
 N 021026 001   8147852          Mar 30, 2028           U-1426
MIFEPRISTONE - KORLYM
 N 202107 001                                                                              NP            Feb 17, 2015
                                                                                           ODE           Feb 17, 2019
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 142 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                               PATENT                         EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT            DELIST        EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES           REQUESTED        CODE(S)            DATE
	
MILNACIPRAN HYDROCHLORIDE - SAVELLA
	
 N 022256 001   6602911          Jan 14, 2023                    U-882
	
                6992110          Nov 05, 2021                    U-882
	
                7888342          Nov 05, 2021                    U-882
	
                7994220          Sep 19, 2029                    U-819
	
MILNACIPRAN HYDROCHLORIDE - SAVELLA
	
 N 022256 002   6602911          Jan 14, 2023                    U-882
	
                6992110          Nov 05, 2021                    U-882
	
                7888342          Nov 05, 2021                    U-882
	
                7994220          Sep 19, 2029                    U-819
	
MILNACIPRAN HYDROCHLORIDE - SAVELLA
	
 N 022256 003   6602911          Jan 14, 2023                    U-882
	
                6992110          Nov 05, 2021                    U-882
	
                7888342          Nov 05, 2021                    U-882
	
                7994220          Sep 19, 2029                    U-819
	
MILNACIPRAN HYDROCHLORIDE - SAVELLA
	
 N 022256 004   6602911          Jan 14, 2023                    U-882
	
                6992110          Nov 05, 2021                    U-882
	
                7888342          Nov 05, 2021                    U-882
	
                7994220          Sep 19, 2029                    U-819
	
MILTEFOSINE - IMPAVIDO
	
 N 204684 001                                                                               NCE           Mar 19, 2019
	
                                                                                            ODE           Mar 19, 2021
	
MINOCYCLINE HYDROCHLORIDE - ARESTIN
	
 N 050781 001   6682348          Mar 29, 2022             DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 143 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES            REQUESTED       CODE(S)            DATE
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 001   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 002   5908838          Feb 19, 2018                U-917
	
                7541347          Apr 02, 2027                U-917
	
                7544373          Apr 02, 2027         DP
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 003   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 004   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 005   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 006   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
                8722650          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 007   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
                8722650          Jun 24, 2025                U-1078
	
MINOCYCLINE HYDROCHLORIDE - SOLODYN
	
 N 050808 008   5908838          Feb 19, 2018                U-917
	
                7790705          Jun 24, 2025                U-1078
	
                7919483          Mar 07, 2027                U-1078
	
                8252776          Jun 24, 2025                U-124
	
                8268804          Jun 24, 2025                U-1078
	
                8722650          Jun 24, 2025                U-1078
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 144 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
MINOCYCLINE HYDROCHLORIDE - XIMINO
 N 201922 001   5908838          Feb     19,   2018             U-1376
                7541347          Apr     02,   2027             U-917
                7544373          Apr     02,   2027        DP
                7790705          Jun     24,   2025             U-124
                7919483          Mar     07,   2027             U-124
                8252776          Jun     24,   2025             U-124
                8268804          Jun     24,   2025             U-124
MINOCYCLINE HYDROCHLORIDE - XIMINO
 N 201922 003   5908838          Feb     19,   2018             U-1376
                7541347          Apr     02,   2027             U-917
                7544373          Apr     02,   2027        DP
                7790705          Jun     24,   2025             U-124
                7919483          Mar     07,   2027             U-124
                8252776          Jun     24,   2025             U-124
                8268804          Jun     24,   2025             U-124
MINOCYCLINE HYDROCHLORIDE - XIMINO
 N 201922 005   5908838          Feb     19,   2018             U-1376
                7541347          Apr     02,   2027             U-917
                7544373          Apr     02,   2027        DP
                7790705          Jun     24,   2025             U-124
                7919483          Mar     07,   2027             U-124
                8252776          Jun     24,   2025             U-124
                8268804          Jun     24,   2025             U-124
MINOXIDIL - MEN'S ROGAINE
 N 021812 001   6946120            Apr 20, 2019            DP U-702
MINOXIDIL - WOMEN'S ROGAINE
 N 021812 002                                                                              NP            Feb 28, 2017
MIPOMERSEN SODIUM - KYNAMRO
 N 203568 001   6166197            Dec   26,   2017   DS                                   NCE           Jan 29, 2018
                6222025            Mar   06,   2015   DS                                   ODE           Jan 29, 2020
                6451991            Feb   11,   2017   DS
                7015315            Mar   21,   2023   DS
                7101993            Sep   05,   2023   DS
                7407943            Aug   01,   2021             U-1353
                7511131            Dec   13,   2025   DS
MIRABEGRON - MYRBETRIQ
 N 202611 001   6346532            Oct   15,   2018   DS DP                                NCE           Jun 28, 2017
                6562375            Aug   01,   2020      DP
                7342117            Nov   04,   2023   DS
                7750029            Dec   18,   2023             U-913
                7982049            Nov   04,   2023        DP
                8835474            Nov   04,   2023             U-1527
                RE44872            Dec   18,   2023             U-1527
MIRABEGRON - MYRBETRIQ
 N 202611 002   6346532            Oct   15,   2018   DS DP                                NCE           Jun 28, 2017
                6562375            Aug   01,   2020      DP
                7342117            Nov   04,   2023   DS
                7750029            Dec   18,   2023             U-913
                7982049            Nov   04,   2023        DP
                8835474            Nov   04,   2023             U-1527
                RE44872            Dec   18,   2023             U-1527
MITOMYCIN - MITOSOL
 N 022572 001   7806265            Feb 01, 2029            DP                              ODE           Feb 07, 2019
                8186511            Jul 19, 2026            DP
MODAFINIL - PROVIGIL
 N 020717 001   7297346            Nov 29, 2023            DP
                RE37516            Oct 06, 2014                 U-255
MODAFINIL - PROVIGIL
 N 020717 002   7297346            Nov 29, 2023            DP
                RE37516            Oct 06, 2014                 U-255
MOMETASONE FUROATE - ELOCON
 N 019625 002                                                                              NP            Apr 19, 2016
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 145 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
	
MOMETASONE FUROATE - ASMANEX TWISTHALER
 N 021067 001   5687710          Nov 18,   2014       DP
                5829434          Nov 03,   2015       DP
                6240918          Feb 20,   2017       DP
                6503537          Mar 17,   2018       DP
                8173172          Mar 17,   2018       DP
MOMETASONE FUROATE - ASMANEX TWISTHALER
 N 021067 002   5687710          Nov 18,   2014       DP
                5829434          Nov 03,   2015       DP
                6240918          Feb 20,   2017       DP
                6503537          Mar 17,   2018       DP
                8173172          Mar 17,   2018       DP
MOMETASONE FUROATE - ASMANEX HFA
 N 205641 001   5889015*PED      Jul 27, 2014
                6057307*PED      Jul 27, 2014
                6068832          Aug 27, 2017         DP U-645
                6365581*PED      Jul 27, 2014
MOMETASONE FUROATE - ASMANEX HFA
 N 205641 002   5889015*PED      Jul 27, 2014
                6057307*PED      Jul 27, 2014
                6068832          Aug 27, 2017         DP U-645
                6365581*PED      Jul 27, 2014
MOMETASONE FUROATE MONOHYDRATE - NASONEX
 N 020762 001   6127353          Oct 03, 2017      DS DP
MONTELUKAST SODIUM - SINGULAIR
 N 020829 002                                                                           NPP           Mar 26, 2015
MONTELUKAST SODIUM - SINGULAIR
 N 020830 001                                                                           NPP           Mar 26, 2015
MONTELUKAST SODIUM - SINGULAIR
 N 020830 002                                                                           NPP           Mar 26, 2015
MONTELUKAST SODIUM - SINGULAIR
 N 021409 001   8007830          Oct 24, 2022         DP                                NPP           Mar 26, 2015
MORPHINE SULFATE - AVINZA
 N 021260 001   6066339          Nov 25, 2017         DP
MORPHINE SULFATE - AVINZA
 N 021260 002   6066339          Nov 25, 2017         DP
MORPHINE SULFATE - AVINZA
 N 021260 003   6066339          Nov 25, 2017         DP
MORPHINE SULFATE - AVINZA
 N 021260 004   6066339          Nov 25, 2017         DP
MORPHINE SULFATE - AVINZA
 N 021260 005   6066339          Nov 25, 2017         DP
MORPHINE SULFATE - AVINZA
 N 021260 006   6066339          Nov 25, 2017         DP
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 146 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                            PATENT                            EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
                                          DATE               CODES        REQUESTED           CODE(S)            DATE
MORPHINE SULFATE - DEPODUR
 N 021671    001   5723147            Mar   03,   2015      DP U-584
                   5807572            Sep   15,   2015      DP
                   5891467            Jan   31,   2017      DP
                   5931809            Jul   14,   2015         U-584
                   5962016            Jan   31,   2017      DP U-584
                   5997899            Sep   01,   2016      DP
                   6171613            Oct   01,   2016      DP
                   6193998            Sep   01,   2016      DP
                   6241999            Sep   01,   2016      DP
MORPHINE SULFATE - DEPODUR
 N 021671 002   5723147               Mar   03,   2015      DP U-584
                5807572               Sep   15,   2015      DP
                5891467               Jan   31,   2017      DP
                5931809               Jul   14,   2015         U-584
                5962016               Jan   31,   2017      DP U-584
                5997899               Sep   01,   2016      DP
                6171613               Oct   01,   2016      DP
                6193998               Sep   01,   2016      DP
                6241999               Sep   01,   2016      DP
MORPHINE SULFATE - DEPODUR
 N 021671 003   5723147               Mar   03,   2015      DP U-584
                5807572               Sep   15,   2015      DP
                5891467               Jan   31,   2017      DP
                5931809               Jul   14,   2015         U-584
                5962016               Jan   31,   2017      DP U-584
                5997899               Sep   01,   2016      DP
                6171613               Oct   01,   2016      DP
                6193998               Sep   01,   2016      DP
                6241999               Sep   01,   2016      DP
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 147 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                                PATENT                        EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
                                          DATE              CODES            REQUESTED        CODE(S)            DATE
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
 N 022321    001   7682633            Jun   19,   2027             U-1510
                   7682634            Jun   19,   2027      DP
                   7815934            Dec   12,   2027      DP
                   8158156            Jun   19,   2027             U-1510
                   8685443            Jul   03,   2025             U-1508
                   8685444            Jul   03,   2025      DP
                   8846104            Jun   19,   2027      DP
                   8877247            Jun   19,   2027      DP
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
 N 022321    002   7682633            Jun   19,   2027             U-1510
                   7682634            Jun   19,   2027      DP
                   7815934            Dec   12,   2027      DP
                   8158156            Jun   19,   2027             U-1510
                   8685443            Jul   03,   2025             U-1508
                   8685444            Jul   03,   2025      DP
                   8846104            Jun   19,   2027      DP
                   8877247            Jun   19,   2027      DP
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
 N 022321 003   7682633          Jun 19, 2027                      U-1510
                7682634          Jun 19, 2027               DP
                7815934          Dec 12, 2027               DP
                8158156          Jun 19, 2027                      U-1510
                8685443          Jul 03, 2025                      U-1508
                8685444          Jul 03, 2025               DP
                8846104          Jun 19, 2027               DP
                8877247          Jun 19, 2027               DP
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
 N 022321 004   7682633          Jun 19, 2027                      U-1510
                7682634          Jun 19, 2027               DP
                7815934          Dec 12, 2027               DP
                8158156          Jun 19, 2027                      U-1510
                8685443          Jul 03, 2025                      U-1508
                8685444          Jul 03, 2025               DP
                8846104          Jun 19, 2027               DP
                8877247          Jun 19, 2027               DP
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
 N 022321 005   7682633          Jun 19, 2027                      U-1510
                7682634          Jun 19, 2027               DP
                7815934          Dec 12, 2027               DP
                8158156          Jun 19, 2027                      U-1510
                8685443          Jul 03, 2025                      U-1508
                8685444          Jul 03, 2025               DP
                8846104          Jun 19, 2027               DP
                8877247          Jun 19, 2027               DP
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA
 N 022321 006   7682633          Jun 19, 2027                      U-1510
                7682634          Jun 19, 2027               DP
                7815934          Dec 12, 2027               DP
                8158156          Jun 19, 2027                      U-1510
                8685443          Jul 03, 2025                      U-1508
                8685444          Jul 03, 2025               DP
                8846104          Jun 19, 2027               DP
                8877247          Jun 19, 2027               DP
MOXIFLOXACIN HYDROCHLORIDE - AVELOX
 N 021085 001   5849752          Dec 05, 2016                  U-298
                6610327          Oct 29, 2019               DP U-298
MOXIFLOXACIN HYDROCHLORIDE - AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
	
 N 021277 001   5849752          Dec 05, 2016           U-298
	
                6548079          Jul 25, 2020       DP U-298
	
MOXIFLOXACIN HYDROCHLORIDE - VIGAMOX
	
 N 021598 001   6716830          Sep 29, 2019               DP
	
                7671070          Sep 29, 2019                      U-709
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 148 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
MOXIFLOXACIN HYDROCHLORIDE - MOXEZA
 N 022428 001   6716830          Sep 29, 2019            DP
                7671070          Sep 29, 2019            DP U-709
                8450311          May 29, 2029            DP
MUPIROCIN - CENTANY
 N 050788 001   6013657            Jul 08, 2018          DP
MUPIROCIN CALCIUM - BACTROBAN
 N 050746 001   6025389            Oct 20, 2014          DP U-1122
MYCOPHENOLATE MOFETIL - CELLCEPT
 N 050759 001   5688529          Nov 18, 2014            DP
MYCOPHENOLIC ACID - MYCOPHENOLIC ACID
 A 091248 001                                                                              PC            Jul 07, 2014
MYCOPHENOLIC ACID - MYFORTIC
 N 050791 001   6025391            Apr 10, 2017          DP U-908
                6172107            Apr 10, 2017          DP U-908
                6306900            Feb 27, 2018          DP
MYCOPHENOLIC ACID - MYFORTIC
 N 050791 002   6025391            Apr 10, 2017          DP U-908
                6172107            Apr 10, 2017          DP U-908
                6306900            Feb 27, 2018          DP
NAFTIFINE HYDROCHLORIDE - NAFTIN
 N 019599 002                                                                              NS            Jan 13, 2015
NAFTIFINE HYDROCHLORIDE - NAFTIN
 N 204286 001   8778365          Jan 31, 2033            DP                                NP            Jun 27, 2016
NALOXEGOL OXALATE - MOVANTIK
 N 204760 001   7662365            Oct   18,   2022   DS DP                                NCE           Sep 16, 2019
                7786133            Dec   19,   2027      DP
                8067431            Dec   16,   2024           U-1185
                8617530            Oct   18,   2022           U-1185
NALOXEGOL OXALATE - MOVANTIK
 N 204760 002   7662365            Oct   18,   2022   DS DP                                NCE           Sep 16, 2019
                7786133            Dec   19,   2027      DP
                8067431            Dec   16,   2024           U-1185
                8617530            Oct   18,   2022           U-1185
NALOXONE HYDROCHLORIDE - EVZIO
 N 205787 001   7731686            Jun   10,   2026      DP
                7731690            Jan   15,   2025      DP
                7749194            Oct   30,   2028      DP
                7918823            Nov   23,   2024      DP
                7947017            Mar   12,   2028      DP
                8016788            Mar   21,   2025      DP
                8021344            Nov   02,   2029      DP
                8206360            Feb   27,   2027      DP
                8226610            Apr   10,   2029      DP
                8231573            Nov   25,   2028      DP
                8313466            Nov   23,   2024      DP
                8361029            Nov   23,   2024      DP
                8425462            Nov   23,   2024      DP
                8608698            Nov   23,   2024      DP
                8627816            Feb   04,   2032      DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                     ADA 149 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                   PATENT                      EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION         PATENT                  DELIST     EXCLUSIVITY       EXPIRATION
	
                                       DATE             CODES                 REQUESTED     CODE(S)            DATE
	
NALOXONE HYDROCHLORIDE;   OXYCODONE HYDROCHLORIDE - TARGINIQ
	
 N 205777 001   6277384            Dec 22, 2018         DP
	
                6696066            Dec 22, 2018         DP
	
                7674799            Mar 30, 2025         DP
	
                7674800            Mar 30, 2025    DS
	
                7683072            Mar 30, 2025    DS
	
                8673355            Dec 22, 2018         DP
	
                8822487            Dec 22, 2018         DP
	
                8846090            Apr 04, 2023         DP
	
                8846091            Apr 04, 2023         DP
	
NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE - TARGINIQ
	
 N 205777 002   6277384          Dec 22, 2018         DP
	
                6696066          Dec 22, 2018         DP
	
                7674799          Mar 30, 2025         DP
	
                7674800          Mar 30, 2025    DS
	
                7683072          Mar 30, 2025    DS
	
                8673355          Dec 22, 2018         DP
	
                8822487          Dec 22, 2018         DP
	
                8846090          Apr 04, 2023         DP
	
                8846091          Apr 04, 2023         DP
	
NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE - TARGINIQ
	
 N 205777 003   6277384          Dec 22, 2018         DP
	
                6696066          Dec 22, 2018         DP
	
                7674799          Mar 30, 2025         DP
	
                7674800          Mar 30, 2025    DS
	
                7683072          Mar 30, 2025    DS
	
                8673355          Dec 22, 2018         DP
	
                8822487          Dec 22, 2018         DP
	
                8846090          Apr 04, 2023         DP
	
                8846091          Apr 04, 2023         DP
	
NALTREXONE - VIVITROL
	
 N 021897 001   5792477            May   02,   2017         DP
	
                5916598            May   02,   2017         DP
	
                6194006            Dec   30,   2018         DP
	
                6264987            May   19,   2020         DP
	
                6331317            Nov   12,   2019         DP
	
                6379703            Dec   30,   2018         DP
	
                6379704            May   19,   2020         DP
	
                6395304            Nov   12,   2019         DP
	
                6403114            May   02,   2017         DP
	
                6495164            May   25,   2020         DP
	
                6495166            Nov   12,   2019         DP
	
                6534092            May   19,   2020         DP
	
                6537586            Nov   12,   2019         DP
	
                6596316            Dec   30,   2018         DP
	
                6667061            May   25,   2020         DP
	
                6713090            Nov   12,   2019         DP
	
                6939033            Nov   12,   2019         DP
	
                7799345            May   25,   2020         DP
	
                7919499            Oct   15,   2029                U-1123
	
                7919499            Oct   15,   2029                U-1124
	
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE -       TREXIMET
	
 N 021926 001   6060499          Aug 14,       2017         DP     U-867
	
                6586458          Aug 14,       2017         DP     U-867
	
                7332183          Oct 02,       2025         DP     U-867
	
                8022095          Aug 14,       2017         DP     U-867
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 150 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES         REQUESTED          CODE(S)            DATE
	
NATEGLINIDE - STARLIX
 N 021204 001   6559188            Sep   15,   2020       DP U-827
                6641841            Nov   14,   2017       DP U-214
                6844008            Nov   14,   2017       DP U-214
                6878749            Sep   15,   2020       DP
NATEGLINIDE - STARLIX
 N 021204 002   6559188            Sep   15,   2020       DP U-827
                6641841            Nov   14,   2017       DP U-214
                6844008            Nov   14,   2017       DP U-214
                6878749            Sep   15,   2020       DP
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC
 N 021742 002   5759580          Jun 02, 2015             DP
                6545040          Dec 17, 2021             DP U-3
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC
 N 021742 003   5759580          Jun 02, 2015             DP
                6545040          Dec 17, 2021             DP U-3
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC
 N 021742 004   5759580          Jun 02, 2015             DP
                6545040          Dec 17, 2021             DP U-3
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC
 N 021742 005   5759580          Jun 02, 2015             DP
                6545040          Dec 17, 2021             DP U-3
NELARABINE - ARRANON
 N 021877 001   5424295            Jun 13, 2017        DS DP
NEPAFENAC - NEVANAC
 N 021862 001   7834059            Jan 31, 2027                U-1095
                8071648            Dec 02, 2025           DP
                8324281            Dec 02, 2025           DP
NEPAFENAC - ILEVRO
 N 203491 001   6403609            Jul 17, 2018           DP                               NP            Oct 16, 2015
                7947295            Jun 08, 2024           DP
NETUPITANT; PALONOSETRON HYDROCHLORIDE -       AKYNZEO
 N 205718 001   5202333          Apr 13,       2015    DS DP U-528                         NCE           Oct 10, 2019
                6297375          Feb 22,       2020    DS
                8623826          Nov 18,       2030          U-528
NEVIRAPINE - NEVIRAPINE
 A 203411 001                                                                              PC            Oct 12, 2014
NEVIRAPINE - NEVIRAPINE
 A 205258 001                                                                              PC            Oct 12, 2014
NEVIRAPINE - VIRAMUNE XR
 N 201152 001   8460704            Mar 12, 2029                U-1409                      NPP           Nov 08, 2015
NEVIRAPINE - VIRAMUNE XR
 N 201152 002                                                                              NPP           Nov 08, 2015
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 151 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES         REQUESTED          CODE(S)            DATE
	
NIACIN - NIASPAN
	
 N 020381 001    6080428            May 27, 2017              U-331
	
NIACIN - NIASPAN
	
 N 020381 002    6080428            May   27,   2017          U-331
	
                 6080428            May   27,   2017          U-1138
	
                 6080428            May   27,   2017          U-1139
	
                 6080428            May   27,   2017          U-1140
	
                 6080428            May   27,   2017          U-1141
	
                 6469035            Mar   15,   2018          U-768
	
                 6469035            Mar   15,   2018          U-1142
	
                 6469035            Mar   15,   2018          U-1143
	
                 6469035            Mar   15,   2018          U-1144
	
                 6469035            Mar   15,   2018          U-1145
	
NIACIN - NIASPAN
	
 N 020381 003    6080428            May   27,   2017          U-331
	
                 6080428            May   27,   2017          U-1138
	
                 6080428            May   27,   2017          U-1139
	
                 6080428            May   27,   2017          U-1140
	
                 6080428            May   27,   2017          U-1141
	
                 6469035            Mar   15,   2018          U-768
	
                 6469035            Mar   15,   2018          U-1142
	
                 6469035            Mar   15,   2018          U-1143
	
                 6469035            Mar   15,   2018          U-1144
	
                 6469035            Mar   15,   2018          U-1145
	
NIACIN - NIASPAN
	
 N 020381 004    6080428            May   27,   2017          U-331
	
                 6080428            May   27,   2017          U-1138
	
                 6080428            May   27,   2017          U-1139
	
                 6080428            May   27,   2017          U-1140
	
                 6080428            May   27,   2017          U-1141
	
                 6469035            Mar   15,   2018          U-768
	
                 6469035            Mar   15,   2018          U-1142
	
                 6469035            Mar   15,   2018          U-1143
	
                 6469035            Mar   15,   2018          U-1144
	
                 6469035            Mar   15,   2018          U-1145
	
NIACIN - NIASPAN TITRATION STARTER PACK
	
 N 020381 005   6080428          May 27, 2017                 U-331
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 152 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES            REQUESTED       CODE(S)            DATE
	
NIACIN; SIMVASTATIN - SIMCOR
	
 N 022078 001   6080428             May   27,   2017             U-862
	
                6080428             May   27,   2017             U-1132
	
                6080428             May   27,   2017             U-1134
	
                6469035             Mar   15,   2018             U-863
	
                6469035             Mar   15,   2018             U-1129
	
                6469035             Mar   15,   2018             U-1149
	
NIACIN; SIMVASTATIN - SIMCOR
	
 N 022078 002   6080428             May   27,   2017             U-862
	
                6080428             May   27,   2017             U-1132
	
                6080428             May   27,   2017             U-1134
	
                6469035             Mar   15,   2018             U-863
	
                6469035             Mar   15,   2018             U-1129
	
                6469035             Mar   15,   2018             U-1149
	
NIACIN; SIMVASTATIN - SIMCOR
	
 N 022078 003   6080428             May   27,   2017             U-862
	
                6080428             May   27,   2017             U-1132
	
                6080428             May   27,   2017             U-1134
	
                6469035             Mar   15,   2018             U-863
	
                6469035             Mar   15,   2018             U-1129
	
                6469035             Mar   15,   2018             U-1149
	
NIACIN; SIMVASTATIN - SIMCOR
	
 N 022078 004   6080428             May   27,   2017             U-862
	
                6080428             May   27,   2017             U-1132
	
                6080428             May   27,   2017             U-1134
	
                6469035             Mar   15,   2018             U-863
	
                6469035             Mar   15,   2018             U-1129
	
                6469035             Mar   15,   2018             U-1149
	
NIACIN; SIMVASTATIN - SIMCOR
	
 N 022078 005   6080428             May   27,   2017             U-862
	
                6080428             May   27,   2017             U-1132
	
                6080428             May   27,   2017             U-1134
	
                6469035             Mar   15,   2018             U-863
	
                6469035             Mar   15,   2018             U-1129
	
                6469035             Mar   15,   2018             U-1149
	
NICARDIPINE HYDROCHLORIDE - CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
	
 N 019734 002   7612102          Dec 26, 2027       DP
	
                7659291          Apr 18, 2027            U-1029
	
                8455524          Apr 18, 2027            U-1029
	
NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
	
 N 019734 003   7612102          Dec 26, 2027       DP
	
                7659291          Apr 18, 2027            U-1029
	
                8455524          Apr 18, 2027            U-1029
	
NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
	
 N 019734 004   7612102          Dec 26, 2027       DP
	
                7659291          Apr 18, 2027            U-1029
	
                8455524          Apr 18, 2027            U-1029
	
NICARDIPINE HYDROCHLORIDE - CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
	
 N 019734 005   7612102          Dec 26, 2027       DP
	
                7659291          Apr 18, 2027            U-1029
	
                8455524          Apr 18, 2027            U-1029
	
NICOTINE - NICODERM CQ
	
 N 020165 004   8075911             May 22, 2021          DP
	
                8663680             Feb 13, 2020          DP
	
NICOTINE - NICODERM CQ
	
 N 020165 005   8075911             May 22, 2021          DP
	
                8663680             Feb 13, 2020          DP
	
NICOTINE - NICODERM CQ
	
 N 020165 006   8075911             May 22, 2021          DP
	
                8663680             Feb 13, 2020          DP
	
NICOTINE - NICOTROL
	
 N 020385 001   5656255             Aug 12, 2014
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 153 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
NICOTINE POLACRILEX - NICORETTE
 N 018612 002   8323683            Apr 30, 2028
NICOTINE POLACRILEX - NICORETTE
 N 020066 002   8323683            Apr 30, 2028          DP
NICOTINE POLACRILEX - NICORETTE
 N 022360 001   8501164            Jun 14, 2029          DP
NICOTINE POLACRILEX - NICORETTE
 N 022360 002   8501164            Jun 14, 2029          DP
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA
 N 022068 001   7169791          Jul 04, 2023         DS DP U-836                          ODE           Oct 29, 2014
                8163904          Aug 23, 2028         DS DP
                8293756          Sep 25, 2027            DP
                8389537          Jul 18, 2026         DS DP U-1374
                8415363          Jul 18, 2026         DS DP U-1407
                8501760          Jul 18, 2026         DS DP
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA
 N 022068 002   7169791          Jul 04, 2023         DS DP U-836                          ODE           Oct 29, 2014
                8163904          Aug 23, 2028         DS DP
                8293756          Sep 25, 2027            DP
                8389537          Jul 18, 2026         DS DP U-1374
                8415363          Jul 18, 2026         DS DP U-1407
                8501760          Jul 18, 2026         DS DP
NIMODIPINE - NYMALIZE
 N 203340 001                                                                              ODE           May 10, 2020
NINTEDANIB - OFEV
 N 205832 001   6762180            Dec 10, 2020       DS DP                                NCE           Oct 15, 2019
                7119093            Feb 21, 2024       DS DP                                ODE           Oct 15, 2021
NINTEDANIB - OFEV
 N 205832 002   6762180            Dec 10, 2020       DS DP                                NCE           Oct 15, 2019
                7119093            Feb 21, 2024       DS DP                                ODE           Oct 15, 2021
NISOLDIPINE - SULAR
 N 020356 005   5626874            Nov 30, 2014          DP
NISOLDIPINE - SULAR
 N 020356 006   5626874            Nov 30, 2014          DP
NISOLDIPINE - SULAR
 N 020356 007   5626874            Nov 30, 2014          DP
NISOLDIPINE - SULAR
 N 020356 008   5626874            Nov 30, 2014          DP
NITAZOXANIDE - ALINIA
 N 021497 001   5968961            May 07, 2017          DP
                6020353            Sep 18, 2014       DS DP
NITAZOXANIDE - ALINIA
 N 021498 001   5578621            Sep   08,   2014           U-525
                5965590            Jul   03,   2017           U-523
                5968961            May   07,   2017
                6020353            Sep   08,   2014
                6117894            May   07,   2017
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 154 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES            REQUESTED       CODE(S)            DATE
	
NITRIC OXIDE - INOMAX
	
 N 020845 002   5732693            Dec   13,   2016      DP U-1230
	
                5752504            Dec   13,   2016      DP U-1230
	
                6125846            May   16,   2017      DP U-1457
	
                8282966            Jun   30,   2029         U-1286
	
                8291904            Jan   06,   2031      DP U-1226
	
                8293284            Jun   30,   2029         U-1286
	
                8431163            Jun   30,   2029         U-1286
	
                8431163*PED        Dec   30,   2029
	
                8573209            Jan   06,   2031      DP
	
                8573209*PED        Jul   06,   2031
	
                8573210            Jan   06,   2031      DP U-1453
	
                8573210*PED        Jul   06,   2031
	
                8776794            Jan   06,   2031      DP U-1226
	
                8776794*PED        Jul   06,   2031
	
                8776795            Jan   06,   2031      DP U-1226
	
                8776795*PED        Jul   06,   2031
	
                8795741            Jun   30,   2029             U-1286
	
                8795741*PED        Dec   30,   2029
	
                8846112            Jun   30,   2029             U-1286
	
                8846112*PED        Dec   30,   2029
	
NITRIC OXIDE - INOMAX
	
 N 020845 003   5732693            Dec   13,   2016      DP U-1230
	
                5752504            Dec   13,   2016      DP U-1230
	
                6125846            May   16,   2017      DP U-1457
	
                8282966            Jun   30,   2029         U-1286
	
                8291904            Jan   06,   2031      DP U-1226
	
                8293284            Jun   30,   2029         U-1286
	
                8431163            Jun   30,   2029         U-1286
	
                8431163*PED        Dec   30,   2029
	
                8573209            Jan   06,   2031      DP
	
                8573209*PED        Jul   06,   2031
	
                8573210            Jan   06,   2031      DP U-1453
	
                8573210*PED        Jul   06,   2031
	
                8776794            Jan   06,   2031      DP U-1226
	
                8776794*PED        Jul   06,   2031
	
                8776795            Jan   06,   2031      DP U-1226
	
                8776795*PED        Jul   06,   2031
	
                8795741            Jun   30,   2029             U-1286
	
                8795741*PED        Dec   30,   2029
	
                8846112            Jun   30,   2029             U-1286
	
                8846112*PED        Dec   30,   2029
	
NITROGLYCERIN - NITROLINGUAL PUMPSPRAY
	
 N 018705 002   7872049          Mar 14, 2028            DP U-39
	
NITROGLYCERIN - NITROSTAT
	
 N 021134 001   6500456            Sep 16, 2018
	
NITROGLYCERIN - NITROSTAT
	
 N 021134 002   6500456            Sep 16, 2018
	
NITROGLYCERIN - NITROSTAT
	
 N 021134 003   6500456            Sep 16, 2018
	
NITROGLYCERIN - NITROMIST
	
 N 021780 001   5869082            Apr 16, 2016          DP
	
NIZATIDINE - AXID
	
 N 021494 001   6930119            Jul 17, 2022          DP
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 155 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
OCTREOTIDE ACETATE - SANDOSTATIN
 N 019667 001   5753618          May 19, 2015
OCTREOTIDE ACETATE - SANDOSTATIN
 N 019667 002   5753618          May 19, 2015
OCTREOTIDE ACETATE - SANDOSTATIN
 N 019667 003   5753618          May 19, 2015
OCTREOTIDE ACETATE - SANDOSTATIN
 N 019667 004   5753618          May 19, 2015
OCTREOTIDE ACETATE - SANDOSTATIN
 N 019667 005   5753618          May 19, 2015
OCTREOTIDE ACETATE - SANDOSTATIN   LAR
 N 021008 001   5688530            Nov 18, 2014               U-268
                5922338            Jul 13, 2016          DP
                5922682            Jul 13, 2016          DP
OCTREOTIDE ACETATE - SANDOSTATIN   LAR
 N 021008 002   5688530            Nov 18, 2014               U-268
                5922338            Jul 13, 2016          DP
                5922682            Jul 13, 2016          DP
OCTREOTIDE ACETATE - SANDOSTATIN   LAR
 N 021008 003   5688530            Nov 18, 2014               U-268
                5922338            Jul 13, 2016          DP
                5922682            Jul 13, 2016          DP
OLANZAPINE - ZYPREXA
 N 020592 001   6960577            Nov 01, 2017               U-963                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA
 N 020592 002   6960577            Nov 01, 2017               U-963                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA
 N 020592 003   6960577            Nov 01, 2017               U-963                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA
 N 020592 004   6960577            Nov 01, 2017               U-963                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA
 N 020592 005   6960577            Nov 01, 2017               U-963                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA
 N 020592 006   6960577            Nov 01, 2017               U-963                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA ZYDIS
 N 021086 001   6960577            Nov 01, 2017               U-964                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA ZYDIS
 N 021086 002   6960577            Nov 01, 2017               U-964                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA ZYDIS
 N 021086 003   6960577            Nov 01, 2017               U-964                        NPP           Jul 26, 2016
OLANZAPINE - ZYPREXA ZYDIS
 N 021086 004   6960577            Nov 01, 2017               U-964                        NPP           Jul 26, 2016
OLANZAPINE PAMOATE - ZYPREXA RELPREVV
 N 022173 001   6169084          Sep 30, 2018         DS DP U-1026
OLANZAPINE PAMOATE - ZYPREXA RELPREVV
 N 022173 002   6169084          Sep 30, 2018         DS DP U-1026
OLANZAPINE PAMOATE - ZYPREXA RELPREVV
 N 022173 003   6169084          Sep 30, 2018         DS DP U-1026
OLAPARIB - OLAPARIB
 N 206162 001                                                                              NCE           Dec 19, 2019
OLIVE OIL; SOYBEAN OIL - CLINOLIPID 20%
 N 204508 001   5840757          Nov 24, 2015            DP                                NP            Oct 03, 2016
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 156 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
	
OLMESARTAN MEDOXOMIL - BENICAR
 N 021286 001   5616599          Apr 25, 2016       DS DP U-500
                6878703          Nov 19, 2021             U-3              Y
OLMESARTAN MEDOXOMIL - BENICAR
 N 021286 003   5616599          Apr 25, 2016       DS DP U-500
                6878703          Nov 19, 2021             U-3              Y
OLMESARTAN MEDOXOMIL - BENICAR
 N 021286 004   5616599          Apr 25, 2016       DS DP U-500
                6878703          Nov 19, 2021             U-3              Y
OLODATEROL HYDROCHLORIDE - STRIVERDI RESPIMAT
 N 203108 001   5964416          Oct 04, 2016          DP                               NCE           Jul 31, 2019
                6149054          Dec 19, 2016          DP
                6176442          Oct 04, 2016          DP
                6453795          Dec 05, 2016          DP
                6726124          Oct 04, 2016          DP
                6846413          Aug 28, 2018          DP
                6977042          Aug 28, 2018          DP
                6988496          Feb 23, 2020          DP U-1547
                7056916          Dec 07, 2023       DS DP
                7104470          Oct 04, 2016          DP
                7220742          May 12, 2025       DS DP U-1547
                7246615          May 31, 2016          DP
                7284474          Aug 26, 2024          DP
                7396341          Oct 10, 2026          DP U-1547
                7491719          Nov 10, 2023       DS DP
                7727984          Nov 10, 2023       DS
                7786111          Nov 10, 2023          DP
                7802568          Feb 26, 2019          DP
                7837235          Mar 13, 2028          DP
                7896264          May 26, 2025          DP
                7988001          Aug 04, 2021          DP
                8034809          May 12, 2025             U-1547
                8044046          Nov 10, 2023             U-1547
OLOPATADINE HYDROCHLORIDE - PATANOL
 N 020688 001   5641805          Jun 06, 2015               U-184
OLOPATADINE HYDROCHLORIDE - PATADAY
 N 021545 001   5641805          Jun   06,   2015           U-765          Y
                5641805*PED      Dec   06,   2015
                6995186          Nov   12,   2023      DP U-765
                7402609          Jun   19,   2022      DP
OLOPATADINE HYDROCHLORIDE - PATANASE
 N 021861 001   7977376          Feb 02, 2023          DP
                8399508          Sep 17, 2022               U-726
                8399508*PED      Mar 17, 2023
OMACETAXINE MEPESUCCINATE - SYNRIBO
 N 203585 001   6987103          Jun 28, 2023             U-1300                        NCE           Oct 26, 2017
                RE45128          Mar 16, 2019       DS DP U-1576                        ODE           Oct 26, 2019
OMEGA-3-ACID ETHYL ESTERS - LOVAZA
 N 021654 001   5656667          Apr 10, 2017       DS DP U-822
OMEGA-3-CARBOXYLIC ACIDS - EPANOVA
 N 205060 001   5792795          May   13,   2016      DP
                5948818          May   13,   2016      DP
                7960370          Feb   07,   2025      DP
                8383678          Feb   07,   2025      DP U-1511
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                     ADA 157 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT
	                                  PATENT                      EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION               PATENT
	           DELIST     EXCLUSIVITY      EXPIRATION
	
                                       DATE                   CODES
	          REQUESTED     CODE(S)            DATE
	
OMEPRAZOLE - PRILOSEC
	
 N 019810 001		 6147103            Oct   09,   2018
	
                6150380            Nov   10,   2018
	
                6166213            Oct   09,   2018
	
                6191148            Oct   09,   2018
	
OMEPRAZOLE - PRILOSEC
	
 N 019810 002		 6147103            Oct   09,   2018
	
                6150380            Nov   10,   2018
	
                6166213            Oct   09,   2018
	
                6191148            Oct   09,   2018
	
OMEPRAZOLE - PRILOSEC
	
 N 019810 003		 6147103            Oct   09,   2018
	
                6150380            Nov   10,   2018
	
                6166213            Oct   09,   2018
	
                6191148            Oct   09,   2018
	
OMEPRAZOLE MAGNESIUM - PRILOSEC OTC
	
 N 021229 001		 5690960          Nov 25, 2014
	
                5753265          Jun 07, 2015
	
                5817338          Oct 06, 2015
	
                5900424          May 04, 2016

                6403616          Nov 15, 2019
	
                6428810          Nov 03, 2019
	
OMEPRAZOLE MAGNESIUM - PRILOSEC
	
 N 022056 001		 5690960           Nov 25, 2014               DP U-864
	
                5900424           May 04, 2016          DS      U-864
	
                6428810           Nov 03, 2019               DP U-864
	
OMEPRAZOLE MAGNESIUM - PRILOSEC
	
 N 022056 002		 5690960           Nov 25, 2014               DP U-864
	
                5900424           May 04, 2016          DS      U-864
	
                6428810           Nov 03, 2019               DP U-864
	
OMEPRAZOLE; SODIUM BICARBONATE - ZEGERID
	
 N 021636 001		 5840737          Jul 16, 2016                   U-588
	
                6489346          Jul 16, 2016           DS DP U-588
	                Y
	
                6645988          Jul 16, 2016           DS DP
	                      Y
	
                6699885          Jul 16, 2016                   U-588
	              Y
	
                6780882          Jul 16, 2016           DS DP
	
                7399772          Jul 16, 2016                   U-588
	
                RE45198          Jul 16, 2016                   U-588
	
OMEPRAZOLE; SODIUM BICARBONATE - ZEGERID
	
 N 021636 002		 5840737          Jul 16, 2016                   U-623
	
                5840737          Jul 16, 2016                   U-624
	
                6489346          Jul 16, 2016           DS DP U-623
	                Y
	
                6489346          Jul 16, 2016           DS DP U-624
	                Y
	
                6645988          Jul 16, 2016           DS DP
	                      Y
	
                6699885          Jul 16, 2016                   U-623
	              Y
	
                6699885          Jul 16, 2016                   U-624
	              Y
	
                6780882          Jul 16, 2016           DS DP
	
                7399772          Jul 16, 2016                   U-623
	
                7399772          Jul 16, 2016                   U-624
	
                RE45198          Jul 16, 2016                   U-588
	
OMEPRAZOLE; SODIUM BICARBONATE - ZEGERID
	
 N 021849 001		 7399772          Jul 16, 2016                       U-588
	
OMEPRAZOLE; SODIUM BICARBONATE - ZEGERID
	
 N 021849 002		 7399772          Jul 16, 2016                       U-623
	
OMEPRAZOLE; SODIUM BICARBONATE - ZEGERID OTC
	
 N 022281 001		 6489346          Jul 15, 2016                DP U-1025
	             Y
	
                6645988          Jul 15, 2016                DP
	                    Y
	
                6699885          Jul 15, 2016                DP
	                    Y
	
                7399772          Jul 15, 2016                     U-1025
	
OMEPRAZOLE; SODIUM BICARBONATE - ZEGERID OTC
	
 N 022283 001		 5840737          Jul 16, 2016                       U-1025
	
                6780882          Jul 16, 2016                DP
	
                7399772          Jul 16, 2016                       U-1025
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 158 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
ONDANSETRON - ZOFRAN ODT
 N 020781 001   5955488            Nov 14, 2015
                6063802            Nov 14, 2015
ONDANSETRON - ZOFRAN ODT
 N 020781 002   5955488            Nov 14, 2015
                6063802            Nov 14, 2015
ONDANSETRON - ZUPLENZ
 N 022524 001   8580830            Nov 23, 2029          DP
ONDANSETRON - ZUPLENZ
 N 022524 002   8580830            Nov 23, 2029          DP
ONDANSETRON HYDROCHLORIDE - ZOFRAN
 N 020605 001   5854270          Nov 20, 2015            DP U-44
ORITAVANCIN DIPHOSPHATE - ORBACTIV
 N 206334 001   5840684          Nov 24, 2015         DS DP U-1569                         NCE           Aug 06, 2019
                5998581          Nov 12, 2017         DS                                   GAIN          Aug 06, 2024
                8420592          Aug 29, 2029               U-1570
ORLISTAT - XENICAL
 N 020766 001   6004996            Jan 06, 2018
ORLISTAT - ALLI
 N 021887 001   6004996            Jan 06, 2018          DP
OSELTAMIVIR PHOSPHATE - TAMIFLU
 N 021087 001   5763483            Dec 27, 2016       DS    U-1113                         NPP           Dec 21, 2015
                5866601            Feb 02, 2016       DS DP
                5952375            Feb 27, 2015       DS DP
OSELTAMIVIR PHOSPHATE - TAMIFLU
 N 021087 002   5763483            Dec 27, 2016       DS    U-1113                         NPP           Dec 21, 2015
                5866601            Feb 02, 2016       DS DP
                5952375            Feb 27, 2015       DS DP
OSELTAMIVIR PHOSPHATE - TAMIFLU
 N 021087 003   5763483            Dec 27, 2016       DS    U-1113                         NPP           Dec 21, 2015
                5866601            Feb 02, 2016       DS DP
                5952375            Feb 27, 2015       DS DP
OSELTAMIVIR PHOSPHATE - TAMIFLU
 N 021246 001   5763483            Dec   27,   2016   DS    U-376                          NPP           Dec 21, 2015
                5763483            Dec   27,   2016   DS    U-1113
                5866601            Feb   02,   2016   DS DP
                5952375            Feb   27,   2015   DS DP
OSELTAMIVIR PHOSPHATE - TAMIFLU
 N 021246 002   5763483            Dec 27, 2016       DS DP U-1113                         NPP           Dec 21, 2015
                5866601            Feb 02, 2016       DS DP
                5952375            Feb 27, 2015       DS DP
OSPEMIFENE - OSPHENA
 N 203505 001   6245819            Jul   21,   2020           U-1369                       NCE           Feb 26, 2018
                8236861            Aug   11,   2026           U-1369
                8236861            Aug   11,   2026           U-1370
                8470890            Feb   13,   2024           U-1369
                8470890            Feb   13,   2024           U-1370
                8642079            Mar   01,   2028      DP
                8772353            Feb   13,   2024           U-1369
                8772353            Feb   13,   2024           U-1370
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 159 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                              PATENT                          EXCLUSIVITY
     NO            PATENT NO           EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
                                          DATE                 CODES        REQUESTED         CODE(S)            DATE
OXALIPLATIN - ELOXATIN
 N 021492    001   5420319            Aug 09, 2016       DS
OXALIPLATIN - ELOXATIN
 N 021492 002   5420319               Aug 09, 2016       DS
OXALIPLATIN - ELOXATIN
 N 021759 001   5420319               Aug 09, 2016       DS
                5716988               Aug 07, 2015            DP
OXALIPLATIN - ELOXATIN
 N 021759 002   5420319               Aug 09, 2016       DS
                5716988               Aug 07, 2015            DP
OXALIPLATIN - ELOXATIN
 N 021759 003   5420319               Aug 09, 2016       DS
                5716988               Aug 07, 2015            DP
OXANDROLONE - OXANDRIN
 N 013718 001   5872147               Dec   05,   2017             U-585
                6090799               Jul   18,   2017             U-585
                6576659               Dec   05,   2017             U-585
                6828313               Dec   05,   2017             U-585
OXANDROLONE - OXANDRIN
 N 013718 002   5872147               Dec   05,   2017             U-585
                6090799               Jul   18,   2017             U-585
                6576659               Dec   05,   2017             U-585
                6828313               Dec   05,   2017             U-585
OXCARBAZEPINE - TRILEPTAL
 N 021014 001   7037525               Feb 12, 2018                 U-724
OXCARBAZEPINE - TRILEPTAL
 N 021014 002   7037525               Feb 12, 2018                 U-724
OXCARBAZEPINE - TRILEPTAL
 N 021014 003   7037525               Feb 12, 2018                 U-724
OXCARBAZEPINE - TRILEPTAL
 N 021285 001   7037525               Feb 12, 2018               U-724
                8119148               Dec 19, 2020            DP U-724
OXCARBAZEPINE - OXTELLAR XR
 N 202810 001   7722898               Apr   13,   2027        DP                              NDF           Oct 19, 2015
                7910131               Apr   13,   2027             U-1298
                8617600               Apr   13,   2027        DP
                8821930               Apr   13,   2027        DP
OXCARBAZEPINE - OXTELLAR XR
 N 202810 002   7722898               Apr   13,   2027        DP                              NDF           Oct 19, 2015
                7910131               Apr   13,   2027             U-1298
                8617600               Apr   13,   2027        DP
                8821930               Apr   13,   2027        DP
OXCARBAZEPINE - OXTELLAR XR
 N 202810 003   7722898               Apr   13,   2027        DP                              NDF           Oct 19, 2015
                7910131               Apr   13,   2027             U-1298
                8617600               Apr   13,   2027        DP
                8821930               Apr   13,   2027        DP
OXYBUTYNIN - OXYTROL
 N 021351 002   5601839               Apr   26,   2015
                5834010               Apr   26,   2015
                6743441               Apr   26,   2020      DP     U-318
                7081249               Apr   26,   2020      DP     U-318
                7081250               Apr   26,   2020      DP     U-318
                7081251               Apr   26,   2020      DP     U-318
                7081252               Apr   26,   2020      DP     U-318
                7179483               Apr   26,   2020   DS DP     U-318
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 160 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                           PATENT                             PATENT                          EXCLUSIVITY
	
     NO          PATENT NO         EXPIRATION          PATENT           DELIST         EXCLUSIVITY       EXPIRATION
	
                                      DATE              CODES          REQUESTED         CODE(S)            DATE
	
OXYBUTYNIN - OXYTROL FOR WOMEN
	
 N 202211 001   5601839            Apr   26,   2015    DP   U-1329                       NP            Jan 25, 2016
	
                5834010            Apr   26,   2015    DP   U-1329
	
                6743441            Apr   26,   2020    DP   U-1329
	
                7081249            Apr   26,   2020    DP   U-1329
	
                7081250            Apr   26,   2020    DP   U-1329
	
                7081251            Apr   26,   2020    DP   U-1329
	
                7081252            Apr   26,   2020    DP   U-1329
	
                7179483            Apr   26,   2020         U-1329
	
OXYBUTYNIN - GELNIQUE 3%
	
 N 202513 001   7029694            Apr   26,   2020    DP U-318                          NP            Dec 07, 2014
	
                7179483            Apr   26,   2020         U-318
	
                7198801            Jun   25,   2022    DP
	
                8241662            Apr   26,   2020         U-318
	
OXYBUTYNIN CHLORIDE - DITROPAN XL
	
 N 020897 001   5674895          May     22,   2015

                5840754          May     22,   2015

                5912268          May     22,   2015

                6262115          May     22,   2015         U-393
	
OXYBUTYNIN CHLORIDE - DITROPAN XL
	
 N 020897 002   5674895          May     22,   2015

                5840754          May     22,   2015

                5912268          May     22,   2015

                6262115          May     22,   2015         U-393
	
OXYBUTYNIN CHLORIDE - DITROPAN XL
	
 N 020897 003   5674895          May     22,   2015

                5840754          May     22,   2015

                5912268          May     22,   2015

                6262115          May     22,   2015         U-393
	
OXYBUTYNIN CHLORIDE - GELNIQUE
	
 N 022204 001   7029694            Apr 26, 2020        DP U-318
	
                7179483            Apr 26, 2020           U-318
	
                8241662            Apr 26, 2020           U-318
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 161 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION              PATENT       DELIST          EXCLUSIVITY       EXPIRATION
	
                                    DATE                  CODES      REQUESTED          CODE(S)            DATE
	
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272 001   6488963          Jun   24,   2017        DP
                7674799          Mar   30,   2025        DP
                7674800          Mar   30,   2025   DS
                7683072          Mar   30,   2025   DS
                7776314          Apr   19,   2025        DP                Y
                8114383          Oct   10,   2024        DP
                8309060          Nov   20,   2023        DP U-1556
                8337888          Aug   06,   2022        DP
                8808741          Aug   24,   2027           U-1556
                8894987          Mar   29,   2030        DP
                8894988          Aug   24,   2027        DP
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272 002   6488963          Jun   24,   2017        DP
                7674799          Mar   30,   2025        DP
                7674800          Mar   30,   2025   DS
                7683072          Mar   30,   2025   DS
                7776314          Apr   19,   2025        DP                Y
                8114383          Oct   10,   2024        DP
                8309060          Nov   20,   2023        DP U-1556
                8337888          Aug   06,   2022        DP
                8808741          Aug   24,   2027           U-1556
                8894987          Mar   29,   2030        DP
                8894988          Aug   24,   2027        DP
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272 003   6488963          Jun   24,   2017        DP
                7674799          Mar   30,   2025        DP
                7674800          Mar   30,   2025   DS
                7683072          Mar   30,   2025   DS
                7776314          Apr   19,   2025        DP                Y
                8114383          Oct   10,   2024        DP
                8309060          Nov   20,   2023        DP U-1556
                8337888          Aug   06,   2022        DP
                8808741          Aug   24,   2027           U-1556
                8894987          Mar   29,   2030        DP
                8894988          Aug   24,   2027        DP
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272 004   6488963          Jun   24,   2017        DP
                7674799          Mar   30,   2025        DP
                7674800          Mar   30,   2025   DS
                7683072          Mar   30,   2025   DS
                7776314          Apr   19,   2025        DP                Y
                8114383          Oct   10,   2024        DP
                8309060          Nov   20,   2023        DP U-1556
                8337888          Aug   06,   2022        DP
                8808741          Aug   24,   2027           U-1556
                8894987          Mar   29,   2030        DP
                8894988          Aug   24,   2027        DP
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272 005   6488963          Jun   24,   2017        DP
                7674799          Mar   30,   2025        DP
                7674800          Mar   30,   2025   DS
                7683072          Mar   30,   2025   DS
                7776314          Apr   19,   2025        DP                Y
                8114383          Oct   10,   2024        DP
                8309060          Nov   20,   2023        DP U-1556
                8337888          Aug   06,   2022        DP
                8808741          Aug   24,   2027           U-1556
                8894988          Aug   24,   2027        DP
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 162 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                          PATENT                                  PATENT                           EXCLUSIVITY
     NO            PATENT NO     EXPIRATION                   PATENT        DELIST          EXCLUSIVITY       EXPIRATION
                                     DATE                      CODES      REQUESTED           CODE(S)            DATE
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272    006   6488963            Jun   24,   2017        DP
                   7674799            Mar   30,   2025        DP
                   7674800            Mar   30,   2025   DS
                   7683072            Mar   30,   2025   DS
                   7776314            Apr   19,   2025        DP                 Y
                   8114383            Oct   10,   2024        DP
                   8309060            Nov   20,   2023        DP U-1556
                   8337888            Aug   06,   2022        DP
                   8808741            Aug   24,   2027           U-1556
                   8894988            Aug   24,   2027        DP
OXYCODONE HYDROCHLORIDE - OXYCONTIN
 N 022272 007   6488963          Jun        24,   2017        DP
                7674799          Mar        30,   2025        DP
                7674800          Mar        30,   2025   DS
                7683072          Mar        30,   2025   DS
                7776314          Apr        19,   2025        DP                 Y
                8114383          Oct        10,   2024        DP
                8309060          Nov        20,   2023        DP U-1556
                8337888          Aug        06,   2022        DP
                8808741          Aug        24,   2027           U-1556
                8894988          Aug        24,   2027        DP
OXYCODONE HYDROCHLORIDE - OXECTA
 N 202080 001   7201920          Mar 16, 2025                 DP
                7510726          Nov 26, 2023                 DP
                7981439          Nov 26, 2023                 DP
                8409616          Nov 26, 2023                 DP
                8637540          Nov 26, 2023                 DP
OXYCODONE HYDROCHLORIDE - OXECTA
 N 202080 002   7201920          Mar 16, 2025                 DP
                7510726          Nov 26, 2023                 DP
                7981439          Nov 26, 2023                 DP
                8409616          Nov 26, 2023                 DP
                8637540          Nov 26, 2023                 DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 163 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                                    PATENT                      EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT                 DELIST     EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES                REQUESTED     CODE(S)            DATE
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 001   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 002   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 003   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 004   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 005   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 006   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 021610 007   7276250          Feb 04, 2023             DP U-826
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 201655 001   7851482          Jul 10,   2029    DS
	
                8075872          Nov 20,   2023           DP
	
                8114383          Aug 08,   2024           DP
	
                8192722          Sep 15,   2025           DP
	
                8309060          Nov 20,   2023           DP
	
                8309122          Feb 04,   2023           DP
	
                8329216          Feb 04,   2023           DP
	
                8808737          Jun 21,   2027                  U-1598
	
                8871779          Nov 22,   2029    DS
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 201655 002   7851482          Jul 10,   2029    DS
	
                8075872          Nov 20,   2023           DP
	
                8114383          Aug 08,   2024           DP
	
                8192722          Sep 15,   2025           DP
	
                8309060          Nov 20,   2023           DP
	
                8309122          Feb 04,   2023           DP
	
                8329216          Feb 04,   2023           DP
	
                8808737          Jun 21,   2027                  U-1598
	
                8871779          Nov 22,   2029    DS
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 201655 003   7851482          Jul 10,   2029    DS
	
                8075872          Nov 20,   2023           DP
	
                8114383          Aug 08,   2024           DP
	
                8192722          Sep 15,   2025           DP
	
                8309060          Nov 20,   2023           DP
	
                8309122          Feb 04,   2023           DP
	
                8329216          Feb 04,   2023           DP
	
                8808737          Jun 21,   2027                  U-1598
	
                8871779          Nov 22,   2029    DS
	
OXYMORPHONE HYDROCHLORIDE - OPANA ER
	
 N 201655 004   7851482          Jul 10,   2029    DS
	
                8075872          Nov 20,   2023           DP
	
                8114383          Aug 08,   2024           DP
	
                8192722          Sep 15,   2025           DP
	
                8309060          Nov 20,   2023           DP
	
                8309122          Feb 04,   2023           DP
	
                8329216          Feb 04,   2023           DP
	
                8808737          Jun 21,   2027                  U-1598
	
                8871779          Nov 22,   2029    DS
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 164 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                         PATENT                                     PATENT                         EXCLUSIVITY
     NO            PATENT NO     EXPIRATION                   PATENT          DELIST        EXCLUSIVITY       EXPIRATION
                                     DATE                      CODES        REQUESTED         CODE(S)            DATE
OXYMORPHONE HYDROCHLORIDE - OPANA ER
 N 201655    005   7851482            Jul   10,   2029   DS
                   8075872            Nov   20,   2023        DP
                   8114383            Aug   08,   2024        DP
                   8192722            Sep   15,   2025        DP
                   8309060            Nov   20,   2023        DP
                   8309122            Feb   04,   2023        DP
                   8329216            Feb   04,   2023        DP
                   8808737            Jun   21,   2027             U-1598
                   8871779            Nov   22,   2029   DS
OXYMORPHONE HYDROCHLORIDE - OPANA ER
 N 201655 006   7851482          Jul        10,   2029   DS
                8075872          Nov        20,   2023        DP
                8114383          Aug        08,   2024        DP
                8192722          Sep        15,   2025        DP
                8309060          Nov        20,   2023        DP
                8309122          Feb        04,   2023        DP
                8329216          Feb        04,   2023        DP
                8808737          Jun        21,   2027             U-1598
                8871779          Nov        22,   2029   DS
OXYMORPHONE HYDROCHLORIDE - OPANA ER
 N 201655 007   7851482          Jul        10,   2029   DS
                8075872          Nov        20,   2023        DP
                8114383          Aug        08,   2024        DP
                8192722          Sep        15,   2025        DP
                8309060          Nov        20,   2023        DP
                8309122          Feb        04,   2023        DP
                8329216          Feb        04,   2023        DP
                8808737          Jun        21,   2027             U-1598
                8871779          Nov        22,   2029   DS
PACLITAXEL - ABRAXANE
 N 021660 001   7758891               Feb   21,   2026           U-1434                       I-658         Oct 11, 2015
                7820788               Mar   03,   2024        DP U-1092                       I-676         Sep 06, 2016
                7820788               Mar   03,   2024        DP U-1290                       ODE           Sep 06, 2020
                7820788               Mar   03,   2024        DP U-1434
                7923536               Dec   09,   2023           U-1117
                7923536               Dec   09,   2023           U-1290
                7923536               Dec   09,   2023           U-1434
                8034375               Aug   13,   2026           U-1290
                8138229               Dec   09,   2023        DP U-1092
                8138229               Dec   09,   2023        DP U-1290
                8138229               Dec   09,   2023        DP U-1434
                8268348               Feb   21,   2026           U-1290
                8314156               Dec   09,   2023           U-1290
                8314156               Dec   09,   2023           U-1434
                8853260               Aug   14,   2020        DP
                RE41884               Aug   14,   2016           U-1117
                RE41884               Aug   14,   2016           U-1290
                RE41884               Aug   14,   2016           U-1434
PALIPERIDONE - INVEGA
 N 021999 001                                                                                 PED           Oct 06, 2014
PALIPERIDONE - INVEGA
 N 021999 002                                                                                 PED           Oct 06, 2014
PALIPERIDONE - INVEGA
 N 021999 003                                                                                 PED           Oct 06, 2014
PALIPERIDONE - INVEGA
 N 021999 004                                                                                 PED           Oct 06, 2014
PALIPERIDONE - INVEGA
 N 021999 006                                                                                 PED           Oct 06, 2014
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 165 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION             PATENT        DELIST          EXCLUSIVITY       EXPIRATION
	
                                    DATE                 CODES       REQUESTED          CODE(S)            DATE
	
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
 N 022264 001   6077843          May 12, 2017            DP U-543                       I-698         Nov 12, 2017
                6555544          Nov 10, 2018            DP U-543                       M-119         Aug 29, 2015
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
 N 022264 002   6077843          May 12, 2017            DP U-543                       I-698         Nov 12, 2017
                6555544          Nov 10, 2018            DP U-543                       M-119         Aug 29, 2015
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
 N 022264 003   6077843          May 12, 2017            DP U-543                       I-698         Nov 12, 2017
                6555544          Nov 10, 2018            DP U-543                       M-119         Aug 29, 2015
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
 N 022264 004   6077843          May 12, 2017            DP U-543                       I-698         Nov 12, 2017
                6555544          Nov 10, 2018            DP U-543                       M-119         Aug 29, 2015
PALIPERIDONE PALMITATE - INVEGA SUSTENNA
 N 022264 005   6077843          May 12, 2017            DP U-543                       I-698         Nov 12, 2017
                6555544          Nov 10, 2018            DP U-543                       M-119         Aug 29, 2015
PALONOSETRON HYDROCHLORIDE - ALOXI
 N 021372 001   5202333          Apr   13,   2015     DS DP U-528                       I-684         May   27,   2017
                5202333*PED      Oct   13,   2015                                       M-136         May   27,   2017
                7947724          Jan   30,   2024        DP                             PED           Nov   27,   2017
                7947724*PED      Jul   30,   2024                                       PED           Nov   27,   2017
                7947725          Jan   30,   2024        DP
                7947725*PED      Jul   30,   2024
                7960424          Jan   30,   2024        DP
                7960424*PED      Jul   30,   2024
                8518981          Jan   30,   2024        DP
                8518981*PED      Jul   30,   2024
                8598218          Jan   30,   2024        DP
                8598218*PED      Jul   30,   2024
                8598219          Jan   30,   2024        DP
                8598219*PED      Jul   30,   2024
                8729094          Jan   30,   2024        DP U-528
                8729094*PED      Jul   30,   2024
PALONOSETRON HYDROCHLORIDE - ALOXI
 N 021372 002   5202333          Apr   13,   2015     DS DP U-901                       I-684         May   27,   2017
                5202333*PED      Oct   13,   2015                                       M-136         May   27,   2017
                7947724          Jan   30,   2024        DP                             PED           Nov   27,   2017
                7947724*PED      Jul   30,   2024                                       PED           Nov   27,   2017
                7947725          Jan   30,   2024        DP
                7947725*PED      Jul   30,   2024
                7960424          Jan   30,   2024        DP
                7960424*PED      Jul   30,   2024
                8518981          Jan   30,   2024        DP
                8518981*PED      Jul   30,   2024
                8598218          Jan   30,   2024        DP
                8598218*PED      Jul   30,   2024
                8598219          Jan   30,   2024        DP
                8598219*PED      Jul   30,   2024
PALONOSETRON HYDROCHLORIDE - ALOXI
 N 022233 001   5202333          Apr 13, 2015         DS DP U-528
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PERTZYE
 N 022175 001                                                                           NCE           May 17, 2017
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PERTZYE
 N 022175 002                                                                           NCE           May 17, 2017
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) -     ZENPEP
 N 022210 007   8221747          Feb 20,     2028        DP
                8562978          Feb 20,     2028        DP
                8562979          Feb 20,     2028        DP U-1274
                8562980          Feb 20,     2028        DP U-1274
                8562981          Feb 20,     2028           U-1274
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 166 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE
	
 N 022523 001                                                                            NCE           Apr 12, 2015
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE
	
 N 022523 002                                                                            NCE           Apr 12, 2015
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE
	
 N 022523 003                                                                            NCE           Apr 12, 2015
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE
	
 N 022523 004                                                                            NCE           Apr 12, 2015
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - CREON

 N 020725 004                                                                    M-93         Jul 29, 2019
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - CREON

 N 020725 005                                                                    M-93         Jul 29, 2019
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ZENPEP

 N 022210 001   7658918          Feb 20, 2028       DP                           NCE          Aug 27, 2014

                8221747          Feb 20, 2028       DP
	
                8246950          Feb 20, 2028            U-1274
	
                8562978          Feb 20, 2028       DP
	
                8562979          Feb 20, 2028       DP U-1274
	
                8562980          Feb 20, 2028       DP U-1274
	
                8562981          Feb 20, 2028            U-1274
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ZENPEP

 N 022210 002   7658918          Feb 20, 2028       DP                           NCE          Aug 27, 2014

                8221747          Feb 20, 2028       DP
	
                8246950          Feb 20, 2028            U-1274
	
                8562978          Feb 20, 2028       DP
	
                8562979          Feb 20, 2028       DP U-1274
	
                8562980          Feb 20, 2028       DP U-1274
	
                8562981          Feb 20, 2028            U-1274
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ZENPEP

 N 022210 003   7658918          Feb 20, 2028       DP                           NCE          Aug 27, 2014

                8221747          Feb 20, 2028       DP
	
                8246950          Feb 20, 2028            U-1274
	
                8562978          Feb 20, 2028       DP
	
                8562979          Feb 20, 2028       DP U-1274
	
                8562980          Feb 20, 2028       DP U-1274
	
                8562981          Feb 20, 2028
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ZENPEP

 N 022210 004   7658918          Feb 20, 2028       DP                           NCE          Aug 27, 2014

                8221747          Feb 20, 2028       DP
	
                8246950          Feb 20, 2028            U-1274
	
                8562978          Feb 20, 2028       DP
	
                8562979          Feb 20, 2028       DP U-1274
	
                8562980          Feb 20, 2028       DP U-1274
	
                8562981          Feb 20, 2028            U-1274
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ZENPEP

 N 022210 005   8221747          Feb 20, 2028       DP                           NCE          Aug 27, 2014

                8562978          Feb 20, 2028       DP
	
                8562979          Feb 20, 2028       DP U-1274
	
                8562980          Feb 20, 2028       DP U-1274
	
                8562981          Feb 20, 2028            U-1274
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ZENPEP

 N 022210 006   8221747          Feb 20, 2028       DP                           NCE          Aug 27, 2014

                8562978          Feb 20, 2028       DP
	
                8562979          Feb 20, 2028       DP U-1274
	
                8562980          Feb 20, 2028       DP U-1274
	
                8562981          Feb 20, 2028            U-1274
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                        ADA 167 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                     PATENT                       EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION     PATENT        DELIST      EXCLUSIVITY       EXPIRATION
	
                                        DATE         CODES       REQUESTED      CODE(S)            DATE
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ULTRESA

 N 022222 001                                                                    NCE          Mar 01, 2017
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ULTRESA

 N 022222 002                                                                    NCE          Mar 01, 2017
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - ULTRESA

 N 022222 003                                                                    NCE          Mar 01, 2017
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - VIOKACE

 N 022542 001                                                                    NCE          Mar 01, 2017
	
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE (AMYLASE;LIPASE;PROTEASE); PANCRELIPASE

(AMYLASE;LIPASE;PROTEASE) - VIOKACE

 N 022542 002                                                                    NCE          Mar 01, 2017
	
PANTOPRAZOLE SODIUM - PROTONIX
	
 N 020987 001   5997903             Dec 07, 2016
	
PANTOPRAZOLE SODIUM - PROTONIX
	
 N 020987 002   5997903             Dec 07, 2016
	
PANTOPRAZOLE SODIUM - PROTONIX IV
	
 N 020988 001   6780881          Nov      17,   2021      DP
	
                7351723          Nov      17,   2021      DP
	
                8754108          Nov      17,   2021      DP
	
                8754108*PED      May      17,   2022
	
PANTOPRAZOLE SODIUM - PROTONIX
	
 N 022020 001   7544370             Jun   07,   2026      DP
	
                7550153             Sep   30,   2024         U-859
	
                7553498             Sep   30,   2024         U-859
	
                7838027             Sep   30,   2024      DP U-859
	
PARICALCITOL - ZEMPLAR
	
 N 020819 001   5597815             Jul 13, 2015                 U-1195
	
                6136799             Apr 08, 2018

                6361758             Apr 08, 2018          DP
	
PARICALCITOL - ZEMPLAR
	
 N 020819 002   5597815             Jul 13, 2015                 U-1195
	
                6136799             Apr 08, 2018

                6361758             Apr 08, 2018          DP
	
PARICALCITOL - ZEMPLAR
	
 N 020819 003   5597815             Jul   13,   2015             U-1195
	
                5597815*PED         Jan   13,   2016
	
                6136799             Apr   08,   2018

                6136799*PED         Oct   08,   2018
	
                6361758             Apr   08,   2018      DP
	
                6361758*PED         Oct   08,   2018
	
PARICALCITOL - ZEMPLAR
	
 N 021606 001   5597815             Jul 13, 2015                 U-1195
	
PARICALCITOL - ZEMPLAR
	
 N 021606 002   5597815             Jul 13, 2015                 U-1195
	
PARICALCITOL - ZEMPLAR
	
 N 021606 003   5597815             Jul 13, 2015                 U-1195
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 168 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020031 001   5872132           May   19,   2015

                5900423           May   19,   2015

                6113944           Dec   14,   2014
	
                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020031 002   5872132           May   19,   2015

                5900423           May   19,   2015

                6113944           Dec   14,   2014
	
                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020031 003   5872132           May   19,   2015

                5900423           May   19,   2015

                6113944           Dec   14,   2014
	
                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020031 004   5872132           May   19,   2015

                5900423           May   19,   2015

                6113944           Dec   14,   2014
	
                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020031 005   5872132           May   19,   2015

                5900423           May   19,   2015

                6113944           Dec   14,   2014
	
                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020710 001   5811436           Sep   22,   2015

                5872132           May   19,   2015

                5900423           May   19,   2015

                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020885 001   5872132           May   19,   2015

                5900423           May   19,   2015

                6063927           Apr   23,   2019

                6080759           May   19,   2015

                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
                6172233           Jan   15,   2018
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020885 002   5872132           May   19,   2015

                5900423           May   19,   2015

                6063927           Apr   23,   2019

                6080759           May   19,   2015

                6121291           Mar   17,   2017         U-286
	
                6121291           Mar   17,   2017         U-431
	
                6133289           May   19,   2015         U-358
	
                6172233           Jan   15,   2018
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 169 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                                  PATENT                      EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION              PATENT            DELIST     EXCLUSIVITY       EXPIRATION
	
                                     DATE                  CODES           REQUESTED     CODE(S)            DATE
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020885 003		 5872132           May   19,   2015

                5900423           May   19,   2015

                6063927           Apr   23,   2019

                6080759           May   19,   2015

                6121291           Mar   17,   2017               U-286
	
                6121291           Mar   17,   2017               U-431
	
                6133289           May   19,   2015               U-358
	
                6172233           Jan   15,   2018
	
PAROXETINE HYDROCHLORIDE - PAXIL
	
 N 020885 004		 5872132           May   19,   2015

                5900423           May   19,   2015

                6063927           Apr   23,   2019

                6080759           May   19,   2015

                6121291           Mar   17,   2017               U-286
	
                6121291           Mar   17,   2017               U-431
	
                6133289           May   19,   2015               U-358
	
                6172233           Jan   15,   2018
	
PAROXETINE HYDROCHLORIDE - PAXIL CR
	
 N 020936 001		 5872132          May 19, 2015

                5900423          May 19, 2015

                6121291          Mar 17, 2017                    U-286
	
                6133289          May 19, 2015                    U-286
	
                6548084          Jul 19, 2016
	
                7229640          Jul 19, 2016             DP U-816
	
PAROXETINE HYDROCHLORIDE - PAXIL CR
	
 N 020936 002		 5872132          May 19, 2015

                5900423          May 19, 2015

                6121291          Mar 17, 2017                    U-286
	
                6133289          May 19, 2015                    U-286
	
                6548084          Jul 19, 2016
	
                7229640          Jul 19, 2016             DP U-816
	
PAROXETINE HYDROCHLORIDE - PAXIL CR
	
 N 020936 003		 5872132          May 19, 2015

                5900423          May 19, 2015

                6121291          Mar 17, 2017                    U-286
	
                6133289          May 19, 2015                    U-286
	
                6548084          Jul 19, 2016
	
                7229640          Jul 19, 2016             DP U-816
	
PAROXETINE MESYLATE - PEXEVA
	
 N 021299 001		 5874447          Jun    10,   2017               U-46
	
                5874447          Jun    10,   2017               U-286
	
                5874447          Jun    10,   2017               U-518
	
                7598271          Feb    12,   2023     DS DP
	
PAROXETINE MESYLATE - PEXEVA
	
 N 021299 002		 5874447          Jun    10,   2017               U-46
	
                5874447          Jun    10,   2017               U-286
	
                5874447          Jun    10,   2017               U-518
	
                7598271          Feb    12,   2023     DS DP
	
PAROXETINE MESYLATE - PEXEVA
	
 N 021299 003		 5874447          Jun    10,   2017               U-46
	
                5874447          Jun    10,   2017               U-286
	
                5874447          Jun    10,   2017               U-518
	
                7598271          Feb    12,   2023     DS DP
	
PAROXETINE MESYLATE - PEXEVA
	
 N 021299 004		 5874447          Jun    10,   2017               U-46
	
                5874447          Jun    10,   2017               U-286
	
                5874447          Jun    10,   2017               U-518
	
                7598271          Feb    12,   2023     DS DP
	
PAROXETINE MESYLATE - BRISDELLE
	
 N 204516 001		 5874447           Jun 10, 2017         DS                                NP            Jun 28, 2016
	
                7598271           Feb 12, 2023         DS
	
                8658663           Apr 06, 2029         DS DP U-904
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 170 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT
	                            PATENT                          EXCLUSIVITY
     NO          PATENT NO        EXPIRATION
	             PATENT       DELIST         EXCLUSIVITY      EXPIRATION
                                     DATE
	                 CODES     REQUESTED          CODE(S)            DATE
PASIREOTIDE DIASPARTATE - SIGNIFOR
	
 N 200677 001		 6225284          Jun 28, 2016
	       DS DP                              NCE           Dec 14, 2017
                7473761          Jul 29, 2025
	       DS DP                              ODE           Dec 14, 2019
                8299209          Dec 27, 2025
	       DS DP
PASIREOTIDE DIASPARTATE - SIGNIFOR
	
 N 200677 002		 6225284          Jun 28, 2016
	       DS DP                              NCE           Dec 14, 2017
                7473761          Jul 29, 2025
	       DS DP                              ODE           Dec 14, 2019
                8299209          Dec 27, 2025
	       DS DP
PASIREOTIDE DIASPARTATE - SIGNIFOR
	
 N 200677 003		 6225284          Jun 28, 2016
	       DS DP                              NCE           Dec 14, 2017
                7473761          Jul 29, 2025
	       DS DP                              ODE           Dec 14, 2019
                8299209          Dec 27, 2025
	       DS DP
PASIREOTIDE PAMOATE - SIGNIFOR LAR
	
 N 203255 001		 6225284          Jun   28,   2016
	   DS DP U-1628                       NCE           Dec 14, 2017
                7473761          Jul   29,   2025
	   DS DP                              NP            Dec 15, 2017
                7759308          Oct   25,   2026
	      DP                              ODE           Dec 15, 2021
                8822637          Aug   06,   2023
	         U-1629
PASIREOTIDE PAMOATE - SIGNIFOR LAR
	
 N 203255 002		 6225284          Jun   28,   2016
	   DS DP U-1628                       NCE           Dec 14, 2017
                7473761          Jul   29,   2025
	   DS DP                              NP            Dec 15, 2017
                7759308          Oct   25,   2026
	      DP                              ODE           Dec 15, 2021
                8822637          Aug   06,   2023
	         U-1629
PASIREOTIDE PAMOATE - SIGNIFOR LAR
	
 N 203255 003		 6225284          Jun   28,   2016
	   DS DP U-1628                       NCE           Dec 14, 2017
                7473761          Jul   29,   2025
	   DS DP                              NP            Dec 15, 2017
                7759308          Oct   25,   2026
	      DP                              ODE           Dec 15, 2021
                8822637          Aug   06,   2023
	         U-1629
PAZOPANIB HYDROCHLORIDE - VOTRIENT
	
 N 022465 001		 7105530          Oct 19, 2023
	       DS DP                              I-649         Apr 26, 2015
                7262203          Dec 19, 2021
	       DS DP                              NCE           Oct 19, 2014
                8114885          Dec 19, 2021
	       DS DP                              ODE           Apr 26, 2019
PAZOPANIB HYDROCHLORIDE - VOTRIENT
	
 N 022465 002		 7105530          Oct 19, 2023
	       DS DP                              I-649         Apr 26, 2015
                7262203          Dec 19, 2021
	       DS DP                              NCE           Oct 19, 2014
                8114885          Dec 19, 2021
	       DS DP                              ODE           Apr 26, 2019
PEGAPTANIB SODIUM - MACUGEN
	
 N 021756 001		 5932462          Aug 03, 2016
        DS
                6011020          Jan 04, 2017
	       DS
                6051698          May 19, 2015
	       DS      U-622
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 171 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO         PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
	
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE
 N 202799 001   7084245          May 12, 2024       DS DP U-1238                        NCE           Mar 27, 2017
                7414105          May 12, 2024       DS DP U-1238
                7528104          May 12, 2024       DS DP
                7550433          Jun 02, 2026             U-1238
                7919118          May 12, 2024       DS DP
                7919461          Jun 02, 2026             U-1238
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE
 N 202799 002   7084245          May 12, 2024       DS DP U-1238                        NCE           Mar 27, 2017
                7414105          May 12, 2024       DS DP U-1238
                7528104          May 12, 2024       DS DP
                7550433          Jun 02, 2026             U-1238
                7919118          May 12, 2024       DS DP
                7919461          Jun 02, 2026             U-1238
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE
 N 202799 003   7084245          May 12, 2024       DS DP U-1238                        NCE           Mar 27, 2017
                7414105          May 12, 2024       DS DP U-1238
                7528104          May 12, 2024       DS DP
                7550433          Jun 02, 2026             U-1238
                7919118          May 12, 2024       DS DP
                7919461          Jun 02, 2026             U-1238
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE
 N 202799 004   7084245          May 12, 2024       DS DP U-1238                        NCE           Mar 27, 2017
                7414105          May 12, 2024       DS DP U-1238
                7528104          May 12, 2024       DS DP
                7550433          Jun 02, 2026             U-1238
                7919118          May 12, 2024       DS DP
                7919461          Jun 02, 2026             U-1238
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE
 N 202799 005   7084245          May 12, 2024       DS DP U-1238                        NCE           Mar 27, 2017
                7414105          May 12, 2024       DS DP U-1238
                7528104          May 12, 2024       DS DP
                7550433          Jun 02, 2026             U-1238
                7919118          May 12, 2024       DS DP
                7919461          Jun 02, 2026             U-1238
PEGINESATIDE ACETATE - OMONTYS PRESERVATIVE FREE
 N 202799 006   7084245          May 12, 2024       DS DP U-1238                        NCE           Mar 27, 2017
                7414105          May 12, 2024       DS DP U-1238
                7528104          May 12, 2024       DS DP
                7550433          Jun 02, 2026             U-1238
                7919118          May 12, 2024       DS DP
                7919461          Jun 02, 2026             U-1238
PEGINESATIDE ACETATE - OMONTYS
 N 202799 007   7084245          May   12,   2024   DS DP U-1238
                7414105          May   12,   2024   DS DP U-1238
                7528104          May   12,   2024   DS DP
                7550433          Jun   02,   2026         U-1238
                7919118          May   12,   2024   DS DP
                7919461          Jun   02,   2026         U-1238
PEGINESATIDE ACETATE - OMONTYS
 N 202799 008   7084245          May   12,   2024   DS DP U-1238
                7414105          May   12,   2024   DS DP U-1238
                7528104          May   12,   2024   DS DP
                7550433          Jun   02,   2026         U-1238
                7919118          May   12,   2024   DS DP
                7919461          Jun   02,   2026         U-1238
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 172 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                 PATENT                       EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT              DELIST      EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES             REQUESTED      CODE(S)            DATE
	
PEGVISOMANT - SOMAVERT
	
 N 021106 001   5849535             Mar 25, 2017       DS
	
                6057292             Sep 21, 2015                  U-507
	
PEGVISOMANT - SOMAVERT
	
 N 021106 002   5849535             Mar 25, 2017       DS
	
                6057292             Sep 21, 2015                  U-507
	
PEGVISOMANT - SOMAVERT
	
 N 021106 003   5849535             Mar 25, 2017       DS
	
                6057292             Sep 21, 2015                  U-507
	
PEGVISOMANT - SOMAVERT
	
 N 021106 004   5849535             Mar 25, 2017       DS
	
                6057292             Sep 21, 2015                  U-507
	
PEGVISOMANT - SOMAVERT
	
 N 021106 005   5849535             Mar 25, 2017       DS
	
                6057292             Sep 21, 2015                  U-507
	
PEMETREXED DISODIUM - ALIMTA
	
 N 021462 001   5344932             Jul 24, 2016       DS DP                                M-122         Oct 17, 2015
	
                7772209             Nov 24, 2021                  U-1077                    PED           Sep 17, 2014

                7772209             Nov 24, 2021                  U-1296
	
PEMETREXED DISODIUM - ALIMTA
	
 N 021462 002   5344932             Jul 24, 2016       DS DP                                M-122         Oct 17, 2015
	
                7772209             Nov 24, 2021                  U-1296                    PED           Sep 17, 2014
	
PENCICLOVIR SODIUM - DENAVIR
	
 N 020629 001   5840763             Sep   01,   2015              U-501
	
                5866581             Oct   04,   2014              U-501
	
                5916893             Sep   01,   2015              U-501
	
                6124304             Oct   04,   2014              U-501
	
                6469015             Oct   22,   2019              U-501
	
                6579981             Jun   17,   2020              U-501
	
PERAMIVIR - RAPIVAB
	
 N 206426 001   6503745             Nov 05, 2019       DS                                   NCE           Dec 19, 2019
	
                6562861             Dec 17, 2018       DS
	
                8778997             May 07, 2027                  U-1627
	
PERAMPANEL - FYCOMPA
	
 N 202834 001   6949571             Jun 08, 2021       DS DP U-106                          NCE           Oct 22, 2017
	
                8772497             May 16, 2026       DS
	
PERAMPANEL - FYCOMPA
	
 N 202834 002   6949571             Jun 08, 2021       DS DP U-106                          NCE           Oct 22, 2017
	
                8772497             May 16, 2026       DS
	
PERAMPANEL - FYCOMPA
	
 N 202834 003   6949571             Jun 08, 2021       DS DP U-106                          NCE           Oct 22, 2017
	
                8772497             May 16, 2026       DS
	
PERAMPANEL - FYCOMPA
	
 N 202834 004   6949571             Jun 08, 2021       DS DP U-106                          NCE           Oct 22, 2017
	
                8772497             May 16, 2026       DS
	
PERAMPANEL - FYCOMPA
	
 N 202834 005   6949571             Jun 08, 2021       DS DP U-106                          NCE           Oct 22, 2017
	
                8772497             May 16, 2026       DS
	
PERAMPANEL - FYCOMPA
	
 N 202834 006   6949571             Jun 08, 2021       DS DP U-106                          NCE           Oct 22, 2017
	
                8772497             May 16, 2026       DS
	
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE - SKIN EXPOSURE REDUCTION PASTE AGAINST

CHEMICAL WARFARE AGENTS
	
 N 021084 001   5607979          May 30, 2015
	
PERFLUTREN - DEFINITY
	
 N 021064 001   5527521             Feb   22,   2015          DP U-665
	
                6033645             Jun   19,   2016               U-665
	
                8658205             Apr   20,   2019          DP
	
                8685441             Jan   13,   2019               U-665
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 173 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
PHENTERMINE HYDROCHLORIDE - SUPRENZA
 N 202088 001   6149938          Jul 23, 2018            DP
                8440170          Mar 14, 2029            DP
PHENTERMINE HYDROCHLORIDE - SUPRENZA
 N 202088 002   6149938          Jul 23, 2018            DP
                8440170          Mar 14, 2029            DP
PHENTERMINE HYDROCHLORIDE - SUPRENZA
 N 202088 003   6149938          Jul 23, 2018            DP U-1243
                8440170          Mar 14, 2029            DP
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE - QSYMIA
 N 022580 001   6071537          Jun 23, 2017               U-1262                         NC            Jul 17, 2015
                7056890          Jun 14, 2020            DP U-1262
                7553818          Jun 14, 2020               U-1262
                7659256          Jun 14, 2020            DP U-1262
                7674776          Jun 14, 2020            DP U-1262
                8580298          May 15, 2029            DP
                8580299          Jun 14, 2029               U-1262
                8895057          Jun 09, 2028               U-1262
                8895058          Jun 09, 2028            DP
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE - QSYMIA
 N 022580 002   6071537          Jun 23, 2017               U-1262                         NC            Jul 17, 2015
                7056890          Jun 14, 2020            DP U-1262
                7553818          Jun 14, 2020               U-1262
                7659256          Jun 14, 2020            DP U-1262
                7674776          Jun 14, 2020            DP U-1262
                8580298          May 15, 2029            DP
                8580299          Jun 14, 2029               U-1262
                8895057          Jun 09, 2028               U-1262
                8895058          Jun 09, 2028            DP
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE - QSYMIA
 N 022580 003   6071537          Jun 23, 2017               U-1262                         NC            Jul 17, 2015
                7056890          Jun 14, 2020            DP U-1262
                7553818          Jun 14, 2020               U-1262
                7659256          Jun 14, 2020            DP U-1262
                7674776          Jun 14, 2020            DP U-1262
                8580298          May 15, 2029            DP
                8580299          Jun 14, 2029               U-1262
                8895057          Jun 09, 2028               U-1262
                8895058          Jun 09, 2028            DP
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE - QSYMIA
 N 022580 004   6071537          Jun 23, 2017               U-1262                         NC            Jul 17, 2015
                7056890          Jun 14, 2020            DP U-1262
                7553818          Jun 14, 2020               U-1262
                7659256          Jun 14, 2020            DP U-1262
                7674776          Jun 14, 2020            DP U-1262
                8580298          May 15, 2029            DP
                8580299          Jun 14, 2029               U-1262
                8895057          Jun 09, 2028               U-1262
                8895058          Jun 09, 2028            DP
PHENTOLAMINE MESYLATE - ORAVERSE
 N 022159 001   6764678          May 11, 2021                 U-967
                6872390          May 11, 2021            DP
                7229630          Jun 20, 2023            DP
                7569230          Oct 17, 2023                 U-967
                7575757          Apr 21, 2025            DP
PHENYLEPHRINE HYDROCHLORIDE - PHENYLEPHRINE HYDROCHLORIDE
 N 203510 001   8859623          Nov 14, 2033           U-1594
PHENYLEPHRINE HYDROCHLORIDE - PHENYLEPHRINE HYDROCHLORIDE
 N 203510 002   8859623          Nov 14, 2033           U-1594
PIMECROLIMUS - ELIDEL
 N 021302 001   5912238            Jun 15, 2016
                6352998            Oct 26, 2015
                6423722            Jun 26, 2018
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 174 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                    DATE                 CODES        REQUESTED         CODE(S)            DATE
	
PIOGLITAZONE HYDROCHLORIDE - ACTOS
	
 N 021073 001   5965584          Jun   19,   2016           U-753
	
                6150383          Jun   19,   2016           U-418
	
                6150384          Jun   19,   2016           U-419
	
                6166042          Jun   19,   2016           U-414
	
                6166043          Jun   19,   2016           U-415
	
                6172090          Jun   19,   2016           U-416
	
                6211205          Jun   19,   2016           U-410
	
                6271243          Jun   19,   2016           U-411
	
                6303640          Aug   09,   2016           U-425
	
                6329404          Jun   19,   2016           U-753
	
PIOGLITAZONE HYDROCHLORIDE - ACTOS
	
 N 021073 002   5965584          Jun   19,   2016           U-753
	
                6150383          Jun   19,   2016           U-418
	
                6150384          Jun   19,   2016           U-419
	
                6166042          Jun   19,   2016           U-414
	
                6166043          Jun   19,   2016           U-415
	
                6172090          Jun   19,   2016           U-416
	
                6211205          Jun   19,   2016           U-410
	
                6271243          Jun   19,   2016           U-411
	
                6303640          Aug   09,   2016           U-425
	
                6329404          Jun   19,   2016           U-753
	
PIOGLITAZONE HYDROCHLORIDE - ACTOS
	
 N 021073 003   5965584          Jun   19,   2016           U-753
	
                6150383          Jun   19,   2016           U-418
	
                6150384          Jun   19,   2016           U-419
	
                6166042          Jun   19,   2016           U-414
	
                6166043          Jun   19,   2016           U-415
	
                6172090          Jun   19,   2016           U-416
	
                6211205          Jun   19,   2016           U-410
	
                6271243          Jun   19,   2016           U-411
	
                6303640          Aug   09,   2016           U-425
	
                6329404          Jun   19,   2016           U-753
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN
	
 N 050684 001   6900184          Apr 14,     2023        DP U-282
	
                7915229          Apr 14,     2023        DP
	
                8133883          Apr 14,     2023        DP U-282
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN
	
 N 050684 002   6900184          Apr 14,     2023        DP U-282
	
                7915229          Apr 14,     2023        DP
	
                8133883          Apr 14,     2023        DP U-282
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN
	
 N 050684 003   6900184          Apr 14,     2023        DP U-282
	
                7915229          Apr 14,     2023        DP
	
                8133883          Apr 14,     2023        DP U-282
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN
	
 N 050684 004   6900184          Apr 14,     2023        DP U-282
	
                7915229          Apr 14,     2023        DP
	
                8133883          Apr 14,     2023        DP U-282
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN IN PLASTIC CONTAINER
	
 N 050750 001   6207661          Feb 22,     2019       DP
	
                6900184          Apr 14,     2023       DP U-282
	
                7915229          Apr 14,     2023       DP
	
                8133883          Apr 14,     2023       DP U-282
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN IN PLASTIC CONTAINER
	
 N 050750 002   6207661          Feb 22,     2019       DP
	
                6900184          Apr 14,     2023       DP U-282
	
                7915229          Apr 14,     2023       DP
	
                8133883          Apr 14,     2023       DP U-282
	
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM -     ZOSYN IN PLASTIC CONTAINER
	
 N 050750 003   6207661          Feb 22,     2019       DP
	
                6900184          Apr 14,     2023       DP U-282
	
                7915229          Apr 14,     2023       DP
	
                8133883          Apr 14,     2023       DP U-282
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 175 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
     NO         PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
                                       DATE              CODES         REQUESTED           CODE(S)            DATE
PIRFENIDONE - ESBRIET
 N 022535 001   7566729            Apr   22,   2029           U-1600                       NCE           Oct 16, 2019
                7635707            Apr   22,   2029           U-1609                       ODE           Oct 15, 2021
                7696326            Dec   18,   2027           U-1601
                7767225            Sep   22,   2026      DP   U-1602
                7767700            Dec   18,   2027           U-1601
                7816383            Jan   08,   2030           U-1603
                7910610            Jan   08,   2030           U-1604
                7988994            Sep   22,   2026      DP   U-1602
                8013002            Jan   08,   2030           U-1603
                8084475            Jan   08,   2030           U-1605
                8318780            Jan   08,   2030           U-1606
                8383150            Sep   22,   2026      DP   U-1607
                8420674            Dec   18,   2027      DP   U-1608
                8592462            Apr   22,   2029           U-1609
                8609701            Apr   22,   2029           U-1610
                8648098            Jan   08,   2030           U-1611
                8753679            Sep   22,   2026      DP   U-1602
                8754109            Jan   08,   2030           U-1612
                8778947            Aug   30,   2033           U-1613
PITAVASTATIN CALCIUM - LIVALO
 N 022363 001   5753675            May   19,   2015   DS DP U-998                          NCE           Aug 03, 2014
                5854259            Dec   29,   2015      DP
                5856336            Dec   25,   2020   DS    U-998
                6465477            Dec   20,   2016      DP
                7022713            Feb   19,   2024         U-998
                8557993            Feb   02,   2024      DP
PITAVASTATIN CALCIUM - LIVALO
 N 022363 002   5753675            May   19,   2015   DS DP U-998                          NCE           Aug 03, 2014
                5854259            Dec   29,   2015      DP
                5856336            Dec   25,   2020   DS    U-998
                6465477            Dec   20,   2016      DP
                7022713            Feb   19,   2024         U-998
                8557993            Feb   02,   2024      DP
PITAVASTATIN CALCIUM - LIVALO
 N 022363 003   5753675            May   19,   2015   DS DP U-998                          NCE           Aug 03, 2014
                5854259            Dec   29,   2015      DP
                5856336            Dec   25,   2020   DS    U-998
                6465477            Dec   20,   2016      DP
                7022713            Feb   19,   2024         U-998
                8557993            Feb   02,   2024   DS DP
PLERIXAFOR - MOZOBIL
 N 022311 001   6987102            Jul 22, 2023               U-936                        ODE           Dec 15, 2015
                7897590            Jul 22, 2023               U-936
                RE42152            Dec 10, 2018          DP
POLIDOCANOL - ASCLERA
 N 021201 001                                                                              NCE           Mar 30, 2015
POLIDOCANOL - ASCLERA
 N 021201 002                                                                              NCE           Mar 30, 2015
POLIDOCANOL - VARITHENA
 N 205098 001   6572873            May   26,   2020         U-1461
                6846412            Jul   19,   2022      DP
                6942165            May   26,   2020      DP
                7025290            May   26,   2020      DP U-1461
                7357336            May   26,   2020         U-1461
                7604185            May   26,   2020   DS DP U-1462
                7731986            Nov   17,   2024   DS DP U-1463
                7814943            Nov   19,   2027      DP U-1461
                7842282            May   26,   2020         U-1461
                7842283            May   26,   2020      DP
                8122917            Sep   09,   2024      DP
                8323677            May   26,   2020   DS
                8734833            May   26,   2020   DS DP
                RE38919            Oct   14,   2014   DS DP
                RE40640            Oct   14,   2015   DS DP U-1462
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 176 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT           DELIST         EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES          REQUESTED         CODE(S)            DATE
	
POMALIDOMIDE - POMALYST
	
 N 204026 001   5635517          Jul   24,   2016           U-1359                       NCE           Feb 08, 2018
	
                6045501          Aug   28,   2018           U-1361                       ODE           Feb 08, 2020
	
                6315720          Oct   23,   2020           U-1361
	
                6316471          Aug   10,   2016      DP U-1360
	
                6476052          Jul   24,   2016      DP U-1360
	
                6561976          Aug   28,   2018           U-1361
	
                6561977          Oct   23,   2020           U-1361
	
                6755784          Oct   23,   2020           U-1361
	
                6908432          Aug   28,   2018           U-1361
	
                8158653          Aug   10,   2016      DP
	
                8198262          Oct   19,   2024           U-1360
	
                8204763          Aug   28,   2018           U-1361
	
                8315886          Oct   23,   2020           U-1361
	
                8589188          Aug   28,   2018           U-1361
	
                8626531          Oct   23,   2020           U-1361
	
                8673939          May   15,   2023           U-1360
	
                8735428          May   15,   2023           U-1360
	
                8828427          Jun   21,   2031   DS DP
	
POMALIDOMIDE - POMALYST
	
 N 204026 002   5635517          Jul   24,   2016           U-1359                       NCE           Feb 08, 2018
	
                6045501          Aug   28,   2018           U-1361                       ODE           Feb 08, 2020
	
                6315720          Oct   23,   2020           U-1361
	
                6316471          Aug   10,   2016      DP U-1360
	
                6476052          Jul   24,   2016      DP U-1360
	
                6561976          Aug   28,   2018           U-1361
	
                6561977          Oct   23,   2020           U-1361
	
                6755784          Oct   23,   2020           U-1361
	
                6908432          Aug   28,   2018           U-1361
	
                8158653          Aug   10,   2016      DP
	
                8198262          Oct   19,   2024           U-1360
	
                8204763          Aug   28,   2018           U-1361
	
                8315886          Oct   23,   2020           U-1361
	
                8589188          Aug   28,   2018           U-1361
	
                8626531          Oct   23,   2020           U-1361
	
                8673939          May   15,   2023           U-1360
	
                8735428          May   15,   2023           U-1360
	
                8828427          Jun   21,   2031   DS DP
	
POMALIDOMIDE - POMALYST
	
 N 204026 003   5635517          Jul   24,   2016           U-1359                       NCE           Feb 08, 2018
	
                6045501          Aug   28,   2018           U-1361                       ODE           Feb 08, 2020
	
                6315720          Oct   23,   2020           U-1361
	
                6316471          Aug   10,   2016      DP U-1360
	
                6476052          Jul   24,   2016      DP U-1360
	
                6561976          Aug   28,   2018           U-1361
	
                6561977          Oct   23,   2020           U-1361
	
                6755784          Oct   23,   2020           U-1361
	
                6908432          Aug   28,   2018           U-1361
	
                8158653          Aug   10,   2016      DP
	
                8198262          Oct   19,   2024           U-1360
	
                8204763          Aug   28,   2018           U-1361
	
                8315886          Oct   23,   2020           U-1361
	
                8589188          Aug   28,   2018           U-1361
	
                8626531          Oct   23,   2020           U-1361
	
                8673939          May   15,   2023           U-1360
	
                8735428          May   15,   2023           U-1360
	
                8828427          Jun   21,   2031   DS DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 177 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT           DELIST         EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES          REQUESTED         CODE(S)            DATE
	
POMALIDOMIDE - POMALYST
	
 N 204026 004		 5635517             Jul   24,   2016           U-1359                       NCE           Feb 08, 2018
	
                6045501             Aug   28,   2018           U-1361                       ODE           Feb 08, 2020
	
                6315720             Oct   23,   2020           U-1361
	
                6316471             Aug   10,   2016      DP U-1360
	
                6476052             Jul   24,   2016      DP U-1360
	
                6561976             Aug   28,   2018           U-1361
	
                6561977             Oct   23,   2020           U-1361
	
                6755784             Oct   23,   2020           U-1361
	
                6908432             Aug   28,   2018           U-1361
	
                8158653             Aug   10,   2016      DP
	
                8198262             Oct   19,   2024           U-1360
	
                8204763             Aug   28,   2018           U-1361
	
                8315886             Oct   23,   2020           U-1361
	
                8589188             Aug   28,   2018           U-1361
	
                8626531             Oct   23,   2020           U-1361
	
                8673939             May   15,   2023           U-1360
	
                8735428             May   15,   2023           U-1360
	
                8828427             Jun   21,   2031   DS DP
	
PONATINIB HYDROCHLORIDE - ICLUSIG
	
 N 203469 001   8114874          Dec 22, 2026          DS DP		                              NCE           Dec 14, 2017
	
                                                                                            ODE           Dec 14, 2019
	
PONATINIB HYDROCHLORIDE - ICLUSIG
	
 N 203469 002   8114874          Dec 22, 2026          DS DP		                              NCE           Dec 14, 2017
	
                                                                                            ODE           Dec 14, 2019
	
POSACONAZOLE - NOXAFIL
	
 N 022003 001		 5661151             Jul   19,   2019   DS DP U-760
	
                5703079             Aug   26,   2014   DS DP U-760
	
                6958337             Oct   05,   2018   DS DP U-760
	
                8263600             Apr   01,   2022      DP
	
POSACONAZOLE - NOXAFIL
	
 N 205053 001		 5661151             Jul 19, 2019       DS DP U-1454
	
                5703079             Aug 26, 2014       DS DP U-1454
	
POSACONAZOLE - NOXAFIL
	
 N 205596 001		 5661151             Jul 19, 2019       DS DP U-1454
	
                5703079             Aug 26, 2014       DS DP U-1454
	
                8410077             Mar 13, 2029          DP
	
PRALATREXATE - FOLOTYN
	
 N 022468 001		 6028071             Jul 16, 2022       DS DP U-1004                         NCE           Sep 24, 2014

                7622470             May 31, 2025             U-1015                         ODE           Sep 24, 2016

                8299078             May 31, 2025             U-1004
	
PRALATREXATE - FOLOTYN
	
 N 022468 002		 6028071             Jul 16, 2022       DS DP U-1004                         NCE           Sep 24, 2014

                7622470             May 31, 2025             U-1015                         ODE           Sep 24, 2016

                8299078             May 31, 2025             U-1004
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 178 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX
	
 N 020667 001   6001861          Jan 16, 2018              U-784
	
                6194445          Jan 16, 2018              U-784
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX
	
 N 020667 002   6001861          Jan 16, 2018              U-784
	
                6194445          Jan 16, 2018              U-784
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX
	
 N 020667 003   6001861          Jan 16, 2018              U-784
	
                6194445          Jan 16, 2018              U-784
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX
	
 N 020667 005   6001861          Jan 16, 2018              U-784
	
                6194445          Jan 16, 2018              U-784
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX
	
 N 020667 006   6001861          Jan 16, 2018              U-784
	
                6194445          Jan 16, 2018              U-784
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX
	
 N 020667 007   6001861          Jan 16, 2018              U-784
	
                6194445          Jan 16, 2018              U-784
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 001   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 002   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 003   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 004   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 005   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 006   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER
	
 N 022421 007   7695734          Apr 26, 2028          DP
	
                8679533          Sep 08, 2029          DP U-219
	
PRAMLINTIDE ACETATE - SYMLIN
	
 N 021332 001   5686411          Mar 16, 2019       DS DP U-638
	
                5814600          Sep 29, 2015             U-639
	
                6114304          Sep 05, 2017             U-640
	
PRAMLINTIDE ACETATE - SYMLIN
	
 N 021332 002   5686411          Mar   16,   2019   DS DP U-638
	
                5814600          Sep   29,   2015         U-637
	
                5814600          Sep   29,   2015         U-638
	
                5814600          Sep   29,   2015         U-639
	
                6114304          Sep   05,   2017         U-637
	
                6114304          Sep   05,   2017         U-640
	
PRAMLINTIDE ACETATE - SYMLIN
	
 N 021332 003   5686411          Mar   16,   2019   DS DP U-638
	
                5814600          Sep   29,   2015         U-637
	
                5814600          Sep   29,   2015         U-638
	
                5814600          Sep   29,   2015         U-639
	
                6114304          Sep   05,   2017         U-637
	
                6114304          Sep   05,   2017         U-640
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 179 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
PRASUGREL HYDROCHLORIDE - EFFIENT
 N 022307 001   5288726          Apr 14, 2017         DS DP U-991                          NCE           Jul 10, 2014
                8404703          Jan 02, 2023               U-1381
                8569325          Jan 02, 2023               U-1381
PRASUGREL HYDROCHLORIDE - EFFIENT
 N 022307 002   5288726          Apr 14, 2017         DS DP U-991                          NCE           Jul 10, 2014
                8404703          Jan 02, 2023               U-1381
                8569325          Jan 02, 2023               U-1381
PREDNISOLONE ACETATE - FLO-PRED
 N 022067 001   5881926            Mar   16,   2016      DP
                6071523            Jun   03,   2018      DP
                6399079            Jun   03,   2018      DP
                6656482            Jun   03,   2018      DP
                7799331            Oct   11,   2028      DP U-139
                7799331            Oct   11,   2028      DP U-1068
PREDNISOLONE ACETATE - FLO-PRED
 N 022067 002   5881926            Mar   16,   2016      DP
                6071523            Jun   03,   2018      DP
                6399079            Jun   03,   2018      DP
                6656482            Jun   03,   2018      DP
                7799331            Oct   11,   2028      DP U-139
                7799331            Oct   11,   2028      DP U-1068
PREDNISOLONE SODIUM PHOSPHATE - PREDNISOLONE SODIUM PHOSPHATE
 A 202179 001                                                                              PC            Jun 06, 2015
PREDNISOLONE SODIUM PHOSPHATE - PREDNISOLONE SODIUM PHOSPHATE
 A 202179 002                                                                              PC            Jun 06, 2015
PREDNISOLONE SODIUM PHOSPHATE - PREDNISOLONE SODIUM PHOSPHATE
 A 202179 003                                                                              PC            Jun 06, 2015
PREDNISOLONE SODIUM PHOSPHATE - ORAPRED ODT
 N 021959 001   6024981          Apr 09, 2018            DP                   Y
                6221392          Apr 09, 2018            DP                   Y
                6740341          Nov 24, 2019            DP
PREDNISOLONE SODIUM PHOSPHATE - ORAPRED ODT
 N 021959 002   6024981          Apr 09, 2018            DP                   Y
                6221392          Apr 09, 2018            DP                   Y
                6740341          Nov 24, 2019            DP
PREDNISOLONE SODIUM PHOSPHATE - ORAPRED ODT
 N 021959 003   6024981          Apr 09, 2018            DP                   Y
                6221392          Apr 09, 2018            DP                   Y
                6740341          Nov 24, 2019            DP
PREDNISONE - RAYOS
 N 202020 001   6488960            Mar   14,   2020      DP U-1267                         M-128         Jul 26, 2015
                6677326            Mar   14,   2020      DP U-1268
                8309124            Apr   23,   2024         U-1292
                8394407            Apr   23,   2024      DP U-1362
PREDNISONE - RAYOS
 N 202020 002   6488960            Mar   14,   2020      DP U-1267                         M-128         Jul 26, 2015
                6677326            Mar   14,   2020      DP U-1268
                8309124            Apr   23,   2024
                8394407            Apr   23,   2024      DP U-1362
PREDNISONE - RAYOS
 N 202020 003   8168218            Jan 07, 2028          DP U-1269                         M-128         Jul 26, 2015
                8309124            Apr 23, 2024             U-1292
                8394407            Apr 23, 2024          DP U-1362
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 180 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
PREGABALIN - LYRICA
 N 021446 001   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 002   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 003   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 004   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 005   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 006   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 007   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 021446 008   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PREGABALIN - LYRICA
 N 022488 001   6001876            Dec   30,   2018           U-55            Y            I-651         Jun 20, 2015
                6001876            Dec   30,   2018           U-819           Y
                6197819            Dec   30,   2018   DS DP
                RE41920            Dec   30,   2018           U-1250
PROGESTERONE - ENDOMETRIN
 N 022057 001   7300664            Nov 17, 2019             U-856
                7320800            Nov 17, 2019             U-856
                7393543            Nov 17, 2019          DP U-880
PROPAFENONE HYDROCHLORIDE - RYTHMOL SR
 N 021416 001   5681588          Oct 28, 2014
PROPAFENONE HYDROCHLORIDE - RYTHMOL SR
 N 021416 002   5681588          Oct 28, 2014
PROPAFENONE HYDROCHLORIDE - RYTHMOL SR
 N 021416 003   5681588          Oct 28, 2014
PROPOFOL - DIPRIVAN
 N 019627 002   5714520            Mar   22,   2015
                5731355            Mar   22,   2015           U-217
                5731356            Mar   22,   2015           U-218
                5908869            Mar   22,   2015           U-270
                8476010            Dec   01,   2024   DS DP
                8476010*PED        Jun   01,   2025
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 181 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES        REQUESTED           CODE(S)            DATE
	
PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL
 N 021438 001   6500454          Oct 04, 2021             DP
PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL
 N 021438 002   6500454          Oct 04, 2021             DP
PROPRANOLOL HYDROCHLORIDE - HEMANGEOL
 N 205410 001   8338489          Oct 16, 2028                  U-1496                       NP            Mar 14, 2017
                                                                                            ODE           Mar 14, 2021
QUAZEPAM - DORAL
 N 018708 001    7608616            Jun 03, 2028               U-1012
QUAZEPAM - DORAL
 N 018708 003    7608616            Jun 03, 2028               U-1012
QUETIAPINE FUMARATE - SEROQUEL XR
 N 022047 001   5948437          May 28, 2017             DP U-601
                5948437          May 28, 2017             DP U-814
                5948437          May 28, 2017             DP U-839
QUETIAPINE FUMARATE - SEROQUEL XR
 N 022047 002   5948437          May 28, 2017             DP U-601
                5948437          May 28, 2017             DP U-814
                5948437          May 28, 2017             DP U-839
QUETIAPINE FUMARATE - SEROQUEL XR
 N 022047 003   5948437          May 28, 2017             DP U-601
                5948437          May 28, 2017             DP U-814
                5948437          May 28, 2017             DP U-839
QUETIAPINE FUMARATE - SEROQUEL XR
 N 022047 004   5948437          May 28, 2017             DP U-601
                5948437          May 28, 2017             DP U-814
                5948437          May 28, 2017             DP U-839
QUETIAPINE FUMARATE - SEROQUEL XR
 N 022047 005   5948437          May 28, 2017             DP U-601
                5948437          May 28, 2017             DP U-814
                5948437          May 28, 2017             DP U-839
QUINAPRIL HYDROCHLORIDE - ACCUPRIL
 N 019885 001   5684016          Nov 04, 2014                  U-210
QUINAPRIL HYDROCHLORIDE - ACCUPRIL
 N 019885 002   5684016          Nov 04, 2014                  U-210
QUINAPRIL HYDROCHLORIDE - ACCUPRIL
 N 019885 003   5684016          Nov 04, 2014                  U-210
QUINAPRIL HYDROCHLORIDE - ACCUPRIL
 N 019885 004   5684016          Nov 04, 2014                  U-210
RABEPRAZOLE SODIUM - ACIPHEX SPRINKLE
 N 204736 001                                                                               NDF           Mar 26, 2016
                                                                                            PED           Sep 26, 2016
RABEPRAZOLE SODIUM - ACIPHEX SPRINKLE
 N 204736 002                                                                               NDF           Mar 26, 2016
                                                                                            PED           Sep 26, 2016
RADIUM RA-223 DICHLORIDE - XOFIGO
 N 203971 001   6635234          Jan 03, 2020                  U-1405                       NCE           May 15, 2018
RALOXIFENE HYDROCHLORIDE - RALOXIFENE HYDROCHLORIDE
 A 078193 001                                                                               PC            Sep 24, 2014
RALOXIFENE HYDROCHLORIDE - EVISTA
 N 020815 001   6458811          Mar     10,   2017    DS DP U-825                          ODE           Sep 13, 2014
                6797719          Mar     10,   2017       DP
                6894064          Mar     10,   2017       DP U-657
                8030330          Mar     10,   2017       DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 182 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
RALTEGRAVIR POTASSIUM - ISENTRESS
 N 022145 001   7169780          Oct     03,   2023   DS DP                                M-114         Mar 28, 2015
                7217713          Oct     21,   2022         U-257                          NPP           Dec 21, 2014
                7435734          Oct     21,   2022         U-257
                7435734          Oct     21,   2022         U-900
                7754731          Mar     11,   2029   DS DP U-257
RALTEGRAVIR POTASSIUM - ISENTRESS
 N 203045 001   7169780          Oct     03,   2023   DS DP                                M-114         Mar 28, 2015
                7217713          Oct     21,   2022         U-257                          NDF           Dec 21, 2014
                7435734          Oct     21,   2022         U-257
                7754731          Mar     11,   2029   DS DP U-257
RALTEGRAVIR POTASSIUM - ISENTRESS
 N 203045 002   7169780          Oct     03,   2023   DS DP                                M-114         Mar 28, 2015
                7217713          Oct     21,   2022         U-257                          NDF           Dec 21, 2014
                7435734          Oct     21,   2022         U-257
                7754731          Mar     11,   2029   DS DP U-257
RALTEGRAVIR POTASSIUM - ISENTRESS
 N 205786 001   7169780          Oct     03,   2023   DS DP                                NDF           Dec 20, 2016
                7217713          Oct     21,   2022         U-257
                7435734          Oct     21,   2022         U-257
                7754731          Mar     11,   2029   DS DP U-257
RAMELTEON - ROZEREM
 N 021782 001   6034239            Jul 22, 2019       DS DP U-674
RAMIPRIL - ALTACE
 N 019901 001   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 019901 002   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 019901 003   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 019901 004   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 022021 001   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 022021 002   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 022021 003   7368469            Aug 30, 2020               U-871
RAMIPRIL - ALTACE
 N 022021 004   7368469            Aug 30, 2020               U-871
RANOLAZINE - RANEXA
 N 021526 001   6303607            May   27,   2019           U-705
                6369062            May   27,   2019      DP                   Y
                6479496            May   27,   2019           U-705
                6503911            May   27,   2019      DP
                6525057            May   27,   2019           U-705
                6562826            May   27,   2019           U-705
                6617328            May   27,   2019      DP
                6620814            May   27,   2019           U-705
                6852724            May   27,   2019           U-705
                6864258            May   27,   2019           U-705
RANOLAZINE - RANEXA
 N 021526 002   6303607            May   27,   2019           U-705
                6369062            May   27,   2019      DP
                6479496            May   27,   2019           U-705
                6503911            May   27,   2019      DP
                6525057            May   27,   2019           U-705
                6562826            May   27,   2019           U-705
                6617328            May   27,   2019      DP
                6620814            May   27,   2019           U-705
                6852724            May   27,   2019           U-705
                6864258            May   27,   2019           U-705
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 183 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
RASAGILINE MESYLATE - AZILECT
 N 021641 001   5453446            Feb   07,   2017         U-219                          I-685         May 29, 2017
                6126968            Sep   18,   2016      DP
                7572834            Dec   05,   2026      DP
                7815942            Aug   27,   2027   DS DP U-219
RASAGILINE MESYLATE - AZILECT
 N 021641 002   5453446            Feb   07,   2017         U-219                          I-685         May 29, 2017
                6126968            Sep   18,   2016      DP
                7572834            Dec   05,   2026      DP
                7815942            Aug   27,   2027   DS DP U-219
REGADENOSON - LEXISCAN
 N 022161 001   6403567            Apr   10,   2022   DS   DP
                                                            U-869
                6642210            Jun   22,   2019   DS   DP
                                                            U-869
                7144872            Jun   22,   2019   DS   DP
                                                            U-116
                7144872            Jun   22,   2019   DS   DP
                                                            U-869
                7144872            Jun   22,   2019   DS   DP
                                                            U-870
                7183264            Jun   22,   2019        DP
                                                            U-116
                7183264            Jun   22,   2019        DP
                                                            U-869
                7183264            Jun   22,   2019        DP
                                                            U-870
                7582617            Jun   22,   2019         U-1003
                7655636            Jun   22,   2019         U-869
                7655637            Jun   22,   2019   DS DP U-869
                7683037            Jun   22,   2019         U-1042
                8106029            Jun   22,   2019         U-1042
                8106183            Feb   02,   2027   DS
                8133879            Jun   22,   2019      DP
                8183226            Jun   22,   2019         U-116
                8470801            Jun   22,   2019         U-116
                8536150            Jun   22,   2019         U-116
REGORAFENIB - STIVARGA
 N 203085 001   7351834            Jan 12, 2020       DS                                   I-667         Feb 25, 2016
                8637553            Jul 08, 2029       DS DP                                NCE           Sep 27, 2017
                8680124            Jul 20, 2028                 U-1506                     ODE           Feb 25, 2020
REMIFENTANIL HYDROCHLORIDE - ULTIVA
 N 020630 001   5866591          Sep 10, 2017              DP
REMIFENTANIL HYDROCHLORIDE - ULTIVA
 N 020630 002   5866591          Sep 10, 2017              DP
REMIFENTANIL HYDROCHLORIDE - ULTIVA
 N 020630 003   5866591          Sep 10, 2017              DP
RETAPAMULIN - ALTABAX
 N 022055 001   7875630            Feb 14, 2027       DS
                RE39128            Apr 12, 2021       DS DP U-805
                RE43390            Apr 12, 2021       DS DP U-805
RIBAVIRIN - VIRAZOLE
 N 018859 001   6150337            Nov 21, 2017                 U-400
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 184 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                              PATENT                          EXCLUSIVITY
     NO            PATENT NO           EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
                                          DATE                 CODES        REQUESTED         CODE(S)            DATE
RIBAVIRIN - REBETOL
 N 020903    001   6172046            Sep   21,   2017             U-377
                   6172046            Sep   21,   2017             U-1014
                   6177074            Nov   01,   2016             U-454
                   6177074            Nov   01,   2016             U-1013
                   6461605            Nov   01,   2016             U-478
                   6461605            Nov   01,   2016             U-1013
                   6472373            Sep   21,   2017             U-479
                   6472373            Sep   21,   2017             U-1014
                   6524570            Nov   01,   2016             U-499
                   6524570            Nov   01,   2016             U-1013
RIBAVIRIN - REBETOL
 N 020903 002   6172046               Sep   21,   2017             U-377
                6172046               Sep   21,   2017             U-1014
                6177074               Nov   01,   2016             U-454
                6177074               Nov   01,   2016             U-1013
                6461605               Nov   01,   2016             U-478
                6461605               Nov   01,   2016             U-1013
                6472373               Sep   21,   2017             U-479
                6472373               Sep   21,   2017             U-1014
                6524570               Nov   01,   2016             U-499
                6524570               Nov   01,   2016             U-1013
RIBAVIRIN - COPEGUS
 N 021511 001                                                                                 NPP           Aug 09, 2014
RIBAVIRIN - REBETOL
 N 021546 001   6172046               Sep   21,   2017             U-521
                6172046               Sep   21,   2017             U-1014
                6177074               Nov   01,   2016             U-1013
                6461605               Nov   01,   2016             U-521
                6461605               Nov   01,   2016             U-1013
                6472373               Sep   21,   2017             U-521
                6524570               Nov   01,   2016             U-1013
                6790837               Apr   05,   2023        DP
RIFAXIMIN - XIFAXAN
 N 021361 001   7045620               Jun   19,   2024   DS   DP
                7612199               Jun   19,   2024   DS   DP
                7902206               Jun   19,   2024   DS   DP
                7906542               Jun   01,   2025   DS   DP
                7928115               Jul   24,   2029             U-1121
                8158644               Jun   19,   2024        DP
                8158781               Jun   19,   2024   DS
                8193196               Sep   02,   2027   DS DP
                8518949               Feb   27,   2026      DP
                8741904               Feb   27,   2026   DS    U-1526
                8835452               Jun   19,   2024   DS DP
                8853231               Jun   19,   2024      DP
RIFAXIMIN - XIFAXAN
 N 022554 001   7045620               Jun   19,   2024   DS                                   ODE           Mar 24, 2017
                7612199               Jun   19,   2024   DS DP
                7902206               Jun   19,   2024   DS DP
                7906542               Jun   01,   2025   DS DP
                8158644               Jun   19,   2024      DP
                8158781               Jun   19,   2024   DS
                8193196               Sep   02,   2027   DS DP
                8518949               Feb   27,   2026      DP
                8642573               Oct   02,   2029             U-1481
                8741904               Feb   27,   2026   DS        U-1526
                8829017               Jul   24,   2029             U-1562
                8835452               Jun   19,   2024   DS DP
                8853231               Jun   19,   2024      DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 185 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT        DELIST          EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES       REQUESTED          CODE(S)            DATE
	
RILPIVIRINE HYDROCHLORIDE - EDURANT
 N 202022 001   6838464          Feb     26,   2021   DS DP                                NCE           May 20, 2016
                7067522          Dec     20,   2019   DS DP
                7125879          Apr     14,   2023   DS DP U-1153
                7125879          Apr     14,   2023   DS DP U-1307
                7638522          Apr     14,   2023      DP
                8080551          Apr     11,   2023   DS DP
                8101629          Aug     09,   2022      DP
RIOCIGUAT - ADEMPAS
 N 204819 001   6743798            Jul 16, 2019       DS DP                                NCE           Oct 08, 2018
                7173037            Apr 25, 2023       DS DP                                ODE           Oct 08, 2020
RIOCIGUAT - ADEMPAS
 N 204819 002   6743798            Jul 16, 2019       DS DP                                NCE           Oct 08, 2018
                7173037            Apr 25, 2023       DS DP                                ODE           Oct 08, 2020
RIOCIGUAT - ADEMPAS
 N 204819 003   6743798            Jul 16, 2019       DS DP                                NCE           Oct 08, 2018
                7173037            Apr 25, 2023       DS DP                                ODE           Oct 08, 2020
RIOCIGUAT - ADEMPAS
 N 204819 004   6743798            Jul 16, 2019       DS DP                                NCE           Oct 08, 2018
                7173037            Apr 25, 2023       DS DP                                ODE           Oct 08, 2020
RIOCIGUAT - ADEMPAS
 N 204819 005   6743798            Jul 16, 2019       DS DP                                NCE           Oct 08, 2018
                7173037            Apr 25, 2023       DS DP                                ODE           Oct 08, 2020
RISEDRONATE SODIUM - ACTONEL
 N 020835 001   6165513            Jun 10, 2018
RISEDRONATE SODIUM - ACTONEL
 N 020835 002   6165513            Jun 10, 2018
RISEDRONATE SODIUM - ACTONEL
 N 020835 003   5994329            Jul   17,   2018             U-353
                6015801            Jul   17,   2018             U-353
                6165513            Jun   10,   2018        DP
                6432932            Jul   17,   2018             U-595
                6465443            Aug   14,   2018        DP
RISEDRONATE SODIUM - ACTONEL
 N 020835 004   6165513            Jun 10, 2018            DP
RISEDRONATE SODIUM - ACTONEL
 N 020835 005   6165513            Jun 10, 2018            DP
                7192938            May 06, 2023                 U-353
                7718634            May 06, 2023                 U-662
RISEDRONATE SODIUM - ATELVIA
 N 022560 001   7645459            Jan 09, 2028            DP U-662
                7645460            Jan 09, 2028            DP U-662
                8246989            Jan 16, 2026            DP
RISPERIDONE - RISPERDAL
 N 020588 001   5453425            Jul 11, 2014            DP
                RE39181            Jul 11, 2014            DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 186 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
     NO         PATENT NO           EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
                                       DATE              CODES         REQUESTED           CODE(S)            DATE
RISPERIDONE - RISPERDAL CONSTA
 N 021346 001   5688801            Nov   18,   2014           U-543
                5688801            Nov   18,   2014           U-972
                5792477            May   02,   2017      DP
                5916598            May   02,   2017      DP
                6194006            Dec   30,   2018      DP
                6379703            Dec   30,   2018      DP
                6403114            May   02,   2017      DP
                6596316            Dec   30,   2018      DP
                6667061            May   25,   2020      DP
RISPERIDONE - RISPERDAL CONSTA
 N 021346 002   5688801            Nov   18,   2014           U-543
                5688801            Nov   18,   2014           U-972
                5792477            May   02,   2017      DP
                5916598            May   02,   2017      DP
                6194006            Dec   30,   2018      DP
                6379703            Dec   30,   2018      DP
                6403114            May   02,   2017      DP
                6596316            Dec   30,   2018      DP
                6667061            May   25,   2020      DP
RISPERIDONE - RISPERDAL CONSTA
 N 021346 003   5688801            Nov   18,   2014           U-543
                5688801            Nov   18,   2014           U-972
                5792477            May   02,   2017      DP
                5916598            May   02,   2017      DP
                6194006            Dec   30,   2018      DP
                6379703            Dec   30,   2018      DP
                6403114            May   02,   2017      DP
                6596316            Dec   30,   2018      DP
                6667061            May   25,   2020      DP
RISPERIDONE - RISPERDAL CONSTA
 N 021346 004   5688801            Nov   18,   2014           U-543
                5688801            Nov   18,   2014           U-972
                5792477            May   02,   2017      DP
                5916598            May   02,   2017      DP
                6194006            Dec   30,   2018      DP
                6379703            Dec   30,   2018      DP
                6403114            May   02,   2017      DP
                6596316            Dec   30,   2018      DP
RISPERIDONE - RISPERDAL
 N 021444 001   5648093            Jul 15, 2014          DP
                6224905            Jun 10, 2017          DP
RISPERIDONE - RISPERDAL
 N 021444 002   5648093            Jul 15, 2014          DP
                6224905            Jun 10, 2017          DP
RISPERIDONE - RISPERDAL
 N 021444 003   5648093            Jul 15, 2014          DP
                6224905            Jun 10, 2017          DP
RISPERIDONE - RISPERDAL
 N 021444 004   5648093            Jul 15, 2014          DP
                6224905            Jun 10, 2017          DP
RISPERIDONE - RISPERDAL
 N 021444 005   5648093            Jul 15, 2014          DP
                6224905            Jun 10, 2017          DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 187 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
     NO         PATENT NO           EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
                                       DATE                CODES        REQUESTED          CODE(S)            DATE
RITONAVIR - NORVIR
 N 020659 001   5648497            Jul 15, 2014
                6037157            Jun 26, 2016
                6703403            Jun 26, 2016                 U-564
RITONAVIR - NORVIR
 N 020680 001   5648497            Jul 15, 2014
RITONAVIR - NORVIR
 N 020945 001   5648497            Jul   15,   2014
                6037157            Jun   26,   2016             U-895
                6232333            Nov   07,   2017
                6703403            Jun   26,   2016             U-564
                7141593            May   22,   2020        DP
                7432294            May   22,   2020        DP
RITONAVIR - NORVIR
 N 022417 001   5648497            Jul   15,   2014   DS
                6037157            Jun   26,   2016             U-688
                6703403            Jun   26,   2016             U-688
                7148359            Jul   19,   2019        DP
                7364752            Nov   10,   2020        DP U-688
                8268349            Aug   25,   2024        DP
                8399015            Aug   25,   2024        DP
                8399015*PED        Feb   25,   2025
                8470347            Sep   17,   2026        DP
                8470347*PED        Mar   17,   2027
                8691878            Aug   25,   2024             U-688
                8691878*PED        Feb   25,   2025
RIVAROXABAN - XARELTO
 N 022406 001   7157456            Feb   08,   2021   DS DP U-1301                         I-660         Nov   02,   2015
                7157456            Feb   08,   2021   DS DP U-1302                         I-661         Nov   02,   2015
                7585860            Dec   11,   2020   DS    U-1303                         I-662         Nov   02,   2015
                7592339            Dec   11,   2020         U-1167                         NCE           Jul   01,   2016
                7592339            Dec   11,   2020         U-1200
                7592339            Dec   11,   2020         U-1301
                7592339            Dec   11,   2020         U-1302
                7592339            Dec   11,   2020         U-1303
RIVAROXABAN - XARELTO
 N 022406 002   7157456            Feb   08,   2021   DS DP U-1301                         I-643         Nov   04,   2014
                7157456            Feb   08,   2021   DS DP U-1302                         I-660         Nov   02,   2015
                7585860            Dec   11,   2020   DS    U-1303                         I-661         Nov   02,   2015
                7592339            Dec   11,   2020         U-1167                         I-662         Nov   02,   2015
                7592339            Dec   11,   2020         U-1200                         NCE           Jul   01,   2016
                7592339            Dec   11,   2020         U-1301
                7592339            Dec   11,   2020         U-1302
                7592339            Dec   11,   2020         U-1303
RIVAROXABAN - XARELTO
 N 022406 003   7157456            Feb   08,   2021   DS DP U-1301                         I-643         Nov   04,   2014
                7157456            Feb   08,   2021   DS DP U-1302                         I-660         Nov   02,   2015
                7585860            Dec   11,   2020   DS    U-1303                         I-661         Nov   02,   2015
                7592339            Dec   11,   2020         U-1167                         I-662         Nov   02,   2015
                7592339            Dec   11,   2020         U-1200                         NCE           Jul   01,   2016
                7592339            Dec   11,   2020         U-1301
                7592339            Dec   11,   2020         U-1302
                7592339            Dec   11,   2020         U-1303
RIVASTIGMINE - EXELON
 N 022083 001   6316023            Jan 08, 2019            DP
                6335031            Jan 08, 2019            DP
RIVASTIGMINE - EXELON
 N 022083 002   6316023            Jan 08, 2019            DP
                6335031            Jan 08, 2019            DP
RIVASTIGMINE - EXELON
 N 022083 005   6316023            Jan 08, 2019            DP                              NPP           Jun 27, 2016
                6335031            Jan 08, 2019            DP                              NS            Aug 31, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 188 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT       DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES      REQUESTED           CODE(S)            DATE
	
RIZATRIPTAN BENZOATE - MAXALT
 N 020864 001                                                                              NPP           Dec 16, 2014
                                                                                           PED           Jun 16, 2015
RIZATRIPTAN BENZOATE - MAXALT
 N 020864 002                                                                              NPP           Dec 16, 2014
                                                                                           PED           Jun 16, 2015
RIZATRIPTAN BENZOATE - MAXALT-MLT
 N 020865 001                                                                              NPP           Dec 16, 2014
                                                                                           PED           Jun 16, 2015
RIZATRIPTAN BENZOATE - MAXALT-MLT
 N 020865 002                                                                              NPP           Dec 16, 2014
                                                                                           PED           Jun 16, 2015
ROFECOXIB - VIOXX
 N 021042 001   5691374            May 18, 2015
                6063811            May 06, 2017               U-602
ROFECOXIB - VIOXX
 N 021042 002   5691374            May 18, 2015
                6063811            May 06, 2017               U-602
ROFECOXIB - VIOXX
 N 021042 003   5691374            May 18, 2015
                6063811            May 06, 2017               U-602
ROFECOXIB - VIOXX
 N 021052 001   5691374            May 18, 2015
                6063811            May 06, 2017               U-266
ROFECOXIB - VIOXX
 N 021052 002   5691374            May 18, 2015
                6063811            May 06, 2017               U-266
ROFLUMILAST - DALIRESP
 N 022522 001   5712298            Jan   27,   2015   DS DP U-1115                         NCE           Feb 28, 2016
                8431154            Feb   19,   2023      DP
                8536206            Mar   08,   2024         U-1115
                8604064            Mar   08,   2024         U-1115
                8618142            Mar   08,   2024      DP
ROMIDEPSIN - ISTODAX
 N 022393 001   7608280            Aug 22, 2021       DS                                   NCE           Nov 05, 2014
                7611724            Aug 22, 2021       DS                                   ODE           Nov 05, 2016
                                                                                           ODE           Jun 16, 2018
ROPINIROLE HYDROCHLORIDE - REQUIP XL
 N 022008 001   7927624          Dec 02, 2021              DP U-20
                8303986          Apr 12, 2021              DP
ROPINIROLE HYDROCHLORIDE - REQUIP XL
 N 022008 002   7927624          Dec 02, 2021              DP U-20
                8303986          Apr 12, 2021              DP
ROPINIROLE HYDROCHLORIDE - REQUIP XL
 N 022008 003   7927624          Dec 02, 2021              DP U-20
                8303986          Apr 12, 2021              DP
ROPINIROLE HYDROCHLORIDE - REQUIP XL
 N 022008 004   7927624          Dec 02, 2021              DP U-20
                8303986          Apr 12, 2021              DP
ROPINIROLE HYDROCHLORIDE - REQUIP XL
 N 022008 005   7927624          Dec 02, 2021              DP U-20
                8303986          Apr 12, 2021              DP
ROPINIROLE HYDROCHLORIDE - REQUIP XL
 N 022008 006   7927624          Dec 02, 2021              DP U-20
                8303986          Apr 12, 2021              DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                  ADA 189 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                         See report footnote for information regarding report content

 APPL/PROD                           PATENT
	                                PATENT                      EXCLUSIVITY
     NO          PATENT NO         EXPIRATION
	              PATENT          DELIST     EXCLUSIVITY      EXPIRATION
                                      DATE
	                  CODES        REQUESTED      CODE(S)            DATE
ROPIVACAINE HYDROCHLORIDE - NAROPIN
	
 N 020533 001		 5670524          Sep 23, 2014
          DS DP U-833
                7828787          Oct 18, 2025
	            DP
                7857802          Nov 28, 2026
	            DP
                8118802          May 18, 2023
             DP
                8162915          May 23, 2024
	            DP
ROPIVACAINE HYDROCHLORIDE - NAROPIN
	
 N 020533 003		 5670524          Sep 23, 2014
	         DS DP U-833
ROPIVACAINE HYDROCHLORIDE - NAROPIN
	
 N 020533 004		 5670524          Sep 23, 2014
	         DS DP U-833
ROPIVACAINE HYDROCHLORIDE - NAROPIN
	
 N 020533 005		 5670524          Sep 23, 2014
	         DS DP U-833
ROSIGLITAZONE MALEATE - AVANDIA
	
 N 021071 002		 5741803           Apr 21, 2015
         DS DP U-329              Y
                5741803           Apr 21, 2015
         DS DP U-628              Y
                6288095           Feb 11, 2017
	              U-420              Y
                7358366           Apr 19, 2020
	        DS
ROSIGLITAZONE MALEATE - AVANDIA
	
 N 021071 003		 5741803           Apr 21, 2015
         DS DP U-329              Y
                5741803           Apr 21, 2015
         DS DP U-628              Y
                6288095           Feb 11, 2017
	              U-420              Y
                7358366           Apr 19, 2020
	        DS
ROSIGLITAZONE MALEATE - AVANDIA
	
 N 021071 004		 5741803           Apr 21, 2015
         DS DP U-329              Y
                5741803           Apr 21, 2015
         DS DP U-628              Y
                6288095           Feb 11, 2017
	              U-420              Y
                7358366           Apr 19, 2020
	        DS
ROSUVASTATIN CALCIUM - CRESTOR
	
 N 021366 002		 6316460            Aug   04,   2020
         DP
                6858618            Dec   17,   2021
	             U-618
                7030152            Apr   02,   2018
              U-1032
                7964614            Apr   02,   2018
              U-1032
                RE37314            Jan   08,   2016
	   DS
ROSUVASTATIN CALCIUM - CRESTOR
	
 N 021366 003		 6316460            Aug   04,   2020
         DP
                6858618            Dec   17,   2021
	             U-618
                7030152            Apr   02,   2018
              U-1032
                7964614            Apr   02,   2018
              U-1032
                RE37314            Jan   08,   2016
	   DS
ROSUVASTATIN CALCIUM - CRESTOR
	
 N 021366 004		 6316460            Aug   04,   2020
         DP
                6858618            Dec   17,   2021
	             U-618
                7030152            Apr   02,   2018
              U-1032
                7964614            Apr   02,   2018
              U-1032
                RE37314            Jan   08,   2016
	   DS
ROSUVASTATIN CALCIUM - CRESTOR
	
 N 021366 005		 6316460            Aug   04,   2020
         DP
                6858618            Dec   17,   2021
	             U-618
                7030152            Apr   02,   2018
              U-1032
                7964614            Apr   02,   2018
              U-1032
                RE37314            Jan   08,   2016
	   DS
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 190 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                           PATENT                           EXCLUSIVITY
     NO          PATENT NO
	      EXPIRATION
	         PATENT          DELIST          EXCLUSIVITY       EXPIRATION
                                     DATE
	             CODES        REQUESTED           CODE(S)            DATE
ROTIGOTINE - NEUPRO
	
 N 021829 001   6699498
	        Nov   27,   2020
	    DP                                I-646         Apr 02, 2015
                6884434
	        Mar   30,   2021
	    DP                                I-647         Apr 02, 2015
                7413747
	        Mar   18,   2019
	    DP
                8246979
	        Sep   01,   2027
     DP U-1272
                8246979
	        Sep   01,   2027
     DP U-1273
                8246980
	        Nov   27,   2025
	    DP
                8617591
	        Jul   22,   2023
	    DP U-1474
ROTIGOTINE - NEUPRO
	
 N 021829 002   6699498
	        Nov   27,   2020
	    DP                                I-646         Apr 02, 2015
                6884434
	        Mar   30,   2021
	    DP                                I-647         Apr 02, 2015
                7413747
	        Mar   18,   2019
	    DP
                8246979
	        Sep   01,   2027
     DP U-1272
                8246979
	        Sep   01,   2027
     DP U-1273
                8246980
	        Nov   27,   2025
	    DP
                8617591
	        Jul   22,   2023
	    DP U-1474
ROTIGOTINE - NEUPRO
	
 N 021829 003   6699498
	        Nov   27,   2020
	    DP                                I-646         Apr 02, 2015
                6884434
	        Mar   30,   2021
	    DP                                I-647         Apr 02, 2015
                7413747
	        Mar   18,   2019
	    DP
                8246979
	        Sep   01,   2027
     DP U-1272
                8246979
	        Sep   01,   2027
     DP U-1273
                8246980
	        Nov   27,   2025
	    DP
                8617591
	        Jul   22,   2023
	    DP U-1474
ROTIGOTINE - NEUPRO
	
 N 021829 004   6699498
	        Nov   27,   2020
	    DP                                I-646         Apr 02, 2015
                6884434
	        Mar   30,   2021
	    DP                                I-647         Apr 02, 2015
                7413747
	        Mar   18,   2019
	    DP
                8246979
	        Sep   01,   2027
     DP U-1272
                8246979
	        Sep   01,   2027
     DP U-1273
                8246980
	        Nov   27,   2025
	    DP
                8617591
	        Jul   22,   2023
	    DP U-1474
ROTIGOTINE - NEUPRO
	
 N 021829 005   6699498
	        Nov   27,   2020
	    DP                                I-646         Apr 02, 2015
                6884434
	        Mar   30,   2021
	    DP                                I-647         Apr 02, 2015
                7413747
	        Mar   18,   2019
	    DP
                8246979
	        Sep   01,   2027
     DP U-1272
                8246979
	        Sep   01,   2027
     DP U-1273
                8246980
	        Nov   27,   2025
	    DP
                8617591
	        Jul   22,   2023
	    DP U-1474
ROTIGOTINE - NEUPRO
	
 N 021829 006   6699498
	        Nov   27,   2020
	    DP                                I-646         Apr 02, 2015
                6884434
	        Mar   30,   2021
	    DP                                I-647         Apr 02, 2015
                7413747
	        Mar   18,   2019
	    DP
                8246979
	        Sep   01,   2027
     DP U-1272
                8246979
	        Sep   01,   2027
     DP U-1273
                8246980
	        Nov   27,   2025
	    DP
                8617591
	        Jul   22,   2023
	    DP U-1474
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 191 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT                            PATENT                            EXCLUSIVITY
     NO          PATENT NO
	      EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
RUFINAMIDE - BANZEL
	
 N 021911 001   6740669
	        Nov   14,   2022   DS DP                                ODE           Nov 14, 2015
                6740669*PED
	    May   14,   2023                                        PED           May 14, 2016
                7750028
	        Oct   19,   2018           U-106
                7750028*PED
	    Apr   19,   2019
                8076362
	        Jun   08,   2018      DP
                8076362*PED
	    Dec   08,   2018
RUFINAMIDE - BANZEL
	
 N 021911 002   6740669
	        Nov   14,   2022   DS DP                                ODE           Nov 14, 2015
                6740669*PED
	    May   14,   2023                                        PED           May 14, 2016
                7750028
	        Oct   19,   2018           U-106
                7750028*PED
	    Apr   19,   2019
                8076362
	        Jun   08,   2018      DP
                8076362*PED
	    Dec   08,   2018
RUFINAMIDE - BANZEL
	
 N 021911 003   6740669
	        Nov   14,   2022   DS DP                                ODE           Nov 14, 2015
                6740669*PED
	    May   14,   2023                                        PED           May 14, 2016
                7750028
	        Oct   19,   2018           U-106
                7750028*PED
	    Apr   19,   2019
                8076362
	        Jun   08,   2018      DP
                8076362*PED
	    Dec   08,   2018
RUFINAMIDE - BANZEL
	
 N 201367 001   6740669
	        Nov   14,   2022   DS DP                                ODE           Nov 14, 2015
                6740669*PED
	    May   14,   2023                                        PED           May 14, 2016
                7750028
	        Oct   19,   2018           U-106
                7750028*PED
	    Apr   19,   2019
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 192 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                          PATENT                             PATENT                          EXCLUSIVITY
	
     NO         PATENT NO         EXPIRATION              PATENT       DELIST         EXCLUSIVITY       EXPIRATION
	
                                     DATE                  CODES      REQUESTED         CODE(S)            DATE
	
RUXOLITINIB PHOSPHATE - JAKAFI
 N 202192 001   7598257           Dec   24,   2027   DS   DP U-1201                     I-699         Dec   04,   2017
                7598257           Dec   24,   2027   DS   DP U-1622                     NCE           Nov   16,   2016
                8415362           Dec   24,   2027   DS   DP                            ODE           Nov   16,   2018
                8722693           Jun   12,   2028   DS   DP                            ODE           Dec   04,   2021
                8822481           Jun   12,   2028           U-1573
                8829013           Jun   12,   2028           U-1201
                8829013           Jun   12,   2028           U-1622
RUXOLITINIB PHOSPHATE - JAKAFI
 N 202192 002   7598257           Dec   24,   2027   DS   DP U-1201                     I-699         Dec   04,   2017
                7598257           Dec   24,   2027   DS   DP U-1622                     NCE           Nov   16,   2016
                8415362           Dec   24,   2027   DS   DP                            ODE           Nov   16,   2018
                8722693           Jun   12,   2028   DS   DP                            ODE           Dec   04,   2021
                8822481           Jun   12,   2028           U-1573
                8829013           Jun   12,   2028           U-1201
                8829013           Jun   12,   2028           U-1622
RUXOLITINIB PHOSPHATE - JAKAFI
 N 202192 003   7598257           Dec   24,   2027   DS   DP U-1201                     I-699         Dec   04,   2017
                7598257           Dec   24,   2027   DS   DP U-1622                     NCE           Nov   16,   2016
                8415362           Dec   24,   2027   DS   DP                            ODE           Nov   16,   2018
                8722693           Jun   12,   2028   DS   DP                            ODE           Dec   04,   2021
                8822481           Jun   12,   2028           U-1573
                8829013           Jun   12,   2028           U-1201
                8829013           Jun   12,   2028           U-1622
RUXOLITINIB PHOSPHATE - JAKAFI
 N 202192 004   7598257           Dec   24,   2027   DS   DP U-1201                     I-699         Dec   04,   2017
                7598257           Dec   24,   2027   DS   DP U-1622                     NCE           Nov   16,   2016
                8415362           Dec   24,   2027   DS   DP                            ODE           Nov   16,   2018
                8722693           Jun   12,   2028   DS   DP                            ODE           Dec   04,   2021
                8822481           Jun   12,   2028           U-1573
                8829013           Jun   12,   2028           U-1201
                8829013           Jun   12,   2028           U-1622
RUXOLITINIB PHOSPHATE - JAKAFI
 N 202192 005   7598257           Dec   24,   2027   DS   DP U-1201                     I-699         Dec   04,   2017
                7598257           Dec   24,   2027   DS   DP U-1622                     NCE           Nov   16,   2016
                8415362           Dec   24,   2027   DS   DP                            ODE           Nov   16,   2018
                8722693           Jun   12,   2028   DS   DP                            ODE           Dec   04,   2021
                8822481           Jun   12,   2028           U-1573
                8829013           Jun   12,   2028           U-1201
                8829013           Jun   12,   2028           U-1622
SALMETEROL XINAFOATE - SEREVENT
 N 020692 001   5873360           Feb 23, 2016            DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 193 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
SAPROPTERIN DIHYDROCHLORIDE - KUVAN
 N 022181 001   7566462          Nov    16,   2025       DP                                NPP           Apr   23,   2017
                7566462*PED      May    16,   2026                                         ODE           Dec   13,   2014
                7566714          Nov    17,   2024            U-989                        PED           Jun   13,   2015
                7566714*PED      May    17,   2025                                         PED           Oct   23,   2017
                7612073          Nov    17,   2024            U-1010
                7612073*PED      May    17,   2025
                7727987          Nov    17,   2024       DP
                7727987*PED      May    17,   2025
                7947681          Nov    17,   2024            U-1156          Y
                7947681*PED      May    17,   2025
                8003126          Nov    16,   2025
                8003126*PED      May    17,   2015
                8067416          Nov    17,   2024            U-989
                8067416*PED      May    17,   2025
                8318745          Nov    17,   2024       DP
                8318745*PED      May    17,   2025
                RE43797          Nov    17,   2024            U-1156
                RE43797*PED      May    17,   2025
SAPROPTERIN DIHYDROCHLORIDE - KUVAN
 N 205065 001   7566714          Nov    17,   2024            U-1589
                7612073          Nov    17,   2024            U-1010
                8067416          Nov    17,   2024            U-1589
                RE43797          Nov    17,   2024            U-1590
SAQUINAVIR - FORTOVASE
 N 020828 001   6008228            Jun 06, 2015
                6352717            Nov 16, 2019
SAQUINAVIR MESYLATE - INVIRASE
 N 020628 001                                                                              M-61          Nov 30, 2015
                                                                                           PED           May 30, 2016
SAQUINAVIR MESYLATE - INVIRASE
 N 021785 001                                                                              M-61          Nov 30, 2015
                                                                                           PED           May 30, 2016
SAXAGLIPTIN HYDROCHLORIDE - ONGLYZA
 N 022350 001   7951400          Nov 30, 2028            DP                                M-108         Dec 16, 2014
                RE44186          Jul 31, 2023         DS DP U-995                          M-134         May 24, 2016
                                                                                           NCE           Jul 31, 2014
SAXAGLIPTIN HYDROCHLORIDE - ONGLYZA
 N 022350 002   7951400          Nov 30, 2028            DP                                M-108         Dec 16, 2014
                RE44186          Jul 31, 2023         DS DP U-995                          M-134         May 24, 2016
                                                                                           NCE           Jul 31, 2014
SELEGILINE - EMSAM
 N 021336 001   7070808            May 10, 2018       DS DP
                7150881            Jun 12, 2018       DS DP
                7638140            May 10, 2018          DP
SELEGILINE - EMSAM
 N 021336 002   7070808            May 10, 2018       DS DP
                7150881            Jun 12, 2018       DS DP
                7638140            May 10, 2018          DP
SELEGILINE - EMSAM
 N 021336 003   7070808            May 10, 2018       DS DP
                7150881            Jun 12, 2018       DS DP
                7638140            May 10, 2018          DP
SELEGILINE HYDROCHLORIDE - ZELAPAR
 N 021479 001   5648093          Jul 15, 2014            DP
                6423342          Mar 01, 2016            DP
SERTRALINE HYDROCHLORIDE - ZOLOFT
 N 020990 001   6727283          Oct 11, 2019            DP U-580
                7067555          Oct 11, 2019            DP
                7067555*PED      Apr 11, 2020
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 194 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                             PATENT                           EXCLUSIVITY
     NO          PATENT NO          EXPIRATION           PATENT          DELIST          EXCLUSIVITY       EXPIRATION
                                       DATE              CODES         REQUESTED           CODE(S)            DATE
SEVELAMER CARBONATE - RENVELA
 N 022127 001   5667775            Sep 16, 2014               U-246
                7985418            Oct 27, 2025          DP
SEVELAMER CARBONATE - RENVELA
 N 022318 001   5667775            Sep 16, 2014               U-246
SEVELAMER CARBONATE - RENVELA
 N 022318 002   5667775            Sep 16, 2014               U-246
SEVELAMER HYDROCHLORIDE - RENAGEL
 N 020926 001   5667775          Sep 16, 2014                 U-246
SEVELAMER HYDROCHLORIDE - RENAGEL
 N 021179 001   5667775          Sep 16, 2014                 U-246
                6733780          Oct 18, 2020            DP
SEVELAMER HYDROCHLORIDE - RENAGEL
 N 021179 002   5667775          Sep 16, 2014                 U-246
                6733780          Oct 18, 2020            DP
SEVOFLURANE - ULTANE
 N 020478 001   5990176            Jan   27,   2017
                6074668            Jan   09,   2018
                6288127            Jan   27,   2017
                6444859            Jan   27,   2017
SILDENAFIL CITRATE - VIAGRA
 N 020895 001   6469012            Oct 22, 2019               U-155
SILDENAFIL CITRATE - VIAGRA
 N 020895 002   6469012            Oct 22, 2019               U-155
SILDENAFIL CITRATE - VIAGRA
 N 020895 003   6469012            Oct 22, 2019               U-155
SILDENAFIL CITRATE - REVATIO
 N 021845 001                                                                              D-137         Jan   31,   2017
                                                                                           M-133         Jan   31,   2017
                                                                                           M-61          Aug   30,   2015
                                                                                           PED           Mar   01,   2016
SILDENAFIL CITRATE - REVATIO
 N 022473 001                                                                              D-137         Jan   31,   2017
                                                                                           M-133         Jan   31,   2017
                                                                                           M-61          Aug   30,   2015
                                                                                           PED           Mar   01,   2016
SILDENAFIL CITRATE - REVATIO
 N 203109 001                                                                              D-137         Jan   31,   2017
                                                                                           M-133         Jan   31,   2017
                                                                                           NDF           Aug   30,   2015
                                                                                           PED           Mar   01,   2016
SILODOSIN - RAPAFLO
 N 022206 001   5387603            Dec 01, 2018       DS DP
SILODOSIN - RAPAFLO
 N 022206 002   5387603            Dec 01, 2018       DS DP
SIMEPREVIR SODIUM - OLYSIO
 N 205123 001   7671032            May   19,   2025   DS DP                                I-697         Nov 05, 2017
                8148399            Sep   05,   2029   DS DP U-1467                         NCE           Nov 22, 2018
                8349869            Jul   28,   2026   DS DP U-1467
                8741926            Jul   28,   2026   DS    U-1467
                8754106            Jul   28,   2026   DS    U-1467
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 195 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT
	                            PATENT                          EXCLUSIVITY
	
     NO         PATENT NO        EXPIRATION
	         PATENT           DELIST         EXCLUSIVITY       EXPIRATION
	
                                    DATE
	             CODES         REQUESTED          CODE(S)            DATE
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE -   JUVISYNC
	
 N 202343 001		 6303661          Apr   24, 2017
          U-1188
	
                6699871          Jul   26, 2022
	   DS DP U-1188
	
                6890898          Feb   02, 2019
	         U-1189
	
                6890898          Feb   02, 2019
	         U-1190
	
                6890898          Feb   02, 2019
	         U-1191
	
                7078381          Feb   02, 2019
	         U-1188
	
                7125873          Jul   26, 2022
	      DP U-1189
	
                7125873          Jul   26, 2022
	      DP U-1190
	
                7125873          Jul   26, 2022
	      DP U-1192
	
                7125873          Jul   26, 2022
	      DP U-1193
	
                7326708          Apr   11, 2026
    DS DP U-1188
	
                7459428          Feb   02, 2019
	         U-1189
	
                8168637          Jun   26, 2022
	      DP U-1188
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE -   JUVISYNC
	
 N 202343 002		 6303661          Apr   24, 2017
          U-1188
	
                6699871          Jul   26, 2022
	   DS DP U-1188
	
                6890898          Feb   02, 2019
	         U-1189
	
                6890898          Feb   02, 2019
	         U-1190
	
                6890898          Feb   02, 2019
	         U-1191
	
                7078381          Feb   02, 2019
	         U-1188
	
                7125873          Jul   26, 2022
	      DP U-1189
	
                7125873          Jul   26, 2022
	      DP U-1190
	
                7125873          Jul   26, 2022
	      DP U-1192
	
                7125873          Jul   26, 2022
	      DP U-1193
	
                7326708          Apr   11, 2026
    DS DP U-1188
	
                7459428          Feb   02, 2019
	         U-1189
	
                8168637          Jun   26, 2022
	      DP U-1188
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE -   JUVISYNC
	
 N 202343 003		 6303661          Apr   24, 2017
          U-1188
	
                6699871          Jul   26, 2022
	   DS DP U-1188
	
                6890898          Feb   02, 2019
	         U-1189
	
                6890898          Feb   02, 2019
	         U-1190
	
                6890898          Feb   02, 2019
	         U-1191
	
                7078381          Feb   02, 2019
	         U-1188
	
                7125873          Jul   26, 2022
	      DP U-1189
	
                7125873          Jul   26, 2022
	      DP U-1190
	
                7125873          Jul   26, 2022
	      DP U-1192
	
                7125873          Jul   26, 2022
	      DP U-1193
	
                7326708          Apr   11, 2026
    DS DP U-1188
	
                7459428          Feb   02, 2019
	         U-1189
	
                8168637          Jun   26, 2022
	      DP U-1188
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE -   JUVISYNC
	
 N 202343 004		 6303661          Apr   24, 2017
          U-1188
	
                6699871          Jul   26, 2022
	   DS DP U-1188
	
                6890898          Feb   02, 2019
	         U-1189
	
                6890898          Feb   02, 2019
	         U-1190
	
                6890898          Feb   02, 2019
	         U-1191
	
                7078381          Feb   02, 2019
	         U-1188
	
                7125873          Jul   26, 2022
	      DP U-1189
	
                7125873          Jul   26, 2022
	      DP U-1190
	
                7125873          Jul   26, 2022
	      DP U-1192
	
                7125873          Jul   26, 2022
	      DP U-1193
	
                7326708          Apr   11, 2026
    DS DP U-1188
	
                7459428          Feb   02, 2019
	         U-1189
	
                8168637          Jun   26, 2022
	      DP U-1188
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 196 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                         PATENT                               PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION              PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE                  CODES        REQUESTED           CODE(S)            DATE
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC
	
 N 202343 005		 6303661          Apr 24, 2017               U-1188
	
                6699871          Jul 26, 2022         DS DP U-1188
	
                6890898          Feb 02, 2019               U-1189
	
                6890898          Feb 02, 2019               U-1190
	
                6890898          Feb 02, 2019               U-1191
	
                7078381          Feb 02, 2019               U-1188
	
                7125873          Jul 26, 2022            DP U-1189
	
                7125873          Jul 26, 2022            DP U-1190
	
                7125873          Jul 26, 2022            DP U-1192
	
                7125873          Jul 26, 2022            DP U-1193
	
                7326708          Apr 11, 2026         DS DP U-1188
	
                7459428          Feb 02, 2019               U-1189
	
                8168637          Jun 26, 2022            DP U-1188
	
SIMVASTATIN; SITAGLIPTIN PHOSPHATE -    JUVISYNC
	
 N 202343 006		 6303661          Apr    24, 2017            U-1188
	
                6699871          Jul    26, 2022      DS DP U-1188
	
                6890898          Feb    02, 2019            U-1189
	
                6890898          Feb    02, 2019            U-1190
	
                6890898          Feb    02, 2019            U-1191
	
                7078381          Feb    02, 2019            U-1188
	
                7125873          Jul    26, 2022         DP U-1189
	
                7125873          Jul    26, 2022         DP U-1190
	
                7125873          Jul    26, 2022         DP U-1192
	
                7125873          Jul    26, 2022         DP U-1193
	
                7326708          Apr    11, 2026      DS DP U-1188
	
                7459428          Feb    02, 2019            U-1189
	
                8168637          Jun    26, 2022         DP U-1188
	
SINCALIDE - KINEVAC
	
 N 017697 001		 6803046            Aug 16, 2022          DP
	
SINECATECHINS - VEREGEN
	
 N 021902 001		 5795911            Oct 31, 2020             U-172
	
                5968973            Apr 10, 2017             U-172
	
                7858662            Oct 02, 2026          DP U-172
	
SIROLIMUS - SIROLIMUS
	
 A 201676 003		                                                                            PC            Jul 15, 2014
	
SIROLIMUS - RAPAMUNE
	
 N 021110 001		 5989591            Mar 11, 2018          DP
	
SIROLIMUS - RAPAMUNE
	
 N 021110 002		 5989591            Mar 11, 2018          DP
	
SIROLIMUS - RAPAMUNE
	
 N 021110 003		 5989591            Mar 11, 2018          DP
	
SIROLIMUS - RAPAMUNE
	
 N 021110 004		 5989591            Mar 11, 2018          DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 197 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD                          PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO        EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                     DATE               CODES        REQUESTED           CODE(S)            DATE
	
SITAGLIPTIN PHOSPHATE - JANUVIA
	
 N 021995 001   6303661           Apr 24, 2017            U-774
	
                6699871           Jul 26, 2022      DS DP U-774
	
                6890898           Feb 02, 2019            U-775
	
                6890898           Feb 02, 2019            U-1036
	
                6890898           Feb 02, 2019            U-1039
	
                7078381           Feb 02, 2019            U-775
	
                7078381           Feb 02, 2019            U-1036
	
                7078381           Feb 02, 2019            U-1037
	
                7078381           Feb 02, 2019            U-1038
	
                7125873           Jul 26, 2022            U-775
	
                7125873           Jul 26, 2022            U-1036
	
                7125873           Jul 26, 2022            U-1037
	
                7125873           Jul 26, 2022            U-1038
	
                7326708           Apr 11, 2026      DS DP U-802
	
SITAGLIPTIN PHOSPHATE - JANUVIA
	
 N 021995 002   6303661           Apr 24, 2017            U-774
	
                6699871           Jul 26, 2022      DS DP U-774
	
                6890898           Feb 02, 2019            U-775
	
                6890898           Feb 02, 2019            U-1036
	
                6890898           Feb 02, 2019            U-1039
	
                7078381           Feb 02, 2019            U-775
	
                7078381           Feb 02, 2019            U-1036
	
                7078381           Feb 02, 2019            U-1037
	
                7078381           Feb 02, 2019            U-1038
	
                7125873           Jul 26, 2022            U-775
	
                7125873           Jul 26, 2022            U-1036
	
                7125873           Jul 26, 2022            U-1037
	
                7125873           Jul 26, 2022            U-1038
	
                7326708           Apr 11, 2026      DS DP U-802
	
SITAGLIPTIN PHOSPHATE - JANUVIA
	
 N 021995 003   6303661           Apr 24, 2017            U-774
	
                6699871           Jul 26, 2022      DS DP U-774
	
                6890898           Feb 02, 2019            U-775
	
                6890898           Feb 02, 2019            U-1036
	
                6890898           Feb 02, 2019            U-1039
	
                7078381           Feb 02, 2019            U-775
	
                7078381           Feb 02, 2019            U-1036
	
                7078381           Feb 02, 2019            U-1037
	
                7078381           Feb 02, 2019            U-1038
	
                7125873           Jul 26, 2022            U-775
	
                7125873           Jul 26, 2022            U-1036
	
                7125873           Jul 26, 2022            U-1037
	
                7125873           Jul 26, 2022            U-1038
	
                7326708           Apr 11, 2026      DS DP U-802
	
SODIUM NITRITE - SODIUM NITRITE
	
 N 203922 001   8568793           Dec 24, 2031      DS DP                                ODE           Jan 14, 2018
	
SODIUM NITRITE; SODIUM THIOSULFATE - NITHIODOTE
	
 N 201444 001   8496973          Mar 29, 2031     DS DP U-1419                           ODE           Jan 14, 2018
	
                8568793          Dec 24, 2031     DS DP
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 198 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                  PATENT                      EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION             PATENT             DELIST     EXCLUSIVITY       EXPIRATION
	
                                        DATE                 CODES            REQUESTED     CODE(S)            DATE
	
SODIUM OXYBATE - XYREM
	
 N 021196 001   6780889             Jul   04,   2020        DP
	
                7262219             Jul   04,   2020        DP
	
                7668730             Jun   16,   2024             U-1110
	
                7765106             Jun   16,   2024             U-1069
	
                7765107             Jun   16,   2024             U-1070
	
                7851506             Dec   22,   2019             U-1101
	
                7851506             Dec   22,   2019             U-1102
	
                7895059             Dec   17,   2022             U-1110
	
                8263650             Dec   22,   2019        DP U-1101
	
                8263650             Dec   22,   2019        DP U-1102
	
                8324275             Dec   22,   2019             U-1101
	
                8324275             Dec   22,   2019             U-1102
	
                8457988             Dec   17,   2022             U-1110
	
                8589182             Dec   17,   2022             U-1110
	
                8731963             Dec   17,   2022             U-1110
	
                8772306             Mar   15,   2033             U-1532
	
                8859619             Dec   22,   2019        DP
	
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE - OSMOPREP
	
 N 021892 001   7687075          Jun 22, 2028    DS DP
	
SODIUM THIOSULFATE - SODIUM THIOSULFATE
	
 N 203923 001   8496973          Mar 29, 2031          DS DP U-1419                         ODE           Jan 14, 2018
	
SOFOSBUVIR - SOVALDI
	
 N 204671 001   7964580             Mar   26,   2029   DS   DP     U-1470                   NCE           Dec 06, 2018
	
                8334270             Mar   21,   2028   DS   DP     U-1470
	
                8580765             Mar   21,   2028   DS   DP     U-1470
	
                8618076             Dec   11,   2030   DS   DP     U-1470
	
                8633309             Mar   26,   2029   DS   DP     U-1470
	
                8889159             Mar   26,   2029        DP     U-1470
	
SOLIFENACIN SUCCINATE - VESICARE
	
 N 021518 001   6017927           Nov 19, 2018         DS DP
	
SOLIFENACIN SUCCINATE - VESICARE
	
 N 021518 002   6017927           Nov 19, 2018         DS DP
	
SOMATROPIN RECOMBINANT - SAIZEN
	
 N 019764 002   5898030           Apr 27, 2016              DP
	
SOMATROPIN RECOMBINANT - SAIZEN
	
 N 019764 003   5898030           Apr 27, 2016              DP
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 199 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                             PATENT                           EXCLUSIVITY
     NO          PATENT NO       EXPIRATION         PATENT            DELIST          EXCLUSIVITY       EXPIRATION
                                    DATE             CODES          REQUESTED           CODE(S)            DATE
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 001   5716338          Feb 10, 2015        DP
                6152897          Nov 20, 2018        DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 002   5716338          Feb 10, 2015       DP
                6152897          Nov 20, 2018       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 003   5716338          Feb 10, 2015       DP
                6152897          Nov 20, 2018       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 005   5716338          Feb 10, 2015       DP
                6152897          Nov 20, 2018       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 008   5716338          Feb 10, 2015       DP
                6152897          Nov 20, 2018       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 009   5716338          Feb 10, 2015       DP
                6152897          Nov 20, 2018       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 010   5716338          Feb 10, 2015       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 011   5716338          Feb 10, 2015       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 012   5716338          Feb 10, 2015       DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE
 N 020280 013   5716338          Feb 10, 2015       DP
SOMATROPIN RECOMBINANT - NUTROPIN AQ
 N 020522 001   5763394          Jun 09, 2015         DP
SOMATROPIN RECOMBINANT - NUTROPIN AQ PEN
 N 020522 002   5763394          Jun 09, 2015         DP
SOMATROPIN RECOMBINANT - SEROSTIM
 N 020604 001   5898030          Apr 27, 2016         DP
SOMATROPIN RECOMBINANT - SEROSTIM
 N 020604 002   5898030          Apr 27, 2016         DP
SOMATROPIN RECOMBINANT - SEROSTIM
 N 020604 003   5898030          Apr 27, 2016         DP
SOMATROPIN RECOMBINANT - SEROSTIM
 N 020604 004   5898030          Apr 27, 2016         DP
SOMATROPIN RECOMBINANT - NUTROPIN DEPOT
 N 021075 001   5654010          Aug 05, 2014
                5656297          Jul 25, 2014
SOMATROPIN RECOMBINANT - NUTROPIN DEPOT
 N 021075 002   5654010          Aug 05, 2014
                5656297          Jul 25, 2014
SOMATROPIN RECOMBINANT - NUTROPIN DEPOT
 N 021075 003   5654010          Aug 05, 2014
                5656297          Jul 25, 2014
SOMATROPIN RECOMBINANT - NORDITROPIN
 N 021148 001   5849700          Dec 15, 2015              U-340
                5849704          Dec 15, 2015
SOMATROPIN RECOMBINANT - NORDITROPIN
 N 021148 002   5849700          Dec 15, 2015              U-340
                5849704          Dec 15, 2015
SOMATROPIN RECOMBINANT - NORDITROPIN
 N 021148 003   5849700          Dec 15, 2015              U-340
                5849704          Dec 15, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 200 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                    DATE               CODES        REQUESTED           CODE(S)            DATE
	
SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX
 N 021148 004   5849700          Dec 15, 2015            U-340
                5849704          Dec 15, 2015         DP U-340
                6004297          Jan 28, 2019         DP
                6235004          Jan 28, 2019         DP
                RE41956          Jan 21, 2021         DP
SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX
 N 021148 005   5849700          Dec 15, 2015            U-340
                5849704          Dec 15, 2015         DP U-340
                6004297          Jan 28, 2019         DP
                6235004          Jan 28, 2019         DP
                RE41956          Jan 21, 2021         DP
SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX
 N 021148 006   5849700          Dec 15, 2015            U-340
                5849704          Dec 15, 2015         DP U-340
                6004297          Jan 28, 2019         DP
                6235004          Jan 28, 2019         DP
                RE41956          Jan 21, 2021         DP
SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX
 N 021148 007   5849700          Dec 15, 2015            U-340
                5849704          Dec 15, 2015         DP U-340
                6004297          Jan 28, 2019         DP
                8841252          Dec 26, 2017         DP
                RE41956          Jan 21, 2021         DP
                RE43834          Jan 28, 2019         DP
SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO
 N 021148 008   5849700          Dec 15, 2015            U-1041
                5849704          Dec 15, 2015         DP U-1041
                6899699          Jan 02, 2022         DP
                7686786          Aug 03, 2026         DP
                8672898          Jan 02, 2022         DP
                8684969          Oct 20, 2025         DP
                8841252          Dec 26, 2017         DP
SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO
 N 021148 009   5849700          Dec 15, 2015            U-1041
                5849704          Dec 15, 2015         DP U-1041
                6899699          Jan 02, 2022         DP
                7686786          Aug 03, 2026         DP
                8672898          Jan 02, 2022         DP
                8684969          Oct 20, 2025         DP
                8841252          Dec 26, 2017         DP
SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO
 N 021148 010   5849700          Dec 15, 2015            U-1041
                5849704          Dec 15, 2015         DP U-1041
                6899699          Jan 02, 2022         DP
                7686786          Aug 03, 2026         DP
                8672898          Jan 02, 2022         DP
                8684969          Oct 20, 2025         DP
                8841252          Dec 26, 2017         DP
SOMATROPIN RECOMBINANT - ZORBTIVE
 N 021597 004   5898030          Apr 27, 2016         DP
SORAFENIB TOSYLATE - NEXAVAR
 N 021923 001   7235576         Jan   12,   2020   DS DP                                I-677         Nov 22, 2016
                7351834         Jan   12,   2020   DS                                   ODE           Nov 16, 2014
                7897623         Jan   12,   2020      DP                                ODE           Nov 22, 2020
                8124630         Jul   13,   2022         U-1459
                8618141         Feb   11,   2023         U-1480
                8877933         Dec   24,   2027   DS DP U-1624
SOTALOL HYDROCHLORIDE - SOTALOL HYDROCHLORIDE
 N 022306 001                                                                           ODE           Jul 02, 2016
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 201 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
SPINOSAD - NATROBA
 N 022408 001   6063771            Jun 22, 2019            DP U-1105                       NCE           Jan 18, 2016
                6342482            Jun 22, 2019            DP U-1105
                7030095            Jul 02, 2021            DP U-1105
STAVUDINE - ZERIT XR
 N 021453 001   7135465            Feb 18, 2023            DP U-167
STAVUDINE - ZERIT XR
 N 021453 002   7135465            Feb 18, 2023            DP U-167
STAVUDINE - ZERIT XR
 N 021453 003   7135465            Feb 18, 2023            DP U-167
STAVUDINE - ZERIT XR
 N 021453 004   7135465            Feb 18, 2023            DP U-167
SUCROFERRIC OXYHYDROXIDE - VELPHORO
 N 205109 001   6174442          Dec 19, 2016         DS        U-1468                     NP            Nov 27, 2016
SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES - LUMASON
 N 203684 001                                                                              NCE           Oct 10, 2019
SUMATRIPTAN SUCCINATE - SUMAVEL DOSEPRO
 N 022239 001   5891086          Jul 27,       2014        DP
                5957886          Mar 08,       2016        DP
                6135979          Mar 21,       2017        DP
                6174304          Dec 13,       2015        DP
                6251091          Dec 09,       2016        DP
                6280410          Mar 27,       2017        DP
                6681810          Dec 13,       2015        DP
                7776007          Nov 22,       2026        DP
                7901385          Jul 31,       2026        DP
                8118771          Aug 10,       2023        DP
                8241243          Aug 10,       2023        DP
                8241244          Nov 21,       2022        DP
                8267903          Mar 18,       2023        DP
                8287489          Dec 06,       2024        DP
                8343130          Oct 18,       2022        DP
                8491524          Nov 21,       2022        DP
SUMATRIPTAN SUCCINATE - ALSUMA
 N 022377 001   7811254            Aug 26, 2027            DP U-1083
SUMATRIPTAN SUCCINATE - ZECUITY
 N 202278 001   6745071            Feb   21,   2023        DP                              NDF           Jan 17, 2016
                7973058            Apr   12,   2027             U-1328
                8155737            Apr   12,   2027             U-1328
                8366600            Apr   21,   2029             U-1327
                8470853            Apr   12,   2027             U-1328
                8597272            Apr   12,   2027        DP
SUNITINIB MALATE - SUTENT
 N 021938 001   6573293            Feb 15, 2021       DS DP U-1154
                7125905            Feb 15, 2021       DS DP
                7211600            Dec 22, 2020             U-883
SUNITINIB MALATE - SUTENT
 N 021938 002   6573293            Feb 15, 2021       DS DP U-1154
                7125905            Feb 15, 2021       DS DP
                7211600            Dec 22, 2020             U-883
SUNITINIB MALATE - SUTENT
 N 021938 003   6573293            Feb 15, 2021       DS DP U-1154
                7125905            Feb 15, 2021       DS DP
                7211600            Dec 22, 2020             U-883
SUNITINIB MALATE - SUTENT
 N 021938 004   6573293            Feb 15, 2021       DS DP U-1154
                7125905            Feb 15, 2021       DS DP
                7211600            Dec 22, 2020             U-883
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 202 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                            PATENT                            EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
                                          DATE               CODES        REQUESTED           CODE(S)            DATE
SUVOREXANT - BELSOMRA
 N 204569    001   7951797            Nov 20, 2029       DS DP U-620                          NCE           Aug 13, 2019
SUVOREXANT - BELSOMRA
 N 204569 002   7951797               Nov 20, 2029       DS DP U-620                          NCE           Aug 13, 2019
SUVOREXANT - BELSOMRA
 N 204569 003   7951797               Nov 20, 2029       DS DP U-620                          NCE           Aug 13, 2019
SUVOREXANT - BELSOMRA
 N 204569 004   7951797               Nov 20, 2029       DS DP U-620                          NCE           Aug 13, 2019
TACROLIMUS - PROTOPIC
 N 050777 001   5665727               Sep 09, 2014               U-919
TACROLIMUS - PROTOPIC
 N 050777 002   5665727               Sep 09, 2014               U-919
TACROLIMUS - ASTAGRAF XL
 N 204096 001   6440458               Mar   25,   2019      DP                                NDF           Jul 19, 2016
                6576259               Mar   25,   2019      DP U-1420
                6884433               Mar   25,   2019      DP U-1420
                8551522               Mar   25,   2019      DP
TACROLIMUS - ASTAGRAF XL
 N 204096 002   6440458               Mar   25,   2019      DP                                NDF           Jul 19, 2016
                6576259               Mar   25,   2019      DP U-1420
                6884433               Mar   25,   2019      DP U-1420
                8551522               Mar   25,   2019      DP
TACROLIMUS - ASTAGRAF XL
 N 204096 003   6440458               Mar   25,   2019      DP                                NDF           Jul 19, 2016
                6576259               Mar   25,   2019      DP U-1420
                6884433               Mar   25,   2019      DP U-1420
                8551522               Mar   25,   2019      DP
TADALAFIL - CIALIS
 N 021368 001   5859006               Nov   21,   2017   DS DP                                I-641         Oct 06, 2014
                6140329               Jul   11,   2016      DP U-155                          I-642         Oct 06, 2014
                6140329               Jul   11,   2016      DP U-1184
                6821975               Nov   19,   2020   DS DP U-533
                6821975               Nov   19,   2020   DS DP U-614
                6821975               Nov   19,   2020   DS DP U-1184
                6943166               Apr   26,   2020         U-155
                6943166               Apr   26,   2020         U-614
                6943166               Apr   26,   2020         U-1184
                7182958               Apr   26,   2020      DP U-155
                7182958               Apr   26,   2020      DP U-1184
TADALAFIL - CIALIS
 N 021368 002   5859006               Nov   21,   2017   DS DP                                I-641         Oct 06, 2014
                6140329               Jul   11,   2016      DP U-155                          I-642         Oct 06, 2014
                6821975               Nov   19,   2020   DS DP U-533
                6821975               Nov   19,   2020   DS DP U-614
                6943166               Apr   26,   2020         U-155
                6943166               Apr   26,   2020         U-614
                7182958               Apr   26,   2020      DP U-155
TADALAFIL - CIALIS
 N 021368 003   5859006               Nov   21,   2017   DS DP                                I-641         Oct 06, 2014
                6140329               Jul   11,   2016      DP U-155                          I-642         Oct 06, 2014
                6821975               Nov   19,   2020   DS DP U-533
                6821975               Nov   19,   2020   DS DP U-614
                6943166               Apr   26,   2020         U-614
                7182958               Apr   26,   2020      DP U-155
TADALAFIL - CIALIS
 N 021368 004   5859006               Nov   21,   2017   DS DP                                I-641         Oct 06, 2014
                6140329               Jul   11,   2016      DP U-155                          I-642         Oct 06, 2014
                6821975               Nov   19,   2020   DS DP U-533
                6821975               Nov   19,   2020   DS DP U-614
                6943166               Apr   26,   2020         U-155
                7182958               Apr   26,   2020      DP U-155
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 203 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                         PATENT
	                            PATENT                          EXCLUSIVITY
	
     NO          PATENT NO
	      EXPIRATION
	          PATENT          DELIST         EXCLUSIVITY       EXPIRATION
	
                                     DATE
	              CODES         REQUESTED         CODE(S)            DATE
	
TADALAFIL - ADCIRCA
	
 N 022332 001   5859006
	        Nov 21, 2017
	       DS DP U-975                        ODE           May 22, 2016
	
                6821975
	        Nov 19, 2020
	       DS DP
                7182958
	        Apr 26, 2020
	          DP
TAFLUPROST - ZIOPTAN
	
 N 202514 001   5886035
	        Dec 18, 2017
	       DS DP U-778                        NCE           Feb 10, 2017
	
TALIGLUCERASE ALFA - ELELYSO
	
 N 022458 001   8227230
	        Feb   24,   2024
	   DS DP                              NCE           May 01, 2017

                8741620
	        Feb   24,   2024
	   DS DP                              NPP           Aug 27, 2017
	
                8790641
	        Oct   18,   2025
	           U-1564
                8790641
	        Oct   18,   2025
	           U-1574
TAMOXIFEN CITRATE - SOLTAMOX
	
 N 021807 001   6127425
	        Jun 26, 2018
	          DP
TAPENTADOL HYDROCHLORIDE - NUCYNTA
	
 N 022304 001   6071970          Jun 06, 2017               U-931
                7994364          Jun 27, 2025         DS DP U-931
                RE39593          Aug 05, 2022         DS DP U-931
TAPENTADOL HYDROCHLORIDE - NUCYNTA
	
 N 022304 002   6071970          Jun 06, 2017
	             U-931
                7994364          Jun 27, 2025
	       DS DP U-931
                RE39593          Aug 05, 2022
	       DS DP U-931
TAPENTADOL HYDROCHLORIDE - NUCYNTA
	
 N 022304 003   6071970          Jun 06, 2017
	             U-931
                7994364          Jun 27, 2025
	       DS DP U-931
                RE39593          Aug 05, 2022
	       DS DP U-931
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 204 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT
	                           PATENT                           EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION
	         PATENT          DELIST          EXCLUSIVITY       EXPIRATION
	
                                    DATE
	             CODES        REQUESTED           CODE(S)            DATE
	
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER
	
 N 200533 001		 6071970          Jun 06,   2017
	         U-1178                        I-656         Aug 28, 2015

                6071970          Jun 06,   2017
	         U-1276                        NDF           Aug 25, 2014
	
                7994364          Jun 27,   2025
	   DS DP U-1178
                7994364          Jun 27,   2025
	   DS DP U-1276
                8075872          Nov 20,   2023
	      DP
                8114383          Oct 10,   2024
	      DP                  Y
                8309060          Nov 20,   2023
	      DP U-1178
                8309060          Nov 20,   2023
	      DP U-1276
                8420056          Nov 20,   2023
	      DP
                8536130          Sep 22,   2028
          U-1276
                RE39593          Aug 05,   2022
    DS DP U-1178
                RE39593          Aug 05,   2022
	   DS DP U-1276
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER
	
 N 200533 002		 6071970          Jun 06,   2017
	         U-1178                        I-656         Aug 28, 2015

                6071970          Jun 06,   2017
	         U-1276                        NDF           Aug 25, 2014
	
                7994364          Jun 27,   2025
	   DS DP U-1178
                7994364          Jun 27,   2025
	   DS DP U-1276
                8075872          Nov 20,   2023
	      DP
                8114383          Oct 10,   2024
	      DP                  Y
                8309060          Nov 20,   2023
	      DP U-1178
                8309060          Nov 20,   2023
	      DP U-1276
                8420056          Nov 20,   2023
	      DP
                8536130          Sep 22,   2028
          U-1276
                RE39593          Aug 05,   2022
    DS DP U-1178
                RE39593          Aug 05,   2022
	   DS DP U-1276
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER
	
 N 200533 003		 6071970          Jun 06,   2017
	         U-1178                        I-656         Aug 28, 2015

                6071970          Jun 06,   2017
	         U-1276                        NDF           Aug 25, 2014
	
                7994364          Jun 27,   2025
	   DS DP U-1178
                7994364          Jun 27,   2025
	   DS DP U-1276
                8075872          Nov 20,   2023
	      DP
                8114383          Oct 10,   2024
	      DP                  Y
                8309060          Nov 20,   2023
	      DP U-1178
                8309060          Nov 20,   2023
	      DP U-1276
                8420056          Nov 20,   2023
	      DP
                8536130          Sep 22,   2028
          U-1276
                RE39593          Aug 05,   2022
    DS DP U-1178
                RE39593          Aug 05,   2022
	   DS DP U-1276
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER
	
 N 200533 004		 6071970          Jun 06,   2017
	         U-1178                        I-656         Aug 28, 2015

                6071970          Jun 06,   2017
	         U-1276                        NDF           Aug 25, 2014
	
                7994364          Jun 27,   2025
	   DS DP U-1178
                7994364          Jun 27,   2025
	   DS DP U-1276
                8075872          Nov 20,   2023
	      DP
                8114383          Oct 10,   2024
	      DP                  Y
                8309060          Nov 20,   2023
	      DP U-1178
                8309060          Nov 20,   2023
	      DP U-1276
                8420056          Nov 20,   2023
	      DP
                8536130          Sep 22,   2028
          U-1276
                RE39593          Aug 05,   2022
    DS DP U-1178
                RE39593          Aug 05,   2022
	   DS DP U-1276
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER
	
 N 200533 005		 6071970          Jun 06,   2017
	         U-1178                        I-656         Aug 28, 2015

                6071970          Jun 06,   2017
	         U-1276                        NDF           Aug 25, 2014
	
                7994364          Jun 27,   2025
	   DS DP U-1178
                7994364          Jun 27,   2025
	   DS DP U-1276
                8075872          Nov 20,   2023
	      DP
                8114383          Oct 10,   2024
	      DP                  Y
                8309060          Nov 20,   2023
	      DP U-1178
                8309060          Nov 20,   2023
	      DP U-1276
                8420056          Nov 20,   2023
	      DP
                8536130          Sep 22,   2028
          U-1276
                RE39593          Aug 05,   2022
    DS DP U-1178
                RE39593          Aug 05,   2022
	   DS DP U-1276
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 205 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
TAPENTADOL HYDROCHLORIDE - NUCYNTA
 N 203794 001   6071970          Jun 06, 2017               U-1289
                7994364          Jun 27, 2025         DS DP U-1289
                RE39593          Aug 05, 2022         DS DP U-1289
TASIMELTEON - HETLIOZ
 N 205677 001   5856529            Dec 09, 2017       DS DP U-1486                         NCE           Jan 31, 2019
                8785492            Jan 25, 2033             U-1486                         ODE           Jan 31, 2021
TAVABOROLE - KERYDIN
 N 204427 001   7582621            May 26, 2027                 U-718                      NCE           Jul 07, 2019
                7767657            May 22, 2027            DP
TAZAROTENE - FABIOR
 N 202428 001   8808716            Feb 24, 2030            DP                              NDF           May 11, 2015
TECHNETIUM TC-99M APCITIDE - ACUTECT
 N 020887 001   5645815          Jul 08, 2014
TECHNETIUM TC-99M SULFUR COLLOID KIT - AN-SULFUR COLLOID
 N 017858 001                                                                              ODE           Aug 13, 2019
TECHNETIUM TC-99M TEBOROXIME KIT - CARDIOTEC
 N 019928 001   6056941          Jul 28, 2019              DP
TECHNETIUM TC-99M TILMANOCEPT - LYMPHOSEEK KIT
 N 202207 001   6409990          May 12, 2020         DS                                   I-687         Jun 13, 2017
                                                                                           NCE           Mar 13, 2018
                                                                                           ODE           Jun 13, 2021
TEDIZOLID PHOSPHATE - SIVEXTRO
 N 205435 001   7816379            Feb 23, 2028       DS DP U-282                          NCE           Jun 20, 2019
                8420676            Feb 23, 2028       DS DP U-282                          GAIN          Jun 20, 2024
                8426389            Dec 31, 2030       DS DP U-282
TEDIZOLID PHOSPHATE - SIVEXTRO
 N 205436 001   7816379            Feb 23, 2028       DS DP U-282                          NCE           Jun 20, 2019
                8420676            Feb 23, 2028       DS DP U-282                          GAIN          Jun 20, 2024
                8426389            Dec 31, 2030       DS DP U-282
TEDUGLUTIDE RECOMBINANT - GATTEX KIT
 N 203441 001   5789379          Apr 14, 2015         DS DP U-1320                         NCE           Dec 21, 2017
                7056886          Sep 18, 2022            DP U-1320                         ODE           Dec 21, 2019
                7847061          Nov 01, 2025               U-1320
TELAPREVIR - INCIVEK
 N 201917 001   7820671            Feb 25, 2025       DS DP                                NCE           May 23, 2016
                8431615            May 30, 2028                 U-1398
                8529882            Aug 31, 2021                 U-1398
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 206 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
TELAVANCIN HYDROCHLORIDE - VIBATIV
 N 022110 001   6635618          Sep     11,   2023   DS DP U-728                          I-673         Jun 21, 2016
                6858584          Aug     24,   2022      DP                                NCE           Sep 11, 2014
                6872701          Jun     05,   2021      DP
                7008923          May     06,   2021         U-1005
                7208471          May     01,   2021   DS DP
                7351691          May     01,   2021   DS DP U-728
                7531623          Jan     01,   2027   DS
                7544364          May     01,   2021      DP
                7700550          May     01,   2021         U-282
                8101575          May     01,   2021      DP
                8158580          May     01,   2021      DP
TELAVANCIN HYDROCHLORIDE - VIBATIV
 N 022110 002   6635618          Sep     11,   2023   DS DP U-728                          I-673         Jun 21, 2016
                6858584          Aug     24,   2022      DP                                NCE           Sep 11, 2014
                6872701          Jun     05,   2021      DP
                7008923          May     06,   2021         U-1005
                7208471          May     01,   2021   DS DP
                7351691          May     01,   2021   DS DP U-728
                7531623          Jan     01,   2027   DS
                7544364          May     01,   2021      DP
                7700550          May     01,   2021         U-282
                8101575          May     01,   2021      DP
                8158580          May     01,   2021      DP
TELBIVUDINE - TYZEKA
 N 022011 001   6395716            Aug   10,   2019         U-782                          M-124         Jan 28, 2016
                6444652            Aug   10,   2019         U-782
                6566344            Aug   10,   2019         U-782
                6569837            Oct   25,   2020         U-782
                6569837            Oct   25,   2020         U-999
                7589079            Sep   11,   2023   DS DP U-999
                7795238            Aug   10,   2019         U-999
                7858594            Sep   11,   2023   DS DP U-999
TELBIVUDINE - TYZEKA
 N 022154 001   6395716            Aug   10,   2019         U-999                          M-124         Jan 28, 2016
                6444652            Aug   10,   2019         U-999
                6566344            Aug   10,   2019         U-999
                6569837            Oct   25,   2020         U-999
                7795238            Aug   10,   2019         U-999
                7858594            Sep   11,   2023   DS DP U-999
TELITHROMYCIN - KETEK
 N 021144 001   5635485            Apr 01, 2018       DS DP U-578
                D459798            Sep 24, 2015          DP
TELITHROMYCIN - KETEK
 N 021144 002   5635485            Apr 01, 2018       DS DP U-578
                D459798            Sep 24, 2015          DP
TELMISARTAN - TELMISARTAN
 A 078710 001                                                                              PC            Jul 07, 2014
TELMISARTAN - TELMISARTAN
 A 078710 002                                                                              PC            Jul 07, 2014
TELMISARTAN - TELMISARTAN
 A 078710 003                                                                              PC            Jul 07, 2014
TELMISARTAN - MICARDIS
 N 020850 001   6358986            Jan 10, 2020
TELMISARTAN - MICARDIS
 N 020850 002   6358986            Jan 10, 2020
                7998953            Jun 06, 2020              U-1177
                8003679            Oct 06, 2022              U-1176
TELMISARTAN - MICARDIS
 N 020850 003   6358986            Jan 10, 2020
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 207 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO         PATENT NO           EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
TEMOZOLOMIDE - TEMODAR
 N 022277 001   6987108            Sep 08, 2023          DP
                7786118            Feb 21, 2023          DP
                8623868            Feb 21, 2023          DP
TEMSIROLIMUS - TORISEL
 N 022088 001   5362718            Feb   15,   2019   DS DP                   Y            M-61          May 30, 2015
                5362718*PED        Aug   15,   2019                                        PED           Nov 30, 2014
                8026276            Jan   20,   2026      DP                                PED           Nov 30, 2015
                8299116            Jul   25,   2023      DP
                8455539            Jul   25,   2023      DP
                8455539*PED        Jan   25,   2024
                8722700            Jul   25,   2023      DP
                8722700*PED        Jan   25,   2024
                8791097            May   10,   2032           U-1550
                8791097            May   10,   2032           U-1551
                RE44768            Feb   15,   2019   DS DP
                RE44768*PED        Aug   15,   2019
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 208 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                       See report footnote for information regarding report content

 APPL/PROD                         PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO       EXPIRATION             PATENT           DELIST       EXCLUSIVITY       EXPIRATION
	
                                    DATE                 CODES          REQUESTED       CODE(S)            DATE
	
TENOFOVIR DISOPROXIL FUMARATE - VIREAD
	
 N 021356 001   5922695          Jul 25,   2017    DS        U-248                      M-128         Jul   24,   2016
	
                5922695          Jul 25,   2017    DS        U-250                      NPP           Jan   18,   2015
	
                5922695          Jul 25,   2017    DS        U-256                      NPP           Aug   16,   2015

                5922695          Jul 25,   2017    DS        U-999                      ODE           Mar   24,   2017
	
                5922695          Jul 25,   2017    DS        U-1275                     PED           Jul   18,   2015
	
                5935946          Jul 25,   2017    DS   DP   U-248                      PED           Sep   24,   2017

                5935946          Jul 25,   2017    DS   DP   U-250
	
                5935946          Jul 25,   2017    DS   DP   U-256
	
                5935946          Jul 25,   2017    DS   DP   U-999
	
                5935946          Jul 25,   2017    DS   DP   U-1275
	
                5977089          Jul 25,   2017    DS   DP   U-248
	
                5977089          Jul 25,   2017    DS   DP   U-250
	
                5977089          Jul 25,   2017    DS   DP   U-256
	
                5977089          Jul 25,   2017    DS   DP   U-999
	
                5977089          Jul 25,   2017    DS   DP   U-1275
	
                6043230          Jul 25,   2017              U-248
	
                6043230          Jul 25,   2017              U-250
	
                6043230          Jul 25,   2017              U-256
	
                6043230          Jul 25,   2017              U-999
	
                6043230          Jul 25,   2017              U-1275
	
TENOFOVIR DISOPROXIL FUMARATE - VIREAD
	
 N 021356 002   5922695          Jul 25,   2017    DS        U-248                      M-128         Jul   24,   2016
	
                5922695          Jul 25,   2017    DS        U-250                      NPP           Jan   18,   2015
	
                5922695          Jul 25,   2017    DS        U-256                      NPP           Aug   16,   2015

                5922695          Jul 25,   2017    DS        U-999                      ODE           Mar   24,   2017
	
                5922695          Jul 25,   2017    DS        U-1275                     PED           Jul   18,   2015
	
                5935946          Jul 25,   2017    DS   DP   U-248                      PED           Sep   24,   2017

                5935946          Jul 25,   2017    DS   DP   U-250
	
                5935946          Jul 25,   2017    DS   DP   U-256
	
                5935946          Jul 25,   2017    DS   DP   U-999
	
                5935946          Jul 25,   2017    DS   DP   U-1275
	
                5977089          Jul 25,   2017    DS   DP   U-248
	
                5977089          Jul 25,   2017    DS   DP   U-250
	
                5977089          Jul 25,   2017    DS   DP   U-256
	
                5977089          Jul 25,   2017    DS   DP   U-999
	
                5977089          Jul 25,   2017    DS   DP   U-1275
	
                6043230          Jul 25,   2017              U-248
	
                6043230          Jul 25,   2017              U-250
	
                6043230          Jul 25,   2017              U-256
	
                6043230          Jul 25,   2017              U-999
	
                6043230          Jul 25,   2017              U-1275
	
TENOFOVIR DISOPROXIL FUMARATE - VIREAD
	
 N 021356 003   5922695          Jul 25,   2017    DS        U-248                      M-128         Jul   24,   2016
	
                5922695          Jul 25,   2017    DS        U-250                      NPP           Jan   18,   2015
	
                5922695          Jul 25,   2017    DS        U-256                      NPP           Aug   16,   2015

                5922695          Jul 25,   2017    DS        U-999                      ODE           Mar   24,   2017
	
                5922695          Jul 25,   2017    DS        U-1275                     PED           Jul   18,   2015
	
                5935946          Jul 25,   2017    DS   DP   U-248                      PED           Sep   24,   2017

                5935946          Jul 25,   2017    DS   DP   U-250
	
                5935946          Jul 25,   2017    DS   DP   U-256
	
                5935946          Jul 25,   2017    DS   DP   U-999
	
                5935946          Jul 25,   2017    DS   DP   U-1275
	
                5977089          Jul 25,   2017    DS   DP   U-248
	
                5977089          Jul 25,   2017    DS   DP   U-250
	
                5977089          Jul 25,   2017    DS   DP   U-256
	
                5977089          Jul 25,   2017    DS   DP   U-999
	
                5977089          Jul 25,   2017    DS   DP   U-1275
	
                6043230          Jul 25,   2017              U-248
	
                6043230          Jul 25,   2017              U-250
	
                6043230          Jul 25,   2017              U-256
	
                6043230          Jul 25,   2017              U-999
	
                6043230          Jul 25,   2017              U-1275
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 209 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                         PATENT                                     PATENT                         EXCLUSIVITY
     NO            PATENT NO     EXPIRATION                   PATENT          DELIST        EXCLUSIVITY       EXPIRATION
                                    DATE                      CODES         REQUESTED         CODE(S)            DATE
TENOFOVIR DISOPROXIL FUMARATE - VIREAD
 N 021356    004   5922695            Jul   25,   2017   DS        U-248                      M-128         Jul   24,   2016
                   5922695            Jul   25,   2017   DS        U-250                      NPP           Jan   18,   2015
                   5922695            Jul   25,   2017   DS        U-256                      NPP           Aug   16,   2015
                   5922695            Jul   25,   2017   DS        U-999                      ODE           Mar   24,   2017
                   5922695            Jul   25,   2017   DS        U-1275                     PED           Jul   18,   2015
                   5935946            Jul   25,   2017   DS   DP   U-248                      PED           Sep   24,   2017
                   5935946            Jul   25,   2017   DS   DP   U-250
                   5935946            Jul   25,   2017   DS   DP   U-256
                   5935946            Jul   25,   2017   DS   DP   U-999
                   5935946            Jul   25,   2017   DS   DP   U-1275
                   5977089            Jul   25,   2017   DS   DP   U-248
                   5977089            Jul   25,   2017   DS   DP   U-250
                   5977089            Jul   25,   2017   DS   DP   U-256
                   5977089            Jul   25,   2017   DS   DP   U-999
                   5977089            Jul   25,   2017   DS   DP   U-1275
                   6043230            Jul   25,   2017             U-248
                   6043230            Jul   25,   2017             U-250
                   6043230            Jul   25,   2017             U-256
                   6043230            Jul   25,   2017             U-999
                   6043230            Jul   25,   2017             U-1275
TENOFOVIR DISOPROXIL FUMARATE - VIREAD
 N 022577 001   5922695          Jul 25,          2017   DS        U-248                      M-128         Jul   24,   2016
                5922695          Jul 25,          2017   DS        U-250                      NDF           Jan   18,   2015
                5922695          Jul 25,          2017   DS        U-256                      NPP           Aug   16,   2015
                5922695          Jul 25,          2017   DS        U-999                      ODE           Mar   24,   2017
                5922695          Jul 25,          2017   DS        U-1275                     PED           Jul   18,   2015
                5935946          Jul 25,          2017   DS   DP   U-248                      PED           Sep   24,   2017
                5935946          Jul 25,          2017   DS   DP   U-250
                5935946          Jul 25,          2017   DS   DP   U-256
                5935946          Jul 25,          2017   DS   DP   U-999
                5935946          Jul 25,          2017   DS   DP   U-1275
                5977089          Jul 25,          2017   DS   DP   U-248
                5977089          Jul 25,          2017   DS   DP   U-250
                5977089          Jul 25,          2017   DS   DP   U-256
                5977089          Jul 25,          2017   DS   DP   U-999
                5977089          Jul 25,          2017   DS   DP   U-1275
                6043230          Jul 25,          2017             U-248
                6043230          Jul 25,          2017             U-250
                6043230          Jul 25,          2017             U-256
                6043230          Jul 25,          2017             U-999
                6043230          Jul 25,          2017             U-1275
TERBINAFINE - LAMISIL
 N 020846 001   5681849               Oct 28, 2014            DP
TERBINAFINE - LAMISIL AT
 N 021958 001   5681849               Oct 28, 2014            DP
TERBINAFINE HYDROCHLORIDE - LAMISIL AT
 N 021124 001   5681849          Oct 28, 2014
TERBINAFINE HYDROCHLORIDE - LAMISIL AT
 N 021124 002   5681849          Oct 28, 2014
TERIFLUNOMIDE - AUBAGIO
 N 202992 001   5679709               Oct 21, 2014            DP U-1285                       NCE           Sep 12, 2017
                6794410               Apr 15, 2022               U-1285
                8802735               Sep 14, 2030            DP
TERIFLUNOMIDE - AUBAGIO
 N 202992 002   5679709               Oct 21, 2014            DP U-1285                       NCE           Sep 12, 2017
                6794410               Apr 15, 2022               U-1285
                8802735               Sep 14, 2030            DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 210 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES            REQUESTED       CODE(S)            DATE
	
TERIPARATIDE RECOMBINANT HUMAN - FORTEO
	
 N 021318 001   6770623          Dec 08, 2018             DP U-597
	
                6977077          Aug 19, 2019                  U-597
	
                7144861          Dec 08, 2018             DP
	
                7163684          Aug 19, 2019                  U-790
	
                7351414          Aug 19, 2019                  U-865
	
                7517334          Mar 25, 2025             DP
	
                7550434          Dec 08, 2018             DP U-982
	
TERIPARATIDE RECOMBINANT HUMAN - FORTEO
	
 N 021318 002   6770623          Dec 08, 2018             DP U-982
	
                6977077          Aug 19, 2019                  U-982
	
                6977077          Aug 19, 2019                  U-994
	
                7144861          Dec 08, 2018             DP
	
                7163684          Aug 19, 2019                  U-983
	
                7163684          Aug 19, 2019                  U-994
	
                7351414          Aug 19, 2019                  U-984
	
                7351414          Aug 19, 2019                  U-994
	
                7517334          Mar 25, 2025             DP
	
                7550434          Dec 08, 2018             DP U-982
	
TESAMORELIN ACETATE - EGRIFTA
	
 N 022505 001   5861379             May   26,   2020   DS DP U-1100                         NCE           Nov 10, 2015
	
                6020311             May   26,   2015   DS DP U-1100
	
                7144577             Jul   14,   2020         U-1100
	
                7316997             Aug   14,   2023         U-1100
	
TESAMORELIN ACETATE - EGRIFTA
	
 N 022505 002   5861379             May   26,   2015   DS DP U-1100                         NCE           Nov 10, 2015
	
                6020311             May   26,   2015   DS DP U-1100
	
                7144577             Jul   14,   2020         U-1100
	
                7316997             Aug   14,   2023         U-1100
	
TESTOSTERONE - TESTODERM
	
 N 019762 001   5840327             Aug 15, 2016
	
TESTOSTERONE - TESTODERM
	
 N 019762 002   5840327             Aug 15, 2016
	
TESTOSTERONE - ANDRODERM
	
 N 020489 003                                                                               NS            Oct 20, 2014
	
TESTOSTERONE - ANDRODERM
	
 N 020489 004                                                                               NS            Oct 20, 2014
	
TESTOSTERONE - TESTODERM TTS
	
 N 020791 001   6348210             Nov 10, 2019                 U-440
	
TESTOSTERONE - ANDROGEL
	
 N 021015 001   6503894             Aug 30, 2020                 U-490
	
TESTOSTERONE - ANDROGEL
	
 N 021015 002   6503894             Aug 30, 2020                 U-490
	
TESTOSTERONE - ANDROGEL
	
 N 021015 003   6503894             Aug 30, 2020                 U-490
	
TESTOSTERONE - TESTIM
	
 N 021454 001   7320968             Jan   18,   2025             U-843
	
                7608605             Apr   21,   2023             U-1009
	
                7608606             Apr   21,   2023             U-1009
	
                7608607             Apr   21,   2023             U-1009
	
                7608608             Apr   21,   2023             U-1009
	
                7608609             Apr   21,   2023             U-1009
	
                7608610             Apr   21,   2023             U-1009
	
                7935690             Apr   21,   2023             U-1009
	
                8063029             Apr   21,   2023             U-843
	
                8178518             Apr   21,   2023      DP
	
TESTOSTERONE - FORTESTA
	
 N 021463 001   6319913             Nov 09, 2018                 U-490
	
                6579865             Nov 09, 2018          DP
	
TESTOSTERONE - STRIANT
	
 N 021543 001   6248358             Aug 23, 2019                 U-527
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 211 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                             See report footnote for information regarding report content

 APPL/PROD                               PATENT                              PATENT                          EXCLUSIVITY
     NO            PATENT NO           EXPIRATION           PATENT           DELIST         EXCLUSIVITY       EXPIRATION
                                          DATE               CODES          REQUESTED         CODE(S)            DATE
TESTOSTERONE - ANDROGEL
 N 022309    001   6503894            Aug   30,   2020           U-1103
                   8466136            Oct   12,   2026      DP
                   8466137            Oct   12,   2026           U-1103
                   8466138            Oct   12,   2026           U-1103
                   8486925            Oct   12,   2026      DP
                   8729057            Oct   12,   2026      DP
                   8741881            Oct   12,   2026           U-1103
                   8754070            Oct   12,   2026      DP
                   8759329            Oct   12,   2026      DP
TESTOSTERONE - ANDROGEL
 N 022309 002   6503894               Aug   30,   2020           U-1103
                8466136               Oct   12,   2026      DP
                8466137               Oct   12,   2026           U-1103
                8466138               Oct   12,   2026           U-1103
                8486925               Oct   12,   2026      DP
                8729057               Oct   12,   2026      DP
                8741881               Oct   12,   2026           U-1103
                8754070               Oct   12,   2026      DP
                8759329               Oct   12,   2026      DP
TESTOSTERONE - ANDROGEL
 N 022309 003   6503894               Aug   30,   2020           U-1103
                8466136               Oct   12,   2026      DP
                8466137               Oct   12,   2026           U-1103
                8466138               Oct   12,   2026           U-1103
                8486925               Oct   12,   2026      DP
                8729057               Oct   12,   2026      DP
                8741881               Oct   12,   2026           U-1103
                8754070               Oct   12,   2026      DP
                8759329               Oct   12,   2026      DP
TESTOSTERONE - AXIRON
 N 022504 001   6299900               Feb   19,   2017      DP U-1103
                6818226               Feb   19,   2017      DP U-1103
                6923983               Feb   19,   2017      DP U-1103
                8071075               Feb   19,   2017      DP U-1103
                8419307               Feb   26,   2027         U-1386
                8435944               Jul   05,   2027         U-1390
                8784878               Jul   13,   2023      DP U-1545
                8807861               Feb   26,   2027      DP U-1563
TESTOSTERONE - TESTOSTERONE
 N 202763 001                                                                                 NP            Feb 14, 2015
TESTOSTERONE - TESTOSTERONE
 N 203098 001                                                                                 NP            Jan 31, 2016
TESTOSTERONE - TESTOSTERONE
 N 203098 002                                                                                 NP            Jan 31, 2016
TESTOSTERONE - TESTOSTERONE
 N 203098 003                                                                                 NP            Jan 31, 2016
TESTOSTERONE - VOGELXO
 N 204399 002   8785426               Feb 11, 2034          DP U-1531                         NP            Jun 04, 2017
TESTOSTERONE - VOGELXO
 N 204399 003   8785426               Feb 11, 2034          DP U-1531                         NP            Jun 04, 2017
TESTOSTERONE - NATESTO
 N 205488 001   8574622               Feb   04,   2024      DP                                NP            May 28, 2017
                8784869               Feb   04,   2024      DP
                8784882               Feb   04,   2024      DP U-1557
                8877230               Feb   04,   2024         U-1616
TESTOSTERONE UNDECANOATE - AVEED
	
 N 022219 001   7718640           Mar 14, 2027              DP                                NP            Mar 05, 2017
	
                8338395           Feb 27, 2026                   U-1500
	
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 212 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                         See report footnote for information regarding report content

 APPL/PROD                           PATENT                            PATENT                            EXCLUSIVITY
     NO            PATENT NO       EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
                                      DATE               CODES        REQUESTED           CODE(S)            DATE
TETRABENAZINE - XENAZINE
 N 021894    001                                                                          ODE           Aug 15, 2015
TETRABENAZINE - XENAZINE
 N 021894 002                                                                             ODE           Aug 15, 2015
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 213 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES            REQUESTED       CODE(S)            DATE
	
THALIDOMIDE - THALOMID
	
 N 020785 001   6045501             Aug   28,   2018             U-371
	
                6045501             Aug   28,   2018             U-731
	
                6315720             Oct   23,   2020             U-442
	
                6315720             Oct   23,   2020             U-731
	
                6561976             Aug   28,   2018             U-371
	
                6561976             Aug   28,   2018             U-731
	
                6561977             Oct   23,   2020             U-371
	
                6561977             Oct   23,   2020             U-731
	
                6755784             Oct   23,   2020             U-371
	
                6755784             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-371
	
                6869399             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-732
	
                6869399             Oct   23,   2020             U-733
	
                6908432             Aug   28,   2018             U-371
	
                6908432             Aug   28,   2018             U-731
	
                7141018             Oct   23,   2020             U-371
	
                7141018             Oct   23,   2020             U-731
	
                7141018             Oct   23,   2020             U-732
	
                7141018             Oct   23,   2020             U-733
	
                7230012             Dec   09,   2023      DP
	
                7435745             Nov   03,   2017             U-899
	
                7874984             Aug   28,   2018             U-371
	
                7874984             Aug   28,   2018             U-442
	
                7874984             Aug   28,   2018             U-732
	
                7874984             Aug   28,   2018             U-733
	
                7874984             Aug   28,   2018             U-1109
	
                7959566             Oct   23,   2020             U-1155
	
                8204763             Aug   28,   2018             U-1249
	
                8315886             Oct   23,   2020             U-1249
	
                8589188             Aug   28,   2018             U-1465
	
                8626531             Oct   23,   2020             U-1465
	
THALIDOMIDE - THALOMID
	
 N 020785 002   6045501             Aug   28,   2018             U-371
	
                6045501             Aug   28,   2018             U-731
	
                6315720             Oct   23,   2020             U-442
	
                6315720             Oct   23,   2020             U-731
	
                6561976             Aug   28,   2018             U-371
	
                6561976             Aug   28,   2018             U-731
	
                6561977             Oct   23,   2020             U-371
	
                6561977             Oct   23,   2020             U-731
	
                6755784             Oct   23,   2020             U-371
	
                6755784             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-371
	
                6869399             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-732
	
                6869399             Oct   23,   2020             U-733
	
                6908432             Aug   28,   2018             U-371
	
                6908432             Aug   28,   2018             U-731
	
                7141018             Oct   23,   2020             U-371
	
                7141018             Oct   23,   2020             U-731
	
                7141018             Oct   23,   2020             U-732
	
                7141018             Oct   23,   2020             U-733
	
                7230012             Dec   09,   2023      DP
	
                7435745             Nov   03,   2017             U-899
	
                7874984             Aug   28,   2018             U-371
	
                7874984             Aug   28,   2018             U-442
	
                7874984             Aug   28,   2018             U-732
	
                7874984             Aug   28,   2018             U-733
	
                7874984             Aug   28,   2018             U-1109
	
                7959566             Oct   23,   2020             U-1155
	
                8204763             Aug   28,   2018             U-1249
	
                8315886             Oct   23,   2020             U-1249
	
                8589188             Aug   28,   2018             U-1465
	
                8626531             Oct   23,   2020             U-1465
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 214 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                        DATE               CODES            REQUESTED       CODE(S)            DATE
	
THALIDOMIDE - THALOMID
	
 N 020785 003		 6045501             Aug   28,   2018             U-371
	
                6045501             Aug   28,   2018             U-731
	
                6315720             Oct   23,   2020             U-442
	
                6315720             Oct   23,   2020             U-731
	
                6561976             Aug   28,   2018             U-371
	
                6561976             Aug   28,   2018             U-731
	
                6561977             Oct   23,   2020             U-371
	
                6561977             Oct   23,   2020             U-731
	
                6755784             Oct   23,   2020             U-371
	
                6755784             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-371
	
                6869399             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-732
	
                6869399             Oct   23,   2020             U-733
	
                6908432             Aug   28,   2018             U-371
	
                6908432             Aug   28,   2018             U-731
	
                7141018             Oct   23,   2020             U-371
	
                7141018             Oct   23,   2020             U-731
	
                7141018             Oct   23,   2020             U-732
	
                7141018             Oct   23,   2020             U-733
	
                7230012             Dec   09,   2023      DP
	
                7435745             Nov   03,   2017             U-899
	
                7874984             Aug   28,   2018             U-371
	
                7874984             Aug   28,   2018             U-442
	
                7874984             Aug   28,   2018             U-732
	
                7874984             Aug   28,   2018             U-733
	
                7874984             Aug   28,   2018             U-1109
	
                7959566             Oct   23,   2020             U-1155
	
                8204763             Aug   28,   2018             U-1249
	
                8315886             Oct   23,   2020             U-1249
	
                8589188             Aug   28,   2018             U-1465
	
                8626531             Oct   23,   2020             U-1465
	
THALIDOMIDE - THALOMID
	
 N 020785 004		 6045501             Aug   28,   2018             U-731
	
                6315720             Oct   23,   2020             U-731
	
                6561976             Aug   28,   2018             U-731
	
                6561977             Oct   23,   2020             U-731
	
                6755784             Oct   23,   2020             U-731
	
                6869399             Oct   23,   2020             U-731
	
                6908432             Aug   28,   2018             U-731
	
                7141018             Oct   23,   2020             U-731
	
                7435745             Nov   03,   2017             U-899
	
                7874984             Aug   28,   2018             U-371
	
                7874984             Aug   28,   2018             U-442
	
                7874984             Aug   28,   2018             U-732
	
                7874984             Aug   28,   2018             U-733
	
                7874984             Aug   28,   2018             U-1109
	
                7959566             Oct   23,   2020             U-1155
	
                8204763             Aug   28,   2018             U-1249
	
                8315886             Oct   23,   2020             U-1249
	
                8589188             Aug   28,   2018             U-1465
	
                8626531             Oct   23,   2020             U-1465
	
THYROTROPIN ALFA - THYROGEN
	
 N 020898 001		 5840566             Nov 24, 2015                                            ODE           Dec 14, 2014
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 215 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT
	                             PATENT
	                       EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION
	           PATENT          DELIST
	      EXCLUSIVITY       EXPIRATION
	
                                       DATE
	               CODES        REQUESTED
	       CODE(S)            DATE
	
TIAGABINE HYDROCHLORIDE - GABITRIL
	
 N 020646 001   5866590          Apr 29, 2016

                5958951          Jun 10, 2017
	
TIAGABINE HYDROCHLORIDE - GABITRIL
	
 N 020646 002   5866590          Apr 29, 2016

                5958951          Jun 10, 2017
	
TIAGABINE HYDROCHLORIDE - GABITRIL
	
 N 020646 003   5866590          Apr 29, 2016

                5958951          Jun 10, 2017
	
TIAGABINE HYDROCHLORIDE - GABITRIL
	
 N 020646 004   5866590          Apr 29, 2016

                5958951          Jun 10, 2017
	
TIAGABINE HYDROCHLORIDE - GABITRIL
	
 N 020646 005   5866590          Apr 29, 2016

                5958951          Jun 10, 2017
	
TICAGRELOR - BRILINTA
	
 N 022433 001		 6251910            Jul   15,   2018
	   DS
	                               NCE           Jul 20, 2016
	
                6525060            Dec   02,   2019
	   DS DP U-1171
	
                7250419            Dec   02,   2019
	   DS DP U-1171
	
                7265124            Jul   09,   2021
	   DS DP U-1171
	
                8425934            Apr   17,   2030
	        DP
	
TIGECYCLINE - TYGACIL
	
 N 021821 001   7879828            Feb 05, 2029
	          DP
	
                8372995            Oct 08, 2030
	          DP
	
                RE40183            Apr 09, 2016
	       DS DP
TIMOLOL MALEATE - TIMOLOL MALEATE
	
 N 020963 001   6174524          Mar 26, 2019
	            DP
	
TIMOLOL MALEATE - TIMOLOL MALEATE
	
 N 020963 002		 6174524
	        Mar 26, 2019
	            DP
	
TIMOLOL MALEATE - ISTALOL
	
 N 021516 001   6335335
	          Nov 02, 2018
	          DP
	
                6645963
	          Nov 16, 2018
	          DP
	
TIOTROPIUM BROMIDE - SPIRIVA
	
 N 021395 001   6777423
	          Sep   24,   2021
    DS DP
	
                6908928
	          Sep   24,   2021
    DS DP U-566
	
                6908928
	          Sep   24,   2021
    DS DP U-762
	
                7070800
	          Jan   22,   2022
	      DP U-566
	
                7309707
	          Sep   24,   2021
    DS DP
	
                7642268
	          Sep   24,   2021
    DS DP
	
                7694676
	          Mar   12,   2027
	      DP
	
                8022082
	          Jan   19,   2026
	      DP U-1186
	
                RE38912
	          Oct   11,   2021
	      DP
	
                RE39820
	          Jan   30,   2018
	   DS DP U-566
	
TIOTROPIUM BROMIDE - SPIRIVA RESPIMAT
	
 N 021936 001   5964416          Oct 04,       2016        DP
	                            NP            Sep 24, 2017
	
                6149054          Dec 16,       2016        DP
	
                6176242          May 31,       2016        DP
	
                6453795          Dec 05,       2016        DP
	
                6726124          Oct 04,       2016        DP
	
                6846413          Aug 28,       2018        DP
	
                6977042          Aug 28,       2018        DP
	
                6988496          Feb 23,       2020        DP
	
                7104470          Oct 04,       2016        DP
	
                7246615          May 31,       2016        DP
	
                7284474          Aug 26,       2024        DP
	
                7396341          Oct 10,       2026        DP
	
                7802568          Feb 26,       2019        DP
	
                7837235          Mar 13,       2028        DP
	
                7896264          May 26,       2025        DP
	
                7988001          Aug 04,       2021        DP
	
                RE39820          Jan 30,       2018     DS DP U-1593
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 216 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
TIPRANAVIR - APTIVUS
 N 021814 001   5852195            Jun 22, 2019       DS
                6147095            Oct 29, 2019                 U-670
                6231887            Jul 27, 2018            DP
TIPRANAVIR - APTIVUS
 N 022292 001   5852195            Jun 22, 2019       DS
                6147095            Oct 29, 2019                 U-670
TIROFIBAN HYDROCHLORIDE - AGGRASTAT
 N 020912 001   5733919          Oct     23,   2016
                5965581          Oct     23,   2016
                5972967          Oct     23,   2016
                5978698          Oct     08,   2017
                6136794          Jan     29,   2019
                6770660          May     01,   2023
TIROFIBAN HYDROCHLORIDE - AGGRASTAT
 N 020913 001   5733919          Oct     23,   2016
                5965581          Oct     23,   2016
                5972967          Oct     23,   2016
                5978698          Oct     08,   2017
                6136794          Jan     29,   2019
                6770660          Jun     01,   2023
TIROFIBAN HYDROCHLORIDE - AGGRASTAT
 N 020913 002   5733919          Oct     23,   2016
                5965581          Oct     23,   2016
                5972967          Oct     23,   2016
                5978698          Oct     08,   2017
                6136794          Jan     29,   2019
                6770660          Jun     01,   2023
TIROFIBAN HYDROCHLORIDE - AGGRASTAT
 N 020913 003   5733919          Oct     23,   2016
                5965581          Oct     23,   2016
                5972967          Oct     23,   2016
                5978698          Oct     08,   2017
                6136794          Jan     29,   2019
                6770660          Jun     01,   2023
TOBRAMYCIN - TOBI
 N 050753 001   5508269            Oct 19, 2014            DP U-909
TOBRAMYCIN - TOBI PODHALER
 N 201688 001   7097827            Apr   16,   2016        DP                              NP            Mar 22, 2016
                7368102            Dec   19,   2022        DP U-909
                7442388            May   10,   2020        DP
                7516741            Jan   11,   2024        DP
                7559325            Oct   27,   2025        DP
                8069851            Sep   24,   2024        DP
                8349294            May   10,   2020        DP
                8715623            Dec   19,   2022        DP U-909
TOBRAMYCIN - BETHKIS
 N 201820 001   6987094            Sep 22, 2022            DP
                7696178            Mar 17, 2023            DP
                7939502            Jun 14, 2022                 U-1324
TOFACITINIB CITRATE - XELJANZ
 N 203214 001   6956041            Dec   08,   2020        DP                              M-135         Feb 21, 2017
                6965027            Mar   25,   2023   DS                                   NCE           Nov 06, 2017
                7091208            Dec   08,   2020             U-247
                7265221            Dec   08,   2020   DS
                7301023            May   23,   2022   DS
                RE41783            Dec   08,   2020   DS
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 217 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                 PATENT                       EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT            DELIST      EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES           REQUESTED      CODE(S)            DATE
	
TOLTERODINE TARTRATE - DETROL LA
	
 N 021228 001   6630162           Nov    11,   2019            DP U-544
	
                6770295           Aug    26,   2019            DP U-544
	
                6911217           Nov    11,   2019            DP U-544
	
                6911217*PED       May    11,   2020
	
TOLTERODINE TARTRATE - DETROL LA
	
 N 021228 002   6630162           Nov    11,   2019            DP U-544
	
                6770295           Aug    26,   2019            DP U-544
	
                6911217           Nov    11,   2019            DP U-544
	
                6911217*PED       May    11,   2020
	
TOLVAPTAN - SAMSCA
	
 N 022275 001   5753677            May 19, 2020                   U-978
	
                8501730            Sep 01, 2026         DS
	
TOLVAPTAN - SAMSCA
	
 N 022275 002   5753677            May 19, 2020                   U-978
	
                8501730            Sep 01, 2026         DS
	
TOLVAPTAN - SAMSCA
	
 N 022275 003   5753677            May 19, 2020                   U-978
	
                8501730            Sep 01, 2026         DS
	
TOPIRAMATE - TOPAMAX
	
 N 020505 001   5998380            Oct   13,   2015               U-598                    NPP           Jul 15, 2014
	
                6503884            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                7018983            Oct   13,   2015               U-723
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020505 002   5998380            Oct   13,   2015               U-598                    NPP           Jul 15, 2014
	
                6503884            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                7018983            Oct   13,   2015               U-723
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020505 003   5998380            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                6503884            Oct   13,   2015               U-598
	
                7018983            Oct   13,   2015               U-723
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020505 004   5998380            Oct   13,   2015               U-598                    NPP           Jul 15, 2014
	
                6503884            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                7018983            Oct   13,   2015               U-723
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020505 005   5998380            Oct   13,   2015               U-598                    NPP           Jul 15, 2014
	
                6503884            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                7018983            Oct   13,   2015               U-723
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020505 006   5998380            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                6503884            Oct   13,   2015               U-598
	
                7018983            Oct   13,   2015               U-723
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020844 001   5998380            Oct   13,   2015               U-598                    NPP           Jul 15, 2014
	
                6503884            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                7018983            Oct   13,   2015               U-723
	
                7125560            Mar   01,   2019               U-766
	
                7498311            Oct   13,   2015               U-955
	
TOPIRAMATE - TOPAMAX
	
 N 020844 002   5998380            Oct   13,   2015               U-598                    NPP           Jul 15, 2014
	
                6503884            Oct   13,   2015               U-598                    NPP           Mar 28, 2017
	
                7018983            Oct   13,   2015               U-723
	
                7125560            Mar   01,   2019               U-766
	
                7498311            Oct   13,   2015               U-955
	
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 218 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
TOPIRAMATE - TOPAMAX SPRINKLE
 N 020844 003   5998380            Oct   13,   2015           U-598                        NPP           Mar 28, 2017
                6503884            Oct   13,   2015           U-598
                7018983            Oct   13,   2015           U-723
                7125560            Mar   01,   2019           U-766
                7498311            Oct   13,   2015           U-955
TOPIRAMATE - TROKENDI XR
 N 201635 001   8298576            Mar   18,   2029      DP   U-106
                8298580            Nov   16,   2027      DP   U-106
                8663683            Nov   16,   2027      DP   U-106
                8877248            Nov   16,   2027      DP   U-106
                8889191            Nov   16,   2027           U-106
TOPIRAMATE - TROKENDI XR
 N 201635 002   8298576            Mar   18,   2029      DP   U-106
                8298580            Nov   16,   2027      DP   U-106
                8663683            Nov   16,   2027      DP   U-106
                8877248            Nov   16,   2027      DP   U-106
                8889191            Nov   16,   2027           U-106
TOPIRAMATE - TROKENDI XR
 N 201635 003   8298576            Mar   18,   2029      DP   U-106
                8298580            Nov   16,   2027      DP   U-106
                8663683            Nov   16,   2027      DP   U-106
                8877248            Nov   16,   2027      DP   U-106
                8889191            Nov   16,   2027           U-106
TOPIRAMATE - TROKENDI XR
 N 201635 004   8298576            Mar   18,   2029      DP   U-106
                8298580            Nov   16,   2027      DP   U-106
                8663683            Nov   16,   2027      DP   U-106
                8877248            Nov   16,   2027      DP   U-106
                8889191            Nov   16,   2027           U-106
TOPIRAMATE - QUDEXY XR
 N 205122 001   8652527            Mar 19, 2033          DP
                8889190            Mar 19, 2033          DP
TOPIRAMATE - QUDEXY XR
 N 205122 002   8652527            Mar 19, 2033          DP
                8889190            Mar 19, 2033          DP
TOPIRAMATE - QUDEXY XR
 N 205122 003   8652527            Mar 19, 2033          DP
                8889190            Mar 19, 2033          DP
TOPIRAMATE - QUDEXY XR
 N 205122 004   8652527            Mar 19, 2033          DP
                8889190            Mar 19, 2033          DP
TOPIRAMATE - QUDEXY XR
 N 205122 005   8652527            Mar 19, 2033          DP
                8889190            Mar 19, 2033          DP
TOPOTECAN HYDROCHLORIDE - HYCAMTIN
 N 020671 001   5674872          Oct 07, 2014                 U-910
TOPOTECAN HYDROCHLORIDE - HYCAMTIN
 N 020981 001   8158645          Dec 10, 2024            DP
TOPOTECAN HYDROCHLORIDE - HYCAMTIN
 N 020981 002   8158645          Dec 10, 2024            DP
TRAMADOL HYDROCHLORIDE - ULTRAM
 N 020281 001   6339105            Oct 12, 2019               U-435
TRAMADOL HYDROCHLORIDE - ULTRAM
 N 020281 002   6339105            Oct 12, 2019               U-435
TRAMADOL HYDROCHLORIDE - RYBIX ODT
 N 021693 001   6106861          Dec 05, 2017            DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 219 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
TRAMADOL HYDROCHLORIDE - RYZOLT
 N 021745 001   6607748            Jun 29, 2020          DP
                7988998            Oct 27, 2023          DP
TRAMADOL HYDROCHLORIDE - RYZOLT
 N 021745 002   6607748            Jun 29, 2020          DP
                7988998            Oct 27, 2023          DP
TRAMADOL HYDROCHLORIDE - RYZOLT
 N 021745 003   6607748            Jun 29, 2020          DP
                7988998            Oct 27, 2023          DP
TRAMADOL HYDROCHLORIDE - CONZIP
 N 022370 001   7858118            Apr 11, 2022          DP U-1104
TRAMADOL HYDROCHLORIDE - CONZIP
 N 022370 002   7858118            Apr 11, 2022          DP U-1104
TRAMADOL HYDROCHLORIDE - CONZIP
 N 022370 003   7858118            Apr 11, 2022          DP U-1104
TRAMETINIB DIMETHYL SULFOXIDE - MEKINIST
 N 204114 001   7378423          Sep 13, 2025         DS DP                                I-678         Jan   08,   2017
                8580304          Jan 28, 2032            DP                                NCE           May   29,   2018
                8835443          Sep 13, 2025                 U-1581                       ODE           May   29,   2020
                8835443          Sep 13, 2025                 U-1582                       ODE           Jan   08,   2021
TRAMETINIB DIMETHYL SULFOXIDE - MEKINIST
 N 204114 002   7378423          Sep 13, 2025         DS DP                                I-678         Jan   08,   2017
                8580304          Jan 28, 2032            DP                                NCE           May   29,   2018
                8835443          Sep 13, 2025                 U-1581                       ODE           May   29,   2020
                8835443          Sep 13, 2025                 U-1582                       ODE           Jan   08,   2021
TRAMETINIB DIMETHYL SULFOXIDE - MEKINIST
 N 204114 003   7378423          Sep 13, 2025         DS DP                                I-678         Jan   08,   2017
                8580304          Jan 28, 2032            DP                                NCE           May   29,   2018
                8835443          Sep 13, 2025                 U-1581                       ODE           May   29,   2020
                8835443          Sep 13, 2025                 U-1582                       ODE           Jan   08,   2021
TRANDOLAPRIL - MAVIK
 N 020528 001   5744496            Apr 28, 2015               U-229
TRANDOLAPRIL - MAVIK
 N 020528 002   5744496            Apr 28, 2015               U-229
TRANDOLAPRIL - MAVIK
 N 020528 003   5744496            Apr 28, 2015               U-229
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA
 N 020591 001   5721244          Feb 24, 2015
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA
 N 020591 002   5721244          Feb 24, 2015
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA
 N 020591 003   5721244          Feb 24, 2015
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA
 N 020591 004   5721244          Feb 24, 2015
TRANEXAMIC ACID - LYSTEDA
 N 022430 001   7947739            Mar   04,   2025      DP
                8022106            Mar   04,   2025         U-1182
                8273795            Mar   04,   2025         U-1182
                8487005            Mar   04,   2025      DP U-1182
                8791160            Mar   04,   2025      DP U-1182
                8809394            Mar   04,   2025      DP U-1182
TRAVOPROST - TRAVATAN
 N 021257 001   5631287            Dec   22,   2014         U-382
                5849792            Dec   22,   2014      DP U-383
                5889052            Dec   02,   2014      DP U-383
                6011062            Dec   22,   2014      DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 220 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
TRAVOPROST - TRAVATAN Z
 N 021994 001   5889052            Dec   02,   2014        DP U-383
                8268299            Oct   13,   2029        DP
                8323630            Sep   20,   2027        DP
                8388941            Sep   20,   2027        DP
TRAVOPROST - IZBA
 N 204822 001   8722735            Oct 10, 2029            DP                              NP            May 15, 2017
                8754123            May 19, 2029            DP
TRAZODONE HYDROCHLORIDE - OLEPTRO
 N 022411 001   6607748          Jun 29, 2020            DP
                7829120          Mar 27, 2027            DP U-796
                8133893          Mar 13, 2029         DS DP
TRAZODONE HYDROCHLORIDE - OLEPTRO
 N 022411 002   6607748          Jun 29, 2020            DP
                7829120          Mar 27, 2027            DP U-796
                8133893          Mar 13, 2029         DS DP
TREPROSTINIL - REMODULIN
 N 021272 001   5153222            Oct   06,   2014             U-455
                6765117            Oct   24,   2017   DS
                7999007            Mar   29,   2029        DP U-1437
                8497393            Dec   15,   2028   DS
                8653137            Sep   05,   2028             U-1437
                8658694            Sep   05,   2028             U-1437
TREPROSTINIL - REMODULIN
 N 021272 002   5153222            Oct   06,   2014             U-455
                6765117            Oct   24,   2017   DS
                7999007            Mar   29,   2029        DP U-1437
                8497393            Dec   15,   2028   DS
                8653137            Sep   05,   2028             U-1437
                8658694            Sep   05,   2028             U-1437
TREPROSTINIL - REMODULIN
 N 021272 003   5153222            Oct   06,   2014             U-455
                6765117            Oct   24,   2017   DS
                7999007            Mar   29,   2029        DP U-1437
                8497393            Dec   15,   2028   DS
                8653137            Sep   05,   2028             U-1437
                8658694            Sep   05,   2028             U-1437
TREPROSTINIL - REMODULIN
 N 021272 004   5153222            Oct   06,   2014             U-455
                6765117            Oct   24,   2017   DS
                7999007            Mar   29,   2029        DP U-1437
                8497393            Dec   15,   2028   DS
                8653137            Sep   05,   2028             U-1437
                8658694            Sep   05,   2028             U-1437
TREPROSTINIL - TYVASO
 N 022387 001   5153222            Oct   16,   2014             U-1019                     M-145         May 20, 2017
                6521212            Nov   13,   2018             U-1018                     ODE           Jul 30, 2016
                6756033            Nov   13,   2018             U-1018
                6765117            Oct   24,   2017   DS
                8497393            Dec   15,   2028   DS
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 221 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
	
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
	
TREPROSTINIL DIOLAMINE - ORENITRAM
 N 203496 001   5153222          Oct    16,   2014              U-1475                     NDF           Dec 20, 2016
                6765117          Oct    24,   2017    DS
                7417070          Aug    30,   2026    DS
                7544713          Jul    14,   2024              U-1475
                8252839          May    24,   2024         DP
                8349892          Jan    22,   2031         DP
                8410169          Feb    13,   2030         DP
                8497393          Dec    15,   2028    DS
                8747897          Oct    08,   2029         DP
TREPROSTINIL DIOLAMINE - ORENITRAM
 N 203496 002   5153222          Oct    16,   2014              U-1475                     NDF           Dec 20, 2016
                6765117          Oct    24,   2017    DS
                7417070          Aug    30,   2026    DS
                7544713          Jul    14,   2024
                8252839          May    24,   2024         DP
                8349892          Jan    22,   2031         DP
                8410169          Feb    13,   2030         DP
                8497393          Dec    15,   2028    DS
                8747897          Oct    08,   2029         DP
TREPROSTINIL DIOLAMINE - ORENITRAM
 N 203496 003   5153222          Oct    16,   2014              U-1475                     NDF           Dec 20, 2016
                6765117          Oct    24,   2017    DS
                7417070          Aug    30,   2026    DS
                7544713          Jul    14,   2024
                8252839          May    24,   2024         DP
                8349892          Jan    22,   2031         DP
                8410169          Feb    13,   2030         DP
                8497393          Dec    15,   2028    DS
                8747897          Oct    08,   2029         DP
TREPROSTINIL DIOLAMINE - ORENITRAM
 N 203496 004   5153222          Oct    16,   2014              U-1475                     NDF           Dec 20, 2016
                6765117          Oct    24,   2017    DS
                7417070          Aug    30,   2026    DS
                7544713          Jul    14,   2024
                8252839          May    24,   2024         DP
                8349892          Jan    22,   2031         DP
                8410169          Feb    13,   2030         DP
                8497393          Dec    15,   2028    DS
                8747897          Oct    08,   2029         DP
TRETINOIN - RETIN-A MICRO
 N 020475 001   5955109            Sep 21, 2016            DP U-134
TRETINOIN - RETIN-A MICRO
 N 020475 002   5955109            Sep 21, 2016                 U-134
TRETINOIN - RENOVA
 N 021108 001   6531141            Mar 07, 2020
TRETINOIN - ATRALIN
 N 022070 001   5670547            Sep 23, 2014            DP
TRIAMCINOLONE ACETONIDE - NASACORT ALLERGY 24 HOUR
 N 020468 002   5976573          Jul 03, 2016              DP
                6143329          Jul 03, 2016              DP
                7977045          Jul 03, 2016              DP
TRIAMCINOLONE ACETONIDE - TRIESENCE
 N 022048 001   6395294          Jan    13,   2020         DP U-846
                8128960          Dec    17,   2029         DP
                8211880          Mar    10,   2029            U-1257
                8211880          Mar    10,   2029            U-1258
TRIMETHOPRIM HYDROCHLORIDE - PRIMSOL
 N 074973 001   5763449          Aug 07, 2016
                5962461          Aug 07, 2016
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 222 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
TRIMETREXATE GLUCURONATE - NEUTREXIN
 N 020326 001   6017922          May 18, 2018
TRIMETREXATE GLUCURONATE - NEUTREXIN
 N 020326 002   6017922          May 18, 2018
TRIPTORELIN PAMOATE - TRELSTAR
 N 020715 001   5776885            Jul 07, 2015
TRIPTORELIN PAMOATE - TRELSTAR
 N 021288 001   5776885            Jul 07, 2015          DP
TRIPTORELIN PAMOATE - TRELSTAR
 N 022437 001   5776885            Jul 07, 2015          DP
TROGLITAZONE - PRELAY
 N 020719 001   5859037            Nov 13, 2017               U-251
                6011049            Nov 13, 2017               U-301
TROGLITAZONE - PRELAY
 N 020719 002   5859037            Nov 13, 2017               U-251
                6011049            Nov 13, 2017               U-301
TROGLITAZONE - PRELAY
 N 020719 003   5859037            Nov 13, 2017               U-251
                6011049            Nov 13, 2017               U-301
TROGLITAZONE - REZULIN
 N 020720 001   5859037            Nov 13, 2017               U-251
                6011049            Nov 13, 2017               U-301
TROGLITAZONE - REZULIN
 N 020720 002   5859037            Nov 13, 2017               U-251
                6011049            Nov 13, 2017               U-301
TROGLITAZONE - REZULIN
 N 020720 003   5859037            Nov 13, 2017               U-251
                6011049            Nov 13, 2017               U-301
TROSPIUM CHLORIDE - SANCTURA XR
 N 022103 001   7410978            Feb   01,   2025      DP
                7759359            Nov   04,   2024           U-1071
                7763635            Nov   04,   2024           U-1071
                7781448            Nov   04,   2024           U-1071
                7781449            Nov   04,   2024           U-1071
TROVAFLOXACIN MESYLATE - TROVAN
 N 020759 001   5763454            Jun 15, 2015               U-282
                6187341            Jan 20, 2019
TROVAFLOXACIN MESYLATE - TROVAN
 N 020759 002   5763454            Jun 15, 2015               U-282
                6187341            Jan 20, 2019
TRYPAN BLUE - MEMBRANEBLUE
 N 022278 001                                                                              ODE           Feb 20, 2016
ULIPRISTAL ACETATE - ELLA
 N 022474 001   8426392            Jun 12, 2030               U-1389                       NCE           Aug 13, 2015
                8512745            Feb 14, 2030          DP
                8735380            Feb 20, 2029          DP
UMECLIDINIUM BROMIDE - INCRUSE ELLIPTA
 N 205382 001   5873360          Feb 23,       2016      DP
                7488827          Apr 27,       2025   DS DP
                7498440          Apr 27,       2025   DS DP
                8113199          Oct 23,       2027      DP
                8161968          Feb 05,       2028      DP
                8183257          Jul 27,       2025           U-1476
                8201556          Feb 05,       2029      DP
                8309572          Apr 27,       2025           U-1476
                8534281          Aug 10,       2029      DP
                8746242          Oct 11,       2030      DP
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 223 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION      PATENT              DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE          CODES             REQUESTED           CODE(S)            DATE
	
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE - ANORO ELLIPTA
 N 203975 001   5873360          Feb 23, 2016       DP                                     NP            Dec 18, 2016
                7439393          Sep 11, 2022    DS DP U-1476
                7488827          Apr 27, 2025    DS DP
                7498440          Apr 27, 2025    DS DP
                7776895          Sep 11, 2022       DP
                8113199          Oct 23, 2027       DP
                8161968          Feb 05, 2028       DP
                8183257          Jul 27, 2025           U-1476
                8309572          Apr 27, 2025           U-1476
                8511304          Nov 11, 2025       DP U-1476
                8534281          Aug 10, 2029       DP
                8746242          Oct 11, 2030       DP
                RE44874          Mar 23, 2023    DS DP U-1476
UNOPROSTONE ISOPROPYL - RESCULA
 N 021214 001   6458836            Jul 09, 2021             U-333
                6458836            Jul 09, 2021             U-1315
                6770675            Nov 24, 2018          DP U-1322
UROFOLLITROPIN - FERTINEX
 N 019415 004   5767067            Jun 16, 2015
UROFOLLITROPIN - FERTINEX
 N 019415 005   5767067            Jun 16, 2015
UROFOLLITROPIN - BRAVELLE
 N 021289 001                                                                              D-139         Feb 19, 2017
VALACYCLOVIR HYDROCHLORIDE - VALTREX
 N 020487 001   5879706          Jan 19, 2016            DP U-530
                5879706          Jan 19, 2016            DP U-894
                6107302          Jan 19, 2016         DS    U-530
                6107302          Jan 19, 2016         DS    U-894
VALACYCLOVIR HYDROCHLORIDE - VALTREX
 N 020487 002   5879706          Jan 19, 2016            DP U-530
                5879706          Jan 19, 2016            DP U-894
                6107302          Jan 19, 2016         DS    U-530
                6107302          Jan 19, 2016         DS    U-894
VALDECOXIB - BEXTRA
 N 021341 002   5633272            Feb 13, 2015              U-462
VALDECOXIB - BEXTRA
 N 021341 003   5633272            Feb 13, 2015              U-462
VALGANCICLOVIR HYDROCHLORIDE - VALCYTE
 N 021304 001   6083953          Mar 29, 2015         DS DP U-384
                6083953          Mar 29, 2015         DS DP U-854
VALGANCICLOVIR HYDROCHLORIDE - VALCYTE
 N 022257 001   6083953          Mar 29, 2015         DS DP U-384
                6083953          Mar 29, 2015         DS DP U-854
                6083953*PED      Sep 29, 2015
VALSARTAN - VALSARTAN
 A 077492 001                                                                              PC            Jan 03, 2015
VALSARTAN - VALSARTAN
 A 077492 002                                                                              PC            Jan 03, 2015
VALSARTAN - VALSARTAN
 A 077492 003                                                                              PC            Jan 03, 2015
VALSARTAN - VALSARTAN
 A 077492 004                                                                              PC            Jan 03, 2015
                   35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 224 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                            PATENT                            EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT         DELIST           EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES        REQUESTED           CODE(S)            DATE
	
VALSARTAN - DIOVAN
 N 021283 001   5972990            Oct 26, 2016               U-692
                6294197            Jun 18, 2017               U-3
VALSARTAN - DIOVAN
 N 021283 002   5972990            Oct 26, 2016               U-692
                6294197            Jun 18, 2017               U-3
VALSARTAN - DIOVAN
 N 021283 003   5972990            Oct 26, 2016               U-692
                6294197            Jun 18, 2017               U-3
VALSARTAN - DIOVAN
 N 021283 004   5972990            Oct 26, 2016               U-692
                6294197            Jun 18, 2017               U-3
VANDETANIB - CAPRELSA
 N 022405 001   7173038            Aug   14,   2021   DS DP                                NCE           Apr 06, 2016
                8067427            Aug   08,   2028      DP                                ODE           Apr 06, 2018
                8642608            Feb   06,   2022           U-1490
                RE42353            Sep   23,   2017   DS DP
VANDETANIB - CAPRELSA
 N 022405 002   7173038            Aug   14,   2021   DS DP                                NCE           Apr 06, 2016
                8067427            Aug   08,   2028      DP                                ODE           Apr 06, 2018
                8642608            Feb   06,   2022           U-1490
                RE42353            Sep   23,   2017   DS DP
VARDENAFIL HYDROCHLORIDE - LEVITRA
 N 021400 001   6362178          Oct     31,   2018   DS DP U-533
                7696206          Oct     31,   2018   DS DP U-533
                8273876          Jul     23,   2027         U-1288
                8841446          Jul     03,   2023      DP
VARDENAFIL HYDROCHLORIDE - LEVITRA
 N 021400 002   6362178          Oct     31,   2018   DS DP U-533
                7696206          Oct     31,   2018   DS DP U-533
                8273876          Jul     23,   2027         U-1288
                8841446          Jul     03,   2023      DP
VARDENAFIL HYDROCHLORIDE - LEVITRA
 N 021400 003   6362178          Oct     31,   2018   DS DP U-533
                7696206          Oct     31,   2018   DS DP U-533
                8273876          Jul     23,   2027         U-1288
                8841446          Jul     03,   2023      DP
VARDENAFIL HYDROCHLORIDE - LEVITRA
 N 021400 004   6362178          Oct     31,   2018   DS DP U-533
                7696206          Oct     31,   2018   DS DP U-533
                8273876          Jul     23,   2027         U-1288
                8841446          Jul     03,   2023      DP
VARDENAFIL HYDROCHLORIDE - STAXYN
 N 200179 001   6362178          Oct 31, 2018                 U-155
                7696206          Oct 31, 2018                 U-155
                8613950          Dec 23, 2028            DP
VARENICLINE TARTRATE - CHANTIX
 N 021928 001   6410550            May 10, 2020       DS DP U-56                           M-105         Jul 22, 2014
                6890927            May 06, 2022       DS DP U-56                           M-143         Oct 15, 2017
                7265119            Aug 03, 2022       DS DP U-56                           M-144         Oct 15, 2017
VARENICLINE TARTRATE - CHANTIX
 N 021928 002   6410550            May 10, 2020       DS DP U-56                           M-105         Jul 22, 2014
                6890927            May 06, 2022       DS DP U-56                           M-143         Oct 15, 2017
                7265119            Aug 03, 2022       DS DP U-56                           M-144         Oct 15, 2017
VELAGLUCERASE ALFA - VPRIV
 N 022575 001                                                                              M-130         Nov 21, 2016
                                                                                           NCE           Feb 26, 2015
VELAGLUCERASE ALFA - VPRIV
 N 022575 002                                                                              M-130         Nov 21, 2016
                                                                                           NCE           Feb 26, 2015
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                    ADA 225 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                           See report footnote for information regarding report content

 APPL/PROD                             PATENT                                  PATENT                      EXCLUSIVITY
	
     NO          PATENT NO           EXPIRATION             PATENT             DELIST     EXCLUSIVITY       EXPIRATION
	
                                        DATE                 CODES            REQUESTED     CODE(S)            DATE
	
VEMURAFENIB - ZELBORAF
	
 N 202429 001   7504509             Oct   22,   2026     DS DP                              NCE           Aug 17, 2016

                7863288             Jun   20,   2029     DS DP                              ODE           Aug 17, 2018

                8143271             Jun   21,   2026     DS DP
	
                8470818             Aug   02,   2026               U-1418
	
                8741920             Jul   27,   2030     DS DP
	
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR
	
 N 020699 001   6274171          Mar 20,        2017
	
                6403120          Mar 20,        2017               U-451
	
                6403120          Mar 20,        2017               U-535
	
                6419958          Mar 20,        2017               U-459
	
                6419958          Mar 20,        2017               U-535
	
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR
	
 N 020699 002   6274171          Mar 20,        2017
	
                6403120          Mar 20,        2017               U-451
	
                6403120          Mar 20,        2017               U-535
	
                6419958          Mar 20,        2017               U-459
	
                6419958          Mar 20,        2017               U-535
	
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR
	
 N 020699 003   6274171          Mar 20,        2017
	
                6403120          Mar 20,        2017               U-451
	
                6403120          Mar 20,        2017               U-535
	
                6419958          Mar 20,        2017               U-459
	
                6419958          Mar 20,        2017               U-535
	
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR
	
 N 020699 004   6274171          Mar 20,        2017
	
                6403120          Mar 20,        2017               U-451
	
                6403120          Mar 20,        2017               U-535
	
                6419958          Mar 20,        2017               U-459
	
                6419958          Mar 20,        2017               U-535
	
VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE
	
 N 022104 001   6403120          Mar 20, 2017                      U-535
	
                6403120          Mar 20, 2017                      U-839
	
                6419958          Mar 20, 2017                      U-535
	
                6419958          Mar 20, 2017                      U-839
	
VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE
	
 N 022104 002   6403120          Mar 20, 2017                      U-535
	
                6403120          Mar 20, 2017                      U-839
	
                6419958          Mar 20, 2017                      U-535
	
                6419958          Mar 20, 2017                      U-839
	
VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE
	
 N 022104 003   6403120          Mar 20, 2017                      U-535
	
                6403120          Mar 20, 2017                      U-839
	
                6419958          Mar 20, 2017                      U-535
	
                6419958          Mar 20, 2017                      U-839
	
VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE
	
 N 022104 004   6403120          Mar 20, 2017                      U-535
	
                6403120          Mar 20, 2017                      U-839
	
                6419958          Mar 20, 2017                      U-535
	
                6419958          Mar 20, 2017                      U-839
	
VERAPAMIL HYDROCHLORIDE - COVERA-HS
	
 N 020552 001   6096339          Apr 04, 2017                      U-365
	
VERAPAMIL HYDROCHLORIDE - COVERA-HS
	
 N 020552 002   6096339          Apr 04, 2017                      U-365
	
VERTEPORFIN - VISUDYNE
	
 N 021119 001   5707608             Aug   02,   2015

                5756541             Mar   11,   2016               U-357
	
                5770619             Jan   06,   2015               U-357
	
                5798349             Aug   25,   2015               U-357
	
                      35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 226 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                              PATENT                          EXCLUSIVITY
     NO            PATENT NO        EXPIRATION             PATENT         DELIST         EXCLUSIVITY       EXPIRATION
                                       DATE                 CODES        REQUESTED         CODE(S)            DATE
VIGABATRIN - SABRIL
 N 020427    001                                                                           NCE           Aug   21,   2014
                                                                                           NPP           Oct   26,   2016
                                                                                           PED           Feb   21,   2015
                                                                                           PED           Apr   26,   2017
VIGABATRIN - SABRIL
 N 022006 001                                                                              NCE           Aug   21,   2014
                                                                                           NPP           Oct   26,   2016
                                                                                           ODE           Aug   21,   2016
                                                                                           PED           Feb   21,   2015
                                                                                           PED           Feb   21,   2017
                                                                                           PED           Apr   26,   2017
VILAZODONE HYDROCHLORIDE - VIIBRYD
 N 022567 001   5532241          Sep     29,   2019   DS DP                                NCE           Jan 21, 2016
                7834020          Jun     05,   2022   DS DP U-839
                8193195          Jun     05,   2022         U-839
                8236804          Jun     05,   2022         U-839
                8673921          Jun     05,   2022   DS DP
VILAZODONE HYDROCHLORIDE - VIIBRYD
 N 022567 002   5532241          Sep     29,   2019   DS DP                                NCE           Jan 21, 2016
                7834020          Jun     05,   2022   DS DP U-839
                8193195          Jun     05,   2022         U-839
                8236804          Jun     05,   2022         U-839
                8673921          Jun     05,   2022   DS DP
VILAZODONE HYDROCHLORIDE - VIIBRYD
 N 022567 003   5532241          Sep     29,   2019   DS DP                                NCE           Jan 21, 2016
                7834020          Jun     05,   2022   DS DP U-839
                8193195          Jun     05,   2022         U-839
                8236804          Jun     05,   2022         U-839
                8673921          Jun     05,   2022   DS DP
VINCRISTINE SULFATE - MARQIBO KIT
 N 202497 001   6723338          Mar 31, 2020                   U-1271                     NP            Aug 09, 2015
                7247316          Sep 25, 2020              DP                              ODE           Aug 09, 2019
                7887836          Mar 31, 2020                   U-1271
VISMODEGIB - ERIVEDGE
 N 203388 001   7888364            Nov 11, 2028       DS DP                                NCE           Jan 30, 2017
VORAPAXAR SULFATE - ZONTIVITY
 N 204886 001   7235567            Jun 13, 2021       DS DP                                NCE           May 08, 2019
                7304078            Apr 06, 2024       DS DP U-1512
VORICONAZOLE - VFEND
 N 021266 001   5567817            May 24, 2016       DS DP U-540
VORICONAZOLE - VFEND
 N 021266 002   5567817            May 24, 2016       DS DP U-540
VORICONAZOLE - VFEND
 N 021267 001   5567817            May 24, 2016       DS DP U-540
                6632803            Jun 02, 2018          DP
VORICONAZOLE - VFEND
 N 021630 001   5567817            May 24, 2016       DS DP U-540
VORINOSTAT - ZOLINZA
 N 021991 001   7399787            Feb   09,   2025             U-892
                7456219            Mar   11,   2027   DS
                7652069            Mar   04,   2023        DP
                7732490            Mar   04,   2023         U-892
                7851509            Feb   21,   2024      DP U-892
                8067472            Mar   04,   2023         U-892
                8093295            May   16,   2026      DP
                8101663            Mar   04,   2023         U-892
                8450372            Mar   18,   2028         U-892
                RE38506            Jul   07,   2015   DS DP
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 227 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                               PATENT                         EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT            DELIST        EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES           REQUESTED        CODE(S)            DATE
	
VORTIOXETINE HYDROBROMIDE - BRINTELLIX
	
 N 204447 001   7144884          Jan 09, 2023         DS DP U-1439                         NCE           Sep 30, 2018

                8476279          Oct 02, 2022            DP U-1439
	
                8722684          Nov 11, 2030         DS DP
	
VORTIOXETINE HYDROBROMIDE - BRINTELLIX
	
 N 204447 002   7144884          Jan 09, 2023         DS DP U-1439                         NCE           Sep 30, 2018

                8476279          Oct 02, 2022            DP U-1439
	
                8722684          Nov 11, 2030         DS DP
	
VORTIOXETINE HYDROBROMIDE - BRINTELLIX
	
 N 204447 003   7144884          Jan 09, 2023         DS DP U-1439                         NCE           Sep 30, 2018

                8476279          Oct 02, 2022            DP U-1439
	
                8722684          Nov 11, 2030         DS DP
	
VORTIOXETINE HYDROBROMIDE - BRINTELLIX
	
 N 204447 004   7144884          Jan 09, 2023         DS DP U-1439                         NCE           Sep 30, 2018

                8476279          Oct 02, 2022            DP U-1439
	
                8722684          Nov 11, 2030         DS DP
	
ZANAMIVIR - RELENZA
	
 N 021036 001   5648379            Jul   15,   2014             U-274
	
                5648379            Jul   15,   2014             U-721
	
                5648379            Jul   15,   2014             U-722
	
                6294572            Dec   15,   2014   DS DP
	
ZICONOTIDE ACETATE - PRIALT
	
 N 021060 001   5364842            Dec   30,   2016             U-48
	
                5364842            Dec   30,   2016             U-55
	
                5795864            Jun   27,   2015      DP
	
                8653033            Oct   01,   2024             U-48
	
                8653033            Oct   01,   2024             U-55
	
                8765680            Oct   01,   2024             U-48
	
                8765680            Oct   01,   2024             U-55
	
ZICONOTIDE ACETATE - PRIALT
	
 N 021060 002   5364842            Dec   30,   2016             U-48
	
                5364842            Dec   30,   2016             U-55
	
                5795864            Jun   27,   2015      DP
	
                8653033            Oct   01,   2024             U-48
	
                8653033            Oct   01,   2024             U-55
	
                8765680            Oct   01,   2024             U-48
	
                8765680            Oct   01,   2024             U-55
	
ZICONOTIDE ACETATE - PRIALT
	
 N 021060 003   5364842            Dec   30,   2016             U-48
	
                5364842            Dec   30,   2016             U-55
	
                5795864            Jun   27,   2015      DP
	
                8653033            Oct   01,   2024             U-48
	
                8653033            Oct   01,   2024             U-55
	
                8765680            Oct   01,   2024             U-48
	
                8765680            Oct   01,   2024             U-55
	
ZICONOTIDE ACETATE - PRIALT
	
 N 021060 004   5364842            Dec   30,   2016             U-48
	
                5364842            Dec   30,   2016             U-55
	
                5795864            Jun   27,   2015      DP
	
                8653033            Oct   01,   2024             U-48
	
                8653033            Oct   01,   2024             U-55
	
                8765680            Oct   01,   2024             U-48
	
                8765680            Oct   01,   2024             U-55
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                   ADA 228 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                          See report footnote for information regarding report content

 APPL/PROD                            PATENT                                PATENT                        EXCLUSIVITY
	
     NO          PATENT NO          EXPIRATION           PATENT             DELIST       EXCLUSIVITY       EXPIRATION
	
                                       DATE               CODES            REQUESTED       CODE(S)            DATE
	
ZIPRASIDONE HYDROCHLORIDE - GEODON
	
 N 020825 001   6150366          May 27, 2019            DP
	
                6245766          Dec 18, 2018                   U-601
	
ZIPRASIDONE HYDROCHLORIDE - GEODON
	
 N 020825 002   6150366          May 27, 2019            DP
	
                6245766          Dec 18, 2018                   U-601
	
ZIPRASIDONE HYDROCHLORIDE - GEODON
	
 N 020825 003   6150366          May 27, 2019            DP
	
                6245766          Dec 18, 2018                   U-601
	
ZIPRASIDONE HYDROCHLORIDE - GEODON
	
 N 020825 004   6150366          May 27, 2019            DP
	
                6245766          Dec 18, 2018                   U-601
	
ZIPRASIDONE HYDROCHLORIDE - GEODON
	
 N 021483 001   6150366          May 27, 2019            DP U-719
	
                6245766          Dec 18, 2018                 U-601
	
                7175855          May 18, 2020            DP
	
ZIPRASIDONE MESYLATE - GEODON
	
 N 020919 001   6110918            Mar 26, 2017
	
                6232304            Apr 01, 2017

                6399777            Apr 01, 2017
	
ZOLEDRONIC ACID - ZOMETA
	
 N 021223 002   8324189            May 29, 2025                 U-53
	
                8324189            May 29, 2025                 U-1308
	
                8324189            May 29, 2025                 U-1309
	
ZOLEDRONIC ACID - ZOMETA
	
 N 021223 003   7932241            Feb   05,   2028      DP
	
                8324189            May   29,   2025             U-53
	
                8324189            May   29,   2025             U-1308
	
                8324189            May   29,   2025             U-1309
	
ZOLEDRONIC ACID - RECLAST
	
 N 021817 001   7932241            Feb 05, 2028          DP
	
                8052987            Oct 27, 2023                 U-1199
	
ZOLMITRIPTAN - ZOMIG
	
 N 021450 003   6750237            Nov   28,   2020      DP
	
                6750237*PED        May   28,   2021

                7220767            Nov   28,   2020      DP
	
                7220767*PED        May   28,   2021
	
ZOLMITRIPTAN - ZOMIG
	
 N 021450 004   6750237            Nov 28, 2020          DP
	
                7220767            Nov 28, 2020          DP
	
ZOLPIDEM TARTRATE - AMBIEN CR
	
 N 021774 001   6514531            Dec 01, 2019          DP
	
ZOLPIDEM TARTRATE - AMBIEN CR
	
 N 021774 002   6514531            Dec 01, 2019          DP
	
ZOLPIDEM TARTRATE - EDLUAR
	
 N 021997 001   6761910            Sep 24, 2019          DP U-674
	
                8512747            Sep 24, 2019             U-674
	
ZOLPIDEM TARTRATE - EDLUAR
	
 N 021997 002   6761910            Sep 24, 2019          DP U-674
	
                8512747            Sep 24, 2019             U-674
	
ZOLPIDEM TARTRATE - ZOLPIMIST
	
 N 022196 001   7632517            Oct 01, 2017                 U-70
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST                                 ADA 229 of 229
	
 PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST
	
                        See report footnote for information regarding report content

 APPL/PROD
                          PATENT                           PATENT                            EXCLUSIVITY
     NO          PATENT NO
	       EXPIRATION          PATENT         DELIST           EXCLUSIVITY       EXPIRATION
                                      DATE              CODES        REQUESTED           CODE(S)            DATE
ZOLPIDEM TARTRATE - INTERMEZZO
	
 N 022328 001   7658945
	          Apr   15,   2027    DP U-1194                         NP            Nov 23, 2014
                7682628
	          Feb   16,   2025       U-1194
                8242131
	          Aug   20,   2029       U-1266
                8252809
	          Feb   16,   2025    DP
ZOLPIDEM TARTRATE - INTERMEZZO
	
 N 022328 002   7658945
	          Apr   15,   2027    DP U-1194                         NP            Nov 23, 2014
                7682628
	          Feb   16,   2025       U-1194
                8242131
	          Aug   20,   2029       U-1266
                8252809
	          Feb   16,   2025    DP
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                        ADB 1 of 67

                            PATENT & EXCLUSIVITY ABBREVIATIONS

 D        NEW DOSING SCHEDULE (SEE INDIVIDUAL REFERENCES)
 I        NEW INDICATION (SEE INDIVIDUAL REFERENCES)
 M        MISCELLANEOUS EXCLUSIVITY CODES (SEE INDIVIDUAL REFERENCES)
 NC       NEW COMBINATION
 NCE      NEW CHEMICAL ENTITY
 NCE*     NEW CHEMICAL ENTITY (AN ENANTIOMER OF PREVIOUSLY APPROVED RACEMIC MIXTURE. SEE
          SECTION 505(U) OF THE FEDERAL FOOD AND DRUG COSMETIC ACT).
 NDF      NEW DOSAGE FORM
 NE       NEW ESTER OR SALT OF AN ACTIVE INGREDIENT
 NP       NEW PRODUCT
 NP*      NEW PRODUCT (MINT FLAVORED)
 NPP      NEW PATIENT POPULATION
 NR       NEW ROUTE
 NS       NEW STRENGTH
 ODE      ORPHAN DRUG EXCLUSIVITY
 PC       PATENT CHALLENGE
 PED      PEDIATRIC EXCLUSIVITY
 RTO      RX TO OTC SWITCH OR OTC USE
 RTO*     OTC USE FOR WOMEN AGES 15 AND 16
 RTO**    OTC USE FOR WOMEN 14 AND BELOW
 U        PATENT USE CODE
 W        EXCLUSIVITY ON THIS APPLICATION EXPIRING ON THIS DATE HAS BEEN WAIVED BY SPONSOR
          - SEE SECTION 1.8 OF ORANGE BOOK PREFACE WAIVED EXCLUSIVITY



                               EXCLUSIVITY DOSING SCHEDULE

D-1      ONCE A DAY APPLICATION
D-2      ONCE DAILY DOSING
D-3      SEVEN DAYS/SEVEN DAYS/SEVEN DAYS DOSING SCHEDULE
D-4      SEVEN DAYS/FOURTEEN DAYS DOSING SCHEDULE
D-5      TEN DAYS/ELEVEN DAYS DOSING SCHEDULE
D-6      SEVEN DAYS/NINE DAYS/FIVE DAYS DOSING SCHEDULE
D-7      BID DOSING
D-8      INTRAVENOUS, EPIDURAL AND INTRATHECAL DOSING
D-9      NARCOTIC OVERDOSE IN ADULTS
D-10     NARCOTIC OVERDOSE IN CHILDREN
D-11     POSTOPERATIVE NARCOTIC DEPRESSION IN CHILDREN
D-12     BEDTIME DOSING OF 800MG FOR TREATMENT OF ACTIVE DUODENAL ULCER
D-13     INCREASED MAXIMUM DAILY DOSAGE RECOMMENDATION
D-14     BEDTIME DOSING OF 800MG FOR TREATMENT OF ACTIVE BENIGN GASTRIC ULCER
D-15     SINGLE DAILY DOSE OF 25MG/37.5MG
D-16     CONTINUOUS INTRAVENOUS INFUSION
D-17     400MG EVERY 12 HOURS FOR THREE DAYS FOR UNCOMPLICATED URINARY TRACT INFECTIONS
D-18     LOWER RECOMMENDED STARTING DOSE GUIDELINES
D-19     BOLUS DOSING GUIDELINES
D-20     SINGLE 32MG DOSE
D-21     ALTERNATIVE DOSAGE OF 300MG ONCE DAILY AFTER THE EVENING MEAL
D-22     REDUCTION IN INFUSION TIME FROM 24 TO 4 HOURS FOR THE 60MG DOSE
D-23     INCREASE MAXIMUM DOSE AND VARIATIONS IN THE DOSING REGIMEN
D-24     FOR OVARIAN CANCER THE RECOMMENDED REGIMEN IS 135MG/M2 OR 175MG/M2 INTRAVENOUSLY
         OVER THREE HOURS EVERY THREE WEEKS
D-25     ADDITIONAL DOSAGE REGIMEN EQUAL TO HALF THE ORIGINAL DOSING REGIMEN
D-26     ONCE WEEKLY APPLICATION
D-27     BID DOSING IN PATIENTS 12 YEARS OF AGE AND OLDER FOR PREVENTION OF NAUSEA AND
         VOMITING ASSOCIATED WITH MODERATE EMETOGENIC CANCER CHEMOTHERAPY
D-28     USE OF ISOVUE-370 IN EXCRETORY UROGRAPHY AT EQUIVALENT GRAMS OF IODINE TO THE
         CURRENTLY APPROVED ISOVUE-250 AND ISOVUE-300
D-29     INCREASE OF CUMULATIVE DOSE TO 0.3MMOL/KG FOR MRI OF CNS IN ADULTS
D-30     5000 IU DOSE FOR PHOPHYLAXIX AGAINST DEEP VEIN THROMBOSIS
D-31     CHANGE IN RECOMMENDED TOTAL DAILY DOSE TO 80MG (40MG BID)
D-32     REMOVAL OF THE RESTRICTIONS LIMITING TREATMENT TO TWO CONSECUTIVE WEEKS AND TO
         SMALL AREAS
D-33     ONCE DAILY DOSING FOR PLAQUE PSORIASIS
                35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                        PATENT AND EXCLUSIVITY TERMS                        ADB 2 of 67


                             EXCLUSIVITY DOSING SCHEDULE

D-34   EVERY FOUR MONTHS DOSAGE REGIMEN
D-35   FOR A ONE WEEK DOSING OF INTERDIGITAL TINEA PEDIS
D-36   FOR A SINGLE 2MG DOSE AS AN ALTERNATIVE TO THE 1MG DOSE GIVEN TWICE DAILY
D-37   DOSING REGIMEN FOR ADMINISTRATION EITHER ONCE DAILY (QD) OR TWICE DAILY (BID)
D-38   CONTINUOUS INFUSION AS AN ALTERNATE METHOD OF ADMINISTRATION
D-39   CHANGE IN TIME TO TAKE THE DRUG PRIOR TO A MEAL TO PREVENT MEAL-INDUCED HEARTBURN
       SYMPTOMS FROM "..1/2 TO 1 HOUR BEFORE EATING" TO ".. RIGHT BEFORE EATING OR UP TO
       60MIN BEFORE CONSUMING..."
D-40   ONCE-A-DAY DOSING REGIMEN
D-41   DRUG MAY BE DOSED RIGHT BEFORE A MEAL OR ANY TIME UP TO 30MIN BEFORE EATING OR
       DRINKING FOOD AND BEVERAGES THAT WOULD BE EXPECTED TO CAUSE SYMPTOMS
D-42   TEN DAY DOSING REGIMEN FOR TRIPLE THERAPY, PREVACID IN COMBINATION WITH
       CLARITHROMYCIN AND AMOXICILLIN, FOR THE ERADICATION OF H.PYLORI IN PATIENTS WITH
       DUODENAL ULCER DISEASE
D-43   INITIATION OF TREATMENT WITH 900MG/DAY BY DELETION OF THE REQUIREMENT TO TITRATE
       TO 900MG/DAY OVER A 3-DAY PERIOD
D-44   IN A CLINICAL TRIAL, FEWER DISCONTINUATIONS DUE TO ADVERSE EVENTS, ESPECIALLY
       DIZZINESS AND VERTIGO, WERE OBSERVED WHEN TITRATING THE DOSE IN INCREMENTS OF
       50MG/DAY EVERY 3 DAYS UNTIL AN EFFECTIVE DOSE (NOT EXCEEDING 400MG/DAY) WAS
       REACHED
D-45   ONCE DAILY DOSING FOR MAINTENANCE ONLY
D-46   NEW DOSING REGIMEN OF 80MG DAILY
D-47   PREVENTION OF HEARTBURN SYMPTOMS WHEN ADMINISTERED FROM 15 MINUTES UP TO, BUT NOT
       INCLUDING, 1 HOUR PRIOR TO A PROVOCATIVE MEAL
D-48   ADIMISTRATION OF CISATRICURIUM A NEUROMUSCULAR BLOCKING AGENT AT DOSES OF 3 AND 4X
       THE ED95 OF CISATRICURIUM FOLLOWING INDUCTION WITH THIOPENTAL
D-49   PEDIATRIC DOSING GUIDELINES
D-50   INFORMATION FOR USE OF CORVERT IN POST-CARDIAC SURGERY PATIENTS
D-51   OPTIONAL STARTING DOSE OF 40MG/DAY
D-52   ALTERNATE DOSING REGIMEN OF 1250MG TWICE DAILY
D-53   USE IN PEDIATRIC PATIENTS FROM 1 MONTH TO 16 YEARS OF AGE
D-54   USE OF ZYBAN FOR MAINTENANCE THERAPY. TREATMENT UP TO 6 MONTHS WAS SHOWN
       EFFICACIOUS
D-55   ADDITION OF A HIGHER DOSE OF NUTROPIN FOR PUBERTAL PATIENTS (PUBERTAL DOSE LESS
       THAN OR EQUAL TO 0.7MG/KG/WEEK)
D-56   ADDITION OF POSTPRANDIAL DOSING
D-57   3-HOUR INFUSION OF TAXOL GIVEN EVERY THREE WEEKS AT A DOSE OF 175MG/M2 FOLLOWED BY
       CISPLATIN AT A DOSE OF 75MG/M2 FOR THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN
       CANCER
D-58   CHANGE IN DOSING INTERVAL TO ONCE-DAILY ADMINISTRATION
D-59   REDUCTION OF ELEVATED LDL-C IN A NEW, HIGHER STRENGTH TABLET, 0.8MG, AND FOR
       EXTENSION OF THE DOSAGE RANGE TO 0.8MG DAILY
D-60   ADDITION OF A POST-OPERATIVE DOSING REGIMEN
D-61   ONCE WEEKLY DOSING FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
D-62   ONCE WEEKLY DOSING FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
D-63   TO ALLOW A TITRATION DOSING REGIMEN USING A 25MG DOSE
D-64   INCREASING DOSAGE FOR NERVE BLOCK ANESTHESIA USING NAROPIN 7.5MG/ML AND FOR
       EXTENDING THE DURATION OF TREATMENT FOR POSTOPERATIVE ANALGESIA USING NAROPIN
       2MG/ML
D-65   CHANGE DOSING AND ADMINISTRATION TO INDICATE MAINTENANCE OF WEIGHT LOSS OVER AN 18
       MONTH PERIOD THUS EXTENDING THE USE OF THIS DRUG FROM ONE TO TWO YEARS
D-66   DOSING RECOMMENDATIONS FOR PATIENTS UNDERGOING PCI
D-67   SHORTER TREATMENT COURSE OF THREE DAYS IN THE TREATMENT OF RECURRENT EPISODES OF
       GENITAL HERPES
D-68   CHANGE OF ADMIN RATE FOR INFUSION OF AREDIA FOR TREATMENT OF MODERATE AND SEVERE
       HYPERCALCEMIA OF MALIGNANCY FROM 24 HOURS TO 2 HOURS UP TO BUT NOT INCLUDING 24
       HOURS
D-69   SHORTENED DOSING REGIMEN TO 5 DAYS FOR THE TREATMENT OF ACUTE EXACERBATION OF
       CHRONIC BRONCHITIS
D-70   80MG ONCE DAILY DOSING REGIMEN
D-71   EIGHT WEEK DOSING REGIMEN
D-72   INFORMATION REGARDING INCREASED RATE OF INFUSION FOR DEPACON
D-73   ONCE A WEEK DOSING FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
D-74   ONCE A WEEK DOSING FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
D-75   INTERMITTENT DOSING REGIMEN, STARTING DAILY DOSE 14 DAYS PRIOR TO THE ANTICIPATED
       ONSET OF MENSTRUATION THROUGH THE FIRST FULL DAY OF MENSES AND REPEATING WITH EACH
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                        ADB 3 of 67


                              EXCLUSIVITY DOSING SCHEDULE

        NEW CYCLE
D-76    FOR USE ON AN "AS NEEDED" OR PRN BASIS FOR THE MANAGEMENT OF NASAL SYMPTOMS IN
        PATIENTS FOR WHOM THE DRUG IS INDICATED
D-77    ADDITION OF 20MG AND 40MG DAILY AS OPTIONAL STARTING DOSES WITH 40MG INTENDED FOR
        PATIENTS WHO REQUIRE A LARGE REDUCTION IN LDL-C (MORE THAN 45%)
D-78    USE OF FLEXERIL 5MG FOR THE RELIEF OF MUSCLE SPASM ASSOCIATED WITH ACUTE, PAINFUL,
        MUSCULOSKELETAL CONDITIONS
D-79    NEW LOWER STARTING DOSE FOR TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS
        AND/OR MODERATE TO SEVERE SYMPTOMS OF VULVAR AND VAGINAL ATROPHY ASSOCIATED W/ THE
        MENOPAUSE
D-80    CHANGE OF DOSING SCHEDULE FOR LANTUS FROM ONCE DAILY AT BEDTIME TO FLEXIBLE DAILY
        DOSING
D-81    NEW LOWER STARTING DOSE FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPORSIS
D-82    USE OF PREMARIN 0.3 MG AND 0.45 MG FOR THE PREVENTION OF POSTMENOPAUSAL
        OSTEOPOROSIS
D-83    750 MG, ONCE DAILY FOR 5 DAYS FOR COMMUNITY ACQUIRED PNEUMONIA (CAP)
D-84    ONCE-A-DAY DOSING OF FLOXACIN OTIC FOR THE TREATMENT OF ADULTS AND PEDIATRIC
        PATIENTS(AGES 6 MO & OLDER) W/ OTITIS EXTERNA CAUSED BY SUSCEPTIBLE STRAINS OF
        E.COLI, P.AERUGINOSA AND S.AUREUS
D-85    LOWER RECOMMENDED STARTING DOSE GUIDELINES FOR TREATMENT OF MODERATE TO SEVERE
        VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE
D-86    FOR USE IN SELECT EXTERNAL INSULIN PUMPS
D-87    ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH
        OSTEOPOROSIS
D-88    NEW DOSING RANGE OF 200-400MG PER DAY IN TWO DIVIDED DOSES FOR ADULTS WITH PARTIAL
        SEIZURES
D-89    USE OF REYATAZ 300 MG/RITONAVIR 100 MG ONCE DAILY FOR TREATMENT IN HIV-INFECTED
        ANTIRETROVIRAL-EXPERIENCED PATIENTS
D-90    ADDITION OF DAYTIME ADMINISTRATION TO TREAT VULVOVAGINAL CANDIDIASIS
D-91    ALTERNATE INTERMITTENT DOSING REGIMEN
D-92    ALTERNATIVE DOSAGE OF 1000MG ONCE DAILY AT BEDTIME
D-93    ALTERNATE TWO OR THREE TIMES DAILY DOSING REGIMENS
D-94    NEW MAXIMUM DOSAGE OF 72 MG/DAY IN ADOLESCENTS 13-17 YEARS OF AGE WITH ATTENTION
        DEFECIT HYPERACTIVITY DISORDER (ADHD)
D-95    BROADENED INITIAL STARTING DOSE FOR HYPERTENSION FROM 50 MG TO 100 MG TO 25 MG TO
        100 MG DOSE RANGE
D-96    ONCE-MONTHLY TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH BONIVA (IBANDRONATE
        SODIUM) 150 MG TABLETS
D-97    PED CANCER PT POPULATION EXPANDED TO INCLUDE PTS 6 MOS UP TO BUT NOT INCLUDING 4
        YRS AND DOSING INSTRUCTIONS TO ADMIN 30 MIN BEFPRE CHEMO WITH SECOND AND THIRD
        DOSES 4 & 8 HOURS AFTER FIRST DOSE
D-98    DOSING FOR PED SURGICAL PTS EXPANDED TO INCLUDE PTS 1 MONTH UP TO BUT NOT
        INCLUDING 2 YEARS OF AGE
D-99    ONCE DAILY ADMINISTRATION FOR THE TREATMENT OF HIV INFECTION IN THERAPY NAIVE
        ADULT PATIENTS
D-100   750 MG ONCE DAILY FOR FIVE DAYS FOR THE TREATMENT OF ACUTE BACTERIAL SINUSITIS
D-101   ONCE DAILY IN CHRONIC IDIOPATHIC UTICARIA FOR ADULTS AND CHILDREN 12 YEARS OF AGE
        AND OLDER
D-102   NEW DOSING REGIMEN OF ONE SPRAY TWICE DAILY FOR SEASONAL ALLERIC RHINITIS IN
        PATIENTS 12 YRS OF AGE AND OLDER
D-103   NEW DOSING RECOMMENDATION FOR THE TREATMENT OF RECURRENT GENITAL HERPES IN
        IMMUNOCOMPETENT PATIENTS, SPECIFICALLY A REDUCTION IN COURSE OF THERAPY FROM
        FAMCICLOVIR 125 MG TWICE-A-DAY FOR 5 DAYS TO 1000 MG TWICE-A-DAY FOR 1 DAY.
D-104   0.5MG/0.1MG FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED
        WITH MENOPAUSE IN WOMEN WHO HAVE A UTERUS
D-105   USE OF ACTONEL 75MG TWO CONSECUTIVE DAYS PER MONTH FOR THE PREVENTION AND
        TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
D-106   FIVE DAY TREATMENT OF SELECTED SUSCEPTIBLE STRAINS OF STREPTOCOCCUS PNEUMONIAE,
        HAEMOPHILUS INFLUENZA, MYCOPLASMA PNEUMONIAE, AND CHLAMYDIA PNEUMONIAE FOR
        COMMUNITY-ACQUIRED PNEUMONIA
D-107   PROVIDES FOR THE COMBINATION TABLET OF 70MG ALENDRONATE AND 5600 IU OF VITAMIN D3
        FOR THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AND TO INCREASE BONE
        MASS IN MEN WITH OSTEOPOROSIS
D-108   TREATMENT OF COMPLICATED URINARY TRACT INFECTION AND ACUTE PYELONEPHRITIS WITH
        LEVAQUIN 750MG ONCE DAILY FOR FIVE DAYS
D-109   PROVIDE FOR THE USE OF A LOWER DOSE FOR THE TREATMENT OF ADULTS WITH CHRONIC PHASE
        CHRONIC MYELOID LEUKEMIA (CML) WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY
        INCLUDING IMATINIB MESYLATE
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                        ADB 4 of 67


                              EXCLUSIVITY DOSING SCHEDULE

D-110   TREATMENT OF SCHIZOPHRENIA IN ADOLESCENTS AGED 13-17
D-111   PROVIDES FOR ONCE DAILY USE OF CIALIS, 2.5 MG AND 5 MG, FOR THE TREAMTENT OF
        ERECTILE DYSFUNCTION
D-112   PROVIDES FOR PEDIATRIC PUMP USE
D-113   ONCE DAILY DOSING REGIMEN FOR PATIENTS WHO BECOME CONSTIPATED ON TWICE DAILY
        REGIMEN
D-114   NEW DOSING RECOMMENDATIONS FOR USE OF SIROLIMUS IN COMBINATION WITH CYCLOSPORINE
        FOR THE PROPHYLAXIS OF REJECTION IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS
D-115   STARTING DOSE OF 15MG/DAY FOR MONOTHERAPY IN ACUTE TREATMENT OF BIPOLAR DISORDER,
        MANIC OR MIXED
D-116   ALTERNATIVE DOSING REGIMEN ATAZANAVIR SULATE CO-ADMINISTERED WITH RITONAVIR FOR
        THE TREATMENT OF HIV-1 INFECTION IN TREATMENT NAIVE PATIENTS
D-117   50 MG TABLET FOR INITIATION OF DOSE TITRATION FOR BIPOLAR DISORDER
D-118   TWO 400MG TABLETS ONCE DAILY, CO-ADMINISTERED WITH 100MG RITONAVIR
D-119   DOSING RECOMMENDATIONS FOR HIV INFECTED PEDIATRIC PATIENTS 6 TO LESS THAN 18 YEARS
        OF AGE
D-120   DOSING REGIMEN ADJUSTMENTS
D-121   CHANGE TO REMOVE 20 MG MAXIMUM DOSAGE RESTRICTION
D-122   USE OF VAGIFEM 10 MCG FOR THE TREATMENT OF ATROPHIC VAGINITIS DUE TO MENOPAUSE
D-123   ALTERNATIVE DOSING REGIMEN DOSE OF 20 MG/METER SQUARE BY CONTINUOUS INTRAVENOUS
        INFUSION OVER 1 HOUR REPEATED DAILY FOR 5 DAYS
D-124   ONCE DAILY DOSING REGIMEN IN ADULT PATIENTS WITH LESS THAN THREE LOPINAVIR
        RESISTANCE-ASSOCIATED SUBSTITUTIONS
D-125   EXTEND CURRENT DOSING REGIMEN TO 900MG (2-450MG TABLETS) ONCE A DAY WITHIN 10 DAYS
        OF TRANSPLANTATION UNTIL 200 DAYS POST-TRANSPLANTATION FOR THE PREVENTION OF
        CYTOMEGALOVIRUS (CMV) DISEASE IN ADULT KIDNEY TRANSPLANT PATIENTS AT HIGH RISK.
D-126   CHANGE DOSAGE REGIMEN FROM 250MG TO 500MG
D-127   DOSING REGIMEN FOR ADULT PATIENTS WITH CHRONIC HEPATITIS B (CHB) AND DECOMPENSATED
        LIVER DESEASE
D-128   SINGLE IV DOSE OF FOSAPREPITANT 150MG, DOSED CONCOMITANTLY WITH 5HT3 RECEPTOR
        ANTAGONIST & CORTICOSTEROID, FOR PREVENTION OF ACUTE & DELAYED NAUSEA & VOMITING
        ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY EMETOGENIC CANCER CHEMO
D-129   800/100 MG DARUNAVIR/RITONAVIR, ONCE DAILY, IN TREATMENT -EXPERIENCED HIV-1
        INFECTED PATIENTS WITH NO DARUNIVIR RESISTANCE ASSOCIATED SUBSITUTIONS
D-130   DOSING RECOMMENDATIONS FOR TREATMENT OF HIV-1 INFECTION DURING PREGNANCY BASED ON
        DATA FROM STUDY AI424-182, A STUDY OF ATAZANAVIR/RITONAVIR IN COMBINATION WITH
        ZIDOVUDINE/LAMIVUDINE IN HIV INFECTED PREGNANT WOMEN
D-131   EVERY 6 TO 8 WEEKS FOR THE 120MG STRENGTH FOR PATIENTS WHO ARE CONTROLLED ON
        SOMATULINE DEPOT 60MG OR 90MG
D-132   45MG FOR 6 MONTH ADMINISTRATION
D-133   NEW EFFICACY DATA AND DOSING REGIMEN FOR PREGNANCY IN NORMAL OVULATORY WOMEN
        UNDERGOING CONTROLLED OVARIAN STIMULATION AS PART OF AN IVF OR INTRACYTOPLASMIC
        SPERM INJECTION (ICSI) CYCLE
D-134   INCREASING MAXIMUM DOSING OF PATIENTS WITH SCHIZOPHRENIA TO 160 MG/DAY
D-135   UPDATE LABELING WITH ONCE DAILY DOSING IN HIV-1 INFECTED, TREATMENT-NAIVE
        PEDIATRIC PATIENTS 12 TO LESS THAN 18 YEARS OF AGE
D-136   ALTERNATE DOSING REGIMEN FOR UNCOMPLICATED URETHRAL OR ENDOCERVICAL INFECTION
        CAUSED BY CHLAMYDIA TRACHOMATIS, ADMINISTER 200 MG BY MOUTH ONCE-A-DAY FOR 7 DAYS
D-137   NEW LOWER DOSING REGIMEN FOR REVATIO IN THE TREATMENT OF PULMONARY ARTERIAL
        HYPERTENSION (WHO GROUP 1) IN ADULTS
D-138   80 MG DOSING REGIMEN FOR THE RISK REDUCTION OF REBLEEDING OF GASTRIC AND DUODENAL
        ULCERS IN THE FIRST 72 HOURS FOLLOWING THERAPEUTIC ENDOSCOPY IN ADULTS
D-139   Additional information added to the Dosing and Administration section of the
        labeling regarding the administration of Bravelle and Menopur in the same syringe
        to ovulatory women as part of an ART cycle
D-140   REVISED DOSING SCHEDULE TO ADMINISTER AVANAFIL 15 MINUTES PRIOR TO SEXUAL ACTIVITY
D-141   DOSING INFORMATION IN PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA
D-142   DOSE MODIFICATION GUIDELINES FOR BORTEZOMIB WHEN GIVEN IN COMBINATION WITH
        RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE
D-143   INITIATION OF VIMPAT THERAPY WITH A LOADING DOSE OF 200MG
D-144   LOWER LIMIT OF 15 MINUTES FOR THE INFUSION DURATION
D-145   UPDATES TO THE DOSAGE AND ADMINISTRATION SECTION OF THE LABELING TO REFLECT THE
        RESULTS OF TWO SHORT TERM STUDIES EVALUATING THE SAFETY AND EFFICACY OF INTUNIV IN
        CHILDREN AND ADOLESCENTS AGES 6 TO 17 WITH ADHD.
                35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                        PATENT AND EXCLUSIVITY TERMS                        ADB 5 of 67


                                EXCLUSIVITY INDICATION

I-1    DYSMENORRHEA
I-2    CHOLANGIOPANCREATOGRAPHY
I-3    INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY
I-4    PERIPHERAL VENOGRAPHY (PHLEBOGRAPHY)
I-5    HYSTEROSALPINGOGRAPHY
I-6    TREATMENT OF JUVENILE ARTHRITIS
I-7    BIOPSY PROVEN MINIMAL CHANGE NEPHROTIC SYNDROME IN CHILDREN
I-8    ADULT INTRAVENOUS CONTRAST-ENHANCED COMPUTED TOMOGRAPHY OF THE HEAD AND BODY
I-9    PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
I-10   PREVENTION OF POSTOPERATIVE DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN TOTAL
       HIP REPLACEMENT SURGERY
I-11   RELIEF OF MILD TO MODERATE PAIN
I-12   TREATMENT OF CUTANEOUS CANDIDIASIS
I-13   URINARY TRACT INFECTION (UTI) PREVENTION FOR PERIODS UP TO FIVE MONTHS IN WOMEN
       WITH A HISTORY OF RECURRENT UTI
I-14   SEBORRHEIC DERMATITIS
I-15   PHOTOPHERESIS IN THE PALLIATIVE TREATMENT OF SKIN MANIFESTATIONS OF CUTANEOUS T-
       CELL LYMPHOMA IN PERSONS NOT RESPONSIVE TO OTHER TREATMENT
I-16   STIMULATE THE DEVELOPMENT OF MULTIPLE FOLLICLES/OOCYTES IN OVULATORY PATIENTS
       PARTICIPATING IN AN IN VITRO FERTILIZATION PROGRAM
I-17   MANAGEMENT OF CONGESTIVE HEART FAILURE
I-18   ENDOSCOPIC RETROGRADE PANCREATOGRAPHY
I-19   HERNIOGRAPHY
I-20   KNEE ARTHROGRAPHY
I-21   HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE IN COMBINATION WITH OTHER
       CHEMOTHERAPEUTIC AGENTS TO DELAY RECURRENCE IN PATIENTS WITH NONMETASTATIC
       OSTEOSARCOMA WHO HAVE UNDERGONE SURGICAL RESECTION OR AMPUTATION FOR THE PRIMARY
       TUMOR
I-22   RESCUE AFTER HIGH-DOSE METHOTREXATE THERAPY IN OSTEOSARCOMA
I-23   SHORT-TERM TREATMENT OF ACTIVE BENIGN GASTRIC ULCER
I-24   TREATMENT OF RHEUMATOID ARTHRITIS
I-25   ADULT INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY OF THE HEAD, NECK, ABDOMINAL,
       RENAL AND PERIPHERAL VESSELS
I-26   TREATMENT OF LIVER FLUKES
I-27   ADJUNCTIVE THERAPY TO DIET TO REDUCE THE RISK OF CORONARY ARTERY DISEASE
I-28   SELECTIVE ADULT VISCERAL ARTERIOGRAPHY
I-29   METASTATIC BREAST CANCER IN PREMENOPAUSAL WOMEN AS AN ALTERNATIVE TO OOPHORECTOMY
       OR OVARIAN IRRADIATION
I-30   TREATMENT OF TINEA PEDIS
I-31   CONTRAST ENHANCEMENT AGENT TO FACILITATE VISUALIZATION OF LESIONS IN THE SPINE AND
       ASSOCIATED TISSUES
I-32   PEDIATRIC MYELOGRAPHY
I-33   ORAL USE OF DILUTED OMNIPAQUE INJECTION IN ADULTS FOR CONTRAST ENHANCED COMPUTED
       TOMOGRAPHY OF THE ABDOMEN
I-34   ORAL USE IN ADULTS FOR PASS-THROUGH EXAMINATION OF THE GASTROINTESTINAL TRACT
I-35   PEDIATRIC CONTRAST ENHANCEMENT OF COMPUTED TOMOGRAPHIC HEAD IMAGING
I-36   ARTHROGRAPHY OF THE SHOULDER JOINTS IN ADULTS
I-37   RADIOGRAPHY OF THE TEMPOROMANDIBULAR JOINT IN ADULTS
I-38   CONTRAST ENHANCEMENT AGENT TO FACILITATE VISUALIZATION OF LESIONS OF THE CENTRAL
       NERVOUS SYSTEM IN CHILDREN (2 YEARS OF AGE AND OLDER)
I-39   TREATMENT OF ACUTE MYOCARDIAL INFARCTION
I-40   PRIMARY NOCTURNAL ENURESIS
I-41   MIGRAINE HEADACHE PROPHYLAXIS
I-42   HERPES ZOSTER
I-43   HERPES SIMPLEX ENCEPHALITIS
I-44   MAINTENANCE THERAPY IN HEALED DUODENAL ULCER PATIENTS AT DOSE OF 1 GRAM TWICE
       DAILY
I-45   ACUTE TREATMENT OF VARICELLA ZOSTER VIRUS
I-46   USE IN PEDIATRIC COMPUTED TOMOGRAPHIC HEAD AND BODY IMAGING
I-47   TREATMENT OF PEDIATRIC PATIENTS WITH SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS
       (HIV) DISEASE
I-48   PEDIATRIC ANGIOCARDIOGRAPHY
I-49   TREATMENT OF TRAVELERS' DIARRHEA DUE TO SUSCEPTIBLE STRAINS OF ENTEROTOXIGENIC
       ESCHERICHIA COLI
I-50   FOR USE IN WOMEN WITH AXILLARY NODE-NEGATIVE BREAST CANCER
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                        ADB 6 of 67


                                 EXCLUSIVITY INDICATION

I-51    TREATMENT OF PRIMARY DYSMENORRHEA AND FOR THE TREATMENT OF IDIOPATHIC HEAVY
        MENSTRUAL BLOOD LOSS
I-52    PEDIATRIC EXCRETORY UROGRAPHY
I-53    TREATMENT OF PANIC DISORDER, WITH OR WITHOUT AGORAPHOBIA
I-54    RENAL CONCENTRATION CAPACITY TEST
I-55    HYPERTENSION
I-56    EROSIVE GASTROESOPHAGEAL REFLUX DISEASE
I-57    SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER
I-58    INITIAL TREATMENT OF ADVANCED OVARIAN CARCINOMA IN COMBINATION WITH OTHER APPROVED
        CHEMOTHERAPEUTIC AGENTS
I-59    ENDOSCOPICALLY DIAGNOSED ESOPHAGITIS, INCLUDING EROSIVE AND ULCERATIVE
        ESOPHAGITIS, AND ASSOCIATED HEARTBURN DUE TO GASTROESOPHAGEAL REFLUX DISEASE
I-60    SINGLE APPLICATION TREATMENT OF HEAD LICE IN CHILDREN TWO MONTHS TO TWO YEARS IN
        AGE
I-61    FEMALE ANDROGENETIC ALOPECIA
I-62    PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
I-63    ONCE DAILY TREATMENT AS INITIAL THERAPY IN THE TREATMENT OF HYPERTENSION
I-64    PREVENTION OF SUPRAVENTRICULAR TACHYCARDIAS
I-65    PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN CRITICALLY ILL PATIENTS
I-66    UNCOMPLICATED GONORRHEA
I-67    TREATMENT OF ACUTE ASTHMATIC ATTACKS IN CHILDREN SIX YEARS OF AGE AND OLDER
I-68    CENTRAL PRECOCIOUS PUBERTY
I-69    SHORT TERM TREATMENT OF PATIENTS WITH SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE
        (GERD), AND FOR THE SHORT TERM TREATMENT OF ESOPHAGITIS DUE TO GERD INCLUDING
        ULCERATIVE DISEASE DIAGNOSED BY ENDOSCOPY
I-70    USE IN COMBINATION WITH 5-FLUOROURACIL TO PROLONG SURVIVAL IN THE PALLIATIVE
        TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL CANCER
I-71    VARICELLA INFECTIONS (CHICKENPOX)
I-72    PREVENTION OF CMV DISEASE IN TRANSPLANT PATIENTS AT RISK FOR CMV DISEASE
I-73    INITIATE AND MAINTAIN MONITORED ANESTHESIA CARE (MAC) SEDATION DURING DIAGNOSTIC
        PROCEDURES
I-74    INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY
I-75    TREATMENT OF ENDOSCOPICALLY DIAGNOSED EROSIVE ESOPHAGITIS
I-76    PREVENTION OF OSTEOPOROSIS
I-77    DERMAL INFECTIONS-TINEA PEDIS, TINEA CORPORIS, TINEA CRURIS DUE TO EPIDERMOPHYTON
        FLOCCOSUM
I-78    CONTRAST ENHANCED COMPUTED TOMOGRAPHIC IMAGING OF THE HEAD AND BODY AND
        INTRAVENOUS EXCRETORY UROGRAPHY
I-79    MANAGEMENT OF CHRONIC STABLE ANGINA AND ANGINA DUE TO CORONARY ARTERY SPASM
I-80    DIAGNOSIS AND LOCALIZATION OF ISCHEMIA AND CORONARY HEART DISEASE
I-81    PROPHYLAXIS IN DESIGNATED IMMUNOCOMPROMISED CONDITIONS TO REDUCE THE INCIDENCE OF
        OROPHARYNGEAL CANDIDIASIS
I-82    TREATMENT OF TRAVELERS' DIARRHEA
I-83    ANGIOCARDIOGRAPHY, CONTRAST ENHANCED COMPUTED TOMOGRAPHIC IMAGING OF THE HEAD AND
        BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY IN CHILDREN
I-84    INTRAOPERATIVE AND POSTOPERATIVE TACHYCARDIA AND/OR HYPERTENSION
I-85    TREATMENT OF ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN PATIENTS WITH AIDS
I-86    TREATMENT OF SECONDARY CARNITINE DEFICIENCY
I-87    RENAL IMAGING AGENT FOR USE IN CHILDREN
I-88    MANAGEMENT OF ENDOMETRIOSIS
I-89    EPIDURAL USE IN LABOR AND DELIVERY AS AN ANALGESIC ADJUNCT TO BUPIVACAINE
I-90    INTENSIVE CARE UNIT SEDATION
I-91    MONOTHERAPY USE FOR HYPERTENSION
I-92    ADJUNCTIVE THERAPY IN THE MANAGEMENT OF HEART FAILURE
I-93    PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN CHILDREN AGES 4-11 YEARS
I-94    USE WITH MRI IN ADULTS TO PROVIDE CONTRAST ENHANCEMENT AND FACILITATE
        VISUALIZATION OF LESIONS IN THE BODY [EXCLUDING THE HEART]
I-95    TREATMENT OF LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION
I-96    TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
I-97    ORAL OR RECTAL USE IN CHILDREN FOR THE EXAMINATION OF THE GASTROINTESTINAL TRACT
I-98    TREATMENT OF CHILDREN WHO HAVE GROWTH FAILURE ASSOCIATED WITH CHRONIC RENAL
        INSUFFICIENCY
I-99    PEDIATRIC ANESTHESIA IN CHILDREN 3 YEARS AND OLDER
I-100   TO DECREASE THE INCIDENCE OF CANDIDIASIS IN PATIENTS UNDERGOING BONE MARROW
        TRANSPLANTATION WHO RECEIVE CYTOTOXIC CHEMOTHERAPY AND/OR RADIATION THERAPY
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                        ADB 7 of 67


                                 EXCLUSIVITY INDICATION

I-101   TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN-DEPENDENT
        DIABETES MELLITUS AND RETINOPATHY
I-102   TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
I-103   PROPHYLAXIS AGAINST PNEUMOCYSTIS CARINII PNEUMONIA IN INDIVIDUALS WHO ARE
        IMMUNOCOMPROMISED AND CONSIDERED TO BE AT RISK OF DEVELOPING PNEUMOCYSTIS CARINII
        PNEUMONIA
I-104   TREATMENT OF PULMONARY AND EXTRAPULMONARY ASPERGILLOSIS IN PATENTS WHO ARE
        INTOLERANT OF OR WHO ARE REFRACTORY TO AMPHOTERICIN B THERAPY
I-105   TREATMENT OF METASTATIC CARCINOMA OF THE BREAST AFTER FAILURE OF FIRST-LINE OR
        SUBSEQUENT CHEMOTHERAPY
I-106   TREATMENT OF ACROMEGALY
I-107   VAGINAL CANDIDIASIS
I-108   EXPANDED USE-FOR ICU PATIENTS UNDERGOING LONG-TERM INFUSION DURING MECHANICAL
        VENTILATION
I-109   TYPHOID FEVER
I-110   PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH RADIOTHERAPY
I-111   TREATMENT OF PAGET'S DISEASE OF BONE
I-112   MANAGEMENT OF MODERATE TO SEVERE PAIN
I-113   TREATMENT OF PROSTATITIS
I-114   USE IN CHILDREN TO VISUALIZE LESIONS WITH ABNORMAL VASCULARITY IN THE BRAIN
        (INTRACRANIAL LESIONS), SPINE, AND ASSOCIATED TISSUE
I-115   USE IN MRI IN ADULTS TO VISUALIZE LESIONS IN THE HEAD AND NECK
I-116   MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS
I-117   TO SLOW THE PROGRESSION FO CORONANY ATHEROSCLEROSIS IN PATIENTS WITH CORONARY
        HEART DISEASE
I-118   PREVENTION OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM FOLLOWING
        KNEE REPLACEMENT SURGERY
I-119   TREATMENT OF ANEMIA CAUSED BY UTERINE LEIOMYOMATA IN WOMEN WHO FAIL IRON THERAPY
I-120   MAINTENANCE THERAPY FOR GASTRIC ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING
        ACUTE ULCERS
I-121   EXPANDED PATIENT POPULATION -- USE IN ICU PATIENTS
I-122   PSORIASIS OF THE SCALP
I-123   RELIEF OF MILD TO MODERATE PAIN IN PATIENTS AGED 6 MONTHS AND OLDER
I-124   LEUCOCYTE LABELED SCINTIGRAPHY AS AN ADJUNCT IN THE LOCALIZATION OF INTRA-
        ABDOMINAL INFECTION AND INFLAMMATORY BOWEL DISEASE
I-125   EXPANSION OF CONSCIOUS SEDATION INDICATION TO INCLUDE SHORT THERAPEUTIC PROCEDURES
I-126   ADJUNCT TO THALLIUM- 201 MYOCARDIAL PERFUSION IN PATIENTS UNABLE TO EXERCISE
        ADEQUATELY
I-127   TREATMENT OF ACYCLOVIR-RESISTANT HERPES IN IMMUNOCOMPROMISED PATIENTS
I-128   IN PT W/ CH DISEASE AND HYPERCHOLESTEROLEMIA: REDUCE RISK TOTAL MORTALITY BY
        REDUCING CORONARY DEATH; REDUCE RISK NON-FATAL MI; REDUCE RISK UNDERGOING
        MYOCARDIAL REVASCULARIZATION PROCEDURES; REDUCTION ELEVATED TOTAL AND LDL CHOL
        LEVELS...
I-129   TREATMENT OF ALCOHOL DEPENDENCE
I-130   MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS
I-131   PERIPHERAL ARTERIOGRAPHY
I-132   TREATMENT OF MANIC PHASE OF BIPOLAR DISORDER
I-133   MANAGEMENT OF CHRONIC STABLE ANGINA
I-134   HEART FAILURE POST MYOCARDIAL INFARCTION
I-135   BONE METASTASES ASSOCIATED WITH MULTIPLE MYELOMA
I-136   IDIOPATHIC CHRONIC URTICARIA
I-137   PREVENTION OF METAL-INDUCED HEART BURN, ACID INDIGESTION, AND SOUR STOMACH WHEN
        TAKEN 30 MINUTES PRIOR TO CONSUMING FOOD OR BEVERAGES
I-138   TREATMENT OF ACUTE RECURRENT GENITAL HERPES
I-139   PALLIATIVE TREATMENT OF ADVANCED BREAST CANCER IN PRE- AND PERIMENOPAUSAL WOMEN
I-140   PREVENTION OF CYTOMEGALOVIRUS (CMV) DISEASE IN INDIVIDUALS WITH HIV INFECTION AT
        RISK FOR DEVELOPING CMV DISEASE
I-141   TREATMENT OF HEMODYNAMICALLY STABLE PATIENTS WITHIN 24 HOURS OF ACUTE MYOCARDIAL
        INFARCTION TO IMPROVE SURVIVAL
I-142   LOCALIZE MYOCARDIAL ISCHEMIA(REVERSIBLE DEFECT) AND INFARCTION (NON-REVERSIBLE
        DEFECTS) IN EVALUATING MYOCARDIAL FUNCTION
I-143   EPISODIC TREATMENT OF RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT ADULTS
I-144   ENHANCEMENT OF MRI OF THE ADULT BODY INTERNAL ORGANS
I-145   0.1MMOL/KG AS A SINGLE INTRAVEOUS BOLUS FOR MRI OF THE CNS IN CHILDREN
I-146   CONTRAST ENHANCEMENT AND FACILITATION OF VISUALIZATION OF EXTRACRANIAL HEAD AND
        NECK LESIONS
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                        ADB 8 of 67


                                 EXCLUSIVITY INDICATION

I-147   PREVENTION OF GALLSTONE FORMATION IN OBESE PATIENTS EXPERIENCING RAPID WEIGHT LOSS
I-148   TREATMENT OF ACUTE PNEUMOCYSTIC CARINI PNEUMONIA (PCP) IN HIV-INFECTED PATIENTS
        WHOSE ALVEOLAR-ARTERIAL OXYGEN DIFFERENCE (AaDO2) IS LESS THAN OR EQUAL TO 55 TORR
I-149   TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
I-150   TREATMENT OF OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER
I-151   PREVENTION OF AND PREVENTION OF FURTHER POSTOPERATIVE NAUSEA AND VOMITING IN
        PEDIATRIC PATIENTS RECEIVING GENERAL ANESTHESIA
I-152   SLOWING THE PROGRESSION OF CORONARY ATHEROSCLEROSIS AND REDUCING THE RISK OF ACUTE
        CORONARY EVENTS
I-153   MANAGEMENT OF SEVERE SPASTICITY [ENCOMPASES SPINAL AND CEREBRAL ORIGIN]
I-154   PATIENT POPULATION ALTERED TO INCLUDE PEDIATRIC USE
I-155   TREATMENT OF ONCHOMYCOSIS DUE TO DERMATOPHYTES (TINEA UNGUIUM) OF THE TOENAIL WITH
        OR WITHOUT FINGERNAIL INVOLVEMENT
I-156   ADDITIONAL DATA REGARDING THE SAFE USE OF NORVASC IN PATIENTS WITH HEART FAILURE
I-157   TREATMENT OF ACUTE UNCOMPLICATED CYSTITIS IN FEMALES
I-158   TREATMENT OF OSTEOLYTIC BONE METASTASES OF BREAST CANCER
I-159   FOR HYPERCHOLESTEROLEMIC PATIENTS WITHOUT CLINICALLY EVIDENT HEART DISEASE REDUCE
        THE RISK OF MYOCARDIAL INFARCTION, REVASCULARIZATION, AND DEATH DUE TO
        CARDIOVASCULAR CAUSES WITH NO INCREASE IN DEATH FROM NON-CARDIOVASCULAR CAUSES
I-160   TREATMENT OF BACTERIAL CORNEAL ULCERS
I-161   TREATMENT OF ADULT-ONSET OR CHILDHOOD-ONSET ADULT GROWTH HORMONE DEFICIENCY
I-162   FOR USE IN PATIENTS 6-11 YEARS OF AGE
I-163   TREATMENT OF PHOTOPHOBIA
I-164   CHRONIC BACTERIAL PROSTATITIS
I-165   MANAGEMENT OF ADULTS WITH ACTIVE, CLASSIC AND DEFINITIVE RHEUMATOID ARTHRITIS WHO
        HAVE HAD INSUFFICIENT THERAPEUTIC RESPONSE TO OR ARE INTOLERANT OF AN ADEQUATE
        TRIAL OF FULL DOSES OF ONE OR MORE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
I-166   TREATMENT OF BULIMIA
I-167   COMPLICATED INTRA-ABDOMINAL INFECTIONS (USED IN COMBINATION WITH METRONIDAZOLE)
        CAUSED BY MIXED AEROBIC/ANAEROBIC PATHOGENS
I-168   MANAGEMENT OF LOCALLY CONFINED STAGE B2-C METASTATIC CARCINOMA OF THE PROSTATE (IN
        COMBINATION WITH LHRH AGONISTS)
I-169   USE IN COMBINATION WITH CORTICOSTEROIDS AS INITIAL CHEMOTHERAPY FOR THE TREATMENT
        OF PATIENTS WITH PAIN RELATED TO ADVANCED HORMONE-REFRACTORY PROSTATE CANCER
I-170   PROPHYLACTIC USE DURING HEAD LICE EPIDEMICS
I-171   RELIEF OF SYMPTOMS OF THE COMMON COLD
I-172   TREATMENT OF INITIAL EPISODE OF GENITAL HERPES
I-173   PREOPERATIVELY FOR THE PREVENTION OF INFECTION IN TRANSRECTAL PROSTATE BIOPSY
I-174   PELVIC INFLAMMATORY DISEASE
I-175   TREATMENT OF TINEA CORPORIS AND TINEA CRURIS
I-176   TREATMENT OF POSTOPERATIVE INFLAMMATION IN PATIENTS WHO HAVE UNDERGONE CATARACT
        EXTRACTION
I-177   TX OF MODERATE ACNE VULGARIS IN FEMALES,GREATER OR EQUAL TO 15YRS OF AGE,WHO HAVE
        NO KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY,DESIRE CONTRACEPTION,HAVE
        ACHIEVED MENARCHE AND ARE UNRESPONSIVE TO TOPICAL ANTI-ACNE MEDICATIONS
I-178   TREATMENT OF ONCHOMYCOSIS OF THE FINGERNAIL WITHOUT CONCOMITANT ONCHOMYCOSIS OF
        THE TOENAIL WITH A PULSE DOSING REGIMEN
I-179   NOSOCOMIAL PNEUMONIA-MILD TO MODERATE AND SEVERE CAUSED BY HAEMOPHILUS INFLUENZAE
        OR KLEBSIELLA PNEUMONIAE
I-180   TREATMENT OF PLANTAR TINEA PEDIS (MOCCASIN TYPE)
I-181   TREATMENT OF PATIENTS WITH COMPLEX PARTIAL SEIZURES WITH AND WITHOUT SECONDARY
        GENERALIZATION
I-182   TREATMENT OF GROWTH FAILURE ASSOCIATED WITH TURNER SYNDROME
I-183   MAINTENANCE THERAPY IN THE MANAGEMENT OF MILD TO MODERATE ASTHMA IN PEDIATRIC
        PATIENTS AGES 6-11
I-184   TREATMENT OF PANIC DISORDER AT A RECOMMENDED DOSE RANGE OF 1 TO 2MG/DAY (MAXIMUM
        OF 4MG)
I-185   PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
I-186   TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR CAUSED BY OR PRESUMED TO BE CAUSED BY
        PITYROSPORUM ORBICULARE (ALSO KNOWN AS MALASSEZIA FURFUR OR M. ORBICULARE)
I-187   PREVENTION OF FRACTURES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
I-188   TREATMENT OF ACUTE SINUSITIS AND ACUTE EXACERBATION OF CHRONIC SINUSITIS
I-189   TREATMENT OF ACUTE OTITIS MEDIA IN PEDIATRIC PATIENTS
I-190   PLANAR IMAGING AS A SECOND LINE DIAGNOSTIC DRUG AFTER MAMMOGRAPHY TO ASSIST IN THE
        EVALUATION OF BREAST LESIONS IN PATIENTS WITH AN ABNORMAL MAMMOGRAM OR A PALPABLE
        BREAST MASS
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                        ADB 9 of 67


                                 EXCLUSIVITY INDICATION

I-191   ENDOMETRIAL THINNING AGENT PRIOR TO ENDOMETRIAL ABLATION FOR DYSFUNCTIONAL UTERINE
        BLEEDING
I-192   THE PREVENTION OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM, IN
        PATIENTS UNDERGOING ABDOMINAL SURGERY WHO ARE AT RISK FOR THROMBOEMBOLIC
        COMPLICATIONS AND A NEW DOSAGE REGIMEN, 40MG ONCE DAILY, FOR THIS INDICATION
I-193   TREATMENT OF PANIC DISORDER IN A RECOMMENDED DOSE RANGE OF 50 TO 200MG/DAY
I-194   CONGESTIVE HEART FAILURE
I-195   FOR USE OF LANSOPRAZOLE IN COMBINATION WITH CLARITHROMYCIN AND AMOXICILLIN FOR THE
        ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH ACTIVE DUODENAL ULCER DISEASE
        OR A ONE-YEAR HISTORY OF DUODENAL ULCER
I-196   ACUTE TREATMENT OF ACTIVE BENIGN GASTRIC ULCER
I-197   MAINTENANCE OF HEALING OF DUODENAL ULCER
I-198   FOR THE USE OF LANSOPRAZOLE IN COMBINATION WITH AMOXICILLIN FOR THE ERADICATION OF
        HELICOBACTER PYLORI IN PATIENTS WITH ACTIVE DUODENAL ULCER DISEASE OR A ONE-YEAR
        HISTORY OF A DUODENAL ULCER
I-199   MONOTHERAPY AND COMBINATION THERAPY WITH SULFONYL UREAS IN THE TREATMENT OF TYPE
        II DIABETES
I-200   TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR
I-201   EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS
I-202   SECOND-LINE TREAMENT OF AIDS-RELATED KAPOSI'S SARCOMA
I-203   MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS
I-204   USE IN PEDIATRIC PATIENTS BETWEEN THE AGES OF 6 AND 11 FOR THE TREATMENT OF THE
        NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS
I-205   INITIAL ANTICONVULSANT TREATMENT OF STATUS EPILEPTICUS
I-206   TREATMENT OF EDEMA ASSOCIATED WITH CHRONIC RENAL FAILURE
I-207   FOR THE SUPPRESSION OF RECURRENT EPISODES OF GENITAL HERPES IN IMMUNOCOMPETENT
        ADULTS
I-208   TREATMENT OF OBSESSIVE COMPULSIVE DISORDER IN THE PEDIATRIC POPULATION
I-209   PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT)
I-210   TO SLOW THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CORONARY
        HEART DISEASE AS PART OF A TREATMENT STRATEGY TO LOWER TOTAL AND LDL CHOLESTEROL
        TO TARGET LEVELS
I-211   FOR USE IN PEDIATRIC POPULATION
I-212   TREATMENT OF SYMPTOMS OF DRY MOUTH IN PATIENTS WITH SJOGREN'S SYNDROME
I-213   TEMPORARY RELIEF OF PAIN AND PHOTOPHOBIA IN PATIENTS UNDERGOING CORNEAL REFRACTIVE
        SURGERY
I-214   TREATMENT OF OSTEOPOROSIS
I-215   PRE-PROCEDURAL APPLICATION TO ADULT MALE GENITAL SKIN PRIOR TO SITE-SPECIFIC
        SUBCUTANEOUS INFILTRATION WITH LIDOCAINE FOR THE REMOVAL OF GENITAL WARTS
I-216   FOR THE LONG-TERM TWICE-DAILY (MORNING AND EVENING) ADMINISTRATION IN THE
        MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD, INCLUDING CHRONIC
        BRONCHITIS AND EMPHYSEMA
I-217   PREVENTION (DURING AND FOLLOWING HOSPITALIZATION) OF DEEP VEIN THROMBOSIS, WHICH
        MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING HIP REPLACEMENT SURGERY
I-218   USE OF LIPITOR AS AN ADJUNCTIVE THERAPY TO DIET FOR THE TREATMENT OF PATIENTS WITH
        ELEVATED SERUM TRIGLYCERIDE LEVELS (FREDERICKSON TYPE IV)
I-219   USE OF LIPITOR BY PATIENTS WITH PRIMARY DYSBETALIPOPROTEINEMIA (FREDERICKSON TYPE
        III) WHO DO NOT RESPOND ADEQUATELY TO DIET
I-220   TREATMENT OF EPISODIC- HEARTBURN, ACID INDIGESTION AND SOUR STOMACH
I-221   TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN MEN WITH AN ENLARGED PROSTATE
        TO IMPROVE SYMPTOMS, REDUCE THE RISK OF ACUTE URINARY RETENTION AND REDUCE THE
        RISK OF THE NEED OF SURGERY
I-222   PREVENTION OF ISCHEMIC COMPLICATIONS OF UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL
        INFARCTION, WHEN CONCURRENTLY ADMINISTERED WITH ASPIRIN
I-223   USE IN THE SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH ALLERGIC AND
        NONALLERGIC-PERENNIAL RHINITIS IN CHILDREN AGE 6-11 YEARS
I-224   FOR THE USE IN PEDIATRIC PATIENTS 4 TO 11 YEARS OF AGE FOR THE MANAGEMENT OF THE
        NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS
I-225   USE IN PATIENTS WITH PREVIOUS MI AND NORMAL CHOLESTEROL LEVELS, TO REDUCE RISK OF
        RECURRENT MI, MYOCARDIAL REVASCULARIZATION, AND CEREBROVASCULAR DISEASE EVENTS
I-226   FIRST-LINE THERAPY FOR THE TREATMENT OF ADVANCED CARCINOMA OF THE OVARY IN
        COMBINATION WITH CISPLATIN
I-227   SHORT-TERM TREATMENT OF SYMPTOMATIC GASTROESPHAGEAL REFLUX DISEASE (GERD)
I-228   PREVENTION OF MEAL INDUCED HEARTBURN AT A DOSE OF 75MG TAKEN 30-60MIN PRIOR TO A
        MEAL
I-229   PRILOSEC (OMEPRAZOLE), AMOXICILLIN, AND CLARITHROMYCIN FOR THE ERADICATION OF H.
        PYLORI IN PATIENTS WITH DUODENAL ULCER DISEASE
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 10 of 67


                                 EXCLUSIVITY INDICATION

I-230   IN COMBINATION WITH CIS-PLATIN, FOR THE FIRST LINE TREATMENT OF NON-SMALL CELL
        LUNG CANCER IN PATIENTS WHO ARE NOT CANDIDATES FOR POTENTIALLY CURATIVE SURGERY
        AND/OR RADIATION
I-231   TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER
        FAILURE OF PRIOR CHEMOTHERAPY
I-232   TREATMENT OF RECURRENT MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN HIV-AFFECTED
        PATIENTS AT A DOSE OF 500MG TWICE DAILY
I-233   PROPHYLACTIC USE TO REDUCE PERIOPERATIVE BLOOD LOSS AND THE NEED FOR BLOOD
        TRANSUFSION IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS IN THE COURSE OF
        CORONARY ARTERY BYPASS GRAFT SURGERY
I-234   FOR USE IN COMBINATION WITH CISPLATIN FOR THE FIRST-LINE TREATMENT OF PATIENTS
        WITH INOPERABLE LOCALLY ADVANCED (STAGE IIIA OR IIIB) OR METASTATIC (STAGE IV)
        NON-SMALL CELL LUNG CANCER
I-235   PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN PATIENTS 12 YEARS OF AGE AND OLDER
I-236   PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER
I-237   MAINTENANCE TREATMENT OF ASTHMA AND PREVENTION OF BRONCHOSPASM IN PATIENTS 4 YEARS
        OF AGE AND OLDER
I-238   ADJUNCTIVE TREATMENT OF LENNOX-GASTAUT SYNDROME IN PEDIATRIC AND ADULT PATIENTS
I-239   TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
I-240   MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULTANT METABOLIC BONE DISEASE
        IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENAL FAILURE (CCR 15 TO 55ML/MIN) NOT
        YET ON DIALYSIS
I-241   USE IN PHOTODYNAMIC THERAPY (PDT) FOR REDUCTION OF OBSTRUCTION AND PALLIATION OF
        SYMPTOMS IN PATIENTS WITH COMPLETELY OR PARTIALLY OBSTRUCTING ENDOBRONCHIAL
        NONSMALL CELL LUNG CANCER
I-242   TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE
        AND IN THE TREATMENT OF VULVAR AND VAGINAL ATROPHY IN WOMEN WITH AN INTACT UTERUS
I-243   USE IN THE SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH THE COMMON COLD IN
        CHILDREN AGE 5 TO 11 YEARS
I-244   REDUCE THE INCIDENCE OF BREAST CANCER IN WOMEN AT HIGH RISK FOR BREAST CANCER
I-245   TREATMENT OF ACUTE SINUSITIS
I-246   TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS
I-247   USE IN CONVERSION TO MONOTHERAPY IN ADULTS WITH PARTIAL SEIZURES WHO ARE RECEIVING
        TREATMENT WITH A SINGLE ENZYME-INDUCING ANTIEPILEPTIC DRUG
I-248   INPATIENT TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITH/WITHOUT PULMONARY EMBOLISM
        WHEN ADMIN WITH WARFARIN SODIM AND OUTPATIENT TREATMENT OF ACUTE DEEP VEIN
        THROMBOSIS WITHOUT PULMONARY EMBOLISM WHEN ADMIN WITH WARFARIN SODIUM
I-249   TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE
        PREVIOUSLY UNTREATED WITH ALPHA INTERFERON THERAPY
I-250   PRIMARY PREVENTION OF CORONARY HEART DISEASE IN PATIENTS WITHOUT SYMPATOMATIC
        CARDIOVASCULAR DISEASE WHO HAVE AVERAGE TO MODERATELY ELEVATED TOTAL-C AND LDL-C
        AND BELOW AVERAGE HDL-C
I-251   TREATMENT OF GENERALIZED ANXIETY DISORDER
I-252   NEW COMBINATION USE OF PRECOSE FOR PATIENTS WITH TYPE 2 DIABETES TREATED WITH DIET
        PLUS METFORMIN
I-253   COMBINATION USE OF PRECOSE FOR PATIENTS WITH TYPE 2 DIABETES TREATED WITH DIET
        PLUS INSULIN
I-254   PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS (LOSS OF BONE MASS)
I-255   PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA (PCP)
I-256   USE IN TREATMENT OF SMALL CELL LUNG CANCER SENSITIVE DISEASE AFTER FAILURE OF
        FIRST-LINE CHEMOTHERAPY
I-257   TREATMENT OF CHRONIC HEPATITIS B ASSOCIATED WITH EVIDENCE OF HEPATITIS B VIRAL
        REPLICATION AND ACTIVE LIVER INFLAMATION
I-258   FOR PERENNIAL NONALLERGIC RHINITIS FOR AGES 4 AND ABOVE
I-259   PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT), WHICH MAY LEAD TO PULMONARY EMBOLISM,
        IN PATIENTS UNDERGOING HIP REPLACEMENT SURGERY
I-260   EXPANDED PEDIATRIC USE IN CHILDREN YOUNGER THAN ONE MONTH OF AGE TO BIRTH (WITH A
        GESTATIONAL AGE OF 37 WEEKS OR GREATER)
I-261   TREATMENT OF SOCIAL ANXIETY DISORDER
I-262   TREATMENT OR PREVENTION OF BRONCHOSPASM WITH REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE
        AND FOR THE PREVENTION OF EXERCISE INDUCED BRONCHOSPASM IN CHILDREN AGES 4-12
I-263   TREATMENT OF UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL INFARCTION FOR THE
        PREVENTION OF ISCHEMIC COMPLICATIONS IN PATIENTS ON CONCURRENT ASPIRIN THERAPY
I-264   PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH RADIATION, INCLUDING TOTAL BODY
        IRRADIATION (TBI) AND FRACTIONATED ABDOMINAL RADIATION
I-265   TREATMENT OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS 6 YEARS AND OLDER
I-266   USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN PEDIATRIC PATIENTS AGES 2-16 YEARS WITH
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 11 of 67


                                 EXCLUSIVITY INDICATION

        PARTIAL ONSET SEIZURES
I-267   USE IN PEDIATRIC PATIENTS 3 MONTHS OLD AND OLDER - FOR CORTICOSTEROID-RESPONSIVE
        DERMATOSES
I-268   PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN PATIENTS 7-11 YEARS OF AGE
I-269   PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CANCER
        CHEMOTHERAPY, INCLUDING CISPLATIN
I-270   ADJUVANT TREATMENT OF NODE-POSITIVE BREAST CANCER ADMINISTRERED SEQUENTIALLY TO
        STANDARD DOXORUBICIN-CONTAINING COMBINATION CHEMOTHERAPY
I-271   TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
I-272   TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN MEN AND WOMEN RECEIVING
        GLUCOCORTICOIDS IN A DAILY DOSE EQUIVALENT TO 7.5MG OR GREATER OF PREDNISONE AND
        WHO HAVE LOW BONE MINERAL DENSITY
I-273   ADJUNCT TO DIET TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
        (HETEROZYGOUS FAMILIAL AND NON FAMILIAL) AND MIXED DYSLIPIDEMIA (FREDERICKSON
        TYPES IIA AND IIB)
I-274   USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED
        TONIC-CLONIC SEIZURES
I-275   USE IN COMBINATION WITH METFORMIN AND SULFONYLUREA IN PATIENTS WITH TYPE 2
        DIABETES
I-276   USE OF REZULIN IN COMBINATION WITH METFORMIN AND SULFONYLUREAS IN PATIENTS WITH
        TYPE 2 DIABETES
I-277   TREATMENT OF TYPE III HYPERLIPOPROTEINEMIA
I-278   TREATMENT OF PATIENTS WITH ISOLATED HYPERTRIGLYCERIDEMIA (FREDERICKSON TYPE IV)
I-279   TREATMENT OF POST-TRAUMATIC STRESS DISORDER
I-280   USE OF CARNITOR INJECTION FOR THE PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY
        IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS
I-281   INCREASING HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA (HETEROZYGOUS
        FAMILIAL AND NONFAMILIAL) AND MIXED DYSLIPIDEMIA (FREDERICKSON TYPES IIA AND IIB)
I-282   TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG
        CANCER AFTER FAILURE OF PRIOR PLATINUM-BASED CHEMOTHERAPY
I-283   TO REDUCE THE INCIDENCE OF MODERATE TO SEVERE XEROSTOMIA IN PATIENTS UNDERGOING
        POST-OPERATIVE RADIATION TREATMENT FOR HEAD AND NECK CANCER, WHERE THE RADIATION
        PORT INCLUDES A SUBSTANTIAL PORTION OF THE PAROTID GLANDS
I-284   TO REDUCE THE NUMBER OF ADENOMATOUS COLORECTAL POLYPS IN FAMILIAL ADENOMATOUS
        POLYPOSIS PATIENTS AS AN ADJUNCT TO USUAL CARE
I-285   TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL RHINITIS IN ADULTS AND
        CHILDREN 3 YEARS OF AGE AND OLDER
I-286   TREATMENT OF PATIENTS WITH FREDERICKSON TYPE III
I-287   USE OF PRAVASTATIN IN PATIENTS WITH EVIDENT CORONARY HEART DISEASE TO REDUCE THE
        RISK OF TOTAL MORTALITY BY REDUCING CORONARY DEATH
I-288   CHANGES IN SEVERAL SECTIONS OF THE INSERT TO INCORPORATE STATEMENTS CONCERNING THE
        USE OF HIGH DOSES OF LISINOPRIL TO REDUCE THE RISK OF THE COMBINED OUTCOMES OF
        MORTALITY AND HOSPITALIZATION IN PATIENTS WITH CONGESTIVE HEART FAILURE
I-289   USE OF AVANDIA IN COMBINATION WITH A SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES
        MELLLITUS WHEN DIET AND EXERCISE WITH EITHER SINGLE AGENT DOES NOT ACHIEVE
        ADEQUATE GLYCEMIC CONTROL
I-290   PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
I-291   PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
I-292   TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
I-293   TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
I-294   TREATMENT OF UNCOMPLICATED ACUTE ILLNESS DUE TO INFLUENZA A AND B IN PEDIATRIC
        PATIENTS 7 YEARS AND OLDER WHO HAVE BEEN SYMPTOMATIC FOR NO MORE THAN 2 DAYS
I-295   PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR WOMEN WITH AN INTACT UTERUS
I-296   LONG-TERM INTRAVENOUS TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH THE
        SCLERODERMA SPECTRUM OF DISEASE IN NYHA CLASS III AND CLASS IV PATIENTS WHO DO NOT
        RESPOND TO CONVENTIONAL THERAPY
I-297   SHORT-TERM TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
I-298   TREATMENT OF PATIENTS WITH FREDERICKSON TYPE IIA AND IIB HYPERLIPOPROTEINEMIA
I-299   USE OF CAMPTOSAR AS A COMPONENT OF FIRST-LINE THERAPY IN COMBINATION WITH 5-
        FLUROURACIL AND LEUCOVARIN FOR PATIENTS WITH METASTATIC CARCINOMA OF THE COLON OR
        RECTUM
I-300   PROPHYLAXIS FOR ASTHMA IN CHILDREN 2-5 YEARS OF AGE
I-301   TREATMENT OF SIGNS AND SYMPTOMS OF ALLERGIC CONJUNCTIVITIS
I-302   TREATMENT OF PEDIATRIC PATIENTS WITH PRADER-WILLI SYNDROME
I-303   INCREASING HDL-CHOLESTEROL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED
        DYSLIPIDEMIAS
I-304   TREATMENT OF PATIENTS WITH FREDERICKSON TYPE IV
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 12 of 67


                                 EXCLUSIVITY INDICATION

I-305   TREATMENT OF LEVOFLOXACIN SUSCEPTIBLE STRAINS OF PENICILLIN-RESISTANT
        STREPTOCOCCUS PNEUMONIAE IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
I-306   INDUCTION OF SPERMATOGENESIS IN MEN WITH PRIMARY AND SECONDARY HYPOGONADOTROPIC
        HYPOGONADISM IN WHOM THE CAUSE OF INFERTILITY IS NOT DUE TO PRIMARY TESTICULAR
        FAILURE
I-307   NEW COMBINATION USE OF METFORMIN AND INSULIN IN TYPE 2 DIABETES
I-308   TREATMENT OF PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE RHEUMOTOID
        ARTHRITIS WHO RESPONDED INADEQUATELY TO SALICYLATES OR OTHER NSAIDS
I-309   USE OF ACTONEL 35MG ONCE A WEEK TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
I-310   REDUCTION IN RISK OF MYOCARDIAL INFARCTION, STROKE, AND DEATH FROM CARDIOVASCULAR
        CAUSES
I-311   ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES IN PEDIATRIC PATIENTS AGE
        3 TO 12 YEARS
I-312   FIRST LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR
        HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER
I-313   EXTENSION OF INDICATION TO PROVIDE FOR MAINTENANCE OF RESPONSE
I-314   TOPICAL ANESTHETIC FOR SUPERFICIAL MINOR SURGERY OF GENITAL MUCOUS MEMBRANES AND
        AS AN ADJUNCT FOR LOCAL INFILTRATION ANESTHESIA IN GENITAL MUCOUS MEMBRANES
I-315   THROMBOPROPHYLAXIS OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY
        EMBOLISM,IN MEDICAL PATIENTS WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS DUE
        TO SEVERELY RESTRICTED MOBILITY DURING ACUTE ILLNESS
I-316   TREATMENT OF NSAID-ASSOCIATED GASTRIC ULCER PATIENTS WHO CONTINUE NSAID USE AND
        REDUCING RISK OF NSAID-ASSOCIATED GASTRIC ULCERS IN PATIENTS WITH HISTORY OF
        DOCUMENTED GASTRIC ULCER WHO REQUIRE USE OF AN NSAID
I-317   PROPHYLAXIS OF INFLUENZA IN ADULTS AND ADOLESCENTS 13 YEARS AND OLDER
I-318   FIRSTLINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR
        HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER
I-319   USE FOR SUSPECTED OR CONFIRMED METHANOL POISONING, EITHER ALONE OR IN COMBINATION
        WITH HEMODIALYSIS
I-320   TREATMENT OF TYPE 2 DIABETES IN PEDIATRIC PATIENTS (AGES 10-16 YEARS)
I-321   JUVENILE RHEUMATOID ARTHRITIS
I-322   USE OF DIPRIVAN IN PATIENTS 3 MONTHS TO 16 YEARS
I-323   COLORECTAL CANCER
I-324   REDUCING NEUROLOGIC DISABILITY AND/OR FREQUENCY OF CLINICAL RELAPSES IN PATIENTS
        WITH SECONDARY (CHRONIC) PROGRESSIVE, PROGRESSIVE RELAPSING, OR WORSENING
        RELAPSING-REMITTING MULTIPLE SCLEROSIS
I-325   PREVENTION OF RELAPSE AND RECURRENCE OF DEPRESSION
I-326   GENERALIZED ANXIETY DISORDER
I-327   SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN
        PATIENTS 5 YEARS AND OLDER
I-328   PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN PATIENTS 5-6 YEARS OF AGE
I-329   UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS
I-330   MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND CONTROL OF DAYTIME AND NIGHTTIME
        HEARTBURN SYSTOMS IN PATIENTS WITH GERD
I-331   TREATMENT OF MODERATE ACNE VULGARIS
I-332   EMPIRIC THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH SUSPECTED FUNGAL INFECTIONS
        (EFTN)
I-333   TOPICAL TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR DUE TO MALASSEZIA FURFUR
        (FORMERLY PITYROSPORUM ORBICULARE)
I-334   LONG-TERM TREATMENT OF GROWTH FAILURE IN CHILDREN BORN SMALL FOR GESTATIONAL AGE
        WHO FAIL TO MANIFEST CATCH-UP GROWTH BY TWO YEARS OF AGE
I-335   ADJUNCTIVE THERAPY IN PATIENTS TWO YEARS AND OLDER WITH SEIZURES ASSOCIATED WITH
        LENNOX-GASTAUT SYNDROME
I-336   EXPANSION OF INDICATION TO INCLUDE THE TREATMENT OF PATIENTS WITH PREDOMINATELY
        CLASSIC SUBFOVEAL CHOROIDAL NEOVASCULARIZATION DUE TO PATHOLOGIC MYOPIA OR
        PRESUMED OCULAR HISTOPLASMOSIS
I-337   PATHOLOGICAL HYPERSECRETION ASSOCIATED WITH ZOLLINGER-ELLISON SNYDROME
I-338   MANAGEMENT OF ACUTE PAIN IN ADULTS AND TREATMENT OF PRIMARY DYSMENORRHEA
I-339   TREATMENT OF HEPATITIS B IN PEDIATRIC PATIENTS AGES 2-17 YEARS
I-340   ATOPIC DERMATITIS IN PEDIATRIC PATIENTS AGES 2-5
I-341   BREAST CANCER COMBINATION THERAPY
I-342   USE OF FORADIL FOR LONG-TERM, TWICE DAILY (MORNING AND EVENING) ADMINISTRATION IN
        THE MAINTENANCE TREATMENT OF BRONCHO-CONSTRICTION IN PATIENTS WITH COPD INCLUDING
        CHRONIC BRONCHITIS AND EMPHYSEMA
I-343   USE OF COREG FOR SEVERE HEART FAILURE
I-344   ACNE VULGARIS
I-345   TREATMENT OF POSTTRAUMATIC STRESS DISORDER
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 13 of 67


                                 EXCLUSIVITY INDICATION

I-346   TREATMENT OF SYMPTOMATIC GASTRO ESOPHAGEAL REFLUX DISEASE (GERD)
I-347   TREATMENT OR PREVENTION OF BRONCHOSPASM IN CHILDREN 6 YEARS OF AGE AND OLDER WITH
        OBSTRUCTIVE AIRWAY DISEASE
I-348   LONG-TERM, TWICE-DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE
        TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD (INCLUDING EMPHYSEMA AND CHRONIC
        BRONCHITIS)
I-349   ACUTE CORONARY SYNDROME
I-350   TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ADOLESCENT BOYS AND
        GIRLS AT LEAST ONE YEAR POSTMENARCHAL, AGES 10 TO 17 YEARS, WITH A RECOMMENDED
        DOSING RANGE OF 10 TO 40MG ONCE DAILY
I-351   PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR ALL STRENGTHS
I-352   ANTICOAGULANT IN PATIENTS WITH OR AT RISK FOR HEPARIN-INDUCED THROMBOCYTOPENIA
        UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS (PCI)
I-353   TREATMENT OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS
I-354   MANAGEMENT OF POST HERPETIC NEURALGIA
I-355   PREMENSTRUAL DYSPHORIC DISORDER
I-356   TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS, INCLUDING ZOLLINGER-ELLISON
        SYNDROME
I-357   TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS
I-358   TREATMENT OF PANIC DISORDER
I-359   TREATMENT OF VULVAR AND VAGINAL ATROPHY ASSOCIATED WITH THE MENOPAUSE
I-360   TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL RHINITIS IN CHILDREN AGES
        TWO UP TO AGE THREE
I-361   TREATMENT OF MULTIPLE MYELOMA AND DOCUMENTED BONE METASTASES FROM SOLID TUMORS, IN
        CONJUNCTION WITH STANDARD ANTINEOPLASTIC THERAPY. PROSTATE CANCER SHOULD HAVE
        PROGRESSED AFTER TREATMENT WITH AT LEAST ONE HORMONAL THERAPY
I-362   TREATMENT OF PANIC DISORDER, WITH OR WITHOUT AGORAPHOBIA
I-363   ADJUVANT TREATMENT OF POST MENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY
        BREAST CANCER
I-364   TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
I-365   TREATMENT OF HEART FAILURE (NYHA CLASS II-IV) IN PATIENTS WHO ARE INTOLERANT TO AN
        ACE INHIBITOR
I-366   PREVENTION OF RELAPSE FOLLOWING LONG-TERM TREATMENT OF MAJOR DEPRESSIVE DISORDER
I-367   COMBINATION THERAPY WITH THIAZOLIDINEDIONE TO LOWER BLOOD GLUCOSE IN PTS WHOSE
        HYPERGLYCEMIA CANNOT BE CONTROLLED BY DIET/EXERCISE PLUS MONOTHERAPY WITH ANY OF
        THE FOLLOWING AGENTS:METFORMIN,SULFONYLUREAS,REPAGLINIDE,OR THIAZOLIDINEDIONES
I-368   USE OF GLUCOVANCE WITH A THIAZOLIDINEDIONE WHEN GLYCEMIC CONTROL IS NOT OBTAINED
        WITH GLUCOVANCE ALONE
I-369   PREVENTION AND TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING
I-370   TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN, AGES 8-13
        YEARS, WITH RECOMMENDED DOSE OF 20MG ONCE DAILY AND IN ADOLESCENTS, AGES 14-18
        WITH A RECOMMENDED DOSE OF 40MG ONCE DAILY
I-371   HELICOBACTER PYLORI ERADICATION TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE
I-372   NOSOCOMIAL PNEUMONIA
I-373   TREATMENT OF TYPE 2 DIABETIC NEPHROPATHY
I-374   SHORT TERM TOPICAL TREATMENT OF MILD TO MODERATE PLAQUE-TYPE PSORIASIS OF NON
        SCALP REGIONS
I-375   FIRST LINE THERAPY FOR THE REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH
        OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION
I-376   TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE
        CHRONIC MYELOID LEUKEMIA (CML)
I-377   USE OF BRAVELLE FOR MULTIPLE FOLLICULAR DEVELOPMENT (CONTROLLED OVARIAN
        STIMULATION) DURING ASSISTED REPRODUCTIVE TECHNOLOGY CYCLES IN PATIENTS WHO HAVE
        PREVIOUSLY RECEIVED PITUITARY SUPPRESSION
I-378   RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS
        2 YEARS OF AGE AND OLDER
I-379   USE TAXOTERE IN COMBINATION WITH CISPLATIN FOR THE TREATMENT OF PATIENTS WITH
        UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHO HAVE
        NOT PREVIOUSLY RECEIVED CHEMOTHERAPY FOR THIS CONDITION
I-380   TO TREAT PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER AT RISK FOR
        EMERGENT SUICIDAL BEHAVIOR
I-381   TREATMENT OF COLD SORES (HERPES LABIALIS) IN ADULT AND ADOLESCENT PATIENTS 12
        YEARS OF AGE AND OLDER
I-382   FOR NEWLY-DIAGNOSED HIGH GRADE MALIGNANT GLIOMA PATIENTS AS AN ADJUNCT TO SURGERY
        AND RADIATION
I-383   TREATMENT OF TYPE 2 DIABETIC NEPHROPATHY
I-384   USE IN COMBINATION WITH INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 14 of 67


                                 EXCLUSIVITY INDICATION

        MELLITUS
I-385   MODIFICATION OF THE INDICATION FOR COMMUNITY ACQUIRED PNEUMONIA TO ADD"INCLUDING
        PENICILLIN-RESISTANT STRAINS, MIC PENICILLIN>=2MCG/ML TO STREPTOCOCCUS PNEUMONIAE
I-386   RAPAMUNE (SIROLIMUS) WITHIN AN IMMUNOSUPPRESSIVE REGIMEN THAT WOULD ALLOW FOR THE
        WITHDRAWAL OF CYCLOSPORINE 2 TO 4 MONTHS AFTER RENAL TRANSPLANTATION IN PATIENTS
        CONSIDERED AT LOW TO MODERATE IMMUNOLOGIC RISK FOR RENAL TRANSPLANT REJECTION
I-387   ADJUNCTIVE THERAPY OF PARTIAL SEIZURES IN PEDIATRIC PATIENTS GREATER THAT OR EQUAL
        TO 2 YEARS OF AGE
I-388   TREATMENT OF PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL
        INFARCTION
I-389   SUPRESSION OF RECURRENT GENITAL HERPES IN HIV-INFECTED INDIVIDUALS
I-390   USE IN PTS AT HIGH RISK CORONARY EVENTS DUE TO EXISTING CORONARY HEART
        DISEASE,DIABETES,PERIPHERAL VESSEL DISEASE,STROKE HISTORY,OTHER CV DISEASE TO
        REDUCE RISK TOTAL MORTALITY BY REDUCING CORONARY DEATH,REDUCE NONFATAL MI &
I-391   ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT'S ESOPHAGUS PATIENTS WHO DO NOT
        UNDERGO ESOPHAGECTOMY
I-392   TX OF PED PATIENTS W/PH+ CHRONIC PHASE CML DISEASE RECUR AFTER STEM CELL TRNSPLT
        OR RESIST TO INTERFERON ALPHA THERAPY.NO CONTROLLED TRIALS DEMONSTRATING A
        CLINICAL BENEFIT SUCH AS IMPROVE IN DISEASE RELATED SX OR INCREASED SURVIVAL
I-393   CHRONIC BACTERIAL PROSTATITIS
I-394   USE IN PATIENTS WITH CORONARY HEART DISEASE TO REDUCE THE RISK OF UNDERGOING
        CORONARY REVASCULARIZATION PROCEDURES
I-395   TO IMPROVE PHYSICAL FUNCTION
I-396   EXPANDED INDICATION TO INCLUDE THE ASSESSMENT OF VENTRICULAR FUNCTION IN SUBJECTS
        BEING EVALUATED FOR HEART DISEASE AND/OR VENTRICULAR FUNCTION
I-397   EXTENDED PROPHYLAXIS IN PATIENTS UNDERGOING HIP FRACTURE SURGERY
I-398   IDIOPATHIC SHORT STATURE
I-399   TREATMENT OF CANDIDEMIA AND THE FOLLOWING CANDIDA INFECTIONS: INTRA-ABDOMINAL
        ABSCESSES, PERITONITIS AND PLEURAL SPACE INFECTIONS
I-400   USE OF OLANZAPINE IN COMBINATION WITH LITHIUM OR VALPROATE FOR THE TREATMENT OF
        ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR DISORDER
I-401   LONGER-TERM EFFICACY OF ARIPIPRAZOLE IN THE TREATMENT OF SCHIZOPHRENIA
I-402   DIABETIC FOOT INFECTIONS WITHOUT CONCOMITANT OSTEOMYELITIS
I-403   USE OF VALTREX IN COMBINATION WITH SAFER SEX PRACTICES FOR THE REDUCTION OF THE
        RISK OF TRANSMISSION OF GENITAL HERPES DURING SUPPRESIVE THERAPY OF THE SOURCE
        PARTNER IN A HETEROSEXUAL COUPLE
I-404   MAINTENANCE TREATMENT OF BIPOLAR I DISORDER TO DELAY THE TIME TO OCCURRENCE OF
        MOOD EPISODES (DEPRESSION, MANIA, HYPOMANIA, MIXED EPISODES) IN PATIENTS TREATED
        FOR ACUTE MOOD EPISODES WITH STANDARD THERAPY
I-405   TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER (PMDD) USING AN INTERMITTENT DOSING
        REGIMEN
I-406   PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS
        TRANSPLANT PATIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPIENT CMV
        SERONEGATIVE)
I-407   IMPROVE SURVIVAL OF STABLE PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
        (EJECTION FRACTION<=40%) AND CLINICAL EVIDENCE OF CONGESTIVE HEART FAILURE AFTER
        AN ACUTE MYOCARDIAL INFARCTION
I-408   STIMULATION OF PANCREATIC SECRETIONS TO FACILITATE THE INDENTIFICATION OF THE
        AMPULLA OF VATER AND ACCESSORY PAPILLA DURING ENDOSCOPIC RETROGRADE CHOLANGIO-
        PANCREATOGRAPHY (ERCP)
I-409   ESOPHAGEAL CANDIDIASIS
I-410   USE OF ADVAIR DISKUS 250/50 FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
        ASSOCIATED WITH CHRONIC BRONCHITIS
I-411   EXPANDED INDICATION FOR USE IN COMBINATION WITH ANTIDIABETIC DRUGS IN THE
        THIAZOLIDINEDIONE CLASS
I-412   MONOTHERAPY FOR THE SHORT TERM TREATMENT OF ACUTE MANIC OR MIXED EPISODES
        ASSOCIATED WITH BIPOLAR I DISORDER
I-413   ADJUNCTIVE THERAPY FOR THE SHORT TERM TREATMENT OF ACUTE MANIC OR MIXED EPISODES
        ASSOCIATED WITH BIPOLAR I DISORDER
I-414   PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT), WHICH MAY LEAD TO PULMONARY EMBOLISM
        (PE) IN MEDICAL PATIENTS WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS DUE TO
        SEVERELY RESTRICTED MOBILITY DURING ACUTE ILLNESS
I-415   SEVERE HYPERTENSION WHEN THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL
        EXCEEDS THE RISK OF INITIATING COMBINATION THERAPY
I-416   THE USE OF CIPRO XR FOR COMPLICATED URINARY TRACT INFECTIONS AND ACUTE
        UNCOMPLICATED PYELONEPHRITIS
I-417   USE IN THE LONG TERM TREATMENT OF BIPOLAR I DISORDER
I-418   ADJUNCTIVE THERAPY W/ MOOD STABILIZERS (LITHIUM OR DIVALPROEX) IN THE TREATMENT OF
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 15 of 67


                                 EXCLUSIVITY INDICATION

        ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDERS
I-419   MONOTHERAPY IN THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I
        DISORDER
I-420   TOPICAL TREATMENT OF CLINICALLY TYPICAL, NONHYPERKERATOTIC, NONHYPERTROPHIC
        ACTINIC KERATOSES ON THE FACE OR SCALP IN IMMUNOCOMPETENT ADULTS
I-421   TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND PYELONEPHRITIS DUE TO E.COLI
        FOR PED PATIENTS (1-17) NOT AS FIRST CHOICE
I-422   INDICATED FOR THE IN-HOSPITAL SHORT-TERM (UP TO 4 HOURS) REDUCTION IN BLOOD
        PRESSURE IN PEDIATRIC PATIENTS
I-423   ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
I-424   MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH MODERATE TO SEVERE
        CHRONIC RENAL INSUFFICIENCY NOT YET ON DIALYSIS
I-425   FLOXATIN IN COMBINATION WITH INFUSIONAL 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV)
        FOR THE TREATMENT OF PATIENTS PREVIOUSLY UNTREATED FOR ADVANCED COLORECTAL CANCER
I-426   TREATMENT OF ACUTE PULMONARY EMBOLISM WHEN ADMINISTERED IN CONJUNCTION WITH
        WARFARIN SODIUM
I-427   TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITHOUT PULMONARY EMBOLISM WHEN
        ADMINISTERED IN CONJUNCTION WITH WARFARIN SODIUM
I-428   FOR USE IN COMBINATION WITH PACLITAXEL FOR THE FIRST-LINE TREATMENT OF PATIENTS
        WITH METASTATIC BREAST CANCER AFTER FAILURE OF PRIOR ANTHRACYCLINE CONTAINING
        ADJUVANT CHEMOTHERAPY UNLESS ANTHRACYCLINES WERE CLINICALLY CONTRAINDICATED
I-429   FOR USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH ANDROGEN
        INDEPENDENT (HORMONE REFRACTORY) METASTATIC PROSTATE CANCER
I-430   FOR USE IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN ADULTS
I-431   NOSOCOMIAL PNEUMONIA AND COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY STREPTOCOCCUS
        PNEUMONIAE INDICATION EXPANDED TO INCLUDE MULTI-DRUG RESISTANT STRAINS
I-432   TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA CAUSED BY MULTI-DRUG RESISTANT
        STREPTOCOCCUS PNEUMONIAE
I-433   TREATMENT OF BIOPSY-CONFIRMED, PRIMARY SUPERFICIAL BASAL CELL CARCINOMA IN
        IMMUNOCOMPETENT ADULTS, WITH A MAXIMUM TUMOR DIAMETER OF 2.0CM, LOCATED ON THE
        TRUNK (EXCLUDING ANOGENITAL SKIN), NECK, OR EXTREMITIES (EXCLUDING HANDS AND FEET)
I-434   PREVENTION OF CARDIOVASCULAR DISEASE IN ADULT PATIENTS WITHOUT CLINICALLY EVIDENT
        HEART DISEASE, BUT WITH MULTIPLE RISK FACTORS FOR CORONARY HEART DISEASE TO REDUCE
        RISK OF MI AND RISK FOR REVASCULARIZATION PROCEDURES AND ANGINA
I-435   CHRONIC IDIOPATHIC CONSTIPATION
I-436   FOR USE IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR THE ADJUVANT
        TREATMENT OF PATIENTS WITH OPERABLE NODE-POSITIVE BREAST CANCER
I-437   TREATMENT OF ACUTE MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR DISORDER
I-438   EMPIRICAL THERAPY FOR PRESUMED FUNGAL INFECTIONS IN FEBRILE, NEUTROPENIC PATIENTS
I-439   USED TO TREAT ADULTS WITH GROWTH HORMONE DEFICIENCY
I-440   FOR THE REPLACEMENT OF ENDOGENOUS GROWTH HORMONE IN ADULTS WITH GROWTH HORMONE
        DEFICIENCY
I-441   USE COMBINATION WITH INFUSIONAL 5-FU/LV FOR ADJUVANT TREATMENT STAGE III COLON
        CANCER PTS WHO HAVE UNDERGONE COMPLETE RESECTION PRIMARY TUMOR-BASED ON
        IMPROVEMENT IN DISEASE FREE SURVIVAL, NO DEMONSTRATED BENEFIT OVERALL SURVIVAL
        AFTER 4YRS
I-442   USED FOR CANDIDEMIA IN NONNEUTROPENIC PATIENTS AND THE FOLLOWING CANDIDA
        INFECTIONS: DISSEMINATED INFECTIONS IN SKIN & INFECTIONS IN ABDOMEN, KIDNEY,
        BLADDER WALL, AND WOUNDS
I-443   TREATMENT OF NASAL POLYPS IN PATIENTS 18 YEARS OF AGE AND OLDER
I-444   USE OF PROTONIX IV FOR INJECTION AS STAND ALONE THERAPY FOR THE SHORT-TERM
        TREATMENT OF PATIENTS HAVING GASTROESOPHAGEAL REFLUX (GERD) WITH A HISTORY OF
        EROSIVE ESOPHAGITIS
I-445   TO IMPROVE (COMPARED TO 4.25% DEXTROSE) LONG-DWELL ULTRAFILTRATION AND CLEARANCE
        OF CREATININE AND UREA NITROGEN IN PATIENTS WITH HIGH AVERAGE OR GREATER TRANSPORT
        CHARACTERISTICS, AS DEFINED USING THE PERITONEAL EQUILIBRATION TEST (PET)
I-446   EXTENDED ADJUVANT TREATMENT OF EARLY BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO
        HAVE RECEIVED 5 YRS ADJUVANT TAMOXIFEN THERAPY-EFFECTIVENESS BASED ON AN ANALYSIS
        OF DISEASE FREE SURVIVAL IN PATIENTS TREATED FOR A MEDIAN 24 MONTHS
I-447   USE OF COPEGUS (RIBAVIRIN) FOR TREATMENT OF CHRONIC HEPATITIS C IN ADULT PATIENTS
        COINFECTED WITH HIV IN COMBINATION WITH PEGASYS (PEGINTERFERON ALFA-2A)
I-448   TREATMENT OF HEART FAILURE (NYHA CLASS II-IV AND EJECTION FRACTION <=40%) TO
        REDUCE THE RISK OF DEATH FROM CARDIOVASCULAR CAUSES AND TO REDUCE HOSPITALIZATIONS
        FOR HEART FAILURE
I-449   TO IMPROVE WAKEFULNESS IN TWO NEW PATIENT POPULATIONS WITH EXCESSIVE SLEEPINESS:
        THOSE WITH OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME AND THOSE WITH SHIFT WORK
        SLEEP DISORDER
I-450   TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMAS CONCOMITANTLY WITH
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 16 of 67


                                 EXCLUSIVITY INDICATION

        RADIOTHERAPY AND THEN AS ADJUVANT TREATMENT
I-451   MANAGEMENT OF ENDOMETRIOSIS ASSOCIATED PAIN
I-452   EXPANDED INDICATION TO INCLUDE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE
        RECEIVED AT LEAST 1 PRIOR THERAPY
I-453   USE IN COMBINATION WITH A SULFONYLUREA PLUS METFORMIN WHEN DIET, EXERCISE AND BOTH
        AGENTS DO NOT RESULT IN ADEQUATE GLYCEMIC CONTROL (TRIPLE THERAPY)
I-454   MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE CHRON'S DISEASE INVOLVING
        THE ILEUM AND/OR THE ASCENDING COLON FOR UP TO 3 MONTHS
I-455   MODIFIED HEART FAILURE INDICATION TO INCLUDE TREATMENT OF HEART FAILURE IN
        PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (NYHA CLASS II-IV; EJECTION
        FRACTION LESS THAN OR EQUAL TO 40%
I-456   TO REDUCE CARDIOVASCULAR DEATH AND TO REDUCE HEART FAILURE HOSPITALIZATIONS.
        INCLUDES ADDITIONAL INFORMATION ON THE ADDED EFFECT ON THESE OUTCOMES WHEN USED
        WITH AN ACE INHIBITOR
I-457   TREATMENT OF PATIENTS UNDERGOING ABDOMINAL SUREGERY WHO ARE AT RISK FOR
        THROMBOEMBOLIC COMPLIATIONS
I-458   USE OF BIVALIRUDIN FOR INJECTION WITH PROVISIONAL USE OF GLYCOPROTEIN IIB/IIA
        INHIBITOR (GPI) AS LISTED IN THE CLINICAL TRIALS REPLACE-2 SECTION FOR USE AS AN
        ANTICOAGULANT IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
I-459   NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) PATIENTS RECEIVING OR NOT
        RECEIVING AN ERYTHROPOIETIN
I-460   TREATMENT OF DIARRHEA CAUSED BY CRYPTOSPORIDIUM PARVUM IN NON-HIV INFECTED
        PATIENTS 12 YEARS OF AGE AND OLDER
I-461   USE AS A SINGLE AGENT FOR ADJUVANT TREATMENT IN PATIENTS WITH DUKES' C COLON
        CANCER WHO HAVE UNDERGONE COMPLETE RESECTION OF THE PRIMARY TUMOR WHEN TREATMENT
        WITH FLUOROPYRIMIDINE THERAPY ALONE IS PREFERRED
I-462   LONG TERM TREATMENT OF IDIOPATHIC SHORT STATURE
I-463   TREATMENT OF PATIENTS POST MYOCARDIAL INFARCTION
I-464   TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME
I-465   PERENNIAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND
        OLDER
I-466   FOR RELIEF OF THE SIGNS AND SYMPTOMS OF ANKYLOSING SPONDYLITIS
I-467   USE OF TOPIRAMATE AS INITIAL MONOTHERAPY IN PATIENTS 10 YEARS OF AGE AND OLDER
        WITH PARTIAL ONSET OR PRIMARY GENERALIZED TONIC CLONIC SEIZURES
I-468   USE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE TO REDUSE THE RISK OF
        CARDIOVASCULAR MORTALITY OR NON-FATAL MYOCARDIAL INFECTION
I-469   RELIEF OF THE SIGNS AND SYMPTOMS OF PAUCIARTICULAR OR POLYARTICULAR COURSE
        JUVENILE RHEUMATOID ARTHRITIS IN PATIENTS 2 YEARS OF AGE AND OLDER
I-470   DIABETIC PERIPHERAL NEUROPATHIC PAIN
I-471   INDICATED TO REDUCE THE RISK OF MYOCARDIAL INFARCTION AND STROKE IN PATIENTS WITH
        TYPE 2 DIABETES AND WITHOUT CLINICALLY EVIDENT CORONARY HEART DISEASE BUT WITH
        MULTIPLE RISK FACTORS FOR CORONARY HEART DISEASE
I-472   USE IN PATIENTS WITH ANGIOGRAPHICALLY DOCUMENTED CORONARY ARTERY DISEASE
I-473   USE IN COMBINATION WITH GEMCITABINE FOR THE FIRST LINE TREATMENT OF PATIENTS WITH
        LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PANCREATIC CANCER
I-474   TREATMENT OF IRON DEFICIENCY ANEMIA IN PERITONEAL DIALYSIS DEPENDANT CHRONIC
        KIDNEY DISEASE IN PATIENTS RECIEVING AN ERYTHROPOIETIN
I-475   PREVENTION OF NAUSEA AND VOMITTING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF
        MODERATELY EMETOGENIC CANCER CHEMOTHERAPY
I-476   TREATMENT OF DIABETIC FOOT INFECTIONS WITHOUT OSTEOMYELITIS
I-477   TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS CAUSED BY METHICILLIN
        SUSCEPTIBLE STAPHYLOCOCCUS AUREUS, ESCHERICHIA COLI, KLEBSIELLA PNEUMONIAE, OR
        ENTEROBACTER CLOACAE
I-478   FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES IN CHILDREN
        WITH EPILEPSY AGED 2-4 YEARS
I-479   TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS CAUSED BY E.COLI, B. FRAGILIS,
        S.ANGINOSUS, S.CONSTELLATUS, E. FAECALIS, P. MIRABILIS, C. PERFRINGENS, B.
        THETAIOTAOMICRON OR PEPTOSTREPTOCOCCUS SPECIES
I-480   PROPHYLAXIS OF INFLUENZA FOR PATIENTS BETWEEN 1-12 YEARS OF AGE
I-481   INDICATED FOR THE ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR
        POSITIVE EARLY BREAST CANCER
I-482   TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER WITH
        OR WITHOUT PSYCHOTIC FEATURES
I-483   PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
I-484   FOR THE RISK REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCERS
I-485   TREATMENT OF POSTOPERATIVE INFLAMMATION AND REDUCTION OF OCULAR PAIN IN PATIENTS
        WHO HAVE UNDERGONE CATARACT EXTRACTION
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 17 of 67


                                 EXCLUSIVITY INDICATION

I-486   ANGIOMAX IS INDICATED FOR PATIENTS WITH, OR AT RISK OF, HIT/HITTS UNDERGOING PCI
I-487   INDICATED FOR THE RELIEF OF THE INFAMMATORY AND PRURITIC MANIFESTATIONS OF
        CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YRS OF AGE OR OLDER
I-488   MAINTENANCE THERAPY IN BIPOLAR I DISORDER
I-489   FOR USE IN PEDIATRIC PATIENTS WITH TYPE I DIABETES
I-490   FOR USE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE TREATMENT OF
        PATIENTS WITH ADVANCED GASTRIC ADENOCARCINOMA, INCLUDING ADENOCARCINOMA OF
        GASTROESOPHAGEAL JUNCTION, WHO HAVE NOT RECEIVED PRIOR CHEMOTHERAPY FOR ADVANCED
        DISEASE
I-491   INFLUENZA PROPHYLAXIS
I-492   MONOTHERAPY IN THE TREATMENT OF ACUTE MANIC OR MIXED EPISODES IN BIPOLAR I
        DISORDER, WITH OR WITHOUT PSYCHOTIC FEATURES
I-493   ADMINISTERED IN COMBINATION WITH FENOFIBRATE, AS ADJUNCTIVE THERAPY TO DIET FOR
        THE REDUCTION OF ELEVATED TOTAL-C, LDL-C, APO B, AND NON-HDL-C IN PATIENTS WITH
        MIXED HYPERLIPIDEMIA
I-494   CLINICAL DATA IN SUPPORT OF AVANDAMET AS AN ADJUNCT TO DIET AND EXERCISE TO
        IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT
        WITH DUAL ROSIGLITAZONE AND METFORMIN THERAPY IS APPROPRIATE
I-495   ADJUVANT TX OF POSTMENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR POSITIVE EARLY BREAST
        CANCER WHO HAVE RECEIVED 2 TO 3 YRS OF TAMOXIFEN AND ARE SWITCHED TO AROMASIN FOR
        COMPLETION OF A TOTAL OF 5 CONSECUTIVE YRS OF ADJUVANT HORMONAL THERAPY
I-496   LONG TERM TREATMENT OF GROWTH FAILURE ASSOCIATED WITH TURNER SYNDROME IN PATIENTS
        WHO HAVE OPEN EPIPHYSES
I-497   PREVENTION OF SEASONAL MAJOR DEPRESSIVE EPISODES IN PATIENTS WITH SEASONAL
        AFFECTIVE DISORDER
I-498   PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
I-499   USE OF GEMZAR IN COMBINATION WITH CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH
        ADVANCED OVARIAN CANCER THAT HAS RELAPSED AT LEAST 6 MONTHS AFTER COMPLETION OF
        PLATINUM-BASED THERAPY
I-500   FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF MULTIPLE MYELOMA
        PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY
I-501   TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN IMMUNOCOMPETANT PATIENTS
        WITH A SINGLE DOSE OF FAMCICLOVIR 1500 MG.
I-502   FOR PTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION, PLAVIX TO REDUCE
        RATE OF DEATH FROM ANY CAUSE AND THE RATE OF A COMBINED ENDPOINT OF DEATH,
        REINFARCTION OR STROKE. NOT KNOWN TO PERTAIN TO PTS WHO RECEIVE PRIMARY
        ANGIOPLASTY
I-503   TREATMENT OF MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER
I-504   TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS INCLUDING ZOLLINGER-ELLISON
        SYNDROME
I-505   TREATMENT OF STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA), INCLUDING
        THOSE WITH RIGHT SIDED INFECTIVE ENDOCARDITIS, CAUSED BY METHICILLIN-SUSCEPTIBLE
        AND METHICILLIN-RESISTANT ISOLATES
I-506   ADJUNCTIVE THERAPY OF MYOCLONIC SEIZURES IN ADULTS AND ADOLESCENTS AGE 12 AND OVER
        WITH JUVENILE MYOCLONIC EPILEPSY
I-507   ADJUNCT TO DIET TO REDUCE TOTAL-C, LDL-C AND APO B LEVELS IN ADOLESCENT BOYS AND
        GIRLS WHO ARE AT LEAST ONE YEAR POST-MENARCHE, 10-16 YEARS OF AGE, WITH
        HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
I-508   PREMENSTRUAL DYSPHONIC DISORDER
I-509   TREATMENT OF IRRATABILITY ASSOCIATED WITH AUTISTIC DISORDER
I-510   ADULT DERMAFIBROSARCOMA PROTUBERANS (DFSP)
I-511   ADULT MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE DISEASES (MDS/MDP)
I-512   ADULT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) MONOTHERAPY
I-513   ADULT AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM)
I-514   ADULT HYPEREOSINOPHILIC SYNDROME/CHRONIC EOSINOPHILIC LEUKEMIA (HES/CEL)
I-515   PROPHYLAXIS OF SURGICAL SITE INFECTION FOLLOWING ELECTIVE COLORECTAL SURGERY
I-516   PRIMARY GENERALIZED TONIC CLONIC SEIZURES IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS
        OF AGE AND OLDER
I-517   TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEG SYNDROME (RLS)
I-518   TREATMENT OF SHORT STATURE OR GROWTH FAILURE IN CHILDREN WITH SHOX (SHORT STATURE
        HOMEOBOX CONTAINING GENE) DEFICIENCY WHOSE EPIPHYSES ARE NOT CLOSED
I-519   USE OF TAXOTERE (DOCETAXEL) INJECTION CONCENTRATE IN COMBINATION WITH CISPLATIN
        AND FLUOROURACIL FOR THE INDUCTION OF PATIENTS WITH INOPERABLE LOCALLY ADVANCED
        SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
I-520   USE OF EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO ARE USING A
        THIAZOLIDINEDIONE ALONE OR IN COMBINATION WITH METFORMIN BUT HAVE NOT ACHIEVED
        ADEQUATE GLYCEMIC CONTROL
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 18 of 67


                                 EXCLUSIVITY INDICATION

I-521   TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST 1 YEAR
        PRIOR THERAPY
I-522   TREATMENT OF MODERATE ACNE VULGARIS IN WOMEN AT LEAST 14 YRS OF AGE, WHO HAVE NO
        KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY, AND HAVE ACHIEVED MENARCHE,
        IF THE PATIENT DESIRES AN ORAL CONTRACEPTIVE FOR BIRTH CONTROL.
I-523   USE IN ADULT PATIENTS WITH CLINICALLY EVIDENT CORONARY HEART DISEASE TO REDUCE THE
        RISK OF NONFATAL MYOCARDIAL INFARCTION, FATAL AND NONFATAL STROKE, ANGINA,
        REVASCULARIZATION PROCEDURES AND HOSPITALIZATION FOR CONGESTIVE HEART FAILURE
I-524   GENERALIZED ANXIETY DISORDER (GAD)
I-525   USE OF 0.5MG/0.1MG FOR PREVENTION OF POST-MENOPAUSAL OSTEOPOROSIS
I-526   TREATMENT OF HYPONATREMIA IN HOSPITALIZED PATIENTS
I-527   ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
        IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER WITH IDIOPATHIC GENERALIZED
        EPILEPSY
I-528   TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE,
        SYMPTOMS OF VULVAR AND VAGINAL ATROPHY ASSOCIATED WITH MENOPAUSE
I-529   TREATMENT OF DEMENTIA OF THE ALZHEIMER'S TYPE IN PATIENTS WITH SEVERE ALZHEIMER'S
        DISEASE
I-530   PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION IN PATIENTS 15 YEARS OF AGE AND
        OLDER
I-531   MAINTENANCE TREATMENT OF SCHIZOPHRENIA
I-532   TREATMENT OF BACTERIAL VAGINOSIS IN NON-PREGNANT FEMALES
I-533   ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
I-534   EXTENDED TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) AND/OR PULMONARY
        EMBOLISM TO REDUCE THE RECCURENCE OF VTE IN PATIENTS WITH CANCER
I-535   MANAGEMENT OF FIBROMYALGIA
I-536   FOR THE TREATMENT OF SHORT STATURE IN CHILDREN WITH NOONAN SYNDROME
I-537   LONG TERM TREATMENT OF PANIC DISORDER
I-538   SHORT TERM TREATMENT OF PANIC DISORDER
I-539   REDUCTION IN RISK OF INVASIVE BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH
        OSTEOPOROSIS OR AT HIGH RISK FOR INVASIVE BREAST CANCER
I-540   TREATMENT OF SCHIZOPHRENIA IN ADOLESCENTS AGES 13-17
I-541   TREATMENT OF BIPOLAR I DISORDER IN CHILDREN AGES 10-12 AND ADOLESCENTS AGES 13-17
I-542   EXPANSION OF PATIENT POPULATION FOR HEAD AND NECK CANCER FROM "INOPERABLE"
        PATIENTS TO ALL PATIENTS
I-543   USE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE INDUCTION TREATMENT OF
        PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
        (SCCHN)
I-544   ADJUNCTIVE THERAPY OF MYOCLONIC SEIZURES IN ADULTS AND ADOLESCENTS AGE 16 AND OVER
        WITH JUVENILE MYOCLONIC EPILEPSY
I-545   ADJUNCTIVE TREATMENT TO TREAT PATIENTS WITH MAJOR DEPRESSIVE DISORDER
I-546   TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA
I-547   ADJUNCTIVE THERAPY TO DIET TO SLOW THE PROGRESSION OF ARTHEROSCLEROSIS IN ADULT
        PATIENTS AS PART OF A TREATMENT STRATEGY TO LOWER TOTAL-C AND LDL-C TO TARGET
        LEVELS
I-548   SEASONAL ALLERGIC RHINITIS IN PATIENTS 6 THROUGH LESS THAN 12 YEARS OF AGE
I-549   USE OF AVALIDE TABLETS AS INITIAL THERAPY IN PATIENTS WHO ARE LIKELY TO NEED
        MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS
I-550   TREATMENT OF HYPERTENSION IN PEDIATRIC PATIENTS 6-16 YEARS OF AGE
I-551   TREATMENT OF SHORT STATURE IN CHILDREN WITH TURNER'S SYNDROME
I-552   ADJUNCTIVE TREATMENT FOR RADIOIODINE ABLATION OF THYROID TISSUE REMNANTS IN
        PATIENTS WHO HAVE UNDERGONE THYROIDECTOMY FOR WELL-DIFFERENTIATED THYROID CANCER
        AND WHO DO NOT HAVE EVIDENCE OF METASTATIC THYROID CANCER
I-553   FOR USE AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS
        WITH TYPE 2 DIABETES MELLITUS
I-554   TREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA
        PERITONIS AND ABSCESSES
I-555   TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER IN
        PEDIATRIC PATIENTS AGED 10-17 YEARS
I-556   PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOR UP TO 24 HOURS FOLLOWING
        SURGERY
I-557   USE OF AMITIZA (LUBIPROSTONE) 8 MCG TWICE DAILY FOR TREATMENT OF IRRITABLE BOWEL
        SYNDROME WITH CONSTIPATION IN WOMEN GREATER THAN OR EQUAL TO 18 YEARS OLD
I-558   MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION AND REDUCING EXACERATIONS IN PATIENTS
        WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) INCLUDING CHRONIC BRONCHITIS AND
        EMPHYSEMA
I-559   ADJUNCTIVE THERAPY ADDED TO LITHIUM OR VALPROATE IN SHORT TERM TREATMENT OF
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                            PATENT AND EXCLUSIVITY TERMS                       ADB 19 of 67



                                   EXCLUSIVITY INDICATION


          BIPOLAR DISORDER, MANIC OR MIXED
	
I-560		   MAINTENANCE TREATMENT FOR BIPOLAR I DISORDER, AS ADJUNCTIVE THERAPY TO LITHIUM OR

          DIVALPROEX
	
I-561		   LONG-TERM TREATMENT OF SOCIAL ANXIETY DISORDER
	
I-562		   MAINTENANCE TREATMENT OF ATTENTION-DEFICIT DISORDER (ADHD) IN CHILDREN AND

          ADOLESCENTS
	
I-563		   ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SIEZURES
	
          IN ADULTS AND CHILDREN 16 YEARS OF AGE AND OLDER WITH IDIOPATHIC GENERALIZED
	
          EPILEPSY
	
I-564		   TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
	
I-565		   USE OF DUTASTERIDE IN COMBINATION WITH TAMSULOSIN FOR THE TREATMENT OF SYMPTOMATIC
	
          BENIGN PROSTATIC HYPERPLASIA (BPH)

I-566		   MANAGEMENT OF FIBROMYALGIA
	
I-567		   INITIAL THERAPY IN PATIENTS LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD
	
          PRESSURE GOALS
	
I-568		   USE OF APTIVUS, CO-ADMINISTERED W/RITONAVIR, FOR COMBINATION ANTIRETROVIRAL

          TREATMENT OF HIV-1 INFECTED PED (AGE 2-18 YRS) PATIENTS WHO ARE TREATMENT-
          EXPERIENCED AND INFECTED W/HIV-1 STRAINS RESISTANT TO MORE THAN ONE PROTEASE

          INHIBITOR
	
I-569		   TREATMENT OF CHRONIC HEPATITIS B
	
I-570		   TREATMENT OF CHICKEN POX IN IMMUNOCOMPETENT PEDIATRIC PATIENTS 2 TO <18 YEARS OF
	
          AGE
	
I-571		   NON-SMALL CELL LUNG CANCER IN COMBINATION WITH CISPLATIN AND AS SINGLE AGENT FOR
	
          NONSQAUMOUS NON-SMALL CELL LUNG CANCER

I-572		   TREATMENT OF GROWTH FAILURE IN CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA) WITH

          NO CATCH-UP BY AGE 2-4 YRS.
	
I-573		   TO TREAT PATIENTS WITH PRIMARY DYSBETALIPOPROTEINEMIA (FREDICKSON TYPE III

          HYPERLIPOPROTEINEMIA) AS AN ADJUNCT TO DIET

I-574		   MONOTHERAPY IN THE TREATMENT OF BIPOLAR DEPRESSION
	
I-575		   MONOTHERAPY IN THE TREATMENT OF BIPOLAR MANIA
	
I-576		   ADJUNCTIVE THERAPY IN THE TREATMENT OF BIPOLAR MANIA
	
I-577		   SEDATION OF NON-INTUBATED PATIENTS PRIOR TO AND/OR DURING SURGICAL AND OTHER

          PROCUDURES
	
I-578		   EXPANSION OF INDICATION TO INCLUDE TREATMENT OF HIV IN TREATMENT NAIVE ADULTS
	
I-579		   TREATMENT OF MODERATE TO SEVERE DYSPAREUNIA, A SYMPTOM OF VULVAR AND VAGINAL

          ATROPHY, DUE TO MENOPAUSE AND NEW TWICE WEEKLY DOSING REGIMEN FOR THIS INDICATION

I-580		   INDOLENT B-CELL NON-HODGKINS LYMPHOMA (NHL) THAT HAS PROGRESSED DURING OR WITHIN

          SIX MONTHS OF TREATMENT WITH RITUXIMAB OR A RITUXIMAB CONTAINING REGIMEN
	
I-581		   TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
	
I-582		   TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
	
I-583		   ADJUVANT TREATMENT OF ADULT PATIENTS FOLLOWING COMPLETE GROSS RESECTION OF KIT
	
          (CD117) POSITIVE GASTOINTESTINAL STROMAL TUMORS (GIST)

I-584		   TREATMENT AND PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PATIENTS
	
          EXPECTED TO BE ON GLUCOCORTICOIDS FOR AT LEAST 12 MONTHS
	
I-585		   TREATMENT OF SHORT STATURE IN PEDIATRIC PATIENTS SMALL FOR GESTATIONAL AGE WHO DO
	
          NOT MANIFEST CATCH UP GROWTH BY AGE 2 TO 4 YEARS
	
I-586		   COMMUNITY ACQUIRED BACTERIAL PNEUMONIA
	
I-587		   ADDITIONAL PATHOGENS TO COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS INDICATION
	
I-588		   ADDITIONAL PATHOGENS TO COMPLICATED INTRA-ABDOMINAL INFECTIONS INDICATION
	
I-589		   TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH OLANZAPINE

I-590		   ACUTE TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER (IN

          COMBINATION WITH OLANZAPINE)

I-591		   TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH FLUOXETINE

I-592		   ACUTE TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER (IN

          COMBINATION WITH FLUOXETINE)

I-593		   TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD)

I-594		   INDICATION EXPANDED TO INCLUDE PATIENTS WHO HAVE EXPERIENCED A FIRST CLINICAL
	
          EPISODE AND HAVE MRI FEATURES CONSISTENT WITH MULTIPLE SCLEROSIS
	
I-595		   PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
	
I-596		   USE AS ADJUNCTIVE THERAPY WITH LITHIUM OR VALPROATE FOR THE MAINTENANCE TREATMENT
	
          OF BIPOLAR I DISORDER
	
I-597		   MONOTHERAPY FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER
	
I-598		   TREATMENT OF PULMONARY ARTERIAL HYPERTENSION INDICATION EXPANDED TO INCLUDE DELAY
	
          IN CLINICAL WORSENING
	
I-599		   PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC
	
          KIDNEY DISEASE (CKD) STAGE 5 IN PATIENTS ON HEMODIALYSIS OR PERITONEAL DIALYSIS

I-600		   FOR USE AS INITIAL THERAPY IN PATIENTS WHO ARE LIKELY TO NEED MULTIPLE DRUGS TO
	
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 20 of 67


                                 EXCLUSIVITY INDICATION

        ACHIEVE THEIR BLOOD PRESSURE GOALS
I-601   MAINTENANCE TREATMENT IN PATIENTS WITH ADVANCED OR METASTATIC NONSQUAMOUS NON-
        SMALL CELL LUNG CANCER WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES OF
        PLATINUM-BASED FIRST LINE CHEMOTHERAPY
I-602   TREATMENT OF MEN AND WOMEN WITH OSTEOPOROSIS ASSOCIATED WITH SUSTAINED SYSTEMIC
        GLUCOCORTICOID THERAPY AT HIGH RISK FOR FRACTURE
I-603   GOUT FLARES
I-604   PREVENTION OF CMV DISEASE IN KIDNEY AND HEART TRANSPLANT PATIENTS 4 MONTHS TO 16
        YEARS AT HIGH RISK
I-605   ADJUNCT TO MOOD STABILIZERS AND/OR ANTIDEPRESSANTS FOR SCHIZOAFFECTIVE DISORDER
I-606   TREATMENT OF SCHIZOAFFECTIVE DISORDER AS MONOTHERAPY
I-607   INDICATION EXPANDED TO INCLUDE TREATMENT OF PULMONARY ARTENAL HYPERTENSION (WHO
        GROUP I) IN PATIENTS WITH CLASS II SYMPTOMS
I-608   REDUCE LDL-C LEVELS IN BOYS AND POSTMENARCHAL GIRLS, 10 TO 17 YEARS OF AGE, WITH
        HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AS MONOTHERAPY OR IN COMBINATION WITH A
        STATIN AFTER FAILING AN ADEQUATE TRIAL OF DIET THERAPY
I-610   TREATMENT OF HEAVY MENSTRUAL BLEEDING FOR WOMEN WHO CHOOSE TO USE INTRAUTERINE
        CONTRACEPTION AS THEIR METHOD OF CONTRACEPTION
I-611   TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ADOLESCENT BOYS AND
        POSTMENARCHAL GIRLS, AGES 10 TO 17 YEARS, WITH A RECOMMENDATION DOSING RANGE OF 5
        TO 20 MG ONCE DAILY
I-612   MICARDIS 80 MG FOR REDUCTION OF THE RISK OF MYOCARDIAL INFARCTION, STROKE, OR
        DEATH FROM CARDIOVASCULAR CAUSES IN PATIENTS 55 YEARS OF AGE OR OLDER AT HIGH RISK
        OF DEVELOPING MAJOR CARDIOVASCULAR EVENTS WHO ARE UNABLE TO TAKE ACE INHIBITORS
I-613   MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE TO LESS THAN 18
        YEARS OF AGE
I-614   SHORT TERM TREATMENT OF EROSIVE ESOPHAGITIS ASSOCIATED WITH GERD IN PEDIATRIC
        PATIENTS AGES FIVE YEARS AND OLDER
I-615   MAINTENANCE TREATMENT OF BIPOLAR DISORDER AS AN ADJUNCT TO LITHIUM OR VALPROATE
I-616   TREATMENT OF IRRITABILITY ASSOCIATED WITH AUTISTIC DISORDER IN PEDIATRIC PATIENTS
        AGES 6-17 YEARS OF AGE
I-617   MAINTENANCE OF GENERALIZED ANXIETY DISORDER (GAD)
I-618   ADJUNCTIVE THERAPY IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
I-619   INTRAVENOUS CONTRAST ENHANCED COMPUTER TOMOGRAPHY OF THE HEAD AND BODY
I-620   FOR USE IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN
        WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER THAT OVEREXPRESSES THE
        HER2 RECEPTOR FOR WHOM HORMONAL THERAPY IS INDICATED
I-621   PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE, BASED ON THE RESULTS OF
        JUSTIFICATION FOR THE USE OF STATINS IN PRIMARY PREVENTION; AN INTERVENTION TRIAL
        EVALUATING ROSUVASTATIN (JUPITER)
I-622   ADJUNCTIVE THERAPY FOR PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN PATIENTS
        THIRTEEN YEARS OF AGE AND OLDER
I-623   TREATMENT OF SIGNS AND SYMPTOMS OF ADVANCED IDIOPATHIC PARKINSON'S DISEASE
I-624   MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL
        CELL LUNG CANCER WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES OF PLATINUM-
        BASED FIRST-LINE CHEMOTHERAPY
I-625   PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY
I-626   RELIEF OF NASAL CONGESTION ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS
        AND PEDIATRIC PATENTS 2 YEARS OF AGE AND OLDER
I-627   TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE
        CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE.
I-628   MAINTENANCE TREATMENT OF SCHIZOPHRENIA IN ADULTS
I-629   ADJUNCTIVE THERAPY WITH EITHER LITHIUM OR VALPROATE FOR THE ACUTE TREATMENT OF
        MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
I-630   TREATMENT OF PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) ASSOCIATED
        WITH TUBEROUS SCLEROSIS (TS) WHO REQUIRE THERAPEUTIC INTERVENTION BUT ARE NOT
        CANDIDATES FOR CURATIVE SURGICAL RESECTION.
I-631   PREVENTION OF RELAPSE TO OPIOID DEPENDENCE FOLLOWING OPIOID DETOXIFICATION
I-632   MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN
I-633   MAINTENANCE TREATMENT OF BIPOLAR I DISORDER AS AN ADJUNCT TO LITHIUM OR VALPROATE
I-634   TREATMENT OF SEVERE HYPERCALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM WHO
        ARE UNABLE TO UNDERGO PARATHYROIDECTOMY
I-635   ADJUNCTIVE TREATMENT WITH LONG-ACTING ORAL PSYCHOSTIMULANTS FOR THE TREATMENT OF
        ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
I-636   TREATMENT OF EXTERNAL GENITAL AND PERIANAL WARTS/CONDYLOMA ACUMINATA IN PATIENTS
        12 YEARS OR OLDER
I-637   USE IN COMBINATION CHEMOTHERAPY WITH 5-FLUOROURACIL IN THE PALLIATIVE TREATMENT OF
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                            PATENT AND EXCLUSIVITY TERMS                       ADB 21 of 67



                                   EXCLUSIVITY INDICATION


          PATIENTS WITH ADVANCED METASTATIC COLORECTAL CANCER
	
I-638		   FOR PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET)

          THAT ARE UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC.

I-639		   TREATMENT OF PROGRESSIVE, WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMORS IN

          PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC DISEASE

I-640		   MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS
	
I-641		   TREATMENT OF THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH)

I-642		   TREATMENT OF ERECTILE DYSFUNCTION (ED) AND THE SIGNS AND SYMPTOMS OF BENIGN

          PROSTATIC HYPERPLASIA (BPH)

I-643		   REDUCE THE RISK OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WITH NONVALVULAR
	
          ATRIAL FIBRILLATION.
	
I-644		   MONOTHERAPY IN PATIENTS 13 YEARS OF AGE AND OLDER WITH PARTIAL SEIZURES WHO ARE
	
          RECEIVING THERAPY WITH A SINGLE ANTIEPILEPTIC DRUG (AED)

I-645		   MAINTENANCE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS

I-646		   SIGNS AND SYMPTOMS OF ADVANCED PARKINSON'S DISEASE (APD)

I-647		   SIGNS AND SYMPTOMS OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME (RLS)

I-648		   TREATMENT OF HEAVY MENSTRUAL BLEEDING IN WOMEN WITHOUT ORGANIC PATHOLOGY WHO
	
          CHOOSE TO USE AN ORAL CONTRACEPTIVE AS THEIR METHOD OF CONTRACEPTION
	
I-649		   TREATMENT OF PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA (STS) WHO HAVE RECEIVED

          PRIOR CHEMOTHERAPY
	
I-650		   TREATMENT OF ADULTS WITH RENAL ANGIOMYOLIPOMA AND TUBEROUS SCLEROSIS COMPLEX
	
          (TSC), NOT REQUIRING IMMEDIATE SURGERY

I-651		   MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH SPINAL CORD INJURY
	
I-652		   MANAGEMENT OF POSTHERPETIC NEURALGIA
	
I-653		   TREATMENT OF ENDOGENOUS ANTERIOR UVEITIS
	
I-654		   MAGNETIC RESONANCE ANGIOGRAPHY (MRA) TO EVALUATE ADULTS WITH KNOWN OR SUSPECTED

          RENAL OR AORTO-ILIO-FEMORAL OCCLUSIVE VASCULAR DISEASE
	
I-655		   TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED HORMONE RECEPTOR-POSITIVE,HER2-
          NEGATIVE BREAST CANCER (ADVANCED HR+BC) IN COMBINATION WITH EXEMESTANE, AFTER

          FAILURE OF TREATMENT WITH LETROZOLE OR ANASTROZOLE
	
I-656		   MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
	
          (DPN) IN ADULTS WHEN A CONTINUOUS, AROUND-THE-CLOCK OPIOID ANALGESIC IS NEEDED FOR

          AN EXTENDED PERIOD OF TIME
	
I-657		   PLAQUE PSORIASIS OF THE SCALP
	
I-658		   FIRST-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER,

          IN COMBINATION WITH CARBOPLATIN, IN PATIENTS WHO ARE NOT CANDIDATES FOR CURATIVE

          SURGERY OR RADIATION THERAPY
	
I-659		   PLAQUE PSORIASIS OF THE BODY
	
I-660		   TREATMENT OF DEEP VEIN THROMBOSIS
	
I-661		   TREATMENT OF PULMONARY EMBOLISM
	
I-662		   REDUCTION IN RISK FOR DEEP VEIN THROMBOSIS AND THE REDUCTION IN RISK FOR PULMONARY
	
          EMBOLISM
	
I-663		   IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC
	
          CASTRATION-RESISTANT PROSTATE CANCER
	
I-664		   TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE
	
          INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY
	
I-665		   TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS 10 YRS OF AGE AND OLDER WITH
	
          (NTDT)SYNDROMES AND WITH A (LIC) OF AT LEAST 5 MG OF IRON PER GRAM OF LIVER DRY

          WEIGHT (MG FE/G DW) AND SERUM FERRITIN GREATER THAN 300MCG/L

I-666		   TREATMENT OF PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-
          POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL) IN COMBINATION WITH CHEMOTHERAPY

I-667		   TREATMENT OF PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC

          GASTROINTESTINAL STROMAL TUMOR (GIST) WHO HAVE BEEN PREVIOUSLY TREATED WITH

          IMATINIB MESYLATE AND SUNITINIB MALATE
	
I-668		   PROPHYLAXIS OF ALLOGRAFT REJECTION IN ADULT PATIENTS RECEIVING A LIVER TRANSPLANT
	
I-669		   SCINTIGRAPIC ASSESSMENT OF SYMPATHETIC INNERVATION OF THE MYOCARDIUM BY
	
          MEASUREMENT OF THE HEART TO MEDIASTINUM (H/M) RATIO OF RADIOACTIVITY UPTAKE IN

          PATIENTS WITH NYHA CLASS II OR CLASS III HEART FAILURE AND LVEF LESS THAN 35%
	
I-670		   TREATMENT OF OPIOID-INDUCED CONSTIPATION (OIC) IN ADULTS WITH CHRONIC, NON-CANCER

          PAIN
	
I-671		   FIRSTLINE TREATMENT OF PATIENTS WITH METASTATIC NON- SMALL CELL LUNG CANCER
	
          (NSCLC) WHOSE TUMORS HAVE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) EXON 19

          DELETIONS OR EXON 21(L858R) SUBSTITUTION MUTATIONS AS DETECTED BY AN FDA- APPROVED

          TEST
	
I-672		   USE IN PATIENTS WITH MANTLE CELL LYMPHOMA WHOSE DISEASE HAS RELAPSED OR PROGRESSED
	
          AFTER TWO PRIOR THERAPIES, ONE OF WHICH INCLUDED BORTEZOMIB

I-673		   TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA/VENTILATOR-ASSOCIATED BACTERIAL
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                            PATENT AND EXCLUSIVITY TERMS                       ADB 22 of 67



                                   EXCLUSIVITY INDICATION


          PNEUMONIA (HABP/VABP) CAUSED BY SUSCEPTIBLE ISOLATES OF S. AUREUS (INCL.

          METHICILLIN-SUSCEPTIBLE AND -RESISTANT ISOLATES) WHEN ALTERNATIVE TREATMENTS ARE

          NOT SUITABLE
	
I-674		   TREATMENT OF PATIENTS WITH DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR I DISORDER
	
          (BIPOLAR DEPRESSION) AS MONOTHERAPY AND AS ADJUNCTIVE THERAPY WITH LITHIUM OR

          VALPROATE
	
I-675		   MAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER
	
I-676		   FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC ADENOCARACINOMA OF THE PANCREAS,

          IN COMBINATION WITH GEMCITABINE
	
I-677		   TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE,

          DIFFERENTIATED THYROID CARCINOMA (DTC) THAT IS REFRACTORY TO RADIOCACTIVE IODINE

          TREATMENT
	
I-678		   TRAMETINIB, IN COMBINATION WITH DABRAFENIB, FOR THE TREATMENT OF PATIENTS WITH

          UNRESECTABLE OR METASTATIC MELANOMA WITH BRAF V600E OR V600K MUTATIONS AS DETECTED
	
          BY AN FDA-APPROVED TEST
	
I-679		   RISK REDUCTION OF REBLEEDING OF GASTRIC OR DUODENAL ULCERS FOLLOWING THERAPEUTIC
	
          ENDOSCOPY IN ADULTS
	
I-680		   TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO HAVE RECEIVED AT

          LEAST ONE PRIOR THERAPY
	
I-681		   PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) WHICH MAY LEAD TO PULMONARY EMBOLISM

          (PE), IN ADULT PATIENTS WHO HAVE UNDERGONE HIP OR KNEE REPLACEMENT

I-682		   TREATMENT OF DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM (PE) IN PATIENTS

          WHO HAVE BEEN TREATED WITH A PARENTERAL ANTICOAGULANT FOR 5-10 DAYS
	
I-683		   TO REDUCE THE RISK OF RECURRENCE OF DVT AND PE IN PATIENTS WHO HAVE BEEN
	
          PREVIOUSLY TREATED
	
I-684		   PREVENTION OF ACUTE NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES
	
          OF EMETOGENIC CANCER CHEMOTHERAPY, INCLUDING HIGHLY EMETOGENIC CANCER CHEMOTHERAPY

          IN PEDIATRIC PATIENTS AGED 1 MONTH TO LESS THAN 17 YEARS
	
I-685		   EXPANDED INDICATION OF RASAGILINE AS AN ADD-ON THERAPY TO STABLE DOSES OF DOPAMINE
	
          AGONISTS IN THE TREATMENT OF EARLY PARKINSON'S DISEASE
	
I-686		   INDICATED FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN PATIENTS WHO ARE
	
          PSEUDOPHAKIC OR ARE PHAKIC AND SCHEDULED FOR CATARACT SURGERY
	
I-687		   GUIDING SENTINEL LYMPH NODE BIOPSY, USING A HAND-HELD GAMMA COUNTER IN PATIENTS

          WITH CLINICALLY NODE NEGATIVE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY

I-688		   GADAVIST IS INDICATED WITH MRI TO DETECT THE PRESENCE AND EXTENT OF MALIGNANT
	
          BREAST DISEASE
	
I-689		   TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH 17P DELETION

I-690		   INDICATED FOR THE TREATMENT OF DEEP VEIN THROMBOSIS (DVT)

I-691		   INDICATED TO REDUCE THE RISK OF RECURRENT DEEP VEIN THROMBOSIS (DVT) AND PULMONARY

          EMBOLISM (PE) FOLLOWING INITIAL THERAPY

I-692		   INDICATED FOR MANAGEMENT OF OSTEOARTHRITIS PAIN.
	
I-693		   TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-REISISTANT PROSTATE CANCER (CRPC)

I-694		   TREATMENT OF PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS WHO ARE CANDIDATES

          FOR PHOTOTHERAPY OR SYSTEMIC THERAPY
	
I-695		   REVISED INDICATION FOR BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MANTLE CELL
	
          LYMPHOMA
	
I-696		   USE AS MONOTHERAPY IN THE TREATMENT OF PARTIAL-ONSET SEIZURES IN PATIENTS WITH
	
          EPILEPSY AGE 17 YEARS AND OLDER
	
I-697		   FOR USE IN COMBINATION WITH SOFOSBUVIR FOR THE TREATMENT OF PATIENTS WITH CHRONIC
	
          HEPATITIS C VIRUS GENOTYPE 1 INFECTION
	
I-698		   SCHIZOAFFECTIVE DISORDER AS MONOTHERAPY AND AS AN ADJUNCT TO MOOD STABILIZERS OR
	
          ANTIDEPRESSANTS
	
I-699		   FOR TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA WHO HAVE HAD AN INADEQUATE

          RESPONSE TO OR ARE INTOLERANT OF HYDROXYUREA
	
I-700		   TREATMENT OF PEDIATRIC PATIENTS WITH TOURETTE'S DISORDER (6-18 YEARS)

I-701		   FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE, WELL-OR MODERATELY-
          DIFFERENTIATED, LOCALLY ADVANCED OR METASTATIC GASTROENTEROPANCREATIC

          NEUROENDOCRINE TUMORS (GEP-NETS) TO IMPROVE PROGRESSIONFREE SURVIVAL.
	


                                  EXCLUSIVITY MISCELLANEOUS


M-1		     INFORMATION REGARDING SUPERIORITY CLAIM OVER RANITIDINE FOR DAY AND NIGHT
	
          HEARTBURN ADDED TO CLINICAL STUDIES SECTION
	
M-2		     APPROVAL FOR ADDTION TO CLINICAL PHARMACOLOGY SECTION OF THE LABEL REGARDING (1)

          IMPROVEMENT IN BONE MINERAL DENSITY IN CHILDHOOD-ONSET ADULT GROWTH HORMONE
	
          DEFICIENT PATIENTS AND (2) INCREASES IN SERUM ALKALINE PHOSPHATASE

M-3		     ADDITION OF EFFICACY AND SAFETY INFORMATION IN WHICH FOSAMAX WAS USED
	
                35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                        PATENT AND EXCLUSIVITY TERMS                       ADB 23 of 67


                              EXCLUSIVITY MISCELLANEOUS

       CONCOMITANTLY WITH ESTROGEN ALONE OR WITH ESTROGEN PLUS PROGESTIN
M-4    CHANGES TO PEDIATRIC USE SECTION TO PROVIDE INFORMATION REGARDING SAFETY AND
       EFFICACY IN PEDIATRIC PATIENTS AS YOUNG AS 2 YEARS OLD
M-5    INFORMATION REGARDING EFFECTS IN PATIENTS WITH ASTHMA ON CONCOMITANT INHALED
       CORTICOSTEROIDS IN CLINICAL PHARMACOLOGY SECTION
M-6    ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES DONE WITH GLUCOPHAGE/GLYBURIDE
       COMBINATION ADDED TO CLINICAL PHARMACOLOGY AND DOSING AND ADMINISTRATION
M-7    CLINICAL PHARMACOLOGY IN PEDIATRIC PATIENTS; DOSAGE AND ADMINISTRATION INFORMATION
M-8    ADDITIONAL INFORMATION FOR THE USE OF SONATA CAPSULES FOR UP TO 5 WEEKS (35
       NIGHTS) OF TREATMENT IN A CONTROLLED TRIAL SETTING
M-9    ADDITION TO THE CLINICAL STUDIES SECTION OF THE LABELING OF TEXT AND TWO TABLES
       CONTAINING INFORMATION FOR THE PRESCRIBING PHYSICIAN ON BLOOD PRESSURE, HEART
       RATE, AND HEART RATE VARIABILITY
M-10   INFORMATION REGARDING MAINTENANCE OF AN ANTIDEPRESSANT EFFECT UP TO 1 YEAR OF
       DOSING
M-11   USE FOR LONG-TERM TREATMENT OF POSTTRAUMATIC STRESS DISORDER
M-12   NEW LANGUAGE FOR PEDIATRIC USE
M-13   INFORMATION FROM PEDIATRIC STUDIES ADDED TO CLINICAL PHARMACOLOGY, PRECAUTIONS,
       AND DOSAGE AND ADMINISTRATION
M-14   ADDITIONAL CLINICAL TRIAL INFORMATION ADDED TO PEDIATRIC USE SUBSECTION
M-15   LONGER TERM EFFICACY INFORMATION FOR RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA
M-16   CHANGE IN WORDING OF THE PEDIATRIC SECTION OF THE PACKAGE INSERT
M-17   INFORMATION REGARDING USE OF ULTANE IN PEDIATRIC PATIENTS WITH CONGENITAL HEART
       DISEASE
M-18   INFORMATION DENOTING THE EFFICACY OF REMERON IN MAINTAINING A RESPONSE IN PATIENTS
       WITH MAJOR DEPRESSIVE DISORDER (MDD)
M-19   INFORMATION REGARDING USE IN PEDIATRIC PATIENTS TWO YEARS OF AGE AND OLDER
M-20   LABELING REVISIONS RELATED TO MCCUNE ALBRIGHT SYNDROME
M-21   COMPARISON DATA ON THE ANTIHYPERTENSIVE EFFECTS OF ATACAND AND COZAAR
M-22   CHANGE IN TIME TO ONSET OF ACTION
M-23   INFORMATION REGARDING ELIMINATION ADDED TO CLINICAL PHARMACOLOGY, STUDY RESULTS IN
       PATIENTS WITH HEPATIC AND RENAL IMPAIRMENT
M-24   INFORMATION ON RESULTS OF A LONG TERM LONGITUDINAL GROWTH STUDY AND PEDIATRIC
       SAFETY INFORMATION
M-25   ADDITIONAL SAFETY & PK INFORMATION IN CHILDREN 6 MONTHS TO LESS THAN 6 YEARS OF
       AGE ADDED TO PKG INSERT
M-26   INCORPORATION OF INFORMATION CONTAINED IN THE PEG-INTRON PACKAGE INSERT INTO THE
       REBETOL PACKAGE INSERT AND MEDGUIDE-PEG-INTRON WAS APPROVED FOR USE IN COMBINATION
       WITH REBETOL FOR TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION ON 8/7/01
M-27   INFORMATION DESCRIBING ASPIRIN ENDOSCOPY STUDY AND THE MAXIMUM RECOMMENDED DOSE
       FOR PATIENTS WITH MODERATE HEPATIC INSUFFICIENCY
M-28   INFORMATION FROM A STUDY IN PEDIATRIC PATIENTS IN ASSOCIATION WITH A NEUROLOGICAL
       CONDITION
M-29   LABELING CHANGES TO PROVIDE INFORMATION IN THE MANAGEMENT OF OBESITY IN
       ADOLESCENTS AGED 12 TO 16 YEARS
M-30   CHANGES TO CLINICAL PHARMACOLOGY, PRECAUTIONS, AND DOSAGE AND ADMINISTRATION
       SECTIONS OF LABELING CONCERNING USE OF LOTENSIN IN PEDIATRIC PATIENTS WITH
       HYPERTENSION
M-31   INFORMATION FOR USE IN PEDIATRIC PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5
       (END-STAGE RENAL DISEASE)
M-32   ADDITIONAL LANGUAGE TO CLINICAL PHARMACOLOGY AND CLINICAL STUDIES
M-33   INFORMATION FOR USE OF ADVAIR DISKUS 100/50 IN CHILDREN 4 TO 11 YEARS OF AGE WITH
       ASTHMA
M-34   EXPANDED INFORMATION TO PEDIATRIC USE SUBSECTION OF LABELING IN RESPONSE TO
       PEDIATRIC WRITTEN REQUEST
M-35   ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES DONE WITH ACTOS IN COMBINATION
       WITH METFORMIN, A SULFONYLUREA, OR INSULIN ADDED TO CLINICAL PHARMACOLOGY
M-36   ADDITION OF INFORMATION TO CLINICAL STUDIES REGARDING PREVENTION OF CARDIOVASCULAR
       DISEASE
M-37   INFORMATION ADDED TO THE LABELING THAT DETAILS INFORMATION RELATIVE TO STUDIES
       DONE IN PEDIATRIC POPULATIONS IN THE CLINICAL PHARMACOLOGY AND PEDIATRIC USE
       SUBSECTIONS
M-38   SAFETY AND IOP-LOWERING EFFECTS OF TRUSOPT HAVE BEEN DEMONSTRATED IN PEDIATRIC
       PATIENTS IN A 3 MONTH, MULTI-CENTER DOUBLE MASKED ACTIVE-TREATMENT-CONTROLLED
       TRIAL
M-39   FOR LABELING CHANGES BASED ON RESULTS OF THE SPD422-202 CLINICAL STUDY REPORT
       (CSR) SUBMITTED IN RESPONSE TO THE WRITTEN REQUEST
                35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                        PATENT AND EXCLUSIVITY TERMS                       ADB 24 of 67


                              EXCLUSIVITY MISCELLANEOUS

M-40   ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES PERFORMED IN PEDIATRIC PATIENTS
       WITH LEUKEMIA ADDED TO PRECAUTIONS
M-41   REVISION TO THE PEDIATRIC USE PRECAUTIONS OF THE PRESCRIBING INFORMATION TO
       INCORPORATE THE RESULTS FROM THE CAPPS-169 STUDY ENTITLED "THE EFFECT OF ORTHO
       TRICYCLEN ON BONE MINERAL DENISTY IN PEDIATRIC SUBJECTS WITH ANOREXIA NERVOSA"
M-42   ADDITION OF A GERIATRIC USE SUBSECTION TO THE PRECAUTIONS SECTION OF THE PACKAGE
       INSERT AND GERIATRIC DOSING INFORMATION
M-43   INCLUSION OF RESULTS OF STUDY-"PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND
       PILOT EFFICACY OF ILOPROST AS ADD ON THERAPY WITH BOSENTAN IN SUBJECTS WITH
       PULMONARY ARTERIAL HYPERTENSION
M-44   CLINICAL INFORMATION ADDED TO THE PEDIATRIC USE SUBSECTION OF PRECAUTIONS
       REGARDING THE USE OF NOVOLOG IN ADOLESCENTS WITH TYPE I DIABETES AGE 6 TO 18
M-45   INFORMATION ADDED TO CLINICAL TRIALS SECTION OF LABELING - EFFECTS OF HUMATROPE
       TREATMENT IN ADULTS WITH GROWTH HORMONE DEFICIENCY
M-46   PROVISION OF RESULTS OF STUDY AND PROPOSED REVISIONS TO PACKAGE INSERT SEE SECTION
       ON CARDIAC ELECTROPHYSIOLOGY
M-47   PROVIDES FOR USE OF ANTARA WITHOUT REGARD TO MEALS
M-48   CHANGES TO THE LABELING DESCRIBING THE RESULTS OF A STUDY OF THE USE OF NOVOLOG
       MIX 70/30 WITH ORAL ANTIDIABETIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES
M-49   CLINICAL DATA ADDED TO THE CLINICAL PHARMACOLOGY SECTION REGARDING EFFECT OF
       SINGULAIR ON GROWTH RATES IN PREPUBERTAL CHILDREN
M-50   NEW INFO TO THE CLINICAL STUDIES, ADULT GROWTH HORMONE DEFICIENCY (GHD) SUBSECTION
       OF THE NUTROPIN AQ PACKAGE INSERT DESCRIBING THE EFFECTS OF SOMATROPIN ON VISCERAL
       ADIPOSE TISSUE IN THE ADULT GROWTH HORMONE DEFICIENT PATIENT POPULATION
M-51   INFORMATION ADDED TO LABELING REGARDING OSTEOGENESIS IMPERFECTA STUDY
M-52   INFORMATION ADDED TO THE CLINICAL PHARMACOLOGY/CLINICAL STUDIES SECTION REGARDING
       THE USE OF RISEDRONATE ADMINISTERED ONCE A WEEK IN THE PREVENTION OF OSTEOPOROSIS
       IN POSTMENOPAUSAL WOMEN
M-53   FOR LABELING CHANGES TO THE QUALITY OF LIFE (QOL) STATEMENT IN THE APPROVED
       PACKAGE INSERT
M-54   INFORMATION FROM PEDIATRIC STUDIES ADDED TO LABEL
M-55   INFORMATION ON RESULTS OF A STUDY OF THE USE OF SANDOSTATIN LAR DEPOT IN PEDIATRIC
       PATIENTS WITH HYPOTHALAMIC OBESITY.
M-56   INFORMATION ADDED TO CLINICAL TRIAL SECTION WITH INFORMATION ON "GEMINI" TRIAL
M-57   CLINICAL DATA ADDED TO THE CLINICAL PHARMACOLOGY SECTION REGARDING THE
       PHARMACOKINETICS OF EZETIMIBE IN ASIAN SUBJECTS
M-58   CHANGES TO THE CLINICAL STUDIES, PRIMARY HYPERCHOLESTEROLEMIA, VYTORIN SUBSECTION
       OF THE PACKAGE INSERT TO ADD EFFICACY DATA FOR THE EZETIMIBE/SIMVASTATIN
       COMBINATION PRODUCT AND FOR AN ATORVASTATIN PRODUCT ON LDL-C AND OTHER LIPID
       PRMTRS
M-59   RESULTS OF THE T20-310 STUDY WHICH EVALUATED THE PHARMACOKINETICS, SAFETY, AND
       ANTIVIRAL ACTIVITY OF FUZEON IN TREATMENT EXPERIENCED PEDIATRIC SUBJECTS AND
       ADOLSCENTS WAS ADDED TO THE PEDIATRIC SUBSECTION OF PRECAUTIONS
M-60   CHANGES TO CLINICAL STUDIES, PRIMARY HYPERCHOLESTEROLEMIA, TO ADD EFFICACY DATA
       FOR THE EZETIMIBE/SIMVASTATIN COMBINATION PRODUCT AND FOR A ROSUVASTATIN PRODUCT
       ON LDL-C AND OTHER LIPID PARAMETERS IN PATIENTS WTH HYPERCHOLESTEROLEMIA
M-61   REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN
       REQUEST
M-62   CLINICAL INFORMATION FROM ONE CLINICAL STUDY INVESTIGATING THE USE OF AVANDAMET
       PLUS INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE NOT ACHIEVED
       ADEQUATE GLYCEMIC CONTROL WITH PREVIOUS ANTI-DIABETIC THERAPIES
M-63   DETAILED INFORMATION ON AN INCONCLUSIVE PEDIATRIC STUDY
M-64   CHANGES TO CLINICAL PHARMACOLOGY DETAILING STUDY RESULTS
M-65   ADDITION OF INFORMATION TO LABEL TO INCLUDE INFORMATION REGARDING USE IN PATIENTS
       WITH HIV-ASSOCIATED ADIPOSE REDISTRIBUTION SYNDROME (HARS)
M-66   USE IN SPECIFIC POPULATIONS - PATIENTS WITH CONCOMITANT ILLNESS SUBSECTION OF THE
       LABELING REGARDING USE OF STRATTERA IN PATIENTS WITH ADHD WHO HAVE COMORBID TIC
       DISORDER
M-67   INDICATION EXPANDED TO INCLUDE PATIENTS ON PERITONEAL DIALYSIS
M-68   DESCRIPTION OF RESULTS OF STUDY OF INITIAL THERAPY IN COMBINATION WITH METFORMIN
       WHEN DIET AND EXERCISE DO NOT PROVIDE GLYCEMIC CONTROL
M-69   RESULTS OF STUDY OF COMBINATION THERAPY AND NON-INFERIORITY STUDY
M-70   PROVISION OF INFORMATION OF THE RESULTS OF A PHASE 2 RANDOMIZED TRIAL OF SPRYCEL
       70MG TWICE DAILY OR IMATINIB 800MG DAILY
M-71   REVISIONS TO PROVIDE FOR RESULTS OF MAINTENANCE DATA IN ADULT PATIENTS WITH MAJOR
       DEPRESSIVE DISORDER
M-72   INFORMATION ABOUT USE OF INSPRA (EPLERENONE) FOR HYPERTENSION IN PEDIATRIC
       PATIENTS
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 25 of 67


                               EXCLUSIVITY MISCELLANEOUS

M-73    NEW INFORMATION ADDED REGARDING THE TUMOR SHRINKING POTENTIAL OF SANDOSTATIN LAR
        DEPOT INJECTION ON GH - SECRETING PITUITARY ADENOMAS
M-74    REVISIONS TO CLINICAL STUDIES - CHILDREN AND ADOLSCENTS BASED ON CLINICAL TRIAL
        DATA TO SUPPORT A DURATION OF ACTION CLAIM UP TO 12 HOURS
M-75    PROVISION FOR USE OF ARGAGATROBAN IN CERTAIN PEDIATRIC PATIENTS WITH HEPARIN-
        INDUCED THROMBOCYTOPENIA (HIT) OR HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOSIS
        (HITTS)
M-76    REMOVAL OF SCREEN REQUIREMENT IN PTS WITH G6PD DEFICIENCY PRIOR TO INITIATING
        ACZONE TREATMENT; REMOVAL OF BLOOD COUNT & RETICULOCYTE MONITORING DURING
        TREATMENT IN G6PD DEFICIENT PTS AND IN PATIENTS WITH HISTORY OF ANEMIA
M-77    USE IN COMBINATION WITH THE NEW AKTILITE CL128 LAMP FOR THE TREATMENT OF THIN AND
        MODERATELY THICK, NON-HYPERKERATOTIC, NON-PIGMENTED ACTINIC KERATOSES OF THE FACE
        AND SCALP IN IMMUNOCOMPETENT PATIENTS
M-78    CLINICAL TRIAL INFO ON USE OF STRATTERA IN PATIENTS WITH ATTENTION DEFICIT
        HYPERACTIVITY DISORDER (ADHD) AND COMORBID ANXIETY DISORDER WITHOUT CAUSING
        WORSENING OF ANXIETY
M-79    LABELING REVISIONS RELATED TO SMOKING AND ERLOTIMB EXPOSURE
M-80    ADDITIONAL TIME POINT OF 30 MINUTES (0.5 HOUR) IN CHILDREN AGED 6-12 YEARS WITH A
        DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)
M-81    ADDITIONAL INFO FOR PEDIATRIC USE FOR CASODEX (STUDIED IN COMBINATION WITH
        ARIMIDEX) IN THE PEDIATRIC POPULATION, SPECIFICALLY BOYS WITH FAMILIAL MALE-
        LIMITED PRECOCIOUS PUBERTY (TESTOXICOSIS)
M-82    LABELING REVISIONS RELATED TO CLINICAL STUDIES
M-83    ADDITIONAL INFORMATION ADDED TO LABELING REGARDING ESTABLISHMENT OF EFFICACY IN
        ADDITIONAL CLINICAL TRIALS AND ONE MAINTENANCE TRIAL
M-84    STUDY INFORMATION ADDED TO LABEL REGARDING BONE MINERAL DENSITY
M-85    INFORMATION ADDED TO LABELING REGARDING USE OF PREVACID IN PATIENTS LESS THAN 1
        YEAR WITH SYMPTOMATIC GERD
M-86    LABELING CHANGES SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST FOR INFANTS
        AGES BIRTH TO 11 MONTH INCLUSIVE REFLECTING LACK OF EFFICACY FOR GERD INDICATION
        FOR THIS PATIENT POPULATION
M-87    INCLUSION OF RESULTS FROM TWO DRUG INTERACTION STUDIES WITH LIPITOR AND CRESTOR IN
        CLINICAL PHARMACOLOGY SECTION
M-88    ADDITION OF INFORMATION REGARDING ABUSE POTENTIAL OF CONCERTA VERSUS IMMEDIATE-
        RELEASE METHYLPHENIDATE
M-89    PROVIDES FOR REVISIONS TO MULTIPLE SECTIONS OF THE PACKAGE INSERT TO REFLECT
        RESULTS OF CLINICAL TRIALS 205.235 (UPLIFT) AND 205.266 (VA STUDY) IN SUPPORT OF
        EXACERBATION CLAIM
M-90    LABELING CHANGES BASED ON DATA FROM CLINICAL STUDIES NV20235 AND NV20236 STUDIES
        OF SEASONAL PROPHYLAXIS OF INFLUENZA IN IMMUNOCOMPROMISED PATIENTS AND CHILDREN
        AGES 1-12
M-91    UPDATED LABELING BASED UPON STUDY: A SINGLE-DOSE, SINGLE-BLIND, PLACEBO-AND
        MOXIFLOXACIN-CONTROLLED 2-PERIOD, RANDOMIZED, CROSSOVER, 3RD PERIOD SEQUENTIAL
        STUDY OF SIDE EFFECTS OF TEMSIROLIMUS ON CARDIAC REPOLARIZATION IN HEALTHY
        SUBJECTS
M-92    UPDATES TO THE PACKAGE INSERT BASED UPON THE TRIAL ENTITLED "A PHASE I
        PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF TEMSIROLIMUS IN PATIENTS WITH
        ADVANCED MALIGNANCIES AND NORMAL AND IMPAIRED LIVER FUNCTION
M-93    EXPANSION OF LABELING TO INCLUDE INFORMATION ON SAFETY AND EFFICACY OF CREON IN
        PATIENTS AGES 7 YEARS THROUGH 11 YEARS WITH PANCREATIC EXOCRINE INSUFFICIENCY DUE
        TO CYSTIC FIBROSIS
M-94    INFO ADDED TO LABEL RELATED TO NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE
        (PH+) CHRONIC MYELOID LEUKEMIA IC CHRONIC PHASE
M-95    INFORMATION FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN ADULT PATIENTS WITH
        DECOMPENSATED LIVER DISEASE BASED ON DATA FROM CLINICAL TRIAL GS-US-174-0108
M-96    UPDATED INFORMATION IN THE CLINICAL STUDIES SECTION RELATED TO THE LOSS AND
        RECOVERY OF BONE MINERAL DENSITY IN ADOLESCENT GIRLS DURING AND FOLLOWING THE USE
        OF DEPO-PROVERA CONTRACEPTIVE INJECTION
M-97    LABELING CHANGES IN RESPONSE TO PEDIATRIC STUDIES - NOT INDICATED FOR USE IN
        PEDIATRIC POPULATION
M-98    NEW INFORMATION FROM A STUDY WHICH EVALUATED THE SAFETY AND EFFICACY OF FAMVIR IN
        TREATING RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT BLACK/AFRICAN AMERICAN
        SUBJECTS.
M-99    ADDITION OF FINDINGS FROM A SINGLE PEDIATRIC CLINICAL TRIAL (P04292) OF NASONEX
        NASAL SPRAY IN THE TREATMENT OF NASAL POLYPS IN PATENTS 6 TO <18 YEARS OF AGE TO
        THE PACKAGE INSERT.
M-100   INFORMATION ADDED TO LABEL BASED UPON COMPLETED CLINICAL TRIAL REPORTS
M-101   INCLUSION OF DATA FROM AN ADDITIONAL 19 SUBJECTS WITH HYPERCALCEMIA FROM
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 26 of 67


                               EXCLUSIVITY MISCELLANEOUS

        PARATHYROID CARCINOMA TO THE INFORMATION CURRENTLY PRESENTED IN THE LABEL
M-102   INFORMATION FROM PEDIATRIC STUDY REPORT ML16633, "INTRAVENOUS GRANISETRON (KYTRIL)
        IN THE PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING (PONV) IN PEDIATRIC
        SUBJECTS UNDERGOING TONSILLECTOMY OR ADENOTONSILLECTOMY."
M-103   SAFETY, EFFICACY AND PHARMACOKINETIC INFO FOR FASLODEX IN THE PEDIATRIC
        POPULATION, SPECIFICALLY FOR GIRLS WITH PROGRESSIVE PRECOCIOUS PUBERTY ASSOCIATED
        WITH MCCUNE-ALBRIGHT SYNDROME ADDED TO THE PEDIATRIC USE SECTION OF THE LABELING
M-104   INFORMATION ADDED TO DOSING AND ADMINISTRATION REGARDING A 26 WEEK STUDY
M-105   NEW LANGUAGE ADDED TO CLINICAL STUDIES REGARDING USE IN SMOKERS WITH
        CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND USE ACCORDING
        TO AN ALTERNATIVE SET OF DIRECTIONS FOR SETTING A QUIT DATE
M-106   ADDITION OF THE T1-WEIGHTED GD-ENHANCED LESION EFFICACY VARIABLE IN THE CLINICAL
        STUDIES SECTION 14 OF THE PACKAGE INSERT
M-107    INFORMATION TO THE CLINICAL STUDIES SECTION OF THE LUPRON DEPOT-PED,1-MONTH,BASED
        UPON THE PHASE 3/4 COMPLETED CLINICAL STUDY REPORT FOR STUDY M90-516, ENTITLED
        "STUDY OF LUPRON DEPOT IN THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY".
M-108   CHANGES ARE BASED ON RESULTS FROM STUDY CV181057
M-109   CHANGES TO THE PACKAGE INSERT TO REFLECT THE RESULTS OF THE STUDY OF HEART AND
        RENAL PROTECTION (SHARP) TRIAL
M-110   CHANGES TO THE PACKAGE INSERT TO REFLECT THE RESULTS OF THE STUDY OF HEART AND
        RENAL PROTECTION (SHARP) TRIAL
M-111   LABELING CHANGES BASED ON STUDY HW80-EW-GWCI ENTITLED A PLACEBO AND POSITIVE
        CONTROLLED STUDY OF THE ELECTROPHYSIOLOGICAL EFFECTS OF A SINGLE 10 MCG DOSE OF
        EXENATIDE ON THE 12 LEAD ELECTROCARDIOGRAM QT INTERVAL IN HEALTHY SUBJECTS
M-112   REVISIONS TO THE PEDIATRIC USE SECTION OF THE PACKAGE INSERT TO ADD INFORMATION
        FROM A PEDIATRIC STUDY IN PATIENTS AGED 12 YEARS TO LESS THAN 18 YEARS OF AGE WITH
        RECURRENT HERPES LABIALIS
M-113   LABELING CHANGES BASED ON STUDY H80-US-GWCO ENTITLED A RANDOMIZED TRIAL COMPARING
        EXENATIDE WITH PLACEBO IN SUBJECTS WITH TYPE 2 DIABETES ON INSULIN GLARGINE WITH
        OR WITHOUT ORAL ANTIHYPERGLYCEMIC MEDICATIONS
M-114   CHANGES IN SECTION 14 OF THE PACKAGE INSERT TO INCLUDE DATA FROM THE SWITCHMRK
        STUDIES (SWITCH OF SUPPRESSED SUBJECTS FROM LOPINAVIR/RITONAVIR TO RALTEGRAVIR)
M-115   REVISIONS TO THE PI BASED ON RESULTS FROM STUDY NN2211-1842, ENTITLED THE EFFECT
        OF INSULIN DETEMIR IN COMBINATION WITH LIRAGLUTIDE AND METFORMIN COMPARED TO
        LIRAGLUTIDE AND METFORMIN IN SUBJECTS WITH TYPE 2 DIABETES
M-116   LABELING CHANGES BASED ON RESULTS FROM CLINICAL STUDY 01-06-TL-OPIMET-008
M-117   ADDITION OF RESULTS OF PEDIATRIC TRIAL TO LABEL
M-118   LABELING CHANGES BASED UPON SAFETY AND EFFICACY RESULTS FROM TRIAL 1218.36
M-119   LABELING CHANGES REGARDING MISSED DOSES
M-120   CHANGES TO CLINICAL TRIALS DETAILING STUDY RESULTS
M-121   LABELING CHANGES BASED UPON SAFETY AND EFFICACY RESULTS FROM TRIAL 1218.43

M-122   LABELING CHANGES TO INCLUDE THE RESULTS OF THE PARAMOUNT TRIAL
M-123   UPDATED RESULTS OF OVERALL SURVIVAL FROM 'CONFIRM' STUDY
M-124   LONG TERM SAFETY AND EFFICACY DATA FROM STUDY CLDT600A2303 FOR SUBJECTS PREVIOUSLY
        ENROLLED IN THE ORIGINAL TWO YEAR GLOBE (NV-02B-007/CLDT600A2302) AND NV02B-015
        STUDIES WHO CONTINUED TELBIVUDINE TREATMENT FOR UP TO 208 WEEKS
M-125   LABELING CHANGES TO INCLUDE LACK OF EFFICACY IN CHILDREN 6 MONTHS TO 4 YEARS OF
        AGE
M-126   UPDATES TO THE CLINICAL STUDIES SECTION 14, OF THE PACKAGE INSERT (PI), WITH THE
        RESULTS OF CLINICAL TRIAL P06086
M-127   REVISIONS TO THE PEDIATRIC USE SECTION OF THE PACKAGE INSERT TO REFLECT THE
        RESULTS FROM CLINICAL STUDY C-10-004
M-128   CLINICAL TRIAL STUDY RESULTS
M-129   RESULTS OF A CLINICAL STUDY REPORT WHICH ASSESSES THE SAFETY AND EFFICACY IN
        CHILDREN AGES 6 TO 12 YEARS OF AGE
M-130   ADDITION OF INFORMATION ON LONG-TERM TREATMENT WITH VPRIV IN THE CLINICAL TRIALS
        SECTION OF THE PACKAGE INSERT
M-131   INFORMATION FROM STUDIES CONDUCTED IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED NON-
        DISSEMINATED DIFFUSED INTRINSIC BRAINSTEM GLIOMAS
M-132   REVISIONS TO THE CLINICAL TRIALS SECTION IN THE INOMAX LABEL TO REFLECT RESULTS
        FROM THE PEDIATRIC STUDY REPORTS
M-133   INFORMATION ADDED TO THE LABELING REGARDING THE ADDITION OF SILDENAFIL TO BOSENTAN
        THERAPY
M-134   ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES PERFORMED WITH SAXAGLIPTIN IN
        COMBINATION WITH METFORMIN AND A SULFONYLUREA ADDED TO THE LABELING
M-135   ADDITION OF INFORMATION TO THE CLINICAL STUDIES - RADIOGRAPHIC RESPONSE SECTION OF
        THE PACKAGE INSERT
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 27 of 67


                               EXCLUSIVITY MISCELLANEOUS

M-136   ADDITIONAL INFORMATION ADDED TO THE USE IN SPECIFIC POPULATIONS SECTION OF THE
        LABELING REGARDING POST-OPERATIVE NAUSEA AND VOMITING STUDIES IN PEDIATRIC
        PATIENTS
M-137   LABELING REVISIONS RESULTING FROM A MAINTENANCE TRIAL IN PEDIATRIC PATIENTS WITH
        IRRITABILITY ASSOCIATED WITH AUTISTIC DISORDER
M-138   INFORMATION ADDED TO THE 8.4 PEDIATRIC USE SECTION ON THE USE OF MEMANTINE IN
        CHILDREN AGES 6-12 YEARS WITH AUTISM SPECTRUM DISORDER
M-139   INFORMATION ADDED TO THE DOSING AND ADMINISTRATION SECTION OF THE PACKAGE INSERT
        REGARDING RETREATMENT WITH VELCADE FOR PATIENTS WITH MULTIPLE MYELOMA
M-140   INFORMATION ADDED TO THE PEDIATRIC USE SECTION OF THE LABELING REGARDING USE OF
        LATISSE IN PATIENTS WHO WERE POST-CHEMOTHERAPY OR HAD ALOPECIA AREATA, AND
        ADOLESCENTS WHO HAD HYPERTRICHOSIS WITH NO ASSOCIATED MEDICAL CONDITION
M-141   REVISIONS TO THE PEDIATRIC USE SECTION OF THE LABELING TO INCORPORATE STUDY
        RESULTS FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER IN ADOLESCENTS (AGES 12-17)
M-142   ADDITIONS TO THE LABELING DESCRIBING RESULTS FROM STUDY H6P-MC-HDAY
M-143   INFORMATION ADDED TO THE LABELING REGARDING THE SAFETY AND EFFICACY OF VARENICLINE
        FOR SMOKING CESSATION IN PATIENTS WITH CURRENT OR PAST HISTORY OF MAJOR DEPRESSIVE
        DISORDER
M-144   INFORMATION ADDED TO THE LABELING REGARDING THE SAFETY AND EFFICACY OF VARENICLINE
        FOR SMOKING CESSATION IN PATIENTS WHO HAD BEEN PREVIOUSLY TREATED WITH VARENICLINE
M-145   ADDITION OF INFORMATION ABOUT LONG-TERM TREATMENT OF PULMONARY ARTERIAL
        HYPERTENSION TO THE CLINICAL STUDIES SECTION OF THE LABELING
M-146   INFORMATION ADDED TO THE CLINICAL STUDIES SECTION ON INITIAL COMBINATION THERAPY
        WITH LINAGLIPTIN AND METFORMIN VS. LINAGLIPTIN MONOTHERAPY IN TREATMENT NAIVE
        PATIENTS
M-147   OTC USE FOR TEMPORARY RELIEF OF OCULAR SYMPTOMS DUE TO HAY FEVER OR OTHER UPPER
        RESPIRATORY ALLERGIES
M-148   LABELING CHANGES BASED ON STUDY H80-EW-GWDM
M-149   INFORMATION ADDED TO THE LABELING REGARDING MAINTENANCE MONOTHERAPY FOR ADHD
M-150   ADDITION OF THE RESULTS OF A CONTROLLED CLINICAL STUDY TREATING ADULT PATIENTS
        WITH SCHIZOPHRENIA EXPERIENCING AN ACUTE RELAPSE


                                       PATENT USE

U-1     PREVENTION OF PREGNANCY
U-2     TREATMENT OR PROPHYLAXIS OF ANGINA PECTORIS AND ARRHYTHMIA
U-3     TREATMENT OF HYPERTENSION
U-4     PROVIDING PREVENTION AND TREATMENT OF EMESIS AND NAUSEA IN MAMMALS
U-5     METHOD OF PRODUCING BRONCHODILATION
U-6     METHOD OF PRODUCING SYMPATHOMIMETIC EFFECTS
U-7     INCREASING CARDIAC CONTRACTILITY
U-8     ACUTE MYOCARDIAL INFARCTION
U-9     CONTROL OF EMESIS ASSOCIATED WITH ANY CANCER CHEMOTHERAPY AGENT
U-10    DIAGNOSTIC METHOD FOR DISTINGUISHING BETWEEN HYPOTHALMIC MALFUNCTIONS OR LESIONS
        IN HUMANS
U-11    TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS
U-12    METHOD OF TREATING [A] HUMAN SUFFERING FROM DEPRESSION
U-13    A METHOD FOR TREATING ANXIETY IN A HUMAN SUBJECT IN NEED OF SUCH TREATMENT
U-14    ADJUNCTIVE THERAPY FOR THE PREVENTION AND TREATMENT OF HYPERAMMONEMIA IN THE
        CHRONIC MANAGEMENT OF PATIENTS WITH UREA CYCLE ENZYMOPATHIES
U-15    METHOD OF LOWERING INTRAOCULAR PRESSURE
U-16    USE IN LUNG SCANNING PROCEDURES
U-17    TREATMENT OF VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS
U-18    METHOD FOR INHIBITING GASTRIC SECRETION IN MAMMALS
U-19    TREATMENT OF INFLAMMATION
U-20    A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED
        OF TREATMENT
U-21    TREATMENT OF HUMANS SUFFERING UNDESIRED UROTOXIC SIDE EFFECTS CAUSED BY
        CYTOSTATICALLY ACTIVE ALKYLATING AGENTS
U-22    METHOD OF COMBATTING PATHOLOGICALLY REDUCED CEREBRAL FUNCTIONS AND PERFORMANCE
        WEAKNESSES, CEREBRAL INSUFFICIENCY AND DISORDERS IN CEREBRAL CIRCULATION AND
        METABOLISM IN WARM-BLOODED ANIMALS
U-23    METHOD FOR TREATING PROSTATIC CARCINOMA COMPRISING ADMINISTERING FLUTAMIDE
U-24    METHOD FOR TREATING PROSTATE ADENOCARCINOMA COMPRISING ADMINISTERING AN
        ANTIANDROGEN INCLUDING FLUTAMIDE AND AN LHRH AGONIST
U-25    REDUCING CHOLESTEROL IN CHOLELITHIASIS PATIENTS
                35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                        PATENT AND EXCLUSIVITY TERMS                       ADB 28 of 67


                                      PATENT USE

U-26   REDUCING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF
U-27   DISSOLVING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF
U-28   CEREBRAL, CORONARY, PERIPHERAL, VISCERAL AND RENAL ARTERIOGRAPHY, AORTOGRAPHY AND
       LEFT VENTRICULOGRAPHY
U-29   CT IMAGING OF THE HEAD AND BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY
U-30   CEREBRAL ANGIOGRAPHY, AND VENOGRAPHY
U-31   INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY
U-32   PALLIATIVE TREATMENT OF PATIENTS WITH OVARIAN CARCINOMA RECURRENT AFTER PRIOR
       CHEMOTHERAPY, INCLUDING PATIENTS WHO HAVE BEEN PREVIOUSLY TREATED WITH CISPLATIN
U-33   TREATING VIRAL INFECTIONS IN A MAMMAL
U-34   TREATING VIRAL INFECTIONS IN A WARM-BLOODED ANIMAL
U-35   TREATING CYTOMEGALOVIRUS IN A HUMAN WITH AN INJECTABLE COMPOSITION
U-36   METHODS OF TREATING BACTERIAL ILLNESSES
U-37   METHOD OF TREATING GASTROINTESTINAL DISEASE
U-38   TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
U-39   ANGINA PECTORIS
U-40   METHOD OF TREATMENT OF BURNS
U-41   METHOD OF TREATING CARDIAC ARRHYTHMIAS
U-42   ADJUVANT TREATMENT IN COMBINATION WITH FLUOROURACIL AFTER SURGICAL RESECTION IN
       PATIENTS WITH DUKES' STAGE C COLON CANCER
U-43   MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA
U-44   RELIEF OF NAUSEA AND VOMITING
U-45   TREATMENT OF INFLAMMATION AND ANALGESIA
U-46   TREATMENT OF PANIC DISORDER
U-47   STIMULATION OF THE RELEASE OF GROWTH HORMONE
U-48   ANALGESIA
U-49   SYMPTOMATIC CANCER-RELATED HYPERCALCEMIA
U-50   USE IN TREATING INFLAMMATORY DERMATOSES
U-51   BLOOD POOL IMAGING, INCLUDING CARDIAC FIRST PASS AND GATED EQUILIBRIUM IMAGING AND
       FOR DETECTION OF SITES OF GASTROINTESTINAL BLEEDING
U-52   TREATMENT OF ADULT AND PEDIATRIC PATIENTS(OVER SIX MONTHS OF AGE) WITH ADVANCED
       HIV INFECTION
U-53   HYPERCALCEMIA OF MALIGNANCY
U-54   REVERSAL AGENT OR ANTAGONIST OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS
U-55   TREATMENT OF PAIN
U-56   AID TO SMOKING CESSATION
U-57   OPHTHALMIC USE OF NORFLOXACIN
U-58   METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES
U-59   METHOD OF TREATING HYPERCHOLESTEROLEMIA
U-60   NASAL ADMINISTRATION OF BUTORPHANOL
U-61   CEREBRAL AND PERIPHERAL ARTERIOGRAPHY AND CT IMAGING OF THE HEAD
U-62   CORONARY ARTERIOGRAPHY, LEFT VENTRICULOGRAPHY, CT IMAGING OF THE BODY, INTRAVENOUS
       EXCRETORY UROGRAPHY, INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY AND VENOGRAPHY
U-63   ISOPRENALINE ANTAGONISM ON THE HEART RATE OR BLOOD PRESSURE
U-64   TREATMENT OF VIRAL INFECTIONS
U-65   METHOD OF TREATMENT OF A PATIENT INFECTED WITH HIV
U-66   TRIPHASIC REGIMEN
U-67   METHOD OF INDUCING ANESTHESIA IN A WARM BLOODED ANIMAL
U-68   TREATMENT OF ACTINIC KERATOSIS
U-69   TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS
U-70   TREATMENT OF TRANSIENT INSOMNIA
U-71   METHOD OF TREATMENT OF HEART FAILURE
U-72   TREATMENT OF MIGRAINE
U-73   METHOD OF TREATING DISEASES OR INFECTIONS CAUSED BY MYCETES
U-74   METHOD OF PROVIDING HYPNOTIC EFFECT
U-75   RELIEF OF OCULAR ITCHING DUE TO SEASONAL ALLERGIC CONJUNCTIVITIS
U-76   USE TO IMAGE A SUBJECT WITH A MAGNETIC RESONANCE IMAGING SYSTEM
U-77   TREATMENT OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS
U-78   ULCERATIVE COLITIS
U-79   SYMPTOMATIC TREATMENT OF PATIENTS WITH NOCTURNAL HEARTBURNDUE TO GERD
U-80   METHOD OF TREATING OCULAR BACTERIAL INFECTIONS
U-81   RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS
U-82   TREATMENT FOR DEMENTIA IN PATIENTS WITH ALZHEIMER'S DISEASE
U-83   TREATMENT OF SEIZURES
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 29 of 67


                                       PATENT USE

U-84    A METHOD OF BLOCKING THE UPTAKE OF MONOAMINES BY BRAIN NEURONS IN ANIMALS
U-85    NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
U-86    METHOD OF TREATING CERTAIN FORMS OF EPILEPSY
U-87    METHOD FOR NONINVASIVE ADMINISTRATION OF SEDATIVES, ANALGESICS, AND ANESTHETICS
U-88    TREATMENT OF MODERATE PLAQUE PSORIASIS
U-89    TREATMENT OR PROPHYLAXIS OF EMESIS
U-90    TREATMENT OF PYSCHOTIC DISORDERS
U-91    ALTERNATIVE THERAPY TO TRIMETHOPRIM-SULFAMETHOXAZOLE FOR TREATMENT OF MODERATE-TO-
        SEVERE PNEUMOCYSTIS CARINII PNEUMONIA IN IMMUNOCOMPROMISED AND AIDS PATIENTS
U-92    TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN DEPENDENT
        DIABETES MELLITUS AND RETINOPATY
U-93    USE AS AN ANTIHISTAMINE/DECONGESTANT
U-94    TREATMENT-ADULTS W/ ADVANCED HIV,INTOLERANT OF APPROVED THERAPIES,INTOLERANT OF
        APPROVED THERAPIES W/PROVEN BENEFIT OR HAVE EXPERIENCED CLINICAL/IMMUNOLOGICAL
        DETERIORATION WHILE RECEIVING..OR FOR WHOM SUCH THERAPIES-CONTRAINDICATED
U-95    SHORT TERM MANAGEMENT OF MODERATE PRURITIS IN ADULTS WITH ATOPIC DERMATITIS AND
        LICHEN SIMPLEX CHRONICUS
U-96    METHOD OF TREATING VARICELLA ZOSTER (SHINGLES) INFECTIONS
U-97    A METHOD OF TREATING A PATIENT IN NEED OF MEMORY ENHANCEMENT
U-98    A METHOD OF INDUCING REGRESSION OF LEUKEMIA CELL GROWTH IN A MAMMAL
U-99    METHOD OF PROVIDING POTASSIUM TO A SUBJECT IN NEED OF POTASSIUM
U-100   METHOD OF TREATING OCULAR INFLAMMATION
U-101   ADJUNCT TO CONVENTIONAL CT OR MRI IMAGING IN THE LOCALIZATION OF STROKE IN
        PATIENTS IN WHOM STROKE HAS ALREADY BEEN DIAGNOSED
U-102   METHOD OF HORMONALLY TREATING MENOPAUSAL OR POST-MENOPAUSAL DISORDERS IN WOMEN
U-103   TREATMENT OF OCULAR HYPERTENSION
U-104   TREATMENT OF AQUEOUS HUMOR FORMATION AND INTRAOCULAR PRESSURE
U-105   EMESIS
U-106   TREATMENT OF EPILEPSY
U-107   TREATMENT OF HYPERTENSION AND ANGINA PECTORIS
U-108   SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER, GASTROESOPHAGEAL REFLUX DISEASE
        (GERD), SEVERE EROSIVE ESOPHAGITIS, POORLY RESPONSIVE SYMPTOMATIC GERD AND
        PATHOLOGIAL HYPERSECRETORY CONDITIONS AND MAINTENANCE HEALING OF EROSIVE
        ESOPHAGITIS
U-109   ADJUNCT DIET IN THE TX OF ELEVATED TOTAL CHOLESTEROL AND LDL-C LEVELS IN PTS
        W/PRIMARY HYPERCHOLESTEROLEMIA WHOSE RESPONSE TO DIETARY RESTRICTION OF SAT FAT
        AND CHOLESTEROL AND OTHER NONPHARMACOLOGICAL MEASURES HAS NOT BEEN ADEQUATE
U-110   USE AS A RETRIEVABLE PERSSARY
U-111   DIABETES
U-112   CONTRACEPTION
U-113   METHOD OF CONDUCTING RADIOLOGICAL EXAMINATION OF A PATIENT BY ADMINISTERING TO
        SAID PATIENT A RADIOPAQUE AMOUNT OF IOPROMIDE
U-114   USE FOR INHIBITING BONE RESORPTION
U-115   USE OF VASODILATORS TO EFFECT AND ENHANCE AN ERECTION (AND THUS TREAT ERECTILE
        DYSFUNCTION), BY INJECTION INTO THE PENIS
U-116   METHOD OF MYOCARDIAL IMAGING
U-117   TREATMENT OF OCULAR ALLERGIC RESPONSE IN HUMAN EYES
U-118   METHOD OF LOWERING BLOOD SUGAR LEVEL
U-119   TREATMENT OF NASAL HYPERSECRETION
U-120   CONTROLLING OR PREVENTING POST-OPERATIVE INTRAOCULAR PRESSURE RISES ASSOCIATED
        WITH OPHTHALMIC LASER SURGICAL PROCEDURES
U-121   METHOD OF TREATING CONDITIONS MEDIATED THROUGH HISTAMINE H2-RECEPTORS
U-122   A THERAPEUTIC METHOD FOR CONTROLLING THROMBOSIS
U-123   METHOD FOR CONTROLLING THROMBOSIS AND DECREASING BLOOD HYPERCOAGULATION AND
        HEMORRHAGING RISKS
U-124   TREATMENT OF ACNE
U-125   TREATMENT NEUROGENERATIVE DISEASES
U-126   TREATMENT OF GASTRITIS
U-127   METHOD OF PRODUCING NEUROMUSCULAR BLOCKADE
U-128   METHOD FOR TREATMENT OF TUMORS
U-129   METHOD TO DESTROY OR IMPAIR TARGET CELLS
U-130   MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS
U-131   PHOTODAMAGED SKIN
U-132   INHIBITING HIV PROTEASE
U-133   MANAGEMENT OF OBESITY INCLUDING WEIGHT LOSS AND MAINTENANCE IN PATIENTS ON A
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 30 of 67


                                       PATENT USE

        REDUCED-CALORIE DIET
U-134   TREATMENT OF ACNE VULGARIS
U-135   ANTITUMOR AGENT
U-136   PROCESS FOR WASTE NITROGEN REMOVAL
U-137   METHOD OF TREATING BACTERIAL VAGINOSIS
U-138   TREATMENT OF ALLERGIC RHINITIS
U-139   TREATMENT OF ALLERGIC REACTIONS
U-140   USE OF NORVIR TO INHIBIT HIV PROTEASE OR TO INHIBIT AN HIV INFECTION
U-141   TREATMENT OF ULCERATIVE COLITIS
U-142   METHOD OF TREATING ALLERGIC REACTIONS IN A MAMMAL BY USING THIS ACTIVE METABOLITE
U-143   BIODEGRADABLE SUPERPARAMAGNETIC METAL OXIDES AS CONTRAST AGENTS FOR MR IMAGING
U-144   BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC MATERIALS FOR USE IN CLINICAL
        APPLICATIONS
U-145   BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC PARTICLES FOR USE AS NUCLEAR MAGNETIC
        RESONANCE IMAGING AGENTS
U-146   METHOD OF TREATING SUSCEPTIBLE NEOPLASMS IN MAMMALS
U-147   DETECTION OF GASTROINTESTINAL DISORDERS AND THE SUBSEQUENT BREATH COLLECTION AND
        MEASUREMENT OF 13CO2
U-148   DEVICE FOR COLLECTING A BREATH SAMPLE
U-149   METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN SUFFERING FROM OR SUSCEPTIBLE TO
        PSYCHOSIS, ACUTE MANIA OR MILD ANXIETY STATES
U-150   METHOD OF USE FOR CONTROLLING HYPERGLYCEMIA BY ADMINISTRATION OF THIS SUSTAINED
        RELEASE DOSAGE FORM OF GLIPIZIDE
U-151   RELIEF OF SYMPTOMS OF THE COMMON COLD
U-152   METHOD OF TREATING ANXIETY RELATED DISORDERS INCLUDING OBSESSIVE COMPULSIVE
        DISORDER
U-153   TREATMENT OF INITIAL EPISODE GENITAL HERPES
U-154   METHOD OF TREATING ANIMALS SUFFERING FROM AN APPETITE DISORDER
U-155   TREATMENT OF ERECTILE DYSFUNCTION
U-156   METHOD OF PROVIDING ANESTHESIA
U-157   TREATMENT OF A HUMAN SUFFERING FROM VITAMIN B12 DEFICIENCY
U-158   ANGINA
U-159   TREATMENT OF INTERSTITIAL CYSTITIS
U-160   TREATMENT OF BACTERIAL INFECTIOUS DISEASE
U-161   METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS IN A PATIENT
U-162   METHOD OF USE TO INHIBIT CHOLESTEROL SYNTHESIS IN A HUMAN SUFFERING FROM
        HYPERCHOLESTEROLEMIA
U-163   METHOD OF USING TROGLITAZONE TO TREAT IMPAIRED GLUCOSE TOLERANCE TO PREVENT OR
        DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS
U-164   METHOD OF USING TROGLITAZONE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT
        DIABETES MELLITUS IN A DEFINED POPULATION OF PATIENTS
U-165   TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
U-166   TREATMENT OF H.PYLORI-ASSOCIATED DUODENAL ULCER
U-167   METHOD FOR TREATING HIV-1 INFECTION
U-168   METHOD OF INHIBITING LIPOXYGENASE ACTIVITY IN A MAMMAL WHICH IS THE MODE OF ACTION
        IN THE TREATMENT OF ASTHMA
U-169   METHODS OF USING THE COMPOUND/DRUG PRODUCT AS A CONTRAST AGENT IN MAGNETIC
        RESONANCE IMAGING
U-170   METHOD OF OBTAINING AN MR IMAGE USING THE COMPOSITION/DRUG PRODUCT AS A CONTRAST
        AGENT
U-171   METHODS OF USING THE COMPOUND/DRUG PRODUCT AS AN ORAL CONTRAST AGENT IN MAGNETIC
        RESONANCE IMAGING OF THE GASTROINTESTINAL TRACT
U-172   TREATMENT OF GENITAL WARTS
U-173   ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
U-174   USE AS AN ANTIHISTAMINE AGENT
U-175   METHOD OF TREATING MALIGNANT TUMORS
U-176   METHOD OF TREATING A PATIENT SUFFERING FROM LISTED CONDITIONS, INCLUDING SPECIFIC
        PSYCHOSES
U-177   FUNGICIDE
U-178   FACILITATED ADHERENCE OF AGENTS TO SKIN
U-179   ENHANCED CUTANEOUS PENETRATION OF A DERMALLY-APPLIED PHARMACOLOGICALLY ACTIVE
        AGENT
U-180   TREATMENT OF ADULT AND PEDIATRIC PATIENTS (OVER 6 MONTHS OF AGE) WITH ADVANCED HIV
        INFECTION
U-181   PRODUCING ALPHA ADRENERGIC ANTAGONISTIC ACTION IN A HOST
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 31 of 67


                                       PATENT USE

U-182   USE OF SALMETEROL IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION
U-183   TREATMENT OF CONDITIONS CAUSED BY DISTURBANCE OF NEURONAL 5HT FUNCTION
U-184   TREATING ALLERGIC EYE DISEASES IN HUMANS
U-185   METHOD OF TREATING HYPERTENSION
U-186   METHOD FOR TREATING GI DISORDERS CAUSED BY H.RYLORI WHICH COMPRISES ADMINISTRATION
        OF RANITIDINE BISMUTH CITRATE AND CLARITHROMYCIN FOR A GREATER THAN ADDITIVE
        EFFECT
U-187   THERAPEUTIC TREATMENT OF CALCIFIC TUMORS
U-188   TREATMENT OF H.PYLORI ASSOCIATED DUODENAL ULCER
U-189   ENHANCEMENT OF THE BIOAVAILABILITY OF THE DRUG SUBSTANCE
U-190   USE OF RITONAVIR IN COMBINATION WITH ANY REVERSE TRANSCRIPTASE INHIBITOR
U-191   METHOD OF TREATMENT FOR CONTROLLING AND LOWERING INTRAOCULAR PRESSURE IN A HUMAN
U-192   USE IN TREATING ALLERGIC REACTIONS
U-193   PSORIASIS
U-194   TREATING ANGINA PECTORIS AND HIGH BLOOD PRESSURE
U-195   METHOD FOR THE DIAGNOSIS OF GASTROINTESTINAL DISORDERS BY UREA ISOTOAC OR NITROGEN
        LABELED CARBON
U-196   TREATMENT OF METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH ESTROGEN
        RECEPTOR POSITIVE TUMORS
U-197   USE IN COMBINATION WITH CERTAIN LHRH ANALOGUES FOR THE TREATMENT OF ADVANCED
        PROSTATE CANCER
U-198   TREATMENT METASTATIC CARCINOMA OF OVARY AFTER 1ST LINE FAILURE OR SUBSQUENT
        CHEMOTHERAPY, TREATMENT OF BREAST CANCER AFTER FAILURE OF COMBINATION CHEMOTHERAPY
        FOR METASTATIC DISEASE AND 2ND LINE TREATMENT OF AIDS RELATED KAPOSI'S SARCOMA
U-199   METHOD OF TREATING INFECTIOUS UPPER GI TRACT DISORDERS CAUSED BY CAMPYLOBACTER
        PYLORIDIS INFECTION COMPRISING ADMINISTRATION OF A BISMUTH AGENT AND AN
        ANTIMICROBIAL AGENT
U-200   METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF A BISMUTH-CONTAINING
        AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT
U-201   METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF CAMPYLOBACTER-
        INHIBITING ANTIMICROBIAL AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT
U-202   METHOD OF TREATING PEPTIC ULCER DISEASE CAUSED BY CAMPYLOBACTER PYLORIDIS
        COMPRISING ORAL ADMINISTRATION OF 50 TO 5,000MG BISMUTH DAILY FOR 3-56 DAYS
U-203   TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE
        PROGRESSION FOLLOWING ANTIESTROGEN THERAPY
U-204   USE OF TAXOL IN COMBINATION WITH G-CSF FOR TREATMENT OF PATIENTS WITH AIDS-RELATED
        KAPOSI'S SARCOMA
U-205   METHOD FOR TREATING HEARTBURN
U-206   METHOD OF USING FSH ALONE, WITHOUT THE PRESENCE OF EXOGENEOUS LH, IN IN VITRO
        FERTILIZATION
U-207   USE AS NASAL SPRAY
U-208   VAGINAL ADMINISTRATION USING SPECIFIED FORMULATION
U-209   VAGINAL ADMINISTRATION OF PROGESTERONE USING SPECIFIED FORMULATION
U-210   METHOD OF TREATING CONGESTIVE HEART FAILURE
U-211   USE IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION
U-212   METHOD OF TREATMENT OF PARKINSON'S DISEASE
U-213   METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA
        AND METHOD FOR TREATING HYPERLIPIDEMIA
U-214   USE AS A BLOOD GLUCOSE-LOWERING AGENT
U-215   TREATMENT OF EPILEPSY TWICE DAILY. TREATING A PATIENT BY ADMINISTERING
        CARBAMAZEPINE IN A DOSAGE FORM CAPABLE OF MAINTAINING BLOOD CONCENTRATION FROM 4-
        12MCG/ML OVER 12 HOURS
U-216   TREATMENT OF ADENOCARCINOMA, INCLUDING STAGE B2-C BY ADMINISTERING AN AGONIST OF
        LH-RH AND FLUTAMIDE
U-217   METHOD OF PRODUCING ANESTHESIA
U-218   METHOD FOR LIMITING THE POTENTIAL FOR MICROBIAL GROWTH IN THE DRUG PRODUCT
U-219   TREATMENT OF PARKINSON'S DISEASE
U-220   METHOD OF DIAGNOSIS
U-221   SELECTIVE VASODILATION BY CONTINUOUS ADENOSINE INFUSION
U-222   METHOD OF TREATING PAGET'S DISEASE USING ACTONEL
U-223   TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF
        MICROORGANISMS
U-224   CONTROLLING INTRAOCULAR PRESSURE
U-225   METHOD FOR DELIVERY
U-226   METHOD OF ENHANCING THE DISSOLUTION PROFILE OF A PHARMACEUTICAL FROM A SOLID
        DOSAGE FORM CONTAINING THE PHARMACEUTICAL AND SIMETHICONE
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 32 of 67


                                       PATENT USE

U-227   NASAL ADMINISTRATION
U-228   ASTHMA
U-229   CARDIAC INSUFFICIENCY (CONGESTIVE HEART FAILURE)
U-230   PREVENTION OF ACUTE CARDIAC ISCHEMIC EVENTS
U-231   USE IN PARKINSON'S DISEASE
U-232   METHOD OF TREATING MIGRAINE
U-233   DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILURE
U-234   METHOD OF USING RIBAVIRIN TO TREAT VIRAL INFECTIONS IN MAMMALS
U-235   METHOD OF MODULATING TH1 AND TH2 RESPONSE IN ACTIVATED T CELLS OF A HUMAN
        COMPRISING ADMINISTERING RIBAVIRIN TO THE T CELLS IN A DOSAGE WHICH PROMOTES THE
        TH1 RESPONSE AND SUPPRESSES THE TH2 RESPONSE
U-236   TREATING MALE PATTERN BALDNESS WITH 0.05 TO 3.0MG/DAY
U-237   METHOD OF PERFORMING NMR IMAGING WITH A PATIENT COMPRISING ADMINISTERING TO THE
        PATIENT AN EFFECTIVE AMOUNT OF CONTRAST AGENT DISCLOSED IN THE CLAIMS
U-238   IMAGING A BODY TISSUE AND SUBJECTING TO NMR TOMOGRAPHY, ADMINISTERING AN AMOUNT OF
        PHARMACEUTICAL AGENT FOR AFFECTING THE RELAXATION TIMES OF ATOMS IN BODY TISSUES
        UNDERGOING NMR DIAGNOSIS, WHEREBY THE IMAGE CONTRAST IN ENHANCED....
U-239   TREATING OR CONTROLLING OCULAR INFLAMATION WHICH COMPRISES TOPICALLY ADMINISTERING
        TO AFFECTED EYE A COMPOSITION COMPRISING AN NSAID, A POLYMERIC QUATERNARY AMMONIUM
        COMPOUND AND BORIC ACID
U-240   TREATMENT OF ACUTE MIGRAINE ATTACKS
U-241   FOR SHORT-TERM TREATMENT ACTIVE DUODENAL ULCER, MAINTENANCE THERAPY FOR DUODENAL
        ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING OF ACTIVE ULCER, SHORT-TERM
        TREATMENT ACTIVE BENIGN GASTRIC ULCER & GERD, PATHOLOGICAL HYPERSECRETORY
        CONDITIONS
U-242   USE OF FOLLITROPIN ALPHA ALONE IN IN-VITRO FERTILIZATION
U-243   TOPICAL ADMINISTRATION
U-244   PLATELET AGGREGATION INHIBITORS
U-245   TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS
U-246   PHOSPHATE BINDING
U-247   TREATMENT OF RHEUMATOID ARTHRITIS
U-248   TREATMENT OF HIV
U-249   METHOD OF TREATING ALLERGIC OR NON-ALLERGIC RHINITIS IN PATIENTS BY ADMINISTERING
        AEROSOLIZED PARTICLES OF MOMETASONE FUROATE
U-250   TREATMENT OF HEPATITIS B INFECTION
U-251   USE OF TROGLITAZONE IN COMBINATION WITH SULFONYLUREAS IN THE TREATMENT OF TYPE II
        DIABETES
U-252   METHOD OF TREATING A HUMAN SUBJECT HAVING GAUCHER'S DISEASE
U-253   ORAL TRANSMUCOSAL USE
U-254   USE OF AGGRASTAT IN COMBINATION WITH HEPARIN
U-255   IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH
        NARCOLEPSY
U-256   TREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV
        ANTIVIRAL AGENTS
U-257   TREATMENT OF HIV INFECTION
U-258   TREATMENT OF NEURODEGENERATIVE DISEASES
U-259   TREATMENT OF ANDROGENIC ALOPECIA BY ORAL ADMINISTRATION DRUG SUBSTANCE
U-260   REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR
        HYPERTENSION WHO ARE INTOLERANT OF OTHER IOP LOWERING MEDICATIONS OR
        INSUFFICIENTLY RESPONSIVE TO ANOTHER IOP LOWERING MEDICATION
U-261   TREATING BENIGN PROSTATIC HYPERPLASIA WITH A GENUS OF COMPOUNDS, INCLUDING
        FINASTERIDE
U-262   TREATING BENIGN PROSTATIC HYPERTROPHY WITH FINASTERIDE
U-263   METHOD OF TREATING A MALIGNANT CONDITION THROUGH INTRAVASCULAR ADMINISTRATION OF
        BUSULFAN. METHOD FOR TREATING LEUKEMIA OR LYMPHOMA IN A PATIENT UNDERGOING A BONE
        MARROW TRANSPLANT THROUGH INTRAVENOUS ADMINISTRATION OF BUSULFAN
U-264   METHOD OF TREATING A MALIGNANT DISEASE THROUGH PARENTERAL ADMINISTRATION OF
        BUSULFAN. METHOD FOR TREATING A PATIENT UNDERGOING A BONE MARROW TRANSPLANT
        THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN
U-265   USE AS LAXATIVE
U-266   RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS; RELIEF OF THE SIGNS AND
        SYMPTOMS OF RHEUMATOID ARTHRITIS IN ADULTS; MANAGEMENT OF ACUTE PAIN IN ADULTS;
        TREATMENT OF PRIMARY DYSMENNORRHEA; ACUTE TREATMENT OF MIGRAINE ATTACKS IN ADULTS
U-267   PREVENTING HEARTBURN EPISODES FOLLOWING INGESTION OF HEARTBURN-INDUCING
        FOOD/BEVERAGE, COMPRISING ADMIN TO PT, 30 MIN PRIOR TO CONSUMPTION BY THE PT THE
        FOOD/BEVERAGE, A COMPOSITION COMPRISING 10MG FAMOTIDINE
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 33 of 67


                                       PATENT USE

U-268   ACROMEGALY
U-269   EXCESS GH-SECRETION OR GASTRO-INTESTINAL DISORDERS
U-270   METHOD OF IMPROVING THE TIME FOR ADMINISTRATION OR THE TIME BETWEEN CHANGES OF
        GIVING SETS FOR THE DRUG PRODUCT
U-271   METHOD OF TREATING TUMORS
U-272   METHOD OF TREATING CARCINOMA
U-273   CUTANEOUS T-CELL LYMPHOMA
U-274   ZANAMIVIR FOR INHALATION
U-275   METHOD OF USE OF THE DRUG SUBSTANCE
U-276   METHOD OF USE OF LEVOBUPIVACAINE
U-277   NEUROLOGICAL AND OTHER DISORDERS (TREATMENT OF EPILEPSY, BID ORAL DOSING)
U-278   METHOD OF USE OF THE INDICATION OF THE DRUG PRODUCT
U-279   METHOD OF USE OF THE APPROVED PRODUCT
U-280   TREATING PRECIPITATED ACUTE URINARY RETENTION WITH FINASTERIDE
U-281   ANTIMYCOTIC USES, SPECIFICALLY TREATMENT OF ONYCHOMYCOSIS
U-282   METHOD OF TREATING BACTERIAL INFECTIONS
U-283   METHOD FOR TREATING MENOPAUSAL SYMPTOMS IN A POSTMENOPAUSAL FEMALE
U-284   MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCIATED
        WITH MENOPAUSE, AND VULVAR AND VAGINAL ATROPHY) AND OSTEOPOROSIS
U-285   DEPRESSION AND SOCIAL ANXIETY DISORDER/SOCIAL PHOBIA
U-286   DEPRESSION
U-287   TREATMENT OR PREVENTION OF OSTEOPOROSIS
U-288   THERAPY OF INFLUENZA
U-289   TREATMENT OF NON-HYPERKERATOTIC ACTINIC KERATOSES OF FACE AND SCALP
U-290   INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS)
U-291   INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH
        CYCLOSPORIN
U-292   INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH
        AZATHIOPRINE
U-293   INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH A
        CORTICOSTEROID
U-294   TREATMENT OF HYPERPIGMENTARY DISORDERS
U-295   TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
U-296   TREATING MIGRAINE PAIN AND ONE OR MORE OF A CLUSTER OF SYMPTOMS CHARACTERISTIC OF
        A MIGRAINE ATTACK SYMPTOMS BEING SELECTED FROM PHOTOPHOBIA, PHONOPHOBIA NAUSEA AND
        FUNCTIONAL DISABILITY
U-297   PREVENTION OR TREATMENT OF REVERSIBLE VASOCONSTRICTION BY THE INHALATION OF NITRIC
        OXIDE WITH AN OXYGEN CONTAINING GAS
U-298   METHOD OF COMBATING BACTERIA IN A PATIENT
U-299   TREATMENT OF ADENOMATOUS POLYPS
U-300   INDICATED FOR THE REDUCTION OF ELEVATED TOTAL AND LDL CHOLESTEROL LEVELS IN
        PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
U-301   USE OF TROGLITAZONE IN COMBINATION WITH SULFONYLUREAS AND BIGUANIDES IN THE
        TREATMENT OF TYPE II DIABETES
U-302   TO REDUCE THE RISK OF STROKE IN PATIENTS WHO HAVE HAD TRANSIENT ISCHEMIA OF THE
        BRAIN OR COMPLETED ISCHEMIC STROKE DUE TO THROMBOSIS
U-303   METHOD OF USE PATENT-PRODUCT APPROVED FOR TREATMENT OF OSTEOPOROSIS, PAGET'S
        DISEASE, PREVENTION AND TREATMENT OF GLUCOCORTICOID INDUCED OSTEOPOROSIS
U-304   A METHOD OF TREATMENT OF A CONDITION INVOLVING AN ANTIBODY ANTIGEN REACTION
U-305   METHODS FOR USING THE DRUG PRODUCT
U-306   TREATMENT OF POST-MENOPAUSAL UROGENITAL SYMPTOMS ASSOCIATED WITH ESTROGEN
        DEFICIENCY
U-307   CLAIMS AN OLANZAPINE POLYMORPH USEFUL FOR TREATING ANY NUMBER OF LISTED
        CONDITIONS, INCLUDING SPECIFIC PSYCHOSES,EMPLOYING OLANZAPINE AS PER THE
        INDICATION OF THIS NDA
U-308   CLAIMS A SOLID ORAL FORMULATION INCLUDING TABLETS AND GRANULES OF OLANZAPINE
        USEFUL FOR TREATING ANY NUMBER OF LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOLES,
        EMPLOYING OLANZAPINE AS PER THE INDICATIONS OF THIS NDA
U-309   TREATING SJOEGREN SYNDROME
U-310   TREATMENT OF XEROSTOMIA
U-311   HORMONE REPLACEMENT
U-312   PANIC DISORDER, OBSESSIVE-COMPULSIVE DISORDER, POSTTRAUMATIC STRESS DISORDER
U-313   TREATMENT OF CONGESTIVE HEART FAILURE
U-314   METHOD FOR TREATING HYPERPARATHYROIDISM WHICH COMPRISES SUPPRESSING PARATHYROID
        ACTIVITY
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 34 of 67


                                       PATENT USE

U-315   METHOD FOR ADMINISTERING DRUG TO GASTROINTESTINAL TRACT
U-316   METHOD OF TREATING A SUBJECT SUFFERING FROM PROSTATE CANCER
U-317   METHOD OF USING TROGLITAZONE TO TREAT PATIENTS HAVING INSULIN RESISTANCE
U-318   TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER WITH SYMPTOMS OF URINARY
        FREQUENCY, URGENCY, OR URGE INCONTINENCE
U-319   TREATMENT OF MICROBIAL INFECTIONS
U-320   INHIBITING OR ELIMINATING ACUTE MYELOID LEUKEMIA
U-321   REDUCTION OF ELEVATED IPTH LEVELS IN THE MGT OF SECONDARY HYPERPARATHYROIDISM IN
        PATIENTS UNDERGONG CHRONIC RENAL DIALYSIS
U-322   TREATMENT OF ALZHEIMER'S DEMENTIA
U-323   USE AS A BILE ACID SEQUESTRANT
U-324   METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN, SUFFERING FROM OR SUSCEPTIBLE TO
        PSYCHOSIS OR ACUTE MANIA EMPLOYING OLANZAPINE
U-325   METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED CONDITIONS,
        INCLUDING "BIPOLAR DISORDER NOS" EMPLOYING OLANZAPINE
U-326   METHOD OF TREATING SCHIZOPHRENIA AND BIPOLAR DISORDER
U-327   METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED PSYCHOTIC
        CONDITONS EMPLOYING OLANZAPINE
U-328   METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED CONDITIONS
        INCLUDING "A PSYCHOTIC CONDITION" EMPLOYING AN OLANZAPINE POLYMORPH
U-329   USE OF AVANDIA AS MONOTHERAPY, IN COMBINATION WITH METFORMIN, AND IN COMBINATION
        WITH SULFONYLUREAS TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
        MELLITUS
U-330   TREATMENT OF NAUSEA AND VOMITING
U-331   METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN
        THE EVENING OR AT NIGHT
U-332   TREATMENT OR PREVENTION OF BRONCHOSPASM
U-333   METHOD OF TREATING OCULAR HYPERTENSION
U-334   TREATMENT OF EXCESSIVE FEMALE FACIAL HAIR
U-335   USE OF PRAVASTATIN SODIUM FOR SECONDARY PREVENTION OF CORONARY EVENTS IN MEN AND
        WOMEN WHO HAVE HAD A MYOCARDIAL INFARCTION AND HAVE NORMAL CHOLESTEROL LEVELS
U-336   DIAGNOSTIC RADIOIMAGING
U-337   USE OF CARDIOLITE/MIRALUMA KIT FOR THE PREPARATION OF TC99M SESTAMIBI
U-338   METHODS FOR TREATING DISTURBANCES OF MOOD, DISTURBANCES OF APPETITE, DEPRESSED
        MOOD, OR CARBOHYDRATE CRAVING ALL ASSOCIATED WITH PREMENSTRUAL SYNDROME
U-339   PREVENTION OF CARDIO-TOXICITY CAUSED BY THE ADMINISTRATION OF DOXORUBICIN
U-340   THE LONG TERM TREATMENT OF GROWTH FAILURE DUE TO LACK OF ADEQUATE ENDOGENOUS
        GROWTH HORMONE SECRETION IN CHILDREN
U-341   METHOD FOR ENHANCING THE TREATMENT OF ... LATE LUTEAL PHASE DYSPHORIC DISORDER
U-342   METHOD FOR TREATMENT OF LATE LUTEAL PHASE DYSPHORIC DISORDER
U-343   REDUCTION OF INTESTINAL GAS, CRAMPING AND ANORECTAL IRRITATION
U-344   METHOD FOR INHIBITING HIV INFECTION BY ADMINISTERING RITONAVIR IN COMBINATION WITH
        ANOTHER HIV PROTEASE INHIBITOR
U-345   RITONAVIR AND ANOTHER HIV PROTEASE INHIBITOR FOR CONCOMITANT ADMINISTRATION FOR
        THE TREATMENT OF AN HIV INFECTION
U-346   METHOD FOR INHIBITING CYTOCHROME P450 MONOOXYGENASE WITH RITONAVIR AND A METHOD
        FOR IMPROVING THE PHARMCOKINETICS OF A DRUG THAT IS MTABOLIZED BY CYTOCHROME P450
        MONOOXYGENASE BY ADMIN THE DRUG AND RITONAVIR
U-347   METHOD OF USE IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS
U-348   METHOD OF USE FOR INHIBITING HIV INFECTION
U-349   METHOD OF USE WHICH IS SUBJECT OF THE APPLICATION
U-350   PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR CONCOMITANT ADMIN WITH A REVERSE
        TRANSCRIPTASE INHIBITOR
U-351   INHIBITING PROTEASE WITH LOPINAVIR AND INHIBITING AN HIV INFECTION WITH LOPINAVIIR
U-352   INHIBITING HIV INFECTION BY ADMINISTERING RITONAVIR IN COMBINATION WITH A REVERSE
        TRANSCRIPTASE INHIBITOR
U-353   PREVENTION AND TREATMENT OF OSTEOPOROSIS
U-354   METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID WITHOUT CAUSING TREATMENT-
        LIMITING ELEVATIONS IN URIC ACID OR GLUCOSE LEVELS OR CAUSING LIVER DAMAGE, BY
        DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
U-355   METHOD OF ASSISTING PERSON TO QUIT SMOKING...TRANSDERMALLY ADMIN NICOTINE
        VIA..PATCH ADHERED TO SKIN AT DOSING RATE APPROX SAME AS ABSORBED FROM SMOKING
U-356   DELIVERING A MEDICINAL AEROSOL FORMULATION USING CFC-FREE PROPELLANT 134A.
U-357   USE OF THE DRUG PRODUCT IN PHOTODYNAMIC THERAPEUTIC PROTOCOLS FOR THE TREATMENT OF
        AGE-RELATED MACULAR DEGENERATION AND RELATED CONDITIONS INVOLVING UNWANTED
        NEOVASCULATURE IN THE EYE
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 35 of 67


                                       PATENT USE

U-358   DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, PANIC DISORDER AND SOCIAL ANXIETY
        DISORDER
U-359   METHOD OF USE OF VISICOL
U-360   METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF PATHOLOGICAL
        PSYCHOLOGICAL CONDITIONS INCLUDING MENTAL DISORDERS EMPLOYING OLANZAPINE AS PER
        THE INDICATION WHICH IS THE SUBJECT MATTER OF THIS SNDA-011
U-361   MANAGEMENT OF ANXIETY DISORDERS AND THE SHORT-TERM RELIEF OF THE SYMPTOMS OF
        ANXIETY
U-362   USE OF APPROVED FORMULATIONS TO TREAT ALL APPROVED DISEASE INDICATIONS
U-363   METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF PATHOLOGICAL
        PSYCHOLOGICAL CONDITIONS THAT RELATE TO THE USE OF A PSYCHOACTIVE SUBSTANCE
        EMPLOYING OLANZAPINE AS PER THE INDICATION THE SUBJECT MATTER OF SUPPLEMENT 011
U-364   TREATING A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO ANY NUMBER OF LISTED
        CONDITIONS INCLUDING PSYCHOSIS, EMPLOYING OLANZAPINE AS PER THE INDICATION WHICH
        IS THE SUBJECT MATTER OF THIS SNDA-011
U-365   METHOD FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THROUGH THE ADMINISTRATION OF A
        CALCIUM BLOCKING VASODILATOR IN OUR EXTENDED, CONTROLLED RELEASE FORMULATION
U-366   METHOD FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THROUGH THE ADMINISTRATION OF A
        CALCIUM BLOCKING VASODILATOR IN A DELAYED RELEASE FORMULATION
U-367   TREATMENT OF CARDIOVASCULAR DISORDERS
U-368   HEARTBURN
U-369   METHOD OF CONTROLLING AND LOWERING INTRAOCULAR PRESSURE
U-370   INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE
        COMPOSITIONS
U-371   APPROVAL FOR MARKETING ONLY UNDER A SPECIAL RESTRICTION PROGRAM APPROVED BY FDA
        CALLED "SYSTEM FOR THALIDOMIDE EDUCATION AND PRESCRIBING SAFETY" (S.T.E.P.S.)
U-372   METHOD FOR ADMINISTERING A BENEFICIAL DRUG TO THE GI TRACT OF AN ANIMAL, WHICH
        METHOD COMPRISES ADMITTING AN OSMOTIC DEVICE ORALLY INTO THE ANIMAL...
U-373   GENERAL USE CLAIM SUBMITTED FOR 12 NEXIUM PATIENTS STATING "PERTINENT TO THE
        CAPSULE FORMULATION FOR NEXIUM AND ITS INDICATIONS FOR THE TREATMENT OF GERD AND
        ERADICATION OF H.PYLORI TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE
U-374   KIT ADAPTED AND DESIGNED TO PROVIDE BOTH DATA ON THE CURRENT REPRODUCTIVE STATUS
        OF A PATIENT AND CONTRACEPTION FOR THOSE WHO ARE NOT PREGNANT, BUT RECENTLY
        ENGAGED IN UNPROTECTED SEX
U-375   METHOD OF USING RIBAVIRIN FOR TREATING A DISEASE RESPONSIVE TO RIBAVIRIN, E.G.
        HEPATITIS C
U-376   TREATMENT OF INFLUENZA
U-377   METHOD OF TREATING PT WITH CHRONIC HEPATITIS C HAVING HCV GENOTYPE 1 AND VIRAL
        LOAD GREATER THAN 2 MILLION COPIES/ML TO ERADICATE DETECTABLE HCV-RNA BY ADMIN
        COMBINATION OF RIBAVIRIN AND INTERFERON ALFA-2B FOR A LEAST 24 WEEKS
U-378   METHOD FOR TREATING INCONTINENCE
U-379   METHOD OF TREATING ONYCHROMYCOSIS
U-380   COMBINATIONS OF TAXOL (PACLITAXEL) AND CISPLATIN WHICH ARE SUITABLE FOR THE
        TREATMENT OF OVARIAN AND NON-SMALL CELL LUNG CARCINOMAS
U-381   TREATMENT OF HYPERPHOSPHATEMIA
U-382   METHOD OF STABLIZING PROSTAGLANDIN
U-383   METHOD FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION
U-384   TREATMENT OF CMV RETINITIS
U-385   TREATMENT OF PEPTIC ULCERS
U-386   TREATMENT OF PATIENTS SUFFERING FROM A LATE ASTHMATIC REACTION OR LATE PHASE
        ASTHMA
U-387   TREATMENT OF PATIENTS WITH RESPIRATORY DISORDERS
U-388   SMOKING CESSATION AID APPLIED TO THE SKIN
U-389   SMOKING CESSATION AID APPLIED TO THE SKIN ON WAKING AND REMOVED PRIOR TO SLEEP
        AFTER ABOUT 16 HOURS
U-390   METHOD OF USING THE DRUG TO TREAT NEUROIMMUNOLOGIC DISEASES (INCLUDING MULTIPLE
        SCLEROSIS)
U-391   USE OF CASODEX IN COMBINATION WITH LHRH AGONISTS FOR THE TREATMENT OF PROSTATE
        CANCER
U-392   TREATMENT OF PATIENTS FOR INFLAMMATION
U-393   MANAGEMENT OF INCONTINENCE, MGT OF HORMONE REPLACEMENT THERAPY, TREATMENT OF
        INVOLUNTARY INCONTINENCE, MGT OVERACTIVE BLADDER AND INCREASING COMPLIANCE IN SUCH
        PT
U-394   METHOD OF USE OF ALPHAGAN
U-395   METHOD OF USE OF ALPHAGAN P
U-396   METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION
U-397   METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 36 of 67


                                       PATENT USE

U-398   TREATMENT OF GENERALIZED ANXIETY DISORDER
U-399   IN-THE-EYE USE OF CHLORINE DIOXIDE CONTAINING COMPOSITIONS
U-400   USE OF RIBAVIRIN TO INCREASE TYPE 1 CYTOKINE RESPONSE AND SUPPRESS TYPE 2 CYTOKINE
        RESP0NSE TO LYMPHOCYTES, INCLUDING METHODS THAT TAKE ADVANTAGE OF SUCH MODULATION
        TO TREAT INFECTIONS AND INFESTATIONS
U-401   USE OF LOPINAVIR IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR TREATING
        HIV INFECTION AND IN COMBO WITH OTHER HIV PROTEASE INHIBITORS
U-402   TREATMENT OF ACTINIC KERATOSES
U-403   ANTI-ALLERGIC FOR VARIOUS ALLERGIC DISEASES
U-404   TREATMENT OF ALLERGIC CONJUNCTIVITIS
U-405   FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS)
U-406   METHOD OF USE OF ATOVAQUONE AND PROGUANIL
U-407   METHOD OF TREATING OTOPATHY
U-408   FOR INDUCING OVULATION IN CONJUNCTION WITH A GONADOTROPIN RELEASING FACTOR
        ANTAGONIST AND RECRUITING OOCYTES FOR IN-VITRO FERTILIZATION
U-409   METHOD OF TREATING INFLAMMATION USING DRUG SUBSTANCE
U-410   METHOD OF REDUCING AMOUNT OF RESPECTIVE ACTIVE COMPONENTS ADMINISTERED TO A
        DIABETIC PATIENT BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA
        (INCLUDING PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER
U-411   METHOD OF REDUCING THE SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A
        DIABETIC PATIENT BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA
        (WHICH INCLUDES PIOGLITAZONE) IN COMBINATION WITH AN INSULIN PREPARATION
U-412   TREATMENT OF TYPE 2 DIABETES
U-413   USE OF THE ACTIVE INGREDIENT FOR INHIBITING THE BIOSYNTHESIS OF CHOLESTEROL AND
        TREATMENT OF ATHEROSCLEROSIS
U-414   A METHOD OF TREATING GLYCOMETABOLISM DISORDERS BY ADMINISTERING AN INSULIN
        SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE
U-415   A METHOD FOR REDUCING THE AMOUNT OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC
        PATIENT BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE)
        IN COMBINATION WITH A BIGUANIDE AS SAID ACTIVE COMPONENTS
U-416   A METHOD FOR REDUCING SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC
        PATIENT BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE)
        IN COMBINATION WITH A BIGUANIDE AS SAID ACTIVE COMPONENTS
U-417   COMBINATION USE OF AD-4833 WITH A BIGUANIDE
U-418   A METHOD OF TREATING LIPID METABOLISM DISORDERS BY ADMINISTERING A CHEMICAL
        COMPOUND HAVING A PARTICULAR FORMULA (WHICH INCLUDES PIOGLITAZONE) IN COMBINATION
        WITH AN INSULIN SECRETION ENHANCER
U-419   A METHOD OF TREATING LIPID METABOLISM DISORDERS BY ADMINISTERING AN INSULIN
        SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE
U-420   METHOD OF TREATMENT OF TYPE II DIABETES
U-421   USE FOR SEDATION
U-422   METHOD OF TREATING AT LEAST ONE OF ATTENTION DEFICIT DISORDER AND ATTENTION
        DEFICIT HYPERACTIVITY DISORDER
U-423   METHOD OF TREATING AT LEAST ONE OF ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT
        HYPERACTIVITY DISORDER, OR AIDS RELATED DEMENTIA
U-424   FOR ONCE DAILY, BOLUS ADMINISTRATION TO A PATIENT IN ORDER TO ENGENDER TREATMENT
        FOR A NERVOUS DISORDER FOR SUBSTANTIALLY AN ENTIRE DAY ON A CHRONIC BASIS
U-425   METHOD OF REDUCING SIDE EFFECTS OF ACTIVE COMPONENTS ADMIN TO A DIABETIC BY ADMIN
        A CHEMICAL COMPOUND HAVING FORMULA (INCL PIOGLITAZONE) IN COMBINATION WITH AN
        INSULIN SECRETION ENHANCER
U-426   PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN
        STIMULATION
U-427   METHOD OF TREATING ALLERGIC REACTIONS IN MAMMALS
U-428   METHOD OF TREATING ALLERGY IN A MAMMAL USING THIS ACTIVE METABOLITE
U-429   METHOD OF USING DESLORATADINE TO TREAT ALLERGIC RHINITIS
U-430   METHOD OF TREATING A DIABETIC BY ADMINISTERING AN INSULIN SENSITIZER IN
        COMBINATION WITH AN INSULIN SECRETION ENHANCER, AND A DRUG PRODUCT C0MPRISING AN
        INSULIN SENSITIZER AND AN INSULIN SECRETION ENHANCER
U-431   POSTTRAUMATIC STRESS DISORDER
U-432   REDUCTION OF ATHEROSCLEROTIC EVENTS (MYOCARDIAL INFARCTION, STROKE, AND VASCULAR
        DEATH) IN PATIENTS WITH ATHEROSCLEROSIS DOCUMENTED BY RECENT STROKE, RECENT
        MYOCARDIAL INFARCTION OR ESTABLISHED PERIPHERAL ARTERIAL DISEASE
U-433   USE OF LEVOCARITINE IN PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN
        PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS
U-434   CONTROLLED SYMPTOMS OF DIARRHEA, BLOATING PRESSURE AND CRAMPS, COMMONLY REFERRED
        TO AS GAS
U-435   A TITRATION DOSING REGIMEN FOR THE TREATMENT OF PAIN USING AN INITIAL DOSE OF
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 37 of 67


                                       PATENT USE

        ABOUT 25MG
U-436   ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
U-437   METHOD OF USE EQUAL TO PROCESS OF PREPARATION
U-438   TREATMENT/PREVENTION OF NEURODEGENERATIVE DISEASE
U-439   TREATMENT OF OBESITY
U-440   METHOD FOR TRANSDERMAL ADMINISTRATION OF A DRUG THROUGH NON-SCROTAL SKIN USING A
        TRANSDERMAL DRUG DELIVERY DEVICE CONTAINING THE DRUG AND HAVING AN ADHESIVE
        SURFACE
U-441   METHOD OF TREATING MS BY ADMINISTERING COPAXONE
U-442   METHOD FOR DELIVERING A DRUG TO A PATIENT IN NEED OF THE DRUG, WHILE AVOIDING THE
        OCCURENCE OF AN ADVERSE SIDE EFFECT KNOWN OR SUSPECTED OF BEING CAUSED BY SAID
        DRUG
U-443   MANAGEMENT OF MODERATE TO SEVERE PAIN WHEN A CONTINUOUS, AROUND-THE-CLOCK
        ANALGESIC IS NEEDED FOR AN EXTENDED PERIOD OF TIME
U-444   TREATMENT OF MIGRAINE
U-445   USE AS AN ANTIMYCOTIC AGENT
U-446   TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
U-447   METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN
        THE EVENING OR AT NIGHT
U-448   METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID WITHOUT CAUSING TREATMENT-
        LIMITING ELEVATIONS IN URIC ACID OR GLUCOSE LEVELS OR CAUSING LIVER DAMAGE, BY
        DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
U-449   USE IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN FOR THE TREATMENT OF
        METASTATIC COLORECTAL CANCER WHERE THE DOSE OF LEUCOVORIN IS AT LEAST 200MG PER
        SQUARE METER
U-450   INTERMEDIATE REL NICOTINIC ACID FORMULATIONS HAVING UNIQUE URINARY METAB PROFILES
        RESULTING FROM ABSORPTION PROFILES OF NICOTINIC ACID FROM THE INTERMEDIATE
        NICOTINIC ACID FORMULATIONS,SUITABLE FOR TX HYPERLIPIDEMIA FOLLOWING QD DOSING
U-451   TREATMENT OF DEPRESSION AND GENERALIZED ANXIETY DISORDER
U-452   USE OF LANSOPRAZOLE FOR COMBATTING DISEASES CAUSED BY THE GENUS CAMPYLOBACTER
        (C.PYLORI=H.PYLORI)
U-453   TREATMENT OF PLATELET ASSOCIATED ISCHEMIC DISORDERS
U-454   METHOD OF TX A PT SUSPECTED OF HAVING HEPATITIS C BY ADMIN, IN COMBINATION, A
        CONJUGATE COMPRISING PEG 12000 & INTERFERON ALFA-2B IN AN AMT OF FROM 0.5MCG/KG TO
        2MCG/KG, ONCE WEEKLY, AND RIBAVIRIN
U-455   TREATMENT OF PULMONARY HYPERTENSION WITH UT-15
U-456   METHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES
        BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S
        DISEASE
U-457   METHOD OF TREATING A VAGINAL FUNGAL INFECTION IN A FEMALE HUMAN
U-458   METHOD OF USE OF IMAGENT
U-459   TREATMENT OF DEPRESSION AND GENERALIZED ANXIETY DISORDER
U-460   METHOD OF TREATING PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PREMENSTRUAL DISORDERS
        USING SERTRALINE
U-461   METHOD OF TREATMENT OF LATE LUTEAL PHASE DYSPHORIC DISORDER (PMDD) USING
        SERTRALINE
U-462   SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND ADULT RHEUMATOID ARTHRITIS AND TREATMENT
        OF PRIMARY DYSMENORRHEA
U-463   VENOGRAPHY
U-464   PERIPHERAL ARTERIOGRAPHY
U-465   CT IMAGING OF THE HEAD
U-466   TREATMENT OF IRRITABLE BOWEL SYNDROME
U-467   USE OF EPLERENONE IN COMBINATION WITH AN ANGIOTENSIN CONVERTING ENZYME (ACE)
        INHIBITOR FOR TREATING HYPERTENSION
U-468   METHOD OF USING FEXOFENADINE HCL IN TREATING ALLERGIC RHINITIS
U-469   TREATMENT OF GASTROESOPHAGEAL REFLEX DISEASE (GERD) AND ERADICATION OF H.PYLORI TO
        REDUCE RISK OF DUODENAL ULCER RECURRENCE
U-470   THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTION
U-471   METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
U-472   TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING METHYLPHENIDATE BI-
        MODAL RELEASE PROFILE EXTENDED-RELEASE CAPSULES
U-473   TO REDUCE PLASMA CHOLESTEROL LEVELS IN A MAMMAL
U-474   TO REDUCE PLASMA CHOLESTEROL LEVELS BY ADMIN EZETIMIBE IN COMBO WITH CHOLESTEROL
        BIOSYNTHESIS INHIB SELECTED FROM GROUP CONSISTING OF HMG COA REDUCTASE INHIBITORS
        INCL SIMVASTATIN
U-475   TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 38 of 67


                                       PATENT USE

        ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY
U-476   METHOD OF TREATING ANDROGEN RESPONSIVE/MEDIATED CONDITION IN MAMMAL BY ADMIN A
        SAFE, EFFECTIVE AMOUNT OF DUTASTERIDE OR PHARMACEUTICALLY ACCEPTABLE DERIVATIVE
        THEREOF..CONDITIONS INCLUDE BENIGN PROSTATIC HYPERTROPHY
U-477   METHOD OF INHIBITING 5 ALPHA TESTOSTERONE REDUCTASE ENZYME WITH DUTASTERIDE OR ITS
        DERIVATIVE AND TREATING ANDROGEN RESPONSIVE/MEDIATED DISEASE INCLUDING BENIGN
        PROSTATIC HYPERPLASIA
U-478   METHOD OF TREATING HEPATITIS C VIRAL INFECTION BY CONTINUOUS PARENTERAL ADMIN
        INTERFERON ALPHA 2-10 MILLION IU WEEKLY, SUBCUTANEOUSLY, INJECTION OF POLYMER-
        INTERFERON ALPHA CONJUGATE-POLYMER IS PEG-INTERFERON IS ALPHA 2B
U-479   METHOD OF USING PEG-INTRON/REBETOL COMBINATION THERAPY AND INTRON/REBETOL
        COMBINATION THERAPY
U-480   CONTRAST AGENT FOR MRI
U-481   DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING
        RETINOID-LIKE ACTIVITY
U-482   METHOD OF IN VITRO FERTILIZATION THERAPY INCLUDING MEANS FOR INDUCING
        OVULATION....
U-483   METHOD FOR THE ADMINISTRATION OF DRUGS USING THAT COMPOUND
U-484   METHOD OF TREATING A SKIN DISEASE WITH A CORTICOSTEROID-CONTAINING PHARMACEUTICAL
        COMPOSITION
U-485   METHOD AND COMPOSITION FOR REDUCING NERVE INJURY PAIN ASSOCIATED WITH SHINGLES
        (HERPES ZOSTER AND POST-HERPETIC NEURALGIA)
U-486   EXTERNAL PREPARATION FOR APPLICATION TO THE SKIN CONTAINING LIDOCAINE-DRUG
        RETAINING LAYER PLACED ON SUPPORT AND COMPRISES ADHESIVE GEL BASE 1-10% BY WEIGHT
        OF LIDOCAINE
U-487   METHOD AND COMPOSITION FOR REDUCING NERVE INJURY PAIN ASSOCIATED WITH SHINGLES
        (HERPES ZOSTER AND POST-HERPETIC NEURALGIA)
U-488   METHOD FOR REDUCING THE PAIN ASSOCIATED WITH HERPES-ZOSTER AND POST-HERPETIC
        NEURALGIA
U-489   EXPECTORANT
U-490   TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A
        DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
U-491   METHOD OF DELIVERING A DRUG TO THE LUNG
U-492   METHOD FOR THE TREATMENT OF SKIN, SUFFERING FROM A CONDITION SELECTED FROM A GROUP
        CONSISTING OF NONACNE INFLAMMATORY DERMATOSES... COMPRISING APPLYING TO AFFECTED
        AREA. A THERAPEUTICALLY EFFECTIVE AMT AZELAIC ACID
U-493   TREATMENT OF TYPE 2 DIABETES MELLITUS
U-494   TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
U-495   PERITONEAL DIALYSIS SOLUTION
U-496   METHOD FOR TREATING CHRONIC RENAL FAILURE
U-497   RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS
U-498   INTRA-ARTERIAL AND INTRAVENOUS USES OF ULTRAVIST
U-499   METHOD OF USING REBETOL CAPSULES IN COMBINATION WITH A CONJUGATE COMPRISING
        POLYETHYLENE GLYCOL(PEG) AND AN ALPHA INTERFERON, INCLUDING, FOR EXAMPLE, PEG-
        INTRON POWDER FOR INJECTION
U-500   USE AS AN ANTIHYPERTENSIVE AGENT
U-501   TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN ADULTS
U-502   PITYRIASIS VERSICOLOR
U-503   GENERATOR MUST BE USED WITH INFUSION SYSTEM SPECIFICALLY LABELED FOR USE WITH
        GENERATOR
U-504   TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS
U-505   ULTRASOUND CONTRAST AGENT
U-506   PHARM PRODUCT CONTAINER 1ST CHAMBER IS DISPOSED AQUEOUS DILUENT SOL 2ND CHAMBER
        PHARM ACTIVE AGENT COMPRISING ACETYLCHOLINE,BUFFER IN 1ST CHAM IS SUFFICIENT TO
        BUFFER PH OF MIXED SOL RESULTING MIXTURE OF AQUEOUS DILUENT SOL & PHARM ACTIVE..
U-507   ACROMEGALY IN PATIENTS W/INADEQUATE RESPONSE TO SURGERY AND/OR RADIATION THERAPY
        AND/OR MEDICAL THERAPIES, OR FOR WHOM THESE THERAPIES ARE NOT APPROPRIATE
U-508   METHOD OF RELEASING 17-BETA OESTRADIOL PRECURSOR IN A SUBSTANTIALLY ZERO ORDER
        PATTERN FOR AT LEAST THREE WEEKS
U-509   TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO
        ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY
U-510   TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA
        (STAGE IA AND IB) WHO HAVE REFRACTORY OR PERSISTENT DISEASE AFTER OTHER THERAPIES
        OR WHO HAVE NOT TOLERATED OTHER THERAPIES
U-511   USE OF QUINOLONE COMPOUNDS AGAINST ANAEROBIC PATHOGENIC BACTERIA
U-512   USE OF QUINOLONE COMPOUNDS AGAINST ATYPICAL UPPER RESPIRATORY PATHOGENIC BACTERIA
U-513   METHODS OF USE OF ANTIMICROBIAL COMPOUNDS AGAINST PATHOGENIC AMYCOPLASMA BACTERIA
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 39 of 67


                                       PATENT USE

U-514   PREVENTION OF OVULATION IN A WOMAN
U-515   TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST TWO PRIOR
        THERAPIES AND HAVE DEMONSTRATED DISEASE PROGRESSION ON THE LAST THERAPY
U-516   METHOD OF TREATING A PSYCHOTIC DISEASE
U-517   STABLE GEL FORMULATION FOR TOPICAL TREATMENT OF SKIN CONDITIONS
U-518   OBSESSIVE COMPULSIVE DISORDER
U-519   POST OPERATIVE NAUSEA AND VOMITING
U-520   PREMENOPAUSAL OSTEOPOROSIS
U-521   METHOD OF USING RIBAVIRIN IN COMBINATION WITH INTRON A (INTERFERON ALPHA-2 B
        RECOMBINANT) INJECTION TO TREAT PATIENTS WITH CHRONIC HEPATITIS C
U-522   TREATMENT OF CMV RETINITIS BY INTRAVITREAL ADMIN OF A PHOSPHOROTHIOATE
        OLIGONUCLEOTIDE CAPABLE OF HYBRIDIZING WITH CMV MRNA
U-523   METHOD OF TREATING INFECTION BY CRYPTOSPORIDIUM PARVUM IN AN IMMUNOCOMPROMISED
        MAMMAL
U-524   METHOD OF TREATING DIARRHEA
U-525   METHOD OF TREATING PARASITIC INFECTIONS
U-526   METHOD OF PROVIDING CONTROLLED RELEASE OF A TREATING AGENT USING A CONTROLLED
        RELEASE COMPOSITION
U-527   METHOD OF DELIVERING AN ACTIVE INGREDIENT USING A PROGRESSIVE HYDRATION
        BIOADHESIVE
U-528   PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
U-529   ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE
U-530   TREATMENT OF HERPES ZOSTER, TREATMENT OF GENITAL HERPES, TREATMENT OF COLD SORES,
        SUPPRESSION OF GENITAL HERPES IN IMMUNOCOPETENT AND HIV-INFECTED INDIVIDUALS,
        REDUCTION OF RISK OF HETEROSEXUAL TRANSMISSION OF GENITAL HERPES
U-531   TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION. MAY BE USED ALONE OR GIVEN
        WITH OTHER CLASSES OF ANTIHYPERTENSIVES, ESPECIALLY THIAZIDE DERIVATIVES
U-532   TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD IN PATIENTS REQUIRING MORE THAN ONE
        BRONCHO DILATOR
U-533   ERECTILE DYSFUNCTION
U-534   HUMALOG IS AN INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH
        DIABETES MELLITUS FOR THE CONTROL OF HYPERGLYCEMIA
U-535   TREATMENT OF SOCIAL ANXIETY DISORDER
U-536   CONTRAST AGENT FOR MAGNETIC RESONACE IMAGING
U-537   TREATMENT OF CONDITIONS RELATED TO HYPERALDOSTERONISM SUCH AS HYPERTENSION AND
        CARDIAC INSUFFICIENCY, WITH EPLERENONE
U-538   FIRST LINE TREATMENT OF SEVERE HYPERTENSION, IN PATIENTS WITH HYPERTENSION SEVERE
        ENOUGH THAT THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL EXCEEDS THE RISK
        OF INITIATING COMBINATION THERAPY IN THESE PATIENTS
U-539   TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE
U-540   TREATMENT OF FUNGAL INFECTIONS
U-541   METHOD OF TREATMENT OF ADULTS INFECTED WITH HIV-1
U-542   METHOD OF TREATING PATIENT WITH TYPE 2 DIABETES BY ONCE DAILY ADMINISTRATION
U-543   TREATMENT OF SCHIZOPHRENIA
U-544   TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE.
U-545   METHOD FOR THE PREVENTION AND/OR TREATMENT OF THROMBOTIC EPISODES, SUCH AS
        MYOCARDIAL INFARCTION, IN A HUMAN PATIENT AND METHOD FOR THE PREVENTION OF VENOUS
        THROMBOSIS IN A POSTOPERATIVE HUMAN PATIENT
U-546   USE OF REPAGLINIDE IN COMBINATION WITH METFORMIN TO LOWER BLOOD GLUCOSE
U-547   MAINTENANCE MONOTHERAPY FOR BIPOLAR DISORDER
U-548   A METHOD OF REDUCING FLUSH IN AN INDIVIDUAL BEING TREATED FOR A LIPIDEMIC DISORDER
        AND EFFECTIVELY TREATING THE LIPIDEMIC DISORDER
U-549   USE IN THE TREATMENT OF MEN WITH ADVANCED SYMPTOMATIC PROSTATE CANCER
U-550   TREATMENT OF BIPOLAR DISORDER AND SCHIZOPHRENIA
U-551   METHOD FOR REDUCING TOXICITY OF ALIMTA TREATED PATIENTS BY ADMINISTERING FOLIC
        ACID
U-552   TREATMENT OF HYPERTENSION AND HYPERLIPIDEMIA WITH A SINGLE COMPOSITION
U-553   MANAGEMENT OF PAIN AND DISCOMFORT ASSOCIATED WITH PERIDONTAL SCALING AND ROOT
        PLANNING PROCEDURES BY APPLICATION OF AN EUTECTIC MIXTURE OF LOCAL ANESTHETICS TO
        PERIDONTAL POCKETS
U-554   TREATING HIV INFECTION WITH INDINAVIR SULFATE IN COMBINATION WITH ANTIRETROVIRAL
        AGENTS
U-555   TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND ACUTE UNCOMPLICATED
        PYELONEPHRITIS
U-556   USE AS ADJUNCT DIAGNOSTIC FOR SERUM THYROGLOBULIN (TG) TESTING
U-557   NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                            PATENT AND EXCLUSIVITY TERMS                       ADB 40 of 67



                                         PATENT USE


U-558		   INDICATED FOR THE RELIEF OF BRONCHOSPASM IN PATIENTS 2-12 YEARS OF AGE WITH ASTHMA
	
          (REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE)

U-559		   METHOD OF DECREASING OR REDUCING PARATHYROID HORMONE LEVEL; METHOD OF MODULATING

          PARATHYROID HORMONE SECRETION;METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF

          REDUCING SERUM IONIZED CALCIUM LEVEL
	
U-560		   METHOD OF DECREASING PARATHYROID HORMONE LEVEL;METHOD OF TREATING

          HYPERPARATHYROIDISM
	
U-561		   COSOPT IS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS
	
          WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INSUFFICIENTLY RESPONSIVE
	
          TO BETA BLOCKERS
	
U-562		   TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH AIDS-RELATED KAPOSI'S
	
          SARCOMA
	
U-563		   MARINOL IS INDICATED FOR, INTER ALIA, ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN

          PATIENTS WITH AIDS
	
U-564		   TREATMENT OF HIV IN CONCOMITANT THERAPY
	
U-565		   TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS, AND CHRONIC

          URTICARIA
	
U-566		   FOR THE LONG-TERM, ONCE-DAILY, MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED

          WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS

          AND EMPHYSEMA
	
U-567		   METHOD OF TREATING INFERTILITY
	
U-568		   METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION

U-569		   METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION AND

          WHEREIN THEREAFTER AN OVULATORY INDUCING AMOUNT OF HCG IS ADMINISTERED
	
U-570		   METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION AND

          WHEREIN THE DAILY AMOUNT OF FSH IS ABOUT 5-10 IU/KG

U-571		   TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA AND BIPOLAR I MANIA
	
U-572		   INTENSIVE CARE UNIT SEDATION
	
U-573		   TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL)

U-574		   PROPHYLAXIS AND TREATMENT OF THE NASAL SYMPTOMS OF SEASONAL ALLERGIC RHINITIS AND
	
          TREATMENT OF THE NASAL SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS IN ADULTS AND
	
          PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER
	
U-575		   LOTEMAX OPTHALMIC SUSPENSION IS INDICATED FOR THE TREATMENT OF STEROID RESPONSIVE
	
          CONDITIONS OF THE PALPEBRAL BULBAR CONJUNCTIVA, CORNEA AND ANTERIOR SEGMENT OF THE

          GLOBE.
	
U-576		   ALREX OPTHALMIC SUSPENSION IS INDICATED FOR THE TEMPORARY RELIEF OF THE SIGNS AND
	
          SYMPTOMS OF SEASONAL ALLERGIC CONJUNCTIVITIS.
	
U-577		   TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH FINASTERIDE IN COMBINATION WITH
	
          DOXAZOSIN
	
U-578		   TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC

          BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF

          DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER.
	
U-579		   TREATMENT OF EPILEPSY AND/OR MIGRAINE.

U-580		   TREATMENT OF DISORDERS OF THE SEROTONERGIC SYSTEM SUCH AS DEPRESSION AND ANXIETY-
          RELATED DISORDERS
	
U-581		   METHOD OF TREATING A CONDITION CAPABLE OF TREATMENT BY INHALATION, E.G. ASTHMA,

          COMPRISING ADMINISTRATION OF A FORMULATION CLAIMED IN US PATENT NO. 6743413
	
U-582		   METHOD FOR THE TREATMENT OF A RESPIRATORY DISORDER, E.G. ASTHMA, COMPRISING

          ADMINISTERING AN EFFECTIVE AMOUNT OF AN AEROSOL COMPOSITION TO A PATIENT FROM A
	
          METERED DOSE INHALER SYSTEM AS CLAIMED IN US PATENT NO. 6253762
	
U-583		   METHOD FOR THE TREATMENT OF A RESPIRATORY DISORDER, E.G. ASTHMA, COMPRISING

          ADMINISTERING TO A PATIENT BY INHALATION, A METERED AEROSOL DOSE OF A DRUG

          FORMULATION FROM THE METERED DOSE INHALER SYSTEM CLAIMED IN US 6546928
	
U-584		   SINGLE-DOSE ADMINISTRATION BY THE EPIDURAL ROUTE, AT THE LUMBAR LEVEL, FOR THE

          TREATMENT OF PAIN FOLLOWING MAJOR SURGERY
	
U-585		   TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS
	
U-586		   AN INTERMEDIATE RELEASE NICOTINIC ACID FORMULATION SUITABLE FOR ORAL
	
          ADMINISTRATION ONCE-A-DAY AS A SINGLE DOSE FOR TREATING HYPERLIPIDEMIA WITHOUT
	
          CAUSING DRUG-INDUCED HEPATOTOXICITY OR ELEVATIONS IN URIC ACID OR GLUCOSE OR BOTH
	
U-587		   USE OF EPLERENONE IN COMBINATION WITH AN ANGIOTENSIN CONVERTING ENZYME (ACE)

          INHIBITOR (AND OPTIONALLY A DIURETIC) FOR TREATING CONGESTIVE HEART FAILURE AND

          HYPERTENSION
	
U-588		   SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER; TREATMENT OF HEARTBURN AND OTHER

          SYMPTOMS ASSOCIATED WITH GERD; SHORT-TERM TREATMENT OF EROSIVE ESOPHAGITIS;

          MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS
	
U-589		   METHOD FOR TREATMENT OF A RESPIRATORY DISORDER, E.G., BRONCHOSPASM, COMPRISING

          ADMINISTERING AN EFFECTIVE AMOUNT OF AN AEROSOL COMPOSITION TO A PATIENT FROM A
	
          METERED DOSE INHALER SYSTEM AS CLAIMED IN U.S. PATENT NO. 6131966
	
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                            PATENT AND EXCLUSIVITY TERMS                       ADB 41 of 67



                                         PATENT USE


U-590		   METHOD FOR TREATMENT OF A RESPIRATORY DISORDER,E.G.,BRONCHOSPASM,COMPRISING

          ADMINISTERING TO A PATIENT BY ORAL OR NASAL INHALATION A DRUG FORMULATION BY USING
	
          THE METERED DOSE INHALER SYSTEM AS CLAIMED IN US PATENT NO.6532955
	
U-591		   TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING A DOSAGE FORM WHICH
	
          PROVIDES ONCE-DAILY ORAL ADMINISTRATION OF A PHENIDATE DRUG
	
U-592		   TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, MIXED HYPERLIPIDEMIA AND/OR HOMOZYGOUS

          FAMILIAL HYPERCHOLESTEROLEMIA (HOFH)

U-593		   TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, MIXED HYPERLIPIDEMIA AND/OR HOMOZYGOUS

          FAMILIAL HYPERCHOLESTEROLEMIA (HOFH)

U-594		   PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
	
U-595		   35 MG ORALLY ONCE A WEEK FOR PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN;

          35 MG ORALLY ONCE A WEEK FOR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
	
U-596		   TREATMENT OF HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER IN POSTMENOPAUSAL
	
          WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTIESTROGEN THERAPY
	
U-597		   FORTEO IS INDICATED FOR THE TREATMENT OF POST MENOPAUSAL WOMEN WITH OSTEOPOROSIS
	
          WHO ARE AT HIGH RISK FOR FRACTURE
	
U-598		   PROPHYLACTIC TREATMENT OF MIGRAINE
	
U-599		   METHOD FOR TREATING ALLERGIC CONJUNCTIVITIS
	
U-600		   A METHOD OF TREATING A PATIENT IN NEED OF OPHTHALMIC ANTIMICROBIAL THERAPY WITH
	
          LEVOFLOXACIN
	
U-601		   TREATMENT OF BIPOLAR DISORDER
	
U-602		   SIGNS AND SYMPTOMS OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS IN ADULTS, AND/OR

          PAUCIARTICULAR OR POLYARTICULAR COURSE JUVENILE RHEUMATOID ARTHRITIS, ACUTE PAIN

          IN ADULTS; PRIMARY DYSMENORRHEA; AND/OR ACUTE MIGRAINE ATTACKS IN ADULTS

U-603		   METHOD OF TREATING INFECTIONS COMPRISING ORALLY ADMINISTERING AN EFFECTIVE AMOUNT
	
          OF THE FDA APPROVED ORAL SUSPENSION
	
U-604		   METHOD OF LOWERING BLOOD GLUCOSE BY ONCE DAILY ADMINISTRATION
	
U-605		   TREATMENT OF MAJOR DEPRESSIVE DISORDER(MDD);ALTHOUGH THE MEHCHANISM OF THE

          ANTIDEPRESSANT ACTION OF DULOXETINE IN HUMANS IS UNKNOWN, IT IS BELIEVED TO BE

          RELATED TO ITS POTENTIATION OF SERATONERGIC AND NORADRENERGIC ACTIVITY IN THE CNS
	
U-606		   USE OF IRINOTECAN IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN FOR THE
	
          TREATMENT OF METASTATIC COLRECTAL CANCER
	
U-607		   CANCIDAS IS INDICATED FOR EMPIRICAL THERAPY FOR PRESUMED FUNGAL INFECTIONS IN
	
          FEBRILE, NEUTROPENIC PATIENTS.

U-608		   USE OF QUINOLONE COMPOUNDS AGAINST PNEUMOCOCCAL PATHOGENIC BACTERIA
	
U-609		   USE OF QUINOLONE COMPOUNDS AGAINST QUINOLONE-RESISTANT PNEUMOCOCCAL PATHOGENIC

          BACTERIA
	
U-610		   ATROVENT HFA (IPRATROPIUM BROMIDE HFA) INHALATION AEROSOL IS INDICATED AS A

          BRONCHODILATOR FOR MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH CHRONIC
	
          OBSTRUCTIVE PULMONARY DISEASE, INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA.

U-611		   METHOD OF USING DESLORATADINE TO TREAT SEASONAL AND PERENNIAL ALLERGIC RHINITIS,

          PRURITIS, AND CHRONIC IDIOPATHIC URTICARIA IN PATIENTS 2 YEARS OF AGE AND OLDER

U-612		   TREATMENT OF SEASONAL ALLERGY SYMPTOMS WITH NASAL CONGESTION IN ADULTS AND
	
          CHILDREN 12 YEARS OF AGE AND OLDER
	
U-613		   REDUCTION OF SERUM PHOSPHATE
	
U-614		   TREATMENT OF SEXUAL DYSFUNCTION
	
U-615		   ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TOTAL-C, TRIGLYCERIDES AND

          APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED

          DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)

U-616		   MANAGEMENT OF PERSISTENT, MODERATE TO SEVERE PAIN IN PATIENTS REQUIRING

          CONTINUOUS, AROUND-THE-CLOCK ANALGESIA WITH A HIGH POTENCY OPIOID FOR AN EXTENDED

          PERIOD OF TIME GENERALLY WEEKS TO MONTHS OR LONGER
	
U-617		   TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL)

U-618		   USE OF ROSUVASTATIN CALCIUM TO REDUCE ELEVATED TOTAL-C, LDL-C, APOB, NONHDL-C OR

          TG LEVELS; TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR

          MIXED DYSLIPIDEMIA; AND TO SLOW THE PROGRESSION OF ATHEROSCLEROSIS.

U-619		   TREATMENT OF MALIGNANT NEOPLASM
	
U-620		   TREATMENT OF INSOMNIA
	
U-621		   METHOD OF TREATING CANCER
	
U-622		   TREATMENT OF VEGF MEDIATED OCULAR DISEASE.
	
U-623		   SHORT TERM TREATMENT OF ACTIVE BENIGN GASTRIC ULCER
	
U-624		   REDUCTION OF RISK OF UPPER GASTROINTESTINAL BLEEDING IN CRITICALLY ILL PATIENTS
	
U-625		   ALLERGIC RHINITIS OR NASAL POLYPS
	
U-626		   CLOLAR IS INDICATED FOR THE TREATMENT OF PEDIATRIC PATIENTS 1 TO 21 YEARS OLD WITH
	
          RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AFTER AT LEAST TWO PRIOR
	
          REGIMENS
	
U-627		   TREATMENT OF PATIENTS USING EXTENDED-RELEASE CARBAMAZEPINE
	
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 42 of 67


                                       PATENT USE

U-628   USE OF AVANDIA IN COMBINATION WITH A SULFONYLUREA, AND IN COMBINATION WITH
        METFORMIN AND A SULFONYLUREA TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2
        DIABETES MELLITUS
U-629   METHOD OF INDUCING A HYPNOTIC OR SEDATIVE EFFECT IN A HUMAN BY ADMINISTERING
        ESZOPICLONE
U-630   TREATING URINARY INCONTINENCE BY ADMINISTERING AN EXTENDED-RELEASE FORM OF
        DARIFENACIN
U-631   TREATING A DISEASE OF ALTERED MOTILITY OR TONE OF SMOOTH MUSCLE BY ADMINISTERING A
        MUSCARINIC RECEPTOR ANTAGONIZING AMOUNT OF DARIFENACIN
U-632   METHOD OF TREATMENT OF CANCER BY ADMINISTERING PARTICLES OF PACLITAXEL THAT HAVE A
        PROTEIN COATING
U-633   METHOD FOR TREATMENT OF TUMORS BY ADMINISTERING PACLITAXEL AT A DOSE IN THE RANGE
        OF ABOUT 30MG/METER SQUARE TO ABOUT 100MG/METER SQUARE IN A PHARMACEUTICALLY
        ACCEPTABLE FORMULATION THAT DOES NOT CONTAIN CREMOPHOR
U-634   METHOD FOR DELIVERY OF A BIOLOGIC (INCLUDING ANTINEOPLASTIC AGENTS) BY
        ADMINISTERING TO A PATIENT AN EFFECTIVE AMOUNT OF A BIOLOGIC AS A SOLID OR LIQUID
        WITH A POLYMERIC BIOCOMPATIBLE MATERIAL
U-635   TREATMENT OF GERD, MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND RISK
        REDUCTION OF NSAID ASSOCIATED GASTRIC ULCERS
U-636   TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS
U-637   TREATMENT OF DIABETES WITH AN AMYLIN AGONIST
U-638   TREATMENT OF DIABETES WITH AN AMYLIN AGONIST, INCLUDING WITH INSULIN
U-639   TREATMENT OF A MAMMAL HAVING A NEED OF OR REDUCED ABILITY TO PRODUCE INSULIN WITH
        AN INSULIN AND AN AMYLIN SUCH AS PRAMLINTIDE
U-640   USE OF AN AMYLIN AGONIST TO REDUCE GASTRIC MOTILITY AND TREAT POST PRANDIAL
        HYPERGYLCEMIA
U-641   USE OF AN AMYLIN AGONIST HAVING SPECIFIED BINDING ACTIVITY TO REDUCE GASTRIC
        MOTILITY, INCLUDING USE THROUGH PARENTERAL ADMINISTRATION
U-642   TREATMENT AND PREVENTION OF OSTEOPOROSIS
U-643   THE SHORT TERM TREATMENT (UP TO 10 DAYS) IN PTS HAVING GASTROESOPHAGEAL REFLUX
        DISEASE (GERD) AS AN ALTERNATIVE TO ORAL THERAPY IN PTS WHEN THERAPY WITH NEXIUM
        CAPSULES IS NOT POSSIBLE OR APPROPRIATE
U-644   TREATMENT OF SEASONAL ALLERGIC RHINITIS
U-645   TREATMENT OF ASTHMA
U-646   METHOD OF TREATING OTITIS
U-647   TREATMENT OF OSTEOPOROSIS IN POST MENOPAUSAL WOMEN AND/OR THE TREATMENT TO
        INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
U-648   THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AND/OR THE TREATMENT TO
        INCREASE BONE MASS IN MEN
U-649   A METHOD FOR TREATING A TUMOR DISEASE
U-650   TREATMENT OF ESOPHAGEAL CANDIDIASIS AND PROPHYLAXIS OF CANDIDA INFECTIONS IN HSCT
        PATIENTS
U-651   TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)
U-652   TREATMENT OF CARDIAC ARRHYTHMIA
U-653   STIMULATING INSULIN RELEASE BY ADMINISTERING EXENATIDE
U-654   LOWERING PLASMA GLUCAGON IN A SUBJECT IN NEED THEREOF, INCLUDING ONE WITH TYPE 2
        DIABETES, BY ADMINISTERING AN EXEDIN OR ANALOG, SUCH AS EXENDIN-4
U-655   TREATMENT OF MILD TO MODERATE ACTIVE CHROHN'S DISEASE INVOLVING THE ILEUM AND/OR
        THE ASCENDING COLON AND THE MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE
        CROHN'S DISEASE INVOLVING THE ILEUM AND/OR ASCENDING COLON FOR UP TO 3 MONTHS
U-656   REDUCING GASTRIC MOTILITY OR DELAYING GASTRIC EMPTYING BY ADMINISTERING AN
        EXENDIN, SUCH AS EXENDIN-4
U-657   PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
U-658   TREATMENT OF ADVANCED HORMONE-DEPENDENT BREAST CANCER
U-659   TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER (NSCLC)
        AFTER FAILURE OF AT LEAST ONE PRIOR CHEMOTHERAPY REGIMEN
U-660   TREATMENT OF HYPERTENSION AND TREATMENT OF HEART FAILURE
U-661   TREATMENT OF SEIZURE DISORDER
U-662   TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
U-663   THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS
U-664   TREATMENT OF CONDITIONS FOR WHICH AN ALDOSTERONE RECEPTOR BLOCKER IS INDICATED,
        SUCH AS HYPERTENSION, HEART FAILURE, AND POST-MYOCARDIAL INFARCTION
U-665   METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING
U-666   METHOD OF TREATING ADHD
U-667   MANAGEMENT OF INCONTINENCE; METHOD FOR TREATING INCONTINENCE
U-668   LEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT
        OF PATIENTS WITH DIABETES MELLITUS
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 43 of 67


                                       PATENT USE

U-669   INDICATION OF TYPE II DIABETES
U-670   TREATMENT OF HIV-1 INFECTION BY THE CO-ADMINISTRATION OF TIPRANAVIR AND RITONAVIR.
U-671   PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC
        KIDNEY DISEASE (CKD) STAGE 3 AND 4
U-672   TREATMENT OF INFLAMMATION OR AN INFLAMMATION-ASSOCIATED DISORDER
U-673   METHOD OF TREATMENT WITH ONCE-DAILY DOSES OF 625MG/5ML
U-674   METHOD OF TREATING INSOMNIA CHARACHTERIZED BY DIFFICULTY WITH SLEEP ONSET
U-675   PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA; RELIEF OF SYMPTOMS OF ALLERGIC
        RHINITIS
U-676   METHOD OF TREATING ATTENTION DEFICIT DISORDER USING ORAL ADMINISTRATION OF A BI-
        MODAL OR PULSATILE RELEASE COMPOSITION
U-677   A METHOD OF TREATING DISEASE AMENABLE TO TREATMENT WITH A PHENIDATE DRUG BY ONCE
        DAILY ORAL ADMINISTRATION OF AN EXTENDED RELEASE DOSAGE FORM
U-678   METHOD OF TREATING ATTENTION DEFICIT DISORDER AND/OR ATTENTION DEFICIT
        HYPERACTIVITY DISORDER
U-679   ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2
        DIABETES WHO ARE ALREADY TREATED WITH A PIOGLITAZONE AND METFORMIN
U-680   A METHOD OF TREATING DYSLIPIDEMIA AND DYSLIPOPROTEINEMIA USING A DOSAGE FORM THAT
        CAN PROVIDE AN EFFECTIVE AMOUNT OF FENOFIBRATE TO A PATIENT IN A FASTED STATE
        WHICH IS AT LEAST 90% OF THE AUC AMOUNT PROVIDED BY THE DOSAGE FORM
U-681   TREATMENT OF PRIMARY IGF-1 DEFICIENCY
U-682   NON-BENZODIAZEPINE HYPNOTIC AGENT INDICATED FOR TREATMENT OF INSOMNIA,
        CHARACTERIZED BY DIFFICULTIES WITH SLEEP ONSET AND/OR SLEEP MAINTENANCE
U-683   PREVENTION OR TREATMENT OF ISCHEMIC HEART DISEASE
U-684   TREATMENT OF UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN
        ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER
U-685   EXPECTORANT AND COUGH SUPPRESSANT
U-686   EXPECTORANT AND NASAL DECONGESTANT
U-687   REDUCING FOOD INTAKE IN A SUBJECT WITH TYPE 2 DIABETES BY ADMINISTERING AN
        EXENDIN, SUCH AS EXENDIN-4
U-688   TREATMENT OF HIV-INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS
U-689   TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WHOSE DISEASE HAS
        NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO
        CHEMOTHERAPY REGIMENS
U-690   TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
U-691   USE AS A MONOTHERAPY, IN COMBINATION WITH A SULFONYLUREA, METFORMIN OR INSULIN OR
        IN COMBINATION WITH A SULFONYLUREA PLUS METFORMIN TO IMPROVE GLYCEMIC CONTROL IN
        PATIENTS WITH TYPE 2 DIABETES MELLITUS
U-692   USE OF VALSARTAN TO REDUCE CARDIOVASCULAR MORTALITY IN CLINICALLY STABLE PATIENTS
        WITH LEFT VENTRICULAR FAILURE OR LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL
        INFARCTION
U-693   THE RECOMMENDED INITIAL DOSE OF EQUETRO IS 400MG/DAY GIVEN IN DIVIDED DOSES, TWICE
        DAILY. THE DOSE SHOULD BE ADJUSTED IN 200MG DAILY INCREMENTS TO ACHIEVE OPTIMAL
        CLINICAL RESPONSE.
U-694   LENALIDOMIDE IS AN ANALOGUE OF THALIDOMIDE. THALIDOMIDE IS A KNOWN HUMAN TERATOGEN
        THAT CAUSES SEVERE LIFE-THREATENING HUMAN BIRTH DEFECTS. IF LENALIDOMIDE IS TAKEN
        DURING PREGNANCY, IT MAY CAUSE BIRTH DEFECTS OR DEATH TO AN UNBORN BABY.
U-695   TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND T-CELL
        LYMPHOBLASTIC LYMPHOMA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED
        FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS
U-696   TREATMENT OF PATIENTS WITH T-CELL LYMPHOBLASTIC LYMPHOMA WHOSE DISEASE HAS NOT
        RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY
        REGIMENS
U-697   A METHOD OF USING RINFABATE RECOMBINANT (RHIGFBP-3) WITH MECASERMIN RECOMBINANT
        (RHIGF-1) TO PROMOTE LINEAR GROWTH IN THE TRATMENT OF PRIMARY IGF-1 DEFICIENCY
U-698   METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR
        INTRAVENOUS TREATMENT OF PATEINTS WITH EUVOLEMIC HYPONATREMIA
U-699   NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
U-700   TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
U-701   TREATMENT OF HYPERCHOLESTEROLEMIA AND/OR HYPERTRIGLYCERIDEMIA
U-702   TOPICAL AEROSOL HAIR REGROWTH TREATMENT
U-703   TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL
        TUMOR AND RENAL CELL CARCINOMA WITH SUNITINIB
U-704   METHOD OF ADMINISTERING INSULIN VIA INHALATION
U-705   TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE
U-706   TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
U-707   ALLERGIC RHINITIS
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 44 of 67


                                       PATENT USE

U-708   TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE
        EYE
U-709   METHOD OF COMBATING BACTERIA IN A PATIENT
U-710   A METHOD OF TREATING RESPIRATORY DISORDERS, E.G., ASTHMA, WHICH COMPRISES
        ADMINISTRATION BY INHALATION OF AN EFFECTIVE AMOUNT OF A PHARMACEUTICAL
        FORMULATION AS CLAIMED IN US PATENT NO. 5658549
U-711   ACUTE AND LONGER-TERM TREATMENT OF MAJOR DEPRESSIVE DISORDER
U-712   A METHOD OF USING A NICOTINIC ACID FORMULATION TO REDUCE ELEVATED TC, LDL-C AND TG
        LEVELS, AND RAISE HDL-C LEVELS IN PATIENTS WITH HYPERLIPIDEMIA
U-713   TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEIMER'S TYPE
U-714   TOPICAL TREATMENT OF INTERDIGITAL TINEA PEDIS AND TINEA CORPORIS DUE TO
        TRICHOPHYTON RUBRUM, TRICHOPHYTON MENTAGROPHYTES OR EPIDERMOPHYTON FLOCCOSUM
U-715   FOR CLEANSING THE BOWEL IN PREPARATION FOR COLONOSCOPY, IN ADULTS 18 YEARS OF AGE
        OR OLDER
U-716   THE TREATMENT OR PREVENTION OF BRONCHOSPASM IN ADULTS AND CHILDREN 4 YEARS OF AGE
        AND OLDER WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE AND THE PREVENTION OF
        EXERCISED-INDUCED BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER
U-717   METHOD OF RELIEVING OR PREVENTING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT
U-718   TREATMENT OF FUNGAL INFECTIONS
U-719   TREATENT OF PSYCHOSIS
U-720   TREATMENT OF NEUROLEPTIC DISEASES
U-721   TREATMENT OF INFLUENZA
U-722   PROPHYLAXIS OF INFLUENZA
U-723   PROPHYLACTIC TREATMENT OF MIGRAINE
U-724   METHOD OF TREATING SEIZURES
U-725   ALLERGIC RHINITIS AND URTICARIA
U-726   ALLERGIC RHINITIS
U-727   FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
U-728   METHOD FOR TREATING BACTERIAL INFECTION
U-729   TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD), RISK-REDUCTION OF NSAID-
        ASSOCIATED GASTRIC ULCER, H. PYLORI ERADICATION TO REDUCE THE RISK OF DUODENAL
        ULCER RECURRENCE
U-730   USE AS A NASAL SPRAY FOR TREATMENT OF THE SYMPTOMS OF SEASONAL ALLERGIC RHINITIS
        AND VASOMOTOR RHINITIS
U-731   USE IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF PATIENTS
        WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
U-732   ACUTE TREATMENT OF THE CUTANEOUS MANIFESTATIONS OF MODERATE TO SEVERE ERYTHEMA
        NODOSUM LEPROSUM (ENL)
U-733   MAINTENANCE THERAPY FOR PREVENTION AND SUPRESSION OF THE CUTANEOUS MANIFESTATIONS
        OF ENL RECURRENCE
U-734   FIRST LINE THERAPY FOR TYPE 2 DIABETES MELLITUS
U-735   METHOD OF TREATING CHRONIC IRON OVERLOAD
U-736   METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE
U-737   DISINFECTION OF PATIENT SKIN PRIOR TO AN INVASIVE PROCEDURE
U-738   INDICATED FOR THE LONG-TERM, TWICE-DAILY MAINTENANCE TREATMENT OF ASTHMA IN
        PATIENTS 12 YEARS OF AGE OR OLDER
U-739   METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMALIAN SUBJECT
U-740   FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
U-741   COMBINATION THERAPY WITH CISPLATIN FOR THE TREATMENT OF LATE STAGE CERVICAL CANCER
U-742   TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
U-743   ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA
U-744   TREATMENT OF HIV INFECTION IN ANTIRETROVIRAL TREATMENT-EXPERIENCED ADULT PATIENTS
U-745   TREATMENT OR PREVENTION OF EMESIS
U-746   PREVENTION OR TREATMENT OF NAUSEA OR EMESIS INDUCED BY A CANCER CHEMOTHERAPEUTIC
        AGENT
U-747   PREVENTION OR TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING
U-748   A METHOD FOR THE TREATMENT OF A PROTEIN TYROSINE KINASE-ASSOCIATED DISORDER
U-749   METHOD OF CONTRACEPTION
U-750   TREATMENT OF HIV-1 INFECTION IN ADULTS
U-751   ONCE DAILY DOSING OF BUDESONIDE VIA NEBULIZER FOR THE TREATMENT OF ASTHMA
U-752   SUNSCREEN
U-753   AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH
        TYPE 2 DIABETES
U-754   USE FOR THE LONG-TERM MAINTENANCE TREATMENT OF ASTHMA
U-755   TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 45 of 67


                                       PATENT USE

        PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
U-756   ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH
        OSTEOPOROSIS
U-757   USE AS A BILE ACID SEQUESTRANT FOR LOWERING CHOLESTEROL
U-758   TREATMENT OF SYMPTOMS OF PREMENSTRUAL DYSPHORIC DISORDER
U-759   METHOD OF USE OF ADMINISTERING LEVOTHYROXINE
U-760   PROPHYLAXIS OF INVASIVE ASPERGILLUS AND CANDIDA INFECTIONS AND TREATMENT OF
        OROPHARYNGEAL CANDIDAIASIS
U-761   TREATMENT OF SCHIZOPHRENIA INCLUDING MAINTAINING STABILITY IN PATIENTS WITH
        SCHIZOPHRENIA
U-762   TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
U-763   ADMINISTRATION OF ARIPIPRAZOLE BY INJECTION
U-764   TREATMENT OF SCHIZOPHRENIA
U-765   METHOD OF TREATING ALLERGIC CONJUNCTIVITIS
U-766   TREATMENT OF SEIZURES
U-767   MANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER
U-768   A METHOD OF REDUCING THE CAPACITY OF EXTENDED RELEASE NICOTINIC ACID TO PROVOKE A
        FLUSHING REACTION BY PRETREATING AN INDIVIDUAL WITH A FLUSH INHIBITING AGENT PRIOR
        TO THE ADMINISTRATION OF THE EXTENDED RELEASE NICOTINIC ACID
U-769   REVLIMID (LENALIDOMIDE) IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE
        TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEASET ONE PRIOR
        THERAPY
U-770   LONG-TERM TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS
U-771   METHOD FOR THE TREATMENT OF DIABETES MELLITUS, SUCH AS TYPE 1 DIABETES MELLITUS OR
        TYPE 2 DIABETES MELITUS, IN A HUMAN PATIENT
U-772   RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN CHILDREN 2 TO 11
        YEARS AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH UNCOMPLICATED SKIN
        MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN CHILDREN 6 MONTHS TO 11 YEARS
U-773   PATHOLOGICAL HYPERSECRETORY CONDITIONS
U-774   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
        PEPTIDASTE-IV INHIBITOR
U-775   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
        PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN AND/OR A SULFONYLUREA
U-776   TREATMENT OF CUTANEOUS MANIFESTATION IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA
        (CTCL) WHO HAVE PROGRESSIVE, PERSISTENT OR RECURRENT DISEASE ON OR FOLLOWING TWO
        SYSTEMIC THERAPIES.
U-777   DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILURE
U-778   REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATEINTS WITH OPEN ANGLE GLAUCOMA OR
        OCULAR HYPERTENSION
U-779   A METHOD FOR TREATMENT OF A CANCER, WHEREIN THE CANCER IS CHRONIC MYELOGENOUS
        LEUKEMIA
U-780   A METHOD FOR THE TREATMENT OF CANCER
U-781   FOR TREATMENT OF ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO ARE NAIVE TO
        PHARMACOLOGIC THERAPY
U-782   TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS WITH EVIDENCE OF VIRAL
        REPLICATION AND EITHER EVIDENCE OF PERSISTANT ELEVATIONS IN SERUM
        AMINOTRANSFERASES (ALT OR AST) OR HISTOLOGICALLY ACTIVE DISEASE
U-783   DESONATE GEL IS INDICATED FOR THE TREATMENT OF MILD TO MODERATE ATOPIC DERMATITIS
        IN PATIENTS 3 MONTHS OF AGE AND OLDER
U-784   TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME (RLS)
U-785   USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION
        IN CONTINUOUS RENAL REPLACEMENT THERAPY
U-786   PRODUCT IS APPROVED FOR THE TOPICAL TREATMENT OF TINEA PEDIS
U-787   MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND PEDIATRIC
        PATIENTS SIX YEARS OF AGE OR OLDER, INCLUDING PATIENTS REQUIRING ORAL
        CORTICOSTEROID THERAPY FOR ASTHMA
U-788   METHOD OF TREATING PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PREMENSTRUAL DISORDERS
        USING PAROXETINE
U-789   TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING
U-790   FORTEO IS INDICATED FOR THE TREATMENT OF POST MENOPAUSAL WOMEN WITH OSTEOPOROSIS
        WHO ARE AT RISK FOR FRACTURE. FORTEO CAN BE USED BY PEOPLE WHO HAVE HAD A FRACTURE
        RELATED TO OSTEOPOROSIS
U-791   GLEEVEC IS ALSO INDICATED FOR THE TREATMENT OF PATIENTS WITH KIT (CD117) POSITIVE
        UNRESECTABLE AND/OR METASTATIC MALIGNANT GASTROINTESTINAL STROMAL TUMORS (GIST)
U-792   TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS
U-793   FOR THE LONG TERM TREATMENT, TWICE DAILY (MORNING AND EVENING) MAINTENANCE
        TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 46 of 67


                                       PATENT USE

        DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA
U-794   CLOSURE OF A CLNICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS IN PREMATURE INFANTS
        WEIGHING BETWEEN 500 AND 1500G, WHO ARE NO MORE THAN 32 WEEKS GESTATIONAL AGE WHEN
        USUAL MEDICAL MANAGEMENT IS INEFFECTIVE
U-795   METHOD FOR INHIBITING NOREPINEPHRINE UPTAKE
U-796   METHOD OF TREATING DEPRESSION
U-797   METHOD OF TREATING ANXIETY
U-798   TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN BY ONCE-MONTHLY
        ORAL ADMINISTRATION OF IBANDRONATE SODIUM MONOHYDRATE EQUIVALENT TO 150MG OF
        IBANDRONIC ACID
U-799   METHOD FOR INHIBITING SEROTONIN UPTAKE
U-800   TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER WHOSE TUMORS
        OVEREXPRESS HER2 AND WHO HAVE RECEIVED PRIOR THERAPY INCLUDING ANTHRACYCLINE, A
        TAXANE AND TRASTUZUMAB
U-801   METHOD OF TREATING CANCER
U-802   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
        PEPTIDASE-IV INHIBITOR
U-803   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
        PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN
U-804   TREATMENT OF ACTINIC KERATOSES BY PHOTODYNAMIC THERAPY
U-805   TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES
U-806   INTRATHECAL TREATMENT OF LYMPHOMATOUS MENINGITIS
U-807   PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION
U-808   THE TREATMENT OF THE SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN
        PATIENTS 2 YEARS OF AGE AND OLDER
U-809   TREATMENT OF CHRONIC IDIOPATHIC URTICARIA
U-810   METHOD OF TREATMENT TO ALLEVIATE INFLAMMATION OF THE EYE
U-811   RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS AND
        TREATMENT OF THE UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA
U-812   RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS
U-813   MAINTENANCE TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE
        PULMONARY DISEASE (COPD)
U-814   TREATMENT OF SCHIZOPHRENIA
U-815   TREATS COLD SORES/FEVER BLISTERS ON THE FACE OR LIPS. SHORTENS HEALING TIME AND
        DURATION OF SYMPTOMS: TINGLING, PAIN, BURNING AND/OR ITCHING
U-816   DEPRESSION, PANIC DISORDER, PREMENSTRUAL DISORDERS AND SOCIAL ANXIETY DISORDER
U-817   NASAL ADMINISTRATION OF CYANOCOBALAMIN
U-818   TOPICAL TREATMENT OF ACNE VULGARIS
U-819   MANAGEMENT OF FIBROMYALGIA
U-820   IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE SLEEPINESS ASSOCIATED WITH
        NARCOLEPSY, OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME, AND SHIFT WORK SLEEP
        DISORDER
U-821   METHOD OF INHIBITING ENTHOTHELIN RECEPTORS BY ADMINISTERING AMBRISENTAN TO A
        PATIENT TO TREAT PULMONARY ARTERIAL HYPERTENSION.
U-822   USE IN LIPID MANAGEMENT
U-823   RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS AND FOR THE
        TREATMENT OF UNCOMPLCATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN
        CHILDREN 6 TO 11 YEARS OF AGE
U-824   METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1
U-825   USE FOR PREVENTION OF BREAST CANCER
U-826   RELIEF OF MODERATE TO SEVERE PAIN
U-827   USE FOR TREATMENT OF DIABETES, PARTICULARLY TYPE 2 DIABETES
U-828   PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD
        OF CONTRACEPTION
U-829   TREATMENT OF EXTRAVASATION RESULTING FROM IV ANTHRACYCLINE CHEMOTHERAPY
U-830   TREATMENT OF RELAPSED SMALL CELL LUNG CANCER
U-831   METHOD OF ADMINISTERING LANREOTIDE ACETATE
U-832   ZINGO IS INDICATED FOR THE USE ON INTACT SKIN TO PROVIDE LOCAL ANALGESIA PRIOR TO
        VENIPUNCTURE OR INTRAVENOUS CANNULATION.
U-833   METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE
        AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.25% BY WEIGHT OF
        ROPIVACAINE
U-834   INVIRASE IN COMBINATION WITH RITONAVIR AND OTHER ANTIRETROVIRAL AGENTS IS
        INDICATED FOR THE TREATMENT OF HIV INFECTION
U-835   RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF ATOPIC DERMATITIS IN
        PATIENTS ONE YEAR OF AGE OR OLDER
                    35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                            PATENT AND EXCLUSIVITY TERMS                       ADB 47 of 67



                                         PATENT USE


U-836		   A METHOD FOR THE TREATMENT OF LEUKEMIAS
	
U-837		   GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR
	
          COLONOSCOPY IN ADULTS
	
U-838		   METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE
	
          AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.5% BY WEIGHT OF ROPIVACAINE
	
U-839		   TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

U-840		   TREATMENT FOR TYPE 2 DIABETES MELLITUS
	
U-841		   INDICATED FOR THE LONG-TERM, MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS 12 YEARS

          OF AGE AND OLDER
	
U-842		   INDICATED FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

U-843		   METHOD FOR ADMINISTRATION OF TESTOSTERONE
	
U-844		   PREFEST IS INDICATED IN WOMEN WHO HAVE A UTERUS FOR THE TREATMENT OF MODERATE TO
	
          SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE; TREATMENT OF VULVAR AND

          VAGINAL ATROPHY; PREVENTION OF OSTEOPOROSIS

U-845		   TREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA

          PERITONITIS AND ABCESSES
	
U-846		   USE FOR DELINEATION (VISUALIZATION) DURING A VITRECTOMY SURGICAL PROCEDURE

U-847		   ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TRIGLYCERIDES AND APO B, AND

          INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA
	
          (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)

U-848		   ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA
	
U-849		   REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR

          OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO

          INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE

          TWICE DAILY
	
U-850		   PREVENTION OR TREATMENT OF NAUSEA OR EMESIS INDUCED BY A CANCER CHEMOTHERAPEUTIC
	
          AGENT
	
U-851		   TREATMENT OF TYPE 2 DIABETES MELLITUS
	
U-852		   RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS
	
U-853		   TREATMENT OR PREVENTION OF EMESIS
	
U-854		   PREVENTION OF CMV DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS TRANSPLANT

          PATIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPIENT CMV SERONEGATIVE)

U-855		   METHOD TO INDUCE NATRIURESIS, DIURESIS AND/OR VASODILATION

U-856		   SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS
	
          LUTEAL FUNCTION AS PART OF AN ASSISTED REPORDUCTIVE TECHNOLOGY (ART) TREATMENT

          PROGRAM FOR INFERTILE WOMEN
	
U-857		   INHIBITION OF TRANSPLANT REJECTION
	
U-858		   PEDIATRIC USE AGED 1-11 YEARS, GERD AND EROSIVE ESOPHAGITIS

U-859		   EROSIVE ESOPHAGITIS, HYPERSECRETORY CONDITIONS INCLUDING ZOLLINGER-ELLISON

          SYNDROME, MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND REDUCTION OF SYMPTOMS

          IN PATIENTS WITH GERD
	
U-860		   FOR THE APPROVED USES AND CONDITIONS OF USE, INCLUDING DEPRESSION
	
U-861		   RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID
	
          RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER
	
U-862		   ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, NON-HDL-C, APO B, TG, AND LP(A)

          LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, MIXED

          DYSLIPIDEMIA, AND HYPERTRIGLYCERIDEMIA

U-863		   TAKING ASPIRIN OR NON-STEROIDAL ANTI-INFLAMMATORY MEDICATIONS APPROXIMATELY 30
	
          MINUTES BEFORE DOSING CAN MINIMIZE FLUSHING, A COMMON SIDE EFFECT OF NIACIN

          THERAPY
	
U-864		   PEDIATRIC USE AGES 1-2 YEARS, GERD AND EROSIVE ESOPHAGITIS

U-865		   TREATMENT OF A WOMAN WITH OSTEOPOROSIS AND A HIGH RISK FOR BONE FRACTURE BY
	
          REDUCING THE RISK OF VERTEBRAL AND NONVERTEBRAL BONE FRACTURE
	
U-866		   THE LABEL REFERENCES THE EFFECTS OF THE ACTIVE INGREDIENT OF REVLIMID UPON
	
          CYTOKINES
	
U-867		   TREATMENT OF MIGRAINE
	
U-868		   METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR

          INTRAVENOUS TREATMENT OF PATIENTS WITH HYPERVOLEMIC HYPONATREMIA
	
U-869		   METHOD FOR STIMULATING CORONOARY VASODILATION FOR PURPOSES OF IMAGING THE HEART
	
U-870		   METHOD OF PRODUCING CORONARY VASODILATION WITHOUT PERIPHERAL VASODILATION
	
U-871		   METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH
	
U-872		   TWICE DAILY MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC
	
          OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA.

          TO REDUCE EXACERBATIONS OF COPD IN PATIENTS WITH A HISTORY OF EXACERBATIONS
	
U-873		   METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY
	
          OPENING CHLORIDE CHANNELS (CIC)

U-874		   METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME
	
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 48 of 67


                                       PATENT USE

U-875   FIRST-LINE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PANCREATIC
        CANCER, IN COMBINATION WITH GEMCITABINE
U-876   TREATMENT OF MIGRAINE WITH OR WITHOUT AURA
U-877   FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PEPTIC ULCER
U-878   A METHOD FOR BINDING A PERIPHERAL OPIOID RECEPTOR
U-879   A METHOD OF TREATING OR PREVENTING ILEUS
U-880   ENDOMETRIN IS A PROGESTERONE INDICATED TO SUPPORT EMBRYO IMPLANTATION AND EARLY
        PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED
        REPRODUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN
U-881   TREATMENT OF NON-SMALL CELL LUNG CANCER
U-882   MANAGEMENT OF FIBROMYALGIA (FM)
U-883   TREATMENT OF GASTROINTESTINAL STROMAL TUMOR WITH SUNITINIB
U-884   TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
U-885   TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST 1 PRIOR
        THERAPY
U-886   ADMINISTERING DESLORATADINE TO TREAT THE SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS,
        SEASONAL ALLERGIC RHINITIS, OR CHRONIC IDIOPATHIC URTICARIA
U-887   TREATMENT AND PREVENTION OF OSTEOPOROSIS
U-888   FEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN
U-889   MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED
        WITH MENOPAUSE)
U-890   REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE
U-891   USE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING
        PERFUSION OF THE EYE
U-892   TREATMENT OF CUTANEOUS MANIFESTATIONS IN PATIENTS WTIH CUTANEOUS T-CELL LYMPHOMA
        (CTCL)
U-893   CLEVIPREX IS A DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER INDICATED FOR THE REDUCTION
        OF BLOOD PRESSURE WHEN ORAL THERAPY IS NOT FEASIBLE OR NOT DESIRABLE
U-894   TREATMENT OF COLD SORES IN PEDIATRIC PATIENTS TWELVE YEARS OF AGE AND OLDER
U-895   TREATMENT OF HIV INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS
U-896   TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS
        AND CHILDREN TWO YEARS OF AGE AND OLDER
U-897   METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS
        PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT
U-898   USE OF GLUTAMINE TOGETHER WITH GROWTH HORMONE FOR THE TREATMENT OF PATIENTS WITH
        SHORT BOWEL SYNDROME
U-899   USE OF THALIDOMIDE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS
        WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
U-900   INTEGRASE INHIBITION FOR THE TREATMENT OF HIV INFECTION
U-901   PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
U-902   USE IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA
        (BPH)
U-903   TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN ADULT PATIENTS
U-904   TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
U-905   TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE,
        SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE
U-906   PROPHYLAXIS OF ORGAN REJECTION IN KIDNEY, LIVER AND HEART ALLOGENIC TRANSPLANTS;
        TREATMENT OF PATIENTS WITH SEVERE ACTIVE, RHEUMATOID ARTHRITIS; TREATMENT OF
        ADULT, NONIMMUNOCOMPROMISED PATIENTS WITH SEVERE, RECALCITRANT, PLAQUE PSORIASIS
U-907   FOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS IN SUBJECTS 18 YEARS OF AGE
        AND OLDER
U-908   PROPHYLAXIS OF ORGAN REJECTION IN PATIENTS RECEIVING ALLOGENEIC RENAL TRANSPLANTS
U-909   TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA
U-910   TREATMENT OF METASTATIC CARCINOMA OF THE OVARY AFTER FAILURE OF INITIAL OR
        SUBSEQUENT CHEMOTHERAPY
U-911   METHOD OF TREATING, AS ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT
        WITH EPILEPSY AGED 17 YEARS AND OLDER WHEN ORAL TREATMENT IS TEMPORARILY NOT
        FEASIBLE
U-912   SEDATION OF NON-INTUBATED PATIENTS PRIOR TO AND/OR DURING SURGICAL AND OTHER
        PROCEDURES
U-913   TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE,
        URGENCY, AND FREQUENCY
U-914   METHOD OF TREATING, AS ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT
        WITH EPILEPSY AGED 17 YEARS AND OLDER
U-915   TREATMENT OF MUSCULOSKELETAL CONDITIONS
U-916   TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OR OLDER
U-917   TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 49 of 67


                                       PATENT USE

U-918   TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-
        RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET
U-919   FOR THE TREATMENT OF DERMATITIS
U-920   STEROID-RESPONSIVE INFLAMMATORY OCULAR CONDITIONS FOR WHICH A CORTICOSTEROID IS
        INDICATED AND WHERE SUPERFICIAL BACTERIAL OCULAR INFECTION OR A RISK OF BACTERIAL
        OCULAR INFECTION EXISTS
U-921   TREATMENT OF ACNE VULGARIS
U-922   FOR THE TREATMENT OF FUNGAL INFECTIONS
U-923   METHOD OF TREATING OPHTHALMIC INFLAMMATION AND INFECTION
U-924   TREATMENT OF MILD TO MODERATE INFECTION CAUSED ABY SUSCEPTIBLE STRAINS
U-925   TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTILES) OF ROSACEA
U-926   MGT SPECIFIC BACTERIAL INFECTIONS. TREATMENT PTS W/ COMMUNITY ACQUIRED PNEUMONIA
        OR BACTERIAL SINUSITIS DUE TO CONFIRMED, OR SUSPECTED B-LACTAMASE PRODUCING
        PATHOGENS & S. PNEUMONIAE WITH REDUCED SUSCEPTIBILITY TO PENICILLIN (MIC=2MC/ML)
U-927   METHOD FOR INCREASING TEAR PRODUCTION
U-928   TREATMENT OF BACTERIAL INFECTIOUS DISEASE
U-929   TREATMENT OF OBSESSIVE COMPULSIVE DISORDER TREATABLE WITH AN SSRI
U-930   TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
U-931   RELIEF OF MODERATE TO SEVERE ACUTE PAIN
U-932   PYLERA CAPSULES, IN COMBINATION WITH OMEPRAZOLE ARE INDICATED FOR THE TREATMENT OF
        PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE TO
        ERADICATE H. PYLORI
U-933   FOR THE TREATMENT OF PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL
        ULCER DISEASE TO ERADICATE H. PYLORI. THE ERADICATION OF HELICOBACTER PYLORI HAS
        BEEN SHOWN TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE
U-934   IN COMBINATION WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) TO MOBILIZE
        HEMATOPOIETIC STEM CELL TO THE PERIPHERAL BLOOD FOR COLLECTION AND SUBSEQUENT
        AUTOLOGOUS TRANSPLANTATION WITH NON-HODGKINS LYMPHOMA AND MULTIPLE MYELOMA
U-935   TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN ADULT PATIENTS, AND
        TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN PEDIATRIC PATIENTS 6 YEARS OF
        AGE AND OLDER
U-936   USE IN COMBINATION WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) TO MOBILIZE
        HEMATOPOIETIC STEM CELLS TO PERIPHERAL BLOOD FOR COLLECTION & SUBSEQUENT
        AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA & MULTIPLE
        MYELOMA
U-937   TREATMENT OF PROSTATE CANCER
U-938   TREATMENT OF HAIR LOSS AND HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR
        GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS
U-939   TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING AND STIMULATING THEIR
        GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS
U-940   METHOD TO TREAT AIDS-RELATED KAPOSI'S SARCOMA
U-941   METHOD TO TREAT OVARIAN CANCER
U-942   METHOD TO TREAT MULTIPLE MYELOMA
U-943   GNRH ANTAGONIST INDICATED FOR TREATMENT OF PATIENTS WITH ADVANCED PROSTATE CANCER
U-944   TREATMENT OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
U-945   SEDATIVE-HYPNOTIC AGENT INDICATED FOR MONITORED ANESTHESIA CARE (MAC) SEDATION
U-946   TREATMENT OF BREAST CANCER
U-947   WHEN PATIENTS ARE UNABLE TO TAKE THE ORAL FORMULATIONS, PREVACID IV, FOR INJECTION
        IS INDICATED AS AN ALTERNATIVE FOR THE SHORT-TERM TREATMENT (UP TO 7 DAYS) OF ALL
        GRADES OF EROSIVE ESOPHAGITIS
U-948   TREATMENT OF DIABETES MELLITUS
U-949   HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 8 WEEKS
U-950   MAINTAIN HEALING OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 6 MONTHS
U-951   TREATMENT OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE
        (GERD) FOR 4 WEEKS
U-952   USE AS AN ANALGESIC
U-953   METHOD OF TREATING OPHTHALMIC INFLAMMATION AND INFECTION
U-954   CHRONIC MANAGEMENT OF HYPERURICEMIA IN PATIENTS WITH GOUT. NOT RECOMMENDED FOR THE
        TREATMENT OF ASYMPTOMATIC HYPERURICEMIA
U-955   PROPHYLACTIC TREATMENT OF MIGRAINE
U-956   TREATMENT OF PATIENTS WITH H. PYLORI INFECTION AND DUODENAL ULCER DISEASE
U-957   A METHOD OF TREATING CANCER IN A PATIENT COMPRISING ADMINISTERING IXABEPILONE OR
        PHARMACEUTICAL COMPOSITIONS COMPRISING IXABEPILONE
U-958   METHOD OF TREATING PATIENT COMPRISING MIXING FIRST AND SECOND VIALS OF PRODUCT
        COMPRISING LYOPHILIZED IXABEPILONE TO PROVIDE AN EPOTHILONE ANALOG SOLUTION,
        DILUTING SOLUTION WITH A SUITABLE DILUENT TO PREPARE INTRAVENOUS FORMULATION FOR
                 35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                         PATENT AND EXCLUSIVITY TERMS                       ADB 50 of 67


                                       PATENT USE

        PT
U-959   METHOD OF TREATING CANCER, IV ADMIN, LYOPHYLIZED IXABEPILONE DILUTED, EVERY WEEK
        OR 3 WEEKS; LYOPHILIZED IXABEPILONE WITH SOLVENT(DEHYDRATED ETHANOL) DILUTED TO
        CONCENTRATION OF 0.1MG/ML TO 0.9MG/ML
U-960   METHOD OF TREATING CANCER IN A PATIENT COMPRISING INTRAVENOUSLY ADMINISTERING TO
        THE PATIENT IXABEPILONE DILUTED IN A PARENTERAL DILUENT
U-961   METHOD OF TREATING BREAST CANCER BY ADMINISTERING IXABEPILONE; A METHOD OF
        TREATING A CANCER RESPONSIBLE TO MICROTUBULE STABILIZATION BY ADMINISTERING
        IXABEPILONE
U-962   SYMBYAX IS INDICATED FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN
        ADULTS
U-963   PROZAC AND OLANZAPINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT
        RESISTANT DEPRESSION IN ADULTS
U-964   ZYPREXA ZYDIS AND FLUOXETINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT
        RESISTANT DEPRESSION IN ADULTS
U-965   USE OF IXABEPILONE IN COMBINATION WITH CAPECITABINE IN TREATMENT OF METASTASIS
        BREAST CANCER
U-966   TREATMENT OF ASTHMA (MAINTENANCE AND PROPHYLACTIC THERAPY)
U-967   A METHOD OF REVERSING SOFT-TISSUE ANESTHESIA I.E. ANESTHESIA OF THE LIP AND
        TONGUE, AND THE ASSOCIATED FUNCTIONAL DEFICITS RESULTING FROM AN INTRAORAL
        SUBMUCOSAL INJECTION OF A LOCAL ANESTHETIC
U-968   A METHOD FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS
U-969   TREATMENT OF MIGRAINE
U-970   TOPICAL TREATMENT OF LICE INFESTATIONS
U-971   INDICATED FOR THE ACUTE TREATMENT OF ADULTS WITH SCHIZOPHRENIA
U-972   MONOTHERAPY OR AS ADJUNCTIVE THERAPY TO LITHIUM OR VALPROATE FOR THE MAINTENANCE
        TREATMENT OF BIPOLAR I DISORDER
U-973   ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2
        DIABETES MELLITUS WHO ARE ALREADY TREATED WITH PIOGLITAZONE AND METFORMIN OR WHO
        HAVE INADEQUATE GLYCEMIC CONTROL ON PIOGLITAZONE OR METFORMIN ALONE
U-974   ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2
        DIABETES WHO ARE ALREADY TREATED WITH A PIOGLITAZONE AND METFORMIN
U-975   TREATMENT OF PULMONARY HYPERTENSION
U-976   IMPROVEMENT OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES
U-977   TREATMENT OF ACUTE, UNCOMPLICATED MALARIA INFECTION DUE TO PLASMODIUM FALCIPARUM
        IN PATIENTS OF 5KG BODYWEIGHT AND ABOVE
U-978   METHOD OF TREATING HYPONATREMIA
U-979   RELIEF OF MUSCLE SPASM
U-980   NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE
        PAIN
U-981   MANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN
        ADJUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI-INFLAMMATORY,
        ANALGESIC, AND ANTIPYRETIC ACTIVITY
U-982   A METHOD OF TREATING OSTEOPOROSIS
U-983   METHOD OF TREATING OSTEOPOROSIS IN A POST-MENOPAUSAL WOMAN AT RISK FOR FRACTURE
U-984   METHOD FOR THE TREATMENT OF A WOMAN WITH OSTEOPOROSIS AND AT RISK FOR BONE
        FRACTURE
U-985   TREATMENT OF MACULAR EDEMA FOLLOWING BRANCH RETINAL VEIN OCCLUSION (BRVO) OR
        CENTRAL RETINAL VEIN OCCLUSION (CRVO)
U-986   TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR
        OVA) OF THE SCALP HAIR
U-987   TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH CHRONIC KIDNEY DISEASE
        ON DIALYSIS
U-988   TREATMENT OF RHINITIS COMPRISING THE NASAL APPLICATION OF A PHARMACEUTICAL
        FORMULATION AS CLAIMED IN US PATENT 7541350
U-989   FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM
        HYPERPHENYLALANINEMIA
U-990   TREATMENT OF PROTOZOAL INFECTION
U-991   TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISMS
U-992   REDUCTION OF THE RISK OF CARDIOVASCULAR HOSPITALIZATION
U-993   METHOD OF TREATING INFERTILITY
U-994   METHOD OF TREATMENT OF OSTEOPOROSIS WHEREIN THE OSTEOPOROSIS IS STEROID-INDUCED
U-995   METHOD FOR TREATING TYPE II DIABETES BY ADMINISTERING SAXAGLIPTIN
U-996   AN ADJUNCTIVE THERAPY TO DIET TO REDUCT ELEVATED TOTAL CHLORESTEROL (TC), LOW-
        DENSITY LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN B, TRIGLYCERIDES, AND TO INCREASE
        HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIX DYSLIPIDEMIA
U-997   TREATMENT OF MAJOR DEPRESSIVE DISORDER BY DOSING AT INTERVALS OF 24 HOURS
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 51 of 67


                                        PATENT USE

U-998    ADJUNCITVE THERAPY TO DIET TO REDUCE ELEVATED TOTAL CHOLESTEROL, LOW-DENSITY
         LIPOPROTEIN CHOLESTEROL, APOLIPOPRTEIN B, TRIGLYCERIDES AND TO INCREASE HDL-C IN
         ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA
U-999    TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS
U-1000   ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS
U-1001   METHOD FOR DELIVERING DRUG TO LUNG OF MAMMAL, COMPRISING ADMINISTERING DRUG
         PRODUCT BY INHALATION. TREATING A MAMMAL HAVING A CONDITION CAPABLE OF TREATMENT
         BY INHALATION, COMPRISING ADMINISTERING TO THE LUNG THE DRUG PRODUCT BY INHALATION
U-1002   METHOD OF TREATING INFLAMMATORY CONDITIONS
U-1003   A METHOD OF MYOCARDIAL PERFUSION IMAGING AND INCREASING CORONARY BLOOD FLOW
U-1004   TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
U-1005   METHOD OF TREATING A STAPHYLOCOCCAL INFECTION
U-1006   NEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD
         SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION
         HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
U-1007   METHOD OF TREATING GOUT FLARES
U-1008   APPLICATION OF ANTISEPTIC WITH MOISTURIZERS FOR SURGICAL AND HEALTHCARE PERSONNEL
         SKIN DISINFECTION
U-1009   METHOD FOR ADMINISTRATION OF TESTOSTERONE
U-1010   TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH HYPERPHENYLALANINEMIA DUE TO
         TETRA HYDROBIOPTERIN RESPONSIVE PHENYLKETONURIA. KUVAN SHOULD BE TAKEN ORALLY WITH
         FOOD TO INCREASE ABSORPTION
U-1011   USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA
         AND VOMITING
U-1012   METHOD FOR TREATING INSOMNIA WHILE REDUCING THE RISK OF AN ADVERSE DRUG
         INTERACTION
U-1013   METHOD OF USING RIBAVIRIN IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2B TO
         TREAT PATIENTS WITH CHRONIC HEPATITIS C
U-1014   METHOD OF USING RIBAVIRIN IN COMBINATION WITH INTERFERON ALPHA-2B(PEGYLATED AND
         NONPEGYLATED) TO TREAT PATIENTS WITH CHRONIC HEPATITIS C
U-1015   TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
U-1016   IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1
         INFECTION IN TREATMENT-EXPERIENCED ADULT PATIENTS, WHO HAVE EVIDENCE OF VIRAL
         REPLICATION AND HIV-1 STRAINS RESISTANT TO AN NNRTI AND OTHER ANTIRETROVIRAL
         AGENTS
U-1017   A METHOD OF TREATING NASAL AND NON-NASAL SYMPTOMS OF SEASONAL ALLERGIC RHINITIS
U-1018   TREATMENT OF PULMONARY HYPERTENSION BY INHALATION
U-1019   TREATMENT OF PULMONARY HYPERTENSION
U-1020   METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES
U-1021   SHORT-TERM TREATMENT (4-8 WEEKS) OF ACTIVE BENIGN GASTRIC ULCER
U-1022   FOR THE PREPARATION OF SKIN PRIOR TO SURGERY; HELPS REDUCE BACTERIA THAT CAN
         POTENTIALLY CAUSE SKIN INFECTION
U-1023   TREATMENT OF ATROPHIC VAGINITIS DUE TO MENOPAUSE
U-1024   REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR
         HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY
         CONTROLLED IOP
U-1025   TREATING FREQUENT HEARTBURN
U-1026   A METHOD OF TREATING HUMAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS.
U-1027   REDUCTION OF ELEVATED PLASMA STEROL AND/OR STANOL LEVELS IN A MAMMAL
U-1028   A METHOD OF DISTRIBUTING SODIUM OXYBATE UNDER CONTROL OF A CENTRAL PHARMACY
U-1029   METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED
         THEREOF
U-1030   IMPROVEMENT OF WALKING IN PATIENTS WITH MULTIPLE SCLEROSIS (MS)
U-1031   IMPROVE RESPIRATORY SYMPTOMS IN CYSTIC FIBROSIS IN PATIENTS WITH PSEUDOMONAS
         AERUGINOSA
U-1032   USE OF ROSUVASTATIN CALCIUM FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
         IN INDIVIDUALS WITHOUT CLINICALLY EVIDENT CORONARY HEART DISEASE BUT WITH
         INCREASED RISK FACTORS
U-1033   TOPICAL TREATMENT OF ACNE VULGARIS
U-1034   TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS
U-1035   NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE
         PAIN
U-1036   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
         PEPTIDASE-4 INHIBITOR IN COMBINATION WITH INSULIN
U-1037   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
         PEPTIDASE-IV INHIBITOR IN COMBINATION WITH A PPAR-GAMMA AGONIST
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 52 of 67


                                        PATENT USE

U-1038   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
         PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN AND A PPAR-GAMMA AGONIST
U-1039   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
         PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN
U-1040   INHIBITION OF THROMBIN IN A PATIENT
U-1041   TREATMENT OF DISORDERS RESPONSIVE TO GROWTH HORMONE
U-1042   METHOD FOR STIMULATING CORONARY VASODILATION FOR PURPOSES OF IMAGING THE HEART
U-1043   MANAGEMENT OF MODERATE TO SEVERE PAIN
U-1044   TOPICAL TREATMENT OF SCALP PSORIASIS
U-1045   MAINTENANCE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WHO
         HAVE NOT PROGRESSED ON 1ST-LINE TREATMENT WTH PLATINUM-BASED CHEMOTHERAPY
U-1046   MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WHOSE
         DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES PLATINUM-BASED CHEMOTHERAPY
U-1047   TREATMENT OF BIOPSY-CONFIRMED, PRIMARY SUPERFICIAL BASAL CELL CARCINOMA (SBCC)
U-1048   WORKS THROUGH THE INDUCTION OF INTERFERON AND OTHER CYTOKINES
U-1049   PROPHYLAXIS OF ORGAN REJECTION IN ADULT PATIENTS AT LOW-MODERATE IMMUNOLOGIC RISK
         RECEIVING A RENAL TRANSPLANT
U-1050   USE OF METAXALONE FOR TREATMENT OF MUSCULSKELETAL CONDITIONS
U-1051   TREATMENT OF OROPHARYNGEAL CANDIDIASIS
U-1052   RELIEF OF SIGNS AND SYMPTOMS OF ARTHRITIS AND RISK-REDUCTION OF NSAID-ASSOCIATED
         GASTRIC ULCER
U-1053   RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER
U-1054   ONYCHOMYCOSIS OF THE TOENAIL CAUSED BY TRICOPHYTON RUBRUM OR TRICHOPHYTON
         MENTAGROPHYTES, ONCE DAILY USE FOR 12 CONSECUTIVE WEEKS
U-1055   AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2
         DIABETES MELLITUS WHO ARE ALREADY TREATED WITH A THIAZOLIDINEDIONE (TZD) AND
         METFORMIN OR WHO HAVE INADEQUATE GLYCEMIC CONTROL ON A TZD OR METFORMIN ALONE
U-1056   TREATMENT OF PAIN USING A NASAL SPRAY OF KETOROLAC TROMETHAMINE
U-1057   TREATMENT OF INFLAMMATION AND PAIN USING A NASAL SPRAY OF KETOROLAC TROMETHAMINE
U-1058   USE OF THALIDOMIDE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS
         WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
U-1059   ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA
U-1060   ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID
         LEVELS
U-1061   ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA
U-1062   ADMINISTRATION OF APPROVED PRODUCT FOR TREATMENT OF ALZHEIMER'S DISEASE
U-1063   TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA
U-1064   TREATMENT OF BIPOLAR DISORDER AND SCHIZOPHRENIA
U-1065   METHOD OF TREATING ANDROGEN RESPONSIVE OR MEDICATED CONDITION IN A MAMMAL BY
         ADMINISTERING A SAFE & EFFECTIVE AMOUNT OF DUTASTERIDE OR A PHARMACEUTICALLY
         ACCEPTABLE SOLVATE THEREOF.. CONDITIONS INCLUDE BENIGN PROSTATIC HYPERTROPHY
U-1066   METHOD OF TREATING AN ANDROGEN RESPONSE OR MEDIATED DISEASE IN A MAMMAL BY
         ADMININSTERING AN EFFECTIVE ANDROGEN RESPONSIVE OR MEDICATED DISEASE AMOUNT OF
         DUTASTERIDE..CONDITIONS INCLUDE BENIGN PROSTATIC HYPERPLASIA
U-1067   TREATMENT OF CANCER
U-1068   TREATMENT OF ASTHMA
U-1069   A METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING AN EXCLUSIVE
         COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION
U-1070   A METHOD TO CONTROL ABUSE OF A SENSITIVE DRUG BY CONTROLLING WITH A COMPUTER
         PROCESSOR THE DISTRIBUTION OF THE SENSITIVE DRUG VIA AN EXCLUSIVITY CENTRAL
         PHARMACY THAT MAINTAINS A CENTRAL DATABASE
U-1071   METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION
U-1072   THE MANAGEMENT OF MODERATE TO SEVERE CHRONIC PAIN IN PATIENTS REQUIRING A
         CONTINUOUS, AROUND-THE-CLOCK OPIOID ANALGESIC FOR AN EXTENDED PERIOD OF TIME
U-1073   USE FOR THE TREATMENT OF ASTHMA AND COPD
U-1074   USE OF EXENATIDE MAY RESULT IN REDUCTION IN BODY WEIGHT
U-1075   USE FOR THE TREATMENT OF ASTHMA
U-1076   REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA) IN PATIENTS WITH NEUROLOGIC
         CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
U-1077   PRETREATMENT OF PATIENTS WITH VITAMIN B12 AND FOLIC ACID PRIOR TO PEMETREXED
         DISODIUM ADMINISTRATION
U-1078   TREATMENT OF ACNE
U-1079   REVLIMID (LENALIDOMIDE) IS INDICATED FOR THE TREATMENT OF PATIENTS WITH
         TRANSFUSION-DEPENDENT ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS)
U-1080   METHOD TO TREAT PULMONARY HYPERTENSION BY ADMINISTERING AMBRISENTAN TO A PATIENT
U-1081   LUMIGAN IS A PROSTAGLANDIN ANALOG INDICATED FOR THE REDUCTION OF ELEVATED
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 53 of 67


                                        PATENT USE

         INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
U-1082   USE OF A COMBINATION OF TOBRAMYCIN AND DEXAMETHASONE TO TREAT OCULAR INFLAMMATION
         WHERE AN INFECTION OR RISK OF INFECTION EXISTS
U-1083   ACUTE TREATMENT OF MIGRAINE ATTACKS, WITH OR WITHOUT AURA, AND THE TREATMENT OF
         CLUSTER HEADACHE EPISODES
U-1084   RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID
         RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER
U-1085   METHOD FOR TREATING IRRITABLE BOWEL SYNDROME AND METHOD FOR TREATING ABDOMINAL
         DISCOMFORT ASSOCIATED WITH IRRITABLE BOWEL SYNDROME
U-1086   TREATMENT OF AUTOIMMUNE DISEASE
U-1087   DETECTION OF NON-MUSCLE INVASIVE PAPILLARY CANCER OF THE BLADDER BY PHOTODYNAMIC
         CYSTOSCOPY
U-1088   RELIEF OF MUSCLE SPASM
U-1089   INHIBITION OF THROMBIN
U-1090   LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO
         USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION
U-1091   ASSESSMENT OF BRONCHIAL HYPERRESPONSIVENESS IN PATIENTS 6 YEARS OF AGE OR OLDER
         WHO DO NOT HAVE CLINICALLY APPARENT ASTHMA
U-1092   TREATMENT OF BREAST CANCER
U-1093   TREATMENT OF PSEUDOBULBAR AFFECT
U-1094   MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN
U-1095   METHOD OF TREATING OCULAR INFLAMMATION
U-1096   TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER
U-1097   ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2
         DIABETES MELLITUS WHEN TREATMENT WITH BOTH SAXAGLIPTIN AND METFORMIN IS
         APPROPRIATE
U-1098   METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF TREATING HYPERCALCEMIA
U-1099   TREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL
         NEUROPATHY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA
U-1100   REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
U-1101   METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY
U-1102   METHOD OF TREATING CATAPLEXY IN PATIENTS WITH NARCOLEPSY
U-1103   TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A
         DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
U-1104   USE OF TRAMADOL FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE CHRONIC PAIN
U-1105   TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND
         OLDER
U-1106   TREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT
U-1107   TREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT
U-1108   TREATING TYPE 2 DIABETES MELLITUS WITH EXENATIDE BY STIMULATING INSULIN RELEASE
U-1109   TREATMENT OF CUTANEOUS MANIFESTATIONS OF ERYTHEMA NODOSUM LEPROSUM (ENL) IN
         CONNECTION WITH A SPECIAL PROGRAM APPROVED BY FDA CALLED "SYSTEM FOR THALIDOMIDE
         EDUCATION AND PRESCRIBING SAFETY" (S.T.E.P.S.)
U-1110   METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN
         A COMPUTER SYSTEM FOR DISTRIBUTION
U-1111   NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE
         PAIN
U-1112   METHOD OF MR IMAGING OF A MAMMAL
U-1113   TREATMENT AND PROPHYLAXIS OF INFLUENZA
U-1114   TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING
         NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA
U-1115   TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD
         ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS
U-1116   METHOD OF ADMINISTERING COLCHICINE TO FAMILIAL MEDITERRANEAN FEVER PATIENTS
U-1117   TREATMENT OF BREAST CANCER
U-1118   USE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING
         CHRONIC BRONCHITIS AND EMPHYSEMA
U-1119   CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING
U-1120   TO REDUCE GASTROINTESTINAL SIDE EFFECTS ADMINISTER WITH A MEAL; AS STARTING DOSE
         ADMINISTER ONCE DAILY WITH EVENING MEAL
U-1121   METHOD OF TREATING TRAVELERS' DIARRHEA
U-1122   TREATMENT OF SECONDARILY INFECTED TRAUMATIC SKIN LESIONS DUE TO S. AUREUS AND S.
         PYOGENES
U-1123   TREATMENT OF ALCOHOL DEPENDENCE
U-1124   PREVENTION OF RELAPSE TO OPIOID DEPENDENCE, FOLLOWING OPIOID DETOXIFICATION
U-1125   METHOD FOR THE DETECTION OF NEUROENDOCRINE TUMORS
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 54 of 67


                                        PATENT USE

U-1126   USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC
         CASTRATION-RESISTANT PROSTATE CANCER WHO HAVE RECEIVED PRIOR CHEMOTHERAPY
         CONTAINING DOCETAXEL
U-1127   TREATMENT OF PATENT DUCTUS ARTERIOSUS
U-1128   TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION IN COMBINATION WITH
         PEGINTERFERON ALFA AND RIBAVIRIN IN ADULT PATIENTS (>=18 YEARS OF AGE) WITH
         COMPENSATED LIVER DISEASE
U-1129   TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN
U-1130   SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE
         EVENING OR A NIGHT WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN
U-1131   TREATMENT OF HYPERTRIGLYDERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN
U-1132   TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT
U-1133   SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE
         EVENING OR AT NIGHT
U-1134   TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT
U-1135   TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A) AND INCREASE OF HDL-C
U-1136   SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE
         EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF
         HDL-C
U-1137   TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C
U-1138   TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING
         OR AT NIGHT
U-1139   REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER
         DAY IN THE EVENING OR AT NIGHT
U-1140   REDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT
U-1141   REDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
U-1142   TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING
         OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN
U-1143   REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER
         DAY IN THE EVENING OR A T NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT
         SUCH AS ASPIRIN
U-1144   REDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN
U-1145   REDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH
         PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN
U-1146   REDUCTION IN TG WITH REDUCED FLUSHING BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT
U-1147   TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING
         OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C
U-1148   REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER
         DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTINO OF LDL-C, TC, TG, LP(A), AND
         INCREASE OF HDL-C
U-1149   TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN
U-1150   TRETMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, THROUGH REDUCTION IN TOTAL-C, LDL-C, TG, LP(A), AND INCREASE OF HDL-C
U-1151   TREATMENT OF HYPERTRIGLYCDERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT
         NIGHT, THROUGH REDUCTION IN TOTAL-C, LDL-C, LP(A), AND INCREASE OF HDL-C
U-1152   CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION
U-1153   IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, IS INDICATED FOR THE TREATMENT OF
         HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN ANTIRETROVIRAL TREATMENT-
         NAIVE ADULT PATIENTS, AS SET FORTH IN THE LABELING, INCLUDING I&U SECTION
U-1154   TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL
         TUMORS, RENAL CELL CARCINOMA AND ADVANCED PANCREATIC NEUROENDOCRINE TUMORS, WITH
         SUNITINIB
U-1155   USE OF THALIDOMIDE IN TREATMENT OF CUTANEOUS MANIFESTATIONS OF ERYTHEMA NODOSUM
         LEPROSUM (ENL)
U-1156   TO REDUCE BLOOD PHENYLALANINE (PHE) LEVELS IN PATINETS WITH HYPERPHENYLALANINEMIA
         (HPA)
U-1157   RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES IN ADULTS AND CHILDREN 2
         YEARS OF AGE AND OLDER AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 55 of 67


                                        PATENT USE

         (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER
U-1158   RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES AND FOR THE RELIEF OF
         SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE
         AND OLDER
U-1159   RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES, SWELLING OF THE NASAL
         PASSAGES AND SINUS CONGESTION AND PRESSURE IN ADULTS AND CHILDREN 12 YEARS OF AGE
         AND OLDER
U-1160   RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES AND FOR THE RELIEF OF
         SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE
         AND OLDER AND 12 YEARS OF AGE AND OLDER
U-1161   FOR THE TREATMENT AND PROPHYLAXIS OF GOUT FLARES & THE TREATMENT OF FAMILIAL
         MEDITERRANEAN FEVER
U-1162   TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP
U-1163   METHOD OF TREATING THROMBOSIS
U-1164   METHOD OF TREATING AN ARGATROBAN TREATABLE CONDITION
U-1165   USE FOR THE TREATMENT OF MULTIPLE MYELOMA
U-1166   A METHOD FOR TREATMENT OF GOUT FLARES DURING PROPHYLAXIS
U-1167   PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)
U-1168   THE LONG TERM, ONCE-DAILY MAINTENANCE BROCHODILATOR TREATMENT OF AIRFLOW
         OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),
         INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA
U-1169   MANAGEMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS 18 YEARS OF AGE AND OLDER WHO
         ARE RECEIVING AND TOLERANT TO OPIOID THERAPY FOR THEIR UNDERLYING PERSISTENT
         CANCER PAIN
U-1170   TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER
U-1171   REDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY
         SYNDROME
U-1172   TO REDUCE ELEVATED TOTAL-C, APO B, AND NON-HDL-C IN PATIENTS WIHT PRIMARY
         HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE IN COMBINATION WITH A STATIN
U-1173   TO REDUCE ELEVATED TOTAL-C, LDL-C, APO B AND NON-HDL-C IN PATIENTS WITH PRIMARY
         HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE ALONE OR IN COMBINATION WITH A
         STATIN OR WITH FENOFIBRATE
U-1174   ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE WATER
         FOR INJECTION, 0.9% SODIUM CHLORIDE INJECTION, OR FLOLAN STERIILE DILUENT FOR
         INJECTION PRIOR TO ADMINISTRATION
U-1175   REDUCTION OF CARDIAC TISSUE DAMAGE ASSOCIATED WITH MYOCARDIAL INFARCTION
U-1176   TREATMENT OR PREVENTION OF STROKE
U-1177   REDUCTION OF CARDIAC TISSUE DAMAGE ASSOCIATED WITH MYOCARDIAL INFARCTION
U-1178   RELIEF OF MODERATE TO SEVERE CHRONIC PAIN
U-1179   TREATMENT OF A CANCER MEDIATED BY AN ANAPLASTIC LYMPHOMA KINASE (ALK)
U-1180   TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE
         INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA) INCLUDING
         THOSE WITH RIGHT-SIDED INFECTIVE ENDOCARDITIS
U-1181   A METHOD OF TREATING OR PREVENTING OCULAR PAIN IN A PATIENT
U-1182   TREATMENT OF CYCLIC HEAVY MENSTRUAL BLEEDING
U-1183   A METHOD FOR ADMINISTERING FOLLICLE STIMULATING HORMONE (FSH) FOR OVARIAN FOLLICLE
         OR TESTICULAR STIMULATION IN THE HUMAN
U-1184   TREATMENT OF ERECTILE DYSFUNCTION AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC
         HYPERPLASIA
U-1185   TREATMENT OF OPIOID-INDUCED CONSTIPATION
U-1186   ADMINISTRATION OF AN INHALABLE POWDER COMPRISING TIOTROPIUM VIA DEVICE
U-1187   TREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING
         TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE)
U-1188   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH
         BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE
U-1189   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH
         BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH METFORMIN
U-1190   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH
         BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH INSULIN
U-1191   METHOD OF TX TYPE 2 DM IN PTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND
         SIMVASTATIN IS APPROPRIATE, IN COMBO WITH AN AGENT ACTING ON AN ATP-DEPENDENT
         CHANNEL IN BETA CELLS SUCH AS A SULFYONYLUREA(INCL GLIPIZIDE, GLIMEPIRIIDE &
         GLYBURIDE)
U-1192   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH
         BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH A
         SULFONYLUREA (SUCH AS GLIPIZIDE, GLIMEPIRIDE AND GLYBURIDE)
U-1193   METHOD OF TREATING TYPE 2 DIABETES MELITUS IN PATIENTS FOR WHOM TREATMENT WITH
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 56 of 67


                                        PATENT USE

         BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH A PPAR-GAMMA
         AGONIST (SUCH AS PIOGLITAZONE AND ROSIGLITAZONE)
U-1194   METHOD FOR TREATING INSOMNIA
U-1195   PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC
         KIDNEY DISEASE (CKD) STAGE 5, WHICH MAY RESULT IN RENAL OSTEODYSTROPHY, WHILE
         AVOIDING HYPERPHOSPHATEMIA
U-1196   RELIEF OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS AND TO
         DECREASE RISK OF DEVELOPING UPPER GASTROINTESTINAL ULCERS IN PATIENTS WHO ARE
         TAKING IBUPROFEN FOR THOSE INDICATIONS
U-1197   METHOD OF TREATMENT OF CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY
U-1198   RECTIV IS A NITRATE VASODILATOR INDICATED FOR THE TREATMENT OF MODERATE TO SEVERE
         PAIN ASSOCIATED WITH CHRONIC ANAL FISSURE
U-1199   TREATMENT AND PREVENTION OF POSTMENOPAUSAL OR GLUCOCORTICOID-INDUCED OSTEOPOROSIS
         AND TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
U-1200   REDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM
U-1201   FOR THE TREATMENT OF INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS
U-1202   METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL
         SYNDROME
U-1203   METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT
U-1204   TREATMENT OF UVEITIS
U-1205   TREATMENT OF MACULAR EDEMA
U-1206   DELIVERING AN OCULAR IMPLANT AS DESCRIBED IN THE DOSAGE AND ADMINISTRATION SECTION
         OF THE APPROVED LABELING OF OZURDEX
U-1207   INFANT USE AGED 1 MONTH TO LESS THAN ONE YEAR, GERD AND EROSIVE ESOPHAGITIS
U-1208   TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING
         LENGTH, THICKNESS AND DARKNESS
U-1209   TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN ADULT PATIENTS, AND
         TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN PEDIATRIC PATIENTS 3
         YEARS OF AGE AND OLDER
U-1210   USE OF REVLIMID (LENALIDOMIDE) WHILE PREVENTING THE EXPOSURE OF A FETUS OR OTHER
         CONTRAINDICATED INDIVIDUAL TO REVLIMID (LENALIDOMIDE)
U-1211   USE OF REVLIMID (LENALIDOMIDE) TO INHIBIT THE SECRETION OF PRO-INFLAMMATORY
         CYTOKINES, INCLUDING TUMOR NECROSIS FACTOR ALPHA
U-1212   USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF MULTIPLE MYELOMA AND
         TRANSFUSION-DEPENDENT ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS)
U-1213   TOPICAL TREATMENT OF SEBORRHEIC DERMATITIS IN IMMUNOCOMPETETENT PATIENTS 12 YEARS
         OF AGE AND OLDER
U-1214   METHOD FOR RELIEVING CONSTIPATION IN A HUMAN PATIENT THAT COMPRISES ADMINISTERING
         TO THE PATIENT A DOSAGE UNIT COMPRISING (I) 24MCG+/- 10% OF A DRUG SUBSTANCE AND
         (II) A PHARMACEUTICALLY SUITABLE EXCIPIENT
U-1215   USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF TRANSFUSION-DEPENDENT ANEMIA
         IN MYELODYSPLASTIC SYNDROMES (MDS)
U-1216   USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF MULTIPLE MYELOMA
U-1217   METHOD OF INCREASING HAIR GROWTH
U-1218   METHOD OF STIMULATING HAIR GROWTH
U-1219   METHOD OF INCREASING THE NUMBER OF HAIRS
U-1220   TREATMENT OF RENAL CELL CARCINOMA
U-1221   TO STIMULATE THE IMMUNE SYSTEM TO INDUCE T CELL PROLIFERATION
U-1222   TO INHIBIT THE PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS
U-1223   METHOD FOR TREATING TYPE 2 DIABETES USING A SUSTAINED-RELEASE COMPOSITION
         CONTAINING EXENATIDE
U-1224   REDUCTIONS IN BODY WEIGHT ARE OBSERVED WITH EXENATIDE
U-1225   ACCELERATING THE TIME TO UPPER AND LOWER GASTROINTESTINAL RECOVERY FOLLOWING
         PARTIAL LARGE OR SMALL BOWEL RESECTION SURGERY WITH PRIMARY ANASTOMOSIS
U-1226   A METHOD OF PROVIDING A PREDETERMINED CONCENTRATION OF NITRIC OXIDE TO A PATIENT
U-1227   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH
         BOTH SITAGLIPTIN AND METFORMIN HCL EXTENDED RELEASE IS APPROPRIATE
U-1228   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH
         BOTH SITAGLIPTIN AND METFORMIN HCL EXTENDED RELEASE IS APPROPRIATE ALONE OR IN
         COMBINATION WITH INSULIN
U-1229   TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS
U-1230   A METHOD OF PROVIDING NITRIC OXIDE THERAPY TO A PATIENT
U-1231   TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS
U-1232   USE AS ANTICOAGULANT IN PTS W/ UNSTABLE ANGINA UNDERGOING PTCA; W/ PROVISIONAL USE
         OF GLYCOPROTEIN IIB/IIIA INHIBITOR, AS ANTICOAGULANT IN PTS UNDERGOING PCI AND FOR
         PTS W/, OR AT RISK OF, HIT/HITTS UNDERGOING PCI.INTENTED FOR USE W/ASPIRIN
U-1233   TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION, ADMINISTERED WITH
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 57 of 67


                                        PATENT USE

         FOOD
U-1234   FOR REDUCING TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-LIPOPROTEIN B, OR TOTAL
         TRIGLYCERIDES, AND TREATING HYPERTRIGLYCERIDEMIA
U-1235   REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR
         HYPERTENSION
U-1236   USE OF THALOMID (THALIDOMIDE) FOR THE TREATMENT OF MULTIPLE MYELOMA
U-1237   COMBO W/ OTHER ANTIRETROVIRALS FOR TX OF HIV-1 IN ANTIRETROVIRAL TX-EXPERIENCED PT
         6 YEARS UP, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO
         NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND OTHER ANTIRETROVIRALS
U-1238   TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE
U-1239   MAGNETIC RESONANCE IMAGING OF THE LIVER
U-1240   TREATMENT OF HEAVY MENSTRUAL BLEEDING IN WOMEN WITHOUT ORGANIC PATHOLOGY WHO
         CHOOSE TO USE AN ORAL CONTRACEPTIVE AS THEIR METHOD OF CONTRACEPTION
U-1241   MANAGEMENT OF MODERATE TO SEVERE PAIN BY ORALLY ADMINISTERING AN INTACT
         COMPOSITION AS CLAIMED
U-1242   PREVENTION OF RESPIRATORY DISTRESS (RDS) IN PREMATURE INFANTS
U-1243   WITH DRY HANDS, GENTLY REMOVE THE SUPRENZA (PHENTERMINE HYDROCHLORIDE ODT) TABLET
         FROM THE BOTTLE. IMMEDIATELY PLACE THE SUPRENZA TABLET ON TOP OF THE TONGUE WHERE
         IT WILL DISSOLVE, THEN SWALLOW WITH OR WITHOUT WATER
U-1244   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
         PEPTIDASE-4 INHIBITOR IN COMBINATION WITH SULFONLYUREA
U-1245   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL
         PEPTIDASE-4 INHIBITOR IN COMBINATION WITH PIOGLITAZONE
U-1246   SINGLE DOSE ADMINISTRATION INTO THE SURGICAL SITE TO PRODUCE POSTSURGICAL
         ANALGESIA
U-1247   MANAGEMENT OF POSTHERPETIC NEURALGIA (PHN) IN ADULTS
U-1248   USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL MEDICATION ON THE SAME
         KNEE
U-1249   TREATMENT OF MALE PATIENT HAVING A DISEASE OR CONDITION RESPONSIVE TO A
         TERATOGENIC DRUG
U-1250   TREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL
         NEUROPATHY OR SPINAL CORD INJURY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA
U-1251   A METHOD OF CONTROLLING POSTOPERATIVE OCULAR PAIN AND BURNING/STINGING IN A
         PATIENT
U-1252   METHOD FOR CHRONIC WEIGHT MANAGEMENT BY DECREASING FOOD INTAKE
U-1253   METHOD FOR CHRONIC WEIGHT MANAGEMENT BY INDUCING SATIETY
U-1254   METHOD FOR CHRONIC WIEGHT MANAGEMENT BY CONTROLLING WEIGHT GAIN
U-1255   METHOD FOR CHRONIC WEIGHT MANAGEMENT BY TREATING OBESITY
U-1256   TREATMENT OF SEBORRHEIC DERMATITIS
U-1257   TREATMENT OF OPHTHALMIC DISORDERS
U-1258   VISUALIZATION DURING VITRECTOMY PROCEDURES
U-1259   PROPHYLAXIS OF HIV-1 INFECTION
U-1260   TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR
         THERAPIES INCLUDING BORTEZOMIB AND AN IMMUNOMODULATORY AGENT AND HAVE DEMONSTRATED
         DISEASE PROGRESSION ON OR WITHIN 60 DAYS OF COMPLETION OF THE LAST THERAPY
U-1261   REDUCTION OF THE RISK OF HOSPITALIZATION FOR ATRIAL FIBRILLATION
U-1262   USE OF QSYMIA (PHENTERMINE AND TOPIRAMATE) FOR WEIGHT MANAGEMENT, INCLUDING, BUT
         NOT LIMITED TO EFFECTING WEIGHT LOSS, TREATING OBESITY, AND/OR TREATING OVERWEIGHT
U-1263   TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) OR CHRONIC BRONCHITIS
U-1264   TREATMENT OF A RESPIRATORY DISEASE
U-1265   PATENTED METHOD OF USING REPAGLINIDE IN COMBINATION WITH METFORMIN AS INDICATED
         FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS
U-1266   METHOD OF TREATING MIDDLE-OF-THE-NIGHT INSOMNIA
U-1267   TREATMENT OF RHEUMATOID ARTHRITIS BY DELAYED RELEASE FORMULATION OF 1MG OR 2MG OF
         PREDNISONE
U-1268   TREATMENT OF PULMONARY, GASTROINTESTINAL AND/OR RHEUMATOLOGICAL DISEASES OR
         CONDITIONS BY USE OF DELAYED RELEASE FORMULATIONS OF 1MG OR 2MG PREDNISONE
U-1269   TREATMENT OF RHEUMATOLOGIC, ALLERGIC, PULMONARY, GASTROINTESTINAL, DERMATOLOGIC
         DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 5MG PREDNISONE TABLET
U-1270   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN
         COMBINATION WITH INSULIN (WITH OR WITHOUT METFORMIN AND/OR PIOGLITAZONE)
U-1271   TREATMENT OF ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE(PH-) ACUTE
         LYMPHOBLASTIC LEUKEMIA (ALL) IN SECOND OR GREATER RELAPSE OR WHOSE DISEASE HAS
         PROGRESSED FOLLOWING TWO OR MOR ANTI-LEUKEMIA THERAPIES
U-1272   TREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED
         TRANSDERMAL SYSTEM
U-1273   TREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 58 of 67


                                        PATENT USE

         SYSTEM
U-1274   TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CYSTIC FIBROSIS OR OTHER
         CONDITIONS
U-1275   TREATMENT OF CHRONIC HEPATITIS B IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE
         AND OLDER
U-1276   MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
U-1277   METHOD OF INCREASING EYELASH GROWTH INCLUDING LENGTH, THICKNESS, DARKNESS AND/OR
         NUMBER OF EYELASHES BY ADMINISTERING BIMATOPROST TO AN EYELID MARGIN
U-1278   METHOD OF TREATING IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULTS
U-1279   TREATMENT OF HIV INFECTION USING A COMPOSITION CONTAINING A PHARMACOKNIETIC
         ENHANCER THAT INHIBITS CYTOCHROME P450 MONOOXYGENASE
U-1280   USE OF A CALCIPOTRIENE CONTAINING FOAM FOR THE TREATMENT OF PSORIASIS
U-1281   THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO
         HAVE PREVIOUSLY RECEIVED DOCETAXEL
U-1282   PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING
U-1283   A METHOD OF TREATING CHRONIC MYELOGENOUS LEUKEMIA
U-1284   A METHOD OF TREATING A NEOPLASM
U-1285   TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
U-1286   A METHOD OF REDUCING THE RISK OF PULMONARY EDEMA IN PATIENTS IN NEED OF TREATMENT
         WITH INHALED NITRIC OXIDE
U-1287   METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA
U-1288   TREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET
U-1289   MANAGEMENT OF MODERATE TO SEVERE ACUTE PAIN
U-1290   TREATMENT OF LUNG CANCER
U-1291   TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN PATIENTS WHOSE APL IS
         CHARACTERIZED BY THE PRESENCE OF THE (15;17) TRANSLOCATION OR PML/RAR-ALPHA GENE
         EXPRESSION
U-1292   TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 1, 2, OR 5 MG
         PREDNISONE TABLET
U-1293   A METHOD OF LOWERING INTRAOCULAR PRESSURE IN A PATIENT WITH OPEN ANGLE GLAUCOMA OR
         OCULAR HYPERTENSION
U-1294   METHOD OF TREATING GLAUCOMA IN A PATIENT
U-1295   A METHOD OF TREATING A PATIENT WITH GLAUCOMA OR OCULAR HYPERTENSION
U-1296   USE OF PEMETREXED WITH PRIOR AND/OR REPEATED VITAMIN B12 AND FOLIC ACID
         ADMINISTRATION
U-1297   TREATMENT OF PULMONARY ARTERIAL HYPERTENSION BY INHIBITING ENDOTHELIN RECEPTORS
U-1298   ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES
U-1299   TREATMENT OF PATIENTS WITH LEUKEMIA INCLUDING CHRONIC MYELOID/MYELOGENOUS LEUKEMIA
         (CML)
U-1300   TREATMENT OF PATIENTS WITH TYROSINE KINASE INHIBITOR (TKI) RESISTANT OR INTOLERANT
         CHRONIC MYELOID/MYELOGENOUS LEUKEMIA (CML)
U-1301   TREATMENT OF DEEP VEIN THROMBOSIS (DVT)
U-1302   TREATMENT OF PULMONARY EMBOLISM (PE)
U-1303   REDUCTION IN THE RISK OF RECURRENCE OF DEEP VEIN THROMBOSIS (DVT) AND PULMONARY
         EMBOLISM
U-1304   USE OF ONCE-A-DAY AMOXICILLIN PRODUCT TO TREAT TONSILLITIS AND/OR PHARYNGITIS
         SECONDARY TO STREPTOCOCCUS PYOGENES
U-1305   TREATMENT OF HIV-1INFECTION IN ADULT PATIENTS, AND TREATMENT OF HIV-1 INFECTION IN
         PEDIATRIC PATIENTS 3 YEARS OF AGE AND OLDER, CO-ADMINISTERED WITH RITONAVIR
         (PREZISTA/RITONAVIR) AND WITH OTHER ANTIRETROVIRAL AGENTS
U-1306   TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE
         INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY
U-1307   IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1
         INFECTION IN TREATMENT-NAIVE ADULT PATIENTS WITH HIV-1 RNA LESS THAN OR EQUAL TO
         100,000 AT THE START OF THERAPY
U-1308   MULTIPLE MYELOMA
U-1309   BONE METASTASES
U-1310   FOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS
U-1311   METHOD OF TREATING CYSTIC FIBROSIS
U-1312   USE FOR THE TREATMENT OF HYPERGLYCEMIA
U-1313   AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE
         2 DIABETES MELLITUS
U-1314   USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC
         CASTRATION-RESISTANT PROSTATE CANCER
U-1315   THE LONG TERM TREATMENT OF PROPHYLACTIC MANAGEMENT OF OCULAR HYPERTENSION AND
         GLAUCOMA
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 59 of 67


                                        PATENT USE

U-1316   A DOSING REGIMEN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND HYPERLIPIDEMIA IN
         PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA USING AT LEAST THREE STEP-
         WISE INCREASING DOSES
U-1317   TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA IN
         PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
U-1318   TREATMENT OF HYPERCHOLESTEROLEMIA BY DECREASING THE AMOUNT OR ACTIVITY OF
         MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN IN PATIENTS WITH HOMOZYGOUS FAMILIAL
         HYPERCHOLESTEROLEMIA
U-1319   SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA
U-1320   TREATMENT OF ADULT PATIENTS WITH SHORT BOWEL SYNDROME WHO ARE DEPENDENT ON
         PARENTERAL SUPPORT
U-1321   TREATMENT OF PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS
U-1322   METHOD OF REDUCING OCULAR HYPERTENSION
U-1323   REDUCING THE RISK OF STROKE
U-1324   MANAGEMENT OF CYSTIC FIBROSIS PATIENTS
U-1325   INDUCTION OF REMISSION IN PATIENTS WITH ACTIVE, MILD TO MODERATE ULCERATIVE
         COLITIS
U-1326   METHOD OF INDUCING CONTRACEPTION IN A FEMALE OF REPRODUCTIVE AGE WHO HAS NOT YET
         REACHED PREMENOPAUSE
U-1327   METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING
         IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF, USING A
         FLOWABLE HYDROGEL FORMULATION
U-1328   METHOF FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA, COMPRISING
         IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF
U-1329   TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER
U-1330   METHODS OF TREATING LIPID METABOLISM AND GLYCOMETABOLISM DISORDERS COMPRISING
         ADMINISTERING AN INSULIN SENSITIVITY ENHANCER SUCH AS PIOGLITAZONE IN COMBINATION
         WITH AN INSULIN SECRETION ENHANCER
U-1331   METHODS OF REDUCING THE AMOUNT OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC
         PATIENT COMPRISING ADMINISTERING AN INSULIN SENSITIVITY ENHANCER SUCH AS
         PIOGLITAZONE IN COMBINATION WITH AN INSULIN SECRETION ENHANCER
U-1332   METHODS OF REDUCING THE SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A
         DIABETIC PATIENT COMPRISING ADMINISTERING AN INSULIN SENSITIVITY ENHANCER SUCH AS
         PIOGLITAZONE IN COMBINATION WITH AN INSULIN SECRETION ENHANCER
U-1333   METHODS OF LOWERING ELEVATED POST PRANDIAL BLOOD GLUCOSE LEVELS COMPRISING
         ADMINISTERING A DIPEPTIDYL PEPTIDASE INHIBITOR
U-1334   METHODS OF TREATING DIABETES COMPRISING ADMINISTERING AN INSULIN SENSITIVITY
         ENHANCER SUCH AS PIOGLITAZONE IN COMBINATION WITH AN INSULIN SECRETION ENHANCER
U-1335   METHODS OF MODIFYING GLUCOSE METABOLISM AND TREATING DIABETES COMPRISING
         ADMINISTERING A DIPEPTIDYL PEPTIDASE INHIBITOR AND ONE OR MORE OTHER THERAPEUTIC
         AGENTS SUCH AS METFORMIN
U-1336   METHODS OF TREATING DIABETES COMPRISING ADMINISTERING A DIPEPTIDYL PEPTIDASE
         INHIBITOR AND METFORMIN
U-1337   METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN
U-1338   METHOD OF TREATING DIABETES COMPRISING ADMINISTERING A COMPOUND SUCH AS ALOGLIPTIN
U-1339   METHODS OF TREATING DIABETES COMPRISING ADMINISTERING AN INSULIN SENSITIVITY
         ENHANCER SUCH AS PIOGLITAZONE IN COMBINATION WITH A BIGUANIDE SUCH AS METFORMIN
U-1340   METHODS OF TREATING LIPID METABOLISM DISORDERS COMPRISING ADMINISTERING AN INSULIN
         SENSITIVITY ENHANCER SUCH AS PIOGLITAZONE IN COMBINATION WITH A BIGUANIDE SUCH AS
         METFORMIN
U-1341   METHODS OF TREATING GLYCOMETABOLISM DISORDERS COMPRISING ADMINISTERING AN INSULIN
         SENSITIVITY ENHANCER SUCH AS PIOGLITAZONE IN COMBINATION WITH A BIGUANIDE SUCH AS
         METFORMIN
U-1342   METHODS OF REDUCING THE AMOUNT OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC
         PATIENT COMPRISING ADMINISTERING AN INSULIN SENSITIVITY ENHANCER SUCH AS
         PIOGLITAZONE IN COMBINATION WITH A BIGUANIDE SUCH AS METFORMIN
U-1343   METHODS OF REDUCING THE SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A
         DIABETIC PATIENT COMPRISING ADMINISTERING AN INSULIN SENSITIVITY ENHANCER SUCH AS
         PIOGLITAZONE IN COMBINATION WITH A BIGUANIDE SUCH AS METFORMIN
U-1344   METHODS OF REDUCING THE SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A
         DIABETIC PATIENT COMPRISING ADMINISTERING AN INSULIN SENSITIVITY ENHANCER SUCH AS
         PIOGLITAZONE IN COMBINATION WITH AN INSULIN PREPARATION
U-1345   USE IN RELIEVING OR PREVENTING CONSTIPATION IN A HUMAN PATIENT WITH A DOSAGE UNIT
         COMPRISING 24MICROG+/- 10% OF A DRUG SUBSTANCE AND A PHARMACEUTICALLY SUITABLE
         EXCIPIENT
U-1346   USE OF FEBUXOSTAT FOR THE MANAGEMENT OF HYPERURICEMIA IN PATIENTS SUFFERING FROM
         GOUT AND, WHEN USED WITH THEOPHYLLINE WITHOUT THE NEED FOR DOSE ADJUSTMENT OF
         THEOPHYLLINE
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 60 of 67


                                        PATENT USE

U-1347   TREATMENT OF A SKIN DISORDER
U-1348   TREATMENT OF OSTEOARTHRITIS
U-1349   TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS
U-1350   TREATMENT OF ANKYLOSING SPONDYLITIS
U-1351   TREATMENT OF ACUTE PAIN
U-1352   TREATMENT OF PRIMARY DYSMENORRHEA
U-1353   ADJUNCTIVE THERAPY TO LIPID-LOWERING MEDICATIONS AND DIET TO REDUCE LOW DENSITY
         LIPOPROTEIN-CHOLESTEROL, APOLIPOPROTEIN B, TOTAL CHOLESTEROL, AND NON-HIGH DENSITY
         LIPOPROTEIN CHOLESTEROL IN PTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
U-1354   INHIBITION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN
         HYPERSTIMULATION WITH FSH
U-1355   MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND ADOLESCENT
         PATIENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHOD FOR TREATING A
         RESPIRATORY DISEASE IN A CHILD
U-1356   TREATMENT OF NASAL SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS
         AND CHILDREN 6 YEARS OF AGE AND OLDER. TREATMENT OF NASAL SYMPTOMS ASSOCIATED W
         PERENNIAL ALLERGIC RHINITIS IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER
U-1357   TREATMENT OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN
         ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER. PATENT CLAIMS METHODS FOR
         TREATING A RESPIRATORY DISEASE IN A CHILD
U-1358   TREATMENT OF BACTERIAL INFECTIONS IN THE NASAL PASSAGE OF ADULT PATIENTS AND
         HEALTH CARE WORKERS WITH METHICILLIN RESISTANT S. AUREUS
U-1359   USE OF POMALIDOMIDE TO INHIBIT THE SECRETION OF PRO-INFLAMMATION CYTOKINES,
         INCLUDING TUMOR NECROSIS FACTOR ALPHA
U-1360   USE OF POMALIDOMIDE FOR THE TREATMENT OF MULTIPLE MYELOMA
U-1361   USE OF POMALIDOMIDE WHILE PREVENTING THE EXPOSURE OF A FETUS OR OTHER
         CONTRAINDICATED INDIVIDUAL TO POMALIDOMIDE
U-1362   TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG
         PREDNISONE TABLET
U-1363   A METHOD OF TREATING OR PREVENTING OCULAR PAIN AND BURNING/STINGING FOLLOWING
         CORNEAL SURGERY
U-1364   MAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
U-1365   PROPHYLAXIS OF ALLOGRAFT REJECTION IN ADULT PATIENTS RECEIVING A LIVER TRANSPLANT
U-1366   TREATMENT OF INFERTILITY THROUGH INDUCTION OF OVULATION AND PREGNANCY TO
         ANOVULATORY INFERTILE WOMEN
U-1367   METHOD OF ADMINISTERING FSH FOR THE TREATMENT OF INFERTILITY THROUGH INDUCTION OF
         OVULATION AND PREGNANCY IN ANOVULATORY INFERTILE WOMEN
U-1368   TREATMENT OF SOLID EXCRETORY SYSTEM TUMORS; ADVANCED RENAL CELL CARCINOMA (RCC),
         AFTER FAILURE OF TREATMENT WITH SUNITINIB OR SORAFENIB
U-1369   TREATMENT OF VAGINAL SYMPTOMS OF UROGENITAL ATROPHY BY ORALLY ADMINISTERING
         OSPEMIFENE WITH FOOD TO ENHANCE BIOAVAILABILITY OF OSPEMIFENE
U-1370   TREATMENT OF DYSPAREUNIA ASSOCIATED WITH MENOPAUSE
U-1371   REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE
         OR GLAUCOMA
U-1372   ADMINISTRATION WITHOUT FOOD FOR TREATMENT OF HIV-1 INFECTION
U-1373   METHOD OF TREATING ACETAMINOPHEN OVERDOSE WITH ACETYLCYSTEINE SOLUTIONS
U-1374   TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH+CML)
U-1375   ADASUVE IS A TYPICAL ANTIPSYCHOTIC INDICATED FOR THE ACUTE TREATMENT OF AGITATION
         ASSOCIATED WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER IN ADULTS
U-1376   TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS
U-1377   IMPROVE RESPIRATORY SYMPTOMS IN CYSTIC FIBROSIS IN PATIENTS WITH PSEUDOMONAS
         AERUGINOSA
U-1378   TREATMENT OF A NITROGEN METAOLISM DISORDER
U-1379   IMPROVEMENT OF GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE
         ONE OR MORE SPECIFIED CARDIOVASCULAR RISK FACTORS
U-1380   IMPROVEMENT OF GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE
         ONE OR MORE SPECIFIED CARDIOVASCULAR RISK FACTORS WHEREIN THE PATIENT HAS
         CARDIOVASCULAR DISEASE
U-1381   USE OF PRASUGREL AND ASPIRIN IN PATIENTS REQUIRING THE REDUCTION OF THROMBOTIC
         CARDIOVASCULAR EVENTS
U-1382   TREATMETN OF NAUSEA AND VOMITING OF PREGNANCY IN WOMEN WHO DO NOT RESPOND TO
         CONSERVATIVE MANAGEMENT
U-1383   DOSAGE ADJUSTMENT OF A NITROGEN SCAVENGING DRUG IN THE TREATMENT OF A UREA CYCLE
         DISORDER
U-1384   METHOD OF TREATING MULTIPLE SCLEROSIS
U-1385   METHOD OF TREATING AN AUTOIMMUNE DISEASE SELECTED FROM AUTOIMMUNE POLYARTHRITIS
         AND MULTIPLE SCLEROSIS BUT NOT TREATING PSORIATIC ARTHRITIS
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 61 of 67


                                        PATENT USE

U-1386   A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF A PERSON IN NEED THEREOF
U-1387   REDUCTION IN RISK OF HOSPITALIZATION IN PATIENTS WITH A HISTORY OF PAROXYSMAL OR
         PERSISTENT AF WITHOUT SEVERE HEART FAILURE AND WITH ONE OR MORE RISK FACTORS BY
         ADMINISTRATION TWICE A DAILY WITH MORNING AND EVENING MEALS
U-1388   TREATMENT OF PATIENTS WITH A HISTORY OF PAROXYSMAL OR PERSISTENT AF WITHOUT SEVERE
         HEART FAILURE AND WITH ONE OR MORE RISK FACTORS BY ADMINISTRATION TWICE A DAY WITH
         MORNING AND EVENING MEALS
U-1389   ELLA IS AN PROGESTERONE AGONIST/ANTAGONIST EMERGENCY CONTRACEPTION INDICATED FOR
         THE PREVENTION OF PREGNANCY FOLLOWING UNPROTECTED INTERCOURSE OR A KNOWN OR
         SUSPECTED CONTRACEPTIVE FAILURE. ELLA CAN BE TAKEN WITH OR WITHOUT FOOD
U-1390   A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN
         NEED THEREOF
U-1391   METHOD FOR TREATING OPIOID-INDUCED CONSTIPATION
U-1392   METHOD OF RELIEVING OR PREVENTING CONSTIPATION IN A HUMAN PATIENT WITH OPIOID-
         INDUCED CONSTIPATION
U-1393   METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED
         CONSTIPATION
U-1394   METHOD FOR RELIEVING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED CONSTIPATION
         THAT COMPRISES ADMINISTERING TO THE PATIENT A DOSAGE UNIT COMPRISING(I)24MICROG+/-
         10% OF A DRUG SUBSTANCE AND (II) A PHARMACEUTICALLY SUITABLE EXCIPIENT
U-1395   USE IN RELIEVING OR PREVENTING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED
         CONSTIPATION WITH A DOSAGE UNIT COMPRISING 24MICROG +/- 10% OF A DRUG SUBSTANCE
         AND A PHARMACEUTICALLY SUITABLE EXCIPIENT
U-1396   TREATMENT OF ADVANCED HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE BREAST CANCER IN
         COMBINATION WITH EXEMESTANE AFTER FAILURE OF TREATMENT WITH LETROZOLE OR
         ANASTROZOLE
U-1397   USE AS AN ANTISEPTIC FOR THE PREPARATION OF A PATIENT'S SKIN PRIOR TO SURGERY
U-1398   METHOD OF TREATING CHRONIC HEPATITIS C
U-1399   MANAGEMENT OF NEPHROPATHIC CYSTINOSIS BY ADMINISTERING A TOTAL DAILY DOSE IN TWO
         DIVIDED DOSES
U-1400   FOR THE TREATMENT OF PRIMARY HYPERLIPIDEMIA, MIXED HYPERLIPIDEMIA OR HOMOZYGOUS
         FAMILIAL HYPERCHOLESTEROLEMIA
U-1401   INDICATED FOR LONG-TERM, ONCE-DAILY MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION
         IN PTS WITH COPD, INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA, ALSO TO REDUCE
         EXACERBATIONS OF COPD IN PTS WITH A HISTORY OF EXACERBATIONS
U-1402   FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
         AND/OR INDOLENT B-CELL NON-HODGKIN LYMPHOMA (NHL)
U-1403   FIRST-LINE TREATMENT OF METASTATIC NON SMAL-CELL LUNG CANCER (NSCLC) WITH EGFR
         EXON 19 DELETIONS OR EXON 21 (L858R) SUBSTITUTION MUTATIONS AS DETECTED BY AN FDA-
         APPROVED TEST
U-1404   METHOD FOR TREATING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED CONSTIPATION BY
         OPENING CIC CHANNELS
U-1405   THERAPEUTIC TREATMENT OF BONE METASTASES
U-1406   TREATMENT OF MELANOMA
U-1407   TREATMENT OF NEWLY DIAGNOSED PHILADELPIA CHROMOSOME POSITIVE CHRONIC MYELOID
         LEUKEMIA (PH + CML)
U-1408   TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
U-1409   TREATMENT OF HIV-1 BY ONCE DAILY ADMINISTRATION
U-1410   TREATMENT OF CORTICOSTEROID-RESPONSIVE DERMATOSES
U-1411   THIS DRUG IS ADMINISTERED BY SUBLINGUAL ROUTE TO HUMANS FOR MAINTENANCE TREATMENT
         OF OPIOID DEPENDENCE
U-1412   TREATMENT OF ATOPIC DERMATITIS
U-1413   ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH FLOLAN STERILE
         DILUENT FOR INJECTION PRIOR TO INFUSION
U-1414   USE OF REVLIMID (LENALIDOMIDE) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL)
U-1415   TREATMING A PATIENT HAVING A CONDITION SUSCEPTIBLE TO TREATMENT WITH
         METHYLPHENIDATE, SUCH AS ADHD, BY ADMINISTERING THE FORMULATION RECITED IN CLAIMS
         1 OR 2
U-1416   USE OF FENOFIBRATE FOR REDUCING ELEVATED TOTAL CHOLESTEROL (TOTAL-C), LDL-C, APO-
         LIPOPROTEIN B, OR TOTAL TRIGLYCERIDES
U-1417   USE FOR TREATMENT OF HELICOBACTER INFECTIONS
U-1418   TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH BRAFV600E
         MUTATION AS DETECTED BY AN FDA APPROVED TEST
U-1419   TREATMENT OF ACUTE CYANIDE POISONING THAT IS JUDGED TO BE LIFE THREATENING
U-1420   METHOD OF ONCE A DAY ADMINISTRATION
U-1421   SUBLINGUAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE
U-1422   METHOD OF TREATING PATIENTS NEEDING AN IRON SUPPLEMENT
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 62 of 67


                                        PATENT USE

U-1423   AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET)
         IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT
         PATIENTS WITH COGNITIVE IMPAIRMENT
U-1424    LONG-TERM, ONCE DAILY MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PTS WITH
         COPD, INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA, ALSOTO REDUCE EXACERBATIONS
         OF COPD IN PATIENTS WITH A HISTORY OF EXACERBATIONS
U-1425   SUBLINGUAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING BUPRENORPHINE
         AND NALOXONE
U-1426   USE FOR TREATMENT OF DIAPER DERMATITIS COMPLICATED BY CANDIDIASIS
U-1427   ALKYLATING DRUG INDICATED FOR THE TOPICAL TREATMENT OF STAGE IA AND IB MYCOSIS
         FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO HAVE RECEIVED PRIOR SKIN
         DIRECTED THERAPY
U-1428   TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA
U-1429   TREATMENT OF PATIENTS WITH BREAST CANCER WHOSE TUMORS OVEREXPRESS THE HER2
         RECEPTOR
U-1430   TREATMENT OF ALLERGIC RHINITIS, INCLUDING SEASONAL AND PERENNIAL ALLERGIC RHINITIS
U-1431   METHOD OF TREATING HYPERGLYCEMIA TO IMPROVE GLYCEMIC CONTROL IN A PATIENT BY ORAL
         ADMIN OF ONCE A DAY OSMOTIC DOSAGE FORM OF GLIPIZIDE WITH POLYETHYLENE OXIDE,
         HYDROXYPROPYLMETHYLCELLULOSE, CELLULOSE ACETATE, AND SODIUM CHLORIDE
U-1432   METHOD OF TREATMENT OF IRON-RELATED CONDITIONS WITH AT LEAST 0.6 GRAMS OF
         ELEMENTAL IRON VIA AN IRON CARBOHYDRATE COMPLEX
U-1433   IMPROVEMENTS OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES WHO HAVE ONE
         OR MORE SPECIFIED CARDIOVASCULAR RISK FACTORS
U-1434   TREATMENT OF PANCREATIC CANCER
U-1435   COMBINATION USE OF TOPICAL DICLOFENAC ON THE KNEE AN DADMINISTRATION OF AN ORAL
         NSAID.
U-1436   USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL AGENT SELECTED FROM
         SUNSCREEN AND INSECT REPELLANT
U-1437   ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE DILUENT
         FOR FLOLAN OR STERILE DILUENT FOR EPOPROSTENOL SODIUM PRIOR TO ADMINISTRATION
U-1438   ZINGO INTRADERMAL INJECTION SYSTEM IS A DRUG DELIVERY SYSTEM THAT IS CAPABLE OF
         DELIVERING FINE DRY POWDERED LIDOCAINE HYDROCHLORIDE MONOHYDRATE FOR LOCAL
         ANESTHETIC ACTION
U-1439   METHOD OF TREATING AN AFFECTIVE DISORDER SUCH AS DEPRESSION
U-1440   USE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS
U-1441   A METHOD OF TREATING OR REDUCING OCULAR PAIN AND BURNING/STINGING
U-1442   SUBCUTANEOUS INJECTION OF METHOTREXATE
U-1443   ACCELERATING THE TIME TO UPPER AND LOWER GASTROINTESTINAL RECOVERY FOLLOWING
         SURGERIES THAT INCLUDE PARTIAL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS
U-1444   A DOSING REGIMEN OF AGGRASTAT (TIROFIBAN HYDROCHLORIDE)(25MCG/KG FOLLOWED BY
         0.15MCG/KG/MIN) TO REDUCE THE RATE OF THROMBOTIC CORONARY EVENTS ASSOCIATED WITH
         ACUTE CORONARY SYNDROME (ACS) IN PATIENTS WITH NON-ST ELEVATION ACS
U-1445   METHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION BY ADMINISTERING A
         PHARMACEUTICAL COMPOSITION COMPRISING MACITENTAN AND A POLYSORBATE, WHERIN THE
         POLYSORBATE REPRESENTS 0.1 TO 1% OF THE WEIGHT OF SAID PHARMACEUTICAL COMPOSITION
U-1446   METHOD OF TREATING PULMONARY HYPERTENSION COMPRISING ADMINISTERING MACITENTAN IN
         COMBINATION WITH A COMPOUND HAVING PHOSPHODIESTERASE-5 INHIBITORY PROPERTIES
U-1447   TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
U-1448   TREATING SEVERE HYPERTRIGLYCERIDEMIA
U-1449   METHOD OF ALLEVIATING A SKIN CONDITION
U-1450   TREATMENT OF ALLERGIC RHINITIS SYMPTOMS
U-1451   APPROVED INDICATIONS: APTIOM (ESLICARBAZEPINE ACETATE) IS INDICATED AS ADJUNCTIVE
         TREATMENT OF PARTIAL-ONSET SEIZURES AND APPROVED IN PATIENTS WITH EPILEPSY.
         PATENT CLAIMS: IN A METHOD OF TREATING A SUBJECT AFFLICTED WITH EPILEPSY
U-1452   METHOD FOR CHRONIC WEIGHT MANAGEMENT
U-1453   A METHOD OF TREATING HYPOXIC RESPIRATORY FAILURE BY VERIFYING GAS INFORMATION OF
         NITRIC OXIDE PRIOR TO DELIVERY TO PATIENT
U-1454   PROPHYLAXIS OF INVASIVE ASPERGILLUS AND CANDIDA INFECTIONS
U-1455   TREATMENT OF PERIANAL WARTS
U-1456   TREATMENT OF MANTLE CELL LYMPHOMA
U-1457   A METHOD OF PURGING A NITRIC OXIDE DELIVERY SYSTEM
U-1458   A METHOD OF REDUCING INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR
         OCULAR HYPERTENSION
U-1459   TREATMENT OF CARCINOMA OF THE THYROID
U-1460   TREATMENT OF HERPES LABIALIS
U-1461   A METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE
U-1462   A METHOD OF USING A SCLEROSING AGENT FOR THE TREATMENT OF INCOMPETENT GREAT
                     35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                             PATENT AND EXCLUSIVITY TERMS                       ADB 63 of 67



                                          PATENT USE


           SAPHENOUS VEINS, ACCESSORY SAPHENOUS VEINS AND VISIBLE VARICOSITIES OF THE GREAT

           SAPHENOUS (GSV) SYSTEM ABOVE AND BELOW THE KNEE

U-1463		   A METHOD OF INTRAVENOUS INJECTION USING ULTRASOUND GUIDANCE, ADMINISTERED VIA A

           SINGLE CANNULA INTO THE LUMEN OF THE TARGET INCOMPETENT TRUNK VEINS OR BY DIRECT
	
           INJECTION INTO VARICOSITIES
	
U-1464		   TREATMENT OF OPIOID DEPENDENCE/SUBLINGUAL OR BUCCAL APPLICATION

U-1465		   USE OF THALIDOMIDE WHILE PREVENTING THE EXPOSURE OF A FETUS OR OTHER
	
           CONTRAINDICATED INDIVIDUAL TO THALIDOMIDE
	
U-1466		   RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES ADULTS AND CHILDREN 6
	
           YEARS OF AGE AND OLDER
	
U-1467		   METHOD OF TREATING HEPATITIS C
	
U-1468		   CONTROL OF PHOSPHOROUS LEVELS IN PATIENTS
	
U-1469		   USE OF PHOSYLRA FOR REDUCTION OF SERUM PHOSPHOROUS IN PATIENTS
	
U-1470		   FOR THE TREATMENT OF HEPATITIS C
	
U-1471		   A METHOD FOR TREATING CARDIOVASCULAR DISEASE COMPRISING ADMINISTERING A
	
           RECONSTITUTED LYOPHILIZED PHARMACEUTICAL COMPOSITION COMPRISING EPOPROSTENOL,

           ARGININE AND SODIUM HYDROXIDE.
	
U-1472		   INTENSIVE CARE UNIT SEDATION, INCLUDING SEDATION OF NON-INTUBATED PATIENTS PRIOR

           TO AND/OR DURING SURGICAL AND OTHER PROCEDURES

U-1473		   MANAGEMENT OF RISK OF DRONEDARONE/BETA-BLOCKER INTERACTION IN PATIENTS IN SINUS

           RYTHM WITH A HISTORY OF PAROXYSMAL OR PERSISTENT AF
	
U-1474		   A METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH
	
           ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO

           THE SKIN OF THE PATIENT
	
U-1475		   USE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO

           GROUP 1).

U-1476		   INDICATED FOR THE LONG-TERM, ONCE-DAILY, MAINTENANCE TREATMENT OF AIRFLOW

           OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),

           INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA.

U-1477		   USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL PRESCRIPTION MEDICATION
	
           ON THE SAME KNEE
	
U-1478		   METHOD OF REDUCING TG LEVELS IN PATIENT ON STATIN THERAPY SUFFERING FROM SEVERE
	
           HYPERTRIGLYCERIDEMIA
	
U-1479		   INCREASE TEAR PRODUCTION TO TREAT PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY

           EYE).

U-1480		   TREATMENT OF ADVANCED RENAL CELL CARCINOMA
	
U-1481		   REDUCTION IN RISK OF OVERT HEPATIC ENCEPHALOPATHY (HE) RECURRENCE

U-1482		   DICLOFENAC POTASSIUM FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
	
U-1483		   INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).

U-1484		   COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD

           SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION

           HEALING TIME IN ADULTS AND CHILDREN (6 YEARS OF AGE AND OLDER)

U-1485		   TREATING A SUBJECT UNDERGOING ABDOMINAL SURGERY BY ADMINISTERING ALVIMOPAN TO
	
           ACCELERATE THE TIME TO UPPER AND LOWER GASTROINTESTINAL RECOVERY FOLLOWING
	
           SURGERIES THAT INCLUDE PARTIAL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS
	
U-1486		   TREATMENT OF NON-24-HOUR SLEEP-WAKE DISORDER
	
U-1487		   METHOD OF INCREASING EYELASH GROWTH
	
U-1488		   USE OF TOPICAL DICLOFENAC FOR TREATING PAIN
	
U-1489		   USE OF TOPICAL DICLOFENAC ON A JOINT FOR TREATING OSTEOARTHRITIS
	
U-1490		   FOR USE IN PATIENTS HAVING SYMPTOMATIC OR PROGRESSIVE MEDULLARY THYROID CANCER,

           WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC DISEASE
	
U-1491		   TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
	
U-1492		   TREATMENT OF IRRITABILITY ASSOCIATED WITH AUTISTIC DISORDER
	
U-1493		   METHOD FOR PREVENTING ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS
	
U-1494		   SUBLINGUAL OR BUCCAL ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION COMPRISING
	
           BUPRENORPHINE AND NALOXONE
	
U-1495		   RISK REDUCTION OF REBLEEDING IN PTS FOLLOWING THERAPEUTIC ENDOSCOPY FOR ACUTE
	
           BLEEDING GASTRIC OR DUODENAL ULCERS IN ADULTS.
	
U-1496		   METHOD TO TREAT HEMANGIOMA.
	
U-1497		   NEURACEQ IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET)

           IMAGING OF THE BRAIN TO ESTIMATE P-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT

           PATIENTS WITH COGNITIVE IMPAIRMENT
	
U-1498		   METHOD OF TREATING PATIENTS WITH GASTRIC RETENTIVE DOSAGE FORM
	
U-1499		   MANAGEMENT OF ACUTE PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA
	
U-1500		   TESTOSTERONE REPLACEMENT THERAPY IN ADULT MALES FOR CONDITIONS ASSOCIATED WITH A
	
           DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE; PRIMARY HYPOGONADISM (CONGENITAL

           OR ACQUIRED); HYPOGONADOTROPIC HYPOGONADISM (CONGENITAL OR ACQUIRED).
	
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 64 of 67


                                        PATENT USE

U-1501   PROPHYLAXIS OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
U-1502   PROPHYLAXIS OF PULMONARY EMBOLISM
U-1503   METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN
         COMBINATION WITH METFORMIN
U-1504   USE OF OTEZLA (APREMILAST) FOR INHIBITING PDE4
U-1505   USE OF OTEZLA (APREMILAST) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
U-1506   TREATMENT OF PATIENTS WITH GASTROINTESTINAL STROMAL TUMOR (GIST), INCLUDING BUT
         NOT LIMITED TO PATIENTS PREVIOUSLY TREATED WITH IMATINIB AND PATIENTS WITH GIST
         HAVING RESISTANCE TO A KIT TYROSINE KINASE INHIBITOR
U-1507   TO MAINTAIN HEALING OF EE AND RELIEF OF HEARTBURN
U-1508   MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM
         OPIOID TREATMENT BY ORALLY ADMINISTERING A PLURALITY OF COMPOSITE SUBUNITS AS
         CLAIMED
U-1509   TREATMENT OF FREQUENT HEARTBURN BY ADMINISTERING A GASTRIC ACID REDUCER
U-1510   MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM
         OPIOD TREATEMENT BY ORALLY ADMINISTERING AN INTACT COMPOSITION AS CLAIMED.
U-1511   TREATMENT OF HYPERTRIGLYCERIDEMIA
U-1512   REDUCTION OF THROMBOTIC CARDIOVASCULAR EVENTS
U-1513   TREATMENT OF HIV-1 INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS
U-1514   MANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER BY BUCCAL OR SUBLINGUAL
         ADMINISTRATION OF FENTANYL
U-1515   METHOD OF TREATING IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULT PATIENTS.
U-1516   METHOD OF TREATING CHRONIC IDIOPATHIC CONSTIPATION IN ADULT PATIENTS.
U-1517   TREATMENT OF BACTERIAL INFECTIONS USING A TWO-DOSE REGIMEN OF DALBAVANCIN.
U-1518   MAINTAINING PUPIL SIZE BY PREVENTING INTRAOPERATIVE MIOSIS AND REDUCING
         POSTOPERATIVE OCULAR PAIN
U-1519   METHOD FOR THE LONG TERM TREATMENT OF CHRONIC CONSTIPATION IN A HUMAN SUBJECT WITH
         IRRITABLE BOWEL SYNDROME
U-1520   METHOD FOR THE LONG TERM TREATMENT OF CHRONIC CONSTIPATION IN A HUMAN SUBJECT
U-1521   MAINTENANCE TREATMENT OF OPIOID DEPENDENCE
U-1522   TREATMENT OF TYPE 2 DIABETES MELLITUS IN A PATIENT, WHEREIN GLYCEMIC CONTROL
         (HBA1C < 7.0%) IS NOT ACHIEVABLE USING ONE OR MORE OF INSULIN, METFORMIN,
         PIOGLITAZONE, OR ROSIGLITAZONE
U-1523   METHOD OF INDUCING TOPICAL ANESTHESIA IN THE EYE
U-1524   REDUCTION OF ELEVATED INTRAOCULAR PRESSURE
U-1525   METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY
U-1526   THE TREATMENT OF PATIENTS WITH TRAVELERS' DIARRHEA (TD) OR THE REDUCTION IN RISK
         OF OVERT HEPATIC ENCEPHALOPATHY (HE) RECURRENCE
U-1527   FOR THE TREATMENT OF OVERACTIVE BLADDER (OAB) WITH SYMPTOMS OF URGE URINARY
         INCONTINENCE, URGENCY, AND URINARY FREQUENCY
U-1528   A METHOD OF LOWERING INTRAOCULAR PRESSURE
U-1529   ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
U-1530   USE OF ARIPIPRAZOLE IN EXTENDED RELEASE INJECTABLE SUSPENSION
U-1531   METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
U-1532   METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS AND/OR CATAPLEXY IN NARCOLEPSY
         PATIENTS WITH SODIUM OXYBATE WHEN DIVALPROEX SODIUM IS CONCOMITANTLY ADMINISTERED.
U-1533   PULMONARY ADMINISTRATION OF PARTICLES COMPRISING A DIKETOPIPERAZINE AND INSULIN.
U-1534   ADMINISTRATION OF A COMPOSITION COMPRISING INSULIN COMPLEXED WITH A
         DIKETOPIPERAZINE.
U-1535   ADMINISTRATION OF A COMPOSITION COMPRISING INSULIN COMPLEXED WITH MICROPARTICLES
         OF A DIKETOPIPERAZINE.
U-1536   ADMINISTRATION OF A COMPOSITION COMPRISING A DIKETOPIPERAZINE AND INSULIN.
U-1537   TREATMENT OF A PATIENT HAVING DIABETES MELLITUS WITH A PRANDIAL RAPID ACTING
         INSULIN.
U-1538   ADMINISTRATION OF FDKP MICROPARTICLES COMPRISING INSULIN.
U-1539   PULMONARY ADMINISTRATION OF AN INSULIN COMPOSITION COMPRISING FDKP AT THE
         BEGINNING OF A MEAL TO A PATIENT ALSO BEING TREATED WITH A LONG-ACTING INSULIN.
U-1540   BUTRANS IS A PARTIAL OPIOID AGONIST PRODUCT INDICATED FOR THE MANAGEMENT OF PAIN
         SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG TERM OPIOID TREATMENT FOR
         WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE.
U-1541   TREATMENT OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) WHO HAVE SUBEPENDYMAL
         GIANT CELL ASTROCYTOMA (SEGA) THAT REQUIRES THERAPEUTIC INTERVENTION BUT CANNOT BE
         CURATIVELY RESECTED.
U-1542   FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND/OR NON-
         HODGKINS LYMPHOMA
U-1543   TREATMENT OF A PATIENT BY ADMINISTERING THE FORMULATION RECITED IN CLAIM 1 OR
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 65 of 67


                                        PATENT USE

         CLAIM 23
U-1544   TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
         (PTCL).
U-1545   A METHOD OF TRANSDERMALLY DELIVERING TESTOSTERONE
U-1546   FOR USE IN THE TREATMENT OF MALIGNANT HYPERTHERMIA IN CONJUNCTION WITH APPROPRIATE
         SUPPORTIVE MEASURES AND FOR THE PREVENTION OF MALIGNANT HYPERTHERMIA IN PATIENTS
         AT HIGH RISK.
U-1547   TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), CHRONIC BRONCHITIS OR
         EMPHYSEMA
U-1548   FOR THE LONG-TERM, ONCE-DAILY MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN
         PATIENTS WITH COPD, INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA, ALSO TO REDUCE
         EXACERBATIONS OF COPD IN PATIENTS WITH A HISTORY OF EXACERBATIONS
U-1549   FOR THE TREATMENT OF PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA
U-1550   METHOD OF TREATING METASTATIC PAPILLARY RENAL CELL CARCINOMA WITH TEMSIROLIMUS.
U-1551   METHOD OF TREATING PAPILLARY RENAL CELL CARCINOMA WITH TEMSIROLIMUS, IN THE
         ABSENCE OF INTERFERON ALPHA.
U-1552   FOR HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS (EE)
U-1553   TO MAINTAIN HEALING OF EE AND RELIEF OF HEARTBURN
U-1554   FOR THE TREATMENT OF HEARTBURN ASSOCIATED WITH SYMPTOMATIC NON-EROSIVE
         GASTROESOPHAGEAL DISEASE (GERD)
U-1555   MANAGEMENT OF MODERATE TO SEVERE PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-
         CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE
         INADEQUATE.
U-1556   MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM
         OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE.
U-1557   A METHOD OF TESTOSTERONE REPLACEMENT THERAPY COMPRISING THE STEP OF NASALLY
         ADMINISTERING TO A PATIENT IN NEED OF SUCH TREATMENT AN EFFECTIVE AMOUNT OF
         TESTOSTERONE GEL FORMULATION.
U-1558   FOR THE TREATMENT OF PATIENTS WITH RELAPSED FOLLICULAR B-CELL NON-HODGKIN LYMPHOMA
         OR [RELAPSED] SMALL LYMPHOCYTIC LYMPHOMA
U-1559   INDICATED FOR THE ONCE-DAILY MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC
         THERAPY IN PATIENTS AGED 12 YEARS OF AGE AND OLDER
U-1560   A METHOD OF DISRUPTING LEUKOCYTE FUNCTION, INCLUDING AS AN INHIBITOR OF PI3KDELTA
         KINASE
U-1561   USE OF OTEZLA (APREMILAST) FOR THE TREATMENT OF PSORIATIC ARTHRITIS
U-1562   TREATMENT OF PATIENTS WITH HEPATIC ENCEPHALOPATHY (HE)
U-1563   A METHOD OF TRANSDERMAL ADMINISTRATION OF A PHYSIOLOGICALLY ACTIVE AGENT TO A
         SUBJECT.
U-1564   A METHOD OF TREATING GAUCHER'S DISEASE
U-1565   METHOD OF TREATING, AS INTITIAL LOADING DOSE FOR MONOTHERAPY OR ADJUNCTIVE
         THERAPY, PARITAL ONSET-SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS OR OLDER
         WHEN ORAL ADMINISTRATION IS TEMPORARILY NOT FEASIBLE
U-1566   METHOD OF TREATING, AS MONOTHERAPY OR ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES
         IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER
U-1567   METHOD OF TREATING, AS INTITIAL LOADING DOSE FOR MONOTHERAPY OR ADJUNCTIVE
         THERAPY, PARITAL ONSET-SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS OR OLDER
U-1568   METHOD OF TREATING, AS MONOTHERAPY OR ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES
         IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER WHEN ORAL ADMINISTRATION IS
         TEMPORARILY NOT FEASIBLE
U-1569   TREATMENT OF BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS
U-1570   TREATMENT OF BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS USING A SINGLE DOSE
U-1571   TREATMENT OF GAUCHER DISEASE TYPE 1
U-1572   TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION.
U-1573   USE OF RUXOLITINIB (JAKAFI) FOR INHIBITING JANUS ASSOCIATED KINASES (JAKS) JAK1
         AND/OR JAK2.
U-1574   A METHOD OF CATALYZING THE HYDROLYSIS OF GLUCOCEREBROSIDE TO GLUCOSE AND CERAMIDE.
U-1575   PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO
         IMMUNOSUPPRESSIVE THERAPY
U-1576   TREATMENT OF LEUKEMIA
U-1577   CONTROL OF SERUM PHOSPHOROUS LEVELS
U-1578   TREATMENT OF ACUTE OTITIS MEDIA
U-1579   USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC
         CASTRATION-RESISTANT PROSTATE CANCER
U-1580   USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC
         CASTRATION-RESISTANT PROSTATE CANCER WHO HAD RECEIVED PRIOR DOCETAXEL CHEMOTHERAPY
U-1581   IN COMBINATION WITH DABRAFENIB FOR THE TREATMENT OF UNRESECTABLE OR METASTATIC
         MELANOMA.
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 66 of 67


                                        PATENT USE

U-1582   TREATMENT OF UNRESECTABLE OR METASTATIC MELANOMA
U-1583   FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
U-1584   USE OF NALTREXONE AND BUPROPION IN A LAYERED FORMULATION FOR CHRONIC WEIGHT
         MANAGEMENT FOR AFFECTING WEIGHT LOSS
U-1585   USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE
U-1586   FOR EFFECT ON BLOOD GLUCOSE PARAMETERS IN PATIENTS WITH INSULIN RESISTANCE
U-1587   SINGLE-DOSE INFILTRATION INTO THE SURGICAL SITE TO PRODUCE POSTSURGICAL ANALGESIA.
U-1588   THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
         (CRPC).
U-1589   METHOD OF USE FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM
         HYPERPHENYLALANINEMIA
U-1590   KUVAN IS INDICATED TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH
         HYPERPHENYLALANINEMIA
U-1591   TREATMENT OF ASTHMA IN PATIENTS AGED 12 YEARS AND OLDER
U-1592   TO REDUCE SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE
U-1593   MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD, INCLUDING CHRONIC
         BRONCHITIS AND EMPHYSEMA, AND REDUCTION OF EXACERBATIONS IN COPD PATIENTS.
U-1594   DILATION OF THE PUPIL
U-1595   USE OF OTEZLA (APREMILAST) FOR THE TREATMENT OF PSORIASIS
U-1596   LAMICTAL IS AN ANTIEPILEPTIC DRUG (AED) INDICATED FOR: EPILEPSY-ADJUNCTIVE THERAPY
         IN PATIENTS ≥ 2 YEARS OF AGE: (1.1) PARTIAL SEIZURES PRIMARY GENERALIZED TONIC-
         CLONIC SEIZURES
U-1597   TREATMENT OF DIABETIC MACULAR EDEMA
U-1598   METHOD OF ADMINISTRATION OF CONTROLLED RELEASE OXYMORPHONE
U-1599   MANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN
         ADNUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI INFLAMMATORY,
         ANALGESIC, AND ANTIPYRETIC ACTIVITY
U-1600   DOSAGE MODIFICATION FOLLOWING ELEVATED LIVER ENZYMES IN TREATMENT OF IDIOPATHIC
         PULMONARY FIBROSIS
U-1601   DOSE ESCALATION OVER 14 DAYS FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
U-1602   METHOD OF ADMINISTERING PIRFENIDONE CAPSULES TO TREAT A FIBROTIC CONDITION
U-1603   METHOD FOR ADMINISTERING PIRFENDONE TO REDUCE DRUG INTERACTIONS WITH FLUVOXAMINE
U-1604   METHOD FOR ADMINISTERING PIRFENDONE TO REDUCE DRUG INTERACTIONS WITH A STRONG
         INHIBITOR OF CYP1A2
U-1605   METHOD FOR ADMINISTERING PIRFENIDONE TO AVOID REDUCED EFFICACY BY DISCONTINUING
         SMOKING OR BY DISCONTINUING OR AVOIDING ANOTHER STRONG CYP1A2 INDUCER
U-1606   METHOD FOR ADMINISTERING PIRFENIDONE WHILE AVOIDING OR DISCONTINUING CONCOMITANT
         USE OF A MODERATE TO STRONG INHIBITOR OF BOTH CYP1A2 AND ANOTHER CYP ENZYME
         INVOLVED IN PIRFENIDONE METABOLISM
U-1607   METHOD OF ADMINISTERING A DOSAGE FORM THAT INCLUDES A GRANULATE FORMULATION OF
         PIRFENIDONE TO TREAT A FIBROTIC CONDITION
U-1608   DOSE ESCALATION OVER 14 DAYS FOR TREATMENT OF A FIBROSIS CONDITION
U-1609   CONTINUED DOSING OR DOSAGE MODIFICATION FOLLOWING ELEVATED LIVER ENZYMES IN
         TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
U-1610   CONTINUED DOSING OR DOSAGE MODIFICATION FOLLOWING ELVATED LIVER ENZYMES IN USE OF
         PIRFENIDONE
U-1611   METHOD FOR ADMINISTERING PIRFENIDONE TO AVOID REDUCED EFFICACY BY DISCONTINUING
         SMOKING OR BY DISCONTINUING A STRONG CYP1A2 INDUCER
U-1612   METHOD FOR ADMINISTERING PIRFENIDONE TO AVOID REDUCED EFFICACY BY AVOIDING SMOKING
         OR BY AVOIDING ANOTHER STRONG CYP1A2 INDUCER
U-1613   DOSAGE MODIFICATION IN TREATMENT WITH PIRFENIDONE TO REDUCE DRUG INTERACTIONS WITH
         CIPROFLOXACIN
U-1614   USE OF TOPICAL DICLOFENAC SODIUM FOR TREATING PAIN
U-1615   FOR THE TREATMENT OF PATIENTS WITH CCL, FL, OR SLL
U-1616   NASAL ADMINISTRATION OF A TESTOSTERONE GEL TO A PATIENT TO TREAT THE PATIENT FOR A
         CONDITION ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
U-1617   METHOD OF TREATING MEDULLARY THYROID CANCER
U-1618   A METHOD OF TREATING A PATIENT SUFFERING FROM A PAIN ASSOCIATED SLEEP DISTURBANCE
         COMPRISING ADMINISTERING A LIQUID COMPOSITION FONNULATED INSIDE A SOFT GEL
         CAPSULE, AS CLAIMED, TO THE PATIENT
U-1619   TREATMENT OF IMMUNE (IDIOPATIC) THROMBOCYTOPENIA (ITP)
U-1620   METHOD OF TREATMENT OF IRON-RELATED CONDITIONS WITH AT LEAST 0.6 GRAMS OF
         ELEMENTAL IRON VIA AN IRON CARBOHYDRATE COMPLEX, WITH A SUBSTANTIALLY NON-
         IMMUNOGENIC CARBOHYDRATE COMPONENT, IN ABOUT 15 MINUTES OR LESS.
U-1621   PULMONARY ADMINISTRATION OF A COMPOSITION COMPRISING INSULIN BOUND TO A COMPLEXING
         AGENT.
U-1622   FOR THE TREATMENT OF POLYCYTHEMIA VERA
                  35TH EDITION - 2015 - APPROVED DRUG PRODUCT LIST
	

                          PATENT AND EXCLUSIVITY TERMS                       ADB 67 of 67


                                        PATENT USE

U-1623   USE OF EXENATIDE MAY RESULT IN REDUCTION IN APPETITE.
U-1624   TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA, ADVANCED RENAL CELL CARCINOMA,
         OR DIFFERENTIATED THYROID CARCINOMA.
U-1625   METHOD OF TREATING SCHIZOPHRENIA BY ADMINISTERING ILOPERIDONE TO A PATIENT BY
         REDUCING THE DOSE IN PATIENTS WHO ARE POOR METABOLIZERS OF CYP2D6
U-1626   A METHOD OF TREATING OR PREVENTING OCULAR PAIN AND BURNING
U-1627   TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA IN ADULTS
U-1628   METHOD OF TREATING DISORDERS WITH AN ETIOLOGY COMPRISING OR ASSOCIATED WITH EXCESS
         GH-SECRETION
U-1629   METHOD OF TREATING ACROMEGALY
U-1630   TREATMENT IN COMBINATION WITH A CORTICOID SUCH AS PREDNISONE OF PROSTATE CANCER
         PREVIOUSLY TREATED IWTH DOCETAXEL
U-1631   TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA.
U-1632   TREATMENT OF SCHIZOPHRENIA, WITH EFFICACY IN TREATING ACUTE EPISODES OF
         SCHIZOPHRENIA
U-1633   USE OF ARIPIPRAZOLE IN EXTENDED RELEASE INJECTABLE SUSPENSION IN TREATING ACUTE
         EPISODES OF SCHIZOPHRENIA
U-1634   TREATMENT OF BRCA MUTATED OVARIAN CANCER USING PARP INHIBITOR
U-1635   USE OF RITONAVIR AS A POTENT CYP3A INHIBITOR TO INCREASE PLASMA DRUG CONCENTRATION
         OF PARITAPREVIR AND OVERALL DRUG EXPOSURE FOR TREATMENT OF HCV INFECTION
U-1636   USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION.
U-1637   TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND
         DASABUVIR WITH RIBAVIRIN.
U-1638   TREATMENT OF HCV INFECTION USING PARITAPREVIR
U-1639   USE OF NALTREXONE AND BUPROPION IN EXTENDED-RELEASE FORM FOR CHRONIC WEIGHT
         MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY
U-1640   TREATMENT OF MODERATE TO SEVERE CHRONIC PAIN BY ADMINISTERING AN INTACT
         COMPOSITION AS CLAIMED
U-1641   MEMANTINE HCL/DONEPEZIL HCL COMBINATION FOR THE TREATMENT OF MODERATE TO SEVERE
         DEMENTIA OF THE ALZHEIMER'S TYPE
U-1642   METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SEVERE CHRONIC RENAL
         IMPAIRMENT AND FOR WHOM METFORMIN THERAPY IS INAPPROPRIATE BY ADMINISTERING
         LINAGLIPTIN